Citrus Sinensis ID: 044312
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
|
|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
| ID | Alignment graph | Length |
Definition |
RBH(Q2H) |
RBH(H2Q) |
Q cover |
H cover |
Identity |
E-value |
| Query | 608 | 2.2.26 [Sep-21-2011] | |||||||
| Q9C9L5 | 792 | Wall-associated receptor | yes | no | 0.567 | 0.435 | 0.616 | 1e-128 | |
| Q7X8C5 | 748 | Wall-associated receptor | no | no | 0.633 | 0.514 | 0.553 | 1e-125 | |
| Q9S9M5 | 730 | Wall-associated receptor | no | no | 0.536 | 0.446 | 0.614 | 1e-124 | |
| Q9LN59 | 788 | Putative wall-associated | no | no | 0.569 | 0.439 | 0.625 | 1e-123 | |
| Q8VYA3 | 769 | Wall-associated receptor | no | no | 0.552 | 0.436 | 0.603 | 1e-122 | |
| Q9S9M2 | 761 | Wall-associated receptor | no | no | 0.547 | 0.437 | 0.602 | 1e-122 | |
| Q8RY17 | 751 | Wall-associated receptor | no | no | 0.534 | 0.432 | 0.625 | 1e-122 | |
| Q9LMT9 | 764 | Putative wall-associated | no | no | 0.536 | 0.426 | 0.622 | 1e-122 | |
| Q9S9M3 | 730 | Wall-associated receptor | no | no | 0.529 | 0.441 | 0.621 | 1e-121 | |
| Q9SA25 | 720 | Wall-associated receptor | no | no | 0.606 | 0.512 | 0.544 | 1e-118 |
| >sp|Q9C9L5|WAKLH_ARATH Wall-associated receptor kinase-like 9 OS=Arabidopsis thaliana GN=WAKL9 PE=2 SV=1 | Back alignment and function desciption |
|---|
Score = 459 bits (1180), Expect = e-128, Method: Compositional matrix adjust.
Identities = 223/362 (61%), Positives = 286/362 (79%), Gaps = 17/362 (4%)
Query: 205 FRFVISILRLYLSGVGCTSGGLGMFLLIGAWWLFKFVKRRREIKLKRKYFKRNGGLLLQQ 264
F+ V + R G+G + G L ++G + L+KF+K++R++ K+K+FKRNGGLLLQQ
Sbjct: 363 FKCVYNNHRPLAIGLGASFGSL--IFVVGIYLLYKFIKKQRKLNQKKKFFKRNGGLLLQQ 420
Query: 265 ELASTEGTIEKTKLFTSKELEKATDNFDLNRILGQGGQ--------------AVKKSKVI 310
+L ST G +EKT +F+S+ELEKAT+NF NRILGQGGQ AVKKSKV+
Sbjct: 421 QLISTVGMVEKTIVFSSRELEKATENFSSNRILGQGGQGTVYKGMLVDGRIVAVKKSKVV 480
Query: 311 DESKVEEFINEVVILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGTLFQYIHDQ-NEDF 369
DE K+EEFINEVVILSQINHRN+VKLLGCCLET+VP+LVYEFIPNG LF+++HD+ +E+
Sbjct: 481 DEDKLEEFINEVVILSQINHRNIVKLLGCCLETKVPVLVYEFIPNGNLFEHLHDEFDENI 540
Query: 370 PITWEIRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAV 429
TW IRLRIAI+++GALSYLHS+AS PIYHRD+KSTNI+LD+KYRAKVSDFG SR++ V
Sbjct: 541 MATWNIRLRIAIDIAGALSYLHSSASSPIYHRDVKSTNIMLDEKYRAKVSDFGTSRTVTV 600
Query: 430 DQTHMTTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLTELLTGEKPIRFTILEEDKSL 489
D TH+TT V GT GY+DPEYF+SSQFTDKSDVYSFGVVL EL+TGEK I F +E+++L
Sbjct: 601 DHTHLTTVVSGTVGYMDPEYFQSSQFTDKSDVYSFGVVLVELITGEKSISFLRSQENRTL 660
Query: 490 AAYFLCAMKEERLFEILDARVMKQGGKDEIITVAKLAKRCLNLNGKKRPTMREVASELAG 549
A YF+ AMKE +LF+I+DAR+ ++ AK+A++CLNL G+KRP+MREV+ EL
Sbjct: 661 ATYFILAMKENKLFDIIDARIRDGCMLSQVTATAKVARKCLNLKGRKRPSMREVSMELDS 720
Query: 550 IK 551
I+
Sbjct: 721 IR 722
|
Serine/threonine-protein kinase that may function as a signaling receptor of extracellular matrix component. Arabidopsis thaliana (taxid: 3702) EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: - |
| >sp|Q7X8C5|WAKLB_ARATH Wall-associated receptor kinase-like 2 OS=Arabidopsis thaliana GN=WAKL2 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 450 bits (1158), Expect = e-125, Method: Compositional matrix adjust.
Identities = 221/399 (55%), Positives = 297/399 (74%), Gaps = 14/399 (3%)
Query: 220 GCTSGGLGMFLLIGAWWLFKFVKRRREIKLKRKYFKRNGGLLLQQELASTEGTIEKTKLF 279
G G + G + L+KFV++RR++ RK+F+RNGG+LL+Q+LA EG +E +++F
Sbjct: 345 GVLIGSALLLFAFGIFGLYKFVQKRRKLIRMRKFFRRNGGMLLKQQLARKEGNVEMSRIF 404
Query: 280 TSKELEKATDNFDLNRILGQGGQ--------------AVKKSKVIDESKVEEFINEVVIL 325
+S ELEKATDNF+ NR+LGQGGQ AVK+SK +DE +VEEFINEVV+L
Sbjct: 405 SSHELEKATDNFNKNRVLGQGGQGTVYKGMLVDGRIVAVKRSKAVDEDRVEEFINEVVVL 464
Query: 326 SQINHRNVVKLLGCCLETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEIRLRIAIEVSG 385
+QINHRN+VKLLGCCLETEVP+LVYEF+PNG L + +HD+++D+ +TWE+RL IAIE++G
Sbjct: 465 AQINHRNIVKLLGCCLETEVPVLVYEFVPNGDLCKRLHDESDDYTMTWEVRLHIAIEIAG 524
Query: 386 ALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHGTFGYL 445
ALSYLHSAAS PIYHRDIK+TNILLD++ RAKVSDFG SRS+ +DQTH+TTQV GTFGY+
Sbjct: 525 ALSYLHSAASFPIYHRDIKTTNILLDERNRAKVSDFGTSRSVTIDQTHLTTQVAGTFGYV 584
Query: 446 DPEYFRSSQFTDKSDVYSFGVVLTELLTGEKPIRFTILEEDKSLAAYFLCAMKEERLFEI 505
DPEYF+SS+FT+KSDVYSFGVVL ELLTGEKP EE++ LAA+F+ A+KE R+ +I
Sbjct: 585 DPEYFQSSKFTEKSDVYSFGVVLVELLTGEKPSSRVRSEENRGLAAHFVEAVKENRVLDI 644
Query: 506 LDARVMKQGGKDEIITVAKLAKRCLNLNGKKRPTMREVASELAGIKAWNGASNVIEEGLE 565
+D R+ + D++++VA LA+RCLN GKKRP MREV+ EL I++ + S + E +
Sbjct: 645 VDDRIKDECNMDQVMSVANLARRCLNRKGKKRPNMREVSIELEMIRSSHYDSGIHIEDDD 704
Query: 566 EIDCALGDIYIVANSETNGSINESFLDDVTVSVDANPLI 604
E D ++ E + S ++ + + DA PL+
Sbjct: 705 EEDDQAMELNFNDTWEVGATAPASMFNNASPTSDAEPLV 743
|
Serine/threonine-protein kinase that may function as a signaling receptor of extracellular matrix component. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: - |
| >sp|Q9S9M5|WAKLA_ARATH Wall-associated receptor kinase-like 1 OS=Arabidopsis thaliana GN=WAKL1 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 446 bits (1147), Expect = e-124, Method: Compositional matrix adjust.
Identities = 209/340 (61%), Positives = 275/340 (80%), Gaps = 14/340 (4%)
Query: 227 GMFLLIGAWWLFKFVKRRREIKLKRKYFKRNGGLLLQQELASTEGTIEKTKLFTSKELEK 286
G+ +G +WLFK +K+RR I +K+FKRNGGLLL+Q+L + +G +E +K+F+SKEL K
Sbjct: 365 GLVFFVGLFWLFKLIKKRRNINRSKKFFKRNGGLLLKQQLTTKDGNVEMSKIFSSKELRK 424
Query: 287 ATDNFDLNRILGQGGQ--------------AVKKSKVIDESKVEEFINEVVILSQINHRN 332
ATDNF ++R+LGQGGQ AVK+SKV+DE K+EEFINE+V+LSQINHRN
Sbjct: 425 ATDNFSIDRVLGQGGQGTVYKGMLVDGSIVAVKRSKVVDEDKMEEFINEIVLLSQINHRN 484
Query: 333 VVKLLGCCLETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEIRLRIAIEVSGALSYLHS 392
+VKLLGCCLETEVP+LVYE+IPNG LF+ +HD+++D+ +TWE+RLRIAIE++GAL+Y+HS
Sbjct: 485 IVKLLGCCLETEVPILVYEYIPNGDLFKRLHDESDDYTMTWEVRLRIAIEIAGALTYMHS 544
Query: 393 AASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHGTFGYLDPEYFRS 452
AAS PI+HRDIK+TNILLD+KYRAKVSDFG SRS+ +DQTH+TT V GTFGY+DPEYF S
Sbjct: 545 AASFPIFHRDIKTTNILLDEKYRAKVSDFGTSRSVTLDQTHLTTLVAGTFGYMDPEYFLS 604
Query: 453 SQFTDKSDVYSFGVVLTELLTGEKPIRFTILEEDKSLAAYFLCAMKEERLFEILDARVMK 512
SQ+T KSDVYSFGVVL EL+TGEKP+ EE + LA +FL AMKE R+ +I+D R+
Sbjct: 605 SQYTHKSDVYSFGVVLVELITGEKPLSRVRSEEGRGLATHFLEAMKENRVIDIIDIRIKD 664
Query: 513 QGGKDEIITVAKLAKRCLNLNGKKRPTMREVASELAGIKA 552
+ ++++ VAKLA++CLN GK RP M+EV++EL I++
Sbjct: 665 ESKLEQVMAVAKLARKCLNRKGKNRPNMKEVSNELERIRS 704
|
Serine/threonine-protein kinase that may function as a signaling receptor of extracellular matrix component. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: - |
| >sp|Q9LN59|WAKLK_ARATH Putative wall-associated receptor kinase-like 11 OS=Arabidopsis thaliana GN=WAKL11 PE=3 SV=2 | Back alignment and function description |
|---|
Score = 441 bits (1134), Expect = e-123, Method: Compositional matrix adjust.
Identities = 227/363 (62%), Positives = 281/363 (77%), Gaps = 17/363 (4%)
Query: 205 FRFVISILRLYLSGVGCTSGGLGMFLLIGAWWLFKFVKRRREIKLKRKYFKRNGGLLLQQ 264
F + + R+ + GVG G L L++G WWL KF+K+RR K KRK+FKRNGGLLLQQ
Sbjct: 367 FNCIGNKTRVTMIGVGSAFGIL--VLVVGIWWLRKFLKKRRMSKRKRKFFKRNGGLLLQQ 424
Query: 265 ELASTEGTIEKTKLFTSKELEKATDNFDLNRILGQGGQ--------------AVKKSKVI 310
+L + +G +EKT++F+S+ELEKATDNF +RILGQGGQ AVKKSKV+
Sbjct: 425 QLNTNKGNVEKTRIFSSRELEKATDNFSESRILGQGGQGTVYKGMLVDGRTVAVKKSKVV 484
Query: 311 DESKVEEFINEVVILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGTLFQYIHDQNEDFP 370
DE K+EEFINEVVILSQINHR+VVKLLGCCLETEVP LVYEFIPNG LFQ+IH++++D+
Sbjct: 485 DEDKLEEFINEVVILSQINHRHVVKLLGCCLETEVPTLVYEFIPNGNLFQHIHEESDDYT 544
Query: 371 ITWEIRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVD 430
TW +RLRIA++++GALSYLHSAAS PIYHRDIKSTNILLD+KYR KVSDFG SRS+ +D
Sbjct: 545 KTWGMRLRIAVDIAGALSYLHSAASSPIYHRDIKSTNILLDEKYRTKVSDFGTSRSVTID 604
Query: 431 QTHMTTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLTELLTGEKP-IRFTILEEDKSL 489
TH TT + GT GY+DPEY+ SSQ+TDKSDVYSFGVVL EL+TGEKP I + +E + L
Sbjct: 605 HTHWTTVISGTVGYVDPEYYGSSQYTDKSDVYSFGVVLVELITGEKPVITVSNSQEIRGL 664
Query: 490 AAYFLCAMKEERLFEILDARVMKQGGKDEIITVAKLAKRCLNLNGKKRPTMREVASELAG 549
A +F AMKE R FEI+DAR+ ++++ VA LA+RCLN GKKRP MR+V ++L
Sbjct: 665 ADHFRVAMKENRFFEIMDARIRDGCKPEQVMAVANLARRCLNSKGKKRPCMRKVFTDLEK 724
Query: 550 IKA 552
I A
Sbjct: 725 ILA 727
|
Putative serine/threonine-protein kinase that may function as a signaling receptor of extracellular matrix component. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: - |
| >sp|Q8VYA3|WAKLJ_ARATH Wall-associated receptor kinase-like 10 OS=Arabidopsis thaliana GN=WAKL10 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 440 bits (1132), Expect = e-122, Method: Compositional matrix adjust.
Identities = 212/351 (60%), Positives = 282/351 (80%), Gaps = 15/351 (4%)
Query: 219 VGCTSGGLGMFLLIGAWWLFKFVKRRREIKLKRKYFKRNGGLLLQQELASTEGTIEKTKL 278
+G ++ + + G +WL+KF++R+R + K+K+FKRNGGLLLQQ+L +TEG ++ T++
Sbjct: 361 IGLSTSFSTLVFIGGIYWLYKFIRRQRRLNQKKKFFKRNGGLLLQQQLTTTEGNVDSTRV 420
Query: 279 FTSKELEKATDNFDLNRILGQGGQ--------------AVKKSKVIDESKVEEFINEVVI 324
F S+ELEKAT+NF L RILG+GGQ AVKKSKV+DE K+EEFINEVVI
Sbjct: 421 FNSRELEKATENFSLTRILGEGGQGTVYKGMLVDGRIVAVKKSKVVDEDKLEEFINEVVI 480
Query: 325 LSQINHRNVVKLLGCCLETEVPLLVYEFIPNGTLFQYIHDQNEDFPIT-WEIRLRIAIEV 383
LSQINHRN+VKLLGCCLET+VP+LVYEFIPNG LF+++HD ++D+ +T WE+RLRIA+++
Sbjct: 481 LSQINHRNIVKLLGCCLETDVPILVYEFIPNGNLFEHLHDDSDDYTMTTWEVRLRIAVDI 540
Query: 384 SGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHGTFG 443
+GALSYLHSAAS PIYHRDIKSTNI+LD+K+RAKVSDFG SR++ VD TH+TT V GT G
Sbjct: 541 AGALSYLHSAASSPIYHRDIKSTNIMLDEKHRAKVSDFGTSRTVTVDHTHLTTVVSGTVG 600
Query: 444 YLDPEYFRSSQFTDKSDVYSFGVVLTELLTGEKPIRFTILEEDKSLAAYFLCAMKEERLF 503
Y+DPEYF+SSQFTDKSDVYSFGVVL EL+TGEK + F +E ++LA YF AMKE RL
Sbjct: 601 YMDPEYFQSSQFTDKSDVYSFGVVLAELITGEKSVSFLRSQEYRTLATYFTLAMKENRLS 660
Query: 504 EILDARVMKQGGKDEIITVAKLAKRCLNLNGKKRPTMREVASELAGIKAWN 554
+I+DAR+ +++ AK+A++CLN+ G+KRP+MR+V+ EL I++++
Sbjct: 661 DIIDARIRDGCKLNQVTAAAKIARKCLNMKGRKRPSMRQVSMELEKIRSYS 711
|
Serine/threonine-protein kinase that may function as a signaling receptor of extracellular matrix component. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: - |
| >sp|Q9S9M2|WAKLD_ARATH Wall-associated receptor kinase-like 4 OS=Arabidopsis thaliana GN=WAKL4 PE=2 SV=2 | Back alignment and function description |
|---|
Score = 440 bits (1132), Expect = e-122, Method: Compositional matrix adjust.
Identities = 209/347 (60%), Positives = 268/347 (77%), Gaps = 14/347 (4%)
Query: 220 GCTSGGLGMFLLIGAWWLFKFVKRRREIKLKRKYFKRNGGLLLQQELASTEGTIEKTKLF 279
G G + G + L+KF+K++R R +F+RNGG+LL+Q+LA EG +E +K+F
Sbjct: 353 GVLIGSALLLFAFGIFGLYKFIKKQRRSSRMRVFFRRNGGMLLKQQLARKEGNVEMSKIF 412
Query: 280 TSKELEKATDNFDLNRILGQGGQ--------------AVKKSKVIDESKVEEFINEVVIL 325
+S ELEKATDNF+ NR+LGQGGQ AVK+SK +DE KVEEFINEVV+L
Sbjct: 413 SSNELEKATDNFNTNRVLGQGGQGTVYKGMLVDGRIVAVKRSKAMDEDKVEEFINEVVVL 472
Query: 326 SQINHRNVVKLLGCCLETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEIRLRIAIEVSG 385
+QINHRN+VKLLGCCLETEVP+LVYEF+PNG L + + D+ +D+ +TWE+RL IAIE++G
Sbjct: 473 AQINHRNIVKLLGCCLETEVPVLVYEFVPNGDLCKRLRDECDDYIMTWEVRLHIAIEIAG 532
Query: 386 ALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHGTFGYL 445
ALSYLHSAAS PIYHRDIK+TNILLD+KY+ KVSDFG SRS+ +DQTH+TTQV GTFGY+
Sbjct: 533 ALSYLHSAASFPIYHRDIKTTNILLDEKYQVKVSDFGTSRSVTIDQTHLTTQVAGTFGYV 592
Query: 446 DPEYFRSSQFTDKSDVYSFGVVLTELLTGEKPIRFTILEEDKSLAAYFLCAMKEERLFEI 505
DPEYF+SS+FTDKSDVYSFGVVL EL+TG+ P EE++ AA+F+ A+KE R +I
Sbjct: 593 DPEYFQSSKFTDKSDVYSFGVVLVELITGKNPSSRVQSEENRGFAAHFVAAVKENRFLDI 652
Query: 506 LDARVMKQGGKDEIITVAKLAKRCLNLNGKKRPTMREVASELAGIKA 552
+D R+ + D+++ VAKLAKRCLN GKKRP MREV+ EL I++
Sbjct: 653 VDERIKDECNLDQVMAVAKLAKRCLNRKGKKRPNMREVSVELERIRS 699
|
Serine/threonine-protein kinase that may function as a signaling receptor of extracellular matrix component. Plays a role in plant mineral nutrients response. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: - |
| >sp|Q8RY17|WAKLI_ARATH Wall-associated receptor kinase-like 22 OS=Arabidopsis thaliana GN=WAKL22 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 439 bits (1130), Expect = e-122, Method: Compositional matrix adjust.
Identities = 212/339 (62%), Positives = 277/339 (81%), Gaps = 14/339 (4%)
Query: 228 MFLLIGAWWLFKFVKRRREIKLKRKYFKRNGGLLLQQELASTEGTIEKTKLFTSKELEKA 287
+FL++G W L KFVK+RR+I KR +FKRNGGLLL+Q+L + G ++ +K+F+SKELEKA
Sbjct: 358 LFLVLGIWGLIKFVKKRRKIIRKRMFFKRNGGLLLKQQLTTRGGNVQSSKIFSSKELEKA 417
Query: 288 TDNFDLNRILGQGGQ--------------AVKKSKVIDESKVEEFINEVVILSQINHRNV 333
TDNF++NR+LGQGGQ AVK+SKV+DE KVEEFINEV +LSQINHRN+
Sbjct: 418 TDNFNMNRVLGQGGQGTVYKGMLVDGRIVAVKRSKVLDEDKVEEFINEVGVLSQINHRNI 477
Query: 334 VKLLGCCLETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEIRLRIAIEVSGALSYLHSA 393
VKL+GCCLETEVP+LVYE IPNG LF+ +H ++D+ +TW++RLRI++E++GAL+YLHSA
Sbjct: 478 VKLMGCCLETEVPILVYEHIPNGDLFKRLHHDSDDYTMTWDVRLRISVEIAGALAYLHSA 537
Query: 394 ASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHGTFGYLDPEYFRSS 453
AS P+YHRD+K+TNILLD+KYRAKVSDFG SRS+ VDQTH+TT V GTFGYLDPEYF++S
Sbjct: 538 ASTPVYHRDVKTTNILLDEKYRAKVSDFGTSRSINVDQTHLTTLVAGTFGYLDPEYFQTS 597
Query: 454 QFTDKSDVYSFGVVLTELLTGEKPIRFTILEEDKSLAAYFLCAMKEERLFEILDARVMKQ 513
QFTDKSDVYSFGVVL EL+TGEKP EE++ L ++F AMK+ R+ +I+D+R+ +
Sbjct: 598 QFTDKSDVYSFGVVLVELITGEKPFSVMRPEENRGLVSHFNEAMKQNRVLDIVDSRIKEG 657
Query: 514 GGKDEIITVAKLAKRCLNLNGKKRPTMREVASELAGIKA 552
++++ VAKLA+RCL+L GKKRP MREV+ EL I++
Sbjct: 658 CTLEQVLAVAKLARRCLSLKGKKRPNMREVSVELERIRS 696
|
Serine/threonine-protein kinase that may function as a signaling receptor of extracellular matrix component. Required during plant's response to pathogen infection. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: - |
| >sp|Q9LMT9|WAKLL_ARATH Putative wall-associated receptor kinase-like 13 OS=Arabidopsis thaliana GN=WAKL13 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 439 bits (1130), Expect = e-122, Method: Compositional matrix adjust.
Identities = 214/344 (62%), Positives = 265/344 (77%), Gaps = 18/344 (5%)
Query: 225 GLGMFLLI---GAWWLFKFVKRRREIKLKRKYFKRNGGLLLQQELASTEGTIEKTKLFTS 281
G G F+LI G WW K +++RR KRK+FKRNGGLLLQQ+L +T+G +EKTKLF+S
Sbjct: 385 GAGFFVLIVGGGIWWWRKLLRKRRMTNRKRKFFKRNGGLLLQQQLNTTQGRVEKTKLFSS 444
Query: 282 KELEKATDNFDLNRILGQGGQ--------------AVKKSKVIDESKVEEFINEVVILSQ 327
+ELEKATDNF+ NR++GQGGQ AVKKS V+DE K++EFINEV+ILSQ
Sbjct: 445 RELEKATDNFNDNRVIGQGGQGTVYKGMLVDGRSVAVKKSNVVDEDKLQEFINEVIILSQ 504
Query: 328 INHRNVVKLLGCCLETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEIRLRIAIEVSGAL 387
INHR+VVKLLGCCLETEVP+LVYEFIPNG LFQ++H++ +D+ W +R+RIA+++SGA
Sbjct: 505 INHRHVVKLLGCCLETEVPILVYEFIPNGNLFQHLHEEFDDYTALWGVRMRIAVDISGAF 564
Query: 388 SYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHGTFGYLDP 447
SYLH+AA PIYHRDIKSTNILLD+KYRAKVSDFG SRS+++D TH TT + GT GY+DP
Sbjct: 565 SYLHTAACSPIYHRDIKSTNILLDEKYRAKVSDFGTSRSVSIDHTHWTTVISGTVGYVDP 624
Query: 448 EYFRSSQFTDKSDVYSFGVVLTELLTGEKP-IRFTILEEDKSLAAYFLCAMKEERLFEIL 506
EY+ SS FT+KSDVYSFGVVL EL+TGEKP I + +E LA YF AM+E RLFEI+
Sbjct: 625 EYYGSSHFTEKSDVYSFGVVLVELITGEKPVITLSETQEITGLADYFRLAMRENRLFEII 684
Query: 507 DARVMKQGGKDEIITVAKLAKRCLNLNGKKRPTMREVASELAGI 550
DAR+ +++I VA LA RCL GK RP MREV++ L I
Sbjct: 685 DARIRNDCKLEQVIAVANLALRCLKKTGKTRPDMREVSTALERI 728
|
Putative serine/threonine-protein kinase that may function as a signaling receptor of extracellular matrix component. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: - |
| >sp|Q9S9M3|WAKLC_ARATH Wall-associated receptor kinase-like 3 OS=Arabidopsis thaliana GN=WAKL3 PE=2 SV=2 | Back alignment and function description |
|---|
Score = 435 bits (1118), Expect = e-121, Method: Compositional matrix adjust.
Identities = 210/338 (62%), Positives = 271/338 (80%), Gaps = 16/338 (4%)
Query: 229 FLLIGAWWLFKFVKRRREIKLKRKYFKRNGGLLLQQELASTEGTIEKTKLFTSKELEKAT 288
F +IG + L+KF+++RR I K+FKRNGGLLL+Q+L + +G++E +K+F+S+ELEKAT
Sbjct: 366 FFVIGIFGLYKFIRKRRRIIRSMKFFKRNGGLLLKQQLTTKDGSVEMSKIFSSRELEKAT 425
Query: 289 DNFDLNRILGQGGQ--------------AVKKSKVIDESKVEEFINEVVILSQINHRNVV 334
DNF ++R+LGQGGQ AVK+SKV+DE K+EEFINE+V+LSQINHRN+V
Sbjct: 426 DNFSIDRVLGQGGQGTVYKRMLVDGSIVAVKRSKVVDEDKMEEFINEIVLLSQINHRNIV 485
Query: 335 KLLGCCLETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEIRLRIAIEVSGALSYLHSAA 394
KLLGCCLETEVP+LVYE+IPNG LF+ +HD+ +D+ +TWE+RLRIA+E++GALSY+HSAA
Sbjct: 486 KLLGCCLETEVPILVYEYIPNGDLFKRLHDEYDDYMMTWEVRLRIAVEIAGALSYMHSAA 545
Query: 395 SIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHGTFGYLDPEYFRSSQ 454
S PI+HRDIK+TNILLD+KYRAK+SDFG SRS+A DQTH+TT V GTFGY+DPEYF SSQ
Sbjct: 546 SFPIFHRDIKTTNILLDEKYRAKISDFGTSRSVATDQTHLTTLVAGTFGYMDPEYFLSSQ 605
Query: 455 FTDKSDVYSFGVVLTELLTGEKPIRFTILEEDKSLAAYFLCAMKEERLFEILDARVMKQG 514
+T KSDVYSFGVVL EL+TGEKP+ EE LA YFL AMKE R +I+D R+ +
Sbjct: 606 YTHKSDVYSFGVVLVELITGEKPMSRVRSEEGIGLATYFLEAMKENRAVDIIDIRIKDE- 664
Query: 515 GKDEIITVAKLAKRCLNLNGKKRPTMREVASELAGIKA 552
+++ VAKLA+RCLN G KRP MREV+ +L I++
Sbjct: 665 -SKQVMAVAKLARRCLNRKGNKRPNMREVSIKLERIRS 701
|
Serine/threonine-protein kinase that may function as a signaling receptor of extracellular matrix component. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: - |
| >sp|Q9SA25|WAKLG_ARATH Wall-associated receptor kinase-like 8 OS=Arabidopsis thaliana GN=WAKL8 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 426 bits (1094), Expect = e-118, Method: Compositional matrix adjust.
Identities = 213/391 (54%), Positives = 283/391 (72%), Gaps = 22/391 (5%)
Query: 231 LIGAWWLFKFVKRRREIKLKRKYFKRNGGLLLQQELASTEGTIEKTKLFTSKELEKATDN 290
+ G W L K ++R+ K KRK+F+RNGGLLLQQ+ + G++ +TK+F+S +LE ATD
Sbjct: 330 IFGMWLLCKANRKRKVAKQKRKFFQRNGGLLLQQQTSFLHGSVNRTKVFSSNDLENATDR 389
Query: 291 FDLNRILGQGGQ--------------AVKKSKVIDESKVEEFINEVVILSQINHRNVVKL 336
F+ +RILGQGGQ AVKKSK + E +EEFINE+++LSQINHRNVVK+
Sbjct: 390 FNASRILGQGGQGTVYKGMLEDGMIVAVKKSKALKEENLEEFINEIILLSQINHRNVVKI 449
Query: 337 LGCCLETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEIRLRIAIEVSGALSYLHSAASI 396
LGCCLETEVP+LVYEFIPN LF ++H+ +EDFP++WE+RL IA EV+ ALSYLHSA SI
Sbjct: 450 LGCCLETEVPILVYEFIPNRNLFDHLHNPSEDFPMSWEVRLCIACEVADALSYLHSAVSI 509
Query: 397 PIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHGTFGYLDPEYFRSSQFT 456
PIYHRD+KSTNILLD+K+RAKVSDFG SRS+A+D TH+TT V GT GY+DPEY +S+ FT
Sbjct: 510 PIYHRDVKSTNILLDEKHRAKVSDFGISRSVAIDDTHLTTIVQGTIGYVDPEYLQSNHFT 569
Query: 457 DKSDVYSFGVVLTELLTGEKPIRFTILEEDKSLAAYFLCAMKEERLFEILDARVMKQGGK 516
KSDVYSFGV+L ELLTGEKP+ +E + L AYFL AM+ +RL EILDAR+ ++ +
Sbjct: 570 GKSDVYSFGVLLIELLTGEKPVSLLRRQEVRMLGAYFLEAMRNDRLHEILDARIKEECDR 629
Query: 517 DEIITVAKLAKRCLNLNGKKRPTMREVASELAGIKAWNGASNVIEEGLEE---IDCALGD 573
+E++ VAKLA+RCL+LN + RPTMR+V EL +++ + + EE I A+ +
Sbjct: 630 EEVLAVAKLARRCLSLNSEHRPTMRDVFIELDRMQSKRKGTQSQAQNGEEHAHIQIAMPE 689
Query: 574 IYIVANSETNGSINESFLDDVTVSVDANPLI 604
++ S N + S + S+D PL+
Sbjct: 690 SMSLSYSSPNIVVENS-----SFSLDTKPLM 715
|
Serine/threonine-protein kinase that may function as a signaling receptor of extracellular matrix component. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: - |
Close Homologs in the Non-Redundant Database Detected by BLAST
Original result of BLAST against Nonredundant Database
| GI | Alignment Graph | Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 608 | ||||||
| 255545828 | 694 | kinase, putative [Ricinus communis] gi|2 | 0.891 | 0.780 | 0.482 | 1e-159 | |
| 359475622 | 867 | PREDICTED: wall-associated receptor kina | 0.888 | 0.622 | 0.487 | 1e-153 | |
| 147765961 | 679 | hypothetical protein VITISV_007744 [Viti | 0.883 | 0.790 | 0.479 | 1e-152 | |
| 359475620 | 822 | PREDICTED: wall-associated receptor kina | 0.879 | 0.650 | 0.480 | 1e-151 | |
| 224118592 | 642 | predicted protein [Populus trichocarpa] | 0.865 | 0.819 | 0.465 | 1e-144 | |
| 255545824 | 727 | kinase, putative [Ricinus communis] gi|2 | 0.601 | 0.503 | 0.656 | 1e-144 | |
| 224143699 | 635 | predicted protein [Populus trichocarpa] | 0.850 | 0.814 | 0.477 | 1e-142 | |
| 255541802 | 743 | kinase, putative [Ricinus communis] gi|2 | 0.585 | 0.479 | 0.683 | 1e-141 | |
| 224103351 | 685 | predicted protein [Populus trichocarpa] | 0.934 | 0.829 | 0.445 | 1e-138 | |
| 224053054 | 722 | predicted protein [Populus trichocarpa] | 0.975 | 0.821 | 0.447 | 1e-138 |
| >gi|255545828|ref|XP_002513974.1| kinase, putative [Ricinus communis] gi|223547060|gb|EEF48557.1| kinase, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 567 bits (1461), Expect = e-159, Method: Compositional matrix adjust.
Identities = 320/663 (48%), Positives = 408/663 (61%), Gaps = 121/663 (18%)
Query: 6 CPDRCGDVGIQYPFGIGAGCYFDESFEVVC------------------------------ 35
C CG+V I++PFGIG GCY DESFEV C
Sbjct: 32 CESYCGNVPIEFPFGIGKGCYMDESFEVTCNSSSEPPKPFLTSINMELLEVLSPNQVQVN 91
Query: 36 ----------------------TPFSFSQGINKFLAIGCDNYANNQQNDSISSNSILTDA 73
TPF+FS N+F A GC+NYA Q+ + D
Sbjct: 92 NPVIYSNCSHKTSTASRVSLSGTPFTFSNASNRFTAKGCNNYAILMQD--------IGDT 143
Query: 74 GGECISICTCNPSESSGCCDMVC---NIPQNSSTKVLDANTSNVYSRSIPEGCTSLSLVY 130
G C+SIC + + SSGC + C IP K +AN +N +S + C S +V
Sbjct: 144 VGGCLSICR-DEANSSGCYGINCWQTTIP--PYMKSFEANMTNPFSDNT-NNCKSAFMVD 199
Query: 131 ADWIFSHYLETP--SGLKHEKMIPAVLEWGKYKGVC--YEDYN----SQTKVC----NKD 178
W + L ++ +PAVL+W Y+G C E YN + + C N+
Sbjct: 200 QSWFAFQSSSSRSLDDLNYKDHVPAVLDWANYQGYCDISEYYNITCTTDSSYCWKELNRS 259
Query: 179 DRCLIQLSSGTIFPHIVFG-NISSFIIFR---FVISILR---LYLSGVGCTSGGLG---- 227
C+ Q P N F ++R + R Y + C +
Sbjct: 260 QVCICQCEDPNKCPDQSSNYNCRLFCMYRPGGYNCPCPRGHGKYENSNRCYPNSVFWGKS 319
Query: 228 -----------------MFLLIGAWWLFKFVKRRREIKLKRKYFKRNGGLLLQQELASTE 270
+ LLIG W L+K +KRRR +KLK+ +FKRNGGLLL+Q+L+STE
Sbjct: 320 RTKTKSIIIGCGSGIGFLLLLIGIWSLYKIIKRRRAMKLKQNFFKRNGGLLLEQQLSSTE 379
Query: 271 GTIEKTKLFTSKELEKATDNFDLNRILGQGGQ--------------AVKKSKVIDESKVE 316
+E+TK+FTSKELEKATD++ NRILGQGGQ A+KKSKV+DE K++
Sbjct: 380 NYVEQTKVFTSKELEKATDDYHTNRILGQGGQGTVYKGMLIDGRVVAIKKSKVVDEDKLD 439
Query: 317 EFINEVVILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEIR 376
+FINEVVILSQINHRNVVKL+GCCLETEVPLLVYEFIPNGTL+QYIH+ NE+FP+TWE+R
Sbjct: 440 QFINEVVILSQINHRNVVKLIGCCLETEVPLLVYEFIPNGTLYQYIHNPNEEFPVTWEMR 499
Query: 377 LRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTT 436
LRIA EV+GAL+YLH+AAS+PIYHRDIKS+NILLD+KYRAKV+DFG S+S+++DQTH+TT
Sbjct: 500 LRIATEVAGALAYLHAAASMPIYHRDIKSSNILLDEKYRAKVADFGTSKSISIDQTHVTT 559
Query: 437 QVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLTELLTGEKPIRFTILEEDKSLAAYFLCA 496
+V GTFGYLDPEYF+SSQFT+KSDVYSFGVVL ELLTG+KPI E++SLA YFL
Sbjct: 560 RVQGTFGYLDPEYFQSSQFTEKSDVYSFGVVLVELLTGQKPISSYRSVEERSLATYFLMT 619
Query: 497 MKEERLFEILDARVMKQGGKDEIITVAKLAKRCLNLNGKKRPTMREVASELAGIKAWNGA 556
M+E RLFEILDARV+K+GG++EII +AKLA++CLNLNGKKRP M+ VA EL GI++ G
Sbjct: 620 MEESRLFEILDARVLKEGGREEIIAMAKLAEKCLNLNGKKRPKMKTVAIELEGIRSSQGH 679
Query: 557 SNV 559
++
Sbjct: 680 NHT 682
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|359475622|ref|XP_003631717.1| PREDICTED: wall-associated receptor kinase-like 10-like, partial [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 549 bits (1415), Expect = e-153, Method: Compositional matrix adjust.
Identities = 318/652 (48%), Positives = 397/652 (60%), Gaps = 112/652 (17%)
Query: 5 ACPDRCGDVGIQYPFGIG-AGCYFDESFEVVCT--------------------------- 36
C +RCGDV I YPFGIG AGCYFDE FEV C
Sbjct: 36 GCQERCGDVDIPYPFGIGSAGCYFDEWFEVTCNNSTDPPKPFLKGVNLEVLNVSLDGTIR 95
Query: 37 -------------------------PFSFSQGINKFLAIGCDNYANNQQNDSISSNSILT 71
PFSFS +F A+GC Q+D++
Sbjct: 96 VNNPVLLSQNCSGKPSNDTQWWEGGPFSFSNTYTRFTAVGCSALVYIMQDDTVI------ 149
Query: 72 DAGGECISICTCNPSESS--GCCDMVC---NIPQNSSTKVLDANTSNVYSRSIPEGCTSL 126
G C++ C + + + C + C +P + + T + S E C
Sbjct: 150 ---GGCMTFCKKDATAAKKASCYGLECCQTQVPPGLLSFTANLGTFSDGSADEQEQCKFA 206
Query: 127 SLVYADWIFSHYLETPSGLKHEKMIPAVLEWGKYKGVC---YEDYNSQTKVCNKDDRCLI 183
+V +W S+ + P +K + +PAVL+W Y C + N+ T C ++ C
Sbjct: 207 FMVDQEWFISN-VPDPHTVKDMEYVPAVLDWRIYNATCAASTSNLNTSTSFCGENTLC-- 263
Query: 184 QLSSGTIFPHIVFGNISSFIIFRFVISILRLYLSGVGC------------TSGGLGMFLL 231
S+ T SS I F + YL GC T G LG LL
Sbjct: 264 --STDT--------QTSSLICSCFPVYEGNPYLPQ-GCQGTQSIEDCAVITIGALGTLLL 312
Query: 232 I-GAWWLFKFVKRRREIKLKRKYFKRNGGLLLQQELASTEGTIEKTKLFTSKELEKATDN 290
+ AWWL+ +KRR++IK K K F RNGGLLL+Q+L+STEG I+KTKLFTSKELEKATD
Sbjct: 313 VLCAWWLYIVLKRRKKIKYKEKCFNRNGGLLLEQQLSSTEGNIDKTKLFTSKELEKATDR 372
Query: 291 FDLNRILGQGGQ--------------AVKKSKVIDESKVEEFINEVVILSQINHRNVVKL 336
++ NR++GQGG+ AVKK K++ +SK+E+FINEVVIL QINHRNVVKL
Sbjct: 373 YNENRVIGQGGEGTVYKGMLMDGRIVAVKKLKIMSDSKLEQFINEVVILCQINHRNVVKL 432
Query: 337 LGCCLETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEIRLRIAIEVSGALSYLHSAASI 396
LGCCLETEVPLLVYEFIPNGTL ++IH QNE+FPITWEIRLRIA EV+GALSYLHSAAS+
Sbjct: 433 LGCCLETEVPLLVYEFIPNGTLSEHIHGQNEEFPITWEIRLRIATEVAGALSYLHSAASV 492
Query: 397 PIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHGTFGYLDPEYFRSSQFT 456
PIYHRDIKSTNILLDDKYRAKV+DFG S+ +A+DQTH+TTQV GTFGYLDPEYF+SSQFT
Sbjct: 493 PIYHRDIKSTNILLDDKYRAKVADFGISKFVAIDQTHLTTQVQGTFGYLDPEYFQSSQFT 552
Query: 457 DKSDVYSFGVVLTELLTGEKPIRFTILEEDKSLAAYFLCAMKEERLFEILDARVMKQGGK 516
+KSDVYSFG+VL ELLTG+KPI T EE KSLA+YF+ +M E+RL ++LDA+V+K+ K
Sbjct: 553 EKSDVYSFGIVLIELLTGKKPILSTASEEGKSLASYFILSMNEDRLSDLLDAQVVKESRK 612
Query: 517 DEIITVAKLAKRCLNLNGKKRPTMREVASELAGIKAWNGASNVIEEGLEEID 568
+EI +A LA+RC+NLNGKKRPTM EVA EL I+ G +E EEI+
Sbjct: 613 EEINAIAFLARRCINLNGKKRPTMMEVAMELERIRKCQGDFGA-QENSEEIE 663
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|147765961|emb|CAN70207.1| hypothetical protein VITISV_007744 [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 543 bits (1399), Expect = e-152, Method: Compositional matrix adjust.
Identities = 310/647 (47%), Positives = 394/647 (60%), Gaps = 110/647 (17%)
Query: 5 ACPDRCGDVGIQYPFGIGA-GCYFDESFEVVCT--------------------------- 36
C + CGDV I YPFGIG+ GCYFDE FEV C
Sbjct: 29 GCQEWCGDVDIPYPFGIGSSGCYFDEWFEVTCNNSTDPPKPFLKGVNLEVLNVSLHGTVR 88
Query: 37 -------------------------PFSFSQGINKFLAIGCDNYANNQQNDSISSNSILT 71
PFSFS +F A+GC A Q+D++
Sbjct: 89 VNNPVLLSQNCSGKPSNDTQWWEGGPFSFSNTYTRFTAVGCSAMAYFMQDDTVI------ 142
Query: 72 DAGGECISIC---TCNPSESSGCCDMVC---NIPQNSSTKVLDANTSNVYSRSIPEGCTS 125
G C+++C ++++ C + C +P + + +T S E C
Sbjct: 143 ---GGCMTLCKKDVATAAKNASCYGLECCQTQVPPGLLSFTANLDTFPEGSADEQEPCKY 199
Query: 126 LSLVYADWIFSHYLETPSGLKHEKMIPAVLEWGKYKGVC---YEDYNSQTKVCNKDDRCL 182
+V +W S+ + P +K + +PAVL+W Y C + N+ T C ++ C
Sbjct: 200 AFMVDQEWFISN-VPDPHTVKDMEYVPAVLDWRIYNATCDASTSNLNTSTSFCGENTFCS 258
Query: 183 IQLSSGTIF---PHIVFGNISSFIIFRFVISILRLYLSGVGC---TSGGLGMFLLI-GAW 235
+ ++ P + GN YL GC T G LG LL+ AW
Sbjct: 259 TDTQTSSLTCSCPLLYEGNP---------------YLPQ-GCQVITIGSLGTLLLVLCAW 302
Query: 236 WLFKFVKRRREIKLKRKYFKRNGGLLLQQELASTEGTIEKTKLFTSKELEKATDNFDLNR 295
WL+ +KRR++IK K K F RNGGLLL+Q+L+S+EG I+KTKLFTSKELEKATD ++ NR
Sbjct: 303 WLYIXLKRRKKIKYKEKCFNRNGGLLLEQQLSSSEGNIDKTKLFTSKELEKATDRYNENR 362
Query: 296 ILGQGGQ--------------AVKKSKVIDESKVEEFINEVVILSQINHRNVVKLLGCCL 341
++GQG Q AVKK K++ +SK+E+FINEVVIL QINHRNVVKLLGCCL
Sbjct: 363 VIGQGXQGTXYKGMLMDGRIVAVKKLKIMSDSKLEQFINEVVILCQINHRNVVKLLGCCL 422
Query: 342 ETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEIRLRIAIEVSGALSYLHSAASIPIYHR 401
ETEVPLLVYEFIPNGTL ++IH QNE+FPITWE+RLRIA EV GALSYLHS ASIPIYHR
Sbjct: 423 ETEVPLLVYEFIPNGTLSEHIHGQNEEFPITWEMRLRIATEVXGALSYLHSXASIPIYHR 482
Query: 402 DIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHGTFGYLDPEYFRSSQFTDKSDV 461
DIKSTNILLBDKYRAKV+DFG S+ +A+DQTH+TTQV GTFGYLDPEYF+SSQFT+KSDV
Sbjct: 483 DIKSTNILLBDKYRAKVADFGISKFVAIDQTHLTTQVQGTFGYLDPEYFQSSQFTEKSDV 542
Query: 462 YSFGVVLTELLTGEKPIRFTILEEDKSLAAYFLCAMKEERLFEILDARVMKQGGKDEIIT 521
YSFG+VL ELLTG+KPI EE KSLA+YF+ +M E+RL ++LDA+V+K+ K+EI
Sbjct: 543 YSFGIVLIELLTGKKPILSIASEEGKSLASYFILSMNEDRLSDLLDAQVVKESRKEEINA 602
Query: 522 VAKLAKRCLNLNGKKRPTMREVASELAGIKAWNGASNVIEEGLEEID 568
+A LA+RC+NLNGKKRPTM EVA EL I+ G +E EEI+
Sbjct: 603 IAFLARRCINLNGKKRPTMMEVAMELERIRKCQGDFRA-QENFEEIE 648
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|359475620|ref|XP_002266785.2| PREDICTED: wall-associated receptor kinase-like 1-like [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 542 bits (1396), Expect = e-151, Method: Compositional matrix adjust.
Identities = 320/666 (48%), Positives = 397/666 (59%), Gaps = 131/666 (19%)
Query: 5 ACPDRCGDVGIQYPFGIG-AGCYFDESFEVVCT---------PF---------------- 38
C + CGDV I YPFGIG AGCYFDE FEV C PF
Sbjct: 152 GCLETCGDVDIPYPFGIGSAGCYFDEWFEVTCNNSIHPHIPKPFLKILNLEVLNVSLNRS 211
Query: 39 ------------------------------SFSQGINKFLAIGCDNYANNQQNDSISSNS 68
SFS +F A+GC A QNDS+
Sbjct: 212 TIRVNNPVLGYMNCSGKPSNDAQSWEGGPFSFSDTYTRFTAVGCSTLAYITQNDSVI--- 268
Query: 69 ILTDAGGECISICT--CNPSESSGCCDMVCNIPQNSS-----TKVLDANTSNVYSRSIPE 121
G C+S C +++ C + C Q T +L SN + +
Sbjct: 269 ------GGCMSYCKQGTTAAKNGSCYGLKCCQTQFPPGLQYFTTMLGDFPSNSDDQ---D 319
Query: 122 GCTSLSLVYADWIFSHYLETPSGLKHEKMIPAVLEWGKYKGVC-------------YEDY 168
C +V +W S + P +K PAVL+W Y C +
Sbjct: 320 ECKYAFMVDQEWFISME-QDPDKVKDVGHAPAVLDWRIYNATCKSVGWNNTSTSNTSTSF 378
Query: 169 NSQTKVCNKDD-------RC---------LIQLSSGTIFPHIVFG--------NISSFII 204
+C+ D RC L + GT + G N S + +
Sbjct: 379 CGANAICSADTQTPSLTCRCPRGYEGNPYLTEGCEGTNYKLYENGTVCINRNANFSCYPV 438
Query: 205 FRFVIS--ILRLYLSG--VGCTSGGLGMFLLIGAWWLFKFVKRRREIKLKRKYFKRNGGL 260
+ ++ R+ L G VG +G + L+I AWWL+K +KRR++IK K K FKRNGGL
Sbjct: 439 DKLIVDPRPRRMVLPGICVGILAGVGTLLLVICAWWLYKVLKRRQKIKYKEKCFKRNGGL 498
Query: 261 LLQQELASTEGTIEKTKLFTSKELEKATDNFDLNRILGQGGQ--------------AVKK 306
LL+Q+L+S+EG ++KTKLFTSKELEKATD ++ NR++GQGGQ AVKK
Sbjct: 499 LLEQQLSSSEGNVDKTKLFTSKELEKATDRYNENRVIGQGGQGTVYKGMLMDGRIVAVKK 558
Query: 307 SKVIDESKVEEFINEVVILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGTLFQYIHDQN 366
K++ + KVE+FINEVVILSQINHRNVVKLLGCCLET VPLLVYEFIPNGTL ++IHDQN
Sbjct: 559 LKIVGDGKVEQFINEVVILSQINHRNVVKLLGCCLETAVPLLVYEFIPNGTLSEHIHDQN 618
Query: 367 EDFPITWEIRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRS 426
E+FPITWE+RLRIAIEV+GALSYLHSAASIPIYHRDIKSTNILLDDKYRAKV+DFG S+S
Sbjct: 619 EEFPITWEMRLRIAIEVAGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVADFGTSKS 678
Query: 427 MAVDQTHMTTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLTELLTGEKPIRFTILEED 486
+A+DQTH+TTQV GTFGYLDPEYF+SSQFT+KSDVYSFG+VL ELLTG+KPI T EE
Sbjct: 679 VAIDQTHLTTQVQGTFGYLDPEYFQSSQFTEKSDVYSFGIVLIELLTGKKPILSTASEEG 738
Query: 487 KSLAAYFLCAMKEERLFEILDARVMKQGGKDEIITVAKLAKRCLNLNGKKRPTMREVASE 546
KSLA+YF+ +M E+RL ++LDA+V+K+G K+EI +A LA+RC+NLNGKKRPTM EVA E
Sbjct: 739 KSLASYFILSMNEDRLSDLLDAQVVKEGKKEEINAIAFLARRCINLNGKKRPTMMEVAME 798
Query: 547 LAGIKA 552
L +K
Sbjct: 799 LEILKT 804
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224118592|ref|XP_002331400.1| predicted protein [Populus trichocarpa] gi|222873614|gb|EEF10745.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 518 bits (1333), Expect = e-144, Method: Compositional matrix adjust.
Identities = 300/645 (46%), Positives = 377/645 (58%), Gaps = 119/645 (18%)
Query: 5 ACPDRCGDVGIQYPFGIGAGCYFDESFEVVC----------------------------- 35
C CGD+ I YPFG+ GCY DE F+++C
Sbjct: 5 GCESYCGDISIPYPFGMKEGCYLDERFKILCNSSSGVPKLTVNGTDLEVNNISVDDSTIA 64
Query: 36 -----------------------TPFSFSQGINKFLAIGCDNYANNQQNDSISSNSILTD 72
+PF FS N F+A GC N A QN S
Sbjct: 65 VMFPIVFANCSGKDGNTVVDLEGSPFVFSSE-NYFIARGCGNLALMNQNQS--------- 114
Query: 73 AGGECISICTCNPSESSGCCDMV--CNIPQNSSTKVLDANTSNVYSRSIPEG---CTSLS 127
A G C+S+C N C + C S KV + + G C
Sbjct: 115 AIGGCVSLCDKNRDSMMASCSGIDCCQTRIPSFLKVFNVTMKGLEDGKGSRGENECRYAF 174
Query: 128 LVYADWI--------------FSHYLETPSGLKHEKMIPAVLEWGKYKGVCYED------ 167
L+ W F Y + + +P VL+WG + V +E
Sbjct: 175 LIDERWTNYGGYYYDYYFGGNFDFYYDK----RERDHVPVVLDWGIDRRV-FESLVKNGS 229
Query: 168 -YNSQ-TKVCNKDDRCLIQLSSGTIFPHIVFGNISSFIIFRFVISILRLYLSGVGCTSGG 225
YNS T C + + L + G + IV SSF S+ +L C G
Sbjct: 230 FYNSSYTSTCFEGNPYLSGICQGKLL--IVVSQFSSFP------SMNNAFLKK--CVGGF 279
Query: 226 LGMFLLIGAWWLFKFVKRRREIKLKRKYFKRNGGLLLQQELASTEGTIEKTKLFTSKELE 285
+FLLIG WWL+K KR+R KLK+KYFKRNGGLLLQ++L+S E +EK K+F SKEL+
Sbjct: 280 GALFLLIGLWWLYKVFKRKRSEKLKKKYFKRNGGLLLQEQLSSGEVNVEKIKMFPSKELD 339
Query: 286 KATDNFDLNRILGQGGQ--------------AVKKSKVIDESKVEEFINEVVILSQINHR 331
KATD++++NR LGQGGQ AVKKSK IDE + +FINEVV+LSQINHR
Sbjct: 340 KATDHYNVNRTLGQGGQGTVYKGMLADGKIVAVKKSKEIDEGNLRQFINEVVLLSQINHR 399
Query: 332 NVVKLLGCCLETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEIRLRIAIEVSGALSYLH 391
NVVKLLGCCLETE+PLL+YEFIPNGTLFQ++HD NE+FP+TWE+RLRIA EV+GAL YLH
Sbjct: 400 NVVKLLGCCLETELPLLIYEFIPNGTLFQFLHDPNEEFPLTWEMRLRIAAEVAGALFYLH 459
Query: 392 SAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHGTFGYLDPEYFR 451
SAAS+PI+HRDIKSTNILLD++YRAKV+DFG SRS+++DQTH+TT+V GTFGYLDPEYF+
Sbjct: 460 SAASLPIFHRDIKSTNILLDEEYRAKVADFGTSRSVSIDQTHVTTRVQGTFGYLDPEYFQ 519
Query: 452 SSQFTDKSDVYSFGVVLTELLTGEKPIRFTILEED-KSLAAYFLCAMKEERLFEILDARV 510
SSQFTDKSDVYSFGVVL ELLTG+KPI FT EE +SLA YF+ AM+ LF+ILD +V
Sbjct: 520 SSQFTDKSDVYSFGVVLVELLTGQKPISFTRSEEQGRSLATYFIMAMESNCLFDILDPQV 579
Query: 511 MKQGGKDEIITVAKLAKRCLNLNGKKRPTMREVASELAGIKAWNG 555
+KQG +++++ VA LA+ CL LNGK+RPTM+ V +NG
Sbjct: 580 VKQGEREDVLMVASLARSCLRLNGKERPTMKGVTMRSGTKTDYNG 624
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|255545824|ref|XP_002513972.1| kinase, putative [Ricinus communis] gi|223547058|gb|EEF48555.1| kinase, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 516 bits (1330), Expect = e-144, Method: Compositional matrix adjust.
Identities = 254/387 (65%), Positives = 315/387 (81%), Gaps = 21/387 (5%)
Query: 238 FKFVKRRREIKLKRKYFKRNGGLLLQQELASTEGTIEKTKLFTSKELEKATDNFDLNRIL 297
+K +KRRR KLK+K+FKRNGGLLL+Q+L+STE +E+TK+FTSKELEKATDN+ +RIL
Sbjct: 342 YKIIKRRRATKLKQKFFKRNGGLLLEQQLSSTESHVEQTKVFTSKELEKATDNYHTSRIL 401
Query: 298 GQGGQ--------------AVKKSKVIDESKVEEFINEVVILSQINHRNVVKLLGCCLET 343
GQGGQ A+KKSK++DE K+++FINEVVILSQINHRNVVKL GCCLET
Sbjct: 402 GQGGQGTVYKGMLTDGRVVAIKKSKLVDEDKLDQFINEVVILSQINHRNVVKLTGCCLET 461
Query: 344 EVPLLVYEFIPNGTLFQYIHDQNEDFPITWEIRLRIAIEVSGALSYLHSAASIPIYHRDI 403
EVPLLVYEFIPNGTLFQYI + N++FPITWE+RLRIA EV+GAL+YLHSAAS+PIYHRDI
Sbjct: 462 EVPLLVYEFIPNGTLFQYIQNPNKEFPITWEMRLRIATEVAGALAYLHSAASMPIYHRDI 521
Query: 404 KSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHGTFGYLDPEYFRSSQFTDKSDVYS 463
KS+NILLD+KYRAKV+DFG S+S+A++QTH+TT V GTFGYLDPEYF+SSQFT+KSDVYS
Sbjct: 522 KSSNILLDEKYRAKVADFGTSKSIAIEQTHVTTLVQGTFGYLDPEYFQSSQFTEKSDVYS 581
Query: 464 FGVVLTELLTGEKPIRFTILEEDKSLAAYFLCAMKEERLFEILDARVMKQGGKDEIITVA 523
FGVVL ELLTG+KPI E++SLA YFL M+E RLFEILDARV+K+GG++EII +A
Sbjct: 582 FGVVLVELLTGQKPISSLRSVEERSLATYFLMTMEENRLFEILDARVLKEGGREEIIAMA 641
Query: 524 KLAKRCLNLNGKKRPTMREVASELAGIKAWNGASNVIEEGLEEIDCALGDI---YIVANS 580
K+A++CLNLNGKKRP M+ VA EL GI++ G S+ I++ EE+D +GD + VA+S
Sbjct: 642 KMAEKCLNLNGKKRPKMKTVAIELEGIRSSQGVSSTIQQDYEEVDYVVGDYTASWDVASS 701
Query: 581 ETNGSINESFLDDVTVSVDANPLIKSN 607
T GS+N + + D PL+ SN
Sbjct: 702 ST-GSLNST---TIRARFDVKPLLPSN 724
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224143699|ref|XP_002336072.1| predicted protein [Populus trichocarpa] gi|222869913|gb|EEF07044.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 511 bits (1315), Expect = e-142, Method: Compositional matrix adjust.
Identities = 305/639 (47%), Positives = 380/639 (59%), Gaps = 122/639 (19%)
Query: 5 ACPDRCGDVGIQYPFGIGAGCYFDESFEVVC----------------------------- 35
CPDRCGD+ I YPFGI CY +E F + C
Sbjct: 26 GCPDRCGDISIPYPFGIRKDCYMNEWFAIECNASVNPARAFISRINMEVLNISAERATAT 85
Query: 36 -----------------------TPFSFSQGINKFLAIGCDNYANNQQNDSISSNSILTD 72
TPF FS+ N F+A+GC+ A I+ N I
Sbjct: 86 VKSPIISSNCTGREDGVPLNLTGTPFVFSRYDNVFIAVGCNTQA---LMTGITPNLI--- 139
Query: 73 AGGECISICTCNPSESSGCCDMVCNIPQNSSTKVLDANTSNVYSRSIPEGCTSLSLVYAD 132
C+S TC+ +S C+ + +P SS +V + EGC LV
Sbjct: 140 ---GCVS--TCSDVKSKNFCEAL--LP--SSLQVFNPRIEATDDNQDREGCKLAFLVNHT 190
Query: 133 WIFSHYLETPSGLKHEKMIPAVLEW---------------------------GKYKGVCY 165
W F + P L+ +PA L W G Y+G+ Y
Sbjct: 191 W-FESNVSDPFSLQSRDYVPAELGWAMSVNDDDPVYCRGYYNRSFGSECECDGGYEGIPY 249
Query: 166 EDYNSQTKVCNKDDRCLIQLSSGTIFPHIVFGNISSFIIFRFVISILRLYLSGVGCTSGG 225
C D C S V N + F I +LY++ + +
Sbjct: 250 LG-------CIDVDECKESKHSCRGLLKCV--NTRGY----FNCEINKLYIALIVIGAVV 296
Query: 226 LGMFLLIGAWWLFKFVKRRREIKLKRKYFKRNGGLLLQQELASTEGTIEKTKLFTSKELE 285
L + LL+G WWL+K VK+ ++I+LK+K+FKRNGGLLLQQEL + EG ++KTK+++SKELE
Sbjct: 297 LALSLLMGIWWLYKLVKKWKKIELKKKFFKRNGGLLLQQELRAAEGWVQKTKIYSSKELE 356
Query: 286 KATDNFDLNRILGQGGQ--------------AVKKSKVIDESKVEEFINEVVILSQINHR 331
ATD F++NRILGQGGQ AVKKS V+DE K+EEFINEVV+LSQINHR
Sbjct: 357 VATDRFNVNRILGQGGQGTVYKGMLADGRIVAVKKSMVVDEGKLEEFINEVVVLSQINHR 416
Query: 332 NVVKLLGCCLETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEIRLRIAIEVSGALSYLH 391
NVVKLLGCCLETEVPLLVYEFIPNG L++YIHD NEDF ++WE+RLRIAIEV+GALSYLH
Sbjct: 417 NVVKLLGCCLETEVPLLVYEFIPNGNLYKYIHDPNEDFLLSWEMRLRIAIEVAGALSYLH 476
Query: 392 SAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHGTFGYLDPEYFR 451
SA SIPIYHRDIKSTNILLD+KYRAKVSDFG+SRS+++DQTH+TT V GTFGYLDPEYF+
Sbjct: 477 SATSIPIYHRDIKSTNILLDEKYRAKVSDFGSSRSISIDQTHLTTLVQGTFGYLDPEYFQ 536
Query: 452 SSQFTDKSDVYSFGVVLTELLTGEKPIRFTILEEDKSLAAYFLCAMKEERLFEILDARVM 511
SSQFT+KSDVYSFGVVL EL++G+KPI E +SLA +F+ M++ RL ++LDARV
Sbjct: 537 SSQFTEKSDVYSFGVVLVELISGQKPIFSVSQTETRSLATHFIMLMEDNRLSDVLDARVK 596
Query: 512 KQGGKDEIITVAKLAKRCLNLNGKKRPTMREVASELAGI 550
+ +E+I+VA LAKRCLNLNGK RPTMREV SEL I
Sbjct: 597 EGCQNEEVISVANLAKRCLNLNGKNRPTMREVTSELERI 635
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|255541802|ref|XP_002511965.1| kinase, putative [Ricinus communis] gi|223549145|gb|EEF50634.1| kinase, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 508 bits (1308), Expect = e-141, Method: Compositional matrix adjust.
Identities = 261/382 (68%), Positives = 313/382 (81%), Gaps = 26/382 (6%)
Query: 205 FRFVISILRLYLSGVGCTSGGLGM-FLLIGAWWLFKFVKRRREIKLKRKYFKRNGGLLLQ 263
FR VI+I+ S GLG+ FLLIG WWL+K KRR++ KL++++FKRNGGLLLQ
Sbjct: 324 FRPVIAIV---------LSAGLGIPFLLIGTWWLYKVQKRRKDAKLRQRFFKRNGGLLLQ 374
Query: 264 QELASTEGTIEKTKLFTSKELEKATDNFDLNRILGQGGQ--------------AVKKSKV 309
Q+L+S+E +IEKT +FT+KELEKATD+++ NRILGQGGQ A+KKSK+
Sbjct: 375 QQLSSSESSIEKTNMFTAKELEKATDHYNENRILGQGGQGTVYKGMLTDGKVVAIKKSKI 434
Query: 310 IDESKVEEFINEVVILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGTLFQYIHDQNEDF 369
DESK E+FINEVVILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGTL+Q++HD +E+F
Sbjct: 435 ADESKTEQFINEVVILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGTLYQHLHDPSEEF 494
Query: 370 PITWEIRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAV 429
PITWE+RLRIAIE ALSYLHSAAS+PIYHRDIKSTNILLDDKYRAKVSDFG S+S+AV
Sbjct: 495 PITWEMRLRIAIETGSALSYLHSAASVPIYHRDIKSTNILLDDKYRAKVSDFGTSKSIAV 554
Query: 430 DQTHMTTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLTELLTGEKPIRFTILEEDKSL 489
DQTH+TT+V GTFGYLDPEYF+SSQFT+KSDVYSFGVVL ELLTG+KPI E++SL
Sbjct: 555 DQTHVTTRVQGTFGYLDPEYFQSSQFTEKSDVYSFGVVLVELLTGQKPISSARAVEERSL 614
Query: 490 AAYFLCAMKEERLFEILDARVMKQGGKDEIITVAKLAKRCLNLNGKKRPTMREVASELAG 549
A YFL +M++ RLFEILDARV+K+GGK+EI+ VAKLA+RCLNLNGKKRPTMR V +E+
Sbjct: 615 AMYFLLSMEQNRLFEILDARVLKEGGKEEILAVAKLARRCLNLNGKKRPTMRTVVTEVER 674
Query: 550 IKAWNGASNVI--EEGLEEIDC 569
I+A + E +E+DC
Sbjct: 675 IRASQQGTCFTNGENDYQELDC 696
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224103351|ref|XP_002334062.1| predicted protein [Populus trichocarpa] gi|222869636|gb|EEF06767.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 498 bits (1282), Expect = e-138, Method: Compositional matrix adjust.
Identities = 304/682 (44%), Positives = 402/682 (58%), Gaps = 114/682 (16%)
Query: 6 CPDRCGDVGIQYPFGIGAGCYFDESFEVVCTPFS-------FSQGIN------------- 45
C D CG++ I +PFGIG GCY + F V C + F IN
Sbjct: 6 CKDTCGNISIPFPFGIGTGCYLNYWFSVHCNKTTADSRSRAFLSSINMEVLEISLRRSVV 65
Query: 46 ----KFLAIGCDNYANNQQND------SISSNSILTDAGGECISI----------CTCNP 85
++ GC N D + SS++I G ++ CT
Sbjct: 66 RVNSPIISSGCSGRGANISIDMTGSPFAFSSSNIFIAMGCNNRALLSRIEPEIVGCTTTG 125
Query: 86 SESSG----------CCDMVCNIPQNSSTKVLDANTSNVYSRSIPEG---CTSLSLVYAD 132
S + G CC IP N +V +A+ +G C +V +
Sbjct: 126 SSTEGKENSYCSGNNCCQTT--IPSN--LQVFNASLGTTEHPINDQGRNQCKVAFIVEEE 181
Query: 133 WIFSHYLETPSGLKHEKMIPAVLEWGKYKGV------------------------CYEDY 168
W F + + +P ++ + +P +L W Y G C Y
Sbjct: 182 W-FRNNISSPEVVQDMQYVPVILRWLMYYGTDIPEGVTLWGLSTVTLYSNSITCWCSPGY 240
Query: 169 NSQTKV---CNKDDRCLI---QLSSGTIFPHIVFGNISSFIIFRFVISILRLYLSGVGCT 222
+ + C D+C I SG V G + + + ++ +
Sbjct: 241 DGHPYLPDGCTDIDQCKIPGVNWCSGMTKCVNVPG--------WYKCELDKAKITFLSAA 292
Query: 223 SGGLGMFLLIGAWWLFKFVKRRREIKLKRKYFKRNGGLLLQQELASTEGTIEKTKLFTSK 282
+G L LL+G W L+K VK+R+ I+LK+K+FKRNGGLLLQQ+L+S++G+I+KTK+FTSK
Sbjct: 293 TGLL--LLLVGIWRLYKLVKKRKNIELKKKFFKRNGGLLLQQQLSSSDGSIQKTKIFTSK 350
Query: 283 ELEKATDNFDLNRILGQGGQ--------------AVKKSKVIDESKVEEFINEVVILSQI 328
ELEKATD F+ NRILGQGGQ AVKKS ++DE K+EEFINEVVILSQ+
Sbjct: 351 ELEKATDRFNDNRILGQGGQGTVYKGMQADGMIVAVKKSILVDEEKLEEFINEVVILSQV 410
Query: 329 NHRNVVKLLGCCLETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEIRLRIAIEVSGALS 388
NHRNVVKLLGCCLETEVPLLVYEFIPNG LF+YIHDQ E+F +WE+RLRIA EV+ ALS
Sbjct: 411 NHRNVVKLLGCCLETEVPLLVYEFIPNGNLFEYIHDQKEEFEFSWEMRLRIATEVARALS 470
Query: 389 YLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHGTFGYLDPE 448
YLHSAASIP+YHRDIKSTNI+LD+K+RAKVSDFG SRS+A+DQTH+TT V GTFGYLDPE
Sbjct: 471 YLHSAASIPVYHRDIKSTNIMLDEKFRAKVSDFGTSRSIAIDQTHLTTHVQGTFGYLDPE 530
Query: 449 YFRSSQFTDKSDVYSFGVVLTELLTGEKPIRFTILEEDKSLAAYFLCAMKEERLFEILDA 508
YF+SSQFT KSDVYSFGVVL ELL+G+KPI + E+ +SLA +F+ M+E ++F+ILD
Sbjct: 531 YFQSSQFTGKSDVYSFGVVLAELLSGQKPISYERPEDRRSLATHFILLMEENKIFDILDE 590
Query: 509 RVMKQGGKDEIITVAKLAKRCLNLNGKKRPTMREVASELAGIKAWNGASNVIE--EGLEE 566
R+M Q ++E+I VA LA+RCLNLNG+KRPTMREVA EL I+ GA + + + LE
Sbjct: 591 RLMGQDREEEVIAVANLARRCLNLNGRKRPTMREVAIELEQIRVSKGAPHAQQSCKDLEN 650
Query: 567 IDCALGDIYIVANSETNGSINE 588
I + +++ +A T+ +I +
Sbjct: 651 IRDEVPNVWEIAGPTTSVTIGD 672
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224053054|ref|XP_002297684.1| predicted protein [Populus trichocarpa] gi|222844942|gb|EEE82489.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 497 bits (1279), Expect = e-138, Method: Compositional matrix adjust.
Identities = 310/692 (44%), Positives = 412/692 (59%), Gaps = 99/692 (14%)
Query: 6 CPDRCGDVGIQYPFGIGAGCYFDESFEVVCTPFSFSQGINKFL----------------- 48
C + CG++ I +PFGIG GCY ++ F V C + FL
Sbjct: 32 CTETCGNITIPFPFGIGTGCYMNDWFSVHCNETTADSPSRAFLSRINMEVFKISLESSVV 91
Query: 49 -------AIGCD----NYANNQQND--SISSNSILTDAGGE--------------CISIC 81
+ GC N A N S SS++I T G C S C
Sbjct: 92 RVNSPIISSGCSGRGANLAINMTGSPFSFSSSNIFTAMGCNNRALLNGIEPEIVGCTSTC 151
Query: 82 --TCNPSESSGCC-DMVCNIPQNSSTKVLDANTSNVYSRSIPEG---CTSLSLVYADWIF 135
+ E+S C + C SS +V++A+ +G C +V W F
Sbjct: 152 GASTEGKENSYCSGNNCCQTTIPSSLQVVNASLGTPEHPINDQGRNQCKVAFIVQEKW-F 210
Query: 136 SHYLETPSGLKHEKMIPAVLEWGKYKGVCYEDYNSQTKVCNKDDRCLIQLSSGTIF---- 191
+ + +P ++ + +P +L+W C N + R + S+ TI
Sbjct: 211 RNNISSPEVVQDMQYVPVILDWNSDAMYCDPPMNLTSG--RSGLRTVTLYSNSTICSCNW 268
Query: 192 -----PHIVFG--NISSFIIFR----------------FVISILRLYLSGVGCTSGGLGM 228
P++ G +I I R F + + ++ + +G L
Sbjct: 269 GYDGNPYLPDGCTDIDECKIPRGNSCSGMTKCVNVPGGFKCELDKAKITFLSAATGLL-- 326
Query: 229 FLLIGAWWLFKFVKRRREIKLKRKYFKRNGGLLLQQELASTEGTIEKTKLFTSKELEKAT 288
LL+G W L+K VK+R+ I+LK+K+FKRNGGLLLQQ+L+S++G+I+KTK+FTSKELEKAT
Sbjct: 327 LLLVGIWRLYKLVKKRKNIELKKKFFKRNGGLLLQQQLSSSDGSIQKTKIFTSKELEKAT 386
Query: 289 DNFDLNRILGQGGQ--------------AVKKSKVIDESKVEEFINEVVILSQINHRNVV 334
D F+ NRILGQGGQ AVKKS ++DE K+EEFINEVVILSQ+NHRNVV
Sbjct: 387 DRFNDNRILGQGGQGTVYKGMQADGMIVAVKKSILVDEEKLEEFINEVVILSQVNHRNVV 446
Query: 335 KLLGCCLETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEIRLRIAIEVSGALSYLHSAA 394
KLLGCCLETEVPLLVYEFIPNG LF+YIHDQ E+F +WE+RLRIA EV+ ALSYLHSAA
Sbjct: 447 KLLGCCLETEVPLLVYEFIPNGNLFEYIHDQKEEFEFSWEMRLRIATEVARALSYLHSAA 506
Query: 395 SIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHGTFGYLDPEYFRSSQ 454
SIP+YHRDIKSTNI+LD+K+RAKVSDFG SRS+A+DQTH+TT V GTFGYLDPEYF+SSQ
Sbjct: 507 SIPVYHRDIKSTNIMLDEKFRAKVSDFGTSRSIAIDQTHLTTHVQGTFGYLDPEYFQSSQ 566
Query: 455 FTDKSDVYSFGVVLTELLTGEKPIRFTILEEDKSLAAYFLCAMKEERLFEILDARVMKQG 514
FT KSDVYSFGVVL ELL+G+KPI + EE SLA +F+ ++E ++F+ILD R+M Q
Sbjct: 567 FTGKSDVYSFGVVLAELLSGQKPISYERSEERGSLATHFILLVEENKIFDILDERLMGQD 626
Query: 515 GKDEIITVAKLAKRCLNLNGKKRPTMREVASELAGIKAWNGASNVIE--EGLEEIDCALG 572
++E+I VA LA+RCLNL G+KRPTMREVA EL I+ GA + + + LE I +
Sbjct: 627 REEEVIAVANLARRCLNLIGRKRPTMREVAIELEQIRLSKGALHPQQCSKELENIWDEVP 686
Query: 573 DIYIVANSETNGSINESFLDDVTVSVDANPLI 604
+++ +A T+ +I + F + S+D PLI
Sbjct: 687 NVWEIAGPPTSVTIGD-FRNGTAPSLDVQPLI 717
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST
Original result of BLAST against Gene Ontology (AMIGO)
| ID |
Alignment graph |
Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 608 | ||||||
| TAIR|locus:2205040 | 792 | AT1G69730 [Arabidopsis thalian | 0.546 | 0.419 | 0.633 | 1.9e-126 | |
| TAIR|locus:2019843 | 769 | WAKL10 "WALL ASSOCIATED KINASE | 0.631 | 0.499 | 0.557 | 5.6e-126 | |
| TAIR|locus:2016377 | 788 | AT1G19390 [Arabidopsis thalian | 0.552 | 0.426 | 0.641 | 8.2e-126 | |
| TAIR|locus:2019893 | 751 | RFO1 "RESISTANCE TO FUSARIUM O | 0.616 | 0.499 | 0.57 | 6.5e-123 | |
| TAIR|locus:2200552 | 730 | WAKL1 "wall associated kinase- | 0.547 | 0.456 | 0.608 | 2.8e-122 | |
| TAIR|locus:2200562 | 748 | WAKL2 "wall associated kinase- | 0.631 | 0.513 | 0.56 | 5.8e-122 | |
| TAIR|locus:2126316 | 786 | AT4G31100 [Arabidopsis thalian | 0.536 | 0.414 | 0.618 | 2.8e-121 | |
| TAIR|locus:2030988 | 764 | AT1G17910 [Arabidopsis thalian | 0.534 | 0.425 | 0.623 | 1.4e-120 | |
| TAIR|locus:2032875 | 720 | AT1G16260 [Arabidopsis thalian | 0.621 | 0.525 | 0.548 | 1.5e-119 | |
| TAIR|locus:2126271 | 793 | AT4G31110 [Arabidopsis thalian | 0.536 | 0.411 | 0.615 | 6e-116 |
| TAIR|locus:2205040 AT1G69730 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1140 (406.4 bits), Expect = 1.9e-126, Sum P(3) = 1.9e-126
Identities = 221/349 (63%), Positives = 283/349 (81%)
Query: 218 GVGCTSGGLGMFLLIGAWWLFKFVKRRREIKLKRKYFKRNGGLLLQQELASTEGTIEKTK 277
G+G + G L +F+ +G + L+KF+K++R++ K+K+FKRNGGLLLQQ+L ST G +EKT
Sbjct: 376 GLGASFGSL-IFV-VGIYLLYKFIKKQRKLNQKKKFFKRNGGLLLQQQLISTVGMVEKTI 433
Query: 278 LFTSKELEKATDNFDLNRILGQGGQ--------------AVKKSKVIDESKVEEFINEVV 323
+F+S+ELEKAT+NF NRILGQGGQ AVKKSKV+DE K+EEFINEVV
Sbjct: 434 VFSSRELEKATENFSSNRILGQGGQGTVYKGMLVDGRIVAVKKSKVVDEDKLEEFINEVV 493
Query: 324 ILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGTLFQYIHDQ-NEDFPITWEIRLRIAIE 382
ILSQINHRN+VKLLGCCLET+VP+LVYEFIPNG LF+++HD+ +E+ TW IRLRIAI+
Sbjct: 494 ILSQINHRNIVKLLGCCLETKVPVLVYEFIPNGNLFEHLHDEFDENIMATWNIRLRIAID 553
Query: 383 VSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHGTF 442
++GALSYLHS+AS PIYHRD+KSTNI+LD+KYRAKVSDFG SR++ VD TH+TT V GT
Sbjct: 554 IAGALSYLHSSASSPIYHRDVKSTNIMLDEKYRAKVSDFGTSRTVTVDHTHLTTVVSGTV 613
Query: 443 GYLDPEYFRSSQFTDKSDVYSFGVVLTELLTGEKPIRFTILEEDKSLAAYFLCAMKEERL 502
GY+DPEYF+SSQFTDKSDVYSFGVVL EL+TGEK I F +E+++LA YF+ AMKE +L
Sbjct: 614 GYMDPEYFQSSQFTDKSDVYSFGVVLVELITGEKSISFLRSQENRTLATYFILAMKENKL 673
Query: 503 FEILDARVMKQGGKDEIITVAKLAKRCLNLNGKKRPTMREVASELAGIK 551
F+I+DAR+ ++ AK+A++CLNL G+KRP+MREV+ EL I+
Sbjct: 674 FDIIDARIRDGCMLSQVTATAKVARKCLNLKGRKRPSMREVSMELDSIR 722
|
|
| TAIR|locus:2019843 WAKL10 "WALL ASSOCIATED KINASE (WAK)-LIKE 10" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1141 (406.7 bits), Expect = 5.6e-126, Sum P(2) = 5.6e-126
Identities = 227/407 (55%), Positives = 302/407 (74%)
Query: 219 VGCTSGGLGMFLLIGAWWLFKFVKRRREIKLKRKYFKRNGGLLLQQELASTEGTIEKTKL 278
+G ++ + + G +WL+KF++R+R + K+K+FKRNGGLLLQQ+L +TEG ++ T++
Sbjct: 361 IGLSTSFSTLVFIGGIYWLYKFIRRQRRLNQKKKFFKRNGGLLLQQQLTTTEGNVDSTRV 420
Query: 279 FTSKELEKATDNFDLNRILGQGGQ--------------AVKKSKVIDESKVEEFINEVVI 324
F S+ELEKAT+NF L RILG+GGQ AVKKSKV+DE K+EEFINEVVI
Sbjct: 421 FNSRELEKATENFSLTRILGEGGQGTVYKGMLVDGRIVAVKKSKVVDEDKLEEFINEVVI 480
Query: 325 LSQINHRNVVKLLGCCLETEVPLLVYEFIPNGTLFQYIHDQNEDFPIT-WEIRLRIAIEV 383
LSQINHRN+VKLLGCCLET+VP+LVYEFIPNG LF+++HD ++D+ +T WE+RLRIA+++
Sbjct: 481 LSQINHRNIVKLLGCCLETDVPILVYEFIPNGNLFEHLHDDSDDYTMTTWEVRLRIAVDI 540
Query: 384 SGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHGTFG 443
+GALSYLHSAAS PIYHRDIKSTNI+LD+K+RAKVSDFG SR++ VD TH+TT V GT G
Sbjct: 541 AGALSYLHSAASSPIYHRDIKSTNIMLDEKHRAKVSDFGTSRTVTVDHTHLTTVVSGTVG 600
Query: 444 YLDPEYFRSSQFTDKSDVYSFGVVLTELLTGEKPIRFTILEEDKSLAAYFLCAMKEERLF 503
Y+DPEYF+SSQFTDKSDVYSFGVVL EL+TGEK + F +E ++LA YF AMKE RL
Sbjct: 601 YMDPEYFQSSQFTDKSDVYSFGVVLAELITGEKSVSFLRSQEYRTLATYFTLAMKENRLS 660
Query: 504 EILDARVMKQGGK-DEIITVAKLAKRCLNLNGKKRPTMREVASELAGIKAWNGASNVIE- 561
+I+DAR+ + G K +++ AK+A++CLN+ G+KRP+MR+V+ EL I++++ E
Sbjct: 661 DIIDARI-RDGCKLNQVTAAAKIARKCLNMKGRKRPSMRQVSMELEKIRSYSEDMQPYEY 719
Query: 562 --EGLEEIDCALGDIYIVAN---SETNGSINESFLDDVTVSVDANPL 603
E EE L D+ + + S T S S + D PL
Sbjct: 720 ASENEEEKKETLVDVNVESRNYVSVTAASSQYSIATTSSSRSDVEPL 766
|
|
| TAIR|locus:2016377 AT1G19390 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1137 (405.3 bits), Expect = 8.2e-126, Sum P(3) = 8.2e-126
Identities = 229/357 (64%), Positives = 281/357 (78%)
Query: 213 RLYLSGVGCTSGGLGMFLLIGAWWLFKFVKRRREIKLKRKYFKRNGGLLLQQELASTEGT 272
R+ + GVG G L L++G WWL KF+K+RR K KRK+FKRNGGLLLQQ+L + +G
Sbjct: 375 RVTMIGVGSAFGIL--VLVVGIWWLRKFLKKRRMSKRKRKFFKRNGGLLLQQQLNTNKGN 432
Query: 273 IEKTKLFTSKELEKATDNFDLNRILGQGGQ--------------AVKKSKVIDESKVEEF 318
+EKT++F+S+ELEKATDNF +RILGQGGQ AVKKSKV+DE K+EEF
Sbjct: 433 VEKTRIFSSRELEKATDNFSESRILGQGGQGTVYKGMLVDGRTVAVKKSKVVDEDKLEEF 492
Query: 319 INEVVILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEIRLR 378
INEVVILSQINHR+VVKLLGCCLETEVP LVYEFIPNG LFQ+IH++++D+ TW +RLR
Sbjct: 493 INEVVILSQINHRHVVKLLGCCLETEVPTLVYEFIPNGNLFQHIHEESDDYTKTWGMRLR 552
Query: 379 IAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQV 438
IA++++GALSYLHSAAS PIYHRDIKSTNILLD+KYR KVSDFG SRS+ +D TH TT +
Sbjct: 553 IAVDIAGALSYLHSAASSPIYHRDIKSTNILLDEKYRTKVSDFGTSRSVTIDHTHWTTVI 612
Query: 439 HGTFGYLDPEYFRSSQFTDKSDVYSFGVVLTELLTGEKPIRFTIL--EEDKSLAAYFLCA 496
GT GY+DPEY+ SSQ+TDKSDVYSFGVVL EL+TGEKP+ T+ +E + LA +F A
Sbjct: 613 SGTVGYVDPEYYGSSQYTDKSDVYSFGVVLVELITGEKPV-ITVSNSQEIRGLADHFRVA 671
Query: 497 MKEERLFEILDARVMKQGGKDE-IITVAKLAKRCLNLNGKKRPTMREVASELAGIKA 552
MKE R FEI+DAR+ + G K E ++ VA LA+RCLN GKKRP MR+V ++L I A
Sbjct: 672 MKENRFFEIMDARI-RDGCKPEQVMAVANLARRCLNSKGKKRPCMRKVFTDLEKILA 727
|
|
| TAIR|locus:2019893 RFO1 "RESISTANCE TO FUSARIUM OXYSPORUM 1" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1143 (407.4 bits), Expect = 6.5e-123, Sum P(2) = 6.5e-123
Identities = 228/400 (57%), Positives = 307/400 (76%)
Query: 228 MFLLIGAWWLFKFVKRRREIKLKRKYFKRNGGLLLQQELASTEGTIEKTKLFTSKELEKA 287
+FL++G W L KFVK+RR+I KR +FKRNGGLLL+Q+L + G ++ +K+F+SKELEKA
Sbjct: 358 LFLVLGIWGLIKFVKKRRKIIRKRMFFKRNGGLLLKQQLTTRGGNVQSSKIFSSKELEKA 417
Query: 288 TDNFDLNRILGQGGQ--------------AVKKSKVIDESKVEEFINEVVILSQINHRNV 333
TDNF++NR+LGQGGQ AVK+SKV+DE KVEEFINEV +LSQINHRN+
Sbjct: 418 TDNFNMNRVLGQGGQGTVYKGMLVDGRIVAVKRSKVLDEDKVEEFINEVGVLSQINHRNI 477
Query: 334 VKLLGCCLETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEIRLRIAIEVSGALSYLHSA 393
VKL+GCCLETEVP+LVYE IPNG LF+ +H ++D+ +TW++RLRI++E++GAL+YLHSA
Sbjct: 478 VKLMGCCLETEVPILVYEHIPNGDLFKRLHHDSDDYTMTWDVRLRISVEIAGALAYLHSA 537
Query: 394 ASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHGTFGYLDPEYFRSS 453
AS P+YHRD+K+TNILLD+KYRAKVSDFG SRS+ VDQTH+TT V GTFGYLDPEYF++S
Sbjct: 538 ASTPVYHRDVKTTNILLDEKYRAKVSDFGTSRSINVDQTHLTTLVAGTFGYLDPEYFQTS 597
Query: 454 QFTDKSDVYSFGVVLTELLTGEKPIRFTILEEDKSLAAYFLCAMKEERLFEILDARVMKQ 513
QFTDKSDVYSFGVVL EL+TGEKP EE++ L ++F AMK+ R+ +I+D+R+ +
Sbjct: 598 QFTDKSDVYSFGVVLVELITGEKPFSVMRPEENRGLVSHFNEAMKQNRVLDIVDSRIKEG 657
Query: 514 GGKDEIITVAKLAKRCLNLNGKKRPTMREVASELAGIKAWNGASNV-IEEGLEEIDCALG 572
++++ VAKLA+RCL+L GKKRP MREV+ EL I++ + IEE EE +CA+
Sbjct: 658 CTLEQVLAVAKLARRCLSLKGKKRPNMREVSVELERIRSSPEDLELHIEEEDEE-ECAM- 715
Query: 573 DIYIVANSETNGSIN---ESFLDDVTVSVDANPLI-KSNW 608
+I N + + S++ + L D++ +D PL+ + W
Sbjct: 716 EI----NMDDSWSVDMTAPASLFDLSPKLDVEPLVPQRTW 751
|
|
| TAIR|locus:2200552 WAKL1 "wall associated kinase-like 1" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1136 (405.0 bits), Expect = 2.8e-122, Sum P(2) = 2.8e-122
Identities = 211/347 (60%), Positives = 277/347 (79%)
Query: 220 GCTSGGLGMFLLIGAWWLFKFVKRRREIKLKRKYFKRNGGLLLQQELASTEGTIEKTKLF 279
G G G+ +G +WLFK +K+RR I +K+FKRNGGLLL+Q+L + +G +E +K+F
Sbjct: 358 GILIGLSGLVFFVGLFWLFKLIKKRRNINRSKKFFKRNGGLLLKQQLTTKDGNVEMSKIF 417
Query: 280 TSKELEKATDNFDLNRILGQGGQ--------------AVKKSKVIDESKVEEFINEVVIL 325
+SKEL KATDNF ++R+LGQGGQ AVK+SKV+DE K+EEFINE+V+L
Sbjct: 418 SSKELRKATDNFSIDRVLGQGGQGTVYKGMLVDGSIVAVKRSKVVDEDKMEEFINEIVLL 477
Query: 326 SQINHRNVVKLLGCCLETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEIRLRIAIEVSG 385
SQINHRN+VKLLGCCLETEVP+LVYE+IPNG LF+ +HD+++D+ +TWE+RLRIAIE++G
Sbjct: 478 SQINHRNIVKLLGCCLETEVPILVYEYIPNGDLFKRLHDESDDYTMTWEVRLRIAIEIAG 537
Query: 386 ALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHGTFGYL 445
AL+Y+HSAAS PI+HRDIK+TNILLD+KYRAKVSDFG SRS+ +DQTH+TT V GTFGY+
Sbjct: 538 ALTYMHSAASFPIFHRDIKTTNILLDEKYRAKVSDFGTSRSVTLDQTHLTTLVAGTFGYM 597
Query: 446 DPEYFRSSQFTDKSDVYSFGVVLTELLTGEKPIRFTILEEDKSLAAYFLCAMKEERLFEI 505
DPEYF SSQ+T KSDVYSFGVVL EL+TGEKP+ EE + LA +FL AMKE R+ +I
Sbjct: 598 DPEYFLSSQYTHKSDVYSFGVVLVELITGEKPLSRVRSEEGRGLATHFLEAMKENRVIDI 657
Query: 506 LDARVMKQGGKDEIITVAKLAKRCLNLNGKKRPTMREVASELAGIKA 552
+D R+ + ++++ VAKLA++CLN GK RP M+EV++EL I++
Sbjct: 658 IDIRIKDESKLEQVMAVAKLARKCLNRKGKNRPNMKEVSNELERIRS 704
|
|
| TAIR|locus:2200562 WAKL2 "wall associated kinase-like 2" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1134 (404.2 bits), Expect = 5.8e-122, Sum P(2) = 5.8e-122
Identities = 224/400 (56%), Positives = 301/400 (75%)
Query: 220 GCTSGGLGMFLLIGAWWLFKFVKRRREIKLKRKYFKRNGGLLLQQELASTEGTIEKTKLF 279
G G + G + L+KFV++RR++ RK+F+RNGG+LL+Q+LA EG +E +++F
Sbjct: 345 GVLIGSALLLFAFGIFGLYKFVQKRRKLIRMRKFFRRNGGMLLKQQLARKEGNVEMSRIF 404
Query: 280 TSKELEKATDNFDLNRILGQGGQ--------------AVKKSKVIDESKVEEFINEVVIL 325
+S ELEKATDNF+ NR+LGQGGQ AVK+SK +DE +VEEFINEVV+L
Sbjct: 405 SSHELEKATDNFNKNRVLGQGGQGTVYKGMLVDGRIVAVKRSKAVDEDRVEEFINEVVVL 464
Query: 326 SQINHRNVVKLLGCCLETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEIRLRIAIEVSG 385
+QINHRN+VKLLGCCLETEVP+LVYEF+PNG L + +HD+++D+ +TWE+RL IAIE++G
Sbjct: 465 AQINHRNIVKLLGCCLETEVPVLVYEFVPNGDLCKRLHDESDDYTMTWEVRLHIAIEIAG 524
Query: 386 ALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHGTFGYL 445
ALSYLHSAAS PIYHRDIK+TNILLD++ RAKVSDFG SRS+ +DQTH+TTQV GTFGY+
Sbjct: 525 ALSYLHSAASFPIYHRDIKTTNILLDERNRAKVSDFGTSRSVTIDQTHLTTQVAGTFGYV 584
Query: 446 DPEYFRSSQFTDKSDVYSFGVVLTELLTGEKPIRFTILEEDKSLAAYFLCAMKEERLFEI 505
DPEYF+SS+FT+KSDVYSFGVVL ELLTGEKP EE++ LAA+F+ A+KE R+ +I
Sbjct: 585 DPEYFQSSKFTEKSDVYSFGVVLVELLTGEKPSSRVRSEENRGLAAHFVEAVKENRVLDI 644
Query: 506 LDARVMKQGGKDEIITVAKLAKRCLNLNGKKRPTMREVASELAGIKAWNGASNV-IEEGL 564
+D R+ + D++++VA LA+RCLN GKKRP MREV+ EL I++ + S + IE+
Sbjct: 645 VDDRIKDECNMDQVMSVANLARRCLNRKGKKRPNMREVSIELEMIRSSHYDSGIHIEDDD 704
Query: 565 EEIDCALGDIYIVANSETNGSINESFLDDVTVSVDANPLI 604
EE D A+ ++ E + S ++ + + DA PL+
Sbjct: 705 EEDDQAM-ELNFNDTWEVGATAPASMFNNASPTSDAEPLV 743
|
|
| TAIR|locus:2126316 AT4G31100 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1081 (385.6 bits), Expect = 2.8e-121, Sum P(3) = 2.8e-121
Identities = 212/343 (61%), Positives = 268/343 (78%)
Query: 225 GLGMFLLIGA-WWLFKFVKRRREIKLKRKYFKRNGGLLLQQELASTEGTIEKTKLFTSKE 283
G G+ +L+G WWL KF+ +RR K K+K+FKRNGGLLLQQEL + +G +EK ++FTSKE
Sbjct: 377 GFGVLVLVGGVWWLRKFLVKRRMAKRKKKFFKRNGGLLLQQELNTRQGVVEKARIFTSKE 436
Query: 284 LEKATDNFDLNRILGQGGQ--------------AVKKSKVIDESKVEEFINEVVILSQIN 329
LEKAT+NF NR+LG GGQ AVKKSKVIDE K++EFINEVVILSQIN
Sbjct: 437 LEKATENFSENRVLGHGGQGTVYKGMLVDGRTVAVKKSKVIDEDKLQEFINEVVILSQIN 496
Query: 330 HRNVVKLLGCCLETEVPLLVYEFIPNGTLFQYIHDQN-EDFPITWEIRLRIAIEVSGALS 388
HR+VVKLLGCCLETEVP+LVYEFI NG LF++IH++ +D+ + W +RLRIA++++GALS
Sbjct: 497 HRHVVKLLGCCLETEVPILVYEFIINGNLFKHIHEEEADDYTMIWGMRLRIAVDIAGALS 556
Query: 389 YLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHGTFGYLDPE 448
YLHSAAS PIYHRDIKSTNILLD+KYRAKV+DFG SRS+ +DQTH TT + GT GY+DPE
Sbjct: 557 YLHSAASSPIYHRDIKSTNILLDEKYRAKVADFGTSRSVTIDQTHWTTVISGTVGYVDPE 616
Query: 449 YFRSSQFTDKSDVYSFGVVLTELLTGEKP-IRFTILEEDKSLAAYFLCAMKEERLFEILD 507
Y+RSSQ+T+KSDVYSFGV+L EL+TG+KP I +E +LA +F AMKE RL +I+D
Sbjct: 617 YYRSSQYTEKSDVYSFGVILAELITGDKPVIMVQNTQEIIALAEHFRVAMKERRLSDIMD 676
Query: 508 ARVMKQGGKDEIITVAKLAKRCLNLNGKKRPTMREVASELAGI 550
AR+ ++++ VA LA +CL+ G+ RP MREV +EL I
Sbjct: 677 ARIRDDSKPEQVMAVANLAMKCLSSRGRNRPNMREVFTELERI 719
|
|
| TAIR|locus:2030988 AT1G17910 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1092 (389.5 bits), Expect = 1.4e-120, Sum P(2) = 1.4e-120
Identities = 215/345 (62%), Positives = 266/345 (77%)
Query: 225 GLGMFLLI---GAWWLFKFVKRRREIKLKRKYFKRNGGLLLQQELASTEGTIEKTKLFTS 281
G G F+LI G WW K +++RR KRK+FKRNGGLLLQQ+L +T+G +EKTKLF+S
Sbjct: 385 GAGFFVLIVGGGIWWWRKLLRKRRMTNRKRKFFKRNGGLLLQQQLNTTQGRVEKTKLFSS 444
Query: 282 KELEKATDNFDLNRILGQGGQ--------------AVKKSKVIDESKVEEFINEVVILSQ 327
+ELEKATDNF+ NR++GQGGQ AVKKS V+DE K++EFINEV+ILSQ
Sbjct: 445 RELEKATDNFNDNRVIGQGGQGTVYKGMLVDGRSVAVKKSNVVDEDKLQEFINEVIILSQ 504
Query: 328 INHRNVVKLLGCCLETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEIRLRIAIEVSGAL 387
INHR+VVKLLGCCLETEVP+LVYEFIPNG LFQ++H++ +D+ W +R+RIA+++SGA
Sbjct: 505 INHRHVVKLLGCCLETEVPILVYEFIPNGNLFQHLHEEFDDYTALWGVRMRIAVDISGAF 564
Query: 388 SYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHGTFGYLDP 447
SYLH+AA PIYHRDIKSTNILLD+KYRAKVSDFG SRS+++D TH TT + GT GY+DP
Sbjct: 565 SYLHTAACSPIYHRDIKSTNILLDEKYRAKVSDFGTSRSVSIDHTHWTTVISGTVGYVDP 624
Query: 448 EYFRSSQFTDKSDVYSFGVVLTELLTGEKPIRFTILE--EDKSLAAYFLCAMKEERLFEI 505
EY+ SS FT+KSDVYSFGVVL EL+TGEKP+ T+ E E LA YF AM+E RLFEI
Sbjct: 625 EYYGSSHFTEKSDVYSFGVVLVELITGEKPV-ITLSETQEITGLADYFRLAMRENRLFEI 683
Query: 506 LDARVMKQGGKDEIITVAKLAKRCLNLNGKKRPTMREVASELAGI 550
+DAR+ +++I VA LA RCL GK RP MREV++ L I
Sbjct: 684 IDARIRNDCKLEQVIAVANLALRCLKKTGKTRPDMREVSTALERI 728
|
|
| TAIR|locus:2032875 AT1G16260 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1077 (384.2 bits), Expect = 1.5e-119, Sum P(2) = 1.5e-119
Identities = 221/403 (54%), Positives = 291/403 (72%)
Query: 220 GCTSGGLGMFLLIGAWWLFKFVKRRREIKLKRKYFKRNGGLLLQQELASTEGTIEKTKLF 279
G S GL + L+ G W L K ++R+ K KRK+F+RNGGLLLQQ+ + G++ +TK+F
Sbjct: 320 GTLSSGL-LLLIFGMWLLCKANRKRKVAKQKRKFFQRNGGLLLQQQTSFLHGSVNRTKVF 378
Query: 280 TSKELEKATDNFDLNRILGQGGQ--------------AVKKSKVIDESKVEEFINEVVIL 325
+S +LE ATD F+ +RILGQGGQ AVKKSK + E +EEFINE+++L
Sbjct: 379 SSNDLENATDRFNASRILGQGGQGTVYKGMLEDGMIVAVKKSKALKEENLEEFINEIILL 438
Query: 326 SQINHRNVVKLLGCCLETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEIRLRIAIEVSG 385
SQINHRNVVK+LGCCLETEVP+LVYEFIPN LF ++H+ +EDFP++WE+RL IA EV+
Sbjct: 439 SQINHRNVVKILGCCLETEVPILVYEFIPNRNLFDHLHNPSEDFPMSWEVRLCIACEVAD 498
Query: 386 ALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHGTFGYL 445
ALSYLHSA SIPIYHRD+KSTNILLD+K+RAKVSDFG SRS+A+D TH+TT V GT GY+
Sbjct: 499 ALSYLHSAVSIPIYHRDVKSTNILLDEKHRAKVSDFGISRSVAIDDTHLTTIVQGTIGYV 558
Query: 446 DPEYFRSSQFTDKSDVYSFGVVLTELLTGEKPIRFTILEEDKSLAAYFLCAMKEERLFEI 505
DPEY +S+ FT KSDVYSFGV+L ELLTGEKP+ +E + L AYFL AM+ +RL EI
Sbjct: 559 DPEYLQSNHFTGKSDVYSFGVLLIELLTGEKPVSLLRRQEVRMLGAYFLEAMRNDRLHEI 618
Query: 506 LDARVMKQGGKDEIITVAKLAKRCLNLNGKKRPTMREVASELAGIKAWN-GASNVIEEGL 564
LDAR+ ++ ++E++ VAKLA+RCL+LN + RPTMR+V EL +++ G + + G
Sbjct: 619 LDARIKEECDREEVLAVAKLARRCLSLNSEHRPTMRDVFIELDRMQSKRKGTQSQAQNGE 678
Query: 565 EE--IDCALGDIYIVANSETNGSI-NESFLDDVTVSVDANPLI 604
E I A+ + ++ S N + N SF S+D PL+
Sbjct: 679 EHAHIQIAMPESMSLSYSSPNIVVENSSF------SLDTKPLM 715
|
|
| TAIR|locus:2126271 AT4G31110 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1073 (382.8 bits), Expect = 6.0e-116, Sum P(2) = 6.0e-116
Identities = 211/343 (61%), Positives = 271/343 (79%)
Query: 225 GLGMFLLIGA-WWLFKFVKRRREIKLKRKYFKRNGGLLLQQELASTEGTIEKTKLFTSKE 283
G G+ +L+G WWL KF+ +RR K K+K+FKRNGGLLL QEL + EG +EKT++F S+E
Sbjct: 386 GFGVLVLVGGLWWLRKFLIKRRITKRKKKFFKRNGGLLLLQELNTREGYVEKTRVFNSRE 445
Query: 284 LEKATDNFDLNRILGQGGQ--------------AVKKSKVIDESKVEEFINEVVILSQIN 329
LEKAT+NF NR+LG GGQ AVKKSKVIDE K++EFINEVVILSQIN
Sbjct: 446 LEKATENFSENRVLGHGGQGTVYKGMLVDGRTVAVKKSKVIDEDKLQEFINEVVILSQIN 505
Query: 330 HRNVVKLLGCCLETEVPLLVYEFIPNGTLFQYIHDQ-NEDFPITWEIRLRIAIEVSGALS 388
HR+VVKLLGCCLETEVP+LVYEFI NG LF++IH++ ++D+ + W +RLRIA++++GALS
Sbjct: 506 HRHVVKLLGCCLETEVPMLVYEFIINGNLFKHIHEEESDDYTMLWGMRLRIAVDIAGALS 565
Query: 389 YLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHGTFGYLDPE 448
YLHS+AS PIYHRDIKSTNILLD+KYRAKV+DFG SRS+ +DQTH TT + GT GY+DPE
Sbjct: 566 YLHSSASSPIYHRDIKSTNILLDEKYRAKVADFGTSRSVTIDQTHWTTVISGTVGYVDPE 625
Query: 449 YFRSSQFTDKSDVYSFGVVLTELLTGEKP-IRFTILEEDKSLAAYFLCAMKEERLFEILD 507
Y++SSQ+T+KSDVYSFGV+L EL+TG+KP I +E +LA +F AMKE+RL +I+D
Sbjct: 626 YYQSSQYTEKSDVYSFGVILAELITGDKPVIMVQNTQEIVALAEHFRVAMKEKRLTDIID 685
Query: 508 ARVMKQGGKDEIITVAKLAKRCLNLNGKKRPTMREVASELAGI 550
AR+ ++++ VAK+A +CL+ GKKRP MREV +EL I
Sbjct: 686 ARIRNDCKPEQVMAVAKVAMKCLSSKGKKRPNMREVFTELERI 728
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries
Original result of BLAST against SWISS-PROT
No confident hit for EC number transfering in SWISSPROT detected by BLAST
EC Number Prediction by Ezypred Server
Original result from Ezypred Server
Fail to connect to Ezypred Server
EC Number Prediction by EFICAz Software
| Prediction Level | EC number | Confidence of Prediction |
| 4th Layer | 2.7.11.1 | LOW CONFIDENCE prediction! |
| 3rd Layer | 2.7.11 | 0.691 |
Prediction of Functionally Associated Proteins
Functionally Associated Proteins Detected by STRING
Original result from the STRING server
Fail to connect to STRING server
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST
Original result of RPS-BLAST against CDD database part I
| ID | Alignment Graph | Length |
Definition |
E-value |
| Query | 608 | |||
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 3e-48 | |
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 1e-47 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 5e-45 | |
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 9e-45 | |
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 2e-44 | |
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 2e-43 | |
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 1e-42 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 1e-35 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 2e-32 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 1e-29 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 1e-28 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 4e-28 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 6e-28 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 5e-27 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 3e-26 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 3e-26 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 3e-25 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 5e-25 | |
| cd05058 | 262 | cd05058, PTKc_Met_Ron, Catalytic domain of the Pro | 5e-25 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 7e-25 | |
| cd05049 | 280 | cd05049, PTKc_Trk, Catalytic domain of the Protein | 9e-25 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 1e-24 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 6e-24 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 9e-24 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 1e-23 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 3e-23 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 6e-23 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 7e-23 | |
| cd05112 | 256 | cd05112, PTKc_Itk, Catalytic domain of the Protein | 9e-23 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 1e-22 | |
| cd05046 | 275 | cd05046, PTK_CCK4, Pseudokinase domain of the Prot | 1e-22 | |
| cd05045 | 290 | cd05045, PTKc_RET, Catalytic domain of the Protein | 1e-22 | |
| cd05048 | 283 | cd05048, PTKc_Ror, Catalytic Domain of the Protein | 7e-22 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 8e-22 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 1e-21 | |
| cd05056 | 270 | cd05056, PTKc_FAK, Catalytic domain of the Protein | 2e-21 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 2e-21 | |
| cd05082 | 256 | cd05082, PTKc_Csk, Catalytic domain of the Protein | 2e-21 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 3e-21 | |
| cd05035 | 273 | cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li | 3e-21 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 5e-21 | |
| cd05051 | 296 | cd05051, PTKc_DDR, Catalytic domain of the Protein | 6e-21 | |
| cd05113 | 256 | cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro | 6e-21 | |
| cd05057 | 279 | cd05057, PTKc_EGFR_like, Catalytic domain of Epide | 7e-21 | |
| cd05092 | 280 | cd05092, PTKc_TrkA, Catalytic domain of the Protei | 9e-21 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 1e-20 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 1e-20 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 2e-20 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 2e-20 | |
| cd05033 | 266 | cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec | 3e-20 | |
| cd05083 | 254 | cd05083, PTKc_Chk, Catalytic domain of the Protein | 3e-20 | |
| cd05063 | 268 | cd05063, PTKc_EphR_A2, Catalytic domain of the Pro | 4e-20 | |
| cd05032 | 277 | cd05032, PTKc_InsR_like, Catalytic domain of Insul | 4e-20 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 4e-20 | |
| cd05114 | 256 | cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro | 4e-20 | |
| cd05115 | 257 | cd05115, PTKc_Zap-70, Catalytic domain of the Prot | 5e-20 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 1e-19 | |
| cd05110 | 303 | cd05110, PTKc_HER4, Catalytic domain of the Protei | 1e-19 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 1e-19 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 2e-19 | |
| cd05116 | 257 | cd05116, PTKc_Syk, Catalytic domain of the Protein | 2e-19 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 2e-19 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 3e-19 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 4e-19 | |
| cd05044 | 269 | cd05044, PTKc_c-ros, Catalytic domain of the Prote | 9e-19 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 1e-18 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 1e-18 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 2e-18 | |
| cd05097 | 295 | cd05097, PTKc_DDR_like, Catalytic domain of Discoi | 2e-18 | |
| cd05093 | 288 | cd05093, PTKc_TrkB, Catalytic domain of the Protei | 3e-18 | |
| cd05085 | 250 | cd05085, PTKc_Fer, Catalytic domain of the Protein | 4e-18 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 4e-18 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 4e-18 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 6e-18 | |
| cd05036 | 277 | cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro | 6e-18 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 6e-18 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 7e-18 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 8e-18 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 1e-17 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 1e-17 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 2e-17 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 2e-17 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 3e-17 | |
| cd05066 | 267 | cd05066, PTKc_EphR_A, Catalytic domain of the Prot | 3e-17 | |
| cd05084 | 252 | cd05084, PTKc_Fes, Catalytic domain of the Protein | 3e-17 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 3e-17 | |
| cd05062 | 277 | cd05062, PTKc_IGF-1R, Catalytic domain of the Prot | 4e-17 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 4e-17 | |
| TIGR03903 | 1266 | TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas | 5e-17 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 5e-17 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 5e-17 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 5e-17 | |
| cd05065 | 269 | cd05065, PTKc_EphR_B, Catalytic domain of the Prot | 8e-17 | |
| cd05583 | 288 | cd05583, STKc_MSK_N, N-terminal catalytic domain o | 8e-17 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 9e-17 | |
| cd05055 | 302 | cd05055, PTKc_PDGFR, Catalytic domain of the Prote | 1e-16 | |
| cd05094 | 291 | cd05094, PTKc_TrkC, Catalytic domain of the Protei | 2e-16 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 2e-16 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 2e-16 | |
| cd08219 | 255 | cd08219, STKc_Nek3, Catalytic domain of the Protei | 3e-16 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 4e-16 | |
| cd05050 | 288 | cd05050, PTKc_Musk, Catalytic domain of the Protei | 4e-16 | |
| cd05613 | 290 | cd05613, STKc_MSK1_N, N-terminal catalytic domain | 4e-16 | |
| cd05053 | 293 | cd05053, PTKc_FGFR, Catalytic domain of the Protei | 4e-16 | |
| cd05109 | 279 | cd05109, PTKc_HER2, Catalytic domain of the Protei | 5e-16 | |
| cd05096 | 304 | cd05096, PTKc_DDR1, Catalytic domain of the Protei | 5e-16 | |
| cd05090 | 283 | cd05090, PTKc_Ror1, Catalytic domain of the Protei | 5e-16 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 6e-16 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 6e-16 | |
| cd05075 | 272 | cd05075, PTKc_Axl, Catalytic domain of the Protein | 7e-16 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 8e-16 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 9e-16 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 1e-15 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 1e-15 | |
| cd05074 | 273 | cd05074, PTKc_Tyro3, Catalytic domain of the Prote | 1e-15 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 2e-15 | |
| cd06652 | 265 | cd06652, STKc_MEKK2, Catalytic domain of the Prote | 2e-15 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 2e-15 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 2e-15 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 3e-15 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 3e-15 | |
| cd05108 | 316 | cd05108, PTKc_EGFR, Catalytic domain of the Protei | 4e-15 | |
| cd05589 | 324 | cd05589, STKc_PKN, Catalytic domain of the Protein | 4e-15 | |
| cd05604 | 325 | cd05604, STKc_SGK3, Catalytic domain of the Protei | 5e-15 | |
| cd05098 | 307 | cd05098, PTKc_FGFR1, Catalytic domain of the Prote | 5e-15 | |
| cd05590 | 320 | cd05590, STKc_nPKC_eta, Catalytic domain of the Pr | 7e-15 | |
| cd05061 | 288 | cd05061, PTKc_InsR, Catalytic domain of the Protei | 8e-15 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 8e-15 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 8e-15 | |
| cd05095 | 296 | cd05095, PTKc_DDR2, Catalytic domain of the Protei | 9e-15 | |
| cd05089 | 297 | cd05089, PTKc_Tie1, Catalytic domain of the Protei | 1e-14 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 1e-14 | |
| cd05614 | 332 | cd05614, STKc_MSK2_N, N-terminal catalytic domain | 2e-14 | |
| cd05043 | 280 | cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece | 2e-14 | |
| cd05042 | 269 | cd05042, PTKc_Aatyk, Catalytic domain of the Prote | 2e-14 | |
| cd05071 | 262 | cd05071, PTKc_Src, Catalytic domain of the Protein | 2e-14 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 2e-14 | |
| cd06653 | 264 | cd06653, STKc_MEKK3_like_1, Catalytic domain of MA | 3e-14 | |
| cd05101 | 304 | cd05101, PTKc_FGFR2, Catalytic domain of the Prote | 3e-14 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 3e-14 | |
| cd08218 | 256 | cd08218, STKc_Nek1, Catalytic domain of the Protei | 3e-14 | |
| cd05585 | 312 | cd05585, STKc_YPK1_like, Catalytic domain of Yeast | 6e-14 | |
| cd05069 | 260 | cd05069, PTKc_Yes, Catalytic domain of the Protein | 7e-14 | |
| cd05630 | 285 | cd05630, STKc_GRK6, Catalytic domain of the Protei | 8e-14 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 8e-14 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 8e-14 | |
| cd05596 | 370 | cd05596, STKc_ROCK, Catalytic domain of the Protei | 9e-14 | |
| cd05621 | 370 | cd05621, STKc_ROCK2, Catalytic domain of the Prote | 1e-13 | |
| cd05111 | 279 | cd05111, PTK_HER3, Pseudokinase domain of the Prot | 1e-13 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 1e-13 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 1e-13 | |
| cd06649 | 331 | cd06649, PKc_MEK2, Catalytic domain of the dual-sp | 1e-13 | |
| cd05088 | 303 | cd05088, PTKc_Tie2, Catalytic domain of the Protei | 2e-13 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 2e-13 | |
| cd05575 | 323 | cd05575, STKc_SGK, Catalytic domain of the Protein | 2e-13 | |
| pfam13947 | 106 | pfam13947, GUB_WAK_bind, Wall-associated receptor | 2e-13 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 2e-13 | |
| cd05047 | 270 | cd05047, PTKc_Tie, Catalytic domain of Tie Protein | 3e-13 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 3e-13 | |
| cd05573 | 350 | cd05573, STKc_ROCK_NDR_like, Catalytic domain of R | 3e-13 | |
| cd06615 | 308 | cd06615, PKc_MEK, Catalytic domain of the dual-spe | 4e-13 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 4e-13 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 4e-13 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 5e-13 | |
| cd05605 | 285 | cd05605, STKc_GRK4_like, Catalytic domain of G pro | 5e-13 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 7e-13 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 8e-13 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 1e-12 | |
| cd05100 | 334 | cd05100, PTKc_FGFR3, Catalytic domain of the Prote | 1e-12 | |
| PTZ00426 | 340 | PTZ00426, PTZ00426, cAMP-dependent protein kinase | 1e-12 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 1e-12 | |
| cd05622 | 371 | cd05622, STKc_ROCK1, Catalytic domain of the Prote | 1e-12 | |
| cd05091 | 283 | cd05091, PTKc_Ror2, Catalytic domain of the Protei | 1e-12 | |
| cd06650 | 333 | cd06650, PKc_MEK1, Catalytic domain of the dual-sp | 2e-12 | |
| cd05608 | 280 | cd05608, STKc_GRK1, Catalytic domain of the Protei | 2e-12 | |
| cd07864 | 302 | cd07864, STKc_CDK12, Catalytic domain of the Serin | 2e-12 | |
| cd05632 | 285 | cd05632, STKc_GRK5, Catalytic domain of the Protei | 2e-12 | |
| cd05618 | 329 | cd05618, STKc_aPKC_iota, Catalytic domain of the P | 2e-12 | |
| PHA03209 | 357 | PHA03209, PHA03209, serine/threonine kinase US3; P | 3e-12 | |
| cd05099 | 314 | cd05099, PTKc_FGFR4, Catalytic domain of the Prote | 3e-12 | |
| cd05593 | 328 | cd05593, STKc_PKB_gamma, Catalytic domain of the P | 3e-12 | |
| cd05073 | 260 | cd05073, PTKc_Hck, Catalytic domain of the Protein | 3e-12 | |
| cd06618 | 296 | cd06618, PKc_MKK7, Catalytic domain of the dual-sp | 3e-12 | |
| cd05617 | 327 | cd05617, STKc_aPKC_zeta, Catalytic domain of the P | 3e-12 | |
| cd05591 | 321 | cd05591, STKc_nPKC_epsilon, Catalytic domain of th | 4e-12 | |
| cd06633 | 313 | cd06633, STKc_TAO3, Catalytic domain of the Protei | 4e-12 | |
| cd05603 | 321 | cd05603, STKc_SGK2, Catalytic domain of the Protei | 4e-12 | |
| cd08223 | 257 | cd08223, STKc_Nek4, Catalytic domain of the Protei | 5e-12 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 6e-12 | |
| cd05078 | 258 | cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat | 8e-12 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 9e-12 | |
| PTZ00283 | 496 | PTZ00283, PTZ00283, serine/threonine protein kinas | 9e-12 | |
| cd05077 | 262 | cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) do | 1e-11 | |
| cd05595 | 323 | cd05595, STKc_PKB_beta, Catalytic domain of the Pr | 1e-11 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 1e-11 | |
| PHA02988 | 283 | PHA02988, PHA02988, hypothetical protein; Provisio | 1e-11 | |
| cd05602 | 325 | cd05602, STKc_SGK1, Catalytic domain of the Protei | 1e-11 | |
| cd06635 | 317 | cd06635, STKc_TAO1, Catalytic domain of the Protei | 1e-11 | |
| cd05631 | 285 | cd05631, STKc_GRK4, Catalytic domain of the Protei | 2e-11 | |
| cd06616 | 288 | cd06616, PKc_MKK4, Catalytic domain of the dual-sp | 2e-11 | |
| cd05571 | 323 | cd05571, STKc_PKB, Catalytic domain of the Protein | 2e-11 | |
| cd05588 | 329 | cd05588, STKc_aPKC, Catalytic domain of the Protei | 3e-11 | |
| cd05601 | 330 | cd05601, STKc_CRIK, Catalytic domain of the Protei | 3e-11 | |
| PHA03390 | 267 | PHA03390, pk1, serine/threonine-protein kinase 1; | 3e-11 | |
| cd06634 | 308 | cd06634, STKc_TAO2, Catalytic domain of the Protei | 3e-11 | |
| cd06617 | 283 | cd06617, PKc_MKK3_6, Catalytic domain of the dual- | 5e-11 | |
| cd05615 | 323 | cd05615, STKc_cPKC_alpha, Catalytic domain of the | 1e-10 | |
| PRK13184 | 932 | PRK13184, pknD, serine/threonine-protein kinase; R | 1e-10 | |
| cd05600 | 333 | cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun | 2e-10 | |
| cd07852 | 337 | cd07852, STKc_MAPK15, Catalytic domain of the Seri | 2e-10 | |
| cd08222 | 260 | cd08222, STKc_Nek11, Catalytic domain of the Prote | 2e-10 | |
| cd07853 | 372 | cd07853, STKc_NLK, Catalytic domain of the Serine/ | 2e-10 | |
| cd07851 | 343 | cd07851, STKc_p38, Catalytic domain of the Serine/ | 2e-10 | |
| PHA03210 | 501 | PHA03210, PHA03210, serine/threonine kinase US3; P | 2e-10 | |
| cd05594 | 325 | cd05594, STKc_PKB_alpha, Catalytic domain of the P | 2e-10 | |
| cd05087 | 269 | cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t | 2e-10 | |
| PTZ00267 | 478 | PTZ00267, PTZ00267, NIMA-related protein kinase; P | 3e-10 | |
| cd05616 | 323 | cd05616, STKc_cPKC_beta, Catalytic domain of the P | 4e-10 | |
| cd07855 | 334 | cd07855, STKc_ERK5, Catalytic domain of the Serine | 6e-10 | |
| cd06643 | 282 | cd06643, STKc_SLK, Catalytic domain of the Protein | 6e-10 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 7e-10 | |
| PHA03207 | 392 | PHA03207, PHA03207, serine/threonine kinase US3; P | 7e-10 | |
| cd07854 | 342 | cd07854, STKc_MAPK4_6, Catalytic domain of the Ser | 7e-10 | |
| cd05037 | 259 | cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom | 9e-10 | |
| cd05064 | 266 | cd05064, PTKc_EphR_A10, Catalytic domain of the Pr | 1e-09 | |
| cd08216 | 314 | cd08216, PK_STRAD, Pseudokinase domain of STE20-re | 1e-09 | |
| cd07849 | 336 | cd07849, STKc_ERK1_2_like, Catalytic domain of Ext | 1e-09 | |
| cd06637 | 272 | cd06637, STKc_TNIK, Catalytic domain of the Protei | 1e-09 | |
| cd06645 | 267 | cd06645, STKc_MAP4K3, Catalytic domain of the Prot | 1e-09 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 1e-09 | |
| cd07861 | 285 | cd07861, STKc_CDK1_euk, Catalytic domain of the Se | 2e-09 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 2e-09 | |
| cd07862 | 290 | cd07862, STKc_CDK6, Catalytic domain of the Serine | 2e-09 | |
| cd05587 | 324 | cd05587, STKc_cPKC, Catalytic domain of the Protei | 2e-09 | |
| cd07858 | 337 | cd07858, STKc_TEY_MAPK_plant, Catalytic domain of | 4e-09 | |
| cd06639 | 291 | cd06639, STKc_myosinIIIB, Catalytic domain of the | 4e-09 | |
| PTZ00266 | 1021 | PTZ00266, PTZ00266, NIMA-related protein kinase; P | 4e-09 | |
| cd07871 | 288 | cd07871, STKc_PCTAIRE3, Catalytic domain of the Se | 4e-09 | |
| cd05633 | 279 | cd05633, STKc_GRK3, Catalytic domain of the Protei | 4e-09 | |
| cd06622 | 286 | cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of | 4e-09 | |
| cd05607 | 277 | cd05607, STKc_GRK7, Catalytic domain of the Protei | 5e-09 | |
| cd05584 | 323 | cd05584, STKc_p70S6K, Catalytic domain of the Prot | 6e-09 | |
| cd07843 | 293 | cd07843, STKc_CDC2L1, Catalytic domain of the Seri | 6e-09 | |
| cd07857 | 332 | cd07857, STKc_MPK1, Catalytic domain of the Serine | 6e-09 | |
| cd07876 | 359 | cd07876, STKc_JNK2, Catalytic domain of the Serine | 6e-09 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 8e-09 | |
| cd05609 | 305 | cd05609, STKc_MAST, Catalytic domain of the Protei | 8e-09 | |
| cd07866 | 311 | cd07866, STKc_BUR1, Catalytic domain of the Serine | 8e-09 | |
| cd07865 | 310 | cd07865, STKc_CDK9, Catalytic domain of the Serine | 8e-09 | |
| cd07859 | 338 | cd07859, STKc_TDY_MAPK_plant, Catalytic domain of | 9e-09 | |
| cd05606 | 278 | cd05606, STKc_beta_ARK, Catalytic domain of the Pr | 9e-09 | |
| PLN00009 | 294 | PLN00009, PLN00009, cyclin-dependent kinase A; Pro | 1e-08 | |
| cd06636 | 282 | cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr | 1e-08 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 1e-08 | |
| cd05624 | 331 | cd05624, STKc_MRCK_beta, Catalytic domain of the P | 1e-08 | |
| cd05598 | 376 | cd05598, STKc_LATS, Catalytic domain of the Protei | 2e-08 | |
| cd05076 | 274 | cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) do | 2e-08 | |
| cd07873 | 301 | cd07873, STKc_PCTAIRE1, Catalytic domain of the Se | 2e-08 | |
| PTZ00024 | 335 | PTZ00024, PTZ00024, cyclin-dependent protein kinas | 2e-08 | |
| cd05599 | 364 | cd05599, STKc_NDR_like, Catalytic domain of Nuclea | 2e-08 | |
| cd07872 | 309 | cd07872, STKc_PCTAIRE2, Catalytic domain of the Se | 2e-08 | |
| cd07847 | 286 | cd07847, STKc_CDKL1_4, Catalytic domain of the Ser | 3e-08 | |
| cd05574 | 316 | cd05574, STKc_phototropin_like, Catalytic domain o | 3e-08 | |
| cd05054 | 337 | cd05054, PTKc_VEGFR, Catalytic domain of the Prote | 3e-08 | |
| cd05103 | 343 | cd05103, PTKc_VEGFR2, Catalytic domain of the Prot | 4e-08 | |
| cd05597 | 331 | cd05597, STKc_DMPK_like, Catalytic domain of Myoto | 4e-08 | |
| cd07863 | 288 | cd07863, STKc_CDK4, Catalytic domain of the Serine | 6e-08 | |
| cd07869 | 303 | cd07869, STKc_PFTAIRE1, Catalytic domain of the Se | 6e-08 | |
| cd07831 | 282 | cd07831, STKc_MOK, Catalytic domain of the Serine/ | 8e-08 | |
| cd07850 | 353 | cd07850, STKc_JNK, Catalytic domain of the Serine/ | 8e-08 | |
| cd06646 | 267 | cd06646, STKc_MAP4K5, Catalytic domain of the Prot | 8e-08 | |
| cd05626 | 381 | cd05626, STKc_LATS2, Catalytic domain of the Prote | 9e-08 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 1e-07 | |
| cd06638 | 286 | cd06638, STKc_myosinIIIA, Catalytic domain of the | 1e-07 | |
| cd07842 | 316 | cd07842, STKc_CDK8_like, Catalytic domain of Cycli | 1e-07 | |
| cd05623 | 332 | cd05623, STKc_MRCK_alpha, Catalytic domain of the | 1e-07 | |
| cd05586 | 330 | cd05586, STKc_Sck1_like, Catalytic domain of Suppr | 1e-07 | |
| cd05627 | 360 | cd05627, STKc_NDR2, Catalytic domain of the Protei | 1e-07 | |
| cd05102 | 338 | cd05102, PTKc_VEGFR3, Catalytic domain of the Prot | 1e-07 | |
| PTZ00036 | 440 | PTZ00036, PTZ00036, glycogen synthase kinase; Prov | 2e-07 | |
| cd05628 | 363 | cd05628, STKc_NDR1, Catalytic domain of the Protei | 2e-07 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 2e-07 | |
| PHA03212 | 391 | PHA03212, PHA03212, serine/threonine kinase US3; P | 3e-07 | |
| cd07874 | 355 | cd07874, STKc_JNK3, Catalytic domain of the Serine | 3e-07 | |
| cd05629 | 377 | cd05629, STKc_NDR_like_fungal, Catalytic domain of | 3e-07 | |
| cd07875 | 364 | cd07875, STKc_JNK1, Catalytic domain of the Serine | 5e-07 | |
| cd07870 | 291 | cd07870, STKc_PFTAIRE2, Catalytic domain of the Se | 7e-07 | |
| cd07877 | 345 | cd07877, STKc_p38alpha_MAPK14, Catalytic domain of | 1e-06 | |
| cd05086 | 268 | cd05086, PTKc_Aatyk2, Catalytic domain of the Prot | 1e-06 | |
| cd05104 | 375 | cd05104, PTKc_Kit, Catalytic domain of the Protein | 2e-06 | |
| cd05107 | 401 | cd05107, PTKc_PDGFR_beta, Catalytic domain of the | 3e-06 | |
| cd05576 | 237 | cd05576, STKc_RPK118_like, Catalytic domain of the | 3e-06 | |
| cd07878 | 343 | cd07878, STKc_p38beta_MAPK11, Catalytic domain of | 3e-06 | |
| cd07879 | 342 | cd07879, STKc_p38delta_MAPK13, Catalytic domain of | 5e-06 | |
| cd07839 | 284 | cd07839, STKc_CDK5, Catalytic domain of the Serine | 6e-06 | |
| cd07880 | 343 | cd07880, STKc_p38gamma_MAPK12, Catalytic domain of | 6e-06 | |
| cd07844 | 291 | cd07844, STKc_PCTAIRE_like, Catalytic domain of PC | 1e-05 | |
| cd07848 | 287 | cd07848, STKc_CDKL5, Catalytic domain of the Serin | 1e-05 | |
| cd07837 | 295 | cd07837, STKc_CdkB_plant, Catalytic domain of the | 2e-05 | |
| cd05105 | 400 | cd05105, PTKc_PDGFR_alpha, Catalytic domain of the | 3e-05 | |
| cd05625 | 382 | cd05625, STKc_LATS1, Catalytic domain of the Prote | 5e-05 | |
| PTZ00284 | 467 | PTZ00284, PTZ00284, protein kinase; Provisional | 2e-04 | |
| cd07867 | 317 | cd07867, STKc_CDC2L6, Catalytic domain of Serine/T | 2e-04 | |
| cd07868 | 317 | cd07868, STKc_CDK8, Catalytic domain of the Serine | 3e-04 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 3e-04 | |
| PHA03211 | 461 | PHA03211, PHA03211, serine/threonine kinase US3; P | 3e-04 | |
| cd08226 | 328 | cd08226, PK_STRAD_beta, Pseudokinase domain of STE | 6e-04 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 168 bits (429), Expect = 3e-48
Identities = 77/252 (30%), Positives = 120/252 (47%), Gaps = 32/252 (12%)
Query: 303 AVKKSKVI-DESKVEEFINEVVILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGTLFQY 361
AVK K E ++EEF+ E I+ +++H N+VKLLG C E E ++V E++P G L Y
Sbjct: 32 AVKTLKEDASEQQIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLMIVMEYMPGGDLLDY 91
Query: 362 IHDQNEDFPITWEIRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDF 421
+ N ++ L A++++ + YL S HRD+ + N L+ + K+SDF
Sbjct: 92 LRK-NRPKELSLSDLLSFALQIARGMEYLE---SKNFIHRDLAARNCLVGENLVVKISDF 147
Query: 422 GASRSMAVDQTHMTTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLTELLT-GEKPIRF 480
G SR + D + ++ PE + +FT KSDV+SFGV+L E+ T GE+P
Sbjct: 148 GLSRDLYDDDYYKVKGGKLPIRWMAPESLKEGKFTSKSDVWSFGVLLWEIFTLGEEP--- 204
Query: 481 TILEEDKSLAAYFLCAMKEERLFEILDARVMKQGGKDEIIT-----VAKLAKRCLNLNGK 535
Y M + E L K+G + + KL +C + +
Sbjct: 205 -----------YP--GMSNAEVLEYL-----KKGYRLPKPPNCPPELYKLMLQCWAEDPE 246
Query: 536 KRPTMREVASEL 547
RPT E+ L
Sbjct: 247 DRPTFSELVEIL 258
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 166 bits (424), Expect = 1e-47
Identities = 73/247 (29%), Positives = 113/247 (45%), Gaps = 23/247 (9%)
Query: 303 AVKKSKVI-DESKVEEFINEVVILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGTLFQY 361
AVK K E ++EEF+ E I+ +++H NVVKLLG C E E +V E++ G L Y
Sbjct: 32 AVKTLKEDASEQQIEEFLREARIMRKLDHPNVVKLLGVCTEEEPLYIVMEYMEGGDLLSY 91
Query: 362 IHDQNEDFPITWEIRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDF 421
+ ++ L A++++ + YL S HRD+ + N L+ + K+SDF
Sbjct: 92 LRKNRP--KLSLSDLLSFALQIARGMEYLE---SKNFIHRDLAARNCLVGENLVVKISDF 146
Query: 422 GASRSMAVDQTHMTTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLTELLT-GEKPIRF 480
G SR + D + ++ PE + +FT KSDV+SFGV+L E+ T GE+P
Sbjct: 147 GLSRDLYDDDYYRKRGGKLPIRWMAPESLKEGKFTSKSDVWSFGVLLWEIFTLGEQP--- 203
Query: 481 TILEEDKSLAAYFLCAMKEERLFEILDARVMKQGGKDEIITVAKLAKRCLNLNGKKRPTM 540
S RL + + E+ L +C + + RPT
Sbjct: 204 ---YPGMSNEEVLEYLKNGYRLPQPPNCP-------PEL---YDLMLQCWAEDPEDRPTF 250
Query: 541 REVASEL 547
E+ L
Sbjct: 251 SELVEIL 257
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 160 bits (407), Expect = 5e-45
Identities = 75/260 (28%), Positives = 117/260 (45%), Gaps = 38/260 (14%)
Query: 303 AVKKSKVI-DESKVEEFINEVVILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGTLFQY 361
AVK K E + ++F+ E ++ ++ H NVV+LLG C E E LV E++ G L Y
Sbjct: 27 AVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEYMEGGDLLDY 86
Query: 362 IHDQNEDFP------ITWEIRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYR 415
+ FP ++ + L AI+++ + YL S HRD+ + N L+ +
Sbjct: 87 LRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLA---SKKFVHRDLAARNCLVGEDLV 143
Query: 416 AKVSDFGASRSMAVDQTHMTTQVHGT---FGYLDPEYFRSSQFTDKSDVYSFGVVLTELL 472
K+SDFG SR + D + G ++ PE + FT KSDV+SFGV+L E+
Sbjct: 144 VKISDFGLSRDVYDDDYYRKK--TGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIF 201
Query: 473 T-GEKPIRFTILEEDKSLAAYFLCAMKEERLFE-ILDARVMKQ--GGKDEIITVAKLAKR 528
T G P Y + E + E + + + DE+ +L
Sbjct: 202 TLGATP--------------Y--PGLSNEEVLEYLRKGYRLPKPEYCPDEL---YELMLS 242
Query: 529 CLNLNGKKRPTMREVASELA 548
C L+ + RPT E+ L
Sbjct: 243 CWQLDPEDRPTFSELVERLE 262
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 159 bits (404), Expect = 9e-45
Identities = 81/273 (29%), Positives = 125/273 (45%), Gaps = 39/273 (14%)
Query: 291 FDLNRILGQGGQ---------------AVKKSKV--IDESKVEEFINEVVILSQINHRNV 333
++L R LG G AVK K K + E+ IL +++H N+
Sbjct: 1 YELLRKLGSGSFGTVYKAKHKGTGKIVAVKILKKRSEKSKKDQTARREIRILRRLSHPNI 60
Query: 334 VKLLGCCLETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEIRLRIAIEVSGALSYLHSA 393
V+L+ + + LV E+ G LF Y+ P++ + +IA+++ L YLHS
Sbjct: 61 VRLIDAFEDKDHLYLVMEYCEGGDLFDYLSRGG---PLSEDEAKKIALQILRGLEYLHSN 117
Query: 394 ASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHGTFGYLDPE-YFRS 452
I HRD+K NILLD+ K++DFG ++ + + +TT V GT Y+ PE
Sbjct: 118 G---IIHRDLKPENILLDENGVVKIADFGLAKKLLKSSSSLTTFV-GTPWYMAPEVLLGG 173
Query: 453 SQFTDKSDVYSFGVVLTELLTGEKPIRFTILEEDKSLAAYFLCAMKEERLFEILDARVM- 511
+ + K DV+S GV+L ELLTG+ P F+ L + + IL +
Sbjct: 174 NGYGPKVDVWSLGVILYELLTGKPP--FSGENILDQL----------QLIRRILGPPLEF 221
Query: 512 -KQGGKDEIITVAKLAKRCLNLNGKKRPTMREV 543
+ L K+CLN + KRPT E+
Sbjct: 222 DEPKWSSGSEEAKDLIKKCLNKDPSKRPTAEEI 254
|
Length = 260 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 157 bits (398), Expect = 2e-44
Identities = 62/172 (36%), Positives = 96/172 (55%), Gaps = 9/172 (5%)
Query: 303 AVKK-SKVIDESKVEEFINEVVILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGTLFQY 361
A+K K S +EE + E+ IL ++NH N+VKL G + LV E+ G+L
Sbjct: 22 AIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSLKDL 81
Query: 362 IHDQNEDFPITWEIRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLD-DKYRAKVSD 420
+ + ++ + LRI +++ L YLH S I HRD+K NILLD D + K++D
Sbjct: 82 LKENE--GKLSEDEILRILLQILEGLEYLH---SNGIIHRDLKPENILLDSDNGKVKLAD 136
Query: 421 FGASRSMAVDQTHMTTQVHGTFGYLDPEYFRSSQ-FTDKSDVYSFGVVLTEL 471
FG S+ + D++ + T V GT Y+ PE +++KSD++S GV+L EL
Sbjct: 137 FGLSKLLTSDKSLLKTIV-GTPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL 187
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 155 bits (395), Expect = 2e-43
Identities = 74/252 (29%), Positives = 123/252 (48%), Gaps = 32/252 (12%)
Query: 303 AVKKSKVI-DESKVEEFINEVVILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGTLFQY 361
AVK K E + EEF+ E I+ +++H N+V+LLG C + E +V E++P G L +
Sbjct: 32 AVKTLKEGASEEEREEFLEEASIMKKLSHPNIVRLLGVCTQGEPLYIVTEYMPGGDLLDF 91
Query: 362 IHDQNEDFPITWEIRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDF 421
+ E + L++A++++ + YL S HRD+ + N L+ + K+SDF
Sbjct: 92 LRKHGEKLTLKD--LLQMALQIAKGMEYLE---SKNFVHRDLAARNCLVTENLVVKISDF 146
Query: 422 GASRSMAVDQTHMTTQVHGTF--GYLDPEYFRSSQFTDKSDVYSFGVVLTELLT-GEKPI 478
G SR + D + + G ++ PE + +FT KSDV+SFGV+L E+ T GE+P
Sbjct: 147 GLSRDIYEDDYY-RKRGGGKLPIKWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGEQP- 204
Query: 479 RFTILEEDKSLAAYFLCAMKEERLFE-ILDARVMKQ--GGKDEIITVAKLAKRCLNLNGK 535
M E + E + D + + DE+ +L +C + +
Sbjct: 205 ---------------YPGMSNEEVLELLEDGYRLPRPENCPDEL---YELMLQCWAYDPE 246
Query: 536 KRPTMREVASEL 547
RPT E+ +L
Sbjct: 247 DRPTFSELVEDL 258
|
Length = 258 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 153 bits (389), Expect = 1e-42
Identities = 75/269 (27%), Positives = 114/269 (42%), Gaps = 37/269 (13%)
Query: 291 FDLNRILGQGG-----QAVKKS-------KVID----ESKVEEFINEVVILSQINHRNVV 334
+++ LG+G A K KVI + E + E+ IL ++ H N+V
Sbjct: 1 YEILEKLGEGSFGKVYLARDKKTGKLVAIKVIKKKKIKKDRERILREIKILKKLKHPNIV 60
Query: 335 KLLGCCLETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEIRLRIAIEVSGALSYLHSAA 394
+L + + LV E+ G LF + + E R ++ AL YLHS
Sbjct: 61 RLYDVFEDEDKLYLVMEYCEGGDLFDLLKKRGR-LSE-DEAR-FYLRQILSALEYLHSK- 116
Query: 395 SIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHGTFGYLDPEYFRSSQ 454
I HRD+K NILLD+ K++DFG +R + +TT V GT Y+ PE
Sbjct: 117 --GIVHRDLKPENILLDEDGHVKLADFGLARQLD-PGEKLTTFV-GTPEYMAPEVLLGKG 172
Query: 455 FTDKSDVYSFGVVLTELLTGEKPIRFTILEEDKSLAAYFLCAMKEERLFEILDARVMKQG 514
+ D++S GV+L ELLTG+ P D L F + + + +
Sbjct: 173 YGKAVDIWSLGVILYELLTGKPP-----FPGDDQLLELF-KKIGKPKPPFPPPEWDISPE 226
Query: 515 GKDEIITVAKLAKRCLNLNGKKRPTMREV 543
KD L ++ L + +KR T E
Sbjct: 227 AKD-------LIRKLLVKDPEKRLTAEEA 248
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 134 bits (339), Expect = 1e-35
Identities = 76/283 (26%), Positives = 127/283 (44%), Gaps = 54/283 (19%)
Query: 290 NFDLNRILGQG-------------GQ--AVKKSKV--IDESKVEEFINEVVILSQINHRN 332
+ +LG+G G+ AVK ++ E ++E E+ ILS + H N
Sbjct: 1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPN 60
Query: 333 VVKLLGCCL-ETEVPLLVY-EFIPNGTLFQYIHDQNEDFPITWEIRLRIAIEVSGALSYL 390
+V+ G E + L ++ E++ G+L + + P IR + ++ L+YL
Sbjct: 61 IVRYYGSERDEEKNTLNIFLEYVSGGSLSSLLK-KFGKLPEP-VIR-KYTRQILEGLAYL 117
Query: 391 HSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMA-VDQTHMTTQVHGTFGYLDPEY 449
HS I HRDIK NIL+D K++DFG ++ + ++ T V GT ++ PE
Sbjct: 118 HSNG---IVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGTGSVRGTPYWMAPEV 174
Query: 450 FRSSQFTDKSDVYSFGVVLTELLTGEKPIRFTILEEDKSLAAYFLCAMKEERLFEILDAR 509
R ++ +D++S G + E+ TG+ P E +AA + +
Sbjct: 175 IRGEEYGRAADIWSLGCTVIEMATGKPPWS----ELGNPMAALY---------------K 215
Query: 510 VMKQGGKDEI-ITVAKLAK----RCLNLNGKKRPTMREVASEL 547
+ G EI +++ AK +CL + KKRPT A EL
Sbjct: 216 IGSSGEPPEIPEHLSEEAKDFLRKCLRRDPKKRPT----ADEL 254
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 125 bits (316), Expect = 2e-32
Identities = 79/272 (29%), Positives = 126/272 (46%), Gaps = 38/272 (13%)
Query: 290 NFDLNRILGQG--GQAVK---KS-------KVID-----ESKVEEFINEVVILSQINHRN 332
+++ + +G+G G+ KS K ID E + E+ +NEV IL ++NH N
Sbjct: 1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPN 60
Query: 333 VVKLLGCCLETEVPLLVYEFIPNGTLFQYIHDQNEDF-PITWEIRLRIAIEVSGALSYLH 391
++K E +V E+ G L Q I Q ++ P E L +++ AL YLH
Sbjct: 61 IIKYYESFEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLH 120
Query: 392 SAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHGTFGYLDPEYFR 451
S I HRDIK NI L K+ DFG S+ ++ T V GT YL PE +
Sbjct: 121 SRK---ILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTVDLAKTVV-GTPYYLSPELCQ 176
Query: 452 SSQFTDKSDVYSFGVVLTELLTGEKPIRFTILEEDKSLAAYFLCAMKEERLFEILDARVM 511
+ + KSD++S G VL EL T + P F E ++L L +K + + + ++
Sbjct: 177 NKPYNYKSDIWSLGCVLYELCTLKHP--F----EGENLLELALKILKGQ--YPPIPSQY- 227
Query: 512 KQGGKDEIITVAKLAKRCLNLNGKKRPTMREV 543
E+ L L + ++RP++ ++
Sbjct: 228 ----SSELR---NLVSSLLQKDPEERPSIAQI 252
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 117 bits (295), Expect = 1e-29
Identities = 76/265 (28%), Positives = 112/265 (42%), Gaps = 37/265 (13%)
Query: 286 KATDNFDLNRILGQGGQAVKKSKVIDESKVEEFINEVVILSQINHRNVVKLLGCCLETEV 345
KA + A+K K+ + K E+ INE+ IL + H N+VK G L+ +
Sbjct: 18 KARHKRTGKEV------AIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGSYLKKDE 71
Query: 346 PLLVYEFIPNGTLFQYIHDQNEDFPITWEIRLRIA---IEVSGALSYLHSAASIPIYHRD 402
+V EF G+L + N+ + IA E+ L YLHS I HRD
Sbjct: 72 LWIVMEFCSGGSLKDLLKSTNQTLTESQ-----IAYVCKELLKGLEYLHSNG---IIHRD 123
Query: 403 IKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHGTFGYLDPEYFRSSQFTDKSDVY 462
IK+ NILL K+ DFG S ++ + T GT ++ PE + K+D++
Sbjct: 124 IKAANILLTSDGEVKLIDFGLSAQLSDTKARNTMV--GTPYWMAPEVINGKPYDYKADIW 181
Query: 463 SFGVVLTELLTGEKPIRFTILEEDKSLAAYFLCAMKEERLFEILDARVMKQGGKDEIITV 522
S G+ EL G+ P E + A F A + + KD +
Sbjct: 182 SLGITAIELAEGKPPYS-----ELPPMKALFKIATNG--PPGLRNPEKWSDEFKDFL--- 231
Query: 523 AKLAKRCLNLNGKKRPTMREVASEL 547
K+CL N +KRPT A +L
Sbjct: 232 ----KKCLQKNPEKRPT----AEQL 248
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 117 bits (293), Expect = 1e-28
Identities = 72/278 (25%), Positives = 112/278 (40%), Gaps = 32/278 (11%)
Query: 290 NFDLNRILGQGG---------------QAVKKSKVIDESKVEEFINEVVILSQINH-RNV 333
++ + R LG+G + + K +VE F+ E+ IL+ +NH N+
Sbjct: 1 SYRILRKLGEGSFGEVYLARDRKLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNI 60
Query: 334 VKLLGCCLETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEIRLRIAIEVSGALSYLHSA 393
VKL + LV E++ G+L + P++ L I ++ AL YLHS
Sbjct: 61 VKLYDFFQDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSK 120
Query: 394 ASIPIYHRDIKSTNILLD-DKYRAKVSDFGASRSMAVDQTHMTTQ-----VHGTFGYLDP 447
I HRDIK NILLD D K+ DFG ++ + + + GT GY+ P
Sbjct: 121 GII---HRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYMAP 177
Query: 448 EYFRSSQF---TDKSDVYSFGVVLTELLTGEKPIRFTILEEDKSLAAYFLCAMKEERLFE 504
E + SD++S G+ L ELLTG P S + E
Sbjct: 178 EVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTL----KIILELPTP 233
Query: 505 ILDARVMKQGGKDEIITVAKLAKRCLNLNGKKRPTMRE 542
L + + + + L K+ L + K R +
Sbjct: 234 SLASPLSPSNPELISKAASDLLKKLLAKDPKNRLSSSS 271
|
Length = 384 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 112 bits (283), Expect = 4e-28
Identities = 66/174 (37%), Positives = 92/174 (52%), Gaps = 9/174 (5%)
Query: 305 KKSKVIDESKVEEFINEVVILSQINHRNVVKLLGCCLETEVPL-LVYEFIPNGTLFQYIH 363
KK K+I +VE + E ILS+INH +VKL +TE L LV E+ P G LF ++
Sbjct: 27 KKKKIIKRKEVEHTLTERNILSRINHPFIVKLH-YAFQTEEKLYLVLEYAPGGELFSHLS 85
Query: 364 DQNEDFPITWEIRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGA 423
+ F R A E+ AL YLHS I +RD+K NILLD K++DFG
Sbjct: 86 -KEGRFSEER-ARFYAA-EIVLALEYLHSLG---IIYRDLKPENILLDADGHIKLTDFGL 139
Query: 424 SRSMAVDQTHMTTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLTELLTGEKP 477
++ ++ + + T GT YL PE + D +S GV+L E+LTG+ P
Sbjct: 140 AKELSSEGSRTNTFC-GTPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPP 192
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 112 bits (282), Expect = 6e-28
Identities = 72/266 (27%), Positives = 127/266 (47%), Gaps = 38/266 (14%)
Query: 290 NFDLNRILGQGG-----QAVKKS-------KVIDESKV-----EEFINEVVILSQINHRN 332
+F++ +G+G + V+K+ K ID SK+ EE I+E +L++++
Sbjct: 1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSY 60
Query: 333 VVKLLGCCLETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEIRLRIAIEVSGALSYLHS 392
+++ L+ +V E+ NG L + + Q P+ + R I++ L++LHS
Sbjct: 61 IIRYYESFLDKGKLNIVMEYAENGDLHKLLKMQRGR-PLPEDQVWRFFIQILLGLAHLHS 119
Query: 393 AASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHGTFGYLDPEYFRS 452
I HRDIKS N+ LD K+ D G ++ ++ D T+ + GT YL PE
Sbjct: 120 KK---ILHRDIKSLNLFLDAYDNVKIGDLGVAKLLS-DNTNFANTIVGTPYYLSPELCED 175
Query: 453 SQFTDKSDVYSFGVVLTELLTGEKPIRFTILEEDKSLAAYFLCAMKEERLFEILDARVMK 512
+ +KSDV++ GVVL E TG+ P + + A L ++ +F + +
Sbjct: 176 KPYNEKSDVWALGVVLYECCTGKHPF------DANNQGALILKIIRG--VFPPVSQMYSQ 227
Query: 513 QGGKDEIITVAKLAKRCLNLNGKKRP 538
Q +A+L +CL + ++RP
Sbjct: 228 Q--------LAQLIDQCLTKDYRQRP 245
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 109 bits (275), Expect = 5e-27
Identities = 57/181 (31%), Positives = 94/181 (51%), Gaps = 13/181 (7%)
Query: 303 AVK--KSKVIDESKVEEFINEVVILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGTLFQ 360
AVK KS + + +++F+ E I+ ++H N+++L G L T ++V E P G+L
Sbjct: 27 AVKCLKSDKLSDI-MDDFLKEAAIMHSLDHENLIRLYGVVL-THPLMMVTELAPLGSLLD 84
Query: 361 YIHDQNED-FPITWEIRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVS 419
+ F I+ A++++ + YL S I HRD+ + NILL + K+
Sbjct: 85 RLRKDALGHFLIS--TLCDYAVQIANGMRYLESKRFI---HRDLAARNILLASDDKVKIG 139
Query: 420 DFGASRSMAVDQTHMTTQVHGT--FGYLDPEYFRSSQFTDKSDVYSFGVVLTELLT-GEK 476
DFG R++ ++ H + H F + PE R+ F+ SDV+ FGV L E+ T GE+
Sbjct: 140 DFGLMRALPQNEDHYVMEEHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEE 199
Query: 477 P 477
P
Sbjct: 200 P 200
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 107 bits (270), Expect = 3e-26
Identities = 63/243 (25%), Positives = 114/243 (46%), Gaps = 36/243 (14%)
Query: 316 EEFINEVVILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEI 375
+EF+ E +++Q++H +V+L+G C E +LV E P G L +Y+ + P++ ++
Sbjct: 41 KEFLREASVMAQLDHPCIVRLIGVCKG-EPLMLVMELAPLGPLLKYLKK-RREIPVS-DL 97
Query: 376 RLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMT 435
+ +A +V+ ++YL S + HRD+ + N+LL ++++AK+SDFG SR++ +
Sbjct: 98 KE-LAHQVAMGMAYLESKHFV---HRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYR 153
Query: 436 TQVHGTF--GYLDPEYFRSSQFTDKSDVYSFGVVLTELLT-GEKPIRFTILEEDKSLAAY 492
G + + PE +F+ KSDV+S+GV L E + G KP
Sbjct: 154 ATTAGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYG------------- 200
Query: 493 FLCAMKEERLFEILDARVMKQGGKDEI-----ITVAKLAKRCLNLNGKKRPTMREVASEL 547
MK + +L+ G + + + C + RPT E+ S
Sbjct: 201 ---EMKGAEVIAMLE-----SGERLPRPEECPQEIYSIMLSCWKYRPEDRPTFSELESTF 252
Query: 548 AGI 550
Sbjct: 253 RRD 255
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 107 bits (269), Expect = 3e-26
Identities = 73/250 (29%), Positives = 120/250 (48%), Gaps = 28/250 (11%)
Query: 303 AVKKSKVIDESK-VEEFINEVVILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGTLFQY 361
AVK K D+S + F+ E +++ + H N+V+LLG L+ +V E++ G+L Y
Sbjct: 33 AVKCLK--DDSTAAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLYIVTEYMAKGSLVDY 90
Query: 362 IHDQNEDFPITWEIRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDF 421
+ + IT +L A++V + YL HRD+ + N+L+ + AKVSDF
Sbjct: 91 LRSRGRAV-ITLAQQLGFALDVCEGMEYLEEKN---FVHRDLAARNVLVSEDLVAKVSDF 146
Query: 422 GASRSMAVDQTHMTTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLTELLT-GEKPIRF 480
G ++ + Q V T PE R +F+ KSDV+SFG++L E+ + G P
Sbjct: 147 GLAKEASQGQDSGKLPVKWT----APEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPR 202
Query: 481 TILEEDKSLAAYFLCAMKEERLFEILDARVMKQGGKDEIITVAKLAKRCLNLNGKKRPTM 540
L++ + + + E +G E V K+ K C L+ KRPT
Sbjct: 203 IPLKD---VVPHVEKGYRME----------APEGCPPE---VYKVMKDCWELDPAKRPTF 246
Query: 541 REVASELAGI 550
+++ +LA I
Sbjct: 247 KQLREQLALI 256
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 105 bits (265), Expect = 3e-25
Identities = 70/230 (30%), Positives = 106/230 (46%), Gaps = 46/230 (20%)
Query: 289 DNFDLNRILGQG--GQ-------------AVK---KSKVIDESKVEEFINEVVILSQIN- 329
D+F +I+G+G A+K K ++I E KV+ E +L+++N
Sbjct: 1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNG 60
Query: 330 HRNVVKLLGCCLETEVPLLVYEFIPNGTLFQYIHDQ-NEDFPITWEIRLRIAIEVSGALS 388
H ++KL + E V E+ PNG L QYI + D T R A E+ AL
Sbjct: 61 HPGIIKLYYTFQDEENLYFVLEYAPNGELLQYIRKYGSLDEKCT---RFYAA-EILLALE 116
Query: 389 YLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASR---------SMAVDQTHMTTQVH 439
YLHS I HRD+K NILLD K++DFG ++ S D T++ +Q+
Sbjct: 117 YLHS---KGIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNKGDATNIDSQIE 173
Query: 440 ----------GTFGYLDPEYFRSSQFTDKSDVYSFGVVLTELLTGEKPIR 479
GT Y+ PE SD+++ G ++ ++LTG+ P R
Sbjct: 174 KNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFR 223
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 104 bits (263), Expect = 5e-25
Identities = 71/246 (28%), Positives = 112/246 (45%), Gaps = 27/246 (10%)
Query: 303 AVKKSKVIDESKVEEFINEVVILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGTLFQYI 362
A+KK ++ ++K E INE++I+ H N+V L + +V E++ G+L I
Sbjct: 48 AIKKMRLRKQNK-ELIINEILIMKDCKHPNIVDYYDSYLVGDELWVVMEYMDGGSL-TDI 105
Query: 363 HDQNEDFPITWEIRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFG 422
QN + + EV L YLHS I HRDIKS NILL K++DFG
Sbjct: 106 ITQN-FVRMNEPQIAYVCREVLQGLEYLHSQNVI---HRDIKSDNILLSKDGSVKLADFG 161
Query: 423 ASRSMAVDQTHMTTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLTELLTGEKP-IRFT 481
+ + +++ + V GT ++ PE + + K D++S G++ E+ GE P +R
Sbjct: 162 FAAQLTKEKSKRNSVV-GTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREP 220
Query: 482 ILEEDKSLAAYFLCAMKEERLFEILDARVMKQGGKDEIITVAKLAKRCLNLNGKKRPTMR 541
L A FL K + + + KD +CL + +KRP+
Sbjct: 221 PLR------ALFLITTKG--IPPLKNPEKWSPEFKD-------FLNKCLVKDPEKRPS-- 263
Query: 542 EVASEL 547
A EL
Sbjct: 264 --AEEL 267
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Score = 104 bits (260), Expect = 5e-25
Identities = 60/176 (34%), Positives = 100/176 (56%), Gaps = 10/176 (5%)
Query: 303 AVKK-SKVIDESKVEEFINEVVILSQINHRNVVKLLGCCLETE-VPLLVYEFIPNGTLFQ 360
AVK +++ D +VE+F+ E +I+ +H NV+ LLG CL +E PL+V ++ +G L
Sbjct: 27 AVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPYMKHGDLRN 86
Query: 361 YIHDQNEDFPITWEIRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSD 420
+I ++E T + + ++V+ + YL AS HRD+ + N +LD+ + KV+D
Sbjct: 87 FI--RSETHNPTVKDLIGFGLQVAKGMEYL---ASKKFVHRDLAARNCMLDESFTVKVAD 141
Query: 421 FGASRSM---AVDQTHMTTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLTELLT 473
FG +R + H T ++ E ++ +FT KSDV+SFGV+L EL+T
Sbjct: 142 FGLARDIYDKEYYSVHNHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMT 197
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 103 bits (259), Expect = 7e-25
Identities = 73/249 (29%), Positives = 117/249 (46%), Gaps = 28/249 (11%)
Query: 303 AVKKSKVIDESKVEEFINEVVILSQINHRNVVKLLGCCLETEVPL-LVYEFIPNGTLFQY 361
AVK K D +VEEF+ E ++ +I H N+V+LLG C E P ++ EF+ G L Y
Sbjct: 35 AVKTLKE-DTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTR-EPPFYIITEFMTYGNLLDY 92
Query: 362 IHDQNEDFPITWEIRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDF 421
+ + N + + L +A ++S A+ YL I HRD+ + N L+ + + KV+DF
Sbjct: 93 LRECNRQ-EVNAVVLLYMATQISSAMEYLEKKNFI---HRDLAARNCLVGENHLVKVADF 148
Query: 422 GASRSMAVDQTHMTTQVHGTF--GYLDPEYFRSSQFTDKSDVYSFGVVLTELLT-GEKPI 478
G SR M D T F + PE ++F+ KSDV++FGV+L E+ T G P
Sbjct: 149 GLSRLMTGDT--YTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPY 206
Query: 479 RFTILEEDKSLAAYFLCAMKEERLFEILDARVMKQGGKDEIITVAKLAKRCLNLNGKKRP 538
+ +++E+L+ + + V +L + C N RP
Sbjct: 207 P----------------GIDLSQVYELLEKGYRMERPEGCPPKVYELMRACWQWNPSDRP 250
Query: 539 TMREVASEL 547
+ E+
Sbjct: 251 SFAEIHQAF 259
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Score = 104 bits (260), Expect = 9e-25
Identities = 67/265 (25%), Positives = 119/265 (44%), Gaps = 45/265 (16%)
Query: 303 AVKKSK-VIDESKVEEFINEVVILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGTLFQY 361
AVK K ++F E +L+ H N+VK G C E + P++V+E++ +G L ++
Sbjct: 39 AVKTLKETASNDARKDFEREAELLTNFQHENIVKFYGVCTEGDPPIMVFEYMEHGDLNKF 98
Query: 362 I--HD---------QNEDFPITWEIRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILL 410
+ H + +T L+IA++++ + YL AS HRD+ + N L+
Sbjct: 99 LRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYL---ASQHFVHRDLATRNCLV 155
Query: 411 DDKYRAKVSDFGASRSMAVDQTHMTT---QVHGT----FGYLDPEYFRSSQFTDKSDVYS 463
K+ DFG SR + TT +V G ++ PE +FT +SDV+S
Sbjct: 156 GYDLVVKIGDFGMSRDV------YTTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWS 209
Query: 464 FGVVLTELLT-GEKPIRFTILEEDKSLAAYFLCAMKEERLFEILDARVMKQGGKDEIITV 522
FGVVL E+ T G++P ++ + E + E + + Q + V
Sbjct: 210 FGVVLWEIFTYGKQP--------------WY--GLSNEEVIECITQGRLLQRPRTCPSEV 253
Query: 523 AKLAKRCLNLNGKKRPTMREVASEL 547
+ C + ++R ++++ L
Sbjct: 254 YDIMLGCWKRDPQQRINIKDIHERL 278
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 103 bits (258), Expect = 1e-24
Identities = 52/161 (32%), Positives = 86/161 (53%), Gaps = 5/161 (3%)
Query: 316 EEFINEVVILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEI 375
++FI E ++ +++H N+V+L G C + +V E++ NG L Y+ ++ E
Sbjct: 44 DDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIVTEYMANGCLLNYLRERKGKLGT--EW 101
Query: 376 RLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMT 435
L + +V A+ YL S I HRD+ + N L+ + KVSDFG +R + DQ +
Sbjct: 102 LLDMCSDVCEAMEYLESNGFI---HRDLAARNCLVGEDNVVKVSDFGLARYVLDDQYTSS 158
Query: 436 TQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLTELLTGEK 476
+ PE F S+F+ KSDV+SFGV++ E+ + K
Sbjct: 159 QGTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGK 199
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 101 bits (254), Expect = 6e-24
Identities = 75/268 (27%), Positives = 124/268 (46%), Gaps = 34/268 (12%)
Query: 298 GQGGQ-AVKKSKVIDESKV-EEFINEVVILSQINHRNVVKLLGCCLET--EVPLLVYEFI 353
G Q AVK E + +F E+ IL ++H N+VK G C + L+ E++
Sbjct: 31 NTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKYKGVCEKPGGRSLRLIMEYL 90
Query: 354 PNGTLFQYIHDQNEDFPITWEIRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDK 413
P+G+L Y+ + I + L + ++ + YL S I HRD+ + NIL++ +
Sbjct: 91 PSGSLRDYLQRHRDQ--INLKRLLLFSSQICKGMDYLGSQRYI---HRDLAARNILVESE 145
Query: 414 YRAKVSDFGASRSMAVDQTHMTTQVHG---TFGYLDPEYFRSSQFTDKSDVYSFGVVLTE 470
K+SDFG ++ + D+ + + G F Y PE R+S+F+ SDV+SFGV L E
Sbjct: 146 DLVKISDFGLAKVLPEDKDYYYVKEPGESPIFWY-APECLRTSKFSSASDVWSFGVTLYE 204
Query: 471 LLTGEKPIRFTILEEDKSLAAYFLCAMKEERLFEILD--ARVMKQGGK--------DEII 520
L FT + +S A FL + + I+ ++K+G + DE
Sbjct: 205 L--------FTYGDPSQSPPAEFLRMIGIAQGQMIVTRLLELLKEGERLPRPPSCPDE-- 254
Query: 521 TVAKLAKRCLNLNGKKRPTMREVASELA 548
V L K C + RP+ ++ +
Sbjct: 255 -VYDLMKLCWEAEPQDRPSFADLILIVD 281
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 100 bits (251), Expect = 9e-24
Identities = 62/197 (31%), Positives = 98/197 (49%), Gaps = 24/197 (12%)
Query: 295 RILGQG--GQAVKKSKVIDESKV---------------EEFINEVVILSQINHRNVVKLL 337
R+LG+G G+A + D+S V + +NE+VILS + H N++
Sbjct: 6 RVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYY 65
Query: 338 GCCLETEVPLLVYEFIPNGTLFQYI-HDQNEDFPITWEIRLRIAIEVSGALSYLHSAASI 396
++ L+ E+ GTL+ I + + F E+ L ++ A+SY+H A
Sbjct: 66 NHFMDDNTLLIEMEYANGGTLYDKIVRQKGQLFE--EEMVLWYLFQIVSAVSYIHKAG-- 121
Query: 397 PIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHGTFGYLDPEYFRSSQFT 456
I HRDIK+ NI L K+ DFG S+ + + + T V GT Y+ PE + ++
Sbjct: 122 -ILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYSMAETVV-GTPYYMSPELCQGVKYN 179
Query: 457 DKSDVYSFGVVLTELLT 473
KSD+++ G VL ELLT
Sbjct: 180 FKSDIWALGCVLYELLT 196
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 100 bits (251), Expect = 1e-23
Identities = 76/269 (28%), Positives = 121/269 (44%), Gaps = 42/269 (15%)
Query: 290 NFDLNRILGQGGQAVKKSKVIDE--SKVEEFINEVVILSQINHRNVVKLLGCCLETEVPL 347
N D ++ AVK+ ++ D ++E +E+ +L + H N+VK G + E
Sbjct: 21 NLDTGELM-----AVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVY 75
Query: 348 LVYEFIPNGTLFQYI-HDQNEDFPITWEIRLRI-AIEVSGALSYLHSAASIPIYHRDIKS 405
+ E+ GTL + + H + D E +R+ +++ L+YLHS I HRDIK
Sbjct: 76 IFMEYCSGGTLEELLEHGRILD-----EHVIRVYTLQLLEGLAYLHSHG---IVHRDIKP 127
Query: 406 TNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHGTFG---YLDPEYFRSSQFTDK---S 459
NI LD K+ DFG + + + T M +V G Y+ PE + +
Sbjct: 128 ANIFLDHNGVIKLGDFGCAVKLKNNTTTMGEEVQSLAGTPAYMAPEVITGGKGKGHGRAA 187
Query: 460 DVYSFGVVLTELLTGEKPIRFTILEEDKSLA-AYFLCAMKEERLFEILDARVMKQGGKDE 518
D++S G V+ E+ TG++P E D + + A + + + L GKD
Sbjct: 188 DIWSLGCVVLEMATGKRPWS----ELDNEFQIMFHVGAGHKPPIPDSLQLSPE---GKDF 240
Query: 519 IITVAKLAKRCLNLNGKKRPTMREVASEL 547
+ RCL + KKRPT ASEL
Sbjct: 241 L-------DRCLESDPKKRPT----ASEL 258
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 99.1 bits (247), Expect = 3e-23
Identities = 69/255 (27%), Positives = 110/255 (43%), Gaps = 47/255 (18%)
Query: 303 AVKKSKVIDESKVE--EFINEVVILSQINHRNVVK-----LLGCCLETEVPLLVYEFIPN 355
A+K+ + S+ E + +NE+ IL+ +NH N++ L G L +V E+ P
Sbjct: 29 ALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFLDGNKL-----CIVMEYAPF 83
Query: 356 GTLFQYI-HDQNEDFPITWEIRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKY 414
G L + I + + I + RI I++ L LH I HRD+KS NILL
Sbjct: 84 GDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQK---ILHRDLKSANILLVAND 140
Query: 415 RAKVSDFGASRSMAVDQTHMTTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLTELLTG 474
K+ D G S+ + + TQ+ GT Y+ PE ++ ++ KSD++S G +L E+ T
Sbjct: 141 LVKIGDLGISKVLK--KNMAKTQI-GTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATF 197
Query: 475 EKPIRFTILEEDKSLAAYFLCAMKEERLFEILDARVMKQGGKDEIIT------VAKLAKR 528
P E +S+ D R Q GK I + +
Sbjct: 198 APPF------EARSMQ----------------DLRYKVQRGKYPPIPPIYSQDLQNFIRS 235
Query: 529 CLNLNGKKRPTMREV 543
L + K RP ++
Sbjct: 236 MLQVKPKLRPNCDKI 250
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 98.4 bits (246), Expect = 6e-23
Identities = 68/272 (25%), Positives = 109/272 (40%), Gaps = 38/272 (13%)
Query: 289 DNFDLNRILGQGGQ---------------AVKKSKVIDESKVEEFI-NEVVILSQINHRN 332
+ + ++LGQG A+KK V + + + + E+ L
Sbjct: 1 SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPY 60
Query: 333 VVKLLGCCLETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEIRL-RIAIEVSGALSYLH 391
VVK G + +V E++ G+L + + P E L IA ++ L YLH
Sbjct: 61 VVKCYGAFYKEGEISIVLEYMDGGSL-ADLLKKVGKIP---EPVLAYIARQILKGLDYLH 116
Query: 392 SAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHGTFGYLDPEYFR 451
+ I HRDIK +N+L++ K K++DFG S+ + T V GT Y+ PE +
Sbjct: 117 TKRHI--IHRDIKPSNLLINSKGEVKIADFGISKVLENTLDQCNTFV-GTVTYMSPERIQ 173
Query: 452 SSQFTDKSDVYSFGVVLTELLTGEKPIRFTILEEDKSLAAYFLCA-MKEERLFEILDARV 510
++ +D++S G+ L E G+ P S + A L A
Sbjct: 174 GESYSYAADIWSLGLTLLECALGKFPFLPP---GQPSFFE-LMQAICDGPPPS--LPAEE 227
Query: 511 MKQGGKDEIITVAKLAKRCLNLNGKKRPTMRE 542
+D I CL + KKRP+ E
Sbjct: 228 FSPEFRDFI-------SACLQKDPKKRPSAAE 252
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 98.7 bits (246), Expect = 7e-23
Identities = 76/269 (28%), Positives = 127/269 (47%), Gaps = 41/269 (15%)
Query: 303 AVKKSKVIDESKVEEFINEVVILSQINHRNVVKLLGCCLETEVP--LLVYEFIPNGTLFQ 360
AVKK + + +F E+ IL + H N+VK G C LV E++P G+L
Sbjct: 37 AVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLRLVMEYLPYGSLRD 96
Query: 361 YI--HDQNEDFPITWEIRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKV 418
Y+ H + D L A ++ + YL S + HRD+ + NIL++ + R K+
Sbjct: 97 YLQKHRERLDHRKL----LLYASQICKGMEYLGSKRYV---HRDLATRNILVESENRVKI 149
Query: 419 SDFGASRSMAVDQTHMTTQVHG---TFGYLDPEYFRSSQFTDKSDVYSFGVVLTELLTGE 475
DFG ++ + D+ + + G F Y PE S+F+ SDV+SFGVVL EL
Sbjct: 150 GDFGLTKVLPQDKEYYKVREPGESPIFWYA-PESLTESKFSVASDVWSFGVVLYEL---- 204
Query: 476 KPIRFTILEEDKSLAAYFLCAMKEER-----LFEILDARVMKQGGK--------DEIITV 522
FT ++ S A F+ M ++ ++ +++ ++K G+ EI
Sbjct: 205 ----FTYSDKSCSPPAEFMRMMGNDKQGQMIVYHLIE--LLKNNGRLPAPPGCPAEI--- 255
Query: 523 AKLAKRCLNLNGKKRPTMREVASELAGIK 551
+ K C N + +RP+ E+A ++ I+
Sbjct: 256 YAIMKECWNNDPSQRPSFSELALQVEAIR 284
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Score = 97.7 bits (243), Expect = 9e-23
Identities = 56/163 (34%), Positives = 92/163 (56%), Gaps = 6/163 (3%)
Query: 316 EEFINEVVILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEI 375
E+FI E ++ +++H +V+L G C E LV+EF+ +G L Y+ Q F + E
Sbjct: 44 EDFIEEAQVMMKLSHPKLVQLYGVCTERSPICLVFEFMEHGCLSDYLRAQRGKF--SQET 101
Query: 376 RLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMT 435
L + ++V ++YL S+ I HRD+ + N L+ + KVSDFG +R + DQ +
Sbjct: 102 LLGMCLDVCEGMAYLESSNVI---HRDLAARNCLVGENQVVKVSDFGMTRFVLDDQYTSS 158
Query: 436 TQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLTELLT-GEKP 477
T + PE F S+++ KSDV+SFGV++ E+ + G+ P
Sbjct: 159 TGTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTP 201
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 97.4 bits (243), Expect = 1e-22
Identities = 68/226 (30%), Positives = 103/226 (45%), Gaps = 28/226 (12%)
Query: 290 NFDLNRILGQGG---------------QAVK---KSKVIDESKVEEFINEVVILSQINHR 331
+F+L R++G+G A+K K K +++ V +NE IL ++NH
Sbjct: 1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHP 60
Query: 332 NVVKLLGCCLETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEIRLRIAI-EVSGALSYL 390
+V L + E LV + + G L +Y Q F E +++ I E+ AL YL
Sbjct: 61 FLVNLWYSFQDEENMYLVVDLLLGGDL-RYHLSQKVKFS---EEQVKFWICEIVLALEYL 116
Query: 391 HSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHGTFGYLDPEYF 450
HS I HRDIK NILLD++ ++DF + + D +TT GT GY+ PE
Sbjct: 117 HSKG---IIHRDIKPDNILLDEQGHVHITDFNIATKVTPDT--LTTSTSGTPGYMAPEVL 171
Query: 451 RSSQFTDKSDVYSFGVVLTELLTGEKPIRFTILEEDKSLAAYFLCA 496
++ D +S GV E L G++P R + A A
Sbjct: 172 CRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRTIRDQIRAKQETA 217
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Score = 97.5 bits (243), Expect = 1e-22
Identities = 69/261 (26%), Positives = 121/261 (46%), Gaps = 40/261 (15%)
Query: 303 AVKK-SKVIDESKVEEFINEVVILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGTLFQY 361
VK K DE+ EF E+ + +++H+NVV+LLG C E E ++ E+ G L Q+
Sbjct: 39 LVKALQKTKDENLQSEFRRELDMFRKLSHKNVVRLLGLCREAEPHYMILEYTDLGDLKQF 98
Query: 362 I------HDQNEDFPITWEIRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYR 415
+ ++ + P++ + ++ + +++ + +L +A + HRD+ + N L+ +
Sbjct: 99 LRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNARFV---HRDLAARNCLVSSQRE 155
Query: 416 AKVSDFGASRSMAVDQTHMTTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLTELLT-G 474
KVS S+ + + + +L PE + F+ KSDV+SFGV++ E+ T G
Sbjct: 156 VKVSLLSLSKDVYNSEYYKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQG 215
Query: 475 EKPIRFTILEEDKSLAAYFLCAMKEERLFEILDARVMKQGGKDEII-------TVAKLAK 527
E P F L +++ L Q GK E+ + KL
Sbjct: 216 ELP--FYGLSDEEVLNRL--------------------QAGKLELPVPEGCPSRLYKLMT 253
Query: 528 RCLNLNGKKRPTMREVASELA 548
RC +N K RP+ E+ S L
Sbjct: 254 RCWAVNPKDRPSFSELVSALG 274
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275 |
| >gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Score = 97.7 bits (243), Expect = 1e-22
Identities = 71/301 (23%), Positives = 132/301 (43%), Gaps = 61/301 (20%)
Query: 290 NFDLNRILGQG--GQAVKKS---------------KVIDE----SKVEEFINEVVILSQI 328
N L + LG+G G+ VK + K++ E S++ + ++E +L Q+
Sbjct: 1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQV 60
Query: 329 NHRNVVKLLGCCLETEVPLLVYEFIPNGTLFQYIH---------------------DQNE 367
NH +V+KL G C + LL+ E+ G+L ++ D +
Sbjct: 61 NHPHVIKLYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPD 120
Query: 368 DFPITWEIRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSM 427
+ +T + A ++S + YL A + + HRD+ + N+L+ + + K+SDFG SR +
Sbjct: 121 ERALTMGDLISFAWQISRGMQYL---AEMKLVHRDLAARNVLVAEGRKMKISDFGLSRDV 177
Query: 428 AVDQTHMT-TQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLTELLTGEKPIRFTILEED 486
+ +++ ++ ++ E +T +SDV+SFGV+L E++T
Sbjct: 178 YEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVT------------- 224
Query: 487 KSLAAYFLCAMKEERLFEILDARVMKQGGKDEIITVAKLAKRCLNLNGKKRPTMREVASE 546
L + ERLF +L + ++ + L C KRPT +++ E
Sbjct: 225 --LGGNPYPGIAPERLFNLLKTGYRMERPENCSEEMYNLMLTCWKQEPDKRPTFADISKE 282
Query: 547 L 547
L
Sbjct: 283 L 283
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290 |
| >gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Score = 95.6 bits (238), Expect = 7e-22
Identities = 67/267 (25%), Positives = 124/267 (46%), Gaps = 38/267 (14%)
Query: 303 AVKKSKVIDESKV-EEFINEVVILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGTLFQY 361
A+K K E KV +EF E ++S + H N+V LLG C + + +++E++ +G L ++
Sbjct: 39 AIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKEQPTCMLFEYLAHGDLHEF 98
Query: 362 I--HDQNEDFPITWEIR-----------LRIAIEVSGALSYLHSAASIPIYHRDIKSTNI 408
+ + + D L IAI+++ + YL +S HRD+ + N
Sbjct: 99 LVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYL---SSHHFVHRDLAARNC 155
Query: 409 LLDDKYRAKVSDFGASRSM-AVDQTHMTTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVV 467
L+ + K+SDFG SR + + D + ++ ++ PE +FT +SD++SFGVV
Sbjct: 156 LVGEGLTVKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVV 215
Query: 468 LTELLT-GEKPIRFTILEEDKSLAAYFLCAMKEERLFEILDARVMKQGGKDEIITVAKLA 526
L E+ + G +P + + E++ +R + +D V L
Sbjct: 216 LWEIFSYGLQP----------------YYGFSNQEVIEMIRSRQLLPCPEDCPARVYALM 259
Query: 527 KRCLNLNGKKRPTMREVASELAGIKAW 553
C N +RP +++ + L ++W
Sbjct: 260 IECWNEIPARRPRFKDIHTRL---RSW 283
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 95.3 bits (237), Expect = 8e-22
Identities = 62/244 (25%), Positives = 106/244 (43%), Gaps = 22/244 (9%)
Query: 304 VKKSKVIDESKVEEFINEVVILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGTLFQYIH 363
V+ + E VE E+ +++++NH +++++LG E L E++ G++ +
Sbjct: 36 VRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNLFVEWMAGGSVSHLLS 95
Query: 364 DQNEDFPITWEIRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDK-YRAKVSDFG 422
+ + ++ LSYLH I HRD+K N+L+D R +++DFG
Sbjct: 96 KYG---AFKEAVIINYTEQLLRGLSYLHENQ---IIHRDVKGANLLIDSTGQRLRIADFG 149
Query: 423 ASRSMAVDQT---HMTTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLTELLTGEKPIR 479
A+ +A T Q+ GT ++ PE R Q+ DV+S G V+ E+ T + P
Sbjct: 150 AAARLAAKGTGAGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWN 209
Query: 480 FTILEEDKSLAAYFLCAMKEERLFEILDARVMKQGGKDEIITVAKLAKRCLNLNGKKRPT 539
+L A + E L G +D + RCL L + RP
Sbjct: 210 AEKHSNHLALIFKIASATTAPSIPEHL-----SPGLRD-------VTLRCLELQPEDRPP 257
Query: 540 MREV 543
RE+
Sbjct: 258 SREL 261
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 94.2 bits (235), Expect = 1e-21
Identities = 55/178 (30%), Positives = 90/178 (50%), Gaps = 11/178 (6%)
Query: 303 AVKKSKV--IDESKVEEFINEVVILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGTLFQ 360
A+K+ + I E ++ + E+ +L + H N+VK +G ++ ++ E+ NG+L Q
Sbjct: 29 AIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYIILEYAENGSLRQ 88
Query: 361 YIHDQNEDFPITWEIRLRIAI-EVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVS 419
I + FP E + + + +V L+YLH I HRDIK+ NIL K++
Sbjct: 89 IIK-KFGPFP---ESLVAVYVYQVLQGLAYLHEQGVI---HRDIKAANILTTKDGVVKLA 141
Query: 420 DFGASRSMAVDQTHMTTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLTELLTGEKP 477
DFG + + D + V GT ++ PE S + SD++S G + ELLTG P
Sbjct: 142 DFGVATKLN-DVSKDDASVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPP 198
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Score = 94.4 bits (235), Expect = 2e-21
Identities = 64/214 (29%), Positives = 100/214 (46%), Gaps = 28/214 (13%)
Query: 285 EKATDNFDLNRILGQG--GQ----------------AVKKSKV-IDESKVEEFINEVVIL 325
E ++ L R +G+G G AVK K S E+F+ E I+
Sbjct: 2 EIQREDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIM 61
Query: 326 SQINHRNVVKLLGCCLETEVPL-LVYEFIPNGTLFQYIHDQNEDFPITWEIRLRIAIEVS 384
Q +H ++VKL+G TE P+ +V E P G L Y+ Q + + + + ++S
Sbjct: 62 RQFDHPHIVKLIGVI--TENPVWIVMELAPLGELRSYL--QVNKYSLDLASLILYSYQLS 117
Query: 385 GALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHGTFGY 444
AL+YL S HRDI + N+L+ K+ DFG SR + + + ++ +
Sbjct: 118 TALAYLES---KRFVHRDIAARNVLVSSPDCVKLGDFGLSRYLEDESYYKASKGKLPIKW 174
Query: 445 LDPEYFRSSQFTDKSDVYSFGVVLTELLT-GEKP 477
+ PE +FT SDV+ FGV + E+L G KP
Sbjct: 175 MAPESINFRRFTSASDVWMFGVCMWEILMLGVKP 208
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 94.6 bits (235), Expect = 2e-21
Identities = 74/250 (29%), Positives = 112/250 (44%), Gaps = 25/250 (10%)
Query: 303 AVKKSKVIDESKVEE-FINEVVILSQINHRNVVKLLGCCLET--EVPLLVYEFIPNGTLF 359
AVK K + + E+ IL + H N+VK GCC E + L+ E++P G+L
Sbjct: 37 AVKTLKRECGQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKGLQLIMEYVPLGSLR 96
Query: 360 QYIHDQNEDFPITWEIRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVS 419
Y+ + L A ++ ++YLHS I HRD+ + N+LLD+ K+
Sbjct: 97 DYLPKHK----LNLAQLLLFAQQICEGMAYLHSQHYI---HRDLAARNVLLDNDRLVKIG 149
Query: 420 DFGASRSMAVDQTHMTTQVHG---TFGYLDPEYFRSSQFTDKSDVYSFGVVLTELLTG-- 474
DFG ++++ + + G F Y E + ++F+ SDV+SFGV L ELLT
Sbjct: 150 DFGLAKAVPEGHEYYRVREDGDSPVFWYA-VECLKENKFSYASDVWSFGVTLYELLTHCD 208
Query: 475 ---EKPIRFTILEEDKSLAAYFLCAMKEERLFEILDARVMKQGGKDEIITVAKLAKRCLN 531
P +F + K M RL E+L+ + K+ V L K C
Sbjct: 209 SKQSPPKKFEEMIGPKQ------GQMTVVRLIELLERGMRLPCPKNCPQEVYILMKNCWE 262
Query: 532 LNGKKRPTMR 541
K RPT R
Sbjct: 263 TEAKFRPTFR 272
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Score = 93.5 bits (232), Expect = 2e-21
Identities = 66/252 (26%), Positives = 126/252 (50%), Gaps = 26/252 (10%)
Query: 301 GQAVKKSKVIDESKVEEFINEVVILSQINHRNVVKLLGCCLETEVPL-LVYEFIPNGTLF 359
G V + +++ + F+ E +++Q+ H N+V+LLG +E + L +V E++ G+L
Sbjct: 29 GNKVAVKCIKNDATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLV 88
Query: 360 QYIHDQNEDFPITWEIRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVS 419
Y+ + + + L+ +++V A+ YL + + HRD+ + N+L+ + AKVS
Sbjct: 89 DYLRSRGRSV-LGGDCLLKFSLDVCEAMEYLEANNFV---HRDLAARNVLVSEDNVAKVS 144
Query: 420 DFGASRSMAVDQTHMTTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLTELLT-GEKPI 478
DFG ++ + Q V T PE R +F+ KSDV+SFG++L E+ + G P
Sbjct: 145 DFGLTKEASSTQDTGKLPVKWT----APEALREKKFSTKSDVWSFGILLWEIYSFGRVPY 200
Query: 479 RFTILEEDKSLAAYFLCAMKEERLFEILDARVMKQGGKDEIITVAKLAKRCLNLNGKKRP 538
L++ + E+ ++ +DA G + V + K+C +L+ RP
Sbjct: 201 PRIPLKD---------VVPRVEKGYK-MDA----PDGCPPV--VYDVMKQCWHLDAATRP 244
Query: 539 TMREVASELAGI 550
+ ++ +L I
Sbjct: 245 SFLQLREQLEHI 256
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 93.1 bits (232), Expect = 3e-21
Identities = 62/242 (25%), Positives = 99/242 (40%), Gaps = 30/242 (12%)
Query: 310 IDESKVEEFINEVVILSQINHRNVVKLLGCCL--ETEVPLLVYEFIPNGTLFQYI-HDQN 366
+ E + ++ ++EV IL ++ H N+V+ + + +V E+ G L Q I +
Sbjct: 38 MTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIVMEYCEGGDLAQLIQKCKK 97
Query: 367 EDFPITWEIRLRIAIEVSGALSYLH--SAASIPIYHRDIKSTNILLDDKYRAKVSDFGAS 424
E I E RI ++ AL H S + HRD+K NI LD K+ DFG +
Sbjct: 98 ERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLA 157
Query: 425 RSMAVDQTHMTTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLTELLTGEKPIRFTILE 484
+ + D + T V GT Y+ PE + +KSD++S G ++ EL P
Sbjct: 158 KILGHDSSFAKTYV-GTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARNQL 216
Query: 485 EDKSLAAY--FLC--AMKEERLFEILDARVMKQGGKDEIITVAKLAKRCLNLNGKKRPTM 540
+ S F L E++ K LN++ KRP+
Sbjct: 217 QLASKIKEGKFRRIPYRYSSELNEVI--------------------KSMLNVDPDKRPST 256
Query: 541 RE 542
E
Sbjct: 257 EE 258
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 93.3 bits (232), Expect = 3e-21
Identities = 58/223 (26%), Positives = 101/223 (45%), Gaps = 44/223 (19%)
Query: 291 FDLNRILGQG-------GQ-----------AVKKSKV--IDESKVEEFINEVVILSQINH 330
L +ILG+G GQ AVK K+ S++EEF++E + +H
Sbjct: 1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDH 60
Query: 331 RNVVKLLGCCLETE------VPLLVYEFIPNGTLFQY-----IHDQNEDFPITWEIRLRI 379
NV+KL+G C E P+++ F+ +G L + + E P+ + L+
Sbjct: 61 PNVMKLIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPL--QTLLKF 118
Query: 380 AIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVD----QTHMT 435
++++ + YL + I HRD+ + N +L + V+DFG S+ + Q +
Sbjct: 119 MVDIALGMEYLSNRNFI---HRDLAARNCMLREDMTVCVADFGLSKKIYSGDYYRQGRIA 175
Query: 436 TQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLTELLT-GEKP 477
++ E +T KSDV++FGV + E+ T G+ P
Sbjct: 176 KM---PVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTP 215
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 93.0 bits (231), Expect = 5e-21
Identities = 50/162 (30%), Positives = 89/162 (54%), Gaps = 11/162 (6%)
Query: 321 EVVILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEIRLRIA 380
E+ +L ++ H N+V+ LG L+ + + E++P G++ + + F T +R +
Sbjct: 56 EIALLKELQHENIVQYLGSSLDADHLNIFLEYVPGGSV-AALLNNYGAFEETL-VRNFVR 113
Query: 381 IEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVH- 439
+ G L+YLH+ I HRDIK NIL+D+K K+SDFG S+ + + T
Sbjct: 114 QILKG-LNYLHNRG---IIHRDIKGANILVDNKGGIKISDFGISKKLEANSLSTKTNGAR 169
Query: 440 ----GTFGYLDPEYFRSSQFTDKSDVYSFGVVLTELLTGEKP 477
G+ ++ PE + + +T K+D++S G ++ E+LTG+ P
Sbjct: 170 PSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHP 211
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Score = 93.2 bits (232), Expect = 6e-21
Identities = 67/255 (26%), Positives = 121/255 (47%), Gaps = 28/255 (10%)
Query: 303 AVKKSKV-IDESKVEEFINEVVILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGTLFQY 361
AVK + ++ E+F+ EV ILS+++ N+ +LLG C ++ E++ NG L Q+
Sbjct: 50 AVKVLRPDASDNAREDFLKEVKILSRLSDPNIARLLGVCTVDPPLCMIMEYMENGDLNQF 109
Query: 362 I--HDQNEDF------PITWEIRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDK 413
+ H +++ L +A +++ + YL S+ HRD+ + N L+
Sbjct: 110 LQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYL---ESLNFVHRDLATRNCLVGKN 166
Query: 414 YRAKVSDFGASRSM-AVDQTHMTTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLTELL 472
Y K++DFG SR++ + D + + ++ E +FT KSDV++FGV L E+L
Sbjct: 167 YTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEIL 226
Query: 473 T--GEKPIRFTILEEDKSL--AAYFLCAMKEERLFEILDARVMKQGGKDEIITVAKLAKR 528
T E+P + L + + + A +F ++ L +I +L
Sbjct: 227 TLCREQP--YEHLTDQQVIENAGHFFR---DDGRQIYLP---RPPNCPKDIY---ELMLE 275
Query: 529 CLNLNGKKRPTMREV 543
C + + RPT RE+
Sbjct: 276 CWRRDEEDRPTFREI 290
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296 |
| >gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Score = 92.3 bits (229), Expect = 6e-21
Identities = 58/175 (33%), Positives = 96/175 (54%), Gaps = 12/175 (6%)
Query: 308 KVIDESKV--EEFINEVVILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGTLFQYIHDQ 365
K+I E + +EFI E ++ +++H +V+L G C + +V E++ NG L Y+ +
Sbjct: 34 KMIKEGSMSEDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIVTEYMSNGCLLNYLREH 93
Query: 366 NEDFPITWEIRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASR 425
+ F L + +V ++YL S I HRD+ + N L+DD+ KVSDFG SR
Sbjct: 94 GKRF--QPSQLLEMCKDVCEGMAYLESKQFI---HRDLAARNCLVDDQGCVKVSDFGLSR 148
Query: 426 SMAVDQTHMTTQVHGTF--GYLDPEYFRSSQFTDKSDVYSFGVVLTELLT-GEKP 477
+ D+ T+ V F + PE S+F+ KSDV++FGV++ E+ + G+ P
Sbjct: 149 YVLDDE--YTSSVGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMP 201
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256 |
| >gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 92.9 bits (231), Expect = 7e-21
Identities = 64/256 (25%), Positives = 121/256 (47%), Gaps = 46/256 (17%)
Query: 308 KVIDESK----VEEFINEVVILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGTLFQYIH 363
KV+ E +E ++E +++ ++H +VV+LLG CL + L+ + +P G L Y+
Sbjct: 42 KVLREETSPKANKEILDEAYVMASVDHPHVVRLLGICL-SSQVQLITQLMPLGCLLDYVR 100
Query: 364 DQNEDFPITWEIRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGA 423
++D I + L ++++ +SYL + HRD+ + N+L+ K++DFG
Sbjct: 101 -NHKD-NIGSQYLLNWCVQIAKGMSYLEEKR---LVHRDLAARNVLVKTPQHVKITDFGL 155
Query: 424 SRSMAVDQTHMTTQVHGTFG-----YLDPEYFRSSQFTDKSDVYSFGVVLTELLT-GEKP 477
++ + VD+ H G ++ E +T KSDV+S+GV + EL+T G KP
Sbjct: 156 AKLLDVDEKE----YHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKP 211
Query: 478 IRFTILEEDKSLAAYFLCAMKEERLFEILDARVMKQGGKDE-----IITVAKLAKRCLNL 532
+ EI D ++++G + I V + +C +
Sbjct: 212 -------------------YEGIPAVEIPD--LLEKGERLPQPPICTIDVYMVLVKCWMI 250
Query: 533 NGKKRPTMREVASELA 548
+ + RPT +E+ +E +
Sbjct: 251 DAESRPTFKELINEFS 266
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279 |
| >gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Score = 92.4 bits (229), Expect = 9e-21
Identities = 56/189 (29%), Positives = 96/189 (50%), Gaps = 17/189 (8%)
Query: 303 AVKKSKVIDESKVEEFINEVVILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGTLFQYI 362
AVK K ES ++F E +L+ + H+++V+ G C E L+V+E++ +G L +++
Sbjct: 39 AVKALKEASESARQDFQREAELLTVLQHQHIVRFYGVCTEGRPLLMVFEYMRHGDLNRFL 98
Query: 363 HDQNEDF------------PITWEIRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILL 410
D +T L IA +++ + YL AS+ HRD+ + N L+
Sbjct: 99 RSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYL---ASLHFVHRDLATRNCLV 155
Query: 411 DDKYRAKVSDFGASRSM-AVDQTHMTTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLT 469
K+ DFG SR + + D + + ++ PE +FT +SD++SFGVVL
Sbjct: 156 GQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLW 215
Query: 470 ELLT-GEKP 477
E+ T G++P
Sbjct: 216 EIFTYGKQP 224
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 91.4 bits (227), Expect = 1e-20
Identities = 52/183 (28%), Positives = 95/183 (51%), Gaps = 15/183 (8%)
Query: 298 GQGGQAVK--KSKVIDESKVEEFINEVVILSQINHRNVVKLLGCCLETEVPLLVYEFIPN 355
G AVK +S + + K +F+ E IL Q +H N+VKL+G C++ + +V E +P
Sbjct: 18 GNTEVAVKTCRSTLPPDLK-RKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPG 76
Query: 356 GTLFQYIHDQNEDFPITWEIRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYR 415
G+L ++ + + + L+++++ + + YL S I HRD+ + N L+ +
Sbjct: 77 GSLLTFLRKKKNRLTV--KKLLQMSLDAAAGMEYLESKNCI---HRDLAARNCLVGENNV 131
Query: 416 AKVSDFGASRSMAVDQTHMTTQVHGT----FGYLDPEYFRSSQFTDKSDVYSFGVVLTEL 471
K+SDFG SR ++ + T G + PE ++T +SDV+S+G++L E
Sbjct: 132 LKISDFGMSRE---EEGGIYTVSDGLKQIPIKWTAPEALNYGRYTSESDVWSYGILLWET 188
Query: 472 LTG 474
+
Sbjct: 189 FSL 191
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 91.1 bits (226), Expect = 1e-20
Identities = 73/276 (26%), Positives = 126/276 (45%), Gaps = 42/276 (15%)
Query: 290 NFDLNRILGQG---------GQAVKKSKVIDESKVEEFI--------NEVVILSQINHRN 332
++ R++G+G +A +K +I + VE+ NE +L ++H N
Sbjct: 1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPN 60
Query: 333 VVKLLGCCLETEVPLLVYEFIPNGTLFQYIHDQ-NEDFPITWEIRLRIAIEVSGALSYLH 391
+++ LE + ++V E+ P GTL +YI + N + L +++ AL ++H
Sbjct: 61 IIEYYENFLEDKALMIVMEYAPGGTLAEYIQKRCNSLLD--EDTILHFFVQILLALHHVH 118
Query: 392 SAASIPIYHRDIKSTNILLDD-KYRAKVSDFGASRSMAVDQTHMTTQVHGTFGYLDPEYF 450
+ I HRD+K+ NILLD K K+ DFG S+ ++ T V GT Y+ PE
Sbjct: 119 TKL---ILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKSKAYT--VVGTPCYISPELC 173
Query: 451 RSSQFTDKSDVYSFGVVLTELLTGEKPIRFTILEEDKSLAAYFLCAMKEERLFEILDARV 510
+ KSD+++ G VL EL + ++ E +L A L M F + R
Sbjct: 174 EGKPYNQKSDIWALGCVLYELASLKRAF------EAANLPALVLKIMSGT--FAPISDRY 225
Query: 511 MKQGGKDEIITVAKLAKRCLNLNGKKRPTMREVASE 546
+ +L LNL+ KRP + ++ ++
Sbjct: 226 SPD--------LRQLILSMLNLDPSKRPQLSQIMAQ 253
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 90.9 bits (226), Expect = 2e-20
Identities = 47/171 (27%), Positives = 86/171 (50%), Gaps = 5/171 (2%)
Query: 303 AVKKSKVIDESKVEEFINEVVILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGTLFQYI 362
AVK K ++F+ E I+ ++ H +++L C E +V E + G+L +Y+
Sbjct: 34 AVKTLKP-GTMDPKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIYIVTELMKYGSLLEYL 92
Query: 363 HDQNEDFPITWEIRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFG 422
+ + +A +V+ ++YL + I HRD+ + N+L+ + KV+DFG
Sbjct: 93 QG-GAGRALKLPQLIDMAAQVASGMAYLEAQNYI---HRDLAARNVLVGENNICKVADFG 148
Query: 423 ASRSMAVDQTHMTTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLTELLT 473
+R + D + PE ++F+ KSDV+SFG++LTE++T
Sbjct: 149 LARVIKEDIYEAREGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVT 199
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 90.9 bits (226), Expect = 2e-20
Identities = 60/183 (32%), Positives = 84/183 (45%), Gaps = 21/183 (11%)
Query: 308 KVIDESK----VEEFINEVVILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGTL----- 358
K ID K V+E EV +SQ NH NVVK + + LV ++ G+L
Sbjct: 32 KRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVMPYLSGGSLLDIMK 91
Query: 359 FQYIHDQNEDFPITWEIRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKV 418
Y ++ I ++ EV L YLHS I HRDIK+ NILL + K+
Sbjct: 92 SSYPRGGLDEAIIATVLK-----EVLKGLEYLHSNGQI---HRDIKAGNILLGEDGSVKI 143
Query: 419 SDFGASRSMAVD---QTHMTTQVHGTFGYLDPEYFRSSQ-FTDKSDVYSFGVVLTELLTG 474
+DFG S S+A + GT ++ PE + K+D++SFG+ EL TG
Sbjct: 144 ADFGVSASLADGGDRTRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATG 203
Query: 475 EKP 477
P
Sbjct: 204 AAP 206
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 90.5 bits (225), Expect = 3e-20
Identities = 47/163 (28%), Positives = 89/163 (54%), Gaps = 7/163 (4%)
Query: 317 EFINEVVILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEIR 376
+F+ E I+ Q +H N+++L G ++ +++ E++ NG+L +++ + + F T
Sbjct: 51 DFLTEASIMGQFDHPNIIRLEGVVTKSRPVMIITEYMENGSLDKFLRENDGKF--TVGQL 108
Query: 377 LRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSM-AVDQTHMT 435
+ + ++ + YL + HRD+ + NIL++ KVSDFG SR + + T+ T
Sbjct: 109 VGMLRGIASGMKYLSEMNYV---HRDLAARNILVNSNLVCKVSDFGLSRRLEDSEATYTT 165
Query: 436 TQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLTELLT-GEKP 477
+ PE +FT SDV+SFG+V+ E+++ GE+P
Sbjct: 166 KGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERP 208
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Score = 90.4 bits (224), Expect = 3e-20
Identities = 71/270 (26%), Positives = 126/270 (46%), Gaps = 41/270 (15%)
Query: 293 LNRILGQG-----------GQAVKKSKVIDESKVEEFINEVVILSQINHRNVVKLLGCCL 341
L I+G+G GQ V + + + F+ E ++++++H+N+V+LLG L
Sbjct: 10 LGEIIGEGEFGAVLQGEYTGQKVAVKNIKCDVTAQAFLEETAVMTKLHHKNLVRLLGVIL 69
Query: 342 ETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEIRLRIAIEVSGALSYLHSAASIPIYHR 401
+ +V E + G L ++ + ++ L+ +++V+ + YL S + HR
Sbjct: 70 HNGL-YIVMELMSKGNLVNFLRTRGR-ALVSVIQLLQFSLDVAEGMEYLESKK---LVHR 124
Query: 402 DIKSTNILLDDKYRAKVSDFGASR--SMAVDQTHMTTQVHGTFGYLDPEYFRSSQFTDKS 459
D+ + NIL+ + AKVSDFG +R SM VD + + + + PE + +F+ KS
Sbjct: 125 DLAARNILVSEDGVAKVSDFGLARVGSMGVDNSKLPVK------WTAPEALKHKKFSSKS 178
Query: 460 DVYSFGVVLTELLT-GEKPIRFTILEEDKSLAAYFLCAMKEERLFEILDARVMKQGGKDE 518
DV+S+GV+L E+ + G P L+E K C K R+ + +
Sbjct: 179 DVWSYGVLLWEVFSYGRAPYPKMSLKEVKE------CVEKGYRM----------EPPEGC 222
Query: 519 IITVAKLAKRCLNLNGKKRPTMREVASELA 548
V L C KKRP+ ++ +L
Sbjct: 223 PADVYVLMTSCWETEPKKRPSFHKLREKLE 252
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254 |
| >gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Score = 90.4 bits (224), Expect = 4e-20
Identities = 52/170 (30%), Positives = 94/170 (55%), Gaps = 10/170 (5%)
Query: 312 ESKVEEFINEVVILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGTLFQYIHDQNEDF-P 370
E + ++F++E I+ Q +H N+++L G + + +++ E++ NG L +Y+ D + +F
Sbjct: 47 EKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFKPAMIITEYMENGALDKYLRDHDGEFSS 106
Query: 371 ITWEIRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVD 430
LR ++ + YL + + HRD+ + NIL++ KVSDFG SR + D
Sbjct: 107 YQLVGMLR---GIAAGMKYL---SDMNYVHRDLAARNILVNSNLECKVSDFGLSRVLEDD 160
Query: 431 --QTHMTTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLTELLT-GEKP 477
T+ T+ + PE +FT SDV+SFG+V+ E+++ GE+P
Sbjct: 161 PEGTYTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERP 210
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268 |
| >gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 90.5 bits (225), Expect = 4e-20
Identities = 66/242 (27%), Positives = 111/242 (45%), Gaps = 30/242 (12%)
Query: 317 EFINEVVILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGTLFQYI--HDQNEDF----- 369
EF+NE ++ + N +VV+LLG + L+V E + G L Y+ +
Sbjct: 55 EFLNEASVMKEFNCHHVVRLLGVVSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLG 114
Query: 370 PITWEIRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSM-A 428
P T + +++A E++ ++YL A+ HRD+ + N ++ + K+ DFG +R +
Sbjct: 115 PPTLQKFIQMAAEIADGMAYL---AAKKFVHRDLAARNCMVAEDLTVKIGDFGMTRDIYE 171
Query: 429 VDQTHMTTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLTELLT-GEKPIRFTILEEDK 487
D + ++ PE + FT KSDV+SFGVVL E+ T E+P +
Sbjct: 172 TDYYRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPY--------Q 223
Query: 488 SLAAYFLCAMKEERLFEILDARVMKQ-GGKDEIITVAKLAKRCLNLNGKKRPTMREVASE 546
L+ EE L ++D + + + +L + C N K RPT E+ S
Sbjct: 224 GLS-------NEEVLKFVIDGGHLDLPENCPDK--LLELMRMCWQYNPKMRPTFLEIVSS 274
Query: 547 LA 548
L
Sbjct: 275 LK 276
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 90.1 bits (224), Expect = 4e-20
Identities = 48/163 (29%), Positives = 86/163 (52%), Gaps = 10/163 (6%)
Query: 314 KVEEFINEVVILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGTLFQYIH-DQNEDFPIT 372
E F+ E I+ ++ H +V+L C E E +V E++ G+L ++ + + +
Sbjct: 44 SPEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPIYIVTEYMSKGSLLDFLKSGEGKKLRLP 103
Query: 373 WEIRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQT 432
+ +A +++ ++YL S I HRD+ + NIL+ + K++DFG +R + D
Sbjct: 104 QLVD--MAAQIAEGMAYLESRNYI---HRDLAARNILVGENLVCKIADFGLARLIEDD-- 156
Query: 433 HMTTQVHGTF--GYLDPEYFRSSQFTDKSDVYSFGVVLTELLT 473
T + F + PE +FT KSDV+SFG++LTE++T
Sbjct: 157 EYTAREGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVT 199
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Score = 89.9 bits (223), Expect = 4e-20
Identities = 53/173 (30%), Positives = 93/173 (53%), Gaps = 8/173 (4%)
Query: 308 KVIDESKV--EEFINEVVILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGTLFQYIHDQ 365
K I+E + E+FI E ++ +++H +V+L G C + + +V EF+ NG L Y+ +
Sbjct: 34 KAINEGAMSEEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIVTEFMENGCLLNYLRQR 93
Query: 366 NEDFPITWEIRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASR 425
+ ++ L + +V + YL + I HRD+ + N L+ KVSDFG +R
Sbjct: 94 QGKL--SKDMLLSMCQDVCEGMEYLERNSFI---HRDLAARNCLVSSTGVVKVSDFGMTR 148
Query: 426 SMAVDQTHMTTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLTELLT-GEKP 477
+ D+ ++ + PE F S+++ KSDV+SFGV++ E+ T G+ P
Sbjct: 149 YVLDDEYTSSSGAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMP 201
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256 |
| >gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Score = 89.6 bits (222), Expect = 5e-20
Identities = 51/181 (28%), Positives = 101/181 (55%), Gaps = 10/181 (5%)
Query: 303 AVKKSKVIDESKV-EEFINEVVILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGTLFQY 361
A+K K +E V +E + E I+ Q+++ +V+++G C E E +LV E G L ++
Sbjct: 26 AIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIGVC-EAEALMLVMEMASGGPLNKF 84
Query: 362 IHDQNEDFPITWEIRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDF 421
+ + ++ ++ + L +VS + YL + HRD+ + N+LL +++ AK+SDF
Sbjct: 85 LSGKKDEITVSNVVEL--MHQVSMGMKYLEGKNFV---HRDLAARNVLLVNQHYAKISDF 139
Query: 422 GASRSMAVDQTHMTTQVHGTF--GYLDPEYFRSSQFTDKSDVYSFGVVLTELLT-GEKPI 478
G S+++ D ++ + G + + PE +F+ +SDV+S+G+ + E + G+KP
Sbjct: 140 GLSKALGADDSYYKARSAGKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPY 199
Query: 479 R 479
+
Sbjct: 200 K 200
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 88.8 bits (220), Expect = 1e-19
Identities = 50/172 (29%), Positives = 88/172 (51%), Gaps = 11/172 (6%)
Query: 312 ESKVEEFINEVVILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGTLFQYIHDQNEDFPI 371
E + E+ EV +L + H N+V+ LG CL+ + EF+P G++ + N P+
Sbjct: 43 EKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISIFMEFVPGGSISSIL---NRFGPL 99
Query: 372 TWEIRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMA--- 428
+ + ++ ++YLH+ + HRDIK N++L K+ DFG +R +A
Sbjct: 100 PEPVFCKYTKQILDGVAYLHNNCVV---HRDIKGNNVMLMPNGIIKLIDFGCARRLAWVG 156
Query: 429 --VDQTHMTTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLTELLTGEKPI 478
++M +HGT ++ PE S + KSD++S G + E+ TG+ P+
Sbjct: 157 LHGTHSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPL 208
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Score = 89.7 bits (222), Expect = 1e-19
Identities = 62/234 (26%), Positives = 114/234 (48%), Gaps = 24/234 (10%)
Query: 317 EFINEVVILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEIR 376
EF++E +I++ ++H ++V+LLG CL + LV + +P+G L Y+H+ ++ I ++
Sbjct: 55 EFMDEALIMASMDHPHLVRLLGVCLSPTIQ-LVTQLMPHGCLLDYVHEHKDN--IGSQLL 111
Query: 377 LRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTT 436
L ++++ + YL + HRD+ + N+L+ K++DFG +R + D+
Sbjct: 112 LNWCVQIAKGMMYLEERR---LVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNA 168
Query: 437 QVHGT-FGYLDPEYFRSSQFTDKSDVYSFGVVLTELLT-GEKPIRFTILEEDKSLAAYFL 494
++ E +FT +SDV+S+GV + EL+T G KP E L
Sbjct: 169 DGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTREIPDLLE--- 225
Query: 495 CAMKEERLFEILDARVMKQGGKDEIITVAKLAKRCLNLNGKKRPTMREVASELA 548
K ERL + I V + +C ++ RP +E+A+E +
Sbjct: 226 ---KGERLPQPPIC----------TIDVYMVMVKCWMIDADSRPKFKELAAEFS 266
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 88.8 bits (221), Expect = 1e-19
Identities = 58/183 (31%), Positives = 87/183 (47%), Gaps = 15/183 (8%)
Query: 303 AVKKSKVIDESKVEEFINEVVILSQINHRNVVKLLGCCLETEVPL-LVYEFIPNGTLFQY 361
+KK+ +I +++V++ + E ILSQ VVKL + + L LV E++P G L
Sbjct: 25 VIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLY-YSFQGKKNLYLVMEYLPGGDLASL 83
Query: 362 IHDQNEDFPITWEIRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDF 421
+ + R+ IA E+ AL YLHS I HRD+K NIL+D K++DF
Sbjct: 84 LENVGS-LDEDV-ARIYIA-EIVLALEYLHS---NGIIHRDLKPDNILIDSNGHLKLTDF 137
Query: 422 GASRSMAVDQTHM-------TTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLTELLTG 474
G S+ V + ++ GT Y+ PE + D +S G +L E L G
Sbjct: 138 GLSKVGLVRRQINLNDDEKEDKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVG 197
Query: 475 EKP 477
P
Sbjct: 198 IPP 200
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 88.8 bits (221), Expect = 2e-19
Identities = 65/207 (31%), Positives = 100/207 (48%), Gaps = 28/207 (13%)
Query: 289 DNFDLNRILGQG-------------GQ--AVK---KSKVIDESKVEEFINEVVILSQINH 330
D+F+ + LG G G+ A+K K+K++ +VE +NE IL I H
Sbjct: 1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRH 60
Query: 331 RNVVKLLGCCLETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEIRLRIAIEVSGALSYL 390
+V L G + LV E++P G LF + ++ FP R A +V AL YL
Sbjct: 61 PFLVNLYGSFQDDSNLYLVMEYVPGGELFSH-LRKSGRFPEPV-ARFYAA-QVVLALEYL 117
Query: 391 HSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHGTFGYLDPEYF 450
HS I +RD+K N+LLD K++DFG ++ + +T+ GT YL PE
Sbjct: 118 HSLD---IVYRDLKPENLLLDSDGYIKITDFGFAKRV-KGRTYTLC---GTPEYLAPEII 170
Query: 451 RSSQFTDKSDVYSFGVVLTELLTGEKP 477
S + D ++ G+++ E+L G P
Sbjct: 171 LSKGYGKAVDWWALGILIYEMLAGYPP 197
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Score = 88.1 bits (218), Expect = 2e-19
Identities = 55/182 (30%), Positives = 102/182 (56%), Gaps = 12/182 (6%)
Query: 303 AVK--KSKVIDESKVEEFINEVVILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGTLFQ 360
AVK K+ D + +E + E ++ Q+++ +V+++G C E E +LV E G L +
Sbjct: 26 AVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGIC-EAESWMLVMELAELGPLNK 84
Query: 361 YIHDQNEDFPITWEIRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSD 420
++ +N+ +T + + +VS + YL + HRD+ + N+LL ++ AK+SD
Sbjct: 85 FLQ-KNKH--VTEKNITELVHQVSMGMKYLEETNFV---HRDLAARNVLLVTQHYAKISD 138
Query: 421 FGASRSMAVDQTHMTTQVHGTF--GYLDPEYFRSSQFTDKSDVYSFGVVLTELLT-GEKP 477
FG S+++ D+ + + HG + + PE +F+ KSDV+SFGV++ E + G+KP
Sbjct: 139 FGLSKALGADENYYKAKTHGKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKP 198
Query: 478 IR 479
+
Sbjct: 199 YK 200
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 87.9 bits (218), Expect = 2e-19
Identities = 56/203 (27%), Positives = 100/203 (49%), Gaps = 19/203 (9%)
Query: 285 EKATDNFDLNRILGQG--GQ------------AVKKSKVIDESKVEEFINEVVILSQINH 330
E+ + F L R LG G G+ A+K K D K ++F EV L ++ H
Sbjct: 2 ERPREEFTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRH 61
Query: 331 RNVVKLLGCCLETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEIRLRIAIEVSGALSYL 390
++++ L C E ++ E + G+L ++ E + + +A +V+ ++YL
Sbjct: 62 KHLISLFAVCSVGEPVYIITELMEKGSLLAFLRSP-EGQVLPVASLIDMACQVAEGMAYL 120
Query: 391 HSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHGTFGYLDPEYF 450
SI HRD+ + NIL+ + KV+DFG +R + + ++++ + + PE
Sbjct: 121 EEQNSI---HRDLAARNILVGEDLVCKVADFGLARLIK-EDVYLSSDKKIPYKWTAPEAA 176
Query: 451 RSSQFTDKSDVYSFGVVLTELLT 473
F+ KSDV+SFG++L E+ T
Sbjct: 177 SHGTFSTKSDVWSFGILLYEMFT 199
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 88.3 bits (219), Expect = 3e-19
Identities = 54/175 (30%), Positives = 87/175 (49%), Gaps = 8/175 (4%)
Query: 303 AVKKSKVIDESKVEEFINEVVILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGTLFQYI 362
AVKK + + + E NEVVI+ H N+V++ L + +V EF+ G L +
Sbjct: 48 AVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVMEFLEGGALTDIV 107
Query: 363 HDQNEDFPITWEIRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFG 422
+ E + + V ALS+LH+ I HRDIKS +ILL R K+SDFG
Sbjct: 108 THTR----MNEEQIATVCLAVLKALSFLHAQGVI---HRDIKSDSILLTSDGRVKLSDFG 160
Query: 423 ASRSMAVDQTHMTTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLTELLTGEKP 477
++ + + V GT ++ PE + + D++S G+++ E++ GE P
Sbjct: 161 FCAQVSKEVPRRKSLV-GTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPP 214
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 88.0 bits (218), Expect = 4e-19
Identities = 70/249 (28%), Positives = 115/249 (46%), Gaps = 38/249 (15%)
Query: 303 AVKKSKVIDESKVEEFINEVVILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGTLFQYI 362
A+K+ + + K E INE++++ + H N+V L L + +V E++ G+L +
Sbjct: 48 AIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVV 107
Query: 363 HD-QNEDFPITWEIRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDF 421
+ ++ I R E AL +LHS I HRDIKS NILL K++DF
Sbjct: 108 TETCMDEGQIAAVCR-----ECLQALEFLHSNQVI---HRDIKSDNILLGMDGSVKLTDF 159
Query: 422 GASRSMAVDQTHMTTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLTELLTGEKPIRFT 481
G + +Q+ +T V GT ++ PE + K D++S G++ E++ GE P
Sbjct: 160 GFCAQITPEQSKRSTMV-GTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPP---- 214
Query: 482 ILEEDKSLAAYFLCAMKEERLFEILDARVMKQGGKDEIITVAKLA-------KRCLNLNG 534
L E+ L A +L A G E+ KL+ RCL ++
Sbjct: 215 YLNEN-PLRALYLIATN----------------GTPELQNPEKLSAIFRDFLNRCLEMDV 257
Query: 535 KKRPTMREV 543
+KR + +E+
Sbjct: 258 EKRGSAKEL 266
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Score = 86.4 bits (214), Expect = 9e-19
Identities = 62/190 (32%), Positives = 98/190 (51%), Gaps = 22/190 (11%)
Query: 302 QAVKKSKVIDESKVEEFINEVVILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGTLFQY 361
+ ++K E K EF+ E ++S NH N+VKLLG CL E ++ E + G L Y
Sbjct: 32 KTLRKGATDQEKK--EFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIMELMEGGDLLSY 89
Query: 362 IHD-QNEDFP---ITWEIRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDK-YRA 416
+ D + E F +T + L I ++V+ YL I HRD+ + N L+ +K Y A
Sbjct: 90 LRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQMHFI---HRDLAARNCLVSEKGYDA 146
Query: 417 ----KVSDFGASRSMAVDQTHMTTQVHG----TFGYLDPEYFRSSQFTDKSDVYSFGVVL 468
K+ DFG +R + + + G ++ PE +FT +SDV+SFGV++
Sbjct: 147 DRVVKIGDFGLARDIYKSDYY---RKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLM 203
Query: 469 TELLT-GEKP 477
E+LT G++P
Sbjct: 204 WEILTLGQQP 213
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 86.0 bits (213), Expect = 1e-18
Identities = 65/248 (26%), Positives = 120/248 (48%), Gaps = 27/248 (10%)
Query: 303 AVKKSKVIDESKVEEFINEVVIL-SQINHRNVVKLLGCCLETEVPLLVYEFI---PNGTL 358
A K K + + + ++EV I+ Q+ H N+V+ LE + +V + I P G
Sbjct: 40 AFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLENDRLYIVMDLIEGAPLGEH 99
Query: 359 FQYIHDQNEDFPITWEIRL-RIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAK 417
F + ++ + F E R+ I +++ AL YLH I HRD+ NI+L + +
Sbjct: 100 FNSLKEKKQRFT---EERIWNIFVQMVLALRYLHKEKRI--VHRDLTPNNIMLGEDDKVT 154
Query: 418 VSDFGASRSMAVDQTHMTTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLTELLTGEKP 477
++DFG ++ ++ +T+ V GT Y PE ++ + +K+DV++FG +L ++ T + P
Sbjct: 155 ITDFGLAKQKQ-PESKLTSVV-GTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPP 212
Query: 478 IRFTILEEDKSLAAYFLCAMKEERLFEILDARVMKQGGKDEIITVAKLAKRCLNLNGKKR 537
T + SLA + E ++E L + + D I CL + + R
Sbjct: 213 FYSTNM---LSLATKIV-----EAVYEPLPEGMYSEDVTDVI-------TSCLTPDAEAR 257
Query: 538 PTMREVAS 545
P + +V++
Sbjct: 258 PDIIQVSA 265
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 85.8 bits (213), Expect = 1e-18
Identities = 52/185 (28%), Positives = 89/185 (48%), Gaps = 23/185 (12%)
Query: 303 AVKKSKVIDESKVEEFIN--EVVILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGTLFQ 360
A+KK K+ ES+ E+ +L ++NH N++KLL LV+EF+ + L++
Sbjct: 28 AIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVFEFM-DTDLYK 86
Query: 361 YIHDQNEDFP------ITWEIRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKY 414
I D+ P +++ L+ L++ HS I HRD+K N+L++ +
Sbjct: 87 LIKDRQRGLPESLIKSYLYQL-LQ-------GLAFCHSHG---ILHRDLKPENLLINTEG 135
Query: 415 RAKVSDFGASRSMAVDQTHMTTQVHGTFGYLDPE-YFRSSQFTDKSDVYSFGVVLTELLT 473
K++DFG +RS T V T Y PE ++ D++S G + ELL+
Sbjct: 136 VLKLADFGLARSFGSPVRPYTHYV-VTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLS 194
Query: 474 GEKPI 478
+P+
Sbjct: 195 R-RPL 198
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 86.1 bits (214), Expect = 2e-18
Identities = 80/289 (27%), Positives = 117/289 (40%), Gaps = 60/289 (20%)
Query: 286 KATDNFDLNRILGQGGQAVKKSKVIDESKVEEFIN-----EVVILSQINHRNVVKLLGCC 340
KA D + RI+ A+KK K+ + + ++ IN E+ +L ++ H N++ LL
Sbjct: 18 KARDK-ETGRIV-----AIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVF 71
Query: 341 LETEVPLLVYEFIPNGTLFQYIHDQNEDF------PITWEIRLRIAIEVSGALSYLHSAA 394
LV+EF+ L + I D++ LR L YLHS
Sbjct: 72 GHKSNINLVFEFME-TDLEKVIKDKSIVLTPADIKSYMLMT-LR-------GLEYLHSNW 122
Query: 395 SIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHGTFGYLDPE-YFRSS 453
I HRD+K N+L+ K++DFG +RS MT QV T Y PE F +
Sbjct: 123 ---ILHRDLKPNNLLIASDGVLKLADFGLARSFGSPNRKMTHQVV-TRWYRAPELLFGAR 178
Query: 454 QFTDKSDVYSFGVVLTEL------LTGEKPIR-----FTIL----EED----KSLAAYFL 494
+ D++S G + EL L G+ I F L EE+ SL Y
Sbjct: 179 HYGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQLGKIFEALGTPTEENWPGVTSLPDY-- 236
Query: 495 CAMKEERLFEILDAR-VMKQGGKDEIITVAKLAKRCLNLNGKKRPTMRE 542
K F + + D + L +R L LN KR T R+
Sbjct: 237 VEFKP---FPPTPLKQIFPAASDDAL----DLLQRLLTLNPNKRITARQ 278
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 85.8 bits (212), Expect = 2e-18
Identities = 48/181 (26%), Positives = 100/181 (55%), Gaps = 13/181 (7%)
Query: 317 EFINEVVILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGTLFQYIHDQN--------ED 368
+F+ E+ I+S++ + N+++LLG C+ + ++ E++ NG L Q++ + +
Sbjct: 63 DFLKEIKIMSRLKNPNIIRLLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANN 122
Query: 369 FP-ITWEIRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSM 427
P ++ L +A++++ + YL AS+ HRD+ + N L+ + Y K++DFG SR++
Sbjct: 123 IPSVSIANLLYMAVQIASGMKYL---ASLNFVHRDLATRNCLVGNHYTIKIADFGMSRNL 179
Query: 428 -AVDQTHMTTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLTELLTGEKPIRFTILEED 486
+ D + + ++ E +FT SDV++FGV L E+ T K +++L ++
Sbjct: 180 YSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSLLSDE 239
Query: 487 K 487
+
Sbjct: 240 Q 240
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295 |
| >gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Score = 85.5 bits (211), Expect = 3e-18
Identities = 54/187 (28%), Positives = 95/187 (50%), Gaps = 15/187 (8%)
Query: 303 AVKKSKVIDESKVEEFINEVVILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGTLFQYI 362
AVK K ++ ++F E +L+ + H ++VK G C+E + ++V+E++ +G L +++
Sbjct: 39 AVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIMVFEYMKHGDLNKFL 98
Query: 363 HDQNED----------FPITWEIRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDD 412
D +T L IA +++ + YL AS HRD+ + N L+ +
Sbjct: 99 RAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYL---ASQHFVHRDLATRNCLVGE 155
Query: 413 KYRAKVSDFGASRSM-AVDQTHMTTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLTEL 471
K+ DFG SR + + D + ++ PE +FT +SDV+S GVVL E+
Sbjct: 156 NLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEI 215
Query: 472 LT-GEKP 477
T G++P
Sbjct: 216 FTYGKQP 222
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288 |
| >gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Score = 83.9 bits (207), Expect = 4e-18
Identities = 63/250 (25%), Positives = 115/250 (46%), Gaps = 27/250 (10%)
Query: 303 AVK--KSKVIDESKVEEFINEVVILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGTLFQ 360
AVK K + E K++ F++E IL Q +H N+VKL+G C + + +V E +P G
Sbjct: 23 AVKTCKEDLPQELKIK-FLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGGDFLS 81
Query: 361 YIHDQNEDFPITWEIRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSD 420
++ + ++ + ++ A++ + ++YL S I HRD+ + N L+ + K+SD
Sbjct: 82 FLRKKKDELKT--KQLVKFALDAAAGMAYLESKNCI---HRDLAARNCLVGENNVLKISD 136
Query: 421 FGASRSM--AVDQTHMTTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLTELLTGEKPI 478
FG SR + + Q+ + PE +++ +SDV+S+G++L E
Sbjct: 137 FGMSRQEDDGIYSSSGLKQI--PIKWTAPEALNYGRYSSESDVWSYGILLWETF------ 188
Query: 479 RFTILEEDKSLAAYFLCAMKEERLFEILDARVMKQGGKDEIITVAKLAKRCLNLNGKKRP 538
SL M ++ E ++ + V K+ +RC + + RP
Sbjct: 189 ---------SLGVCPYPGMTNQQAREQVEKGYRMSCPQKCPDDVYKVMQRCWDYKPENRP 239
Query: 539 TMREVASELA 548
E+ ELA
Sbjct: 240 KFSELQKELA 249
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 84.5 bits (210), Expect = 4e-18
Identities = 56/198 (28%), Positives = 93/198 (46%), Gaps = 21/198 (10%)
Query: 286 KATDNFDLNRILGQGGQAVKKSKVIDESKVEEF----INEVVILSQINHRNVVKLLGCCL 341
KA D I+ A+KK ++ +E E + E+ +L ++ H N+VKLL
Sbjct: 17 KARDKKT-GEIV-----ALKKIRLDNEE--EGIPSTALREISLLKELKHPNIVKLLDVIH 68
Query: 342 ETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEIRLRIAIEVSGALSYLHSAASIPIYHR 401
LV+E+ L +Y+ + I+ I ++ L+Y HS I HR
Sbjct: 69 TERKLYLVFEYCDM-DLKKYLDKRPGPLSPN-LIK-SIMYQLLRGLAYCHSHR---ILHR 122
Query: 402 DIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHGTFGYLDPEYFRSSQFTDKS-D 460
D+K NIL++ K++DFG +R+ + T +V T Y PE S+ + D
Sbjct: 123 DLKPQNILINRDGVLKLADFGLARAFGIPLRTYTHEVV-TLWYRAPEILLGSKHYSTAVD 181
Query: 461 VYSFGVVLTELLTGEKPI 478
++S G + E++TG KP+
Sbjct: 182 IWSVGCIFAEMITG-KPL 198
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 84.7 bits (209), Expect = 4e-18
Identities = 76/253 (30%), Positives = 118/253 (46%), Gaps = 38/253 (15%)
Query: 303 AVKKSKVIDESKVEEFINEVVILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGTLFQYI 362
AVKK + + + E NEVVI+ +H NVV + L + +V EF+ G L +
Sbjct: 51 AVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVMEFLEGGALTDIV 110
Query: 363 -HDQ-NEDFPITWEIRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSD 420
H + NE+ T + + V ALSYLH+ I HRDIKS +ILL R K+SD
Sbjct: 111 THTRMNEEQIAT------VCLSVLRALSYLHNQGVI---HRDIKSDSILLTSDGRIKLSD 161
Query: 421 FGASRSMAVDQTHMTTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLTELLTGEKPIRF 480
FG ++ + + V GT ++ PE + + D++S G+++ E++ GE P
Sbjct: 162 FGFCAQVSKEVPKRKSLV-GTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPP--- 217
Query: 481 TILEEDKSLAAYF----LCAMKEERLFEILDARVMKQGGKDEIITVAKLAKRCLNLNGKK 536
YF L AM+ R+ + L RV + V+ + + L+L +
Sbjct: 218 -----------YFNEPPLQAMR--RIRDNLPPRV------KDSHKVSSVLRGFLDLMLVR 258
Query: 537 RPTMREVASELAG 549
P+ R A EL
Sbjct: 259 EPSQRATAQELLQ 271
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 88.0 bits (218), Expect = 6e-18
Identities = 84/353 (23%), Positives = 149/353 (42%), Gaps = 60/353 (16%)
Query: 219 VGCTSGGLGMFLLIGAWWLFKFVKRRREIKLKRKYFKRNGGLLLQQELASTEGTIEKTKL 278
+ CT G + L+ + F F++ R ++LKR ++ E +GT E +
Sbjct: 632 ITCTLGAFLVLALVA--FGFVFIRGRNNLELKR----------VENE----DGTWE-LQF 674
Query: 279 FTSKELEKATDNFDLNRIL-----------GQGGQAVKKSKVIDESK--VEEF------- 318
F SK + + +N IL G+ G + K + + + V+E
Sbjct: 675 FDSK----VSKSITINDILSSLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNSIP 730
Query: 319 INEVVILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEIRLR 378
+E+ + ++ H N+VKL+G C + L++E+I L + + + ++WE R +
Sbjct: 731 SSEIADMGKLQHPNIVKLIGLCRSEKGAYLIHEYIEGKNLSEVLRN------LSWERRRK 784
Query: 379 IAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQV 438
IAI ++ AL +LH S + ++ I++D K + + D +
Sbjct: 785 IAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLCTDTKCFISS- 842
Query: 439 HGTFGYLDPEYFRSSQFTDKSDVYSFGVVLTELLTGEKP--IRFTILEEDKSLAAYFLCA 496
Y+ PE + T+KSD+Y FG++L ELLTG+ P F + A Y
Sbjct: 843 ----AYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADAEFGVHGSIVEWARY---C 895
Query: 497 MKEERLFEILDARVMKQGG--KDEIITVAKLAKRCLNLNGKKRPTMREVASEL 547
+ L +D + ++EI+ V LA C + RP +V L
Sbjct: 896 YSDCHLDMWIDPSIRGDVSVNQNEIVEVMNLALHCTATDPTARPCANDVLKTL 948
|
Length = 968 |
| >gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Score = 84.0 bits (208), Expect = 6e-18
Identities = 63/218 (28%), Positives = 98/218 (44%), Gaps = 32/218 (14%)
Query: 285 EKATDNFDLNRILGQG--------------GQAVK---KSKVIDESKVEE----FINEVV 323
E D+ L R LG G G AV+ K + ES E+ F+ E +
Sbjct: 2 EVPRDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEAL 61
Query: 324 ILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGTLFQYIHD----QNEDFPITWEIRLRI 379
I+S+ NH+N+V+L+G E ++ E + G L ++ + +T + L
Sbjct: 62 IMSKFNHQNIVRLIGVSFERLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFC 121
Query: 380 AIEVSGALSYLHSAASIPIYHRDIKSTNILLDDK---YRAKVSDFGASRSM-AVDQTHMT 435
A +V+ YL I HRDI + N LL K AK++DFG +R +
Sbjct: 122 ARDVAKGCKYLEENHFI---HRDIAARNCLLTCKGPGRVAKIADFGMARDIYRASYYRKG 178
Query: 436 TQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLTELLT 473
+ ++ PE F FT K+DV+SFGV+L E+ +
Sbjct: 179 GRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFS 216
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 83.8 bits (208), Expect = 6e-18
Identities = 71/246 (28%), Positives = 107/246 (43%), Gaps = 41/246 (16%)
Query: 308 KVID----ESKVEEFINEVVILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGTLFQYIH 363
KVID E ++E+ E+ LSQ + K G L+ ++ E+ G+ +
Sbjct: 32 KVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWIIMEYCGGGSCLDLLK 91
Query: 364 DQNEDFPITWEIRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGA 423
D I LR EV L YLH I HRDIK+ NILL ++ K++DFG
Sbjct: 92 PGKLDETYIAFI-LR---EVLLGLEYLHEEGKI---HRDIKAANILLSEEGDVKLADFGV 144
Query: 424 SRSMAVDQTHMTTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLTELLTGEKPIRFTIL 483
S + + T V GT ++ PE + S + +K+D++S G+ EL GE P
Sbjct: 145 SGQLTSTMSKRNTFV-GTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPP------ 197
Query: 484 EEDKSLAAYFLCAMKEERLFEI-------LDARVMKQGGKDEIITVAKLAKRCLNLNGKK 536
L+ M+ LF I L+ + KD + CLN + K+
Sbjct: 198 -----LSDLH--PMRV--LFLIPKNNPPSLEGNKFSKPFKDFV-------SLCLNKDPKE 241
Query: 537 RPTMRE 542
RP+ +E
Sbjct: 242 RPSAKE 247
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 83.3 bits (206), Expect = 7e-18
Identities = 62/212 (29%), Positives = 99/212 (46%), Gaps = 33/212 (15%)
Query: 290 NFDLNRILGQG--GQ-------------AVKKSKVIDESK-----VEEFINEVVILSQIN 329
N+ ++LGQG G+ AVK+ +S V E+ +L +
Sbjct: 3 NWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQ 62
Query: 330 HRNVVKLLGCCLETEVPLLVYEFIPNGTLFQYIHDQNEDF-PITWEIRLRIAIEVSGALS 388
H +V+ GC + E + E++P G+ + DQ + + +T + + ++ +
Sbjct: 63 HERIVQYYGCLRDDETLSIFMEYMPGGS----VKDQLKAYGALTETVTRKYTRQILEGVE 118
Query: 389 YLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASR---SMAVDQTHMTTQVHGTFGYL 445
YLHS I HRDIK NIL D K+ DFGAS+ ++ T M + V GT ++
Sbjct: 119 YLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSSGTGMKS-VTGTPYWM 174
Query: 446 DPEYFRSSQFTDKSDVYSFGVVLTELLTGEKP 477
PE + K+DV+S G + E+LT EKP
Sbjct: 175 SPEVISGEGYGRKADVWSVGCTVVEMLT-EKP 205
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 83.9 bits (207), Expect = 8e-18
Identities = 60/181 (33%), Positives = 89/181 (49%), Gaps = 20/181 (11%)
Query: 303 AVKKSKVIDESKVEEFINEVVILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGTLFQYI 362
AVK + + + E NEVVI+ H+NVV++ L E ++ EF+ G L
Sbjct: 50 AVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFLQGGALTD-- 107
Query: 363 HDQNEDFPITWEIRL---RIAI---EVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRA 416
I + RL +IA V AL YLHS I HRDIKS +ILL R
Sbjct: 108 --------IVSQTRLNEEQIATVCESVLQALCYLHSQGVI---HRDIKSDSILLTLDGRV 156
Query: 417 KVSDFGASRSMAVDQTHMTTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLTELLTGEK 476
K+SDFG ++ D + V GT ++ PE + + + D++S G+++ E++ GE
Sbjct: 157 KLSDFGFCAQISKDVPKRKSLV-GTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEP 215
Query: 477 P 477
P
Sbjct: 216 P 216
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 82.7 bits (205), Expect = 1e-17
Identities = 54/178 (30%), Positives = 94/178 (52%), Gaps = 10/178 (5%)
Query: 303 AVKKSKV-IDESKVEEFINEVVILSQINHRNVVKLLGCCL-ETEVPLLVYEFIPNGTLFQ 360
AVK ++ I+E+ ++ + E+ IL + N +V G ++ + + E++ G+L +
Sbjct: 30 AVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAFYNNGDISICM-EYMDGGSLDK 88
Query: 361 YIHDQNEDFPITWEIRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSD 420
+ + P I +IA+ V L+YLH I HRD+K +NIL++ + + K+ D
Sbjct: 89 ILKEVQGRIPE--RILGKIAVAVLKGLTYLHEKHKI--IHRDVKPSNILVNSRGQIKLCD 144
Query: 421 FGASRSMAVDQTHMTTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLTELLTGEKPI 478
FG S + V+ T GT Y+ PE + + ++ KSD++S G+ L EL TG P
Sbjct: 145 FGVSGQL-VNSLAKTFV--GTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPY 199
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 83.4 bits (206), Expect = 1e-17
Identities = 51/167 (30%), Positives = 94/167 (56%), Gaps = 11/167 (6%)
Query: 312 ESKVEEFINEVVILSQINHRNVVKLLGCCLET--EVPLLVYEFIPNGTLFQYI-HDQNED 368
+ + + E+ IL + H N+VK G C E L+ EF+P+G+L +Y+ ++N+
Sbjct: 47 GNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPRNKNK- 105
Query: 369 FPITWEIRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMA 428
I + +L+ A+++ + YL S + HRD+ + N+L++ +++ K+ DFG ++++
Sbjct: 106 --INLKQQLKYAVQICKGMDYLGSRQYV---HRDLAARNVLVESEHQVKIGDFGLTKAIE 160
Query: 429 VDQTHMTTQ--VHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLTELLT 473
D+ + T + + + PE S+F SDV+SFGV L ELLT
Sbjct: 161 TDKEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLT 207
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 82.1 bits (203), Expect = 2e-17
Identities = 71/275 (25%), Positives = 120/275 (43%), Gaps = 36/275 (13%)
Query: 288 TDNFDLNRILGQGG---------------QAVKKSKV---IDESKVEEFINEVVILSQIN 329
NF + + +G+G A+KK ++ +D ++ + E+ +L Q++
Sbjct: 1 LGNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLD 60
Query: 330 HRNVVKLLGCCLETEVPLLVYEFIPNGTLFQYI-HDQNEDFPITWEIRLRIAIEVSGALS 388
H NV+K L +E +V E G L + I H + + I + +++ AL
Sbjct: 61 HPNVIKYLASFIENNELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALE 120
Query: 389 YLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHGTFGYLDPE 448
++HS I HRDIK N+ + K+ D G R + T + V GT Y+ PE
Sbjct: 121 HMHSKR---IMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLV-GTPYYMSPE 176
Query: 449 YFRSSQFTDKSDVYSFGVVLTELLTGEKPIRFTILEEDKSLAAYFLCAMKEERLFEILDA 508
+ + KSD++S G +L E+ + P DK + Y LC E+ + L A
Sbjct: 177 RIHENGYNFKSDIWSLGCLLYEMAALQSP-----FYGDK-MNLYSLCKKIEKCDYPPLPA 230
Query: 509 RVMKQGGKDEIITVAKLAKRCLNLNGKKRPTMREV 543
+ +D L RC+N + +KRP + V
Sbjct: 231 DHYSEELRD-------LVSRCINPDPEKRPDISYV 258
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 83.2 bits (206), Expect = 2e-17
Identities = 54/188 (28%), Positives = 87/188 (46%), Gaps = 14/188 (7%)
Query: 302 QAVKKSKVIDESKVEEFINEVVILSQINHRNVVKLLGCCLETEVPL-LVYEFIPNGTLFQ 360
+ +KK ++ + VE + E +L+ + L C +T+ L V E++ G L
Sbjct: 26 KVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVNGGDLMF 85
Query: 361 YIHDQNEDFPITWEIRLRI-AIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVS 419
+I F E R R A E+ L +LH I +RD+K N+LLD + K++
Sbjct: 86 HIQRSGR-FD---EPRARFYAAEIVLGLQFLHERG---IIYRDLKLDNVLLDSEGHIKIA 138
Query: 420 DFGASR-SMAVDQTHMTTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLTELLTGEKPI 478
DFG + + T T+ GT Y+ PE + D ++ GV+L E+L G+ P
Sbjct: 139 DFGMCKEGILGGVT--TSTFCGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSP- 195
Query: 479 RFTILEED 486
F +ED
Sbjct: 196 -FEGDDED 202
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 82.4 bits (203), Expect = 3e-17
Identities = 56/176 (31%), Positives = 88/176 (50%), Gaps = 10/176 (5%)
Query: 303 AVKKSKVIDESKVEEFINEVVILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGTLFQYI 362
AVKK + + + E NEVVI+ H NVV++ L + +V EF+ G L +
Sbjct: 49 AVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALTDIV 108
Query: 363 -HDQNEDFPITWEIRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDF 421
H + + I + + V ALS LH+ I HRDIKS +ILL R K+SDF
Sbjct: 109 THTRMNEEQIA-----AVCLAVLKALSVLHAQGVI---HRDIKSDSILLTHDGRVKLSDF 160
Query: 422 GASRSMAVDQTHMTTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLTELLTGEKP 477
G ++ + + V GT ++ PE + + D++S G+++ E++ GE P
Sbjct: 161 GFCAQVSKEVPRRKSLV-GTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPP 215
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Score = 81.9 bits (202), Expect = 3e-17
Identities = 52/179 (29%), Positives = 93/179 (51%), Gaps = 9/179 (5%)
Query: 303 AVKKSKV-IDESKVEEFINEVVILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGTLFQY 361
A+K K E + +F++E I+ Q +H N++ L G +++ ++V E++ NG+L +
Sbjct: 36 AIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKPVMIVTEYMENGSLDAF 95
Query: 362 IHDQNEDFPITWEIRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDF 421
+ + F + + + I + + YL + HRD+ + NIL++ KVSDF
Sbjct: 96 LRKHDGQFTVIQLVGMLRGI--ASGMKYLSDMGYV---HRDLAARNILVNSNLVCKVSDF 150
Query: 422 GASRSMAVDQTHMTTQVHGTFG--YLDPEYFRSSQFTDKSDVYSFGVVLTELLT-GEKP 477
G SR + D T G + PE +FT SDV+S+G+V+ E+++ GE+P
Sbjct: 151 GLSRVLEDDPEAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERP 209
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267 |
| >gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Score = 81.2 bits (200), Expect = 3e-17
Identities = 60/240 (25%), Positives = 107/240 (44%), Gaps = 37/240 (15%)
Query: 317 EFINEVVILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEIR 376
+F+ E IL Q +H N+V+L+G C + + +V E + G ++ + E + +
Sbjct: 39 KFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDFLTFL--RTEGPRLKVKEL 96
Query: 377 LRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTT 436
+++ + + YL S I HRD+ + N L+ +K K+SDFG SR D + +T
Sbjct: 97 IQMVENAAAGMEYLESKHCI---HRDLAARNCLVTEKNVLKISDFGMSREEE-DGVYAST 152
Query: 437 ----QVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLTELLTGEKPIRFTILEEDKSLAAY 492
Q+ + PE +++ +SDV+SFG++L E SL A
Sbjct: 153 GGMKQI--PVKWTAPEALNYGRYSSESDVWSFGILLWEAF---------------SLGAV 195
Query: 493 FLCAMKEERLFEILDARVMKQGGKDEII-----TVAKLAKRCLNLNGKKRPTMREVASEL 547
+ ++ E ++ QG + V +L +RC + +RP+ V EL
Sbjct: 196 PYANLSNQQTREAIE-----QGVRLPCPELCPDAVYRLMERCWEYDPGQRPSFSTVHQEL 250
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 81.5 bits (201), Expect = 3e-17
Identities = 57/211 (27%), Positives = 98/211 (46%), Gaps = 33/211 (15%)
Query: 290 NFDLNRILGQG---------GQAVKKSKVIDESKVEEFI--------NEVVILSQINHRN 332
+++ + +G+G ++ + VI E + + EV++L+++ H N
Sbjct: 1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPN 60
Query: 333 VVKLLGCCLETEVPLLVYEFIPNGTLFQYIHDQ-----NEDFPITWEIRLRIAIEVSGAL 387
+V E +V E+ G L + I+ Q +ED ++W +++S L
Sbjct: 61 IVTFFASFQENGRLFIVMEYCDGGDLMKRINRQRGVLFSEDQILSW------FVQISLGL 114
Query: 388 SYLHSAASIPIYHRDIKSTNILLDDKYR-AKVSDFGASRSMAVDQTHMTTQVHGTFGYLD 446
++H I HRDIKS NI L AK+ DFG +R + D + GT YL
Sbjct: 115 KHIHDRK---ILHRDIKSQNIFLSKNGMVAKLGDFGIARQLN-DSMELAYTCVGTPYYLS 170
Query: 447 PEYFRSSQFTDKSDVYSFGVVLTELLTGEKP 477
PE ++ + +K+D++S G VL EL T + P
Sbjct: 171 PEICQNRPYNNKTDIWSLGCVLYELCTLKHP 201
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 81.6 bits (201), Expect = 4e-17
Identities = 72/297 (24%), Positives = 130/297 (43%), Gaps = 57/297 (19%)
Query: 285 EKATDNFDLNRILGQGG-----QAVKKSKVIDESKVE----------------EFINEVV 323
E A + ++R LGQG + + K V DE + EF+NE
Sbjct: 2 EVAREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEAS 61
Query: 324 ILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGTLFQYIHDQNEDF-------PITWEIR 376
++ + N +VV+LLG + + L++ E + G L Y+ + P + +
Sbjct: 62 VMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKM 121
Query: 377 LRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSM-AVDQTHMT 435
+++A E++ ++YL++ + HRD+ + N ++ + + K+ DFG +R + D
Sbjct: 122 IQMAGEIADGMAYLNANKFV---HRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKG 178
Query: 436 TQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLTELLT-GEKPIRFTILEEDKSLAAYFL 494
+ ++ PE + FT SDV+SFGVVL E+ T E+P +
Sbjct: 179 GKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQ--------------- 223
Query: 495 CAMKEERLFEILDARVMKQGGKDEIIT----VAKLAKRCLNLNGKKRPTMREVASEL 547
M E++ VM+ G D+ + +L + C N K RP+ E+ S +
Sbjct: 224 -GMSNEQVLRF----VMEGGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSI 275
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 80.9 bits (200), Expect = 4e-17
Identities = 69/249 (27%), Positives = 116/249 (46%), Gaps = 35/249 (14%)
Query: 303 AVKKSKVIDESK-----VEEFINEVVILSQINHRNVVKLLGCCLETEVPLLVY-EFIPNG 356
AVK+ + D+ + V++ E+ +LS++ H N+V+ LG E + L ++ E +P G
Sbjct: 29 AVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREED-NLYIFLELVPGG 87
Query: 357 TLFQYIHDQNEDFPITWE--IRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKY 414
+ + + + E IRL + G L YLH ++ HRDIK NIL+D
Sbjct: 88 S----LAKLLKKYGSFPEPVIRLYTRQILLG-LEYLHDRNTV---HRDIKGANILVDTNG 139
Query: 415 RAKVSDFGASRSMAVDQTHMTTQVHGTFGYLDPEYFRSS-QFTDKSDVYSFGVVLTELLT 473
K++DFG ++ V + G+ ++ PE + +D++S G + E+ T
Sbjct: 140 VVKLADFGMAKQ--VVEFSFAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMAT 197
Query: 474 GEKPIRFTILEEDKSLAAYFLCAMKEERLFEILDARVMKQGGKDEIITVAKLAKRCLNLN 533
G+ P ++ LE +AA F +E L I D + KD I+ +CL +
Sbjct: 198 GKPP--WSQLEG---VAAVFKIGRSKE-LPPIPDH--LSDEAKDFIL-------KCLQRD 242
Query: 534 GKKRPTMRE 542
RPT E
Sbjct: 243 PSLRPTAAE 251
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein | Back alignment and domain information |
|---|
Score = 84.9 bits (210), Expect = 5e-17
Identities = 55/178 (30%), Positives = 84/178 (47%), Gaps = 22/178 (12%)
Query: 311 DESKVEEFINEVVILSQINHRNVVKLL--GCCLETEVPLL--VYEFIPNGTLFQYIHDQN 366
+E + F E + +++ H N+V LL G E LL V+E++P TL + +
Sbjct: 18 EEHQRARFRRETALCARLYHPNIVALLDSG---EAPPGLLFAVFEYVPGRTLREVLAADG 74
Query: 367 EDFPITWEIRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILL---DDKYRAKVSDFGA 423
+ R+ ++V AL+ H+ I HRD+K NI++ + AKV DFG
Sbjct: 75 ---ALPAGETGRLMLQVLDALACAHNQG---IVHRDLKPQNIMVSQTGVRPHAKVLDFGI 128
Query: 424 S------RSMAVDQTHMTTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLTELLTGE 475
R V TT+V GT Y PE R T SD+Y++G++ E LTG+
Sbjct: 129 GTLLPGVRDADVATLTRTTEVLGTPTYCAPEQLRGEPVTPNSDLYAWGLIFLECLTGQ 186
|
This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 81.3 bits (200), Expect = 5e-17
Identities = 55/181 (30%), Positives = 90/181 (49%), Gaps = 14/181 (7%)
Query: 302 QAVKKSKVID----ESKVEEFINEVVILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGT 357
Q V K+ID E ++E+ E+ +LSQ + V K G L+ ++ E++ G+
Sbjct: 29 QQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWIIMEYLGGGS 88
Query: 358 LFQYIHDQN-EDFPITWEIRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRA 416
+ ++F I ++ E+ L YLHS I HRDIK+ N+LL ++
Sbjct: 89 ALDLLRAGPFDEFQIATMLK-----EILKGLDYLHSEKKI---HRDIKAANVLLSEQGDV 140
Query: 417 KVSDFGASRSMAVDQTHMTTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLTELLTGEK 476
K++DFG + + Q T V GT ++ PE + S + K+D++S G+ EL GE
Sbjct: 141 KLADFGVAGQLTDTQIKRNTFV-GTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEP 199
Query: 477 P 477
P
Sbjct: 200 P 200
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 81.3 bits (200), Expect = 5e-17
Identities = 71/250 (28%), Positives = 108/250 (43%), Gaps = 32/250 (12%)
Query: 302 QAVKKSKVID----ESKVEEFINEVVILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGT 357
Q V K+ID E ++E+ E+ +LSQ + V K G L+ ++ E++ G+
Sbjct: 29 QKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYLGGGS 88
Query: 358 LFQYIHDQNEDFPITWEIRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAK 417
D E P+ I E+ L YLHS I HRDIK+ N+LL + K
Sbjct: 89 AL----DLLEPGPLDETQIATILREILKGLDYLHSEKKI---HRDIKAANVLLSEHGEVK 141
Query: 418 VSDFGASRSMAVDQTHMTTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLTELLTGEKP 477
++DFG + + Q T V GT ++ PE + S + K+D++S G+ EL GE P
Sbjct: 142 LADFGVAGQLTDTQIKRNTFV-GTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPP 200
Query: 478 IRFTILEEDKSLAAYFLCAMKEERLFEILDARVMKQGGKDEIITVAKLAKRCLNLNGKKR 537
E + FL E ++ +K+ + CLN K
Sbjct: 201 -----HSELHPMKVLFLIPKNNPPTLEGNYSKPLKE-----------FVEACLN----KE 240
Query: 538 PTMREVASEL 547
P+ R A EL
Sbjct: 241 PSFRPTAKEL 250
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 81.4 bits (201), Expect = 5e-17
Identities = 65/222 (29%), Positives = 106/222 (47%), Gaps = 30/222 (13%)
Query: 289 DNFDLNRI--LGQG-GQAVKK-----------SKVI----DESKVEEFINEVVILSQINH 330
N DL I LG G G +V K KV+ S ++ + E+ I+ +
Sbjct: 3 RNEDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRS 62
Query: 331 RNVVKLLGCCLETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEIRLRIAIEVSGALSYL 390
+V G L + EF+ G+L + + PI EI +IA+ V L+YL
Sbjct: 63 PYIVSFYGAFLNENNICMCMEFMDCGSLDRIY---KKGGPIPVEILGKIAVAVVEGLTYL 119
Query: 391 HSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSM--AVDQTHMTTQVHGTFGYLDPE 448
++ I HRDIK +NIL++ + + K+ DFG S + ++ T + GT Y+ PE
Sbjct: 120 YNVHRI--MHRDIKPSNILVNSRGQIKLCDFGVSGELINSIADTFV-----GTSTYMSPE 172
Query: 449 YFRSSQFTDKSDVYSFGVVLTELLTGEKPIRFTILEEDKSLA 490
+ ++T KSDV+S G+ + EL G+ P F+ +++D
Sbjct: 173 RIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDD 214
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Score = 80.7 bits (199), Expect = 8e-17
Identities = 53/181 (29%), Positives = 94/181 (51%), Gaps = 11/181 (6%)
Query: 303 AVKKSKV-IDESKVEEFINEVVILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGTLFQY 361
A+K K E + +F++E I+ Q +H N++ L G ++ +++ EF+ NG L +
Sbjct: 36 AIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRPVMIITEFMENGALDSF 95
Query: 362 IHDQNEDFPITWEIRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDF 421
+ + F + + + I + + YL + + HRD+ + NIL++ KVSDF
Sbjct: 96 LRQNDGQFTVIQLVGMLRGI--AAGMKYL---SEMNYVHRDLAARNILVNSNLVCKVSDF 150
Query: 422 GASRSMAVDQTHMT-TQVHG---TFGYLDPEYFRSSQFTDKSDVYSFGVVLTELLT-GEK 476
G SR + D + T T G + PE +FT SDV+S+G+V+ E+++ GE+
Sbjct: 151 GLSRFLEDDTSDPTYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGER 210
Query: 477 P 477
P
Sbjct: 211 P 211
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269 |
| >gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Score = 81.0 bits (200), Expect = 8e-17
Identities = 67/224 (29%), Positives = 105/224 (46%), Gaps = 33/224 (14%)
Query: 290 NFDLNRILGQGG---------------------QAVKKSKVIDESKVEEFI-NEVVILSQ 327
NF+L R+LG G + +KK+ ++ ++K E E +L
Sbjct: 1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEA 60
Query: 328 INHRNVVKLLGCCLETEVPL-LVYEFIPNGTLFQYIHDQNEDFPITWEIRLRIAIEVSGA 386
+ + L +T+ L L+ +++ G LF +++ Q E F + E+R+ IA E+ A
Sbjct: 61 VRRCPFLVTLHYAFQTDTKLHLILDYVNGGELFTHLY-QREHFTES-EVRVYIA-EIVLA 117
Query: 387 LSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHGTFGYLD 446
L +LH + I +RDIK NILLD + ++DFG S+ ++ GT Y+
Sbjct: 118 LDHLHQ---LGIIYRDIKLENILLDSEGHVVLTDFGLSKEFLAEEEERAYSFCGTIEYMA 174
Query: 447 PEYFR--SSQFTDKSDVYSFGVVLTELLTGEKPIRFTILEEDKS 488
PE R S D +S GV+ ELLTG P FT+ E S
Sbjct: 175 PEVIRGGSGGHDKAVDWWSLGVLTFELLTGASP--FTVDGEQNS 216
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 80.6 bits (199), Expect = 9e-17
Identities = 50/178 (28%), Positives = 85/178 (47%), Gaps = 16/178 (8%)
Query: 308 KVI----DESKVEEFINEVVILSQINH---RNVVKLLGCCLETEVPLLVYEFIPNGTLFQ 360
K+I + V + EV +LSQ+ N+ K G L+ ++ E+ G++
Sbjct: 32 KIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWIIMEYAEGGSVRT 91
Query: 361 YIHDQNEDFPITWEIRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSD 420
+ PI + I EV AL Y+H + HRDIK+ NIL+ + K+ D
Sbjct: 92 LMKAG----PIAEKYISVIIREVLVALKYIHKV---GVIHRDIKAANILVTNTGNVKLCD 144
Query: 421 FGASRSMAVDQTHMTTQVHGTFGYLDPEYFRSSQFTD-KSDVYSFGVVLTELLTGEKP 477
FG + + + + +T V GT ++ PE ++ D K+D++S G+ + E+ TG P
Sbjct: 145 FGVAALLNQNSSKRSTFV-GTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPP 201
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 80.6 bits (199), Expect = 1e-16
Identities = 60/227 (26%), Positives = 105/227 (46%), Gaps = 33/227 (14%)
Query: 273 IEKTKLFTSKELEKATDNFDLNRILGQGG---------------QAVKKSKV------ID 311
I+ T+L + E +N + LG G AV K V
Sbjct: 19 IDPTQLPYDLKWEFPRNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAH 78
Query: 312 ESKVEEFINEVVILSQI-NHRNVVKLLGCCLETEVPLLVYEFIPNGTLFQYIHDQNEDFP 370
S+ E ++E+ I+S + NH N+V LLG C L++ E+ G L ++ + E F
Sbjct: 79 SSEREALMSELKIMSHLGNHENIVNLLGACTIGGPILVITEYCCYGDLLNFLRRKRESFL 138
Query: 371 ITWEIRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVD 430
++ L + +V+ +++L S I HRD+ + N+LL K+ DFG +R + D
Sbjct: 139 TLEDL-LSFSYQVAKGMAFLASKNCI---HRDLAARNVLLTHGKIVKICDFGLARDIMND 194
Query: 431 QTHMTTQVHGT----FGYLDPEYFRSSQFTDKSDVYSFGVVLTELLT 473
++ V G ++ PE + +T +SDV+S+G++L E+ +
Sbjct: 195 SNYV---VKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFS 238
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302 |
| >gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Score = 80.1 bits (197), Expect = 2e-16
Identities = 67/250 (26%), Positives = 111/250 (44%), Gaps = 42/250 (16%)
Query: 243 RRREIKLKRKYFKRNGGLLLQQELASTEGTIEKTKLFTSKELEKATDNFDLNRILGQGGQ 302
+RR+I LKR EL EG K L L D +
Sbjct: 3 KRRDIVLKR-------------ELG--EGAFGKVFLAECYNLSPTKDKMLV--------- 38
Query: 303 AVKKSKVIDESKVEEFINEVVILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGTLFQYI 362
AVK K + ++F E +L+ + H ++VK G C + + ++V+E++ +G L +++
Sbjct: 39 AVKALKDPTLAARKDFQREAELLTNLQHEHIVKFYGVCGDGDPLIMVFEYMKHGDLNKFL 98
Query: 363 HDQNEDFPITWEIR-------------LRIAIEVSGALSYLHSAASIPIYHRDIKSTNIL 409
D I + + L IA +++ + YL AS HRD+ + N L
Sbjct: 99 RAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYL---ASQHFVHRDLATRNCL 155
Query: 410 LDDKYRAKVSDFGASRSM-AVDQTHMTTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVL 468
+ K+ DFG SR + + D + ++ PE +FT +SDV+SFGV+L
Sbjct: 156 VGANLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVIL 215
Query: 469 TELLT-GEKP 477
E+ T G++P
Sbjct: 216 WEIFTYGKQP 225
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 80.2 bits (197), Expect = 2e-16
Identities = 65/249 (26%), Positives = 115/249 (46%), Gaps = 38/249 (15%)
Query: 303 AVKKSKVIDESKVEEFINEVVILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGTLFQYI 362
A+K+ + + K E INE++++ ++ + N+V L L + +V E++ G+L +
Sbjct: 48 AIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDSFLVGDELFVVMEYLAGGSLTDVV 107
Query: 363 HDQNEDFPITWEIRLR-IAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDF 421
+ D E ++ + E AL +LH+ I HRDIKS N+LL K++DF
Sbjct: 108 TETCMD-----EAQIAAVCRECLQALEFLHANQVI---HRDIKSDNVLLGMDGSVKLTDF 159
Query: 422 GASRSMAVDQTHMTTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLTELLTGEKPIRFT 481
G + +Q+ +T V GT ++ PE + K D++S G++ E++ GE P
Sbjct: 160 GFCAQITPEQSKRSTMV-GTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPP---- 214
Query: 482 ILEEDKSLAAYFLCAMKEERLFEILDARVMKQGGKDEIITVAKLA-------KRCLNLNG 534
L E+ A Y + G E+ KL+ RCL ++
Sbjct: 215 YLNENPLRALYLIAT-----------------NGTPELQNPEKLSPIFRDFLNRCLEMDV 257
Query: 535 KKRPTMREV 543
+KR + +E+
Sbjct: 258 EKRGSAKEL 266
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 79.7 bits (196), Expect = 2e-16
Identities = 65/240 (27%), Positives = 109/240 (45%), Gaps = 28/240 (11%)
Query: 308 KVID----ESKVEEFINEVVILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGTLFQYIH 363
K+ID E ++E+ E+ +LSQ + + + G L+ ++ E++ G+
Sbjct: 35 KIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWIIMEYLGGGSAL---- 90
Query: 364 DQNEDFPITWEIRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGA 423
D + P+ I E+ L YLHS I HRDIK+ N+LL ++ K++DFG
Sbjct: 91 DLLKPGPLEETYIATILREILKGLDYLHSERKI---HRDIKAANVLLSEQGDVKLADFGV 147
Query: 424 SRSMAVDQTHMTTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLTELLTGEKPIRFTIL 483
+ + Q T V GT ++ PE + S + K+D++S G+ EL GE P + L
Sbjct: 148 AGQLTDTQIKRNTFV-GTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPP--NSDL 204
Query: 484 EEDKSLAAYFLCAMKEERLFEILDARVMKQGGKDEIITVAKLAKRCLNLNGKKRPTMREV 543
+ L FL E ++ K+ + CLN + + RPT +E+
Sbjct: 205 HPMRVL---FLIPKNSPPTLEGQYSKPFKE-----------FVEACLNKDPRFRPTAKEL 250
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Score = 78.9 bits (194), Expect = 3e-16
Identities = 53/173 (30%), Positives = 88/173 (50%), Gaps = 17/173 (9%)
Query: 313 SKVEEFINEVVILSQINHRNVVKLLGCCLETEVPL-LVYEFIPNGTLFQYIHDQN----- 366
S VE+ E V+L+++ H N+V E + L +V E+ G L Q I Q
Sbjct: 40 SAVEDSRKEAVLLAKMKHPNIVAFKES-FEADGHLYIVMEYCDGGDLMQKIKLQRGKLFP 98
Query: 367 EDFPITWEIRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRS 426
ED + W +++ + ++ ++H + HRDIKS NI L + K+ DFG++R
Sbjct: 99 EDTILQWFVQMCLGVQ------HIHEKR---VLHRDIKSKNIFLTQNGKVKLGDFGSARL 149
Query: 427 MAVDQTHMTTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLTELLTGEKPIR 479
+ + T V GT Y+ PE + + + +KSD++S G +L EL T + P +
Sbjct: 150 LTSPGAYACTYV-GTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQ 201
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 79.5 bits (196), Expect = 4e-16
Identities = 55/162 (33%), Positives = 89/162 (54%), Gaps = 15/162 (9%)
Query: 320 NEVVILSQINHRNVVKLLGCCLETEVPL-LVYEFIPNGTLFQYIHDQ---NEDFPITWEI 375
E IL+++NH +VKL +TE L L+ +F+ G LF + + E+ ++
Sbjct: 47 MERDILAEVNHPFIVKL-HYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEE-----DV 100
Query: 376 RLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMT 435
+ +A E++ AL +LHS + I +RD+K NILLD++ K++DFG S+ ++D
Sbjct: 101 KFYLA-ELALALDHLHS---LGIIYRDLKPENILLDEEGHIKLTDFGLSKE-SIDHEKKA 155
Query: 436 TQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLTELLTGEKP 477
GT Y+ PE T +D +SFGV++ E+LTG P
Sbjct: 156 YSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLP 197
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Score = 78.7 bits (194), Expect = 4e-16
Identities = 57/250 (22%), Positives = 114/250 (45%), Gaps = 44/250 (17%)
Query: 317 EFINEVVILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGTLFQYIHDQN---------- 366
+F E ++++ +H N+VKLLG C + L++E++ G L +++ ++
Sbjct: 54 DFQREAALMAEFDHPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHS 113
Query: 367 ---------EDFPITWEIRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAK 417
P++ +L IA +V+ ++YL + HRD+ + N L+ + K
Sbjct: 114 TSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSERKFV---HRDLATRNCLVGENMVVK 170
Query: 418 VSDFGASRSM-AVDQTHMTTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLTELLT-GE 475
++DFG SR++ + D + ++ PE +++T +SDV+++GVVL E+ + G
Sbjct: 171 IADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGM 230
Query: 476 KPIRFTILEEDKSLAAYFLCAMKEERLFEILDARVMK--QGGKDEIITVAKLAKRCLNLN 533
+P Y+ A EE ++ + D V+ E+ L + C +
Sbjct: 231 QP--------------YYGMA-HEEVIYYVRDGNVLSCPDNCPLELYN---LMRLCWSKL 272
Query: 534 GKKRPTMREV 543
RP+ +
Sbjct: 273 PSDRPSFASI 282
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288 |
| >gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Score = 78.9 bits (194), Expect = 4e-16
Identities = 69/236 (29%), Positives = 107/236 (45%), Gaps = 33/236 (13%)
Query: 290 NFDLNRILGQGG---------------------QAVKKSKVIDESKVEEFI-NEVVILSQ 327
NF+L ++LG G + +KK+ ++ ++K E E +L
Sbjct: 1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEH 60
Query: 328 INHRNVVKLLGCCLETEVPL-LVYEFIPNGTLFQYIHDQNEDFPITWEIRLRIAIEVSGA 386
I + L +T+ L L+ ++I G LF ++ Q E F E+++ E+ A
Sbjct: 61 IRQSPFLVTLHYAFQTDTKLHLILDYINGGELFTHL-SQRERFK-EQEVQIYSG-EIVLA 117
Query: 387 LSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHGTFGYLD 446
L +LH + I +RDIK NILLD ++DFG S+ D+ GT Y+
Sbjct: 118 LEHLHK---LGIIYRDIKLENILLDSNGHVVLTDFGLSKEFHEDEVERAYSFCGTIEYMA 174
Query: 447 PEYFRSSQFT-DKS-DVYSFGVVLTELLTGEKPIRFTILEEDKSLAAYFLCAMKEE 500
P+ R DK+ D +S GV++ ELLTG P FT+ E S A +K E
Sbjct: 175 PDIVRGGDGGHDKAVDWWSMGVLMYELLTGASP--FTVDGEKNSQAEISRRILKSE 228
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290 |
| >gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 78.6 bits (194), Expect = 4e-16
Identities = 68/270 (25%), Positives = 121/270 (44%), Gaps = 52/270 (19%)
Query: 303 AVKKSKV-IDESKVEEFINEVVILSQI-NHRNVVKLLGCCLETEVPLLVYEFIPNGTLFQ 360
AVK K E + + ++E+ ++ I H+N++ LLG C + +V E+ +G L
Sbjct: 46 AVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGVCTQEGPLYVVVEYAAHGNLRD 105
Query: 361 YIHDQ-------NEDFPITWEIRL------RIAIEVSGALSYLHSAASIPIYHRDIKSTN 407
++ + + D P E L A +V+ + +L S I HRD+ + N
Sbjct: 106 FLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASKKCI---HRDLAARN 162
Query: 408 ILLDDKYRAKVSDFGASRSM-AVDQTHMTTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGV 466
+L+ + + K++DFG +R + +D TT ++ PE +T +SDV+SFGV
Sbjct: 163 VLVTEDHVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGV 222
Query: 467 VLTELLT-GEKPIRFTILEEDKSLAAYFLCAMKEERLFEILDARVMKQGGK--------D 517
+L E+ T G P +EE LF++L K+G +
Sbjct: 223 LLWEIFTLGGSPYPGIPVEE----------------LFKLL-----KEGYRMEKPQNCTQ 261
Query: 518 EIITVAKLAKRCLNLNGKKRPTMREVASEL 547
E+ L + C + +RPT +++ +L
Sbjct: 262 ELYH---LMRDCWHEVPSQRPTFKQLVEDL 288
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293 |
| >gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Score = 78.5 bits (193), Expect = 5e-16
Identities = 63/239 (26%), Positives = 112/239 (46%), Gaps = 32/239 (13%)
Query: 316 EEFINEVVILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEI 375
+E ++E +++ + V +LLG CL + V L V + +P G L Y+ + + I +
Sbjct: 54 KEILDEAYVMAGVGSPYVCRLLGICLTSTVQL-VTQLMPYGCLLDYVRENKDR--IGSQD 110
Query: 376 RLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMT 435
L ++++ +SYL + + HRD+ + N+L+ K++DFG +R + +D+
Sbjct: 111 LLNWCVQIAKGMSYLEE---VRLVHRDLAARNVLVKSPNHVKITDFGLARLLDIDE---- 163
Query: 436 TQVHGTFG-----YLDPEYFRSSQFTDKSDVYSFGVVLTELLT-GEKPIRFTILEEDKSL 489
T+ H G ++ E +FT +SDV+S+GV + EL+T G KP E L
Sbjct: 164 TEYHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPAREIPDL 223
Query: 490 AAYFLCAMKEERLFEILDARVMKQGGKDEIITVAKLAKRCLNLNGKKRPTMREVASELA 548
K ERL + I V + +C ++ + RP RE+ E +
Sbjct: 224 LE------KGERLPQPPIC----------TIDVYMIMVKCWMIDSECRPRFRELVDEFS 266
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279 |
| >gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Score = 78.8 bits (194), Expect = 5e-16
Identities = 48/173 (27%), Positives = 91/173 (52%), Gaps = 20/173 (11%)
Query: 317 EFINEVVILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGTLFQYI-HDQNED------- 368
+F+ EV ILS++ N+++LLG C++ + ++ E++ NG L Q++ +D
Sbjct: 65 DFLKEVKILSRLKDPNIIRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGND 124
Query: 369 --------FPITWEIRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSD 420
I++ L +A++++ + YL +S+ HRD+ + N L+ + K++D
Sbjct: 125 AVPPAHCLPAISYSSLLHVALQIASGMKYL---SSLNFVHRDLATRNCLVGENLTIKIAD 181
Query: 421 FGASRSM-AVDQTHMTTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLTELL 472
FG SR++ A D + + ++ E +FT SDV++FGV L E+L
Sbjct: 182 FGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEIL 234
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304 |
| >gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Score = 78.5 bits (193), Expect = 5e-16
Identities = 58/253 (22%), Positives = 118/253 (46%), Gaps = 38/253 (15%)
Query: 317 EFINEVVILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGTLFQYI-----H-----DQN 366
EF E ++++++H N+V LLG + + +++E++ G L +++ H +
Sbjct: 53 EFQQEASLMAELHHPNIVCLLGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSD 112
Query: 367 EDFPITWEIR----LRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFG 422
ED + + L IAI+++ + YL S + H+D+ + NIL+ ++ K+SD G
Sbjct: 113 EDGTVKSSLDHGDFLHIAIQIAAGMEYLSSHFFV---HKDLAARNILIGEQLHVKISDLG 169
Query: 423 ASRSM-AVDQTHMTTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLTELLT-GEKPIRF 480
SR + + D + + ++ PE +F+ SD++SFGVVL E+ + G +P
Sbjct: 170 LSREIYSADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQP--- 226
Query: 481 TILEEDKSLAAYFLCAMKEERLFEILDARVMKQGGKDEIITVAKLAKRCLNLNGKKRPTM 540
Y+ + + E++ R + +D + L C +RP
Sbjct: 227 -----------YY--GFSNQEVIEMVRKRQLLPCSEDCPPRMYSLMTECWQEGPSRRPRF 273
Query: 541 REVASELAGIKAW 553
+++ + L ++W
Sbjct: 274 KDIHTRL---RSW 283
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 78.2 bits (192), Expect = 6e-16
Identities = 61/229 (26%), Positives = 110/229 (48%), Gaps = 30/229 (13%)
Query: 321 EVVILSQINHRNVVKLLGCCLE-TEVPLLVY-EFIPNGTLFQYIHDQNEDF-PITWEIRL 377
E+ +L + H +V+ GC + E L ++ E++P G+ + DQ + + +T +
Sbjct: 54 EIQLLKNLQHERIVQYYGCLRDRAEKTLTIFMEYMPGGS----VKDQLKAYGALTESVTR 109
Query: 378 RIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASR---SMAVDQTHM 434
+ ++ +SYLHS I HRDIK NIL D K+ DFGAS+ ++ + T +
Sbjct: 110 KYTRQILEGMSYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKRLQTICMSGTGI 166
Query: 435 TTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLTELLTGEKPIRFTILEEDKSLAAYFL 494
+ V GT ++ PE + K+DV+S G + E+LT + P E +++AA F
Sbjct: 167 RS-VTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPP-----WAEYEAMAAIFK 220
Query: 495 CAMKEERLFEILDARVMKQGGKDEIITVAKLAKRCLNLNGKKRPTMREV 543
A + L + + + +D + C+ + + RP+ E+
Sbjct: 221 IATQPTN--PQLPSHISEH-ARDFL--------GCIFVEARHRPSAEEL 258
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 78.4 bits (194), Expect = 6e-16
Identities = 54/190 (28%), Positives = 92/190 (48%), Gaps = 30/190 (15%)
Query: 303 AVKKSKVIDESKVEEF----INEVVILSQINHRNVVKLLGCCLETEVP--LLVYEFIPNG 356
A+KK ++ E++ E F I E+ +L ++ H N+V+L +V+E++
Sbjct: 28 ALKKIRM--ENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVFEYMD-- 83
Query: 357 TLFQYIHD-----QNEDFPITW-EIRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILL 410
HD + + T +I+ ++ L YLHS I HRDIK +NIL+
Sbjct: 84 ------HDLTGLLDSPEVKFTESQIK-CYMKQLLEGLQYLHSNG---ILHRDIKGSNILI 133
Query: 411 DDKYRAKVSDFGASRSMAVDQTH-MTTQVHGTFGYLDPE-YFRSSQFTDKSDVYSFGVVL 468
++ K++DFG +R + T +V T Y PE ++++ + D++S G +L
Sbjct: 134 NNDGVLKLADFGLARPYTKRNSADYTNRVI-TLWYRPPELLLGATRYGPEVDMWSVGCIL 192
Query: 469 TELLTGEKPI 478
EL G KPI
Sbjct: 193 AELFLG-KPI 201
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Score = 77.8 bits (191), Expect = 7e-16
Identities = 67/263 (25%), Positives = 126/263 (47%), Gaps = 42/263 (15%)
Query: 303 AVKKSKV--IDESKVEEFINEVVILSQINHRNVVKLLGCCLETE------VPLLVYEFIP 354
AVK K+ S++E+F++E V + + +H NV++L+G CL+T P+++ F+
Sbjct: 30 AVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPSPVVILPFMK 89
Query: 355 NGTLFQY-IHDQNEDFP--ITWEIRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLD 411
+G L + ++ + D P + ++ ++ +++ + YL S + I HRD+ + N +L+
Sbjct: 90 HGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSKSFI---HRDLAARNCMLN 146
Query: 412 DKYRAKVSDFGASRSMAVDQTHMTTQVHGT-FGYLDPEYFRSSQFTDKSDVYSFGVVLTE 470
+ V+DFG S+ + + ++ ++ E +T KSDV+SFGV + E
Sbjct: 147 ENMNVCVADFGLSKKIYNGDYYRQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWE 206
Query: 471 LLT-GEKPIRFTILEEDKSLAAYFLCAMKEERLFEILDARVMKQGGK-----DEIITVAK 524
+ T G+ P + +E EI D ++QG + D + +
Sbjct: 207 IATRGQTP--YPGVENS-----------------EIYD--YLRQGNRLKQPPDCLDGLYS 245
Query: 525 LAKRCLNLNGKKRPTMREVASEL 547
L C LN K RP+ + EL
Sbjct: 246 LMSSCWLLNPKDRPSFETLRCEL 268
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 77.7 bits (192), Expect = 8e-16
Identities = 51/177 (28%), Positives = 82/177 (46%), Gaps = 11/177 (6%)
Query: 303 AVKKSKVIDESKV--EEFINEVVILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGTLFQ 360
A+KK K ++ + + + EV +L Q+ H N+V L LV+E++ TL +
Sbjct: 30 AIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYLVFEYVER-TLLE 88
Query: 361 YIHDQNEDFPITWEIRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSD 420
+ P + ++ A++Y HS I HRDIK NIL+ + K+ D
Sbjct: 89 LLEASPGGLPP--DAVRSYIWQLLQAIAYCHSHN---IIHRDIKPENILVSESGVLKLCD 143
Query: 421 FGASRSMAVD-QTHMTTQVHGTFGYLDPEYFRSSQFTDKS-DVYSFGVVLTELLTGE 475
FG +R++ + +T V T Y PE K DV++ G ++ ELL GE
Sbjct: 144 FGFARALRARPASPLTDYV-ATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGE 199
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 77.6 bits (191), Expect = 9e-16
Identities = 53/185 (28%), Positives = 83/185 (44%), Gaps = 21/185 (11%)
Query: 303 AVKKSKVIDESKVEEFINEVVILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGTLFQYI 362
A+K+ D V+ E+ + S + HRN+V+ LG E + E +P G+L +
Sbjct: 37 AIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSDSENGFFKIFMEQVPGGSLSALL 96
Query: 363 HDQ------NEDFPITWEIRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRA 416
+ NE I + ++ L YLH I HRDIK N+L+ + Y
Sbjct: 97 RSKWGPLKDNEQTIIFY------TKQILEGLKYLHDNQ---IVHRDIKGDNVLV-NTYSG 146
Query: 417 --KVSDFGASRSMAVDQTHMTTQVHGTFGYLDPEYFRSSQ--FTDKSDVYSFGVVLTELL 472
K+SDFG S+ +A T GT Y+ PE + +D++S G + E+
Sbjct: 147 VVKISDFGTSKRLA-GINPCTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMA 205
Query: 473 TGEKP 477
TG+ P
Sbjct: 206 TGKPP 210
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 77.3 bits (191), Expect = 1e-15
Identities = 45/176 (25%), Positives = 82/176 (46%), Gaps = 11/176 (6%)
Query: 303 AVKK--SKVIDESKVEEFINEVVILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGTLFQ 360
A+KK + ++ + + E+ L H VVKLL +LV E++P L +
Sbjct: 29 ALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFPHGSGFVLVMEYMP-SDLSE 87
Query: 361 YIHDQNEDFPITWEIRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSD 420
+ D+ P +++ + ++Y+H+ I HRD+K N+L+ K++D
Sbjct: 88 VLRDEERPLPEA-QVK-SYMRMLLKGVAYMHANG---IMHRDLKPANLLISADGVLKIAD 142
Query: 421 FGASRSMAVDQTH-MTTQVHGTFGYLDPEYFRSSQFTDKS-DVYSFGVVLTELLTG 474
FG +R + ++ + QV T Y PE ++ D D+++ G + ELL G
Sbjct: 143 FGLARLFSEEEPRLYSHQV-ATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNG 197
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 76.5 bits (189), Expect = 1e-15
Identities = 63/211 (29%), Positives = 95/211 (45%), Gaps = 41/211 (19%)
Query: 291 FDLNRILGQG-------------GQAVKKSKVIDESKVEEFINEVVILSQINHRNVVKLL 337
FD+ LG+G GQ V V E ++E I E+ IL Q + +VK
Sbjct: 5 FDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEEDLQEIIKEISILKQCDSPYIVKYY 64
Query: 338 GCCLETEVPLLVYEF-----------IPNGTLFQYIHDQNEDFPITWEIRLRIAIEVSGA 386
G + +V E+ I N TL E+ EI + + G
Sbjct: 65 GSYFKNTDLWIVMEYCGAGSVSDIMKITNKTL-------TEE-----EIAAILYQTLKG- 111
Query: 387 LSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHGTFGYLD 446
L YLHS I HRDIK+ NILL+++ +AK++DFG S + D V GT ++
Sbjct: 112 LEYLHSNKKI---HRDIKAGNILLNEEGQAKLADFGVSGQL-TDTMAKRNTVIGTPFWMA 167
Query: 447 PEYFRSSQFTDKSDVYSFGVVLTELLTGEKP 477
PE + + +K+D++S G+ E+ G+ P
Sbjct: 168 PEVIQEIGYNNKADIWSLGITAIEMAEGKPP 198
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Score = 77.3 bits (190), Expect = 1e-15
Identities = 73/291 (25%), Positives = 130/291 (44%), Gaps = 50/291 (17%)
Query: 291 FDLNRILGQG----------------GQ--AVK--KSKVIDESKVEEFINEVVILSQINH 330
F L R+LG+G Q AVK K+ + S +EEF+ E + + +H
Sbjct: 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDH 60
Query: 331 RNVVKLLGCCLETE------VPLLVYEFIPNGTLFQYI---HDQNEDFPITWEIRLRIAI 381
NV+KL+G L + +P+++ F+ +G L ++ E F + + +R I
Sbjct: 61 PNVIKLIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMI 120
Query: 382 EVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSM-AVDQTHMTTQVHG 440
+++ + YL S I HRD+ + N +L++ V+DFG S+ + + D
Sbjct: 121 DIASGMEYLSSKNFI---HRDLAARNCMLNENMTVCVADFGLSKKIYSGDYYRQGCASKL 177
Query: 441 TFGYLDPEYFRSSQFTDKSDVYSFGVVLTELLT-GEKPIRFTILEEDKSLAAYFLCAMKE 499
+L E + +T SDV++FGV + E++T G+ P E+ + Y + K
Sbjct: 178 PVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGV---ENSEIYNYLI---KG 231
Query: 500 ERLFEILDARVMKQGGKDEIITVAKLAKRCLNLNGKKRPTMREVASELAGI 550
RL + D + V +L +C + K RP+ + + +L I
Sbjct: 232 NRLKQPPDC----------LEDVYELMCQCWSPEPKCRPSFQHLRDQLELI 272
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 76.4 bits (188), Expect = 2e-15
Identities = 45/162 (27%), Positives = 86/162 (53%), Gaps = 13/162 (8%)
Query: 316 EEFINEVVILSQINHRNVVKLLGCCLETEVPL-LVYEFIPNGTLFQYIH-DQNEDFPITW 373
E F+ E ++ Q+ H +V+L T+ P+ ++ E++ NG+L ++ + I
Sbjct: 46 EAFLAEANLMKQLQHPRLVRLYAVV--TQEPIYIITEYMENGSLVDFLKTPEGIKLTINK 103
Query: 374 EIRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTH 433
I + A +++ ++++ I HRD+++ NIL+ + K++DFG +R ++
Sbjct: 104 LIDM--AAQIAEGMAFIERKNYI---HRDLRAANILVSETLCCKIADFGLAR--LIEDNE 156
Query: 434 MTTQVHGTF--GYLDPEYFRSSQFTDKSDVYSFGVVLTELLT 473
T + F + PE FT KSDV+SFG++LTE++T
Sbjct: 157 YTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVT 198
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Score = 76.6 bits (188), Expect = 2e-15
Identities = 68/235 (28%), Positives = 111/235 (47%), Gaps = 39/235 (16%)
Query: 290 NFDLNRILGQGG---------------QAVKKSKVIDES-----KVEEFINEVVILSQIN 329
N+ L ++LGQG AVK+ + ES +V E+ +L +
Sbjct: 3 NWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLL 62
Query: 330 HRNVVKLLGCCLET-EVPLLVY-EFIPNGTLFQYIHDQNEDF-PITWEIRLRIAIEVSGA 386
H +V+ GC + E L ++ E +P G+ I DQ + + +T + + ++
Sbjct: 63 HERIVQYYGCLRDPMERTLSIFMEHMPGGS----IKDQLKSYGALTENVTRKYTRQILEG 118
Query: 387 LSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASR---SMAVDQTHMTTQVHGTFG 443
+SYLHS I HRDIK NIL D K+ DFGAS+ ++ + T M + V GT
Sbjct: 119 VSYLHSNM---IVHRDIKGANILRDSVGNVKLGDFGASKRLQTICLSGTGMKS-VTGTPY 174
Query: 444 YLDPEYFRSSQFTDKSDVYSFGVVLTELLTGEKPIRFTILEEDKSLAAYFLCAMK 498
++ PE + K+D++S G + E+LT + P E +++AA F A +
Sbjct: 175 WMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPP-----WAEFEAMAAIFKIATQ 224
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 76.2 bits (187), Expect = 2e-15
Identities = 49/160 (30%), Positives = 85/160 (53%), Gaps = 9/160 (5%)
Query: 316 EEFINEVVILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEI 375
E F+ E I+ ++ H +V+L E + +V E++ G+L ++ D E +
Sbjct: 46 ESFLEEAQIMKKLRHDKLVQLYAVVSEEPI-YIVTEYMSKGSLLDFLKD-GEGRALKLPN 103
Query: 376 RLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMT 435
+ +A +V+ ++Y+ I HRD++S NIL+ D K++DFG +R ++ T
Sbjct: 104 LVDMAAQVAAGMAYIERMNYI---HRDLRSANILVGDGLVCKIADFGLAR--LIEDNEYT 158
Query: 436 TQVHGTF--GYLDPEYFRSSQFTDKSDVYSFGVVLTELLT 473
+ F + PE +FT KSDV+SFG++LTEL+T
Sbjct: 159 ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVT 198
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 76.1 bits (188), Expect = 2e-15
Identities = 57/184 (30%), Positives = 88/184 (47%), Gaps = 10/184 (5%)
Query: 303 AVKKSKVIDESKVEEFINEVVILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGTLFQYI 362
VKK +++ + E +E IL + NH +VKL + + ++ E+ G L+ +
Sbjct: 25 CVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGELWTIL 84
Query: 363 HDQNEDFPITWEIRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFG 422
D+ F + R IA V A YLH+ I +RD+K N+LLD K+ DFG
Sbjct: 85 RDRGL-FD-EYTARFYIACVVL-AFEYLHN---RGIIYRDLKPENLLLDSNGYVKLVDFG 138
Query: 423 ASRSMAVDQTHMTTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLTELLTGEKPIRFTI 482
++ + Q T GT Y+ PE + + D +S G++L ELLTG P F
Sbjct: 139 FAKKLKSGQK--TWTFCGTPEYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPP--FGE 194
Query: 483 LEED 486
+ED
Sbjct: 195 DDED 198
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 76.0 bits (187), Expect = 3e-15
Identities = 60/239 (25%), Positives = 111/239 (46%), Gaps = 30/239 (12%)
Query: 313 SKVEEFINEVVILSQINHRNVVKLLGCCLETEVPLLVY-EFIPNGTLFQYIHDQNEDFPI 371
V+ +E+ L ++H N+V+ LG TE L ++ E++P G++ +
Sbjct: 50 DMVKALRSEIETLKDLDHLNIVQYLGF-ETTEEYLSIFLEYVPGGSIGSCLRTYG---RF 105
Query: 372 TWEIRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASR-SMAVD 430
++ +V L+YLHS I HRD+K+ N+L+D K+SDFG S+ S +
Sbjct: 106 EEQLVRFFTEQVLEGLAYLHSKG---ILHRDLKADNLLVDADGICKISDFGISKKSDDIY 162
Query: 431 QTHMTTQVHGTFGYLDPEYFRSSQ--FTDKSDVYSFGVVLTELLTGEKPIRFTILEEDKS 488
+ G+ ++ PE S ++ K D++S G V+ E+ G +P ++++
Sbjct: 163 DNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRP-----WSDEEA 217
Query: 489 LAAYFLCAMKEERLFEILDARVMKQGGKDEIITVAKLA----KRCLNLNGKKRPTMREV 543
+AA +F++ + R D + ++ +A C +N RPT RE+
Sbjct: 218 IAA----------MFKLGNKRSAPPIPPDVSMNLSPVALDFLNACFTINPDNRPTAREL 266
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 76.3 bits (188), Expect = 3e-15
Identities = 50/173 (28%), Positives = 86/173 (49%), Gaps = 10/173 (5%)
Query: 307 SKVIDESKVEEFINEVVILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGTLFQYIHDQN 366
+VI + + NE +L +++H +++L + ++ E++P G LF Y+ +
Sbjct: 37 PEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYMLMEYVPGGELFSYLRNSG 96
Query: 367 EDFPITWEIRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRS 426
+ L A E+ AL YLHS I +RD+K NILLD + K++DFG ++
Sbjct: 97 R---FSNSTGLFYASEIVCALEYLHSKE---IVYRDLKPENILLDKEGHIKLTDFGFAKK 150
Query: 427 MAVDQTHMTTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLTELLTGEKPIR 479
+ D+T + GT YL PE +S D ++ G+++ E+L G P
Sbjct: 151 L-RDRTWT---LCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFF 199
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Score = 76.6 bits (188), Expect = 4e-15
Identities = 56/246 (22%), Positives = 112/246 (45%), Gaps = 46/246 (18%)
Query: 316 EEFINEVVILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEI 375
+E ++E +++ +++ +V +LLG CL + V L + + +P G L Y+ + ++ +
Sbjct: 54 KEILDEAYVMASVDNPHVCRLLGICLTSTVQL-ITQLMPFGCLLDYVREHKDNIGSQY-- 110
Query: 376 RLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMT 435
L ++++ ++YL + HRD+ + N+L+ K++DFG ++ + D+
Sbjct: 111 LLNWCVQIAKGMNYLEERR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLGADE---- 163
Query: 436 TQVHGTFG-----YLDPEYFRSSQFTDKSDVYSFGVVLTELLT-GEKPIR-------FTI 482
+ H G ++ E +T +SDV+S+GV + EL+T G KP +I
Sbjct: 164 KEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSI 223
Query: 483 LEEDKSLAAYFLCAMKEERLFEILDARVMKQGGKDEIITVAKLAKRCLNLNGKKRPTMRE 542
LE+ + L +C I V + +C ++ RP RE
Sbjct: 224 LEKGERLPQPPICT-----------------------IDVYMIMVKCWMIDADSRPKFRE 260
Query: 543 VASELA 548
+ E +
Sbjct: 261 LIIEFS 266
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316 |
| >gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Score = 76.6 bits (189), Expect = 4e-15
Identities = 56/183 (30%), Positives = 81/183 (44%), Gaps = 15/183 (8%)
Query: 302 QAVKKSKVIDESKVEEFINEVVILSQIN---HRNVVKLLGCCLETEVPLLVYEFIPNGTL 358
+A+KK +I +VE + E I N H +V L C + V E+ G L
Sbjct: 30 KALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCFVMEYAAGGDL 89
Query: 359 FQYIHDQNEDFPITWEIRLRI-AIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAK 417
+IH + F E R A V L YLH I +RD+K N+LLD + K
Sbjct: 90 MMHIHT--DVFS---EPRAVFYAACVVLGLQYLHENK---IVYRDLKLDNLLLDTEGFVK 141
Query: 418 VSDFGASRS-MAVDQTHMTTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLTELLTGEK 476
++DFG + M T+ GT +L PE + +T D + GV++ E+L GE
Sbjct: 142 IADFGLCKEGMGFGDR--TSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGES 199
Query: 477 PIR 479
P
Sbjct: 200 PFP 202
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324 |
| >gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Score = 76.2 bits (187), Expect = 5e-15
Identities = 63/178 (35%), Positives = 87/178 (48%), Gaps = 13/178 (7%)
Query: 304 VKKSKVIDESKVEEFI--NEVVILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGTLFQY 361
V + K++ K ++ I V+L + H +V L TE V +F+ G LF
Sbjct: 27 VLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNGGELF-- 84
Query: 362 IHDQNE-DFPITWEIRLRI-AIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVS 419
H Q E FP E R R A E++ AL YLHS I I +RD+K NILLD + ++
Sbjct: 85 FHLQRERSFP---EPRARFYAAEIASALGYLHS---INIVYRDLKPENILLDSQGHVVLT 138
Query: 420 DFGASRSMAVDQTHMTTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLTELLTGEKP 477
DFG + + Q+ TT GT YL PE R + + D + G VL E+L G P
Sbjct: 139 DFGLCKE-GIAQSDTTTTFCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPP 195
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325 |
| >gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Score = 75.8 bits (186), Expect = 5e-15
Identities = 51/190 (26%), Positives = 93/190 (48%), Gaps = 19/190 (10%)
Query: 312 ESKVEEFINEVVILSQI-NHRNVVKLLGCCLETEVPLLVYEFIPNGTLFQYIH------- 363
E + + I+E+ ++ I H+N++ LLG C + ++ E+ G L +Y+
Sbjct: 64 EKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGM 123
Query: 364 ------DQNEDFPITWEIRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAK 417
Q + ++++ + A +V+ + YL S I HRD+ + N+L+ + K
Sbjct: 124 EYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASKKCI---HRDLAARNVLVTEDNVMK 180
Query: 418 VSDFGASRSMA-VDQTHMTTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLTELLT-GE 475
++DFG +R + +D TT ++ PE +T +SDV+SFGV+L E+ T G
Sbjct: 181 IADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGG 240
Query: 476 KPIRFTILEE 485
P +EE
Sbjct: 241 SPYPGVPVEE 250
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307 |
| >gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Score = 75.7 bits (186), Expect = 7e-15
Identities = 74/257 (28%), Positives = 112/257 (43%), Gaps = 39/257 (15%)
Query: 302 QAVKKSKVIDESKVEEFINEVVILSQINHRNVVKLLGCCLET-EVPLLVYEFIPNGTLFQ 360
+ +KK ++ + VE + E ILS + + L CC +T + V EF+ G L
Sbjct: 26 KVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVNGGDLMF 85
Query: 361 YIHDQNEDFPITWEIRLRI-AIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVS 419
+I ++ F E R R A E++ AL +LH I +RD+K N+LLD + K++
Sbjct: 86 HIQ-KSRRFD---EARARFYAAEITSALMFLHDKG---IIYRDLKLDNVLLDHEGHCKLA 138
Query: 420 DFGASRSMAVDQTHMTTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLTELLTGEKPIR 479
DFG + + T+ GT Y+ PE + + D ++ GV+L E+L G P
Sbjct: 139 DFGMCKE-GIFNGKTTSTFCGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFE 197
Query: 480 FTILEEDKSLAAYFLCAMKEERLFE-ILDARVMKQGGKDEIITVAKL---AKRCLNLNGK 535
A E+ LFE IL DE++ L A L
Sbjct: 198 ----------------AENEDDLFEAIL---------NDEVVYPTWLSQDAVDILKAFMT 232
Query: 536 KRPTMREVASELAGIKA 552
K PTMR + L G +A
Sbjct: 233 KNPTMRLGSLTLGGEEA 249
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320 |
| >gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Score = 75.0 bits (184), Expect = 8e-15
Identities = 61/244 (25%), Positives = 110/244 (45%), Gaps = 36/244 (14%)
Query: 317 EFINEVVILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGTLFQYIHDQNED-------F 369
EF+NE ++ +VV+LLG + + L+V E + +G L Y+ +
Sbjct: 55 EFLNEASVMKGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRP 114
Query: 370 PITWEIRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSM-A 428
P T + +++A E++ ++YL++ + HRD+ + N ++ + K+ DFG +R +
Sbjct: 115 PPTLQEMIQMAAEIADGMAYLNAKKFV---HRDLAARNCMVAHDFTVKIGDFGMTRDIYE 171
Query: 429 VDQTHMTTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLTELLT-GEKPIRFTILEEDK 487
D + ++ PE + FT SD++SFGVVL E+ + E+P +
Sbjct: 172 TDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQ-------- 223
Query: 488 SLAAYFLCAMKEERLFEILDARVMKQGGKDEIIT----VAKLAKRCLNLNGKKRPTMREV 543
+ E++ + VM G D+ V L + C N K RPT E+
Sbjct: 224 --------GLSNEQVLKF----VMDGGYLDQPDNCPERVTDLMRMCWQFNPKMRPTFLEI 271
Query: 544 ASEL 547
+ L
Sbjct: 272 VNLL 275
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 75.1 bits (184), Expect = 8e-15
Identities = 64/242 (26%), Positives = 110/242 (45%), Gaps = 24/242 (9%)
Query: 303 AVKKSKVIDESKVEEFINEVVILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGTLFQYI 362
A+K+ + + K E INE++++ + + N+V L L + +V E++ G+L +
Sbjct: 48 AIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVV 107
Query: 363 HDQNEDFPITWEIRLR-IAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDF 421
+ D E ++ + E AL +LHS I HRDIKS NILL K++DF
Sbjct: 108 TETCMD-----EGQIAAVCRECLQALDFLHSNQVI---HRDIKSDNILLGMDGSVKLTDF 159
Query: 422 GASRSMAVDQTHMTTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLTELLTGEKPIRFT 481
G + +Q+ +T V GT ++ PE + K D++S G++ E++ GE P
Sbjct: 160 GFCAQITPEQSKRSTMV-GTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPP---- 214
Query: 482 ILEEDKSLAAYFLCAMKEERLFEILDARVMKQGGKDEIITVAKLAKRCLNLNGKKRPTMR 541
L E+ A Y + L Q + RCL ++ +R + +
Sbjct: 215 YLNENPLRALYLIATNGTPEL----------QNPERLSAVFRDFLNRCLEMDVDRRGSAK 264
Query: 542 EV 543
E+
Sbjct: 265 EL 266
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 74.7 bits (183), Expect = 8e-15
Identities = 65/247 (26%), Positives = 112/247 (45%), Gaps = 21/247 (8%)
Query: 303 AVKKSKVID--ESKV-EEFINEVVILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGTLF 359
A+KK ++ D ++K + I E+ +L Q+NH NV+K +E +V E G L
Sbjct: 31 ALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVLELADAGDLS 90
Query: 360 QYI-HDQNEDFPITWEIRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKV 418
+ I H + + I + + +++ AL ++HS + HRDIK N+ + K+
Sbjct: 91 RMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSRR---VMHRDIKPANVFITATGVVKL 147
Query: 419 SDFGASRSMAVDQTHMTTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLTELLTGEKPI 478
D G R + T + V GT Y+ PE + + KSD++S G +L E+ + P
Sbjct: 148 GDLGLGRFFSSKTTAAHSLV-GTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSP- 205
Query: 479 RFTILEEDKSLAAYFLCAMKEERLFEILDARVMKQGGKDEIITVAKLAKRCLNLNGKKRP 538
DK + Y LC E+ + L + + + +L C+N + +KRP
Sbjct: 206 ----FYGDK-MNLYSLCKKIEQCDYPPLPSDHYSE-------ELRQLVNMCINPDPEKRP 253
Query: 539 TMREVAS 545
+ V
Sbjct: 254 DITYVYD 260
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Score = 74.9 bits (184), Expect = 9e-15
Identities = 63/255 (24%), Positives = 123/255 (48%), Gaps = 49/255 (19%)
Query: 317 EFINEVVILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGTLFQYI--HDQNEDFP---- 370
+F+ E+ I+S++ N+++LL C+ ++ ++ E++ NG L Q++ H+ E
Sbjct: 65 DFLKEIKIMSRLKDPNIIRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADV 124
Query: 371 --ITWEIRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSM- 427
I++ + +A +++ + YL +S+ HRD+ + N L+ Y K++DFG SR++
Sbjct: 125 VTISYSTLIFMATQIASGMKYL---SSLNFVHRDLATRNCLVGKNYTIKIADFGMSRNLY 181
Query: 428 AVDQTHMTTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLTELLTGEKPIRFTILEEDK 487
+ D + + ++ E +FT SDV++FGV L E+LT
Sbjct: 182 SGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILT-------------- 227
Query: 488 SLAAYFLCAMKEERLFEILDARVMKQGG---KDE------------IITVAKLAKRCLNL 532
LC KE+ ++ D +V++ G +D+ ++ KL C
Sbjct: 228 ------LC--KEQPYSQLSDEQVIENTGEFFRDQGRQVYLPKPALCPDSLYKLMLSCWRR 279
Query: 533 NGKKRPTMREVASEL 547
N K+RP+ +E+ + L
Sbjct: 280 NAKERPSFQEIHATL 294
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296 |
| >gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Score = 74.7 bits (183), Expect = 1e-14
Identities = 64/256 (25%), Positives = 111/256 (43%), Gaps = 44/256 (17%)
Query: 312 ESKVEEFINEVVILSQI-NHRNVVKLLGCCLETEVPLLVYEFIPNGTLFQYIHDQN--ED 368
E+ +F E+ +L ++ +H N++ LLG C + E+ P G L ++ E
Sbjct: 43 ENDHRDFAGELEVLCKLGHHPNIINLLGACENRGYLYIAIEYAPYGNLLDFLRKSRVLET 102
Query: 369 FP-----------ITWEIRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAK 417
P +T + L+ A +V+ + YL I HRD+ + N+L+ + +K
Sbjct: 103 DPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEKQFI---HRDLAARNVLVGENLASK 159
Query: 418 VSDFGASRSMAVDQTHMTTQVHGTFG-----YLDPEYFRSSQFTDKSDVYSFGVVLTELL 472
++DFG SR V V T G ++ E S +T KSDV+SFGV+L E++
Sbjct: 160 IADFGLSRGEEV-------YVKKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIV 212
Query: 473 TGEKPIRFTILEEDKSLAAYFLCAMKEERLFEILDARVMKQGGKDEIITVAKLAKRCLNL 532
SL C M L+E L + ++ V +L ++C
Sbjct: 213 ---------------SLGGTPYCGMTCAELYEKLPQGYRMEKPRNCDDEVYELMRQCWRD 257
Query: 533 NGKKRPTMREVASELA 548
+RP +++ +L+
Sbjct: 258 RPYERPPFAQISVQLS 273
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 74.4 bits (182), Expect = 1e-14
Identities = 66/249 (26%), Positives = 115/249 (46%), Gaps = 38/249 (15%)
Query: 303 AVKKSKVIDESKVEEFINEVVILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGTLFQYI 362
A+++ + + K E INE++++ + + N+V L L + +V E++ G+L +
Sbjct: 49 AIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVV 108
Query: 363 HDQNEDFPITWEIRLR-IAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDF 421
+ D E ++ + E AL +LHS I HRDIKS NILL K++DF
Sbjct: 109 TETCMD-----EGQIAAVCRECLQALEFLHSNQVI---HRDIKSDNILLGMDGSVKLTDF 160
Query: 422 GASRSMAVDQTHMTTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLTELLTGEKPIRFT 481
G + +Q+ +T V GT ++ PE + K D++S G++ E++ GE P
Sbjct: 161 GFCAQITPEQSKRSTMV-GTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPP---- 215
Query: 482 ILEEDKSLAAYFLCAMKEERLFEILDARVMKQGGKDEIITVAKLA-------KRCLNLNG 534
L E+ A Y + G E+ KL+ RCL+++
Sbjct: 216 YLNENPLRALYLIAT-----------------NGTPELQNPEKLSAIFRDFLNRCLDMDV 258
Query: 535 KKRPTMREV 543
+KR + +E+
Sbjct: 259 EKRGSAKEL 267
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Score = 74.6 bits (183), Expect = 2e-14
Identities = 61/226 (26%), Positives = 106/226 (46%), Gaps = 34/226 (15%)
Query: 290 NFDLNRILGQGG---------------------QAVKKSKVIDESKVEEFI-NEVVILSQ 327
NF+L ++LG G + ++K+ ++ ++K E E +L
Sbjct: 1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEH 60
Query: 328 INHRNVVKLLGCCLETEVPL-LVYEFIPNGTLFQYIHDQNEDFPITWEIRLRIAI-EVSG 385
+ + L +TE L L+ +++ G +F +++ Q ++F E +R E+
Sbjct: 61 VRQSPFLVTLHYAFQTEAKLHLILDYVSGGEMFTHLY-QRDNFS---EDEVRFYSGEIIL 116
Query: 386 ALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHGTFGYL 445
AL +LH + I +RDIK NILLD + ++DFG S+ ++ T GT Y+
Sbjct: 117 ALEHLHK---LGIVYRDIKLENILLDSEGHVVLTDFGLSKEFLSEEKERTYSFCGTIEYM 173
Query: 446 DPEYFRSSQFTDKS-DVYSFGVVLTELLTGEKPIRFTILEEDKSLA 490
PE R K+ D +S G+++ ELLTG P FT+ E + +
Sbjct: 174 APEIIRGKGGHGKAVDWWSLGILIFELLTGASP--FTLEGERNTQS 217
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332 |
| >gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Score = 73.6 bits (181), Expect = 2e-14
Identities = 49/188 (26%), Positives = 94/188 (50%), Gaps = 16/188 (8%)
Query: 302 QAVKKSKVID---ESKVEEFINEVVILSQINHRNVVKLLGCCLE-TEVPLLVYEFIPNGT 357
+ V V D E +V + E +L ++H+N++ +L C+E E P ++Y ++ G
Sbjct: 36 EEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILHVCIEDGEPPFVLYPYMNWGN 95
Query: 358 LFQYIHDQNEDFPITWEIRLR------IAIEVSGALSYLHSAASIPIYHRDIKSTNILLD 411
L ++ Q L +AI+++ +SYLH + H+DI + N ++D
Sbjct: 96 LKLFLQ-QCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKRG---VIHKDIAARNCVID 151
Query: 412 DKYRAKVSDFGASRSMAVDQTH-MTTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLTE 470
++ + K++D SR + H + + ++ E + +++ SDV+SFGV+L E
Sbjct: 152 EELQVKITDNALSRDLFPMDYHCLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWE 211
Query: 471 LLT-GEKP 477
L+T G+ P
Sbjct: 212 LMTLGQTP 219
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280 |
| >gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Score = 73.4 bits (180), Expect = 2e-14
Identities = 62/239 (25%), Positives = 106/239 (44%), Gaps = 31/239 (12%)
Query: 296 ILGQGGQAVKKSKVI-----DESKVEE---FINEVVILSQINHRNVVKLLGCCLETEVPL 347
+LG+ + + K++V+ + +E F+ EV ++NH NV++ LG C+E+ L
Sbjct: 12 LLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYL 71
Query: 348 LVYEFIPNGTLFQYIHDQNEDFPITWEIRL--RIAIEVSGALSYLHSAASIPIYHRDIKS 405
LV EF P G L Y+ + + R+A EV+ L +LH A I H D+
Sbjct: 72 LVLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQADFI---HSDLAL 128
Query: 406 TNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHGT-FGYLDPEYFRSSQ-------FTD 457
N L K+ D+G + + ++T H +L PE T
Sbjct: 129 RNCQLTADLSVKIGDYGLALEQYPEDYYITKDCHAVPLRWLAPELVEIRGQDLLPKDQTK 188
Query: 458 KSDVYSFGVVLTELLT-GEKP---------IRFTILEEDKSLAAYFLCAMKEERLFEIL 506
KS+++S GV + EL T ++P ++ + E+D L L +R +E++
Sbjct: 189 KSNIWSLGVTMWELFTAADQPYPDLSDEQVLKQVVREQDIKLPKPQLDLKYSDRWYEVM 247
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269 |
| >gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Score = 73.2 bits (179), Expect = 2e-14
Identities = 43/162 (26%), Positives = 83/162 (51%), Gaps = 13/162 (8%)
Query: 316 EEFINEVVILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEI 375
E F+ E ++ ++ H +V+L E + +V E++ G+L ++ + + +
Sbjct: 46 EAFLQEAQVMKKLRHEKLVQLYAVVSEEPI-YIVTEYMSKGSLLDFLKGEMGKY-----L 99
Query: 376 RL----RIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQ 431
RL +A +++ ++Y+ + HRD+++ NIL+ + KV+DFG +R + ++
Sbjct: 100 RLPQLVDMAAQIASGMAYVERMNYV---HRDLRAANILVGENLVCKVADFGLARLIEDNE 156
Query: 432 THMTTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLTELLT 473
+ PE +FT KSDV+SFG++LTEL T
Sbjct: 157 YTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTT 198
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 73.2 bits (180), Expect = 2e-14
Identities = 55/185 (29%), Positives = 89/185 (48%), Gaps = 21/185 (11%)
Query: 303 AVKKSKVIDESKVEEFINEVVILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGTLFQYI 362
A K ++ E ++E+F+ E+ ILS+ H N+V L ++ EF G L +
Sbjct: 34 AAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYFYENKLWILIEFCDGGALDSIM 93
Query: 363 ----HDQNEDFPITWEIRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKV 418
E +IR + ++ AL++LHS I HRD+K+ NILL K+
Sbjct: 94 LELERGLTEP-----QIRY-VCRQMLEALNFLHSHKVI---HRDLKAGNILLTLDGDVKL 144
Query: 419 SDFGAS-RSMAVDQTHMTTQVHGTFGYLDPEY-----FRSSQFTDKSDVYSFGVVLTELL 472
+DFG S ++ + Q T GT ++ PE F+ + + K+D++S G+ L EL
Sbjct: 145 ADFGVSAKNKSTLQKRDT--FIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELA 202
Query: 473 TGEKP 477
E P
Sbjct: 203 QMEPP 207
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 73.1 bits (179), Expect = 3e-14
Identities = 56/183 (30%), Positives = 89/183 (48%), Gaps = 17/183 (9%)
Query: 321 EVVILSQINHRNVVKLLGCCLE-TEVPLLVY-EFIPNGTLFQYIHDQNEDF-PITWEIRL 377
E+ +L + H +V+ GC + E L ++ E++P G+ I DQ + + +T +
Sbjct: 54 EIQLLKNLRHDRIVQYYGCLRDPEEKKLSIFVEYMPGGS----IKDQLKAYGALTENVTR 109
Query: 378 RIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMT-- 435
R ++ +SYLHS I HRDIK NIL D K+ DFGAS+ + T
Sbjct: 110 RYTRQILQGVSYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKRIQTICMSGTGI 166
Query: 436 TQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLTELLTGEKPIRFTILEEDKSLAAYFLC 495
V GT ++ PE + K+DV+S + E+LT + P E +++AA F
Sbjct: 167 KSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPP-----WAEYEAMAAIFKI 221
Query: 496 AMK 498
A +
Sbjct: 222 ATQ 224
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264 |
| >gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 73.5 bits (180), Expect = 3e-14
Identities = 61/240 (25%), Positives = 108/240 (45%), Gaps = 42/240 (17%)
Query: 285 EKATDNFDLNRILGQG--GQAVKKSKV-IDESKVEE--------------------FINE 321
E + D L + LG+G GQ V + ID+ K +E ++E
Sbjct: 11 EFSRDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSE 70
Query: 322 VVILSQI-NHRNVVKLLGCCLETEVPLLVYEFIPNGTLFQYIHDQN-------------E 367
+ ++ I H+N++ LLG C + ++ E+ G L +Y+ +
Sbjct: 71 MEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVP 130
Query: 368 DFPITWEIRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSM 427
D +T++ + +V+ + YL S I HRD+ + N+L+ + K++DFG +R +
Sbjct: 131 DEQMTFKDLVSCTYQVARGMEYLASQKCI---HRDLAARNVLVTENNVMKIADFGLARDV 187
Query: 428 -AVDQTHMTTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLTELLT-GEKPIRFTILEE 485
+D TT ++ PE +T +SDV+SFGV++ E+ T G P +EE
Sbjct: 188 NNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEE 247
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 72.7 bits (178), Expect = 3e-14
Identities = 37/159 (23%), Positives = 79/159 (49%), Gaps = 4/159 (2%)
Query: 315 VEEFINEVVILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWE 374
V+ F+ E ++ + H +V+L + E ++ E++ G+L ++ E +
Sbjct: 45 VQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIYIITEYMAKGSLLDFLKSD-EGGKVLLP 103
Query: 375 IRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHM 434
+ + +++ ++Y+ I HRD+++ N+L+ + K++DFG +R + ++
Sbjct: 104 KLIDFSAQIAEGMAYIERKNYI---HRDLRAANVLVSESLMCKIADFGLARVIEDNEYTA 160
Query: 435 TTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLTELLT 473
+ PE FT KSDV+SFG++L E++T
Sbjct: 161 REGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVT 199
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Score = 72.6 bits (178), Expect = 3e-14
Identities = 50/163 (30%), Positives = 78/163 (47%), Gaps = 15/163 (9%)
Query: 316 EEFINEVVILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGTLFQYIHDQN-----EDFP 370
EE EV +LS + H N+V+ E +V ++ G L++ I+ Q ED
Sbjct: 44 EESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVMDYCEGGDLYKKINAQRGVLFPEDQI 103
Query: 371 ITWEIRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVD 430
+ W +++ +A L ++H I HRDIKS NI L K+ DFG +R +
Sbjct: 104 LDWFVQICLA------LKHVHDRK---ILHRDIKSQNIFLTKDGTIKLGDFGIARVLN-S 153
Query: 431 QTHMTTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLTELLT 473
+ GT YL PE + + +KSD+++ G VL E+ T
Sbjct: 154 TVELARTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCT 196
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256 |
| >gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 72.7 bits (178), Expect = 6e-14
Identities = 57/177 (32%), Positives = 82/177 (46%), Gaps = 9/177 (5%)
Query: 302 QAVKKSKVIDESKVEEFINEVVILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGTLFQY 361
+ ++K+ ++ S+V + E +L+Q+N +V L E LV FI G LF
Sbjct: 24 KTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGELFH- 82
Query: 362 IHDQNEDFPITWEIRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDF 421
H Q E R A E+ AL LH + +RD+K NILLD + + DF
Sbjct: 83 -HLQREGRFDLSRARFYTA-ELLCALENLHK---FNVIYRDLKPENILLDYQGHIALCDF 137
Query: 422 GASR-SMAVDQTHMTTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLTELLTGEKP 477
G + +M D T GT YL PE +T D ++ GV+L E+LTG P
Sbjct: 138 GLCKLNMKDDDK--TNTFCGTPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPP 192
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312 |
| >gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Score = 71.6 bits (175), Expect = 7e-14
Identities = 44/158 (27%), Positives = 83/158 (52%), Gaps = 5/158 (3%)
Query: 316 EEFINEVVILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEI 375
E F+ E I+ ++ H +V L E + +V EF+ G+L ++ + + + +
Sbjct: 46 EAFLQEAQIMKKLRHDKLVPLYAVVSEEPI-YIVTEFMGKGSLLDFLKEGDGKY-LKLPQ 103
Query: 376 RLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMT 435
+ +A +++ ++Y+ I HRD+++ NIL+ D K++DFG +R + ++
Sbjct: 104 LVDMAAQIADGMAYIERMNYI---HRDLRAANILVGDNLVCKIADFGLARLIEDNEYTAR 160
Query: 436 TQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLTELLT 473
+ PE +FT KSDV+SFG++LTEL+T
Sbjct: 161 QGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVT 198
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260 |
| >gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Score = 72.0 bits (176), Expect = 8e-14
Identities = 68/210 (32%), Positives = 98/210 (46%), Gaps = 30/210 (14%)
Query: 291 FDLNRILGQGG---------------QAVKK--SKVIDESKVEEF-INEVVILSQINHRN 332
F R+LG+GG A KK K I + K E +NE IL ++N R
Sbjct: 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRF 61
Query: 333 VVKLLGCCLETEVPL-LVYEFIPNGTL-FQYIHDQNEDFPITWEIR-LRIAIEVSGALSY 389
VV L ET+ L LV + G L F H F E R + A E+ L
Sbjct: 62 VVSL-AYAYETKDALCLVLTLMNGGDLKFHIYHMGEAGFE---EGRAVFYAAEICCGLED 117
Query: 390 LHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHGTFGYLDPEY 449
LH I +RD+K NILLDD ++SD G + + QT + +V GT GY+ PE
Sbjct: 118 LHQER---IVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQT-IKGRV-GTVGYMAPEV 172
Query: 450 FRSSQFTDKSDVYSFGVVLTELLTGEKPIR 479
++ ++T D ++ G +L E++ G+ P +
Sbjct: 173 VKNERYTFSPDWWALGCLLYEMIAGQSPFQ 202
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 72.9 bits (179), Expect = 8e-14
Identities = 57/189 (30%), Positives = 86/189 (45%), Gaps = 40/189 (21%)
Query: 308 KVI----DESKVEEFINEVVILSQINHRNVVKLLGCCLET-----EVPLLVYEFIPNGTL 358
KVI +++ + E+ IL +NH NVVK C + E+ +L+ EF+ G+L
Sbjct: 105 KVIYGNHEDTVRRQICREIEILRDVNHPNVVK----CHDMFDHNGEIQVLL-EFMDGGSL 159
Query: 359 FQYIHDQNEDFPITWEIRLR-IAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAK 417
E I E L +A ++ ++YLH I HRDIK +N+L++ K
Sbjct: 160 --------EGTHIADEQFLADVARQILSGIAYLHRRH---IVHRDIKPSNLLINSAKNVK 208
Query: 418 VSDFGASRSMAVDQTHMTTQVHGTFGYLDPEYFRSSQFTD---------KSDVYSFGVVL 468
++DFG SR +A + V GT Y+ PE TD D++S GV +
Sbjct: 209 IADFGVSRILAQTMDPCNSSV-GTIAYMSPERIN----TDLNHGAYDGYAGDIWSLGVSI 263
Query: 469 TELLTGEKP 477
E G P
Sbjct: 264 LEFYLGRFP 272
|
Length = 353 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 72.4 bits (178), Expect = 8e-14
Identities = 46/162 (28%), Positives = 81/162 (50%), Gaps = 14/162 (8%)
Query: 319 INEVVILSQINHRNVVKLL----GCCLETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWE 374
+ E+ +L + H N+V+L G L++ LV E+ L + + F + +
Sbjct: 54 LREITLLLNLRHPNIVELKEVVVGKHLDS--IFLVMEYCEQ-DLASLLDNMPTPFSES-Q 109
Query: 375 IRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHM 434
++ + +++ L YLH I HRD+K +N+LL DK K++DFG +R+ + M
Sbjct: 110 VKC-LMLQLLRGLQYLHENF---IIHRDLKVSNLLLTDKGCLKIADFGLARTYGLPAKPM 165
Query: 435 TTQVHGTFGYLDPE-YFRSSQFTDKSDVYSFGVVLTELLTGE 475
T +V T Y PE + +T D+++ G +L ELL +
Sbjct: 166 TPKVV-TLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHK 206
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Score = 72.9 bits (179), Expect = 9e-14
Identities = 65/220 (29%), Positives = 99/220 (45%), Gaps = 33/220 (15%)
Query: 282 KELEKATDNFDLNRILGQGG----QAVK--------------KSKVIDESKVEEFINEVV 323
+L ++FD+ +++G+G Q V+ K ++I S F E
Sbjct: 36 TKLRMKAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERD 95
Query: 324 ILSQINHRNVVKLLGCCLETEVPL-LVYEFIPNGTLFQYIHDQNEDFPITWEIRLRIAIE 382
I++ N +V+L + + L +V E++P G L + N D P W R A E
Sbjct: 96 IMAHANSEWIVQLH-YAFQDDKYLYMVMEYMPGGDLVNLM--SNYDIPEKWA-RFYTA-E 150
Query: 383 VSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVD-QTHMTTQVHGT 441
V AL +HS I HRD+K N+LLD K++DFG M + T V GT
Sbjct: 151 VVLALDAIHSMGFI---HRDVKPDNMLLDKSGHLKLADFGTCMKMDANGMVRCDTAV-GT 206
Query: 442 FGYLDPEYFRS----SQFTDKSDVYSFGVVLTELLTGEKP 477
Y+ PE +S + + D +S GV L E+L G+ P
Sbjct: 207 PDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTP 246
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370 |
| >gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Score = 72.4 bits (177), Expect = 1e-13
Identities = 66/222 (29%), Positives = 105/222 (47%), Gaps = 37/222 (16%)
Query: 282 KELEKATDNFDLNRILGQGG------------------QAVKKSKVIDESKVEEFINEVV 323
++L+ +++D+ +++G+G + + K ++I S F E
Sbjct: 36 RKLQMKAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERD 95
Query: 324 ILSQINHRNVVKLLGCCLETEVPL-LVYEFIPNGTLFQYIHDQNEDFPITWEIRLRIAIE 382
I++ N VV+L C + + L +V E++P G L + N D P W + A E
Sbjct: 96 IMAFANSPWVVQLF-CAFQDDKYLYMVMEYMPGGDLVNLM--SNYDVPEKWA-KFYTA-E 150
Query: 383 VSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMT---TQVH 439
V AL +HS I HRD+K N+LLD K++DFG M +D+T M T V
Sbjct: 151 VVLALDAIHSMGLI---HRDVKPDNMLLDKHGHLKLADFGT--CMKMDETGMVRCDTAV- 204
Query: 440 GTFGYLDPEYFRSS----QFTDKSDVYSFGVVLTELLTGEKP 477
GT Y+ PE +S + + D +S GV L E+L G+ P
Sbjct: 205 GTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTP 246
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370 |
| >gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Score = 71.1 bits (174), Expect = 1e-13
Identities = 55/236 (23%), Positives = 109/236 (46%), Gaps = 28/236 (11%)
Query: 316 EEFINEVVILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEI 375
+E + ++ + ++H +V+LLG C + L V + P G+L ++ Q+ D + +
Sbjct: 54 QEITDHMLAMGSLDHAYIVRLLGICPGASLQL-VTQLSPLGSLLDHVR-QHRD-SLDPQR 110
Query: 376 RLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFG-ASRSMAVDQTHM 434
L ++++ + YL + HR++ + NILL +++DFG A D+ +
Sbjct: 111 LLNWCVQIAKGMYYLEEHRMV---HRNLAARNILLKSDSIVQIADFGVADLLYPDDKKYF 167
Query: 435 TTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLTELLT-GEKPIRFTILEEDKSLAAYF 493
++ ++ E ++T +SDV+S+GV + E+++ G +P E L
Sbjct: 168 YSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPHEVPDLLE-- 225
Query: 494 LCAMKEERLFEILDARVMKQGGKDEIIT--VAKLAKRCLNLNGKKRPTMREVASEL 547
K ERL + +I T V + +C ++ RPT +E+A+E
Sbjct: 226 ----KGERL------------AQPQICTIDVYMVMVKCWMIDENVRPTFKELANEF 265
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 71.4 bits (176), Expect = 1e-13
Identities = 55/182 (30%), Positives = 92/182 (50%), Gaps = 17/182 (9%)
Query: 303 AVKKSKVIDESKVEEFIN--EVVILSQIN-HRNVVKLLGCCLETEVPLLVYEFIPNGTLF 359
A+KK K S EE +N EV L ++N H N+VKL E + V+E++ G L+
Sbjct: 28 AIKKMKKKFYS-WEECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVFEYM-EGNLY 85
Query: 360 QYIHDQNED-FPITWEIRLR-IAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAK 417
Q + D+ F E +R I ++ L+++H +HRD+K N+L+ K
Sbjct: 86 QLMKDRKGKPFS---ESVIRSIIYQILQGLAHIHKHG---FFHRDLKPENLLVSGPEVVK 139
Query: 418 VSDFGASRSMAVDQTHMTTQVHGTFGYLDPEYF-RSSQFTDKSDVYSFGVVLTELLTGEK 476
++DFG +R + + T V T Y PE RS+ ++ D+++ G ++ EL T +
Sbjct: 140 IADFGLAREI-RSRPPYTDYV-STRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTL-R 196
Query: 477 PI 478
P+
Sbjct: 197 PL 198
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 71.9 bits (176), Expect = 1e-13
Identities = 54/179 (30%), Positives = 88/179 (49%), Gaps = 12/179 (6%)
Query: 302 QAVKKSKVIDESKVEEFINEVVILSQINHRNVVKLLGCCLETEVPLL-VYEFIPNGTLFQ 360
+A+KK V+ + VE + E +L+ + L C +T+ L V EF+ G L
Sbjct: 26 KALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLNGGDLMF 85
Query: 361 YIHDQN--EDFPITWEIRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKV 418
+I D+ + + T+ A E+ L +LHS I +RD+K N++LD K+
Sbjct: 86 HIQDKGRFDLYRATF-----YAAEIVCGLQFLHSKGII---YRDLKLDNVMLDRDGHIKI 137
Query: 419 SDFGASRSMAVDQTHMTTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLTELLTGEKP 477
+DFG + +T GT Y+ PE + ++T D +SFGV+L E+L G+ P
Sbjct: 138 ADFGMCKENVFGDNRAST-FCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSP 195
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Score = 72.0 bits (176), Expect = 1e-13
Identities = 48/162 (29%), Positives = 79/162 (48%), Gaps = 8/162 (4%)
Query: 317 EFINEVVILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEIR 376
+ I E+ +L + N +V G + E + G+L Q + + I EI
Sbjct: 49 QIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKEAKR---IPEEIL 105
Query: 377 LRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTT 436
+++I V L+YL I HRD+K +NIL++ + K+ DFG S + +D M
Sbjct: 106 GKVSIAVLRGLAYLREKHQI--MHRDVKPSNILVNSRGEIKLCDFGVSGQL-IDS--MAN 160
Query: 437 QVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLTELLTGEKPI 478
GT Y+ PE + + ++ +SD++S G+ L EL G PI
Sbjct: 161 SFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPI 202
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331 |
| >gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Score = 71.2 bits (174), Expect = 2e-13
Identities = 70/267 (26%), Positives = 114/267 (42%), Gaps = 49/267 (18%)
Query: 303 AVKKSK-VIDESKVEEFINEVVILSQIN-HRNVVKLLGCCLETEVPLLVYEFIPNGTLFQ 360
A+K+ K + +F E+ +L ++ H N++ LLG C L E+ P+G L
Sbjct: 38 AIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLD 97
Query: 361 YIH-----DQNEDFPI--------TWEIRLRIAIEVSGALSYLHSAASIPIYHRDIKSTN 407
++ + + F I + + L A +V+ + YL I HRD+ + N
Sbjct: 98 FLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFI---HRDLAARN 154
Query: 408 ILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHGTFG-----YLDPEYFRSSQFTDKSDVY 462
IL+ + Y AK++DFG SR V V T G ++ E S +T SDV+
Sbjct: 155 ILVGENYVAKIADFGLSRGQEV-------YVKKTMGRLPVRWMAIESLNYSVYTTNSDVW 207
Query: 463 SFGVVLTELLTGEKPIRFTILEEDKSLAAYFLCAMKEERLFEILDA--RVMKQGGKDEII 520
S+GV+L E++ SL C M L+E L R+ K D+
Sbjct: 208 SYGVLLWEIV---------------SLGGTPYCGMTCAELYEKLPQGYRLEKPLNCDD-- 250
Query: 521 TVAKLAKRCLNLNGKKRPTMREVASEL 547
V L ++C +RP+ ++ L
Sbjct: 251 EVYDLMRQCWREKPYERPSFAQILVSL 277
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 71.8 bits (176), Expect = 2e-13
Identities = 50/174 (28%), Positives = 84/174 (48%), Gaps = 10/174 (5%)
Query: 304 VKKSKVIDESKVEEFINEVVILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGTLFQYIH 363
+KK +++ +V+ E IL +++H +V ++ + + EF+ G LF ++
Sbjct: 51 LKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENRVYFLLEFVVGGELFTHLR 110
Query: 364 DQNEDFPITWEIRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGA 423
FP ++ E+ A YLHS I +RD+K N+LLD+K KV+DFG
Sbjct: 111 KAGR-FPN--DVAKFYHAELVLAFEYLHSKD---IIYRDLKPENLLLDNKGHVKVTDFGF 164
Query: 424 SRSMAVDQTHMTTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLTELLTGEKP 477
++ + T + GT YL PE +S D ++ GV+L E + G P
Sbjct: 165 AKKV----PDRTFTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPP 214
|
Length = 329 |
| >gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Score = 71.4 bits (175), Expect = 2e-13
Identities = 53/157 (33%), Positives = 76/157 (48%), Gaps = 11/157 (7%)
Query: 323 VILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGTLFQYIHDQNED-FPITWEIRLRI-A 380
V+L + H +V L + V +++ G LF H Q E FP E R R A
Sbjct: 48 VLLKNVKHPFLVGLHYSFQTADKLYFVLDYVNGGELF--FHLQRERSFP---EPRARFYA 102
Query: 381 IEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHG 440
E++ AL YLHS + I +RD+K NILLD + ++DFG + ++ + T+ G
Sbjct: 103 AEIASALGYLHS---LNIIYRDLKPENILLDSQGHVVLTDFGLCKE-GIEHSKTTSTFCG 158
Query: 441 TFGYLDPEYFRSSQFTDKSDVYSFGVVLTELLTGEKP 477
T YL PE R + D + G VL E+L G P
Sbjct: 159 TPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPP 195
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323 |
| >gnl|CDD|222467 pfam13947, GUB_WAK_bind, Wall-associated receptor kinase galacturonan-binding | Back alignment and domain information |
|---|
Score = 66.1 bits (162), Expect = 2e-13
Identities = 20/30 (66%), Positives = 22/30 (73%)
Query: 6 CPDRCGDVGIQYPFGIGAGCYFDESFEVVC 35
CPDRCG+V I YPFGIG GC D FE+ C
Sbjct: 4 CPDRCGNVSIPYPFGIGPGCARDPGFELTC 33
|
This cysteine-rich GUB_WAK_bind domain is the extracellular part of this serine/threonine kinase that binds to the cell-wall pectins. Length = 106 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 71.0 bits (174), Expect = 2e-13
Identities = 55/186 (29%), Positives = 89/186 (47%), Gaps = 25/186 (13%)
Query: 303 AVKKSKVIDESKVEEF---INEVVILSQINHRNVVKLLGCCLETEVPLLVYEF-IPNGTL 358
A+KK + E++ I EV L Q+ H N ++ GC L LV E+ + + +
Sbjct: 44 AIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTAWLVMEYCLGSASD 103
Query: 359 FQYIHDQNEDFPITWEIRLRIAIEVSGAL---SYLHSAASIPIYHRDIKSTNILLDDKYR 415
+H + P+ + IA GAL +YLHS I HRDIK+ NILL +
Sbjct: 104 ILEVHKK----PLQ---EVEIAAICHGALQGLAYLHSHERI---HRDIKAGNILLTEPGT 153
Query: 416 AKVSDFGASRSMAVDQTHMTTQVHGTFGYLDPEYFRS---SQFTDKSDVYSFGVVLTELL 472
K++DFG++ ++ + + GT ++ PE + Q+ K DV+S G+ EL
Sbjct: 154 VKLADFGSASLVSPANSFV-----GTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELA 208
Query: 473 TGEKPI 478
+ P+
Sbjct: 209 ERKPPL 214
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 70.1 bits (171), Expect = 3e-13
Identities = 64/256 (25%), Positives = 105/256 (41%), Gaps = 44/256 (17%)
Query: 312 ESKVEEFINEVVILSQINHR-NVVKLLGCCLETEVPLLVYEFIPNGTLFQYIHDQN--ED 368
+ +F E+ +L ++ H N++ LLG C L E+ P+G L ++ E
Sbjct: 36 KDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLET 95
Query: 369 FP-----------ITWEIRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAK 417
P ++ + L A +V+ + YL I HRD+ + NIL+ + Y AK
Sbjct: 96 DPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFI---HRDLAARNILVGENYVAK 152
Query: 418 VSDFGASRSMAVDQTHMTTQVHGTFG-----YLDPEYFRSSQFTDKSDVYSFGVVLTELL 472
++DFG SR V V T G ++ E S +T SDV+S+GV+L E++
Sbjct: 153 IADFGLSRGQEV-------YVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIV 205
Query: 473 TGEKPIRFTILEEDKSLAAYFLCAMKEERLFEILDARVMKQGGKDEIITVAKLAKRCLNL 532
SL C M L+E L + + V L ++C
Sbjct: 206 ---------------SLGGTPYCGMTCAELYEKLPQGYRLEKPLNCDDEVYDLMRQCWRE 250
Query: 533 NGKKRPTMREVASELA 548
+RP+ ++ L
Sbjct: 251 KPYERPSFAQILVSLN 266
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 70.1 bits (171), Expect = 3e-13
Identities = 49/179 (27%), Positives = 86/179 (48%), Gaps = 8/179 (4%)
Query: 303 AVKKSKV---IDESKVEEFINEVVILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGTLF 359
A+KK ++ +D ++ + E+ +L Q+NH NV+K L +E +V E G L
Sbjct: 31 ALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNIVLELADAGDLS 90
Query: 360 QYI-HDQNEDFPITWEIRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKV 418
Q I + + + I + +++ A+ ++HS + HRDIK N+ + K+
Sbjct: 91 QMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSRR---VMHRDIKPANVFITATGVVKL 147
Query: 419 SDFGASRSMAVDQTHMTTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLTELLTGEKP 477
D G R + T + V GT Y+ PE + + KSD++S G +L E+ + P
Sbjct: 148 GDLGLGRFFSSKTTAAHSLV-GTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSP 205
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 70.8 bits (174), Expect = 3e-13
Identities = 63/236 (26%), Positives = 100/236 (42%), Gaps = 54/236 (22%)
Query: 289 DNFDLNRILGQGGQA------------------VKKSKVIDESKVEEFINEVVILSQINH 330
D+F++ +++G+G ++KS +I +++ E IL+ +
Sbjct: 1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADS 60
Query: 331 RNVVKLLGCCLETEVPL-LVYEFIPNGTLFQYIHDQNEDFPITWEIRLRIAIEVSGALSY 389
+VKL + E L LV E++P G L + ++ FP R IA E+ AL
Sbjct: 61 PWIVKLY-YSFQDEEHLYLVMEYMPGGDLMNLLIRKD-VFPEET-ARFYIA-ELVLALDS 116
Query: 390 LHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSM--AVDQTHMTTQVH-------- 439
+H I HRDIK NIL+D K++DFG + M A D+ + H
Sbjct: 117 VHKLGFI---HRDIKPDNILIDADGHIKLADFGLCKKMNKAKDREYYLNDSHNLLFRDNV 173
Query: 440 ------------------GTFGYLDPEYFRSSQFTDKSDVYSFGVVLTELLTGEKP 477
GT Y+ PE R + + + D +S GV+L E+L G P
Sbjct: 174 LVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPP 229
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350 |
| >gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Score = 70.2 bits (172), Expect = 4e-13
Identities = 41/123 (33%), Positives = 62/123 (50%), Gaps = 10/123 (8%)
Query: 378 RIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQ 437
+I+I V L+YL I HRD+K +NIL++ + K+ DFG S +D M
Sbjct: 103 KISIAVLRGLTYLREKHKI--MHRDVKPSNILVNSRGEIKLCDFGVS-GQLIDS--MANS 157
Query: 438 VHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLTELLTGEKPIRFTILEEDKS-LAAYFLCA 496
GT Y+ PE + + +T +SD++S G+ L E+ G R+ I D L A F
Sbjct: 158 FVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIG----RYPIPPPDAKELEAMFGRP 213
Query: 497 MKE 499
+ E
Sbjct: 214 VSE 216
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 69.6 bits (171), Expect = 4e-13
Identities = 64/227 (28%), Positives = 93/227 (40%), Gaps = 43/227 (18%)
Query: 284 LEKATDNFDLNRILGQG-------------GQ--AVKKSKVIDESKVEEFINEVVILSQI 328
L T F+L ++G+G GQ A+K +I++ + EE E IL +
Sbjct: 1 LPDPTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIEDEE-EEIKEEYNILRKY 59
Query: 329 -NHRNVVKLLGCCLETEVPL------LVYEFIPNGT---LFQYIHDQNEDFPITWEIRLR 378
NH N+ G ++ P LV E G+ L + + + + W
Sbjct: 60 SNHPNIATFYGAFIKKNPPGNDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEW----- 114
Query: 379 IAI---EVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMT 435
IA E L+YLH I HRDIK NILL K+ DFG S +
Sbjct: 115 IAYILRETLRGLAYLHENKVI---HRDIKGQNILLTKNAEVKLVDFGVSAQLDSTLGRRN 171
Query: 436 TQVHGTFGYLDPEYFRSSQFTD-----KSDVYSFGVVLTELLTGEKP 477
T + GT ++ PE + D +SDV+S G+ EL G+ P
Sbjct: 172 TFI-GTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPP 217
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 70.2 bits (172), Expect = 4e-13
Identities = 53/178 (29%), Positives = 86/178 (48%), Gaps = 10/178 (5%)
Query: 302 QAVKKSKVIDESKVEEFINEVVILSQINHRNVVKLLGCCLETEVPLL-VYEFIPNGTLFQ 360
+A+KK V+++ VE + E +L+ + L C +T+ L V E++ G L
Sbjct: 26 KALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLNGGDLMF 85
Query: 361 YIHDQNEDFPITWEIRLRI-AIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVS 419
+I F E R R A E+ L +LH I +RD+K N+LLD K++
Sbjct: 86 HIQSSGR-FD---EARARFYAAEIICGLQFLHKKGII---YRDLKLDNVLLDKDGHIKIA 138
Query: 420 DFGASRSMAVDQTHMTTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLTELLTGEKP 477
DFG + + + GT Y+ PE + ++ + D +SFGV+L E+L G+ P
Sbjct: 139 DFGMCKENMNGEG-KASTFCGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSP 195
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 69.5 bits (170), Expect = 5e-13
Identities = 53/204 (25%), Positives = 88/204 (43%), Gaps = 28/204 (13%)
Query: 277 KLFTSKELEKATDNFDLNRILGQGGQAVKKSKVIDESKVEEFINEVVILSQINHRNVVKL 336
K++ K+L+K R+ + G+ + +NE IL +++ R +V L
Sbjct: 19 KMYACKKLDK-------KRLKKRKGEQMA-------------LNEKKILEKVSSRFIVSL 58
Query: 337 LGCCLETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEIRLRI-AIEVSGALSYLHSAAS 395
ET+ L + + NG +Y H N P E R A ++ L +LH
Sbjct: 59 -AYAFETKDDLCLVMTLMNGGDLKY-HIYNVGEPGFPEARAIFYAAQIICGLEHLHQRR- 115
Query: 396 IPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHGTFGYLDPEYFRSSQF 455
I +RD+K N+LLDD ++SD G + + + GT GY+ PE + +
Sbjct: 116 --IVYRDLKPENVLLDDHGNVRISDLGLAVELKGGKK--IKGRAGTPGYMAPEVLQGEVY 171
Query: 456 TDKSDVYSFGVVLTELLTGEKPIR 479
D ++ G L E++ G P R
Sbjct: 172 DFSVDWFALGCTLYEMIAGRSPFR 195
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 69.5 bits (170), Expect = 5e-13
Identities = 67/210 (31%), Positives = 101/210 (48%), Gaps = 30/210 (14%)
Query: 291 FDLNRILGQGG---------------QAVKK--SKVIDESKVEEF-INEVVILSQINHRN 332
F R+LG+GG A KK K I + K E +NE IL ++N R
Sbjct: 2 FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRF 61
Query: 333 VVKLLGCCLETEVPL-LVYEFIPNGTLFQYIHDQ-NEDFPITWEIR-LRIAIEVSGALSY 389
VV L ET+ L LV + G L +I++ N F E R + A E++ L
Sbjct: 62 VVSL-AYAYETKDALCLVLTLMNGGDLKFHIYNMGNPGFD---EERAVFYAAEITCGLED 117
Query: 390 LHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHGTFGYLDPEY 449
LH I +RD+K NILLDD ++SD G + + +T + +V GT GY+ PE
Sbjct: 118 LHRER---IVYRDLKPENILLDDYGHIRISDLGLAVEIPEGET-IRGRV-GTVGYMAPEV 172
Query: 450 FRSSQFTDKSDVYSFGVVLTELLTGEKPIR 479
++ ++T D + G ++ E++ G+ P R
Sbjct: 173 VKNERYTFSPDWWGLGCLIYEMIEGKSPFR 202
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 68.7 bits (168), Expect = 7e-13
Identities = 55/180 (30%), Positives = 78/180 (43%), Gaps = 18/180 (10%)
Query: 302 QAVKKSKVIDESKVEEFINEVVIL-SQINHRNVVKLLGCCLETEVPLLVYEFIPNG---T 357
+ +KKS +I +++V E I+ Q V KL + LV E++ G +
Sbjct: 27 KVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLNGGDCAS 86
Query: 358 LFQYIHDQNEDFPITWEIRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAK 417
L + + ED W + IA EV + LH I HRDIK N+L+D K
Sbjct: 87 LIKTLGGLPED----W-AKQYIA-EVVLGVEDLHQRG---IIHRDIKPENLLIDQTGHLK 137
Query: 418 VSDFGASRSMAVDQTHMTTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLTELLTGEKP 477
++DFG SR+ + GT YL PE SD +S G V+ E L G P
Sbjct: 138 LTDFGLSRN-----GLENKKFVGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPP 192
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 69.3 bits (169), Expect = 8e-13
Identities = 56/185 (30%), Positives = 94/185 (50%), Gaps = 18/185 (9%)
Query: 303 AVKKSKVID---ESKVEEFINEVVILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGTLF 359
A+ +KVI+ E ++E+++ E+ IL+ NH +VKLLG ++ EF P G +
Sbjct: 38 ALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFYWDGKLWIMIEFCPGGAVD 97
Query: 360 QYIH--DQNEDFPITWEIRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAK 417
+ D+ P +I++ I ++ AL YLHS + I HRD+K+ N+LL K
Sbjct: 98 AIMLELDRGLTEP---QIQV-ICRQMLEALQYLHS---MKIIHRDLKAGNVLLTLDGDIK 150
Query: 418 VSDFGASRSMAVDQTHMTTQVHGTFGYLDPEY-----FRSSQFTDKSDVYSFGVVLTELL 472
++DFG S + V GT ++ PE + + + K+D++S G+ L E+
Sbjct: 151 LADFGVS-AKNVKTLQRRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMA 209
Query: 473 TGEKP 477
E P
Sbjct: 210 QIEPP 214
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 68.1 bits (167), Expect = 1e-12
Identities = 50/182 (27%), Positives = 81/182 (44%), Gaps = 17/182 (9%)
Query: 303 AVKKSKVIDESKVEEFINEVVILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGTLFQYI 362
A+K K+ E E+ +L + H N+V G L + +V E+ G+L Q I
Sbjct: 32 AIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLWIVMEYCGGGSL-QDI 90
Query: 363 HDQNEDFPITWEIRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFG 422
+ P++ + E L+YLH I HRDIK NILL + K++DFG
Sbjct: 91 YQVTRG-PLSELQIAYVCRETLKGLAYLHETGKI---HRDIKGANILLTEDGDVKLADFG 146
Query: 423 AS----RSMAVDQTHMTTQVHGTFGYLDPEYF---RSSQFTDKSDVYSFGVVLTELLTGE 475
S ++A ++ + GT ++ PE R + K D+++ G+ EL +
Sbjct: 147 VSAQLTATIAKRKSFI-----GTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQ 201
Query: 476 KP 477
P
Sbjct: 202 PP 203
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 69.3 bits (169), Expect = 1e-12
Identities = 50/190 (26%), Positives = 94/190 (49%), Gaps = 19/190 (10%)
Query: 312 ESKVEEFINEVVILSQI-NHRNVVKLLGCCLETEVPLLVYEFIPNGTLFQYIHDQNE--- 367
+ + + ++E+ ++ I H+N++ LLG C + ++ E+ G L +Y+ +
Sbjct: 58 DKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVLVEYASKGNLREYLRARRPPGM 117
Query: 368 DFP----------ITWEIRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAK 417
D+ +T++ + A +V+ + YL S I HRD+ + N+L+ + K
Sbjct: 118 DYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQKCI---HRDLAARNVLVTEDNVMK 174
Query: 418 VSDFGASRSM-AVDQTHMTTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLTELLT-GE 475
++DFG +R + +D TT ++ PE +T +SDV+SFGV+L E+ T G
Sbjct: 175 IADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGG 234
Query: 476 KPIRFTILEE 485
P +EE
Sbjct: 235 SPYPGIPVEE 244
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334 |
| >gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 69.2 bits (169), Expect = 1e-12
Identities = 64/243 (26%), Positives = 110/243 (45%), Gaps = 37/243 (15%)
Query: 254 FKRNGGLLLQQELASTEGTIEKTKLFTSKELEKATDNFDLNRILGQG--GQAV------- 304
F +N L +++ ST+ K K+ ++F+ R LG G G+ +
Sbjct: 3 FLKNLQLHKKKDSDSTKEPKRKNKM--------KYEDFNFIRTLGTGSFGRVILATYKNE 54
Query: 305 ----------KKSKVIDESKVEEFINEVVILSQINHRNVVKLLGCCLETEVPLLVYEFIP 354
+KSK+I + +V+ +E IL+ INH V L G + LV EF+
Sbjct: 55 DFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDESYLYLVLEFVI 114
Query: 355 NGTLFQYIHDQNEDFPITWEIRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKY 414
G F ++ +N+ FP ++ A ++ YL S+ I +RD+K N+LLD
Sbjct: 115 GGEFFTFLR-RNKRFPN--DVGCFYAAQIVLIFEYLQ---SLNIVYRDLKPENLLLDKDG 168
Query: 415 RAKVSDFGASRSMAVDQTHMTTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLTELLTG 474
K++DFG ++ + T + GT Y+ PE + +D ++ G+ + E+L G
Sbjct: 169 FIKMTDFGFAKVVDT----RTYTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVG 224
Query: 475 EKP 477
P
Sbjct: 225 CPP 227
|
Length = 340 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 68.2 bits (167), Expect = 1e-12
Identities = 41/105 (39%), Positives = 53/105 (50%), Gaps = 14/105 (13%)
Query: 378 RIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGAS----RSMAVDQTH 433
+IA V LSYLHS I HRDIK +NILL K + K+ DFG S S+A T
Sbjct: 109 KIAESVLKGLSYLHSRKII---HRDIKPSNILLTRKGQVKLCDFGVSGELVNSLAGTFT- 164
Query: 434 MTTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLTELLTGEKPI 478
GT Y+ PE + ++ SDV+S G+ L E+ P
Sbjct: 165 ------GTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPF 203
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Score = 69.3 bits (169), Expect = 1e-12
Identities = 59/218 (27%), Positives = 95/218 (43%), Gaps = 29/218 (13%)
Query: 282 KELEKATDNFDLNRILGQGG------------------QAVKKSKVIDESKVEEFINEVV 323
++L +++++ +++G+G + + K ++I S F E
Sbjct: 36 RDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERD 95
Query: 324 ILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEIRLRIAIEV 383
I++ N VV+L + +V E++P G L + N D P W R A EV
Sbjct: 96 IMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLM--SNYDVPEKWA-RFYTA-EV 151
Query: 384 SGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHGTFG 443
AL +HS I HRD+K N+LLD K++DFG M + GT
Sbjct: 152 VLALDAIHSMGFI---HRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPD 208
Query: 444 YLDPEYFRSS----QFTDKSDVYSFGVVLTELLTGEKP 477
Y+ PE +S + + D +S GV L E+L G+ P
Sbjct: 209 YISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTP 246
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371 |
| >gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Score = 68.1 bits (166), Expect = 1e-12
Identities = 62/274 (22%), Positives = 120/274 (43%), Gaps = 40/274 (14%)
Query: 298 GQGGQAVKKSKVIDESKV---EEFINEVVILSQINHRNVVKLLGCCLETEVPLLVYEFIP 354
G+ QAV + D+++ EEF +E ++ S++ H N+V LLG + + +++ +
Sbjct: 32 GEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQPLSMIFSYCS 91
Query: 355 NGTLFQYI-----------HDQNEDFPITWEIR--LRIAIEVSGALSYLHSAASIPIYHR 401
+ L +++ D ++ T E + I +++ + +L S + H+
Sbjct: 92 HSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSHH---VVHK 148
Query: 402 DIKSTNILLDDKYRAKVSDFGASRSM-AVDQTHMTTQVHGTFGYLDPEYFRSSQFTDKSD 460
D+ + N+L+ DK K+SD G R + A D + ++ PE +F+ SD
Sbjct: 149 DLATRNVLVFDKLNVKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSD 208
Query: 461 VYSFGVVLTELLT-GEKPIRFTILEEDKSLAAYFLCAMKEERLFEILDARVMKQGGKDEI 519
++S+GVVL E+ + G +P C + + E++ R + D
Sbjct: 209 IWSYGVVLWEVFSYGLQP----------------YCGYSNQDVIEMIRNRQVLPCPDDCP 252
Query: 520 ITVAKLAKRCLNLNGKKRPTMREVASELAGIKAW 553
V L C N +RP +++ S L + W
Sbjct: 253 AWVYTLMLECWNEFPSRRPRFKDIHSRL---RTW 283
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283 |
| >gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Score = 68.5 bits (167), Expect = 2e-12
Identities = 46/162 (28%), Positives = 78/162 (48%), Gaps = 8/162 (4%)
Query: 317 EFINEVVILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEIR 376
+ I E+ +L + N +V G + E + G+L Q + I +I
Sbjct: 49 QIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGR---IPEQIL 105
Query: 377 LRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTT 436
+++I V L+YL I HRD+K +NIL++ + K+ DFG S + +D M
Sbjct: 106 GKVSIAVIKGLTYLREKHKI--MHRDVKPSNILVNSRGEIKLCDFGVSGQL-IDS--MAN 160
Query: 437 QVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLTELLTGEKPI 478
GT Y+ PE + + ++ +SD++S G+ L E+ G PI
Sbjct: 161 SFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPI 202
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333 |
| >gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Score = 67.6 bits (165), Expect = 2e-12
Identities = 54/205 (26%), Positives = 95/205 (46%), Gaps = 27/205 (13%)
Query: 277 KLFTSKELEKATDNFDLNRILGQGGQAVKKSKVIDESKVEEFINEVVILSQINHRNVVKL 336
KL+ K+L K + +KK K + + VE+ IL++++ R +V L
Sbjct: 19 KLYACKKLNK---------------KRLKKRKGYEGAMVEK-----RILAKVHSRFIVSL 58
Query: 337 LGCCLETEVPL-LVYEFIPNGTLFQYIHDQNEDFPITWEIR-LRIAIEVSGALSYLHSAA 394
+T+ L LV + G L +I++ +E+ P E R ++ L +LH
Sbjct: 59 -AYAFQTKTDLCLVMTIMNGGDLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRR 117
Query: 395 SIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHGTFGYLDPEYFRSSQ 454
I +RD+K N+LLD+ ++SD G + + Q+ T GT G++ PE + +
Sbjct: 118 ---IIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQSK-TKGYAGTPGFMAPELLQGEE 173
Query: 455 FTDKSDVYSFGVVLTELLTGEKPIR 479
+ D ++ GV L E++ P R
Sbjct: 174 YDFSVDYFALGVTLYEMIAARGPFR 198
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280 |
| >gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Score = 67.9 bits (166), Expect = 2e-12
Identities = 65/225 (28%), Positives = 105/225 (46%), Gaps = 41/225 (18%)
Query: 285 EKATDNFDLNRILGQG-------------GQAVKKSKVIDESKVEEF----INEVVILSQ 327
++ D FD+ +G+G G+ V KV +++ E F I E+ IL Q
Sbjct: 3 KRCVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQ 62
Query: 328 INHRNVVKLLGCCLETEVPL----------LVYEFIPN---GTLFQYIHDQNEDFPITWE 374
+NHRN+V L + + L LV+E++ + G L + +ED
Sbjct: 63 LNHRNIVNLKEIVTDKQDALDFKKDKGAFYLVFEYMDHDLMGLLESGLVHFSED-----H 117
Query: 375 IRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHM 434
I+ ++ L+Y H + HRDIK +NILL++K + K++DFG +R +++
Sbjct: 118 IK-SFMKQLLEGLNYCHKKNFL---HRDIKCSNILLNNKGQIKLADFGLARLYNSEESRP 173
Query: 435 TTQVHGTFGYLDPEYFRSSQ-FTDKSDVYSFGVVLTELLTGEKPI 478
T T Y PE + + DV+S G +L EL T +KPI
Sbjct: 174 YTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFT-KKPI 217
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302 |
| >gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Score = 67.7 bits (165), Expect = 2e-12
Identities = 62/208 (29%), Positives = 95/208 (45%), Gaps = 26/208 (12%)
Query: 291 FDLNRILGQGG---------------QAVKK--SKVIDESKVEEF-INEVVILSQINHRN 332
F R+LG+GG A K+ K I + K E +NE IL ++N +
Sbjct: 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQF 61
Query: 333 VVKLLGCCLETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEIR-LRIAIEVSGALSYLH 391
VV L ET+ L + I NG ++ H N P E R L A E+ L LH
Sbjct: 62 VVNL-AYAYETKDALCLVLTIMNGGDLKF-HIYNMGNPGFEEERALFYAAEILCGLEDLH 119
Query: 392 SAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHGTFGYLDPEYFR 451
++ +RD+K NILLDD ++SD G + + + + GT GY+ PE
Sbjct: 120 RENTV---YRDLKPENILLDDYGHIRISDLGLA--VKIPEGESIRGRVGTVGYMAPEVLN 174
Query: 452 SSQFTDKSDVYSFGVVLTELLTGEKPIR 479
+ ++T D + G ++ E++ G+ P R
Sbjct: 175 NQRYTLSPDYWGLGCLIYEMIEGQSPFR 202
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285 |
| >gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Score = 68.2 bits (166), Expect = 2e-12
Identities = 49/177 (27%), Positives = 85/177 (48%), Gaps = 8/177 (4%)
Query: 302 QAVKKSKVIDESKVEEFINEVVILSQINHRNVVKLLGCCLETEVPLL-VYEFIPNGTLFQ 360
+ VKK V D+ ++ E + Q ++ + L C +TE L V E++ G L
Sbjct: 26 KVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNGGDLMF 85
Query: 361 YIHDQNEDFPITWEIRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSD 420
++ Q + + E + E+S AL+YLH I +RD+K N+LLD + K++D
Sbjct: 86 HMQRQRK---LPEEHARFYSAEISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTD 139
Query: 421 FGASRSMAVDQTHMTTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLTELLTGEKP 477
+G + + T+ GT Y+ PE R + D ++ GV++ E++ G P
Sbjct: 140 YGMCKE-GLRPGDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSP 195
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329 |
| >gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 68.0 bits (166), Expect = 3e-12
Identities = 40/154 (25%), Positives = 75/154 (48%), Gaps = 12/154 (7%)
Query: 321 EVVILSQINHRNVVKLLGCCLETEVPLLVYEFIP--NGTLFQYIHDQNEDFPITWEIRLR 378
E ++L +NH +V+++ + + +V +P + L+ Y+ P+ + L
Sbjct: 107 EAMLLQNVNHPSVIRMKDTLVSGAITCMV---LPHYSSDLYTYL--TKRSRPLPIDQALI 161
Query: 379 IAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQV 438
I ++ L YLH+ I HRD+K+ NI ++D + + D GA++ V +
Sbjct: 162 IEKQILEGLRYLHAQR---IIHRDVKTENIFINDVDQVCIGDLGAAQFPVVAP--AFLGL 216
Query: 439 HGTFGYLDPEYFRSSQFTDKSDVYSFGVVLTELL 472
GT PE ++ K+D++S G+VL E+L
Sbjct: 217 AGTVETNAPEVLARDKYNSKADIWSAGIVLFEML 250
|
Length = 357 |
| >gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Score = 67.7 bits (165), Expect = 3e-12
Identities = 47/173 (27%), Positives = 88/173 (50%), Gaps = 20/173 (11%)
Query: 317 EFINEVVILSQIN-HRNVVKLLGCCLETEVPLLV-YEFIPNGTLFQYIH-------DQNE 367
+ I+E+ ++ I H+N++ LLG C + E PL V E+ G L +++ D
Sbjct: 63 DLISEMELMKLIGKHKNIINLLGVCTQ-EGPLYVIVEYAAKGNLREFLRARRPPGPDYTF 121
Query: 368 DFP------ITWEIRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDF 421
D ++++ + A +V+ + YL S I HRD+ + N+L+ + K++DF
Sbjct: 122 DITKVPEEQLSFKDLVSCAYQVARGMEYLESRRCI---HRDLAARNVLVTEDNVMKIADF 178
Query: 422 GASRSM-AVDQTHMTTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLTELLT 473
G +R + +D T+ ++ PE +T +SDV+SFG+++ E+ T
Sbjct: 179 GLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFT 231
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314 |
| >gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Score = 67.8 bits (165), Expect = 3e-12
Identities = 55/194 (28%), Positives = 85/194 (43%), Gaps = 16/194 (8%)
Query: 285 EKATDNFDLNRILGQGGQAVKKSKVIDESKVEEFINEVVILSQINHRNVVKLLGCCLETE 344
EKA+ + +IL KK +I + +V + E +L H + L +
Sbjct: 16 EKASGKYYAMKIL-------KKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKD 68
Query: 345 VPLLVYEFIPNGTLFQYIHDQNEDFPITWEIRLRI-AIEVSGALSYLHSAASIPIYHRDI 403
V E++ G LF ++ + + E R R E+ AL YLHS I +RD+
Sbjct: 69 RLCFVMEYVNGGELFFHLSRER----VFSEDRTRFYGAEIVSALDYLHSGK---IVYRDL 121
Query: 404 KSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHGTFGYLDPEYFRSSQFTDKSDVYS 463
K N++LD K++DFG + D M T GT YL PE + + D +
Sbjct: 122 KLENLMLDKDGHIKITDFGLCKEGITDAATMKT-FCGTPEYLAPEVLEDNDYGRAVDWWG 180
Query: 464 FGVVLTELLTGEKP 477
GVV+ E++ G P
Sbjct: 181 LGVVMYEMMCGRLP 194
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328 |
| >gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Score = 66.6 bits (162), Expect = 3e-12
Identities = 44/165 (26%), Positives = 82/165 (49%), Gaps = 8/165 (4%)
Query: 315 VEEFINEVVILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGTLFQYIH-DQNEDFPITW 373
VE F+ E ++ + H +VKL + E ++ EF+ G+L ++ D+ P+
Sbjct: 45 VEAFLAEANVMKTLQHDKLVKL-HAVVTKEPIYIITEFMAKGSLLDFLKSDEGSKQPLPK 103
Query: 374 EIRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTH 433
I + +++ ++++ I HRD+++ NIL+ K++DFG +R + ++
Sbjct: 104 LIDF--SAQIAEGMAFIEQRNYI---HRDLRAANILVSASLVCKIADFGLARVIEDNEYT 158
Query: 434 MTTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLTELLT-GEKP 477
+ PE FT KSDV+SFG++L E++T G P
Sbjct: 159 AREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIP 203
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260 |
| >gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Score = 67.4 bits (165), Expect = 3e-12
Identities = 40/126 (31%), Positives = 59/126 (46%), Gaps = 19/126 (15%)
Query: 370 PITWEIRLRIAIEVSGALSYL---HSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRS 426
PI +I ++ + + AL YL H + HRD+K +NILLD K+ DFG S
Sbjct: 110 PIPEDILGKMTVAIVKALHYLKEKHG-----VIHRDVKPSNILLDASGNVKLCDFGISGR 164
Query: 427 MAVDQTHMTTQVHGTFGYLDPEYFRSSQFTDK----SDVYSFGVVLTELLTGEKPIR--- 479
+ + T+ G Y+ PE K +DV+S G+ L EL TG+ P +
Sbjct: 165 LVDSKAK--TRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCK 222
Query: 480 --FTIL 483
F +L
Sbjct: 223 TEFEVL 228
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296 |
| >gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Score = 67.7 bits (165), Expect = 3e-12
Identities = 53/206 (25%), Positives = 96/206 (46%), Gaps = 17/206 (8%)
Query: 302 QAVKKSKVIDESKVEEFINEVVILSQINHRNVVKLLGCCLETEVPL-LVYEFIPNGTLFQ 360
+ VKK V D+ ++ E + Q + + L C +T L LV E++ G L
Sbjct: 26 KVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVNGGDLMF 85
Query: 361 YIHDQNEDFPITWEIRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSD 420
++ Q + + E A E+ AL++LH I +RD+K N+LLD K++D
Sbjct: 86 HMQRQRK---LPEEHARFYAAEICIALNFLHERG---IIYRDLKLDNVLLDADGHIKLTD 139
Query: 421 FGASRSMAVDQTHMTTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLTELLTGEKPIRF 480
+G + + T+ GT Y+ PE R ++ D ++ GV++ E++ G P F
Sbjct: 140 YGMCKE-GLGPGDTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSP--F 196
Query: 481 TILEEDKSLAAYFLCAMKEERLFEIL 506
I+ ++ + E+ LF+++
Sbjct: 197 DIITDNPDMNT-------EDYLFQVI 215
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327 |
| >gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Score = 67.6 bits (165), Expect = 4e-12
Identities = 55/178 (30%), Positives = 88/178 (49%), Gaps = 14/178 (7%)
Query: 304 VKKSKVIDESKVEEFINEVVILSQINHRNVVKLLGCCLETEVPLL-VYEFIPNGTL-FQY 361
+KK ++ + V+ + E IL+ + L CC +T+ L V E++ G L FQ
Sbjct: 28 LKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVNGGDLMFQI 87
Query: 362 IHDQNEDFPITWEIRLRI-AIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSD 420
+ D E R R A EV+ AL +LH I +RD+K NILLD + K++D
Sbjct: 88 QRSRKFD-----EPRSRFYAAEVTLALMFLHRHGVI---YRDLKLDNILLDAEGHCKLAD 139
Query: 421 FGASR-SMAVDQTHMTTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLTELLTGEKP 477
FG + + T TT GT Y+ PE + ++ D ++ GV++ E++ G+ P
Sbjct: 140 FGMCKEGILNGVT--TTTFCGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPP 195
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321 |
| >gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Score = 67.4 bits (164), Expect = 4e-12
Identities = 58/187 (31%), Positives = 92/187 (49%), Gaps = 27/187 (14%)
Query: 303 AVKK----SKVIDESKVEEFINEVVILSQINHRNVVKLLGCCLETEVPLLVYEF-IPNGT 357
AVKK K +E K ++ I EV L Q+ H N ++ GC L+ LV E+ + + +
Sbjct: 50 AVKKMSYSGKQTNE-KWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVMEYCLGSAS 108
Query: 358 LFQYIHDQNEDFPITWEIRLRIAIEVSGAL---SYLHSAASIPIYHRDIKSTNILLDDKY 414
+H + P+ + IA GAL +YLHS I HRDIK+ NILL +
Sbjct: 109 DLLEVHKK----PLQ---EVEIAAITHGALQGLAYLHSHNMI---HRDIKAGNILLTEPG 158
Query: 415 RAKVSDFGASRSMAVDQTHMTTQVHGTFGYLDPEYFRS---SQFTDKSDVYSFGVVLTEL 471
+ K++DFG++ + + + GT ++ PE + Q+ K DV+S G+ EL
Sbjct: 159 QVKLADFGSASKSSPANSFV-----GTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIEL 213
Query: 472 LTGEKPI 478
+ P+
Sbjct: 214 AERKPPL 220
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313 |
| >gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Score = 67.3 bits (164), Expect = 4e-12
Identities = 60/180 (33%), Positives = 83/180 (46%), Gaps = 13/180 (7%)
Query: 303 AVK--KSKVIDESKVEEFI--NEVVILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGTL 358
AVK + K I + K + I V+L + H +V L E V +++ G L
Sbjct: 24 AVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYVNGGEL 83
Query: 359 FQYIHDQNEDFPITWEIRLRI-AIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAK 417
F H Q E E R R A EV+ A+ YLHS + I +RD+K NILLD +
Sbjct: 84 F--FHLQRER--CFLEPRARFYAAEVASAIGYLHS---LNIIYRDLKPENILLDSQGHVV 136
Query: 418 VSDFGASRSMAVDQTHMTTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLTELLTGEKP 477
++DFG + V+ T+ GT YL PE R + D + G VL E+L G P
Sbjct: 137 LTDFGLCKE-GVEPEETTSTFCGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPP 195
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321 |
| >gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Score = 66.2 bits (161), Expect = 5e-12
Identities = 60/230 (26%), Positives = 101/230 (43%), Gaps = 34/230 (14%)
Query: 321 EVVILSQINHRNVVKLLGCCLETEVPLL--VYEFIPNGTLFQYIHDQN-----EDFPITW 373
E +LSQ+ H N+V E E LL V F G L+ + +Q E+ + W
Sbjct: 49 EAQLLSQLKHPNIVAYRES-WEGEDGLLYIVMGFCEGGDLYHKLKEQKGKLLPENQVVEW 107
Query: 374 EIRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTH 433
++++ AL YLH I HRD+K+ N+ L KV D G +R + +Q
Sbjct: 108 ------FVQIAMALQYLHEKH---ILHRDLKTQNVFLTRTNIIKVGDLGIARVLE-NQCD 157
Query: 434 MTTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLTELLTGEKPIRFTILEEDKSLAAYF 493
M + + GT Y+ PE F + + KSDV++ G + E+ T L F
Sbjct: 158 MASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMAT---------------LKHAF 202
Query: 494 LCAMKEERLFEILDARVMKQGGKDEIITVAKLAKRCLNLNGKKRPTMREV 543
++ I++ + + KD + +L L+ +KRP+++ +
Sbjct: 203 NAKDMNSLVYRIIEGK-LPPMPKDYSPELGELIATMLSKRPEKRPSVKSI 251
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 66.4 bits (162), Expect = 6e-12
Identities = 37/100 (37%), Positives = 54/100 (54%), Gaps = 6/100 (6%)
Query: 378 RIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQ 437
RIA+ V L+YL S + I HRD+K +N+L++ + + K+ DFG S + + T
Sbjct: 99 RIAVAVVKGLTYLWS---LKILHRDVKPSNMLVNTRGQVKLCDFGVSTQLV--NSIAKTY 153
Query: 438 VHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLTELLTGEKP 477
V GT Y+ PE Q+ SDV+S G+ EL G P
Sbjct: 154 V-GTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFP 192
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
| >gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 65.6 bits (160), Expect = 8e-12
Identities = 66/269 (24%), Positives = 122/269 (45%), Gaps = 44/269 (16%)
Query: 295 RILGQGGQAVKKS---KVIDESK---VEEFINEVVILSQINHRNVVKLLGCCLETEVPLL 348
R +G G+ K KV+D+S E F ++SQ++H+++V G C+ + ++
Sbjct: 17 REVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIM 76
Query: 349 VYEFIPNGTLFQYIHDQNEDFPITWEIRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNI 408
V E++ G+L Y+ I+W +L +A +++ AL +L + H ++ + N+
Sbjct: 77 VQEYVKFGSLDTYLKKNKNLINISW--KLEVAKQLAWALHFLEDKG---LTHGNVCAKNV 131
Query: 409 LL----DDKYRA----KVSDFGASRSMAVDQTHMTTQVHGTFGYLDPEYFRSSQ-FTDKS 459
LL D K K+SD G S+ V + + ++ PE + Q + +
Sbjct: 132 LLIREEDRKTGNPPFIKLSDPGI--SITVLPKEILLE---RIPWVPPECIENPQNLSLAA 186
Query: 460 DVYSFGVVLTELLTG-EKPIRFTILEEDKSLAAYFLCAMKEERLFEILDARVMKQGGKDE 518
D +SFG L E+ +G +KP+ + L+ K L Y E+R Q +
Sbjct: 187 DKWSFGTTLWEIFSGGDKPL--SALDSQKKLQFY------EDRH----------QLPAPK 228
Query: 519 IITVAKLAKRCLNLNGKKRPTMREVASEL 547
+A L +C++ RP+ R + +L
Sbjct: 229 WTELANLINQCMDYEPDFRPSFRAIIRDL 257
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 66.1 bits (161), Expect = 9e-12
Identities = 55/178 (30%), Positives = 84/178 (47%), Gaps = 10/178 (5%)
Query: 302 QAVKKSKVIDESKVEEFINEVVILSQINHRNVVKLLGCCLETEVPLL-VYEFIPNGTLFQ 360
+A+KK V+ + VE + E +LS + L C +T+ L V E++ G L
Sbjct: 26 KALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLNGGDLMF 85
Query: 361 YIHDQNE-DFPITWEIRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVS 419
+I ++ D P A E+ L +LHS I +RD+K NILLD K++
Sbjct: 86 HIQSCHKFDLPRA----TFYAAEIICGLQFLHSKG---IVYRDLKLDNILLDTDGHIKIA 138
Query: 420 DFGASRSMAVDQTHMTTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLTELLTGEKP 477
DFG + + T GT Y+ PE ++ D +SFGV+L E+L G+ P
Sbjct: 139 DFGMCKENMLGDAK-TCTFCGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSP 195
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 67.2 bits (164), Expect = 9e-12
Identities = 46/121 (38%), Positives = 66/121 (54%), Gaps = 16/121 (13%)
Query: 381 IEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMA------VDQTHM 434
I+V A+ ++HS I HRDIKS NILL K+ DFG S+ A V +T
Sbjct: 150 IQVLLAVHHVHSKHMI---HRDIKSANILLCSNGLVKLGDFGFSKMYAATVSDDVGRTFC 206
Query: 435 TTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLTELLTGEKPIRFTILEE--DKSLAAY 492
GT Y+ PE +R ++ K+D++S GV+L ELLT ++P +EE K+LA
Sbjct: 207 -----GTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGENMEEVMHKTLAGR 261
Query: 493 F 493
+
Sbjct: 262 Y 262
|
Length = 496 |
| >gnl|CDD|173643 cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 65.3 bits (159), Expect = 1e-11
Identities = 70/296 (23%), Positives = 131/296 (44%), Gaps = 65/296 (21%)
Query: 275 KTKLFTSKELEKATDNFDLNRILGQGGQAVKKS-KVIDESKVE---EFINEVVILSQINH 330
+T+++ K D D + +K KV+D S + F ++ Q++H
Sbjct: 8 RTQIYAGILNYKDDDEDDG----YSYEKEIKVILKVLDPSHRDISLAFFETASMMRQVSH 63
Query: 331 RNVVKLLGCCLETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEIRLRIAIEVSGALSYL 390
+++V L G C+ ++V EF+ G L ++H +++ W + ++A +++ ALSYL
Sbjct: 64 KHIVLLYGVCVRDVENIMVEEFVEFGPLDLFMHRKSDVLTTPW--KFKVAKQLASALSYL 121
Query: 391 HSAASIPIYHRDIKSTNILL-----DDKYRA--KVSDFGA-----SRSMAVDQTHMTTQV 438
+ H ++ + NILL D + K+SD G SR V++
Sbjct: 122 EDKDLV---HGNVCTKNILLAREGIDGECGPFIKLSDPGIPITVLSRQECVER------- 171
Query: 439 HGTFGYLDPEYFRSSQ-FTDKSDVYSFGVVLTEL-LTGEKPIRFTILEEDKSLAAYFLCA 496
++ PE S+ + +D +SFG L E+ GE P++ DK+LA
Sbjct: 172 ---IPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLK------DKTLA------ 216
Query: 497 MKEERLFEILDARVMKQGGKDEIIT-----VAKLAKRCLNLNGKKRPTMREVASEL 547
++ER +E G+ ++T +A L C+N + +RP R + ++
Sbjct: 217 -EKERFYE----------GQCMLVTPSCKELADLMTHCMNYDPNQRPFFRAIMRDI 261
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 262 |
| >gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Score = 66.2 bits (161), Expect = 1e-11
Identities = 67/238 (28%), Positives = 99/238 (41%), Gaps = 35/238 (14%)
Query: 285 EKATDNFDLNRILGQGGQAVKKSKVIDESKVEEFINEVVILSQINHRNVVKLLGCCLETE 344
EKAT + +IL +K +I + +V + E +L H + L +
Sbjct: 16 EKATGRYYAMKIL-------RKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHD 68
Query: 345 VPLLVYEFIPNGTLFQYIHDQNEDFPITWEIRLRI-AIEVSGALSYLHSAASIPIYHRDI 403
V E+ G LF ++ + + E R R E+ AL YLHS + +RDI
Sbjct: 69 RLCFVMEYANGGELFFHLSRER----VFTEERARFYGAEIVSALEYLHSRD---VVYRDI 121
Query: 404 KSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHGTFGYLDPEYFRSSQFTDKSDVYS 463
K N++LD K++DFG + D M T GT YL PE + + D +
Sbjct: 122 KLENLMLDKDGHIKITDFGLCKEGISDGATMKT-FCGTPEYLAPEVLEDNDYGRAVDWWG 180
Query: 464 FGVVLTELLTGEKP-----------------IRF--TILEEDKSLAAYFLCAMKEERL 502
GVV+ E++ G P IRF T+ E KSL A L ++RL
Sbjct: 181 LGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPRTLSPEAKSLLAGLLKKDPKQRL 238
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 65.1 bits (159), Expect = 1e-11
Identities = 51/178 (28%), Positives = 86/178 (48%), Gaps = 14/178 (7%)
Query: 303 AVKKSKVIDESKVEEFI--NEVVILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGTLFQ 360
A+KK ++ K+ + I E+ +L Q+ H N+V L+ + LV+EF+ + L
Sbjct: 30 AIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLVFEFVDHTVL-- 87
Query: 361 YIHDQNEDFP--ITWEIRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKV 418
D E +P + + ++ + + HS I HRDIK NIL+ K+
Sbjct: 88 ---DDLEKYPNGLDESRVRKYLFQILRGIEFCHSHN---IIHRDIKPENILVSQSGVVKL 141
Query: 419 SDFGASRSMAVDQTHMTTQVHGTFGYLDPEYF-RSSQFTDKSDVYSFGVVLTELLTGE 475
DFG +R++A T V T Y PE +++ D+++ G ++TE+LTGE
Sbjct: 142 CDFGFARTLAAPGEVYTDYV-ATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGE 198
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|165291 PHA02988, PHA02988, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 65.1 bits (159), Expect = 1e-11
Identities = 43/179 (24%), Positives = 87/179 (48%), Gaps = 19/179 (10%)
Query: 305 KKSKVIDESKVEEFINEVVILSQINHRNVVKLLGCCLETEVPL----LVYEFIPNGTLFQ 360
K KV+ ++ NE+ L +I+ N++K+ G ++ L L+ E+ G L +
Sbjct: 56 KGHKVL----IDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILEYCTRGYLRE 111
Query: 361 YIHDQNEDFPITWEIRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSD 420
+ D+ +D ++++ +L +AI+ L L+ + P ++++ S + L+ + Y+ K+
Sbjct: 112 VL-DKEKD--LSFKTKLDMAIDCCKGLYNLYKYTNKP--YKNLTSVSFLVTENYKLKIIC 166
Query: 421 FGASRSMAVDQTHMTTQVHGTFGYLDPEYFRS--SQFTDKSDVYSFGVVLTELLTGEKP 477
G + ++ Y + S++T K D+YS GVVL E+ TG+ P
Sbjct: 167 HGLEKILSSPPFKNVN----FMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIP 221
|
Length = 283 |
| >gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Score = 65.8 bits (160), Expect = 1e-11
Identities = 54/177 (30%), Positives = 81/177 (45%), Gaps = 11/177 (6%)
Query: 304 VKKSKVIDESKVEEFI--NEVVILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGTLFQY 361
V + K I + K E+ I V+L + H +V L + V ++I G LF +
Sbjct: 27 VLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYINGGELFYH 86
Query: 362 IHDQNEDFPITWEIRLRI-AIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSD 420
+ + E R R A E++ AL YLHS + I +RD+K NILLD + ++D
Sbjct: 87 LQRER----CFLEPRARFYAAEIASALGYLHS---LNIVYRDLKPENILLDSQGHIVLTD 139
Query: 421 FGASRSMAVDQTHMTTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLTELLTGEKP 477
FG + ++ T+ GT YL PE + D + G VL E+L G P
Sbjct: 140 FGLCKE-NIEHNGTTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPP 195
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325 |
| >gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Score = 65.5 bits (159), Expect = 1e-11
Identities = 55/172 (31%), Positives = 83/172 (48%), Gaps = 22/172 (12%)
Query: 314 KVEEFINEVVILSQINHRNVVKLLGCCLETEVPLLVYEF-IPNGTLFQYIHDQNEDFPIT 372
K ++ I EV L +I H N ++ GC L LV E+ + + + +H + P+
Sbjct: 68 KWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVMEYCLGSASDLLEVHKK----PLQ 123
Query: 373 WEIRLRIAIEVSGAL---SYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAV 429
+ IA GAL +YLHS I HRDIK+ NILL + + K++DFG S S+A
Sbjct: 124 ---EVEIAAITHGALQGLAYLHSHNMI---HRDIKAGNILLTEPGQVKLADFG-SASIAS 176
Query: 430 DQTHMTTQVHGTFGYLDPEYFRS---SQFTDKSDVYSFGVVLTELLTGEKPI 478
GT ++ PE + Q+ K DV+S G+ EL + P+
Sbjct: 177 PANSFV----GTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPL 224
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317 |
| >gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Score = 65.0 bits (158), Expect = 2e-11
Identities = 64/204 (31%), Positives = 96/204 (47%), Gaps = 26/204 (12%)
Query: 295 RILGQGG---------------QAVKK--SKVIDESKVEEF-INEVVILSQINHRNVVKL 336
R+LG+GG A KK K I + K E +NE IL ++N R VV L
Sbjct: 6 RVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSL 65
Query: 337 LGCCLETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEIR-LRIAIEVSGALSYLHSAAS 395
ET+ L + I NG ++ H N P E R + A E+ L L
Sbjct: 66 -AYAYETKDALCLVLTIMNGGDLKF-HIYNMGNPGFDEQRAIFYAAELCCGLEDLQRER- 122
Query: 396 IPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHGTFGYLDPEYFRSSQF 455
I +RD+K NILLDD+ ++SD G + + +T + +V GT GY+ PE + ++
Sbjct: 123 --IVYRDLKPENILLDDRGHIRISDLGLAVQIPEGET-VRGRV-GTVGYMAPEVINNEKY 178
Query: 456 TDKSDVYSFGVVLTELLTGEKPIR 479
T D + G ++ E++ G+ P R
Sbjct: 179 TFSPDWWGLGCLIYEMIQGQSPFR 202
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285 |
| >gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Score = 64.7 bits (158), Expect = 2e-11
Identities = 43/124 (34%), Positives = 63/124 (50%), Gaps = 10/124 (8%)
Query: 358 LFQYIHD-QNEDFPITWEIRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRA 416
++Y+++ P EI +IA+ AL+YL + I HRD+K +NILLD
Sbjct: 92 FYKYVYEVLKSVIP--EEILGKIAVATVKALNYLKE--ELKIIHRDVKPSNILLDRNGNI 147
Query: 417 KVSDFGASRSMAVDQTHMTTQVHGTFGYLDPEYFRSSQ---FTDKSDVYSFGVVLTELLT 473
K+ DFG S + VD T G Y+ PE S + +SDV+S G+ L E+ T
Sbjct: 148 KLCDFGISGQL-VDSIAKTRDA-GCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVAT 205
Query: 474 GEKP 477
G+ P
Sbjct: 206 GKFP 209
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288 |
| >gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Score = 65.2 bits (159), Expect = 2e-11
Identities = 67/238 (28%), Positives = 99/238 (41%), Gaps = 35/238 (14%)
Query: 285 EKATDNFDLNRILGQGGQAVKKSKVIDESKVEEFINEVVILSQINHRNVVKLLGCCLETE 344
EKAT + +IL KK +I + +V + E +L H + L +
Sbjct: 16 EKATGKYYAMKIL-------KKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHD 68
Query: 345 VPLLVYEFIPNGTLFQYIHDQNEDFPITWEIRLRI-AIEVSGALSYLHSAASIPIYHRDI 403
V E+ G LF ++ + + E R R E+ AL YLHS + +RD+
Sbjct: 69 RLCFVMEYANGGELFFHLSRER----VFSEDRARFYGAEIVSALGYLHSCD---VVYRDL 121
Query: 404 KSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHGTFGYLDPEYFRSSQFTDKSDVYS 463
K N++LD K++DFG + D M T GT YL PE + + D +
Sbjct: 122 KLENLMLDKDGHIKITDFGLCKEGISDGATMKT-FCGTPEYLAPEVLEDNDYGRAVDWWG 180
Query: 464 FGVVLTELLTGEKP-----------------IRF--TILEEDKSLAAYFLCAMKEERL 502
GVV+ E++ G P IRF T+ E KSL A L ++RL
Sbjct: 181 LGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPRTLSPEAKSLLAGLLKKDPKQRL 238
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323 |
| >gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Score = 64.8 bits (158), Expect = 3e-11
Identities = 49/178 (27%), Positives = 85/178 (47%), Gaps = 10/178 (5%)
Query: 302 QAVKKSKVIDESKVEEFINEVVILSQINHRNVVKLLGCCLETEVPL-LVYEFIPNGTLFQ 360
+ +KK V D+ ++ E + ++ + L C +TE L V EF+ G L
Sbjct: 26 KVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVSGGDLMF 85
Query: 361 YIHDQNEDFPITWEIRLRI-AIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVS 419
++ Q + P E R + E+S AL++LH I +RD+K N+LLD + K++
Sbjct: 86 HMQRQRK-LP---EEHARFYSAEISLALNFLHERG---IIYRDLKLDNVLLDAEGHIKLT 138
Query: 420 DFGASRSMAVDQTHMTTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLTELLTGEKP 477
D+G + + T+ GT Y+ PE R + D ++ GV++ E++ G P
Sbjct: 139 DYGMCKE-GIRPGDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSP 195
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329 |
| >gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Score = 64.8 bits (158), Expect = 3e-11
Identities = 53/199 (26%), Positives = 87/199 (43%), Gaps = 24/199 (12%)
Query: 304 VKKSKVIDESKVEEFINEVVILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGTLFQYIH 363
+KKS ++ + V F E ILS N + +L + + LV E+ P G L ++
Sbjct: 34 MKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYLVMEYQPGGDLLSLLN 93
Query: 364 ---DQ-NEDFPITWEIRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVS 419
DQ +ED + +A E+ A+ +H + HRDIK N+L+D K++
Sbjct: 94 RYEDQFDEDM-----AQFYLA-ELVLAIHSVHQMGYV---HRDIKPENVLIDRTGHIKLA 144
Query: 420 DFGASRSMAVDQTHMTTQVHGTFGYLDPEYFRSSQFTDKS------DVYSFGVVLTELLT 473
DFG++ + ++ + GT Y+ PE + K D +S GV+ E++
Sbjct: 145 DFGSAARLTANKMVNSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIY 204
Query: 474 GEKPIRFTILEEDKSLAAY 492
G P E S Y
Sbjct: 205 GRSP-----FHEGTSAKTY 218
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330 |
| >gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Score = 64.1 bits (157), Expect = 3e-11
Identities = 41/150 (27%), Positives = 69/150 (46%), Gaps = 12/150 (8%)
Query: 329 NHRNVVKLLGCCLETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEIRLRIAIEVSGALS 388
++ N +KL + +L+ ++I +G LF + + E E++ I ++ AL+
Sbjct: 67 DNPNFIKLYYSVTTLKGHVLIMDYIKDGDLFDLL--KKEGKLSEAEVKK-IIRQLVEALN 123
Query: 389 YLHSAASIPIYHRDIKSTNILLDD-KYRAKVSDFGASRSMAVDQTHMTTQVHGTFGYLDP 447
LH I H DIK N+L D K R + D+G + + + GT Y P
Sbjct: 124 DLHKHNII---HNDIKLENVLYDRAKDRIYLCDYGLCKIIGTPSCY-----DGTLDYFSP 175
Query: 448 EYFRSSQFTDKSDVYSFGVVLTELLTGEKP 477
E + + D ++ GV+ ELLTG+ P
Sbjct: 176 EKIKGHNYDVSFDWWAVGVLTYELLTGKHP 205
|
Length = 267 |
| >gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Score = 64.3 bits (156), Expect = 3e-11
Identities = 52/172 (30%), Positives = 82/172 (47%), Gaps = 22/172 (12%)
Query: 314 KVEEFINEVVILSQINHRNVVKLLGCCLETEVPLLVYEF-IPNGTLFQYIHDQNEDFPIT 372
K ++ I EV L ++ H N ++ GC L LV E+ + + + +H + P+
Sbjct: 58 KWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKK----PLQ 113
Query: 373 WEIRLRIAIEVSGAL---SYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAV 429
+ IA GAL +YLHS I HRD+K+ NILL + K+ DFG++ MA
Sbjct: 114 ---EVEIAAVTHGALQGLAYLHSHNMI---HRDVKAGNILLSEPGLVKLGDFGSASIMAP 167
Query: 430 DQTHMTTQVHGTFGYLDPEYFRS---SQFTDKSDVYSFGVVLTELLTGEKPI 478
+ GT ++ PE + Q+ K DV+S G+ EL + P+
Sbjct: 168 ANXFV-----GTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPL 214
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308 |
| >gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Score = 63.2 bits (154), Expect = 5e-11
Identities = 38/104 (36%), Positives = 55/104 (52%), Gaps = 8/104 (7%)
Query: 378 RIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQ 437
+IA+ + AL YLHS S+ HRD+K +N+L++ + K+ DFG S + VD T
Sbjct: 107 KIAVSIVKALEYLHSKLSV--IHRDVKPSNVLINRNGQVKLCDFGISGYL-VDSVAKTID 163
Query: 438 VHGTFGYLDPEYF----RSSQFTDKSDVYSFGVVLTELLTGEKP 477
G Y+ PE + KSDV+S G+ + EL TG P
Sbjct: 164 A-GCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFP 206
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283 |
| >gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Score = 63.1 bits (153), Expect = 1e-10
Identities = 58/194 (29%), Positives = 90/194 (46%), Gaps = 17/194 (8%)
Query: 286 KATDNFDLNRILGQGGQAVKKSKVIDESKVEEFINEVVILSQINHRNVVKLLGCCLETEV 345
K TD +IL KK VI + VE + E +L+ + + L C +T
Sbjct: 22 KGTDELYAIKIL-------KKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVD 74
Query: 346 PL-LVYEFIPNGTLFQYIHDQNEDFPITWEIRLRIAIEVSGALSYLHSAASIPIYHRDIK 404
L V E++ G L +I Q F + A E+S L +LH I +RD+K
Sbjct: 75 RLYFVMEYVNGGDLMYHIQ-QVGKFKEPQAVFY--AAEISVGLFFLHRRG---IIYRDLK 128
Query: 405 STNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVH-GTFGYLDPEYFRSSQFTDKSDVYS 463
N++LD + K++DFG + VD +TT+ GT Y+ PE + D ++
Sbjct: 129 LDNVMLDSEGHIKIADFGMCKEHMVDG--VTTRTFCGTPDYIAPEIIAYQPYGKSVDWWA 186
Query: 464 FGVVLTELLTGEKP 477
+GV+L E+L G+ P
Sbjct: 187 YGVLLYEMLAGQPP 200
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323 |
| >gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Score = 64.0 bits (156), Expect = 1e-10
Identities = 51/232 (21%), Positives = 93/232 (40%), Gaps = 46/232 (19%)
Query: 291 FDLNRILGQGGQA-------VKKSKVIDESKVEE-----------FINEVVILSQINHRN 332
+D+ R++G+GG S+ + K+ E F+ E I + + H
Sbjct: 4 YDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPG 63
Query: 333 VVKLLGCCLETEVPLLVYEFIPNGTLFQYIHD--QNEDFPITWEIR------LRIAIEVS 384
+V + C + + +I TL + Q E + L I ++
Sbjct: 64 IVPVYSICSDGDPVYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKIC 123
Query: 385 GALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQ------------- 431
+ Y+HS + HRD+K NILL + D+GA+ +++
Sbjct: 124 ATIEYVHSKG---VLHRDLKPDNILLGLFGEVVILDWGAAIFKKLEEEDLLDIDVDERNI 180
Query: 432 --THMTT--QVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLTELLTGEKPIR 479
+ MT ++ GT Y+ PE ++ +D+Y+ GV+L ++LT P R
Sbjct: 181 CYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYR 232
|
Length = 932 |
| >gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 62.4 bits (152), Expect = 2e-10
Identities = 54/176 (30%), Positives = 78/176 (44%), Gaps = 16/176 (9%)
Query: 305 KKSKVIDESKVEEFINEVVILSQINHRNVVKLLGCCLETEVPLLVYEFIPNG---TLFQY 361
KKS + ++V + E IL+ +VKLL + E L E++P G TL
Sbjct: 35 KKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYLAMEYVPGGDFRTLLNN 94
Query: 362 IHDQNEDFPITWEIRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDF 421
+ +ED R +A E+ A+ LH I HRD+K N L+D K++DF
Sbjct: 95 LGVLSED-----HARFYMA-EMFEAVDALHELGYI---HRDLKPENFLIDASGHIKLTDF 145
Query: 422 GASRSMAVDQTHMTTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLTELLTGEKP 477
G S V + V G+ Y+ PE R + D +S G +L E L G P
Sbjct: 146 GLS-KGIVTYAN---SVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPP 197
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333 |
| >gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Score = 62.6 bits (153), Expect = 2e-10
Identities = 52/178 (29%), Positives = 88/178 (49%), Gaps = 41/178 (23%)
Query: 321 EVVILSQI-NHRNVVKLLGC--------------CLETEVPLLVYEFIPNGTLFQYIHDQ 365
E++ L ++ +H N+VKLL +ET++ + I L + +H +
Sbjct: 56 EIMFLQELGDHPNIVKLLNVIKAENDKDIYLVFEYMETDL----HAVIRANIL-EDVHKR 110
Query: 366 NEDFPITWEIRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASR 425
I +++ L+ AL Y+HS I HRD+K +NILL+ R K++DFG +R
Sbjct: 111 Y----IMYQL-LK-------ALKYIHSGNVI---HRDLKPSNILLNSDCRVKLADFGLAR 155
Query: 426 SMA----VDQTHMTTQVHGTFGYLDPE-YFRSSQFTDKSDVYSFGVVLTELLTGEKPI 478
S++ + + T T Y PE S+++T D++S G +L E+L G KP+
Sbjct: 156 SLSELEENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLG-KPL 212
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337 |
| >gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Score = 61.5 bits (149), Expect = 2e-10
Identities = 49/179 (27%), Positives = 80/179 (44%), Gaps = 26/179 (14%)
Query: 308 KVIDESKVEEF-INEVV-------ILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGTL- 358
KV+ E V E NE V +LS+++H +VK LE + ++ E+ L
Sbjct: 31 KVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERDAFCIITEYCEGRDLD 90
Query: 359 --FQYIHDQNEDFP----ITWEIRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDD 412
+ + + W I+L + + Y+H I HRD+K+ NI L +
Sbjct: 91 CKLEELKHTGKTLSENQVCEWFIQLLLGVH------YMHQRR---ILHRDLKAKNIFLKN 141
Query: 413 KYRAKVSDFGASRSMAVDQTHMTTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLTEL 471
K+ DFG SR + + + T GT Y+ PE + + KSD++S G +L E+
Sbjct: 142 NL-LKIGDFGVSR-LLMGSCDLATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEM 198
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260 |
| >gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Score = 62.5 bits (152), Expect = 2e-10
Identities = 35/90 (38%), Positives = 49/90 (54%), Gaps = 6/90 (6%)
Query: 387 LSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQT-HMTTQVHGTFGYL 445
L YLHSA I HRDIK N+L++ K+ DFG +R D++ HMT +V + Y
Sbjct: 116 LKYLHSAG---ILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDESKHMTQEVVTQY-YR 171
Query: 446 DPEYFRSSQ-FTDKSDVYSFGVVLTELLTG 474
PE S+ +T D++S G + ELL
Sbjct: 172 APEILMGSRHYTSAVDIWSVGCIFAELLGR 201
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372 |
| >gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 62.3 bits (152), Expect = 2e-10
Identities = 51/167 (30%), Positives = 79/167 (47%), Gaps = 29/167 (17%)
Query: 321 EVVILSQINHRNVVKLLGC-----CLE--TEVPLLVYEFIP---NGTL-FQYIHDQNEDF 369
E+ +L ++H NV+ LL LE +V LV + N + Q + D + F
Sbjct: 64 ELRLLKHMDHENVIGLLDVFTPASSLEDFQDV-YLVTHLMGADLNNIVKCQKLSDDHIQF 122
Query: 370 PITWEIRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAV 429
+ ++I LR L Y+HSA I HRD+K +NI +++ K+ DFG +R
Sbjct: 123 -LVYQI-LR-------GLKYIHSAG---IIHRDLKPSNIAVNEDCELKILDFGLARHTDD 170
Query: 430 DQTHMTTQVHGTFGYLDPE-YFRSSQFTDKSDVYSFGVVLTELLTGE 475
+ MT V T Y PE + D++S G ++ ELLTG+
Sbjct: 171 E---MTGYV-ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGK 213
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343 |
| >gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 63.2 bits (153), Expect = 2e-10
Identities = 41/162 (25%), Positives = 78/162 (48%), Gaps = 14/162 (8%)
Query: 320 NEVVILSQINHRNVVK---LLGCCLETEVPLLVYEFIPNGTLFQYIHD---QNEDFPITW 373
NE++ L ++NH N++K +L T + Y+F L+ +++D +D P+
Sbjct: 212 NEILALGRLNHENILKIEEILRSEANTYMITQKYDF----DLYSFMYDEAFDWKDRPLLK 267
Query: 374 EIRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTH 433
+ R I ++ A+ Y+H I HRDIK NI L+ + + DFG + ++
Sbjct: 268 QTR-AIMKQLLCAVEYIHDKKLI---HRDIKLENIFLNCDGKIVLGDFGTAMPFEKEREA 323
Query: 434 MTTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLTELLTGE 475
GT PE + + +D++S G++L ++L+ +
Sbjct: 324 FDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHD 365
|
Length = 501 |
| >gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Score = 62.0 bits (150), Expect = 2e-10
Identities = 54/194 (27%), Positives = 85/194 (43%), Gaps = 15/194 (7%)
Query: 285 EKATDNFDLNRILGQGGQAVKKSKVIDESKVEEFINEVVILSQINHRNVVKLLGCCLETE 344
EKAT + +IL KK ++ + +V + E +L H + L +
Sbjct: 16 EKATGRYYAMKIL-------KKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHD 68
Query: 345 VPLLVYEFIPNGTLFQYIHDQNEDFPITWEIRLRI-AIEVSGALSYLHSAASIPIYHRDI 403
V E+ G LF ++ + + E R R E+ AL YLHS ++ +RD+
Sbjct: 69 RLCFVMEYANGGELFFHLSRER----VFSEDRARFYGAEIVSALDYLHSEKNV--VYRDL 122
Query: 404 KSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHGTFGYLDPEYFRSSQFTDKSDVYS 463
K N++LD K++DFG + D M T GT YL PE + + D +
Sbjct: 123 KLENLMLDKDGHIKITDFGLCKEGIKDGATMKT-FCGTPEYLAPEVLEDNDYGRAVDWWG 181
Query: 464 FGVVLTELLTGEKP 477
GVV+ E++ G P
Sbjct: 182 LGVVMYEMMCGRLP 195
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325 |
| >gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Score = 61.5 bits (149), Expect = 2e-10
Identities = 61/235 (25%), Positives = 97/235 (41%), Gaps = 41/235 (17%)
Query: 302 QAVKKSKVIDESKVEE--FINEVVILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGTLF 359
Q V K + S E+ F+ E + H N+++ LG C E LLV EF P G L
Sbjct: 24 QVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCPLGDLK 83
Query: 360 QYIHDQNEDFPITWEIRL--RIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAK 417
Y+ + +T + R+A E++ L +LH I H D+ N LL K
Sbjct: 84 GYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNNFI---HSDLALRNCLLTADLTVK 140
Query: 418 VSDFGASRSMAVDQTHMTT----------------QVHGTFGYLDPEYFRSSQFTDKSDV 461
+ D+G S + + ++T +VHG +D T +S+V
Sbjct: 141 IGDYGLSHNKYKEDYYVTPDQLWVPLRWIAPELVDEVHGNLLVVDQ--------TKESNV 192
Query: 462 YSFGVVLTELLT-GEKPIR---------FTILEEDKSLAAYFLCAMKEERLFEIL 506
+S GV + EL G +P R +T+ E+ L L +R +E++
Sbjct: 193 WSLGVTIWELFELGSQPYRHLSDEQVLTYTVREQQLKLPKPRLKLPLSDRWYEVM 247
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269 |
| >gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 62.7 bits (152), Expect = 3e-10
Identities = 53/175 (30%), Positives = 89/175 (50%), Gaps = 13/175 (7%)
Query: 311 DESKVEEFINEVVILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGTLFQYIHDQ-NEDF 369
DE + +E+ L+ +H +VK + LL+ E+ G L + I + E
Sbjct: 105 DERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYGSGGDLNKQIKQRLKEHL 164
Query: 370 PIT-WEIRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASR--- 425
P +E+ L + ++ AL +HS + HRD+KS NI L K+ DFG S+
Sbjct: 165 PFQEYEVGL-LFYQIVLALDEVHSRK---MMHRDLKSANIFLMPTGIIKLGDFGFSKQYS 220
Query: 426 -SMAVDQTHMTTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLTELLTGEKPIR 479
S+++D + + GT YL PE + +++ K+D++S GV+L ELLT +P +
Sbjct: 221 DSVSLD---VASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFK 272
|
Length = 478 |
| >gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Score = 61.2 bits (148), Expect = 4e-10
Identities = 56/196 (28%), Positives = 85/196 (43%), Gaps = 21/196 (10%)
Query: 286 KATDNFDLNRILGQGGQAVKKSKVIDESKVEEFINEVVILSQINHRNVVKLLGCCLETEV 345
K TD +IL KK VI + VE + E +L+ + L C +T
Sbjct: 22 KGTDELYAIKIL-------KKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMD 74
Query: 346 PL-LVYEFIPNGTLFQYIHDQ---NEDFPITWEIRLRIAIEVSGALSYLHSAASIPIYHR 401
L V E++ G L I E + + A E++ L +LHS I +R
Sbjct: 75 RLYFVMEYVNGGDLMYQIQQVGRFKEPHAVFY------AAEIAIGLFFLHSKG---IIYR 125
Query: 402 DIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHGTFGYLDPEYFRSSQFTDKSDV 461
D+K N++LD + K++DFG + D T GT Y+ PE + D
Sbjct: 126 DLKLDNVMLDSEGHIKIADFGMCKENMWDGV-TTKTFCGTPDYIAPEIIAYQPYGKSVDW 184
Query: 462 YSFGVVLTELLTGEKP 477
++FGV+L E+L G+ P
Sbjct: 185 WAFGVLLYEMLAGQAP 200
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323 |
| >gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Score = 60.8 bits (148), Expect = 6e-10
Identities = 47/175 (26%), Positives = 77/175 (44%), Gaps = 34/175 (19%)
Query: 321 EVVILSQINHRNVVKLLGCCLETEVPL-----LVYEFIPNGTLFQYIHDQNEDFPITWE- 374
E+ IL H N++ + L +V + + + L IH P+T E
Sbjct: 54 ELKILRHFKHDNIIAIRDI-LRPPGADFKDVYVVMDLMES-DLHHIIHSDQ---PLTEEH 108
Query: 375 IR------LRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMA 428
IR LR L Y+HSA + HRD+K +N+L+++ ++ DFG +R ++
Sbjct: 109 IRYFLYQLLR-------GLKYIHSAN---VIHRDLKPSNLLVNEDCELRIGDFGMARGLS 158
Query: 429 VDQT----HMTTQVHGTFGYLDPE-YFRSSQFTDKSDVYSFGVVLTELLTGEKPI 478
T MT V T Y PE ++T D++S G + E+L G + +
Sbjct: 159 SSPTEHKYFMTEYV-ATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEML-GRRQL 211
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334 |
| >gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Score = 60.4 bits (146), Expect = 6e-10
Identities = 54/180 (30%), Positives = 87/180 (48%), Gaps = 16/180 (8%)
Query: 307 SKVID---ESKVEEFINEVVILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGTLFQYIH 363
+KVID E ++E+++ E+ IL+ +H N+VKLL ++ EF G + +
Sbjct: 35 AKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAGGAVDAVML 94
Query: 364 DQNEDFPITWEIRLRIAIEVS-GALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFG 422
+ P+T E ++R+ + + AL+YLH I HRD+K+ NIL K++DFG
Sbjct: 95 ELER--PLT-EPQIRVVCKQTLEALNYLHENK---IIHRDLKAGNILFTLDGDIKLADFG 148
Query: 423 ASRSMAVDQTHMTTQVHGTFGYLDPEYFRSSQFTD-----KSDVYSFGVVLTELLTGEKP 477
S + GT ++ PE D K+DV+S G+ L E+ E P
Sbjct: 149 VS-AKNTRTIQRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPP 207
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 60.2 bits (146), Expect = 7e-10
Identities = 46/157 (29%), Positives = 83/157 (52%), Gaps = 9/157 (5%)
Query: 319 INEVVILSQINHRNVVKLLGCCLETEVPL-LVYEFIPNGTLFQYIHDQNEDFPITWEIRL 377
I E+ +L ++NH N+VKLL + TE L LV+EF+ + L +++ D + I +
Sbjct: 47 IREISLLKELNHPNIVKLLDV-IHTENKLYLVFEFL-HQDLKKFM-DASPLSGIPLPLIK 103
Query: 378 RIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQ 437
++ L++ HS + HRD+K N+L++ + K++DFG +R+ V T +
Sbjct: 104 SYLFQLLQGLAFCHSHRVL---HRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHE 160
Query: 438 VHGTFGYLDPEYFRSSQF-TDKSDVYSFGVVLTELLT 473
V T Y PE ++ + D++S G + E++T
Sbjct: 161 VV-TLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT 196
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 61.0 bits (148), Expect = 7e-10
Identities = 52/161 (32%), Positives = 78/161 (48%), Gaps = 24/161 (14%)
Query: 321 EVVILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGT--LFQYIHDQNEDFP----ITWE 374
E+ IL I+HR ++ L+ +V +P LF Y+ D++ P IT +
Sbjct: 136 EIDILKTISHRAIINLIHAYRWKSTVCMV---MPKYKCDLFTYV-DRSGPLPLEQAITIQ 191
Query: 375 IRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHM 434
RL AL+YLH I HRD+K+ NI LD+ A + DFGA + +D
Sbjct: 192 RRLL------EALAYLHGRG---IIHRDVKTENIFLDEPENAVLGDFGA--ACKLDAHPD 240
Query: 435 TTQVHGTFGYLD---PEYFRSSQFTDKSDVYSFGVVLTELL 472
T Q +G G L+ PE + K+D++S G+VL E+
Sbjct: 241 TPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMS 281
|
Length = 392 |
| >gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Score = 60.6 bits (147), Expect = 7e-10
Identities = 65/278 (23%), Positives = 115/278 (41%), Gaps = 72/278 (25%)
Query: 303 AVKKSKVIDESKVEEFINEVVILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGTLFQYI 362
AVKK + D V+ + E+ I+ +++H N+VK VYE L
Sbjct: 34 AVKKIVLTDPQSVKHALREIKIIRRLDHDNIVK-------------VYE-----VLGPSG 75
Query: 363 HDQNEDFPITWEIR------------LRIAIEVSGALS----------------YLHSAA 394
D ED E+ L +E G LS Y+HSA
Sbjct: 76 SDLTEDVGSLTELNSVYIVQEYMETDLANVLE-QGPLSEEHARLFMYQLLRGLKYIHSAN 134
Query: 395 SIPIYHRDIKSTNILLD-DKYRAKVSDFGASRSMAVDQTH--MTTQVHGTFGYLDPEYFR 451
+ HRD+K N+ ++ + K+ DFG +R + +H ++ T Y P
Sbjct: 135 VL---HRDLKPANVFINTEDLVLKIGDFGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLL 191
Query: 452 S-SQFTDKSDVYSFGVVLTELLTGEKPIRFTILEEDKSLAAYFLCAMKEERLFEILDA-R 509
S + +T D+++ G + E+LTG KP+ F A + E++ IL++
Sbjct: 192 SPNNYTKAIDMWAAGCIFAEMLTG-KPL--------------FAGAHELEQMQLILESVP 236
Query: 510 VMKQGGKDEIITVAKLAKRCLNLNGKKRPTMREVASEL 547
V+++ ++E++ V + N G+ R +R++ +
Sbjct: 237 VVREEDRNELLNV--IPSFVRNDGGEPRRPLRDLLPGV 272
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342 |
| >gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 59.4 bits (144), Expect = 9e-10
Identities = 61/257 (23%), Positives = 115/257 (44%), Gaps = 51/257 (19%)
Query: 308 KVIDESKV--EEFINEVVILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGTLFQYIHDQ 365
KV+ F ++SQ++H+++VKL G C+ E ++V E++ G L ++H +
Sbjct: 36 KVLGSDHRDSLAFFETASLMSQLSHKHLVKLYGVCVRDEN-IMVEEYVKFGPLDVFLHRE 94
Query: 366 NEDFPITWEIRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILL-----DDKYR--AKV 418
+ + W +L +A +++ AL YL + H ++ NIL+ ++ Y K+
Sbjct: 95 KNNVSLHW--KLDVAKQLASALHYLEDKKLV---HGNVCGKNILVARYGLNEGYVPFIKL 149
Query: 419 SDFG-----ASRSMAVDQTHMTTQVHGTFGYLDPEYFR--SSQFTDKSDVYSFGVVLTEL 471
SD G SR V++ ++ PE R + T +D +SFG L E+
Sbjct: 150 SDPGIPITVLSREERVERI----------PWIAPECIRNGQASLTIAADKWSFGTTLLEI 199
Query: 472 LT-GEKPIRFTILEEDKSLAAYFLCAMKEERLFEILDARVMKQGGKDEIITVAKLAKRCL 530
+ GE+P+ S + ++ER ++ D + + +A L +C
Sbjct: 200 CSNGEEPL------STLSSS-------EKERFYQ--DQHRLPM---PDCAELANLINQCW 241
Query: 531 NLNGKKRPTMREVASEL 547
+ KRP+ R + +L
Sbjct: 242 TYDPTKRPSFRAILRDL 258
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259 |
| >gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Score = 59.2 bits (143), Expect = 1e-09
Identities = 36/161 (22%), Positives = 76/161 (47%), Gaps = 6/161 (3%)
Query: 318 FINEVVILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEIRL 377
F+ E + L Q +H N+V+L G ++V E++ NG L ++ + + + +
Sbjct: 53 FLAEALTLGQFDHSNIVRLEGVITRGNTMMIVTEYMSNGALDSFL--RKHEGQLVAGQLM 110
Query: 378 RIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQ 437
+ ++ + YL + H+ + + +L++ K+S F + + + T
Sbjct: 111 GMLPGLASGMKYLSEMGYV---HKGLAAHKVLVNSDLVCKISGFRRLQEDKSEAIYTTMS 167
Query: 438 VHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLTELLT-GEKP 477
+ PE + F+ SDV+SFG+V+ E+++ GE+P
Sbjct: 168 GKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERP 208
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Score = 59.7 bits (145), Expect = 1e-09
Identities = 46/187 (24%), Positives = 76/187 (40%), Gaps = 18/187 (9%)
Query: 303 AVKKS--KVIDESKVEEFINEVVILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGTLFQ 360
AVKK + ++ E++ Q+ H N++ + + +V + G+
Sbjct: 29 AVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAYGSCED 88
Query: 361 YIHDQ-NEDFPITWEIRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVS 419
+ E P I I +V AL Y+HS I HR +K+++ILL + +S
Sbjct: 89 LLKTHFPEGLPEL-AIAF-ILKDVLNALDYIHSKGFI---HRSVKASHILLSGDGKVVLS 143
Query: 420 DFGASRSMAVDQTHMTTQVHG-------TFGYLDPEYFRSS--QFTDKSDVYSFGVVLTE 470
S SM + VH +L PE + + + +KSD+YS G+ E
Sbjct: 144 GLRYSVSM-IKHGKRQRVVHDFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACE 202
Query: 471 LLTGEKP 477
L G P
Sbjct: 203 LANGHVP 209
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314 |
| >gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 59.6 bits (145), Expect = 1e-09
Identities = 33/96 (34%), Positives = 50/96 (52%), Gaps = 7/96 (7%)
Query: 386 ALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAV--DQTHMTTQVHGTFG 443
L Y+HSA + HRD+K +N+LL+ K+ DFG +R D T T+ T
Sbjct: 118 GLKYIHSANVL---HRDLKPSNLLLNTNCDLKICDFGLARIADPEHDHTGFLTEYVATRW 174
Query: 444 YLDPE-YFRSSQFTDKSDVYSFGVVLTELLTGEKPI 478
Y PE S +T D++S G +L E+L+ +P+
Sbjct: 175 YRAPEIMLNSKGYTKAIDIWSVGCILAEMLSN-RPL 209
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336 |
| >gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Score = 59.0 bits (142), Expect = 1e-09
Identities = 60/214 (28%), Positives = 94/214 (43%), Gaps = 31/214 (14%)
Query: 291 FDLNRILGQG-------GQAVKKS-----KVIDES--KVEEFINEVVILSQINH-RNVVK 335
F+L ++G G G+ VK KV+D + + EE E+ +L + +H RN+
Sbjct: 8 FELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIAT 67
Query: 336 LLGCCLETEVP------LLVYEFIPNGTLFQYIHDQNEDFPITWEIRLRIAIEVSGALSY 389
G ++ P LV EF G++ I + + + E I E+ LS+
Sbjct: 68 YYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGN-TLKEEWIAYICREILRGLSH 126
Query: 390 LHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHGTFGYLDPEY 449
LH I HRDIK N+LL + K+ DFG S + T + GT ++ PE
Sbjct: 127 LHQHKVI---HRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFI-GTPYWMAPEV 182
Query: 450 FRSSQFTD-----KSDVYSFGVVLTELLTGEKPI 478
+ D KSD++S G+ E+ G P+
Sbjct: 183 IACDENPDATYDFKSDLWSLGITAIEMAEGAPPL 216
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272 |
| >gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Score = 58.9 bits (142), Expect = 1e-09
Identities = 62/241 (25%), Positives = 97/241 (40%), Gaps = 31/241 (12%)
Query: 308 KVIDESKVEEFI---NEVVILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGTLFQYIHD 364
KVI E+F E++++ H N+V G L + + EF G+L H
Sbjct: 40 KVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKLWICMEFCGGGSLQDIYHV 99
Query: 365 QNEDFPITWEIRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGAS 424
P++ ++ E L YLHS + HRDIK NILL D K++DFG S
Sbjct: 100 TG---PLSESQIAYVSRETLQGLYYLHSKGKM---HRDIKGANILLTDNGHVKLADFGVS 153
Query: 425 RSMAVDQTHMTTQVHGTFGYLDPEYF---RSSQFTDKSDVYSFGVVLTELLTGEKPIRFT 481
+ + + GT ++ PE R + D+++ G+ EL + P+
Sbjct: 154 AQITATIAKRKSFI-GTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPM--- 209
Query: 482 ILEEDKSLAAYFLCAMKEERLFEILDARVMKQGGKDEII---TVAKLAKRCLNLNGKKRP 538
+ L M+ LF + + KD++ + K L N KKRP
Sbjct: 210 ----------FDLHPMRA--LFLMTKSNFQPPKLKDKMKWSNSFHHFVKMALTKNPKKRP 257
Query: 539 T 539
T
Sbjct: 258 T 258
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 59.5 bits (144), Expect = 1e-09
Identities = 31/99 (31%), Positives = 52/99 (52%), Gaps = 21/99 (21%)
Query: 387 LSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHGTFGYLD 446
L Y+HSA + HRD+K +NIL+++ K+ DFG +R + MT GY+
Sbjct: 121 LKYVHSAGVV---HRDLKPSNILINENCDLKICDFGLAR---IQDPQMT-------GYVS 167
Query: 447 PEYFRSSQ-------FTDKSDVYSFGVVLTELLTGEKPI 478
Y+R+ + + + D++S G + E+L G KP+
Sbjct: 168 TRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEG-KPL 205
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Score = 59.0 bits (143), Expect = 2e-09
Identities = 49/183 (26%), Positives = 90/183 (49%), Gaps = 11/183 (6%)
Query: 301 GQAVKKSKVIDESKVEEF----INEVVILSQINHRNVVKLLGCCLETEVPLLVYEFIPNG 356
GQ V K+ ES+ E I E+ +L ++ H N+V L ++ L++EF+ +
Sbjct: 25 GQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLMQESRLYLIFEFL-SM 83
Query: 357 TLFQYIHDQNEDFPITWEIRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRA 416
L +Y+ + + E+ ++ + + HS + HRD+K N+L+D+K
Sbjct: 84 DLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSRR---VLHRDLKPQNLLIDNKGVI 140
Query: 417 KVSDFGASRSMAVDQTHMTTQVHGTFGYLDPEYFRSSQ-FTDKSDVYSFGVVLTELLTGE 475
K++DFG +R+ + T +V T Y PE S ++ D++S G + E+ T +
Sbjct: 141 KLADFGLARAFGIPVRVYTHEVV-TLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMAT-K 198
Query: 476 KPI 478
KP+
Sbjct: 199 KPL 201
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 59.1 bits (144), Expect = 2e-09
Identities = 55/230 (23%), Positives = 97/230 (42%), Gaps = 67/230 (29%)
Query: 291 FDLNRILGQGGQ---------------AVKK-----SKVIDESKVEEFINEVVILSQINH 330
++L + +G G A+KK +ID ++ + E+ +L + H
Sbjct: 2 YELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRI---LREIKLLRHLRH 58
Query: 331 RNVVKLLGCCLETEVPL-----------LVYEFIPNGT-LFQYIHDQNEDFPITWEIRLR 378
N++ LL ++ +V E + T L + I P+T +
Sbjct: 59 ENIIGLL------DILRPPSPEDFNDVYIVTELME--TDLHKVIKSPQ---PLTDDHIQY 107
Query: 379 IAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVD---QTHMT 435
++ L YLHSA + HRD+K +NIL++ K+ DFG +R + D + +T
Sbjct: 108 FLYQILRGLKYLHSAN---VIHRDLKPSNILVNSNCDLKICDFGLARGVDPDEDEKGFLT 164
Query: 436 TQVHGTFGYLDPEYFR-------SSQFTDKSDVYSFGVVLTELLTGEKPI 478
Y+ ++R SS++T D++S G + ELLT KP+
Sbjct: 165 -------EYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTR-KPL 206
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Score = 58.9 bits (142), Expect = 2e-09
Identities = 55/197 (27%), Positives = 89/197 (45%), Gaps = 22/197 (11%)
Query: 295 RILGQGGQAVKKSKVIDESKVEEF----INEVVILSQIN---HRNVVKLLGCCL------ 341
R L GG+ V +V ++ E I EV +L + H NVV+L C
Sbjct: 21 RDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDR 80
Query: 342 ETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEIRLRIAIEVSGALSYLHSAASIPIYHR 401
ET++ L V+E + + L Y+ D+ + + E + ++ L +LHS + HR
Sbjct: 81 ETKLTL-VFEHV-DQDLTTYL-DKVPEPGVPTETIKDMMFQLLRGLDFLHSHR---VVHR 134
Query: 402 DIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHGTFGYLDPEYFRSSQFTDKSDV 461
D+K NIL+ + K++DFG +R + T V T Y PE S + D+
Sbjct: 135 DLKPQNILVTSSGQIKLADFGLARIYSFQM--ALTSVVVTLWYRAPEVLLQSSYATPVDL 192
Query: 462 YSFGVVLTELLTGEKPI 478
+S G + E+ KP+
Sbjct: 193 WSVGCIFAEMFR-RKPL 208
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290 |
| >gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Score = 59.0 bits (143), Expect = 2e-09
Identities = 52/178 (29%), Positives = 83/178 (46%), Gaps = 14/178 (7%)
Query: 304 VKKSKVIDESKVEEFINEVVILSQINHRNVVKLLGCCLETEVPL-LVYEFIPNGTLFQYI 362
+KK +I + VE + E +L+ + L C +T L V E++ G L +I
Sbjct: 33 LKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHI 92
Query: 363 HDQNEDF--PITWEIRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSD 420
Q F P + A E++ L +LHS I +RD+K N++LD + K++D
Sbjct: 93 Q-QVGKFKEPHA----VFYAAEIAIGLFFLHSKG---IIYRDLKLDNVMLDAEGHIKIAD 144
Query: 421 FGASRSMAVDQTHMTTQVH-GTFGYLDPEYFRSSQFTDKSDVYSFGVVLTELLTGEKP 477
FG + TT+ GT Y+ PE + D ++FGV+L E+L G+ P
Sbjct: 145 FGMCKENIFGGK--TTRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPP 200
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324 |
| >gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 58.5 bits (142), Expect = 4e-09
Identities = 36/93 (38%), Positives = 51/93 (54%), Gaps = 6/93 (6%)
Query: 387 LSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHGTFGYLD 446
L Y+HSA + HRD+K +N+LL+ K+ DFG +R+ + MT V T Y
Sbjct: 121 LKYIHSAN---VLHRDLKPSNLLLNANCDLKICDFGLARTTSEKGDFMTEYV-VTRWYRA 176
Query: 447 PE-YFRSSQFTDKSDVYSFGVVLTELLTGEKPI 478
PE S++T DV+S G + ELL G KP+
Sbjct: 177 PELLLNCSEYTTAIDVWSVGCIFAELL-GRKPL 208
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337 |
| >gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Score = 58.1 bits (140), Expect = 4e-09
Identities = 65/234 (27%), Positives = 101/234 (43%), Gaps = 38/234 (16%)
Query: 275 KTKLFTSKELEKATDNFDLNRILGQG--GQAVKKS----------KVIDE-SKVEEFIN- 320
+ + + L TD +++ +G+G G+ K + K++D S V+E I
Sbjct: 8 NSSMLGLESLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPISDVDEEIEA 67
Query: 321 EVVILSQI-NHRNVVKLLGCCLETEVPL-----LVYEFIPNGTLFQYIHD-----QNEDF 369
E IL + NH NVVK G + + + LV E G++ + + Q D
Sbjct: 68 EYNILQSLPNHPNVVKFYGMFYKADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDE 127
Query: 370 PITWEIRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAV 429
+ I+ + GAL L + I HRD+K NILL + K+ DFG S +
Sbjct: 128 AM-------ISYILYGALLGLQHLHNNRIIHRDVKGNNILLTTEGGVKLVDFGVSAQLTS 180
Query: 430 DQTHMTTQVHGTFGYLDPEYFRSSQFTDKS-----DVYSFGVVLTELLTGEKPI 478
+ T V GT ++ PE Q D S DV+S G+ EL G+ P+
Sbjct: 181 TRLRRNTSV-GTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPL 233
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291 |
| >gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 59.4 bits (143), Expect = 4e-09
Identities = 49/194 (25%), Positives = 88/194 (45%), Gaps = 28/194 (14%)
Query: 310 IDESKVEEFINEVVILSQINHRNVVKLLGCCLE--TEVPLLVYEFIPNGTLFQYIHDQNE 367
+ E + + + EV ++ ++ H+N+V+ + L + ++ EF G L + I +
Sbjct: 51 LKEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKANQKLYILMEFCDAGDLSRNIQKCYK 110
Query: 368 DF-PITWEIRLRIAIEVSGALSYLHSAASIP----IYHRDIKSTNILLDDKYR------- 415
F I + I ++ AL+Y H+ P + HRD+K NI L R
Sbjct: 111 MFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITA 170
Query: 416 ----------AKVSDFGASRSMAVDQTHMTTQVHGTFGYLDPEYF--RSSQFTDKSDVYS 463
AK+ DFG S+++ ++ M GT Y PE + + DKSD+++
Sbjct: 171 QANNLNGRPIAKIGDFGLSKNIGIES--MAHSCVGTPYYWSPELLLHETKSYDDKSDMWA 228
Query: 464 FGVVLTELLTGEKP 477
G ++ EL +G+ P
Sbjct: 229 LGCIIYELCSGKTP 242
|
Length = 1021 |
| >gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Score = 57.7 bits (139), Expect = 4e-09
Identities = 47/158 (29%), Positives = 83/158 (52%), Gaps = 10/158 (6%)
Query: 319 INEVVILSQINHRNVVKLLGCCLETEVPL-LVYEFIPNGTLFQYIHDQNEDFPITWEIRL 377
I EV +L + H N+V L + TE L LV+E++ + L QY+ D + +++
Sbjct: 51 IREVSLLKNLKHANIVTLHDI-IHTERCLTLVFEYLDS-DLKQYL-DNCGNLMSMHNVKI 107
Query: 378 RIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQ 437
++ LSY H I HRD+K N+L+++K K++DFG +R+ +V + +
Sbjct: 108 -FMFQLLRGLSYCHKRK---ILHRDLKPQNLLINEKGELKLADFGLARAKSVPTKTYSNE 163
Query: 438 VHGTFGYLDPE-YFRSSQFTDKSDVYSFGVVLTELLTG 474
V T Y P+ S++++ D++ G +L E+ TG
Sbjct: 164 VV-TLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATG 200
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288 |
| >gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Score = 57.7 bits (139), Expect = 4e-09
Identities = 33/101 (32%), Positives = 52/101 (51%), Gaps = 7/101 (6%)
Query: 380 AIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVH 439
A E+ L ++H+ + +RD+K NILLD+ ++SD G + + + H +
Sbjct: 103 ATEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASV--- 156
Query: 440 GTFGYLDPEYFRSSQFTDKS-DVYSFGVVLTELLTGEKPIR 479
GT GY+ PE + D S D +S G +L +LL G P R
Sbjct: 157 GTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFR 197
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279 |
| >gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 57.6 bits (139), Expect = 4e-09
Identities = 47/176 (26%), Positives = 82/176 (46%), Gaps = 15/176 (8%)
Query: 310 IDESKVEEFINEVVILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGTLFQYIHDQNEDF 369
+DESK + I E+ IL + +V G + E++ G+L +
Sbjct: 38 LDESKFNQIIMELDILHKAVSPYIVDFYGAFFIEGAVYMCMEYMDAGSLDKLYAGGVATE 97
Query: 370 PITWEIRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSM-- 427
I ++ RI V L +L +I HRD+K TN+L++ + K+ DFG S ++
Sbjct: 98 GIPEDVLRRITYAVVKGLKFLKEEHNI--IHRDVKPTNVLVNGNGQVKLCDFGVSGNLVA 155
Query: 428 AVDQTHMTTQVHGTFGYLDPEYFRS------SQFTDKSDVYSFGVVLTELLTGEKP 477
++ +T++ Q Y+ PE +S +T +SDV+S G+ + E+ G P
Sbjct: 156 SLAKTNIGCQ-----SYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYP 206
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286 |
| >gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Score = 57.3 bits (138), Expect = 5e-09
Identities = 49/204 (24%), Positives = 97/204 (47%), Gaps = 28/204 (13%)
Query: 277 KLFTSKELEKATDNFDLNRILGQGGQAVKKSKVIDESKVEEFINEVVILSQINHRNVVKL 336
K++ K+L+K R+ + G+ + + E ++ E +N I++
Sbjct: 19 KMYACKKLDK-------KRLKKKSGEKM----ALLEKEILEKVNSPFIVN---------- 57
Query: 337 LGCCLETEVPL-LVYEFIPNGTLFQYIHDQNEDFPITWEIRLRIAIEVSGALSYLHSAAS 395
L E++ L LV + G L +I++ E + E + + +++ + +LHS
Sbjct: 58 LAYAFESKTHLCLVMSLMNGGDLKYHIYNVGE-RGLEMERVIHYSAQITCGILHLHS--- 113
Query: 396 IPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHGTFGYLDPEYFRSSQF 455
+ I +RD+K N+LLDD+ ++SD G + + +T TQ GT GY+ PE + +
Sbjct: 114 MDIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGKT--ITQRAGTNGYMAPEILKEEPY 171
Query: 456 TDKSDVYSFGVVLTELLTGEKPIR 479
+ D ++ G + E++ G P +
Sbjct: 172 SYPVDWFAMGCSIYEMVAGRTPFK 195
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277 |
| >gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 57.5 bits (139), Expect = 6e-09
Identities = 59/202 (29%), Positives = 90/202 (44%), Gaps = 28/202 (13%)
Query: 277 KLFTSKELEKATDNFDLNRILGQGGQAVKKSKVIDESKVEEFINEVVILSQINHRNVVKL 336
K+F K L+KAT V+ K +K E I E V H +V L
Sbjct: 25 KIFAMKVLKKAT--------------IVRNQKDTAHTKAERNILEAV-----KHPFIVDL 65
Query: 337 LGCCLETEVPL-LVYEFIPNGTLFQYIHDQNEDFPITWEIRLRIAIEVSGALSYLHSAAS 395
+ +T L L+ E++ G LF ++ + T L E+S AL +LH
Sbjct: 66 I-YAFQTGGKLYLILEYLSGGELFMHLEREGIFMEDTACFYLS---EISLALEHLHQQG- 120
Query: 396 IPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHGTFGYLDPEYFRSSQF 455
I +RD+K NILLD + K++DFG + ++ + +T GT Y+ PE S
Sbjct: 121 --IIYRDLKPENILLDAQGHVKLTDFGLCKE-SIHEGTVTHTFCGTIEYMAPEILMRSGH 177
Query: 456 TDKSDVYSFGVVLTELLTGEKP 477
D +S G ++ ++LTG P
Sbjct: 178 GKAVDWWSLGALMYDMLTGAPP 199
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323 |
| >gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Score = 57.2 bits (139), Expect = 6e-09
Identities = 48/186 (25%), Positives = 91/186 (48%), Gaps = 28/186 (15%)
Query: 303 AVKKSKVIDESKVEEF----INEVVILSQINHRNVVKLLGCCLETEVPL--------LVY 350
A+KK K+ E + E F + E+ IL ++ H N+V + EV + +V
Sbjct: 34 ALKKLKM--EKEKEGFPITSLREINILLKLQHPNIVTV------KEVVVGSNLDKIYMVM 85
Query: 351 EFIPNGTLFQYIHDQNEDFPITWEIRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILL 410
E++ + L + + F + E++ + +++ +++LH I HRD+K++N+LL
Sbjct: 86 EYVEH-DLKSLMETMKQPFLQS-EVKC-LMLQLLSGVAHLHDNW---ILHRDLKTSNLLL 139
Query: 411 DDKYRAKVSDFGASRSMAVDQTHMTTQVHGTFGYLDPE-YFRSSQFTDKSDVYSFGVVLT 469
+++ K+ DFG +R T V T Y PE + +++ D++S G +
Sbjct: 140 NNRGILKICDFGLAREYGSPLKPYTQLVV-TLWYRAPELLLGAKEYSTAIDMWSVGCIFA 198
Query: 470 ELLTGE 475
ELLT +
Sbjct: 199 ELLTKK 204
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293 |
| >gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Score = 57.8 bits (140), Expect = 6e-09
Identities = 37/98 (37%), Positives = 51/98 (52%), Gaps = 10/98 (10%)
Query: 386 ALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVD----QTHMTTQVHGT 441
L Y+HSA + HRD+K N+L++ K+ DFG +R + + MT V T
Sbjct: 117 GLKYIHSANVL---HRDLKPGNLLVNADCELKICDFGLARGFSENPGENAGFMTEYV-AT 172
Query: 442 FGYLDPEYFRSSQ-FTDKSDVYSFGVVLTELLTGEKPI 478
Y PE S Q +T DV+S G +L ELL G KP+
Sbjct: 173 RWYRAPEIMLSFQSYTKAIDVWSVGCILAELL-GRKPV 209
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332 |
| >gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Score = 57.7 bits (139), Expect = 6e-09
Identities = 44/160 (27%), Positives = 78/160 (48%), Gaps = 17/160 (10%)
Query: 321 EVVILSQINHRNVVKLLGCCL------ETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWE 374
E+V+L +NH+N++ LL E + LV E + + L Q IH + + +++
Sbjct: 70 ELVLLKCVNHKNIISLLNVFTPQKSLEEFQDVYLVMELM-DANLCQVIHMELDHERMSY- 127
Query: 375 IRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHM 434
+ ++ + +LHSA I HRD+K +NI++ K+ DFG +R+ + M
Sbjct: 128 ----LLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTACTN--FM 178
Query: 435 TTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLTELLTG 474
T T Y PE + + D++S G ++ EL+ G
Sbjct: 179 MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKG 218
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 57.5 bits (139), Expect = 8e-09
Identities = 36/119 (30%), Positives = 64/119 (53%), Gaps = 11/119 (9%)
Query: 364 DQNEDFPITWEIRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGA 423
D + +P+ + LR + +V+ + +L S I HRD+ + N+LL D AK+ DFG
Sbjct: 202 DTEDSWPLDLDDLLRFSSQVAQGMDFLASKNCI---HRDVAARNVLLTDGRVAKICDFGL 258
Query: 424 SRSMAVDQTHMTTQVHGT----FGYLDPEYFRSSQFTDKSDVYSFGVVLTELLT-GEKP 477
+R + D ++ V G ++ PE +T +SDV+S+G++L E+ + G+ P
Sbjct: 259 ARDIMNDSNYV---VKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSP 314
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Score = 57.1 bits (138), Expect = 8e-09
Identities = 52/193 (26%), Positives = 87/193 (45%), Gaps = 30/193 (15%)
Query: 304 VKKSKVIDESKVEEFINEVVILSQINHRNVVKLLGCCLETEVPL-LVYEFIPNG---TLF 359
+ K +I +++++ E IL+ + VV + C ET+ L +V E++ G TL
Sbjct: 34 INKQNLILRNQIQQVFVERDILTFAENPFVVSMF-CSFETKRHLCMVMEYVEGGDCATLL 92
Query: 360 QYIHDQNEDFPITWEI-RLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKV 418
+ I + ++ R+ A E AL YLH+ I HRD+K N+L+ K+
Sbjct: 93 KNIG------ALPVDMARMYFA-ETVLALEYLHNYG---IVHRDLKPDNLLITSMGHIKL 142
Query: 419 SDFGASR-------------SMAVD-QTHMTTQVHGTFGYLDPEYFRSSQFTDKSDVYSF 464
+DFG S+ + D + + QV GT Y+ PE + D ++
Sbjct: 143 TDFGLSKIGLMSLTTNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAM 202
Query: 465 GVVLTELLTGEKP 477
G++L E L G P
Sbjct: 203 GIILYEFLVGCVP 215
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305 |
| >gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Score = 56.9 bits (138), Expect = 8e-09
Identities = 56/232 (24%), Positives = 98/232 (42%), Gaps = 51/232 (21%)
Query: 287 ATDNFDLNRILGQG-------------GQAVKKSKVIDESKVEEF----INEVVILSQIN 329
++++ LG+G G+ V K++ ++ + F + E+ IL ++
Sbjct: 6 KLRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLK 65
Query: 330 HRNVVKLLGCCLE-----TEVPLLVYEFIPNGTLFQYI-HD-----QNEDFPITW-EIRL 377
H NVV L+ +E VY + Y+ HD +N +T +I+
Sbjct: 66 HPNVVPLIDMAVERPDKSKRKRGSVY------MVTPYMDHDLSGLLENPSVKLTESQIKC 119
Query: 378 RIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSM---------- 427
+++ ++YLH I HRDIK+ NIL+D++ K++DFG +R
Sbjct: 120 -YMLQLLEGINYLHENH---ILHRDIKAANILIDNQGILKIADFGLARPYDGPPPNPKGG 175
Query: 428 AVDQTHMTTQVHGTFGYLDPEY-FRSSQFTDKSDVYSFGVVLTELLTGEKPI 478
T T + T Y PE ++T D++ G V E+ T +PI
Sbjct: 176 GGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTR-RPI 226
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311 |
| >gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Score = 57.0 bits (138), Expect = 8e-09
Identities = 53/190 (27%), Positives = 89/190 (46%), Gaps = 24/190 (12%)
Query: 301 GQAVKKSKVIDESKVEEF----INEVVILSQINHRNVVKLLGCCLETEVP--------LL 348
Q V KV+ E++ E F + E+ IL + H NVV L+ C P L
Sbjct: 37 KQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPYNRYKGSFYL 96
Query: 349 VYEFIPNGTLFQYIHDQNEDFPITWEIRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNI 408
V+EF + L + ++N F ++ EI+ + + ++G L Y+H I HRD+K+ NI
Sbjct: 97 VFEFCEH-DLAGLLSNKNVKFTLS-EIKKVMKMLLNG-LYYIHRNK---ILHRDMKAANI 150
Query: 409 LLDDKYRAKVSDFGASRSMAV----DQTHMTTQVHGTFGYLDPEYFRSS-QFTDKSDVYS 463
L+ K++DFG +R+ ++ T +V T Y PE + D++
Sbjct: 151 LITKDGILKLADFGLARAFSLSKNSKPNRYTNRV-VTLWYRPPELLLGERDYGPPIDMWG 209
Query: 464 FGVVLTELLT 473
G ++ E+ T
Sbjct: 210 AGCIMAEMWT 219
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310 |
| >gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 57.1 bits (138), Expect = 9e-09
Identities = 35/97 (36%), Positives = 51/97 (52%), Gaps = 8/97 (8%)
Query: 386 ALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVD--QTHMTTQVHGTFG 443
AL Y+H+A ++HRD+K NIL + + K+ DFG +R D T T
Sbjct: 115 ALKYIHTAN---VFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRW 171
Query: 444 YLDPEYFRS--SQFTDKSDVYSFGVVLTELLTGEKPI 478
Y PE S S++T D++S G + E+LTG KP+
Sbjct: 172 YRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTG-KPL 207
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338 |
| >gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Score = 56.5 bits (136), Expect = 9e-09
Identities = 33/101 (32%), Positives = 52/101 (51%), Gaps = 7/101 (6%)
Query: 380 AIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVH 439
A E+ L ++H+ + +RD+K NILLD+ ++SD G + + + H +
Sbjct: 103 AAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASV--- 156
Query: 440 GTFGYLDPEYFRSSQFTDKS-DVYSFGVVLTELLTGEKPIR 479
GT GY+ PE + D S D +S G +L +LL G P R
Sbjct: 157 GTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFR 197
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278 |
| >gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Score = 56.8 bits (137), Expect = 1e-08
Identities = 45/170 (26%), Positives = 85/170 (50%), Gaps = 9/170 (5%)
Query: 311 DESKVEEFINEVVILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGTLFQYIHDQNEDFP 370
DE I E+ +L ++ H N+V+L + LV+E++ + L +++ D + DF
Sbjct: 41 DEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKRLYLVFEYL-DLDLKKHM-DSSPDFA 98
Query: 371 ITWEIRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRA-KVSDFGASRSMAV 429
+ ++ ++Y HS + HRD+K N+L+D + A K++DFG +R+ +
Sbjct: 99 KNPRLIKTYLYQILRGIAYCHSHR---VLHRDLKPQNLLIDRRTNALKLADFGLARAFGI 155
Query: 430 DQTHMTTQVHGTFGYLDPEYFRSS-QFTDKSDVYSFGVVLTELLTGEKPI 478
T +V T Y PE S ++ D++S G + E++ +KP+
Sbjct: 156 PVRTFTHEVV-TLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVN-QKPL 203
|
Length = 294 |
| >gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Score = 56.6 bits (136), Expect = 1e-08
Identities = 58/215 (26%), Positives = 94/215 (43%), Gaps = 33/215 (15%)
Query: 291 FDLNRILGQG-------GQAVKKS-----KVID--ESKVEEFINEVVILSQINH-RNVVK 335
F+L ++G G G+ VK KV+D E + EE E+ +L + +H RN+
Sbjct: 18 FELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTEDEEEEIKLEINMLKKYSHHRNIAT 77
Query: 336 LLGCCLETEVP------LLVYEFIPNGTLFQYIHD-QNEDFPITWEIRLRIAIEVSGALS 388
G ++ P LV EF G++ + + + W I E+ L+
Sbjct: 78 YYGAFIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDW--IAYICREILRGLA 135
Query: 389 YLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHGTFGYLDPE 448
+LH+ I HRDIK N+LL + K+ DFG S + T + GT ++ PE
Sbjct: 136 HLHAHKVI---HRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFI-GTPYWMAPE 191
Query: 449 YFRSSQFTD-----KSDVYSFGVVLTELLTGEKPI 478
+ D +SD++S G+ E+ G P+
Sbjct: 192 VIACDENPDATYDYRSDIWSLGITAIEMAEGAPPL 226
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 56.5 bits (137), Expect = 1e-08
Identities = 52/183 (28%), Positives = 87/183 (47%), Gaps = 25/183 (13%)
Query: 303 AVKKSKV-IDESKVEEF-INEVVILSQI---NHRNVVKLLGCC----LETEVPL-LVYEF 352
A+KK +V + E + + E+ +L Q+ H N+V+LL C + E+ L LV+E
Sbjct: 28 ALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELKLTLVFEH 87
Query: 353 IPNGTLFQYIHDQNEDFPITWEIRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDD 412
+ + L Y+ + I+ + ++ + +LHS I HRD+K NIL+
Sbjct: 88 V-DQDLATYLSKCPKPGLPPETIK-DLMRQLLRGVDFLHSHR---IVHRDLKPQNILVTS 142
Query: 413 KYRAKVSDFGASR----SMAVDQTHMTTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVL 468
+ K++DFG +R MA +T+ V T Y PE S + D++S G +
Sbjct: 143 DGQVKIADFGLARIYSFEMA-----LTSVV-VTLWYRAPEVLLQSSYATPVDMWSVGCIF 196
Query: 469 TEL 471
EL
Sbjct: 197 AEL 199
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Score = 56.6 bits (136), Expect = 1e-08
Identities = 31/93 (33%), Positives = 49/93 (52%), Gaps = 5/93 (5%)
Query: 390 LHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHGTFGYLDPEY 449
+HS + HRDIK N+LLD +++DFG+ M D T ++ GT Y+ PE
Sbjct: 115 IHSIHQLHYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGTVQSSVAVGTPDYISPEI 174
Query: 450 FRS-----SQFTDKSDVYSFGVVLTELLTGEKP 477
++ ++ + D +S GV + E+L GE P
Sbjct: 175 LQAMEDGMGKYGPECDWWSLGVCMYEMLYGETP 207
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331 |
| >gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Score = 56.7 bits (137), Expect = 2e-08
Identities = 54/218 (24%), Positives = 88/218 (40%), Gaps = 48/218 (22%)
Query: 302 QAVKKSKVIDESKVEEFINEVVILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGTLFQY 361
+ ++K+ V+ ++ E IL++ ++ VVKL + + V ++IP G +
Sbjct: 32 KTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMDYIPGGDMMSL 91
Query: 362 IHDQNEDFPITWEIRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDF 421
+ + F R IA E++ A+ +H I HRDIK NIL+D K++DF
Sbjct: 92 L-IRLGIFEEDLA-RFYIA-ELTCAIESVHKMGFI---HRDIKPDNILIDRDGHIKLTDF 145
Query: 422 GA---------SR-----------SMAVDQT-------------------HMTTQVH--- 439
G S+ SM + H H
Sbjct: 146 GLCTGFRWTHDSKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLV 205
Query: 440 GTFGYLDPEYFRSSQFTDKSDVYSFGVVLTELLTGEKP 477
GT Y+ PE + +T D +S GV+L E+L G+ P
Sbjct: 206 GTPNYIAPEVLLRTGYTQLCDWWSVGVILYEMLVGQPP 243
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376 |
| >gnl|CDD|133207 cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 55.7 bits (134), Expect = 2e-08
Identities = 63/257 (24%), Positives = 112/257 (43%), Gaps = 50/257 (19%)
Query: 308 KVIDESKVE---EFINEVVILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGTLFQYIHD 364
KV+D S + F ++SQ++H ++ + G C+ ++V EF+ +G L +
Sbjct: 50 KVLDPSHRDIALAFFETASLMSQVSHIHLAFVHGVCVRGSENIMVEEFVEHGPLDVCLRK 109
Query: 365 QNEDFPITWEIRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRA-------K 417
+ P+ W+I +A +++ ALSYL + H ++ + NILL A K
Sbjct: 110 EKGRVPVAWKI--TVAQQLASALSYLEDKN---LVHGNVCAKNILLARLGLAEGTSPFIK 164
Query: 418 VSD----FGA-SRSMAVDQTHMTTQVHGTFGYLDPEYFRS-SQFTDKSDVYSFGVVLTEL 471
+SD F A SR V++ ++ PE + + +D +SFG L E+
Sbjct: 165 LSDPGVSFTALSREERVER----------IPWIAPECVPGGNSLSTAADKWSFGTTLLEI 214
Query: 472 -LTGEKPIRFTILEEDKSLAAYFLCAMKEERLFEILDARVMKQGGKDEIITVAKLAKRCL 530
GE P++ E +ER +E R+ + K+ +A L +CL
Sbjct: 215 CFDGEVPLKERTPSE-------------KERFYE-KKHRLPEPSCKE----LATLISQCL 256
Query: 531 NLNGKKRPTMREVASEL 547
+RP+ R + +L
Sbjct: 257 TYEPTQRPSFRTILRDL 273
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 274 |
| >gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 56.2 bits (135), Expect = 2e-08
Identities = 46/170 (27%), Positives = 87/170 (51%), Gaps = 10/170 (5%)
Query: 319 INEVVILSQINHRNVVKLLGCCLETEVPL-LVYEFIPNGTLFQYIHDQNEDFPITWEIRL 377
I EV +L + H N+V L + TE L LV+E++ + L QY+ D + ++L
Sbjct: 52 IREVSLLKDLKHANIVTLHDI-IHTEKSLTLVFEYL-DKDLKQYLDDCGNSINMH-NVKL 108
Query: 378 RIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQ 437
+ + G L+Y H + HRD+K N+L++++ K++DFG +R+ ++ + +
Sbjct: 109 FLFQLLRG-LNYCHRRK---VLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYSNE 164
Query: 438 VHGTFGYLDPE-YFRSSQFTDKSDVYSFGVVLTELLTGEKPIRFTILEED 486
V T Y P+ S+ ++ + D++ G + E+ TG + +EE
Sbjct: 165 VV-TLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQ 213
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301 |
| >gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 56.3 bits (136), Expect = 2e-08
Identities = 53/211 (25%), Positives = 91/211 (43%), Gaps = 50/211 (23%)
Query: 303 AVKKSKVI----DESKVEEFIN----------EVVILSQINHRNVVKLLGCCLETEVPLL 348
A+KK K+I D +K + + E+ I+++I H N++ L+ +E + L
Sbjct: 38 AIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLVDVYVEGDFINL 97
Query: 349 VYEFIPNGTLFQYIHDQNEDFPITWEIRLR------IAIEVSGALSYLHSAASIPIYHRD 402
V + I L + + + IRL I +++ L+ LH HRD
Sbjct: 98 VMD-IMASDLKKVVDRK---------IRLTESQVKCILLQILNGLNVLHKWY---FMHRD 144
Query: 403 IKSTNILLDDKYRAKVSDFGASRSMAVD--------------QTHMTTQVHGTFGYLDPE 448
+ NI ++ K K++DFG +R + MT++V T Y PE
Sbjct: 145 LSPANIFINSKGICKIADFGLARRYGYPPYSDTLSKDETMQRREEMTSKVV-TLWYRAPE 203
Query: 449 -YFRSSQFTDKSDVYSFGVVLTELLTGEKPI 478
+ ++ D++S G + ELLTG KP+
Sbjct: 204 LLMGAEKYHFAVDMWSVGCIFAELLTG-KPL 233
|
Length = 335 |
| >gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 56.2 bits (136), Expect = 2e-08
Identities = 56/216 (25%), Positives = 91/216 (42%), Gaps = 55/216 (25%)
Query: 305 KKSKVIDESKVEEFINEVVILSQINHRNVVKLLGCCLETEVPL-LVYEFIPNGTLFQYIH 363
+KS+++++ +V E IL++ ++ VVKL + E L L+ E++P G + +
Sbjct: 35 RKSEMLEKEQVAHVRAERDILAEADNPWVVKLY-YSFQDENYLYLIMEYLPGGDMMTLLM 93
Query: 364 DQN---EDFPITWEIRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSD 420
++ E+ E R IA E A+ +H I HRDIK N+LLD K K+SD
Sbjct: 94 KKDTFTEE-----ETRFYIA-ETILAIDSIHKLGYI---HRDIKPDNLLLDAKGHIKLSD 144
Query: 421 FGASRSMAVDQTHMTT---------------------------------------QVHGT 441
FG + ++H T GT
Sbjct: 145 FGL--CTGLKKSHRTEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGT 202
Query: 442 FGYLDPEYFRSSQFTDKSDVYSFGVVLTELLTGEKP 477
Y+ PE F + + + D +S GV++ E+L G P
Sbjct: 203 PDYIAPEVFLQTGYNKECDWWSLGVIMYEMLVGYPP 238
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364 |
| >gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 55.8 bits (134), Expect = 2e-08
Identities = 45/183 (24%), Positives = 90/183 (49%), Gaps = 8/183 (4%)
Query: 319 INEVVILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEIRLR 378
I EV +L + H N+V L + LV+E++ + L QY+ D + +++
Sbjct: 52 IREVSLLKDLKHANIVTLHDIVHTDKSLTLVFEYL-DKDLKQYMDDCGNIMSMH-NVKIF 109
Query: 379 IAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQV 438
+ ++ L+Y H + HRD+K N+L++++ K++DFG +R+ +V + +V
Sbjct: 110 L-YQILRGLAYCHRRK---VLHRDLKPQNLLINERGELKLADFGLARAKSVPTKTYSNEV 165
Query: 439 HGTFGYLDPEYFR-SSQFTDKSDVYSFGVVLTELLTGEKPIRFTILEEDKSLAAYFLCAM 497
T Y P+ SS+++ + D++ G + E+ +G + +E++ L L
Sbjct: 166 V-TLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTP 224
Query: 498 KEE 500
EE
Sbjct: 225 TEE 227
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309 |
| >gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Score = 55.1 bits (133), Expect = 3e-08
Identities = 45/161 (27%), Positives = 70/161 (43%), Gaps = 18/161 (11%)
Query: 321 EVVILSQINHRNVVKLLGCCLETEVPLLVYEFIPN---GTLFQYIHDQNEDF--PITWEI 375
E+ +L Q+ H N+V L+ LV+E+ + L + E I W+
Sbjct: 50 EIRMLKQLKHPNLVNLIEVFRRKRKLHLVFEYCDHTVLNELEKNPRGVPEHLIKKIIWQT 109
Query: 376 RLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMT 435
A+++ H I HRD+K NIL+ + + K+ DFG +R + T
Sbjct: 110 LQ--------AVNFCHKHNCI---HRDVKPENILITKQGQIKLCDFGFARILTGPGDDYT 158
Query: 436 TQVHGTFGYLDPEYF-RSSQFTDKSDVYSFGVVLTELLTGE 475
V T Y PE +Q+ DV++ G V ELLTG+
Sbjct: 159 DYV-ATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQ 198
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286 |
| >gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 55.4 bits (134), Expect = 3e-08
Identities = 55/210 (26%), Positives = 86/210 (40%), Gaps = 39/210 (18%)
Query: 303 AVK---KSKVIDESKVEEFINEVVILSQINHRNVVKLLGCCLETEVPL-LVYEFIPNGTL 358
A+K K ++I +KV+ + E IL+ ++H + L +TE L LV ++ P G L
Sbjct: 30 ALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLY-ASFQTETYLCLVMDYCPGGEL 88
Query: 359 FQYIHDQNED-FPITWEIRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAK 417
F+ + Q R A EV AL YLH I +RD+K NILL +
Sbjct: 89 FRLLQRQPGKCLSEE-VARFYAA-EVLLALEYLHLLG---IVYRDLKPENILLHESGHIM 143
Query: 418 VSDFGASRSMAVDQTHMTTQVH----------------------------GTFGYLDPEY 449
+SDF S+ V+ ++ + GT Y+ PE
Sbjct: 144 LSDFDLSKQSDVEPPPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEV 203
Query: 450 FRSSQFTDKSDVYSFGVVLTELLTGEKPIR 479
D ++ G++L E+L G P +
Sbjct: 204 ISGDGHGSAVDWWTLGILLYEMLYGTTPFK 233
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316 |
| >gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 55.2 bits (133), Expect = 3e-08
Identities = 36/128 (28%), Positives = 56/128 (43%), Gaps = 37/128 (28%)
Query: 368 DFPITWEIRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSM 427
P+T E + + +V+ + +L S I HRD+ + NILL + K+ DFG +R +
Sbjct: 167 KEPLTLEDLISYSFQVARGMEFLASRKCI---HRDLAARNILLSENNVVKICDFGLARDI 223
Query: 428 AVDQTHMTTQVHGTFGYLDPEYFRSSQ-----------------FTDKSDVYSFGVVLTE 470
Y DP+Y R +T +SDV+SFGV+L E
Sbjct: 224 ----------------YKDPDYVRKGDARLPLKWMAPESIFDKVYTTQSDVWSFGVLLWE 267
Query: 471 LLT-GEKP 477
+ + G P
Sbjct: 268 IFSLGASP 275
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337 |
| >gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 55.0 bits (132), Expect = 4e-08
Identities = 37/132 (28%), Positives = 64/132 (48%), Gaps = 11/132 (8%)
Query: 370 PITWEIRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAV 429
+T E + + +V+ + +L S I HRD+ + NILL + K+ DFG +R +
Sbjct: 175 VLTLEDLICYSFQVAKGMEFLASRKCI---HRDLAARNILLSENNVVKICDFGLARDIYK 231
Query: 430 DQTHMTT-QVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLTELLT-GEKPIRFTILEEDK 487
D ++ ++ PE +T +SDV+SFGV+L E+ + G P ++E+
Sbjct: 232 DPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEE- 290
Query: 488 SLAAYFLCAMKE 499
F +KE
Sbjct: 291 -----FCRRLKE 297
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343 |
| >gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 54.8 bits (132), Expect = 4e-08
Identities = 29/93 (31%), Positives = 47/93 (50%), Gaps = 5/93 (5%)
Query: 390 LHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHGTFGYLDPEY 449
+ S + HRDIK N+LLD +++DFG+ + D T + GT Y+ PE
Sbjct: 115 IDSVHQLGYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLADGTVQSNVAVGTPDYISPEI 174
Query: 450 FRS-----SQFTDKSDVYSFGVVLTELLTGEKP 477
++ ++ + D +S GV + E+L GE P
Sbjct: 175 LQAMEDGKGRYGPECDWWSLGVCMYEMLYGETP 207
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331 |
| >gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Score = 54.2 bits (130), Expect = 6e-08
Identities = 48/173 (27%), Positives = 72/173 (41%), Gaps = 41/173 (23%)
Query: 325 LSQINHRNVVKLLGCCL------ETEVPLLVYEFI------------PNGTLFQYIHDQN 366
L +H N+V+L+ C ET+V L V+E + P G + I D
Sbjct: 56 LEAFDHPNIVRLMDVCATSRTDRETKVTL-VFEHVDQDLRTYLDKVPPPGLPAETIKDLM 114
Query: 367 EDFPITWEIRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRS 426
F + G L +LH+ I HRD+K NIL+ + K++DFG +R
Sbjct: 115 RQF-------------LRG-LDFLHANC---IVHRDLKPENILVTSGGQVKLADFGLAR- 156
Query: 427 MAVDQTHMT-TQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLTELLTGEKPI 478
+ M T V T Y PE S + D++S G + E+ KP+
Sbjct: 157 --IYSCQMALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFR-RKPL 206
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288 |
| >gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 54.3 bits (130), Expect = 6e-08
Identities = 43/157 (27%), Positives = 79/157 (50%), Gaps = 8/157 (5%)
Query: 319 INEVVILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEIRLR 378
I E +L + H N+V L E LV+E++ + L QY+ D++ ++L
Sbjct: 51 IREASLLKGLKHANIVLLHDIIHTKETLTLVFEYV-HTDLCQYM-DKHPGGLHPENVKLF 108
Query: 379 IAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQV 438
+ ++ LSY+H I HRD+K N+L+ D K++DFG +R+ +V +H +
Sbjct: 109 L-FQLLRGLSYIHQRY---ILHRDLKPQNLLISDTGELKLADFGLARAKSV-PSHTYSNE 163
Query: 439 HGTFGYLDPEYFR-SSQFTDKSDVYSFGVVLTELLTG 474
T Y P+ S++++ D++ G + E++ G
Sbjct: 164 VVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQG 200
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303 |
| >gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Score = 53.8 bits (130), Expect = 8e-08
Identities = 43/166 (25%), Positives = 78/166 (46%), Gaps = 21/166 (12%)
Query: 319 INEVVILSQIN-------HRNVVKLLGCCLE--TEVPLLVYEFIPNGTLFQYIHDQNEDF 369
+ +V L +I H N+++L+ + T LV+E + + L++ I +
Sbjct: 39 LEQVNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALVFELM-DMNLYELIKGRKRPL 97
Query: 370 PITWEIRLR-IAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMA 428
P E R++ ++ +L ++H I+HRDIK NIL+ D K++DFG+ R
Sbjct: 98 P---EKRVKSYMYQLLKSLDHMHRNG---IFHRDIKPENILIKD-DILKLADFGSCRG-- 148
Query: 429 VDQTHMTTQVHGTFGYLDPEYFRSSQF-TDKSDVYSFGVVLTELLT 473
+ T+ T Y PE + + K D+++ G V E+L+
Sbjct: 149 IYSKPPYTEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILS 194
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282 |
| >gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Score = 54.3 bits (131), Expect = 8e-08
Identities = 47/163 (28%), Positives = 80/163 (49%), Gaps = 23/163 (14%)
Query: 321 EVVILSQINHRNVVKLLGC-----CLET--EVPLLVYEFIPNGTLFQYIH-DQNEDFPIT 372
E+V++ +NH+N++ LL LE +V LV E + + L Q I D + +
Sbjct: 65 ELVLMKLVNHKNIIGLLNVFTPQKSLEEFQDV-YLVMELM-DANLCQVIQMDLDHE---- 118
Query: 373 WEIRLRIAI-EVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQ 431
R+ + ++ + +LHSA I HRD+K +NI++ K+ DFG +R+ A
Sbjct: 119 ---RMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLART-AGTS 171
Query: 432 THMTTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLTELLTG 474
MT V T Y PE + + D++S G ++ E++ G
Sbjct: 172 FMMTPYVV-TRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRG 213
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353 |
| >gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Score = 53.5 bits (128), Expect = 8e-08
Identities = 44/164 (26%), Positives = 74/164 (45%), Gaps = 16/164 (9%)
Query: 321 EVVILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEIRLRIA 380
E+ ++ + H N+V G L E + E+ G+L H P++ L+IA
Sbjct: 56 EIFMVKECKHCNIVAYFGSYLSREKLWICMEYCGGGSLQDIYHVTG---PLS---ELQIA 109
Query: 381 I---EVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQ 437
E L+YLHS + HRDIK NILL D K++DFG + + +
Sbjct: 110 YVCRETLQGLAYLHSKGKM---HRDIKGANILLTDNGDVKLADFGVAAKITATIAKRKSF 166
Query: 438 VHGTFGYLDPEYF---RSSQFTDKSDVYSFGVVLTELLTGEKPI 478
+ GT ++ PE ++ + D+++ G+ EL + P+
Sbjct: 167 I-GTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPM 209
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267 |
| >gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Score = 54.2 bits (130), Expect = 9e-08
Identities = 56/223 (25%), Positives = 90/223 (40%), Gaps = 54/223 (24%)
Query: 302 QAVKKSKVIDESKVEEFINEVVILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGTLFQY 361
+ ++K V++ ++V E IL++ ++ VVKL + + V ++IP G +
Sbjct: 32 KTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMDYIPGGDMMSL 91
Query: 362 IHDQNEDFPITWEIRLRIAI-EVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSD 420
+ + E FP E+ R I E++ A+ +H I HRDIK NIL+D K++D
Sbjct: 92 L-IRMEVFP---EVLARFYIAELTLAIESVHKMGFI---HRDIKPDNILIDLDGHIKLTD 144
Query: 421 FG---------------------------------------ASRSMAVDQ----THMTTQ 437
FG R ++Q H
Sbjct: 145 FGLCTGFRWTHNSKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCL 204
Query: 438 VH---GTFGYLDPEYFRSSQFTDKSDVYSFGVVLTELLTGEKP 477
H GT Y+ PE +T D +S GV+L E+L G+ P
Sbjct: 205 AHSLVGTPNYIAPEVLLRKGYTQLCDWWSVGVILFEMLVGQPP 247
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 53.3 bits (128), Expect = 1e-07
Identities = 37/158 (23%), Positives = 80/158 (50%), Gaps = 8/158 (5%)
Query: 319 INEVVILSQINHRNVVKLLGCCLETEVPL-LVYEFIPNGTLFQYIHDQNEDFPITWEIRL 377
I E+ ++ ++ H N+V+L + TE L LV+E++ + L +Y+ +
Sbjct: 46 IREISLMKELKHENIVRLHDV-IHTENKLMLVFEYM-DKDLKKYMDTHGVRGALDPNTVK 103
Query: 378 RIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQ 437
++ +++ H + HRD+K N+L++ + K++DFG +R+ + + +
Sbjct: 104 SFTYQLLKGIAFCHENR---VLHRDLKPQNLLINKRGELKLADFGLARAFGIPVNTFSNE 160
Query: 438 VHGTFGYLDPEYFRSSQ-FTDKSDVYSFGVVLTELLTG 474
V T Y P+ S+ ++ D++S G ++ E++TG
Sbjct: 161 VV-TLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITG 197
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Score = 53.5 bits (128), Expect = 1e-07
Identities = 64/235 (27%), Positives = 98/235 (41%), Gaps = 42/235 (17%)
Query: 275 KTKLFTSKELEKATDNFDLNRILGQG--GQAVKKSKVIDESKV------------EEFIN 320
KT +F S +D +++ +G+G G+ K + SK EE
Sbjct: 6 KTIIFDS--FPDPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIHDIDEEIEA 63
Query: 321 EVVILSQI-NHRNVVKLLGCCLETEVP-----LLVYEFIPNGTLFQYIH------DQNED 368
E IL + +H NVVK G + +V LV E G++ + ++ E+
Sbjct: 64 EYNILKALSDHPNVVKFYGMYYKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEE 123
Query: 369 FPITWEIRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMA 428
I + I E L +LH +I HRD+K NILL + K+ DFG S +
Sbjct: 124 PIIAY-----ILHEALMGLQHLHVNKTI---HRDVKGNNILLTTEGGVKLVDFGVSAQLT 175
Query: 429 VDQTHMTTQVHGTFGYLDPEYFRSSQFTDKS-----DVYSFGVVLTELLTGEKPI 478
+ T V GT ++ PE Q D + DV+S G+ EL G+ P+
Sbjct: 176 STRLRRNTSV-GTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPL 229
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286 |
| >gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 53.4 bits (129), Expect = 1e-07
Identities = 54/213 (25%), Positives = 93/213 (43%), Gaps = 46/213 (21%)
Query: 319 INEVVILSQINHRNVVKLLGCCLE-TEVPL-LVYEFIPNGTLFQYIHD----QNEDFP-- 370
E+ +L ++ H NVV L+ LE + + L++++ + L+Q I + P
Sbjct: 50 CREIALLRELKHENVVSLVEVFLEHADKSVYLLFDYAEH-DLWQIIKFHRQAKRVSIPPS 108
Query: 371 ----ITWEIRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILL----DDKYRAKVSDFG 422
+ W+I ++G + YLHS + HRD+K NIL+ ++ K+ D G
Sbjct: 109 MVKSLLWQI-------LNG-VHYLHSNW---VLHRDLKPANILVMGEGPERGVVKIGDLG 157
Query: 423 ASR--------SMAVDQTHMTTQVHGTFGYLDPEYFRSSQ-FTDKSDVYSFGVVLTELLT 473
+R +D V T Y PE ++ +T D+++ G + ELLT
Sbjct: 158 LARLFNAPLKPLADLD------PVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLT 211
Query: 474 GEKPIRFTILEEDKSLAAYFLCAMKEERLFEIL 506
E PI + K + + ER+FE+L
Sbjct: 212 LE-PIFKGREAKIKKSNPFQRDQL--ERIFEVL 241
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316 |
| >gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Score = 53.5 bits (128), Expect = 1e-07
Identities = 38/127 (29%), Positives = 60/127 (47%), Gaps = 15/127 (11%)
Query: 357 TLFQYIHDQ-NEDFPITWEIRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYR 415
TL D+ ED + + IAI+ L Y+H RDIK NIL+D
Sbjct: 90 TLLSKFEDRLPEDMARFYLAEMVIAIDSVHQLHYVH---------RDIKPDNILMDMNGH 140
Query: 416 AKVSDFGASRSMAVDQTHMTTQVHGTFGYLDPEYFRS-----SQFTDKSDVYSFGVVLTE 470
+++DFG+ + D T ++ GT Y+ PE ++ ++ + D +S GV + E
Sbjct: 141 IRLADFGSCLKLMEDGTVQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYE 200
Query: 471 LLTGEKP 477
+L GE P
Sbjct: 201 MLYGETP 207
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332 |
| >gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 53.4 bits (128), Expect = 1e-07
Identities = 53/191 (27%), Positives = 84/191 (43%), Gaps = 15/191 (7%)
Query: 292 DLNRILGQGGQAVKKSKVIDESKVEEFINEVVILSQINHRNVVKLLGCCLETEVP---LL 348
D RI + + K +++ + +V I E IL + ++G + L
Sbjct: 16 DTRRIYAM--KVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYL 73
Query: 349 VYEFIPNGTLFQYIHDQNEDFPITWEIRLRIAI-EVSGALSYLHSAASIPIYHRDIKSTN 407
V +++ G LF ++ + F E R + I E+ AL +LH I +RD+K N
Sbjct: 74 VTDYMSGGELFWHLQKEGR-FS---EDRAKFYIAELVLALEHLHKY---DIVYRDLKPEN 126
Query: 408 ILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHGTFGYLDPEYFRSSQ-FTDKSDVYSFGV 466
ILLD + DFG S++ D T GT YL PE + +T D +S GV
Sbjct: 127 ILLDATGHIALCDFGLSKANLTDNK-TTNTFCGTTEYLAPEVLLDEKGYTKHVDFWSLGV 185
Query: 467 VLTELLTGEKP 477
++ E+ G P
Sbjct: 186 LVFEMCCGWSP 196
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330 |
| >gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Score = 53.5 bits (128), Expect = 1e-07
Identities = 53/241 (21%), Positives = 94/241 (39%), Gaps = 58/241 (24%)
Query: 289 DNFDLNRILGQGG------------------QAVKKSKVIDESKVEEFINEVVILSQINH 330
D+F+ +++G+G + ++K+ ++++ +V E IL + +
Sbjct: 1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADG 60
Query: 331 RNVVKLLGCCLETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEIRLRIAIEVSGALSYL 390
VVK+ + L+ EF+P G + + +D + IA E A+ +
Sbjct: 61 AWVVKMFYSFQDKRNLYLIMEFLPGGDMMTLL--MKKDTLSEEATQFYIA-ETVLAIDAI 117
Query: 391 HSAASIPIYHRDIKSTNILLDDKYRAKVSDFG---------------------------- 422
H I HRDIK N+LLD K K+SDFG
Sbjct: 118 HQLGFI---HRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTEFYRNLTHNPPSDFSFQ 174
Query: 423 ------ASRSMAVDQTHMTTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLTELLTGEK 476
+ + ++ + GT Y+ PE F + + D +S GV++ E+L G
Sbjct: 175 NMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYP 234
Query: 477 P 477
P
Sbjct: 235 P 235
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360 |
| >gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 53.5 bits (128), Expect = 1e-07
Identities = 34/110 (30%), Positives = 57/110 (51%), Gaps = 5/110 (4%)
Query: 370 PITWEIRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAV 429
P+T E + + +V+ + +L S I HRD+ + NILL + K+ DFG +R +
Sbjct: 170 PLTMEDLICYSFQVARGMEFLASRKCI---HRDLAARNILLSENNVVKICDFGLARDIYK 226
Query: 430 DQTHMTT-QVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLTELLT-GEKP 477
D ++ ++ PE +T +SDV+SFGV+L E+ + G P
Sbjct: 227 DPDYVRKGSARLPLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASP 276
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338 |
| >gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Score = 53.5 bits (128), Expect = 2e-07
Identities = 56/249 (22%), Positives = 114/249 (45%), Gaps = 37/249 (14%)
Query: 254 FKRNGGLLLQQELASTE---GTIEKTKLFTSKELEKATDNFDLNRILGQGG--------- 301
F+ N L ++E + ++ K+ + ++ L I+G G
Sbjct: 28 FEMNDKKLDEEERSHNNNAGEDEDEEKMIDNDINRSPNKSYKLGNIIGNGSFGVVYEAIC 87
Query: 302 ----QAVKKSKVIDESKVEEFINEVVILSQINHRNVVKL-----LGCCLETEVPL---LV 349
+ V KV+ + + + E++I+ +NH N++ L C + E + +V
Sbjct: 88 IDTSEKVAIKKVLQDPQYKN--RELLIMKNLNHINIIFLKDYYYTECFKKNEKNIFLNVV 145
Query: 350 YEFIPNGT--LFQYIHDQNEDFPITWEIRLRIAIEVSGALSYLHSAASIPIYHRDIKSTN 407
EFIP ++ N P+ + ++L + ++ AL+Y+HS I HRD+K N
Sbjct: 146 MEFIPQTVHKYMKHYARNNHALPL-FLVKL-YSYQLCRALAYIHSKF---ICHRDLKPQN 200
Query: 408 ILLDDK-YRAKVSDFGASRSMAVDQTHMTTQVHGTFGYLDPE-YFRSSQFTDKSDVYSFG 465
+L+D + K+ DFG+++++ Q + + + F Y PE ++ +T D++S G
Sbjct: 201 LLIDPNTHTLKLCDFGSAKNLLAGQRSV-SYICSRF-YRAPELMLGATNYTTHIDLWSLG 258
Query: 466 VVLTELLTG 474
++ E++ G
Sbjct: 259 CIIAEMILG 267
|
Length = 440 |
| >gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Score = 53.1 bits (127), Expect = 2e-07
Identities = 53/208 (25%), Positives = 85/208 (40%), Gaps = 40/208 (19%)
Query: 304 VKKSKVIDESKVEEFINEVVILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGTLFQYIH 363
++K+ ++++ +V E IL + + VVK+ + L+ EF+P G + +
Sbjct: 34 LRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLIMEFLPGGDMMTLL- 92
Query: 364 DQNEDFPITWEIRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFG- 422
+D E + IA E A+ +H I HRDIK N+LLD K K+SDFG
Sbjct: 93 -MKKDTLTEEETQFYIA-ETVLAIDSIHQLGFI---HRDIKPDNLLLDSKGHVKLSDFGL 147
Query: 423 ---------------ASRSMAVDQT------------------HMTTQVHGTFGYLDPEY 449
+ S+ D T + GT Y+ PE
Sbjct: 148 CTGLKKAHRTEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEV 207
Query: 450 FRSSQFTDKSDVYSFGVVLTELLTGEKP 477
F + + D +S GV++ E+L G P
Sbjct: 208 FMQTGYNKLCDWWSLGVIMYEMLIGYPP 235
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 52.7 bits (127), Expect = 2e-07
Identities = 45/161 (27%), Positives = 82/161 (50%), Gaps = 8/161 (4%)
Query: 319 INEVVILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEIRLR 378
I E+ +L ++NH N+V+LL LV+EF+ + L +Y+ D + + +
Sbjct: 46 IREISLLKELNHPNIVRLLDVVHSENKLYLVFEFL-DLDLKKYM-DSSPLTGLDPPLIKS 103
Query: 379 IAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQV 438
++ ++Y HS + HRD+K N+L+D + K++DFG +R+ V T +V
Sbjct: 104 YLYQLLQGIAYCHSHR---VLHRDLKPQNLLIDREGALKLADFGLARAFGVPVRTYTHEV 160
Query: 439 HGTFGYLDPE-YFRSSQFTDKSDVYSFGVVLTELLTGEKPI 478
T Y PE S Q++ D++S G + E++ +P+
Sbjct: 161 V-TLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNR-RPL 199
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 52.7 bits (126), Expect = 3e-07
Identities = 48/170 (28%), Positives = 73/170 (42%), Gaps = 13/170 (7%)
Query: 309 VIDESKVEEFINEVVILSQINHRNVVKLLGCCLETEVPLLVYEFIP--NGTLFQYIHDQN 366
VI + E IL INH ++++L G + L+ +P L+ Y+ +
Sbjct: 121 VIKAGQRGGTATEAHILRAINHPSIIQLKGTFTYNKFTCLI---LPRYKTDLYCYLAAK- 176
Query: 367 EDFPITWEIRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRS 426
+ I +I L I V A+ YLH I HRDIK+ NI ++ + DFGA+
Sbjct: 177 RNIAIC-DI-LAIERSVLRAIQYLHENR---IIHRDIKAENIFINHPGDVCLGDFGAA-C 230
Query: 427 MAVDQT-HMTTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLTELLTGE 475
VD + GT PE + D++S G+VL E+ T
Sbjct: 231 FPVDINANKYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCH 280
|
Length = 391 |
| >gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Score = 52.4 bits (125), Expect = 3e-07
Identities = 44/174 (25%), Positives = 78/174 (44%), Gaps = 29/174 (16%)
Query: 311 DESKVEEFINEVVILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGTL--FQ--YIHDQN 366
+++ + E+V++ +NH+N++ LL F P +L FQ Y+ +
Sbjct: 56 NQTHAKRAYRELVLMKCVNHKNIISLLNV------------FTPQKSLEEFQDVYLVMEL 103
Query: 367 EDFPITWEIRLRIAIEVSGALSY--------LHSAASIPIYHRDIKSTNILLDDKYRAKV 418
D + I++ + E L Y LHSA I HRD+K +NI++ K+
Sbjct: 104 MDANLCQVIQMELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKI 160
Query: 419 SDFGASRSMAVDQTHMTTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLTELL 472
DFG +R+ + M T T Y PE + + D++S G ++ E++
Sbjct: 161 LDFGLARTAGT--SFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMV 212
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355 |
| >gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 52.5 bits (126), Expect = 3e-07
Identities = 50/206 (24%), Positives = 75/206 (36%), Gaps = 64/206 (31%)
Query: 324 ILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEI------RL 377
+L++ + VV L + + L+ EF+P G L + I ++ R
Sbjct: 54 VLAESDSPWVVSLYYSFQDAQYLYLIMEFLPGGDLMTML--------IKYDTFSEDVTRF 105
Query: 378 RIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGAS------------- 424
+A E A+ +H I HRDIK NIL+D K+SDFG S
Sbjct: 106 YMA-ECVLAIEAVHKLGFI---HRDIKPDNILIDRGGHIKLSDFGLSTGFHKQHDSAYYQ 161
Query: 425 ---------------RSMAVDQTHMTTQVH------------------GTFGYLDPEYFR 451
S+AVD ++T GT Y+ PE F
Sbjct: 162 KLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFL 221
Query: 452 SSQFTDKSDVYSFGVVLTELLTGEKP 477
+ + D +S G ++ E L G P
Sbjct: 222 QQGYGQECDWWSLGAIMFECLIGWPP 247
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377 |
| >gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Score = 52.0 bits (124), Expect = 5e-07
Identities = 46/166 (27%), Positives = 75/166 (45%), Gaps = 29/166 (17%)
Query: 321 EVVILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGTL--FQ--YIHDQNEDFPITWEIR 376
E+V++ +NH+N++ LL F P +L FQ YI + D + I+
Sbjct: 73 ELVLMKCVNHKNIIGLLNV------------FTPQKSLEEFQDVYIVMELMDANLCQVIQ 120
Query: 377 LRIAIEVSGALSY--------LHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMA 428
+ + E L Y LHSA I HRD+K +NI++ K+ DFG +R+
Sbjct: 121 MELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAG 177
Query: 429 VDQTHMTTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLTELLTG 474
+ M T T Y PE + + D++S G ++ E++ G
Sbjct: 178 T--SFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKG 221
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364 |
| >gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 51.1 bits (122), Expect = 7e-07
Identities = 42/159 (26%), Positives = 78/159 (49%), Gaps = 10/159 (6%)
Query: 319 INEVVILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEIRLR 378
I E +L + H N+V L E V+E++ + L QY+ Q+ + +RL
Sbjct: 51 IREASLLKGLKHANIVLLHDIIHTKETLTFVFEYM-HTDLAQYM-IQHPGGLHPYNVRL- 107
Query: 379 IAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAV-DQTHMTTQ 437
++ L+Y+H I HRD+K N+L+ K++DFG +R+ ++ QT+ +
Sbjct: 108 FMFQLLRGLAYIHGQH---ILHRDLKPQNLLISYLGELKLADFGLARAKSIPSQTYSSEV 164
Query: 438 VHGTFGYLDPEYFR-SSQFTDKSDVYSFGVVLTELLTGE 475
V T Y P+ ++ ++ D++ G + E+L G+
Sbjct: 165 V--TLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQ 201
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291 |
| >gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 50.4 bits (120), Expect = 1e-06
Identities = 28/96 (29%), Positives = 48/96 (50%), Gaps = 20/96 (20%)
Query: 386 ALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHGTFGYL 445
L Y+HSA I HRD+K +N+ +++ K+ DFG +R + T GY+
Sbjct: 132 GLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMT----------GYV 178
Query: 446 DPEYFRSSQ-------FTDKSDVYSFGVVLTELLTG 474
++R+ + + D++S G ++ ELLTG
Sbjct: 179 ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTG 214
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345 |
| >gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 49.9 bits (119), Expect = 1e-06
Identities = 39/155 (25%), Positives = 70/155 (45%), Gaps = 14/155 (9%)
Query: 328 INHRNVVKLLGCCLETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEIRL-RIAIEVSGA 386
+ H N+++ LG C+E LLV+E+ G L Y+ + + + L R+A E++
Sbjct: 52 LQHPNILQCLGQCVEAIPYLLVFEYCELGDLKSYLSQEQWHRRNSQLLLLQRMACEIAAG 111
Query: 387 LSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQ--VHGTFGY 444
++++H + H D+ N L KV D+G S + ++ T+ +
Sbjct: 112 VTHMHKHNFL---HSDLALRNCFLTSDLTVKVGDYGIGPS-RYKEDYIETEDDKCVPLRW 167
Query: 445 LDPEYFRS-------SQFTDKSDVYSFGVVLTELL 472
L PE ++ T S+V++ GV L EL
Sbjct: 168 LAPELVGEFHGGLITAEQTKPSNVWALGVTLWELF 202
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268 |
| >gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Score = 50.3 bits (120), Expect = 2e-06
Identities = 34/118 (28%), Positives = 61/118 (51%), Gaps = 11/118 (9%)
Query: 365 QNEDFPITWEIRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGAS 424
+ ++ + E L + +V+ +S+L S I HRD+ + NILL K+ DFG +
Sbjct: 205 EEDELALDTEDLLSFSYQVAKGMSFLASKNCI---HRDLAARNILLTHGRITKICDFGLA 261
Query: 425 RSMAVDQTHMTTQVHGT----FGYLDPEYFRSSQFTDKSDVYSFGVVLTELLT-GEKP 477
R + D ++ V G ++ PE + +T +SDV+S+G++L E+ + G P
Sbjct: 262 RDIRNDSNYV---VKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSP 316
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375 |
| >gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Score = 49.6 bits (118), Expect = 3e-06
Identities = 30/111 (27%), Positives = 60/111 (54%), Gaps = 8/111 (7%)
Query: 366 NEDFPITWEIRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASR 425
NE +++ + + +V+ + +L S + HRD+ + N+L+ + K+ DFG +R
Sbjct: 231 NESPALSYMDLVGFSYQVANGMEFLASKNCV---HRDLAARNVLICEGKLVKICDFGLAR 287
Query: 426 SMAVDQTHMTTQVHGTF---GYLDPEYFRSSQFTDKSDVYSFGVVLTELLT 473
+ D +++ TF ++ PE ++ +T SDV+SFG++L E+ T
Sbjct: 288 DIMRDSNYISKG--STFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFT 336
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401 |
| >gnl|CDD|173667 cd05576, STKc_RPK118_like, Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Score = 48.7 bits (116), Expect = 3e-06
Identities = 43/150 (28%), Positives = 61/150 (40%), Gaps = 24/150 (16%)
Query: 332 NVVKLLGCCLETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEIRLRIAIEVSGALSYLH 391
N+V L + + LV + G L+ +I I E R A E+ AL LH
Sbjct: 46 NMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISKF---LNIPEECVKRWAAEMVVALDALH 102
Query: 392 SAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSM-------AVDQTHMTTQVHGTFGY 444
I RD+ NILLDD+ +++ F + AV+ Y
Sbjct: 103 REG---IVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDSCDGEAVENM-----------Y 148
Query: 445 LDPEYFRSSQFTDKSDVYSFGVVLTELLTG 474
PE S+ T+ D +S G +L ELLTG
Sbjct: 149 CAPEVGGISEETEACDWWSLGAILFELLTG 178
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phosphate (SPP), a lipid messenger involved in many cellular events. RPK118 may be involved in transmitting SPP-mediated signaling. RPK118 also binds the antioxidant peroxiredoxin-3 (PRDX3). RPK118 may be involved in the transport of PRDX3 from the cytoplasm to its site of function in the mitochondria. Length = 237 |
| >gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 49.3 bits (117), Expect = 3e-06
Identities = 44/172 (25%), Positives = 77/172 (44%), Gaps = 39/172 (22%)
Query: 321 EVVILSQINHRNVVKLL-----GCCLE--TEVPL---LVYEFIPNGTLFQYIHDQNEDFP 370
E+ +L + H NV+ LL +E EV L L+ + N Q + D++ F
Sbjct: 64 ELRLLKHMKHENVIGLLDVFTPATSIENFNEVYLVTNLMGADLNNIVKCQKLSDEHVQFL 123
Query: 371 ITWEIRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVD 430
I +R L Y+HSA I HRD+K +N+ +++ ++ DFG +R +
Sbjct: 124 IYQLLR---------GLKYIHSAG---IIHRDLKPSNVAVNEDCELRILDFGLARQADDE 171
Query: 431 QTHMTTQVHGTFGYLDPEYFRSSQ-------FTDKSDVYSFGVVLTELLTGE 475
T GY+ ++R+ + + D++S G ++ ELL G+
Sbjct: 172 MT----------GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGK 213
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343 |
| >gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 48.7 bits (116), Expect = 5e-06
Identities = 44/170 (25%), Positives = 77/170 (45%), Gaps = 36/170 (21%)
Query: 321 EVVILSQINHRNVVKLLGCCLETEVPLL-----VYEFIP-NGTLFQYI--HDQNEDFPIT 372
E+ +L + H NV+ LL + T Y +P T Q I H +ED
Sbjct: 64 ELTLLKHMQHENVIGLLD--VFTSAVSGDEFQDFYLVMPYMQTDLQKIMGHPLSED---- 117
Query: 373 WEIRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQT 432
+++ + + G L Y+HSA I HRD+K N+ +++ K+ DFG +R + T
Sbjct: 118 -KVQYLVYQMLCG-LKYIHSAG---IIHRDLKPGNLAVNEDCELKILDFGLARHADAEMT 172
Query: 433 HMTTQVHGTFGYLDPEYFRSSQ-------FTDKSDVYSFGVVLTELLTGE 475
GY+ ++R+ + + D++S G ++ E+LTG+
Sbjct: 173 ----------GYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGK 212
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342 |
| >gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Score = 47.8 bits (114), Expect = 6e-06
Identities = 41/159 (25%), Positives = 77/159 (48%), Gaps = 8/159 (5%)
Query: 321 EVVILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEIRLRIA 380
E+ +L ++ H+N+V+L + LV+E+ + L +Y N D I EI
Sbjct: 49 EICLLKELKHKNIVRLYDVLHSDKKLTLVFEYC-DQDLKKYFDSCNGD--IDPEIVKSFM 105
Query: 381 IEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHG 440
++ L++ HS + HRD+K N+L++ K++DFG +R+ + + +V
Sbjct: 106 FQLLKGLAFCHSHN---VLHRDLKPQNLLINKNGELKLADFGLARAFGIPVRCYSAEVV- 161
Query: 441 TFGYLDPEYFRSSQFTDKS-DVYSFGVVLTELLTGEKPI 478
T Y P+ ++ S D++S G + EL +P+
Sbjct: 162 TLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPL 200
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284 |
| >gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 48.4 bits (115), Expect = 6e-06
Identities = 32/93 (34%), Positives = 50/93 (53%), Gaps = 9/93 (9%)
Query: 387 LSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHGTFGYLD 446
L Y+H+A I HRD+K N+ +++ K+ DFG +R + MT V T Y
Sbjct: 131 LKYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGLARQT---DSEMTGYVV-TRWYRA 183
Query: 447 PEYFRS-SQFTDKSDVYSFGVVLTELLTGEKPI 478
PE + +T D++S G ++ E+LTG KP+
Sbjct: 184 PEVILNWMHYTQTVDIWSVGCIMAEMLTG-KPL 215
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343 |
| >gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 47.0 bits (112), Expect = 1e-05
Identities = 43/158 (27%), Positives = 79/158 (50%), Gaps = 10/158 (6%)
Query: 319 INEVVILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEIRLR 378
I E +L + H N+V L + LV+E++ + L QY+ D + +RL
Sbjct: 51 IREASLLKDLKHANIVTLHDIIHTKKTLTLVFEYL-DTDLKQYMDDCGGGLSMH-NVRLF 108
Query: 379 IAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAV-DQTHMTTQ 437
+ + G L+Y H + HRD+K N+L+ ++ K++DFG +R+ +V +T+
Sbjct: 109 LFQLLRG-LAYCHQRR---VLHRDLKPQNLLISERGELKLADFGLARAKSVPSKTYSNEV 164
Query: 438 VHGTFGYLDPEYFR-SSQFTDKSDVYSFGVVLTELLTG 474
V T Y P+ S++++ D++ G + E+ TG
Sbjct: 165 V--TLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATG 200
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291 |
| >gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Score = 46.9 bits (111), Expect = 1e-05
Identities = 45/175 (25%), Positives = 81/175 (46%), Gaps = 8/175 (4%)
Query: 303 AVKKSKVIDESK--VEEFINEVVILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGTLFQ 360
A+KK K +E++ E + E+ +L + N+V+L LV+E++ L +
Sbjct: 30 AIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLVFEYVEKNML-E 88
Query: 361 YIHDQNEDFPITWEIRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSD 420
+ + P ++R I ++ A+ + H I HRDIK N+L+ K+ D
Sbjct: 89 LLEEMPNGVPPE-KVRSYI-YQLIKAIHWCHKND---IVHRDIKPENLLISHNDVLKLCD 143
Query: 421 FGASRSMAVDQTHMTTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLTELLTGE 475
FG +R+++ T+ T Y PE + + D++S G +L EL G+
Sbjct: 144 FGFARNLSEGSNANYTEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQ 198
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287 |
| >gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Score = 46.7 bits (111), Expect = 2e-05
Identities = 42/215 (19%), Positives = 89/215 (41%), Gaps = 34/215 (15%)
Query: 289 DNFDLNRILGQG-------------GQAVKKSKVIDESKVEEF----INEVVILSQINHR 331
D ++ +G+G G+ V K E E + E+ +L ++
Sbjct: 1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSES 60
Query: 332 N-VVKLLGCCLETEVPL------LVYEFIPNGTLFQYI--HDQNEDFPITWEIRLRIAIE 382
+V+LL E LV+E++ + L +++ + + P+ + +
Sbjct: 61 IYIVRLL-DVEHVEEKNGKPSLYLVFEYL-DSDLKKFMDSNGRGPGRPLPAKTIKSFMYQ 118
Query: 383 VSGALSYLHSAASIPIYHRDIKSTNILLD-DKYRAKVSDFGASRSMAVDQTHMTTQVHGT 441
+ +++ H + HRD+K N+L+D K K++D G R+ ++ T ++ T
Sbjct: 119 LLKGVAHCHKHG---VMHRDLKPQNLLVDKQKGLLKIADLGLGRAFSIPVKSYTHEIV-T 174
Query: 442 FGYLDPE-YFRSSQFTDKSDVYSFGVVLTELLTGE 475
Y PE S+ ++ D++S G + E+ +
Sbjct: 175 LWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQ 209
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295 |
| >gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Score = 46.6 bits (110), Expect = 3e-05
Identities = 28/100 (28%), Positives = 52/100 (52%), Gaps = 8/100 (8%)
Query: 377 LRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTT 436
L +V+ + +L S + HRD+ + N+LL K+ DFG +R + D +++
Sbjct: 240 LSFTYQVARGMEFLASKNCV---HRDLAARNVLLAQGKIVKICDFGLARDIMHDSNYVSK 296
Query: 437 QVHGTF---GYLDPEYFRSSQFTDKSDVYSFGVVLTELLT 473
TF ++ PE + +T SDV+S+G++L E+ +
Sbjct: 297 G--STFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFS 334
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400 |
| >gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Score = 45.4 bits (107), Expect = 5e-05
Identities = 54/225 (24%), Positives = 88/225 (39%), Gaps = 58/225 (25%)
Query: 302 QAVKKSKVIDESKVEEFINEVVILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGTLFQY 361
+ ++K V+ ++V E IL++ ++ VV+L + + V ++IP G +
Sbjct: 32 KTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMDYIPGGDMMSL 91
Query: 362 IHDQN---EDFPITWEIRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKV 418
+ ED R IA E++ A+ +H I HRDIK NIL+D K+
Sbjct: 92 LIRMGIFPEDLA-----RFYIA-ELTCAVESVHKMGFI---HRDIKPDNILIDRDGHIKL 142
Query: 419 SDFGAS------------------RSMAVD-------------------------QTHMT 435
+DFG R ++D + H
Sbjct: 143 TDFGLCTGFRWTHDSKYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQR 202
Query: 436 TQVH---GTFGYLDPEYFRSSQFTDKSDVYSFGVVLTELLTGEKP 477
H GT Y+ PE + +T D +S GV+L E+L G+ P
Sbjct: 203 CLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYEMLVGQPP 247
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382 |
| >gnl|CDD|140307 PTZ00284, PTZ00284, protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 44.2 bits (104), Expect = 2e-04
Identities = 29/114 (25%), Positives = 48/114 (42%), Gaps = 22/114 (19%)
Query: 378 RIAIEVSGALSYLHSAASIPIYHRDIKSTNILLD----------------DKYRAKVSDF 421
+I + AL Y H+ + + H D+K NIL++ D R ++ D
Sbjct: 235 QIIFQTGVALDYFHT--ELHLMHTDLKPENILMETSDTVVDPVTNRALPPDPCRVRICDL 292
Query: 422 GASRSMAVDQTHMTTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLTELLTGE 475
G D+ H T + T Y PE + +D++S G ++ EL TG+
Sbjct: 293 GG----CCDERHSRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGK 342
|
Length = 467 |
| >gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Score = 43.1 bits (101), Expect = 2e-04
Identities = 34/112 (30%), Positives = 56/112 (50%), Gaps = 12/112 (10%)
Query: 382 EVSGALSYLHSAASIPIYHRDIKSTNILL----DDKYRAKVSDFGASR--SMAVDQTHMT 435
++ + YLH+ + HRD+K NIL+ ++ R K++D G +R + +
Sbjct: 116 QILDGIHYLHANW---VLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADL 172
Query: 436 TQVHGTFGYLDPEYFRSSQ-FTDKSDVYSFGVVLTELLTGEKPIRFTILEED 486
V TF Y PE ++ +T D+++ G + ELLT E PI F +ED
Sbjct: 173 DPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSE-PI-FHCRQED 222
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317 |
| >gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Score = 43.1 bits (101), Expect = 3e-04
Identities = 34/112 (30%), Positives = 56/112 (50%), Gaps = 12/112 (10%)
Query: 382 EVSGALSYLHSAASIPIYHRDIKSTNILL----DDKYRAKVSDFGASR--SMAVDQTHMT 435
++ + YLH+ + HRD+K NIL+ ++ R K++D G +R + +
Sbjct: 116 QILDGIHYLHANW---VLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADL 172
Query: 436 TQVHGTFGYLDPEYFRSSQ-FTDKSDVYSFGVVLTELLTGEKPIRFTILEED 486
V TF Y PE ++ +T D+++ G + ELLT E PI F +ED
Sbjct: 173 DPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSE-PI-FHCRQED 222
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 43.7 bits (103), Expect = 3e-04
Identities = 35/127 (27%), Positives = 60/127 (47%), Gaps = 16/127 (12%)
Query: 304 VKKSKVIDESKVEEFINEVVILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGTLFQYIH 363
VKK+ +I+++ V + E L+ +V L LV E++ G + +H
Sbjct: 37 VKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQSANNVYLVMEYLIGGDVKSLLH 96
Query: 364 -----DQNEDFPITWEIRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKV 418
D+ E+ ++ EV+ AL YLH I HRD+K N+L+ ++ K+
Sbjct: 97 IYGYFDE--------EMAVKYISEVALALDYLHRHG---IIHRDLKPDNMLISNEGHIKL 145
Query: 419 SDFGASR 425
+DFG S+
Sbjct: 146 TDFGLSK 152
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 43.3 bits (102), Expect = 3e-04
Identities = 29/96 (30%), Positives = 48/96 (50%), Gaps = 10/96 (10%)
Query: 379 IAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQV 438
+A ++ A+ Y+H I HRDIK+ N+L++ + DFGA+ + +T
Sbjct: 265 VARQLLSAIDYIHGEG---IIHRDIKTENVLVNGPEDICLGDFGAA---CFARGSWSTPF 318
Query: 439 H-GTFGYLD---PEYFRSSQFTDKSDVYSFGVVLTE 470
H G G +D PE +T D++S G+V+ E
Sbjct: 319 HYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFE 354
|
Length = 461 |
| >gnl|CDD|173766 cd08226, PK_STRAD_beta, Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Score = 42.3 bits (99), Expect = 6e-04
Identities = 31/103 (30%), Positives = 44/103 (42%), Gaps = 17/103 (16%)
Query: 386 ALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDF---------GASRSMAVDQTHMTT 436
L+YLH I HR+IK+++IL+ +S G + D +T
Sbjct: 113 GLNYLHQNGYI---HRNIKASHILISGDGLVSLSGLSHLYSLVRNGQKAKVVYDFPQFST 169
Query: 437 QVHGTFGYLDPEYFRS--SQFTDKSDVYSFGVVLTELLTGEKP 477
V +L PE R + KSD+YS G+ EL TG P
Sbjct: 170 SV---LPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVP 209
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. STRAD-beta is also referred to as ALS2CR2 (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 2 protein), since the human gene encoding it is located within the juvenile ALS2 critical region on chromosome 2q33-q34. It is not linked to the development of ALS2. Length = 328 |
Conserved Domains Detected by HHsearch
Original result of HHsearch against CDD database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 608 | |||
| KOG1187 | 361 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0197 | 468 | consensus Tyrosine kinases [Signal transduction me | 100.0 | |
| KOG0192 | 362 | consensus Tyrosine kinase specific for activated ( | 100.0 | |
| KOG1026 | 774 | consensus Nerve growth factor receptor TRKA and re | 100.0 | |
| KOG0581 | 364 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG0575 | 592 | consensus Polo-like serine/threonine protein kinas | 100.0 | |
| KOG0615 | 475 | consensus Serine/threonine protein kinase Chk2 and | 100.0 | |
| KOG0595 | 429 | consensus Serine/threonine-protein kinase involved | 100.0 | |
| KOG0591 | 375 | consensus NIMA (never in mitosis)-related G2-speci | 100.0 | |
| KOG0196 | 996 | consensus Tyrosine kinase, EPH (ephrin) receptor f | 100.0 | |
| KOG0598 | 357 | consensus Ribosomal protein S6 kinase and related | 100.0 | |
| KOG0198 | 313 | consensus MEKK and related serine/threonine protei | 100.0 | |
| KOG0578 | 550 | consensus p21-activated serine/threonine protein k | 100.0 | |
| KOG1095 | 1025 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| KOG4278 | 1157 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| KOG0600 | 560 | consensus Cdc2-related protein kinase [Cell cycle | 100.0 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0593 | 396 | consensus Predicted protein kinase KKIAMRE [Genera | 100.0 | |
| KOG0582 | 516 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| KOG0194 | 474 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| KOG0592 | 604 | consensus 3-phosphoinositide-dependent protein kin | 100.0 | |
| KOG4721 | 904 | consensus Serine/threonine protein kinase, contain | 100.0 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 100.0 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 100.0 | |
| KOG0661 | 538 | consensus MAPK related serine/threonine protein ki | 100.0 | |
| KOG0193 | 678 | consensus Serine/threonine protein kinase RAF [Sig | 100.0 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0659 | 318 | consensus Cdk activating kinase (CAK)/RNA polymera | 100.0 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 100.0 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0588 | 786 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 100.0 | |
| KOG2345 | 302 | consensus Serine/threonine protein kinase/TGF-beta | 100.0 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 100.0 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 100.0 | |
| KOG0583 | 370 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 100.0 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0616 | 355 | consensus cAMP-dependent protein kinase catalytic | 100.0 | |
| KOG0599 | 411 | consensus Phosphorylase kinase gamma subunit [Carb | 100.0 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 100.0 | |
| KOG1094 | 807 | consensus Discoidin domain receptor DDR1 [Signal t | 100.0 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 100.0 | |
| KOG0589 | 426 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 100.0 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 100.0 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 100.0 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 100.0 | |
| KOG4257 | 974 | consensus Focal adhesion tyrosine kinase FAK, cont | 100.0 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 100.0 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 100.0 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG1025 | 1177 | consensus Epidermal growth factor receptor EGFR an | 100.0 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 100.0 | |
| KOG0597 | 808 | consensus Serine-threonine protein kinase FUSED [G | 100.0 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 100.0 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 100.0 | |
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 100.0 | |
| KOG0199 | 1039 | consensus ACK and related non-receptor tyrosine ki | 100.0 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 100.0 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 100.0 | |
| KOG0660 | 359 | consensus Mitogen-activated protein kinase [Signal | 100.0 | |
| KOG0201 | 467 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 100.0 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 100.0 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 100.0 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 100.0 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 100.0 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG1989 | 738 | consensus ARK protein kinase family [Signal transd | 100.0 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 100.0 | |
| KOG0605 | 550 | consensus NDR and related serine/threonine kinases | 100.0 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0580 | 281 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 100.0 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 100.0 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 100.0 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 100.0 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 100.0 | |
| KOG0585 | 576 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 100.0 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 100.0 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 100.0 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 100.0 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 100.0 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 100.0 | |
| KOG0694 | 694 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 100.0 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 100.0 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 100.0 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 100.0 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| KOG0611 | 668 | consensus Predicted serine/threonine protein kinas | 100.0 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 100.0 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 100.0 | |
| KOG0033 | 355 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 100.0 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 100.0 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 100.0 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 100.0 | |
| KOG0610 | 459 | consensus Putative serine/threonine protein kinase | 100.0 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 100.0 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 100.0 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 100.0 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 100.0 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 100.0 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 100.0 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 100.0 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 100.0 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 100.0 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 100.0 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 100.0 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 100.0 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 100.0 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 100.0 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 100.0 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0663 | 419 | consensus Protein kinase PITSLRE and related kinas | 100.0 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 100.0 | |
| KOG0584 | 632 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 100.0 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 100.0 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 100.0 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 100.0 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 100.0 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 100.0 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 100.0 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 100.0 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 100.0 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 100.0 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 100.0 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 100.0 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 100.0 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 100.0 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 100.0 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 100.0 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 100.0 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0658 | 364 | consensus Glycogen synthase kinase-3 [Carbohydrate | 100.0 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 100.0 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 100.0 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 100.0 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 100.0 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 100.0 | |
| KOG0577 | 948 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG4279 | 1226 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 100.0 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0594 | 323 | consensus Protein kinase PCTAIRE and related kinas | 100.0 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 100.0 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 100.0 | |
| KOG0032 | 382 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 100.0 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 100.0 | |
| KOG0200 | 609 | consensus Fibroblast/platelet-derived growth facto | 100.0 | |
| KOG4717 | 864 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 100.0 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 100.0 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 100.0 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 100.0 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 100.0 | |
| KOG3653 | 534 | consensus Transforming growth factor beta/activin | 100.0 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 100.0 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 100.0 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 100.0 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 100.0 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 100.0 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 100.0 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 100.0 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 100.0 | |
| PTZ00284 | 467 | protein kinase; Provisional | 100.0 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 100.0 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 100.0 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 100.0 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 100.0 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 100.0 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 100.0 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 100.0 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0574 | 502 | consensus STE20-like serine/threonine kinase MST [ | 100.0 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0596 | 677 | consensus Dual specificity; serine/threonine and t | 100.0 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 99.98 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 99.98 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 99.98 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 99.98 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 99.98 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 99.98 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 99.98 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 99.98 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 99.98 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 99.98 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 99.98 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 99.98 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 99.98 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 99.98 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 99.98 | |
| KOG0579 | 1187 | consensus Ste20-like serine/threonine protein kina | 99.98 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 99.98 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 99.98 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 99.98 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 99.97 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 99.97 | |
| KOG0667 | 586 | consensus Dual-specificity tyrosine-phosphorylatio | 99.97 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 99.97 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 99.97 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 99.97 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 99.97 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 99.97 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 99.97 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 99.97 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 99.97 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 99.97 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 99.97 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 99.97 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 99.97 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 99.97 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 99.97 | |
| KOG4645 | 1509 | consensus MAPKKK (MAP kinase kinase kinase) SSK2 a | 99.97 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 99.97 | |
| KOG0986 | 591 | consensus G protein-coupled receptor kinase [Signa | 99.97 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 99.97 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 99.97 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 99.97 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 99.97 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 99.97 | |
| KOG0586 | 596 | consensus Serine/threonine protein kinase [General | 99.97 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 99.97 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 99.97 | |
| KOG0604 | 400 | consensus MAP kinase-activated protein kinase 2 [S | 99.97 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 99.97 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 99.97 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 99.97 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 99.97 | |
| KOG2052 | 513 | consensus Activin A type IB receptor, serine/threo | 99.97 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 99.97 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 99.97 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 99.97 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 99.97 | |
| KOG0607 | 463 | consensus MAP kinase-interacting kinase and relate | 99.97 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 99.97 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 99.97 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 99.97 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 99.97 | |
| KOG0666 | 438 | consensus Cyclin C-dependent kinase CDK8 [Transcri | 99.97 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 99.97 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 99.97 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 99.97 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 99.97 | |
| KOG1024 | 563 | consensus Receptor-like protein tyrosine kinase RY | 99.97 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.97 | |
| KOG4250 | 732 | consensus TANK binding protein kinase TBK1 [Signal | 99.97 | |
| KOG0690 | 516 | consensus Serine/threonine protein kinase [Signal | 99.97 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 99.96 | |
| KOG0983 | 391 | consensus Mitogen-activated protein kinase (MAPK) | 99.96 | |
| KOG0612 | 1317 | consensus Rho-associated, coiled-coil containing p | 99.96 | |
| KOG1151 | 775 | consensus Tousled-like protein kinase [Signal tran | 99.96 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 99.96 | |
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 99.96 | |
| KOG0669 | 376 | consensus Cyclin T-dependent kinase CDK9 [Cell cyc | 99.96 | |
| KOG0671 | 415 | consensus LAMMER dual specificity kinases [Signal | 99.96 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 99.96 | |
| KOG0696 | 683 | consensus Serine/threonine protein kinase [Signal | 99.96 | |
| KOG1006 | 361 | consensus Mitogen-activated protein kinase (MAPK) | 99.96 | |
| KOG0614 | 732 | consensus cGMP-dependent protein kinase [Signal tr | 99.95 | |
| KOG0662 | 292 | consensus Cyclin-dependent kinase CDK5 [Intracellu | 99.95 | |
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 99.95 | |
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 99.95 | |
| KOG0587 | 953 | consensus Traf2- and Nck-interacting kinase and re | 99.95 | |
| KOG4236 | 888 | consensus Serine/threonine protein kinase PKC mu/P | 99.95 | |
| KOG1027 | 903 | consensus Serine/threonine protein kinase and endo | 99.94 | |
| KOG0695 | 593 | consensus Serine/threonine protein kinase [Signal | 99.94 | |
| KOG0608 | 1034 | consensus Warts/lats-like serine threonine kinases | 99.94 | |
| KOG0665 | 369 | consensus Jun-N-terminal kinase (JNK) [Signal tran | 99.94 | |
| KOG0984 | 282 | consensus Mitogen-activated protein kinase (MAPK) | 99.94 | |
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.94 | |
| KOG0668 | 338 | consensus Casein kinase II, alpha subunit [Signal | 99.93 | |
| KOG0664 | 449 | consensus Nemo-like MAPK-related serine/threonine | 99.93 | |
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 99.93 | |
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 99.93 | |
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 99.91 | |
| KOG0670 | 752 | consensus U4/U6-associated splicing factor PRP4 [R | 99.91 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 99.91 | |
| KOG1290 | 590 | consensus Serine/threonine protein kinase [Signal | 99.91 | |
| KOG1345 | 378 | consensus Serine/threonine kinase [Signal transduc | 99.9 | |
| KOG1152 | 772 | consensus Signal transduction serine/threonine kin | 99.89 | |
| KOG1167 | 418 | consensus Serine/threonine protein kinase of the C | 99.89 | |
| KOG1164 | 322 | consensus Casein kinase (serine/threonine/tyrosine | 99.86 | |
| KOG0195 | 448 | consensus Integrin-linked kinase [Signal transduct | 99.83 | |
| KOG1165 | 449 | consensus Casein kinase (serine/threonine/tyrosine | 99.83 | |
| KOG1023 | 484 | consensus Natriuretic peptide receptor, guanylate | 99.82 | |
| KOG1163 | 341 | consensus Casein kinase (serine/threonine/tyrosine | 99.81 | |
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.81 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.8 | |
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.79 | |
| KOG1240 | 1431 | consensus Protein kinase containing WD40 repeats [ | 99.79 | |
| KOG1033 | 516 | consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati | 99.73 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.71 | |
| PF13947 | 106 | GUB_WAK_bind: Wall-associated receptor kinase gala | 99.71 | |
| KOG4158 | 598 | consensus BRPK/PTEN-induced protein kinase [Signal | 99.71 | |
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.71 | |
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.66 | |
| PRK10345 | 210 | hypothetical protein; Provisional | 99.65 | |
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.63 | |
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.59 | |
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 99.57 | |
| PF08488 | 103 | WAK: Wall-associated kinase; InterPro: IPR013695 T | 99.56 | |
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 99.52 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.5 | |
| KOG1166 | 974 | consensus Mitotic checkpoint serine/threonine prot | 99.5 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.48 | |
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 99.46 | |
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 99.41 | |
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 99.41 | |
| KOG1266 | 458 | consensus Protein kinase [Signal transduction mech | 99.4 | |
| smart00090 | 237 | RIO RIO-like kinase. | 99.38 | |
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 99.35 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 99.33 | |
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 99.14 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.08 | |
| KOG1243 | 690 | consensus Protein kinase [General function predict | 99.03 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 98.92 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 98.9 | |
| cd05151 | 170 | ChoK Choline Kinase (ChoK). The ChoK subfamily is | 98.82 | |
| KOG3741 | 655 | consensus Poly(A) ribonuclease subunit [RNA proces | 98.79 | |
| cd05146 | 197 | RIO3_euk RIO kinase family; eukaryotic RIO3, catal | 98.73 | |
| COG3642 | 204 | Mn2+-dependent serine/threonine protein kinase [Si | 98.69 | |
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 98.66 | |
| COG4248 | 637 | Uncharacterized protein with protein kinase and he | 98.63 | |
| PRK15123 | 268 | lipopolysaccharide core heptose(I) kinase RfaP; Pr | 98.54 | |
| KOG2137 | 700 | consensus Protein kinase [Signal transduction mech | 98.51 | |
| cd05154 | 223 | ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an | 98.51 | |
| PRK04750 | 537 | ubiB putative ubiquinone biosynthesis protein UbiB | 98.5 | |
| KOG3087 | 229 | consensus Serine/threonine protein kinase [General | 98.49 | |
| PF06293 | 206 | Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; | 98.38 | |
| PF01163 | 188 | RIO1: RIO1 family; InterPro: IPR018934 Protein pho | 98.36 | |
| PF12260 | 188 | PIP49_C: Protein-kinase domain of FAM69; InterPro: | 98.18 | |
| PRK09902 | 216 | hypothetical protein; Provisional | 98.01 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 97.71 | |
| COG0478 | 304 | RIO-like serine/threonine protein kinase fused to | 97.65 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 97.58 | |
| PF06176 | 229 | WaaY: Lipopolysaccharide core biosynthesis protein | 97.5 | |
| cd05150 | 244 | APH Aminoglycoside 3'-phosphotransferase (APH). Th | 97.41 | |
| PF10707 | 199 | YrbL-PhoP_reg: PhoP regulatory network protein Yrb | 97.34 | |
| TIGR02172 | 226 | Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou | 97.26 | |
| KOG1826 | 2724 | consensus Ras GTPase activating protein RasGAP/neu | 97.03 | |
| cd05155 | 235 | APH_ChoK_like_1 Uncharacterized bacterial proteins | 96.93 | |
| PF01636 | 239 | APH: Phosphotransferase enzyme family This family | 96.93 | |
| PLN02876 | 822 | acyl-CoA dehydrogenase | 96.78 | |
| COG0661 | 517 | AarF Predicted unusual protein kinase [General fun | 96.43 | |
| COG1718 | 268 | RIO1 Serine/threonine protein kinase involved in c | 96.39 | |
| PRK10593 | 297 | hypothetical protein; Provisional | 96.05 | |
| cd05157 | 235 | ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes. | 95.9 | |
| TIGR02721 | 256 | ycfN_thiK thiamine kinase. Members of this family | 95.87 | |
| KOG1093 | 725 | consensus Predicted protein kinase (contains TBC a | 95.71 | |
| COG3173 | 321 | Predicted aminoglycoside phosphotransferase [Gener | 95.42 | |
| cd05153 | 296 | HomoserineK_II Homoserine Kinase, type II. Homoser | 95.35 | |
| TIGR00938 | 307 | thrB_alt homoserine kinase, Neisseria type. Homose | 95.3 | |
| KOG1235 | 538 | consensus Predicted unusual protein kinase [Genera | 95.23 | |
| TIGR02906 | 313 | spore_CotS spore coat protein, CotS family. Member | 94.96 | |
| cd05152 | 276 | MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH | 94.7 | |
| PRK05231 | 319 | homoserine kinase; Provisional | 94.47 | |
| PF01633 | 211 | Choline_kinase: Choline/ethanolamine kinase; Inter | 93.79 | |
| PF07387 | 308 | Seadorna_VP7: Seadornavirus VP7; InterPro: IPR0099 | 93.78 | |
| KOG2268 | 465 | consensus Serine/threonine protein kinase [Signal | 93.56 | |
| PLN02236 | 344 | choline kinase | 93.4 | |
| COG5072 | 488 | ALK1 Serine/threonine kinase of the haspin family | 93.06 | |
| COG3001 | 286 | Uncharacterized protein conserved in bacteria [Fun | 92.84 | |
| PF13095 | 207 | FTA2: Kinetochore Sim4 complex subunit FTA2 | 92.67 | |
| COG2112 | 201 | Predicted Ser/Thr protein kinase [Signal transduct | 92.29 | |
| PF03881 | 288 | Fructosamin_kin: Fructosamine kinase; InterPro: IP | 90.66 | |
| PLN02421 | 330 | phosphotransferase, alcohol group as acceptor/kina | 89.1 | |
| cd05156 | 302 | ChoK_euk Choline Kinase (ChoK) in eukaryotes. The | 89.09 | |
| PTZ00384 | 383 | choline kinase; Provisional | 87.11 | |
| PF12662 | 24 | cEGF: Complement Clr-like EGF-like | 86.47 | |
| PHA03111 | 444 | Ser/Thr kinase; Provisional | 85.92 | |
| PRK10271 | 188 | thiK thiamine kinase; Provisional | 83.37 | |
| COG2334 | 331 | Putative homoserine kinase type II (protein kinase | 82.85 | |
| PF05445 | 434 | Pox_ser-thr_kin: Poxvirus serine/threonine protein | 82.4 | |
| COG4499 | 434 | Predicted membrane protein [Function unknown] | 82.22 | |
| COG0510 | 269 | ycfN Thiamine kinase and related kinases [Coenzyme | 81.67 |
| >KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-52 Score=437.85 Aligned_cols=276 Identities=46% Similarity=0.732 Sum_probs=242.4
Q ss_pred ccccCCHHHHHHHhcCccccceeccCce--------------EEEEEeecChhhHHHHHHHHHHHhhcCCCCccceeccc
Q 044312 275 KTKLFTSKELEKATDNFDLNRILGQGGQ--------------AVKKSKVIDESKVEEFINEVVILSQINHRNVVKLLGCC 340 (608)
Q Consensus 275 ~~~~~~~~~l~~~t~~f~~~~~lG~G~~--------------avk~~~~~~~~~~~~~~~Ei~il~~l~H~niv~l~~~~ 340 (608)
..+.|++++|++||++|...++||+|+| |||+.......+..+|.+|+.+|++++|||||+|+|||
T Consensus 61 ~~~~fs~~el~~AT~~Fs~~~~ig~Ggfg~VYkG~l~~~~~vAVK~~~~~~~~~~~eF~~Ei~~ls~l~H~Nlv~LlGyC 140 (361)
T KOG1187|consen 61 PLRSFSYDELRKATNNFSESNLIGEGGFGTVYKGVLSDGTVVAVKRLSSNSGQGEREFLNEVEILSRLRHPNLVKLLGYC 140 (361)
T ss_pred CcceeeHHHHHHHHhCCchhcceecCCCeEEEEEEECCCCEEEEEEecCCCCcchhHHHHHHHHHhcCCCcCcccEEEEE
Confidence 5678999999999999999999999984 77866554333155699999999999999999999999
Q ss_pred ccCc-cceEEEeecCCCccchhccccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEEcCCCcEEEe
Q 044312 341 LETE-VPLLVYEFIPNGTLFQYIHDQNEDFPITWEIRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVS 419 (608)
Q Consensus 341 ~~~~-~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~ 419 (608)
.+.+ ..+||||||++|+|.++|+..... +++|.+|++||.++|+||+|||+...++|+||||||+|||||+++++||+
T Consensus 141 ~e~~~~~~LVYEym~nGsL~d~L~~~~~~-~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~aKls 219 (361)
T KOG1187|consen 141 LEGGEHRLLVYEYMPNGSLEDHLHGKKGE-PLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFNAKLS 219 (361)
T ss_pred ecCCceEEEEEEccCCCCHHHHhCCCCCC-CCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCCEEcc
Confidence 9998 599999999999999999986554 79999999999999999999999998899999999999999999999999
Q ss_pred eccCcccccc-CCcceeeeeeccCCCCChhhhccCCCCCccchHhHHHHHHHHHhCCCCCCccchhhcccHHHHHHHHhh
Q 044312 420 DFGASRSMAV-DQTHMTTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLTELLTGEKPIRFTILEEDKSLAAYFLCAMK 498 (608)
Q Consensus 420 DFGls~~~~~-~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~elltg~~p~~~~~~~~~~~l~~~~~~~~~ 498 (608)
|||+|+..+. ........ .||.+|+|||++..+.+++|+|||||||+|+||+||++|.+.........+..|....+.
T Consensus 220 DFGLa~~~~~~~~~~~~~~-~gt~gY~~PEy~~~g~lt~KsDVySFGVvllElitgr~~~d~~~~~~~~~l~~w~~~~~~ 298 (361)
T KOG1187|consen 220 DFGLAKLGPEGDTSVSTTV-MGTFGYLAPEYASTGKLTEKSDVYSFGVVLLELITGRKAVDQSRPRGELSLVEWAKPLLE 298 (361)
T ss_pred CccCcccCCccccceeeec-CCCCccCChhhhccCCcCcccccccchHHHHHHHhCCcccCCCCCcccccHHHHHHHHHH
Confidence 9999977664 32221111 799999999999999999999999999999999999999886665556668999988888
Q ss_pred hhhhHHHhhhhhh-ccCCh-hHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhhHH
Q 044312 499 EERLFEILDARVM-KQGGK-DEIITVAKLAKRCLNLNGKKRPTMREVASELAGIKA 552 (608)
Q Consensus 499 ~~~~~~~~d~~~~-~~~~~-~~~~~l~~Li~~cl~~dp~~RPs~~evl~~L~~i~~ 552 (608)
+..+.+++|+.+. .+... .....+..++.+|++.+|.+||+|.||+++|+.+..
T Consensus 299 ~~~~~eiiD~~l~~~~~~~~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~~L~~~~~ 354 (361)
T KOG1187|consen 299 EGKLREIVDPRLKEGEYPDEKEVKKLAELALRCLRPDPKERPTMSQVVKELEGILS 354 (361)
T ss_pred CcchhheeCCCccCCCCChHHHHHHHHHHHHHHcCcCCCcCcCHHHHHHHHHhhcc
Confidence 8899999999987 55553 678889999999999999999999999999965544
|
|
| >KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-45 Score=379.47 Aligned_cols=243 Identities=30% Similarity=0.481 Sum_probs=211.9
Q ss_pred CccccceeccCce--------------EEEEEeecChhhHHHHHHHHHHHhhcCCCCccceecccccCccceEEEeecCC
Q 044312 290 NFDLNRILGQGGQ--------------AVKKSKVIDESKVEEFINEVVILSQINHRNVVKLLGCCLETEVPLLVYEFIPN 355 (608)
Q Consensus 290 ~f~~~~~lG~G~~--------------avk~~~~~~~~~~~~~~~Ei~il~~l~H~niv~l~~~~~~~~~~~lV~E~~~~ 355 (608)
.+.+.+.||+|.| |+|.++.. ....++|.+|+++|++|+|+|||+|+|+|...+.++||||||+.
T Consensus 207 ~l~l~~~LG~G~FG~V~~g~~~~~~~vavk~ik~~-~m~~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~piyIVtE~m~~ 285 (468)
T KOG0197|consen 207 ELKLIRELGSGQFGEVWLGKWNGSTKVAVKTIKEG-SMSPEAFLREAQIMKKLRHEKLVKLYGVCTKQEPIYIVTEYMPK 285 (468)
T ss_pred HHHHHHHhcCCccceEEEEEEcCCCcccceEEecc-ccChhHHHHHHHHHHhCcccCeEEEEEEEecCCceEEEEEeccc
Confidence 3445788999975 77777654 44568899999999999999999999999998899999999999
Q ss_pred CccchhccccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEEcCCCcEEEeeccCccccccCCccee
Q 044312 356 GTLFQYIHDQNEDFPITWEIRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMT 435 (608)
Q Consensus 356 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGls~~~~~~~~~~~ 435 (608)
|+|.++|+.... ..+...+.+.++.|||+||+||++++ +|||||.++||||+++..+||+||||||....+.....
T Consensus 286 GsLl~yLr~~~~-~~l~~~~Ll~~a~qIaeGM~YLes~~---~IHRDLAARNiLV~~~~~vKIsDFGLAr~~~d~~Y~~~ 361 (468)
T KOG0197|consen 286 GSLLDYLRTREG-GLLNLPQLLDFAAQIAEGMAYLESKN---YIHRDLAARNILVDEDLVVKISDFGLARLIGDDEYTAS 361 (468)
T ss_pred CcHHHHhhhcCC-CccchHHHHHHHHHHHHHHHHHHhCC---ccchhhhhhheeeccCceEEEcccccccccCCCceeec
Confidence 999999997332 35899999999999999999999999 99999999999999999999999999996555554444
Q ss_pred eeeeccCCCCChhhhccCCCCCccchHhHHHHHHHHHh-CCCCCCccchhhcccHHHHHHHHhhhhhhHHHhhhhhhccC
Q 044312 436 TQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLTELLT-GEKPIRFTILEEDKSLAAYFLCAMKEERLFEILDARVMKQG 514 (608)
Q Consensus 436 ~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~ellt-g~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~ 514 (608)
....-+..|.|||.+..+.++.|||||||||+||||+| |+.|+. .+...++.+.++...+...
T Consensus 362 ~~~kfPIkWtAPEa~~~~~FS~kSDVWSFGVlL~E~fT~G~~py~----------------~msn~ev~~~le~GyRlp~ 425 (468)
T KOG0197|consen 362 EGGKFPIKWTAPEALNYGKFSSKSDVWSFGVLLWELFTYGRVPYP----------------GMSNEEVLELLERGYRLPR 425 (468)
T ss_pred CCCCCCceecCHHHHhhCCcccccceeehhhhHHHHhccCCCCCC----------------CCCHHHHHHHHhccCcCCC
Confidence 55556779999999999999999999999999999999 888876 2344456777888888889
Q ss_pred ChhHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhhHHh
Q 044312 515 GKDEIITVAKLAKRCLNLNGKKRPTMREVASELAGIKAW 553 (608)
Q Consensus 515 ~~~~~~~l~~Li~~cl~~dp~~RPs~~evl~~L~~i~~~ 553 (608)
|..++.++.+||..||+.+|++|||++.+...|+.+...
T Consensus 426 P~~CP~~vY~lM~~CW~~~P~~RPtF~~L~~~l~~~~~~ 464 (468)
T KOG0197|consen 426 PEGCPDEVYELMKSCWHEDPEDRPTFETLREVLEDFFTS 464 (468)
T ss_pred CCCCCHHHHHHHHHHhhCCcccCCCHHHHHHHHHHhhhc
Confidence 999999999999999999999999999999888877653
|
|
| >KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-43 Score=370.49 Aligned_cols=234 Identities=35% Similarity=0.543 Sum_probs=193.7
Q ss_pred EEEEEeecCh--hhHHHHHHHHHHHhhcCCCCccceecccccCc-cceEEEeecCCCccchhccccCCCCCCCHHHHHHH
Q 044312 303 AVKKSKVIDE--SKVEEFINEVVILSQINHRNVVKLLGCCLETE-VPLLVYEFIPNGTLFQYIHDQNEDFPITWEIRLRI 379 (608)
Q Consensus 303 avk~~~~~~~--~~~~~~~~Ei~il~~l~H~niv~l~~~~~~~~-~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i 379 (608)
|||++...+. ...++|.+|+.+|++++|||||+++|+|.+.. ...|||||+++|+|.++++.. .+..+++..+++|
T Consensus 69 avK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~~~~iVtEy~~~GsL~~~l~~~-~~~~l~~~~~l~~ 147 (362)
T KOG0192|consen 69 AVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACTSPPGSLCIVTEYMPGGSLSVLLHKK-RKRKLPLKVRLRI 147 (362)
T ss_pred EEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCceEEEEEeCCCCcHHHHHhhc-ccCCCCHHHHHHH
Confidence 6676664322 22669999999999999999999999999887 789999999999999999885 2336999999999
Q ss_pred HHHHHHHHHHHhhcCCCCeeccCCCCCcEEEcCCC-cEEEeeccCccccccCCcceeeeeeccCCCCChhhhc--cCCCC
Q 044312 380 AIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKY-RAKVSDFGASRSMAVDQTHMTTQVHGTFGYLDPEYFR--SSQFT 456 (608)
Q Consensus 380 ~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~-~~kl~DFGls~~~~~~~~~~~~~~~gt~~y~aPE~~~--~~~~t 456 (608)
|.|||+||.|||+++. ||||||||+|||++.++ ++||+|||+++...... ...+...||+.|||||++. ...++
T Consensus 148 aldiArGm~YLH~~~~--iIHrDLK~~NiLv~~~~~~~KI~DFGlsr~~~~~~-~~~~~~~GT~~wMAPEv~~~~~~~~~ 224 (362)
T KOG0192|consen 148 ALDIARGMEYLHSEGP--IIHRDLKSDNILVDLKGKTLKIADFGLSREKVISK-TSMTSVAGTYRWMAPEVLRGEKSPYT 224 (362)
T ss_pred HHHHHHHHHHHhcCCC--eeecccChhhEEEcCCCCEEEECCCccceeecccc-ccccCCCCCccccChhhhcCCCCcCC
Confidence 9999999999999884 99999999999999997 99999999998765432 2334478999999999999 56999
Q ss_pred CccchHhHHHHHHHHHhCCCCCCccchhhcccHHHHHHHHhhhhhhHHHhhhhhhccCChhHHHHHHHHHHHHhccCCCC
Q 044312 457 DKSDVYSFGVVLTELLTGEKPIRFTILEEDKSLAAYFLCAMKEERLFEILDARVMKQGGKDEIITVAKLAKRCLNLNGKK 536 (608)
Q Consensus 457 ~ksDV~S~Gvvl~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~Li~~cl~~dp~~ 536 (608)
.|+||||||++||||+||+.||...... . ....+.....+...+..++..+..|+.+||+.||+.
T Consensus 225 ~K~DvySFgIvlWEl~t~~~Pf~~~~~~------~---------~~~~v~~~~~Rp~~p~~~~~~l~~l~~~CW~~dp~~ 289 (362)
T KOG0192|consen 225 EKSDVYSFGIVLWELLTGEIPFEDLAPV------Q---------VASAVVVGGLRPPIPKECPPHLSSLMERCWLVDPSR 289 (362)
T ss_pred ccchhhhHHHHHHHHHHCCCCCCCCCHH------H---------HHHHHHhcCCCCCCCccCCHHHHHHHHHhCCCCCCc
Confidence 9999999999999999999999743221 1 111222222333445557889999999999999999
Q ss_pred CCCHHHHHHHHHhhHHhcC
Q 044312 537 RPTMREVASELAGIKAWNG 555 (608)
Q Consensus 537 RPs~~evl~~L~~i~~~~~ 555 (608)
||++.|++..|+.+.....
T Consensus 290 RP~f~ei~~~l~~~~~~~~ 308 (362)
T KOG0192|consen 290 RPSFLEIVSRLESIMSHIS 308 (362)
T ss_pred CCCHHHHHHHHHHHHHhhc
Confidence 9999999999999876443
|
|
| >KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-43 Score=380.17 Aligned_cols=248 Identities=29% Similarity=0.472 Sum_probs=209.9
Q ss_pred HhcCccccceeccCce--------------------EEEEEeecChh-hHHHHHHHHHHHhhcCCCCccceecccccCcc
Q 044312 287 ATDNFDLNRILGQGGQ--------------------AVKKSKVIDES-KVEEFINEVVILSQINHRNVVKLLGCCLETEV 345 (608)
Q Consensus 287 ~t~~f~~~~~lG~G~~--------------------avk~~~~~~~~-~~~~~~~Ei~il~~l~H~niv~l~~~~~~~~~ 345 (608)
.+.+....+.||+|+| |||.++...+. ..++|++|+++|..|+|||||+|+|+|.+++.
T Consensus 484 ~r~~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a~~~~~~dF~REaeLla~l~H~nIVrLlGVC~~~~P 563 (774)
T KOG1026|consen 484 PRSDIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKAENQARQDFRREAELLAELQHPNIVRLLGVCREGDP 563 (774)
T ss_pred chhheeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEccCCe
Confidence 3455667889999975 88988876665 78899999999999999999999999999999
Q ss_pred ceEEEeecCCCccchhccccCC-----------CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEEcCCC
Q 044312 346 PLLVYEFIPNGTLFQYIHDQNE-----------DFPITWEIRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKY 414 (608)
Q Consensus 346 ~~lV~E~~~~gsL~~~l~~~~~-----------~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~ 414 (608)
.+||+|||..|+|.+||..... +.+|+..+.+.||.|||.||+||-++. ++||||..+|+||.++.
T Consensus 564 ~~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~~---FVHRDLATRNCLVge~l 640 (774)
T KOG1026|consen 564 LCMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSHH---FVHRDLATRNCLVGENL 640 (774)
T ss_pred eEEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCc---ccccchhhhhceeccce
Confidence 9999999999999999975321 224889999999999999999999998 99999999999999999
Q ss_pred cEEEeeccCccccccCCcceee-eeeccCCCCChhhhccCCCCCccchHhHHHHHHHHHh-CCCCCCccchhhcccHHHH
Q 044312 415 RAKVSDFGASRSMAVDQTHMTT-QVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLTELLT-GEKPIRFTILEEDKSLAAY 492 (608)
Q Consensus 415 ~~kl~DFGls~~~~~~~~~~~~-~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~ellt-g~~p~~~~~~~~~~~l~~~ 492 (608)
.+||+||||+|.+...+.+... .-.-..+|||||.+..++||.+||||||||+|||+++ |+.||....
T Consensus 641 ~VKIsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~kFTteSDVWs~GVvLWEIFsyG~QPy~glS---------- 710 (774)
T KOG1026|consen 641 VVKISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYGKFTTESDVWSFGVVLWEIFSYGKQPYYGLS---------- 710 (774)
T ss_pred EEEecccccchhhhhhhhhcccCCceeeeecCCHHHhhcCcccchhhhhhhhhhhhhhhccccCcccccc----------
Confidence 9999999999977654444332 3345679999999999999999999999999999999 888987332
Q ss_pred HHHHhhhhhhHHHhhhhhhccCChhHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhhHHh
Q 044312 493 FLCAMKEERLFEILDARVMKQGGKDEIITVAKLAKRCLNLNGKKRPTMREVASELAGIKAW 553 (608)
Q Consensus 493 ~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~evl~~L~~i~~~ 553 (608)
.+.+.+.+..+-..+.+..++.++++||..||+.+|.+||+++||-..|+..-..
T Consensus 711 ------n~EVIe~i~~g~lL~~Pe~CP~~vY~LM~~CW~~~P~~RPsF~eI~~~L~~~~~~ 765 (774)
T KOG1026|consen 711 ------NQEVIECIRAGQLLSCPENCPTEVYSLMLECWNENPKRRPSFKEIHSRLQAWAQA 765 (774)
T ss_pred ------hHHHHHHHHcCCcccCCCCCCHHHHHHHHHHhhcCcccCCCHHHHHHHHHHHHhc
Confidence 2223333333333667888999999999999999999999999999999876543
|
|
| >KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-42 Score=345.09 Aligned_cols=242 Identities=26% Similarity=0.382 Sum_probs=198.3
Q ss_pred CCHHHHHHHhcCccccceeccCc---------------eEEEEEee-cChhhHHHHHHHHHHHhhcCCCCccceeccccc
Q 044312 279 FTSKELEKATDNFDLNRILGQGG---------------QAVKKSKV-IDESKVEEFINEVVILSQINHRNVVKLLGCCLE 342 (608)
Q Consensus 279 ~~~~~l~~~t~~f~~~~~lG~G~---------------~avk~~~~-~~~~~~~~~~~Ei~il~~l~H~niv~l~~~~~~ 342 (608)
.+..+|++ .+.||+|. +|+|.+.. .++...+++.+|+++++..+||+||+++|.|..
T Consensus 76 i~~~dle~-------~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~ 148 (364)
T KOG0581|consen 76 ISLSDLER-------LGVLGSGNGGTVYKVRHKPTGKIYALKVILLNIDPALQKQILRELEILRSCQSPYIVGFYGAFYS 148 (364)
T ss_pred cCHHHhhh-------hhhcccCCCcEEEEEEEcCCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEe
Confidence 44555554 67899985 47887743 466677899999999999999999999999998
Q ss_pred Cc-cceEEEeecCCCccchhccccCCCCCCCHHHHHHHHHHHHHHHHHHhh-cCCCCeeccCCCCCcEEEcCCCcEEEee
Q 044312 343 TE-VPLLVYEFIPNGTLFQYIHDQNEDFPITWEIRLRIAIEVSGALSYLHS-AASIPIYHRDIKSTNILLDDKYRAKVSD 420 (608)
Q Consensus 343 ~~-~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~-~~~~~iiHrDlk~~NILl~~~~~~kl~D 420 (608)
.. ...|+||||++|+|.+++...+ .+++...-+|+.+|++||.|||+ ++ ||||||||+|||++..|.+||+|
T Consensus 149 ~~~~isI~mEYMDgGSLd~~~k~~g---~i~E~~L~~ia~~VL~GL~YLh~~~~---IIHRDIKPsNlLvNskGeVKicD 222 (364)
T KOG0581|consen 149 NGEEISICMEYMDGGSLDDILKRVG---RIPEPVLGKIARAVLRGLSYLHEERK---IIHRDIKPSNLLVNSKGEVKICD 222 (364)
T ss_pred CCceEEeehhhcCCCCHHHHHhhcC---CCCHHHHHHHHHHHHHHHHHHhhccC---eeeccCCHHHeeeccCCCEEecc
Confidence 88 4999999999999999998753 48999999999999999999996 67 99999999999999999999999
Q ss_pred ccCccccccCCcceeeeeeccCCCCChhhhccCCCCCccchHhHHHHHHHHHhCCCCCCccchhhcccHHHHHHHHhhhh
Q 044312 421 FGASRSMAVDQTHMTTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLTELLTGEKPIRFTILEEDKSLAAYFLCAMKEE 500 (608)
Q Consensus 421 FGls~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~ 500 (608)
||.++.+... ......||..|||||.+.+..|+.++||||||++++|+.+|+.||...... ......
T Consensus 223 FGVS~~lvnS---~a~tfvGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~~~~-~~~~~~--------- 289 (364)
T KOG0581|consen 223 FGVSGILVNS---IANTFVGTSAYMSPERISGESYSVKSDIWSLGLSLLELAIGRFPYPPPNPP-YLDIFE--------- 289 (364)
T ss_pred ccccHHhhhh---hcccccccccccChhhhcCCcCCcccceecccHHHHHHhhCCCCCCCcCCC-CCCHHH---------
Confidence 9999887644 445678999999999999999999999999999999999999998743111 011111
Q ss_pred hhHHHhhhhhhccCCh-hHHHHHHHHHHHHhccCCCCCCCHHHHHHHH
Q 044312 501 RLFEILDARVMKQGGK-DEIITVAKLAKRCLNLNGKKRPTMREVASEL 547 (608)
Q Consensus 501 ~~~~~~d~~~~~~~~~-~~~~~l~~Li~~cl~~dp~~RPs~~evl~~L 547 (608)
-+..|++... ...+. ..+.+++.++..||+.||.+||+++|++++-
T Consensus 290 Ll~~Iv~~pp-P~lP~~~fS~ef~~FV~~CL~Kdp~~R~s~~qLl~Hp 336 (364)
T KOG0581|consen 290 LLCAIVDEPP-PRLPEGEFSPEFRSFVSCCLRKDPSERPSAKQLLQHP 336 (364)
T ss_pred HHHHHhcCCC-CCCCcccCCHHHHHHHHHHhcCCcccCCCHHHHhcCH
Confidence 1122332111 12223 3778899999999999999999999999764
|
|
| >KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-41 Score=354.87 Aligned_cols=235 Identities=26% Similarity=0.424 Sum_probs=199.3
Q ss_pred cCccccceeccCce---------------EEEEEe---ecChhhHHHHHHHHHHHhhcCCCCccceecccccCccceEEE
Q 044312 289 DNFDLNRILGQGGQ---------------AVKKSK---VIDESKVEEFINEVVILSQINHRNVVKLLGCCLETEVPLLVY 350 (608)
Q Consensus 289 ~~f~~~~~lG~G~~---------------avk~~~---~~~~~~~~~~~~Ei~il~~l~H~niv~l~~~~~~~~~~~lV~ 350 (608)
..|...+.||+||| |+|.+. +....+.+...+||+|.++|+|||||+++++|++.+..|||.
T Consensus 18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~nVYivL 97 (592)
T KOG0575|consen 18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSNNVYIVL 97 (592)
T ss_pred ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecCCceEEEE
Confidence 46888999999996 666653 345667889999999999999999999999999999999999
Q ss_pred eecCCCccchhccccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEEcCCCcEEEeeccCccccccC
Q 044312 351 EFIPNGTLFQYIHDQNEDFPITWEIRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVD 430 (608)
Q Consensus 351 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGls~~~~~~ 430 (608)
|+|++++|..++++. .++++.++..++.||+.||.|||+++ |+|||||..|+||+++.++||+|||||..+..+
T Consensus 98 ELC~~~sL~el~Krr---k~ltEpEary~l~QIv~GlkYLH~~~---IiHRDLKLGNlfL~~~~~VKIgDFGLAt~le~~ 171 (592)
T KOG0575|consen 98 ELCHRGSLMELLKRR---KPLTEPEARYFLRQIVEGLKYLHSLG---IIHRDLKLGNLFLNENMNVKIGDFGLATQLEYD 171 (592)
T ss_pred EecCCccHHHHHHhc---CCCCcHHHHHHHHHHHHHHHHHHhcC---ceecccchhheeecCcCcEEecccceeeeecCc
Confidence 999999999988743 36999999999999999999999999 999999999999999999999999999987654
Q ss_pred CcceeeeeeccCCCCChhhhccCCCCCccchHhHHHHHHHHHhCCCCCCccchhhcccHHHHHHHHhhhhhhHHHhhhhh
Q 044312 431 QTHMTTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLTELLTGEKPIRFTILEEDKSLAAYFLCAMKEERLFEILDARV 510 (608)
Q Consensus 431 ~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~ 510 (608)
. .......|||.|+|||++....++-.+||||+|||||.||+|++||+.....+ . ...++.. .
T Consensus 172 ~-Erk~TlCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G~PPFetk~vke------t-y~~Ik~~--------~- 234 (592)
T KOG0575|consen 172 G-ERKKTLCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVGRPPFETKTVKE------T-YNKIKLN--------E- 234 (592)
T ss_pred c-cccceecCCCcccChhHhccCCCCCchhhhhhhhHHHhhhhCCCCcccchHHH------H-HHHHHhc--------C-
Confidence 3 34566789999999999999999999999999999999999999997432221 0 1111111 1
Q ss_pred hccCChhHHHHHHHHHHHHhccCCCCCCCHHHHHHHH
Q 044312 511 MKQGGKDEIITVAKLAKRCLNLNGKKRPTMREVASEL 547 (608)
Q Consensus 511 ~~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~evl~~L 547 (608)
-..|...+.+.++||.++|+.||.+|||+++|+.+-
T Consensus 235 -Y~~P~~ls~~A~dLI~~lL~~~P~~Rpsl~~vL~h~ 270 (592)
T KOG0575|consen 235 -YSMPSHLSAEAKDLIRKLLRPNPSERPSLDEVLDHP 270 (592)
T ss_pred -cccccccCHHHHHHHHHHhcCCcccCCCHHHHhcCH
Confidence 123335667889999999999999999999999764
|
|
| >KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-41 Score=341.30 Aligned_cols=239 Identities=26% Similarity=0.391 Sum_probs=190.4
Q ss_pred HhcCccccceeccCce---------------EEEEEeecC-------hhhHHHHHHHHHHHhhcCCCCccceecccccCc
Q 044312 287 ATDNFDLNRILGQGGQ---------------AVKKSKVID-------ESKVEEFINEVVILSQINHRNVVKLLGCCLETE 344 (608)
Q Consensus 287 ~t~~f~~~~~lG~G~~---------------avk~~~~~~-------~~~~~~~~~Ei~il~~l~H~niv~l~~~~~~~~ 344 (608)
..+.|-+.+.||+|+| |||.++... ........+|+++|++|+|||||++++++...+
T Consensus 170 ~~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~~d 249 (475)
T KOG0615|consen 170 FNDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEVPD 249 (475)
T ss_pred hcceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeecCC
Confidence 4566788999999986 555543211 112233579999999999999999999999999
Q ss_pred cceEEEeecCCCccchhccccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEEcCC---CcEEEeec
Q 044312 345 VPLLVYEFIPNGTLFQYIHDQNEDFPITWEIRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDK---YRAKVSDF 421 (608)
Q Consensus 345 ~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~---~~~kl~DF 421 (608)
..||||||+.||+|.+++..+. .+.+..-..++.|++.|+.|||+.| |+||||||+|||+..+ ..+||+||
T Consensus 250 s~YmVlE~v~GGeLfd~vv~nk---~l~ed~~K~~f~Qll~avkYLH~~G---I~HRDiKPeNILl~~~~e~~llKItDF 323 (475)
T KOG0615|consen 250 SSYMVLEYVEGGELFDKVVANK---YLREDLGKLLFKQLLTAVKYLHSQG---IIHRDIKPENILLSNDAEDCLLKITDF 323 (475)
T ss_pred ceEEEEEEecCccHHHHHHhcc---ccccchhHHHHHHHHHHHHHHHHcC---cccccCCcceEEeccCCcceEEEeccc
Confidence 9999999999999999998765 3777888899999999999999999 9999999999999765 78999999
Q ss_pred cCccccccCCcceeeeeeccCCCCChhhhccCCC---CCccchHhHHHHHHHHHhCCCCCCccchhhcccHHHHHHHHhh
Q 044312 422 GASRSMAVDQTHMTTQVHGTFGYLDPEYFRSSQF---TDKSDVYSFGVVLTELLTGEKPIRFTILEEDKSLAAYFLCAMK 498 (608)
Q Consensus 422 Gls~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~---t~ksDV~S~Gvvl~elltg~~p~~~~~~~~~~~l~~~~~~~~~ 498 (608)
|+|+... .........||+.|.|||++.+..+ ..|+|+||+|||||-+++|.+||.....+ .++.
T Consensus 324 GlAK~~g--~~sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~--~sl~-------- 391 (475)
T KOG0615|consen 324 GLAKVSG--EGSFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTD--PSLK-------- 391 (475)
T ss_pred chhhccc--cceehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCC--ccHH--------
Confidence 9999876 2344566789999999999987643 34889999999999999999999732111 1111
Q ss_pred hhhhHHHhhhhhhc--cCChhHHHHHHHHHHHHhccCCCCCCCHHHHHHHH
Q 044312 499 EERLFEILDARVMK--QGGKDEIITVAKLAKRCLNLNGKKRPTMREVASEL 547 (608)
Q Consensus 499 ~~~~~~~~d~~~~~--~~~~~~~~~l~~Li~~cl~~dp~~RPs~~evl~~L 547 (608)
.++...++.. ....+.+++..+||.+||..||++|||+.|++++-
T Consensus 392 ----eQI~~G~y~f~p~~w~~Iseea~dlI~~mL~VdP~~R~s~~eaL~hp 438 (475)
T KOG0615|consen 392 ----EQILKGRYAFGPLQWDRISEEALDLINWMLVVDPENRPSADEALNHP 438 (475)
T ss_pred ----HHHhcCcccccChhhhhhhHHHHHHHHHhhEeCcccCcCHHHHhcCh
Confidence 1222222221 12346678899999999999999999999999764
|
|
| >KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-40 Score=335.39 Aligned_cols=187 Identities=31% Similarity=0.534 Sum_probs=166.1
Q ss_pred hcCccccceeccCce---------------EEEEEeec--ChhhHHHHHHHHHHHhhcCCCCccceecccccCccceEEE
Q 044312 288 TDNFDLNRILGQGGQ---------------AVKKSKVI--DESKVEEFINEVVILSQINHRNVVKLLGCCLETEVPLLVY 350 (608)
Q Consensus 288 t~~f~~~~~lG~G~~---------------avk~~~~~--~~~~~~~~~~Ei~il~~l~H~niv~l~~~~~~~~~~~lV~ 350 (608)
..+|.+.++||+|.| |||.+... .....+.+..|+.+|+.|+|||||+|++++...+..+|||
T Consensus 9 ~~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~~i~lVM 88 (429)
T KOG0595|consen 9 VGDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCIEDDDFIYLVM 88 (429)
T ss_pred cccceehhhccCcceEEEEEeEeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEEecCCeEEEEE
Confidence 357888999999987 45544332 4556778899999999999999999999999999999999
Q ss_pred eecCCCccchhccccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEEcCC------CcEEEeeccCc
Q 044312 351 EFIPNGTLFQYIHDQNEDFPITWEIRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDK------YRAKVSDFGAS 424 (608)
Q Consensus 351 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~------~~~kl~DFGls 424 (608)
|||.+|+|.++|++.+ .+++.+...++.|||.||++||+++ ||||||||.||||+.. -.+||+|||+|
T Consensus 89 EyC~gGDLs~yi~~~~---~l~e~t~r~Fm~QLA~alq~L~~~~---IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGfA 162 (429)
T KOG0595|consen 89 EYCNGGDLSDYIRRRG---RLPEATARHFMQQLASALQFLHENN---IIHRDLKPQNILLSTTARNDTSPVLKIADFGFA 162 (429)
T ss_pred EeCCCCCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCCcceEEeccCCCCCCCceEEecccchh
Confidence 9999999999999865 4999999999999999999999999 9999999999999864 56899999999
Q ss_pred cccccCCcceeeeeeccCCCCChhhhccCCCCCccchHhHHHHHHHHHhCCCCCCccc
Q 044312 425 RSMAVDQTHMTTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLTELLTGEKPIRFTI 482 (608)
Q Consensus 425 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~elltg~~p~~~~~ 482 (608)
|.+.. ........|++.|||||++..++|+.|+|+||+|+|||++++|+.||....
T Consensus 163 R~L~~--~~~a~tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~l~g~~Pf~a~t 218 (429)
T KOG0595|consen 163 RFLQP--GSMAETLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQCLTGKPPFDAET 218 (429)
T ss_pred hhCCc--hhHHHHhhCCccccCHHHHHhccccchhhHHHHHHHHHHHHhCCCCccccC
Confidence 98863 334456789999999999999999999999999999999999999997433
|
|
| >KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-41 Score=321.90 Aligned_cols=241 Identities=25% Similarity=0.394 Sum_probs=191.1
Q ss_pred CccccceeccCce---------------EEEEEe--ecChhhHHHHHHHHHHHhhcCCCCccceec-ccccC-ccceEEE
Q 044312 290 NFDLNRILGQGGQ---------------AVKKSK--VIDESKVEEFINEVVILSQINHRNVVKLLG-CCLET-EVPLLVY 350 (608)
Q Consensus 290 ~f~~~~~lG~G~~---------------avk~~~--~~~~~~~~~~~~Ei~il~~l~H~niv~l~~-~~~~~-~~~~lV~ 350 (608)
+|.+.++||+|.| |.|+++ ..+....++...|+.+|++|+|||||++++ .+.+. +.++|||
T Consensus 20 ~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~evlnivm 99 (375)
T KOG0591|consen 20 DYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNEVLNIVM 99 (375)
T ss_pred HHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccchhhHHHH
Confidence 4777889999986 445544 245667788999999999999999999999 44444 4589999
Q ss_pred eecCCCccchhccc-cCCCCCCCHHHHHHHHHHHHHHHHHHhhcCC-CCeeccCCCCCcEEEcCCCcEEEeeccCccccc
Q 044312 351 EFIPNGTLFQYIHD-QNEDFPITWEIRLRIAIEVSGALSYLHSAAS-IPIYHRDIKSTNILLDDKYRAKVSDFGASRSMA 428 (608)
Q Consensus 351 E~~~~gsL~~~l~~-~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~-~~iiHrDlk~~NILl~~~~~~kl~DFGls~~~~ 428 (608)
|++..|+|...++. +.++..++++++++++.|++.||..+|+.-+ ..|+||||||.||+|+.+|.+||+||||++.+.
T Consensus 100 E~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~gvvKLGDfGL~r~l~ 179 (375)
T KOG0591|consen 100 ELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANGVVKLGDFGLGRFLS 179 (375)
T ss_pred HhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCCceeeccchhHhHhc
Confidence 99999999999976 2334469999999999999999999999321 239999999999999999999999999999987
Q ss_pred cCCcceeeeeeccCCCCChhhhccCCCCCccchHhHHHHHHHHHhCCCCCCccchhhcccHHHHHHHHhhhhhhHHHhhh
Q 044312 429 VDQTHMTTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLTELLTGEKPIRFTILEEDKSLAAYFLCAMKEERLFEILDA 508 (608)
Q Consensus 429 ~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 508 (608)
.+.+. .....|||.||+||.+....|+.||||||+||++|||..-++||.... +.. .-..+.....
T Consensus 180 s~~tf-A~S~VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyEMcaL~~PF~g~n------~~~-L~~KI~qgd~------ 245 (375)
T KOG0591|consen 180 SKTTF-AHSLVGTPYYMSPERIHESGYNFKSDIWSLGCLLYEMCALQSPFYGDN------LLS-LCKKIEQGDY------ 245 (375)
T ss_pred chhHH-HHhhcCCCcccCHHHHhcCCCCcchhHHHHHHHHHHHHhcCCCccccc------HHH-HHHHHHcCCC------
Confidence 55443 455789999999999999999999999999999999999999997431 111 1111222211
Q ss_pred hhhccCC-hhHHHHHHHHHHHHhccCCCCCCCHHHHHHHH
Q 044312 509 RVMKQGG-KDEIITVAKLAKRCLNLNGKKRPTMREVASEL 547 (608)
Q Consensus 509 ~~~~~~~-~~~~~~l~~Li~~cl~~dp~~RPs~~evl~~L 547 (608)
...+ .-++..+.+|+..|+..||+.||+...++..+
T Consensus 246 ---~~~p~~~YS~~l~~li~~ci~vd~~~RP~t~~~v~di 282 (375)
T KOG0591|consen 246 ---PPLPDEHYSTDLRELINMCIAVDPEQRPDTVPYVQDI 282 (375)
T ss_pred ---CCCcHHHhhhHHHHHHHHHccCCcccCCCcchHHHHH
Confidence 1112 45678899999999999999999955554443
|
|
| >KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-40 Score=356.04 Aligned_cols=244 Identities=24% Similarity=0.442 Sum_probs=214.7
Q ss_pred ccccceeccCce------------------EEEEEee-cChhhHHHHHHHHHHHhhcCCCCccceecccccCccceEEEe
Q 044312 291 FDLNRILGQGGQ------------------AVKKSKV-IDESKVEEFINEVVILSQINHRNVVKLLGCCLETEVPLLVYE 351 (608)
Q Consensus 291 f~~~~~lG~G~~------------------avk~~~~-~~~~~~~~~~~Ei~il~~l~H~niv~l~~~~~~~~~~~lV~E 351 (608)
..+.++||.|.| |||.+|. ..+.+..+|+.|..||.+++||||++|.|+.......+||.|
T Consensus 631 i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~GytekqrrdFL~EAsIMGQFdHPNIIrLEGVVTks~PvMIiTE 710 (996)
T KOG0196|consen 631 VKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIRLEGVVTKSKPVMIITE 710 (996)
T ss_pred eEEEEEEecccccceecccccCCCCcceeEEEeeeccCccHHHHhhhhhhhhhcccCCCCcEEEEEEEEecCceeEEEhh
Confidence 357789999864 8898886 456778899999999999999999999999999999999999
Q ss_pred ecCCCccchhccccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEEcCCCcEEEeeccCccccccCC
Q 044312 352 FIPNGTLFQYIHDQNEDFPITWEIRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQ 431 (608)
Q Consensus 352 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGls~~~~~~~ 431 (608)
||+||+|+.+|+.+.. .+++.++.-++.+||.||.||.+.+ ++||||.++|||++.+...||+||||+|.+..+.
T Consensus 711 yMENGsLDsFLR~~DG--qftviQLVgMLrGIAsGMkYLsdm~---YVHRDLAARNILVNsnLvCKVsDFGLSRvledd~ 785 (996)
T KOG0196|consen 711 YMENGSLDSFLRQNDG--QFTVIQLVGMLRGIASGMKYLSDMN---YVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDP 785 (996)
T ss_pred hhhCCcHHHHHhhcCC--ceEeehHHHHHHHHHHHhHHHhhcC---chhhhhhhhheeeccceEEEeccccceeecccCC
Confidence 9999999999998765 4899999999999999999999999 9999999999999999999999999999876544
Q ss_pred cceee--eeeccCCCCChhhhccCCCCCccchHhHHHHHHHHHh-CCCCCCccchhhcccHHHHHHHHhhhhhhHHHhhh
Q 044312 432 THMTT--QVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLTELLT-GEKPIRFTILEEDKSLAAYFLCAMKEERLFEILDA 508 (608)
Q Consensus 432 ~~~~~--~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~ellt-g~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 508 (608)
....+ .-.-..+|.|||.+..+++|.+||||||||||||.++ |.+||. .|.+.++...++.
T Consensus 786 ~~~ytt~GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVmWEVmSyGERPYW----------------dmSNQdVIkaIe~ 849 (996)
T KOG0196|consen 786 EAAYTTLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYW----------------DMSNQDVIKAIEQ 849 (996)
T ss_pred CccccccCCccceeecChhHhhhcccCchhhccccceEEEEecccCCCccc----------------ccchHHHHHHHHh
Confidence 22222 2234679999999999999999999999999999887 999986 3444556666777
Q ss_pred hhhccCChhHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhhHHhcC
Q 044312 509 RVMKQGGKDEIITVAKLAKRCLNLNGKKRPTMREVASELAGIKAWNG 555 (608)
Q Consensus 509 ~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~evl~~L~~i~~~~~ 555 (608)
.++.+.+.+++..+.+|+..||++|-.+||.+.+|+..|.++.....
T Consensus 850 gyRLPpPmDCP~aL~qLMldCWqkdR~~RP~F~qiV~~lDklIrnP~ 896 (996)
T KOG0196|consen 850 GYRLPPPMDCPAALYQLMLDCWQKDRNRRPKFAQIVSTLDKLIRNPN 896 (996)
T ss_pred ccCCCCCCCCcHHHHHHHHHHHHHHhhcCCCHHHHHHHHHHHhcCch
Confidence 88889999999999999999999999999999999999988866433
|
|
| >KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-39 Score=325.46 Aligned_cols=229 Identities=28% Similarity=0.422 Sum_probs=189.5
Q ss_pred hcCccccceeccCce---------------EEEEE---eecChhhHHHHHHHHHHHhhcCCCCccceecccccCccceEE
Q 044312 288 TDNFDLNRILGQGGQ---------------AVKKS---KVIDESKVEEFINEVVILSQINHRNVVKLLGCCLETEVPLLV 349 (608)
Q Consensus 288 t~~f~~~~~lG~G~~---------------avk~~---~~~~~~~~~~~~~Ei~il~~l~H~niv~l~~~~~~~~~~~lV 349 (608)
.+.|++.++||+|+| |+|.+ ++......+...+|..||.+++||.||+|+..|.+.+.+|||
T Consensus 24 ~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~kLylV 103 (357)
T KOG0598|consen 24 PDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQTEEKLYLV 103 (357)
T ss_pred hhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecccCCeEEEE
Confidence 457999999999985 43332 334556678899999999999999999999999999999999
Q ss_pred EeecCCCccchhccccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEEcCCCcEEEeeccCcccccc
Q 044312 350 YEFIPNGTLFQYIHDQNEDFPITWEIRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAV 429 (608)
Q Consensus 350 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGls~~~~~ 429 (608)
+||+.||.|..+|++.+ .+++..+.-++.+|+.||.|||+++ |+||||||+|||||++|+++|+||||++....
T Consensus 104 ld~~~GGeLf~hL~~eg---~F~E~~arfYlaEi~lAL~~LH~~g---IiyRDlKPENILLd~~GHi~LtDFgL~k~~~~ 177 (357)
T KOG0598|consen 104 LDYLNGGELFYHLQREG---RFSEDRARFYLAEIVLALGYLHSKG---IIYRDLKPENILLDEQGHIKLTDFGLCKEDLK 177 (357)
T ss_pred EeccCCccHHHHHHhcC---CcchhHHHHHHHHHHHHHHHHHhCC---eeeccCCHHHeeecCCCcEEEeccccchhccc
Confidence 99999999999998765 4899999999999999999999999 99999999999999999999999999986544
Q ss_pred CCcceeeeeeccCCCCChhhhccCCCCCccchHhHHHHHHHHHhCCCCCCccchhhcccHHHHHHHHhhhhhhHHHhhhh
Q 044312 430 DQTHMTTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLTELLTGEKPIRFTILEEDKSLAAYFLCAMKEERLFEILDAR 509 (608)
Q Consensus 430 ~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 509 (608)
... .+....||+.|||||++....|+..+|.||+|+++|||++|.+||..... ..+.. .++..+
T Consensus 178 ~~~-~t~tfcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML~G~pPF~~~~~------~~~~~---------~I~~~k 241 (357)
T KOG0598|consen 178 DGD-ATRTFCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLTGKPPFYAEDV------KKMYD---------KILKGK 241 (357)
T ss_pred CCC-ccccccCCccccChHHHhcCCCCcccchHhHHHHHHHHhhCCCCCcCccH------HHHHH---------HHhcCc
Confidence 332 34457899999999999999999999999999999999999999973221 11111 111111
Q ss_pred hhccCChhHHHHHHHHHHHHhccCCCCCCC
Q 044312 510 VMKQGGKDEIITVAKLAKRCLNLNGKKRPT 539 (608)
Q Consensus 510 ~~~~~~~~~~~~l~~Li~~cl~~dp~~RPs 539 (608)
....+.-.+.+.++|+.+.|..||++|..
T Consensus 242 -~~~~p~~ls~~ardll~~LL~rdp~~RLg 270 (357)
T KOG0598|consen 242 -LPLPPGYLSEEARDLLKKLLKRDPRQRLG 270 (357)
T ss_pred -CCCCCccCCHHHHHHHHHHhccCHHHhcC
Confidence 12223335678999999999999999963
|
|
| >KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-39 Score=326.77 Aligned_cols=241 Identities=29% Similarity=0.438 Sum_probs=192.4
Q ss_pred cCccccceeccCce---------------EEEEEeecChhhHHHHHHHHHHHhhcCCCCccceecccccCc--cceEEEe
Q 044312 289 DNFDLNRILGQGGQ---------------AVKKSKVIDESKVEEFINEVVILSQINHRNVVKLLGCCLETE--VPLLVYE 351 (608)
Q Consensus 289 ~~f~~~~~lG~G~~---------------avk~~~~~~~~~~~~~~~Ei~il~~l~H~niv~l~~~~~~~~--~~~lV~E 351 (608)
.++...+.||+|.| |||.....+....+.+.+|+.+|++|+|||||+++|.....+ .+++.||
T Consensus 17 ~~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~~~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~i~mE 96 (313)
T KOG0198|consen 17 SNWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDSPTSESLEREIRILSRLNHPNIVQYYGSSSSRENDEYNIFME 96 (313)
T ss_pred chhhhhccccCccceEEEEEEecCCCcceeeeeeecccchhHHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeEeeee
Confidence 34566788999874 677666554444777999999999999999999999865554 6899999
Q ss_pred ecCCCccchhccccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEEcC-CCcEEEeeccCcccccc-
Q 044312 352 FIPNGTLFQYIHDQNEDFPITWEIRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDD-KYRAKVSDFGASRSMAV- 429 (608)
Q Consensus 352 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~-~~~~kl~DFGls~~~~~- 429 (608)
|+++|+|.+++.+.+. .+++..+.+++.||++||+|||+++ |+||||||+|||++. ++.+||+|||+++....
T Consensus 97 y~~~GsL~~~~~~~g~--~l~E~~v~~ytr~iL~GL~ylHs~g---~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~~~ 171 (313)
T KOG0198|consen 97 YAPGGSLSDLIKRYGG--KLPEPLVRRYTRQILEGLAYLHSKG---IVHCDIKPANILLDPSNGDVKLADFGLAKKLESK 171 (313)
T ss_pred ccCCCcHHHHHHHcCC--CCCHHHHHHHHHHHHHHHHHHHhCC---EeccCcccceEEEeCCCCeEEeccCccccccccc
Confidence 9999999999988654 4999999999999999999999999 999999999999999 79999999999987653
Q ss_pred -CCcceeeeeeccCCCCChhhhccCC-CCCccchHhHHHHHHHHHhCCCCCCccchhhcccHHHHHHHHhhhhhhHHHhh
Q 044312 430 -DQTHMTTQVHGTFGYLDPEYFRSSQ-FTDKSDVYSFGVVLTELLTGEKPIRFTILEEDKSLAAYFLCAMKEERLFEILD 507 (608)
Q Consensus 430 -~~~~~~~~~~gt~~y~aPE~~~~~~-~t~ksDV~S~Gvvl~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 507 (608)
..........||+.|||||++..+. ...++|||||||+++||+||++||... .....+ +..+..
T Consensus 172 ~~~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~-----~~~~~~---------~~~ig~ 237 (313)
T KOG0198|consen 172 GTKSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEF-----FEEAEA---------LLLIGR 237 (313)
T ss_pred cccccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhh-----cchHHH---------HHHHhc
Confidence 2222334578999999999999643 335999999999999999999998732 111111 111211
Q ss_pred hhhhccCChhHHHHHHHHHHHHhccCCCCCCCHHHHHHHHH
Q 044312 508 ARVMKQGGKDEIITVAKLAKRCLNLNGKKRPTMREVASELA 548 (608)
Q Consensus 508 ~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~evl~~L~ 548 (608)
.....+.+...+.+..+++.+|+..+|++|||+.|++++..
T Consensus 238 ~~~~P~ip~~ls~~a~~Fl~~C~~~~p~~Rpta~eLL~hpf 278 (313)
T KOG0198|consen 238 EDSLPEIPDSLSDEAKDFLRKCFKRDPEKRPTAEELLEHPF 278 (313)
T ss_pred cCCCCCCCcccCHHHHHHHHHHhhcCcccCcCHHHHhhChh
Confidence 11122445556778999999999999999999999998753
|
|
| >KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-39 Score=333.99 Aligned_cols=235 Identities=26% Similarity=0.440 Sum_probs=199.2
Q ss_pred CccccceeccCc---------------eEEEEEeecChhhHHHHHHHHHHHhhcCCCCccceecccccCccceEEEeecC
Q 044312 290 NFDLNRILGQGG---------------QAVKKSKVIDESKVEEFINEVVILSQINHRNVVKLLGCCLETEVPLLVYEFIP 354 (608)
Q Consensus 290 ~f~~~~~lG~G~---------------~avk~~~~~~~~~~~~~~~Ei~il~~l~H~niv~l~~~~~~~~~~~lV~E~~~ 354 (608)
.|+...+||+|+ +|||+.........+-+++|+.+|+..+|+|||++++.|...+.++.|||||+
T Consensus 274 ~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~~keLilnEi~Vm~~~~H~NiVnfl~Sylv~deLWVVMEym~ 353 (550)
T KOG0578|consen 274 KYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQPKKELLLNEILVMRDLHHPNIVNFLDSYLVGDELWVVMEYME 353 (550)
T ss_pred hhcchhhhccccccceeeeeeccCCceEEEEEEEeccCCchhhhHHHHHHHHhccchHHHHHHHHhcccceeEEEEeecC
Confidence 466677788875 48888888878888899999999999999999999999999999999999999
Q ss_pred CCccchhccccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEEcCCCcEEEeeccCccccccCCcce
Q 044312 355 NGTLFQYIHDQNEDFPITWEIRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHM 434 (608)
Q Consensus 355 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGls~~~~~~~~~~ 434 (608)
+|+|.+.+... .+++.++..|+.+++.||+|||.++ |+|||||++|||++.++.+||+|||++..+......
T Consensus 354 ggsLTDvVt~~----~~~E~qIA~Icre~l~aL~fLH~~g---IiHrDIKSDnILL~~~g~vKltDFGFcaqi~~~~~K- 425 (550)
T KOG0578|consen 354 GGSLTDVVTKT----RMTEGQIAAICREILQGLKFLHARG---IIHRDIKSDNILLTMDGSVKLTDFGFCAQISEEQSK- 425 (550)
T ss_pred CCchhhhhhcc----cccHHHHHHHHHHHHHHHHHHHhcc---eeeeccccceeEeccCCcEEEeeeeeeeccccccCc-
Confidence 99999998765 3899999999999999999999999 999999999999999999999999999888766554
Q ss_pred eeeeeccCCCCChhhhccCCCCCccchHhHHHHHHHHHhCCCCCCccchhhcccHHHHHHHHhhhhhhHHHhhhhhhccC
Q 044312 435 TTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLTELLTGEKPIRFTILEEDKSLAAYFLCAMKEERLFEILDARVMKQG 514 (608)
Q Consensus 435 ~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~ 514 (608)
.....||+.|||||++....|.+|.||||||++++||+-|++||-... .+.+.++ +..+ .......
T Consensus 426 R~TmVGTPYWMAPEVvtrk~YG~KVDIWSLGIMaIEMveGEPPYlnE~-----PlrAlyL--Ia~n-------g~P~lk~ 491 (550)
T KOG0578|consen 426 RSTMVGTPYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVEGEPPYLNEN-----PLRALYL--IATN-------GTPKLKN 491 (550)
T ss_pred cccccCCCCccchhhhhhcccCccccchhhhhHHHHHhcCCCCccCCC-----hHHHHHH--Hhhc-------CCCCcCC
Confidence 345679999999999999999999999999999999999999986311 1111111 1111 1112233
Q ss_pred ChhHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 044312 515 GKDEIITVAKLAKRCLNLNGKKRPTMREVASE 546 (608)
Q Consensus 515 ~~~~~~~l~~Li~~cl~~dp~~RPs~~evl~~ 546 (608)
+...+..+++++.+||+.|+++||+++|+|++
T Consensus 492 ~~klS~~~kdFL~~cL~~dv~~RasA~eLL~H 523 (550)
T KOG0578|consen 492 PEKLSPELKDFLDRCLVVDVEQRASAKELLEH 523 (550)
T ss_pred ccccCHHHHHHHHHHhhcchhcCCCHHHHhcC
Confidence 44567789999999999999999999999975
|
|
| >KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-39 Score=361.02 Aligned_cols=249 Identities=27% Similarity=0.451 Sum_probs=206.3
Q ss_pred hcCccccceeccCce--------------------EEEEEee-cChhhHHHHHHHHHHHhhcCCCCccceecccccCccc
Q 044312 288 TDNFDLNRILGQGGQ--------------------AVKKSKV-IDESKVEEFINEVVILSQINHRNVVKLLGCCLETEVP 346 (608)
Q Consensus 288 t~~f~~~~~lG~G~~--------------------avk~~~~-~~~~~~~~~~~Ei~il~~l~H~niv~l~~~~~~~~~~ 346 (608)
..+.+..+.||+|.| |||.++. .+..+..+|++|..+|+.++|||||+++|+|.+....
T Consensus 691 ~~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~~~~~ 770 (1025)
T KOG1095|consen 691 RKNVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLSSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLDSGPP 770 (1025)
T ss_pred hhheEeeeeeccccccceEEEEEecCCCCccceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCcceeeEEEeecCCCCc
Confidence 345567889999975 6666654 4667788999999999999999999999999999999
Q ss_pred eEEEeecCCCccchhccccCC----CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEEcCCCcEEEeecc
Q 044312 347 LLVYEFIPNGTLFQYIHDQNE----DFPITWEIRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFG 422 (608)
Q Consensus 347 ~lV~E~~~~gsL~~~l~~~~~----~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFG 422 (608)
+|++|||.+|+|..+|++.+. ...++....+.|+.|||+|+.||++++ +|||||.++|+||++...+||+|||
T Consensus 771 ~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~~---fvHRDLAaRNCLL~~~r~VKIaDFG 847 (1025)
T KOG1095|consen 771 LILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESKH---FVHRDLAARNCLLDERRVVKIADFG 847 (1025)
T ss_pred EEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhCC---CcCcchhhhheeecccCcEEEcccc
Confidence 999999999999999987521 235899999999999999999999999 9999999999999999999999999
Q ss_pred CccccccCCcceeeee-eccCCCCChhhhccCCCCCccchHhHHHHHHHHHh-CCCCCCccchhhcccHHHHHHHHhhhh
Q 044312 423 ASRSMAVDQTHMTTQV-HGTFGYLDPEYFRSSQFTDKSDVYSFGVVLTELLT-GEKPIRFTILEEDKSLAAYFLCAMKEE 500 (608)
Q Consensus 423 ls~~~~~~~~~~~~~~-~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~ellt-g~~p~~~~~~~~~~~l~~~~~~~~~~~ 500 (608)
||+.+...+....... .-..+|||||.+..+.+|.|+|||||||+|||++| |..||......
T Consensus 848 lArDiy~~~yyr~~~~a~lPvkWm~PEsl~d~iFtskSDvWsFGVllWEifslG~~PY~~~~n~---------------- 911 (1025)
T KOG1095|consen 848 LARDIYDKDYYRKHGEAMLPVKWMPPESLKDGIFTSKSDVWSFGVLLWEIFSLGATPYPSRSNF---------------- 911 (1025)
T ss_pred hhHhhhhchheeccCccccceecCCHHHHhhcccccccchhhhHHHHHHHHhCCCCCCCCcchH----------------
Confidence 9995544333333222 34568999999999999999999999999999999 88898632211
Q ss_pred hhHHHhhhhhhccCChhHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhhHHhcC
Q 044312 501 RLFEILDARVMKQGGKDEIITVAKLAKRCLNLNGKKRPTMREVASELAGIKAWNG 555 (608)
Q Consensus 501 ~~~~~~d~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~evl~~L~~i~~~~~ 555 (608)
++...+-..-+.+.+..++..+.+||.+||+.+|++||++..|++++..+.....
T Consensus 912 ~v~~~~~~ggRL~~P~~CP~~ly~lM~~CW~~~pe~RP~F~~i~~q~~~i~~~~~ 966 (1025)
T KOG1095|consen 912 EVLLDVLEGGRLDPPSYCPEKLYQLMLQCWKHDPEDRPSFRTIVEQDPAISNAAL 966 (1025)
T ss_pred HHHHHHHhCCccCCCCCCChHHHHHHHHHccCChhhCccHHHHHhhhhhhhhhhc
Confidence 1122111112556778899999999999999999999999999999988876544
|
|
| >KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-39 Score=334.04 Aligned_cols=250 Identities=29% Similarity=0.475 Sum_probs=218.3
Q ss_pred HHHHHHhcCccccceeccCce---------------EEEEEeecChhhHHHHHHHHHHHhhcCCCCccceecccccCccc
Q 044312 282 KELEKATDNFDLNRILGQGGQ---------------AVKKSKVIDESKVEEFINEVVILSQINHRNVVKLLGCCLETEVP 346 (608)
Q Consensus 282 ~~l~~~t~~f~~~~~lG~G~~---------------avk~~~~~~~~~~~~~~~Ei~il~~l~H~niv~l~~~~~~~~~~ 346 (608)
++|+.-..+....++||-|.+ |||.++. +...+++|+.|..+|+.|+|||+|+|+|+|......
T Consensus 260 DkWEmeRtdItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKE-DtMeveEFLkEAAvMKeikHpNLVqLLGVCT~EpPF 338 (1157)
T KOG4278|consen 260 DKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKE-DTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTHEPPF 338 (1157)
T ss_pred chhhccchheeeeeccCCCcccceeeeeeeccceeeehhhhhh-cchhHHHHHHHHHHHHhhcCccHHHHhhhhccCCCe
Confidence 556655566777899998863 6666664 456789999999999999999999999999999999
Q ss_pred eEEEeecCCCccchhccccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEEcCCCcEEEeeccCccc
Q 044312 347 LLVYEFIPNGTLFQYIHDQNEDFPITWEIRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRS 426 (608)
Q Consensus 347 ~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGls~~ 426 (608)
|||+|||..|+|.++|++..+. .++...++.+|.||+.||+||..++ +|||||.++|.|+.++..+||+||||+++
T Consensus 339 YIiTEfM~yGNLLdYLRecnr~-ev~avvLlyMAtQIsSaMeYLEkkn---FIHRDLAARNCLVgEnhiVKvADFGLsRl 414 (1157)
T KOG4278|consen 339 YIITEFMCYGNLLDYLRECNRS-EVPAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHIVKVADFGLSRL 414 (1157)
T ss_pred EEEEecccCccHHHHHHHhchh-hcchhHHHHHHHHHHHHHHHHHHhh---hhhhhhhhhhccccccceEEeeccchhhh
Confidence 9999999999999999986554 5888889999999999999999999 99999999999999999999999999999
Q ss_pred cccCCcceeeeeeccCCCCChhhhccCCCCCccchHhHHHHHHHHHh-CCCCCCccchhhcccHHHHHHHHhhhhhhHHH
Q 044312 427 MAVDQTHMTTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLTELLT-GEKPIRFTILEEDKSLAAYFLCAMKEERLFEI 505 (608)
Q Consensus 427 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~ellt-g~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 505 (608)
+..+.........-...|.|||-+....++.|+|||+|||+|||+.| |..||.. +....+..+
T Consensus 415 MtgDTYTAHAGAKFPIKWTAPEsLAyNtFSiKSDVWAFGVLLWEIATYGMsPYPG----------------idlSqVY~L 478 (1157)
T KOG4278|consen 415 MTGDTYTAHAGAKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPYPG----------------IDLSQVYGL 478 (1157)
T ss_pred hcCCceecccCccCcccccCcccccccccccchhhHHHHHHHHHHHhcCCCCCCC----------------ccHHHHHHH
Confidence 88765544445556778999999999999999999999999999999 7888762 223356778
Q ss_pred hhhhhhccCChhHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhhHH
Q 044312 506 LDARVMKQGGKDEIITVAKLAKRCLNLNGKKRPTMREVASELAGIKA 552 (608)
Q Consensus 506 ~d~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~evl~~L~~i~~ 552 (608)
+...++.+.+..++..+++|+++||+.+|.+||++.|+-+.++.+-.
T Consensus 479 LEkgyRM~~PeGCPpkVYeLMraCW~WsPsDRPsFaeiHqafEtmf~ 525 (1157)
T KOG4278|consen 479 LEKGYRMDGPEGCPPKVYELMRACWNWSPSDRPSFAEIHQAFETMFS 525 (1157)
T ss_pred HhccccccCCCCCCHHHHHHHHHHhcCCcccCccHHHHHHHHHHHhc
Confidence 88888899999999999999999999999999999999988877654
|
|
| >KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-38 Score=327.04 Aligned_cols=251 Identities=25% Similarity=0.310 Sum_probs=197.3
Q ss_pred cCccccceeccCce---------------EEEEEeecC--hhhHHHHHHHHHHHhhcCCCCccceecccccC--ccceEE
Q 044312 289 DNFDLNRILGQGGQ---------------AVKKSKVID--ESKVEEFINEVVILSQINHRNVVKLLGCCLET--EVPLLV 349 (608)
Q Consensus 289 ~~f~~~~~lG~G~~---------------avk~~~~~~--~~~~~~~~~Ei~il~~l~H~niv~l~~~~~~~--~~~~lV 349 (608)
+.|+..++||+|.| |+|++.... +.......+||.||++|+||||++|.+...+. ..+|||
T Consensus 117 ~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~siYlV 196 (560)
T KOG0600|consen 117 DSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEIVTSKLSGSIYLV 196 (560)
T ss_pred HHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeEEEecCCceEEEE
Confidence 34566778899864 888887644 55577789999999999999999999999877 689999
Q ss_pred EeecCCCccchhccccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEEcCCCcEEEeeccCcccccc
Q 044312 350 YEFIPNGTLFQYIHDQNEDFPITWEIRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAV 429 (608)
Q Consensus 350 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGls~~~~~ 429 (608)
+|||++ +|.-++....- .|+..++..++.|++.||+|+|+.+ |+|||||.+|||||.+|.+||+|||||+++..
T Consensus 197 FeYMdh-DL~GLl~~p~v--kft~~qIKc~mkQLl~Gl~~cH~~g---vlHRDIK~SNiLidn~G~LKiaDFGLAr~y~~ 270 (560)
T KOG0600|consen 197 FEYMDH-DLSGLLSSPGV--KFTEPQIKCYMKQLLEGLEYCHSRG---VLHRDIKGSNILIDNNGVLKIADFGLARFYTP 270 (560)
T ss_pred Eecccc-hhhhhhcCCCc--ccChHHHHHHHHHHHHHHHHHhhcC---eeeccccccceEEcCCCCEEeccccceeeccC
Confidence 999987 88888876443 4999999999999999999999999 99999999999999999999999999999887
Q ss_pred CCcceeeeeeccCCCCChhhhccC-CCCCccchHhHHHHHHHHHhCCCCCCccchhhcccHHHHHHHHhhhhhhH-----
Q 044312 430 DQTHMTTQVHGTFGYLDPEYFRSS-QFTDKSDVYSFGVVLTELLTGEKPIRFTILEEDKSLAAYFLCAMKEERLF----- 503 (608)
Q Consensus 430 ~~~~~~~~~~gt~~y~aPE~~~~~-~~t~ksDV~S~Gvvl~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~----- 503 (608)
......+..+-|++|.|||.+.+. .|+.+.|+||.||||.||++|++.|.....-++....-.+-....+.-+.
T Consensus 271 ~~~~~~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEveQl~kIfklcGSP~e~~W~~~kLP 350 (560)
T KOG0600|consen 271 SGSAPYTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTEVEQLHKIFKLCGSPTEDYWPVSKLP 350 (560)
T ss_pred CCCcccccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccHHHHHHHHHHHhCCCChhccccccCC
Confidence 777777888899999999998865 79999999999999999999999987543332222111111111111111
Q ss_pred --HHhh------hhhhccCChhHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 044312 504 --EILD------ARVMKQGGKDEIITVAKLAKRCLNLNGKKRPTMREVASE 546 (608)
Q Consensus 504 --~~~d------~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~evl~~ 546 (608)
.++. ..+. +.....+....+|+..+|.+||++|.|+.++++.
T Consensus 351 ~~~~~kp~~~y~r~l~-E~~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~s 400 (560)
T KOG0600|consen 351 HATIFKPQQPYKRRLR-ETFKDFPASALDLLEKLLSLDPDKRGTASSALQS 400 (560)
T ss_pred cccccCCCCcccchHH-HHhccCCHHHHHHHHHHhccCccccccHHHHhcC
Confidence 0000 0111 1123345678899999999999999999999863
|
|
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-38 Score=330.42 Aligned_cols=248 Identities=28% Similarity=0.468 Sum_probs=191.3
Q ss_pred HhcCccccceeccCce--------------------EEEEEeec-ChhhHHHHHHHHHHHhhc-CCCCccceecccccC-
Q 044312 287 ATDNFDLNRILGQGGQ--------------------AVKKSKVI-DESKVEEFINEVVILSQI-NHRNVVKLLGCCLET- 343 (608)
Q Consensus 287 ~t~~f~~~~~lG~G~~--------------------avk~~~~~-~~~~~~~~~~Ei~il~~l-~H~niv~l~~~~~~~- 343 (608)
..++|++.++||+|+| |||+.+.. .....+.+.+|+.+|+++ +||||+++++++...
T Consensus 5 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~ 84 (338)
T cd05102 5 PRDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATASEHKALMSELKILIHIGNHLNVVNLLGACTKPN 84 (338)
T ss_pred chhHceeeeEeccCCcceEEEEEEeccCCcccchhhheeccccccchHHHHHHHHHHHHHHHhccCcceeeEEeEecCCC
Confidence 4567888999999986 23333221 123356799999999999 899999999988754
Q ss_pred ccceEEEeecCCCccchhccccCC--------------------------------------------------------
Q 044312 344 EVPLLVYEFIPNGTLFQYIHDQNE-------------------------------------------------------- 367 (608)
Q Consensus 344 ~~~~lV~E~~~~gsL~~~l~~~~~-------------------------------------------------------- 367 (608)
...++||||+++|+|.+++.....
T Consensus 85 ~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 164 (338)
T cd05102 85 GPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQETD 164 (338)
T ss_pred CceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccchhcc
Confidence 457899999999999999875321
Q ss_pred ---CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEEcCCCcEEEeeccCccccccCCcce-eeeeeccCC
Q 044312 368 ---DFPITWEIRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHM-TTQVHGTFG 443 (608)
Q Consensus 368 ---~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGls~~~~~~~~~~-~~~~~gt~~ 443 (608)
..++++..++.++.||++||+|||+.+ |+||||||+|||+++++.+||+|||+++......... .....+++.
T Consensus 165 ~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~ 241 (338)
T cd05102 165 DLWKSPLTMEDLICYSFQVARGMEFLASRK---CIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPLK 241 (338)
T ss_pred ccccCCCCHHHHHHHHHHHHHHHHHHHHCC---EECCCCccceEEEcCCCcEEEeecccccccccCcchhcccCCCCCcc
Confidence 124888999999999999999999998 9999999999999999999999999998654332211 223345678
Q ss_pred CCChhhhccCCCCCccchHhHHHHHHHHHh-CCCCCCccchhhcccHHHHHHHHhhhhhhHHHhhhhhhccCChhHHHHH
Q 044312 444 YLDPEYFRSSQFTDKSDVYSFGVVLTELLT-GEKPIRFTILEEDKSLAAYFLCAMKEERLFEILDARVMKQGGKDEIITV 522 (608)
Q Consensus 444 y~aPE~~~~~~~t~ksDV~S~Gvvl~ellt-g~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l 522 (608)
|+|||++.+..++.++||||||++||||++ |..||....... .+...+..+ .....+...+..+
T Consensus 242 y~aPE~~~~~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~~------~~~~~~~~~---------~~~~~~~~~~~~l 306 (338)
T cd05102 242 WMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINE------EFCQRLKDG---------TRMRAPENATPEI 306 (338)
T ss_pred ccCcHHhhcCCCCcccCHHHHHHHHHHHHhCCCCCCCCCCccH------HHHHHHhcC---------CCCCCCCCCCHHH
Confidence 999999999999999999999999999997 999986432111 011111111 1111233455679
Q ss_pred HHHHHHHhccCCCCCCCHHHHHHHHHhhHH
Q 044312 523 AKLAKRCLNLNGKKRPTMREVASELAGIKA 552 (608)
Q Consensus 523 ~~Li~~cl~~dp~~RPs~~evl~~L~~i~~ 552 (608)
.+|+.+||+.||++|||+.||++.|+.+..
T Consensus 307 ~~li~~cl~~dp~~RPs~~el~~~l~~~~~ 336 (338)
T cd05102 307 YRIMLACWQGDPKERPTFSALVEILGDLLQ 336 (338)
T ss_pred HHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 999999999999999999999999987754
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=308.52 Aligned_cols=249 Identities=22% Similarity=0.322 Sum_probs=191.2
Q ss_pred CccccceeccCce---------------EEEEEeecCh--hhHHHHHHHHHHHhhcCCCCccceecccccCccceEEEee
Q 044312 290 NFDLNRILGQGGQ---------------AVKKSKVIDE--SKVEEFINEVVILSQINHRNVVKLLGCCLETEVPLLVYEF 352 (608)
Q Consensus 290 ~f~~~~~lG~G~~---------------avk~~~~~~~--~~~~~~~~Ei~il~~l~H~niv~l~~~~~~~~~~~lV~E~ 352 (608)
.|+...++|+|.+ |||+....++ .-.+-.++|+++|++|+|+|+|.|+++|.....++||+||
T Consensus 3 kYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrklhLVFE~ 82 (396)
T KOG0593|consen 3 KYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVFRRKRKLHLVFEY 82 (396)
T ss_pred HHhhhhccccCcceEEEEeccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcceeEEEeee
Confidence 4677788999974 7777765443 3345688999999999999999999999999999999999
Q ss_pred cCCCccchhccccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEEcCCCcEEEeeccCccccccCCc
Q 044312 353 IPNGTLFQYIHDQNEDFPITWEIRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQT 432 (608)
Q Consensus 353 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGls~~~~~~~~ 432 (608)
++. ++.+-|..... .++...+.+++.|+++|+.|+|+++ +|||||||+||||+.++.+||+|||.|+.+.. ..
T Consensus 83 ~dh-TvL~eLe~~p~--G~~~~~vk~~l~Q~l~ai~~cHk~n---~IHRDIKPENILit~~gvvKLCDFGFAR~L~~-pg 155 (396)
T KOG0593|consen 83 CDH-TVLHELERYPN--GVPSELVKKYLYQLLKAIHFCHKNN---CIHRDIKPENILITQNGVVKLCDFGFARTLSA-PG 155 (396)
T ss_pred cch-HHHHHHHhccC--CCCHHHHHHHHHHHHHHhhhhhhcC---eecccCChhheEEecCCcEEeccchhhHhhcC-Cc
Confidence 987 44455555444 3899999999999999999999999 99999999999999999999999999998874 33
Q ss_pred ceeeeeeccCCCCChhhhcc-CCCCCccchHhHHHHHHHHHhCCCCCCccchhhcccHHHHHHHHhhhhhhHHHhhh---
Q 044312 433 HMTTQVHGTFGYLDPEYFRS-SQFTDKSDVYSFGVVLTELLTGEKPIRFTILEEDKSLAAYFLCAMKEERLFEILDA--- 508 (608)
Q Consensus 433 ~~~~~~~gt~~y~aPE~~~~-~~~t~ksDV~S~Gvvl~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~--- 508 (608)
...+....|.+|+|||.+.+ .+|...+||||.||++.||++|.+-|.....-+...+....+..+.. +..+++..
T Consensus 156 d~YTDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQLy~I~ktLG~L~p-rhq~iF~~N~~ 234 (396)
T KOG0593|consen 156 DNYTDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQLYLIRKTLGNLIP-RHQSIFSSNPF 234 (396)
T ss_pred chhhhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcchHHHHHHHHHHHcccCH-HHHHHhccCCc
Confidence 34566778999999999987 68999999999999999999999988744332222222111111111 11111110
Q ss_pred ------------hhhccCChhHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 044312 509 ------------RVMKQGGKDEIITVAKLAKRCLNLNGKKRPTMREVASE 546 (608)
Q Consensus 509 ------------~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~evl~~ 546 (608)
......-...+.-+.+|++.||++||++|++-+|++.+
T Consensus 235 F~Gv~lP~~~~~epLe~k~p~~s~~~ld~~k~cL~~dP~~R~sc~qll~H 284 (396)
T KOG0593|consen 235 FHGVRLPEPEHPEPLERKYPKISNVLLDLLKKCLKMDPDDRLSCEQLLHH 284 (396)
T ss_pred eeeeecCCCCCccchhhhcccchHHHHHHHHHHhcCCccccccHHHHhcC
Confidence 00111112334568899999999999999999999864
|
|
| >KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-38 Score=318.25 Aligned_cols=248 Identities=25% Similarity=0.385 Sum_probs=195.4
Q ss_pred hcCccccceeccCc---------------eEEEEEeecCh-hhHHHHHHHHHHHhhcCCCCccceecccccCccceEEEe
Q 044312 288 TDNFDLNRILGQGG---------------QAVKKSKVIDE-SKVEEFINEVVILSQINHRNVVKLLGCCLETEVPLLVYE 351 (608)
Q Consensus 288 t~~f~~~~~lG~G~---------------~avk~~~~~~~-~~~~~~~~Ei~il~~l~H~niv~l~~~~~~~~~~~lV~E 351 (608)
.+.|++..+||.|. +|||++.+.+- ...+.+.+|+..|+.++||||++++..|..+..+++||+
T Consensus 25 ~~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~ld~l~kE~~~msl~~HPNIv~~~~sFvv~~~LWvVmp 104 (516)
T KOG0582|consen 25 AKDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNNDLDALRKEVQTMSLIDHPNIVTYHCSFVVDSELWVVMP 104 (516)
T ss_pred ccceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhhHHHHHHHHHHhhhcCCCCcceEEEEEEecceeEEeeh
Confidence 45788999999995 37888776333 236889999999999999999999999999999999999
Q ss_pred ecCCCccchhccccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEEcCCCcEEEeeccCccccccCC
Q 044312 352 FIPNGTLFQYIHDQNEDFPITWEIRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQ 431 (608)
Q Consensus 352 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGls~~~~~~~ 431 (608)
||.+|++.+++...-.. .+++..+..|+.++++||.|||+++ .||||||+.||||+++|.+||+|||.+..+....
T Consensus 105 fMa~GS~ldIik~~~~~-Gl~E~~Ia~iLre~LkaL~YLH~~G---~IHRdvKAgnILi~~dG~VkLadFgvsa~l~~~G 180 (516)
T KOG0582|consen 105 FMAGGSLLDIIKTYYPD-GLEEASIATILREVLKALDYLHQNG---HIHRDVKAGNILIDSDGTVKLADFGVSASLFDSG 180 (516)
T ss_pred hhcCCcHHHHHHHHccc-cccHHHHHHHHHHHHHHHHHHHhcC---ceecccccccEEEcCCCcEEEcCceeeeeecccC
Confidence 99999999999875433 4999999999999999999999999 9999999999999999999999999887665433
Q ss_pred ccee---eeeeccCCCCChhhhcc--CCCCCccchHhHHHHHHHHHhCCCCCCccchhhcccHHHHHHHHhhhhhhHHHh
Q 044312 432 THMT---TQVHGTFGYLDPEYFRS--SQFTDKSDVYSFGVVLTELLTGEKPIRFTILEEDKSLAAYFLCAMKEERLFEIL 506 (608)
Q Consensus 432 ~~~~---~~~~gt~~y~aPE~~~~--~~~t~ksDV~S~Gvvl~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 506 (608)
.... ....||+.|||||++.. ..|+.|+||||||+...||.+|..||....+ ....+..+....- ...
T Consensus 181 ~R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pP------mkvLl~tLqn~pp-~~~ 253 (516)
T KOG0582|consen 181 DRQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPP------MKVLLLTLQNDPP-TLL 253 (516)
T ss_pred ceeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCCh------HHHHHHHhcCCCC-Ccc
Confidence 2211 44589999999999643 4799999999999999999999999973221 1111112221110 000
Q ss_pred hhhhhccCChhHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 044312 507 DARVMKQGGKDEIITVAKLAKRCLNLNGKKRPTMREVASE 546 (608)
Q Consensus 507 d~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~evl~~ 546 (608)
-.....+..+.....+++++..||+.||++|||+++++++
T Consensus 254 t~~~~~d~~k~~~ksf~e~i~~CL~kDP~kRptAskLlkh 293 (516)
T KOG0582|consen 254 TSGLDKDEDKKFSKSFREMIALCLVKDPSKRPTASKLLKH 293 (516)
T ss_pred cccCChHHhhhhcHHHHHHHHHHhhcCcccCCCHHHHhcc
Confidence 0011112223345589999999999999999999999874
|
|
| >KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=337.34 Aligned_cols=251 Identities=29% Similarity=0.439 Sum_probs=207.3
Q ss_pred HHHHhcCccccceeccCce-------------------EEEEEee---cChhhHHHHHHHHHHHhhcCCCCccceecccc
Q 044312 284 LEKATDNFDLNRILGQGGQ-------------------AVKKSKV---IDESKVEEFINEVVILSQINHRNVVKLLGCCL 341 (608)
Q Consensus 284 l~~~t~~f~~~~~lG~G~~-------------------avk~~~~---~~~~~~~~~~~Ei~il~~l~H~niv~l~~~~~ 341 (608)
|+-..++..+.++||+|+| |||..+. ....+..+|.+|.++|++++|||||+++|++.
T Consensus 152 Wel~H~~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yGVa~ 231 (474)
T KOG0194|consen 152 WELSHSDIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYGVAV 231 (474)
T ss_pred cEEeccCccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEEEEc
Confidence 4444455566789999975 5555553 44677899999999999999999999999999
Q ss_pred cCccceEEEeecCCCccchhccccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEEcCCCcEEEeec
Q 044312 342 ETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEIRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDF 421 (608)
Q Consensus 342 ~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DF 421 (608)
....++||||+++||+|.++|++... .++..++++++.++|.||+|||+++ ++||||.++|+|++.++.+||+||
T Consensus 232 ~~~Pl~ivmEl~~gGsL~~~L~k~~~--~v~~~ek~~~~~~AA~Gl~YLh~k~---~IHRDIAARNcL~~~~~~vKISDF 306 (474)
T KOG0194|consen 232 LEEPLMLVMELCNGGSLDDYLKKNKK--SLPTLEKLRFCYDAARGLEYLHSKN---CIHRDIAARNCLYSKKGVVKISDF 306 (474)
T ss_pred CCCccEEEEEecCCCcHHHHHHhCCC--CCCHHHHHHHHHHHHhHHHHHHHCC---CcchhHhHHHheecCCCeEEeCcc
Confidence 99999999999999999999998664 4999999999999999999999999 999999999999999999999999
Q ss_pred cCccccccCCcceeeeeeccCCCCChhhhccCCCCCccchHhHHHHHHHHHh-CCCCCCccchhhcccHHHHHHHHhhhh
Q 044312 422 GASRSMAVDQTHMTTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLTELLT-GEKPIRFTILEEDKSLAAYFLCAMKEE 500 (608)
Q Consensus 422 Gls~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~ellt-g~~p~~~~~~~~~~~l~~~~~~~~~~~ 500 (608)
||++.-..... ......-+..|+|||.+....++.++|||||||++||+.+ |..||......
T Consensus 307 GLs~~~~~~~~-~~~~~klPirWLAPEtl~~~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~~~---------------- 369 (474)
T KOG0194|consen 307 GLSRAGSQYVM-KKFLKKLPIRWLAPETLNTGIFSFKTDVWSFGVLLWEIFENGAEPYPGMKNY---------------- 369 (474)
T ss_pred ccccCCcceee-ccccccCcceecChhhhccCccccccchhheeeeEEeeeccCCCCCCCCCHH----------------
Confidence 99986541111 1112245679999999999999999999999999999999 78898733221
Q ss_pred hhH-HHhhhhhhccCChhHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhhHHhcCC
Q 044312 501 RLF-EILDARVMKQGGKDEIITVAKLAKRCLNLNGKKRPTMREVASELAGIKAWNGA 556 (608)
Q Consensus 501 ~~~-~~~d~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~evl~~L~~i~~~~~~ 556 (608)
.+. .++....+...+...+.++..++.+||..+|++||+|.++.+.|+.+......
T Consensus 370 ~v~~kI~~~~~r~~~~~~~p~~~~~~~~~c~~~~p~~R~tm~~i~~~l~~~~~~~~~ 426 (474)
T KOG0194|consen 370 EVKAKIVKNGYRMPIPSKTPKELAKVMKQCWKKDPEDRPTMSTIKKKLEALEKKKEA 426 (474)
T ss_pred HHHHHHHhcCccCCCCCCCHHHHHHHHHHhccCChhhccCHHHHHHHHHHHHhcccc
Confidence 122 22234455566667788999999999999999999999999999998876553
|
|
| >KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-38 Score=324.72 Aligned_cols=240 Identities=30% Similarity=0.434 Sum_probs=198.0
Q ss_pred HHHhcCccccceeccCce---------------EEEEEe---ecChhhHHHHHHHHHHHhhc-CCCCccceecccccCcc
Q 044312 285 EKATDNFDLNRILGQGGQ---------------AVKKSK---VIDESKVEEFINEVVILSQI-NHRNVVKLLGCCLETEV 345 (608)
Q Consensus 285 ~~~t~~f~~~~~lG~G~~---------------avk~~~---~~~~~~~~~~~~Ei~il~~l-~H~niv~l~~~~~~~~~ 345 (608)
.+.-.+|.+.+.||.|.| |||++. ++.+..++-...|-.+|.+| .||.|++|+..|.+...
T Consensus 69 kk~~~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~s 148 (604)
T KOG0592|consen 69 KKTPNDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEES 148 (604)
T ss_pred cCChhhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecccc
Confidence 344567999999999985 555432 23344455677888999999 89999999999999999
Q ss_pred ceEEEeecCCCccchhccccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEEcCCCcEEEeeccCcc
Q 044312 346 PLLVYEFIPNGTLFQYIHDQNEDFPITWEIRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASR 425 (608)
Q Consensus 346 ~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGls~ 425 (608)
+|+|+||.++|+|.++|++.+ .|++.....++.||+.||+|||+++ ||||||||+|||||.++++||+|||.|+
T Consensus 149 LYFvLe~A~nGdll~~i~K~G---sfde~caR~YAAeIldAleylH~~G---IIHRDlKPENILLd~dmhikITDFGsAK 222 (604)
T KOG0592|consen 149 LYFVLEYAPNGDLLDLIKKYG---SFDETCARFYAAEILDALEYLHSNG---IIHRDLKPENILLDKDGHIKITDFGSAK 222 (604)
T ss_pred eEEEEEecCCCcHHHHHHHhC---cchHHHHHHHHHHHHHHHHHHHhcC---ceeccCChhheeEcCCCcEEEeeccccc
Confidence 999999999999999999875 4899999999999999999999999 9999999999999999999999999999
Q ss_pred ccccCCcc----------e--eeeeeccCCCCChhhhccCCCCCccchHhHHHHHHHHHhCCCCCCccchhhcccHHHHH
Q 044312 426 SMAVDQTH----------M--TTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLTELLTGEKPIRFTILEEDKSLAAYF 493 (608)
Q Consensus 426 ~~~~~~~~----------~--~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~elltg~~p~~~~~~~~~~~l~~~~ 493 (608)
.+...... . ....+||..|.+||++.....+..+|+|+||||||+|+.|++||..... ...|
T Consensus 223 ~l~~~~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCilyQmlaG~PPFra~Ne------yliF 296 (604)
T KOG0592|consen 223 ILSPSQKSQENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALGCILYQMLAGQPPFRAANE------YLIF 296 (604)
T ss_pred cCChhhccccCccCcccccCcccceeeeecccCHHHhcCCCCCcccchHHHHHHHHHHhcCCCCCccccH------HHHH
Confidence 88643221 1 1447899999999999999999999999999999999999999973211 1111
Q ss_pred HHHhhhhhhHHHhhhhhhccCChhHHHHHHHHHHHHhccCCCCCCCHHHHHHHH
Q 044312 494 LCAMKEERLFEILDARVMKQGGKDEIITVAKLAKRCLNLNGKKRPTMREVASEL 547 (608)
Q Consensus 494 ~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~evl~~L 547 (608)
..|++ +.-+++...++.+.+|+.+.|..||.+|+|..||-++.
T Consensus 297 ---------qkI~~--l~y~fp~~fp~~a~dLv~KLLv~dp~~Rlt~~qIk~Hp 339 (604)
T KOG0592|consen 297 ---------QKIQA--LDYEFPEGFPEDARDLIKKLLVRDPSDRLTSQQIKAHP 339 (604)
T ss_pred ---------HHHHH--hcccCCCCCCHHHHHHHHHHHccCccccccHHHHhhCc
Confidence 12222 22345566678899999999999999999998887753
|
|
| >KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=329.58 Aligned_cols=229 Identities=29% Similarity=0.491 Sum_probs=189.4
Q ss_pred cceeccCce-------------EEEEEeecChhhHHHHHHHHHHHhhcCCCCccceecccccCccceEEEeecCCCccch
Q 044312 294 NRILGQGGQ-------------AVKKSKVIDESKVEEFINEVVILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGTLFQ 360 (608)
Q Consensus 294 ~~~lG~G~~-------------avk~~~~~~~~~~~~~~~Ei~il~~l~H~niv~l~~~~~~~~~~~lV~E~~~~gsL~~ 360 (608)
.+-||.|++ |||+++...+ .+|+-|++|+|+||+.+.|+|.....++||||||+.|.|..
T Consensus 129 LeWlGSGaQGAVF~Grl~netVAVKKV~elkE-------TdIKHLRkLkH~NII~FkGVCtqsPcyCIiMEfCa~GqL~~ 201 (904)
T KOG4721|consen 129 LEWLGSGAQGAVFLGRLHNETVAVKKVRELKE-------TDIKHLRKLKHPNIITFKGVCTQSPCYCIIMEFCAQGQLYE 201 (904)
T ss_pred hhhhccCcccceeeeeccCceehhHHHhhhhh-------hhHHHHHhccCcceeeEeeeecCCceeEEeeeccccccHHH
Confidence 455888763 5555544333 36778999999999999999999999999999999999999
Q ss_pred hccccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEEcCCCcEEEeeccCccccccCCcceeeeeec
Q 044312 361 YIHDQNEDFPITWEIRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHG 440 (608)
Q Consensus 361 ~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGls~~~~~~~~~~~~~~~g 440 (608)
.|+..+ +++......|..+||.||.|||.+. |||||||+-||||..+..+||+|||-++..... .......|
T Consensus 202 VLka~~---~itp~llv~Wsk~IA~GM~YLH~hK---IIHRDLKSPNiLIs~~d~VKIsDFGTS~e~~~~--STkMSFaG 273 (904)
T KOG4721|consen 202 VLKAGR---PITPSLLVDWSKGIAGGMNYLHLHK---IIHRDLKSPNILISYDDVVKISDFGTSKELSDK--STKMSFAG 273 (904)
T ss_pred HHhccC---ccCHHHHHHHHHHhhhhhHHHHHhh---HhhhccCCCceEeeccceEEeccccchHhhhhh--hhhhhhhh
Confidence 998754 5889999999999999999999999 999999999999999999999999999876543 22345789
Q ss_pred cCCCCChhhhccCCCCCccchHhHHHHHHHHHhCCCCCCccchhhcccHHHHHHHHhhhhhhHHHhhhhhhccCChhHHH
Q 044312 441 TFGYLDPEYFRSSQFTDKSDVYSFGVVLTELLTGEKPIRFTILEEDKSLAAYFLCAMKEERLFEILDARVMKQGGKDEII 520 (608)
Q Consensus 441 t~~y~aPE~~~~~~~t~ksDV~S~Gvvl~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~ 520 (608)
|..|||||++.+...++|+|||||||||||||||..||...... . ++..+. ...+....+..++.
T Consensus 274 TVaWMAPEvIrnePcsEKVDIwSfGVVLWEmLT~EiPYkdVdss----A---IIwGVG--------sNsL~LpvPstcP~ 338 (904)
T KOG4721|consen 274 TVAWMAPEVIRNEPCSEKVDIWSFGVVLWEMLTGEIPYKDVDSS----A---IIWGVG--------SNSLHLPVPSTCPD 338 (904)
T ss_pred hHhhhCHHHhhcCCcccccceehhHHHHHHHHhcCCCccccchh----e---eEEecc--------CCcccccCcccCch
Confidence 99999999999999999999999999999999999998622111 0 001111 12233455667888
Q ss_pred HHHHHHHHHhccCCCCCCCHHHHHHHHHhhHH
Q 044312 521 TVAKLAKRCLNLNGKKRPTMREVASELAGIKA 552 (608)
Q Consensus 521 ~l~~Li~~cl~~dp~~RPs~~evl~~L~~i~~ 552 (608)
-+.-|+++||+..|..||++++++.+|.....
T Consensus 339 GfklL~Kqcw~sKpRNRPSFrqil~HldIa~p 370 (904)
T KOG4721|consen 339 GFKLLLKQCWNSKPRNRPSFRQILLHLDIASP 370 (904)
T ss_pred HHHHHHHHHHhcCCCCCccHHHHHHHHhhcCH
Confidence 89999999999999999999999999976654
|
|
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-37 Score=313.66 Aligned_cols=226 Identities=21% Similarity=0.343 Sum_probs=180.9
Q ss_pred eEEEEEeecChhh---HHHHHHHHHHHhhcCCCCccceeccccc----CccceEEEeecCCCccchhccccCCCCCCCHH
Q 044312 302 QAVKKSKVIDESK---VEEFINEVVILSQINHRNVVKLLGCCLE----TEVPLLVYEFIPNGTLFQYIHDQNEDFPITWE 374 (608)
Q Consensus 302 ~avk~~~~~~~~~---~~~~~~Ei~il~~l~H~niv~l~~~~~~----~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~ 374 (608)
+|||+.+...... .+.|.+|+.+|++++||||+++++++.+ ....++||||+++|+|.+++.... .+++.
T Consensus 46 vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~~~~~~~lv~Ey~~~g~L~~~l~~~~---~~~~~ 122 (283)
T PHA02988 46 VIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILEYCTRGYLREVLDKEK---DLSFK 122 (283)
T ss_pred EEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecccCCCceEEEEEeCCCCcHHHHHhhCC---CCChh
Confidence 3777766433322 5788899999999999999999999876 346789999999999999997643 58999
Q ss_pred HHHHHHHHHHHHHHHHhhc-CCCCeeccCCCCCcEEEcCCCcEEEeeccCccccccCCcceeeeeeccCCCCChhhhcc-
Q 044312 375 IRLRIAIEVSGALSYLHSA-ASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHGTFGYLDPEYFRS- 452 (608)
Q Consensus 375 ~~~~i~~~ia~aL~yLH~~-~~~~iiHrDlk~~NILl~~~~~~kl~DFGls~~~~~~~~~~~~~~~gt~~y~aPE~~~~- 452 (608)
..++++.+++.||.|||+. + ++||||||+|||+++++.+||+|||+++...... ....++..|+|||++.+
T Consensus 123 ~~~~i~~~i~~~l~~lH~~~~---~~Hrdlkp~nill~~~~~~kl~dfg~~~~~~~~~----~~~~~~~~y~aPE~~~~~ 195 (283)
T PHA02988 123 TKLDMAIDCCKGLYNLYKYTN---KPYKNLTSVSFLVTENYKLKIICHGLEKILSSPP----FKNVNFMVYFSYKMLNDI 195 (283)
T ss_pred HHHHHHHHHHHHHHHHHhcCC---CCCCcCChhhEEECCCCcEEEcccchHhhhcccc----ccccCcccccCHHHhhhc
Confidence 9999999999999999985 6 7799999999999999999999999998654321 23357889999999976
Q ss_pred -CCCCCccchHhHHHHHHHHHhCCCCCCccchhhcccHHHHHHHHhhhhhhHHHhhhhhhccCChhHHHHHHHHHHHHhc
Q 044312 453 -SQFTDKSDVYSFGVVLTELLTGEKPIRFTILEEDKSLAAYFLCAMKEERLFEILDARVMKQGGKDEIITVAKLAKRCLN 531 (608)
Q Consensus 453 -~~~t~ksDV~S~Gvvl~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~Li~~cl~ 531 (608)
..++.++|||||||++|||++|+.||......+ .+. .++........+...+..+.+|+.+||+
T Consensus 196 ~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~~~~------~~~---------~i~~~~~~~~~~~~~~~~l~~li~~cl~ 260 (283)
T PHA02988 196 FSEYTIKDDIYSLGVVLWEIFTGKIPFENLTTKE------IYD---------LIINKNNSLKLPLDCPLEIKCIVEACTS 260 (283)
T ss_pred cccccchhhhhHHHHHHHHHHHCCCCCCCCCHHH------HHH---------HHHhcCCCCCCCCcCcHHHHHHHHHHhc
Confidence 689999999999999999999999997432111 111 1111111112233466789999999999
Q ss_pred cCCCCCCCHHHHHHHHHhhHH
Q 044312 532 LNGKKRPTMREVASELAGIKA 552 (608)
Q Consensus 532 ~dp~~RPs~~evl~~L~~i~~ 552 (608)
.||++|||++||++.|+.++.
T Consensus 261 ~dp~~Rps~~ell~~l~~~~~ 281 (283)
T PHA02988 261 HDSIKRPNIKEILYNLSLYKF 281 (283)
T ss_pred CCcccCcCHHHHHHHHHHHHh
Confidence 999999999999999988764
|
|
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-37 Score=311.31 Aligned_cols=241 Identities=20% Similarity=0.371 Sum_probs=189.7
Q ss_pred cCccccceeccCce------------------EEEEEeec-ChhhHHHHHHHHHHHhhcCCCCccceecccccCccceEE
Q 044312 289 DNFDLNRILGQGGQ------------------AVKKSKVI-DESKVEEFINEVVILSQINHRNVVKLLGCCLETEVPLLV 349 (608)
Q Consensus 289 ~~f~~~~~lG~G~~------------------avk~~~~~-~~~~~~~~~~Ei~il~~l~H~niv~l~~~~~~~~~~~lV 349 (608)
++|++.+.||+|+| |+|..+.. .......|.+|+.++++++||||+++++++...+..++|
T Consensus 5 ~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 84 (266)
T cd05064 5 KSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLEGVITRGNTMMIV 84 (266)
T ss_pred HHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEecCCCcEEE
Confidence 45778888999875 33433322 223456799999999999999999999999999999999
Q ss_pred EeecCCCccchhccccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEEcCCCcEEEeeccCcccccc
Q 044312 350 YEFIPNGTLFQYIHDQNEDFPITWEIRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAV 429 (608)
Q Consensus 350 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGls~~~~~ 429 (608)
|||+++|+|.+++..... .+++..++.++.|++.||+|||+.+ ++||||||+|||++.++.+|++|||.+.....
T Consensus 85 ~e~~~~~~L~~~l~~~~~--~l~~~~~~~~~~~i~~al~~lH~~~---iiH~dikp~nili~~~~~~~l~dfg~~~~~~~ 159 (266)
T cd05064 85 TEYMSNGALDSFLRKHEG--QLVAGQLMGMLPGLASGMKYLSEMG---YVHKGLAAHKVLVNSDLVCKISGFRRLQEDKS 159 (266)
T ss_pred EEeCCCCcHHHHHHhCCC--CCCHHHHHHHHHHHHHHHHHHHHCC---EeeccccHhhEEEcCCCcEEECCCcccccccc
Confidence 999999999999876432 5899999999999999999999999 99999999999999999999999998765432
Q ss_pred CCcceeeeeeccCCCCChhhhccCCCCCccchHhHHHHHHHHHh-CCCCCCccchhhcccHHHHHHHHhhhhhhHHHhhh
Q 044312 430 DQTHMTTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLTELLT-GEKPIRFTILEEDKSLAAYFLCAMKEERLFEILDA 508 (608)
Q Consensus 430 ~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~ellt-g~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 508 (608)
..........++..|+|||.+.+..++.++||||||++++|+++ |+.||......+ ....+. .
T Consensus 160 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~p~~~~~~~~-------~~~~~~---------~ 223 (266)
T cd05064 160 EAIYTTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMSGQD-------VIKAVE---------D 223 (266)
T ss_pred cchhcccCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHHhcCCCCCcCcCCHHH-------HHHHHH---------C
Confidence 22111122335678999999999999999999999999999775 999986332211 111111 1
Q ss_pred hhhccCChhHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhh
Q 044312 509 RVMKQGGKDEIITVAKLAKRCLNLNGKKRPTMREVASELAGI 550 (608)
Q Consensus 509 ~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~evl~~L~~i 550 (608)
......+...+..+.+++.+||+.+|++||++.||.+.|..+
T Consensus 224 ~~~~~~~~~~~~~~~~li~~c~~~~p~~RP~~~~i~~~l~~~ 265 (266)
T cd05064 224 GFRLPAPRNCPNLLHQLMLDCWQKERGERPRFSQIHSILSKM 265 (266)
T ss_pred CCCCCCCCCCCHHHHHHHHHHcCCCchhCCCHHHHHHHHHhh
Confidence 111223345667899999999999999999999999988654
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-38 Score=320.59 Aligned_cols=251 Identities=24% Similarity=0.317 Sum_probs=190.1
Q ss_pred hcCccccceeccCce---------------EEEEEeecChhhHHH--HHHHHHHHhhcC-CCCccceecccccCc-cceE
Q 044312 288 TDNFDLNRILGQGGQ---------------AVKKSKVIDESKVEE--FINEVVILSQIN-HRNVVKLLGCCLETE-VPLL 348 (608)
Q Consensus 288 t~~f~~~~~lG~G~~---------------avk~~~~~~~~~~~~--~~~Ei~il~~l~-H~niv~l~~~~~~~~-~~~l 348 (608)
-++|.+.++||.|.| |||+++..- ...++ =++|++.|++|+ |||||+|++++.+.+ .+++
T Consensus 9 m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf-~s~ee~~nLREvksL~kln~hpniikL~Evi~d~~~~L~f 87 (538)
T KOG0661|consen 9 MDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKF-YSWEECMNLREVKSLRKLNPHPNIIKLKEVIRDNDRILYF 87 (538)
T ss_pred HHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhh-ccHHHHHHHHHHHHHHhcCCCCcchhhHHHhhccCceEee
Confidence 356888899999986 444443211 11222 468999999998 999999999999988 9999
Q ss_pred EEeecCCCccchhccccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEEcCCCcEEEeeccCccccc
Q 044312 349 VYEFIPNGTLFQYIHDQNEDFPITWEIRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMA 428 (608)
Q Consensus 349 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGls~~~~ 428 (608)
|||||+ .+|+++++..+ .++++..+..|+.||++||+|+|.+| +.|||+||+|||+..+..+||+||||||.+.
T Consensus 88 VfE~Md-~NLYqLmK~R~--r~fse~~irnim~QilqGL~hiHk~G---fFHRDlKPENiLi~~~~~iKiaDFGLARev~ 161 (538)
T KOG0661|consen 88 VFEFMD-CNLYQLMKDRN--RLFSESDIRNIMYQILQGLAHIHKHG---FFHRDLKPENILISGNDVIKIADFGLAREVR 161 (538)
T ss_pred eHHhhh-hhHHHHHhhcC--CcCCHHHHHHHHHHHHHHHHHHHhcC---cccccCChhheEecccceeEecccccccccc
Confidence 999995 59999998763 37999999999999999999999999 9999999999999988999999999999876
Q ss_pred cCCcceeeeeeccCCCCChhhhc-cCCCCCccchHhHHHHHHHHHhCCCCCCccchhhcccHHHHHHHHhhhhhh-----
Q 044312 429 VDQTHMTTQVHGTFGYLDPEYFR-SSQFTDKSDVYSFGVVLTELLTGEKPIRFTILEEDKSLAAYFLCAMKEERL----- 502 (608)
Q Consensus 429 ~~~~~~~~~~~gt~~y~aPE~~~-~~~~t~ksDV~S~Gvvl~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~----- 502 (608)
... ..+....|.+|+|||++. .+-|+.+.|||++|||++|+.+-++-|.....-+...-...++..-....+
T Consensus 162 Skp--PYTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~Dqi~KIc~VLGtP~~~~~~eg~~ 239 (538)
T KOG0661|consen 162 SKP--PYTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASEIDQIYKICEVLGTPDKDSWPEGYN 239 (538)
T ss_pred cCC--CcchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcHHHHHHHHHHHhCCCccccchhHHH
Confidence 443 346678899999999965 567899999999999999999999888743322211111111111111111
Q ss_pred -HHHhhhhhhcc-------CChhHHHHHHHHHHHHhccCCCCCCCHHHHHHHH
Q 044312 503 -FEILDARVMKQ-------GGKDEIITVAKLAKRCLNLNGKKRPTMREVASEL 547 (608)
Q Consensus 503 -~~~~d~~~~~~-------~~~~~~~~l~~Li~~cl~~dp~~RPs~~evl~~L 547 (608)
...+.-++..- .-...+.+..+|+.+|+++||++|||+.|.+++-
T Consensus 240 La~~mnf~~P~~~~~~l~~L~p~~s~~~~~li~~ll~WDP~kRpTA~~al~~p 292 (538)
T KOG0661|consen 240 LASAMNFRFPQVKPSPLKDLLPNASSEAASLIERLLAWDPDKRPTASQALQHP 292 (538)
T ss_pred HHHHhccCCCcCCCCChHHhCcccCHHHHHHHHHHhcCCCccCccHHHHhcCc
Confidence 11111111000 0123567899999999999999999999999853
|
|
| >KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=326.39 Aligned_cols=258 Identities=26% Similarity=0.472 Sum_probs=206.4
Q ss_pred CCHHHHHHHhcCccccceeccCce------------EEEEEeec--ChhhHHHHHHHHHHHhhcCCCCccceecccccCc
Q 044312 279 FTSKELEKATDNFDLNRILGQGGQ------------AVKKSKVI--DESKVEEFINEVVILSQINHRNVVKLLGCCLETE 344 (608)
Q Consensus 279 ~~~~~l~~~t~~f~~~~~lG~G~~------------avk~~~~~--~~~~~~~~~~Ei~il~~l~H~niv~l~~~~~~~~ 344 (608)
...++++...+.+.+...||+|.| |||++++. ...+.+.|++|+..+++-+|.||+-+.|+|....
T Consensus 382 ~s~~~WeIp~~ev~l~~rIGsGsFGtV~Rg~whGdVAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~p~ 461 (678)
T KOG0193|consen 382 DSLEEWEIPPEEVLLGERIGSGSFGTVYRGRWHGDVAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENILLFMGACMNPP 461 (678)
T ss_pred ccccccccCHHHhhccceeccccccceeecccccceEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhheeeehhhcCCc
Confidence 344677777777888999999974 99999874 4467899999999999999999999999998887
Q ss_pred cceEEEeecCCCccchhccccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEEcCCCcEEEeeccCc
Q 044312 345 VPLLVYEFIPNGTLFQYIHDQNEDFPITWEIRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGAS 424 (608)
Q Consensus 345 ~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGls 424 (608)
. .||+-+|.|-+|+.+||.... .|...+.+.||.|||+|+.|||.++ |||||||+.||||.+++++||+||||+
T Consensus 462 ~-AIiTqwCeGsSLY~hlHv~et--kfdm~~~idIAqQiaqGM~YLHAK~---IIHrDLKSnNIFl~~~~kVkIgDFGLa 535 (678)
T KOG0193|consen 462 L-AIITQWCEGSSLYTHLHVQET--KFDMNTTIDIAQQIAQGMDYLHAKN---IIHRDLKSNNIFLHEDLKVKIGDFGLA 535 (678)
T ss_pred e-eeeehhccCchhhhhccchhh--hhhHHHHHHHHHHHHHhhhhhhhhh---hhhhhccccceEEccCCcEEEecccce
Confidence 7 999999999999999998665 4899999999999999999999999 999999999999999999999999998
Q ss_pred ccccc-CCcceeeeeeccCCCCChhhhccC---CCCCccchHhHHHHHHHHHhCCCCCCccchhhcccHHHHHHHHhhhh
Q 044312 425 RSMAV-DQTHMTTQVHGTFGYLDPEYFRSS---QFTDKSDVYSFGVVLTELLTGEKPIRFTILEEDKSLAAYFLCAMKEE 500 (608)
Q Consensus 425 ~~~~~-~~~~~~~~~~gt~~y~aPE~~~~~---~~t~ksDV~S~Gvvl~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~ 500 (608)
..... ..........|...|||||++... .|+..|||||||+|+|||+||..||.....+. .+..+..+
T Consensus 536 tvk~~w~g~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi~~~dq-------IifmVGrG 608 (678)
T KOG0193|consen 536 TVKTRWSGEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSIQNRDQ-------IIFMVGRG 608 (678)
T ss_pred eeeeeeccccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCCCChhh-------eEEEeccc
Confidence 64331 222223344577889999998643 68999999999999999999999987221111 01111111
Q ss_pred hhHHHhhhhhhccCChhHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhhHHhc
Q 044312 501 RLFEILDARVMKQGGKDEIITVAKLAKRCLNLNGKKRPTMREVASELAGIKAWN 554 (608)
Q Consensus 501 ~~~~~~d~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~evl~~L~~i~~~~ 554 (608)
-+. .| .......++++|.+|+..||..++++||.+.+|+..|+.+....
T Consensus 609 ~l~--pd---~s~~~s~~pk~mk~Ll~~C~~~~~~eRP~F~~il~~l~~l~~~~ 657 (678)
T KOG0193|consen 609 YLM--PD---LSKIRSNCPKAMKRLLSDCWKFDREERPLFPQLLSKLEELLPSL 657 (678)
T ss_pred ccC--cc---chhhhccCHHHHHHHHHHHHhcCcccCccHHHHHHHHHHhhhcc
Confidence 000 00 01122466789999999999999999999999999888876643
|
|
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-37 Score=325.92 Aligned_cols=249 Identities=25% Similarity=0.437 Sum_probs=192.8
Q ss_pred HHHHHhcCccccceeccCce--------------------EEEEEeec-ChhhHHHHHHHHHHHhhc-CCCCccceeccc
Q 044312 283 ELEKATDNFDLNRILGQGGQ--------------------AVKKSKVI-DESKVEEFINEVVILSQI-NHRNVVKLLGCC 340 (608)
Q Consensus 283 ~l~~~t~~f~~~~~lG~G~~--------------------avk~~~~~-~~~~~~~~~~Ei~il~~l-~H~niv~l~~~~ 340 (608)
++....++|++.+.||+|+| |||+++.. .....+.+.+|+.+|+.+ +||||+++++++
T Consensus 29 ~~~~~~~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~ 108 (375)
T cd05104 29 KWEFPRNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHINIVNLLGAC 108 (375)
T ss_pred ccccchHHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcCcHHHHHHHHHHHHHHHhcCCcceeeeeeee
Confidence 34444567888999999975 44444322 223456789999999999 899999999999
Q ss_pred ccCccceEEEeecCCCccchhccccCC-----------------------------------------------------
Q 044312 341 LETEVPLLVYEFIPNGTLFQYIHDQNE----------------------------------------------------- 367 (608)
Q Consensus 341 ~~~~~~~lV~E~~~~gsL~~~l~~~~~----------------------------------------------------- 367 (608)
.+.+..++||||+++|+|.++++....
T Consensus 109 ~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ 188 (375)
T cd05104 109 TVGGPTLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRS 188 (375)
T ss_pred ccCCcceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCcccccccccccccc
Confidence 999999999999999999998865321
Q ss_pred -------------------CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEEcCCCcEEEeeccCccccc
Q 044312 368 -------------------DFPITWEIRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMA 428 (608)
Q Consensus 368 -------------------~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGls~~~~ 428 (608)
...+++..+++++.||++||+|||+.+ |+||||||+|||+++++.+||+|||+++...
T Consensus 189 ~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~ 265 (375)
T cd05104 189 VRSGSYIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASKN---CIHRDLAARNILLTHGRITKICDFGLARDIR 265 (375)
T ss_pred cccceecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCchhhEEEECCCcEEEecCccceecc
Confidence 124788999999999999999999998 9999999999999999999999999998764
Q ss_pred cCCcce-eeeeeccCCCCChhhhccCCCCCccchHhHHHHHHHHHh-CCCCCCccchhhcccHHHHHHHHhhhhhhHHHh
Q 044312 429 VDQTHM-TTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLTELLT-GEKPIRFTILEEDKSLAAYFLCAMKEERLFEIL 506 (608)
Q Consensus 429 ~~~~~~-~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~ellt-g~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 506 (608)
...... .....++..|+|||.+.+..++.++||||||++++||++ |..||....... .+ .+.+
T Consensus 266 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~~~------~~---------~~~~ 330 (375)
T cd05104 266 NDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVDS------KF---------YKMI 330 (375)
T ss_pred CcccccccCCCCCCcceeChhHhcCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCchH------HH---------HHHH
Confidence 332211 122334667999999999999999999999999999998 888886322111 01 1111
Q ss_pred hhhhhccCChhHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHh
Q 044312 507 DARVMKQGGKDEIITVAKLAKRCLNLNGKKRPTMREVASELAG 549 (608)
Q Consensus 507 d~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~evl~~L~~ 549 (608)
........+...+.++.+|+.+||+.||++||++.||++.|+.
T Consensus 331 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~l~~ 373 (375)
T cd05104 331 KEGYRMLSPECAPSEMYDIMKSCWDADPLKRPTFKQIVQLIEQ 373 (375)
T ss_pred HhCccCCCCCCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHh
Confidence 1111112222345689999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-37 Score=291.46 Aligned_cols=249 Identities=24% Similarity=0.300 Sum_probs=192.9
Q ss_pred cCccccceeccCce---------------EEEEEeecChh--hHHHHHHHHHHHhhcCCCCccceecccccCccceEEEe
Q 044312 289 DNFDLNRILGQGGQ---------------AVKKSKVIDES--KVEEFINEVVILSQINHRNVVKLLGCCLETEVPLLVYE 351 (608)
Q Consensus 289 ~~f~~~~~lG~G~~---------------avk~~~~~~~~--~~~~~~~Ei~il~~l~H~niv~l~~~~~~~~~~~lV~E 351 (608)
++|...++||+|.| |||+++..+.. -....++|++.|+.++|+||+.|+++|...+...||+|
T Consensus 2 ~rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~F~~~~~l~lVfE 81 (318)
T KOG0659|consen 2 DRYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDVFPHKSNLSLVFE 81 (318)
T ss_pred chhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhhccCCCceEEEEE
Confidence 35667788999975 78888765333 24568999999999999999999999999999999999
Q ss_pred ecCCCccchhccccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEEcCCCcEEEeeccCccccccCC
Q 044312 352 FIPNGTLFQYIHDQNEDFPITWEIRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQ 431 (608)
Q Consensus 352 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGls~~~~~~~ 431 (608)
||+. +|...++.... .++...+..++.++++||+|||++. |+||||||.|+|+++++.+||+|||+++.+....
T Consensus 82 fm~t-dLe~vIkd~~i--~l~pa~iK~y~~m~LkGl~y~H~~~---IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~p~ 155 (318)
T KOG0659|consen 82 FMPT-DLEVVIKDKNI--ILSPADIKSYMLMTLKGLAYCHSKW---ILHRDLKPNNLLISSDGQLKIADFGLARFFGSPN 155 (318)
T ss_pred eccc-cHHHHhccccc--ccCHHHHHHHHHHHHHHHHHHHhhh---hhcccCCccceEEcCCCcEEeecccchhccCCCC
Confidence 9965 99999987543 6999999999999999999999999 9999999999999999999999999999987654
Q ss_pred cceeeeeeccCCCCChhhhccC-CCCCccchHhHHHHHHHHHhCCCCCCccchhhcccHHHHHH--HHhhhhhhHHH---
Q 044312 432 THMTTQVHGTFGYLDPEYFRSS-QFTDKSDVYSFGVVLTELLTGEKPIRFTILEEDKSLAAYFL--CAMKEERLFEI--- 505 (608)
Q Consensus 432 ~~~~~~~~gt~~y~aPE~~~~~-~~t~ksDV~S~Gvvl~elltg~~p~~~~~~~~~~~l~~~~~--~~~~~~~~~~~--- 505 (608)
..... ..-|.+|.|||.+.+. .|+...||||.|||+.||+-|.+-|.....-+ .+...|. ..-.++.+.++
T Consensus 156 ~~~~~-~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~sDid--QL~~If~~LGTP~~~~WP~~~~l 232 (318)
T KOG0659|consen 156 RIQTH-QVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDSDID--QLSKIFRALGTPTPDQWPEMTSL 232 (318)
T ss_pred ccccc-ceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCchHH--HHHHHHHHcCCCCcccCcccccc
Confidence 43333 3679999999998765 79999999999999999999988776433222 2222221 11111111111
Q ss_pred hh---hh-----hhccCChhHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 044312 506 LD---AR-----VMKQGGKDEIITVAKLAKRCLNLNGKKRPTMREVASE 546 (608)
Q Consensus 506 ~d---~~-----~~~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~evl~~ 546 (608)
-| -+ .....-...+.+..+|+.+|+..||.+|+++.|++++
T Consensus 233 pdY~~~~~~P~~~~~~lf~aas~d~ldLl~~m~~ynP~~Rita~qaL~~ 281 (318)
T KOG0659|consen 233 PDYVKIQQFPKPPLNNLFPAASSDALDLLSKMLTYNPKKRITASQALKH 281 (318)
T ss_pred ccHHHHhcCCCCccccccccccHHHHHHHHhhhccCchhcccHHHHhcc
Confidence 01 00 0011112345677999999999999999999999875
|
|
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-36 Score=306.80 Aligned_cols=240 Identities=30% Similarity=0.489 Sum_probs=191.1
Q ss_pred CccccceeccCce---------------EEEEEeecChhhHHHHHHHHHHHhhcCCCCccceecccccCccceEEEeecC
Q 044312 290 NFDLNRILGQGGQ---------------AVKKSKVIDESKVEEFINEVVILSQINHRNVVKLLGCCLETEVPLLVYEFIP 354 (608)
Q Consensus 290 ~f~~~~~lG~G~~---------------avk~~~~~~~~~~~~~~~Ei~il~~l~H~niv~l~~~~~~~~~~~lV~E~~~ 354 (608)
.|++.+.||+|++ |+|..+. +....+++.+|++++++++|+||+++++++......++||||++
T Consensus 7 ~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 85 (263)
T cd05052 7 DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKE-DTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMT 85 (263)
T ss_pred HeEEeeecCCcccceEEEEEEecCCceEEEEEecC-CchHHHHHHHHHHHHHhCCCCChhheEEEEcCCCCcEEEEEeCC
Confidence 4677788888863 4454432 33346789999999999999999999999999999999999999
Q ss_pred CCccchhccccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEEcCCCcEEEeeccCccccccCCcce
Q 044312 355 NGTLFQYIHDQNEDFPITWEIRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHM 434 (608)
Q Consensus 355 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGls~~~~~~~~~~ 434 (608)
+++|.+++..... ..+++..++.++.|+++||+|||+.+ ++||||||+|||+++++.+||+|||+++.........
T Consensus 86 ~~~L~~~~~~~~~-~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~dlkp~nil~~~~~~~kl~df~~~~~~~~~~~~~ 161 (263)
T cd05052 86 YGNLLDYLRECNR-QEVNAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTA 161 (263)
T ss_pred CCcHHHHHHhCCC-CCCCHHHHHHHHHHHHHHHHHHHhCC---EeecccCcceEEEcCCCcEEeCCCccccccccceeec
Confidence 9999999876432 25899999999999999999999998 9999999999999999999999999998765332221
Q ss_pred eeeeeccCCCCChhhhccCCCCCccchHhHHHHHHHHHh-CCCCCCccchhhcccHHHHHHHHhhhhhhHHHhhhhhhcc
Q 044312 435 TTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLTELLT-GEKPIRFTILEEDKSLAAYFLCAMKEERLFEILDARVMKQ 513 (608)
Q Consensus 435 ~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~ellt-g~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~ 513 (608)
.....++..|+|||++.+..++.++||||||++++||++ |..||.....++ . ...+......+
T Consensus 162 ~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~------~----------~~~~~~~~~~~ 225 (263)
T cd05052 162 HAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQ------V----------YELLEKGYRME 225 (263)
T ss_pred cCCCCCccccCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHH------H----------HHHHHCCCCCC
Confidence 122234568999999999999999999999999999998 889986322111 1 11111112223
Q ss_pred CChhHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhh
Q 044312 514 GGKDEIITVAKLAKRCLNLNGKKRPTMREVASELAGI 550 (608)
Q Consensus 514 ~~~~~~~~l~~Li~~cl~~dp~~RPs~~evl~~L~~i 550 (608)
.+...+.++.+++.+||+.+|++||++.|+++.|+.+
T Consensus 226 ~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~~l~~~ 262 (263)
T cd05052 226 RPEGCPPKVYELMRACWQWNPSDRPSFAEIHQAFETM 262 (263)
T ss_pred CCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHhh
Confidence 3445567899999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=324.25 Aligned_cols=248 Identities=27% Similarity=0.489 Sum_probs=192.2
Q ss_pred HHHhcCccccceeccCce--------------------EEEEEeec-ChhhHHHHHHHHHHHhhc-CCCCccceeccccc
Q 044312 285 EKATDNFDLNRILGQGGQ--------------------AVKKSKVI-DESKVEEFINEVVILSQI-NHRNVVKLLGCCLE 342 (608)
Q Consensus 285 ~~~t~~f~~~~~lG~G~~--------------------avk~~~~~-~~~~~~~~~~Ei~il~~l-~H~niv~l~~~~~~ 342 (608)
.-..++|++.+.||+|+| |||+++.. .....+.+.+|+.+++.+ +|+|||++++++.+
T Consensus 34 ~~~~~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~~ 113 (374)
T cd05106 34 EFPRDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQHKNIVNLLGACTH 113 (374)
T ss_pred cccHHHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCCHHHHHHHHHHHHHHHhhccCCceeeEeeEecC
Confidence 344557888999999975 33444322 223356788999999999 89999999999999
Q ss_pred CccceEEEeecCCCccchhccccCC-------------------------------------------------------
Q 044312 343 TEVPLLVYEFIPNGTLFQYIHDQNE------------------------------------------------------- 367 (608)
Q Consensus 343 ~~~~~lV~E~~~~gsL~~~l~~~~~------------------------------------------------------- 367 (608)
....++||||+++|+|.++++....
T Consensus 114 ~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 193 (374)
T cd05106 114 GGPVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSSQ 193 (374)
T ss_pred CCCeEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCccccccc
Confidence 9999999999999999998864211
Q ss_pred ------------CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEEcCCCcEEEeeccCccccccCCcce-
Q 044312 368 ------------DFPITWEIRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHM- 434 (608)
Q Consensus 368 ------------~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGls~~~~~~~~~~- 434 (608)
..++++..+++++.||+.||+|||+.+ |+||||||+|||+++++.+||+|||+++.........
T Consensus 194 ~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~g---iiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~~~~ 270 (374)
T cd05106 194 SSDSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASKN---CIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVV 270 (374)
T ss_pred cccccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHCC---EEeccCchheEEEeCCCeEEEeeceeeeeccCCcceee
Confidence 124788999999999999999999998 9999999999999999999999999998654332211
Q ss_pred eeeeeccCCCCChhhhccCCCCCccchHhHHHHHHHHHh-CCCCCCccchhhcccHHHHHHHHhhhhhhHHHhhhhhhcc
Q 044312 435 TTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLTELLT-GEKPIRFTILEEDKSLAAYFLCAMKEERLFEILDARVMKQ 513 (608)
Q Consensus 435 ~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~ellt-g~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~ 513 (608)
.....++..|+|||++....++.++||||||++++||++ |+.||....... .+...+.......
T Consensus 271 ~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~---------------~~~~~~~~~~~~~ 335 (374)
T cd05106 271 KGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNS---------------KFYKMVKRGYQMS 335 (374)
T ss_pred ccCCCCccceeCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCccccccH---------------HHHHHHHcccCcc
Confidence 112235668999999999999999999999999999997 999986322111 1111111111112
Q ss_pred CChhHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhh
Q 044312 514 GGKDEIITVAKLAKRCLNLNGKKRPTMREVASELAGI 550 (608)
Q Consensus 514 ~~~~~~~~l~~Li~~cl~~dp~~RPs~~evl~~L~~i 550 (608)
.+...+.++.+++.+||+.||++|||+.+|++.|+.+
T Consensus 336 ~~~~~~~~l~~li~~cl~~dp~~RPs~~~l~~~l~~~ 372 (374)
T cd05106 336 RPDFAPPEIYSIMKMCWNLEPTERPTFSQISQLIQRQ 372 (374)
T ss_pred CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 2223456899999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-36 Score=308.48 Aligned_cols=242 Identities=26% Similarity=0.454 Sum_probs=191.0
Q ss_pred CccccceeccCce--------------------EEEEEeec-ChhhHHHHHHHHHHHhhcCCCCccceecccccCccceE
Q 044312 290 NFDLNRILGQGGQ--------------------AVKKSKVI-DESKVEEFINEVVILSQINHRNVVKLLGCCLETEVPLL 348 (608)
Q Consensus 290 ~f~~~~~lG~G~~--------------------avk~~~~~-~~~~~~~~~~Ei~il~~l~H~niv~l~~~~~~~~~~~l 348 (608)
+|++.+.||+|++ |+|..+.. .....+.|.+|+.++++++||||+++++++......++
T Consensus 6 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~ 85 (283)
T cd05048 6 AVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKEQPTCM 85 (283)
T ss_pred HcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCCCHHHHHHHHHHHHHHHhcCCcccceEEEEEcCCCceEE
Confidence 4666777877763 44444322 22345678999999999999999999999999899999
Q ss_pred EEeecCCCccchhccccCC-------------CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEEcCCCc
Q 044312 349 VYEFIPNGTLFQYIHDQNE-------------DFPITWEIRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYR 415 (608)
Q Consensus 349 V~E~~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~ 415 (608)
+|||+++++|.+++..... ...+++..++.++.|++.||.|||+.+ ++|+||||+|||+++++.
T Consensus 86 ~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~~---i~H~dlkp~Nil~~~~~~ 162 (283)
T cd05048 86 LFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSHH---FVHRDLAARNCLVGEGLT 162 (283)
T ss_pred EEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccccceEEEcCCCc
Confidence 9999999999999875321 124889999999999999999999999 999999999999999999
Q ss_pred EEEeeccCccccccCCc-ceeeeeeccCCCCChhhhccCCCCCccchHhHHHHHHHHHh-CCCCCCccchhhcccHHHHH
Q 044312 416 AKVSDFGASRSMAVDQT-HMTTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLTELLT-GEKPIRFTILEEDKSLAAYF 493 (608)
Q Consensus 416 ~kl~DFGls~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~ellt-g~~p~~~~~~~~~~~l~~~~ 493 (608)
+||+|||+++....... .......+++.|+|||++....++.++||||||++++||++ |..||......
T Consensus 163 ~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~el~~~g~~p~~~~~~~--------- 233 (283)
T cd05048 163 VKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFSNQ--------- 233 (283)
T ss_pred EEECCCcceeeccccccccccCCCcccccccCHHHhccCcCchhhhHHHHHHHHHHHHcCCCCCCCCCCHH---------
Confidence 99999999986543221 12233346788999999998999999999999999999998 99998632211
Q ss_pred HHHhhhhhhHHHhhhhhhccCChhHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhh
Q 044312 494 LCAMKEERLFEILDARVMKQGGKDEIITVAKLAKRCLNLNGKKRPTMREVASELAGI 550 (608)
Q Consensus 494 ~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~evl~~L~~i 550 (608)
.+.+.+........+...+.++.+|+.+||+.||.+||++.||+++|+.+
T Consensus 234 -------~~~~~i~~~~~~~~~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~l~~~ 283 (283)
T cd05048 234 -------EVIEMIRSRQLLPCPEDCPARVYALMIECWNEIPARRPRFKDIHTRLRSW 283 (283)
T ss_pred -------HHHHHHHcCCcCCCcccCCHHHHHHHHHHccCChhhCcCHHHHHHHHhcC
Confidence 11111222222233445678899999999999999999999999999753
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-36 Score=304.13 Aligned_cols=236 Identities=26% Similarity=0.441 Sum_probs=186.3
Q ss_pred CccccceeccCce--------------EEEEEeecChhhHHHHHHHHHHHhhcCCCCccceecccccCccceEEEeecCC
Q 044312 290 NFDLNRILGQGGQ--------------AVKKSKVIDESKVEEFINEVVILSQINHRNVVKLLGCCLETEVPLLVYEFIPN 355 (608)
Q Consensus 290 ~f~~~~~lG~G~~--------------avk~~~~~~~~~~~~~~~Ei~il~~l~H~niv~l~~~~~~~~~~~lV~E~~~~ 355 (608)
.|++.+.||+|++ |+|.... .....++|.+|+.++++++||||+++++++.+....++||||+++
T Consensus 5 ~~~~~~~lg~G~~~~vy~~~~~~~~~~a~K~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~~~~ 83 (256)
T cd05114 5 ELTFMKELGSGQFGVVHLGKWRAQIKVAIKAINE-GAMSEEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIVTEFMEN 83 (256)
T ss_pred HcEEeeEecCCcCceEEEEEeccCceEEEEeccc-CCccHHHHHHHHHHHHHCCCCCceeEEEEEccCCCEEEEEEcCCC
Confidence 4777888898875 4444332 223356899999999999999999999999999999999999999
Q ss_pred CccchhccccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEEcCCCcEEEeeccCccccccCCccee
Q 044312 356 GTLFQYIHDQNEDFPITWEIRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMT 435 (608)
Q Consensus 356 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGls~~~~~~~~~~~ 435 (608)
|+|.++++.... .+++..++.++.|++.||+|||+.+ ++||||||+||++++++.+||+|||+++..........
T Consensus 84 ~~L~~~~~~~~~--~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~~~~~~~ 158 (256)
T cd05114 84 GCLLNYLRQRQG--KLSKDMLLSMCQDVCEGMEYLERNS---FIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYTSS 158 (256)
T ss_pred CcHHHHHHhCcc--CCCHHHHHHHHHHHHHHHHHHHHCC---ccccccCcceEEEcCCCeEEECCCCCccccCCCceecc
Confidence 999999875432 4899999999999999999999999 99999999999999999999999999986543322222
Q ss_pred eeeeccCCCCChhhhccCCCCCccchHhHHHHHHHHHh-CCCCCCccchhhcccHHHHHHHHhhhhhhHHHhhhhhhccC
Q 044312 436 TQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLTELLT-GEKPIRFTILEEDKSLAAYFLCAMKEERLFEILDARVMKQG 514 (608)
Q Consensus 436 ~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~ellt-g~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~ 514 (608)
....++..|+|||++....++.++||||||++++||++ |+.||...... .... ..... .....
T Consensus 159 ~~~~~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~~~------~~~~-~i~~~---------~~~~~ 222 (256)
T cd05114 159 SGAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSNY------EVVE-MISRG---------FRLYR 222 (256)
T ss_pred CCCCCchhhCChhhcccCccchhhhhHHHHHHHHHHHcCCCCCCCCCCHH------HHHH-HHHCC---------CCCCC
Confidence 23335668999999998899999999999999999999 88998632211 1111 11111 01112
Q ss_pred ChhHHHHHHHHHHHHhccCCCCCCCHHHHHHHH
Q 044312 515 GKDEIITVAKLAKRCLNLNGKKRPTMREVASEL 547 (608)
Q Consensus 515 ~~~~~~~l~~Li~~cl~~dp~~RPs~~evl~~L 547 (608)
+...+..+.+|+.+||+.+|++||++.|+++.|
T Consensus 223 ~~~~~~~~~~li~~c~~~~p~~Rps~~~l~~~l 255 (256)
T cd05114 223 PKLASMTVYEVMYSCWHEKPEGRPTFAELLRAI 255 (256)
T ss_pred CCCCCHHHHHHHHHHccCCcccCcCHHHHHHhh
Confidence 223456799999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-36 Score=304.81 Aligned_cols=241 Identities=22% Similarity=0.406 Sum_probs=191.5
Q ss_pred cCccccceeccCce--------------EEEEEeecChhhHHHHHHHHHHHhhcCCCCccceecccccCccceEEEeecC
Q 044312 289 DNFDLNRILGQGGQ--------------AVKKSKVIDESKVEEFINEVVILSQINHRNVVKLLGCCLETEVPLLVYEFIP 354 (608)
Q Consensus 289 ~~f~~~~~lG~G~~--------------avk~~~~~~~~~~~~~~~Ei~il~~l~H~niv~l~~~~~~~~~~~lV~E~~~ 354 (608)
++|++.++||+|++ |+|.... .....+.+.+|+.++++++|+||+++++.+.+.+..+++|||++
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~~~~~~v~iK~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 84 (261)
T cd05072 6 ESIKLVKKLGAGQFGEVWMGYYNNSTKVAVKTLKP-GTMSVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIYIITEYMA 84 (261)
T ss_pred HHeEEeeecCCcCCceEEEEEecCCceEEEEEccC-CchhHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcEEEEecCC
Confidence 46788889999874 4554433 23346789999999999999999999999999999999999999
Q ss_pred CCccchhccccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEEcCCCcEEEeeccCccccccCCcce
Q 044312 355 NGTLFQYIHDQNEDFPITWEIRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHM 434 (608)
Q Consensus 355 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGls~~~~~~~~~~ 434 (608)
+++|.++++.... ..+++..++.++.|++.||+|||+.+ ++||||||+|||+++++.+||+|||+++.........
T Consensus 85 ~~~L~~~l~~~~~-~~~~~~~~~~~~~~l~~~l~~LH~~~---i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~~~ 160 (261)
T cd05072 85 KGSLLDFLKSDEG-GKVLLPKLIDFSAQIAEGMAYIERKN---YIHRDLRAANVLVSESLMCKIADFGLARVIEDNEYTA 160 (261)
T ss_pred CCcHHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccchhhEEecCCCcEEECCCccceecCCCceec
Confidence 9999999976432 25899999999999999999999998 9999999999999999999999999998765332222
Q ss_pred eeeeeccCCCCChhhhccCCCCCccchHhHHHHHHHHHh-CCCCCCccchhhcccHHHHHHHHhhhhhhHHHhhhhhhcc
Q 044312 435 TTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLTELLT-GEKPIRFTILEEDKSLAAYFLCAMKEERLFEILDARVMKQ 513 (608)
Q Consensus 435 ~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~ellt-g~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~ 513 (608)
.....++..|+|||++....++.++||||||++++||+| |+.||....... . ...+.. ....+
T Consensus 161 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~---~----~~~~~~---------~~~~~ 224 (261)
T cd05072 161 REGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNSD---V----MSALQR---------GYRMP 224 (261)
T ss_pred cCCCccceecCCHHHhccCCCChhhhhhhhHHHHHHHHccCCCCCCCCCHHH---H----HHHHHc---------CCCCC
Confidence 223345678999999998899999999999999999998 999986322111 0 011111 11111
Q ss_pred CChhHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhh
Q 044312 514 GGKDEIITVAKLAKRCLNLNGKKRPTMREVASELAGI 550 (608)
Q Consensus 514 ~~~~~~~~l~~Li~~cl~~dp~~RPs~~evl~~L~~i 550 (608)
.....+.++.+++.+||+.+|++||+++++.+.|+.+
T Consensus 225 ~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 261 (261)
T cd05072 225 RMENCPDELYDIMKTCWKEKAEERPTFDYLQSVLDDF 261 (261)
T ss_pred CCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHhcC
Confidence 2223456799999999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-37 Score=321.60 Aligned_cols=233 Identities=27% Similarity=0.427 Sum_probs=195.0
Q ss_pred CccccceeccCc---------------eEEEEEeec---ChhhHHHHHHHHHHHhhcCCCCccceecccccCccceEEEe
Q 044312 290 NFDLNRILGQGG---------------QAVKKSKVI---DESKVEEFINEVVILSQINHRNVVKLLGCCLETEVPLLVYE 351 (608)
Q Consensus 290 ~f~~~~~lG~G~---------------~avk~~~~~---~~~~~~~~~~Ei~il~~l~H~niv~l~~~~~~~~~~~lV~E 351 (608)
-|++.+-||.|+ -|||.+... .......+.+||.||+.|.||||++|++++.+...+|||.|
T Consensus 13 pwkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~~lylvlE 92 (786)
T KOG0588|consen 13 PWKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQHLYLVLE 92 (786)
T ss_pred ceeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeeccCceEEEEEE
Confidence 366778888886 277766542 34456778899999999999999999999999999999999
Q ss_pred ecCCCccchhccccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEEcCCCcEEEeeccCccccccCC
Q 044312 352 FIPNGTLFQYIHDQNEDFPITWEIRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQ 431 (608)
Q Consensus 352 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGls~~~~~~~ 431 (608)
|+++|.|++++..++ ++++.+..+++.||+.|+.|+|..+ |+||||||+|+|||.++++||+|||+|..-..+
T Consensus 93 yv~gGELFdylv~kG---~l~e~eaa~ff~QIi~gv~yCH~~~---icHRDLKpENlLLd~~~nIKIADFGMAsLe~~g- 165 (786)
T KOG0588|consen 93 YVPGGELFDYLVRKG---PLPEREAAHFFRQILDGVSYCHAFN---ICHRDLKPENLLLDVKNNIKIADFGMASLEVPG- 165 (786)
T ss_pred ecCCchhHHHHHhhC---CCCCHHHHHHHHHHHHHHHHHhhhc---ceeccCCchhhhhhcccCEeeeccceeecccCC-
Confidence 999999999998765 5999999999999999999999999 999999999999999999999999999765433
Q ss_pred cceeeeeeccCCCCChhhhccCCC-CCccchHhHHHHHHHHHhCCCCCCccchhhcccHHHHHHHHhhhhhhHHHhhhhh
Q 044312 432 THMTTQVHGTFGYLDPEYFRSSQF-TDKSDVYSFGVVLTELLTGEKPIRFTILEEDKSLAAYFLCAMKEERLFEILDARV 510 (608)
Q Consensus 432 ~~~~~~~~gt~~y~aPE~~~~~~~-t~ksDV~S~Gvvl~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~ 510 (608)
.......|.+.|.+||++.+..| ..++||||.|||||.||||+.||... ++-. .+.+++.+.
T Consensus 166 -klLeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdDd------Nir~-LLlKV~~G~--------- 228 (786)
T KOG0588|consen 166 -KLLETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDDD------NIRV-LLLKVQRGV--------- 228 (786)
T ss_pred -ccccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCCc------cHHH-HHHHHHcCc---------
Confidence 34456689999999999999988 46899999999999999999999722 1111 122222221
Q ss_pred hccCChhHHHHHHHHHHHHhccCCCCCCCHHHHHHHH
Q 044312 511 MKQGGKDEIITVAKLAKRCLNLNGKKRPTMREVASEL 547 (608)
Q Consensus 511 ~~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~evl~~L 547 (608)
.+.+...+.+.++|+.+||..||++|.|++||+++-
T Consensus 229 -f~MPs~Is~eaQdLLr~ml~VDp~~RiT~~eI~kHP 264 (786)
T KOG0588|consen 229 -FEMPSNISSEAQDLLRRMLDVDPSTRITTEEILKHP 264 (786)
T ss_pred -ccCCCcCCHHHHHHHHHHhccCccccccHHHHhhCc
Confidence 234566778999999999999999999999999864
|
|
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-36 Score=308.91 Aligned_cols=252 Identities=22% Similarity=0.263 Sum_probs=187.2
Q ss_pred cCccccceeccCce---------------EEEEEeec--ChhhHHHHHHHHHHHhhcCCCCccceecccccCccceEEEe
Q 044312 289 DNFDLNRILGQGGQ---------------AVKKSKVI--DESKVEEFINEVVILSQINHRNVVKLLGCCLETEVPLLVYE 351 (608)
Q Consensus 289 ~~f~~~~~lG~G~~---------------avk~~~~~--~~~~~~~~~~Ei~il~~l~H~niv~l~~~~~~~~~~~lV~E 351 (608)
++|++.+.||+|++ |+|+.+.. .....+.+.+|+.++++++||||+++++++.+.+..++|||
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (287)
T cd07848 1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLVFE 80 (287)
T ss_pred CCceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhEecCCEEEEEEe
Confidence 36888899999874 66666542 23345678899999999999999999999999999999999
Q ss_pred ecCCCccchhccccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEEcCCCcEEEeeccCccccccCC
Q 044312 352 FIPNGTLFQYIHDQNEDFPITWEIRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQ 431 (608)
Q Consensus 352 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGls~~~~~~~ 431 (608)
|++++.|..+... . ..+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++......
T Consensus 81 ~~~~~~l~~~~~~-~--~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~ 154 (287)
T cd07848 81 YVEKNMLELLEEM-P--NGVPPEKVRSYIYQLIKAIHWCHKND---IVHRDIKPENLLISHNDVLKLCDFGFARNLSEGS 154 (287)
T ss_pred cCCCCHHHHHHhc-C--CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCcEEEeeccCcccccccc
Confidence 9998766554432 2 25899999999999999999999999 9999999999999999999999999998765433
Q ss_pred cceeeeeeccCCCCChhhhccCCCCCccchHhHHHHHHHHHhCCCCCCccchhhcccHHHHHHHHhhhhhhHHHh-hhh-
Q 044312 432 THMTTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLTELLTGEKPIRFTILEEDKSLAAYFLCAMKEERLFEIL-DAR- 509 (608)
Q Consensus 432 ~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~-d~~- 509 (608)
........|++.|+|||++.+..++.++|||||||+++||++|+.||......+..................... ++.
T Consensus 155 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (287)
T cd07848 155 NANYTEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQMKLFYSNPRF 234 (287)
T ss_pred cccccccccccccCCcHHHcCCCCCCchhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCHHHHHhhhccchh
Confidence 333344568999999999999899999999999999999999999997432211100000000000000000000 000
Q ss_pred -------h------hccCChhHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 044312 510 -------V------MKQGGKDEIITVAKLAKRCLNLNGKKRPTMREVASE 546 (608)
Q Consensus 510 -------~------~~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~evl~~ 546 (608)
. ........+..+.+|+.+||+.||++|||++|++++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~h 284 (287)
T cd07848 235 HGLRFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLNH 284 (287)
T ss_pred cccccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhcC
Confidence 0 000011245679999999999999999999999853
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-36 Score=305.36 Aligned_cols=243 Identities=26% Similarity=0.440 Sum_probs=196.3
Q ss_pred HhcCccccceeccCce--------------EEEEEeecChhhHHHHHHHHHHHhhcCCCCccceecccccCccceEEEee
Q 044312 287 ATDNFDLNRILGQGGQ--------------AVKKSKVIDESKVEEFINEVVILSQINHRNVVKLLGCCLETEVPLLVYEF 352 (608)
Q Consensus 287 ~t~~f~~~~~lG~G~~--------------avk~~~~~~~~~~~~~~~Ei~il~~l~H~niv~l~~~~~~~~~~~lV~E~ 352 (608)
...+|++.++||.|++ ++|..........+.+.+|+.+++.++|+||+++++++.+.+..++||||
T Consensus 4 ~~~~y~~~~~ig~g~~~~vy~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 83 (261)
T cd05148 4 PREEFTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVYIITEL 83 (261)
T ss_pred cHHHHHHhhhhccCCCccEEEeEecCCCcEEEEeccccchhhHHHHHHHHHHHhcCCCcchhheeeeEecCCCeEEEEee
Confidence 4456778888888874 55665555555677899999999999999999999999999999999999
Q ss_pred cCCCccchhccccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEEcCCCcEEEeeccCccccccCCc
Q 044312 353 IPNGTLFQYIHDQNEDFPITWEIRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQT 432 (608)
Q Consensus 353 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGls~~~~~~~~ 432 (608)
+++++|.+++..... ..+++..+..++.||+.||.|||+.+ ++|+||||+|||+++++.+||+|||++........
T Consensus 84 ~~~~~L~~~~~~~~~-~~~~~~~~~~~~~~i~~al~~lH~~~---i~h~dl~~~nilv~~~~~~kl~d~g~~~~~~~~~~ 159 (261)
T cd05148 84 MEKGSLLAFLRSPEG-QVLPVASLIDMACQVAEGMAYLEEQN---SIHRDLAARNILVGEDLVCKVADFGLARLIKEDVY 159 (261)
T ss_pred cccCCHHHHHhcCCC-CCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccCcceEEEcCCceEEEccccchhhcCCccc
Confidence 999999999986533 35899999999999999999999999 99999999999999999999999999977643221
Q ss_pred ceeeeeeccCCCCChhhhccCCCCCccchHhHHHHHHHHHh-CCCCCCccchhhcccHHHHHHHHhhhhhhHHHhhhhhh
Q 044312 433 HMTTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLTELLT-GEKPIRFTILEEDKSLAAYFLCAMKEERLFEILDARVM 511 (608)
Q Consensus 433 ~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~ellt-g~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~ 511 (608)
......++..|+|||.+....++.++||||||+++++|++ |+.||...... .....+.....
T Consensus 160 -~~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~~~----------------~~~~~~~~~~~ 222 (261)
T cd05148 160 -LSSDKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNNH----------------EVYDQITAGYR 222 (261)
T ss_pred -cccCCCCceEecCHHHHccCCCCchhhHHHHHHHHHHHHcCCCCCCCcCCHH----------------HHHHHHHhCCc
Confidence 1223345678999999998899999999999999999998 88998632211 01111111122
Q ss_pred ccCChhHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhh
Q 044312 512 KQGGKDEIITVAKLAKRCLNLNGKKRPTMREVASELAGI 550 (608)
Q Consensus 512 ~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~evl~~L~~i 550 (608)
...+...+..+.+++.+||+.+|++|||++++++.|+.+
T Consensus 223 ~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~l~~~L~~~ 261 (261)
T cd05148 223 MPCPAKCPQEIYKIMLECWAAEPEDRPSFKALREELDNI 261 (261)
T ss_pred CCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHhcC
Confidence 233445667899999999999999999999999999764
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-36 Score=308.05 Aligned_cols=246 Identities=27% Similarity=0.442 Sum_probs=193.2
Q ss_pred cCccccceeccCce--------------------EEEEEeecChhhHHHHHHHHHHHhhcCCCCccceecccccCccceE
Q 044312 289 DNFDLNRILGQGGQ--------------------AVKKSKVIDESKVEEFINEVVILSQINHRNVVKLLGCCLETEVPLL 348 (608)
Q Consensus 289 ~~f~~~~~lG~G~~--------------------avk~~~~~~~~~~~~~~~Ei~il~~l~H~niv~l~~~~~~~~~~~l 348 (608)
++|.+.+.||+|++ |+|..........+.+.+|+.++++++||||+++++++......++
T Consensus 5 ~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 84 (288)
T cd05093 5 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIM 84 (288)
T ss_pred HHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEE
Confidence 45777778888764 3344433344556789999999999999999999999999999999
Q ss_pred EEeecCCCccchhccccC----------CCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEEcCCCcEEE
Q 044312 349 VYEFIPNGTLFQYIHDQN----------EDFPITWEIRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKV 418 (608)
Q Consensus 349 V~E~~~~gsL~~~l~~~~----------~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl 418 (608)
||||+++++|.+++.... ....+++..++.++.|++.||+|||+++ ++||||||+|||+++++.+||
T Consensus 85 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~~---i~H~dlkp~Nili~~~~~~kl 161 (288)
T cd05093 85 VFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQH---FVHRDLATRNCLVGENLLVKI 161 (288)
T ss_pred EEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccCcceEEEccCCcEEe
Confidence 999999999999987532 1224899999999999999999999999 999999999999999999999
Q ss_pred eeccCccccccCCcc-eeeeeeccCCCCChhhhccCCCCCccchHhHHHHHHHHHh-CCCCCCccchhhcccHHHHHHHH
Q 044312 419 SDFGASRSMAVDQTH-MTTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLTELLT-GEKPIRFTILEEDKSLAAYFLCA 496 (608)
Q Consensus 419 ~DFGls~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~ellt-g~~p~~~~~~~~~~~l~~~~~~~ 496 (608)
+|||+++........ ......++..|+|||++....++.++||||||++++||++ |..||....... ....
T Consensus 162 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t~g~~p~~~~~~~~-------~~~~ 234 (288)
T cd05093 162 GDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNE-------VIEC 234 (288)
T ss_pred ccCCccccccCCceeecCCCCCccccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHH-------HHHH
Confidence 999999865432221 1122335678999999999999999999999999999998 889886332111 1111
Q ss_pred hhhhhhHHHhhhhhhccCChhHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhhHHh
Q 044312 497 MKEERLFEILDARVMKQGGKDEIITVAKLAKRCLNLNGKKRPTMREVASELAGIKAW 553 (608)
Q Consensus 497 ~~~~~~~~~~d~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~evl~~L~~i~~~ 553 (608)
...+. ....+...+.++.+|+.+||+.+|.+|||+.||++.|+.+...
T Consensus 235 i~~~~---------~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~v~~~l~~~~~~ 282 (288)
T cd05093 235 ITQGR---------VLQRPRTCPKEVYDLMLGCWQREPHMRLNIKEIHSLLQNLAKA 282 (288)
T ss_pred HHcCC---------cCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHHHh
Confidence 11111 1112223456799999999999999999999999999888754
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-36 Score=308.57 Aligned_cols=245 Identities=24% Similarity=0.401 Sum_probs=192.8
Q ss_pred CccccceeccCce--------------------EEEEEeecChhhHHHHHHHHHHHhhcCCCCccceecccccCccceEE
Q 044312 290 NFDLNRILGQGGQ--------------------AVKKSKVIDESKVEEFINEVVILSQINHRNVVKLLGCCLETEVPLLV 349 (608)
Q Consensus 290 ~f~~~~~lG~G~~--------------------avk~~~~~~~~~~~~~~~Ei~il~~l~H~niv~l~~~~~~~~~~~lV 349 (608)
+|.+.+.||+|++ ++|..+.......+.+.+|+.++++++|+||+++++++.+....++|
T Consensus 6 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 85 (291)
T cd05094 6 DIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKFYGVCGDGDPLIMV 85 (291)
T ss_pred HeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCccHHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCceEEE
Confidence 4666777777763 33444433344457899999999999999999999999999999999
Q ss_pred EeecCCCccchhccccCC-------------CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEEcCCCcE
Q 044312 350 YEFIPNGTLFQYIHDQNE-------------DFPITWEIRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRA 416 (608)
Q Consensus 350 ~E~~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ 416 (608)
|||+++++|.+++..... ...+++..++.++.||+.||+|||+++ ++||||||+|||++.++.+
T Consensus 86 ~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---i~H~dlkp~Nil~~~~~~~ 162 (291)
T cd05094 86 FEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQH---FVHRDLATRNCLVGANLLV 162 (291)
T ss_pred EecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccCcceEEEccCCcE
Confidence 999999999999975321 124899999999999999999999999 9999999999999999999
Q ss_pred EEeeccCccccccCCc-ceeeeeeccCCCCChhhhccCCCCCccchHhHHHHHHHHHh-CCCCCCccchhhcccHHHHHH
Q 044312 417 KVSDFGASRSMAVDQT-HMTTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLTELLT-GEKPIRFTILEEDKSLAAYFL 494 (608)
Q Consensus 417 kl~DFGls~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~ellt-g~~p~~~~~~~~~~~l~~~~~ 494 (608)
||+|||+++....... .......++..|+|||++....++.++||||||++++||+| |+.||......+ ..
T Consensus 163 ~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~-------~~ 235 (291)
T cd05094 163 KIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTE-------VI 235 (291)
T ss_pred EECCCCcccccCCCceeecCCCCCcceeecChHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHH-------HH
Confidence 9999999976543221 11223446788999999999999999999999999999999 999986332211 11
Q ss_pred HHhhhhhhHHHhhhhhhccCChhHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhhHHh
Q 044312 495 CAMKEERLFEILDARVMKQGGKDEIITVAKLAKRCLNLNGKKRPTMREVASELAGIKAW 553 (608)
Q Consensus 495 ~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~evl~~L~~i~~~ 553 (608)
..+... .....+...+..+.+++.+||+.+|++||++++|+++|+.+...
T Consensus 236 ~~~~~~---------~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~~l~~~~~~ 285 (291)
T cd05094 236 ECITQG---------RVLERPRVCPKEVYDIMLGCWQREPQQRLNIKEIYKILHALGKA 285 (291)
T ss_pred HHHhCC---------CCCCCCccCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHhh
Confidence 111111 11122234466899999999999999999999999999998654
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-36 Score=304.19 Aligned_cols=243 Identities=25% Similarity=0.393 Sum_probs=192.3
Q ss_pred HhcCccccceeccCce--------------EEEEEeecChhhHHHHHHHHHHHhhcCCCCccceecccccCccceEEEee
Q 044312 287 ATDNFDLNRILGQGGQ--------------AVKKSKVIDESKVEEFINEVVILSQINHRNVVKLLGCCLETEVPLLVYEF 352 (608)
Q Consensus 287 ~t~~f~~~~~lG~G~~--------------avk~~~~~~~~~~~~~~~Ei~il~~l~H~niv~l~~~~~~~~~~~lV~E~ 352 (608)
..++|++.+.||+|++ |+|..+.. ....++|.+|+.++++++|+||+++++++...+..++||||
T Consensus 4 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~v~iK~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 82 (261)
T cd05068 4 DRTSIQLLRKLGAGQFGEVWEGLWNNTTPVAVKTLKPG-TMDPKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIYIVTEL 82 (261)
T ss_pred chhheeeEEEecccCCccEEEEEecCCeEEEEEeeCCC-cccHHHHHHHHHHHHHCCCCCccceeEEEecCCCeeeeeec
Confidence 3456888889998874 55554432 23457799999999999999999999999999999999999
Q ss_pred cCCCccchhccccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEEcCCCcEEEeeccCccccccCCc
Q 044312 353 IPNGTLFQYIHDQNEDFPITWEIRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQT 432 (608)
Q Consensus 353 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGls~~~~~~~~ 432 (608)
+++++|.+++.... ...+++..+..++.|++.||.|||+.+ ++||||||+|||+++++.+||+|||+++.......
T Consensus 83 ~~~~~L~~~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~ 158 (261)
T cd05068 83 MKYGSLLEYLQGGA-GRALKLPQLIDMAAQVASGMAYLEAQN---YIHRDLAARNVLVGENNICKVADFGLARVIKEDIY 158 (261)
T ss_pred ccCCcHHHHHhccC-CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCCcceEEEcCCCCEEECCcceEEEccCCcc
Confidence 99999999997644 225899999999999999999999998 99999999999999999999999999987653222
Q ss_pred ceeeeeeccCCCCChhhhccCCCCCccchHhHHHHHHHHHh-CCCCCCccchhhcccHHHHHHHHhhhhhhHHHhhhhhh
Q 044312 433 HMTTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLTELLT-GEKPIRFTILEEDKSLAAYFLCAMKEERLFEILDARVM 511 (608)
Q Consensus 433 ~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~ellt-g~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~ 511 (608)
........+..|+|||++....++.++||||||++++||++ |+.||....... +...+.....
T Consensus 159 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~----------------~~~~~~~~~~ 222 (261)
T cd05068 159 EAREGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTNAE----------------VLQQVDQGYR 222 (261)
T ss_pred cccCCCcCceeccCccccccCCCCchhhHHHHHHHHHHHHhcCCCCCCCCCHHH----------------HHHHHHcCCC
Confidence 21222223457999999999999999999999999999999 999986322110 1111111111
Q ss_pred ccCChhHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhh
Q 044312 512 KQGGKDEIITVAKLAKRCLNLNGKKRPTMREVASELAGI 550 (608)
Q Consensus 512 ~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~evl~~L~~i 550 (608)
...+...+..+.+++.+||+.+|++||++.++.+.|+.+
T Consensus 223 ~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~l~~~l~~~ 261 (261)
T cd05068 223 MPCPPGCPKELYDIMLDCWKEDPDDRPTFETLQWKLEDF 261 (261)
T ss_pred CCCCCcCCHHHHHHHHHHhhcCcccCCCHHHHHHHHhcC
Confidence 122334567899999999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-36 Score=287.75 Aligned_cols=249 Identities=26% Similarity=0.404 Sum_probs=201.2
Q ss_pred hcCccccceeccCce---------------EEEEEeecChhhHHHHHHHHHHHhhcCCCCccceecccccCc-----cce
Q 044312 288 TDNFDLNRILGQGGQ---------------AVKKSKVIDESKVEEFINEVVILSQINHRNVVKLLGCCLETE-----VPL 347 (608)
Q Consensus 288 t~~f~~~~~lG~G~~---------------avk~~~~~~~~~~~~~~~Ei~il~~l~H~niv~l~~~~~~~~-----~~~ 347 (608)
.++|++.+.||+||| |+|++......+.+..++|++..++++||||++++++...+. ..|
T Consensus 20 ~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~~~~~y 99 (302)
T KOG2345|consen 20 NKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHSQEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKDGKHEAY 99 (302)
T ss_pred CceEEEeeeecCCCceeeeeecccCcccchhhheeeccchHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhccCceeEE
Confidence 467999999999995 778888777788899999999999999999999999986544 489
Q ss_pred EEEeecCCCccchhccccCC-CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEEcCCCcEEEeeccCccc
Q 044312 348 LVYEFIPNGTLFQYIHDQNE-DFPITWEIRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRS 426 (608)
Q Consensus 348 lV~E~~~~gsL~~~l~~~~~-~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGls~~ 426 (608)
|+++|...|+|.+.+..... +..+++.+++.|+.+|.+||++||+..+ |++||||||.|||+.+.+.+++.|||.+..
T Consensus 100 ll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~~~-~yAH~DiKP~NILls~~~~~vl~D~GS~~~ 178 (302)
T KOG2345|consen 100 LLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEKEP-PYAHRDIKPANILLSDSGLPVLMDLGSATQ 178 (302)
T ss_pred EEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhccCC-cccccCCCcceeEecCCCceEEEeccCccc
Confidence 99999999999999986432 2359999999999999999999999874 699999999999999999999999999876
Q ss_pred cccCCcce--------eeeeeccCCCCChhhhc---cCCCCCccchHhHHHHHHHHHhCCCCCCccchhhcccHHHHHHH
Q 044312 427 MAVDQTHM--------TTQVHGTFGYLDPEYFR---SSQFTDKSDVYSFGVVLTELLTGEKPIRFTILEEDKSLAAYFLC 495 (608)
Q Consensus 427 ~~~~~~~~--------~~~~~gt~~y~aPE~~~---~~~~t~ksDV~S~Gvvl~elltg~~p~~~~~~~~~~~l~~~~~~ 495 (608)
....-... -.....|..|.|||.+. +...++++|||||||+||+|+.|..||+.... ...++
T Consensus 179 a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~~-~GgSl------ 251 (302)
T KOG2345|consen 179 APIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERIYQ-QGGSL------ 251 (302)
T ss_pred cceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHHhh-cCCeE------
Confidence 54321111 12234688999999985 44678999999999999999999999973222 11111
Q ss_pred HhhhhhhHHHhhhhhhccCChhHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhh
Q 044312 496 AMKEERLFEILDARVMKQGGKDEIITVAKLAKRCLNLNGKKRPTMREVASELAGI 550 (608)
Q Consensus 496 ~~~~~~~~~~~d~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~evl~~L~~i 550 (608)
...+..+++..+.....++.+.+|+++||+.||.+||+..|++..+..+
T Consensus 252 ------aLAv~n~q~s~P~~~~yse~l~~lik~mlqvdP~qRP~i~~ll~~~d~L 300 (302)
T KOG2345|consen 252 ------ALAVQNAQISIPNSSRYSEALHQLIKSMLQVDPNQRPTIPELLSKLDDL 300 (302)
T ss_pred ------EEeeeccccccCCCCCccHHHHHHHHHHhcCCcccCCCHHHHHHHHHhh
Confidence 1222333333334445788999999999999999999999999988765
|
|
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-37 Score=308.62 Aligned_cols=225 Identities=38% Similarity=0.601 Sum_probs=174.0
Q ss_pred EEEEEeec-ChhhHHHHHHHHHHHhhcCCCCccceecccccCccceEEEeecCCCccchhccccCCCCCCCHHHHHHHHH
Q 044312 303 AVKKSKVI-DESKVEEFINEVVILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEIRLRIAI 381 (608)
Q Consensus 303 avk~~~~~-~~~~~~~~~~Ei~il~~l~H~niv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~ 381 (608)
+||..+.. .....+.|.+|++++++++||||++++|++...+..++||||+++|+|.++|..... ..+++..+++|+.
T Consensus 32 ~vk~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~lv~e~~~~g~L~~~L~~~~~-~~~~~~~~~~i~~ 110 (259)
T PF07714_consen 32 AVKILKPSSSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLFLVMEYCPGGSLDDYLKSKNK-EPLSEQQRLSIAI 110 (259)
T ss_dssp EEEEESTTSSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEEEEEE--TTEBHHHHHHHTCT-TTSBHHHHHHHHH
T ss_pred EEEEeccccccccceeeeeccccccccccccccccccccccccccccccccccccccccccccccc-ccccccccccccc
Confidence 56666442 334578999999999999999999999999988889999999999999999988622 2589999999999
Q ss_pred HHHHHHHHHhhcCCCCeeccCCCCCcEEEcCCCcEEEeeccCccccccCCc-ceeeeeeccCCCCChhhhccCCCCCccc
Q 044312 382 EVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQT-HMTTQVHGTFGYLDPEYFRSSQFTDKSD 460 (608)
Q Consensus 382 ~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGls~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~t~ksD 460 (608)
|||+||+|||+.+ ++|++|+++|||+++++.+||+|||+++....... ...........|+|||.+....++.++|
T Consensus 111 ~i~~~l~~Lh~~~---iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~ksD 187 (259)
T PF07714_consen 111 QIAEALSYLHSNN---IIHGNLSPSNILLDSNGQVKLSDFGLSRPISEKSKYKNDSSQQLPLRYLAPEVLKDGEYTKKSD 187 (259)
T ss_dssp HHHHHHHHHHHTT---EEEST-SGGGEEEETTTEEEEESTTTGEETTTSSSEEESTTSESGGGGS-HHHHHHSEESHHHH
T ss_pred ccccccccccccc---cccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc
Confidence 9999999999998 99999999999999999999999999987632221 2223345678899999999999999999
Q ss_pred hHhHHHHHHHHHh-CCCCCCccchhhcccHHHHHHHHhhhhhhHHHhhhhhhccCChhHHHHHHHHHHHHhccCCCCCCC
Q 044312 461 VYSFGVVLTELLT-GEKPIRFTILEEDKSLAAYFLCAMKEERLFEILDARVMKQGGKDEIITVAKLAKRCLNLNGKKRPT 539 (608)
Q Consensus 461 V~S~Gvvl~ellt-g~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPs 539 (608)
|||||+++|||++ |+.||...... .+.+.+........+...+..+.+++.+||+.+|++||+
T Consensus 188 VysfG~~l~ei~~~~~~p~~~~~~~----------------~~~~~~~~~~~~~~~~~~~~~~~~li~~C~~~~p~~RPs 251 (259)
T PF07714_consen 188 VYSFGMLLYEILTLGKFPFSDYDNE----------------EIIEKLKQGQRLPIPDNCPKDIYSLIQQCWSHDPEKRPS 251 (259)
T ss_dssp HHHHHHHHHHHHTTSSGTTTTSCHH----------------HHHHHHHTTEETTSBTTSBHHHHHHHHHHT-SSGGGS--
T ss_pred ccccccccccccccccccccccccc----------------cccccccccccceeccchhHHHHHHHHHHcCCChhhCcC
Confidence 9999999999999 67887532111 111111111222233455678999999999999999999
Q ss_pred HHHHHHHH
Q 044312 540 MREVASEL 547 (608)
Q Consensus 540 ~~evl~~L 547 (608)
+.++++.|
T Consensus 252 ~~~i~~~L 259 (259)
T PF07714_consen 252 FQEILQEL 259 (259)
T ss_dssp HHHHHHHH
T ss_pred HHHHHhcC
Confidence 99999876
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-36 Score=303.29 Aligned_cols=241 Identities=24% Similarity=0.438 Sum_probs=192.0
Q ss_pred cCccccceeccCce------------------EEEEEee-cChhhHHHHHHHHHHHhhcCCCCccceecccccCccceEE
Q 044312 289 DNFDLNRILGQGGQ------------------AVKKSKV-IDESKVEEFINEVVILSQINHRNVVKLLGCCLETEVPLLV 349 (608)
Q Consensus 289 ~~f~~~~~lG~G~~------------------avk~~~~-~~~~~~~~~~~Ei~il~~l~H~niv~l~~~~~~~~~~~lV 349 (608)
++|++.+.||+|+| |||..+. .......+|.+|+.++++++||||+++++.+.+.+..++|
T Consensus 4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv 83 (266)
T cd05033 4 SYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSRPVMII 83 (266)
T ss_pred HHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCcceEeEEEecCCceEEE
Confidence 46788889999875 3444332 2233456799999999999999999999999999999999
Q ss_pred EeecCCCccchhccccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEEcCCCcEEEeeccCcccccc
Q 044312 350 YEFIPNGTLFQYIHDQNEDFPITWEIRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAV 429 (608)
Q Consensus 350 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGls~~~~~ 429 (608)
|||+++++|.+++..... .+++..++.++.|++.||+|||+.+ |+|+||||+|||+++++.+||+|||+++....
T Consensus 84 ~e~~~~~~L~~~~~~~~~--~~~~~~~~~~~~~l~~~l~~Lh~~~---i~H~di~p~nili~~~~~~~l~dfg~~~~~~~ 158 (266)
T cd05033 84 TEYMENGSLDKFLRENDG--KFTVGQLVGMLRGIASGMKYLSEMN---YVHRDLAARNILVNSNLVCKVSDFGLSRRLED 158 (266)
T ss_pred EEcCCCCCHHHHHHhccC--CCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCcceEEEcCCCCEEECccchhhcccc
Confidence 999999999999976543 5899999999999999999999998 99999999999999999999999999987752
Q ss_pred CCcc-eeeeeeccCCCCChhhhccCCCCCccchHhHHHHHHHHHh-CCCCCCccchhhcccHHHHHHHHhhhhhhHHHhh
Q 044312 430 DQTH-MTTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLTELLT-GEKPIRFTILEEDKSLAAYFLCAMKEERLFEILD 507 (608)
Q Consensus 430 ~~~~-~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~ellt-g~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 507 (608)
.... ......++..|+|||.+.+..++.++||||||++++||++ |..||....... +.+.+.
T Consensus 159 ~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~~~~----------------~~~~~~ 222 (266)
T cd05033 159 SEATYTTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMSNQD----------------VIKAVE 222 (266)
T ss_pred cccceeccCCCCCccccChhhhccCCCccccchHHHHHHHHHHHccCCCCCCCCCHHH----------------HHHHHH
Confidence 2221 2222334678999999999999999999999999999998 999985322110 111111
Q ss_pred hhhhccCChhHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhh
Q 044312 508 ARVMKQGGKDEIITVAKLAKRCLNLNGKKRPTMREVASELAGI 550 (608)
Q Consensus 508 ~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~evl~~L~~i 550 (608)
.....+.+...+..+.+|+.+||+.+|++||++.||+++|+.+
T Consensus 223 ~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rp~~~ei~~~l~~~ 265 (266)
T cd05033 223 DGYRLPPPMDCPSALYQLMLDCWQKDRNERPTFSQIVSTLDKM 265 (266)
T ss_pred cCCCCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 1111122334567899999999999999999999999999765
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-36 Score=316.44 Aligned_cols=242 Identities=26% Similarity=0.379 Sum_probs=193.8
Q ss_pred HHhcCccccceeccCce---------------EEEEEeec----Ch-hhHHHHHHHHHHHhhcC-CCCccceecccccCc
Q 044312 286 KATDNFDLNRILGQGGQ---------------AVKKSKVI----DE-SKVEEFINEVVILSQIN-HRNVVKLLGCCLETE 344 (608)
Q Consensus 286 ~~t~~f~~~~~lG~G~~---------------avk~~~~~----~~-~~~~~~~~Ei~il~~l~-H~niv~l~~~~~~~~ 344 (608)
...++|.+.+.||+|.| |+|..... .. ...+.+.+|+.++++++ ||||++++.++....
T Consensus 14 ~~~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~ 93 (370)
T KOG0583|consen 14 LSIGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATPT 93 (370)
T ss_pred cccCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecCC
Confidence 34568999999999975 55533221 11 23456668999999998 999999999999999
Q ss_pred cceEEEeecCCCccchhccccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEEcCC-CcEEEeeccC
Q 044312 345 VPLLVYEFIPNGTLFQYIHDQNEDFPITWEIRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDK-YRAKVSDFGA 423 (608)
Q Consensus 345 ~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~-~~~kl~DFGl 423 (608)
..++||||+.+|+|.+++.+.+ ++.+.....++.|++.|++|+|+++ |+||||||+|||++.+ +++||+|||+
T Consensus 94 ~~~ivmEy~~gGdL~~~i~~~g---~l~E~~ar~~F~Qlisav~y~H~~g---i~HRDLK~ENilld~~~~~~Kl~DFG~ 167 (370)
T KOG0583|consen 94 KIYIVMEYCSGGDLFDYIVNKG---RLKEDEARKYFRQLISAVAYCHSRG---IVHRDLKPENILLDGNEGNLKLSDFGL 167 (370)
T ss_pred eEEEEEEecCCccHHHHHHHcC---CCChHHHHHHHHHHHHHHHHHHhCC---EeeCCCCHHHEEecCCCCCEEEecccc
Confidence 9999999999999999998833 5889999999999999999999999 9999999999999999 9999999999
Q ss_pred ccccccCCcceeeeeeccCCCCChhhhccCC-CC-CccchHhHHHHHHHHHhCCCCCCccchhhcccHHHHHHHHhhhhh
Q 044312 424 SRSMAVDQTHMTTQVHGTFGYLDPEYFRSSQ-FT-DKSDVYSFGVVLTELLTGEKPIRFTILEEDKSLAAYFLCAMKEER 501 (608)
Q Consensus 424 s~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~t-~ksDV~S~Gvvl~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~ 501 (608)
+.... ..........||+.|+|||++.+.. |+ .++||||+||+||.|++|+.||.. ......+.. +..+
T Consensus 168 s~~~~-~~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d------~~~~~l~~k-i~~~- 238 (370)
T KOG0583|consen 168 SAISP-GEDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDD------SNVPNLYRK-IRKG- 238 (370)
T ss_pred ccccC-CCCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCC------ccHHHHHHH-HhcC-
Confidence 99874 2233455678999999999999987 86 789999999999999999999974 122221211 1111
Q ss_pred hHHHhhhhhhccCChhH-HHHHHHHHHHHhccCCCCCCCHHHHHHHHHhhHH
Q 044312 502 LFEILDARVMKQGGKDE-IITVAKLAKRCLNLNGKKRPTMREVASELAGIKA 552 (608)
Q Consensus 502 ~~~~~d~~~~~~~~~~~-~~~l~~Li~~cl~~dp~~RPs~~evl~~L~~i~~ 552 (608)
. ...+... +.++..|+.+||..||.+|+++.|++ .-.-++.
T Consensus 239 -------~--~~~p~~~~S~~~~~Li~~mL~~~P~~R~t~~~i~-~h~w~~~ 280 (370)
T KOG0583|consen 239 -------E--FKIPSYLLSPEARSLIEKMLVPDPSTRITLLEIL-EHPWFQK 280 (370)
T ss_pred -------C--ccCCCCcCCHHHHHHHHHHcCCCcccCCCHHHHh-hChhhcc
Confidence 1 1122233 67899999999999999999999999 4444443
|
|
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-36 Score=309.36 Aligned_cols=224 Identities=24% Similarity=0.423 Sum_probs=172.6
Q ss_pred hhHHHHHHHHHHHhhcCCCCccceecccccCccceEEEeecCCCccchhccccC----------------CCCCCCHHHH
Q 044312 313 SKVEEFINEVVILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGTLFQYIHDQN----------------EDFPITWEIR 376 (608)
Q Consensus 313 ~~~~~~~~Ei~il~~l~H~niv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~----------------~~~~l~~~~~ 376 (608)
....+|.+|+.+|++++||||+++++++.+.+..++||||+++|+|.+++.... ....+++..+
T Consensus 61 ~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 140 (304)
T cd05096 61 NARNDFLKEVKILSRLKDPNIIRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSL 140 (304)
T ss_pred HHHHHHHHHHHHHhhcCCCCeeEEEEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHH
Confidence 345689999999999999999999999999999999999999999999886421 1124788999
Q ss_pred HHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEEcCCCcEEEeeccCccccccCCcc-eeeeeeccCCCCChhhhccCCC
Q 044312 377 LRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTH-MTTQVHGTFGYLDPEYFRSSQF 455 (608)
Q Consensus 377 ~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGls~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~ 455 (608)
++++.||+.||.|||+.+ |+||||||+|||+++++.+||+|||+++........ ......++..|+|||++....+
T Consensus 141 ~~i~~~i~~al~~lH~~~---ivH~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~ 217 (304)
T cd05096 141 LHVALQIASGMKYLSSLN---FVHRDLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKF 217 (304)
T ss_pred HHHHHHHHHHHHHHHHCC---ccccCcchhheEEcCCccEEECCCccceecccCceeEecCcCCCCccccCHHHHhcCCC
Confidence 999999999999999999 999999999999999999999999999865433221 1222345788999999998999
Q ss_pred CCccchHhHHHHHHHHHh--CCCCCCccchhhcccHHHHHHHHhhhhhhHHHhhhhhhccCChhHHHHHHHHHHHHhccC
Q 044312 456 TDKSDVYSFGVVLTELLT--GEKPIRFTILEEDKSLAAYFLCAMKEERLFEILDARVMKQGGKDEIITVAKLAKRCLNLN 533 (608)
Q Consensus 456 t~ksDV~S~Gvvl~ellt--g~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~Li~~cl~~d 533 (608)
+.++||||||++++||++ +..||....... ............ ........+..++..+.+|+.+||+.|
T Consensus 218 ~~~~Dv~slG~~l~el~~~~~~~p~~~~~~~~---~~~~~~~~~~~~------~~~~~~~~~~~~~~~~~~li~~cl~~~ 288 (304)
T cd05096 218 TTASDVWAFGVTLWEILMLCKEQPYGELTDEQ---VIENAGEFFRDQ------GRQVYLFRPPPCPQGLYELMLQCWSRD 288 (304)
T ss_pred CchhhhHHHHHHHHHHHHccCCCCCCcCCHHH---HHHHHHHHhhhc------cccccccCCCCCCHHHHHHHHHHccCC
Confidence 999999999999999987 456665322111 111010000000 000111122345678999999999999
Q ss_pred CCCCCCHHHHHHHHH
Q 044312 534 GKKRPTMREVASELA 548 (608)
Q Consensus 534 p~~RPs~~evl~~L~ 548 (608)
|++|||+.||.+.|+
T Consensus 289 p~~RPs~~~i~~~l~ 303 (304)
T cd05096 289 CRERPSFSDIHAFLT 303 (304)
T ss_pred chhCcCHHHHHHHHh
Confidence 999999999998875
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-36 Score=307.41 Aligned_cols=243 Identities=27% Similarity=0.437 Sum_probs=188.6
Q ss_pred HhcCccccceeccCce--------------------EEEEEeec-ChhhHHHHHHHHHHHhhcCCCCccceecccccCcc
Q 044312 287 ATDNFDLNRILGQGGQ--------------------AVKKSKVI-DESKVEEFINEVVILSQINHRNVVKLLGCCLETEV 345 (608)
Q Consensus 287 ~t~~f~~~~~lG~G~~--------------------avk~~~~~-~~~~~~~~~~Ei~il~~l~H~niv~l~~~~~~~~~ 345 (608)
++++|++.+.||+|++ |+|+.... ......+|.+|+.+++.++||||+++++++.+...
T Consensus 4 ~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~ 83 (277)
T cd05062 4 AREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQP 83 (277)
T ss_pred cHHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCC
Confidence 5667888889999874 33433221 12345678999999999999999999999999999
Q ss_pred ceEEEeecCCCccchhccccCC-------CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEEcCCCcEEE
Q 044312 346 PLLVYEFIPNGTLFQYIHDQNE-------DFPITWEIRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKV 418 (608)
Q Consensus 346 ~~lV~E~~~~gsL~~~l~~~~~-------~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl 418 (608)
.++||||+++++|.+++..... ...+++..++.++.|++.||+|||+.+ ++|+||||+|||+++++.+||
T Consensus 84 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---~vH~dlkp~Nil~~~~~~~~l 160 (277)
T cd05062 84 TLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNANK---FVHRDLAARNCMVAEDFTVKI 160 (277)
T ss_pred eEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCcchheEEEcCCCCEEE
Confidence 9999999999999999875321 124688999999999999999999998 999999999999999999999
Q ss_pred eeccCccccccCCcce-eeeeeccCCCCChhhhccCCCCCccchHhHHHHHHHHHh-CCCCCCccchhhcccHHHHHHHH
Q 044312 419 SDFGASRSMAVDQTHM-TTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLTELLT-GEKPIRFTILEEDKSLAAYFLCA 496 (608)
Q Consensus 419 ~DFGls~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~ellt-g~~p~~~~~~~~~~~l~~~~~~~ 496 (608)
+|||+++......... .....+++.|+|||++....++.++||||||++++||++ |..||....... ....
T Consensus 161 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~p~~~~~~~~-------~~~~ 233 (277)
T cd05062 161 GDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSNEQ-------VLRF 233 (277)
T ss_pred CCCCCccccCCcceeecCCCCccCHhhcChhHhhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHH-------HHHH
Confidence 9999987654322211 112245678999999999999999999999999999999 688876322111 0001
Q ss_pred hhhhhhHHHhhhhhhccCChhHHHHHHHHHHHHhccCCCCCCCHHHHHHHHH
Q 044312 497 MKEERLFEILDARVMKQGGKDEIITVAKLAKRCLNLNGKKRPTMREVASELA 548 (608)
Q Consensus 497 ~~~~~~~~~~d~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~evl~~L~ 548 (608)
.... .....+...+..+.+++.+||+.+|++|||+.|+++.|+
T Consensus 234 ~~~~---------~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~ 276 (277)
T cd05062 234 VMEG---------GLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIK 276 (277)
T ss_pred HHcC---------CcCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHhh
Confidence 0111 111223345568999999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-36 Score=302.35 Aligned_cols=237 Identities=27% Similarity=0.428 Sum_probs=186.3
Q ss_pred CccccceeccCce--------------EEEEEeecChhhHHHHHHHHHHHhhcCCCCccceecccccCccceEEEeecCC
Q 044312 290 NFDLNRILGQGGQ--------------AVKKSKVIDESKVEEFINEVVILSQINHRNVVKLLGCCLETEVPLLVYEFIPN 355 (608)
Q Consensus 290 ~f~~~~~lG~G~~--------------avk~~~~~~~~~~~~~~~Ei~il~~l~H~niv~l~~~~~~~~~~~lV~E~~~~ 355 (608)
+|++.+.||+|++ |+|..+. .....++|.+|+.++++++||||+++++++.+....++||||+++
T Consensus 5 ~~~~~~~lg~G~~~~vy~~~~~~~~~~aik~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~ 83 (256)
T cd05113 5 DLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKE-GSMSEDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIVTEYMSN 83 (256)
T ss_pred HeEEeeEecCcccceEEEEEecCCCcEEEEEcCC-CcccHHHHHHHHHHHhcCCCCCeeeEEEEEccCCCcEEEEEcCCC
Confidence 3566677777753 5665543 223457799999999999999999999999998899999999999
Q ss_pred CccchhccccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEEcCCCcEEEeeccCccccccCCccee
Q 044312 356 GTLFQYIHDQNEDFPITWEIRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMT 435 (608)
Q Consensus 356 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGls~~~~~~~~~~~ 435 (608)
++|.+++..... .+++..++.++.||+.||+|||+.+ ++|+||||+|||+++++.+||+|||+++..........
T Consensus 84 ~~l~~~i~~~~~--~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~~~~~~~ 158 (256)
T cd05113 84 GCLLNYLREHGK--RFQPSQLLEMCKDVCEGMAYLESKQ---FIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEYTSS 158 (256)
T ss_pred CcHHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHhCC---eeccccCcceEEEcCCCCEEECCCccceecCCCceeec
Confidence 999999876433 5899999999999999999999999 99999999999999999999999999886643322222
Q ss_pred eeeeccCCCCChhhhccCCCCCccchHhHHHHHHHHHh-CCCCCCccchhhcccHHHHHHHHhhhhhhHHHhhhhhhccC
Q 044312 436 TQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLTELLT-GEKPIRFTILEEDKSLAAYFLCAMKEERLFEILDARVMKQG 514 (608)
Q Consensus 436 ~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~ellt-g~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~ 514 (608)
....++..|+|||++....++.++||||||++++||++ |+.||....... ... .... ......
T Consensus 159 ~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~------~~~-~~~~---------~~~~~~ 222 (256)
T cd05113 159 VGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNNSE------TVE-KVSQ---------GLRLYR 222 (256)
T ss_pred CCCccChhhCCHHHHhcCcccchhHHHHHHHHHHHHhcCCCCCcCcCCHHH------HHH-HHhc---------CCCCCC
Confidence 22345678999999998899999999999999999999 999986322211 000 0100 011112
Q ss_pred ChhHHHHHHHHHHHHhccCCCCCCCHHHHHHHHH
Q 044312 515 GKDEIITVAKLAKRCLNLNGKKRPTMREVASELA 548 (608)
Q Consensus 515 ~~~~~~~l~~Li~~cl~~dp~~RPs~~evl~~L~ 548 (608)
+...+..+.+++.+||+.+|++||++.+|++.|+
T Consensus 223 ~~~~~~~~~~li~~cl~~~p~~Rp~~~~ll~~~~ 256 (256)
T cd05113 223 PHLASEKVYAIMYSCWHEKAEERPTFQQLLSSIE 256 (256)
T ss_pred CCCCCHHHHHHHHHHcCCCcccCCCHHHHHHhhC
Confidence 2234568999999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-36 Score=307.43 Aligned_cols=237 Identities=24% Similarity=0.296 Sum_probs=186.0
Q ss_pred ccccceeccCce---------------EEEEEeec---ChhhHHHHHHHHHHHhhcCCCCccceecccccCccceEEEee
Q 044312 291 FDLNRILGQGGQ---------------AVKKSKVI---DESKVEEFINEVVILSQINHRNVVKLLGCCLETEVPLLVYEF 352 (608)
Q Consensus 291 f~~~~~lG~G~~---------------avk~~~~~---~~~~~~~~~~Ei~il~~l~H~niv~l~~~~~~~~~~~lV~E~ 352 (608)
|+..+.||+|+| |+|..... .......+.+|+.++++++|+||+++++++.+.+..++||||
T Consensus 2 f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~~lv~e~ 81 (285)
T cd05631 2 FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDALCLVLTI 81 (285)
T ss_pred ceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCCeEEEEEEe
Confidence 667788998874 55554421 122334688999999999999999999999999999999999
Q ss_pred cCCCccchhccccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEEcCCCcEEEeeccCccccccCCc
Q 044312 353 IPNGTLFQYIHDQNEDFPITWEIRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQT 432 (608)
Q Consensus 353 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGls~~~~~~~~ 432 (608)
+++|+|.+++..... ..+++..+..++.|++.||+|||+.+ |+||||||+|||+++++.+||+|||+++......
T Consensus 82 ~~~g~L~~~~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~---iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~- 156 (285)
T cd05631 82 MNGGDLKFHIYNMGN-PGFDEQRAIFYAAELCCGLEDLQRER---IVYRDLKPENILLDDRGHIRISDLGLAVQIPEGE- 156 (285)
T ss_pred cCCCcHHHHHHhhCC-CCCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCCCHHHEEECCCCCEEEeeCCCcEEcCCCC-
Confidence 999999988865332 25899999999999999999999999 9999999999999999999999999998754322
Q ss_pred ceeeeeeccCCCCChhhhccCCCCCccchHhHHHHHHHHHhCCCCCCccchhhcccHHHHHHHHhhhhhhHHHhhhhhhc
Q 044312 433 HMTTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLTELLTGEKPIRFTILEEDKSLAAYFLCAMKEERLFEILDARVMK 512 (608)
Q Consensus 433 ~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~ 512 (608)
......||..|+|||++.+..++.++|||||||+++||++|+.||........ ........ .....
T Consensus 157 -~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~---~~~~~~~~----------~~~~~ 222 (285)
T cd05631 157 -TVRGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVK---REEVDRRV----------KEDQE 222 (285)
T ss_pred -eecCCCCCCCccCHhhhcCCCCCcccCchhHHHHHHHHHhCCCCCCCCCcchh---HHHHHHHh----------hcccc
Confidence 22345689999999999999999999999999999999999999974322110 00000000 00111
Q ss_pred cCChhHHHHHHHHHHHHhccCCCCCCC-----HHHHHHH
Q 044312 513 QGGKDEIITVAKLAKRCLNLNGKKRPT-----MREVASE 546 (608)
Q Consensus 513 ~~~~~~~~~l~~Li~~cl~~dp~~RPs-----~~evl~~ 546 (608)
..+...+..+.+|+.+||+.||++||+ ++|++++
T Consensus 223 ~~~~~~s~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~h 261 (285)
T cd05631 223 EYSEKFSEDAKSICRMLLTKNPKERLGCRGNGAAGVKQH 261 (285)
T ss_pred cCCccCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHhcC
Confidence 233345678999999999999999997 7777754
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-36 Score=290.68 Aligned_cols=221 Identities=30% Similarity=0.428 Sum_probs=188.6
Q ss_pred CccccceeccCce---------------EEEEEe---ecChhhHHHHHHHHHHHhhcCCCCccceecccccCccceEEEe
Q 044312 290 NFDLNRILGQGGQ---------------AVKKSK---VIDESKVEEFINEVVILSQINHRNVVKLLGCCLETEVPLLVYE 351 (608)
Q Consensus 290 ~f~~~~~lG~G~~---------------avk~~~---~~~~~~~~~~~~Ei~il~~l~H~niv~l~~~~~~~~~~~lV~E 351 (608)
+|+..+.||.|.| |+|.+. +..-.++++..+|..+|+.+.||.+++|.+.+.+...++||||
T Consensus 45 dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~~~lymvme 124 (355)
T KOG0616|consen 45 DFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDNSNLYMVME 124 (355)
T ss_pred hhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeeccCCeEEEEEe
Confidence 5677889999975 666554 3445677889999999999999999999999999999999999
Q ss_pred ecCCCccchhccccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEEcCCCcEEEeeccCccccccCC
Q 044312 352 FIPNGTLFQYIHDQNEDFPITWEIRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQ 431 (608)
Q Consensus 352 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGls~~~~~~~ 431 (608)
|++||.|..++++.+ +++++...-+|.||+.||+|||+.. |++|||||+|||||.+|.+||+|||.|+.+..
T Consensus 125 yv~GGElFS~Lrk~~---rF~e~~arFYAAeivlAleylH~~~---iiYRDLKPENiLlD~~G~iKitDFGFAK~v~~-- 196 (355)
T KOG0616|consen 125 YVPGGELFSYLRKSG---RFSEPHARFYAAEIVLALEYLHSLD---IIYRDLKPENLLLDQNGHIKITDFGFAKRVSG-- 196 (355)
T ss_pred ccCCccHHHHHHhcC---CCCchhHHHHHHHHHHHHHHHHhcC---eeeccCChHHeeeccCCcEEEEeccceEEecC--
Confidence 999999999998765 4999999999999999999999999 99999999999999999999999999998753
Q ss_pred cceeeeeeccCCCCChhhhccCCCCCccchHhHHHHHHHHHhCCCCCCccchhhcccHHHHHHHHhhhhhhHHHhhhhhh
Q 044312 432 THMTTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLTELLTGEKPIRFTILEEDKSLAAYFLCAMKEERLFEILDARVM 511 (608)
Q Consensus 432 ~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~ 511 (608)
.+....|||.|+|||.+....+..++|.|||||++|||+.|.+||..... ... ...|+..++
T Consensus 197 --rT~TlCGTPeYLAPEii~sk~ynkavDWWalGVLIYEMlaG~pPF~~~~~------~~i---------Y~KI~~~~v- 258 (355)
T KOG0616|consen 197 --RTWTLCGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLAGYPPFYDDNP------IQI---------YEKILEGKV- 258 (355)
T ss_pred --cEEEecCCccccChHHhhcCCCCcchhHHHHHHHHHHHHcCCCCCcCCCh------HHH---------HHHHHhCcc-
Confidence 25678899999999999999999999999999999999999999974332 111 122333222
Q ss_pred ccCChhHHHHHHHHHHHHhccCCCCC
Q 044312 512 KQGGKDEIITVAKLAKRCLNLNGKKR 537 (608)
Q Consensus 512 ~~~~~~~~~~l~~Li~~cl~~dp~~R 537 (608)
.+|.-...++.+|+...|+.|-.+|
T Consensus 259 -~fP~~fs~~~kdLl~~LL~vD~t~R 283 (355)
T KOG0616|consen 259 -KFPSYFSSDAKDLLKKLLQVDLTKR 283 (355)
T ss_pred -cCCcccCHHHHHHHHHHHhhhhHhh
Confidence 2445566789999999999999988
|
|
| >KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-36 Score=288.11 Aligned_cols=240 Identities=29% Similarity=0.444 Sum_probs=192.2
Q ss_pred cCccccceeccCc---------------eEEEEEeecCh--------hhHHHHHHHHHHHhhc-CCCCccceecccccCc
Q 044312 289 DNFDLNRILGQGG---------------QAVKKSKVIDE--------SKVEEFINEVVILSQI-NHRNVVKLLGCCLETE 344 (608)
Q Consensus 289 ~~f~~~~~lG~G~---------------~avk~~~~~~~--------~~~~~~~~Ei~il~~l-~H~niv~l~~~~~~~~ 344 (608)
.+|...++||.|+ ||+|++..... .-.+.-++|+.||+++ -||||++|.+++....
T Consensus 17 ~~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~yes~s 96 (411)
T KOG0599|consen 17 AKYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVYESDA 96 (411)
T ss_pred hhcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeeccCcc
Confidence 3455556666664 68888765321 2235567899999999 6999999999999999
Q ss_pred cceEEEeecCCCccchhccccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEEcCCCcEEEeeccCc
Q 044312 345 VPLLVYEFIPNGTLFQYIHDQNEDFPITWEIRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGAS 424 (608)
Q Consensus 345 ~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGls 424 (608)
..++|+|.|+.|.|.|+|.... .++++...+|+.|+.+|++|||..+ |+||||||+|||+|++.++||+|||.+
T Consensus 97 F~FlVFdl~prGELFDyLts~V---tlSEK~tR~iMrqlfegVeylHa~~---IVHRDLKpENILlddn~~i~isDFGFa 170 (411)
T KOG0599|consen 97 FVFLVFDLMPRGELFDYLTSKV---TLSEKETRRIMRQLFEGVEYLHARN---IVHRDLKPENILLDDNMNIKISDFGFA 170 (411)
T ss_pred hhhhhhhhcccchHHHHhhhhe---eecHHHHHHHHHHHHHHHHHHHHhh---hhhcccChhheeeccccceEEecccee
Confidence 9999999999999999998754 5999999999999999999999999 999999999999999999999999999
Q ss_pred cccccCCcceeeeeeccCCCCChhhhcc------CCCCCccchHhHHHHHHHHHhCCCCCCccchhhcccHHHHHHHHhh
Q 044312 425 RSMAVDQTHMTTQVHGTFGYLDPEYFRS------SQFTDKSDVYSFGVVLTELLTGEKPIRFTILEEDKSLAAYFLCAMK 498 (608)
Q Consensus 425 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~t~ksDV~S~Gvvl~elltg~~p~~~~~~~~~~~l~~~~~~~~~ 498 (608)
..+.... ......|||+|+|||.+.- ..|+...|+|+.|||||.|+.|.+||.... ...++..+.
T Consensus 171 ~~l~~Ge--kLrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHRk-------QmlMLR~Im 241 (411)
T KOG0599|consen 171 CQLEPGE--KLRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHRK-------QMLMLRMIM 241 (411)
T ss_pred eccCCch--hHHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHHH-------HHHHHHHHH
Confidence 8876543 4567789999999999853 367889999999999999999999986321 111222222
Q ss_pred hhhhHHHhhhhhhccCChhHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHh
Q 044312 499 EERLFEILDARVMKQGGKDEIITVAKLAKRCLNLNGKKRPTMREVASELAG 549 (608)
Q Consensus 499 ~~~~~~~~d~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~evl~~L~~ 549 (608)
++.. ....+...+.+..+.+|+.+||+.||.+|.|++|++.+-.-
T Consensus 242 eGky------qF~speWadis~~~KdLIsrlLqVdp~~Ritake~LaHpff 286 (411)
T KOG0599|consen 242 EGKY------QFRSPEWADISATVKDLISRLLQVDPTKRITAKEALAHPFF 286 (411)
T ss_pred hccc------ccCCcchhhccccHHHHHHHHHeeCchhcccHHHHhcChHH
Confidence 2211 11223334667789999999999999999999999986543
|
|
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-36 Score=312.05 Aligned_cols=249 Identities=27% Similarity=0.403 Sum_probs=191.2
Q ss_pred hcCccccceeccCce---------------EEEEEeec-ChhhHHHHHHHHHHHhhcCCCCccceecccccCccceEEEe
Q 044312 288 TDNFDLNRILGQGGQ---------------AVKKSKVI-DESKVEEFINEVVILSQINHRNVVKLLGCCLETEVPLLVYE 351 (608)
Q Consensus 288 t~~f~~~~~lG~G~~---------------avk~~~~~-~~~~~~~~~~Ei~il~~l~H~niv~l~~~~~~~~~~~lV~E 351 (608)
.++|++.+.||+|++ |+|..... .....+.+.+|+++|++++||||+++++++...+..++|||
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 83 (331)
T cd06649 4 DDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME 83 (331)
T ss_pred cccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEee
Confidence 357888999999975 45554432 23445679999999999999999999999999999999999
Q ss_pred ecCCCccchhccccCCCCCCCHHHHHHHHHHHHHHHHHHhhc-CCCCeeccCCCCCcEEEcCCCcEEEeeccCccccccC
Q 044312 352 FIPNGTLFQYIHDQNEDFPITWEIRLRIAIEVSGALSYLHSA-ASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVD 430 (608)
Q Consensus 352 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~-~~~~iiHrDlk~~NILl~~~~~~kl~DFGls~~~~~~ 430 (608)
|+++++|.+++.... .+++..+..++.|++.||.|||+. + |+||||||+|||++.++.+||+|||+++.....
T Consensus 84 ~~~~~~L~~~l~~~~---~~~~~~~~~~~~~i~~~l~~lH~~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 157 (331)
T cd06649 84 HMDGGSLDQVLKEAK---RIPEEILGKVSIAVLRGLAYLREKHQ---IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS 157 (331)
T ss_pred cCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHhhcCC---EEcCCCChhhEEEcCCCcEEEccCccccccccc
Confidence 999999999997643 489999999999999999999985 5 999999999999999999999999998765432
Q ss_pred CcceeeeeeccCCCCChhhhccCCCCCccchHhHHHHHHHHHhCCCCCCccchhhcccHHHHHHHHh-------------
Q 044312 431 QTHMTTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLTELLTGEKPIRFTILEEDKSLAAYFLCAM------------- 497 (608)
Q Consensus 431 ~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~elltg~~p~~~~~~~~~~~l~~~~~~~~------------- 497 (608)
......|++.|+|||++.+..++.++||||||++++||++|+.||......+ +...+....
T Consensus 158 ---~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~ 231 (331)
T cd06649 158 ---MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPPPDAKE---LEAIFGRPVVDGEEGEPHSISP 231 (331)
T ss_pred ---ccccCCCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHH---HHHHhcccccccccCCccccCc
Confidence 1234468999999999999999999999999999999999999996432211 111000000
Q ss_pred -----------------hhhhhHHHhhhhh----hccCChhHHHHHHHHHHHHhccCCCCCCCHHHHHHHHH
Q 044312 498 -----------------KEERLFEILDARV----MKQGGKDEIITVAKLAKRCLNLNGKKRPTMREVASELA 548 (608)
Q Consensus 498 -----------------~~~~~~~~~d~~~----~~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~evl~~L~ 548 (608)
......+..+... ........+.++.+|+.+||+.||++|||++|++++..
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~~P~~Rpt~~ell~h~~ 303 (331)
T cd06649 232 RPRPPGRPVSGHGMDSRPAMAIFELLDYIVNEPPPKLPNGVFTPDFQEFVNKCLIKNPAERADLKMLMNHTF 303 (331)
T ss_pred ccccccccccccccccccchhHHHHHHHHHhCCCcCCCCccccHHHHHHHHHHccCCcccCCCHHHHhcChH
Confidence 0000011111100 01111235678999999999999999999999997653
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=316.03 Aligned_cols=247 Identities=25% Similarity=0.399 Sum_probs=198.4
Q ss_pred hcCccccceeccCce--------------EEEEEeecChhh-HHHHHHHHHHHhhcCCCCccceecccccCccceEEEee
Q 044312 288 TDNFDLNRILGQGGQ--------------AVKKSKVIDESK-VEEFINEVVILSQINHRNVVKLLGCCLETEVPLLVYEF 352 (608)
Q Consensus 288 t~~f~~~~~lG~G~~--------------avk~~~~~~~~~-~~~~~~Ei~il~~l~H~niv~l~~~~~~~~~~~lV~E~ 352 (608)
.....+.++||+|.| |||+++...... ..+|.+|+++|.+|+|||||+|+|+|..++.+++|+||
T Consensus 537 Rs~L~~~ekiGeGqFGEVhLCeveg~lkVAVK~Lr~~a~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~DePicmI~EY 616 (807)
T KOG1094|consen 537 RSRLRFKEKIGEGQFGEVHLCEVEGPLKVAVKILRPDATKNARNDFLKEIKILSRLKHPNIVELLGVCVQDDPLCMITEY 616 (807)
T ss_pred hhheehhhhhcCcccceeEEEEecCceEEEEeecCcccchhHHHHHHHHHHHHhccCCCCeeEEEeeeecCCchHHHHHH
Confidence 344567899999975 888887654443 58999999999999999999999999999999999999
Q ss_pred cCCCccchhccccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEEcCCCcEEEeeccCccccccCCc
Q 044312 353 IPNGTLFQYIHDQNEDFPITWEIRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQT 432 (608)
Q Consensus 353 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGls~~~~~~~~ 432 (608)
|++|+|.+++.++... .+.-...++|+.|||.||+||.+.+ ++||||.++|+|+|.++++||+|||++|.+...+.
T Consensus 617 mEnGDLnqFl~aheap-t~~t~~~vsi~tqiasgmaYLes~n---fVHrd~a~rNcLv~~e~~iKiadfgmsR~lysg~y 692 (807)
T KOG1094|consen 617 MENGDLNQFLSAHELP-TAETAPGVSICTQIASGMAYLESLN---FVHRDLATRNCLVDGEFTIKIADFGMSRNLYSGDY 692 (807)
T ss_pred HhcCcHHHHHHhccCc-ccccchhHHHHHHHHHHHHHHHhhc---hhhccccccceeecCcccEEecCcccccccccCCc
Confidence 9999999999876432 1455666889999999999999999 99999999999999999999999999997665444
Q ss_pred ceee-eeeccCCCCChhhhccCCCCCccchHhHHHHHHHHHh--CCCCCCccchhhcccHHHHHHHHhhhhhhHHHhhh-
Q 044312 433 HMTT-QVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLTELLT--GEKPIRFTILEEDKSLAAYFLCAMKEERLFEILDA- 508 (608)
Q Consensus 433 ~~~~-~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~ellt--g~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~- 508 (608)
+... ...-..+|||||.+..+++|.+||||+||+.|||+++ ...||.....+.. . +..-++++.
T Consensus 693 y~vqgr~vlpiRwmawEsillgkFttaSDvWafgvTlwE~~~~C~e~Py~~lt~e~v---v---------en~~~~~~~~ 760 (807)
T KOG1094|consen 693 YRVQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEVFMLCREQPYSQLTDEQV---V---------ENAGEFFRDQ 760 (807)
T ss_pred eeeecceeeeeeehhHHHHHhccccchhhhhhhHHHHHHHHHHHhhCchhhhhHHHH---H---------HhhhhhcCCC
Confidence 4332 3345679999999999999999999999999999866 7888863322210 0 011122221
Q ss_pred --hhhccCChhHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhh
Q 044312 509 --RVMKQGGKDEIITVAKLAKRCLNLNGKKRPTMREVASELAGI 550 (608)
Q Consensus 509 --~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~evl~~L~~i 550 (608)
......+.-++..+.+|+.+||+.+-++||++++|...|+..
T Consensus 761 ~~~~~l~~P~~cp~~lyelml~Cw~~es~~RPsFe~lh~~lq~~ 804 (807)
T KOG1094|consen 761 GRQVVLSRPPACPQGLYELMLRCWRRESEQRPSFEQLHLFLQED 804 (807)
T ss_pred CcceeccCCCcCcHHHHHHHHHHhchhhhcCCCHHHHHHHHHHh
Confidence 122334556788999999999999999999999998887653
|
|
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=309.50 Aligned_cols=242 Identities=24% Similarity=0.459 Sum_probs=190.5
Q ss_pred cCccccceeccCce-------------------EEEEEeec-ChhhHHHHHHHHHHHhhcCCCCccceecccccCccceE
Q 044312 289 DNFDLNRILGQGGQ-------------------AVKKSKVI-DESKVEEFINEVVILSQINHRNVVKLLGCCLETEVPLL 348 (608)
Q Consensus 289 ~~f~~~~~lG~G~~-------------------avk~~~~~-~~~~~~~~~~Ei~il~~l~H~niv~l~~~~~~~~~~~l 348 (608)
.+|++.+.||+|++ |+|..+.. .....++|.+|+.+++.++||||+++++++... ..++
T Consensus 7 ~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~-~~~~ 85 (316)
T cd05108 7 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQL 85 (316)
T ss_pred hhceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCC-Ccee
Confidence 35788888998874 44444322 234467899999999999999999999999764 5689
Q ss_pred EEeecCCCccchhccccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEEcCCCcEEEeeccCccccc
Q 044312 349 VYEFIPNGTLFQYIHDQNEDFPITWEIRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMA 428 (608)
Q Consensus 349 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGls~~~~ 428 (608)
|+||+++|+|.+++..... .+++..++.++.||+.||+|||+.+ |+||||||+|||+++++.+||+|||+++...
T Consensus 86 v~e~~~~g~l~~~l~~~~~--~~~~~~~~~~~~qi~~~L~~LH~~~---iiH~dlkp~Nill~~~~~~kl~DfG~a~~~~ 160 (316)
T cd05108 86 ITQLMPFGCLLDYVREHKD--NIGSQYLLNWCVQIAKGMNYLEERR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLG 160 (316)
T ss_pred eeecCCCCCHHHHHHhccc--cCCHHHHHHHHHHHHHHHHHHHhcC---eeccccchhheEecCCCcEEEcccccccccc
Confidence 9999999999999986543 4889999999999999999999999 9999999999999999999999999998765
Q ss_pred cCCccee-eeeeccCCCCChhhhccCCCCCccchHhHHHHHHHHHh-CCCCCCccchhhcccHHHHHHHHhhhhhhHHHh
Q 044312 429 VDQTHMT-TQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLTELLT-GEKPIRFTILEEDKSLAAYFLCAMKEERLFEIL 506 (608)
Q Consensus 429 ~~~~~~~-~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~ellt-g~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 506 (608)
....... ....++..|+|||++....++.++||||||+++|||++ |+.||......+ +..++
T Consensus 161 ~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~t~g~~p~~~~~~~~----------------~~~~~ 224 (316)
T cd05108 161 ADEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE----------------ISSIL 224 (316)
T ss_pred CCCcceeccCCccceeecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHH----------------HHHHH
Confidence 4332211 22234678999999999999999999999999999998 999986321111 11111
Q ss_pred hhhhhccCChhHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhhHH
Q 044312 507 DARVMKQGGKDEIITVAKLAKRCLNLNGKKRPTMREVASELAGIKA 552 (608)
Q Consensus 507 d~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~evl~~L~~i~~ 552 (608)
........+..++.++.+++.+||..+|++||++.+++..|..+..
T Consensus 225 ~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~l~~~l~~~~~ 270 (316)
T cd05108 225 EKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMAR 270 (316)
T ss_pred hCCCCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHc
Confidence 1111112223445678999999999999999999999999887754
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-36 Score=327.41 Aligned_cols=238 Identities=25% Similarity=0.319 Sum_probs=189.5
Q ss_pred CccccceeccCce----------------EEEEEeecChhhHHHHHHHHHHHhhcCCCCccceecccccCccceEEEeec
Q 044312 290 NFDLNRILGQGGQ----------------AVKKSKVIDESKVEEFINEVVILSQINHRNVVKLLGCCLETEVPLLVYEFI 353 (608)
Q Consensus 290 ~f~~~~~lG~G~~----------------avk~~~~~~~~~~~~~~~Ei~il~~l~H~niv~l~~~~~~~~~~~lV~E~~ 353 (608)
.|.+.+.||+|++ ++|+....+......+.+|+.+|+.++|||||++++++...+..+|||||+
T Consensus 68 ~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~E~~ 147 (478)
T PTZ00267 68 MYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLNDERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYG 147 (478)
T ss_pred eEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECCEEEEEEECC
Confidence 3888899999874 334333344455567889999999999999999999999999999999999
Q ss_pred CCCccchhcccc-CCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEEcCCCcEEEeeccCccccccCCc
Q 044312 354 PNGTLFQYIHDQ-NEDFPITWEIRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQT 432 (608)
Q Consensus 354 ~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGls~~~~~~~~ 432 (608)
++|+|.+++... ....++++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++.......
T Consensus 148 ~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~---ivHrDlkp~NIll~~~~~~kL~DFgla~~~~~~~~ 224 (478)
T PTZ00267 148 SGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSRK---MMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVS 224 (478)
T ss_pred CCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCC---EEECCcCHHhEEECCCCcEEEEeCcCceecCCccc
Confidence 999999988642 22336899999999999999999999998 99999999999999999999999999987643221
Q ss_pred -ceeeeeeccCCCCChhhhccCCCCCccchHhHHHHHHHHHhCCCCCCccchhhcccHHHHHHHHhhhhhhHHHhhhhhh
Q 044312 433 -HMTTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLTELLTGEKPIRFTILEEDKSLAAYFLCAMKEERLFEILDARVM 511 (608)
Q Consensus 433 -~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~ 511 (608)
.......||+.|+|||++.+..++.++||||||++++||++|+.||...... ..+ ..++... .
T Consensus 225 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~Pf~~~~~~------~~~---------~~~~~~~-~ 288 (478)
T PTZ00267 225 LDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGPSQR------EIM---------QQVLYGK-Y 288 (478)
T ss_pred cccccccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHH------HHH---------HHHHhCC-C
Confidence 1233456899999999999999999999999999999999999998632111 101 1111110 1
Q ss_pred ccCChhHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 044312 512 KQGGKDEIITVAKLAKRCLNLNGKKRPTMREVASE 546 (608)
Q Consensus 512 ~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~evl~~ 546 (608)
...+...+..+.+|+.+||+.+|++||++.+++.+
T Consensus 289 ~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~~ 323 (478)
T PTZ00267 289 DPFPCPVSSGMKALLDPLLSKNPALRPTTQQLLHT 323 (478)
T ss_pred CCCCccCCHHHHHHHHHHhccChhhCcCHHHHHhC
Confidence 11223455689999999999999999999998753
|
|
| >KOG0589 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-36 Score=312.34 Aligned_cols=237 Identities=26% Similarity=0.398 Sum_probs=201.3
Q ss_pred cCccccceeccCce---------------EEEEEeecC--hhhHHHHHHHHHHHhhcCCCCccceecccccCcc-ceEEE
Q 044312 289 DNFDLNRILGQGGQ---------------AVKKSKVID--ESKVEEFINEVVILSQINHRNVVKLLGCCLETEV-PLLVY 350 (608)
Q Consensus 289 ~~f~~~~~lG~G~~---------------avk~~~~~~--~~~~~~~~~Ei~il~~l~H~niv~l~~~~~~~~~-~~lV~ 350 (608)
++|...+++|+|+| ++|++.... +...+..++|+.++++++|||||.+.+.|.+++. .+|||
T Consensus 4 ~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~Ivm 83 (426)
T KOG0589|consen 4 DNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLCIVM 83 (426)
T ss_pred chhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchhcCCceEEEEE
Confidence 46788899999986 677776533 3445578999999999999999999999999988 89999
Q ss_pred eecCCCccchhccccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEEcCCCcEEEeeccCccccccC
Q 044312 351 EFIPNGTLFQYIHDQNEDFPITWEIRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVD 430 (608)
Q Consensus 351 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGls~~~~~~ 430 (608)
+|++||+|.+.|.+++ ...++++.+..++.|++.|+.|||++. |+|||||+.|||++.+..+||+|||+|+.+..+
T Consensus 84 ~Y~eGg~l~~~i~~~k-~~~f~E~~i~~~~~Q~~~av~ylH~~~---iLHRDlK~~Nifltk~~~VkLgDfGlaK~l~~~ 159 (426)
T KOG0589|consen 84 EYCEGGDLAQLIKEQK-GVLFPEERILKWFVQILLAVNYLHENR---VLHRDLKCANIFLTKDKKVKLGDFGLAKILNPE 159 (426)
T ss_pred eecCCCCHHHHHHHHh-hccccHHHHHHHHHHHHHHHHHHHhhh---hhcccchhhhhhccccCceeecchhhhhhcCCc
Confidence 9999999999998765 336999999999999999999999888 999999999999999999999999999998765
Q ss_pred CcceeeeeeccCCCCChhhhccCCCCCccchHhHHHHHHHHHhCCCCCCccchhhcccHHHHHHHHhhhhhhHHHhhhhh
Q 044312 431 QTHMTTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLTELLTGEKPIRFTILEEDKSLAAYFLCAMKEERLFEILDARV 510 (608)
Q Consensus 431 ~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~ 510 (608)
.. ....+.||+.||.||.+.+..|..|+|||||||+++||++-+++|..... ....... ....
T Consensus 160 ~~-~a~tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~~lk~aF~a~~m------~~Li~ki----------~~~~ 222 (426)
T KOG0589|consen 160 DS-LASTVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMCTLKPAFKASNM------SELILKI----------NRGL 222 (426)
T ss_pred hh-hhheecCCCcccCHHHhCCCCCCccCcchhhcchHHHHHhcccccCccch------HHHHHHH----------hhcc
Confidence 52 34567799999999999999999999999999999999999999873322 2111111 1112
Q ss_pred hccCChhHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 044312 511 MKQGGKDEIITVAKLAKRCLNLNGKKRPTMREVASE 546 (608)
Q Consensus 511 ~~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~evl~~ 546 (608)
....+..++.+++.|+..||+.+|+.||++.+++.+
T Consensus 223 ~~Plp~~ys~el~~lv~~~l~~~P~~RPsa~~LL~~ 258 (426)
T KOG0589|consen 223 YSPLPSMYSSELRSLVKSMLRKNPEHRPSALELLRR 258 (426)
T ss_pred CCCCCccccHHHHHHHHHHhhcCCccCCCHHHHhhC
Confidence 344566778899999999999999999999999987
|
|
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-36 Score=307.83 Aligned_cols=231 Identities=26% Similarity=0.394 Sum_probs=186.4
Q ss_pred cCccccceeccCce---------------EEEEEeec---ChhhHHHHHHHHHHHhhcCCCCccceecccccCccceEEE
Q 044312 289 DNFDLNRILGQGGQ---------------AVKKSKVI---DESKVEEFINEVVILSQINHRNVVKLLGCCLETEVPLLVY 350 (608)
Q Consensus 289 ~~f~~~~~lG~G~~---------------avk~~~~~---~~~~~~~~~~Ei~il~~l~H~niv~l~~~~~~~~~~~lV~ 350 (608)
++|++.+.||+|++ |+|..... +....+.+.+|+.++++++||||+++++++.+....++||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 80 (291)
T cd05612 1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYMLM 80 (291)
T ss_pred CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCCeEEEEE
Confidence 36788889999874 56665432 2234567889999999999999999999999999999999
Q ss_pred eecCCCccchhccccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEEcCCCcEEEeeccCccccccC
Q 044312 351 EFIPNGTLFQYIHDQNEDFPITWEIRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVD 430 (608)
Q Consensus 351 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGls~~~~~~ 430 (608)
||+++|+|.+++.... .+++..+..++.||+.||+|||+++ |+||||||+|||+++++.+||+|||+++.....
T Consensus 81 e~~~~~~L~~~~~~~~---~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~ 154 (291)
T cd05612 81 EYVPGGELFSYLRNSG---RFSNSTGLFYASEIVCALEYLHSKE---IVYRDLKPENILLDKEGHIKLTDFGFAKKLRDR 154 (291)
T ss_pred eCCCCCCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHeEECCCCCEEEEecCcchhccCC
Confidence 9999999999997643 4899999999999999999999999 999999999999999999999999999865422
Q ss_pred CcceeeeeeccCCCCChhhhccCCCCCccchHhHHHHHHHHHhCCCCCCccchhhcccHHHHHHHHhhhhhhHHHhhhhh
Q 044312 431 QTHMTTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLTELLTGEKPIRFTILEEDKSLAAYFLCAMKEERLFEILDARV 510 (608)
Q Consensus 431 ~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~ 510 (608)
.....|++.|+|||++.+..++.++||||||++++||++|+.||...... ..+. .+....
T Consensus 155 ----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~------~~~~---------~i~~~~- 214 (291)
T cd05612 155 ----TWTLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDNPF------GIYE---------KILAGK- 214 (291)
T ss_pred ----cccccCChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH------HHHH---------HHHhCC-
Confidence 12346899999999999999999999999999999999999998632211 1110 111111
Q ss_pred hccCChhHHHHHHHHHHHHhccCCCCCCC-----HHHHHHH
Q 044312 511 MKQGGKDEIITVAKLAKRCLNLNGKKRPT-----MREVASE 546 (608)
Q Consensus 511 ~~~~~~~~~~~l~~Li~~cl~~dp~~RPs-----~~evl~~ 546 (608)
...+...+..+.+|+.+||+.||.+||+ +.|++++
T Consensus 215 -~~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h 254 (291)
T cd05612 215 -LEFPRHLDLYAKDLIKKLLVVDRTRRLGNMKNGADDVKNH 254 (291)
T ss_pred -cCCCccCCHHHHHHHHHHcCCCHHHccCCccCCHHHHhcC
Confidence 1223334567899999999999999995 7777654
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-35 Score=305.05 Aligned_cols=246 Identities=26% Similarity=0.441 Sum_probs=191.2
Q ss_pred cCccccceeccCce-----------------EEEEEee-cChhhHHHHHHHHHHHhhc-CCCCccceecccccCccceEE
Q 044312 289 DNFDLNRILGQGGQ-----------------AVKKSKV-IDESKVEEFINEVVILSQI-NHRNVVKLLGCCLETEVPLLV 349 (608)
Q Consensus 289 ~~f~~~~~lG~G~~-----------------avk~~~~-~~~~~~~~~~~Ei~il~~l-~H~niv~l~~~~~~~~~~~lV 349 (608)
++|++.+.||+|++ ++|..+. ......+.|.+|+.+++++ +||||+++++++.+....++|
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv 81 (297)
T cd05089 2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLLGACENRGYLYIA 81 (297)
T ss_pred ccceeeeeecCCCcceEEEEEecCCCCcceeEEEEccccCCHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCcceEE
Confidence 46788889999875 3333332 2233456799999999999 799999999999999999999
Q ss_pred EeecCCCccchhccccCC-------------CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEEcCCCcE
Q 044312 350 YEFIPNGTLFQYIHDQNE-------------DFPITWEIRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRA 416 (608)
Q Consensus 350 ~E~~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ 416 (608)
|||+++++|.++++.... ...+++..++.++.|++.||+|||+.+ |+||||||+|||+++++.+
T Consensus 82 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~---ivH~dlkp~Nill~~~~~~ 158 (297)
T cd05089 82 IEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEKQ---FIHRDLAARNVLVGENLAS 158 (297)
T ss_pred EEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCcCCcceEEECCCCeE
Confidence 999999999999965321 124889999999999999999999998 9999999999999999999
Q ss_pred EEeeccCccccccCCcceeeeeeccCCCCChhhhccCCCCCccchHhHHHHHHHHHh-CCCCCCccchhhcccHHHHHHH
Q 044312 417 KVSDFGASRSMAVDQTHMTTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLTELLT-GEKPIRFTILEEDKSLAAYFLC 495 (608)
Q Consensus 417 kl~DFGls~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~ellt-g~~p~~~~~~~~~~~l~~~~~~ 495 (608)
||+|||++....... .......+..|+|||++....++.++||||||++++||++ |..||.......
T Consensus 159 kl~dfg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t~g~~pf~~~~~~~---------- 226 (297)
T cd05089 159 KIADFGLSRGEEVYV--KKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTCAE---------- 226 (297)
T ss_pred EECCcCCCcccccee--ccCCCCcCccccCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHH----------
Confidence 999999986432111 1111223557999999998899999999999999999998 999986332211
Q ss_pred HhhhhhhHHHhhhhhhccCChhHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhhHHhcC
Q 044312 496 AMKEERLFEILDARVMKQGGKDEIITVAKLAKRCLNLNGKKRPTMREVASELAGIKAWNG 555 (608)
Q Consensus 496 ~~~~~~~~~~~d~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~evl~~L~~i~~~~~ 555 (608)
+.+.+........+...+..+.+|+.+||+.+|.+||++.+++++|+.+....+
T Consensus 227 ------~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~~~~~~ 280 (297)
T cd05089 227 ------LYEKLPQGYRMEKPRNCDDEVYELMRQCWRDRPYERPPFAQISVQLSRMLEARK 280 (297)
T ss_pred ------HHHHHhcCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhhc
Confidence 011111111122233456789999999999999999999999999988876553
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=303.78 Aligned_cols=249 Identities=29% Similarity=0.455 Sum_probs=190.2
Q ss_pred cCccccceeccCce-------------------EEEEEeecChhhHHHHHHHHHHHhhcCCCCccceeccccc--Cccce
Q 044312 289 DNFDLNRILGQGGQ-------------------AVKKSKVIDESKVEEFINEVVILSQINHRNVVKLLGCCLE--TEVPL 347 (608)
Q Consensus 289 ~~f~~~~~lG~G~~-------------------avk~~~~~~~~~~~~~~~Ei~il~~l~H~niv~l~~~~~~--~~~~~ 347 (608)
.+|++.+.||+|++ |+|+.+.......+.|.+|++++++++||||+++++++.. ....+
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 83 (284)
T cd05081 4 RHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLR 83 (284)
T ss_pred ccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCCCceE
Confidence 35667777888763 5566555555667789999999999999999999998743 34678
Q ss_pred EEEeecCCCccchhccccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEEcCCCcEEEeeccCcccc
Q 044312 348 LVYEFIPNGTLFQYIHDQNEDFPITWEIRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSM 427 (608)
Q Consensus 348 lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGls~~~ 427 (608)
+||||+++++|.+++..... .+++..+..++.|++.||+|||+.+ ++||||||+|||+++++.+||+|||+++..
T Consensus 84 lv~e~~~~~~L~~~l~~~~~--~l~~~~~~~~~~~l~~aL~~LH~~~---i~H~dlkp~nili~~~~~~~l~dfg~~~~~ 158 (284)
T cd05081 84 LVMEYLPYGSLRDYLQKHRE--RLDHRKLLLYASQICKGMEYLGSKR---YVHRDLATRNILVESENRVKIGDFGLTKVL 158 (284)
T ss_pred EEEEecCCCCHHHHHHhcCc--CCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCCHhhEEECCCCeEEECCCcccccc
Confidence 99999999999999975432 4899999999999999999999999 999999999999999999999999999876
Q ss_pred ccCCccee--eeeeccCCCCChhhhccCCCCCccchHhHHHHHHHHHhCCCCCCccchhhcccHHHHHHHHhhh------
Q 044312 428 AVDQTHMT--TQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLTELLTGEKPIRFTILEEDKSLAAYFLCAMKE------ 499 (608)
Q Consensus 428 ~~~~~~~~--~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~elltg~~p~~~~~~~~~~~l~~~~~~~~~~------ 499 (608)
........ ....++..|+|||++.+..++.++||||||++++||++|..|+...... +...+..
T Consensus 159 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~--------~~~~~~~~~~~~~ 230 (284)
T cd05081 159 PQDKEYYKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSCSPPAE--------FMRMMGNDKQGQM 230 (284)
T ss_pred cCCCcceeecCCCCCceEeeCHHHhccCCcChHHHHHHHHHHHHHHhhcCCcCCCcchh--------hhhhccccccccc
Confidence 54332211 1122345699999999889999999999999999999987765421110 1111111
Q ss_pred --hhhHHHhhhhhhccCChhHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhh
Q 044312 500 --ERLFEILDARVMKQGGKDEIITVAKLAKRCLNLNGKKRPTMREVASELAGI 550 (608)
Q Consensus 500 --~~~~~~~d~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~evl~~L~~i 550 (608)
..+.+.+........+...+.++.+|+.+||..+|++|||+.||++.|+.+
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~~ 283 (284)
T cd05081 231 IVYHLIELLKNNGRLPAPPGCPAEIYAIMKECWNNDPSQRPSFSELALQVEAI 283 (284)
T ss_pred chHHHHHHHhcCCcCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHhc
Confidence 011122222222223344567899999999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=302.77 Aligned_cols=227 Identities=27% Similarity=0.450 Sum_probs=180.9
Q ss_pred EEEEEeecChh-hHHHHHHHHHHHhhcCCCCccceecccccCccceEEEeecCCCccchhccccCC-----------CCC
Q 044312 303 AVKKSKVIDES-KVEEFINEVVILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGTLFQYIHDQNE-----------DFP 370 (608)
Q Consensus 303 avk~~~~~~~~-~~~~~~~Ei~il~~l~H~niv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~-----------~~~ 370 (608)
|||..+..... ..+.|.+|+++|+.++|+||+++++++......++||||+++++|.+++..... ...
T Consensus 39 aiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~ 118 (280)
T cd05049 39 AVKTLKETASNDARKDFEREAELLTNFQHENIVKFYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGE 118 (280)
T ss_pred EEEeecccCCHHHHHHHHHHHHHHHhcCCCCchheeeEEecCCCeEEEEecCCCCCHHHHHHhcCCchhhhccccccccc
Confidence 56665543333 457899999999999999999999999999999999999999999999975421 234
Q ss_pred CCHHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEEcCCCcEEEeeccCccccccCCc-ceeeeeeccCCCCChhh
Q 044312 371 ITWEIRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQT-HMTTQVHGTFGYLDPEY 449 (608)
Q Consensus 371 l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGls~~~~~~~~-~~~~~~~gt~~y~aPE~ 449 (608)
+++..+..++.|++.||.|||+++ ++||||||+|||++.++.+||+|||+++....... .......+++.|+|||+
T Consensus 119 l~~~~~~~~~~~i~~~l~~lH~~~---i~h~dlkp~nili~~~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~ 195 (280)
T cd05049 119 LTLSQLLQIAVQIASGMVYLASQH---FVHRDLATRNCLVGYDLVVKIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPES 195 (280)
T ss_pred ccHHHHHHHHHHHHHHHHHHhhCC---eeccccccceEEEcCCCeEEECCcccceecccCcceecCCCCcccceecChhh
Confidence 789999999999999999999999 99999999999999999999999999976533221 11223345778999999
Q ss_pred hccCCCCCccchHhHHHHHHHHHh-CCCCCCccchhhcccHHHHHHHHhhhhhhHHHhhhhhhccCChhHHHHHHHHHHH
Q 044312 450 FRSSQFTDKSDVYSFGVVLTELLT-GEKPIRFTILEEDKSLAAYFLCAMKEERLFEILDARVMKQGGKDEIITVAKLAKR 528 (608)
Q Consensus 450 ~~~~~~t~ksDV~S~Gvvl~ellt-g~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~Li~~ 528 (608)
+.+..++.++||||||++++||++ |+.||......+ .. .... .......+...+..+.+++.+
T Consensus 196 ~~~~~~~~~~Di~slG~il~e~~~~g~~p~~~~~~~~---~~----~~~~---------~~~~~~~~~~~~~~~~~li~~ 259 (280)
T cd05049 196 IMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSNEE---VI----ECIT---------QGRLLQRPRTCPSEVYDIMLG 259 (280)
T ss_pred hccCCcchhhhHHHHHHHHHHHHhcCCCCCCCCCHHH---HH----HHHH---------cCCcCCCCCCCCHHHHHHHHH
Confidence 999999999999999999999999 999986332211 00 0111 111112233456789999999
Q ss_pred HhccCCCCCCCHHHHHHHHH
Q 044312 529 CLNLNGKKRPTMREVASELA 548 (608)
Q Consensus 529 cl~~dp~~RPs~~evl~~L~ 548 (608)
||+.||++||++.||++.|+
T Consensus 260 ~l~~~p~~Rp~~~eil~~l~ 279 (280)
T cd05049 260 CWKRDPQQRINIKDIHERLQ 279 (280)
T ss_pred HcCCCcccCCCHHHHHHHhh
Confidence 99999999999999999885
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=318.08 Aligned_cols=249 Identities=26% Similarity=0.426 Sum_probs=193.6
Q ss_pred HHHhcCccccceeccCce--------------------EEEEEeec-ChhhHHHHHHHHHHHhhcC-CCCccceeccccc
Q 044312 285 EKATDNFDLNRILGQGGQ--------------------AVKKSKVI-DESKVEEFINEVVILSQIN-HRNVVKLLGCCLE 342 (608)
Q Consensus 285 ~~~t~~f~~~~~lG~G~~--------------------avk~~~~~-~~~~~~~~~~Ei~il~~l~-H~niv~l~~~~~~ 342 (608)
+...++|.+.++||+|+| |||+++.. .....+.|.+|+.+|++++ ||||+++++++.+
T Consensus 33 ~~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~~ 112 (400)
T cd05105 33 EFPRDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARSSEKQALMSELKIMTHLGPHLNIVNLLGACTK 112 (400)
T ss_pred eccccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCCeeeEEEEEcc
Confidence 344567888899999975 34444322 2234567999999999995 9999999999999
Q ss_pred CccceEEEeecCCCccchhccccCC-------------------------------------------------------
Q 044312 343 TEVPLLVYEFIPNGTLFQYIHDQNE------------------------------------------------------- 367 (608)
Q Consensus 343 ~~~~~lV~E~~~~gsL~~~l~~~~~------------------------------------------------------- 367 (608)
....+|||||+++|+|.++++....
T Consensus 113 ~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 192 (400)
T cd05105 113 SGPIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVPML 192 (400)
T ss_pred CCceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccchhh
Confidence 9999999999999999998865311
Q ss_pred --------------------------------------CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEE
Q 044312 368 --------------------------------------DFPITWEIRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNIL 409 (608)
Q Consensus 368 --------------------------------------~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NIL 409 (608)
...+++..++.++.||++||+|||+.+ |+||||||+|||
T Consensus 193 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivH~dikp~Nil 269 (400)
T cd05105 193 EIKEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASKN---CVHRDLAARNVL 269 (400)
T ss_pred hhhhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChHhEE
Confidence 124788899999999999999999998 999999999999
Q ss_pred EcCCCcEEEeeccCccccccCCcc-eeeeeeccCCCCChhhhccCCCCCccchHhHHHHHHHHHh-CCCCCCccchhhcc
Q 044312 410 LDDKYRAKVSDFGASRSMAVDQTH-MTTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLTELLT-GEKPIRFTILEEDK 487 (608)
Q Consensus 410 l~~~~~~kl~DFGls~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~ellt-g~~p~~~~~~~~~~ 487 (608)
+++++.+||+|||+++........ ......++..|+|||.+.+..++.++||||||++++||++ |..||.......
T Consensus 270 l~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt~g~~P~~~~~~~~-- 347 (400)
T cd05105 270 LAQGKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGMIVDS-- 347 (400)
T ss_pred EeCCCEEEEEeCCcceeccccccccccCCcCCCcceEChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCcccchhH--
Confidence 999999999999999865433221 1222346778999999999999999999999999999997 889986322111
Q ss_pred cHHHHHHHHhhhhhhHHHhhhhhhccCChhHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhhH
Q 044312 488 SLAAYFLCAMKEERLFEILDARVMKQGGKDEIITVAKLAKRCLNLNGKKRPTMREVASELAGIK 551 (608)
Q Consensus 488 ~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~evl~~L~~i~ 551 (608)
.+. ..+........+...+..+.+++.+||+.+|++||++.+|.++|+.+.
T Consensus 348 ----~~~---------~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~l~~l~ 398 (400)
T cd05105 348 ----TFY---------NKIKSGYRMAKPDHATQEVYDIMVKCWNSEPEKRPSFLHLSDIVESLL 398 (400)
T ss_pred ----HHH---------HHHhcCCCCCCCccCCHHHHHHHHHHCccCHhHCcCHHHHHHHHHHHc
Confidence 011 111111112223345678999999999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=298.91 Aligned_cols=235 Identities=29% Similarity=0.466 Sum_probs=185.1
Q ss_pred ccccceeccCce--------------EEEEEeecChhhHHHHHHHHHHHhhcCCCCccceecccccCccceEEEeecCCC
Q 044312 291 FDLNRILGQGGQ--------------AVKKSKVIDESKVEEFINEVVILSQINHRNVVKLLGCCLETEVPLLVYEFIPNG 356 (608)
Q Consensus 291 f~~~~~lG~G~~--------------avk~~~~~~~~~~~~~~~Ei~il~~l~H~niv~l~~~~~~~~~~~lV~E~~~~g 356 (608)
|++.+.||+|++ |+|.... .....+.|.+|+.++++++|+||+++++++.+....++||||++++
T Consensus 6 ~~~~~~lg~G~~~~v~~~~~~~~~~~~iK~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~ 84 (256)
T cd05059 6 LTFLKELGSGQFGVVHLGKWRGKIDVAIKMIRE-GAMSEDDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIVTEYMANG 84 (256)
T ss_pred cchhhhhccCCCceEEEeEecCCccEEEEEecc-CCCCHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCceEEEEecCCCC
Confidence 556667777753 5555432 1223467899999999999999999999999999999999999999
Q ss_pred ccchhccccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEEcCCCcEEEeeccCccccccCCcceee
Q 044312 357 TLFQYIHDQNEDFPITWEIRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTT 436 (608)
Q Consensus 357 sL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGls~~~~~~~~~~~~ 436 (608)
+|.+++..... .+++..++.++.|++.||+|||+.+ ++||||||+|||+++++.+||+|||+++...........
T Consensus 85 ~L~~~l~~~~~--~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~~~~~~~~ 159 (256)
T cd05059 85 CLLNYLRERKG--KLGTEWLLDMCSDVCEAMEYLESNG---FIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQYTSSQ 159 (256)
T ss_pred CHHHHHHhccc--CCCHHHHHHHHHHHHHHHHHHHHCC---cccccccHhhEEECCCCcEEECCcccceecccccccccC
Confidence 99999976433 5899999999999999999999999 999999999999999999999999999866432222122
Q ss_pred eeeccCCCCChhhhccCCCCCccchHhHHHHHHHHHh-CCCCCCccchhhcccHHHHHHHHhhhhhhHHHhhhhhhccCC
Q 044312 437 QVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLTELLT-GEKPIRFTILEEDKSLAAYFLCAMKEERLFEILDARVMKQGG 515 (608)
Q Consensus 437 ~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~ellt-g~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~ 515 (608)
...++..|+|||.+....++.++||||||++++||++ |+.||......+ . ...+........+
T Consensus 160 ~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~---~-------------~~~~~~~~~~~~~ 223 (256)
T cd05059 160 GTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNSE---V-------------VESVSAGYRLYRP 223 (256)
T ss_pred CCCCCccccCHHHhccCCCCchhhHHHHHHHHHHHhccCCCCCCCCCHHH---H-------------HHHHHcCCcCCCC
Confidence 2234457999999999999999999999999999999 788886322111 0 0011111112233
Q ss_pred hhHHHHHHHHHHHHhccCCCCCCCHHHHHHHH
Q 044312 516 KDEIITVAKLAKRCLNLNGKKRPTMREVASEL 547 (608)
Q Consensus 516 ~~~~~~l~~Li~~cl~~dp~~RPs~~evl~~L 547 (608)
...+.++.+++.+||+.+|++|||+.|+++.|
T Consensus 224 ~~~~~~~~~li~~cl~~~p~~Rpt~~~~l~~l 255 (256)
T cd05059 224 KLAPTEVYTIMYSCWHEKPEDRPAFKKLLSQL 255 (256)
T ss_pred CCCCHHHHHHHHHHhcCChhhCcCHHHHHHHh
Confidence 44667899999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-36 Score=316.04 Aligned_cols=244 Identities=27% Similarity=0.456 Sum_probs=208.3
Q ss_pred CccccceeccCce-------------------EEEEEee-cChhhHHHHHHHHHHHhhcCCCCccceecccccCccceEE
Q 044312 290 NFDLNRILGQGGQ-------------------AVKKSKV-IDESKVEEFINEVVILSQINHRNVVKLLGCCLETEVPLLV 349 (608)
Q Consensus 290 ~f~~~~~lG~G~~-------------------avk~~~~-~~~~~~~~~~~Ei~il~~l~H~niv~l~~~~~~~~~~~lV 349 (608)
.....++||.|.| |||..+. .+....+.|+.|..+|++++|||||+|+|+|.+ ...+||
T Consensus 390 ~Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~d~tekflqEa~iMrnfdHphIikLIGv~~e-~P~Wiv 468 (974)
T KOG4257|consen 390 LITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTPDDTEKFLQEASIMRNFDHPHIIKLIGVCVE-QPMWIV 468 (974)
T ss_pred hccHHHhhcCCcccceeeeEecccccCcceeeeeehhccCCChhhHHHHHHHHHHHHhCCCcchhheeeeeec-cceeEE
Confidence 3455788999864 7777765 566778999999999999999999999999965 467999
Q ss_pred EeecCCCccchhccccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEEcCCCcEEEeeccCcccccc
Q 044312 350 YEFIPNGTLFQYIHDQNEDFPITWEIRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAV 429 (608)
Q Consensus 350 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGls~~~~~ 429 (608)
||+++-|.|..+|+.+.. .++..+...++.||..||+|||+.. .+||||..+|||+...-.+||+||||+|.+..
T Consensus 469 mEL~~~GELr~yLq~nk~--sL~l~tL~ly~~Qi~talaYLeSkr---fVHRDIAaRNiLVsSp~CVKLaDFGLSR~~ed 543 (974)
T KOG4257|consen 469 MELAPLGELREYLQQNKD--SLPLRTLTLYCYQICTALAYLESKR---FVHRDIAARNILVSSPQCVKLADFGLSRYLED 543 (974)
T ss_pred EecccchhHHHHHHhccc--cchHHHHHHHHHHHHHHHHHHHhhc---hhhhhhhhhheeecCcceeeecccchhhhccc
Confidence 999999999999987654 5999999999999999999999999 99999999999999999999999999999876
Q ss_pred CCcceeeeeeccCCCCChhhhccCCCCCccchHhHHHHHHHHHh-CCCCCCccchhhcccHHHHHHHHhhhhhhHHHhhh
Q 044312 430 DQTHMTTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLTELLT-GEKPIRFTILEEDKSLAAYFLCAMKEERLFEILDA 508 (608)
Q Consensus 430 ~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~ellt-g~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 508 (608)
+.....+...-...|||||.+.-++++.+||||-|||.+||++. |.+||... ++..+.-.++.
T Consensus 544 ~~yYkaS~~kLPIKWmaPESINfRrFTtASDVWMFgVCmWEIl~lGvkPfqgv----------------kNsDVI~~iEn 607 (974)
T KOG4257|consen 544 DAYYKASRGKLPIKWMAPESINFRRFTTASDVWMFGVCMWEILSLGVKPFQGV----------------KNSDVIGHIEN 607 (974)
T ss_pred cchhhccccccceeecCccccchhcccchhhHHHHHHHHHHHHHhcCCccccc----------------cccceEEEecC
Confidence 66555555556778999999999999999999999999999887 99999732 22222223344
Q ss_pred hhhccCChhHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhhHHhcC
Q 044312 509 RVMKQGGKDEIITVAKLAKRCLNLNGKKRPTMREVASELAGIKAWNG 555 (608)
Q Consensus 509 ~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~evl~~L~~i~~~~~ 555 (608)
.-+.+.+..++..++.|+.+||..+|.+||++.|+...|..+....+
T Consensus 608 GeRlP~P~nCPp~LYslmskcWayeP~kRPrftei~~~lsdv~qeek 654 (974)
T KOG4257|consen 608 GERLPCPPNCPPALYSLMSKCWAYEPSKRPRFTEIKAILSDVLQEEK 654 (974)
T ss_pred CCCCCCCCCCChHHHHHHHHHhccCcccCCcHHHHHHHHHHHHHHhh
Confidence 44556778899999999999999999999999999999998876443
|
|
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-35 Score=298.61 Aligned_cols=241 Identities=25% Similarity=0.438 Sum_probs=189.8
Q ss_pred cCccccceeccCce------------------EEEEEeec-ChhhHHHHHHHHHHHhhcCCCCccceecccccCccceEE
Q 044312 289 DNFDLNRILGQGGQ------------------AVKKSKVI-DESKVEEFINEVVILSQINHRNVVKLLGCCLETEVPLLV 349 (608)
Q Consensus 289 ~~f~~~~~lG~G~~------------------avk~~~~~-~~~~~~~~~~Ei~il~~l~H~niv~l~~~~~~~~~~~lV 349 (608)
++|+..+.||+|++ ++|+.+.. .....+.+.+|++++++++|+||+++++++.+.+..++|
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 84 (268)
T cd05063 5 SHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFKPAMII 84 (268)
T ss_pred HHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCCCeeEEEEEEccCCCcEEE
Confidence 46777888888864 34443322 234467899999999999999999999999999999999
Q ss_pred EeecCCCccchhccccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEEcCCCcEEEeeccCcccccc
Q 044312 350 YEFIPNGTLFQYIHDQNEDFPITWEIRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAV 429 (608)
Q Consensus 350 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGls~~~~~ 429 (608)
|||+++++|.+++..... .+++..+..++.|++.||+|||+.+ ++|+||||+|||+++++.+||+|||++.....
T Consensus 85 ~e~~~~~~L~~~~~~~~~--~~~~~~~~~~~~~l~~al~~lH~~~---i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~ 159 (268)
T cd05063 85 TEYMENGALDKYLRDHDG--EFSSYQLVGMLRGIAAGMKYLSDMN---YVHRDLAARNILVNSNLECKVSDFGLSRVLED 159 (268)
T ss_pred EEcCCCCCHHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHHCC---eeccccchhhEEEcCCCcEEECCCccceeccc
Confidence 999999999999876432 5899999999999999999999999 99999999999999999999999999986653
Q ss_pred CCcceee--eeeccCCCCChhhhccCCCCCccchHhHHHHHHHHHh-CCCCCCccchhhcccHHHHHHHHhhhhhhHHHh
Q 044312 430 DQTHMTT--QVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLTELLT-GEKPIRFTILEEDKSLAAYFLCAMKEERLFEIL 506 (608)
Q Consensus 430 ~~~~~~~--~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~ellt-g~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 506 (608)
....... ....+..|+|||++....++.++||||||++++||++ |+.||......+ . ...+
T Consensus 160 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ell~~g~~p~~~~~~~~-------~---------~~~i 223 (268)
T cd05063 160 DPEGTYTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSNHE-------V---------MKAI 223 (268)
T ss_pred ccccceeccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHHHhCCCCCCCcCCHHH-------H---------HHHH
Confidence 3222111 1223457999999998899999999999999999998 999986322110 1 1111
Q ss_pred hhhhhccCChhHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhh
Q 044312 507 DARVMKQGGKDEIITVAKLAKRCLNLNGKKRPTMREVASELAGI 550 (608)
Q Consensus 507 d~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~evl~~L~~i 550 (608)
......+.....+..+.+++.+||+.+|++||++.+|++.|+++
T Consensus 224 ~~~~~~~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~i~~~l~~~ 267 (268)
T cd05063 224 NDGFRLPAPMDCPSAVYQLMLQCWQQDRARRPRFVDIVNLLDKL 267 (268)
T ss_pred hcCCCCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 11111222334567899999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-35 Score=302.34 Aligned_cols=241 Identities=24% Similarity=0.421 Sum_probs=187.8
Q ss_pred CccccceeccCce-------------------EEEEEee-cChhhHHHHHHHHHHHhhcCCCCccceecccccCccceEE
Q 044312 290 NFDLNRILGQGGQ-------------------AVKKSKV-IDESKVEEFINEVVILSQINHRNVVKLLGCCLETEVPLLV 349 (608)
Q Consensus 290 ~f~~~~~lG~G~~-------------------avk~~~~-~~~~~~~~~~~Ei~il~~l~H~niv~l~~~~~~~~~~~lV 349 (608)
.|++.++||+|+| ++|..+. ........|.+|+.++++++||||+++++++......++|
T Consensus 6 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv 85 (283)
T cd05090 6 AVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQPVCML 85 (283)
T ss_pred hceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCceEEE
Confidence 4666778888764 3444432 2233456799999999999999999999999999999999
Q ss_pred EeecCCCccchhccccCC--------------CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEEcCCCc
Q 044312 350 YEFIPNGTLFQYIHDQNE--------------DFPITWEIRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYR 415 (608)
Q Consensus 350 ~E~~~~gsL~~~l~~~~~--------------~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~ 415 (608)
|||+++++|.+++..... ...+++..++.++.|++.||+|||+++ ++||||||+|||+++++.
T Consensus 86 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---i~H~dlkp~nili~~~~~ 162 (283)
T cd05090 86 FEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSHF---FVHKDLAARNILIGEQLH 162 (283)
T ss_pred EEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhcC---eehhccccceEEEcCCCc
Confidence 999999999999853221 124789999999999999999999999 999999999999999999
Q ss_pred EEEeeccCccccccCCc-ceeeeeeccCCCCChhhhccCCCCCccchHhHHHHHHHHHh-CCCCCCccchhhcccHHHHH
Q 044312 416 AKVSDFGASRSMAVDQT-HMTTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLTELLT-GEKPIRFTILEEDKSLAAYF 493 (608)
Q Consensus 416 ~kl~DFGls~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~ellt-g~~p~~~~~~~~~~~l~~~~ 493 (608)
+||+|||+++....... .......++..|+|||++.+..++.++||||||++++||++ |..||......
T Consensus 163 ~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~g~~p~~~~~~~--------- 233 (283)
T cd05090 163 VKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSNQ--------- 233 (283)
T ss_pred EEeccccccccccCCcceecccCCCccceecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHH---------
Confidence 99999999986543221 11222335678999999998899999999999999999999 88887532111
Q ss_pred HHHhhhhhhHHHhhhhhhccCChhHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHh
Q 044312 494 LCAMKEERLFEILDARVMKQGGKDEIITVAKLAKRCLNLNGKKRPTMREVASELAG 549 (608)
Q Consensus 494 ~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~evl~~L~~ 549 (608)
.+.+.+........+...+..+.+++.+||+.+|++||++.+|.++|..
T Consensus 234 -------~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~ 282 (283)
T cd05090 234 -------EVIEMVRKRQLLPCSEDCPPRMYSLMTECWQEGPSRRPRFKDIHTRLRS 282 (283)
T ss_pred -------HHHHHHHcCCcCCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHhhc
Confidence 1111111111122334456789999999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=305.03 Aligned_cols=249 Identities=27% Similarity=0.451 Sum_probs=194.0
Q ss_pred HHHHhcCccccceeccCce--------------------EEEEEee-cChhhHHHHHHHHHHHhhc-CCCCccceecccc
Q 044312 284 LEKATDNFDLNRILGQGGQ--------------------AVKKSKV-IDESKVEEFINEVVILSQI-NHRNVVKLLGCCL 341 (608)
Q Consensus 284 l~~~t~~f~~~~~lG~G~~--------------------avk~~~~-~~~~~~~~~~~Ei~il~~l-~H~niv~l~~~~~ 341 (608)
++...++|++.+.||+|++ |+|..+. .......++.+|+.+++++ +|+||+++++++.
T Consensus 7 ~~~~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~ 86 (293)
T cd05053 7 WELPRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGVCT 86 (293)
T ss_pred cccCHhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEc
Confidence 3344556788888898864 3333332 1233456789999999999 8999999999999
Q ss_pred cCccceEEEeecCCCccchhccccC-------------CCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcE
Q 044312 342 ETEVPLLVYEFIPNGTLFQYIHDQN-------------EDFPITWEIRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNI 408 (608)
Q Consensus 342 ~~~~~~lV~E~~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NI 408 (608)
+....+++|||+++|+|.++++... ....+++..++.++.|++.||+|||+.+ |+||||||+||
T Consensus 87 ~~~~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~---ivH~dlkp~Ni 163 (293)
T cd05053 87 QEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASKK---CIHRDLAARNV 163 (293)
T ss_pred CCCCeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHCC---ccccccceeeE
Confidence 9999999999999999999986421 1235899999999999999999999998 99999999999
Q ss_pred EEcCCCcEEEeeccCccccccCCcc-eeeeeeccCCCCChhhhccCCCCCccchHhHHHHHHHHHh-CCCCCCccchhhc
Q 044312 409 LLDDKYRAKVSDFGASRSMAVDQTH-MTTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLTELLT-GEKPIRFTILEED 486 (608)
Q Consensus 409 Ll~~~~~~kl~DFGls~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~ellt-g~~p~~~~~~~~~ 486 (608)
|+++++.+||+|||+++.+...... ......++..|+|||++....++.++||||||+++|||++ |..||......+
T Consensus 164 l~~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~- 242 (293)
T cd05053 164 LVTEDHVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEE- 242 (293)
T ss_pred EEcCCCeEEeCccccccccccccceeccCCCCCCccccCHHHhccCCcCcccceeehhhHHHHHhcCCCCCCCCCCHHH-
Confidence 9999999999999999876533221 1122335678999999999999999999999999999998 888886322111
Q ss_pred ccHHHHHHHHhhhhhhHHHhhhhhhccCChhHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhhH
Q 044312 487 KSLAAYFLCAMKEERLFEILDARVMKQGGKDEIITVAKLAKRCLNLNGKKRPTMREVASELAGIK 551 (608)
Q Consensus 487 ~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~evl~~L~~i~ 551 (608)
+.+.+........+...+..+.+|+.+||..+|++|||+.|+++.|+.+.
T Consensus 243 ---------------~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~eil~~l~~~~ 292 (293)
T cd05053 243 ---------------LFKLLKEGYRMEKPQNCTQELYHLMRDCWHEVPSQRPTFKQLVEDLDRML 292 (293)
T ss_pred ---------------HHHHHHcCCcCCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHHHHhh
Confidence 11111122222233455678999999999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-35 Score=300.74 Aligned_cols=241 Identities=22% Similarity=0.395 Sum_probs=186.6
Q ss_pred CccccceeccCce-------------------EEEEEeec-ChhhHHHHHHHHHHHhhcCCCCccceecccccCccceEE
Q 044312 290 NFDLNRILGQGGQ-------------------AVKKSKVI-DESKVEEFINEVVILSQINHRNVVKLLGCCLETEVPLLV 349 (608)
Q Consensus 290 ~f~~~~~lG~G~~-------------------avk~~~~~-~~~~~~~~~~Ei~il~~l~H~niv~l~~~~~~~~~~~lV 349 (608)
.|++.+.||+|++ ++|..... ......++..|+.++++++||||+++++++.. ...+++
T Consensus 8 ~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~~-~~~~~i 86 (279)
T cd05111 8 ELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRLLGICPG-ASLQLV 86 (279)
T ss_pred hceeccccCccCCcceEEEEEcCCCCceeeEEEEeecccccchHHHHHHHHHHHHHhcCCCCCcceEEEEECC-CccEEE
Confidence 4666788888874 22332211 12234678888889999999999999998854 457899
Q ss_pred EeecCCCccchhccccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEEcCCCcEEEeeccCcccccc
Q 044312 350 YEFIPNGTLFQYIHDQNEDFPITWEIRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAV 429 (608)
Q Consensus 350 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGls~~~~~ 429 (608)
+||+++|+|.+++..... .+++..++.++.||+.||+|||+.+ ++||||||+|||+++++.+||+|||+++....
T Consensus 87 ~e~~~~gsL~~~l~~~~~--~~~~~~~~~i~~qi~~~l~~lH~~~---iiH~dlkp~nili~~~~~~kl~Dfg~~~~~~~ 161 (279)
T cd05111 87 TQLSPLGSLLDHVRQHRD--SLDPQRLLNWCVQIAKGMYYLEEHR---MVHRNLAARNILLKSDSIVQIADFGVADLLYP 161 (279)
T ss_pred EEeCCCCcHHHHHHhccc--CCCHHHHHHHHHHHHHHHHHHHHCC---EeccccCcceEEEcCCCcEEEcCCccceeccC
Confidence 999999999999976433 5899999999999999999999998 99999999999999999999999999987643
Q ss_pred CCc-ceeeeeeccCCCCChhhhccCCCCCccchHhHHHHHHHHHh-CCCCCCccchhhcccHHHHHHHHhhhhhhHHHhh
Q 044312 430 DQT-HMTTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLTELLT-GEKPIRFTILEEDKSLAAYFLCAMKEERLFEILD 507 (608)
Q Consensus 430 ~~~-~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~ellt-g~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 507 (608)
... .......++..|+|||++.+..++.++||||||+++|||++ |+.||....... +.+++.
T Consensus 162 ~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~----------------~~~~~~ 225 (279)
T cd05111 162 DDKKYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPHE----------------VPDLLE 225 (279)
T ss_pred CCcccccCCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCCCCCHHH----------------HHHHHH
Confidence 322 12233456778999999999999999999999999999998 999986332211 111111
Q ss_pred hhhhccCChhHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhhHH
Q 044312 508 ARVMKQGGKDEIITVAKLAKRCLNLNGKKRPTMREVASELAGIKA 552 (608)
Q Consensus 508 ~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~evl~~L~~i~~ 552 (608)
.......+..++..+.+++.+||..+|++|||+.|+++.|..+..
T Consensus 226 ~~~~~~~~~~~~~~~~~li~~c~~~~p~~Rps~~el~~~l~~~~~ 270 (279)
T cd05111 226 KGERLAQPQICTIDVYMVMVKCWMIDENVRPTFKELANEFTRMAR 270 (279)
T ss_pred CCCcCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHh
Confidence 111112222345578899999999999999999999999988765
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-35 Score=302.35 Aligned_cols=221 Identities=27% Similarity=0.476 Sum_probs=178.9
Q ss_pred hhHHHHHHHHHHHhhcCCCCccceecccccCccceEEEeecCCCccchhccccC---------------------CCCCC
Q 044312 313 SKVEEFINEVVILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGTLFQYIHDQN---------------------EDFPI 371 (608)
Q Consensus 313 ~~~~~~~~Ei~il~~l~H~niv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~---------------------~~~~l 371 (608)
...+++.+|+.+++.++||||+++++.+...+..++++||+++++|.+++.... ...++
T Consensus 45 ~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 124 (290)
T cd05045 45 SELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERAL 124 (290)
T ss_pred HHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCCcEEEEEecCCCCHHHHHHhcCCccccccccccccccccccCcccccc
Confidence 345689999999999999999999999999999999999999999999876421 11258
Q ss_pred CHHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEEcCCCcEEEeeccCccccccCCcce-eeeeeccCCCCChhhh
Q 044312 372 TWEIRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHM-TTQVHGTFGYLDPEYF 450 (608)
Q Consensus 372 ~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGls~~~~~~~~~~-~~~~~gt~~y~aPE~~ 450 (608)
++..++.++.|++.||+|||+.+ ++||||||+|||+++++.+||+|||+++......... .....++..|+|||.+
T Consensus 125 ~~~~~~~i~~~i~~~l~~LH~~~---ivH~dikp~nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~ 201 (290)
T cd05045 125 TMGDLISFAWQISRGMQYLAEMK---LVHRDLAARNVLVAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESL 201 (290)
T ss_pred CHHHHHHHHHHHHHHHHHHHHCC---eehhhhhhheEEEcCCCcEEeccccccccccCccchhcccCCCCCccccCHHHH
Confidence 89999999999999999999998 9999999999999999999999999998654332211 1223456789999999
Q ss_pred ccCCCCCccchHhHHHHHHHHHh-CCCCCCccchhhcccHHHHHHHHhhhhhhHHHhhhhhhccCChhHHHHHHHHHHHH
Q 044312 451 RSSQFTDKSDVYSFGVVLTELLT-GEKPIRFTILEEDKSLAAYFLCAMKEERLFEILDARVMKQGGKDEIITVAKLAKRC 529 (608)
Q Consensus 451 ~~~~~t~ksDV~S~Gvvl~ellt-g~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~Li~~c 529 (608)
.+..++.++||||||++++||++ |..||.....+ .+.+.+........+...+.++.+++.+|
T Consensus 202 ~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~----------------~~~~~~~~~~~~~~~~~~~~~~~~~i~~c 265 (290)
T cd05045 202 FDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIAPE----------------RLFNLLKTGYRMERPENCSEEMYNLMLTC 265 (290)
T ss_pred ccCCcchHhHHHHHHHHHHHHHhcCCCCCCCCCHH----------------HHHHHHhCCCCCCCCCCCCHHHHHHHHHH
Confidence 98899999999999999999999 99998632211 11122222222223345567899999999
Q ss_pred hccCCCCCCCHHHHHHHHHhhHH
Q 044312 530 LNLNGKKRPTMREVASELAGIKA 552 (608)
Q Consensus 530 l~~dp~~RPs~~evl~~L~~i~~ 552 (608)
|+.+|++||++.|+++.|+.+-.
T Consensus 266 l~~~P~~Rp~~~~i~~~l~~~~~ 288 (290)
T cd05045 266 WKQEPDKRPTFADISKELEKMMV 288 (290)
T ss_pred ccCCcccCCCHHHHHHHHHHHHh
Confidence 99999999999999999988754
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-35 Score=297.74 Aligned_cols=229 Identities=25% Similarity=0.436 Sum_probs=179.3
Q ss_pred EEEEEeec--ChhhHHHHHHHHHHHhhcCCCCccceecccccCcc------ceEEEeecCCCccchhccccC---CCCCC
Q 044312 303 AVKKSKVI--DESKVEEFINEVVILSQINHRNVVKLLGCCLETEV------PLLVYEFIPNGTLFQYIHDQN---EDFPI 371 (608)
Q Consensus 303 avk~~~~~--~~~~~~~~~~Ei~il~~l~H~niv~l~~~~~~~~~------~~lV~E~~~~gsL~~~l~~~~---~~~~l 371 (608)
|+|+++.. .....+.+.+|+.+++.++|+||+++++++.+... .+++|||+++++|..++.... ....+
T Consensus 31 aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~ 110 (273)
T cd05035 31 AVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKL 110 (273)
T ss_pred EEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccCcccEEEEeccCCCCHHHHHHHhhccCCcccC
Confidence 66665532 23456789999999999999999999998876554 799999999999999885432 22358
Q ss_pred CHHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEEcCCCcEEEeeccCccccccCCccee-eeeeccCCCCChhhh
Q 044312 372 TWEIRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMT-TQVHGTFGYLDPEYF 450 (608)
Q Consensus 372 ~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGls~~~~~~~~~~~-~~~~gt~~y~aPE~~ 450 (608)
++..+..++.|++.||+|||+.+ ++||||||+|||+++++.+||+|||+++.......... ....++..|+|||++
T Consensus 111 ~~~~~~~~~~~i~~aL~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~ 187 (273)
T cd05035 111 PLQTLLKFMVDIALGMEYLSNRN---FIHRDLAARNCMLREDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESL 187 (273)
T ss_pred CHHHHHHHHHHHHHHHHHHHhCC---eeccccchheEEECCCCeEEECCccceeeccccccccccccccCCccccCHhhc
Confidence 99999999999999999999998 99999999999999999999999999987653322211 122346789999999
Q ss_pred ccCCCCCccchHhHHHHHHHHHh-CCCCCCccchhhcccHHHHHHHHhhhhhhHHHhhhhhhccCChhHHHHHHHHHHHH
Q 044312 451 RSSQFTDKSDVYSFGVVLTELLT-GEKPIRFTILEEDKSLAAYFLCAMKEERLFEILDARVMKQGGKDEIITVAKLAKRC 529 (608)
Q Consensus 451 ~~~~~t~ksDV~S~Gvvl~ellt-g~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~Li~~c 529 (608)
....++.++||||||++++||++ |..||...... . +.+.+........+...+.++.+++.+|
T Consensus 188 ~~~~~~~~~Dv~SlG~il~el~~~g~~p~~~~~~~------~----------~~~~~~~~~~~~~~~~~~~~~~~li~~~ 251 (273)
T cd05035 188 ADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVENH------E----------IYDYLRHGNRLKQPEDCLDELYDLMYSC 251 (273)
T ss_pred ccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHH------H----------HHHHHHcCCCCCCCcCCCHHHHHHHHHH
Confidence 98899999999999999999999 88888532211 0 0111111111122344567899999999
Q ss_pred hccCCCCCCCHHHHHHHHHhh
Q 044312 530 LNLNGKKRPTMREVASELAGI 550 (608)
Q Consensus 530 l~~dp~~RPs~~evl~~L~~i 550 (608)
|+.||++||++.||++.|+.+
T Consensus 252 l~~~p~~Rp~~~e~~~~l~~~ 272 (273)
T cd05035 252 WRADPKDRPTFTKLREVLENI 272 (273)
T ss_pred cCCChhhCcCHHHHHHHHHhh
Confidence 999999999999999999765
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-35 Score=301.46 Aligned_cols=240 Identities=27% Similarity=0.424 Sum_probs=188.0
Q ss_pred CccccceeccCce--------------------EEEEEeecChhhHHHHHHHHHHHhhcCCCCccceecccccCccceEE
Q 044312 290 NFDLNRILGQGGQ--------------------AVKKSKVIDESKVEEFINEVVILSQINHRNVVKLLGCCLETEVPLLV 349 (608)
Q Consensus 290 ~f~~~~~lG~G~~--------------------avk~~~~~~~~~~~~~~~Ei~il~~l~H~niv~l~~~~~~~~~~~lV 349 (608)
+++..++||+|++ |+|..........+.|.+|+++++.++|+||+++++++.+....+++
T Consensus 6 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 85 (280)
T cd05092 6 DIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRFYGVCTEGRPLLMV 85 (280)
T ss_pred hceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcCCHHHHHHHHHHHHHHhcCCCCCCceEEEEEecCCceEEE
Confidence 4566777777764 33444444445567899999999999999999999999999999999
Q ss_pred EeecCCCccchhccccCC------------CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEEcCCCcEE
Q 044312 350 YEFIPNGTLFQYIHDQNE------------DFPITWEIRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAK 417 (608)
Q Consensus 350 ~E~~~~gsL~~~l~~~~~------------~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~k 417 (608)
|||+++++|.+++..... ...+++..++.++.|++.||+|||+.+ ++||||||+|||+++++.+|
T Consensus 86 ~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~---i~H~dlkp~nil~~~~~~~k 162 (280)
T cd05092 86 FEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASLH---FVHRDLATRNCLVGQGLVVK 162 (280)
T ss_pred EecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHCC---eecccccHhhEEEcCCCCEE
Confidence 999999999999876431 124889999999999999999999999 99999999999999999999
Q ss_pred EeeccCccccccCCcce-eeeeeccCCCCChhhhccCCCCCccchHhHHHHHHHHHh-CCCCCCccchhhcccHHHHHHH
Q 044312 418 VSDFGASRSMAVDQTHM-TTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLTELLT-GEKPIRFTILEEDKSLAAYFLC 495 (608)
Q Consensus 418 l~DFGls~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~ellt-g~~p~~~~~~~~~~~l~~~~~~ 495 (608)
|+|||+++......... .....+++.|+|||++.+..++.++||||||++++||++ |+.||......+
T Consensus 163 L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~---------- 232 (280)
T cd05092 163 IGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSNTE---------- 232 (280)
T ss_pred ECCCCceeEcCCCceeecCCCccccccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCccCCHHH----------
Confidence 99999997654322111 122235678999999999999999999999999999998 889985322111
Q ss_pred HhhhhhhHHHhhhhhhccCChhHHHHHHHHHHHHhccCCCCCCCHHHHHHHHH
Q 044312 496 AMKEERLFEILDARVMKQGGKDEIITVAKLAKRCLNLNGKKRPTMREVASELA 548 (608)
Q Consensus 496 ~~~~~~~~~~~d~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~evl~~L~ 548 (608)
..+.+........+...+..+.+|+.+||+.||.+||++.||++.|+
T Consensus 233 ------~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~l~~~l~ 279 (280)
T cd05092 233 ------AIECITQGRELERPRTCPPEVYAIMQGCWQREPQQRMVIKDIHSRLQ 279 (280)
T ss_pred ------HHHHHHcCccCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHh
Confidence 00111111111223345667999999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-35 Score=318.87 Aligned_cols=237 Identities=26% Similarity=0.479 Sum_probs=202.5
Q ss_pred cceeccCce-------------------EEEEEee-cChhhHHHHHHHHHHHhhcCCCCccceecccccCccceEEEeec
Q 044312 294 NRILGQGGQ-------------------AVKKSKV-IDESKVEEFINEVVILSQINHRNVVKLLGCCLETEVPLLVYEFI 353 (608)
Q Consensus 294 ~~~lG~G~~-------------------avk~~~~-~~~~~~~~~~~Ei~il~~l~H~niv~l~~~~~~~~~~~lV~E~~ 353 (608)
.++||+|+| |+|.+.. ......++|+.|+-+|.+|+|||+++|+|+|.... +.||++||
T Consensus 701 ~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~-~qlvtq~m 779 (1177)
T KOG1025|consen 701 DKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTSPKASIELLDEALRMASLDHPNLLRLLGVCMLST-LQLVTQLM 779 (1177)
T ss_pred hceeccccceeEEeeeEecCCceecceeEEEEeeccCCchhhHHHHHHHHHHhcCCCchHHHHhhhcccch-HHHHHHhc
Confidence 688999975 5555543 23345688999999999999999999999998776 88999999
Q ss_pred CCCccchhccccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEEcCCCcEEEeeccCccccccCCcc
Q 044312 354 PNGTLFQYIHDQNEDFPITWEIRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTH 433 (608)
Q Consensus 354 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGls~~~~~~~~~ 433 (608)
+.|+|.++++.++. .+-.+..+.|..|||+||.|||.+. ++||||.++|||+..-..+||.|||+++.+..+...
T Consensus 780 P~G~LlDyvr~hr~--~igsq~lLnw~~QIAkgM~YLe~qr---lVHrdLaaRNVLVksP~hvkitdfgla~ll~~d~~e 854 (1177)
T KOG1025|consen 780 PLGCLLDYVREHRD--NIGSQDLLNWCYQIAKGMKYLEEQR---LVHRDLAARNVLVKSPNHVKITDFGLAKLLAPDEKE 854 (1177)
T ss_pred ccchHHHHHHHhhc--cccHHHHHHHHHHHHHHHHHHHhcc---hhhhhhhhhheeecCCCeEEEEecchhhccCccccc
Confidence 99999999998655 5888999999999999999999998 999999999999999999999999999998876654
Q ss_pred eeee-eeccCCCCChhhhccCCCCCccchHhHHHHHHHHHh-CCCCCCccchhhcccHHHHHHHHhhhhhhHHHhhhhhh
Q 044312 434 MTTQ-VHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLTELLT-GEKPIRFTILEEDKSLAAYFLCAMKEERLFEILDARVM 511 (608)
Q Consensus 434 ~~~~-~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~ellt-g~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~ 511 (608)
.... ..-.+.|||-|.+....++.+||||||||.+|||+| |.+|+... ....+.+++....+
T Consensus 855 y~~~~gK~pikwmale~i~~~~~thqSDVWsfGVtiWElmTFGa~Py~gi----------------~~~eI~dlle~geR 918 (1177)
T KOG1025|consen 855 YSAPGGKVPIKWMALESIRIRKYTHQSDVWSFGVTIWELMTFGAKPYDGI----------------PAEEIPDLLEKGER 918 (1177)
T ss_pred ccccccccCcHHHHHHHhhccCCCchhhhhhhhhhHHHHHhcCCCccCCC----------------CHHHhhHHHhcccc
Confidence 4333 334568999999999999999999999999999999 99998632 33345556666666
Q ss_pred ccCChhHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhhHH
Q 044312 512 KQGGKDEIITVAKLAKRCLNLNGKKRPTMREVASELAGIKA 552 (608)
Q Consensus 512 ~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~evl~~L~~i~~ 552 (608)
...+.-++.++..++.+||..|++.||+++++..++.++-.
T Consensus 919 LsqPpiCtiDVy~~mvkCwmid~~~rp~fkel~~~fs~~ar 959 (1177)
T KOG1025|consen 919 LSQPPICTIDVYMVMVKCWMIDADSRPTFKELAEEFSRMAR 959 (1177)
T ss_pred CCCCCCccHHHHHHHHHHhccCcccCccHHHHHHHHHHHhc
Confidence 67788899999999999999999999999999998877644
|
|
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-35 Score=301.46 Aligned_cols=241 Identities=28% Similarity=0.414 Sum_probs=181.4
Q ss_pred EEEEEeecC-hhhHHHHHHHHHHHhhcCCCCccceecccccC--ccceEEEeecCCCccchhccccCCCCCCCHHHHHHH
Q 044312 303 AVKKSKVID-ESKVEEFINEVVILSQINHRNVVKLLGCCLET--EVPLLVYEFIPNGTLFQYIHDQNEDFPITWEIRLRI 379 (608)
Q Consensus 303 avk~~~~~~-~~~~~~~~~Ei~il~~l~H~niv~l~~~~~~~--~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i 379 (608)
|+|..+... ....+.|.+|+++|++++||||+++++++... ...++||||+++++|.+++... .+++..++.+
T Consensus 37 aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~----~l~~~~~~~i 112 (283)
T cd05080 37 AVKTLKRECGQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKGLQLIMEYVPLGSLRDYLPKH----KLNLAQLLLF 112 (283)
T ss_pred EEEEeccccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCceEEEEecCCCCCCHHHHHHHc----CCCHHHHHHH
Confidence 445444322 23456789999999999999999999987653 3578999999999999998653 4899999999
Q ss_pred HHHHHHHHHHHhhcCCCCeeccCCCCCcEEEcCCCcEEEeeccCccccccCCcce--eeeeeccCCCCChhhhccCCCCC
Q 044312 380 AIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHM--TTQVHGTFGYLDPEYFRSSQFTD 457 (608)
Q Consensus 380 ~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGls~~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~t~ 457 (608)
+.|++.||.|||+.+ |+||||||+|||+++++.+||+|||+++......... .....++..|+|||.+....++.
T Consensus 113 ~~~l~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~ 189 (283)
T cd05080 113 AQQICEGMAYLHSQH---YIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAVECLKENKFSY 189 (283)
T ss_pred HHHHHHHHHHHHHCC---eeccccChheEEEcCCCcEEEeecccccccCCcchhhccCCCCCCCceeeCHhHhcccCCCc
Confidence 999999999999999 9999999999999999999999999998765322211 12223566799999999889999
Q ss_pred ccchHhHHHHHHHHHhCCCCCCccchhhcccHHHHHHHHhhhhhhHHHhhhhhhccCChhHHHHHHHHHHHHhccCCCCC
Q 044312 458 KSDVYSFGVVLTELLTGEKPIRFTILEEDKSLAAYFLCAMKEERLFEILDARVMKQGGKDEIITVAKLAKRCLNLNGKKR 537 (608)
Q Consensus 458 ksDV~S~Gvvl~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~Li~~cl~~dp~~R 537 (608)
++||||||++++||+||..|+........ ..............+.+.++.......+...+.++.+++.+||+.+|++|
T Consensus 190 ~~Di~slG~~l~el~tg~~p~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~R 268 (283)
T cd05080 190 ASDVWSFGVTLYELLTHCDSKQSPPKKFE-EMIGPKQGQMTVVRLIELLERGMRLPCPKNCPQEVYILMKNCWETEAKFR 268 (283)
T ss_pred ccccHHHHHHHHHHHhCCCCCCCCcchhh-hhhcccccccchhhhhhhhhcCCCCCCCCCCCHHHHHHHHHHhccChhhC
Confidence 99999999999999999999763221100 00000000111112222222222223344556789999999999999999
Q ss_pred CCHHHHHHHHHhhH
Q 044312 538 PTMREVASELAGIK 551 (608)
Q Consensus 538 Ps~~evl~~L~~i~ 551 (608)
||+++|++.|+.+.
T Consensus 269 ps~~~i~~~l~~~~ 282 (283)
T cd05080 269 PTFRSLIPILKEMH 282 (283)
T ss_pred CCHHHHHHHHHHhh
Confidence 99999999998764
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=304.70 Aligned_cols=251 Identities=23% Similarity=0.306 Sum_probs=185.5
Q ss_pred cCccccceeccCce---------------EEEEEeecC-hhhHHHHHHHHHHHhhcCCCCccceecccccCccceEEEee
Q 044312 289 DNFDLNRILGQGGQ---------------AVKKSKVID-ESKVEEFINEVVILSQINHRNVVKLLGCCLETEVPLLVYEF 352 (608)
Q Consensus 289 ~~f~~~~~lG~G~~---------------avk~~~~~~-~~~~~~~~~Ei~il~~l~H~niv~l~~~~~~~~~~~lV~E~ 352 (608)
++|.+.++||.|++ |+|..+... ......+.+|+.++++++||||+++++++.+....++||||
T Consensus 5 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 84 (288)
T cd07871 5 ETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDIIHTERCLTLVFEY 84 (288)
T ss_pred ccceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccccCCcchhHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEEeC
Confidence 45888889999874 666655322 23345788999999999999999999999998899999999
Q ss_pred cCCCccchhccccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEEcCCCcEEEeeccCccccccCCc
Q 044312 353 IPNGTLFQYIHDQNEDFPITWEIRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQT 432 (608)
Q Consensus 353 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGls~~~~~~~~ 432 (608)
+++ +|.+++..... .+++..+..++.||+.||+|||+.+ |+||||||+|||+++++.+||+|||+++.......
T Consensus 85 ~~~-~l~~~l~~~~~--~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~~~~~ 158 (288)
T cd07871 85 LDS-DLKQYLDNCGN--LMSMHNVKIFMFQLLRGLSYCHKRK---ILHRDLKPQNLLINEKGELKLADFGLARAKSVPTK 158 (288)
T ss_pred CCc-CHHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEECcCcceeeccCCCc
Confidence 975 89888875433 4789999999999999999999999 99999999999999999999999999976543221
Q ss_pred ceeeeeeccCCCCChhhhcc-CCCCCccchHhHHHHHHHHHhCCCCCCccchhhcccHHHHHHHHhhhh---------hh
Q 044312 433 HMTTQVHGTFGYLDPEYFRS-SQFTDKSDVYSFGVVLTELLTGEKPIRFTILEEDKSLAAYFLCAMKEE---------RL 502 (608)
Q Consensus 433 ~~~~~~~gt~~y~aPE~~~~-~~~t~ksDV~S~Gvvl~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~---------~~ 502 (608)
......+++.|+|||.+.+ ..++.++||||||++++||+||+.||......+............... ..
T Consensus 159 -~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (288)
T cd07871 159 -TYSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLIFRLLGTPTEETWPGITSNEEF 237 (288)
T ss_pred -cccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhccccchhh
Confidence 1233457899999999865 568999999999999999999999997443222111100000000000 00
Q ss_pred HHHhhhhhh----ccCChhHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 044312 503 FEILDARVM----KQGGKDEIITVAKLAKRCLNLNGKKRPTMREVASE 546 (608)
Q Consensus 503 ~~~~d~~~~----~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~evl~~ 546 (608)
.....+... .......+.+..+|+.+||+.||.+|||++|++++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~h 285 (288)
T cd07871 238 RSYLFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALRH 285 (288)
T ss_pred hccccCccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHhcC
Confidence 111111000 00111234678899999999999999999999853
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-36 Score=308.29 Aligned_cols=233 Identities=27% Similarity=0.433 Sum_probs=195.1
Q ss_pred cCccccceeccCce---------------EEEEEee--cChhhHHHHHHHHHHHhhcCCCCccceecccccCccceEEEe
Q 044312 289 DNFDLNRILGQGGQ---------------AVKKSKV--IDESKVEEFINEVVILSQINHRNVVKLLGCCLETEVPLLVYE 351 (608)
Q Consensus 289 ~~f~~~~~lG~G~~---------------avk~~~~--~~~~~~~~~~~Ei~il~~l~H~niv~l~~~~~~~~~~~lV~E 351 (608)
++|.+.+.||+|.| |+|.+.. ..+.+.+.+.+|++|++.|+|||||.++++|+...+.++|.|
T Consensus 2 e~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~~~~vVte 81 (808)
T KOG0597|consen 2 EQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLESFETSAHLWVVTE 81 (808)
T ss_pred cchhHHHHhcCCccceeeecccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHhhcccceEEEEeh
Confidence 45777788888864 5555433 234556779999999999999999999999999999999999
Q ss_pred ecCCCccchhccccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEEcCCCcEEEeeccCccccccCC
Q 044312 352 FIPNGTLFQYIHDQNEDFPITWEIRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQ 431 (608)
Q Consensus 352 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGls~~~~~~~ 431 (608)
|+.| +|..+|.... .++++.+..|+.++..||.|||++. |+|||+||.|||++.++++|++|||+|+.+.. .
T Consensus 82 ~a~g-~L~~il~~d~---~lpEe~v~~~a~~LVsaL~yLhs~r---ilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~~-~ 153 (808)
T KOG0597|consen 82 YAVG-DLFTILEQDG---KLPEEQVRAIAYDLVSALYYLHSNR---ILHRDMKPQNILLEKGGTLKLCDFGLARAMST-N 153 (808)
T ss_pred hhhh-hHHHHHHhcc---CCCHHHHHHHHHHHHHHHHHHHhcC---cccccCCcceeeecCCCceeechhhhhhhccc-C
Confidence 9976 9999998654 4999999999999999999999999 99999999999999999999999999998775 3
Q ss_pred cceeeeeeccCCCCChhhhccCCCCCccchHhHHHHHHHHHhCCCCCCccchhhcccHHHHHHHHhhhhhhHHHhhhhhh
Q 044312 432 THMTTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLTELLTGEKPIRFTILEEDKSLAAYFLCAMKEERLFEILDARVM 511 (608)
Q Consensus 432 ~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~ 511 (608)
+...+.+.|||.|||||.+.++.|+..+|+||+|||+||+.+|++||.. .+....+.....+.
T Consensus 154 t~vltsikGtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~G~PPF~a------~si~~Lv~~I~~d~----------- 216 (808)
T KOG0597|consen 154 TSVLTSIKGTPLYMAPELVEEQPYDHTSDLWSLGCILYELYVGQPPFYA------RSITQLVKSILKDP----------- 216 (808)
T ss_pred ceeeeeccCcccccCHHHHcCCCccchhhHHHHHHHHHHHhcCCCCchH------HHHHHHHHHHhcCC-----------
Confidence 4567788999999999999999999999999999999999999999862 11111111111111
Q ss_pred ccCChhHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 044312 512 KQGGKDEIITVAKLAKRCLNLNGKKRPTMREVASE 546 (608)
Q Consensus 512 ~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~evl~~ 546 (608)
...+...+..+..++...|..||.+|.+..+++.+
T Consensus 217 v~~p~~~S~~f~nfl~gLL~kdP~~RltW~~Ll~H 251 (808)
T KOG0597|consen 217 VKPPSTASSSFVNFLQGLLIKDPAQRLTWTDLLGH 251 (808)
T ss_pred CCCcccccHHHHHHHHHHhhcChhhcccHHHHhcC
Confidence 12334667789999999999999999999998875
|
|
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-35 Score=296.53 Aligned_cols=239 Identities=28% Similarity=0.429 Sum_probs=187.2
Q ss_pred cCccccceeccCce--------------EEEEEeecChhhHHHHHHHHHHHhhcCCCCccceecccccCccceEEEeecC
Q 044312 289 DNFDLNRILGQGGQ--------------AVKKSKVIDESKVEEFINEVVILSQINHRNVVKLLGCCLETEVPLLVYEFIP 354 (608)
Q Consensus 289 ~~f~~~~~lG~G~~--------------avk~~~~~~~~~~~~~~~Ei~il~~l~H~niv~l~~~~~~~~~~~lV~E~~~ 354 (608)
++|++.++||+|++ |+|..+.. ....+.|.+|+.++++++|+|++++++++. ....+++|||++
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~k~~~~~-~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv~e~~~ 83 (260)
T cd05070 6 ESLQLIKKLGNGQFGEVWMGTWNGNTKVAVKTLKPG-TMSPESFLEEAQIMKKLRHDKLVQLYAVVS-EEPIYIVTEYMS 83 (260)
T ss_pred HHhhhhheeccccCceEEEEEecCCceeEEEEecCC-CCCHHHHHHHHHHHHhcCCCceEEEEeEEC-CCCcEEEEEecC
Confidence 45777888888864 45554432 224567999999999999999999999875 456789999999
Q ss_pred CCccchhccccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEEcCCCcEEEeeccCccccccCCcce
Q 044312 355 NGTLFQYIHDQNEDFPITWEIRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHM 434 (608)
Q Consensus 355 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGls~~~~~~~~~~ 434 (608)
+++|.++++.... ..+++..+..++.+++.||+|||+.+ ++||||||+|||+++++.+||+|||++..........
T Consensus 84 ~~~L~~~~~~~~~-~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~di~p~Nili~~~~~~~l~dfg~~~~~~~~~~~~ 159 (260)
T cd05070 84 KGSLLDFLKDGEG-RALKLPNLVDMAAQVAAGMAYIERMN---YIHRDLRSANILVGDGLVCKIADFGLARLIEDNEYTA 159 (260)
T ss_pred CCcHHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCccceEEEeCCceEEeCCceeeeeccCccccc
Confidence 9999999976432 25899999999999999999999999 9999999999999999999999999998664332222
Q ss_pred eeeeeccCCCCChhhhccCCCCCccchHhHHHHHHHHHh-CCCCCCccchhhcccHHHHHHHHhhhhhhHHHhhhhhhcc
Q 044312 435 TTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLTELLT-GEKPIRFTILEEDKSLAAYFLCAMKEERLFEILDARVMKQ 513 (608)
Q Consensus 435 ~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~ellt-g~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~ 513 (608)
.....++..|+|||++....++.++||||||++++||++ |..||......+ ..+.+......+
T Consensus 160 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~----------------~~~~~~~~~~~~ 223 (260)
T cd05070 160 RQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNNRE----------------VLEQVERGYRMP 223 (260)
T ss_pred ccCCCCCccccChHHHhcCCCcchhhhHHHHHHHHHHHhcCCCCCCCCCHHH----------------HHHHHHcCCCCC
Confidence 222335668999999998899999999999999999999 888886321110 011111111122
Q ss_pred CChhHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHh
Q 044312 514 GGKDEIITVAKLAKRCLNLNGKKRPTMREVASELAG 549 (608)
Q Consensus 514 ~~~~~~~~l~~Li~~cl~~dp~~RPs~~evl~~L~~ 549 (608)
.+...+..+.+|+.+||..+|++|||+.++.+.|+.
T Consensus 224 ~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~ 259 (260)
T cd05070 224 CPQDCPISLHELMLQCWKKDPEERPTFEYLQSFLED 259 (260)
T ss_pred CCCcCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence 334556789999999999999999999999988864
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=311.05 Aligned_cols=231 Identities=26% Similarity=0.353 Sum_probs=186.9
Q ss_pred cCccccceeccCce---------------EEEEEeec---ChhhHHHHHHHHHHHhhcCCCCccceecccccCccceEEE
Q 044312 289 DNFDLNRILGQGGQ---------------AVKKSKVI---DESKVEEFINEVVILSQINHRNVVKLLGCCLETEVPLLVY 350 (608)
Q Consensus 289 ~~f~~~~~lG~G~~---------------avk~~~~~---~~~~~~~~~~Ei~il~~l~H~niv~l~~~~~~~~~~~lV~ 350 (608)
++|++.+.||+|++ |+|..+.. .....+.+.+|+.++++++||||+++++++.+.+..++||
T Consensus 18 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 97 (329)
T PTZ00263 18 SDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENRVYFLL 97 (329)
T ss_pred hheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcCCEEEEEE
Confidence 46888999999974 66665432 2234567899999999999999999999999999999999
Q ss_pred eecCCCccchhccccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEEcCCCcEEEeeccCccccccC
Q 044312 351 EFIPNGTLFQYIHDQNEDFPITWEIRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVD 430 (608)
Q Consensus 351 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGls~~~~~~ 430 (608)
||+++|+|.+++.... .+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++.....
T Consensus 98 e~~~~~~L~~~l~~~~---~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~ 171 (329)
T PTZ00263 98 EFVVGGELFTHLRKAG---RFPNDVAKFYHAELVLAFEYLHSKD---IIYRDLKPENLLLDNKGHVKVTDFGFAKKVPDR 171 (329)
T ss_pred cCCCCChHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHEEECCCCCEEEeeccCceEcCCC
Confidence 9999999999987643 4889999999999999999999999 999999999999999999999999999865432
Q ss_pred CcceeeeeeccCCCCChhhhccCCCCCccchHhHHHHHHHHHhCCCCCCccchhhcccHHHHHHHHhhhhhhHHHhhhhh
Q 044312 431 QTHMTTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLTELLTGEKPIRFTILEEDKSLAAYFLCAMKEERLFEILDARV 510 (608)
Q Consensus 431 ~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~ 510 (608)
. ....||+.|+|||++.+..++.++|||||||++|||++|+.||...... .. .. .+....
T Consensus 172 ~----~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~------~~-~~--------~i~~~~- 231 (329)
T PTZ00263 172 T----FTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDTPF------RI-YE--------KILAGR- 231 (329)
T ss_pred c----ceecCChhhcCHHHHcCCCCCCcceeechHHHHHHHHcCCCCCCCCCHH------HH-HH--------HHhcCC-
Confidence 1 2356899999999999999999999999999999999999998632211 00 01 111111
Q ss_pred hccCChhHHHHHHHHHHHHhccCCCCCCC-----HHHHHHH
Q 044312 511 MKQGGKDEIITVAKLAKRCLNLNGKKRPT-----MREVASE 546 (608)
Q Consensus 511 ~~~~~~~~~~~l~~Li~~cl~~dp~~RPs-----~~evl~~ 546 (608)
...+...+.++.+|+.+||+.||.+||+ +++++++
T Consensus 232 -~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~h 271 (329)
T PTZ00263 232 -LKFPNWFDGRARDLVKGLLQTDHTKRLGTLKGGVADVKNH 271 (329)
T ss_pred -cCCCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcC
Confidence 1122334567899999999999999997 5776654
|
|
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=310.05 Aligned_cols=221 Identities=24% Similarity=0.299 Sum_probs=179.0
Q ss_pred eEEEEEeec---ChhhHHHHHHHHHHHhhcCCCCccceecccccCccceEEEeecCCCccchhccccCCCCCCCHHHHHH
Q 044312 302 QAVKKSKVI---DESKVEEFINEVVILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEIRLR 378 (608)
Q Consensus 302 ~avk~~~~~---~~~~~~~~~~Ei~il~~l~H~niv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~ 378 (608)
+|+|.++.. .......+.+|+.++++++||||+++++++.+.+..++||||+++++|.+++.... .+++..+..
T Consensus 23 ~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~ 99 (323)
T cd05571 23 YAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRER---VFSEDRARF 99 (323)
T ss_pred EEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEeCCCCCcHHHHHHHcC---CCCHHHHHH
Confidence 477766532 33455678899999999999999999999999999999999999999999887643 589999999
Q ss_pred HHHHHHHHHHHHhhcCCCCeeccCCCCCcEEEcCCCcEEEeeccCccccccCCcceeeeeeccCCCCChhhhccCCCCCc
Q 044312 379 IAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHGTFGYLDPEYFRSSQFTDK 458 (608)
Q Consensus 379 i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGls~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k 458 (608)
++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++...... .......||+.|+|||++.+..++.+
T Consensus 100 ~~~qi~~~L~~lH~~~---ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~ 175 (323)
T cd05571 100 YGAEIVSALGYLHSCD---VVYRDLKLENLMLDKDGHIKITDFGLCKEGISDG-ATMKTFCGTPEYLAPEVLEDNDYGRA 175 (323)
T ss_pred HHHHHHHHHHHHHhCC---eEeCCCCHHHEEECCCCCEEEeeCCCCcccccCC-CcccceecCccccChhhhcCCCCCcc
Confidence 9999999999999999 9999999999999999999999999987543221 22334569999999999999999999
Q ss_pred cchHhHHHHHHHHHhCCCCCCccchhhcccHHHHHHHHhhhhhhHHHhhhhhhccCChhHHHHHHHHHHHHhccCCCCCC
Q 044312 459 SDVYSFGVVLTELLTGEKPIRFTILEEDKSLAAYFLCAMKEERLFEILDARVMKQGGKDEIITVAKLAKRCLNLNGKKRP 538 (608)
Q Consensus 459 sDV~S~Gvvl~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RP 538 (608)
+|||||||+++||++|+.||....... ... .+... ....+...+.++.+|+.+||+.||++||
T Consensus 176 ~DiwSlG~il~elltg~~Pf~~~~~~~------~~~-~~~~~----------~~~~p~~~~~~~~~li~~~L~~dP~~R~ 238 (323)
T cd05571 176 VDWWGLGVVMYEMMCGRLPFYNQDHEK------LFE-LILME----------EIRFPRTLSPEAKSLLAGLLKKDPKQRL 238 (323)
T ss_pred ccCcccchhhhhhhcCCCCCCCCCHHH------HHH-HHHcC----------CCCCCCCCCHHHHHHHHHHccCCHHHcC
Confidence 999999999999999999986322111 000 00000 0122334567899999999999999999
Q ss_pred -----CHHHHHHH
Q 044312 539 -----TMREVASE 546 (608)
Q Consensus 539 -----s~~evl~~ 546 (608)
++.|++++
T Consensus 239 ~~~~~~~~~ll~h 251 (323)
T cd05571 239 GGGPEDAKEIMEH 251 (323)
T ss_pred CCCCCCHHHHHcC
Confidence 78888764
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-35 Score=304.65 Aligned_cols=249 Identities=26% Similarity=0.447 Sum_probs=194.1
Q ss_pred hcCccccceeccCceE----------------------EEEEeec-ChhhHHHHHHHHHHHhhc-CCCCccceecccccC
Q 044312 288 TDNFDLNRILGQGGQA----------------------VKKSKVI-DESKVEEFINEVVILSQI-NHRNVVKLLGCCLET 343 (608)
Q Consensus 288 t~~f~~~~~lG~G~~a----------------------vk~~~~~-~~~~~~~~~~Ei~il~~l-~H~niv~l~~~~~~~ 343 (608)
.++|.+.+.||+|+|. +|..+.. ......++.+|+.+++.+ +|+||+++++++...
T Consensus 17 ~~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~ 96 (307)
T cd05098 17 RDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQD 96 (307)
T ss_pred hHHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCCChHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecC
Confidence 3578899999999752 2222211 133456788999999999 799999999999999
Q ss_pred ccceEEEeecCCCccchhccccCC-------------CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEE
Q 044312 344 EVPLLVYEFIPNGTLFQYIHDQNE-------------DFPITWEIRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILL 410 (608)
Q Consensus 344 ~~~~lV~E~~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl 410 (608)
...++||||+++|+|.+++..... ...+++.++++++.|++.||+|||+.+ ++||||||+|||+
T Consensus 97 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~g---i~H~dlkp~Nill 173 (307)
T cd05098 97 GPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASKK---CIHRDLAARNVLV 173 (307)
T ss_pred CceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCC---cccccccHHheEE
Confidence 999999999999999999976421 124899999999999999999999998 9999999999999
Q ss_pred cCCCcEEEeeccCccccccCCcc-eeeeeeccCCCCChhhhccCCCCCccchHhHHHHHHHHHh-CCCCCCccchhhccc
Q 044312 411 DDKYRAKVSDFGASRSMAVDQTH-MTTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLTELLT-GEKPIRFTILEEDKS 488 (608)
Q Consensus 411 ~~~~~~kl~DFGls~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~ellt-g~~p~~~~~~~~~~~ 488 (608)
++++.+||+|||+++........ ......++..|+|||.+.+..++.++||||||++++||++ |..||.....+
T Consensus 174 ~~~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~~g~~p~~~~~~~---- 249 (307)
T cd05098 174 TEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVE---- 249 (307)
T ss_pred cCCCcEEECCCcccccccccchhhccccCCCccceeChHHhccCCCCcHHHHHHHHHHHHHHHcCCCCCCCcCCHH----
Confidence 99999999999998765432211 1122234568999999999999999999999999999998 88887532211
Q ss_pred HHHHHHHHhhhhhhHHHhhhhhhccCChhHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhhHHhcC
Q 044312 489 LAAYFLCAMKEERLFEILDARVMKQGGKDEIITVAKLAKRCLNLNGKKRPTMREVASELAGIKAWNG 555 (608)
Q Consensus 489 l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~evl~~L~~i~~~~~ 555 (608)
. +.+.+......+.+...+.++.+|+.+||+.+|++||++.||++.|+.+.....
T Consensus 250 --~----------~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~~l~~~~~~~~ 304 (307)
T cd05098 250 --E----------LFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILALTS 304 (307)
T ss_pred --H----------HHHHHHcCCCCCCCCcCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHHHhh
Confidence 1 111111111223334456789999999999999999999999999999877543
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-35 Score=304.04 Aligned_cols=245 Identities=25% Similarity=0.438 Sum_probs=189.7
Q ss_pred cCccccceeccCce-----------------EEEEEee-cChhhHHHHHHHHHHHhhc-CCCCccceecccccCccceEE
Q 044312 289 DNFDLNRILGQGGQ-----------------AVKKSKV-IDESKVEEFINEVVILSQI-NHRNVVKLLGCCLETEVPLLV 349 (608)
Q Consensus 289 ~~f~~~~~lG~G~~-----------------avk~~~~-~~~~~~~~~~~Ei~il~~l-~H~niv~l~~~~~~~~~~~lV 349 (608)
++|++.+.||+|++ ++|..+. ........|.+|+.++.++ +|+||+++++++.+.+..++|
T Consensus 7 ~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~~~~lv 86 (303)
T cd05088 7 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA 86 (303)
T ss_pred hhceeeeeecCCCCceEEEEEEccCCceeeEEEEEecccCCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCCCceEE
Confidence 46788889999975 3333322 2234456789999999999 899999999999999999999
Q ss_pred EeecCCCccchhccccCC-------------CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEEcCCCcE
Q 044312 350 YEFIPNGTLFQYIHDQNE-------------DFPITWEIRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRA 416 (608)
Q Consensus 350 ~E~~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ 416 (608)
|||+++++|.++++.... ...+++..++.++.|++.||+|||+.+ ++||||||+|||+++++.+
T Consensus 87 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~g---i~H~dlkp~Nili~~~~~~ 163 (303)
T cd05088 87 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYVA 163 (303)
T ss_pred EEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhCC---ccccccchheEEecCCCcE
Confidence 999999999999975321 124789999999999999999999999 9999999999999999999
Q ss_pred EEeeccCccccccCCcceeeeeeccCCCCChhhhccCCCCCccchHhHHHHHHHHHh-CCCCCCccchhhcccHHHHHHH
Q 044312 417 KVSDFGASRSMAVDQTHMTTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLTELLT-GEKPIRFTILEEDKSLAAYFLC 495 (608)
Q Consensus 417 kl~DFGls~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~ellt-g~~p~~~~~~~~~~~l~~~~~~ 495 (608)
||+|||+++..... .......++..|+|||++....++.++||||||++++||+| |..||......+ .+
T Consensus 164 kl~dfg~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~------~~-- 233 (303)
T cd05088 164 KIADFGLSRGQEVY--VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAE------LY-- 233 (303)
T ss_pred EeCccccCcccchh--hhcccCCCcccccCHHHHhccCCcccccchhhhhHHHHHHhcCCCCcccCChHH------HH--
Confidence 99999998643211 11111234567999999988889999999999999999998 999986322111 01
Q ss_pred HhhhhhhHHHhhhhhhccCChhHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhhHHhc
Q 044312 496 AMKEERLFEILDARVMKQGGKDEIITVAKLAKRCLNLNGKKRPTMREVASELAGIKAWN 554 (608)
Q Consensus 496 ~~~~~~~~~~~d~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~evl~~L~~i~~~~ 554 (608)
+.+........+...+..+.+|+.+||+.+|++||++.++++.|+.+....
T Consensus 234 --------~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~l~~~~~~~ 284 (303)
T cd05088 234 --------EKLPQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEER 284 (303)
T ss_pred --------HHHhcCCcCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhh
Confidence 001111111222334567899999999999999999999999998775543
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=311.04 Aligned_cols=239 Identities=24% Similarity=0.344 Sum_probs=189.2
Q ss_pred cCccccceeccCce---------------EEEEEeec---ChhhHHHHHHHHHHHhhcCCCCccceecccccCccceEEE
Q 044312 289 DNFDLNRILGQGGQ---------------AVKKSKVI---DESKVEEFINEVVILSQINHRNVVKLLGCCLETEVPLLVY 350 (608)
Q Consensus 289 ~~f~~~~~lG~G~~---------------avk~~~~~---~~~~~~~~~~Ei~il~~l~H~niv~l~~~~~~~~~~~lV~ 350 (608)
++|++.+.||+|++ |||+.+.. .......+.+|+.++++++||||+++++++.+.+..+|||
T Consensus 1 ~~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~ 80 (333)
T cd05600 1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYLAM 80 (333)
T ss_pred CCcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCCEEEEEE
Confidence 36888899999974 56665432 2234567889999999999999999999999999999999
Q ss_pred eecCCCccchhccccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEEcCCCcEEEeeccCccccccC
Q 044312 351 EFIPNGTLFQYIHDQNEDFPITWEIRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVD 430 (608)
Q Consensus 351 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGls~~~~~~ 430 (608)
||+++++|.+++.... .+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++....
T Consensus 81 e~~~g~~L~~~l~~~~---~l~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~~~- 153 (333)
T cd05600 81 EYVPGGDFRTLLNNLG---VLSEDHARFYMAEMFEAVDALHELG---YIHRDLKPENFLIDASGHIKLTDFGLSKGIVT- 153 (333)
T ss_pred eCCCCCCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEECCCCCEEEEeCcCCccccc-
Confidence 9999999999997543 5899999999999999999999999 99999999999999999999999999976543
Q ss_pred CcceeeeeeccCCCCChhhhccCCCCCccchHhHHHHHHHHHhCCCCCCccchhhcccHHHHHHHHhhhhhhHHHhhhhh
Q 044312 431 QTHMTTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLTELLTGEKPIRFTILEEDKSLAAYFLCAMKEERLFEILDARV 510 (608)
Q Consensus 431 ~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~ 510 (608)
......||+.|+|||++.+..++.++||||||++++||++|+.||......+. +....... ..+....
T Consensus 154 ---~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~------~~~i~~~~---~~~~~~~ 221 (333)
T cd05600 154 ---YANSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNET------WENLKYWK---ETLQRPV 221 (333)
T ss_pred ---ccCCcccCccccChhHhcCCCCCCccceecchHHHhhhhhCCCCCCCCCHHHH------HHHHHhcc---ccccCCC
Confidence 22345689999999999999999999999999999999999999974322211 10000000 0000000
Q ss_pred hccCChhHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 044312 511 MKQGGKDEIITVAKLAKRCLNLNGKKRPTMREVASE 546 (608)
Q Consensus 511 ~~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~evl~~ 546 (608)
........+.++.+|+.+||..+|++||+++|++++
T Consensus 222 ~~~~~~~~s~~~~~li~~~l~~~~~rr~s~~~ll~h 257 (333)
T cd05600 222 YDDPRFNLSDEAWDLITKLINDPSRRFGSLEDIKNH 257 (333)
T ss_pred CCccccccCHHHHHHHHHHhhChhhhcCCHHHHHhC
Confidence 000112346688999999999999999999999976
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-35 Score=312.25 Aligned_cols=237 Identities=25% Similarity=0.441 Sum_probs=201.8
Q ss_pred ccceeccCce------------------EEEEEeecChh-hHHHHHHHHHHHhhcCCCCccceecccccCccceEEEeec
Q 044312 293 LNRILGQGGQ------------------AVKKSKVIDES-KVEEFINEVVILSQINHRNVVKLLGCCLETEVPLLVYEFI 353 (608)
Q Consensus 293 ~~~~lG~G~~------------------avk~~~~~~~~-~~~~~~~Ei~il~~l~H~niv~l~~~~~~~~~~~lV~E~~ 353 (608)
+.++||+|.| |||.++..... ...+|++|+.+|.+|+|+|+++|+|+..+ ....||||++
T Consensus 114 l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~~mddflrEas~M~~L~H~hliRLyGvVl~-qp~mMV~ELa 192 (1039)
T KOG0199|consen 114 LYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNAIMDDFLREASHMLKLQHPHLIRLYGVVLD-QPAMMVFELA 192 (1039)
T ss_pred HHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccchhHHHHHHHHHHHHhccCcceeEEeeeecc-chhhHHhhhc
Confidence 3678999875 77877765544 67899999999999999999999999988 6788999999
Q ss_pred CCCccchhccccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEEcCCCcEEEeeccCccccccCCcc
Q 044312 354 PNGTLFQYIHDQNEDFPITWEIRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTH 433 (608)
Q Consensus 354 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGls~~~~~~~~~ 433 (608)
+.|+|.+.|++. .+..|....+-.++.|||.||.||.++. .|||||..+|+||-....+||+||||.|.+...+..
T Consensus 193 plGSLldrLrka-~~~~llv~~Lcdya~QiA~aM~YLeskr---lvHRDLAARNlllasprtVKI~DFGLmRaLg~ned~ 268 (1039)
T KOG0199|consen 193 PLGSLLDRLRKA-KKAILLVSRLCDYAMQIAKAMQYLESKR---LVHRDLAARNLLLASPRTVKICDFGLMRALGENEDM 268 (1039)
T ss_pred ccchHHHHHhhc-cccceeHHHHHHHHHHHHHHHHHHhhhh---hhhhhhhhhhheecccceeeeecccceeccCCCCcc
Confidence 999999999983 3346888889999999999999999999 999999999999999999999999999988755443
Q ss_pred eee--eeeccCCCCChhhhccCCCCCccchHhHHHHHHHHHh-CCCCCCccchhhcccHHHHHHHHhhhhhhHHHhhhhh
Q 044312 434 MTT--QVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLTELLT-GEKPIRFTILEEDKSLAAYFLCAMKEERLFEILDARV 510 (608)
Q Consensus 434 ~~~--~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~ellt-g~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~ 510 (608)
... ...-...|.|||.+....++.+||||+|||.||||+| |+.||.. .....+.+.+|.+-
T Consensus 269 Yvm~p~rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMFtyGEePW~G----------------~~g~qIL~~iD~~e 332 (1039)
T KOG0199|consen 269 YVMAPQRKVPFAWCAPESLRHRKFSHASDVWMYGVTIWEMFTYGEEPWVG----------------CRGIQILKNIDAGE 332 (1039)
T ss_pred eEecCCCcCcccccCHhHhccccccccchhhhhhhhHHhhhccCCCCCCC----------------CCHHHHHHhccccc
Confidence 322 2334668999999999999999999999999999999 7888862 22334566677667
Q ss_pred hccCChhHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhh
Q 044312 511 MKQGGKDEIITVAKLAKRCLNLNGKKRPTMREVASELAGI 550 (608)
Q Consensus 511 ~~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~evl~~L~~i 550 (608)
+.+.++.+++++++++++||..+|.+|||+..|.+.+-..
T Consensus 333 rLpRPk~csedIY~imk~cWah~paDRptFsair~~~~l~ 372 (1039)
T KOG0199|consen 333 RLPRPKYCSEDIYQIMKNCWAHNPADRPTFSAIREDLVLA 372 (1039)
T ss_pred cCCCCCCChHHHHHHHHHhccCCccccccHHHHHHhHHHH
Confidence 7788899999999999999999999999999998655333
|
|
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-35 Score=309.11 Aligned_cols=248 Identities=28% Similarity=0.454 Sum_probs=190.8
Q ss_pred HhcCccccceeccCce--------------------EEEEEeec-ChhhHHHHHHHHHHHhhc-CCCCccceeccccc-C
Q 044312 287 ATDNFDLNRILGQGGQ--------------------AVKKSKVI-DESKVEEFINEVVILSQI-NHRNVVKLLGCCLE-T 343 (608)
Q Consensus 287 ~t~~f~~~~~lG~G~~--------------------avk~~~~~-~~~~~~~~~~Ei~il~~l-~H~niv~l~~~~~~-~ 343 (608)
..++|++.+.||+|+| |+|+.+.. .....+.+.+|+.+++++ +|+||++++++|.. .
T Consensus 5 ~~~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~~~ 84 (337)
T cd05054 5 PRDRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELKILIHIGHHLNVVNLLGACTKPG 84 (337)
T ss_pred CHHHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCCCHHHHHHHHHHHHHHHhhccCcchhheeeeEecCC
Confidence 3457888899999874 44444321 223456788999999999 89999999998864 4
Q ss_pred ccceEEEeecCCCccchhccccCC--------------------------------------------------------
Q 044312 344 EVPLLVYEFIPNGTLFQYIHDQNE-------------------------------------------------------- 367 (608)
Q Consensus 344 ~~~~lV~E~~~~gsL~~~l~~~~~-------------------------------------------------------- 367 (608)
...+++|||+++++|.+++.....
T Consensus 85 ~~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 164 (337)
T cd05054 85 GPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGDE 164 (337)
T ss_pred CCEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchhhhH
Confidence 567899999999999998864221
Q ss_pred --CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEEcCCCcEEEeeccCccccccCCcce-eeeeeccCCC
Q 044312 368 --DFPITWEIRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHM-TTQVHGTFGY 444 (608)
Q Consensus 368 --~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGls~~~~~~~~~~-~~~~~gt~~y 444 (608)
..++++..+..++.||+.||+|||+.+ |+||||||+|||+++++.+||+|||+++.+....... .....++..|
T Consensus 165 ~~~~~l~~~~~~~~~~qi~~aL~~lH~~~---ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~~~~~~~~~~~~y 241 (337)
T cd05054 165 LYKEPLTLEDLISYSFQVARGMEFLASRK---CIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKW 241 (337)
T ss_pred HhhcCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCcceEEEeCCCcEEEeccccchhcccCcchhhccCCCCCccc
Confidence 125899999999999999999999998 9999999999999999999999999998764332221 2234456789
Q ss_pred CChhhhccCCCCCccchHhHHHHHHHHHh-CCCCCCccchhhcccHHHHHHHHhhhhhhHHHhhhhhhccCChhHHHHHH
Q 044312 445 LDPEYFRSSQFTDKSDVYSFGVVLTELLT-GEKPIRFTILEEDKSLAAYFLCAMKEERLFEILDARVMKQGGKDEIITVA 523 (608)
Q Consensus 445 ~aPE~~~~~~~t~ksDV~S~Gvvl~ellt-g~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~ 523 (608)
+|||++.+..++.++|||||||+++||++ |..||......+ .+...+. .......+...+.++.
T Consensus 242 ~aPE~~~~~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~~------~~~~~~~---------~~~~~~~~~~~~~~~~ 306 (337)
T cd05054 242 MAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDE------EFCRRLK---------EGTRMRAPEYATPEIY 306 (337)
T ss_pred cCcHHhcCCCCCccccHHHHHHHHHHHHHcCCCCCCCCCccH------HHHHHHh---------ccCCCCCCccCCHHHH
Confidence 99999999999999999999999999998 999986322111 0111111 1111122234456799
Q ss_pred HHHHHHhccCCCCCCCHHHHHHHHHhhHH
Q 044312 524 KLAKRCLNLNGKKRPTMREVASELAGIKA 552 (608)
Q Consensus 524 ~Li~~cl~~dp~~RPs~~evl~~L~~i~~ 552 (608)
+++.+||+.+|++||++.||+++|+.+..
T Consensus 307 ~l~~~cl~~~p~~RPs~~ell~~l~~~~~ 335 (337)
T cd05054 307 SIMLDCWHNNPEDRPTFSELVEILGDLLQ 335 (337)
T ss_pred HHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 99999999999999999999999987654
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-35 Score=295.77 Aligned_cols=240 Identities=24% Similarity=0.416 Sum_probs=190.2
Q ss_pred hcCccccceeccCce--------------EEEEEeecChhhHHHHHHHHHHHhhcCCCCccceecccccCccceEEEeec
Q 044312 288 TDNFDLNRILGQGGQ--------------AVKKSKVIDESKVEEFINEVVILSQINHRNVVKLLGCCLETEVPLLVYEFI 353 (608)
Q Consensus 288 t~~f~~~~~lG~G~~--------------avk~~~~~~~~~~~~~~~Ei~il~~l~H~niv~l~~~~~~~~~~~lV~E~~ 353 (608)
.+.|++.++||+|++ |+|.... .....+.|.+|+.++++++|+||+++++++. .+..+++|||+
T Consensus 5 ~~~~~~~~~ig~G~~g~v~~~~~~~~~~~a~K~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~~ 82 (260)
T cd05067 5 RETLKLVKKLGAGQFGEVWMGYYNGHTKVAIKSLKQ-GSMSPEAFLAEANLMKQLQHPRLVRLYAVVT-QEPIYIITEYM 82 (260)
T ss_pred hHHceeeeeeccCccceEEeeecCCCceEEEEEecC-CCCcHHHHHHHHHHHHhcCCcCeeeEEEEEc-cCCcEEEEEcC
Confidence 456888899999874 5665543 2334578999999999999999999999874 45689999999
Q ss_pred CCCccchhccccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEEcCCCcEEEeeccCccccccCCcc
Q 044312 354 PNGTLFQYIHDQNEDFPITWEIRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTH 433 (608)
Q Consensus 354 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGls~~~~~~~~~ 433 (608)
++++|.+++..... ..+++..++.++.|++.||+|||+.+ ++||||||+||++++++.++|+|||++.........
T Consensus 83 ~~~~L~~~~~~~~~-~~~~~~~~~~i~~~i~~al~~LH~~~---i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~~ 158 (260)
T cd05067 83 ENGSLVDFLKTPEG-IKLTINKLIDMAAQIAEGMAFIERKN---YIHRDLRAANILVSETLCCKIADFGLARLIEDNEYT 158 (260)
T ss_pred CCCCHHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHhcCC---eecccccHHhEEEcCCCCEEEccCcceeecCCCCcc
Confidence 99999999876433 35899999999999999999999998 999999999999999999999999999776533222
Q ss_pred eeeeeeccCCCCChhhhccCCCCCccchHhHHHHHHHHHh-CCCCCCccchhhcccHHHHHHHHhhhhhhHHHhhhhhhc
Q 044312 434 MTTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLTELLT-GEKPIRFTILEEDKSLAAYFLCAMKEERLFEILDARVMK 512 (608)
Q Consensus 434 ~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~ellt-g~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~ 512 (608)
......++..|+|||++....++.++||||||++++||++ |+.||......+ +.+.+......
T Consensus 159 ~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~----------------~~~~~~~~~~~ 222 (260)
T cd05067 159 AREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTNPE----------------VIQNLERGYRM 222 (260)
T ss_pred cccCCcccccccCHHHhccCCcCcccchHHHHHHHHHHHhCCCCCCCCCChHH----------------HHHHHHcCCCC
Confidence 2223345678999999999999999999999999999999 999986322111 01111111111
Q ss_pred cCChhHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHh
Q 044312 513 QGGKDEIITVAKLAKRCLNLNGKKRPTMREVASELAG 549 (608)
Q Consensus 513 ~~~~~~~~~l~~Li~~cl~~dp~~RPs~~evl~~L~~ 549 (608)
+.+...+.++.+++.+||+.+|++||+++++.+.|+.
T Consensus 223 ~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 259 (260)
T cd05067 223 PRPDNCPEELYELMRLCWKEKPEERPTFEYLRSVLED 259 (260)
T ss_pred CCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHhhc
Confidence 2233455689999999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-35 Score=296.15 Aligned_cols=229 Identities=25% Similarity=0.441 Sum_probs=176.3
Q ss_pred EEEEEee--cChhhHHHHHHHHHHHhhcCCCCccceecccccC------ccceEEEeecCCCccchhcccc---CCCCCC
Q 044312 303 AVKKSKV--IDESKVEEFINEVVILSQINHRNVVKLLGCCLET------EVPLLVYEFIPNGTLFQYIHDQ---NEDFPI 371 (608)
Q Consensus 303 avk~~~~--~~~~~~~~~~~Ei~il~~l~H~niv~l~~~~~~~------~~~~lV~E~~~~gsL~~~l~~~---~~~~~l 371 (608)
|+|..+. ......+.|.+|+.+++.++|+||+++++++... ...+++|||+++|+|.+++... .....+
T Consensus 30 a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~ 109 (272)
T cd05075 30 AVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYL 109 (272)
T ss_pred EEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCCcEEEEEeCCCCcHHHHHHHhcccCCcccC
Confidence 4554443 2345577899999999999999999999987532 2468999999999999887432 122348
Q ss_pred CHHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEEcCCCcEEEeeccCccccccCCcce-eeeeeccCCCCChhhh
Q 044312 372 TWEIRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHM-TTQVHGTFGYLDPEYF 450 (608)
Q Consensus 372 ~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGls~~~~~~~~~~-~~~~~gt~~y~aPE~~ 450 (608)
++..+..++.|++.||+|||+++ |+||||||+|||+++++.+||+|||+++......... .....+++.|+|||++
T Consensus 110 ~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~ 186 (272)
T cd05075 110 PTQMLVKFMTDIASGMEYLSSKS---FIHRDLAARNCMLNENMNVCVADFGLSKKIYNGDYYRQGRIAKMPVKWIAIESL 186 (272)
T ss_pred CHHHHHHHHHHHHHHHHHHHHCC---eeccccchhheEEcCCCCEEECCCCcccccCcccceecCCcccCCcccCCHHHc
Confidence 99999999999999999999998 9999999999999999999999999998764332211 1222356789999999
Q ss_pred ccCCCCCccchHhHHHHHHHHHh-CCCCCCccchhhcccHHHHHHHHhhhhhhHHHhhhhhhccCChhHHHHHHHHHHHH
Q 044312 451 RSSQFTDKSDVYSFGVVLTELLT-GEKPIRFTILEEDKSLAAYFLCAMKEERLFEILDARVMKQGGKDEIITVAKLAKRC 529 (608)
Q Consensus 451 ~~~~~t~ksDV~S~Gvvl~ellt-g~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~Li~~c 529 (608)
....++.++||||||++++||++ |+.||...... . ........ .....+...+..+.+++.+|
T Consensus 187 ~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~---~----~~~~~~~~---------~~~~~~~~~~~~~~~li~~~ 250 (272)
T cd05075 187 ADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVENS---E----IYDYLRQG---------NRLKQPPDCLDGLYSLMSSC 250 (272)
T ss_pred cCCCcChHHHHHHHHHHHHHHHcCCCCCCCCCCHH---H----HHHHHHcC---------CCCCCCCCCCHHHHHHHHHH
Confidence 99999999999999999999999 78888632111 1 11111111 11122334566799999999
Q ss_pred hccCCCCCCCHHHHHHHHHhh
Q 044312 530 LNLNGKKRPTMREVASELAGI 550 (608)
Q Consensus 530 l~~dp~~RPs~~evl~~L~~i 550 (608)
|+.+|++|||+.||+++|+.+
T Consensus 251 l~~~p~~Rps~~~l~~~l~~~ 271 (272)
T cd05075 251 WLLNPKDRPSFETLRCELEKA 271 (272)
T ss_pred cCCCcccCcCHHHHHHHHHhh
Confidence 999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-35 Score=305.07 Aligned_cols=220 Identities=26% Similarity=0.311 Sum_probs=177.8
Q ss_pred eEEEEEee---cChhhHHHHHHHHHHHhhcCCCCccceecccccCccceEEEeecCCCccchhccccCCCCCCCHHHHHH
Q 044312 302 QAVKKSKV---IDESKVEEFINEVVILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEIRLR 378 (608)
Q Consensus 302 ~avk~~~~---~~~~~~~~~~~Ei~il~~l~H~niv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~ 378 (608)
+|+|.++. ........+.+|+.++++++||||+++++++.+.+..++||||+++|+|.+++.... .+++..+..
T Consensus 21 ~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~---~~~~~~~~~ 97 (312)
T cd05585 21 YALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGELFHHLQREG---RFDLSRARF 97 (312)
T ss_pred EEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCCCCCcHHHHHHhcC---CCCHHHHHH
Confidence 57887653 234456778999999999999999999999999999999999999999999987643 489999999
Q ss_pred HHHHHHHHHHHHhhcCCCCeeccCCCCCcEEEcCCCcEEEeeccCccccccCCcceeeeeeccCCCCChhhhccCCCCCc
Q 044312 379 IAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHGTFGYLDPEYFRSSQFTDK 458 (608)
Q Consensus 379 i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGls~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k 458 (608)
++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++...... .......||+.|+|||++.+..++.+
T Consensus 98 ~~~qi~~~l~~lH~~~---i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~ 173 (312)
T cd05585 98 YTAELLCALENLHKFN---VIYRDLKPENILLDYQGHIALCDFGLCKLNMKDD-DKTNTFCGTPEYLAPELLLGHGYTKA 173 (312)
T ss_pred HHHHHHHHHHHHHhCC---eEeCCCCHHHeEECCCCcEEEEECcccccCccCC-CccccccCCcccCCHHHHcCCCCCCc
Confidence 9999999999999999 9999999999999999999999999998643222 22334568999999999999999999
Q ss_pred cchHhHHHHHHHHHhCCCCCCccchhhcccHHHHHHHHhhhhhhHHHhhhhhhccCChhHHHHHHHHHHHHhccCCCCCC
Q 044312 459 SDVYSFGVVLTELLTGEKPIRFTILEEDKSLAAYFLCAMKEERLFEILDARVMKQGGKDEIITVAKLAKRCLNLNGKKRP 538 (608)
Q Consensus 459 sDV~S~Gvvl~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RP 538 (608)
+|||||||+++||++|+.||..... ...+.. ++.. ....+...+..+.+|+.+||+.||++||
T Consensus 174 ~DvwslGvil~el~tg~~pf~~~~~------~~~~~~---------~~~~--~~~~~~~~~~~~~~li~~~L~~dp~~R~ 236 (312)
T cd05585 174 VDWWTLGVLLYEMLTGLPPFYDENV------NEMYRK---------ILQE--PLRFPDGFDRDAKDLLIGLLSRDPTRRL 236 (312)
T ss_pred cceechhHHHHHHHhCCCCcCCCCH------HHHHHH---------HHcC--CCCCCCcCCHHHHHHHHHHcCCCHHHcC
Confidence 9999999999999999999863221 111111 1111 1122334566899999999999999998
Q ss_pred C---HHHHHH
Q 044312 539 T---MREVAS 545 (608)
Q Consensus 539 s---~~evl~ 545 (608)
+ +.|++.
T Consensus 237 ~~~~~~e~l~ 246 (312)
T cd05585 237 GYNGAQEIKN 246 (312)
T ss_pred CCCCHHHHHc
Confidence 6 455554
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-35 Score=293.75 Aligned_cols=237 Identities=29% Similarity=0.495 Sum_probs=191.4
Q ss_pred cCccccceeccCce-------------EEEEEeecChhhHHHHHHHHHHHhhcCCCCccceecccccCccceEEEeecCC
Q 044312 289 DNFDLNRILGQGGQ-------------AVKKSKVIDESKVEEFINEVVILSQINHRNVVKLLGCCLETEVPLLVYEFIPN 355 (608)
Q Consensus 289 ~~f~~~~~lG~G~~-------------avk~~~~~~~~~~~~~~~Ei~il~~l~H~niv~l~~~~~~~~~~~lV~E~~~~ 355 (608)
++|++.+.||+|++ |+|..+.... ..+++.+|+.+++.++|+||+++++++.+....++||||+++
T Consensus 6 ~~~~~~~~ig~g~~g~v~~~~~~~~~v~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~ 84 (256)
T cd05039 6 KELKLGATIGKGEFGDVMLGDYRGQKVAVKCLKDDST-AAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLYIVTEYMAK 84 (256)
T ss_pred hhccceeeeecCCCceEEEEEecCcEEEEEEeccchh-HHHHHHHHHHHHHhcCCcceeeeEEEEcCCCCeEEEEEecCC
Confidence 45677788888863 6666654333 567899999999999999999999999988999999999999
Q ss_pred CccchhccccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEEcCCCcEEEeeccCccccccCCccee
Q 044312 356 GTLFQYIHDQNEDFPITWEIRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMT 435 (608)
Q Consensus 356 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGls~~~~~~~~~~~ 435 (608)
++|.+++...... .+++..+..++.|++.||.|||+.+ ++|+||||+|||+++++.+||+|||+++.......
T Consensus 85 ~~L~~~~~~~~~~-~~~~~~~~~~~~qi~~~l~~lh~~~---i~H~di~p~Nili~~~~~~~l~d~g~~~~~~~~~~--- 157 (256)
T cd05039 85 GSLVDYLRSRGRA-VITLAQQLGFALDVCEGMEYLEEKN---FVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQD--- 157 (256)
T ss_pred CcHHHHHHhcCCC-CCCHHHHHHHHHHHHHHHHHHHhCC---ccchhcccceEEEeCCCCEEEcccccccccccccc---
Confidence 9999999765432 5899999999999999999999999 99999999999999999999999999987632221
Q ss_pred eeeeccCCCCChhhhccCCCCCccchHhHHHHHHHHHh-CCCCCCccchhhcccHHHHHHHHhhhhhhHHHhhhhhhccC
Q 044312 436 TQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLTELLT-GEKPIRFTILEEDKSLAAYFLCAMKEERLFEILDARVMKQG 514 (608)
Q Consensus 436 ~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~ellt-g~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~ 514 (608)
....+..|+|||++....++.++||||||++++|+++ |..||....... +.+.+........
T Consensus 158 -~~~~~~~~~ape~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~----------------~~~~~~~~~~~~~ 220 (256)
T cd05039 158 -SGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKD----------------VVPHVEKGYRMEA 220 (256)
T ss_pred -cCCCcccccCchhhcCCcCCcHHHHHHHHHHHHHHHhcCCCCCCCCCHHH----------------HHHHHhcCCCCCC
Confidence 2334668999999998899999999999999999997 999986332111 1111111111222
Q ss_pred ChhHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhh
Q 044312 515 GKDEIITVAKLAKRCLNLNGKKRPTMREVASELAGI 550 (608)
Q Consensus 515 ~~~~~~~l~~Li~~cl~~dp~~RPs~~evl~~L~~i 550 (608)
+...+..+.+++.+||..+|++||++.|++++|+.+
T Consensus 221 ~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~~ 256 (256)
T cd05039 221 PEGCPPEVYKVMKDCWELDPAKRPTFKQLREQLALI 256 (256)
T ss_pred ccCCCHHHHHHHHHHhccChhhCcCHHHHHHHHhcC
Confidence 334567899999999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-36 Score=296.20 Aligned_cols=254 Identities=26% Similarity=0.348 Sum_probs=194.5
Q ss_pred HhcCccccceeccCce---------------EEEEEe--ecChhhHHHHHHHHHHHhhcCCCCccceeccccc-----Cc
Q 044312 287 ATDNFDLNRILGQGGQ---------------AVKKSK--VIDESKVEEFINEVVILSQINHRNVVKLLGCCLE-----TE 344 (608)
Q Consensus 287 ~t~~f~~~~~lG~G~~---------------avk~~~--~~~~~~~~~~~~Ei~il~~l~H~niv~l~~~~~~-----~~ 344 (608)
....|...+.||+|++ |||++. ..+....+...+|+++|+.++|+||+.+++.+.- -.
T Consensus 20 i~~~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~f~ 99 (359)
T KOG0660|consen 20 IPRYYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDKFN 99 (359)
T ss_pred ccceecccccccCcceeeEEEEEEcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeecccccccccc
Confidence 3445666788999975 666665 3455667888999999999999999999999865 34
Q ss_pred cceEEEeecCCCccchhccccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEEcCCCcEEEeeccCc
Q 044312 345 VPLLVYEFIPNGTLFQYIHDQNEDFPITWEIRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGAS 424 (608)
Q Consensus 345 ~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGls 424 (608)
..|+|+|+| ..+|.+.++.+. .++......++.||++||.|+|+.+ |+||||||+|+|++.+..+||+|||||
T Consensus 100 DvYiV~elM-etDL~~iik~~~---~L~d~H~q~f~YQiLrgLKyiHSAn---ViHRDLKPsNll~n~~c~lKI~DFGLA 172 (359)
T KOG0660|consen 100 DVYLVFELM-ETDLHQIIKSQQ---DLTDDHAQYFLYQILRGLKYIHSAN---VIHRDLKPSNLLLNADCDLKICDFGLA 172 (359)
T ss_pred eeEEehhHH-hhHHHHHHHcCc---cccHHHHHHHHHHHHHhcchhhccc---ccccccchhheeeccCCCEEeccccce
Confidence 679999999 669999988654 4899999999999999999999999 999999999999999999999999999
Q ss_pred cccccC-CcceeeeeeccCCCCChhhhc-cCCCCCccchHhHHHHHHHHHhCCCCCCccchhhcccHHHHHHHHhhhhhh
Q 044312 425 RSMAVD-QTHMTTQVHGTFGYLDPEYFR-SSQFTDKSDVYSFGVVLTELLTGEKPIRFTILEEDKSLAAYFLCAMKEERL 502 (608)
Q Consensus 425 ~~~~~~-~~~~~~~~~gt~~y~aPE~~~-~~~~t~ksDV~S~Gvvl~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~ 502 (608)
|..... .....+....|.+|.|||++. ...||.+.||||.||||.||++|++-|.....-.+-.+.........++.+
T Consensus 173 R~~~~~~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql~lI~~~lGtP~~e~l 252 (359)
T KOG0660|consen 173 RYLDKFFEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQLQLILELLGTPSEEDL 252 (359)
T ss_pred eeccccCcccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCchHHHHHHHHHhcCCCCHHHH
Confidence 987542 122335667899999999975 458999999999999999999999999865444433333333222222222
Q ss_pred HHHhhhh---hhcc-----------CChhHHHHHHHHHHHHhccCCCCCCCHHHHHHHH
Q 044312 503 FEILDAR---VMKQ-----------GGKDEIITVAKLAKRCLNLNGKKRPTMREVASEL 547 (608)
Q Consensus 503 ~~~~d~~---~~~~-----------~~~~~~~~l~~Li~~cl~~dp~~RPs~~evl~~L 547 (608)
..+-... .... .-+.......+|+.+||..||.+|+|++|.+++-
T Consensus 253 ~~i~s~~ar~yi~slp~~p~~~f~~~fp~a~p~AidLlekmL~fdP~kRita~eAL~hP 311 (359)
T KOG0660|consen 253 QKIRSEKARPYIKSLPQIPKQPFSSIFPNANPLAIDLLEKMLVFDPKKRITAEEALAHP 311 (359)
T ss_pred HHhccHHHHHHHHhCCCCCCCCHHHHcCCCCHHHHHHHHHHhccCccccCCHHHHhcCh
Confidence 2221110 0000 0023456788999999999999999999998763
|
|
| >KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-36 Score=307.24 Aligned_cols=233 Identities=25% Similarity=0.394 Sum_probs=192.9
Q ss_pred ccccceeccCce---------------EEEEEeec-ChhhHHHHHHHHHHHhhcCCCCccceecccccCccceEEEeecC
Q 044312 291 FDLNRILGQGGQ---------------AVKKSKVI-DESKVEEFINEVVILSQINHRNVVKLLGCCLETEVPLLVYEFIP 354 (608)
Q Consensus 291 f~~~~~lG~G~~---------------avk~~~~~-~~~~~~~~~~Ei~il~~l~H~niv~l~~~~~~~~~~~lV~E~~~ 354 (608)
|+....||+|.| |+|.+.+. .+..+++..+|+.+|++++++||.++++.+..+..++++|||+.
T Consensus 15 ~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~~deIediqqei~~Ls~~~~~~it~yygsyl~g~~LwiiMey~~ 94 (467)
T KOG0201|consen 15 YTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEAEDEIEDIQQEISVLSQCDSPNITEYYGSYLKGTKLWIIMEYCG 94 (467)
T ss_pred cccchhccccccceeeeeeeccccceEEEEEechhhcchhhHHHHHHHHHHHhcCcchHHhhhhheeecccHHHHHHHhc
Confidence 455677888865 77777653 34557889999999999999999999999999999999999999
Q ss_pred CCccchhccccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEEcCCCcEEEeeccCccccccCCcce
Q 044312 355 NGTLFQYIHDQNEDFPITWEIRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHM 434 (608)
Q Consensus 355 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGls~~~~~~~~~~ 434 (608)
+|++.+.+.... .+.+..+.-|+.+++.||.|||.++ .+|||||+.|||+..++.+||+|||.+..+.......
T Consensus 95 gGsv~~lL~~~~---~~~E~~i~~ilre~l~~l~ylH~~~---kiHrDIKaanil~s~~g~vkl~DfgVa~ql~~~~~rr 168 (467)
T KOG0201|consen 95 GGSVLDLLKSGN---ILDEFEIAVILREVLKGLDYLHSEK---KIHRDIKAANILLSESGDVKLADFGVAGQLTNTVKRR 168 (467)
T ss_pred CcchhhhhccCC---CCccceeeeehHHHHHHhhhhhhcc---eecccccccceeEeccCcEEEEecceeeeeechhhcc
Confidence 999999998654 3577888889999999999999999 9999999999999999999999999998877555443
Q ss_pred eeeeeccCCCCChhhhccCCCCCccchHhHHHHHHHHHhCCCCCCccchhhcccHHHHHHHHhhhhhhHHHhhhhhhccC
Q 044312 435 TTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLTELLTGEKPIRFTILEEDKSLAAYFLCAMKEERLFEILDARVMKQG 514 (608)
Q Consensus 435 ~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~ 514 (608)
....||+.|||||++....|+.|+||||||++.+||.+|.+|+....+ .++.-++-.......
T Consensus 169 -~tfvGTPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~GePP~s~~hP----------------mrvlflIpk~~PP~L 231 (467)
T KOG0201|consen 169 -KTFVGTPFWMAPEVIKQSGYDTKADIWSLGITAIELAKGEPPHSKLHP----------------MRVLFLIPKSAPPRL 231 (467)
T ss_pred -ccccccccccchhhhccccccchhhhhhhhHHHHHHhcCCCCCcccCc----------------ceEEEeccCCCCCcc
Confidence 667899999999999988999999999999999999999999863221 111112221111122
Q ss_pred ChhHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 044312 515 GKDEIITVAKLAKRCLNLNGKKRPTMREVASE 546 (608)
Q Consensus 515 ~~~~~~~l~~Li~~cl~~dp~~RPs~~evl~~ 546 (608)
....+..+.+++..||+.||+.||++.+++++
T Consensus 232 ~~~~S~~~kEFV~~CL~k~P~~RpsA~~LLKh 263 (467)
T KOG0201|consen 232 DGDFSPPFKEFVEACLDKNPEFRPSAKELLKH 263 (467)
T ss_pred ccccCHHHHHHHHHHhhcCcccCcCHHHHhhh
Confidence 22556679999999999999999999999875
|
|
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-35 Score=298.64 Aligned_cols=242 Identities=28% Similarity=0.415 Sum_probs=187.1
Q ss_pred hcCccccceeccCce--------------------EEEEEeec-ChhhHHHHHHHHHHHhhcCCCCccceecccccCccc
Q 044312 288 TDNFDLNRILGQGGQ--------------------AVKKSKVI-DESKVEEFINEVVILSQINHRNVVKLLGCCLETEVP 346 (608)
Q Consensus 288 t~~f~~~~~lG~G~~--------------------avk~~~~~-~~~~~~~~~~Ei~il~~l~H~niv~l~~~~~~~~~~ 346 (608)
+++|.+.+.||+|++ ++|..... .......|.+|+.++++++|+||+++++++.+....
T Consensus 5 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~ 84 (277)
T cd05036 5 RDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVRLIGVSFERLPR 84 (277)
T ss_pred HHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCc
Confidence 456888888998874 23333222 223346799999999999999999999999999999
Q ss_pred eEEEeecCCCccchhccccCC----CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEEcCCC---cEEEe
Q 044312 347 LLVYEFIPNGTLFQYIHDQNE----DFPITWEIRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKY---RAKVS 419 (608)
Q Consensus 347 ~lV~E~~~~gsL~~~l~~~~~----~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~---~~kl~ 419 (608)
++||||+++++|.+++..... ...+++..+++++.||+.||+|||+.+ ++||||||+|||++.++ .+||+
T Consensus 85 ~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~nil~~~~~~~~~~kl~ 161 (277)
T cd05036 85 FILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEENH---FIHRDIAARNCLLTCKGPGRVAKIA 161 (277)
T ss_pred EEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccchheEEEeccCCCcceEec
Confidence 999999999999999876432 124899999999999999999999999 99999999999998654 69999
Q ss_pred eccCccccccCCcce-eeeeeccCCCCChhhhccCCCCCccchHhHHHHHHHHHh-CCCCCCccchhhcccHHHHHHHHh
Q 044312 420 DFGASRSMAVDQTHM-TTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLTELLT-GEKPIRFTILEEDKSLAAYFLCAM 497 (608)
Q Consensus 420 DFGls~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~ellt-g~~p~~~~~~~~~~~l~~~~~~~~ 497 (608)
|||+++......... ......+..|+|||++.+..++.++|||||||+++||++ |..||.....+.
T Consensus 162 dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~~g~~pf~~~~~~~------------ 229 (277)
T cd05036 162 DFGMARDIYRASYYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQE------------ 229 (277)
T ss_pred cCccccccCCccceecCCCCCccHhhCCHHHHhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHH------------
Confidence 999998763221111 112223567999999999999999999999999999997 999986332211
Q ss_pred hhhhhHHHhhhhhhccCChhHHHHHHHHHHHHhccCCCCCCCHHHHHHHHH
Q 044312 498 KEERLFEILDARVMKQGGKDEIITVAKLAKRCLNLNGKKRPTMREVASELA 548 (608)
Q Consensus 498 ~~~~~~~~~d~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~evl~~L~ 548 (608)
+.+.+........+...+..+.+++.+||+.+|++||++.+|+++|+
T Consensus 230 ----~~~~~~~~~~~~~~~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~l~ 276 (277)
T cd05036 230 ----VMEFVTGGGRLDPPKGCPGPVYRIMTDCWQHTPEDRPNFATILERIQ 276 (277)
T ss_pred ----HHHHHHcCCcCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHhh
Confidence 11111111112233455678999999999999999999999999885
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-35 Score=311.96 Aligned_cols=252 Identities=22% Similarity=0.254 Sum_probs=184.8
Q ss_pred hcCccccceeccCceEEEEEe---------ecChhhHHHHHHHHHHHhhcCCCCccceecccccCccceEEEeecCCCcc
Q 044312 288 TDNFDLNRILGQGGQAVKKSK---------VIDESKVEEFINEVVILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGTL 358 (608)
Q Consensus 288 t~~f~~~~~lG~G~~avk~~~---------~~~~~~~~~~~~Ei~il~~l~H~niv~l~~~~~~~~~~~lV~E~~~~gsL 358 (608)
..+|.+.+.||+|++...... .......+.+.+|+++|++|+||||+++++++......++|+|++. ++|
T Consensus 91 ~~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~~~-~~L 169 (391)
T PHA03212 91 KAGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQRGGTATEAHILRAINHPSIIQLKGTFTYNKFTCLILPRYK-TDL 169 (391)
T ss_pred cCCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechhhhhhHHHHHHHHhCCCCCCCCEeEEEEECCeeEEEEecCC-CCH
Confidence 457999999999986321110 1112234568899999999999999999999999999999999995 688
Q ss_pred chhccccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEEcCCCcEEEeeccCccccccCCcceeeee
Q 044312 359 FQYIHDQNEDFPITWEIRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQV 438 (608)
Q Consensus 359 ~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGls~~~~~~~~~~~~~~ 438 (608)
.+++.... .+++..++.|+.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++.............
T Consensus 170 ~~~l~~~~---~l~~~~~~~i~~qi~~aL~ylH~~~---IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~~~~~~~~~~~ 243 (391)
T PHA03212 170 YCYLAAKR---NIAICDILAIERSVLRAIQYLHENR---IIHRDIKAENIFINHPGDVCLGDFGAACFPVDINANKYYGW 243 (391)
T ss_pred HHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChHhEEEcCCCCEEEEeCCcccccccccccccccc
Confidence 88886543 4899999999999999999999999 99999999999999999999999999975433222233445
Q ss_pred eccCCCCChhhhccCCCCCccchHhHHHHHHHHHhCCCCCCccchhhc----ccHHHHHHHHhh----------hhhhHH
Q 044312 439 HGTFGYLDPEYFRSSQFTDKSDVYSFGVVLTELLTGEKPIRFTILEED----KSLAAYFLCAMK----------EERLFE 504 (608)
Q Consensus 439 ~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~elltg~~p~~~~~~~~~----~~l~~~~~~~~~----------~~~~~~ 504 (608)
.||+.|+|||++....++.++|||||||++|||++|+.|+........ ............ ...+.+
T Consensus 244 ~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~i~~~~g~~p~~~~~~~~~~~~~ 323 (391)
T PHA03212 244 AGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRRSGTHPNEFPIDAQANLDE 323 (391)
T ss_pred cCccCCCChhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHHHHHHhcCChhhcCcchhHHHHH
Confidence 799999999999999999999999999999999999988643211000 000111111000 000111
Q ss_pred Hhhh---h-hhc--c-----CChhHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 044312 505 ILDA---R-VMK--Q-----GGKDEIITVAKLAKRCLNLNGKKRPTMREVASE 546 (608)
Q Consensus 505 ~~d~---~-~~~--~-----~~~~~~~~l~~Li~~cl~~dp~~RPs~~evl~~ 546 (608)
+... . ... . .....+.++.+|+.+||+.||++|||++|++++
T Consensus 324 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpta~elL~h 376 (391)
T PHA03212 324 IYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHRPSAEALLDF 376 (391)
T ss_pred HHHHHHhccCCCCCCCCCHHHHhhhhhhHHHHHHHHhcCChhhCCCHHHHhcC
Confidence 1000 0 000 0 001345678999999999999999999999864
|
|
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-35 Score=293.94 Aligned_cols=227 Identities=25% Similarity=0.425 Sum_probs=179.5
Q ss_pred eEEEEEeecC-hhhHHHHHHHHHHHhhcCCCCccceecccccCccceEEEeecCCCccchhccccCCCCCCCHHHHHHHH
Q 044312 302 QAVKKSKVID-ESKVEEFINEVVILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEIRLRIA 380 (608)
Q Consensus 302 ~avk~~~~~~-~~~~~~~~~Ei~il~~l~H~niv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~ 380 (608)
.|+|...... ....+.|.+|+.++++++|+||+++++++. ....++||||+++++|.+++..... .+++..+++++
T Consensus 25 vavk~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~-~~~~~lv~e~~~~~~L~~~l~~~~~--~~~~~~~~~~~ 101 (257)
T cd05115 25 VAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIGVCE-AEALMLVMEMASGGPLNKFLSGKKD--EITVSNVVELM 101 (257)
T ss_pred EEEEEcccccChHHHHHHHHHHHHHHhcCCCCeEEEEEEEc-CCCeEEEEEeCCCCCHHHHHHhCCC--CCCHHHHHHHH
Confidence 4666665432 334567999999999999999999999885 4578999999999999999875432 58999999999
Q ss_pred HHHHHHHHHHhhcCCCCeeccCCCCCcEEEcCCCcEEEeeccCccccccCCccee--eeeeccCCCCChhhhccCCCCCc
Q 044312 381 IEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMT--TQVHGTFGYLDPEYFRSSQFTDK 458 (608)
Q Consensus 381 ~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGls~~~~~~~~~~~--~~~~gt~~y~aPE~~~~~~~t~k 458 (608)
.|++.||+|||+++ ++||||||+|||++.++.+||+|||+++.......... ....++..|+|||.+....++.+
T Consensus 102 ~~i~~~l~~lH~~~---i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~ 178 (257)
T cd05115 102 HQVSMGMKYLEGKN---FVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKARSAGKWPLKWYAPECINFRKFSSR 178 (257)
T ss_pred HHHHHHHHHHHhcC---eeecccchheEEEcCCCcEEeccCCccccccCCccceeccCCCCCCcccCCHHHHccCCCCch
Confidence 99999999999998 99999999999999999999999999986544332211 11223578999999998889999
Q ss_pred cchHhHHHHHHHHHh-CCCCCCccchhhcccHHHHHHHHhhhhhhHHHhhhhhhccCChhHHHHHHHHHHHHhccCCCCC
Q 044312 459 SDVYSFGVVLTELLT-GEKPIRFTILEEDKSLAAYFLCAMKEERLFEILDARVMKQGGKDEIITVAKLAKRCLNLNGKKR 537 (608)
Q Consensus 459 sDV~S~Gvvl~ellt-g~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~Li~~cl~~dp~~R 537 (608)
+||||||++++||++ |+.||......+ +...+........+...+.++.+++.+||..+|++|
T Consensus 179 ~Di~slG~~l~el~~~g~~p~~~~~~~~----------------~~~~~~~~~~~~~~~~~~~~l~~li~~c~~~~~~~R 242 (257)
T cd05115 179 SDVWSYGITMWEAFSYGQKPYKKMKGPE----------------VMSFIEQGKRLDCPAECPPEMYALMKDCWIYKWEDR 242 (257)
T ss_pred hhHHHHHHHHHHHhcCCCCCcCcCCHHH----------------HHHHHHCCCCCCCCCCCCHHHHHHHHHHcCCChhhC
Confidence 999999999999996 999986332111 111111111223334556789999999999999999
Q ss_pred CCHHHHHHHHHhh
Q 044312 538 PTMREVASELAGI 550 (608)
Q Consensus 538 Ps~~evl~~L~~i 550 (608)
|++.+|++.|+.+
T Consensus 243 p~~~~i~~~l~~~ 255 (257)
T cd05115 243 PNFAKVEERMRTY 255 (257)
T ss_pred cCHHHHHHHHhhh
Confidence 9999999988754
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-35 Score=307.83 Aligned_cols=250 Identities=25% Similarity=0.377 Sum_probs=188.5
Q ss_pred hcCccccceeccCce---------------EEEEEeec-ChhhHHHHHHHHHHHhhcCCCCccceecccccCccceEEEe
Q 044312 288 TDNFDLNRILGQGGQ---------------AVKKSKVI-DESKVEEFINEVVILSQINHRNVVKLLGCCLETEVPLLVYE 351 (608)
Q Consensus 288 t~~f~~~~~lG~G~~---------------avk~~~~~-~~~~~~~~~~Ei~il~~l~H~niv~l~~~~~~~~~~~lV~E 351 (608)
.++|++.++||+|++ |+|..... .....+.+.+|++++++++|+||+++++++.+.+..++|||
T Consensus 4 ~~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 83 (333)
T cd06650 4 DDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME 83 (333)
T ss_pred hhhhheeccccCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCcccceeEEEEECCEEEEEEe
Confidence 367888999999975 45554432 33445779999999999999999999999999999999999
Q ss_pred ecCCCccchhccccCCCCCCCHHHHHHHHHHHHHHHHHHhhc-CCCCeeccCCCCCcEEEcCCCcEEEeeccCccccccC
Q 044312 352 FIPNGTLFQYIHDQNEDFPITWEIRLRIAIEVSGALSYLHSA-ASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVD 430 (608)
Q Consensus 352 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~-~~~~iiHrDlk~~NILl~~~~~~kl~DFGls~~~~~~ 430 (608)
|+++++|.+++.... .+++..+..++.+++.||.|||+. + ++||||||+|||+++++.+||+|||++......
T Consensus 84 ~~~~~~L~~~l~~~~---~~~~~~~~~~~~~l~~~l~~lH~~~~---ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~ 157 (333)
T cd06650 84 HMDGGSLDQVLKKAG---RIPEQILGKVSIAVIKGLTYLREKHK---IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS 157 (333)
T ss_pred cCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHhcCC---EEecCCChhhEEEcCCCCEEEeeCCcchhhhhh
Confidence 999999999997643 488999999999999999999974 5 999999999999999999999999998765322
Q ss_pred CcceeeeeeccCCCCChhhhccCCCCCccchHhHHHHHHHHHhCCCCCCccchhhcccHHHH------------------
Q 044312 431 QTHMTTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLTELLTGEKPIRFTILEEDKSLAAY------------------ 492 (608)
Q Consensus 431 ~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~elltg~~p~~~~~~~~~~~l~~~------------------ 492 (608)
......|+..|+|||++.+..++.++|||||||+++||++|+.||..............
T Consensus 158 ---~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (333)
T cd06650 158 ---MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPPPDAKELELMFGCPVEGDPAESETSPRPRPP 234 (333)
T ss_pred ---ccccCCCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcchhHHHHHhcCcccCCccccccCcccCCc
Confidence 12334689999999999998999999999999999999999999864322111000000
Q ss_pred --HHHHhh-----hhhhHHHhhhhhhcc---C-ChhHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 044312 493 --FLCAMK-----EERLFEILDARVMKQ---G-GKDEIITVAKLAKRCLNLNGKKRPTMREVASE 546 (608)
Q Consensus 493 --~~~~~~-----~~~~~~~~d~~~~~~---~-~~~~~~~l~~Li~~cl~~dp~~RPs~~evl~~ 546 (608)
...... ......+.+...... . ....+.++.+|+.+||+.||++|||+.|++++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~P~~Rpt~~ell~h 299 (333)
T cd06650 235 GRPLSSYGPDSRPPMAIFELLDYIVNEPPPKLPSGVFGAEFQDFVNKCLIKNPAERADLKQLMVH 299 (333)
T ss_pred cchhhhhcccccccccHHHHHHHHhcCCCccCCCCCcCHHHHHHHHHhccCCcccCcCHHHHhhC
Confidence 000000 000011111111000 0 11235678999999999999999999999865
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-35 Score=308.95 Aligned_cols=250 Identities=25% Similarity=0.388 Sum_probs=181.9
Q ss_pred CccccceeccCce---------------EEEEEeec--ChhhHHHHHHHHHHHhhcCCCCccceecccccC-----ccce
Q 044312 290 NFDLNRILGQGGQ---------------AVKKSKVI--DESKVEEFINEVVILSQINHRNVVKLLGCCLET-----EVPL 347 (608)
Q Consensus 290 ~f~~~~~lG~G~~---------------avk~~~~~--~~~~~~~~~~Ei~il~~l~H~niv~l~~~~~~~-----~~~~ 347 (608)
+|++.++||+|++ |||+.+.. .......+.+|+.++++++||||+++++++... ...+
T Consensus 1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~ 80 (338)
T cd07859 1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIY 80 (338)
T ss_pred CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceEE
Confidence 4677888888864 66765532 223456789999999999999999999987543 2479
Q ss_pred EEEeecCCCccchhccccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEEcCCCcEEEeeccCcccc
Q 044312 348 LVYEFIPNGTLFQYIHDQNEDFPITWEIRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSM 427 (608)
Q Consensus 348 lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGls~~~ 427 (608)
+||||+. ++|.+++.... .+++..+..++.||++||.|||+.+ |+||||||+|||++.++.+||+|||+++..
T Consensus 81 lv~e~~~-~~L~~~l~~~~---~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIll~~~~~~kL~Dfg~~~~~ 153 (338)
T cd07859 81 VVFELME-SDLHQVIKAND---DLTPEHHQFFLYQLLRALKYIHTAN---VFHRDLKPKNILANADCKLKICDFGLARVA 153 (338)
T ss_pred EEEecCC-CCHHHHHHhcc---cCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCcEEEccCcccccc
Confidence 9999995 68988886543 4899999999999999999999999 999999999999999999999999999865
Q ss_pred ccCCc--ceeeeeeccCCCCChhhhcc--CCCCCccchHhHHHHHHHHHhCCCCCCccchhhcccHHHH--------HHH
Q 044312 428 AVDQT--HMTTQVHGTFGYLDPEYFRS--SQFTDKSDVYSFGVVLTELLTGEKPIRFTILEEDKSLAAY--------FLC 495 (608)
Q Consensus 428 ~~~~~--~~~~~~~gt~~y~aPE~~~~--~~~t~ksDV~S~Gvvl~elltg~~p~~~~~~~~~~~l~~~--------~~~ 495 (608)
..... .......||+.|+|||++.+ ..++.++||||||++++||++|+.||.............. ...
T Consensus 154 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (338)
T cd07859 154 FNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLGTPSPETIS 233 (338)
T ss_pred ccccCccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHHH
Confidence 33221 11234568999999999876 6789999999999999999999999864322111000000 000
Q ss_pred HhhhhhhHHHhhh---hhhc---cCChhHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 044312 496 AMKEERLFEILDA---RVMK---QGGKDEIITVAKLAKRCLNLNGKKRPTMREVASE 546 (608)
Q Consensus 496 ~~~~~~~~~~~d~---~~~~---~~~~~~~~~l~~Li~~cl~~dp~~RPs~~evl~~ 546 (608)
.+......+.+.. .... +.....+..+.+++.+||+.||++|||++|++++
T Consensus 234 ~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~h 290 (338)
T cd07859 234 RVRNEKARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALAD 290 (338)
T ss_pred HhhhhhHHHHHHhhcccCCCchHHhcCCCChHHHHHHHHHcCcCcccCCCHHHHhcC
Confidence 1111111111110 0000 0001234568899999999999999999999975
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-35 Score=295.62 Aligned_cols=246 Identities=24% Similarity=0.364 Sum_probs=193.4
Q ss_pred cCccccceeccCce---------------EEEEEee---cChhhHHHHHHHHHHHhhcCCCCccceecccccCccceEEE
Q 044312 289 DNFDLNRILGQGGQ---------------AVKKSKV---IDESKVEEFINEVVILSQINHRNVVKLLGCCLETEVPLLVY 350 (608)
Q Consensus 289 ~~f~~~~~lG~G~~---------------avk~~~~---~~~~~~~~~~~Ei~il~~l~H~niv~l~~~~~~~~~~~lV~ 350 (608)
++|++.+.||+|++ |||..+. .+......+.+|+++++.++||||+++++++.+.+..++|+
T Consensus 2 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 81 (267)
T cd08228 2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNIVL 81 (267)
T ss_pred cceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECCeEEEEE
Confidence 46788888888863 6665543 23445567899999999999999999999999999999999
Q ss_pred eecCCCccchhccccC-CCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEEcCCCcEEEeeccCcccccc
Q 044312 351 EFIPNGTLFQYIHDQN-EDFPITWEIRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAV 429 (608)
Q Consensus 351 E~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGls~~~~~ 429 (608)
||+++++|.+++.... ....+++..++.++.|++.||+|||+.+ ++|+||||+|||++.++.++|+|||++.....
T Consensus 82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~~~nil~~~~~~~~l~d~g~~~~~~~ 158 (267)
T cd08228 82 ELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSRR---VMHRDIKPANVFITATGVVKLGDLGLGRFFSS 158 (267)
T ss_pred EecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhCC---eeCCCCCHHHEEEcCCCCEEECccccceeccc
Confidence 9999999998886422 1235889999999999999999999998 99999999999999999999999999887653
Q ss_pred CCcceeeeeeccCCCCChhhhccCCCCCccchHhHHHHHHHHHhCCCCCCccchhhcccHHHHHHHHhhhhhhHHHhhhh
Q 044312 430 DQTHMTTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLTELLTGEKPIRFTILEEDKSLAAYFLCAMKEERLFEILDAR 509 (608)
Q Consensus 430 ~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 509 (608)
... ......+++.|+|||.+.+..++.++||||||++++||++|+.||...... ..... ..+... .
T Consensus 159 ~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~----~~~~~-~~~~~~--------~ 224 (267)
T cd08228 159 KTT-AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMN----LFSLC-QKIEQC--------D 224 (267)
T ss_pred hhH-HHhcCCCCccccChhhhccCCCCchhhHHHHHHHHHHHhcCCCCCcccccc----HHHHH-HHHhcC--------C
Confidence 222 122345788999999999889999999999999999999999998632211 11111 111110 0
Q ss_pred hhccCChhHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhhH
Q 044312 510 VMKQGGKDEIITVAKLAKRCLNLNGKKRPTMREVASELAGIK 551 (608)
Q Consensus 510 ~~~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~evl~~L~~i~ 551 (608)
.........+..+.+++.+||..+|++||++.||++.|++++
T Consensus 225 ~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~vl~~~~~~~ 266 (267)
T cd08228 225 YPPLPTEHYSEKLRELVSMCIYPDPDQRPDIGYVHQIAKQMH 266 (267)
T ss_pred CCCCChhhcCHHHHHHHHHHCCCCcccCcCHHHHHHHHHHhc
Confidence 111112244567999999999999999999999999998875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-35 Score=302.13 Aligned_cols=247 Identities=26% Similarity=0.445 Sum_probs=193.0
Q ss_pred hcCccccceeccCce----------------------EEEEEee-cChhhHHHHHHHHHHHhhc-CCCCccceecccccC
Q 044312 288 TDNFDLNRILGQGGQ----------------------AVKKSKV-IDESKVEEFINEVVILSQI-NHRNVVKLLGCCLET 343 (608)
Q Consensus 288 t~~f~~~~~lG~G~~----------------------avk~~~~-~~~~~~~~~~~Ei~il~~l-~H~niv~l~~~~~~~ 343 (608)
.++|.+.+.||+|++ |+|..+. ......+.+.+|+.+++.+ +||||+++++++...
T Consensus 14 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~ 93 (304)
T cd05101 14 RDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD 93 (304)
T ss_pred HHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccccchHHHHHHHHHHHHHHhhccCCCchheeEEEecC
Confidence 456788899999975 2222221 1233456789999999999 899999999999999
Q ss_pred ccceEEEeecCCCccchhccccCC-------------CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEE
Q 044312 344 EVPLLVYEFIPNGTLFQYIHDQNE-------------DFPITWEIRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILL 410 (608)
Q Consensus 344 ~~~~lV~E~~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl 410 (608)
...++||||+++++|.+++..... ...+++..++.++.||+.||.|||+++ ++||||||+|||+
T Consensus 94 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~g---ivH~dlkp~Nili 170 (304)
T cd05101 94 GPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQK---CIHRDLAARNVLV 170 (304)
T ss_pred CceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHCC---eeecccccceEEE
Confidence 999999999999999999976321 124789999999999999999999999 9999999999999
Q ss_pred cCCCcEEEeeccCccccccCCcce-eeeeeccCCCCChhhhccCCCCCccchHhHHHHHHHHHh-CCCCCCccchhhccc
Q 044312 411 DDKYRAKVSDFGASRSMAVDQTHM-TTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLTELLT-GEKPIRFTILEEDKS 488 (608)
Q Consensus 411 ~~~~~~kl~DFGls~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~ellt-g~~p~~~~~~~~~~~ 488 (608)
++++.+||+|||+++......... .....++..|+|||++.+..++.++||||||++++||++ |..||......
T Consensus 171 ~~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~---- 246 (304)
T cd05101 171 TENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVE---- 246 (304)
T ss_pred cCCCcEEECCCccceecccccccccccCCCCCceeeCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHH----
Confidence 999999999999998765332221 222345678999999998899999999999999999998 77887532111
Q ss_pred HHHHHHHHhhhhhhHHHhhhhhhccCChhHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhhHHh
Q 044312 489 LAAYFLCAMKEERLFEILDARVMKQGGKDEIITVAKLAKRCLNLNGKKRPTMREVASELAGIKAW 553 (608)
Q Consensus 489 l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~evl~~L~~i~~~ 553 (608)
.. .+.+........+...+..+.+|+.+||+.+|++||++.||++.|+.+...
T Consensus 247 --~~----------~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~l~~l~~~~~~ 299 (304)
T cd05101 247 --EL----------FKLLKEGHRMDKPANCTNELYMMMRDCWHAIPSHRPTFKQLVEDLDRILTL 299 (304)
T ss_pred --HH----------HHHHHcCCcCCCCCCCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHHHHh
Confidence 11 111111111122334567899999999999999999999999999888764
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-35 Score=292.66 Aligned_cols=235 Identities=26% Similarity=0.438 Sum_probs=188.2
Q ss_pred ccccceeccCce---------------EEEEEee--cChhhHHHHHHHHHHHhhcCCCCccceecccccCccceEEEeec
Q 044312 291 FDLNRILGQGGQ---------------AVKKSKV--IDESKVEEFINEVVILSQINHRNVVKLLGCCLETEVPLLVYEFI 353 (608)
Q Consensus 291 f~~~~~lG~G~~---------------avk~~~~--~~~~~~~~~~~Ei~il~~l~H~niv~l~~~~~~~~~~~lV~E~~ 353 (608)
|++.+.||+|++ ++|.... ......+.+.+|++++++++||||+++++++.+....++||||+
T Consensus 2 ~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 81 (256)
T cd08529 2 FEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIVMEYA 81 (256)
T ss_pred ceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeeeccCCEEEEEEEeC
Confidence 566677777763 5555443 23456778999999999999999999999999999999999999
Q ss_pred CCCccchhccccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEEcCCCcEEEeeccCccccccCCcc
Q 044312 354 PNGTLFQYIHDQNEDFPITWEIRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTH 433 (608)
Q Consensus 354 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGls~~~~~~~~~ 433 (608)
++++|.++++.... ..+++..+..++.|++.||.|||+.+ ++|+||||+||+++.++.+||+|||+++.......
T Consensus 82 ~~~~L~~~l~~~~~-~~~~~~~~~~i~~~l~~al~~lH~~~---i~h~dl~~~nili~~~~~~~l~df~~~~~~~~~~~- 156 (256)
T cd08529 82 ENGDLHKLLKMQRG-RPLPEDQVWRFFIQILLGLAHLHSKK---ILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTN- 156 (256)
T ss_pred CCCcHHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcceEEEeCCCCEEEcccccceeccCccc-
Confidence 99999999987532 25899999999999999999999998 99999999999999999999999999887653322
Q ss_pred eeeeeeccCCCCChhhhccCCCCCccchHhHHHHHHHHHhCCCCCCccchhhcccHHHHHHHHhhhhhhHHHhhhhhhcc
Q 044312 434 MTTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLTELLTGEKPIRFTILEEDKSLAAYFLCAMKEERLFEILDARVMKQ 513 (608)
Q Consensus 434 ~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~ 513 (608)
......+++.|+|||++.+..++.++||||||++++||++|+.||....... ....... .....
T Consensus 157 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~-------~~~~~~~---------~~~~~ 220 (256)
T cd08529 157 FANTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANNQGA-------LILKIIR---------GVFPP 220 (256)
T ss_pred hhhccccCccccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHH-------HHHHHHc---------CCCCC
Confidence 2233467889999999999999999999999999999999999986432110 0001111 11112
Q ss_pred CChhHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 044312 514 GGKDEIITVAKLAKRCLNLNGKKRPTMREVASE 546 (608)
Q Consensus 514 ~~~~~~~~l~~Li~~cl~~dp~~RPs~~evl~~ 546 (608)
.+...+..+.+++.+||+.+|++||++.+++++
T Consensus 221 ~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~ 253 (256)
T cd08529 221 VSQMYSQQLAQLIDQCLTKDYRQRPDTFQLLRN 253 (256)
T ss_pred CccccCHHHHHHHHHHccCCcccCcCHHHHhhC
Confidence 222456789999999999999999999999864
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-35 Score=302.40 Aligned_cols=245 Identities=25% Similarity=0.458 Sum_probs=191.9
Q ss_pred HhcCccccceeccCce--------------------EEEEEeec-ChhhHHHHHHHHHHHhhc-CCCCccceecccccCc
Q 044312 287 ATDNFDLNRILGQGGQ--------------------AVKKSKVI-DESKVEEFINEVVILSQI-NHRNVVKLLGCCLETE 344 (608)
Q Consensus 287 ~t~~f~~~~~lG~G~~--------------------avk~~~~~-~~~~~~~~~~Ei~il~~l-~H~niv~l~~~~~~~~ 344 (608)
..++|.+.+.||+|++ |||..+.. .....+.+.+|+.+++++ +|+||+++++++...+
T Consensus 33 ~~~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~ 112 (302)
T cd05055 33 PRNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIVNLLGACTIGG 112 (302)
T ss_pred cHHHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCChHHHHHHHHHHHHHHhccCCCCcceEEEEEecCC
Confidence 3456888899999875 33333322 233456799999999999 8999999999999999
Q ss_pred cceEEEeecCCCccchhccccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEEcCCCcEEEeeccCc
Q 044312 345 VPLLVYEFIPNGTLFQYIHDQNEDFPITWEIRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGAS 424 (608)
Q Consensus 345 ~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGls 424 (608)
..++||||+++|+|.++++..... .+++.++..++.|++.||+|||+.+ ++|+||||+|||+++++.+||+|||++
T Consensus 113 ~~~lv~e~~~~~~L~~~i~~~~~~-~l~~~~~~~i~~~i~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~~l~dfg~~ 188 (302)
T cd05055 113 PILVITEYCCYGDLLNFLRRKRES-FLTLEDLLSFSYQVAKGMAFLASKN---CIHRDLAARNVLLTHGKIVKICDFGLA 188 (302)
T ss_pred ceEEEEEcCCCCcHHHHHHhCCCC-CCCHHHHHHHHHHHHHHHHHHHHCC---eehhhhccceEEEcCCCeEEECCCccc
Confidence 999999999999999999764322 3899999999999999999999998 999999999999999999999999999
Q ss_pred cccccCCcc-eeeeeeccCCCCChhhhccCCCCCccchHhHHHHHHHHHh-CCCCCCccchhhcccHHHHHHHHhhhhhh
Q 044312 425 RSMAVDQTH-MTTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLTELLT-GEKPIRFTILEEDKSLAAYFLCAMKEERL 502 (608)
Q Consensus 425 ~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~ellt-g~~p~~~~~~~~~~~l~~~~~~~~~~~~~ 502 (608)
+........ ......++..|+|||.+....++.++||||||++++||++ |..||....... ..
T Consensus 189 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~t~g~~p~~~~~~~~---------------~~ 253 (302)
T cd05055 189 RDIMNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPVDS---------------KF 253 (302)
T ss_pred ccccCCCceeecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHHHhCCCCCcCCCCchH---------------HH
Confidence 866543221 1122345678999999999999999999999999999998 999986322111 01
Q ss_pred HHHhhhhhhccCChhHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhh
Q 044312 503 FEILDARVMKQGGKDEIITVAKLAKRCLNLNGKKRPTMREVASELAGI 550 (608)
Q Consensus 503 ~~~~d~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~evl~~L~~i 550 (608)
.+.+........+...+.++.+++.+||+.+|++||++.||++.|+.+
T Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ell~~l~~~ 301 (302)
T cd05055 254 YKLIKEGYRMAQPEHAPAEIYDIMKTCWDADPLKRPTFKQIVQLIGKQ 301 (302)
T ss_pred HHHHHcCCcCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHhh
Confidence 111111111122233456899999999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-35 Score=293.20 Aligned_cols=225 Identities=26% Similarity=0.402 Sum_probs=179.8
Q ss_pred eEEEEEeec--ChhhHHHHHHHHHHHhhcCCCCccceecccccCccceEEEeecCCCccchhccccCCCCCCCHHHHHHH
Q 044312 302 QAVKKSKVI--DESKVEEFINEVVILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEIRLRI 379 (608)
Q Consensus 302 ~avk~~~~~--~~~~~~~~~~Ei~il~~l~H~niv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i 379 (608)
+|+|..+.. +....+++.+|+.+++.++|+||+++++++. .+..++||||+++++|.+++.... .+++..+..+
T Consensus 25 ~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~~~~~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~i 100 (257)
T cd05116 25 VAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICE-AESWMLVMELAELGPLNKFLQKNK---HVTEKNITEL 100 (257)
T ss_pred EEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEc-CCCcEEEEecCCCCcHHHHHHhcC---CCCHHHHHHH
Confidence 577776543 2345678999999999999999999999885 456789999999999999987543 5899999999
Q ss_pred HHHHHHHHHHHhhcCCCCeeccCCCCCcEEEcCCCcEEEeeccCccccccCCccee--eeeeccCCCCChhhhccCCCCC
Q 044312 380 AIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMT--TQVHGTFGYLDPEYFRSSQFTD 457 (608)
Q Consensus 380 ~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGls~~~~~~~~~~~--~~~~gt~~y~aPE~~~~~~~t~ 457 (608)
+.|++.||+|||+.+ ++||||||+|||+++++.+||+|||+++.......... ....++..|+|||.+....++.
T Consensus 101 ~~qi~~al~~lH~~~---i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~ 177 (257)
T cd05116 101 VHQVSMGMKYLEETN---FVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAKTHGKWPVKWYAPECMNYYKFSS 177 (257)
T ss_pred HHHHHHHHHHHHHCC---EeecccchhhEEEcCCCeEEECCCccccccCCCCCeeeecCCCCCCccccCHhHhccCCcCc
Confidence 999999999999999 99999999999999999999999999987654332211 1223457899999998888999
Q ss_pred ccchHhHHHHHHHHHh-CCCCCCccchhhcccHHHHHHHHhhhhhhHHHhhhhhhccCChhHHHHHHHHHHHHhccCCCC
Q 044312 458 KSDVYSFGVVLTELLT-GEKPIRFTILEEDKSLAAYFLCAMKEERLFEILDARVMKQGGKDEIITVAKLAKRCLNLNGKK 536 (608)
Q Consensus 458 ksDV~S~Gvvl~ellt-g~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~Li~~cl~~dp~~ 536 (608)
++||||||++++||++ |+.||...... .+.+.+........+...+.++.+|+.+||+.||++
T Consensus 178 ~~Di~slG~~l~el~t~g~~p~~~~~~~----------------~~~~~i~~~~~~~~~~~~~~~l~~li~~~~~~~p~~ 241 (257)
T cd05116 178 KSDVWSFGVLMWEAFSYGQKPYKGMKGN----------------EVTQMIESGERMECPQRCPPEMYDLMKLCWTYGVDE 241 (257)
T ss_pred hhHHHHHHHHHHHHHhCCCCCCCCCCHH----------------HHHHHHHCCCCCCCCCCCCHHHHHHHHHHhccCchh
Confidence 9999999999999998 99998632211 111112221222233456678999999999999999
Q ss_pred CCCHHHHHHHHHh
Q 044312 537 RPTMREVASELAG 549 (608)
Q Consensus 537 RPs~~evl~~L~~ 549 (608)
||++.+|.+.|+.
T Consensus 242 Rp~~~~i~~~l~~ 254 (257)
T cd05116 242 RPGFAVVELRLRN 254 (257)
T ss_pred CcCHHHHHHHHhc
Confidence 9999999999875
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-34 Score=343.91 Aligned_cols=249 Identities=24% Similarity=0.430 Sum_probs=194.6
Q ss_pred hcCccccceeccCce---------------EEEEEeecChhhHHHHHHHHHHHhhcCCCCccceecccccCccceEEEee
Q 044312 288 TDNFDLNRILGQGGQ---------------AVKKSKVIDESKVEEFINEVVILSQINHRNVVKLLGCCLETEVPLLVYEF 352 (608)
Q Consensus 288 t~~f~~~~~lG~G~~---------------avk~~~~~~~~~~~~~~~Ei~il~~l~H~niv~l~~~~~~~~~~~lV~E~ 352 (608)
...|...++||+|++ |||+.+.... ....|++++++++|||||+++++|.+.+..++||||
T Consensus 689 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~----~~~~~~~~l~~l~HpnIv~~~~~~~~~~~~~lv~Ey 764 (968)
T PLN00113 689 LSSLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNS----IPSSEIADMGKLQHPNIVKLIGLCRSEKGAYLIHEY 764 (968)
T ss_pred HhhCCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCcc----ccHHHHHHHhhCCCCCcceEEEEEEcCCCCEEEEeC
Confidence 345777889999975 4554432221 223568899999999999999999999999999999
Q ss_pred cCCCccchhccccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEEcCCCcEEEeeccCccccccCCc
Q 044312 353 IPNGTLFQYIHDQNEDFPITWEIRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQT 432 (608)
Q Consensus 353 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGls~~~~~~~~ 432 (608)
+++|+|.++++ .++|..+.+|+.|||+||+|||+...++|+||||||+|||++.++..++. |+.+.....+
T Consensus 765 ~~~g~L~~~l~------~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~~~~~~~~~-- 835 (968)
T PLN00113 765 IEGKNLSEVLR------NLSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLCTD-- 835 (968)
T ss_pred CCCCcHHHHHh------cCCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE-eccccccccC--
Confidence 99999999985 27899999999999999999996655559999999999999999888875 6665543221
Q ss_pred ceeeeeeccCCCCChhhhccCCCCCccchHhHHHHHHHHHhCCCCCCccchhhcccHHHHHHHHhhhhhhHHHhhhhhhc
Q 044312 433 HMTTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLTELLTGEKPIRFTILEEDKSLAAYFLCAMKEERLFEILDARVMK 512 (608)
Q Consensus 433 ~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~ 512 (608)
....+++.|+|||++.+..++.|+|||||||++|||+||+.||.... ........|............++|+.+..
T Consensus 836 ---~~~~~t~~y~aPE~~~~~~~~~~sDv~S~Gvvl~el~tg~~p~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 911 (968)
T PLN00113 836 ---TKCFISSAYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADAEF-GVHGSIVEWARYCYSDCHLDMWIDPSIRG 911 (968)
T ss_pred ---CCccccccccCcccccCCCCCcccchhhHHHHHHHHHhCCCCCCccc-CCCCcHHHHHHHhcCccchhheeCccccC
Confidence 12357899999999999999999999999999999999999985322 22334455554444444444555554432
Q ss_pred --cCChhHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhhHHh
Q 044312 513 --QGGKDEIITVAKLAKRCLNLNGKKRPTMREVASELAGIKAW 553 (608)
Q Consensus 513 --~~~~~~~~~l~~Li~~cl~~dp~~RPs~~evl~~L~~i~~~ 553 (608)
....+...++.+++.+||+.||++||+|+||+++|+.+...
T Consensus 912 ~~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~~~~~ 954 (968)
T PLN00113 912 DVSVNQNEIVEVMNLALHCTATDPTARPCANDVLKTLESASRS 954 (968)
T ss_pred CCCccHHHHHHHHHHHHhhCcCCchhCcCHHHHHHHHHHhhcc
Confidence 22345667889999999999999999999999999887653
|
|
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-35 Score=294.63 Aligned_cols=240 Identities=25% Similarity=0.405 Sum_probs=187.4
Q ss_pred cCccccceeccCce--------------EEEEEeecChhhHHHHHHHHHHHhhcCCCCccceecccccCccceEEEeecC
Q 044312 289 DNFDLNRILGQGGQ--------------AVKKSKVIDESKVEEFINEVVILSQINHRNVVKLLGCCLETEVPLLVYEFIP 354 (608)
Q Consensus 289 ~~f~~~~~lG~G~~--------------avk~~~~~~~~~~~~~~~Ei~il~~l~H~niv~l~~~~~~~~~~~lV~E~~~ 354 (608)
++|++.++||+|++ |+|+.+. .....+.|.+|++++++++|+||+++++.+.+ ...++||||++
T Consensus 6 ~~~~~~~~lg~g~~~~v~~~~~~~~~~valK~~~~-~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~-~~~~lv~e~~~ 83 (262)
T cd05071 6 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKP-GTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYMS 83 (262)
T ss_pred HHeeEeeecCCCCCCcEEEEEecCCceEEEEeccc-CccCHHHHHHHHHHHHhCCCCCcceEEEEECC-CCcEEEEEcCC
Confidence 45778888888864 4555442 12235679999999999999999999998754 56799999999
Q ss_pred CCccchhccccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEEcCCCcEEEeeccCccccccCCcce
Q 044312 355 NGTLFQYIHDQNEDFPITWEIRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHM 434 (608)
Q Consensus 355 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGls~~~~~~~~~~ 434 (608)
+++|.+++..... ..+++..++.++.|+++||+|||+.+ ++||||||+|||+++++.+||+|||+++.........
T Consensus 84 ~~~L~~~~~~~~~-~~~~~~~~~~~~~~l~~aL~~lH~~~---i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~~~~~~~ 159 (262)
T cd05071 84 KGSLLDFLKGEMG-KYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTA 159 (262)
T ss_pred CCcHHHHHhhccc-cCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccCcccEEEcCCCcEEeccCCceeecccccccc
Confidence 9999999976432 24799999999999999999999998 9999999999999999999999999998665333222
Q ss_pred eeeeeccCCCCChhhhccCCCCCccchHhHHHHHHHHHh-CCCCCCccchhhcccHHHHHHHHhhhhhhHHHhhhhhhcc
Q 044312 435 TTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLTELLT-GEKPIRFTILEEDKSLAAYFLCAMKEERLFEILDARVMKQ 513 (608)
Q Consensus 435 ~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~ellt-g~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~ 513 (608)
.....++..|+|||+.....++.++||||||++++||+| |+.||......+ . . +.+.......
T Consensus 160 ~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ellt~g~~p~~~~~~~~---~----~---------~~~~~~~~~~ 223 (262)
T cd05071 160 RQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNRE---V----L---------DQVERGYRMP 223 (262)
T ss_pred ccCCcccceecCHhHhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCChHH---H----H---------HHHhcCCCCC
Confidence 223346678999999998999999999999999999999 788876322111 0 0 0011111112
Q ss_pred CChhHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhh
Q 044312 514 GGKDEIITVAKLAKRCLNLNGKKRPTMREVASELAGI 550 (608)
Q Consensus 514 ~~~~~~~~l~~Li~~cl~~dp~~RPs~~evl~~L~~i 550 (608)
.....+..+.+|+.+||+.+|++||++.++++.|+..
T Consensus 224 ~~~~~~~~l~~li~~~l~~~p~~Rp~~~~~~~~l~~~ 260 (262)
T cd05071 224 CPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDY 260 (262)
T ss_pred CccccCHHHHHHHHHHccCCcccCCCHHHHHHHHHHh
Confidence 2335567899999999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-35 Score=295.20 Aligned_cols=241 Identities=25% Similarity=0.441 Sum_probs=189.0
Q ss_pred cCccccceeccCce------------------EEEEEee-cChhhHHHHHHHHHHHhhcCCCCccceecccccCccceEE
Q 044312 289 DNFDLNRILGQGGQ------------------AVKKSKV-IDESKVEEFINEVVILSQINHRNVVKLLGCCLETEVPLLV 349 (608)
Q Consensus 289 ~~f~~~~~lG~G~~------------------avk~~~~-~~~~~~~~~~~Ei~il~~l~H~niv~l~~~~~~~~~~~lV 349 (608)
.+|++.+.||+|++ |+|..+. ......+.|.+|+.++++++||||+++++++.+.+..++|
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 83 (267)
T cd05066 4 SCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKPVMIV 83 (267)
T ss_pred HHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEEE
Confidence 35677778888764 3343332 1233456899999999999999999999999999999999
Q ss_pred EeecCCCccchhccccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEEcCCCcEEEeeccCcccccc
Q 044312 350 YEFIPNGTLFQYIHDQNEDFPITWEIRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAV 429 (608)
Q Consensus 350 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGls~~~~~ 429 (608)
|||+++++|.+++..... .+++.+++.++.|++.||+|||+.+ ++||||||+|||++.++.+||+|||+++....
T Consensus 84 ~e~~~~~~L~~~~~~~~~--~~~~~~~~~i~~~i~~~l~~lH~~~---i~h~dlkp~nili~~~~~~~l~dfg~~~~~~~ 158 (267)
T cd05066 84 TEYMENGSLDAFLRKHDG--QFTVIQLVGMLRGIASGMKYLSDMG---YVHRDLAARNILVNSNLVCKVSDFGLSRVLED 158 (267)
T ss_pred EEcCCCCCHHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHHCC---EeehhhchhcEEECCCCeEEeCCCCccccccc
Confidence 999999999999976543 4899999999999999999999999 99999999999999999999999999987654
Q ss_pred CCcceee--eeeccCCCCChhhhccCCCCCccchHhHHHHHHHHHh-CCCCCCccchhhcccHHHHHHHHhhhhhhHHHh
Q 044312 430 DQTHMTT--QVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLTELLT-GEKPIRFTILEEDKSLAAYFLCAMKEERLFEIL 506 (608)
Q Consensus 430 ~~~~~~~--~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~ellt-g~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 506 (608)
......+ ...++..|+|||++.+..++.++||||||++++|+++ |..||......+ ....+...
T Consensus 159 ~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~~~-------~~~~~~~~------ 225 (267)
T cd05066 159 DPEAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQD-------VIKAIEEG------ 225 (267)
T ss_pred ccceeeecCCCccceeecCHhHhccCccCchhhhHHHHHHHHHHhcCCCCCcccCCHHH-------HHHHHhCC------
Confidence 3322221 1223567999999999899999999999999999887 999986322111 01111110
Q ss_pred hhhhhccCChhHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhh
Q 044312 507 DARVMKQGGKDEIITVAKLAKRCLNLNGKKRPTMREVASELAGI 550 (608)
Q Consensus 507 d~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~evl~~L~~i 550 (608)
.....+...+..+.+++.+||+.+|++||+|.++++.|+.+
T Consensus 226 ---~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 266 (267)
T cd05066 226 ---YRLPAPMDCPAALHQLMLDCWQKDRNERPKFEQIVSILDKL 266 (267)
T ss_pred ---CcCCCCCCCCHHHHHHHHHHcccCchhCCCHHHHHHHHHhh
Confidence 11122234566889999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-35 Score=292.64 Aligned_cols=226 Identities=25% Similarity=0.410 Sum_probs=178.6
Q ss_pred eEEEEEee-cChhhHHHHHHHHHHHhhcCCCCccceecccccCccceEEEeecCCCccchhccccCCCCCCCHHHHHHHH
Q 044312 302 QAVKKSKV-IDESKVEEFINEVVILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEIRLRIA 380 (608)
Q Consensus 302 ~avk~~~~-~~~~~~~~~~~Ei~il~~l~H~niv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~ 380 (608)
+|+|.... ........|.+|++++++++||||+++++++......++||||+++++|.+++..... .+++..++.++
T Consensus 23 ~a~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~--~~~~~~~~~~~ 100 (252)
T cd05084 23 VAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDFLTFLRTEGP--RLKVKELIQMV 100 (252)
T ss_pred EEEEecCccCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEeeccCCcHHHHHHhCCC--CCCHHHHHHHH
Confidence 46665543 2344567899999999999999999999999999999999999999999999875432 48999999999
Q ss_pred HHHHHHHHHHhhcCCCCeeccCCCCCcEEEcCCCcEEEeeccCccccccCCccee-eeeeccCCCCChhhhccCCCCCcc
Q 044312 381 IEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMT-TQVHGTFGYLDPEYFRSSQFTDKS 459 (608)
Q Consensus 381 ~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGls~~~~~~~~~~~-~~~~gt~~y~aPE~~~~~~~t~ks 459 (608)
.|++.||+|||+.+ ++||||||+|||++.++.+||+|||+++.......... .....+..|+|||.+....++.++
T Consensus 101 ~qi~~~L~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~ 177 (252)
T cd05084 101 ENAAAGMEYLESKH---CIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGGMKQIPVKWTAPEALNYGRYSSES 177 (252)
T ss_pred HHHHHHHHHHHhCC---ccccccchheEEEcCCCcEEECccccCcccccccccccCCCCCCceeecCchhhcCCCCChHH
Confidence 99999999999999 99999999999999999999999999876432211110 111234579999999999999999
Q ss_pred chHhHHHHHHHHHh-CCCCCCccchhhcccHHHHHHHHhhhhhhHHHhhhhhhccCChhHHHHHHHHHHHHhccCCCCCC
Q 044312 460 DVYSFGVVLTELLT-GEKPIRFTILEEDKSLAAYFLCAMKEERLFEILDARVMKQGGKDEIITVAKLAKRCLNLNGKKRP 538 (608)
Q Consensus 460 DV~S~Gvvl~ellt-g~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RP 538 (608)
||||||++++||++ |..||...... .....+........+...+..+.+|+.+||+.+|++||
T Consensus 178 Dv~slG~il~e~~~~~~~p~~~~~~~----------------~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp 241 (252)
T cd05084 178 DVWSFGILLWEAFSLGAVPYANLSNQ----------------QTREAIEQGVRLPCPELCPDAVYRLMERCWEYDPGQRP 241 (252)
T ss_pred HHHHHHHHHHHHHhCCCCCccccCHH----------------HHHHHHHcCCCCCCcccCCHHHHHHHHHHcCCChhhCc
Confidence 99999999999998 88887532211 11111111112223334567899999999999999999
Q ss_pred CHHHHHHHHH
Q 044312 539 TMREVASELA 548 (608)
Q Consensus 539 s~~evl~~L~ 548 (608)
|+.||++.|+
T Consensus 242 s~~~~~~~l~ 251 (252)
T cd05084 242 SFSTVHQELQ 251 (252)
T ss_pred CHHHHHHHHh
Confidence 9999998875
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-35 Score=302.43 Aligned_cols=247 Identities=25% Similarity=0.440 Sum_probs=191.5
Q ss_pred hcCccccceeccCce----------------------EEEEEee-cChhhHHHHHHHHHHHhhc-CCCCccceecccccC
Q 044312 288 TDNFDLNRILGQGGQ----------------------AVKKSKV-IDESKVEEFINEVVILSQI-NHRNVVKLLGCCLET 343 (608)
Q Consensus 288 t~~f~~~~~lG~G~~----------------------avk~~~~-~~~~~~~~~~~Ei~il~~l-~H~niv~l~~~~~~~ 343 (608)
.++|.+.+.||+|++ |+|..+. .......++.+|+.+++++ +||||+++++++.+.
T Consensus 11 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~ 90 (314)
T cd05099 11 RDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKNIINLLGVCTQE 90 (314)
T ss_pred HHHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCChHHHHHHHHHHHHHHhccCCCCeeeEEEEEccC
Confidence 356777888888874 3333332 1234456789999999999 699999999999998
Q ss_pred ccceEEEeecCCCccchhccccCC-------------CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEE
Q 044312 344 EVPLLVYEFIPNGTLFQYIHDQNE-------------DFPITWEIRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILL 410 (608)
Q Consensus 344 ~~~~lV~E~~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl 410 (608)
...++||||+++|+|.+++..... ...+++..+++++.|++.||.|||+++ ++||||||+|||+
T Consensus 91 ~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~g---i~H~dlkp~Nill 167 (314)
T cd05099 91 GPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESRR---CIHRDLAARNVLV 167 (314)
T ss_pred CceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHCC---eeeccccceeEEE
Confidence 899999999999999999975321 124899999999999999999999998 9999999999999
Q ss_pred cCCCcEEEeeccCccccccCCcce-eeeeeccCCCCChhhhccCCCCCccchHhHHHHHHHHHh-CCCCCCccchhhccc
Q 044312 411 DDKYRAKVSDFGASRSMAVDQTHM-TTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLTELLT-GEKPIRFTILEEDKS 488 (608)
Q Consensus 411 ~~~~~~kl~DFGls~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~ellt-g~~p~~~~~~~~~~~ 488 (608)
++++.+||+|||+++......... .....++..|+|||.+....++.++||||||++++||++ |..||......+
T Consensus 168 ~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~--- 244 (314)
T cd05099 168 TEDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGIPVEE--- 244 (314)
T ss_pred cCCCcEEEccccccccccccccccccccCCCCccccCHHHHccCCcCccchhhHHHHHHHHHHhCCCCCCCCCCHHH---
Confidence 999999999999998664322111 112234467999999999999999999999999999999 888885322111
Q ss_pred HHHHHHHHhhhhhhHHHhhhhhhccCChhHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhhHHh
Q 044312 489 LAAYFLCAMKEERLFEILDARVMKQGGKDEIITVAKLAKRCLNLNGKKRPTMREVASELAGIKAW 553 (608)
Q Consensus 489 l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~evl~~L~~i~~~ 553 (608)
+.+.+........+...+.++.+|+.+||+.+|++||++.|+++.|+.+...
T Consensus 245 -------------~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l~~~~~~ 296 (314)
T cd05099 245 -------------LFKLLREGHRMDKPSNCTHELYMLMRECWHAVPTQRPTFKQLVEALDKVLAA 296 (314)
T ss_pred -------------HHHHHHcCCCCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHHH
Confidence 1111111111122334556889999999999999999999999999888664
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=294.29 Aligned_cols=243 Identities=28% Similarity=0.413 Sum_probs=189.9
Q ss_pred cCccccceeccCce------------------EEEEEeecC-hhhHHHHHHHHHHHhhcCCCCccceecccccCccceEE
Q 044312 289 DNFDLNRILGQGGQ------------------AVKKSKVID-ESKVEEFINEVVILSQINHRNVVKLLGCCLETEVPLLV 349 (608)
Q Consensus 289 ~~f~~~~~lG~G~~------------------avk~~~~~~-~~~~~~~~~Ei~il~~l~H~niv~l~~~~~~~~~~~lV 349 (608)
++|.+.+.||+|++ ++|...... ....+.|.+|+.++++++||||+++++++.+ +..++|
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-~~~~lv 84 (270)
T cd05056 6 EDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKLIGVITE-NPVWIV 84 (270)
T ss_pred hhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcCCHHHHHHHHHHHHHHHhCCCCchhceeEEEcC-CCcEEE
Confidence 34667777887764 334433322 4456789999999999999999999998865 457899
Q ss_pred EeecCCCccchhccccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEEcCCCcEEEeeccCcccccc
Q 044312 350 YEFIPNGTLFQYIHDQNEDFPITWEIRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAV 429 (608)
Q Consensus 350 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGls~~~~~ 429 (608)
|||+++++|.+++..... .+++..++.++.+++.||+|||+.+ ++|+||||+|||++.++.+||+|||+++....
T Consensus 85 ~e~~~~~~L~~~l~~~~~--~~~~~~~~~~~~~l~~~l~~lH~~~---~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~ 159 (270)
T cd05056 85 MELAPLGELRSYLQVNKY--SLDLASLILYSYQLSTALAYLESKR---FVHRDIAARNVLVSSPDCVKLGDFGLSRYLED 159 (270)
T ss_pred EEcCCCCcHHHHHHhCCC--CCCHHHHHHHHHHHHHHHHHHHhCC---eeccccChheEEEecCCCeEEccCceeeeccc
Confidence 999999999999976433 4899999999999999999999998 99999999999999999999999999987654
Q ss_pred CCcceeeeeeccCCCCChhhhccCCCCCccchHhHHHHHHHHHh-CCCCCCccchhhcccHHHHHHHHhhhhhhHHHhhh
Q 044312 430 DQTHMTTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLTELLT-GEKPIRFTILEEDKSLAAYFLCAMKEERLFEILDA 508 (608)
Q Consensus 430 ~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~ellt-g~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 508 (608)
..........++..|+|||.+....++.++||||||++++||++ |..||......+ ... .+...
T Consensus 160 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~------~~~-~~~~~-------- 224 (270)
T cd05056 160 ESYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKNND------VIG-RIENG-------- 224 (270)
T ss_pred ccceecCCCCccccccChhhhccCCCCchhhhHHHHHHHHHHHHcCCCCCCCCCHHH------HHH-HHHcC--------
Confidence 43222223334568999999988899999999999999999986 999986332111 010 11110
Q ss_pred hhhccCChhHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhhHHh
Q 044312 509 RVMKQGGKDEIITVAKLAKRCLNLNGKKRPTMREVASELAGIKAW 553 (608)
Q Consensus 509 ~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~evl~~L~~i~~~ 553 (608)
.....+...+..+.+++.+|+..+|++|||+.++++.|+.++..
T Consensus 225 -~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~~~~l~~~~~~ 268 (270)
T cd05056 225 -ERLPMPPNCPPTLYSLMTKCWAYDPSKRPRFTELKAQLSDILQE 268 (270)
T ss_pred -CcCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhc
Confidence 11122345567899999999999999999999999999887653
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-35 Score=322.23 Aligned_cols=251 Identities=23% Similarity=0.351 Sum_probs=205.9
Q ss_pred HHhcCccccceeccCce---------------EEEEEeecChhhHHHHHHHHHHHhhcC-CCCccceec-cccc------
Q 044312 286 KATDNFDLNRILGQGGQ---------------AVKKSKVIDESKVEEFINEVVILSQIN-HRNVVKLLG-CCLE------ 342 (608)
Q Consensus 286 ~~t~~f~~~~~lG~G~~---------------avk~~~~~~~~~~~~~~~Ei~il~~l~-H~niv~l~~-~~~~------ 342 (608)
....+.++.+.|.+||| |+|+.-..++...+...+||.+|++|+ |||||.+++ ....
T Consensus 34 Vg~~~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~~~ 113 (738)
T KOG1989|consen 34 VGSHRVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVNDEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSNNG 113 (738)
T ss_pred ECCEEEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecCCHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCCCc
Confidence 34556788899999996 777777778899999999999999996 999999999 3321
Q ss_pred CccceEEEeecCCCccchhccccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEEcCCCcEEEeecc
Q 044312 343 TEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEIRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFG 422 (608)
Q Consensus 343 ~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFG 422 (608)
.-+.+|.||||.+|.|.+++...... .|++.++++|+.++++|+++||... +||||||||-+||||+.++..||+|||
T Consensus 114 ~~EvllLmEyC~gg~Lvd~mn~Rlq~-~lte~eVLkIf~dv~~AVa~mH~~~-pPiIHRDLKiENvLls~~g~~KLCDFG 191 (738)
T KOG1989|consen 114 VWEVLLLMEYCKGGSLVDFMNTRLQT-RLTEDEVLKIFYDVCEAVAAMHYLK-PPIIHRDLKIENVLLSADGNYKLCDFG 191 (738)
T ss_pred eeEEEeehhhccCCcHHHHHHHHHhc-cCChHHHHHHHHHHHHHHHHHhcCC-CccchhhhhhhheEEcCCCCEEeCccc
Confidence 12568999999999999999875444 4999999999999999999999987 679999999999999999999999999
Q ss_pred CccccccCCc--cee------eeeeccCCCCChhhh---ccCCCCCccchHhHHHHHHHHHhCCCCCCccchhhcccHHH
Q 044312 423 ASRSMAVDQT--HMT------TQVHGTFGYLDPEYF---RSSQFTDKSDVYSFGVVLTELLTGEKPIRFTILEEDKSLAA 491 (608)
Q Consensus 423 ls~~~~~~~~--~~~------~~~~gt~~y~aPE~~---~~~~~t~ksDV~S~Gvvl~elltg~~p~~~~~~~~~~~l~~ 491 (608)
.+.-...... ... -...-|+-|+|||++ .+...++|+|||+|||+||-|+....||+..
T Consensus 192 Satt~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~s---------- 261 (738)
T KOG1989|consen 192 SATTKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEES---------- 261 (738)
T ss_pred ccccccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcC----------
Confidence 8864332211 000 012358899999986 4567899999999999999999999999722
Q ss_pred HHHHHhhhhhhHHHhhhhhhccCChhHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhhHHhcCCC
Q 044312 492 YFLCAMKEERLFEILDARVMKQGGKDEIITVAKLAKRCLNLNGKKRPTMREVASELAGIKAWNGAS 557 (608)
Q Consensus 492 ~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~evl~~L~~i~~~~~~~ 557 (608)
-...|++..+.......++..|.+||+.||+.||++||++-+|+..+..+.......
T Consensus 262 ---------g~laIlng~Y~~P~~p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~~~~l~~~~~~~ 318 (738)
T KOG1989|consen 262 ---------GKLAILNGNYSFPPFPNYSDRLKDLIRTMLQPNPDERPNIYQVLEEIFELANKPCPI 318 (738)
T ss_pred ---------cceeEEeccccCCCCccHHHHHHHHHHHHhccCcccCCCHHHHHHHHHHHhcCCCCc
Confidence 123566666666666788999999999999999999999999999998887654433
|
|
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-34 Score=294.85 Aligned_cols=228 Identities=26% Similarity=0.441 Sum_probs=177.9
Q ss_pred EEEEEee-cChhhHHHHHHHHHHHhhc-CCCCccceecccccCccceEEEeecCCCccchhccccC-------------C
Q 044312 303 AVKKSKV-IDESKVEEFINEVVILSQI-NHRNVVKLLGCCLETEVPLLVYEFIPNGTLFQYIHDQN-------------E 367 (608)
Q Consensus 303 avk~~~~-~~~~~~~~~~~Ei~il~~l-~H~niv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~-------------~ 367 (608)
++|..+. ......+.+.+|+++++++ +||||+++++++......++||||+++++|.+++.... .
T Consensus 26 ~~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~ 105 (270)
T cd05047 26 AIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANST 105 (270)
T ss_pred EEEEccccCCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEeCCCCcHHHHHHhccccccccccccccCC
Confidence 4455442 2344567899999999999 89999999999999999999999999999999987532 1
Q ss_pred CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEEcCCCcEEEeeccCccccccCCcceeeeeeccCCCCCh
Q 044312 368 DFPITWEIRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHGTFGYLDP 447 (608)
Q Consensus 368 ~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGls~~~~~~~~~~~~~~~gt~~y~aP 447 (608)
...+++..++.++.|++.||+|||+.+ ++||||||+|||+++++.+||+|||+++...... .......+..|+||
T Consensus 106 ~~~l~~~~~~~~~~~i~~al~~lH~~~---i~H~dikp~nili~~~~~~kl~dfgl~~~~~~~~--~~~~~~~~~~y~ap 180 (270)
T cd05047 106 ASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYVAKIADFGLSRGQEVYV--KKTMGRLPVRWMAI 180 (270)
T ss_pred cCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccccceEEEcCCCeEEECCCCCccccchhh--hccCCCCccccCCh
Confidence 124789999999999999999999998 9999999999999999999999999986432111 11112235679999
Q ss_pred hhhccCCCCCccchHhHHHHHHHHHh-CCCCCCccchhhcccHHHHHHHHhhhhhhHHHhhhhhhccCChhHHHHHHHHH
Q 044312 448 EYFRSSQFTDKSDVYSFGVVLTELLT-GEKPIRFTILEEDKSLAAYFLCAMKEERLFEILDARVMKQGGKDEIITVAKLA 526 (608)
Q Consensus 448 E~~~~~~~t~ksDV~S~Gvvl~ellt-g~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~Li 526 (608)
|++....++.++||||||++++||++ |..||...... . ..+.+......+.+...+.++.+|+
T Consensus 181 E~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~------~----------~~~~~~~~~~~~~~~~~~~~~~~li 244 (270)
T cd05047 181 ESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCA------E----------LYEKLPQGYRLEKPLNCDDEVYDLM 244 (270)
T ss_pred HHHccCCCCchhhHHHHHHHHHHHHcCCCCCccccCHH------H----------HHHHHhCCCCCCCCCcCCHHHHHHH
Confidence 99998899999999999999999997 99998532111 1 1111111111122334456799999
Q ss_pred HHHhccCCCCCCCHHHHHHHHHhhH
Q 044312 527 KRCLNLNGKKRPTMREVASELAGIK 551 (608)
Q Consensus 527 ~~cl~~dp~~RPs~~evl~~L~~i~ 551 (608)
.+||+.+|.+|||+.|+++.|+.+.
T Consensus 245 ~~~l~~~p~~Rps~~~il~~l~~~~ 269 (270)
T cd05047 245 RQCWREKPYERPSFAQILVSLNRML 269 (270)
T ss_pred HHHcccChhhCCCHHHHHHHHHHhh
Confidence 9999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-35 Score=304.03 Aligned_cols=238 Identities=26% Similarity=0.378 Sum_probs=192.7
Q ss_pred HHhcCccccceeccCce---------------EEEEEee---cChhhHHHHHHHHHHHhhcCCCCccceecccccCccce
Q 044312 286 KATDNFDLNRILGQGGQ---------------AVKKSKV---IDESKVEEFINEVVILSQINHRNVVKLLGCCLETEVPL 347 (608)
Q Consensus 286 ~~t~~f~~~~~lG~G~~---------------avk~~~~---~~~~~~~~~~~Ei~il~~l~H~niv~l~~~~~~~~~~~ 347 (608)
...++|++.+.||+|+| |+|+++. ....++++.+.|-.+|...++|+||+|+..|.+.+.+|
T Consensus 138 ~~~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~~~LY 217 (550)
T KOG0605|consen 138 LSLDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQDKEYLY 217 (550)
T ss_pred CCcccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecCCCeeE
Confidence 35678999999999985 7776653 45677889999999999999999999999999999999
Q ss_pred EEEeecCCCccchhccccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEEcCCCcEEEeeccCcccc
Q 044312 348 LVYEFIPNGTLFQYIHDQNEDFPITWEIRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSM 427 (608)
Q Consensus 348 lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGls~~~ 427 (608)
|||||+|||++..+|.+.+ .|++.....++.+++.|+..||+.| +|||||||+|+|||..|++||+||||+.-+
T Consensus 218 LiMEylPGGD~mTLL~~~~---~L~e~~arfYiaE~vlAI~~iH~~g---yIHRDIKPdNlLiD~~GHiKLSDFGLs~gl 291 (550)
T KOG0605|consen 218 LIMEYLPGGDMMTLLMRKD---TLTEDWARFYIAETVLAIESIHQLG---YIHRDIKPDNLLIDAKGHIKLSDFGLSTGL 291 (550)
T ss_pred EEEEecCCccHHHHHHhcC---cCchHHHHHHHHHHHHHHHHHHHcC---cccccCChhheeecCCCCEeeccccccchh
Confidence 9999999999999998765 5999999999999999999999999 999999999999999999999999998532
Q ss_pred cc-----------------------CCc----ce-------------------eeeeeccCCCCChhhhccCCCCCccch
Q 044312 428 AV-----------------------DQT----HM-------------------TTQVHGTFGYLDPEYFRSSQFTDKSDV 461 (608)
Q Consensus 428 ~~-----------------------~~~----~~-------------------~~~~~gt~~y~aPE~~~~~~~t~ksDV 461 (608)
.. +.. .. .....|||.|||||++.+..|+..+|.
T Consensus 292 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kgY~~~cDw 371 (550)
T KOG0605|consen 292 DKKHRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKGYGKECDW 371 (550)
T ss_pred hhhhhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCCCCccccH
Confidence 11 000 00 012469999999999999999999999
Q ss_pred HhHHHHHHHHHhCCCCCCccchhhcccHHHHHHHHhhhhhhHHHhhhh--hhccCChhHHHHHHHHHHHHhccCCCCCCC
Q 044312 462 YSFGVVLTELLTGEKPIRFTILEEDKSLAAYFLCAMKEERLFEILDAR--VMKQGGKDEIITVAKLAKRCLNLNGKKRPT 539 (608)
Q Consensus 462 ~S~Gvvl~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~--~~~~~~~~~~~~l~~Li~~cl~~dp~~RPs 539 (608)
||||||+||||.|.+||....+.+- ...++.-+ +..+.......+..+||.+|+. ||++|..
T Consensus 372 WSLG~ImyEmLvGyPPF~s~tp~~T---------------~rkI~nwr~~l~fP~~~~~s~eA~DLI~rll~-d~~~RLG 435 (550)
T KOG0605|consen 372 WSLGCIMYEMLVGYPPFCSETPQET---------------YRKIVNWRETLKFPEEVDLSDEAKDLITRLLC-DPENRLG 435 (550)
T ss_pred HHHHHHHHHHHhCCCCCCCCCHHHH---------------HHHHHHHhhhccCCCcCcccHHHHHHHHHHhc-CHHHhcC
Confidence 9999999999999999985444321 11111111 1122223445789999999999 9999975
Q ss_pred ---HHHHHH
Q 044312 540 ---MREVAS 545 (608)
Q Consensus 540 ---~~evl~ 545 (608)
+.||-+
T Consensus 436 ~~G~~EIK~ 444 (550)
T KOG0605|consen 436 SKGAEEIKK 444 (550)
T ss_pred cccHHHHhc
Confidence 555543
|
|
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-35 Score=300.31 Aligned_cols=246 Identities=25% Similarity=0.364 Sum_probs=179.9
Q ss_pred CccccceeccCce----------------EEEEEeecC--hhhHHHHHHHHHHHhhc---CCCCccceecccc-----cC
Q 044312 290 NFDLNRILGQGGQ----------------AVKKSKVID--ESKVEEFINEVVILSQI---NHRNVVKLLGCCL-----ET 343 (608)
Q Consensus 290 ~f~~~~~lG~G~~----------------avk~~~~~~--~~~~~~~~~Ei~il~~l---~H~niv~l~~~~~-----~~ 343 (608)
+|++.+.||+|++ |+|..+... ......+.+|+.+++++ +||||+++++++. ..
T Consensus 2 ~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~~ 81 (290)
T cd07862 2 QYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRE 81 (290)
T ss_pred CcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCCC
Confidence 5777788888864 555554322 22345677788877766 6999999999875 23
Q ss_pred ccceEEEeecCCCccchhccccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEEcCCCcEEEeeccC
Q 044312 344 EVPLLVYEFIPNGTLFQYIHDQNEDFPITWEIRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGA 423 (608)
Q Consensus 344 ~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGl 423 (608)
...++||||++ ++|.+++...... .+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+
T Consensus 82 ~~~~lv~e~~~-~~l~~~~~~~~~~-~~~~~~~~~i~~qi~~aL~~lH~~~---iiH~dlkp~Nil~~~~~~~kl~Dfg~ 156 (290)
T cd07862 82 TKLTLVFEHVD-QDLTTYLDKVPEP-GVPTETIKDMMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLADFGL 156 (290)
T ss_pred CcEEEEEccCC-CCHHHHHHhCCCC-CCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEEcCCCCEEEccccc
Confidence 46899999996 5899988764332 5899999999999999999999999 99999999999999999999999999
Q ss_pred ccccccCCcceeeeeeccCCCCChhhhccCCCCCccchHhHHHHHHHHHhCCCCCCccchhhcccHHHHHHHHhh---hh
Q 044312 424 SRSMAVDQTHMTTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLTELLTGEKPIRFTILEEDKSLAAYFLCAMK---EE 500 (608)
Q Consensus 424 s~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~elltg~~p~~~~~~~~~~~l~~~~~~~~~---~~ 500 (608)
++..... .......||+.|+|||.+....++.++||||||++++||++|++||......+. ......... ..
T Consensus 157 ~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~---~~~i~~~~~~~~~~ 231 (290)
T cd07862 157 ARIYSFQ--MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQ---LGKILDVIGLPGEE 231 (290)
T ss_pred eEeccCC--cccccccccccccChHHHhCCCCCCccchHHHHHHHHHHHcCCCCcCCCCHHHH---HHHHHHHhCCCChh
Confidence 9865433 223445689999999999988999999999999999999999999874332211 111111100 00
Q ss_pred hhHH-------Hhhhh---hhccCChhHHHHHHHHHHHHhccCCCCCCCHHHHHH
Q 044312 501 RLFE-------ILDAR---VMKQGGKDEIITVAKLAKRCLNLNGKKRPTMREVAS 545 (608)
Q Consensus 501 ~~~~-------~~d~~---~~~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~evl~ 545 (608)
.... .+... .........+..+.+|+.+||+.||++|||+.|+++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~ 286 (290)
T cd07862 232 DWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS 286 (290)
T ss_pred hchhhhcccchhccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHHhc
Confidence 0000 00000 000011234567889999999999999999999985
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=279.06 Aligned_cols=236 Identities=26% Similarity=0.360 Sum_probs=195.4
Q ss_pred hcCccccceeccCce---------------EEEEEee---cChhhHHHHHHHHHHHhhcCCCCccceecccccCccceEE
Q 044312 288 TDNFDLNRILGQGGQ---------------AVKKSKV---IDESKVEEFINEVVILSQINHRNVVKLLGCCLETEVPLLV 349 (608)
Q Consensus 288 t~~f~~~~~lG~G~~---------------avk~~~~---~~~~~~~~~~~Ei~il~~l~H~niv~l~~~~~~~~~~~lV 349 (608)
-++|++.+.||+|-| |+|++.. .......++.+|++|.+.|+||||++++++|.+....||+
T Consensus 21 l~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~~riyLi 100 (281)
T KOG0580|consen 21 LDDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDSKRIYLI 100 (281)
T ss_pred hhhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheeccceeEEE
Confidence 356888999999965 6666542 2223346789999999999999999999999999999999
Q ss_pred EeecCCCccchhccccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEEcCCCcEEEeeccCcccccc
Q 044312 350 YEFIPNGTLFQYIHDQNEDFPITWEIRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAV 429 (608)
Q Consensus 350 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGls~~~~~ 429 (608)
+||.++|+|...|...... .+++.....++.|+|.||.|+|..+ |+||||||+|+|++..+.+||+|||-+...+
T Consensus 101 lEya~~gel~k~L~~~~~~-~f~e~~~a~Yi~q~A~Al~y~h~k~---VIhRdiKpenlLlg~~~~lkiAdfGwsV~~p- 175 (281)
T KOG0580|consen 101 LEYAPRGELYKDLQEGRMK-RFDEQRAATYIKQLANALLYCHLKR---VIHRDIKPENLLLGSAGELKIADFGWSVHAP- 175 (281)
T ss_pred EEecCCchHHHHHHhcccc-cccccchhHHHHHHHHHHHHhccCC---cccCCCCHHHhccCCCCCeeccCCCceeecC-
Confidence 9999999999999865433 5888889999999999999999999 9999999999999999999999999987654
Q ss_pred CCcceeeeeeccCCCCChhhhccCCCCCccchHhHHHHHHHHHhCCCCCCccchhhcccHHHHHHHHhhhhhhHHHhhhh
Q 044312 430 DQTHMTTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLTELLTGEKPIRFTILEEDKSLAAYFLCAMKEERLFEILDAR 509 (608)
Q Consensus 430 ~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 509 (608)
........||..|+|||...+..++.++|+|++|++.+|++.|.+||..... .+...++..-
T Consensus 176 --~~kR~tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflvg~ppFes~~~---------------~etYkrI~k~- 237 (281)
T KOG0580|consen 176 --SNKRKTLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLVGLPPFESQSH---------------SETYKRIRKV- 237 (281)
T ss_pred --CCCceeeecccccCCHhhcCCCCccchhhHHHHHHHHHHHHhcCCchhhhhh---------------HHHHHHHHHc-
Confidence 2334567899999999999999999999999999999999999999973321 1111122111
Q ss_pred hhccCChhHHHHHHHHHHHHhccCCCCCCCHHHHHHHH
Q 044312 510 VMKQGGKDEIITVAKLAKRCLNLNGKKRPTMREVASEL 547 (608)
Q Consensus 510 ~~~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~evl~~L 547 (608)
....+...+...++||.+|+..+|.+|.+..|++++-
T Consensus 238 -~~~~p~~is~~a~dlI~~ll~~~p~~r~~l~~v~~hp 274 (281)
T KOG0580|consen 238 -DLKFPSTISGGAADLISRLLVKNPIERLALTEVMDHP 274 (281)
T ss_pred -cccCCcccChhHHHHHHHHhccCccccccHHHHhhhH
Confidence 1223345667899999999999999999999998764
|
|
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-35 Score=293.48 Aligned_cols=242 Identities=27% Similarity=0.436 Sum_probs=191.8
Q ss_pred HhcCccccceeccCce--------------EEEEEeecChhhHHHHHHHHHHHhhcCCCCccceecccccCccceEEEee
Q 044312 287 ATDNFDLNRILGQGGQ--------------AVKKSKVIDESKVEEFINEVVILSQINHRNVVKLLGCCLETEVPLLVYEF 352 (608)
Q Consensus 287 ~t~~f~~~~~lG~G~~--------------avk~~~~~~~~~~~~~~~Ei~il~~l~H~niv~l~~~~~~~~~~~lV~E~ 352 (608)
..++|.+.++||+|++ |||.... +....+++.+|+.++++++|+||+++++++......++||||
T Consensus 4 ~~~~~~i~~~ig~g~~~~v~~~~~~~~~~~~vK~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 82 (261)
T cd05034 4 PRESLKLERKLGAGQFGEVWMGTWNGTTKVAVKTLKP-GTMSPEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPIYIVTEY 82 (261)
T ss_pred chhheeeeeeeccCcceEEEEEEEcCCceEEEEEecC-CccCHHHHHHHHHHHhhCCCCCEeeeeeeeecCCceEEEEec
Confidence 3467888889998874 4454442 233457899999999999999999999999988899999999
Q ss_pred cCCCccchhccccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEEcCCCcEEEeeccCccccccCCc
Q 044312 353 IPNGTLFQYIHDQNEDFPITWEIRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQT 432 (608)
Q Consensus 353 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGls~~~~~~~~ 432 (608)
+++++|.+++...... .+++..+..++.+++.||.|||+.+ ++|+||||+||++++++.+||+|||+++.......
T Consensus 83 ~~~~~L~~~i~~~~~~-~~~~~~~~~~~~~i~~al~~lh~~~---i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~ 158 (261)
T cd05034 83 MSKGSLLDFLKSGEGK-KLRLPQLVDMAAQIAEGMAYLESRN---YIHRDLAARNILVGENLVCKIADFGLARLIEDDEY 158 (261)
T ss_pred cCCCCHHHHHhccccC-CCCHHHHHHHHHHHHHHHHHHHhCC---cccCCcchheEEEcCCCCEEECccccceeccchhh
Confidence 9999999999765422 5899999999999999999999999 99999999999999999999999999987653222
Q ss_pred ceeeeeeccCCCCChhhhccCCCCCccchHhHHHHHHHHHh-CCCCCCccchhhcccHHHHHHHHhhhhhhHHHhhhhhh
Q 044312 433 HMTTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLTELLT-GEKPIRFTILEEDKSLAAYFLCAMKEERLFEILDARVM 511 (608)
Q Consensus 433 ~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~ellt-g~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~ 511 (608)
.......++..|+|||.+.+..++.++||||||++++||++ |+.||....... .... +.....
T Consensus 159 ~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~-------~~~~---------~~~~~~ 222 (261)
T cd05034 159 TAREGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMTNRE-------VLEQ---------VERGYR 222 (261)
T ss_pred hhhhccCCCccccCHHHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHH-------HHHH---------HHcCCC
Confidence 22222334678999999998899999999999999999999 999985322110 0001 111111
Q ss_pred ccCChhHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHh
Q 044312 512 KQGGKDEIITVAKLAKRCLNLNGKKRPTMREVASELAG 549 (608)
Q Consensus 512 ~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~evl~~L~~ 549 (608)
...+...+.++.+++.+||+.+|++||+++|+.+.|+.
T Consensus 223 ~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~l~~ 260 (261)
T cd05034 223 MPRPPNCPEELYDLMLQCWDKDPEERPTFEYLQSFLED 260 (261)
T ss_pred CCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHhc
Confidence 12233446789999999999999999999999988865
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-35 Score=308.67 Aligned_cols=231 Identities=26% Similarity=0.369 Sum_probs=186.2
Q ss_pred cCccccceeccCce----------------EEEEEee---cChhhHHHHHHHHHHHhhcCCCCccceecccccCccceEE
Q 044312 289 DNFDLNRILGQGGQ----------------AVKKSKV---IDESKVEEFINEVVILSQINHRNVVKLLGCCLETEVPLLV 349 (608)
Q Consensus 289 ~~f~~~~~lG~G~~----------------avk~~~~---~~~~~~~~~~~Ei~il~~l~H~niv~l~~~~~~~~~~~lV 349 (608)
++|.+.+.||+|++ |+|.... ......+.+.+|+.+++.++||||+++++++.+....++|
T Consensus 30 ~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv 109 (340)
T PTZ00426 30 EDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDESYLYLV 109 (340)
T ss_pred hhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeCCEEEEE
Confidence 46888899999975 3443322 1233456788999999999999999999999999999999
Q ss_pred EeecCCCccchhccccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEEcCCCcEEEeeccCcccccc
Q 044312 350 YEFIPNGTLFQYIHDQNEDFPITWEIRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAV 429 (608)
Q Consensus 350 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGls~~~~~ 429 (608)
|||+++|+|.+++.... .+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+++....
T Consensus 110 ~Ey~~~g~L~~~i~~~~---~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDLkp~NILl~~~~~ikL~DFG~a~~~~~ 183 (340)
T PTZ00426 110 LEFVIGGEFFTFLRRNK---RFPNDVGCFYAAQIVLIFEYLQSLN---IVYRDLKPENLLLDKDGFIKMTDFGFAKVVDT 183 (340)
T ss_pred EeCCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---eEccCCCHHHEEECCCCCEEEecCCCCeecCC
Confidence 99999999999997643 4899999999999999999999999 99999999999999999999999999986542
Q ss_pred CCcceeeeeeccCCCCChhhhccCCCCCccchHhHHHHHHHHHhCCCCCCccchhhcccHHHHHHHHhhhhhhHHHhhhh
Q 044312 430 DQTHMTTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLTELLTGEKPIRFTILEEDKSLAAYFLCAMKEERLFEILDAR 509 (608)
Q Consensus 430 ~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 509 (608)
. .....||+.|+|||++.+..++.++|||||||+++||++|+.||...... . .... +....
T Consensus 184 ~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~------~-~~~~--------i~~~~ 244 (340)
T PTZ00426 184 R----TYTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYANEPL------L-IYQK--------ILEGI 244 (340)
T ss_pred C----cceecCChhhcCHHHHhCCCCCccccccchhhHHHHHhcCCCCCCCCCHH------H-HHHH--------HhcCC
Confidence 2 23456899999999999989999999999999999999999999632211 0 0011 11110
Q ss_pred hhccCChhHHHHHHHHHHHHhccCCCCCC-----CHHHHHHH
Q 044312 510 VMKQGGKDEIITVAKLAKRCLNLNGKKRP-----TMREVASE 546 (608)
Q Consensus 510 ~~~~~~~~~~~~l~~Li~~cl~~dp~~RP-----s~~evl~~ 546 (608)
...+...+..+.+++.+||+.||++|+ +++|++++
T Consensus 245 --~~~p~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~h 284 (340)
T PTZ00426 245 --IYFPKFLDNNCKHLMKKLLSHDLTKRYGNLKKGAQNVKEH 284 (340)
T ss_pred --CCCCCCCCHHHHHHHHHHcccCHHHcCCCCCCCHHHHHcC
Confidence 112333456789999999999999995 78888765
|
|
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-35 Score=296.63 Aligned_cols=242 Identities=29% Similarity=0.427 Sum_probs=189.2
Q ss_pred hcCccccceeccCce--------------------EEEEEeec-ChhhHHHHHHHHHHHhhcCCCCccceecccccCccc
Q 044312 288 TDNFDLNRILGQGGQ--------------------AVKKSKVI-DESKVEEFINEVVILSQINHRNVVKLLGCCLETEVP 346 (608)
Q Consensus 288 t~~f~~~~~lG~G~~--------------------avk~~~~~-~~~~~~~~~~Ei~il~~l~H~niv~l~~~~~~~~~~ 346 (608)
.++|.+.+.||+|++ |+|..... .......+.+|+.+++.++|+||+++++++......
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~ 84 (277)
T cd05032 5 REKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVRLLGVVSTGQPT 84 (277)
T ss_pred hHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCccCHHHHHHHHHHHHHHHhCCCCceeEEEEEEcCCCCc
Confidence 346777888888874 33443322 223456789999999999999999999999999999
Q ss_pred eEEEeecCCCccchhccccCC-------CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEEcCCCcEEEe
Q 044312 347 LLVYEFIPNGTLFQYIHDQNE-------DFPITWEIRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVS 419 (608)
Q Consensus 347 ~lV~E~~~~gsL~~~l~~~~~-------~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~ 419 (608)
++||||+++++|.+++..... ...+++..++.++.|++.||.|||+.+ ++||||||+|||++.++.+||+
T Consensus 85 ~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~di~p~nill~~~~~~kl~ 161 (277)
T cd05032 85 LVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAKK---FVHRDLAARNCMVAEDLTVKIG 161 (277)
T ss_pred EEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccChheEEEcCCCCEEEC
Confidence 999999999999999875321 124789999999999999999999998 9999999999999999999999
Q ss_pred eccCccccccCCc-ceeeeeeccCCCCChhhhccCCCCCccchHhHHHHHHHHHh-CCCCCCccchhhcccHHHHHHHHh
Q 044312 420 DFGASRSMAVDQT-HMTTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLTELLT-GEKPIRFTILEEDKSLAAYFLCAM 497 (608)
Q Consensus 420 DFGls~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~ellt-g~~p~~~~~~~~~~~l~~~~~~~~ 497 (608)
|||+++....... .......++..|+|||.+....++.++||||||++++||++ |+.||......+
T Consensus 162 dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~------------ 229 (277)
T cd05032 162 DFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSNEE------------ 229 (277)
T ss_pred CcccchhhccCcccccCCCCCccccccCHHHHhcCCCCcccchHHHHHHHHHhhccCCCCCccCCHHH------------
Confidence 9999986643322 11223346788999999998899999999999999999998 888886322111
Q ss_pred hhhhhHHHhhhhhhccCChhHHHHHHHHHHHHhccCCCCCCCHHHHHHHHH
Q 044312 498 KEERLFEILDARVMKQGGKDEIITVAKLAKRCLNLNGKKRPTMREVASELA 548 (608)
Q Consensus 498 ~~~~~~~~~d~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~evl~~L~ 548 (608)
+...+........+...+..+.+++.+||+.+|++|||+.|+++.|+
T Consensus 230 ----~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~ 276 (277)
T cd05032 230 ----VLKFVIDGGHLDLPENCPDKLLELMRMCWQYNPKMRPTFLEIVSSLK 276 (277)
T ss_pred ----HHHHHhcCCCCCCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHhc
Confidence 01111111111233345678999999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-35 Score=298.99 Aligned_cols=246 Identities=27% Similarity=0.413 Sum_probs=188.8
Q ss_pred HHhcCccccceeccCce--------------------EEEEEeecC-hhhHHHHHHHHHHHhhcCCCCccceecccccCc
Q 044312 286 KATDNFDLNRILGQGGQ--------------------AVKKSKVID-ESKVEEFINEVVILSQINHRNVVKLLGCCLETE 344 (608)
Q Consensus 286 ~~t~~f~~~~~lG~G~~--------------------avk~~~~~~-~~~~~~~~~Ei~il~~l~H~niv~l~~~~~~~~ 344 (608)
...++|++.++||+|++ |+|...... ......+.+|+.+++.++|+||+++++++.+..
T Consensus 3 ~~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~ 82 (288)
T cd05061 3 VSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVSKGQ 82 (288)
T ss_pred ccHHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCC
Confidence 45667888999999975 333322211 223456889999999999999999999999999
Q ss_pred cceEEEeecCCCccchhccccCC-------CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEEcCCCcEE
Q 044312 345 VPLLVYEFIPNGTLFQYIHDQNE-------DFPITWEIRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAK 417 (608)
Q Consensus 345 ~~~lV~E~~~~gsL~~~l~~~~~-------~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~k 417 (608)
..++||||+++|+|.+++..... ...+++..++.++.|++.||.|||+++ |+||||||+|||+++++.+|
T Consensus 83 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dikp~nili~~~~~~~ 159 (288)
T cd05061 83 PTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKK---FVHRDLAARNCMVAHDFTVK 159 (288)
T ss_pred CcEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---CcCCCCChheEEEcCCCcEE
Confidence 99999999999999999975321 124577889999999999999999999 99999999999999999999
Q ss_pred EeeccCccccccCCcce-eeeeeccCCCCChhhhccCCCCCccchHhHHHHHHHHHh-CCCCCCccchhhcccHHHHHHH
Q 044312 418 VSDFGASRSMAVDQTHM-TTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLTELLT-GEKPIRFTILEEDKSLAAYFLC 495 (608)
Q Consensus 418 l~DFGls~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~ellt-g~~p~~~~~~~~~~~l~~~~~~ 495 (608)
|+|||+++......... .....++..|+|||.+.+..++.++||||||++++||++ |..||.....++ .. .
T Consensus 160 L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~l~el~~~~~~p~~~~~~~~------~~-~ 232 (288)
T cd05061 160 IGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQ------VL-K 232 (288)
T ss_pred ECcCCccccccccccccccCCCcccccccCHHHhccCCCChHhHHHHHHHHHHHHHhCCCCCCCCCCHHH------HH-H
Confidence 99999998654322211 112234678999999999999999999999999999999 788875322111 00 0
Q ss_pred HhhhhhhHHHhhhhhhccCChhHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhh
Q 044312 496 AMKEERLFEILDARVMKQGGKDEIITVAKLAKRCLNLNGKKRPTMREVASELAGI 550 (608)
Q Consensus 496 ~~~~~~~~~~~d~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~evl~~L~~i 550 (608)
.+.+. .....+...+..+.+++.+||+.+|++|||+.++++.|+..
T Consensus 233 --------~~~~~-~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~ 278 (288)
T cd05061 233 --------FVMDG-GYLDQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDD 278 (288)
T ss_pred --------HHHcC-CCCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHhh
Confidence 01111 01112234456899999999999999999999999888764
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=295.74 Aligned_cols=246 Identities=25% Similarity=0.410 Sum_probs=191.5
Q ss_pred hcCccccceeccCce-------------------EEEEEee-cChhhHHHHHHHHHHHhhcCCCCccceeccccc-Cccc
Q 044312 288 TDNFDLNRILGQGGQ-------------------AVKKSKV-IDESKVEEFINEVVILSQINHRNVVKLLGCCLE-TEVP 346 (608)
Q Consensus 288 t~~f~~~~~lG~G~~-------------------avk~~~~-~~~~~~~~~~~Ei~il~~l~H~niv~l~~~~~~-~~~~ 346 (608)
.++|.+.+.||+|++ ++|+.+. .+....+.+.+|+.+++.++|+||+++++++.+ ....
T Consensus 5 ~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~ 84 (280)
T cd05043 5 RDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILHVCIEDGEPP 84 (280)
T ss_pred hhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCCC
Confidence 456788888888875 2232221 233456779999999999999999999998766 4678
Q ss_pred eEEEeecCCCccchhccccCCC-----CCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEEcCCCcEEEeec
Q 044312 347 LLVYEFIPNGTLFQYIHDQNED-----FPITWEIRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDF 421 (608)
Q Consensus 347 ~lV~E~~~~gsL~~~l~~~~~~-----~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DF 421 (608)
++++||+++++|.+++...... ..+++..++.++.|++.||+|||+.+ ++||||||+|||+++++.+||+||
T Consensus 85 ~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~---i~H~di~p~nil~~~~~~~kl~d~ 161 (280)
T cd05043 85 FVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKRG---VIHKDIAARNCVIDEELQVKITDN 161 (280)
T ss_pred EEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccCHhhEEEcCCCcEEECCC
Confidence 9999999999999998764321 35899999999999999999999998 999999999999999999999999
Q ss_pred cCccccccCCcce-eeeeeccCCCCChhhhccCCCCCccchHhHHHHHHHHHh-CCCCCCccchhhcccHHHHHHHHhhh
Q 044312 422 GASRSMAVDQTHM-TTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLTELLT-GEKPIRFTILEEDKSLAAYFLCAMKE 499 (608)
Q Consensus 422 Gls~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~ellt-g~~p~~~~~~~~~~~l~~~~~~~~~~ 499 (608)
|+++.+....... .....++..|+|||++....++.++||||||++++|+++ |+.||......+ +..
T Consensus 162 g~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~---~~~-------- 230 (280)
T cd05043 162 ALSRDLFPMDYHCLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEIDPFE---MAA-------- 230 (280)
T ss_pred CCcccccCCceEEeCCCCCcchhccCHHHHhcCCCCchhhHHHhHHHHHHHhcCCCCCcCcCCHHH---HHH--------
Confidence 9998664333221 122345678999999998899999999999999999999 999986322111 111
Q ss_pred hhhHHHhhhhhhccCChhHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhhHH
Q 044312 500 ERLFEILDARVMKQGGKDEIITVAKLAKRCLNLNGKKRPTMREVASELAGIKA 552 (608)
Q Consensus 500 ~~~~~~~d~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~evl~~L~~i~~ 552 (608)
.+............+.++.+++.+||+.+|++|||+.||++.|+.+..
T Consensus 231 -----~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~~~~~ 278 (280)
T cd05043 231 -----YLKDGYRLAQPINCPDELFAVMACCWALDPEERPSFSQLVQCLTDFHA 278 (280)
T ss_pred -----HHHcCCCCCCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHh
Confidence 111111111223345689999999999999999999999999988764
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-35 Score=306.63 Aligned_cols=238 Identities=25% Similarity=0.314 Sum_probs=184.7
Q ss_pred CccccceeccCce------------------EEEEEeec----ChhhHHHHHHHHHHHhhc-CCCCccceecccccCccc
Q 044312 290 NFDLNRILGQGGQ------------------AVKKSKVI----DESKVEEFINEVVILSQI-NHRNVVKLLGCCLETEVP 346 (608)
Q Consensus 290 ~f~~~~~lG~G~~------------------avk~~~~~----~~~~~~~~~~Ei~il~~l-~H~niv~l~~~~~~~~~~ 346 (608)
+|++.+.||+|++ |+|..... .....+.+.+|+.+++++ +|+||+++++++.+.+..
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (332)
T cd05614 1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKL 80 (332)
T ss_pred CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCEE
Confidence 4777888999875 34443321 122345688899999999 599999999999999999
Q ss_pred eEEEeecCCCccchhccccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEEcCCCcEEEeeccCccc
Q 044312 347 LLVYEFIPNGTLFQYIHDQNEDFPITWEIRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRS 426 (608)
Q Consensus 347 ~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGls~~ 426 (608)
++||||+++|+|.+++.... .+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++.
T Consensus 81 ~lv~e~~~~g~L~~~l~~~~---~~~~~~~~~~~~qi~~~l~~lH~~~---ivHrDlkp~Nili~~~~~~kl~DfG~~~~ 154 (332)
T cd05614 81 HLILDYVSGGEMFTHLYQRD---NFSEDEVRFYSGEIILALEHLHKLG---IVYRDIKLENILLDSEGHVVLTDFGLSKE 154 (332)
T ss_pred EEEEeCCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---cEecCCCHHHeEECCCCCEEEeeCcCCcc
Confidence 99999999999999987543 4899999999999999999999999 99999999999999999999999999987
Q ss_pred cccCCcceeeeeeccCCCCChhhhccC-CCCCccchHhHHHHHHHHHhCCCCCCccchhhcccHHHHHHHHhhhhhhHHH
Q 044312 427 MAVDQTHMTTQVHGTFGYLDPEYFRSS-QFTDKSDVYSFGVVLTELLTGEKPIRFTILEEDKSLAAYFLCAMKEERLFEI 505 (608)
Q Consensus 427 ~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~t~ksDV~S~Gvvl~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 505 (608)
.............||+.|+|||++.+. .++.++||||||++++||+||+.||........ ...+... +
T Consensus 155 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~---~~~~~~~--------~ 223 (332)
T cd05614 155 FLSEEKERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNT---QSEVSRR--------I 223 (332)
T ss_pred ccccCCCccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCCCC---HHHHHHH--------H
Confidence 644333334456799999999999865 478999999999999999999999863221111 1111100 0
Q ss_pred hhhhhhccCChhHHHHHHHHHHHHhccCCCCCC-----CHHHHHHH
Q 044312 506 LDARVMKQGGKDEIITVAKLAKRCLNLNGKKRP-----TMREVASE 546 (608)
Q Consensus 506 ~d~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RP-----s~~evl~~ 546 (608)
.. .....+...+..+.+++.+||+.||++|| ++++++++
T Consensus 224 ~~--~~~~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h 267 (332)
T cd05614 224 LK--CDPPFPSFIGPEAQDLLHKLLRKDPKKRLGAGPQGASEIKEH 267 (332)
T ss_pred hc--CCCCCCCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHHcC
Confidence 00 01122334566789999999999999999 67777754
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-35 Score=300.46 Aligned_cols=250 Identities=24% Similarity=0.326 Sum_probs=193.2
Q ss_pred HHHHHHHhcCccccceeccCce---------------EEEEEeecC--------------hhhHHHHHHHHHHHhhcCCC
Q 044312 281 SKELEKATDNFDLNRILGQGGQ---------------AVKKSKVID--------------ESKVEEFINEVVILSQINHR 331 (608)
Q Consensus 281 ~~~l~~~t~~f~~~~~lG~G~~---------------avk~~~~~~--------------~~~~~~~~~Ei~il~~l~H~ 331 (608)
..+-.+.-+.|++.+.||+|.| |||.+.... ....+...+||.||++++||
T Consensus 89 ~~~~~k~lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~ 168 (576)
T KOG0585|consen 89 DDQDRKQLNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHP 168 (576)
T ss_pred CcccceehhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCc
Confidence 3344456678999999999974 666653211 11246889999999999999
Q ss_pred Cccceeccccc--CccceEEEeecCCCccchhccccCCCCC-CCHHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcE
Q 044312 332 NVVKLLGCCLE--TEVPLLVYEFIPNGTLFQYIHDQNEDFP-ITWEIRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNI 408 (608)
Q Consensus 332 niv~l~~~~~~--~~~~~lV~E~~~~gsL~~~l~~~~~~~~-l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NI 408 (608)
|||+|+.+..+ .+.+|||+|||..|.+...=. ..+ ++..+..+++.++..||+|||.++ ||||||||+|+
T Consensus 169 nVV~LiEvLDDP~s~~~YlVley~s~G~v~w~p~----d~~els~~~Ar~ylrDvv~GLEYLH~Qg---iiHRDIKPsNL 241 (576)
T KOG0585|consen 169 NVVKLIEVLDDPESDKLYLVLEYCSKGEVKWCPP----DKPELSEQQARKYLRDVVLGLEYLHYQG---IIHRDIKPSNL 241 (576)
T ss_pred CeeEEEEeecCcccCceEEEEEeccCCccccCCC----CcccccHHHHHHHHHHHHHHHHHHHhcC---eeccccchhhe
Confidence 99999999864 458899999999888754322 224 899999999999999999999999 99999999999
Q ss_pred EEcCCCcEEEeeccCccccccCC----cceeeeeeccCCCCChhhhccCC----CCCccchHhHHHHHHHHHhCCCCCCc
Q 044312 409 LLDDKYRAKVSDFGASRSMAVDQ----THMTTQVHGTFGYLDPEYFRSSQ----FTDKSDVYSFGVVLTELLTGEKPIRF 480 (608)
Q Consensus 409 Ll~~~~~~kl~DFGls~~~~~~~----~~~~~~~~gt~~y~aPE~~~~~~----~t~ksDV~S~Gvvl~elltg~~p~~~ 480 (608)
||++++++||+|||.+...+... ........|||.|+|||...++. -+.+.||||+||+||.|+.|+.||-.
T Consensus 242 Ll~~~g~VKIsDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~ 321 (576)
T KOG0585|consen 242 LLSSDGTVKISDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFD 321 (576)
T ss_pred EEcCCCcEEeeccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCccc
Confidence 99999999999999998663221 11123367999999999988743 35688999999999999999999862
Q ss_pred cchhhcccHHHHHHHHhhhhhhHHHhhhhhhccCChhHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhhHH
Q 044312 481 TILEEDKSLAAYFLCAMKEERLFEILDARVMKQGGKDEIITVAKLAKRCLNLNGKKRPTMREVASELAGIKA 552 (608)
Q Consensus 481 ~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~evl~~L~~i~~ 552 (608)
.. ... -...|+...+......+..+++.+||+++|..||+.|.+..+|..+..-.+.
T Consensus 322 ~~------~~~---------l~~KIvn~pL~fP~~pe~~e~~kDli~~lL~KdP~~Ri~l~~ik~Hpwvt~~ 378 (576)
T KOG0585|consen 322 DF------ELE---------LFDKIVNDPLEFPENPEINEDLKDLIKRLLEKDPEQRITLPDIKLHPWVTRD 378 (576)
T ss_pred ch------HHH---------HHHHHhcCcccCCCcccccHHHHHHHHHHhhcChhheeehhhheecceeccC
Confidence 11 111 1123333344444445667889999999999999999999999887755543
|
|
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-35 Score=297.65 Aligned_cols=228 Identities=24% Similarity=0.372 Sum_probs=178.8
Q ss_pred EEEEEeecCh-hhHHHHHHHHHHHhhcCCCCccceecccccCccceEEEeecCCCccchhccccC-------------CC
Q 044312 303 AVKKSKVIDE-SKVEEFINEVVILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGTLFQYIHDQN-------------ED 368 (608)
Q Consensus 303 avk~~~~~~~-~~~~~~~~Ei~il~~l~H~niv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~-------------~~ 368 (608)
|+|+.+.... ...+.|.+|+.++++++||||+++++++.+....++++||+++++|.+++.... .+
T Consensus 39 aiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~ 118 (283)
T cd05091 39 AIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVK 118 (283)
T ss_pred EEEEccCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCCceEEEEEcCCCCcHHHHHHhcCCCccccccccccccc
Confidence 5565553322 235678999999999999999999999999999999999999999999985321 12
Q ss_pred CCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEEcCCCcEEEeeccCccccccCCc-ceeeeeeccCCCCCh
Q 044312 369 FPITWEIRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQT-HMTTQVHGTFGYLDP 447 (608)
Q Consensus 369 ~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGls~~~~~~~~-~~~~~~~gt~~y~aP 447 (608)
..+++..+++++.|++.||+|||+.+ ++||||||+|||+++++.+||+|||+++....... .......+++.|+||
T Consensus 119 ~~~~~~~~~~~~~ql~~aL~~lH~~g---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aP 195 (283)
T cd05091 119 STLEPADFVHIVTQIAAGMEFLSSHH---VVHKDLATRNVLVFDKLNVKISDLGLFREVYAADYYKLMGNSLLPIRWMSP 195 (283)
T ss_pred cccCHHHHHHHHHHHHHHHHHHHHcC---ccccccchhheEecCCCceEecccccccccccchheeeccCccCCccccCH
Confidence 24889999999999999999999999 99999999999999999999999999886543221 112233457789999
Q ss_pred hhhccCCCCCccchHhHHHHHHHHHh-CCCCCCccchhhcccHHHHHHHHhhhhhhHHHhhhhhhccCChhHHHHHHHHH
Q 044312 448 EYFRSSQFTDKSDVYSFGVVLTELLT-GEKPIRFTILEEDKSLAAYFLCAMKEERLFEILDARVMKQGGKDEIITVAKLA 526 (608)
Q Consensus 448 E~~~~~~~t~ksDV~S~Gvvl~ellt-g~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~Li 526 (608)
|.+....++.++||||||++++||++ |..||...... . +.+.+........+...+..+.+|+
T Consensus 196 E~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~------~----------~~~~i~~~~~~~~~~~~~~~~~~li 259 (283)
T cd05091 196 EAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQ------D----------VIEMIRNRQVLPCPDDCPAWVYTLM 259 (283)
T ss_pred HHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHH------H----------HHHHHHcCCcCCCCCCCCHHHHHHH
Confidence 99998899999999999999999998 77887532111 0 1111111111223345677899999
Q ss_pred HHHhccCCCCCCCHHHHHHHHHh
Q 044312 527 KRCLNLNGKKRPTMREVASELAG 549 (608)
Q Consensus 527 ~~cl~~dp~~RPs~~evl~~L~~ 549 (608)
.+||+.+|++||+++||+..|+.
T Consensus 260 ~~cl~~~p~~RP~~~~i~~~l~~ 282 (283)
T cd05091 260 LECWNEFPSRRPRFKDIHSRLRT 282 (283)
T ss_pred HHHhCCCcccCCCHHHHHHHhhC
Confidence 99999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-35 Score=306.48 Aligned_cols=221 Identities=24% Similarity=0.308 Sum_probs=178.7
Q ss_pred eEEEEEeec---ChhhHHHHHHHHHHHhhcCCCCccceecccccCccceEEEeecCCCccchhccccCCCCCCCHHHHHH
Q 044312 302 QAVKKSKVI---DESKVEEFINEVVILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEIRLR 378 (608)
Q Consensus 302 ~avk~~~~~---~~~~~~~~~~Ei~il~~l~H~niv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~ 378 (608)
+|+|.+... .......+.+|+.+++.++||||+++++++...+..++||||+++|+|.+++.... .+++..+..
T Consensus 23 ~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~~~g~L~~~l~~~~---~l~~~~~~~ 99 (328)
T cd05593 23 YAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGGELFFHLSRER---VFSEDRTRF 99 (328)
T ss_pred EEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEeCCCCCCHHHHHHhcC---CCCHHHHHH
Confidence 477776532 33456788999999999999999999999999999999999999999998886543 589999999
Q ss_pred HHHHHHHHHHHHhhcCCCCeeccCCCCCcEEEcCCCcEEEeeccCccccccCCcceeeeeeccCCCCChhhhccCCCCCc
Q 044312 379 IAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHGTFGYLDPEYFRSSQFTDK 458 (608)
Q Consensus 379 i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGls~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k 458 (608)
++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++...... .......||+.|+|||++.+..++.+
T Consensus 100 ~~~qi~~aL~~LH~~~---ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~ 175 (328)
T cd05593 100 YGAEIVSALDYLHSGK---IVYRDLKLENLMLDKDGHIKITDFGLCKEGITDA-ATMKTFCGTPEYLAPEVLEDNDYGRA 175 (328)
T ss_pred HHHHHHHHHHHHHhCC---eEecccCHHHeEECCCCcEEEecCcCCccCCCcc-cccccccCCcCccChhhhcCCCCCcc
Confidence 9999999999999999 9999999999999999999999999987543221 22234568999999999999999999
Q ss_pred cchHhHHHHHHHHHhCCCCCCccchhhcccHHHHHHHHhhhhhhHHHhhhhhhccCChhHHHHHHHHHHHHhccCCCCCC
Q 044312 459 SDVYSFGVVLTELLTGEKPIRFTILEEDKSLAAYFLCAMKEERLFEILDARVMKQGGKDEIITVAKLAKRCLNLNGKKRP 538 (608)
Q Consensus 459 sDV~S~Gvvl~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RP 538 (608)
+|||||||+++||++|+.||....... ... .. ... ....+...+.++.+|+.+||+.||++||
T Consensus 176 ~DiwslGvil~elltG~~Pf~~~~~~~------~~~-~~--------~~~--~~~~p~~~~~~~~~li~~~L~~dP~~R~ 238 (328)
T cd05593 176 VDWWGLGVVMYEMMCGRLPFYNQDHEK------LFE-LI--------LME--DIKFPRTLSADAKSLLSGLLIKDPNKRL 238 (328)
T ss_pred CCccccchHHHHHhhCCCCCCCCCHHH------HHH-Hh--------ccC--CccCCCCCCHHHHHHHHHHcCCCHHHcC
Confidence 999999999999999999996322111 000 00 000 0122334566799999999999999997
Q ss_pred -----CHHHHHHH
Q 044312 539 -----TMREVASE 546 (608)
Q Consensus 539 -----s~~evl~~ 546 (608)
++.|++++
T Consensus 239 ~~~~~~~~~il~h 251 (328)
T cd05593 239 GGGPDDAKEIMRH 251 (328)
T ss_pred CCCCCCHHHHhcC
Confidence 88998865
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-35 Score=309.29 Aligned_cols=236 Identities=26% Similarity=0.381 Sum_probs=190.0
Q ss_pred cCccccceeccCce---------------EEEEEeec---ChhhHHHHHHHHHHHhhcCCCCccceecccccCccceEEE
Q 044312 289 DNFDLNRILGQGGQ---------------AVKKSKVI---DESKVEEFINEVVILSQINHRNVVKLLGCCLETEVPLLVY 350 (608)
Q Consensus 289 ~~f~~~~~lG~G~~---------------avk~~~~~---~~~~~~~~~~Ei~il~~l~H~niv~l~~~~~~~~~~~lV~ 350 (608)
++|++.+.||+|++ |+|+.+.. .......+.+|+.+++.++|+||+++++++.+.+..++||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (350)
T cd05573 1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDEEHLYLVM 80 (350)
T ss_pred CCceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheecCCeEEEEE
Confidence 36888999999974 66666532 2245667899999999999999999999999999999999
Q ss_pred eecCCCccchhccccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEEcCCCcEEEeeccCccccccC
Q 044312 351 EFIPNGTLFQYIHDQNEDFPITWEIRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVD 430 (608)
Q Consensus 351 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGls~~~~~~ 430 (608)
||+++++|.+++.... .+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++.....
T Consensus 81 e~~~~~~L~~~l~~~~---~l~~~~~~~i~~qi~~aL~~LH~~g---iiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~ 154 (350)
T cd05573 81 EYMPGGDLMNLLIRKD---VFPEETARFYIAELVLALDSVHKLG---FIHRDIKPDNILIDADGHIKLADFGLCKKMNKA 154 (350)
T ss_pred cCCCCCCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEeecCCCCccCccc
Confidence 9999999999997652 5899999999999999999999998 999999999999999999999999999876533
Q ss_pred C----------------------------cceeeeeeccCCCCChhhhccCCCCCccchHhHHHHHHHHHhCCCCCCccc
Q 044312 431 Q----------------------------THMTTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLTELLTGEKPIRFTI 482 (608)
Q Consensus 431 ~----------------------------~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~elltg~~p~~~~~ 482 (608)
. ........||+.|+|||++.+..++.++|||||||+++||++|+.||....
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~ 234 (350)
T cd05573 155 KDREYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPFYSDT 234 (350)
T ss_pred CcccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCceeeEecchhhhhhccCCCCCCCCC
Confidence 2 112234568999999999999999999999999999999999999987432
Q ss_pred hhhcccHHHHHHHHhhhhhhHHHhh--hhhhccCChhHHHHHHHHHHHHhccCCCCCCC-HHHHHHH
Q 044312 483 LEEDKSLAAYFLCAMKEERLFEILD--ARVMKQGGKDEIITVAKLAKRCLNLNGKKRPT-MREVASE 546 (608)
Q Consensus 483 ~~~~~~l~~~~~~~~~~~~~~~~~d--~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPs-~~evl~~ 546 (608)
... .. ..+.. ...........+.++.+|+.+||. +|.+||+ ++|++++
T Consensus 235 ~~~------~~---------~~i~~~~~~~~~p~~~~~~~~~~~li~~ll~-dp~~R~~s~~~ll~h 285 (350)
T cd05573 235 LQE------TY---------NKIINWKESLRFPPDPPVSPEAIDLICRLLC-DPEDRLGSFEEIKSH 285 (350)
T ss_pred HHH------HH---------HHHhccCCcccCCCCCCCCHHHHHHHHHHcc-ChhhcCCCHHHHhcC
Confidence 111 01 01111 111111112246789999999997 9999999 9999875
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-34 Score=290.99 Aligned_cols=245 Identities=25% Similarity=0.391 Sum_probs=194.8
Q ss_pred cCccccceeccCce---------------EEEEEee---cChhhHHHHHHHHHHHhhcCCCCccceecccccCccceEEE
Q 044312 289 DNFDLNRILGQGGQ---------------AVKKSKV---IDESKVEEFINEVVILSQINHRNVVKLLGCCLETEVPLLVY 350 (608)
Q Consensus 289 ~~f~~~~~lG~G~~---------------avk~~~~---~~~~~~~~~~~Ei~il~~l~H~niv~l~~~~~~~~~~~lV~ 350 (608)
++|++.+.||+|++ |+|..+. .+....+.+.+|++++++++|+||+++++++.+.+..++||
T Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 81 (267)
T cd08224 2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIENNELNIVL 81 (267)
T ss_pred CceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEE
Confidence 57888889999873 6665543 23345678999999999999999999999999999999999
Q ss_pred eecCCCccchhccccC-CCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEEcCCCcEEEeeccCcccccc
Q 044312 351 EFIPNGTLFQYIHDQN-EDFPITWEIRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAV 429 (608)
Q Consensus 351 E~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGls~~~~~ 429 (608)
||+++++|.+++.... ....+++..++.++.+++.||.|||+.+ ++|+||+|+||+++.++.++|+|||+++....
T Consensus 82 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~dl~p~nil~~~~~~~~l~d~~~~~~~~~ 158 (267)
T cd08224 82 ELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSKR---IMHRDIKPANVFITATGVVKLGDLGLGRFFSS 158 (267)
T ss_pred ecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhCC---EecCCcChhhEEECCCCcEEEeccceeeeccC
Confidence 9999999999886522 2235899999999999999999999999 99999999999999999999999999876543
Q ss_pred CCcceeeeeeccCCCCChhhhccCCCCCccchHhHHHHHHHHHhCCCCCCccchhhcccHHHHHHHHhhhhhhHHHhhhh
Q 044312 430 DQTHMTTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLTELLTGEKPIRFTILEEDKSLAAYFLCAMKEERLFEILDAR 509 (608)
Q Consensus 430 ~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 509 (608)
... ......++..|+|||.+.+..++.++||||||+++++|++|+.||..... .+.... +.+...
T Consensus 159 ~~~-~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~----~~~~~~----------~~~~~~ 223 (267)
T cd08224 159 KTT-AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKM----NLYSLC----------KKIEKC 223 (267)
T ss_pred CCc-ccceecCCccccCHHHhccCCCCchhcHHHHHHHHHHHHHCCCCcccCCc----cHHHHH----------hhhhcC
Confidence 322 12334578899999999988999999999999999999999999853221 111110 001111
Q ss_pred hhccCC-hhHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhhH
Q 044312 510 VMKQGG-KDEIITVAKLAKRCLNLNGKKRPTMREVASELAGIK 551 (608)
Q Consensus 510 ~~~~~~-~~~~~~l~~Li~~cl~~dp~~RPs~~evl~~L~~i~ 551 (608)
.....+ ...+..+.+++.+||..+|++||++.+|++.|+.+.
T Consensus 224 ~~~~~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~il~~~~~~~ 266 (267)
T cd08224 224 DYPPLPADHYSEELRDLVSRCINPDPEKRPDISYVLQVAKEMH 266 (267)
T ss_pred CCCCCChhhcCHHHHHHHHHHcCCCcccCCCHHHHHHHHHHhc
Confidence 111111 245568999999999999999999999999998764
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-34 Score=291.72 Aligned_cols=237 Identities=28% Similarity=0.425 Sum_probs=188.3
Q ss_pred cCccccceeccCce---------------EEEEEeecC-----hhhHHHHHHHHHHHhhcCCCCccceecccccCccceE
Q 044312 289 DNFDLNRILGQGGQ---------------AVKKSKVID-----ESKVEEFINEVVILSQINHRNVVKLLGCCLETEVPLL 348 (608)
Q Consensus 289 ~~f~~~~~lG~G~~---------------avk~~~~~~-----~~~~~~~~~Ei~il~~l~H~niv~l~~~~~~~~~~~l 348 (608)
++|.+.+.||+|++ |+|...... ....+.+.+|++++++++||||+++++++.+.+..++
T Consensus 2 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~ 81 (263)
T cd06625 2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDETLSI 81 (263)
T ss_pred CcccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCCeEEE
Confidence 46888889998863 566554321 1234678999999999999999999999999999999
Q ss_pred EEeecCCCccchhccccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEEcCCCcEEEeeccCccccc
Q 044312 349 VYEFIPNGTLFQYIHDQNEDFPITWEIRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMA 428 (608)
Q Consensus 349 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGls~~~~ 428 (608)
|+||+++++|.+++.... .+++..+..++.|++.||.|||+.+ ++||||+|+||++++++.+||+|||+++...
T Consensus 82 v~e~~~~~~l~~~~~~~~---~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dl~p~nilv~~~~~~~l~dfg~~~~~~ 155 (263)
T cd06625 82 FMEYMPGGSVKDQLKAYG---ALTETVTRKYTRQILEGVEYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKRLQ 155 (263)
T ss_pred EEEECCCCcHHHHHHHhC---CCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEeecccceecc
Confidence 999999999999887643 4889999999999999999999999 9999999999999999999999999987654
Q ss_pred cCCccee--eeeeccCCCCChhhhccCCCCCccchHhHHHHHHHHHhCCCCCCccchhhcccHHHHHHHHhhhhhhHHHh
Q 044312 429 VDQTHMT--TQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLTELLTGEKPIRFTILEEDKSLAAYFLCAMKEERLFEIL 506 (608)
Q Consensus 429 ~~~~~~~--~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 506 (608)
....... ....++..|+|||.+.+..++.++||||||+++|||++|+.||...... .. . ....
T Consensus 156 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~-----~~-~---------~~~~ 220 (263)
T cd06625 156 TICSSGTGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEFEAM-----AA-I---------FKIA 220 (263)
T ss_pred ccccccccccCCCcCccccCcceeccCCCCchhhhHHHHHHHHHHHhCCCCccccchH-----HH-H---------HHHh
Confidence 3221111 2345788999999999999999999999999999999999998632111 00 0 1111
Q ss_pred hhhhhccCChhHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 044312 507 DARVMKQGGKDEIITVAKLAKRCLNLNGKKRPTMREVASE 546 (608)
Q Consensus 507 d~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~evl~~ 546 (608)
........+...+..+.+++.+||..+|++|||+.|++++
T Consensus 221 ~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~ 260 (263)
T cd06625 221 TQPTNPQLPSHVSPDARNFLRRTFVENAKKRPSAEELLRH 260 (263)
T ss_pred ccCCCCCCCccCCHHHHHHHHHHhhcCcccCCCHHHHhhC
Confidence 1111122334456789999999999999999999999864
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-34 Score=292.46 Aligned_cols=245 Identities=25% Similarity=0.381 Sum_probs=191.4
Q ss_pred CccccceeccCc---------------eEEEEEee---cChhhHHHHHHHHHHHhhcCCCCccceecccccCccceEEEe
Q 044312 290 NFDLNRILGQGG---------------QAVKKSKV---IDESKVEEFINEVVILSQINHRNVVKLLGCCLETEVPLLVYE 351 (608)
Q Consensus 290 ~f~~~~~lG~G~---------------~avk~~~~---~~~~~~~~~~~Ei~il~~l~H~niv~l~~~~~~~~~~~lV~E 351 (608)
+|++.+.||+|+ ++||.... .+....+++.+|+.+++.++|+||+++++++.+.+..+++||
T Consensus 3 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e 82 (267)
T cd08229 3 NFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVLE 82 (267)
T ss_pred hhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCCeEEEEEE
Confidence 466667777775 36665543 233455789999999999999999999999999999999999
Q ss_pred ecCCCccchhccccC-CCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEEcCCCcEEEeeccCccccccC
Q 044312 352 FIPNGTLFQYIHDQN-EDFPITWEIRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVD 430 (608)
Q Consensus 352 ~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGls~~~~~~ 430 (608)
|+++++|.+++.... ....+++..++.++.||+.||.|||+.+ ++|+||||+||+++.++.++|+|||++......
T Consensus 83 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~ 159 (267)
T cd08229 83 LADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSRR---VMHRDIKPANVFITATGVVKLGDLGLGRFFSSK 159 (267)
T ss_pred ecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCCEEECcchhhhccccC
Confidence 999999999886422 2235899999999999999999999999 999999999999999999999999998766433
Q ss_pred CcceeeeeeccCCCCChhhhccCCCCCccchHhHHHHHHHHHhCCCCCCccchhhcccHHHHHHHHhhhhhhHHHhhhhh
Q 044312 431 QTHMTTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLTELLTGEKPIRFTILEEDKSLAAYFLCAMKEERLFEILDARV 510 (608)
Q Consensus 431 ~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~ 510 (608)
.. ......++..|+|||.+....++.++||||||++++||++|..||.....+ ..... . .+.....
T Consensus 160 ~~-~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~----~~~~~-~--------~~~~~~~ 225 (267)
T cd08229 160 TT-AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMN----LYSLC-K--------KIEQCDY 225 (267)
T ss_pred Cc-ccccccCCcCccCHHHhcCCCccchhhHHHHHHHHHHHHhCCCCcccccch----HHHHh-h--------hhhcCCC
Confidence 22 123345888999999999999999999999999999999999998532211 00000 0 0000001
Q ss_pred hccCChhHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhhH
Q 044312 511 MKQGGKDEIITVAKLAKRCLNLNGKKRPTMREVASELAGIK 551 (608)
Q Consensus 511 ~~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~evl~~L~~i~ 551 (608)
........+..+.+++.+||+.+|++||||.+|++.++++.
T Consensus 226 ~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~i~~~~~~~~ 266 (267)
T cd08229 226 PPLPSDHYSEELRQLVNMCINPDPEKRPDITYVYDVAKRMH 266 (267)
T ss_pred CCCCcccccHHHHHHHHHhcCCCcccCCCHHHHHHHHhhhc
Confidence 11112345678999999999999999999999999987753
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=293.53 Aligned_cols=240 Identities=25% Similarity=0.434 Sum_probs=187.5
Q ss_pred CccccceeccCce------------------EEEEEeec-ChhhHHHHHHHHHHHhhcCCCCccceecccccCccceEEE
Q 044312 290 NFDLNRILGQGGQ------------------AVKKSKVI-DESKVEEFINEVVILSQINHRNVVKLLGCCLETEVPLLVY 350 (608)
Q Consensus 290 ~f~~~~~lG~G~~------------------avk~~~~~-~~~~~~~~~~Ei~il~~l~H~niv~l~~~~~~~~~~~lV~ 350 (608)
.|++.+.||+|++ |||..+.. +....++|.+|+.++++++||||+++++++.+....++||
T Consensus 5 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~ 84 (269)
T cd05065 5 CVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRPVMIIT 84 (269)
T ss_pred HeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCcCcceEEEEECCCCceEEEE
Confidence 3566777887763 55554432 3445678999999999999999999999999999999999
Q ss_pred eecCCCccchhccccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEEcCCCcEEEeeccCccccccC
Q 044312 351 EFIPNGTLFQYIHDQNEDFPITWEIRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVD 430 (608)
Q Consensus 351 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGls~~~~~~ 430 (608)
||+++++|.+++..... .+++..++.++.|++.||+|||+.+ ++|+||||+|||++.++.+||+|||+++.....
T Consensus 85 e~~~~~~L~~~l~~~~~--~~~~~~~~~i~~~l~~al~~lH~~g---~~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~ 159 (269)
T cd05065 85 EFMENGALDSFLRQNDG--QFTVIQLVGMLRGIAAGMKYLSEMN---YVHRDLAARNILVNSNLVCKVSDFGLSRFLEDD 159 (269)
T ss_pred ecCCCCcHHHHHhhCCC--CCCHHHHHHHHHHHHHHHHHHHHCC---EeecccChheEEEcCCCcEEECCCccccccccC
Confidence 99999999999876433 4899999999999999999999998 999999999999999999999999998766432
Q ss_pred Cccee-e-eee--ccCCCCChhhhccCCCCCccchHhHHHHHHHHHh-CCCCCCccchhhcccHHHHHHHHhhhhhhHHH
Q 044312 431 QTHMT-T-QVH--GTFGYLDPEYFRSSQFTDKSDVYSFGVVLTELLT-GEKPIRFTILEEDKSLAAYFLCAMKEERLFEI 505 (608)
Q Consensus 431 ~~~~~-~-~~~--gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~ellt-g~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 505 (608)
..... . ... .+..|+|||++....++.++||||||++++|+++ |..||....... +...+.
T Consensus 160 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~~~~-------~~~~i~------- 225 (269)
T cd05065 160 TSDPTYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQD-------VINAIE------- 225 (269)
T ss_pred ccccccccccCCCcceeecCHhHhccCcccchhhhhhhHHHHHHHhcCCCCCCCCCCHHH-------HHHHHH-------
Confidence 22111 1 111 2457999999999999999999999999999887 999986322111 000110
Q ss_pred hhhhhhccCChhHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhh
Q 044312 506 LDARVMKQGGKDEIITVAKLAKRCLNLNGKKRPTMREVASELAGI 550 (608)
Q Consensus 506 ~d~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~evl~~L~~i 550 (608)
.......+.+.+..+.+++.+||+.+|++||++.+|+..|+.+
T Consensus 226 --~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 268 (269)
T cd05065 226 --QDYRLPPPMDCPTALHQLMLDCWQKDRNARPKFGQIVSTLDKM 268 (269)
T ss_pred --cCCcCCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 1111122234566789999999999999999999999988764
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-34 Score=291.97 Aligned_cols=240 Identities=24% Similarity=0.407 Sum_probs=189.2
Q ss_pred hcCccccceeccCce--------------EEEEEeecChhhHHHHHHHHHHHhhcCCCCccceecccccCccceEEEeec
Q 044312 288 TDNFDLNRILGQGGQ--------------AVKKSKVIDESKVEEFINEVVILSQINHRNVVKLLGCCLETEVPLLVYEFI 353 (608)
Q Consensus 288 t~~f~~~~~lG~G~~--------------avk~~~~~~~~~~~~~~~Ei~il~~l~H~niv~l~~~~~~~~~~~lV~E~~ 353 (608)
.++|.+.++||+|++ ++|..+. .....+.|.+|+.++++++|+||+++++++.+ ...+++|||+
T Consensus 5 ~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~iK~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~v~e~~ 82 (260)
T cd05073 5 RESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKP-GSMSVEAFLAEANVMKTLQHDKLVKLHAVVTK-EPIYIITEFM 82 (260)
T ss_pred ccceeEEeEecCccceEEEEEEecCCccEEEEecCC-ChhHHHHHHHHHHHHHhcCCCCcceEEEEEcC-CCeEEEEEeC
Confidence 456888899999875 4444432 23345789999999999999999999999887 7789999999
Q ss_pred CCCccchhccccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEEcCCCcEEEeeccCccccccCCcc
Q 044312 354 PNGTLFQYIHDQNEDFPITWEIRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTH 433 (608)
Q Consensus 354 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGls~~~~~~~~~ 433 (608)
++++|.+++..... ..+++..++.++.|++.||.|||+.+ ++|+||||+||+++.++.+||+|||++.........
T Consensus 83 ~~~~L~~~~~~~~~-~~~~~~~~~~~~~~l~~aL~~lH~~~---i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~ 158 (260)
T cd05073 83 AKGSLLDFLKSDEG-SKQPLPKLIDFSAQIAEGMAFIEQRN---YIHRDLRAANILVSASLVCKIADFGLARVIEDNEYT 158 (260)
T ss_pred CCCcHHHHHHhCCc-cccCHHHHHHHHHHHHHHHHHHHhCC---ccccccCcceEEEcCCCcEEECCCcceeeccCCCcc
Confidence 99999999976432 25889999999999999999999998 999999999999999999999999999765433222
Q ss_pred eeeeeeccCCCCChhhhccCCCCCccchHhHHHHHHHHHh-CCCCCCccchhhcccHHHHHHHHhhhhhhHHHhhhhhhc
Q 044312 434 MTTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLTELLT-GEKPIRFTILEEDKSLAAYFLCAMKEERLFEILDARVMK 512 (608)
Q Consensus 434 ~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~ellt-g~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~ 512 (608)
......++..|+|||++....++.++||||||+++++++| |+.||....... + .+.+......
T Consensus 159 ~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~---~-------------~~~~~~~~~~ 222 (260)
T cd05073 159 AREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPE---V-------------IRALERGYRM 222 (260)
T ss_pred cccCCcccccccCHhHhccCCcCccccchHHHHHHHHHHhcCCCCCCCCCHHH---H-------------HHHHhCCCCC
Confidence 2223345678999999998899999999999999999999 888986322110 0 0111111111
Q ss_pred cCChhHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHh
Q 044312 513 QGGKDEIITVAKLAKRCLNLNGKKRPTMREVASELAG 549 (608)
Q Consensus 513 ~~~~~~~~~l~~Li~~cl~~dp~~RPs~~evl~~L~~ 549 (608)
+.....+.++.+++.+||+.+|++||++.++++.|+.
T Consensus 223 ~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~L~~ 259 (260)
T cd05073 223 PRPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDD 259 (260)
T ss_pred CCcccCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence 2233455679999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-35 Score=311.92 Aligned_cols=251 Identities=24% Similarity=0.420 Sum_probs=195.0
Q ss_pred HHHHHhcCccccceeccCce--------------------EEEEEeec-ChhhHHHHHHHHHHHhhcC-CCCccceeccc
Q 044312 283 ELEKATDNFDLNRILGQGGQ--------------------AVKKSKVI-DESKVEEFINEVVILSQIN-HRNVVKLLGCC 340 (608)
Q Consensus 283 ~l~~~t~~f~~~~~lG~G~~--------------------avk~~~~~-~~~~~~~~~~Ei~il~~l~-H~niv~l~~~~ 340 (608)
+++...++|.+.++||+|+| |||+++.. .....+.+.+|+++|.++. ||||+++++++
T Consensus 31 ~~~~~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~~H~niv~~~~~~ 110 (401)
T cd05107 31 AWEMPRDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSSEKQALMSELKIMSHLGPHLNIVNLLGAC 110 (401)
T ss_pred cceecHHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCChhHHHHHHHHHHHHHhcCCCCCeEEEEEEE
Confidence 35555667888899999974 44555432 2233457899999999997 99999999999
Q ss_pred ccCccceEEEeecCCCccchhccccCC-----------------------------------------------------
Q 044312 341 LETEVPLLVYEFIPNGTLFQYIHDQNE----------------------------------------------------- 367 (608)
Q Consensus 341 ~~~~~~~lV~E~~~~gsL~~~l~~~~~----------------------------------------------------- 367 (608)
......++||||+++|+|.++++....
T Consensus 111 ~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 190 (401)
T cd05107 111 TKGGPIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYV 190 (401)
T ss_pred ccCCCcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCcc
Confidence 999999999999999999999875321
Q ss_pred ------------------------------------------CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCC
Q 044312 368 ------------------------------------------DFPITWEIRLRIAIEVSGALSYLHSAASIPIYHRDIKS 405 (608)
Q Consensus 368 ------------------------------------------~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~ 405 (608)
...+++..++.|+.||+.||+|||+.+ ++||||||
T Consensus 191 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrdlkp 267 (401)
T cd05107 191 PMQDMKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASKN---CVHRDLAA 267 (401)
T ss_pred chhcchhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCC---cCcccCCc
Confidence 123678889999999999999999988 99999999
Q ss_pred CcEEEcCCCcEEEeeccCccccccCCcc-eeeeeeccCCCCChhhhccCCCCCccchHhHHHHHHHHHh-CCCCCCccch
Q 044312 406 TNILLDDKYRAKVSDFGASRSMAVDQTH-MTTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLTELLT-GEKPIRFTIL 483 (608)
Q Consensus 406 ~NILl~~~~~~kl~DFGls~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~ellt-g~~p~~~~~~ 483 (608)
+|||+++++.+||+|||+++........ ......++..|+|||.+....++.++||||||++++||++ |..||.....
T Consensus 268 ~NiLl~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~e~l~~g~~P~~~~~~ 347 (401)
T cd05107 268 RNVLICEGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPELPM 347 (401)
T ss_pred ceEEEeCCCEEEEEecCcceecccccccccCCCcCCCCceeChHHhcCCCCCcHhHHHHHHHHHHHHHHcCCCCCCCCCc
Confidence 9999999999999999999865432211 1122346788999999998899999999999999999998 8889863221
Q ss_pred hhcccHHHHHHHHhhhhhhHHHhhhhhhccCChhHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhhH
Q 044312 484 EEDKSLAAYFLCAMKEERLFEILDARVMKQGGKDEIITVAKLAKRCLNLNGKKRPTMREVASELAGIK 551 (608)
Q Consensus 484 ~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~evl~~L~~i~ 551 (608)
.+ .+.+.+........+...+.++.+|+.+||..+|++||+++||++.|+.+.
T Consensus 348 ~~---------------~~~~~~~~~~~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L~~~~ 400 (401)
T cd05107 348 NE---------------QFYNAIKRGYRMAKPAHASDEIYEIMQKCWEEKFEIRPDFSQLVHLVGDLL 400 (401)
T ss_pred hH---------------HHHHHHHcCCCCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHh
Confidence 11 011111111112233345678999999999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-34 Score=296.87 Aligned_cols=234 Identities=25% Similarity=0.399 Sum_probs=176.1
Q ss_pred EEEEEeec-ChhhHHHHHHHHHHHhhcCCCCccceecccccCccceEEEeecCCCccchhccccCC---------CCCCC
Q 044312 303 AVKKSKVI-DESKVEEFINEVVILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGTLFQYIHDQNE---------DFPIT 372 (608)
Q Consensus 303 avk~~~~~-~~~~~~~~~~Ei~il~~l~H~niv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~---------~~~l~ 372 (608)
|+|..+.. .....+.|.+|++++++++|+||+++++++......++||||+++++|.+++..... ...++
T Consensus 48 avK~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~ 127 (295)
T cd05097 48 AVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRLLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVS 127 (295)
T ss_pred EEEecCCCCCHHHHHHHHHHHHHHHhCCCCCcCeEEEEEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCccc
Confidence 44444321 334456799999999999999999999999999999999999999999998864321 11378
Q ss_pred HHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEEcCCCcEEEeeccCccccccCCcc-eeeeeeccCCCCChhhhc
Q 044312 373 WEIRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTH-MTTQVHGTFGYLDPEYFR 451 (608)
Q Consensus 373 ~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGls~~~~~~~~~-~~~~~~gt~~y~aPE~~~ 451 (608)
+..++.++.|++.||+|||+.+ ++||||||+|||+++++.+||+|||+++........ ......++..|+|||++.
T Consensus 128 ~~~~~~i~~~i~~al~~lH~~~---i~H~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~ 204 (295)
T cd05097 128 IANLLYMAVQIASGMKYLASLN---FVHRDLATRNCLVGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESIL 204 (295)
T ss_pred HHHHHHHHHHHHHHHHHHHhcC---eeccccChhhEEEcCCCcEEecccccccccccCcceeccCcCcCceeecChhhhc
Confidence 8999999999999999999999 999999999999999999999999999765432211 112234567899999999
Q ss_pred cCCCCCccchHhHHHHHHHHHh--CCCCCCccchhhcccHHHHHHHHhhhhhhHHHhhhhhhccCChhHHHHHHHHHHHH
Q 044312 452 SSQFTDKSDVYSFGVVLTELLT--GEKPIRFTILEEDKSLAAYFLCAMKEERLFEILDARVMKQGGKDEIITVAKLAKRC 529 (608)
Q Consensus 452 ~~~~t~ksDV~S~Gvvl~ellt--g~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~Li~~c 529 (608)
...++.++||||||++++||++ +..||....... ......... ...........+...+..+.+|+.+|
T Consensus 205 ~~~~~~~~DvwSlG~~l~el~~~~~~~p~~~~~~~~---~~~~~~~~~------~~~~~~~~~~~~~~~~~~l~~li~~~ 275 (295)
T cd05097 205 LGKFTTASDVWAFGVTLWEMFTLCKEQPYSLLSDEQ---VIENTGEFF------RNQGRQIYLSQTPLCPSPVFKLMMRC 275 (295)
T ss_pred cCCcCchhhHHHHHHHHHHHHHcCCCCCCcccChHH---HHHHHHHhh------hhccccccCCCCCCCCHHHHHHHHHH
Confidence 9999999999999999999998 556665322111 000000000 00001111112233456899999999
Q ss_pred hccCCCCCCCHHHHHHHHH
Q 044312 530 LNLNGKKRPTMREVASELA 548 (608)
Q Consensus 530 l~~dp~~RPs~~evl~~L~ 548 (608)
|+.+|++||++.+|++.|+
T Consensus 276 l~~~p~~RPs~~~i~~~l~ 294 (295)
T cd05097 276 WSRDIKDRPTFNKIHHFLR 294 (295)
T ss_pred cCCCchhCcCHHHHHHHHh
Confidence 9999999999999999885
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-35 Score=309.20 Aligned_cols=229 Identities=29% Similarity=0.410 Sum_probs=192.4
Q ss_pred HhcCccccceeccCce---------------EEEEEe---ecChhhHHHHHHHHHHHhhc-CCCCccceecccccCccce
Q 044312 287 ATDNFDLNRILGQGGQ---------------AVKKSK---VIDESKVEEFINEVVILSQI-NHRNVVKLLGCCLETEVPL 347 (608)
Q Consensus 287 ~t~~f~~~~~lG~G~~---------------avk~~~---~~~~~~~~~~~~Ei~il~~l-~H~niv~l~~~~~~~~~~~ 347 (608)
.-++|.+.++||+|.| |||.++ +....+++....|.+|+... +||.+++|+.+|...++++
T Consensus 366 ~l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~~l~ 445 (694)
T KOG0694|consen 366 TLDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKEHLF 445 (694)
T ss_pred cccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccCCeEE
Confidence 3567999999999974 777665 46777889999999999888 5999999999999999999
Q ss_pred EEEeecCCCccchhccccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEEcCCCcEEEeeccCcccc
Q 044312 348 LVYEFIPNGTLFQYIHDQNEDFPITWEIRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSM 427 (608)
Q Consensus 348 lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGls~~~ 427 (608)
+||||+.||++..+.+.. .+++..+.-+|++|+.||.|||+++ ||+||||.+|||||.+|.+||+||||++..
T Consensus 446 fvmey~~Ggdm~~~~~~~----~F~e~rarfyaAev~l~L~fLH~~~---IIYRDlKLdNiLLD~eGh~kiADFGlcKe~ 518 (694)
T KOG0694|consen 446 FVMEYVAGGDLMHHIHTD----VFSEPRARFYAAEVVLGLQFLHENG---IIYRDLKLDNLLLDTEGHVKIADFGLCKEG 518 (694)
T ss_pred EEEEecCCCcEEEEEecc----cccHHHHHHHHHHHHHHHHHHHhcC---ceeeecchhheEEcccCcEEeccccccccc
Confidence 999999999955544432 4999999999999999999999999 999999999999999999999999999875
Q ss_pred ccCCcceeeeeeccCCCCChhhhccCCCCCccchHhHHHHHHHHHhCCCCCCccchhhcccHHHHHHHHhhhhhhHHHhh
Q 044312 428 AVDQTHMTTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLTELLTGEKPIRFTILEEDKSLAAYFLCAMKEERLFEILD 507 (608)
Q Consensus 428 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 507 (608)
.... ..+....||+.|||||++.+..|+..+|.|||||+||||+.|+.||.....++ .|...+.++
T Consensus 519 m~~g-~~TsTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~gddEee------~FdsI~~d~------- 584 (694)
T KOG0694|consen 519 MGQG-DRTSTFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLVGESPFPGDDEEE------VFDSIVNDE------- 584 (694)
T ss_pred CCCC-CccccccCChhhcChhhhccCcccchhhHHHHHHHHHHHHcCCCCCCCCCHHH------HHHHHhcCC-------
Confidence 5332 35677899999999999999999999999999999999999999997432221 121111111
Q ss_pred hhhhccCChhHHHHHHHHHHHHhccCCCCCCCH
Q 044312 508 ARVMKQGGKDEIITVAKLAKRCLNLNGKKRPTM 540 (608)
Q Consensus 508 ~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPs~ 540 (608)
..+|...+.+..++++++|..+|++|.-+
T Consensus 585 ----~~yP~~ls~ea~~il~~ll~k~p~kRLG~ 613 (694)
T KOG0694|consen 585 ----VRYPRFLSKEAIAIMRRLLRKNPEKRLGS 613 (694)
T ss_pred ----CCCCCcccHHHHHHHHHHhccCcccccCC
Confidence 12455667789999999999999999877
|
|
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-35 Score=312.22 Aligned_cols=238 Identities=26% Similarity=0.382 Sum_probs=188.5
Q ss_pred HhcCccccceeccCce---------------EEEEEee---cChhhHHHHHHHHHHHhhcCCCCccceecccccCccceE
Q 044312 287 ATDNFDLNRILGQGGQ---------------AVKKSKV---IDESKVEEFINEVVILSQINHRNVVKLLGCCLETEVPLL 348 (608)
Q Consensus 287 ~t~~f~~~~~lG~G~~---------------avk~~~~---~~~~~~~~~~~Ei~il~~l~H~niv~l~~~~~~~~~~~l 348 (608)
..++|++.++||+|++ |+|.+.. ......+.+.+|+.+++.++||||+++++++.+....++
T Consensus 41 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~~~~~l 120 (370)
T cd05596 41 KAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDDKYLYM 120 (370)
T ss_pred CHHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEEE
Confidence 4567899999999974 5665542 223344568899999999999999999999999999999
Q ss_pred EEeecCCCccchhccccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEEcCCCcEEEeeccCccccc
Q 044312 349 VYEFIPNGTLFQYIHDQNEDFPITWEIRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMA 428 (608)
Q Consensus 349 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGls~~~~ 428 (608)
||||+++|+|.+++... .+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++...
T Consensus 121 v~Ey~~gg~L~~~l~~~----~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDLkp~NILl~~~~~~kL~DfG~~~~~~ 193 (370)
T cd05596 121 VMEYMPGGDLVNLMSNY----DIPEKWARFYTAEVVLALDAIHSMG---FIHRDVKPDNMLLDKSGHLKLADFGTCMKMD 193 (370)
T ss_pred EEcCCCCCcHHHHHHhc----CCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEEcCCCCEEEEeccceeecc
Confidence 99999999999988653 3788889999999999999999999 9999999999999999999999999998764
Q ss_pred cCCcceeeeeeccCCCCChhhhccC----CCCCccchHhHHHHHHHHHhCCCCCCccchhhcccHHHHHHHHhhhhhhHH
Q 044312 429 VDQTHMTTQVHGTFGYLDPEYFRSS----QFTDKSDVYSFGVVLTELLTGEKPIRFTILEEDKSLAAYFLCAMKEERLFE 504 (608)
Q Consensus 429 ~~~~~~~~~~~gt~~y~aPE~~~~~----~~t~ksDV~S~Gvvl~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~ 504 (608)
...........||+.|+|||++... .++.++|||||||+++||++|+.||..... ...+ ..
T Consensus 194 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~------~~~~---------~~ 258 (370)
T cd05596 194 ANGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSL------VGTY---------SK 258 (370)
T ss_pred CCCcccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCH------HHHH---------HH
Confidence 3332223345699999999998653 478999999999999999999999973221 1111 11
Q ss_pred Hhhhh--hhccCChhHHHHHHHHHHHHhccCCCC--CCCHHHHHHH
Q 044312 505 ILDAR--VMKQGGKDEIITVAKLAKRCLNLNGKK--RPTMREVASE 546 (608)
Q Consensus 505 ~~d~~--~~~~~~~~~~~~l~~Li~~cl~~dp~~--RPs~~evl~~ 546 (608)
++... +........+.++.+|+.+||+.+|++ ||++.|++++
T Consensus 259 i~~~~~~~~~~~~~~~s~~~~~li~~~L~~~p~r~~R~s~~ell~h 304 (370)
T cd05596 259 IMDHKNSLTFPDDIEISKQAKDLICAFLTDREVRLGRNGVDEIKSH 304 (370)
T ss_pred HHcCCCcCCCCCcCCCCHHHHHHHHHHccChhhccCCCCHHHHhcC
Confidence 11111 111112235678999999999999988 9999999876
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-34 Score=319.58 Aligned_cols=245 Identities=25% Similarity=0.325 Sum_probs=193.0
Q ss_pred HHHHHhcCccccceeccCce---------------EEEEEee--cChhhHHHHHHHHHHHhhcCCCCccceecccccCc-
Q 044312 283 ELEKATDNFDLNRILGQGGQ---------------AVKKSKV--IDESKVEEFINEVVILSQINHRNVVKLLGCCLETE- 344 (608)
Q Consensus 283 ~l~~~t~~f~~~~~lG~G~~---------------avk~~~~--~~~~~~~~~~~Ei~il~~l~H~niv~l~~~~~~~~- 344 (608)
+.+...++|.+.+.||+|+| |||.+.. .+......+.+|+.++..++|+||++++..+...+
T Consensus 26 ~~~~~~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~ 105 (496)
T PTZ00283 26 TAKEQAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDP 105 (496)
T ss_pred cccccCCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecceecccc
Confidence 34455679999999999985 6666543 23455677899999999999999999988765332
Q ss_pred -------cceEEEeecCCCccchhccccC-CCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEEcCCCcE
Q 044312 345 -------VPLLVYEFIPNGTLFQYIHDQN-EDFPITWEIRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRA 416 (608)
Q Consensus 345 -------~~~lV~E~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ 416 (608)
..++||||+++|+|.+++.... ...++++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+
T Consensus 106 ~~~~~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~~---IiHrDLKP~NILl~~~~~v 182 (496)
T PTZ00283 106 RNPENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSKH---MIHRDIKSANILLCSNGLV 182 (496)
T ss_pred cCcccceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEeCCCCE
Confidence 3679999999999999987532 2236899999999999999999999998 9999999999999999999
Q ss_pred EEeeccCccccccCCc-ceeeeeeccCCCCChhhhccCCCCCccchHhHHHHHHHHHhCCCCCCccchhhcccHHHHHHH
Q 044312 417 KVSDFGASRSMAVDQT-HMTTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLTELLTGEKPIRFTILEEDKSLAAYFLC 495 (608)
Q Consensus 417 kl~DFGls~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~elltg~~p~~~~~~~~~~~l~~~~~~ 495 (608)
||+|||+++.+..... .......||+.|+|||++....++.++||||||+++|||++|+.||..... ...+..
T Consensus 183 kL~DFGls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvilyeLltG~~Pf~~~~~------~~~~~~ 256 (496)
T PTZ00283 183 KLGDFGFSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGENM------EEVMHK 256 (496)
T ss_pred EEEecccCeeccccccccccccccCCcceeCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCH------HHHHHH
Confidence 9999999987643221 122345689999999999999999999999999999999999999863221 111111
Q ss_pred HhhhhhhHHHhhhhhhccCChhHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 044312 496 AMKEERLFEILDARVMKQGGKDEIITVAKLAKRCLNLNGKKRPTMREVASE 546 (608)
Q Consensus 496 ~~~~~~~~~~~d~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~evl~~ 546 (608)
++.. .....+...+.++.+|+.+||+.||++||++.+++++
T Consensus 257 ---------~~~~-~~~~~~~~~~~~l~~li~~~L~~dP~~RPs~~ell~~ 297 (496)
T PTZ00283 257 ---------TLAG-RYDPLPPSISPEMQEIVTALLSSDPKRRPSSSKLLNM 297 (496)
T ss_pred ---------HhcC-CCCCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHhC
Confidence 1110 1112334556789999999999999999999999864
|
|
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-34 Score=301.61 Aligned_cols=221 Identities=26% Similarity=0.311 Sum_probs=176.6
Q ss_pred eEEEEEeec----ChhhHHHHHHHHHHHhhcCCCCccceecccccCccceEEEeecCCCccchhccccCCCCCCCHHHHH
Q 044312 302 QAVKKSKVI----DESKVEEFINEVVILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEIRL 377 (608)
Q Consensus 302 ~avk~~~~~----~~~~~~~~~~Ei~il~~l~H~niv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~ 377 (608)
+|||..+.. +......+.+|+.+|++++||||+++++++...+..++||||+++++|.+++.... .+++..+.
T Consensus 27 ~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~---~~~~~~~~ 103 (323)
T cd05584 27 FAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLILEYLSGGELFMHLEREG---IFMEDTAC 103 (323)
T ss_pred EEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeEEEEEeCCCCchHHHHHHHcC---CCCHHHHH
Confidence 466665532 22334567899999999999999999999999999999999999999999987643 47888999
Q ss_pred HHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEEcCCCcEEEeeccCccccccCCcceeeeeeccCCCCChhhhccCCCCC
Q 044312 378 RIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHGTFGYLDPEYFRSSQFTD 457 (608)
Q Consensus 378 ~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGls~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ 457 (608)
.++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++...... .......||+.|+|||++.+..++.
T Consensus 104 ~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~ 179 (323)
T cd05584 104 FYLSEISLALEHLHQQG---IIYRDLKPENILLDAQGHVKLTDFGLCKESIHEG-TVTHTFCGTIEYMAPEILMRSGHGK 179 (323)
T ss_pred HHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCCEEEeeCcCCeecccCC-CcccccCCCccccChhhccCCCCCC
Confidence 99999999999999999 9999999999999999999999999987543222 2223456899999999999989999
Q ss_pred ccchHhHHHHHHHHHhCCCCCCccchhhcccHHHHHHHHhhhhhhHHHhhhhhhccCChhHHHHHHHHHHHHhccCCCCC
Q 044312 458 KSDVYSFGVVLTELLTGEKPIRFTILEEDKSLAAYFLCAMKEERLFEILDARVMKQGGKDEIITVAKLAKRCLNLNGKKR 537 (608)
Q Consensus 458 ksDV~S~Gvvl~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~Li~~cl~~dp~~R 537 (608)
++||||||++++||++|+.||...... ... ..+.... ...+...+..+.+|+.+||+.+|++|
T Consensus 180 ~~DiwslG~il~ell~G~~pf~~~~~~------~~~---------~~~~~~~--~~~~~~~~~~~~~li~~~l~~~p~~R 242 (323)
T cd05584 180 AVDWWSLGALMYDMLTGAPPFTAENRK------KTI---------DKILKGK--LNLPPYLTPEARDLLKKLLKRNPSSR 242 (323)
T ss_pred cceecccHHHHHHHhcCCCCCCCCCHH------HHH---------HHHHcCC--CCCCCCCCHHHHHHHHHHcccCHhHc
Confidence 999999999999999999998632211 001 1111111 12233445678999999999999999
Q ss_pred C-----CHHHHHHH
Q 044312 538 P-----TMREVASE 546 (608)
Q Consensus 538 P-----s~~evl~~ 546 (608)
| ++.+++++
T Consensus 243 ~~~~~~~~~~l~~h 256 (323)
T cd05584 243 LGAGPGDAAEVQSH 256 (323)
T ss_pred CCCCCCCHHHHhcC
Confidence 9 78887764
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-34 Score=301.87 Aligned_cols=221 Identities=25% Similarity=0.307 Sum_probs=178.1
Q ss_pred eEEEEEeec---ChhhHHHHHHHHHHHhhcCCCCccceecccccCccceEEEeecCCCccchhccccCCCCCCCHHHHHH
Q 044312 302 QAVKKSKVI---DESKVEEFINEVVILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEIRLR 378 (608)
Q Consensus 302 ~avk~~~~~---~~~~~~~~~~Ei~il~~l~H~niv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~ 378 (608)
+|+|..+.. .......+.+|+.+++.++||||+++++++...+..+|||||+++|+|..++.... .+++..+..
T Consensus 23 vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~~L~~~l~~~~---~~~~~~~~~ 99 (323)
T cd05595 23 YAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRER---VFTEERARF 99 (323)
T ss_pred EEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEeCCCCCcHHHHHHHcC---CCCHHHHHH
Confidence 477766532 33455678899999999999999999999999999999999999999998886543 589999999
Q ss_pred HHHHHHHHHHHHhhcCCCCeeccCCCCCcEEEcCCCcEEEeeccCccccccCCcceeeeeeccCCCCChhhhccCCCCCc
Q 044312 379 IAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHGTFGYLDPEYFRSSQFTDK 458 (608)
Q Consensus 379 i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGls~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k 458 (608)
++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++...... .......||+.|+|||++.+..++.+
T Consensus 100 ~~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~ 175 (323)
T cd05595 100 YGAEIVSALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCKEGISDG-ATMKTFCGTPEYLAPEVLEDNDYGRA 175 (323)
T ss_pred HHHHHHHHHHHHHHCC---eEecCCCHHHEEEcCCCCEEecccHHhccccCCC-CccccccCCcCcCCcccccCCCCCch
Confidence 9999999999999999 9999999999999999999999999987543222 12234568999999999999999999
Q ss_pred cchHhHHHHHHHHHhCCCCCCccchhhcccHHHHHHHHhhhhhhHHHhhhhhhccCChhHHHHHHHHHHHHhccCCCCCC
Q 044312 459 SDVYSFGVVLTELLTGEKPIRFTILEEDKSLAAYFLCAMKEERLFEILDARVMKQGGKDEIITVAKLAKRCLNLNGKKRP 538 (608)
Q Consensus 459 sDV~S~Gvvl~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RP 538 (608)
+|||||||+++||++|+.||....... ... .+.... ...+...+.++.+|+.+||+.||++||
T Consensus 176 ~DiwSlGvil~ell~g~~Pf~~~~~~~------~~~---------~~~~~~--~~~p~~~~~~~~~li~~~L~~dP~~R~ 238 (323)
T cd05595 176 VDWWGLGVVMYEMMCGRLPFYNQDHER------LFE---------LILMEE--IRFPRTLSPEAKSLLAGLLKKDPKQRL 238 (323)
T ss_pred hchhhhHHHHHHHHhCCCCCCCCCHHH------HHH---------HHhcCC--CCCCCCCCHHHHHHHHHHccCCHHHhC
Confidence 999999999999999999986332111 000 011000 112334567899999999999999998
Q ss_pred -----CHHHHHHH
Q 044312 539 -----TMREVASE 546 (608)
Q Consensus 539 -----s~~evl~~ 546 (608)
++.+++++
T Consensus 239 ~~~~~~~~~~l~h 251 (323)
T cd05595 239 GGGPSDAKEVMEH 251 (323)
T ss_pred CCCCCCHHHHHcC
Confidence 88888764
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-34 Score=293.84 Aligned_cols=242 Identities=25% Similarity=0.460 Sum_probs=188.3
Q ss_pred cCccccceeccCce-------------------EEEEEee-cChhhHHHHHHHHHHHhhcCCCCccceecccccCccceE
Q 044312 289 DNFDLNRILGQGGQ-------------------AVKKSKV-IDESKVEEFINEVVILSQINHRNVVKLLGCCLETEVPLL 348 (608)
Q Consensus 289 ~~f~~~~~lG~G~~-------------------avk~~~~-~~~~~~~~~~~Ei~il~~l~H~niv~l~~~~~~~~~~~l 348 (608)
+.|++.++||+|++ |+|..+. ......+.+.+|+.+++.++|+||+++++++... ..++
T Consensus 7 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~l 85 (279)
T cd05109 7 TELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRLLGICLTS-TVQL 85 (279)
T ss_pred hheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCCCHHHHHHHHHHHHHHHhcCCCCCceEEEEEcCC-CcEE
Confidence 35677788888864 4444433 2333456789999999999999999999998754 5689
Q ss_pred EEeecCCCccchhccccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEEcCCCcEEEeeccCccccc
Q 044312 349 VYEFIPNGTLFQYIHDQNEDFPITWEIRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMA 428 (608)
Q Consensus 349 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGls~~~~ 428 (608)
++||+++|+|.++++.... .+++..++.++.||+.||+|||+.+ ++||||||+|||+++++.+||+|||+++...
T Consensus 86 ~~~~~~~g~l~~~l~~~~~--~~~~~~~~~~~~qi~~~L~~lH~~~---iiH~dlkp~Nil~~~~~~~kL~dfG~~~~~~ 160 (279)
T cd05109 86 VTQLMPYGCLLDYVRENKD--RIGSQDLLNWCVQIAKGMSYLEEVR---LVHRDLAARNVLVKSPNHVKITDFGLARLLD 160 (279)
T ss_pred EEEcCCCCCHHHHHhhccC--CCCHHHHHHHHHHHHHHHHHHHHCC---eeccccccceEEEcCCCcEEECCCCceeecc
Confidence 9999999999999976433 4899999999999999999999999 9999999999999999999999999998765
Q ss_pred cCCcce-eeeeeccCCCCChhhhccCCCCCccchHhHHHHHHHHHh-CCCCCCccchhhcccHHHHHHHHhhhhhhHHHh
Q 044312 429 VDQTHM-TTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLTELLT-GEKPIRFTILEEDKSLAAYFLCAMKEERLFEIL 506 (608)
Q Consensus 429 ~~~~~~-~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~ellt-g~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 506 (608)
...... .....++..|+|||.+.+..++.++||||||+++|||++ |..||....... +...+
T Consensus 161 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~----------------~~~~~ 224 (279)
T cd05109 161 IDETEYHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPARE----------------IPDLL 224 (279)
T ss_pred cccceeecCCCccchhhCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHH----------------HHHHH
Confidence 332221 112234678999999999999999999999999999998 889986322111 11111
Q ss_pred hhhhhccCChhHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhhHH
Q 044312 507 DARVMKQGGKDEIITVAKLAKRCLNLNGKKRPTMREVASELAGIKA 552 (608)
Q Consensus 507 d~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~evl~~L~~i~~ 552 (608)
........+...+.++.+++.+||+.||++||++.|+++.|+.+..
T Consensus 225 ~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~l~~~l~~~~~ 270 (279)
T cd05109 225 EKGERLPQPPICTIDVYMIMVKCWMIDSECRPRFRELVDEFSRMAR 270 (279)
T ss_pred HCCCcCCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhc
Confidence 1111112223455678999999999999999999999998877654
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-34 Score=290.46 Aligned_cols=239 Identities=26% Similarity=0.416 Sum_probs=185.8
Q ss_pred cCccccceeccCce--------------EEEEEeecChhhHHHHHHHHHHHhhcCCCCccceecccccCccceEEEeecC
Q 044312 289 DNFDLNRILGQGGQ--------------AVKKSKVIDESKVEEFINEVVILSQINHRNVVKLLGCCLETEVPLLVYEFIP 354 (608)
Q Consensus 289 ~~f~~~~~lG~G~~--------------avk~~~~~~~~~~~~~~~Ei~il~~l~H~niv~l~~~~~~~~~~~lV~E~~~ 354 (608)
++|.+.++||+|++ |+|.... +....+.+.+|+.++++++|+|++++++++. .+..++||||++
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~lK~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~~~ 83 (260)
T cd05069 6 ESLRLDVKLGQGCFGEVWMGTWNGTTKVAIKTLKP-GTMMPEAFLQEAQIMKKLRHDKLVPLYAVVS-EEPIYIVTEFMG 83 (260)
T ss_pred HHeeeeeeecCcCCCeEEEEEEcCCceEEEEEccc-CCccHHHHHHHHHHHHhCCCCCeeeEEEEEc-CCCcEEEEEcCC
Confidence 34677777888763 4454432 2233467899999999999999999999875 456889999999
Q ss_pred CCccchhccccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEEcCCCcEEEeeccCccccccCCcce
Q 044312 355 NGTLFQYIHDQNEDFPITWEIRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHM 434 (608)
Q Consensus 355 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGls~~~~~~~~~~ 434 (608)
+++|.++++.... ..+++..+..++.|++.||.|||+.+ ++|+||||+|||+++++.+||+|||+++.........
T Consensus 84 ~~~L~~~~~~~~~-~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~~~~~~~ 159 (260)
T cd05069 84 KGSLLDFLKEGDG-KYLKLPQLVDMAAQIADGMAYIERMN---YIHRDLRAANILVGDNLVCKIADFGLARLIEDNEYTA 159 (260)
T ss_pred CCCHHHHHhhCCC-CCCCHHHHHHHHHHHHHHHHHHHhCC---EeecccCcceEEEcCCCeEEECCCccceEccCCcccc
Confidence 9999999976432 25899999999999999999999998 9999999999999999999999999997664332222
Q ss_pred eeeeeccCCCCChhhhccCCCCCccchHhHHHHHHHHHh-CCCCCCccchhhcccHHHHHHHHhhhhhhHHHhhhhhhcc
Q 044312 435 TTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLTELLT-GEKPIRFTILEEDKSLAAYFLCAMKEERLFEILDARVMKQ 513 (608)
Q Consensus 435 ~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~ellt-g~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~ 513 (608)
.....++..|+|||++....++.++||||||++++||+| |+.||......+ .. +.+.......
T Consensus 160 ~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~---~~-------------~~~~~~~~~~ 223 (260)
T cd05069 160 RQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVNRE---VL-------------EQVERGYRMP 223 (260)
T ss_pred cCCCccchhhCCHHHhccCCcChHHHHHHHHHHHHHHHhCCCCCCCCCCHHH---HH-------------HHHHcCCCCC
Confidence 223345678999999998999999999999999999999 889986322111 00 0011111112
Q ss_pred CChhHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHh
Q 044312 514 GGKDEIITVAKLAKRCLNLNGKKRPTMREVASELAG 549 (608)
Q Consensus 514 ~~~~~~~~l~~Li~~cl~~dp~~RPs~~evl~~L~~ 549 (608)
.+...+..+.+++.+||+.+|++||++++|.+.|+.
T Consensus 224 ~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 259 (260)
T cd05069 224 CPQGCPESLHELMKLCWKKDPDERPTFEYIQSFLED 259 (260)
T ss_pred CCcccCHHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence 233456789999999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-34 Score=288.76 Aligned_cols=226 Identities=25% Similarity=0.419 Sum_probs=179.2
Q ss_pred eEEEEEeec-ChhhHHHHHHHHHHHhhcCCCCccceecccccCccceEEEeecCCCccchhccccCCCCCCCHHHHHHHH
Q 044312 302 QAVKKSKVI-DESKVEEFINEVVILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEIRLRIA 380 (608)
Q Consensus 302 ~avk~~~~~-~~~~~~~~~~Ei~il~~l~H~niv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~ 380 (608)
+|+|..+.. .......|.+|+.++++++||||+++++++......++||||+++++|.+++..... .+++..++.++
T Consensus 22 ~a~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~--~~~~~~~~~~~ 99 (250)
T cd05085 22 VAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGGDFLSFLRKKKD--ELKTKQLVKFA 99 (250)
T ss_pred EEEEecCCcCCHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEECCCCCcHHHHHHhcCC--CCCHHHHHHHH
Confidence 466665533 233345799999999999999999999999999999999999999999998875432 48999999999
Q ss_pred HHHHHHHHHHhhcCCCCeeccCCCCCcEEEcCCCcEEEeeccCccccccCCcceeeeeeccCCCCChhhhccCCCCCccc
Q 044312 381 IEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHGTFGYLDPEYFRSSQFTDKSD 460 (608)
Q Consensus 381 ~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGls~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksD 460 (608)
.|++.||.|||+.+ ++||||||+||++++++.+||+|||++...............++..|+|||++....++.++|
T Consensus 100 ~~i~~~l~~lH~~~---~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~D 176 (250)
T cd05085 100 LDAAAGMAYLESKN---CIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYSSSGLKQIPIKWTAPEALNYGRYSSESD 176 (250)
T ss_pred HHHHHHHHHHHhCC---eeecccChheEEEcCCCeEEECCCccceeccccccccCCCCCCcccccCHHHhccCCCCchhH
Confidence 99999999999999 999999999999999999999999998754332221122233466799999999999999999
Q ss_pred hHhHHHHHHHHHh-CCCCCCccchhhcccHHHHHHHHhhhhhhHHHhhhhhhccCChhHHHHHHHHHHHHhccCCCCCCC
Q 044312 461 VYSFGVVLTELLT-GEKPIRFTILEEDKSLAAYFLCAMKEERLFEILDARVMKQGGKDEIITVAKLAKRCLNLNGKKRPT 539 (608)
Q Consensus 461 V~S~Gvvl~ellt-g~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPs 539 (608)
|||||++++|+++ |..||....... .... +........+...+..+.+++.+||+.+|++||+
T Consensus 177 i~slG~ll~~~~~~g~~p~~~~~~~~-------~~~~---------~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~ 240 (250)
T cd05085 177 VWSYGILLWETFSLGVCPYPGMTNQQ-------AREQ---------VEKGYRMSCPQKCPDDVYKVMQRCWDYKPENRPK 240 (250)
T ss_pred HHHHHHHHHHHhcCCCCCCCCCCHHH-------HHHH---------HHcCCCCCCCCCCCHHHHHHHHHHcccCcccCCC
Confidence 9999999999998 899986332111 0001 1111112223345678999999999999999999
Q ss_pred HHHHHHHHH
Q 044312 540 MREVASELA 548 (608)
Q Consensus 540 ~~evl~~L~ 548 (608)
+.|++++|.
T Consensus 241 ~~~l~~~l~ 249 (250)
T cd05085 241 FSELQKELA 249 (250)
T ss_pred HHHHHHHhc
Confidence 999998874
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-34 Score=289.97 Aligned_cols=235 Identities=27% Similarity=0.486 Sum_probs=185.4
Q ss_pred CccccceeccCce-------------EEEEEeecChhhHHHHHHHHHHHhhcCCCCccceecccc-cCccceEEEeecCC
Q 044312 290 NFDLNRILGQGGQ-------------AVKKSKVIDESKVEEFINEVVILSQINHRNVVKLLGCCL-ETEVPLLVYEFIPN 355 (608)
Q Consensus 290 ~f~~~~~lG~G~~-------------avk~~~~~~~~~~~~~~~Ei~il~~l~H~niv~l~~~~~-~~~~~~lV~E~~~~ 355 (608)
+|.+.+.||+|++ ++|..+ .....+.|.+|+.++++++|+|++++++++. +....++||||+++
T Consensus 7 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~k~~~--~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e~~~~ 84 (256)
T cd05082 7 ELKLLQTIGKGEFGDVMLGDYRGNKVAVKCIK--NDATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAK 84 (256)
T ss_pred hCeeeeeecccCCCeEEEEEEcCCcEEEEEeC--CCchHHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCceEEEEECCCC
Confidence 5777888888874 444443 2334568999999999999999999999764 45678999999999
Q ss_pred CccchhccccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEEcCCCcEEEeeccCccccccCCccee
Q 044312 356 GTLFQYIHDQNEDFPITWEIRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMT 435 (608)
Q Consensus 356 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGls~~~~~~~~~~~ 435 (608)
++|.+++..... ..+++..++.++.|++.||+|||+.+ ++||||||+|||+++++.+||+|||+++......
T Consensus 85 ~~L~~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~---- 156 (256)
T cd05082 85 GSLVDYLRSRGR-SVLGGDCLLKFSLDVCEAMEYLEANN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ---- 156 (256)
T ss_pred CcHHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHhCC---EeccccchheEEEcCCCcEEecCCccceeccccC----
Confidence 999999876433 24899999999999999999999999 9999999999999999999999999987643222
Q ss_pred eeeeccCCCCChhhhccCCCCCccchHhHHHHHHHHHh-CCCCCCccchhhcccHHHHHHHHhhhhhhHHHhhhhhhccC
Q 044312 436 TQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLTELLT-GEKPIRFTILEEDKSLAAYFLCAMKEERLFEILDARVMKQG 514 (608)
Q Consensus 436 ~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~ellt-g~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~ 514 (608)
....++..|+|||++....++.++||||||++++||++ |+.||...... ... ..+........
T Consensus 157 ~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~~~~------~~~----------~~~~~~~~~~~ 220 (256)
T cd05082 157 DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLK------DVV----------PRVEKGYKMDA 220 (256)
T ss_pred CCCccceeecCHHHHccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCCHH------HHH----------HHHhcCCCCCC
Confidence 22234568999999999899999999999999999998 89988632211 111 11111111122
Q ss_pred ChhHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhh
Q 044312 515 GKDEIITVAKLAKRCLNLNGKKRPTMREVASELAGI 550 (608)
Q Consensus 515 ~~~~~~~l~~Li~~cl~~dp~~RPs~~evl~~L~~i 550 (608)
+...+..+.+++.+||+.+|++|||+.++++.|+.+
T Consensus 221 ~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~~ 256 (256)
T cd05082 221 PDGCPPVVYDVMKQCWHLDAATRPSFLQLREQLEHI 256 (256)
T ss_pred CCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHhcC
Confidence 334567899999999999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-35 Score=307.35 Aligned_cols=239 Identities=23% Similarity=0.319 Sum_probs=188.8
Q ss_pred cCccccceeccCce---------------EEEEEeec---ChhhHHHHHHHHHHHhhcCCCCccceecccccCccceEEE
Q 044312 289 DNFDLNRILGQGGQ---------------AVKKSKVI---DESKVEEFINEVVILSQINHRNVVKLLGCCLETEVPLLVY 350 (608)
Q Consensus 289 ~~f~~~~~lG~G~~---------------avk~~~~~---~~~~~~~~~~Ei~il~~l~H~niv~l~~~~~~~~~~~lV~ 350 (608)
++|.+.+.||+|++ |+|..+.. .....+.+.+|+.+++.++|+||+++++++.+.+..+|||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (330)
T cd05601 1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYLVM 80 (330)
T ss_pred CCceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCCeEEEEE
Confidence 36888899999974 56665532 2234567889999999999999999999999999999999
Q ss_pred eecCCCccchhccccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEEcCCCcEEEeeccCccccccC
Q 044312 351 EFIPNGTLFQYIHDQNEDFPITWEIRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVD 430 (608)
Q Consensus 351 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGls~~~~~~ 430 (608)
||+++|+|.+++..... .+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++.....
T Consensus 81 e~~~~~~L~~~l~~~~~--~l~~~~~~~~~~qi~~aL~~lH~~~---i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~ 155 (330)
T cd05601 81 EYQPGGDLLSLLNRYED--QFDEDMAQFYLAELVLAIHSVHQMG---YVHRDIKPENVLIDRTGHIKLADFGSAARLTAN 155 (330)
T ss_pred CCCCCCCHHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCC---eEcccCchHheEECCCCCEEeccCCCCeECCCC
Confidence 99999999999976533 5899999999999999999999999 999999999999999999999999999876544
Q ss_pred CcceeeeeeccCCCCChhhhc------cCCCCCccchHhHHHHHHHHHhCCCCCCccchhhcccHHHHHHHHhhhhhhHH
Q 044312 431 QTHMTTQVHGTFGYLDPEYFR------SSQFTDKSDVYSFGVVLTELLTGEKPIRFTILEEDKSLAAYFLCAMKEERLFE 504 (608)
Q Consensus 431 ~~~~~~~~~gt~~y~aPE~~~------~~~~t~ksDV~S~Gvvl~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~ 504 (608)
.........||+.|+|||++. ...++.++||||||++++||++|+.||...... ..+...+.....
T Consensus 156 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~------~~~~~i~~~~~~-- 227 (330)
T cd05601 156 KMVNSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSA------KTYNNIMNFQRF-- 227 (330)
T ss_pred CceeeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCHH------HHHHHHHcCCCc--
Confidence 433334456899999999987 456789999999999999999999999633211 111111111000
Q ss_pred HhhhhhhccCChhHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 044312 505 ILDARVMKQGGKDEIITVAKLAKRCLNLNGKKRPTMREVASE 546 (608)
Q Consensus 505 ~~d~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~evl~~ 546 (608)
.........+..+.+|+.+||+ +|++||++.+++++
T Consensus 228 -----~~~~~~~~~~~~~~~li~~ll~-~p~~R~t~~~l~~h 263 (330)
T cd05601 228 -----LKFPEDPKVSSDFLDLIQSLLC-GQKERLGYEGLCCH 263 (330)
T ss_pred -----cCCCCCCCCCHHHHHHHHHHcc-ChhhCCCHHHHhCC
Confidence 0011112346678999999998 99999999999864
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-34 Score=303.09 Aligned_cols=248 Identities=25% Similarity=0.440 Sum_probs=192.9
Q ss_pred hcCccccceeccCce----------------------EEEEEee-cChhhHHHHHHHHHHHhhc-CCCCccceecccccC
Q 044312 288 TDNFDLNRILGQGGQ----------------------AVKKSKV-IDESKVEEFINEVVILSQI-NHRNVVKLLGCCLET 343 (608)
Q Consensus 288 t~~f~~~~~lG~G~~----------------------avk~~~~-~~~~~~~~~~~Ei~il~~l-~H~niv~l~~~~~~~ 343 (608)
..+|.+.+.||+|+| |+|..+. ......+++.+|+.+++++ +||||+++++++.+.
T Consensus 11 ~~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~ 90 (334)
T cd05100 11 RTRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD 90 (334)
T ss_pred HhHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccccCHHHHHHHHHHHHHHHhhcCCCCeeeeeEEEccC
Confidence 346788899999975 2333221 1233467899999999999 899999999999999
Q ss_pred ccceEEEeecCCCccchhccccC-------------CCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEE
Q 044312 344 EVPLLVYEFIPNGTLFQYIHDQN-------------EDFPITWEIRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILL 410 (608)
Q Consensus 344 ~~~~lV~E~~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl 410 (608)
...+++|||+++|+|.+++.... ....+++..++.++.|++.||+|||+++ ++||||||+|||+
T Consensus 91 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~g---ivH~dlkp~Nill 167 (334)
T cd05100 91 GPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQK---CIHRDLAARNVLV 167 (334)
T ss_pred CceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCC---eeccccccceEEE
Confidence 99999999999999999987532 1224889999999999999999999999 9999999999999
Q ss_pred cCCCcEEEeeccCccccccCCcc-eeeeeeccCCCCChhhhccCCCCCccchHhHHHHHHHHHh-CCCCCCccchhhccc
Q 044312 411 DDKYRAKVSDFGASRSMAVDQTH-MTTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLTELLT-GEKPIRFTILEEDKS 488 (608)
Q Consensus 411 ~~~~~~kl~DFGls~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~ellt-g~~p~~~~~~~~~~~ 488 (608)
++++.+||+|||+++........ ......++..|+|||++....++.++||||||++++||++ |..||.....++
T Consensus 168 ~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~--- 244 (334)
T cd05100 168 TEDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEE--- 244 (334)
T ss_pred cCCCcEEECCcccceecccccccccccCCCcCceEcCHHHhccCCcCchhhhHHHHHHHHHHHhcCCCCCCCCCHHH---
Confidence 99999999999999865432211 1122334567999999999999999999999999999998 888875322111
Q ss_pred HHHHHHHHhhhhhhHHHhhhhhhccCChhHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhhHHhc
Q 044312 489 LAAYFLCAMKEERLFEILDARVMKQGGKDEIITVAKLAKRCLNLNGKKRPTMREVASELAGIKAWN 554 (608)
Q Consensus 489 l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~evl~~L~~i~~~~ 554 (608)
.+ ..+........+...+.++.+|+.+||+.+|++||++.|+++.|+.+....
T Consensus 245 ---~~----------~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~ell~~l~~~~~~~ 297 (334)
T cd05100 245 ---LF----------KLLKEGHRMDKPANCTHELYMIMRECWHAVPSQRPTFKQLVEDLDRVLTVT 297 (334)
T ss_pred ---HH----------HHHHcCCCCCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHhhhc
Confidence 11 111111112223345668999999999999999999999999998887543
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-34 Score=298.83 Aligned_cols=250 Identities=23% Similarity=0.334 Sum_probs=183.7
Q ss_pred hcCccccceeccCce---------------EEEEEeecCh-hhHHHHHHHHHHHhhcCCCCccceecccccCccceEEEe
Q 044312 288 TDNFDLNRILGQGGQ---------------AVKKSKVIDE-SKVEEFINEVVILSQINHRNVVKLLGCCLETEVPLLVYE 351 (608)
Q Consensus 288 t~~f~~~~~lG~G~~---------------avk~~~~~~~-~~~~~~~~Ei~il~~l~H~niv~l~~~~~~~~~~~lV~E 351 (608)
.++|++.+.||+|++ |||..+.... .....+.+|+.+++.++||||+++++++.+....++|||
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 83 (303)
T cd07869 4 ADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDIIHTKETLTLVFE 83 (303)
T ss_pred cccceEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccccccchhHHHHHHHHhhCCCCCcCeEEEEEecCCeEEEEEE
Confidence 467899999999974 6666654322 234567899999999999999999999999999999999
Q ss_pred ecCCCccchhccccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEEcCCCcEEEeeccCccccccCC
Q 044312 352 FIPNGTLFQYIHDQNEDFPITWEIRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQ 431 (608)
Q Consensus 352 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGls~~~~~~~ 431 (608)
|++ ++|.+++..... .+++..+..++.||+.||+|||+.+ |+||||||+|||+++++.+||+|||+++......
T Consensus 84 ~~~-~~l~~~~~~~~~--~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~ 157 (303)
T cd07869 84 YVH-TDLCQYMDKHPG--GLHPENVKLFLFQLLRGLSYIHQRY---ILHRDLKPQNLLISDTGELKLADFGLARAKSVPS 157 (303)
T ss_pred CCC-cCHHHHHHhCCC--CCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEECCCCcceeccCCC
Confidence 995 688887765432 4889999999999999999999999 9999999999999999999999999987543222
Q ss_pred cceeeeeeccCCCCChhhhcc-CCCCCccchHhHHHHHHHHHhCCCCCCccchhhcccHHHHHHHHhhh---hhhHHH--
Q 044312 432 THMTTQVHGTFGYLDPEYFRS-SQFTDKSDVYSFGVVLTELLTGEKPIRFTILEEDKSLAAYFLCAMKE---ERLFEI-- 505 (608)
Q Consensus 432 ~~~~~~~~gt~~y~aPE~~~~-~~~t~ksDV~S~Gvvl~elltg~~p~~~~~~~~~~~l~~~~~~~~~~---~~~~~~-- 505 (608)
.......+++.|+|||++.+ ..++.++|||||||+++||++|+.||....... ..+...+ ..... ......
T Consensus 158 -~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~-~~~~~~~-~~~~~~~~~~~~~~~~ 234 (303)
T cd07869 158 -HTYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQ-DQLERIF-LVLGTPNEDTWPGVHS 234 (303)
T ss_pred -ccCCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCccHH-HHHHHHH-HHhCCCChhhccchhh
Confidence 12233467899999999865 458899999999999999999999997432110 1111110 00000 000000
Q ss_pred ---hhh-hhhccC---------ChhHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 044312 506 ---LDA-RVMKQG---------GKDEIITVAKLAKRCLNLNGKKRPTMREVASE 546 (608)
Q Consensus 506 ---~d~-~~~~~~---------~~~~~~~l~~Li~~cl~~dp~~RPs~~evl~~ 546 (608)
..+ ...... ....+..+.+|+.+||+.||++|||++|++++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l~h 288 (303)
T cd07869 235 LPHFKPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALSH 288 (303)
T ss_pred ccccccccccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHHhcC
Confidence 000 000000 00123568899999999999999999999863
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-35 Score=293.10 Aligned_cols=234 Identities=24% Similarity=0.426 Sum_probs=194.3
Q ss_pred hcCccccceeccCce---------------EEEE---EeecChhhHHHHHHHHHHHhhcCCCCccceecccccCccceEE
Q 044312 288 TDNFDLNRILGQGGQ---------------AVKK---SKVIDESKVEEFINEVVILSQINHRNVVKLLGCCLETEVPLLV 349 (608)
Q Consensus 288 t~~f~~~~~lG~G~~---------------avk~---~~~~~~~~~~~~~~Ei~il~~l~H~niv~l~~~~~~~~~~~lV 349 (608)
..+|++.+.||+|.+ |||. .++.++.+.-.+.+||+||+.|+||||++++.+|...+.+.||
T Consensus 52 kHRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFENkdKIviv 131 (668)
T KOG0611|consen 52 KHRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENKDKIVIV 131 (668)
T ss_pred hhHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCCceEEEE
Confidence 346777888888864 5543 3456777788899999999999999999999999999999999
Q ss_pred EeecCCCccchhccccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEEcCCCcEEEeeccCcccccc
Q 044312 350 YEFIPNGTLFQYIHDQNEDFPITWEIRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAV 429 (608)
Q Consensus 350 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGls~~~~~ 429 (608)
|||..+|.|++++...+ .|++.....|+.||..|+.|+|.+. ++|||||.+|||||+|+++||+||||+-++..
T Consensus 132 MEYaS~GeLYDYiSer~---~LsErEaRhfFRQIvSAVhYCHknr---VvHRDLKLENILLD~N~NiKIADFGLSNly~~ 205 (668)
T KOG0611|consen 132 MEYASGGELYDYISERG---SLSEREARHFFRQIVSAVHYCHKNR---VVHRDLKLENILLDQNNNIKIADFGLSNLYAD 205 (668)
T ss_pred EEecCCccHHHHHHHhc---cccHHHHHHHHHHHHHHHHHHhhcc---ceecccchhheeecCCCCeeeeccchhhhhcc
Confidence 99999999999998765 4999999999999999999999999 99999999999999999999999999987754
Q ss_pred CCcceeeeeeccCCCCChhhhccCCC-CCccchHhHHHHHHHHHhCCCCCCccchhhcccHHHHHHHHhhhhhhHHHhhh
Q 044312 430 DQTHMTTQVHGTFGYLDPEYFRSSQF-TDKSDVYSFGVVLTELLTGEKPIRFTILEEDKSLAAYFLCAMKEERLFEILDA 508 (608)
Q Consensus 430 ~~~~~~~~~~gt~~y~aPE~~~~~~~-t~ksDV~S~Gvvl~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 508 (608)
+ ...+...|.+-|.+||++.+..| .+.+|-|||||+||.|+.|..||+..... . + +.+|-..
T Consensus 206 ~--kfLqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~Dhk---~----l--------vrQIs~G 268 (668)
T KOG0611|consen 206 K--KFLQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGRDHK---R----L--------VRQISRG 268 (668)
T ss_pred c--cHHHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCchHH---H----H--------HHHhhcc
Confidence 3 33466789999999999999988 47899999999999999999999732211 1 1 1122222
Q ss_pred hhhccCChhHHHHHHHHHHHHhccCCCCCCCHHHHHHHH
Q 044312 509 RVMKQGGKDEIITVAKLAKRCLNLNGKKRPTMREVASEL 547 (608)
Q Consensus 509 ~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~evl~~L 547 (608)
.++. .+.+....-||++||..+|++|-|+.+|+.+-
T Consensus 269 aYrE---P~~PSdA~gLIRwmLmVNP~RRATieDiAsHW 304 (668)
T KOG0611|consen 269 AYRE---PETPSDASGLIRWMLMVNPERRATIEDIASHW 304 (668)
T ss_pred cccC---CCCCchHHHHHHHHHhcCcccchhHHHHhhhh
Confidence 1211 12344677899999999999999999999865
|
|
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-34 Score=288.60 Aligned_cols=226 Identities=28% Similarity=0.446 Sum_probs=178.4
Q ss_pred eEEEEEeecCh-hhHHHHHHHHHHHhhcCCCCccceecccccCccceEEEeecCCCccchhccccCCCCCCCHHHHHHHH
Q 044312 302 QAVKKSKVIDE-SKVEEFINEVVILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEIRLRIA 380 (608)
Q Consensus 302 ~avk~~~~~~~-~~~~~~~~Ei~il~~l~H~niv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~ 380 (608)
+|+|....... ...+++.+|+.++++++|+||+++++++. .+..++||||+++++|.+++.... .+++..++.++
T Consensus 26 ~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~v~e~~~~~~L~~~l~~~~---~~~~~~~~~~~ 101 (257)
T cd05060 26 VAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLIGVCK-GEPLMLVMELAPLGPLLKYLKKRR---EIPVSDLKELA 101 (257)
T ss_pred EEEEecccccchHHHHHHHHHHHHHHhcCCCCeeeEEEEEc-CCceEEEEEeCCCCcHHHHHHhCC---CCCHHHHHHHH
Confidence 35555543222 34567999999999999999999999875 456799999999999999997654 48999999999
Q ss_pred HHHHHHHHHHhhcCCCCeeccCCCCCcEEEcCCCcEEEeeccCccccccCCccee--eeeeccCCCCChhhhccCCCCCc
Q 044312 381 IEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMT--TQVHGTFGYLDPEYFRSSQFTDK 458 (608)
Q Consensus 381 ~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGls~~~~~~~~~~~--~~~~gt~~y~aPE~~~~~~~t~k 458 (608)
.|++.||+|||+.+ ++|+||||+|||++.++.+||+|||+++.......... ....++..|+|||.+....++.+
T Consensus 102 ~qi~~~l~~lh~~~---i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~ 178 (257)
T cd05060 102 HQVAMGMAYLESKH---FVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRATTAGRWPLKWYAPECINYGKFSSK 178 (257)
T ss_pred HHHHHHHHHHhhcC---eeccCcccceEEEcCCCcEEeccccccceeecCCcccccccCccccccccCHHHhcCCCCCcc
Confidence 99999999999998 99999999999999999999999999987654332211 11223567999999999999999
Q ss_pred cchHhHHHHHHHHHh-CCCCCCccchhhcccHHHHHHHHhhhhhhHHHhhhhhhccCChhHHHHHHHHHHHHhccCCCCC
Q 044312 459 SDVYSFGVVLTELLT-GEKPIRFTILEEDKSLAAYFLCAMKEERLFEILDARVMKQGGKDEIITVAKLAKRCLNLNGKKR 537 (608)
Q Consensus 459 sDV~S~Gvvl~ellt-g~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~Li~~cl~~dp~~R 537 (608)
+||||||++++|+++ |..||...... ... ..+........+...+..+.+++.+||..+|++|
T Consensus 179 ~Di~slG~~l~~~~~~g~~p~~~~~~~---~~~-------------~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~R 242 (257)
T cd05060 179 SDVWSYGVTLWEAFSYGAKPYGEMKGA---EVI-------------AMLESGERLPRPEECPQEIYSIMLSCWKYRPEDR 242 (257)
T ss_pred chHHHHHHHHHHHHcCCCCCcccCCHH---HHH-------------HHHHcCCcCCCCCCCCHHHHHHHHHHhcCChhhC
Confidence 999999999999998 99998632211 111 1111111112333455689999999999999999
Q ss_pred CCHHHHHHHHHhh
Q 044312 538 PTMREVASELAGI 550 (608)
Q Consensus 538 Ps~~evl~~L~~i 550 (608)
|++.+|++.|+.+
T Consensus 243 p~~~~l~~~l~~~ 255 (257)
T cd05060 243 PTFSELESTFRRD 255 (257)
T ss_pred cCHHHHHHHHHhc
Confidence 9999999999875
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-34 Score=295.49 Aligned_cols=255 Identities=27% Similarity=0.420 Sum_probs=187.2
Q ss_pred CccccceeccCce-------------------EEEEEeec-ChhhHHHHHHHHHHHhhcCCCCccceecccccC--ccce
Q 044312 290 NFDLNRILGQGGQ-------------------AVKKSKVI-DESKVEEFINEVVILSQINHRNVVKLLGCCLET--EVPL 347 (608)
Q Consensus 290 ~f~~~~~lG~G~~-------------------avk~~~~~-~~~~~~~~~~Ei~il~~l~H~niv~l~~~~~~~--~~~~ 347 (608)
.|.+.+.||+|++ |+|..+.. .....+.+.+|+.++++++||||+++.+++.+. ...+
T Consensus 5 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 84 (284)
T cd05079 5 FLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGIK 84 (284)
T ss_pred hhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccccHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCCceE
Confidence 3566777777764 44544432 234456899999999999999999999998765 5678
Q ss_pred EEEeecCCCccchhccccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEEcCCCcEEEeeccCcccc
Q 044312 348 LVYEFIPNGTLFQYIHDQNEDFPITWEIRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSM 427 (608)
Q Consensus 348 lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGls~~~ 427 (608)
+||||+++++|.+++..... .+++..++.++.|++.||+|||+.+ ++||||||+|||++.++.+||+|||+++..
T Consensus 85 lv~e~~~g~~L~~~l~~~~~--~~~~~~~~~i~~~i~~aL~~lH~~g---i~H~dlkp~Nil~~~~~~~~l~dfg~~~~~ 159 (284)
T cd05079 85 LIMEFLPSGSLKEYLPRNKN--KINLKQQLKYAVQICKGMDYLGSRQ---YVHRDLAARNVLVESEHQVKIGDFGLTKAI 159 (284)
T ss_pred EEEEccCCCCHHHHHHhccC--CCCHHHHHHHHHHHHHHHHHHHHCC---eeecccchheEEEcCCCCEEECCCcccccc
Confidence 99999999999999865432 4899999999999999999999999 999999999999999999999999999876
Q ss_pred ccCCcc--eeeeeeccCCCCChhhhccCCCCCccchHhHHHHHHHHHhCCCCCCccchhhcccHHHHHHHHhhhhhhHHH
Q 044312 428 AVDQTH--MTTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLTELLTGEKPIRFTILEEDKSLAAYFLCAMKEERLFEI 505 (608)
Q Consensus 428 ~~~~~~--~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 505 (608)
...... ......++..|+|||++.+..++.++||||||++++||+|++.|.............. .............
T Consensus 160 ~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ellt~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~ 238 (284)
T cd05079 160 ETDKEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSESSPMTLFLKMIGP-THGQMTVTRLVRV 238 (284)
T ss_pred ccCccceeecCCCCCCccccCHHHhccCCCCccccchhhhhhhhhhhcCCCCCccccchhhhhccc-ccccccHHHHHHH
Confidence 533221 1123446778999999998899999999999999999999877643211000000000 0000000001111
Q ss_pred hhhhhhccCChhHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhh
Q 044312 506 LDARVMKQGGKDEIITVAKLAKRCLNLNGKKRPTMREVASELAGI 550 (608)
Q Consensus 506 ~d~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~evl~~L~~i 550 (608)
+........+...+..+.+|+.+||+.+|++||++.++++.|+.+
T Consensus 239 ~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~~~ 283 (284)
T cd05079 239 LEEGKRLPRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEGFEAI 283 (284)
T ss_pred HHcCccCCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHHhh
Confidence 111111222334567899999999999999999999999998765
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-34 Score=290.00 Aligned_cols=236 Identities=25% Similarity=0.392 Sum_probs=188.1
Q ss_pred CccccceeccCce---------------EEEEEee-cChhhHHHHHHHHHHHhhcCCCCccceecccccCccceEEEeec
Q 044312 290 NFDLNRILGQGGQ---------------AVKKSKV-IDESKVEEFINEVVILSQINHRNVVKLLGCCLETEVPLLVYEFI 353 (608)
Q Consensus 290 ~f~~~~~lG~G~~---------------avk~~~~-~~~~~~~~~~~Ei~il~~l~H~niv~l~~~~~~~~~~~lV~E~~ 353 (608)
+|++.++||+|++ ++|..+. ......+.+.+|+.+++.++|+||+++++.+.+....++||||+
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (255)
T cd08219 1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIVMEYC 80 (255)
T ss_pred CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcchHHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEeeC
Confidence 3667788888863 6666543 23445678899999999999999999999999999999999999
Q ss_pred CCCccchhccccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEEcCCCcEEEeeccCccccccCCcc
Q 044312 354 PNGTLFQYIHDQNEDFPITWEIRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTH 433 (608)
Q Consensus 354 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGls~~~~~~~~~ 433 (608)
++++|.+++..... ..+++..++.++.|++.||.|||+.+ ++|+||||+|||+++++.++|+|||+++.......
T Consensus 81 ~~~~l~~~~~~~~~-~~~~~~~~~~~~~~i~~al~~lH~~~---i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~- 155 (255)
T cd08219 81 DGGDLMQKIKLQRG-KLFPEDTILQWFVQMCLGVQHIHEKR---VLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGA- 155 (255)
T ss_pred CCCcHHHHHHhccC-CCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCcceEEECCCCcEEEcccCcceeeccccc-
Confidence 99999998865432 25889999999999999999999999 99999999999999999999999999976643221
Q ss_pred eeeeeeccCCCCChhhhccCCCCCccchHhHHHHHHHHHhCCCCCCccchhhcccHHHHHHHHhhhhhhHHHhhhhhhcc
Q 044312 434 MTTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLTELLTGEKPIRFTILEEDKSLAAYFLCAMKEERLFEILDARVMKQ 513 (608)
Q Consensus 434 ~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~ 513 (608)
......+++.|+|||++.+..++.++||||||+++++|++|+.||...... .... ...... ...
T Consensus 156 ~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~------~~~~-~~~~~~---------~~~ 219 (255)
T cd08219 156 YACTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQANSWK------NLIL-KVCQGS---------YKP 219 (255)
T ss_pred ccccccCCccccCHHHHccCCcCchhhhhhhchhheehhhccCCCCCCCHH------HHHH-HHhcCC---------CCC
Confidence 223456889999999999999999999999999999999999998632211 1110 111111 111
Q ss_pred CChhHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 044312 514 GGKDEIITVAKLAKRCLNLNGKKRPTMREVASE 546 (608)
Q Consensus 514 ~~~~~~~~l~~Li~~cl~~dp~~RPs~~evl~~ 546 (608)
.+...+..+.+|+.+||+.||++||++.|++.+
T Consensus 220 ~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~ 252 (255)
T cd08219 220 LPSHYSYELRSLIKQMFKRNPRSRPSATTILSR 252 (255)
T ss_pred CCcccCHHHHHHHHHHHhCCcccCCCHHHHhhc
Confidence 223345678999999999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-34 Score=295.44 Aligned_cols=234 Identities=26% Similarity=0.434 Sum_probs=178.3
Q ss_pred EEEEEeec-ChhhHHHHHHHHHHHhhcCCCCccceecccccCccceEEEeecCCCccchhccccCC--------CCCCCH
Q 044312 303 AVKKSKVI-DESKVEEFINEVVILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGTLFQYIHDQNE--------DFPITW 373 (608)
Q Consensus 303 avk~~~~~-~~~~~~~~~~Ei~il~~l~H~niv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~--------~~~l~~ 373 (608)
|+|..... .....+.+.+|++++++++||||+++++++......++||||+++++|.+++..... ...+++
T Consensus 50 a~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~ 129 (296)
T cd05051 50 AVKVLRPDASDNAREDFLKEVKILSRLSDPNIARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSF 129 (296)
T ss_pred EEEEecCccCHHHHHHHHHHHHHHHhcCCCCEeEEEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCH
Confidence 44444332 234567899999999999999999999999999999999999999999999876431 125899
Q ss_pred HHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEEcCCCcEEEeeccCccccccCCc-ceeeeeeccCCCCChhhhcc
Q 044312 374 EIRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQT-HMTTQVHGTFGYLDPEYFRS 452 (608)
Q Consensus 374 ~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGls~~~~~~~~-~~~~~~~gt~~y~aPE~~~~ 452 (608)
..++.++.|++.||+|||+.+ ++||||||+|||++.++.+||+|||+++....... .......++..|+|||++..
T Consensus 130 ~~~~~~~~~i~~al~~LH~~~---i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~ 206 (296)
T cd05051 130 STLLYMATQIASGMRYLESLN---FVHRDLATRNCLVGKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLL 206 (296)
T ss_pred HHHHHHHHHHHHHHHHHHHcC---ccccccchhceeecCCCceEEccccceeecccCcceeecCcCCCCceecCHHHhhc
Confidence 999999999999999999998 99999999999999999999999999976543221 12223446778999999998
Q ss_pred CCCCCccchHhHHHHHHHHHh--CCCCCCccchhhcccHHHHHHHHhhhhhhHHHhhhhhhccCChhHHHHHHHHHHHHh
Q 044312 453 SQFTDKSDVYSFGVVLTELLT--GEKPIRFTILEEDKSLAAYFLCAMKEERLFEILDARVMKQGGKDEIITVAKLAKRCL 530 (608)
Q Consensus 453 ~~~t~ksDV~S~Gvvl~ellt--g~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~Li~~cl 530 (608)
..++.++||||||++++||++ +..||....... ............ ........+...+.++.+|+.+||
T Consensus 207 ~~~~~~~Dv~slG~~l~el~~~~~~~p~~~~~~~~---~~~~~~~~~~~~------~~~~~~~~~~~~~~~l~~li~~cl 277 (296)
T cd05051 207 GKFTTKSDVWAFGVTLWEILTLCREQPYEHLTDQQ---VIENAGHFFRDD------GRQIYLPRPPNCPKDIYELMLECW 277 (296)
T ss_pred CCCCccchhhhhHHHHHHHHhcCCCCCCCCcChHH---HHHHHHhccccc------cccccCCCccCCCHHHHHHHHHHh
Confidence 899999999999999999998 666765321111 001010000000 011111122344568999999999
Q ss_pred ccCCCCCCCHHHHHHHHH
Q 044312 531 NLNGKKRPTMREVASELA 548 (608)
Q Consensus 531 ~~dp~~RPs~~evl~~L~ 548 (608)
+.||++|||+.||++.|+
T Consensus 278 ~~~p~~Rpt~~el~~~L~ 295 (296)
T cd05051 278 RRDEEDRPTFREIHLFLQ 295 (296)
T ss_pred ccChhcCCCHHHHHHHhc
Confidence 999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-35 Score=309.95 Aligned_cols=239 Identities=25% Similarity=0.369 Sum_probs=186.4
Q ss_pred HHhcCccccceeccCce---------------EEEEEee---cChhhHHHHHHHHHHHhhcCCCCccceecccccCccce
Q 044312 286 KATDNFDLNRILGQGGQ---------------AVKKSKV---IDESKVEEFINEVVILSQINHRNVVKLLGCCLETEVPL 347 (608)
Q Consensus 286 ~~t~~f~~~~~lG~G~~---------------avk~~~~---~~~~~~~~~~~Ei~il~~l~H~niv~l~~~~~~~~~~~ 347 (608)
...++|++.+.||+|+| |+|.... ......+.+.+|+.+++.++||||+++++++.+....+
T Consensus 40 ~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~~ 119 (370)
T cd05621 40 MKAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDKYLY 119 (370)
T ss_pred CCHHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEE
Confidence 34567999999999985 4555432 22234456889999999999999999999999999999
Q ss_pred EEEeecCCCccchhccccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEEcCCCcEEEeeccCcccc
Q 044312 348 LVYEFIPNGTLFQYIHDQNEDFPITWEIRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSM 427 (608)
Q Consensus 348 lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGls~~~ 427 (608)
+||||+++|+|.+++... .+++..+..++.||+.||+|||+.+ |+||||||+|||+++++.+||+|||+++..
T Consensus 120 lv~Ey~~gg~L~~~l~~~----~~~~~~~~~~~~qil~aL~~LH~~~---IvHrDLKp~NILl~~~~~~kL~DFG~a~~~ 192 (370)
T cd05621 120 MVMEYMPGGDLVNLMSNY----DVPEKWAKFYTAEVVLALDAIHSMG---LIHRDVKPDNMLLDKHGHLKLADFGTCMKM 192 (370)
T ss_pred EEEcCCCCCcHHHHHHhc----CCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHEEECCCCCEEEEecccceec
Confidence 999999999999998643 3788999999999999999999999 999999999999999999999999999876
Q ss_pred ccCCcceeeeeeccCCCCChhhhccC----CCCCccchHhHHHHHHHHHhCCCCCCccchhhcccHHHHHHHHhhhhhhH
Q 044312 428 AVDQTHMTTQVHGTFGYLDPEYFRSS----QFTDKSDVYSFGVVLTELLTGEKPIRFTILEEDKSLAAYFLCAMKEERLF 503 (608)
Q Consensus 428 ~~~~~~~~~~~~gt~~y~aPE~~~~~----~~t~ksDV~S~Gvvl~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~ 503 (608)
............||+.|+|||++... .++.++||||||++++||++|+.||..... ...+ .
T Consensus 193 ~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~------~~~~---------~ 257 (370)
T cd05621 193 DETGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSL------VGTY---------S 257 (370)
T ss_pred ccCCceecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCH------HHHH---------H
Confidence 43332223455699999999998754 378999999999999999999999963321 1111 1
Q ss_pred HHhhhh--hhccCChhHHHHHHHHHHHHhccCCCC--CCCHHHHHHH
Q 044312 504 EILDAR--VMKQGGKDEIITVAKLAKRCLNLNGKK--RPTMREVASE 546 (608)
Q Consensus 504 ~~~d~~--~~~~~~~~~~~~l~~Li~~cl~~dp~~--RPs~~evl~~ 546 (608)
.+++.. .........+..+.+++.+||..++.+ ||++.|++++
T Consensus 258 ~i~~~~~~~~~p~~~~~s~~~~~li~~~L~~~~~r~~R~~~~e~l~h 304 (370)
T cd05621 258 KIMDHKNSLNFPEDVEISKHAKNLICAFLTDREVRLGRNGVEEIKQH 304 (370)
T ss_pred HHHhCCcccCCCCcccCCHHHHHHHHHHccCchhccCCCCHHHHhcC
Confidence 122111 111112234667889999999855543 8899999876
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-34 Score=294.23 Aligned_cols=243 Identities=26% Similarity=0.450 Sum_probs=186.5
Q ss_pred hcCccccceeccCce--------------------EEEEEeec-ChhhHHHHHHHHHHHhhcCCCCccceecccccCccc
Q 044312 288 TDNFDLNRILGQGGQ--------------------AVKKSKVI-DESKVEEFINEVVILSQINHRNVVKLLGCCLETEVP 346 (608)
Q Consensus 288 t~~f~~~~~lG~G~~--------------------avk~~~~~-~~~~~~~~~~Ei~il~~l~H~niv~l~~~~~~~~~~ 346 (608)
.++|++.+.||+|++ |+|..... ......+|.+|+.++++++||||+++++++.+....
T Consensus 4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~~~~ 83 (288)
T cd05050 4 RNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVKLLGVCAVGKPM 83 (288)
T ss_pred hHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCcCHHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCcc
Confidence 356777788888764 34443322 223356799999999999999999999999999999
Q ss_pred eEEEeecCCCccchhccccC-------------------CCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCc
Q 044312 347 LLVYEFIPNGTLFQYIHDQN-------------------EDFPITWEIRLRIAIEVSGALSYLHSAASIPIYHRDIKSTN 407 (608)
Q Consensus 347 ~lV~E~~~~gsL~~~l~~~~-------------------~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~N 407 (608)
++||||+++++|.+++.... ....+++..++.++.|++.||+|||+.+ ++||||||+|
T Consensus 84 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~~---i~H~dl~p~n 160 (288)
T cd05050 84 CLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSERK---FVHRDLATRN 160 (288)
T ss_pred EEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCC---eecccccHhh
Confidence 99999999999999987421 1124788999999999999999999998 9999999999
Q ss_pred EEEcCCCcEEEeeccCccccccCCcc-eeeeeeccCCCCChhhhccCCCCCccchHhHHHHHHHHHh-CCCCCCccchhh
Q 044312 408 ILLDDKYRAKVSDFGASRSMAVDQTH-MTTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLTELLT-GEKPIRFTILEE 485 (608)
Q Consensus 408 ILl~~~~~~kl~DFGls~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~ellt-g~~p~~~~~~~~ 485 (608)
||+++++.+||+|||+++........ .......+..|+|||.+.+..++.++||||||++++||++ |..||......+
T Consensus 161 il~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~~~~p~~~~~~~~ 240 (288)
T cd05050 161 CLVGENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYGMAHEE 240 (288)
T ss_pred eEecCCCceEECccccceecccCccccccCCCccChhhcCHHHHhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCHHH
Confidence 99999999999999998765432211 1122234567999999998999999999999999999998 878875322111
Q ss_pred cccHHHHHHHHhhhhhhHHHhhhhhhccCChhHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHh
Q 044312 486 DKSLAAYFLCAMKEERLFEILDARVMKQGGKDEIITVAKLAKRCLNLNGKKRPTMREVASELAG 549 (608)
Q Consensus 486 ~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~evl~~L~~ 549 (608)
......... . ...+...+.++.+|+.+||+.+|++|||+.|+++.|++
T Consensus 241 -------~~~~~~~~~--------~-~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~el~~~l~~ 288 (288)
T cd05050 241 -------VIYYVRDGN--------V-LSCPDNCPLELYNLMRLCWSKLPSDRPSFASINRILQR 288 (288)
T ss_pred -------HHHHHhcCC--------C-CCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHhhC
Confidence 111111111 1 11223456789999999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-34 Score=307.20 Aligned_cols=247 Identities=23% Similarity=0.288 Sum_probs=184.4
Q ss_pred CccccceeccCce---------------EEEEEeec--ChhhHHHHHHHHHHHhhcCCCCccceecccccCc-----cce
Q 044312 290 NFDLNRILGQGGQ---------------AVKKSKVI--DESKVEEFINEVVILSQINHRNVVKLLGCCLETE-----VPL 347 (608)
Q Consensus 290 ~f~~~~~lG~G~~---------------avk~~~~~--~~~~~~~~~~Ei~il~~l~H~niv~l~~~~~~~~-----~~~ 347 (608)
+|++.++||+|++ |||+.... +....+.+.+|+.+++.++|+||+++++++...+ ..+
T Consensus 1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 80 (372)
T cd07853 1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIY 80 (372)
T ss_pred CCcccceeeeCCCEEEEEEEECCCCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceEE
Confidence 3677888998874 56655432 2334567899999999999999999999998766 789
Q ss_pred EEEeecCCCccchhccccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEEcCCCcEEEeeccCcccc
Q 044312 348 LVYEFIPNGTLFQYIHDQNEDFPITWEIRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSM 427 (608)
Q Consensus 348 lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGls~~~ 427 (608)
+||||+. ++|.+.+.... .+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++..
T Consensus 81 lv~e~~~-~~l~~~~~~~~---~l~~~~~~~~~~qi~~aL~~LH~~~---ivH~dlkp~Nili~~~~~~kL~Dfg~a~~~ 153 (372)
T cd07853 81 VVTELMQ-SDLHKIIVSPQ---PLSSDHVKVFLYQILRGLKYLHSAG---ILHRDIKPGNLLVNSNCVLKICDFGLARVE 153 (372)
T ss_pred EEeeccc-cCHHHHHhcCC---CCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChHHEEECCCCCEEeccccceeec
Confidence 9999996 57877775432 5899999999999999999999999 999999999999999999999999999865
Q ss_pred ccCCcceeeeeeccCCCCChhhhccC-CCCCccchHhHHHHHHHHHhCCCCCCccchhhcccHHHHHHHHhhhhh-----
Q 044312 428 AVDQTHMTTQVHGTFGYLDPEYFRSS-QFTDKSDVYSFGVVLTELLTGEKPIRFTILEEDKSLAAYFLCAMKEER----- 501 (608)
Q Consensus 428 ~~~~~~~~~~~~gt~~y~aPE~~~~~-~~t~ksDV~S~Gvvl~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~----- 501 (608)
............+++.|+|||++.+. .++.++|||||||+++||++|+.||......... ...........
T Consensus 154 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~---~~i~~~~g~~~~~~~~ 230 (372)
T cd07853 154 EPDESKHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQL---DLITDLLGTPSLEAMR 230 (372)
T ss_pred ccCccccCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHHHH---HHHHHHcCCCCHHHHH
Confidence 44333333444678999999998774 5799999999999999999999999743322111 11111000000
Q ss_pred -----hHHHhhhhh--------hccCChhHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 044312 502 -----LFEILDARV--------MKQGGKDEIITVAKLAKRCLNLNGKKRPTMREVASE 546 (608)
Q Consensus 502 -----~~~~~d~~~--------~~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~evl~~ 546 (608)
....+.... ........+.++.+|+.+||+.||++|||+.|++++
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~h 288 (372)
T cd07853 231 SACEGARAHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALAH 288 (372)
T ss_pred HhhHHHHHHHHhCCCCCCchHHhcccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhcC
Confidence 000000000 001112335678999999999999999999999875
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-35 Score=308.44 Aligned_cols=238 Identities=25% Similarity=0.368 Sum_probs=186.2
Q ss_pred cCccccceeccCce---------------EEEEEeec---ChhhHHHHHHHHHHHhhcCCCCccceecccccCccceEEE
Q 044312 289 DNFDLNRILGQGGQ---------------AVKKSKVI---DESKVEEFINEVVILSQINHRNVVKLLGCCLETEVPLLVY 350 (608)
Q Consensus 289 ~~f~~~~~lG~G~~---------------avk~~~~~---~~~~~~~~~~Ei~il~~l~H~niv~l~~~~~~~~~~~lV~ 350 (608)
++|++.+.||+|++ |||..+.. .......+.+|+.+|+.++||||+++++++.+.+..+|||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~ 80 (364)
T cd05599 1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDENYLYLIM 80 (364)
T ss_pred CCceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCeEEEEE
Confidence 36888999999974 66666532 2344567889999999999999999999999999999999
Q ss_pred eecCCCccchhccccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEEcCCCcEEEeeccCccccccC
Q 044312 351 EFIPNGTLFQYIHDQNEDFPITWEIRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVD 430 (608)
Q Consensus 351 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGls~~~~~~ 430 (608)
||+++|+|.+++.... .+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++.+...
T Consensus 81 E~~~~g~L~~~l~~~~---~l~~~~~~~~~~qi~~aL~~lH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~ 154 (364)
T cd05599 81 EYLPGGDMMTLLMKKD---TFTEEETRFYIAETILAIDSIHKLG---YIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKS 154 (364)
T ss_pred CCCCCcHHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeEECCCCCEEEeecccceecccc
Confidence 9999999999987643 4899999999999999999999999 999999999999999999999999998754321
Q ss_pred Ccc-------------------------------------eeeeeeccCCCCChhhhccCCCCCccchHhHHHHHHHHHh
Q 044312 431 QTH-------------------------------------MTTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLTELLT 473 (608)
Q Consensus 431 ~~~-------------------------------------~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~ellt 473 (608)
... ......||+.|+|||++....++.++|||||||+++||++
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~ 234 (364)
T cd05599 155 HRTEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEMLV 234 (364)
T ss_pred ccccccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCCCeeeeecchhHHHHhhc
Confidence 100 0112358999999999999999999999999999999999
Q ss_pred CCCCCCccchhhcccHHHHHHHHhhhhhhHHHhhhhhhccCChhHHHHHHHHHHHHhccCCCCCCC---HHHHHHH
Q 044312 474 GEKPIRFTILEEDKSLAAYFLCAMKEERLFEILDARVMKQGGKDEIITVAKLAKRCLNLNGKKRPT---MREVASE 546 (608)
Q Consensus 474 g~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPs---~~evl~~ 546 (608)
|..||......+ ......... ...........+..+.+|+.+|+. +|.+|++ +.|++++
T Consensus 235 G~~Pf~~~~~~~------~~~~i~~~~-------~~~~~~~~~~~s~~~~~li~~ll~-~p~~R~~~~~~~~ll~h 296 (364)
T cd05599 235 GYPPFCSDNPQE------TYRKIINWK-------ETLQFPDEVPLSPEAKDLIKRLCC-EAERRLGNNGVNEIKSH 296 (364)
T ss_pred CCCCCCCCCHHH------HHHHHHcCC-------CccCCCCCCCCCHHHHHHHHHHcc-CHhhcCCCCCHHHHhcC
Confidence 999996332211 111010000 001111112345678899999996 9999998 8888764
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-35 Score=278.41 Aligned_cols=236 Identities=28% Similarity=0.403 Sum_probs=189.9
Q ss_pred hcCccccceeccCce---------------EEEEEee--cChhhHHHHHHHHHHHhhcCCCCccceecccccCccceEEE
Q 044312 288 TDNFDLNRILGQGGQ---------------AVKKSKV--IDESKVEEFINEVVILSQINHRNVVKLLGCCLETEVPLLVY 350 (608)
Q Consensus 288 t~~f~~~~~lG~G~~---------------avk~~~~--~~~~~~~~~~~Ei~il~~l~H~niv~l~~~~~~~~~~~lV~ 350 (608)
++.|++.+.||+|.| |+|.+.. ......+++.+|++|-+.|+|||||+|.....+....|||+
T Consensus 10 ~d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~~~ylvF 89 (355)
T KOG0033|consen 10 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVF 89 (355)
T ss_pred chhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhhhcccceeEEEE
Confidence 456777888999975 4444322 23346788999999999999999999999999999999999
Q ss_pred eecCCCccchhccccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEEcC---CCcEEEeeccCcccc
Q 044312 351 EFIPNGTLFQYIHDQNEDFPITWEIRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDD---KYRAKVSDFGASRSM 427 (608)
Q Consensus 351 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~---~~~~kl~DFGls~~~ 427 (608)
|+|.|++|..-|... ..+++...-..+.||++||.|.|.++ |+|||+||.|+||-. ..-+||+|||++..+
T Consensus 90 e~m~G~dl~~eIV~R---~~ySEa~aSH~~rQiLeal~yCH~n~---IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~l 163 (355)
T KOG0033|consen 90 DLVTGGELFEDIVAR---EFYSEADASHCIQQILEALAYCHSNG---IVHRDLKPENLLLASKAKGAAVKLADFGLAIEV 163 (355)
T ss_pred ecccchHHHHHHHHH---HHHHHHHHHHHHHHHHHHHHHHHhcC---ceeccCChhheeeeeccCCCceeecccceEEEe
Confidence 999999998766543 35788899999999999999999999 999999999999953 346999999999887
Q ss_pred ccCCcceeeeeeccCCCCChhhhccCCCCCccchHhHHHHHHHHHhCCCCCCccchhhcccHHHHHHHHhhhhhhHH-Hh
Q 044312 428 AVDQTHMTTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLTELLTGEKPIRFTILEEDKSLAAYFLCAMKEERLFE-IL 506 (608)
Q Consensus 428 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~-~~ 506 (608)
. ....--...|||+|||||++....|+..+|||+.||||+-|+.|.+||.... . .++.+ |.
T Consensus 164 ~--~g~~~~G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL~G~~PF~~~~------~----------~rlye~I~ 225 (355)
T KOG0033|consen 164 N--DGEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDED------Q----------HRLYEQIK 225 (355)
T ss_pred C--CccccccccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHHhCCCCCCCcc------H----------HHHHHHHh
Confidence 7 3334456789999999999999999999999999999999999999997311 1 11111 11
Q ss_pred hhhh--hccCChhHHHHHHHHHHHHhccCCCCCCCHHHHHHHH
Q 044312 507 DARV--MKQGGKDEIITVAKLAKRCLNLNGKKRPTMREVASEL 547 (608)
Q Consensus 507 d~~~--~~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~evl~~L 547 (608)
...+ .........++..+|+++||..||.+|.|+.|.+++-
T Consensus 226 ~g~yd~~~~~w~~is~~Ak~LvrrML~~dP~kRIta~EAL~Hp 268 (355)
T KOG0033|consen 226 AGAYDYPSPEWDTVTPEAKSLIRRMLTVNPKKRITADEALKHP 268 (355)
T ss_pred ccccCCCCcccCcCCHHHHHHHHHHhccChhhhccHHHHhCCc
Confidence 1111 1112234567889999999999999999999988753
|
|
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-34 Score=293.68 Aligned_cols=234 Identities=25% Similarity=0.410 Sum_probs=176.9
Q ss_pred EEEEEeec-ChhhHHHHHHHHHHHhhcCCCCccceecccccCccceEEEeecCCCccchhccccCC--------CCCCCH
Q 044312 303 AVKKSKVI-DESKVEEFINEVVILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGTLFQYIHDQNE--------DFPITW 373 (608)
Q Consensus 303 avk~~~~~-~~~~~~~~~~Ei~il~~l~H~niv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~--------~~~l~~ 373 (608)
|+|..+.. .....++|.+|+.+++.++|+||+++++++...+..++||||+++++|.+++..... ...+++
T Consensus 50 a~K~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~ 129 (296)
T cd05095 50 AVKMLREDANKNARNDFLKEIKIMSRLKDPNIIRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISY 129 (296)
T ss_pred EEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCH
Confidence 34444332 233457899999999999999999999999999999999999999999999876321 124778
Q ss_pred HHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEEcCCCcEEEeeccCccccccCCcce-eeeeeccCCCCChhhhcc
Q 044312 374 EIRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHM-TTQVHGTFGYLDPEYFRS 452 (608)
Q Consensus 374 ~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGls~~~~~~~~~~-~~~~~gt~~y~aPE~~~~ 452 (608)
.+++.++.|++.||+|||+.+ ++|+||||+|||+++++.+||+|||+++.+....... .....++..|++||....
T Consensus 130 ~~~~~~~~~i~~al~~lH~~~---i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~ 206 (296)
T cd05095 130 STLIFMATQIASGMKYLSSLN---FVHRDLATRNCLVGKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILL 206 (296)
T ss_pred HHHHHHHHHHHHHHHHHHHCC---eecccCChheEEEcCCCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhc
Confidence 899999999999999999999 9999999999999999999999999998654332211 122234678999999988
Q ss_pred CCCCCccchHhHHHHHHHHHh--CCCCCCccchhhcccHHHHHHHHhhhhhhHHHhhhhhhccCChhHHHHHHHHHHHHh
Q 044312 453 SQFTDKSDVYSFGVVLTELLT--GEKPIRFTILEEDKSLAAYFLCAMKEERLFEILDARVMKQGGKDEIITVAKLAKRCL 530 (608)
Q Consensus 453 ~~~t~ksDV~S~Gvvl~ellt--g~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~Li~~cl 530 (608)
..++.++||||||+++|||++ |..||......+. ........... ........+..++..+.+|+.+||
T Consensus 207 ~~~~~~~DiwSlG~~l~el~~~~~~~p~~~~~~~~~---~~~~~~~~~~~------~~~~~~~~~~~~~~~~~~li~~cl 277 (296)
T cd05095 207 GKFTTASDVWAFGVTLWEILTLCKEQPYSQLSDEQV---IENTGEFFRDQ------GRQVYLPKPALCPDSLYKLMLSCW 277 (296)
T ss_pred CCccchhhhhHHHHHHHHHHHhCCCCCccccChHHH---HHHHHHHHhhc------cccccCCCCCCCCHHHHHHHHHHc
Confidence 899999999999999999998 6677753221110 00000000000 000111122345578999999999
Q ss_pred ccCCCCCCCHHHHHHHHH
Q 044312 531 NLNGKKRPTMREVASELA 548 (608)
Q Consensus 531 ~~dp~~RPs~~evl~~L~ 548 (608)
+.||++||++.||.+.|+
T Consensus 278 ~~~p~~Rp~~~~i~~~l~ 295 (296)
T cd05095 278 RRNAKERPSFQEIHATLL 295 (296)
T ss_pred CCCcccCCCHHHHHHHHh
Confidence 999999999999999885
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-34 Score=288.72 Aligned_cols=229 Identities=29% Similarity=0.442 Sum_probs=176.2
Q ss_pred eEEEEEee-cChhhHHHHHHHHHHHhhcCCCCccceecccc-cCccceEEEeecCCCccchhccccCCCCCCCHHHHHHH
Q 044312 302 QAVKKSKV-IDESKVEEFINEVVILSQINHRNVVKLLGCCL-ETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEIRLRI 379 (608)
Q Consensus 302 ~avk~~~~-~~~~~~~~~~~Ei~il~~l~H~niv~l~~~~~-~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i 379 (608)
+|+|+... .+....+.+.+|+.+++.++||||+++++++. .....++||||+++++|.+++..... .+++..++.+
T Consensus 26 ~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~--~~~~~~~~~~ 103 (262)
T cd05058 26 CAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPYMKHGDLRNFIRSETH--NPTVKDLIGF 103 (262)
T ss_pred EEEEecCccCCHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEecCCCCCHHHHHHhcCC--CCCHHHHHHH
Confidence 46666543 23445678999999999999999999999775 45568899999999999999976433 3678888999
Q ss_pred HHHHHHHHHHHhhcCCCCeeccCCCCCcEEEcCCCcEEEeeccCccccccCCcc---eeeeeeccCCCCChhhhccCCCC
Q 044312 380 AIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTH---MTTQVHGTFGYLDPEYFRSSQFT 456 (608)
Q Consensus 380 ~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGls~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~t 456 (608)
+.|++.||+|||+.+ ++||||||+|||+++++.+||+|||+++........ ......++..|+|||++....++
T Consensus 104 ~~~i~~~l~~lH~~~---i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~ 180 (262)
T cd05058 104 GLQVAKGMEYLASKK---FVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVHNHTGAKLPVKWMALESLQTQKFT 180 (262)
T ss_pred HHHHHHHHHHHHhCC---ccccccCcceEEEcCCCcEEECCccccccccCCcceeecccccCcCCccccChhHhccCccc
Confidence 999999999999998 999999999999999999999999999765432111 11233457789999999989999
Q ss_pred CccchHhHHHHHHHHHhC-CCCCCccchhhcccHHHHHHHHhhhhhhHHHhhhhhhccCChhHHHHHHHHHHHHhccCCC
Q 044312 457 DKSDVYSFGVVLTELLTG-EKPIRFTILEEDKSLAAYFLCAMKEERLFEILDARVMKQGGKDEIITVAKLAKRCLNLNGK 535 (608)
Q Consensus 457 ~ksDV~S~Gvvl~elltg-~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~Li~~cl~~dp~ 535 (608)
.++||||||++++||++| .+||...... .+... +.. ......+...+..+.+++.+||+.+|+
T Consensus 181 ~~~Di~slG~~l~el~~~~~~~~~~~~~~---~~~~~------------~~~-~~~~~~~~~~~~~~~~li~~cl~~~p~ 244 (262)
T cd05058 181 TKSDVWSFGVLLWELMTRGAPPYPDVDSF---DITVY------------LLQ-GRRLLQPEYCPDPLYEVMLSCWHPKPE 244 (262)
T ss_pred hHHHHHHHHHHHHHHHcCCCCCCCCCCHH---HHHHH------------Hhc-CCCCCCCCcCCHHHHHHHHHHcCCChh
Confidence 999999999999999995 5555422111 01100 000 001111223456799999999999999
Q ss_pred CCCCHHHHHHHHHhhH
Q 044312 536 KRPTMREVASELAGIK 551 (608)
Q Consensus 536 ~RPs~~evl~~L~~i~ 551 (608)
+||++.||++.|+.+.
T Consensus 245 ~Rp~~~~il~~l~~~~ 260 (262)
T cd05058 245 MRPTFSELVSRIEQIF 260 (262)
T ss_pred hCCCHHHHHHHHHHHh
Confidence 9999999999998765
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-34 Score=294.63 Aligned_cols=238 Identities=25% Similarity=0.314 Sum_probs=186.1
Q ss_pred CccccceeccCce---------------EEEEEeec---ChhhHHHHHHHHHHHhhcCCCCccceecccccCccceEEEe
Q 044312 290 NFDLNRILGQGGQ---------------AVKKSKVI---DESKVEEFINEVVILSQINHRNVVKLLGCCLETEVPLLVYE 351 (608)
Q Consensus 290 ~f~~~~~lG~G~~---------------avk~~~~~---~~~~~~~~~~Ei~il~~l~H~niv~l~~~~~~~~~~~lV~E 351 (608)
+|++.++||+|++ |+|++... .......+.+|+.++++++||||+++++.+.+.+..++|||
T Consensus 1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (285)
T cd05605 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCeEEEEEe
Confidence 3677788888874 66665432 12233567889999999999999999999999999999999
Q ss_pred ecCCCccchhccccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEEcCCCcEEEeeccCccccccCC
Q 044312 352 FIPNGTLFQYIHDQNEDFPITWEIRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQ 431 (608)
Q Consensus 352 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGls~~~~~~~ 431 (608)
|+++|+|.+++..... ..+++..+..++.|++.||.|||+.+ ++||||||+|||+++++.++|+|||+++......
T Consensus 81 ~~~~~~L~~~~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~ 156 (285)
T cd05605 81 LMNGGDLKFHIYNMGN-PGFDEERAVFYAAEITCGLEDLHRER---IVYRDLKPENILLDDYGHIRISDLGLAVEIPEGE 156 (285)
T ss_pred ccCCCcHHHHHHhcCc-CCCCHHHHHHHHHHHHHHHHHHHHCC---cEecCCCHHHEEECCCCCEEEeeCCCceecCCCC
Confidence 9999999988865432 25899999999999999999999999 9999999999999999999999999998754322
Q ss_pred cceeeeeeccCCCCChhhhccCCCCCccchHhHHHHHHHHHhCCCCCCccchhhcccHHHHHHHHhhhhhhHHHhhhhhh
Q 044312 432 THMTTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLTELLTGEKPIRFTILEEDKSLAAYFLCAMKEERLFEILDARVM 511 (608)
Q Consensus 432 ~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~ 511 (608)
. .....|++.|+|||++.+..++.++||||||++++||++|+.||........ ... +...+.. ..
T Consensus 157 ~--~~~~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g~~pf~~~~~~~~---~~~---------~~~~~~~-~~ 221 (285)
T cd05605 157 T--IRGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKVK---REE---------VERRVKE-DQ 221 (285)
T ss_pred c--cccccCCCCccCcHHhcCCCCCccccchhHHHHHHHHHHCCCCCCCCchhhH---HHH---------HHHHhhh-cc
Confidence 2 2234689999999999989999999999999999999999999974322110 000 0111110 11
Q ss_pred ccCChhHHHHHHHHHHHHhccCCCCCC-----CHHHHHHH
Q 044312 512 KQGGKDEIITVAKLAKRCLNLNGKKRP-----TMREVASE 546 (608)
Q Consensus 512 ~~~~~~~~~~l~~Li~~cl~~dp~~RP-----s~~evl~~ 546 (608)
...+...+..+.+|+.+||+.||++|| ++.+++++
T Consensus 222 ~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~ 261 (285)
T cd05605 222 EEYSEKFSEAARSICRQLLTKDPGFRLGCRGEGAEEVKAH 261 (285)
T ss_pred cccCcccCHHHHHHHHHHccCCHHHhcCCCCCCHHHHhcC
Confidence 122334567899999999999999999 77787654
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-34 Score=301.00 Aligned_cols=228 Identities=25% Similarity=0.385 Sum_probs=177.4
Q ss_pred eEEEEEee---cChhhHHHHHHHHHHHhhc-CCCCccceecccccCccceEEEeecCCCccchhccccCCCCCCCHHHHH
Q 044312 302 QAVKKSKV---IDESKVEEFINEVVILSQI-NHRNVVKLLGCCLETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEIRL 377 (608)
Q Consensus 302 ~avk~~~~---~~~~~~~~~~~Ei~il~~l-~H~niv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~ 377 (608)
+|+|.++. .+....+.+.+|..+++++ +||||+++++++.+....+|||||+++|+|.+++.... .+++..+.
T Consensus 23 ~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~~g~L~~~~~~~~---~l~~~~~~ 99 (329)
T cd05588 23 YAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVSGGDLMFHMQRQR---KLPEEHAR 99 (329)
T ss_pred EEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCCCCCCHHHHHHHcC---CCCHHHHH
Confidence 46776653 2234456788999999998 79999999999999999999999999999998886543 58999999
Q ss_pred HHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEEcCCCcEEEeeccCccccccCCcceeeeeeccCCCCChhhhccCCCCC
Q 044312 378 RIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHGTFGYLDPEYFRSSQFTD 457 (608)
Q Consensus 378 ~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGls~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ 457 (608)
.++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++...... .......||+.|+|||++.+..++.
T Consensus 100 ~~~~qi~~~l~~lH~~~---ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~ 175 (329)
T cd05588 100 FYSAEISLALNFLHERG---IIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPG-DTTSTFCGTPNYIAPEILRGEDYGF 175 (329)
T ss_pred HHHHHHHHHHHHHHHCC---eEecCCCHHHeEECCCCCEEECcCccccccccCC-CccccccCCccccCHHHHcCCCCCC
Confidence 99999999999999999 9999999999999999999999999987532211 2233456899999999999999999
Q ss_pred ccchHhHHHHHHHHHhCCCCCCccchhh--cccHHHHHHHHhhhhhhHHHhhhhhhccCChhHHHHHHHHHHHHhccCCC
Q 044312 458 KSDVYSFGVVLTELLTGEKPIRFTILEE--DKSLAAYFLCAMKEERLFEILDARVMKQGGKDEIITVAKLAKRCLNLNGK 535 (608)
Q Consensus 458 ksDV~S~Gvvl~elltg~~p~~~~~~~~--~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~Li~~cl~~dp~ 535 (608)
++||||||+++|||++|+.||....... ......+....+. ... ...+...+.++.+|+.+||+.||.
T Consensus 176 ~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~--------~~~--~~~p~~~~~~~~~li~~~L~~dP~ 245 (329)
T cd05588 176 SVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVIL--------EKQ--IRIPRSLSVKASSVLKGFLNKDPK 245 (329)
T ss_pred ccceechHHHHHHHHHCCCCcccccccccccccchHHHHHHHH--------cCC--CCCCCCCCHHHHHHHHHHhccCHH
Confidence 9999999999999999999996432211 1111111111111 111 112334556789999999999999
Q ss_pred CCCC------HHHHHHH
Q 044312 536 KRPT------MREVASE 546 (608)
Q Consensus 536 ~RPs------~~evl~~ 546 (608)
+||+ +.+++++
T Consensus 246 ~R~~~~~~~~~~~i~~h 262 (329)
T cd05588 246 ERLGCHPQTGFRDIKSH 262 (329)
T ss_pred HcCCCCCCCCHHHHhcC
Confidence 9998 5666643
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-34 Score=306.08 Aligned_cols=239 Identities=24% Similarity=0.348 Sum_probs=182.2
Q ss_pred cCccccceeccCce---------------EEEEEeec---ChhhHHHHHHHHHHHhhcCCCCccceecccccCccceEEE
Q 044312 289 DNFDLNRILGQGGQ---------------AVKKSKVI---DESKVEEFINEVVILSQINHRNVVKLLGCCLETEVPLLVY 350 (608)
Q Consensus 289 ~~f~~~~~lG~G~~---------------avk~~~~~---~~~~~~~~~~Ei~il~~l~H~niv~l~~~~~~~~~~~lV~ 350 (608)
++|++.+.||+|++ |+|.++.. .......+.+|+.++.+++|+||+++++.+.+....+|||
T Consensus 1 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~~~lv~ 80 (363)
T cd05628 1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLIM 80 (363)
T ss_pred CCceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCCeEEEEE
Confidence 36888999999974 66665432 2334567889999999999999999999999999999999
Q ss_pred eecCCCccchhccccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEEcCCCcEEEeeccCccccccC
Q 044312 351 EFIPNGTLFQYIHDQNEDFPITWEIRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVD 430 (608)
Q Consensus 351 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGls~~~~~~ 430 (608)
||+++|+|.+++.... .+++..+..++.|++.||+|||+++ |+||||||+|||++.++.+||+|||+++.+...
T Consensus 81 E~~~gg~L~~~l~~~~---~l~~~~~~~~~~qi~~aL~~lH~~g---ivHrDlKp~NILi~~~~~vkL~DFGla~~~~~~ 154 (363)
T cd05628 81 EFLPGGDMMTLLMKKD---TLTEEETQFYIAETVLAIDSIHQLG---FIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKA 154 (363)
T ss_pred cCCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCC---eEecCCCHHHeEECCCCCEEEeeccCccccccc
Confidence 9999999999997643 5899999999999999999999999 999999999999999999999999998754321
Q ss_pred Cc----------------------------------ceeeeeeccCCCCChhhhccCCCCCccchHhHHHHHHHHHhCCC
Q 044312 431 QT----------------------------------HMTTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLTELLTGEK 476 (608)
Q Consensus 431 ~~----------------------------------~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~elltg~~ 476 (608)
.. .......||+.|+|||++.+..++.++|||||||+++||++|+.
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~ 234 (363)
T cd05628 155 HRTEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYP 234 (363)
T ss_pred ccccccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCCCchhhhhhHHHHHHHHhCCC
Confidence 10 00123469999999999999999999999999999999999999
Q ss_pred CCCccchhhcccHHHHHHHHhhhhhhHHHhhhhhhccCChhHHHHHHHHHHHHhc--cCCCCCCCHHHHHHH
Q 044312 477 PIRFTILEEDKSLAAYFLCAMKEERLFEILDARVMKQGGKDEIITVAKLAKRCLN--LNGKKRPTMREVASE 546 (608)
Q Consensus 477 p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~Li~~cl~--~dp~~RPs~~evl~~ 546 (608)
||......+ .+....... ..+........+.++.+++.+++. .++..||++.||+++
T Consensus 235 Pf~~~~~~~------~~~~i~~~~-------~~~~~p~~~~~s~~~~~li~~l~~~~~~r~~r~~~~ei~~h 293 (363)
T cd05628 235 PFCSETPQE------TYKKVMNWK-------ETLIFPPEVPISEKAKDLILRFCCEWEHRIGAPGVEEIKTN 293 (363)
T ss_pred CCCCCCHHH------HHHHHHcCc-------CcccCCCcCCCCHHHHHHHHHHcCChhhcCCCCCHHHHhCC
Confidence 996332111 111111000 000011111234567888888664 233356899999875
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-34 Score=288.09 Aligned_cols=236 Identities=28% Similarity=0.470 Sum_probs=185.1
Q ss_pred CccccceeccCce--------------EEEEEeecChhhHHHHHHHHHHHhhcCCCCccceecccccCccceEEEeecCC
Q 044312 290 NFDLNRILGQGGQ--------------AVKKSKVIDESKVEEFINEVVILSQINHRNVVKLLGCCLETEVPLLVYEFIPN 355 (608)
Q Consensus 290 ~f~~~~~lG~G~~--------------avk~~~~~~~~~~~~~~~Ei~il~~l~H~niv~l~~~~~~~~~~~lV~E~~~~ 355 (608)
.|++.+.||+|++ |+|..+. .....++|.+|++++++++|||++++++++......++||||+++
T Consensus 5 ~~~~~~~ig~g~~g~v~~~~~~~~~~~~~k~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~ 83 (256)
T cd05112 5 ELTLVQEIGSGQFGLVWLGYWLEKRKVAIKTIRE-GAMSEEDFIEEAQVMMKLSHPKLVQLYGVCTERSPICLVFEFMEH 83 (256)
T ss_pred HeEEEeeecCcccceEEEEEEeCCCeEEEEECCC-CCCCHHHHHHHHHHHHhCCCCCeeeEEEEEccCCceEEEEEcCCC
Confidence 4667778888764 4444432 222346799999999999999999999999999999999999999
Q ss_pred CccchhccccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEEcCCCcEEEeeccCccccccCCccee
Q 044312 356 GTLFQYIHDQNEDFPITWEIRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMT 435 (608)
Q Consensus 356 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGls~~~~~~~~~~~ 435 (608)
++|.+++..... .+++..+..++.+++.||+|||+.+ ++|+||||+||+++.++.+||+|||+++..........
T Consensus 84 ~~L~~~~~~~~~--~~~~~~~~~~~~~l~~~l~~lH~~~---i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~~~ 158 (256)
T cd05112 84 GCLSDYLRAQRG--KFSQETLLGMCLDVCEGMAYLESSN---VIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQYTSS 158 (256)
T ss_pred CcHHHHHHhCcc--CCCHHHHHHHHHHHHHHHHHHHHCC---ccccccccceEEEcCCCeEEECCCcceeecccCccccc
Confidence 999999876433 4889999999999999999999999 99999999999999999999999999876543322212
Q ss_pred eeeeccCCCCChhhhccCCCCCccchHhHHHHHHHHHh-CCCCCCccchhhcccHHHHHHHHhhhhhhHHHhhhhhhccC
Q 044312 436 TQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLTELLT-GEKPIRFTILEEDKSLAAYFLCAMKEERLFEILDARVMKQG 514 (608)
Q Consensus 436 ~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~ellt-g~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~ 514 (608)
....++..|+|||++.+..++.++||||||++++||++ |..||....... ....+.. ......
T Consensus 159 ~~~~~~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~-------~~~~~~~---------~~~~~~ 222 (256)
T cd05112 159 TGTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRSNSE-------VVETINA---------GFRLYK 222 (256)
T ss_pred CCCccchhhcCHhHhccCCcChHHHHHHHHHHHHHHHcCCCCCCCcCCHHH-------HHHHHhC---------CCCCCC
Confidence 22334678999999998999999999999999999998 899986322111 1111111 011111
Q ss_pred ChhHHHHHHHHHHHHhccCCCCCCCHHHHHHHH
Q 044312 515 GKDEIITVAKLAKRCLNLNGKKRPTMREVASEL 547 (608)
Q Consensus 515 ~~~~~~~l~~Li~~cl~~dp~~RPs~~evl~~L 547 (608)
+...+..+.+|+.+||+.+|++||++.|++++|
T Consensus 223 ~~~~~~~~~~l~~~~l~~~p~~Rp~~~~~l~~l 255 (256)
T cd05112 223 PRLASQSVYELMQHCWKERPEDRPSFSLLLHQL 255 (256)
T ss_pred CCCCCHHHHHHHHHHcccChhhCCCHHHHHHhh
Confidence 223456899999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-34 Score=286.95 Aligned_cols=237 Identities=29% Similarity=0.419 Sum_probs=190.1
Q ss_pred CccccceeccCce---------------EEEEEeec--ChhhHHHHHHHHHHHhhcCCCCccceecccccCccceEEEee
Q 044312 290 NFDLNRILGQGGQ---------------AVKKSKVI--DESKVEEFINEVVILSQINHRNVVKLLGCCLETEVPLLVYEF 352 (608)
Q Consensus 290 ~f~~~~~lG~G~~---------------avk~~~~~--~~~~~~~~~~Ei~il~~l~H~niv~l~~~~~~~~~~~lV~E~ 352 (608)
+|+..+.||.|++ ++|+.... +.....++.+|++++++++|+||+++++++.+....+++|||
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~~~e~ 80 (256)
T cd08221 1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEMEY 80 (256)
T ss_pred CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEEecCCeEEEEEEe
Confidence 4677888888864 55655432 345567899999999999999999999999999999999999
Q ss_pred cCCCccchhccccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEEcCCCcEEEeeccCccccccCCc
Q 044312 353 IPNGTLFQYIHDQNEDFPITWEIRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQT 432 (608)
Q Consensus 353 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGls~~~~~~~~ 432 (608)
+++++|.+++..... ..+++..+..++.|++.||.|||+.+ ++|+||+|+||++++++.+||+|||++........
T Consensus 81 ~~~~~L~~~~~~~~~-~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~~~~ 156 (256)
T cd08221 81 ANGGTLYDKIVRQKG-QLFEEEMVLWYLFQIVSAVSYIHKAG---ILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYS 156 (256)
T ss_pred cCCCcHHHHHHhccc-cCCCHHHHHHHHHHHHHHHHHHHhCC---ccccCCChHhEEEeCCCCEEECcCcceEEcccccc
Confidence 999999999976532 25899999999999999999999998 99999999999999999999999999987644332
Q ss_pred ceeeeeeccCCCCChhhhccCCCCCccchHhHHHHHHHHHhCCCCCCccchhhcccHHHHHHHHhhhhhhHHHhhhhhhc
Q 044312 433 HMTTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLTELLTGEKPIRFTILEEDKSLAAYFLCAMKEERLFEILDARVMK 512 (608)
Q Consensus 433 ~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~ 512 (608)
......+++.|+|||++.+..++.++||||||++++||++|..||...... .... .+..... .
T Consensus 157 -~~~~~~~~~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~------~~~~---------~~~~~~~-~ 219 (256)
T cd08221 157 -MAETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATNPL------NLVV---------KIVQGNY-T 219 (256)
T ss_pred -cccccCCCccccCHhhcCCCCCCCcchhHHHHHHHHHHHHCCCCCCCCCHH------HHHH---------HHHcCCC-C
Confidence 223456889999999999888999999999999999999999998632211 1111 1111111 1
Q ss_pred cCChhHHHHHHHHHHHHhccCCCCCCCHHHHHHHH
Q 044312 513 QGGKDEIITVAKLAKRCLNLNGKKRPTMREVASEL 547 (608)
Q Consensus 513 ~~~~~~~~~l~~Li~~cl~~dp~~RPs~~evl~~L 547 (608)
......+.++.+++.+||+.+|++||+++|+++++
T Consensus 220 ~~~~~~~~~~~~~i~~~l~~~p~~R~s~~~ll~~~ 254 (256)
T cd08221 220 PVVSVYSSELISLVHSLLQQDPEKRPTADEVLDQP 254 (256)
T ss_pred CCccccCHHHHHHHHHHcccCcccCCCHHHHhhCc
Confidence 11234456799999999999999999999998753
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-35 Score=303.52 Aligned_cols=221 Identities=24% Similarity=0.300 Sum_probs=177.3
Q ss_pred eEEEEEeec---ChhhHHHHHHHHHHHhhcCCCCccceecccccCccceEEEeecCCCccchhccccCCCCCCCHHHHHH
Q 044312 302 QAVKKSKVI---DESKVEEFINEVVILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEIRLR 378 (608)
Q Consensus 302 ~avk~~~~~---~~~~~~~~~~Ei~il~~l~H~niv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~ 378 (608)
+|+|..+.. .......+.+|+++++.++||||+++++++...+..+|||||+++|+|.+++.... .+++..+..
T Consensus 23 ~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~~L~~~l~~~~---~l~~~~~~~ 99 (325)
T cd05594 23 YAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRER---VFSEDRARF 99 (325)
T ss_pred EEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEeCCCCCcHHHHHHhcC---CCCHHHHHH
Confidence 467766532 23445678899999999999999999999999999999999999999998886543 589999999
Q ss_pred HHHHHHHHHHHHhh-cCCCCeeccCCCCCcEEEcCCCcEEEeeccCccccccCCcceeeeeeccCCCCChhhhccCCCCC
Q 044312 379 IAIEVSGALSYLHS-AASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHGTFGYLDPEYFRSSQFTD 457 (608)
Q Consensus 379 i~~~ia~aL~yLH~-~~~~~iiHrDlk~~NILl~~~~~~kl~DFGls~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ 457 (608)
++.||+.||+|||+ .+ |+||||||+|||++.++.+||+|||+++....... ......||+.|+|||++.+..++.
T Consensus 100 ~~~qi~~aL~~lH~~~~---ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~ 175 (325)
T cd05594 100 YGAEIVSALDYLHSEKN---VVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGA-TMKTFCGTPEYLAPEVLEDNDYGR 175 (325)
T ss_pred HHHHHHHHHHHHHhcCC---EEecCCCCCeEEECCCCCEEEecCCCCeecCCCCc-ccccccCCcccCCHHHHccCCCCC
Confidence 99999999999997 67 99999999999999999999999999875432221 223456899999999999999999
Q ss_pred ccchHhHHHHHHHHHhCCCCCCccchhhcccHHHHHHHHhhhhhhHHHhhhhhhccCChhHHHHHHHHHHHHhccCCCCC
Q 044312 458 KSDVYSFGVVLTELLTGEKPIRFTILEEDKSLAAYFLCAMKEERLFEILDARVMKQGGKDEIITVAKLAKRCLNLNGKKR 537 (608)
Q Consensus 458 ksDV~S~Gvvl~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~Li~~cl~~dp~~R 537 (608)
++||||||++++||++|+.||....... .+. . +... ....+...+.++.+|+.+||+.||++|
T Consensus 176 ~~DiwslG~il~el~tG~~Pf~~~~~~~------~~~-~--------i~~~--~~~~p~~~~~~~~~li~~~L~~dP~~R 238 (325)
T cd05594 176 AVDWWGLGVVMYEMMCGRLPFYNQDHEK------LFE-L--------ILME--EIRFPRTLSPEAKSLLSGLLKKDPKQR 238 (325)
T ss_pred ccccccccceeeeeccCCCCCCCCCHHH------HHH-H--------HhcC--CCCCCCCCCHHHHHHHHHHhhcCHHHh
Confidence 9999999999999999999986332111 000 0 0000 011233455679999999999999999
Q ss_pred C-----CHHHHHHH
Q 044312 538 P-----TMREVASE 546 (608)
Q Consensus 538 P-----s~~evl~~ 546 (608)
+ ++.+++++
T Consensus 239 ~~~~~~~~~~il~h 252 (325)
T cd05594 239 LGGGPDDAKEIMQH 252 (325)
T ss_pred CCCCCCCHHHHhcC
Confidence 6 89998865
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-34 Score=303.38 Aligned_cols=233 Identities=23% Similarity=0.321 Sum_probs=178.7
Q ss_pred CccccceeccCce---------------EEEEEeec-ChhhHHHHHHHHHHHhhcCCCCccceecccccCccceEEEeec
Q 044312 290 NFDLNRILGQGGQ---------------AVKKSKVI-DESKVEEFINEVVILSQINHRNVVKLLGCCLETEVPLLVYEFI 353 (608)
Q Consensus 290 ~f~~~~~lG~G~~---------------avk~~~~~-~~~~~~~~~~Ei~il~~l~H~niv~l~~~~~~~~~~~lV~E~~ 353 (608)
+|+..++||+|++ |||..... .....+.+.+|+++++.++|+||+++++++.+.+..++||||+
T Consensus 75 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 154 (353)
T PLN00034 75 ELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQVLLEFM 154 (353)
T ss_pred HHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCCcHHHHHHHHHHHHHHHhCCCCCcceeeeEeccCCeEEEEEecC
Confidence 3555778998874 66665432 2334567999999999999999999999999999999999999
Q ss_pred CCCccchhccccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEEcCCCcEEEeeccCccccccCCcc
Q 044312 354 PNGTLFQYIHDQNEDFPITWEIRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTH 433 (608)
Q Consensus 354 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGls~~~~~~~~~ 433 (608)
++++|.+.. ...+..+..++.||+.||+|||+.+ |+||||||+|||+++++.+||+|||+++.+.....
T Consensus 155 ~~~~L~~~~-------~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~~~~~- 223 (353)
T PLN00034 155 DGGSLEGTH-------IADEQFLADVARQILSGIAYLHRRH---IVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMD- 223 (353)
T ss_pred CCCcccccc-------cCCHHHHHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEcCCCCEEEcccccceecccccc-
Confidence 999986532 2567788899999999999999999 99999999999999999999999999987643221
Q ss_pred eeeeeeccCCCCChhhhccC-----CCCCccchHhHHHHHHHHHhCCCCCCccchhhcccHHHHHHHHhhhhhhHHHhhh
Q 044312 434 MTTQVHGTFGYLDPEYFRSS-----QFTDKSDVYSFGVVLTELLTGEKPIRFTILEEDKSLAAYFLCAMKEERLFEILDA 508 (608)
Q Consensus 434 ~~~~~~gt~~y~aPE~~~~~-----~~t~ksDV~S~Gvvl~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 508 (608)
......||..|+|||++... ..+.++|||||||++|||++|+.||......+ ...... .. ..
T Consensus 224 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~---~~~~~~-~~---------~~ 290 (353)
T PLN00034 224 PCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGD---WASLMC-AI---------CM 290 (353)
T ss_pred cccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCcc---HHHHHH-HH---------hc
Confidence 12345689999999987532 34568999999999999999999987322111 111000 00 00
Q ss_pred hhhccCChhHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 044312 509 RVMKQGGKDEIITVAKLAKRCLNLNGKKRPTMREVASE 546 (608)
Q Consensus 509 ~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~evl~~ 546 (608)
..........+.++.+|+.+||+.||++||++.|++++
T Consensus 291 ~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~ell~h 328 (353)
T PLN00034 291 SQPPEAPATASREFRHFISCCLQREPAKRWSAMQLLQH 328 (353)
T ss_pred cCCCCCCCccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 01112233456689999999999999999999999875
|
|
| >KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-34 Score=290.91 Aligned_cols=237 Identities=27% Similarity=0.334 Sum_probs=195.7
Q ss_pred CccccceeccCc---------------eEEEEEee---cChhhHHHHHHHHHHHhhcCCCCccceecccccCccceEEEe
Q 044312 290 NFDLNRILGQGG---------------QAVKKSKV---IDESKVEEFINEVVILSQINHRNVVKLLGCCLETEVPLLVYE 351 (608)
Q Consensus 290 ~f~~~~~lG~G~---------------~avk~~~~---~~~~~~~~~~~Ei~il~~l~H~niv~l~~~~~~~~~~~lV~E 351 (608)
.|++.+.||.|. ||+|++.. ...........|-+||+.++||.++.|++.+..++..+||||
T Consensus 78 ~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~~~~cl~me 157 (459)
T KOG0610|consen 78 HFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFETDKYSCLVME 157 (459)
T ss_pred HHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheeeccceeEEEEe
Confidence 466688899985 58887653 234455677889999999999999999999999999999999
Q ss_pred ecCCCccchhccccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEEcCCCcEEEeeccCccccccC-
Q 044312 352 FIPNGTLFQYIHDQNEDFPITWEIRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVD- 430 (608)
Q Consensus 352 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGls~~~~~~- 430 (608)
||+||+|..+++++..+ .+++..+.-+|.+|+-||+|||-.| ||.|||||+||||.++|++-|+||.|+......
T Consensus 158 yCpGGdL~~LrqkQp~~-~fse~~aRFYaAEvl~ALEYLHmlG---ivYRDLKPENILvredGHIMLsDFDLS~~~~~~P 233 (459)
T KOG0610|consen 158 YCPGGDLHSLRQKQPGK-RFSESAARFYAAEVLLALEYLHMLG---IVYRDLKPENILVREDGHIMLSDFDLSLRCPVSP 233 (459)
T ss_pred cCCCccHHHHHhhCCCC-ccchhhHHHHHHHHHHHHHHHHhhc---eeeccCCcceeEEecCCcEEeeeccccccCCCCC
Confidence 99999999999887655 6999999999999999999999999 999999999999999999999999987543210
Q ss_pred ---------------------------------Cc---------------------ceeeeeeccCCCCChhhhccCCCC
Q 044312 431 ---------------------------------QT---------------------HMTTQVHGTFGYLDPEYFRSSQFT 456 (608)
Q Consensus 431 ---------------------------------~~---------------------~~~~~~~gt~~y~aPE~~~~~~~t 456 (608)
.. .......||-.|+|||++.+...+
T Consensus 234 t~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~G~GHg 313 (459)
T KOG0610|consen 234 TLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIRGEGHG 313 (459)
T ss_pred eeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceeeecCCCC
Confidence 00 011235699999999999999999
Q ss_pred CccchHhHHHHHHHHHhCCCCCCccchhhcccHHHHHHHHhhhhhhHHHhhhhhhccCChhHHHHHHHHHHHHhccCCCC
Q 044312 457 DKSDVYSFGVVLTELLTGEKPIRFTILEEDKSLAAYFLCAMKEERLFEILDARVMKQGGKDEIITVAKLAKRCLNLNGKK 536 (608)
Q Consensus 457 ~ksDV~S~Gvvl~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~Li~~cl~~dp~~ 536 (608)
.++|.|+|||+||||+.|..||.... ++..+.+++-..+........+..+++||++.|..||.+
T Consensus 314 sAVDWWtfGIflYEmLyG~TPFKG~~---------------~~~Tl~NIv~~~l~Fp~~~~vs~~akDLIr~LLvKdP~k 378 (459)
T KOG0610|consen 314 SAVDWWTFGIFLYEMLYGTTPFKGSN---------------NKETLRNIVGQPLKFPEEPEVSSAAKDLIRKLLVKDPSK 378 (459)
T ss_pred chhhHHHHHHHHHHHHhCCCCcCCCC---------------chhhHHHHhcCCCcCCCCCcchhHHHHHHHHHhccChhh
Confidence 99999999999999999999997432 233455565555544445567788999999999999999
Q ss_pred CCC----HHHHHH
Q 044312 537 RPT----MREVAS 545 (608)
Q Consensus 537 RPs----~~evl~ 545 (608)
|.. +.||-+
T Consensus 379 Rlg~~rGA~eIK~ 391 (459)
T KOG0610|consen 379 RLGSKRGAAEIKR 391 (459)
T ss_pred hhccccchHHhhc
Confidence 998 666544
|
|
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-34 Score=306.92 Aligned_cols=236 Identities=22% Similarity=0.316 Sum_probs=183.5
Q ss_pred CccccceeccCce---------------EEEEEee---cChhhHHHHHHHHHHHhhcCCCCccceecccccCccceEEEe
Q 044312 290 NFDLNRILGQGGQ---------------AVKKSKV---IDESKVEEFINEVVILSQINHRNVVKLLGCCLETEVPLLVYE 351 (608)
Q Consensus 290 ~f~~~~~lG~G~~---------------avk~~~~---~~~~~~~~~~~Ei~il~~l~H~niv~l~~~~~~~~~~~lV~E 351 (608)
.|++.+.||+|+| |+|++.. ......+.+.+|+.++++++|+||+++++++.+.+..++|||
T Consensus 2 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv~E 81 (381)
T cd05626 2 MFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMD 81 (381)
T ss_pred CceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCEEEEEEe
Confidence 5788899999975 6666543 233456779999999999999999999999999999999999
Q ss_pred ecCCCccchhccccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEEcCCCcEEEeeccCccccccCC
Q 044312 352 FIPNGTLFQYIHDQNEDFPITWEIRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQ 431 (608)
Q Consensus 352 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGls~~~~~~~ 431 (608)
|+++|+|.+++.... .+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++......
T Consensus 82 ~~~gg~L~~~l~~~~---~~~e~~~~~~~~qi~~aL~~LH~~g---ivHrDlKp~Nili~~~~~~kL~DFGl~~~~~~~~ 155 (381)
T cd05626 82 YIPGGDMMSLLIRME---VFPEVLARFYIAELTLAIESVHKMG---FIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTH 155 (381)
T ss_pred cCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCcHHHEEECCCCCEEEeeCcCCccccccc
Confidence 999999999987643 4889999999999999999999999 9999999999999999999999999976432100
Q ss_pred c----------------------------------------------ceeeeeeccCCCCChhhhccCCCCCccchHhHH
Q 044312 432 T----------------------------------------------HMTTQVHGTFGYLDPEYFRSSQFTDKSDVYSFG 465 (608)
Q Consensus 432 ~----------------------------------------------~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~G 465 (608)
. .......||+.|+|||++....++.++||||||
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlG 235 (381)
T cd05626 156 NSKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVG 235 (381)
T ss_pred ccccccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCCCCccceeehh
Confidence 0 001234699999999999999999999999999
Q ss_pred HHHHHHHhCCCCCCccchhhcccHHHHHHHHhhhhhhHHHhh--hhhhccCChhHHHHHHHHHHHHh--ccCCCCCCCHH
Q 044312 466 VVLTELLTGEKPIRFTILEEDKSLAAYFLCAMKEERLFEILD--ARVMKQGGKDEIITVAKLAKRCL--NLNGKKRPTMR 541 (608)
Q Consensus 466 vvl~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d--~~~~~~~~~~~~~~l~~Li~~cl--~~dp~~RPs~~ 541 (608)
|+++||++|+.||......+. . ..++. ...........+.++.+|+.+++ ..+|..||++.
T Consensus 236 ~il~elltG~~Pf~~~~~~~~------~---------~~i~~~~~~~~~~~~~~~s~~~~dli~~ll~~~~~~~~R~~~~ 300 (381)
T cd05626 236 VILFEMLVGQPPFLAPTPTET------Q---------LKVINWENTLHIPPQVKLSPEAVDLITKLCCSAEERLGRNGAD 300 (381)
T ss_pred hHHHHHHhCCCCCcCCCHHHH------H---------HHHHccccccCCCCCCCCCHHHHHHHHHHccCcccccCCCCHH
Confidence 999999999999974322110 0 01111 00111112234567888998855 45566699999
Q ss_pred HHHHH
Q 044312 542 EVASE 546 (608)
Q Consensus 542 evl~~ 546 (608)
|++++
T Consensus 301 ~~l~h 305 (381)
T cd05626 301 DIKAH 305 (381)
T ss_pred HHhcC
Confidence 99875
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-34 Score=290.30 Aligned_cols=242 Identities=27% Similarity=0.415 Sum_probs=187.8
Q ss_pred cCccccceeccCce--------------------EEEEEeecChh-hHHHHHHHHHHHhhcCCCCccceecccccCccce
Q 044312 289 DNFDLNRILGQGGQ--------------------AVKKSKVIDES-KVEEFINEVVILSQINHRNVVKLLGCCLETEVPL 347 (608)
Q Consensus 289 ~~f~~~~~lG~G~~--------------------avk~~~~~~~~-~~~~~~~Ei~il~~l~H~niv~l~~~~~~~~~~~ 347 (608)
.+|++.+.||+|++ ++|........ ..+.+.+|++++++++|+||+++++++.+....+
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 84 (275)
T cd05046 5 SNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVRLLGLCREAEPHY 84 (275)
T ss_pred HhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCccchHHHHHHHHHHHHHHhcCCcceeeeEEEECCCCcce
Confidence 45777888888875 22332222222 3568999999999999999999999999989999
Q ss_pred EEEeecCCCccchhccccCCC------CCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEEcCCCcEEEeec
Q 044312 348 LVYEFIPNGTLFQYIHDQNED------FPITWEIRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDF 421 (608)
Q Consensus 348 lV~E~~~~gsL~~~l~~~~~~------~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DF 421 (608)
+||||+++++|.+++...... ..+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+|++||
T Consensus 85 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~---i~H~dlkp~Nili~~~~~~~l~~~ 161 (275)
T cd05046 85 MILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNAR---FVHRDLAARNCLVSSQREVKVSLL 161 (275)
T ss_pred EEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhcC---cccCcCccceEEEeCCCcEEEccc
Confidence 999999999999999765422 15899999999999999999999999 999999999999999999999999
Q ss_pred cCccccccCCcceeeeeeccCCCCChhhhccCCCCCccchHhHHHHHHHHHh-CCCCCCccchhhcccHHHHHHHHhhhh
Q 044312 422 GASRSMAVDQTHMTTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLTELLT-GEKPIRFTILEEDKSLAAYFLCAMKEE 500 (608)
Q Consensus 422 Gls~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~ellt-g~~p~~~~~~~~~~~l~~~~~~~~~~~ 500 (608)
|+++..............++..|+|||.+.+...+.++||||||+++++|++ |..||...... . +......
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~~~~~p~~~~~~~------~-~~~~~~~- 233 (275)
T cd05046 162 SLSKDVYNSEYYKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSDE------E-VLNRLQA- 233 (275)
T ss_pred ccccccCcccccccCCceeEEeecChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCccccchH------H-HHHHHHc-
Confidence 9987553322222233346778999999998889999999999999999999 77887522111 0 1111111
Q ss_pred hhHHHhhhhhhccCChhHHHHHHHHHHHHhccCCCCCCCHHHHHHHHH
Q 044312 501 RLFEILDARVMKQGGKDEIITVAKLAKRCLNLNGKKRPTMREVASELA 548 (608)
Q Consensus 501 ~~~~~~d~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~evl~~L~ 548 (608)
.......+...+..+.+++.+||+.+|++||++.|+++.|.
T Consensus 234 -------~~~~~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~l~ 274 (275)
T cd05046 234 -------GKLELPVPEGCPSRLYKLMTRCWAVNPKDRPSFSELVSALG 274 (275)
T ss_pred -------CCcCCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhc
Confidence 11111122345678999999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-34 Score=296.61 Aligned_cols=248 Identities=27% Similarity=0.406 Sum_probs=187.7
Q ss_pred cCccccceeccCce---------------EEEEEeec-ChhhHHHHHHHHHHHhhcCCCCccceecccccCccceEEEee
Q 044312 289 DNFDLNRILGQGGQ---------------AVKKSKVI-DESKVEEFINEVVILSQINHRNVVKLLGCCLETEVPLLVYEF 352 (608)
Q Consensus 289 ~~f~~~~~lG~G~~---------------avk~~~~~-~~~~~~~~~~Ei~il~~l~H~niv~l~~~~~~~~~~~lV~E~ 352 (608)
++|++.+.||+|++ |+|..+.. ......++.+|++++++++||||+++++++.+.+..++||||
T Consensus 1 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ey 80 (308)
T cd06615 1 DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISICMEH 80 (308)
T ss_pred CCceEEeeccCCCCeEEEEEEEcCCCeEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCEEEEEeec
Confidence 36888899999875 34444332 233456789999999999999999999999999999999999
Q ss_pred cCCCccchhccccCCCCCCCHHHHHHHHHHHHHHHHHHhh-cCCCCeeccCCCCCcEEEcCCCcEEEeeccCccccccCC
Q 044312 353 IPNGTLFQYIHDQNEDFPITWEIRLRIAIEVSGALSYLHS-AASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQ 431 (608)
Q Consensus 353 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~-~~~~~iiHrDlk~~NILl~~~~~~kl~DFGls~~~~~~~ 431 (608)
+++++|.+++.... .+++..+..++.|+++||.|||+ .+ ++|+||||+|||++.++.+||+|||++.......
T Consensus 81 ~~~~~L~~~l~~~~---~~~~~~~~~~~~~i~~~l~~lH~~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~ 154 (308)
T cd06615 81 MDGGSLDQVLKKAG---RIPENILGKISIAVLRGLTYLREKHK---IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM 154 (308)
T ss_pred cCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhhCC---EEECCCChHHEEEecCCcEEEccCCCcccccccc
Confidence 99999999997653 58999999999999999999997 46 9999999999999999999999999987653221
Q ss_pred cceeeeeeccCCCCChhhhccCCCCCccchHhHHHHHHHHHhCCCCCCccchhhcccHHHHHHHHhh-------------
Q 044312 432 THMTTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLTELLTGEKPIRFTILEEDKSLAAYFLCAMK------------- 498 (608)
Q Consensus 432 ~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~elltg~~p~~~~~~~~~~~l~~~~~~~~~------------- 498 (608)
.....++..|+|||.+.+..++.++||||||++++||++|+.||....... ....+.....
T Consensus 155 ---~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~ 228 (308)
T cd06615 155 ---ANSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPDAKE---LEAMFGRPVSEGEAKESHRPVSG 228 (308)
T ss_pred ---cccCCCCcCccChhHhcCCCCCccchHHHHHHHHHHHHhCCCCCCCcchhh---HHHhhcCccccccccCCcccccC
Confidence 233467899999999988889999999999999999999999986332111 1110100000
Q ss_pred -------hhhhHHHhhhhhhcc----CChhHHHHHHHHHHHHhccCCCCCCCHHHHHHHHH
Q 044312 499 -------EERLFEILDARVMKQ----GGKDEIITVAKLAKRCLNLNGKKRPTMREVASELA 548 (608)
Q Consensus 499 -------~~~~~~~~d~~~~~~----~~~~~~~~l~~Li~~cl~~dp~~RPs~~evl~~L~ 548 (608)
.....+..+...... .....+.++++|+.+||..+|++||+++||+++..
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~ 289 (308)
T cd06615 229 HPPDSPRPMAIFELLDYIVNEPPPKLPSGAFSDEFQDFVDKCLKKNPKERADLKELTKHPF 289 (308)
T ss_pred CCCCccchhhHHHHHHHHhcCCCccCcCcccCHHHHHHHHHHccCChhhCcCHHHHhcChh
Confidence 000011111100000 01124567999999999999999999999997653
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-34 Score=289.30 Aligned_cols=245 Identities=25% Similarity=0.374 Sum_probs=189.2
Q ss_pred HHHHhcCccccceeccCce---------------EEEEEeecChhhHHHHHHHHHHHhhcCCCCccceecccccCccceE
Q 044312 284 LEKATDNFDLNRILGQGGQ---------------AVKKSKVIDESKVEEFINEVVILSQINHRNVVKLLGCCLETEVPLL 348 (608)
Q Consensus 284 l~~~t~~f~~~~~lG~G~~---------------avk~~~~~~~~~~~~~~~Ei~il~~l~H~niv~l~~~~~~~~~~~l 348 (608)
++.+++++.....||+|++ ++|..........+.+.+|+.++++++|+||+++++++...+..++
T Consensus 3 ~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 82 (268)
T cd06624 3 YEYEYDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSDSENGFFKI 82 (268)
T ss_pred cccccccCCceEEEecCCceEEEEeEecCCCcEEEEEEecCCCHHHHHHHHHHHHHHHhcCCCCeeeeeeeeccCCEEEE
Confidence 4556777877888999874 4555554445567789999999999999999999999999999999
Q ss_pred EEeecCCCccchhccccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEEcC-CCcEEEeeccCcccc
Q 044312 349 VYEFIPNGTLFQYIHDQNEDFPITWEIRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDD-KYRAKVSDFGASRSM 427 (608)
Q Consensus 349 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~-~~~~kl~DFGls~~~ 427 (608)
|+||+++++|.+++.........++..+..++.||+.||+|||+.+ |+||||||+||+++. ++.+||+|||++...
T Consensus 83 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~h~dl~p~nil~~~~~~~~~l~dfg~~~~~ 159 (268)
T cd06624 83 FMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDNQ---IVHRDIKGDNVLVNTYSGVVKISDFGTSKRL 159 (268)
T ss_pred EEecCCCCCHHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEcCCCCeEEEecchhheec
Confidence 9999999999999976432211278889999999999999999998 999999999999976 679999999998765
Q ss_pred ccCCcceeeeeeccCCCCChhhhccCC--CCCccchHhHHHHHHHHHhCCCCCCccchhhcccHHHHHHHHhhhhhhHHH
Q 044312 428 AVDQTHMTTQVHGTFGYLDPEYFRSSQ--FTDKSDVYSFGVVLTELLTGEKPIRFTILEEDKSLAAYFLCAMKEERLFEI 505 (608)
Q Consensus 428 ~~~~~~~~~~~~gt~~y~aPE~~~~~~--~t~ksDV~S~Gvvl~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 505 (608)
..... ......++..|+|||++.... ++.++||||||+++++|++|+.||....... ...+. .
T Consensus 160 ~~~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~----~~~~~----------~ 224 (268)
T cd06624 160 AGINP-CTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQ----AAMFK----------V 224 (268)
T ss_pred ccCCC-ccccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccChh----hhHhh----------h
Confidence 43222 122345789999999986643 7899999999999999999999986321110 00000 0
Q ss_pred hhhhhhccCChhHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 044312 506 LDARVMKQGGKDEIITVAKLAKRCLNLNGKKRPTMREVASE 546 (608)
Q Consensus 506 ~d~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~evl~~ 546 (608)
.........+.....++.+++.+||+.+|++|||+.|++++
T Consensus 225 ~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~ 265 (268)
T cd06624 225 GMFKIHPEIPESLSAEAKNFILRCFEPDPDKRASAHDLLQD 265 (268)
T ss_pred hhhccCCCCCcccCHHHHHHHHHHcCCCchhCCCHHHHHhC
Confidence 00001112233455679999999999999999999999864
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-34 Score=306.95 Aligned_cols=247 Identities=25% Similarity=0.363 Sum_probs=189.9
Q ss_pred HHHHHHHhcCccccceeccCce---------------EEEEEee---cChhhHHHHHHHHHHHhhcCCCCccceeccccc
Q 044312 281 SKELEKATDNFDLNRILGQGGQ---------------AVKKSKV---IDESKVEEFINEVVILSQINHRNVVKLLGCCLE 342 (608)
Q Consensus 281 ~~~l~~~t~~f~~~~~lG~G~~---------------avk~~~~---~~~~~~~~~~~Ei~il~~l~H~niv~l~~~~~~ 342 (608)
..++....++|++.+.||+|++ |+|.... ......+.+.+|+.+++.++||||+++++.+.+
T Consensus 35 ~~~~~~~~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~ 114 (371)
T cd05622 35 IRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQD 114 (371)
T ss_pred HhhcCcchhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEc
Confidence 3445556688999999999985 5555432 223344568899999999999999999999999
Q ss_pred CccceEEEeecCCCccchhccccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEEcCCCcEEEeecc
Q 044312 343 TEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEIRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFG 422 (608)
Q Consensus 343 ~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFG 422 (608)
....++||||+++|+|.+++... .++...+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||
T Consensus 115 ~~~~~lv~Ey~~gg~L~~~~~~~----~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDLkp~NIll~~~~~ikL~DfG 187 (371)
T cd05622 115 DRYLYMVMEYMPGGDLVNLMSNY----DVPEKWARFYTAEVVLALDAIHSMG---FIHRDVKPDNMLLDKSGHLKLADFG 187 (371)
T ss_pred CCEEEEEEcCCCCCcHHHHHHhc----CCCHHHHHHHHHHHHHHHHHHHHCC---EEeCCCCHHHEEECCCCCEEEEeCC
Confidence 99999999999999999998653 3788889999999999999999999 9999999999999999999999999
Q ss_pred CccccccCCcceeeeeeccCCCCChhhhccC----CCCCccchHhHHHHHHHHHhCCCCCCccchhhcccHHHHHHHHhh
Q 044312 423 ASRSMAVDQTHMTTQVHGTFGYLDPEYFRSS----QFTDKSDVYSFGVVLTELLTGEKPIRFTILEEDKSLAAYFLCAMK 498 (608)
Q Consensus 423 ls~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----~~t~ksDV~S~Gvvl~elltg~~p~~~~~~~~~~~l~~~~~~~~~ 498 (608)
+++..............||+.|+|||++... .++.++|||||||++|||++|+.||..... ...+...+.
T Consensus 188 ~a~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~------~~~~~~i~~ 261 (371)
T cd05622 188 TCMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSL------VGTYSKIMN 261 (371)
T ss_pred ceeEcCcCCcccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCCH------HHHHHHHHc
Confidence 9987654333333456799999999998754 378999999999999999999999973221 111111111
Q ss_pred hhhhHHHhhhhhhccCChhHHHHHHHHHHHHhccCCCC--CCCHHHHHHHH
Q 044312 499 EERLFEILDARVMKQGGKDEIITVAKLAKRCLNLNGKK--RPTMREVASEL 547 (608)
Q Consensus 499 ~~~~~~~~d~~~~~~~~~~~~~~l~~Li~~cl~~dp~~--RPs~~evl~~L 547 (608)
... ..........+..+.+|+.+||..++.+ ||++.|++++.
T Consensus 262 ~~~-------~~~~~~~~~~s~~~~~li~~~L~~~~~r~~r~~~~ei~~h~ 305 (371)
T cd05622 262 HKN-------SLTFPDDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRHL 305 (371)
T ss_pred CCC-------cccCCCcCCCCHHHHHHHHHHcCChhhhcCCCCHHHHhcCc
Confidence 100 0111112345678899999999844433 77898888764
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-34 Score=299.98 Aligned_cols=230 Identities=27% Similarity=0.352 Sum_probs=179.0
Q ss_pred ccccceeccCce---------------EEEEEeec---ChhhHHHHHHHHHHH---hhcCCCCccceecccccCccceEE
Q 044312 291 FDLNRILGQGGQ---------------AVKKSKVI---DESKVEEFINEVVIL---SQINHRNVVKLLGCCLETEVPLLV 349 (608)
Q Consensus 291 f~~~~~lG~G~~---------------avk~~~~~---~~~~~~~~~~Ei~il---~~l~H~niv~l~~~~~~~~~~~lV 349 (608)
|++.+.||+|++ |||..+.. .....+.+.+|++++ +.++||||+++++++.+.+..++|
T Consensus 1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv 80 (324)
T cd05589 1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCFV 80 (324)
T ss_pred CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEEEE
Confidence 556778888863 66666532 233455677776655 566899999999999999999999
Q ss_pred EeecCCCccchhccccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEEcCCCcEEEeeccCcccccc
Q 044312 350 YEFIPNGTLFQYIHDQNEDFPITWEIRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAV 429 (608)
Q Consensus 350 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGls~~~~~ 429 (608)
|||+++++|..+++.. .+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++....
T Consensus 81 ~E~~~~~~L~~~~~~~----~l~~~~~~~~~~qi~~al~~lH~~~---ivHrdlkp~Nill~~~~~~kL~Dfg~~~~~~~ 153 (324)
T cd05589 81 MEYAAGGDLMMHIHTD----VFSEPRAVFYAACVVLGLQYLHENK---IVYRDLKLDNLLLDTEGFVKIADFGLCKEGMG 153 (324)
T ss_pred EcCCCCCcHHHHhhcC----CCCHHHHHHHHHHHHHHHHHHHhCC---eEecCCCHHHeEECCCCcEEeCcccCCccCCC
Confidence 9999999998887642 4899999999999999999999999 99999999999999999999999999875432
Q ss_pred CCcceeeeeeccCCCCChhhhccCCCCCccchHhHHHHHHHHHhCCCCCCccchhhcccHHHHHHHHhhhhhhHHHhhhh
Q 044312 430 DQTHMTTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLTELLTGEKPIRFTILEEDKSLAAYFLCAMKEERLFEILDAR 509 (608)
Q Consensus 430 ~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 509 (608)
.. .......|++.|+|||++.+..++.++||||||+++|||++|+.||......+ .. ..+....
T Consensus 154 ~~-~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~G~~pf~~~~~~~------~~---------~~i~~~~ 217 (324)
T cd05589 154 FG-DRTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDDEEE------VF---------DSIVNDE 217 (324)
T ss_pred CC-CcccccccCccccCHhHhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCCHHH------HH---------HHHHhCC
Confidence 22 22234568999999999999999999999999999999999999986432111 00 0111111
Q ss_pred hhccCChhHHHHHHHHHHHHhccCCCCCCC-----HHHHHH
Q 044312 510 VMKQGGKDEIITVAKLAKRCLNLNGKKRPT-----MREVAS 545 (608)
Q Consensus 510 ~~~~~~~~~~~~l~~Li~~cl~~dp~~RPs-----~~evl~ 545 (608)
...+...+..+.+++.+||+.||.+||+ +.++++
T Consensus 218 --~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~l~~ 256 (324)
T cd05589 218 --VRYPRFLSREAISIMRRLLRRNPERRLGSGEKDAEDVKK 256 (324)
T ss_pred --CCCCCCCCHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhh
Confidence 1123345667899999999999999995 555544
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-34 Score=295.76 Aligned_cols=220 Identities=23% Similarity=0.323 Sum_probs=173.4
Q ss_pred eEEEEEeec---ChhhHHHHHHHHHHHhhc-CCCCccceecccccCccceEEEeecCCCccchhccccCCCCCCCHHHHH
Q 044312 302 QAVKKSKVI---DESKVEEFINEVVILSQI-NHRNVVKLLGCCLETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEIRL 377 (608)
Q Consensus 302 ~avk~~~~~---~~~~~~~~~~Ei~il~~l-~H~niv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~ 377 (608)
+|+|.++.. .....+.+..|..++..+ +||||+++++++...+..++||||+++|+|.+++.... .+++..+.
T Consensus 23 vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~gg~L~~~~~~~~---~~~~~~~~ 99 (316)
T cd05592 23 FAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLNGGDLMFHIQSSG---RFDEARAR 99 (316)
T ss_pred EEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCCCcHHHHHHHcC---CCCHHHHH
Confidence 477766532 233455667777777655 89999999999999999999999999999999887643 48999999
Q ss_pred HHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEEcCCCcEEEeeccCccccccCCcceeeeeeccCCCCChhhhccCCCCC
Q 044312 378 RIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHGTFGYLDPEYFRSSQFTD 457 (608)
Q Consensus 378 ~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGls~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ 457 (608)
.++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++...... .......||+.|+|||++.+..++.
T Consensus 100 ~~~~qi~~al~~LH~~~---ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~ 175 (316)
T cd05592 100 FYAAEIICGLQFLHKKG---IIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGE-GKASTFCGTPDYIAPEILKGQKYNE 175 (316)
T ss_pred HHHHHHHHHHHHHHHCC---EEeCCCCHHHeEECCCCCEEEccCcCCeECCCCC-CccccccCCccccCHHHHcCCCCCC
Confidence 99999999999999999 9999999999999999999999999997653322 2234456899999999999999999
Q ss_pred ccchHhHHHHHHHHHhCCCCCCccchhhcccHHHHHHHHhhhhhhHHHhhhhhhccCChhHHHHHHHHHHHHhccCCCCC
Q 044312 458 KSDVYSFGVVLTELLTGEKPIRFTILEEDKSLAAYFLCAMKEERLFEILDARVMKQGGKDEIITVAKLAKRCLNLNGKKR 537 (608)
Q Consensus 458 ksDV~S~Gvvl~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~Li~~cl~~dp~~R 537 (608)
++||||||++++||++|+.||......+ .+ ..+... ....+...+.++.+|+.+||+.+|++|
T Consensus 176 ~~DvwslG~il~ell~G~~Pf~~~~~~~------~~-~~i~~~----------~~~~~~~~~~~~~~ll~~~l~~~P~~R 238 (316)
T cd05592 176 SVDWWSFGVLLYEMLIGQSPFHGEDEDE------LF-DSILND----------RPHFPRWISKEAKDCLSKLFERDPTKR 238 (316)
T ss_pred cccchhHHHHHHHHHhCCCCCCCCCHHH------HH-HHHHcC----------CCCCCCCCCHHHHHHHHHHccCCHHHc
Confidence 9999999999999999999996432111 01 011100 111233445678999999999999999
Q ss_pred CCHH-HHHH
Q 044312 538 PTMR-EVAS 545 (608)
Q Consensus 538 Ps~~-evl~ 545 (608)
|++. ++++
T Consensus 239 ~~~~~~l~~ 247 (316)
T cd05592 239 LGVDGDIRQ 247 (316)
T ss_pred CCChHHHHc
Confidence 9975 4443
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-34 Score=289.33 Aligned_cols=243 Identities=25% Similarity=0.456 Sum_probs=189.6
Q ss_pred cCccccceeccCce-------------------EEEEEeec-ChhhHHHHHHHHHHHhhcCCCCccceecccccCccceE
Q 044312 289 DNFDLNRILGQGGQ-------------------AVKKSKVI-DESKVEEFINEVVILSQINHRNVVKLLGCCLETEVPLL 348 (608)
Q Consensus 289 ~~f~~~~~lG~G~~-------------------avk~~~~~-~~~~~~~~~~Ei~il~~l~H~niv~l~~~~~~~~~~~l 348 (608)
.+|++.+.||+|++ |+|..... ......++.+|+.++++++||||+++++++.. ...++
T Consensus 7 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~ 85 (279)
T cd05057 7 TELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRLLGICLS-SQVQL 85 (279)
T ss_pred HHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEec-CceEE
Confidence 34667788888874 33333322 22345789999999999999999999999987 78899
Q ss_pred EEeecCCCccchhccccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEEcCCCcEEEeeccCccccc
Q 044312 349 VYEFIPNGTLFQYIHDQNEDFPITWEIRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMA 428 (608)
Q Consensus 349 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGls~~~~ 428 (608)
||||+++|+|.+++..... .+++..++.++.||+.||+|||+.+ ++||||||+|||+++++.+||+|||+++...
T Consensus 86 v~e~~~~g~L~~~l~~~~~--~~~~~~~~~~~~qi~~~l~~LH~~~---i~H~di~p~nil~~~~~~~kL~dfg~~~~~~ 160 (279)
T cd05057 86 ITQLMPLGCLLDYVRNHKD--NIGSQYLLNWCVQIAKGMSYLEEKR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLD 160 (279)
T ss_pred EEecCCCCcHHHHHHhccC--CCCHHHHHHHHHHHHHHHHHHHhCC---EEecccCcceEEEcCCCeEEECCCccccccc
Confidence 9999999999999986543 4899999999999999999999988 9999999999999999999999999998765
Q ss_pred cCCccee-eeeeccCCCCChhhhccCCCCCccchHhHHHHHHHHHh-CCCCCCccchhhcccHHHHHHHHhhhhhhHHHh
Q 044312 429 VDQTHMT-TQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLTELLT-GEKPIRFTILEEDKSLAAYFLCAMKEERLFEIL 506 (608)
Q Consensus 429 ~~~~~~~-~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~ellt-g~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 506 (608)
....... ....++..|+|||.+....++.++||||||++++|+++ |+.||......+ +.+.+
T Consensus 161 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~----------------~~~~~ 224 (279)
T cd05057 161 VDEKEYHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAVE----------------IPDLL 224 (279)
T ss_pred CcccceecCCCcccccccCHHHhhcCCcCchhhHHHHHHHHHHHhcCCCCCCCCCCHHH----------------HHHHH
Confidence 3322111 12223568999999988899999999999999999999 999986432211 11111
Q ss_pred hhhhhccCChhHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhhHHh
Q 044312 507 DARVMKQGGKDEIITVAKLAKRCLNLNGKKRPTMREVASELAGIKAW 553 (608)
Q Consensus 507 d~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~evl~~L~~i~~~ 553 (608)
........+...+..+.+++.+||..+|.+||++.++++.|..+...
T Consensus 225 ~~~~~~~~~~~~~~~~~~~~~~~l~~~p~~Rp~~~~l~~~l~~~~~~ 271 (279)
T cd05057 225 EKGERLPQPPICTIDVYMVLVKCWMIDAESRPTFKELINEFSKMARD 271 (279)
T ss_pred hCCCCCCCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHhC
Confidence 11111122233456789999999999999999999999999887553
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-34 Score=290.93 Aligned_cols=240 Identities=25% Similarity=0.359 Sum_probs=186.6
Q ss_pred cCccccceeccCce---------------EEEEEeecChhhHHHHHHHHHHHhhcCCCCccceecccccCccceEEEeec
Q 044312 289 DNFDLNRILGQGGQ---------------AVKKSKVIDESKVEEFINEVVILSQINHRNVVKLLGCCLETEVPLLVYEFI 353 (608)
Q Consensus 289 ~~f~~~~~lG~G~~---------------avk~~~~~~~~~~~~~~~Ei~il~~l~H~niv~l~~~~~~~~~~~lV~E~~ 353 (608)
++|++.+.||+|++ |+|+...........+.+|+.++++++||||+++++.+...+..++||||+
T Consensus 9 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~~~~iv~e~~ 88 (267)
T cd06646 9 HDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGSYLSREKLWICMEYC 88 (267)
T ss_pred hhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCccchHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEEEEEeCC
Confidence 46888889998874 566665544455677889999999999999999999999999999999999
Q ss_pred CCCccchhccccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEEcCCCcEEEeeccCccccccCCcc
Q 044312 354 PNGTLFQYIHDQNEDFPITWEIRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTH 433 (608)
Q Consensus 354 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGls~~~~~~~~~ 433 (608)
++++|.++++... ++++..+..++.|++.||.|||+.+ |+||||||+||+++.++.+||+|||+++.......
T Consensus 89 ~~~~L~~~~~~~~---~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~~- 161 (267)
T cd06646 89 GGGSLQDIYHVTG---PLSELQIAYVCRETLQGLAYLHSKG---KMHRDIKGANILLTDNGDVKLADFGVAAKITATIA- 161 (267)
T ss_pred CCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEECCCCCEEECcCccceeeccccc-
Confidence 9999999887543 5899999999999999999999998 99999999999999999999999999986642221
Q ss_pred eeeeeeccCCCCChhhhc---cCCCCCccchHhHHHHHHHHHhCCCCCCccchhhcccHHHHHHHHhhhhhhHHHhhhhh
Q 044312 434 MTTQVHGTFGYLDPEYFR---SSQFTDKSDVYSFGVVLTELLTGEKPIRFTILEEDKSLAAYFLCAMKEERLFEILDARV 510 (608)
Q Consensus 434 ~~~~~~gt~~y~aPE~~~---~~~~t~ksDV~S~Gvvl~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~ 510 (608)
......++..|+|||.+. ...++.++||||||++++||++|+.||......... . .+..... ..+..
T Consensus 162 ~~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~~-----~--~~~~~~~---~~~~~ 231 (267)
T cd06646 162 KRKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRAL-----F--LMSKSNF---QPPKL 231 (267)
T ss_pred ccCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhhh-----e--eeecCCC---CCCCC
Confidence 123345788999999984 445788999999999999999999998532211100 0 0000000 00000
Q ss_pred hccCChhHHHHHHHHHHHHhccCCCCCCCHHHHHHHH
Q 044312 511 MKQGGKDEIITVAKLAKRCLNLNGKKRPTMREVASEL 547 (608)
Q Consensus 511 ~~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~evl~~L 547 (608)
......+..+.+++.+||+.+|++||++++++++|
T Consensus 232 --~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~l 266 (267)
T cd06646 232 --KDKTKWSSTFHNFVKISLTKNPKKRPTAERLLTHL 266 (267)
T ss_pred --ccccccCHHHHHHHHHHhhCChhhCcCHHHHhcCC
Confidence 01123456899999999999999999999998754
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-34 Score=286.21 Aligned_cols=227 Identities=26% Similarity=0.406 Sum_probs=182.1
Q ss_pred eEEEEEeecCh-hhHHHHHHHHHHHhhcCCCCccceecccccCccceEEEeecCCCccchhccccCCCCCCCHHHHHHHH
Q 044312 302 QAVKKSKVIDE-SKVEEFINEVVILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEIRLRIA 380 (608)
Q Consensus 302 ~avk~~~~~~~-~~~~~~~~Ei~il~~l~H~niv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~ 380 (608)
+|+|....... ...+.|.+|+.++++++||||+++++.+.+ ...++||||+++++|.+++..... ..+++..+..++
T Consensus 26 vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~~~~~L~~~l~~~~~-~~~~~~~~~~~~ 103 (257)
T cd05040 26 VAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLYGVVLT-HPLMMVTELAPLGSLLDRLRKDAL-GHFLISTLCDYA 103 (257)
T ss_pred EEEeecCCcccHHHHHHHHHHHHHHhhcCCCCccceeEEEcC-CeEEEEEEecCCCcHHHHHHhccc-ccCcHHHHHHHH
Confidence 47777665444 567789999999999999999999999988 888999999999999999987542 358999999999
Q ss_pred HHHHHHHHHHhhcCCCCeeccCCCCCcEEEcCCCcEEEeeccCccccccCCcce--eeeeeccCCCCChhhhccCCCCCc
Q 044312 381 IEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHM--TTQVHGTFGYLDPEYFRSSQFTDK 458 (608)
Q Consensus 381 ~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGls~~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~t~k 458 (608)
.|++.||+|||+.+ ++|+||||+|||++.++.+||+|||+++.+....... .....++..|+|||++....++.+
T Consensus 104 ~qi~~~L~~lH~~~---i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~ 180 (257)
T cd05040 104 VQIANGMRYLESKR---FIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVMEEHLKVPFAWCAPESLRTRTFSHA 180 (257)
T ss_pred HHHHHHHHHHHhCC---ccccccCcccEEEecCCEEEeccccccccccccccceecccCCCCCceecCHHHhcccCcCch
Confidence 99999999999999 9999999999999999999999999998775432211 123456788999999999999999
Q ss_pred cchHhHHHHHHHHHh-CCCCCCccchhhcccHHHHHHHHhhhhhhHHHhhhhhhccCChhHHHHHHHHHHHHhccCCCCC
Q 044312 459 SDVYSFGVVLTELLT-GEKPIRFTILEEDKSLAAYFLCAMKEERLFEILDARVMKQGGKDEIITVAKLAKRCLNLNGKKR 537 (608)
Q Consensus 459 sDV~S~Gvvl~ellt-g~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~Li~~cl~~dp~~R 537 (608)
+||||||++++||++ |+.||......+ ....... .......+...+..+.+++.+||+.+|++|
T Consensus 181 ~Di~slG~~l~el~t~g~~p~~~~~~~~------~~~~~~~---------~~~~~~~~~~~~~~~~~li~~~l~~~p~~R 245 (257)
T cd05040 181 SDVWMFGVTLWEMFTYGEEPWAGLSGSQ------ILKKIDK---------EGERLERPEACPQDIYNVMLQCWAHNPADR 245 (257)
T ss_pred hhhHHHHHHHHHHHhCCCCCCCCCCHHH------HHHHHHh---------cCCcCCCCccCCHHHHHHHHHHCCCCcccC
Confidence 999999999999999 999985322111 0000000 001111223445689999999999999999
Q ss_pred CCHHHHHHHHH
Q 044312 538 PTMREVASELA 548 (608)
Q Consensus 538 Ps~~evl~~L~ 548 (608)
|++.||++.|.
T Consensus 246 ps~~~~~~~l~ 256 (257)
T cd05040 246 PTFAALREFLP 256 (257)
T ss_pred CCHHHHHHHhc
Confidence 99999998874
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-34 Score=299.54 Aligned_cols=228 Identities=25% Similarity=0.370 Sum_probs=176.4
Q ss_pred eEEEEEee---cChhhHHHHHHHHHHHhhc-CCCCccceecccccCccceEEEeecCCCccchhccccCCCCCCCHHHHH
Q 044312 302 QAVKKSKV---IDESKVEEFINEVVILSQI-NHRNVVKLLGCCLETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEIRL 377 (608)
Q Consensus 302 ~avk~~~~---~~~~~~~~~~~Ei~il~~l-~H~niv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~ 377 (608)
+|+|..+. .+....+.+.+|+.++.++ +||||+++++++.+....++||||+++|+|..++.... .+++..+.
T Consensus 23 ~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~~~~L~~~~~~~~---~l~~~~~~ 99 (329)
T cd05618 23 YAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQR---KLPEEHAR 99 (329)
T ss_pred EEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCCCCCCHHHHHHHcC---CCCHHHHH
Confidence 46776653 2334456788899988877 89999999999999999999999999999988886543 58999999
Q ss_pred HHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEEcCCCcEEEeeccCccccccCCcceeeeeeccCCCCChhhhccCCCCC
Q 044312 378 RIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHGTFGYLDPEYFRSSQFTD 457 (608)
Q Consensus 378 ~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGls~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ 457 (608)
.++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++...... .......||+.|+|||++.+..++.
T Consensus 100 ~i~~qi~~~l~~lH~~~---ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~ 175 (329)
T cd05618 100 FYSAEISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPG-DTTSTFCGTPNYIAPEILRGEDYGF 175 (329)
T ss_pred HHHHHHHHHHHHHHHCC---eeeCCCCHHHEEECCCCCEEEeeCCccccccCCC-CccccccCCccccCHHHHcCCCCCC
Confidence 99999999999999999 9999999999999999999999999987543221 1223456899999999999999999
Q ss_pred ccchHhHHHHHHHHHhCCCCCCccchhhc--ccHHHHHHHHhhhhhhHHHhhhhhhccCChhHHHHHHHHHHHHhccCCC
Q 044312 458 KSDVYSFGVVLTELLTGEKPIRFTILEED--KSLAAYFLCAMKEERLFEILDARVMKQGGKDEIITVAKLAKRCLNLNGK 535 (608)
Q Consensus 458 ksDV~S~Gvvl~elltg~~p~~~~~~~~~--~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~Li~~cl~~dp~ 535 (608)
++||||||++++||++|+.||........ .....+....... . ....+...+..+.+|+.+||+.||+
T Consensus 176 ~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~i~~--------~--~~~~p~~~~~~~~~ll~~~L~~dP~ 245 (329)
T cd05618 176 SVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILE--------K--QIRIPRSLSVKAASVLKSFLNKDPK 245 (329)
T ss_pred ccceecccHHHHHHhhCCCCCccCCCcCCcccccHHHHHHHHhc--------C--CCCCCCCCCHHHHHHHHHHhcCCHH
Confidence 99999999999999999999963221111 1111111111111 1 1123334566789999999999999
Q ss_pred CCCC------HHHHHHH
Q 044312 536 KRPT------MREVASE 546 (608)
Q Consensus 536 ~RPs------~~evl~~ 546 (608)
+||+ +.+++++
T Consensus 246 ~R~~~~~~~~~~~i~~h 262 (329)
T cd05618 246 ERLGCHPQTGFADIQGH 262 (329)
T ss_pred HcCCCCCCCCHHHHhcC
Confidence 9998 4566543
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-34 Score=285.51 Aligned_cols=228 Identities=31% Similarity=0.471 Sum_probs=184.0
Q ss_pred eEEEEEeecChh-hHHHHHHHHHHHhhcCCCCccceecccccCccceEEEeecCCCccchhccccCC------CCCCCHH
Q 044312 302 QAVKKSKVIDES-KVEEFINEVVILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGTLFQYIHDQNE------DFPITWE 374 (608)
Q Consensus 302 ~avk~~~~~~~~-~~~~~~~Ei~il~~l~H~niv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~------~~~l~~~ 374 (608)
+++|..+..... ..+.+.+|+++++.++|+||+++++++.+....++||||+++++|.+++..... ...+++.
T Consensus 26 ~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~ 105 (262)
T cd00192 26 VAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLK 105 (262)
T ss_pred EEeEeeccccchhHHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEEEeccCCcHHHHHhhccccccccccccCCHH
Confidence 466666543333 378899999999999999999999999999999999999999999999987521 1368999
Q ss_pred HHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEEcCCCcEEEeeccCccccccCCc-ceeeeeeccCCCCChhhhccC
Q 044312 375 IRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQT-HMTTQVHGTFGYLDPEYFRSS 453 (608)
Q Consensus 375 ~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGls~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~ 453 (608)
.+..++.|++.||+|||+.+ ++|+||||+|||+++++.+||+|||.++....... .......++..|+|||.+...
T Consensus 106 ~~~~~~~~l~~al~~lH~~~---i~H~di~p~nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~ 182 (262)
T cd00192 106 DLLSFAIQIAKGMEYLASKK---FVHRDLAARNCLVGEDLVVKISDFGLSRDVYDDDYYRKKTGGKLPIRWMAPESLKDG 182 (262)
T ss_pred HHHHHHHHHHHHHHHHHcCC---cccCccCcceEEECCCCcEEEcccccccccccccccccccCCCcCccccCHHHhccC
Confidence 99999999999999999998 99999999999999999999999999987754321 122344578899999999988
Q ss_pred CCCCccchHhHHHHHHHHHh-CCCCCCccchhhcccHHHHHHHHhhhhhhHHHhhhhhhccCChhHHHHHHHHHHHHhcc
Q 044312 454 QFTDKSDVYSFGVVLTELLT-GEKPIRFTILEEDKSLAAYFLCAMKEERLFEILDARVMKQGGKDEIITVAKLAKRCLNL 532 (608)
Q Consensus 454 ~~t~ksDV~S~Gvvl~ellt-g~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~Li~~cl~~ 532 (608)
.++.++||||||++++||++ |..||....... +..... .......+...+.++.+++.+||+.
T Consensus 183 ~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~-------~~~~~~---------~~~~~~~~~~~~~~~~~li~~~l~~ 246 (262)
T cd00192 183 IFTSKSDVWSFGVLLWEIFTLGATPYPGLSNEE-------VLEYLR---------KGYRLPKPEYCPDELYELMLSCWQL 246 (262)
T ss_pred CcchhhccHHHHHHHHHHHhcCCCCCCCCCHHH-------HHHHHH---------cCCCCCCCccCChHHHHHHHHHccC
Confidence 99999999999999999999 689986431110 111111 1111223344567899999999999
Q ss_pred CCCCCCCHHHHHHHHH
Q 044312 533 NGKKRPTMREVASELA 548 (608)
Q Consensus 533 dp~~RPs~~evl~~L~ 548 (608)
+|++|||+.|+++.|+
T Consensus 247 ~p~~Rps~~~l~~~l~ 262 (262)
T cd00192 247 DPEDRPTFSELVERLE 262 (262)
T ss_pred CcccCcCHHHHHHhhC
Confidence 9999999999998873
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-34 Score=290.38 Aligned_cols=228 Identities=22% Similarity=0.269 Sum_probs=176.8
Q ss_pred eEEEEEeec---ChhhHHHHHHHHHHHhhcCCCCccceecccccCccceEEEeecCCCccchhccccCCCCCCCHHHHHH
Q 044312 302 QAVKKSKVI---DESKVEEFINEVVILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEIRLR 378 (608)
Q Consensus 302 ~avk~~~~~---~~~~~~~~~~Ei~il~~l~H~niv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~ 378 (608)
+|+|.+... .......+..|++++++++||||+++++++.+....++||||+++++|.+++..... ..+++..+..
T Consensus 21 ~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g~~L~~~~~~~~~-~~~~~~~~~~ 99 (277)
T cd05607 21 YACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDLKYHIYNVGE-RGLEMERVIH 99 (277)
T ss_pred EEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecCCCCCHHHHHHhccc-cCCCHHHHHH
Confidence 466666431 122344567799999999999999999999999999999999999999988865433 2589999999
Q ss_pred HHHHHHHHHHHHhhcCCCCeeccCCCCCcEEEcCCCcEEEeeccCccccccCCcceeeeeeccCCCCChhhhccCCCCCc
Q 044312 379 IAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHGTFGYLDPEYFRSSQFTDK 458 (608)
Q Consensus 379 i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGls~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k 458 (608)
++.||+.||+|||+.+ ++||||||+|||+++++.+||+|||++....... ......|+..|+|||++.+..++.+
T Consensus 100 ~~~qi~~al~~lH~~~---ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~ 174 (277)
T cd05607 100 YSAQITCGILHLHSMD---IVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGK--TITQRAGTNGYMAPEILKEEPYSYP 174 (277)
T ss_pred HHHHHHHHHHHHHHCC---EEEccCChHhEEEcCCCCEEEeeceeeeecCCCc--eeeccCCCCCccCHHHHccCCCCCc
Confidence 9999999999999999 9999999999999999999999999987664322 2234568999999999999899999
Q ss_pred cchHhHHHHHHHHHhCCCCCCccchhhcccHHHHHHHHhhhhhhHHHhhhhhhccCChhHHHHHHHHHHHHhccCCCCCC
Q 044312 459 SDVYSFGVVLTELLTGEKPIRFTILEEDKSLAAYFLCAMKEERLFEILDARVMKQGGKDEIITVAKLAKRCLNLNGKKRP 538 (608)
Q Consensus 459 sDV~S~Gvvl~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RP 538 (608)
+|||||||+++||++|+.||........ ... . ....+..... ......+.++.+|+.+||+.||++||
T Consensus 175 ~DvwslGv~l~el~~g~~p~~~~~~~~~--~~~-~--------~~~~~~~~~~-~~~~~~~~~~~~li~~~L~~~P~~R~ 242 (277)
T cd05607 175 VDWFAMGCSIYEMVAGRTPFKDHKEKVA--KEE-L--------KRRTLEDEVK-FEHQNFTEESKDICRLFLAKKPEDRL 242 (277)
T ss_pred hhHHHHHHHHHHHHhCCCCCCCCcchhh--HHH-H--------HHHhhccccc-cccccCCHHHHHHHHHHhccCHhhCC
Confidence 9999999999999999999863221110 000 0 0011111110 01123456789999999999999999
Q ss_pred CHHHHHHHH
Q 044312 539 TMREVASEL 547 (608)
Q Consensus 539 s~~evl~~L 547 (608)
+++|+++.+
T Consensus 243 ~~~~~~~~~ 251 (277)
T cd05607 243 GSREKNDDP 251 (277)
T ss_pred CCccchhhh
Confidence 998876544
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-34 Score=291.23 Aligned_cols=242 Identities=27% Similarity=0.416 Sum_probs=182.6
Q ss_pred EEEEEeecChh-hHHHHHHHHHHHhhcCCCCccceeccccc--CccceEEEeecCCCccchhccccCCCCCCCHHHHHHH
Q 044312 303 AVKKSKVIDES-KVEEFINEVVILSQINHRNVVKLLGCCLE--TEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEIRLRI 379 (608)
Q Consensus 303 avk~~~~~~~~-~~~~~~~Ei~il~~l~H~niv~l~~~~~~--~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i 379 (608)
|||..+..... ..+.|.+|+++++.++|+||+++++++.. ....++||||+++++|.+++..... .+++..+..+
T Consensus 37 avK~~~~~~~~~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e~~~~~~l~~~l~~~~~--~~~~~~~~~~ 114 (284)
T cd05038 37 AVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKYKGVCEKPGGRSLRLIMEYLPSGSLRDYLQRHRD--QINLKRLLLF 114 (284)
T ss_pred EEEEeccccchHHHHHHHHHHHHHHhCCCCChheEEeeeecCCCCceEEEEecCCCCCHHHHHHhCcc--ccCHHHHHHH
Confidence 55655543332 46789999999999999999999999876 5578999999999999999976543 4899999999
Q ss_pred HHHHHHHHHHHhhcCCCCeeccCCCCCcEEEcCCCcEEEeeccCccccccCCcce--eeeeeccCCCCChhhhccCCCCC
Q 044312 380 AIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHM--TTQVHGTFGYLDPEYFRSSQFTD 457 (608)
Q Consensus 380 ~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGls~~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~t~ 457 (608)
+.|++.||+|||+.+ ++|+||||+|||++.++.+||+|||++.......... .....++..|+|||.+....++.
T Consensus 115 ~~~l~~aL~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~ 191 (284)
T cd05038 115 SSQICKGMDYLGSQR---YIHRDLAARNILVESEDLVKISDFGLAKVLPEDKDYYYVKEPGESPIFWYAPECLRTSKFSS 191 (284)
T ss_pred HHHHHHHHHHHHhCC---eecCCCCHHhEEEcCCCCEEEcccccccccccCCcceeccCCCCCcccccCcHHHccCCCCc
Confidence 999999999999998 9999999999999999999999999998765322211 11234456799999999889999
Q ss_pred ccchHhHHHHHHHHHhCCCCCCccchhhcccHHHHHHHHhhhhhhHHHhhhhhhccCChhHHHHHHHHHHHHhccCCCCC
Q 044312 458 KSDVYSFGVVLTELLTGEKPIRFTILEEDKSLAAYFLCAMKEERLFEILDARVMKQGGKDEIITVAKLAKRCLNLNGKKR 537 (608)
Q Consensus 458 ksDV~S~Gvvl~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~Li~~cl~~dp~~R 537 (608)
++||||||++++||++|+.|+............. .........+.+.+........+...+.++.+|+.+||+.+|++|
T Consensus 192 ~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~R 270 (284)
T cd05038 192 ASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGI-AQGQMIVTRLLELLKEGERLPRPPSCPDEVYDLMKLCWEAEPQDR 270 (284)
T ss_pred ccchHHHhhhhheeeccCCCcccccchhcccccc-ccccccHHHHHHHHHcCCcCCCCccCCHHHHHHHHHHhccChhhC
Confidence 9999999999999999999875322111000000 000000111112222222222233455789999999999999999
Q ss_pred CCHHHHHHHHHhh
Q 044312 538 PTMREVASELAGI 550 (608)
Q Consensus 538 Ps~~evl~~L~~i 550 (608)
||+.||+++|+.+
T Consensus 271 pt~~ei~~~l~~i 283 (284)
T cd05038 271 PSFADLILIVDRL 283 (284)
T ss_pred CCHHHHHHHHhhc
Confidence 9999999999876
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-34 Score=291.23 Aligned_cols=228 Identities=21% Similarity=0.247 Sum_probs=177.6
Q ss_pred eEEEEEeec---ChhhHHHHHHHHHHHhhcCCCCccceecccccCccceEEEeecCCCccchhccccC-CCCCCCHHHHH
Q 044312 302 QAVKKSKVI---DESKVEEFINEVVILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGTLFQYIHDQN-EDFPITWEIRL 377 (608)
Q Consensus 302 ~avk~~~~~---~~~~~~~~~~Ei~il~~l~H~niv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~-~~~~l~~~~~~ 377 (608)
+|+|+.... .....+.+..|+.++++++|+||+++.+++......++||||+++|+|.+++.... ....+++..++
T Consensus 21 ~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L~~~~~~~~~~~~~l~~~~~~ 100 (280)
T cd05608 21 YACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGDLRYHIYNVDEENPGFPEPRAC 100 (280)
T ss_pred EEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCCCCHHHHHHhccccCCCCCHHHHH
Confidence 577776532 22234677899999999999999999999999999999999999999988875422 22358999999
Q ss_pred HHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEEcCCCcEEEeeccCccccccCCcceeeeeeccCCCCChhhhccCCCCC
Q 044312 378 RIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHGTFGYLDPEYFRSSQFTD 457 (608)
Q Consensus 378 ~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGls~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ 457 (608)
.++.||+.||+|||+.+ |+||||||+|||+++++.+||+|||+++....... ......||+.|+|||++.+..++.
T Consensus 101 ~~~~qi~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~-~~~~~~g~~~y~aPE~~~~~~~~~ 176 (280)
T cd05608 101 FYTAQIISGLEHLHQRR---IIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQS-KTKGYAGTPGFMAPELLQGEEYDF 176 (280)
T ss_pred HHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEeeCccceecCCCCc-cccccCCCcCccCHHHhcCCCCCc
Confidence 99999999999999999 99999999999999999999999999976543322 223456899999999999999999
Q ss_pred ccchHhHHHHHHHHHhCCCCCCccchhhcccHHHHHHHHhhhhhhHHHhhhhhhccCChhHHHHHHHHHHHHhccCCCCC
Q 044312 458 KSDVYSFGVVLTELLTGEKPIRFTILEEDKSLAAYFLCAMKEERLFEILDARVMKQGGKDEIITVAKLAKRCLNLNGKKR 537 (608)
Q Consensus 458 ksDV~S~Gvvl~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~Li~~cl~~dp~~R 537 (608)
++||||||++++||++|+.||........ ... . ...++.. ....+...+..+.+++.+||+.||++|
T Consensus 177 ~~DvwslG~il~el~~g~~pf~~~~~~~~--~~~-~--------~~~~~~~--~~~~~~~~~~~~~~li~~~l~~~P~~R 243 (280)
T cd05608 177 SVDYFALGVTLYEMIAARGPFRARGEKVE--NKE-L--------KQRILND--SVTYPDKFSPASKSFCEALLAKDPEKR 243 (280)
T ss_pred cccHHHHHHHHHHHHhCCCCCCCCCcchh--HHH-H--------HHhhccc--CCCCcccCCHHHHHHHHHHhcCCHHHh
Confidence 99999999999999999999863221110 000 0 0011111 012233456789999999999999999
Q ss_pred C-----CHHHHHHH
Q 044312 538 P-----TMREVASE 546 (608)
Q Consensus 538 P-----s~~evl~~ 546 (608)
| +++|++++
T Consensus 244 ~~~~~~~~~~~l~h 257 (280)
T cd05608 244 LGFRDGNCDGLRTH 257 (280)
T ss_pred cCCCCCCHHHHhcC
Confidence 9 56666653
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-34 Score=295.27 Aligned_cols=220 Identities=25% Similarity=0.323 Sum_probs=173.7
Q ss_pred eEEEEEeec---ChhhHHHHHHHHHHHhhc-CCCCccceecccccCccceEEEeecCCCccchhccccCCCCCCCHHHHH
Q 044312 302 QAVKKSKVI---DESKVEEFINEVVILSQI-NHRNVVKLLGCCLETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEIRL 377 (608)
Q Consensus 302 ~avk~~~~~---~~~~~~~~~~Ei~il~~l-~H~niv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~ 377 (608)
+|||.++.. .....+.+..|..+++.+ +||||+++++++.+.+..++||||+++|+|.+++.... .+++..+.
T Consensus 23 vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~---~~~~~~~~ 99 (316)
T cd05619 23 FAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLNGGDLMFHIQSCH---KFDLPRAT 99 (316)
T ss_pred EEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCCCCCcHHHHHHHcC---CCCHHHHH
Confidence 477776542 223456677788888765 99999999999999999999999999999999987543 48999999
Q ss_pred HHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEEcCCCcEEEeeccCccccccCCcceeeeeeccCCCCChhhhccCCCCC
Q 044312 378 RIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHGTFGYLDPEYFRSSQFTD 457 (608)
Q Consensus 378 ~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGls~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ 457 (608)
.++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++....... ......||+.|+|||++.+..++.
T Consensus 100 ~~~~qi~~al~~LH~~~---ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~ 175 (316)
T cd05619 100 FYAAEIICGLQFLHSKG---IVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDA-KTCTFCGTPDYIAPEILLGQKYNT 175 (316)
T ss_pred HHHHHHHHHHHHHHhCC---eEeCCCCHHHEEECCCCCEEEccCCcceECCCCCC-ceeeecCCccccCHHHHcCCCCCc
Confidence 99999999999999999 99999999999999999999999999875432221 233456899999999999999999
Q ss_pred ccchHhHHHHHHHHHhCCCCCCccchhhcccHHHHHHHHhhhhhhHHHhhhhhhccCChhHHHHHHHHHHHHhccCCCCC
Q 044312 458 KSDVYSFGVVLTELLTGEKPIRFTILEEDKSLAAYFLCAMKEERLFEILDARVMKQGGKDEIITVAKLAKRCLNLNGKKR 537 (608)
Q Consensus 458 ksDV~S~Gvvl~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~Li~~cl~~dp~~R 537 (608)
++|||||||++|||++|+.||......+ ........ . ...+...+.++.+|+.+||+.||++|
T Consensus 176 ~~DvwslG~il~el~~G~~pf~~~~~~~-------~~~~i~~~------~----~~~~~~~~~~~~~li~~~l~~~P~~R 238 (316)
T cd05619 176 SVDWWSFGVLLYEMLIGQSPFHGHDEEE-------LFQSIRMD------N----PCYPRWLTREAKDILVKLFVREPERR 238 (316)
T ss_pred hhhhhhHHHHHHHHHhCCCCCCCCCHHH-------HHHHHHhC------C----CCCCccCCHHHHHHHHHHhccCHhhc
Confidence 9999999999999999999986432111 00011000 0 11122345678999999999999999
Q ss_pred CCHH-HHHH
Q 044312 538 PTMR-EVAS 545 (608)
Q Consensus 538 Ps~~-evl~ 545 (608)
|++. ++.+
T Consensus 239 ~~~~~~l~~ 247 (316)
T cd05619 239 LGVKGDIRQ 247 (316)
T ss_pred CCChHHHHc
Confidence 9997 5543
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-34 Score=306.57 Aligned_cols=238 Identities=23% Similarity=0.345 Sum_probs=183.1
Q ss_pred cCccccceeccCce---------------EEEEEeec---ChhhHHHHHHHHHHHhhcCCCCccceecccccCccceEEE
Q 044312 289 DNFDLNRILGQGGQ---------------AVKKSKVI---DESKVEEFINEVVILSQINHRNVVKLLGCCLETEVPLLVY 350 (608)
Q Consensus 289 ~~f~~~~~lG~G~~---------------avk~~~~~---~~~~~~~~~~Ei~il~~l~H~niv~l~~~~~~~~~~~lV~ 350 (608)
++|++.++||+|++ |||++... .....+.+.+|++++++++||||+++++++.+....+|||
T Consensus 1 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~ 80 (377)
T cd05629 1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQYLYLIM 80 (377)
T ss_pred CCceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCeeEEEE
Confidence 36888899999974 56655431 2334567889999999999999999999999999999999
Q ss_pred eecCCCccchhccccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEEcCCCcEEEeeccCccccccC
Q 044312 351 EFIPNGTLFQYIHDQNEDFPITWEIRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVD 430 (608)
Q Consensus 351 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGls~~~~~~ 430 (608)
||+++|+|.+++.... .+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++.+...
T Consensus 81 E~~~gg~L~~~l~~~~---~~~~~~~~~~~~ql~~aL~~LH~~g---ivHrDlkp~NIll~~~~~~kl~DfGla~~~~~~ 154 (377)
T cd05629 81 EFLPGGDLMTMLIKYD---TFSEDVTRFYMAECVLAIEAVHKLG---FIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQ 154 (377)
T ss_pred eCCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEECCCCCEEEeecccccccccc
Confidence 9999999999987543 5889999999999999999999999 999999999999999999999999999643210
Q ss_pred Ccc----------------------------------------------eeeeeeccCCCCChhhhccCCCCCccchHhH
Q 044312 431 QTH----------------------------------------------MTTQVHGTFGYLDPEYFRSSQFTDKSDVYSF 464 (608)
Q Consensus 431 ~~~----------------------------------------------~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~ 464 (608)
... ......||+.|+|||++.+..++.++|||||
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSl 234 (377)
T cd05629 155 HDSAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWSL 234 (377)
T ss_pred cccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCCCCceeeEec
Confidence 000 0012458999999999999999999999999
Q ss_pred HHHHHHHHhCCCCCCccchhhcccHHHHHHHHhhhhhhHHHhhhhhhccCChhHHHHHHHHHHHHhccCCCCC---CCHH
Q 044312 465 GVVLTELLTGEKPIRFTILEEDKSLAAYFLCAMKEERLFEILDARVMKQGGKDEIITVAKLAKRCLNLNGKKR---PTMR 541 (608)
Q Consensus 465 Gvvl~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~Li~~cl~~dp~~R---Ps~~ 541 (608)
||+++||++|+.||......+ .+....... ..+........+.++.+|+.+||. +|.+| |++.
T Consensus 235 Gvil~elltG~~Pf~~~~~~~------~~~~i~~~~-------~~~~~p~~~~~s~~~~dli~~lL~-~~~~r~~r~~~~ 300 (377)
T cd05629 235 GAIMFECLIGWPPFCSENSHE------TYRKIINWR-------ETLYFPDDIHLSVEAEDLIRRLIT-NAENRLGRGGAH 300 (377)
T ss_pred chhhhhhhcCCCCCCCCCHHH------HHHHHHccC-------CccCCCCCCCCCHHHHHHHHHHhc-CHhhcCCCCCHH
Confidence 999999999999996332211 011110000 001011112345678999999998 67765 5999
Q ss_pred HHHHH
Q 044312 542 EVASE 546 (608)
Q Consensus 542 evl~~ 546 (608)
|++++
T Consensus 301 ~~l~h 305 (377)
T cd05629 301 EIKSH 305 (377)
T ss_pred HHhcC
Confidence 98875
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=283.54 Aligned_cols=226 Identities=25% Similarity=0.444 Sum_probs=179.4
Q ss_pred eEEEEEeecCh-hhHHHHHHHHHHHhhcCCCCccceecccccCccceEEEeecCCCccchhccccCCCCCCCHHHHHHHH
Q 044312 302 QAVKKSKVIDE-SKVEEFINEVVILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEIRLRIA 380 (608)
Q Consensus 302 ~avk~~~~~~~-~~~~~~~~Ei~il~~l~H~niv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~ 380 (608)
+++|....... ...+.|.+|++++++++|+||+++++++.+....++||||+++++|.+++..... .+++..++.++
T Consensus 22 v~~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~l~~~l~~~~~--~~~~~~~~~~~ 99 (251)
T cd05041 22 VAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGGSLLTFLRKKKN--RLTVKKLLQMS 99 (251)
T ss_pred EEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEcCCCCcHHHHHHhcCC--CCCHHHHHHHH
Confidence 46776654333 3567899999999999999999999999999999999999999999999876433 48899999999
Q ss_pred HHHHHHHHHHhhcCCCCeeccCCCCCcEEEcCCCcEEEeeccCccccccCCccee-eeeeccCCCCChhhhccCCCCCcc
Q 044312 381 IEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMT-TQVHGTFGYLDPEYFRSSQFTDKS 459 (608)
Q Consensus 381 ~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGls~~~~~~~~~~~-~~~~gt~~y~aPE~~~~~~~t~ks 459 (608)
.+++.||+|||+++ ++||||||+|||++.++.+||+|||+++.......... .....+..|+|||.+.+..++.++
T Consensus 100 ~~~~~~l~~lH~~~---i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~ 176 (251)
T cd05041 100 LDAAAGMEYLESKN---CIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLKQIPIKWTAPEALNYGRYTSES 176 (251)
T ss_pred HHHHHHHHHHHhCC---EehhhcCcceEEEcCCCcEEEeeccccccccCCcceeccccCcceeccCChHhhccCCCCcch
Confidence 99999999999999 99999999999999999999999999876542111111 112335679999999988999999
Q ss_pred chHhHHHHHHHHHh-CCCCCCccchhhcccHHHHHHHHhhhhhhHHHhhhhhhccCChhHHHHHHHHHHHHhccCCCCCC
Q 044312 460 DVYSFGVVLTELLT-GEKPIRFTILEEDKSLAAYFLCAMKEERLFEILDARVMKQGGKDEIITVAKLAKRCLNLNGKKRP 538 (608)
Q Consensus 460 DV~S~Gvvl~ellt-g~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RP 538 (608)
||||||++++||+| |..||....... ....+........+...+.++.+++.+||+.+|++||
T Consensus 177 Di~slG~i~~~l~t~~~~p~~~~~~~~----------------~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp 240 (251)
T cd05041 177 DVWSYGILLWETFSLGDTPYPGMSNQQ----------------TRERIESGYRMPAPQLCPEEIYRLMLQCWAYDPENRP 240 (251)
T ss_pred hHHHHHHHHHHHHhccCCCCccCCHHH----------------HHHHHhcCCCCCCCccCCHHHHHHHHHHhccChhhCc
Confidence 99999999999999 788875332111 1111111111122334567899999999999999999
Q ss_pred CHHHHHHHHH
Q 044312 539 TMREVASELA 548 (608)
Q Consensus 539 s~~evl~~L~ 548 (608)
++.||++.|+
T Consensus 241 ~~~ell~~l~ 250 (251)
T cd05041 241 SFSEIYNELQ 250 (251)
T ss_pred CHHHHHHHhh
Confidence 9999999875
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-34 Score=299.17 Aligned_cols=216 Identities=27% Similarity=0.356 Sum_probs=173.3
Q ss_pred eEEEEEee---cChhhHHHHHHHHHHHhhc-CCCCccceecccccCccceEEEeecCCCccchhccccCCCCCCCHHHHH
Q 044312 302 QAVKKSKV---IDESKVEEFINEVVILSQI-NHRNVVKLLGCCLETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEIRL 377 (608)
Q Consensus 302 ~avk~~~~---~~~~~~~~~~~Ei~il~~l-~H~niv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~ 377 (608)
+|||.++. ......+.+..|..+++.+ +||||+++++++.+.+..++||||+++|+|.+++.... .+++..+.
T Consensus 23 ~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~~~g~L~~~i~~~~---~l~~~~~~ 99 (320)
T cd05590 23 YAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVNGGDLMFHIQKSR---RFDEARAR 99 (320)
T ss_pred EEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCCCCchHHHHHHHcC---CCCHHHHH
Confidence 47776653 2334566788899999877 79999999999999999999999999999999887643 48999999
Q ss_pred HHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEEcCCCcEEEeeccCccccccCCcceeeeeeccCCCCChhhhccCCCCC
Q 044312 378 RIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHGTFGYLDPEYFRSSQFTD 457 (608)
Q Consensus 378 ~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGls~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ 457 (608)
.++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++...... .......||+.|+|||++.+..++.
T Consensus 100 ~~~~ql~~~L~~lH~~~---ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~ 175 (320)
T cd05590 100 FYAAEITSALMFLHDKG---IIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNG-KTTSTFCGTPDYIAPEILQEMLYGP 175 (320)
T ss_pred HHHHHHHHHHHHHHHCC---eEeCCCCHHHeEECCCCcEEEeeCCCCeecCcCC-CcccccccCccccCHHHHcCCCCCC
Confidence 99999999999999999 9999999999999999999999999987543222 2233456899999999999999999
Q ss_pred ccchHhHHHHHHHHHhCCCCCCccchhhcccHHHHHHHHhhhhhhHHHhhhhhhccCChhHHHHHHHHHHHHhccCCCCC
Q 044312 458 KSDVYSFGVVLTELLTGEKPIRFTILEEDKSLAAYFLCAMKEERLFEILDARVMKQGGKDEIITVAKLAKRCLNLNGKKR 537 (608)
Q Consensus 458 ksDV~S~Gvvl~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~Li~~cl~~dp~~R 537 (608)
++||||||++++||++|+.||....... ... . +.... ...+...+.++.+|+.+||+.||++|
T Consensus 176 ~~DiwslG~il~el~~g~~Pf~~~~~~~------~~~-~--------i~~~~--~~~~~~~~~~~~~li~~~L~~dP~~R 238 (320)
T cd05590 176 SVDWWAMGVLLYEMLCGHAPFEAENEDD------LFE-A--------ILNDE--VVYPTWLSQDAVDILKAFMTKNPTMR 238 (320)
T ss_pred ccchhhhHHHHHHHhhCCCCCCCCCHHH------HHH-H--------HhcCC--CCCCCCCCHHHHHHHHHHcccCHHHC
Confidence 9999999999999999999996432211 110 1 11100 11222345678999999999999999
Q ss_pred CCHH
Q 044312 538 PTMR 541 (608)
Q Consensus 538 Ps~~ 541 (608)
|++.
T Consensus 239 ~~~~ 242 (320)
T cd05590 239 LGSL 242 (320)
T ss_pred CCCC
Confidence 9983
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-34 Score=298.44 Aligned_cols=223 Identities=25% Similarity=0.341 Sum_probs=174.8
Q ss_pred eEEEEEeec---ChhhHHHHHHHHHHHhhc-CCCCccceecccccCccceEEEeecCCCccchhccccCCCCCCCHHHHH
Q 044312 302 QAVKKSKVI---DESKVEEFINEVVILSQI-NHRNVVKLLGCCLETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEIRL 377 (608)
Q Consensus 302 ~avk~~~~~---~~~~~~~~~~Ei~il~~l-~H~niv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~ 377 (608)
+|+|..+.. +....+.+.+|+.++.++ +||||+++++++.+....++||||+++|+|.+++.... .+++..+.
T Consensus 23 ~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~---~l~~~~~~ 99 (327)
T cd05617 23 YAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVNGGDLMFHMQRQR---KLPEEHAR 99 (327)
T ss_pred EEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCCCCCcHHHHHHHcC---CCCHHHHH
Confidence 366766532 234556788999999888 69999999999999999999999999999998886543 58999999
Q ss_pred HHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEEcCCCcEEEeeccCccccccCCcceeeeeeccCCCCChhhhccCCCCC
Q 044312 378 RIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHGTFGYLDPEYFRSSQFTD 457 (608)
Q Consensus 378 ~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGls~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ 457 (608)
.++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++...... .......||+.|+|||++.+..++.
T Consensus 100 ~~~~qi~~al~~lH~~~---ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~ 175 (327)
T cd05617 100 FYAAEICIALNFLHERG---IIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPG-DTTSTFCGTPNYIAPEILRGEEYGF 175 (327)
T ss_pred HHHHHHHHHHHHHHHCC---eeccCCCHHHEEEeCCCCEEEeccccceeccCCC-CceecccCCcccCCHHHHCCCCCCc
Confidence 99999999999999999 9999999999999999999999999987533221 1223456899999999999999999
Q ss_pred ccchHhHHHHHHHHHhCCCCCCccchhhcccHHHHHHHHhhhhhhHHHhhhhhhccCChhHHHHHHHHHHHHhccCCCCC
Q 044312 458 KSDVYSFGVVLTELLTGEKPIRFTILEEDKSLAAYFLCAMKEERLFEILDARVMKQGGKDEIITVAKLAKRCLNLNGKKR 537 (608)
Q Consensus 458 ksDV~S~Gvvl~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~Li~~cl~~dp~~R 537 (608)
++||||||++++||++|+.||..................+.. . ....+...+..+.+++.+||+.||++|
T Consensus 176 ~~DiwslGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~--------~--~~~~p~~~~~~~~~li~~~L~~dP~~R 245 (327)
T cd05617 176 SVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVILE--------K--PIRIPRFLSVKASHVLKGFLNKDPKER 245 (327)
T ss_pred hheeehhHHHHHHHHhCCCCCCccCCCcccccHHHHHHHHHh--------C--CCCCCCCCCHHHHHHHHHHhccCHHHc
Confidence 999999999999999999999643222221111111111111 1 111233445678999999999999999
Q ss_pred CCHH
Q 044312 538 PTMR 541 (608)
Q Consensus 538 Ps~~ 541 (608)
|++.
T Consensus 246 ~~~~ 249 (327)
T cd05617 246 LGCQ 249 (327)
T ss_pred CCCC
Confidence 9853
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-34 Score=299.02 Aligned_cols=247 Identities=28% Similarity=0.425 Sum_probs=187.6
Q ss_pred hcCccccceeccCce--------------------EEEEEeec-ChhhHHHHHHHHHHHhhc-CCCCccceecccccC-c
Q 044312 288 TDNFDLNRILGQGGQ--------------------AVKKSKVI-DESKVEEFINEVVILSQI-NHRNVVKLLGCCLET-E 344 (608)
Q Consensus 288 t~~f~~~~~lG~G~~--------------------avk~~~~~-~~~~~~~~~~Ei~il~~l-~H~niv~l~~~~~~~-~ 344 (608)
.++|++.+.||+|+| |||.++.. .......+.+|+.+|.++ +|+||+++++++... .
T Consensus 6 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~ 85 (343)
T cd05103 6 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGG 85 (343)
T ss_pred hhHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCChHHHHHHHHHHHHHHhccCCccHhhhcceeecCCC
Confidence 356888999999874 44544432 223456788999999999 789999999988654 4
Q ss_pred cceEEEeecCCCccchhccccCC---------------------------------------------------------
Q 044312 345 VPLLVYEFIPNGTLFQYIHDQNE--------------------------------------------------------- 367 (608)
Q Consensus 345 ~~~lV~E~~~~gsL~~~l~~~~~--------------------------------------------------------- 367 (608)
..++||||+++|+|.++++....
T Consensus 86 ~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 165 (343)
T cd05103 86 PLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEE 165 (343)
T ss_pred ceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccchhhh
Confidence 67899999999999998864321
Q ss_pred -------CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEEcCCCcEEEeeccCccccccCCcc-eeeeee
Q 044312 368 -------DFPITWEIRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTH-MTTQVH 439 (608)
Q Consensus 368 -------~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGls~~~~~~~~~-~~~~~~ 439 (608)
...+++..+..++.||++||+|||+.+ |+||||||+|||+++++.+||+|||+++........ ......
T Consensus 166 ~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~ 242 (343)
T cd05103 166 AEQEDLYKKVLTLEDLICYSFQVAKGMEFLASRK---CIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDAR 242 (343)
T ss_pred hhhhhhhhccCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCccCeEEEcCCCcEEEEecccccccccCcchhhcCCCC
Confidence 123688899999999999999999999 999999999999999999999999999865432221 112234
Q ss_pred ccCCCCChhhhccCCCCCccchHhHHHHHHHHHh-CCCCCCccchhhcccHHHHHHHHhhhhhhHHHhhhhhhccCChhH
Q 044312 440 GTFGYLDPEYFRSSQFTDKSDVYSFGVVLTELLT-GEKPIRFTILEEDKSLAAYFLCAMKEERLFEILDARVMKQGGKDE 518 (608)
Q Consensus 440 gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~ellt-g~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~ 518 (608)
++..|+|||.+....++.++||||||++++||++ |..||....... .+...+... .....+...
T Consensus 243 ~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~------~~~~~~~~~---------~~~~~~~~~ 307 (343)
T cd05103 243 LPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDE------EFCRRLKEG---------TRMRAPDYT 307 (343)
T ss_pred CCcceECcHHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCccccH------HHHHHHhcc---------CCCCCCCCC
Confidence 5678999999998999999999999999999997 888986322110 011111111 111112223
Q ss_pred HHHHHHHHHHHhccCCCCCCCHHHHHHHHHhhHH
Q 044312 519 IITVAKLAKRCLNLNGKKRPTMREVASELAGIKA 552 (608)
Q Consensus 519 ~~~l~~Li~~cl~~dp~~RPs~~evl~~L~~i~~ 552 (608)
+.++.+++.+||+.+|++||++.||+++|+.+..
T Consensus 308 ~~~~~~~~~~cl~~~p~~Rps~~eil~~l~~~~~ 341 (343)
T cd05103 308 TPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQ 341 (343)
T ss_pred CHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 4578999999999999999999999999988754
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-34 Score=293.01 Aligned_cols=236 Identities=25% Similarity=0.409 Sum_probs=188.7
Q ss_pred cCccccceeccCce---------------EEEEEeecChhhHHHHHHHHHHHhhcCCCCccceecccccCccceEEEeec
Q 044312 289 DNFDLNRILGQGGQ---------------AVKKSKVIDESKVEEFINEVVILSQINHRNVVKLLGCCLETEVPLLVYEFI 353 (608)
Q Consensus 289 ~~f~~~~~lG~G~~---------------avk~~~~~~~~~~~~~~~Ei~il~~l~H~niv~l~~~~~~~~~~~lV~E~~ 353 (608)
.+|++.+.||+|++ ++|..........+.+.+|+.+++.++|+||+++++.+......++||||+
T Consensus 20 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~~~~lv~e~~ 99 (296)
T cd06654 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYL 99 (296)
T ss_pred cceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCcchHHHHHHHHHHHHhCCCCCEeeEEEEEEeCCEEEEeeccc
Confidence 46777888888863 556665545555678999999999999999999999999999999999999
Q ss_pred CCCccchhccccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEEcCCCcEEEeeccCccccccCCcc
Q 044312 354 PNGTLFQYIHDQNEDFPITWEIRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTH 433 (608)
Q Consensus 354 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGls~~~~~~~~~ 433 (608)
++++|.+++... .+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||++........
T Consensus 100 ~~~~L~~~~~~~----~~~~~~~~~i~~ql~~aL~~LH~~g---i~H~dLkp~Nill~~~~~~kl~dfg~~~~~~~~~~- 171 (296)
T cd06654 100 AGGSLTDVVTET----CMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS- 171 (296)
T ss_pred CCCCHHHHHHhc----CCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEcCCCCEEECccccchhcccccc-
Confidence 999999998643 4789999999999999999999999 99999999999999999999999999876543221
Q ss_pred eeeeeeccCCCCChhhhccCCCCCccchHhHHHHHHHHHhCCCCCCccchhhcccHHHHHHHHhhhhhhHHHhhhhhhcc
Q 044312 434 MTTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLTELLTGEKPIRFTILEEDKSLAAYFLCAMKEERLFEILDARVMKQ 513 (608)
Q Consensus 434 ~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~ 513 (608)
......+++.|+|||.+....++.++||||||++++||++|+.||....... .... ... .......
T Consensus 172 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~~-----~~~~-~~~--------~~~~~~~ 237 (296)
T cd06654 172 KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLR-----ALYL-IAT--------NGTPELQ 237 (296)
T ss_pred ccCcccCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHHH-----hHHH-Hhc--------CCCCCCC
Confidence 1223457889999999998889999999999999999999999986332211 0000 000 0000111
Q ss_pred CChhHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 044312 514 GGKDEIITVAKLAKRCLNLNGKKRPTMREVASE 546 (608)
Q Consensus 514 ~~~~~~~~l~~Li~~cl~~dp~~RPs~~evl~~ 546 (608)
.+...+..+.+++.+||..+|++||++.|++++
T Consensus 238 ~~~~~~~~l~~li~~~l~~~p~~Rpt~~eil~~ 270 (296)
T cd06654 238 NPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQH 270 (296)
T ss_pred CccccCHHHHHHHHHHCcCCcccCcCHHHHhhC
Confidence 223455678999999999999999999999874
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-34 Score=290.80 Aligned_cols=240 Identities=26% Similarity=0.384 Sum_probs=184.5
Q ss_pred HHhcCccccceeccCce---------------EEEEEeecChhhHHHHHHHHHHHhhc-CCCCccceecccccC------
Q 044312 286 KATDNFDLNRILGQGGQ---------------AVKKSKVIDESKVEEFINEVVILSQI-NHRNVVKLLGCCLET------ 343 (608)
Q Consensus 286 ~~t~~f~~~~~lG~G~~---------------avk~~~~~~~~~~~~~~~Ei~il~~l-~H~niv~l~~~~~~~------ 343 (608)
.+++.|++.+.||+|++ |+|..... ......+.+|+.+++++ +|+||+++++++...
T Consensus 3 ~~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~-~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~ 81 (272)
T cd06637 3 DPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVT-GDEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMD 81 (272)
T ss_pred ChhhhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcC-CccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCCC
Confidence 45677888888888864 55555432 33456789999999999 799999999998653
Q ss_pred ccceEEEeecCCCccchhccccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEEcCCCcEEEeeccC
Q 044312 344 EVPLLVYEFIPNGTLFQYIHDQNEDFPITWEIRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGA 423 (608)
Q Consensus 344 ~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGl 423 (608)
...++||||+++++|.+++..... ..+++..+..++.|++.||+|||+.+ |+|+||||+||++++++.+||+|||+
T Consensus 82 ~~~~iv~e~~~~~~L~~~l~~~~~-~~l~~~~~~~~~~qi~~~l~~LH~~~---ivh~dl~~~nili~~~~~~~l~Dfg~ 157 (272)
T cd06637 82 DQLWLVMEFCGAGSVTDLIKNTKG-NTLKEEWIAYICREILRGLSHLHQHK---VIHRDIKGQNVLLTENAEVKLVDFGV 157 (272)
T ss_pred cEEEEEEEcCCCCcHHHHHHhccC-CCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCCHHHEEECCCCCEEEccCCC
Confidence 357899999999999999876432 25899999999999999999999998 99999999999999999999999999
Q ss_pred ccccccCCcceeeeeeccCCCCChhhhc-----cCCCCCccchHhHHHHHHHHHhCCCCCCccchhhcccHHHHHHHHhh
Q 044312 424 SRSMAVDQTHMTTQVHGTFGYLDPEYFR-----SSQFTDKSDVYSFGVVLTELLTGEKPIRFTILEEDKSLAAYFLCAMK 498 (608)
Q Consensus 424 s~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~t~ksDV~S~Gvvl~elltg~~p~~~~~~~~~~~l~~~~~~~~~ 498 (608)
++....... ......|+..|+|||++. ...++.++|||||||+++||++|+.||....... ... ..
T Consensus 158 ~~~~~~~~~-~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~~~-----~~~--~~- 228 (272)
T cd06637 158 SAQLDRTVG-RRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMR-----ALF--LI- 228 (272)
T ss_pred ceecccccc-cCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCHHH-----HHH--HH-
Confidence 976543221 223456889999999986 3457889999999999999999999985221110 000 00
Q ss_pred hhhhHHHhhhhhhccCChhHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 044312 499 EERLFEILDARVMKQGGKDEIITVAKLAKRCLNLNGKKRPTMREVASE 546 (608)
Q Consensus 499 ~~~~~~~~d~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~evl~~ 546 (608)
.............+..+.+|+.+||..+|.+|||+.|++++
T Consensus 229 -------~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~ 269 (272)
T cd06637 229 -------PRNPAPRLKSKKWSKKFQSFIESCLVKNHSQRPTTEQLMKH 269 (272)
T ss_pred -------hcCCCCCCCCCCcCHHHHHHHHHHcCCChhhCCCHHHHhhC
Confidence 00001111122345679999999999999999999999753
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-34 Score=285.23 Aligned_cols=232 Identities=28% Similarity=0.493 Sum_probs=184.0
Q ss_pred CccccceeccCce-------------EEEEEeecChhhHHHHHHHHHHHhhcCCCCccceecccccCccceEEEeecCCC
Q 044312 290 NFDLNRILGQGGQ-------------AVKKSKVIDESKVEEFINEVVILSQINHRNVVKLLGCCLETEVPLLVYEFIPNG 356 (608)
Q Consensus 290 ~f~~~~~lG~G~~-------------avk~~~~~~~~~~~~~~~Ei~il~~l~H~niv~l~~~~~~~~~~~lV~E~~~~g 356 (608)
+|.+.+.||+|++ |+|..+. ....+.+.+|+.++++++|||++++++++... ..++||||++++
T Consensus 7 ~~~~~~~lg~g~~g~v~~~~~~~~~~~iK~~~~--~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~~v~e~~~~~ 83 (254)
T cd05083 7 KLTLGEIIGEGEFGAVLQGEYTGQKVAVKNIKC--DVTAQAFLEETAVMTKLHHKNLVRLLGVILHN-GLYIVMELMSKG 83 (254)
T ss_pred HceeeeeeccCCCCceEecccCCCceEEEeecC--cchHHHHHHHHHHHHhCCCCCcCeEEEEEcCC-CcEEEEECCCCC
Confidence 4777888888874 5665543 22456899999999999999999999998654 479999999999
Q ss_pred ccchhccccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEEcCCCcEEEeeccCccccccCCcceee
Q 044312 357 TLFQYIHDQNEDFPITWEIRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTT 436 (608)
Q Consensus 357 sL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGls~~~~~~~~~~~~ 436 (608)
+|.+++..... ..+++..++.++.|++.||.|||+.+ ++||||||+|||++.++.+||+|||+++...... .
T Consensus 84 ~L~~~l~~~~~-~~~~~~~~~~~~~qi~~al~~lH~~~---~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~~~~----~ 155 (254)
T cd05083 84 NLVNFLRTRGR-ALVSVIQLLQFSLDVAEGMEYLESKK---LVHRDLAARNILVSEDGVAKVSDFGLARVGSMGV----D 155 (254)
T ss_pred CHHHHHHhcCc-CCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccCcceEEEcCCCcEEECCCccceeccccC----C
Confidence 99999976433 25899999999999999999999998 9999999999999999999999999987543211 1
Q ss_pred eeeccCCCCChhhhccCCCCCccchHhHHHHHHHHHh-CCCCCCccchhhcccHHHHHHHHhhhhhhHHHhhhhhhccCC
Q 044312 437 QVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLTELLT-GEKPIRFTILEEDKSLAAYFLCAMKEERLFEILDARVMKQGG 515 (608)
Q Consensus 437 ~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~ellt-g~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~ 515 (608)
....+..|+|||++.+..++.++||||||++++||++ |+.||......+ . .+.+.........
T Consensus 156 ~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~------~----------~~~~~~~~~~~~~ 219 (254)
T cd05083 156 NSKLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSLKE------V----------KECVEKGYRMEPP 219 (254)
T ss_pred CCCCCceecCHHHhccCCcCchhhHHHHHHHHHHHHhCCCCCCccCCHHH------H----------HHHHhCCCCCCCC
Confidence 2234567999999998899999999999999999998 899986332211 0 1111111112223
Q ss_pred hhHHHHHHHHHHHHhccCCCCCCCHHHHHHHHH
Q 044312 516 KDEIITVAKLAKRCLNLNGKKRPTMREVASELA 548 (608)
Q Consensus 516 ~~~~~~l~~Li~~cl~~dp~~RPs~~evl~~L~ 548 (608)
...+..+.+++.+||+.+|++||++++|++.|+
T Consensus 220 ~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~ 252 (254)
T cd05083 220 EGCPADVYVLMTSCWETEPKKRPSFHKLREKLE 252 (254)
T ss_pred CcCCHHHHHHHHHHcCCChhhCcCHHHHHHHHc
Confidence 345678999999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-34 Score=293.43 Aligned_cols=242 Identities=26% Similarity=0.489 Sum_probs=185.5
Q ss_pred cCccccceeccCce-------------------EEEEEeecC-hhhHHHHHHHHHHHhhcCCCCccceecccccCccceE
Q 044312 289 DNFDLNRILGQGGQ-------------------AVKKSKVID-ESKVEEFINEVVILSQINHRNVVKLLGCCLETEVPLL 348 (608)
Q Consensus 289 ~~f~~~~~lG~G~~-------------------avk~~~~~~-~~~~~~~~~Ei~il~~l~H~niv~l~~~~~~~~~~~l 348 (608)
+.|+..+.||+|++ |+|...... .....++.+|+.+++.++||||+++++++... ..++
T Consensus 7 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~-~~~~ 85 (303)
T cd05110 7 TELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRLLGVCLSP-TIQL 85 (303)
T ss_pred hhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEcCC-Ccee
Confidence 34566778888874 333333221 22345789999999999999999999998654 4679
Q ss_pred EEeecCCCccchhccccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEEcCCCcEEEeeccCccccc
Q 044312 349 VYEFIPNGTLFQYIHDQNEDFPITWEIRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMA 428 (608)
Q Consensus 349 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGls~~~~ 428 (608)
++||+++|+|.+++..... .+++..++.++.|++.||+|||+.+ |+||||||+|||+++++.+||+|||+++...
T Consensus 86 v~e~~~~g~l~~~~~~~~~--~~~~~~~~~~~~qi~~~L~~LH~~~---ivH~dikp~Nill~~~~~~kL~Dfg~~~~~~ 160 (303)
T cd05110 86 VTQLMPHGCLLDYVHEHKD--NIGSQLLLNWCVQIAKGMMYLEERR---LVHRDLAARNVLVKSPNHVKITDFGLARLLE 160 (303)
T ss_pred eehhcCCCCHHHHHHhccc--CCCHHHHHHHHHHHHHHHHHHhhcC---eeccccccceeeecCCCceEEcccccccccc
Confidence 9999999999999876433 4899999999999999999999998 9999999999999999999999999998764
Q ss_pred cCCcc-eeeeeeccCCCCChhhhccCCCCCccchHhHHHHHHHHHh-CCCCCCccchhhcccHHHHHHHHhhhhhhHHHh
Q 044312 429 VDQTH-MTTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLTELLT-GEKPIRFTILEEDKSLAAYFLCAMKEERLFEIL 506 (608)
Q Consensus 429 ~~~~~-~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~ellt-g~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 506 (608)
..... ......++..|+|||++.+..++.++||||||++++||++ |+.||....... . .+++
T Consensus 161 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t~g~~p~~~~~~~~---~-------------~~~~ 224 (303)
T cd05110 161 GDEKEYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTRE---I-------------PDLL 224 (303)
T ss_pred CcccccccCCCccccccCCHHHhccCCCChHHHHHHHHHHHHHHHhCCCCCCCCCCHHH---H-------------HHHH
Confidence 32221 1222345678999999999999999999999999999998 889986322111 0 1111
Q ss_pred hhhhhccCChhHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhhHH
Q 044312 507 DARVMKQGGKDEIITVAKLAKRCLNLNGKKRPTMREVASELAGIKA 552 (608)
Q Consensus 507 d~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~evl~~L~~i~~ 552 (608)
........+...+..+.+++.+||..+|++||+++++++.|+.+..
T Consensus 225 ~~~~~~~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~l~~~l~~~~~ 270 (303)
T cd05110 225 EKGERLPQPPICTIDVYMVMVKCWMIDADSRPKFKELAAEFSRMAR 270 (303)
T ss_pred HCCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHh
Confidence 1111111222345678999999999999999999999999887644
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-34 Score=297.67 Aligned_cols=227 Identities=26% Similarity=0.363 Sum_probs=180.6
Q ss_pred CccccceeccCce---------------EEEEEee---cChhhHHHHHHHHHHHhhcCC-CCccceecccccCccceEEE
Q 044312 290 NFDLNRILGQGGQ---------------AVKKSKV---IDESKVEEFINEVVILSQINH-RNVVKLLGCCLETEVPLLVY 350 (608)
Q Consensus 290 ~f~~~~~lG~G~~---------------avk~~~~---~~~~~~~~~~~Ei~il~~l~H-~niv~l~~~~~~~~~~~lV~ 350 (608)
+|++.+.||+|++ |||..+. ......+.+..|.++++.++| ++|+++++++.+.+..++||
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (324)
T cd05587 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVM 80 (324)
T ss_pred CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEEEE
Confidence 4777888998874 6666553 233456778899999999966 56889999999999999999
Q ss_pred eecCCCccchhccccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEEcCCCcEEEeeccCccccccC
Q 044312 351 EFIPNGTLFQYIHDQNEDFPITWEIRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVD 430 (608)
Q Consensus 351 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGls~~~~~~ 430 (608)
||+++|+|.+++.... .+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++.....
T Consensus 81 E~~~~g~L~~~~~~~~---~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~ 154 (324)
T cd05587 81 EYVNGGDLMYHIQQVG---KFKEPHAVFYAAEIAIGLFFLHSKG---IIYRDLKLDNVMLDAEGHIKIADFGMCKENIFG 154 (324)
T ss_pred cCCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEEcCCCCEEEeecCcceecCCC
Confidence 9999999999887543 4899999999999999999999999 999999999999999999999999998754322
Q ss_pred CcceeeeeeccCCCCChhhhccCCCCCccchHhHHHHHHHHHhCCCCCCccchhhcccHHHHHHHHhhhhhhHHHhhhhh
Q 044312 431 QTHMTTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLTELLTGEKPIRFTILEEDKSLAAYFLCAMKEERLFEILDARV 510 (608)
Q Consensus 431 ~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~ 510 (608)
. .......||+.|+|||++.+..++.++||||||++++||+||+.||......+ .+ ..+...
T Consensus 155 ~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~------~~---------~~i~~~-- 216 (324)
T cd05587 155 G-KTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDE------LF---------QSIMEH-- 216 (324)
T ss_pred C-CceeeecCCccccChhhhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHH------HH---------HHHHcC--
Confidence 2 12334568999999999999999999999999999999999999986322111 01 011111
Q ss_pred hccCChhHHHHHHHHHHHHhccCCCCCCCH
Q 044312 511 MKQGGKDEIITVAKLAKRCLNLNGKKRPTM 540 (608)
Q Consensus 511 ~~~~~~~~~~~l~~Li~~cl~~dp~~RPs~ 540 (608)
....+...+.++.+++.+||+.||.+||+.
T Consensus 217 ~~~~~~~~~~~~~~li~~~l~~~P~~R~~~ 246 (324)
T cd05587 217 NVSYPKSLSKEAVSICKGLLTKHPAKRLGC 246 (324)
T ss_pred CCCCCCCCCHHHHHHHHHHhhcCHHHcCCC
Confidence 112233456678999999999999999986
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-33 Score=284.05 Aligned_cols=236 Identities=24% Similarity=0.378 Sum_probs=185.3
Q ss_pred CccccceeccCce---------------EEEEEeec--ChhhHHHHHHHHHHHhhcCCCCccceeccccc-CccceEEEe
Q 044312 290 NFDLNRILGQGGQ---------------AVKKSKVI--DESKVEEFINEVVILSQINHRNVVKLLGCCLE-TEVPLLVYE 351 (608)
Q Consensus 290 ~f~~~~~lG~G~~---------------avk~~~~~--~~~~~~~~~~Ei~il~~l~H~niv~l~~~~~~-~~~~~lV~E 351 (608)
+|++.+.||+|++ ++|+.... .....+.+.+|++++++++|+|++++++.+.. ....+++||
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e 80 (257)
T cd08223 1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVMG 80 (257)
T ss_pred CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEEEec
Confidence 3667777887763 66666432 23445678999999999999999999998764 446789999
Q ss_pred ecCCCccchhccccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEEcCCCcEEEeeccCccccccCC
Q 044312 352 FIPNGTLFQYIHDQNEDFPITWEIRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQ 431 (608)
Q Consensus 352 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGls~~~~~~~ 431 (608)
|+++++|.+++..... ..+++.++..++.+++.||+|||+.+ ++|+||||+||+++.++.++|+|||++.......
T Consensus 81 ~~~~~~l~~~l~~~~~-~~l~~~~~~~~~~~l~~~l~~lH~~~---i~H~di~p~nil~~~~~~~~l~df~~~~~~~~~~ 156 (257)
T cd08223 81 FCEGGDLYHKLKEQKG-KLLPENQVVEWFVQIAMALQYLHEKH---ILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQC 156 (257)
T ss_pred ccCCCcHHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCchhEEEecCCcEEEecccceEEecccC
Confidence 9999999999976432 25899999999999999999999999 9999999999999999999999999998664322
Q ss_pred cceeeeeeccCCCCChhhhccCCCCCccchHhHHHHHHHHHhCCCCCCccchhhcccHHHHHHHHhhhhhhHHHhhhhhh
Q 044312 432 THMTTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLTELLTGEKPIRFTILEEDKSLAAYFLCAMKEERLFEILDARVM 511 (608)
Q Consensus 432 ~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~ 511 (608)
. ......+++.|+|||++.+..++.++||||||++++||++|+.||...... .... ..... ..
T Consensus 157 ~-~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~------~~~~-~~~~~---------~~ 219 (257)
T cd08223 157 D-MASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKDMN------SLVY-RIIEG---------KL 219 (257)
T ss_pred C-ccccccCCcCccChhHhcCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHH------HHHH-HHHhc---------CC
Confidence 2 223445789999999999999999999999999999999999998632211 1110 01111 11
Q ss_pred ccCChhHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 044312 512 KQGGKDEIITVAKLAKRCLNLNGKKRPTMREVASE 546 (608)
Q Consensus 512 ~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~evl~~ 546 (608)
...+...+..+.+++.+||+.+|++||++.|++++
T Consensus 220 ~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~ 254 (257)
T cd08223 220 PPMPKDYSPELGELIATMLSKRPEKRPSVKSILRQ 254 (257)
T ss_pred CCCccccCHHHHHHHHHHhccCcccCCCHHHHhcC
Confidence 12233456789999999999999999999999854
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-34 Score=295.79 Aligned_cols=251 Identities=23% Similarity=0.332 Sum_probs=184.8
Q ss_pred cCccccceeccCce---------------EEEEEeecC-hhhHHHHHHHHHHHhhcCCCCccceecccccCccceEEEee
Q 044312 289 DNFDLNRILGQGGQ---------------AVKKSKVID-ESKVEEFINEVVILSQINHRNVVKLLGCCLETEVPLLVYEF 352 (608)
Q Consensus 289 ~~f~~~~~lG~G~~---------------avk~~~~~~-~~~~~~~~~Ei~il~~l~H~niv~l~~~~~~~~~~~lV~E~ 352 (608)
++|.+.+.||+|++ |+|..+... ......+.+|+.++++++||||+++++++...+..++||||
T Consensus 6 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 85 (309)
T cd07872 6 ETYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIVHTDKSLTLVFEY 85 (309)
T ss_pred CceEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccCCcchhHHHHHHHHHhCCCCCcceEEEEEeeCCeEEEEEeC
Confidence 45788888999874 666665432 23345688999999999999999999999999999999999
Q ss_pred cCCCccchhccccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEEcCCCcEEEeeccCccccccCCc
Q 044312 353 IPNGTLFQYIHDQNEDFPITWEIRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQT 432 (608)
Q Consensus 353 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGls~~~~~~~~ 432 (608)
+++ +|.+++..... .+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++.......
T Consensus 86 ~~~-~l~~~~~~~~~--~~~~~~~~~~~~qi~~aL~~lH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~ 159 (309)
T cd07872 86 LDK-DLKQYMDDCGN--IMSMHNVKIFLYQILRGLAYCHRRK---VLHRDLKPQNLLINERGELKLADFGLARAKSVPTK 159 (309)
T ss_pred CCC-CHHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEECccccceecCCCcc
Confidence 975 88888765432 4889999999999999999999999 99999999999999999999999999976543221
Q ss_pred ceeeeeeccCCCCChhhhcc-CCCCCccchHhHHHHHHHHHhCCCCCCccchhhcccHHHHHHHHhhhhhhHHHh-----
Q 044312 433 HMTTQVHGTFGYLDPEYFRS-SQFTDKSDVYSFGVVLTELLTGEKPIRFTILEEDKSLAAYFLCAMKEERLFEIL----- 506 (608)
Q Consensus 433 ~~~~~~~gt~~y~aPE~~~~-~~~t~ksDV~S~Gvvl~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~----- 506 (608)
......+++.|+|||.+.+ ..++.++||||||++++||+||+.||......+...................+.
T Consensus 160 -~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (309)
T cd07872 160 -TYSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTEETWPGISSNDEF 238 (309)
T ss_pred -ccccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhhcchhhh
Confidence 1223457899999999865 468999999999999999999999997543322111110000000000000000
Q ss_pred -hhhhhc-------cCChhHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 044312 507 -DARVMK-------QGGKDEIITVAKLAKRCLNLNGKKRPTMREVASE 546 (608)
Q Consensus 507 -d~~~~~-------~~~~~~~~~l~~Li~~cl~~dp~~RPs~~evl~~ 546 (608)
+..... ......+.++.+|+.+||+.||.+|||+.|++++
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h 286 (309)
T cd07872 239 KNYNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMKH 286 (309)
T ss_pred hhhhcCccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHHHhcC
Confidence 000000 0112345678899999999999999999999864
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-34 Score=306.10 Aligned_cols=235 Identities=22% Similarity=0.318 Sum_probs=181.6
Q ss_pred CccccceeccCce---------------EEEEEeec---ChhhHHHHHHHHHHHhhcCCCCccceecccccCccceEEEe
Q 044312 290 NFDLNRILGQGGQ---------------AVKKSKVI---DESKVEEFINEVVILSQINHRNVVKLLGCCLETEVPLLVYE 351 (608)
Q Consensus 290 ~f~~~~~lG~G~~---------------avk~~~~~---~~~~~~~~~~Ei~il~~l~H~niv~l~~~~~~~~~~~lV~E 351 (608)
.|++.++||+|+| |+|.+... .....+.+.+|+.++++++|+||+++++.+.+.+..+||||
T Consensus 2 ~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~~lv~E 81 (382)
T cd05625 2 MFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMD 81 (382)
T ss_pred CcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEEEEEEe
Confidence 5788899999985 55655432 23445678999999999999999999999999999999999
Q ss_pred ecCCCccchhccccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEEcCCCcEEEeeccCccccccCC
Q 044312 352 FIPNGTLFQYIHDQNEDFPITWEIRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQ 431 (608)
Q Consensus 352 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGls~~~~~~~ 431 (608)
|+++|+|.+++.+.. .+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++......
T Consensus 82 ~~~gg~L~~~l~~~~---~~~e~~~~~~~~qi~~al~~lH~~~---ivHrDlKp~NILl~~~g~~kL~DFGla~~~~~~~ 155 (382)
T cd05625 82 YIPGGDMMSLLIRMG---IFPEDLARFYIAELTCAVESVHKMG---FIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTH 155 (382)
T ss_pred CCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEEeECCCCccccccc
Confidence 999999999987643 4889999999999999999999999 9999999999999999999999999975321000
Q ss_pred ----------------------------------------------cceeeeeeccCCCCChhhhccCCCCCccchHhHH
Q 044312 432 ----------------------------------------------THMTTQVHGTFGYLDPEYFRSSQFTDKSDVYSFG 465 (608)
Q Consensus 432 ----------------------------------------------~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~G 465 (608)
........||+.|+|||++.+..++.++||||||
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlG 235 (382)
T cd05625 156 DSKYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVG 235 (382)
T ss_pred cccccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCCCCeeeEEech
Confidence 0001224689999999999999999999999999
Q ss_pred HHHHHHHhCCCCCCccchhhcccHHHHHHHHhhhhhhHHHhh--hhhhccCChhHHHHHHHHHHHHhccCCCCCCC---H
Q 044312 466 VVLTELLTGEKPIRFTILEEDKSLAAYFLCAMKEERLFEILD--ARVMKQGGKDEIITVAKLAKRCLNLNGKKRPT---M 540 (608)
Q Consensus 466 vvl~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d--~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPs---~ 540 (608)
|+|+||++|+.||......+. ...++. ...........+.++.+++.+++ .+|++|++ +
T Consensus 236 vil~elltG~~Pf~~~~~~~~---------------~~~i~~~~~~~~~p~~~~~s~~~~~li~~l~-~~p~~R~~~~~~ 299 (382)
T cd05625 236 VILYEMLVGQPPFLAQTPLET---------------QMKVINWQTSLHIPPQAKLSPEASDLIIKLC-RGPEDRLGKNGA 299 (382)
T ss_pred HHHHHHHhCCCCCCCCCHHHH---------------HHHHHccCCCcCCCCcccCCHHHHHHHHHHc-cCHhHcCCCCCH
Confidence 999999999999974322110 001111 01111112234567888888876 59999997 7
Q ss_pred HHHHHH
Q 044312 541 REVASE 546 (608)
Q Consensus 541 ~evl~~ 546 (608)
.|++++
T Consensus 300 ~ei~~h 305 (382)
T cd05625 300 DEIKAH 305 (382)
T ss_pred HHHhcC
Confidence 777653
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-34 Score=296.93 Aligned_cols=221 Identities=24% Similarity=0.337 Sum_probs=176.9
Q ss_pred eEEEEEeec---ChhhHHHHHHHHHHHhhc-CCCCccceecccccCccceEEEeecCCCccchhccccCCCCCCCHHHHH
Q 044312 302 QAVKKSKVI---DESKVEEFINEVVILSQI-NHRNVVKLLGCCLETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEIRL 377 (608)
Q Consensus 302 ~avk~~~~~---~~~~~~~~~~Ei~il~~l-~H~niv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~ 377 (608)
+|||.++.. .....+.+.+|+.+++.+ +||||+++++++.+.+..++||||+++++|..++.... .+++..+.
T Consensus 23 ~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~---~l~~~~~~ 99 (318)
T cd05570 23 YAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVNGGDLMFHIQRSG---RFDEPRAR 99 (318)
T ss_pred EEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCCCCHHHHHHHcC---CCCHHHHH
Confidence 477776532 234456788899999888 79999999999999999999999999999998887643 48999999
Q ss_pred HHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEEcCCCcEEEeeccCccccccCCcceeeeeeccCCCCChhhhccCCCCC
Q 044312 378 RIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHGTFGYLDPEYFRSSQFTD 457 (608)
Q Consensus 378 ~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGls~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ 457 (608)
.++.||+.||+|||+.+ |+||||||+|||+++++.+||+|||+++....... ......|++.|+|||++.+..++.
T Consensus 100 ~~~~qi~~~l~~LH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~-~~~~~~g~~~y~aPE~~~~~~~~~ 175 (318)
T cd05570 100 FYAAEIVLGLQFLHERG---IIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGV-TTSTFCGTPDYIAPEILSYQPYGP 175 (318)
T ss_pred HHHHHHHHHHHHHHhCC---eEccCCCHHHeEECCCCcEEecccCCCeecCcCCC-cccceecCccccCHHHhcCCCCCc
Confidence 99999999999999999 99999999999999999999999999875332221 223456899999999999999999
Q ss_pred ccchHhHHHHHHHHHhCCCCCCccchhhcccHHHHHHHHhhhhhhHHHhhhhhhccCChhHHHHHHHHHHHHhccCCCCC
Q 044312 458 KSDVYSFGVVLTELLTGEKPIRFTILEEDKSLAAYFLCAMKEERLFEILDARVMKQGGKDEIITVAKLAKRCLNLNGKKR 537 (608)
Q Consensus 458 ksDV~S~Gvvl~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~Li~~cl~~dp~~R 537 (608)
++|||||||+++||++|+.||...... ..+ ..+ .... ...+...+..+.+|+.+||+.||++|
T Consensus 176 ~~DiwslGvil~~l~~G~~pf~~~~~~------~~~-~~i--------~~~~--~~~~~~~~~~~~~li~~~l~~dP~~R 238 (318)
T cd05570 176 AVDWWALGVLLYEMLAGQSPFEGDDED------ELF-QSI--------LEDE--VRYPRWLSKEAKSILKSFLTKNPEKR 238 (318)
T ss_pred chhhhhHHHHHHHHhhCCCCCCCCCHH------HHH-HHH--------HcCC--CCCCCcCCHHHHHHHHHHccCCHHHc
Confidence 999999999999999999998633211 111 111 1110 11223456689999999999999999
Q ss_pred CCH-----HHHHHH
Q 044312 538 PTM-----REVASE 546 (608)
Q Consensus 538 Ps~-----~evl~~ 546 (608)
|++ .+++++
T Consensus 239 ~s~~~~~~~~ll~~ 252 (318)
T cd05570 239 LGCLPTGEQDIKGH 252 (318)
T ss_pred CCCCCCCHHHHhcC
Confidence 999 777653
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-34 Score=297.83 Aligned_cols=227 Identities=26% Similarity=0.354 Sum_probs=180.4
Q ss_pred CccccceeccCce---------------EEEEEeec---ChhhHHHHHHHHHHHhhc-CCCCccceecccccCccceEEE
Q 044312 290 NFDLNRILGQGGQ---------------AVKKSKVI---DESKVEEFINEVVILSQI-NHRNVVKLLGCCLETEVPLLVY 350 (608)
Q Consensus 290 ~f~~~~~lG~G~~---------------avk~~~~~---~~~~~~~~~~Ei~il~~l-~H~niv~l~~~~~~~~~~~lV~ 350 (608)
+|++.+.||+|++ |+|.++.. .....+.+..|..++..+ +|++|+++++++.+.+..++||
T Consensus 1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05616 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFVM 80 (323)
T ss_pred CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEEEE
Confidence 4777888999874 56655431 233445677888888877 6899999999999999999999
Q ss_pred eecCCCccchhccccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEEcCCCcEEEeeccCccccccC
Q 044312 351 EFIPNGTLFQYIHDQNEDFPITWEIRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVD 430 (608)
Q Consensus 351 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGls~~~~~~ 430 (608)
||+++|+|.+++.... .+++..+..++.||+.||+|||+.+ |+||||||+|||+++++.+||+|||+++.....
T Consensus 81 E~~~~g~L~~~~~~~~---~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~kL~DfG~~~~~~~~ 154 (323)
T cd05616 81 EYVNGGDLMYQIQQVG---RFKEPHAVFYAAEIAIGLFFLHSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKENMWD 154 (323)
T ss_pred cCCCCCCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---EEecCCCHHHeEECCCCcEEEccCCCceecCCC
Confidence 9999999999887543 4899999999999999999999999 999999999999999999999999999754322
Q ss_pred CcceeeeeeccCCCCChhhhccCCCCCccchHhHHHHHHHHHhCCCCCCccchhhcccHHHHHHHHhhhhhhHHHhhhhh
Q 044312 431 QTHMTTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLTELLTGEKPIRFTILEEDKSLAAYFLCAMKEERLFEILDARV 510 (608)
Q Consensus 431 ~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~ 510 (608)
. .......||+.|+|||++....++.++|||||||+++||+||+.||....... .+ ..+....
T Consensus 155 ~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~------~~---------~~i~~~~- 217 (323)
T cd05616 155 G-VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDE------LF---------QSIMEHN- 217 (323)
T ss_pred C-CccccCCCChhhcCHHHhcCCCCCCccchhchhHHHHHHHhCCCCCCCCCHHH------HH---------HHHHhCC-
Confidence 2 12334568999999999999999999999999999999999999996432111 01 1111111
Q ss_pred hccCChhHHHHHHHHHHHHhccCCCCCCCH
Q 044312 511 MKQGGKDEIITVAKLAKRCLNLNGKKRPTM 540 (608)
Q Consensus 511 ~~~~~~~~~~~l~~Li~~cl~~dp~~RPs~ 540 (608)
...+...+.++.+|+.+||+.+|++|++.
T Consensus 218 -~~~p~~~s~~~~~li~~~l~~~p~~R~~~ 246 (323)
T cd05616 218 -VAYPKSMSKEAVAICKGLMTKHPGKRLGC 246 (323)
T ss_pred -CCCCCcCCHHHHHHHHHHcccCHHhcCCC
Confidence 12233456788999999999999999985
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-34 Score=297.71 Aligned_cols=221 Identities=24% Similarity=0.320 Sum_probs=176.4
Q ss_pred eEEEEEeec---ChhhHHHHHHHHHHHhhc-CCCCccceecccccCccceEEEeecCCCccchhccccCCCCCCCHHHHH
Q 044312 302 QAVKKSKVI---DESKVEEFINEVVILSQI-NHRNVVKLLGCCLETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEIRL 377 (608)
Q Consensus 302 ~avk~~~~~---~~~~~~~~~~Ei~il~~l-~H~niv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~ 377 (608)
+|+|..+.. .....+.+..|.++++.+ +||||+++++++.+.+..+|||||+++++|..++.... .+++..+.
T Consensus 23 ~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~~L~~~l~~~~---~~~~~~~~ 99 (321)
T cd05591 23 YAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVNGGDLMFQIQRSR---KFDEPRSR 99 (321)
T ss_pred EEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCCCCCcHHHHHHHcC---CCCHHHHH
Confidence 477776532 234456788899999876 89999999999999999999999999999998887543 48999999
Q ss_pred HHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEEcCCCcEEEeeccCccccccCCcceeeeeeccCCCCChhhhccCCCCC
Q 044312 378 RIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHGTFGYLDPEYFRSSQFTD 457 (608)
Q Consensus 378 ~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGls~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ 457 (608)
.++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++...... .......||+.|+|||++.+..++.
T Consensus 100 ~~~~qi~~aL~~LH~~~---ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~ 175 (321)
T cd05591 100 FYAAEVTLALMFLHRHG---VIYRDLKLDNILLDAEGHCKLADFGMCKEGILNG-VTTTTFCGTPDYIAPEILQELEYGP 175 (321)
T ss_pred HHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEEeecccceecccCC-ccccccccCccccCHHHHcCCCCCC
Confidence 99999999999999999 9999999999999999999999999987543222 2233456899999999999999999
Q ss_pred ccchHhHHHHHHHHHhCCCCCCccchhhcccHHHHHHHHhhhhhhHHHhhhhhhccCChhHHHHHHHHHHHHhccCCCCC
Q 044312 458 KSDVYSFGVVLTELLTGEKPIRFTILEEDKSLAAYFLCAMKEERLFEILDARVMKQGGKDEIITVAKLAKRCLNLNGKKR 537 (608)
Q Consensus 458 ksDV~S~Gvvl~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~Li~~cl~~dp~~R 537 (608)
++||||||++++||++|+.||....... .+. .+.... ...+...+.++.+|+.+||+.||++|
T Consensus 176 ~~DvwslG~il~el~tg~~Pf~~~~~~~------~~~---------~i~~~~--~~~p~~~~~~~~~ll~~~L~~dp~~R 238 (321)
T cd05591 176 SVDWWALGVLMYEMMAGQPPFEADNEDD------LFE---------SILHDD--VLYPVWLSKEAVSILKAFMTKNPNKR 238 (321)
T ss_pred ccceechhHHHHHHhcCCCCCCCCCHHH------HHH---------HHHcCC--CCCCCCCCHHHHHHHHHHhccCHHHc
Confidence 9999999999999999999997432211 111 111110 01222345678999999999999999
Q ss_pred C-------CHHHHHHH
Q 044312 538 P-------TMREVASE 546 (608)
Q Consensus 538 P-------s~~evl~~ 546 (608)
| ++.+++++
T Consensus 239 ~~~~~~~~~~~~~~~h 254 (321)
T cd05591 239 LGCVASQGGEDAIKQH 254 (321)
T ss_pred CCCCCCCCCHHHHhcC
Confidence 9 77777754
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-34 Score=290.66 Aligned_cols=236 Identities=26% Similarity=0.328 Sum_probs=183.8
Q ss_pred ccccceeccCce---------------EEEEEeecChhhHHHHHHHHHHHhhcCCCCccceecccccCccceEEEeecCC
Q 044312 291 FDLNRILGQGGQ---------------AVKKSKVIDESKVEEFINEVVILSQINHRNVVKLLGCCLETEVPLLVYEFIPN 355 (608)
Q Consensus 291 f~~~~~lG~G~~---------------avk~~~~~~~~~~~~~~~Ei~il~~l~H~niv~l~~~~~~~~~~~lV~E~~~~ 355 (608)
|++.+.||+|++ ++|..........+.+.+|+++++.++||||+++++.+......++||||+++
T Consensus 7 ~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~~v~e~~~~ 86 (282)
T cd06643 7 WEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAG 86 (282)
T ss_pred HHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCCCHHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEEEEEEecCC
Confidence 455667777763 45555444556678899999999999999999999999999999999999999
Q ss_pred CccchhccccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEEcCCCcEEEeeccCccccccCCccee
Q 044312 356 GTLFQYIHDQNEDFPITWEIRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMT 435 (608)
Q Consensus 356 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGls~~~~~~~~~~~ 435 (608)
++|..++..... ++++..+..++.|++.||.|||+.+ ++||||||+|||++.++.+||+|||++....... ...
T Consensus 87 ~~l~~~~~~~~~--~l~~~~~~~~~~qi~~~L~~LH~~~---i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~-~~~ 160 (282)
T cd06643 87 GAVDAVMLELER--PLTEPQIRVVCKQTLEALNYLHENK---IIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTI-QRR 160 (282)
T ss_pred CcHHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCcccEEEccCCCEEEccccccccccccc-ccc
Confidence 999988765332 5899999999999999999999999 9999999999999999999999999987653221 122
Q ss_pred eeeeccCCCCChhhhc-----cCCCCCccchHhHHHHHHHHHhCCCCCCccchhhcccHHHHHHHHhhhhhhHHHhhhhh
Q 044312 436 TQVHGTFGYLDPEYFR-----SSQFTDKSDVYSFGVVLTELLTGEKPIRFTILEEDKSLAAYFLCAMKEERLFEILDARV 510 (608)
Q Consensus 436 ~~~~gt~~y~aPE~~~-----~~~~t~ksDV~S~Gvvl~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~ 510 (608)
....++..|+|||++. ...++.++|||||||+++||++|+.||...... .......... ..
T Consensus 161 ~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~------~~~~~~~~~~--------~~ 226 (282)
T cd06643 161 DSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPM------RVLLKIAKSE--------PP 226 (282)
T ss_pred ccccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCHH------HHHHHHhhcC--------CC
Confidence 3346889999999984 445788999999999999999999998632211 0011110000 00
Q ss_pred hccCChhHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 044312 511 MKQGGKDEIITVAKLAKRCLNLNGKKRPTMREVASE 546 (608)
Q Consensus 511 ~~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~evl~~ 546 (608)
....+...+.++.+++.+||+.+|++||++.+++++
T Consensus 227 ~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 262 (282)
T cd06643 227 TLAQPSRWSSEFKDFLKKCLEKNVDARWTTTQLLQH 262 (282)
T ss_pred CCCCccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 111223345689999999999999999999998754
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-34 Score=297.13 Aligned_cols=241 Identities=22% Similarity=0.360 Sum_probs=184.6
Q ss_pred cCccccceeccCce---------------EEEEEee---cChhhHHHHHHHHHHHhhcCCCCccceecccccCccceEEE
Q 044312 289 DNFDLNRILGQGGQ---------------AVKKSKV---IDESKVEEFINEVVILSQINHRNVVKLLGCCLETEVPLLVY 350 (608)
Q Consensus 289 ~~f~~~~~lG~G~~---------------avk~~~~---~~~~~~~~~~~Ei~il~~l~H~niv~l~~~~~~~~~~~lV~ 350 (608)
++|++.+.||+|++ |+|.... ......+.|.+|+.+++.++|+||+++++++.+.+..++||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (331)
T cd05597 1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDENNLYLVM 80 (331)
T ss_pred CCceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCCeEEEEE
Confidence 36888899999974 5665542 22334566889999999999999999999999999999999
Q ss_pred eecCCCccchhccccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEEcCCCcEEEeeccCccccccC
Q 044312 351 EFIPNGTLFQYIHDQNEDFPITWEIRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVD 430 (608)
Q Consensus 351 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGls~~~~~~ 430 (608)
||+++|+|.+++..... .+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||++......
T Consensus 81 e~~~g~~L~~~l~~~~~--~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~ 155 (331)
T cd05597 81 DYYVGGDLLTLLSKFED--RLPEDMARFYLAEMVLAIDSVHQLG---YVHRDIKPDNVLLDKNGHIRLADFGSCLRLLAD 155 (331)
T ss_pred ecCCCCcHHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCC---eEECCCCHHHEEECCCCCEEEEECCceeecCCC
Confidence 99999999999975432 4899999999999999999999999 999999999999999999999999998766543
Q ss_pred CcceeeeeeccCCCCChhhhcc-----CCCCCccchHhHHHHHHHHHhCCCCCCccchhhcccHHHHHHHHhhhhhhHHH
Q 044312 431 QTHMTTQVHGTFGYLDPEYFRS-----SQFTDKSDVYSFGVVLTELLTGEKPIRFTILEEDKSLAAYFLCAMKEERLFEI 505 (608)
Q Consensus 431 ~~~~~~~~~gt~~y~aPE~~~~-----~~~t~ksDV~S~Gvvl~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 505 (608)
.........||+.|+|||++.. ..++.++|||||||++|||++|+.||..... ...+...........
T Consensus 156 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~------~~~~~~i~~~~~~~~- 228 (331)
T cd05597 156 GTVQSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESL------VETYGKIMNHKEHFQ- 228 (331)
T ss_pred CCccccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCCCH------HHHHHHHHcCCCccc-
Confidence 3333334568999999999863 4578899999999999999999999863221 111111111110000
Q ss_pred hhhhhhccCChhHHHHHHHHHHHHhccCCCC--CCCHHHHHHH
Q 044312 506 LDARVMKQGGKDEIITVAKLAKRCLNLNGKK--RPTMREVASE 546 (608)
Q Consensus 506 ~d~~~~~~~~~~~~~~l~~Li~~cl~~dp~~--RPs~~evl~~ 546 (608)
. .......+..+.+++.+||..++++ ||++++++++
T Consensus 229 ----~-~~~~~~~~~~~~~li~~ll~~~~~r~~r~~~~~~l~h 266 (331)
T cd05597 229 ----F-PPDVTDVSEEAKDLIRRLICSPETRLGRNGLQDFKDH 266 (331)
T ss_pred ----C-CCccCCCCHHHHHHHHHHccCcccccCCCCHHHHhcC
Confidence 0 0111234567899999988654443 7899999876
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-33 Score=287.67 Aligned_cols=218 Identities=22% Similarity=0.376 Sum_probs=170.8
Q ss_pred eEEEEEeecChhhHHHHHHHHHHHhhcCCCCccceecccccCccceEEEeecCCCccchhccccCCCCCCCHHHHHHHHH
Q 044312 302 QAVKKSKVIDESKVEEFINEVVILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEIRLRIAI 381 (608)
Q Consensus 302 ~avk~~~~~~~~~~~~~~~Ei~il~~l~H~niv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~ 381 (608)
.++|............|.+|+.++++++||||+++++++.+....+|||||+++|+|..++..... .+++..++.++.
T Consensus 47 v~~k~~~~~~~~~~~~~~~~~~~~~~l~h~niv~~~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~--~~~~~~~~~i~~ 124 (274)
T cd05076 47 VVLKVLDPSHRDIALAFFETASLMSQVSHIHLAFVHGVCVRGSENIMVEEFVEHGPLDVCLRKEKG--RVPVAWKITVAQ 124 (274)
T ss_pred EEEEecChHHHHHHHHHHHHHHHHhcCCCCCeeeEEEEEEeCCceEEEEecCCCCcHHHHHHhcCC--CCCHHHHHHHHH
Confidence 366666544444456789999999999999999999999999999999999999999998875433 488999999999
Q ss_pred HHHHHHHHHhhcCCCCeeccCCCCCcEEEcCCC-------cEEEeeccCccccccCCcceeeeeeccCCCCChhhhcc-C
Q 044312 382 EVSGALSYLHSAASIPIYHRDIKSTNILLDDKY-------RAKVSDFGASRSMAVDQTHMTTQVHGTFGYLDPEYFRS-S 453 (608)
Q Consensus 382 ~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~-------~~kl~DFGls~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~ 453 (608)
||++||+|||+.+ |+||||||+|||++..+ .+|++|||++...... ....++..|+|||.+.+ .
T Consensus 125 qi~~~l~~lH~~~---iiH~dlkp~Nill~~~~~~~~~~~~~kl~d~g~~~~~~~~-----~~~~~~~~~~aPe~~~~~~ 196 (274)
T cd05076 125 QLASALSYLEDKN---LVHGNVCAKNILLARLGLAEGTSPFIKLSDPGVSFTALSR-----EERVERIPWIAPECVPGGN 196 (274)
T ss_pred HHHHHHHHHHcCC---ccCCCCCcccEEEeccCcccCccceeeecCCccccccccc-----cccccCCcccCchhhcCCC
Confidence 9999999999998 99999999999997543 3899999988654321 12346788999998875 5
Q ss_pred CCCCccchHhHHHHHHHHH-hCCCCCCccchhhcccHHHHHHHHhhhhhhHHHhhhhhhccCChhHHHHHHHHHHHHhcc
Q 044312 454 QFTDKSDVYSFGVVLTELL-TGEKPIRFTILEEDKSLAAYFLCAMKEERLFEILDARVMKQGGKDEIITVAKLAKRCLNL 532 (608)
Q Consensus 454 ~~t~ksDV~S~Gvvl~ell-tg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~Li~~cl~~ 532 (608)
.++.++||||||+++|||+ +|+.||......+. . ....... ..+......+.+++.+||+.
T Consensus 197 ~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~---~-------------~~~~~~~--~~~~~~~~~~~~li~~cl~~ 258 (274)
T cd05076 197 SLSTAADKWSFGTTLLEICFDGEVPLKERTPSEK---E-------------RFYEKKH--RLPEPSCKELATLISQCLTY 258 (274)
T ss_pred CCCcHHHHHHHHHHHHHHHhCCCCCccccChHHH---H-------------HHHHhcc--CCCCCCChHHHHHHHHHccc
Confidence 6899999999999999985 68888863322110 0 0111111 11112234689999999999
Q ss_pred CCCCCCCHHHHHHHH
Q 044312 533 NGKKRPTMREVASEL 547 (608)
Q Consensus 533 dp~~RPs~~evl~~L 547 (608)
+|++|||+.+|++.|
T Consensus 259 ~p~~Rps~~~il~~L 273 (274)
T cd05076 259 EPTQRPSFRTILRDL 273 (274)
T ss_pred ChhhCcCHHHHHHhh
Confidence 999999999999877
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-33 Score=284.81 Aligned_cols=217 Identities=24% Similarity=0.413 Sum_probs=170.6
Q ss_pred EEEEEeecChhhHHHHHHHHHHHhhcCCCCccceecccccCccceEEEeecCCCccchhccccCCCCCCCHHHHHHHHHH
Q 044312 303 AVKKSKVIDESKVEEFINEVVILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEIRLRIAIE 382 (608)
Q Consensus 303 avk~~~~~~~~~~~~~~~Ei~il~~l~H~niv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ 382 (608)
++|............|.+|+.++++++||||+++++++......++||||+++++|..++..... .+++..+++++.|
T Consensus 36 ~~k~~~~~~~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~--~~~~~~~~~i~~q 113 (262)
T cd05077 36 ILKVLDPSHRDISLAFFETASMMRQVSHKHIVLLYGVCVRDVENIMVEEFVEFGPLDLFMHRKSD--VLTTPWKFKVAKQ 113 (262)
T ss_pred EEeecChhhhhHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCEEEEecccCCCHHHHHHhcCC--CCCHHHHHHHHHH
Confidence 55555544445556889999999999999999999999999999999999999999988875433 5899999999999
Q ss_pred HHHHHHHHhhcCCCCeeccCCCCCcEEEcCCCc-------EEEeeccCccccccCCcceeeeeeccCCCCChhhhc-cCC
Q 044312 383 VSGALSYLHSAASIPIYHRDIKSTNILLDDKYR-------AKVSDFGASRSMAVDQTHMTTQVHGTFGYLDPEYFR-SSQ 454 (608)
Q Consensus 383 ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~-------~kl~DFGls~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~ 454 (608)
|++||+|||+.+ |+||||||+|||++.++. +|++|||++...... ....++..|+|||.+. ...
T Consensus 114 i~~~l~~lH~~~---ivH~dlkp~Nill~~~~~~~~~~~~~~l~d~g~~~~~~~~-----~~~~~~~~y~aPE~~~~~~~ 185 (262)
T cd05077 114 LASALSYLEDKD---LVHGNVCTKNILLAREGIDGECGPFIKLSDPGIPITVLSR-----QECVERIPWIAPECVEDSKN 185 (262)
T ss_pred HHHHHHHhhhCC---eECCCCCcccEEEecCCccCCCCceeEeCCCCCCccccCc-----ccccccccccChhhhcCCCC
Confidence 999999999998 999999999999986654 899999998755322 2234778899999987 467
Q ss_pred CCCccchHhHHHHHHHHH-hCCCCCCccchhhcccHHHHHHHHhhhhhhHHHhhhhhhccCChhHHHHHHHHHHHHhccC
Q 044312 455 FTDKSDVYSFGVVLTELL-TGEKPIRFTILEEDKSLAAYFLCAMKEERLFEILDARVMKQGGKDEIITVAKLAKRCLNLN 533 (608)
Q Consensus 455 ~t~ksDV~S~Gvvl~ell-tg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~Li~~cl~~d 533 (608)
++.++||||||+++|||+ +|..|+......+. ........ ........++.+|+.+||+.|
T Consensus 186 ~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~----------------~~~~~~~~--~~~~~~~~~~~~li~~cl~~d 247 (262)
T cd05077 186 LSIAADKWSFGTTLWEICYNGEIPLKDKTLAEK----------------ERFYEGQC--MLVTPSCKELADLMTHCMNYD 247 (262)
T ss_pred CCchhHHHHHHHHHHHHHhCCCCCCCCcchhHH----------------HHHHhcCc--cCCCCChHHHHHHHHHHcCCC
Confidence 899999999999999998 57888753221110 00000000 011123457899999999999
Q ss_pred CCCCCCHHHHHHHH
Q 044312 534 GKKRPTMREVASEL 547 (608)
Q Consensus 534 p~~RPs~~evl~~L 547 (608)
|++||++.+|++.|
T Consensus 248 p~~Rp~~~~il~~~ 261 (262)
T cd05077 248 PNQRPFFRAIMRDI 261 (262)
T ss_pred hhhCcCHHHHHHhc
Confidence 99999999998875
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-33 Score=289.30 Aligned_cols=237 Identities=28% Similarity=0.351 Sum_probs=185.3
Q ss_pred ccccceeccCce---------------EEEEEeec---ChhhHHHHHHHHHHHhhcCCCCccceecccccCccceEEEee
Q 044312 291 FDLNRILGQGGQ---------------AVKKSKVI---DESKVEEFINEVVILSQINHRNVVKLLGCCLETEVPLLVYEF 352 (608)
Q Consensus 291 f~~~~~lG~G~~---------------avk~~~~~---~~~~~~~~~~Ei~il~~l~H~niv~l~~~~~~~~~~~lV~E~ 352 (608)
|+..+.||+|++ |||..... .....+.+.+|+.++++++|+||+++++.+.+.+..++||||
T Consensus 2 f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~ 81 (285)
T cd05630 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTL 81 (285)
T ss_pred ceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCCEEEEEEEe
Confidence 666788888864 56655432 122345678899999999999999999999999999999999
Q ss_pred cCCCccchhccccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEEcCCCcEEEeeccCccccccCCc
Q 044312 353 IPNGTLFQYIHDQNEDFPITWEIRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQT 432 (608)
Q Consensus 353 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGls~~~~~~~~ 432 (608)
+++++|.+++..... ..+++..++.++.|++.||.|||+.+ |+||||||+|||+++++.++|+|||++........
T Consensus 82 ~~g~~L~~~l~~~~~-~~l~~~~~~~~~~qi~~~l~~lH~~~---iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~ 157 (285)
T cd05630 82 MNGGDLKFHIYHMGE-AGFEEGRAVFYAAEICCGLEDLHQER---IVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQT 157 (285)
T ss_pred cCCCcHHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCCCHHHEEECCCCCEEEeeccceeecCCCcc
Confidence 999999998865432 25899999999999999999999998 99999999999999999999999999876543222
Q ss_pred ceeeeeeccCCCCChhhhccCCCCCccchHhHHHHHHHHHhCCCCCCccchhhcccHHHHHHHHhhhhhhHHHhhhhhhc
Q 044312 433 HMTTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLTELLTGEKPIRFTILEEDKSLAAYFLCAMKEERLFEILDARVMK 512 (608)
Q Consensus 433 ~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~ 512 (608)
.....|+..|+|||++.+..++.++||||||++++||++|+.||.......... ....... ....
T Consensus 158 --~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~------------~~~~~~~-~~~~ 222 (285)
T cd05630 158 --IKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKRE------------EVERLVK-EVQE 222 (285)
T ss_pred --ccCCCCCccccChHHHcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCccchHH------------HHHhhhh-hhhh
Confidence 123468999999999999999999999999999999999999997432111000 0000110 0111
Q ss_pred cCChhHHHHHHHHHHHHhccCCCCCCC-----HHHHHHH
Q 044312 513 QGGKDEIITVAKLAKRCLNLNGKKRPT-----MREVASE 546 (608)
Q Consensus 513 ~~~~~~~~~l~~Li~~cl~~dp~~RPs-----~~evl~~ 546 (608)
..+...+.++.+|+.+||+.||++||| ++|++++
T Consensus 223 ~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~~~~~h 261 (285)
T cd05630 223 EYSEKFSPDARSLCKMLLCKDPKERLGCQGGGAREVKEH 261 (285)
T ss_pred hcCccCCHHHHHHHHHHhhcCHHHccCCCCCchHHHHcC
Confidence 122344567899999999999999999 7888764
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=286.60 Aligned_cols=217 Identities=29% Similarity=0.460 Sum_probs=174.2
Q ss_pred hhHHHHHHHHHHHhhcCCCCccceecccccCccceEEEeecCCCccchhccccC----CCCCCCHHHHHHHHHHHHHHHH
Q 044312 313 SKVEEFINEVVILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGTLFQYIHDQN----EDFPITWEIRLRIAIEVSGALS 388 (608)
Q Consensus 313 ~~~~~~~~Ei~il~~l~H~niv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~----~~~~l~~~~~~~i~~~ia~aL~ 388 (608)
.....|.+|+.+++.++||||+++++++...+..++||||+++++|.+++.... ....+++..++.++.|++.||.
T Consensus 41 ~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~ 120 (269)
T cd05044 41 QEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCV 120 (269)
T ss_pred hhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEEEEeccCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHH
Confidence 456789999999999999999999999999999999999999999999997532 1124789999999999999999
Q ss_pred HHhhcCCCCeeccCCCCCcEEEcCCC-----cEEEeeccCccccccCCcc-eeeeeeccCCCCChhhhccCCCCCccchH
Q 044312 389 YLHSAASIPIYHRDIKSTNILLDDKY-----RAKVSDFGASRSMAVDQTH-MTTQVHGTFGYLDPEYFRSSQFTDKSDVY 462 (608)
Q Consensus 389 yLH~~~~~~iiHrDlk~~NILl~~~~-----~~kl~DFGls~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~t~ksDV~ 462 (608)
|||+.+ ++|+||||+|||++.+. .+||+|||+++........ ......++..|+|||++.+..++.++|||
T Consensus 121 ~lH~~~---i~H~dl~p~nil~~~~~~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~ 197 (269)
T cd05044 121 YLEQMH---FIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYKSDYYRKEGEGLLPVRWMAPESLLDGKFTTQSDVW 197 (269)
T ss_pred HHHhCC---cccCCCChheEEEecCCCCCCcceEECCcccccccccccccccCcccCCCccccCHHHHccCCcccchhHH
Confidence 999998 99999999999999877 8999999999765432211 11223456789999999999999999999
Q ss_pred hHHHHHHHHHh-CCCCCCccchhhcccHHHHHHHHhhhhhhHHHhhhhhhccCChhHHHHHHHHHHHHhccCCCCCCCHH
Q 044312 463 SFGVVLTELLT-GEKPIRFTILEEDKSLAAYFLCAMKEERLFEILDARVMKQGGKDEIITVAKLAKRCLNLNGKKRPTMR 541 (608)
Q Consensus 463 S~Gvvl~ellt-g~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~ 541 (608)
|||++++||++ |+.||......+ .. ..+........+...+..+.+++.+||+.+|++||++.
T Consensus 198 slG~il~ellt~g~~p~~~~~~~~---~~-------------~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~ 261 (269)
T cd05044 198 SFGVLMWEILTLGQQPYPALNNQE---VL-------------QHVTAGGRLQKPENCPDKIYQLMTNCWAQDPSERPTFD 261 (269)
T ss_pred HHHHHHHHHHHcCCCCCcccCHHH---HH-------------HHHhcCCccCCcccchHHHHHHHHHHcCCCcccCCCHH
Confidence 99999999998 999986322111 00 11111111122334567899999999999999999999
Q ss_pred HHHHHHH
Q 044312 542 EVASELA 548 (608)
Q Consensus 542 evl~~L~ 548 (608)
+|++.|+
T Consensus 262 ~i~~~l~ 268 (269)
T cd05044 262 RIQEILQ 268 (269)
T ss_pred HHHHHHh
Confidence 9999885
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-34 Score=306.15 Aligned_cols=237 Identities=22% Similarity=0.315 Sum_probs=183.1
Q ss_pred CccccceeccCce---------------EEEEEeec---ChhhHHHHHHHHHHHhhcCCCCccceecccccCccceEEEe
Q 044312 290 NFDLNRILGQGGQ---------------AVKKSKVI---DESKVEEFINEVVILSQINHRNVVKLLGCCLETEVPLLVYE 351 (608)
Q Consensus 290 ~f~~~~~lG~G~~---------------avk~~~~~---~~~~~~~~~~Ei~il~~l~H~niv~l~~~~~~~~~~~lV~E 351 (608)
+|++.+.||+|++ |||.+... .....+.+.+|+.+|++++|+||+++++.+.+.+..++|||
T Consensus 2 ~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~E 81 (376)
T cd05598 2 MFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMD 81 (376)
T ss_pred CceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCCEEEEEEe
Confidence 6888999999985 55655321 22345678899999999999999999999999999999999
Q ss_pred ecCCCccchhccccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEEcCCCcEEEeeccCccccccCC
Q 044312 352 FIPNGTLFQYIHDQNEDFPITWEIRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQ 431 (608)
Q Consensus 352 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGls~~~~~~~ 431 (608)
|+++|+|.+++.... .+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||++..+....
T Consensus 82 ~~~~g~L~~~i~~~~---~~~~~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~Nill~~~~~ikL~DFG~a~~~~~~~ 155 (376)
T cd05598 82 YIPGGDMMSLLIRLG---IFEEDLARFYIAELTCAIESVHKMG---FIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTH 155 (376)
T ss_pred CCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCCHHHEEECCCCCEEEEeCCCCccccccc
Confidence 999999999997643 4889999999999999999999999 9999999999999999999999999975321000
Q ss_pred ------------------------------------------cceeeeeeccCCCCChhhhccCCCCCccchHhHHHHHH
Q 044312 432 ------------------------------------------THMTTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLT 469 (608)
Q Consensus 432 ------------------------------------------~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~ 469 (608)
........||+.|+|||++.+..++.++|||||||+++
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvily 235 (376)
T cd05598 156 DSKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILY 235 (376)
T ss_pred cccccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCCcceeeeeccceee
Confidence 00011346899999999999999999999999999999
Q ss_pred HHHhCCCCCCccchhhcccHHHHHHHHhhhhhhHHHhhhhhhccCChhHHHHHHHHHHHHhccCCCCCC---CHHHHHHH
Q 044312 470 ELLTGEKPIRFTILEEDKSLAAYFLCAMKEERLFEILDARVMKQGGKDEIITVAKLAKRCLNLNGKKRP---TMREVASE 546 (608)
Q Consensus 470 elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RP---s~~evl~~ 546 (608)
||++|+.||......+. ....... ............+.++.+++.+|+ .+|.+|+ ++.|++++
T Consensus 236 ell~G~~Pf~~~~~~~~------~~~i~~~-------~~~~~~~~~~~~s~~~~~li~~l~-~~p~~R~~~~t~~ell~h 301 (376)
T cd05598 236 EMLVGQPPFLADTPAET------QLKVINW-------ETTLHIPSQAKLSREASDLILRLC-CGAEDRLGKNGADEIKAH 301 (376)
T ss_pred ehhhCCCCCCCCCHHHH------HHHHhcc-------CccccCCCCCCCCHHHHHHHHHHh-cCHhhcCCCCCHHHHhCC
Confidence 99999999974322110 0000000 000111112234567888898876 5999999 88888865
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-34 Score=281.38 Aligned_cols=249 Identities=22% Similarity=0.281 Sum_probs=189.0
Q ss_pred cCccccceeccCce---------------EEEEEeecChhh--HHHHHHHHHHHhhcCCCCccceecccccC--ccceEE
Q 044312 289 DNFDLNRILGQGGQ---------------AVKKSKVIDESK--VEEFINEVVILSQINHRNVVKLLGCCLET--EVPLLV 349 (608)
Q Consensus 289 ~~f~~~~~lG~G~~---------------avk~~~~~~~~~--~~~~~~Ei~il~~l~H~niv~l~~~~~~~--~~~~lV 349 (608)
+.|+..++|++|.| |+|+++...+.. .-.-++||.+|.+++|||||.+..+.... +..|||
T Consensus 76 ~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~d~iy~V 155 (419)
T KOG0663|consen 76 EEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVVGSNMDKIYIV 155 (419)
T ss_pred HHHHHHhhcccCcceeEEEeccCCcceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEeccccceeeee
Confidence 34666888999974 777776543221 23468999999999999999999887543 578999
Q ss_pred EeecCCCccchhccccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEEcCCCcEEEeeccCcccccc
Q 044312 350 YEFIPNGTLFQYIHDQNEDFPITWEIRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAV 429 (608)
Q Consensus 350 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGls~~~~~ 429 (608)
|||+++ +|..++....+ ++...++.-++.|+++||+|||.+. |+|||||++|+|+++.|.+||+||||||.+..
T Consensus 156 Me~~Eh-DLksl~d~m~q--~F~~~evK~L~~QlL~glk~lH~~w---ilHRDLK~SNLLm~~~G~lKiaDFGLAR~ygs 229 (419)
T KOG0663|consen 156 MEYVEH-DLKSLMETMKQ--PFLPGEVKTLMLQLLRGLKHLHDNW---ILHRDLKTSNLLLSHKGILKIADFGLAREYGS 229 (419)
T ss_pred HHHHHh-hHHHHHHhccC--CCchHHHHHHHHHHHHHHHHHhhce---eEecccchhheeeccCCcEEecccchhhhhcC
Confidence 999977 99999998764 5899999999999999999999999 99999999999999999999999999998875
Q ss_pred CCcceeeeeeccCCCCChhhhccC-CCCCccchHhHHHHHHHHHhCCCCCCccchhhcccHHHHHHHH-hhhhhhHH-H-
Q 044312 430 DQTHMTTQVHGTFGYLDPEYFRSS-QFTDKSDVYSFGVVLTELLTGEKPIRFTILEEDKSLAAYFLCA-MKEERLFE-I- 505 (608)
Q Consensus 430 ~~~~~~~~~~gt~~y~aPE~~~~~-~~t~ksDV~S~Gvvl~elltg~~p~~~~~~~~~~~l~~~~~~~-~~~~~~~~-~- 505 (608)
.. ...+...-|.+|.|||.+.+. .|+...|+||+|||+.||+++++-|.....-+ .+...|... ...+.+.. +
T Consensus 230 p~-k~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~d--Ql~~If~llGtPte~iwpg~~ 306 (419)
T KOG0663|consen 230 PL-KPYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSEID--QLDKIFKLLGTPSEAIWPGYS 306 (419)
T ss_pred Cc-ccCcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCchHH--HHHHHHHHhCCCccccCCCcc
Confidence 53 345667789999999998765 68999999999999999999998886432222 222222111 01111100 0
Q ss_pred -------------hhhhhhccCChh-HHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 044312 506 -------------LDARVMKQGGKD-EIITVAKLAKRCLNLNGKKRPTMREVASE 546 (608)
Q Consensus 506 -------------~d~~~~~~~~~~-~~~~l~~Li~~cl~~dp~~RPs~~evl~~ 546 (608)
.-..++..+... ..+.-.+|+..+|.+||.+|.|+.|.+++
T Consensus 307 ~lp~~k~~~f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA~~~L~h 361 (419)
T KOG0663|consen 307 ELPAVKKMTFSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRITAEDGLKH 361 (419)
T ss_pred ccchhhccccCCCCchhhhhhccccccchhHHHHHHHHhccCccccccHHHhhcc
Confidence 001111111111 44677899999999999999999998864
|
|
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-33 Score=289.16 Aligned_cols=251 Identities=27% Similarity=0.410 Sum_probs=190.4
Q ss_pred cCccccceeccCce---------------EEEEEeecC-hhhHHHHHHHHHHHhhcCCCCccceecccccCccceEEEee
Q 044312 289 DNFDLNRILGQGGQ---------------AVKKSKVID-ESKVEEFINEVVILSQINHRNVVKLLGCCLETEVPLLVYEF 352 (608)
Q Consensus 289 ~~f~~~~~lG~G~~---------------avk~~~~~~-~~~~~~~~~Ei~il~~l~H~niv~l~~~~~~~~~~~lV~E~ 352 (608)
++|++.+.||+|++ |+|...... ....+.+.+|+++++.++||||+++++++......+|||||
T Consensus 5 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 84 (284)
T cd06620 5 EDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAFLNENNICMCMEF 84 (284)
T ss_pred HHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecCcchHHHHHHHHHHHHHHcCCCCcceEeeeEecCCEEEEEEec
Confidence 35666777888763 555554332 33457899999999999999999999999999999999999
Q ss_pred cCCCccchhccccCCCCCCCHHHHHHHHHHHHHHHHHHhh-cCCCCeeccCCCCCcEEEcCCCcEEEeeccCccccccCC
Q 044312 353 IPNGTLFQYIHDQNEDFPITWEIRLRIAIEVSGALSYLHS-AASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQ 431 (608)
Q Consensus 353 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~-~~~~~iiHrDlk~~NILl~~~~~~kl~DFGls~~~~~~~ 431 (608)
+++++|.+++.... ++++..+..++.+++.||.|||+ .+ ++||||||+||++++++.++|+|||++.......
T Consensus 85 ~~~~~L~~~~~~~~---~~~~~~~~~~~~~i~~~l~~LH~~~~---i~H~dl~p~nil~~~~~~~~l~d~gl~~~~~~~~ 158 (284)
T cd06620 85 MDCGSLDRIYKKGG---PIPVEILGKIAVAVVEGLTYLYNVHR---IMHRDIKPSNILVNSRGQIKLCDFGVSGELINSI 158 (284)
T ss_pred CCCCCHHHHHHhcc---CCCHHHHHHHHHHHHHHHHHHHHhcC---eeccCCCHHHEEECCCCcEEEccCCcccchhhhc
Confidence 99999999887643 58999999999999999999997 46 9999999999999999999999999987543221
Q ss_pred cceeeeeeccCCCCChhhhccCCCCCccchHhHHHHHHHHHhCCCCCCccchhhcccHHHHHHHHhhhhhhHHHhhhhhh
Q 044312 432 THMTTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLTELLTGEKPIRFTILEEDKSLAAYFLCAMKEERLFEILDARVM 511 (608)
Q Consensus 432 ~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~ 511 (608)
.....|+..|+|||++.+..++.++||||||++++||++|+.||.............. ... ..+..++.....
T Consensus 159 ---~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~---~~~-~~~~~~~~~~~~ 231 (284)
T cd06620 159 ---ADTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPM---GIL-DLLQQIVQEPPP 231 (284)
T ss_pred ---cCccccCcccCCHHHHccCCCCccchHHHHHHHHHHHHhCCCCCcccchhhhhhhhhh---HHH-HHHHHHhhccCC
Confidence 1234689999999999888999999999999999999999999974433211100000 000 001111111101
Q ss_pred ccCChhHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhhHH
Q 044312 512 KQGGKDEIITVAKLAKRCLNLNGKKRPTMREVASELAGIKA 552 (608)
Q Consensus 512 ~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~evl~~L~~i~~ 552 (608)
.......+..+.+|+.+||+.||++|||+.|++++..-++.
T Consensus 232 ~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~e~~~~~~~~~~ 272 (284)
T cd06620 232 RLPSSDFPEDLRDFVDACLLKDPTERPTPQQLCAMPPFIQA 272 (284)
T ss_pred CCCchhcCHHHHHHHHHHhcCCcccCcCHHHHhcCcccccc
Confidence 11112255679999999999999999999999987655543
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >KOG0584 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-34 Score=304.23 Aligned_cols=209 Identities=24% Similarity=0.448 Sum_probs=174.4
Q ss_pred hhhHHHHHHHHHHHhhcCCCCccceecccccCcc--ceEEEeecCCCccchhccccCCCCCCCHHHHHHHHHHHHHHHHH
Q 044312 312 ESKVEEFINEVVILSQINHRNVVKLLGCCLETEV--PLLVYEFIPNGTLFQYIHDQNEDFPITWEIRLRIAIEVSGALSY 389 (608)
Q Consensus 312 ~~~~~~~~~Ei~il~~l~H~niv~l~~~~~~~~~--~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~y 389 (608)
+...+.|..|+.+|+.|+||||++++..+.+... ..+|+|++..|+|..|+.+.+ .++.+.+..|+.||++||.|
T Consensus 82 ~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~in~iTEL~TSGtLr~Y~kk~~---~vn~kaik~W~RQILkGL~y 158 (632)
T KOG0584|consen 82 PEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKTINFITELFTSGTLREYRKKHR---RVNIKAIKSWCRQILKGLVY 158 (632)
T ss_pred hHHHHHHHHHHHHHccCCCCceeeeeeheecCCCceeeeeeecccCCcHHHHHHHhc---cCCHHHHHHHHHHHHHHhhh
Confidence 3445789999999999999999999999987665 779999999999999998865 38999999999999999999
Q ss_pred HhhcCCCCeeccCCCCCcEEEcC-CCcEEEeeccCccccccCCcceeeeeeccCCCCChhhhccCCCCCccchHhHHHHH
Q 044312 390 LHSAASIPIYHRDIKSTNILLDD-KYRAKVSDFGASRSMAVDQTHMTTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVL 468 (608)
Q Consensus 390 LH~~~~~~iiHrDlk~~NILl~~-~~~~kl~DFGls~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl 468 (608)
||++. +||||||||-+||||+. .|.+||+|+|||....... ...+.|||.|||||++. ..|++.+||||||+.|
T Consensus 159 LHs~~-PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl~r~s~---aksvIGTPEFMAPEmYE-E~YnE~VDVYaFGMCm 233 (632)
T KOG0584|consen 159 LHSQD-PPIIHRDLKCDNIFVNGNLGEVKIGDLGLATLLRKSH---AKSVIGTPEFMAPEMYE-ENYNELVDVYAFGMCM 233 (632)
T ss_pred hhcCC-CCccccccccceEEEcCCcCceeecchhHHHHhhccc---cceeccCccccChHHHh-hhcchhhhhhhhhHHH
Confidence 99986 67999999999999985 5889999999998765432 24478999999999988 8899999999999999
Q ss_pred HHHHhCCCCCCccchhhcccHHHHHHH---HhhhhhhHHHhhhhhhccCChhHHHHHHHHHHHHhccCCCCCCCHHHHHH
Q 044312 469 TELLTGEKPIRFTILEEDKSLAAYFLC---AMKEERLFEILDARVMKQGGKDEIITVAKLAKRCLNLNGKKRPTMREVAS 545 (608)
Q Consensus 469 ~elltg~~p~~~~~~~~~~~l~~~~~~---~~~~~~~~~~~d~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~evl~ 545 (608)
+||+|+..||. +-.+.+..+.. ..+...+..+- ..+++++|.+||.. .++|||+.|+++
T Consensus 234 LEMvT~eYPYs-----EC~n~AQIYKKV~SGiKP~sl~kV~------------dPevr~fIekCl~~-~~~R~sa~eLL~ 295 (632)
T KOG0584|consen 234 LEMVTSEYPYS-----ECTNPAQIYKKVTSGIKPAALSKVK------------DPEVREFIEKCLAT-KSERLSAKELLK 295 (632)
T ss_pred HHHHhccCChh-----hhCCHHHHHHHHHcCCCHHHhhccC------------CHHHHHHHHHHhcC-chhccCHHHHhh
Confidence 99999999986 33333333322 22223333332 24799999999999 999999999986
Q ss_pred H
Q 044312 546 E 546 (608)
Q Consensus 546 ~ 546 (608)
.
T Consensus 296 d 296 (632)
T KOG0584|consen 296 D 296 (632)
T ss_pred C
Confidence 4
|
|
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-34 Score=299.38 Aligned_cols=217 Identities=28% Similarity=0.287 Sum_probs=174.4
Q ss_pred eEEEEEeecC--hhhHHHHHHHHHHHhhcCCCCccceecccccCccceEEEeecCCCccchhccccCCCCCCCHHHHHHH
Q 044312 302 QAVKKSKVID--ESKVEEFINEVVILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEIRLRI 379 (608)
Q Consensus 302 ~avk~~~~~~--~~~~~~~~~Ei~il~~l~H~niv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i 379 (608)
+|+|..+... ......+.+|+++|++++||||+++++++.+....++||||+++|+|.+++.... .+++..+..+
T Consensus 27 ~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~---~l~~~~~~~~ 103 (318)
T cd05582 27 YAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEV---MFTEEDVKFY 103 (318)
T ss_pred EEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEEcCCCCCcHHHHHHHcC---CCCHHHHHHH
Confidence 4666665321 2234567889999999999999999999999999999999999999999986543 5899999999
Q ss_pred HHHHHHHHHHHhhcCCCCeeccCCCCCcEEEcCCCcEEEeeccCccccccCCcceeeeeeccCCCCChhhhccCCCCCcc
Q 044312 380 AIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHGTFGYLDPEYFRSSQFTDKS 459 (608)
Q Consensus 380 ~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGls~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ks 459 (608)
+.||+.||+|||+.+ |+||||||+|||+++++.+||+|||+++...... .......|++.|+|||.+....++.++
T Consensus 104 ~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~-~~~~~~~g~~~y~aPE~~~~~~~~~~~ 179 (318)
T cd05582 104 LAELALALDHLHSLG---IIYRDLKPENILLDEEGHIKLTDFGLSKESIDHE-KKAYSFCGTVEYMAPEVVNRRGHTQSA 179 (318)
T ss_pred HHHHHHHHHHHHHCC---EecCCCCHHHeEECCCCcEEEeeccCCcccCCCC-CceecccCChhhcCHHHHcCCCCCCcc
Confidence 999999999999999 9999999999999999999999999997654332 223345689999999999998999999
Q ss_pred chHhHHHHHHHHHhCCCCCCccchhhcccHHHHHHHHhhhhhhHHHhhhhhhccCChhHHHHHHHHHHHHhccCCCCCCC
Q 044312 460 DVYSFGVVLTELLTGEKPIRFTILEEDKSLAAYFLCAMKEERLFEILDARVMKQGGKDEIITVAKLAKRCLNLNGKKRPT 539 (608)
Q Consensus 460 DV~S~Gvvl~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPs 539 (608)
||||||++++||++|+.||....... .. ..+... ....+...+..+.+|+.+||+.||++||+
T Consensus 180 DiwslG~il~el~tg~~p~~~~~~~~------~~---------~~i~~~--~~~~p~~~~~~~~~li~~~l~~~P~~R~~ 242 (318)
T cd05582 180 DWWSFGVLMFEMLTGSLPFQGKDRKE------TM---------TMILKA--KLGMPQFLSPEAQSLLRALFKRNPANRLG 242 (318)
T ss_pred ceeccceEeeeeccCCCCCCCCCHHH------HH---------HHHHcC--CCCCCCCCCHHHHHHHHHHhhcCHhHcCC
Confidence 99999999999999999986322110 00 011111 01123345567899999999999999999
Q ss_pred HHH
Q 044312 540 MRE 542 (608)
Q Consensus 540 ~~e 542 (608)
+.+
T Consensus 243 a~~ 245 (318)
T cd05582 243 AGP 245 (318)
T ss_pred CCC
Confidence 655
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-33 Score=283.67 Aligned_cols=239 Identities=24% Similarity=0.358 Sum_probs=189.2
Q ss_pred cCccccceeccCce---------------EEEEEeecChhhHHHHHHHHHHHhhcCCCCccceecccccCccceEEEeec
Q 044312 289 DNFDLNRILGQGGQ---------------AVKKSKVIDESKVEEFINEVVILSQINHRNVVKLLGCCLETEVPLLVYEFI 353 (608)
Q Consensus 289 ~~f~~~~~lG~G~~---------------avk~~~~~~~~~~~~~~~Ei~il~~l~H~niv~l~~~~~~~~~~~lV~E~~ 353 (608)
++|++.+.||+|++ ++|..........+.+.+|+.++++++||||+++++++.+....+++|||+
T Consensus 3 ~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l~~e~~ 82 (262)
T cd06613 3 EDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLWIVMEYC 82 (262)
T ss_pred cceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCchhhHHHHHHHHHHHHhCCCCChhceEEEEEeCCEEEEEEeCC
Confidence 46777888888863 566666555556788999999999999999999999999999999999999
Q ss_pred CCCccchhccccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEEcCCCcEEEeeccCccccccCCcc
Q 044312 354 PNGTLFQYIHDQNEDFPITWEIRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTH 433 (608)
Q Consensus 354 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGls~~~~~~~~~ 433 (608)
++++|.+++..... .+++..+..++.|++.||+|||+.+ ++|+||+|+||++++++.+||+|||++....... .
T Consensus 83 ~~~~l~~~~~~~~~--~l~~~~~~~~~~ql~~~l~~lh~~~---i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~-~ 156 (262)
T cd06613 83 GGGSLQDIYQVTRG--PLSELQIAYVCRETLKGLAYLHETG---KIHRDIKGANILLTEDGDVKLADFGVSAQLTATI-A 156 (262)
T ss_pred CCCcHHHHHHhhcc--CCCHHHHHHHHHHHHHHHHHHHhCC---ceecCCChhhEEECCCCCEEECccccchhhhhhh-h
Confidence 99999998876432 5899999999999999999999998 9999999999999999999999999987654322 1
Q ss_pred eeeeeeccCCCCChhhhccC---CCCCccchHhHHHHHHHHHhCCCCCCccchhhcccHHHHHHHHhhhhhhHHHhhhhh
Q 044312 434 MTTQVHGTFGYLDPEYFRSS---QFTDKSDVYSFGVVLTELLTGEKPIRFTILEEDKSLAAYFLCAMKEERLFEILDARV 510 (608)
Q Consensus 434 ~~~~~~gt~~y~aPE~~~~~---~~t~ksDV~S~Gvvl~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~ 510 (608)
......++..|+|||.+... .++.++||||||++++||++|+.||........ .. ....... .+ .
T Consensus 157 ~~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~~~--~~-----~~~~~~~----~~-~ 224 (262)
T cd06613 157 KRKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMRA--LF-----LISKSNF----PP-P 224 (262)
T ss_pred ccccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHHHH--HH-----HHHhccC----CC-c
Confidence 22334678899999999777 889999999999999999999999863221110 00 0000000 00 0
Q ss_pred hccCChhHHHHHHHHHHHHhccCCCCCCCHHHHHH
Q 044312 511 MKQGGKDEIITVAKLAKRCLNLNGKKRPTMREVAS 545 (608)
Q Consensus 511 ~~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~evl~ 545 (608)
........+.++.+++.+||..+|.+|||+.+|+.
T Consensus 225 ~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~ 259 (262)
T cd06613 225 KLKDKEKWSPVFHDFIKKCLTKDPKKRPTATKLLQ 259 (262)
T ss_pred cccchhhhhHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 01112344567999999999999999999999975
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=283.97 Aligned_cols=235 Identities=26% Similarity=0.396 Sum_probs=185.6
Q ss_pred cCccccceeccCce---------------EEEEEeecChhhHHHHHHHHHHHhhcCCCCccceecccccCccceEEEeec
Q 044312 289 DNFDLNRILGQGGQ---------------AVKKSKVIDESKVEEFINEVVILSQINHRNVVKLLGCCLETEVPLLVYEFI 353 (608)
Q Consensus 289 ~~f~~~~~lG~G~~---------------avk~~~~~~~~~~~~~~~Ei~il~~l~H~niv~l~~~~~~~~~~~lV~E~~ 353 (608)
++|++.+.||+|++ ++|..... ...+++.+|++++++++|+||+++++.+.+....++++||+
T Consensus 3 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~--~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~ 80 (256)
T cd06612 3 EVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVE--EDLQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWIVMEYC 80 (256)
T ss_pred ccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecH--HHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCcEEEEEecC
Confidence 45677777777763 44444332 23778999999999999999999999999999999999999
Q ss_pred CCCccchhccccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEEcCCCcEEEeeccCccccccCCcc
Q 044312 354 PNGTLFQYIHDQNEDFPITWEIRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTH 433 (608)
Q Consensus 354 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGls~~~~~~~~~ 433 (608)
++++|.+++..... .+++..+..++.|++.||.|||+.+ ++|+||+|+||+++.++.+||+|||++........
T Consensus 81 ~~~~L~~~l~~~~~--~l~~~~~~~~~~~l~~~l~~lh~~~---i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~~~~- 154 (256)
T cd06612 81 GAGSVSDIMKITNK--TLTEEEIAAILYQTLKGLEYLHSNK---KIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMA- 154 (256)
T ss_pred CCCcHHHHHHhCcc--CCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcceEEECCCCcEEEcccccchhcccCcc-
Confidence 99999999875433 5899999999999999999999998 99999999999999999999999999987653321
Q ss_pred eeeeeeccCCCCChhhhccCCCCCccchHhHHHHHHHHHhCCCCCCccchhhcccHHHHHHHHhhhhhhHHHhhhhhhcc
Q 044312 434 MTTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLTELLTGEKPIRFTILEEDKSLAAYFLCAMKEERLFEILDARVMKQ 513 (608)
Q Consensus 434 ~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~ 513 (608)
......++..|+|||++.+..++.++||||||++++||++|+.||........ .. ..... ......
T Consensus 155 ~~~~~~~~~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~~------~~-~~~~~-------~~~~~~ 220 (256)
T cd06612 155 KRNTVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHPMRA------IF-MIPNK-------PPPTLS 220 (256)
T ss_pred ccccccCCccccCHHHHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCcchhhh------hh-hhccC-------CCCCCC
Confidence 22334578899999999999999999999999999999999999863221110 00 00000 000011
Q ss_pred CChhHHHHHHHHHHHHhccCCCCCCCHHHHHH
Q 044312 514 GGKDEIITVAKLAKRCLNLNGKKRPTMREVAS 545 (608)
Q Consensus 514 ~~~~~~~~l~~Li~~cl~~dp~~RPs~~evl~ 545 (608)
.+...+..+.+++.+||+.+|++|||+.||++
T Consensus 221 ~~~~~~~~~~~~i~~~l~~~P~~Rps~~~il~ 252 (256)
T cd06612 221 DPEKWSPEFNDFVKKCLVKDPEERPSAIQLLQ 252 (256)
T ss_pred chhhcCHHHHHHHHHHHhcChhhCcCHHHHhc
Confidence 12234567999999999999999999999985
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-33 Score=285.00 Aligned_cols=232 Identities=25% Similarity=0.361 Sum_probs=172.9
Q ss_pred eEEEEEeecC-hhhHHHHHHHHHHHhhcCCCCccceecccccCccceEEEeecCCCccchhccccCC--CCCCCHHHHHH
Q 044312 302 QAVKKSKVID-ESKVEEFINEVVILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGTLFQYIHDQNE--DFPITWEIRLR 378 (608)
Q Consensus 302 ~avk~~~~~~-~~~~~~~~~Ei~il~~l~H~niv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~--~~~l~~~~~~~ 378 (608)
.++|+.+... ......|.+|+.++++++||||+++++++.+....++||||+++|+|.++++.... ....++..+..
T Consensus 25 ~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~ 104 (269)
T cd05087 25 VVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCPLGDLKGYLRSCRKAELMTPDPTTLQR 104 (269)
T ss_pred EEEEecCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEECCCCCcHHHHHHHhhhcccccccHHHHHH
Confidence 3566555432 23345789999999999999999999999999999999999999999999975322 22467888899
Q ss_pred HHHHHHHHHHHHhhcCCCCeeccCCCCCcEEEcCCCcEEEeeccCccccccCCcce-eeeeeccCCCCChhhhccC----
Q 044312 379 IAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHM-TTQVHGTFGYLDPEYFRSS---- 453 (608)
Q Consensus 379 i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGls~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~---- 453 (608)
++.|++.||+|||+.+ ++||||||+||+++.++.+||+|||+++......... .....++..|+|||++...
T Consensus 105 ~~~qi~~al~~lH~~~---i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~ 181 (269)
T cd05087 105 MACEIALGLLHLHKNN---FIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYVTPDQLWVPLRWIAPELVDEVHGNL 181 (269)
T ss_pred HHHHHHHHHHHHHHCC---EeccccCcceEEEcCCCcEEECCccccccccCcceeecCCCcCCcccccCHhHhccccccc
Confidence 9999999999999999 9999999999999999999999999997544322211 1234567889999998642
Q ss_pred ---CCCCccchHhHHHHHHHHHh-CCCCCCccchhhcccHHHHHHHHhhhhhhHHHhhhhhhccCChhHHHHHHHHHHHH
Q 044312 454 ---QFTDKSDVYSFGVVLTELLT-GEKPIRFTILEEDKSLAAYFLCAMKEERLFEILDARVMKQGGKDEIITVAKLAKRC 529 (608)
Q Consensus 454 ---~~t~ksDV~S~Gvvl~ellt-g~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~Li~~c 529 (608)
.++.++||||||++++||++ |+.||......+. ... ..... ...+.++ ......+..+.+++.+|
T Consensus 182 ~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~---~~~---~~~~~-~~~~~~~----~~~~~~~~~~~~l~~~c 250 (269)
T cd05087 182 LVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQV---LTY---TVREQ-QLKLPKP----RLKLPLSDRWYEVMQFC 250 (269)
T ss_pred cccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHHH---HHH---Hhhcc-cCCCCCC----ccCCCCChHHHHHHHHH
Confidence 35789999999999999996 9999864322111 000 00100 0011111 11113345688899999
Q ss_pred hccCCCCCCCHHHHHHHHH
Q 044312 530 LNLNGKKRPTMREVASELA 548 (608)
Q Consensus 530 l~~dp~~RPs~~evl~~L~ 548 (608)
+ .+|++|||++||+..|+
T Consensus 251 ~-~~P~~Rpt~~~l~~~l~ 268 (269)
T cd05087 251 W-LQPEQRPSAEEVHLLLS 268 (269)
T ss_pred h-cCcccCCCHHHHHHHhc
Confidence 9 68999999999998774
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-33 Score=287.28 Aligned_cols=233 Identities=26% Similarity=0.389 Sum_probs=185.9
Q ss_pred CccccceeccCce---------------EEEEEeecC-hhhHHHHHHHHHHHhhcCCCCccceecccccCccceEEEeec
Q 044312 290 NFDLNRILGQGGQ---------------AVKKSKVID-ESKVEEFINEVVILSQINHRNVVKLLGCCLETEVPLLVYEFI 353 (608)
Q Consensus 290 ~f~~~~~lG~G~~---------------avk~~~~~~-~~~~~~~~~Ei~il~~l~H~niv~l~~~~~~~~~~~lV~E~~ 353 (608)
+|++.+.||.|++ |+|...... ......+.+|+.+++.++|+||+++++++.+....++|+||+
T Consensus 2 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~ 81 (274)
T cd06609 2 LFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWIIMEYC 81 (274)
T ss_pred hhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccccchHHHHHHHHHHHHHHcCCCCeeeeeEEEEECCeEEEEEEee
Confidence 4666677777753 566554332 445678899999999999999999999999999999999999
Q ss_pred CCCccchhccccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEEcCCCcEEEeeccCccccccCCcc
Q 044312 354 PNGTLFQYIHDQNEDFPITWEIRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTH 433 (608)
Q Consensus 354 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGls~~~~~~~~~ 433 (608)
++++|.+++... ++++..+..++.|++.||.|||+.+ ++|+||+|+||++++++.++|+|||+++.......
T Consensus 82 ~~~~L~~~~~~~----~~~~~~~~~~~~ql~~~l~~lh~~~---i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~- 153 (274)
T cd06609 82 GGGSCLDLLKPG----KLDETYIAFILREVLLGLEYLHEEG---KIHRDIKAANILLSEEGDVKLADFGVSGQLTSTMS- 153 (274)
T ss_pred CCCcHHHHHhhc----CCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEEcccccceeeccccc-
Confidence 999999998754 5899999999999999999999998 99999999999999999999999999987654321
Q ss_pred eeeeeeccCCCCChhhhccCCCCCccchHhHHHHHHHHHhCCCCCCccchhhcccHHHHHHHHhhhhhhHHHhhhhhhcc
Q 044312 434 MTTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLTELLTGEKPIRFTILEEDKSLAAYFLCAMKEERLFEILDARVMKQ 513 (608)
Q Consensus 434 ~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~ 513 (608)
......++..|+|||++.+..++.++||||||++++||+||+.||....... ........ ....
T Consensus 154 ~~~~~~~~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~tg~~p~~~~~~~~-------~~~~~~~~---------~~~~ 217 (274)
T cd06609 154 KRNTFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLHPMR-------VLFLIPKN---------NPPS 217 (274)
T ss_pred ccccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccCchHH-------HHHHhhhc---------CCCC
Confidence 2233457889999999999899999999999999999999999986322110 00001100 1111
Q ss_pred CChh-HHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 044312 514 GGKD-EIITVAKLAKRCLNLNGKKRPTMREVASE 546 (608)
Q Consensus 514 ~~~~-~~~~l~~Li~~cl~~dp~~RPs~~evl~~ 546 (608)
.... .+..+.+++.+||..+|++||++++++++
T Consensus 218 ~~~~~~~~~~~~~l~~~l~~~p~~Rpt~~~il~~ 251 (274)
T cd06609 218 LEGNKFSKPFKDFVSLCLNKDPKERPSAKELLKH 251 (274)
T ss_pred CcccccCHHHHHHHHHHhhCChhhCcCHHHHhhC
Confidence 1111 45679999999999999999999999874
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=288.36 Aligned_cols=222 Identities=24% Similarity=0.379 Sum_probs=178.2
Q ss_pred eEEEEEeec-ChhhHHHHHHHHHHHhhcCCCCccceecccccCccceEEEeecCCCccchhccccCCCCCCCHHHHHHHH
Q 044312 302 QAVKKSKVI-DESKVEEFINEVVILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEIRLRIA 380 (608)
Q Consensus 302 ~avk~~~~~-~~~~~~~~~~Ei~il~~l~H~niv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~ 380 (608)
+|+|..... .....+.+.+|+.++++++||||+++++++......++||||+++++|.+++... .+++..+..++
T Consensus 32 vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~----~~~~~~~~~~~ 107 (277)
T cd06642 32 VAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWIIMEYLGGGSALDLLKPG----PLEETYIATIL 107 (277)
T ss_pred EEEEEeccccchHHHHHHHHHHHHHHcCCCCccHhhhcccccCCceEEEEEccCCCcHHHHhhcC----CCCHHHHHHHH
Confidence 366665532 2345568999999999999999999999999999999999999999999988642 48999999999
Q ss_pred HHHHHHHHHHhhcCCCCeeccCCCCCcEEEcCCCcEEEeeccCccccccCCcceeeeeeccCCCCChhhhccCCCCCccc
Q 044312 381 IEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHGTFGYLDPEYFRSSQFTDKSD 460 (608)
Q Consensus 381 ~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGls~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksD 460 (608)
.|+++||.|||+.+ ++|+||+|+||++++++.+||+|||++........ ......++..|+|||++.+..++.++|
T Consensus 108 ~~i~~~l~~lH~~~---ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~D 183 (277)
T cd06642 108 REILKGLDYLHSER---KIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQI-KRNTFVGTPFWMAPEVIKQSAYDFKAD 183 (277)
T ss_pred HHHHHHHHHHhcCC---eeccCCChheEEEeCCCCEEEccccccccccCcch-hhhcccCcccccCHHHhCcCCCchhhh
Confidence 99999999999998 99999999999999999999999999976643221 222345788999999999999999999
Q ss_pred hHhHHHHHHHHHhCCCCCCccchhhcccHHHHHHHHhhhhhhHHHhhhhhhccCChhHHHHHHHHHHHHhccCCCCCCCH
Q 044312 461 VYSFGVVLTELLTGEKPIRFTILEEDKSLAAYFLCAMKEERLFEILDARVMKQGGKDEIITVAKLAKRCLNLNGKKRPTM 540 (608)
Q Consensus 461 V~S~Gvvl~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPs~ 540 (608)
|||||++++||++|+.|+....... . ...+............+..+.+++.+||+.+|++||++
T Consensus 184 v~slG~il~el~tg~~p~~~~~~~~-------~---------~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~ 247 (277)
T cd06642 184 IWSLGITAIELAKGEPPNSDLHPMR-------V---------LFLIPKNSPPTLEGQYSKPFKEFVEACLNKDPRFRPTA 247 (277)
T ss_pred HHHHHHHHHHHHhCCCCCcccchhh-------H---------HhhhhcCCCCCCCcccCHHHHHHHHHHccCCcccCcCH
Confidence 9999999999999999976321110 0 00011111112223455679999999999999999999
Q ss_pred HHHHHHH
Q 044312 541 REVASEL 547 (608)
Q Consensus 541 ~evl~~L 547 (608)
.||+++-
T Consensus 248 ~~il~~~ 254 (277)
T cd06642 248 KELLKHK 254 (277)
T ss_pred HHHHHhH
Confidence 9999853
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-33 Score=283.17 Aligned_cols=236 Identities=24% Similarity=0.379 Sum_probs=188.0
Q ss_pred CccccceeccCce---------------EEEEEeec--ChhhHHHHHHHHHHHhhcCCCCccceecccccCccceEEEee
Q 044312 290 NFDLNRILGQGGQ---------------AVKKSKVI--DESKVEEFINEVVILSQINHRNVVKLLGCCLETEVPLLVYEF 352 (608)
Q Consensus 290 ~f~~~~~lG~G~~---------------avk~~~~~--~~~~~~~~~~Ei~il~~l~H~niv~l~~~~~~~~~~~lV~E~ 352 (608)
+|++.+.||+|++ ++|..... .....+++.+|+.++++++||||+++++++.+.+..++||||
T Consensus 1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08218 1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVMDY 80 (256)
T ss_pred CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEeeecCCCeEEEEEec
Confidence 4677788888863 66665532 344557899999999999999999999999999999999999
Q ss_pred cCCCccchhccccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEEcCCCcEEEeeccCccccccCCc
Q 044312 353 IPNGTLFQYIHDQNEDFPITWEIRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQT 432 (608)
Q Consensus 353 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGls~~~~~~~~ 432 (608)
+++++|.+++..... ..+++..++.++.|++.||.|||+.+ ++|+||+|+|||++.++.++|+|||++........
T Consensus 81 ~~~~~l~~~~~~~~~-~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~~~~ 156 (256)
T cd08218 81 CEGGDLYKKINAQRG-VLFPEDQILDWFVQICLALKHVHDRK---ILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVE 156 (256)
T ss_pred CCCCcHHHHHHhccC-CCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCEEEeeccceeecCcchh
Confidence 999999998876432 24789999999999999999999998 99999999999999999999999999976543221
Q ss_pred ceeeeeeccCCCCChhhhccCCCCCccchHhHHHHHHHHHhCCCCCCccchhhcccHHHHHHHHhhhhhhHHHhhhhhhc
Q 044312 433 HMTTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLTELLTGEKPIRFTILEEDKSLAAYFLCAMKEERLFEILDARVMK 512 (608)
Q Consensus 433 ~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~ 512 (608)
......|++.|+|||++.+...+.++||||||+++++|++|+.||...... ..+. .++.. ...
T Consensus 157 -~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~------~~~~---------~~~~~-~~~ 219 (256)
T cd08218 157 -LARTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAGNMK------NLVL---------KIIRG-SYP 219 (256)
T ss_pred -hhhhccCCccccCHHHhCCCCCCCccchhHHHHHHHHHHcCCCCccCCCHH------HHHH---------HHhcC-CCC
Confidence 122345788999999999999999999999999999999999998632211 1111 11111 011
Q ss_pred cCChhHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 044312 513 QGGKDEIITVAKLAKRCLNLNGKKRPTMREVASE 546 (608)
Q Consensus 513 ~~~~~~~~~l~~Li~~cl~~dp~~RPs~~evl~~ 546 (608)
..+...+.++.+++.+||+.+|++||++.||+++
T Consensus 220 ~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~vl~~ 253 (256)
T cd08218 220 PVSSHYSYDLRNLVSQLFKRNPRDRPSVNSILEK 253 (256)
T ss_pred CCcccCCHHHHHHHHHHhhCChhhCcCHHHHhhC
Confidence 1233456689999999999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-34 Score=295.79 Aligned_cols=220 Identities=23% Similarity=0.313 Sum_probs=173.6
Q ss_pred eEEEEEeec---ChhhHHHHHHHHHHHhhc-CCCCccceecccccCccceEEEeecCCCccchhccccCCCCCCCHHHHH
Q 044312 302 QAVKKSKVI---DESKVEEFINEVVILSQI-NHRNVVKLLGCCLETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEIRL 377 (608)
Q Consensus 302 ~avk~~~~~---~~~~~~~~~~Ei~il~~l-~H~niv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~ 377 (608)
+|+|..+.. .....+.+..|..++..+ +||||+++++++.+.+..++||||+++|+|.+++.... .+++..+.
T Consensus 23 ~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~g~L~~~i~~~~---~~~~~~~~ 99 (316)
T cd05620 23 FAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLNGGDLMFHIQDKG---RFDLYRAT 99 (316)
T ss_pred EEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCCCCCcHHHHHHHcC---CCCHHHHH
Confidence 467766542 123456677888888765 89999999999999999999999999999999887643 48999999
Q ss_pred HHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEEcCCCcEEEeeccCccccccCCcceeeeeeccCCCCChhhhccCCCCC
Q 044312 378 RIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHGTFGYLDPEYFRSSQFTD 457 (608)
Q Consensus 378 ~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGls~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ 457 (608)
.++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++...... .......||+.|+|||++.+..++.
T Consensus 100 ~~~~qi~~~l~~lH~~~---ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~ 175 (316)
T cd05620 100 FYAAEIVCGLQFLHSKG---IIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGD-NRASTFCGTPDYIAPEILQGLKYTF 175 (316)
T ss_pred HHHHHHHHHHHHHHHCC---eEecCCCHHHeEECCCCCEEeCccCCCeecccCC-CceeccCCCcCccCHHHHcCCCCCc
Confidence 99999999999999999 9999999999999999999999999987533221 2234456899999999999999999
Q ss_pred ccchHhHHHHHHHHHhCCCCCCccchhhcccHHHHHHHHhhhhhhHHHhhhhhhccCChhHHHHHHHHHHHHhccCCCCC
Q 044312 458 KSDVYSFGVVLTELLTGEKPIRFTILEEDKSLAAYFLCAMKEERLFEILDARVMKQGGKDEIITVAKLAKRCLNLNGKKR 537 (608)
Q Consensus 458 ksDV~S~Gvvl~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~Li~~cl~~dp~~R 537 (608)
++||||||++++||++|+.||...... . ....+... ....+...+.++.+|+.+||+.||++|
T Consensus 176 ~~DiwslGvil~el~~g~~Pf~~~~~~------~-~~~~~~~~----------~~~~~~~~~~~~~~li~~~l~~dP~~R 238 (316)
T cd05620 176 SVDWWSFGVLLYEMLIGQSPFHGDDED------E-LFESIRVD----------TPHYPRWITKESKDILEKLFERDPTRR 238 (316)
T ss_pred ccchhhhHHHHHHHHhCCCCCCCCCHH------H-HHHHHHhC----------CCCCCCCCCHHHHHHHHHHccCCHHHc
Confidence 999999999999999999999633211 0 00011100 011223345678999999999999999
Q ss_pred CCHH-HHHH
Q 044312 538 PTMR-EVAS 545 (608)
Q Consensus 538 Ps~~-evl~ 545 (608)
|++. ++++
T Consensus 239 ~~~~~~~~~ 247 (316)
T cd05620 239 LGVVGNIRG 247 (316)
T ss_pred CCChHHHHc
Confidence 9985 5553
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-33 Score=285.40 Aligned_cols=209 Identities=25% Similarity=0.499 Sum_probs=170.8
Q ss_pred HHHHHHHHHHHhhcCCCCccceecccccCccceEEEeecCCCccchhccccCCCCCCCHHHHHHHHHHHHHHHHHHhhcC
Q 044312 315 VEEFINEVVILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEIRLRIAIEVSGALSYLHSAA 394 (608)
Q Consensus 315 ~~~~~~Ei~il~~l~H~niv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~ 394 (608)
.+.+.+|+.++++++||||+++++++.+.+..++||||+++++|.+++.... .+++..+..++.|++.||+|||+.+
T Consensus 50 ~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~---~l~~~~~~~~~~~l~~~l~~lH~~~ 126 (267)
T cd06628 50 LDALAREIALLKELQHENIVQYLGSSLDADHLNIFLEYVPGGSVAALLNNYG---AFEETLVRNFVRQILKGLNYLHNRG 126 (267)
T ss_pred HHHHHHHHHHHHhcCCCCeeeEEEEEEeCCccEEEEEecCCCCHHHHHHhcc---CccHHHHHHHHHHHHHHHHHHHhcC
Confidence 3678899999999999999999999999999999999999999999997643 4889999999999999999999998
Q ss_pred CCCeeccCCCCCcEEEcCCCcEEEeeccCccccccCCcc-----eeeeeeccCCCCChhhhccCCCCCccchHhHHHHHH
Q 044312 395 SIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTH-----MTTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLT 469 (608)
Q Consensus 395 ~~~iiHrDlk~~NILl~~~~~~kl~DFGls~~~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~ 469 (608)
++||||+|+|||+++++.+||+|||+++........ ......|+..|+|||.+....++.++||||||++++
T Consensus 127 ---ivH~di~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~ 203 (267)
T cd06628 127 ---IIHRDIKGANILVDNKGGIKISDFGISKKLEANSLSTKTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVV 203 (267)
T ss_pred ---cccccCCHHHEEEcCCCCEEecccCCCcccccccccCCccccccccCCCcCccChhHhccCCCCchhhhHHHHHHHH
Confidence 999999999999999999999999999876522111 112245788999999999889999999999999999
Q ss_pred HHHhCCCCCCccchhhcccHHHHHHHHhhhhhhHHHhhhhhhccCChhHHHHHHHHHHHHhccCCCCCCCHHHHHH
Q 044312 470 ELLTGEKPIRFTILEEDKSLAAYFLCAMKEERLFEILDARVMKQGGKDEIITVAKLAKRCLNLNGKKRPTMREVAS 545 (608)
Q Consensus 470 elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~evl~ 545 (608)
+|++|+.||...... .. +..+.. ......+...+..+.+++.+||+.||++||++.||++
T Consensus 204 ~l~~g~~p~~~~~~~-----~~----------~~~~~~-~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 263 (267)
T cd06628 204 EMLTGKHPFPDCTQL-----QA----------IFKIGE-NASPEIPSNISSEAIDFLEKTFEIDHNKRPTAAELLK 263 (267)
T ss_pred HHhhCCCCCCCccHH-----HH----------HHHHhc-cCCCcCCcccCHHHHHHHHHHccCCchhCcCHHHHhh
Confidence 999999998632110 00 001101 1111223345678999999999999999999999985
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-33 Score=287.75 Aligned_cols=237 Identities=25% Similarity=0.369 Sum_probs=182.7
Q ss_pred CccccceeccCce---------------EEEEEeec-ChhhHHHHHHHHHHHhhcCCCCccceecccccCccceEEEeec
Q 044312 290 NFDLNRILGQGGQ---------------AVKKSKVI-DESKVEEFINEVVILSQINHRNVVKLLGCCLETEVPLLVYEFI 353 (608)
Q Consensus 290 ~f~~~~~lG~G~~---------------avk~~~~~-~~~~~~~~~~Ei~il~~l~H~niv~l~~~~~~~~~~~lV~E~~ 353 (608)
+|++.+.||+|++ |+|..... .....+.|.+|+.++++++||||+++++.+...+..++||||+
T Consensus 2 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 81 (279)
T cd06619 2 DIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAFFVENRISICTEFM 81 (279)
T ss_pred cchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCCChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECCEEEEEEecC
Confidence 4666777888763 66665432 2344567999999999999999999999999999999999999
Q ss_pred CCCccchhccccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEEcCCCcEEEeeccCccccccCCcc
Q 044312 354 PNGTLFQYIHDQNEDFPITWEIRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTH 433 (608)
Q Consensus 354 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGls~~~~~~~~~ 433 (608)
++++|..+. .+++..+..++.|++.||.|||+.+ |+|+||||+|||++.++.+||+|||++......
T Consensus 82 ~~~~l~~~~-------~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~~--- 148 (279)
T cd06619 82 DGGSLDVYR-------KIPEHVLGRIAVAVVKGLTYLWSLK---ILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNS--- 148 (279)
T ss_pred CCCChHHhh-------cCCHHHHHHHHHHHHHHHHHHHHCC---EeeCCCCHHHEEECCCCCEEEeeCCcceecccc---
Confidence 999986542 3688889999999999999999999 999999999999999999999999999765422
Q ss_pred eeeeeeccCCCCChhhhccCCCCCccchHhHHHHHHHHHhCCCCCCccchhhcccHHHHHHHHhhhhhhHHHhhhhhhcc
Q 044312 434 MTTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLTELLTGEKPIRFTILEEDKSLAAYFLCAMKEERLFEILDARVMKQ 513 (608)
Q Consensus 434 ~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~ 513 (608)
......++..|+|||++....++.++||||||++++||++|+.||............. .....+.+......
T Consensus 149 ~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~--------~~~~~~~~~~~~~~ 220 (279)
T cd06619 149 IAKTYVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPL--------QLLQCIVDEDPPVL 220 (279)
T ss_pred cccCCCCChhhcCceeecCCCCCCcchHHHHHHHHHHHHhCCCCchhhcccccccchH--------HHHHHHhccCCCCC
Confidence 1233468899999999999999999999999999999999999986422211110000 00001111100111
Q ss_pred CChhHHHHHHHHHHHHhccCCCCCCCHHHHHHHH
Q 044312 514 GGKDEIITVAKLAKRCLNLNGKKRPTMREVASEL 547 (608)
Q Consensus 514 ~~~~~~~~l~~Li~~cl~~dp~~RPs~~evl~~L 547 (608)
.....+.++.+++.+||+.+|++||+++|++++.
T Consensus 221 ~~~~~~~~~~~li~~~l~~~P~~Rp~~~eil~~~ 254 (279)
T cd06619 221 PVGQFSEKFVHFITQCMRKQPKERPAPENLMDHP 254 (279)
T ss_pred CCCcCCHHHHHHHHHHhhCChhhCCCHHHHhcCc
Confidence 1123456789999999999999999999998764
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-33 Score=292.31 Aligned_cols=248 Identities=23% Similarity=0.362 Sum_probs=184.9
Q ss_pred cCccccceeccCce---------------EEEEEeecC-hhhHHHHHHHHHHHhhcCCCCccceecccccCccceEEEee
Q 044312 289 DNFDLNRILGQGGQ---------------AVKKSKVID-ESKVEEFINEVVILSQINHRNVVKLLGCCLETEVPLLVYEF 352 (608)
Q Consensus 289 ~~f~~~~~lG~G~~---------------avk~~~~~~-~~~~~~~~~Ei~il~~l~H~niv~l~~~~~~~~~~~lV~E~ 352 (608)
++|.+.+.||+|++ |+|..+... ......+.+|+.+++.++||||+++++++.+....++||||
T Consensus 6 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~e~ 85 (301)
T cd07873 6 ETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEY 85 (301)
T ss_pred cceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccccCchhHHHHHHHHHHhcCCCCcceEEEEEecCCeEEEEEec
Confidence 45788888998874 566555332 23345788999999999999999999999999999999999
Q ss_pred cCCCccchhccccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEEcCCCcEEEeeccCccccccCCc
Q 044312 353 IPNGTLFQYIHDQNEDFPITWEIRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQT 432 (608)
Q Consensus 353 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGls~~~~~~~~ 432 (608)
++ ++|.+++..... .+++..+..++.||+.||+|||+.+ ++|+||||+|||+++++.+||+|||+++.......
T Consensus 86 ~~-~~l~~~l~~~~~--~~~~~~~~~~~~qi~~aL~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~ 159 (301)
T cd07873 86 LD-KDLKQYLDDCGN--SINMHNVKLFLFQLLRGLNYCHRRK---VLHRDLKPQNLLINERGELKLADFGLARAKSIPTK 159 (301)
T ss_pred cc-cCHHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCHHHEEECCCCcEEECcCcchhccCCCCC
Confidence 97 589888876433 4889999999999999999999999 99999999999999999999999999976543221
Q ss_pred ceeeeeeccCCCCChhhhccC-CCCCccchHhHHHHHHHHHhCCCCCCccchhhcccHHHHHHHHhh---hhhhHHHhhh
Q 044312 433 HMTTQVHGTFGYLDPEYFRSS-QFTDKSDVYSFGVVLTELLTGEKPIRFTILEEDKSLAAYFLCAMK---EERLFEILDA 508 (608)
Q Consensus 433 ~~~~~~~gt~~y~aPE~~~~~-~~t~ksDV~S~Gvvl~elltg~~p~~~~~~~~~~~l~~~~~~~~~---~~~~~~~~d~ 508 (608)
......+++.|+|||.+.+. .++.++||||||++++||++|+.||......+. ...+...+. ......+++.
T Consensus 160 -~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~ 235 (301)
T cd07873 160 -TYSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQ---LHFIFRILGTPTEETWPGILSN 235 (301)
T ss_pred -cccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHHHH---HHHHHHHcCCCChhhchhhhcc
Confidence 12233568899999998654 578899999999999999999999974432211 111111110 1111111110
Q ss_pred ---------hhh----ccCChhHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 044312 509 ---------RVM----KQGGKDEIITVAKLAKRCLNLNGKKRPTMREVASE 546 (608)
Q Consensus 509 ---------~~~----~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~evl~~ 546 (608)
... .......+..+.+|+.+||+.||.+|||++|++++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~h 286 (301)
T cd07873 236 EEFKSYNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMKH 286 (301)
T ss_pred ccccccccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhcC
Confidence 000 01112345678999999999999999999999864
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-33 Score=287.53 Aligned_cols=232 Identities=25% Similarity=0.297 Sum_probs=180.2
Q ss_pred ccccceeccCce---------------EEEEEeec---ChhhHHHHHHHHHHHhhcCCCCccceecccccCccceEEEee
Q 044312 291 FDLNRILGQGGQ---------------AVKKSKVI---DESKVEEFINEVVILSQINHRNVVKLLGCCLETEVPLLVYEF 352 (608)
Q Consensus 291 f~~~~~lG~G~~---------------avk~~~~~---~~~~~~~~~~Ei~il~~l~H~niv~l~~~~~~~~~~~lV~E~ 352 (608)
|+..+.||+|+| |+|..... .....+.+.+|+++|++++|+||+++.+.+..++..++||||
T Consensus 2 ~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~ 81 (285)
T cd05632 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVLTI 81 (285)
T ss_pred ceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCCEEEEEEEe
Confidence 566778888864 55655432 122345678999999999999999999999999999999999
Q ss_pred cCCCccchhccccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEEcCCCcEEEeeccCccccccCCc
Q 044312 353 IPNGTLFQYIHDQNEDFPITWEIRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQT 432 (608)
Q Consensus 353 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGls~~~~~~~~ 432 (608)
+++++|.+++..... ..+++..+..++.|++.||.|||+.+ |+||||||+||++++++.+||+|||++.......
T Consensus 82 ~~~~~L~~~~~~~~~-~~~~~~~~~~~~~ql~~~l~~lH~~~---iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~- 156 (285)
T cd05632 82 MNGGDLKFHIYNMGN-PGFEEERALFYAAEILCGLEDLHREN---TVYRDLKPENILLDDYGHIRISDLGLAVKIPEGE- 156 (285)
T ss_pred ccCccHHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCCHHHEEECCCCCEEEecCCcceecCCCC-
Confidence 999999988875432 25999999999999999999999999 9999999999999999999999999987654322
Q ss_pred ceeeeeeccCCCCChhhhccCCCCCccchHhHHHHHHHHHhCCCCCCccchhhcccHHHHHHHHhhhhhhHHHhhhhhhc
Q 044312 433 HMTTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLTELLTGEKPIRFTILEEDKSLAAYFLCAMKEERLFEILDARVMK 512 (608)
Q Consensus 433 ~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~ 512 (608)
......|+..|+|||++.+..++.++||||||++++||++|+.||......... ........ .. ..
T Consensus 157 -~~~~~~g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~~~~---~~~~~~~~--------~~--~~ 222 (285)
T cd05632 157 -SIRGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVKR---EEVDRRVL--------ET--EE 222 (285)
T ss_pred -cccCCCCCcCccChHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHH---HHHHHhhh--------cc--cc
Confidence 123346899999999999999999999999999999999999999643221110 00000000 00 01
Q ss_pred cCChhHHHHHHHHHHHHhccCCCCCCCHH
Q 044312 513 QGGKDEIITVAKLAKRCLNLNGKKRPTMR 541 (608)
Q Consensus 513 ~~~~~~~~~l~~Li~~cl~~dp~~RPs~~ 541 (608)
......+..+.+|+.+||+.||++||++.
T Consensus 223 ~~~~~~~~~~~~li~~~l~~~P~~R~~~~ 251 (285)
T cd05632 223 VYSAKFSEEAKSICKMLLTKDPKQRLGCQ 251 (285)
T ss_pred ccCccCCHHHHHHHHHHccCCHhHcCCCc
Confidence 12234456789999999999999999943
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-33 Score=281.76 Aligned_cols=225 Identities=31% Similarity=0.506 Sum_probs=179.5
Q ss_pred EEEEEeecChh-hHHHHHHHHHHHhhcCCCCccceecccccCccceEEEeecCCCccchhccccCCCCCCCHHHHHHHHH
Q 044312 303 AVKKSKVIDES-KVEEFINEVVILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEIRLRIAI 381 (608)
Q Consensus 303 avk~~~~~~~~-~~~~~~~Ei~il~~l~H~niv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~ 381 (608)
|+|..+..... ..+.+.+|+.++++++|+||+++++++.+.+..+++|||+++++|.+++...... .+++..+..++.
T Consensus 32 aiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~i~e~~~~~~l~~~~~~~~~~-~~~~~~~~~~~~ 110 (258)
T smart00219 32 AVKTLKEDADEQQIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLMIVMEYMEGGDLLDYLRKNRPK-ELSLSDLLSFAL 110 (258)
T ss_pred EEEEccCCCChHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCeeEEEEeccCCCCHHHHHHhhhhc-cCCHHHHHHHHH
Confidence 56665543322 5778999999999999999999999999999999999999999999999764432 289999999999
Q ss_pred HHHHHHHHHhhcCCCCeeccCCCCCcEEEcCCCcEEEeeccCccccccCCcceeeeeeccCCCCChhhhccCCCCCccch
Q 044312 382 EVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHGTFGYLDPEYFRSSQFTDKSDV 461 (608)
Q Consensus 382 ~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGls~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV 461 (608)
|++.||+|||+.+ ++|+||||+||++++++.+||+|||+++..............+++.|+|||.+....++.++||
T Consensus 111 ql~~~l~~lh~~~---~~h~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di 187 (258)
T smart00219 111 QIARGMEYLESKN---FIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYKKKGGKLPIRWMAPESLKDGKFTSKSDV 187 (258)
T ss_pred HHHHHHHHHhcCC---eeecccccceEEEccCCeEEEcccCCceecccccccccccCCCcccccChHHhccCCCCcchhH
Confidence 9999999999998 9999999999999999999999999998765443322222346789999999988899999999
Q ss_pred HhHHHHHHHHHh-CCCCCCccchhhcccHHHHHHHHhhhhhhHHHhhhhhhccCChhHHHHHHHHHHHHhccCCCCCCCH
Q 044312 462 YSFGVVLTELLT-GEKPIRFTILEEDKSLAAYFLCAMKEERLFEILDARVMKQGGKDEIITVAKLAKRCLNLNGKKRPTM 540 (608)
Q Consensus 462 ~S~Gvvl~ellt-g~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPs~ 540 (608)
||||++++||++ |..||..... .... +.+........+...+.++.+++.+||..+|++|||+
T Consensus 188 ~slG~i~~~l~~~g~~p~~~~~~------~~~~----------~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~ 251 (258)
T smart00219 188 WSFGVLLWEIFTLGESPYPGMSN------EEVL----------EYLKKGYRLPKPENCPPEIYKLMLQCWAEDPEDRPTF 251 (258)
T ss_pred HHHHHHHHHHHhCCCCCCCCCCH------HHHH----------HHHhcCCCCCCCCcCCHHHHHHHHHHCcCChhhCcCH
Confidence 999999999998 7788753111 1111 1111111112223356789999999999999999999
Q ss_pred HHHHHHH
Q 044312 541 REVASEL 547 (608)
Q Consensus 541 ~evl~~L 547 (608)
.|+++.|
T Consensus 252 ~~ll~~l 258 (258)
T smart00219 252 SELVEIL 258 (258)
T ss_pred HHHHhhC
Confidence 9998754
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-34 Score=308.48 Aligned_cols=247 Identities=23% Similarity=0.349 Sum_probs=178.7
Q ss_pred HhcCccccceeccCce---------------EEEEEeecChhhHHHHHHHHHHHhhcCCCCccceecccccC--------
Q 044312 287 ATDNFDLNRILGQGGQ---------------AVKKSKVIDESKVEEFINEVVILSQINHRNVVKLLGCCLET-------- 343 (608)
Q Consensus 287 ~t~~f~~~~~lG~G~~---------------avk~~~~~~~~~~~~~~~Ei~il~~l~H~niv~l~~~~~~~-------- 343 (608)
...+|.+.++||+|+| |||++.. ......+|+.+|++++||||+++++++...
T Consensus 64 ~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~----~~~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~~~ 139 (440)
T PTZ00036 64 PNKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQ----DPQYKNRELLIMKNLNHINIIFLKDYYYTECFKKNEKN 139 (440)
T ss_pred cCCeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEec----CcchHHHHHHHHHhcCCCCCcceeeeEeecccccCCCc
Confidence 4567999999999985 4554432 123345799999999999999998876422
Q ss_pred ccceEEEeecCCCccchhcccc-CCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEEcCC-CcEEEeec
Q 044312 344 EVPLLVYEFIPNGTLFQYIHDQ-NEDFPITWEIRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDK-YRAKVSDF 421 (608)
Q Consensus 344 ~~~~lV~E~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~-~~~kl~DF 421 (608)
...++||||+++ +|.+++... .....+++..+..++.||+.||+|||+.+ |+||||||+|||++.+ +.+||+||
T Consensus 140 ~~l~lvmE~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~~---IiHrDLKp~NILl~~~~~~vkL~DF 215 (440)
T PTZ00036 140 IFLNVVMEFIPQ-TVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSKF---ICHRDLKPQNLLIDPNTHTLKLCDF 215 (440)
T ss_pred eEEEEEEecCCc-cHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCcCHHHEEEcCCCCceeeecc
Confidence 246789999975 777766532 12235899999999999999999999999 9999999999999865 47999999
Q ss_pred cCccccccCCcceeeeeeccCCCCChhhhccC-CCCCccchHhHHHHHHHHHhCCCCCCccchhhcccHHHHHHHHhhh-
Q 044312 422 GASRSMAVDQTHMTTQVHGTFGYLDPEYFRSS-QFTDKSDVYSFGVVLTELLTGEKPIRFTILEEDKSLAAYFLCAMKE- 499 (608)
Q Consensus 422 Gls~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~t~ksDV~S~Gvvl~elltg~~p~~~~~~~~~~~l~~~~~~~~~~- 499 (608)
|+++.+..... .....||+.|+|||++.+. .++.++|||||||+|+||++|.+||......+ .+.. ....+..
T Consensus 216 Gla~~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~--~~~~-i~~~~~~p 290 (440)
T PTZ00036 216 GSAKNLLAGQR--SVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVD--QLVR-IIQVLGTP 290 (440)
T ss_pred ccchhccCCCC--cccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHH--HHHH-HHHHhCCC
Confidence 99987653322 2334679999999998654 68999999999999999999999997432211 1111 1111100
Q ss_pred --hhhHH------------HhhhhhhccCChhHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 044312 500 --ERLFE------------ILDARVMKQGGKDEIITVAKLAKRCLNLNGKKRPTMREVASE 546 (608)
Q Consensus 500 --~~~~~------------~~d~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~evl~~ 546 (608)
+.+.. +....+....+...+.++.+|+.+||+.||.+|||+.|++++
T Consensus 291 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~h 351 (440)
T PTZ00036 291 TEDQLKEMNPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALAD 351 (440)
T ss_pred CHHHHHHhchhhhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHhCC
Confidence 00000 000111112223345689999999999999999999999975
|
|
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-33 Score=297.89 Aligned_cols=247 Identities=24% Similarity=0.337 Sum_probs=183.5
Q ss_pred HhcCccccceeccCce---------------EEEEEee--cChhhHHHHHHHHHHHhhcCCCCccceecccccCc-----
Q 044312 287 ATDNFDLNRILGQGGQ---------------AVKKSKV--IDESKVEEFINEVVILSQINHRNVVKLLGCCLETE----- 344 (608)
Q Consensus 287 ~t~~f~~~~~lG~G~~---------------avk~~~~--~~~~~~~~~~~Ei~il~~l~H~niv~l~~~~~~~~----- 344 (608)
..++|.+.+.||+|++ |||+... .+......+.+|+.+++.++||||+++++++....
T Consensus 19 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 98 (359)
T cd07876 19 VLKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEF 98 (359)
T ss_pred hhhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCcccc
Confidence 3468999999999985 6666543 23345677889999999999999999999886443
Q ss_pred -cceEEEeecCCCccchhccccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEEcCCCcEEEeeccC
Q 044312 345 -VPLLVYEFIPNGTLFQYIHDQNEDFPITWEIRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGA 423 (608)
Q Consensus 345 -~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGl 423 (608)
..++||||+++ +|.+.++. .+++..+..++.|++.||.|||+++ |+||||||+|||++.++.+||+|||+
T Consensus 99 ~~~~lv~e~~~~-~l~~~~~~-----~~~~~~~~~~~~qi~~~L~~LH~~~---ivHrDlkp~NIl~~~~~~~kl~Dfg~ 169 (359)
T cd07876 99 QDVYLVMELMDA-NLCQVIHM-----ELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGL 169 (359)
T ss_pred ceeEEEEeCCCc-CHHHHHhc-----cCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEEecCCC
Confidence 46899999965 66666542 3788999999999999999999999 99999999999999999999999999
Q ss_pred ccccccCCcceeeeeeccCCCCChhhhccCCCCCccchHhHHHHHHHHHhCCCCCCccchhhcccHHHHHHHHhhhh---
Q 044312 424 SRSMAVDQTHMTTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLTELLTGEKPIRFTILEEDKSLAAYFLCAMKEE--- 500 (608)
Q Consensus 424 s~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~--- 500 (608)
++..... .......||+.|+|||.+.+..++.++||||||+++|||++|+.||........ +. .........
T Consensus 170 a~~~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~--~~-~~~~~~~~~~~~ 244 (359)
T cd07876 170 ARTACTN--FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQ--WN-KVIEQLGTPSAE 244 (359)
T ss_pred ccccccC--ccCCCCcccCCCCCchhccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHH--HH-HHHHhcCCCcHH
Confidence 9764322 222345689999999999999999999999999999999999999974322110 00 000000000
Q ss_pred -------hhHHHhhhhhh------------------ccCChhHHHHHHHHHHHHhccCCCCCCCHHHHHHHH
Q 044312 501 -------RLFEILDARVM------------------KQGGKDEIITVAKLAKRCLNLNGKKRPTMREVASEL 547 (608)
Q Consensus 501 -------~~~~~~d~~~~------------------~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~evl~~L 547 (608)
.+......... .......+..+.+|+.+||+.||++|||+.|++++-
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp 316 (359)
T cd07876 245 FMNRLQPTVRNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEALRHP 316 (359)
T ss_pred HHHHHHHHHHHHHhhCCCCCCcchhhhccccccccccccccccchhHHHHHHHHhccCcccCCCHHHHhcCc
Confidence 00000000000 001112245789999999999999999999999764
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-33 Score=288.17 Aligned_cols=250 Identities=21% Similarity=0.320 Sum_probs=183.0
Q ss_pred CccccceeccCc---------------eEEEEEeec--ChhhHHHHHHHHHHHhhcCCCCccceecccccCccceEEEee
Q 044312 290 NFDLNRILGQGG---------------QAVKKSKVI--DESKVEEFINEVVILSQINHRNVVKLLGCCLETEVPLLVYEF 352 (608)
Q Consensus 290 ~f~~~~~lG~G~---------------~avk~~~~~--~~~~~~~~~~Ei~il~~l~H~niv~l~~~~~~~~~~~lV~E~ 352 (608)
+|++.+.||+|+ +|+|+.+.. +....+.+.+|+.++++++||||+++++++.+....++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (285)
T cd07861 1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLMQESRLYLIFEF 80 (285)
T ss_pred CceEeeEecccCceEEEEEEECCCCcEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeEEEEEec
Confidence 366677778776 366766543 223456788999999999999999999999999999999999
Q ss_pred cCCCccchhccccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEEcCCCcEEEeeccCccccccCCc
Q 044312 353 IPNGTLFQYIHDQNEDFPITWEIRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQT 432 (608)
Q Consensus 353 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGls~~~~~~~~ 432 (608)
++ ++|.+++........+++..+..++.||+.||+|||+.+ ++|+||||+|||+++++.+||+|||++.......
T Consensus 81 ~~-~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~- 155 (285)
T cd07861 81 LS-MDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSRR---VLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPV- 155 (285)
T ss_pred CC-CCHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCCHHHEEEcCCCcEEECcccceeecCCCc-
Confidence 97 688888876443346899999999999999999999999 9999999999999999999999999997654322
Q ss_pred ceeeeeeccCCCCChhhhccC-CCCCccchHhHHHHHHHHHhCCCCCCccchhhcccHHHHHHHHhh--hh---------
Q 044312 433 HMTTQVHGTFGYLDPEYFRSS-QFTDKSDVYSFGVVLTELLTGEKPIRFTILEEDKSLAAYFLCAMK--EE--------- 500 (608)
Q Consensus 433 ~~~~~~~gt~~y~aPE~~~~~-~~t~ksDV~S~Gvvl~elltg~~p~~~~~~~~~~~l~~~~~~~~~--~~--------- 500 (608)
.......+++.|+|||.+.+. .++.++||||||++++||+||+.||....... .....+..... ..
T Consensus 156 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~ 233 (285)
T cd07861 156 RVYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEID--QLFRIFRILGTPTEDVWPGVTSLP 233 (285)
T ss_pred ccccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHH--HHHHHHHHhCCCChhhhhcchhhH
Confidence 112233568899999988654 57899999999999999999999986432111 01100000000 00
Q ss_pred hhHHHhhh---hhhccCChhHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 044312 501 RLFEILDA---RVMKQGGKDEIITVAKLAKRCLNLNGKKRPTMREVASE 546 (608)
Q Consensus 501 ~~~~~~d~---~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~evl~~ 546 (608)
........ ..........+.++.+++.+||..||++|||+.+|+++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~~ 282 (285)
T cd07861 234 DYKNTFPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALNH 282 (285)
T ss_pred HHHhhccccCcchhHHhcCCCCHHHHHHHHHHhcCChhhCCCHHHHhcC
Confidence 00000000 00001112345678899999999999999999999753
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-33 Score=287.43 Aligned_cols=238 Identities=26% Similarity=0.340 Sum_probs=188.3
Q ss_pred cCccccceeccCce---------------EEEEEeecChhhHHHHHHHHHHHhhcCCCCccceecccccCccceEEEeec
Q 044312 289 DNFDLNRILGQGGQ---------------AVKKSKVIDESKVEEFINEVVILSQINHRNVVKLLGCCLETEVPLLVYEFI 353 (608)
Q Consensus 289 ~~f~~~~~lG~G~~---------------avk~~~~~~~~~~~~~~~Ei~il~~l~H~niv~l~~~~~~~~~~~lV~E~~ 353 (608)
++|++.+.||.|++ |+|..........+.|.+|+.++++++|+||+++++.+.+....++||||+
T Consensus 5 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 84 (280)
T cd06611 5 DIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYFYENKLWILIEFC 84 (280)
T ss_pred hHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeCCHHHHHHHHHHHHHHHhCCCCceeEEEEEEecCCeEEEEeecc
Confidence 45667777777763 677777666777889999999999999999999999999999999999999
Q ss_pred CCCccchhccccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEEcCCCcEEEeeccCccccccCCcc
Q 044312 354 PNGTLFQYIHDQNEDFPITWEIRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTH 433 (608)
Q Consensus 354 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGls~~~~~~~~~ 433 (608)
++++|.+++..... .+++..+..++.|++.||.|||+.+ |+|+||||+||+++.++.+||+|||++........
T Consensus 85 ~~~~L~~~~~~~~~--~l~~~~~~~~~~ql~~~l~~lh~~~---i~h~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~- 158 (280)
T cd06611 85 DGGALDSIMLELER--GLTEPQIRYVCRQMLEALNFLHSHK---VIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQ- 158 (280)
T ss_pred CCCcHHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChhhEEECCCCCEEEccCccchhhccccc-
Confidence 99999999876433 5899999999999999999999999 99999999999999999999999999876543221
Q ss_pred eeeeeeccCCCCChhhhc-----cCCCCCccchHhHHHHHHHHHhCCCCCCccchhhcccHHHHHHHHhhhhhhHHHhhh
Q 044312 434 MTTQVHGTFGYLDPEYFR-----SSQFTDKSDVYSFGVVLTELLTGEKPIRFTILEEDKSLAAYFLCAMKEERLFEILDA 508 (608)
Q Consensus 434 ~~~~~~gt~~y~aPE~~~-----~~~~t~ksDV~S~Gvvl~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 508 (608)
......+++.|+|||.+. ...++.++||||||+++|||++|+.||...... .... .+.....
T Consensus 159 ~~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~~------~~~~-~~~~~~~------ 225 (280)
T cd06611 159 KRDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPM------RVLL-KILKSEP------ 225 (280)
T ss_pred ccceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCHH------HHHH-HHhcCCC------
Confidence 223456889999999975 345678999999999999999999998632111 0010 0000000
Q ss_pred hhhccCChhHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 044312 509 RVMKQGGKDEIITVAKLAKRCLNLNGKKRPTMREVASE 546 (608)
Q Consensus 509 ~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~evl~~ 546 (608)
.....+...+.++.+++.+||+.+|++||++.+++++
T Consensus 226 -~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 262 (280)
T cd06611 226 -PTLDQPSKWSSSFNDFLKSCLVKDPDDRPTAAELLKH 262 (280)
T ss_pred -CCcCCcccCCHHHHHHHHHHhccChhhCcCHHHHhcC
Confidence 0011122345678999999999999999999999875
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-33 Score=293.82 Aligned_cols=235 Identities=20% Similarity=0.277 Sum_probs=173.7
Q ss_pred eEEEEEeec--ChhhHHHHHHHHHHHhhcCCCCccceecccccCccceEEEeecCCCccchhccccCCCCCCCHHHHHHH
Q 044312 302 QAVKKSKVI--DESKVEEFINEVVILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEIRLRI 379 (608)
Q Consensus 302 ~avk~~~~~--~~~~~~~~~~Ei~il~~l~H~niv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i 379 (608)
+|+|++... .....+.+.+|+.+++.++||||+++++++...+..++||||+++|+|.+++...... .+++..++.+
T Consensus 28 vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~-~l~~~~~~~i 106 (327)
T cd08227 28 VTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFMAYGSAKDLICTHFMD-GMSELAIAYI 106 (327)
T ss_pred EEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEEEEEeccCCCcHHHHHHhhccC-CCCHHHHHHH
Confidence 367766542 2334566788999999999999999999999999999999999999999998754322 4899999999
Q ss_pred HHHHHHHHHHHhhcCCCCeeccCCCCCcEEEcCCCcEEEeeccCccccccCCcc------eeeeeeccCCCCChhhhcc-
Q 044312 380 AIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTH------MTTQVHGTFGYLDPEYFRS- 452 (608)
Q Consensus 380 ~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGls~~~~~~~~~------~~~~~~gt~~y~aPE~~~~- 452 (608)
+.|++.||+|||+++ |+||||||+|||++.++.++++||+........... ......++..|+|||++.+
T Consensus 107 ~~qi~~~L~~LH~~~---iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~ 183 (327)
T cd08227 107 LQGVLKALDYIHHMG---YVHRSVKASHILISVDGKVYLSGLRSNLSMINHGQRLRVVHDFPKYSVKVLPWLSPEVLQQN 183 (327)
T ss_pred HHHHHHHHHHHHHCC---EecCCCChhhEEEecCCcEEEcccchhhccccccccccccccccccccceecccChHHhhcc
Confidence 999999999999999 999999999999999999999999865433211100 0112246678999999976
Q ss_pred -CCCCCccchHhHHHHHHHHHhCCCCCCccchhhcccHHHHHHHHhhhhhhHHHhhh-----------------------
Q 044312 453 -SQFTDKSDVYSFGVVLTELLTGEKPIRFTILEEDKSLAAYFLCAMKEERLFEILDA----------------------- 508 (608)
Q Consensus 453 -~~~t~ksDV~S~Gvvl~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~----------------------- 508 (608)
..++.++||||||++++||++|+.||....... ....... ..+...++.
T Consensus 184 ~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~------~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 256 (327)
T cd08227 184 LQGYDAKSDIYSVGITACELANGHVPFKDMPATQ------MLLEKLN-GTVPCLLDTTTIPAEELTMKPSRSGANSGLGE 256 (327)
T ss_pred cCCCCchhhHHHHHHHHHHHHHCCCCCCCcchhH------HHHHHhc-CCccccccccchhhhhcccCCcccCCcCCCCc
Confidence 468999999999999999999999986322111 0000000 000000000
Q ss_pred -------------hhhccCChhHHHHHHHHHHHHhccCCCCCCCHHHHHHHH
Q 044312 509 -------------RVMKQGGKDEIITVAKLAKRCLNLNGKKRPTMREVASEL 547 (608)
Q Consensus 509 -------------~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~evl~~L 547 (608)
..........+..+.+|+.+||+.||++|||++||+++-
T Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~ell~~p 308 (327)
T cd08227 257 STTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQCLQRNPDARPSASTLLNHS 308 (327)
T ss_pred ccccCCcCccccCCcccccccccCHHHHHHHHHHHhhCchhcCCHHHHhcCh
Confidence 000011123456789999999999999999999998753
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-33 Score=284.31 Aligned_cols=208 Identities=23% Similarity=0.416 Sum_probs=166.7
Q ss_pred hhhHHHHHHHHHHHhhcCCCCccceecccccCccceEEEeecCCCccchhccccCCCCCCCHHHHHHHHHHHHHHHHHHh
Q 044312 312 ESKVEEFINEVVILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEIRLRIAIEVSGALSYLH 391 (608)
Q Consensus 312 ~~~~~~~~~Ei~il~~l~H~niv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH 391 (608)
....+.+.+|+.+++.++||||+++++++......++||||+++|+|.++++.... .+++..++.++.||+.||+|||
T Consensus 40 ~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~--~~~~~~~~~~~~qi~~~l~~lH 117 (258)
T cd05078 40 RNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMVQEYVKFGSLDTYLKKNKN--LINISWKLEVAKQLAWALHFLE 117 (258)
T ss_pred HHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcEEEEecCCCCcHHHHHhcCCC--CCCHHHHHHHHHHHHHHHHHHH
Confidence 34456789999999999999999999999998899999999999999999986543 4899999999999999999999
Q ss_pred hcCCCCeeccCCCCCcEEEcCCCc--------EEEeeccCccccccCCcceeeeeeccCCCCChhhhccC-CCCCccchH
Q 044312 392 SAASIPIYHRDIKSTNILLDDKYR--------AKVSDFGASRSMAVDQTHMTTQVHGTFGYLDPEYFRSS-QFTDKSDVY 462 (608)
Q Consensus 392 ~~~~~~iiHrDlk~~NILl~~~~~--------~kl~DFGls~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~t~ksDV~ 462 (608)
+.+ |+||||||+|||++.++. +|++|||++...... ....++..|+|||++.+. .++.++|||
T Consensus 118 ~~~---iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g~~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~~Diw 189 (258)
T cd05078 118 DKG---LTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISITVLPK-----EILLERIPWVPPECIENPQNLSLAADKW 189 (258)
T ss_pred HCC---eecCCCccceEEEecccccccCCCceEEecccccccccCCc-----hhccccCCccCchhccCCCCCCchhhHH
Confidence 999 999999999999987654 699999988654321 224578899999999864 579999999
Q ss_pred hHHHHHHHHHhCC-CCCCccchhhcccHHHHHHHHhhhhhhHHHhhhhhhccCChhHHHHHHHHHHHHhccCCCCCCCHH
Q 044312 463 SFGVVLTELLTGE-KPIRFTILEEDKSLAAYFLCAMKEERLFEILDARVMKQGGKDEIITVAKLAKRCLNLNGKKRPTMR 541 (608)
Q Consensus 463 S~Gvvl~elltg~-~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~ 541 (608)
|||+++|||++|. .|+....... ....... ....+.....++.+|+.+||+.+|++|||++
T Consensus 190 slG~~l~~l~~g~~~~~~~~~~~~----------------~~~~~~~--~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ 251 (258)
T cd05078 190 SFGTTLWEIFSGGDKPLSALDSQK----------------KLQFYED--RHQLPAPKWTELANLINQCMDYEPDFRPSFR 251 (258)
T ss_pred HHHHHHHHHHcCCCCChhhccHHH----------------HHHHHHc--cccCCCCCcHHHHHHHHHHhccChhhCCCHH
Confidence 9999999999985 5543211110 0000010 1122223446799999999999999999999
Q ss_pred HHHHHH
Q 044312 542 EVASEL 547 (608)
Q Consensus 542 evl~~L 547 (608)
++++.|
T Consensus 252 ~il~~l 257 (258)
T cd05078 252 AIIRDL 257 (258)
T ss_pred HHHHhc
Confidence 999876
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-33 Score=286.18 Aligned_cols=239 Identities=25% Similarity=0.370 Sum_probs=185.2
Q ss_pred cCccccceeccCce---------------EEEEEeecChhhHHHHHHHHHHHhhcCCCCccceecccccCccceEEEeec
Q 044312 289 DNFDLNRILGQGGQ---------------AVKKSKVIDESKVEEFINEVVILSQINHRNVVKLLGCCLETEVPLLVYEFI 353 (608)
Q Consensus 289 ~~f~~~~~lG~G~~---------------avk~~~~~~~~~~~~~~~Ei~il~~l~H~niv~l~~~~~~~~~~~lV~E~~ 353 (608)
++|.+.+.||+|++ |+|..+.........+.+|+.+++.++||||+++++.+...+..++||||+
T Consensus 9 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~~~~lv~e~~ 88 (267)
T cd06645 9 EDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKLWICMEFC 88 (267)
T ss_pred HHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEEecc
Confidence 35666777788763 666666555555677899999999999999999999999999999999999
Q ss_pred CCCccchhccccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEEcCCCcEEEeeccCccccccCCcc
Q 044312 354 PNGTLFQYIHDQNEDFPITWEIRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTH 433 (608)
Q Consensus 354 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGls~~~~~~~~~ 433 (608)
++++|.+++.... .+++.+++.++.|++.||.|||+.+ ++|+||||+|||++.++.+||+|||++...... ..
T Consensus 89 ~~~~L~~~~~~~~---~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~-~~ 161 (267)
T cd06645 89 GGGSLQDIYHVTG---PLSESQIAYVSRETLQGLYYLHSKG---KMHRDIKGANILLTDNGHVKLADFGVSAQITAT-IA 161 (267)
T ss_pred CCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEECcceeeeEccCc-cc
Confidence 9999999987543 4899999999999999999999999 999999999999999999999999998765422 12
Q ss_pred eeeeeeccCCCCChhhhc---cCCCCCccchHhHHHHHHHHHhCCCCCCccchhhcccHHHHHHHHhhhhhhHHHhhhhh
Q 044312 434 MTTQVHGTFGYLDPEYFR---SSQFTDKSDVYSFGVVLTELLTGEKPIRFTILEEDKSLAAYFLCAMKEERLFEILDARV 510 (608)
Q Consensus 434 ~~~~~~gt~~y~aPE~~~---~~~~t~ksDV~S~Gvvl~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~ 510 (608)
......|+..|+|||++. ...++.++|||||||+++||++|+.||........ .+ ........ .+..
T Consensus 162 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~~-----~~--~~~~~~~~---~~~~ 231 (267)
T cd06645 162 KRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRA-----LF--LMTKSNFQ---PPKL 231 (267)
T ss_pred ccccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccchhh-----HH--hhhccCCC---CCcc
Confidence 223446899999999974 45688999999999999999999999853221110 00 00000000 0000
Q ss_pred hccCChhHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 044312 511 MKQGGKDEIITVAKLAKRCLNLNGKKRPTMREVASE 546 (608)
Q Consensus 511 ~~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~evl~~ 546 (608)
......+..+.+++.+||+.+|++||++.+|+++
T Consensus 232 --~~~~~~~~~~~~li~~~l~~~P~~R~~~~~ll~~ 265 (267)
T cd06645 232 --KDKMKWSNSFHHFVKMALTKNPKKRPTAEKLLQH 265 (267)
T ss_pred --cccCCCCHHHHHHHHHHccCCchhCcCHHHHhcC
Confidence 0011234578999999999999999999998753
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-33 Score=295.59 Aligned_cols=241 Identities=21% Similarity=0.339 Sum_probs=184.3
Q ss_pred cCccccceeccCce---------------EEEEEee---cChhhHHHHHHHHHHHhhcCCCCccceecccccCccceEEE
Q 044312 289 DNFDLNRILGQGGQ---------------AVKKSKV---IDESKVEEFINEVVILSQINHRNVVKLLGCCLETEVPLLVY 350 (608)
Q Consensus 289 ~~f~~~~~lG~G~~---------------avk~~~~---~~~~~~~~~~~Ei~il~~l~H~niv~l~~~~~~~~~~~lV~ 350 (608)
++|++.++||+|+| |+|.... ........|.+|+.++..++|+||+++++++.+.+..++||
T Consensus 1 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (332)
T cd05623 1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDENNLYLVM 80 (332)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCEEEEEE
Confidence 36888899999985 4554432 12233456889999999999999999999999999999999
Q ss_pred eecCCCccchhccccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEEcCCCcEEEeeccCccccccC
Q 044312 351 EFIPNGTLFQYIHDQNEDFPITWEIRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVD 430 (608)
Q Consensus 351 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGls~~~~~~ 430 (608)
||+++|+|.+++.+... .+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++.....
T Consensus 81 ey~~~g~L~~~l~~~~~--~l~~~~~~~~~~qi~~al~~lH~~~---iiHrDlkp~Nili~~~~~~kL~DfG~a~~~~~~ 155 (332)
T cd05623 81 DYYVGGDLLTLLSKFED--RLPEDMARFYLAEMVIAIDSVHQLH---YVHRDIKPDNILMDMNGHIRLADFGSCLKLMED 155 (332)
T ss_pred eccCCCcHHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHEEECCCCCEEEeecchheecccC
Confidence 99999999999976433 4899999999999999999999999 999999999999999999999999999765444
Q ss_pred CcceeeeeeccCCCCChhhhc-----cCCCCCccchHhHHHHHHHHHhCCCCCCccchhhcccHHHHHHHHhhhhhhHHH
Q 044312 431 QTHMTTQVHGTFGYLDPEYFR-----SSQFTDKSDVYSFGVVLTELLTGEKPIRFTILEEDKSLAAYFLCAMKEERLFEI 505 (608)
Q Consensus 431 ~~~~~~~~~gt~~y~aPE~~~-----~~~~t~ksDV~S~Gvvl~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 505 (608)
.........||+.|+|||++. ...++.++|||||||++|||++|+.||..... ...+...........
T Consensus 156 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~~------~~~~~~i~~~~~~~~- 228 (332)
T cd05623 156 GTVQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESL------VETYGKIMNHKERFQ- 228 (332)
T ss_pred CcceecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCCH------HHHHHHHhCCCcccc-
Confidence 333334457999999999986 34688999999999999999999999963221 111111111100000
Q ss_pred hhhhhhccCChhHHHHHHHHHHHHhccCCCC--CCCHHHHHHH
Q 044312 506 LDARVMKQGGKDEIITVAKLAKRCLNLNGKK--RPTMREVASE 546 (608)
Q Consensus 506 ~d~~~~~~~~~~~~~~l~~Li~~cl~~dp~~--RPs~~evl~~ 546 (608)
........+.++.+|+.+|+..++++ ||++.|++++
T Consensus 229 -----~p~~~~~~s~~~~~li~~ll~~~~~r~~r~~~~~~~~h 266 (332)
T cd05623 229 -----FPAQVTDVSEDAKDLIRRLICSREHRLGQNGIEDFKQH 266 (332)
T ss_pred -----CCCccccCCHHHHHHHHHHccChhhhcCCCCHHHHhCC
Confidence 01111234668899999998665444 6899998876
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-33 Score=283.09 Aligned_cols=239 Identities=33% Similarity=0.537 Sum_probs=185.8
Q ss_pred ccccceeccCce---------------EEEEEeecChhhHH--HHHHHHHHHhhcCCCCccceecccccCccceEEEeec
Q 044312 291 FDLNRILGQGGQ---------------AVKKSKVIDESKVE--EFINEVVILSQINHRNVVKLLGCCLETEVPLLVYEFI 353 (608)
Q Consensus 291 f~~~~~lG~G~~---------------avk~~~~~~~~~~~--~~~~Ei~il~~l~H~niv~l~~~~~~~~~~~lV~E~~ 353 (608)
|++.+.||+|++ |+|........... ...+|+.++++++||||+++++++.+....++|||++
T Consensus 1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~v~~~~ 80 (260)
T PF00069_consen 1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQDDNYLYIVMEYC 80 (260)
T ss_dssp EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEESSEEEEEEEEE
T ss_pred CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccccchhhhhhhcccccccccccccccccccccccccccccc
Confidence 567788999874 67777665443332 3456999999999999999999999999999999999
Q ss_pred CCCccchhccccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEEcCCCcEEEeeccCccccccCCcc
Q 044312 354 PNGTLFQYIHDQNEDFPITWEIRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTH 433 (608)
Q Consensus 354 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGls~~~~~~~~~ 433 (608)
++++|.+++.... .+++..++.++.|+++||++||+.+ ++|+||||+|||++.++.++|+|||.+.... ....
T Consensus 81 ~~~~L~~~l~~~~---~~~~~~~~~~~~qi~~~L~~Lh~~~---i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~~-~~~~ 153 (260)
T PF00069_consen 81 PGGSLQDYLQKNK---PLSEEEILKIAYQILEALAYLHSKG---IVHRDIKPENILLDENGEVKLIDFGSSVKLS-ENNE 153 (260)
T ss_dssp TTEBHHHHHHHHS---SBBHHHHHHHHHHHHHHHHHHHHTT---EEESSBSGGGEEESTTSEEEESSGTTTEEST-STTS
T ss_pred ccccccccccccc---ccccccccccccccccccccccccc---ccccccccccccccccccccccccccccccc-cccc
Confidence 9999999998332 5899999999999999999999999 9999999999999999999999999997642 2223
Q ss_pred eeeeeeccCCCCChhhhc-cCCCCCccchHhHHHHHHHHHhCCCCCCccchhhcccHHHHHHHHhhhhhhHHHhhhhhhc
Q 044312 434 MTTQVHGTFGYLDPEYFR-SSQFTDKSDVYSFGVVLTELLTGEKPIRFTILEEDKSLAAYFLCAMKEERLFEILDARVMK 512 (608)
Q Consensus 434 ~~~~~~gt~~y~aPE~~~-~~~~t~ksDV~S~Gvvl~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~ 512 (608)
......++..|+|||.+. ....+.++||||+|+++++|++|..||........ ...+...... . .....
T Consensus 154 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~~~~---~~~~~~~~~~----~-~~~~~-- 223 (260)
T PF00069_consen 154 NFNPFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESNSDDQ---LEIIEKILKR----P-LPSSS-- 223 (260)
T ss_dssp EBSSSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSHHHH---HHHHHHHHHT----H-HHHHT--
T ss_pred ccccccccccccccccccccccccccccccccccccccccccccccccccchhh---hhhhhhcccc----c-ccccc--
Confidence 344566899999999998 88899999999999999999999999874311111 0001000000 0 00000
Q ss_pred cCChhHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 044312 513 QGGKDEIITVAKLAKRCLNLNGKKRPTMREVASE 546 (608)
Q Consensus 513 ~~~~~~~~~l~~Li~~cl~~dp~~RPs~~evl~~ 546 (608)
.........+.+++.+||+.||++||++.+++++
T Consensus 224 ~~~~~~~~~l~~li~~~l~~~p~~R~~~~~l~~~ 257 (260)
T PF00069_consen 224 QQSREKSEELRDLIKKMLSKDPEQRPSAEELLKH 257 (260)
T ss_dssp TSHTTSHHHHHHHHHHHSSSSGGGSTTHHHHHTS
T ss_pred cccchhHHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 0001113689999999999999999999999853
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-33 Score=297.65 Aligned_cols=246 Identities=21% Similarity=0.314 Sum_probs=183.0
Q ss_pred HhcCccccceeccCce---------------EEEEEeec--ChhhHHHHHHHHHHHhhcCCCCccceecccccC------
Q 044312 287 ATDNFDLNRILGQGGQ---------------AVKKSKVI--DESKVEEFINEVVILSQINHRNVVKLLGCCLET------ 343 (608)
Q Consensus 287 ~t~~f~~~~~lG~G~~---------------avk~~~~~--~~~~~~~~~~Ei~il~~l~H~niv~l~~~~~~~------ 343 (608)
..++|++.+.||+|++ |||+.... +....+.+.+|+.+++.++||||+++++++...
T Consensus 15 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 94 (355)
T cd07874 15 VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEEF 94 (355)
T ss_pred hhhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeeeecccccccc
Confidence 4568999999999985 55655432 334456788999999999999999999988543
Q ss_pred ccceEEEeecCCCccchhccccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEEcCCCcEEEeeccC
Q 044312 344 EVPLLVYEFIPNGTLFQYIHDQNEDFPITWEIRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGA 423 (608)
Q Consensus 344 ~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGl 423 (608)
...++||||+++ +|.+.+.. .+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+
T Consensus 95 ~~~~lv~e~~~~-~l~~~~~~-----~l~~~~~~~~~~qi~~aL~~LH~~g---ivHrDikp~Nill~~~~~~kl~Dfg~ 165 (355)
T cd07874 95 QDVYLVMELMDA-NLCQVIQM-----ELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGL 165 (355)
T ss_pred ceeEEEhhhhcc-cHHHHHhh-----cCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChHHEEECCCCCEEEeeCcc
Confidence 346899999965 66666642 3788999999999999999999999 99999999999999999999999999
Q ss_pred ccccccCCcceeeeeeccCCCCChhhhccCCCCCccchHhHHHHHHHHHhCCCCCCccchhhcccHHHHHHHHhhh----
Q 044312 424 SRSMAVDQTHMTTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLTELLTGEKPIRFTILEEDKSLAAYFLCAMKE---- 499 (608)
Q Consensus 424 s~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~elltg~~p~~~~~~~~~~~l~~~~~~~~~~---- 499 (608)
++..... .......||+.|+|||++.+..++.++||||||++++||++|+.||......+. ... ....+..
T Consensus 166 ~~~~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~--~~~-~~~~~~~~~~~ 240 (355)
T cd07874 166 ARTAGTS--FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQ--WNK-VIEQLGTPCPE 240 (355)
T ss_pred cccCCCc--cccCCccccCCccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH--HHH-HHHHhCCCCHH
Confidence 9865322 222345689999999999999999999999999999999999999974322111 000 0000000
Q ss_pred ------hhhHHHhhh----------hh--------hccCChhHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 044312 500 ------ERLFEILDA----------RV--------MKQGGKDEIITVAKLAKRCLNLNGKKRPTMREVASE 546 (608)
Q Consensus 500 ------~~~~~~~d~----------~~--------~~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~evl~~ 546 (608)
......++. .. ...........+.+|+.+||+.||++|||+.|++++
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~~ell~h 311 (355)
T cd07874 241 FMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQH 311 (355)
T ss_pred HHHhhcHHHHHHHhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCchhcCCHHHHhcC
Confidence 000000000 00 000111234578999999999999999999999975
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-34 Score=286.46 Aligned_cols=249 Identities=24% Similarity=0.295 Sum_probs=184.0
Q ss_pred hcCccccceeccCce---------------EEEEEeecChhhHHHHHHHHHHHhhcCCCCccceecccccCc-----cce
Q 044312 288 TDNFDLNRILGQGGQ---------------AVKKSKVIDESKVEEFINEVVILSQINHRNVVKLLGCCLETE-----VPL 347 (608)
Q Consensus 288 t~~f~~~~~lG~G~~---------------avk~~~~~~~~~~~~~~~Ei~il~~l~H~niv~l~~~~~~~~-----~~~ 347 (608)
+-.|...+++|.|.| |||+.....+ ---+|+++|+.++|||||+|+.+|.... ...
T Consensus 23 ~i~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r----~knrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~ln 98 (364)
T KOG0658|consen 23 EISYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKR----YKNRELQIMRKLDHPNIVRLLYFFSSSTESDEVYLN 98 (364)
T ss_pred EEEEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCCC----cCcHHHHHHHhcCCcCeeeEEEEEEecCCCchhHHH
Confidence 335677889999986 5555543222 2246999999999999999999885332 345
Q ss_pred EEEeecCCCccchhcccc-CCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEEcCC-CcEEEeeccCcc
Q 044312 348 LVYEFIPNGTLFQYIHDQ-NEDFPITWEIRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDK-YRAKVSDFGASR 425 (608)
Q Consensus 348 lV~E~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~-~~~kl~DFGls~ 425 (608)
|||||||. +|.+.++.. ..+..++...+.-+..||.+||+|||+.+ |+||||||.|+|+|.+ +.+||+|||.|+
T Consensus 99 lVleymP~-tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~~---IcHRDIKPqNlLvD~~tg~LKicDFGSAK 174 (364)
T KOG0658|consen 99 LVLEYMPE-TLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSHG---ICHRDIKPQNLLVDPDTGVLKICDFGSAK 174 (364)
T ss_pred HHHHhchH-HHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhcC---cccCCCChheEEEcCCCCeEEeccCCcce
Confidence 89999987 899888752 11224788888889999999999999999 9999999999999965 999999999999
Q ss_pred ccccCCcceeeeeeccCCCCChhhhccC-CCCCccchHhHHHHHHHHHhCCCCCCccchhhcccHHHHHHHHhhhhhhHH
Q 044312 426 SMAVDQTHMTTQVHGTFGYLDPEYFRSS-QFTDKSDVYSFGVVLTELLTGEKPIRFTILEEDKSLAAYFLCAMKEERLFE 504 (608)
Q Consensus 426 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~t~ksDV~S~Gvvl~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~ 504 (608)
.+...... .....|..|+|||.+.+. .|+.+.||||.|||+.||+-|++-|......+.......++.....+.+..
T Consensus 175 ~L~~~epn--iSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~~dQL~eIik~lG~Pt~e~I~~ 252 (364)
T KOG0658|consen 175 VLVKGEPN--ISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDSSVDQLVEIIKVLGTPTREDIKS 252 (364)
T ss_pred eeccCCCc--eeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCCHHHHHHHHHHHhCCCCHHHHhh
Confidence 88655443 445678999999998765 799999999999999999999999875433322222222222112222221
Q ss_pred Hhh-------hhhh-----ccCChhHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 044312 505 ILD-------ARVM-----KQGGKDEIITVAKLAKRCLNLNGKKRPTMREVASE 546 (608)
Q Consensus 505 ~~d-------~~~~-----~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~evl~~ 546 (608)
+-. +++. .-.....+.+..+|+.++|..+|.+|.++.|++.+
T Consensus 253 mn~~y~~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~h 306 (364)
T KOG0658|consen 253 MNPNYTEFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALAH 306 (364)
T ss_pred cCcccccccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHhcc
Confidence 111 1111 11234566789999999999999999999998864
|
|
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-33 Score=301.17 Aligned_cols=250 Identities=22% Similarity=0.299 Sum_probs=184.0
Q ss_pred hcCccccceeccCceEEEE--------------EeecChhhHHHHHHHHHHHhhcCCCCccceecccccCccceEEEeec
Q 044312 288 TDNFDLNRILGQGGQAVKK--------------SKVIDESKVEEFINEVVILSQINHRNVVKLLGCCLETEVPLLVYEFI 353 (608)
Q Consensus 288 t~~f~~~~~lG~G~~avk~--------------~~~~~~~~~~~~~~Ei~il~~l~H~niv~l~~~~~~~~~~~lV~E~~ 353 (608)
..+|.+.+.||+|++.... ++... ....+.+|+++|++++||||+++++++......++|||++
T Consensus 91 ~~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~--~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 168 (392)
T PHA03207 91 RMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVT--GGKTPGREIDILKTISHRAIINLIHAYRWKSTVCMVMPKY 168 (392)
T ss_pred cCceEEEEeecCCCCeEEEEEEEcCCccceeEEEEecc--ccccHHHHHHHHHhcCCCCccceeeeEeeCCEEEEEehhc
Confidence 3468999999999862211 01111 1234678999999999999999999999989999999999
Q ss_pred CCCccchhccccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEEcCCCcEEEeeccCccccccCCc-
Q 044312 354 PNGTLFQYIHDQNEDFPITWEIRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQT- 432 (608)
Q Consensus 354 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGls~~~~~~~~- 432 (608)
. ++|.+++... ..+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++.......
T Consensus 169 ~-~~l~~~l~~~---~~l~~~~~~~i~~ql~~aL~~LH~~g---ivHrDlkp~Nill~~~~~~~l~DfG~a~~~~~~~~~ 241 (392)
T PHA03207 169 K-CDLFTYVDRS---GPLPLEQAITIQRRLLEALAYLHGRG---IIHRDVKTENIFLDEPENAVLGDFGAACKLDAHPDT 241 (392)
T ss_pred C-CCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEcCCCCEEEccCccccccCccccc
Confidence 5 6888888433 25899999999999999999999999 99999999999999999999999999976543322
Q ss_pred ceeeeeeccCCCCChhhhccCCCCCccchHhHHHHHHHHHhCCCCCCccchhhcccHHHHHHHHhhhhh----------h
Q 044312 433 HMTTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLTELLTGEKPIRFTILEEDKSLAAYFLCAMKEER----------L 502 (608)
Q Consensus 433 ~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~----------~ 502 (608)
.......||+.|+|||++....++.++|||||||++|||++|+.||..................+.... +
T Consensus 242 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~l~~i~~~~~~~~~~~~~~~~~~~ 321 (392)
T PHA03207 242 PQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIRCMQVHPLEFPQNGSTNL 321 (392)
T ss_pred ccccccccccCccCHhHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCCCCcHHHHHHHHHHhccCccccCCccchhH
Confidence 222345799999999999999999999999999999999999999864433221111111111111000 0
Q ss_pred HHHh---hhhhhccCC-------hhHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 044312 503 FEIL---DARVMKQGG-------KDEIITVAKLAKRCLNLNGKKRPTMREVASE 546 (608)
Q Consensus 503 ~~~~---d~~~~~~~~-------~~~~~~l~~Li~~cl~~dp~~RPs~~evl~~ 546 (608)
...+ ....+.... ...+.++.+++.+||..||++|||+.|++.+
T Consensus 322 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~~ 375 (392)
T PHA03207 322 CKHFKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDILSL 375 (392)
T ss_pred HHHHHhhcccccCCccccchhhccCcchhHHHHHHHHhccChhhCCCHHHHhhC
Confidence 0000 000000000 1234568899999999999999999999876
|
|
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-33 Score=286.00 Aligned_cols=239 Identities=26% Similarity=0.379 Sum_probs=185.5
Q ss_pred CccccceeccCce---------------EEEEEeec-ChhhHHHHHHHHHHHhhcCCCCccceecccccCccceEEEeec
Q 044312 290 NFDLNRILGQGGQ---------------AVKKSKVI-DESKVEEFINEVVILSQINHRNVVKLLGCCLETEVPLLVYEFI 353 (608)
Q Consensus 290 ~f~~~~~lG~G~~---------------avk~~~~~-~~~~~~~~~~Ei~il~~l~H~niv~l~~~~~~~~~~~lV~E~~ 353 (608)
+|++.+.||+|++ |+|..+.. +....+.+.+|+.++++++|+||+++++.+......++||||+
T Consensus 2 ~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~ 81 (286)
T cd06622 2 EIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAFFIEGAVYMCMEYM 81 (286)
T ss_pred hhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeecccCHHHHHHHHHHHHHHHhcCCCcHHhhhhheecCCeEEEEEeec
Confidence 4666777777763 66665542 3445678999999999999999999999999999999999999
Q ss_pred CCCccchhccccCCCCCCCHHHHHHHHHHHHHHHHHHhh-cCCCCeeccCCCCCcEEEcCCCcEEEeeccCccccccCCc
Q 044312 354 PNGTLFQYIHDQNEDFPITWEIRLRIAIEVSGALSYLHS-AASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQT 432 (608)
Q Consensus 354 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~-~~~~~iiHrDlk~~NILl~~~~~~kl~DFGls~~~~~~~~ 432 (608)
++++|..++........+++..+..++.|++.||.|||+ .+ ++|+||||+|||++.++.+||+|||++.......
T Consensus 82 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~- 157 (286)
T cd06622 82 DAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEHN---IIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVASL- 157 (286)
T ss_pred CCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhcCC---EeeCCCCHHHEEECCCCCEEEeecCCcccccCCc-
Confidence 999999988764323358999999999999999999997 46 9999999999999999999999999987653221
Q ss_pred ceeeeeeccCCCCChhhhccCC------CCCccchHhHHHHHHHHHhCCCCCCccchhhcccHHHHHHHHhhhhhhHHHh
Q 044312 433 HMTTQVHGTFGYLDPEYFRSSQ------FTDKSDVYSFGVVLTELLTGEKPIRFTILEEDKSLAAYFLCAMKEERLFEIL 506 (608)
Q Consensus 433 ~~~~~~~gt~~y~aPE~~~~~~------~t~ksDV~S~Gvvl~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 506 (608)
.....+++.|+|||.+.... ++.++||||||++++||++|+.||....... ... .+..+.
T Consensus 158 --~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~---~~~---------~~~~~~ 223 (286)
T cd06622 158 --AKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYAN---IFA---------QLSAIV 223 (286)
T ss_pred --cccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcchhh---HHH---------HHHHHh
Confidence 22335788999999986543 5889999999999999999999986321110 000 011111
Q ss_pred hhhhhccCChhHHHHHHHHHHHHhccCCCCCCCHHHHHHHH
Q 044312 507 DARVMKQGGKDEIITVAKLAKRCLNLNGKKRPTMREVASEL 547 (608)
Q Consensus 507 d~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~evl~~L 547 (608)
+. .....+...+.++.+++.+||+.+|++||++.+++++-
T Consensus 224 ~~-~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~~ 263 (286)
T cd06622 224 DG-DPPTLPSGYSDDAQDFVAKCLNKIPNRRPTYAQLLEHP 263 (286)
T ss_pred hc-CCCCCCcccCHHHHHHHHHHcccCcccCCCHHHHhcCh
Confidence 11 11122334667899999999999999999999998753
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-33 Score=282.87 Aligned_cols=219 Identities=27% Similarity=0.372 Sum_probs=166.0
Q ss_pred hHHHHHHHHHHHhhcCCCCccceecccccCccceEEEeecCCCccchhccccCCC--CCCCHHHHHHHHHHHHHHHHHHh
Q 044312 314 KVEEFINEVVILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGTLFQYIHDQNED--FPITWEIRLRIAIEVSGALSYLH 391 (608)
Q Consensus 314 ~~~~~~~Ei~il~~l~H~niv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~--~~l~~~~~~~i~~~ia~aL~yLH 391 (608)
....|.+|+.+++.++|+||+++++.+.+....++||||+++|+|.+++...... ...++...+.++.||+.||+|||
T Consensus 38 ~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH 117 (269)
T cd05042 38 EQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLH 117 (269)
T ss_pred HHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEEeCCCCcHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHH
Confidence 3567899999999999999999999999999999999999999999999764321 23567888999999999999999
Q ss_pred hcCCCCeeccCCCCCcEEEcCCCcEEEeeccCccccccCCcce-eeeeeccCCCCChhhhcc-------CCCCCccchHh
Q 044312 392 SAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHM-TTQVHGTFGYLDPEYFRS-------SQFTDKSDVYS 463 (608)
Q Consensus 392 ~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGls~~~~~~~~~~-~~~~~gt~~y~aPE~~~~-------~~~t~ksDV~S 463 (608)
+.+ |+||||||+|||+++++.+||+|||+++......... .....++..|+|||++.. ..++.++||||
T Consensus 118 ~~~---ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~Diws 194 (269)
T cd05042 118 QAD---FIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYITKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWS 194 (269)
T ss_pred hcC---EecccccHhheEecCCCcEEEeccccccccccchheeccCCCCCcccccCHHHHhhccccccccccchhhHHHH
Confidence 999 9999999999999999999999999987543322111 122345678999999753 35688999999
Q ss_pred HHHHHHHHHh-CCCCCCccchhhcccHHHHHHHHhhhhhhHHHhhhhhhccCChhHHHHHHHHHHHHhccCCCCCCCHHH
Q 044312 464 FGVVLTELLT-GEKPIRFTILEEDKSLAAYFLCAMKEERLFEILDARVMKQGGKDEIITVAKLAKRCLNLNGKKRPTMRE 542 (608)
Q Consensus 464 ~Gvvl~ellt-g~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~e 542 (608)
||++++||++ |..||......+ .......... ..+..+ ......+..+.+++..|| .||++|||++|
T Consensus 195 lG~~l~el~~~~~~p~~~~~~~~------~~~~~~~~~~-~~~~~~----~~~~~~~~~~~~~~~~~~-~dp~~Rpt~~~ 262 (269)
T cd05042 195 LGVTMWELFTAADQPYPDLSDEQ------VLKQVVREQD-IKLPKP----QLDLKYSDRWYEVMQFCW-LDPETRPTAEE 262 (269)
T ss_pred HHHHHHHHHhCCCCCCCcCCHHH------HHHHHhhccC-ccCCCC----cccccCCHHHHHHHHHHh-cCcccccCHHH
Confidence 9999999999 778876322111 0000111110 011111 112244567788999998 59999999999
Q ss_pred HHHHH
Q 044312 543 VASEL 547 (608)
Q Consensus 543 vl~~L 547 (608)
|++.|
T Consensus 263 v~~~l 267 (269)
T cd05042 263 VHELL 267 (269)
T ss_pred HHHHh
Confidence 99886
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-33 Score=284.48 Aligned_cols=222 Identities=25% Similarity=0.375 Sum_probs=179.7
Q ss_pred EEEEEeecC-hhhHHHHHHHHHHHhhcCCCCccceecccccCccceEEEeecCCCccchhccccCCCCCCCHHHHHHHHH
Q 044312 303 AVKKSKVID-ESKVEEFINEVVILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEIRLRIAI 381 (608)
Q Consensus 303 avk~~~~~~-~~~~~~~~~Ei~il~~l~H~niv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~ 381 (608)
|+|...... ....+.+.+|+.++++++|+||+++++++.+....++||||+++++|.+++... ++++..+..++.
T Consensus 33 aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~----~l~~~~~~~~~~ 108 (277)
T cd06640 33 AIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWIIMEYLGGGSALDLLRAG----PFDEFQIATMLK 108 (277)
T ss_pred EEEEEeccccHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEecCCCCcHHHHHhcC----CCCHHHHHHHHH
Confidence 666655432 345678999999999999999999999999999999999999999999988642 488999999999
Q ss_pred HHHHHHHHHhhcCCCCeeccCCCCCcEEEcCCCcEEEeeccCccccccCCcceeeeeeccCCCCChhhhccCCCCCccch
Q 044312 382 EVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHGTFGYLDPEYFRSSQFTDKSDV 461 (608)
Q Consensus 382 ~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGls~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV 461 (608)
|++.||+|||+.+ ++|+||+|+||+++.++.++|+|||++........ ......++..|+|||++.+..++.++||
T Consensus 109 ~l~~~l~~lh~~~---ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~-~~~~~~~~~~y~apE~~~~~~~~~~~Dv 184 (277)
T cd06640 109 EILKGLDYLHSEK---KIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQI-KRNTFVGTPFWMAPEVIQQSAYDSKADI 184 (277)
T ss_pred HHHHHHHHHHhCC---ccCcCCChhhEEEcCCCCEEEcccccceeccCCcc-ccccccCcccccCHhHhccCCCccHHHH
Confidence 9999999999998 99999999999999999999999999976643321 2233457889999999998899999999
Q ss_pred HhHHHHHHHHHhCCCCCCccchhhcccHHHHHHHHhhhhhhHHHhhhhhhccCChhHHHHHHHHHHHHhccCCCCCCCHH
Q 044312 462 YSFGVVLTELLTGEKPIRFTILEEDKSLAAYFLCAMKEERLFEILDARVMKQGGKDEIITVAKLAKRCLNLNGKKRPTMR 541 (608)
Q Consensus 462 ~S~Gvvl~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~ 541 (608)
||||++++||++|+.||....... ....+............+..+.+++.+||+.+|++||++.
T Consensus 185 ~slG~il~el~tg~~p~~~~~~~~----------------~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~ 248 (277)
T cd06640 185 WSLGITAIELAKGEPPNSDMHPMR----------------VLFLIPKNNPPTLTGEFSKPFKEFIDACLNKDPSFRPTAK 248 (277)
T ss_pred HHHHHHHHHHHHCCCCCCCcChHh----------------HhhhhhcCCCCCCchhhhHHHHHHHHHHcccCcccCcCHH
Confidence 999999999999999986322110 0001111111223335667899999999999999999999
Q ss_pred HHHHHHH
Q 044312 542 EVASELA 548 (608)
Q Consensus 542 evl~~L~ 548 (608)
+++.+-.
T Consensus 249 ~il~~~~ 255 (277)
T cd06640 249 ELLKHKF 255 (277)
T ss_pred HHHhChH
Confidence 9987643
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-33 Score=288.78 Aligned_cols=236 Identities=24% Similarity=0.403 Sum_probs=189.2
Q ss_pred cCccccceeccCce---------------EEEEEeecChhhHHHHHHHHHHHhhcCCCCccceecccccCccceEEEeec
Q 044312 289 DNFDLNRILGQGGQ---------------AVKKSKVIDESKVEEFINEVVILSQINHRNVVKLLGCCLETEVPLLVYEFI 353 (608)
Q Consensus 289 ~~f~~~~~lG~G~~---------------avk~~~~~~~~~~~~~~~Ei~il~~l~H~niv~l~~~~~~~~~~~lV~E~~ 353 (608)
.+|++.+.||.|++ ++|..........+.+.+|+.+++.++||||+++++.+...+..++|+||+
T Consensus 19 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 98 (296)
T cd06655 19 KKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDSFLVGDELFVVMEYL 98 (296)
T ss_pred ceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecccCchHHHHHHHHHHHHhcCCCceeeeeeeEecCceEEEEEEec
Confidence 35778888888863 566665555556778999999999999999999999999999999999999
Q ss_pred CCCccchhccccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEEcCCCcEEEeeccCccccccCCcc
Q 044312 354 PNGTLFQYIHDQNEDFPITWEIRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTH 433 (608)
Q Consensus 354 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGls~~~~~~~~~ 433 (608)
++++|.+++... .+++..+..++.+++.||+|||+.+ ++|+||||+||+++.++.+||+|||++.........
T Consensus 99 ~~~~L~~~~~~~----~l~~~~~~~i~~~l~~al~~LH~~~---i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~~~~~~ 171 (296)
T cd06655 99 AGGSLTDVVTET----CMDEAQIAAVCRECLQALEFLHANQ---VIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQSK 171 (296)
T ss_pred CCCcHHHHHHhc----CCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEccCccchhccccccc
Confidence 999999988643 4899999999999999999999999 999999999999999999999999998765433221
Q ss_pred eeeeeeccCCCCChhhhccCCCCCccchHhHHHHHHHHHhCCCCCCccchhhcccHHHHHHHHhhhhhhHHHhhhhhhcc
Q 044312 434 MTTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLTELLTGEKPIRFTILEEDKSLAAYFLCAMKEERLFEILDARVMKQ 513 (608)
Q Consensus 434 ~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~ 513 (608)
.....++..|+|||.+.+..++.++|||||||++++|++|+.||........ ....... ......
T Consensus 172 -~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~~lltg~~pf~~~~~~~~------~~~~~~~--------~~~~~~ 236 (296)
T cd06655 172 -RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRA------LYLIATN--------GTPELQ 236 (296)
T ss_pred -CCCcCCCccccCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH------HHHHHhc--------CCcccC
Confidence 2234578899999999998999999999999999999999999864322110 0000000 000111
Q ss_pred CChhHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 044312 514 GGKDEIITVAKLAKRCLNLNGKKRPTMREVASE 546 (608)
Q Consensus 514 ~~~~~~~~l~~Li~~cl~~dp~~RPs~~evl~~ 546 (608)
.+...+..+.+++.+||..+|++||++.+++++
T Consensus 237 ~~~~~~~~~~~li~~~l~~dp~~Rpt~~~il~~ 269 (296)
T cd06655 237 NPEKLSPIFRDFLNRCLEMDVEKRGSAKELLQH 269 (296)
T ss_pred CcccCCHHHHHHHHHHhhcChhhCCCHHHHhhC
Confidence 233455679999999999999999999999864
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-33 Score=293.27 Aligned_cols=228 Identities=25% Similarity=0.356 Sum_probs=180.4
Q ss_pred CccccceeccCce---------------EEEEEeec---ChhhHHHHHHHHHHHhhcC-CCCccceecccccCccceEEE
Q 044312 290 NFDLNRILGQGGQ---------------AVKKSKVI---DESKVEEFINEVVILSQIN-HRNVVKLLGCCLETEVPLLVY 350 (608)
Q Consensus 290 ~f~~~~~lG~G~~---------------avk~~~~~---~~~~~~~~~~Ei~il~~l~-H~niv~l~~~~~~~~~~~lV~ 350 (608)
+|+..+.||+|++ |+|.+... .....+.+..|..+++.+. |++|+++++++.+.+..++||
T Consensus 1 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05615 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFVM 80 (323)
T ss_pred CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEEEE
Confidence 3677788888874 66766532 2344567888999998885 678889999999999999999
Q ss_pred eecCCCccchhccccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEEcCCCcEEEeeccCccccccC
Q 044312 351 EFIPNGTLFQYIHDQNEDFPITWEIRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVD 430 (608)
Q Consensus 351 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGls~~~~~~ 430 (608)
||+++|+|.+++.... .+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++.....
T Consensus 81 Ey~~~g~L~~~i~~~~---~l~~~~~~~i~~qi~~al~~lH~~~---ivHrDikp~Nill~~~~~ikL~Dfg~~~~~~~~ 154 (323)
T cd05615 81 EYVNGGDLMYHIQQVG---KFKEPQAVFYAAEISVGLFFLHRRG---IIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVD 154 (323)
T ss_pred cCCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEEeccccccccCCC
Confidence 9999999999887543 4899999999999999999999999 999999999999999999999999998764322
Q ss_pred CcceeeeeeccCCCCChhhhccCCCCCccchHhHHHHHHHHHhCCCCCCccchhhcccHHHHHHHHhhhhhhHHHhhhhh
Q 044312 431 QTHMTTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLTELLTGEKPIRFTILEEDKSLAAYFLCAMKEERLFEILDARV 510 (608)
Q Consensus 431 ~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~ 510 (608)
.. ......||+.|+|||++.+..++.++||||||++++||++|+.||....... . ...+....
T Consensus 155 ~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~------~---------~~~i~~~~- 217 (323)
T cd05615 155 GV-TTRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDEDE------L---------FQSIMEHN- 217 (323)
T ss_pred Cc-cccCccCCccccCHHHHcCCCCCCccchhhhHHHHHHHHhCCCCCCCCCHHH------H---------HHHHHhCC-
Confidence 21 2234568999999999999999999999999999999999999987432110 0 11111111
Q ss_pred hccCChhHHHHHHHHHHHHhccCCCCCCCHH
Q 044312 511 MKQGGKDEIITVAKLAKRCLNLNGKKRPTMR 541 (608)
Q Consensus 511 ~~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~ 541 (608)
...+...+.++.+++.+||+.+|.+|++..
T Consensus 218 -~~~p~~~~~~~~~li~~~l~~~p~~R~~~~ 247 (323)
T cd05615 218 -VSYPKSLSKEAVSICKGLMTKHPSKRLGCG 247 (323)
T ss_pred -CCCCccCCHHHHHHHHHHcccCHhhCCCCC
Confidence 122334556789999999999999999853
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-33 Score=296.07 Aligned_cols=252 Identities=21% Similarity=0.330 Sum_probs=179.3
Q ss_pred HhcCccccceeccCceEEEEEee---------cChhhHHHHHHHHHHHhhcCCCCccceecccccCccceEEEeecCCCc
Q 044312 287 ATDNFDLNRILGQGGQAVKKSKV---------IDESKVEEFINEVVILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGT 357 (608)
Q Consensus 287 ~t~~f~~~~~lG~G~~avk~~~~---------~~~~~~~~~~~Ei~il~~l~H~niv~l~~~~~~~~~~~lV~E~~~~gs 357 (608)
...+|++.+.||+|+++...... ...........|+.++++++|+||+++++++.+....++|||++. ++
T Consensus 64 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~-~~ 142 (357)
T PHA03209 64 ASLGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKGTTLIEAMLLQNVNHPSVIRMKDTLVSGAITCMVLPHYS-SD 142 (357)
T ss_pred hhcCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCccccHHHHHHHHhCCCCCCcChhheEEeCCeeEEEEEccC-Cc
Confidence 34579999999999862211100 001122345679999999999999999999999999999999994 68
Q ss_pred cchhccccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEEcCCCcEEEeeccCccccccCCcceeee
Q 044312 358 LFQYIHDQNEDFPITWEIRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQ 437 (608)
Q Consensus 358 L~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGls~~~~~~~~~~~~~ 437 (608)
|.+++..... ++++..++.|+.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++..... .....
T Consensus 143 l~~~l~~~~~--~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~--~~~~~ 215 (357)
T PHA03209 143 LYTYLTKRSR--PLPIDQALIIEKQILEGLRYLHAQR---IIHRDVKTENIFINDVDQVCIGDLGAAQFPVVA--PAFLG 215 (357)
T ss_pred HHHHHHhccC--CCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEEecCccccccccC--ccccc
Confidence 8888875433 5899999999999999999999999 999999999999999999999999999754322 12234
Q ss_pred eeccCCCCChhhhccCCCCCccchHhHHHHHHHHHhCCCCCCccchhhcc----cHHHHHHHHhhh-----hhh------
Q 044312 438 VHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLTELLTGEKPIRFTILEEDK----SLAAYFLCAMKE-----ERL------ 502 (608)
Q Consensus 438 ~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~elltg~~p~~~~~~~~~~----~l~~~~~~~~~~-----~~~------ 502 (608)
..||+.|+|||++.+..++.++|||||||++|||+++..|+......... .....+...+.. ..+
T Consensus 216 ~~gt~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell~~~~~~f~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~ 295 (357)
T PHA03209 216 LAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTIFEDPPSTPEEYVKSCHSHLLKIISTLKVHPEEFPRDPGS 295 (357)
T ss_pred ccccccccCCeecCCCCCCchhhHHHHHHHHHHHHHcCCccccCCCCcHHHHHHHHHHHHHHHHHHhccChhhcCCCCcc
Confidence 56899999999999999999999999999999999966554221111100 000111110000 000
Q ss_pred ---HHHhhhhhhc---------cCChhHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 044312 503 ---FEILDARVMK---------QGGKDEIITVAKLAKRCLNLNGKKRPTMREVASE 546 (608)
Q Consensus 503 ---~~~~d~~~~~---------~~~~~~~~~l~~Li~~cl~~dp~~RPs~~evl~~ 546 (608)
...++..... ......+..+.+|+.+||+.||++|||+.||+++
T Consensus 296 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rpta~e~l~h 351 (357)
T PHA03209 296 RLVRGFIEYASLERQPYTRYPCFQRVNLPIDGEFLVHKMLTFDAAMRPSAEEILNY 351 (357)
T ss_pred HHHHHHHhhcccCCCcccccHHHhccCCCchHHHHHHHHHcCCcccCcCHHHHhcC
Confidence 0000000000 0001223456779999999999999999999864
|
|
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-33 Score=317.75 Aligned_cols=247 Identities=22% Similarity=0.356 Sum_probs=190.0
Q ss_pred cCccccceeccCce---------------EEEEEeec---ChhhHHHHHHHHHHHhhcCCCCccceecccccCccceEEE
Q 044312 289 DNFDLNRILGQGGQ---------------AVKKSKVI---DESKVEEFINEVVILSQINHRNVVKLLGCCLETEVPLLVY 350 (608)
Q Consensus 289 ~~f~~~~~lG~G~~---------------avk~~~~~---~~~~~~~~~~Ei~il~~l~H~niv~l~~~~~~~~~~~lV~ 350 (608)
++|++.++||+|++ |+|+.... .+...+.|.+|++++++++||||+++++++.+.+..++||
T Consensus 2 grYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~lyLVM 81 (932)
T PRK13184 2 QRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGDPVYYTM 81 (932)
T ss_pred CCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCCEEEEEE
Confidence 47889999999974 66666431 2234567999999999999999999999999999999999
Q ss_pred eecCCCccchhccccCC--------CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEEcCCCcEEEeecc
Q 044312 351 EFIPNGTLFQYIHDQNE--------DFPITWEIRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFG 422 (608)
Q Consensus 351 E~~~~gsL~~~l~~~~~--------~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFG 422 (608)
||+++++|.+++..... ...+++..+++++.||++||+|||+.+ |+||||||+|||++.++.+||+|||
T Consensus 82 EY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~G---IIHRDLKPeNILLd~dg~vKLiDFG 158 (932)
T PRK13184 82 PYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSKG---VLHRDLKPDNILLGLFGEVVILDWG 158 (932)
T ss_pred EcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHCC---ccccCCchheEEEcCCCCEEEEecC
Confidence 99999999998864211 124677888999999999999999999 9999999999999999999999999
Q ss_pred CccccccCCc-----------------ceeeeeeccCCCCChhhhccCCCCCccchHhHHHHHHHHHhCCCCCCccchhh
Q 044312 423 ASRSMAVDQT-----------------HMTTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLTELLTGEKPIRFTILEE 485 (608)
Q Consensus 423 ls~~~~~~~~-----------------~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~elltg~~p~~~~~~~~ 485 (608)
+++....... .......||+.|+|||++.+..++.++|||||||+++||+||+.||.......
T Consensus 159 LAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~kSDIWSLGVILyELLTG~~PF~~~~~~k 238 (932)
T PRK13184 159 AAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRRKKGRK 238 (932)
T ss_pred cceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCCcHhHHHHHHHHHHHHHHCCCCCCCcchhh
Confidence 9987621110 01112468999999999999999999999999999999999999986321110
Q ss_pred cccHHHHHHHHhhhhhhHHHhhhhhhccCChhHHHHHHHHHHHHhccCCCCCC-CHHHHHHHHHhhHH
Q 044312 486 DKSLAAYFLCAMKEERLFEILDARVMKQGGKDEIITVAKLAKRCLNLNGKKRP-TMREVASELAGIKA 552 (608)
Q Consensus 486 ~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RP-s~~evl~~L~~i~~ 552 (608)
.. . .. .+.++.. .....+.+..+.+++.+||+.||++|| +++++.+.|+....
T Consensus 239 ---i~--~-----~~---~i~~P~~-~~p~~~iP~~L~~LI~rcL~~DP~kR~ss~eeLl~~Le~~lq 292 (932)
T PRK13184 239 ---IS--Y-----RD---VILSPIE-VAPYREIPPFLSQIAMKALAVDPAERYSSVQELKQDLEPHLQ 292 (932)
T ss_pred ---hh--h-----hh---hccChhh-ccccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHh
Confidence 00 0 00 0011100 011124456789999999999999995 57777777776644
|
|
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-33 Score=287.69 Aligned_cols=247 Identities=22% Similarity=0.318 Sum_probs=178.7
Q ss_pred CccccceeccCce---------------EEEEEeecC--hhhHHHHHHHHHHHhhc---CCCCccceecccccC-----c
Q 044312 290 NFDLNRILGQGGQ---------------AVKKSKVID--ESKVEEFINEVVILSQI---NHRNVVKLLGCCLET-----E 344 (608)
Q Consensus 290 ~f~~~~~lG~G~~---------------avk~~~~~~--~~~~~~~~~Ei~il~~l---~H~niv~l~~~~~~~-----~ 344 (608)
+|++.+.||+|++ |+|..+... ......+.+|+.+++.+ +||||+++++++... .
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~ 80 (288)
T cd07863 1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRET 80 (288)
T ss_pred CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCc
Confidence 4777888998874 566554321 22234566777777665 799999999988642 3
Q ss_pred cceEEEeecCCCccchhccccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEEcCCCcEEEeeccCc
Q 044312 345 VPLLVYEFIPNGTLFQYIHDQNEDFPITWEIRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGAS 424 (608)
Q Consensus 345 ~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGls 424 (608)
..++||||+++ +|.+++..... ..+++..+..++.|++.||.|||+.+ ++||||||+|||++.++.+||+|||++
T Consensus 81 ~~~lv~e~~~~-~l~~~~~~~~~-~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dikp~Nili~~~~~~kl~dfg~~ 155 (288)
T cd07863 81 KVTLVFEHVDQ-DLRTYLDKVPP-PGLPAETIKDLMRQFLRGLDFLHANC---IVHRDLKPENILVTSGGQVKLADFGLA 155 (288)
T ss_pred eEEEEEccccc-CHHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEECccCcc
Confidence 57899999974 88888876433 24899999999999999999999999 999999999999999999999999999
Q ss_pred cccccCCcceeeeeeccCCCCChhhhccCCCCCccchHhHHHHHHHHHhCCCCCCccchhhcccHHHHHHHHhh---hhh
Q 044312 425 RSMAVDQTHMTTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLTELLTGEKPIRFTILEEDKSLAAYFLCAMK---EER 501 (608)
Q Consensus 425 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~elltg~~p~~~~~~~~~~~l~~~~~~~~~---~~~ 501 (608)
+...... ......+|..|+|||++.+..++.++|||||||+++||++|++||....... .+.. ...... ...
T Consensus 156 ~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~~f~~~~~~~--~~~~-~~~~~~~~~~~~ 230 (288)
T cd07863 156 RIYSCQM--ALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEAD--QLGK-IFDLIGLPPEDD 230 (288)
T ss_pred ccccCcc--cCCCccccccccCchHhhCCCCCCcchhhhHHHHHHHHHhCCcCcCCCCHHH--HHHH-HHHHhCCCChhh
Confidence 8664322 2233467899999999999999999999999999999999999986432211 1111 111000 000
Q ss_pred hHHHh-------hh---hhhccCChhHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 044312 502 LFEIL-------DA---RVMKQGGKDEIITVAKLAKRCLNLNGKKRPTMREVASE 546 (608)
Q Consensus 502 ~~~~~-------d~---~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~evl~~ 546 (608)
..... .+ ..........+..+.+|+.+||+.||++|||+.|++++
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~h 285 (288)
T cd07863 231 WPRDVTLPRGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQH 285 (288)
T ss_pred CcccccccccccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhcC
Confidence 00000 00 00001112345678999999999999999999999853
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-33 Score=295.02 Aligned_cols=216 Identities=25% Similarity=0.337 Sum_probs=169.8
Q ss_pred eEEEEEeec---ChhhHHHHHHHHH-HHhhcCCCCccceecccccCccceEEEeecCCCccchhccccCCCCCCCHHHHH
Q 044312 302 QAVKKSKVI---DESKVEEFINEVV-ILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEIRL 377 (608)
Q Consensus 302 ~avk~~~~~---~~~~~~~~~~Ei~-il~~l~H~niv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~ 377 (608)
+|+|..... .......+.+|.. +++.++||||+++++.+.+.+..++||||+++|+|.+++.... .+++..+.
T Consensus 23 vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~---~~~~~~~~ 99 (323)
T cd05575 23 YAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYVNGGELFFHLQRER---SFPEPRAR 99 (323)
T ss_pred EEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEcCCCCCCHHHHHHhcC---CCCHHHHH
Confidence 467766532 1223345556655 5678999999999999999999999999999999999887543 58999999
Q ss_pred HHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEEcCCCcEEEeeccCccccccCCcceeeeeeccCCCCChhhhccCCCCC
Q 044312 378 RIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHGTFGYLDPEYFRSSQFTD 457 (608)
Q Consensus 378 ~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGls~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ 457 (608)
.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++...... .......||+.|+|||++.+..++.
T Consensus 100 ~~~~qi~~~l~~lH~~g---ivH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~ 175 (323)
T cd05575 100 FYAAEIASALGYLHSLN---IIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHS-KTTSTFCGTPEYLAPEVLRKQPYDR 175 (323)
T ss_pred HHHHHHHHHHHHHHHCC---eEeCCCCHHHeEECCCCcEEEeccCCCcccccCC-CccccccCChhhcChhhhcCCCCCc
Confidence 99999999999999999 9999999999999999999999999987543221 2233456899999999999999999
Q ss_pred ccchHhHHHHHHHHHhCCCCCCccchhhcccHHHHHHHHhhhhhhHHHhhhhhhccCChhHHHHHHHHHHHHhccCCCCC
Q 044312 458 KSDVYSFGVVLTELLTGEKPIRFTILEEDKSLAAYFLCAMKEERLFEILDARVMKQGGKDEIITVAKLAKRCLNLNGKKR 537 (608)
Q Consensus 458 ksDV~S~Gvvl~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~Li~~cl~~dp~~R 537 (608)
++||||||++++||++|+.||...... ..+. .++... .......+..+.+++.+||+.||.+|
T Consensus 176 ~~DvwslG~il~ell~g~~pf~~~~~~------~~~~---------~i~~~~--~~~~~~~~~~~~~li~~~l~~~p~~R 238 (323)
T cd05575 176 TVDWWCLGAVLYEMLYGLPPFYSRDTA------EMYD---------NILNKP--LRLKPNISVSARHLLEGLLQKDRTKR 238 (323)
T ss_pred cccccccchhhhhhhcCCCCCCCCCHH------HHHH---------HHHcCC--CCCCCCCCHHHHHHHHHHhhcCHHhC
Confidence 999999999999999999998632211 1111 111111 11222346689999999999999999
Q ss_pred CCHH
Q 044312 538 PTMR 541 (608)
Q Consensus 538 Ps~~ 541 (608)
|+++
T Consensus 239 ~~~~ 242 (323)
T cd05575 239 LGAK 242 (323)
T ss_pred CCCC
Confidence 9985
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-33 Score=279.68 Aligned_cols=235 Identities=27% Similarity=0.437 Sum_probs=185.9
Q ss_pred CccccceeccCce---------------EEEEEeec--ChhhHHHHHHHHHHHhhcCCCCccceecccccCccceEEEee
Q 044312 290 NFDLNRILGQGGQ---------------AVKKSKVI--DESKVEEFINEVVILSQINHRNVVKLLGCCLETEVPLLVYEF 352 (608)
Q Consensus 290 ~f~~~~~lG~G~~---------------avk~~~~~--~~~~~~~~~~Ei~il~~l~H~niv~l~~~~~~~~~~~lV~E~ 352 (608)
+|+..+.||+|++ |+|..... .....+.+.+|++++++++||||+++++.+...+..++||||
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08220 1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIVMEY 80 (256)
T ss_pred CceEEEEecccCceEEEEEEEcCCCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeEecCCEEEEEEec
Confidence 4677788888863 56665432 334567899999999999999999999999999999999999
Q ss_pred cCCCccchhccccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEEcCC-CcEEEeeccCccccccCC
Q 044312 353 IPNGTLFQYIHDQNEDFPITWEIRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDK-YRAKVSDFGASRSMAVDQ 431 (608)
Q Consensus 353 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~-~~~kl~DFGls~~~~~~~ 431 (608)
+++++|.+++..... ..+++..+..++.+++.||+|||+++ ++|+||||+||+++++ ..+||+|||++.......
T Consensus 81 ~~~~~L~~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lh~~~---i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~ 156 (256)
T cd08220 81 APGGTLAEYIQKRCN-SLLDEDTILHFFVQILLALHHVHTKL---ILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKS 156 (256)
T ss_pred CCCCCHHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEEccCCCceecCCCc
Confidence 999999999976432 25899999999999999999999998 9999999999999854 468999999998765332
Q ss_pred cceeeeeeccCCCCChhhhccCCCCCccchHhHHHHHHHHHhCCCCCCccchhhcccHHHHHHHHhhhhhhHHHhhhhhh
Q 044312 432 THMTTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLTELLTGEKPIRFTILEEDKSLAAYFLCAMKEERLFEILDARVM 511 (608)
Q Consensus 432 ~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~ 511 (608)
......++..|+|||.+....++.++||||||+++++|++|+.||...... ....... .. ..
T Consensus 157 --~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~------~~~~~~~---------~~-~~ 218 (256)
T cd08220 157 --KAYTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAANLP------ALVLKIM---------SG-TF 218 (256)
T ss_pred --cccccccCCcccCchhccCCCCCcccchHHHHHHHHHHHhCCCCcccCchH------HHHHHHH---------hc-CC
Confidence 122345788999999999888999999999999999999999998632211 1111110 00 01
Q ss_pred ccCChhHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 044312 512 KQGGKDEIITVAKLAKRCLNLNGKKRPTMREVASE 546 (608)
Q Consensus 512 ~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~evl~~ 546 (608)
...+...+..+.+++.+||+.+|++|||+.|++++
T Consensus 219 ~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~ll~~ 253 (256)
T cd08220 219 APISDRYSPDLRQLILSMLNLDPSKRPQLSQIMAQ 253 (256)
T ss_pred CCCCCCcCHHHHHHHHHHccCChhhCCCHHHHhhC
Confidence 11222356679999999999999999999999863
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-33 Score=286.15 Aligned_cols=238 Identities=26% Similarity=0.346 Sum_probs=186.6
Q ss_pred cCccccceeccCce---------------EEEEEeecChhhHHHHHHHHHHHhhcCCCCccceecccccCccceEEEeec
Q 044312 289 DNFDLNRILGQGGQ---------------AVKKSKVIDESKVEEFINEVVILSQINHRNVVKLLGCCLETEVPLLVYEFI 353 (608)
Q Consensus 289 ~~f~~~~~lG~G~~---------------avk~~~~~~~~~~~~~~~Ei~il~~l~H~niv~l~~~~~~~~~~~lV~E~~ 353 (608)
++|++.++||+|++ ++|.....+....+.+.+|+.++++++|+||+++++.+......++||||+
T Consensus 12 ~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 91 (292)
T cd06644 12 EVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFYWDGKLWIMIEFC 91 (292)
T ss_pred hhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccCCHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCCeEEEEEecC
Confidence 56778888999874 555555555566788999999999999999999999999889999999999
Q ss_pred CCCccchhccccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEEcCCCcEEEeeccCccccccCCcc
Q 044312 354 PNGTLFQYIHDQNEDFPITWEIRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTH 433 (608)
Q Consensus 354 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGls~~~~~~~~~ 433 (608)
++++|..++.+... .+++..+..++.|++.||+|||+.+ ++||||||+|||++.++.+||+|||++....... .
T Consensus 92 ~~~~l~~~~~~~~~--~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~-~ 165 (292)
T cd06644 92 PGGAVDAIMLELDR--GLTEPQIQVICRQMLEALQYLHSMK---IIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKTL-Q 165 (292)
T ss_pred CCCcHHHHHHhhcC--CCCHHHHHHHHHHHHHHHHHHhcCC---eeecCCCcceEEEcCCCCEEEccCccceeccccc-c
Confidence 99999888765433 5899999999999999999999998 9999999999999999999999999987543221 1
Q ss_pred eeeeeeccCCCCChhhhc-----cCCCCCccchHhHHHHHHHHHhCCCCCCccchhhcccHHHHHHHHhhhhhhHHHhhh
Q 044312 434 MTTQVHGTFGYLDPEYFR-----SSQFTDKSDVYSFGVVLTELLTGEKPIRFTILEEDKSLAAYFLCAMKEERLFEILDA 508 (608)
Q Consensus 434 ~~~~~~gt~~y~aPE~~~-----~~~~t~ksDV~S~Gvvl~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 508 (608)
......+++.|+|||++. ...++.++||||||+++|||++|+.||...... ..+....... .+
T Consensus 166 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~------~~~~~~~~~~------~~ 233 (292)
T cd06644 166 RRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPM------RVLLKIAKSE------PP 233 (292)
T ss_pred ccceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccHH------HHHHHHhcCC------Cc
Confidence 223456788999999984 345788999999999999999999998632211 1111110000 00
Q ss_pred hhhccCChhHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 044312 509 RVMKQGGKDEIITVAKLAKRCLNLNGKKRPTMREVASE 546 (608)
Q Consensus 509 ~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~evl~~ 546 (608)
....+...+.++.+++.+||+.+|++||++.|++++
T Consensus 234 --~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 269 (292)
T cd06644 234 --TLSQPSKWSMEFRDFLKTALDKHPETRPSAAQLLEH 269 (292)
T ss_pred --cCCCCcccCHHHHHHHHHHhcCCcccCcCHHHHhcC
Confidence 011123445678999999999999999999999864
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-34 Score=296.07 Aligned_cols=230 Identities=28% Similarity=0.398 Sum_probs=187.7
Q ss_pred ccccceeccCce---------------EEEEEeecCh---hhHHHHHHHHHHHhhcCCCCccceecccccCccceEEEee
Q 044312 291 FDLNRILGQGGQ---------------AVKKSKVIDE---SKVEEFINEVVILSQINHRNVVKLLGCCLETEVPLLVYEF 352 (608)
Q Consensus 291 f~~~~~lG~G~~---------------avk~~~~~~~---~~~~~~~~Ei~il~~l~H~niv~l~~~~~~~~~~~lV~E~ 352 (608)
|...+.||.|.| |||+.....+ ...++++.|+..|++|+|||++.+.|||......+|||||
T Consensus 28 f~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~TaWLVMEY 107 (948)
T KOG0577|consen 28 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREHTAWLVMEY 107 (948)
T ss_pred HHHHHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeeccchHHHHHHH
Confidence 555788999975 7777765433 4467899999999999999999999999999999999999
Q ss_pred cCCCccchhccccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEEcCCCcEEEeeccCccccccCCc
Q 044312 353 IPNGTLFQYIHDQNEDFPITWEIRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQT 432 (608)
Q Consensus 353 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGls~~~~~~~~ 432 (608)
| -|+-.|++..... ++-+..+..|..+.+.||+|||+++ .||||||+.||||++.+.+||+|||.+.....
T Consensus 108 C-lGSAsDlleVhkK--plqEvEIAAi~~gaL~gLaYLHS~~---~IHRDiKAGNILLse~g~VKLaDFGSAsi~~P--- 178 (948)
T KOG0577|consen 108 C-LGSASDLLEVHKK--PLQEVEIAAITHGALQGLAYLHSHN---RIHRDIKAGNILLSEPGLVKLADFGSASIMAP--- 178 (948)
T ss_pred H-hccHHHHHHHHhc--cchHHHHHHHHHHHHHHHHHHHHhh---HHhhhccccceEecCCCeeeeccccchhhcCc---
Confidence 9 5588888876543 6999999999999999999999999 99999999999999999999999999876543
Q ss_pred ceeeeeeccCCCCChhhhc---cCCCCCccchHhHHHHHHHHHhCCCCCCccchhhcccHHHHHHHHhhhhhhHHHhhhh
Q 044312 433 HMTTQVHGTFGYLDPEYFR---SSQFTDKSDVYSFGVVLTELLTGEKPIRFTILEEDKSLAAYFLCAMKEERLFEILDAR 509 (608)
Q Consensus 433 ~~~~~~~gt~~y~aPE~~~---~~~~t~ksDV~S~Gvvl~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 509 (608)
.....|||.|||||++. .++|+.|+||||||+...||.-.++|+.....- ..+..|....
T Consensus 179 --AnsFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMNAM---------------SALYHIAQNe 241 (948)
T KOG0577|consen 179 --ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAM---------------SALYHIAQNE 241 (948)
T ss_pred --hhcccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCchHH---------------HHHHHHHhcC
Confidence 34567999999999974 678999999999999999999999997532111 0112222111
Q ss_pred hhccCChhHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 044312 510 VMKQGGKDEIITVAKLAKRCLNLNGKKRPTMREVASE 546 (608)
Q Consensus 510 ~~~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~evl~~ 546 (608)
...-...+.+..++.++..||+.-|.+|||..+++.+
T Consensus 242 sPtLqs~eWS~~F~~Fvd~CLqKipqeRptse~ll~H 278 (948)
T KOG0577|consen 242 SPTLQSNEWSDYFRNFVDSCLQKIPQERPTSEELLKH 278 (948)
T ss_pred CCCCCCchhHHHHHHHHHHHHhhCcccCCcHHHHhhc
Confidence 1111234567789999999999999999999998764
|
|
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-33 Score=281.92 Aligned_cols=236 Identities=26% Similarity=0.418 Sum_probs=180.4
Q ss_pred cCccccceeccCce---------------EEEEEeec-----ChhhHHHHHHHHHHHhhcCCCCccceeccccc--Cccc
Q 044312 289 DNFDLNRILGQGGQ---------------AVKKSKVI-----DESKVEEFINEVVILSQINHRNVVKLLGCCLE--TEVP 346 (608)
Q Consensus 289 ~~f~~~~~lG~G~~---------------avk~~~~~-----~~~~~~~~~~Ei~il~~l~H~niv~l~~~~~~--~~~~ 346 (608)
.+|+..+.||+|++ ++|+.... .....+.+.+|+.++++++||||+++++++.+ ....
T Consensus 2 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (266)
T cd06651 2 INWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTL 81 (266)
T ss_pred CCccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEE
Confidence 36788888888864 55554432 12345678999999999999999999998865 3567
Q ss_pred eEEEeecCCCccchhccccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEEcCCCcEEEeeccCccc
Q 044312 347 LLVYEFIPNGTLFQYIHDQNEDFPITWEIRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRS 426 (608)
Q Consensus 347 ~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGls~~ 426 (608)
++++||+++++|.+++.... .+++..++.++.|++.||+|||+.+ ++||||||+||+++.++.+||+|||+++.
T Consensus 82 ~l~~e~~~~~~L~~~l~~~~---~l~~~~~~~~~~qi~~~l~~LH~~~---i~H~~l~p~nil~~~~~~~~l~dfg~~~~ 155 (266)
T cd06651 82 TIFMEYMPGGSVKDQLKAYG---ALTESVTRKYTRQILEGMSYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKR 155 (266)
T ss_pred EEEEeCCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEECCCCCEEEccCCCccc
Confidence 89999999999999997643 4889999999999999999999998 99999999999999999999999999976
Q ss_pred cccCC--cceeeeeeccCCCCChhhhccCCCCCccchHhHHHHHHHHHhCCCCCCccchhhcccHHHHHHHHhhhhhhHH
Q 044312 427 MAVDQ--THMTTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLTELLTGEKPIRFTILEEDKSLAAYFLCAMKEERLFE 504 (608)
Q Consensus 427 ~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~ 504 (608)
..... ........++..|+|||++.+..++.++||||||++++||++|+.||...... .. +..
T Consensus 156 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~~g~~pf~~~~~~-----~~----------~~~ 220 (266)
T cd06651 156 LQTICMSGTGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYEAM-----AA----------IFK 220 (266)
T ss_pred cccccccCCccccCCccccccCHHHhCCCCCCchhhhHHHHHHHHHHHHCCCCccccchH-----HH----------HHH
Confidence 54211 11122345788999999999989999999999999999999999998632110 00 000
Q ss_pred HhhhhhhccCChhHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 044312 505 ILDARVMKQGGKDEIITVAKLAKRCLNLNGKKRPTMREVASE 546 (608)
Q Consensus 505 ~~d~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~evl~~ 546 (608)
+.........+......+.+++ +||..+|++||+++||+++
T Consensus 221 ~~~~~~~~~~~~~~~~~~~~li-~~~~~~p~~Rp~~~eil~h 261 (266)
T cd06651 221 IATQPTNPQLPSHISEHARDFL-GCIFVEARHRPSAEELLRH 261 (266)
T ss_pred HhcCCCCCCCchhcCHHHHHHH-HHhcCChhhCcCHHHHhcC
Confidence 1000011122233445677777 7888999999999999753
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-33 Score=299.47 Aligned_cols=238 Identities=24% Similarity=0.368 Sum_probs=182.6
Q ss_pred cCccccceeccCce---------------EEEEEeec---ChhhHHHHHHHHHHHhhcCCCCccceecccccCccceEEE
Q 044312 289 DNFDLNRILGQGGQ---------------AVKKSKVI---DESKVEEFINEVVILSQINHRNVVKLLGCCLETEVPLLVY 350 (608)
Q Consensus 289 ~~f~~~~~lG~G~~---------------avk~~~~~---~~~~~~~~~~Ei~il~~l~H~niv~l~~~~~~~~~~~lV~ 350 (608)
++|++.+.||+|++ |+|.++.. .......+.+|+.++.+++|+||+++++.+.+.+..+|||
T Consensus 1 ~~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~ 80 (360)
T cd05627 1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYLIM 80 (360)
T ss_pred CCceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence 36888899999974 56655432 2344567889999999999999999999999999999999
Q ss_pred eecCCCccchhccccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEEcCCCcEEEeeccCccccccC
Q 044312 351 EFIPNGTLFQYIHDQNEDFPITWEIRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVD 430 (608)
Q Consensus 351 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGls~~~~~~ 430 (608)
||+++|+|.+++.+.. .+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++.....
T Consensus 81 E~~~gg~L~~~l~~~~---~l~~~~~~~~~~qi~~~L~~lH~~g---ivHrDLkp~NIli~~~~~vkL~DfG~~~~~~~~ 154 (360)
T cd05627 81 EFLPGGDMMTLLMKKD---TLSEEATQFYIAETVLAIDAIHQLG---FIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKA 154 (360)
T ss_pred eCCCCccHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC---eEccCCCHHHEEECCCCCEEEeeccCCcccccc
Confidence 9999999999987643 4899999999999999999999999 999999999999999999999999998754321
Q ss_pred Cc----------------------------------ceeeeeeccCCCCChhhhccCCCCCccchHhHHHHHHHHHhCCC
Q 044312 431 QT----------------------------------HMTTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLTELLTGEK 476 (608)
Q Consensus 431 ~~----------------------------------~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~elltg~~ 476 (608)
.. .......||+.|+|||++.+..++.++|||||||+++||++|+.
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvilyel~tG~~ 234 (360)
T cd05627 155 HRTEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYP 234 (360)
T ss_pred cccccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCCCcceeccccceeeecccCCC
Confidence 10 00113468999999999999999999999999999999999999
Q ss_pred CCCccchhhcccHHHHHHHHhhhhhhHHHhhhhhhccCChhHHHHHHHHHHHHhccCCCCCCC---HHHHHHH
Q 044312 477 PIRFTILEEDKSLAAYFLCAMKEERLFEILDARVMKQGGKDEIITVAKLAKRCLNLNGKKRPT---MREVASE 546 (608)
Q Consensus 477 p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPs---~~evl~~ 546 (608)
||....... .+....... ...........+.++.+|+.+++. ||.+|++ +.|++++
T Consensus 235 Pf~~~~~~~------~~~~i~~~~-------~~~~~p~~~~~s~~~~~li~~l~~-~p~~R~~~~~~~ei~~h 293 (360)
T cd05627 235 PFCSETPQE------TYRKVMNWK-------ETLVFPPEVPISEKAKDLILRFCT-DSENRIGSNGVEEIKSH 293 (360)
T ss_pred CCCCCCHHH------HHHHHHcCC-------CceecCCCCCCCHHHHHHHHHhcc-ChhhcCCCCCHHHHhcC
Confidence 996432211 111011000 000001111245678889988774 9999985 5666544
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-33 Score=294.25 Aligned_cols=241 Identities=22% Similarity=0.348 Sum_probs=184.0
Q ss_pred cCccccceeccCce---------------EEEEEee---cChhhHHHHHHHHHHHhhcCCCCccceecccccCccceEEE
Q 044312 289 DNFDLNRILGQGGQ---------------AVKKSKV---IDESKVEEFINEVVILSQINHRNVVKLLGCCLETEVPLLVY 350 (608)
Q Consensus 289 ~~f~~~~~lG~G~~---------------avk~~~~---~~~~~~~~~~~Ei~il~~l~H~niv~l~~~~~~~~~~~lV~ 350 (608)
++|.+.+.||+|+| |+|.... ......+.+.+|+.++..++|+||+++++++.+.+..++||
T Consensus 1 d~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~~~lv~ 80 (331)
T cd05624 1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDENYLYLVM 80 (331)
T ss_pred CCceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence 46888999999975 5555432 12234456888999999999999999999999999999999
Q ss_pred eecCCCccchhccccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEEcCCCcEEEeeccCccccccC
Q 044312 351 EFIPNGTLFQYIHDQNEDFPITWEIRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVD 430 (608)
Q Consensus 351 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGls~~~~~~ 430 (608)
||+++|+|.+++..... .+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++.....
T Consensus 81 Ey~~gg~L~~~l~~~~~--~l~~~~~~~~~~qi~~~L~~lH~~~---iiHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~ 155 (331)
T cd05624 81 DYYVGGDLLTLLSKFED--RLPEDMARFYIAEMVLAIHSIHQLH---YVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQD 155 (331)
T ss_pred eCCCCCcHHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCchHHEEEcCCCCEEEEeccceeeccCC
Confidence 99999999999976433 4899999999999999999999999 999999999999999999999999999876544
Q ss_pred CcceeeeeeccCCCCChhhhcc-----CCCCCccchHhHHHHHHHHHhCCCCCCccchhhcccHHHHHHHHhhhhhhHHH
Q 044312 431 QTHMTTQVHGTFGYLDPEYFRS-----SQFTDKSDVYSFGVVLTELLTGEKPIRFTILEEDKSLAAYFLCAMKEERLFEI 505 (608)
Q Consensus 431 ~~~~~~~~~gt~~y~aPE~~~~-----~~~t~ksDV~S~Gvvl~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 505 (608)
.........||+.|+|||++.. ..++.++||||||++||||++|+.||..... ...+..........
T Consensus 156 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~------~~~~~~i~~~~~~~-- 227 (331)
T cd05624 156 GTVQSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESL------VETYGKIMNHEERF-- 227 (331)
T ss_pred CceeeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCCH------HHHHHHHHcCCCcc--
Confidence 3333334569999999999875 4678999999999999999999999863221 11111111110000
Q ss_pred hhhhhhccCChhHHHHHHHHHHHHhccCCCC--CCCHHHHHHH
Q 044312 506 LDARVMKQGGKDEIITVAKLAKRCLNLNGKK--RPTMREVASE 546 (608)
Q Consensus 506 ~d~~~~~~~~~~~~~~l~~Li~~cl~~dp~~--RPs~~evl~~ 546 (608)
.. .......+.++.+++.+|+..++++ |+++++++++
T Consensus 228 ---~~-p~~~~~~~~~~~~li~~ll~~~~~~~~~~~~~~~~~h 266 (331)
T cd05624 228 ---QF-PSHITDVSEEAKDLIQRLICSRERRLGQNGIEDFKKH 266 (331)
T ss_pred ---cC-CCccccCCHHHHHHHHHHccCchhhcCCCCHHHHhcC
Confidence 00 0111234567899999999866544 4678877754
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-33 Score=289.11 Aligned_cols=236 Identities=25% Similarity=0.396 Sum_probs=189.5
Q ss_pred cCccccceeccCce---------------EEEEEeecChhhHHHHHHHHHHHhhcCCCCccceecccccCccceEEEeec
Q 044312 289 DNFDLNRILGQGGQ---------------AVKKSKVIDESKVEEFINEVVILSQINHRNVVKLLGCCLETEVPLLVYEFI 353 (608)
Q Consensus 289 ~~f~~~~~lG~G~~---------------avk~~~~~~~~~~~~~~~Ei~il~~l~H~niv~l~~~~~~~~~~~lV~E~~ 353 (608)
.+|.+.+.||+|++ |+|..........+.+.+|+.+++.++|+||+++++++......++||||+
T Consensus 19 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~ 98 (297)
T cd06656 19 KKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYL 98 (297)
T ss_pred hhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCEEEEeeccc
Confidence 46888888998863 667666555556678899999999999999999999999999999999999
Q ss_pred CCCccchhccccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEEcCCCcEEEeeccCccccccCCcc
Q 044312 354 PNGTLFQYIHDQNEDFPITWEIRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTH 433 (608)
Q Consensus 354 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGls~~~~~~~~~ 433 (608)
++++|.+++.+. .+++..+..++.|++.||.|||+.+ ++||||||+|||++.++.+||+|||++........
T Consensus 99 ~~~~L~~~~~~~----~~~~~~~~~~~~~l~~~L~~LH~~~---i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~~~~~- 170 (297)
T cd06656 99 AGGSLTDVVTET----CMDEGQIAAVCRECLQALDFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS- 170 (297)
T ss_pred CCCCHHHHHHhC----CCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEECcCccceEccCCcc-
Confidence 999999998643 4789999999999999999999998 99999999999999999999999999876543322
Q ss_pred eeeeeeccCCCCChhhhccCCCCCccchHhHHHHHHHHHhCCCCCCccchhhcccHHHHHHHHhhhhhhHHHhhhhhhcc
Q 044312 434 MTTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLTELLTGEKPIRFTILEEDKSLAAYFLCAMKEERLFEILDARVMKQ 513 (608)
Q Consensus 434 ~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~ 513 (608)
......+++.|+|||.+.+..++.++||||||+++++|++|+.||......... .. .... ......
T Consensus 171 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~~~-----~~-~~~~--------~~~~~~ 236 (297)
T cd06656 171 KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRAL-----YL-IATN--------GTPELQ 236 (297)
T ss_pred CcCcccCCccccCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcchhe-----ee-eccC--------CCCCCC
Confidence 123345788999999999999999999999999999999999998632211100 00 0000 000111
Q ss_pred CChhHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 044312 514 GGKDEIITVAKLAKRCLNLNGKKRPTMREVASE 546 (608)
Q Consensus 514 ~~~~~~~~l~~Li~~cl~~dp~~RPs~~evl~~ 546 (608)
.+...+..+.+++.+||+.+|++||++++++++
T Consensus 237 ~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 269 (297)
T cd06656 237 NPERLSAVFRDFLNRCLEMDVDRRGSAKELLQH 269 (297)
T ss_pred CccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 223445678999999999999999999999874
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-34 Score=299.63 Aligned_cols=231 Identities=26% Similarity=0.428 Sum_probs=192.3
Q ss_pred eeccCce---------------EEEEEeecChhhHHHHHHHHHHHhhcCCCCccceecccccCccceEEEeecCCCccch
Q 044312 296 ILGQGGQ---------------AVKKSKVIDESKVEEFINEVVILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGTLFQ 360 (608)
Q Consensus 296 ~lG~G~~---------------avk~~~~~~~~~~~~~~~Ei~il~~l~H~niv~l~~~~~~~~~~~lV~E~~~~gsL~~ 360 (608)
+||+|.+ |||.+...+....+-+..||.+.++|+|+|||+++|.+.+++..-+.||-+|||+|.+
T Consensus 582 VLGKGTYG~VYA~RD~~tqvrIaIKEIpekdsr~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEqVPGGSLSs 661 (1226)
T KOG4279|consen 582 VLGKGTYGTVYAARDMDTQVRIAIKEIPEKDSREVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQVPGGSLSS 661 (1226)
T ss_pred EeecCceeEEEeeccccceeEEEeeecccccchhhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeecCCCCcHHH
Confidence 5888874 6777766677778889999999999999999999999999999999999999999999
Q ss_pred hccccCCCCCC--CHHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEEc-CCCcEEEeeccCccccccCCcceeee
Q 044312 361 YIHDQNEDFPI--TWEIRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLD-DKYRAKVSDFGASRSMAVDQTHMTTQ 437 (608)
Q Consensus 361 ~l~~~~~~~~l--~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~-~~~~~kl~DFGls~~~~~~~~~~~~~ 437 (608)
+|+..=. |+ ++.++-.+..||++||.|||++. |+|||||-+|||++ -.|.+||+|||-++.+.. -+..+..
T Consensus 662 LLrskWG--PlKDNEstm~fYtkQILeGLkYLHen~---IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAg-inP~TET 735 (1226)
T KOG4279|consen 662 LLRSKWG--PLKDNESTMNFYTKQILEGLKYLHENK---IVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAG-INPCTET 735 (1226)
T ss_pred HHHhccC--CCccchhHHHHHHHHHHHHhhhhhhcc---eeeccccCCcEEEeeccceEEecccccchhhcc-CCccccc
Confidence 9987533 45 78888999999999999999999 99999999999996 678999999999987642 2344566
Q ss_pred eeccCCCCChhhhccC--CCCCccchHhHHHHHHHHHhCCCCCCccchhhcccHHHHHHHHhhhhhhHHHhhhhhhccCC
Q 044312 438 VHGTFGYLDPEYFRSS--QFTDKSDVYSFGVVLTELLTGEKPIRFTILEEDKSLAAYFLCAMKEERLFEILDARVMKQGG 515 (608)
Q Consensus 438 ~~gt~~y~aPE~~~~~--~~t~ksDV~S~Gvvl~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~ 515 (608)
..||..|||||++..+ .|..++|||||||.+.||.||++||.-.... .++.| .+---+...+.+
T Consensus 736 FTGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~Elgsp----qAAMF----------kVGmyKvHP~iP 801 (1226)
T KOG4279|consen 736 FTGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSP----QAAMF----------KVGMYKVHPPIP 801 (1226)
T ss_pred cccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCCh----hHhhh----------hhcceecCCCCc
Confidence 7799999999999865 5899999999999999999999999733222 12222 111112334556
Q ss_pred hhHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 044312 516 KDEIITVAKLAKRCLNLNGKKRPTMREVASE 546 (608)
Q Consensus 516 ~~~~~~l~~Li~~cl~~dp~~RPs~~evl~~ 546 (608)
.+.+.+...+|.+|+.+||.+||+++++++.
T Consensus 802 eelsaeak~FilrcFepd~~~R~sA~~LL~D 832 (1226)
T KOG4279|consen 802 EELSAEAKNFILRCFEPDPCDRPSAKDLLQD 832 (1226)
T ss_pred HHHHHHHHHHHHHHcCCCcccCccHHHhccC
Confidence 7788899999999999999999999999863
|
|
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-33 Score=281.51 Aligned_cols=229 Identities=27% Similarity=0.481 Sum_probs=175.5
Q ss_pred EEEEEee--cChhhHHHHHHHHHHHhhcCCCCccceecccccCc------cceEEEeecCCCccchhccccC---CCCCC
Q 044312 303 AVKKSKV--IDESKVEEFINEVVILSQINHRNVVKLLGCCLETE------VPLLVYEFIPNGTLFQYIHDQN---EDFPI 371 (608)
Q Consensus 303 avk~~~~--~~~~~~~~~~~Ei~il~~l~H~niv~l~~~~~~~~------~~~lV~E~~~~gsL~~~l~~~~---~~~~l 371 (608)
|||.... ......+++.+|++++++++||||+++++++.... ..++++||+++|+|.+++.... ....+
T Consensus 31 aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l 110 (273)
T cd05074 31 AVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTL 110 (273)
T ss_pred EEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCcccceEEEEecCCCCcHHHHHHHhcccCCCCCC
Confidence 5565543 23445678999999999999999999999876432 3478999999999998875321 22247
Q ss_pred CHHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEEcCCCcEEEeeccCccccccCCcce-eeeeeccCCCCChhhh
Q 044312 372 TWEIRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHM-TTQVHGTFGYLDPEYF 450 (608)
Q Consensus 372 ~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGls~~~~~~~~~~-~~~~~gt~~y~aPE~~ 450 (608)
++..++.++.|++.||+|||+.+ |+||||||+|||+++++.+||+|||+++......... .....+++.|++||.+
T Consensus 111 ~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~ 187 (273)
T cd05074 111 PLQTLVRFMIDIASGMEYLSSKN---FIHRDLAARNCMLNENMTVCVADFGLSKKIYSGDYYRQGCASKLPVKWLALESL 187 (273)
T ss_pred CHHHHHHHHHHHHHHHHHHHhCC---EeecccchhhEEEcCCCCEEECcccccccccCCcceecCCCccCchhhcCHhHH
Confidence 89999999999999999999998 9999999999999999999999999998764332211 1223356789999999
Q ss_pred ccCCCCCccchHhHHHHHHHHHh-CCCCCCccchhhcccHHHHHHHHhhhhhhHHHhhhhhhccCChhHHHHHHHHHHHH
Q 044312 451 RSSQFTDKSDVYSFGVVLTELLT-GEKPIRFTILEEDKSLAAYFLCAMKEERLFEILDARVMKQGGKDEIITVAKLAKRC 529 (608)
Q Consensus 451 ~~~~~t~ksDV~S~Gvvl~ellt-g~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~Li~~c 529 (608)
....++.++||||||++++||++ |++||......+ +..+ ..... ....+...+..+.+++.+|
T Consensus 188 ~~~~~~~~sDi~slG~il~el~~~g~~p~~~~~~~~---~~~~---~~~~~----------~~~~~~~~~~~~~~l~~~~ 251 (273)
T cd05074 188 ADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVENSE---IYNY---LIKGN----------RLKQPPDCLEDVYELMCQC 251 (273)
T ss_pred hcCccchhhhhHHHHHHHHHHhhCCCCCCCCCCHHH---HHHH---HHcCC----------cCCCCCCCCHHHHHHHHHH
Confidence 98999999999999999999999 888876322110 1100 00000 0112234556899999999
Q ss_pred hccCCCCCCCHHHHHHHHHhh
Q 044312 530 LNLNGKKRPTMREVASELAGI 550 (608)
Q Consensus 530 l~~dp~~RPs~~evl~~L~~i 550 (608)
|+.+|++||++.|+++.|+.+
T Consensus 252 l~~~p~~Rps~~~~~~~l~~~ 272 (273)
T cd05074 252 WSPEPKCRPSFQHLRDQLELI 272 (273)
T ss_pred cCCChhhCcCHHHHHHHHHhh
Confidence 999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-33 Score=281.43 Aligned_cols=215 Identities=25% Similarity=0.400 Sum_probs=172.1
Q ss_pred hHHHHHHHHHHHhh-cCCCCccceecccccCccceEEEeecCCCccchhcccc-CCCCCCCHHHHHHHHHHHHHHHHHHh
Q 044312 314 KVEEFINEVVILSQ-INHRNVVKLLGCCLETEVPLLVYEFIPNGTLFQYIHDQ-NEDFPITWEIRLRIAIEVSGALSYLH 391 (608)
Q Consensus 314 ~~~~~~~Ei~il~~-l~H~niv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~ia~aL~yLH 391 (608)
...++.+|+.++.+ ++||||+++++++.+.+..++||||+++++|.+++... .....+++..++.++.|++.||.|||
T Consensus 51 ~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh 130 (269)
T cd08528 51 SIGDIVSEVTIIKEQLRHPNIVRYYKTFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLH 130 (269)
T ss_pred HHHHHHHHHHHHhhcCCCCCeeeEEeeEccCCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhc
Confidence 45668889998875 79999999999999999999999999999999988542 22235899999999999999999999
Q ss_pred h-cCCCCeeccCCCCCcEEEcCCCcEEEeeccCccccccCCcceeeeeeccCCCCChhhhccCCCCCccchHhHHHHHHH
Q 044312 392 S-AASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLTE 470 (608)
Q Consensus 392 ~-~~~~~iiHrDlk~~NILl~~~~~~kl~DFGls~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~e 470 (608)
+ .+ ++|+||+|+|||++.++.+||+|||++....... ......++..|+|||.+.+..++.++||||||+++||
T Consensus 131 ~~~~---i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~--~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~ 205 (269)
T cd08528 131 KEKR---IVHRDLTPNNIMLGEDDKVTITDFGLAKQKQPES--KLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQ 205 (269)
T ss_pred cCCc---eeecCCCHHHEEECCCCcEEEecccceeeccccc--ccccccCcccCcChhhhcCCCCchHHHHHHHHHHHHH
Confidence 6 56 9999999999999999999999999998754332 2344568899999999998889999999999999999
Q ss_pred HHhCCCCCCccchhhcccHHHHHHHHhhhhhhHHHhhhhhhccCChhHHHHHHHHHHHHhccCCCCCCCHHHHHHHHH
Q 044312 471 LLTGEKPIRFTILEEDKSLAAYFLCAMKEERLFEILDARVMKQGGKDEIITVAKLAKRCLNLNGKKRPTMREVASELA 548 (608)
Q Consensus 471 lltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~evl~~L~ 548 (608)
|++|+.||....... .. ..+.+...........+..+.+++.+||+.||++||++.||..+++
T Consensus 206 l~~g~~p~~~~~~~~------~~---------~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rp~~~e~~~~~~ 268 (269)
T cd08528 206 MCTLQPPFYSTNMLS------LA---------TKIVEAVYEPLPEGMYSEDVTDVITSCLTPDAEARPDIIQVSAMIS 268 (269)
T ss_pred HHhCCCcccccCHHH------HH---------HHHhhccCCcCCcccCCHHHHHHHHHHCCCCCccCCCHHHHHHHhc
Confidence 999999986321110 00 0111111111111234567999999999999999999999998875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-33 Score=303.25 Aligned_cols=253 Identities=22% Similarity=0.313 Sum_probs=183.3
Q ss_pred hcCccccceeccCceEEEEEe---------ecChhhHHHHHHHHHHHhhcCCCCccceecccccCccceEEEeecCCCcc
Q 044312 288 TDNFDLNRILGQGGQAVKKSK---------VIDESKVEEFINEVVILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGTL 358 (608)
Q Consensus 288 t~~f~~~~~lG~G~~avk~~~---------~~~~~~~~~~~~Ei~il~~l~H~niv~l~~~~~~~~~~~lV~E~~~~gsL 358 (608)
..+|.+.++||+|++...... .........+.+|+++|++|+|+|||++++++......+||||++ .++|
T Consensus 168 ~~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~~~~~~~E~~iL~~L~HpnIv~l~~~~~~~~~~~lv~e~~-~~~L 246 (461)
T PHA03211 168 GLGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGWYASSVHEARLLRRLSHPAVLALLDVRVVGGLTCLVLPKY-RSDL 246 (461)
T ss_pred cCCeEEEEEEccCCCeEEEEEEECCCCCEEEEecccccCHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEEcc-CCCH
Confidence 457999999999986321110 011122345778999999999999999999999999999999999 4688
Q ss_pred chhccccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEEcCCCcEEEeeccCccccccCCc-ceeee
Q 044312 359 FQYIHDQNEDFPITWEIRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQT-HMTTQ 437 (608)
Q Consensus 359 ~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGls~~~~~~~~-~~~~~ 437 (608)
.+++..... .+++..++.|+.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++....... .....
T Consensus 247 ~~~l~~~~~--~l~~~~~~~i~~qi~~aL~yLH~~g---IvHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~ 321 (461)
T PHA03211 247 YTYLGARLR--PLGLAQVTAVARQLLSAIDYIHGEG---IIHRDIKTENVLVNGPEDICLGDFGAACFARGSWSTPFHYG 321 (461)
T ss_pred HHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHHCC---EEECcCCHHHEEECCCCCEEEcccCCceecccccccccccc
Confidence 888865432 5999999999999999999999999 99999999999999999999999999986543221 12234
Q ss_pred eeccCCCCChhhhccCCCCCccchHhHHHHHHHHHhCCCCCCccc-hhhcccHHHHHHHHhhhhh-------------hH
Q 044312 438 VHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLTELLTGEKPIRFTI-LEEDKSLAAYFLCAMKEER-------------LF 503 (608)
Q Consensus 438 ~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~elltg~~p~~~~~-~~~~~~l~~~~~~~~~~~~-------------~~ 503 (608)
..||..|+|||++.+..++.++|||||||+||||++|..|+.... ..........+...+.... +.
T Consensus 322 ~~GT~~Y~APE~~~~~~~~~~sDvwSlGviL~El~~g~~~lf~~~~~~~~~~~~~~l~~~i~~~~~~~~~~~~~~~~~l~ 401 (461)
T PHA03211 322 IAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQILRIIRQAQVHVDEFPQHAGSRLV 401 (461)
T ss_pred cCCCcCCcCHHHHcCCCCCchHHHHHHHHHHHHHHHcCCCcccCCcccccCCcHHHHHHHHHhhccccccCCCCcchHHH
Confidence 569999999999999999999999999999999999887653221 1111111111111111100 00
Q ss_pred HHhhhh----hhccCC-------hhHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 044312 504 EILDAR----VMKQGG-------KDEIITVAKLAKRCLNLNGKKRPTMREVASE 546 (608)
Q Consensus 504 ~~~d~~----~~~~~~-------~~~~~~l~~Li~~cl~~dp~~RPs~~evl~~ 546 (608)
...... ...... ......+.+|+.+||+.||.+|||+.|++++
T Consensus 402 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~DP~~RPsa~elL~h 455 (461)
T PHA03211 402 SQYRHRAARNRRPAYTRPAWTRYYKLDLDVEYLVCRALTFDGARRPSAAELLRL 455 (461)
T ss_pred HHHHhhhhcccCCccCCcchhhhccccchHHHHHHHHcccChhhCcCHHHHhhC
Confidence 000000 000000 0123468899999999999999999999875
|
|
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-33 Score=280.93 Aligned_cols=234 Identities=27% Similarity=0.466 Sum_probs=184.1
Q ss_pred ccccceeccCce--------------EEEEEeecC------hhhHHHHHHHHHHHhhcCCCCccceecccccCccceEEE
Q 044312 291 FDLNRILGQGGQ--------------AVKKSKVID------ESKVEEFINEVVILSQINHRNVVKLLGCCLETEVPLLVY 350 (608)
Q Consensus 291 f~~~~~lG~G~~--------------avk~~~~~~------~~~~~~~~~Ei~il~~l~H~niv~l~~~~~~~~~~~lV~ 350 (608)
|+..+.||+|++ |||..+... ....+.+.+|+.++++++|+||+++++++.+....++||
T Consensus 2 ~~~~~~ig~g~~~~v~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 81 (265)
T cd06631 2 WTKGEVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISIFM 81 (265)
T ss_pred ccccceEeccCCeEEEEEEEcCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCCeEEEEE
Confidence 556677777753 666655321 223467899999999999999999999999999999999
Q ss_pred eecCCCccchhccccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEEcCCCcEEEeeccCccccccC
Q 044312 351 EFIPNGTLFQYIHDQNEDFPITWEIRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVD 430 (608)
Q Consensus 351 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGls~~~~~~ 430 (608)
||+++++|.+++.+.. ++++..+..++.|++.||+|||+.+ ++|+||+|+||++++++.+||+|||++......
T Consensus 82 e~~~~~~L~~~l~~~~---~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~ 155 (265)
T cd06631 82 EFVPGGSISSILNRFG---PLPEPVFCKYTKQILDGVAYLHNNC---VVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWV 155 (265)
T ss_pred ecCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCC---cccCCcCHHhEEECCCCeEEeccchhhHhhhhc
Confidence 9999999999997543 4889999999999999999999998 999999999999999999999999998765321
Q ss_pred C-----cceeeeeeccCCCCChhhhccCCCCCccchHhHHHHHHHHHhCCCCCCccchhhcccHHHHHHHHhhhhhhHHH
Q 044312 431 Q-----THMTTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLTELLTGEKPIRFTILEEDKSLAAYFLCAMKEERLFEI 505 (608)
Q Consensus 431 ~-----~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 505 (608)
. ........++..|+|||++.+..++.++||||||++++||++|+.||...... .... .+
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~-----~~~~----------~~ 220 (265)
T cd06631 156 GLHGTHSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDRL-----AAMF----------YI 220 (265)
T ss_pred cccccccccccccCCCccccChhhhcCCCCcchhhHHHHHHHHHHHHhCCCccccCChH-----HHHH----------Hh
Confidence 1 11123345889999999999999999999999999999999999998632111 1000 00
Q ss_pred hhh-hhhccCChhHHHHHHHHHHHHhccCCCCCCCHHHHHH
Q 044312 506 LDA-RVMKQGGKDEIITVAKLAKRCLNLNGKKRPTMREVAS 545 (608)
Q Consensus 506 ~d~-~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~evl~ 545 (608)
... ......+...+.++.+++.+||+.+|++||++.|+++
T Consensus 221 ~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~ 261 (265)
T cd06631 221 GAHRGLMPRLPDSFSAAAIDFVTSCLTRDQHERPSALQLLR 261 (265)
T ss_pred hhccCCCCCCCCCCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 000 0111223345678999999999999999999999875
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-33 Score=295.67 Aligned_cols=246 Identities=22% Similarity=0.339 Sum_probs=182.7
Q ss_pred HhcCccccceeccCce---------------EEEEEee--cChhhHHHHHHHHHHHhhcCCCCccceecccccC------
Q 044312 287 ATDNFDLNRILGQGGQ---------------AVKKSKV--IDESKVEEFINEVVILSQINHRNVVKLLGCCLET------ 343 (608)
Q Consensus 287 ~t~~f~~~~~lG~G~~---------------avk~~~~--~~~~~~~~~~~Ei~il~~l~H~niv~l~~~~~~~------ 343 (608)
..++|.+.+.||+|++ |||++.. .+......+.+|+.+++.++||||+++++++...
T Consensus 22 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~~ 101 (364)
T cd07875 22 VLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEF 101 (364)
T ss_pred hhcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeeccccccccc
Confidence 3568999999999985 5665543 2334457788999999999999999999987543
Q ss_pred ccceEEEeecCCCccchhccccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEEcCCCcEEEeeccC
Q 044312 344 EVPLLVYEFIPNGTLFQYIHDQNEDFPITWEIRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGA 423 (608)
Q Consensus 344 ~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGl 423 (608)
...++||||+++ +|.+.+.. .+++..+..++.|++.||+|||+++ |+||||||+|||++.++.+||+|||+
T Consensus 102 ~~~~lv~e~~~~-~l~~~~~~-----~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~DfG~ 172 (364)
T cd07875 102 QDVYIVMELMDA-NLCQVIQM-----ELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGL 172 (364)
T ss_pred CeEEEEEeCCCC-CHHHHHHh-----cCCHHHHHHHHHHHHHHHHHHhhCC---eecCCCCHHHEEECCCCcEEEEeCCC
Confidence 356999999965 67776642 3788999999999999999999999 99999999999999999999999999
Q ss_pred ccccccCCcceeeeeeccCCCCChhhhccCCCCCccchHhHHHHHHHHHhCCCCCCccchhhcccHHHHHHHHhhh--hh
Q 044312 424 SRSMAVDQTHMTTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLTELLTGEKPIRFTILEEDKSLAAYFLCAMKE--ER 501 (608)
Q Consensus 424 s~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~elltg~~p~~~~~~~~~~~l~~~~~~~~~~--~~ 501 (608)
++..... .......+|..|+|||++.+..++.++|||||||+++||++|+.||......+. .......... ..
T Consensus 173 a~~~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~---~~~~~~~~~~~~~~ 247 (364)
T cd07875 173 ARTAGTS--FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQ---WNKVIEQLGTPCPE 247 (364)
T ss_pred ccccCCC--CcccCCcccCCcCCHHHHhCCCCCchhhHHhHHHHHHHHHhCCCCCCCCCHHHH---HHHHHHhcCCCCHH
Confidence 9865432 122345689999999999999999999999999999999999999974332111 0000000000 00
Q ss_pred hH--------HHhhhh--------------hh----ccCChhHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 044312 502 LF--------EILDAR--------------VM----KQGGKDEIITVAKLAKRCLNLNGKKRPTMREVASE 546 (608)
Q Consensus 502 ~~--------~~~d~~--------------~~----~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~evl~~ 546 (608)
.. ...... .. ..........+++|+.+||+.||.+|||+.|++++
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~t~~e~L~h 318 (364)
T cd07875 248 FMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQH 318 (364)
T ss_pred HHHhhhHHHHHHHhhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCcCcccCCCHHHHhcC
Confidence 00 000000 00 00011123568899999999999999999999875
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-33 Score=293.51 Aligned_cols=221 Identities=26% Similarity=0.315 Sum_probs=171.3
Q ss_pred eEEEEEeecC---hhhHHHHHHHHH-HHhhcCCCCccceecccccCccceEEEeecCCCccchhccccCCCCCCCHHHHH
Q 044312 302 QAVKKSKVID---ESKVEEFINEVV-ILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEIRL 377 (608)
Q Consensus 302 ~avk~~~~~~---~~~~~~~~~Ei~-il~~l~H~niv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~ 377 (608)
+|+|...... ......+..|.. +++.++|+||+++++++.+.+..++||||+++++|.+++.... .+++..+.
T Consensus 23 ~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~---~~~~~~~~ 99 (325)
T cd05602 23 YAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYINGGELFYHLQRER---CFLEPRAR 99 (325)
T ss_pred EEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEEeCCCCCcHHHHHHhcC---CCCHHHHH
Confidence 4667665321 222334455544 5688899999999999999999999999999999999887643 47888889
Q ss_pred HHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEEcCCCcEEEeeccCccccccCCcceeeeeeccCCCCChhhhccCCCCC
Q 044312 378 RIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHGTFGYLDPEYFRSSQFTD 457 (608)
Q Consensus 378 ~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGls~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ 457 (608)
.++.||++||+|||+.+ |+||||||+|||++.++.+||+|||+++...... .......||+.|+|||++.+..++.
T Consensus 100 ~~~~qi~~~L~~lH~~g---iiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~ 175 (325)
T cd05602 100 FYAAEIASALGYLHSLN---IVYRDLKPENILLDSQGHIVLTDFGLCKENIEHN-GTTSTFCGTPEYLAPEVLHKQPYDR 175 (325)
T ss_pred HHHHHHHHHHHHHHHCC---eEecCCCHHHeEECCCCCEEEccCCCCcccccCC-CCcccccCCccccCHHHHcCCCCCC
Confidence 99999999999999999 9999999999999999999999999997543222 2234456899999999999999999
Q ss_pred ccchHhHHHHHHHHHhCCCCCCccchhhcccHHHHHHHHhhhhhhHHHhhhhhhccCChhHHHHHHHHHHHHhccCCCCC
Q 044312 458 KSDVYSFGVVLTELLTGEKPIRFTILEEDKSLAAYFLCAMKEERLFEILDARVMKQGGKDEIITVAKLAKRCLNLNGKKR 537 (608)
Q Consensus 458 ksDV~S~Gvvl~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~Li~~cl~~dp~~R 537 (608)
++||||||++++||++|+.||......+ .+. .+.... .......+..+.+++.+||+.||.+|
T Consensus 176 ~~DiwslG~il~el~~g~~pf~~~~~~~------~~~---------~i~~~~--~~~~~~~~~~~~~li~~~l~~~p~~R 238 (325)
T cd05602 176 TVDWWCLGAVLYEMLYGLPPFYSRNTAE------MYD---------NILNKP--LQLKPNITNSARHLLEGLLQKDRTKR 238 (325)
T ss_pred ccccccccHHHHHHhcCCCCCCCCCHHH------HHH---------HHHhCC--cCCCCCCCHHHHHHHHHHcccCHHHC
Confidence 9999999999999999999996322111 111 111111 11223456679999999999999999
Q ss_pred CCHHHHHHH
Q 044312 538 PTMREVASE 546 (608)
Q Consensus 538 Ps~~evl~~ 546 (608)
|++.+.+.+
T Consensus 239 ~~~~~~~~~ 247 (325)
T cd05602 239 LGAKDDFME 247 (325)
T ss_pred CCCCCCHHH
Confidence 998754433
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-33 Score=281.69 Aligned_cols=249 Identities=22% Similarity=0.301 Sum_probs=187.2
Q ss_pred ccccceeccCce---------------EEEEEeecCh--hhHHHHHHHHHHHhhcCCCC-ccceecccccCc------cc
Q 044312 291 FDLNRILGQGGQ---------------AVKKSKVIDE--SKVEEFINEVVILSQINHRN-VVKLLGCCLETE------VP 346 (608)
Q Consensus 291 f~~~~~lG~G~~---------------avk~~~~~~~--~~~~~~~~Ei~il~~l~H~n-iv~l~~~~~~~~------~~ 346 (608)
|...++||+|.+ |+|+++...+ .......+|+.+|+.|+|+| ||+|++++...+ ..
T Consensus 13 ~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~~~l 92 (323)
T KOG0594|consen 13 YEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGIGKL 92 (323)
T ss_pred HHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeeecccccccceE
Confidence 444566888863 7888876543 24567799999999999999 999999998777 78
Q ss_pred eEEEeecCCCccchhccccCCC-CCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEEcCCCcEEEeeccCcc
Q 044312 347 LLVYEFIPNGTLFQYIHDQNED-FPITWEIRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASR 425 (608)
Q Consensus 347 ~lV~E~~~~gsL~~~l~~~~~~-~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGls~ 425 (608)
+|||||++ -+|..++...... ..++...+..++.||+.||+|||+++ |+||||||.||||++++.+||+|||+|+
T Consensus 93 ~lvfe~~d-~DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~~---IlHRDLKPQNlLi~~~G~lKlaDFGlAr 168 (323)
T KOG0594|consen 93 YLVFEFLD-RDLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSHG---ILHRDLKPQNLLISSSGVLKLADFGLAR 168 (323)
T ss_pred EEEEEeec-ccHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhCC---eecccCCcceEEECCCCcEeeeccchHH
Confidence 99999995 4999999875431 24777899999999999999999999 9999999999999999999999999999
Q ss_pred ccccCCcceeeeeeccCCCCChhhhccC-CCCCccchHhHHHHHHHHHhCCCCCCccchhhcccHHHHHHHH--hhhhhh
Q 044312 426 SMAVDQTHMTTQVHGTFGYLDPEYFRSS-QFTDKSDVYSFGVVLTELLTGEKPIRFTILEEDKSLAAYFLCA--MKEERL 502 (608)
Q Consensus 426 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~t~ksDV~S~Gvvl~elltg~~p~~~~~~~~~~~l~~~~~~~--~~~~~~ 502 (608)
....... ..+...+|.+|.|||++.+. .|+...||||+|||++||++++.-|...... ..+...|... -.+...
T Consensus 169 a~~ip~~-~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se~--~ql~~If~~lGtP~e~~W 245 (323)
T KOG0594|consen 169 AFSIPMR-TYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSEI--DQLFRIFRLLGTPNEKDW 245 (323)
T ss_pred HhcCCcc-cccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcHH--HHHHHHHHHcCCCCccCC
Confidence 7664332 24556789999999999877 7999999999999999999999888643331 1122211111 111111
Q ss_pred HHHh---h----------hhhhccCChhHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 044312 503 FEIL---D----------ARVMKQGGKDEIITVAKLAKRCLNLNGKKRPTMREVASE 546 (608)
Q Consensus 503 ~~~~---d----------~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~evl~~ 546 (608)
.... + +............+..+++.+||+.+|.+|.|++.++++
T Consensus 246 p~v~~~~~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~al~h 302 (323)
T KOG0594|consen 246 PGVSSLPDYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAKGALTH 302 (323)
T ss_pred CCccccccccccCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcCHHHHhcC
Confidence 1110 0 000000001112478899999999999999999999876
|
|
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-33 Score=294.72 Aligned_cols=221 Identities=27% Similarity=0.340 Sum_probs=171.8
Q ss_pred eEEEEEeec---ChhhHHHHHHHHH-HHhhcCCCCccceecccccCccceEEEeecCCCccchhccccCCCCCCCHHHHH
Q 044312 302 QAVKKSKVI---DESKVEEFINEVV-ILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEIRL 377 (608)
Q Consensus 302 ~avk~~~~~---~~~~~~~~~~Ei~-il~~l~H~niv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~ 377 (608)
+|+|..... +......+..|.. +++.++||||+++++.+...+..++||||+++|+|..++.... .+++..+.
T Consensus 23 ~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~---~~~~~~~~ 99 (325)
T cd05604 23 YAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNGGELFFHLQRER---SFPEPRAR 99 (325)
T ss_pred EEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcCCCCCCHHHHHHHcC---CCCHHHHH
Confidence 366766432 2233455666665 5677899999999999999999999999999999998886543 58999999
Q ss_pred HHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEEcCCCcEEEeeccCccccccCCcceeeeeeccCCCCChhhhccCCCCC
Q 044312 378 RIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHGTFGYLDPEYFRSSQFTD 457 (608)
Q Consensus 378 ~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGls~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ 457 (608)
.++.||+.||+|||+.+ |+||||||+|||+++++.+||+|||+++...... .......||+.|+|||++.+..++.
T Consensus 100 ~~~~qi~~al~~lH~~g---ivH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~ 175 (325)
T cd05604 100 FYAAEIASALGYLHSIN---IVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQS-DTTTTFCGTPEYLAPEVIRKQPYDN 175 (325)
T ss_pred HHHHHHHHHHHHHHHCC---eeecCCCHHHeEECCCCCEEEeecCCcccCCCCC-CCcccccCChhhCCHHHHcCCCCCC
Confidence 99999999999999999 9999999999999999999999999987543221 2234456899999999999999999
Q ss_pred ccchHhHHHHHHHHHhCCCCCCccchhhcccHHHHHHHHhhhhhhHHHhhhhhhccCChhHHHHHHHHHHHHhccCCCCC
Q 044312 458 KSDVYSFGVVLTELLTGEKPIRFTILEEDKSLAAYFLCAMKEERLFEILDARVMKQGGKDEIITVAKLAKRCLNLNGKKR 537 (608)
Q Consensus 458 ksDV~S~Gvvl~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~Li~~cl~~dp~~R 537 (608)
++||||||++++||++|+.||...... ..+.. ++... .......+..+.+++.+||+.+|.+|
T Consensus 176 ~~DvwslG~il~el~~G~~pf~~~~~~------~~~~~---------~~~~~--~~~~~~~~~~~~~ll~~ll~~~p~~R 238 (325)
T cd05604 176 TVDWWCLGAVLYEMLYGLPPFYCRDVA------EMYDN---------ILHKP--LVLRPGASLTAWSILEELLEKDRQRR 238 (325)
T ss_pred cCccccccceehhhhcCCCCCCCCCHH------HHHHH---------HHcCC--ccCCCCCCHHHHHHHHHHhccCHHhc
Confidence 999999999999999999998633211 11111 11110 01122345678899999999999999
Q ss_pred CCHHHHHHH
Q 044312 538 PTMREVASE 546 (608)
Q Consensus 538 Ps~~evl~~ 546 (608)
|++++.++.
T Consensus 239 ~~~~~~~~~ 247 (325)
T cd05604 239 LGAKEDFLE 247 (325)
T ss_pred CCCCCCHHH
Confidence 998644433
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-32 Score=279.64 Aligned_cols=221 Identities=22% Similarity=0.338 Sum_probs=167.0
Q ss_pred hhHHHHHHHHHHHhhcCCCCccceecccccCccceEEEeecCCCccchhccccCC-CCCCCHHHHHHHHHHHHHHHHHHh
Q 044312 313 SKVEEFINEVVILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGTLFQYIHDQNE-DFPITWEIRLRIAIEVSGALSYLH 391 (608)
Q Consensus 313 ~~~~~~~~Ei~il~~l~H~niv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~-~~~l~~~~~~~i~~~ia~aL~yLH 391 (608)
...+.|.+|+.+++.++||||+++++.+.+....++||||+++|+|.+++++... ...+++..+..++.||++||+|||
T Consensus 37 ~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH 116 (268)
T cd05086 37 KEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEYCELGDLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMH 116 (268)
T ss_pred HHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEEecCCCCcHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHH
Confidence 3457899999999999999999999999999999999999999999999976432 224677788899999999999999
Q ss_pred hcCCCCeeccCCCCCcEEEcCCCcEEEeeccCccccccCC-cceeeeeeccCCCCChhhhcc-------CCCCCccchHh
Q 044312 392 SAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQ-THMTTQVHGTFGYLDPEYFRS-------SQFTDKSDVYS 463 (608)
Q Consensus 392 ~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGls~~~~~~~-~~~~~~~~gt~~y~aPE~~~~-------~~~t~ksDV~S 463 (608)
+.+ ++||||||+|||++.++.+||+|||++....... ........++..|+|||++.. ..++.++||||
T Consensus 117 ~~~---i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~Diws 193 (268)
T cd05086 117 KHN---FLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIETEDDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWA 193 (268)
T ss_pred HCC---eeccCCccceEEEcCCccEEecccccccccCcchhhhcccCCcCcccccCchhcccccCccccCCCCCcchhHH
Confidence 998 9999999999999999999999999986432211 111233457889999999753 24578999999
Q ss_pred HHHHHHHHHhC-CCCCCccchhhcccHHHHHHHHhhhhhhHHHhhhhhhccCChhHHHHHHHHHHHHhccCCCCCCCHHH
Q 044312 464 FGVVLTELLTG-EKPIRFTILEEDKSLAAYFLCAMKEERLFEILDARVMKQGGKDEIITVAKLAKRCLNLNGKKRPTMRE 542 (608)
Q Consensus 464 ~Gvvl~elltg-~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~e 542 (608)
||++++||+++ ..||...... ..+...... ......++.. .......+.+++..|| .+|++||+++|
T Consensus 194 lG~~l~el~~~~~~p~~~~~~~------~~~~~~~~~-~~~~~~~~~~----~~~~~~~~~~l~~~c~-~~P~~Rp~~~~ 261 (268)
T cd05086 194 LGVTLWELFENAAQPYSHLSDR------EVLNHVIKD-QQVKLFKPQL----ELPYSERWYEVLQFCW-LSPEKRATAEE 261 (268)
T ss_pred HHHHHHHHHhCCCCCCCCCCHH------HHHHHHHhh-cccccCCCcc----CCCCcHHHHHHHHHHh-hCcccCCCHHH
Confidence 99999999974 6676532211 111111111 1111112211 2234567888999999 68999999999
Q ss_pred HHHHHH
Q 044312 543 VASELA 548 (608)
Q Consensus 543 vl~~L~ 548 (608)
|++.|.
T Consensus 262 i~~~l~ 267 (268)
T cd05086 262 VHRLLT 267 (268)
T ss_pred HHHHhc
Confidence 998873
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-33 Score=284.63 Aligned_cols=245 Identities=25% Similarity=0.373 Sum_probs=188.3
Q ss_pred CHHHHHHHhcCccccceeccCce---------------EEEEEeecChhhHHHHHHHHHHHhhc-CCCCccceeccccc-
Q 044312 280 TSKELEKATDNFDLNRILGQGGQ---------------AVKKSKVIDESKVEEFINEVVILSQI-NHRNVVKLLGCCLE- 342 (608)
Q Consensus 280 ~~~~l~~~t~~f~~~~~lG~G~~---------------avk~~~~~~~~~~~~~~~Ei~il~~l-~H~niv~l~~~~~~- 342 (608)
+..++..+.+.|++.+.||+|++ |+|.... ......++..|+.+++++ +|+||+++++++..
T Consensus 7 ~~~~~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~-~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~ 85 (282)
T cd06636 7 DLSALRDPAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDV-TEDEEEEIKLEINMLKKYSHHRNIATYYGAFIKK 85 (282)
T ss_pred hhhhhcChhhhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEec-ChHHHHHHHHHHHHHHHhcCCCcEEEEeeehhcc
Confidence 45566667788999999999985 4444433 334456788999999999 79999999999853
Q ss_pred -----CccceEEEeecCCCccchhccccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEEcCCCcEE
Q 044312 343 -----TEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEIRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAK 417 (608)
Q Consensus 343 -----~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~k 417 (608)
....+++|||+++|+|.+++..... ..+++..+..++.||+.||.|||+.+ ++|+||||+||++++++.+|
T Consensus 86 ~~~~~~~~~~iv~e~~~~~~L~~~~~~~~~-~~~~~~~~~~~~~qi~~al~~LH~~~---ivH~dl~~~nili~~~~~~~ 161 (282)
T cd06636 86 SPPGHDDQLWLVMEFCGAGSVTDLVKNTKG-NALKEDWIAYICREILRGLAHLHAHK---VIHRDIKGQNVLLTENAEVK 161 (282)
T ss_pred cccCCCCEEEEEEEeCCCCcHHHHHHHccC-CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEE
Confidence 4567999999999999999876432 25888999999999999999999999 99999999999999999999
Q ss_pred EeeccCccccccCCcceeeeeeccCCCCChhhhc-----cCCCCCccchHhHHHHHHHHHhCCCCCCccchhhcccHHHH
Q 044312 418 VSDFGASRSMAVDQTHMTTQVHGTFGYLDPEYFR-----SSQFTDKSDVYSFGVVLTELLTGEKPIRFTILEEDKSLAAY 492 (608)
Q Consensus 418 l~DFGls~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~t~ksDV~S~Gvvl~elltg~~p~~~~~~~~~~~l~~~ 492 (608)
|+|||++........ ......|++.|+|||.+. ...++.++||||||++++||++|+.||....... .
T Consensus 162 l~dfg~~~~~~~~~~-~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~-----~- 234 (282)
T cd06636 162 LVDFGVSAQLDRTVG-RRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMR-----A- 234 (282)
T ss_pred EeeCcchhhhhcccc-CCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCHHh-----h-
Confidence 999999876542211 123345889999999976 3467889999999999999999999986322110 0
Q ss_pred HHHHhhhhhhHHHhhhhhhccCChhHHHHHHHHHHHHhccCCCCCCCHHHHHH
Q 044312 493 FLCAMKEERLFEILDARVMKQGGKDEIITVAKLAKRCLNLNGKKRPTMREVAS 545 (608)
Q Consensus 493 ~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~evl~ 545 (608)
+..+.............+..+.+|+.+||+.||++||++.||++
T Consensus 235 ---------~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~ell~ 278 (282)
T cd06636 235 ---------LFLIPRNPPPKLKSKKWSKKFIDFIEGCLVKNYLSRPSTEQLLK 278 (282)
T ss_pred ---------hhhHhhCCCCCCcccccCHHHHHHHHHHhCCChhhCcCHHHHhc
Confidence 00011111111112245668999999999999999999999975
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-33 Score=287.46 Aligned_cols=223 Identities=27% Similarity=0.393 Sum_probs=178.8
Q ss_pred eEEEEEeecChhhHHHHHHHHHHHhhcCCCCccceecccccCccceEEEeecCCCccchhccccCCCCCCCHHHHHHHHH
Q 044312 302 QAVKKSKVIDESKVEEFINEVVILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEIRLRIAI 381 (608)
Q Consensus 302 ~avk~~~~~~~~~~~~~~~Ei~il~~l~H~niv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~ 381 (608)
+|||+.........+.+.+|+.++++++|+||+++++.+...+..++||||+++++|.+++... .+++..+..++.
T Consensus 50 vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~----~l~~~~~~~~~~ 125 (292)
T cd06658 50 VAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVMEFLEGGALTDIVTHT----RMNEEQIATVCL 125 (292)
T ss_pred EEEEEEecchHHHHHHHHHHHHHHHhCCCCcHHHHHHheecCCeEEEEEeCCCCCcHHHHHhcC----CCCHHHHHHHHH
Confidence 3777766555566778999999999999999999999999999999999999999999987542 488999999999
Q ss_pred HHHHHHHHHhhcCCCCeeccCCCCCcEEEcCCCcEEEeeccCccccccCCcceeeeeeccCCCCChhhhccCCCCCccch
Q 044312 382 EVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHGTFGYLDPEYFRSSQFTDKSDV 461 (608)
Q Consensus 382 ~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGls~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV 461 (608)
||+.||+|||+.+ |+||||||+||++++++.+||+|||++........ ......++..|+|||.+....++.++||
T Consensus 126 qi~~~l~~LH~~~---ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Dv 201 (292)
T cd06658 126 SVLRALSYLHNQG---VIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVP-KRKSLVGTPYWMAPEVISRLPYGTEVDI 201 (292)
T ss_pred HHHHHHHHHHHCC---EeecCCCHHHEEEcCCCCEEEccCcchhhcccccc-cCceeecCccccCHHHHccCCCCchhhH
Confidence 9999999999998 99999999999999999999999999876543222 2233568899999999998899999999
Q ss_pred HhHHHHHHHHHhCCCCCCccchhhcccHHHHHHHHhhhhhhHHHhhhhhhccCChhHHHHHHHHHHHHhccCCCCCCCHH
Q 044312 462 YSFGVVLTELLTGEKPIRFTILEEDKSLAAYFLCAMKEERLFEILDARVMKQGGKDEIITVAKLAKRCLNLNGKKRPTMR 541 (608)
Q Consensus 462 ~S~Gvvl~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~ 541 (608)
||||++++||++|+.||....... .+ ..+ ...+.... ......+..+.+++.+||..||.+|||++
T Consensus 202 ~slGvil~el~~g~~p~~~~~~~~------~~-~~~-----~~~~~~~~--~~~~~~~~~~~~li~~~l~~~P~~Rpt~~ 267 (292)
T cd06658 202 WSLGIMVIEMIDGEPPYFNEPPLQ------AM-RRI-----RDNLPPRV--KDSHKVSSVLRGFLDLMLVREPSQRATAQ 267 (292)
T ss_pred HHHHHHHHHHHhCCCCCCCCCHHH------HH-HHH-----HhcCCCcc--ccccccCHHHHHHHHHHccCChhHCcCHH
Confidence 999999999999999986322110 00 000 01111111 11123455788999999999999999999
Q ss_pred HHHHH
Q 044312 542 EVASE 546 (608)
Q Consensus 542 evl~~ 546 (608)
|++++
T Consensus 268 ~il~~ 272 (292)
T cd06658 268 ELLQH 272 (292)
T ss_pred HHhhC
Confidence 99864
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-33 Score=279.19 Aligned_cols=237 Identities=25% Similarity=0.395 Sum_probs=185.6
Q ss_pred CccccceeccCce---------------EEEEEee--cChhhHHHHHHHHHHHhhcCCCCccceeccccc--CccceEEE
Q 044312 290 NFDLNRILGQGGQ---------------AVKKSKV--IDESKVEEFINEVVILSQINHRNVVKLLGCCLE--TEVPLLVY 350 (608)
Q Consensus 290 ~f~~~~~lG~G~~---------------avk~~~~--~~~~~~~~~~~Ei~il~~l~H~niv~l~~~~~~--~~~~~lV~ 350 (608)
+|++.+.||.|++ ++|.... ......+.+.+|+.++++++|+||+++++++.. ....+++|
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 80 (265)
T cd08217 1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIVM 80 (265)
T ss_pred CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEEe
Confidence 3566777777763 5565543 234556789999999999999999999997753 44678999
Q ss_pred eecCCCccchhccccC-CCCCCCHHHHHHHHHHHHHHHHHHh-----hcCCCCeeccCCCCCcEEEcCCCcEEEeeccCc
Q 044312 351 EFIPNGTLFQYIHDQN-EDFPITWEIRLRIAIEVSGALSYLH-----SAASIPIYHRDIKSTNILLDDKYRAKVSDFGAS 424 (608)
Q Consensus 351 E~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~aL~yLH-----~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGls 424 (608)
||+++++|.+++.... ...++++..++.++.||+.||.||| +.+ ++|+||||+||++++++.+||+|||++
T Consensus 81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~---i~h~dl~p~nili~~~~~~kl~d~g~~ 157 (265)
T cd08217 81 EYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNT---VLHRDLKPANIFLDANNNVKLGDFGLA 157 (265)
T ss_pred hhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCc---ceecCCCHHHEEEecCCCEEEeccccc
Confidence 9999999999987532 2236899999999999999999999 666 999999999999999999999999999
Q ss_pred cccccCCcceeeeeeccCCCCChhhhccCCCCCccchHhHHHHHHHHHhCCCCCCccchhhcccHHHHHHHHhhhhhhHH
Q 044312 425 RSMAVDQTHMTTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLTELLTGEKPIRFTILEEDKSLAAYFLCAMKEERLFE 504 (608)
Q Consensus 425 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~ 504 (608)
........ ......+++.|+|||.+....++.++||||||+++++|++|+.||...... . +.....
T Consensus 158 ~~~~~~~~-~~~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~------~-~~~~~~------ 223 (265)
T cd08217 158 KILGHDSS-FAKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARNQL------Q-LASKIK------ 223 (265)
T ss_pred ccccCCcc-cccccccCCCccChhhhcCCCCCchhHHHHHHHHHHHHHHCCCcccCcCHH------H-HHHHHh------
Confidence 87654332 123346899999999999989999999999999999999999998743211 0 111111
Q ss_pred HhhhhhhccCChhHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 044312 505 ILDARVMKQGGKDEIITVAKLAKRCLNLNGKKRPTMREVASE 546 (608)
Q Consensus 505 ~~d~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~evl~~ 546 (608)
.......+...+..+.+++.+||+.+|++||++++|+++
T Consensus 224 ---~~~~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~il~~ 262 (265)
T cd08217 224 ---EGKFRRIPYRYSSELNEVIKSMLNVDPDKRPSTEELLQL 262 (265)
T ss_pred ---cCCCCCCccccCHHHHHHHHHHccCCcccCCCHHHHhhC
Confidence 111112333456789999999999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-33 Score=293.07 Aligned_cols=245 Identities=22% Similarity=0.304 Sum_probs=180.2
Q ss_pred HhcCccccceeccCce---------------EEEEEeec--ChhhHHHHHHHHHHHhhcCCCCccceecccccC------
Q 044312 287 ATDNFDLNRILGQGGQ---------------AVKKSKVI--DESKVEEFINEVVILSQINHRNVVKLLGCCLET------ 343 (608)
Q Consensus 287 ~t~~f~~~~~lG~G~~---------------avk~~~~~--~~~~~~~~~~Ei~il~~l~H~niv~l~~~~~~~------ 343 (608)
..++|.+.+.||+|+| |||+.... .....+.+.+|+.+|++++||||+++++++...
T Consensus 13 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 92 (343)
T cd07878 13 VPERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIENF 92 (343)
T ss_pred hhhhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhccccccccc
Confidence 4567888999999975 56655432 123346688999999999999999999988543
Q ss_pred ccceEEEeecCCCccchhccccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEEcCCCcEEEeeccC
Q 044312 344 EVPLLVYEFIPNGTLFQYIHDQNEDFPITWEIRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGA 423 (608)
Q Consensus 344 ~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGl 423 (608)
...++++|++ +++|.+++... .+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+
T Consensus 93 ~~~~~~~~~~-~~~l~~~~~~~----~l~~~~~~~i~~qi~~aL~~LH~~~---ivHrdikp~Nil~~~~~~~kl~Dfg~ 164 (343)
T cd07878 93 NEVYLVTNLM-GADLNNIVKCQ----KLSDEHVQFLIYQLLRGLKYIHSAG---IIHRDLKPSNVAVNEDCELRILDFGL 164 (343)
T ss_pred CcEEEEeecC-CCCHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHCC---eecccCChhhEEECCCCCEEEcCCcc
Confidence 3468999988 77898877532 4899999999999999999999999 99999999999999999999999999
Q ss_pred ccccccCCcceeeeeeccCCCCChhhhcc-CCCCCccchHhHHHHHHHHHhCCCCCCccchhhcccHHHHH---------
Q 044312 424 SRSMAVDQTHMTTQVHGTFGYLDPEYFRS-SQFTDKSDVYSFGVVLTELLTGEKPIRFTILEEDKSLAAYF--------- 493 (608)
Q Consensus 424 s~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~t~ksDV~S~Gvvl~elltg~~p~~~~~~~~~~~l~~~~--------- 493 (608)
++..... .....||+.|+|||++.+ ..++.++||||||++++||++|+.||....... .+....
T Consensus 165 ~~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~--~~~~~~~~~~~~~~~ 238 (343)
T cd07878 165 ARQADDE----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYID--QLKRIMEVVGTPSPE 238 (343)
T ss_pred ceecCCC----cCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCCHHH--HHHHHHHHhCCCCHH
Confidence 9865432 233468999999999876 568999999999999999999999986432111 000000
Q ss_pred -HHHhhhhhhHHHhhhhhhcc-------CChhHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 044312 494 -LCAMKEERLFEILDARVMKQ-------GGKDEIITVAKLAKRCLNLNGKKRPTMREVASE 546 (608)
Q Consensus 494 -~~~~~~~~~~~~~d~~~~~~-------~~~~~~~~l~~Li~~cl~~dp~~RPs~~evl~~ 546 (608)
...+........+.. +... ........+.+|+.+||+.||++|||+.|++++
T Consensus 239 ~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dp~~R~s~~ell~h 298 (343)
T cd07878 239 VLKKISSEHARKYIQS-LPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALAH 298 (343)
T ss_pred HHHhcchhhHHHHhhc-cccccchhHHHhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 000000000000000 0000 001123457899999999999999999999975
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-33 Score=291.90 Aligned_cols=236 Identities=28% Similarity=0.400 Sum_probs=197.3
Q ss_pred HhcCccccceeccCce---------------EEEEEeec---ChhhHHHHHHHHHHHhhcC-CCCccceecccccCccce
Q 044312 287 ATDNFDLNRILGQGGQ---------------AVKKSKVI---DESKVEEFINEVVILSQIN-HRNVVKLLGCCLETEVPL 347 (608)
Q Consensus 287 ~t~~f~~~~~lG~G~~---------------avk~~~~~---~~~~~~~~~~Ei~il~~l~-H~niv~l~~~~~~~~~~~ 347 (608)
....|++.+.||+|.| |+|.+... .....+.+.+|+.+|+++. |||||++.+.+.+....+
T Consensus 33 ~~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~~~~ 112 (382)
T KOG0032|consen 33 IKEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDPDSVY 112 (382)
T ss_pred ccccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCCeEE
Confidence 4557888899999975 66655432 2234578999999999998 999999999999999999
Q ss_pred EEEeecCCCccchhccccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEEcCC----CcEEEeeccC
Q 044312 348 LVYEFIPNGTLFQYIHDQNEDFPITWEIRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDK----YRAKVSDFGA 423 (608)
Q Consensus 348 lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~----~~~kl~DFGl 423 (608)
+|||++.||.|.+.+... .+++.....++.||+.++.|||+.+ |+||||||+|+|+... +.+|++|||+
T Consensus 113 lvmEL~~GGeLfd~i~~~----~~sE~da~~~~~~il~av~~lH~~g---vvHrDlKpEN~L~~~~~~~~~~ik~~DFGl 185 (382)
T KOG0032|consen 113 LVMELCEGGELFDRIVKK----HYSERDAAGIIRQILEAVKYLHSLG---VVHRDLKPENLLLASKDEGSGRIKLIDFGL 185 (382)
T ss_pred EEEEecCCchHHHHHHHc----cCCHHHHHHHHHHHHHHHHHHHhCC---ceeccCCHHHeeeccccCCCCcEEEeeCCC
Confidence 999999999999999876 2899999999999999999999999 9999999999999633 5799999999
Q ss_pred ccccccCCcceeeeeeccCCCCChhhhccCCCCCccchHhHHHHHHHHHhCCCCCCccchhhcccHHHHHHHHhhhhhhH
Q 044312 424 SRSMAVDQTHMTTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLTELLTGEKPIRFTILEEDKSLAAYFLCAMKEERLF 503 (608)
Q Consensus 424 s~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~ 503 (608)
+..... ........||+.|+|||++....|+..+||||+||++|.|++|..||........ ..
T Consensus 186 a~~~~~--~~~~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~~---------------~~ 248 (382)
T KOG0032|consen 186 AKFIKP--GERLHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILLSGVPPFWGETEFEI---------------FL 248 (382)
T ss_pred ceEccC--CceEeeecCCccccCchhhcCCCCCcccchhHHHHHHHHHhhCCCCCcCCChhHH---------------HH
Confidence 998765 4456778899999999999999999999999999999999999999974332211 11
Q ss_pred HHhhhh--hhccCChhHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 044312 504 EILDAR--VMKQGGKDEIITVAKLAKRCLNLNGKKRPTMREVASE 546 (608)
Q Consensus 504 ~~~d~~--~~~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~evl~~ 546 (608)
.++... ...+.....+..+.+++..++..||.+|+|+.+++++
T Consensus 249 ~i~~~~~~f~~~~w~~is~~akd~i~~ll~~dp~~R~ta~~~L~H 293 (382)
T KOG0032|consen 249 AILRGDFDFTSEPWDDISESAKDFIRKLLEFDPRKRLTAAQALQH 293 (382)
T ss_pred HHHcCCCCCCCCCccccCHHHHHHHHHhcccCcccCCCHHHHhcC
Confidence 222221 1223334567789999999999999999999999986
|
|
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-33 Score=288.17 Aligned_cols=162 Identities=24% Similarity=0.424 Sum_probs=134.0
Q ss_pred HHHHHHHHHHHhhcCCCCccceeccccc--CccceEEEeecCCCccchhccccC------CCCCCCHHHHHHHHHHHHHH
Q 044312 315 VEEFINEVVILSQINHRNVVKLLGCCLE--TEVPLLVYEFIPNGTLFQYIHDQN------EDFPITWEIRLRIAIEVSGA 386 (608)
Q Consensus 315 ~~~~~~Ei~il~~l~H~niv~l~~~~~~--~~~~~lV~E~~~~gsL~~~l~~~~------~~~~l~~~~~~~i~~~ia~a 386 (608)
...+.+|+.+|++++||||+++++++.. ....++||||+. ++|.+++.... ....+++..+..++.||+.|
T Consensus 42 ~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~a 120 (317)
T cd07868 42 SMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAE-HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDG 120 (317)
T ss_pred cHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEeccC-CCHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHH
Confidence 4567899999999999999999998854 446789999995 58877765321 12258999999999999999
Q ss_pred HHHHhhcCCCCeeccCCCCCcEEE----cCCCcEEEeeccCccccccCCc--ceeeeeeccCCCCChhhhccC-CCCCcc
Q 044312 387 LSYLHSAASIPIYHRDIKSTNILL----DDKYRAKVSDFGASRSMAVDQT--HMTTQVHGTFGYLDPEYFRSS-QFTDKS 459 (608)
Q Consensus 387 L~yLH~~~~~~iiHrDlk~~NILl----~~~~~~kl~DFGls~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~-~~t~ks 459 (608)
|+|||+.+ |+||||||+|||+ +.++.+||+|||+++....... .......+|+.|+|||++.+. .++.++
T Consensus 121 l~~LH~~~---ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~ 197 (317)
T cd07868 121 IHYLHANW---VLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAI 197 (317)
T ss_pred HHHHHhCC---EEcCCCCHHHEEEecCCCCcCcEEEeecCceeccCCCCccccccCCccccccccCCHHHcCCCCcCchh
Confidence 99999999 9999999999999 4567899999999987643221 122345689999999998764 589999
Q ss_pred chHhHHHHHHHHHhCCCCCCc
Q 044312 460 DVYSFGVVLTELLTGEKPIRF 480 (608)
Q Consensus 460 DV~S~Gvvl~elltg~~p~~~ 480 (608)
|||||||+++||++|++||..
T Consensus 198 DiwslG~il~el~~g~~~f~~ 218 (317)
T cd07868 198 DIWAIGCIFAELLTSEPIFHC 218 (317)
T ss_pred hHHHHHHHHHHHHhCCCCccC
Confidence 999999999999999999964
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-33 Score=285.42 Aligned_cols=250 Identities=24% Similarity=0.318 Sum_probs=184.9
Q ss_pred CccccceeccCce---------------EEEEEee--cChhhHHHHHHHHHHHhhcCCCCccceecccccCccceEEEee
Q 044312 290 NFDLNRILGQGGQ---------------AVKKSKV--IDESKVEEFINEVVILSQINHRNVVKLLGCCLETEVPLLVYEF 352 (608)
Q Consensus 290 ~f~~~~~lG~G~~---------------avk~~~~--~~~~~~~~~~~Ei~il~~l~H~niv~l~~~~~~~~~~~lV~E~ 352 (608)
+|++.+.||+|++ ++|+.+. .+....+.+.+|++++++++|+||+++++++...+..++||||
T Consensus 2 ~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~ 81 (288)
T cd07833 2 KYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYLVFEY 81 (288)
T ss_pred ceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheEEECCEEEEEEec
Confidence 5778888888864 4554432 1233457899999999999999999999999999999999999
Q ss_pred cCCCccchhccccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEEcCCCcEEEeeccCccccccCCc
Q 044312 353 IPNGTLFQYIHDQNEDFPITWEIRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQT 432 (608)
Q Consensus 353 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGls~~~~~~~~ 432 (608)
++++.|..++.... .+++..+..++.||+.||.|||+.+ ++|+||+|+||++++++.+||+|||++........
T Consensus 82 ~~~~~l~~~~~~~~---~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~~~~ 155 (288)
T cd07833 82 VERTLLELLEASPG---GLPPDAVRSYIWQLLQAIAYCHSHN---IIHRDIKPENILVSESGVLKLCDFGFARALRARPA 155 (288)
T ss_pred CCCCHHHHHHhcCC---CCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCCEEEEeeecccccCCCcc
Confidence 99876665554322 4899999999999999999999999 99999999999999999999999999987654433
Q ss_pred ceeeeeeccCCCCChhhhccC-CCCCccchHhHHHHHHHHHhCCCCCCccchhhcccHHHHHHHHhhhh-----------
Q 044312 433 HMTTQVHGTFGYLDPEYFRSS-QFTDKSDVYSFGVVLTELLTGEKPIRFTILEEDKSLAAYFLCAMKEE----------- 500 (608)
Q Consensus 433 ~~~~~~~gt~~y~aPE~~~~~-~~t~ksDV~S~Gvvl~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~----------- 500 (608)
.......++..|+|||++... .++.++||||||+++++|++|+.||......+...........+...
T Consensus 156 ~~~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (288)
T cd07833 156 SPLTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPPSHQELFSSNPRF 235 (288)
T ss_pred ccccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHhhhcccCccc
Confidence 233345678899999999888 88999999999999999999999986332211000000000000000
Q ss_pred ---hhHHHhhhh-hhccCChhHHHHHHHHHHHHhccCCCCCCCHHHHHH
Q 044312 501 ---RLFEILDAR-VMKQGGKDEIITVAKLAKRCLNLNGKKRPTMREVAS 545 (608)
Q Consensus 501 ---~~~~~~d~~-~~~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~evl~ 545 (608)
...+..++. .....+...+.++.+|+++||..+|++||+++++++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 284 (288)
T cd07833 236 AGVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQ 284 (288)
T ss_pred cccccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhc
Confidence 000000000 001112233678999999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-33 Score=278.12 Aligned_cols=204 Identities=25% Similarity=0.480 Sum_probs=165.4
Q ss_pred HHHHHHHHHHHhhcCCCCccceecccccCccceEEEeecCCCccchhccccCCCCCCCHHHHHHHHHHHHHHHHHHhhcC
Q 044312 315 VEEFINEVVILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEIRLRIAIEVSGALSYLHSAA 394 (608)
Q Consensus 315 ~~~~~~Ei~il~~l~H~niv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~ 394 (608)
...|.+|+.++++++||||+++++++.. ...++||||+++|+|.+++..... .+++..++.++.||+.||+|||+.+
T Consensus 45 ~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~lv~e~~~~~~L~~~l~~~~~--~~~~~~~~~~~~~i~~~l~~LH~~~ 121 (259)
T cd05037 45 SLAFFETASLMSQLSHKHLVKLYGVCVR-DENIMVEEYVKFGPLDVFLHREKN--NVSLHWKLDVAKQLASALHYLEDKK 121 (259)
T ss_pred HHHHHHHHHHHHcCCCcchhheeeEEec-CCcEEEEEcCCCCcHHHHHHhhcc--CCCHHHHHHHHHHHHHHHHHHhhCC
Confidence 6789999999999999999999999988 778999999999999999986543 5899999999999999999999998
Q ss_pred CCCeeccCCCCCcEEEcCCC-------cEEEeeccCccccccCCcceeeeeeccCCCCChhhhccC--CCCCccchHhHH
Q 044312 395 SIPIYHRDIKSTNILLDDKY-------RAKVSDFGASRSMAVDQTHMTTQVHGTFGYLDPEYFRSS--QFTDKSDVYSFG 465 (608)
Q Consensus 395 ~~~iiHrDlk~~NILl~~~~-------~~kl~DFGls~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~t~ksDV~S~G 465 (608)
|+||||||+|||++.++ .+||+|||++..... .....++..|+|||++... .++.++||||||
T Consensus 122 ---i~H~dlkp~Nill~~~~~~~~~~~~~kl~Dfg~a~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG 193 (259)
T cd05037 122 ---LVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIPITVLS-----REERVERIPWIAPECIRNGQASLTIAADKWSFG 193 (259)
T ss_pred ---eecccCccceEEEecCccccCCceeEEeCCCCccccccc-----ccccccCCCccChhhhcCCCCCcchhhHHHHHH
Confidence 99999999999999887 799999999986543 1223466789999999876 789999999999
Q ss_pred HHHHHHHh-CCCCCCccchhhcccHHHHHHHHhhhhhhHHHhhhhhhccCChhHHHHHHHHHHHHhccCCCCCCCHHHHH
Q 044312 466 VVLTELLT-GEKPIRFTILEEDKSLAAYFLCAMKEERLFEILDARVMKQGGKDEIITVAKLAKRCLNLNGKKRPTMREVA 544 (608)
Q Consensus 466 vvl~ellt-g~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~evl 544 (608)
++++||++ |..|+........ ...+ . .. ...+......+.+++.+||..+|++|||+.||+
T Consensus 194 ~~~~~l~~~~~~p~~~~~~~~~---~~~~----~--------~~---~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il 255 (259)
T cd05037 194 TTLLEICSNGEEPLSTLSSSEK---ERFY----Q--------DQ---HRLPMPDCAELANLINQCWTYDPTKRPSFRAIL 255 (259)
T ss_pred HHHHHHHhCCCCCcccCCchhH---HHHH----h--------cC---CCCCCCCchHHHHHHHHHhccChhhCCCHHHHH
Confidence 99999999 5677653221110 0000 0 00 001111126789999999999999999999999
Q ss_pred HHH
Q 044312 545 SEL 547 (608)
Q Consensus 545 ~~L 547 (608)
+.|
T Consensus 256 ~~l 258 (259)
T cd05037 256 RDL 258 (259)
T ss_pred Hhc
Confidence 876
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-33 Score=312.76 Aligned_cols=250 Identities=28% Similarity=0.456 Sum_probs=206.0
Q ss_pred HHHHHhcCccccceeccCce----------------------EEEEEee-cChhhHHHHHHHHHHHhhc-CCCCccceec
Q 044312 283 ELEKATDNFDLNRILGQGGQ----------------------AVKKSKV-IDESKVEEFINEVVILSQI-NHRNVVKLLG 338 (608)
Q Consensus 283 ~l~~~t~~f~~~~~lG~G~~----------------------avk~~~~-~~~~~~~~~~~Ei~il~~l-~H~niv~l~~ 338 (608)
.++...++..+.+.||+|.| |||..+. ....+.+.+..|+++|+.+ +|+||+.++|
T Consensus 290 ~~e~~~~~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~~~~~~~~~El~~m~~~g~H~niv~llG 369 (609)
T KOG0200|consen 290 KWEIPRENLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASSSEKKDLMSELNVLKELGKHPNIVNLLG 369 (609)
T ss_pred ceeechhhccccceeecccccceEeEEEeecccccccceEEEEEEecccccCcHHHHHHHHHHHHHHHhcCCcchhhhee
Confidence 45555566667778999864 6666653 3446778999999999999 7999999999
Q ss_pred ccccCccceEEEeecCCCccchhccccC-------------CCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCC
Q 044312 339 CCLETEVPLLVYEFIPNGTLFQYIHDQN-------------EDFPITWEIRLRIAIEVSGALSYLHSAASIPIYHRDIKS 405 (608)
Q Consensus 339 ~~~~~~~~~lV~E~~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~ 405 (608)
+|..+...++|+||+..|+|.++++..+ +...++....+.++.|||.|++||++.. ++||||.+
T Consensus 370 ~~t~~~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~~---~vHRDLAa 446 (609)
T KOG0200|consen 370 ACTQDGPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASVP---CVHRDLAA 446 (609)
T ss_pred eeccCCceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhCC---ccchhhhh
Confidence 9999999999999999999999998765 0013889999999999999999999998 99999999
Q ss_pred CcEEEcCCCcEEEeeccCccccccCCcceeeeeec--cCCCCChhhhccCCCCCccchHhHHHHHHHHHh-CCCCCCccc
Q 044312 406 TNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHG--TFGYLDPEYFRSSQFTDKSDVYSFGVVLTELLT-GEKPIRFTI 482 (608)
Q Consensus 406 ~NILl~~~~~~kl~DFGls~~~~~~~~~~~~~~~g--t~~y~aPE~~~~~~~t~ksDV~S~Gvvl~ellt-g~~p~~~~~ 482 (608)
+|||+.++..+||+|||+++....+.........+ ...|||||.+....|+.|||||||||+|||++| |..||....
T Consensus 447 RNVLi~~~~~~kIaDFGlar~~~~~~~y~~~~~~~~LP~kWmApEsl~~~~ft~kSDVWSfGI~L~EifsLG~~PYp~~~ 526 (609)
T KOG0200|consen 447 RNVLITKNKVIKIADFGLARDHYNKDYYRTKSSAGTLPVKWMAPESLFDRVFTSKSDVWSFGILLWEIFTLGGTPYPGIP 526 (609)
T ss_pred hhEEecCCCEEEEccccceeccCCCCceEecCCCCccceeecCHHHhccCcccccchhhHHHHHHHHHhhCCCCCCCCCC
Confidence 99999999999999999999766555444333232 456999999999999999999999999999999 788876311
Q ss_pred hhhcccHHHHHHHHhhhhhhHHHhhhhhhccCChhHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhh
Q 044312 483 LEEDKSLAAYFLCAMKEERLFEILDARVMKQGGKDEIITVAKLAKRCLNLNGKKRPTMREVASELAGI 550 (608)
Q Consensus 483 ~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~evl~~L~~i 550 (608)
. ...+.+.+....+.+.|..+..++.++++.||+.+|++||++.|+.+.++..
T Consensus 527 ~---------------~~~l~~~l~~G~r~~~P~~c~~eiY~iM~~CW~~~p~~RP~F~~~~~~~~~~ 579 (609)
T KOG0200|consen 527 P---------------TEELLEFLKEGNRMEQPEHCSDEIYDLMKSCWNADPEDRPTFSECVEFFEKH 579 (609)
T ss_pred c---------------HHHHHHHHhcCCCCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHHHHH
Confidence 0 1222334455556677778889999999999999999999999999999874
|
|
| >KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-33 Score=284.90 Aligned_cols=234 Identities=26% Similarity=0.400 Sum_probs=194.0
Q ss_pred hcCccccceeccCceEE---------------EEEee--cChhhHHHHHHHHHHHhhcCCCCccceecccccCccceEEE
Q 044312 288 TDNFDLNRILGQGGQAV---------------KKSKV--IDESKVEEFINEVVILSQINHRNVVKLLGCCLETEVPLLVY 350 (608)
Q Consensus 288 t~~f~~~~~lG~G~~av---------------k~~~~--~~~~~~~~~~~Ei~il~~l~H~niv~l~~~~~~~~~~~lV~ 350 (608)
..-|++.+-||+|-||| |++.. .+.....++.+|++.|+.++|||||+|+.+......+|||+
T Consensus 17 AGLYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEViDTQTKlyLiL 96 (864)
T KOG4717|consen 17 AGLYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEVIDTQTKLYLIL 96 (864)
T ss_pred eeeehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeehhcccceEEEEE
Confidence 34577788899998744 44322 23344567899999999999999999999999999999999
Q ss_pred eecCCCccchhccccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEEc-CCCcEEEeeccCcccccc
Q 044312 351 EFIPNGTLFQYIHDQNEDFPITWEIRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLD-DKYRAKVSDFGASRSMAV 429 (608)
Q Consensus 351 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~-~~~~~kl~DFGls~~~~~ 429 (608)
|+-++|+|++||-++.. .+.+....+++.||+.|+.|+|+.. ++||||||+||.+- .-|.+||.|||++-.+..
T Consensus 97 ELGD~GDl~DyImKHe~--Gl~E~La~kYF~QI~~AI~YCHqLH---VVHRDLKPENVVFFEKlGlVKLTDFGFSNkf~P 171 (864)
T KOG4717|consen 97 ELGDGGDLFDYIMKHEE--GLNEDLAKKYFAQIVHAISYCHQLH---VVHRDLKPENVVFFEKLGLVKLTDFGFSNKFQP 171 (864)
T ss_pred EecCCchHHHHHHhhhc--cccHHHHHHHHHHHHHHHHHHhhhh---hhcccCCcceeEEeeecCceEeeeccccccCCC
Confidence 99999999999987665 4899999999999999999999999 99999999999765 567899999999977654
Q ss_pred CCcceeeeeeccCCCCChhhhccCCCC-CccchHhHHHHHHHHHhCCCCCCccchhhcccHHHHHHHHhhhhhhHHHhhh
Q 044312 430 DQTHMTTQVHGTFGYLDPEYFRSSQFT-DKSDVYSFGVVLTELLTGEKPIRFTILEEDKSLAAYFLCAMKEERLFEILDA 508 (608)
Q Consensus 430 ~~~~~~~~~~gt~~y~aPE~~~~~~~t-~ksDV~S~Gvvl~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 508 (608)
.+ ..+...|.+.|.|||++.+..|+ +++||||||||||.|++|+.||+.... .+.+..|+|-
T Consensus 172 G~--kL~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeAND---------------SETLTmImDC 234 (864)
T KOG4717|consen 172 GK--KLTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEAND---------------SETLTMIMDC 234 (864)
T ss_pred cc--hhhcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccc---------------hhhhhhhhcc
Confidence 33 34567899999999999999886 689999999999999999999973322 2334445554
Q ss_pred hhhccCChhHHHHHHHHHHHHhccCCCCCCCHHHHHH
Q 044312 509 RVMKQGGKDEIITVAKLAKRCLNLNGKKRPTMREVAS 545 (608)
Q Consensus 509 ~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~evl~ 545 (608)
++ ..+...+.+.++||..||..||.+|.+.+||+.
T Consensus 235 KY--tvPshvS~eCrdLI~sMLvRdPkkRAslEeI~s 269 (864)
T KOG4717|consen 235 KY--TVPSHVSKECRDLIQSMLVRDPKKRASLEEIVS 269 (864)
T ss_pred cc--cCchhhhHHHHHHHHHHHhcCchhhccHHHHhc
Confidence 33 344567789999999999999999999999886
|
|
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-33 Score=292.27 Aligned_cols=216 Identities=25% Similarity=0.336 Sum_probs=168.7
Q ss_pred eEEEEEeec---ChhhHHHHHHHHH-HHhhcCCCCccceecccccCccceEEEeecCCCccchhccccCCCCCCCHHHHH
Q 044312 302 QAVKKSKVI---DESKVEEFINEVV-ILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEIRL 377 (608)
Q Consensus 302 ~avk~~~~~---~~~~~~~~~~Ei~-il~~l~H~niv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~ 377 (608)
+|+|..... .......+.+|.. +++.++||||+++++.+.+.+..++||||+++++|..++.... .+++..+.
T Consensus 23 ~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~---~~~~~~~~ 99 (321)
T cd05603 23 YAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYVNGGELFFHLQRER---CFLEPRAR 99 (321)
T ss_pred EEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEcCCCCCCHHHHHHHcC---CCCHHHHH
Confidence 366665432 2223345566654 6788999999999999999999999999999999988886532 48889999
Q ss_pred HHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEEcCCCcEEEeeccCccccccCCcceeeeeeccCCCCChhhhccCCCCC
Q 044312 378 RIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHGTFGYLDPEYFRSSQFTD 457 (608)
Q Consensus 378 ~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGls~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ 457 (608)
.++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++...... .......||+.|+|||.+.+..++.
T Consensus 100 ~~~~qi~~~L~~lH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~ 175 (321)
T cd05603 100 FYAAEVASAIGYLHSLN---IIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPE-ETTSTFCGTPEYLAPEVLRKEPYDR 175 (321)
T ss_pred HHHHHHHHHHHHHHHCC---eEeccCCHHHeEECCCCCEEEccCCCCccCCCCC-CccccccCCcccCCHHHhcCCCCCC
Confidence 99999999999999999 9999999999999999999999999987532221 2233456899999999999999999
Q ss_pred ccchHhHHHHHHHHHhCCCCCCccchhhcccHHHHHHHHhhhhhhHHHhhhhhhccCChhHHHHHHHHHHHHhccCCCCC
Q 044312 458 KSDVYSFGVVLTELLTGEKPIRFTILEEDKSLAAYFLCAMKEERLFEILDARVMKQGGKDEIITVAKLAKRCLNLNGKKR 537 (608)
Q Consensus 458 ksDV~S~Gvvl~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~Li~~cl~~dp~~R 537 (608)
++|||||||+++||++|+.||..... ..... .+... ....+...+..+.+++.+||+.||.+|
T Consensus 176 ~~DiwslG~il~el~~g~~pf~~~~~------~~~~~---------~i~~~--~~~~~~~~~~~~~~li~~~l~~~p~~R 238 (321)
T cd05603 176 TVDWWCLGAVLYEMLYGLPPFYSRDV------SQMYD---------NILHK--PLQLPGGKTVAACDLLVGLLHKDQRRR 238 (321)
T ss_pred cCcccccchhhhhhhcCCCCCCCCCH------HHHHH---------HHhcC--CCCCCCCCCHHHHHHHHHHccCCHhhc
Confidence 99999999999999999999964321 11111 11111 112233455679999999999999999
Q ss_pred CCHH
Q 044312 538 PTMR 541 (608)
Q Consensus 538 Ps~~ 541 (608)
|+..
T Consensus 239 ~~~~ 242 (321)
T cd05603 239 LGAK 242 (321)
T ss_pred CCCC
Confidence 9864
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-33 Score=285.55 Aligned_cols=249 Identities=24% Similarity=0.324 Sum_probs=187.6
Q ss_pred CHHHHHHHhcCccccceeccCce---------------EEEEEeecChhhHHHHHHHHHHHhhc-CCCCccceecccc--
Q 044312 280 TSKELEKATDNFDLNRILGQGGQ---------------AVKKSKVIDESKVEEFINEVVILSQI-NHRNVVKLLGCCL-- 341 (608)
Q Consensus 280 ~~~~l~~~t~~f~~~~~lG~G~~---------------avk~~~~~~~~~~~~~~~Ei~il~~l-~H~niv~l~~~~~-- 341 (608)
..+.+..+.++|++.+.||+|++ |+|..... .....++.+|+.+++.+ +||||+++++++.
T Consensus 9 ~~~~~~~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~-~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~ 87 (286)
T cd06638 9 IFDSFPDPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPI-HDIDEEIEAEYNILKALSDHPNVVKFYGMYYKK 87 (286)
T ss_pred EeecCCCcccceeeeeeeccCCCcEEEEEEECCCCceeEEEeeccc-cchHHHHHHHHHHHHHHhcCCCeeeeeeeeeec
Confidence 34566678889999999999975 34443321 22346788999999999 7999999999874
Q ss_pred ---cCccceEEEeecCCCccchhccccC-CCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEEcCCCcEE
Q 044312 342 ---ETEVPLLVYEFIPNGTLFQYIHDQN-EDFPITWEIRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAK 417 (608)
Q Consensus 342 ---~~~~~~lV~E~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~k 417 (608)
.....++||||+++++|.+++.... ....+++..+..++.|++.||.|||+.+ ++||||||+||++++++.+|
T Consensus 88 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nili~~~~~~k 164 (286)
T cd06638 88 DVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVNK---TIHRDVKGNNILLTTEGGVK 164 (286)
T ss_pred ccCCCCeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHhCC---ccccCCCHHhEEECCCCCEE
Confidence 3456899999999999999876421 2235889999999999999999999998 99999999999999999999
Q ss_pred EeeccCccccccCCcceeeeeeccCCCCChhhhcc-----CCCCCccchHhHHHHHHHHHhCCCCCCccchhhcccHHHH
Q 044312 418 VSDFGASRSMAVDQTHMTTQVHGTFGYLDPEYFRS-----SQFTDKSDVYSFGVVLTELLTGEKPIRFTILEEDKSLAAY 492 (608)
Q Consensus 418 l~DFGls~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~t~ksDV~S~Gvvl~elltg~~p~~~~~~~~~~~l~~~ 492 (608)
|+|||+++....... ......|++.|+|||++.. ..++.++||||||++++||++|+.||....... .
T Consensus 165 l~dfg~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~~~------~ 237 (286)
T cd06638 165 LVDFGVSAQLTSTRL-RRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMR------A 237 (286)
T ss_pred EccCCceeecccCCC-ccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCchhH------H
Confidence 999999886643221 2233468999999999753 457889999999999999999999986322110 0
Q ss_pred HHHHhhhhhhHHHhhhhhhccCChhHHHHHHHHHHHHhccCCCCCCCHHHHHHHH
Q 044312 493 FLCAMKEERLFEILDARVMKQGGKDEIITVAKLAKRCLNLNGKKRPTMREVASEL 547 (608)
Q Consensus 493 ~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~evl~~L 547 (608)
.. ....... + ....+...+..+.+|+.+||+.+|++|||+.||++++
T Consensus 238 ~~-~~~~~~~-----~--~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~~ 284 (286)
T cd06638 238 LF-KIPRNPP-----P--TLHQPELWSNEFNDFIRKCLTKDYEKRPTVSDLLQHV 284 (286)
T ss_pred Hh-hccccCC-----C--cccCCCCcCHHHHHHHHHHccCCcccCCCHHHHhhcc
Confidence 00 0000000 0 0011122345799999999999999999999998754
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-33 Score=282.90 Aligned_cols=248 Identities=21% Similarity=0.281 Sum_probs=185.4
Q ss_pred CccccceeccCce---------------EEEEEeecC--hhhHHHHHHHHHHHhhcCCCCccceecccccCccceEEEee
Q 044312 290 NFDLNRILGQGGQ---------------AVKKSKVID--ESKVEEFINEVVILSQINHRNVVKLLGCCLETEVPLLVYEF 352 (608)
Q Consensus 290 ~f~~~~~lG~G~~---------------avk~~~~~~--~~~~~~~~~Ei~il~~l~H~niv~l~~~~~~~~~~~lV~E~ 352 (608)
+|++.+.||+|++ ++|+..... ....+.+.+|+.++++++||||+++++++......++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~ 80 (286)
T cd07832 1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFPHGSGFVLVMEY 80 (286)
T ss_pred CceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEEecCCeeEEEecc
Confidence 3566777777753 666665433 34457899999999999999999999999999999999999
Q ss_pred cCCCccchhccccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEEcCCCcEEEeeccCccccccCCc
Q 044312 353 IPNGTLFQYIHDQNEDFPITWEIRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQT 432 (608)
Q Consensus 353 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGls~~~~~~~~ 432 (608)
+ +++|.+++..... ++++..+..++.||++||+|||+.+ ++|+||||+||++++++.++|+|||++........
T Consensus 81 ~-~~~L~~~~~~~~~--~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~~~~ 154 (286)
T cd07832 81 M-PSDLSEVLRDEER--PLPEAQVKSYMRMLLKGVAYMHANG---IMHRDLKPANLLISADGVLKIADFGLARLFSEEEP 154 (286)
T ss_pred c-CCCHHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHHCC---eecCCcCHHHEEEcCCCcEEEeeeeecccccCCCC
Confidence 9 9999999876442 5899999999999999999999999 99999999999999999999999999987654332
Q ss_pred ceeeeeeccCCCCChhhhccC-CCCCccchHhHHHHHHHHHhCCCCCCccchhhcccHHHHHHHHhhhh---hhHH----
Q 044312 433 HMTTQVHGTFGYLDPEYFRSS-QFTDKSDVYSFGVVLTELLTGEKPIRFTILEEDKSLAAYFLCAMKEE---RLFE---- 504 (608)
Q Consensus 433 ~~~~~~~gt~~y~aPE~~~~~-~~t~ksDV~S~Gvvl~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~---~~~~---- 504 (608)
.......++..|+|||.+.+. .++.++||||||++++||++|.+||....... ............ ...+
T Consensus 155 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~ 231 (286)
T cd07832 155 RLYSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGENDIE---QLAIVFRTLGTPNEETWPGLTSL 231 (286)
T ss_pred CccccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCHHH---HHHHHHHHcCCCChHHHhhccCc
Confidence 223345688999999998654 46899999999999999999987775322111 111111111000 0000
Q ss_pred -----Hhhh----hhhccCChhHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 044312 505 -----ILDA----RVMKQGGKDEIITVAKLAKRCLNLNGKKRPTMREVASE 546 (608)
Q Consensus 505 -----~~d~----~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~evl~~ 546 (608)
+..+ ....+...+.+..+.+|+.+||+.+|++||++++++++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~h 282 (286)
T cd07832 232 PDYNKITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALRH 282 (286)
T ss_pred chhhcccCCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCHHHHhhC
Confidence 0000 00001112345789999999999999999999999864
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-33 Score=278.77 Aligned_cols=243 Identities=28% Similarity=0.428 Sum_probs=189.4
Q ss_pred cCccccceeccCce---------------EEEEEeecC-hhhHHHHHHHHHHHhhcCCCCccceecccccCccceEEEee
Q 044312 289 DNFDLNRILGQGGQ---------------AVKKSKVID-ESKVEEFINEVVILSQINHRNVVKLLGCCLETEVPLLVYEF 352 (608)
Q Consensus 289 ~~f~~~~~lG~G~~---------------avk~~~~~~-~~~~~~~~~Ei~il~~l~H~niv~l~~~~~~~~~~~lV~E~ 352 (608)
++|++.+.||.|++ ++|+..... ....+.+.+|+++++.++|+||+++++.+...+..++|||+
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~ 80 (267)
T cd06610 1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVMPY 80 (267)
T ss_pred CcceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcchHHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCEEEEEEec
Confidence 36788888888874 455554322 23567899999999999999999999999999999999999
Q ss_pred cCCCccchhccccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEEcCCCcEEEeeccCccccccCCc
Q 044312 353 IPNGTLFQYIHDQNEDFPITWEIRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQT 432 (608)
Q Consensus 353 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGls~~~~~~~~ 432 (608)
+++++|.+++........+++..+..++.|++.||+|||+.+ ++|+||+|+||++++++.+||+|||++..+.....
T Consensus 81 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh~~~---i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~~~~~ 157 (267)
T cd06610 81 LSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSNG---QIHRDIKAGNILLGEDGSVKIADFGVSASLADGGD 157 (267)
T ss_pred cCCCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHhEEEcCCCCEEEcccchHHHhccCcc
Confidence 999999999976433235899999999999999999999999 99999999999999999999999999877654322
Q ss_pred c---eeeeeeccCCCCChhhhccC-CCCCccchHhHHHHHHHHHhCCCCCCccchhhcccHHHHHHHHhhhhhhHHHhhh
Q 044312 433 H---MTTQVHGTFGYLDPEYFRSS-QFTDKSDVYSFGVVLTELLTGEKPIRFTILEEDKSLAAYFLCAMKEERLFEILDA 508 (608)
Q Consensus 433 ~---~~~~~~gt~~y~aPE~~~~~-~~t~ksDV~S~Gvvl~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 508 (608)
. ......++..|+|||++... .++.++||||||++++||++|+.||...... ..+....... .+
T Consensus 158 ~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~------~~~~~~~~~~------~~ 225 (267)
T cd06610 158 RTRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPM------KVLMLTLQND------PP 225 (267)
T ss_pred ccccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChh------hhHHHHhcCC------CC
Confidence 2 22334588999999998877 7899999999999999999999998632211 0111111110 00
Q ss_pred hhhccC-ChhHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 044312 509 RVMKQG-GKDEIITVAKLAKRCLNLNGKKRPTMREVASE 546 (608)
Q Consensus 509 ~~~~~~-~~~~~~~l~~Li~~cl~~dp~~RPs~~evl~~ 546 (608)
...... ....+..+.+++.+||..||++||++.||+++
T Consensus 226 ~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~ll~~ 264 (267)
T cd06610 226 SLETGADYKKYSKSFRKMISLCLQKDPSKRPTAEELLKH 264 (267)
T ss_pred CcCCccccccccHHHHHHHHHHcCCChhhCcCHHHHhhC
Confidence 010000 12445778999999999999999999999863
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-32 Score=278.04 Aligned_cols=237 Identities=27% Similarity=0.423 Sum_probs=185.7
Q ss_pred CccccceeccCce---------------EEEEEeecCh--hhHHHHHHHHHHHhhcCCCCccceecccccCccceEEEee
Q 044312 290 NFDLNRILGQGGQ---------------AVKKSKVIDE--SKVEEFINEVVILSQINHRNVVKLLGCCLETEVPLLVYEF 352 (608)
Q Consensus 290 ~f~~~~~lG~G~~---------------avk~~~~~~~--~~~~~~~~Ei~il~~l~H~niv~l~~~~~~~~~~~lV~E~ 352 (608)
+|.+.+.||+|++ ++|..+.... ...+.+.+|+.+++.++|+||+++++.+.+.+..++|+||
T Consensus 1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (264)
T cd06626 1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIFMEY 80 (264)
T ss_pred CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeEecCCEEEEEEec
Confidence 3666778888763 6666654433 3678899999999999999999999999999999999999
Q ss_pred cCCCccchhccccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEEcCCCcEEEeeccCccccccCCc
Q 044312 353 IPNGTLFQYIHDQNEDFPITWEIRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQT 432 (608)
Q Consensus 353 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGls~~~~~~~~ 432 (608)
+++++|.+++.... .+++..+..++.+++.||+|||+.+ ++|+||+|+||++++++.+||+|||++........
T Consensus 81 ~~~~~L~~~~~~~~---~~~~~~~~~i~~~i~~~l~~lh~~~---i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~~~~ 154 (264)
T cd06626 81 CSGGTLEELLEHGR---ILDEHVIRVYTLQLLEGLAYLHSHG---IVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTT 154 (264)
T ss_pred CCCCcHHHHHhhcC---CCChHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEcccccccccCCCCC
Confidence 99999999987643 4789999999999999999999999 99999999999999999999999999987654332
Q ss_pred cee---eeeeccCCCCChhhhccCC---CCCccchHhHHHHHHHHHhCCCCCCccchhhcccHHHHHHHHhhhhhhHHHh
Q 044312 433 HMT---TQVHGTFGYLDPEYFRSSQ---FTDKSDVYSFGVVLTELLTGEKPIRFTILEEDKSLAAYFLCAMKEERLFEIL 506 (608)
Q Consensus 433 ~~~---~~~~gt~~y~aPE~~~~~~---~t~ksDV~S~Gvvl~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 506 (608)
... ....++..|+|||++.... .+.++||||||++++|+++|+.||...... ....+.... .
T Consensus 155 ~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~~----~~~~~~~~~--~------ 222 (264)
T cd06626 155 TMGEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNE----FQIMFHVGA--G------ 222 (264)
T ss_pred cccccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcch----HHHHHHHhc--C------
Confidence 221 1345788999999998776 899999999999999999999998632111 000000000 0
Q ss_pred hhhhhccCChhHHHHHHHHHHHHhccCCCCCCCHHHHHH
Q 044312 507 DARVMKQGGKDEIITVAKLAKRCLNLNGKKRPTMREVAS 545 (608)
Q Consensus 507 d~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~evl~ 545 (608)
...........+..+.+++.+||+.+|++||++.|++.
T Consensus 223 -~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~i~~ 260 (264)
T cd06626 223 -HKPPIPDSLQLSPEGKDFLDRCLESDPKKRPTASELLQ 260 (264)
T ss_pred -CCCCCCcccccCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence 00001111223567889999999999999999999874
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-33 Score=287.40 Aligned_cols=237 Identities=27% Similarity=0.374 Sum_probs=185.2
Q ss_pred CccccceeccCce---------------EEEEEeecCh---hhHHHHHHHHHHHhhcCCCCccceecccccCccceEEEe
Q 044312 290 NFDLNRILGQGGQ---------------AVKKSKVIDE---SKVEEFINEVVILSQINHRNVVKLLGCCLETEVPLLVYE 351 (608)
Q Consensus 290 ~f~~~~~lG~G~~---------------avk~~~~~~~---~~~~~~~~Ei~il~~l~H~niv~l~~~~~~~~~~~lV~E 351 (608)
+|++.+.||+|++ |+|....... ...+.+.+|+++++.++|+||+++++.+.+....++|||
T Consensus 2 ~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 81 (316)
T cd05574 2 HFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTETYLCLVMD 81 (316)
T ss_pred ceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeecCCEEEEEEE
Confidence 5777888888863 5666554222 345678999999999999999999999999999999999
Q ss_pred ecCCCccchhccccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEEcCCCcEEEeeccCccccccCC
Q 044312 352 FIPNGTLFQYIHDQNEDFPITWEIRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQ 431 (608)
Q Consensus 352 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGls~~~~~~~ 431 (608)
|+.+++|.+++..... ..+++..+..++.|++.||+|||+.+ ++|+||||+|||++.++.++|+|||++.......
T Consensus 82 ~~~~~~L~~~~~~~~~-~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~ 157 (316)
T cd05574 82 YCPGGELFRLLQRQPG-KCLSEEVARFYAAEVLLALEYLHLLG---IVYRDLKPENILLHESGHIMLSDFDLSKQSDVEP 157 (316)
T ss_pred ecCCCCHHHHHHhCCC-CccCHHHHHHHHHHHHHHHHHHHHCC---eeccCCChHHeEEcCCCCEEEeecchhhcccccc
Confidence 9999999999875432 35899999999999999999999998 9999999999999999999999999987653221
Q ss_pred cc----------------------------eeeeeeccCCCCChhhhccCCCCCccchHhHHHHHHHHHhCCCCCCccch
Q 044312 432 TH----------------------------MTTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLTELLTGEKPIRFTIL 483 (608)
Q Consensus 432 ~~----------------------------~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~elltg~~p~~~~~~ 483 (608)
.. ......|+..|+|||++.+..++.++||||||+++|+|++|+.||.....
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~ 237 (316)
T cd05574 158 PPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTPFKGSNR 237 (316)
T ss_pred cccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCCchHHHHHHHHHHHHHhhCCCCCCCCch
Confidence 10 11123578899999999999999999999999999999999999863221
Q ss_pred hhcccHHHHHHHHhhhhhhHHHhhhhhhccCChhHHHHHHHHHHHHhccCCCCCCC----HHHHHH
Q 044312 484 EEDKSLAAYFLCAMKEERLFEILDARVMKQGGKDEIITVAKLAKRCLNLNGKKRPT----MREVAS 545 (608)
Q Consensus 484 ~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPs----~~evl~ 545 (608)
.. .+..+.............+..+.+++.+||..+|++||+ +.|+++
T Consensus 238 ~~---------------~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~ll~ 288 (316)
T cd05574 238 DE---------------TFSNILKKEVTFPGSPPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQ 288 (316)
T ss_pred HH---------------HHHHHhcCCccCCCccccCHHHHHHHHHHccCCHhHCCCchhhHHHHHc
Confidence 10 111111111111112225678999999999999999999 555554
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-33 Score=282.28 Aligned_cols=250 Identities=22% Similarity=0.286 Sum_probs=182.8
Q ss_pred cCccccceeccCce---------------EEEEEeecC--hhhHHHHHHHHHHHhhcCCCCccceecccccCccceEEEe
Q 044312 289 DNFDLNRILGQGGQ---------------AVKKSKVID--ESKVEEFINEVVILSQINHRNVVKLLGCCLETEVPLLVYE 351 (608)
Q Consensus 289 ~~f~~~~~lG~G~~---------------avk~~~~~~--~~~~~~~~~Ei~il~~l~H~niv~l~~~~~~~~~~~lV~E 351 (608)
++|++.+.||+|++ |+|+..... ....+.+.+|+.++++++|+||+++++++......++|||
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e 80 (286)
T cd07847 1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVFRRKRKLHLVFE 80 (286)
T ss_pred CceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEEeeCCEEEEEEe
Confidence 35777788888763 556554322 2234568899999999999999999999999999999999
Q ss_pred ecCCCccchhccccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEEcCCCcEEEeeccCccccccCC
Q 044312 352 FIPNGTLFQYIHDQNEDFPITWEIRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQ 431 (608)
Q Consensus 352 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGls~~~~~~~ 431 (608)
|+++++|..++.... .+++..++.++.|++.||+|||+.+ ++|+||||+||+++.++.+||+|||++.......
T Consensus 81 ~~~~~~l~~~~~~~~---~~~~~~~~~~~~ql~~~l~~LH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~ 154 (286)
T cd07847 81 YCDHTVLNELEKNPR---GVPEHLIKKIIWQTLQAVNFCHKHN---CIHRDVKPENILITKQGQIKLCDFGFARILTGPG 154 (286)
T ss_pred ccCccHHHHHHhCCC---CCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCChhhEEEcCCCcEEECccccceecCCCc
Confidence 999988887765432 4899999999999999999999998 9999999999999999999999999998765432
Q ss_pred cceeeeeeccCCCCChhhhcc-CCCCCccchHhHHHHHHHHHhCCCCCCccchhhcccHHHHHHHHhhhhhhHHHhhh--
Q 044312 432 THMTTQVHGTFGYLDPEYFRS-SQFTDKSDVYSFGVVLTELLTGEKPIRFTILEEDKSLAAYFLCAMKEERLFEILDA-- 508 (608)
Q Consensus 432 ~~~~~~~~gt~~y~aPE~~~~-~~~t~ksDV~S~Gvvl~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~-- 508 (608)
. ......++..|+|||++.+ ..++.++||||||++++||++|+.||......+.............. ...+..+.
T Consensus 155 ~-~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~ 232 (286)
T cd07847 155 D-DYTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDLIP-RHQQIFSTNQ 232 (286)
T ss_pred c-cccCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCh-HHhhhccccc
Confidence 1 1223457889999999876 46789999999999999999999998643321110000000000000 00000000
Q ss_pred --------hhhc-----cCChhHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 044312 509 --------RVMK-----QGGKDEIITVAKLAKRCLNLNGKKRPTMREVASE 546 (608)
Q Consensus 509 --------~~~~-----~~~~~~~~~l~~Li~~cl~~dp~~RPs~~evl~~ 546 (608)
.... ......+..+.+|+.+||+.+|++||++.|++.+
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~ 283 (286)
T cd07847 233 FFKGLSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLEH 283 (286)
T ss_pred ccccccCCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhcC
Confidence 0000 0001235678999999999999999999999753
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-32 Score=276.51 Aligned_cols=232 Identities=24% Similarity=0.385 Sum_probs=184.0
Q ss_pred ccccceeccCce---------------EEEEEeecC-----hhhHHHHHHHHHHHhhcCCCCccceecccccCccceEEE
Q 044312 291 FDLNRILGQGGQ---------------AVKKSKVID-----ESKVEEFINEVVILSQINHRNVVKLLGCCLETEVPLLVY 350 (608)
Q Consensus 291 f~~~~~lG~G~~---------------avk~~~~~~-----~~~~~~~~~Ei~il~~l~H~niv~l~~~~~~~~~~~lV~ 350 (608)
|+..+.||+|++ ++|...... ....+.+.+|+.+++.++|+||+++++++.+....++||
T Consensus 2 ~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~ 81 (258)
T cd06632 2 WRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDNLYIFL 81 (258)
T ss_pred ccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecCCeEEEEE
Confidence 555667777753 566554433 235678999999999999999999999999999999999
Q ss_pred eecCCCccchhccccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEEcCCCcEEEeeccCccccccC
Q 044312 351 EFIPNGTLFQYIHDQNEDFPITWEIRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVD 430 (608)
Q Consensus 351 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGls~~~~~~ 430 (608)
||+++++|.+++.... ++++..+..++.|++.||+|||+.+ ++|+||+|+||+++.++.+||+|||++......
T Consensus 82 e~~~~~~L~~~~~~~~---~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~~~~ 155 (258)
T cd06632 82 ELVPGGSLAKLLKKYG---SFPEPVIRLYTRQILLGLEYLHDRN---TVHRDIKGANILVDTNGVVKLADFGMAKQVVEF 155 (258)
T ss_pred EecCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEccCccceecccc
Confidence 9999999999987643 4889999999999999999999999 999999999999999999999999998765433
Q ss_pred CcceeeeeeccCCCCChhhhccCC-CCCccchHhHHHHHHHHHhCCCCCCccchhhcccHHHHHHHHhhhhhhHHHhhhh
Q 044312 431 QTHMTTQVHGTFGYLDPEYFRSSQ-FTDKSDVYSFGVVLTELLTGEKPIRFTILEEDKSLAAYFLCAMKEERLFEILDAR 509 (608)
Q Consensus 431 ~~~~~~~~~gt~~y~aPE~~~~~~-~t~ksDV~S~Gvvl~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 509 (608)
. ......++..|++||.+.... ++.++|+||||+++++|++|+.||...... .... .+....
T Consensus 156 ~--~~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~~------~~~~---------~~~~~~ 218 (258)
T cd06632 156 S--FAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEGV------AAVF---------KIGRSK 218 (258)
T ss_pred c--cccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCcHH------HHHH---------HHHhcc
Confidence 2 223456888999999988776 899999999999999999999998632210 0000 000000
Q ss_pred hhccCChhHHHHHHHHHHHHhccCCCCCCCHHHHHH
Q 044312 510 VMKQGGKDEIITVAKLAKRCLNLNGKKRPTMREVAS 545 (608)
Q Consensus 510 ~~~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~evl~ 545 (608)
.....+...+..+.+++.+||+.+|++||++.+++.
T Consensus 219 ~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~ 254 (258)
T cd06632 219 ELPPIPDHLSDEAKDFILKCLQRDPSLRPTAAELLE 254 (258)
T ss_pred cCCCcCCCcCHHHHHHHHHHhhcCcccCcCHHHHhc
Confidence 011122344567899999999999999999999975
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-32 Score=279.60 Aligned_cols=257 Identities=26% Similarity=0.381 Sum_probs=186.5
Q ss_pred ccccceeccCce-------------EEEEEeecChhhHHHHHHHHHHHhhc--CCCCccceecccccCc----cceEEEe
Q 044312 291 FDLNRILGQGGQ-------------AVKKSKVIDESKVEEFINEVVILSQI--NHRNVVKLLGCCLETE----VPLLVYE 351 (608)
Q Consensus 291 f~~~~~lG~G~~-------------avk~~~~~~~~~~~~~~~Ei~il~~l--~H~niv~l~~~~~~~~----~~~lV~E 351 (608)
..+..+||+|+| |||+. ...+.+.|.+|-.|.+.. +|+||+++++.-.... .++||+|
T Consensus 212 l~l~eli~~Grfg~V~KaqL~~~~VAVKif---p~~~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~eywLVt~ 288 (534)
T KOG3653|consen 212 LQLLELIGRGRFGCVWKAQLDNRLVAVKIF---PEQEKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADRMEYWLVTE 288 (534)
T ss_pred hhhHHHhhcCccceeehhhccCceeEEEec---CHHHHHHHHhHHHHHhccCccchhHHHhhchhccCCccccceeEEee
Confidence 345667888876 55544 467788899998887765 8999999999876555 7899999
Q ss_pred ecCCCccchhccccCCCCCCCHHHHHHHHHHHHHHHHHHhhcC------CCCeeccCCCCCcEEEcCCCcEEEeeccCcc
Q 044312 352 FIPNGTLFQYIHDQNEDFPITWEIRLRIAIEVSGALSYLHSAA------SIPIYHRDIKSTNILLDDKYRAKVSDFGASR 425 (608)
Q Consensus 352 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~------~~~iiHrDlk~~NILl~~~~~~kl~DFGls~ 425 (608)
|.+.|+|.++|..+ .++|....+|+..+++||+|||+.- .++|+|||||++||||..+++..|+|||||.
T Consensus 289 fh~kGsL~dyL~~n----tisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccIaDFGLAl 364 (534)
T KOG3653|consen 289 FHPKGSLCDYLKAN----TISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCIADFGLAL 364 (534)
T ss_pred eccCCcHHHHHHhc----cccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEeeccceeE
Confidence 99999999999876 4899999999999999999999753 4679999999999999999999999999998
Q ss_pred ccccCCcc-eeeeeeccCCCCChhhhccC-CCC-----CccchHhHHHHHHHHHhCCCCCCc-cchhhcccHHHHH----
Q 044312 426 SMAVDQTH-MTTQVHGTFGYLDPEYFRSS-QFT-----DKSDVYSFGVVLTELLTGEKPIRF-TILEEDKSLAAYF---- 493 (608)
Q Consensus 426 ~~~~~~~~-~~~~~~gt~~y~aPE~~~~~-~~t-----~ksDV~S~Gvvl~elltg~~p~~~-~~~~~~~~l~~~~---- 493 (608)
.+...... ......||.+|||||++.+. .+. .+.||||+|.|||||+++-.-+.. ..++........+
T Consensus 365 ~~~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp~Yqlpfe~evG~hP 444 (534)
T KOG3653|consen 365 RLEPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPVPEYQLPFEAEVGNHP 444 (534)
T ss_pred EecCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCCCcccCchhHHhcCCC
Confidence 87644332 22336799999999999765 233 368999999999999996543321 0000000000000
Q ss_pred -HHHhhhhhhHHHhhhhhhccCC-hhHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhhHHhc
Q 044312 494 -LCAMKEERLFEILDARVMKQGG-KDEIITVAKLAKRCLNLNGKKRPTMREVASELAGIKAWN 554 (608)
Q Consensus 494 -~~~~~~~~~~~~~d~~~~~~~~-~~~~~~l~~Li~~cl~~dp~~RPs~~evl~~L~~i~~~~ 554 (608)
...+++..+.+...|.++.... ...+.-+.+.+..||..||+.|.|+.=|.+++..+....
T Consensus 445 t~e~mq~~VV~kK~RP~~p~~W~~h~~~~~l~et~EeCWDhDaeARLTA~Cv~eR~~~l~~~~ 507 (534)
T KOG3653|consen 445 TLEEMQELVVRKKQRPKIPDAWRKHAGMAVLCETIEECWDHDAEARLTAGCVEERMAELMMLW 507 (534)
T ss_pred CHHHHHHHHHhhccCCCChhhhhcCccHHHHHHHHHHHcCCchhhhhhhHHHHHHHHHHhccC
Confidence 0011111111111111111111 133556899999999999999999999999988877644
|
|
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-33 Score=284.59 Aligned_cols=251 Identities=24% Similarity=0.312 Sum_probs=190.4
Q ss_pred ccCCHHHHHHHhcCccccceeccCce---------------EEEEEeecChhhHHHHHHHHHHHhhc-CCCCccceeccc
Q 044312 277 KLFTSKELEKATDNFDLNRILGQGGQ---------------AVKKSKVIDESKVEEFINEVVILSQI-NHRNVVKLLGCC 340 (608)
Q Consensus 277 ~~~~~~~l~~~t~~f~~~~~lG~G~~---------------avk~~~~~~~~~~~~~~~Ei~il~~l-~H~niv~l~~~~ 340 (608)
++++..++..++++|.+.+.||+|++ |+|..... ....+.+.+|+.+++++ +|||++++++++
T Consensus 10 ~~~~~~~~~~~~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~-~~~~~~~~~e~~~l~~l~~h~ni~~~~~~~ 88 (291)
T cd06639 10 SMLGLESLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPI-SDVDEEIEAEYNILQSLPNHPNVVKFYGMF 88 (291)
T ss_pred hhhhcccCCCCCCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEeccc-ccHHHHHHHHHHHHHHhcCCCCeEEEEEEE
Confidence 34666777888999999999999974 44444322 22346778899999999 899999999998
Q ss_pred ccC-----ccceEEEeecCCCccchhccccC-CCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEEcCCC
Q 044312 341 LET-----EVPLLVYEFIPNGTLFQYIHDQN-EDFPITWEIRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKY 414 (608)
Q Consensus 341 ~~~-----~~~~lV~E~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~ 414 (608)
... ...++||||+++++|.++++... ....+++..+..++.|++.||.|||+.+ ++||||||+||++++++
T Consensus 89 ~~~~~~~~~~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dlkp~nili~~~~ 165 (291)
T cd06639 89 YKADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNNR---IIHRDVKGNNILLTTEG 165 (291)
T ss_pred EeccccCCCeeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEEcCCC
Confidence 653 35799999999999999886421 2235899999999999999999999998 99999999999999999
Q ss_pred cEEEeeccCccccccCCcceeeeeeccCCCCChhhhccC-----CCCCccchHhHHHHHHHHHhCCCCCCccchhhcccH
Q 044312 415 RAKVSDFGASRSMAVDQTHMTTQVHGTFGYLDPEYFRSS-----QFTDKSDVYSFGVVLTELLTGEKPIRFTILEEDKSL 489 (608)
Q Consensus 415 ~~kl~DFGls~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~t~ksDV~S~Gvvl~elltg~~p~~~~~~~~~~~l 489 (608)
.+||+|||+++....... ......++..|+|||.+... .++.++||||||++++||++|+.||.......
T Consensus 166 ~~kl~dfg~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~~~---- 240 (291)
T cd06639 166 GVKLVDFGVSAQLTSTRL-RRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPVK---- 240 (291)
T ss_pred CEEEeecccchhcccccc-cccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcHHH----
Confidence 999999999886543221 12234578899999998644 36899999999999999999999986322110
Q ss_pred HHHHHHHhhhhhhHHHhhhhhhccCChhHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 044312 490 AAYFLCAMKEERLFEILDARVMKQGGKDEIITVAKLAKRCLNLNGKKRPTMREVASE 546 (608)
Q Consensus 490 ~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~evl~~ 546 (608)
. .. ......... ...+......+.+|+.+||+.+|++||++.|++++
T Consensus 241 -~-~~-~~~~~~~~~-------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~ 287 (291)
T cd06639 241 -T-LF-KIPRNPPPT-------LLHPEKWCRSFNHFISQCLIKDFEARPSVTHLLEH 287 (291)
T ss_pred -H-HH-HHhcCCCCC-------CCcccccCHHHHHHHHHHhhcChhhCcCHHHHhcC
Confidence 0 00 010010000 01122344579999999999999999999999864
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-32 Score=278.27 Aligned_cols=236 Identities=27% Similarity=0.400 Sum_probs=182.2
Q ss_pred cCccccceeccCce---------------EEEEEeecC-----hhhHHHHHHHHHHHhhcCCCCccceecccccC--ccc
Q 044312 289 DNFDLNRILGQGGQ---------------AVKKSKVID-----ESKVEEFINEVVILSQINHRNVVKLLGCCLET--EVP 346 (608)
Q Consensus 289 ~~f~~~~~lG~G~~---------------avk~~~~~~-----~~~~~~~~~Ei~il~~l~H~niv~l~~~~~~~--~~~ 346 (608)
.+|++.+.||+|++ |+|...... ....+.+.+|+.++++++||||+++++++.+. ...
T Consensus 2 ~~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (265)
T cd06652 2 TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTL 81 (265)
T ss_pred CcceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceE
Confidence 46788888888874 566554321 23456889999999999999999999988764 467
Q ss_pred eEEEeecCCCccchhccccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEEcCCCcEEEeeccCccc
Q 044312 347 LLVYEFIPNGTLFQYIHDQNEDFPITWEIRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRS 426 (608)
Q Consensus 347 ~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGls~~ 426 (608)
++||||+++++|.+++.... .+++..+++++.|++.||+|||+.+ ++|+||||+|||++.++.+||+|||+++.
T Consensus 82 ~~v~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~l~Dfg~~~~ 155 (265)
T cd06652 82 SIFMEHMPGGSIKDQLKSYG---ALTENVTRKYTRQILEGVSYLHSNM---IVHRDIKGANILRDSVGNVKLGDFGASKR 155 (265)
T ss_pred EEEEEecCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEecCCCCEEECcCccccc
Confidence 89999999999999987543 4788999999999999999999999 99999999999999999999999999876
Q ss_pred cccCCc--ceeeeeeccCCCCChhhhccCCCCCccchHhHHHHHHHHHhCCCCCCccchhhcccHHHHHHHHhhhhhhHH
Q 044312 427 MAVDQT--HMTTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLTELLTGEKPIRFTILEEDKSLAAYFLCAMKEERLFE 504 (608)
Q Consensus 427 ~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~ 504 (608)
...... .......++..|+|||.+.+..++.++||||||++++||++|+.||...... .. ..+
T Consensus 156 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~-----~~----------~~~ 220 (265)
T cd06652 156 LQTICLSGTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEFEAM-----AA----------IFK 220 (265)
T ss_pred cccccccccccccCCCCccccChhhhcCCCCCcchhHHHHHHHHHHHhhCCCCCCccchH-----HH----------HHH
Confidence 532111 1122345888999999999888999999999999999999999998632111 00 011
Q ss_pred HhhhhhhccCChhHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 044312 505 ILDARVMKQGGKDEIITVAKLAKRCLNLNGKKRPTMREVASE 546 (608)
Q Consensus 505 ~~d~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~evl~~ 546 (608)
..........+......+.+++.+|+. +|++||+++||+++
T Consensus 221 ~~~~~~~~~~~~~~~~~~~~~i~~~l~-~p~~Rp~~~~il~~ 261 (265)
T cd06652 221 IATQPTNPVLPPHVSDHCRDFLKRIFV-EAKLRPSADELLRH 261 (265)
T ss_pred HhcCCCCCCCchhhCHHHHHHHHHHhc-ChhhCCCHHHHhcC
Confidence 111111112233455678899999995 99999999999854
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-33 Score=317.36 Aligned_cols=242 Identities=24% Similarity=0.411 Sum_probs=184.4
Q ss_pred HHhcCccccceeccCce---------------EEEEEee--cChhhHHHHHHHHHHHhhcCCCCccceeccccc--Cccc
Q 044312 286 KATDNFDLNRILGQGGQ---------------AVKKSKV--IDESKVEEFINEVVILSQINHRNVVKLLGCCLE--TEVP 346 (608)
Q Consensus 286 ~~t~~f~~~~~lG~G~~---------------avk~~~~--~~~~~~~~~~~Ei~il~~l~H~niv~l~~~~~~--~~~~ 346 (608)
...++|.+.++||+|+| |+|.+.. ........|..|+.+|++|+|||||++++++.+ ...+
T Consensus 10 ~~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~~~~l 89 (1021)
T PTZ00266 10 SRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKANQKL 89 (1021)
T ss_pred cccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEecCCCEE
Confidence 34568999999999985 4555443 234456789999999999999999999998854 3568
Q ss_pred eEEEeecCCCccchhccccCC-CCCCCHHHHHHHHHHHHHHHHHHhhcCC----CCeeccCCCCCcEEEcC---------
Q 044312 347 LLVYEFIPNGTLFQYIHDQNE-DFPITWEIRLRIAIEVSGALSYLHSAAS----IPIYHRDIKSTNILLDD--------- 412 (608)
Q Consensus 347 ~lV~E~~~~gsL~~~l~~~~~-~~~l~~~~~~~i~~~ia~aL~yLH~~~~----~~iiHrDlk~~NILl~~--------- 412 (608)
+|||||+++++|.++|..... ...+++..++.|+.||+.||+|||+.+. .+|+||||||+||||+.
T Consensus 90 yIVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~lg~i~ 169 (1021)
T PTZ00266 90 YILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKIT 169 (1021)
T ss_pred EEEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCcccccccc
Confidence 999999999999999975321 2359999999999999999999998542 23999999999999964
Q ss_pred --------CCcEEEeeccCccccccCCcceeeeeeccCCCCChhhhcc--CCCCCccchHhHHHHHHHHHhCCCCCCccc
Q 044312 413 --------KYRAKVSDFGASRSMAVDQTHMTTQVHGTFGYLDPEYFRS--SQFTDKSDVYSFGVVLTELLTGEKPIRFTI 482 (608)
Q Consensus 413 --------~~~~kl~DFGls~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~t~ksDV~S~Gvvl~elltg~~p~~~~~ 482 (608)
...+||+|||+++.+.... ......||+.|+|||++.. ..++.++||||||||||||+||+.||....
T Consensus 170 ~~~~n~ng~~iVKLsDFGlAr~l~~~s--~~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk~PF~~~~ 247 (1021)
T PTZ00266 170 AQANNLNGRPIAKIGDFGLSKNIGIES--MAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFHKAN 247 (1021)
T ss_pred ccccccCCCCceEEccCCccccccccc--cccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCCCCCCcCC
Confidence 2358999999998654322 2234568999999999854 458999999999999999999999986321
Q ss_pred hhhcccHHHHHHHHhhhhhhHHHhhhhhhccCChhHHHHHHHHHHHHhccCCCCCCCHHHHHH
Q 044312 483 LEEDKSLAAYFLCAMKEERLFEILDARVMKQGGKDEIITVAKLAKRCLNLNGKKRPTMREVAS 545 (608)
Q Consensus 483 ~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~evl~ 545 (608)
. ... +...+... + .......+.++.+||.+||+.+|.+||++.|++.
T Consensus 248 ~-----~~q-li~~lk~~-------p---~lpi~~~S~eL~dLI~~~L~~dPeeRPSa~QlL~ 294 (1021)
T PTZ00266 248 N-----FSQ-LISELKRG-------P---DLPIKGKSKELNILIKNLLNLSAKERPSALQCLG 294 (1021)
T ss_pred c-----HHH-HHHHHhcC-------C---CCCcCCCCHHHHHHHHHHhcCChhHCcCHHHHhc
Confidence 1 111 11111110 0 0111234567999999999999999999999985
|
|
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-33 Score=304.98 Aligned_cols=256 Identities=18% Similarity=0.238 Sum_probs=182.3
Q ss_pred HhcCccccceeccCceEEEEE-e--------------------------------ecChhhHHHHHHHHHHHhhcCCCCc
Q 044312 287 ATDNFDLNRILGQGGQAVKKS-K--------------------------------VIDESKVEEFINEVVILSQINHRNV 333 (608)
Q Consensus 287 ~t~~f~~~~~lG~G~~avk~~-~--------------------------------~~~~~~~~~~~~Ei~il~~l~H~ni 333 (608)
..++|++.+.||+|+|..... . .........+.+|+.+|++++|+||
T Consensus 146 ~~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l~HpnI 225 (501)
T PHA03210 146 FLAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLNHENI 225 (501)
T ss_pred hhhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhCCCCCc
Confidence 356899999999999852211 0 0011223568899999999999999
Q ss_pred cceecccccCccceEEEeecCCCccchhccccCC--CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEEc
Q 044312 334 VKLLGCCLETEVPLLVYEFIPNGTLFQYIHDQNE--DFPITWEIRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLD 411 (608)
Q Consensus 334 v~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~--~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~ 411 (608)
|++++++...+..++|+|++. ++|.+++..... ........+..|+.||+.||+|||+++ |+||||||+|||++
T Consensus 226 v~l~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~g---IiHrDLKP~NILl~ 301 (501)
T PHA03210 226 LKIEEILRSEANTYMITQKYD-FDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDKK---LIHRDIKLENIFLN 301 (501)
T ss_pred CcEeEEEEECCeeEEEEeccc-cCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEC
Confidence 999999999999999999994 577777654221 112345677889999999999999999 99999999999999
Q ss_pred CCCcEEEeeccCccccccCCcceeeeeeccCCCCChhhhccCCCCCccchHhHHHHHHHHHhCCCC-CCccchhhcccHH
Q 044312 412 DKYRAKVSDFGASRSMAVDQTHMTTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLTELLTGEKP-IRFTILEEDKSLA 490 (608)
Q Consensus 412 ~~~~~kl~DFGls~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~elltg~~p-~~~~~~~~~~~l~ 490 (608)
.++.+||+|||+++.+............||..|+|||++.+..++.++|||||||++|||++|..+ +..........+.
T Consensus 302 ~~~~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~~~~~p~~~~~~~~~~~~~ 381 (501)
T PHA03210 302 CDGKIVLGDFGTAMPFEKEREAFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDFCPIGDGGGKPGKQLL 381 (501)
T ss_pred CCCCEEEEeCCCceecCcccccccccccCCcCCCCchhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCccCCCCCHHHHHH
Confidence 999999999999987654433333456799999999999999999999999999999999998754 4322111111111
Q ss_pred HHHHHH------hhh--hhhHHHhhhhhhccCC---------hhHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 044312 491 AYFLCA------MKE--ERLFEILDARVMKQGG---------KDEIITVAKLAKRCLNLNGKKRPTMREVASE 546 (608)
Q Consensus 491 ~~~~~~------~~~--~~~~~~~d~~~~~~~~---------~~~~~~l~~Li~~cl~~dp~~RPs~~evl~~ 546 (608)
...... +.. ..+.+.++.......+ ...+..+.+++.+||+.||.+|||+.|++++
T Consensus 382 ~~~~~~~~~~~~~p~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~li~kmL~~DP~~Rpsa~elL~h 454 (501)
T PHA03210 382 KIIDSLSVCDEEFPDPPCKLFDYIDSAEIDHAGHSVPPLIRNLGLPADFEYPLVKMLTFDWHLRPGAAELLAL 454 (501)
T ss_pred HHHHhcccChhhcCCcHHHHHHHhhhhhcccCccchhhHHHhcCCChHHHHHHHHHhccCcccCcCHHHHhhC
Confidence 111000 000 0111111110000000 1123457788999999999999999999874
|
|
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-32 Score=278.29 Aligned_cols=238 Identities=27% Similarity=0.468 Sum_probs=185.3
Q ss_pred CccccceeccCce---------------EEEEEeecC------hhhHHHHHHHHHHHhhcCCCCccceecccccCccceE
Q 044312 290 NFDLNRILGQGGQ---------------AVKKSKVID------ESKVEEFINEVVILSQINHRNVVKLLGCCLETEVPLL 348 (608)
Q Consensus 290 ~f~~~~~lG~G~~---------------avk~~~~~~------~~~~~~~~~Ei~il~~l~H~niv~l~~~~~~~~~~~l 348 (608)
+|+..+.||+|++ |+|...... ....+.+.+|++++++++|+||+++++++.+.+..++
T Consensus 1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 80 (268)
T cd06630 1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNL 80 (268)
T ss_pred CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCCeEEE
Confidence 3566677777763 666665322 1235789999999999999999999999999999999
Q ss_pred EEeecCCCccchhccccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEEcCCC-cEEEeeccCcccc
Q 044312 349 VYEFIPNGTLFQYIHDQNEDFPITWEIRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKY-RAKVSDFGASRSM 427 (608)
Q Consensus 349 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~-~~kl~DFGls~~~ 427 (608)
||||+++++|.+++.+.. ++++..+..++.|++.||.|||+.+ ++|+||+|+||+++.++ .+||+|||++...
T Consensus 81 v~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~ql~~al~~LH~~~---i~H~~i~~~nil~~~~~~~~~l~dfg~~~~~ 154 (268)
T cd06630 81 FVEWMAGGSVSHLLSKYG---AFKEAVIINYTEQLLRGLSYLHENQ---IIHRDVKGANLLIDSTGQRLRIADFGAAARL 154 (268)
T ss_pred EEeccCCCcHHHHHHHhC---CCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEEccccccccc
Confidence 999999999999987543 5899999999999999999999999 99999999999998765 5999999998776
Q ss_pred ccCCc---ceeeeeeccCCCCChhhhccCCCCCccchHhHHHHHHHHHhCCCCCCccchhhcccHHHHHHHHhhhhhhHH
Q 044312 428 AVDQT---HMTTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLTELLTGEKPIRFTILEEDKSLAAYFLCAMKEERLFE 504 (608)
Q Consensus 428 ~~~~~---~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~ 504 (608)
..... .......++..|+|||.+.+..++.++||||+|+++++|++|+.||....... .... ..+
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~---~~~~---------~~~ 222 (268)
T cd06630 155 AAKGTGAGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSN---HLAL---------IFK 222 (268)
T ss_pred ccccccCCccccccccccceeCHhHhccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcc---hHHH---------HHH
Confidence 53311 11223457889999999988889999999999999999999999986322111 0100 001
Q ss_pred HhhhhhhccCChhHHHHHHHHHHHHhccCCCCCCCHHHHHH
Q 044312 505 ILDARVMKQGGKDEIITVAKLAKRCLNLNGKKRPTMREVAS 545 (608)
Q Consensus 505 ~~d~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~evl~ 545 (608)
+.........+...+.++.+++.+||..+|++||++.|+++
T Consensus 223 ~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~ll~ 263 (268)
T cd06630 223 IASATTAPSIPEHLSPGLRDVTLRCLELQPEDRPPSRELLK 263 (268)
T ss_pred HhccCCCCCCchhhCHHHHHHHHHHcCCCcccCcCHHHHhc
Confidence 11111112233345678999999999999999999999985
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-33 Score=281.10 Aligned_cols=240 Identities=28% Similarity=0.397 Sum_probs=184.4
Q ss_pred HHhcCccccceeccCce---------------EEEEEeecChhhHHHHHHHHHHHhhc-CCCCccceecccccCc-----
Q 044312 286 KATDNFDLNRILGQGGQ---------------AVKKSKVIDESKVEEFINEVVILSQI-NHRNVVKLLGCCLETE----- 344 (608)
Q Consensus 286 ~~t~~f~~~~~lG~G~~---------------avk~~~~~~~~~~~~~~~Ei~il~~l-~H~niv~l~~~~~~~~----- 344 (608)
.++++|++.+.||+|++ ++|..... ....+.|.+|+.+++++ +|+||+++++++.+..
T Consensus 3 ~~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~-~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~ 81 (275)
T cd06608 3 DPTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDII-EDEEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGND 81 (275)
T ss_pred CchhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecC-chhHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCcc
Confidence 45688999999999873 45544432 23457899999999999 7999999999996544
Q ss_pred -cceEEEeecCCCccchhccccC-CCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEEcCCCcEEEeecc
Q 044312 345 -VPLLVYEFIPNGTLFQYIHDQN-EDFPITWEIRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFG 422 (608)
Q Consensus 345 -~~~lV~E~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFG 422 (608)
..++||||+++++|.+++.... .+..+++..+..++.|++.||.|||+.+ ++|+||+|+||++++++.+||+|||
T Consensus 82 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~---i~H~~l~p~ni~~~~~~~~~l~d~~ 158 (275)
T cd06608 82 DQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHENK---VIHRDIKGQNILLTKNAEVKLVDFG 158 (275)
T ss_pred eEEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCC---cccCCCCHHHEEEccCCeEEECCCc
Confidence 4899999999999999887532 1235899999999999999999999999 9999999999999999999999999
Q ss_pred CccccccCCcceeeeeeccCCCCChhhhcc-----CCCCCccchHhHHHHHHHHHhCCCCCCccchhhcccHHHHHHHHh
Q 044312 423 ASRSMAVDQTHMTTQVHGTFGYLDPEYFRS-----SQFTDKSDVYSFGVVLTELLTGEKPIRFTILEEDKSLAAYFLCAM 497 (608)
Q Consensus 423 ls~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~t~ksDV~S~Gvvl~elltg~~p~~~~~~~~~~~l~~~~~~~~ 497 (608)
++........ ......++..|+|||++.. ..++.++||||||++++||++|+.||....... .
T Consensus 159 ~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~------~----- 226 (275)
T cd06608 159 VSAQLDSTLG-RRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPMR------A----- 226 (275)
T ss_pred cceecccchh-hhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccchHH------H-----
Confidence 9876543221 2233458889999998753 346789999999999999999999986321110 0
Q ss_pred hhhhhHHHhhhhh-hccCChhHHHHHHHHHHHHhccCCCCCCCHHHHHH
Q 044312 498 KEERLFEILDARV-MKQGGKDEIITVAKLAKRCLNLNGKKRPTMREVAS 545 (608)
Q Consensus 498 ~~~~~~~~~d~~~-~~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~evl~ 545 (608)
+.++..... ....+...+..+.+|+.+||..||++|||+.|+++
T Consensus 227 ----~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~ 271 (275)
T cd06608 227 ----LFKIPRNPPPTLKSPENWSKKFNDFISECLIKNYEQRPFMEELLE 271 (275)
T ss_pred ----HHHhhccCCCCCCchhhcCHHHHHHHHHHhhcChhhCcCHHHHhc
Confidence 011111000 01112234568999999999999999999999985
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-32 Score=285.67 Aligned_cols=228 Identities=21% Similarity=0.331 Sum_probs=162.5
Q ss_pred HHHHHHHHHHHhhcCCCCccceecccc--cCccceEEEeecCCCccchhcccc------CCCCCCCHHHHHHHHHHHHHH
Q 044312 315 VEEFINEVVILSQINHRNVVKLLGCCL--ETEVPLLVYEFIPNGTLFQYIHDQ------NEDFPITWEIRLRIAIEVSGA 386 (608)
Q Consensus 315 ~~~~~~Ei~il~~l~H~niv~l~~~~~--~~~~~~lV~E~~~~gsL~~~l~~~------~~~~~l~~~~~~~i~~~ia~a 386 (608)
...+.+|+.++++++||||+++++++. .....++||||+.+ +|.+++... .....+++..+..++.||+.|
T Consensus 42 ~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~a 120 (317)
T cd07867 42 SMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFDYAEH-DLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDG 120 (317)
T ss_pred cHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEeeeCC-cHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHH
Confidence 356889999999999999999999885 34567899999964 777776421 112258899999999999999
Q ss_pred HHHHhhcCCCCeeccCCCCCcEEE----cCCCcEEEeeccCccccccCCc--ceeeeeeccCCCCChhhhccC-CCCCcc
Q 044312 387 LSYLHSAASIPIYHRDIKSTNILL----DDKYRAKVSDFGASRSMAVDQT--HMTTQVHGTFGYLDPEYFRSS-QFTDKS 459 (608)
Q Consensus 387 L~yLH~~~~~~iiHrDlk~~NILl----~~~~~~kl~DFGls~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~-~~t~ks 459 (608)
|.|||+.+ |+||||||+|||+ ++++.+||+|||+++....... .......+|+.|+|||++.+. .++.++
T Consensus 121 L~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~ 197 (317)
T cd07867 121 IHYLHANW---VLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAI 197 (317)
T ss_pred HHHHHhCC---EEcCCCCHHHEEEccCCCCCCcEEEeeccceeccCCCcccccccCcceecccccCcHHhcCCCccCcHH
Confidence 99999999 9999999999999 5667899999999987643322 122345689999999998764 589999
Q ss_pred chHhHHHHHHHHHhCCCCCCccchhhccc------HHHHHHHHhhh---hhh---------HHHhhh------------h
Q 044312 460 DVYSFGVVLTELLTGEKPIRFTILEEDKS------LAAYFLCAMKE---ERL---------FEILDA------------R 509 (608)
Q Consensus 460 DV~S~Gvvl~elltg~~p~~~~~~~~~~~------l~~~~~~~~~~---~~~---------~~~~d~------------~ 509 (608)
||||||++++||+||++||.....+.... ........+.. ... ...... .
T Consensus 198 DiwSlG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 277 (317)
T cd07867 198 DIWAIGCIFAELLTSEPIFHCRQEDIKTSNPFHHDQLDRIFSVMGFPADKDWEDIRKMPEYPTLQKDFRRTTYANSSLIK 277 (317)
T ss_pred HHHhHHHHHHHHHhCCCCcccccccccccccccHHHHHHHHHhcCCCChhhhhhhhhcccchhhhhhhcccccCCchhhh
Confidence 99999999999999999986432211100 00000000000 000 000000 0
Q ss_pred hhccCChhHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 044312 510 VMKQGGKDEIITVAKLAKRCLNLNGKKRPTMREVASE 546 (608)
Q Consensus 510 ~~~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~evl~~ 546 (608)
............+.+|+.+||+.||.+|||+.|++++
T Consensus 278 ~~~~~~~~~~~~~~~ll~~~l~~dP~~R~t~~e~l~h 314 (317)
T cd07867 278 YMEKHKVKPDSKVFLLLQKLLTMDPTKRITSEQALQD 314 (317)
T ss_pred hhhcccCCCChHHHHHHHHHhccCcccccCHHHHhcC
Confidence 0001111234568899999999999999999999853
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-33 Score=283.15 Aligned_cols=248 Identities=24% Similarity=0.343 Sum_probs=182.9
Q ss_pred cCccccceeccCce---------------EEEEEeec--ChhhHHHHHHHHHHHhhcCCCCccceecccccCccceEEEe
Q 044312 289 DNFDLNRILGQGGQ---------------AVKKSKVI--DESKVEEFINEVVILSQINHRNVVKLLGCCLETEVPLLVYE 351 (608)
Q Consensus 289 ~~f~~~~~lG~G~~---------------avk~~~~~--~~~~~~~~~~Ei~il~~l~H~niv~l~~~~~~~~~~~lV~E 351 (608)
++|++.++||+|++ |+|+.... .....+.+.+|+++++.++||||+++++++......++|||
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 80 (286)
T cd07846 1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLVFE 80 (286)
T ss_pred CceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhcccCCeEEEEEe
Confidence 35777888888874 45544321 12235678899999999999999999999999999999999
Q ss_pred ecCCCccchhccccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEEcCCCcEEEeeccCccccccCC
Q 044312 352 FIPNGTLFQYIHDQNEDFPITWEIRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQ 431 (608)
Q Consensus 352 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGls~~~~~~~ 431 (608)
|+++++|.++..... .+++..++.++.||+.||+|||+.+ ++|+||+|+||++++++.+||+|||++.......
T Consensus 81 ~~~~~~l~~~~~~~~---~~~~~~~~~~~~~i~~~l~~LH~~~---i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~~~~ 154 (286)
T cd07846 81 FVDHTVLDDLEKYPN---GLDESRVRKYLFQILRGIEFCHSHN---IIHRDIKPENILVSQSGVVKLCDFGFARTLAAPG 154 (286)
T ss_pred cCCccHHHHHHhccC---CCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEECCCCcEEEEeeeeeeeccCCc
Confidence 999988887765432 4899999999999999999999998 9999999999999999999999999988754332
Q ss_pred cceeeeeeccCCCCChhhhcc-CCCCCccchHhHHHHHHHHHhCCCCCCccchhhcccHHHHHHHHhhh--hhhHHHhh-
Q 044312 432 THMTTQVHGTFGYLDPEYFRS-SQFTDKSDVYSFGVVLTELLTGEKPIRFTILEEDKSLAAYFLCAMKE--ERLFEILD- 507 (608)
Q Consensus 432 ~~~~~~~~gt~~y~aPE~~~~-~~~t~ksDV~S~Gvvl~elltg~~p~~~~~~~~~~~l~~~~~~~~~~--~~~~~~~d- 507 (608)
. ......++..|+|||++.+ ..++.++||||||++++||++|++||......+ ........... .......+
T Consensus 155 ~-~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~ 230 (286)
T cd07846 155 E-VYTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDID---QLYHIIKCLGNLIPRHQEIFQK 230 (286)
T ss_pred c-ccCcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCchHH---HHHHHHHHhCCCchhhHHHhcc
Confidence 2 2233457889999999875 457889999999999999999999986332111 00000000000 00000000
Q ss_pred -----hhhh---------ccCChhHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 044312 508 -----ARVM---------KQGGKDEIITVAKLAKRCLNLNGKKRPTMREVASE 546 (608)
Q Consensus 508 -----~~~~---------~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~evl~~ 546 (608)
.... .......+..+.+|+.+||+.+|++||++.+++++
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~ 283 (286)
T cd07846 231 NPLFAGMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLHH 283 (286)
T ss_pred chHhhccccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhcC
Confidence 0000 00112345679999999999999999999999753
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-33 Score=285.20 Aligned_cols=224 Identities=26% Similarity=0.388 Sum_probs=179.6
Q ss_pred eEEEEEeecChhhHHHHHHHHHHHhhcCCCCccceecccccCccceEEEeecCCCccchhccccCCCCCCCHHHHHHHHH
Q 044312 302 QAVKKSKVIDESKVEEFINEVVILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEIRLRIAI 381 (608)
Q Consensus 302 ~avk~~~~~~~~~~~~~~~Ei~il~~l~H~niv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~ 381 (608)
+|+|..........+.+.+|+.+++.++||||+++++++...+..++||||+++++|.+++... .+++..++.++.
T Consensus 49 v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~iv~e~~~~~~L~~~~~~~----~~~~~~~~~~~~ 124 (297)
T cd06659 49 VAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFLQGGALTDIVSQT----RLNEEQIATVCE 124 (297)
T ss_pred EEEEEEEecccchHHHHHHHHHHHHhCCCCchhhhhhheeeCCeEEEEEecCCCCCHHHHHhhc----CCCHHHHHHHHH
Confidence 4777776655556678999999999999999999999999999999999999999999877542 489999999999
Q ss_pred HHHHHHHHHhhcCCCCeeccCCCCCcEEEcCCCcEEEeeccCccccccCCcceeeeeeccCCCCChhhhccCCCCCccch
Q 044312 382 EVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHGTFGYLDPEYFRSSQFTDKSDV 461 (608)
Q Consensus 382 ~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGls~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV 461 (608)
|++.||+|||+.+ ++||||||+|||++.++.+||+|||++........ ......++..|+|||++.+..++.++||
T Consensus 125 qi~~~L~~LH~~~---ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Dv 200 (297)
T cd06659 125 SVLQALCYLHSQG---VIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVP-KRKSLVGTPYWMAPEVISRTPYGTEVDI 200 (297)
T ss_pred HHHHHHHHHHhCC---eecCCCCHHHeEEccCCcEEEeechhHhhcccccc-cccceecCccccCHHHHccCCCCchhhH
Confidence 9999999999999 99999999999999999999999999876543321 2234568899999999998899999999
Q ss_pred HhHHHHHHHHHhCCCCCCccchhhcccHHHHHHHHhhhhhhHHHhhhhhhccCChhHHHHHHHHHHHHhccCCCCCCCHH
Q 044312 462 YSFGVVLTELLTGEKPIRFTILEEDKSLAAYFLCAMKEERLFEILDARVMKQGGKDEIITVAKLAKRCLNLNGKKRPTMR 541 (608)
Q Consensus 462 ~S~Gvvl~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~ 541 (608)
||||++++||++|+.||......+. . ..+.... .. ........+..+.+++.+||+.+|++||++.
T Consensus 201 ~slG~il~el~~g~~p~~~~~~~~~------~-~~~~~~~-----~~--~~~~~~~~~~~l~~~i~~~l~~~P~~Rps~~ 266 (297)
T cd06659 201 WSLGIMVIEMVDGEPPYFSDSPVQA------M-KRLRDSP-----PP--KLKNAHKISPVLRDFLERMLTREPQERATAQ 266 (297)
T ss_pred HHHHHHHHHHHhCCCCCCCCCHHHH------H-HHHhccC-----CC--CccccCCCCHHHHHHHHHHhcCCcccCcCHH
Confidence 9999999999999999863221110 0 0111000 00 0011123345789999999999999999999
Q ss_pred HHHHHH
Q 044312 542 EVASEL 547 (608)
Q Consensus 542 evl~~L 547 (608)
||+++-
T Consensus 267 ~ll~~~ 272 (297)
T cd06659 267 ELLDHP 272 (297)
T ss_pred HHhhCh
Confidence 999853
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-32 Score=276.97 Aligned_cols=236 Identities=25% Similarity=0.393 Sum_probs=184.8
Q ss_pred CccccceeccCce---------------EEEEEeec--ChhhHHHHHHHHHHHhhcCCCCccceecccccCccceEEEee
Q 044312 290 NFDLNRILGQGGQ---------------AVKKSKVI--DESKVEEFINEVVILSQINHRNVVKLLGCCLETEVPLLVYEF 352 (608)
Q Consensus 290 ~f~~~~~lG~G~~---------------avk~~~~~--~~~~~~~~~~Ei~il~~l~H~niv~l~~~~~~~~~~~lV~E~ 352 (608)
+|++.+.||+|++ |+|..... .....+.+.+|+.++++++|+||+++++.+.+....++|+||
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~ 80 (257)
T cd08225 1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASFQENGRLFIVMEY 80 (257)
T ss_pred CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhheeccCCeEEEEEec
Confidence 3666777777753 55655432 223456788999999999999999999999999999999999
Q ss_pred cCCCccchhccccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEEcCCC-cEEEeeccCccccccCC
Q 044312 353 IPNGTLFQYIHDQNEDFPITWEIRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKY-RAKVSDFGASRSMAVDQ 431 (608)
Q Consensus 353 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~-~~kl~DFGls~~~~~~~ 431 (608)
+++++|.+++..... ..+++..+..++.|++.||.|||+.+ ++|+||||+||++++++ .+||+|||.+.......
T Consensus 81 ~~~~~L~~~~~~~~~-~~~~~~~~~~~~~~l~~~l~~lh~~~---i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~ 156 (257)
T cd08225 81 CDGGDLMKRINRQRG-VLFSEDQILSWFVQISLGLKHIHDRK---ILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSM 156 (257)
T ss_pred CCCCcHHHHHHhccC-CCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCCHHHEEEcCCCCeEEecccccchhccCCc
Confidence 999999999876432 25899999999999999999999998 99999999999999875 57999999987664322
Q ss_pred cceeeeeeccCCCCChhhhccCCCCCccchHhHHHHHHHHHhCCCCCCccchhhcccHHHHHHHHhhhhhhHHHhhhhhh
Q 044312 432 THMTTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLTELLTGEKPIRFTILEEDKSLAAYFLCAMKEERLFEILDARVM 511 (608)
Q Consensus 432 ~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~ 511 (608)
.......|++.|+|||++....++.++||||||++++||++|+.||..... ....... .... .
T Consensus 157 -~~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~------~~~~~~~---------~~~~-~ 219 (257)
T cd08225 157 -ELAYTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGNNL------HQLVLKI---------CQGY-F 219 (257)
T ss_pred -ccccccCCCccccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCccH------HHHHHHH---------hccc-C
Confidence 222334588899999999988999999999999999999999999863221 1111111 1111 1
Q ss_pred ccCChhHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 044312 512 KQGGKDEIITVAKLAKRCLNLNGKKRPTMREVASE 546 (608)
Q Consensus 512 ~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~evl~~ 546 (608)
.......+..+.+++.+||..+|++|||+.||+++
T Consensus 220 ~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~ 254 (257)
T cd08225 220 APISPNFSRDLRSLISQLFKVSPRDRPSITSILKR 254 (257)
T ss_pred CCCCCCCCHHHHHHHHHHhccChhhCcCHHHHhhC
Confidence 11222345679999999999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-32 Score=276.12 Aligned_cols=237 Identities=26% Similarity=0.392 Sum_probs=190.0
Q ss_pred CccccceeccCce---------------EEEEEeecCh-hhHHHHHHHHHHHhhcCCCCccceecccccCccceEEEeec
Q 044312 290 NFDLNRILGQGGQ---------------AVKKSKVIDE-SKVEEFINEVVILSQINHRNVVKLLGCCLETEVPLLVYEFI 353 (608)
Q Consensus 290 ~f~~~~~lG~G~~---------------avk~~~~~~~-~~~~~~~~Ei~il~~l~H~niv~l~~~~~~~~~~~lV~E~~ 353 (608)
+|++.+.||+|++ +||+...... ...+.+.+|+.++++++|+||+++++++......++||||+
T Consensus 2 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~ 81 (264)
T cd06623 2 DLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISIVLEYM 81 (264)
T ss_pred cceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCeEEEEEEec
Confidence 5777788888763 5666554333 45678999999999999999999999999999999999999
Q ss_pred CCCccchhccccCCCCCCCHHHHHHHHHHHHHHHHHHhh-cCCCCeeccCCCCCcEEEcCCCcEEEeeccCccccccCCc
Q 044312 354 PNGTLFQYIHDQNEDFPITWEIRLRIAIEVSGALSYLHS-AASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQT 432 (608)
Q Consensus 354 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~-~~~~~iiHrDlk~~NILl~~~~~~kl~DFGls~~~~~~~~ 432 (608)
++++|.+++.... ++++..++.++.|+++||+|||+ .+ ++|+||+|+||+++.++.++|+|||++........
T Consensus 82 ~~~~L~~~l~~~~---~l~~~~~~~~~~~l~~~l~~lh~~~~---~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~~~~~ 155 (264)
T cd06623 82 DGGSLADLLKKVG---KIPEPVLAYIARQILKGLDYLHTKRH---IIHRDIKPSNLLINSKGEVKIADFGISKVLENTLD 155 (264)
T ss_pred CCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHhccCC---CccCCCCHHHEEECCCCCEEEccCccceecccCCC
Confidence 9999999997642 58999999999999999999999 88 99999999999999999999999999987654332
Q ss_pred ceeeeeeccCCCCChhhhccCCCCCccchHhHHHHHHHHHhCCCCCCccchhhcccHHHHHHHHhhhhhhHHHhhhhhhc
Q 044312 433 HMTTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLTELLTGEKPIRFTILEEDKSLAAYFLCAMKEERLFEILDARVMK 512 (608)
Q Consensus 433 ~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~ 512 (608)
. .....++..|+|||.+....++.++||||||++++||++|+.||...... ...... ..+... ...
T Consensus 156 ~-~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~---~~~~~~---------~~~~~~-~~~ 221 (264)
T cd06623 156 Q-CNTFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQP---SFFELM---------QAICDG-PPP 221 (264)
T ss_pred c-ccceeecccccCHhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCcccccc---CHHHHH---------HHHhcC-CCC
Confidence 2 23456788999999999999999999999999999999999998643210 111111 111111 111
Q ss_pred cCChh-HHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 044312 513 QGGKD-EIITVAKLAKRCLNLNGKKRPTMREVASE 546 (608)
Q Consensus 513 ~~~~~-~~~~l~~Li~~cl~~dp~~RPs~~evl~~ 546 (608)
..+.. .+..+.+++.+||+.+|++||++.|++++
T Consensus 222 ~~~~~~~~~~l~~li~~~l~~~p~~R~~~~~ll~~ 256 (264)
T cd06623 222 SLPAEEFSPEFRDFISACLQKDPKKRPSAAELLQH 256 (264)
T ss_pred CCCcccCCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence 12222 56789999999999999999999999874
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-33 Score=279.25 Aligned_cols=238 Identities=25% Similarity=0.391 Sum_probs=185.9
Q ss_pred CccccceeccCce---------------EEEEEeec-ChhhHHHHHHHHHHHhhcCCCCccceecccccCccceEEEeec
Q 044312 290 NFDLNRILGQGGQ---------------AVKKSKVI-DESKVEEFINEVVILSQINHRNVVKLLGCCLETEVPLLVYEFI 353 (608)
Q Consensus 290 ~f~~~~~lG~G~~---------------avk~~~~~-~~~~~~~~~~Ei~il~~l~H~niv~l~~~~~~~~~~~lV~E~~ 353 (608)
+|+..+.||+|++ ++|..... .....+++.+|++++++++||||+++++.+......++++||+
T Consensus 2 ~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~ 81 (265)
T cd06605 2 DLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAFYNNGDISICMEYM 81 (265)
T ss_pred cchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccChHHHHHHHHHHHHHHHCCCCchhhhheeeecCCEEEEEEEec
Confidence 4666677777753 56655443 2345678999999999999999999999999999999999999
Q ss_pred CCCccchhccccCCCCCCCHHHHHHHHHHHHHHHHHHhh-cCCCCeeccCCCCCcEEEcCCCcEEEeeccCccccccCCc
Q 044312 354 PNGTLFQYIHDQNEDFPITWEIRLRIAIEVSGALSYLHS-AASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQT 432 (608)
Q Consensus 354 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~-~~~~~iiHrDlk~~NILl~~~~~~kl~DFGls~~~~~~~~ 432 (608)
++++|.+++.... .++++..+.+++.|++.||+|||+ .+ ++|+||||+||++++++.+||+|||++........
T Consensus 82 ~~~~L~~~~~~~~--~~~~~~~~~~~~~~l~~~l~~lH~~~~---i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~~~~~ 156 (265)
T cd06605 82 DGGSLDKILKEVQ--GRIPERILGKIAVAVLKGLTYLHEKHK---IIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSLA 156 (265)
T ss_pred CCCcHHHHHHHcc--CCCCHHHHHHHHHHHHHHHHHHcCCCC---eecCCCCHHHEEECCCCCEEEeecccchhhHHHHh
Confidence 9999999997653 258999999999999999999999 88 99999999999999999999999999876543222
Q ss_pred ceeeeeeccCCCCChhhhccCCCCCccchHhHHHHHHHHHhCCCCCCccchhhcccHHHHHHHHhhhhhhHHHhhhhhhc
Q 044312 433 HMTTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLTELLTGEKPIRFTILEEDKSLAAYFLCAMKEERLFEILDARVMK 512 (608)
Q Consensus 433 ~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~ 512 (608)
. ...++..|+|||.+.+..++.++||||||+++++|++|+.||....... ........ .++... ..
T Consensus 157 ~---~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~-~~~~~~~~---------~~~~~~-~~ 222 (265)
T cd06605 157 K---TFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPENDPP-DGIFELLQ---------YIVNEP-PP 222 (265)
T ss_pred h---cccCChhccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccccc-ccHHHHHH---------HHhcCC-CC
Confidence 1 1568889999999999999999999999999999999999986332110 11111110 111100 01
Q ss_pred cCChh-HHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 044312 513 QGGKD-EIITVAKLAKRCLNLNGKKRPTMREVASE 546 (608)
Q Consensus 513 ~~~~~-~~~~l~~Li~~cl~~dp~~RPs~~evl~~ 546 (608)
..+.. .+..+.+++.+||..+|++|||+.|++.+
T Consensus 223 ~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~ 257 (265)
T cd06605 223 RLPSGKFSPDFQDFVNLCLIKDPRERPSYKELLEH 257 (265)
T ss_pred CCChhhcCHHHHHHHHHHcCCCchhCcCHHHHhhC
Confidence 11111 55679999999999999999999999854
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-32 Score=284.32 Aligned_cols=241 Identities=22% Similarity=0.303 Sum_probs=183.9
Q ss_pred cCccccceeccCce---------------EEEEEeecC---hhhHHHHHHHHHHHhhcCCCCccceecccccCccceEEE
Q 044312 289 DNFDLNRILGQGGQ---------------AVKKSKVID---ESKVEEFINEVVILSQINHRNVVKLLGCCLETEVPLLVY 350 (608)
Q Consensus 289 ~~f~~~~~lG~G~~---------------avk~~~~~~---~~~~~~~~~Ei~il~~l~H~niv~l~~~~~~~~~~~lV~ 350 (608)
++|++.+.||+|++ ++|...... ....+.+.+|+.+++.++||||+++++.+......++||
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (305)
T cd05609 1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETKRHLCMVM 80 (305)
T ss_pred CCceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCCEEEEEE
Confidence 35778888888864 556554322 234567889999999999999999999999999999999
Q ss_pred eecCCCccchhccccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEEcCCCcEEEeeccCccccccC
Q 044312 351 EFIPNGTLFQYIHDQNEDFPITWEIRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVD 430 (608)
Q Consensus 351 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGls~~~~~~ 430 (608)
||+++++|.+++.... .+++..+..++.|++.||+|||+.+ ++||||||+|||++.++.+||+|||+++.....
T Consensus 81 e~~~g~~L~~~l~~~~---~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~NIll~~~~~~~l~dfg~~~~~~~~ 154 (305)
T cd05609 81 EYVEGGDCATLLKNIG---ALPVDMARMYFAETVLALEYLHNYG---IVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMS 154 (305)
T ss_pred ecCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCchHHEEECCCCCEEEeeCCCccccCcC
Confidence 9999999999997643 5899999999999999999999998 999999999999999999999999998742111
Q ss_pred C--------------cceeeeeeccCCCCChhhhccCCCCCccchHhHHHHHHHHHhCCCCCCccchhhcccHHHHHHHH
Q 044312 431 Q--------------THMTTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLTELLTGEKPIRFTILEEDKSLAAYFLCA 496 (608)
Q Consensus 431 ~--------------~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~elltg~~p~~~~~~~~~~~l~~~~~~~ 496 (608)
. ........++..|+|||++....++.++||||||++++||++|+.||...... .... .
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~vl~el~~g~~pf~~~~~~------~~~~-~ 227 (305)
T cd05609 155 LTTNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPE------ELFG-Q 227 (305)
T ss_pred ccccccccccccchhhccccCCccCccccCchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH------HHHH-H
Confidence 0 00111235788999999999889999999999999999999999998632211 1110 1
Q ss_pred hhhhhhHHHhhhhhhccCChhHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHh
Q 044312 497 MKEERLFEILDARVMKQGGKDEIITVAKLAKRCLNLNGKKRPTMREVASELAG 549 (608)
Q Consensus 497 ~~~~~~~~~~d~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~evl~~L~~ 549 (608)
...... .. .......+..+.+++.+||+.+|++||++.++.+.|+.
T Consensus 228 ~~~~~~---~~----~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll~~ 273 (305)
T cd05609 228 VISDDI---EW----PEGDEALPADAQDLISRLLRQNPLERLGTGGAFEVKQH 273 (305)
T ss_pred HHhccc---CC----CCccccCCHHHHHHHHHHhccChhhccCccCHHHHHhC
Confidence 000000 00 01111345679999999999999999997666555533
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-32 Score=281.45 Aligned_cols=248 Identities=21% Similarity=0.314 Sum_probs=180.1
Q ss_pred CccccceeccCce---------------EEEEEeec--ChhhHHHHHHHHHHHhhcCCCCccceecccccCccceEEEee
Q 044312 290 NFDLNRILGQGGQ---------------AVKKSKVI--DESKVEEFINEVVILSQINHRNVVKLLGCCLETEVPLLVYEF 352 (608)
Q Consensus 290 ~f~~~~~lG~G~~---------------avk~~~~~--~~~~~~~~~~Ei~il~~l~H~niv~l~~~~~~~~~~~lV~E~ 352 (608)
+|++.+.||+|++ |+|..+.. .......+.+|+.++++++|+||+++++++.+....++|+||
T Consensus 1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 80 (284)
T cd07839 1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVLHSDKKLTLVFEY 80 (284)
T ss_pred CceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHHhccCCceEEEEec
Confidence 3666777887763 55655432 222345688899999999999999999999999999999999
Q ss_pred cCCCccchhccccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEEcCCCcEEEeeccCccccccCCc
Q 044312 353 IPNGTLFQYIHDQNEDFPITWEIRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQT 432 (608)
Q Consensus 353 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGls~~~~~~~~ 432 (608)
++ ++|.+++..... .+++..++.++.||++||.|||+.+ ++||||||+|||++.++.+||+|||+++.......
T Consensus 81 ~~-~~l~~~~~~~~~--~~~~~~~~~~~~qi~~al~~LH~~~---i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~ 154 (284)
T cd07839 81 CD-QDLKKYFDSCNG--DIDPEIVKSFMFQLLKGLAFCHSHN---VLHRDLKPQNLLINKNGELKLADFGLARAFGIPVR 154 (284)
T ss_pred CC-CCHHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEEcCCCcEEECccchhhccCCCCC
Confidence 96 578887765332 4899999999999999999999999 99999999999999999999999999986543221
Q ss_pred ceeeeeeccCCCCChhhhccC-CCCCccchHhHHHHHHHHHhCCCCCCccchhhcccHHHHHHHHhhhh---h---hHHH
Q 044312 433 HMTTQVHGTFGYLDPEYFRSS-QFTDKSDVYSFGVVLTELLTGEKPIRFTILEEDKSLAAYFLCAMKEE---R---LFEI 505 (608)
Q Consensus 433 ~~~~~~~gt~~y~aPE~~~~~-~~t~ksDV~S~Gvvl~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~---~---~~~~ 505 (608)
......+++.|+|||.+.+. .++.++||||||++++||+||..|+....... ..+.. ........ . +.+.
T Consensus 155 -~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~-~~~~~-~~~~~~~~~~~~~~~~~~~ 231 (284)
T cd07839 155 -CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVD-DQLKR-IFRLLGTPTEESWPGVSKL 231 (284)
T ss_pred -CcCCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHH-HHHHH-HHHHhCCCChHHhHHhhhc
Confidence 12234578899999998765 47899999999999999999998864322111 11110 00000000 0 0000
Q ss_pred hhhhhh---------ccCChhHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 044312 506 LDARVM---------KQGGKDEIITVAKLAKRCLNLNGKKRPTMREVASE 546 (608)
Q Consensus 506 ~d~~~~---------~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~evl~~ 546 (608)
.+.... .+.....+.++.+|+.+||+.||.+|||++|++++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~h 281 (284)
T cd07839 232 PDYKPYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQH 281 (284)
T ss_pred ccccccCCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhcC
Confidence 000000 01112345678999999999999999999999763
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-32 Score=281.86 Aligned_cols=230 Identities=28% Similarity=0.385 Sum_probs=184.7
Q ss_pred cCccccceeccCce---------------EEEEEeec---ChhhHHHHHHHHHHHhhcCCCCccceecccccCccceEEE
Q 044312 289 DNFDLNRILGQGGQ---------------AVKKSKVI---DESKVEEFINEVVILSQINHRNVVKLLGCCLETEVPLLVY 350 (608)
Q Consensus 289 ~~f~~~~~lG~G~~---------------avk~~~~~---~~~~~~~~~~Ei~il~~l~H~niv~l~~~~~~~~~~~lV~ 350 (608)
++|.+.+.||+|++ |+|..... .....+.+.+|++++++++||||+++++++.+....++||
T Consensus 1 ~~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 80 (290)
T cd05580 1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYLVM 80 (290)
T ss_pred CceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCCeEEEEE
Confidence 35777888888874 55555431 2344677899999999999999999999999999999999
Q ss_pred eecCCCccchhccccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEEcCCCcEEEeeccCccccccC
Q 044312 351 EFIPNGTLFQYIHDQNEDFPITWEIRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVD 430 (608)
Q Consensus 351 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGls~~~~~~ 430 (608)
||+++++|.+++.... .+++..+..++.|++.||.|||+.+ ++|+||+|+|||+++++.+||+|||+++.....
T Consensus 81 e~~~~~~L~~~~~~~~---~l~~~~~~~~~~qil~~l~~lH~~~---i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~ 154 (290)
T cd05580 81 EYVPGGELFSHLRKSG---RFPEPVARFYAAQVVLALEYLHSLD---IVYRDLKPENLLLDSDGYIKITDFGFAKRVKGR 154 (290)
T ss_pred ecCCCCCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEECCCCCEEEeeCCCccccCCC
Confidence 9999999999987653 5899999999999999999999998 999999999999999999999999999876543
Q ss_pred CcceeeeeeccCCCCChhhhccCCCCCccchHhHHHHHHHHHhCCCCCCccchhhcccHHHHHHHHhhhhhhHHHhhhhh
Q 044312 431 QTHMTTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLTELLTGEKPIRFTILEEDKSLAAYFLCAMKEERLFEILDARV 510 (608)
Q Consensus 431 ~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~ 510 (608)
.....+++.|+|||.+.+...+.++||||||+++++|++|+.||...... . .. ..+...
T Consensus 155 ----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~------~-~~--------~~~~~~-- 213 (290)
T cd05580 155 ----TYTLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDDNPI------Q-IY--------EKILEG-- 213 (290)
T ss_pred ----CCCCCCCccccChhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHH------H-HH--------HHHhcC--
Confidence 23345889999999998888999999999999999999999998632211 0 00 011111
Q ss_pred hccCChhHHHHHHHHHHHHhccCCCCCC-----CHHHHHH
Q 044312 511 MKQGGKDEIITVAKLAKRCLNLNGKKRP-----TMREVAS 545 (608)
Q Consensus 511 ~~~~~~~~~~~l~~Li~~cl~~dp~~RP-----s~~evl~ 545 (608)
....+...+..+.+++.+||..+|.+|| +++|+++
T Consensus 214 ~~~~~~~~~~~l~~li~~~l~~~p~~R~~~~~~~~~~l~~ 253 (290)
T cd05580 214 KVRFPSFFSPDAKDLIRNLLQVDLTKRLGNLKNGVNDIKN 253 (290)
T ss_pred CccCCccCCHHHHHHHHHHccCCHHHccCcccCCHHHHHc
Confidence 0112233456889999999999999999 6666654
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-33 Score=303.78 Aligned_cols=253 Identities=20% Similarity=0.287 Sum_probs=180.2
Q ss_pred HHHHHHhcCccccceeccCce---------------EEEEEeecChhhHHHHHHHHHHHhhcCC------CCccceeccc
Q 044312 282 KELEKATDNFDLNRILGQGGQ---------------AVKKSKVIDESKVEEFINEVVILSQINH------RNVVKLLGCC 340 (608)
Q Consensus 282 ~~l~~~t~~f~~~~~lG~G~~---------------avk~~~~~~~~~~~~~~~Ei~il~~l~H------~niv~l~~~~ 340 (608)
+++...+++|++.++||+|+| |||+++... ....++..|+.+++.++| .+++++++++
T Consensus 122 ~~~~~~~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~-~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~ 200 (467)
T PTZ00284 122 EDIDVSTQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVP-KYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYF 200 (467)
T ss_pred CccccCCCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecch-hhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEE
Confidence 344556788999999999985 666664322 234456778888777755 4588888888
Q ss_pred ccC-ccceEEEeecCCCccchhccccCCCCCCCHHHHHHHHHHHHHHHHHHhh-cCCCCeeccCCCCCcEEEcCCC----
Q 044312 341 LET-EVPLLVYEFIPNGTLFQYIHDQNEDFPITWEIRLRIAIEVSGALSYLHS-AASIPIYHRDIKSTNILLDDKY---- 414 (608)
Q Consensus 341 ~~~-~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~-~~~~~iiHrDlk~~NILl~~~~---- 414 (608)
... ...++|||++ +++|.+++.+.. .+++..+..|+.||+.||+|||+ .+ |+||||||+|||++.++
T Consensus 201 ~~~~~~~~iv~~~~-g~~l~~~l~~~~---~l~~~~~~~i~~qi~~aL~yLH~~~g---IiHrDlKP~NILl~~~~~~~~ 273 (467)
T PTZ00284 201 QNETGHMCIVMPKY-GPCLLDWIMKHG---PFSHRHLAQIIFQTGVALDYFHTELH---LMHTDLKPENILMETSDTVVD 273 (467)
T ss_pred EcCCceEEEEEecc-CCCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHhcCC---eecCCCCHHHEEEecCCcccc
Confidence 654 4688999988 778988887543 58999999999999999999998 47 99999999999998665
Q ss_pred ------------cEEEeeccCccccccCCcceeeeeeccCCCCChhhhccCCCCCccchHhHHHHHHHHHhCCCCCCccc
Q 044312 415 ------------RAKVSDFGASRSMAVDQTHMTTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLTELLTGEKPIRFTI 482 (608)
Q Consensus 415 ------------~~kl~DFGls~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~elltg~~p~~~~~ 482 (608)
.+||+|||++.... .......||+.|+|||++.+..++.++|||||||++|||++|+.||....
T Consensus 274 ~~~~~~~~~~~~~vkl~DfG~~~~~~----~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~ 349 (467)
T PTZ00284 274 PVTNRALPPDPCRVRICDLGGCCDER----HSRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGKLLYDTHD 349 (467)
T ss_pred cccccccCCCCceEEECCCCccccCc----cccccccCCccccCcHHhhcCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence 49999999876432 22344678999999999999999999999999999999999999997433
Q ss_pred hhhcccHHHHHHHHhh--------hhhhHHHhh----------hhhh----cc---CChhHHHHHHHHHHHHhccCCCCC
Q 044312 483 LEEDKSLAAYFLCAMK--------EERLFEILD----------ARVM----KQ---GGKDEIITVAKLAKRCLNLNGKKR 537 (608)
Q Consensus 483 ~~~~~~l~~~~~~~~~--------~~~~~~~~d----------~~~~----~~---~~~~~~~~l~~Li~~cl~~dp~~R 537 (608)
..+............. .....++.+ +... .. ........+.+|+.+||+.||++|
T Consensus 350 ~~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R 429 (467)
T PTZ00284 350 NLEHLHLMEKTLGRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLIYGLLHYDRQKR 429 (467)
T ss_pred hHHHHHHHHHHcCCCCHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhcccchhhhhchHHHHHHHHHhCCcChhhC
Confidence 2211111100000000 000000000 0000 00 000123467899999999999999
Q ss_pred CCHHHHHHH
Q 044312 538 PTMREVASE 546 (608)
Q Consensus 538 Ps~~evl~~ 546 (608)
||++|++++
T Consensus 430 ~ta~e~L~H 438 (467)
T PTZ00284 430 LNARQMTTH 438 (467)
T ss_pred CCHHHHhcC
Confidence 999999865
|
|
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-32 Score=278.69 Aligned_cols=232 Identities=25% Similarity=0.405 Sum_probs=184.4
Q ss_pred ccccceeccCce---------------EEEEEeecC-hhhHHHHHHHHHHHhhcCCCCccceecccccCccceEEEeecC
Q 044312 291 FDLNRILGQGGQ---------------AVKKSKVID-ESKVEEFINEVVILSQINHRNVVKLLGCCLETEVPLLVYEFIP 354 (608)
Q Consensus 291 f~~~~~lG~G~~---------------avk~~~~~~-~~~~~~~~~Ei~il~~l~H~niv~l~~~~~~~~~~~lV~E~~~ 354 (608)
|++.+.||.|++ |+|...... ....+.+.+|+.++++++||||+++++++.+....++||||++
T Consensus 6 ~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 85 (277)
T cd06641 6 FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYLG 85 (277)
T ss_pred hhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeEEEEEEeCC
Confidence 555677787764 555544322 3345678999999999999999999999999999999999999
Q ss_pred CCccchhccccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEEcCCCcEEEeeccCccccccCCcce
Q 044312 355 NGTLFQYIHDQNEDFPITWEIRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHM 434 (608)
Q Consensus 355 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGls~~~~~~~~~~ 434 (608)
+++|.+++... .+++..+..++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||++........ .
T Consensus 86 ~~~l~~~i~~~----~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~~~~-~ 157 (277)
T cd06641 86 GGSALDLLEPG----PLDETQIATILREILKGLDYLHSEK---KIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQI-K 157 (277)
T ss_pred CCcHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHccCC---eecCCCCHHhEEECCCCCEEEeecccceecccchh-h
Confidence 99999988643 4899999999999999999999998 99999999999999999999999999876543221 1
Q ss_pred eeeeeccCCCCChhhhccCCCCCccchHhHHHHHHHHHhCCCCCCccchhhcccHHHHHHHHhhhhhhHHHhhhhhhccC
Q 044312 435 TTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLTELLTGEKPIRFTILEEDKSLAAYFLCAMKEERLFEILDARVMKQG 514 (608)
Q Consensus 435 ~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~ 514 (608)
.....++..|+|||.+.+..++.++||||||+++++|++|..||....... ....+........
T Consensus 158 ~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~----------------~~~~~~~~~~~~~ 221 (277)
T cd06641 158 RNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSELHPMK----------------VLFLIPKNNPPTL 221 (277)
T ss_pred hccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCccchHH----------------HHHHHhcCCCCCC
Confidence 233457889999999998889999999999999999999999985321100 0000111111122
Q ss_pred ChhHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 044312 515 GKDEIITVAKLAKRCLNLNGKKRPTMREVASE 546 (608)
Q Consensus 515 ~~~~~~~l~~Li~~cl~~dp~~RPs~~evl~~ 546 (608)
....+..+.+++.+||+.+|++||++.+++++
T Consensus 222 ~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~ 253 (277)
T cd06641 222 EGNYSKPLKEFVEACLNKEPSFRPTAKELLKH 253 (277)
T ss_pred CcccCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence 23456679999999999999999999999986
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-32 Score=271.30 Aligned_cols=235 Identities=29% Similarity=0.434 Sum_probs=186.4
Q ss_pred ccccceeccCc---------------eEEEEEeecChhhHHHHHHHHHHHhhcCCCCccceecccccCccceEEEeecCC
Q 044312 291 FDLNRILGQGG---------------QAVKKSKVIDESKVEEFINEVVILSQINHRNVVKLLGCCLETEVPLLVYEFIPN 355 (608)
Q Consensus 291 f~~~~~lG~G~---------------~avk~~~~~~~~~~~~~~~Ei~il~~l~H~niv~l~~~~~~~~~~~lV~E~~~~ 355 (608)
|+..+.||+|+ +++|+.........+.+.+|++++++++|+||+++++++......++++||+++
T Consensus 2 y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~ 81 (253)
T cd05122 2 FEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIVMEFCSG 81 (253)
T ss_pred ceeeeeeccCCceEEEEEEECCCCcEEEEEEecccchhHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEecCCC
Confidence 55566677665 356666554445678899999999999999999999999999999999999999
Q ss_pred CccchhccccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEEcCCCcEEEeeccCccccccCCccee
Q 044312 356 GTLFQYIHDQNEDFPITWEIRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMT 435 (608)
Q Consensus 356 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGls~~~~~~~~~~~ 435 (608)
++|.+++.... ..+++..+..++.|++.||.|||+.+ ++|+||+|+||++++++.+||+|||.+........ .
T Consensus 82 ~~L~~~~~~~~--~~~~~~~~~~i~~~i~~~l~~lh~~~---i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~--~ 154 (253)
T cd05122 82 GSLKDLLKSTN--QTLTESQIAYVCKELLKGLEYLHSNG---IIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKA--R 154 (253)
T ss_pred CcHHHHHhhcC--CCCCHHHHHHHHHHHHHHHHHhhcCC---EecCCCCHHHEEEccCCeEEEeecccccccccccc--c
Confidence 99999987653 25899999999999999999999988 99999999999999999999999999987654332 3
Q ss_pred eeeeccCCCCChhhhccCCCCCccchHhHHHHHHHHHhCCCCCCccchhhcccHHHHHHHHhhhhhhHHHhhhhhhccCC
Q 044312 436 TQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLTELLTGEKPIRFTILEEDKSLAAYFLCAMKEERLFEILDARVMKQGG 515 (608)
Q Consensus 436 ~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~ 515 (608)
....++..|+|||++.....+.++||||||+++++|++|+.||....... ... ........ .....
T Consensus 155 ~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~------~~~-~~~~~~~~-------~~~~~ 220 (253)
T cd05122 155 NTMVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSELPPMK------ALF-KIATNGPP-------GLRNP 220 (253)
T ss_pred cceecCCcccCHHHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCchHH------HHH-HHHhcCCC-------CcCcc
Confidence 44568899999999998889999999999999999999999986321110 000 00000000 00111
Q ss_pred hhHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 044312 516 KDEIITVAKLAKRCLNLNGKKRPTMREVASE 546 (608)
Q Consensus 516 ~~~~~~l~~Li~~cl~~dp~~RPs~~evl~~ 546 (608)
...+..+.+++.+||+.||++|||+.|++++
T Consensus 221 ~~~~~~~~~~i~~~l~~~p~~R~t~~~~l~~ 251 (253)
T cd05122 221 EKWSDEFKDFLKKCLQKNPEKRPTAEQLLKH 251 (253)
T ss_pred cccCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 1225679999999999999999999999853
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-32 Score=277.49 Aligned_cols=215 Identities=26% Similarity=0.424 Sum_probs=170.0
Q ss_pred HHHHHHHHHHHhhcCCCCccceecccccCccceEEEeecCCCccchhccccCCCCCCCHHHHHHHHHHHHHHHHHHhhcC
Q 044312 315 VEEFINEVVILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEIRLRIAIEVSGALSYLHSAA 394 (608)
Q Consensus 315 ~~~~~~Ei~il~~l~H~niv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~ 394 (608)
.+.+.+|+.++++++|+||+++++++...+..++||||+++++|.+++.... .+++..+..++.||+.||.|||+.+
T Consensus 52 ~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~---~l~~~~~~~~~~qi~~~l~~lH~~~ 128 (272)
T cd06629 52 VKALRSEIETLKDLDHLNIVQYLGFETTEEYLSIFLEYVPGGSIGSCLRTYG---RFEEQLVRFFTEQVLEGLAYLHSKG 128 (272)
T ss_pred HHHHHHHHHHHHhcCCCCcceEEEEeccCCceEEEEecCCCCcHHHHHhhcc---CCCHHHHHHHHHHHHHHHHHHhhCC
Confidence 3568899999999999999999999999999999999999999999997653 5899999999999999999999998
Q ss_pred CCCeeccCCCCCcEEEcCCCcEEEeeccCccccccCCcc-eeeeeeccCCCCChhhhccCC--CCCccchHhHHHHHHHH
Q 044312 395 SIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTH-MTTQVHGTFGYLDPEYFRSSQ--FTDKSDVYSFGVVLTEL 471 (608)
Q Consensus 395 ~~~iiHrDlk~~NILl~~~~~~kl~DFGls~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~--~t~ksDV~S~Gvvl~el 471 (608)
++||||+|+||++++++.+||+|||+++........ ......++..|+|||.+.... ++.++||||||++++|+
T Consensus 129 ---i~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l 205 (272)
T cd06629 129 ---ILHRDLKADNLLVDADGICKISDFGISKKSDDIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEM 205 (272)
T ss_pred ---eeecCCChhhEEEcCCCeEEEeeccccccccccccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHH
Confidence 999999999999999999999999999765422111 123456888999999987654 88999999999999999
Q ss_pred HhCCCCCCccchhhcccHHHHHHHHhhhhhhHHHhhhhhhccCChhHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 044312 472 LTGEKPIRFTILEEDKSLAAYFLCAMKEERLFEILDARVMKQGGKDEIITVAKLAKRCLNLNGKKRPTMREVASE 546 (608)
Q Consensus 472 ltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~evl~~ 546 (608)
++|..||..... ....+. . ..... ............+..+.+++.+||+.+|++||++.+|+++
T Consensus 206 ~~g~~p~~~~~~-----~~~~~~-~-~~~~~----~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 269 (272)
T cd06629 206 FAGRRPWSDEEA-----IAAMFK-L-GNKRS----APPIPPDVSMNLSPVALDFLNACFTINPDNRPTARELLQH 269 (272)
T ss_pred HhCCCCCcCcch-----HHHHHH-h-hcccc----CCcCCccccccCCHHHHHHHHHHhcCChhhCCCHHHHhhC
Confidence 999999852211 111110 0 00000 0001111222346789999999999999999999999864
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-32 Score=280.03 Aligned_cols=249 Identities=23% Similarity=0.321 Sum_probs=180.6
Q ss_pred CccccceeccCce---------------EEEEEeecC--hhhHHHHHHHHHHHhhcCCCCccceecccccCccceEEEee
Q 044312 290 NFDLNRILGQGGQ---------------AVKKSKVID--ESKVEEFINEVVILSQINHRNVVKLLGCCLETEVPLLVYEF 352 (608)
Q Consensus 290 ~f~~~~~lG~G~~---------------avk~~~~~~--~~~~~~~~~Ei~il~~l~H~niv~l~~~~~~~~~~~lV~E~ 352 (608)
+|+..+.||.|++ |||+.+... ....+.+.+|++++++++||||+++++++.+.+..++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (284)
T cd07860 1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEF 80 (284)
T ss_pred CceeeeeecCCCceEEEEEEECCCCCEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhcccCCcEEEEeec
Confidence 3666777777763 566554322 22346789999999999999999999999999999999999
Q ss_pred cCCCccchhccccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEEcCCCcEEEeeccCccccccCCc
Q 044312 353 IPNGTLFQYIHDQNEDFPITWEIRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQT 432 (608)
Q Consensus 353 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGls~~~~~~~~ 432 (608)
+. ++|.+++..... ..+++..+..++.|++.||+|||+.+ ++|+||+|+||++++++.+||+|||+++.......
T Consensus 81 ~~-~~l~~~~~~~~~-~~l~~~~~~~~~~~i~~~l~~lh~~~---i~H~~l~p~nill~~~~~~~l~dfg~~~~~~~~~~ 155 (284)
T cd07860 81 LH-QDLKKFMDASPL-SGIPLPLIKSYLFQLLQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR 155 (284)
T ss_pred cc-cCHHHHHHhCCC-CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEEeeccchhhcccCcc
Confidence 95 688888865432 25899999999999999999999998 99999999999999999999999999876543221
Q ss_pred ceeeeeeccCCCCChhhhccCC-CCCccchHhHHHHHHHHHhCCCCCCccchhhcccHHHHHHHHhh-hhhh----HHHh
Q 044312 433 HMTTQVHGTFGYLDPEYFRSSQ-FTDKSDVYSFGVVLTELLTGEKPIRFTILEEDKSLAAYFLCAMK-EERL----FEIL 506 (608)
Q Consensus 433 ~~~~~~~gt~~y~aPE~~~~~~-~t~ksDV~S~Gvvl~elltg~~p~~~~~~~~~~~l~~~~~~~~~-~~~~----~~~~ 506 (608)
......++..|+|||++.+.. ++.++||||||++++||+||+.||...... ..+...+...-. .... ..+.
T Consensus 156 -~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (284)
T cd07860 156 -TYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEI--DQLFRIFRTLGTPDEVVWPGVTSLP 232 (284)
T ss_pred -ccccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHH--HHHHHHHHHhCCCChhhhhhhhHHH
Confidence 122334678999999887654 688999999999999999999998643211 111111100000 0000 0000
Q ss_pred h-----hhh----hccCChhHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 044312 507 D-----ARV----MKQGGKDEIITVAKLAKRCLNLNGKKRPTMREVASE 546 (608)
Q Consensus 507 d-----~~~----~~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~evl~~ 546 (608)
. +.. ........+.++.+++.+||+.||++|||++|++++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~ 281 (284)
T cd07860 233 DYKPSFPKWARQDFSKVVPPLDEDGRDLLSQMLHYDPNKRISAKAALAH 281 (284)
T ss_pred HHHhhcccccccCHHHHcccCCHHHHHHHHHhcCCCcccCCCHHHHhcC
Confidence 0 000 000011234568899999999999999999999853
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-32 Score=277.45 Aligned_cols=248 Identities=25% Similarity=0.299 Sum_probs=185.5
Q ss_pred cCccccceeccCce---------------EEEEEeecCh-hhHHHHHHHHHHHhhcCCCCccceecccccC--ccceEEE
Q 044312 289 DNFDLNRILGQGGQ---------------AVKKSKVIDE-SKVEEFINEVVILSQINHRNVVKLLGCCLET--EVPLLVY 350 (608)
Q Consensus 289 ~~f~~~~~lG~G~~---------------avk~~~~~~~-~~~~~~~~Ei~il~~l~H~niv~l~~~~~~~--~~~~lV~ 350 (608)
++|+..+.||.|++ |+|....... .....+.+|++++++++||||+++++++.+. ...++||
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~ 80 (287)
T cd06621 1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGIAM 80 (287)
T ss_pred CceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCchHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEEEE
Confidence 35777888888863 5665553322 3457799999999999999999999988643 3679999
Q ss_pred eecCCCccchhccccC-CCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEEcCCCcEEEeeccCcccccc
Q 044312 351 EFIPNGTLFQYIHDQN-EDFPITWEIRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAV 429 (608)
Q Consensus 351 E~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGls~~~~~ 429 (608)
||+++++|.+++.... ....+++..+..++.|++.||+|||+.+ ++|+||+|+||++++++.+||+|||++.....
T Consensus 81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~---i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~ 157 (287)
T cd06621 81 EYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSRK---IIHRDIKPSNILLTRKGQVKLCDFGVSGELVN 157 (287)
T ss_pred EecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEecCCeEEEeeccccccccc
Confidence 9999999998876421 2235899999999999999999999999 99999999999999999999999999876542
Q ss_pred CCcceeeeeeccCCCCChhhhccCCCCCccchHhHHHHHHHHHhCCCCCCccchhhcccHHHHHHHHhhhhhhHHHhhhh
Q 044312 430 DQTHMTTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLTELLTGEKPIRFTILEEDKSLAAYFLCAMKEERLFEILDAR 509 (608)
Q Consensus 430 ~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 509 (608)
.. .....++..|+|||.+.+..++.++||||||++++||++|+.||........ ...... ..........+.+.
T Consensus 158 ~~---~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~-~~~~~~-~~~~~~~~~~~~~~- 231 (287)
T cd06621 158 SL---AGTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPL-GPIELL-SYIVNMPNPELKDE- 231 (287)
T ss_pred cc---cccccCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccCCCC-ChHHHH-HHHhcCCchhhccC-
Confidence 22 1234578899999999999999999999999999999999999874422101 111111 11111000000000
Q ss_pred hhccCChhHHHHHHHHHHHHhccCCCCCCCHHHHHHHH
Q 044312 510 VMKQGGKDEIITVAKLAKRCLNLNGKKRPTMREVASEL 547 (608)
Q Consensus 510 ~~~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~evl~~L 547 (608)
.......+..+.+++.+||+.+|++|||+.||+++-
T Consensus 232 --~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~eil~~~ 267 (287)
T cd06621 232 --PGNGIKWSEEFKDFIKQCLEKDPTRRPTPWDMLEHP 267 (287)
T ss_pred --CCCCCchHHHHHHHHHHHcCCCcccCCCHHHHHhCc
Confidence 001123456799999999999999999999999754
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-32 Score=281.22 Aligned_cols=240 Identities=19% Similarity=0.276 Sum_probs=179.9
Q ss_pred eEEEEEeec--ChhhHHHHHHHHHHHhhcCCCCccceecccccCccceEEEeecCCCccchhccccCCCCCCCHHHHHHH
Q 044312 302 QAVKKSKVI--DESKVEEFINEVVILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEIRLRI 379 (608)
Q Consensus 302 ~avk~~~~~--~~~~~~~~~~Ei~il~~l~H~niv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i 379 (608)
+|||+.+.. .....+.+.+|+.++++++|+||+++++++.+.+..+++|||+++++|.+++...... .+++..+..+
T Consensus 28 ~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~~l~~~~~~-~~~~~~~~~~ 106 (314)
T cd08216 28 VAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAYGSCEDLLKTHFPE-GLPELAIAFI 106 (314)
T ss_pred EEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEeccCCCCHHHHHHHhccc-CCCHHHHHHH
Confidence 588887653 4556788999999999999999999999999999999999999999999999864322 4889999999
Q ss_pred HHHHHHHHHHHhhcCCCCeeccCCCCCcEEEcCCCcEEEeeccCccccccCCc------ceeeeeeccCCCCChhhhcc-
Q 044312 380 AIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQT------HMTTQVHGTFGYLDPEYFRS- 452 (608)
Q Consensus 380 ~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGls~~~~~~~~------~~~~~~~gt~~y~aPE~~~~- 452 (608)
+.|++.||+|||+++ |+||||||+|||++.++.+||+|||.+........ .......++..|+|||++..
T Consensus 107 ~~~l~~~L~~LH~~~---ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~ 183 (314)
T cd08216 107 LKDVLNALDYIHSKG---FIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVHDFPKSSVKNLPWLSPEVLQQN 183 (314)
T ss_pred HHHHHHHHHHHHHCC---eecCCCCcceEEEecCCceEEecCccceeeccccccccccccccccccccccccCHHHhcCC
Confidence 999999999999999 99999999999999999999999998875532211 11123456778999999876
Q ss_pred -CCCCCccchHhHHHHHHHHHhCCCCCCccchhhcccHHHHHHHHh----hhhh-------hHH----Hhh----hhhhc
Q 044312 453 -SQFTDKSDVYSFGVVLTELLTGEKPIRFTILEEDKSLAAYFLCAM----KEER-------LFE----ILD----ARVMK 512 (608)
Q Consensus 453 -~~~t~ksDV~S~Gvvl~elltg~~p~~~~~~~~~~~l~~~~~~~~----~~~~-------~~~----~~d----~~~~~ 512 (608)
..++.++||||||++++||++|+.||....... .+........ .... ... ..+ .....
T Consensus 184 ~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 261 (314)
T cd08216 184 LQGYNEKSDIYSVGITACELANGHVPFKDMPATQ--MLLEKVRGTVPCLLDKSTYPLYEDSMSQSRSSNEHPNNRDSVDH 261 (314)
T ss_pred CCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHH--HHHHHHhccCccccccCchhhhcCCcCcccccccccchhhhhhc
Confidence 358899999999999999999999997432111 1110000000 0000 000 000 00011
Q ss_pred cCChhHHHHHHHHHHHHhccCCCCCCCHHHHHHHH
Q 044312 513 QGGKDEIITVAKLAKRCLNLNGKKRPTMREVASEL 547 (608)
Q Consensus 513 ~~~~~~~~~l~~Li~~cl~~dp~~RPs~~evl~~L 547 (608)
........++.+|+.+||+.||++|||++|++++-
T Consensus 262 ~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~p 296 (314)
T cd08216 262 PYTRTFSEHFHQFVELCLQRDPESRPSASQLLNHS 296 (314)
T ss_pred chhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhcCc
Confidence 11233456789999999999999999999999753
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-32 Score=279.28 Aligned_cols=223 Identities=26% Similarity=0.389 Sum_probs=178.9
Q ss_pred eEEEEEeecChhhHHHHHHHHHHHhhcCCCCccceecccccCccceEEEeecCCCccchhccccCCCCCCCHHHHHHHHH
Q 044312 302 QAVKKSKVIDESKVEEFINEVVILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEIRLRIAI 381 (608)
Q Consensus 302 ~avk~~~~~~~~~~~~~~~Ei~il~~l~H~niv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~ 381 (608)
+++|+.........+.+.+|+.+++.++|+||+++++++...+..++|+||+++++|.+++... .+++..+..++.
T Consensus 47 ~~iK~~~~~~~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~----~~~~~~~~~~~~ 122 (285)
T cd06648 47 VAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVMEFLEGGALTDIVTHT----RMNEEQIATVCL 122 (285)
T ss_pred EEEEEEeccchhHHHHHHHHHHHHHHcCCCChheEEEEEEcCCeEEEEEeccCCCCHHHHHHhC----CCCHHHHHHHHH
Confidence 3677766555566678999999999999999999999999999999999999999999998762 489999999999
Q ss_pred HHHHHHHHHhhcCCCCeeccCCCCCcEEEcCCCcEEEeeccCccccccCCcceeeeeeccCCCCChhhhccCCCCCccch
Q 044312 382 EVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHGTFGYLDPEYFRSSQFTDKSDV 461 (608)
Q Consensus 382 ~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGls~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV 461 (608)
|++.||+|||+.+ ++||||+|+||+++.++.+||+|||++........ ......|++.|+|||.+.+..++.++||
T Consensus 123 ql~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Dv 198 (285)
T cd06648 123 AVLKALSFLHAQG---VIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVP-RRKSLVGTPYWMAPEVISRLPYGTEVDI 198 (285)
T ss_pred HHHHHHHHHHhCC---eecCCCChhhEEEcCCCcEEEcccccchhhccCCc-ccccccCCccccCHHHhcCCCCCCcccH
Confidence 9999999999999 99999999999999999999999998876543322 2233458899999999998889999999
Q ss_pred HhHHHHHHHHHhCCCCCCccchhhcccHHHHHHHHhhhhhhHHHhhhhhhccCChhHHHHHHHHHHHHhccCCCCCCCHH
Q 044312 462 YSFGVVLTELLTGEKPIRFTILEEDKSLAAYFLCAMKEERLFEILDARVMKQGGKDEIITVAKLAKRCLNLNGKKRPTMR 541 (608)
Q Consensus 462 ~S~Gvvl~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~ 541 (608)
||||++++||++|+.||...... ... ...... ..+. .......+..+.+++.+||+.+|++||++.
T Consensus 199 ~slGv~l~ell~g~~p~~~~~~~------~~~-~~~~~~-----~~~~--~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~ 264 (285)
T cd06648 199 WSLGIMVIEMVDGEPPYFNEPPL------QAM-KRIRDN-----LPPK--LKNLHKVSPRLRSFLDRMLVRDPAQRATAA 264 (285)
T ss_pred HHHHHHHHHHHhCCCCCcCCCHH------HHH-HHHHhc-----CCCC--CcccccCCHHHHHHHHHHcccChhhCcCHH
Confidence 99999999999999998632111 000 011100 0000 011122456899999999999999999999
Q ss_pred HHHHH
Q 044312 542 EVASE 546 (608)
Q Consensus 542 evl~~ 546 (608)
+++++
T Consensus 265 ~il~~ 269 (285)
T cd06648 265 ELLNH 269 (285)
T ss_pred HHccC
Confidence 99853
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-33 Score=292.10 Aligned_cols=221 Identities=25% Similarity=0.261 Sum_probs=169.2
Q ss_pred eEEEEEeec---ChhhHHHHHHHHHHHhhc---CCCCccceecccccCccceEEEeecCCCccchhccccCCCCCCCHHH
Q 044312 302 QAVKKSKVI---DESKVEEFINEVVILSQI---NHRNVVKLLGCCLETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEI 375 (608)
Q Consensus 302 ~avk~~~~~---~~~~~~~~~~Ei~il~~l---~H~niv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~ 375 (608)
+|||..... .......+..|..++..+ +||||+++++.+.+....++||||+++|+|.+++.... .+++..
T Consensus 21 ~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~---~~~~~~ 97 (330)
T cd05586 21 YAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMSGGELFWHLQKEG---RFSEDR 97 (330)
T ss_pred EEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCCCCChHHHHHHhcC---CCCHHH
Confidence 577776432 223344566777777665 69999999999999999999999999999999887543 489999
Q ss_pred HHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEEcCCCcEEEeeccCccccccCCcceeeeeeccCCCCChhhhccC-C
Q 044312 376 RLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHGTFGYLDPEYFRSS-Q 454 (608)
Q Consensus 376 ~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGls~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~ 454 (608)
+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++....... ......||+.|+|||++.+. .
T Consensus 98 ~~~~~~qil~al~~LH~~~---ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~ 173 (330)
T cd05586 98 AKFYIAELVLALEHLHKYD---IVYRDLKPENILLDATGHIALCDFGLSKANLTDNK-TTNTFCGTTEYLAPEVLLDEKG 173 (330)
T ss_pred HHHHHHHHHHHHHHHHHCC---eEeccCCHHHeEECCCCCEEEecCCcCcCCCCCCC-CccCccCCccccCHHHHcCCCC
Confidence 9999999999999999999 99999999999999999999999999876432221 22345689999999998765 4
Q ss_pred CCCccchHhHHHHHHHHHhCCCCCCccchhhcccHHHHHHHHhhhhhhHHHhhhhhhccCChhHHHHHHHHHHHHhccCC
Q 044312 455 FTDKSDVYSFGVVLTELLTGEKPIRFTILEEDKSLAAYFLCAMKEERLFEILDARVMKQGGKDEIITVAKLAKRCLNLNG 534 (608)
Q Consensus 455 ~t~ksDV~S~Gvvl~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~Li~~cl~~dp 534 (608)
++.++|||||||+++||++|+.||...... ..+ ..+.... .. ......+.++.+++.+||+.||
T Consensus 174 ~~~~~DvwslGvil~elltG~~Pf~~~~~~------~~~-~~i~~~~--------~~-~~~~~~~~~~~~li~~~L~~~P 237 (330)
T cd05586 174 YTKHVDFWSLGVLVFEMCCGWSPFYAEDTQ------QMY-RNIAFGK--------VR-FPKNVLSDEGRQFVKGLLNRNP 237 (330)
T ss_pred CCCccceeccccEEEEeccCCCCCCCCCHH------HHH-HHHHcCC--------CC-CCCccCCHHHHHHHHHHcCCCH
Confidence 899999999999999999999998632211 111 1111000 00 0111245678899999999999
Q ss_pred CCCCC----HHHHHH
Q 044312 535 KKRPT----MREVAS 545 (608)
Q Consensus 535 ~~RPs----~~evl~ 545 (608)
++||+ +.|+++
T Consensus 238 ~~R~~~~~~~~~ll~ 252 (330)
T cd05586 238 QHRLGAHRDAVELKE 252 (330)
T ss_pred HHCCCCCCCHHHHhc
Confidence 99985 555554
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-32 Score=273.31 Aligned_cols=223 Identities=26% Similarity=0.373 Sum_probs=179.3
Q ss_pred eEEEEEeec--ChhhHHHHHHHHHHHhhcCCCCccceecccccCccceEEEeecCCCccchhccccC-CCCCCCHHHHHH
Q 044312 302 QAVKKSKVI--DESKVEEFINEVVILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGTLFQYIHDQN-EDFPITWEIRLR 378 (608)
Q Consensus 302 ~avk~~~~~--~~~~~~~~~~Ei~il~~l~H~niv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~-~~~~l~~~~~~~ 378 (608)
+++|..... .......+.+|++++++++|+||+++++++.+....++||||+++++|.+++.... ....+++..+..
T Consensus 28 ~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~ 107 (256)
T cd08530 28 YALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFLDGNKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWR 107 (256)
T ss_pred EEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhhccCCEEEEEehhcCCCCHHHHHHHHHhhcCCCCHHHHHH
Confidence 366665432 33456678899999999999999999999999999999999999999999987622 123589999999
Q ss_pred HHHHHHHHHHHHhhcCCCCeeccCCCCCcEEEcCCCcEEEeeccCccccccCCcceeeeeeccCCCCChhhhccCCCCCc
Q 044312 379 IAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHGTFGYLDPEYFRSSQFTDK 458 (608)
Q Consensus 379 i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGls~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k 458 (608)
++.+++.||+|||+.+ ++|+||+|+||++++++.+||+|||+++..... ......++..|++||.+.+..++.+
T Consensus 108 ~~~~l~~al~~lh~~~---i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~~~---~~~~~~~~~~~~~Pe~~~~~~~~~~ 181 (256)
T cd08530 108 IFIQLLRGLQALHEQK---ILHRDLKSANILLVANDLVKIGDLGISKVLKKN---MAKTQIGTPHYMAPEVWKGRPYSYK 181 (256)
T ss_pred HHHHHHHHHHHHhhCC---cccCCCCcceEEEecCCcEEEeeccchhhhccC---CcccccCCccccCHHHHCCCCCCch
Confidence 9999999999999999 999999999999999999999999999876543 2223457889999999999999999
Q ss_pred cchHhHHHHHHHHHhCCCCCCccchhhcccHHHHHHHHhhhhhhHHHhhhhhhccCChhHHHHHHHHHHHHhccCCCCCC
Q 044312 459 SDVYSFGVVLTELLTGEKPIRFTILEEDKSLAAYFLCAMKEERLFEILDARVMKQGGKDEIITVAKLAKRCLNLNGKKRP 538 (608)
Q Consensus 459 sDV~S~Gvvl~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RP 538 (608)
+|+||||++++||++|+.||....... +..... .......+...+.++.+++.+||+.+|++||
T Consensus 182 ~D~~slG~~~~~l~~g~~p~~~~~~~~-------~~~~~~---------~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp 245 (256)
T cd08530 182 SDIWSLGCLLYEMATFAPPFEARSMQD-------LRYKVQ---------RGKYPPIPPIYSQDLQNFIRSMLQVKPKLRP 245 (256)
T ss_pred hhHHHHHHHHHHHHhCCCCCCCCCHHH-------HHHHHh---------cCCCCCCchhhCHHHHHHHHHHcCCCcccCC
Confidence 999999999999999999986332111 000111 1111122234567899999999999999999
Q ss_pred CHHHHHHH
Q 044312 539 TMREVASE 546 (608)
Q Consensus 539 s~~evl~~ 546 (608)
++.|++++
T Consensus 246 ~~~~~l~~ 253 (256)
T cd08530 246 NCDKILAS 253 (256)
T ss_pred CHHHHhcC
Confidence 99999864
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-32 Score=282.99 Aligned_cols=236 Identities=25% Similarity=0.391 Sum_probs=188.3
Q ss_pred cCccccceeccCce---------------EEEEEeecChhhHHHHHHHHHHHhhcCCCCccceecccccCccceEEEeec
Q 044312 289 DNFDLNRILGQGGQ---------------AVKKSKVIDESKVEEFINEVVILSQINHRNVVKLLGCCLETEVPLLVYEFI 353 (608)
Q Consensus 289 ~~f~~~~~lG~G~~---------------avk~~~~~~~~~~~~~~~Ei~il~~l~H~niv~l~~~~~~~~~~~lV~E~~ 353 (608)
++|.+.+.||+|++ ++|..........+.+.+|+.++++++||||+++++.+...+..++|+||+
T Consensus 19 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~ 98 (293)
T cd06647 19 KKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDSYLVGDELWVVMEYL 98 (293)
T ss_pred hhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEeccccchHHHHHHHHHHHHhhcCCCCeeehhheeeeCCcEEEEEecC
Confidence 56788888888864 556655444555678999999999999999999999999999999999999
Q ss_pred CCCccchhccccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEEcCCCcEEEeeccCccccccCCcc
Q 044312 354 PNGTLFQYIHDQNEDFPITWEIRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTH 433 (608)
Q Consensus 354 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGls~~~~~~~~~ 433 (608)
++++|.+++.+. .+++..+..++.|++.||.|||+.+ ++|+||||+||+++.++.+||+|||++........
T Consensus 99 ~~~~L~~~~~~~----~l~~~~~~~i~~~l~~al~~LH~~g---i~H~dL~p~Nili~~~~~~kL~dfg~~~~~~~~~~- 170 (293)
T cd06647 99 AGGSLTDVVTET----CMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS- 170 (293)
T ss_pred CCCcHHHHHhhc----CCCHHHHHHHHHHHHHHHHHHHhCC---EeeccCCHHHEEEcCCCCEEEccCcceeccccccc-
Confidence 999999998653 3789999999999999999999999 99999999999999999999999999876543322
Q ss_pred eeeeeeccCCCCChhhhccCCCCCccchHhHHHHHHHHHhCCCCCCccchhhcccHHHHHHHHhhhhhhHHHhhhhhhcc
Q 044312 434 MTTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLTELLTGEKPIRFTILEEDKSLAAYFLCAMKEERLFEILDARVMKQ 513 (608)
Q Consensus 434 ~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~ 513 (608)
......+++.|+|||.+....++.++||||||++++|+++|+.||......... ..... .......
T Consensus 171 ~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~~------~~~~~--------~~~~~~~ 236 (293)
T cd06647 171 KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRAL------YLIAT--------NGTPELQ 236 (293)
T ss_pred ccccccCChhhcCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhhe------eehhc--------CCCCCCC
Confidence 223345888999999998888999999999999999999999999643221100 00000 0000111
Q ss_pred CChhHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 044312 514 GGKDEIITVAKLAKRCLNLNGKKRPTMREVASE 546 (608)
Q Consensus 514 ~~~~~~~~l~~Li~~cl~~dp~~RPs~~evl~~ 546 (608)
.+...+..+.+++.+||..+|++||++.+++.+
T Consensus 237 ~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~h 269 (293)
T cd06647 237 NPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQH 269 (293)
T ss_pred CccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 122345678999999999999999999999875
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-33 Score=273.29 Aligned_cols=235 Identities=24% Similarity=0.377 Sum_probs=193.9
Q ss_pred cCccccceeccCce---------------EEEEEeecChhhHHHHHHHHHHHhhcCCCCccceecccccCccceEEEeec
Q 044312 289 DNFDLNRILGQGGQ---------------AVKKSKVIDESKVEEFINEVVILSQINHRNVVKLLGCCLETEVPLLVYEFI 353 (608)
Q Consensus 289 ~~f~~~~~lG~G~~---------------avk~~~~~~~~~~~~~~~Ei~il~~l~H~niv~l~~~~~~~~~~~lV~E~~ 353 (608)
+-|++..+||+|.+ |+|+.. -+.+.+++++|+.||++.+.|+||+++|.+.....+++|||||
T Consensus 33 EVFDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VP--V~sDLQEIIKEISIMQQC~S~yVVKYYGSYFK~sDLWIVMEYC 110 (502)
T KOG0574|consen 33 EVFDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVP--VDTDLQEIIKEISIMQQCKSKYVVKYYGSYFKHSDLWIVMEYC 110 (502)
T ss_pred HHHHHHHHhcCCcchHHHHHHHhccCcEEEEEecC--ccchHHHHHHHHHHHHHcCCchhhhhhhhhccCCceEeehhhc
Confidence 34788889999974 555444 4778899999999999999999999999999999999999999
Q ss_pred CCCccchhccccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEEcCCCcEEEeeccCccccccCCcc
Q 044312 354 PNGTLFQYIHDQNEDFPITWEIRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTH 433 (608)
Q Consensus 354 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGls~~~~~~~~~ 433 (608)
-.|+..+.++..+. +|++..+..++...++||+|||... =+|||||+.||||+.+|.+||+|||.+-.+... -.
T Consensus 111 GAGSiSDI~R~R~K--~L~E~EIs~iL~~TLKGL~YLH~~~---KIHRDIKAGNILLNT~G~AKLADFGVAGQLTDT-MA 184 (502)
T KOG0574|consen 111 GAGSISDIMRARRK--PLSEQEISAVLRDTLKGLQYLHDLK---KIHRDIKAGNILLNTDGIAKLADFGVAGQLTDT-MA 184 (502)
T ss_pred CCCcHHHHHHHhcC--CccHHHHHHHHHHHHhHHHHHHHHH---HHHhhcccccEEEcccchhhhhhccccchhhhh-HH
Confidence 99999999987543 7999999999999999999999988 789999999999999999999999999766432 22
Q ss_pred eeeeeeccCCCCChhhhccCCCCCccchHhHHHHHHHHHhCCCCCCccchhhcccHHHHHHHHhhhhhhHHHh-hhhhhc
Q 044312 434 MTTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLTELLTGEKPIRFTILEEDKSLAAYFLCAMKEERLFEIL-DARVMK 512 (608)
Q Consensus 434 ~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~-d~~~~~ 512 (608)
....+.||+.|||||++..-.|+.++||||||+...||.-|++||....+- ..++-+- .+....
T Consensus 185 KRNTVIGTPFWMAPEVI~EIGY~~~ADIWSLGITaIEMAEG~PPYsDIHPM---------------RAIFMIPT~PPPTF 249 (502)
T KOG0574|consen 185 KRNTVIGTPFWMAPEVIEEIGYDTKADIWSLGITAIEMAEGRPPYSDIHPM---------------RAIFMIPTKPPPTF 249 (502)
T ss_pred hhCccccCcccccHHHHHHhccchhhhHhhhcchhhhhhcCCCCccccccc---------------ceeEeccCCCCCCC
Confidence 345577999999999999999999999999999999999999998622110 0011000 011111
Q ss_pred cCChhHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 044312 513 QGGKDEIITVAKLAKRCLNLNGKKRPTMREVASE 546 (608)
Q Consensus 513 ~~~~~~~~~l~~Li~~cl~~dp~~RPs~~evl~~ 546 (608)
..+..-+.++-+++++||..+|++|-|+.+++++
T Consensus 250 ~KPE~WS~~F~DFi~~CLiK~PE~R~TA~~L~~H 283 (502)
T KOG0574|consen 250 KKPEEWSSEFNDFIRSCLIKKPEERKTALRLCEH 283 (502)
T ss_pred CChHhhhhHHHHHHHHHhcCCHHHHHHHHHHhhh
Confidence 2334557789999999999999999999988875
|
|
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-32 Score=275.71 Aligned_cols=233 Identities=27% Similarity=0.350 Sum_probs=187.2
Q ss_pred CccccceeccCce---------------EEEEEeec---ChhhHHHHHHHHHHHhhcCCCCccceecccccCccceEEEe
Q 044312 290 NFDLNRILGQGGQ---------------AVKKSKVI---DESKVEEFINEVVILSQINHRNVVKLLGCCLETEVPLLVYE 351 (608)
Q Consensus 290 ~f~~~~~lG~G~~---------------avk~~~~~---~~~~~~~~~~Ei~il~~l~H~niv~l~~~~~~~~~~~lV~E 351 (608)
+|++.+.||+|++ |+|..... .....+.+.+|++++++++||||+++++++.+....++|+|
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 80 (258)
T cd05578 1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEENMYLVVD 80 (258)
T ss_pred CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCeEEEEEe
Confidence 4677788888864 56655432 22456789999999999999999999999999999999999
Q ss_pred ecCCCccchhccccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEEcCCCcEEEeeccCccccccCC
Q 044312 352 FIPNGTLFQYIHDQNEDFPITWEIRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQ 431 (608)
Q Consensus 352 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGls~~~~~~~ 431 (608)
|+++++|.+++.... ++++..+..++.|+++||.|||+.+ ++|+||+|+||++++++.++|+|||++.......
T Consensus 81 ~~~~~~L~~~l~~~~---~l~~~~~~~~~~~i~~~l~~lh~~~---i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~ 154 (258)
T cd05578 81 LLLGGDLRYHLSQKV---KFSEEQVKFWICEIVLALEYLHSKG---IIHRDIKPDNILLDEQGHVHITDFNIATKVTPDT 154 (258)
T ss_pred CCCCCCHHHHHHhcC---CcCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeEEcCCCCEEEeecccccccCCCc
Confidence 999999999987652 5899999999999999999999998 9999999999999999999999999988765332
Q ss_pred cceeeeeeccCCCCChhhhccCCCCCccchHhHHHHHHHHHhCCCCCCccchhhcccHHHHHHHHhhhhhhHHHhhhhhh
Q 044312 432 THMTTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLTELLTGEKPIRFTILEEDKSLAAYFLCAMKEERLFEILDARVM 511 (608)
Q Consensus 432 ~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~ 511 (608)
......++..|+|||.+....++.++||||||+++++|++|+.||....... ...+...... ..
T Consensus 155 --~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~----~~~~~~~~~~----------~~ 218 (258)
T cd05578 155 --LTTSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRTI----RDQIRAKQET----------AD 218 (258)
T ss_pred --cccccCCChhhcCHHHHcccCCCCcccchhhHHHHHHHHhCCCCCCCCCccH----HHHHHHHhcc----------cc
Confidence 2234568889999999998889999999999999999999999987433211 1111111110 11
Q ss_pred ccCChhHHHHHHHHHHHHhccCCCCCCCH--HHHH
Q 044312 512 KQGGKDEIITVAKLAKRCLNLNGKKRPTM--REVA 544 (608)
Q Consensus 512 ~~~~~~~~~~l~~Li~~cl~~dp~~RPs~--~evl 544 (608)
...+...+..+.+++.+||+.||.+||++ +|++
T Consensus 219 ~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~l~ 253 (258)
T cd05578 219 VLYPATWSTEAIDAINKLLERDPQKRLGDNLKDLK 253 (258)
T ss_pred ccCcccCcHHHHHHHHHHccCChhHcCCccHHHHh
Confidence 22333455789999999999999999999 6654
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-33 Score=286.73 Aligned_cols=238 Identities=24% Similarity=0.383 Sum_probs=189.1
Q ss_pred hcCccccceeccCce--------------EEEEEe--ecChhhHHHHHHHHHHHhhc-CCCCccceecccccCccceEEE
Q 044312 288 TDNFDLNRILGQGGQ--------------AVKKSK--VIDESKVEEFINEVVILSQI-NHRNVVKLLGCCLETEVPLLVY 350 (608)
Q Consensus 288 t~~f~~~~~lG~G~~--------------avk~~~--~~~~~~~~~~~~Ei~il~~l-~H~niv~l~~~~~~~~~~~lV~ 350 (608)
...|++.++||+||- |+|+.. ..+......|.+|+..|.+| .|.+||+|+++-..++.+||||
T Consensus 360 g~~Yeilk~iG~GGSSkV~kV~~s~~~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~~lYmvm 439 (677)
T KOG0596|consen 360 GREYEILKQIGSGGSSKVFKVLNSDKQIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTDGYLYMVM 439 (677)
T ss_pred cchhhHHHhhcCCCcceeeeeecCCCcchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccCceEEEEe
Confidence 445788999999982 444433 24566778899999999999 5999999999999999999999
Q ss_pred eecCCCccchhccccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEEcCCCcEEEeeccCccccccC
Q 044312 351 EFIPNGTLFQYIHDQNEDFPITWEIRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVD 430 (608)
Q Consensus 351 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGls~~~~~~ 430 (608)
|+= ..+|..+|.+.... ...| .+..+..|++.|+.++|+++ |||.||||.|+|+-. |.+||+|||+|..+..+
T Consensus 440 E~G-d~DL~kiL~k~~~~-~~~~-~lk~ywkqML~aV~~IH~~g---IVHSDLKPANFLlVk-G~LKLIDFGIA~aI~~D 512 (677)
T KOG0596|consen 440 ECG-DIDLNKILKKKKSI-DPDW-FLKFYWKQMLLAVKTIHQHG---IVHSDLKPANFLLVK-GRLKLIDFGIANAIQPD 512 (677)
T ss_pred ecc-cccHHHHHHhccCC-CchH-HHHHHHHHHHHHHHHHHHhc---eeecCCCcccEEEEe-eeEEeeeechhcccCcc
Confidence 987 55999999876542 2334 67788899999999999999 999999999999975 58999999999988876
Q ss_pred Ccce-eeeeeccCCCCChhhhccC-----------CCCCccchHhHHHHHHHHHhCCCCCCccchhhcccHHHHHHHHhh
Q 044312 431 QTHM-TTQVHGTFGYLDPEYFRSS-----------QFTDKSDVYSFGVVLTELLTGEKPIRFTILEEDKSLAAYFLCAMK 498 (608)
Q Consensus 431 ~~~~-~~~~~gt~~y~aPE~~~~~-----------~~t~ksDV~S~Gvvl~elltg~~p~~~~~~~~~~~l~~~~~~~~~ 498 (608)
.+.. .....||+.||+||.+... +.+++|||||+|||||+|+.|+.||.... + .
T Consensus 513 TTsI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~~-----n---------~ 578 (677)
T KOG0596|consen 513 TTSIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQII-----N---------Q 578 (677)
T ss_pred ccceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHHH-----H---------H
Confidence 5543 3456799999999998533 25679999999999999999999986211 0 1
Q ss_pred hhhhHHHhhhhhhccCChh-HHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 044312 499 EERLFEILDARVMKQGGKD-EIITVAKLAKRCLNLNGKKRPTMREVASE 546 (608)
Q Consensus 499 ~~~~~~~~d~~~~~~~~~~-~~~~l~~Li~~cl~~dp~~RPs~~evl~~ 546 (608)
-.++..+.++....+++.- ...++.++++.||..||++||+..||+++
T Consensus 579 ~aKl~aI~~P~~~Iefp~~~~~~~li~~mK~CL~rdPkkR~si~eLLqh 627 (677)
T KOG0596|consen 579 IAKLHAITDPNHEIEFPDIPENDELIDVMKCCLARDPKKRWSIPELLQH 627 (677)
T ss_pred HHHHHhhcCCCccccccCCCCchHHHHHHHHHHhcCcccCCCcHHHhcC
Confidence 2345566666554444422 12239999999999999999999999875
|
|
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=99.98 E-value=4e-32 Score=281.38 Aligned_cols=234 Identities=27% Similarity=0.381 Sum_probs=181.3
Q ss_pred cCccccceeccCce---------------EEEEEeec---ChhhHHHHHHHHHHHhhcCCCCccceecccccCccceEEE
Q 044312 289 DNFDLNRILGQGGQ---------------AVKKSKVI---DESKVEEFINEVVILSQINHRNVVKLLGCCLETEVPLLVY 350 (608)
Q Consensus 289 ~~f~~~~~lG~G~~---------------avk~~~~~---~~~~~~~~~~Ei~il~~l~H~niv~l~~~~~~~~~~~lV~ 350 (608)
..|+..+.||+|++ |+|..... .....+++.+|+.+++.++||||+++++++.+.+..++||
T Consensus 15 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~lv~ 94 (307)
T cd06607 15 KLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTAWLVM 94 (307)
T ss_pred hhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCCeEEEEH
Confidence 34777788888863 56655432 2234567899999999999999999999999999999999
Q ss_pred eecCCCccchhccccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEEcCCCcEEEeeccCccccccC
Q 044312 351 EFIPNGTLFQYIHDQNEDFPITWEIRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVD 430 (608)
Q Consensus 351 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGls~~~~~~ 430 (608)
||++ |+|.+++..... ++++..+..++.|++.||.|||+.+ ++|+||+|+||++++++.+||+|||++......
T Consensus 95 e~~~-g~l~~~~~~~~~--~l~~~~~~~~~~ql~~~L~~LH~~~---i~H~dl~p~nIl~~~~~~~kL~dfg~~~~~~~~ 168 (307)
T cd06607 95 EYCL-GSASDILEVHKK--PLQEVEIAAICHGALQGLAYLHSHE---RIHRDIKAGNILLTEPGTVKLADFGSASLVSPA 168 (307)
T ss_pred HhhC-CCHHHHHHHccc--CCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCcccEEECCCCCEEEeecCcceecCCC
Confidence 9996 577777654332 5899999999999999999999998 999999999999999999999999998765432
Q ss_pred CcceeeeeeccCCCCChhhhc---cCCCCCccchHhHHHHHHHHHhCCCCCCccchhhcccHHHHHHHHhhhhhhHHHhh
Q 044312 431 QTHMTTQVHGTFGYLDPEYFR---SSQFTDKSDVYSFGVVLTELLTGEKPIRFTILEEDKSLAAYFLCAMKEERLFEILD 507 (608)
Q Consensus 431 ~~~~~~~~~gt~~y~aPE~~~---~~~~t~ksDV~S~Gvvl~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 507 (608)
....++..|+|||++. ...++.++||||||+++|||+||+.||....... . . ..+..
T Consensus 169 -----~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~~~-----~-~---------~~~~~ 228 (307)
T cd06607 169 -----NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMS-----A-L---------YHIAQ 228 (307)
T ss_pred -----CCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccHHH-----H-H---------HHHhc
Confidence 2235788999999874 4568899999999999999999999986322111 0 0 00000
Q ss_pred hhhhccCChhHHHHHHHHHHHHhccCCCCCCCHHHHHHHHH
Q 044312 508 ARVMKQGGKDEIITVAKLAKRCLNLNGKKRPTMREVASELA 548 (608)
Q Consensus 508 ~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~evl~~L~ 548 (608)
...........+..+.+++.+||+.+|++||++.+|+.+..
T Consensus 229 ~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~ 269 (307)
T cd06607 229 NDSPTLSSNDWSDYFRNFVDSCLQKIPQDRPSSEELLKHRF 269 (307)
T ss_pred CCCCCCCchhhCHHHHHHHHHHhcCChhhCcCHHHHhcChh
Confidence 00001112234567999999999999999999999987643
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=3.2e-32 Score=277.25 Aligned_cols=234 Identities=24% Similarity=0.393 Sum_probs=182.8
Q ss_pred CccccceeccCce---------------EEEEEeec-ChhhHHHHHHHHHHHhhcC---CCCccceecccccCccceEEE
Q 044312 290 NFDLNRILGQGGQ---------------AVKKSKVI-DESKVEEFINEVVILSQIN---HRNVVKLLGCCLETEVPLLVY 350 (608)
Q Consensus 290 ~f~~~~~lG~G~~---------------avk~~~~~-~~~~~~~~~~Ei~il~~l~---H~niv~l~~~~~~~~~~~lV~ 350 (608)
.|++.+.||+|++ |+|..... .....+++.+|+.++++++ |||++++++++.+....++||
T Consensus 2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~lv~ 81 (277)
T cd06917 2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWIIM 81 (277)
T ss_pred hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCCCchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEEEEEE
Confidence 3566677777763 56655432 3445678999999999996 999999999999999999999
Q ss_pred eecCCCccchhccccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEEcCCCcEEEeeccCccccccC
Q 044312 351 EFIPNGTLFQYIHDQNEDFPITWEIRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVD 430 (608)
Q Consensus 351 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGls~~~~~~ 430 (608)
||+++++|.+++... .+++..++.++.|++.||.|||+.+ ++|+||+|+||++++++.++|+|||++......
T Consensus 82 e~~~~~~L~~~~~~~----~l~~~~~~~i~~~i~~~l~~lh~~~---i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~ 154 (277)
T cd06917 82 EYAEGGSVRTLMKAG----PIAEKYISVIIREVLVALKYIHKVG---VIHRDIKAANILVTNTGNVKLCDFGVAALLNQN 154 (277)
T ss_pred ecCCCCcHHHHHHcc----CCCHHHHHHHHHHHHHHHHHHHhCC---cccCCcCHHHEEEcCCCCEEEccCCceeecCCC
Confidence 999999999988653 5899999999999999999999999 999999999999999999999999999876543
Q ss_pred CcceeeeeeccCCCCChhhhccC-CCCCccchHhHHHHHHHHHhCCCCCCccchhhcccHHHHHHHHhhhhhhHHHhhhh
Q 044312 431 QTHMTTQVHGTFGYLDPEYFRSS-QFTDKSDVYSFGVVLTELLTGEKPIRFTILEEDKSLAAYFLCAMKEERLFEILDAR 509 (608)
Q Consensus 431 ~~~~~~~~~gt~~y~aPE~~~~~-~~t~ksDV~S~Gvvl~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 509 (608)
.. ......|+..|+|||.+... .++.++||||||+++++|++|+.||....... ... ...... .+.
T Consensus 155 ~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~------~~~-~~~~~~-----~~~ 221 (277)
T cd06917 155 SS-KRSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFR------AMM-LIPKSK-----PPR 221 (277)
T ss_pred cc-ccccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCChhh------hhh-ccccCC-----CCC
Confidence 32 22334688899999998754 46899999999999999999999986322111 000 000000 000
Q ss_pred hhccCChhHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 044312 510 VMKQGGKDEIITVAKLAKRCLNLNGKKRPTMREVASE 546 (608)
Q Consensus 510 ~~~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~evl~~ 546 (608)
+ .....+.++.+++.+||+.||++||++.|++++
T Consensus 222 ~---~~~~~~~~~~~~i~~~l~~~p~~R~~~~~il~~ 255 (277)
T cd06917 222 L---EDNGYSKLLREFVAACLDEEPKERLSAEELLKS 255 (277)
T ss_pred C---CcccCCHHHHHHHHHHcCCCcccCcCHHHHhhC
Confidence 0 111245679999999999999999999999864
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=4e-32 Score=278.12 Aligned_cols=240 Identities=25% Similarity=0.385 Sum_probs=188.4
Q ss_pred HhcCccccceeccCce---------------EEEEEeecChhhHHHHHHHHHHHhhcCCCCccceecccccCccceEEEe
Q 044312 287 ATDNFDLNRILGQGGQ---------------AVKKSKVIDESKVEEFINEVVILSQINHRNVVKLLGCCLETEVPLLVYE 351 (608)
Q Consensus 287 ~t~~f~~~~~lG~G~~---------------avk~~~~~~~~~~~~~~~Ei~il~~l~H~niv~l~~~~~~~~~~~lV~E 351 (608)
.+++|+..+.||+|++ ++|....... ..+.+.+|++++++++|+||+++++.+......++|+|
T Consensus 17 ~~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 95 (286)
T cd06614 17 PRELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ-NKELIINEILIMKDCKHPNIVDYYDSYLVGDELWVVME 95 (286)
T ss_pred ccccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCch-hHHHHHHHHHHHHHCCCCCeeEEEEEEEECCEEEEEEe
Confidence 4456667777777763 5565554333 56789999999999999999999999999999999999
Q ss_pred ecCCCccchhccccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEEcCCCcEEEeeccCccccccCC
Q 044312 352 FIPNGTLFQYIHDQNEDFPITWEIRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQ 431 (608)
Q Consensus 352 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGls~~~~~~~ 431 (608)
|+++++|.+++.... ..+++..+..++.|++.||+|||+.+ ++|+||+|+||+++.++.+||+|||++.......
T Consensus 96 ~~~~~~L~~~l~~~~--~~l~~~~~~~i~~~i~~~L~~lH~~g---i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~ 170 (286)
T cd06614 96 YMDGGSLTDIITQNF--VRMNEPQIAYVCREVLQGLEYLHSQN---VIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEK 170 (286)
T ss_pred ccCCCcHHHHHHHhc--cCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCChhhEEEcCCCCEEECccchhhhhccch
Confidence 999999999998754 25899999999999999999999988 9999999999999999999999999987654322
Q ss_pred cceeeeeeccCCCCChhhhccCCCCCccchHhHHHHHHHHHhCCCCCCccchhhcccHHHHHHHHhhhhhhHHHhhhhhh
Q 044312 432 THMTTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLTELLTGEKPIRFTILEEDKSLAAYFLCAMKEERLFEILDARVM 511 (608)
Q Consensus 432 ~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~ 511 (608)
. ......++..|++||++.+..++.++||||||+++++|++|+.||....... ....... ... ..
T Consensus 171 ~-~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~~g~~p~~~~~~~~------~~~~~~~-~~~-------~~ 235 (286)
T cd06614 171 S-KRNSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPPLR------ALFLITT-KGI-------PP 235 (286)
T ss_pred h-hhccccCCcccCCHhHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCHHH------HHHHHHh-cCC-------CC
Confidence 1 2233457889999999998889999999999999999999999986322111 0000000 000 00
Q ss_pred ccCChhHHHHHHHHHHHHhccCCCCCCCHHHHHHHH
Q 044312 512 KQGGKDEIITVAKLAKRCLNLNGKKRPTMREVASEL 547 (608)
Q Consensus 512 ~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~evl~~L 547 (608)
.......+..+.+++.+||+.+|.+||++.+++++.
T Consensus 236 ~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~ 271 (286)
T cd06614 236 LKNPEKWSPEFKDFLNKCLVKDPEKRPSAEELLQHP 271 (286)
T ss_pred CcchhhCCHHHHHHHHHHhccChhhCcCHHHHhhCh
Confidence 111122456799999999999999999999998643
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.8e-32 Score=279.90 Aligned_cols=248 Identities=22% Similarity=0.330 Sum_probs=180.8
Q ss_pred cCccccceeccCce---------------EEEEEeecC-hhhHHHHHHHHHHHhhcCCCCccceecccccCccceEEEee
Q 044312 289 DNFDLNRILGQGGQ---------------AVKKSKVID-ESKVEEFINEVVILSQINHRNVVKLLGCCLETEVPLLVYEF 352 (608)
Q Consensus 289 ~~f~~~~~lG~G~~---------------avk~~~~~~-~~~~~~~~~Ei~il~~l~H~niv~l~~~~~~~~~~~lV~E~ 352 (608)
++|++.+.||+|++ |+|...... ......+.+|+.++++++|+||+++++++.+.+..++||||
T Consensus 5 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 84 (291)
T cd07844 5 ETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTLHDIIHTKKTLTLVFEY 84 (291)
T ss_pred cceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccccCCchhHHHHHHHHhhCCCcceeeEEEEEecCCeEEEEEec
Confidence 46778888888863 666655422 22235678899999999999999999999999999999999
Q ss_pred cCCCccchhccccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEEcCCCcEEEeeccCccccccCCc
Q 044312 353 IPNGTLFQYIHDQNEDFPITWEIRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQT 432 (608)
Q Consensus 353 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGls~~~~~~~~ 432 (608)
+++ +|.+++..... .+++..+..++.|+++||.|||+.+ ++||||||+|||+++++.+||+|||+++.......
T Consensus 85 ~~~-~L~~~~~~~~~--~~~~~~~~~~~~ql~~al~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~ 158 (291)
T cd07844 85 LDT-DLKQYMDDCGG--GLSMHNVRLFLFQLLRGLAYCHQRR---VLHRDLKPQNLLISERGELKLADFGLARAKSVPSK 158 (291)
T ss_pred CCC-CHHHHHHhCCC--CCCHHHHHHHHHHHHHHHHHHHhCC---eecccCCHHHEEEcCCCCEEECccccccccCCCCc
Confidence 975 89988876443 5899999999999999999999999 99999999999999999999999999875432211
Q ss_pred ceeeeeeccCCCCChhhhcc-CCCCCccchHhHHHHHHHHHhCCCCCCccchhhcccHHHHHHHHhh---hhhhHHHhh-
Q 044312 433 HMTTQVHGTFGYLDPEYFRS-SQFTDKSDVYSFGVVLTELLTGEKPIRFTILEEDKSLAAYFLCAMK---EERLFEILD- 507 (608)
Q Consensus 433 ~~~~~~~gt~~y~aPE~~~~-~~~t~ksDV~S~Gvvl~elltg~~p~~~~~~~~~~~l~~~~~~~~~---~~~~~~~~d- 507 (608)
......++..|+|||++.+ ..++.++||||||++++||++|+.||....... .........+. ......+..
T Consensus 159 -~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~ 235 (291)
T cd07844 159 -TYSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVE--DQLHKIFRVLGTPTEETWPGVSSN 235 (291)
T ss_pred -cccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCccHH--HHHHHHHHhcCCCChhhhhhhhhc
Confidence 1122346788999999875 458999999999999999999999986332110 00110111100 000000000
Q ss_pred -------------hhhhcc-CChhHHHHHHHHHHHHhccCCCCCCCHHHHHH
Q 044312 508 -------------ARVMKQ-GGKDEIITVAKLAKRCLNLNGKKRPTMREVAS 545 (608)
Q Consensus 508 -------------~~~~~~-~~~~~~~~l~~Li~~cl~~dp~~RPs~~evl~ 545 (608)
..+... ........+.+++.+||+.+|++|||+.|+++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~Rps~~e~l~ 287 (291)
T cd07844 236 PEFKPYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMK 287 (291)
T ss_pred cccccccccccCChhHHHhCcCCCCchhHHHHHHHHhccCcccccCHHHHhc
Confidence 000000 00111257889999999999999999999875
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=99.98 E-value=4.9e-32 Score=276.76 Aligned_cols=248 Identities=22% Similarity=0.334 Sum_probs=183.5
Q ss_pred CccccceeccCc---------------eEEEEEeecC-hhhHHHHHHHHHHHhhcCCCCccceecccccCccceEEEeec
Q 044312 290 NFDLNRILGQGG---------------QAVKKSKVID-ESKVEEFINEVVILSQINHRNVVKLLGCCLETEVPLLVYEFI 353 (608)
Q Consensus 290 ~f~~~~~lG~G~---------------~avk~~~~~~-~~~~~~~~~Ei~il~~l~H~niv~l~~~~~~~~~~~lV~E~~ 353 (608)
+|++.+.||.|+ +|||..+... ....+.+.+|+.++++++|+||+++++++.+.+..++||||+
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (284)
T cd07836 1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDVIHTENKLMLVFEYM 80 (284)
T ss_pred CceEeeeeccCCceEEEEEEECCCCeEEEEEEecccccccchHHHHHHHHHHHhhcCCCEeeeeeeEeeCCcEEEEEecC
Confidence 466777888776 3666665432 234567889999999999999999999999999999999999
Q ss_pred CCCccchhccccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEEcCCCcEEEeeccCccccccCCcc
Q 044312 354 PNGTLFQYIHDQNEDFPITWEIRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTH 433 (608)
Q Consensus 354 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGls~~~~~~~~~ 433 (608)
++ +|.+++........+++..+..++.|++.||+|||+.+ ++||||||+||++++++.+||+|||+++.......
T Consensus 81 ~~-~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~~~~~- 155 (284)
T cd07836 81 DK-DLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHENR---VLHRDLKPQNLLINKRGELKLADFGLARAFGIPVN- 155 (284)
T ss_pred Cc-cHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEECCCCcEEEeecchhhhhcCCcc-
Confidence 75 88888876543446899999999999999999999999 99999999999999999999999999976543221
Q ss_pred eeeeeeccCCCCChhhhccC-CCCCccchHhHHHHHHHHHhCCCCCCccchhhcccHHHHHHHHhh---hhhhHHHhh--
Q 044312 434 MTTQVHGTFGYLDPEYFRSS-QFTDKSDVYSFGVVLTELLTGEKPIRFTILEEDKSLAAYFLCAMK---EERLFEILD-- 507 (608)
Q Consensus 434 ~~~~~~gt~~y~aPE~~~~~-~~t~ksDV~S~Gvvl~elltg~~p~~~~~~~~~~~l~~~~~~~~~---~~~~~~~~d-- 507 (608)
......++..|++||.+.+. .++.++||||||++++||++|+.||......+. ... ...... ......+.+
T Consensus 156 ~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~--~~~-~~~~~~~~~~~~~~~~~~~~ 232 (284)
T cd07836 156 TFSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQ--LLK-IFRIMGTPTESTWPGISQLP 232 (284)
T ss_pred ccccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHHH--HHH-HHHHhCCCChhhHHHHhcCc
Confidence 12234568899999998654 578999999999999999999999874332211 000 000000 000000000
Q ss_pred ---h-------hhhccCChhHHHHHHHHHHHHhccCCCCCCCHHHHHH
Q 044312 508 ---A-------RVMKQGGKDEIITVAKLAKRCLNLNGKKRPTMREVAS 545 (608)
Q Consensus 508 ---~-------~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~evl~ 545 (608)
. ..........+..+.+++.+||+.||++||++.|+++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~ 280 (284)
T cd07836 233 EYKPTFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQ 280 (284)
T ss_pred hhcccccCCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 0 0000011123567889999999999999999999975
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=4.3e-32 Score=278.64 Aligned_cols=250 Identities=20% Similarity=0.262 Sum_probs=180.7
Q ss_pred HhcCccccceeccCce---------------EEEEEeecC-hhhHHHHHHHHHHHhhcCCCCccceecccccCccceEEE
Q 044312 287 ATDNFDLNRILGQGGQ---------------AVKKSKVID-ESKVEEFINEVVILSQINHRNVVKLLGCCLETEVPLLVY 350 (608)
Q Consensus 287 ~t~~f~~~~~lG~G~~---------------avk~~~~~~-~~~~~~~~~Ei~il~~l~H~niv~l~~~~~~~~~~~lV~ 350 (608)
++++|.+.+.||+|++ ++|...... ......+.+|+.+++.++|+||+++++++...+..++||
T Consensus 3 ~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~ 82 (291)
T cd07870 3 AATSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDIIHTKETLTFVF 82 (291)
T ss_pred ccceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcCCCcHHHHHHHHHHHhcCCCCEeEEEEEEecCCeEEEEE
Confidence 4567888999999874 455554322 222346789999999999999999999999999999999
Q ss_pred eecCCCccchhccccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEEcCCCcEEEeeccCccccccC
Q 044312 351 EFIPNGTLFQYIHDQNEDFPITWEIRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVD 430 (608)
Q Consensus 351 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGls~~~~~~ 430 (608)
||+. ++|.+++..... .+++..+..++.|++.||.|||+.+ |+|+||||+|||++.++.+||+|||+++.....
T Consensus 83 e~~~-~~l~~~~~~~~~--~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~ 156 (291)
T cd07870 83 EYMH-TDLAQYMIQHPG--GLHPYNVRLFMFQLLRGLAYIHGQH---ILHRDLKPQNLLISYLGELKLADFGLARAKSIP 156 (291)
T ss_pred eccc-CCHHHHHHhCCC--CCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChHHEEEcCCCcEEEeccccccccCCC
Confidence 9995 677776654332 4788889999999999999999998 999999999999999999999999998764332
Q ss_pred CcceeeeeeccCCCCChhhhccC-CCCCccchHhHHHHHHHHHhCCCCCCccchhhcccHHHHHHHHhh--hhhhH----
Q 044312 431 QTHMTTQVHGTFGYLDPEYFRSS-QFTDKSDVYSFGVVLTELLTGEKPIRFTILEEDKSLAAYFLCAMK--EERLF---- 503 (608)
Q Consensus 431 ~~~~~~~~~gt~~y~aPE~~~~~-~~t~ksDV~S~Gvvl~elltg~~p~~~~~~~~~~~l~~~~~~~~~--~~~~~---- 503 (608)
.. ......+++.|+|||.+.+. .++.++||||||++++||++|+.||....... ..+.. ....+. .....
T Consensus 157 ~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~~-~~~~~-~~~~~~~~~~~~~~~~~ 233 (291)
T cd07870 157 SQ-TYSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVF-EQLEK-IWTVLGVPTEDTWPGVS 233 (291)
T ss_pred CC-CCCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchhHH-HHHHH-HHHHcCCCChhhhhhhh
Confidence 21 12233468899999998754 57899999999999999999999986432211 10000 000000 00000
Q ss_pred -------HHhh---h-hhhc-cCChhHHHHHHHHHHHHhccCCCCCCCHHHHHH
Q 044312 504 -------EILD---A-RVMK-QGGKDEIITVAKLAKRCLNLNGKKRPTMREVAS 545 (608)
Q Consensus 504 -------~~~d---~-~~~~-~~~~~~~~~l~~Li~~cl~~dp~~RPs~~evl~ 545 (608)
.... + .... ......+..+.+++.+|+..||++|||+.|++.
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~l~ 287 (291)
T cd07870 234 KLPNYKPEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALL 287 (291)
T ss_pred hcccccchhccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCHHHHhc
Confidence 0000 0 0000 000112457889999999999999999999875
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=3.4e-32 Score=277.82 Aligned_cols=247 Identities=23% Similarity=0.295 Sum_probs=183.0
Q ss_pred ccccceeccCc---------------eEEEEEeec--ChhhHHHHHHHHHHHhhcCCCCccceecccccC--ccceEEEe
Q 044312 291 FDLNRILGQGG---------------QAVKKSKVI--DESKVEEFINEVVILSQINHRNVVKLLGCCLET--EVPLLVYE 351 (608)
Q Consensus 291 f~~~~~lG~G~---------------~avk~~~~~--~~~~~~~~~~Ei~il~~l~H~niv~l~~~~~~~--~~~~lV~E 351 (608)
|++.+.||+|+ +|+|+.... .......+.+|+.++++++|+|++++++++... ...++|||
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e 80 (287)
T cd07840 1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVFE 80 (287)
T ss_pred CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEec
Confidence 44566677765 367776654 234456789999999999999999999999887 78999999
Q ss_pred ecCCCccchhccccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEEcCCCcEEEeeccCccccccCC
Q 044312 352 FIPNGTLFQYIHDQNEDFPITWEIRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQ 431 (608)
Q Consensus 352 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGls~~~~~~~ 431 (608)
|+++ +|.+++.... ..+++..++.++.||++||+|||+.+ ++|+||+|+|||+++++.+||+|||++.......
T Consensus 81 ~~~~-~l~~~~~~~~--~~~~~~~~~~i~~~i~~al~~LH~~~---~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~~~ 154 (287)
T cd07840 81 YMDH-DLTGLLDSPE--VKFTESQIKCYMKQLLEGLQYLHSNG---ILHRDIKGSNILINNDGVLKLADFGLARPYTKRN 154 (287)
T ss_pred cccc-cHHHHHhccC--CCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCcHHHeEEcCCCCEEEccccceeeccCCC
Confidence 9975 8888886543 25899999999999999999999998 9999999999999999999999999998765443
Q ss_pred cceeeeeeccCCCCChhhhcc-CCCCCccchHhHHHHHHHHHhCCCCCCccchhhcccHHHHHHHHhh---hhhhH----
Q 044312 432 THMTTQVHGTFGYLDPEYFRS-SQFTDKSDVYSFGVVLTELLTGEKPIRFTILEEDKSLAAYFLCAMK---EERLF---- 503 (608)
Q Consensus 432 ~~~~~~~~gt~~y~aPE~~~~-~~~t~ksDV~S~Gvvl~elltg~~p~~~~~~~~~~~l~~~~~~~~~---~~~~~---- 503 (608)
....+...++..|+|||.+.+ ..++.++||||||++++||++|+.||........ ......... .....
T Consensus 155 ~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~ 231 (287)
T cd07840 155 SADYTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQ---LEKIFELCGSPTDENWPGVSK 231 (287)
T ss_pred cccccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCChHHH---HHHHHHHhCCCchhhcccccc
Confidence 222334456888999998764 4679999999999999999999999864332211 000100000 00000
Q ss_pred ----------HHhhhhhhccCChhHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 044312 504 ----------EILDARVMKQGGKDEIITVAKLAKRCLNLNGKKRPTMREVASE 546 (608)
Q Consensus 504 ----------~~~d~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~evl~~ 546 (608)
..............++..+.+++.+||+.+|++||+++++++.
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~ 284 (287)
T cd07840 232 LPWFENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQH 284 (287)
T ss_pred chhhhhccccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhhC
Confidence 0000000011111135678999999999999999999999853
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=99.98 E-value=4.1e-32 Score=277.16 Aligned_cols=238 Identities=24% Similarity=0.396 Sum_probs=178.4
Q ss_pred cCccccceeccCce---------------EEEEEeecC-hhhHHHHHHHHHH-HhhcCCCCccceecccccCccceEEEe
Q 044312 289 DNFDLNRILGQGGQ---------------AVKKSKVID-ESKVEEFINEVVI-LSQINHRNVVKLLGCCLETEVPLLVYE 351 (608)
Q Consensus 289 ~~f~~~~~lG~G~~---------------avk~~~~~~-~~~~~~~~~Ei~i-l~~l~H~niv~l~~~~~~~~~~~lV~E 351 (608)
++|++.+.||+|++ |+|..+... ......+..|+.+ ++.++||||+++++++......++|||
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~lv~e 80 (283)
T cd06617 1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGALFREGDVWICME 80 (283)
T ss_pred CCceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcHHHHHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEEEEhh
Confidence 36777888888864 666655422 2233456667665 666799999999999999999999999
Q ss_pred ecCCCccchhcccc-CCCCCCCHHHHHHHHHHHHHHHHHHhhc-CCCCeeccCCCCCcEEEcCCCcEEEeeccCcccccc
Q 044312 352 FIPNGTLFQYIHDQ-NEDFPITWEIRLRIAIEVSGALSYLHSA-ASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAV 429 (608)
Q Consensus 352 ~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~ia~aL~yLH~~-~~~~iiHrDlk~~NILl~~~~~~kl~DFGls~~~~~ 429 (608)
|++ ++|.+++... .....+++..++.++.||+.||+|||++ + ++||||||+|||++.++.+||+|||+++....
T Consensus 81 ~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~---i~h~dlkp~nil~~~~~~~kl~dfg~~~~~~~ 156 (283)
T cd06617 81 VMD-TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKLS---VIHRDVKPSNVLINRNGQVKLCDFGISGYLVD 156 (283)
T ss_pred hhc-ccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhcCC---eecCCCCHHHEEECCCCCEEEeeccccccccc
Confidence 996 6888877642 2223689999999999999999999987 7 99999999999999999999999999986543
Q ss_pred CCcceeeeeeccCCCCChhhhcc----CCCCCccchHhHHHHHHHHHhCCCCCCccchhhcccHHHHHHHHhhhhhhHHH
Q 044312 430 DQTHMTTQVHGTFGYLDPEYFRS----SQFTDKSDVYSFGVVLTELLTGEKPIRFTILEEDKSLAAYFLCAMKEERLFEI 505 (608)
Q Consensus 430 ~~~~~~~~~~gt~~y~aPE~~~~----~~~t~ksDV~S~Gvvl~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 505 (608)
.. ..+...++..|+|||.+.. ..++.++|+||||++++||++|+.||...... .. .+...
T Consensus 157 ~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~----~~----------~~~~~ 220 (283)
T cd06617 157 SV--AKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTP----FQ----------QLKQV 220 (283)
T ss_pred cc--ccccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCccccC----HH----------HHHHH
Confidence 21 1233457889999998864 45688999999999999999999998532110 00 01111
Q ss_pred hhhhhhccCChhHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 044312 506 LDARVMKQGGKDEIITVAKLAKRCLNLNGKKRPTMREVASE 546 (608)
Q Consensus 506 ~d~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~evl~~ 546 (608)
+............+.++.+++.+||..+|++||++.+++++
T Consensus 221 ~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~ 261 (283)
T cd06617 221 VEEPSPQLPAEKFSPEFQDFVNKCLKKNYKERPNYPELLQH 261 (283)
T ss_pred HhcCCCCCCccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 11100011112345679999999999999999999999864
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=7.2e-32 Score=270.34 Aligned_cols=237 Identities=30% Similarity=0.423 Sum_probs=189.3
Q ss_pred CccccceeccCc---------------eEEEEEeecC--hhhHHHHHHHHHHHhhcCCCCccceecccccCccceEEEee
Q 044312 290 NFDLNRILGQGG---------------QAVKKSKVID--ESKVEEFINEVVILSQINHRNVVKLLGCCLETEVPLLVYEF 352 (608)
Q Consensus 290 ~f~~~~~lG~G~---------------~avk~~~~~~--~~~~~~~~~Ei~il~~l~H~niv~l~~~~~~~~~~~lV~E~ 352 (608)
+|++.+.||.|+ +++|+..... ....+.+.+|++++++++|+|++++++.+......++|+||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~lv~e~ 80 (258)
T cd08215 1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFEEKGKLCIVMEY 80 (258)
T ss_pred CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEEecCCEEEEEEEe
Confidence 466677788776 3666665432 35667899999999999999999999999999999999999
Q ss_pred cCCCccchhccccC-CCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEEcCCCcEEEeeccCccccccCC
Q 044312 353 IPNGTLFQYIHDQN-EDFPITWEIRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQ 431 (608)
Q Consensus 353 ~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGls~~~~~~~ 431 (608)
+++++|.+++.... ....+++..+..++.+++.||.|||+.+ ++|+||+|+||++++++.++|+|||++.......
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~---~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~ 157 (258)
T cd08215 81 ADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSRK---ILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTV 157 (258)
T ss_pred cCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhCC---EecccCChHHeEEcCCCcEEECCccceeecccCc
Confidence 99999999997642 1236999999999999999999999998 9999999999999999999999999998765432
Q ss_pred cceeeeeeccCCCCChhhhccCCCCCccchHhHHHHHHHHHhCCCCCCccchhhcccHHHHHHHHhhhhhhHHHhhhhhh
Q 044312 432 THMTTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLTELLTGEKPIRFTILEEDKSLAAYFLCAMKEERLFEILDARVM 511 (608)
Q Consensus 432 ~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~ 511 (608)
.......+++.|+|||.+....++.++||||||+++++|++|+.||..... ........ . ...
T Consensus 158 -~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~------~~~~~~~~-~---------~~~ 220 (258)
T cd08215 158 -DLAKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGENL------LELALKIL-K---------GQY 220 (258)
T ss_pred -ceecceeeeecccChhHhccCCCCccccHHHHHHHHHHHHcCCCCCCCCcH------HHHHHHHh-c---------CCC
Confidence 223334688899999999999999999999999999999999999863321 11111110 0 011
Q ss_pred ccCChhHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 044312 512 KQGGKDEIITVAKLAKRCLNLNGKKRPTMREVASE 546 (608)
Q Consensus 512 ~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~evl~~ 546 (608)
...+...+..+.+++.+||..+|++||++.|++++
T Consensus 221 ~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~ 255 (258)
T cd08215 221 PPIPSQYSSELRNLVSSLLQKDPEERPSIAQILQS 255 (258)
T ss_pred CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 12223455689999999999999999999999863
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=99.98 E-value=4.5e-32 Score=279.27 Aligned_cols=247 Identities=26% Similarity=0.307 Sum_probs=181.7
Q ss_pred CccccceeccCce---------------EEEEEeecChh-----hHHHHHHHHHHHhhcCCCCccceecccccCccceEE
Q 044312 290 NFDLNRILGQGGQ---------------AVKKSKVIDES-----KVEEFINEVVILSQINHRNVVKLLGCCLETEVPLLV 349 (608)
Q Consensus 290 ~f~~~~~lG~G~~---------------avk~~~~~~~~-----~~~~~~~Ei~il~~l~H~niv~l~~~~~~~~~~~lV 349 (608)
+|++.+.||+|++ |||+.+..... ....+.+|+.++++++|+||+++++++.+.+..++|
T Consensus 1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 80 (298)
T cd07841 1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKSNINLV 80 (298)
T ss_pred CceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecCCEEEEE
Confidence 3566677777763 66766543222 345678899999999999999999999999999999
Q ss_pred EeecCCCccchhccccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEEcCCCcEEEeeccCcccccc
Q 044312 350 YEFIPNGTLFQYIHDQNEDFPITWEIRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAV 429 (608)
Q Consensus 350 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGls~~~~~ 429 (608)
|||+ +++|.+++.... ..+++..++.++.||++||+|||+++ ++|+||||+|||++.++.+||+|||+++....
T Consensus 81 ~e~~-~~~L~~~i~~~~--~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~ 154 (298)
T cd07841 81 FEFM-ETDLEKVIKDKS--IVLTPADIKSYMLMTLRGLEYLHSNW---ILHRDLKPNNLLIASDGVLKLADFGLARSFGS 154 (298)
T ss_pred Eccc-CCCHHHHHhccC--CCCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCChhhEEEcCCCCEEEccceeeeeccC
Confidence 9999 899999997644 25899999999999999999999999 99999999999999999999999999987654
Q ss_pred CCcceeeeeeccCCCCChhhhcc-CCCCCccchHhHHHHHHHHHhCCCCCCccchhhcccHHHHHHHHhhhh---h----
Q 044312 430 DQTHMTTQVHGTFGYLDPEYFRS-SQFTDKSDVYSFGVVLTELLTGEKPIRFTILEEDKSLAAYFLCAMKEE---R---- 501 (608)
Q Consensus 430 ~~~~~~~~~~gt~~y~aPE~~~~-~~~t~ksDV~S~Gvvl~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~---~---- 501 (608)
... ......+++.|+|||.+.+ ..++.++||||||++++||++|.+||......+ .+... ....... .
T Consensus 155 ~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~~--~~~~~-~~~~~~~~~~~~~~~ 230 (298)
T cd07841 155 PNR-KMTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDID--QLGKI-FEALGTPTEENWPGV 230 (298)
T ss_pred CCc-cccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCccHH--HHHHH-HHHcCCCchhhhhhc
Confidence 322 1223346788999999864 467899999999999999999977765322111 01110 0000000 0
Q ss_pred --hHHHhhhhhh-----ccCChhHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 044312 502 --LFEILDARVM-----KQGGKDEIITVAKLAKRCLNLNGKKRPTMREVASE 546 (608)
Q Consensus 502 --~~~~~d~~~~-----~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~evl~~ 546 (608)
+......... .......+..+.+++.+||+.+|++|||+.||+++
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~~ 282 (298)
T cd07841 231 TSLPDYVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALEH 282 (298)
T ss_pred ccccccccccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhhC
Confidence 0000000000 00112335678999999999999999999999863
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=99.98 E-value=4.5e-32 Score=278.77 Aligned_cols=248 Identities=21% Similarity=0.281 Sum_probs=182.3
Q ss_pred cCccccceeccCce---------------EEEEEeecC--hhhHHHHHHHHHHHhhcCCCCccceecccccC--ccceEE
Q 044312 289 DNFDLNRILGQGGQ---------------AVKKSKVID--ESKVEEFINEVVILSQINHRNVVKLLGCCLET--EVPLLV 349 (608)
Q Consensus 289 ~~f~~~~~lG~G~~---------------avk~~~~~~--~~~~~~~~~Ei~il~~l~H~niv~l~~~~~~~--~~~~lV 349 (608)
++|++.+.||+|++ ++|..+... ......+.+|+.++++++||||+++++++... ...++|
T Consensus 5 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~lv 84 (293)
T cd07843 5 DEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKIYMV 84 (293)
T ss_pred hhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcEEEE
Confidence 35667777787763 566665432 22334678899999999999999999998777 789999
Q ss_pred EeecCCCccchhccccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEEcCCCcEEEeeccCcccccc
Q 044312 350 YEFIPNGTLFQYIHDQNEDFPITWEIRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAV 429 (608)
Q Consensus 350 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGls~~~~~ 429 (608)
|||++ ++|.+++..... .+++..++.++.||+.||+|||+.+ ++|+||||+|||+++++.+||+|||+++....
T Consensus 85 ~e~~~-~~L~~~~~~~~~--~l~~~~~~~i~~qi~~aL~~LH~~~---i~H~dl~p~nili~~~~~~~l~d~g~~~~~~~ 158 (293)
T cd07843 85 MEYVE-HDLKSLMETMKQ--PFLQSEVKCLMLQLLSGVAHLHDNW---ILHRDLKTSNLLLNNRGILKICDFGLAREYGS 158 (293)
T ss_pred ehhcC-cCHHHHHHhccC--CCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCCHHHEEECCCCcEEEeecCceeeccC
Confidence 99997 489888876433 5899999999999999999999999 99999999999999999999999999987654
Q ss_pred CCcceeeeeeccCCCCChhhhccC-CCCCccchHhHHHHHHHHHhCCCCCCccchhhcccHHHHHHHHhh---h------
Q 044312 430 DQTHMTTQVHGTFGYLDPEYFRSS-QFTDKSDVYSFGVVLTELLTGEKPIRFTILEEDKSLAAYFLCAMK---E------ 499 (608)
Q Consensus 430 ~~~~~~~~~~gt~~y~aPE~~~~~-~~t~ksDV~S~Gvvl~elltg~~p~~~~~~~~~~~l~~~~~~~~~---~------ 499 (608)
... ......+++.|+|||.+.+. .++.++||||||++++||++|+.||........ ... ...... .
T Consensus 159 ~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~~--~~~-~~~~~~~~~~~~~~~~ 234 (293)
T cd07843 159 PLK-PYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQ--LNK-IFKLLGTPTEKIWPGF 234 (293)
T ss_pred Ccc-ccccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCChHHH--HHH-HHHHhCCCchHHHHHh
Confidence 321 12334578899999998754 468999999999999999999999874322111 000 000000 0
Q ss_pred --------hhhHHHhhhhhhccCChh-HHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 044312 500 --------ERLFEILDARVMKQGGKD-EIITVAKLAKRCLNLNGKKRPTMREVASE 546 (608)
Q Consensus 500 --------~~~~~~~d~~~~~~~~~~-~~~~l~~Li~~cl~~dp~~RPs~~evl~~ 546 (608)
..........+....+.. .+..+.+++.+||+.+|++|||+.|++++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~ell~~ 290 (293)
T cd07843 235 SELPGAKKKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALKH 290 (293)
T ss_pred hccchhcccccccccchhhhccccccCCChHHHHHHHHHhccCccccCCHHHHhcC
Confidence 000000001111111111 35678999999999999999999999853
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.1e-31 Score=279.44 Aligned_cols=237 Identities=27% Similarity=0.391 Sum_probs=182.9
Q ss_pred ccccceeccCce---------------EEEEEeec---ChhhHHHHHHHHHHHhhcCCCCccceecccccCccceEEEee
Q 044312 291 FDLNRILGQGGQ---------------AVKKSKVI---DESKVEEFINEVVILSQINHRNVVKLLGCCLETEVPLLVYEF 352 (608)
Q Consensus 291 f~~~~~lG~G~~---------------avk~~~~~---~~~~~~~~~~Ei~il~~l~H~niv~l~~~~~~~~~~~lV~E~ 352 (608)
|+..+.||+|++ |+|+.... .......+.+|++++++++|+|++++++++.+....++||||
T Consensus 27 f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 106 (317)
T cd06635 27 FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVMEY 106 (317)
T ss_pred hhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCeEEEEEeC
Confidence 555667777763 55655422 223456789999999999999999999999999999999999
Q ss_pred cCCCccchhccccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEEcCCCcEEEeeccCccccccCCc
Q 044312 353 IPNGTLFQYIHDQNEDFPITWEIRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQT 432 (608)
Q Consensus 353 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGls~~~~~~~~ 432 (608)
++ |+|.+.+..... ++++..+..++.+++.||.|||+.+ ++||||+|+||+++.++.+||+|||++......
T Consensus 107 ~~-g~l~~~~~~~~~--~l~~~~~~~i~~~i~~~l~~lH~~~---i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~~~-- 178 (317)
T cd06635 107 CL-GSASDLLEVHKK--PLQEVEIAAITHGALQGLAYLHSHN---MIHRDIKAGNILLTEPGQVKLADFGSASIASPA-- 178 (317)
T ss_pred CC-CCHHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcccEEECCCCCEEEecCCCccccCCc--
Confidence 96 478777754332 5899999999999999999999999 999999999999999999999999998754322
Q ss_pred ceeeeeeccCCCCChhhhc---cCCCCCccchHhHHHHHHHHHhCCCCCCccchhhcccHHHHHHHHhhhhhhHHHhhhh
Q 044312 433 HMTTQVHGTFGYLDPEYFR---SSQFTDKSDVYSFGVVLTELLTGEKPIRFTILEEDKSLAAYFLCAMKEERLFEILDAR 509 (608)
Q Consensus 433 ~~~~~~~gt~~y~aPE~~~---~~~~t~ksDV~S~Gvvl~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 509 (608)
....++..|+|||++. ...++.++||||||++++||++|+.||....... .+..+....
T Consensus 179 ---~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~---------------~~~~~~~~~ 240 (317)
T cd06635 179 ---NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMS---------------ALYHIAQNE 240 (317)
T ss_pred ---ccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccHHH---------------HHHHHHhcc
Confidence 2345788999999974 4578999999999999999999999986321110 011111111
Q ss_pred hhccCChhHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhhHHh
Q 044312 510 VMKQGGKDEIITVAKLAKRCLNLNGKKRPTMREVASELAGIKAW 553 (608)
Q Consensus 510 ~~~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~evl~~L~~i~~~ 553 (608)
.........+..+.+|+.+||+.+|.+||++.++++++..+...
T Consensus 241 ~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~~~~~ 284 (317)
T cd06635 241 SPTLQSNEWSDYFRNFVDSCLQKIPQDRPTSEELLKHMFVLRER 284 (317)
T ss_pred CCCCCCccccHHHHHHHHHHccCCcccCcCHHHHHhChhhhccC
Confidence 11112224456799999999999999999999999877665443
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=9.7e-32 Score=278.90 Aligned_cols=251 Identities=23% Similarity=0.319 Sum_probs=179.5
Q ss_pred ccccceeccCc-----------------eEEEEEeecC---hhhHHHHHHHHHHHhhcCCCCccceecccccC--ccceE
Q 044312 291 FDLNRILGQGG-----------------QAVKKSKVID---ESKVEEFINEVVILSQINHRNVVKLLGCCLET--EVPLL 348 (608)
Q Consensus 291 f~~~~~lG~G~-----------------~avk~~~~~~---~~~~~~~~~Ei~il~~l~H~niv~l~~~~~~~--~~~~l 348 (608)
|++.+.||+|+ +|+|...... ....+.+.+|+.++++++||||+++++++.+. ...++
T Consensus 2 y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 81 (316)
T cd07842 2 YEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSVYL 81 (316)
T ss_pred ceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceEEE
Confidence 55666677665 3566555422 33456788999999999999999999999888 78999
Q ss_pred EEeecCCCccchhccccCC--CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEEcC----CCcEEEeecc
Q 044312 349 VYEFIPNGTLFQYIHDQNE--DFPITWEIRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDD----KYRAKVSDFG 422 (608)
Q Consensus 349 V~E~~~~gsL~~~l~~~~~--~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~----~~~~kl~DFG 422 (608)
||||+++ +|.+++..... ...+++..+..++.||+.||.|||+.+ |+||||||+|||++. ++.+||+|||
T Consensus 82 v~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~h~dlkp~Nil~~~~~~~~~~~kl~Dfg 157 (316)
T cd07842 82 LFDYAEH-DLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSNW---VLHRDLKPANILVMGEGPERGVVKIGDLG 157 (316)
T ss_pred EEeCCCc-CHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhCC---EeeCCCCHHHEEEcCCCCccceEEECCCc
Confidence 9999965 67776653221 225899999999999999999999999 999999999999999 8999999999
Q ss_pred CccccccCCc--ceeeeeeccCCCCChhhhccC-CCCCccchHhHHHHHHHHHhCCCCCCccchhhcc-------cHHHH
Q 044312 423 ASRSMAVDQT--HMTTQVHGTFGYLDPEYFRSS-QFTDKSDVYSFGVVLTELLTGEKPIRFTILEEDK-------SLAAY 492 (608)
Q Consensus 423 ls~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~-~~t~ksDV~S~Gvvl~elltg~~p~~~~~~~~~~-------~l~~~ 492 (608)
+++....... .......++..|+|||.+.+. .++.++||||||++++||++|+.||......... .+...
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (316)
T cd07842 158 LARLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQLERI 237 (316)
T ss_pred cccccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCcccccccchhHHHHHHHH
Confidence 9987643222 112334678899999988764 5789999999999999999999999744332200 00000
Q ss_pred HHHHhhhh------------hhHHHhhhhhhccCC-----------hhHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 044312 493 FLCAMKEE------------RLFEILDARVMKQGG-----------KDEIITVAKLAKRCLNLNGKKRPTMREVASE 546 (608)
Q Consensus 493 ~~~~~~~~------------~~~~~~d~~~~~~~~-----------~~~~~~l~~Li~~cl~~dp~~RPs~~evl~~ 546 (608)
...+... ......+.......+ ...+.++.+++.+||+.||++|||+.|++++
T Consensus 238 -~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~eil~~ 313 (316)
T cd07842 238 -FEVLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEYDPTKRITAEEALEH 313 (316)
T ss_pred -HHHhCCCchhHHHHHhhcccchhhhhhccCCCCCCccHHHHHHhccCCCHHHHHHHHHHhcCCcccCcCHHHHhcC
Confidence 0000000 000000000000000 1334578999999999999999999999853
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=3.5e-32 Score=285.57 Aligned_cols=248 Identities=23% Similarity=0.343 Sum_probs=181.5
Q ss_pred hcCccccceeccCce---------------EEEEEeec-ChhhHHHHHHHHHHHhhcCCCCccceecccccCc-----cc
Q 044312 288 TDNFDLNRILGQGGQ---------------AVKKSKVI-DESKVEEFINEVVILSQINHRNVVKLLGCCLETE-----VP 346 (608)
Q Consensus 288 t~~f~~~~~lG~G~~---------------avk~~~~~-~~~~~~~~~~Ei~il~~l~H~niv~l~~~~~~~~-----~~ 346 (608)
+++|.+.++||+|++ |+|+.... .......+.+|+.++++++|+||+++++++.... ..
T Consensus 4 ~~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 83 (336)
T cd07849 4 GPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFNDV 83 (336)
T ss_pred ccceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccccchhHHHHHHHHHHHHhCCCCCcCchhheeecccccccceE
Confidence 468899999999874 55655432 2234567889999999999999999999875443 47
Q ss_pred eEEEeecCCCccchhccccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEEcCCCcEEEeeccCccc
Q 044312 347 LLVYEFIPNGTLFQYIHDQNEDFPITWEIRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRS 426 (608)
Q Consensus 347 ~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGls~~ 426 (608)
++|+||+.+ +|.+++... .+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++.
T Consensus 84 ~lv~e~~~~-~l~~~~~~~----~l~~~~~~~i~~ql~~aL~~LH~~~---ivH~dlkp~Nill~~~~~~kl~dfg~~~~ 155 (336)
T cd07849 84 YIVQELMET-DLYKLIKTQ----HLSNDHIQYFLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTNCDLKICDFGLARI 155 (336)
T ss_pred EEEehhccc-CHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEECCCCCEEECcccceee
Confidence 999999964 787777542 4899999999999999999999999 99999999999999999999999999976
Q ss_pred cccCCcc--eeeeeeccCCCCChhhhcc-CCCCCccchHhHHHHHHHHHhCCCCCCccchhhcccHHHHHHHHhh---hh
Q 044312 427 MAVDQTH--MTTQVHGTFGYLDPEYFRS-SQFTDKSDVYSFGVVLTELLTGEKPIRFTILEEDKSLAAYFLCAMK---EE 500 (608)
Q Consensus 427 ~~~~~~~--~~~~~~gt~~y~aPE~~~~-~~~t~ksDV~S~Gvvl~elltg~~p~~~~~~~~~~~l~~~~~~~~~---~~ 500 (608)
....... ......|+..|+|||.+.+ ..++.++||||||++++||++|+.||....... ....+..... .+
T Consensus 156 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~~~---~~~~~~~~~~~~~~~ 232 (336)
T cd07849 156 ADPEHDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLH---QLNLILGVLGTPSQE 232 (336)
T ss_pred ccccccccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH---HHHHHHHHcCCCCHH
Confidence 5432211 1123467899999998754 568999999999999999999999986332111 1111111111 01
Q ss_pred hhHHHhhhhhh-------c-------cCChhHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 044312 501 RLFEILDARVM-------K-------QGGKDEIITVAKLAKRCLNLNGKKRPTMREVASE 546 (608)
Q Consensus 501 ~~~~~~d~~~~-------~-------~~~~~~~~~l~~Li~~cl~~dp~~RPs~~evl~~ 546 (608)
.+..+.+.... . ......+.++.+++.+||+.+|++|||+.|++++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~h 292 (336)
T cd07849 233 DLNCIISLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAH 292 (336)
T ss_pred HHHHhhchhhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 11111111000 0 0001235678999999999999999999999876
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=6.2e-32 Score=277.74 Aligned_cols=250 Identities=19% Similarity=0.289 Sum_probs=180.0
Q ss_pred cCccccceeccCce---------------EEEEEeecC--hhhHHHHHHHHHHHhhc-CCCCccceecccccCcc-----
Q 044312 289 DNFDLNRILGQGGQ---------------AVKKSKVID--ESKVEEFINEVVILSQI-NHRNVVKLLGCCLETEV----- 345 (608)
Q Consensus 289 ~~f~~~~~lG~G~~---------------avk~~~~~~--~~~~~~~~~Ei~il~~l-~H~niv~l~~~~~~~~~----- 345 (608)
++|++.+.||+|++ |+|+.+... ......+.+|+.+++.+ +|+||+++++++...+.
T Consensus 1 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~ 80 (295)
T cd07837 1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPS 80 (295)
T ss_pred CCceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCce
Confidence 36788888888863 566554322 22346788999999999 56999999999876665
Q ss_pred ceEEEeecCCCccchhccccCC--CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEEcC-CCcEEEeecc
Q 044312 346 PLLVYEFIPNGTLFQYIHDQNE--DFPITWEIRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDD-KYRAKVSDFG 422 (608)
Q Consensus 346 ~~lV~E~~~~gsL~~~l~~~~~--~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~-~~~~kl~DFG 422 (608)
.++||||+++ +|.+++..... ...+++..++.++.||+.||.|||+.+ ++||||||+|||++. ++.+||+|||
T Consensus 81 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~---i~H~dl~~~nil~~~~~~~~kl~dfg 156 (295)
T cd07837 81 LYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKHG---VMHRDLKPQNLLVDKQKGLLKIADLG 156 (295)
T ss_pred EEEEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCChHHEEEecCCCeEEEeecc
Confidence 7999999975 88888765322 235899999999999999999999999 999999999999998 8899999999
Q ss_pred CccccccCCcceeeeeeccCCCCChhhhcc-CCCCCccchHhHHHHHHHHHhCCCCCCccchhhcccHHHHHHHHhhhh-
Q 044312 423 ASRSMAVDQTHMTTQVHGTFGYLDPEYFRS-SQFTDKSDVYSFGVVLTELLTGEKPIRFTILEEDKSLAAYFLCAMKEE- 500 (608)
Q Consensus 423 ls~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~t~ksDV~S~Gvvl~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~- 500 (608)
+++....... ......+++.|+|||++.+ ..++.++||||||++++||++|..||....... .+...+ ......
T Consensus 157 ~~~~~~~~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~--~~~~~~-~~~~~~~ 232 (295)
T cd07837 157 LGRAFSIPVK-SYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQ--QLLHIF-KLLGTPT 232 (295)
T ss_pred cceecCCCcc-ccCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHH--HHHHHH-HHhCCCC
Confidence 9886543221 1122346788999998865 457999999999999999999999986432111 011100 000000
Q ss_pred -hh-HHHh-----------hhhhhccCChhHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 044312 501 -RL-FEIL-----------DARVMKQGGKDEIITVAKLAKRCLNLNGKKRPTMREVASE 546 (608)
Q Consensus 501 -~~-~~~~-----------d~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~evl~~ 546 (608)
.. .... .+..........+.++.+++.+||+.+|.+||++.|++.+
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~~ 291 (295)
T cd07837 233 EQVWPGVSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALTH 291 (295)
T ss_pred hhhCcchhhccchhhcCcccchhHHHhccccCHHHHHHHHHHccCChhhcCCHHHHhcC
Confidence 00 0000 0000001112345678999999999999999999999753
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.5e-32 Score=286.74 Aligned_cols=237 Identities=25% Similarity=0.361 Sum_probs=190.5
Q ss_pred CccccceeccCce---------------EEEEEeecChhhHHHHHHHHHHHhhcCCCCccceecccccCccceEEEeecC
Q 044312 290 NFDLNRILGQGGQ---------------AVKKSKVIDESKVEEFINEVVILSQINHRNVVKLLGCCLETEVPLLVYEFIP 354 (608)
Q Consensus 290 ~f~~~~~lG~G~~---------------avk~~~~~~~~~~~~~~~Ei~il~~l~H~niv~l~~~~~~~~~~~lV~E~~~ 354 (608)
.|.+...||.|+| |-|.+....+...++|+-||.||+..+||+||+|++.|...+.++|+.|||.
T Consensus 33 ~WeIiGELGDGAFGKVyKA~nket~~lAAaKvIetkseEELEDylVEIeILa~CdHP~ivkLl~ayy~enkLwiliEFC~ 112 (1187)
T KOG0579|consen 33 HWEIIGELGDGAFGKVYKAVNKETKLLAAAKVIETKSEEELEDYLVEIEILAECDHPVIVKLLSAYYFENKLWILIEFCG 112 (1187)
T ss_pred HHHHHhhhcCccchhhhhhhcccchhhhhhhhhcccchhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCceEEEEeecC
Confidence 3556777899986 4455555667788999999999999999999999999999999999999999
Q ss_pred CCccchhccccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEEcCCCcEEEeeccCccccccCCcce
Q 044312 355 NGTLFQYIHDQNEDFPITWEIRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHM 434 (608)
Q Consensus 355 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGls~~~~~~~~~~ 434 (608)
||-....+..-+. +|++.++..++.|++.||.|||+.. |||||||+.|||++.+|.++|+|||.+..... ....
T Consensus 113 GGAVDaimlEL~r--~LtE~QIqvvc~q~ldALn~LHs~~---iIHRDLKAGNiL~TldGdirLADFGVSAKn~~-t~qk 186 (1187)
T KOG0579|consen 113 GGAVDAIMLELGR--VLTEDQIQVVCYQVLDALNWLHSQN---IIHRDLKAGNILLTLDGDIRLADFGVSAKNKS-TRQK 186 (1187)
T ss_pred CchHhHHHHHhcc--ccchHHHHHHHHHHHHHHHHHhhcc---hhhhhccccceEEEecCcEeeecccccccchh-HHhh
Confidence 9999988877554 6999999999999999999999999 99999999999999999999999999865332 2233
Q ss_pred eeeeeccCCCCChhhhc-----cCCCCCccchHhHHHHHHHHHhCCCCCCccchhhcccHHHHHHHHhhhhhhHHHhhhh
Q 044312 435 TTQVHGTFGYLDPEYFR-----SSQFTDKSDVYSFGVVLTELLTGEKPIRFTILEEDKSLAAYFLCAMKEERLFEILDAR 509 (608)
Q Consensus 435 ~~~~~gt~~y~aPE~~~-----~~~~t~ksDV~S~Gvvl~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 509 (608)
.....|||+|||||++. ...|+.++||||||+.|.||..+.+|-. ..+....++...+ .. |.
T Consensus 187 RDsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHh------elnpMRVllKiaK-Se------PP 253 (1187)
T KOG0579|consen 187 RDSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHH------ELNPMRVLLKIAK-SE------PP 253 (1187)
T ss_pred hccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCcc------ccchHHHHHHHhh-cC------CC
Confidence 45678999999999864 5678999999999999999999999954 1111111111111 11 11
Q ss_pred hhccCChhHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 044312 510 VMKQGGKDEIITVAKLAKRCLNLNGKKRPTMREVASE 546 (608)
Q Consensus 510 ~~~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~evl~~ 546 (608)
. .-.+......+.+++.+||..||+.||++.+++++
T Consensus 254 T-LlqPS~Ws~~F~DfLk~cL~Knp~~Rp~aaqll~H 289 (1187)
T KOG0579|consen 254 T-LLQPSHWSRSFSDFLKRCLVKNPRNRPPAAQLLKH 289 (1187)
T ss_pred c-ccCcchhhhHHHHHHHHHHhcCCccCCCHHHHhhC
Confidence 1 11233456689999999999999999999999875
|
|
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=99.98 E-value=7.9e-32 Score=277.88 Aligned_cols=251 Identities=25% Similarity=0.332 Sum_probs=183.7
Q ss_pred HHhcCccccceeccCce---------------EEEEEeecC--hhhHHHHHHHHHHHhhcCCCCccceecccccCc----
Q 044312 286 KATDNFDLNRILGQGGQ---------------AVKKSKVID--ESKVEEFINEVVILSQINHRNVVKLLGCCLETE---- 344 (608)
Q Consensus 286 ~~t~~f~~~~~lG~G~~---------------avk~~~~~~--~~~~~~~~~Ei~il~~l~H~niv~l~~~~~~~~---- 344 (608)
.+.++|++.+.||+|++ |+|.++... ......+.+|+.++++++||||+++++++.+..
T Consensus 4 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~~ 83 (302)
T cd07864 4 RCVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDALD 83 (302)
T ss_pred hhhhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhhh
Confidence 45567888899998863 666665432 233457789999999999999999999987655
Q ss_pred ------cceEEEeecCCCccchhccccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEEcCCCcEEE
Q 044312 345 ------VPLLVYEFIPNGTLFQYIHDQNEDFPITWEIRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKV 418 (608)
Q Consensus 345 ------~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl 418 (608)
..++|+||+++ +|.+++..... .+++..+..++.||+.||+|||+.+ |+|+||||+||++++++.+||
T Consensus 84 ~~~~~~~~~lv~e~~~~-~l~~~l~~~~~--~~~~~~~~~i~~qi~~aL~~LH~~~---i~H~dl~p~nili~~~~~~kl 157 (302)
T cd07864 84 FKKDKGAFYLVFEYMDH-DLMGLLESGLV--HFSEDHIKSFMKQLLEGLNYCHKKN---FLHRDIKCSNILLNNKGQIKL 157 (302)
T ss_pred ccccCCcEEEEEcccCc-cHHHHHhcCCC--CCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCcEEe
Confidence 78999999976 77777665422 5899999999999999999999999 999999999999999999999
Q ss_pred eeccCccccccCCcceeeeeeccCCCCChhhhcc-CCCCCccchHhHHHHHHHHHhCCCCCCccchhhcccHHHHHHHHh
Q 044312 419 SDFGASRSMAVDQTHMTTQVHGTFGYLDPEYFRS-SQFTDKSDVYSFGVVLTELLTGEKPIRFTILEEDKSLAAYFLCAM 497 (608)
Q Consensus 419 ~DFGls~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~t~ksDV~S~Gvvl~elltg~~p~~~~~~~~~~~l~~~~~~~~ 497 (608)
+|||++...............++..|+|||.+.. ..++.++||||||++++||++|+.||......+ .+. .+....
T Consensus 158 ~dfg~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~~~--~~~-~~~~~~ 234 (302)
T cd07864 158 ADFGLARLYNSEESRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELA--QLE-LISRLC 234 (302)
T ss_pred CcccccccccCCcccccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHH--HHH-HHHHHh
Confidence 9999998765433222233346788999998864 457899999999999999999999986322111 111 111111
Q ss_pred hhh---hhHHHhh--------------hhhhccCChhHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 044312 498 KEE---RLFEILD--------------ARVMKQGGKDEIITVAKLAKRCLNLNGKKRPTMREVASE 546 (608)
Q Consensus 498 ~~~---~~~~~~d--------------~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~evl~~ 546 (608)
... ....+.. ..... .....+..+.+++.+||+.+|++||++++++++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~ 299 (302)
T cd07864 235 GSPCPAVWPDVIKLPYFNTMKPKKQYRRRLRE-EFSFIPTPALDLLDHMLTLDPSKRCTAEEALNS 299 (302)
T ss_pred CCCChhhcccccccccccccccccccccchhh-hcCCCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 000 0000000 00000 111235679999999999999999999999753
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=99.98 E-value=6.7e-32 Score=283.62 Aligned_cols=255 Identities=23% Similarity=0.324 Sum_probs=185.4
Q ss_pred hcCccccceeccCce---------------EEEEEeec--ChhhHHHHHHHHHHHhhcCCCCccceecccccCc-----c
Q 044312 288 TDNFDLNRILGQGGQ---------------AVKKSKVI--DESKVEEFINEVVILSQINHRNVVKLLGCCLETE-----V 345 (608)
Q Consensus 288 t~~f~~~~~lG~G~~---------------avk~~~~~--~~~~~~~~~~Ei~il~~l~H~niv~l~~~~~~~~-----~ 345 (608)
.++|.+.+.||+|++ |||+.+.. .......+.+|+.+++.++|+||+++++++.... .
T Consensus 4 ~~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~~ 83 (337)
T cd07858 4 DTKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFND 83 (337)
T ss_pred ccceeEEEEeccCCCeEEEEEEecCCCCeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHheecccccccCc
Confidence 457888899999874 55655432 2334567889999999999999999999886442 4
Q ss_pred ceEEEeecCCCccchhccccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEEcCCCcEEEeeccCcc
Q 044312 346 PLLVYEFIPNGTLFQYIHDQNEDFPITWEIRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASR 425 (608)
Q Consensus 346 ~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGls~ 425 (608)
.++||||+. ++|.+++.... ++++..+..++.|++.||.|||+.+ ++||||||+|||++.++.+||+|||+++
T Consensus 84 ~~lv~e~~~-~~L~~~~~~~~---~l~~~~~~~i~~qi~~aL~~LH~~~---i~H~dlkp~Nil~~~~~~~kL~Dfg~~~ 156 (337)
T cd07858 84 VYIVYELMD-TDLHQIIRSSQ---TLSDDHCQYFLYQLLRGLKYIHSAN---VLHRDLKPSNLLLNANCDLKICDFGLAR 156 (337)
T ss_pred EEEEEeCCC-CCHHHHHhcCC---CCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCEEECcCcccc
Confidence 799999995 68888886543 5899999999999999999999999 9999999999999999999999999998
Q ss_pred ccccCCcceeeeeeccCCCCChhhhcc-CCCCCccchHhHHHHHHHHHhCCCCCCccchhhcccHHHHHHH--------H
Q 044312 426 SMAVDQTHMTTQVHGTFGYLDPEYFRS-SQFTDKSDVYSFGVVLTELLTGEKPIRFTILEEDKSLAAYFLC--------A 496 (608)
Q Consensus 426 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~t~ksDV~S~Gvvl~elltg~~p~~~~~~~~~~~l~~~~~~--------~ 496 (608)
...... .......++..|+|||.+.. ..++.++||||||+++++|++|+.||................. .
T Consensus 157 ~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (337)
T cd07858 157 TTSEKG-DFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLKLITELLGSPSEEDLGF 235 (337)
T ss_pred ccCCCc-ccccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCChHHhhh
Confidence 764332 12233457889999998865 4689999999999999999999999864321111000000000 0
Q ss_pred hhhhhhHHHhhhhh------hccCChhHHHHHHHHHHHHhccCCCCCCCHHHHHHH--HHhh
Q 044312 497 MKEERLFEILDARV------MKQGGKDEIITVAKLAKRCLNLNGKKRPTMREVASE--LAGI 550 (608)
Q Consensus 497 ~~~~~~~~~~d~~~------~~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~evl~~--L~~i 550 (608)
.........+.... ........+.++.+|+.+||+.+|++|||++|++++ ++.+
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h~~~~~~ 297 (337)
T cd07858 236 IRNEKARRYIRSLPYTPRQSFARLFPHANPLAIDLLEKMLVFDPSKRITVEEALAHPYLASL 297 (337)
T ss_pred cCchhhhHHHHhcCcccccCHHHHcccCCHHHHHHHHHHhcCChhhccCHHHHHcCcchhhh
Confidence 00001111000000 000112345678999999999999999999999987 4444
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.3e-31 Score=268.31 Aligned_cols=233 Identities=26% Similarity=0.410 Sum_probs=186.4
Q ss_pred CccccceeccCc---------------eEEEEEeecCh--hhHHHHHHHHHHHhhcCCCCccceecccccCccceEEEee
Q 044312 290 NFDLNRILGQGG---------------QAVKKSKVIDE--SKVEEFINEVVILSQINHRNVVKLLGCCLETEVPLLVYEF 352 (608)
Q Consensus 290 ~f~~~~~lG~G~---------------~avk~~~~~~~--~~~~~~~~Ei~il~~l~H~niv~l~~~~~~~~~~~lV~E~ 352 (608)
+|++.+.||+|+ +++|....... ...+.+.+|++++++++|+|++++++++.+....+++|||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 80 (254)
T cd06627 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYIILEY 80 (254)
T ss_pred CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEec
Confidence 356677777775 35666554333 4667899999999999999999999999999999999999
Q ss_pred cCCCccchhccccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEEcCCCcEEEeeccCccccccCCc
Q 044312 353 IPNGTLFQYIHDQNEDFPITWEIRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQT 432 (608)
Q Consensus 353 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGls~~~~~~~~ 432 (608)
+++++|.+++.... .+++..+..++.|++.||.|||+.+ ++||||+|+||+++.++.+||+|||++........
T Consensus 81 ~~~~~L~~~~~~~~---~l~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~ 154 (254)
T cd06627 81 AENGSLRQIIKKFG---PFPESLVAVYVYQVLQGLAYLHEQG---VIHRDIKAANILTTKDGVVKLADFGVATKLNDVSK 154 (254)
T ss_pred CCCCcHHHHHHhcc---CCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCHHHEEECCCCCEEEeccccceecCCCcc
Confidence 99999999987652 5899999999999999999999998 99999999999999999999999999987654332
Q ss_pred ceeeeeeccCCCCChhhhccCCCCCccchHhHHHHHHHHHhCCCCCCccchhhcccHHHHHHHHhhhhhhHHHhhhhhhc
Q 044312 433 HMTTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLTELLTGEKPIRFTILEEDKSLAAYFLCAMKEERLFEILDARVMK 512 (608)
Q Consensus 433 ~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~ 512 (608)
. .....++..|+|||.+.....+.++||||||+++++|++|+.||..... ...... . . .....
T Consensus 155 ~-~~~~~~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~-----~~~~~~-~-~---------~~~~~ 217 (254)
T cd06627 155 D-DASVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYDLNP-----MAALFR-I-V---------QDDHP 217 (254)
T ss_pred c-ccccccchhhcCHhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCccH-----HHHHHH-H-h---------ccCCC
Confidence 1 2334678899999999888899999999999999999999999863221 111000 0 0 00111
Q ss_pred cCChhHHHHHHHHHHHHhccCCCCCCCHHHHHH
Q 044312 513 QGGKDEIITVAKLAKRCLNLNGKKRPTMREVAS 545 (608)
Q Consensus 513 ~~~~~~~~~l~~Li~~cl~~dp~~RPs~~evl~ 545 (608)
..+...+..+.+++.+||..+|++||++.+++.
T Consensus 218 ~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~ 250 (254)
T cd06627 218 PLPEGISPELKDFLMQCFQKDPNLRPTAKQLLK 250 (254)
T ss_pred CCCCCCCHHHHHHHHHHHhCChhhCcCHHHHhc
Confidence 222344668999999999999999999999874
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.5e-31 Score=273.91 Aligned_cols=211 Identities=17% Similarity=0.222 Sum_probs=156.2
Q ss_pred HHHHHhhcCCCCccceecccccCc----cceEEEeecCCCccchhccccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCC
Q 044312 321 EVVILSQINHRNVVKLLGCCLETE----VPLLVYEFIPNGTLFQYIHDQNEDFPITWEIRLRIAIEVSGALSYLHSAASI 396 (608)
Q Consensus 321 Ei~il~~l~H~niv~l~~~~~~~~----~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~ 396 (608)
++..+..++|+|++++++++.... ..++++|++. .++.+.+.... ..++..+..|+.|++.||+|||+.+
T Consensus 73 ~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~---~~~~~~~~~i~~qi~~~l~~lH~~~-- 146 (294)
T PHA02882 73 LWKNIHNIDHLGIPKYYGCGSFKRCRMYYRFILLEKLV-ENTKEIFKRIK---CKNKKLIKNIMKDMLTTLEYIHEHG-- 146 (294)
T ss_pred HHHHhccCCCCCCCcEEEeeeEecCCceEEEEEEehhc-cCHHHHHHhhc---cCCHHHHHHHHHHHHHHHHHHHhCC--
Confidence 344566778999999999765443 3367778764 35666554432 3678889999999999999999998
Q ss_pred CeeccCCCCCcEEEcCCCcEEEeeccCccccccCCcc------eeeeeeccCCCCChhhhccCCCCCccchHhHHHHHHH
Q 044312 397 PIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTH------MTTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLTE 470 (608)
Q Consensus 397 ~iiHrDlk~~NILl~~~~~~kl~DFGls~~~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~e 470 (608)
|+||||||+|||++.++.+||+|||+++.+...... ......||+.|+|||++.+..++.++||||||++++|
T Consensus 147 -iiHrDiKp~Nill~~~~~~~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~~l~e 225 (294)
T PHA02882 147 -ISHGDIKPENIMVDGNNRGYIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLK 225 (294)
T ss_pred -eecCCCCHHHEEEcCCCcEEEEEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCCCcHHHHHHHHHHHHH
Confidence 999999999999999999999999999876432211 1123469999999999999999999999999999999
Q ss_pred HHhCCCCCCccchhhcccHHHHHHHHhhhhhhHHHhhhhhhccCChhHHHHHHHHHHHHhccCCCCCCCHHHHHHHH
Q 044312 471 LLTGEKPIRFTILEEDKSLAAYFLCAMKEERLFEILDARVMKQGGKDEIITVAKLAKRCLNLNGKKRPTMREVASEL 547 (608)
Q Consensus 471 lltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~evl~~L 547 (608)
|++|+.||....... .+.. ....+.+..+..... .....+..+.+++..|++.+|++||++.++.+.|
T Consensus 226 l~~g~~P~~~~~~~~--~~~~----~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~rp~~~~l~~~~ 293 (294)
T PHA02882 226 WAGIKLPWKGFGHNG--NLIH----AAKCDFIKRLHEGKI---KIKNANKFIYDFIECVTKLSYEEKPDYDALIKIF 293 (294)
T ss_pred HHhCCCCCCccccch--HHHH----HhHHHHHHHhhhhhh---ccCCCCHHHHHHHHHHHhCCCCCCCCHHHHHHhh
Confidence 999999997432211 1111 111111112211111 1123457799999999999999999999998865
|
|
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.1e-32 Score=275.14 Aligned_cols=236 Identities=22% Similarity=0.302 Sum_probs=173.6
Q ss_pred EEEEEeecC--hhhHHHHHHHHHHHhhcCCCCccceecccccCccceEEEeecCCCccchhccccCCCCCCCHHHHHHHH
Q 044312 303 AVKKSKVID--ESKVEEFINEVVILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEIRLRIA 380 (608)
Q Consensus 303 avk~~~~~~--~~~~~~~~~Ei~il~~l~H~niv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~ 380 (608)
++|+..... ....+.+.+|+.++++++|||++++++++.+....+++|||++ ++|.+++..... ..+++..++.++
T Consensus 28 ~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~iv~e~~~-~~l~~~~~~~~~-~~~~~~~~~~~~ 105 (283)
T cd07835 28 ALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVVHSENKLYLVFEFLD-LDLKKYMDSSPL-TGLDPPLIKSYL 105 (283)
T ss_pred EEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhheeccCCeEEEEEeccC-cCHHHHHhhCCC-CCCCHHHHHHHH
Confidence 666655432 2334678999999999999999999999999999999999995 689998876542 258999999999
Q ss_pred HHHHHHHHHHhhcCCCCeeccCCCCCcEEEcCCCcEEEeeccCccccccCCcceeeeeeccCCCCChhhhccC-CCCCcc
Q 044312 381 IEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHGTFGYLDPEYFRSS-QFTDKS 459 (608)
Q Consensus 381 ~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGls~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~t~ks 459 (608)
.|+++||+|||+.+ ++||||+|+|||++.++.+||+|||+++........ .....++..|+|||++.+. .++.++
T Consensus 106 ~~i~~~L~~lH~~~---~~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~-~~~~~~~~~~~aPE~~~~~~~~~~~~ 181 (283)
T cd07835 106 YQLLQGIAYCHSHR---VLHRDLKPQNLLIDREGALKLADFGLARAFGVPVRT-YTHEVVTLWYRAPEILLGSRQYSTPV 181 (283)
T ss_pred HHHHHHHHHHHHCC---eeCCCCCHHHEEEcCCCcEEEeecccccccCCCccc-cCccccccCCCCCceeecCcccCcHH
Confidence 99999999999998 999999999999999999999999999765432211 1223468899999987654 578999
Q ss_pred chHhHHHHHHHHHhCCCCCCccchhhcccHHHHHHHHhhhh-h----hHHHhhh---------hhhccCChhHHHHHHHH
Q 044312 460 DVYSFGVVLTELLTGEKPIRFTILEEDKSLAAYFLCAMKEE-R----LFEILDA---------RVMKQGGKDEIITVAKL 525 (608)
Q Consensus 460 DV~S~Gvvl~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~-~----~~~~~d~---------~~~~~~~~~~~~~l~~L 525 (608)
||||||++++||++|+.||....... .+...+....... . ...+.+. ..........+..+.++
T Consensus 182 Di~slG~~l~~l~~g~~pf~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 259 (283)
T cd07835 182 DIWSIGCIFAEMVNRRPLFPGDSEID--QLFRIFRTLGTPDEDVWPGVTSLPDYKPTFPKWARQDLSKVVPNLDEDGLDL 259 (283)
T ss_pred HHHHHHHHHHHHHhCCCCCCCCCHHH--HHHHHHHHhCCCChHHhhhhhhchhhhhhcccccccchhhhcCCCCHHHHHH
Confidence 99999999999999999986432211 1111110000000 0 0000000 00001112334678999
Q ss_pred HHHHhccCCCCCCCHHHHHHH
Q 044312 526 AKRCLNLNGKKRPTMREVASE 546 (608)
Q Consensus 526 i~~cl~~dp~~RPs~~evl~~ 546 (608)
+.+||+.+|++|||++|++++
T Consensus 260 i~~~l~~~P~~Rpt~~~il~~ 280 (283)
T cd07835 260 LSKMLVYDPAKRISAKAALQH 280 (283)
T ss_pred HHHHhcCChhhCcCHHHHhcC
Confidence 999999999999999999853
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.1e-32 Score=288.23 Aligned_cols=181 Identities=28% Similarity=0.411 Sum_probs=155.6
Q ss_pred CccccceeccCce---------------EEEEEeecChhhHHHHHHHHHHHhhcC-C-----CCccceecccccCccceE
Q 044312 290 NFDLNRILGQGGQ---------------AVKKSKVIDESKVEEFINEVVILSQIN-H-----RNVVKLLGCCLETEVPLL 348 (608)
Q Consensus 290 ~f~~~~~lG~G~~---------------avk~~~~~~~~~~~~~~~Ei~il~~l~-H-----~niv~l~~~~~~~~~~~l 348 (608)
+|++.+.||+|.| |||+++. ...-..+...|+.+|..|+ | -|+|+++++|..+++.+|
T Consensus 187 rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN-~k~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~fr~Hlci 265 (586)
T KOG0667|consen 187 RYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKN-KKRFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYFRNHLCI 265 (586)
T ss_pred EEEEEEEecccccceeEEEEecCCCcEEEEEeecc-ChHHHHHHHHHHHHHHHHhccCCCCCeeEEEeeeccccccceee
Confidence 7899999999985 6777664 2334567788999999996 4 499999999999999999
Q ss_pred EEeecCCCccchhccccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEEcCC--CcEEEeeccCccc
Q 044312 349 VYEFIPNGTLFQYIHDQNEDFPITWEIRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDK--YRAKVSDFGASRS 426 (608)
Q Consensus 349 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~--~~~kl~DFGls~~ 426 (608)
|+|.+ ..+|+++|+.+.-+ .++...+..|+.||+.||..||+.+ |||+||||+||||.+- ..+||+|||.|..
T Consensus 266 VfELL-~~NLYellK~n~f~-Glsl~~ir~~~~Qil~~L~~L~~l~---IIHcDLKPENILL~~~~r~~vKVIDFGSSc~ 340 (586)
T KOG0667|consen 266 VFELL-STNLYELLKNNKFR-GLSLPLVRKFAQQILTALLFLHELG---IIHCDLKPENILLKDPKRSRIKVIDFGSSCF 340 (586)
T ss_pred eehhh-hhhHHHHHHhcCCC-CCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCChhheeeccCCcCceeEEecccccc
Confidence 99999 55999999986544 6999999999999999999999999 9999999999999753 3699999999987
Q ss_pred cccCCcceeeeeeccCCCCChhhhccCCCCCccchHhHHHHHHHHHhCCCCCCc
Q 044312 427 MAVDQTHMTTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLTELLTGEKPIRF 480 (608)
Q Consensus 427 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~elltg~~p~~~ 480 (608)
.... .....-+..|+|||++.+..|+.+.||||||||++||.+|.+.|..
T Consensus 341 ~~q~----vytYiQSRfYRAPEVILGlpY~~~IDmWSLGCIlAEL~tG~PLfpG 390 (586)
T KOG0667|consen 341 ESQR----VYTYIQSRFYRAPEVILGLPYDTAIDMWSLGCILAELFTGEPLFPG 390 (586)
T ss_pred cCCc----ceeeeeccccccchhhccCCCCCccceeehhhhHHhHhcCccccCC
Confidence 5421 1234457889999999999999999999999999999999887764
|
|
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.8e-31 Score=267.35 Aligned_cols=236 Identities=27% Similarity=0.425 Sum_probs=188.3
Q ss_pred ccccceeccCce---------------EEEEEeecC--hhhHHHHHHHHHHHhhcCCCCccceecccccC--ccceEEEe
Q 044312 291 FDLNRILGQGGQ---------------AVKKSKVID--ESKVEEFINEVVILSQINHRNVVKLLGCCLET--EVPLLVYE 351 (608)
Q Consensus 291 f~~~~~lG~G~~---------------avk~~~~~~--~~~~~~~~~Ei~il~~l~H~niv~l~~~~~~~--~~~~lV~E 351 (608)
|+..+.||+|++ ++|...... ....+.+.+|+.++++++|+||+++++.+.+. ...++|+|
T Consensus 2 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e 81 (260)
T cd06606 2 WTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIFLE 81 (260)
T ss_pred ceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEEEE
Confidence 556677777753 556554433 24578899999999999999999999999888 88999999
Q ss_pred ecCCCccchhccccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEEcCCCcEEEeeccCccccccCC
Q 044312 352 FIPNGTLFQYIHDQNEDFPITWEIRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQ 431 (608)
Q Consensus 352 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGls~~~~~~~ 431 (608)
|+++++|.+++.... .+++..+..++.+++.||+|||+.+ ++|+||+|+||+++.++.+||+|||.+.......
T Consensus 82 ~~~~~~L~~~~~~~~---~~~~~~~~~~~~~l~~~l~~lh~~~---~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~ 155 (260)
T cd06606 82 YVSGGSLSSLLKKFG---KLPEPVIRKYTRQILEGLAYLHSNG---IVHRDIKGANILVDSDGVVKLADFGCAKRLGDIE 155 (260)
T ss_pred ecCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEcCCCCEEEcccccEEeccccc
Confidence 999999999987654 5899999999999999999999988 9999999999999999999999999998765433
Q ss_pred cc-eeeeeeccCCCCChhhhccCCCCCccchHhHHHHHHHHHhCCCCCCccchhhcccHHHHHHHHhhhhhhHHHhhhhh
Q 044312 432 TH-MTTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLTELLTGEKPIRFTILEEDKSLAAYFLCAMKEERLFEILDARV 510 (608)
Q Consensus 432 ~~-~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~ 510 (608)
.. ......++..|+|||.+.....+.++||||||+++++|++|..||.... ...... ..+.....
T Consensus 156 ~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~-----~~~~~~---------~~~~~~~~ 221 (260)
T cd06606 156 TGEGTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELG-----NPMAAL---------YKIGSSGE 221 (260)
T ss_pred ccccccCCCCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC-----chHHHH---------HhccccCC
Confidence 21 1234567889999999998889999999999999999999999986432 111111 11111111
Q ss_pred hccCChhHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 044312 511 MKQGGKDEIITVAKLAKRCLNLNGKKRPTMREVASE 546 (608)
Q Consensus 511 ~~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~evl~~ 546 (608)
....+...+..+.+++.+|+..+|++||++.|++++
T Consensus 222 ~~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~ll~~ 257 (260)
T cd06606 222 PPEIPEHLSEEAKDFLRKCLRRDPKKRPTADELLQH 257 (260)
T ss_pred CcCCCcccCHHHHHHHHHhCcCChhhCCCHHHHhhC
Confidence 122333446789999999999999999999999864
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.8e-31 Score=270.08 Aligned_cols=236 Identities=26% Similarity=0.389 Sum_probs=184.1
Q ss_pred cCccccceeccCce---------------EEEEEeec-----ChhhHHHHHHHHHHHhhcCCCCccceecccccC--ccc
Q 044312 289 DNFDLNRILGQGGQ---------------AVKKSKVI-----DESKVEEFINEVVILSQINHRNVVKLLGCCLET--EVP 346 (608)
Q Consensus 289 ~~f~~~~~lG~G~~---------------avk~~~~~-----~~~~~~~~~~Ei~il~~l~H~niv~l~~~~~~~--~~~ 346 (608)
.+|++.+.||+|++ |+|..... .......+.+|++++++++|+||+++++++.+. ...
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (264)
T cd06653 2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKL 81 (264)
T ss_pred CceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEE
Confidence 46888899999874 55654321 234456889999999999999999999998654 457
Q ss_pred eEEEeecCCCccchhccccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEEcCCCcEEEeeccCccc
Q 044312 347 LLVYEFIPNGTLFQYIHDQNEDFPITWEIRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRS 426 (608)
Q Consensus 347 ~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGls~~ 426 (608)
++++||+++++|.+++.... .+++..+.+++.|++.||.|||+.+ ++|+||||+||+++.++.++|+|||+++.
T Consensus 82 ~~v~e~~~~~~L~~~~~~~~---~l~~~~~~~~~~~i~~al~~LH~~~---i~H~dl~p~ni~i~~~~~~~l~dfg~~~~ 155 (264)
T cd06653 82 SIFVEYMPGGSIKDQLKAYG---ALTENVTRRYTRQILQGVSYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKR 155 (264)
T ss_pred EEEEEeCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCEEECccccccc
Confidence 89999999999999987543 4789999999999999999999999 99999999999999999999999999986
Q ss_pred cccCC--cceeeeeeccCCCCChhhhccCCCCCccchHhHHHHHHHHHhCCCCCCccchhhcccHHHHHHHHhhhhhhHH
Q 044312 427 MAVDQ--THMTTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLTELLTGEKPIRFTILEEDKSLAAYFLCAMKEERLFE 504 (608)
Q Consensus 427 ~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~ 504 (608)
..... ........++..|+|||++.+..++.++||||||++++||++|+.||...... . .+.+
T Consensus 156 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~-----~----------~~~~ 220 (264)
T cd06653 156 IQTICMSGTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEYEAM-----A----------AIFK 220 (264)
T ss_pred cccccccCccccccCCcccccCHhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCccCHH-----H----------HHHH
Confidence 53211 11122345889999999999888999999999999999999999998632110 0 0111
Q ss_pred HhhhhhhccCChhHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 044312 505 ILDARVMKQGGKDEIITVAKLAKRCLNLNGKKRPTMREVASE 546 (608)
Q Consensus 505 ~~d~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~evl~~ 546 (608)
+.........+......+.+++.+||+ +|..||+..+++.+
T Consensus 221 ~~~~~~~~~~p~~~~~~~~~~i~~~l~-~~~~r~~~~~~~~~ 261 (264)
T cd06653 221 IATQPTKPMLPDGVSDACRDFLKQIFV-EEKRRPTAEFLLRH 261 (264)
T ss_pred HHcCCCCCCCCcccCHHHHHHHHHHhc-CcccCccHHHHhcC
Confidence 111111223344566789999999999 57999999988753
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-31 Score=273.55 Aligned_cols=235 Identities=23% Similarity=0.301 Sum_probs=176.3
Q ss_pred eEEEEEeecC--hhhHHHHHHHHHHHhhcCCCCccceecccccCccceEEEeecCCCccchhccccCCCCCCCHHHHHHH
Q 044312 302 QAVKKSKVID--ESKVEEFINEVVILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEIRLRI 379 (608)
Q Consensus 302 ~avk~~~~~~--~~~~~~~~~Ei~il~~l~H~niv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i 379 (608)
+++|...... ......+.+|+.++++++|+||+++++++......++||||+++ +|.+++..... .+++..+..+
T Consensus 27 ~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~-~l~~~l~~~~~--~~~~~~~~~~ 103 (283)
T cd05118 27 VAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVFEFMDT-DLYKLIKDRQR--GLPESLIKSY 103 (283)
T ss_pred EEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhhccCCCEEEEEeccCC-CHHHHHHhhcc--cCCHHHHHHH
Confidence 3666655432 23456888999999999999999999999999999999999975 88888876432 5899999999
Q ss_pred HHHHHHHHHHHhhcCCCCeeccCCCCCcEEEcCCCcEEEeeccCccccccCCcceeeeeeccCCCCChhhhccC-CCCCc
Q 044312 380 AIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHGTFGYLDPEYFRSS-QFTDK 458 (608)
Q Consensus 380 ~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGls~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~t~k 458 (608)
+.|++.||.|||+.+ ++|+||||+||++++++.+||+|||.+....... .......++..|+|||.+... .++.+
T Consensus 104 ~~~i~~~l~~LH~~~---i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~~-~~~~~~~~~~~~~~PE~~~~~~~~~~~ 179 (283)
T cd05118 104 LYQLLQGLAFCHSHG---ILHRDLKPENLLINTEGVLKLADFGLARSFGSPV-RPYTHYVVTRWYRAPELLLGDKGYSTP 179 (283)
T ss_pred HHHHHHHHHHHHHCC---eeecCcCHHHEEECCCCcEEEeeeeeeEecCCCc-ccccCccCcccccCcHHHhcCCCCCch
Confidence 999999999999999 9999999999999999999999999997765433 122234578889999998876 78999
Q ss_pred cchHhHHHHHHHHHhCCCCCCccchhhcccHHHHHHHHhhh---hhhHHHhh-------------hhhhccCChhHHHHH
Q 044312 459 SDVYSFGVVLTELLTGEKPIRFTILEEDKSLAAYFLCAMKE---ERLFEILD-------------ARVMKQGGKDEIITV 522 (608)
Q Consensus 459 sDV~S~Gvvl~elltg~~p~~~~~~~~~~~l~~~~~~~~~~---~~~~~~~d-------------~~~~~~~~~~~~~~l 522 (608)
+||||||+++++|+||+.||......+. .......... .......+ ...........+.++
T Consensus 180 ~Di~slG~~l~~l~tg~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 256 (283)
T cd05118 180 VDIWSVGCIFAELLSRRPLFPGKSEIDQ---LFKIFRTLGTPDPEVWPKFTSLARNYKFSFPKKAGMPLPKLFPNASPQA 256 (283)
T ss_pred hHHHHHHHHHHHHHhCCCCCCCCCHHHH---HHHHHHHcCCCchHhcccchhhhhhhhhhhccccccCHHHhhhhhCHHH
Confidence 9999999999999999999864332111 0000000000 00000000 000001112356789
Q ss_pred HHHHHHHhccCCCCCCCHHHHHHH
Q 044312 523 AKLAKRCLNLNGKKRPTMREVASE 546 (608)
Q Consensus 523 ~~Li~~cl~~dp~~RPs~~evl~~ 546 (608)
.+++.+||+.||.+||++.|++.+
T Consensus 257 ~~~i~~~l~~~P~~Rp~~~~ll~~ 280 (283)
T cd05118 257 LDLLSQMLHYDPHKRITAEQALAH 280 (283)
T ss_pred HHHHHHHhccCcccCcCHHHHhhC
Confidence 999999999999999999999853
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.8e-31 Score=269.42 Aligned_cols=223 Identities=26% Similarity=0.311 Sum_probs=178.4
Q ss_pred eEEEEEeec---ChhhHHHHHHHHHHHhhcCCCCccceecccccCccceEEEeecCCCccchhccccCCCCCCCHHHHHH
Q 044312 302 QAVKKSKVI---DESKVEEFINEVVILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEIRLR 378 (608)
Q Consensus 302 ~avk~~~~~---~~~~~~~~~~Ei~il~~l~H~niv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~ 378 (608)
+++|..... .....+.+.+|+.++++++||||+++++.+.+....++||||+++++|.+++.+.. .+++..+..
T Consensus 21 ~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~---~l~~~~~~~ 97 (262)
T cd05572 21 FALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGELWTILRDRG---LFDEYTARF 97 (262)
T ss_pred EEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecCCCCcHHHHHhhcC---CCCHHHHHH
Confidence 577776532 23445789999999999999999999999999999999999999999999997643 489999999
Q ss_pred HHHHHHHHHHHHhhcCCCCeeccCCCCCcEEEcCCCcEEEeeccCccccccCCcceeeeeeccCCCCChhhhccCCCCCc
Q 044312 379 IAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHGTFGYLDPEYFRSSQFTDK 458 (608)
Q Consensus 379 i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGls~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k 458 (608)
++.||+.||.|||+.+ ++|+||+|+||+++.++.+||+|||+++...... ......++..|++||.+....++.+
T Consensus 98 ~~~~i~~~l~~lH~~~---~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~--~~~~~~~~~~~~~PE~~~~~~~~~~ 172 (262)
T cd05572 98 YIACVVLAFEYLHNRG---IIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQ--KTWTFCGTPEYVAPEIILNKGYDFS 172 (262)
T ss_pred HHHHHHHHHHHHhhCC---cccCCCCHHHEEEcCCCCEEEeeCCcccccCccc--ccccccCCcCccChhHhcCCCCCCh
Confidence 9999999999999998 9999999999999999999999999998765432 2233467889999999988889999
Q ss_pred cchHhHHHHHHHHHhCCCCCCccchhhcccHHHHHHHHhhhhhhHHHhhhhhhccCChhHHHHHHHHHHHHhccCCCCCC
Q 044312 459 SDVYSFGVVLTELLTGEKPIRFTILEEDKSLAAYFLCAMKEERLFEILDARVMKQGGKDEIITVAKLAKRCLNLNGKKRP 538 (608)
Q Consensus 459 sDV~S~Gvvl~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RP 538 (608)
+|+||||++++||++|..||.....+ ..... ..+.........+...+.++.+++.+||+.+|++||
T Consensus 173 ~Di~slG~il~~l~~g~~p~~~~~~~----~~~~~---------~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~ 239 (262)
T cd05572 173 VDYWSLGILLYELLTGRPPFGEDDED----PMEIY---------NDILKGNGKLEFPNYIDKAAKDLIKQLLRRNPEERL 239 (262)
T ss_pred hhhhhhHHHHHHHHhCCCCcCCCCCC----HHHHH---------HHHhccCCCCCCCcccCHHHHHHHHHHccCChhhCc
Confidence 99999999999999999998643211 11111 111111111222333467899999999999999999
Q ss_pred C-----HHHHHH
Q 044312 539 T-----MREVAS 545 (608)
Q Consensus 539 s-----~~evl~ 545 (608)
+ ++|+++
T Consensus 240 ~~~~~~~~~l~~ 251 (262)
T cd05572 240 GNLKGGIKDIKK 251 (262)
T ss_pred CCcccCHHHHhc
Confidence 9 666654
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.4e-31 Score=272.89 Aligned_cols=244 Identities=21% Similarity=0.299 Sum_probs=176.0
Q ss_pred ccccceeccCc---------------eEEEEEeec-ChhhHHHHHHHHHHHhhcC-CCCccceecccccC--ccceEEEe
Q 044312 291 FDLNRILGQGG---------------QAVKKSKVI-DESKVEEFINEVVILSQIN-HRNVVKLLGCCLET--EVPLLVYE 351 (608)
Q Consensus 291 f~~~~~lG~G~---------------~avk~~~~~-~~~~~~~~~~Ei~il~~l~-H~niv~l~~~~~~~--~~~~lV~E 351 (608)
|++.++||+|+ +|+|+.+.. .........+|+.+++++. |+||+++++++.+. +..++|||
T Consensus 1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~e 80 (282)
T cd07831 1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALVFE 80 (282)
T ss_pred CceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCchhhhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEEEe
Confidence 44566677765 366665432 2222334568999999985 99999999999877 88999999
Q ss_pred ecCCCccchhccccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEEcCCCcEEEeeccCccccccCC
Q 044312 352 FIPNGTLFQYIHDQNEDFPITWEIRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQ 431 (608)
Q Consensus 352 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGls~~~~~~~ 431 (608)
|++ ++|.+++..... .+++..+..++.|++.||+|||+.+ ++||||||+||+++. +.+||+|||+++......
T Consensus 81 ~~~-~~l~~~l~~~~~--~~~~~~~~~~~~qi~~~L~~LH~~~---i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~~~~ 153 (282)
T cd07831 81 LMD-MNLYELIKGRKR--PLPEKRVKSYMYQLLKSLDHMHRNG---IFHRDIKPENILIKD-DILKLADFGSCRGIYSKP 153 (282)
T ss_pred cCC-ccHHHHHHhccC--CCCHHHHHHHHHHHHHHHHHHHHCC---ceecccCHHHEEEcC-CCeEEEecccccccccCC
Confidence 996 588888765432 5899999999999999999999999 999999999999999 999999999998764332
Q ss_pred cceeeeeeccCCCCChhhhcc-CCCCCccchHhHHHHHHHHHhCCCCCCccchhhcccHHHHHHHHhhh--hhhHHHhhh
Q 044312 432 THMTTQVHGTFGYLDPEYFRS-SQFTDKSDVYSFGVVLTELLTGEKPIRFTILEEDKSLAAYFLCAMKE--ERLFEILDA 508 (608)
Q Consensus 432 ~~~~~~~~gt~~y~aPE~~~~-~~~t~ksDV~S~Gvvl~elltg~~p~~~~~~~~~~~l~~~~~~~~~~--~~~~~~~d~ 508 (608)
. .....++..|+|||++.. ..++.++|||||||+++||++|+.||......+ ........... ..+......
T Consensus 154 ~--~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~ 228 (282)
T cd07831 154 P--YTEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELD---QIAKIHDVLGTPDAEVLKKFRK 228 (282)
T ss_pred C--cCCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCHHH---HHHHHHHHcCCCCHHHHHhhcc
Confidence 2 123457889999997654 557899999999999999999999996432211 11111110000 000000000
Q ss_pred h------h-------hccCChhHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 044312 509 R------V-------MKQGGKDEIITVAKLAKRCLNLNGKKRPTMREVASE 546 (608)
Q Consensus 509 ~------~-------~~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~evl~~ 546 (608)
. . ........+..+.+|+.+||+.+|++||++.+++++
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~ 279 (282)
T cd07831 229 SRHMNYNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALRH 279 (282)
T ss_pred cccccccCcccccccHHHHcccccHHHHHHHHHHhccCcccccCHHHHhhC
Confidence 0 0 000012346789999999999999999999999864
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.5e-31 Score=275.23 Aligned_cols=223 Identities=26% Similarity=0.388 Sum_probs=177.5
Q ss_pred eEEEEEeecChhhHHHHHHHHHHHhhcCCCCccceecccccCccceEEEeecCCCccchhccccCCCCCCCHHHHHHHHH
Q 044312 302 QAVKKSKVIDESKVEEFINEVVILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEIRLRIAI 381 (608)
Q Consensus 302 ~avk~~~~~~~~~~~~~~~Ei~il~~l~H~niv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~ 381 (608)
+|+|+.........+.+.+|+.++++++|+||+++++.+...+..++||||+++++|.+++... .+++..+..++.
T Consensus 48 v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~----~~~~~~~~~~~~ 123 (292)
T cd06657 48 VAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALTDIVTHT----RMNEEQIAAVCL 123 (292)
T ss_pred EEEEEecccchhHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEEEecCCCCcHHHHHhcC----CCCHHHHHHHHH
Confidence 3677665555556678999999999999999999999999999999999999999999987542 479999999999
Q ss_pred HHHHHHHHHhhcCCCCeeccCCCCCcEEEcCCCcEEEeeccCccccccCCcceeeeeeccCCCCChhhhccCCCCCccch
Q 044312 382 EVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHGTFGYLDPEYFRSSQFTDKSDV 461 (608)
Q Consensus 382 ~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGls~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV 461 (608)
|++.||+|||+.+ ++|+||+|+||+++.++.++|+|||++........ ......+++.|+|||.+.+..++.++||
T Consensus 124 ql~~~l~~lH~~g---ivH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~~~-~~~~~~~~~~y~~pE~~~~~~~~~~~Dv 199 (292)
T cd06657 124 AVLKALSVLHAQG---VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVP-RRKSLVGTPYWMAPELISRLPYGPEVDI 199 (292)
T ss_pred HHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEEcccccceecccccc-cccccccCccccCHHHhcCCCCCchhhH
Confidence 9999999999998 99999999999999999999999999876543321 2233457899999999988889999999
Q ss_pred HhHHHHHHHHHhCCCCCCccchhhcccHHHHHHHHhhhhhhHHHhhhhhhccCChhHHHHHHHHHHHHhccCCCCCCCHH
Q 044312 462 YSFGVVLTELLTGEKPIRFTILEEDKSLAAYFLCAMKEERLFEILDARVMKQGGKDEIITVAKLAKRCLNLNGKKRPTMR 541 (608)
Q Consensus 462 ~S~Gvvl~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~ 541 (608)
||||++++||++|..||........ ...... .+.... ......+..+.+++.+||..+|.+||++.
T Consensus 200 ~slGvil~el~tg~~p~~~~~~~~~-------~~~~~~-----~~~~~~--~~~~~~~~~l~~li~~~l~~~P~~R~~~~ 265 (292)
T cd06657 200 WSLGIMVIEMVDGEPPYFNEPPLKA-------MKMIRD-----NLPPKL--KNLHKVSPSLKGFLDRLLVRDPAQRATAA 265 (292)
T ss_pred HHHHHHHHHHHhCCCCCCCCCHHHH-------HHHHHh-----hCCccc--CCcccCCHHHHHHHHHHHhCCcccCcCHH
Confidence 9999999999999999863221110 000000 000000 01123455788999999999999999999
Q ss_pred HHHHH
Q 044312 542 EVASE 546 (608)
Q Consensus 542 evl~~ 546 (608)
+++++
T Consensus 266 ~ll~~ 270 (292)
T cd06657 266 ELLKH 270 (292)
T ss_pred HHhcC
Confidence 99874
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.4e-31 Score=276.71 Aligned_cols=252 Identities=23% Similarity=0.310 Sum_probs=179.1
Q ss_pred cCccccceeccCce---------------EEEEEeecC--hhhHHHHHHHHHHHhhcCCCCccceecccccCc-------
Q 044312 289 DNFDLNRILGQGGQ---------------AVKKSKVID--ESKVEEFINEVVILSQINHRNVVKLLGCCLETE------- 344 (608)
Q Consensus 289 ~~f~~~~~lG~G~~---------------avk~~~~~~--~~~~~~~~~Ei~il~~l~H~niv~l~~~~~~~~------- 344 (608)
++|++.++||+|++ |||+..... ......+.+|++++++++||||+++++++....
T Consensus 12 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 91 (310)
T cd07865 12 SKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPYNRYK 91 (310)
T ss_pred hheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEecccccccCCC
Confidence 46888899999874 666654322 223345678999999999999999999886554
Q ss_pred -cceEEEeecCCCccchhccccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEEcCCCcEEEeeccC
Q 044312 345 -VPLLVYEFIPNGTLFQYIHDQNEDFPITWEIRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGA 423 (608)
Q Consensus 345 -~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGl 423 (608)
..++||||+. ++|.+.+..... .+++..++.++.||+.||+|||+++ ++|+||||+|||++.++.+||+|||+
T Consensus 92 ~~~~lv~e~~~-~~l~~~l~~~~~--~~~~~~~~~i~~qi~~al~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~ 165 (310)
T cd07865 92 GSFYLVFEFCE-HDLAGLLSNKNV--KFTLSEIKKVMKMLLNGLYYIHRNK---ILHRDMKAANILITKDGILKLADFGL 165 (310)
T ss_pred ceEEEEEcCCC-cCHHHHHHhccc--CCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEECCCCcEEECcCCC
Confidence 3499999996 478887765432 4899999999999999999999998 99999999999999999999999999
Q ss_pred ccccccCCcc---eeeeeeccCCCCChhhhccC-CCCCccchHhHHHHHHHHHhCCCCCCccchhhcccHHHHHHHHhhh
Q 044312 424 SRSMAVDQTH---MTTQVHGTFGYLDPEYFRSS-QFTDKSDVYSFGVVLTELLTGEKPIRFTILEEDKSLAAYFLCAMKE 499 (608)
Q Consensus 424 s~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~-~~t~ksDV~S~Gvvl~elltg~~p~~~~~~~~~~~l~~~~~~~~~~ 499 (608)
+......... ......++..|+|||.+.+. .++.++||||||++++||++|+.||..............+......
T Consensus 166 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~~~~~~~~~~~~~~~~~ 245 (310)
T cd07865 166 ARAFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQLTLISQLCGSITP 245 (310)
T ss_pred cccccCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCh
Confidence 9866432211 12234577889999998664 4788999999999999999999998643322111111111100000
Q ss_pred hhhH-----HHhhh---------hhhcc-CChhHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 044312 500 ERLF-----EILDA---------RVMKQ-GGKDEIITVAKLAKRCLNLNGKKRPTMREVASE 546 (608)
Q Consensus 500 ~~~~-----~~~d~---------~~~~~-~~~~~~~~l~~Li~~cl~~dp~~RPs~~evl~~ 546 (608)
.... ...+. ..... ........+.+|+.+||+.||++|||++|++++
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~t~~e~l~h 307 (310)
T cd07865 246 EVWPGVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTALNH 307 (310)
T ss_pred hhcccccchhhhhhccCCCccchhhHHhcccccCCHHHHHHHHHHhcCChhhccCHHHHhcC
Confidence 0000 00000 00000 000123457899999999999999999999853
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.9e-32 Score=282.22 Aligned_cols=251 Identities=26% Similarity=0.352 Sum_probs=181.6
Q ss_pred hcCccccceeccCce---------------EEEEEee--cChhhHHHHHHHHHHHhhc-CCCCccceecccccC--ccce
Q 044312 288 TDNFDLNRILGQGGQ---------------AVKKSKV--IDESKVEEFINEVVILSQI-NHRNVVKLLGCCLET--EVPL 347 (608)
Q Consensus 288 t~~f~~~~~lG~G~~---------------avk~~~~--~~~~~~~~~~~Ei~il~~l-~H~niv~l~~~~~~~--~~~~ 347 (608)
.++|++.+.||+|++ |+|+... ........+.+|+.+++++ +||||+++++++... ...+
T Consensus 6 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~~~~ 85 (337)
T cd07852 6 LRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDKDIY 85 (337)
T ss_pred hhHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCceEE
Confidence 456777777887763 5565532 2334556788999999999 999999999988643 3679
Q ss_pred EEEeecCCCccchhccccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEEcCCCcEEEeeccCcccc
Q 044312 348 LVYEFIPNGTLFQYIHDQNEDFPITWEIRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSM 427 (608)
Q Consensus 348 lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGls~~~ 427 (608)
+||||++ ++|.+++... .+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++..
T Consensus 86 lv~e~~~-~~L~~~~~~~----~~~~~~~~~i~~qi~~~L~~LH~~~---i~H~dl~p~nill~~~~~~kl~d~g~~~~~ 157 (337)
T cd07852 86 LVFEYME-TDLHAVIRAN----ILEDVHKRYIMYQLLKALKYIHSGN---VIHRDLKPSNILLNSDCRVKLADFGLARSL 157 (337)
T ss_pred EEecccc-cCHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCcEEEeeccchhcc
Confidence 9999996 5898888653 4889999999999999999999998 999999999999999999999999999876
Q ss_pred ccCCc----ceeeeeeccCCCCChhhhcc-CCCCCccchHhHHHHHHHHHhCCCCCCccchhhcccHHHHH--------H
Q 044312 428 AVDQT----HMTTQVHGTFGYLDPEYFRS-SQFTDKSDVYSFGVVLTELLTGEKPIRFTILEEDKSLAAYF--------L 494 (608)
Q Consensus 428 ~~~~~----~~~~~~~gt~~y~aPE~~~~-~~~t~ksDV~S~Gvvl~elltg~~p~~~~~~~~~~~l~~~~--------~ 494 (608)
..... .......++..|+|||.+.. ..++.++||||||++++||++|+.||............... .
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 237 (337)
T cd07852 158 SELEENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVIGPPSAEDI 237 (337)
T ss_pred ccccccccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHH
Confidence 53322 12233468899999998765 46789999999999999999999998643221110000000 0
Q ss_pred HHhhhhhhHHHhhhh------hhccCChhHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 044312 495 CAMKEERLFEILDAR------VMKQGGKDEIITVAKLAKRCLNLNGKKRPTMREVASE 546 (608)
Q Consensus 495 ~~~~~~~~~~~~d~~------~~~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~evl~~ 546 (608)
..+.......+++.. .........+.++.+++.+||+.+|++|||+.+++++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~~il~~ 295 (337)
T cd07852 238 ESIKSPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALEH 295 (337)
T ss_pred HHHHhhhHHHhhhhcccccccchhhhccCCCHHHHHHHHHhccCCcccccCHHHHhhC
Confidence 000000001111100 0001111245679999999999999999999999975
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-31 Score=281.64 Aligned_cols=253 Identities=21% Similarity=0.308 Sum_probs=184.3
Q ss_pred hcCccccceeccCce---------------EEEEEeec--ChhhHHHHHHHHHHHhhcCCCCccceeccccc----Cccc
Q 044312 288 TDNFDLNRILGQGGQ---------------AVKKSKVI--DESKVEEFINEVVILSQINHRNVVKLLGCCLE----TEVP 346 (608)
Q Consensus 288 t~~f~~~~~lG~G~~---------------avk~~~~~--~~~~~~~~~~Ei~il~~l~H~niv~l~~~~~~----~~~~ 346 (608)
.++|++.+.||+|++ |+|+.... .....+.+.+|+.+|++++||||+++++++.. ....
T Consensus 4 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 83 (334)
T cd07855 4 GSRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKDV 83 (334)
T ss_pred hhceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCceE
Confidence 367888888999874 55655432 22345678899999999999999999998753 3467
Q ss_pred eEEEeecCCCccchhccccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEEcCCCcEEEeeccCccc
Q 044312 347 LLVYEFIPNGTLFQYIHDQNEDFPITWEIRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRS 426 (608)
Q Consensus 347 ~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGls~~ 426 (608)
++||||+. ++|.+++.... .+++..+..++.||+.||+|||+.+ |+||||||+|||+++++.+||+|||+++.
T Consensus 84 ~lv~e~~~-~~l~~~~~~~~---~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~Nil~~~~~~~kl~dfg~~~~ 156 (334)
T cd07855 84 YVVMDLME-SDLHHIIHSDQ---PLTEEHIRYFLYQLLRGLKYIHSAN---VIHRDLKPSNLLVNEDCELRIGDFGMARG 156 (334)
T ss_pred EEEEehhh-hhHHHHhccCC---CCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCcEEeccccccee
Confidence 99999995 68988886543 4899999999999999999999999 99999999999999999999999999976
Q ss_pred cccCCcc---eeeeeeccCCCCChhhhcc-CCCCCccchHhHHHHHHHHHhCCCCCCccchhhcccHHHH--------HH
Q 044312 427 MAVDQTH---MTTQVHGTFGYLDPEYFRS-SQFTDKSDVYSFGVVLTELLTGEKPIRFTILEEDKSLAAY--------FL 494 (608)
Q Consensus 427 ~~~~~~~---~~~~~~gt~~y~aPE~~~~-~~~t~ksDV~S~Gvvl~elltg~~p~~~~~~~~~~~l~~~--------~~ 494 (608)
....... ......++..|+|||.+.. ..++.++||||||++++||++|+.||.............. +.
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~~~~~~~~~~g~~~~~~~ 236 (334)
T cd07855 157 LSSSPTEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVLGSPSEEVL 236 (334)
T ss_pred ecccCcCCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChHHHHHHHHHHhCCChhHhh
Confidence 5432211 1123468889999999865 4689999999999999999999999964322111000000 00
Q ss_pred HHhhhhhhHHHhhhhh-hcc-----CChhHHHHHHHHHHHHhccCCCCCCCHHHHHHHH
Q 044312 495 CAMKEERLFEILDARV-MKQ-----GGKDEIITVAKLAKRCLNLNGKKRPTMREVASEL 547 (608)
Q Consensus 495 ~~~~~~~~~~~~d~~~-~~~-----~~~~~~~~l~~Li~~cl~~dp~~RPs~~evl~~L 547 (608)
.......+.+..+... ... .....+.++.+++.+||+.+|++||++.+++.+-
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~~ 295 (334)
T cd07855 237 NRIGSDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQHP 295 (334)
T ss_pred hhhchhhHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHHhCh
Confidence 0111111111111000 000 0123467899999999999999999999998754
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.3e-31 Score=268.28 Aligned_cols=236 Identities=23% Similarity=0.332 Sum_probs=182.2
Q ss_pred CccccceeccCce---------------EEEEEeec-----ChhhHHHHHHHHHHHhhcCCCCccceecccccCccceEE
Q 044312 290 NFDLNRILGQGGQ---------------AVKKSKVI-----DESKVEEFINEVVILSQINHRNVVKLLGCCLETEVPLLV 349 (608)
Q Consensus 290 ~f~~~~~lG~G~~---------------avk~~~~~-----~~~~~~~~~~Ei~il~~l~H~niv~l~~~~~~~~~~~lV 349 (608)
+|.+.++||+|++ ++|..+.. ......++..|+.++++++||||+++++++.+....++|
T Consensus 1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 80 (260)
T cd08222 1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERDAFCII 80 (260)
T ss_pred CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCCceEEE
Confidence 4677788888874 23333221 223345677899999999999999999999999999999
Q ss_pred EeecCCCccchhccccC-CCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEEcCCCcEEEeeccCccccc
Q 044312 350 YEFIPNGTLFQYIHDQN-EDFPITWEIRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMA 428 (608)
Q Consensus 350 ~E~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGls~~~~ 428 (608)
|||+++++|.+++.... ....+++..++.++.|++.||.|||+.+ ++|+||+|+||++++ +.+||+|||+++...
T Consensus 81 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~h~~l~~~nili~~-~~~~l~d~g~~~~~~ 156 (260)
T cd08222 81 TEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQRR---ILHRDLKAKNIFLKN-NLLKIGDFGVSRLLM 156 (260)
T ss_pred EEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHcC---ccccCCChhheEeec-CCEeecccCceeecC
Confidence 99999999999886521 2235899999999999999999999998 999999999999986 469999999987764
Q ss_pred cCCcceeeeeeccCCCCChhhhccCCCCCccchHhHHHHHHHHHhCCCCCCccchhhcccHHHHHHHHhhhhhhHHHhhh
Q 044312 429 VDQTHMTTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLTELLTGEKPIRFTILEEDKSLAAYFLCAMKEERLFEILDA 508 (608)
Q Consensus 429 ~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 508 (608)
... .......+++.|+|||.+....++.++||||||+++++|++|..||.... ....... +..
T Consensus 157 ~~~-~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~------~~~~~~~---------~~~- 219 (260)
T cd08222 157 GSC-DLATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQN------FLSVVLR---------IVE- 219 (260)
T ss_pred CCc-ccccCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCcc------HHHHHHH---------HHc-
Confidence 322 22234557889999999988889999999999999999999999985221 1111110 000
Q ss_pred hhhccCChhHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 044312 509 RVMKQGGKDEIITVAKLAKRCLNLNGKKRPTMREVASE 546 (608)
Q Consensus 509 ~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~evl~~ 546 (608)
......+...+.++.+++.+||+.+|++||++.|++++
T Consensus 220 ~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 257 (260)
T cd08222 220 GPTPSLPETYSRQLNSIMQSMLNKDPSLRPSAAEILRN 257 (260)
T ss_pred CCCCCCcchhcHHHHHHHHHHhcCChhhCcCHHHHhhC
Confidence 01112233556789999999999999999999999863
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=3e-31 Score=271.96 Aligned_cols=216 Identities=25% Similarity=0.284 Sum_probs=171.4
Q ss_pred HHHHHHHHHHHhhc-CCCCccceecccccCccceEEEeecCCCccchhccccCCCCCCCHHHHHHHHHHHHHHHHHHhhc
Q 044312 315 VEEFINEVVILSQI-NHRNVVKLLGCCLETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEIRLRIAIEVSGALSYLHSA 393 (608)
Q Consensus 315 ~~~~~~Ei~il~~l-~H~niv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~ 393 (608)
.+.+.+|+.+++++ +|+||+++++.+......++||||+++++|.+++.... .+++..+..++.|+++||.|||+.
T Consensus 48 ~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~---~~~~~~~~~~~~ql~~~l~~lH~~ 124 (288)
T cd05583 48 AEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKLHLILDYVNGGELFTHLYQRE---HFTESEVRVYIAEIVLALDHLHQL 124 (288)
T ss_pred HHHHHHHHHHHHhccCCcchhhhheeeecCCEEEEEEecCCCCcHHHHHhhcC---CcCHHHHHHHHHHHHHHHHHHHHC
Confidence 45688999999999 69999999999999999999999999999999987543 589999999999999999999999
Q ss_pred CCCCeeccCCCCCcEEEcCCCcEEEeeccCccccccCCcceeeeeeccCCCCChhhhccCC--CCCccchHhHHHHHHHH
Q 044312 394 ASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHGTFGYLDPEYFRSSQ--FTDKSDVYSFGVVLTEL 471 (608)
Q Consensus 394 ~~~~iiHrDlk~~NILl~~~~~~kl~DFGls~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~t~ksDV~S~Gvvl~el 471 (608)
+ ++||||||+||+++.++.++|+|||+++..............++..|+|||.+.+.. .+.++||||||++++||
T Consensus 125 ~---~~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el 201 (288)
T cd05583 125 G---IIYRDIKLENILLDSEGHVVLTDFGLSKEFLAEEEERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFEL 201 (288)
T ss_pred C---eeccCCCHHHeEECCCCCEEEEECccccccccccccccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHH
Confidence 8 999999999999999999999999998876543332233456889999999987665 78899999999999999
Q ss_pred HhCCCCCCccchhhcccHHHHHHHHhhhhhhHHHhhhhhhccCChhHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHh
Q 044312 472 LTGEKPIRFTILEEDKSLAAYFLCAMKEERLFEILDARVMKQGGKDEIITVAKLAKRCLNLNGKKRPTMREVASELAG 549 (608)
Q Consensus 472 ltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~evl~~L~~ 549 (608)
++|..||...... ..... ... .+... ....+...+..+.+++.+||+.+|++|||+.++.+.|+.
T Consensus 202 ~tg~~p~~~~~~~--~~~~~-~~~--------~~~~~--~~~~~~~~~~~l~~li~~~l~~~p~~R~t~~~~~~~l~~ 266 (288)
T cd05583 202 LTGASPFTVDGEQ--NSQSE-ISR--------RILKS--KPPFPKTMSAEARDFIQKLLEKDPKKRLGANGADEIKNH 266 (288)
T ss_pred HhCCCCcccCccc--chHHH-HHH--------HHHcc--CCCCCcccCHHHHHHHHHHhcCCHhhccCcchHHHHhcC
Confidence 9999998532111 00010 000 00000 011223345678999999999999999999888776644
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.5e-31 Score=277.27 Aligned_cols=249 Identities=24% Similarity=0.316 Sum_probs=181.1
Q ss_pred hcCccccceeccCce---------------EEEEEeecCh--hhHHHHHHHHHHHhhcCCCCccceecccccC--ccceE
Q 044312 288 TDNFDLNRILGQGGQ---------------AVKKSKVIDE--SKVEEFINEVVILSQINHRNVVKLLGCCLET--EVPLL 348 (608)
Q Consensus 288 t~~f~~~~~lG~G~~---------------avk~~~~~~~--~~~~~~~~Ei~il~~l~H~niv~l~~~~~~~--~~~~l 348 (608)
.++|++.+.||+|++ |+|+.+.... .....+.+|+.++++++|+||+++++++.+. +..++
T Consensus 6 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 85 (309)
T cd07845 6 VTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVGKHLDSIFL 85 (309)
T ss_pred ccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEecCCCCeEEE
Confidence 356888888998863 6676654322 2234567899999999999999999998654 46799
Q ss_pred EEeecCCCccchhccccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEEcCCCcEEEeeccCccccc
Q 044312 349 VYEFIPNGTLFQYIHDQNEDFPITWEIRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMA 428 (608)
Q Consensus 349 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGls~~~~ 428 (608)
||||+. ++|.+++.... ..+++..+..++.|++.||+|||+.+ ++||||||+|||+++++.+||+|||++....
T Consensus 86 v~e~~~-~~l~~~l~~~~--~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~kL~dfg~~~~~~ 159 (309)
T cd07845 86 VMEYCE-QDLASLLDNMP--TPFSESQVKCLMLQLLRGLQYLHENF---IIHRDLKVSNLLLTDKGCLKIADFGLARTYG 159 (309)
T ss_pred EEecCC-CCHHHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEECccceeeecC
Confidence 999996 48888877543 25899999999999999999999999 9999999999999999999999999998765
Q ss_pred cCCcceeeeeeccCCCCChhhhcc-CCCCCccchHhHHHHHHHHHhCCCCCCccchhhcccHHHHHHHHhhh--hhhHHH
Q 044312 429 VDQTHMTTQVHGTFGYLDPEYFRS-SQFTDKSDVYSFGVVLTELLTGEKPIRFTILEEDKSLAAYFLCAMKE--ERLFEI 505 (608)
Q Consensus 429 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~t~ksDV~S~Gvvl~elltg~~p~~~~~~~~~~~l~~~~~~~~~~--~~~~~~ 505 (608)
.... ......+++.|+|||.+.+ ..++.++||||||++++||++|+.||......+. .......... ......
T Consensus 160 ~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~~~~---~~~~~~~~~~~~~~~~~~ 235 (309)
T cd07845 160 LPAK-PMTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQ---LDLIIQLLGTPNESIWPG 235 (309)
T ss_pred CccC-CCCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCHHHH---HHHHHHhcCCCChhhchh
Confidence 3321 1223345788999999865 4578999999999999999999999864322111 1111111000 000000
Q ss_pred hhh-----h--hhcc-------CChhHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 044312 506 LDA-----R--VMKQ-------GGKDEIITVAKLAKRCLNLNGKKRPTMREVASE 546 (608)
Q Consensus 506 ~d~-----~--~~~~-------~~~~~~~~l~~Li~~cl~~dp~~RPs~~evl~~ 546 (608)
++. . .... .....+..+.+++.+||+.||++|||+.|++++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il~h 290 (309)
T cd07845 236 FSDLPLVGKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALES 290 (309)
T ss_pred hhcccccccccccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcCHHHHhcC
Confidence 000 0 0000 001135678899999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.9e-31 Score=281.95 Aligned_cols=246 Identities=22% Similarity=0.317 Sum_probs=182.8
Q ss_pred HhcCccccceeccCce---------------EEEEEee--cChhhHHHHHHHHHHHhhcCCCCccceecccccC------
Q 044312 287 ATDNFDLNRILGQGGQ---------------AVKKSKV--IDESKVEEFINEVVILSQINHRNVVKLLGCCLET------ 343 (608)
Q Consensus 287 ~t~~f~~~~~lG~G~~---------------avk~~~~--~~~~~~~~~~~Ei~il~~l~H~niv~l~~~~~~~------ 343 (608)
..++|+..+.||+|++ |+|.... .+....+.+.+|+.++++++|+||+++++++...
T Consensus 14 ~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 93 (353)
T cd07850 14 VLKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEEF 93 (353)
T ss_pred hhcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCcccc
Confidence 4567999999999974 5565432 2334456788999999999999999999988643
Q ss_pred ccceEEEeecCCCccchhccccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEEcCCCcEEEeeccC
Q 044312 344 EVPLLVYEFIPNGTLFQYIHDQNEDFPITWEIRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGA 423 (608)
Q Consensus 344 ~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGl 423 (608)
...++||||+. ++|.+.+.. .+++..+..++.|++.||+|||+.+ ++||||||+|||++.++.+||+|||+
T Consensus 94 ~~~~lv~e~~~-~~l~~~~~~-----~l~~~~~~~~~~ql~~aL~~LH~~g---i~H~dlkp~Nil~~~~~~~kL~Dfg~ 164 (353)
T cd07850 94 QDVYLVMELMD-ANLCQVIQM-----DLDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGL 164 (353)
T ss_pred CcEEEEEeccC-CCHHHHHhh-----cCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEECCCCCEEEccCcc
Confidence 34699999995 588877753 2788999999999999999999999 99999999999999999999999999
Q ss_pred ccccccCCcceeeeeeccCCCCChhhhccCCCCCccchHhHHHHHHHHHhCCCCCCccchhhcccHHHHHHHHhhh--hh
Q 044312 424 SRSMAVDQTHMTTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLTELLTGEKPIRFTILEEDKSLAAYFLCAMKE--ER 501 (608)
Q Consensus 424 s~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~elltg~~p~~~~~~~~~~~l~~~~~~~~~~--~~ 501 (608)
++...... ......++..|+|||.+.+..++.++||||||+++++|++|+.||........ .......... ..
T Consensus 165 ~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~---~~~~~~~~~~~~~~ 239 (353)
T cd07850 165 ARTAGTSF--MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPGTDHIDQ---WNKIIEQLGTPSDE 239 (353)
T ss_pred ceeCCCCC--CCCCCcccccccCHHHHhCCCCCCchhhHhHHHHHHHHHHCCCCCCCCCHHHH---HHHHHHhcCCCCHH
Confidence 98654322 12334578899999999999999999999999999999999999864322110 0000000000 00
Q ss_pred hHHHh-----------------------hhhh----hccCChhHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 044312 502 LFEIL-----------------------DARV----MKQGGKDEIITVAKLAKRCLNLNGKKRPTMREVASE 546 (608)
Q Consensus 502 ~~~~~-----------------------d~~~----~~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~evl~~ 546 (608)
+.+.+ .... ........+..+.+++.+||+.||++|||+.|++++
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eiL~~ 311 (353)
T cd07850 240 FMSRLQPTVRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDDALQH 311 (353)
T ss_pred HHHHhhhhhhHHhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 00000 0000 000012345678999999999999999999999864
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.3e-31 Score=274.41 Aligned_cols=226 Identities=26% Similarity=0.360 Sum_probs=169.9
Q ss_pred EEEEEeec-ChhhHHHHHHHHHHHhhcC-CCCccceecccccCccceEEEeecCCCccchhc---cccCCCCCCCHHHHH
Q 044312 303 AVKKSKVI-DESKVEEFINEVVILSQIN-HRNVVKLLGCCLETEVPLLVYEFIPNGTLFQYI---HDQNEDFPITWEIRL 377 (608)
Q Consensus 303 avk~~~~~-~~~~~~~~~~Ei~il~~l~-H~niv~l~~~~~~~~~~~lV~E~~~~gsL~~~l---~~~~~~~~l~~~~~~ 377 (608)
|+|..... .......+.+|+.++.++. |+||+++++++......+++|||+.. +|.++. .... ...+++..+.
T Consensus 33 aiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~~~e~~~~-~l~~l~~~~~~~~-~~~l~~~~~~ 110 (288)
T cd06616 33 AVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWICMELMDI-SLDKFYKYVYEVL-KSVIPEEILG 110 (288)
T ss_pred EEEEehhccChHHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEEEEEecccC-CHHHHHHHHHHhh-cCCCCHHHHH
Confidence 66665432 2344567899999999996 99999999999988899999999854 555433 2221 2358999999
Q ss_pred HHHHHHHHHHHHHhhc-CCCCeeccCCCCCcEEEcCCCcEEEeeccCccccccCCcceeeeeeccCCCCChhhhccC---
Q 044312 378 RIAIEVSGALSYLHSA-ASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHGTFGYLDPEYFRSS--- 453 (608)
Q Consensus 378 ~i~~~ia~aL~yLH~~-~~~~iiHrDlk~~NILl~~~~~~kl~DFGls~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--- 453 (608)
.++.+++.||+|||+. + ++||||||+|||++.++.+||+|||+++....... .....++..|+|||++...
T Consensus 111 ~i~~~i~~~l~~lh~~~~---i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~ 185 (288)
T cd06616 111 KIAVATVKALNYLKEELK---IIHRDVKPSNILLDRNGNIKLCDFGISGQLVDSIA--KTRDAGCRPYMAPERIDPSARD 185 (288)
T ss_pred HHHHHHHHHHHHHhhcCC---eeccCCCHHHEEEccCCcEEEeecchhHHhccCCc--cccccCccCccCHHHhcccccc
Confidence 9999999999999975 7 99999999999999999999999999976543221 1233578899999998876
Q ss_pred CCCCccchHhHHHHHHHHHhCCCCCCccchhhcccHHHHHHHHhhhhhhHHHhhhhhhccCChhHHHHHHHHHHHHhccC
Q 044312 454 QFTDKSDVYSFGVVLTELLTGEKPIRFTILEEDKSLAAYFLCAMKEERLFEILDARVMKQGGKDEIITVAKLAKRCLNLN 533 (608)
Q Consensus 454 ~~t~ksDV~S~Gvvl~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~Li~~cl~~d 533 (608)
.++.++||||||++++||++|+.||.... ............. .+.+........+.++.+|+.+||+.+
T Consensus 186 ~~~~~~Di~slG~il~el~~g~~p~~~~~-----~~~~~~~~~~~~~------~~~~~~~~~~~~~~~l~~li~~~l~~~ 254 (288)
T cd06616 186 GYDVRSDVWSLGITLYEVATGKFPYPKWN-----SVFDQLTQVVKGD------PPILSNSEEREFSPSFVNFINLCLIKD 254 (288)
T ss_pred CCcchhhhhHHHHHHHHHHhCCCCchhcc-----hHHHHHhhhcCCC------CCcCCCcCCCccCHHHHHHHHHHccCC
Confidence 68999999999999999999999986321 1111111000000 011111222345678999999999999
Q ss_pred CCCCCCHHHHHHH
Q 044312 534 GKKRPTMREVASE 546 (608)
Q Consensus 534 p~~RPs~~evl~~ 546 (608)
|++|||+.||+++
T Consensus 255 p~~Rpt~~~i~~~ 267 (288)
T cd06616 255 ESKRPKYKELLEH 267 (288)
T ss_pred hhhCcCHHHHhcC
Confidence 9999999999875
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.3e-31 Score=280.13 Aligned_cols=250 Identities=25% Similarity=0.356 Sum_probs=186.0
Q ss_pred CccccceeccCce---------------EEEEEeecC--hhhHHHHHHHHHHHhhcCCCCccceecccccCc-----cce
Q 044312 290 NFDLNRILGQGGQ---------------AVKKSKVID--ESKVEEFINEVVILSQINHRNVVKLLGCCLETE-----VPL 347 (608)
Q Consensus 290 ~f~~~~~lG~G~~---------------avk~~~~~~--~~~~~~~~~Ei~il~~l~H~niv~l~~~~~~~~-----~~~ 347 (608)
+|++.+.||+|++ |+|+..... ....+.+.+|+.++++++|+||+++++++.... ..+
T Consensus 1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 80 (330)
T cd07834 1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVY 80 (330)
T ss_pred CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccceE
Confidence 4677778888763 666665432 445678999999999999999999999998775 789
Q ss_pred EEEeecCCCccchhccccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEEcCCCcEEEeeccCcccc
Q 044312 348 LVYEFIPNGTLFQYIHDQNEDFPITWEIRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSM 427 (608)
Q Consensus 348 lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGls~~~ 427 (608)
+||||++ ++|.+++.... ++++..+..++.|++.||+|||+.+ |+|+||||+|||++.++.++|+|||++...
T Consensus 81 lv~e~~~-~~l~~~l~~~~---~l~~~~~~~i~~~l~~~l~~LH~~g---i~H~dlkp~nili~~~~~~~L~dfg~~~~~ 153 (330)
T cd07834 81 IVTELME-TDLHKVIKSPQ---PLTDDHIQYFLYQILRGLKYLHSAN---VIHRDLKPSNILVNSNCDLKICDFGLARGV 153 (330)
T ss_pred EEecchh-hhHHHHHhCCC---CCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEcccCceEee
Confidence 9999997 58888886543 5999999999999999999999999 999999999999999999999999999876
Q ss_pred ccCCc--ceeeeeeccCCCCChhhhccC-CCCCccchHhHHHHHHHHHhCCCCCCccchhhcccHHHHHHHH--------
Q 044312 428 AVDQT--HMTTQVHGTFGYLDPEYFRSS-QFTDKSDVYSFGVVLTELLTGEKPIRFTILEEDKSLAAYFLCA-------- 496 (608)
Q Consensus 428 ~~~~~--~~~~~~~gt~~y~aPE~~~~~-~~t~ksDV~S~Gvvl~elltg~~p~~~~~~~~~~~l~~~~~~~-------- 496 (608)
..... .......++..|+|||.+.+. .++.++||||||+++++|++|+.||......+...........
T Consensus 154 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 233 (330)
T cd07834 154 DPDEDEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNLIVEVLGTPSEEDLKF 233 (330)
T ss_pred cccccccccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHhcCCCChhHhhh
Confidence 54321 122334578899999999887 8899999999999999999999999744322110000000000
Q ss_pred hhhhhhHHHhhh------hhhccCChhHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 044312 497 MKEERLFEILDA------RVMKQGGKDEIITVAKLAKRCLNLNGKKRPTMREVASE 546 (608)
Q Consensus 497 ~~~~~~~~~~d~------~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~evl~~ 546 (608)
.........+.. ....+.....+..+.+++.+||+.+|++||++.+++++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~ 289 (330)
T cd07834 234 ITSEKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAH 289 (330)
T ss_pred ccccchhhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence 000000011100 00001112245678999999999999999999999875
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.7e-33 Score=311.80 Aligned_cols=238 Identities=25% Similarity=0.320 Sum_probs=189.0
Q ss_pred hcCccccceeccCce---------------EEEEEeecC--hhhHHHHHHHHHHHhhcCCCCccceecccccCccceEEE
Q 044312 288 TDNFDLNRILGQGGQ---------------AVKKSKVID--ESKVEEFINEVVILSQINHRNVVKLLGCCLETEVPLLVY 350 (608)
Q Consensus 288 t~~f~~~~~lG~G~~---------------avk~~~~~~--~~~~~~~~~Ei~il~~l~H~niv~l~~~~~~~~~~~lV~ 350 (608)
+-++.-..+||.|.| |+|.++..+ ........+|+.+|..|+|||+|+++|+-.+++..+|.|
T Consensus 1234 ~~rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRekv~IFM 1313 (1509)
T KOG4645|consen 1234 TFRWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREKVYIFM 1313 (1509)
T ss_pred eeeeccccccCCcceeeeEEeecCCccchhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCceeecHHHHHHHH
Confidence 445566778999876 667665533 334567889999999999999999999999999999999
Q ss_pred eecCCCccchhccccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEEcCCCcEEEeeccCccccccC
Q 044312 351 EFIPNGTLFQYIHDQNEDFPITWEIRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVD 430 (608)
Q Consensus 351 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGls~~~~~~ 430 (608)
|||++|+|.+.+...+ -.++.....+..|++.|++|||+++ |+||||||.||||+.+|.+|++|||.|..+...
T Consensus 1314 EyC~~GsLa~ll~~gr---i~dE~vt~vyt~qll~gla~LH~~g---IVHRDIK~aNI~Ld~~g~iK~~DFGsa~ki~~~ 1387 (1509)
T KOG4645|consen 1314 EYCEGGSLASLLEHGR---IEDEMVTRVYTKQLLEGLAYLHEHG---IVHRDIKPANILLDFNGLIKYGDFGSAVKIKNN 1387 (1509)
T ss_pred HHhccCcHHHHHHhcc---hhhhhHHHHHHHHHHHHHHHHHhcC---ceecCCCccceeeecCCcEEeecccceeEecCc
Confidence 9999999999987654 2566667778899999999999999 999999999999999999999999999887644
Q ss_pred Cc---ceeeeeeccCCCCChhhhccCC---CCCccchHhHHHHHHHHHhCCCCCCccchhhcccHHHHHHHHhhhhhhHH
Q 044312 431 QT---HMTTQVHGTFGYLDPEYFRSSQ---FTDKSDVYSFGVVLTELLTGEKPIRFTILEEDKSLAAYFLCAMKEERLFE 504 (608)
Q Consensus 431 ~~---~~~~~~~gt~~y~aPE~~~~~~---~t~ksDV~S~Gvvl~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~ 504 (608)
.. .......||+.|||||++.+.. ...+.||||+|||++||+||++||..... ..+.. -
T Consensus 1388 ~~~~~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dn----e~aIM-----------y 1452 (1509)
T KOG4645|consen 1388 AQTMPGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDN----EWAIM-----------Y 1452 (1509)
T ss_pred hhcCCHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccc----hhHHH-----------h
Confidence 21 1123567999999999997653 56789999999999999999999973221 11111 1
Q ss_pred HhhhhhhccCChhHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 044312 505 ILDARVMKQGGKDEIITVAKLAKRCLNLNGKKRPTMREVASE 546 (608)
Q Consensus 505 ~~d~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~evl~~ 546 (608)
.+......+.|...+.+-.+++.+||..||++|.++.|++++
T Consensus 1453 ~V~~gh~Pq~P~~ls~~g~dFle~Cl~~dP~~Rw~~~qlle~ 1494 (1509)
T KOG4645|consen 1453 HVAAGHKPQIPERLSSEGRDFLEHCLEQDPKMRWTASQLLEH 1494 (1509)
T ss_pred HHhccCCCCCchhhhHhHHHHHHHHHhcCchhhhHHHHHHHh
Confidence 111222334455577888999999999999999988877754
|
|
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.9e-31 Score=267.32 Aligned_cols=223 Identities=28% Similarity=0.365 Sum_probs=177.2
Q ss_pred eEEEEEeecCh---hhHHHHHHHHHHHhhcCCCCccceecccccCccceEEEeecCCCccchhccccCCCCCCCHHHHHH
Q 044312 302 QAVKKSKVIDE---SKVEEFINEVVILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEIRLR 378 (608)
Q Consensus 302 ~avk~~~~~~~---~~~~~~~~Ei~il~~l~H~niv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~ 378 (608)
+++|....... ...+.+.+|++++++++|+||+++++.+......++||||+++++|.+++.... .+++..+..
T Consensus 21 ~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~ 97 (265)
T cd05579 21 YAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGDLASLLENVG---SLDEDVARI 97 (265)
T ss_pred EEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEecCCCCcHHHHHHHcC---CCCHHHHHH
Confidence 57776654322 456789999999999999999999999999999999999999999999997643 589999999
Q ss_pred HHHHHHHHHHHHhhcCCCCeeccCCCCCcEEEcCCCcEEEeeccCccccccCCc-------ceeeeeeccCCCCChhhhc
Q 044312 379 IAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQT-------HMTTQVHGTFGYLDPEYFR 451 (608)
Q Consensus 379 i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGls~~~~~~~~-------~~~~~~~gt~~y~aPE~~~ 451 (608)
++.|++.||+|||+.+ ++|+||+|+|||+++++.+||+|||++........ .......++..|++||.+.
T Consensus 98 i~~qi~~~L~~lH~~~---i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~ 174 (265)
T cd05579 98 YIAEIVLALEYLHSNG---IIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTPDYIAPEVIL 174 (265)
T ss_pred HHHHHHHHHHHHHHcC---eecCCCCHHHeEEcCCCCEEEEecccchhcccCcccccccccccccCcccCccccCHHHhc
Confidence 9999999999999999 99999999999999999999999999876543321 1223345788999999999
Q ss_pred cCCCCCccchHhHHHHHHHHHhCCCCCCccchhhcccHHHHHHHHhhhhhhHHHhhhhhhccCChh--HHHHHHHHHHHH
Q 044312 452 SSQFTDKSDVYSFGVVLTELLTGEKPIRFTILEEDKSLAAYFLCAMKEERLFEILDARVMKQGGKD--EIITVAKLAKRC 529 (608)
Q Consensus 452 ~~~~t~ksDV~S~Gvvl~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~--~~~~l~~Li~~c 529 (608)
....+.++||||||++++||++|+.||...... ..+..... . . ...+.. .+..+.+++.+|
T Consensus 175 ~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~------~~~~~~~~-~--------~--~~~~~~~~~~~~~~~~i~~~ 237 (265)
T cd05579 175 GQGHSKTVDWWSLGCILYEFLVGIPPFHGETPE------EIFQNILN-G--------K--IEWPEDVEVSDEAIDLISKL 237 (265)
T ss_pred CCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHH------HHHHHHhc-C--------C--cCCCccccCCHHHHHHHHHH
Confidence 888999999999999999999999998633211 11111100 0 0 011112 257899999999
Q ss_pred hccCCCCCCCHHHHHHHH
Q 044312 530 LNLNGKKRPTMREVASEL 547 (608)
Q Consensus 530 l~~dp~~RPs~~evl~~L 547 (608)
|+.+|++|||+.++.+.|
T Consensus 238 l~~~p~~Rpt~~~~~~~l 255 (265)
T cd05579 238 LVPDPEKRLGAKSIEEIK 255 (265)
T ss_pred hcCCHhhcCCCccHHHHh
Confidence 999999999995555444
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.7e-32 Score=272.60 Aligned_cols=232 Identities=26% Similarity=0.362 Sum_probs=189.5
Q ss_pred hcCccccceeccCce----EE-----------EEE---eecChhhHHHHHHHHHHHhhcCCCCccceecccccCccceEE
Q 044312 288 TDNFDLNRILGQGGQ----AV-----------KKS---KVIDESKVEEFINEVVILSQINHRNVVKLLGCCLETEVPLLV 349 (608)
Q Consensus 288 t~~f~~~~~lG~G~~----av-----------k~~---~~~~~~~~~~~~~Ei~il~~l~H~niv~l~~~~~~~~~~~lV 349 (608)
.+.|+.-++||+||| |. |++ ++.........++|-.||++++.+.||.|-..|...+.++||
T Consensus 184 ~n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAfeTkd~LClV 263 (591)
T KOG0986|consen 184 KNTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAFETKDALCLV 263 (591)
T ss_pred ccceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeeecCCCceEEE
Confidence 456888999999997 22 111 111122334578899999999999999999999999999999
Q ss_pred EeecCCCccchhccccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEEcCCCcEEEeeccCcccccc
Q 044312 350 YEFIPNGTLFQYIHDQNEDFPITWEIRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAV 429 (608)
Q Consensus 350 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGls~~~~~ 429 (608)
+..|.||+|.-+|.+.+.. .++++..+-+|++|+-||++||+.. |+.|||||+|||||+.|+++|+|+|||..++.
T Consensus 264 LtlMNGGDLkfHiyn~g~~-gF~e~ra~FYAAEi~cGLehlH~~~---iVYRDLKPeNILLDd~GhvRISDLGLAvei~~ 339 (591)
T KOG0986|consen 264 LTLMNGGDLKFHIYNHGNP-GFDEQRARFYAAEIICGLEHLHRRR---IVYRDLKPENILLDDHGHVRISDLGLAVEIPE 339 (591)
T ss_pred EEeecCCceeEEeeccCCC-CCchHHHHHHHHHHHhhHHHHHhcc---eeeccCChhheeeccCCCeEeeccceEEecCC
Confidence 9999999999999887653 5999999999999999999999999 99999999999999999999999999998875
Q ss_pred CCcceeeeeeccCCCCChhhhccCCCCCccchHhHHHHHHHHHhCCCCCCccchhhcccHHHHHHHHhhhhhhHHHhhhh
Q 044312 430 DQTHMTTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLTELLTGEKPIRFTILEEDKSLAAYFLCAMKEERLFEILDAR 509 (608)
Q Consensus 430 ~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 509 (608)
.+. .+...||.+|||||++.+..|+...|.|||||+||||+.|+.||...... .+.+. +|.+
T Consensus 340 g~~--~~~rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~G~sPFr~~KeK------------vk~eE----vdrr 401 (591)
T KOG0986|consen 340 GKP--IRGRVGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIAGHSPFRQRKEK------------VKREE----VDRR 401 (591)
T ss_pred CCc--cccccCcccccCHHHHcCCcccCCccHHHHHhHHHHHHcccCchhhhhhh------------hhHHH----HHHH
Confidence 543 45558999999999999999999999999999999999999998632221 11111 2222
Q ss_pred h---hccCChhHHHHHHHHHHHHhccCCCCCCCHH
Q 044312 510 V---MKQGGKDEIITVAKLAKRCLNLNGKKRPTMR 541 (608)
Q Consensus 510 ~---~~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~ 541 (608)
. ..+.+...+++..+|.+..|..||++|...+
T Consensus 402 ~~~~~~ey~~kFS~eakslc~~LL~Kdp~~RLGcr 436 (591)
T KOG0986|consen 402 TLEDPEEYSDKFSEEAKSLCEGLLTKDPEKRLGCR 436 (591)
T ss_pred HhcchhhcccccCHHHHHHHHHHHccCHHHhccCC
Confidence 1 2234456677899999999999999997544
|
|
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.6e-31 Score=266.81 Aligned_cols=193 Identities=24% Similarity=0.351 Sum_probs=157.1
Q ss_pred CCCCccceecccccCccceEEEeecCCCccchhccccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcE
Q 044312 329 NHRNVVKLLGCCLETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEIRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNI 408 (608)
Q Consensus 329 ~H~niv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NI 408 (608)
+||||+++++.+...+..++||||+++++|.+++.... ++++..+..++.|+++||.|||+.+ ++||||||+||
T Consensus 67 ~h~~iv~~~~~~~~~~~~~iv~e~~~~~~L~~~l~~~~---~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~ni 140 (267)
T PHA03390 67 DNPNFIKLYYSVTTLKGHVLIMDYIKDGDLFDLLKKEG---KLSEAEVKKIIRQLVEALNDLHKHN---IIHNDIKLENV 140 (267)
T ss_pred cCCCEEEEEEEEecCCeeEEEEEcCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHE
Confidence 79999999999999999999999999999999997653 5899999999999999999999999 99999999999
Q ss_pred EEcCCC-cEEEeeccCccccccCCcceeeeeeccCCCCChhhhccCCCCCccchHhHHHHHHHHHhCCCCCCccchhhcc
Q 044312 409 LLDDKY-RAKVSDFGASRSMAVDQTHMTTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLTELLTGEKPIRFTILEEDK 487 (608)
Q Consensus 409 Ll~~~~-~~kl~DFGls~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~elltg~~p~~~~~~~~~~ 487 (608)
+++.++ .++|+|||+++...... ...++..|+|||++....++.++||||||++++||++|+.||.....+. .
T Consensus 141 l~~~~~~~~~l~dfg~~~~~~~~~-----~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~-~ 214 (267)
T PHA03390 141 LYDRAKDRIYLCDYGLCKIIGTPS-----CYDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDEE-L 214 (267)
T ss_pred EEeCCCCeEEEecCccceecCCCc-----cCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCcch-h
Confidence 999988 99999999987654322 2357899999999999999999999999999999999999987332211 0
Q ss_pred cHHHHHHHHhhhhhhHHHhhhhhhccCChhHHHHHHHHHHHHhccCCCCCCC-HHHHHH
Q 044312 488 SLAAYFLCAMKEERLFEILDARVMKQGGKDEIITVAKLAKRCLNLNGKKRPT-MREVAS 545 (608)
Q Consensus 488 ~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPs-~~evl~ 545 (608)
....+ ..... .........+..+.+++.+||+.+|.+||+ ++|+++
T Consensus 215 ~~~~~----------~~~~~--~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~l~ 261 (267)
T PHA03390 215 DLESL----------LKRQQ--KKLPFIKNVSKNANDFVQSMLKYNINYRLTNYNEIIK 261 (267)
T ss_pred hHHHH----------HHhhc--ccCCcccccCHHHHHHHHHHhccChhhCCchHHHHhc
Confidence 11111 00000 011122245678999999999999999996 688874
|
|
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.7e-31 Score=270.13 Aligned_cols=213 Identities=26% Similarity=0.306 Sum_probs=167.6
Q ss_pred hHHHHHHHHHHHhhc-CCCCccceecccccCccceEEEeecCCCccchhccccCCCCCCCHHHHHHHHHHHHHHHHHHhh
Q 044312 314 KVEEFINEVVILSQI-NHRNVVKLLGCCLETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEIRLRIAIEVSGALSYLHS 392 (608)
Q Consensus 314 ~~~~~~~Ei~il~~l-~H~niv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~ 392 (608)
..+.+.+|+.+++++ +|+||+++++++......++||||+++++|.+++.... ++++..+..++.|+++||.|||+
T Consensus 47 ~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~---~l~~~~~~~~~~qi~~al~~lH~ 123 (290)
T cd05613 47 TTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKLHLILDYINGGELFTHLSQRE---RFKEQEVQIYSGEIVLALEHLHK 123 (290)
T ss_pred HHHHHHHHHHHHHhcccCCChhceeeEeecCCeEEEEEecCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHh
Confidence 346788999999999 69999999999998889999999999999999987643 58899999999999999999999
Q ss_pred cCCCCeeccCCCCCcEEEcCCCcEEEeeccCccccccCCcceeeeeeccCCCCChhhhccC--CCCCccchHhHHHHHHH
Q 044312 393 AASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHGTFGYLDPEYFRSS--QFTDKSDVYSFGVVLTE 470 (608)
Q Consensus 393 ~~~~~iiHrDlk~~NILl~~~~~~kl~DFGls~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~t~ksDV~S~Gvvl~e 470 (608)
.+ ++||||+|+|||+++++.+||+|||+++..............|+..|+|||.+... .++.++||||||+++++
T Consensus 124 ~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ 200 (290)
T cd05613 124 LG---IIYRDIKLENILLDSNGHVVLTDFGLSKEFHEDEVERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYE 200 (290)
T ss_pred CC---eeccCCCHHHeEECCCCCEEEeeCccceecccccccccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHH
Confidence 98 99999999999999999999999999987654332223345688999999998753 47889999999999999
Q ss_pred HHhCCCCCCccchhhcccHHHHHHHHhhhhhhHHHhhhhhhccCChhHHHHHHHHHHHHhccCCCCCC-----CHHHHHH
Q 044312 471 LLTGEKPIRFTILEEDKSLAAYFLCAMKEERLFEILDARVMKQGGKDEIITVAKLAKRCLNLNGKKRP-----TMREVAS 545 (608)
Q Consensus 471 lltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RP-----s~~evl~ 545 (608)
|++|+.||...... ............. ....+...+..+.+++.+||+.+|++|| ++.+++.
T Consensus 201 ll~g~~p~~~~~~~--~~~~~~~~~~~~~-----------~~~~~~~~~~~~~~ll~~~l~~~p~~R~~~~~~~~~~l~~ 267 (290)
T cd05613 201 LLTGASPFTVDGEK--NSQAEISRRILKS-----------EPPYPQEMSALAKDIIQRLLMKDPKKRLGCGPSDADEIKK 267 (290)
T ss_pred HhcCCCCCCcCCcc--ccHHHHHHHhhcc-----------CCCCCccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHc
Confidence 99999998632211 1111111000000 1112334556789999999999999997 5666654
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.1e-31 Score=268.79 Aligned_cols=222 Identities=23% Similarity=0.258 Sum_probs=173.4
Q ss_pred eEEEEEeec---ChhhHHHHHHHHHHHhhcCCCCccceecccccCccceEEEeecCCCccchhccccCCCCCCCHHHHHH
Q 044312 302 QAVKKSKVI---DESKVEEFINEVVILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEIRLR 378 (608)
Q Consensus 302 ~avk~~~~~---~~~~~~~~~~Ei~il~~l~H~niv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~ 378 (608)
+|+|..... .....+.+.+|++++++++||||+++++.+...+..++||||+++++|.+++..... ..+++..++.
T Consensus 21 ~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~-~~~~~~~~~~ 99 (277)
T cd05577 21 YACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGDLKYHIYNVGE-PGFPEARAIF 99 (277)
T ss_pred EEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEecCCCCcHHHHHHHcCc-CCCCHHHHHH
Confidence 567766432 223345678899999999999999999999999999999999999999999876543 2589999999
Q ss_pred HHHHHHHHHHHHhhcCCCCeeccCCCCCcEEEcCCCcEEEeeccCccccccCCcceeeeeeccCCCCChhhhccCCCCCc
Q 044312 379 IAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHGTFGYLDPEYFRSSQFTDK 458 (608)
Q Consensus 379 i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGls~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k 458 (608)
++.|++.||.|||+.+ ++||||+|+|||+++++.+||+|||++....... ......++..|+|||++.+..++.+
T Consensus 100 ~~~ql~~~l~~lH~~~---i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~~~--~~~~~~~~~~y~~PE~~~~~~~~~~ 174 (277)
T cd05577 100 YAAQIICGLEHLHQRR---IVYRDLKPENVLLDDHGNVRISDLGLAVELKGGK--KIKGRAGTPGYMAPEVLQGEVYDFS 174 (277)
T ss_pred HHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEEccCcchhhhccCC--ccccccCCCCcCCHHHhcCCCCCch
Confidence 9999999999999999 9999999999999999999999999987654321 2233457889999999998889999
Q ss_pred cchHhHHHHHHHHHhCCCCCCccchhhcccHHHHHHHHhhhhhhHHHhhhhhhccCChhHHHHHHHHHHHHhccCCCCCC
Q 044312 459 SDVYSFGVVLTELLTGEKPIRFTILEEDKSLAAYFLCAMKEERLFEILDARVMKQGGKDEIITVAKLAKRCLNLNGKKRP 538 (608)
Q Consensus 459 sDV~S~Gvvl~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RP 538 (608)
+||||||+++++|++|+.||......... . .+..... ......+...+..+.+++.+||+.+|++||
T Consensus 175 ~Di~slG~il~~l~~g~~p~~~~~~~~~~--~----------~~~~~~~-~~~~~~~~~~~~~~~~li~~~l~~~p~~R~ 241 (277)
T cd05577 175 VDWFALGCTLYEMIAGRSPFRQRKEKVEK--E----------ELKRRTL-EMAVEYPDKFSPEAKDLCEALLQKDPEKRL 241 (277)
T ss_pred hhhHHHHHHHHHHhhCCCCCCCCcccccH--H----------HHHhccc-cccccCCccCCHHHHHHHHHHccCChhHcc
Confidence 99999999999999999998643221100 0 0000000 001122234466899999999999999999
Q ss_pred CHHH
Q 044312 539 TMRE 542 (608)
Q Consensus 539 s~~e 542 (608)
+.+|
T Consensus 242 ~~~~ 245 (277)
T cd05577 242 GCRG 245 (277)
T ss_pred CCCc
Confidence 5444
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.3e-31 Score=271.62 Aligned_cols=249 Identities=21% Similarity=0.316 Sum_probs=179.1
Q ss_pred cCccccceeccCce---------------EEEEEeecC--hhhHHHHHHHHHHHhhcCCCCccceecccccCccceEEEe
Q 044312 289 DNFDLNRILGQGGQ---------------AVKKSKVID--ESKVEEFINEVVILSQINHRNVVKLLGCCLETEVPLLVYE 351 (608)
Q Consensus 289 ~~f~~~~~lG~G~~---------------avk~~~~~~--~~~~~~~~~Ei~il~~l~H~niv~l~~~~~~~~~~~lV~E 351 (608)
++|++.+.||+|++ |+|+..... ....+.+.+|++++++++|+||+++++++.+....++|||
T Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 81 (294)
T PLN00009 2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKRLYLVFE 81 (294)
T ss_pred CceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEEecCCeEEEEEe
Confidence 35777778887763 555544322 2334678899999999999999999999999999999999
Q ss_pred ecCCCccchhccccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEEcC-CCcEEEeeccCccccccC
Q 044312 352 FIPNGTLFQYIHDQNEDFPITWEIRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDD-KYRAKVSDFGASRSMAVD 430 (608)
Q Consensus 352 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~-~~~~kl~DFGls~~~~~~ 430 (608)
|++ ++|.+++..... ..+++..+..++.||+.||+|||+.+ ++|+||+|+||+++. ++.+||+|||++......
T Consensus 82 ~~~-~~l~~~~~~~~~-~~~~~~~~~~~~~qi~~aL~~LH~~~---i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~~~ 156 (294)
T PLN00009 82 YLD-LDLKKHMDSSPD-FAKNPRLIKTYLYQILRGIAYCHSHR---VLHRDLKPQNLLIDRRTNALKLADFGLARAFGIP 156 (294)
T ss_pred ccc-ccHHHHHHhCCC-CCcCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCcceEEEECCCCEEEEcccccccccCCC
Confidence 996 578877755332 24688888999999999999999998 999999999999985 567999999999765432
Q ss_pred CcceeeeeeccCCCCChhhhccC-CCCCccchHhHHHHHHHHHhCCCCCCccchhhcccHHHHHHHHhhhh--hh-----
Q 044312 431 QTHMTTQVHGTFGYLDPEYFRSS-QFTDKSDVYSFGVVLTELLTGEKPIRFTILEEDKSLAAYFLCAMKEE--RL----- 502 (608)
Q Consensus 431 ~~~~~~~~~gt~~y~aPE~~~~~-~~t~ksDV~S~Gvvl~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~--~~----- 502 (608)
.. ......+++.|+|||++.+. .++.++||||||+++++|+||+.||......+ .....+ ...... ..
T Consensus 157 ~~-~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~~--~~~~~~-~~~~~~~~~~~~~~~ 232 (294)
T PLN00009 157 VR-TFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEID--ELFKIF-RILGTPNEETWPGVT 232 (294)
T ss_pred cc-ccccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH--HHHHHH-HHhCCCChhhccccc
Confidence 21 12233568899999998664 57899999999999999999999986432211 111100 000000 00
Q ss_pred --HHHhh--hh----hhccCChhHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 044312 503 --FEILD--AR----VMKQGGKDEIITVAKLAKRCLNLNGKKRPTMREVASE 546 (608)
Q Consensus 503 --~~~~d--~~----~~~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~evl~~ 546 (608)
..... +. .........+.++.+++.+||+.+|++||++.+++++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~~ 284 (294)
T PLN00009 233 SLPDYKSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALEH 284 (294)
T ss_pred cchhhhhhcccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 00000 00 0000112345678999999999999999999999863
|
|
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.1e-31 Score=268.85 Aligned_cols=234 Identities=30% Similarity=0.461 Sum_probs=186.5
Q ss_pred cCccccceeccCce---------------EEEEEee---cChhhHHHHHHHHHHHhhcC-CCCccceecccccCccceEE
Q 044312 289 DNFDLNRILGQGGQ---------------AVKKSKV---IDESKVEEFINEVVILSQIN-HRNVVKLLGCCLETEVPLLV 349 (608)
Q Consensus 289 ~~f~~~~~lG~G~~---------------avk~~~~---~~~~~~~~~~~Ei~il~~l~-H~niv~l~~~~~~~~~~~lV 349 (608)
++|.+.+.||+|++ ++|.... ......+.+.+|+.++++++ |+||+++++++...+..++|
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv 80 (280)
T cd05581 1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYFV 80 (280)
T ss_pred CCceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEEEE
Confidence 35777888888874 5554432 12344567889999999998 99999999999999999999
Q ss_pred EeecCCCccchhccccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEEcCCCcEEEeeccCcccccc
Q 044312 350 YEFIPNGTLFQYIHDQNEDFPITWEIRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAV 429 (608)
Q Consensus 350 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGls~~~~~ 429 (608)
||++++++|.+++.+.. .+++..++.++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||++.....
T Consensus 81 ~e~~~~~~L~~~l~~~~---~l~~~~~~~i~~ql~~~l~~Lh~~~---~~H~dl~~~ni~i~~~~~~~l~df~~~~~~~~ 154 (280)
T cd05581 81 LEYAPNGELLQYIRKYG---SLDEKCTRFYAAEILLALEYLHSKG---IIHRDLKPENILLDKDMHIKITDFGTAKVLDP 154 (280)
T ss_pred EcCCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHeEECCCCCEEecCCccccccCC
Confidence 99999999999997653 5999999999999999999999999 99999999999999999999999999886643
Q ss_pred CCc-------------------ceeeeeeccCCCCChhhhccCCCCCccchHhHHHHHHHHHhCCCCCCccchhhcccHH
Q 044312 430 DQT-------------------HMTTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLTELLTGEKPIRFTILEEDKSLA 490 (608)
Q Consensus 430 ~~~-------------------~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~elltg~~p~~~~~~~~~~~l~ 490 (608)
... .......++..|+|||.+....++.++||||||++++++++|+.||..... .
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~------~ 228 (280)
T cd05581 155 NSSPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSNE------Y 228 (280)
T ss_pred ccccccCCCCCccccccccccccccccccCCccccCHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCccH------H
Confidence 221 112234578899999999988899999999999999999999999873321 0
Q ss_pred HHHHHHhhhhhhHHHhhhhhhccCChhHHHHHHHHHHHHhccCCCCCCCH----HHHHH
Q 044312 491 AYFLCAMKEERLFEILDARVMKQGGKDEIITVAKLAKRCLNLNGKKRPTM----REVAS 545 (608)
Q Consensus 491 ~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPs~----~evl~ 545 (608)
..+ ..+. ......+...+..+.+++.+||+.+|++||++ +++++
T Consensus 229 ~~~---------~~~~--~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ll~ 276 (280)
T cd05581 229 LTF---------QKIL--KLEYSFPPNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKA 276 (280)
T ss_pred HHH---------HHHH--hcCCCCCCccCHHHHHHHHHHhcCCHhhCCCcccCHHHHhc
Confidence 001 0111 11112333446789999999999999999999 77764
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >KOG0586 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.3e-31 Score=282.28 Aligned_cols=235 Identities=28% Similarity=0.419 Sum_probs=191.7
Q ss_pred HhcCccccceeccCceE---------------EEEEee--cChhhHHHHHHHHHHHhhcCCCCccceecccccCccceEE
Q 044312 287 ATDNFDLNRILGQGGQA---------------VKKSKV--IDESKVEEFINEVVILSQINHRNVVKLLGCCLETEVPLLV 349 (608)
Q Consensus 287 ~t~~f~~~~~lG~G~~a---------------vk~~~~--~~~~~~~~~~~Ei~il~~l~H~niv~l~~~~~~~~~~~lV 349 (608)
-...|.+.+.||+|.|| +|.+.. .+....+.+.+|+++|..|+|||||+|+.+......+|+|
T Consensus 54 ~vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v~~t~~~lylV 133 (596)
T KOG0586|consen 54 SVGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSVIETEATLYLV 133 (596)
T ss_pred cccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeeeeeecceeEEE
Confidence 45678999999999874 443322 2333446689999999999999999999999999999999
Q ss_pred EeecCCCccchhccccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEEcCCCcEEEeeccCcccccc
Q 044312 350 YEFIPNGTLFQYIHDQNEDFPITWEIRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAV 429 (608)
Q Consensus 350 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGls~~~~~ 429 (608)
|||..+|.+++++.+.+. +.+.....++.|+.+|++|+|++. |+|||||++||||+.+.++||+|||++..+..
T Consensus 134 ~eya~~ge~~~yl~~~gr---~~e~~ar~~F~q~vsaveYcH~k~---ivHrdLk~eNilL~~~mnikIaDfgfS~~~~~ 207 (596)
T KOG0586|consen 134 MEYASGGELFDYLVKHGR---MKEKEARAKFRQIVSAVEYCHSKN---IVHRDLKAENILLDENMNIKIADFGFSTFFDY 207 (596)
T ss_pred EEeccCchhHHHHHhccc---chhhhhhhhhHHHHHHHHHHhhcc---eeccccchhhcccccccceeeeccccceeecc
Confidence 999999999999998764 566888899999999999999999 99999999999999999999999999988763
Q ss_pred CCcceeeeeeccCCCCChhhhccCCC-CCccchHhHHHHHHHHHhCCCCCCccchhhcccHHHHHHHHhhhhhhHHHhhh
Q 044312 430 DQTHMTTQVHGTFGYLDPEYFRSSQF-TDKSDVYSFGVVLTELLTGEKPIRFTILEEDKSLAAYFLCAMKEERLFEILDA 508 (608)
Q Consensus 430 ~~~~~~~~~~gt~~y~aPE~~~~~~~-t~ksDV~S~Gvvl~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 508 (608)
........|++.|.|||++.+..+ .+.+|+||+|++||-|+.|..||+.....+. ++. .+..
T Consensus 208 --~~~lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~lk~L-----------r~r----vl~g 270 (596)
T KOG0586|consen 208 --GLMLQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQNLKEL-----------RPR----VLRG 270 (596)
T ss_pred --cccccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCcccccc-----------cch----heee
Confidence 344566789999999999998876 5799999999999999999999974332221 111 1111
Q ss_pred hhhccCChhHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 044312 509 RVMKQGGKDEIITVAKLAKRCLNLNGKKRPTMREVASE 546 (608)
Q Consensus 509 ~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~evl~~ 546 (608)
+++. +.-...+..+|++++|.++|.+|++++++.+.
T Consensus 271 k~rI--p~~ms~dce~lLrk~lvl~Pskr~~~dqim~~ 306 (596)
T KOG0586|consen 271 KYRI--PFYMSCDCEDLLRKFLVLNPSKRGPCDQIMKD 306 (596)
T ss_pred eecc--cceeechhHHHHHHhhccCccccCCHHHhhhh
Confidence 1111 12234578899999999999999999999874
|
|
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.5e-31 Score=273.11 Aligned_cols=223 Identities=26% Similarity=0.364 Sum_probs=173.2
Q ss_pred eEEEEEee---cChhhHHHHHHHHHHHhhcCCCCccceecccccCccceEEEeecCCCccchhccccCCCCCCCHHHHHH
Q 044312 302 QAVKKSKV---IDESKVEEFINEVVILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEIRLR 378 (608)
Q Consensus 302 ~avk~~~~---~~~~~~~~~~~Ei~il~~l~H~niv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~ 378 (608)
+++|.... ......+++.+|+++++.++|+|++++++++......++||||+. |+|.+.+..... ++++..+..
T Consensus 43 ~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~--~l~~~~~~~ 119 (308)
T cd06634 43 VAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYCL-GSASDLLEVHKK--PLQEVEIAA 119 (308)
T ss_pred EEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCCeeEEEEEccC-CCHHHHHHHcCC--CCCHHHHHH
Confidence 36666543 223445678899999999999999999999999999999999996 588777754332 589999999
Q ss_pred HHHHHHHHHHHHhhcCCCCeeccCCCCCcEEEcCCCcEEEeeccCccccccCCcceeeeeeccCCCCChhhhc---cCCC
Q 044312 379 IAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHGTFGYLDPEYFR---SSQF 455 (608)
Q Consensus 379 i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGls~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~ 455 (608)
++.|++.||.|||+.+ ++||||+|+|||++.++.+||+|||++...... ....++..|+|||.+. ...+
T Consensus 120 ~~~~l~~~l~~LH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~ 191 (308)
T cd06634 120 VTHGALQGLAYLHSHN---MIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA-----NXFVGTPYWMAPEVILAMDEGQY 191 (308)
T ss_pred HHHHHHHHHHHHHhCC---cccCCCCHHhEEECCCCcEEECCcccceeecCc-----ccccCCccccCHHHHhhcccCCC
Confidence 9999999999999998 999999999999999999999999998765432 2345788999999974 3568
Q ss_pred CCccchHhHHHHHHHHHhCCCCCCccchhhcccHHHHHHHHhhhhhhHHHhhhhhhccCChhHHHHHHHHHHHHhccCCC
Q 044312 456 TDKSDVYSFGVVLTELLTGEKPIRFTILEEDKSLAAYFLCAMKEERLFEILDARVMKQGGKDEIITVAKLAKRCLNLNGK 535 (608)
Q Consensus 456 t~ksDV~S~Gvvl~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~Li~~cl~~dp~ 535 (608)
+.++||||||++++||++|+.||......+ .+..+.............+..+.+|+.+||+.+|+
T Consensus 192 ~~~~Di~slG~il~el~~g~~p~~~~~~~~---------------~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~ 256 (308)
T cd06634 192 DGKVDVWSLGITCIELAERKPPLFNMNAMS---------------ALYHIAQNESPALQSGHWSEYFRNFVDSCLQKIPQ 256 (308)
T ss_pred CcccchHHHHHHHHHHHcCCCCCccccHHH---------------HHHHHhhcCCCCcCcccccHHHHHHHHHHhhCCcc
Confidence 889999999999999999999975321110 00001100011111224556799999999999999
Q ss_pred CCCCHHHHHHHHHhh
Q 044312 536 KRPTMREVASELAGI 550 (608)
Q Consensus 536 ~RPs~~evl~~L~~i 550 (608)
+||++.+|+++....
T Consensus 257 ~Rp~~~~ll~~~~~~ 271 (308)
T cd06634 257 DRPTSEVLLKHRFVL 271 (308)
T ss_pred cCCCHHHHhhCcccc
Confidence 999999999765433
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.5e-31 Score=276.18 Aligned_cols=240 Identities=21% Similarity=0.306 Sum_probs=175.7
Q ss_pred eEEEEEeec--ChhhHHHHHHHHHHHhhcCCCCccceecccccCccceEEEeecCCCccchhccccCCCCCCCHHHHHHH
Q 044312 302 QAVKKSKVI--DESKVEEFINEVVILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEIRLRI 379 (608)
Q Consensus 302 ~avk~~~~~--~~~~~~~~~~Ei~il~~l~H~niv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i 379 (608)
+|+|..... .....+.+.+|+.+++.++||||+++++++...+..++||||+.+++|.+++...... .+++..+..+
T Consensus 28 vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v~e~~~~~~l~~~l~~~~~~-~~~~~~~~~~ 106 (328)
T cd08226 28 VTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMAYGSANSLLKTYFPE-GMSEALIGNI 106 (328)
T ss_pred EEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEEEecccCCCHHHHHHhhccc-CCCHHHHHHH
Confidence 577776642 2344678899999999999999999999999999999999999999999988764332 4899999999
Q ss_pred HHHHHHHHHHHhhcCCCCeeccCCCCCcEEEcCCCcEEEeeccCccccccCCcce------eeeeeccCCCCChhhhccC
Q 044312 380 AIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHM------TTQVHGTFGYLDPEYFRSS 453 (608)
Q Consensus 380 ~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGls~~~~~~~~~~------~~~~~gt~~y~aPE~~~~~ 453 (608)
+.|++.||+|||+.+ ++||||||+|||++.++.+|++||+.+.......... .....++..|+|||++.+.
T Consensus 107 ~~qi~~aL~~lH~~~---ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~ 183 (328)
T cd08226 107 LFGALRGLNYLHQNG---YIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQKAKVVYDFPQFSTSVLPWLSPELLRQD 183 (328)
T ss_pred HHHHHHHHHHHHhCC---eecCCCCHHHEEEeCCCcEEEechHHHhhhhccCccccccccccccccCccCccChhhhcCC
Confidence 999999999999998 9999999999999999999999998654332111100 0112345679999999764
Q ss_pred --CCCCccchHhHHHHHHHHHhCCCCCCccchhhcccHHHHHH----------------HHhh-----------hhhh--
Q 044312 454 --QFTDKSDVYSFGVVLTELLTGEKPIRFTILEEDKSLAAYFL----------------CAMK-----------EERL-- 502 (608)
Q Consensus 454 --~~t~ksDV~S~Gvvl~elltg~~p~~~~~~~~~~~l~~~~~----------------~~~~-----------~~~~-- 502 (608)
.++.++||||||++++||++|+.||........ ...... .... +...
T Consensus 184 ~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 261 (328)
T cd08226 184 LYGYNVKSDIYSVGITACELATGRVPFQDMLRTQM--LLQKLKGPPYSPLDITTFPCEESRMKNSQSGVDSGIGESVVAA 261 (328)
T ss_pred CCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHHH--HHHHhcCCCCCCccccccchhhhhhccchhhhhcccccchhcc
Confidence 478999999999999999999999864321110 000000 0000 0000
Q ss_pred ---HHHhhhhhhccCChhHHHHHHHHHHHHhccCCCCCCCHHHHHHHH
Q 044312 503 ---FEILDARVMKQGGKDEIITVAKLAKRCLNLNGKKRPTMREVASEL 547 (608)
Q Consensus 503 ---~~~~d~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~evl~~L 547 (608)
..+.+...........+..+.+|+.+||+.||++|||+.|++++-
T Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpta~e~l~~~ 309 (328)
T cd08226 262 GMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRPSASSLLSHA 309 (328)
T ss_pred ccccccccccccchhhhhhhHHHHHHHHHHccCCcccCCCHHHHhhCH
Confidence 000011111122234567899999999999999999999998754
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.9e-31 Score=269.56 Aligned_cols=222 Identities=21% Similarity=0.268 Sum_probs=168.5
Q ss_pred eEEEEEeecC---hhhHHHHHHHHHHHh---hcCCCCccceecccccCccceEEEeecCCCccchhccccCCCCCCCHHH
Q 044312 302 QAVKKSKVID---ESKVEEFINEVVILS---QINHRNVVKLLGCCLETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEI 375 (608)
Q Consensus 302 ~avk~~~~~~---~~~~~~~~~Ei~il~---~l~H~niv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~ 375 (608)
+|+|...... ......+.+|..+++ ..+||||+++++.+...+..++||||+++++|.+++.... .+++..
T Consensus 22 ~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~---~l~~~~ 98 (279)
T cd05633 22 YAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLMNGGDLHYHLSQHG---VFSEKE 98 (279)
T ss_pred EEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEecCCCCCHHHHHHhcC---CCCHHH
Confidence 4777654321 122234455554443 3479999999999998889999999999999999887543 589999
Q ss_pred HHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEEcCCCcEEEeeccCccccccCCcceeeeeeccCCCCChhhhcc-CC
Q 044312 376 RLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHGTFGYLDPEYFRS-SQ 454 (608)
Q Consensus 376 ~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGls~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~ 454 (608)
+..++.|++.||+|||+.+ |+||||||+|||+++++.+||+|||++....... .....|+..|+|||.+.. ..
T Consensus 99 ~~~i~~qi~~al~~lH~~~---ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~ 172 (279)
T cd05633 99 MRFYATEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKK---PHASVGTHGYMAPEVLQKGTA 172 (279)
T ss_pred HHHHHHHHHHHHHHHHHCC---cCCCCCCHHHEEECCCCCEEEccCCcceeccccC---ccCcCCCcCccCHHHhcCCCC
Confidence 9999999999999999999 9999999999999999999999999987553221 123458999999999864 56
Q ss_pred CCCccchHhHHHHHHHHHhCCCCCCccchhhcccHHHHHHHHhhhhhhHHHhhhhhhccCChhHHHHHHHHHHHHhccCC
Q 044312 455 FTDKSDVYSFGVVLTELLTGEKPIRFTILEEDKSLAAYFLCAMKEERLFEILDARVMKQGGKDEIITVAKLAKRCLNLNG 534 (608)
Q Consensus 455 ~t~ksDV~S~Gvvl~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~Li~~cl~~dp 534 (608)
++.++||||||++++||++|+.||.......... .. .. ........+...+.++.+++.+||+.||
T Consensus 173 ~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~----~~---------~~-~~~~~~~~~~~~~~~~~~li~~~l~~~p 238 (279)
T cd05633 173 YDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHE----ID---------RM-TLTVNVELPDSFSPELKSLLEGLLQRDV 238 (279)
T ss_pred CCchhhhHHHHHHHHHHHhCCCCcCCCCCcCHHH----HH---------HH-hhcCCcCCccccCHHHHHHHHHHhcCCH
Confidence 8999999999999999999999986432211100 00 00 0001112233456789999999999999
Q ss_pred CCCC-----CHHHHHHH
Q 044312 535 KKRP-----TMREVASE 546 (608)
Q Consensus 535 ~~RP-----s~~evl~~ 546 (608)
++|| +++|++++
T Consensus 239 ~~R~~~~~~~~~~~~~h 255 (279)
T cd05633 239 SKRLGCLGRGAQEVKEH 255 (279)
T ss_pred HHhcCCCCCCHHHHHhC
Confidence 9999 58888775
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.9e-32 Score=261.05 Aligned_cols=244 Identities=22% Similarity=0.290 Sum_probs=183.4
Q ss_pred HhcCccccc-eeccCc--eEEEEEeecChh--------hHHHHHHHHHHHhhc-CCCCccceeccccc----CccceEEE
Q 044312 287 ATDNFDLNR-ILGQGG--QAVKKSKVIDES--------KVEEFINEVVILSQI-NHRNVVKLLGCCLE----TEVPLLVY 350 (608)
Q Consensus 287 ~t~~f~~~~-~lG~G~--~avk~~~~~~~~--------~~~~~~~Ei~il~~l-~H~niv~l~~~~~~----~~~~~lV~ 350 (608)
.|++|.+.. +||-|- ..+...+....+ +....++|+++.-.. .|||||++++++.+ ...+++||
T Consensus 59 itedY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~Ds~KARrEVeLHw~~s~h~~iV~IidVyeNs~~~rkcLLiVm 138 (400)
T KOG0604|consen 59 ITEDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLLDSPKARREVELHWMASGHPHIVSIIDVYENSYQGRKCLLIVM 138 (400)
T ss_pred chhhheehhhhhccccCCceEEEEeccchhhhHHHHHhcCHHHHhHhhhhhhhcCCCceEEeehhhhhhccCceeeEeee
Confidence 466777654 577763 222222221111 224567888876555 69999999999864 34678999
Q ss_pred eecCCCccchhccccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEEc---CCCcEEEeeccCcccc
Q 044312 351 EFIPNGTLFQYIHDQNEDFPITWEIRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLD---DKYRAKVSDFGASRSM 427 (608)
Q Consensus 351 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~---~~~~~kl~DFGls~~~ 427 (608)
|.|+||.|...++.++.. .+++.+...|+.||+.|+.|||+.+ |.||||||+|+|.. .|..+||+|||+|+..
T Consensus 139 E~meGGeLfsriq~~g~~-afTErea~eI~~qI~~Av~~lH~~n---IAHRDlKpENLLyt~t~~na~lKLtDfGFAK~t 214 (400)
T KOG0604|consen 139 ECMEGGELFSRIQDRGDQ-AFTEREASEIMKQIGLAVRYLHSMN---IAHRDLKPENLLYTTTSPNAPLKLTDFGFAKET 214 (400)
T ss_pred ecccchHHHHHHHHcccc-cchHHHHHHHHHHHHHHHHHHHhcc---hhhccCChhheeeecCCCCcceEeccccccccc
Confidence 999999999999987654 6999999999999999999999999 99999999999996 4567999999999865
Q ss_pred ccCCcceeeeeeccCCCCChhhhccCCCCCccchHhHHHHHHHHHhCCCCCCccchhhcccHHHHHHHHhhhhhhHHHhh
Q 044312 428 AVDQTHMTTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLTELLTGEKPIRFTILEEDKSLAAYFLCAMKEERLFEILD 507 (608)
Q Consensus 428 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 507 (608)
.. ........-|+.|.|||++...+|+...|+||+||++|-|++|.+||...... -+ ..+-...|..
T Consensus 215 ~~--~~~L~TPc~TPyYvaPevlg~eKydkscdmwSlgVimYIlLCGyPPFYS~hg~---ai--------spgMk~rI~~ 281 (400)
T KOG0604|consen 215 QE--PGDLMTPCFTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGL---AI--------SPGMKRRIRT 281 (400)
T ss_pred CC--CccccCCcccccccCHHHhCchhcCCCCCccchhHHHHHhhcCCCcccccCCc---cC--------ChhHHhHhhc
Confidence 43 22334556799999999999999999999999999999999999999743221 11 1111111211
Q ss_pred hhh--hccCChhHHHHHHHHHHHHhccCCCCCCCHHHHHHHH
Q 044312 508 ARV--MKQGGKDEIITVAKLAKRCLNLNGKKRPTMREVASEL 547 (608)
Q Consensus 508 ~~~--~~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~evl~~L 547 (608)
... ..+.....++...++|+.+|+.+|++|.|+.|++++-
T Consensus 282 gqy~FP~pEWs~VSe~aKdlIR~LLkt~PteRlTI~~~m~hp 323 (400)
T KOG0604|consen 282 GQYEFPEPEWSCVSEAAKDLIRKLLKTEPTERLTIEEVMDHP 323 (400)
T ss_pred cCccCCChhHhHHHHHHHHHHHHHhcCCchhheeHHHhhcCc
Confidence 111 1222345677889999999999999999999998753
|
|
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.8e-31 Score=277.12 Aligned_cols=248 Identities=22% Similarity=0.310 Sum_probs=178.7
Q ss_pred hcCccccceeccCce---------------EEEEEeec--ChhhHHHHHHHHHHHhhcCCCCccceecccccCc------
Q 044312 288 TDNFDLNRILGQGGQ---------------AVKKSKVI--DESKVEEFINEVVILSQINHRNVVKLLGCCLETE------ 344 (608)
Q Consensus 288 t~~f~~~~~lG~G~~---------------avk~~~~~--~~~~~~~~~~Ei~il~~l~H~niv~l~~~~~~~~------ 344 (608)
.++|.+.+.||+|++ |||+.+.. .......+.+|+.++++++||||+++++++....
T Consensus 14 ~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 93 (342)
T cd07879 14 PERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEFQ 93 (342)
T ss_pred ccceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchhheecccccCCCCc
Confidence 368888899999864 55655421 2233456889999999999999999999986543
Q ss_pred cceEEEeecCCCccchhccccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEEcCCCcEEEeeccCc
Q 044312 345 VPLLVYEFIPNGTLFQYIHDQNEDFPITWEIRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGAS 424 (608)
Q Consensus 345 ~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGls 424 (608)
..++|+||+.. +|.+++. ..+++..+..++.|++.||+|||+.+ ++||||||+|||++.++.+||+|||++
T Consensus 94 ~~~lv~e~~~~-~l~~~~~-----~~~~~~~~~~~~~qi~~aL~~LH~~~---i~H~dlkp~NIll~~~~~~kL~dfg~~ 164 (342)
T cd07879 94 DFYLVMPYMQT-DLQKIMG-----HPLSEDKVQYLVYQMLCGLKYIHSAG---IIHRDLKPGNLAVNEDCELKILDFGLA 164 (342)
T ss_pred eEEEEeccccc-CHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEeeCCCC
Confidence 45899999964 6665542 14899999999999999999999999 999999999999999999999999998
Q ss_pred cccccCCcceeeeeeccCCCCChhhhcc-CCCCCccchHhHHHHHHHHHhCCCCCCccchhhcccHHHHHHHHh--hhhh
Q 044312 425 RSMAVDQTHMTTQVHGTFGYLDPEYFRS-SQFTDKSDVYSFGVVLTELLTGEKPIRFTILEEDKSLAAYFLCAM--KEER 501 (608)
Q Consensus 425 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~t~ksDV~S~Gvvl~elltg~~p~~~~~~~~~~~l~~~~~~~~--~~~~ 501 (608)
+..... .....++..|+|||.+.+ ..++.++||||||++++||++|+.||....... . ........ ....
T Consensus 165 ~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~~--~-~~~~~~~~~~~~~~ 237 (342)
T cd07879 165 RHADAE----MTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLD--Q-LTQILKVTGVPGPE 237 (342)
T ss_pred cCCCCC----CCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCCHHH--H-HHHHHHhcCCCCHH
Confidence 765322 123456889999999876 468999999999999999999999997432111 0 00000000 0000
Q ss_pred h---------HHHhhhhh---hc---cCChhHHHHHHHHHHHHhccCCCCCCCHHHHHHH--HHhhH
Q 044312 502 L---------FEILDARV---MK---QGGKDEIITVAKLAKRCLNLNGKKRPTMREVASE--LAGIK 551 (608)
Q Consensus 502 ~---------~~~~d~~~---~~---~~~~~~~~~l~~Li~~cl~~dp~~RPs~~evl~~--L~~i~ 551 (608)
+ ........ .. ......+..+.+|+.+||+.||++||++.|++.+ ++.++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~e~l~h~~f~~~~ 304 (342)
T cd07879 238 FVQKLEDKAAKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALEHPYFDSFR 304 (342)
T ss_pred HHHHhcccchHHHHhhcCCcccchHHHHhcCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcchhhcc
Confidence 0 00000000 00 0001234568899999999999999999999865 44443
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.1e-31 Score=273.41 Aligned_cols=248 Identities=22% Similarity=0.272 Sum_probs=179.0
Q ss_pred hcCccccceeccCce---------------EEEEEeecC--hhhHHHHHHHHHHHhhcCCCCccceecccccCc------
Q 044312 288 TDNFDLNRILGQGGQ---------------AVKKSKVID--ESKVEEFINEVVILSQINHRNVVKLLGCCLETE------ 344 (608)
Q Consensus 288 t~~f~~~~~lG~G~~---------------avk~~~~~~--~~~~~~~~~Ei~il~~l~H~niv~l~~~~~~~~------ 344 (608)
.++|++.++||+|++ ++|+..... ......+.+|++++++++|+||+++++++.+..
T Consensus 7 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 86 (311)
T cd07866 7 LRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKRK 86 (311)
T ss_pred cccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhheeccccccccc
Confidence 468999999999974 556554322 222356789999999999999999999875443
Q ss_pred --cceEEEeecCCCccchhccccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEEcCCCcEEEeecc
Q 044312 345 --VPLLVYEFIPNGTLFQYIHDQNEDFPITWEIRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFG 422 (608)
Q Consensus 345 --~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFG 422 (608)
..++|+||+.+ +|...+..... .+++..+..++.|+++||+|||+.+ ++|+||||+|||+++++.+||+|||
T Consensus 87 ~~~~~lv~~~~~~-~l~~~~~~~~~--~~~~~~~~~i~~~l~~al~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg 160 (311)
T cd07866 87 RGSVYMVTPYMDH-DLSGLLENPSV--KLTESQIKCYMLQLLEGINYLHENH---ILHRDIKAANILIDNQGILKIADFG 160 (311)
T ss_pred CceEEEEEecCCc-CHHHHHhcccc--CCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEECcCc
Confidence 45899999965 67776665332 5899999999999999999999999 9999999999999999999999999
Q ss_pred CccccccCCc----------ceeeeeeccCCCCChhhhccC-CCCCccchHhHHHHHHHHHhCCCCCCccchhhcccHHH
Q 044312 423 ASRSMAVDQT----------HMTTQVHGTFGYLDPEYFRSS-QFTDKSDVYSFGVVLTELLTGEKPIRFTILEEDKSLAA 491 (608)
Q Consensus 423 ls~~~~~~~~----------~~~~~~~gt~~y~aPE~~~~~-~~t~ksDV~S~Gvvl~elltg~~p~~~~~~~~~~~l~~ 491 (608)
+++....... ...+...+++.|+|||.+.+. .++.++||||||++++||++|++||......... .
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~~~~~---~ 237 (311)
T cd07866 161 LARPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQL---H 237 (311)
T ss_pred cchhccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCCHHHHH---H
Confidence 9976543221 112334578889999987654 5899999999999999999999998643322111 1
Q ss_pred HHHHHhhh---hhh------HHH--------hhhhhhccCChhHHHHHHHHHHHHhccCCCCCCCHHHHHH
Q 044312 492 YFLCAMKE---ERL------FEI--------LDARVMKQGGKDEIITVAKLAKRCLNLNGKKRPTMREVAS 545 (608)
Q Consensus 492 ~~~~~~~~---~~~------~~~--------~d~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~evl~ 545 (608)
........ ... ... ..+.... ........+.+++.+||+.+|++|||+.|++.
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~i~~~l~~~p~~R~t~~ell~ 307 (311)
T cd07866 238 LIFKLCGTPTEETWPGWRSLPGCEGVHSFTNYPRTLEE-RFGKLGPEGLDLLSKLLSLDPYKRLTASDALE 307 (311)
T ss_pred HHHHHhCCCChhhchhhhhcccccccccCCCCCccHHH-HcccCChhHHHHHHHHcccCcccCcCHHHHhc
Confidence 11111000 000 000 0000000 00122357889999999999999999999875
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.9e-31 Score=270.10 Aligned_cols=237 Identities=24% Similarity=0.390 Sum_probs=179.4
Q ss_pred cCccccceeccCce---------------EEEEEeecC-hhhHHHHHHHHHHHhhcC-CCCccceecccccCccceEEEe
Q 044312 289 DNFDLNRILGQGGQ---------------AVKKSKVID-ESKVEEFINEVVILSQIN-HRNVVKLLGCCLETEVPLLVYE 351 (608)
Q Consensus 289 ~~f~~~~~lG~G~~---------------avk~~~~~~-~~~~~~~~~Ei~il~~l~-H~niv~l~~~~~~~~~~~lV~E 351 (608)
++|++.+.||+|++ |||..+... ......+..|+.++.++. |+||+++++++.+....++|||
T Consensus 15 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e 94 (296)
T cd06618 15 NDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKCYGYFITDSDVFICME 94 (296)
T ss_pred chheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCChHHHHHHHHHHHHHHhccCCCchHhhheeeecCCeEEEEee
Confidence 45777888888863 667665432 234566777888777774 9999999999999999999999
Q ss_pred ecCCCccchhccccCCCCCCCHHHHHHHHHHHHHHHHHHhh-cCCCCeeccCCCCCcEEEcCCCcEEEeeccCccccccC
Q 044312 352 FIPNGTLFQYIHDQNEDFPITWEIRLRIAIEVSGALSYLHS-AASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVD 430 (608)
Q Consensus 352 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~-~~~~~iiHrDlk~~NILl~~~~~~kl~DFGls~~~~~~ 430 (608)
|+. ++|.+++..... ++++..+..++.||+.||+|||+ .+ |+||||+|+||++++++.+||+|||++..+...
T Consensus 95 ~~~-~~l~~l~~~~~~--~l~~~~~~~i~~~i~~~l~~lH~~~~---i~H~dl~p~nill~~~~~~kL~dfg~~~~~~~~ 168 (296)
T cd06618 95 LMS-TCLDKLLKRIQG--PIPEDILGKMTVAIVKALHYLKEKHG---VIHRDVKPSNILLDASGNVKLCDFGISGRLVDS 168 (296)
T ss_pred ccC-cCHHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhhCC---EecCCCcHHHEEEcCCCCEEECccccchhccCC
Confidence 985 477776655332 58999999999999999999997 47 999999999999999999999999998765432
Q ss_pred CcceeeeeeccCCCCChhhhccCC----CCCccchHhHHHHHHHHHhCCCCCCccchhhcccHHHHHHHHhhhhhhHHHh
Q 044312 431 QTHMTTQVHGTFGYLDPEYFRSSQ----FTDKSDVYSFGVVLTELLTGEKPIRFTILEEDKSLAAYFLCAMKEERLFEIL 506 (608)
Q Consensus 431 ~~~~~~~~~gt~~y~aPE~~~~~~----~t~ksDV~S~Gvvl~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 506 (608)
.. .....++..|+|||.+.... ++.++||||||++++||++|+.||...... ... +..++
T Consensus 169 ~~--~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~-----~~~---------~~~~~ 232 (296)
T cd06618 169 KA--KTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTE-----FEV---------LTKIL 232 (296)
T ss_pred Cc--ccCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchhH-----HHH---------HHHHh
Confidence 22 22335778999999987554 789999999999999999999998632111 000 11111
Q ss_pred hhhh-hccCChhHHHHHHHHHHHHhccCCCCCCCHHHHHHHH
Q 044312 507 DARV-MKQGGKDEIITVAKLAKRCLNLNGKKRPTMREVASEL 547 (608)
Q Consensus 507 d~~~-~~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~evl~~L 547 (608)
.... ........+.++.+|+.+||+.||++||++.+++++.
T Consensus 233 ~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~~ 274 (296)
T cd06618 233 QEEPPSLPPNEGFSPDFCSFVDLCLTKDHRKRPKYRELLQHP 274 (296)
T ss_pred cCCCCCCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHhcCh
Confidence 1110 0111123456899999999999999999999998764
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.8e-31 Score=276.46 Aligned_cols=255 Identities=23% Similarity=0.288 Sum_probs=186.2
Q ss_pred CCHHHHHHHhcCccccceeccCce---------------EEEEEeec--ChhhHHHHHHHHHHHhhcCCCCccceecccc
Q 044312 279 FTSKELEKATDNFDLNRILGQGGQ---------------AVKKSKVI--DESKVEEFINEVVILSQINHRNVVKLLGCCL 341 (608)
Q Consensus 279 ~~~~~l~~~t~~f~~~~~lG~G~~---------------avk~~~~~--~~~~~~~~~~Ei~il~~l~H~niv~l~~~~~ 341 (608)
...+++..++++|.+.+.||+|++ |+|+.+.. .....+.+.+|+.++++++||||+++++++.
T Consensus 7 ~~~~~~~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~ 86 (345)
T cd07877 7 ELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFT 86 (345)
T ss_pred hHHHHHhhccCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCcccceeeeee
Confidence 345667778899999999999974 56655432 2233567889999999999999999999875
Q ss_pred cC------ccceEEEeecCCCccchhccccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEEcCCCc
Q 044312 342 ET------EVPLLVYEFIPNGTLFQYIHDQNEDFPITWEIRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYR 415 (608)
Q Consensus 342 ~~------~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~ 415 (608)
.. ...+++++++ +++|.+++... .+++..+..++.|+++||+|||+.+ |+||||||+||++++++.
T Consensus 87 ~~~~~~~~~~~~lv~~~~-~~~L~~~~~~~----~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIll~~~~~ 158 (345)
T cd07877 87 PARSLEEFNDVYLVTHLM-GADLNNIVKCQ----KLTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCE 158 (345)
T ss_pred ecccccccccEEEEehhc-ccCHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCChHHEEEcCCCC
Confidence 33 3467888887 77998877542 4899999999999999999999999 999999999999999999
Q ss_pred EEEeeccCccccccCCcceeeeeeccCCCCChhhhcc-CCCCCccchHhHHHHHHHHHhCCCCCCccchhhcccHHHHH-
Q 044312 416 AKVSDFGASRSMAVDQTHMTTQVHGTFGYLDPEYFRS-SQFTDKSDVYSFGVVLTELLTGEKPIRFTILEEDKSLAAYF- 493 (608)
Q Consensus 416 ~kl~DFGls~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~t~ksDV~S~Gvvl~elltg~~p~~~~~~~~~~~l~~~~- 493 (608)
+||+|||+++..... .....++..|+|||.+.+ ..++.++||||||++++||++|+.||........ +....
T Consensus 159 ~kl~dfg~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~--~~~~~~ 232 (345)
T cd07877 159 LKILDFGLARHTDDE----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQ--LKLILR 232 (345)
T ss_pred EEEeccccccccccc----ccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH--HHHHHH
Confidence 999999998764321 233457889999999866 5688999999999999999999999864322110 00000
Q ss_pred ---------HHHhhhhhhHHHhhh--hhh----ccCChhHHHHHHHHHHHHhccCCCCCCCHHHHHHHH
Q 044312 494 ---------LCAMKEERLFEILDA--RVM----KQGGKDEIITVAKLAKRCLNLNGKKRPTMREVASEL 547 (608)
Q Consensus 494 ---------~~~~~~~~~~~~~d~--~~~----~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~evl~~L 547 (608)
...+........+.. ... .......+..+.+++.+||+.||++||++.|++.+-
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~ 301 (345)
T cd07877 233 LVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHA 301 (345)
T ss_pred HhCCCCHHHHhhcccHhHHHHHHHhcccCCcchhhhcCCCCHHHHHHHHHHcCCChhhcCCHHHHhcCh
Confidence 000000000000000 000 000012345789999999999999999999998763
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-30 Score=264.97 Aligned_cols=255 Identities=25% Similarity=0.383 Sum_probs=189.5
Q ss_pred HHhcCccccceeccCce-------------EEEEEeecChhhHHHHHHHHHHHhhc--CCCCccceecccccCc----cc
Q 044312 286 KATDNFDLNRILGQGGQ-------------AVKKSKVIDESKVEEFINEVVILSQI--NHRNVVKLLGCCLETE----VP 346 (608)
Q Consensus 286 ~~t~~f~~~~~lG~G~~-------------avk~~~~~~~~~~~~~~~Ei~il~~l--~H~niv~l~~~~~~~~----~~ 346 (608)
...+...+.+.||+|.| |||.....++ +.+.+|.+|.+.. +|+||+.+++.-..+. ++
T Consensus 208 TiarqI~L~e~IGkGRyGEVwrG~wrGe~VAVKiF~srdE---~SWfrEtEIYqTvmLRHENILgFIaaD~~~~gs~TQL 284 (513)
T KOG2052|consen 208 TIARQIVLQEIIGKGRFGEVWRGRWRGEDVAVKIFSSRDE---RSWFRETEIYQTVMLRHENILGFIAADNKDNGSWTQL 284 (513)
T ss_pred hhhheeEEEEEecCccccceeeccccCCceEEEEecccch---hhhhhHHHHHHHHHhccchhhhhhhccccCCCceEEE
Confidence 34556788899999975 8888775444 5677888887664 9999999998865443 67
Q ss_pred eEEEeecCCCccchhccccCCCCCCCHHHHHHHHHHHHHHHHHHhh-----cCCCCeeccCCCCCcEEEcCCCcEEEeec
Q 044312 347 LLVYEFIPNGTLFQYIHDQNEDFPITWEIRLRIAIEVSGALSYLHS-----AASIPIYHRDIKSTNILLDDKYRAKVSDF 421 (608)
Q Consensus 347 ~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~-----~~~~~iiHrDlk~~NILl~~~~~~kl~DF 421 (608)
+||.+|.++|||+|+|... .++....++++..+|.||++||. ++.+.|.|||||+.|||+..+++.-|+|+
T Consensus 285 wLvTdYHe~GSL~DyL~r~----tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~~C~IADL 360 (513)
T KOG2052|consen 285 WLVTDYHEHGSLYDYLNRN----TVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADL 360 (513)
T ss_pred EEeeecccCCcHHHHHhhc----cCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCCcEEEeec
Confidence 9999999999999999874 59999999999999999999995 45677999999999999999999999999
Q ss_pred cCccccccCCcc---eeeeeeccCCCCChhhhccCC----C--CCccchHhHHHHHHHHHhC----------CCCCCccc
Q 044312 422 GASRSMAVDQTH---MTTQVHGTFGYLDPEYFRSSQ----F--TDKSDVYSFGVVLTELLTG----------EKPIRFTI 482 (608)
Q Consensus 422 Gls~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~----~--t~ksDV~S~Gvvl~elltg----------~~p~~~~~ 482 (608)
|||.....+... ......||.+|||||++...- + -..+||||||.|+||+.-+ +.||....
T Consensus 361 GLAv~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~ggi~eey~~Pyyd~V 440 (513)
T KOG2052|consen 361 GLAVRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGGIVEEYQLPYYDVV 440 (513)
T ss_pred eeeEEecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCCEehhhcCCcccCC
Confidence 999776544221 234567999999999986542 1 2468999999999998652 45665332
Q ss_pred hhhcccHHHHHHHHhhhhhhHHHhhhhhhccCChhHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhhHH
Q 044312 483 LEEDKSLAAYFLCAMKEERLFEILDARVMKQGGKDEIITVAKLAKRCLNLNGKKRPTMREVASELAGIKA 552 (608)
Q Consensus 483 ~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~evl~~L~~i~~ 552 (608)
+.+ .+... +...+=..++...+..+ -...+....+.+|++.||..+|.-|.|+--+-+.|.++..
T Consensus 441 p~D-Ps~ee-MrkVVCv~~~RP~ipnr---W~s~~~l~~m~klMkeCW~~Np~aRltALriKKtl~~l~~ 505 (513)
T KOG2052|consen 441 PSD-PSFEE-MRKVVCVQKLRPNIPNR---WKSDPALRVMAKLMKECWYANPAARLTALRIKKTLAKLSN 505 (513)
T ss_pred CCC-CCHHH-HhcceeecccCCCCCcc---cccCHHHHHHHHHHHHhhcCCchhhhHHHHHHHHHHHHhc
Confidence 221 11111 00011111111111111 1224667789999999999999999999988888877764
|
|
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-30 Score=263.53 Aligned_cols=222 Identities=26% Similarity=0.270 Sum_probs=169.1
Q ss_pred eEEEEEeecC---hhhHHHHHHHHHHH-hhcCCCCccceecccccCccceEEEeecCCCccchhccccCCCCCCCHHHHH
Q 044312 302 QAVKKSKVID---ESKVEEFINEVVIL-SQINHRNVVKLLGCCLETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEIRL 377 (608)
Q Consensus 302 ~avk~~~~~~---~~~~~~~~~Ei~il-~~l~H~niv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~ 377 (608)
+|+|...... ......+..|..++ ..++|+|++++++++.+.+..++|+||+++++|.+++.... ++++..+.
T Consensus 24 vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~---~~~~~~~~ 100 (260)
T cd05611 24 FAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLNGGDCASLIKTLG---GLPEDWAK 100 (260)
T ss_pred EEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEeccCCCCHHHHHHHcC---CCCHHHHH
Confidence 5777664322 22233455555544 45589999999999999999999999999999999987643 58999999
Q ss_pred HHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEEcCCCcEEEeeccCccccccCCcceeeeeeccCCCCChhhhccCCCCC
Q 044312 378 RIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHGTFGYLDPEYFRSSQFTD 457 (608)
Q Consensus 378 ~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGls~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ 457 (608)
.++.|++.||.|||+.+ ++|+||+|+|||+++++.+||+|||+++.... .....++..|+|||.+.+..++.
T Consensus 101 ~i~~qi~~aL~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~-----~~~~~~~~~y~~pe~~~~~~~~~ 172 (260)
T cd05611 101 QYIAEVVLGVEDLHQRG---IIHRDIKPENLLIDQTGHLKLTDFGLSRNGLE-----NKKFVGTPDYLAPETILGVGDDK 172 (260)
T ss_pred HHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCcEEEeecccceeccc-----cccCCCCcCccChhhhcCCCCcc
Confidence 99999999999999998 99999999999999999999999999876433 22345788999999998888999
Q ss_pred ccchHhHHHHHHHHHhCCCCCCccchhhcccHHHHHHHHhhhhhhHHHhhhhhhccCChhHHHHHHHHHHHHhccCCCCC
Q 044312 458 KSDVYSFGVVLTELLTGEKPIRFTILEEDKSLAAYFLCAMKEERLFEILDARVMKQGGKDEIITVAKLAKRCLNLNGKKR 537 (608)
Q Consensus 458 ksDV~S~Gvvl~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~Li~~cl~~dp~~R 537 (608)
++||||||++++||++|..||....... .+ ........ ..........+..+.+++.+||+.+|++|
T Consensus 173 ~~Dv~slG~il~~l~~g~~p~~~~~~~~------~~-~~~~~~~~------~~~~~~~~~~~~~~~~~i~~~l~~~p~~R 239 (260)
T cd05611 173 MSDWWSLGCVIFEFLFGYPPFHAETPDA------VF-DNILSRRI------NWPEEVKEFCSPEAVDLINRLLCMDPAKR 239 (260)
T ss_pred hhhhHHHHHHHHHHHHCCCCCCCCCHHH------HH-HHHHhccc------CCCCcccccCCHHHHHHHHHHccCCHHHc
Confidence 9999999999999999999986322111 11 01110000 00111112346789999999999999999
Q ss_pred CCHHHHHHHH
Q 044312 538 PTMREVASEL 547 (608)
Q Consensus 538 Ps~~evl~~L 547 (608)
|++.++.+.|
T Consensus 240 ~~~~~~~~~l 249 (260)
T cd05611 240 LGANGYQEIK 249 (260)
T ss_pred cCCCcHHHHH
Confidence 9876555443
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.4e-30 Score=265.39 Aligned_cols=235 Identities=24% Similarity=0.339 Sum_probs=176.1
Q ss_pred eEEEEEeec--ChhhHHHHHHHHHHHhhcCCCCccceecccccCccceEEEeecCCCccchhccccCCCCCCCHHHHHHH
Q 044312 302 QAVKKSKVI--DESKVEEFINEVVILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEIRLRI 379 (608)
Q Consensus 302 ~avk~~~~~--~~~~~~~~~~Ei~il~~l~H~niv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i 379 (608)
+++|..... +....+.+.+|+.++++++|+||+++++++.+....++||||++ ++|.+++..... .+++..+..+
T Consensus 27 ~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~~-~~l~~~i~~~~~--~~~~~~~~~~ 103 (282)
T cd07829 27 VALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIHTERKLYLVFEYCD-MDLKKYLDKRPG--PLSPNLIKSI 103 (282)
T ss_pred EEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceEEEecCcC-cCHHHHHHhhcc--CCCHHHHHHH
Confidence 466766653 23445778899999999999999999999999999999999997 589999986532 5899999999
Q ss_pred HHHHHHHHHHHhhcCCCCeeccCCCCCcEEEcCCCcEEEeeccCccccccCCcceeeeeeccCCCCChhhhccC-CCCCc
Q 044312 380 AIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHGTFGYLDPEYFRSS-QFTDK 458 (608)
Q Consensus 380 ~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGls~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~t~k 458 (608)
+.+++.||+|||+.+ ++||||+|+||++++++.+||+|||+++....... ......++..|+|||.+.+. .++.+
T Consensus 104 ~~~i~~~l~~LH~~~---i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~ 179 (282)
T cd07829 104 MYQLLRGLAYCHSHR---ILHRDLKPQNILINRDGVLKLADFGLARAFGIPLR-TYTHEVVTLWYRAPEILLGSKHYSTA 179 (282)
T ss_pred HHHHHHHHHHHHHCC---cccCCCChheEEEcCCCCEEEecCCcccccCCCcc-ccCccccCcCcCChHHhcCCcCCCcc
Confidence 999999999999999 99999999999999999999999999987654322 12233457789999998776 88999
Q ss_pred cchHhHHHHHHHHHhCCCCCCccchhhcccHHHHHHHHhh---hhhhHHHhh--------hhh----hccCChhHHHHHH
Q 044312 459 SDVYSFGVVLTELLTGEKPIRFTILEEDKSLAAYFLCAMK---EERLFEILD--------ARV----MKQGGKDEIITVA 523 (608)
Q Consensus 459 sDV~S~Gvvl~elltg~~p~~~~~~~~~~~l~~~~~~~~~---~~~~~~~~d--------~~~----~~~~~~~~~~~l~ 523 (608)
+||||||++++||++|+.||......+. ......... +.....+.+ +.. ........+..+.
T Consensus 180 ~Dv~slG~~l~~l~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 256 (282)
T cd07829 180 VDIWSVGCIFAEMITGKPLFPGDSEIDQ---LFKIFQILGTPTEESWPGVTKLPDYKPTFPKFPPKDLEKVLPRLDPEGI 256 (282)
T ss_pred ccHHHHHHHHHHHHhCCCCCCCccHHHH---HHHHHHHhCCCcHHHHHhhcccccccccccccCccchHHhcccccHHHH
Confidence 9999999999999999999864322111 000100000 000000000 000 0000112256799
Q ss_pred HHHHHHhccCCCCCCCHHHHHHH
Q 044312 524 KLAKRCLNLNGKKRPTMREVASE 546 (608)
Q Consensus 524 ~Li~~cl~~dp~~RPs~~evl~~ 546 (608)
+++.+||..+|++||++.+++.+
T Consensus 257 ~~i~~~l~~~P~~Rp~~~~~l~~ 279 (282)
T cd07829 257 DLLSKMLQYNPAKRISAKEALKH 279 (282)
T ss_pred HHHHHhhccCcccCCCHHHHhhC
Confidence 99999999999999999999853
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.5e-30 Score=264.15 Aligned_cols=234 Identities=25% Similarity=0.321 Sum_probs=171.3
Q ss_pred eEEEEEeecC--hhhHHHHHHHHHHHhhc---CCCCccceecccccCcc-----ceEEEeecCCCccchhccccCCCCCC
Q 044312 302 QAVKKSKVID--ESKVEEFINEVVILSQI---NHRNVVKLLGCCLETEV-----PLLVYEFIPNGTLFQYIHDQNEDFPI 371 (608)
Q Consensus 302 ~avk~~~~~~--~~~~~~~~~Ei~il~~l---~H~niv~l~~~~~~~~~-----~~lV~E~~~~gsL~~~l~~~~~~~~l 371 (608)
+|+|..+... ......+.+|+.+++++ +|+||+++++++...+. .+++|||++ ++|.+++..... ..+
T Consensus 27 ~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~~~l~~e~~~-~~l~~~l~~~~~-~~l 104 (287)
T cd07838 27 VALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELKLTLVFEHVD-QDLATYLSKCPK-PGL 104 (287)
T ss_pred EEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCceeEEEehhcc-cCHHHHHHHccC-CCC
Confidence 3677765422 22345677888877666 59999999999987776 899999996 488888876433 258
Q ss_pred CHHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEEcCCCcEEEeeccCccccccCCcceeeeeeccCCCCChhhhc
Q 044312 372 TWEIRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHGTFGYLDPEYFR 451 (608)
Q Consensus 372 ~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGls~~~~~~~~~~~~~~~gt~~y~aPE~~~ 451 (608)
++..++.++.|++.||.|||+.+ ++|+||+|+|||++.++.+||+|||++........ .....++..|+|||++.
T Consensus 105 ~~~~~~~~~~~i~~al~~LH~~~---i~h~~l~~~nili~~~~~~~l~dfg~~~~~~~~~~--~~~~~~~~~~~~PE~~~ 179 (287)
T cd07838 105 PPETIKDLMRQLLRGVDFLHSHR---IVHRDLKPQNILVTSDGQVKIADFGLARIYSFEMA--LTSVVVTLWYRAPEVLL 179 (287)
T ss_pred CHHHHHHHHHHHHHHHHHHHHCC---eeeccCChhhEEEccCCCEEEeccCcceeccCCcc--cccccccccccChHHhc
Confidence 99999999999999999999998 99999999999999999999999999977643321 12334788999999999
Q ss_pred cCCCCCccchHhHHHHHHHHHhCCCCCCccchhhcccHHHHHHHHhhh-hhh---------HHHhhhhh---hccCChhH
Q 044312 452 SSQFTDKSDVYSFGVVLTELLTGEKPIRFTILEEDKSLAAYFLCAMKE-ERL---------FEILDARV---MKQGGKDE 518 (608)
Q Consensus 452 ~~~~t~ksDV~S~Gvvl~elltg~~p~~~~~~~~~~~l~~~~~~~~~~-~~~---------~~~~d~~~---~~~~~~~~ 518 (608)
+..++.++||||||++++||++|+.||......+ .+.. +...... ... ........ ........
T Consensus 180 ~~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~~~~--~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 256 (287)
T cd07838 180 QSSYATPVDMWSVGCIFAELFRRRPLFRGTSEAD--QLDK-IFDVIGLPSEEEWPRNVSLPRSSFPSYTPRSFKSFVPEI 256 (287)
T ss_pred cCCCCCcchhhhHHHHHHHHHhCCCcccCCChHH--HHHH-HHHHcCCCChHhcCCCcccchhhcccccccchhhhhhhh
Confidence 9999999999999999999999999886432211 1111 1111000 000 00000000 00111234
Q ss_pred HHHHHHHHHHHhccCCCCCCCHHHHHH
Q 044312 519 IITVAKLAKRCLNLNGKKRPTMREVAS 545 (608)
Q Consensus 519 ~~~l~~Li~~cl~~dp~~RPs~~evl~ 545 (608)
+..+.+++.+||+.||++||++.|++.
T Consensus 257 ~~~~~~li~~~l~~dp~~Rp~~~~il~ 283 (287)
T cd07838 257 CEEGLDLLKKMLTFNPHKRISAFEALQ 283 (287)
T ss_pred hHHHHHHHHHHhccCCccCCCHHHHhc
Confidence 567889999999999999999999975
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.4e-30 Score=269.02 Aligned_cols=218 Identities=26% Similarity=0.380 Sum_probs=169.3
Q ss_pred EEEEEeec---ChhhHHHHHHHHHHHhhcCCCCccceecccccCccceEEEeecCCCccchhccccCCCCCCCHHHHHHH
Q 044312 303 AVKKSKVI---DESKVEEFINEVVILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEIRLRI 379 (608)
Q Consensus 303 avk~~~~~---~~~~~~~~~~Ei~il~~l~H~niv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i 379 (608)
++|+.... .....+.+.+|+.+++.++|||++++++++.+....++||||+. ++|.+++..... ++++..++.+
T Consensus 50 ~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~--~l~~~~~~~~ 126 (313)
T cd06633 50 AVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVMEYCL-GSASDLLEVHKK--PLQEVEIAAI 126 (313)
T ss_pred EEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEEecCC-CCHHHHHHhcCC--CCCHHHHHHH
Confidence 55555432 22345678899999999999999999999999999999999996 577777765332 5899999999
Q ss_pred HHHHHHHHHHHhhcCCCCeeccCCCCCcEEEcCCCcEEEeeccCccccccCCcceeeeeeccCCCCChhhhc---cCCCC
Q 044312 380 AIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHGTFGYLDPEYFR---SSQFT 456 (608)
Q Consensus 380 ~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGls~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~t 456 (608)
+.||+.||.|||+.+ ++|+||+|+||++++++.+||+|||++..... .....|+..|+|||++. ...++
T Consensus 127 ~~qi~~al~~LH~~g---i~H~dl~p~nili~~~~~~kL~dfg~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~ 198 (313)
T cd06633 127 THGALQGLAYLHSHN---MIHRDIKAGNILLTEPGQVKLADFGSASKSSP-----ANSFVGTPYWMAPEVILAMDEGQYD 198 (313)
T ss_pred HHHHHHHHHHHHHCC---eecCCCChhhEEECCCCCEEEeecCCCcccCC-----CCCccccccccChhhccccCCCCCC
Confidence 999999999999999 99999999999999999999999999864322 12346788999999984 45688
Q ss_pred CccchHhHHHHHHHHHhCCCCCCccchhhcccHHHHHHHHhhhhhhHHHhhhhhhccCChhHHHHHHHHHHHHhccCCCC
Q 044312 457 DKSDVYSFGVVLTELLTGEKPIRFTILEEDKSLAAYFLCAMKEERLFEILDARVMKQGGKDEIITVAKLAKRCLNLNGKK 536 (608)
Q Consensus 457 ~ksDV~S~Gvvl~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~Li~~cl~~dp~~ 536 (608)
.++||||||++++||++|..||....... ........ ..........+..+.+|+.+||+.+|.+
T Consensus 199 ~~sDv~slGvil~el~~g~~p~~~~~~~~------~~~~~~~~---------~~~~~~~~~~~~~l~~li~~~l~~~P~~ 263 (313)
T cd06633 199 GKVDVWSLGITCIELAERKPPLFNMNAMS------ALYHIAQN---------DSPTLQSNEWTDSFRGFVDYCLQKIPQE 263 (313)
T ss_pred chhhHHHHHHHHHHHHhCCCCCCCCChHH------HHHHHHhc---------CCCCCCccccCHHHHHHHHHHccCChhh
Confidence 99999999999999999999986322110 00000000 0011111233456899999999999999
Q ss_pred CCCHHHHHHH
Q 044312 537 RPTMREVASE 546 (608)
Q Consensus 537 RPs~~evl~~ 546 (608)
||++.+++.+
T Consensus 264 Rp~~~~~l~~ 273 (313)
T cd06633 264 RPASAELLRH 273 (313)
T ss_pred CcCHHHHhcC
Confidence 9999999864
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.9e-31 Score=273.75 Aligned_cols=251 Identities=21% Similarity=0.302 Sum_probs=183.4
Q ss_pred HHHHhcCccccceeccCce---------------EEEEEee--cChhhHHHHHHHHHHHhhcCCCCccceeccccc-Ccc
Q 044312 284 LEKATDNFDLNRILGQGGQ---------------AVKKSKV--IDESKVEEFINEVVILSQINHRNVVKLLGCCLE-TEV 345 (608)
Q Consensus 284 l~~~t~~f~~~~~lG~G~~---------------avk~~~~--~~~~~~~~~~~Ei~il~~l~H~niv~l~~~~~~-~~~ 345 (608)
+..++++|++.+.||.|++ |+|+... ......+.+.+|+.++++++||||+++.+++.. ...
T Consensus 5 ~~~~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~ 84 (328)
T cd07856 5 VFEITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFISPLED 84 (328)
T ss_pred eeccccceEEEEeecccCCeEEEEEEECCCCCEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEeeeEecCCCc
Confidence 3457788999999999974 5565432 223345778899999999999999999999865 557
Q ss_pred ceEEEeecCCCccchhccccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEEcCCCcEEEeeccCcc
Q 044312 346 PLLVYEFIPNGTLFQYIHDQNEDFPITWEIRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASR 425 (608)
Q Consensus 346 ~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGls~ 425 (608)
.++|+||+ +++|.+++... ++++..+..++.|+++||+|||+.+ ++||||+|+|||+++++.+||+|||++.
T Consensus 85 ~~lv~e~~-~~~L~~~~~~~----~~~~~~~~~~~~ql~~aL~~LH~~~---iiH~dl~p~Nili~~~~~~~l~dfg~~~ 156 (328)
T cd07856 85 IYFVTELL-GTDLHRLLTSR----PLEKQFIQYFLYQILRGLKYVHSAG---VVHRDLKPSNILINENCDLKICDFGLAR 156 (328)
T ss_pred EEEEeehh-ccCHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEeECCCCCEEeCcccccc
Confidence 88999998 56888877642 4788888999999999999999999 9999999999999999999999999987
Q ss_pred ccccCCcceeeeeeccCCCCChhhhcc-CCCCCccchHhHHHHHHHHHhCCCCCCccchhhcccHHHH--------HHHH
Q 044312 426 SMAVDQTHMTTQVHGTFGYLDPEYFRS-SQFTDKSDVYSFGVVLTELLTGEKPIRFTILEEDKSLAAY--------FLCA 496 (608)
Q Consensus 426 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~t~ksDV~S~Gvvl~elltg~~p~~~~~~~~~~~l~~~--------~~~~ 496 (608)
..... .....++..|+|||.+.+ ..++.++||||||++++||++|+.||.............. +...
T Consensus 157 ~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (328)
T cd07856 157 IQDPQ----MTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDDVINT 232 (328)
T ss_pred ccCCC----cCCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHh
Confidence 54321 123356888999998766 5689999999999999999999999864332111000000 0000
Q ss_pred hhhhhhHHHhhh-hhhcc-----CChhHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 044312 497 MKEERLFEILDA-RVMKQ-----GGKDEIITVAKLAKRCLNLNGKKRPTMREVASE 546 (608)
Q Consensus 497 ~~~~~~~~~~d~-~~~~~-----~~~~~~~~l~~Li~~cl~~dp~~RPs~~evl~~ 546 (608)
.......+.+.. ..... .....+..+.+++.+||+.+|++||++.|++.+
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~~ 288 (328)
T cd07856 233 ICSENTLRFVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAH 288 (328)
T ss_pred ccchhhHHHHhhccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 000001111100 00000 011235689999999999999999999998754
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=4e-31 Score=257.54 Aligned_cols=252 Identities=23% Similarity=0.338 Sum_probs=189.8
Q ss_pred HHHHHHHhcCccccceeccCce---------------EEEEEeecChhhHHHHHHHHHHHhhc-CCCCccceecccccCc
Q 044312 281 SKELEKATDNFDLNRILGQGGQ---------------AVKKSKVIDESKVEEFINEVVILSQI-NHRNVVKLLGCCLETE 344 (608)
Q Consensus 281 ~~~l~~~t~~f~~~~~lG~G~~---------------avk~~~~~~~~~~~~~~~Ei~il~~l-~H~niv~l~~~~~~~~ 344 (608)
++++.+.|+ +.||+|++ |||++............+|++++.+. .|+||++|+++|++++
T Consensus 75 F~d~YkLt~-----e~LGeGAyasVqtcv~i~t~~EYAVKiidKq~gHsR~RvfREVe~f~~Cqgh~nilqLiefFEdd~ 149 (463)
T KOG0607|consen 75 FEDMYKLTS-----ELLGEGAYASVQTCVSIQTGKEYAVKIIDKQPGHSRSRVFREVETFYQCQGHKNILQLIEFFEDDT 149 (463)
T ss_pred HHHHHHhHH-----HHhcCccceeeeeeeeeccchhhhhhhhhcCCchHHHHHHHHHHHHHHhcCCccHHHHHHHhcccc
Confidence 455555553 56899874 78877766777788999999999999 5999999999999999
Q ss_pred cceEEEeecCCCccchhccccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEEcCCC---cEEEeec
Q 044312 345 VPLLVYEFIPNGTLFQYIHDQNEDFPITWEIRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKY---RAKVSDF 421 (608)
Q Consensus 345 ~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~---~~kl~DF 421 (608)
..|||||.|.||+|..+|++.. .+++.+..++..+||.||.+||.++ |.||||||+|||..+.. -+||+||
T Consensus 150 ~FYLVfEKm~GGplLshI~~~~---~F~E~EAs~vvkdia~aLdFlH~kg---IAHRDlKPENiLC~~pn~vsPvKiCDf 223 (463)
T KOG0607|consen 150 RFYLVFEKMRGGPLLSHIQKRK---HFNEREASRVVKDIASALDFLHTKG---IAHRDLKPENILCESPNKVSPVKICDF 223 (463)
T ss_pred eEEEEEecccCchHHHHHHHhh---hccHHHHHHHHHHHHHHHHHHhhcC---cccccCCccceeecCCCCcCceeeecc
Confidence 9999999999999999998754 5999999999999999999999999 99999999999997544 4899999
Q ss_pred cCccccccCC------cceeeeeeccCCCCChhhhc-----cCCCCCccchHhHHHHHHHHHhCCCCCCccchhhcccHH
Q 044312 422 GASRSMAVDQ------THMTTQVHGTFGYLDPEYFR-----SSQFTDKSDVYSFGVVLTELLTGEKPIRFTILEEDKSLA 490 (608)
Q Consensus 422 Gls~~~~~~~------~~~~~~~~gt~~y~aPE~~~-----~~~~t~ksDV~S~Gvvl~elltg~~p~~~~~~~~~~~l~ 490 (608)
.|..-+.... +.......|+..|||||+.. ...|+.+.|.||||||||-|++|.+||......+-. ..
T Consensus 224 DLgSg~k~~~~~spastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~dCG-Wd 302 (463)
T KOG0607|consen 224 DLGSGIKLNNDCSPASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGADCG-WD 302 (463)
T ss_pred ccccccccCCCCCCCCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCCcCC-cc
Confidence 8875432211 11223456888999999863 336889999999999999999999999754321100 00
Q ss_pred HHHHHHhhhhhhHHHhhhhhhccCC----hhHHHHHHHHHHHHhccCCCCCCCHHHHHH
Q 044312 491 AYFLCAMKEERLFEILDARVMKQGG----KDEIITVAKLAKRCLNLNGKKRPTMREVAS 545 (608)
Q Consensus 491 ~~~~~~~~~~~~~~~~d~~~~~~~~----~~~~~~l~~Li~~cl~~dp~~RPs~~evl~ 545 (608)
.--.-..-.+.+++-+..... +++ ...+.+..+|+...|..|+.+|.++.+++.
T Consensus 303 rGe~Cr~CQ~~LFesIQEGkY-eFPdkdWahIS~eakdlisnLlvrda~~rlsa~~vln 360 (463)
T KOG0607|consen 303 RGEVCRVCQNKLFESIQEGKY-EFPDKDWAHISSEAKDLISNLLVRDAKQRLSAAQVLN 360 (463)
T ss_pred CCCccHHHHHHHHHHHhccCC-cCChhhhHHhhHHHHHHHHHHHhccHHhhhhhhhccC
Confidence 000000111222222222111 222 234667889999999999999999999887
|
|
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.2e-30 Score=274.59 Aligned_cols=247 Identities=23% Similarity=0.331 Sum_probs=179.8
Q ss_pred cCccccceeccCce---------------EEEEEeecChhhHHHHHHHHHHHhhcCCCCccceecccccC----------
Q 044312 289 DNFDLNRILGQGGQ---------------AVKKSKVIDESKVEEFINEVVILSQINHRNVVKLLGCCLET---------- 343 (608)
Q Consensus 289 ~~f~~~~~lG~G~~---------------avk~~~~~~~~~~~~~~~Ei~il~~l~H~niv~l~~~~~~~---------- 343 (608)
.+|.+.+.||.|++ |+|+....+....+.+.+|++++++++||||+++++++...
T Consensus 5 ~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~ 84 (342)
T cd07854 5 SRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDVGS 84 (342)
T ss_pred cceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCCchHHHHHHHHHHHHhcCCCcchhhHhhhccccccccccccc
Confidence 57888899999874 66766665556677899999999999999999999877654
Q ss_pred ----ccceEEEeecCCCccchhccccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEEc-CCCcEEE
Q 044312 344 ----EVPLLVYEFIPNGTLFQYIHDQNEDFPITWEIRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLD-DKYRAKV 418 (608)
Q Consensus 344 ----~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~-~~~~~kl 418 (608)
...++||||++ ++|.+++... .+++..+..++.||+.||.|||+.+ ++||||||+|||++ +++.+||
T Consensus 85 ~~~~~~~~lv~e~~~-~~L~~~~~~~----~l~~~~~~~~~~qi~~aL~~LH~~g---ivH~dikp~Nili~~~~~~~kl 156 (342)
T cd07854 85 LTELNSVYIVQEYME-TDLANVLEQG----PLSEEHARLFMYQLLRGLKYIHSAN---VLHRDLKPANVFINTEDLVLKI 156 (342)
T ss_pred ccccceEEEEeeccc-ccHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEcCCCceEEE
Confidence 34689999996 5888877532 4889999999999999999999999 99999999999997 5567899
Q ss_pred eeccCccccccCCcc--eeeeeeccCCCCChhhhcc-CCCCCccchHhHHHHHHHHHhCCCCCCccchhhcccHHHHHHH
Q 044312 419 SDFGASRSMAVDQTH--MTTQVHGTFGYLDPEYFRS-SQFTDKSDVYSFGVVLTELLTGEKPIRFTILEEDKSLAAYFLC 495 (608)
Q Consensus 419 ~DFGls~~~~~~~~~--~~~~~~gt~~y~aPE~~~~-~~~t~ksDV~S~Gvvl~elltg~~p~~~~~~~~~~~l~~~~~~ 495 (608)
+|||+++........ ......++..|+|||.+.. ..++.++||||||++++||++|+.||........ ......
T Consensus 157 ~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~---~~~~~~ 233 (342)
T cd07854 157 GDFGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQ---MQLILE 233 (342)
T ss_pred CCcccceecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH---HHHHHH
Confidence 999999765322111 1122357889999998754 5688899999999999999999999964322110 000000
Q ss_pred Hhhh------hhhHHHhhhhhh-----c-----cCChhHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 044312 496 AMKE------ERLFEILDARVM-----K-----QGGKDEIITVAKLAKRCLNLNGKKRPTMREVASE 546 (608)
Q Consensus 496 ~~~~------~~~~~~~d~~~~-----~-----~~~~~~~~~l~~Li~~cl~~dp~~RPs~~evl~~ 546 (608)
.... ......+..... . ......+.++.+|+.+||+.||++|||+.|++.+
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~h 300 (342)
T cd07854 234 SVPVVREEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALMH 300 (342)
T ss_pred hcCCCChHHhhhhhhhhhhhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccCHHHHhCC
Confidence 0000 000000000000 0 0011244678899999999999999999999854
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.1e-30 Score=263.26 Aligned_cols=246 Identities=25% Similarity=0.351 Sum_probs=177.8
Q ss_pred ccccceeccCce---------------EEEEEeecC-hhhHHHHHHHHHHHhhcC-CCCccceecccccCccceEEEeec
Q 044312 291 FDLNRILGQGGQ---------------AVKKSKVID-ESKVEEFINEVVILSQIN-HRNVVKLLGCCLETEVPLLVYEFI 353 (608)
Q Consensus 291 f~~~~~lG~G~~---------------avk~~~~~~-~~~~~~~~~Ei~il~~l~-H~niv~l~~~~~~~~~~~lV~E~~ 353 (608)
|++.+.||+|++ ++|+..... ........+|+..+++++ |+||+++++++.+.+..++||||+
T Consensus 1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (283)
T cd07830 1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVFEYM 80 (283)
T ss_pred CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccchhHHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEEEecC
Confidence 455667777763 555543321 122334567999999998 999999999999999999999999
Q ss_pred CCCccchhccccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEEcCCCcEEEeeccCccccccCCcc
Q 044312 354 PNGTLFQYIHDQNEDFPITWEIRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTH 433 (608)
Q Consensus 354 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGls~~~~~~~~~ 433 (608)
+++|.+++..... ..+++..++.++.|++.+|.|||+++ ++|+||+|+||++++++.++|+|||++........
T Consensus 81 -~~~l~~~~~~~~~-~~~~~~~~~~~~~~l~~~l~~Lh~~~---i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~~~~- 154 (283)
T cd07830 81 -EGNLYQLMKDRKG-KPFSESVIRSIIYQILQGLAHIHKHG---FFHRDLKPENLLVSGPEVVKIADFGLAREIRSRPP- 154 (283)
T ss_pred -CCCHHHHHHhccc-ccCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChhhEEEcCCCCEEEeecccceeccCCCC-
Confidence 8899998876542 25899999999999999999999999 99999999999999999999999999986543221
Q ss_pred eeeeeeccCCCCChhhhc-cCCCCCccchHhHHHHHHHHHhCCCCCCccchhhcccHHHHHHHHhhhh---------hhH
Q 044312 434 MTTQVHGTFGYLDPEYFR-SSQFTDKSDVYSFGVVLTELLTGEKPIRFTILEEDKSLAAYFLCAMKEE---------RLF 503 (608)
Q Consensus 434 ~~~~~~gt~~y~aPE~~~-~~~~t~ksDV~S~Gvvl~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~---------~~~ 503 (608)
.....++..|+|||++. ...++.++||||||++++||++|+.||......+. .......+... .+.
T Consensus 155 -~~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~ 230 (283)
T cd07830 155 -YTDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQ---LYKICSVLGTPTKQDWPEGYKLA 230 (283)
T ss_pred -cCCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHHH---HHHHHHhcCCCChhhhhhHhhhh
Confidence 22345788999999875 45689999999999999999999999864322111 00000000000 000
Q ss_pred HHhhhhh-------hccCChhHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 044312 504 EILDARV-------MKQGGKDEIITVAKLAKRCLNLNGKKRPTMREVASE 546 (608)
Q Consensus 504 ~~~d~~~-------~~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~evl~~ 546 (608)
...+... ........+..+.+++.+||+.+|++|||++|++.+
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~ 280 (283)
T cd07830 231 SKLGFRFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQH 280 (283)
T ss_pred ccccccccccccccHHHHcccCCHHHHHHHHHhcccCcccCCCHHHHhhC
Confidence 0000000 000011124679999999999999999999999753
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.5e-30 Score=273.03 Aligned_cols=220 Identities=21% Similarity=0.274 Sum_probs=165.2
Q ss_pred HHHHHHHHHhhcCCCCccceecccccCccceEEEeecCCCccchhccccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCC
Q 044312 317 EFINEVVILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEIRLRIAIEVSGALSYLHSAASI 396 (608)
Q Consensus 317 ~~~~Ei~il~~l~H~niv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~ 396 (608)
.+.+|++++++++|+||+++++++...+..++||||++ ++|.+++.... .+++.....++.|++.||+|||+.+
T Consensus 66 ~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~---~~~~~~~~~~~~ql~~aL~~LH~~~-- 139 (335)
T PTZ00024 66 TTLRELKIMNEIKHENIMGLVDVYVEGDFINLVMDIMA-SDLKKVVDRKI---RLTESQVKCILLQILNGLNVLHKWY-- 139 (335)
T ss_pred hHHHHHHHHHhCCCcceeeeeEEEecCCcEEEEEeccc-cCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCC--
Confidence 57899999999999999999999999999999999996 68988886532 4899999999999999999999999
Q ss_pred CeeccCCCCCcEEEcCCCcEEEeeccCccccccCC-------------cceeeeeeccCCCCChhhhccC-CCCCccchH
Q 044312 397 PIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQ-------------THMTTQVHGTFGYLDPEYFRSS-QFTDKSDVY 462 (608)
Q Consensus 397 ~iiHrDlk~~NILl~~~~~~kl~DFGls~~~~~~~-------------~~~~~~~~gt~~y~aPE~~~~~-~~t~ksDV~ 462 (608)
++|+||+|+|||++.++.+||+|||+++...... ........++..|+|||.+.+. .++.++|||
T Consensus 140 -i~H~dl~~~nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~ 218 (335)
T PTZ00024 140 -FMHRDLSPANIFINSKGICKIADFGLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMW 218 (335)
T ss_pred -eecccccHHHeEECCCCCEEECCccceeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHH
Confidence 9999999999999999999999999997654111 1111223467889999998764 468999999
Q ss_pred hHHHHHHHHHhCCCCCCccchhhcccHHHHHHHHhhhhh---hHHHhh-----------hhhhccCChhHHHHHHHHHHH
Q 044312 463 SFGVVLTELLTGEKPIRFTILEEDKSLAAYFLCAMKEER---LFEILD-----------ARVMKQGGKDEIITVAKLAKR 528 (608)
Q Consensus 463 S~Gvvl~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~---~~~~~d-----------~~~~~~~~~~~~~~l~~Li~~ 528 (608)
|||++++||++|+.||......+. ............ ..+..+ +..........+..+.+++.+
T Consensus 219 slG~~l~el~tg~~p~~~~~~~~~---~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ 295 (335)
T PTZ00024 219 SVGCIFAELLTGKPLFPGENEIDQ---LGRIFELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQS 295 (335)
T ss_pred HHHHHHHHHHhCCCCCCCCCHHHH---HHHHHHHhCCCchhhCcchhhcccccccCcCCcccHHHhCcCCChHHHHHHHH
Confidence 999999999999999874432211 111111110000 000000 000000111235678999999
Q ss_pred HhccCCCCCCCHHHHHHH
Q 044312 529 CLNLNGKKRPTMREVASE 546 (608)
Q Consensus 529 cl~~dp~~RPs~~evl~~ 546 (608)
||+.+|++||++.|++.+
T Consensus 296 ~l~~~P~~R~s~~~~l~~ 313 (335)
T PTZ00024 296 LLKLNPLERISAKEALKH 313 (335)
T ss_pred HcCCCchhccCHHHHhcC
Confidence 999999999999999864
|
|
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.9e-30 Score=271.92 Aligned_cols=248 Identities=22% Similarity=0.303 Sum_probs=182.2
Q ss_pred HHHhcCccccceeccCce---------------EEEEEeec--ChhhHHHHHHHHHHHhhcCCCCccceecccccCc---
Q 044312 285 EKATDNFDLNRILGQGGQ---------------AVKKSKVI--DESKVEEFINEVVILSQINHRNVVKLLGCCLETE--- 344 (608)
Q Consensus 285 ~~~t~~f~~~~~lG~G~~---------------avk~~~~~--~~~~~~~~~~Ei~il~~l~H~niv~l~~~~~~~~--- 344 (608)
....++|++.+.||+|++ |||+.... .....+.+.+|+.+|++++||||+++++++....
T Consensus 11 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 90 (343)
T cd07880 11 WEVPDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSLD 90 (343)
T ss_pred hccccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeeecCCcccc
Confidence 345678999999999974 56655321 2223457889999999999999999999987553
Q ss_pred ---cceEEEeecCCCccchhccccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEEcCCCcEEEeec
Q 044312 345 ---VPLLVYEFIPNGTLFQYIHDQNEDFPITWEIRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDF 421 (608)
Q Consensus 345 ---~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DF 421 (608)
..++||||+ +++|.+++... .+++..+..++.|+++||+|||+.+ |+||||||+|||++.++.+||+||
T Consensus 91 ~~~~~~lv~e~~-~~~l~~~~~~~----~l~~~~~~~i~~qi~~al~~LH~~g---i~H~dlkp~Nill~~~~~~kl~df 162 (343)
T cd07880 91 RFHDFYLVMPFM-GTDLGKLMKHE----KLSEDRIQFLVYQMLKGLKYIHAAG---IIHRDLKPGNLAVNEDCELKILDF 162 (343)
T ss_pred ccceEEEEEecC-CCCHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEeec
Confidence 358999999 77888887642 4899999999999999999999999 999999999999999999999999
Q ss_pred cCccccccCCcceeeeeeccCCCCChhhhcc-CCCCCccchHhHHHHHHHHHhCCCCCCccchhhcccHHHH--------
Q 044312 422 GASRSMAVDQTHMTTQVHGTFGYLDPEYFRS-SQFTDKSDVYSFGVVLTELLTGEKPIRFTILEEDKSLAAY-------- 492 (608)
Q Consensus 422 Gls~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~t~ksDV~S~Gvvl~elltg~~p~~~~~~~~~~~l~~~-------- 492 (608)
|++...... .....+++.|+|||.+.. ..++.++||||||+++++|++|+.||....... .....
T Consensus 163 g~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~--~~~~~~~~~~~~~ 236 (343)
T cd07880 163 GLARQTDSE----MTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLD--QLMEIMKVTGTPS 236 (343)
T ss_pred ccccccccC----ccccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH--HHHHHHHhcCCCC
Confidence 999865422 123457889999999876 468899999999999999999999986432110 00000
Q ss_pred --HHHHhhhhhhHHHhhh--h----hhccCChhHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 044312 493 --FLCAMKEERLFEILDA--R----VMKQGGKDEIITVAKLAKRCLNLNGKKRPTMREVASE 546 (608)
Q Consensus 493 --~~~~~~~~~~~~~~d~--~----~~~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~evl~~ 546 (608)
+...+........+.. . .........+..+.+++.+|++.||++|||+.+++.+
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l~~ 298 (343)
T cd07880 237 KEFVQKLQSEDAKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALAH 298 (343)
T ss_pred HHHHHhhcchhHHHHHHhccccCcchHHHhccCCChHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 0001100000000000 0 0001112344568899999999999999999999853
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription] | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.1e-31 Score=256.69 Aligned_cols=187 Identities=25% Similarity=0.379 Sum_probs=151.4
Q ss_pred cCccccceeccCceE-------------------EEEEeecCh--hhHHHHHHHHHHHhhcCCCCccceeccccc-Cccc
Q 044312 289 DNFDLNRILGQGGQA-------------------VKKSKVIDE--SKVEEFINEVVILSQINHRNVVKLLGCCLE-TEVP 346 (608)
Q Consensus 289 ~~f~~~~~lG~G~~a-------------------vk~~~~~~~--~~~~~~~~Ei~il~~l~H~niv~l~~~~~~-~~~~ 346 (608)
..|+....||+|.+. +|+++.... .--....+|+.+++.|+||||+.|..++.+ +...
T Consensus 24 ~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~d~~v 103 (438)
T KOG0666|consen 24 FEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFLSHDKKV 103 (438)
T ss_pred HHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHhccCceE
Confidence 357888899999752 222221100 011346789999999999999999999987 7788
Q ss_pred eEEEeecCCCccchhccccC--CCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEEcCC----CcEEEee
Q 044312 347 LLVYEFIPNGTLFQYIHDQN--EDFPITWEIRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDK----YRAKVSD 420 (608)
Q Consensus 347 ~lV~E~~~~gsL~~~l~~~~--~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~----~~~kl~D 420 (608)
+|++||.+. +|.+.|+-.+ ....++...+.+|+.||+.|+.|||++- |+||||||.|||+..+ |.+||+|
T Consensus 104 ~l~fdYAEh-DL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~NW---vlHRDLKPaNIlvmgdgperG~VKIaD 179 (438)
T KOG0666|consen 104 WLLFDYAEH-DLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSNW---VLHRDLKPANILVMGDGPERGRVKIAD 179 (438)
T ss_pred EEEehhhhh-hHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhhh---eeeccCCcceEEEeccCCccCeeEeec
Confidence 999999977 8988886432 2246899999999999999999999999 9999999999999866 8999999
Q ss_pred ccCccccccCCcc--eeeeeeccCCCCChhhhccC-CCCCccchHhHHHHHHHHHhCCCCCC
Q 044312 421 FGASRSMAVDQTH--MTTQVHGTFGYLDPEYFRSS-QFTDKSDVYSFGVVLTELLTGEKPIR 479 (608)
Q Consensus 421 FGls~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~-~~t~ksDV~S~Gvvl~elltg~~p~~ 479 (608)
||++|.+...-.. ....+.-|.+|.|||.+.+. .||++.|||+.|||+.||+|-++-|.
T Consensus 180 lGlaR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~ 241 (438)
T KOG0666|consen 180 LGLARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFK 241 (438)
T ss_pred ccHHHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCcccc
Confidence 9999988643322 23456789999999998875 68999999999999999999887765
|
|
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.3e-30 Score=274.47 Aligned_cols=246 Identities=23% Similarity=0.309 Sum_probs=182.1
Q ss_pred HhcCccccceeccCce---------------EEEEEeec--ChhhHHHHHHHHHHHhhcCCCCccceecccccCcc----
Q 044312 287 ATDNFDLNRILGQGGQ---------------AVKKSKVI--DESKVEEFINEVVILSQINHRNVVKLLGCCLETEV---- 345 (608)
Q Consensus 287 ~t~~f~~~~~lG~G~~---------------avk~~~~~--~~~~~~~~~~Ei~il~~l~H~niv~l~~~~~~~~~---- 345 (608)
..++|++.+.||+|++ |+|+.... .....+.+.+|+.++++++|+||+++++++...+.
T Consensus 13 ~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 92 (343)
T cd07851 13 VPDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLEDF 92 (343)
T ss_pred ccCceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHhhcccccccc
Confidence 4567888999999863 56655432 23345678899999999999999999998876654
Q ss_pred --ceEEEeecCCCccchhccccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEEcCCCcEEEeeccC
Q 044312 346 --PLLVYEFIPNGTLFQYIHDQNEDFPITWEIRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGA 423 (608)
Q Consensus 346 --~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGl 423 (608)
.++|+||+ +++|.+++... .+++..+..++.|+++||+|||+.+ |+||||||+||++++++.+||+|||+
T Consensus 93 ~~~~lv~e~~-~~~L~~~~~~~----~l~~~~~~~~~~ql~~aL~~LH~~g---i~H~dlkp~Nill~~~~~~kL~dfg~ 164 (343)
T cd07851 93 QDVYLVTHLM-GADLNNIVKCQ----KLSDDHIQFLVYQILRGLKYIHSAG---IIHRDLKPSNIAVNEDCELKILDFGL 164 (343)
T ss_pred ccEEEEEecC-CCCHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCCEEEccccc
Confidence 89999999 66998888652 4899999999999999999999999 99999999999999999999999999
Q ss_pred ccccccCCcceeeeeeccCCCCChhhhcc-CCCCCccchHhHHHHHHHHHhCCCCCCccchhhcccHHHH----------
Q 044312 424 SRSMAVDQTHMTTQVHGTFGYLDPEYFRS-SQFTDKSDVYSFGVVLTELLTGEKPIRFTILEEDKSLAAY---------- 492 (608)
Q Consensus 424 s~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~t~ksDV~S~Gvvl~elltg~~p~~~~~~~~~~~l~~~---------- 492 (608)
+...... .....++..|+|||.+.+ ..++.++||||||++++||++|+.||........ +...
T Consensus 165 ~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~--~~~i~~~~~~~~~~ 238 (343)
T cd07851 165 ARHTDDE----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQ--LKRIMNLVGTPDEE 238 (343)
T ss_pred ccccccc----ccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHH--HHHHHHhcCCCCHH
Confidence 9865432 233457889999999865 3678999999999999999999999864322110 0000
Q ss_pred HHHHhhhhhhHHHhhhhhhc------cCChhHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 044312 493 FLCAMKEERLFEILDARVMK------QGGKDEIITVAKLAKRCLNLNGKKRPTMREVASE 546 (608)
Q Consensus 493 ~~~~~~~~~~~~~~d~~~~~------~~~~~~~~~l~~Li~~cl~~dp~~RPs~~evl~~ 546 (608)
+...+........+...... ......+..+.+++.+||+.+|++|||+.||+++
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~h 298 (343)
T cd07851 239 LLQKISSESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALAH 298 (343)
T ss_pred HHhhccchhHHHHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCCHHHHhcC
Confidence 00001111011111100000 0001235679999999999999999999999754
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.3e-30 Score=270.14 Aligned_cols=235 Identities=24% Similarity=0.319 Sum_probs=167.9
Q ss_pred eEEEEEeec--ChhhHHHHHHHHHHHhhc-CCCCccceecccccC----ccceEEEeecCCCccchhccccCCCCCCCHH
Q 044312 302 QAVKKSKVI--DESKVEEFINEVVILSQI-NHRNVVKLLGCCLET----EVPLLVYEFIPNGTLFQYIHDQNEDFPITWE 374 (608)
Q Consensus 302 ~avk~~~~~--~~~~~~~~~~Ei~il~~l-~H~niv~l~~~~~~~----~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~ 374 (608)
+|+|+.... .....+.+.+|+.+++++ +||||+++++.+... ...++++||+. ++|.+++.... .+++.
T Consensus 30 ~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~~~~~~e~~~-~~L~~~l~~~~---~~~~~ 105 (332)
T cd07857 30 VAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFNELYLYEELME-ADLHQIIRSGQ---PLTDA 105 (332)
T ss_pred EEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCCcEEEEEeccc-CCHHHHHhcCC---CCCHH
Confidence 366655432 222356788999999999 599999999875422 45688899885 68988886533 58999
Q ss_pred HHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEEcCCCcEEEeeccCccccccCCcc---eeeeeeccCCCCChhhhc
Q 044312 375 IRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTH---MTTQVHGTFGYLDPEYFR 451 (608)
Q Consensus 375 ~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGls~~~~~~~~~---~~~~~~gt~~y~aPE~~~ 451 (608)
.+..++.||+.||+|||+.+ ++||||||+|||+++++.+||+|||+++........ ......|+..|+|||++.
T Consensus 106 ~~~~~~~qi~~aL~~LH~~g---ivH~dlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~ 182 (332)
T cd07857 106 HFQSFIYQILCGLKYIHSAN---VLHRDLKPGNLLVNADCELKICDFGLARGFSENPGENAGFMTEYVATRWYRAPEIML 182 (332)
T ss_pred HHHHHHHHHHHHHHHHHhCC---cccCCCCHHHeEEcCCCCEEeCcCCCceecccccccccccccCcccCccccCcHHHh
Confidence 99999999999999999999 999999999999999999999999999865432211 123346889999999876
Q ss_pred c-CCCCCccchHhHHHHHHHHHhCCCCCCccchhhcccHHHHHHHHhh---hhhhHHHhhhh-------h-------hcc
Q 044312 452 S-SQFTDKSDVYSFGVVLTELLTGEKPIRFTILEEDKSLAAYFLCAMK---EERLFEILDAR-------V-------MKQ 513 (608)
Q Consensus 452 ~-~~~t~ksDV~S~Gvvl~elltg~~p~~~~~~~~~~~l~~~~~~~~~---~~~~~~~~d~~-------~-------~~~ 513 (608)
+ ..++.++||||||+++++|++|+.||....... ........+. .+.+..+..+. . ...
T Consensus 183 ~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 259 (332)
T cd07857 183 SFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVD---QLNQILQVLGTPDEETLSRIGSPKAQNYIRSLPNIPKKPFES 259 (332)
T ss_pred CCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHHH---HHHHHHHHhCCCCHHHHHhhhhhhHHHHHHhccccCCcchHh
Confidence 5 468999999999999999999999986432111 0000000000 00000000000 0 000
Q ss_pred CChhHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 044312 514 GGKDEIITVAKLAKRCLNLNGKKRPTMREVASE 546 (608)
Q Consensus 514 ~~~~~~~~l~~Li~~cl~~dp~~RPs~~evl~~ 546 (608)
.....+..+.+++.+||+.||++|||+.|+++.
T Consensus 260 ~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll~~ 292 (332)
T cd07857 260 IFPNANPLALDLLEKLLAFDPTKRISVEEALEH 292 (332)
T ss_pred hCCCCCHHHHHHHHHHccCCcccCCCHHHHhcC
Confidence 011234679999999999999999999998754
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=5e-30 Score=256.54 Aligned_cols=217 Identities=31% Similarity=0.356 Sum_probs=175.1
Q ss_pred eEEEEEeec---ChhhHHHHHHHHHHHhhcCCCCccceecccccCccceEEEeecCCCccchhccccCCCCCCCHHHHHH
Q 044312 302 QAVKKSKVI---DESKVEEFINEVVILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEIRLR 378 (608)
Q Consensus 302 ~avk~~~~~---~~~~~~~~~~Ei~il~~l~H~niv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~ 378 (608)
+++|..... .....+.+.+|+.++++++|+||+++++.+......++||||+++++|.+++.... .+++..+..
T Consensus 21 ~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~---~l~~~~~~~ 97 (250)
T cd05123 21 YAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGELFSHLSKEG---RFSEERARF 97 (250)
T ss_pred EEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEecCCCCcHHHHHHhcC---CCCHHHHHH
Confidence 466665532 22356789999999999999999999999999999999999999999999997653 489999999
Q ss_pred HHHHHHHHHHHHhhcCCCCeeccCCCCCcEEEcCCCcEEEeeccCccccccCCcceeeeeeccCCCCChhhhccCCCCCc
Q 044312 379 IAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHGTFGYLDPEYFRSSQFTDK 458 (608)
Q Consensus 379 i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGls~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k 458 (608)
++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||++....... .......++..|++||.+.+...+.+
T Consensus 98 ~~~qi~~~l~~lh~~~---~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~-~~~~~~~~~~~~~~Pe~~~~~~~~~~ 173 (250)
T cd05123 98 YAAEIVLALEYLHSLG---IIYRDLKPENILLDADGHIKLTDFGLAKELSSEG-SRTNTFCGTPEYLAPEVLLGKGYGKA 173 (250)
T ss_pred HHHHHHHHHHHHHHCC---ceecCCCcceEEEcCCCcEEEeecCcceecccCC-CcccCCcCCccccChHHhCCCCCCch
Confidence 9999999999999988 9999999999999999999999999997764332 12334567889999999998889999
Q ss_pred cchHhHHHHHHHHHhCCCCCCccchhhcccHHHHHHHHhhhhhhHHHhhhhhhccCChhHHHHHHHHHHHHhccCCCCCC
Q 044312 459 SDVYSFGVVLTELLTGEKPIRFTILEEDKSLAAYFLCAMKEERLFEILDARVMKQGGKDEIITVAKLAKRCLNLNGKKRP 538 (608)
Q Consensus 459 sDV~S~Gvvl~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RP 538 (608)
+|+||||++++||++|+.||..... .... ..+.. .....+...+..+.+++.+||..||++||
T Consensus 174 ~D~~slG~~~~~l~~g~~p~~~~~~------~~~~---------~~~~~--~~~~~~~~~~~~l~~~i~~~l~~~p~~R~ 236 (250)
T cd05123 174 VDWWSLGVLLYEMLTGKPPFYAEDR------KEIY---------EKILK--DPLRFPEFLSPEARDLISGLLQKDPTKRL 236 (250)
T ss_pred hhHHHHHHHHHHHHHCCCCCCCCCH------HHHH---------HHHhc--CCCCCCCCCCHHHHHHHHHHhcCCHhhCC
Confidence 9999999999999999999863221 0000 01111 11122333467889999999999999999
Q ss_pred CHHH
Q 044312 539 TMRE 542 (608)
Q Consensus 539 s~~e 542 (608)
++.+
T Consensus 237 ~~~~ 240 (250)
T cd05123 237 GSGG 240 (250)
T ss_pred Cccc
Confidence 9944
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.8e-30 Score=262.00 Aligned_cols=221 Identities=19% Similarity=0.260 Sum_probs=168.1
Q ss_pred eEEEEEeecC---hhhHHHHHHHHH---HHhhcCCCCccceecccccCccceEEEeecCCCccchhccccCCCCCCCHHH
Q 044312 302 QAVKKSKVID---ESKVEEFINEVV---ILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEI 375 (608)
Q Consensus 302 ~avk~~~~~~---~~~~~~~~~Ei~---il~~l~H~niv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~ 375 (608)
+|+|...... ......+..|.. +++..+||||+++++++.+.+..++||||+++++|.+++.... .+++..
T Consensus 22 vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~g~~L~~~l~~~~---~l~~~~ 98 (278)
T cd05606 22 YAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHG---VFSEAE 98 (278)
T ss_pred EEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEecCCCCcHHHHHHhcC---CCCHHH
Confidence 5777654321 122223444544 4445589999999999999999999999999999998886533 589999
Q ss_pred HHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEEcCCCcEEEeeccCccccccCCcceeeeeeccCCCCChhhhccC-C
Q 044312 376 RLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHGTFGYLDPEYFRSS-Q 454 (608)
Q Consensus 376 ~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGls~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~ 454 (608)
+..++.|+++||.|||+.+ ++||||||+|||++.++.+||+|||+++...... .....|+..|+|||.+.++ .
T Consensus 99 ~~~~~~ql~~~l~~lH~~~---i~H~di~p~nili~~~~~~kl~dfg~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~ 172 (278)
T cd05606 99 MRFYAAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKK---PHASVGTHGYMAPEVLQKGVA 172 (278)
T ss_pred HHHHHHHHHHHHHHHHHCC---EEcCCCCHHHEEECCCCCEEEccCcCccccCccC---CcCcCCCcCCcCcHHhcCCCC
Confidence 9999999999999999998 9999999999999999999999999987654222 1234589999999998754 6
Q ss_pred CCCccchHhHHHHHHHHHhCCCCCCccchhhcccHHHHHHHHhhhhhhHHHhhhhhhccCChhHHHHHHHHHHHHhccCC
Q 044312 455 FTDKSDVYSFGVVLTELLTGEKPIRFTILEEDKSLAAYFLCAMKEERLFEILDARVMKQGGKDEIITVAKLAKRCLNLNG 534 (608)
Q Consensus 455 ~t~ksDV~S~Gvvl~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~Li~~cl~~dp 534 (608)
++.++||||||++++||++|+.||.......... ..... .....+.+...+.++.+++.+||..+|
T Consensus 173 ~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~~~-------------~~~~~-~~~~~~~~~~~s~~~~~li~~~l~~~p 238 (278)
T cd05606 173 YDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHE-------------IDRMT-LTMAVELPDSFSPELRSLLEGLLQRDV 238 (278)
T ss_pred CCcccchHhHHHHHHHHHhCCCCCCCCCccchHH-------------HHHHh-hccCCCCCCcCCHHHHHHHHHHhhcCH
Confidence 8999999999999999999999986432111100 00000 001112233346789999999999999
Q ss_pred CCCC-----CHHHHHH
Q 044312 535 KKRP-----TMREVAS 545 (608)
Q Consensus 535 ~~RP-----s~~evl~ 545 (608)
.+|| ++.|+++
T Consensus 239 ~~R~~~~~~~~~~ll~ 254 (278)
T cd05606 239 NRRLGCLGRGAQEVKE 254 (278)
T ss_pred HhccCCCCCCHHHHHh
Confidence 9999 8888875
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.3e-30 Score=257.00 Aligned_cols=253 Identities=22% Similarity=0.328 Sum_probs=203.7
Q ss_pred HHHHHHHhcCccccceeccCceE-EEEE-------------------e-ecChhhHHHHHHHHHHHhhcCCCCccceecc
Q 044312 281 SKELEKATDNFDLNRILGQGGQA-VKKS-------------------K-VIDESKVEEFINEVVILSQINHRNVVKLLGC 339 (608)
Q Consensus 281 ~~~l~~~t~~f~~~~~lG~G~~a-vk~~-------------------~-~~~~~~~~~~~~Ei~il~~l~H~niv~l~~~ 339 (608)
.++|.....+++....+-+|.|. |..- + ...+-++..|+.|--.+..++|||+.++.++
T Consensus 276 ~~~l~v~r~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~AS~iQv~~~L~es~lly~~sH~nll~V~~V 355 (563)
T KOG1024|consen 276 LQELTVQRCRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHASQIQVNLLLQESMLLYGASHPNLLSVLGV 355 (563)
T ss_pred HHhhhhhhhheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhcccHHHHHHHHHHHHHHhcCcCCCccceeEE
Confidence 34555567778888888889872 1111 1 0122345568888888888999999999999
Q ss_pred ccc-CccceEEEeecCCCccchhccc-----cCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEEcCC
Q 044312 340 CLE-TEVPLLVYEFIPNGTLFQYIHD-----QNEDFPITWEIRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDK 413 (608)
Q Consensus 340 ~~~-~~~~~lV~E~~~~gsL~~~l~~-----~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~ 413 (608)
+.+ .+.++.+|.++.-|+|..+|.. ......++-.+...++.|++.|++|||+++ |+|.||.++|.+||+.
T Consensus 356 ~ie~~~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~~---ViHkDiAaRNCvIdd~ 432 (563)
T KOG1024|consen 356 SIEDYATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNHG---VIHKDIAARNCVIDDQ 432 (563)
T ss_pred EeeccCcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhcC---cccchhhhhcceehhh
Confidence 864 5678999999999999999983 223335777888999999999999999999 9999999999999999
Q ss_pred CcEEEeeccCccccccCCccee-eeeeccCCCCChhhhccCCCCCccchHhHHHHHHHHHh-CCCCCCccchhhcccHHH
Q 044312 414 YRAKVSDFGASRSMAVDQTHMT-TQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLTELLT-GEKPIRFTILEEDKSLAA 491 (608)
Q Consensus 414 ~~~kl~DFGls~~~~~~~~~~~-~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~ellt-g~~p~~~~~~~~~~~l~~ 491 (608)
.++||+|=.|+|.+-..+.+.. .....+..||+||.+.+..|+.++|||||||+||||+| |+.|+..
T Consensus 433 LqVkltDsaLSRDLFP~DYhcLGDnEnRPvkWMslEal~n~~yssasDvWsfGVllWELmtlg~~Pyae----------- 501 (563)
T KOG1024|consen 433 LQVKLTDSALSRDLFPGDYHCLGDNENRPVKWMSLEALQNSHYSSASDVWSFGVLLWELMTLGKLPYAE----------- 501 (563)
T ss_pred eeEEeccchhccccCcccccccCCCCCCcccccCHHHHhhhhhcchhhhHHHHHHHHHHHhcCCCCccc-----------
Confidence 9999999999987754433322 23345678999999999999999999999999999999 8889762
Q ss_pred HHHHHhhhhhhHHHhhhhhhccCChhHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhhHH
Q 044312 492 YFLCAMKEERLFEILDARVMKQGGKDEIITVAKLAKRCLNLNGKKRPTMREVASELAGIKA 552 (608)
Q Consensus 492 ~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~evl~~L~~i~~ 552 (608)
+...++...+....+...+..++.++..++.-||...|++||+++|+..-|.++..
T Consensus 502 -----IDPfEm~~ylkdGyRlaQP~NCPDeLf~vMacCWallpeeRPsf~Qlv~cLseF~~ 557 (563)
T KOG1024|consen 502 -----IDPFEMEHYLKDGYRLAQPFNCPDELFTVMACCWALLPEERPSFSQLVICLSEFHT 557 (563)
T ss_pred -----cCHHHHHHHHhccceecCCCCCcHHHHHHHHHHHhcCcccCCCHHHHHHHHHHHHH
Confidence 23334455566667777888999999999999999999999999999998877654
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.3e-31 Score=277.31 Aligned_cols=227 Identities=25% Similarity=0.339 Sum_probs=179.4
Q ss_pred hcCccccceeccCceE---------------EEEEeecChhhHHHHHHHHHHHhhc-CCCCccceecccccCccceEEEe
Q 044312 288 TDNFDLNRILGQGGQA---------------VKKSKVIDESKVEEFINEVVILSQI-NHRNVVKLLGCCLETEVPLLVYE 351 (608)
Q Consensus 288 t~~f~~~~~lG~G~~a---------------vk~~~~~~~~~~~~~~~Ei~il~~l-~H~niv~l~~~~~~~~~~~lV~E 351 (608)
++.|.+...+|.|.|+ ||.+... ..+-.+|+.++... +||||+++.+.+.+....++|||
T Consensus 321 ~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~----~~~~~~e~~~~~~~~~h~niv~~~~v~~~~~~~~~v~e 396 (612)
T KOG0603|consen 321 TESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKR----ADDNQDEIPISLLVRDHPNIVKSHDVYEDGKEIYLVME 396 (612)
T ss_pred chhhccccccCCCCccceeeeeccccccchhheecccc----ccccccccchhhhhcCCCcceeecceecCCceeeeeeh
Confidence 6678888889999763 3332221 23345677666555 89999999999999999999999
Q ss_pred ecCCCccchhccccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEE-cCCCcEEEeeccCccccccC
Q 044312 352 FIPNGTLFQYIHDQNEDFPITWEIRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILL-DDKYRAKVSDFGASRSMAVD 430 (608)
Q Consensus 352 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl-~~~~~~kl~DFGls~~~~~~ 430 (608)
.+.++-|.+.+..... +. ..+..|+.+|+.|+.|||+++ ++||||||+|||+ ++.++++|+|||.++....+
T Consensus 397 ~l~g~ell~ri~~~~~---~~-~e~~~w~~~lv~Av~~LH~~g---vvhRDLkp~NIL~~~~~g~lrltyFG~a~~~~~~ 469 (612)
T KOG0603|consen 397 LLDGGELLRRIRSKPE---FC-SEASQWAAELVSAVDYLHEQG---VVHRDLKPGNILLDGSAGHLRLTYFGFWSELERS 469 (612)
T ss_pred hccccHHHHHHHhcch---hH-HHHHHHHHHHHHHHHHHHhcC---eeecCCChhheeecCCCCcEEEEEechhhhCchh
Confidence 9999998888876542 33 778889999999999999999 9999999999999 58899999999999877644
Q ss_pred CcceeeeeeccCCCCChhhhccCCCCCccchHhHHHHHHHHHhCCCCCCccchhhcccHHHHHHHHhhhhhhHHHhhhhh
Q 044312 431 QTHMTTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLTELLTGEKPIRFTILEEDKSLAAYFLCAMKEERLFEILDARV 510 (608)
Q Consensus 431 ~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~ 510 (608)
.....-|..|.|||++....|++++|+||||++||+|++|+.||.....+ .++...-.
T Consensus 470 ----~~tp~~t~~y~APEvl~~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~------------------~ei~~~i~ 527 (612)
T KOG0603|consen 470 ----CDTPALTLQYVAPEVLAIQEYTEACDWWSLGVLLYEMLTGRTLFAAHPAG------------------IEIHTRIQ 527 (612)
T ss_pred ----hcccchhhcccChhhhccCCCCcchhhHHHHHHHHHHHhCCCccccCCch------------------HHHHHhhc
Confidence 22234578899999999999999999999999999999999998743222 01111111
Q ss_pred hccCChhHHHHHHHHHHHHhccCCCCCCCHHHHHHHH
Q 044312 511 MKQGGKDEIITVAKLAKRCLNLNGKKRPTMREVASEL 547 (608)
Q Consensus 511 ~~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~evl~~L 547 (608)
...+....+...++|+.+||+.||.+||+|.++..+-
T Consensus 528 ~~~~s~~vS~~AKdLl~~LL~~dP~~Rl~~~~i~~h~ 564 (612)
T KOG0603|consen 528 MPKFSECVSDEAKDLLQQLLQVDPALRLGADEIGAHP 564 (612)
T ss_pred CCccccccCHHHHHHHHHhccCChhhCcChhhhccCc
Confidence 1222245677899999999999999999999998653
|
|
| >KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.4e-30 Score=276.23 Aligned_cols=255 Identities=27% Similarity=0.383 Sum_probs=189.5
Q ss_pred ccccceeccCce---------------EEEEEee-cChhhHHHHHHHHHHHhhcCCCCccceecccccCc------cceE
Q 044312 291 FDLNRILGQGGQ---------------AVKKSKV-IDESKVEEFINEVVILSQINHRNVVKLLGCCLETE------VPLL 348 (608)
Q Consensus 291 f~~~~~lG~G~~---------------avk~~~~-~~~~~~~~~~~Ei~il~~l~H~niv~l~~~~~~~~------~~~l 348 (608)
+...+.||+|+| |||..+. ......+...+|+++|++|+|+|||++++.-.+.. ...+
T Consensus 15 W~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~~vl 94 (732)
T KOG4250|consen 15 WEMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKESSLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRLPVL 94 (732)
T ss_pred eeehhhhcCCccceeeeecccccccchhHHhhhhhcccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccccceE
Confidence 455678999986 6665543 22344677889999999999999999999865543 5689
Q ss_pred EEeecCCCccchhccccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEEc--C--CCcEEEeeccCc
Q 044312 349 VYEFIPNGTLFQYIHDQNEDFPITWEIRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLD--D--KYRAKVSDFGAS 424 (608)
Q Consensus 349 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~--~--~~~~kl~DFGls 424 (608)
|||||++|+|...|.+......|++...+.++.+++.||.|||+++ |+||||||.||++- + .-..||+|||.|
T Consensus 95 vmEyC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~LrEn~---IvHRDlKP~NIvl~~Gedgq~IyKLtDfG~A 171 (732)
T KOG4250|consen 95 VMEYCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLRENG---IVHRDLKPGNIVLQIGEDGQSIYKLTDFGAA 171 (732)
T ss_pred EEeecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHHHcC---ceeccCCCCcEEEeecCCCceEEeeeccccc
Confidence 9999999999999998766667999999999999999999999999 99999999999984 2 234899999999
Q ss_pred cccccCCcceeeeeeccCCCCChhhhcc-CCCCCccchHhHHHHHHHHHhCCCCCCccchhhcccHHHHHHHHhhhhh--
Q 044312 425 RSMAVDQTHMTTQVHGTFGYLDPEYFRS-SQFTDKSDVYSFGVVLTELLTGEKPIRFTILEEDKSLAAYFLCAMKEER-- 501 (608)
Q Consensus 425 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~t~ksDV~S~Gvvl~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~-- 501 (608)
+.+..+. ..+...||..|++||.+.. ..|+..+|.|||||++||++||..||....... +....++.......
T Consensus 172 rel~d~s--~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~~~pk--~~~~~~~~~~tkkp~~ 247 (732)
T KOG4250|consen 172 RELDDNS--LFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPFGGPK--NNKEIMWHIITKKPSG 247 (732)
T ss_pred ccCCCCC--eeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcCCCcc--ccchhhhhhhccCCCc
Confidence 9876443 6788899999999999994 889999999999999999999999997443321 11111111111110
Q ss_pred hH----HHhhhhh--------hccCChhHHHHHHHHHHHHhccCCCCCC--CHHHHHHHHHhhHH
Q 044312 502 LF----EILDARV--------MKQGGKDEIITVAKLAKRCLNLNGKKRP--TMREVASELAGIKA 552 (608)
Q Consensus 502 ~~----~~~d~~~--------~~~~~~~~~~~l~~Li~~cl~~dp~~RP--s~~evl~~L~~i~~ 552 (608)
+. +-....+ ...........+-..+..+|..+|++|- ...+....+..|..
T Consensus 248 v~i~~~~~eNgpv~~s~~lP~p~~Ls~~l~~~~~kwLa~~L~~~~~~~~~~~~~~~Fa~~~dIL~ 312 (732)
T KOG4250|consen 248 VAIGAQEEENGPVEWSSTLPQPNHLSRGLATRLTKWLASMLEWNPRKRGHEGFDRFFAEVDDILN 312 (732)
T ss_pred eeEeeecccCCceeeeccCCCcccccHHHHhhhhHHHHHHHhhhHHHhCCCCcchHHHHHHHHHh
Confidence 00 0000000 0111123344567788889999999998 66666666655543
|
|
| >KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.6e-30 Score=253.69 Aligned_cols=235 Identities=26% Similarity=0.364 Sum_probs=193.8
Q ss_pred hcCccccceeccCce---------------EEEEEe---ecChhhHHHHHHHHHHHhhcCCCCccceecccccCccceEE
Q 044312 288 TDNFDLNRILGQGGQ---------------AVKKSK---VIDESKVEEFINEVVILSQINHRNVVKLLGCCLETEVPLLV 349 (608)
Q Consensus 288 t~~f~~~~~lG~G~~---------------avk~~~---~~~~~~~~~~~~Ei~il~~l~H~niv~l~~~~~~~~~~~lV 349 (608)
-++|+..++||+|.| |+|+++ ++.+..+.+-+.|-++|+..+||.+..|...|...+.+++|
T Consensus 167 m~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt~drlCFV 246 (516)
T KOG0690|consen 167 MEDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQTQDRLCFV 246 (516)
T ss_pred cchhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhccCceEEEE
Confidence 467999999999985 555443 45666777888899999999999999999999999999999
Q ss_pred EeecCCCccchhccccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEEcCCCcEEEeeccCcccccc
Q 044312 350 YEFIPNGTLFQYIHDQNEDFPITWEIRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAV 429 (608)
Q Consensus 350 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGls~~~~~ 429 (608)
|||..||.|.-+|.+.. .+++....-+..+|..||.|||+.+ |+.||||.+|.|||.+|++||+||||.+.-..
T Consensus 247 MeyanGGeLf~HLsrer---~FsE~RtRFYGaEIvsAL~YLHs~~---ivYRDlKLENLlLDkDGHIKitDFGLCKE~I~ 320 (516)
T KOG0690|consen 247 MEYANGGELFFHLSRER---VFSEDRTRFYGAEIVSALGYLHSRN---IVYRDLKLENLLLDKDGHIKITDFGLCKEEIK 320 (516)
T ss_pred EEEccCceEeeehhhhh---cccchhhhhhhHHHHHHhhhhhhCC---eeeeechhhhheeccCCceEeeecccchhccc
Confidence 99999999998887643 5888888889999999999999999 99999999999999999999999999986443
Q ss_pred CCcceeeeeeccCCCCChhhhccCCCCCccchHhHHHHHHHHHhCCCCCCccchhhcccHHHHHHHHhhhhhhHHHhhhh
Q 044312 430 DQTHMTTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLTELLTGEKPIRFTILEEDKSLAAYFLCAMKEERLFEILDAR 509 (608)
Q Consensus 430 ~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 509 (608)
. ...+....|||.|+|||++....|..++|.|.+|||+|||++|+.||..... +.+++++-..
T Consensus 321 ~-g~t~kTFCGTPEYLAPEVleDnDYgraVDWWG~GVVMYEMmCGRLPFyn~dh----------------~kLFeLIl~e 383 (516)
T KOG0690|consen 321 Y-GDTTKTFCGTPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMMCGRLPFYNKDH----------------EKLFELILME 383 (516)
T ss_pred c-cceeccccCChhhcCchhhccccccceeehhhhhHHHHHHHhccCcccccch----------------hHHHHHHHhh
Confidence 3 3345668899999999999999999999999999999999999999974322 2223322111
Q ss_pred hhccCChhHHHHHHHHHHHHhccCCCCCCC-----HHHHHHH
Q 044312 510 VMKQGGKDEIITVAKLAKRCLNLNGKKRPT-----MREVASE 546 (608)
Q Consensus 510 ~~~~~~~~~~~~l~~Li~~cl~~dp~~RPs-----~~evl~~ 546 (608)
...++...+++...|+...|..||.+|.. ++||.++
T Consensus 384 -d~kFPr~ls~eAktLLsGLL~kdP~kRLGgGpdDakEi~~h 424 (516)
T KOG0690|consen 384 -DLKFPRTLSPEAKTLLSGLLKKDPKKRLGGGPDDAKEIMRH 424 (516)
T ss_pred -hccCCccCCHHHHHHHHHHhhcChHhhcCCCchhHHHHHhh
Confidence 01245556678889999999999999953 5565543
|
|
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.1e-30 Score=288.06 Aligned_cols=180 Identities=27% Similarity=0.391 Sum_probs=131.8
Q ss_pred ceEEEeecCCCccchhccccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEEcCCCcEEEeeccCcc
Q 044312 346 PLLVYEFIPNGTLFQYIHDQNEDFPITWEIRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASR 425 (608)
Q Consensus 346 ~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGls~ 425 (608)
+||-||||+..+|.++++.+... -.....++++.+|++||+|+|+.+ ||||||||.||||+++..+||+|||++.
T Consensus 671 LYIQMEyCE~~ll~~iI~~N~~~--~~~d~~wrLFreIlEGLaYIH~~g---iIHRDLKP~NIFLd~~~~VKIGDFGLAt 745 (1351)
T KOG1035|consen 671 LYIQMEYCEKTLLRDIIRRNHFN--SQRDEAWRLFREILEGLAYIHDQG---IIHRDLKPRNIFLDSRNSVKIGDFGLAT 745 (1351)
T ss_pred EEEEHhhhhhhHHHHHHHhcccc--hhhHHHHHHHHHHHHHHHHHHhCc---eeeccCCcceeEEcCCCCeeecccccch
Confidence 47888999888887777764321 135677899999999999999999 9999999999999999999999999998
Q ss_pred cccc-----------------CCcceeeeeeccCCCCChhhhccCC---CCCccchHhHHHHHHHHHhCCCCCCccchhh
Q 044312 426 SMAV-----------------DQTHMTTQVHGTFGYLDPEYFRSSQ---FTDKSDVYSFGVVLTELLTGEKPIRFTILEE 485 (608)
Q Consensus 426 ~~~~-----------------~~~~~~~~~~gt~~y~aPE~~~~~~---~t~ksDV~S~Gvvl~elltg~~p~~~~~~~~ 485 (608)
.... ......+...||.-|+|||++.... |+.|+|+||+||||+||+. ||.....
T Consensus 746 ~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~~~~~~Yn~KiDmYSLGIVlFEM~y---PF~TsME-- 820 (1351)
T KOG1035|consen 746 DLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSDTSSNKYNSKIDMYSLGIVLFEMLY---PFGTSME-- 820 (1351)
T ss_pred hhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhcccccccccchhhhHHHHHHHHHHhc---cCCchHH--
Confidence 7210 1111335677999999999987654 9999999999999999986 4541110
Q ss_pred cccHHHHHHHHhhhhhhHHHhhhhhhccCChhHHHHHHHHHHHHhccCCCCCCCHHHHHH
Q 044312 486 DKSLAAYFLCAMKEERLFEILDARVMKQGGKDEIITVAKLAKRCLNLNGKKRPTMREVAS 545 (608)
Q Consensus 486 ~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~evl~ 545 (608)
-...+..++.+.+..- ..+.......=+.+|++|++.||.+|||+.|++.
T Consensus 821 ----Ra~iL~~LR~g~iP~~------~~f~~~~~~~e~slI~~Ll~hdP~kRPtA~eLL~ 870 (1351)
T KOG1035|consen 821 ----RASILTNLRKGSIPEP------ADFFDPEHPEEASLIRWLLSHDPSKRPTATELLN 870 (1351)
T ss_pred ----HHHHHHhcccCCCCCC------cccccccchHHHHHHHHHhcCCCccCCCHHHHhh
Confidence 0111222222222111 0112233345678999999999999999999986
|
|
| >KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.1e-30 Score=249.77 Aligned_cols=223 Identities=23% Similarity=0.400 Sum_probs=172.9
Q ss_pred EEEEEee-cChhhHHHHHHHHHHHhhcC-CCCccceecccccCccceEEEeecCCCccchhccccCCCCCCCHHHHHHHH
Q 044312 303 AVKKSKV-IDESKVEEFINEVVILSQIN-HRNVVKLLGCCLETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEIRLRIA 380 (608)
Q Consensus 303 avk~~~~-~~~~~~~~~~~Ei~il~~l~-H~niv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~ 380 (608)
|||.... .+....+.++..+.++..-+ .|.||+.+|+|..+....+.||.|. ..+..++..... ++++..+-++.
T Consensus 121 AVK~M~rt~Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~dV~IcMelMs-~C~ekLlkrik~--piPE~ilGk~t 197 (391)
T KOG0983|consen 121 AVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVQCFGYFITNTDVFICMELMS-TCAEKLLKRIKG--PIPERILGKMT 197 (391)
T ss_pred EEEeecccCCHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCchHHHHHHHHH-HHHHHHHHHhcC--CchHHhhhhhH
Confidence 6776643 45566777888888776664 7999999999999988899999994 466666665433 68999999999
Q ss_pred HHHHHHHHHHhhcCCCCeeccCCCCCcEEEcCCCcEEEeeccCccccccCCcceeeeeeccCCCCChhhhcc---CCCCC
Q 044312 381 IEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHGTFGYLDPEYFRS---SQFTD 457 (608)
Q Consensus 381 ~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGls~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~t~ 457 (608)
..+.+||.||.++.. |+|||+||+|||+|+.|++|++|||++-.+..... .+...|-+.|||||.+.- ..|+.
T Consensus 198 va~v~AL~YLKeKH~--viHRDvKPSNILlDe~GniKlCDFGIsGrlvdSkA--htrsAGC~~YMaPERidp~~~~kYDi 273 (391)
T KOG0983|consen 198 VAIVKALYYLKEKHG--VIHRDVKPSNILLDERGNIKLCDFGISGRLVDSKA--HTRSAGCAAYMAPERIDPPDKPKYDI 273 (391)
T ss_pred HHHHHHHHHHHHhcc--eeecccCccceEEccCCCEEeecccccceeecccc--cccccCCccccCccccCCCCCCccch
Confidence 999999999987653 99999999999999999999999999987764433 345568899999999863 47889
Q ss_pred ccchHhHHHHHHHHHhCCCCCCccchhhcccHHHHHHHHhhhhhhHHHhhhhh-hccCChhHHHHHHHHHHHHhccCCCC
Q 044312 458 KSDVYSFGVVLTELLTGEKPIRFTILEEDKSLAAYFLCAMKEERLFEILDARV-MKQGGKDEIITVAKLAKRCLNLNGKK 536 (608)
Q Consensus 458 ksDV~S~Gvvl~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~-~~~~~~~~~~~l~~Li~~cl~~dp~~ 536 (608)
++||||||+.|+||.||+.||..-..+- +.+..+++... ........+..+.+++..||+.|+.+
T Consensus 274 RaDVWSlGITlveLaTg~yPy~~c~tdF--------------e~ltkvln~ePP~L~~~~gFSp~F~~fv~~CL~kd~r~ 339 (391)
T KOG0983|consen 274 RADVWSLGITLVELATGQYPYKGCKTDF--------------EVLTKVLNEEPPLLPGHMGFSPDFQSFVKDCLTKDHRK 339 (391)
T ss_pred hhhhhhhccchhhhhcccCCCCCCCccH--------------HHHHHHHhcCCCCCCcccCcCHHHHHHHHHHhhcCccc
Confidence 9999999999999999999997422211 11111222100 11112236778999999999999999
Q ss_pred CCCHHHHHHH
Q 044312 537 RPTMREVASE 546 (608)
Q Consensus 537 RPs~~evl~~ 546 (608)
||...+++++
T Consensus 340 RP~Y~~Ll~h 349 (391)
T KOG0983|consen 340 RPKYNKLLEH 349 (391)
T ss_pred CcchHHHhcC
Confidence 9999999865
|
|
| >KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=3e-30 Score=286.09 Aligned_cols=243 Identities=26% Similarity=0.379 Sum_probs=197.4
Q ss_pred HHHHHHhcCccccceeccCce---EEEEE------------ee---cChhhHHHHHHHHHHHhhcCCCCccceecccccC
Q 044312 282 KELEKATDNFDLNRILGQGGQ---AVKKS------------KV---IDESKVEEFINEVVILSQINHRNVVKLLGCCLET 343 (608)
Q Consensus 282 ~~l~~~t~~f~~~~~lG~G~~---avk~~------------~~---~~~~~~~~~~~Ei~il~~l~H~niv~l~~~~~~~ 343 (608)
.++....++|++.++||+|+| +|.+. .. .......-|..|-.+|..-+.+-|++|+..|.+.
T Consensus 68 ~~lrl~~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAFQD~ 147 (1317)
T KOG0612|consen 68 KELRLKAEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAFQDE 147 (1317)
T ss_pred HHHhCCHHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHhcCc
Confidence 455556778999999999997 33322 11 2234456688899999999999999999999999
Q ss_pred ccceEEEeecCCCccchhccccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEEcCCCcEEEeeccC
Q 044312 344 EVPLLVYEFIPNGTLFQYIHDQNEDFPITWEIRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGA 423 (608)
Q Consensus 344 ~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGl 423 (608)
.++|||||||+||+|..++.+.. +++++-...++.+|..||.-||+.| +|||||||+|||||..|++||+|||.
T Consensus 148 ~~LYlVMdY~pGGDlltLlSk~~---~~pE~~ArFY~aEiVlAldslH~mg---yVHRDiKPDNvLld~~GHikLADFGs 221 (1317)
T KOG0612|consen 148 RYLYLVMDYMPGGDLLTLLSKFD---RLPEDWARFYTAEIVLALDSLHSMG---YVHRDIKPDNVLLDKSGHIKLADFGS 221 (1317)
T ss_pred cceEEEEecccCchHHHHHhhcC---CChHHHHHHHHHHHHHHHHHHHhcc---ceeccCCcceeEecccCcEeeccchh
Confidence 99999999999999999998765 4889888999999999999999999 99999999999999999999999999
Q ss_pred ccccccCCcceeeeeeccCCCCChhhhcc-----CCCCCccchHhHHHHHHHHHhCCCCCCccchhhcccHHHHHHHHhh
Q 044312 424 SRSMAVDQTHMTTQVHGTFGYLDPEYFRS-----SQFTDKSDVYSFGVVLTELLTGEKPIRFTILEEDKSLAAYFLCAMK 498 (608)
Q Consensus 424 s~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~t~ksDV~S~Gvvl~elltg~~p~~~~~~~~~~~l~~~~~~~~~ 498 (608)
.-.+..+..-......|||.|++||++.. +.|++..|.||+||++|||+.|..||+ ..+++.-+-..+.
T Consensus 222 Clkm~~dG~V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFY------adslveTY~KIm~ 295 (1317)
T KOG0612|consen 222 CLKMDADGTVRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFY------ADSLVETYGKIMN 295 (1317)
T ss_pred HHhcCCCCcEEeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcch------HHHHHHHHHHHhc
Confidence 98888777777777789999999999853 578999999999999999999999997 2334433333333
Q ss_pred hhhhHHHhhhhhhccCC--hhHHHHHHHHHHHHhccCCCCCCC---HHHHHHH
Q 044312 499 EERLFEILDARVMKQGG--KDEIITVAKLAKRCLNLNGKKRPT---MREVASE 546 (608)
Q Consensus 499 ~~~~~~~~d~~~~~~~~--~~~~~~l~~Li~~cl~~dp~~RPs---~~evl~~ 546 (608)
. +-...+| .+.+.+..+||.+.+. +|+.|.. +.++-.+
T Consensus 296 h---------k~~l~FP~~~~VSeeakdLI~~ll~-~~e~RLgrngiedik~H 338 (1317)
T KOG0612|consen 296 H---------KESLSFPDETDVSEEAKDLIEALLC-DREVRLGRNGIEDIKNH 338 (1317)
T ss_pred h---------hhhcCCCcccccCHHHHHHHHHHhc-ChhhhcccccHHHHHhC
Confidence 2 2222333 4567889999988874 6788877 7776654
|
|
| >KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=6.1e-30 Score=258.11 Aligned_cols=241 Identities=29% Similarity=0.435 Sum_probs=187.5
Q ss_pred cCccccceeccCce---------------EEEEEeecC-------hhhHHHHHHHHHHHhhcCCCCccceecccc-cCcc
Q 044312 289 DNFDLNRILGQGGQ---------------AVKKSKVID-------ESKVEEFINEVVILSQINHRNVVKLLGCCL-ETEV 345 (608)
Q Consensus 289 ~~f~~~~~lG~G~~---------------avk~~~~~~-------~~~~~~~~~Ei~il~~l~H~niv~l~~~~~-~~~~ 345 (608)
++|-+.++||+||| |||+..+.. +.-.+...+|.+|.+.|+||.||++++++. +.+.
T Consensus 463 ~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfslDtds 542 (775)
T KOG1151|consen 463 DRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSLDTDS 542 (775)
T ss_pred HHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeeecccc
Confidence 35667889999996 777765421 122456788999999999999999999984 6678
Q ss_pred ceEEEeecCCCccchhccccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEEcC---CCcEEEeecc
Q 044312 346 PLLVYEFIPNGTLFQYIHDQNEDFPITWEIRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDD---KYRAKVSDFG 422 (608)
Q Consensus 346 ~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~---~~~~kl~DFG 422 (608)
.+-|+||++|.+|+-+|+.+. .++++....|+.||..||.||.... +||||-||||.||||.+ -|.+||.|||
T Consensus 543 FCTVLEYceGNDLDFYLKQhk---lmSEKEARSIiMQiVnAL~YLNEik-pPIIHYDLKPgNILLv~GtacGeIKITDFG 618 (775)
T KOG1151|consen 543 FCTVLEYCEGNDLDFYLKQHK---LMSEKEARSIIMQIVNALKYLNEIK-PPIIHYDLKPGNILLVNGTACGEIKITDFG 618 (775)
T ss_pred ceeeeeecCCCchhHHHHhhh---hhhHHHHHHHHHHHHHHHHHHhccC-CCeeeeccCCccEEEecCcccceeEeeecc
Confidence 899999999999999998754 5899999999999999999998876 67999999999999964 4679999999
Q ss_pred CccccccCCc------ceeeeeeccCCCCChhhhccC----CCCCccchHhHHHHHHHHHhCCCCCCccchhhcccHHHH
Q 044312 423 ASRSMAVDQT------HMTTQVHGTFGYLDPEYFRSS----QFTDKSDVYSFGVVLTELLTGEKPIRFTILEEDKSLAAY 492 (608)
Q Consensus 423 ls~~~~~~~~------~~~~~~~gt~~y~aPE~~~~~----~~t~ksDV~S~Gvvl~elltg~~p~~~~~~~~~~~l~~~ 492 (608)
|++.+..+.. ..+....||.+|++||.+.-+ +.+.|+||||.|||+|..+.|++||.......+
T Consensus 619 LSKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnqsQQd------ 692 (775)
T KOG1151|consen 619 LSKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQSQQD------ 692 (775)
T ss_pred hhhhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCchhHHH------
Confidence 9998864322 234556799999999997644 578899999999999999999999975433221
Q ss_pred HHHHhhhhhhHHHhhhh-hhccCChhHHHHHHHHHHHHhccCCCCCCCHHHHHH
Q 044312 493 FLCAMKEERLFEILDAR-VMKQGGKDEIITVAKLAKRCLNLNGKKRPTMREVAS 545 (608)
Q Consensus 493 ~~~~~~~~~~~~~~d~~-~~~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~evl~ 545 (608)
.+..+.+ +... +..+.-+..+.+..++|++||+..-++|....+++.
T Consensus 693 ---ILqeNTI---lkAtEVqFP~KPvVsseAkaFIRRCLaYRKeDR~DV~qLA~ 740 (775)
T KOG1151|consen 693 ---ILQENTI---LKATEVQFPPKPVVSSEAKAFIRRCLAYRKEDRIDVQQLAC 740 (775)
T ss_pred ---HHhhhch---hcceeccCCCCCccCHHHHHHHHHHHHhhhhhhhhHHHHcc
Confidence 1112211 1111 111122345668899999999999999988877764
|
|
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.4e-29 Score=252.27 Aligned_cols=205 Identities=23% Similarity=0.200 Sum_probs=162.6
Q ss_pred ceEEEEEeecChhhHHHHHHHHHHHhhcCCCCccceecccccCccceEEEeecCCCccchhccccCCCCCCCHHHHHHHH
Q 044312 301 GQAVKKSKVIDESKVEEFINEVVILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEIRLRIA 380 (608)
Q Consensus 301 ~~avk~~~~~~~~~~~~~~~Ei~il~~l~H~niv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~ 380 (608)
.+|+|+.+... .+.+|...+....||||+++++++.+.+..++||||+++|+|.+++.... .+++..+..++
T Consensus 20 ~~~~K~i~~~~-----~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~---~l~~~~~~~~~ 91 (237)
T cd05576 20 TFILKGLRKSS-----EYSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISKFL---NIPEECVKRWA 91 (237)
T ss_pred EEEEEeecchh-----hhhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCCCHHHHHHHhc---CCCHHHHHHHH
Confidence 36888776432 34455566666689999999999999999999999999999999987643 48999999999
Q ss_pred HHHHHHHHHHhhcCCCCeeccCCCCCcEEEcCCCcEEEeeccCccccccCCcceeeeeeccCCCCChhhhccCCCCCccc
Q 044312 381 IEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHGTFGYLDPEYFRSSQFTDKSD 460 (608)
Q Consensus 381 ~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGls~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksD 460 (608)
.|+++||+|||+.+ ++||||||+||+++.++.++++|||++...... .....++..|+|||.+....++.++|
T Consensus 92 ~ql~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~D 164 (237)
T cd05576 92 AEMVVALDALHREG---IVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDS----CDGEAVENMYCAPEVGGISEETEACD 164 (237)
T ss_pred HHHHHHHHHHHhCC---eeccCCCHHHEEEcCCCCEEEecccchhccccc----cccCCcCccccCCcccCCCCCCchhh
Confidence 99999999999999 999999999999999999999999987655321 12234567899999998888999999
Q ss_pred hHhHHHHHHHHHhCCCCCCccchhhcccHHHHHHHHhhhhhhHHHhhhhhhccCChhHHHHHHHHHHHHhccCCCCCCCH
Q 044312 461 VYSFGVVLTELLTGEKPIRFTILEEDKSLAAYFLCAMKEERLFEILDARVMKQGGKDEIITVAKLAKRCLNLNGKKRPTM 540 (608)
Q Consensus 461 V~S~Gvvl~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPs~ 540 (608)
|||+|++++||++|+.|+....... .. ......+...+..+++++.+||+.||++||++
T Consensus 165 vwslG~il~el~~g~~~~~~~~~~~------------~~---------~~~~~~~~~~~~~~~~li~~~l~~dp~~R~~~ 223 (237)
T cd05576 165 WWSLGAILFELLTGKTLVECHPSGI------------NT---------HTTLNIPEWVSEEARSLLQQLLQFNPTERLGA 223 (237)
T ss_pred HHHHHHHHHHHHHCcchhhcCchhc------------cc---------ccccCCcccCCHHHHHHHHHHccCCHHHhcCC
Confidence 9999999999999998864211100 00 00001222345678999999999999999997
Q ss_pred H
Q 044312 541 R 541 (608)
Q Consensus 541 ~ 541 (608)
.
T Consensus 224 ~ 224 (237)
T cd05576 224 G 224 (237)
T ss_pred C
Confidence 4
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=99.96 E-value=5e-29 Score=246.56 Aligned_cols=221 Identities=30% Similarity=0.413 Sum_probs=179.4
Q ss_pred eEEEEEeecChhh-HHHHHHHHHHHhhcCCCCccceecccccCccceEEEeecCCCccchhccccCCCCCCCHHHHHHHH
Q 044312 302 QAVKKSKVIDESK-VEEFINEVVILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEIRLRIA 380 (608)
Q Consensus 302 ~avk~~~~~~~~~-~~~~~~Ei~il~~l~H~niv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~ 380 (608)
+++|......... .+.+.+|++.+++++|+||+++++++......++++||+++++|.+++.... .+++..++.++
T Consensus 17 ~~~k~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~~~~~---~~~~~~~~~~~ 93 (244)
T smart00220 17 VAIKVIKKEKIKKKRERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDLLKKRG---RLSEDEARFYA 93 (244)
T ss_pred EEEEEecccccccHHHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHHHHhcc---CCCHHHHHHHH
Confidence 5778776544444 7899999999999999999999999999899999999999999999987643 28899999999
Q ss_pred HHHHHHHHHHhhcCCCCeeccCCCCCcEEEcCCCcEEEeeccCccccccCCcceeeeeeccCCCCChhhhccCCCCCccc
Q 044312 381 IEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHGTFGYLDPEYFRSSQFTDKSD 460 (608)
Q Consensus 381 ~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGls~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksD 460 (608)
.+++.+|.|||+.+ ++|+||+|+||++++++.++|+|||++....... ......++..|++||.+....++.++|
T Consensus 94 ~~l~~~l~~lh~~~---i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~--~~~~~~~~~~~~~pE~~~~~~~~~~~D 168 (244)
T smart00220 94 RQILSALEYLHSNG---IIHRDLKPENILLDEDGHVKLADFGLARQLDPGG--LLTTFVGTPEYMAPEVLLGKGYGKAVD 168 (244)
T ss_pred HHHHHHHHHHHHcC---eecCCcCHHHeEECCCCcEEEccccceeeecccc--ccccccCCcCCCCHHHHccCCCCchhh
Confidence 99999999999998 9999999999999999999999999998765432 233455788999999999889999999
Q ss_pred hHhHHHHHHHHHhCCCCCCccchhhcccHHHHHHHHhhhhhhHHHhhhhhhccCCh--hHHHHHHHHHHHHhccCCCCCC
Q 044312 461 VYSFGVVLTELLTGEKPIRFTILEEDKSLAAYFLCAMKEERLFEILDARVMKQGGK--DEIITVAKLAKRCLNLNGKKRP 538 (608)
Q Consensus 461 V~S~Gvvl~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~--~~~~~l~~Li~~cl~~dp~~RP 538 (608)
|||||+++++|++|..||...... . .+.+.+.......... ..+.++.+++.+||..+|++||
T Consensus 169 i~slG~~l~~l~~~~~p~~~~~~~-----~----------~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp 233 (244)
T smart00220 169 VWSLGVILYELLTGKPPFPGDDQL-----L----------ELFKKIGKPKPPFPPPEWKISPEAKDLIRKLLVKDPEKRL 233 (244)
T ss_pred HHHHHHHHHHHHhCCCCCCCCCcH-----H----------HHHHHHhccCCCCccccccCCHHHHHHHHHHccCCchhcc
Confidence 999999999999999998632110 0 0111111111000010 1556899999999999999999
Q ss_pred CHHHHHH
Q 044312 539 TMREVAS 545 (608)
Q Consensus 539 s~~evl~ 545 (608)
++.++++
T Consensus 234 ~~~~~~~ 240 (244)
T smart00220 234 TAEEALQ 240 (244)
T ss_pred CHHHHhh
Confidence 9999986
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.2e-30 Score=243.90 Aligned_cols=230 Identities=20% Similarity=0.307 Sum_probs=173.7
Q ss_pred HHHHHHHHHHHhhcCCCCccceecccccC--------ccceEEEeecCCCccchhccccCCCCCCCHHHHHHHHHHHHHH
Q 044312 315 VEEFINEVVILSQINHRNVVKLLGCCLET--------EVPLLVYEFIPNGTLFQYIHDQNEDFPITWEIRLRIAIEVSGA 386 (608)
Q Consensus 315 ~~~~~~Ei~il~~l~H~niv~l~~~~~~~--------~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~a 386 (608)
....++|+++|..|+|+|++.+++.|... ...||||++|+. +|.-+|.+... .++..++.+++.++..|
T Consensus 60 pitalreikiL~~lkHenv~nliEic~tk~Tp~~r~r~t~ylVf~~ceh-DLaGlLsn~~v--r~sls~Ikk~Mk~Lm~G 136 (376)
T KOG0669|consen 60 PITALREIKILQLLKHENVVNLIEICRTKATPTNRDRATFYLVFDFCEH-DLAGLLSNRKV--RFSLSEIKKVMKGLMNG 136 (376)
T ss_pred cHHHHHHHHHHHHhcchhHHHHHHHHhhccCCcccccceeeeeHHHhhh-hHHHHhcCccc--cccHHHHHHHHHHHHHH
Confidence 35678999999999999999999998643 347999999976 88888876533 48999999999999999
Q ss_pred HHHHhhcCCCCeeccCCCCCcEEEcCCCcEEEeeccCccccccCCc---ceeeeeeccCCCCChhhhcc-CCCCCccchH
Q 044312 387 LSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQT---HMTTQVHGTFGYLDPEYFRS-SQFTDKSDVY 462 (608)
Q Consensus 387 L~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGls~~~~~~~~---~~~~~~~gt~~y~aPE~~~~-~~~t~ksDV~ 462 (608)
|.|+|... |+|||+||.|+||+.++.+||+|||+++.+...+. ...+...-|.+|++||.+.+ ..++++.|||
T Consensus 137 L~~iHr~k---ilHRDmKaaNvLIt~dgilklADFGlar~fs~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiW 213 (376)
T KOG0669|consen 137 LYYIHRNK---ILHRDMKAANVLITKDGILKLADFGLARAFSTSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIW 213 (376)
T ss_pred HHHHHHhh---HHhhcccHhhEEEcCCceEEeeccccccceecccccCCCCcccceeeeecCCHHHhhcccccCCcchhH
Confidence 99999999 99999999999999999999999999987764332 22345567999999999876 4799999999
Q ss_pred hHHHHHHHHHhCCCCCCccchhhcccHHHHHHHHhhhhh--------hHHHhhhhhhccC----------ChhHHHHHHH
Q 044312 463 SFGVVLTELLTGEKPIRFTILEEDKSLAAYFLCAMKEER--------LFEILDARVMKQG----------GKDEIITVAK 524 (608)
Q Consensus 463 S~Gvvl~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~--------~~~~~d~~~~~~~----------~~~~~~~l~~ 524 (608)
.-|||+.||+|+.+-++.........+.......+..+. +.+.+......+. +-.-.++..+
T Consensus 214 gAgCimaeMwtrspimqgnteqqql~~Is~LcGs~tkevWP~~d~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~d 293 (376)
T KOG0669|consen 214 GAGCIMAEMWTRSPIMQGNTEQQQLHLISQLCGSITKEVWPNVDNLPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALD 293 (376)
T ss_pred hHHHHHHHHHccCccccCChHHHHHHHHHHHhccCCcccCCCcccchHHHhccCCCCCcchhhhhhhhcccccCChhHHH
Confidence 999999999999988875444333333333322222221 1221110000000 0011336789
Q ss_pred HHHHHhccCCCCCCCHHHHHHHHHhh
Q 044312 525 LAKRCLNLNGKKRPTMREVASELAGI 550 (608)
Q Consensus 525 Li~~cl~~dp~~RPs~~evl~~L~~i 550 (608)
|+.+++..||.+||++.+++.+-.-.
T Consensus 294 Lle~ll~~DP~kR~~ad~alnh~~F~ 319 (376)
T KOG0669|consen 294 LLEKLLKLDPTKRIDADQALNHDFFW 319 (376)
T ss_pred HHHHHhccCcccCcchHhhhchhhhh
Confidence 99999999999999999999875443
|
|
| >KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=7.8e-30 Score=254.85 Aligned_cols=249 Identities=23% Similarity=0.353 Sum_probs=185.2
Q ss_pred hcCccccceeccCce---------------EEEEEeecChhhHHHHHHHHHHHhhcCC--C----CccceecccccCccc
Q 044312 288 TDNFDLNRILGQGGQ---------------AVKKSKVIDESKVEEFINEVVILSQINH--R----NVVKLLGCCLETEVP 346 (608)
Q Consensus 288 t~~f~~~~~lG~G~~---------------avk~~~~~~~~~~~~~~~Ei~il~~l~H--~----niv~l~~~~~~~~~~ 346 (608)
+++|.+.+.+|+|.| |||+++.++. -.+..+-|+++|++|.+ | -+|++.++|.-.++.
T Consensus 88 ~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V~k-YreAa~iEi~vLqki~~~DP~g~~rcv~m~~wFdyrghi 166 (415)
T KOG0671|consen 88 TNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNVDK-YREAALIEIEVLQKINESDPNGKFRCVQMRDWFDYRGHI 166 (415)
T ss_pred ccceehhhhhcCCcccceEEEeecCCCceehHHHHHHHHH-HhhHHHHHHHHHHHHHhcCCCCceEEEeeehhhhccCce
Confidence 678999999999986 4444443322 23566779999999942 2 368888999999999
Q ss_pred eEEEeecCCCccchhccccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEEcC--------------
Q 044312 347 LLVYEFIPNGTLFQYIHDQNEDFPITWEIRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDD-------------- 412 (608)
Q Consensus 347 ~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~-------------- 412 (608)
+||+|.+ |-|+.++|..+.-. +++...+..|+.|+++++++||+.. ++|-||||+|||+.+
T Consensus 167 Civfell-G~S~~dFlk~N~y~-~fpi~~ir~m~~QL~~sv~fLh~~k---l~HTDLKPENILfvss~~~~~~~~k~~~~ 241 (415)
T KOG0671|consen 167 CIVFELL-GLSTFDFLKENNYI-PFPIDHIRHMGYQLLESVAFLHDLK---LTHTDLKPENILFVSSEYFKTYNPKKKVC 241 (415)
T ss_pred EEEEecc-ChhHHHHhccCCcc-ccchHHHHHHHHHHHHHHHHHHhcc---eeecCCChheEEEeccceEEEeccCCccc
Confidence 9999999 67999999886543 7999999999999999999999999 999999999999832
Q ss_pred ------CCcEEEeeccCccccccCCcceeeeeeccCCCCChhhhccCCCCCccchHhHHHHHHHHHhCCCCCCccchhhc
Q 044312 413 ------KYRAKVSDFGASRSMAVDQTHMTTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLTELLTGEKPIRFTILEED 486 (608)
Q Consensus 413 ------~~~~kl~DFGls~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~elltg~~p~~~~~~~~~ 486 (608)
+..+||+|||.|....... ..+..|..|.|||++.+-.++.++||||+||||+||.||...|+.....+.
T Consensus 242 ~~r~~ks~~I~vIDFGsAtf~~e~h----s~iVsTRHYRAPEViLgLGwS~pCDvWSiGCIL~ElytG~~LFqtHen~EH 317 (415)
T KOG0671|consen 242 FIRPLKSTAIKVIDFGSATFDHEHH----STIVSTRHYRAPEVILGLGWSQPCDVWSIGCILVELYTGETLFQTHENLEH 317 (415)
T ss_pred eeccCCCcceEEEecCCcceeccCc----ceeeeccccCCchheeccCcCCccCceeeeeEEEEeeccceecccCCcHHH
Confidence 2358999999998754433 556789999999999999999999999999999999999998875432221
Q ss_pred ccHHHHH--------HHHhhh------hhh-----------HHHhhh----hhhccCChhHHHHHHHHHHHHhccCCCCC
Q 044312 487 KSLAAYF--------LCAMKE------ERL-----------FEILDA----RVMKQGGKDEIITVAKLAKRCLNLNGKKR 537 (608)
Q Consensus 487 ~~l~~~~--------~~~~~~------~~~-----------~~~~d~----~~~~~~~~~~~~~l~~Li~~cl~~dp~~R 537 (608)
..+.... ...... +++ ....++ .........+..++.+|+++||..||.+|
T Consensus 318 LaMMerIlGp~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~LfDLl~~mL~fDP~~R 397 (415)
T KOG0671|consen 318 LAMMERILGPIPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHVQLFDLLRRMLEFDPARR 397 (415)
T ss_pred HHHHHHhhCCCcHHHhhhhhhHhhhhcccccCccccccccchhhhcCCccHHHHhccCcHHHhHHHHHHHHHHccCcccc
Confidence 1111111 111100 000 000000 00011123445679999999999999999
Q ss_pred CCHHHHHHH
Q 044312 538 PTMREVASE 546 (608)
Q Consensus 538 Ps~~evl~~ 546 (608)
+|++|++.+
T Consensus 398 iTl~EAL~H 406 (415)
T KOG0671|consen 398 ITLREALSH 406 (415)
T ss_pred ccHHHHhcC
Confidence 999999864
|
|
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.1e-28 Score=280.95 Aligned_cols=131 Identities=27% Similarity=0.380 Sum_probs=115.5
Q ss_pred cCccccceeccCce---------------EEEEEeec---ChhhHHHHHHHHHHHhhcCCCCccceecccccCccceEEE
Q 044312 289 DNFDLNRILGQGGQ---------------AVKKSKVI---DESKVEEFINEVVILSQINHRNVVKLLGCCLETEVPLLVY 350 (608)
Q Consensus 289 ~~f~~~~~lG~G~~---------------avk~~~~~---~~~~~~~~~~Ei~il~~l~H~niv~l~~~~~~~~~~~lV~ 350 (608)
++|.+.++||+|+| |||+++.. +......+.+|+.+++.++|+||+++++++......+|||
T Consensus 4 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lVm 83 (669)
T cd05610 4 EEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQSANNVYLVM 83 (669)
T ss_pred CCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECCEEEEEE
Confidence 56888999999974 66665432 2334577899999999999999999999999999999999
Q ss_pred eecCCCccchhccccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEEcCCCcEEEeeccCcc
Q 044312 351 EFIPNGTLFQYIHDQNEDFPITWEIRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASR 425 (608)
Q Consensus 351 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGls~ 425 (608)
||+.+++|.+++.... .+++..++.|+.||+.||+|||+.+ |+||||||+||||+.++.+||+|||+++
T Consensus 84 Ey~~g~~L~~li~~~~---~l~~~~~~~i~~qil~aL~yLH~~g---IiHrDLKP~NILl~~~g~vkL~DFGls~ 152 (669)
T cd05610 84 EYLIGGDVKSLLHIYG---YFDEEMAVKYISEVALALDYLHRHG---IIHRDLKPDNMLISNEGHIKLTDFGLSK 152 (669)
T ss_pred eCCCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCccHHHEEEcCCCCEEEEeCCCCc
Confidence 9999999999987543 4889999999999999999999998 9999999999999999999999999986
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.5e-29 Score=250.07 Aligned_cols=227 Identities=27% Similarity=0.391 Sum_probs=186.0
Q ss_pred cCccccceeccCce---------------EEEEEe---ecChhhHHHHHHHHHHHhhc-CCCCccceecccccCccceEE
Q 044312 289 DNFDLNRILGQGGQ---------------AVKKSK---VIDESKVEEFINEVVILSQI-NHRNVVKLLGCCLETEVPLLV 349 (608)
Q Consensus 289 ~~f~~~~~lG~G~~---------------avk~~~---~~~~~~~~~~~~Ei~il~~l-~H~niv~l~~~~~~~~~~~lV 349 (608)
.+|.+..+||+|.| |||+++ ++...+++--..|-++|... +-|.+++|+.+|..-+.+|+|
T Consensus 349 tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTmDRLyFV 428 (683)
T KOG0696|consen 349 TDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTMDRLYFV 428 (683)
T ss_pred cccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhhhheeeE
Confidence 35888999999985 666654 34455556566777888776 678999999999999999999
Q ss_pred EeecCCCccchhccccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEEcCCCcEEEeeccCcccccc
Q 044312 350 YEFIPNGTLFQYIHDQNEDFPITWEIRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAV 429 (608)
Q Consensus 350 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGls~~~~~ 429 (608)
|||+.||+|--+|++-++ +.+....-+|++||-||-+||+++ ||.||||.+|||||.+|++||+|||+.+.-..
T Consensus 429 MEyvnGGDLMyhiQQ~Gk---FKEp~AvFYAaEiaigLFFLh~kg---IiYRDLKLDNvmLd~eGHiKi~DFGmcKEni~ 502 (683)
T KOG0696|consen 429 MEYVNGGDLMYHIQQVGK---FKEPVAVFYAAEIAIGLFFLHSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKENIF 502 (683)
T ss_pred EEEecCchhhhHHHHhcc---cCCchhhhhhHHHHHHhhhhhcCC---eeeeeccccceEeccCCceEeeeccccccccc
Confidence 999999999988887653 778888999999999999999999 99999999999999999999999999986443
Q ss_pred CCcceeeeeeccCCCCChhhhccCCCCCccchHhHHHHHHHHHhCCCCCCccchhhcccHHHHHHHHhhhhhhHHHhhhh
Q 044312 430 DQTHMTTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLTELLTGEKPIRFTILEEDKSLAAYFLCAMKEERLFEILDAR 509 (608)
Q Consensus 430 ~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 509 (608)
+ ...+....||+.|+|||++....|+..+|.|||||+||||+.|++||+....++ .| ..|.+..
T Consensus 503 ~-~~TTkTFCGTPdYiAPEIi~YqPYgksvDWWa~GVLLyEmlaGQpPFdGeDE~e------lF---------~aI~ehn 566 (683)
T KOG0696|consen 503 D-GVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDE------LF---------QAIMEHN 566 (683)
T ss_pred C-CcceeeecCCCcccccceEEecccccchhHHHHHHHHHHHHcCCCCCCCCCHHH------HH---------HHHHHcc
Confidence 3 334566789999999999999999999999999999999999999997332211 11 1222221
Q ss_pred hhccCChhHHHHHHHHHHHHhccCCCCCCC
Q 044312 510 VMKQGGKDEIITVAKLAKRCLNLNGKKRPT 539 (608)
Q Consensus 510 ~~~~~~~~~~~~l~~Li~~cl~~dp~~RPs 539 (608)
..+++..+.+..++.+..|...|.+|..
T Consensus 567 --vsyPKslSkEAv~ickg~ltK~P~kRLG 594 (683)
T KOG0696|consen 567 --VSYPKSLSKEAVAICKGLLTKHPGKRLG 594 (683)
T ss_pred --CcCcccccHHHHHHHHHHhhcCCccccC
Confidence 2456677788899999999999999953
|
|
| >KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=9.4e-30 Score=242.61 Aligned_cols=235 Identities=25% Similarity=0.333 Sum_probs=176.3
Q ss_pred cceeccCce---------------EEEEEeecC-hhhHHHHHHHHHHHh-hcCCCCccceecccccCccceEEEeecCCC
Q 044312 294 NRILGQGGQ---------------AVKKSKVID-ESKVEEFINEVVILS-QINHRNVVKLLGCCLETEVPLLVYEFIPNG 356 (608)
Q Consensus 294 ~~~lG~G~~---------------avk~~~~~~-~~~~~~~~~Ei~il~-~l~H~niv~l~~~~~~~~~~~lV~E~~~~g 356 (608)
...||.|.| |||+++... +.+.++++.|.+... .-+.||||+++|.+...+..++.||+| ..
T Consensus 69 lg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~~keq~rll~e~d~~mks~~cp~IVkfyGa~F~EGdcWiCMELM-d~ 147 (361)
T KOG1006|consen 69 LGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNIEKEQKRLLMEHDTVMKSSNCPNIVKFYGALFSEGDCWICMELM-DI 147 (361)
T ss_pred HHHhcCCcchhhhhhhcCccCcEEEEEEeeeccchHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhcCCceeeeHHHH-hh
Confidence 566888875 999988644 356678888887654 447899999999999999999999999 45
Q ss_pred ccchhccc--cCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEEcCCCcEEEeeccCccccccCCcce
Q 044312 357 TLFQYIHD--QNEDFPITWEIRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHM 434 (608)
Q Consensus 357 sL~~~l~~--~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGls~~~~~~~~~~ 434 (608)
||..+... ..++..+++..+-.|+.-+.+||.||...- .||||||||+||||+..|.+||+|||++-.+..+ ..
T Consensus 148 SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~l--kiIHRDvKPSNILldr~G~vKLCDFGIcGqLv~S--iA 223 (361)
T KOG1006|consen 148 SLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEEL--KIIHRDVKPSNILLDRHGDVKLCDFGICGQLVDS--IA 223 (361)
T ss_pred hHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHHh--hhhhccCChhheEEecCCCEeeecccchHhHHHH--HH
Confidence 76654432 112235899999999999999999998654 2999999999999999999999999998765432 22
Q ss_pred eeeeeccCCCCChhhhccC--CCCCccchHhHHHHHHHHHhCCCCCCccchhhcccHHHHHHHHhhhhhhHHHhhhhhhc
Q 044312 435 TTQVHGTFGYLDPEYFRSS--QFTDKSDVYSFGVVLTELLTGEKPIRFTILEEDKSLAAYFLCAMKEERLFEILDARVMK 512 (608)
Q Consensus 435 ~~~~~gt~~y~aPE~~~~~--~~t~ksDV~S~Gvvl~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~ 512 (608)
.+.-.|-..|||||-+... .|+.+|||||||+.|+|+.||+.|+....+ ......... .-|+....
T Consensus 224 kT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~s-----vfeql~~Vv-------~gdpp~l~ 291 (361)
T KOG1006|consen 224 KTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWDS-----VFEQLCQVV-------IGDPPILL 291 (361)
T ss_pred hhhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHHH-----HHHHHHHHH-------cCCCCeec
Confidence 3445678889999998543 589999999999999999999999863211 111111111 11111111
Q ss_pred --cCChhHHHHHHHHHHHHhccCCCCCCCHHHHHH
Q 044312 513 --QGGKDEIITVAKLAKRCLNLNGKKRPTMREVAS 545 (608)
Q Consensus 513 --~~~~~~~~~l~~Li~~cl~~dp~~RPs~~evl~ 545 (608)
......+..+..++.-||..|-.+||.+.++.+
T Consensus 292 ~~~~~~~~s~~~~~fintCl~Kd~~~Rpky~~Lk~ 326 (361)
T KOG1006|consen 292 FDKECVHYSFSMVRFINTCLIKDRSDRPKYDDLKK 326 (361)
T ss_pred CcccccccCHHHHHHHHHHhhcccccCcchhhhhc
Confidence 112346778999999999999999999998875
|
|
| >KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.9e-29 Score=257.30 Aligned_cols=226 Identities=24% Similarity=0.300 Sum_probs=190.1
Q ss_pred ccccceeccCce------------------EEEEEeecChhhHHHHHHHHHHHhhcCCCCccceecccccCccceEEEee
Q 044312 291 FDLNRILGQGGQ------------------AVKKSKVIDESKVEEFINEVVILSQINHRNVVKLLGCCLETEVPLLVYEF 352 (608)
Q Consensus 291 f~~~~~lG~G~~------------------avk~~~~~~~~~~~~~~~Ei~il~~l~H~niv~l~~~~~~~~~~~lV~E~ 352 (608)
+....-||-||| .+|+.++.+..+.++...|-.||.+.+.|.||+|+-.|.+....|+.||-
T Consensus 422 l~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~kyvYmLmEa 501 (732)
T KOG0614|consen 422 LKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRDSKYVYMLMEA 501 (732)
T ss_pred hhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhccchhhhhhHHh
Confidence 344566899986 24555667777888999999999999999999999999999999999999
Q ss_pred cCCCccchhccccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEEcCCCcEEEeeccCccccccCCc
Q 044312 353 IPNGTLFQYIHDQNEDFPITWEIRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQT 432 (608)
Q Consensus 353 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGls~~~~~~~~ 432 (608)
|-||.|...|++.+ .+...+..-++..+.+|++|||+++ ||.|||||+|.+||.+|-+||.|||.|+.+...
T Consensus 502 ClGGElWTiLrdRg---~Fdd~tarF~~acv~EAfeYLH~k~---iIYRDLKPENllLd~~Gy~KLVDFGFAKki~~g-- 573 (732)
T KOG0614|consen 502 CLGGELWTILRDRG---SFDDYTARFYVACVLEAFEYLHRKG---IIYRDLKPENLLLDNRGYLKLVDFGFAKKIGSG-- 573 (732)
T ss_pred hcCchhhhhhhhcC---CcccchhhhhHHHHHHHHHHHHhcC---ceeccCChhheeeccCCceEEeehhhHHHhccC--
Confidence 99999999998765 4888899999999999999999999 999999999999999999999999999987644
Q ss_pred ceeeeeeccCCCCChhhhccCCCCCccchHhHHHHHHHHHhCCCCCCccchhhcccHHHHHHHHhhhhhhHHHhhhhhhc
Q 044312 433 HMTTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLTELLTGEKPIRFTILEEDKSLAAYFLCAMKEERLFEILDARVMK 512 (608)
Q Consensus 433 ~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~ 512 (608)
..+-...||+.|.|||++.+...+.++|.||||++++||++|.+||....+- ..+. .|+..--..
T Consensus 574 ~KTwTFcGTpEYVAPEIILnKGHD~avDyWaLGIli~ELL~G~pPFs~~dpm------ktYn---------~ILkGid~i 638 (732)
T KOG0614|consen 574 RKTWTFCGTPEYVAPEIILNKGHDRAVDYWALGILIYELLTGSPPFSGVDPM------KTYN---------LILKGIDKI 638 (732)
T ss_pred CceeeecCCcccccchhhhccCcchhhHHHHHHHHHHHHHcCCCCCCCCchH------HHHH---------HHHhhhhhh
Confidence 3456788999999999999999999999999999999999999999743221 1111 111111223
Q ss_pred cCChhHHHHHHHHHHHHhccCCCCCCC
Q 044312 513 QGGKDEIITVAKLAKRCLNLNGKKRPT 539 (608)
Q Consensus 513 ~~~~~~~~~l~~Li~~cl~~dp~~RPs 539 (608)
++|........+|+++....+|.+|..
T Consensus 639 ~~Pr~I~k~a~~Lik~LCr~~P~ERLG 665 (732)
T KOG0614|consen 639 EFPRRITKTATDLIKKLCRDNPTERLG 665 (732)
T ss_pred hcccccchhHHHHHHHHHhcCcHhhhc
Confidence 456666778899999999999999976
|
|
| >KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.1e-28 Score=222.63 Aligned_cols=247 Identities=22% Similarity=0.340 Sum_probs=183.1
Q ss_pred ccccceeccCce---------------EEEEEeecC--hhhHHHHHHHHHHHhhcCCCCccceecccccCccceEEEeec
Q 044312 291 FDLNRILGQGGQ---------------AVKKSKVID--ESKVEEFINEVVILSQINHRNVVKLLGCCLETEVPLLVYEFI 353 (608)
Q Consensus 291 f~~~~~lG~G~~---------------avk~~~~~~--~~~~~~~~~Ei~il~~l~H~niv~l~~~~~~~~~~~lV~E~~ 353 (608)
|+-.++||+|.+ |+|+.+..+ +.-....++|+-+|+.++|+|||+++++...+..+.||+|||
T Consensus 4 ydkmekigegtygtvfkarn~~t~eivalkrvrlddddegvpssalreicllkelkhknivrl~dvlhsdkkltlvfe~c 83 (292)
T KOG0662|consen 4 YDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEFC 83 (292)
T ss_pred hHHHHhhcCCcceeeEecccCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhhhccCceeEEeHHHh
Confidence 444567788763 777776633 334567899999999999999999999999999999999999
Q ss_pred CCCccchhccccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEEcCCCcEEEeeccCccccccCCcc
Q 044312 354 PNGTLFQYIHDQNEDFPITWEIRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTH 433 (608)
Q Consensus 354 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGls~~~~~~~~~ 433 (608)
. .+|..+...... .++.+...+++.|+++||.+.|+++ +.||||||.|.||+.+|.+|++|||+++.+...-.
T Consensus 84 d-qdlkkyfdslng--~~d~~~~rsfmlqllrgl~fchshn---vlhrdlkpqnllin~ngelkladfglarafgipvr- 156 (292)
T KOG0662|consen 84 D-QDLKKYFDSLNG--DLDPEIVRSFMLQLLRGLGFCHSHN---VLHRDLKPQNLLINRNGELKLADFGLARAFGIPVR- 156 (292)
T ss_pred h-HHHHHHHHhcCC--cCCHHHHHHHHHHHHhhhhhhhhhh---hhhccCCcceEEeccCCcEEecccchhhhcCCceE-
Confidence 4 488888876544 4899999999999999999999999 99999999999999999999999999998765432
Q ss_pred eeeeeeccCCCCChhhhccC-CCCCccchHhHHHHHHHHHhCCCC-CCccchhhcccHHHHHHHH--hhhhhhHH---Hh
Q 044312 434 MTTQVHGTFGYLDPEYFRSS-QFTDKSDVYSFGVVLTELLTGEKP-IRFTILEEDKSLAAYFLCA--MKEERLFE---IL 506 (608)
Q Consensus 434 ~~~~~~gt~~y~aPE~~~~~-~~t~ksDV~S~Gvvl~elltg~~p-~~~~~~~~~~~l~~~~~~~--~~~~~~~~---~~ 506 (608)
......-|.+|.+|+++.+. -|+...|+||-|||+.|+.....| |... +.+..+...|... ..++.... +-
T Consensus 157 cysaevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~--dvddqlkrif~~lg~p~ed~wps~t~lp 234 (292)
T KOG0662|consen 157 CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGN--DVDDQLKRIFRLLGTPTEDQWPSMTKLP 234 (292)
T ss_pred eeeceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCC--cHHHHHHHHHHHhCCCccccCCccccCC
Confidence 22344569999999998776 478899999999999999985555 4322 2223333333221 12222111 11
Q ss_pred hhhhhccCC---------hhHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 044312 507 DARVMKQGG---------KDEIITVAKLAKRCLNLNGKKRPTMREVASE 546 (608)
Q Consensus 507 d~~~~~~~~---------~~~~~~l~~Li~~cl~~dp~~RPs~~evl~~ 546 (608)
|-.....++ +.....=++|+.+.|.-+|..|.++++.+++
T Consensus 235 dyk~yp~ypattswsqivp~lns~grdllqkll~cnp~qrisaeaalqh 283 (292)
T KOG0662|consen 235 DYKPYPIYPATTSWSQIVPKLNSTGRDLLQKLLKCNPAQRISAEAALQH 283 (292)
T ss_pred CCcccCCccccchHHHHhhhhcchhHHHHHHHhccCcccccCHHHHhcC
Confidence 111101111 1223345789999999999999999888754
|
|
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.2e-27 Score=258.09 Aligned_cols=221 Identities=21% Similarity=0.190 Sum_probs=149.1
Q ss_pred HHHHHHHhhcCCCCc-----cceeccccc--------CccceEEEeecCCCccchhccccCC------------------
Q 044312 319 INEVVILSQINHRNV-----VKLLGCCLE--------TEVPLLVYEFIPNGTLFQYIHDQNE------------------ 367 (608)
Q Consensus 319 ~~Ei~il~~l~H~ni-----v~l~~~~~~--------~~~~~lV~E~~~~gsL~~~l~~~~~------------------ 367 (608)
..|+.++.+++|.++ ++++++|.. ....+|||||+++++|.++++....
T Consensus 220 ~vE~~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~ 299 (507)
T PLN03224 220 MVEAYMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPD 299 (507)
T ss_pred HHHHHHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhh
Confidence 346677777766654 677787753 3467999999999999999874211
Q ss_pred ---CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEEcCCCcEEEeeccCccccccCCcceeeeeeccCCC
Q 044312 368 ---DFPITWEIRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHGTFGY 444 (608)
Q Consensus 368 ---~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGls~~~~~~~~~~~~~~~gt~~y 444 (608)
...+++..+..++.|++.+|.|||+.+ |+||||||+|||++.++.+||+|||+++..............+|+.|
T Consensus 300 ~~~~~~~~~~~~~~i~~ql~~aL~~lH~~~---ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~g~~tp~Y 376 (507)
T PLN03224 300 NMPQDKRDINVIKGVMRQVLTGLRKLHRIG---IVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGINFNPLYGMLDPRY 376 (507)
T ss_pred hcccccCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCchHhEEECCCCcEEEEeCcCccccccCCccCccccCCCcce
Confidence 112467888999999999999999998 99999999999999999999999999976543322222223357899
Q ss_pred CChhhhccCCC----------------------CCccchHhHHHHHHHHHhCCC-CCCccchhhcccHHHHHHHHhhhhh
Q 044312 445 LDPEYFRSSQF----------------------TDKSDVYSFGVVLTELLTGEK-PIRFTILEEDKSLAAYFLCAMKEER 501 (608)
Q Consensus 445 ~aPE~~~~~~~----------------------t~ksDV~S~Gvvl~elltg~~-p~~~~~~~~~~~l~~~~~~~~~~~~ 501 (608)
+|||.+..... ..+.||||+||+++||+++.. |+.....-. ..+.. .. .....
T Consensus 377 ~aPE~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~-~~~~~-~~--~~~~~ 452 (507)
T PLN03224 377 SPPEELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFN-TELRQ-YD--NDLNR 452 (507)
T ss_pred eChhhhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhh-hHHhh-cc--chHHH
Confidence 99999754321 235799999999999999875 654211000 00000 00 00000
Q ss_pred hHHHhhhhhhccCChhHHHHHHHHHHHHhccCC---CCCCCHHHHHHH
Q 044312 502 LFEILDARVMKQGGKDEIITVAKLAKRCLNLNG---KKRPTMREVASE 546 (608)
Q Consensus 502 ~~~~~d~~~~~~~~~~~~~~l~~Li~~cl~~dp---~~RPs~~evl~~ 546 (608)
......................+|+.++|..+| .+|+|++|++++
T Consensus 453 ~r~~~~~~~~~~~~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~H 500 (507)
T PLN03224 453 WRMYKGQKYDFSLLDRNKEAGWDLACKLITKRDQANRGRLSVGQALSH 500 (507)
T ss_pred HHhhcccCCCcccccccChHHHHHHHHHhccCCCCcccCCCHHHHhCC
Confidence 000000011111122345678899999999866 689999999865
|
|
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.7e-27 Score=265.04 Aligned_cols=245 Identities=21% Similarity=0.279 Sum_probs=155.9
Q ss_pred HhcCccccceeccCceEE-------------------EEEeecChhhHHHHHHHHHHHhhcCCCCccceecc------cc
Q 044312 287 ATDNFDLNRILGQGGQAV-------------------KKSKVIDESKVEEFINEVVILSQINHRNVVKLLGC------CL 341 (608)
Q Consensus 287 ~t~~f~~~~~lG~G~~av-------------------k~~~~~~~~~~~~~~~Ei~il~~l~H~niv~l~~~------~~ 341 (608)
..++|.+.++||+|+|+. |+... ....+.+.+| .++...+.+++.++.. ..
T Consensus 130 ~~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~--~~~~e~~~~e--~l~~~~~~~~~~~~~~~~~~~~~~ 205 (566)
T PLN03225 130 KKDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATE--YGAVEIWMNE--RVRRACPNSCADFVYGFLEPVSSK 205 (566)
T ss_pred ccCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecc--cchhHHHHHH--HHHhhchhhHHHHHHhhhcccccc
Confidence 467899999999998632 22211 1111122221 1222233333333332 23
Q ss_pred cCccceEEEeecCCCccchhccccCCCC-----------------CCCHHHHHHHHHHHHHHHHHHhhcCCCCeeccCCC
Q 044312 342 ETEVPLLVYEFIPNGTLFQYIHDQNEDF-----------------PITWEIRLRIAIEVSGALSYLHSAASIPIYHRDIK 404 (608)
Q Consensus 342 ~~~~~~lV~E~~~~gsL~~~l~~~~~~~-----------------~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk 404 (608)
+....+|||||+++++|.+++....... ......+..++.||+.||+|||+.+ |+|||||
T Consensus 206 ~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~g---IiHRDLK 282 (566)
T PLN03225 206 KEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHSTG---IVHRDVK 282 (566)
T ss_pred cCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHCC---EEeCcCC
Confidence 5567899999999999999887542110 0123445679999999999999998 9999999
Q ss_pred CCcEEEcC-CCcEEEeeccCccccccCCcceeeeeeccCCCCChhhhccC----------------------CCCCccch
Q 044312 405 STNILLDD-KYRAKVSDFGASRSMAVDQTHMTTQVHGTFGYLDPEYFRSS----------------------QFTDKSDV 461 (608)
Q Consensus 405 ~~NILl~~-~~~~kl~DFGls~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----------------------~~t~ksDV 461 (608)
|+|||+++ ++.+||+|||+++.+............+++.|+|||.+... .++.++||
T Consensus 283 P~NILl~~~~~~~KL~DFGlA~~l~~~~~~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k~DV 362 (566)
T PLN03225 283 PQNIIFSEGSGSFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDI 362 (566)
T ss_pred HHHEEEeCCCCcEEEEeCCCccccccccccCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCCccc
Confidence 99999985 57999999999987654444444556789999999965322 24456799
Q ss_pred HhHHHHHHHHHhCCCCCCccchhhcccHHHHHHHHhhh-----hhhHHHhhhhhhcc------CChhHHHHHHHHHHHHh
Q 044312 462 YSFGVVLTELLTGEKPIRFTILEEDKSLAAYFLCAMKE-----ERLFEILDARVMKQ------GGKDEIITVAKLAKRCL 530 (608)
Q Consensus 462 ~S~Gvvl~elltg~~p~~~~~~~~~~~l~~~~~~~~~~-----~~~~~~~d~~~~~~------~~~~~~~~l~~Li~~cl 530 (608)
|||||+|+||+++..|.... +..+ ...+.. ..+...+.+....+ ..........+|+.+||
T Consensus 363 wSlGviL~el~~~~~~~~~~-------~~~~-~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~dLi~~mL 434 (566)
T PLN03225 363 YSAGLIFLQMAFPNLRSDSN-------LIQF-NRQLKRNDYDLVAWRKLVEPRASPDLRRGFEVLDLDGGAGWELLKSMM 434 (566)
T ss_pred HHHHHHHHHHHhCcCCCchH-------HHHH-HHHHHhcCCcHHHHHHhhccccchhhhhhhhhccccchHHHHHHHHHc
Confidence 99999999999976654311 1111 111110 00111111110000 00011223558999999
Q ss_pred ccCCCCCCCHHHHHHH
Q 044312 531 NLNGKKRPTMREVASE 546 (608)
Q Consensus 531 ~~dp~~RPs~~evl~~ 546 (608)
+.||++|||++|++++
T Consensus 435 ~~dP~kR~ta~e~L~H 450 (566)
T PLN03225 435 RFKGRQRISAKAALAH 450 (566)
T ss_pred cCCcccCCCHHHHhCC
Confidence 9999999999999985
|
|
| >KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=4.9e-28 Score=263.06 Aligned_cols=245 Identities=24% Similarity=0.359 Sum_probs=193.3
Q ss_pred HHHHHHHhcCccccceeccCce---------------EEEEEeecChhhHHHHHHHHHHHhhc-CCCCccceecccc---
Q 044312 281 SKELEKATDNFDLNRILGQGGQ---------------AVKKSKVIDESKVEEFINEVVILSQI-NHRNVVKLLGCCL--- 341 (608)
Q Consensus 281 ~~~l~~~t~~f~~~~~lG~G~~---------------avk~~~~~~~~~~~~~~~Ei~il~~l-~H~niv~l~~~~~--- 341 (608)
++.+.-.++.|++...||.|.+ |||+.. .+.+..++...|..+|+.+ +|||++.++|++.
T Consensus 11 ~~~lpdp~d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~-~~~d~deEiE~eynil~~~~~hpnv~~fyg~~~k~~ 89 (953)
T KOG0587|consen 11 LSSLPDPADIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMD-PTEDEEEEIELEYNMLKKYSHHPNVATFYGAFIKKD 89 (953)
T ss_pred hhhCCCCCCccEEEEEEeeccceeEEEEeeeecCceeeeEeec-CCccccHHHHHHHHHHHhccCCCCcceEEEEEEEec
Confidence 3344445677888999999853 444444 4455567788899999988 7999999999986
Q ss_pred --cCccceEEEeecCCCccchhccccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEEcCCCcEEEe
Q 044312 342 --ETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEIRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVS 419 (608)
Q Consensus 342 --~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~ 419 (608)
.++.++||||||.+||..|++++.. ...+.|..+..|+.+++.||.+||.+. ++|||||-.|||++.++.+||.
T Consensus 90 ~~~~DqLWLVMEfC~gGSVTDLVKn~~-g~rl~E~~IaYI~re~lrgl~HLH~nk---viHRDikG~NiLLT~e~~VKLv 165 (953)
T KOG0587|consen 90 PGNGDQLWLVMEFCGGGSVTDLVKNTK-GNRLKEEWIAYILREILRGLAHLHNNK---VIHRDIKGQNVLLTENAEVKLV 165 (953)
T ss_pred CCCCCeEEEEeeccCCccHHHHHhhhc-ccchhhHHHHHHHHHHHHHHHHHhhcc---eeeecccCceEEEeccCcEEEe
Confidence 3568999999999999999998755 336999999999999999999999999 9999999999999999999999
Q ss_pred eccCccccccCCcceeeeeeccCCCCChhhhccC-----CCCCccchHhHHHHHHHHHhCCCCCCccchhhcccHHHHHH
Q 044312 420 DFGASRSMAVDQTHMTTQVHGTFGYLDPEYFRSS-----QFTDKSDVYSFGVVLTELLTGEKPIRFTILEEDKSLAAYFL 494 (608)
Q Consensus 420 DFGls~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~t~ksDV~S~Gvvl~elltg~~p~~~~~~~~~~~l~~~~~ 494 (608)
|||++..+..... ......||+.|||||++... .|+.++|+||||++..||.-|.+|+.... ..
T Consensus 166 DFGvSaQldsT~g-rRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmH-------Pm--- 234 (953)
T KOG0587|consen 166 DFGVSAQLDSTVG-RRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMH-------PM--- 234 (953)
T ss_pred eeeeeeeeecccc-cccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcc-------hh---
Confidence 9999987654333 23445699999999998643 47789999999999999999999975211 11
Q ss_pred HHhhhhhhHHHhh-hhhhccCChhHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 044312 495 CAMKEERLFEILD-ARVMKQGGKDEIITVAKLAKRCLNLNGKKRPTMREVASE 546 (608)
Q Consensus 495 ~~~~~~~~~~~~d-~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~evl~~ 546 (608)
..++.+.. |......+..-.+++-++|..||..|.++||++.+++++
T Consensus 235 -----raLF~IpRNPPPkLkrp~kWs~~FndFIs~cL~Kd~e~RP~~~~ll~h 282 (953)
T KOG0587|consen 235 -----RALFLIPRNPPPKLKRPKKWSKKFNDFISTCLVKDYEQRPSTEELLKH 282 (953)
T ss_pred -----hhhccCCCCCCccccchhhHHHHHHHHHHHHHhhccccCcchhhhccC
Confidence 11222211 112222345567889999999999999999999999864
|
|
| >KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=4.5e-28 Score=249.08 Aligned_cols=231 Identities=25% Similarity=0.351 Sum_probs=182.5
Q ss_pred cceeccCce---------------EEEEEee--cChhhHHHHHHHHHHHhhcCCCCccceecccccCccceEEEeecCCC
Q 044312 294 NRILGQGGQ---------------AVKKSKV--IDESKVEEFINEVVILSQINHRNVVKLLGCCLETEVPLLVYEFIPNG 356 (608)
Q Consensus 294 ~~~lG~G~~---------------avk~~~~--~~~~~~~~~~~Ei~il~~l~H~niv~l~~~~~~~~~~~lV~E~~~~g 356 (608)
.+.||+|.| |||.+.. ....+..++++|+.||++++||.||.|--.|+..+..+.|||.+ +|
T Consensus 569 devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M~ET~ervFVVMEKl-~G 647 (888)
T KOG4236|consen 569 DEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECMFETPERVFVVMEKL-HG 647 (888)
T ss_pred HhhccCCcceeeecceecccCceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEeecCCceEEEEehhh-cc
Confidence 467899864 7777653 33455688999999999999999999999999999999999999 56
Q ss_pred ccchhccccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEEcCC---CcEEEeeccCccccccCCcc
Q 044312 357 TLFQYIHDQNEDFPITWEIRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDK---YRAKVSDFGASRSMAVDQTH 433 (608)
Q Consensus 357 sL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~---~~~kl~DFGls~~~~~~~~~ 433 (608)
+..+.|-..... .|++.....++.||+.||.|||.++ |+|.||||+||||.+. -++||+|||.||.+.+..
T Consensus 648 DMLEMILSsEkg-RL~er~TkFlvtQIL~ALr~LH~kn---IvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgEks-- 721 (888)
T KOG4236|consen 648 DMLEMILSSEKG-RLPERITKFLVTQILVALRYLHFKN---IVHCDLKPENVLLASASPFPQVKLCDFGFARIIGEKS-- 721 (888)
T ss_pred hHHHHHHHhhcc-cchHHHHHHHHHHHHHHHHHhhhcc---eeeccCCchheeeccCCCCCceeeccccceeecchhh--
Confidence 766666543322 5899999999999999999999999 9999999999999754 469999999999987543
Q ss_pred eeeeeeccCCCCChhhhccCCCCCccchHhHHHHHHHHHhCCCCCCccchhhcccHHHHHHHHhhhhhhHHHhhhhhhcc
Q 044312 434 MTTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLTELLTGEKPIRFTILEEDKSLAAYFLCAMKEERLFEILDARVMKQ 513 (608)
Q Consensus 434 ~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~ 513 (608)
....+.||+.|+|||++.+..|...-|+||.|||+|--++|.-||.-.. +.... +.... --+...
T Consensus 722 FRrsVVGTPAYLaPEVLrnkGyNrSLDMWSVGVIiYVsLSGTFPFNEdE-----dIndQ----IQNAa------FMyPp~ 786 (888)
T KOG4236|consen 722 FRRSVVGTPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLSGTFPFNEDE-----DINDQ----IQNAA------FMYPPN 786 (888)
T ss_pred hhhhhcCCccccCHHHHhhccccccccceeeeEEEEEEecccccCCCcc-----chhHH----hhccc------cccCCC
Confidence 3456789999999999999999999999999999999999999986221 11110 00000 011122
Q ss_pred CChhHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 044312 514 GGKDEIITVAKLAKRCLNLNGKKRPTMREVASE 546 (608)
Q Consensus 514 ~~~~~~~~l~~Li~~cl~~dp~~RPs~~evl~~ 546 (608)
...+......+||...|+..-.+|-|...-+.+
T Consensus 787 PW~eis~~AidlIn~LLqVkm~kRysvdk~lsh 819 (888)
T KOG4236|consen 787 PWSEISPEAIDLINNLLQVKMRKRYSVDKSLSH 819 (888)
T ss_pred chhhcCHHHHHHHHHHHHHHHHHhcchHhhccc
Confidence 334556678899999999999999988776543
|
|
| >KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.5e-28 Score=264.23 Aligned_cols=213 Identities=25% Similarity=0.356 Sum_probs=163.5
Q ss_pred hHHHHHHHHHHHhhc-CCCCccceecccccCccceEEEeecCCCccchhccccCCCCC-CCHHHHHHHHHHHHHHHHHHh
Q 044312 314 KVEEFINEVVILSQI-NHRNVVKLLGCCLETEVPLLVYEFIPNGTLFQYIHDQNEDFP-ITWEIRLRIAIEVSGALSYLH 391 (608)
Q Consensus 314 ~~~~~~~Ei~il~~l-~H~niv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~-l~~~~~~~i~~~ia~aL~yLH 391 (608)
..+-..+|+..|+.- +|||||++++.-.++...||..|.| ..+|.+++........ ..-...+.+..|+++||++||
T Consensus 545 ~~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIalELC-~~sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLH 623 (903)
T KOG1027|consen 545 FFDFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIALELC-ACSLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLH 623 (903)
T ss_pred hHHHHHHHHHHHHhccCCCceEEEEeeccCCceEEEEehHh-hhhHHHHHhccccchhhcccccHHHHHHHHHHHHHHHH
Confidence 344567899999888 7999999999999999999999999 5599999987411111 121345778899999999999
Q ss_pred hcCCCCeeccCCCCCcEEEcC-----CCcEEEeeccCccccccCCcce--eeeeeccCCCCChhhhccCCCCCccchHhH
Q 044312 392 SAASIPIYHRDIKSTNILLDD-----KYRAKVSDFGASRSMAVDQTHM--TTQVHGTFGYLDPEYFRSSQFTDKSDVYSF 464 (608)
Q Consensus 392 ~~~~~~iiHrDlk~~NILl~~-----~~~~kl~DFGls~~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~ 464 (608)
+.+ |+||||||.||||+- ...++|+|||+++.+..++... .....||.+|+|||++....-+.++||||+
T Consensus 624 sl~---iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl~~~~sS~~r~s~~sGt~GW~APE~L~~~~~~~avDiFsl 700 (903)
T KOG1027|consen 624 SLK---IVHRDLKPQNILISVPSADGTLRAKISDFGLSKKLAGGKSSFSRLSGGSGTSGWQAPEQLREDRKTQAVDIFSL 700 (903)
T ss_pred hcc---cccccCCCceEEEEccCCCcceeEEecccccccccCCCcchhhcccCCCCcccccCHHHHhccccCcccchhhc
Confidence 998 999999999999975 2579999999999987655432 345679999999999999998999999999
Q ss_pred HHHHHHHHhC-CCCCCccchhhcccHHHHHHHHhhhhhhHHHhhhhhhccCChhHHHHHHHHHHHHhccCCCCCCCHHHH
Q 044312 465 GVVLTELLTG-EKPIRFTILEEDKSLAAYFLCAMKEERLFEILDARVMKQGGKDEIITVAKLAKRCLNLNGKKRPTMREV 543 (608)
Q Consensus 465 Gvvl~elltg-~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~ev 543 (608)
|||+|+.++| .+||...-..+. .-......+..+ +...++ +..+||.+|++++|..||++.+|
T Consensus 701 GCvfyYvltgG~HpFGd~~~R~~-------NIl~~~~~L~~L-------~~~~d~--eA~dLI~~ml~~dP~~RPsa~~V 764 (903)
T KOG1027|consen 701 GCVFYYVLTGGSHPFGDSLERQA-------NILTGNYTLVHL-------EPLPDC--EAKDLISRMLNPDPQLRPSATDV 764 (903)
T ss_pred CceEEEEecCCccCCCchHHhhh-------hhhcCccceeee-------ccCchH--HHHHHHHHhcCCCcccCCCHHHH
Confidence 9999999996 899863221111 000011111110 111111 78899999999999999999999
Q ss_pred HHH
Q 044312 544 ASE 546 (608)
Q Consensus 544 l~~ 546 (608)
+.+
T Consensus 765 L~H 767 (903)
T KOG1027|consen 765 LNH 767 (903)
T ss_pred hCC
Confidence 864
|
|
| >KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=3.4e-27 Score=231.07 Aligned_cols=235 Identities=26% Similarity=0.413 Sum_probs=184.5
Q ss_pred hcCccccceeccCce---------------EEEEEe---ecChhhHHHHHHHHHHHhhc-CCCCccceecccccCccceE
Q 044312 288 TDNFDLNRILGQGGQ---------------AVKKSK---VIDESKVEEFINEVVILSQI-NHRNVVKLLGCCLETEVPLL 348 (608)
Q Consensus 288 t~~f~~~~~lG~G~~---------------avk~~~---~~~~~~~~~~~~Ei~il~~l-~H~niv~l~~~~~~~~~~~l 348 (608)
-++|++.++||+|.+ |+|.++ ..+.++++-...|-.+..+- +||.+|-|..+|.....+++
T Consensus 249 l~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqtesrlff 328 (593)
T KOG0695|consen 249 LQDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQTESRLFF 328 (593)
T ss_pred cccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcccceEEE
Confidence 457999999999985 333332 23445555666777777666 79999999999999999999
Q ss_pred EEeecCCCccchhccccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEEcCCCcEEEeeccCccccc
Q 044312 349 VYEFIPNGTLFQYIHDQNEDFPITWEIRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMA 428 (608)
Q Consensus 349 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGls~~~~ 428 (608)
|.||+++|+|--++++++ .++++...-+..+|.-||.|||+.+ ||.||||.+|+|||..+.+||.|+|+.+.-.
T Consensus 329 vieyv~ggdlmfhmqrqr---klpeeharfys~ei~lal~flh~rg---iiyrdlkldnvlldaeghikltdygmcke~l 402 (593)
T KOG0695|consen 329 VIEYVNGGDLMFHMQRQR---KLPEEHARFYSAEICLALNFLHERG---IIYRDLKLDNVLLDAEGHIKLTDYGMCKEGL 402 (593)
T ss_pred EEEEecCcceeeehhhhh---cCcHHHhhhhhHHHHHHHHHHhhcC---eeeeeccccceEEccCCceeecccchhhcCC
Confidence 999999999988777654 4999999999999999999999999 9999999999999999999999999987643
Q ss_pred cCCcceeeeeeccCCCCChhhhccCCCCCccchHhHHHHHHHHHhCCCCCCccchhhc-ccHHHHHHHHhhhhhhHHHhh
Q 044312 429 VDQTHMTTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLTELLTGEKPIRFTILEED-KSLAAYFLCAMKEERLFEILD 507 (608)
Q Consensus 429 ~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~elltg~~p~~~~~~~~~-~~l~~~~~~~~~~~~~~~~~d 507 (608)
.+ ...+....||+.|+|||++.+..|.-..|.|++||+++||+.|+.||.....+.. .+-..+..+. ++.
T Consensus 403 ~~-gd~tstfcgtpnyiapeilrgeeygfsvdwwalgvlmfemmagrspfdivgm~n~d~ntedylfqv--------ile 473 (593)
T KOG0695|consen 403 GP-GDTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIVGMDNPDMNTEDYLFQV--------ILE 473 (593)
T ss_pred CC-CcccccccCCCcccchhhhcccccCceehHHHHHHHHHHHHcCCCCcceecCCCcccchhHHHHHH--------Hhh
Confidence 22 3345667899999999999999999999999999999999999999985433222 1222222211 222
Q ss_pred hhhhccCChhHHHHHHHHHHHHhccCCCCCCC
Q 044312 508 ARVMKQGGKDEIITVAKLAKRCLNLNGKKRPT 539 (608)
Q Consensus 508 ~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPs 539 (608)
.+++. +...+.....+++.-|+.||.+|..
T Consensus 474 kqiri--prslsvkas~vlkgflnkdp~erlg 503 (593)
T KOG0695|consen 474 KQIRI--PRSLSVKASHVLKGFLNKDPKERLG 503 (593)
T ss_pred hcccc--cceeehhhHHHHHHhhcCCcHHhcC
Confidence 33322 2333445677899999999999964
|
|
| >KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.94 E-value=7.1e-27 Score=244.79 Aligned_cols=192 Identities=26% Similarity=0.409 Sum_probs=159.7
Q ss_pred hcCccccceeccCceE---------------EEEE---eecChhhHHHHHHHHHHHhhcCCCCccceecccccCccceEE
Q 044312 288 TDNFDLNRILGQGGQA---------------VKKS---KVIDESKVEEFINEVVILSQINHRNVVKLLGCCLETEVPLLV 349 (608)
Q Consensus 288 t~~f~~~~~lG~G~~a---------------vk~~---~~~~~~~~~~~~~Ei~il~~l~H~niv~l~~~~~~~~~~~lV 349 (608)
..-|...+-||-|+|. .|.+ .+....++.....|-.||..-+.+-||+|+..|.+++.+|+|
T Consensus 628 KSmFvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySFQDkdnLYFV 707 (1034)
T KOG0608|consen 628 KSMFVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFV 707 (1034)
T ss_pred ccceEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEeccCCceEEE
Confidence 4567888899999872 2211 223445667788899999999999999999999999999999
Q ss_pred EeecCCCccchhccccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEEcCCCcEEEeeccCccccc-
Q 044312 350 YEFIPNGTLFQYIHDQNEDFPITWEIRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMA- 428 (608)
Q Consensus 350 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGls~~~~- 428 (608)
|||++||++-.+|-+.+ .+.+.....+++++..|+++.|..| +|||||||+|||||.+|++||.||||..-+.
T Consensus 708 MdYIPGGDmMSLLIrmg---IFeE~LARFYIAEltcAiesVHkmG---FIHRDiKPDNILIDrdGHIKLTDFGLCTGfRW 781 (1034)
T KOG0608|consen 708 MDYIPGGDMMSLLIRMG---IFEEDLARFYIAELTCAIESVHKMG---FIHRDIKPDNILIDRDGHIKLTDFGLCTGFRW 781 (1034)
T ss_pred EeccCCccHHHHHHHhc---cCHHHHHHHHHHHHHHHHHHHHhcc---ceecccCccceEEccCCceeeeecccccccee
Confidence 99999999999988765 4788888889999999999999999 9999999999999999999999999974321
Q ss_pred --------cCCcc--------------------------------eeeeeeccCCCCChhhhccCCCCCccchHhHHHHH
Q 044312 429 --------VDQTH--------------------------------MTTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVL 468 (608)
Q Consensus 429 --------~~~~~--------------------------------~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl 468 (608)
..... ......||+.|+|||++....++...|.||.||||
T Consensus 782 THdskYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~q~cdwws~gvil 861 (1034)
T KOG0608|consen 782 THDSKYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYTQLCDWWSVGVIL 861 (1034)
T ss_pred ccccccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCccccchhhHhhHHH
Confidence 10000 00125699999999999999999999999999999
Q ss_pred HHHHhCCCCCCccchhh
Q 044312 469 TELLTGEKPIRFTILEE 485 (608)
Q Consensus 469 ~elltg~~p~~~~~~~~ 485 (608)
+||+.|+.||......+
T Consensus 862 ~em~~g~~pf~~~tp~~ 878 (1034)
T KOG0608|consen 862 YEMLVGQPPFLADTPGE 878 (1034)
T ss_pred HHHhhCCCCccCCCCCc
Confidence 99999999997655443
|
|
| >KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.2e-27 Score=232.33 Aligned_cols=224 Identities=24% Similarity=0.361 Sum_probs=169.6
Q ss_pred hhhHHHHHHHHHHHhhcCCCCccceecccccCc------cceEEEeecCCCccchhccccCCCCCCCHHHHHHHHHHHHH
Q 044312 312 ESKVEEFINEVVILSQINHRNVVKLLGCCLETE------VPLLVYEFIPNGTLFQYIHDQNEDFPITWEIRLRIAIEVSG 385 (608)
Q Consensus 312 ~~~~~~~~~Ei~il~~l~H~niv~l~~~~~~~~------~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~ 385 (608)
....+...+|+.++..++|+||++++.++.-.. ..|+|||+| ..+|.+.++- .++-+++..|..|++.
T Consensus 56 ~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~~e~y~v~e~m-~~nl~~vi~~-----elDH~tis~i~yq~~~ 129 (369)
T KOG0665|consen 56 QTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEFQEVYLVMELM-DANLCQVILM-----ELDHETISYILYQMLC 129 (369)
T ss_pred CccchhhhhhhhhhhhhcccceeeeeeccCccccHHHHHhHHHHHHhh-hhHHHHHHHH-----hcchHHHHHHHHHHHH
Confidence 344677889999999999999999999996443 569999999 5599888872 3778899999999999
Q ss_pred HHHHHhhcCCCCeeccCCCCCcEEEcCCCcEEEeeccCccccccCCcceeeeeeccCCCCChhhhccCCCCCccchHhHH
Q 044312 386 ALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHGTFGYLDPEYFRSSQFTDKSDVYSFG 465 (608)
Q Consensus 386 aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGls~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~G 465 (608)
|+.|||+.+ |+||||||+||++..+..+||.|||+++.-..+ ...+....|..|.|||++.+..+.+.+||||.|
T Consensus 130 ~ik~lhs~~---IihRdLkPsnivv~~~~~lKi~dfg~ar~e~~~--~~mtpyVvtRyyrapevil~~~~ke~vdiwSvG 204 (369)
T KOG0665|consen 130 GIKHLHSAG---IIHRDLKPSNIVVNSDCTLKILDFGLARTEDTD--FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVG 204 (369)
T ss_pred HHHHHHhcc---eeecccCcccceecchhheeeccchhhcccCcc--cccCchhheeeccCchheeccCCcccchhhhhh
Confidence 999999999 999999999999999999999999999865433 456777889999999999999999999999999
Q ss_pred HHHHHHHhCCCCCCccchhhc--------ccHHHHHHHHhhh-hh-------------hHHHh-hh--hhhccCChhHHH
Q 044312 466 VVLTELLTGEKPIRFTILEED--------KSLAAYFLCAMKE-ER-------------LFEIL-DA--RVMKQGGKDEII 520 (608)
Q Consensus 466 vvl~elltg~~p~~~~~~~~~--------~~l~~~~~~~~~~-~~-------------~~~~~-d~--~~~~~~~~~~~~ 520 (608)
|++.||++|+.-|.....-+. ..+...|...+.. .+ ..+.+ |. ....+.+.....
T Consensus 205 ci~gEli~~~Vlf~g~d~idQ~~ki~~~lgtpd~~F~~qL~~~~r~yv~~~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~ 284 (369)
T KOG0665|consen 205 CIMGELILGTVLFPGKDHIDQWNKIIEQLGTPDPSFMKQLQPTVRNYVENRPQYQAISFSELFPDSLFPVVLEGSKLDCS 284 (369)
T ss_pred hHHHHHhhceEEecCchHHHHHHHHHHHhcCCCHHHHHHhhHHHHHHhhcChHhhccchhhhCCcccccccccCCccchH
Confidence 999999999987763211111 0000111111100 00 00000 00 001112223345
Q ss_pred HHHHHHHHHhccCCCCCCCHHHHHHH
Q 044312 521 TVAKLAKRCLNLNGKKRPTMREVASE 546 (608)
Q Consensus 521 ~l~~Li~~cl~~dp~~RPs~~evl~~ 546 (608)
..++|+.+||..+|++|.+.++++.+
T Consensus 285 ~ardll~~MLvi~pe~Risv~daL~H 310 (369)
T KOG0665|consen 285 LARDLLSKMLVIDPEKRISVDDALRH 310 (369)
T ss_pred HHHHHHHHhhccChhhcccHHHHhcC
Confidence 68899999999999999999999875
|
|
| >KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=4.7e-27 Score=216.74 Aligned_cols=193 Identities=24% Similarity=0.378 Sum_probs=153.1
Q ss_pred HHHHhcCccccceeccCce---------------EEEEEee-cChhhHHHHHHHHHHHhhc-CCCCccceecccccCccc
Q 044312 284 LEKATDNFDLNRILGQGGQ---------------AVKKSKV-IDESKVEEFINEVVILSQI-NHRNVVKLLGCCLETEVP 346 (608)
Q Consensus 284 l~~~t~~f~~~~~lG~G~~---------------avk~~~~-~~~~~~~~~~~Ei~il~~l-~H~niv~l~~~~~~~~~~ 346 (608)
++...+.......||+|++ |||.++. .+....+..++|+.+..+- ..|.+|+++|........
T Consensus 41 ~eV~ad~L~~i~elGrGayG~vekmrh~~sg~imAvKri~~tvn~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~regdv 120 (282)
T KOG0984|consen 41 FEVPADDLVGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATVNSQEQKRLLMDLDIIMRTVDCPFTVHFYGALFREGDV 120 (282)
T ss_pred cccchhhhhhhhhhcCCccchhhheeeccCCeEEEEeeehhhcChHHHHHHHHhhhhhccCCCCCeEEEeehhhhccccE
Confidence 3334444445667888863 8888775 3445566788888876554 789999999999999999
Q ss_pred eEEEeecCCCccchhccc-cCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEEcCCCcEEEeeccCcc
Q 044312 347 LLVYEFIPNGTLFQYIHD-QNEDFPITWEIRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASR 425 (608)
Q Consensus 347 ~lV~E~~~~gsL~~~l~~-~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGls~ 425 (608)
++.||.| ..||..+..+ -.....+++..+-+||..|.+||.|||++- .++|||+||+||||+.+|++|++|||++-
T Consensus 121 wIcME~M-~tSldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~kL--~vIHRDvKPsNiLIn~~GqVKiCDFGIsG 197 (282)
T KOG0984|consen 121 WICMELM-DTSLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSKL--SVIHRDVKPSNILINYDGQVKICDFGISG 197 (282)
T ss_pred EEeHHHh-hhhHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHHh--hhhhccCCcceEEEccCCcEEEcccccce
Confidence 9999999 4588776654 122235899999999999999999999865 39999999999999999999999999998
Q ss_pred ccccCCcceeeeeeccCCCCChhhhc----cCCCCCccchHhHHHHHHHHHhCCCCCCcc
Q 044312 426 SMAVDQTHMTTQVHGTFGYLDPEYFR----SSQFTDKSDVYSFGVVLTELLTGEKPIRFT 481 (608)
Q Consensus 426 ~~~~~~~~~~~~~~gt~~y~aPE~~~----~~~~t~ksDV~S~Gvvl~elltg~~p~~~~ 481 (608)
++..+- ..+...|-..|||||.+. ...|+.||||||||+.+.||.+++.||...
T Consensus 198 ~L~dSi--Akt~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~w 255 (282)
T KOG0984|consen 198 YLVDSI--AKTMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYESW 255 (282)
T ss_pred eehhhh--HHHHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhcccccccc
Confidence 765322 123235777899999875 347999999999999999999999998743
|
|
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.94 E-value=5.1e-27 Score=273.19 Aligned_cols=197 Identities=18% Similarity=0.229 Sum_probs=142.3
Q ss_pred hhcCC-CCccceeccc-------ccCccceEEEeecCCCccchhccccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCC
Q 044312 326 SQINH-RNVVKLLGCC-------LETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEIRLRIAIEVSGALSYLHSAASIP 397 (608)
Q Consensus 326 ~~l~H-~niv~l~~~~-------~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ 397 (608)
+.++| +||+++++.| .+.+..++++|++ +++|.++|..... ++++..++.++.||++||+|||+++
T Consensus 27 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~~~~--~~~~~~~~~i~~qi~~al~~lH~~g--- 100 (793)
T PLN00181 27 KSLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDNPDR--SVDAFECFHVFRQIVEIVNAAHSQG--- 100 (793)
T ss_pred chhhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhcccc--cccHHHHHHHHHHHHHHHHHHHhCC---
Confidence 34556 6888898887 3334678889988 6699999975432 5999999999999999999999999
Q ss_pred eeccCCCCCcEEEcC-------------------CCcEEEeeccCccccccCCc---------------ceeeeeeccCC
Q 044312 398 IYHRDIKSTNILLDD-------------------KYRAKVSDFGASRSMAVDQT---------------HMTTQVHGTFG 443 (608)
Q Consensus 398 iiHrDlk~~NILl~~-------------------~~~~kl~DFGls~~~~~~~~---------------~~~~~~~gt~~ 443 (608)
|+||||||+||||+. ++.+|++|||+++....... .......||+.
T Consensus 101 IvHrDlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~ 180 (793)
T PLN00181 101 IVVHNVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSW 180 (793)
T ss_pred eeeccCCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcc
Confidence 999999999999954 45567777777654211000 00112357889
Q ss_pred CCChhhhccCCCCCccchHhHHHHHHHHHhCCCCCCccchhhcccHHHHHHHHhhhhhhHHHhhhhhhccCChhHHHHHH
Q 044312 444 YLDPEYFRSSQFTDKSDVYSFGVVLTELLTGEKPIRFTILEEDKSLAAYFLCAMKEERLFEILDARVMKQGGKDEIITVA 523 (608)
Q Consensus 444 y~aPE~~~~~~~t~ksDV~S~Gvvl~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~ 523 (608)
|||||++.+..++.++|||||||+||||++|..|+.... .. + ..+.. ..+.+.. ........
T Consensus 181 Y~APE~~~~~~~~~~sDVwSlGviL~ELl~~~~~~~~~~-----~~---~-~~~~~----~~~~~~~-----~~~~~~~~ 242 (793)
T PLN00181 181 YTSPEEDNGSSSNCASDVYRLGVLLFELFCPVSSREEKS-----RT---M-SSLRH----RVLPPQI-----LLNWPKEA 242 (793)
T ss_pred eEChhhhccCCCCchhhhhhHHHHHHHHhhCCCchhhHH-----HH---H-HHHHH----hhcChhh-----hhcCHHHH
Confidence 999999999999999999999999999999888754110 00 0 00000 0111111 11223466
Q ss_pred HHHHHHhccCCCCCCCHHHHHHH
Q 044312 524 KLAKRCLNLNGKKRPTMREVASE 546 (608)
Q Consensus 524 ~Li~~cl~~dp~~RPs~~evl~~ 546 (608)
.++.+||+.+|.+||+|.||+++
T Consensus 243 ~~~~~~L~~~P~~Rps~~eil~h 265 (793)
T PLN00181 243 SFCLWLLHPEPSCRPSMSELLQS 265 (793)
T ss_pred HHHHHhCCCChhhCcChHHHhhc
Confidence 88999999999999999999864
|
|
| >KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription] | Back alignment and domain information |
|---|
Probab=99.93 E-value=6.2e-26 Score=212.21 Aligned_cols=244 Identities=20% Similarity=0.319 Sum_probs=180.5
Q ss_pred HhcCccccceeccCce---------------EEEEEeecChhhHHHHHHHHHHHhhcC-CCCccceecccccC--ccceE
Q 044312 287 ATDNFDLNRILGQGGQ---------------AVKKSKVIDESKVEEFINEVVILSQIN-HRNVVKLLGCCLET--EVPLL 348 (608)
Q Consensus 287 ~t~~f~~~~~lG~G~~---------------avk~~~~~~~~~~~~~~~Ei~il~~l~-H~niv~l~~~~~~~--~~~~l 348 (608)
.+++|++.+++|+|.+ .||.+ .+...+.+.+|+.||+.|. ||||++|++...+. ..+.|
T Consensus 36 ~~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiL---KPVkkkKIkREikIL~nL~gg~NIi~L~DiV~Dp~SktpaL 112 (338)
T KOG0668|consen 36 NQDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKIL---KPVKKKKIKREIKILQNLRGGPNIIKLLDIVKDPESKTPSL 112 (338)
T ss_pred ccchHHHHHHHcCccHhhHhcccccCCCceEEEeee---chHHHHHHHHHHHHHHhccCCCCeeehhhhhcCccccCchh
Confidence 3567889999999963 34444 4556778899999999996 99999999998765 46789
Q ss_pred EEeecCCCccchhccccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEEcC-CCcEEEeeccCcccc
Q 044312 349 VYEFIPNGTLFQYIHDQNEDFPITWEIRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDD-KYRAKVSDFGASRSM 427 (608)
Q Consensus 349 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~-~~~~kl~DFGls~~~ 427 (608)
|+||+.+.+...+.. .++...+..++.++++||.|+|+.| |+|||+||.|++||. ...++|+|+|||.++
T Consensus 113 iFE~v~n~Dfk~ly~------tl~d~dIryY~~elLkALdyCHS~G---ImHRDVKPhNvmIdh~~rkLrlIDWGLAEFY 183 (338)
T KOG0668|consen 113 IFEYVNNTDFKQLYP------TLTDYDIRYYIYELLKALDYCHSMG---IMHRDVKPHNVMIDHELRKLRLIDWGLAEFY 183 (338)
T ss_pred HhhhhccccHHHHhh------hhchhhHHHHHHHHHHHHhHHHhcC---cccccCCcceeeechhhceeeeeecchHhhc
Confidence 999998876655442 3778888999999999999999999 999999999999995 457999999999988
Q ss_pred ccCCcceeeeeeccCCCCChhhhcc-CCCCCccchHhHHHHHHHHHhCCCCCCccchhhcccHHHHHHHHhhhhhhHHHh
Q 044312 428 AVDQTHMTTQVHGTFGYLDPEYFRS-SQFTDKSDVYSFGVVLTELLTGEKPIRFTILEEDKSLAAYFLCAMKEERLFEIL 506 (608)
Q Consensus 428 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~t~ksDV~S~Gvvl~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 506 (608)
...... .....+..|--||.+.. ..|+-.-|+|||||+|..|+..+.||-...+.. ..++..+ ..+....+...+
T Consensus 184 Hp~~eY--nVRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~dN~-DQLVkIa-kVLGt~el~~Yl 259 (338)
T KOG0668|consen 184 HPGKEY--NVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNY-DQLVKIA-KVLGTDELYAYL 259 (338)
T ss_pred CCCcee--eeeeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCCCCH-HHHHHHH-HHhChHHHHHHH
Confidence 755433 22344667889999765 457888999999999999999999986443322 2222211 111112221111
Q ss_pred -------hhhhh----------------ccCChhHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 044312 507 -------DARVM----------------KQGGKDEIITVAKLAKRCLNLNGKKRPTMREVASE 546 (608)
Q Consensus 507 -------d~~~~----------------~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~evl~~ 546 (608)
|++.. .+...-...+..+|+.+.|..|-.+|||++|.+.+
T Consensus 260 ~KY~i~Ldp~~~~i~~~~~rk~w~~Fi~~~n~hl~~peaiDlldklLrYDHqeRlTakEam~H 322 (338)
T KOG0668|consen 260 NKYQIDLDPQFEDILGRHSRKPWSRFINSENQHLVSPEAIDLLDKLLRYDHQERLTAKEAMAH 322 (338)
T ss_pred HHHccCCChhHhhHhhccccccHHHhCCccccccCChHHHHHHHHHHhhccccccchHHHhcC
Confidence 11110 01111224678999999999999999999999865
|
|
| >KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=4.6e-27 Score=224.66 Aligned_cols=249 Identities=23% Similarity=0.302 Sum_probs=186.3
Q ss_pred cccceeccCceEEEEEeec-----------------ChhhHHHHHHHHHHHhhcCCCCccceecccccC-----ccceEE
Q 044312 292 DLNRILGQGGQAVKKSKVI-----------------DESKVEEFINEVVILSQINHRNVVKLLGCCLET-----EVPLLV 349 (608)
Q Consensus 292 ~~~~~lG~G~~avk~~~~~-----------------~~~~~~~~~~Ei~il~~l~H~niv~l~~~~~~~-----~~~~lV 349 (608)
+-.+-||-|+|.|.-.... .-...+.+.+|+++|..++|.||+..++...-. +++|.+
T Consensus 56 ~PDRPIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEiYV~ 135 (449)
T KOG0664|consen 56 QPDRPIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQELYVL 135 (449)
T ss_pred CCCCcccccceeEEEeccCCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHHHHH
Confidence 3467899999866542211 112346788999999999999999998876433 256889
Q ss_pred EeecCCCccchhccccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEEcCCCcEEEeeccCcccccc
Q 044312 350 YEFIPNGTLFQYIHDQNEDFPITWEIRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAV 429 (608)
Q Consensus 350 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGls~~~~~ 429 (608)
+|+|.. +|.+.|.... +++...+.-+..||++||.|||+.+ |.||||||.|.|++.|..+||+|||+++....
T Consensus 136 TELmQS-DLHKIIVSPQ---~Ls~DHvKVFlYQILRGLKYLHsA~---ILHRDIKPGNLLVNSNCvLKICDFGLARvee~ 208 (449)
T KOG0664|consen 136 TELMQS-DLHKIIVSPQ---ALTPDHVKVFVYQILRGLKYLHTAN---ILHRDIKPGNLLVNSNCILKICDFGLARTWDQ 208 (449)
T ss_pred HHHHHh-hhhheeccCC---CCCcchhhhhHHHHHhhhHHHhhcc---hhhccCCCccEEeccCceEEecccccccccch
Confidence 999954 8888887543 5888999999999999999999999 99999999999999999999999999998877
Q ss_pred CCcceeeeeeccCCCCChhhhccC-CCCCccchHhHHHHHHHHHhCCCCCCccchhhcccHHHHHHHHhh--------hh
Q 044312 430 DQTHMTTQVHGTFGYLDPEYFRSS-QFTDKSDVYSFGVVLTELLTGEKPIRFTILEEDKSLAAYFLCAMK--------EE 500 (608)
Q Consensus 430 ~~~~~~~~~~gt~~y~aPE~~~~~-~~t~ksDV~S~Gvvl~elltg~~p~~~~~~~~~~~l~~~~~~~~~--------~~ 500 (608)
++....+...-|..|.|||.+.+. .|+.+.||||.|||+.||+.++..|....+-+...+....+..-. ++
T Consensus 209 d~~~hMTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~PiqQL~lItdLLGTPs~EaMr~ACEG 288 (449)
T KOG0664|consen 209 RDRLNMTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAGPIEQLQMIIDLLGTPSQEAMKYACEG 288 (449)
T ss_pred hhhhhhHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccChHHHHHHHHHHhCCCcHHHHHHHhhh
Confidence 776666777789999999998875 689999999999999999999988876555444443333222111 11
Q ss_pred hhHHHhhhhhhcc---------CChhHHHHHHHHHHHHhccCCCCCCCHHHHHHHH
Q 044312 501 RLFEILDARVMKQ---------GGKDEIITVAKLAKRCLNLNGKKRPTMREVASEL 547 (608)
Q Consensus 501 ~~~~~~d~~~~~~---------~~~~~~~~l~~Li~~cl~~dp~~RPs~~evl~~L 547 (608)
....++....+.. .+.....+...+..+++..||++|.+..+.+..+
T Consensus 289 Ak~H~LR~~~k~Ps~~vLYtlsS~~~~~heav~~~~~~l~~d~dkris~~~A~~~~ 344 (449)
T KOG0664|consen 289 AKNHVLRAGLRAPDTQRLYKIASPDDKNHEAVDLLQKLLHFDPDKRISVEEALQHR 344 (449)
T ss_pred hHHHhhccCCCCCCccceeeecCCcccchHHHHHHHHHhCCCCcccccHhhhcccc
Confidence 2222232211111 1112234567788899999999999988887654
|
|
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=99.93 E-value=2.9e-25 Score=210.57 Aligned_cols=169 Identities=22% Similarity=0.252 Sum_probs=126.9
Q ss_pred CccchhccccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEEcCCCcEEEeeccCccccccCCccee
Q 044312 356 GTLFQYIHDQNEDFPITWEIRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMT 435 (608)
Q Consensus 356 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGls~~~~~~~~~~~ 435 (608)
|+|.++++.... ++++..++.|+.||++||+|||+.+ ||+|||++.++.+|+ ||+++......
T Consensus 1 GsL~~~l~~~~~--~l~~~~~~~i~~qi~~~L~~lH~~~---------kp~Nil~~~~~~~~~--fG~~~~~~~~~---- 63 (176)
T smart00750 1 VSLADILEVRGR--PLNEEEIWAVCLQCLRALRELHRQA---------KSGNILLTWDGLLKL--DGSVAFKTPEQ---- 63 (176)
T ss_pred CcHHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhcC---------CcccEeEcCccceee--ccceEeecccc----
Confidence 689999976433 5999999999999999999999876 999999999999999 99987654322
Q ss_pred eeeeccCCCCChhhhccCCCCCccchHhHHHHHHHHHhCCCCCCccchhhcccHHHHHHHHhhhhhhHHHhhhhhhccCC
Q 044312 436 TQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLTELLTGEKPIRFTILEEDKSLAAYFLCAMKEERLFEILDARVMKQGG 515 (608)
Q Consensus 436 ~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~ 515 (608)
..||+.|||||++.+..++.++||||||+++|||+||+.||...... ..........+.... +. .....
T Consensus 64 --~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~--~~~~~~~~~~~~~~~------~~-~~~~~ 132 (176)
T smart00750 64 --SRVDPYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEEREL--SAILEILLNGMPADD------PR-DRSNL 132 (176)
T ss_pred --CCCcccccChHHhcCCCCcchhhHHHHHHHHHHHHhCCCCccccchh--cHHHHHHHHHhccCC------cc-ccccH
Confidence 25889999999999999999999999999999999999998532110 011111111111000 00 00011
Q ss_pred hhHHH--HHHHHHHHHhccCCCCCCCHHHHHHHHHhhHH
Q 044312 516 KDEII--TVAKLAKRCLNLNGKKRPTMREVASELAGIKA 552 (608)
Q Consensus 516 ~~~~~--~l~~Li~~cl~~dp~~RPs~~evl~~L~~i~~ 552 (608)
..... ++.+++.+||+.+|++||++.|+++++..+..
T Consensus 133 ~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~ll~~~~~~~~ 171 (176)
T smart00750 133 ESVSAARSFADFMRVCASRLPQRREAANHYLAHCRALFA 171 (176)
T ss_pred HHHHhhhhHHHHHHHHHhcccccccCHHHHHHHHHHHHH
Confidence 12222 69999999999999999999999999877754
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=99.93 E-value=9.7e-25 Score=210.22 Aligned_cols=191 Identities=35% Similarity=0.579 Sum_probs=164.7
Q ss_pred eEEEEEeecChh-hHHHHHHHHHHHhhcCCCCccceecccccCccceEEEeecCCCccchhccccCCCCCCCHHHHHHHH
Q 044312 302 QAVKKSKVIDES-KVEEFINEVVILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEIRLRIA 380 (608)
Q Consensus 302 ~avk~~~~~~~~-~~~~~~~Ei~il~~l~H~niv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~ 380 (608)
+++|+....... ..+.+.+|++.++.++|++|+++++++......++++|++++++|.+++.... ..+++..+..++
T Consensus 21 ~~~K~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~~~~--~~~~~~~~~~~~ 98 (215)
T cd00180 21 VAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSLKDLLKENE--GKLSEDEILRIL 98 (215)
T ss_pred EEEEEeccccchhHHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecCCCCcHHHHHHhcc--CCCCHHHHHHHH
Confidence 566766653332 45789999999999999999999999999899999999999999999987643 258999999999
Q ss_pred HHHHHHHHHHhhcCCCCeeccCCCCCcEEEcC-CCcEEEeeccCccccccCCcceeeeeeccCCCCChhhhccC-CCCCc
Q 044312 381 IEVSGALSYLHSAASIPIYHRDIKSTNILLDD-KYRAKVSDFGASRSMAVDQTHMTTQVHGTFGYLDPEYFRSS-QFTDK 458 (608)
Q Consensus 381 ~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~-~~~~kl~DFGls~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~t~k 458 (608)
.+++++|.+||+.+ ++|+||+|.||+++. ++.++|+|||.+........ ......+...|++||.+... ..+.+
T Consensus 99 ~~l~~~l~~lh~~~---~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~-~~~~~~~~~~~~~pe~~~~~~~~~~~ 174 (215)
T cd00180 99 LQILEGLEYLHSNG---IIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKS-LLKTIVGTPAYMAPEVLLGKGYYSEK 174 (215)
T ss_pred HHHHHHHHHHHhCC---eeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcc-hhhcccCCCCccChhHhcccCCCCch
Confidence 99999999999998 999999999999999 89999999999986653321 12334578899999999887 88899
Q ss_pred cchHhHHHHHHHHHhCCCCCCccchhhcccHHHHHHHHhhhhhhHHHhhhhhhccCChhHHHHHHHHHHHHhccCCCCCC
Q 044312 459 SDVYSFGVVLTELLTGEKPIRFTILEEDKSLAAYFLCAMKEERLFEILDARVMKQGGKDEIITVAKLAKRCLNLNGKKRP 538 (608)
Q Consensus 459 sDV~S~Gvvl~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RP 538 (608)
+|+|++|+++++| ..+.+++.+|++.+|++||
T Consensus 175 ~D~~~lg~~~~~l------------------------------------------------~~~~~~l~~~l~~~p~~R~ 206 (215)
T cd00180 175 SDIWSLGVILYEL------------------------------------------------PELKDLIRKMLQKDPEKRP 206 (215)
T ss_pred hhhHHHHHHHHHH------------------------------------------------HHHHHHHHHHhhCCcccCc
Confidence 9999999999999 3578899999999999999
Q ss_pred CHHHHHHH
Q 044312 539 TMREVASE 546 (608)
Q Consensus 539 s~~evl~~ 546 (608)
++.++++.
T Consensus 207 ~~~~l~~~ 214 (215)
T cd00180 207 SAKEILEH 214 (215)
T ss_pred CHHHHhhC
Confidence 99999864
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.91 E-value=6.9e-24 Score=207.90 Aligned_cols=173 Identities=36% Similarity=0.537 Sum_probs=149.3
Q ss_pred eEEEEEeecChh-hHHHHHHHHHHHhhcCCCCccceecccccCccceEEEeecCCCccchhccccCCCCCCCHHHHHHHH
Q 044312 302 QAVKKSKVIDES-KVEEFINEVVILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEIRLRIA 380 (608)
Q Consensus 302 ~avk~~~~~~~~-~~~~~~~Ei~il~~l~H~niv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~ 380 (608)
+++|........ ..+.+.+|++.+++++|+|++++++++......++++|++++++|.+++..... .+++..+..++
T Consensus 27 ~~iK~~~~~~~~~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~--~~~~~~~~~~~ 104 (225)
T smart00221 27 VAVKVLKKEKTEKQREEFLREIRILKKLKHPNIVKLYGVFEDPEPLYLVMEYCEGGDLFDYLRKKGG--KLSEEEARFYL 104 (225)
T ss_pred EEEEeeccccchHHHHHHHHHHHHHHhCCCCChhhheeeeecCCceEEEEeccCCCCHHHHHHhccc--CCCHHHHHHHH
Confidence 466666554443 678899999999999999999999999998999999999999999999876542 27899999999
Q ss_pred HHHHHHHHHHhhcCCCCeeccCCCCCcEEEcCCCcEEEeeccCccccccCCcceeeeeeccCCCCChhhh-ccCCCCCcc
Q 044312 381 IEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHGTFGYLDPEYF-RSSQFTDKS 459 (608)
Q Consensus 381 ~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGls~~~~~~~~~~~~~~~gt~~y~aPE~~-~~~~~t~ks 459 (608)
.+++.+|.+||+.+ ++|+||+|+||+++.++.++|+|||++...............++..|++||.+ ....++.++
T Consensus 105 ~~l~~~l~~lh~~~---i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~ 181 (225)
T smart00221 105 RQILEALEYLHSLG---IVHRDLKPENILLGMDGLVKLADFGLARFIHRDLAALLKTVKGTPFYLAPEVLLGGKGYGEAV 181 (225)
T ss_pred HHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEeeCceeeEecCcccccccceeccCCcCCHhHhcCCCCCCchh
Confidence 99999999999998 99999999999999999999999999987754431122344578889999999 677788899
Q ss_pred chHhHHHHHHHHHhCCCCCC
Q 044312 460 DVYSFGVVLTELLTGEKPIR 479 (608)
Q Consensus 460 DV~S~Gvvl~elltg~~p~~ 479 (608)
|||+||++++||++|+.||.
T Consensus 182 Dv~~lG~~~~~l~~g~~pf~ 201 (225)
T smart00221 182 DIWSLGVILYELLWGPEPFS 201 (225)
T ss_pred hHHHHHHHHHHHHHCCCCcc
Confidence 99999999999999999986
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.91 E-value=4.3e-25 Score=227.33 Aligned_cols=254 Identities=20% Similarity=0.237 Sum_probs=190.9
Q ss_pred HHHhcCccccceeccCce---------------EEEEEeecChhhHHHHHHHHHHHhhcC------CCCccceecccccC
Q 044312 285 EKATDNFDLNRILGQGGQ---------------AVKKSKVIDESKVEEFINEVVILSQIN------HRNVVKLLGCCLET 343 (608)
Q Consensus 285 ~~~t~~f~~~~~lG~G~~---------------avk~~~~~~~~~~~~~~~Ei~il~~l~------H~niv~l~~~~~~~ 343 (608)
+..-.+|.+....|+|-| |||++.. ++...+.=+.|++||++|+ --|.++|+-.|...
T Consensus 428 E~LD~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRn-NE~M~KtGl~EleiLkKL~~AD~Edk~Hclrl~r~F~hk 506 (752)
T KOG0670|consen 428 ELLDSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRN-NEVMHKTGLKELEILKKLNDADPEDKFHCLRLFRHFKHK 506 (752)
T ss_pred hhhcceeEEEeccccceeeeeeeccccCCCCeeEEEEeec-chHHhhhhhHHHHHHHHhhccCchhhhHHHHHHHHhhhc
Confidence 344567777788888864 8888775 3444566678999999995 35899999999999
Q ss_pred ccceEEEeecCCCccchhccccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEEcCC-CcEEEeecc
Q 044312 344 EVPLLVYEFIPNGTLFQYIHDQNEDFPITWEIRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDK-YRAKVSDFG 422 (608)
Q Consensus 344 ~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~-~~~kl~DFG 422 (608)
++++||||-+ ..+|.+.|.+.+....|....+..++.|+.-||..|...+ |+|.||||.|||+++. ..+||+|||
T Consensus 507 nHLClVFE~L-slNLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK~c~---vlHaDIKPDNiLVNE~k~iLKLCDfG 582 (752)
T KOG0670|consen 507 NHLCLVFEPL-SLNLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLKKCG---VLHADIKPDNILVNESKNILKLCDFG 582 (752)
T ss_pred ceeEEEehhh-hchHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHHhcC---eeecccCccceEeccCcceeeeccCc
Confidence 9999999998 5699999999877777999999999999999999999999 9999999999999875 568999999
Q ss_pred CccccccCCcceeeeeeccCCCCChhhhccCCCCCccchHhHHHHHHHHHhCCCCCCccchhhcccHHHHHHHHh-----
Q 044312 423 ASRSMAVDQTHMTTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLTELLTGEKPIRFTILEEDKSLAAYFLCAM----- 497 (608)
Q Consensus 423 ls~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~elltg~~p~~~~~~~~~~~l~~~~~~~~----- 497 (608)
.|....... .+...-...|.|||++.+..|+...|+||.||.||||.||+..|..........+.......+
T Consensus 583 SA~~~~ene---itPYLVSRFYRaPEIiLG~~yd~~iD~WSvgctLYElYtGkIlFpG~TNN~MLrl~me~KGk~p~Kml 659 (752)
T KOG0670|consen 583 SASFASENE---ITPYLVSRFYRAPEIILGLPYDYPIDTWSVGCTLYELYTGKILFPGRTNNQMLRLFMELKGKFPNKML 659 (752)
T ss_pred ccccccccc---ccHHHHHHhccCcceeecCcccCCccceeeceeeEEeeccceecCCCCcHHHHHHHHHhcCCCcHHHh
Confidence 997765433 233334567999999999999999999999999999999999887433222111111110000
Q ss_pred hhhhh-HHHhh--------------------------h------hh-----hccCChhHHHHHHHHHHHHhccCCCCCCC
Q 044312 498 KEERL-FEILD--------------------------A------RV-----MKQGGKDEIITVAKLAKRCLNLNGKKRPT 539 (608)
Q Consensus 498 ~~~~~-~~~~d--------------------------~------~~-----~~~~~~~~~~~l~~Li~~cl~~dp~~RPs 539 (608)
+.+.+ .+.+| | .+ .........+.+.+|+..||.+||++|.|
T Consensus 660 RKgqF~dqHFD~d~nf~~~e~D~vT~r~~~~vm~~vkPtkdl~s~l~~~q~~~deq~~~~~~~rdLLdkml~LdP~KRit 739 (752)
T KOG0670|consen 660 RKGQFKDQHFDQDLNFLYIEVDKVTEREKRTVMVNVKPTKDLGSELIAVQRLPDEQPKIVQQLRDLLDKMLILDPEKRIT 739 (752)
T ss_pred hhcchhhhhcccccceEEEeccccccceeEEEecccCcchhHHHHHhccCCCCchhHHHHHHHHHHHHHHhccChhhcCC
Confidence 00000 00000 0 00 11112344667999999999999999999
Q ss_pred HHHHHHH
Q 044312 540 MREVASE 546 (608)
Q Consensus 540 ~~evl~~ 546 (608)
..+.+.+
T Consensus 740 ~nqAL~H 746 (752)
T KOG0670|consen 740 VNQALKH 746 (752)
T ss_pred HHHHhcC
Confidence 9998764
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.91 E-value=5.2e-25 Score=232.91 Aligned_cols=240 Identities=25% Similarity=0.350 Sum_probs=192.0
Q ss_pred HhcCccccceeccCce---------------EEEEEeecChhhHHHHHHHHHHHhhcCCCCccceecccccCccceEEEe
Q 044312 287 ATDNFDLNRILGQGGQ---------------AVKKSKVIDESKVEEFINEVVILSQINHRNVVKLLGCCLETEVPLLVYE 351 (608)
Q Consensus 287 ~t~~f~~~~~lG~G~~---------------avk~~~~~~~~~~~~~~~Ei~il~~l~H~niv~l~~~~~~~~~~~lV~E 351 (608)
..++|+....+|.|.+ |||.++........-..+|+-+++..+|+|||.++|.+...+..++.||
T Consensus 13 P~ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep~dd~~~iqqei~~~~dc~h~nivay~gsylr~dklwicME 92 (829)
T KOG0576|consen 13 PQDDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPGDDFSGIQQEIGMLRDCRHPNIVAYFGSYLRRDKLWICME 92 (829)
T ss_pred CccchhheeeecCCcccchhhhcccccCchhhheeeeccCCccccccccceeeeecCCCcChHHHHhhhhhhcCcEEEEE
Confidence 3467888888888864 8999999888888999999999999999999999999999999999999
Q ss_pred ecCCCccchhccccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEEcCCCcEEEeeccCccccccCC
Q 044312 352 FIPNGTLFQYIHDQNEDFPITWEIRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQ 431 (608)
Q Consensus 352 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGls~~~~~~~ 431 (608)
|+.+|+|.+.-+..+ ++++.++..+..+.++||+|||+.+ =+|||||-.|||+++.+.+|++|||.+..+...-
T Consensus 93 ycgggslQdiy~~Tg---plselqiayvcRetl~gl~ylhs~g---k~hRdiKGanilltd~gDvklaDfgvsaqitati 166 (829)
T KOG0576|consen 93 YCGGGSLQDIYHVTG---PLSELQIAYVCRETLQGLKYLHSQG---KIHRDIKGANILLTDEGDVKLADFGVSAQITATI 166 (829)
T ss_pred ecCCCcccceeeecc---cchhHHHHHHHhhhhccchhhhcCC---cccccccccceeecccCceeecccCchhhhhhhh
Confidence 999999999888654 6999999999999999999999999 7899999999999999999999999987665322
Q ss_pred cceeeeeeccCCCCChhhh---ccCCCCCccchHhHHHHHHHHHhCCCCCCccchhhcccHHHHHHHHhhhhhhHHHhhh
Q 044312 432 THMTTQVHGTFGYLDPEYF---RSSQFTDKSDVYSFGVVLTELLTGEKPIRFTILEEDKSLAAYFLCAMKEERLFEILDA 508 (608)
Q Consensus 432 ~~~~~~~~gt~~y~aPE~~---~~~~~t~ksDV~S~Gvvl~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 508 (608)
.......||+.|||||+. ..+.|..++|||+.|+...||---++|.....+ ...+..+.... .++
T Consensus 167 -~KrksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdlhp-------mr~l~LmTkS~----~qp 234 (829)
T KOG0576|consen 167 -AKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLHP-------MRALFLMTKSG----FQP 234 (829)
T ss_pred -hhhhcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcccccch-------HHHHHHhhccC----CCC
Confidence 233456799999999985 456799999999999999999888877431110 11111111110 011
Q ss_pred hhhccCChhHHHHHHHHHHHHhccCCCCCCCHHHHHH
Q 044312 509 RVMKQGGKDEIITVAKLAKRCLNLNGKKRPTMREVAS 545 (608)
Q Consensus 509 ~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~evl~ 545 (608)
... .....-.+.+-++++.++..+|++||+++.++.
T Consensus 235 p~l-kDk~kws~~fh~fvK~altknpKkRptaeklL~ 270 (829)
T KOG0576|consen 235 PTL-KDKTKWSEFFHNFVKGALTKNPKKRPTAEKLLQ 270 (829)
T ss_pred Ccc-cCCccchHHHHHHHHHHhcCCCccCCChhhhee
Confidence 111 111233557889999999999999999987765
|
|
| >KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.91 E-value=2.1e-23 Score=214.06 Aligned_cols=117 Identities=28% Similarity=0.425 Sum_probs=97.4
Q ss_pred cCccccceeccCce---------------EEEEEeecChhhHHHHHHHHHHHhhcC-----C---CCccceeccccc---
Q 044312 289 DNFDLNRILGQGGQ---------------AVKKSKVIDESKVEEFINEVVILSQIN-----H---RNVVKLLGCCLE--- 342 (608)
Q Consensus 289 ~~f~~~~~lG~G~~---------------avk~~~~~~~~~~~~~~~Ei~il~~l~-----H---~niv~l~~~~~~--- 342 (608)
.+|.+.++||-|-| |+|+.+- ...-.+..+.||++|++++ | .+||+|++.|..
T Consensus 78 gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKS-AqhYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~FkhsGp 156 (590)
T KOG1290|consen 78 GRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKS-AQHYTEAALDEIKLLQQVREGDPNDPGKKCVVQLLDHFKHSGP 156 (590)
T ss_pred ceEEEEEeccccccceeEEEeeccCCeEEEEEEEeh-hhHHHHHHHHHHHHHHHHHhcCCCCCCCceeeeeeccceecCC
Confidence 57889999999975 6666653 2334577889999999983 2 489999999964
Q ss_pred -CccceEEEeecCCCccchhccccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEE
Q 044312 343 -TEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEIRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILL 410 (608)
Q Consensus 343 -~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl 410 (608)
+.+.+||+|++ |-+|..+|....-+ .++...+.+|+.||+.||.|||.... |||-||||+|||+
T Consensus 157 NG~HVCMVfEvL-GdnLLklI~~s~Yr-Glpl~~VK~I~~qvL~GLdYLH~ecg--IIHTDlKPENvLl 221 (590)
T KOG1290|consen 157 NGQHVCMVFEVL-GDNLLKLIKYSNYR-GLPLSCVKEICRQVLTGLDYLHRECG--IIHTDLKPENVLL 221 (590)
T ss_pred CCcEEEEEehhh-hhHHHHHHHHhCCC-CCcHHHHHHHHHHHHHHHHHHHHhcC--ccccCCCcceeee
Confidence 45789999999 77899988875433 59999999999999999999998763 9999999999998
|
|
| >KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.90 E-value=4e-24 Score=204.77 Aligned_cols=238 Identities=22% Similarity=0.313 Sum_probs=170.8
Q ss_pred hcCccccceeccCceEEEE------------Ee--ecChhhHHHHHHHHHHHhhc-CCCCccceecc-cccCccceEEEe
Q 044312 288 TDNFDLNRILGQGGQAVKK------------SK--VIDESKVEEFINEVVILSQI-NHRNVVKLLGC-CLETEVPLLVYE 351 (608)
Q Consensus 288 t~~f~~~~~lG~G~~avk~------------~~--~~~~~~~~~~~~Ei~il~~l-~H~niv~l~~~-~~~~~~~~lV~E 351 (608)
.+.|++.+.||+|.|+--. ++ ........+|.+|..---.| .|.||+.-+++ |...+.+++++|
T Consensus 23 ~d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p~tt~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d~YvF~qE 102 (378)
T KOG1345|consen 23 EDVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRPQTTQADFVREFHYSFFLSPHQHIIDTYEVAFQTSDAYVFVQE 102 (378)
T ss_pred hhhhhHHHHhcccceeeEEeeeccCCceEEEeeccCcchhhHHHHHHHhccceeeccchhhhHHHHHHhhcCceEEEeec
Confidence 4678999999999873111 11 12345568899998765555 68999988876 455677889999
Q ss_pred ecCCCccchhccccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEEc--CCCcEEEeeccCcccccc
Q 044312 352 FIPNGTLFQYIHDQNEDFPITWEIRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLD--DKYRAKVSDFGASRSMAV 429 (608)
Q Consensus 352 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~--~~~~~kl~DFGls~~~~~ 429 (608)
|+|.|+|.+-+...+ +-+....+++.|++.||.|||+++ ++|||||.+||||- +...+||+|||+++....
T Consensus 103 ~aP~gdL~snv~~~G----igE~~~K~v~~ql~SAi~fMHskn---lVHRdlK~eNiLif~~df~rvKlcDFG~t~k~g~ 175 (378)
T KOG1345|consen 103 FAPRGDLRSNVEAAG----IGEANTKKVFAQLLSAIEFMHSKN---LVHRDLKAENILIFDADFYRVKLCDFGLTRKVGT 175 (378)
T ss_pred cCccchhhhhcCccc----ccHHHHHHHHHHHHHHHHHhhccc---hhhcccccceEEEecCCccEEEeeecccccccCc
Confidence 999999998887643 778888999999999999999999 99999999999994 344799999999876542
Q ss_pred CCcceeeeeeccCCCCChhhhccC-----CCCCccchHhHHHHHHHHHhCCCCCCccchhhcccHHHHHHHHhhhh-hhH
Q 044312 430 DQTHMTTQVHGTFGYLDPEYFRSS-----QFTDKSDVYSFGVVLTELLTGEKPIRFTILEEDKSLAAYFLCAMKEE-RLF 503 (608)
Q Consensus 430 ~~~~~~~~~~gt~~y~aPE~~~~~-----~~t~ksDV~S~Gvvl~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~-~~~ 503 (608)
. .....-+..|.+||..... ...+.+|||.||++++.++||..||+ .....+.....|....-+.. ++.
T Consensus 176 t----V~~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQ-ka~~~d~~Y~~~~~w~~rk~~~~P 250 (378)
T KOG1345|consen 176 T----VKYLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQ-KASIMDKPYWEWEQWLKRKNPALP 250 (378)
T ss_pred e----ehhhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcch-hhhccCchHHHHHHHhcccCccCc
Confidence 1 1222335668999986533 34678999999999999999999998 33333444444432221111 111
Q ss_pred HHhhhhhhccCChhHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 044312 504 EILDARVMKQGGKDEIITVAKLAKRCLNLNGKKRPTMREVASE 546 (608)
Q Consensus 504 ~~~d~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~evl~~ 546 (608)
.. -...++.+..+.++-|..+|++|=-..++.++
T Consensus 251 ~~---------F~~fs~~a~r~Fkk~lt~~~~drcki~~~kk~ 284 (378)
T KOG1345|consen 251 KK---------FNPFSEKALRLFKKSLTPRFKDRCKIWTAKKM 284 (378)
T ss_pred hh---------hcccCHHHHHHHHHhcCCcccccchhHHHHHH
Confidence 11 11234567788899999999999555555443
|
|
| >KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.89 E-value=4.2e-24 Score=222.68 Aligned_cols=153 Identities=26% Similarity=0.393 Sum_probs=136.7
Q ss_pred HHHHHHHHhhcC---CCCccceecccccCccceEEEeecC-CCccchhccccCCCCCCCHHHHHHHHHHHHHHHHHHhhc
Q 044312 318 FINEVVILSQIN---HRNVVKLLGCCLETEVPLLVYEFIP-NGTLFQYIHDQNEDFPITWEIRLRIAIEVSGALSYLHSA 393 (608)
Q Consensus 318 ~~~Ei~il~~l~---H~niv~l~~~~~~~~~~~lV~E~~~-~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~ 393 (608)
.-.||+||+.|+ |+||+|++++|++++.+||+||-.. +-+|.++|..+. .+++.....|+.||+.|+++||+.
T Consensus 613 Vp~EIqIla~l~~~sH~NIlKlLdfFEddd~yyl~te~hg~gIDLFd~IE~kp---~m~E~eAk~IFkQV~agi~hlh~~ 689 (772)
T KOG1152|consen 613 VPSEIQILATLNKHSHENILKLLDFFEDDDYYYLETEVHGEGIDLFDFIEFKP---RMDEPEAKLIFKQVVAGIKHLHDQ 689 (772)
T ss_pred cchhHHHHHHhhhcCccchhhhhheeecCCeeEEEecCCCCCcchhhhhhccC---ccchHHHHHHHHHHHhcccccccc
Confidence 456999999997 9999999999999999999999863 568999998655 489999999999999999999999
Q ss_pred CCCCeeccCCCCCcEEEcCCCcEEEeeccCccccccCCcceeeeeeccCCCCChhhhccCCCC-CccchHhHHHHHHHHH
Q 044312 394 ASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHGTFGYLDPEYFRSSQFT-DKSDVYSFGVVLTELL 472 (608)
Q Consensus 394 ~~~~iiHrDlk~~NILl~~~~~~kl~DFGls~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t-~ksDV~S~Gvvl~ell 472 (608)
+ |+|||||-+||.++.+|-+||+|||.+.+... ......+||..|.|||++.+..|- ..-|||++|++||.++
T Consensus 690 ~---ivhrdikdenvivd~~g~~klidfgsaa~~ks---gpfd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytiv 763 (772)
T KOG1152|consen 690 G---IVHRDIKDENVIVDSNGFVKLIDFGSAAYTKS---GPFDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIV 763 (772)
T ss_pred C---ceecccccccEEEecCCeEEEeeccchhhhcC---CCcceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEE
Confidence 9 99999999999999999999999999876543 334567899999999999998874 5679999999999999
Q ss_pred hCCCCCC
Q 044312 473 TGEKPIR 479 (608)
Q Consensus 473 tg~~p~~ 479 (608)
....||.
T Consensus 764 ykenpyy 770 (772)
T KOG1152|consen 764 YKENPYY 770 (772)
T ss_pred eccCCCc
Confidence 9988875
|
|
| >KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=99.89 E-value=5.4e-23 Score=208.68 Aligned_cols=249 Identities=24% Similarity=0.340 Sum_probs=179.6
Q ss_pred HHhcCccccceeccCce------------------EEEEEeecChhhHHHHHHHHHHHhhc-CCCCccceecccccCccc
Q 044312 286 KATDNFDLNRILGQGGQ------------------AVKKSKVIDESKVEEFINEVVILSQI-NHRNVVKLLGCCLETEVP 346 (608)
Q Consensus 286 ~~t~~f~~~~~lG~G~~------------------avk~~~~~~~~~~~~~~~Ei~il~~l-~H~niv~l~~~~~~~~~~ 346 (608)
...+.|...++||.|.| |+|.+... .......+|+++|..+ -+.||+++.+++...+..
T Consensus 33 ~~~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~t--s~p~ri~~El~~L~~~gG~~ni~~~~~~~rnnd~v 110 (418)
T KOG1167|consen 33 FISNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRT--SSPSRILNELEMLYRLGGSDNIIKLNGCFRNNDQV 110 (418)
T ss_pred hhhhhhhhhccccccchhhhhhhhHhhhccccceEeeeecccc--cCchHHHHHHHHHHHhccchhhhcchhhhccCCee
Confidence 34556788889999975 44444432 3346689999999999 689999999999999999
Q ss_pred eEEEeecCCCccchhccccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEEcC-CCcEEEeeccCcc
Q 044312 347 LLVYEFIPNGTLFQYIHDQNEDFPITWEIRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDD-KYRAKVSDFGASR 425 (608)
Q Consensus 347 ~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~-~~~~kl~DFGls~ 425 (608)
.+|+||+++..-.+++.. ++...+..++..+..||+++|..+ |+||||||+|+|.+. .+.-.|.||||+.
T Consensus 111 ~ivlp~~~H~~f~~l~~~------l~~~~i~~Yl~~ll~Al~~~h~~G---IvHRDiKpsNFL~n~~t~rg~LvDFgLA~ 181 (418)
T KOG1167|consen 111 AIVLPYFEHDRFRDLYRS------LSLAEIRWYLRNLLKALAHLHKNG---IVHRDIKPSNFLYNRRTQRGVLVDFGLAQ 181 (418)
T ss_pred EEEecccCccCHHHHHhc------CCHHHHHHHHHHHHHHhhhhhccC---ccccCCCccccccccccCCceEEechhHH
Confidence 999999999887777653 678889999999999999999999 999999999999984 4678899999997
Q ss_pred ccccCC-------------c------------------------------ceeeeeeccCCCCChhhhcc-CCCCCccch
Q 044312 426 SMAVDQ-------------T------------------------------HMTTQVHGTFGYLDPEYFRS-SQFTDKSDV 461 (608)
Q Consensus 426 ~~~~~~-------------~------------------------------~~~~~~~gt~~y~aPE~~~~-~~~t~ksDV 461 (608)
...... . .......||++|.|||++.. ..-++++||
T Consensus 182 ~~d~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~QttaiDi 261 (418)
T KOG1167|consen 182 RYDGYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQTTAIDI 261 (418)
T ss_pred HHHhhhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcCCccce
Confidence 211000 0 01123569999999999764 567899999
Q ss_pred HhHHHHHHHHHhCCCCCCccchhhcccHHHHH---HH-Hhh-----hhh-----------hHHH------hh-hh-----
Q 044312 462 YSFGVVLTELLTGEKPIRFTILEEDKSLAAYF---LC-AMK-----EER-----------LFEI------LD-AR----- 509 (608)
Q Consensus 462 ~S~Gvvl~elltg~~p~~~~~~~~~~~l~~~~---~~-~~~-----~~~-----------~~~~------~d-~~----- 509 (608)
||.|||++-+++++.||-....+- ..+...+ -. .++ .++ +.+. ++ ..
T Consensus 262 ws~GVI~Lslls~~~PFf~a~dd~-~al~ei~tifG~~~mrk~A~l~g~~~l~~ksn~~~~~e~~~~f~s~~~~~~~~~~ 340 (418)
T KOG1167|consen 262 WSAGVILLSLLSRRYPFFKAKDDA-DALAEIATIFGSAEMRKCAALPGRILLWQKSNIPTIPELRVNFETLHIESIYKSR 340 (418)
T ss_pred eeccceeehhhccccccccCcccc-chHHHHHHHhChHHHHHHhhcCCceeeeccccccccHHHHhchhccChhhccccc
Confidence 999999999999999986432221 1111111 00 000 011 0000 00 00
Q ss_pred ---hh-ccCChhHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 044312 510 ---VM-KQGGKDEIITVAKLAKRCLNLNGKKRPTMREVASE 546 (608)
Q Consensus 510 ---~~-~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~evl~~ 546 (608)
.. .......+..+.+|+.+|+..||.+|.|++|.+++
T Consensus 341 q~n~~~~~~~d~~~~~~~dlLdk~le~np~kRitAEeALkH 381 (418)
T KOG1167|consen 341 QPNTEREIGSDVFPALLLDLLDKCLELNPQKRITAEDALKH 381 (418)
T ss_pred ccceeeccccccccHHHHHHHHHHccCChhhcccHHHHhcC
Confidence 00 01111223478999999999999999999999865
|
|
| >KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.86 E-value=6.7e-21 Score=198.80 Aligned_cols=249 Identities=22% Similarity=0.259 Sum_probs=186.2
Q ss_pred CccccceeccCce----------------EEEEEeecChhhHHHHHHHHHHHhhcCC----CCccceeccc-ccCccceE
Q 044312 290 NFDLNRILGQGGQ----------------AVKKSKVIDESKVEEFINEVVILSQINH----RNVVKLLGCC-LETEVPLL 348 (608)
Q Consensus 290 ~f~~~~~lG~G~~----------------avk~~~~~~~~~~~~~~~Ei~il~~l~H----~niv~l~~~~-~~~~~~~l 348 (608)
+|.+.++||+|+| |+|............+..|..++..+.+ +++.++++.. ......++
T Consensus 19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~~~i 98 (322)
T KOG1164|consen 19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKPSVLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDFNFI 98 (322)
T ss_pred ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCCccchhHHHHHHHHhhhcCCCCCCEEEEeccCCCceeEE
Confidence 7999999999985 2333332222222368889999998863 6899999998 47778899
Q ss_pred EEeecCCCccchhccccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEEcCC-----CcEEEeeccC
Q 044312 349 VYEFIPNGTLFQYIHDQNEDFPITWEIRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDK-----YRAKVSDFGA 423 (608)
Q Consensus 349 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~-----~~~kl~DFGl 423 (608)
||+.+ |.+|.++..... ...++..+.++|+.|++.+|++||+.+ ++||||||.|+++... ..+.|.|||+
T Consensus 99 VM~l~-G~sL~dl~~~~~-~~~fs~~T~l~ia~q~l~~l~~lH~~G---~iHRDiKp~N~~~g~~~~~~~~~~~llDfGl 173 (322)
T KOG1164|consen 99 VMSLL-GPSLEDLRKRNP-PGRFSRKTVLRIAIQNLNALEDLHSKG---FIHRDIKPENFVVGQSSRSEVRTLYLLDFGL 173 (322)
T ss_pred EEecc-CccHHHHHHhCC-CCCcCHhHHHHHHHHHHHHHHHHHhcC---cccCCcCHHHeeecCCCCcccceEEEEecCC
Confidence 99998 889999886654 336999999999999999999999999 9999999999999854 4699999999
Q ss_pred cc--ccccCCcc----e---eeeeeccCCCCChhhhccCCCCCccchHhHHHHHHHHHhCCCCCCccchhhcccHHHHHH
Q 044312 424 SR--SMAVDQTH----M---TTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLTELLTGEKPIRFTILEEDKSLAAYFL 494 (608)
Q Consensus 424 s~--~~~~~~~~----~---~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~elltg~~p~~~~~~~~~~~l~~~~~ 494 (608)
++ .+...... . ....+||..|.++..+.+...+++.|+||++.++.|++.|..||........ ..
T Consensus 174 ar~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDles~~Y~l~el~~g~LPW~~~~~~~~---~~--- 247 (322)
T KOG1164|consen 174 ARRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGRRDDLESLFYMLLELLKGSLPWEALEMTDL---KS--- 247 (322)
T ss_pred CccccccCCCCcccccCCCCccCCCCccccccHHHhCCCccCCchhhhhHHHHHHHHhcCCCCCccccccch---HH---
Confidence 98 43222211 1 1235699999999999999999999999999999999999999964322111 00
Q ss_pred HHhhhhhhHHHhhhhhhccCChhHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhhHHhcC
Q 044312 495 CAMKEERLFEILDARVMKQGGKDEIITVAKLAKRCLNLNGKKRPTMREVASELAGIKAWNG 555 (608)
Q Consensus 495 ~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~evl~~L~~i~~~~~ 555 (608)
.+....... .........+.++.++...+-..+..++|....+...|+......+
T Consensus 248 -~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pdy~~~~~~l~~~~~~~~ 302 (322)
T KOG1164|consen 248 -KFEKDPRKL-----LTDRFGDLKPEEFAKILEYIDSLDYEDKPDYEKLAELLKDVFDSEG 302 (322)
T ss_pred -HHHHHhhhh-----ccccccCCChHHHHHHHHHhhccCCcCCCCHHHHHHHHHHHHHhcC
Confidence 111111000 1000223345567778888888999999999999999887766553
|
|
| >KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.83 E-value=5.3e-21 Score=183.27 Aligned_cols=215 Identities=20% Similarity=0.345 Sum_probs=167.6
Q ss_pred hHHHHHHHHHHHhhcCCCCccceecccccCccceEEEeecCCCccchhccccCCCCCCCHHHHHHHHHHHHHHHHHHhhc
Q 044312 314 KVEEFINEVVILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEIRLRIAIEVSGALSYLHSA 393 (608)
Q Consensus 314 ~~~~~~~Ei~il~~l~H~niv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~ 393 (608)
...+|..|.-.|+-+.||||+.++|.|.....+.++..||+.|+|+..++.... ..++..+..+++.++|+|++|||+.
T Consensus 230 isrdfneefp~lrifshpnilpvlgacnsppnlv~isq~mp~gslynvlhe~t~-vvvd~sqav~faldiargmaflhsl 308 (448)
T KOG0195|consen 230 ISRDFNEEFPALRIFSHPNILPVLGACNSPPNLVIISQYMPFGSLYNVLHEQTS-VVVDHSQAVRFALDIARGMAFLHSL 308 (448)
T ss_pred hcchhhhhCcceeeecCCchhhhhhhccCCCCceEeeeeccchHHHHHHhcCcc-EEEecchHHHHHHHHHhhHHHHhhc
Confidence 346799999999999999999999999999999999999999999999998653 3577889999999999999999998
Q ss_pred CCCCeeccCCCCCcEEEcCCCcEEEeeccCccccccCCcceeeeeeccCCCCChhhhccCCCC---CccchHhHHHHHHH
Q 044312 394 ASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHGTFGYLDPEYFRSSQFT---DKSDVYSFGVVLTE 470 (608)
Q Consensus 394 ~~~~iiHrDlk~~NILl~~~~~~kl~DFGls~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t---~ksDV~S~Gvvl~e 470 (608)
.++ |.---|.+..+++|++.+++|+= +-+++ +.......-.+.||+||.++....+ .++|+|||.++|||
T Consensus 309 ep~-ipr~~lns~hvmidedltarism-ad~kf-----sfqe~gr~y~pawmspealqrkped~n~raadmwsfaillwe 381 (448)
T KOG0195|consen 309 EPM-IPRFYLNSKHVMIDEDLTARISM-ADTKF-----SFQEVGRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWE 381 (448)
T ss_pred chh-hhhhhcccceEEecchhhhheec-cccee-----eeeccccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHH
Confidence 743 44446899999999999988751 11111 1111222336789999999876543 47899999999999
Q ss_pred HHhCCCCCCccchhhcccHHHHHHHHhhhhhhHHHhhhhhhccCChhHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhh
Q 044312 471 LLTGEKPIRFTILEEDKSLAAYFLCAMKEERLFEILDARVMKQGGKDEIITVAKLAKRCLNLNGKKRPTMREVASELAGI 550 (608)
Q Consensus 471 lltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~evl~~L~~i 550 (608)
|.|...||....+-+-. ..+.-..++...++..+..+.+|+.-|++.||.+||.+..|+-.|+.+
T Consensus 382 l~trevpfadlspmecg---------------mkialeglrv~ippgis~hm~klm~icmnedpgkrpkfdmivpilekm 446 (448)
T KOG0195|consen 382 LNTREVPFADLSPMECG---------------MKIALEGLRVHIPPGISRHMNKLMNICMNEDPGKRPKFDMIVPILEKM 446 (448)
T ss_pred hhccccccccCCchhhh---------------hhhhhccccccCCCCccHHHHHHHHHHhcCCCCcCCCcceehhhHHHh
Confidence 99999999733221111 112223344456667778899999999999999999999999888765
Q ss_pred H
Q 044312 551 K 551 (608)
Q Consensus 551 ~ 551 (608)
+
T Consensus 447 ~ 447 (448)
T KOG0195|consen 447 I 447 (448)
T ss_pred c
Confidence 3
|
|
| >KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.83 E-value=1.1e-19 Score=179.11 Aligned_cols=248 Identities=16% Similarity=0.205 Sum_probs=193.7
Q ss_pred hcCccccceeccCce---------------EEEEEeecChhhHHHHHHHHHHHhhcC-CCCccceecccccCccceEEEe
Q 044312 288 TDNFDLNRILGQGGQ---------------AVKKSKVIDESKVEEFINEVVILSQIN-HRNVVKLLGCCLETEVPLLVYE 351 (608)
Q Consensus 288 t~~f~~~~~lG~G~~---------------avk~~~~~~~~~~~~~~~Ei~il~~l~-H~niv~l~~~~~~~~~~~lV~E 351 (608)
.-+|.+.++||+|.| |||... ......++..|.+..+.|. .++|.+.+.+..++..-.||+|
T Consensus 27 G~hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEP--rkS~APQLrdEYr~YKlL~g~~GIP~vYYFGqeG~~NiLVid 104 (449)
T KOG1165|consen 27 GPHYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEP--RKSEAPQLRDEYRTYKLLGGTEGIPQVYYFGQEGKYNILVID 104 (449)
T ss_pred cccceeccccccCcceeeecccccccCceEEEEecc--ccCCcchHHHHHHHHHHHcCCCCCCceeeeccccchhhhhhh
Confidence 347999999999986 444433 2445678888999988884 6999999999999999999999
Q ss_pred ecCCCccchhccccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEEcC-----CCcEEEeeccCccc
Q 044312 352 FIPNGTLFQYIHDQNEDFPITWEIRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDD-----KYRAKVSDFGASRS 426 (608)
Q Consensus 352 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~-----~~~~kl~DFGls~~ 426 (608)
++ |.||.|++.-.++ .++.+++..||.|++.-++|+|++. .|.|||||+|+||.. ...+.|.|||+|+.
T Consensus 105 LL-GPSLEDLFD~CgR--~FSvKTV~miA~Qmi~rie~vH~k~---LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK~ 178 (449)
T KOG1165|consen 105 LL-GPSLEDLFDLCGR--RFSVKTVAMIAKQMITRIEYVHEKD---LIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAKE 178 (449)
T ss_pred hh-CcCHHHHHHHhcC--cccHHhHHHHHHHHHHHHHHHHhcc---eeecccCccceeecCCCCCCCceEEEEeccchhh
Confidence 99 8899998876665 4899999999999999999999999 999999999999964 34689999999998
Q ss_pred cccCCcce------eeeeeccCCCCChhhhccCCCCCccchHhHHHHHHHHHhCCCCCCccchhhcccHHHHHHHHhhhh
Q 044312 427 MAVDQTHM------TTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLTELLTGEKPIRFTILEEDKSLAAYFLCAMKEE 500 (608)
Q Consensus 427 ~~~~~~~~------~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~ 500 (608)
+....+.. .....||.+||+-..+.+.+-+.+.|+-|||-|+++.|-|..||........+.-
T Consensus 179 YrDp~TkqHIPYrE~KSLsGTARYMSINTHlGrEQSRRDDLEaLGHvFmYFLRGsLPWQGLKA~tnK~k----------- 247 (449)
T KOG1165|consen 179 YRDPKTKQHIPYREHKSLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKADTNKEK----------- 247 (449)
T ss_pred hcCccccccCccccccccccceeeeEeeccccchhhhhhhHHHhhhhhhhhccCCCccccccCcchHHH-----------
Confidence 86544332 2456799999999999999999999999999999999999999985544332211
Q ss_pred hhHHHhhhhh---hccCChhHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhhHHhcC
Q 044312 501 RLFEILDARV---MKQGGKDEIITVAKLAKRCLNLNGKKRPTMREVASELAGIKAWNG 555 (608)
Q Consensus 501 ~~~~~~d~~~---~~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~evl~~L~~i~~~~~ 555 (608)
...|-+.+- ..+.-...+.+++.-+...-+++-++-|..+-+...+..+....+
T Consensus 248 -YeKIGe~Kr~T~i~~Lc~g~P~efa~Yl~yvR~L~F~E~PDYdylr~Lf~dvldr~g 304 (449)
T KOG1165|consen 248 -YEKIGETKRSTPIEVLCEGFPEEFATYLRYVRRLDFFETPDYDYLRKLFDDVLDRLG 304 (449)
T ss_pred -HHHhccccccCCHHHHHhcCHHHHHHHHHHHHhcCcccCCCHHHHHHHHHHHHHhcC
Confidence 111111110 011112356788888888889999999998887777766654433
|
|
| >KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.82 E-value=3.1e-20 Score=197.78 Aligned_cols=219 Identities=25% Similarity=0.459 Sum_probs=164.4
Q ss_pred HhhcCCCCccceecccccCccceEEEeecCCCccchhccccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeccCCC
Q 044312 325 LSQINHRNVVKLLGCCLETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEIRLRIAIEVSGALSYLHSAASIPIYHRDIK 404 (608)
Q Consensus 325 l~~l~H~niv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk 404 (608)
|+++.|.|+.+++|.+.+....+.|.+|++.|+|.+.+..... .++|.-...++.+|++||+|||+.. + ..|+.|+
T Consensus 1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~~~~--~~d~~F~~s~~rdi~~Gl~ylh~s~-i-~~hg~l~ 76 (484)
T KOG1023|consen 1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSNEDI--KLDYFFILSFIRDISKGLAYLHNSP-I-GYHGALK 76 (484)
T ss_pred CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhcccc--CccHHHHHHHHHHHHHHHHHHhcCc-c-eeeeeec
Confidence 4678999999999999999999999999999999999987433 5899999999999999999999865 1 2999999
Q ss_pred CCcEEEcCCCcEEEeeccCccccccC-CcceeeeeeccCCCCChhhhccC-------CCCCccchHhHHHHHHHHHhCCC
Q 044312 405 STNILLDDKYRAKVSDFGASRSMAVD-QTHMTTQVHGTFGYLDPEYFRSS-------QFTDKSDVYSFGVVLTELLTGEK 476 (608)
Q Consensus 405 ~~NILl~~~~~~kl~DFGls~~~~~~-~~~~~~~~~gt~~y~aPE~~~~~-------~~t~ksDV~S~Gvvl~elltg~~ 476 (608)
++|.++|..+.+||+|||+....... .........-..-|.|||.+... ..+.+.||||||++++|+++.+.
T Consensus 77 s~nClvd~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r~~ 156 (484)
T KOG1023|consen 77 SSNCLVDSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFRSG 156 (484)
T ss_pred cccceeeeeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhccC
Confidence 99999999999999999998776420 11111122235579999998764 15778999999999999999999
Q ss_pred CCCccchhhcccHHHHHHHHhhhhhhHHHhhhhhhccCChhHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhhHHh
Q 044312 477 PIRFTILEEDKSLAAYFLCAMKEERLFEILDARVMKQGGKDEIITVAKLAKRCLNLNGKKRPTMREVASELAGIKAW 553 (608)
Q Consensus 477 p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~evl~~L~~i~~~ 553 (608)
||......... ...+.. ++.. ....+.|.+.... +...++..++.+||..+|++||++++|-..++.+...
T Consensus 157 ~~~~~~~~~~~--~eii~~-~~~~-~~~~~rP~i~~~~--e~~~~l~~l~~~cw~e~P~~rPs~~~i~~~~~~~~~~ 227 (484)
T KOG1023|consen 157 PFDLRNLVEDP--DEIILR-VKKG-GSNPFRPSIELLN--ELPPELLLLVARCWEEIPEKRPSIEQIRSKLLTINKG 227 (484)
T ss_pred ccccccccCCh--HHHHHH-HHhc-CCCCcCcchhhhh--hcchHHHHHHHHhcccChhhCccHHHHHhhhhhhccc
Confidence 99854433322 111111 1110 0011111111111 3344789999999999999999999999988877664
|
|
| >KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.81 E-value=2.3e-19 Score=169.64 Aligned_cols=249 Identities=18% Similarity=0.215 Sum_probs=194.2
Q ss_pred hcCccccceeccCce---------------EEEEEeecChhhHHHHHHHHHHHhhcCC-CCccceecccccCccceEEEe
Q 044312 288 TDNFDLNRILGQGGQ---------------AVKKSKVIDESKVEEFINEVVILSQINH-RNVVKLLGCCLETEVPLLVYE 351 (608)
Q Consensus 288 t~~f~~~~~lG~G~~---------------avk~~~~~~~~~~~~~~~Ei~il~~l~H-~niv~l~~~~~~~~~~~lV~E 351 (608)
.++|.+.++||+|.| |||... ......++..|.++...|+| ..|..+..+..+...-.||||
T Consensus 14 ~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es--~~a~hpqL~yEskvY~iL~~g~GiP~i~~y~~e~~ynvlVMd 91 (341)
T KOG1163|consen 14 GGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLES--SKAKHPQLLYESKVYRILQGGVGIPHIRHYGTEKDYNVLVMD 91 (341)
T ss_pred ccceEEEEeecCCchhheeeeeeccCCceEEEEeec--ccCCCcchhHHHHHHHHhccCCCCchhhhhccccccceeeee
Confidence 457999999999985 555543 23445678889999999975 788888889999999999999
Q ss_pred ecCCCccchhccccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEEcCC---CcEEEeeccCccccc
Q 044312 352 FIPNGTLFQYIHDQNEDFPITWEIRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDK---YRAKVSDFGASRSMA 428 (608)
Q Consensus 352 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~---~~~kl~DFGls~~~~ 428 (608)
++ |.+|.+++.-..+ .++.++++-.|-|++.-++|+|.++ ++||||||+|+|..-+ ..+.++|||||+.+.
T Consensus 92 LL-GPsLEdLfnfC~R--~ftmkTvLMLaDQml~RiEyvH~r~---fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaKky~ 165 (341)
T KOG1163|consen 92 LL-GPSLEDLFNFCSR--RFTMKTVLMLADQMLSRIEYVHLRN---FIHRDIKPDNFLMGLGRHCNKLYLIDFGLAKKYR 165 (341)
T ss_pred cc-CccHHHHHHHHhh--hhhHHhHHHHHHHHHHHHHHHHhhc---cccccCCccceeeccccccceEEEEeccchhhhc
Confidence 99 8899998876554 4899999999999999999999999 9999999999999643 468999999998775
Q ss_pred cCCcce------eeeeeccCCCCChhhhccCCCCCccchHhHHHHHHHHHhCCCCCCccchhhcccHHHHHHHHhhhhhh
Q 044312 429 VDQTHM------TTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLTELLTGEKPIRFTILEEDKSLAAYFLCAMKEERL 502 (608)
Q Consensus 429 ~~~~~~------~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~ 502 (608)
...+.. .....||.+|.+-..+.+...+.+.|+-|+|.+|.++.-|..||+........ ...
T Consensus 166 d~~t~~HIpyre~r~ltGTaRYASinAh~g~eqSRRDDmeSvgYvLmYfnrG~LPWQglka~tk~------------QKy 233 (341)
T KOG1163|consen 166 DIRTRQHIPYREDRNLTGTARYASINAHLGIEQSRRDDMESVGYVLMYFNRGSLPWQGLKAATKK------------QKY 233 (341)
T ss_pred cccccccCccccCCccceeeeehhhhhhhhhhhhhhhhhhhhcceeeeeecCCCcccccchhhHH------------HHH
Confidence 432221 23467999999988888888899999999999999999999999854433221 122
Q ss_pred HHHhhhhh---hccCChhHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhhHHhcCC
Q 044312 503 FEILDARV---MKQGGKDEIITVAKLAKRCLNLNGKKRPTMREVASELAGIKAWNGA 556 (608)
Q Consensus 503 ~~~~d~~~---~~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~evl~~L~~i~~~~~~ 556 (608)
..|.+.+. ....-...+.++.-.+..|-.+--++-|...-+.+.+..+.....+
T Consensus 234 EkI~EkK~s~~ie~LC~G~P~EF~myl~Y~R~L~F~E~Pdy~ylrqlFriLfr~ln~ 290 (341)
T KOG1163|consen 234 EKISEKKMSTPIEVLCKGFPAEFAMYLNYCRGLGFEEKPDYMYLRQLFRILFRTLNH 290 (341)
T ss_pred HHHHHhhcCCCHHHHhCCCcHHHHHHHHHHhhcCCCCCCcHHHHHHHHHHHHhhccc
Confidence 22222221 1112234567889999999999999999998888777776655444
|
|
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.81 E-value=8.7e-19 Score=179.49 Aligned_cols=222 Identities=30% Similarity=0.394 Sum_probs=168.4
Q ss_pred hHHHHHHHHHHHhhcCCC-CccceecccccCccceEEEeecCCCccchhccccCCCCCCCHHHHHHHHHHHHHHHHHHhh
Q 044312 314 KVEEFINEVVILSQINHR-NVVKLLGCCLETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEIRLRIAIEVSGALSYLHS 392 (608)
Q Consensus 314 ~~~~~~~Ei~il~~l~H~-niv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~ 392 (608)
....|.+|+.+++.+.|+ +++++.+.+......+++++++.+++|.+++........+.......++.|++.++.|+|+
T Consensus 40 ~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H~ 119 (384)
T COG0515 40 EVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHS 119 (384)
T ss_pred HHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEEEEecCCCCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHHh
Confidence 467899999999999888 7999999997777789999999999999766654311248889999999999999999999
Q ss_pred cCCCCeeccCCCCCcEEEcCCC-cEEEeeccCccccccCCcc-----eeeeeeccCCCCChhhhcc---CCCCCccchHh
Q 044312 393 AASIPIYHRDIKSTNILLDDKY-RAKVSDFGASRSMAVDQTH-----MTTQVHGTFGYLDPEYFRS---SQFTDKSDVYS 463 (608)
Q Consensus 393 ~~~~~iiHrDlk~~NILl~~~~-~~kl~DFGls~~~~~~~~~-----~~~~~~gt~~y~aPE~~~~---~~~t~ksDV~S 463 (608)
.+ ++|||+||+|||++... .+++.|||+++........ ......|+..|+|||.+.. ...+...|+||
T Consensus 120 ~~---~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s 196 (384)
T COG0515 120 KG---IIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWS 196 (384)
T ss_pred CC---eeccCCCHHHeeecCCCCeEEEeccCcceecCCCCccccccccccccccccccCCHHHhcCCCCCCCCchHhHHH
Confidence 99 99999999999999988 6999999999865543322 2356679999999999987 67899999999
Q ss_pred HHHHHHHHHhCCCCCCccchhhcccHHHHHHHHhhhhhhHHHhhhhhhccCC----hhHHHHHHHHHHHHhccCCCCCCC
Q 044312 464 FGVVLTELLTGEKPIRFTILEEDKSLAAYFLCAMKEERLFEILDARVMKQGG----KDEIITVAKLAKRCLNLNGKKRPT 539 (608)
Q Consensus 464 ~Gvvl~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~----~~~~~~l~~Li~~cl~~dp~~RPs 539 (608)
+|++++++++|..||...... .........+...... ....... ......+.+++..++..+|..|.+
T Consensus 197 ~g~~~~~~~~~~~p~~~~~~~---~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~ 268 (384)
T COG0515 197 LGITLYELLTGLPPFEGEKNS---SATSQTLKIILELPTP-----SLASPLSPSNPELISKAASDLLKKLLAKDPKNRLS 268 (384)
T ss_pred HHHHHHHHHhCCCCCCCCCcc---ccHHHHHHHHHhcCCc-----ccccccCccccchhhHHHHHHHHHHHhcCchhcCC
Confidence 999999999999996533221 0000011111100000 0000011 112357889999999999999999
Q ss_pred HHHHHHH
Q 044312 540 MREVASE 546 (608)
Q Consensus 540 ~~evl~~ 546 (608)
+.+....
T Consensus 269 ~~~~~~~ 275 (384)
T COG0515 269 SSSDLSH 275 (384)
T ss_pred HHHHhhc
Confidence 9887764
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.80 E-value=1.4e-20 Score=209.36 Aligned_cols=213 Identities=22% Similarity=0.304 Sum_probs=166.8
Q ss_pred HHHHHHHHhhcCCCCccceecccccCccceEEEeecCCCccchhccccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCC
Q 044312 318 FINEVVILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEIRLRIAIEVSGALSYLHSAASIP 397 (608)
Q Consensus 318 ~~~Ei~il~~l~H~niv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ 397 (608)
+..|+.+-..++|+|++..+....+....+-+|||+++ +|..++.... .++...+-.++.|+..|+.|||+.+
T Consensus 368 i~sE~~i~~~l~h~~~~e~l~~~~~~~~~~~~mE~~~~-Dlf~~~~~~~---~~~~~e~~c~fKqL~~Gv~y~h~~G--- 440 (601)
T KOG0590|consen 368 ITSEFCIGSSLSHPNIIETLDIVQEIDGILQSMEYCPY-DLFSLVMSNG---KLTPLEADCFFKQLLRGVKYLHSMG--- 440 (601)
T ss_pred hhhheeecccccCCchhhhHHHHhhcccchhhhhcccH-HHHHHHhccc---ccchhhhhHHHHHHHHHHHHHHhcC---
Confidence 44566677788999999999888887777777999999 9999988653 3788889999999999999999999
Q ss_pred eeccCCCCCcEEEcCCCcEEEeeccCccccccCCc---ceeeeeeccCCCCChhhhccCCCCC-ccchHhHHHHHHHHHh
Q 044312 398 IYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQT---HMTTQVHGTFGYLDPEYFRSSQFTD-KSDVYSFGVVLTELLT 473 (608)
Q Consensus 398 iiHrDlk~~NILl~~~~~~kl~DFGls~~~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~t~-ksDV~S~Gvvl~ellt 473 (608)
+.|||||++|++++.++.+||+|||.+........ .......|...|+|||.+....|.+ ..||||.|+++..|++
T Consensus 441 iahrdlK~enll~~~~g~lki~Dfg~~~vf~~~~e~~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~ 520 (601)
T KOG0590|consen 441 LAHRDLKLENLLVTENGILKIIDFGAASVFRYPWEKNIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMIL 520 (601)
T ss_pred ceeccCccccEEEecCCceEEeecCcceeeccCcchhhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEec
Confidence 99999999999999999999999999877653322 4456778999999999999999986 5899999999999999
Q ss_pred CCCCCCccchhhcccHHHHHHHHhhhhhhHHHhhhhhhccCChhHHHHHHHHHHHHhccCCCCCCCHHHHHH
Q 044312 474 GEKPIRFTILEEDKSLAAYFLCAMKEERLFEILDARVMKQGGKDEIITVAKLAKRCLNLNGKKRPTMREVAS 545 (608)
Q Consensus 474 g~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~evl~ 545 (608)
|+.||......+.... ......-..+... ........+.+.+.++.+||+.+|.+|.|+++|++
T Consensus 521 ~~~~Wk~a~~~~~~~~------~~~~~~~~~~~~~--~~~~~~~lp~~~~~~~~~~l~~~P~~R~ti~~i~~ 584 (601)
T KOG0590|consen 521 GRFPWKVAKKSDNSFK------TNNYSDQRNIFEG--PNRLLSLLPRETRIIIYRMLQLDPTKRITIEQILN 584 (601)
T ss_pred CCCccccccccccchh------hhccccccccccC--hHHHHHhchhhHHHHHHHHccCChhheecHHHHhh
Confidence 9999975544332210 0000000000000 00111345667899999999999999999999985
|
|
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.79 E-value=3.4e-19 Score=186.50 Aligned_cols=152 Identities=19% Similarity=0.120 Sum_probs=114.6
Q ss_pred HHHhcCccccceeccCce----------------EEEEEeec-----ChhhHHHHHHHHHHHhhcCCCCccc-eeccccc
Q 044312 285 EKATDNFDLNRILGQGGQ----------------AVKKSKVI-----DESKVEEFINEVVILSQINHRNVVK-LLGCCLE 342 (608)
Q Consensus 285 ~~~t~~f~~~~~lG~G~~----------------avk~~~~~-----~~~~~~~~~~Ei~il~~l~H~niv~-l~~~~~~ 342 (608)
....++|++.+.||+|+| |||+.... .....+.|.+|+++|++++|+|+++ ++..
T Consensus 14 ~~~~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~~--- 90 (365)
T PRK09188 14 PALSARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLAT--- 90 (365)
T ss_pred ccccCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEEc---
Confidence 344567999999999986 44443211 1223566999999999999999985 4432
Q ss_pred CccceEEEeecCCCccchhccccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeccCC-CCCcEEEcCCCcEEEeec
Q 044312 343 TEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEIRLRIAIEVSGALSYLHSAASIPIYHRDI-KSTNILLDDKYRAKVSDF 421 (608)
Q Consensus 343 ~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDl-k~~NILl~~~~~~kl~DF 421 (608)
+..+|||||+++++|.. +.. .. ...++.++++||.|||+.+ |+|||| ||+|||++.++.+||+||
T Consensus 91 -~~~~LVmE~~~G~~L~~-~~~------~~---~~~~~~~i~~aL~~lH~~g---IiHrDL~KP~NILv~~~~~ikLiDF 156 (365)
T PRK09188 91 -GKDGLVRGWTEGVPLHL-ARP------HG---DPAWFRSAHRALRDLHRAG---ITHNDLAKPQNWLMGPDGEAAVIDF 156 (365)
T ss_pred -CCcEEEEEccCCCCHHH-hCc------cc---hHHHHHHHHHHHHHHHHCC---CeeCCCCCcceEEEcCCCCEEEEEC
Confidence 45799999999999963 211 11 1467889999999999999 999999 999999999999999999
Q ss_pred cCccccccCCcc-------eeeeeeccCCCCChhhhccC
Q 044312 422 GASRSMAVDQTH-------MTTQVHGTFGYLDPEYFRSS 453 (608)
Q Consensus 422 Gls~~~~~~~~~-------~~~~~~gt~~y~aPE~~~~~ 453 (608)
|+++.+...... ..+...+++.|+|||++...
T Consensus 157 GlA~~~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~~ 195 (365)
T PRK09188 157 QLASVFRRRGALYRIAAYEDLRHLLKHKRTYAPDALTPR 195 (365)
T ss_pred ccceecccCcchhhhhhhhhhhhhhccCccCCcccCChh
Confidence 999876532211 11356688899999998644
|
|
| >KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.79 E-value=2.4e-19 Score=199.39 Aligned_cols=236 Identities=19% Similarity=0.263 Sum_probs=166.3
Q ss_pred CccccceeccCce-------------EEEEEeecC-hhhHHHHHHHHHH--HhhcCCCCccceecccccCccceEEEeec
Q 044312 290 NFDLNRILGQGGQ-------------AVKKSKVID-ESKVEEFINEVVI--LSQINHRNVVKLLGCCLETEVPLLVYEFI 353 (608)
Q Consensus 290 ~f~~~~~lG~G~~-------------avk~~~~~~-~~~~~~~~~Ei~i--l~~l~H~niv~l~~~~~~~~~~~lV~E~~ 353 (608)
++...+.||++.| .||.....+ .-....|.++++- ...++|||++++.-+-......|||-+|.
T Consensus 24 e~~~~~~LGstRFlKv~r~k~~eG~vVvKVFvk~~p~~sL~~~~qrL~~ik~~l~~~pn~lPfqk~~~t~kAAylvRqyv 103 (1431)
T KOG1240|consen 24 ECHYVENLGSTRFLKVARAKDREGLVVVKVFVKQDPTISLRPFKQRLEEIKFALMKAPNCLPFQKVLVTDKAAYLVRQYV 103 (1431)
T ss_pred ceeeecccCchhhhhhhhccCCCceEEEEEEeccCCCCCchHHHHHHHHHHHHhhcCCcccchHHHHHhhHHHHHHHHHH
Confidence 4555666666653 455543322 3344555544433 44559999999999888888889999999
Q ss_pred CCCccchhccccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEEcCCCcEEEeeccCcccc--ccCC
Q 044312 354 PNGTLFQYIHDQNEDFPITWEIRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSM--AVDQ 431 (608)
Q Consensus 354 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGls~~~--~~~~ 431 (608)
.+ +|+|.|.... -+...+...|+.|++.||..+|..+ |+|||||.+||||+.-.-+.|+||..-+.. +++.
T Consensus 104 kh-nLyDRlSTRP---FL~~iEKkWiaFQLL~al~qcH~~g---VcHGDIKsENILiTSWNW~~LtDFAsFKPtYLPeDN 176 (1431)
T KOG1240|consen 104 KH-NLYDRLSTRP---FLVLIEKKWIAFQLLKALSQCHKLG---VCHGDIKSENILITSWNWLYLTDFASFKPTYLPEDN 176 (1431)
T ss_pred hh-hhhhhhccch---HHHHHHHHHHHHHHHHHHHHHHHcC---ccccccccceEEEeeechhhhhcccccCCccCCCCC
Confidence 66 9999997643 3777888899999999999999999 999999999999999989999999876533 3333
Q ss_pred ccee----eeeeccCCCCChhhhccC-----------CCCCccchHhHHHHHHHHHh-CCCCCCccchhhcccHHHHHHH
Q 044312 432 THMT----TQVHGTFGYLDPEYFRSS-----------QFTDKSDVYSFGVVLTELLT-GEKPIRFTILEEDKSLAAYFLC 495 (608)
Q Consensus 432 ~~~~----~~~~gt~~y~aPE~~~~~-----------~~t~ksDV~S~Gvvl~ellt-g~~p~~~~~~~~~~~l~~~~~~ 495 (608)
.... ........|+|||-+... .++++.||||+||+++||++ |++||.. ...+.-
T Consensus 177 Padf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~L---------SQL~aY 247 (1431)
T KOG1240|consen 177 PADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTL---------SQLLAY 247 (1431)
T ss_pred cccceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccH---------HHHHhH
Confidence 2222 222334579999987542 26889999999999999998 6788752 222211
Q ss_pred Hhh-hhhhHHHhhhhhhccCChhHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHh
Q 044312 496 AMK-EERLFEILDARVMKQGGKDEIITVAKLAKRCLNLNGKKRPTMREVASELAG 549 (608)
Q Consensus 496 ~~~-~~~~~~~~d~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~evl~~L~~ 549 (608)
.-. .......+. .. +...++.|+..|++.||++|.++++.++.-++
T Consensus 248 r~~~~~~~e~~Le-----~I---ed~~~Rnlil~Mi~rdPs~RlSAedyL~~yrG 294 (1431)
T KOG1240|consen 248 RSGNADDPEQLLE-----KI---EDVSLRNLILSMIQRDPSKRLSAEDYLQKYRG 294 (1431)
T ss_pred hccCccCHHHHHH-----hC---cCccHHHHHHHHHccCchhccCHHHHHHhhhc
Confidence 111 111111111 00 11268899999999999999999999987443
|
|
| >KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.73 E-value=1.2e-18 Score=182.19 Aligned_cols=175 Identities=25% Similarity=0.409 Sum_probs=133.3
Q ss_pred cceEEEeecCCCccchhccccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEEcCCCcEEEeeccCc
Q 044312 345 VPLLVYEFIPNGTLFQYIHDQNEDFPITWEIRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGAS 424 (608)
Q Consensus 345 ~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGls 424 (608)
.+++.|+++...+|.++|.........++...+.++.|++.|++| ++ .+|+|+||.||+...+..+||.|||+.
T Consensus 330 ~lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y---k~---~ihrdlkp~nif~~~d~q~kIgDFgl~ 403 (516)
T KOG1033|consen 330 YLYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY---KG---LIHRDLKPSNIFFSDDDQLKIGDFGLV 403 (516)
T ss_pred chhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh---cc---chhhhccccccccccchhhhhhhhhhe
Confidence 578999999999999999865555567899999999999999999 66 899999999999999999999999998
Q ss_pred cccccCC-----cceeeeeeccCCCCChhhhccCCCCCccchHhHHHHHHHHHh-CCCCCCccchhhcccHHHHHHHHhh
Q 044312 425 RSMAVDQ-----THMTTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLTELLT-GEKPIRFTILEEDKSLAAYFLCAMK 498 (608)
Q Consensus 425 ~~~~~~~-----~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~ellt-g~~p~~~~~~~~~~~l~~~~~~~~~ 498 (608)
....... ....+...||..||+||.+.+..|+.|+||||||+||+||+. -..+++ .......++
T Consensus 404 ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~EL~~~f~T~~e----------r~~t~~d~r 473 (516)
T KOG1033|consen 404 TSQDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYALGLILAELLIQFSTQFE----------RIATLTDIR 473 (516)
T ss_pred eecccCCcccchhhhhhhcccccccCCHHHHhhhhhhhhcchhhHHHHHHHHHHHhccHHH----------HHHhhhhhh
Confidence 7765444 334566789999999999999999999999999999999988 222221 000111122
Q ss_pred hhhhHHHhhhhhhccCChhHHHHHHHHHHHHhccCCCCCCCHHHHH
Q 044312 499 EERLFEILDARVMKQGGKDEIITVAKLAKRCLNLNGKKRPTMREVA 544 (608)
Q Consensus 499 ~~~~~~~~d~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~evl 544 (608)
++.+ ++......+ .=+.|+.+++.+.|.+||++.++.
T Consensus 474 ~g~i----p~~~~~d~p-----~e~~ll~~lls~~p~~RP~~~~~~ 510 (516)
T KOG1033|consen 474 DGII----PPEFLQDYP-----EEYTLLQQLLSPSPEERPSAIEVA 510 (516)
T ss_pred cCCC----ChHHhhcCc-----HHHHHHHHhcCCCcccCchHHHHh
Confidence 2211 111111222 235799999999999999655443
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.71 E-value=5.1e-18 Score=180.83 Aligned_cols=190 Identities=26% Similarity=0.300 Sum_probs=158.2
Q ss_pred HHHHHHHHHhhcC-CCCccceecccccCccceEEEeecCCCccchhccccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCC
Q 044312 317 EFINEVVILSQIN-HRNVVKLLGCCLETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEIRLRIAIEVSGALSYLHSAAS 395 (608)
Q Consensus 317 ~~~~Ei~il~~l~-H~niv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~ 395 (608)
....|..++..++ ||.+|++...+..+...++++++..+|.|...+.+.. .+.......+..++|-+++++|+.+
T Consensus 42 ~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~~rgg~lft~l~~~~---~f~~~~~~~~~aelaLald~lh~l~- 117 (612)
T KOG0603|consen 42 HTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDFLRGGDLFTRLSKEV---MFDELDVAFYLAELALALDHLHKLG- 117 (612)
T ss_pred ccccHHHHHhhccCCCceeeeeeeeccccchhHhhhhcccchhhhccccCC---chHHHHHHHHHHHHHHHHhhcchhH-
Confidence 5556778888886 9999999999999999999999999999988876644 3667777778889999999999999
Q ss_pred CCeeccCCCCCcEEEcCCCcEEEeeccCccccccCCcceeeeeeccCCCCChhhhccCCCCCccchHhHHHHHHHHHhCC
Q 044312 396 IPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLTELLTGE 475 (608)
Q Consensus 396 ~~iiHrDlk~~NILl~~~~~~kl~DFGls~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~elltg~ 475 (608)
|+|||+|++||+++.+|.+|+.|||+++..-..+.. .||..|||||++. .....+|.||||++++||+||.
T Consensus 118 --iiyrd~k~enilld~~Ghi~~tdfglske~v~~~~~-----cgt~eymApEI~~--gh~~a~D~ws~gvl~felltg~ 188 (612)
T KOG0603|consen 118 --IAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKEKIA-----CGTYEYRAPEIIN--GHLSAADWWSFGVLAFELLTGT 188 (612)
T ss_pred --HHHhcccccceeecccCccccCCchhhhHhHhhhhc-----ccchhhhhhHhhh--ccCCcccchhhhhhHHHHhhCC
Confidence 999999999999999999999999999876543322 7899999999998 6788999999999999999999
Q ss_pred CCCCccchhhcccHHHHHHHHhhhhhhHHHhhhhhhccCChhHHHHHHHHHHHHhccCCCCCCCH
Q 044312 476 KPIRFTILEEDKSLAAYFLCAMKEERLFEILDARVMKQGGKDEIITVAKLAKRCLNLNGKKRPTM 540 (608)
Q Consensus 476 ~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPs~ 540 (608)
.||.. +....|+.. ....+.+......+++.+++..+|..|.-.
T Consensus 189 ~pf~~-------------------~~~~~Il~~--~~~~p~~l~~~a~~~~~~l~~r~p~nrLg~ 232 (612)
T KOG0603|consen 189 LPFGG-------------------DTMKRILKA--ELEMPRELSAEARSLFRQLFKRNPENRLGA 232 (612)
T ss_pred CCCch-------------------HHHHHHhhh--ccCCchhhhHHHHHHHHHHHhhCHHHHhcc
Confidence 99862 111122211 224556677788999999999999999765
|
|
| >PF13947 GUB_WAK_bind: Wall-associated receptor kinase galacturonan-binding | Back alignment and domain information |
|---|
Probab=99.71 E-value=5.6e-18 Score=146.84 Aligned_cols=52 Identities=52% Similarity=1.151 Sum_probs=48.8
Q ss_pred CCCCCCCCcCeeecccCCCCCCCCCCCCCeeee-----------------------------------------------
Q 044312 3 ALACPDRCGDVGIQYPFGIGAGCYFDESFEVVC----------------------------------------------- 35 (608)
Q Consensus 3 ~~~C~~~CG~v~IpyPFGig~gC~~~~~F~l~C----------------------------------------------- 35 (608)
.++||++||||+||||||||+||++++||+|+|
T Consensus 1 ~~~C~~~CGnv~IpYPFgi~~~C~~~~~F~L~C~~~~~~~~l~l~~~~~~V~~I~~~~~~i~v~~~~~~~~~~~~~~~~~ 80 (106)
T PF13947_consen 1 KPGCPSSCGNVSIPYPFGIGPGCGRDPGFELTCNNNTSPPKLLLSSGNYEVLSISYENGTIRVSDPISSNCYSSSSSNSS 80 (106)
T ss_pred CCCCCCccCCEeecCCCccCCCCCCCCCcEEECCCCCCCceeEecCCcEEEEEEecCCCEEEEEeccccceecCCCCccc
Confidence 379999999999999999999999977999999
Q ss_pred -------eceeeccCCCEEEEEcccc
Q 044312 36 -------TPFSFSQGINKFLAIGCDN 54 (608)
Q Consensus 36 -------~pf~~S~~~n~~~~~GC~~ 54 (608)
.||++|+++|+|+++||++
T Consensus 81 ~~~~~~~~~~~~s~~~N~~~~~GC~t 106 (106)
T PF13947_consen 81 NSNLSLNGPFFFSSSSNKFTVVGCNT 106 (106)
T ss_pred ccEEeecCCceEccCCcEEEEECCCC
Confidence 6899999999999999986
|
|
| >KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.71 E-value=3.8e-17 Score=164.51 Aligned_cols=196 Identities=21% Similarity=0.250 Sum_probs=140.0
Q ss_pred CCCCccceeccccc---------------------------CccceEEEeecCCCccchhccccCCCCCCCHHHHHHHHH
Q 044312 329 NHRNVVKLLGCCLE---------------------------TEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEIRLRIAI 381 (608)
Q Consensus 329 ~H~niv~l~~~~~~---------------------------~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~ 381 (608)
+|||||+++++|.+ ...+||||..++. +|.+++..+. .+.....-|+.
T Consensus 274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY~~-tLr~yl~~~~----~s~r~~~~~la 348 (598)
T KOG4158|consen 274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRYRQ-TLREYLWTRH----RSYRTGRVILA 348 (598)
T ss_pred CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcchh-hHHHHHhcCC----CchHHHHHHHH
Confidence 69999999988763 2245899988855 8999887653 56667778999
Q ss_pred HHHHHHHHHhhcCCCCeeccCCCCCcEEEc--CC--CcEEEeeccCccccccC-----CcceeeeeeccCCCCChhhhcc
Q 044312 382 EVSGALSYLHSAASIPIYHRDIKSTNILLD--DK--YRAKVSDFGASRSMAVD-----QTHMTTQVHGTFGYLDPEYFRS 452 (608)
Q Consensus 382 ~ia~aL~yLH~~~~~~iiHrDlk~~NILl~--~~--~~~kl~DFGls~~~~~~-----~~~~~~~~~gt~~y~aPE~~~~ 452 (608)
|+++|+.|||.++ |.|||+|++|||+. ++ -.+.|+|||..-.-... .....-...|...-||||+...
T Consensus 349 QlLEav~hL~~hg---vAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~ta 425 (598)
T KOG4158|consen 349 QLLEAVTHLHKHG---VAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIATA 425 (598)
T ss_pred HHHHHHHHHHHcc---chhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecchhhhhc
Confidence 9999999999999 99999999999993 33 34789999976432110 0111123457778999999865
Q ss_pred CC------CCCccchHhHHHHHHHHHhCCCCCCccchhhcccHHHHHHHHhhhhhhHHHhhhhhhccCChhHHHHHHHHH
Q 044312 453 SQ------FTDKSDVYSFGVVLTELLTGEKPIRFTILEEDKSLAAYFLCAMKEERLFEILDARVMKQGGKDEIITVAKLA 526 (608)
Q Consensus 453 ~~------~t~ksDV~S~Gvvl~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~Li 526 (608)
.. --.|+|.|+.|.+.||+++...||..... ...+. ...++..+ ...+..++..+++|+
T Consensus 426 ~PGp~avvny~kAD~WA~GalaYEIfg~~NPFY~rGe-m~L~~-----r~Yqe~qL---------Palp~~vpp~~rqlV 490 (598)
T KOG4158|consen 426 VPGPNAVVNYEKADTWAAGALAYEIFGRSNPFYKRGE-MLLDT-----RTYQESQL---------PALPSRVPPVARQLV 490 (598)
T ss_pred CCCCceeeccchhhhhhhhhhHHHHhccCCcccccch-heech-----hhhhhhhC---------CCCcccCChHHHHHH
Confidence 42 13589999999999999999999974111 00000 01111111 123445667899999
Q ss_pred HHHhccCCCCCCCHHHHHHHH
Q 044312 527 KRCLNLNGKKRPTMREVASEL 547 (608)
Q Consensus 527 ~~cl~~dp~~RPs~~evl~~L 547 (608)
...|+.||.+||+..=....|
T Consensus 491 ~~lL~r~pskRvsp~iAANvl 511 (598)
T KOG4158|consen 491 FDLLKRDPSKRVSPNIAANVL 511 (598)
T ss_pred HHHhcCCccccCCccHHHhHH
Confidence 999999999999976555544
|
|
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.71 E-value=1.6e-17 Score=162.14 Aligned_cols=159 Identities=13% Similarity=0.171 Sum_probs=119.9
Q ss_pred HhcCccccceeccCce-------------EEEEEeecC---hhhHHH------HHHHHHHHhhcCCCCccceecccccC-
Q 044312 287 ATDNFDLNRILGQGGQ-------------AVKKSKVID---ESKVEE------FINEVVILSQINHRNVVKLLGCCLET- 343 (608)
Q Consensus 287 ~t~~f~~~~~lG~G~~-------------avk~~~~~~---~~~~~~------~~~Ei~il~~l~H~niv~l~~~~~~~- 343 (608)
..++|+..+.||+|++ +||...... +...+. |.+|+..+.+++|++|..+..++...
T Consensus 29 l~~~y~~~~~l~~~~f~~v~l~~~~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~~~~ 108 (232)
T PRK10359 29 LSYNIKTIKVFRNIDDTKVSLIDTDYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYLLAE 108 (232)
T ss_pred hhCceEEEEEecCCCceEEEEEecCCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeeeecc
Confidence 4678999999999875 666654322 122222 67999999999999999999886533
Q ss_pred -------ccceEEEeecCCCccchhccccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEEcCCCcE
Q 044312 344 -------EVPLLVYEFIPNGTLFQYIHDQNEDFPITWEIRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRA 416 (608)
Q Consensus 344 -------~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ 416 (608)
...+|||||++|.+|.++.. ++. ....+++.+|..||+.+ ++|||+||+||+++.++ +
T Consensus 109 ~~~~~~~~~~~lvmEyi~G~tL~~~~~-------~~~----~~~~~i~~~l~~lH~~g---i~H~Dikp~Nili~~~g-i 173 (232)
T PRK10359 109 RKTLRYAHTYIMLIEYIEGVELNDMPE-------ISE----DVKAKIKASIESLHQHG---MVSGDPHKGNFIVSKNG-L 173 (232)
T ss_pred cccccccCCeEEEEEEECCccHHHhhh-------ccH----HHHHHHHHHHHHHHHcC---CccCCCChHHEEEeCCC-E
Confidence 35789999999999977631 232 24568999999999999 99999999999999888 9
Q ss_pred EEeeccCccccccCCcceeeeeeccCCCCChhhhccCCCCCccchHhHHHHHHHHHh
Q 044312 417 KVSDFGASRSMAVDQTHMTTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLTELLT 473 (608)
Q Consensus 417 kl~DFGls~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~ellt 473 (608)
+|+|||.......+... ..++....+..++|+||||+.+..+..
T Consensus 174 ~liDfg~~~~~~e~~a~-------------d~~vler~y~~~~di~~lg~~~~~~~~ 217 (232)
T PRK10359 174 RIIDLSGKRCTAQRKAK-------------DRIDLERHYGIKNEIKDLGYYLLIYKK 217 (232)
T ss_pred EEEECCCcccccchhhH-------------HHHHHHhHhcccccccceeEeehHHHH
Confidence 99999988755322211 114445566789999999999876643
|
|
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.66 E-value=5.4e-16 Score=148.46 Aligned_cols=146 Identities=16% Similarity=0.112 Sum_probs=112.2
Q ss_pred HHHHHHHHHhhcC-CCCccceecccccCccceEEEeecCCCccchhccccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCC
Q 044312 317 EFINEVVILSQIN-HRNVVKLLGCCLETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEIRLRIAIEVSGALSYLHSAAS 395 (608)
Q Consensus 317 ~~~~Ei~il~~l~-H~niv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~ 395 (608)
.|.+|+++|++|+ |+++++++++ +..+++|||+.|.+|.+.+.. ....++.|++.+|.++|+.+
T Consensus 47 l~~rE~~iL~~L~~~~~vP~ll~~----~~~~lvmeyI~G~~L~~~~~~----------~~~~~~~qi~~~L~~lH~~G- 111 (218)
T PRK12274 47 LARREALALRQLDGLPRTPRLLHW----DGRHLDRSYLAGAAMYQRPPR----------GDLAYFRAARRLLQQLHRCG- 111 (218)
T ss_pred HHHHHHHHHHhcCCCCCCCEEEEE----cCEEEEEeeecCccHHhhhhh----------hhHHHHHHHHHHHHHHHHCc-
Confidence 5889999999994 5889999886 346999999999888653311 11357789999999999999
Q ss_pred CCeeccCC-CCCcEEEcCCCcEEEeeccCccccccCCcc----e--------eeeeeccCCCCChhhhccC-CCC-Cccc
Q 044312 396 IPIYHRDI-KSTNILLDDKYRAKVSDFGASRSMAVDQTH----M--------TTQVHGTFGYLDPEYFRSS-QFT-DKSD 460 (608)
Q Consensus 396 ~~iiHrDl-k~~NILl~~~~~~kl~DFGls~~~~~~~~~----~--------~~~~~gt~~y~aPE~~~~~-~~t-~ksD 460 (608)
|+|||| ||+|||++.++.++|+|||++......... . ......++.|++|+...-- ..+ ...+
T Consensus 112 --IvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~~~~~~~r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~ 189 (218)
T PRK12274 112 --VAHNDLAKEANWLVQEDGSPAVIDFQLAVRGNPRARWMRLLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIREL 189 (218)
T ss_pred --CccCCCCCcceEEEcCCCCEEEEECCCceecCCcchHHHHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHH
Confidence 999999 799999999999999999999854432210 0 0112357888888764322 333 5678
Q ss_pred hHhHHHHHHHHHhCCCCCC
Q 044312 461 VYSFGVVLTELLTGEKPIR 479 (608)
Q Consensus 461 V~S~Gvvl~elltg~~p~~ 479 (608)
.++-|.-+|.++|+..+..
T Consensus 190 w~~~g~~~~~~~~~~~~~~ 208 (218)
T PRK12274 190 WFATGKPVYRFVTRRVLHW 208 (218)
T ss_pred HHHhcchHHHHHhccCCcc
Confidence 8899999999999998854
|
|
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.65 E-value=5.6e-16 Score=150.65 Aligned_cols=123 Identities=17% Similarity=0.181 Sum_probs=95.4
Q ss_pred ccceeccCce------------EEEEEeecChhhHHHHHHHHHHHhhc-----CCCCccceecccccCc---c-ceEEEe
Q 044312 293 LNRILGQGGQ------------AVKKSKVIDESKVEEFINEVVILSQI-----NHRNVVKLLGCCLETE---V-PLLVYE 351 (608)
Q Consensus 293 ~~~~lG~G~~------------avk~~~~~~~~~~~~~~~Ei~il~~l-----~H~niv~l~~~~~~~~---~-~~lV~E 351 (608)
-.+.||+|++ +||+....+....+.+.+|+.+++++ +||||++++|++.++. . ..+|+|
T Consensus 6 ~~~~LG~G~~~~Vy~hp~~~~k~IKv~~~~~~~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v~~~I~e 85 (210)
T PRK10345 6 EQSPLGTGRHRKCYAHPEDAQRCIKIVYHRGDGGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYVYDVIAD 85 (210)
T ss_pred CcceecCCCceEEEECCCCcCeEEEEEeccccchHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEEEEEEec
Confidence 3567888874 55655544444567899999999999 5799999999998764 3 337899
Q ss_pred e--cCCCccchhccccCCCCCCCHHHHHHHHHHHHHHH-HHHhhcCCCCeeccCCCCCcEEEcC----CCcEEEeeccCc
Q 044312 352 F--IPNGTLFQYIHDQNEDFPITWEIRLRIAIEVSGAL-SYLHSAASIPIYHRDIKSTNILLDD----KYRAKVSDFGAS 424 (608)
Q Consensus 352 ~--~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL-~yLH~~~~~~iiHrDlk~~NILl~~----~~~~kl~DFGls 424 (608)
| +++++|.+++.+. .+++. ..++.+++.++ +|||+++ |+||||||+|||++. +..++|+||+-+
T Consensus 86 ~~G~~~~tL~~~l~~~----~~~e~--~~~~~~~L~~l~~yLh~~~---IvhrDlKp~NILl~~~~~~~~~~~LiDg~G~ 156 (210)
T PRK10345 86 FDGKPSITLTEFAEQC----RYEED--VAQLRQLLKKLKRYLLDNR---IVTMELKPQNILCQRISESEVIPVVCDNIGE 156 (210)
T ss_pred CCCCcchhHHHHHHcc----cccHh--HHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEeccCCCCCcEEEEECCCC
Confidence 9 5579999999653 25555 35678888777 9999999 999999999999974 347999994433
|
|
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.63 E-value=1.1e-15 Score=147.01 Aligned_cols=100 Identities=17% Similarity=0.162 Sum_probs=79.1
Q ss_pred HHHHHHHhhcCCCCccceecccccCccceEEEeecCCCccchhccccCCCCCCCHHHHHHHHHHHHHHHHHH-hhcCCCC
Q 044312 319 INEVVILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEIRLRIAIEVSGALSYL-HSAASIP 397 (608)
Q Consensus 319 ~~Ei~il~~l~H~niv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yL-H~~~~~~ 397 (608)
.+|+++|.++.|+++....... ....+|||||+++++|...+... .++++.....++.|++.+|.|| |+.+
T Consensus 67 ~~E~~~l~~l~~~~v~~p~~~~--~~~~~iVmE~i~g~~l~~~~~~~---~~~~~~~~~~i~~qi~~~L~~l~H~~g--- 138 (190)
T cd05147 67 EKEMRNLKRLVTAGIPCPEPIL--LKSHVLVMEFIGDDGWAAPRLKD---APLSESKARELYLQVIQIMRILYQDCR--- 138 (190)
T ss_pred HHHHHHHHHHHHCCCCCCcEEE--ecCCEEEEEEeCCCCCcchhhhc---CCCCHHHHHHHHHHHHHHHHHHHHhCC---
Confidence 3499999999887764433222 12348999999887776543322 2588999999999999999999 6888
Q ss_pred eeccCCCCCcEEEcCCCcEEEeeccCcccc
Q 044312 398 IYHRDIKSTNILLDDKYRAKVSDFGASRSM 427 (608)
Q Consensus 398 iiHrDlk~~NILl~~~~~~kl~DFGls~~~ 427 (608)
|+||||||+|||+++ +.++|+|||++...
T Consensus 139 iiHrDlkP~NIli~~-~~v~LiDFG~a~~~ 167 (190)
T cd05147 139 LVHADLSEYNLLYHD-GKLYIIDVSQSVEH 167 (190)
T ss_pred cccCCCCHHHEEEEC-CcEEEEEccccccC
Confidence 999999999999984 68999999999754
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.59 E-value=1.1e-14 Score=140.18 Aligned_cols=102 Identities=20% Similarity=0.156 Sum_probs=81.8
Q ss_pred HHHHHHHHhhcCCCCccceecccccCccceEEEeecCCCccchhccccCCCCCCCHHHHHHHHHHHHHHHHHHhh-cCCC
Q 044312 318 FINEVVILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEIRLRIAIEVSGALSYLHS-AASI 396 (608)
Q Consensus 318 ~~~Ei~il~~l~H~niv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~-~~~~ 396 (608)
+.+|...+.++.|+++.....+... ..+|||||++++++....... ..++......++.|++.+|.+||+ .+
T Consensus 66 ~~~E~~~l~~l~~~~i~~p~~~~~~--~~~lVmE~~~g~~~~~~~l~~---~~~~~~~~~~i~~~l~~~l~~lH~~~g-- 138 (190)
T cd05145 66 AEKEFRNLKRLYEAGVPVPEPILLK--KNVLVMEFIGDDGSPAPRLKD---VPLEEEEAEELYEQVVEQMRRLYQEAG-- 138 (190)
T ss_pred HHHHHHHHHHHHhCCCCCceEEEec--CCEEEEEEecCCCchhhhhhh---ccCCHHHHHHHHHHHHHHHHHHHHhCC--
Confidence 4678999999999987544433322 348999999887654432222 147888999999999999999999 88
Q ss_pred CeeccCCCCCcEEEcCCCcEEEeeccCccccc
Q 044312 397 PIYHRDIKSTNILLDDKYRAKVSDFGASRSMA 428 (608)
Q Consensus 397 ~iiHrDlk~~NILl~~~~~~kl~DFGls~~~~ 428 (608)
|+||||||+|||++ ++.++|+|||++....
T Consensus 139 -ivHrDlkP~NIll~-~~~~~liDFG~a~~~~ 168 (190)
T cd05145 139 -LVHGDLSEYNILYH-DGKPYIIDVSQAVELD 168 (190)
T ss_pred -EecCCCChhhEEEE-CCCEEEEEcccceecC
Confidence 99999999999999 7899999999998654
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=99.57 E-value=2.9e-15 Score=150.65 Aligned_cols=163 Identities=22% Similarity=0.316 Sum_probs=109.5
Q ss_pred ceEEEeecCCCccchhccc---cC-CCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEEcCCCcEEEeec
Q 044312 346 PLLVYEFIPNGTLFQYIHD---QN-EDFPITWEIRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDF 421 (608)
Q Consensus 346 ~~lV~E~~~~gsL~~~l~~---~~-~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DF 421 (608)
.+++|+-+ .++|.+++.. .. ....+....++.+..|+++.+++||+.+ ++|+||+|+|+|++.+|.++|+||
T Consensus 114 ~~~l~P~~-~~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~G---lVHgdi~~~nfll~~~G~v~Lg~F 189 (288)
T PF14531_consen 114 RFLLMPRA-QGDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSYG---LVHGDIKPENFLLDQDGGVFLGDF 189 (288)
T ss_dssp EEEEEE---SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTT---EEEST-SGGGEEE-TTS-EEE--G
T ss_pred hhhccchh-hhcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhcc---eEecccceeeEEEcCCCCEEEcCh
Confidence 36788887 5688887653 11 1123556677888899999999999999 999999999999999999999999
Q ss_pred cCccccccCCcceeeeeeccCCCCChhhhcc--------CCCCCccchHhHHHHHHHHHhCCCCCCccchhhcccHHHHH
Q 044312 422 GASRSMAVDQTHMTTQVHGTFGYLDPEYFRS--------SQFTDKSDVYSFGVVLTELLTGEKPIRFTILEEDKSLAAYF 493 (608)
Q Consensus 422 Gls~~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~t~ksDV~S~Gvvl~elltg~~p~~~~~~~~~~~l~~~~ 493 (608)
+........ ......+..|.+||.... ..++.+.|.|++|+++|.|+++..||...........
T Consensus 190 ~~~~r~g~~----~~~~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~lWC~~lPf~~~~~~~~~~~---- 261 (288)
T PF14531_consen 190 SSLVRAGTR----YRCSEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYSLWCGRLPFGLSSPEADPEW---- 261 (288)
T ss_dssp GGEEETTEE----EEGGGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHHHHHSS-STCCCGGGSTSGG----
T ss_pred HHHeecCce----eeccCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHHHHHccCCCCCCCccccccc----
Confidence 876544321 111335678999998644 2578899999999999999999999975433322111
Q ss_pred HHHhhhhhhHHHhhhhhhccCChhHHHHHHHHHHHHhccCCCCC
Q 044312 494 LCAMKEERLFEILDARVMKQGGKDEIITVAKLAKRCLNLNGKKR 537 (608)
Q Consensus 494 ~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~Li~~cl~~dp~~R 537 (608)
...... +.++.++.||..+|+.+|++|
T Consensus 262 ----------------~f~~C~-~~Pe~v~~LI~~lL~~~~~~R 288 (288)
T PF14531_consen 262 ----------------DFSRCR-DMPEPVQFLIRGLLQRNPEDR 288 (288)
T ss_dssp ----------------GGTTSS----HHHHHHHHHHT-SSGGGS
T ss_pred ----------------cchhcC-CcCHHHHHHHHHHccCCcccC
Confidence 111223 677889999999999999988
|
|
| >PF08488 WAK: Wall-associated kinase; InterPro: IPR013695 This domain is found together with the eukaryotic protein kinase domain IPR000719 from INTERPRO in plant wall-associated kinases (WAKs) and related proteins | Back alignment and domain information |
|---|
Probab=99.56 E-value=6.3e-15 Score=125.36 Aligned_cols=72 Identities=25% Similarity=0.561 Sum_probs=58.0
Q ss_pred CCCCcccccccCCCCCCCceeeeeecccccCC-CCcccceeEeeccceeccccCCCccCCCCCCceeEEEEEeeecc
Q 044312 87 ESSGCCDMVCNIPQNSSTKVLDANTSNVYSRS-IPEGCTSLSLVYADWIFSHYLETPSGLKHEKMIPAVLEWGKYKG 162 (608)
Q Consensus 87 ~g~gCC~~~~~i~~~~~~~~~~~~~~~~~~~~-~~~~c~~af~~~~~~~f~~~~~~~~~~~~~~~vP~vLdW~i~~~ 162 (608)
+|+||||+ +||.++ ++.|++++....... ..++|++|||+|+.||.++ .+++...+..++|||+|||+|...
T Consensus 5 sG~~CCQt--~iP~~~-~qv~~~~i~~~~~~~~~~~~Ck~AFL~d~~~~~~n-~t~p~~~~~~~y~pv~L~W~i~t~ 77 (103)
T PF08488_consen 5 SGIGCCQT--SIPSGL-LQVFNVTIESTDGNNQTSNGCKVAFLVDEDWFSSN-ITDPEDFHAMGYVPVVLDWFIDTS 77 (103)
T ss_pred CCcceecc--CCCCCC-ceEEEEEeEecCCCcccCCCceEEEEecccccccc-CCChHHhccCCeeEEEEEEEEecC
Confidence 59999999 999973 378999988744423 5589999999999998433 567767777899999999999755
|
WAKs are serine-threonine kinases which might be involved in signalling to the cytoplasm and are required for cell expansion []. ; GO: 0004674 protein serine/threonine kinase activity, 0016021 integral to membrane |
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.52 E-value=1.4e-13 Score=134.40 Aligned_cols=100 Identities=25% Similarity=0.330 Sum_probs=88.4
Q ss_pred HHHHHHHHHHhhcCCCCccceecccccCccceEEEeecCCCccchhccccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCC
Q 044312 316 EEFINEVVILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEIRLRIAIEVSGALSYLHSAAS 395 (608)
Q Consensus 316 ~~~~~Ei~il~~l~H~niv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~ 395 (608)
..+.+|+.++..++|++|.....++......++||||++|++|.+++... .+ .+..++.+++.+|.+||+.+
T Consensus 44 ~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~~~G~~L~~~~~~~------~~-~~~~i~~~i~~~l~~lH~~~- 115 (211)
T PRK14879 44 ERTRREARIMSRARKAGVNVPAVYFVDPENFIIVMEYIEGEPLKDLINSN------GM-EELELSREIGRLVGKLHSAG- 115 (211)
T ss_pred HHHHHHHHHHHHHHHCCCCCCeEEEEeCCCCEEEEEEeCCcCHHHHHHhc------cH-HHHHHHHHHHHHHHHHHhCC-
Confidence 46889999999999999988777777777889999999999999988642 12 78899999999999999999
Q ss_pred CCeeccCCCCCcEEEcCCCcEEEeeccCccc
Q 044312 396 IPIYHRDIKSTNILLDDKYRAKVSDFGASRS 426 (608)
Q Consensus 396 ~~iiHrDlk~~NILl~~~~~~kl~DFGls~~ 426 (608)
++|+|++|.|||++ ++.++|+|||+++.
T Consensus 116 --i~H~Dl~p~Nil~~-~~~~~liDf~~a~~ 143 (211)
T PRK14879 116 --IIHGDLTTSNMILS-GGKIYLIDFGLAEF 143 (211)
T ss_pred --cccCCCCcccEEEE-CCCEEEEECCcccC
Confidence 99999999999999 78999999998864
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.50 E-value=2.5e-14 Score=159.88 Aligned_cols=138 Identities=28% Similarity=0.342 Sum_probs=107.6
Q ss_pred HHHHHHHhhcCCCCeeccCCCCCcEEEcCCCcEEEeeccCccccccCCc--------------ceeeeeeccCCCCChhh
Q 044312 384 SGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQT--------------HMTTQVHGTFGYLDPEY 449 (608)
Q Consensus 384 a~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGls~~~~~~~~--------------~~~~~~~gt~~y~aPE~ 449 (608)
+.+++|||+.+ |+|||+||+|.||+.-|.+|+.|||+++....... .....+.||+.|+|||+
T Consensus 153 vla~Eylh~yg---ivhrdlkpdnllIT~mGhiKlTDfgLsk~GLms~atnl~eg~I~k~t~Ef~dKqvcgTPeyiaPeV 229 (1205)
T KOG0606|consen 153 VLAVEYLHSYG---IVHRDLKPDNLLITSMGHIKLTDFGLSKKGLMSLATNLKEGHIEKDTHEFQDKQVCGTPEYIAPEV 229 (1205)
T ss_pred hHHhHhhccCC---eecCCCCCCcceeeecccccccchhhhhhhhhhccchhhhcchHHHHHHhhhccccCCccccChhh
Confidence 78899999999 99999999999999999999999999875432111 11245689999999999
Q ss_pred hccCCCCCccchHhHHHHHHHHHhCCCCCCccchhhcccHHHHHHHHhhhhhhHHHhhhhhhccCChhHHHHHHHHHHHH
Q 044312 450 FRSSQFTDKSDVYSFGVVLTELLTGEKPIRFTILEEDKSLAAYFLCAMKEERLFEILDARVMKQGGKDEIITVAKLAKRC 529 (608)
Q Consensus 450 ~~~~~~t~ksDV~S~Gvvl~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~Li~~c 529 (608)
+....|...+|.|++|+|+||.+.|..||....+++. |...+.+ .....+.....+.+.++++.+.
T Consensus 230 ilrqgygkpvdwwamGiIlyeFLVgcvpffGdtpeel------fg~visd--------~i~wpE~dea~p~Ea~dli~~L 295 (1205)
T KOG0606|consen 230 ILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEEL------FGQVISD--------DIEWPEEDEALPPEAQDLIEQL 295 (1205)
T ss_pred hhhhccCCCccHHHHHHHHHHHheeeeeccCCCHHHH------Hhhhhhh--------hccccccCcCCCHHHHHHHHHH
Confidence 9999999999999999999999999999975444321 1111111 1112223445567899999999
Q ss_pred hccCCCCCC
Q 044312 530 LNLNGKKRP 538 (608)
Q Consensus 530 l~~dp~~RP 538 (608)
|+.+|..|-
T Consensus 296 L~qnp~~Rl 304 (1205)
T KOG0606|consen 296 LRQNPLCRL 304 (1205)
T ss_pred HHhChHhhc
Confidence 999999994
|
|
| >KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.50 E-value=6.7e-14 Score=159.37 Aligned_cols=189 Identities=21% Similarity=0.289 Sum_probs=148.7
Q ss_pred CCHHHHHHHhcCccccceeccCceE--------------EEEEeecChhhHHHHHHHHHHHhhcC---CCCccceecccc
Q 044312 279 FTSKELEKATDNFDLNRILGQGGQA--------------VKKSKVIDESKVEEFINEVVILSQIN---HRNVVKLLGCCL 341 (608)
Q Consensus 279 ~~~~~l~~~t~~f~~~~~lG~G~~a--------------vk~~~~~~~~~~~~~~~Ei~il~~l~---H~niv~l~~~~~ 341 (608)
-...+.+.-...|.+.+.||+|++| +|..+ ....-+|.-=.+++.+|+ -+-|.++..+..
T Consensus 688 ~~~~~~~~~~~~~~I~~e~G~g~y~~vy~a~~~~~~~~alK~e~---P~~~WEfYI~~q~~~RLk~~~~~~~~~~~~a~~ 764 (974)
T KOG1166|consen 688 NPNTEFEVGGEKFCISKEIGEGSYGSVYVATHSNGKLVALKVEK---PPNPWEFYICLQVMERLKPQMLPSIMHISSAHV 764 (974)
T ss_pred CccceeeecceeEEEEeeeccccceEEEEeecCCCcEEEEEeec---CCCceeeeehHHHHHhhchhhhcchHHHHHHHc
Confidence 3444556667789999999999864 44333 333334444445555555 234555666666
Q ss_pred cCccceEEEeecCCCccchhccccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEEc-------CCC
Q 044312 342 ETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEIRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLD-------DKY 414 (608)
Q Consensus 342 ~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~-------~~~ 414 (608)
-.+.-+||+||.+.|+|.+++.... .++|.....++.|+++.++.||..+ |||+||||+|.||. +..
T Consensus 765 ~~~~S~lv~ey~~~Gtlld~~N~~~---~m~e~lv~~~~~qml~ive~lH~~~---IIHgDiKPDNfll~~~~~~~~~~~ 838 (974)
T KOG1166|consen 765 FQNASVLVSEYSPYGTLLDLINTNK---VMDEYLVMFFSCQMLRIVEHLHAMG---IIHGDIKPDNFLLRREICADSDSK 838 (974)
T ss_pred cCCcceeeeeccccccHHHhhccCC---CCCchhhhHHHHHHHHHHHHHHhcc---eecccCCcceeEeecccCCCCccc
Confidence 6777899999999999999998432 5899999999999999999999999 99999999999994 345
Q ss_pred cEEEeeccCccccccC-CcceeeeeeccCCCCChhhhccCCCCCccchHhHHHHHHHHHhCCC
Q 044312 415 RAKVSDFGASRSMAVD-QTHMTTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLTELLTGEK 476 (608)
Q Consensus 415 ~~kl~DFGls~~~~~~-~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~elltg~~ 476 (608)
.++|+|||-+-.+..- +........+|-.+--+|+..+..++-..|.|.|..+++-||.|+.
T Consensus 839 ~l~lIDfG~siDm~lfp~~~~F~~~~~td~f~C~EM~~grpWtYq~DyfGlAa~~h~mLFG~y 901 (974)
T KOG1166|consen 839 GLYLIDFGRSIDMKLFPDGTKFKAVWHTDLFDCIEMREGRPWTYQIDYFGLAATVHVMLFGKY 901 (974)
T ss_pred ceEEEecccceeeeEcCCCcEEeeeeccccchhHHHhcCCCCchhhhhHHHHHHHHHHHHHHH
Confidence 6999999998665432 2235667788999999999999999999999999999999999975
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.48 E-value=5.1e-15 Score=164.97 Aligned_cols=238 Identities=25% Similarity=0.356 Sum_probs=175.2
Q ss_pred cCccccceeccCce----------------EEEEEeecC--hhhHHHHHHHHHHHhhcC-CCCccceecccccCccceEE
Q 044312 289 DNFDLNRILGQGGQ----------------AVKKSKVID--ESKVEEFINEVVILSQIN-HRNVVKLLGCCLETEVPLLV 349 (608)
Q Consensus 289 ~~f~~~~~lG~G~~----------------avk~~~~~~--~~~~~~~~~Ei~il~~l~-H~niv~l~~~~~~~~~~~lV 349 (608)
..|.+.+-||+|.+ |+|...... ....+....|..+-..+. |+|++++++...+.+..+++
T Consensus 20 ~~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~~~~ 99 (601)
T KOG0590|consen 20 SQYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRSYLLS 99 (601)
T ss_pred ccccccccccccccchhhhhhhcCCCcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCccCCCcccccc
Confidence 34566666777764 333333322 233444556788888886 99999999999999999999
Q ss_pred EeecCCCccchhc-cccCCCCCCCHHHHHHHHHHHHHHHHHHh-hcCCCCeeccCCCCCcEEEcCCC-cEEEeeccCccc
Q 044312 350 YEFIPNGTLFQYI-HDQNEDFPITWEIRLRIAIEVSGALSYLH-SAASIPIYHRDIKSTNILLDDKY-RAKVSDFGASRS 426 (608)
Q Consensus 350 ~E~~~~gsL~~~l-~~~~~~~~l~~~~~~~i~~~ia~aL~yLH-~~~~~~iiHrDlk~~NILl~~~~-~~kl~DFGls~~ 426 (608)
.++..++++.+.+ +.... ..+....-.+..|+..++.|+| ..+ +.|||+||+|.+++..+ ..|++|||+|..
T Consensus 100 ~~~s~g~~~f~~i~~~~~~--~~~~~~~~~~~~ql~s~l~~~H~~~~---~~h~~ikP~n~~l~~s~~~l~~~df~~At~ 174 (601)
T KOG0590|consen 100 LSYSDGGSLFSKISHPDST--GTSSSSASRYLPQLNSGLSYLHPENG---VTHRDIKPSNSLLDESGSALKIADFGLATA 174 (601)
T ss_pred cCcccccccccccccCCcc--CCCCcchhhhhhhhccCccccCcccc---cccCCCCCccchhccCCCcccCCCchhhcc
Confidence 9999999999988 43221 2555666778999999999999 877 99999999999999999 999999999988
Q ss_pred ccc--CCcceeeeeec-cCCCCChhhhccC-CCCCccchHhHHHHHHHHHhCCCCCCccchhhcccHHHHHHHHhhhhhh
Q 044312 427 MAV--DQTHMTTQVHG-TFGYLDPEYFRSS-QFTDKSDVYSFGVVLTELLTGEKPIRFTILEEDKSLAAYFLCAMKEERL 502 (608)
Q Consensus 427 ~~~--~~~~~~~~~~g-t~~y~aPE~~~~~-~~t~ksDV~S~Gvvl~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~ 502 (608)
+.. ..........| ++.|+|||...+. ...+..|+||.|+++.-+++|..|+......... ..
T Consensus 175 ~~~~~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~~~-~~------------ 241 (601)
T KOG0590|consen 175 YRNKNGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKDGR-YS------------ 241 (601)
T ss_pred ccccCCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCcccccccccc-ce------------
Confidence 765 22333445667 9999999999885 4567899999999999999999998754433211 01
Q ss_pred HHHhhhhh--hccCChhHHHHHHHHHHHHhccCCCCCCCHHHHHH
Q 044312 503 FEILDARV--MKQGGKDEIITVAKLAKRCLNLNGKKRPTMREVAS 545 (608)
Q Consensus 503 ~~~~d~~~--~~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~evl~ 545 (608)
....... .............+++.+++..+|..|.+.+++..
T Consensus 242 -~~~~~~~~~~~~~~~~~~~~~~~~l~k~l~~~~~~r~s~~~~~~ 285 (601)
T KOG0590|consen 242 -SWKSNKGRFTQLPWNSISDQAHDLLHKILKENPSNRLSIEELKL 285 (601)
T ss_pred -eecccccccccCccccCChhhhhcccccccCCchhccccccccc
Confidence 1111100 01112233446778889999999999999888754
|
|
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=99.46 E-value=1.2e-13 Score=154.00 Aligned_cols=124 Identities=21% Similarity=0.275 Sum_probs=100.1
Q ss_pred hcCccccceeccCceEE-------------EEEee--cC------hhhHHHHHHHHHHHhhcCCCCccceecccccCccc
Q 044312 288 TDNFDLNRILGQGGQAV-------------KKSKV--ID------ESKVEEFINEVVILSQINHRNVVKLLGCCLETEVP 346 (608)
Q Consensus 288 t~~f~~~~~lG~G~~av-------------k~~~~--~~------~~~~~~~~~Ei~il~~l~H~niv~l~~~~~~~~~~ 346 (608)
...|...++||+|+++. |+... .. ....+.+.+|++++++++|++++....++.+....
T Consensus 332 ~~~~~~~~~iG~G~~g~Vy~~~~~~~~~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~ 411 (535)
T PRK09605 332 KRRKIPDHLIGKGAEADIKKGEYLGRDAVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVDPEEK 411 (535)
T ss_pred ccccCccceeccCCcEEEEEEeecCccceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEeCCCC
Confidence 44556788999998632 21111 00 11235688999999999999999888777777788
Q ss_pred eEEEeecCCCccchhccccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEEcCCCcEEEeeccCccc
Q 044312 347 LLVYEFIPNGTLFQYIHDQNEDFPITWEIRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRS 426 (608)
Q Consensus 347 ~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGls~~ 426 (608)
++||||+++++|.+++. ....++.+++++|.|||+.+ ++||||||+|||+ +++.++|+|||+++.
T Consensus 412 ~lv~E~~~g~~L~~~l~-----------~~~~~~~~i~~~L~~lH~~g---iiHrDlkp~NILl-~~~~~~liDFGla~~ 476 (535)
T PRK09605 412 TIVMEYIGGKDLKDVLE-----------GNPELVRKVGEIVAKLHKAG---IVHGDLTTSNFIV-RDDRLYLIDFGLGKY 476 (535)
T ss_pred EEEEEecCCCcHHHHHH-----------HHHHHHHHHHHHHHHHHhCC---CccCCCChHHEEE-ECCcEEEEeCccccc
Confidence 99999999999988775 34678999999999999999 9999999999999 577999999999875
|
|
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=99.41 E-value=7.1e-13 Score=128.25 Aligned_cols=98 Identities=24% Similarity=0.335 Sum_probs=82.8
Q ss_pred HHHHHHHHHHHhhcCCCCccceecccccCccceEEEeecCCCccchhccccCCCCCCCHHHHHHHHHHHHHHHHHHhhcC
Q 044312 315 VEEFINEVVILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEIRLRIAIEVSGALSYLHSAA 394 (608)
Q Consensus 315 ~~~~~~Ei~il~~l~H~niv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~ 394 (608)
.+.+.+|+++++.++|+++....-++...+..++||||+++++|.+++.... . .++.+++.+|.+||+.+
T Consensus 41 ~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~~~g~~l~~~~~~~~----~------~~~~~i~~~l~~lH~~g 110 (199)
T TIGR03724 41 RERTRNEARLLSRARKAGVNTPVVYDVDPDNKTIVMEYIEGKPLKDVIEEGN----D------ELLREIGRLVGKLHKAG 110 (199)
T ss_pred HHHHHHHHHHHHHHHHCCCCCCEEEEEECCCCEEEEEEECCccHHHHHhhcH----H------HHHHHHHHHHHHHHHCC
Confidence 3668899999999998876555555556667799999999999988775421 1 78999999999999999
Q ss_pred CCCeeccCCCCCcEEEcCCCcEEEeeccCccc
Q 044312 395 SIPIYHRDIKSTNILLDDKYRAKVSDFGASRS 426 (608)
Q Consensus 395 ~~~iiHrDlk~~NILl~~~~~~kl~DFGls~~ 426 (608)
++|+|++|.|||++ ++.+++.|||+++.
T Consensus 111 ---i~H~Dl~~~Nil~~-~~~~~liDfg~a~~ 138 (199)
T TIGR03724 111 ---IVHGDLTTSNIIVR-DDKLYLIDFGLGKY 138 (199)
T ss_pred ---eecCCCCcceEEEE-CCcEEEEECCCCcC
Confidence 99999999999999 78999999999865
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=99.41 E-value=1.5e-12 Score=126.09 Aligned_cols=96 Identities=21% Similarity=0.195 Sum_probs=78.0
Q ss_pred HHHHHHHHHhhcCCC--CccceecccccCccceEEEeecCCCccchhccccCCCCCCCHHHHHHHHHHHHHHHHHHhhcC
Q 044312 317 EFINEVVILSQINHR--NVVKLLGCCLETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEIRLRIAIEVSGALSYLHSAA 394 (608)
Q Consensus 317 ~~~~Ei~il~~l~H~--niv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~ 394 (608)
.+.+|+.++..+.|+ .+++.++. ...++||||+++++|.+.... .....++.+++.++.++|+.+
T Consensus 79 ~~~~E~~~l~~l~~~~i~v~~~~~~----~~~~lv~e~~~g~~L~~~~~~---------~~~~~~~~~i~~~l~~lh~~g 145 (198)
T cd05144 79 AAQKEFAALKALYEEGFPVPKPIDW----NRHAVVMEYIDGVELYRVRVL---------EDPEEVLDEILEEIVKAYKHG 145 (198)
T ss_pred HHHHHHHHHHHHHHcCCCCCceeec----CCceEEEEEeCCcchhhcccc---------ccHHHHHHHHHHHHHHHHHCC
Confidence 367889999999887 45555542 345899999999998765431 234578899999999999998
Q ss_pred CCCeeccCCCCCcEEEcCCCcEEEeeccCccccc
Q 044312 395 SIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMA 428 (608)
Q Consensus 395 ~~~iiHrDlk~~NILl~~~~~~kl~DFGls~~~~ 428 (608)
++||||||+||++++++.++|+|||++....
T Consensus 146 ---i~H~Dl~p~Nill~~~~~~~liDfg~~~~~~ 176 (198)
T cd05144 146 ---IIHGDLSEFNILVDDDEKIYIIDWPQMVSTD 176 (198)
T ss_pred ---CCcCCCCcccEEEcCCCcEEEEECCccccCC
Confidence 9999999999999999999999999996554
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >KOG1266 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.40 E-value=1.8e-13 Score=135.32 Aligned_cols=202 Identities=21% Similarity=0.292 Sum_probs=141.3
Q ss_pred HHhhcCCCCccceecccccCc-----cceEEEeecCCCccchhccccC-CCCCCCHHHHHHHHHHHHHHHHHHhhcCCCC
Q 044312 324 ILSQINHRNVVKLLGCCLETE-----VPLLVYEFIPNGTLFQYIHDQN-EDFPITWEIRLRIAIEVSGALSYLHSAASIP 397 (608)
Q Consensus 324 il~~l~H~niv~l~~~~~~~~-----~~~lV~E~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ 397 (608)
-|-++-|.|||+++.++.+.. ...++.|||..|+|..+|++.. .+..+......+|+.||..||.|||+.. +|
T Consensus 120 nllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs~~-Pp 198 (458)
T KOG1266|consen 120 NLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHSCD-PP 198 (458)
T ss_pred HHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhccC-Cc
Confidence 355667999999999987543 4678999999999999998732 2335888889999999999999999976 66
Q ss_pred eeccCCCCCcEEEcCCCcEEEeeccCcccccc----CCcceeeeeeccCCCCChhhhccCCCCCccchHhHHHHHHHHHh
Q 044312 398 IYHRDIKSTNILLDDKYRAKVSDFGASRSMAV----DQTHMTTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLTELLT 473 (608)
Q Consensus 398 iiHrDlk~~NILl~~~~~~kl~DFGls~~~~~----~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~ellt 473 (608)
|+|+++.-+.|++..++-+|+.--. ...... ..........+-++|.+||+=...+.+.++|||+||...+||..
T Consensus 199 iihgnlTc~tifiq~ngLIkig~~a-p~s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~tn~~~a~dIy~fgmcAlemai 277 (458)
T KOG1266|consen 199 IIHGNLTCDTIFIQHNGLIKIGSVA-PDSTHPSVNSTREAEKSVNTSLPGFSAPESGTTTNTTGASDIYKFGMCALEMAI 277 (458)
T ss_pred cccCCcchhheeecCCceEEecccC-ccccchhhhhhhHhhhhccccCCccccCCcCcccccccchhhhhhhHHHHHHHH
Confidence 9999999999999999988875321 111110 00111122346789999999888889999999999999999987
Q ss_pred CCCCCCccchhhcccHHHHHHHHhhhhhhHHHhhhhhhccCChhHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 044312 474 GEKPIRFTILEEDKSLAAYFLCAMKEERLFEILDARVMKQGGKDEIITVAKLAKRCLNLNGKKRPTMREVASE 546 (608)
Q Consensus 474 g~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~evl~~ 546 (608)
+..--... +.. - ..+..+...+ ...+. ..-+.++.+|++..|..||+|++++.+
T Consensus 278 lEiq~tns--eS~-~--------~~ee~ia~~i---~~len-----~lqr~~i~kcl~~eP~~rp~ar~llfH 331 (458)
T KOG1266|consen 278 LEIQSTNS--ESK-V--------EVEENIANVI---IGLEN-----GLQRGSITKCLEGEPNGRPDARLLLFH 331 (458)
T ss_pred heeccCCC--cce-e--------ehhhhhhhhe---eeccC-----ccccCcCcccccCCCCCCcchhhhhcC
Confidence 76431110 000 0 0000000000 00011 123457889999999999999998764
|
|
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=99.38 E-value=3.1e-12 Score=127.29 Aligned_cols=101 Identities=19% Similarity=0.149 Sum_probs=79.7
Q ss_pred HHHHHHHHHhhcCCC--CccceecccccCccceEEEeecCCCccchhccccCCCCCCCHHHHHHHHHHHHHHHHHHhhcC
Q 044312 317 EFINEVVILSQINHR--NVVKLLGCCLETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEIRLRIAIEVSGALSYLHSAA 394 (608)
Q Consensus 317 ~~~~Ei~il~~l~H~--niv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~ 394 (608)
.+.+|+.+++++.+. .+.++++. ...+|||||+++.+|...+.... .+.......++.||+.+|++||+.+
T Consensus 96 ~~~~E~~~L~~L~~~~i~~p~~~~~----~~~~lV~E~~~g~~L~~~~~~~~---~~~~~~~~~i~~qi~~~l~~LH~~g 168 (237)
T smart00090 96 WAEKEFRNLQRLYEAGVPVPKPIAW----RRNVLVMEFIGGDGLPAPRLKDV---EPEEEEEFELYDDILEEMRKLYKEG 168 (237)
T ss_pred HHHHHHHHHHHHHhcCCCCCeeeEe----cCceEEEEEecCCcccccccccC---CcchHHHHHHHHHHHHHHHHHHhcC
Confidence 356899999999753 34455543 23589999999988877653322 3566677899999999999999987
Q ss_pred CCCeeccCCCCCcEEEcCCCcEEEeeccCcccc
Q 044312 395 SIPIYHRDIKSTNILLDDKYRAKVSDFGASRSM 427 (608)
Q Consensus 395 ~~~iiHrDlk~~NILl~~~~~~kl~DFGls~~~ 427 (608)
. ++||||||+|||++ ++.++|+|||++...
T Consensus 169 ~--iiH~Dikp~NIli~-~~~i~LiDFg~a~~~ 198 (237)
T smart00090 169 E--LVHGDLSEYNILVH-DGKVVIIDVSQSVEL 198 (237)
T ss_pred C--EEeCCCChhhEEEE-CCCEEEEEChhhhcc
Confidence 3 99999999999999 789999999998754
|
|
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=99.35 E-value=6e-12 Score=114.85 Aligned_cols=114 Identities=24% Similarity=0.240 Sum_probs=93.7
Q ss_pred ceEEEEEeecChhhHHHHHHHHHHHhhcCC--CCccceecccccCccceEEEeecCCCccchhccccCCCCCCCHHHHHH
Q 044312 301 GQAVKKSKVIDESKVEEFINEVVILSQINH--RNVVKLLGCCLETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEIRLR 378 (608)
Q Consensus 301 ~~avk~~~~~~~~~~~~~~~Ei~il~~l~H--~niv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~ 378 (608)
.+++|....... ...+.+|+.+++.++| .++++++++....+..+++|||++++.+..+ +......
T Consensus 23 ~~~iK~~~~~~~--~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~~~g~~~~~~----------~~~~~~~ 90 (155)
T cd05120 23 DYVLKINPSREK--GADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEWIEGETLDEV----------SEEEKED 90 (155)
T ss_pred eEEEEecCCCCc--hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEEecCCeecccC----------CHHHHHH
Confidence 345665543222 5679999999999976 5999999988888889999999988777554 4566778
Q ss_pred HHHHHHHHHHHHhhcCCCCeeccCCCCCcEEEcCCCcEEEeeccCccc
Q 044312 379 IAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRS 426 (608)
Q Consensus 379 i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGls~~ 426 (608)
++.+++++|++||......++|+|++|+|||+++.+.+++.|||.++.
T Consensus 91 ~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~ 138 (155)
T cd05120 91 IAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGY 138 (155)
T ss_pred HHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccC
Confidence 899999999999986544599999999999999989999999998864
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.33 E-value=7.5e-12 Score=124.74 Aligned_cols=102 Identities=20% Similarity=0.296 Sum_probs=81.8
Q ss_pred HHHHHHHHHHHhhcCCCCc--cceecccccCc----cceEEEeecCC-CccchhccccCCCCCCCHHHHHHHHHHHHHHH
Q 044312 315 VEEFINEVVILSQINHRNV--VKLLGCCLETE----VPLLVYEFIPN-GTLFQYIHDQNEDFPITWEIRLRIAIEVSGAL 387 (608)
Q Consensus 315 ~~~~~~Ei~il~~l~H~ni--v~l~~~~~~~~----~~~lV~E~~~~-gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL 387 (608)
...+.+|+.++.+|+|++| ++.+++..... ..++|||++++ .+|.+++... +++.. .+.+|+.+|
T Consensus 84 ~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~~~~~~~~~lV~e~l~G~~~L~~~l~~~----~l~~~----~~~~i~~~l 155 (239)
T PRK01723 84 RTRAFAEFRLLAQLYEAGLPVPRPIAARVVRHGLFYRADILIERIEGARDLVALLQEA----PLSEE----QWQAIGQLI 155 (239)
T ss_pred hhHHHHHHHHHHHHHhCCCCCceeEeeeeeecCcceeeeEEEEecCCCCCHHHHHhcC----CCCHH----HHHHHHHHH
Confidence 4568899999999998875 67777654322 23599999997 6888887542 34543 356899999
Q ss_pred HHHhhcCCCCeeccCCCCCcEEEcCCCcEEEeeccCcccc
Q 044312 388 SYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSM 427 (608)
Q Consensus 388 ~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGls~~~ 427 (608)
.+||+.+ |+||||||.|||++.++.++|+|||.++..
T Consensus 156 ~~lH~~G---I~HrDlkp~NILv~~~~~v~LIDfg~~~~~ 192 (239)
T PRK01723 156 ARFHDAG---VYHADLNAHNILLDPDGKFWLIDFDRGELR 192 (239)
T ss_pred HHHHHCC---CCCCCCCchhEEEcCCCCEEEEECCCcccC
Confidence 9999999 999999999999998889999999988753
|
|
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=99.14 E-value=2e-10 Score=109.93 Aligned_cols=96 Identities=21% Similarity=0.230 Sum_probs=70.0
Q ss_pred HHHHHHhhcCCC--CccceecccccCccceEEEeecCCCccchh-ccccCCCCCCCHHHHHHHHHHHHHHHHHHhh-cCC
Q 044312 320 NEVVILSQINHR--NVVKLLGCCLETEVPLLVYEFIPNGTLFQY-IHDQNEDFPITWEIRLRIAIEVSGALSYLHS-AAS 395 (608)
Q Consensus 320 ~Ei~il~~l~H~--niv~l~~~~~~~~~~~lV~E~~~~gsL~~~-l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~-~~~ 395 (608)
.|...+.++.+. .+.+.+++ ...++||||++++.+... +.... .. .....++.+++.++.++|. .+
T Consensus 66 ~e~~~l~~l~~~~~~~~~~~~~----~~~~lv~e~~~g~~~~~~~l~~~~----~~-~~~~~~~~~~~~~l~~lh~~~~- 135 (187)
T cd05119 66 KEFRNLKRLYEAGVPVPKPIDL----NRHVLVMEFIGGDGIPAPRLKDVR----LL-EDPEELYDQILELMRKLYREAG- 135 (187)
T ss_pred HHHHHHHHHHHcCCCCCceEec----CCCEEEEEEeCCCCccChhhhhhh----hc-ccHHHHHHHHHHHHHHHhhccC-
Confidence 456666666443 24444443 245899999998654322 21111 11 5678899999999999999 88
Q ss_pred CCeeccCCCCCcEEEcCCCcEEEeeccCccccc
Q 044312 396 IPIYHRDIKSTNILLDDKYRAKVSDFGASRSMA 428 (608)
Q Consensus 396 ~~iiHrDlk~~NILl~~~~~~kl~DFGls~~~~ 428 (608)
|+|+||||+||+++ ++.++|+|||++....
T Consensus 136 --ivH~Dl~p~Nili~-~~~~~liDfg~a~~~~ 165 (187)
T cd05119 136 --LVHGDLSEYNILVD-DGKVYIIDVPQAVEID 165 (187)
T ss_pred --cCcCCCChhhEEEE-CCcEEEEECccccccc
Confidence 99999999999999 8899999999997543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.08 E-value=7.4e-11 Score=126.46 Aligned_cols=221 Identities=20% Similarity=0.226 Sum_probs=158.3
Q ss_pred eEEEEEeecCh--hhHHHHHHHHHHHhhc-CCCCccceecccccCccceEEEeecCCCccchhccccCCCCCCCHHHHHH
Q 044312 302 QAVKKSKVIDE--SKVEEFINEVVILSQI-NHRNVVKLLGCCLETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEIRLR 378 (608)
Q Consensus 302 ~avk~~~~~~~--~~~~~~~~Ei~il~~l-~H~niv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~ 378 (608)
+|+|+.+..-. .....=.+|+.....+ .|+|.++....+.+++..++-+|++ +.+|.++.+.... .++....+.
T Consensus 146 ~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e~~~~lfiqtE~~-~~sl~~~~~~~~~--~~p~~~l~~ 222 (524)
T KOG0601|consen 146 FAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPAWEGSGILFIQTELC-GESLQSYCHTPCN--FLPDNLLWN 222 (524)
T ss_pred cccccccCCCCCccccccccchhhcccccCccccccccCcccccCCcceeeeccc-cchhHHhhhcccc--cCCchhhhh
Confidence 57777554222 3334445677766777 5999999999999999999999999 5788888876543 256666777
Q ss_pred HHHHHHH----HHHHHhhcCCCCeeccCCCCCcEEEcCC-CcEEEeeccCccccccCCcc----eeeeeeccCCCCChhh
Q 044312 379 IAIEVSG----ALSYLHSAASIPIYHRDIKSTNILLDDK-YRAKVSDFGASRSMAVDQTH----MTTQVHGTFGYLDPEY 449 (608)
Q Consensus 379 i~~~ia~----aL~yLH~~~~~~iiHrDlk~~NILl~~~-~~~kl~DFGls~~~~~~~~~----~~~~~~gt~~y~aPE~ 449 (608)
+..+... ||..+|+.. ++|-|+||.||++..+ ...++.|||+...+....-. ......|...|++||.
T Consensus 223 ~~~~~~~~~~~al~~~hs~~---~~~~~~kp~~i~~~~~~~s~~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~ 299 (524)
T KOG0601|consen 223 SLRDWLSRDVTALSHLHSNN---IVHDDLKPANIFTTSDWTSCKLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKEL 299 (524)
T ss_pred HHhhhhhcccccccccCCCc---ccccccchhheecccccceeecCCcceeEEccCCccccceeeeecCCCCceEeChhh
Confidence 7777777 999999999 9999999999999988 88999999999877644311 1223367888999998
Q ss_pred hccCCCCCccchHhHHHHHHHHHhCCCCCCccchhhcccHHHHHHHHhhhhhhHHHhhhhhhccCChhHHHHHHHHHHHH
Q 044312 450 FRSSQFTDKSDVYSFGVVLTELLTGEKPIRFTILEEDKSLAAYFLCAMKEERLFEILDARVMKQGGKDEIITVAKLAKRC 529 (608)
Q Consensus 450 ~~~~~~t~ksDV~S~Gvvl~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~Li~~c 529 (608)
.. ..++.++|+|++|.++++..++..+........ |. ..+ ... +..++-.....++...+.+|
T Consensus 300 ~~-~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~------W~--~~r-----~~~---ip~e~~~~~s~~l~~~~~~~ 362 (524)
T KOG0601|consen 300 LN-GLATFASDIFSLGEVILEAILGSHLPSVGKNSS------WS--QLR-----QGY---IPLEFCEGGSSSLRSVTSQM 362 (524)
T ss_pred hc-cccchHhhhcchhhhhHhhHhhcccccCCCCCC------cc--ccc-----ccc---CchhhhcCcchhhhhHHHHh
Confidence 76 567889999999999999999876643211000 00 000 000 11111122234566689999
Q ss_pred hccCCCCCCCHHHHHH
Q 044312 530 LNLNGKKRPTMREVAS 545 (608)
Q Consensus 530 l~~dp~~RPs~~evl~ 545 (608)
+..+|..|++.+.+..
T Consensus 363 ~d~~~~~~~~~q~~~~ 378 (524)
T KOG0601|consen 363 LDEDPRLRLTAQILTA 378 (524)
T ss_pred cCcchhhhhHHHHHhc
Confidence 9999999999877664
|
|
| >KOG1243 consensus Protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.03 E-value=4.2e-09 Score=114.24 Aligned_cols=160 Identities=18% Similarity=0.185 Sum_probs=119.4
Q ss_pred eEEEEEeecChhhHHHHHHHHHHHhhcCCCCccceecccccCccceEEEeecCCCccchhccccCCCCCCCHHHHHHHHH
Q 044312 302 QAVKKSKVIDESKVEEFINEVVILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEIRLRIAI 381 (608)
Q Consensus 302 ~avk~~~~~~~~~~~~~~~Ei~il~~l~H~niv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~ 381 (608)
..|...+..+....+...+-++-|+.|+||||++++..+......|||+|.+. .|..++.+. ........+.
T Consensus 40 vsVF~~~~~~~~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTErV~--Pl~~~lk~l------~~~~v~~Gl~ 111 (690)
T KOG1243|consen 40 VSVFVYKRSNGEVTELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTERVR--PLETVLKEL------GKEEVCLGLF 111 (690)
T ss_pred eEEEEEeCCCchhhHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEeeccc--cHHHHHHHh------HHHHHHHHHH
Confidence 35666666556556677888899999999999999999999999999999884 566666543 3445566788
Q ss_pred HHHHHHHHHhhcCCCCeeccCCCCCcEEEcCCCcEEEeeccCccccccCCcceeeeeeccCCCCChhhhccCCCCCccch
Q 044312 382 EVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHGTFGYLDPEYFRSSQFTDKSDV 461 (608)
Q Consensus 382 ~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGls~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV 461 (608)
||+.||.+||+.+. ++|++|.-+.|+++..|..||++|.++........ ......---.|..|+.+.... -..|.
T Consensus 112 qIl~AL~FL~~d~~--lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~-~~~~~~~~~s~~~P~~~~~s~--~s~D~ 186 (690)
T KOG1243|consen 112 QILAALSFLNDDCN--LVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNA-PAKSLYLIESFDDPEEIDPSE--WSIDS 186 (690)
T ss_pred HHHHHHHHHhccCC--eeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCc-ccccchhhhcccChhhcCccc--cchhh
Confidence 99999999986553 99999999999999999999999988754332111 111111122456666544322 34699
Q ss_pred HhHHHHHHHHHhC
Q 044312 462 YSFGVVLTELLTG 474 (608)
Q Consensus 462 ~S~Gvvl~elltg 474 (608)
|-||++++|++.|
T Consensus 187 ~~Lg~li~el~ng 199 (690)
T KOG1243|consen 187 WGLGCLIEELFNG 199 (690)
T ss_pred hhHHHHHHHHhCc
Confidence 9999999999999
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=98.92 E-value=2.6e-10 Score=128.33 Aligned_cols=193 Identities=24% Similarity=0.305 Sum_probs=142.9
Q ss_pred cCCCCccceecccccCccceEEEeecCCCccchhccccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCc
Q 044312 328 INHRNVVKLLGCCLETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEIRLRIAIEVSGALSYLHSAASIPIYHRDIKSTN 407 (608)
Q Consensus 328 l~H~niv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~N 407 (608)
.+||-++...--+......+|+++|+.+++|...|+... ..+..........+..+++|||+.. +.|+|++|.|
T Consensus 861 p~~P~v~~~~~s~~~rsP~~L~~~~~~~~~~~Skl~~~~---~~saepaRs~i~~~vqs~e~L~s~~---r~h~~~~p~~ 934 (1205)
T KOG0606|consen 861 PRSPAVVRSFPSFPCRSPLPLVGHYLNGGDLPSKLHNSG---CLSAEPARSPILERVQSLESLHSSL---RKHRDLKPDS 934 (1205)
T ss_pred CCCCceecccCCCCCCCCcchhhHHhccCCchhhhhcCC---CcccccccchhHHHHhhhhccccch---hhcccccccc
Confidence 345666665555667788899999999999999998765 3455555566777889999999987 8999999999
Q ss_pred EEEcCCCcEEEeeccCccccccC------------------------------CcceeeeeeccCCCCChhhhccCCCCC
Q 044312 408 ILLDDKYRAKVSDFGASRSMAVD------------------------------QTHMTTQVHGTFGYLDPEYFRSSQFTD 457 (608)
Q Consensus 408 ILl~~~~~~kl~DFGls~~~~~~------------------------------~~~~~~~~~gt~~y~aPE~~~~~~~t~ 457 (608)
+|+..++..+++|||+......- .........+|+.|.+||...+.....
T Consensus 935 ~l~~~~gh~~l~~~~t~~~vg~~~p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hgs 1014 (1205)
T KOG0606|consen 935 LLIAYDGHRPLTDFGTLSKVGLIPPTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHGS 1014 (1205)
T ss_pred hhhcccCCcccCccccccccccccCcCCcccccccCccccccccccccccccchhhccccccCCCcccCCcccccccCCC
Confidence 99999999999999843322100 000122356899999999999999999
Q ss_pred ccchHhHHHHHHHHHhCCCCCCccchhhcccHHHHHHHHhhhhhhHHHhhhhh-hccCChhHHHHHHHHHHHHhccCCCC
Q 044312 458 KSDVYSFGVVLTELLTGEKPIRFTILEEDKSLAAYFLCAMKEERLFEILDARV-MKQGGKDEIITVAKLAKRCLNLNGKK 536 (608)
Q Consensus 458 ksDV~S~Gvvl~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~-~~~~~~~~~~~l~~Li~~cl~~dp~~ 536 (608)
.+|.|++|++++|.++|..||.....+. .| ..++.... ....+...+.+..+++.+.+..+|.+
T Consensus 1015 ~ad~~~~g~~l~e~l~g~pp~na~tpq~------~f---------~ni~~~~~~~p~g~~~~s~~aq~~~~~ll~~~~~q 1079 (1205)
T KOG0606|consen 1015 AADWWSSGVCLFEVLTGIPPFNAETPQQ------IF---------ENILNRDIPWPEGPEEGSYEAQDLINRLLTEEPTQ 1079 (1205)
T ss_pred cchhhhhhhhhhhhhcCCCCCCCcchhh------hh---------hccccCCCCCCCCccccChhhhhhhhhhhccCchh
Confidence 9999999999999999999987433221 11 11221111 12233445667889999999999999
Q ss_pred CCCHH
Q 044312 537 RPTMR 541 (608)
Q Consensus 537 RPs~~ 541 (608)
|-.+.
T Consensus 1080 r~~a~ 1084 (1205)
T KOG0606|consen 1080 RLGAK 1084 (1205)
T ss_pred ccCcc
Confidence 98776
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.90 E-value=4.8e-10 Score=120.29 Aligned_cols=248 Identities=19% Similarity=0.232 Sum_probs=166.0
Q ss_pred ccccCCHHH-HHHHhcCccccceeccCce----------------EEEEEeecChhhH--HHHHHHHHHHhhc-CCCCcc
Q 044312 275 KTKLFTSKE-LEKATDNFDLNRILGQGGQ----------------AVKKSKVIDESKV--EEFINEVVILSQI-NHRNVV 334 (608)
Q Consensus 275 ~~~~~~~~~-l~~~t~~f~~~~~lG~G~~----------------avk~~~~~~~~~~--~~~~~Ei~il~~l-~H~niv 334 (608)
..++|..++ ....+..|.+...||.|.+ ++|.+...-.... ..-..|+.+...+ .|.|++
T Consensus 250 p~~i~~~~~~~s~~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~ 329 (524)
T KOG0601|consen 250 PANIFTTSDWTSCKLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSV 329 (524)
T ss_pred hhheecccccceeecCCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccC
Confidence 344555555 3445667888888888874 1111111000111 1123466666655 689999
Q ss_pred ceecccccCccceEEEeecCCCccchhccccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEEcCC-
Q 044312 335 KLLGCCLETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEIRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDK- 413 (608)
Q Consensus 335 ~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~- 413 (608)
++...+......++--||+.++++...+.... .+....++++..|++.++.++|+.. ++|+|+||+||++..+
T Consensus 330 g~~~~W~~~r~~~ip~e~~~~~s~~l~~~~~~---~~d~~~~~~~~~q~~~~l~~i~s~~---~~~~d~~psni~i~~~~ 403 (524)
T KOG0601|consen 330 GKNSSWSQLRQGYIPLEFCEGGSSSLRSVTSQ---MLDEDPRLRLTAQILTALNVIHSKL---FVHLDVKPSNILISNDG 403 (524)
T ss_pred CCCCCccccccccCchhhhcCcchhhhhHHHH---hcCcchhhhhHHHHHhccccccchh---hhcccccccceeeccch
Confidence 99998888888899999999998877663221 3677888999999999999999988 9999999999999875
Q ss_pred CcEEEeeccCccccccCCcceeeeeeccCCC-CChhhhccCCCCCccchHhHHHHHHHHHhCCCCCCccchhhcccHHHH
Q 044312 414 YRAKVSDFGASRSMAVDQTHMTTQVHGTFGY-LDPEYFRSSQFTDKSDVYSFGVVLTELLTGEKPIRFTILEEDKSLAAY 492 (608)
Q Consensus 414 ~~~kl~DFGls~~~~~~~~~~~~~~~gt~~y-~aPE~~~~~~~t~ksDV~S~Gvvl~elltg~~p~~~~~~~~~~~l~~~ 492 (608)
+..++.|||....+.... ......+..| .+|+......+-.+.|+||||.-+.|.+++..--.. ... +
T Consensus 404 ~~~~~~~~~~~t~~~~~~---~~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ls~~-----~~~---~ 472 (524)
T KOG0601|consen 404 FFSKLGDFGCWTRLAFSS---GVFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPLSES-----GVQ---S 472 (524)
T ss_pred hhhhccccccccccceec---ccccccccccccchhhccccccccccccccccccccccccCcccCcc-----ccc---c
Confidence 788999999886532111 1111123333 356666677889999999999999999998753210 000 0
Q ss_pred HHHHhhhhhhHHHhhhhhhccCChhHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhhH
Q 044312 493 FLCAMKEERLFEILDARVMKQGGKDEIITVAKLAKRCLNLNGKKRPTMREVASELAGIK 551 (608)
Q Consensus 493 ~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~evl~~L~~i~ 551 (608)
..+..+.. .........+..+.+.++..++..||.+.++..+.+..+
T Consensus 473 --~~i~~~~~----------p~~~~~~~~~q~~~kv~~~~~~~~~~l~~~l~~~~~~~~ 519 (524)
T KOG0601|consen 473 --LTIRSGDT----------PNLPGLKLQLQVLLKVMINPDRKRRPSAVELSLHSEFYR 519 (524)
T ss_pred --eeeecccc----------cCCCchHHhhhhhhhhhcCCccccchhhhhhcccchhhh
Confidence 00111111 111222356788899999999999999988876655444
|
|
| >cd05151 ChoK Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Probab=98.82 E-value=9.8e-09 Score=96.34 Aligned_cols=111 Identities=22% Similarity=0.167 Sum_probs=78.4
Q ss_pred ceEEEEEeecChhhHHHHHHHHHHHhhcCCCCc-cceecccccCccceEEEeecCCCccchhccccCCCCCCCHHHHHHH
Q 044312 301 GQAVKKSKVIDESKVEEFINEVVILSQINHRNV-VKLLGCCLETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEIRLRI 379 (608)
Q Consensus 301 ~~avk~~~~~~~~~~~~~~~Ei~il~~l~H~ni-v~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i 379 (608)
.+++|....... ....+.+|+.+++.+.+.++ .+++.+.. ...++||||+++.++.+. . .. ...+
T Consensus 23 ~~~lK~~~~~~~-~~~~~~~E~~~l~~l~~~~~~P~~~~~~~--~~~~lv~e~i~G~~l~~~----~----~~---~~~~ 88 (170)
T cd05151 23 KYVVRIPGNGTE-LLINRENEAENSKLAAEAGIGPKLYYFDP--ETGVLITEFIEGSELLTE----D----FS---DPEN 88 (170)
T ss_pred EEEEEeCCCCcc-cccCHHHHHHHHHHHHHhCCCCceEEEeC--CCCeEEEEecCCCccccc----c----cc---CHHH
Confidence 466776543221 23457889999999866554 45555432 345899999999887643 0 11 1235
Q ss_pred HHHHHHHHHHHhhcC--CCCeeccCCCCCcEEEcCCCcEEEeeccCccc
Q 044312 380 AIEVSGALSYLHSAA--SIPIYHRDIKSTNILLDDKYRAKVSDFGASRS 426 (608)
Q Consensus 380 ~~~ia~aL~yLH~~~--~~~iiHrDlk~~NILl~~~~~~kl~DFGls~~ 426 (608)
+.+++++|+.||+.. ...++|+|++|.||+++ ++.+++.||+.+..
T Consensus 89 ~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~~ 136 (170)
T cd05151 89 LEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAGM 136 (170)
T ss_pred HHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEecccccC
Confidence 678999999999987 22359999999999999 56899999998753
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph |
| >KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=98.79 E-value=8.1e-08 Score=101.32 Aligned_cols=202 Identities=18% Similarity=0.256 Sum_probs=135.6
Q ss_pred eEEEEEeecChhhHHHHHHHHHHHhhcCCCCccceeccccc----CccceEEEeecCC-CccchhccccC----------
Q 044312 302 QAVKKSKVIDESKVEEFINEVVILSQINHRNVVKLLGCCLE----TEVPLLVYEFIPN-GTLFQYIHDQN---------- 366 (608)
Q Consensus 302 ~avk~~~~~~~~~~~~~~~Ei~il~~l~H~niv~l~~~~~~----~~~~~lV~E~~~~-gsL~~~l~~~~---------- 366 (608)
+.+|+++.........-..-+++++++.|.|||++..++.. +..++|||+|+|+ ++|.++.....
T Consensus 304 YvLkRlhg~r~~~~nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~TL~d~~F~~~~~t~~~n~~~ 383 (655)
T KOG3741|consen 304 YVLKRLHGDRDQSTNKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPTLYDLYFANPPFTKRTNSFY 383 (655)
T ss_pred eeeeeeccccccCcccchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCchHHHHHccCCcccccccccc
Confidence 45566533222222233345778999999999999999873 3467899999986 46766443211
Q ss_pred --CCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEEcCCCcEEEeeccCccccccCCcceeeeeeccCCC
Q 044312 367 --EDFPITWEIRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHGTFGY 444 (608)
Q Consensus 367 --~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGls~~~~~~~~~~~~~~~gt~~y 444 (608)
.....++..++.++.|++.||.++|+.| ..-+-|.+++||++.+.+++|+..|....+..+...
T Consensus 384 ~~~~~~~~e~~lW~y~~QLtaaL~sIHssG---LAck~L~~~kIlv~G~~RIriS~C~i~Dvl~~d~~~----------- 449 (655)
T KOG3741|consen 384 PSQNLKAPEEVLWSYISQLTAALYSIHSSG---LACKTLDLKKILVTGKMRIRISGCGIMDVLQEDPTE----------- 449 (655)
T ss_pred ccCCCCchHHHHHHHHHHHHHHHHHHHhcC---ceeecccHhHeEeeCcceEEEecccceeeecCCCCc-----------
Confidence 1123678899999999999999999999 888999999999999999999988887766544311
Q ss_pred CChhhhccCCCCCccchHhHHHHHHHHHhCCCCCCccchhhcccHHHHHHHHhhhhhhHHHhhhhhhccCChhHHHHHHH
Q 044312 445 LDPEYFRSSQFTDKSDVYSFGVVLTELLTGEKPIRFTILEEDKSLAAYFLCAMKEERLFEILDARVMKQGGKDEIITVAK 524 (608)
Q Consensus 445 ~aPE~~~~~~~t~ksDV~S~Gvvl~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~ 524 (608)
.+. --.+-|.=.||.+++-|.||..--..... ....++..+ ....+.++++
T Consensus 450 ----~le---~~Qq~D~~~lG~ll~aLAt~~~ns~~~d~-------------~~~s~~~~I---------~~~yS~D~rn 500 (655)
T KOG3741|consen 450 ----PLE---SQQQNDLRDLGLLLLALATGTENSNRTDS-------------TQSSHLTRI---------TTTYSTDLRN 500 (655)
T ss_pred ----chh---HHhhhhHHHHHHHHHHHhhcccccccccc-------------hHHHHHHHh---------hhhhhHHHHH
Confidence 111 12356888999999999998543110000 000011111 1234556777
Q ss_pred HHHHHhccCCCCCCCHHHHHHHH
Q 044312 525 LAKRCLNLNGKKRPTMREVASEL 547 (608)
Q Consensus 525 Li~~cl~~dp~~RPs~~evl~~L 547 (608)
++......++++ -+..+++.++
T Consensus 501 ~v~yl~s~~~~~-ksI~~llp~~ 522 (655)
T KOG3741|consen 501 VVEYLESLNFRE-KSIQDLLPMI 522 (655)
T ss_pred HHHHHHhcCccc-ccHHHHHHHH
Confidence 888888888876 5666666543
|
|
| >cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain | Back alignment and domain information |
|---|
Probab=98.73 E-value=6e-08 Score=92.98 Aligned_cols=99 Identities=17% Similarity=0.158 Sum_probs=75.1
Q ss_pred HHHHHHHHhhcC--CCCccceecccccCccceEEEeecCCCccch-hccccCCCCCCCHHHHHHHHHHHHHHHHHH-hhc
Q 044312 318 FINEVVILSQIN--HRNVVKLLGCCLETEVPLLVYEFIPNGTLFQ-YIHDQNEDFPITWEIRLRIAIEVSGALSYL-HSA 393 (608)
Q Consensus 318 ~~~Ei~il~~l~--H~niv~l~~~~~~~~~~~lV~E~~~~gsL~~-~l~~~~~~~~l~~~~~~~i~~~ia~aL~yL-H~~ 393 (608)
..+|++.|+++. .-++.+++++ ..-+|||||+.+..+.. .+.+. .++......+..+++.+|..| |..
T Consensus 73 a~kE~r~L~rl~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~Lkd~----~~~~~~~~~i~~~i~~~l~~l~H~~ 144 (197)
T cd05146 73 AEKEMHNLKRMQKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPKLKDA----KLNDEEMKNAYYQVLSMMKQLYKEC 144 (197)
T ss_pred HHHHHHHHHHHHHcCCCCCeEEEe----cCCEEEEEEcCCCCccchhhhcc----ccCHHHHHHHHHHHHHHHHHHHHhC
Confidence 448999999994 3567777765 45689999997644422 22221 245556677889999999999 888
Q ss_pred CCCCeeccCCCCCcEEEcCCCcEEEeeccCccccc
Q 044312 394 ASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMA 428 (608)
Q Consensus 394 ~~~~iiHrDlk~~NILl~~~~~~kl~DFGls~~~~ 428 (608)
+ ++|+||++.|||+++ +.+.|+|||.+....
T Consensus 145 g---lVHGDLs~~NIL~~~-~~v~iIDF~qav~~~ 175 (197)
T cd05146 145 N---LVHADLSEYNMLWHD-GKVWFIDVSQSVEPT 175 (197)
T ss_pred C---eecCCCCHHHEEEEC-CcEEEEECCCceeCC
Confidence 8 999999999999974 579999999886543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown. |
| >COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.69 E-value=8e-08 Score=89.40 Aligned_cols=97 Identities=26% Similarity=0.328 Sum_probs=75.9
Q ss_pred HHHHHHHHHHhhcCCCCccceecccccCccceEEEeecCCCccchhccccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCC
Q 044312 316 EEFINEVVILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEIRLRIAIEVSGALSYLHSAAS 395 (608)
Q Consensus 316 ~~~~~Ei~il~~l~H~niv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~ 395 (608)
+.-.+|.++|++++--.|.--.=+..+.....|+|||++|-.|.+.+... ...++..+-.-+.-||..+
T Consensus 44 ~Rt~~Earil~~a~~~GV~~P~v~dvD~~~~~I~me~I~G~~lkd~l~~~----------~~~~~r~vG~~vg~lH~~g- 112 (204)
T COG3642 44 ERTRREARILAKAREAGVPVPIVYDVDPDNGLIVMEYIEGELLKDALEEA----------RPDLLREVGRLVGKLHKAG- 112 (204)
T ss_pred HHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCEEEEEEeCChhHHHHHHhc----------chHHHHHHHHHHHHHHhcC-
Confidence 45678999999886444433333344666778999999998888888654 2456777778888999999
Q ss_pred CCeeccCCCCCcEEEcCCCcEEEeeccCccc
Q 044312 396 IPIYHRDIKSTNILLDDKYRAKVSDFGASRS 426 (608)
Q Consensus 396 ~~iiHrDlk~~NILl~~~~~~kl~DFGls~~ 426 (608)
|+|+||.++||++..+. +.++||||+..
T Consensus 113 --ivHGDLTtsNiIl~~~~-i~~IDfGLg~~ 140 (204)
T COG3642 113 --IVHGDLTTSNIILSGGR-IYFIDFGLGEF 140 (204)
T ss_pred --eecCCCccceEEEeCCc-EEEEECCcccc
Confidence 99999999999998764 99999999874
|
|
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=98.66 E-value=5.4e-08 Score=105.49 Aligned_cols=103 Identities=17% Similarity=0.191 Sum_probs=72.3
Q ss_pred HHHHHHHHhhcC----CCCccceecccc-cCccceEEEeecCCCccchhccccCCCCCCCHHHHHHHHHHHHH-HHHHHh
Q 044312 318 FINEVVILSQIN----HRNVVKLLGCCL-ETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEIRLRIAIEVSG-ALSYLH 391 (608)
Q Consensus 318 ~~~Ei~il~~l~----H~niv~l~~~~~-~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~-aL~yLH 391 (608)
|.+|.+.+.++. |.+-+.+-..+. .....+|||||++|++|.++...... .. .+..++..++. .+..+|
T Consensus 200 f~~Ea~n~~~~~~~~~~~~~v~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~~~--~~---~~~~ia~~~~~~~l~ql~ 274 (437)
T TIGR01982 200 LRREAANASELGENFKNDPGVYVPEVYWDRTSERVLTMEWIDGIPLSDIAALDEA--GL---DRKALAENLARSFLNQVL 274 (437)
T ss_pred HHHHHHHHHHHHHhcCCCCCEEeCCEehhhcCCceEEEEeECCcccccHHHHHhc--CC---CHHHHHHHHHHHHHHHHH
Confidence 555666665552 322233222222 23457899999999999887653221 12 23456666666 478899
Q ss_pred hcCCCCeeccCCCCCcEEEcCCCcEEEeeccCccccc
Q 044312 392 SAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMA 428 (608)
Q Consensus 392 ~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGls~~~~ 428 (608)
..+ ++|+|++|.||++++++.+++.|||++..+.
T Consensus 275 ~~g---~~H~D~hPgNilv~~~g~i~liDfG~~~~l~ 308 (437)
T TIGR01982 275 RDG---FFHADLHPGNIFVLKDGKIIALDFGIVGRLS 308 (437)
T ss_pred hCC---ceeCCCCcccEEECCCCcEEEEeCCCeeECC
Confidence 988 9999999999999999999999999997764
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.63 E-value=4.8e-07 Score=93.31 Aligned_cols=202 Identities=16% Similarity=0.192 Sum_probs=132.6
Q ss_pred cceEEEeecCCCcc-chhccc--cCCC-CCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEEcCCCcEEEee
Q 044312 345 VPLLVYEFIPNGTL-FQYIHD--QNED-FPITWEIRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSD 420 (608)
Q Consensus 345 ~~~lV~E~~~~gsL-~~~l~~--~~~~-~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~D 420 (608)
..-+.|+.+++..- ..++.- .++. ....|.-.++.+..+|.+.+.||.++ ..-+|++++|+|++++..+.|.|
T Consensus 84 ~iGflmP~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~G---h~vGDVn~~~~lVsd~~~V~LVd 160 (637)
T COG4248 84 VIGFLMPKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEHG---HVVGDVNQNSFLVSDDSKVVLVD 160 (637)
T ss_pred eeEEecccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhcC---CcccccCccceeeecCceEEEEc
Confidence 36678888876522 222221 1111 23789999999999999999999999 88899999999999999999988
Q ss_pred ccCccccccCCcceeeeeeccCCCCChhhhc-----cCCCCCccchHhHHHHHHHHHhC-CCCCCccchhh--cccHHHH
Q 044312 421 FGASRSMAVDQTHMTTQVHGTFGYLDPEYFR-----SSQFTDKSDVYSFGVVLTELLTG-EKPIRFTILEE--DKSLAAY 492 (608)
Q Consensus 421 FGls~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~t~ksDV~S~Gvvl~elltg-~~p~~~~~~~~--~~~l~~~ 492 (608)
-..-... ..........|...|.+||.-. +..-+...|-|.|||++++|+.| ++||....... ...+..
T Consensus 161 sDsfqi~--~ng~~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~~~~~ap~p~E~- 237 (637)
T COG4248 161 SDSFQIN--ANGTLHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGIPLISDAPNPLET- 237 (637)
T ss_pred ccceeec--cCCceEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCcccccCCCCCcchh-
Confidence 5433222 2223344567889999999865 34557789999999999999886 89987432211 111110
Q ss_pred HHHHhhhhhhHHHhhhh--h---hccCC-hhHHHHHHHHHHHHhccC--CCCCCCHHHHHHHHHhhHHhcC
Q 044312 493 FLCAMKEERLFEILDAR--V---MKQGG-KDEIITVAKLAKRCLNLN--GKKRPTMREVASELAGIKAWNG 555 (608)
Q Consensus 493 ~~~~~~~~~~~~~~d~~--~---~~~~~-~~~~~~l~~Li~~cl~~d--p~~RPs~~evl~~L~~i~~~~~ 555 (608)
.+..+.....-+.+ + ..+.+ .-.+..+..|..+|+... +.-|||++..+..|..++...+
T Consensus 238 ---~Ia~g~f~ya~~~~~g~~p~P~~~P~~~Lpp~vqAlF~qaF~~~~~~~~RP~a~aW~aAl~al~~~L~ 305 (637)
T COG4248 238 ---DIAHGRFAYASDQRRGLKPPPRSIPLSMLPPDVQALFQQAFTESGVATPRPTAKAWVAALDALRQQLK 305 (637)
T ss_pred ---hhhcceeeechhccCCCCCCCCCCChhhcCHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHHHHhhh
Confidence 00111110000100 0 01111 223567888999999764 5789999999888887776543
|
|
| >PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional | Back alignment and domain information |
|---|
Probab=98.54 E-value=3.2e-07 Score=92.75 Aligned_cols=106 Identities=17% Similarity=0.172 Sum_probs=81.3
Q ss_pred HHHHHHHHHhhcCCCC--ccceeccccc-----CccceEEEeecCCC-ccchhccccCCCCCCCHHHHHHHHHHHHHHHH
Q 044312 317 EFINEVVILSQINHRN--VVKLLGCCLE-----TEVPLLVYEFIPNG-TLFQYIHDQNEDFPITWEIRLRIAIEVSGALS 388 (608)
Q Consensus 317 ~~~~Ei~il~~l~H~n--iv~l~~~~~~-----~~~~~lV~E~~~~g-sL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~ 388 (608)
.+.+|...+.++...+ +++++++... ....+||+|++++. +|.+++..... .+.+...+..++.+++..+.
T Consensus 74 ~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~~~~s~LVte~l~~~~sL~~~~~~~~~-~~~~~~~~~~ll~~la~~i~ 152 (268)
T PRK15123 74 GADREWRAIHRLHEVGVDTMTGVAFGERGSNPATRTSFIITEDLAPTISLEDYCADWAT-NPPDPRLKRMLIKRVATMVR 152 (268)
T ss_pred HHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCccceeEEEEeeCCCCccHHHHHHhhcc-cCCCHHHHHHHHHHHHHHHH
Confidence 4789999888884333 3455555533 23468999999876 78888754221 13566777889999999999
Q ss_pred HHhhcCCCCeeccCCCCCcEEEcC-------CCcEEEeeccCccc
Q 044312 389 YLHSAASIPIYHRDIKSTNILLDD-------KYRAKVSDFGASRS 426 (608)
Q Consensus 389 yLH~~~~~~iiHrDlk~~NILl~~-------~~~~kl~DFGls~~ 426 (608)
-||..+ |+|+|++++|||++. +..+.++||+.++.
T Consensus 153 ~LH~~G---i~HgDL~~~NiLl~~~~~~~~~~~~~~LIDl~r~~~ 194 (268)
T PRK15123 153 DMHAAG---INHRDCYICHFLLHLPFPGREEDLKLSVIDLHRAQI 194 (268)
T ss_pred HHHHCc---CccCCCChhhEEEeccccCCCCCceEEEEECCcccc
Confidence 999999 999999999999975 46899999998753
|
|
| >KOG2137 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.51 E-value=2.6e-08 Score=108.64 Aligned_cols=152 Identities=22% Similarity=0.292 Sum_probs=105.1
Q ss_pred HHHHHHHHHHHhhcCCCCeeccCCCCCcEEEcCCCcEEEeeccCccccccCCcc--------eeeeeeccCCCCChhhhc
Q 044312 380 AIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTH--------MTTQVHGTFGYLDPEYFR 451 (608)
Q Consensus 380 ~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGls~~~~~~~~~--------~~~~~~gt~~y~aPE~~~ 451 (608)
+.+++.||.|+|.... ++|++|.|++|.++.++..||+.|+.+......... ..--.+-...|.|||++.
T Consensus 105 l~~v~dgl~flh~sAk--~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~ 182 (700)
T KOG2137|consen 105 LGNVADGLAFLHRSAK--VVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLL 182 (700)
T ss_pred hhcccchhhhhccCcc--eeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhc
Confidence 4456699999998664 999999999999999999999999877544321111 111123456799999999
Q ss_pred cCCCCCccchHhHHHHHHHHHhCCCCCCccchhhcccHHHHHHHHhhhhhhHHHhhhhhhccCChhHHHHHHHHHHHHhc
Q 044312 452 SSQFTDKSDVYSFGVVLTELLTGEKPIRFTILEEDKSLAAYFLCAMKEERLFEILDARVMKQGGKDEIITVAKLAKRCLN 531 (608)
Q Consensus 452 ~~~~t~ksDV~S~Gvvl~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~Li~~cl~ 531 (608)
....+.++|+||+|++++.+..|.++.-... ..+..+ ......+..-........+.++++=+.+++.
T Consensus 183 ~~~~~~~sd~fSlG~li~~i~~~gk~i~~a~----~~~~~~--------~~~~~~~~~~~~~~s~~~p~el~~~l~k~l~ 250 (700)
T KOG2137|consen 183 GTTNTPASDVFSLGVLIYTIYNGGKSIIAAN----GGLLSY--------SFSRNLLNAGAFGYSNNLPSELRESLKKLLN 250 (700)
T ss_pred cccccccccceeeeeEEEEEecCCcchhhcc----CCcchh--------hhhhcccccccccccccCcHHHHHHHHHHhc
Confidence 9888999999999999999985555432110 000000 0011111111122335677889999999999
Q ss_pred cCCCCCCCHHHHHH
Q 044312 532 LNGKKRPTMREVAS 545 (608)
Q Consensus 532 ~dp~~RPs~~evl~ 545 (608)
.++.-||++.++..
T Consensus 251 ~~~~~rp~~~~l~~ 264 (700)
T KOG2137|consen 251 GDSAVRPTLDLLLS 264 (700)
T ss_pred CCcccCcchhhhhc
Confidence 99999998887765
|
|
| >cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins | Back alignment and domain information |
|---|
Probab=98.51 E-value=7.2e-07 Score=87.26 Aligned_cols=122 Identities=19% Similarity=0.220 Sum_probs=92.2
Q ss_pred ceEEEEEeecCh-hhHHHHHHHHHHHhhcCC--CCccceecccccCc---cceEEEeecCCCccchhccccCCCCCCCHH
Q 044312 301 GQAVKKSKVIDE-SKVEEFINEVVILSQINH--RNVVKLLGCCLETE---VPLLVYEFIPNGTLFQYIHDQNEDFPITWE 374 (608)
Q Consensus 301 ~~avk~~~~~~~-~~~~~~~~Ei~il~~l~H--~niv~l~~~~~~~~---~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~ 374 (608)
.+++|....... .....+.+|.++++.+++ .++.+++.+..+.. ..++||||+++.+|.+.+.. ..++..
T Consensus 24 ~~ilK~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e~i~G~~l~~~~~~----~~~~~~ 99 (223)
T cd05154 24 RLVLRRPPPGALLPSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVMERVDGRVLRDRLLR----PELSPE 99 (223)
T ss_pred ceEEEeCCCcccCcccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEEEeCCEecCCCCCC----CCCCHH
Confidence 466776543222 135678999999999975 44677888776543 56899999999988876642 147788
Q ss_pred HHHHHHHHHHHHHHHHhhcC-----------------------------------------------------CCCeecc
Q 044312 375 IRLRIAIEVSGALSYLHSAA-----------------------------------------------------SIPIYHR 401 (608)
Q Consensus 375 ~~~~i~~~ia~aL~yLH~~~-----------------------------------------------------~~~iiHr 401 (608)
.+..++.+++++|.+||+.. ...++|+
T Consensus 100 ~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~Hg 179 (223)
T cd05154 100 ERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAMERLLRWLEAHLPADSRPGLVHG 179 (223)
T ss_pred HHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHHHHHHHHHHhhCCCCCCcEEEEC
Confidence 88889999999999998531 1337999
Q ss_pred CCCCCcEEEcC--CCcEEEeeccCccc
Q 044312 402 DIKSTNILLDD--KYRAKVSDFGASRS 426 (608)
Q Consensus 402 Dlk~~NILl~~--~~~~kl~DFGls~~ 426 (608)
|++|.|||++. ++.+.|.||+.+..
T Consensus 180 D~~~~Nil~~~~~~~~~~iID~e~~~~ 206 (223)
T cd05154 180 DYRLGNVLFHPDEPRVVAVLDWELATL 206 (223)
T ss_pred CCCcccEEEcCCCCcEEEEEecccccc
Confidence 99999999998 66789999997754
|
This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain |
| >PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed | Back alignment and domain information |
|---|
Probab=98.50 E-value=3.4e-07 Score=100.82 Aligned_cols=76 Identities=14% Similarity=0.106 Sum_probs=52.4
Q ss_pred ccceEEEeecCCCccchhc--cccCC-CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEEcCCC----cE
Q 044312 344 EVPLLVYEFIPNGTLFQYI--HDQNE-DFPITWEIRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKY----RA 416 (608)
Q Consensus 344 ~~~~lV~E~~~~gsL~~~l--~~~~~-~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~----~~ 416 (608)
...+|||||++|+.|.++- ...+. ...+.......++.| ++..+ ++|+|+||.||+++.++ .+
T Consensus 234 t~~VLvmE~i~G~~l~d~~~l~~~g~d~~~la~~~v~~~~~Q-------if~~G---ffHaDpHPGNIlv~~~g~~~~~i 303 (537)
T PRK04750 234 SETVMVMERMYGIPVSDVAALRAAGTDMKLLAERGVEVFFTQ-------VFRDG---FFHADMHPGNIFVSYDPPENPRY 303 (537)
T ss_pred CCceEEEeeecCccHHhHHHHHhcCCCHHHHHHHHHHHHHHH-------HHhCC---eeeCCCChHHeEEecCCCCCCeE
Confidence 3557999999999997742 22111 001222223333333 34567 99999999999999887 99
Q ss_pred EEeeccCcccccc
Q 044312 417 KVSDFGASRSMAV 429 (608)
Q Consensus 417 kl~DFGls~~~~~ 429 (608)
++.|||++..+..
T Consensus 304 ~llDFGivg~l~~ 316 (537)
T PRK04750 304 IALDFGIVGSLNK 316 (537)
T ss_pred EEEecceEEECCH
Confidence 9999999987754
|
|
| >KOG3087 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.49 E-value=4.6e-07 Score=83.98 Aligned_cols=107 Identities=23% Similarity=0.245 Sum_probs=78.7
Q ss_pred HHHHHHHHHHhhcCCCCccceecccccCccceEEEeecCC-CccchhccccCCCCCCCHHHHHHHHHHHHHHHHHHhhcC
Q 044312 316 EEFINEVVILSQINHRNVVKLLGCCLETEVPLLVYEFIPN-GTLFQYIHDQNEDFPITWEIRLRIAIEVSGALSYLHSAA 394 (608)
Q Consensus 316 ~~~~~Ei~il~~l~H~niv~l~~~~~~~~~~~lV~E~~~~-gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~ 394 (608)
..-.+|+++|.++.--.|.--.=++.+...-.|+|||+++ .++.+++...... +........++..|-+.+.-||...
T Consensus 55 ~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~~~i~ME~~~g~~~vk~~i~~~~~~-~~~d~~~~~~~~~iG~~igklH~nd 133 (229)
T KOG3087|consen 55 KRTKQEARLLAKCRALGIPAPRLIFIDTYGGQIYMEFIDGASTVKDFILSTMED-ESEDEGLAELARRIGELIGKLHDND 133 (229)
T ss_pred HHHHHHHHHHHHHHHhCCCCceEEEEecCCCeEEEEeccchhHHHHHHHHHccC-cccchhHHHHHHHHHHHHHHhhhCC
Confidence 4567899999888644443333334455666799999976 4788888765443 2333334778899999999999999
Q ss_pred CCCeeccCCCCCcEEEcCCC---cEEEeeccCccc
Q 044312 395 SIPIYHRDIKSTNILLDDKY---RAKVSDFGASRS 426 (608)
Q Consensus 395 ~~~iiHrDlk~~NILl~~~~---~~kl~DFGls~~ 426 (608)
|+|+||..+||+|..++ .+.+.|||++..
T Consensus 134 ---iiHGDLTTSNill~~~~~~~~~~lIdfgls~~ 165 (229)
T KOG3087|consen 134 ---IIHGDLTTSNILLRSDGNQITPILIDFGLSSV 165 (229)
T ss_pred ---eecccccccceEEecCCCcCceEEEeecchhc
Confidence 99999999999996543 458999999864
|
|
| >PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.38 E-value=1.3e-06 Score=85.17 Aligned_cols=107 Identities=20% Similarity=0.240 Sum_probs=83.8
Q ss_pred HHHHHHHHHHHhhcCC--CCccceecccccCc----cceEEEeecCCC-ccchhccccCCCCCCCHHHHHHHHHHHHHHH
Q 044312 315 VEEFINEVVILSQINH--RNVVKLLGCCLETE----VPLLVYEFIPNG-TLFQYIHDQNEDFPITWEIRLRIAIEVSGAL 387 (608)
Q Consensus 315 ~~~~~~Ei~il~~l~H--~niv~l~~~~~~~~----~~~lV~E~~~~g-sL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL 387 (608)
...+.+|...+..|.. =.+.+.+++..... ..+||+|++++. +|.+++..... .+......++.++++.+
T Consensus 55 ~~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~~~---~~~~~~~~ll~~l~~~i 131 (206)
T PF06293_consen 55 RSRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQWEQ---LDPSQRRELLRALARLI 131 (206)
T ss_pred chHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhhcc---cchhhHHHHHHHHHHHH
Confidence 4567788888777743 34566666665432 348999999874 78888876332 55667788999999999
Q ss_pred HHHhhcCCCCeeccCCCCCcEEEcCCC---cEEEeeccCcccc
Q 044312 388 SYLHSAASIPIYHRDIKSTNILLDDKY---RAKVSDFGASRSM 427 (608)
Q Consensus 388 ~yLH~~~~~~iiHrDlk~~NILl~~~~---~~kl~DFGls~~~ 427 (608)
+-||..+ |+|+|+++.|||++.+. .+.++||+.++..
T Consensus 132 ~~lH~~g---i~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~~ 171 (206)
T PF06293_consen 132 AKLHDAG---IYHGDLNPSNILVDPDDGQYRFYLIDLDRMRFR 171 (206)
T ss_pred HHHHHCc---CCCCCCCcccEEEeCCCCceeEEEEcchhceeC
Confidence 9999999 99999999999999876 8999999987653
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane |
| >PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.36 E-value=1.3e-06 Score=83.40 Aligned_cols=100 Identities=26% Similarity=0.297 Sum_probs=66.8
Q ss_pred HHHHHHHHHHHhhcCCC--CccceecccccCccceEEEeecC--CCccchhccccCCCCCCCHHHHHHHHHHHHHHHHH-
Q 044312 315 VEEFINEVVILSQINHR--NVVKLLGCCLETEVPLLVYEFIP--NGTLFQYIHDQNEDFPITWEIRLRIAIEVSGALSY- 389 (608)
Q Consensus 315 ~~~~~~Ei~il~~l~H~--niv~l~~~~~~~~~~~lV~E~~~--~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~y- 389 (608)
.....+|.+.|.++..- ++.+++.+- .-.|||||++ +..|.. +.... ++......++.+++..+..
T Consensus 52 ~~~~~~E~~~L~~l~~~Gv~vP~p~~~~----~~~ivME~I~~~G~~~~~-l~~~~----~~~~~~~~~~~~il~~~~~~ 122 (188)
T PF01163_consen 52 REWAKKEFRNLKRLYEAGVPVPKPYDYN----RNVIVMEYIGEDGVPLPR-LKDVD----LSPEEPKELLEEILEEIIKM 122 (188)
T ss_dssp HHHHHHHHHHHHHCCCTT-SS--EEEEE----TTEEEEE--EETTEEGGC-HHHCG----GGGSTHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHHHHHCCccCCcEEEEe----CCEEEEEecCCCccchhh-HHhcc----ccchhHHHHHHHHHHHHHHH
Confidence 45678899999999755 567777552 4579999998 544544 33221 1233445677777776555
Q ss_pred HhhcCCCCeeccCCCCCcEEEcCCCcEEEeeccCcccc
Q 044312 390 LHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSM 427 (608)
Q Consensus 390 LH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGls~~~ 427 (608)
+|..+ ++|+||.+.|||++++ .+.|+|||.+...
T Consensus 123 ~~~~g---ivHGDLs~~NIlv~~~-~~~iIDf~qav~~ 156 (188)
T PF01163_consen 123 LHKAG---IVHGDLSEYNILVDDG-KVYIIDFGQAVDS 156 (188)
T ss_dssp HHCTT---EEESS-STTSEEEETT-CEEE--GTTEEET
T ss_pred HHhcC---ceecCCChhhEEeecc-eEEEEecCcceec
Confidence 47888 9999999999999988 9999999987654
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A. |
| >PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C) | Back alignment and domain information |
|---|
Probab=98.18 E-value=8.2e-06 Score=78.13 Aligned_cols=105 Identities=25% Similarity=0.353 Sum_probs=83.3
Q ss_pred HHHHHHHhhcCC-CCccceecccccCccceEEEeecCCCccchhccccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCC
Q 044312 319 INEVVILSQINH-RNVVKLLGCCLETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEIRLRIAIEVSGALSYLHSAASIP 397 (608)
Q Consensus 319 ~~Ei~il~~l~H-~niv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ 397 (608)
.+|..+|+.+++ +++++++|.|- .++|.||...+++...-....+-...+|..|.+||.++++.+.+|++....+
T Consensus 7 ~~E~lll~~l~~~~~~pk~lG~CG----~~~v~E~~~~~~~~~~~~~l~~~~~~~w~~R~~iA~~lL~~l~~l~~~~~~~ 82 (188)
T PF12260_consen 7 NNEPLLLQLLQGSEPFPKLLGSCG----RFYVVEYVGAGSLYGIYRPLSQFLQSPWEQRAKIALQLLELLEELDHGPLGF 82 (188)
T ss_pred ccHHHHHHHcCCCCCCCCeeeECC----CEEEEEeecCccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCCCc
Confidence 458888999976 69999999993 3789999987776532111111123689999999999999999999865555
Q ss_pred eeccCCCCCcEEEcCCCcEEEeeccCcccc
Q 044312 398 IYHRDIKSTNILLDDKYRAKVSDFGASRSM 427 (608)
Q Consensus 398 iiHrDlk~~NILl~~~~~~kl~DFGls~~~ 427 (608)
+.-.|++++|+-+++++.+|+.|....-..
T Consensus 83 ~~lcDv~~~nfgv~~~~~lk~iDld~v~~~ 112 (188)
T PF12260_consen 83 FYLCDVSPDNFGVNDDGRLKLIDLDDVFVE 112 (188)
T ss_pred EEEeecchHHeEEeCCCcEEEEechhcchh
Confidence 889999999999999999999999866443
|
Proteins in this uncharacterised family are described as transmembrane proteins. |
| >PRK09902 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.01 E-value=3e-05 Score=74.78 Aligned_cols=109 Identities=19% Similarity=0.172 Sum_probs=82.6
Q ss_pred hHHHHHHHHHHHhhcCC--CCccceecccccC----ccceEEEeecCC-CccchhccccCCCCCCCHHHHHHHHHHHHHH
Q 044312 314 KVEEFINEVVILSQINH--RNVVKLLGCCLET----EVPLLVYEFIPN-GTLFQYIHDQNEDFPITWEIRLRIAIEVSGA 386 (608)
Q Consensus 314 ~~~~~~~Ei~il~~l~H--~niv~l~~~~~~~----~~~~lV~E~~~~-gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~a 386 (608)
....|.+|+..|.+|.. -.+.+...+.... -..+||+|-+++ -+|.+++.+.... +.+...+..+..+++..
T Consensus 62 g~ptf~rE~~~L~~L~~~GvPVP~pvf~~~~k~~~~~rA~LVTe~L~g~~~L~~~l~~~~~~-~~~~~~k~~il~~va~~ 140 (216)
T PRK09902 62 GRPTIVREVAVIKELERAGVIVPKIVFGEAVKIEGEWRALLVTEDMAGFISIADWYAQHAVS-PYSDEVRQAMLKAVALA 140 (216)
T ss_pred CchHHHHHHHHHHHHHHcCCCCCccceeeeeccCCceEEEEEEEeCCCCccHHHHHhcCCcC-CcchHHHHHHHHHHHHH
Confidence 56789999999999953 3355555222221 235799997754 4788887653322 46778888999999999
Q ss_pred HHHHhhcCCCCeeccCCCCCcEEEcCCCc--EEEeeccCccc
Q 044312 387 LSYLHSAASIPIYHRDIKSTNILLDDKYR--AKVSDFGASRS 426 (608)
Q Consensus 387 L~yLH~~~~~~iiHrDlk~~NILl~~~~~--~kl~DFGls~~ 426 (608)
+.-||+.+ +.|+|+.+.|||++.++. ++++||.-++.
T Consensus 141 ia~LH~~G---v~Hgdly~khIll~~~g~~~v~lIDlEk~r~ 179 (216)
T PRK09902 141 FKKMHSVN---RQHGCCYVRHIYVKTEGKAEAGFLDLEKSRR 179 (216)
T ss_pred HHHHHHCC---CcCCCCCHhheeecCCCCeeEEEEEhhccch
Confidence 99999999 999999999999986666 99999986654
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=97.71 E-value=1.6e-05 Score=86.29 Aligned_cols=151 Identities=20% Similarity=0.176 Sum_probs=113.7
Q ss_pred HHHHHHHHHHhhcCCCC-ccceecccccCccceEEEeecCCC-ccchhccccCCCCCCCHHHHHHHHHHHHHHHHHHhhc
Q 044312 316 EEFINEVVILSQINHRN-VVKLLGCCLETEVPLLVYEFIPNG-TLFQYIHDQNEDFPITWEIRLRIAIEVSGALSYLHSA 393 (608)
Q Consensus 316 ~~~~~Ei~il~~l~H~n-iv~l~~~~~~~~~~~lV~E~~~~g-sL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~ 393 (608)
....-++++|.+++||| .+..++-+..+....++++++..+ +......... ..+...+...+...-+++|+|||+.
T Consensus 278 l~~rl~~eLLdK~n~P~~~v~~~~d~~~E~~~~i~~~i~s~~rs~~~~~~~se--~~~~~~~~~~~~r~et~~l~~l~~~ 355 (829)
T KOG0576|consen 278 LSRRLAIELLDKVNNPNPVVRYLEDYDGEDYLWIPMRICSTGRSSALEMTVSE--IALEQYQFAYPLRKETRPLAELHSS 355 (829)
T ss_pred hhhHHHHHHHHHccCCCCcccccccCCcccccchhhhhhcCCccccccCChhh--Hhhhhhhhhhhhhhhcccccccccc
Confidence 45566889999999999 888888888888889999999877 2222222111 1234445556677778899999986
Q ss_pred CCCCeeccCCCCCcEEEcCCCcEEEeeccCccccccCCcceeeeeeccCCCCChhhhccCCCCCccchHhHHHHHHHHHh
Q 044312 394 ASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLTELLT 473 (608)
Q Consensus 394 ~~~~iiHrDlk~~NILl~~~~~~kl~DFGls~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~ellt 473 (608)
. =+|+| |||..+ ...|..||+....+.... ......+++.|+|||+.....+..+.|+|++++--.++.-
T Consensus 356 ~---~~~~d----~~l~s~-~~~~~~~~~v~~~L~~~~--~~~t~~~~~~~~~pev~~~~~~~~~p~~~~~~~~~~~~ap 425 (829)
T KOG0576|consen 356 Y---KVHRD----NILGSE-EEVKLLDFAVPPQLTRTM--KPRTAIGTPEPLAPEVIQENTIDGCPDSGSLAVSAIQMAP 425 (829)
T ss_pred c---ccCcc----cccccc-cccccccccCCcccCccc--ccccCCCCCCCCCchhhcccccccCCCccCCCcchhhcCC
Confidence 5 57888 777766 578999999887665432 2344568999999999999999999999999987777777
Q ss_pred CCCCC
Q 044312 474 GEKPI 478 (608)
Q Consensus 474 g~~p~ 478 (608)
|.+|-
T Consensus 426 ~~pPr 430 (829)
T KOG0576|consen 426 GLPPR 430 (829)
T ss_pred CCCCC
Confidence 76663
|
|
| >COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=97.65 E-value=0.00019 Score=71.15 Aligned_cols=97 Identities=19% Similarity=0.152 Sum_probs=67.9
Q ss_pred HHHHHHHHHHHhhcCCC--CccceecccccCccceEEEeecCCCccchhccccCCCCCCCHHHHHHHHHHHHHHHHHHhh
Q 044312 315 VEEFINEVVILSQINHR--NVVKLLGCCLETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEIRLRIAIEVSGALSYLHS 392 (608)
Q Consensus 315 ~~~~~~Ei~il~~l~H~--niv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~ 392 (608)
.....+|.++|++|.-. .|.+.+++ +.-.+|||++++-.|...--. .-+.+. |+..|++-+.-+-.
T Consensus 153 Rl~A~rEf~~L~~L~~~G~~VP~P~~~----nRHaVvMe~ieG~eL~~~r~~-----~en~~~---il~~il~~~~~~~~ 220 (304)
T COG0478 153 RLAAEREFEALQRLYPEGVKVPKPIAW----NRHAVVMEYIEGVELYRLRLD-----VENPDE---ILDKILEEVRKAYR 220 (304)
T ss_pred HHHHHHHHHHHHHhhhcCCCCCCcccc----ccceeeeehcccceeecccCc-----ccCHHH---HHHHHHHHHHHHHH
Confidence 34577899999999655 77777754 345799999988666543211 122333 33334444444446
Q ss_pred cCCCCeeccCCCCCcEEEcCCCcEEEeeccCccc
Q 044312 393 AASIPIYHRDIKSTNILLDDKYRAKVSDFGASRS 426 (608)
Q Consensus 393 ~~~~~iiHrDlk~~NILl~~~~~~kl~DFGls~~ 426 (608)
.+ |+|+|+++-|||+++++.+.++||--+..
T Consensus 221 ~G---iVHGDlSefNIlV~~dg~~~vIDwPQ~v~ 251 (304)
T COG0478 221 RG---IVHGDLSEFNILVTEDGDIVVIDWPQAVP 251 (304)
T ss_pred cC---ccccCCchheEEEecCCCEEEEeCccccc
Confidence 67 99999999999999999999999976654
|
|
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=97.58 E-value=0.00013 Score=84.36 Aligned_cols=198 Identities=18% Similarity=0.203 Sum_probs=136.1
Q ss_pred HHHHHHHHHHhhcCCCCccceecccccCcc----ceEEEeecCCCccchhccccCCCCCCCHHHHHHHHHHHHHHHHHHh
Q 044312 316 EEFINEVVILSQINHRNVVKLLGCCLETEV----PLLVYEFIPNGTLFQYIHDQNEDFPITWEIRLRIAIEVSGALSYLH 391 (608)
Q Consensus 316 ~~~~~Ei~il~~l~H~niv~l~~~~~~~~~----~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH 391 (608)
....-|+..+.++.|+|++.++.+-.++.. ..+..|+++.-++...+.... .++..+.+.+..++.+||+|+|
T Consensus 227 ~~~E~e~~~l~k~~~~n~~~~~~~~le~~~~g~~~~v~~~~~s~~~~~~~~q~v~---~i~~~~~r~~~~~~~~GL~~~h 303 (1351)
T KOG1035|consen 227 QTTEIELESLSKIAHDNLGGYFVYGLERLFRGIVLDVLQEICSKVELRSLLQSVG---SIPLETLRILHQKLLEGLAYLH 303 (1351)
T ss_pred HHHHHHHHHHHhhccccccceeEEeehhhcchHHHHHHHhhcCccchHHHHhhcc---ccCHHHHHHHHHHHhhhHHHHH
Confidence 334456777888899999999998765542 234557777777777776544 4788899999999999999999
Q ss_pred hcCCCCeeccCCCCC---cEEEcCCCcEEEe--eccCccccccCCcceeeeeeccCCCCChhhhccCCCCC--ccchHhH
Q 044312 392 SAASIPIYHRDIKST---NILLDDKYRAKVS--DFGASRSMAVDQTHMTTQVHGTFGYLDPEYFRSSQFTD--KSDVYSF 464 (608)
Q Consensus 392 ~~~~~~iiHrDlk~~---NILl~~~~~~kl~--DFGls~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~--ksDV~S~ 464 (608)
+.. ..|.-|..+ +-..+..+...++ ||+.++..+...... ...-+..+.+||......+.. ..|+|.+
T Consensus 304 ~~~---l~~v~L~~s~~~~~~~~~e~~~~~sl~~~~ss~~l~d~~~~~--~~~~~~~~~~~e~~~~~~~~~~r~~dL~~l 378 (1351)
T KOG1035|consen 304 SLS---LEHVVLSASSSKESTVDGEGVVAISLSDFDSSKPLPDNEKSF--SDLLAEIRNADEDLKENTAKKSRLTDLWCL 378 (1351)
T ss_pred Hhc---cceeEEecccccccccCccceeecchhhhcccccCCCcccch--hhcCccccccccccccccchhhhhhHHHHH
Confidence 986 666655555 4455666777777 898887765332211 112344577888777665544 4799999
Q ss_pred HHHHHHHHhCCCCCCccchhhcccHHHHHHHHhhhhhhHHHhhhhhhccCChhHHHHHHHHHHHHhccCCCCCCCHHHHH
Q 044312 465 GVVLTELLTGEKPIRFTILEEDKSLAAYFLCAMKEERLFEILDARVMKQGGKDEIITVAKLAKRCLNLNGKKRPTMREVA 544 (608)
Q Consensus 465 Gvvl~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~evl 544 (608)
|..+..+..|..+-... .....+++. .....+.+...+|+..++++|++..+++
T Consensus 379 gll~~~~~~~~~i~~~~------------------~~~~~~l~~--------~~~~~~~d~~~~~~~~~~~~Rl~~~~ll 432 (1351)
T KOG1035|consen 379 GLLLLQLSQGEDISEKS------------------AVPVSLLDV--------LSTSELLDALPKCLDEDSEERLSALELL 432 (1351)
T ss_pred HHHHhhhhhcCcccccc------------------cchhhhhcc--------ccchhhhhhhhhhcchhhhhccchhhhh
Confidence 99999999887652210 001111111 0111467788899999999999999998
Q ss_pred HHH
Q 044312 545 SEL 547 (608)
Q Consensus 545 ~~L 547 (608)
.+.
T Consensus 433 ~~~ 435 (1351)
T KOG1035|consen 433 THP 435 (1351)
T ss_pred hch
Confidence 754
|
|
| >PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY) | Back alignment and domain information |
|---|
Probab=97.50 E-value=0.00018 Score=69.71 Aligned_cols=67 Identities=24% Similarity=0.333 Sum_probs=53.1
Q ss_pred cceEEEeecCCCccchhccccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEEcCCCcEEEeeccCc
Q 044312 345 VPLLVYEFIPNGTLFQYIHDQNEDFPITWEIRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGAS 424 (608)
Q Consensus 345 ~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGls 424 (608)
..+|+|||++|..|.+... ++. .++..+++++.-||+.| ++|+|..|.|++++++ .+++.||+..
T Consensus 117 ~~~ll~EYIeG~~l~d~~~-------i~e----~~~~ki~~~ikqlH~~G---~~HGD~hpgNFlv~~~-~i~iID~~~k 181 (229)
T PF06176_consen 117 SYVLLMEYIEGVELNDIED-------IDE----DLAEKIVEAIKQLHKHG---FYHGDPHPGNFLVSNN-GIRIIDTQGK 181 (229)
T ss_pred EEEEEEEEecCeecccchh-------cCH----HHHHHHHHHHHHHHHcC---CccCCCCcCcEEEECC-cEEEEECccc
Confidence 4568999999988866532 222 24566778899999999 9999999999999965 5999999876
Q ss_pred cc
Q 044312 425 RS 426 (608)
Q Consensus 425 ~~ 426 (608)
+.
T Consensus 182 ~~ 183 (229)
T PF06176_consen 182 RM 183 (229)
T ss_pred cc
Confidence 53
|
The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process |
| >cd05150 APH Aminoglycoside 3'-phosphotransferase (APH) | Back alignment and domain information |
|---|
Probab=97.41 E-value=0.00088 Score=66.85 Aligned_cols=111 Identities=18% Similarity=0.164 Sum_probs=66.1
Q ss_pred HHHHHHHHHHHhhcC-CCCccceecccccCccceEEEeecCCCccchhc-------------------cccCC-CCCCC-
Q 044312 315 VEEFINEVVILSQIN-HRNVVKLLGCCLETEVPLLVYEFIPNGTLFQYI-------------------HDQNE-DFPIT- 372 (608)
Q Consensus 315 ~~~~~~Ei~il~~l~-H~niv~l~~~~~~~~~~~lV~E~~~~gsL~~~l-------------------~~~~~-~~~l~- 372 (608)
..++.+|+++++.+. +--+.+++++....+..++|||+++|.+|.... |.... ..++.
T Consensus 35 ~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i~G~~l~~~~~~~~~~~~~~~l~~~l~~lH~i~~~~~~~~~ 114 (244)
T cd05150 35 TYELEREAERLRWLAGKLPVPEVIDYGSDDGRAWLLTSAVPGVPAAALWEELEPERLVDALAEALRRLHALPVADCPFDR 114 (244)
T ss_pred ccchHHHHHHHHHHHhcCCCCeEEEEEecCCccEEEEEeeCCccHhHhhcccCHHHHHHHHHHHHHHHhcCCcccCCcch
Confidence 446778999988883 444667788776666789999999987776432 11100 00111
Q ss_pred -HHHHHHHHH--------------------HHHHHHHHHhhc----CCCCeeccCCCCCcEEEcCCCcEEEeeccCcc
Q 044312 373 -WEIRLRIAI--------------------EVSGALSYLHSA----ASIPIYHRDIKSTNILLDDKYRAKVSDFGASR 425 (608)
Q Consensus 373 -~~~~~~i~~--------------------~ia~aL~yLH~~----~~~~iiHrDlk~~NILl~~~~~~kl~DFGls~ 425 (608)
....+.... .+...+..|-.. ..+.++|+|+.|.|||++++....|.||+.+.
T Consensus 115 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~iIDwe~a~ 192 (244)
T cd05150 115 RLDRRLAEARARVENGLVDEDDFDDERRGWSAEELYAELEATRPAEEDLVVTHGDACLPNIIVDPGKFSGFIDLGRLG 192 (244)
T ss_pred hHHHHHHHHHHHHhcCCcChhhCcHhhcCCCHHHHHHHHHhhCCCcCceEEECCCCCCccEEEeCCcEEEEEEccccc
Confidence 001110000 011112222111 12348999999999999998778899998764
|
The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio |
| >PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP | Back alignment and domain information |
|---|
Probab=97.34 E-value=0.002 Score=62.16 Aligned_cols=96 Identities=21% Similarity=0.239 Sum_probs=68.8
Q ss_pred hHHHHHHHHHHHhhcC------CCCccceecccccCccceEEEeecCC------CccchhccccCCCCCCCHHHHHHHHH
Q 044312 314 KVEEFINEVVILSQIN------HRNVVKLLGCCLETEVPLLVYEFIPN------GTLFQYIHDQNEDFPITWEIRLRIAI 381 (608)
Q Consensus 314 ~~~~~~~Ei~il~~l~------H~niv~l~~~~~~~~~~~lV~E~~~~------gsL~~~l~~~~~~~~l~~~~~~~i~~ 381 (608)
...++.+|+.-..++. +.+|.+++|+..++.-.-+|+|.+.+ -+|.+++.+. .++. ...+
T Consensus 54 ~~~~~~~E~~~y~~l~~~~~~~~~~i~r~~G~veT~~G~Glv~e~I~d~dG~~s~TL~~~l~~~----~~~~-~~~~--- 125 (199)
T PF10707_consen 54 RYRQNRRELRYYKQLSLRRGVDWSHIPRFYGFVETNLGLGLVVELIRDADGNISPTLEDYLKEG----GLTE-ELRQ--- 125 (199)
T ss_pred hhHHHHHHHHHHHHHhhccCCcccccccEeEEEecCCceEEEEEEEECCCCCcCccHHHHHHcC----CccH-HHHH---
Confidence 3567788887666665 88999999999999989999999854 2566666432 2554 3333
Q ss_pred HHHHHHHHHhhcCCCCeeccCCCCCcEEEcCC---C-cEEEee
Q 044312 382 EVSGALSYLHSAASIPIYHRDIKSTNILLDDK---Y-RAKVSD 420 (608)
Q Consensus 382 ~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~---~-~~kl~D 420 (608)
.+-+-..||-+++ |+.+||+|.||++..+ . .+.|.|
T Consensus 126 ~L~~f~~~l~~~~---Iv~~dl~~~NIv~~~~~~~~~~lvlID 165 (199)
T PF10707_consen 126 ALDEFKRYLLDHH---IVIRDLNPHNIVVQRRDSGEFRLVLID 165 (199)
T ss_pred HHHHHHHHHHHcC---CeecCCCcccEEEEecCCCceEEEEEe
Confidence 3334456777777 9999999999999633 2 477777
|
PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner []. |
| >TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172 | Back alignment and domain information |
|---|
Probab=97.26 E-value=0.0027 Score=62.77 Aligned_cols=114 Identities=15% Similarity=0.075 Sum_probs=68.1
Q ss_pred eEEEEEeecChhhHHHHHHHHHHHhhcCCCC--ccceecccccCccceEEEeecCCCc-cchhccccCCCCCCCHHHHHH
Q 044312 302 QAVKKSKVIDESKVEEFINEVVILSQINHRN--VVKLLGCCLETEVPLLVYEFIPNGT-LFQYIHDQNEDFPITWEIRLR 378 (608)
Q Consensus 302 ~avk~~~~~~~~~~~~~~~Ei~il~~l~H~n--iv~l~~~~~~~~~~~lV~E~~~~gs-L~~~l~~~~~~~~l~~~~~~~ 378 (608)
+.+|.... ........+|.++++.+..-. +.+.+++....+...+|||+++|.+ +...+.. +......
T Consensus 25 ~VlR~~~~--~~~~~~i~~E~~~l~~l~~~glpvP~~~~~~~~~~~~glv~e~i~G~~~~~~~~~~-------~~~~~~~ 95 (226)
T TIGR02172 25 WMLKLYNP--GFDKETIKREFDASRKVFSLGIPTPHPFDLVEDGGRLGLIYELIVGKRSFSRIISD-------NPSRLEE 95 (226)
T ss_pred EEEEeCCC--CCCHHHHHHHHHHHHHHHHcCCCCCceEEEEecCCeeeeeeeecCCccchhhhhcC-------CHHHHHH
Confidence 44455443 223456788999999986433 4677777777777789999998863 2111110 0011111
Q ss_pred HHHHHHHH---------------------------------------HHHHhhc-CCCCeeccCCCCCcEEEcCCCcEEE
Q 044312 379 IAIEVSGA---------------------------------------LSYLHSA-ASIPIYHRDIKSTNILLDDKYRAKV 418 (608)
Q Consensus 379 i~~~ia~a---------------------------------------L~yLH~~-~~~~iiHrDlk~~NILl~~~~~~kl 418 (608)
++.++++. ..+|... ....++|+|+.|.||++++++ +.|
T Consensus 96 l~~~la~~l~~lH~~~~~~~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~l~~~~~~~~~~HgD~~~~Nii~~~~~-~~i 174 (226)
T TIGR02172 96 IAKIFAEMAKKLHSTKCDTSTFQSYKEKIRKFIEEKDFVPKDYKEKARAFIKEVPDTSTCLHGDFQIGNLITSGKG-TYW 174 (226)
T ss_pred HHHHHHHHHHHHhCCCCCCCcHHHHHHHHHHHHHhccCCCHHHHHHHHHHHHhCCCCCceEecCCCCCcEEEcCCC-cEE
Confidence 11111111 2222211 122378999999999999887 999
Q ss_pred eeccCcc
Q 044312 419 SDFGASR 425 (608)
Q Consensus 419 ~DFGls~ 425 (608)
.||+.+.
T Consensus 175 IDwe~a~ 181 (226)
T TIGR02172 175 IDLGDFG 181 (226)
T ss_pred EechhcC
Confidence 9998764
|
This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636. |
| >KOG1826 consensus Ras GTPase activating protein RasGAP/neurofibromin [Defense mechanisms] | Back alignment and domain information |
|---|
Probab=97.03 E-value=0.00011 Score=86.67 Aligned_cols=177 Identities=14% Similarity=-0.010 Sum_probs=120.3
Q ss_pred eEEEEEeecChhhHHHHH-----HHHHHHhhcCCCCccceecccc--cCccceEEEeecCCCccchhccccCCCC-CCCH
Q 044312 302 QAVKKSKVIDESKVEEFI-----NEVVILSQINHRNVVKLLGCCL--ETEVPLLVYEFIPNGTLFQYIHDQNEDF-PITW 373 (608)
Q Consensus 302 ~avk~~~~~~~~~~~~~~-----~Ei~il~~l~H~niv~l~~~~~--~~~~~~lV~E~~~~gsL~~~l~~~~~~~-~l~~ 373 (608)
|-+++-+..+-+..-+-+ .|...++...|+++.....-.. +....+.+++++..|.+.+.|.+..++. ++..
T Consensus 1255 Fk~~I~ke~d~e~LsePlkemll~e~de~~~~~h~~~~~~p~rI~ps~s~ee~~r~~~~~~g~~f~iIikg~ee~~~ld~ 1334 (2724)
T KOG1826|consen 1255 FKFSIYKEYDFENLSEPLKEMLLSERDELREAKHYLTEVDPLRIPPSESTEEYIRSLYVEFGKLFSIIIKGLEESPDLDR 1334 (2724)
T ss_pred eEEEeehhhhHHHHhhHHHHhhhhhhhhhhhhhceeeecccccCCCCCChHHHHHHHHHHHhHHHHHHHhccccCCcchh
Confidence 445554443333333333 3444455568888876665443 3346688999999999999887644332 2333
Q ss_pred HHHHHHHHHHHHHHHHHhhcC--CCCeeccCCCCCcEEEcCCCcEEEeeccCccccccCCcceeeeeeccCCCCChhhhc
Q 044312 374 EIRLRIAIEVSGALSYLHSAA--SIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHGTFGYLDPEYFR 451 (608)
Q Consensus 374 ~~~~~i~~~ia~aL~yLH~~~--~~~iiHrDlk~~NILl~~~~~~kl~DFGls~~~~~~~~~~~~~~~gt~~y~aPE~~~ 451 (608)
.-......+...+..-+|+.. ....+|++||+.|.+|..+..+|++++|+.+...... .......+++.|+.|+...
T Consensus 1335 ~~v~~~~kvsvl~~~~~ls~tnlg~T~v~~~Lkf~lpmIVtny~v~~gk~gLdKIknp~~-sf~Gl~l~sp~~v~qli~N 1413 (2724)
T KOG1826|consen 1335 SPVHLRHKVSVLNRNVILSLTNLGNTNVSKSLKFTLPMIVTNYNVKLGKGGLDKIKNPVL-SFFGLELCSPIYVLQLIKN 1413 (2724)
T ss_pred chHHHHHHHHHhccchhhhcccCCccchhhhhhhhccceecCCcccccccccccccCchH-hhhhhhhCCHHHHHHHHHH
Confidence 333333334355555555433 2347899999999999999999999999998433222 2233445778899999999
Q ss_pred cCCCCCccchHhHHHHHHHHHhCCCCCC
Q 044312 452 SSQFTDKSDVYSFGVVLTELLTGEKPIR 479 (608)
Q Consensus 452 ~~~~t~ksDV~S~Gvvl~elltg~~p~~ 479 (608)
.-.++.++|+|..|..++++--|..+|.
T Consensus 1414 ~ik~t~rsdilr~s~~ly~rs~~n~~fi 1441 (2724)
T KOG1826|consen 1414 EIKFTKRSDILRRSLSLYLRSDGNAYFI 1441 (2724)
T ss_pred HHhhhhHHHHHHHHHHHHHHhcccHHHH
Confidence 9999999999999999999988877753
|
|
| >cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members | Back alignment and domain information |
|---|
Probab=96.93 E-value=0.0077 Score=59.75 Aligned_cols=29 Identities=31% Similarity=0.504 Sum_probs=25.1
Q ss_pred CeeccCCCCCcEEEcCCCcEEEeeccCcc
Q 044312 397 PIYHRDIKSTNILLDDKYRAKVSDFGASR 425 (608)
Q Consensus 397 ~iiHrDlk~~NILl~~~~~~kl~DFGls~ 425 (608)
.++|+|+.+.|||++++...-|.||+.+.
T Consensus 165 ~l~HGD~~~~Nvlv~~~~i~giIDw~~a~ 193 (235)
T cd05155 165 VWFHGDLAPGNLLVQDGRLSAVIDFGCLG 193 (235)
T ss_pred eEEeCCCCCCcEEEECCCEEEEEeCcccC
Confidence 38999999999999977666799999764
|
The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista |
| >PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily | Back alignment and domain information |
|---|
Probab=96.93 E-value=0.0061 Score=59.66 Aligned_cols=123 Identities=22% Similarity=0.235 Sum_probs=65.2
Q ss_pred ceEEEEEeecChhhHHHHHHHHHHHhhcCCC--CccceecccccC---ccceEEEeecCCCccch---------------
Q 044312 301 GQAVKKSKVIDESKVEEFINEVVILSQINHR--NVVKLLGCCLET---EVPLLVYEFIPNGTLFQ--------------- 360 (608)
Q Consensus 301 ~~avk~~~~~~~~~~~~~~~Ei~il~~l~H~--niv~l~~~~~~~---~~~~lV~E~~~~gsL~~--------------- 360 (608)
.+++|..... .....+.+|..+++.+... .+.+++...... ...+++|+++++..+..
T Consensus 22 ~~vlK~~~~~--~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~~~~~~~~~~~i~g~~~~~~~~~~~~~~~~~~~~ 99 (239)
T PF01636_consen 22 RYVLKFYRPP--DAAERLRREAAVLRQLAEHGIPVPRVLAFDTSDEFNGFPYLLMEYIPGRPLDDELSPEQRPELLRQLG 99 (239)
T ss_dssp EEEEEEESSH--HHHHHHHHHHHHHHHHHHTTSBS--EEEEEEETEETSEEEEEEEEESSEEHHHTSTHHHHHHHHHHHH
T ss_pred EEEEEEeCCC--CCHHHHHHHHHHHHHHHhcCCCCceEEeecccccccccceEEEEEeccccccccccccccccccccch
Confidence 4566665432 4567788999999888533 356777644322 24689999999887766
Q ss_pred -hc---cccC-CCCCCCHHH---------HHHH------------HHHHHH-HHHHHhhc----CCCCeeccCCCCCcEE
Q 044312 361 -YI---HDQN-EDFPITWEI---------RLRI------------AIEVSG-ALSYLHSA----ASIPIYHRDIKSTNIL 409 (608)
Q Consensus 361 -~l---~~~~-~~~~l~~~~---------~~~i------------~~~ia~-aL~yLH~~----~~~~iiHrDlk~~NIL 409 (608)
.+ +... ...++.+.. .... ...+.+ .+..+++. ....++|+|+.|.|||
T Consensus 100 ~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~HgD~~~~Nil 179 (239)
T PF01636_consen 100 RALAQLHQVPPPFSPFADWPEWRLEFLRQLESWTARLRASELFDDLEELEERLLQELEALLPKPLPPVLIHGDLHPGNIL 179 (239)
T ss_dssp HHHHHHHHSHTTCCCHTHHHHHHHHHHHHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHCCSCEEEE-SS-SGGGEE
T ss_pred hhhhhcccccccccccccccccccccccccccccccccchhhhhhhHHHHHHHHHHHHhhhccCCCcEEEEeccccccce
Confidence 11 1110 101111111 0000 112222 33344331 2344999999999999
Q ss_pred Ec-CCCcEEEeeccCcc
Q 044312 410 LD-DKYRAKVSDFGASR 425 (608)
Q Consensus 410 l~-~~~~~kl~DFGls~ 425 (608)
++ +++.+-|.||+.+.
T Consensus 180 ~~~~~~~i~iID~e~a~ 196 (239)
T PF01636_consen 180 VDPSDGRIGIIDFEDAG 196 (239)
T ss_dssp EESSTTEEEE--GTT-E
T ss_pred eeeccceeEEEecccce
Confidence 99 55666899998764
|
; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B .... |
| >PLN02876 acyl-CoA dehydrogenase | Back alignment and domain information |
|---|
Probab=96.78 E-value=0.0068 Score=71.48 Aligned_cols=44 Identities=16% Similarity=0.379 Sum_probs=34.5
Q ss_pred HHHHHHHHHHHhhcC-CCCc--cceecccccC---ccceEEEeecCCCcc
Q 044312 315 VEEFINEVVILSQIN-HRNV--VKLLGCCLET---EVPLLVYEFIPNGTL 358 (608)
Q Consensus 315 ~~~~~~Ei~il~~l~-H~ni--v~l~~~~~~~---~~~~lV~E~~~~gsL 358 (608)
...+.+|.++|+.|. |.+| .+++.+|.+. +..++||||+++..+
T Consensus 82 ~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~~v~G~~flVME~v~G~~~ 131 (822)
T PLN02876 82 AHAVEREYQVLRALGEHTDVPVPKVYCLCTDASVIGTAFYIMEYLEGRIF 131 (822)
T ss_pred HHHHHHHHHHHHHHhhcCCCCCCcEEEEecCCCcCCCceEEEEecCCccc
Confidence 457889999999995 6665 7888887664 467899999987654
|
|
| >COG0661 AarF Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=96.43 E-value=0.0098 Score=65.52 Aligned_cols=79 Identities=23% Similarity=0.237 Sum_probs=56.0
Q ss_pred CccceEEEeecCCCccchhccccCCCCCCCHHHHHHHHHHHHHH-HHHHhhcCCCCeeccCCCCCcEEEcCCCcEEEeec
Q 044312 343 TEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEIRLRIAIEVSGA-LSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDF 421 (608)
Q Consensus 343 ~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~a-L~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DF 421 (608)
.....|+|||++|-.+.+...-... .++.+. ++..++++ +..+-..+ ++|.|..|.||+++.++.+-+.||
T Consensus 238 t~~~VLtmE~i~Gi~i~d~~~l~~~--g~d~k~---ia~~~~~~f~~q~~~dg---ffHaDpHpGNi~v~~~g~i~~lDf 309 (517)
T COG0661 238 TTRRVLTMEWIDGIKISDIAALKSA--GIDRKE---LAELLVRAFLRQLLRDG---FFHADPHPGNILVRSDGRIVLLDF 309 (517)
T ss_pred cCCcEEEEEeeCCEecccHHHHHhc--CCCHHH---HHHHHHHHHHHHHHhcC---ccccCCCccceEEecCCcEEEEcC
Confidence 4566899999999999887433222 244333 33333332 33333456 999999999999999999999999
Q ss_pred cCcccccc
Q 044312 422 GASRSMAV 429 (608)
Q Consensus 422 Gls~~~~~ 429 (608)
|+...+..
T Consensus 310 Gi~g~l~~ 317 (517)
T COG0661 310 GIVGRLDP 317 (517)
T ss_pred cceecCCH
Confidence 99887654
|
|
| >COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=96.39 E-value=0.02 Score=56.49 Aligned_cols=98 Identities=20% Similarity=0.213 Sum_probs=65.5
Q ss_pred HHHHHHHhhc--CCCCccceecccccCccceEEEeecCCCc-cchhccccCCCCCCCHHHHHHHHHHHHHHHHHHhh-cC
Q 044312 319 INEVVILSQI--NHRNVVKLLGCCLETEVPLLVYEFIPNGT-LFQYIHDQNEDFPITWEIRLRIAIEVSGALSYLHS-AA 394 (608)
Q Consensus 319 ~~Ei~il~~l--~H~niv~l~~~~~~~~~~~lV~E~~~~gs-L~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~-~~ 394 (608)
.+|+.-|+++ .+-.+.+-+++. .-.|||||+.... -.-.|... ++.......+..++++.+.-|-. .+
T Consensus 116 ~kEf~NL~R~~eAGVrvP~Pi~~~----~nVLvMEfIg~~g~pAP~LkDv----~~e~~e~~~~~~~~v~~~~~l~~~a~ 187 (268)
T COG1718 116 RKEFRNLKRAYEAGVRVPEPIAFR----NNVLVMEFIGDDGLPAPRLKDV----PLELEEAEGLYEDVVEYMRRLYKEAG 187 (268)
T ss_pred HHHHHHHHHHHHcCCCCCCceeec----CCeEEEEeccCCCCCCCCcccC----CcCchhHHHHHHHHHHHHHHHHHhcC
Confidence 3466666666 244455555543 3479999996431 11122211 23333566777788888888877 56
Q ss_pred CCCeeccCCCCCcEEEcCCCcEEEeeccCccccc
Q 044312 395 SIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMA 428 (608)
Q Consensus 395 ~~~iiHrDlk~~NILl~~~~~~kl~DFGls~~~~ 428 (608)
++|+||+.-|||+. ++.+.|+||+-|....
T Consensus 188 ---LVHgDLSEyNiL~~-~~~p~iID~~QaV~~~ 217 (268)
T COG1718 188 ---LVHGDLSEYNILVH-DGEPYIIDVSQAVTID 217 (268)
T ss_pred ---cccccchhhheEEE-CCeEEEEECccccccC
Confidence 99999999999999 7799999999876543
|
|
| >PRK10593 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=96.05 E-value=0.073 Score=54.86 Aligned_cols=45 Identities=13% Similarity=0.086 Sum_probs=35.0
Q ss_pred hHHHHHHHHHHHhhcCC---CCccceeccccc---CccceEEEeecCCCcc
Q 044312 314 KVEEFINEVVILSQINH---RNVVKLLGCCLE---TEVPLLVYEFIPNGTL 358 (608)
Q Consensus 314 ~~~~~~~Ei~il~~l~H---~niv~l~~~~~~---~~~~~lV~E~~~~gsL 358 (608)
....|.+|.+.|+.|.- -.|.++++++.. .+..+||||++++.++
T Consensus 50 ~~~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~~~~g~~~LVmE~i~G~~~ 100 (297)
T PRK10593 50 TPGVAQQEAWKLSMLARSGTVRMPTVYGVMTHEQSPGPDVLLLERLRGVSV 100 (297)
T ss_pred cchHHHHHHHHHHHHccCCCCCcCcEEEEeccCCcCCCeEEEEeccCCEec
Confidence 34688999999998843 368888987754 3568999999998765
|
|
| >cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes | Back alignment and domain information |
|---|
Probab=95.90 E-value=0.047 Score=53.89 Aligned_cols=29 Identities=28% Similarity=0.428 Sum_probs=25.6
Q ss_pred CeeccCCCCCcEEEcC-CCcEEEeeccCcc
Q 044312 397 PIYHRDIKSTNILLDD-KYRAKVSDFGASR 425 (608)
Q Consensus 397 ~iiHrDlk~~NILl~~-~~~~kl~DFGls~ 425 (608)
.++|+|+.+.|||+++ +..+.|.||..+.
T Consensus 171 ~l~H~Dl~~~Nil~~~~~~~~~lIDwe~a~ 200 (235)
T cd05157 171 VFCHNDLLSGNIIYNEEKNSVKFIDYEYAG 200 (235)
T ss_pred EEEcCCCCcCcEEEeCCCCCEEEEEcccCC
Confidence 4899999999999997 5789999998764
|
ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo |
| >TIGR02721 ycfN_thiK thiamine kinase | Back alignment and domain information |
|---|
Probab=95.87 E-value=0.036 Score=55.73 Aligned_cols=28 Identities=18% Similarity=0.297 Sum_probs=24.6
Q ss_pred CeeccCCCCCcEEEcCCCcEEEeeccCcc
Q 044312 397 PIYHRDIKSTNILLDDKYRAKVSDFGASR 425 (608)
Q Consensus 397 ~iiHrDlk~~NILl~~~~~~kl~DFGls~ 425 (608)
.++|+|+.|.||++++++ +.|.||..+.
T Consensus 147 ~l~H~Dl~~~Nil~~~~~-~~lIDwE~a~ 174 (256)
T TIGR02721 147 APLHMDVHAYNLVVTPQG-LKLIDWEYAS 174 (256)
T ss_pred eeecCCCCcCcEEEeCCC-CEEEeccccC
Confidence 489999999999999876 7899998764
|
Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function. |
| >KOG1093 consensus Predicted protein kinase (contains TBC and RHOD domains) [General function prediction only] | Back alignment and domain information |
|---|
Probab=95.71 E-value=0.011 Score=63.58 Aligned_cols=49 Identities=14% Similarity=0.213 Sum_probs=38.8
Q ss_pred HHHHHHHHHHhhcCCCCccceecccccCc-cceEEEeecCCCccchhcccc
Q 044312 316 EEFINEVVILSQINHRNVVKLLGCCLETE-VPLLVYEFIPNGTLFQYIHDQ 365 (608)
Q Consensus 316 ~~~~~Ei~il~~l~H~niv~l~~~~~~~~-~~~lV~E~~~~gsL~~~l~~~ 365 (608)
.+++....+++.+.|+|+..++.+-.... ...+|+|++ +.+|.+.+...
T Consensus 27 ~~ilgr~~~lktl~~~~l~~yl~~~r~~~~r~IVV~e~~-~~Sled~~~~~ 76 (725)
T KOG1093|consen 27 IQILGRFQYLKSLQHDNLCQYLDFSRGKHERVIVVMEHY-TMSLEDILKTG 76 (725)
T ss_pred HHHhhhhHHHHhhcCccceeeEeeecCccceEEEEehhh-ccchHHHHHhc
Confidence 45666778899999999999998876543 457899998 67999888654
|
|
| >COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only] | Back alignment and domain information |
|---|
Probab=95.42 E-value=0.1 Score=53.97 Aligned_cols=106 Identities=16% Similarity=0.305 Sum_probs=68.8
Q ss_pred hhHHHHHHHHHHHhhcCC--CCccceecccccCc--cceEEEeecCCCccchhccccCCCCCCCHHHHHHHHH-HHHHHH
Q 044312 313 SKVEEFINEVVILSQINH--RNVVKLLGCCLETE--VPLLVYEFIPNGTLFQYIHDQNEDFPITWEIRLRIAI-EVSGAL 387 (608)
Q Consensus 313 ~~~~~~~~Ei~il~~l~H--~niv~l~~~~~~~~--~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~-~ia~aL 387 (608)
.......+|.++|+.+.- --+.+.++.|.++. ..+.||+|++|..+.+.+.... .. .+++. .+++.|
T Consensus 63 ~~~~~~~re~~~i~~l~~~~vP~p~~~~~~~~~~~g~pf~v~~~veGe~~~~~~~~~~----~~----~~~~~~~l~~~L 134 (321)
T COG3173 63 ESAHDEKREYRVIAALLDVDVPVPRAFGLCGEGYLGTPFYVMEWVEGEVVWSALPPES----LG----RQFALDALADFL 134 (321)
T ss_pred hhhhHHHhHHHHHHHhcCCCCCCcccccccccCCCCCceEEEEEecceeccCcCCccc----ch----HHHHHHHHHHHH
Confidence 455667788888888743 34456677777666 7799999998854433222111 00 11111 333333
Q ss_pred --------------------------------------------------HHHhhcC-----CCCeeccCCCCCcEEEcC
Q 044312 388 --------------------------------------------------SYLHSAA-----SIPIYHRDIKSTNILLDD 412 (608)
Q Consensus 388 --------------------------------------------------~yLH~~~-----~~~iiHrDlk~~NILl~~ 412 (608)
.+|+.+. .+.++|+|+.+.|+++++
T Consensus 135 a~LH~ida~~~~~~g~~~~~~~rql~~~~~~~~~~~~~~~~~~p~~~~~~~Wl~~~~p~~~~~~~lvHGD~~~gNlii~~ 214 (321)
T COG3173 135 AELHSIDAAGLPDPGKPNAYRGRQLARWDDEYRRAKKELGGRIPLADRLIKWLEANRPPWAGPPVLVHGDYRPGNLIIDP 214 (321)
T ss_pred HHHhCCCCcCCCCCCccCccccchhhHHHHHHHHHHHhccCCCchHHHHHHHHHhcCCCcCCCceeeeCCcccCCEEEeC
Confidence 3444332 235999999999999999
Q ss_pred CCcEEEeeccCccc
Q 044312 413 KYRAKVSDFGASRS 426 (608)
Q Consensus 413 ~~~~kl~DFGls~~ 426 (608)
+..+-|.||+++..
T Consensus 215 ~~~~gVlDwe~~~l 228 (321)
T COG3173 215 GRPTGVLDWELATL 228 (321)
T ss_pred CCeeEEEecccccc
Confidence 88899999999865
|
|
| >cd05153 HomoserineK_II Homoserine Kinase, type II | Back alignment and domain information |
|---|
Probab=95.35 E-value=0.084 Score=54.17 Aligned_cols=124 Identities=18% Similarity=0.195 Sum_probs=71.3
Q ss_pred cCceEEEEEeecChhhHHHHHHHHHHHhhcCCCC--ccceeccc------ccCccceEEEeecCCCccch----------
Q 044312 299 QGGQAVKKSKVIDESKVEEFINEVVILSQINHRN--VVKLLGCC------LETEVPLLVYEFIPNGTLFQ---------- 360 (608)
Q Consensus 299 ~G~~avk~~~~~~~~~~~~~~~Ei~il~~l~H~n--iv~l~~~~------~~~~~~~lV~E~~~~gsL~~---------- 360 (608)
.|.+.+|.... ...+....|++++..|.+.+ +.+++... ...+..++|+++++|..+..
T Consensus 37 ~~~~vLr~~~~---~~~~~~~~e~~~l~~L~~~g~~vp~~i~~~~g~~~~~~~~~~~~l~~~i~G~~~~~~~~~~~~~lg 113 (296)
T cd05153 37 SGRYVLTLFEK---VSAEELPFFLALLDHLAERGLPVPRPIADRDGEYLSELAGKPAALVEFLAGEHLTRPTAAHCRQIG 113 (296)
T ss_pred CCcEEEEEcCC---CChHhccHHHHHHHHHHHCCCCCCccccCCCCcEeeeeCCceEEEEEeCCCCCCCCCCHHHHHHHH
Confidence 45677776543 33456777888888885433 45554421 12345689999999876532
Q ss_pred ----hccccCCC--------CCCCHHHHH----------HHHHHHHHHHHHHhhc----CCCCeeccCCCCCcEEEcCCC
Q 044312 361 ----YIHDQNED--------FPITWEIRL----------RIAIEVSGALSYLHSA----ASIPIYHRDIKSTNILLDDKY 414 (608)
Q Consensus 361 ----~l~~~~~~--------~~l~~~~~~----------~i~~~ia~aL~yLH~~----~~~~iiHrDlk~~NILl~~~~ 414 (608)
.+|..... ....|.... .....+..++.++... .+..++|+|+.|.|||++++.
T Consensus 114 ~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~~~~~~~~~l~HgD~~~~Nil~~~~~ 193 (296)
T cd05153 114 EALARLHLAAQSFPGERNNLRGLAWIRELGKDLLPLLSAEDRALLADELARQDAFDPSDLPRGVIHADLFRDNVLFDGDE 193 (296)
T ss_pred HHHHHHHHHhccCCccCCCcCCcHHHHHHHHHhccccCHHHHHHHHHHHHHHHhhhhhcCCCcCCccCcCcccEEEeCCc
Confidence 11111000 011222211 0112233445555431 123489999999999999987
Q ss_pred cEEEeeccCcc
Q 044312 415 RAKVSDFGASR 425 (608)
Q Consensus 415 ~~kl~DFGls~ 425 (608)
.+.|.||+.+.
T Consensus 194 ~~~iIDfe~a~ 204 (296)
T cd05153 194 LSGVIDFYFAC 204 (296)
T ss_pred eEEEeehhhhc
Confidence 77899998764
|
Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine. |
| >TIGR00938 thrB_alt homoserine kinase, Neisseria type | Back alignment and domain information |
|---|
Probab=95.30 E-value=0.11 Score=53.66 Aligned_cols=125 Identities=21% Similarity=0.260 Sum_probs=68.6
Q ss_pred cCceEEEEEeecChhhHHHHHHHHHHHhhcCCC--Cccceeccc------ccCccceEEEeecCCCccch----------
Q 044312 299 QGGQAVKKSKVIDESKVEEFINEVVILSQINHR--NVVKLLGCC------LETEVPLLVYEFIPNGTLFQ---------- 360 (608)
Q Consensus 299 ~G~~avk~~~~~~~~~~~~~~~Ei~il~~l~H~--niv~l~~~~------~~~~~~~lV~E~~~~gsL~~---------- 360 (608)
.|.+.+|..... ...+....|++++..|... .+.+++... ...+..++++||++|..+..
T Consensus 45 ~~~~vLK~~~~~--~~~~~i~~e~~~l~~L~~~g~pvp~~i~t~~g~~~~~~~g~~~~l~e~i~G~~~~~~~~~~~~~~G 122 (307)
T TIGR00938 45 VGRYILTLYEKR--VKAEELPFFLALTTHLAARGLPVPKPVKSRDGRQLSTLAGKPACLVEFLQGLSVGRPTAMHCRPVG 122 (307)
T ss_pred CCcEEEEEecCC--CCHHHHHHHHHHHHHHHHCCCCCCccccCCCCCeehhcCCeEEEEEEeCCCCCCCCCCHHHHHHHH
Confidence 445666655432 1234556677777777432 244544422 12345689999998865421
Q ss_pred ----hccccCCCC---------CCCHHHHH------------HHHHHHHHHHHHHhh----cCCCCeeccCCCCCcEEEc
Q 044312 361 ----YIHDQNEDF---------PITWEIRL------------RIAIEVSGALSYLHS----AASIPIYHRDIKSTNILLD 411 (608)
Q Consensus 361 ----~l~~~~~~~---------~l~~~~~~------------~i~~~ia~aL~yLH~----~~~~~iiHrDlk~~NILl~ 411 (608)
.+|...... .-.|.... .....+.+.++++.. ..+..++|+|+.+.||+++
T Consensus 123 ~~LA~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~l~~~~~~~l~~~~~~l~~~~~~~~~~~l~HgD~~~~Nvl~~ 202 (307)
T TIGR00938 123 EVLAWMHLAGAHFPENRKNSLRLEAWHILAEKCFEAAPQLEAHMGAELDKELDYLDKFWPRDLPRGVIHADLFPDNVLFD 202 (307)
T ss_pred HHHHHHHhhhccCCCCCCCCCChHHHHHHHHhhhhcccccCHHHHHHHHHHHHHHHhhhhhcCCCccCCCCCCcCcEEEE
Confidence 122111110 01121110 011223345555543 1234599999999999999
Q ss_pred CCCcEEEeeccCcc
Q 044312 412 DKYRAKVSDFGASR 425 (608)
Q Consensus 412 ~~~~~kl~DFGls~ 425 (608)
++....|.||+.+.
T Consensus 203 ~~~~~~vIDfd~~~ 216 (307)
T TIGR00938 203 GDSVKGVIDFYFAC 216 (307)
T ss_pred CCceEEEeeccccc
Confidence 88777899999764
|
Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase. |
| >KOG1235 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=95.23 E-value=0.078 Score=58.49 Aligned_cols=79 Identities=15% Similarity=0.132 Sum_probs=52.9
Q ss_pred ccceEEEeecCCCccchhccccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEEcC----CCcEEEe
Q 044312 344 EVPLLVYEFIPNGTLFQYIHDQNEDFPITWEIRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDD----KYRAKVS 419 (608)
Q Consensus 344 ~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~----~~~~kl~ 419 (608)
....|+||||+|..+.+.-.-... .++...+..-+.++.. +-|=..| ++|.|=.|.|||+.. ++.+.+.
T Consensus 275 t~RVLtME~~~G~~i~Dl~~i~~~--gi~~~~i~~~l~~~~~--~qIf~~G---ffHaDPHPGNilv~~~~~~~~~ivll 347 (538)
T KOG1235|consen 275 TKRVLTMEYVDGIKINDLDAIDKR--GISPHDILNKLVEAYL--EQIFKTG---FFHADPHPGNILVRPNPEGDEEIVLL 347 (538)
T ss_pred cceEEEEEecCCccCCCHHHHHHc--CCCHHHHHHHHHHHHH--HHHHhcC---CccCCCCCCcEEEecCCCCCccEEEE
Confidence 356899999999988775332211 2555544333333222 2222345 999999999999984 6789999
Q ss_pred eccCcccccc
Q 044312 420 DFGASRSMAV 429 (608)
Q Consensus 420 DFGls~~~~~ 429 (608)
|||+...+..
T Consensus 348 DhGl~~~is~ 357 (538)
T KOG1235|consen 348 DHGLYAVISH 357 (538)
T ss_pred cccccccccH
Confidence 9999887653
|
|
| >TIGR02906 spore_CotS spore coat protein, CotS family | Back alignment and domain information |
|---|
Probab=94.96 E-value=0.14 Score=52.78 Aligned_cols=29 Identities=34% Similarity=0.398 Sum_probs=24.7
Q ss_pred CCeeccCCCCCcEEEcCCCcEEEeeccCcc
Q 044312 396 IPIYHRDIKSTNILLDDKYRAKVSDFGASR 425 (608)
Q Consensus 396 ~~iiHrDlk~~NILl~~~~~~kl~DFGls~ 425 (608)
..++|+|+.+.||+++. +.+.|.||+.+.
T Consensus 187 ~~liHgD~~~~Nil~~~-~~i~lIDfd~~~ 215 (313)
T TIGR02906 187 RGFCHQDYAYHNILLKD-NEVYVIDFDYCT 215 (313)
T ss_pred CceEcCCCCcccEEEeC-CcEEEEECcccc
Confidence 34899999999999987 578899998654
|
Members of this family include the spore coat proteins CotS and YtaA from Bacillus subtilis and, from other endospore-forming bacteria, homologs that are more closely related to these two than to the spore coat proteins YutH and YsxE. The CotS family is more broadly distributed than YutH or YsxE, but still is not universal among spore-formers. |
| >cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2') | Back alignment and domain information |
|---|
Probab=94.70 E-value=0.2 Score=51.07 Aligned_cols=30 Identities=23% Similarity=0.492 Sum_probs=24.7
Q ss_pred CeeccCCCCCcEEEcCCCc-EEEeeccCccc
Q 044312 397 PIYHRDIKSTNILLDDKYR-AKVSDFGASRS 426 (608)
Q Consensus 397 ~iiHrDlk~~NILl~~~~~-~kl~DFGls~~ 426 (608)
.++|+|+.+.|||+++++. .-|.||+.+..
T Consensus 186 ~lvHGD~~~~Nilv~~~~~~~gviDWe~a~i 216 (276)
T cd05152 186 VLVHGDLHPGHILIDEDARVTGLIDWTEAKV 216 (276)
T ss_pred eeEeCCCCCCcEEEeCCCCEEEEECcHhccc
Confidence 3899999999999997554 56999997753
|
MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported |
| >PRK05231 homoserine kinase; Provisional | Back alignment and domain information |
|---|
Probab=94.47 E-value=0.32 Score=50.53 Aligned_cols=30 Identities=20% Similarity=0.253 Sum_probs=25.6
Q ss_pred CCeeccCCCCCcEEEcCCCcEEEeeccCcc
Q 044312 396 IPIYHRDIKSTNILLDDKYRAKVSDFGASR 425 (608)
Q Consensus 396 ~~iiHrDlk~~NILl~~~~~~kl~DFGls~ 425 (608)
..++|+|+.|.|||++++...-|.||+.+.
T Consensus 187 ~~liHgD~~~~Nil~~~~~~~~iIDf~~~~ 216 (319)
T PRK05231 187 RGVIHADLFRDNVLFEGDRLSGFIDFYFAC 216 (319)
T ss_pred cccCCCCCCCCcEEEECCceEEEEeccccc
Confidence 349999999999999977666899999764
|
|
| >PF01633 Choline_kinase: Choline/ethanolamine kinase; InterPro: IPR002573 Choline kinase, (ATP:choline phosphotransferase, 2 | Back alignment and domain information |
|---|
Probab=93.79 E-value=0.28 Score=47.64 Aligned_cols=30 Identities=27% Similarity=0.412 Sum_probs=20.8
Q ss_pred CeeccCCCCCcEEE-cCCCcEEEeeccCccc
Q 044312 397 PIYHRDIKSTNILL-DDKYRAKVSDFGASRS 426 (608)
Q Consensus 397 ~iiHrDlk~~NILl-~~~~~~kl~DFGls~~ 426 (608)
-+.|.||.+.|||+ +.++.++++||..+..
T Consensus 144 v~cHnDl~~~Nil~~~~~~~~~lIDfEya~~ 174 (211)
T PF01633_consen 144 VFCHNDLNPGNILINNKDGEVKLIDFEYAGY 174 (211)
T ss_dssp EEE-S--SGGGEEETSSSSCEEE--GTT-EE
T ss_pred eEeeccCccccEEeccCCCeEEEecHHHHhh
Confidence 37899999999999 7888999999987753
|
7.1.32 from EC) belongs to the choline/ethanolamine kinase family. Ethanolamine and choline are major membrane phospholipids, in the form of glycerophosphoethanolamine and glycerophosphocholine. Ethanolamine is also a component of the glycosylphosphatidylinositol (GPI) anchor, which is necessary for cell-surface protein attachment []. The de novo synthesis of these phospholipids begins with the creation of phosphoethanolamine and phosphocholine by ethanolamine and choline kinases in the first step of the CDP-ethanolamine pathway [, ]. There are two putative choline/ethanolamine kinases (C/EKs) in the Trypanosoma brucei genome. Ethanolamine kinase has no choline kinase activity [] and its activity is inhibited by ADP []. Inositol supplementation represses ethanolamine kinase, decreasing the incorporation of ethanolamine into the CDP-ethanolamine pathway and into phosphatidylethanolamine and phosphatidylcholine []. ; GO: 0016773 phosphotransferase activity, alcohol group as acceptor; PDB: 3C5I_A 2IG7_A 3LQ3_A 3FEG_A 2QG7_E 3FI8_A 1NW1_A 3MES_A 3G15_A 2CKP_B .... |
| >PF07387 Seadorna_VP7: Seadornavirus VP7; InterPro: IPR009973 This family consists of several Seadornavirus specific VP7 proteins of around 305 residues in length | Back alignment and domain information |
|---|
Probab=93.78 E-value=0.14 Score=49.58 Aligned_cols=139 Identities=14% Similarity=0.086 Sum_probs=85.8
Q ss_pred ceEEEEEeecChh-hHHHHHHHHHHHhhcCCCCccceecccccCccceEEEeecCCCccchhccccCCCCCCCHHHHHHH
Q 044312 301 GQAVKKSKVIDES-KVEEFINEVVILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEIRLRI 379 (608)
Q Consensus 301 ~~avk~~~~~~~~-~~~~~~~Ei~il~~l~H~niv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i 379 (608)
..-+||+...+-. ....|.++.+++++++ .|++|..- +...+-++.|+|-... ... ..+
T Consensus 87 ~L~lKKi~slp~~~~~~~y~nky~v~Armh--GilrL~ND--n~~~yGvIlE~Cy~~~------------i~~----~N~ 146 (308)
T PF07387_consen 87 PLFLKKIRSLPCCINDALYFNKYRVFARMH--GILRLKND--NNYKYGVILERCYKIK------------INF----SNF 146 (308)
T ss_pred hhhhhhccCCCcccchhhhhhhhhHHHHhh--heeEeecC--CCceeEEEEeeccCcc------------cch----hHH
Confidence 3456666654444 4566788999998876 47777732 3334558888883210 011 111
Q ss_pred HHHHHHHHHHHhhcCCCCeeccCCCCCcEEEcCCCcEEEeeccCccccccCCcceeeeeeccCCCCChhhhccCCCCCcc
Q 044312 380 AIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHGTFGYLDPEYFRSSQFTDKS 459 (608)
Q Consensus 380 ~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGls~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ks 459 (608)
+.-=+++|.-.|+.. ...+|+|..|+||+-|..|.+||.|=+.--. .. .-|.- ......|.++
T Consensus 147 i~agi~~L~~fH~~~-~~~lHGD~np~NiM~D~~G~lKlVDP~~Ll~------~~-------V~~vN---~~Y~~lT~~a 209 (308)
T PF07387_consen 147 ITAGIKDLMDFHSEN-QHCLHGDCNPDNIMCDKFGYLKLVDPVCLLE------NQ-------VNMVN---IEYESLTQEA 209 (308)
T ss_pred HHHhHHHHHHhhccC-CCeecCCCChhheeecCCCCEEecChhhhhh------he-------eeEEe---eeccccChHH
Confidence 111146677888654 3489999999999999999999999653210 00 11111 1123467788
Q ss_pred chHhHHHHHHHHHhCCC
Q 044312 460 DVYSFGVVLTELLTGEK 476 (608)
Q Consensus 460 DV~S~Gvvl~elltg~~ 476 (608)
.+-+|=.-++++....+
T Consensus 210 E~~~fv~s~l~~v~~~~ 226 (308)
T PF07387_consen 210 EVKVFVKSCLKLVEKQR 226 (308)
T ss_pred HHHHHHHHHHHHHHHHh
Confidence 88888877787776443
|
The function of this family is unknown. |
| >KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=93.56 E-value=0.16 Score=52.12 Aligned_cols=95 Identities=20% Similarity=0.185 Sum_probs=65.7
Q ss_pred HHHHHHHHHhhcCC--CCccceecccccCccceEEEeecCCCccchhccccCCCCCCCHHHHHHHHHHHHHHHHHHhhcC
Q 044312 317 EFINEVVILSQINH--RNVVKLLGCCLETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEIRLRIAIEVSGALSYLHSAA 394 (608)
Q Consensus 317 ~~~~Ei~il~~l~H--~niv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~ 394 (608)
...+|+..|+.|.. =-|.+.+++. .-++|||++.+-.|.+.-+-. +..++. ..+..-+.-|..+|
T Consensus 156 aa~kEfafmkaL~e~gfpVPkpiD~~----RH~Vvmelv~g~Pl~~v~~v~------d~~~ly---~~lm~~Iv~la~~G 222 (465)
T KOG2268|consen 156 AATKEFAFMKALYERGFPVPKPIDHN----RHCVVMELVDGYPLRQVRHVE------DPPTLY---DDLMGLIVRLANHG 222 (465)
T ss_pred HHHHHHHHHHHHHHcCCCCCCccccc----ceeeHHHhhcccceeeeeecC------ChHHHH---HHHHHHHHHHHHcC
Confidence 45678888888842 2345555543 457899999988886654322 223333 33334455666788
Q ss_pred CCCeeccCCCCCcEEEcCCCcEEEeeccCcccc
Q 044312 395 SIPIYHRDIKSTNILLDDKYRAKVSDFGASRSM 427 (608)
Q Consensus 395 ~~~iiHrDlk~~NILl~~~~~~kl~DFGls~~~ 427 (608)
+||+|.+--||+++++..++++||--....
T Consensus 223 ---lIHgDFNEFNimv~dd~~i~vIDFPQmvS~ 252 (465)
T KOG2268|consen 223 ---LIHGDFNEFNIMVKDDDKIVVIDFPQMVST 252 (465)
T ss_pred ---ceecccchheeEEecCCCEEEeechHhhcc
Confidence 999999999999999999999999755443
|
|
| >PLN02236 choline kinase | Back alignment and domain information |
|---|
Probab=93.40 E-value=0.29 Score=51.59 Aligned_cols=30 Identities=23% Similarity=0.468 Sum_probs=25.7
Q ss_pred CCeeccCCCCCcEEEcC-CCcEEEeeccCcc
Q 044312 396 IPIYHRDIKSTNILLDD-KYRAKVSDFGASR 425 (608)
Q Consensus 396 ~~iiHrDlk~~NILl~~-~~~~kl~DFGls~ 425 (608)
..++|+|+++.|||+++ ++.+.++||..+.
T Consensus 200 ~~~cH~Dl~~~Nil~~~~~~~~~lID~Eya~ 230 (344)
T PLN02236 200 IGFCHNDLQYGNIMIDEETRAITIIDYEYAS 230 (344)
T ss_pred ceEEeCCCCcCcEEEeCCCCcEEEEeehhcc
Confidence 34899999999999986 4689999998765
|
|
| >COG5072 ALK1 Serine/threonine kinase of the haspin family [Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=93.06 E-value=0.18 Score=52.50 Aligned_cols=72 Identities=24% Similarity=0.224 Sum_probs=54.2
Q ss_pred ccceEEEeecCCCccchhccccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEEcCCCcEEEeeccC
Q 044312 344 EVPLLVYEFIPNGTLFQYIHDQNEDFPITWEIRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGA 423 (608)
Q Consensus 344 ~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGl 423 (608)
...|++|++. |++|. .+. .-.|.+.+.|+.+-+..+.-+..+- +.-|||+.-.||||+ +|++.|+||-+
T Consensus 299 ~y~yl~~kdh-gt~is-~ik------~~~~~e~lsff~s~~sil~~lekkf--~fehrnlt~~niLId-~GnvtLIDfkl 367 (488)
T COG5072 299 LYLYLHFKDH-GTPIS-IIK------ADRSEEELSFFWSCISILDILEKKF--PFEHRNLTLDNILID-EGNVTLIDFKL 367 (488)
T ss_pred eEEEEEEecC-Cceee-eee------cccHHHHHHHHHHHHHHHhhhhhcC--Ccccccccccceeee-cCceEEEEeee
Confidence 3456666654 44442 222 1468888999998888777776543 588999999999999 89999999999
Q ss_pred ccc
Q 044312 424 SRS 426 (608)
Q Consensus 424 s~~ 426 (608)
+|.
T Consensus 368 sRl 370 (488)
T COG5072 368 SRL 370 (488)
T ss_pred eec
Confidence 984
|
|
| >COG3001 Uncharacterized protein conserved in bacteria [Function unknown] | Back alignment and domain information |
|---|
Probab=92.84 E-value=0.77 Score=44.99 Aligned_cols=50 Identities=24% Similarity=0.339 Sum_probs=39.9
Q ss_pred cChhhHHHHHHHHHHHhhc---CCCCccceecccccCccceEEEeecCCCccc
Q 044312 310 IDESKVEEFINEVVILSQI---NHRNVVKLLGCCLETEVPLLVYEFIPNGTLF 359 (608)
Q Consensus 310 ~~~~~~~~~~~Ei~il~~l---~H~niv~l~~~~~~~~~~~lV~E~~~~gsL~ 359 (608)
........|..|+.-|..| +.-+|.+++.+-.+....|||+||++-+.+.
T Consensus 47 n~~~~~~~f~AEa~gL~~la~s~ti~VP~vi~~G~~~~~sylVle~L~~~~~d 99 (286)
T COG3001 47 NQREQLSMFTAEADGLELLARSNTITVPKVIAVGASRDHSYLVLEYLPTGPLD 99 (286)
T ss_pred cchhhHHHHHHHHHHHHHHHhcCCccccceEEecCCCCeeEEEEeeccCCCCC
Confidence 3455667888898877776 4467889999999999999999999987665
|
|
| >PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2 | Back alignment and domain information |
|---|
Probab=92.67 E-value=0.67 Score=44.68 Aligned_cols=85 Identities=28% Similarity=0.448 Sum_probs=58.1
Q ss_pred HHHHHHHHHHhhc---CCCCc--cceecccccC-c-----------------cceEEEeecCCCccchhccccCCCCCCC
Q 044312 316 EEFINEVVILSQI---NHRNV--VKLLGCCLET-E-----------------VPLLVYEFIPNGTLFQYIHDQNEDFPIT 372 (608)
Q Consensus 316 ~~~~~Ei~il~~l---~H~ni--v~l~~~~~~~-~-----------------~~~lV~E~~~~gsL~~~l~~~~~~~~l~ 372 (608)
+-|..|-+...+| .+.++ |+.+|+..-. + ...||.||.+... .+.
T Consensus 99 ~PF~~ECRAfgRLke~~~e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~------------~~~ 166 (207)
T PF13095_consen 99 DPFNCECRAFGRLKEAGREGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP------------PLQ 166 (207)
T ss_pred ChHHHHHHhhHHHHhccccCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc------------ccc
Confidence 3578888877776 45567 8888887311 0 1245666665422 122
Q ss_pred HHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEEcCCCcEEEeeccCc
Q 044312 373 WEIRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGAS 424 (608)
Q Consensus 373 ~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGls 424 (608)
. +-+.+|.+-|..+|..+ |+-+|+++.|.. .-||.|||.+
T Consensus 167 ~----~~~~~~~~dl~~~~k~g---I~~~Dv~~~ny~-----~G~lvDfs~~ 206 (207)
T PF13095_consen 167 I----RDIPQMLRDLKILHKLG---IVPRDVKPRNYR-----GGKLVDFSSS 206 (207)
T ss_pred h----hHHHHHHHHHHHHHHCC---eeeccCcccccc-----CCEEEecccC
Confidence 2 23456777788899999 999999999986 4689999864
|
|
| >COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=92.29 E-value=0.82 Score=43.00 Aligned_cols=98 Identities=17% Similarity=0.209 Sum_probs=63.1
Q ss_pred ChhhHHHHHHHHHHHhhcCCCCcc-ceecccccCccceEEEeecCCCccchhccccCCCCCCCHHHHHHHHHHHHHHHHH
Q 044312 311 DESKVEEFINEVVILSQINHRNVV-KLLGCCLETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEIRLRIAIEVSGALSY 389 (608)
Q Consensus 311 ~~~~~~~~~~Ei~il~~l~H~niv-~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~y 389 (608)
.+.....+..|.++|..+.-.++. +++.+- ...+.|||+.|-.|.+.-... +.+. ...++++---
T Consensus 55 ~ds~r~~l~kEakiLeil~g~~~~p~vy~yg----~~~i~me~i~G~~L~~~~~~~------~rk~----l~~vlE~a~~ 120 (201)
T COG2112 55 RDSPRRNLEKEAKILEILAGEGVTPEVYFYG----EDFIRMEYIDGRPLGKLEIGG------DRKH----LLRVLEKAYK 120 (201)
T ss_pred CCcchhhHHHHHHHHHHhhhcCCCceEEEec----hhhhhhhhhcCcchhhhhhcc------cHHH----HHHHHHHHHH
Confidence 345567899999999998876664 344332 224559999887776654321 2222 2344444344
Q ss_pred HhhcCCCCeeccCCC-C-CcEEEcCCCcEEEeeccCccc
Q 044312 390 LHSAASIPIYHRDIK-S-TNILLDDKYRAKVSDFGASRS 426 (608)
Q Consensus 390 LH~~~~~~iiHrDlk-~-~NILl~~~~~~kl~DFGls~~ 426 (608)
|-..+ |-|+.|. | .||++.++ .+.|+||.-|..
T Consensus 121 LD~~G---I~H~El~~~~k~vlv~~~-~~~iIDFd~At~ 155 (201)
T COG2112 121 LDRLG---IEHGELSRPWKNVLVNDR-DVYIIDFDSATF 155 (201)
T ss_pred HHHhc---cchhhhcCCceeEEecCC-cEEEEEccchhh
Confidence 45556 8899988 4 45555554 899999998863
|
|
| >PF03881 Fructosamin_kin: Fructosamine kinase; InterPro: IPR016477 Ketosamines derive from a non-enzymatic reaction between a sugar and a protein [] | Back alignment and domain information |
|---|
Probab=90.66 E-value=1.1 Score=45.98 Aligned_cols=52 Identities=25% Similarity=0.240 Sum_probs=31.9
Q ss_pred eEEEEEeecChhhHHHHHHHHHHHhhcC---CCCccceecccccCccceEEEeecCCC
Q 044312 302 QAVKKSKVIDESKVEEFINEVVILSQIN---HRNVVKLLGCCLETEVPLLVYEFIPNG 356 (608)
Q Consensus 302 ~avk~~~~~~~~~~~~~~~Ei~il~~l~---H~niv~l~~~~~~~~~~~lV~E~~~~g 356 (608)
+-||... ......|..|.+-|+.|. --.+.+.+++....+..+||+||++.+
T Consensus 43 ~FvK~~~---~~~~~~f~~Ea~gL~~L~~~~~~~vP~vi~~G~~~~~~fLlle~l~~~ 97 (288)
T PF03881_consen 43 YFVKVNS---ESGRDMFEGEAEGLKALAEANPIRVPKVIAWGEYDDDAFLLLEFLEMG 97 (288)
T ss_dssp EEEEEEE---GGGCCHHHHHHHHHHHHCHTTTSBS--EEEEEE-SSCCEEEEE-----
T ss_pred EEEEecC---hhhHHHHHHHHHHHHHHHhcCCCCCCeEEEEEeecCCceEEEEeecCC
Confidence 3455544 444567888888888883 456788898887777789999999876
|
Ketosamine-3-kinases (KT3K), of which fructosamine-3-kinase (FN3K) is the best-known example, catalyse the phosphorylation of the ketosamine moiety of glycated proteins. The instability of a phosphorylated ketosamine leads to its degradation, and KT3K is thus thought to be involved in protein repair []. The function of the prokaryotic members of this group has not been established. However, several lines of evidence indicate that they may function as fructosamine-3-kinases (FN3K). First, they are similar to characterised FN3K from mouse and human. Second, the Escherichia coli members are found in close proximity on the genome to fructose-6-phosphate kinase (PfkB). Last, FN3K activity has been found in a Anacystis montana (Gloeocapsa montana Kutzing 1843) [], indicating such activity-directly demonstrated in eukaryotes-is nonetheless not confined to eukaryotes. This family includes eukaryotic fructosamine-3-kinase enzymes [] which may initiate a process leading to the deglycation of fructoselysine and of glycated proteins and in the phosphorylation of 1-deoxy-1-morpholinofructose, fructoselysine, fructoseglycine, fructose and glycated lysozyme. The family also includes bacterial members that have not been characterised but probably have a similar or identical function. For additional information please see [].; PDB: 3JR1_B 3F7W_A. |
| >PLN02421 phosphotransferase, alcohol group as acceptor/kinase | Back alignment and domain information |
|---|
Probab=89.10 E-value=1.1 Score=46.97 Aligned_cols=28 Identities=25% Similarity=0.402 Sum_probs=24.5
Q ss_pred eeccCCCCCcEEEcC-CCcEEEeeccCcc
Q 044312 398 IYHRDIKSTNILLDD-KYRAKVSDFGASR 425 (608)
Q Consensus 398 iiHrDlk~~NILl~~-~~~~kl~DFGls~ 425 (608)
.+|.|+.+.|||+++ ++.++++||..|.
T Consensus 184 ~CHnDl~~~NiL~~~~~~~l~lID~EYag 212 (330)
T PLN02421 184 FAHNDLLSGNLMLNEDEGKLYFIDFEYGS 212 (330)
T ss_pred EEECCCCcccEEEeCCCCcEEEEcccccC
Confidence 789999999999974 5689999998764
|
|
| >cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes | Back alignment and domain information |
|---|
Probab=89.09 E-value=0.81 Score=47.02 Aligned_cols=31 Identities=26% Similarity=0.402 Sum_probs=26.8
Q ss_pred CCCeeccCCCCCcEEEcCC----CcEEEeeccCcc
Q 044312 395 SIPIYHRDIKSTNILLDDK----YRAKVSDFGASR 425 (608)
Q Consensus 395 ~~~iiHrDlk~~NILl~~~----~~~kl~DFGls~ 425 (608)
...++|+|+.+.|||++++ +.++++||..+.
T Consensus 178 ~~~lcH~Dl~~~Nil~~~~~~~~~~i~lIDwEya~ 212 (302)
T cd05156 178 PVVFCHNDLQEGNILLLNPSSETKKLVLIDFEYAS 212 (302)
T ss_pred CceEEecCCCcCeEEecCCCCCCCcEEEEeeCCCC
Confidence 3458999999999999974 789999998775
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer |
| >PTZ00384 choline kinase; Provisional | Back alignment and domain information |
|---|
Probab=87.11 E-value=2 Score=45.86 Aligned_cols=37 Identities=16% Similarity=0.204 Sum_probs=26.9
Q ss_pred HHHHHHHhhcCCCCc-cceecccccCccceEEEeecCCCccc
Q 044312 319 INEVVILSQINHRNV-VKLLGCCLETEVPLLVYEFIPNGTLF 359 (608)
Q Consensus 319 ~~Ei~il~~l~H~ni-v~l~~~~~~~~~~~lV~E~~~~gsL~ 359 (608)
.+|+++++.+...++ .++++.+.. .+++||++|.+|.
T Consensus 100 ~~E~~i~~~Ls~~glgP~l~~~f~~----g~l~efIeGr~l~ 137 (383)
T PTZ00384 100 DLQYNIAKLLGDNNFGPKIIGRFGD----FTIQEWVEGNTMG 137 (383)
T ss_pred HHHHHHHHHHHhCCCCCeEEEecCC----EEEEEEeccccCC
Confidence 568889999965555 556666543 5999999987764
|
|
| >PF12662 cEGF: Complement Clr-like EGF-like | Back alignment and domain information |
|---|
Probab=86.47 E-value=0.2 Score=30.47 Aligned_cols=10 Identities=10% Similarity=0.036 Sum_probs=9.2
Q ss_pred ccCccccccc
Q 044312 176 NKDDRCLIQL 185 (608)
Q Consensus 176 gy~c~C~~gy 185 (608)
+|.|.|..||
T Consensus 1 sy~C~C~~Gy 10 (24)
T PF12662_consen 1 SYTCSCPPGY 10 (24)
T ss_pred CEEeeCCCCC
Confidence 5899999999
|
|
| >PHA03111 Ser/Thr kinase; Provisional | Back alignment and domain information |
|---|
Probab=85.92 E-value=0.79 Score=47.22 Aligned_cols=55 Identities=24% Similarity=0.229 Sum_probs=34.7
Q ss_pred HHHHHHHHHHHHHHHHHhh-cCCCCeeccCCCCCcEEEcCCC------------------cEEEeeccCccccc
Q 044312 374 EIRLRIAIEVSGALSYLHS-AASIPIYHRDIKSTNILLDDKY------------------RAKVSDFGASRSMA 428 (608)
Q Consensus 374 ~~~~~i~~~ia~aL~yLH~-~~~~~iiHrDlk~~NILl~~~~------------------~~kl~DFGls~~~~ 428 (608)
.-+..+..|||--.-.+-. .+....+|-||||+|||+-+.. .++|.||.+|+...
T Consensus 279 ~YikfifLQiaLLyikIYelp~c~nF~H~DLKPdNILiFds~~~i~I~~~~~~~vF~Epi~~~LnDFDfSqv~~ 352 (444)
T PHA03111 279 EYIKFIFLQIALLYIKIYELPCCDNFLHVDLKPDNILIFDSDEPISITLKDATYVFNEPIKACLNDFDFSQVAN 352 (444)
T ss_pred HHHHHHHHHHHHHHHhhhcCCCcceeeeccCCCCcEEEecCCCcEEEEECCeEEEeccchhhhhcccCHHHHcc
Confidence 3445677788655434422 2233489999999999995432 35667777766543
|
|
| >PRK10271 thiK thiamine kinase; Provisional | Back alignment and domain information |
|---|
Probab=83.37 E-value=0.98 Score=43.03 Aligned_cols=27 Identities=15% Similarity=0.246 Sum_probs=24.3
Q ss_pred eeccCCCCCcEEEcCCCcEEEeeccCcc
Q 044312 398 IYHRDIKSTNILLDDKYRAKVSDFGASR 425 (608)
Q Consensus 398 iiHrDlk~~NILl~~~~~~kl~DFGls~ 425 (608)
.+|+|+.|.||++++++ ++|+||+.+.
T Consensus 79 p~H~D~~~~N~~~~~~~-~~lIDwe~a~ 105 (188)
T PRK10271 79 PLHMDVHAGNLVHSASG-LRLIDWEYAG 105 (188)
T ss_pred eecCCCCCccEEEECCC-EEEEeCCccc
Confidence 78999999999998877 8999999764
|
|
| >COG2334 Putative homoserine kinase type II (protein kinase fold) [General function prediction only] | Back alignment and domain information |
|---|
Probab=82.85 E-value=2.6 Score=44.08 Aligned_cols=28 Identities=32% Similarity=0.564 Sum_probs=25.2
Q ss_pred eeccCCCCCcEEEcCCCc-EEEeeccCcc
Q 044312 398 IYHRDIKSTNILLDDKYR-AKVSDFGASR 425 (608)
Q Consensus 398 iiHrDlk~~NILl~~~~~-~kl~DFGls~ 425 (608)
+||+|+.|.|||++++.. ..+.||+-+.
T Consensus 199 iIH~D~~~~NVl~d~~~~~~g~iDFdDa~ 227 (331)
T COG2334 199 IIHGDLHPDNVLFDDDTDVSGFIDFDDAG 227 (331)
T ss_pred eeecCCCccceeEcCCCCeeeEEEccccc
Confidence 899999999999998874 8999999765
|
|
| >PF05445 Pox_ser-thr_kin: Poxvirus serine/threonine protein kinase; InterPro: IPR008790 This family of proteins contain poxvirus serine/threonine protein kinases, which are essential for phosphorylation of virion proteins during virion assembly | Back alignment and domain information |
|---|
Probab=82.40 E-value=1.3 Score=46.02 Aligned_cols=54 Identities=22% Similarity=0.237 Sum_probs=33.5
Q ss_pred HHHHHHHHHHHHHHHHhhc-CCCCeeccCCCCCcEEEcCC------------------CcEEEeeccCccccc
Q 044312 375 IRLRIAIEVSGALSYLHSA-ASIPIYHRDIKSTNILLDDK------------------YRAKVSDFGASRSMA 428 (608)
Q Consensus 375 ~~~~i~~~ia~aL~yLH~~-~~~~iiHrDlk~~NILl~~~------------------~~~kl~DFGls~~~~ 428 (608)
-+.-+..|||--.--+-.. +..-.+|-||||+|||+-+. -.++|.||.+|+...
T Consensus 276 YvkfifLQiaLLyikIYelp~c~nF~H~DLKPdNILiFds~~~i~I~~~~~~~vF~Epi~~~LnDFDfSqv~~ 348 (434)
T PF05445_consen 276 YVKFIFLQIALLYIKIYELPCCTNFLHVDLKPDNILIFDSKEPIRIKFGNRNYVFKEPIRCCLNDFDFSQVAN 348 (434)
T ss_pred HHHHHHHHHHHHHeeeecCCCcceeeecccCcCcEEEecCCCceEEEECCeEEEecccceeeecccCHHHhcc
Confidence 3455667775332113222 22338999999999999432 236778888877644
|
; GO: 0004672 protein kinase activity, 0005524 ATP binding |
| >COG4499 Predicted membrane protein [Function unknown] | Back alignment and domain information |
|---|
Probab=82.22 E-value=19 Score=37.70 Aligned_cols=124 Identities=15% Similarity=0.159 Sum_probs=75.1
Q ss_pred HHHHHhhcCCCCccceecccccCccceEEEeecCCCccchhccccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeec
Q 044312 321 EVVILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEIRLRIAIEVSGALSYLHSAASIPIYH 400 (608)
Q Consensus 321 Ei~il~~l~H~niv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH 400 (608)
++.++.+ ..|+++.-+.. +.+...|-++-... +..+-.-. .+.....++++.+.+..|.-+... -.|
T Consensus 41 ~~~lld~-~~~f~~~eit~--~~Ds~vIsy~i~~~--~~~F~~~k----~~~k~~Klr~a~~~I~~l~e~~~t----r~~ 107 (434)
T COG4499 41 LAELLDK-SPPFIVAEITE--DNDSFVISYPIPEA--AKSFASAK----RKEKTRKLRLALQNIATLSELNNT----RYT 107 (434)
T ss_pred HHHHhcc-CCCccceeecc--cCceeEEEecCccc--cchHHHHH----HHHHHHHHHHHHHHHHHHHHhhcc----cee
Confidence 4555665 45566554432 33344444444332 32222111 244556677777777777665332 345
Q ss_pred cCCCCCcEEEcCCCcEEEeeccCccccccCCcceeeeeeccCCCCChhhhccCCCCCccchHhHHHHHHHHHhCCCCCCc
Q 044312 401 RDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLTELLTGEKPIRF 480 (608)
Q Consensus 401 rDlk~~NILl~~~~~~kl~DFGls~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~elltg~~p~~~ 480 (608)
-=|.|+||+++.++++-+..+|+-..++ |.=|.||.+.. ++-++++.++.|+.+|+.
T Consensus 108 ~~laPeNilf~~~l~p~~vH~Glk~~lp-------------Pye~tee~f~~----------~ykA~~~~~fn~k~~Fe~ 164 (434)
T COG4499 108 FFLAPENILFDGGLTPFFVHRGLKNSLP-------------PYEMTEERFLK----------EYKALAIYAFNGKFSFES 164 (434)
T ss_pred EEecchheEEcCCCceEEEecchhccCC-------------CCCCCHHHHHH----------HHHHHHHHHHcCCccHHH
Confidence 5577999999999999999999866543 23356664432 566778888889988863
|
|
| >COG0510 ycfN Thiamine kinase and related kinases [Coenzyme transport and metabolism] | Back alignment and domain information |
|---|
Probab=81.67 E-value=2 Score=43.62 Aligned_cols=51 Identities=22% Similarity=0.228 Sum_probs=38.2
Q ss_pred HHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEEcCCCcEEEeeccCcc
Q 044312 374 EIRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASR 425 (608)
Q Consensus 374 ~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGls~ 425 (608)
......+..+-.++.-+|..- ..++|.|+.|.|+|.++.+.++|+||.-|.
T Consensus 132 ~~~~~~~~~l~~~l~~~~~~~-~v~cH~Dl~~~N~l~t~~~~l~LIDWEyAg 182 (269)
T COG0510 132 HLLRKKLKELRRALEEVPKDD-LVPCHNDLNPGNLLLTDKGGLFLIDWEYAG 182 (269)
T ss_pred HHHHHHHHHHHHHhhhcCCCc-eeeecCCCCccceEEcCCCcEEEEecccCC
Confidence 334445666666666666551 238999999999999998999999997664
|
|
Homologous Structure Templates
Structure Templates Detected by BLAST
Original result of BLAST against Protein Data Bank
| ID | Alignment Graph | Length |
Definition |
E-value | |
| Query | 608 | ||||
| 3tl8_A | 349 | The Avrptob-Bak1 Complex Reveals Two Structurally S | 9e-39 | ||
| 3uim_A | 326 | Structural Basis For The Impact Of Phosphorylation | 3e-38 | ||
| 2qkw_B | 321 | Structural Basis For Activation Of Plant Immunity B | 1e-37 | ||
| 3hgk_A | 327 | Crystal Structure Of Effect Protein Avrptob Complex | 9e-37 | ||
| 2nry_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 6e-31 | ||
| 2nru_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 1e-30 | ||
| 2oib_A | 301 | Crystal Structure Of Irak4 Kinase Domain Apo Form L | 4e-30 | ||
| 2o8y_A | 298 | Apo Irak4 Kinase Domain Length = 298 | 1e-26 | ||
| 3ppz_A | 309 | Crystal Structure Of Ctr1 Kinase Domain In Complex | 2e-25 | ||
| 3p86_A | 309 | Crystal Structure Of Ctr1 Kinase Domain Mutant D676 | 4e-25 | ||
| 4f1o_A | 287 | Crystal Structure Of The L1180t Mutant Roco4 Kinase | 2e-24 | ||
| 4f0f_A | 287 | Crystal Structure Of The Roco4 Kinase Domain Bound | 3e-24 | ||
| 4f1m_A | 287 | Crystal Structure Of The G1179s Roco4 Kinase Domain | 1e-23 | ||
| 3dtc_A | 271 | Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp | 2e-23 | ||
| 3dkg_A | 317 | Sgx Clone 5698a109kfg1h1 Length = 317 | 1e-21 | ||
| 3c1x_A | 373 | Crystal Structure Of The Tyrosine Kinase Domain Of | 1e-21 | ||
| 3a4p_A | 319 | Human C-Met Kinase Domain Complexed With 6-Benzylox | 1e-21 | ||
| 3dkc_A | 317 | Sgx Clone 5698a65kfg1h1 Length = 317 | 1e-21 | ||
| 4gs6_A | 315 | Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz | 1e-21 | ||
| 3cth_A | 314 | Crystal Structure Of The Tyrosine Kinase Domain Of | 1e-21 | ||
| 3qti_A | 314 | C-Met Kinase In Complex With Nvp-Bvu972 Length = 31 | 2e-21 | ||
| 2eva_A | 307 | Structural Basis For The Interaction Of Tak1 Kinase | 2e-21 | ||
| 1r0p_A | 312 | Crystal Structure Of The Tyrosine Kinase Domain Of | 2e-21 | ||
| 3dk7_A | 277 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 3e-21 | ||
| 3q6w_A | 307 | Structure Of Dually-phosphorylated Met Receptor Kin | 4e-21 | ||
| 3dk6_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 4e-21 | ||
| 2g15_A | 318 | Structural Characterization Of Autoinhibited C-Met | 4e-21 | ||
| 2wd1_A | 292 | Human C-Met Kinase In Complex With Azaindole Inhibi | 4e-21 | ||
| 3q6u_A | 308 | Structure Of The Apo Met Receptor Kinase In The Dua | 4e-21 | ||
| 2wgj_A | 306 | X-Ray Structure Of Pf-02341066 Bound To The Kinase | 5e-21 | ||
| 3lq8_A | 302 | Structure Of The Kinase Domain Of C-Met Bound To Xl | 5e-21 | ||
| 4gg5_A | 319 | Crystal Structure Of Cmet In Complex With Novel Inh | 5e-21 | ||
| 3f66_A | 298 | Human C-Met Kinase In Complex With Quinoxaline Inhi | 5e-21 | ||
| 3dk3_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 5e-21 | ||
| 2v7a_A | 286 | Crystal Structure Of The T315i Abl Mutant In Comple | 5e-21 | ||
| 2z60_A | 288 | Crystal Structure Of The T315i Mutant Of Abl Kinase | 6e-21 | ||
| 3i5n_A | 309 | Crystal Structure Of C-Met With Triazolopyridazine | 6e-21 | ||
| 3oy3_A | 284 | Crystal Structure Of Abl T315i Mutant Kinase Domain | 6e-21 | ||
| 2qoh_A | 288 | Crystal Structure Of Abl Kinase Bound With Ppy-a Le | 6e-21 | ||
| 2rfn_A | 310 | X-ray Structure Of C-met With Inhibitor. Length = 3 | 6e-21 | ||
| 1fpu_A | 293 | Crystal Structure Of Abl Kinase Domain In Complex W | 6e-21 | ||
| 3oxz_A | 284 | Crystal Structure Of Abl Kinase Domain Bound With A | 6e-21 | ||
| 2g2f_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 7e-21 | ||
| 2f4j_A | 287 | Structure Of The Kinase Domain Of An Imatinib-Resis | 7e-21 | ||
| 2gqg_A | 278 | X-Ray Crystal Structure Of Dasatinib (Bms-354825) B | 7e-21 | ||
| 2e2b_A | 293 | Crystal Structure Of The C-Abl Kinase Domain In Com | 8e-21 | ||
| 3pyy_A | 298 | Discovery And Characterization Of A Cell-Permeable, | 8e-21 | ||
| 2hiw_A | 287 | Crystal Structure Of Inactive Conformation Abl Kina | 9e-21 | ||
| 3qrj_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain T | 1e-20 | ||
| 2hzi_A | 277 | Abl Kinase Domain In Complex With Pd180970 Length = | 1e-20 | ||
| 4e6d_A | 298 | Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W | 1e-20 | ||
| 2g1t_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 1e-20 | ||
| 3gvu_A | 292 | The Crystal Structure Of Human Abl2 In Complex With | 1e-20 | ||
| 2hyy_A | 273 | Human Abl Kinase Domain In Complex With Imatinib (S | 1e-20 | ||
| 2hz0_A | 270 | Abl Kinase Domain In Complex With Nvp-Aeg082 Length | 1e-20 | ||
| 3qri_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain I | 1e-20 | ||
| 3ugc_A | 295 | Structural Basis Of Jak2 Inhibition By The Type Ii | 3e-20 | ||
| 3lpb_A | 295 | Crystal Structure Of Jak2 Complexed With A Potent 2 | 3e-20 | ||
| 1opk_A | 495 | Structural Basis For The Auto-Inhibition Of C-Abl T | 3e-20 | ||
| 4e4m_A | 302 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 3 | 3e-20 | ||
| 3jy9_A | 311 | Janus Kinase 2 Inhibitors Length = 311 | 3e-20 | ||
| 3io7_A | 313 | 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel | 3e-20 | ||
| 3q32_A | 301 | Structure Of Janus Kinase 2 With A Pyrrolotriazine | 4e-20 | ||
| 2b7a_A | 293 | The Structural Basis Of Janus Kinase 2 Inhibition B | 4e-20 | ||
| 3rvg_A | 303 | Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido | 4e-20 | ||
| 3tjc_A | 298 | Co-Crystal Structure Of Jak2 With Thienopyridine 8 | 4e-20 | ||
| 2w1i_A | 326 | Structure Determination Of Aurora Kinase In Complex | 4e-20 | ||
| 4aqc_A | 301 | Triazolopyridine-Based Inhibitor Of Janus Kinase 2 | 4e-20 | ||
| 4hge_A | 300 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 | 4e-20 | ||
| 3e62_A | 293 | Fragment Based Discovery Of Jak-2 Inhibitors Length | 4e-20 | ||
| 3miy_A | 266 | X-Ray Crystal Structure Of Itk Complexed With Sunit | 6e-20 | ||
| 2fo0_A | 495 | Organization Of The Sh3-Sh2 Unit In Active And Inac | 6e-20 | ||
| 1opl_A | 537 | Structural Basis For The Auto-Inhibition Of C-Abl T | 6e-20 | ||
| 4hct_A | 269 | Crystal Structure Of Itk In Complex With Compound 5 | 6e-20 | ||
| 4bbe_A | 298 | Aminoalkylpyrimidine Inhibitor Complexes With Jak2 | 7e-20 | ||
| 2xa4_A | 298 | Inhibitors Of Jak2 Kinase Domain Length = 298 | 9e-20 | ||
| 3v5j_A | 266 | Crystal Structure Of Interleukin-2 Inducible T-Cell | 9e-20 | ||
| 1sm2_A | 264 | Crystal Structure Of The Phosphorylated Interleukin | 1e-19 | ||
| 3qgw_A | 286 | Crystal Structure Of Itk Kinase Bound To An Inhibit | 1e-19 | ||
| 3t9t_A | 267 | Crystal Structure Of Btk Mutant (F435t,K596r) Compl | 3e-19 | ||
| 1u59_A | 287 | Crystal Structure Of The Zap-70 Kinase Domain In Co | 4e-19 | ||
| 2ozo_A | 613 | Autoinhibited Intact Human Zap-70 Length = 613 | 9e-19 | ||
| 3tub_A | 293 | Crystal Structure Of Syk Kinase Domain With 1-(5-(6 | 2e-18 | ||
| 3vf8_A | 299 | Crystal Structure Of Spleen Tyrosine Kinase Syk Cat | 2e-18 | ||
| 3emg_A | 291 | Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami | 2e-18 | ||
| 1xba_A | 291 | Crystal Structure Of Apo Syk Tyrosine Kinase Domain | 2e-18 | ||
| 4f4p_A | 273 | Syk In Complex With Ligand Lasw836 Length = 273 | 2e-18 | ||
| 3srv_B | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 2e-18 | ||
| 4dfl_A | 274 | Crystal Structure Of Spleen Tyrosine Kinase Complex | 3e-18 | ||
| 4fl2_A | 636 | Structural And Biophysical Characterization Of The | 4e-18 | ||
| 3k54_A | 283 | Structures Of Human Bruton's Tyrosine Kinase In Act | 4e-18 | ||
| 3gen_A | 283 | The 1.6 A Crystal Structure Of Human Bruton's Tyros | 4e-18 | ||
| 4aoj_A | 329 | Human Trka In Complex With The Inhibitor Az-23 Leng | 5e-18 | ||
| 3pix_A | 274 | Crystal Structure Of Btk Kinase Domain Complexed Wi | 5e-18 | ||
| 4fl3_A | 635 | Structural And Biophysical Characterization Of The | 5e-18 | ||
| 3srv_A | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 6e-18 | ||
| 2r4b_A | 321 | Erbb4 Kinase Domain Complexed With A Thienopyrimidi | 6e-18 | ||
| 3pls_A | 298 | Ron In Complex With Ligand Amp-Pnp Length = 298 | 6e-18 | ||
| 3ocs_A | 271 | Crystal Structure Of Bruton's Tyrosine Kinase In Co | 6e-18 | ||
| 3p08_A | 267 | Crystal Structure Of The Human Btk Kinase Domain Le | 7e-18 | ||
| 4f0i_A | 300 | Crystal Structure Of Apo Trka Length = 300 | 7e-18 | ||
| 3oct_A | 265 | Crystal Structure Of Bruton's Tyrosine Kinase Mutan | 7e-18 | ||
| 3bbt_B | 328 | Crystal Structure Of The Erbb4 Kinase In Complex Wi | 7e-18 | ||
| 4gt5_A | 306 | Crystal Structure Of The Inactive Trka Kinase Domai | 7e-18 | ||
| 3omv_A | 307 | Crystal Structure Of C-Raf (Raf-1) Length = 307 | 7e-18 | ||
| 1k2p_A | 263 | Crystal Structure Of Bruton's Tyrosine Kinase Domai | 9e-18 | ||
| 2j4z_A | 306 | Structure Of Aurora-2 In Complex With Pha-680626 Le | 1e-17 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 1e-17 | ||
| 1muo_A | 297 | Crystal Structure Of Aurora-2, An Oncogenic Serine- | 1e-17 | ||
| 3dzq_A | 361 | Human Epha3 Kinase Domain In Complex With Inhibitor | 1e-17 | ||
| 2qoc_A | 344 | Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp | 1e-17 | ||
| 2qoo_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 2e-17 | ||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 2e-17 | ||
| 1mqb_A | 333 | Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro | 2e-17 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 2e-17 | ||
| 2qoi_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 2e-17 | ||
| 2gsf_A | 373 | The Human Epha3 Receptor Tyrosine Kinase And Juxtam | 2e-17 | ||
| 2x6d_A | 285 | Aurora-A Bound To An Inhibitor Length = 285 | 2e-17 | ||
| 3fxx_A | 371 | Human Epha3 Kinase And Juxtamembrane Region Bound T | 2e-17 | ||
| 2qof_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f | 2e-17 | ||
| 2qod_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y602f | 2e-17 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 3e-17 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 3e-17 | ||
| 2dwb_A | 285 | Aurora-A Kinase Complexed With Amppnp Length = 285 | 3e-17 | ||
| 2w1d_A | 275 | Structure Determination Of Aurora Kinase In Complex | 3e-17 | ||
| 2qon_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 3e-17 | ||
| 2xng_A | 283 | Structure Of Aurora-A Bound To A Selective Imidazop | 3e-17 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 4e-17 | ||
| 1u54_A | 291 | Crystal Structures Of The Phosphorylated And Unphos | 4e-17 | ||
| 2zm3_A | 308 | Complex Structure Of Insulin-Like Growth Factor Rec | 4e-17 | ||
| 2qob_A | 344 | Human Epha3 Kinase Domain, Base Structure Length = | 5e-17 | ||
| 2xru_A | 280 | Aurora-A T288e Complexed With Pha-828300 Length = 2 | 5e-17 | ||
| 2qok_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 5e-17 | ||
| 4ewh_B | 275 | Co-Crystal Structure Of Ack1 With Inhibitor Length | 5e-17 | ||
| 1u46_A | 291 | Crystal Structure Of The Unphosphorylated Kinase Do | 5e-17 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 5e-17 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 5e-17 | ||
| 3kul_B | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 6e-17 | ||
| 4id7_A | 273 | Ack1 Kinase In Complex With The Inhibitor Cis-3-[8- | 6e-17 | ||
| 4hzs_A | 341 | Crystal Structure Of Ack1 Kinase Domain With C-term | 6e-17 | ||
| 2rei_A | 318 | Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep | 6e-17 | ||
| 4hzr_A | 277 | Crystal Structure Of Ack1 Kinase Domain Length = 27 | 6e-17 | ||
| 3qbn_A | 281 | Structure Of Human Aurora A In Complex With A Diami | 6e-17 | ||
| 3eqp_B | 276 | Crystal Structure Of Ack1 With Compound T95 Length | 6e-17 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 7e-17 | ||
| 2qol_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596:y | 7e-17 | ||
| 1jqh_A | 308 | Igf-1 Receptor Kinase Domain Length = 308 | 8e-17 | ||
| 3kul_A | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 8e-17 | ||
| 2qo7_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Dephos | 9e-17 | ||
| 1ol6_A | 282 | Structure Of Unphosphorylated D274n Mutant Of Auror | 9e-17 | ||
| 2j50_A | 280 | Structure Of Aurora-2 In Complex With Pha-739358 Le | 9e-17 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 9e-17 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 1e-16 | ||
| 1mq4_A | 272 | Crystal Structure Of Aurora-A Protein Kinase Length | 1e-16 | ||
| 3unz_A | 279 | Aurora A In Complex With Rpm1679 Length = 279 | 1e-16 | ||
| 2xne_A | 272 | Structure Of Aurora-A Bound To An Imidazopyrazine I | 1e-16 | ||
| 1uwj_A | 276 | The Complex Of Mutant V599e B-raf And Bay439006 Len | 1e-16 | ||
| 1ol5_A | 282 | Structure Of Aurora-A 122-403, Phosphorylated On Th | 1e-16 | ||
| 2w1c_A | 275 | Structure Determination Of Aurora Kinase In Complex | 1e-16 | ||
| 3e5a_A | 268 | Crystal Structure Of Aurora A In Complex With Vx-68 | 1e-16 | ||
| 3o50_A | 267 | Crystal Structure Of Benzamide 9 Bound To Auroraa L | 1e-16 | ||
| 4g9r_A | 307 | B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr | 1e-16 | ||
| 3idp_A | 300 | B-Raf V600e Kinase Domain In Complex With An Aminoi | 1e-16 | ||
| 2ydj_A | 276 | Discovery Of Checkpoint Kinase Inhibitor Azd7762 By | 1e-16 | ||
| 3o23_A | 305 | Human Unphosphorylated Igf1-R Kinase Domain In Comp | 2e-16 | ||
| 4fsz_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-16 | ||
| 4fsw_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-16 | ||
| 4asz_A | 299 | Crystal Structure Of Apo Trkb Kinase Domain Length | 2e-16 | ||
| 4fst_A | 269 | Crystal Structure Of The Chk1 Length = 269 | 2e-16 | ||
| 3eyg_A | 290 | Crystal Structures Of Jak1 And Jak2 Inhibitor Compl | 2e-16 | ||
| 4e4l_A | 302 | Jak1 Kinase (Jh1 Domain) In Complex With Compound 3 | 2e-16 | ||
| 3orm_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain D76a | 2e-16 | ||
| 2r2p_A | 295 | Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep | 2e-16 | ||
| 1zys_A | 273 | Co-Crystal Structure Of Checkpoint Kinase Chk1 With | 2e-16 | ||
| 4ft3_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-16 | ||
| 2fb8_A | 281 | Structure Of The B-Raf Kinase Domain Bound To Sb-59 | 2e-16 | ||
| 1k9a_A | 450 | Crystal Structure Analysis Of Full-Length Carboxyl- | 2e-16 | ||
| 4h58_A | 275 | Braf In Complex With Compound 3 Length = 275 | 2e-16 | ||
| 4fsu_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-16 | ||
| 2r0u_A | 323 | Crystal Structure Of Chek1 In Complex With Inhibito | 2e-16 | ||
| 3d7t_A | 269 | Structural Basis For The Recognition Of C-Src By It | 2e-16 | ||
| 1byg_A | 278 | Kinase Domain Of Human C-Terminal Src Kinase (Csk) | 2e-16 | ||
| 2br1_A | 297 | Structure-Based Design Of Novel Chk1 Inhibitors: In | 2e-16 | ||
| 1ia8_A | 289 | The 1.7 A Crystal Structure Of Human Cell Cycle Che | 2e-16 | ||
| 4dbn_A | 284 | Crystal Structure Of The Kinase Domain Of Human B-R | 2e-16 | ||
| 3q96_A | 282 | B-Raf Kinase Domain In Complex With A Tetrahydronap | 2e-16 | ||
| 1zlt_A | 295 | Crystal Structure Of Chk1 Complexed With A Hymenald | 2e-16 | ||
| 3d4q_A | 307 | Pyrazole-Based Inhibitors Of B-Raf Kinase Length = | 3e-16 | ||
| 3ot3_A | 273 | X-Ray Crystal Structure Of Compound 22k Bound To Hu | 3e-16 | ||
| 2hog_A | 322 | Crystal Structure Of Chek1 In Complex With Inhibito | 3e-16 | ||
| 3ii5_A | 306 | The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi | 3e-16 | ||
| 4fsn_A | 278 | Crystal Structure Of The Chk1 Length = 278 | 3e-16 | ||
| 3d7u_A | 263 | Structural Basis For The Recognition Of C-Src By It | 3e-16 | ||
| 3f69_A | 311 | Crystal Structure Of The Mycobacterium Tuberculosis | 3e-16 | ||
| 2x8e_A | 276 | Discovery Of A Novel Class Of Triazolones As Checkp | 3e-16 | ||
| 3jvr_A | 271 | Characterization Of The Chk1 Allosteric Inhibitor B | 3e-16 | ||
| 4fsm_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 3e-16 | ||
| 3nrm_A | 283 | Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito | 3e-16 | ||
| 2wqe_A | 262 | Structure Of S155r Aurora-A Somatic Mutant Length = | 3e-16 | ||
| 4fsy_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 3e-16 | ||
| 3i81_A | 315 | Crystal Structure Of Insulin-Like Growth Factor 1 R | 3e-16 | ||
| 2ghg_A | 269 | H-Chk1 Complexed With A431994 Length = 269 | 3e-16 | ||
| 2oj9_A | 307 | Structure Of Igf-1r Kinase Domain Complexed With A | 3e-16 | ||
| 1uwh_A | 276 | The Complex Of Wild Type B-Raf And Bay439006 Length | 3e-16 | ||
| 2ayp_A | 269 | Crystal Structure Of Chk1 With An Indol Inhibitor L | 3e-16 | ||
| 1jpa_A | 312 | Crystal Structure Of Unphosphorylated Ephb2 Recepto | 3e-16 | ||
| 3s95_A | 310 | Crystal Structure Of The Human Limk1 Kinase Domain | 3e-16 | ||
| 2e9v_A | 268 | Structure Of H-Chk1 Complexed With A859017 Length = | 3e-16 | ||
| 3h0y_A | 268 | Aurora A In Complex With A Bisanilinopyrimidine Len | 4e-16 | ||
| 1mru_A | 311 | Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob | 4e-16 | ||
| 1k3a_A | 299 | Structure Of The Insulin-Like Growth Factor 1 Recep | 4e-16 | ||
| 3ori_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain L33d | 4e-16 | ||
| 3f61_A | 311 | Crystal Structure Of M. Tuberculosis Pknb Leu33aspV | 4e-16 | ||
| 3lvp_A | 336 | Crystal Structure Of Bisphosphorylated Igf1-R Kinas | 4e-16 | ||
| 3ha6_A | 268 | Crystal Structure Of Aurora A In Complex With Tpx2 | 4e-16 | ||
| 1m7n_A | 322 | Crystal Structure Of Unactivated Apo Insulin-Like G | 4e-16 | ||
| 1o6y_A | 299 | Catalytic Domain Of Pknb Kinase From Mycobacterium | 5e-16 | ||
| 3r21_A | 271 | Design, Synthesis, And Biological Evaluation Of Pyr | 5e-16 | ||
| 3qqu_A | 301 | Cocrystal Structure Of Unphosphorylated Igf With Py | 8e-16 | ||
| 3d94_A | 301 | Crystal Structure Of The Insulin-Like Growth Factor | 8e-16 | ||
| 2f57_A | 317 | Crystal Structure Of The Human P21-activated Kinase | 8e-16 | ||
| 1p4o_A | 322 | Structure Of Apo Unactivated Igf-1r Kinase Domain A | 9e-16 | ||
| 3lw0_A | 304 | Igf-1rk In Complex With Ligand Msc1609119a-1 Length | 9e-16 | ||
| 3coh_A | 268 | Crystal Structure Of Aurora-A In Complex With A Pen | 9e-16 | ||
| 2hel_A | 306 | Crystal Structure Of A Mutant Epha4 Kinase Domain ( | 1e-15 | ||
| 3cc6_A | 281 | Crystal Structure Of Kinase Domain Of Protein Tyros | 2e-15 | ||
| 4h1j_A | 293 | Crystal Structure Of Pyk2 With The Pyrazole 13a Len | 2e-15 | ||
| 2hen_A | 286 | Crystal Structure Of The Ephb2 Receptor Kinase Doma | 2e-15 | ||
| 3fzo_A | 277 | Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin | 2e-15 | ||
| 2xyu_A | 285 | Crystal Structure Of Epha4 Kinase Domain In Complex | 2e-15 | ||
| 2y6m_A | 291 | Crystal Structure Of Epha4 Kinase Domain Length = 2 | 2e-15 | ||
| 4aw5_A | 291 | Complex Of The Ephb4 Kinase Domain With An Oxindole | 2e-15 | ||
| 2ivs_A | 314 | Crystal Structure Of Non-Phosphorylated Ret Tyrosin | 3e-15 | ||
| 2z8c_A | 303 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 4e-15 | ||
| 1ir3_A | 306 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 4e-15 | ||
| 2vwu_A | 302 | Ephb4 Kinase Domain Inhibitor Complex Length = 302 | 5e-15 | ||
| 2ivt_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 6e-15 | ||
| 2ivv_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 6e-15 | ||
| 1irk_A | 306 | Crystal Structure Of The Tyrosine Kinase Domain Of | 8e-15 | ||
| 1vzo_A | 355 | The Structure Of The N-Terminal Kinase Domain Of Ms | 9e-15 | ||
| 2vwi_A | 303 | Structure Of The Osr1 Kinase, A Hypertension Drug T | 1e-14 | ||
| 3dak_A | 290 | Crystal Structure Of Domain-Swapped Osr1 Kinase Dom | 1e-14 | ||
| 1i44_A | 306 | Crystallographic Studies Of An Activation Loop Muta | 1e-14 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 1e-14 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 1e-14 | ||
| 3sxr_A | 268 | Crystal Structure Of Bmx Non-Receptor Tyrosine Kina | 2e-14 | ||
| 3v5q_A | 297 | Discovery Of A Selective Trk Inhibitor With Efficac | 2e-14 | ||
| 1rqq_A | 306 | Crystal Structure Of The Insulin Receptor Kinase In | 3e-14 | ||
| 1zy4_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 3e-14 | ||
| 4el9_A | 305 | Structure Of N-Terminal Kinase Domain Of Rsk2 With | 3e-14 | ||
| 2bva_A | 292 | Crystal Structure Of The Human P21-Activated Kinase | 3e-14 | ||
| 3eta_A | 317 | Kinase Domain Of Insulin Receptor Complexed With A | 3e-14 | ||
| 2dq7_X | 283 | Crystal Structure Of Fyn Kinase Domain Complexed Wi | 3e-14 | ||
| 3ubd_A | 304 | Structure Of N-Terminal Domain Of Rsk2 Kinase In Co | 3e-14 | ||
| 2x4z_A | 296 | Crystal Structure Of The Human P21-Activated Kinase | 4e-14 | ||
| 2j0l_A | 276 | Crystal Structure Of A The Active Conformation Of T | 4e-14 | ||
| 2jkk_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 4e-14 | ||
| 4fif_A | 346 | Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid | 4e-14 | ||
| 3lxn_A | 318 | Structural And Thermodynamic Characterization Of Th | 4e-14 | ||
| 3orx_A | 316 | Pdk1 Mutant Bound To Allosteric Disulfide Fragment | 4e-14 | ||
| 3ckw_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 4e-14 | ||
| 2q0n_A | 301 | Structure Of Human P21 Activating Kinase 4 (Pak4) I | 4e-14 | ||
| 2cdz_A | 303 | Crystal Structure Of The Human P21-Activated Kinase | 5e-14 | ||
| 3g51_A | 325 | Structural Diversity Of The Active Conformation Of | 5e-14 | ||
| 3zhp_C | 294 | Human Mst3 (stk24) In Complex With Mo25beta Length | 5e-14 | ||
| 2c30_A | 321 | Crystal Structure Of The Human P21-Activated Kinase | 5e-14 | ||
| 1mp8_A | 281 | Crystal Structure Of Focal Adhesion Kinase (Fak) Le | 5e-14 | ||
| 3cjf_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 6e-14 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 6e-14 | ||
| 4fie_A | 423 | Full-Length Human Pak4 Length = 423 | 6e-14 | ||
| 2j0m_B | 276 | Crystal Structure A Two-Chain Complex Between The F | 6e-14 | ||
| 4ebw_A | 304 | Structure Of Focal Adhesion Kinase Catalytic Domain | 6e-14 | ||
| 2etm_A | 281 | Crystal Structure Of Focal Adhesion Kinase Domain C | 6e-14 | ||
| 2jkm_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 6e-14 | ||
| 3pxk_A | 282 | Focal Adhesion Kinase Catalytic Domain In Complex W | 7e-14 | ||
| 3nyx_A | 302 | Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T | 7e-14 | ||
| 4i1z_A | 329 | Crystal Structure Of The Monomeric (v948r) Form Of | 7e-14 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 7e-14 | ||
| 2j0j_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 9e-14 | ||
| 3lzb_A | 327 | Egfr Kinase Domain Complexed With An Imidazo[2,1-B] | 9e-14 | ||
| 4i20_A | 329 | Crystal Structure Of Monomeric (v948r) Primary Onco | 9e-14 | ||
| 3bz3_A | 276 | Crystal Structure Analysis Of Focal Adhesion Kinase | 9e-14 | ||
| 2gs7_A | 330 | Crystal Structure Of The Inactive Egfr Kinase Domai | 1e-13 | ||
| 4hjo_A | 337 | Crystal Structure Of The Inactive Egfr Tyrosine Kin | 1e-13 | ||
| 3kxz_A | 287 | The Complex Crystal Structure Of Lck With A Probe M | 1e-13 | ||
| 3lck_A | 271 | The Kinase Domain Of Human Lymphocyte Kinase (Lck), | 1e-13 | ||
| 2ogv_A | 317 | Crystal Structure Of The Autoinhibited Human C-Fms | 1e-13 | ||
| 3bym_A | 272 | X-Ray Co-Crystal Structure Aminobenzimidazole Triaz | 1e-13 | ||
| 2ofu_A | 273 | X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam | 1e-13 | ||
| 3nz0_A | 302 | Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3 | 1e-13 | ||
| 2zm1_A | 285 | Crystal Structure Of Imidazo Pyrazin 1 Bound To The | 1e-13 | ||
| 3cjg_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 1e-13 | ||
| 1qpe_A | 279 | Structural Analysis Of The Lymphocyte-Specific Kina | 1e-13 | ||
| 3kmm_A | 288 | Structure Of Human Lck Kinase With A Small Molecule | 1e-13 | ||
| 2j0k_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 1e-13 | ||
| 3pp0_A | 338 | Crystal Structure Of The Kinase Domain Of Human Her | 2e-13 | ||
| 3qup_A | 323 | Inhibitor Bound Structure Of The Kinase Domain Of T | 2e-13 | ||
| 3lcd_A | 329 | Inhibitor Bound To A Dfg-In Structure Of The Kinase | 2e-13 | ||
| 3a7f_A | 303 | Human Mst3 Kinase Length = 303 | 2e-13 | ||
| 2of2_A | 271 | Crystal Structure Of Furanopyrimidine 8 Bound To Lc | 2e-13 | ||
| 3ckx_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 2e-13 | ||
| 2ofv_A | 277 | Crystal Structure Of Aminoquinazoline 1 Bound To Lc | 2e-13 | ||
| 3bys_A | 277 | Co-Crystal Structure Of Lck And Aminopyrimidine Ami | 2e-13 | ||
| 3ika_A | 331 | Crystal Structure Of Egfr 696-1022 T790m Mutant Cov | 2e-13 | ||
| 2og8_A | 265 | Crystal Structure Of Aminoquinazoline 36 Bound To L | 2e-13 | ||
| 1qpd_A | 279 | Structural Analysis Of The Lymphocyte-specific Kina | 2e-13 | ||
| 3ekk_A | 307 | Insulin Receptor Kinase Complexed With An Inhibitor | 2e-13 | ||
| 2pl0_A | 289 | Lck Bound To Imatinib Length = 289 | 2e-13 | ||
| 3ggf_A | 301 | Crystal Structure Of Human SerineTHREONINE-Protein | 2e-13 | ||
| 1p14_A | 306 | Crystal Structure Of A Catalytic-Loop Mutant Of The | 2e-13 | ||
| 3bkb_A | 377 | Crystal Structure Of Human Feline Sarcoma Viral Onc | 2e-13 | ||
| 2z7q_A | 321 | Crystal Structure Of The N-Terminal Kinase Domain O | 2e-13 | ||
| 2jiv_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 2e-13 | ||
| 4i21_A | 329 | Crystal Structure Of L858r + T790m Egfr Kinase Doma | 3e-13 | ||
| 1yhv_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Two Po | 3e-13 | ||
| 3ug1_A | 334 | Crystal Structure Of The Mutated Egfr Kinase Domain | 3e-13 | ||
| 4g5p_A | 330 | Crystal Structure Of Egfr Kinase T790m In Complex W | 3e-13 | ||
| 4i24_A | 329 | Structure Of T790m Egfr Kinase Domain Co-crystalliz | 3e-13 | ||
| 1yi6_A | 276 | C-Term Tail Segment Of Human Tyrosine Kinase (258-5 | 3e-13 | ||
| 3w2o_A | 331 | Egfr Kinase Domain T790m/l858r Mutant With Tak-285 | 3e-13 | ||
| 3c7q_A | 316 | Structure Of Vegfr2 Kinase Domain In Complex With B | 3e-13 | ||
| 2hak_A | 328 | Catalytic And Ubiqutin-Associated Domains Of Mark1P | 3e-13 | ||
| 3nus_A | 286 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra | 3e-13 | ||
| 2jiu_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 3e-13 | ||
| 1z5m_A | 286 | Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr | 3e-13 | ||
| 2jit_A | 327 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 3e-13 | ||
| 1zyc_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 3e-13 | ||
| 1uu9_A | 286 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 3e-13 | ||
| 3cd3_A | 377 | Crystal Structure Of Phosphorylated Human Feline Sa | 3e-13 | ||
| 1h1w_A | 289 | High Resolution Crystal Structure Of The Human Pdk1 | 3e-13 | ||
| 2j5e_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 3e-13 | ||
| 4i23_A | 329 | Crystal Structure Of The Wild-type Egfr Kinase Doma | 3e-13 | ||
| 3rzf_A | 677 | Crystal Structure Of Inhibitor Of Kappab Kinase Bet | 3e-13 | ||
| 2eb2_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (G7 | 3e-13 | ||
| 3q4z_A | 306 | Structure Of Unphosphorylated Pak1 Kinase Domain Le | 3e-13 | ||
| 3vjo_A | 334 | Crystal Structure Of The Wild-Type Egfr Kinase Doma | 4e-13 | ||
| 3qa8_A | 676 | Crystal Structure Of Inhibitor Of Kappa B Kinase Be | 4e-13 | ||
| 2eb3_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (L8 | 4e-13 | ||
| 3txo_A | 353 | Pkc Eta Kinase In Complex With A Naphthyridine Leng | 4e-13 | ||
| 3gqi_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 4e-13 | ||
| 2w5a_A | 279 | Human Nek2 Kinase Adp-Bound Length = 279 | 4e-13 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 4e-13 | ||
| 1xkk_A | 352 | Egfr Kinase Domain Complexed With A Quinazoline Inh | 4e-13 | ||
| 1m14_A | 333 | Tyrosine Kinase Domain From Epidermal Growth Factor | 4e-13 | ||
| 4g5j_A | 330 | Crystal Structure Of Egfr Kinase In Complex With Bi | 4e-13 | ||
| 2bdf_A | 279 | Src Kinase In Complex With Inhibitor Ap23451 Length | 4e-13 | ||
| 2gs2_A | 330 | Crystal Structure Of The Active Egfr Kinase Domain | 4e-13 | ||
| 2itt_A | 327 | Crystal Structure Of Egfr Kinase Domain L858r Mutat | 4e-13 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 4e-13 | ||
| 4a07_A | 311 | Human Pdk1 Kinase Domain In Complex With Allosteric | 4e-13 | ||
| 3bel_A | 315 | X-Ray Structure Of Egfr In Complex With Oxime Inhib | 4e-13 | ||
| 3pwy_A | 311 | Crystal Structure Of An Extender (Spd28345)-Modifie | 4e-13 | ||
| 2itn_A | 327 | Crystal Structure Of Egfr Kinase Domain G719s Mutat | 4e-13 | ||
| 3oez_A | 286 | Crystal Structure Of The L317i Mutant Of The Chicke | 4e-13 | ||
| 3c4f_A | 302 | Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M | 4e-13 | ||
| 3gql_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 4e-13 | ||
| 2j5f_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 4e-13 | ||
| 4aaa_A | 331 | Crystal Structure Of The Human Cdkl2 Kinase Domain | 4e-13 | ||
| 3hrc_A | 311 | Crystal Structure Of A Mutant Of Human Pdk1 Kinase | 4e-13 | ||
| 2rfd_A | 324 | Crystal Structure Of The Complex Between The Egfr K | 5e-13 | ||
| 2biy_A | 310 | Structure Of Pdk1-S241a Mutant Kinase Domain Length | 5e-13 | ||
| 3tt0_A | 382 | Co-Structure Of Fibroblast Growth Factor Receptor 1 | 5e-13 | ||
| 3qc4_A | 314 | Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = | 5e-13 | ||
| 4hvd_A | 314 | Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h | 5e-13 | ||
| 3sc1_A | 311 | Novel Isoquinolone Pdk1 Inhibitors Discovered Throu | 5e-13 | ||
| 3u6j_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 5e-13 | ||
| 2oh4_A | 316 | Crystal Structure Of Vegfr2 With A Benzimidazole-Ur | 5e-13 | ||
| 3dqw_A | 286 | C-Src Kinase Domain Thr338ile Mutant In Complex Wit | 5e-13 | ||
| 4f63_A | 309 | Crystal Structure Of Human Fibroblast Growth Factor | 5e-13 | ||
| 3rhx_B | 306 | Crystal Structure Of The Catalytic Domain Of Fgfr1 | 5e-13 | ||
| 3kxx_A | 317 | Structure Of The Mutant Fibroblast Growth Factor Re | 5e-13 | ||
| 4agc_A | 353 | Crystal Structure Of Vegfr2 (Juxtamembrane And Kina | 5e-13 | ||
| 3iop_A | 312 | Pdk-1 In Complex With The Inhibitor Compound-8i Len | 5e-13 | ||
| 3js2_A | 317 | Crystal Structure Of Minimal Kinase Domain Of Fibro | 5e-13 | ||
| 3h9o_A | 311 | Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) | 5e-13 | ||
| 1fgk_A | 310 | Crystal Structure Of The Tyrosine Kinase Domain Of | 5e-13 | ||
| 2h8h_A | 535 | Src Kinase In Complex With A Quinazoline Inhibitor | 5e-13 | ||
| 4e1z_A | 291 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 6e-13 | ||
| 3rwp_A | 311 | Discovery Of A Novel, Potent And Selective Inhibito | 6e-13 | ||
| 4gt4_A | 308 | Structure Of Unliganded, Inactive Ror2 Kinase Domai | 6e-13 | ||
| 2xch_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 6e-13 | ||
| 4dc2_A | 396 | Structure Of Pkc In Complex With A Substrate Peptid | 6e-13 | ||
| 1uu3_A | 310 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 6e-13 | ||
| 4e20_A | 290 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 6e-13 | ||
| 2xck_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 6e-13 | ||
| 3mpm_A | 267 | Lck Complexed With A Pyrazolopyrimidine Length = 26 | 6e-13 | ||
| 3vnt_A | 318 | Crystal Structure Of The Kinase Domain Of Human Veg | 6e-13 | ||
| 3zzw_A | 289 | Crystal Structure Of The Kinase Domain Of Ror2 Leng | 6e-13 | ||
| 2xir_A | 316 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 6e-13 | ||
| 3gop_A | 361 | Crystal Structure Of The Egf Receptor Juxtamembrane | 6e-13 | ||
| 2p0c_A | 313 | Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro | 6e-13 | ||
| 3ewh_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 7e-13 | ||
| 2r7b_A | 312 | Crystal Structure Of The Phosphoinositide-Dependent | 7e-13 | ||
| 3g6h_A | 286 | Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma | 7e-13 | ||
| 3d7u_B | 277 | Structural Basis For The Recognition Of C-Src By It | 7e-13 | ||
| 3u4w_A | 275 | Src In Complex With Dna-Templated Macrocyclic Inhib | 8e-13 | ||
| 2xik_A | 294 | Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K | 8e-13 | ||
| 2oiq_A | 286 | Crystal Structure Of Chicken C-Src Kinase Domain In | 8e-13 | ||
| 1fmk_A | 452 | Crystal Structure Of Human Tyrosine-Protein Kinase | 8e-13 | ||
| 2p2i_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 8e-13 | ||
| 1zmu_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 8e-13 | ||
| 3nun_A | 292 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea | 8e-13 | ||
| 2r0i_A | 327 | Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len | 9e-13 | ||
| 2p2h_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 9e-13 | ||
| 1y57_A | 452 | Structure Of Unphosphorylated C-Src In Complex With | 9e-13 | ||
| 3nay_A | 311 | Pdk1 In Complex With Inhibitor Mp6 Length = 311 | 9e-13 | ||
| 1ywn_A | 316 | Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p | 1e-12 | ||
| 1yvj_A | 290 | Crystal Structure Of The Jak3 Kinase Domain In Comp | 1e-12 | ||
| 3svv_A | 286 | Crystal Structure Of T338c C-Src Covalently Bound T | 1e-12 | ||
| 2qq7_A | 286 | Crystal Structure Of Drug Resistant Src Kinase Doma | 1e-12 | ||
| 3nax_A | 311 | Pdk1 In Complex With Inhibitor Mp7 Length = 311 | 1e-12 | ||
| 3lxk_A | 327 | Structural And Thermodynamic Characterization Of Th | 1e-12 | ||
| 1yoj_A | 283 | Crystal Structure Of Src Kinase Domain Length = 283 | 1e-12 | ||
| 1ksw_A | 452 | Structure Of Human C-Src Tyrosine Kinase (Thr338gly | 1e-12 | ||
| 2wzj_A | 327 | Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82 | 1e-12 | ||
| 2qnj_A | 328 | Kinase And Ubiquitin-Associated Domains Of Mark3PAR | 1e-12 | ||
| 2pml_X | 348 | Crystal Structure Of Pfpk7 In Complex With An Atp A | 1e-12 | ||
| 2jav_A | 279 | Human Kinase With Pyrrole-Indolinone Ligand Length | 1e-12 | ||
| 1rjb_A | 344 | Crystal Structure Of Flt3 Length = 344 | 1e-12 | ||
| 1vr2_A | 316 | Human Vascular Endothelial Growth Factor Receptor 2 | 1e-12 | ||
| 1yol_A | 283 | Crystal Structure Of Src Kinase Domain In Complex W | 1e-12 | ||
| 4a4x_A | 279 | Nek2-Ede Bound To Cct248662 Length = 279 | 1e-12 | ||
| 2hwo_A | 286 | Crystal Structure Of Src Kinase Domain In Complex W | 2e-12 | ||
| 1zmv_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 2e-12 | ||
| 1zrz_A | 364 | Crystal Structure Of The Catalytic Domain Of Atypic | 2e-12 | ||
| 3kex_A | 325 | Crystal Structure Of The Catalytically Inactive Kin | 2e-12 | ||
| 1zmw_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 2e-12 | ||
| 3fe3_A | 328 | Crystal Structure Of The Kinase Mark3PAR-1: T211a-S | 2e-12 | ||
| 3geq_A | 286 | Structural Basis For The Chemical Rescue Of Src Kin | 2e-12 | ||
| 2ptk_A | 453 | Chicken Src Tyrosine Kinase Length = 453 | 2e-12 | ||
| 3lmg_A | 344 | Crystal Structure Of The Erbb3 Kinase Domain In Com | 2e-12 | ||
| 3a8w_A | 345 | Crystal Structure Of Pkciota Kinase Domain Length = | 2e-12 | ||
| 3com_A | 314 | Crystal Structure Of Mst1 Kinase Length = 314 | 2e-12 | ||
| 3zh8_A | 349 | A Novel Small Molecule Apkc Inhibitor Length = 349 | 2e-12 | ||
| 2i0v_A | 335 | C-Fms Tyrosine Kinase In Complex With A Quinolone I | 3e-12 | ||
| 3pjc_A | 315 | Crystal Structure Of Jak3 Complexed With A Potent A | 3e-12 | ||
| 3lco_A | 324 | Inhibitor Bound To A Dfg-Out Structure Of The Kinas | 3e-12 | ||
| 2f2u_A | 402 | Crystal Structure Of The Rho-Kinase Kinase Domain L | 3e-12 | ||
| 3dxn_A | 287 | Crystal Structure Of The Calcium-dependent Kinase F | 4e-12 | ||
| 1s9i_A | 354 | X-Ray Structure Of The Human Mitogen-Activated Prot | 4e-12 | ||
| 3cly_A | 334 | Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase | 4e-12 | ||
| 2pvf_A | 334 | Crystal Structure Of Tyrosine Phosphorylated Activa | 4e-12 | ||
| 2wqm_A | 310 | Structure Of Apo Human Nek7 Length = 310 | 4e-12 | ||
| 3ri1_A | 313 | Crystal Structure Of The Catalytic Domain Of Fgfr2 | 4e-12 | ||
| 1y8g_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 4e-12 | ||
| 3q5i_A | 504 | Crystal Structure Of Pbanka_031420 Length = 504 | 5e-12 | ||
| 3iec_A | 319 | Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K | 5e-12 | ||
| 1gjo_A | 316 | The Fgfr2 Tyrosine Kinase Domain Length = 316 | 5e-12 | ||
| 2oo8_X | 317 | Synthesis, Structural Analysis, And Sar Studies Of | 5e-12 | ||
| 1fvr_A | 327 | Tie2 Kinase Domain Length = 327 | 5e-12 | ||
| 3b2t_A | 311 | Structure Of Phosphotransferase Length = 311 | 6e-12 | ||
| 3hzt_A | 467 | Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4 | 6e-12 | ||
| 2pzp_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 6e-12 | ||
| 2bfx_B | 284 | Mechanism Of Aurora-B Activation By Incenp And Inhi | 6e-12 | ||
| 2vrx_A | 285 | Structure Of Aurora B Kinase In Complex With Zm4474 | 6e-12 | ||
| 3zgw_A | 347 | Crystal Structure Of Maternal Embryonic Leucine Zip | 6e-12 | ||
| 4apc_A | 350 | Crystal Structure Of Human Nima-Related Kinase 1 (N | 6e-12 | ||
| 3orn_A | 307 | Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In | 6e-12 | ||
| 2pwl_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 7e-12 | ||
| 2pz5_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 7e-12 | ||
| 2pvy_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 7e-12 | ||
| 2psq_A | 370 | Crystal Structure Of Unphosphorylated Unactivated W | 7e-12 | ||
| 3nyn_A | 576 | Crystal Structure Of G Protein-Coupled Receptor Kin | 8e-12 | ||
| 1zxe_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 8e-12 | ||
| 2bdw_A | 362 | Crystal Structure Of The Auto-Inhibited Kinase Doma | 8e-12 | ||
| 4euu_A | 319 | Structure Of Bx-795 Complexed With Human Tbk1 Kinas | 8e-12 | ||
| 3kl8_A | 269 | Camkiintide Inhibitor Complex Length = 269 | 8e-12 | ||
| 3kk8_A | 284 | Camkii Substrate Complex A Length = 284 | 9e-12 | ||
| 3c4x_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 9e-12 | ||
| 3qc9_A | 543 | Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4 | 9e-12 | ||
| 3kk9_A | 282 | Camkii Substrate Complex B Length = 282 | 9e-12 | ||
| 3c4w_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 9e-12 | ||
| 3bea_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P | 9e-12 | ||
| 2acx_A | 576 | Crystal Structure Of G Protein Coupled Receptor Kin | 9e-12 | ||
| 3t8o_A | 543 | Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu | 9e-12 | ||
| 2pzr_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-11 | ||
| 2y4i_C | 395 | Ksr2-Mek1 Heterodimer Length = 395 | 1e-11 | ||
| 3sls_A | 304 | Crystal Structure Of Human Mek-1 Kinase In Complex | 1e-11 | ||
| 3mbl_A | 328 | Crystal Structure Of The Human Mitogen-Activated Pr | 1e-11 | ||
| 3dv3_A | 322 | Mek1 With Pf-04622664 Bound Length = 322 | 1e-11 | ||
| 3eqc_A | 360 | X-Ray Structure Of The Human Mitogen-Activated Prot | 1e-11 | ||
| 2v55_A | 406 | Mechanism Of Multi-site Phosphorylation From A Rock | 1e-11 | ||
| 2p55_A | 333 | X-Ray Structure Of The Human Mitogen-Activated Prot | 1e-11 | ||
| 3v8s_A | 410 | Human Rho-Associated Protein Kinase 1 (Rock 1) In C | 1e-11 | ||
| 3is5_A | 285 | Crystal Structure Of Cdpk Kinase Domain From Toxopl | 1e-11 | ||
| 1s9j_A | 341 | X-Ray Structure Of The Human Mitogen-Activated Prot | 1e-11 | ||
| 4an2_A | 301 | Crystal Structures Of Human Mek1 With Carboxamide-B | 1e-11 | ||
| 2esm_A | 415 | Crystal Structure Of Rock 1 Bound To Fasudil Length | 1e-11 | ||
| 4eut_A | 396 | Structure Of Bx-795 Complexed With Unphosphorylated | 1e-11 | ||
| 2i1m_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An | 1e-11 | ||
| 2bfy_A | 284 | Complex Of Aurora-B With Incenp And Hesperidin. Len | 1e-11 | ||
| 2jam_A | 304 | Crystal Structure Of Human Calmodulin-Dependent Pro | 1e-11 | ||
| 2jed_A | 352 | The Crystal Structure Of The Kinase Domain Of The P | 2e-11 | ||
| 2wqb_A | 324 | Structure Of The Tie2 Kinase Domain In Complex With | 2e-11 | ||
| 2zv7_A | 279 | Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | 2e-11 | ||
| 2a19_B | 284 | Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng | 2e-11 | ||
| 3a4o_X | 286 | Lyn Kinase Domain Length = 286 | 2e-11 | ||
| 2hk5_A | 270 | Hck Kinase In Complex With Lck Targetted Inhibitor | 2e-11 | ||
| 2wei_A | 287 | Crystal Structure Of The Kinase Domain Of Cryptospo | 3e-11 | ||
| 2q0b_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 3e-11 | ||
| 3dfa_A | 286 | Crystal Structure Of Kinase Domain Of Calcium-depen | 3e-11 | ||
| 2py3_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 3e-11 | ||
| 2y7j_A | 365 | Structure Of Human Phosphorylase Kinase, Gamma 2 Le | 3e-11 | ||
| 3uiu_A | 306 | Crystal Structure Of Apo-Pkr Kinase Domain Length = | 3e-11 | ||
| 1qcf_A | 454 | Crystal Structure Of Hck In Complex With A Src Fami | 3e-11 | ||
| 3igo_A | 486 | Crystal Structure Of Cryptosporidium Parvum Cdpk1, | 3e-11 | ||
| 3cok_A | 278 | Crystal Structure Of Plk4 Kinase Length = 278 | 4e-11 | ||
| 4fr4_A | 384 | Crystal Structure Of Human SerineTHREONINE-Protein | 4e-11 | ||
| 1a06_A | 332 | Calmodulin-Dependent Protein Kinase From Rat Length | 4e-11 | ||
| 3ma6_A | 298 | Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr | 5e-11 | ||
| 2gnj_A | 350 | Pka Three Fold Mutant Model Of Rho-Kinase With Y-27 | 5e-11 | ||
| 4fg7_A | 293 | Crystal Structure Of Human Calcium/calmodulin-depen | 5e-11 | ||
| 2phk_A | 277 | The Crystal Structure Of A Phosphorylase Kinase Pep | 5e-11 | ||
| 4fg8_A | 315 | Crystal Structure Of Human Calcium/calmodulin-depen | 6e-11 | ||
| 1luf_A | 343 | Crystal Structure Of The Musk Tyrosine Kinase: Insi | 7e-11 | ||
| 2gnf_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 7e-11 | ||
| 4fg9_A | 320 | Crystal Structure Of Human Calcium/calmodulin-depen | 7e-11 | ||
| 3ku2_A | 507 | Crystal Structure Of Inactivated Form Of Cdpk1 From | 7e-11 | ||
| 2gng_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 7e-11 | ||
| 3hx4_A | 508 | Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg | 7e-11 | ||
| 1phk_A | 298 | Two Structures Of The Catalytic Domain Of Phosphory | 7e-11 | ||
| 2jds_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 8e-11 | ||
| 1xh7_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 9e-11 | ||
| 1q8w_A | 350 | The Catalytic Subunit Of Camp-Dependent Protein Kin | 9e-11 | ||
| 2yjr_A | 342 | Structure Of F1174l Mutant Anaplastic Lymphoma Kina | 9e-11 | ||
| 3i79_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 9e-11 | ||
| 4af3_A | 292 | Human Aurora B Kinase In Complex With Incenp And Vx | 9e-11 | ||
| 1xjd_A | 345 | Crystal Structure Of Pkc-Theta Complexed With Staur | 1e-10 | ||
| 2c1a_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 1e-10 | ||
| 3a62_A | 327 | Crystal Structure Of Phosphorylated P70s6k1 Length | 1e-10 | ||
| 2xb7_A | 315 | Structure Of Human Anaplastic Lymphoma Kinase In Co | 1e-10 | ||
| 3a60_A | 327 | Crystal Structure Of Unphosphorylated P70s6k1 (Form | 1e-10 | ||
| 1svh_A | 350 | Crystal Structure Of Protein Kinase A In Complex Wi | 1e-10 | ||
| 2f7e_E | 351 | Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu | 1e-10 | ||
| 3dnd_A | 350 | Camp-Dependent Protein Kinase Pka Catalytic Subunit | 1e-10 | ||
| 1stc_E | 350 | Camp-Dependent Protein Kinase, Alpha-Catalytic Subu | 1e-10 | ||
| 4fnw_A | 327 | Crystal Structure Of The Apo F1174l Anaplastic Lymp | 1e-10 | ||
| 2yfx_A | 327 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 1e-10 | ||
| 1ql6_A | 298 | The Catalytic Mechanism Of Phosphorylase Kinase Pro | 1e-10 | ||
| 2yhv_A | 342 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 1e-10 | ||
| 2xp2_A | 327 | Structure Of The Human Anaplastic Lymphoma Kinase I | 1e-10 | ||
| 1u5q_A | 348 | Crystal Structure Of The Tao2 Kinase Domain: Activa | 1e-10 | ||
| 1szm_A | 350 | Dual Binding Mode Of Bisindolylmaleimide 2 To Prote | 2e-10 | ||
| 3mvj_A | 371 | Human Cyclic Amp-Dependent Protein Kinase Pka Inhib | 2e-10 | ||
| 2yjs_A | 342 | Structure Of C1156y Mutant Anaplastic Lymphoma Kina | 2e-10 | ||
| 2uzt_A | 336 | Pka Structures Of Akt, Indazole-Pyridine Inhibitors | 2e-10 | ||
| 3agm_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 2e-10 | ||
| 3agl_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 2e-10 | ||
| 2gcd_A | 309 | Tao2 Kinase Domain-Staurosporine Structure Length = | 2e-10 | ||
| 1ctp_E | 350 | Structure Of The Mammalian Catalytic Subunit Of Cam | 2e-10 | ||
| 3nx8_A | 351 | Human Camp Dependent Protein Kinase In Complex With | 2e-10 | ||
| 1cdk_A | 350 | Camp-Dependent Protein Kinase Catalytic Subunit (E. | 2e-10 | ||
| 4ae9_A | 343 | Structure And Function Of The Human Sperm-specific | 2e-10 | ||
| 3aox_A | 344 | X-Ray Crystal Structure Of Human Anaplastic Lymphom | 2e-10 | ||
| 4fnz_A | 327 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 2e-10 | ||
| 1cmk_E | 350 | Crystal Structures Of The Myristylated Catalytic Su | 2e-10 | ||
| 3iw4_A | 360 | Crystal Structure Of Pkc Alpha In Complex With Nvp- | 2e-10 | ||
| 1q61_A | 350 | Pka Triple Mutant Model Of Pkb Length = 350 | 2e-10 | ||
| 4fnx_A | 327 | Crystal Structure Of The Apo R1275q Anaplastic Lymp | 2e-10 | ||
| 1xh9_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 2e-10 | ||
| 4dce_A | 333 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 2e-10 | ||
| 3lct_A | 344 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 2e-10 | ||
| 3l9p_A | 367 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 3e-10 | ||
| 4ae6_A | 343 | Structure And Function Of The Human Sperm-specific | 3e-10 | ||
| 3lij_A | 494 | Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) | 3e-10 | ||
| 4fob_A | 353 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 3e-10 | ||
| 1gzk_A | 315 | Molecular Mechanism For The Regulation Of Protein K | 3e-10 | ||
| 3l9m_A | 351 | Crystal Structure Of Pkab3 (Pka Triple Mutant V123a | 3e-10 | ||
| 2r5t_A | 373 | Crystal Structure Of Inactive Serum And Glucocortic | 4e-10 | ||
| 1gzn_A | 335 | Structure Of Pkb Kinase Domain Length = 335 | 5e-10 | ||
| 2uvy_A | 351 | Structure Of Pka-pkb Chimera Complexed With Methyl- | 5e-10 | ||
| 1q24_A | 350 | Pka Double Mutant Model Of Pkb In Complex With Mgat | 5e-10 | ||
| 1smh_A | 350 | Protein Kinase A Variant Complex With Completely Or | 5e-10 | ||
| 1mrv_A | 339 | Crystal Structure Of An Inactive Akt2 Kinase Domain | 5e-10 | ||
| 1t46_A | 313 | Structural Basis For The Autoinhibition And Sti-571 | 5e-10 | ||
| 3g0e_A | 336 | Kit Kinase Domain In Complex With Sunitinib Length | 6e-10 | ||
| 2jdt_A | 351 | Structure Of Pka-Pkb Chimera Complexed With Isoquin | 6e-10 | ||
| 1pkg_A | 329 | Structure Of A C-kit Kinase Product Complex Length | 6e-10 | ||
| 1ad5_A | 438 | Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | 6e-10 | ||
| 2vo0_A | 351 | Structure Of Pka-Pkb Chimera Complexed With C-(4-(4 | 6e-10 | ||
| 1t45_A | 331 | Structural Basis For The Autoinhibition And Sti-571 | 7e-10 | ||
| 3g0f_A | 336 | Kit Kinase Domain Mutant D816h In Complex With Suni | 7e-10 | ||
| 2xuu_A | 334 | Crystal Structure Of A Dap-Kinase 1 Mutant Length = | 8e-10 | ||
| 2pk9_A | 317 | Structure Of The Pho85-pho80 Cdk-cyclin Complex Of | 8e-10 | ||
| 1j3h_A | 350 | Crystal Structure Of Apoenzyme Camp-Dependent Prote | 8e-10 | ||
| 2h6d_A | 276 | Protein Kinase Domain Of The Human 5'-Amp-Activated | 9e-10 | ||
| 2j7t_A | 302 | Crystal Structure Of Human Serine Threonine Kinase- | 1e-09 | ||
| 3fhi_A | 350 | Crystal Structure Of A Complex Between The Catalyti | 1e-09 | ||
| 4bc6_A | 293 | Crystal Structure Of Human Serine Threonine Kinase- | 1e-09 | ||
| 3ama_A | 351 | Protein Kinase A Sixfold Mutant Model Of Aurora B W | 1e-09 | ||
| 4ejn_A | 446 | Crystal Structure Of Autoinhibited Form Of Akt1 In | 1e-09 | ||
| 2y0a_A | 326 | Structure Of Dapk1 Construct Residues 1-304 Length | 1e-09 | ||
| 2jc6_A | 334 | Crystal Structure Of Human Calmodulin-Dependent Pro | 1e-09 | ||
| 4dfx_E | 350 | Crystal Structure Of Myristoylated K7c Catalytic Su | 1e-09 | ||
| 4dg3_E | 371 | Crystal Structure Of R336a Mutant Of Camp-dependent | 1e-09 | ||
| 3o96_A | 446 | Crystal Structure Of Human Akt1 With An Allosteric | 1e-09 | ||
| 3niz_A | 311 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 1e-09 | ||
| 2qkr_A | 313 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 1e-09 | ||
| 3h4j_B | 336 | Crystal Structure Of Pombe Ampk Kdaid Fragment Leng | 1e-09 | ||
| 1ydt_E | 350 | Structure Of Camp-Dependent Protein Kinase, Alpha-C | 1e-09 | ||
| 2qcs_A | 350 | A Complex Structure Between The Catalytic And Regul | 2e-09 | ||
| 2xzs_A | 312 | Death Associated Protein Kinase 1 Residues 1-312 Le | 2e-09 | ||
| 2x0g_A | 334 | X-ray Structure Of A Dap-kinase Calmodulin Complex | 2e-09 | ||
| 1l3r_E | 350 | Crystal Structure Of A Transition State Mimic Of Th | 2e-09 | ||
| 2gu8_A | 337 | Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel | 2e-09 | ||
| 2w4k_A | 302 | X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | 2e-09 | ||
| 2clq_A | 295 | Structure Of Mitogen-Activated Protein Kinase Kinas | 2e-09 | ||
| 3i7c_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 2e-09 | ||
| 1apm_E | 350 | 2.0 Angstrom Refined Crystal Structure Of The Catal | 2e-09 | ||
| 3vw6_A | 269 | Crystal Structure Of Human Apoptosis Signal-Regulat | 2e-09 | ||
| 4dfy_A | 371 | Crystal Structure Of R194a Mutant Of Camp-Dependent | 2e-09 | ||
| 3qal_E | 350 | Crystal Structure Of Arg280ala Mutant Of Catalytic | 2e-09 | ||
| 3d5u_A | 317 | Crystal Structure Of A Wildtype Polo-Like Kinase 1 | 2e-09 | ||
| 2erz_E | 351 | Crystal Structure Of C-amp Dependent Kinase (pka) B | 2e-09 | ||
| 3gu4_A | 295 | Crystal Structure Of Dapkq23v-Amppnp Length = 295 | 2e-09 | ||
| 2w4j_A | 277 | X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | 2e-09 | ||
| 2qur_A | 350 | Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe | 2e-09 | ||
| 2uv2_A | 287 | Crystal Structure Of Human Ste20-Like Kinase Bound | 2e-09 | ||
| 3pvb_A | 345 | Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca | 2e-09 | ||
| 1o6k_A | 336 | Structure Of Activated Form Of Pkb Kinase Domain S4 | 2e-09 | ||
| 2yak_A | 285 | Structure Of Death-Associated Protein Kinase 1 (Dap | 2e-09 | ||
| 1wvw_A | 278 | Crystal Structures Of Kinase Domain Of Dap Kinase I | 2e-09 | ||
| 1fmo_E | 350 | Crystal Structure Of A Polyhistidine-Tagged Recombi | 2e-09 | ||
| 1bkx_A | 350 | A Binary Complex Of The Catalytic Subunit Of Camp-D | 2e-09 | ||
| 1p4f_A | 293 | Death Associated Protein Kinase Catalytic Domain Wi | 2e-09 | ||
| 3dfc_B | 295 | Crystal Structure Of A Glycine-Rich Loop Mutant Of | 2e-09 | ||
| 2jdo_A | 342 | Structure Of Pkb-Beta (Akt2) Complexed With Isoquin | 2e-09 | ||
| 1ig1_A | 294 | 1.8a X-Ray Structure Of Ternary Complex Of A Cataly | 2e-09 | ||
| 3f5u_A | 295 | Crystal Structure Of The Death Associated Protein K | 2e-09 | ||
| 3kb7_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 2e-09 | ||
| 2yac_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 2e-09 | ||
| 3e87_A | 335 | Crystal Structures Of The Kinase Domain Of Akt2 In | 2e-09 | ||
| 1o6l_A | 337 | Crystal Structure Of An Activated Akt/protein Kinas | 2e-09 | ||
| 1jbp_E | 350 | Crystal Structure Of The Catalytic Subunit Of Camp- | 2e-09 | ||
| 2v5q_A | 315 | Crystal Structure Of Wild-type Plk-1 Kinase Domain | 2e-09 | ||
| 3pfq_A | 674 | Crystal Structure And Allosteric Activation Of Prot | 2e-09 | ||
| 3bhh_A | 295 | Crystal Structure Of Human Calcium/calmodulin-depen | 3e-09 | ||
| 3ujg_A | 361 | Crystal Structure Of Snrk2.6 In Complex With Hab1 L | 4e-09 | ||
| 3kn5_A | 325 | Crystal Structure Of The C-Terminal Kinase Domain O | 4e-09 | ||
| 3gu8_A | 295 | Crystal Structure Of Dapkl93g With N6-Cyclopentylad | 4e-09 | ||
| 3udb_A | 317 | Crystal Structure Of Snrk2.6 Length = 317 | 4e-09 | ||
| 1syk_A | 350 | Crystal Structure Of E230q Mutant Of Camp-Dependent | 4e-09 | ||
| 3db6_A | 301 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 5e-09 | ||
| 2yza_A | 276 | Crystal Structure Of Kinase Domain Of Human 5'-Amp- | 5e-09 | ||
| 3o7l_B | 350 | Crystal Structure Of Phospholamban (1-19):pka C-Sub | 5e-09 | ||
| 3ocb_A | 341 | Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor | 6e-09 | ||
| 3d5v_A | 317 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 6e-09 | ||
| 3d5w_A | 317 | Crystal Structure Of A Phosphorylated Polo-Like Kin | 6e-09 | ||
| 4gv1_A | 340 | Pkb Alpha In Complex With Azd5363 Length = 340 | 6e-09 | ||
| 3cqu_A | 342 | Crystal Structure Of Akt-1 Complexed With Substrate | 6e-09 | ||
| 2v7o_A | 336 | Crystal Structure Of Human Calcium-Calmodulin-Depen | 6e-09 | ||
| 3uc3_A | 361 | The Crystal Structure Of Snf1-Related Kinase 2.3 Le | 7e-09 | ||
| 1ua2_A | 346 | Crystal Structure Of Human Cdk7 Length = 346 | 7e-09 | ||
| 2dyl_A | 318 | Crystal Structure Of Human Mitogen-Activated Protei | 7e-09 | ||
| 2y4i_B | 319 | Ksr2-Mek1 Heterodimer Length = 319 | 7e-09 | ||
| 2ou7_A | 335 | Structure Of The Catalytic Domain Of Human Polo-Lik | 8e-09 | ||
| 3thb_A | 333 | Structure Of Plk1 Kinase Domain In Complex With A B | 8e-09 | ||
| 1h4l_A | 292 | Structure And Regulation Of The Cdk5-P25(Nck5a) Com | 8e-09 | ||
| 2rku_A | 294 | Structure Of Plk1 In Complex With Bi2536 Length = 2 | 9e-09 | ||
| 3qam_E | 350 | Crystal Structure Of Glu208ala Mutant Of Catalytic | 9e-09 | ||
| 2iwi_A | 312 | Crystal Structure Of The Human Pim2 In Complex With | 1e-08 | ||
| 3bhy_A | 283 | Crystal Structure Of Human Death Associated Protein | 1e-08 | ||
| 2j90_A | 304 | Crystal Structure Of Human Zip Kinase In Complex Wi | 1e-08 | ||
| 1oit_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 1e-08 | ||
| 2wel_A | 327 | Crystal Structure Of Su6656-Bound CalciumCALMODULIN | 1e-08 | ||
| 2vn9_A | 301 | Crystal Structure Of Human Calcium Calmodulin Depen | 1e-08 | ||
| 1yrp_A | 278 | Catalytic Domain Of Human Zip Kinase Phosphorylated | 1e-08 | ||
| 2i0e_A | 353 | Structure Of Catalytic Domain Of Human Protein Kina | 1e-08 | ||
| 2j51_A | 325 | Crystal Structure Of Human Ste20-Like Kinase Bound | 1e-08 | ||
| 2x4f_A | 373 | The Crystal Structure Of The Human Myosin Light Cha | 1e-08 | ||
| 2jfm_A | 325 | Crystal Structure Of Human Ste20-Like Kinase (Unlig | 1e-08 | ||
| 4erw_A | 306 | Cdk2 In Complex With Staurosporine Length = 306 | 1e-08 | ||
| 2jfl_A | 325 | Crystal Structure Of Human Ste20-Like Kinase ( Diph | 1e-08 | ||
| 4g31_A | 299 | Crystal Structure Of Gsk6414 Bound To Perk (R587-R1 | 1e-08 | ||
| 1gz8_A | 299 | Human Cyclin Dependent Kinase 2 Complexed With The | 2e-08 | ||
| 3pxf_A | 306 | Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N | 2e-08 | ||
| 3pj8_A | 299 | Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D] | 2e-08 | ||
| 1rdq_E | 350 | Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of | 2e-08 | ||
| 3ezr_A | 300 | Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ | 2e-08 | ||
| 2w17_A | 299 | Cdk2 In Complex With The Imidazole Pyrimidine Amide | 2e-08 | ||
| 1pf8_A | 298 | Crystal Structure Of Human Cyclin-dependent Kinase | 2e-08 | ||
| 1fin_A | 298 | Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = | 2e-08 | ||
| 1oir_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 2e-08 | ||
| 1h01_A | 298 | Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili | 2e-08 | ||
| 2qlu_A | 314 | Crystal Structure Of Activin Receptor Type Ii Kinas | 2e-08 | ||
| 3qd2_B | 332 | Crsytal Structure Of Mouse Perk Kinase Domain Lengt | 2e-08 | ||
| 1vyw_A | 309 | Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = | 2e-08 | ||
| 2x7f_A | 326 | Crystal Structure Of The Kinase Domain Of Human Tra | 3e-08 | ||
| 4alv_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 3e-08 | ||
| 3a99_A | 320 | Structure Of Pim-1 Kinase Crystallized In The Prese | 3e-08 | ||
| 2xj0_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-4 Fro | 3e-08 | ||
| 2j2i_B | 312 | Crystal Structure Of The Humab Pim1 In Complex With | 3e-08 | ||
| 3zut_A | 362 | The Structure Of Ost1 (D160a) Kinase Length = 362 | 3e-08 | ||
| 3jpv_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 3e-08 | ||
| 3tku_A | 433 | Mrck Beta In Complex With Fasudil Length = 433 | 3e-08 | ||
| 1xqz_A | 300 | Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut | 4e-08 | ||
| 3qfv_A | 415 | Mrck Beta In Complex With Tpca-1 Length = 415 | 4e-08 | ||
| 3aln_A | 327 | Crystal Structure Of Human Non-Phosphorylated Mkk4 | 4e-08 | ||
| 2xiy_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-2 Fro | 4e-08 | ||
| 2bil_B | 313 | The Human Protein Kinase Pim1 In Complex With Its C | 4e-08 | ||
| 3f2a_A | 300 | Crystal Structure Of Human Pim-1 In Complex With Da | 4e-08 | ||
| 4ic7_A | 442 | Crystal Structure Of The Erk5 Kinase Domain In Comp | 4e-08 | ||
| 3ma3_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 4e-08 | ||
| 3cxw_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 4e-08 | ||
| 2obj_A | 333 | Crystal Structure Of Human Pim-1 Kinase In Complex | 4e-08 | ||
| 1ung_A | 292 | Structural Mechanism For The Inhibition Of Cdk5-P25 | 4e-08 | ||
| 2xix_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-1 Fro | 4e-08 | ||
| 2zv2_A | 298 | Crystal Structure Of Human CalciumCALMODULIN-Depend | 4e-08 | ||
| 2bik_B | 313 | Human Pim1 Phosphorylated On Ser261 Length = 313 | 4e-08 | ||
| 3dcv_A | 328 | Crystal Structure Of Human Pim1 Kinase Complexed Wi | 4e-08 | ||
| 2w4o_A | 349 | Crystal Structure Of Human Camk4 In Complex With 4- | 5e-08 | ||
| 1xws_A | 313 | Crystal Structure Of The Human Pim1 Kinase Domain L | 5e-08 | ||
| 3cy3_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 5e-08 | ||
| 3hng_A | 360 | Crystal Structure Of Vegfr1 In Complex With N-(4-ch | 5e-08 | ||
| 3uc4_A | 362 | The Crystal Structure Of Snf1-Related Kinase 2.6 Le | 5e-08 | ||
| 1bi8_A | 326 | Mechanism Of G1 Cyclin Dependent Kinase Inhibition | 5e-08 | ||
| 3vul_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 5e-08 | ||
| 1jow_B | 308 | Crystal Structure Of A Complex Of Human Cdk6 And A | 5e-08 | ||
| 3nup_A | 307 | Cdk6 (Monomeric) In Complex With Inhibitor Length = | 5e-08 | ||
| 3hyh_A | 275 | Crystal Structure Of The Protein Kinase Domain Of Y | 6e-08 | ||
| 3gb2_A | 353 | Gsk3beta Inhibitor Complex Length = 353 | 6e-08 | ||
| 3dae_A | 283 | Crystal Structure Of Phosphorylated Snf1 Kinase Dom | 6e-08 | ||
| 3vum_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M7 | 6e-08 | ||
| 2fh9_A | 274 | Structure And Dimerization Of The Kinase Domain Fro | 6e-08 | ||
| 3kmw_A | 271 | Crystal Structure Of The IlkALPHA-Parvin Core Compl | 6e-08 | ||
| 3g2f_A | 336 | Crystal Structure Of The Kinase Domain Of Bone Morp | 6e-08 | ||
| 4b99_A | 398 | Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le | 6e-08 | ||
| 4dit_A | 382 | Crystal Structure Of Gsk3beta In Complex With A Imi | 6e-08 | ||
| 3zrk_A | 371 | Identification Of 2-(4-Pyridyl)thienopyridinones As | 7e-08 | ||
| 3mn3_A | 271 | An Inhibited Conformation For The Protein Kinase Do | 7e-08 | ||
| 3zdi_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 7e-08 | ||
| 3f7z_A | 350 | X-ray Co-crystal Structure Of Glycogen Synthase Kin | 7e-08 | ||
| 3e7o_A | 360 | Crystal Structure Of Jnk2 Length = 360 | 7e-08 | ||
| 3zuu_A | 362 | The Structure Of Ost1 (D160a, S175d) Kinase In Comp | 7e-08 | ||
| 2ow3_A | 352 | Glycogen Synthase Kinase-3 Beta In Complex With Bis | 7e-08 | ||
| 4eos_A | 300 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 7e-08 | ||
| 4afj_A | 367 | 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec | 7e-08 | ||
| 4eoi_A | 299 | Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc | 7e-08 | ||
| 3bht_A | 300 | Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN | 7e-08 | ||
| 1ogu_A | 302 | Structure Of Human Thr160-phospho Cdk2/cyclin A Com | 7e-08 | ||
| 3say_A | 430 | Crystal Structure Of Human Glycogen Synthase Kinase | 7e-08 | ||
| 2jgz_A | 289 | Crystal Structure Of Phospho-Cdk2 In Complex With C | 7e-08 | ||
| 1gng_A | 378 | Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With | 7e-08 | ||
| 1h1p_A | 303 | Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP | 7e-08 | ||
| 4eoq_A | 301 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 8e-08 | ||
| 4bcq_A | 301 | Structure Of Cdk2 In Complex With Cyclin A And A 2- | 8e-08 | ||
| 4i3z_A | 296 | Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES | 8e-08 | ||
| 1w98_A | 298 | The Structural Basis Of Cdk2 Activation By Cyclin E | 8e-08 | ||
| 4eoo_A | 299 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 8e-08 | ||
| 1jst_A | 298 | Phosphorylated Cyclin-Dependent Kinase-2 Bound To C | 8e-08 | ||
| 4eop_A | 300 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 8e-08 | ||
| 1omw_A | 689 | Crystal Structure Of The Complex Between G Protein- | 8e-08 | ||
| 1qmz_A | 299 | Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com | 8e-08 | ||
| 3psc_A | 695 | Bovine Grk2 In Complex With Gbetagamma Subunits Len | 8e-08 | ||
| 2iw6_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com | 8e-08 | ||
| 3qhr_A | 298 | Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic | 8e-08 | ||
| 3cik_A | 689 | Human Grk2 In Complex With Gbetagamma Subunits Leng | 8e-08 | ||
| 1e9h_A | 297 | Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex | 8e-08 | ||
| 3mfr_A | 351 | Cask-4m Cam Kinase Domain, Native Length = 351 | 9e-08 | ||
| 3krw_A | 688 | Human Grk2 In Complex With Gbetgamma Subunits And B | 9e-08 | ||
| 2vz6_A | 313 | Structure Of Human Calcium Calmodulin Dependent Pro | 9e-08 | ||
| 3sd0_A | 350 | Identification Of A Glycogen Synthase Kinase-3b Inh | 1e-07 | ||
| 1r0e_A | 391 | Glycogen Synthase Kinase-3 Beta In Complex With 3-I | 1e-07 | ||
| 2o5k_A | 372 | Crystal Structure Of Gsk3beta In Complex With A Ben | 1e-07 | ||
| 1i09_A | 420 | Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len | 1e-07 | ||
| 1q5k_A | 414 | Crystal Structure Of Glycogen Synthase Kinase 3 In | 1e-07 | ||
| 1pyx_A | 422 | Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | 1e-07 | ||
| 4eom_A | 301 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 1e-07 | ||
| 4eon_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 1e-07 | ||
| 1q3d_A | 424 | Gsk-3 Beta Complexed With Staurosporine Length = 42 | 1e-07 | ||
| 4acc_A | 465 | Gsk3b In Complex With Inhibitor Length = 465 | 1e-07 | ||
| 3sa0_A | 360 | Complex Of Erk2 With Norathyriol Length = 360 | 1e-07 | ||
| 1gii_A | 298 | Human Cyclin Dependent Kinase 2 Complexed With The | 1e-07 | ||
| 3q4t_A | 322 | Crystal Structure Of Activin Receptor Type-Iia (Acv | 1e-07 | ||
| 3gok_A | 334 | Binding Site Mapping Of Protein Ligands Length = 33 | 1e-07 | ||
| 2vd5_A | 412 | Structure Of Human Myotonic Dystrophy Protein Kinas | 1e-07 | ||
| 4fux_A | 360 | Crystal Structure Of The Erk2 Complexed With E75 Le | 1e-07 | ||
| 3qyw_A | 364 | Crystal Structure Of Erk2 In Complex With An Inhibi | 1e-07 | ||
| 2y94_A | 476 | Structure Of An Active Form Of Mammalian Ampk Lengt | 1e-07 | ||
| 3vn9_A | 340 | Rifined Crystal Structure Of Non-Phosphorylated Map | 1e-07 | ||
| 4eok_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 1e-07 | ||
| 4fv7_A | 360 | Crystal Structure Of The Erk2 Complexed With E94 Le | 1e-07 | ||
| 4eoj_A | 302 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 1e-07 | ||
| 3npc_A | 364 | Crystal Structure Of Jnk2 Complexed With Birb796 Le | 2e-07 | ||
| 4gsb_A | 364 | Monoclinic Crystal Form Of The Apo-Erk2 Length = 36 | 2e-07 | ||
| 1pme_A | 380 | Structure Of Penta Mutant Human Erk2 Map Kinase Com | 2e-07 | ||
| 3r2b_A | 318 | Mk2 Kinase Bound To Compound 5b Length = 318 | 2e-07 | ||
| 4fvp_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain ( | 2e-07 | ||
| 1kwp_A | 400 | Crystal Structure Of Mapkap2 Length = 400 | 2e-07 | ||
| 3r2y_A | 319 | Mk2 Kinase Bound To Compound 1 Length = 319 | 2e-07 | ||
| 2onl_C | 406 | Crystal Structure Of The P38a-Mapkap Kinase 2 Heter | 2e-07 | ||
| 2jbo_A | 326 | Protein Kinase Mk2 In Complex With An Inhibitor (Cr | 2e-07 | ||
| 2gph_A | 364 | Docking Motif Interactions In The Map Kinase Erk2 L | 2e-07 | ||
| 4h3q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 2e-07 | ||
| 2oza_A | 356 | Structure Of P38alpha Complex Length = 356 | 2e-07 | ||
| 4aw2_A | 437 | Crystal Structure Of Cdc42 Binding Protein Kinase A | 2e-07 | ||
| 3f88_A | 349 | Glycogen Synthase Kinase 3beta Inhibitor Complex Le | 2e-07 | ||
| 3vui_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 2e-07 | ||
| 3o71_A | 358 | Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length | 2e-07 | ||
| 4fvr_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain M | 2e-07 | ||
| 3r63_A | 358 | Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | 2e-07 | ||
| 4fv6_A | 360 | Crystal Structure Of The Erk2 Complexed With E57 Le | 2e-07 | ||
| 2y9q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 2e-07 | ||
| 2pzy_A | 324 | Structure Of Mk2 Complexed With Compound 76 Length | 2e-07 | ||
| 3zu7_A | 365 | Crystal Structure Of A Designed Selected Ankyrin Re | 2e-07 | ||
| 2z7l_A | 366 | Unphosphorylated Mitogen Activated Protein Kinase E | 2e-07 | ||
| 3c9w_A | 357 | Crystal Structure Of Erk-2 With Hypothemycin Covale | 2e-07 | ||
| 2fys_B | 364 | Crystal Structure Of Erk2 Complex With Kim Peptide | 2e-07 | ||
| 3fpm_A | 325 | Crystal Structure Of A Squarate Inhibitor Bound To | 2e-07 | ||
| 2buj_A | 317 | Crystal Structure Of The Human Serine-Threonine Kin | 2e-07 | ||
| 1wzy_A | 368 | Crystal Structure Of Human Erk2 Complexed With A Py | 2e-07 | ||
| 1tvo_A | 368 | The Structure Of Erk2 In Complex With A Small Molec | 2e-07 | ||
| 1gol_A | 364 | Coordinates Of Rat Map Kinase Erk2 With An Arginine | 2e-07 | ||
| 3tei_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 2e-07 | ||
| 2p3g_X | 327 | Crystal Structure Of A Pyrrolopyridine Inhibitor Bo | 2e-07 | ||
| 2ojg_A | 380 | Crystal Structure Of Erk2 In Complex With N,n-dimet | 2e-07 | ||
| 3oz6_A | 388 | Crystal Structure Of Mapk From Cryptosporidium Parv | 3e-07 | ||
| 2wnt_A | 330 | Crystal Structure Of The Human Ribosomal Protein S6 | 3e-07 | ||
| 2qr8_A | 342 | 2.0a X-ray Structure Of C-terminal Kinase Domain Of | 3e-07 | ||
| 3vuk_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M5 | 3e-07 | ||
| 3vid_A | 356 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 3e-07 | ||
| 1zws_A | 288 | Crystal Structure Of The Catalytic Domain Of Human | 3e-07 | ||
| 3rny_A | 346 | Crystal Structure Of Human Rsk1 C-Terminal Kinase D | 3e-07 | ||
| 3vhe_A | 359 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 3e-07 | ||
| 1wmk_A | 321 | Human Death-Associated Kinase Drp-1, Mutant S308d D | 3e-07 | ||
| 3vuh_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M3 | 3e-07 | ||
| 2a27_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 3e-07 | ||
| 3vhk_A | 368 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 3e-07 | ||
| 2a2a_A | 321 | High-resolution Crystallographic Analysis Of The Au | 4e-07 | ||
| 2iw8_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82 | 4e-07 | ||
| 1z9x_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 4e-07 | ||
| 1y6a_A | 366 | Crystal Structure Of Vegfr2 In Complex With A 2-Ani | 4e-07 | ||
| 3soa_A | 444 | Full-Length Human Camkii Length = 444 | 4e-07 | ||
| 1o9u_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 4e-07 | ||
| 3vug_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 5e-07 | ||
| 4agu_A | 311 | Crystal Structure Of The Human Cdkl1 Kinase Domain | 5e-07 | ||
| 3dls_A | 335 | Crystal Structure Of Human Pas Kinase Bound To Adp | 5e-07 | ||
| 1yxs_A | 293 | Crystal Structure Of Kinase Pim1 With P123m Mutatio | 5e-07 | ||
| 2zoq_A | 382 | Structural Dissection Of Human Mitogen-Activated Ki | 5e-07 | ||
| 1uv5_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With 6-Br | 6e-07 | ||
| 1h8f_A | 352 | Glycogen Synthase Kinase 3 Beta. Length = 352 | 6e-07 | ||
| 3fv8_A | 355 | Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le | 6e-07 | ||
| 3i6u_A | 419 | Structure And Activation Mechanism Of The Chk2 Dna- | 6e-07 | ||
| 2w0j_A | 323 | Crystal Structure Of Chk2 In Complex With Nsc 10955 | 6e-07 | ||
| 2xrw_A | 371 | Linear Binding Motifs For Jnk And For Calcineurin A | 6e-07 | ||
| 3i6w_A | 443 | Structure And Activation Mechanism Of The Chk2 Dna- | 6e-07 | ||
| 2i6l_A | 320 | Crystal Structure Of Human Mitogen Activated Protei | 6e-07 | ||
| 2ycf_A | 322 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 7e-07 | ||
| 2ycr_A | 323 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 7e-07 | ||
| 2xk9_A | 322 | Structural Analysis Of Checkpoint Kinase 2 (Chk2) I | 7e-07 | ||
| 1ukh_A | 369 | Structural Basis For The Selective Inhibition Of Jn | 7e-07 | ||
| 3fi3_A | 364 | Crystal Structure Of Jnk3 With Indazole Inhibitor, | 7e-07 | ||
| 2cn5_A | 329 | Crystal Structure Of Human Chk2 In Complex With Adp | 7e-07 | ||
| 3mtl_A | 324 | Crystal Structure Of The Pctaire1 Kinase In Complex | 8e-07 | ||
| 2ya9_A | 361 | Crystal Structure Of The Autoinhibited Form Of Mous | 8e-07 | ||
| 3fi2_A | 353 | Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib | 8e-07 | ||
| 3zuv_A | 364 | Crystal Structure Of A Designed Selected Ankyrin Re | 9e-07 | ||
| 2erk_A | 365 | Phosphorylated Map Kinase Erk2 Length = 365 | 9e-07 | ||
| 3ka0_A | 320 | Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4 | 9e-07 | ||
| 3vud_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 9e-07 | ||
| 1nxk_A | 400 | Crystal Structure Of Staurosporine Bound To Map Kap | 9e-07 | ||
| 3blh_A | 331 | Crystal Structure Of Human Cdk9CYCLINT1 Length = 33 | 9e-07 | ||
| 3v3v_A | 379 | Structural And Functional Analysis Of Quercetagetin | 1e-06 | ||
| 4bcf_A | 331 | Structure Of Cdk9 In Complex With Cyclin T And A 2- | 1e-06 | ||
| 3fme_A | 290 | Crystal Structure Of Human Mitogen-Activated Protei | 1e-06 | ||
| 3uix_A | 298 | Crystal Structure Of Pim1 Kinase In Complex With Sm | 1e-06 | ||
| 1v0o_A | 288 | Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho | 1e-06 | ||
| 1v0b_A | 288 | Crystal Structure Of The T198a Mutant Of Pfpk5 Leng | 1e-06 | ||
| 3gbz_A | 329 | Structure Of The Cmgc Cdk Kinase From Giardia Lambl | 1e-06 | ||
| 3mi9_A | 351 | Crystal Structure Of Hiv-1 Tat Complexed With Human | 1e-06 | ||
| 1ywv_A | 293 | Crystal Structures Of Proto-Oncogene Kinase Pim1: A | 1e-06 | ||
| 3e3p_A | 360 | Glycogen Synthase Kinase From Leishmania Major Leng | 1e-06 | ||
| 2ac5_A | 316 | Structure Of Human Mnk2 Kinase Domain Mutant D228g | 1e-06 | ||
| 2qr7_A | 342 | 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of | 1e-06 | ||
| 3r00_A | 299 | The Discovery Of Novel Benzofuran-2-Carboxylic Acid | 1e-06 | ||
| 2hw6_A | 307 | Crystal Structure Of Mnk1 Catalytic Domain Length = | 1e-06 | ||
| 3jxw_A | 294 | Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4- | 1e-06 | ||
| 4ec8_A | 373 | Structure Of Full Length Cdk9 In Complex With Cycli | 2e-06 | ||
| 4a7c_A | 308 | Crystal Structure Of Pim1 Kinase With Etp46546 Leng | 2e-06 | ||
| 2r9s_A | 356 | C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu | 2e-06 | ||
| 3ttj_A | 464 | Crystal Structure Of Jnk3 Complexed With Cc-359, A | 2e-06 | ||
| 3kvx_A | 364 | Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le | 2e-06 | ||
| 1ob3_A | 288 | Structure Of P. Falciparum Pfpk5 Length = 288 | 2e-06 | ||
| 2xs0_A | 386 | Linear Binding Motifs For Jnk And For Calcineurin A | 2e-06 | ||
| 1jnk_A | 423 | The C-Jun N-Terminal Kinase (Jnk3s) Complexed With | 2e-06 | ||
| 4as0_A | 273 | Cyclometalated Phthalimides As Protein Kinase Inhib | 2e-06 | ||
| 3c4e_A | 273 | Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7 | 2e-06 | ||
| 1pmn_A | 364 | Crystal Structure Of Jnk3 In Complex With An Imidaz | 3e-06 | ||
| 2b1p_A | 355 | Inhibitor Complex Of Jnk3 Length = 355 | 3e-06 | ||
| 3oxi_A | 362 | Design And Synthesis Of Disubstituted Thiophene And | 3e-06 | ||
| 3ptg_A | 363 | Design And Synthesis Of A Novel, Orally Efficacious | 3e-06 | ||
| 2o0u_A | 364 | Crystal Structure Of Human Jnk3 Complexed With N-{3 | 3e-06 | ||
| 2exc_X | 356 | Inhibitor Complex Of Jnk3 Length = 356 | 3e-06 | ||
| 4h36_A | 356 | Crystal Structure Of Jnk3 In Complex With Atf2 Pept | 3e-06 | ||
| 4dtk_A | 276 | Novel And Selective Pan-Pim Kinase Inhibitor Length | 3e-06 | ||
| 2ok1_A | 365 | Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3 | 3e-06 | ||
| 4alu_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 3e-06 | ||
| 1yhs_A | 273 | Crystal Structure Of Pim-1 Bound To Staurosporine L | 4e-06 | ||
| 3fhr_A | 336 | High Resolution Crystal Structure Of Mitogen-Activa | 4e-06 | ||
| 3r1n_A | 317 | Mk3 Kinase Bound To Compound 5b Length = 317 | 4e-06 | ||
| 2wot_A | 306 | Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl) | 4e-06 | ||
| 4exu_A | 371 | Mapk13, Inactive Form Length = 371 | 4e-06 | ||
| 2ac3_A | 316 | Structure Of Human Mnk2 Kinase Domain Length = 316 | 4e-06 | ||
| 3tzm_A | 309 | Tgf-Beta Receptor Type 1 In Complex With Sb431542 L | 4e-06 | ||
| 1vjy_A | 303 | Crystal Structure Of A Naphthyridine Inhibitor Of H | 4e-06 | ||
| 1py5_A | 326 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 4e-06 | ||
| 1b6c_B | 342 | Crystal Structure Of The Cytoplasmic Domain Of The | 5e-06 | ||
| 3kmu_A | 271 | Crystal Structure Of The IlkALPHA-Parvin Core Compl | 5e-06 | ||
| 3coi_A | 353 | Crystal Structure Of P38delta Kinase Length = 353 | 5e-06 | ||
| 1kob_A | 387 | Twitchin Kinase Fragment (Aplysia), Autoregulated P | 5e-06 | ||
| 3h9r_A | 330 | Crystal Structure Of The Kinase Domain Of Type I Ac | 5e-06 | ||
| 1rw8_A | 301 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 5e-06 | ||
| 3elj_A | 369 | Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine | 5e-06 | ||
| 2h34_A | 309 | Apoenzyme Crystal Structure Of The Tuberculosis Ser | 5e-06 | ||
| 3mtf_A | 301 | Crystal Structure Of The Acvr1 Kinase In Complex Wi | 6e-06 | ||
| 4dym_A | 301 | Crystal Structure Of The Acvr1 Kinase Domain In Com | 6e-06 | ||
| 3pze_A | 358 | Jnk1 In Complex With Inhibitor Length = 358 | 6e-06 | ||
| 3ll6_A | 337 | Crystal Structure Of The Human Cyclin G Associated | 6e-06 | ||
| 3enm_A | 316 | The Structure Of The Map2k Mek6 Reveals An Autoinhi | 6e-06 | ||
| 2b9f_A | 353 | Crystal Structure Of Non-Phosphorylated Fus3 Length | 9e-06 | ||
| 2fst_X | 367 | Mitogen Activated Protein Kinase P38alpha (d176a+f3 | 9e-06 | ||
| 3tac_A | 361 | Crystal Structure Of The Liprin-AlphaCASK COMPLEX L | 9e-06 | ||
| 2fsl_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a+f3 | 9e-06 | ||
| 2fso_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a) A | 1e-05 | ||
| 3c0g_A | 351 | Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len | 1e-05 | ||
| 3g33_A | 308 | Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | 1e-05 | ||
| 3uto_A | 573 | Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin- | 1e-05 | ||
| 2w96_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 1e-05 | ||
| 3fpq_A | 290 | Crystal Structure Of The Kinase Domain Of Wnk1 Leng | 1e-05 | ||
| 2b9h_A | 353 | Crystal Structure Of Fus3 With A Docking Motif From | 2e-05 | ||
| 2w9f_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 2e-05 | ||
| 1koa_A | 491 | Twitchin Kinase Fragment (C.Elegans), Autoregulated | 2e-05 | ||
| 3o17_A | 370 | Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3 | 2e-05 | ||
| 3e92_A | 371 | Crystal Structure Of P38 Kinase In Complex With A B | 2e-05 | ||
| 2w99_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 2e-05 | ||
| 2baq_A | 365 | P38alpha Bound To Ro3201195 Length = 365 | 3e-05 | ||
| 3d83_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 3e-05 | ||
| 2bal_A | 365 | P38alpha Map Kinase Bound To Pyrazoloamine Length = | 3e-05 | ||
| 4e7w_A | 394 | Structure Of Gsk3 From Ustilago Maydis Length = 394 | 3e-05 | ||
| 3lm0_A | 327 | Crystal Structure Of Human SerineTHREONINE KINASE 1 | 3e-05 | ||
| 3gc9_A | 370 | The Structure Of P38beta C119s, C162s In Complex Wi | 3e-05 | ||
| 2y8o_A | 362 | Crystal Structure Of Human P38alpha Complexed With | 4e-05 | ||
| 1ove_A | 366 | The Structure Of P38 Alpha In Complex With A Dihydr | 4e-05 | ||
| 4e5a_X | 360 | The W197a Mutant Of P38a Map Kinase Length = 360 | 4e-05 | ||
| 3gc8_A | 370 | The Structure Of P38beta C162s In Complex With A Di | 4e-05 | ||
| 2g01_A | 370 | Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit | 4e-05 | ||
| 3e3b_X | 339 | Crystal Structure Of Catalytic Subunit Of Human Pro | 4e-05 | ||
| 3hko_A | 345 | Crystal Structure Of A Cdpk Kinase Domain From Cryp | 4e-05 | ||
| 3ofm_A | 350 | Structure Of A Human Ck2alpha Prime, The Paralog Is | 5e-05 | ||
| 3kq7_A | 380 | Structure Of Human P38alpha With N-[4-Methyl-3-(6-{ | 5e-05 | ||
| 3dt1_A | 383 | P38 Complexed With A Quinazoline Inhibitor Length = | 5e-05 | ||
| 1bl6_A | 379 | The Complex Structure Of The Map Kinase P38SB216995 | 5e-05 | ||
| 3llt_A | 360 | Crystal Structure Of Pf14_0431, Kinase Domain Lengt | 5e-05 | ||
| 3tg1_A | 380 | Crystal Structure Of P38alpha In Complex With A Map | 5e-05 | ||
| 3oef_X | 360 | Crystal Structure Of Y323f Inactive Mutant Of P38al | 5e-05 | ||
| 3nnu_A | 354 | Crystal Structure Of P38 Alpha In Complex With Dp13 | 5e-05 | ||
| 1zzl_A | 351 | Crystal Structure Of P38 With Triazolopyridine Leng | 5e-05 | ||
| 3hec_A | 348 | P38 In Complex With Imatinib Length = 348 | 5e-05 | ||
| 2npq_A | 367 | A Novel Lipid Binding Site In The P38 Alpha Map Kin | 5e-05 | ||
| 3ody_X | 360 | Crystal Structure Of P38alpha Y323q Active Mutant L | 5e-05 | ||
| 3od6_X | 360 | Crystal Structure Of P38alpha Y323t Active Mutant L | 5e-05 | ||
| 3mpt_A | 371 | Crystal Structure Of P38 Kinase In Complex With A P | 5e-05 | ||
| 3fi4_A | 372 | P38 Kinase Crystal Structure In Complex With Ro4499 | 5e-05 | ||
| 3hvc_A | 362 | Crystal Structure Of Human P38alpha Map Kinase Leng | 5e-05 | ||
| 1oz1_A | 372 | P38 Mitogen-Activated Kinase In Complex With 4-Azai | 5e-05 | ||
| 1m7q_A | 366 | Crystal Structure Of P38 Map Kinase In Complex With | 5e-05 | ||
| 3s3i_A | 349 | P38 Kinase Crystal Structure In Complex With Small | 5e-05 | ||
| 3k3i_A | 350 | P38alpha Bound To Novel Dgf-Out Compound Pf-0021595 | 5e-05 | ||
| 3gcu_A | 360 | Human P38 Map Kinase In Complex With Rl48 Length = | 5e-05 | ||
| 2gfs_A | 372 | P38 Kinase Crystal Structure In Complex With Ro3201 | 5e-05 | ||
| 3odz_X | 360 | Crystal Structure Of P38alpha Y323r Active Mutant L | 5e-05 | ||
| 3k3j_A | 362 | P38alpha Bound To Novel Dfg-Out Compound Pf-0041612 | 5e-05 | ||
| 1bmk_A | 379 | The Complex Structure Of The Map Kinase P38SB218655 | 5e-05 | ||
| 1di9_A | 360 | The Structure Of P38 Mitogen-Activated Protein Kina | 5e-05 | ||
| 2baj_A | 365 | P38alpha Bound To Pyrazolourea Length = 365 | 5e-05 | ||
| 3p4k_A | 370 | The Third Conformation Of P38a Map Kinase Observed | 5e-05 | ||
| 3hrb_A | 359 | P38 Kinase Crystal Structure In Complex With Small | 5e-05 | ||
| 3d7z_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 5e-05 | ||
| 1lew_A | 360 | Crystal Structure Of Map Kinase P38 Complexed To Th | 5e-05 | ||
| 3zsg_A | 362 | X-Ray Structure Of P38alpha Bound To Tak-715 Length | 5e-05 | ||
| 2gtm_A | 348 | Mutated Mouse P38 Map Kinase Domain In Complex With | 6e-05 | ||
| 2puu_A | 348 | Crystal Structure Of P38 Complex With 1-(5-Tert-But | 6e-05 | ||
| 2oza_B | 366 | Structure Of P38alpha Complex Length = 366 | 6e-05 | ||
| 1ian_A | 366 | Human P38 Map Kinase Inhibitor Complex Length = 366 | 6e-05 | ||
| 3p23_A | 432 | Crystal Structure Of The Human Kinase And Rnase Dom | 6e-05 | ||
| 2lgc_A | 359 | Joint Nmr And X-Ray Refinement Reveals The Structur | 6e-05 | ||
| 3nnx_A | 354 | Crystal Structure Of Phosphorylated P38 Alpha In Co | 6e-05 | ||
| 3my0_A | 305 | Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai | 6e-05 | ||
| 3gp0_A | 348 | Crystal Structure Of Human Mitogen Activated Protei | 7e-05 | ||
| 2f9g_A | 353 | Crystal Structure Of Fus3 Phosphorylated On Tyr182 | 7e-05 | ||
| 2wtk_C | 305 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 8e-05 | ||
| 3mdy_A | 337 | Crystal Structure Of The Cytoplasmic Domain Of The | 9e-05 | ||
| 3gcp_A | 360 | Human P38 Map Kinase In Complex With Sb203580 Lengt | 9e-05 | ||
| 1na7_A | 329 | Crystal Structure Of The Catalytic Subunit Of Human | 1e-04 | ||
| 3f3z_A | 277 | Crystal Structure Of Cryptosporidium Parvum Calcium | 1e-04 | ||
| 2qg5_A | 294 | Cryptosporidium Parvum Calcium Dependent Protein Ki | 1e-04 | ||
| 3mh2_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 1e-04 | ||
| 3py3_A | 380 | Crystal Structure Of Phosphorylated P38alpha Map Ki | 1e-04 | ||
| 3oht_A | 389 | Crystal Structure Of Salmo Salar P38alpha Length = | 1e-04 | ||
| 1tki_A | 321 | Autoinhibited Serine Kinase Domain Of The Giant Mus | 2e-04 |
| >pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349 | Back alignment and structure |
|
| >pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326 | Back alignment and structure |
|
| >pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321 | Back alignment and structure |
|
| >pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327 | Back alignment and structure |
|
| >pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301 | Back alignment and structure |
|
| >pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287 | Back alignment and structure |
|
| >pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271 | Back alignment and structure |
|
| >pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373 | Back alignment and structure |
|
| >pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315 | Back alignment and structure |
|
| >pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314 | Back alignment and structure |
|
| >pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307 | Back alignment and structure |
|
| >pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312 | Back alignment and structure |
|
| >pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277 | Back alignment and structure |
|
| >pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307 | Back alignment and structure |
|
| >pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318 | Back alignment and structure |
|
| >pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292 | Back alignment and structure |
|
| >pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308 | Back alignment and structure |
|
| >pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306 | Back alignment and structure |
|
| >pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302 | Back alignment and structure |
|
| >pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286 | Back alignment and structure |
|
| >pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288 | Back alignment and structure |
|
| >pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309 | Back alignment and structure |
|
| >pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284 | Back alignment and structure |
|
| >pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288 | Back alignment and structure |
|
| >pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310 | Back alignment and structure |
|
| >pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284 | Back alignment and structure |
|
| >pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287 | Back alignment and structure |
|
| >pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278 | Back alignment and structure |
|
| >pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293 | Back alignment and structure |
|
| >pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298 | Back alignment and structure |
|
| >pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277 | Back alignment and structure |
|
| >pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277 | Back alignment and structure |
|
| >pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298 | Back alignment and structure |
|
| >pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292 | Back alignment and structure |
|
| >pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273 | Back alignment and structure |
|
| >pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270 | Back alignment and structure |
|
| >pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277 | Back alignment and structure |
|
| >pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295 | Back alignment and structure |
|
| >pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295 | Back alignment and structure |
|
| >pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495 | Back alignment and structure |
|
| >pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311 | Back alignment and structure |
|
| >pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313 | Back alignment and structure |
|
| >pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303 | Back alignment and structure |
|
| >pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298 | Back alignment and structure |
|
| >pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301 | Back alignment and structure |
|
| >pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300 | Back alignment and structure |
|
| >pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293 | Back alignment and structure |
|
| >pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266 | Back alignment and structure |
|
| >pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537 | Back alignment and structure |
|
| >pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269 | Back alignment and structure |
|
| >pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298 | Back alignment and structure |
|
| >pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266 | Back alignment and structure |
|
| >pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264 | Back alignment and structure |
|
| >pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267 | Back alignment and structure |
|
| >pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287 | Back alignment and structure |
|
| >pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613 | Back alignment and structure |
|
| >pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293 | Back alignment and structure |
|
| >pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299 | Back alignment and structure |
|
| >pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291 | Back alignment and structure |
|
| >pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273 | Back alignment and structure |
|
| >pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274 | Back alignment and structure |
|
| >pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636 | Back alignment and structure |
|
| >pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283 | Back alignment and structure |
|
| >pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283 | Back alignment and structure |
|
| >pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329 | Back alignment and structure |
|
| >pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274 | Back alignment and structure |
|
| >pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635 | Back alignment and structure |
|
| >pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321 | Back alignment and structure |
|
| >pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298 | Back alignment and structure |
|
| >pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271 | Back alignment and structure |
|
| >pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267 | Back alignment and structure |
|
| >pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300 | Back alignment and structure |
|
| >pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265 | Back alignment and structure |
|
| >pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328 | Back alignment and structure |
|
| >pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307 | Back alignment and structure |
|
| >pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263 | Back alignment and structure |
|
| >pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297 | Back alignment and structure |
|
| >pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361 | Back alignment and structure |
|
| >pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344 | Back alignment and structure |
|
| >pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373 | Back alignment and structure |
|
| >pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285 | Back alignment and structure |
|
| >pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371 | Back alignment and structure |
|
| >pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285 | Back alignment and structure |
|
| >pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291 | Back alignment and structure |
|
| >pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308 | Back alignment and structure |
|
| >pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344 | Back alignment and structure |
|
| >pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280 | Back alignment and structure |
|
| >pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273 | Back alignment and structure |
|
| >pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341 | Back alignment and structure |
|
| >pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318 | Back alignment and structure |
|
| >pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277 | Back alignment and structure |
|
| >pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281 | Back alignment and structure |
|
| >pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373 | Back alignment and structure |
|
| >pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282 | Back alignment and structure |
|
| >pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272 | Back alignment and structure |
|
| >pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279 | Back alignment and structure |
|
| >pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272 | Back alignment and structure |
|
| >pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282 | Back alignment and structure |
|
| >pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268 | Back alignment and structure |
|
| >pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267 | Back alignment and structure |
|
| >pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300 | Back alignment and structure |
|
| >pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276 | Back alignment and structure |
|
| >pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305 | Back alignment and structure |
|
| >pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299 | Back alignment and structure |
|
| >pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269 | Back alignment and structure |
|
| >pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290 | Back alignment and structure |
|
| >pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311 | Back alignment and structure |
|
| >pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295 | Back alignment and structure |
|
| >pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273 | Back alignment and structure |
|
| >pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281 | Back alignment and structure |
|
| >pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450 | Back alignment and structure |
|
| >pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275 | Back alignment and structure |
|
| >pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323 | Back alignment and structure |
|
| >pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269 | Back alignment and structure |
|
| >pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278 | Back alignment and structure |
|
| >pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297 | Back alignment and structure |
|
| >pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289 | Back alignment and structure |
|
| >pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284 | Back alignment and structure |
|
| >pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282 | Back alignment and structure |
|
| >pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295 | Back alignment and structure |
|
| >pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307 | Back alignment and structure |
|
| >pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273 | Back alignment and structure |
|
| >pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322 | Back alignment and structure |
|
| >pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306 | Back alignment and structure |
|
| >pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278 | Back alignment and structure |
|
| >pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263 | Back alignment and structure |
|
| >pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311 | Back alignment and structure |
|
| >pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276 | Back alignment and structure |
|
| >pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271 | Back alignment and structure |
|
| >pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283 | Back alignment and structure |
|
| >pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262 | Back alignment and structure |
|
| >pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315 | Back alignment and structure |
|
| >pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269 | Back alignment and structure |
|
| >pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312 | Back alignment and structure |
|
| >pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310 | Back alignment and structure |
|
| >pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268 | Back alignment and structure |
|
| >pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268 | Back alignment and structure |
|
| >pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311 | Back alignment and structure |
|
| >pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299 | Back alignment and structure |
|
| >pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311 | Back alignment and structure |
|
| >pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311 | Back alignment and structure |
|
| >pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336 | Back alignment and structure |
|
| >pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268 | Back alignment and structure |
|
| >pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322 | Back alignment and structure |
|
| >pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299 | Back alignment and structure |
|
| >pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271 | Back alignment and structure |
|
| >pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301 | Back alignment and structure |
|
| >pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301 | Back alignment and structure |
|
| >pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317 | Back alignment and structure |
|
| >pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322 | Back alignment and structure |
|
| >pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304 | Back alignment and structure |
|
| >pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268 | Back alignment and structure |
|
| >pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306 | Back alignment and structure |
|
| >pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281 | Back alignment and structure |
|
| >pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293 | Back alignment and structure |
|
| >pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286 | Back alignment and structure |
|
| >pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277 | Back alignment and structure |
|
| >pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285 | Back alignment and structure |
|
| >pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303 | Back alignment and structure |
|
| >pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306 | Back alignment and structure |
|
| >pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302 | Back alignment and structure |
|
| >pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314 | Back alignment and structure |
|
| >pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306 | Back alignment and structure |
|
| >pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355 | Back alignment and structure |
|
| >pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303 | Back alignment and structure |
|
| >pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290 | Back alignment and structure |
|
| >pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268 | Back alignment and structure |
|
| >pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297 | Back alignment and structure |
|
| >pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306 | Back alignment and structure |
|
| >pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305 | Back alignment and structure |
|
| >pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292 | Back alignment and structure |
|
| >pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317 | Back alignment and structure |
|
| >pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283 | Back alignment and structure |
|
| >pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304 | Back alignment and structure |
|
| >pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296 | Back alignment and structure |
|
| >pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276 | Back alignment and structure |
|
| >pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346 | Back alignment and structure |
|
| >pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318 | Back alignment and structure |
|
| >pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316 | Back alignment and structure |
|
| >pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304 | Back alignment and structure |
|
| >pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301 | Back alignment and structure |
|
| >pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303 | Back alignment and structure |
|
| >pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325 | Back alignment and structure |
|
| >pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294 | Back alignment and structure |
|
| >pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321 | Back alignment and structure |
|
| >pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281 | Back alignment and structure |
|
| >pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423 | Back alignment and structure |
|
| >pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276 | Back alignment and structure |
|
| >pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304 | Back alignment and structure |
|
| >pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281 | Back alignment and structure |
|
| >pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282 | Back alignment and structure |
|
| >pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656 | Back alignment and structure |
|
| >pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327 | Back alignment and structure |
|
| >pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329 | Back alignment and structure |
|
| >pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330 | Back alignment and structure |
|
| >pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337 | Back alignment and structure |
|
| >pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287 | Back alignment and structure |
|
| >pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271 | Back alignment and structure |
|
| >pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317 | Back alignment and structure |
|
| >pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272 | Back alignment and structure |
|
| >pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273 | Back alignment and structure |
|
| >pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302 | Back alignment and structure |
|
| >pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285 | Back alignment and structure |
|
| >pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288 | Back alignment and structure |
|
| >pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656 | Back alignment and structure |
|
| >pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338 | Back alignment and structure |
|
| >pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323 | Back alignment and structure |
|
| >pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329 | Back alignment and structure |
|
| >pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303 | Back alignment and structure |
|
| >pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271 | Back alignment and structure |
|
| >pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304 | Back alignment and structure |
|
| >pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277 | Back alignment and structure |
|
| >pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277 | Back alignment and structure |
|
| >pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331 | Back alignment and structure |
|
| >pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265 | Back alignment and structure |
|
| >pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289 | Back alignment and structure |
|
| >pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301 | Back alignment and structure |
|
| >pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377 | Back alignment and structure |
|
| >pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321 | Back alignment and structure |
|
| >pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328 | Back alignment and structure |
|
| >pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329 | Back alignment and structure |
|
| >pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297 | Back alignment and structure |
|
| >pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334 | Back alignment and structure |
|
| >pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329 | Back alignment and structure |
|
| >pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276 | Back alignment and structure |
|
| >pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331 | Back alignment and structure |
|
| >pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316 | Back alignment and structure |
|
| >pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286 | Back alignment and structure |
|
| >pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328 | Back alignment and structure |
|
| >pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286 | Back alignment and structure |
|
| >pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327 | Back alignment and structure |
|
| >pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286 | Back alignment and structure |
|
| >pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377 | Back alignment and structure |
|
| >pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289 | Back alignment and structure |
|
| >pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327 | Back alignment and structure |
|
| >pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329 | Back alignment and structure |
|
| >pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677 | Back alignment and structure |
|
| >pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334 | Back alignment and structure |
|
| >pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676 | Back alignment and structure |
|
| >pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353 | Back alignment and structure |
|
| >pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352 | Back alignment and structure |
|
| >pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333 | Back alignment and structure |
|
| >pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279 | Back alignment and structure |
|
| >pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330 | Back alignment and structure |
|
| >pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311 | Back alignment and structure |
|
| >pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315 | Back alignment and structure |
|
| >pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311 | Back alignment and structure |
|
| >pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286 | Back alignment and structure |
|
| >pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302 | Back alignment and structure |
|
| >pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327 | Back alignment and structure |
|
| >pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331 | Back alignment and structure |
|
| >pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311 | Back alignment and structure |
|
| >pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324 | Back alignment and structure |
|
| >pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310 | Back alignment and structure |
|
| >pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382 | Back alignment and structure |
|
| >pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314 | Back alignment and structure |
|
| >pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314 | Back alignment and structure |
|
| >pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311 | Back alignment and structure |
|
| >pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316 | Back alignment and structure |
|
| >pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286 | Back alignment and structure |
|
| >pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309 | Back alignment and structure |
|
| >pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306 | Back alignment and structure |
|
| >pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317 | Back alignment and structure |
|
| >pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353 | Back alignment and structure |
|
| >pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312 | Back alignment and structure |
|
| >pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317 | Back alignment and structure |
|
| >pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311 | Back alignment and structure |
|
| >pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310 | Back alignment and structure |
|
| >pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535 | Back alignment and structure |
|
| >pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311 | Back alignment and structure |
|
| >pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396 | Back alignment and structure |
|
| >pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310 | Back alignment and structure |
|
| >pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290 | Back alignment and structure |
|
| >pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267 | Back alignment and structure |
|
| >pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318 | Back alignment and structure |
|
| >pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289 | Back alignment and structure |
|
| >pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316 | Back alignment and structure |
|
| >pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361 | Back alignment and structure |
|
| >pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313 | Back alignment and structure |
|
| >pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312 | Back alignment and structure |
|
| >pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286 | Back alignment and structure |
|
| >pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277 | Back alignment and structure |
|
| >pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275 | Back alignment and structure |
|
| >pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294 | Back alignment and structure |
|
| >pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286 | Back alignment and structure |
|
| >pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452 | Back alignment and structure |
|
| >pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327 | Back alignment and structure |
|
| >pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292 | Back alignment and structure |
|
| >pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327 | Back alignment and structure |
|
| >pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452 | Back alignment and structure |
|
| >pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311 | Back alignment and structure |
|
| >pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316 | Back alignment and structure |
|
| >pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290 | Back alignment and structure |
|
| >pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286 | Back alignment and structure |
|
| >pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311 | Back alignment and structure |
|
| >pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327 | Back alignment and structure |
|
| >pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452 | Back alignment and structure |
|
| >pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327 | Back alignment and structure |
|
| >pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348 | Back alignment and structure |
|
| >pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279 | Back alignment and structure |
|
| >pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344 | Back alignment and structure |
|
| >pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283 | Back alignment and structure |
|
| >pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279 | Back alignment and structure |
|
| >pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327 | Back alignment and structure |
|
| >pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364 | Back alignment and structure |
|
| >pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325 | Back alignment and structure |
|
| >pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327 | Back alignment and structure |
|
| >pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328 | Back alignment and structure |
|
| >pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286 | Back alignment and structure |
|
| >pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453 | Back alignment and structure |
|
| >pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344 | Back alignment and structure |
|
| >pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345 | Back alignment and structure |
|
| >pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314 | Back alignment and structure |
|
| >pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315 | Back alignment and structure |
|
| >pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324 | Back alignment and structure |
|
| >pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402 | Back alignment and structure |
|
| >pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354 | Back alignment and structure |
|
| >pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334 | Back alignment and structure |
|
| >pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334 | Back alignment and structure |
|
| >pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310 | Back alignment and structure |
|
| >pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313 | Back alignment and structure |
|
| >pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327 | Back alignment and structure |
|
| >pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504 | Back alignment and structure |
|
| >pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319 | Back alignment and structure |
|
| >pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317 | Back alignment and structure |
|
| >pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327 | Back alignment and structure |
|
| >pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311 | Back alignment and structure |
|
| >pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467 | Back alignment and structure |
|
| >pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285 | Back alignment and structure |
|
| >pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350 | Back alignment and structure |
|
| >pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307 | Back alignment and structure |
|
| >pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370 | Back alignment and structure |
|
| >pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576 | Back alignment and structure |
|
| >pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303 | Back alignment and structure |
|
| >pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362 | Back alignment and structure |
|
| >pdb|4EUU|A Chain A, Structure Of Bx-795 Complexed With Human Tbk1 Kinase Domain Phosphorylated On Ser172 Length = 319 | Back alignment and structure |
|
| >pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269 | Back alignment and structure |
|
| >pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284 | Back alignment and structure |
|
| >pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543 | Back alignment and structure |
|
| >pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543 | Back alignment and structure |
|
| >pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282 | Back alignment and structure |
|
| >pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543 | Back alignment and structure |
|
| >pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576 | Back alignment and structure |
|
| >pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543 | Back alignment and structure |
|
| >pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395 | Back alignment and structure |
|
| >pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304 | Back alignment and structure |
|
| >pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328 | Back alignment and structure |
|
| >pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322 | Back alignment and structure |
|
| >pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360 | Back alignment and structure |
|
| >pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406 | Back alignment and structure |
|
| >pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333 | Back alignment and structure |
|
| >pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410 | Back alignment and structure |
|
| >pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285 | Back alignment and structure |
|
| >pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341 | Back alignment and structure |
|
| >pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301 | Back alignment and structure |
|
| >pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415 | Back alignment and structure |
|
| >pdb|4EUT|A Chain A, Structure Of Bx-795 Complexed With Unphosphorylated Human Tbk1 Kinase- Uld Domain Length = 396 | Back alignment and structure |
|
| >pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284 | Back alignment and structure |
|
| >pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304 | Back alignment and structure |
|
| >pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352 | Back alignment and structure |
|
| >pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324 | Back alignment and structure |
|
| >pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | Back alignment and structure |
|
| >pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284 | Back alignment and structure |
|
| >pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286 | Back alignment and structure |
|
| >pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270 | Back alignment and structure |
|
| >pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287 | Back alignment and structure |
|
| >pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286 | Back alignment and structure |
|
| >pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365 | Back alignment and structure |
|
| >pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454 | Back alignment and structure |
|
| >pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486 | Back alignment and structure |
|
| >pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278 | Back alignment and structure |
|
| >pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384 | Back alignment and structure |
|
| >pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332 | Back alignment and structure |
|
| >pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298 | Back alignment and structure |
|
| >pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350 | Back alignment and structure |
|
| >pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293 | Back alignment and structure |
|
| >pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277 | Back alignment and structure |
|
| >pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315 | Back alignment and structure |
|
| >pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343 | Back alignment and structure |
|
| >pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350 | Back alignment and structure |
|
| >pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320 | Back alignment and structure |
|
| >pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507 | Back alignment and structure |
|
| >pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508 | Back alignment and structure |
|
| >pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298 | Back alignment and structure |
|
| >pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351 | Back alignment and structure |
|
| >pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350 | Back alignment and structure |
|
| >pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484 | Back alignment and structure |
|
| >pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292 | Back alignment and structure |
|
| >pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345 | Back alignment and structure |
|
| >pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351 | Back alignment and structure |
|
| >pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327 | Back alignment and structure |
|
| >pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315 | Back alignment and structure |
|
| >pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327 | Back alignment and structure |
|
| >pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350 | Back alignment and structure |
|
| >pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351 | Back alignment and structure |
|
| >pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350 | Back alignment and structure |
|
| >pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350 | Back alignment and structure |
|
| >pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327 | Back alignment and structure |
|
| >pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298 | Back alignment and structure |
|
| >pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327 | Back alignment and structure |
|
| >pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348 | Back alignment and structure |
|
| >pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350 | Back alignment and structure |
|
| >pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371 | Back alignment and structure |
|
| >pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336 | Back alignment and structure |
|
| >pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351 | Back alignment and structure |
|
| >pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351 | Back alignment and structure |
|
| >pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309 | Back alignment and structure |
|
| >pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350 | Back alignment and structure |
|
| >pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351 | Back alignment and structure |
|
| >pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350 | Back alignment and structure |
|
| >pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344 | Back alignment and structure |
|
| >pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327 | Back alignment and structure |
|
| >pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350 | Back alignment and structure |
|
| >pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360 | Back alignment and structure |
|
| >pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350 | Back alignment and structure |
|
| >pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344 | Back alignment and structure |
|
| >pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367 | Back alignment and structure |
|
| >pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494 | Back alignment and structure |
|
| >pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353 | Back alignment and structure |
|
| >pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315 | Back alignment and structure |
|
| >pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351 | Back alignment and structure |
|
| >pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373 | Back alignment and structure |
|
| >pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335 | Back alignment and structure |
|
| >pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351 | Back alignment and structure |
|
| >pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350 | Back alignment and structure |
|
| >pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350 | Back alignment and structure |
|
| >pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339 | Back alignment and structure |
|
| >pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313 | Back alignment and structure |
|
| >pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351 | Back alignment and structure |
|
| >pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329 | Back alignment and structure |
|
| >pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | Back alignment and structure |
|
| >pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351 | Back alignment and structure |
|
| >pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331 | Back alignment and structure |
|
| >pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334 | Back alignment and structure |
|
| >pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317 | Back alignment and structure |
|
| >pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350 | Back alignment and structure |
|
| >pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276 | Back alignment and structure |
|
| >pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302 | Back alignment and structure |
|
| >pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350 | Back alignment and structure |
|
| >pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293 | Back alignment and structure |
|
| >pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351 | Back alignment and structure |
|
| >pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446 | Back alignment and structure |
|
| >pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326 | Back alignment and structure |
|
| >pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334 | Back alignment and structure |
|
| >pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350 | Back alignment and structure |
|
| >pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371 | Back alignment and structure |
|
| >pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446 | Back alignment and structure |
|
| >pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311 | Back alignment and structure |
|
| >pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313 | Back alignment and structure |
|
| >pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336 | Back alignment and structure |
|
| >pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350 | Back alignment and structure |
|
| >pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350 | Back alignment and structure |
|
| >pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312 | Back alignment and structure |
|
| >pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334 | Back alignment and structure |
|
| >pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337 | Back alignment and structure |
|
| >pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | Back alignment and structure |
|
| >pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295 | Back alignment and structure |
|
| >pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484 | Back alignment and structure |
|
| >pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371 | Back alignment and structure |
|
| >pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317 | Back alignment and structure |
|
| >pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351 | Back alignment and structure |
|
| >pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | Back alignment and structure |
|
| >pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345 | Back alignment and structure |
|
| >pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336 | Back alignment and structure |
|
| >pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285 | Back alignment and structure |
|
| >pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278 | Back alignment and structure |
|
| >pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350 | Back alignment and structure |
|
| >pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350 | Back alignment and structure |
|
| >pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342 | Back alignment and structure |
|
| >pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294 | Back alignment and structure |
|
| >pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295 | Back alignment and structure |
|
| >pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311 | Back alignment and structure |
|
| >pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311 | Back alignment and structure |
|
| >pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335 | Back alignment and structure |
|
| >pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337 | Back alignment and structure |
|
| >pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315 | Back alignment and structure |
|
| >pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674 | Back alignment and structure |
|
| >pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295 | Back alignment and structure |
|
| >pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361 | Back alignment and structure |
|
| >pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325 | Back alignment and structure |
|
| >pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295 | Back alignment and structure |
|
| >pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317 | Back alignment and structure |
|
| >pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350 | Back alignment and structure |
|
| >pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301 | Back alignment and structure |
|
| >pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276 | Back alignment and structure |
|
| >pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350 | Back alignment and structure |
|
| >pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341 | Back alignment and structure |
|
| >pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317 | Back alignment and structure |
|
| >pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317 | Back alignment and structure |
|
| >pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340 | Back alignment and structure |
|
| >pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342 | Back alignment and structure |
|
| >pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336 | Back alignment and structure |
|
| >pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361 | Back alignment and structure |
|
| >pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346 | Back alignment and structure |
|
| >pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318 | Back alignment and structure |
|
| >pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319 | Back alignment and structure |
|
| >pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335 | Back alignment and structure |
|
| >pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292 | Back alignment and structure |
|
| >pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294 | Back alignment and structure |
|
| >pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312 | Back alignment and structure |
|
| >pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283 | Back alignment and structure |
|
| >pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304 | Back alignment and structure |
|
| >pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327 | Back alignment and structure |
|
| >pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301 | Back alignment and structure |
|
| >pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278 | Back alignment and structure |
|
| >pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353 | Back alignment and structure |
|
| >pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373 | Back alignment and structure |
|
| >pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325 | Back alignment and structure |
|
| >pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306 | Back alignment and structure |
|
| >pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299 | Back alignment and structure |
|
| >pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299 | Back alignment and structure |
|
| >pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306 | Back alignment and structure |
|
| >pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299 | Back alignment and structure |
|
| >pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300 | Back alignment and structure |
|
| >pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299 | Back alignment and structure |
|
| >pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298 | Back alignment and structure |
|
| >pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314 | Back alignment and structure |
|
| >pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332 | Back alignment and structure |
|
| >pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309 | Back alignment and structure |
|
| >pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|3A99|A Chain A, Structure Of Pim-1 Kinase Crystallized In The Presence Of P27kip1 Carboxy-Terminal Peptide Length = 320 | Back alignment and structure |
|
| >pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With Ly333531 Length = 312 | Back alignment and structure |
|
| >pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362 | Back alignment and structure |
|
| >pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313 | Back alignment and structure |
|
| >pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433 | Back alignment and structure |
|
| >pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300 | Back alignment and structure |
|
| >pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415 | Back alignment and structure |
|
| >pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313 | Back alignment and structure |
|
| >pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa Length = 300 | Back alignment and structure |
|
| >pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442 | Back alignment and structure |
|
| >pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Naphtho-Difuran Ligand Length = 313 | Back alignment and structure |
|
| >pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314 | Back alignment and structure |
|
| >pdb|2OBJ|A Chain A, Crystal Structure Of Human Pim-1 Kinase In Complex With Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292 | Back alignment and structure |
|
| >pdb|2XIX|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-1 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298 | Back alignment and structure |
|
| >pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261 Length = 313 | Back alignment and structure |
|
| >pdb|3DCV|A Chain A, Crystal Structure Of Human Pim1 Kinase Complexed With 4-(4- Hydroxy-3-Methyl-Phenyl)-6-Phenylpyrimidin-2(1h)-One Length = 328 | Back alignment and structure |
|
| >pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349 | Back alignment and structure |
|
| >pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313 | Back alignment and structure |
|
| >pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And The Jnk Inhibitor V Length = 314 | Back alignment and structure |
|
| >pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360 | Back alignment and structure |
|
| >pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362 | Back alignment and structure |
|
| >pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326 | Back alignment and structure |
|
| >pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308 | Back alignment and structure |
|
| >pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275 | Back alignment and structure |
|
| >pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353 | Back alignment and structure |
|
| >pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274 | Back alignment and structure |
|
| >pdb|3KMW|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Mgatp) Length = 271 | Back alignment and structure |
|
| >pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336 | Back alignment and structure |
|
| >pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398 | Back alignment and structure |
|
| >pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382 | Back alignment and structure |
|
| >pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371 | Back alignment and structure |
|
| >pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271 | Back alignment and structure |
|
| >pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350 | Back alignment and structure |
|
| >pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350 | Back alignment and structure |
|
| >pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360 | Back alignment and structure |
|
| >pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362 | Back alignment and structure |
|
| >pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352 | Back alignment and structure |
|
| >pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367 | Back alignment and structure |
|
| >pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299 | Back alignment and structure |
|
| >pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300 | Back alignment and structure |
|
| >pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430 | Back alignment and structure |
|
| >pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289 | Back alignment and structure |
|
| >pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378 | Back alignment and structure |
|
| >pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303 | Back alignment and structure |
|
| >pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296 | Back alignment and structure |
|
| >pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298 | Back alignment and structure |
|
| >pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299 | Back alignment and structure |
|
| >pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298 | Back alignment and structure |
|
| >pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689 | Back alignment and structure |
|
| >pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299 | Back alignment and structure |
|
| >pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695 | Back alignment and structure |
|
| >pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298 | Back alignment and structure |
|
| >pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689 | Back alignment and structure |
|
| >pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297 | Back alignment and structure |
|
| >pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351 | Back alignment and structure |
|
| >pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688 | Back alignment and structure |
|
| >pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313 | Back alignment and structure |
|
| >pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350 | Back alignment and structure |
|
| >pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391 | Back alignment and structure |
|
| >pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420 | Back alignment and structure |
|
| >pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414 | Back alignment and structure |
|
| >pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | Back alignment and structure |
|
| >pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424 | Back alignment and structure |
|
| >pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465 | Back alignment and structure |
|
| >pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360 | Back alignment and structure |
|
| >pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322 | Back alignment and structure |
|
| >pdb|3GOK|A Chain A, Binding Site Mapping Of Protein Ligands Length = 334 | Back alignment and structure |
|
| >pdb|2VD5|A Chain A, Structure Of Human Myotonic Dystrophy Protein Kinase In Complex With The Bisindoylmaleide Inhibitor Bim Viii Length = 412 | Back alignment and structure |
|
| >pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360 | Back alignment and structure |
|
| >pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476 | Back alignment and structure |
|
| >pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340 | Back alignment and structure |
|
| >pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300 | Back alignment and structure |
|
| >pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360 | Back alignment and structure |
|
| >pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302 | Back alignment and structure |
|
| >pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364 | Back alignment and structure |
|
| >pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|3R2B|A Chain A, Mk2 Kinase Bound To Compound 5b Length = 318 | Back alignment and structure |
|
| >pdb|4FVP|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain (Apo Form) Length = 289 | Back alignment and structure |
|
| >pdb|1KWP|A Chain A, Crystal Structure Of Mapkap2 Length = 400 | Back alignment and structure |
|
| >pdb|3R2Y|A Chain A, Mk2 Kinase Bound To Compound 1 Length = 319 | Back alignment and structure |
|
| >pdb|2ONL|C Chain C, Crystal Structure Of The P38a-Mapkap Kinase 2 Heterodimer Length = 406 | Back alignment and structure |
|
| >pdb|2JBO|A Chain A, Protein Kinase Mk2 In Complex With An Inhibitor (Crystal Form-1, Soaking) Length = 326 | Back alignment and structure |
|
| >pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|2OZA|A Chain A, Structure Of P38alpha Complex Length = 356 | Back alignment and structure |
|
| >pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437 | Back alignment and structure |
|
| >pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349 | Back alignment and structure |
|
| >pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358 | Back alignment and structure |
|
| >pdb|4FVR|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain Mutant V617f (Mg- Atp-Bound Form) Length = 289 | Back alignment and structure |
|
| >pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | Back alignment and structure |
|
| >pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360 | Back alignment and structure |
|
| >pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|2PZY|A Chain A, Structure Of Mk2 Complexed With Compound 76 Length = 324 | Back alignment and structure |
|
| >pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366 | Back alignment and structure |
|
| >pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357 | Back alignment and structure |
|
| >pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364 | Back alignment and structure |
|
| >pdb|3FPM|A Chain A, Crystal Structure Of A Squarate Inhibitor Bound To Mapkap Kinase-2 Length = 325 | Back alignment and structure |
|
| >pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317 | Back alignment and structure |
|
| >pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368 | Back alignment and structure |
|
| >pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368 | Back alignment and structure |
|
| >pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364 | Back alignment and structure |
|
| >pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|2P3G|X Chain X, Crystal Structure Of A Pyrrolopyridine Inhibitor Bound To Mapkap Kinase-2 Length = 327 | Back alignment and structure |
|
| >pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388 | Back alignment and structure |
|
| >pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330 | Back alignment and structure |
|
| >pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342 | Back alignment and structure |
|
| >pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356 | Back alignment and structure |
|
| >pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288 | Back alignment and structure |
|
| >pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346 | Back alignment and structure |
|
| >pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321 | Back alignment and structure |
|
| >pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368 | Back alignment and structure |
|
| >pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321 | Back alignment and structure |
|
| >pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444 | Back alignment and structure |
|
| >pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350 | Back alignment and structure |
|
| >pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311 | Back alignment and structure |
|
| >pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335 | Back alignment and structure |
|
| >pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293 | Back alignment and structure |
|
| >pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382 | Back alignment and structure |
|
| >pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350 | Back alignment and structure |
|
| >pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352 | Back alignment and structure |
|
| >pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355 | Back alignment and structure |
|
| >pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419 | Back alignment and structure |
|
| >pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323 | Back alignment and structure |
|
| >pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371 | Back alignment and structure |
|
| >pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443 | Back alignment and structure |
|
| >pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320 | Back alignment and structure |
|
| >pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322 | Back alignment and structure |
|
| >pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323 | Back alignment and structure |
|
| >pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322 | Back alignment and structure |
|
| >pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369 | Back alignment and structure |
|
| >pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364 | Back alignment and structure |
|
| >pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329 | Back alignment and structure |
|
| >pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324 | Back alignment and structure |
|
| >pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361 | Back alignment and structure |
|
| >pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353 | Back alignment and structure |
|
| >pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|3KA0|A Chain A, Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4-Ylamino)-2- Hydroxyphenyl)-N-Methylbenzo[b]thiophene-2-Carboxamide Length = 320 | Back alignment and structure |
|
| >pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|1NXK|A Chain A, Crystal Structure Of Staurosporine Bound To Map Kap Kinase 2 Length = 400 | Back alignment and structure |
|
| >pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331 | Back alignment and structure |
|
| >pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379 | Back alignment and structure |
|
| >pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331 | Back alignment and structure |
|
| >pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290 | Back alignment and structure |
|
| >pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288 | Back alignment and structure |
|
| >pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329 | Back alignment and structure |
|
| >pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351 | Back alignment and structure |
|
| >pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target Of Aberrant Somatic Hypermutations In Diffuse Large Cell Lymphoma Length = 293 | Back alignment and structure |
|
| >pdb|3E3P|A Chain A, Glycogen Synthase Kinase From Leishmania Major Length = 360 | Back alignment and structure |
|
| >pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316 | Back alignment and structure |
|
| >pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342 | Back alignment and structure |
|
| >pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As Potent Pim-1 Inhibitors Length = 299 | Back alignment and structure |
|
| >pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307 | Back alignment and structure |
|
| >pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As Potent, Highly Selective And Orally Bioavailable Pim Kinases Inhibitors Length = 294 | Back alignment and structure |
|
| >pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373 | Back alignment and structure |
|
| >pdb|4A7C|A Chain A, Crystal Structure Of Pim1 Kinase With Etp46546 Length = 308 | Back alignment and structure |
|
| >pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356 | Back alignment and structure |
|
| >pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464 | Back alignment and structure |
|
| >pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364 | Back alignment and structure |
|
| >pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386 | Back alignment and structure |
|
| >pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423 | Back alignment and structure |
|
| >pdb|4AS0|A Chain A, Cyclometalated Phthalimides As Protein Kinase Inhibitors Length = 273 | Back alignment and structure |
|
| >pdb|3C4E|A Chain A, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7- Azaindole Length = 273 | Back alignment and structure |
|
| >pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355 | Back alignment and structure |
|
| >pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362 | Back alignment and structure |
|
| >pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363 | Back alignment and structure |
|
| >pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364 | Back alignment and structure |
|
| >pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356 | Back alignment and structure |
|
| >pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356 | Back alignment and structure |
|
| >pdb|4DTK|A Chain A, Novel And Selective Pan-Pim Kinase Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365 | Back alignment and structure |
|
| >pdb|4ALU|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|1YHS|A Chain A, Crystal Structure Of Pim-1 Bound To Staurosporine Length = 273 | Back alignment and structure |
|
| >pdb|3FHR|A Chain A, High Resolution Crystal Structure Of Mitogen-Activated Protein Kinase-Activated Protein Kinase 3 (Mk3)-Inhibitor Complex Length = 336 | Back alignment and structure |
|
| >pdb|3R1N|A Chain A, Mk3 Kinase Bound To Compound 5b Length = 317 | Back alignment and structure |
|
| >pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306 | Back alignment and structure |
|
| >pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371 | Back alignment and structure |
|
| >pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309 | Back alignment and structure |
|
| >pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303 | Back alignment and structure |
|
| >pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342 | Back alignment and structure |
|
| >pdb|3KMU|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Apo) Length = 271 | Back alignment and structure |
|
| >pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353 | Back alignment and structure |
|
| >pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387 | Back alignment and structure |
|
| >pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330 | Back alignment and structure |
|
| >pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369 | Back alignment and structure |
|
| >pdb|2H34|A Chain A, Apoenzyme Crystal Structure Of The Tuberculosis SerineTHREONINE Kinase, Pkne Length = 309 | Back alignment and structure |
|
| >pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301 | Back alignment and structure |
|
| >pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358 | Back alignment and structure |
|
| >pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337 | Back alignment and structure |
|
| >pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316 | Back alignment and structure |
|
| >pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353 | Back alignment and structure |
|
| >pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361 | Back alignment and structure |
|
| >pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367 | Back alignment and structure |
|
| >pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351 | Back alignment and structure |
|
| >pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | Back alignment and structure |
|
| >pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573 | Back alignment and structure |
|
| >pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290 | Back alignment and structure |
|
| >pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353 | Back alignment and structure |
|
| >pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491 | Back alignment and structure |
|
| >pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370 | Back alignment and structure |
|
| >pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365 | Back alignment and structure |
|
| >pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365 | Back alignment and structure |
|
| >pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394 | Back alignment and structure |
|
| >pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327 | Back alignment and structure |
|
| >pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370 | Back alignment and structure |
|
| >pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366 | Back alignment and structure |
|
| >pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370 | Back alignment and structure |
|
| >pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370 | Back alignment and structure |
|
| >pdb|3E3B|X Chain X, Crystal Structure Of Catalytic Subunit Of Human Protein Kinase Ck2alpha Prime With A Potent Indazole-Derivative Inhibitor Length = 339 | Back alignment and structure |
|
| >pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345 | Back alignment and structure |
|
| >pdb|3OFM|A Chain A, Structure Of A Human Ck2alpha Prime, The Paralog Isoform Of The Catalytic Subunit Of Protein Kinase Ck2 From Homo Sapiens Length = 350 | Back alignment and structure |
|
| >pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379 | Back alignment and structure |
|
| >pdb|3LLT|A Chain A, Crystal Structure Of Pf14_0431, Kinase Domain Length = 360 | Back alignment and structure |
|
| >pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380 | Back alignment and structure |
|
| >pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354 | Back alignment and structure |
|
| >pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351 | Back alignment and structure |
|
| >pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348 | Back alignment and structure |
|
| >pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367 | Back alignment and structure |
|
| >pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372 | Back alignment and structure |
|
| >pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362 | Back alignment and structure |
|
| >pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350 | Back alignment and structure |
|
| >pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360 | Back alignment and structure |
|
| >pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372 | Back alignment and structure |
|
| >pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362 | Back alignment and structure |
|
| >pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379 | Back alignment and structure |
|
| >pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360 | Back alignment and structure |
|
| >pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365 | Back alignment and structure |
|
| >pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370 | Back alignment and structure |
|
| >pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360 | Back alignment and structure |
|
| >pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362 | Back alignment and structure |
|
| >pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348 | Back alignment and structure |
|
| >pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348 | Back alignment and structure |
|
| >pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366 | Back alignment and structure |
|
| >pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366 | Back alignment and structure |
|
| >pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432 | Back alignment and structure |
|
| >pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359 | Back alignment and structure |
|
| >pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354 | Back alignment and structure |
|
| >pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305 | Back alignment and structure |
|
| >pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348 | Back alignment and structure |
|
| >pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353 | Back alignment and structure |
|
| >pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305 | Back alignment and structure |
|
| >pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337 | Back alignment and structure |
|
| >pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360 | Back alignment and structure |
|
| >pdb|1NA7|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 Length = 329 | Back alignment and structure |
|
| >pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277 | Back alignment and structure |
|
| >pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294 | Back alignment and structure |
|
| >pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389 | Back alignment and structure |
|
| >pdb|1TKI|A Chain A, Autoinhibited Serine Kinase Domain Of The Giant Muscle Protein Titin Length = 321 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST
Original result of RPS-BLAST against PDB70 database
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 325 bits (836), Expect = e-107
Identities = 101/301 (33%), Positives = 162/301 (53%), Gaps = 19/301 (6%)
Query: 266 LASTEGTIEKTKLFTSKELEKATDNFDLNRILGQGG--------------QAVKKSKVID 311
L+S+ ++ +LE+AT+NFD ++G G A+K+
Sbjct: 16 LSSSYLVPFESYRVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPES 75
Query: 312 ESKVEEFINEVVILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGTLFQYIHDQNED-FP 370
+EEF E+ LS H ++V L+G C E +L+Y+++ NG L ++++ +
Sbjct: 76 SQGIEEFETEIETLSFCRHPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYGSDLPTMS 135
Query: 371 ITWEIRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAV- 429
++WE RL I I + L YLH+ I HRD+KS NILLD+ + K++DFG S+
Sbjct: 136 MSWEQRLEICIGAARGLHYLHTR---AIIHRDVKSINILLDENFVPKITDFGISKKGTEL 192
Query: 430 DQTHMTTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLTELLTGEKPIRFTILEEDKSL 489
DQTH++T V GT GY+DPEYF + T+KSDVYSFGVVL E+L I ++ E +L
Sbjct: 193 DQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNL 252
Query: 490 AAYFLCAMKEERLFEILDARVMKQGGKDEIITVAKLAKRCLNLNGKKRPTMREVASELAG 549
A + + + +L +I+D + + + + A +CL L+ + RP+M +V +L
Sbjct: 253 AEWAVESHNNGQLEQIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLEY 312
Query: 550 I 550
Sbjct: 313 A 313
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326 | Back alignment and structure |
|---|
Score = 303 bits (779), Expect = 5e-99
Identities = 99/292 (33%), Positives = 160/292 (54%), Gaps = 18/292 (6%)
Query: 276 TKLFTSKELEKATDNFDLNRILGQGG--------------QAVKKSKVIDESKVE-EFIN 320
K F+ +EL+ A+DNF ILG+GG AVK+ K E +F
Sbjct: 17 LKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGELQFQT 76
Query: 321 EVVILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGTLFQYIHDQNED-FPITWEIRLRI 379
EV ++S HRN+++L G C+ LLVY ++ NG++ + ++ E P+ W R RI
Sbjct: 77 EVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRI 136
Query: 380 AIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVH 439
A+ + L+YLH I HRD+K+ NILLD+++ A V DFG ++ M TH+TT V
Sbjct: 137 ALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVR 196
Query: 440 GTFGYLDPEYFRSSQFTDKSDVYSFGVVLTELLTGEKPIRFTIL--EEDKSLAAYFLCAM 497
GT G++ PEY + + ++K+DV+ +GV+L EL+TG++ L ++D L + +
Sbjct: 197 GTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLL 256
Query: 498 KEERLFEILDARVMKQGGKDEIITVAKLAKRCLNLNGKKRPTMREVASELAG 549
KE++L ++D + +E+ + ++A C + +RP M EV L G
Sbjct: 257 KEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEG 308
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 300 bits (771), Expect = 4e-98
Identities = 96/310 (30%), Positives = 158/310 (50%), Gaps = 32/310 (10%)
Query: 268 STEGTIEKTKLFTSKELEKATDNFD------LNRILGQGG-------------QAVKKSK 308
S E + + F+ EL+ T+NFD +G+GG AVKK
Sbjct: 4 SLEVSDTRFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVNNTTVAVKKLA 63
Query: 309 VIDESKV----EEFINEVVILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGTLFQYIHD 364
+ + ++F E+ ++++ H N+V+LLG + + LVY ++PNG+L +
Sbjct: 64 AMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSC 123
Query: 365 QNEDFPITWEIRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGAS 424
+ P++W +R +IA + +++LH I HRDIKS NILLD+ + AK+SDFG +
Sbjct: 124 LDGTPPLSWHMRCKIAQGAANGINFLHENHHI---HRDIKSANILLDEAFTAKISDFGLA 180
Query: 425 RSMAV-DQTHMTTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLTELLTGEKPIRFTIL 483
R+ QT MT+++ GT Y+ PE R + T KSD+YSFGVVL E++TG +
Sbjct: 181 RASEKFAQTVMTSRIVGTTAYMAPEALR-GEITPKSDIYSFGVVLLEIITGLPAVDEH-- 237
Query: 484 EEDKSLAAYFLCAMKEER-LFEILDARVMKQGGKDEIITVAKLAKRCLNLNGKKRPTMRE 542
E + L EE+ + + +D + M + + +A +CL+ KRP +++
Sbjct: 238 REPQLLLDIKEEIEDEEKTIEDYIDKK-MNDADSTSVEAMYSVASQCLHEKKNKRPDIKK 296
Query: 543 VASELAGIKA 552
V L + A
Sbjct: 297 VQQLLQEMTA 306
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 222 bits (568), Expect = 8e-68
Identities = 61/309 (19%), Positives = 115/309 (37%), Gaps = 43/309 (13%)
Query: 279 FTSKELEKATDNFDLNRILGQG-----------GQ--AVKKSKVIDESKVEEFINEVVIL 325
++ L + L + +G + AVK + D+ + EV L
Sbjct: 14 LGTENLYFQSMPLQLLEVKARGRFGCVWKAQLLNEYVAVKIFPIQDKQS-WQNEYEVYSL 72
Query: 326 SQINHRNVVKLLGCCLETEVP----LLVYEFIPNGTLFQYIHDQNEDFPITWEIRLRIAI 381
+ H N+++ +G L+ F G+L ++ ++W IA
Sbjct: 73 PGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFLKAN----VVSWNELCHIAE 128
Query: 382 EVSGALSYLHSAASI-------PIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTH- 433
++ L+YLH I HRDIKS N+LL + A ++DFG + ++
Sbjct: 129 TMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEAGKSAG 188
Query: 434 -MTTQVHGTFGYLDPEYFRSS-----QFTDKSDVYSFGVVLTELLTGEKPIRFTILE--- 484
QV GT Y+ PE + + D+Y+ G+VL EL + + E
Sbjct: 189 DTHGQV-GTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYML 247
Query: 485 --EDKSLAAYFLCAMKEERLFEILDARVMKQGGKDEII-TVAKLAKRCLNLNGKKRPTMR 541
E++ L M+E + + + K + + + + C + + + R +
Sbjct: 248 PFEEEIGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAG 307
Query: 542 EVASELAGI 550
V + +
Sbjct: 308 CVGERITQM 316
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 221 bits (564), Expect = 2e-67
Identities = 77/282 (27%), Positives = 122/282 (43%), Gaps = 42/282 (14%)
Query: 289 DNFDLNRILGQGGQ-------------AVKKSKV--IDESKVEEFINEVVILSQINHRNV 333
+ ++ +G G AVK +V EF+ EV I+ ++ H N+
Sbjct: 37 CDLNIKEKIGAGSFGTVHRAEWHGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNI 96
Query: 334 VKLLGCCLETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEIRLRIAIEVSGALSYLHSA 393
V +G + +V E++ G+L++ +H + RL +A +V+ ++YLH+
Sbjct: 97 VLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHN- 155
Query: 394 ASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHGTFGYLDPEYFRSS 453
+ PI HR++KS N+L+D KY KV DFG SR A + GT ++ PE R
Sbjct: 156 RNPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKASTFLSSKSAA-GTPEWMAPEVLRDE 214
Query: 454 QFTDKSDVYSFGVVLTELLTGEKPIRFTILEEDKSLAAYFLCAMKEERLFEILDARVMKQ 513
+KSDVYSFGV+L EL T ++P + K +RL
Sbjct: 215 PSNEKSDVYSFGVILWELATLQQP--W---GNLNPAQVVAAVGFKCKRL----------- 258
Query: 514 GGKDEIIT-----VAKLAKRCLNLNGKKRPTMREVASELAGI 550
EI VA + + C KRP+ + L +
Sbjct: 259 ----EIPRNLNPQVAAIIEGCWTNEPWKRPSFATIMDLLRPL 296
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 219 bits (561), Expect = 6e-67
Identities = 74/283 (26%), Positives = 125/283 (44%), Gaps = 48/283 (16%)
Query: 289 DNFDLNRILGQGGQ-------------AVKKSKVIDESKVEEFINEVVILSQINHRNVVK 335
++ ++G+G A+K+ + ES+ + FI E+ LS++NH N+VK
Sbjct: 8 KEIEVEEVVGRGAFGVVCKAKWRAKDVAIKQ--IESESERKAFIVELRQLSRVNHPNIVK 65
Query: 336 LLGCCLETEVPL-LVYEFIPNGTLFQYIHDQNEDFPITWEIRLRIAIEVSGALSYLHSAA 394
L G CL P+ LV E+ G+L+ +H T + ++ S ++YLHS
Sbjct: 66 LYGACLN---PVCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQ 122
Query: 395 SIPIYHRDIKSTNILLDDKYR-AKVSDFGASRSMAVDQTHMTTQVHGTFGYLDPEYFRSS 453
+ HRD+K N+LL K+ DFG + + QTHMT G+ ++ PE F S
Sbjct: 123 PKALIHRDLKPPNLLLVAGGTVLKICDFGTACDI---QTHMTNNK-GSAAWMAPEVFEGS 178
Query: 454 QFTDKSDVYSFGVVLTELLTGEKPIRFTILEEDKSLAAYFLCAMKEERLFEILDARVMKQ 513
+++K DV+S+G++L E++T KP E R
Sbjct: 179 NYSEKCDVFSWGIILWEVITRRKPFD----EIGGPAFRIMWAVHNGTRP----------- 223
Query: 514 GGKDEIIT-----VAKLAKRCLNLNGKKRPTMREVASELAGIK 551
+I + L RC + + +RP+M E+ + +
Sbjct: 224 ----PLIKNLPKPIESLMTRCWSKDPSQRPSMEEIVKIMTHLM 262
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 205 bits (523), Expect = 6e-62
Identities = 81/289 (28%), Positives = 128/289 (44%), Gaps = 57/289 (19%)
Query: 292 DLNRILGQGGQ-------------AVKKSKVIDES----KVEEFINEVVILSQINHRNVV 334
L I+G GG AVK ++ + +E E + + + H N++
Sbjct: 10 TLEEIIGIGGFGKVYRAFWIGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNII 69
Query: 335 KLLGCCLETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEIRLRIAIEVSGALSYLHSAA 394
L G CL+ LV EF G L + + + I +I + A++++ ++YLH A
Sbjct: 70 ALRGVCLKEPNLCLVMEFARGGPLNRVLSGK----RIPPDILVNWAVQIARGMNYLHDEA 125
Query: 395 SIPIYHRDIKSTNILLDDKYR--------AKVSDFGASRSMAVDQTHMTTQVHGTFGYLD 446
+PI HRD+KS+NIL+ K K++DFG +R +T + G + ++
Sbjct: 126 IVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREW--HRTTKMSAA-GAYAWMA 182
Query: 447 PEYFRSSQFTDKSDVYSFGVVLTELLTGEKPIRFTILEEDKSLAAYFLCAMKEERLFEIL 506
PE R+S F+ SDV+S+GV+L ELLTGE P LA + AM + L
Sbjct: 183 PEVIRASMFSKGSDVWSYGVLLWELLTGEVP-----FRGIDGLAVAYGVAMNKLAL---- 233
Query: 507 DARVMKQGGKDEIIT-----VAKLAKRCLNLNGKKRPTMREVASELAGI 550
I + AKL + C N + RP+ + +L I
Sbjct: 234 -----------PIPSTCPEPFAKLMEDCWNPDPHSRPSFTNILDQLTTI 271
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 204 bits (520), Expect = 3e-61
Identities = 82/314 (26%), Positives = 141/314 (44%), Gaps = 61/314 (19%)
Query: 271 GTIEKTKLFTSKELEKATDNFDLNRILGQGGQ---------------AVKKSKVIDES-- 313
G + ++ S+ A + + + +G+GG A+K + D
Sbjct: 1 GAMGGSEFPKSRLPTLADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGE 60
Query: 314 -----KVEEFINEVVILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGTLFQYIHDQNED 368
K +EF EV I+S +NH N+VKL G P +V EF+P G L+ + D+
Sbjct: 61 TEMIEKFQEFQREVFIMSNLNHPNIVKLYGLM--HNPPRMVMEFVPCGDLYHRLLDKAH- 117
Query: 369 FPITWEIRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDK-----YRAKVSDFGA 423
PI W ++LR+ ++++ + Y+ + + PI HRD++S NI L AKV+DFG
Sbjct: 118 -PIKWSVKLRLMLDIALGIEYMQNQ-NPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGL 175
Query: 424 SRSMAVDQTHMTTQVHGTFGYLDPEYF--RSSQFTDKSDVYSFGVVLTELLTGEKPIRFT 481
S+ H + + G F ++ PE +T+K+D YSF ++L +LTGE P F
Sbjct: 176 SQ----QSVHSVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGP--F- 228
Query: 482 ILEEDKSLAAYFLCAMKEERLFEILDARVMKQGGKDEIIT-----VAKLAKRCLNLNGKK 536
+E F+ + ++G + I + + + C + + KK
Sbjct: 229 --DEYSYGKIKFINM-------------IREEGLRPTIPEDCPPRLRNVIELCWSGDPKK 273
Query: 537 RPTMREVASELAGI 550
RP + EL+ +
Sbjct: 274 RPHFSYIVKELSEL 287
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 200 bits (510), Expect = 5e-60
Identities = 55/261 (21%), Positives = 107/261 (40%), Gaps = 40/261 (15%)
Query: 303 AVKKSKV--IDESKVEEFINEVVILSQINHRNVVKLLGCCLETEVPLL--VYEFIPNGTL 358
VK KV K +F E L +H NV+ +LG C P + ++P G+L
Sbjct: 37 VVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPHPTLITHWMPYGSL 96
Query: 359 FQYIHDQNEDFPITWEIRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKV 418
+ +H+ +F + ++ A++++ +++LH+ I + S ++++D+ A++
Sbjct: 97 YNVLHE-GTNFVVDQSQAVKFALDMARGMAFLHTL-EPLIPRHALNSRSVMIDEDMTARI 154
Query: 419 SDFGASRSMAVDQTHMTTQVHGTFGYLDPEYFRSSQ---FTDKSDVYSFGVVLTELLTGE 475
S S ++ ++ PE + +D++SF V+L EL+T E
Sbjct: 155 SMADVKFSF-----QSPGRM-YAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTRE 208
Query: 476 KPIRFTILEEDKSLAAYFLCAMKEERLFEILDARVMKQGGKDEIIT-----VAKLAKRCL 530
P F + ++ A++ R I V+KL K C+
Sbjct: 209 VP--F---ADLSNMEIGMKVALEGLRP---------------TIPPGISPHVSKLMKICM 248
Query: 531 NLNGKKRPTMREVASELAGIK 551
N + KRP + L ++
Sbjct: 249 NEDPAKRPKFDMIVPILEKMQ 269
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 191 bits (488), Expect = 3e-56
Identities = 55/287 (19%), Positives = 106/287 (36%), Gaps = 48/287 (16%)
Query: 292 DLNRILGQGGQ------------AVKKSKV--IDESKVEEFINEVVILSQINHRNVVKLL 337
++ ++G+G A++ + +E +++ F EV+ Q H NVV +
Sbjct: 36 EIGELIGKGRFGQVYHGRWHGEVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFM 95
Query: 338 GCCLETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEIRLRIAIEVSGALSYLHSAASIP 397
G C+ ++ TL+ + D +IA E+ + YLH +
Sbjct: 96 GACMSPPHLAIITSLCKGRTLYSVVRDAKIVLD--VNKTRQIAQEIVKGMGYLH---AKG 150
Query: 398 IYHRDIKSTNILLDDKYRAKVSDFGASRSMAV----DQTHMTTQVHGTFGYLDPEYFRSS 453
I H+D+KS N+ D+ + ++DFG V + +G +L PE R
Sbjct: 151 ILHKDLKSKNVFYDNG-KVVITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQL 209
Query: 454 Q---------FTDKSDVYSFGVVLTELLTGEKPIRFTILEEDKSLAAYFLCAMKEERLFE 504
F+ SDV++ G + EL E P + + A +
Sbjct: 210 SPDTEEDKLPFSKHSDVFALGTIWYELHAREWPF------KTQPAEAIIWQMGTGMKP-N 262
Query: 505 ILDARVMKQGGKDEIITVAKLAKRCLNLNGKKRPTMREVASELAGIK 551
+ + K+ ++ + C ++RPT ++ L +
Sbjct: 263 LSQIGMGKE--------ISDILLFCWAFEQEERPTFTKLMDMLEKLP 301
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 187 bits (477), Expect = 9e-55
Identities = 67/297 (22%), Positives = 120/297 (40%), Gaps = 44/297 (14%)
Query: 303 AVKKSKVIDESKVEEFINEVVILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGTLFQYI 362
+K+ DE F+ EV ++ + H NV+K +G + + + E+I GTL I
Sbjct: 39 VMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRLNFITEYIKGGTLRGII 98
Query: 363 HDQNEDFPITWEIRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFG 422
+ +P W R+ A +++ ++YLH S+ I HRD+ S N L+ + V+DFG
Sbjct: 99 KSMDSQYP--WSQRVSFAKDIASGMAYLH---SMNIIHRDLNSHNCLVRENKNVVVADFG 153
Query: 423 ASRSMAVDQTHMT-------------TQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLT 469
+R M ++T V G ++ PE + +K DV+SFG+VL
Sbjct: 154 LARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLC 213
Query: 470 ELLTGEKPIRFTILEEDKSLAAYFLCAMKEERLFEILDARVMKQGGKDEII------TVA 523
E++ + D + +G D +
Sbjct: 214 EIIGRVNA--------------DPDYLPRTM------DFGLNVRGFLDRYCPPNCPPSFF 253
Query: 524 KLAKRCLNLNGKKRPTMREVASELAGIKAWNGASNVIEEGLEEIDCALGDIYIVANS 580
+ RC +L+ +KRP+ ++ L ++ + LE++D + Y S
Sbjct: 254 PITVRCCDLDPEKRPSFVKLEHWLETLRMHLAGHLPLGPQLEQLDRGFWETYRRGES 310
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 186 bits (475), Expect = 9e-55
Identities = 65/278 (23%), Positives = 119/278 (42%), Gaps = 37/278 (13%)
Query: 289 DNFDLNRILGQGGQ------------AVKKSKV--IDESKVEEFINEVVILSQINHRNVV 334
+ + +G G AVK V +++ F NEV +L + H N++
Sbjct: 24 GQITVGQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNIL 83
Query: 335 KLLGCCLETEVPL-LVYEFIPNGTLFQYIHDQNEDFPITWEIRLRIAIEVSGALSYLHSA 393
+G T L +V ++ +L+ ++H F + + IA + + + YLH+
Sbjct: 84 LFMGYS--TAPQLAIVTQWCEGSSLYHHLHASETKFE--MKKLIDIARQTARGMDYLHA- 138
Query: 394 ASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQ-THMTTQVHGTFGYLDPEYFR- 451
I HRD+KS NI L + K+ DFG + + +H Q+ G+ ++ PE R
Sbjct: 139 --KSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRM 196
Query: 452 --SSQFTDKSDVYSFGVVLTELLTGEKPIRFTILEEDKSLAAYFLCAMKEERLFEILDAR 509
S+ ++ +SDVY+FG+VL EL+TG+ P + + ++ R
Sbjct: 197 QDSNPYSFQSDVYAFGIVLYELMTGQLPY-----SNINNRDQIIEMVGRGSLSPDLSKVR 251
Query: 510 VMKQGGKDEIITVAKLAKRCLNLNGKKRPTMREVASEL 547
+ + +L CL +RP+ + +E+
Sbjct: 252 ------SNCPKRMKRLMAECLKKKRDERPSFPRILAEI 283
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 184 bits (469), Expect = 2e-53
Identities = 64/324 (19%), Positives = 120/324 (37%), Gaps = 62/324 (19%)
Query: 279 FTSKELEKATDNFDLNRILGQG-----------GQ--AVKKSKVIDESKVEEFINEVVI- 324
+ E DN L ++G+G + AVK + + FINE I
Sbjct: 3 AAASEPSLDLDNLKLLELIGRGRYGAVYKGSLDERPVAVKVFSFANR---QNFINEKNIY 59
Query: 325 -LSQINHRNVVKLLGCCLETEVP-----LLVYEFIPNGTLFQYIHDQNEDFPITWEIRLR 378
+ + H N+ + + LLV E+ PNG+L +Y+ W R
Sbjct: 60 RVPLMEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLSLH----TSDWVSSCR 115
Query: 379 IAIEVSGALSYLHSAASI------PIYHRDIKSTNILLDDKYRAKVSDFGASRSMA---- 428
+A V+ L+YLH+ I HRD+ S N+L+ + +SDFG S +
Sbjct: 116 LAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNRL 175
Query: 429 ----VDQTHMTTQVHGTFGYLDPEYFRSS-------QFTDKSDVYSFGVVLTELLTGEKP 477
+ ++V GT Y+ PE + + D+Y+ G++ E+
Sbjct: 176 VRPGEEDNAAISEV-GTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTD 234
Query: 478 IRFTILEEDKSLAAYFLCAMKEERLFEILDARVMKQGGKDEI-----------ITVAKLA 526
+ + +A F + FE + V ++ + + ++ +
Sbjct: 235 LFPGESVPEYQMA--FQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETI 292
Query: 527 KRCLNLNGKKRPTMREVASELAGI 550
+ C + + + R T + +A +
Sbjct: 293 EDCWDQDAEARLTAQXAEERMAEL 316
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 167 bits (425), Expect = 4e-47
Identities = 61/306 (19%), Positives = 112/306 (36%), Gaps = 55/306 (17%)
Query: 289 DNFDLNRILGQG-----------GQ--AVKKSKVIDESKVEEFINE--VVILSQINHRNV 333
+ + +G+G G+ AVK V ++ + E + + H N+
Sbjct: 37 KQIQMVKQIGKGRYGEVWMGKWRGEKVAVK---VFFTTEEASWFRETEIYQTVLMRHENI 93
Query: 334 VKLLGCCLETEVP----LLVYEFIPNGTLFQYIHDQNEDFPITWEIRLRIAIEVSGALSY 389
+ + ++ L+ ++ NG+L+ Y+ + + L++A L +
Sbjct: 94 LGFIAADIKGTGSWTQLYLITDYHENGSLYDYLKST----TLDAKSMLKLAYSSVSGLCH 149
Query: 390 LHSAASI-----PIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTH----MTTQVHG 440
LH+ I HRD+KS NIL+ ++D G + D T+V G
Sbjct: 150 LHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRV-G 208
Query: 441 TFGYLDPE------YFRSSQFTDKSDVYSFGVVLTELLTGEKPIRFTILEEDKSLAAYFL 494
T Y+ PE Q +D+YSFG++L E+ I+EE + Y
Sbjct: 209 TKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVS--GGIVEEYQ--LPYHD 264
Query: 495 CAMKEERLFEILDARVMKQ---------GGKDEIITVAKLAKRCLNLNGKKRPTMREVAS 545
+ ++ + +K+ + + + KL C N R T V
Sbjct: 265 LVPSDPSYEDMREIVCIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKK 324
Query: 546 ELAGIK 551
LA +
Sbjct: 325 TLAKMS 330
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 164 bits (418), Expect = 2e-46
Identities = 55/278 (19%), Positives = 102/278 (36%), Gaps = 42/278 (15%)
Query: 303 AVKKSKVIDESKVEEFINEVVI--LSQINHRNVVKLLGCCLETEVP----LLVYEFIPNG 356
AVK + + + E + + H N++ + + + L+ + G
Sbjct: 35 AVK---IFSSRDEKSWFRETELYNTVMLRHENILGFIASDMTSRHSSTQLWLITHYHEMG 91
Query: 357 TLFQYIHDQNEDFPITWEIRLRIAIEVSGALSYLHSAASI-----PIYHRDIKSTNILLD 411
+L+ Y+ + LRI + ++ L++LH I HRD+KS NIL+
Sbjct: 92 SLYDYLQLT----TLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVK 147
Query: 412 DKYRAKVSDFGASR----SMAVDQTHMTTQVHGTFGYLDPE------YFRSSQFTDKSDV 461
+ ++D G + S +V GT Y+ PE + D+
Sbjct: 148 KNGQCCIADLGLAVMHSQSTNQLDVGNNPRV-GTKRYMAPEVLDETIQVDCFDSYKRVDI 206
Query: 462 YSFGVVLTELLTGEKPIRFTILEEDKSLAAYFLCAMKEERLFEILDARVMKQ-------- 513
++FG+VL E+ I+E+ K ++ + ++ + Q
Sbjct: 207 WAFGLVLWEVARRMVS--NGIVEDYK--PPFYDVVPNDPSFEDMRKVVCVDQQRPNIPNR 262
Query: 514 GGKDEII-TVAKLAKRCLNLNGKKRPTMREVASELAGI 550
D + ++AKL K C N R T + L I
Sbjct: 263 WFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLTKI 300
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 161 bits (408), Expect = 1e-44
Identities = 51/279 (18%), Positives = 104/279 (37%), Gaps = 42/279 (15%)
Query: 303 AVKKSKVIDESKVEEFINE--VVILSQINHRNVVKLLGCCLETEVP----LLVYEFIPNG 356
AVK + + + E + + H N++ + + LV ++ +G
Sbjct: 69 AVK---IFSSREERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSDYHEHG 125
Query: 357 TLFQYIHDQNEDFPITWEIRLRIAIEVSGALSYLHSAAS-----IPIYHRDIKSTNILLD 411
+LF Y++ +T E +++A+ + L++LH I HRD+KS NIL+
Sbjct: 126 SLFDYLNRY----TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVK 181
Query: 412 DKYRAKVSDFGASR----SMAVDQTHMTTQVHGTFGYLDPEYFRSS------QFTDKSDV 461
++D G + + +V GT Y+ PE S + ++D+
Sbjct: 182 KNGTCCIADLGLAVRHDSATDTIDIAPNHRV-GTKRYMAPEVLDDSINMKHFESFKRADI 240
Query: 462 YSFGVVLTELLTGEKPIRFTILEEDKSLAAYFLCAMKEERLFEILDARVMKQ-------- 513
Y+ G+V E+ + Y+ + + E+ ++
Sbjct: 241 YAMGLVFWEIARRCSIGG----IHEDYQLPYYDLVPSDPSVEEMRKVVCEQKLRPNIPNR 296
Query: 514 -GGKDEIITVAKLAKRCLNLNGKKRPTMREVASELAGIK 551
+ + +AK+ + C NG R T + L+ +
Sbjct: 297 WQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLS 335
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 139 bits (352), Expect = 2e-37
Identities = 71/277 (25%), Positives = 118/277 (42%), Gaps = 39/277 (14%)
Query: 289 DNFDLNRILGQG--GQAVK---KS-------KVID-----ESKVEEFINEVVILSQINHR 331
+++++ +G G G+ K KS K +D E++ + ++EV +L ++ H
Sbjct: 6 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHP 65
Query: 332 NVVKLLGCCLETEVPLL--VYEFIPNGTLFQYI-HDQNEDFPITWEIRLRIAIEVSGALS 388
N+V+ ++ L V E+ G L I E + E LR+ +++ AL
Sbjct: 66 NIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALK 125
Query: 389 YLHS--AASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHGTFGYLD 446
H + HRD+K N+ LD K K+ DFG +R + D + T V GT Y+
Sbjct: 126 ECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKTFV-GTPYYMS 184
Query: 447 PEYFRSSQFTDKSDVYSFGVVLTELLTGEKPIRFTILEEDKSLAAYFLCAMKEERLFEIL 506
PE + +KSD++S G +L EL P F S L E F +
Sbjct: 185 PEQMNRMSYNEKSDIWSLGCLLYELCALMPP--F----TAFSQKE--LAGKIREGKFRRI 236
Query: 507 DARVMKQGGKDEIITVAKLAKRCLNLNGKKRPTMREV 543
R + + ++ R LNL RP++ E+
Sbjct: 237 PYRYSDE--------LNEIITRMLNLKDYHRPSVEEI 265
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 139 bits (352), Expect = 3e-37
Identities = 60/197 (30%), Positives = 94/197 (47%), Gaps = 19/197 (9%)
Query: 286 KATDNFDLNRILGQGGQAVK---KSKVIDESKVEEFINEVVILSQINHRNVVKLLGCCLE 342
A D LN + A+K E ++ F EV SQ++H+N+V ++ E
Sbjct: 29 LAEDTI-LNIKV-----AIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEE 82
Query: 343 TEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEIRLRIAIEVSGALSYLHSAASIPIYHRD 402
+ LV E+I TL +YI P++ + + ++ + + H I HRD
Sbjct: 83 DDCYYLVMEYIEGPTLSEYIE---SHGPLSVDTAINFTNQILDGIKHAHDMR---IVHRD 136
Query: 403 IKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTT--QVHGTFGYLDPEYFRSSQFTDKSD 460
IK NIL+D K+ DFG ++ A+ +T +T V GT Y PE + + +D
Sbjct: 137 IKPQNILIDSNKTLKIFDFGIAK--ALSETSLTQTNHVLGTVQYFSPEQAKGEATDECTD 194
Query: 461 VYSFGVVLTELLTGEKP 477
+YS G+VL E+L GE P
Sbjct: 195 IYSIGIVLYEMLVGEPP 211
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 139 bits (351), Expect = 1e-36
Identities = 65/287 (22%), Positives = 113/287 (39%), Gaps = 38/287 (13%)
Query: 274 EKTKLFTSKELEKATDNFDLNRILGQG--GQAVK---KS-------KVID-----ESKVE 316
L T ++ + + + +G+G G+A+ K I+ + E
Sbjct: 9 SGVDLGTENLYFQSMEKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKERE 68
Query: 317 EFINEVVILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEIR 376
E EV +L+ + H N+V+ E +V ++ G LF+ I+ Q +
Sbjct: 69 ESRREVAVLANMKHPNIVQYRESFEENGSLYIVMDYCEGGDLFKRINAQKGV-LFQEDQI 127
Query: 377 LRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTT 436
L +++ AL ++H I HRDIKS NI L ++ DFG +R +
Sbjct: 128 LDWFVQICLALKHVHDRK---ILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVELARA 184
Query: 437 QVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLTELLTGEKPIRFTILEEDKSLAAYFLCA 496
+ GT YL PE + + +KSD+++ G VL EL T + F E S+ L
Sbjct: 185 CI-GTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHA--F----EAGSMKNLVLKI 237
Query: 497 MKEERLFEILDARVMKQGGKDEIITVAKLAKRCLNLNGKKRPTMREV 543
+ F + + L + N + RP++ +
Sbjct: 238 ISGS--FPPVSLHYSYD--------LRSLVSQLFKRNPRDRPSVNSI 274
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 139 bits (353), Expect = 1e-36
Identities = 68/304 (22%), Positives = 122/304 (40%), Gaps = 59/304 (19%)
Query: 276 TKLFTSKELEKATDNFDLNRILGQG-------GQ--------AVKKSKV-IDESKVEEFI 319
+ + ++ L +G+G G+ AVK + + +F+
Sbjct: 101 HRAVPKDKWVLNHEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFL 160
Query: 320 NEVVILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEIRLRI 379
E IL Q +H N+V+L+G C + + +V E + G ++ + E + + L++
Sbjct: 161 QEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDFLTFL--RTEGARLRVKTLLQM 218
Query: 380 AIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVH 439
+ + + YL S I HRD+ + N L+ +K K+SDFG SR A D + +
Sbjct: 219 VGDAAAGMEYLESKCCI---HRDLAARNCLVTEKNVLKISDFGMSREEA-DGVYAASGGL 274
Query: 440 GTFGY--LDPEYFRSSQFTDKSDVYSFGVVLTELLT-GEKP---------IRFTILEEDK 487
PE +++ +SDV+SFG++L E + G P F +E+
Sbjct: 275 RQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSNQQTREF--VEKGG 332
Query: 488 SLAAYFLCAMKEERLFEILDARVMKQGGKDEIITVAKLAKRCLNLNGKKRPTMREVASEL 547
L LC + +F + M+Q C +RP+ + EL
Sbjct: 333 RLPCPELCP---DAVFRL-----MEQ---------------CWAYEPGQRPSFSTIYQEL 369
Query: 548 AGIK 551
I+
Sbjct: 370 QSIR 373
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 141 bits (357), Expect = 2e-36
Identities = 66/243 (27%), Positives = 106/243 (43%), Gaps = 23/243 (9%)
Query: 253 YFKRNGGLL--LQQELASTEGTIEKTKLFTSKELEKATDNFDLNRILGQG--GQ------ 302
+ GL+ L + E + + LG G G+
Sbjct: 182 HSTVADGLITTLHYPAPKRNKPTIYGVSPNYDKWEMERTDITMKHKLGGGQYGEVYEGVW 241
Query: 303 -------AVKKSKVIDESKVEEFINEVVILSQINHRNVVKLLGCCLETEVPLLVYEFIPN 355
AVK K D +VEEF+ E ++ +I H N+V+LLG C ++ EF+
Sbjct: 242 KKYSLTVAVKTLKE-DTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTY 300
Query: 356 GTLFQYIHDQNEDFPITWEIRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYR 415
G L Y+ + ++ + L +A ++S A+ YL I HR++ + N L+ + +
Sbjct: 301 GNLLDYLRE-CNRQEVSAVVLLYMATQISSAMEYLEKKNFI---HRNLAARNCLVGENHL 356
Query: 416 AKVSDFGASRSMAVDQTHMTTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLTELLT-G 474
KV+DFG SR M D + PE ++F+ KSDV++FGV+L E+ T G
Sbjct: 357 VKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYG 416
Query: 475 EKP 477
P
Sbjct: 417 MSP 419
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 137 bits (346), Expect = 3e-36
Identities = 67/274 (24%), Positives = 115/274 (41%), Gaps = 36/274 (13%)
Query: 289 DNFDLNRILGQG-------------GQ--AVKK---SKVIDESKVEEFINEVVILSQINH 330
NF + + +G+G G A+KK ++D + I E+ +L Q+NH
Sbjct: 32 ANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNH 91
Query: 331 RNVVKLLGCCLETEVPLLVYEFIPNGTLFQYIHDQNEDF-PITWEIRLRIAIEVSGALSY 389
NV+K +E +V E G L + I + I + +++ AL +
Sbjct: 92 PNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEH 151
Query: 390 LHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHGTFGYLDPEY 449
+HS + HRDIK N+ + K+ D G R + T + V GT Y+ PE
Sbjct: 152 MHSRR---VMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLV-GTPYYMSPER 207
Query: 450 FRSSQFTDKSDVYSFGVVLTELLTGEKPIRFTILEEDKSLAAYFLCAMKEERLFEILDAR 509
+ + KSD++S G +L E+ + P F + +L + LC E+ + L +
Sbjct: 208 IHENGYNFKSDIWSLGCLLYEMAALQSP--FY--GDKMNLYS--LCKKIEQCDYPPLPSD 261
Query: 510 VMKQGGKDEIITVAKLAKRCLNLNGKKRPTMREV 543
+ + L C+N + +KRP + V
Sbjct: 262 HYSEELRQ-------LVNMCINPDPEKRPDVTYV 288
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 137 bits (346), Expect = 4e-36
Identities = 64/258 (24%), Positives = 115/258 (44%), Gaps = 28/258 (10%)
Query: 303 AVKKSKVIDESKVEEFINEVVILSQINHRNVVKLLGCCLET-EVPL-LVYEFIPNGTLFQ 360
AVK+ + + +F E+ IL ++ +VK G L LV E++P+G L
Sbjct: 56 AVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRD 115
Query: 361 YIHDQNEDFPITWEIRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSD 420
++ Q + L + ++ + YL S + HRD+ + NIL++ + K++D
Sbjct: 116 FL--QRHRARLDASRLLLYSSQICKGMEYLGSRRCV---HRDLAARNILVESEAHVKIAD 170
Query: 421 FGASRSMAVDQTHMTTQVHGTF--GYLDPEYFRSSQFTDKSDVYSFGVVLTELLT-GEKP 477
FG ++ + +D+ + + G + PE + F+ +SDV+SFGVVL EL T +K
Sbjct: 171 FGLAKLLPLDKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKS 230
Query: 478 IRFTILEEDKSLAAYFLCAMKEERLFEILDARVMKQGGK--------DEIITVAKLAKRC 529
+ E + RL E+L ++G + E V +L K C
Sbjct: 231 --CSPSAEFLRMMGCERDVPALSRLLELL-----EEGQRLPAPPACPAE---VHELMKLC 280
Query: 530 LNLNGKKRPTMREVASEL 547
+ + RP+ + +L
Sbjct: 281 WAPSPQDRPSFSALGPQL 298
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 136 bits (345), Expect = 4e-36
Identities = 74/295 (25%), Positives = 116/295 (39%), Gaps = 50/295 (16%)
Query: 289 DNFDLNRILGQG--GQ-----------------AVKKSKV-IDESKVEEFINEVVILSQI 328
R LG+G G+ AVK K + E+ IL +
Sbjct: 31 RYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTL 90
Query: 329 NHRNVVKLLGCCLETEVP--LLVYEFIPNGTLFQYIHDQNEDFPITWEIRLRIAIEVSGA 386
H +++K GCC + LV E++P G+L Y+ + I L A ++
Sbjct: 91 YHEHIIKYKGCCEDAGAASLQLVMEYVPLGSLRDYLPRHS----IGLAQLLLFAQQICEG 146
Query: 387 LSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHGTF--GY 444
++YLH+ I HRD+ + N+LLD+ K+ DFG ++++ + + G +
Sbjct: 147 MAYLHAQHYI---HRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFW 203
Query: 445 LDPEYFRSSQFTDKSDVYSFGVVLTELLT-GEKPIRFTILEEDKSLAAYFLCAMKEERLF 503
PE + +F SDV+SFGV L ELLT + + A M RL
Sbjct: 204 YAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQ--GQMTVLRLT 261
Query: 504 EILDARVMKQGGK--------DEIITVAKLAKRCLNLNGKKRPTMREVASELAGI 550
E+L ++G + E V L K C RPT + L +
Sbjct: 262 ELL-----ERGERLPRPDKCPAE---VYHLMKNCWETEASFRPTFENLIPILKTV 308
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 135 bits (341), Expect = 2e-35
Identities = 63/314 (20%), Positives = 115/314 (36%), Gaps = 68/314 (21%)
Query: 279 FTSKELEKATDNFDLNRILGQGG---------------QAVKKSKVIDESKVEEFINEVV 323
F + ++ + LG+GG A+K+ ++ EE E
Sbjct: 19 FQGHMVIIDNKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREAD 78
Query: 324 ILSQINHRNVVKLLGCCLETEVP----LLVYEFIPNGTLFQYI---HDQNEDFPITWEIR 376
+ NH N+++L+ CL L+ F GTL+ I D+ +I
Sbjct: 79 MHRLFNHPNILRLVAYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLT-EDQI- 136
Query: 377 LRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFG---------ASRSM 427
L + + + L +H+ HRD+K TNILL D+ + + D G
Sbjct: 137 LWLLLGICRGLEAIHAK---GYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQ 193
Query: 428 AVDQTHMTTQVHGTFGYLDPEYF---RSSQFTDKSDVYSFGVVLTELLTGEKPIRFTILE 484
A+ Q T Y PE F +++DV+S G VL ++ GE P +
Sbjct: 194 ALTLQDWAAQ-RCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGP--Y---- 246
Query: 485 EDKSLAAYFLCAMKEERLFEILDARVMKQGGKDEI-------ITVAKLAKRCLNLNGKKR 537
+ +F+ D+ + + I + +L + ++ +R
Sbjct: 247 ---------------DMVFQKGDSVALAVQNQLSIPQSPRHSSALWQLLNSMMTVDPHQR 291
Query: 538 PTMREVASELAGIK 551
P + + S+L ++
Sbjct: 292 PHIPLLLSQLEALQ 305
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 134 bits (339), Expect = 2e-35
Identities = 71/254 (27%), Positives = 116/254 (45%), Gaps = 19/254 (7%)
Query: 303 AVKKSKVIDESKVEEFINEVVILSQINHRNVVKLLGCCLET-EVPL-LVYEFIPNGTLFQ 360
AVKK + E + +F E+ IL + H N+VK G C L L+ E++P G+L
Sbjct: 43 AVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRD 102
Query: 361 YIHDQNEDFPITWEIRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSD 420
Y+ Q I L+ ++ + YL + I HRD+ + NIL++++ R K+ D
Sbjct: 103 YL--QKHKERIDHIKLLQYTSQICKGMEYLGTKRYI---HRDLATRNILVENENRVKIGD 157
Query: 421 FGASRSMAVDQTHMTTQVHGTF--GYLDPEYFRSSQFTDKSDVYSFGVVLTELLTGEKPI 478
FG ++ + D+ + G + PE S+F+ SDV+SFGVVL EL T +
Sbjct: 158 FGLTKVLPQDKEFFKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKS 217
Query: 479 RFTILEEDKSLAAYFLCAMKEERLFEILDARVMKQGGKDEI-----ITVAKLAKRCLNLN 533
+ E + + M L E+L K G+ + + C N N
Sbjct: 218 KSPPAEFMRMIGNDKQGQMIVFHLIELL-----KNNGRLPRPDGCPDEIYMIMTECWNNN 272
Query: 534 GKKRPTMREVASEL 547
+RP+ R++A +
Sbjct: 273 VNQRPSFRDLALRV 286
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 135 bits (341), Expect = 2e-35
Identities = 72/257 (28%), Positives = 118/257 (45%), Gaps = 19/257 (7%)
Query: 303 AVKKSKVIDESKVEEFINEVVILSQINHRNVVKLLGCCLET-EVPL-LVYEFIPNGTLFQ 360
AVKK + E + +F E+ IL + H N+VK G C L L+ E++P G+L
Sbjct: 74 AVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRD 133
Query: 361 YIHDQNEDFPITWEIRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSD 420
Y+ Q I L+ ++ + YL + I HRD+ + NIL++++ R K+ D
Sbjct: 134 YL--QKHKERIDHIKLLQYTSQICKGMEYLGTKRYI---HRDLATRNILVENENRVKIGD 188
Query: 421 FGASRSMAVDQTHMTTQVHGTF--GYLDPEYFRSSQFTDKSDVYSFGVVLTELLTGEKPI 478
FG ++ + D+ + + G + PE S+F+ SDV+SFGVVL EL T +
Sbjct: 189 FGLTKVLPQDKEYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKS 248
Query: 479 RFTILEEDKSLAAYFLCAMKEERLFEILDARVMKQGGKDEI-----ITVAKLAKRCLNLN 533
+ E + + M L E+L K G+ + + C N N
Sbjct: 249 KSPPAEFMRMIGNDKQGQMIVFHLIELL-----KNNGRLPRPDGCPDEIYMIMTECWNNN 303
Query: 534 GKKRPTMREVASELAGI 550
+RP+ R++A + I
Sbjct: 304 VNQRPSFRDLALRVDQI 320
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 137 bits (347), Expect = 3e-35
Identities = 64/245 (26%), Positives = 116/245 (47%), Gaps = 31/245 (12%)
Query: 252 KYFKRNGGLLLQQ--ELASTEGTIEKTKLFTSKELEKATDNFDLNRILGQG--GQ----- 302
+++ + L + + EGT+ F L + +G+G G
Sbjct: 154 EHYTTDADGLCTRLIKPKVMEGTVAAQDEFYRSGWALNMKELKLLQTIGKGEFGDVMLGD 213
Query: 303 ------AVKKSKVIDESKVEEFINEVVILSQINHRNVVKLLGCCLETEVPL-LVYEFIPN 355
AVK K +++ + F+ E +++Q+ H N+V+LLG +E + L +V E++
Sbjct: 214 YRGNKVAVKCIK--NDATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAK 271
Query: 356 GTLFQYIHDQNEDFPITWEIRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYR 415
G+L Y+ + + L+ +++V A+ YL + HRD+ + N+L+ +
Sbjct: 272 GSLVDYLRS-RGRSVLGGDCLLKFSLDVCEAMEYLEGNNFV---HRDLAARNVLVSEDNV 327
Query: 416 AKVSDFGASRSMAVDQTHMTTQVHGTFGY--LDPEYFRSSQFTDKSDVYSFGVVLTELLT 473
AKVSDFG ++ + +TQ G PE R +F+ KSDV+SFG++L E+ +
Sbjct: 328 AKVSDFGLTKEAS------STQDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYS 381
Query: 474 -GEKP 477
G P
Sbjct: 382 FGRVP 386
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 133 bits (337), Expect = 4e-35
Identities = 66/301 (21%), Positives = 121/301 (40%), Gaps = 69/301 (22%)
Query: 288 TDNFDLNRILGQGG-----QAVKKS-------KVID--ESKVEEFINEVVILSQINHRNV 333
+F+ +LGQG +A K I E K+ ++EV++L+ +NH+ V
Sbjct: 5 ASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTEEKLSTILSEVMLLASLNHQYV 64
Query: 334 VKLLGCCLETEVPL-------------LVYEFIPNGTLFQYIHDQNEDFPITWEIRLRIA 380
V+ LE + + E+ NGTL+ IH +N + E R+
Sbjct: 65 VRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRD-EYW-RLF 122
Query: 381 IEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSM------------- 427
++ ALSY+HS I HRD+K NI +D+ K+ DFG ++++
Sbjct: 123 RQILEALSYIHSQG---IIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQN 179
Query: 428 -AVDQTHMTTQVHGTFGYLDPEYFRSSQFTD-KSDVYSFGVVLTELLTGEKPIRFTILEE 485
++T+ + GT Y+ E + + K D+YS G++ E++
Sbjct: 180 LPGSSDNLTSAI-GTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIYP----------- 227
Query: 486 DKSLAAYFLCAMKEERLFEIL---DARVMKQGGKDEIITVAKLAKRCLNLNGKKRPTMRE 542
F M+ + + L +++ K+ + ++ + KRP R
Sbjct: 228 -------FSTGMERVNILKKLRSVSIEFPPDFDDNKMKVEKKIIRLLIDHDPNKRPGART 280
Query: 543 V 543
+
Sbjct: 281 L 281
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 133 bits (338), Expect = 6e-35
Identities = 48/212 (22%), Positives = 100/212 (47%), Gaps = 30/212 (14%)
Query: 289 DNFDLNRILGQG--GQ-----------------AVKKSKV-IDESKVEEFINEVVILSQI 328
F ++LG G G A+K+ + +E ++E +++ +
Sbjct: 15 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 74
Query: 329 NHRNVVKLLGCCLETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEIRLRIAIEVSGALS 388
++ +V +LLG CL + V L+ + +P G L Y+ + ++ + L ++++ ++
Sbjct: 75 DNPHVCRLLGICLTSTV-QLITQLMPFGCLLDYVREHKDNIGS--QYLLNWCVQIAKGMN 131
Query: 389 YLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHGTF--GYLD 446
YL + HRD+ + N+L+ K++DFG ++ + ++ + G ++
Sbjct: 132 YLEDRRLV---HRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAE-GGKVPIKWMA 187
Query: 447 PEYFRSSQFTDKSDVYSFGVVLTELLT-GEKP 477
E +T +SDV+S+GV + EL+T G KP
Sbjct: 188 LESILHRIYTHQSDVWSYGVTVWELMTFGSKP 219
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 133 bits (336), Expect = 6e-35
Identities = 65/259 (25%), Positives = 115/259 (44%), Gaps = 23/259 (8%)
Query: 303 AVKKSKVI-DESKVEEFINEVVILSQINHRNVVKLLGCCLETEVP--LLVYEFIPNGTLF 359
AVK K + + + E+ IL + H N+VK G C E L+ EF+P+G+L
Sbjct: 54 AVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGIKLIMEFLPSGSLK 113
Query: 360 QYIHDQNEDFPITWEIRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVS 419
+Y+ I + +L+ A+++ + YL S + HRD+ + N+L++ +++ K+
Sbjct: 114 EYL--PKNKNKINLKQQLKYAVQICKGMDYLGSRQYV---HRDLAARNVLVESEHQVKIG 168
Query: 420 DFGASRSMAVDQTHMTTQVHGTF--GYLDPEYFRSSQFTDKSDVYSFGVVLTELLT-GEK 476
DFG ++++ D+ + T + + PE S+F SDV+SFGV L ELLT +
Sbjct: 169 DFGLTKAIETDKEYYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDS 228
Query: 477 PIRFTILEEDKSLAAYFLCAMKEERLFEILDARVMKQGGKDEI-----ITVAKLAKRCLN 531
L + M RL L K+G + V +L ++C
Sbjct: 229 DSSPMALFLKMIGPTH--GQMTVTRLVNTL-----KEGKRLPCPPNCPDEVYQLMRKCWE 281
Query: 532 LNGKKRPTMREVASELAGI 550
R + + + +
Sbjct: 282 FQPSNRTSFQNLIEGFEAL 300
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 132 bits (334), Expect = 6e-35
Identities = 61/225 (27%), Positives = 108/225 (48%), Gaps = 29/225 (12%)
Query: 270 EGTIEKTKLFTSKELEKATDNFDLNRILGQG--GQ-----------AVKKSKVIDESKVE 316
G++ F L + +G+G G AVK K +++ +
Sbjct: 2 GGSVAAQDEFYRSGWALNMKELKLLQTIGKGEFGDVMLGDYRGNKVAVKCIK--NDATAQ 59
Query: 317 EFINEVVILSQINHRNVVKLLGCCLETEVPL-LVYEFIPNGTLFQYIHDQNEDFPITWEI 375
F+ E +++Q+ H N+V+LLG +E + L +V E++ G+L Y+ + +
Sbjct: 60 AFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRS-RGRSVLGGDC 118
Query: 376 RLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMT 435
L+ +++V A+ YL + HRD+ + N+L+ + AKVSDFG ++ + +
Sbjct: 119 LLKFSLDVCEAMEYLEGNNFV---HRDLAARNVLVSEDNVAKVSDFGLTKEAS------S 169
Query: 436 TQVHGTFGY--LDPEYFRSSQFTDKSDVYSFGVVLTELLT-GEKP 477
TQ G PE R +F+ KSDV+SFG++L E+ + G P
Sbjct: 170 TQDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVP 214
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 131 bits (332), Expect = 1e-34
Identities = 66/207 (31%), Positives = 101/207 (48%), Gaps = 25/207 (12%)
Query: 289 DNFDLNRILGQG--GQ-------------AVKKSKVIDESKVEEFINEVVILSQINHRNV 333
+ + LG G G+ AVK K D +VEEF+ E ++ +I H N+
Sbjct: 13 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKE-DTMEVEEFLKEAAVMKEIKHPNL 71
Query: 334 VKLLGCCLETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEIRLRIAIEVSGALSYLHSA 393
V+LLG C ++ EF+ G L Y+ + N ++ + L +A ++S A+ YL
Sbjct: 72 VQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQ-EVSAVVLLYMATQISSAMEYLEKK 130
Query: 394 ASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHGTFGY--LDPEYFR 451
I HRD+ + N L+ + + KV+DFG SR M D T F PE
Sbjct: 131 NFI---HRDLAARNCLVGENHLVKVADFGLSRLMTGDT--YTAHAGAKFPIKWTAPESLA 185
Query: 452 SSQFTDKSDVYSFGVVLTELLT-GEKP 477
++F+ KSDV++FGV+L E+ T G P
Sbjct: 186 YNKFSIKSDVWAFGVLLWEIATYGMSP 212
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 130 bits (330), Expect = 2e-34
Identities = 63/285 (22%), Positives = 113/285 (39%), Gaps = 60/285 (21%)
Query: 289 DNFDLNRILGQG--GQAVK---KS-------KVIDESKVEEFINEVVILSQINHRNVVKL 336
+F ++G G GQ K + K + + E+ EV L++++H N+V
Sbjct: 11 MDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN-EKAEREVKALAKLDHVNIVHY 69
Query: 337 LGCCLETEVPL----------------LVYEFIPNGTLFQYIHDQNEDFPITWEIRLRIA 380
GC + + EF GTL Q+I + + + + L +
Sbjct: 70 NGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGE-KLDKVLALELF 128
Query: 381 IEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHG 440
+++ + Y+HS + +RD+K +NI L D + K+ DFG S+ D ++ G
Sbjct: 129 EQITKGVDYIHSKK---LINRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGKRTRSK--G 183
Query: 441 TFGYLDPEYFRSSQFTDKSDVYSFGVVLTELLTGEKPIRFTILEEDKSLAAYFLCAMKEE 500
T Y+ PE S + + D+Y+ G++L ELL A +
Sbjct: 184 TLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDT------------------AFETS 225
Query: 501 RLFEILDARVMKQGGKDEIIT--VAKLAKRCLNLNGKKRPTMREV 543
+ F L + G +I L ++ L+ + RP E+
Sbjct: 226 KFFTDL-----RDGIISDIFDKKEKTLLQKLLSKKPEDRPNTSEI 265
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 131 bits (332), Expect = 3e-34
Identities = 62/201 (30%), Positives = 91/201 (45%), Gaps = 21/201 (10%)
Query: 286 KATDNFDLNRILGQGGQAVKKSK---VIDESKVEEFINEVVILSQINHRNVVKLL--GC- 339
A D +R + AVK + D S F E + +NH +V + G
Sbjct: 30 LARDLR-DHRDV-----AVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEA 83
Query: 340 -CLETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEIRLRIAIEVSGALSYLHSAASIPI 398
+P +V E++ TL +H + P+T + + + + AL++ H I
Sbjct: 84 ETPAGPLPYIVMEYVDGVTLRDIVH---TEGPMTPKRAIEVIADACQALNFSHQNG---I 137
Query: 399 YHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTT--QVHGTFGYLDPEYFRSSQFT 456
HRD+K NI++ KV DFG +R++A +T V GT YL PE R
Sbjct: 138 IHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVD 197
Query: 457 DKSDVYSFGVVLTELLTGEKP 477
+SDVYS G VL E+LTGE P
Sbjct: 198 ARSDVYSLGCVLYEVLTGEPP 218
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 131 bits (331), Expect = 3e-34
Identities = 42/169 (24%), Positives = 63/169 (37%), Gaps = 10/169 (5%)
Query: 311 DESKVEEFINEVVILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGTLFQYIHDQNEDFP 370
D E ++ +VV + + I L + P
Sbjct: 74 DPVFRTRMQREARTAGRLQEPHVVPIHDFGEIDGQLYVDMRLINGVDLAAMLR---RQGP 130
Query: 371 ITWEIRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVD 430
+ + I ++ AL H+A HRD+K NIL+ A + DFG + A
Sbjct: 131 LAPPRAVAIVRQIGSALDAAHAAG---ATHRDVKPENILVSADDFAYLVDFGIAS--ATT 185
Query: 431 QTHMTT--QVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLTELLTGEKP 477
+T GT Y+ PE F S T ++D+Y+ VL E LTG P
Sbjct: 186 DEKLTQLGNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPP 234
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 130 bits (329), Expect = 4e-34
Identities = 66/211 (31%), Positives = 105/211 (49%), Gaps = 33/211 (15%)
Query: 293 LNRILGQG--GQ----------------AVKKSKVI-DESKVEEFINEVVILSQINHRNV 333
N ++G+G G AVK I D +V +F+ E +I+ +H NV
Sbjct: 29 FNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNV 88
Query: 334 VKLLGCCLETEVPLL-VYEFIPNGTLFQYIHDQNEDFPITWEIRLRIAIEVSGALSYLHS 392
+ LLG CL +E L V ++ +G L +I +NE T + + ++V+ + YL S
Sbjct: 89 LSLLGICLRSEGSPLVVLPYMKHGDLRNFI--RNETHNPTVKDLIGFGLQVAKGMKYLAS 146
Query: 393 AASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHGTFGYL-----DP 447
+ HRD+ + N +LD+K+ KV+DFG +R + + + T L
Sbjct: 147 KKFV---HRDLAARNCMLDEKFTVKVADFGLARD--MYDKEYYSVHNKTGAKLPVKWMAL 201
Query: 448 EYFRSSQFTDKSDVYSFGVVLTELLT-GEKP 477
E ++ +FT KSDV+SFGV+L EL+T G P
Sbjct: 202 ESLQTQKFTTKSDVWSFGVLLWELMTRGAPP 232
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 130 bits (328), Expect = 5e-34
Identities = 54/180 (30%), Positives = 99/180 (55%), Gaps = 12/180 (6%)
Query: 303 AVK--KSKVIDESKVEEFINEVVILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGTLFQ 360
AVK K++ D + +E + E ++ Q+++ +V+++G C E +LV E G L +
Sbjct: 48 AVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAELGPLNK 106
Query: 361 YIHDQNEDFPITWEIRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSD 420
Y+ + + + + +VS + YL + + HRD+ + N+LL ++ AK+SD
Sbjct: 107 YLQQNRH---VKDKNIIELVHQVSMGMKYLEESNFV---HRDLAARNVLLVTQHYAKISD 160
Query: 421 FGASRSMAVDQTHMTTQVHGTF--GYLDPEYFRSSQFTDKSDVYSFGVVLTELLT-GEKP 477
FG S+++ D+ + Q HG + + PE +F+ KSDV+SFGV++ E + G+KP
Sbjct: 161 FGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKP 220
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 129 bits (326), Expect = 6e-34
Identities = 58/206 (28%), Positives = 95/206 (46%), Gaps = 25/206 (12%)
Query: 289 DNFDLNRILGQG--GQ------------AVKKSKVIDESKVEEFINEVVILSQINHRNVV 334
+ L + LG G G AVK K +EF E + +++H +V
Sbjct: 8 EEITLLKELGSGQFGVVKLGKWKGQYDVAVKMIKE-GSMSEDEFFQEAQTMMKLSHPKLV 66
Query: 335 KLLGCCLETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEIRLRIAIEVSGALSYLHSAA 394
K G C + +V E+I NG L Y+ ++ + L + +V +++L S
Sbjct: 67 KFYGVCSKEYPIYIVTEYISNGCLLNYL--RSHGKGLEPSQLLEMCYDVCEGMAFLESHQ 124
Query: 395 SIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHGTFGY--LDPEYFRS 452
I HRD+ + N L+D KVSDFG +R + DQ + V F PE F
Sbjct: 125 FI---HRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQY--VSSVGTKFPVKWSAPEVFHY 179
Query: 453 SQFTDKSDVYSFGVVLTELLT-GEKP 477
+++ KSDV++FG+++ E+ + G+ P
Sbjct: 180 FKYSSKSDVWAFGILMWEVFSLGKMP 205
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 131 bits (332), Expect = 7e-34
Identities = 67/211 (31%), Positives = 104/211 (49%), Gaps = 33/211 (15%)
Query: 293 LNRILGQG--GQ----------------AVKKSKVI-DESKVEEFINEVVILSQINHRNV 333
N ++G+G G AVK I D +V +F+ E +I+ +H NV
Sbjct: 93 FNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNV 152
Query: 334 VKLLGCCLETEVPLL-VYEFIPNGTLFQYIHDQNEDFPITWEIRLRIAIEVSGALSYLHS 392
+ LLG CL +E L V ++ +G L +I +NE T + + ++V+ + +L
Sbjct: 153 LSLLGICLRSEGSPLVVLPYMKHGDLRNFI--RNETHNPTVKDLIGFGLQVAKGMKFL-- 208
Query: 393 AASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHGTFGYL-----DP 447
AS HRD+ + N +LD+K+ KV+DFG +R M + T L
Sbjct: 209 -ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHN--KTGAKLPVKWMAL 265
Query: 448 EYFRSSQFTDKSDVYSFGVVLTELLT-GEKP 477
E ++ +FT KSDV+SFGV+L EL+T G P
Sbjct: 266 ESLQTQKFTTKSDVWSFGVLLWELMTRGAPP 296
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 129 bits (327), Expect = 7e-34
Identities = 54/206 (26%), Positives = 97/206 (47%), Gaps = 25/206 (12%)
Query: 289 DNFDLNRILGQG-------GQAVKKSKV------IDESKVEEFINEVVILSQINHRNVVK 335
+ L LG G G +KV + F+ E ++ Q+ H+ +V+
Sbjct: 13 ETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVR 72
Query: 336 LLGCCLETEVPLL-VYEFIPNGTLFQYIHDQNEDFPITWEIRLRIAIEVSGALSYLHSAA 394
L T+ P+ + E++ NG+L ++ +T L +A +++ ++++
Sbjct: 73 LYAVV--TQEPIYIITEYMENGSLVDFLKT-PSGIKLTINKLLDMAAQIAEGMAFIEERN 129
Query: 395 SIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHGTFGY--LDPEYFRS 452
I HRD+++ NIL+ D K++DFG +R + ++ T + F PE
Sbjct: 130 YI---HRDLRAANILVSDTLSCKIADFGLARLIEDNE--YTAREGAKFPIKWTAPEAINY 184
Query: 453 SQFTDKSDVYSFGVVLTELLT-GEKP 477
FT KSDV+SFG++LTE++T G P
Sbjct: 185 GTFTIKSDVWSFGILLTEIVTHGRIP 210
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 130 bits (328), Expect = 9e-34
Identities = 57/231 (24%), Positives = 104/231 (45%), Gaps = 42/231 (18%)
Query: 282 KELEKATDNFDLNRILGQG--GQ----------------AVK--KSKVIDESKVEEFINE 321
+++ F L R+LG+G G AVK K+ +I S +EEF+ E
Sbjct: 16 EDVLIPEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLRE 75
Query: 322 VVILSQINHRNVVKLLGCCLETE------VPLLVYEFIPNGTLFQYI---HDQNEDFPIT 372
+ + +H +V KL+G L + +P+++ F+ +G L ++ F +
Sbjct: 76 AACMKEFDHPHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLP 135
Query: 373 WEIRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQT 432
+ +R ++++ + YL +S HRD+ + N +L + V+DFG SR +
Sbjct: 136 LQTLVRFMVDIACGMEYL---SSRNFIHRDLAARNCMLAEDMTVCVADFGLSRKIYSGDY 192
Query: 433 HMTTQVHGTFGYL-----DPEYFRSSQFTDKSDVYSFGVVLTELLT-GEKP 477
+ G L E + +T SDV++FGV + E++T G+ P
Sbjct: 193 Y----RQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTP 239
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 130 bits (328), Expect = 1e-33
Identities = 56/230 (24%), Positives = 100/230 (43%), Gaps = 41/230 (17%)
Query: 282 KELEKATDNFDLNRILGQG--GQ----------------AVK--KSKVIDESKVEEFINE 321
+++ + L +ILG+G G AVK K + ++EEF++E
Sbjct: 27 EDVVIDRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSE 86
Query: 322 VVILSQINHRNVVKLLGCCLETE-----VPLLVYEFIPNGTLFQYI---HDQNEDFPITW 373
+ +H NV++LLG C+E P+++ F+ G L Y+ + I
Sbjct: 87 AACMKDFSHPNVIRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPL 146
Query: 374 EIRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTH 433
+ L+ ++++ + YL ++ HRD+ + N +L D V+DFG S+ + +
Sbjct: 147 QTLLKFMVDIALGMEYL---SNRNFLHRDLAARNCMLRDDMTVCVADFGLSKKIYSGDYY 203
Query: 434 MTTQVHGTFGYL-----DPEYFRSSQFTDKSDVYSFGVVLTELLT-GEKP 477
G + E +T KSDV++FGV + E+ T G P
Sbjct: 204 ----RQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTP 249
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 130 bits (328), Expect = 1e-33
Identities = 61/218 (27%), Positives = 100/218 (45%), Gaps = 29/218 (13%)
Query: 282 KELEKATDNFDLNRILGQG--GQ----------------AVKKSKV-IDESKVEEFINEV 322
+E+E + +I+G G G+ A+K K E + +F++E
Sbjct: 44 REIEA--SRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEA 101
Query: 323 VILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEIRLRIAIE 382
I+ Q +H N+++L G + ++V E++ NG+L ++ + D T + +
Sbjct: 102 SIMGQFDHPNIIRLEGVVTRGRLAMIVTEYMENGSLDTFL--RTHDGQFTIMQLVGMLRG 159
Query: 383 VSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHGTF 442
V + YL + HRD+ + N+L+D KVSDFG SR + D T G
Sbjct: 160 VGAGMRYLSDLGYV---HRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAYTTTGGKI 216
Query: 443 GYL--DPEYFRSSQFTDKSDVYSFGVVLTELLT-GEKP 477
PE F+ SDV+SFGVV+ E+L GE+P
Sbjct: 217 PIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERP 254
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 129 bits (326), Expect = 1e-33
Identities = 56/182 (30%), Positives = 92/182 (50%), Gaps = 14/182 (7%)
Query: 303 AVK--KSKVIDESKV-EEFINEVVILSQINHRNVVKLLGCCLETEVPL-LVYEFIPNGTL 358
AVK K V+ + + ++FI EV + ++HRN+++L G L P+ +V E P G+L
Sbjct: 50 AVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTP--PMKMVTELAPLGSL 107
Query: 359 FQYIHDQNEDFPITWEIRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKV 418
+ F + R A++V+ + YL S I HRD+ + N+LL + K+
Sbjct: 108 LDRLRKHQGHFLL--GTLSRYAVQVAEGMGYLESKRFI---HRDLAARNLLLATRDLVKI 162
Query: 419 SDFGASRSMAVDQTHMTTQVHGTFGY--LDPEYFRSSQFTDKSDVYSFGVVLTELLT-GE 475
DFG R++ + H Q H + PE ++ F+ SD + FGV L E+ T G+
Sbjct: 163 GDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQ 222
Query: 476 KP 477
+P
Sbjct: 223 EP 224
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 129 bits (326), Expect = 1e-33
Identities = 58/294 (19%), Positives = 107/294 (36%), Gaps = 60/294 (20%)
Query: 289 DNFDLNRILGQG--GQAVK---KS-------KVID----ESKVEEFINEVVILSQINHRN 332
+F+ + LG+G G + K K I E E+ + EV L+++ H
Sbjct: 5 TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPG 64
Query: 333 VVKLLGCCLE---------TEVPLLVY---EFIPNGTLFQYIHDQNEDFPITWEIRLRIA 380
+V+ LE + + +Y + L +++ + + L I
Sbjct: 65 IVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIF 124
Query: 381 IEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVH- 439
++++ A+ +LHS + HRD+K +NI KV DFG +M D+ T
Sbjct: 125 LQIAEAVEFLHSKG---LMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPM 181
Query: 440 ----------GTFGYLDPEYFRSSQFTDKSDVYSFGVVLTELLTGEKPIRFTILEEDKSL 489
GT Y+ PE + ++ K D++S G++L ELL
Sbjct: 182 PAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---------------- 225
Query: 490 AAYFLCAMKEERLFEILDARVMKQGGKDEIITVAKLAKRCLNLNGKKRPTMREV 543
F M+ R + + + + L+ + +RP +
Sbjct: 226 --PFSTQMERVRTLTDVRNLKFPPLFTQKYPCEYVMVQDMLSPSPMERPEAINI 277
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 132 bits (334), Expect = 1e-33
Identities = 57/242 (23%), Positives = 108/242 (44%), Gaps = 23/242 (9%)
Query: 252 KYFKRNGGLLLQQELASTEGTIEKTKLFTSKELEKATDNFDLNRILGQG--GQ------- 302
Y+ ++ L + + +T+ E ++ L LGQG G+
Sbjct: 147 AYYSKHADGLCHRLTTVCPTSKPQTQGLAKDAWEIPRESLRLEVKLGQGCFGEVWMGTWN 206
Query: 303 -----AVKKSKVIDESKVEEFINEVVILSQINHRNVVKLLGCCLETEVPL-LVYEFIPNG 356
A+K K E F+ E ++ ++ H +V+L +E P+ +V E++ G
Sbjct: 207 GTTRVAIKTLKP-GTMSPEAFLQEAQVMKKLRHEKLVQLYAVV--SEEPIYIVTEYMSKG 263
Query: 357 TLFQYIHDQNEDFPITWEIRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRA 416
+L ++ + + +A +++ ++Y+ + HRD+++ NIL+ +
Sbjct: 264 SLLDFLKG-ETGKYLRLPQLVDMAAQIASGMAYVERMNYV---HRDLRAANILVGENLVC 319
Query: 417 KVSDFGASRSMAVDQTHMTTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLTELLT-GE 475
KV+DFG +R + ++ + PE +FT KSDV+SFG++LTEL T G
Sbjct: 320 KVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGR 379
Query: 476 KP 477
P
Sbjct: 380 VP 381
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 128 bits (324), Expect = 2e-33
Identities = 52/180 (28%), Positives = 94/180 (52%), Gaps = 12/180 (6%)
Query: 303 AVK--KSKVIDESKVEEFINEVVILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGTLFQ 360
A+K K EE + E I+ Q+++ +V+L+G C + +LV E G L +
Sbjct: 41 AIKVLKQGTEKADT-EEMMREAQIMHQLDNPYIVRLIGVCQAEAL-MLVMEMAGGGPLHK 98
Query: 361 YIHDQNEDFPITWEIRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSD 420
++ + I + +VS + YL + HRD+ + N+LL +++ AK+SD
Sbjct: 99 FL--VGKREEIPVSNVAELLHQVSMGMKYLEEKNFV---HRDLAARNVLLVNRHYAKISD 153
Query: 421 FGASRSMAVDQTHMTTQVHGTF--GYLDPEYFRSSQFTDKSDVYSFGVVLTELLT-GEKP 477
FG S+++ D ++ T + G + + PE +F+ +SDV+S+GV + E L+ G+KP
Sbjct: 154 FGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKP 213
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 128 bits (323), Expect = 2e-33
Identities = 67/276 (24%), Positives = 114/276 (41%), Gaps = 47/276 (17%)
Query: 289 DNFDLNRILGQGG---------------QAVK---KSKVIDESKVEEFINEVVILSQINH 330
++F + +LG+G A+K K + V+ NEV I Q+ H
Sbjct: 11 EDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKH 70
Query: 331 RNVVKLLGCCLETEVPL-LVYEFIPNGTLFQYIHDQNEDFPITWEIRLRIAI-EVSGALS 388
++++L E + LV E NG + +Y+ ++ + F E R + ++ +
Sbjct: 71 PSILELYNY-FEDSNYVYLVLEMCHNGEMNRYLKNRVKPFS---ENEARHFMHQIITGML 126
Query: 389 YLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFG-ASRSMAVDQTHMTTQVHGTFGYLDP 447
YLHS I HRD+ +N+LL K++DFG A++ + H T GT Y+ P
Sbjct: 127 YLHSHG---ILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKHYTLC--GTPNYISP 181
Query: 448 EYFRSSQFTDKSDVYSFGVVLTELLTGEKPIRFTILEEDKSLAAYFLCAMKEERLFEILD 507
E S +SDV+S G + LL G P F + ++ + + +E+
Sbjct: 182 EIATRSAHGLESDVWSLGCMFYTLLIGRPP--F----DTDTVKNTLNKVVLAD--YEM-- 231
Query: 508 ARVMKQGGKDEIITVAKLAKRCLNLNGKKRPTMREV 543
+ KD L + L N R ++ V
Sbjct: 232 PSFLSIEAKD-------LIHQLLRRNPADRLSLSSV 260
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 127 bits (321), Expect = 3e-33
Identities = 62/205 (30%), Positives = 99/205 (48%), Gaps = 23/205 (11%)
Query: 289 DNFDLNRILGQG-------GQAVKKSKV------IDESKVEEFINEVVILSQINHRNVVK 335
+ +G G G + K KV E+FI E ++ +++H +V+
Sbjct: 8 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQ 67
Query: 336 LLGCCLETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEIRLRIAIEVSGALSYLHSAAS 395
L G CLE LV EF+ +G L Y+ + + E L + ++V ++YL A
Sbjct: 68 LYGVCLEQAPICLVTEFMEHGCLSDYL--RTQRGLFAAETLLGMCLDVCEGMAYLEEACV 125
Query: 396 IPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHGTFGY--LDPEYFRSS 453
I HRD+ + N L+ + KVSDFG +R + DQ T+ F PE F S
Sbjct: 126 I---HRDLAARNCLVGENQVIKVSDFGMTRFVLDDQ--YTSSTGTKFPVKWASPEVFSFS 180
Query: 454 QFTDKSDVYSFGVVLTELLT-GEKP 477
+++ KSDV+SFGV++ E+ + G+ P
Sbjct: 181 RYSSKSDVWSFGVLMWEVFSEGKIP 205
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 127 bits (322), Expect = 3e-33
Identities = 58/206 (28%), Positives = 98/206 (47%), Gaps = 25/206 (12%)
Query: 289 DNFDLNRILGQG--GQ------------AVKKSKVIDESKVEEFINEVVILSQINHRNVV 334
+ + LG G G A+K K +EFI E ++ ++H +V
Sbjct: 24 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKE-GSMSEDEFIEEAKVMMNLSHEKLV 82
Query: 335 KLLGCCLETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEIRLRIAIEVSGALSYLHSAA 394
+L G C + ++ E++ NG L Y+ + + L + +V A+ YL S
Sbjct: 83 QLYGVCTKQRPIFIITEYMANGCLLNYL--REMRHRFQTQQLLEMCKDVCEAMEYLESKQ 140
Query: 395 SIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHGTFGY--LDPEYFRS 452
+ HRD+ + N L++D+ KVSDFG SR + D+ T+ V F PE
Sbjct: 141 FL---HRDLAARNCLVNDQGVVKVSDFGLSRYVLDDE--YTSSVGSKFPVRWSPPEVLMY 195
Query: 453 SQFTDKSDVYSFGVVLTELLT-GEKP 477
S+F+ KSD+++FGV++ E+ + G+ P
Sbjct: 196 SKFSSKSDIWAFGVLMWEIYSLGKMP 221
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 127 bits (322), Expect = 3e-33
Identities = 78/288 (27%), Positives = 121/288 (42%), Gaps = 58/288 (20%)
Query: 281 SKELEKATDNFDLNRILGQG-------------GQ--AVK---KSKVIDESKVEEFINEV 322
SK+ + A ++F++ R LG+G A+K K+++ + EV
Sbjct: 1 SKKRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREV 60
Query: 323 VILSQINHRNVVKLLGCCLETEVPL-LVYEFIPNGTLFQYIHDQNEDFPITWEIRLR-IA 380
I S + H N+++L G + L+ E+ P GT+++ + + F E R
Sbjct: 61 EIQSHLRHPNILRLYGY-FHDATRVYLILEYAPLGTVYREL-QKLSKFD---EQRTATYI 115
Query: 381 IEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHG 440
E++ ALSY HS + HRDIK N+LL K++DFG S A G
Sbjct: 116 TELANALSYCHSKR---VIHRDIKPENLLLGSAGELKIADFGWS-VHAPSSRRTDLC--G 169
Query: 441 TFGYLDPEYFRSSQFTDKSDVYSFGVVLTELLTGEKPIRFTILEEDKSLAAYFLCAMKEE 500
T YL PE +K D++S GV+ E L G+ P F E + + +
Sbjct: 170 TLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPP--F----EANTYQETY------K 217
Query: 501 RLFEILDARV-----MKQGGKDEIITVAKLAKRCLNLNGKKRPTMREV 543
R I + +G +D L R L N +RP +REV
Sbjct: 218 R---ISRVEFTFPDFVTEGARD-------LISRLLKHNPSQRPMLREV 255
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 128 bits (324), Expect = 5e-33
Identities = 48/212 (22%), Positives = 97/212 (45%), Gaps = 30/212 (14%)
Query: 289 DNFDLNRILGQG--GQ-----------------AVKKSKVI-DESKVEEFINEVVILSQI 328
F ++LG G G A+K+ + +E ++E +++ +
Sbjct: 15 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 74
Query: 329 NHRNVVKLLGCCLETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEIRLRIAIEVSGALS 388
++ +V +LLG CL L+ + +P G L Y+ + I + L ++++ ++
Sbjct: 75 DNPHVCRLLGICLT-STVQLITQLMPFGCLLDYV--REHKDNIGSQYLLNWCVQIAKGMN 131
Query: 389 YLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHGTF--GYLD 446
YL + HRD+ + N+L+ K++DFG ++ + ++ + G ++
Sbjct: 132 YLEDRRLV---HRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAE-GGKVPIKWMA 187
Query: 447 PEYFRSSQFTDKSDVYSFGVVLTELLT-GEKP 477
E +T +SDV+S+GV + EL+T G KP
Sbjct: 188 LESILHRIYTHQSDVWSYGVTVWELMTFGSKP 219
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 133 bits (336), Expect = 5e-33
Identities = 41/210 (19%), Positives = 79/210 (37%), Gaps = 43/210 (20%)
Query: 293 LNRILGQGGQ----------------AVKKSKVI----DESKVEEFINEVVILSQINHRN 332
+ + GG +K + D + E L+++ H +
Sbjct: 84 VKGCIAHGGLGWIYLALDRNVNGRPVVLK---GLVHSGDAEAQAMAMAERQFLAEVVHPS 140
Query: 333 VVKLL-----GCCLETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEIRLRIAIEVSGAL 387
+V++ V +V E++ +L + + + +E+ AL
Sbjct: 141 IVQIFNFVEHTDRHGDPVGYIVMEYVGGQSLKRSKGQ-----KLPVAEAIAYLLEILPAL 195
Query: 388 SYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHGTFGYLDP 447
SYLHS + + D+K NI+L ++ + K+ D GA + + ++GT G+ P
Sbjct: 196 SYLHSI---GLVYNDLKPENIMLTEE-QLKLIDLGAVSRI--NSFGY---LYGTPGFQAP 246
Query: 448 EYFRSSQFTDKSDVYSFGVVLTELLTGEKP 477
E R+ T +D+Y+ G L L
Sbjct: 247 EIVRTGP-TVATDIYTVGRTLAALTLDLPT 275
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 130 bits (329), Expect = 7e-33
Identities = 64/248 (25%), Positives = 113/248 (45%), Gaps = 29/248 (11%)
Query: 248 KLKRKYFKRNGGLLLQQELASTEGTIEKTKLFTSKELEKATDNFDLNRILGQG--GQ--- 302
+L Y K N GL Q+L+ + + K + E ++ L + LG G G+
Sbjct: 149 ELVDHYKKGNDGL--CQKLSVPCMSSKPQKPWEKDAWEIPRESLKLEKKLGAGQFGEVWM 206
Query: 303 ---------AVKKSKVIDESKVEEFINEVVILSQINHRNVVKLLGCCLETEVPL-LVYEF 352
AVK K VE F+ E ++ + H +VKL T+ P+ ++ EF
Sbjct: 207 ATYNKHTKVAVKTMKP-GSMSVEAFLAEANVMKTLQHDKLVKLHAVV--TKEPIYIITEF 263
Query: 353 IPNGTLFQYIHDQNEDFPITWEIRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDD 412
+ G+L ++ +E + + +++ ++++ I HRD+++ NIL+
Sbjct: 264 MAKGSLLDFLKS-DEGSKQPLPKLIDFSAQIAEGMAFIEQRNYI---HRDLRAANILVSA 319
Query: 413 KYRAKVSDFGASRSMAVDQTHMTTQVHGTFGY--LDPEYFRSSQFTDKSDVYSFGVVLTE 470
K++DFG +R + ++ T + F PE FT KSDV+SFG++L E
Sbjct: 320 SLVCKIADFGLARVIEDNE--YTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLME 377
Query: 471 LLT-GEKP 477
++T G P
Sbjct: 378 IVTYGRIP 385
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 131 bits (331), Expect = 9e-33
Identities = 57/242 (23%), Positives = 108/242 (44%), Gaps = 23/242 (9%)
Query: 252 KYFKRNGGLLLQQELASTEGTIEKTKLFTSKELEKATDNFDLNRILGQG--GQ------- 302
Y+ ++ L + + +T+ E ++ L LGQG G+
Sbjct: 230 AYYSKHADGLCHRLTTVCPTSKPQTQGLAKDAWEIPRESLRLEVKLGQGCFGEVWMGTWN 289
Query: 303 -----AVKKSKVIDESKVEEFINEVVILSQINHRNVVKLLGCCLETEVPL-LVYEFIPNG 356
A+K K E F+ E ++ ++ H +V+L +E P+ +V E++ G
Sbjct: 290 GTTRVAIKTLKP-GTMSPEAFLQEAQVMKKLRHEKLVQLYAVV--SEEPIYIVTEYMSKG 346
Query: 357 TLFQYIHDQNEDFPITWEIRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRA 416
+L ++ + + +A +++ ++Y+ + HRD+++ NIL+ +
Sbjct: 347 SLLDFLKG-ETGKYLRLPQLVDMAAQIASGMAYVERMNYV---HRDLRAANILVGENLVC 402
Query: 417 KVSDFGASRSMAVDQTHMTTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLTELLT-GE 475
KV+DFG +R + ++ + PE +FT KSDV+SFG++LTEL T G
Sbjct: 403 KVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGR 462
Query: 476 KP 477
P
Sbjct: 463 VP 464
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 127 bits (321), Expect = 1e-32
Identities = 38/179 (21%), Positives = 84/179 (46%), Gaps = 11/179 (6%)
Query: 303 AVKKSKVI-DESKVEEFINEVVILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGTLFQY 361
+K + + + ++ + ++H ++V+LLG C LV +++P G+L +
Sbjct: 46 CIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRLLGLCPG-SSLQLVTQYLPLGSLLDH 104
Query: 362 IHDQNEDFPITWEIRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDF 421
+ ++ L ++++ + YL + HR++ + N+LL + +V+DF
Sbjct: 105 VRQHRGALGP--QLLLNWGVQIAKGMYYLEEHGMV---HRNLAARNVLLKSPSQVQVADF 159
Query: 422 GASRSMAVDQTHMTTQVHGTF--GYLDPEYFRSSQFTDKSDVYSFGVVLTELLT-GEKP 477
G + + D + ++ E ++T +SDV+S+GV + EL+T G +P
Sbjct: 160 GVADLLPPDDKQLLYS-EAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEP 217
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 131 bits (330), Expect = 2e-32
Identities = 51/179 (28%), Positives = 96/179 (53%), Gaps = 10/179 (5%)
Query: 303 AVKKSKV-IDESKVEEFINEVVILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGTLFQY 361
A+K K +++ EE + E I+ Q+++ +V+L+G C + +LV E G L ++
Sbjct: 367 AIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQAEAL-MLVMEMAGGGPLHKF 425
Query: 362 IHDQNEDFPITWEIRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDF 421
+ + I + +VS + YL + HR++ + N+LL +++ AK+SDF
Sbjct: 426 L--VGKREEIPVSNVAELLHQVSMGMKYLEEKNFV---HRNLAARNVLLVNRHYAKISDF 480
Query: 422 GASRSMAVDQTHMTTQVHGTFGY--LDPEYFRSSQFTDKSDVYSFGVVLTELLT-GEKP 477
G S+++ D ++ T + G + PE +F+ +SDV+S+GV + E L+ G+KP
Sbjct: 481 GLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKP 539
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 126 bits (317), Expect = 3e-32
Identities = 62/308 (20%), Positives = 123/308 (39%), Gaps = 53/308 (17%)
Query: 289 DNFDLNRILGQGG-----QAVKKS-------KVIDESKV----EEFINEVVILSQINHRN 332
+ L+ ILGQG + K KV + + + E +L ++NH+N
Sbjct: 9 HLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKN 68
Query: 333 VVKLLGC--CLETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEIRLRIAIEVSGALSYL 390
+VKL T +L+ EF P G+L+ + + + + + L + +V G +++L
Sbjct: 69 IVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHL 128
Query: 391 HSAASIPIYHRDIKSTNILL----DDKYRAKVSDFGASRSMAVDQTHMTTQVHGTFGYLD 446
I HR+IK NI+ D + K++DFGA+R + + ++GT YL
Sbjct: 129 RENG---IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAAREL--EDDEQFVSLYGTEEYLH 183
Query: 447 PEYFRSS--------QFTDKSDVYSFGVVLTELLTGEKP------------IRFTILEED 486
P+ + + ++ D++S GV TG P + + I+
Sbjct: 184 PDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGK 243
Query: 487 KSLAAYFLCAMKEERL---FEILDARVMKQGGKDEIITVAKLAKRCLNLNGKKRPTMREV 543
S A + + + ++ + + +G + + + L + +K +
Sbjct: 244 PSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLT---PVLANILEADQEKCWGFDQF 300
Query: 544 ASELAGIK 551
+E + I
Sbjct: 301 FAETSDIL 308
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 126 bits (318), Expect = 3e-32
Identities = 55/220 (25%), Positives = 103/220 (46%), Gaps = 32/220 (14%)
Query: 282 KELEKATDNFDLNRILGQG-------GQ------------AVK--KSKVIDESKVEEFIN 320
E+ +++G G G A+K K+ ++ + +F+
Sbjct: 39 TEIHP--SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQR-VDFLG 95
Query: 321 EVVILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEIRLRIA 380
E I+ Q +H N+++L G + + +++ E++ NG L +++ + +D + + +
Sbjct: 96 EAGIMGQFSHHNIIRLEGVISKYKPMMIITEYMENGALDKFL--REKDGEFSVLQLVGML 153
Query: 381 IEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHG 440
++ + YL + + HRD+ + NIL++ KVSDFG SR + D T G
Sbjct: 154 RGIAAGMKYLANMNYV---HRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGG 210
Query: 441 TFGY--LDPEYFRSSQFTDKSDVYSFGVVLTELLT-GEKP 477
PE +FT SDV+SFG+V+ E++T GE+P
Sbjct: 211 KIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERP 250
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 125 bits (316), Expect = 3e-32
Identities = 59/211 (27%), Positives = 103/211 (48%), Gaps = 33/211 (15%)
Query: 293 LNRILGQG--GQ----------------AVKKSKVI-DESKVEEFINEVVILSQINHRNV 333
+R++G+G G A+K I + +VE F+ E +++ +NH NV
Sbjct: 25 SDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNV 84
Query: 334 VKLLGCCLETE-VPLLVYEFIPNGTLFQYIHDQNEDFPITWEIRLRIAIEVSGALSYLHS 392
+ L+G L E +P ++ ++ +G L Q+I ++ T + + ++V+ + YL
Sbjct: 85 LALIGIMLPPEGLPHVLLPYMCHGDLLQFI--RSPQRNPTVKDLISFGLQVARGMEYLAE 142
Query: 393 AASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHGTFGYL-----DP 447
+ HRD+ + N +LD+ + KV+DFG +R + + L
Sbjct: 143 QKFV---HRDLAARNCMLDESFTVKVADFGLARD--ILDREYYSVQQHRHARLPVKWTAL 197
Query: 448 EYFRSSQFTDKSDVYSFGVVLTELLT-GEKP 477
E ++ +FT KSDV+SFGV+L ELLT G P
Sbjct: 198 ESLQTYRFTTKSDVWSFGVLLWELLTRGAPP 228
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 127 bits (320), Expect = 4e-32
Identities = 63/308 (20%), Positives = 122/308 (39%), Gaps = 53/308 (17%)
Query: 289 DNFDLNRILGQGG-----QAVKKS-------KVIDESKV----EEFINEVVILSQINHRN 332
+ L+ ILGQG + K KV + + + E +L ++NH+N
Sbjct: 9 HLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKN 68
Query: 333 VVKLLGC--CLETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEIRLRIAIEVSGALSYL 390
+VKL T +L+ EF P G+L+ + + + + + L + +V G +++L
Sbjct: 69 IVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHL 128
Query: 391 HSAASIPIYHRDIKSTNILL----DDKYRAKVSDFGASRSMAVDQTHMTTQVHGTFGYLD 446
I HR+IK NI+ D + K++DFGA+R + D + GT YL
Sbjct: 129 RENG---IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELE-DDEQFVSLY-GTEEYLH 183
Query: 447 PEYFRSS--------QFTDKSDVYSFGVVLTELLTGEKP------------IRFTILEED 486
P+ + + ++ D++S GV TG P + + I+
Sbjct: 184 PDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGK 243
Query: 487 KSLAAYFLCAMKEERL---FEILDARVMKQGGKDEIITVAKLAKRCLNLNGKKRPTMREV 543
S A + + + ++ + + +G + + + L + +K +
Sbjct: 244 PSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLT---PVLANILEADQEKCWGFDQF 300
Query: 544 ASELAGIK 551
+E + I
Sbjct: 301 FAETSDIL 308
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 125 bits (316), Expect = 4e-32
Identities = 68/296 (22%), Positives = 124/296 (41%), Gaps = 63/296 (21%)
Query: 289 DNFDLNRILGQG--GQ------------------AVKKSKVI-DESKVEEFINEVVILSQ 327
+ ++R LGQG G A+K + EF+NE ++ +
Sbjct: 25 EKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKE 84
Query: 328 INHRNVVKLLGCCLETEVPLLVYEFIPNGTLFQY-------IHDQNEDFPITWEIRLRIA 380
N +VV+LLG + + L++ E + G L Y + + P + +++A
Sbjct: 85 FNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMA 144
Query: 381 IEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHG 440
E++ ++YL + HRD+ + N ++ + + K+ DFG +R + + G
Sbjct: 145 GEIADGMAYL---NANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRK----G 197
Query: 441 TFGYL-----DPEYFRSSQFTDKSDVYSFGVVLTELLT-GEKPIRFTILEEDKSLAAYFL 494
G L PE + FT SDV+SFGVVL E+ T E+P Y
Sbjct: 198 GKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQP--------------Y-- 241
Query: 495 CAMKEERLFE-ILDARVMKQ--GGKDEIITVAKLAKRCLNLNGKKRPTMREVASEL 547
+ E++ +++ ++ + D + +L + C N K RP+ E+ S +
Sbjct: 242 QGLSNEQVLRFVMEGGLLDKPDNCPDML---FELMRMCWQYNPKMRPSFLEIISSI 294
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 126 bits (319), Expect = 5e-32
Identities = 60/218 (27%), Positives = 106/218 (48%), Gaps = 29/218 (13%)
Query: 282 KELEKATDNFDLNRILGQG-------GQ-----------AVKKSKV-IDESKVEEFINEV 322
KEL+ N +++++G G G+ A+K KV E + +F+ E
Sbjct: 40 KELDA--TNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEA 97
Query: 323 VILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEIRLRIAIE 382
I+ Q +H N+++L G +++ ++V E++ NG+L ++ + F T + +
Sbjct: 98 SIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQF--TVIQLVGMLRG 155
Query: 383 VSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHGTF 442
++ + YL + HRD+ + NIL++ KVSDFG R + D T G
Sbjct: 156 IASGMKYLSDMGYV---HRDLAARNILINSNLVCKVSDFGLGRVLEDDPEAAYTTRGGKI 212
Query: 443 GYL--DPEYFRSSQFTDKSDVYSFGVVLTELLT-GEKP 477
PE +FT SDV+S+G+VL E+++ GE+P
Sbjct: 213 PIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERP 250
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 124 bits (313), Expect = 6e-32
Identities = 60/212 (28%), Positives = 99/212 (46%), Gaps = 32/212 (15%)
Query: 289 DNFDLNRILGQG-------GQ-----------AVK--KSKVIDESKVEEFINEVVILSQI 328
++ LNRILG+G G AVK K ++K E+F++E VI+ +
Sbjct: 12 EDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNK-EKFMSEAVIMKNL 70
Query: 329 NHRNVVKLLGCCLETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEIRLRIAIEVSGALS 388
+H ++VKL+G E E ++ E P G L Y+ + + ++++ A++
Sbjct: 71 DHPHIVKLIGIIEE-EPTWIIMELYPYGELGHYLERNKNSLKV--LTLVLYSLQICKAMA 127
Query: 389 YLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHGTF--GYLD 446
YL S + HRDI NIL+ K+ DFG SR + + ++
Sbjct: 128 YLESINCV---HRDIAVRNILVASPECVKLGDFGLSRYIEDEDY--YKASVTRLPIKWMS 182
Query: 447 PEYFRSSQFTDKSDVYSFGVVLTELLT-GEKP 477
PE +FT SDV+ F V + E+L+ G++P
Sbjct: 183 PESINFRRFTTASDVWMFAVCMWEILSFGKQP 214
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 124 bits (313), Expect = 6e-32
Identities = 53/255 (20%), Positives = 101/255 (39%), Gaps = 39/255 (15%)
Query: 303 AVKKSKVIDESK--VEEFINEVVILSQINHRNVVKLLGCCLETEVP----LLVYEFIPNG 356
A + + +K + F E +L + H N+V+ T +LV E + +G
Sbjct: 55 AWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVTELMTSG 114
Query: 357 TLFQYIHDQNEDFPITWEIRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKY-R 415
TL Y+ + ++ ++ L +LH+ + PI HRD+K NI +
Sbjct: 115 TLKTYLKRFK---VMKIKVLRSWCRQILKGLQFLHT-RTPPIIHRDLKCDNIFITGPTGS 170
Query: 416 AKVSDFGASRSMAVDQTHMTTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLTELLTGE 475
K+ D G + + + V GT ++ PE + ++ + DVY+FG+ + E+ T E
Sbjct: 171 VKIGDLGLA---TLKRASFAKAVIGTPEFMAPEMYE-EKYDESVDVYAFGMCMLEMATSE 226
Query: 476 KPIRFTILEEDKSLAAYFLCAMKEER---LFEILDARVMKQGGKDEIITVAKLAKRCLNL 532
P E ++ A + + ++ V K+ I + C+
Sbjct: 227 YP-----YSECQNAAQIYRRVTSGVKPASFDKVAIPEV-----KEII-------EGCIRQ 269
Query: 533 NGKKRPTMREVASEL 547
N +R + +L
Sbjct: 270 NKDERYS----IKDL 280
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 123 bits (312), Expect = 2e-31
Identities = 63/278 (22%), Positives = 105/278 (37%), Gaps = 52/278 (18%)
Query: 289 DNFDLNRILGQGG---------------QAVK---KSKVIDESKVEEFINEVVILSQINH 330
+ R LG+GG A K KS ++ + E+ E+ I + H
Sbjct: 41 RRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAH 100
Query: 331 RNVVKLLGCCLETEVPL-LVYEFIPNGTLFQYIHDQ---NEDFPITWEIRLRIAIEVSGA 386
++VV G E + +V E +L + + E E R ++
Sbjct: 101 QHVVGFHGF-FEDNDFVFVVLELCRRRSLLELHKRRKALTEP-----EAR-YYLRQIVLG 153
Query: 387 LSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFG-ASRSMAVDQTHMTTQVHGTFGYL 445
YLH + HRD+K N+ L++ K+ DFG A++ + GT Y+
Sbjct: 154 CQYLHRNR---VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLC--GTPNYI 208
Query: 446 DPEYFRSSQFTDKSDVYSFGVVLTELLTGEKPIRFTILEEDKSLAAYFLCAMKEERLFEI 505
PE + + DV+S G ++ LL G+ P F E L +L K E + I
Sbjct: 209 APEVLSKKGHSFEVDVWSIGCIMYTLLVGKPP--F----ETSCLKETYLRIKKNE--YSI 260
Query: 506 LDARVMKQGGKDEIITVAKLAKRCLNLNGKKRPTMREV 543
+ + L ++ L + RPT+ E+
Sbjct: 261 --PKHINPVAAS-------LIQKMLQTDPTARPTINEL 289
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 122 bits (309), Expect = 2e-31
Identities = 70/281 (24%), Positives = 111/281 (39%), Gaps = 60/281 (21%)
Query: 289 DNFDLNRILGQG-------------GQ--AVK---KSKVIDESKVEEFINEVVILSQINH 330
D+FD+ R LG+G A+K KS++ E + E+ I S + H
Sbjct: 14 DDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRH 73
Query: 331 RNVVKLLGCCLETEVPL-LVYEFIPNGTLFQYIHDQNEDFPITWEIRLR-IAIEVSGALS 388
N++++ + L+ EF P G L++ + ++ F E R E++ AL
Sbjct: 74 PNILRMYNY-FHDRKRIYLMLEFAPRGELYKELQ-KHGRFD---EQRSATFMEELADALH 128
Query: 389 YLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHGTFGYLDPE 448
Y H + HRDIK N+L+ K K++DFG S A T GT YL PE
Sbjct: 129 YCHERK---VIHRDIKPENLLMGYKGELKIADFGWS-VHAPSLRRRTMC--GTLDYLPPE 182
Query: 449 YFRSSQFTDKSDVYSFGVVLTELLTGEKPIRFTILEEDKSLAAYFLCAMKEERLFE-ILD 507
+K D++ GV+ E L G P F + S I++
Sbjct: 183 MIEGKTHDEKVDLWCAGVLCYEFLVGMPP--F----DSPSH----------TETHRRIVN 226
Query: 508 ARV-----MKQGGKDEIITVAKLAKRCLNLNGKKRPTMREV 543
+ + G KD L + L + +R ++ V
Sbjct: 227 VDLKFPPFLSDGSKD-------LISKLLRYHPPQRLPLKGV 260
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 122 bits (308), Expect = 3e-31
Identities = 59/211 (27%), Positives = 94/211 (44%), Gaps = 30/211 (14%)
Query: 289 DNFDLNRILGQG--GQ----------------AVKKSKV-IDESKVEEFINEVVILSQIN 329
+ +L R +G+G G A+K K +S E+F+ E + + Q +
Sbjct: 15 ERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFD 74
Query: 330 HRNVVKLLGCCLETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEIRLRIAIEVSGALSY 389
H ++VKL+G E ++ E G L ++ Q + + + A ++S AL+Y
Sbjct: 75 HPHIVKLIGVITE-NPVWIIMELCTLGELRSFL--QVRKYSLDLASLILYAYQLSTALAY 131
Query: 390 LHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHGTF--GYLDP 447
L S + HRDI + N+L+ K+ DFG SR M G ++ P
Sbjct: 132 LESKRFV---HRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTY--YKASKGKLPIKWMAP 186
Query: 448 EYFRSSQFTDKSDVYSFGVVLTELLT-GEKP 477
E +FT SDV+ FGV + E+L G KP
Sbjct: 187 ESINFRRFTSASDVWMFGVCMWEILMHGVKP 217
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 122 bits (308), Expect = 3e-31
Identities = 47/229 (20%), Positives = 87/229 (37%), Gaps = 58/229 (25%)
Query: 289 DNFDLNRILGQG--GQ--------------------AVKKSKVIDESKVEEFINEVVILS 326
++ N LGQG + +K + E F ++S
Sbjct: 8 EDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMS 67
Query: 327 QINHRNVVKLLGCCLETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEIRLRIAIEVSGA 386
+++H+++V G C+ + +LV EF+ G+L Y+ I W+ L +A +++ A
Sbjct: 68 KLSHKHLVLNYGVCVCGDENILVQEFVKFGSLDTYLKKNKNCINILWK--LEVAKQLAAA 125
Query: 387 LSYLHSAASIPIYHRDIKSTNILLDDKYR--------AKVSDFGASRSMAVDQTHMTTQV 438
+ +L I H ++ + NILL + K+SD G S ++
Sbjct: 126 MHFLEENTLI---HGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPKD------- 175
Query: 439 HGTFGYLDP---------EYFRSSQFTDKSDVYSFGVVLTELLT-GEKP 477
+ E + +D +SFG L E+ + G+KP
Sbjct: 176 ----ILQERIPWVPPECIENPK--NLNLATDKWSFGTTLWEICSGGDKP 218
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 123 bits (310), Expect = 4e-31
Identities = 61/228 (26%), Positives = 101/228 (44%), Gaps = 47/228 (20%)
Query: 289 DNFDLNRILGQG--GQ------------------AVKKSKVIDESKVEEFINEVVILSQI 328
+ L LG+G G+ AVK K ES ++F E +L+ +
Sbjct: 41 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTML 100
Query: 329 NHRNVVKLLGCCLETEVPLLVYEFIPNGTLFQY------------IHDQNEDFPITWEIR 376
H+++V+ G C E L+V+E++ +G L ++ + P+
Sbjct: 101 QHQHIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQL 160
Query: 377 LRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSM-AVDQTHMT 435
L +A +V+ + YL A + HRD+ + N L+ K+ DFG SR + + D +
Sbjct: 161 LAVASQVAAGMVYL---AGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVG 217
Query: 436 TQVHGTFGYL-----DPEYFRSSQFTDKSDVYSFGVVLTELLT-GEKP 477
+ L PE +FT +SDV+SFGVVL E+ T G++P
Sbjct: 218 GR-----TMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQP 260
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 121 bits (307), Expect = 5e-31
Identities = 63/278 (22%), Positives = 105/278 (37%), Gaps = 52/278 (18%)
Query: 289 DNFDLNRILGQGG---------------QAVK---KSKVIDESKVEEFINEVVILSQINH 330
+ R LG+GG A K KS ++ + E+ E+ I + H
Sbjct: 15 RRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAH 74
Query: 331 RNVVKLLGCCLETEVPL-LVYEFIPNGTLFQYIHDQ---NEDFPITWEIRLRIAIEVSGA 386
++VV G E + +V E +L + + E E R ++
Sbjct: 75 QHVVGFHGF-FEDNDFVFVVLELCRRRSLLELHKRRKALTEP-----EAR-YYLRQIVLG 127
Query: 387 LSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFG-ASRSMAVDQTHMTTQVHGTFGYL 445
YLH + HRD+K N+ L++ K+ DFG A++ + GT Y+
Sbjct: 128 CQYLHRNR---VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLC--GTPNYI 182
Query: 446 DPEYFRSSQFTDKSDVYSFGVVLTELLTGEKPIRFTILEEDKSLAAYFLCAMKEERLFEI 505
PE + + DV+S G ++ LL G+ P F E L +L K E + I
Sbjct: 183 APEVLSKKGHSFEVDVWSIGCIMYTLLVGKPP--F----ETSCLKETYLRIKKNE--YSI 234
Query: 506 LDARVMKQGGKDEIITVAKLAKRCLNLNGKKRPTMREV 543
+ + L ++ L + RPT+ E+
Sbjct: 235 --PKHINPVAAS-------LIQKMLQTDPTARPTINEL 263
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 127 bits (320), Expect = 5e-31
Identities = 61/295 (20%), Positives = 111/295 (37%), Gaps = 45/295 (15%)
Query: 285 EKATDNFDLNRILGQGGQA-VKKS-----------KVIDESK----VEEFINEVVILSQI 328
+ +++ LG GG V + K + E + E+ I+ ++
Sbjct: 10 TQTCGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKL 69
Query: 329 NHRNVVKLLGCCLETE-------VPLLVYEFIPNGTLFQYIHDQNEDFPITWEIRLRIAI 381
NH NVV + +PLL E+ G L +Y++ + +
Sbjct: 70 NHPNVVSAR-EVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLS 128
Query: 382 EVSGALSYLHSAASIPIYHRDIKSTNILLD---DKYRAKVSDFGASRSMAVDQTHMTTQV 438
++S AL YLH I HRD+K NI+L + K+ D G ++ + DQ + T+
Sbjct: 129 DISSALRYLHENR---IIHRDLKPENIVLQPGPQRLIHKIIDLGYAKEL--DQGELCTEF 183
Query: 439 HGTFGYLDPEYFRSSQFTDKSDVYSFGVVLTELLTGEKPIR-------FTILEEDKSLAA 491
GT YL PE ++T D +SFG + E +TG +P + +KS
Sbjct: 184 VGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGKVREKSNEH 243
Query: 492 YFLCAMKEERL---FEILDARVMKQGGKDEIITVAKLAKRCLNLNGKKRPTMREV 543
+ + + + ++ + + L + ++R T +
Sbjct: 244 IVVYDDLTGAVKFSSVLPTPNHLSGILAGKLE---RWLQCMLMWHQRQRGTDPQN 295
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 123 bits (311), Expect = 1e-30
Identities = 58/277 (20%), Positives = 109/277 (39%), Gaps = 43/277 (15%)
Query: 290 NFDLNRILGQG--GQAVKKS---------KVIDESKVEEFINEVVILSQIN-HRNVVKLL 337
+F +LG G G V + K I EV +L + + H NV++
Sbjct: 25 SFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPECFSFADREVQLLRESDEHPNVIRYF 84
Query: 338 GCCLETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEIRLRIAIEVSGALSYLHSAASIP 397
+ + + E TL +Y+ + +DF + + + + L++LHS
Sbjct: 85 CTEKDRQFQYIAIELCA-ATLQEYV--EQKDFAHLGLEPITLLQQTTSGLAHLHSLN--- 138
Query: 398 IYHRDIKSTNILLDDK-----YRAKVSDFGASRSMAVDQ---THMTTQVHGTFGYLDPEY 449
I HRD+K NIL+ +A +SDFG + +AV + + + GT G++ PE
Sbjct: 139 IVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVP-GTEGWIAPEM 197
Query: 450 FRSSQF---TDKSDVYSFGVVLTELLTGEKPIRFTILEEDKSLAAYFLCAMKEERLFEIL 506
T D++S G V +++ L+ A L + L +
Sbjct: 198 LSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQ----ANIL--LGACSLDCLH 251
Query: 507 DARVMKQGGKDEIITVAKLAKRCLNLNGKKRPTMREV 543
+ ++ L ++ + ++ +KRP+ + V
Sbjct: 252 PEKHEDVIARE-------LIEKMIAMDPQKRPSAKHV 281
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 120 bits (303), Expect = 2e-30
Identities = 58/228 (25%), Positives = 98/228 (42%), Gaps = 46/228 (20%)
Query: 289 DNFDLNRILGQG--GQ------------------AVKKSKVIDESKVEEFINEVVILSQI 328
+ L R LG+G G+ AVK K + ++F E +L+ +
Sbjct: 15 RDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNL 74
Query: 329 NHRNVVKLLGCCLETEVPLLVYEFIPNGTLFQY-------------IHDQNEDFPITWEI 375
H ++VK G C + + ++V+E++ +G L ++ + +
Sbjct: 75 QHEHIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQ 134
Query: 376 RLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMT 435
L IA +++ + YL AS HRD+ + N L+ K+ DFG SR + +
Sbjct: 135 MLHIASQIASGMVYL---ASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRV 191
Query: 436 TQVHGTFGYL-----DPEYFRSSQFTDKSDVYSFGVVLTELLT-GEKP 477
G L PE +FT +SDV+SFGV+L E+ T G++P
Sbjct: 192 ----GGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQP 235
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 120 bits (303), Expect = 2e-30
Identities = 46/208 (22%), Positives = 76/208 (36%), Gaps = 29/208 (13%)
Query: 289 DNFDLNRILGQG-------------GQ--AVKKSKVIDESKVE--EFINEVVILSQI-NH 330
+F LG G G+ AVK+S + + EV ++ H
Sbjct: 57 QSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQH 116
Query: 331 RNVVKLLGCCLETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEIRLR-IAIEVSGALSY 389
V+L E + L E +L Q+ P E ++ + AL++
Sbjct: 117 PCCVRLEQAWEEGGILYLQTELC-GPSLQQHCEAWGASLP---EAQVWGYLRDTLLALAH 172
Query: 390 LHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHGTFGYLDPEY 449
LHS + H D+K NI L + R K+ DFG + G Y+ PE
Sbjct: 173 LHSQG---LVHLDVKPANIFLGPRGRCKLGDFGLLVEL--GTAGAGEVQEGDPRYMAPEL 227
Query: 450 FRSSQFTDKSDVYSFGVVLTELLTGEKP 477
+ + +DV+S G+ + E+ +
Sbjct: 228 LQ-GSYGTAADVFSLGLTILEVACNMEL 254
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 120 bits (302), Expect = 2e-30
Identities = 63/248 (25%), Positives = 101/248 (40%), Gaps = 25/248 (10%)
Query: 303 AVKKSKVIDESKVEEFINEVVILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGTLFQYI 362
A+K+ D + E+ + + H+N+V+ LG E + E +P G+L +
Sbjct: 51 AIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIFMEQVPGGSLSALL 110
Query: 363 HDQNEDFPITWEIRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKY-RAKVSDF 421
+ + ++ L YLH I HRDIK N+L++ K+SDF
Sbjct: 111 RSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQ---IVHRDIKGDNVLINTYSGVLKISDF 167
Query: 422 GASRSMAVDQTHMTTQVHGTFGYLDPEYFRSSQ--FTDKSDVYSFGVVLTELLTGEKPIR 479
G S+ +A T GT Y+ PE + +D++S G + E+ TG+ P
Sbjct: 168 GTSKRLAGINPCTET-FTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPP-- 224
Query: 480 FTILEEDKSLAAYFLCAMKEERLFEILDARVMKQGGKDEIITVAKLAKRCLNLNGKKRPT 539
F L E AA F M + EI ++ M K I +C + KR
Sbjct: 225 FYELGE--PQAAMFKVGMFKVH-PEIPES--MSAEAKAFI-------LKCFEPDPDKRAC 272
Query: 540 MREVASEL 547
A++L
Sbjct: 273 ----ANDL 276
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 125 bits (315), Expect = 2e-30
Identities = 61/218 (27%), Positives = 102/218 (46%), Gaps = 26/218 (11%)
Query: 280 TSKELEKATDNFDLNRILGQG--GQ----------------AVKKSKV-IDESKVEEFIN 320
++++ E + +L R +G+G G A+K K +S E+F+
Sbjct: 381 STRDYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQ 440
Query: 321 EVVILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEIRLRIA 380
E + + Q +H ++VKL+G E V ++ E G L ++ Q F + + A
Sbjct: 441 EALTMRQFDHPHIVKLIGVITENPV-WIIMELCTLGELRSFL--QVRKFSLDLASLILYA 497
Query: 381 IEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHG 440
++S AL+YL S + HRDI + N+L+ K+ DFG SR M + ++
Sbjct: 498 YQLSTALAYLESKRFV---HRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKL 554
Query: 441 TFGYLDPEYFRSSQFTDKSDVYSFGVVLTELLT-GEKP 477
++ PE +FT SDV+ FGV + E+L G KP
Sbjct: 555 PIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKP 592
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 120 bits (303), Expect = 3e-30
Identities = 61/237 (25%), Positives = 106/237 (44%), Gaps = 55/237 (23%)
Query: 289 DNFDLNRILGQG--GQ------------------AVKKSKVI-DESKVEEFINEVVILSQ 327
N L + LG+G G+ AVK K S++ + ++E +L Q
Sbjct: 23 KNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQ 82
Query: 328 INHRNVVKLLGCCLETEVPLLVYEFIPNGTLFQY---------------------IHDQN 366
+NH +V+KL G C + LL+ E+ G+L + D
Sbjct: 83 VNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHP 142
Query: 367 EDFPITWEIRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRS 426
++ +T + A ++S + YL A + + HRD+ + NIL+ + + K+SDFG SR
Sbjct: 143 DERALTMGDLISFAWQISQGMQYL---AEMKLVHRDLAARNILVAEGRKMKISDFGLSRD 199
Query: 427 MAVDQTHMTTQVHGTFGYL-----DPEYFRSSQFTDKSDVYSFGVVLTELLT-GEKP 477
+ + +++ + G + E +T +SDV+SFGV+L E++T G P
Sbjct: 200 VYEEDSYVK----RSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNP 252
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 119 bits (301), Expect = 4e-30
Identities = 59/285 (20%), Positives = 114/285 (40%), Gaps = 54/285 (18%)
Query: 290 NFDLNRILGQGG-----QAVKKS------KVI-----DESKVEEFINEVVILSQINHRN- 332
+ + + +G GG Q + + K + D ++ + NE+ L+++ +
Sbjct: 29 IYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSD 88
Query: 333 -VVKLLGCCLETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEIRLRIAIEVSGALSYLH 391
+++L + + +V E N L ++ + + WE + + A+ +H
Sbjct: 89 KIIRLYDYEITDQYIYMVMEC-GNIDLNSWLK-KKKSIDP-WERK-SYWKNMLEAVHTIH 144
Query: 392 SAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQT--HMTTQVHGTFGYLDPE- 448
I H D+K N L+ D K+ DFG + M D T +QV GT Y+ PE
Sbjct: 145 QHG---IVHSDLKPANFLIVDG-MLKLIDFGIANQMQPDTTSVVKDSQV-GTVNYMPPEA 199
Query: 449 ----------YFRSSQFTDKSDVYSFGVVLTELLTGEKPIRFTILEEDKSLAAYFLCAMK 498
S+ + KSDV+S G +L + G+ P F + ++
Sbjct: 200 IKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTP--FQ--QIINQISKLH---AI 252
Query: 499 EERLFEILDARVMKQGGKDEIITVAKLAKRCLNLNGKKRPTMREV 543
+ EI + ++ +D + K CL + K+R ++ E+
Sbjct: 253 IDPNHEIEFPDIPEKDLQDVL-------KCCLKRDPKQRISIPEL 290
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 120 bits (303), Expect = 5e-30
Identities = 77/368 (20%), Positives = 140/368 (38%), Gaps = 84/368 (22%)
Query: 239 KFVKRRREIKLKRKYFKRNGGLLLQQELASTEGTIEKTKLFTSKELEKATD--------N 290
+ RR+ N L + T + L E E D
Sbjct: 23 RIPLRRQVTVSAESSSSMNSNTPLVRITTRLSSTADTPMLAGVSEYELPEDPKWEFPRDK 82
Query: 291 FDLNRILGQG--GQ--------------------AVKKSKVI-DESKVEEFINEVVILSQ 327
L + LG+G GQ AVK K E + + ++E+ ++
Sbjct: 83 LTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKM 142
Query: 328 I-NHRNVVKLLGCCLETEVPLLVYEFIPNGTLFQY-------------IHDQNEDFPITW 373
I H+N++ LLG C + ++ E+ G L +Y ++ + +T+
Sbjct: 143 IGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTF 202
Query: 374 EIRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTH 433
+ + +++ + YL AS HRD+ + N+L+ + K++DFG +R + +
Sbjct: 203 KDLVSCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYY 259
Query: 434 MTTQVHGTFGYL-----DPEYFRSSQFTDKSDVYSFGVVLTELLT-GEKPIRFTILEEDK 487
T G L PE +T +SDV+SFGV++ E+ T G P
Sbjct: 260 KK----TTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSP---------- 305
Query: 488 SLAAYFLCAMKEERLFEILDARVMKQGGKDEI-----ITVAKLAKRCLNLNGKKRPTMRE 542
Y + E LF++L K+G + + + + + C + +RPT ++
Sbjct: 306 ----Y--PGIPVEELFKLL-----KEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQ 354
Query: 543 VASELAGI 550
+ +L I
Sbjct: 355 LVEDLDRI 362
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 119 bits (300), Expect = 7e-30
Identities = 57/224 (25%), Positives = 94/224 (41%), Gaps = 43/224 (19%)
Query: 289 DNFDLNRILGQG--GQ------------------AVK--KSKVIDESKVEEFINEVVILS 326
N L R LG G G+ AVK ++ + +F+ E +I+S
Sbjct: 30 KNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDE-LDFLMEALIIS 88
Query: 327 QINHRNVVKLLGCCLETEVPLLVYEFIPNGTLFQYI----HDQNEDFPITWEIRLRIAIE 382
+ NH+N+V+ +G L++ ++ E + G L ++ ++ + L +A +
Sbjct: 89 KFNHQNIVRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARD 148
Query: 383 VSGALSYLHSAASIPIYHRDIKSTNILLD---DKYRAKVSDFGASRSMAVDQTHMTTQVH 439
++ YL HRDI + N LL AK+ DFG +R + +
Sbjct: 149 IACGCQYL---EENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYY----RK 201
Query: 440 GTFGYL-----DPEYFRSSQFTDKSDVYSFGVVLTELLT-GEKP 477
G L PE F FT K+D +SFGV+L E+ + G P
Sbjct: 202 GGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMP 245
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 118 bits (297), Expect = 1e-29
Identities = 78/306 (25%), Positives = 119/306 (38%), Gaps = 68/306 (22%)
Query: 289 DNFDLNRILGQG--GQ------------------AVKKSKVI-DESKVEEFINEVVILSQ 327
D L + LG+G GQ AVK K S+ ++E+ IL
Sbjct: 27 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIH 86
Query: 328 I-NHRNVVKLLGCCLETEVPLLV-YEFIPNGTLFQY-------------IHDQNEDFPIT 372
I +H NVV LLG C + PL+V EF G L Y + +T
Sbjct: 87 IGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLT 146
Query: 373 WEIRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQT 432
E + + +V+ + +L AS HRD+ + NILL +K K+ DFG +R + D
Sbjct: 147 LEHLICYSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPD 203
Query: 433 HMTTQVHGTFGYL-----DPEYFRSSQFTDKSDVYSFGVVLTELLT-GEKPIRFTILEED 486
++ L PE +T +SDV+SFGV+L E+ + G P
Sbjct: 204 YVRK----GDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASP--------- 250
Query: 487 KSLAAYFLCAMKEERLFEILDARVMKQ--GGKDEIITVAKLAKRCLNLNGKKRPTMREVA 544
Y + EE + + M+ E+ + C + +RPT E+
Sbjct: 251 -----YPGVKIDEEFCRRLKEGTRMRAPDYTTPEM---YQTMLDCWHGEPSQRPTFSELV 302
Query: 545 SELAGI 550
L +
Sbjct: 303 EHLGNL 308
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 119 bits (299), Expect = 1e-29
Identities = 43/254 (16%), Positives = 80/254 (31%), Gaps = 41/254 (16%)
Query: 262 LQQELASTEGTIEKT----KLFTSKELEKATDNFDLNRILGQGG-----QAVKKS----- 307
L + ++S T E + E + + ++ +LG+G +A +
Sbjct: 34 LSKPVSSYPNTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAK 93
Query: 308 -------KVIDESKVEEF---INEVVILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGT 357
KV + EF + L +K L +LV E GT
Sbjct: 94 NKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGT 153
Query: 358 LFQYIHD--QNEDFPITWEIRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYR 415
L I+ + + + + A+ + + +H I H DIK N +L + +
Sbjct: 154 LLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCE---IIHGDIKPDNFILGNGFL 210
Query: 416 A-----------KVSDFGASRSMAVDQTHMT-TQVHGTFGYLDPEYFRSSQFTDKSDVYS 463
+ D G S M + T T G+ E + + + D +
Sbjct: 211 EQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFG 270
Query: 464 FGVVLTELLTGEKP 477
+ +L G
Sbjct: 271 VAATVYCMLFGTYM 284
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 119 bits (301), Expect = 1e-29
Identities = 63/322 (19%), Positives = 121/322 (37%), Gaps = 71/322 (22%)
Query: 263 QQELASTEGTIEKTKLFTSKELEKATDN---FDLNRILGQGG-----QAVKKS------K 308
+Q + S + + +S E + + + + +G GG Q + + K
Sbjct: 27 RQHMDSPDLGTDDDDKASSSANECISVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIK 86
Query: 309 VI-----DESKVEEFINEVVILSQINH--RNVVKLLGCCLETEVPLLVYEFIPNGTLFQY 361
+ D ++ + NE+ L+++ +++L + + +V E N L +
Sbjct: 87 YVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVMEC-GNIDLNSW 145
Query: 362 IHDQNEDFPITWEIRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDF 421
+ + + WE + + A+ +H I H D+K N L+ D K+ DF
Sbjct: 146 LK-KKKSIDP-WERK-SYWKNMLEAVHTIHQHG---IVHSDLKPANFLIVDG-MLKLIDF 198
Query: 422 GASRSMAVDQT--HMTTQVHGTFGYLDPE-----------YFRSSQFTDKSDVYSFGVVL 468
G + M D T +QV G Y+ PE S+ + KSDV+S G +L
Sbjct: 199 GIANQMQPDTTSVVKDSQV-GAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCIL 257
Query: 469 TELLTGEKPIRFTILEEDKSLAAYFLCAMKEERLFEILDARV-------MKQGGKDEIIT 521
+ G+ P F + +L I+D ++ +D +
Sbjct: 258 YYMTYGKTP--FQQIINQI------------SKLHAIIDPNHEIEFPDIPEKDLQDVL-- 301
Query: 522 VAKLAKRCLNLNGKKRPTMREV 543
K CL + K+R ++ E+
Sbjct: 302 -----KCCLKRDPKQRISIPEL 318
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 118 bits (298), Expect = 2e-29
Identities = 70/328 (21%), Positives = 127/328 (38%), Gaps = 59/328 (17%)
Query: 262 LQQELASTEGTIEKTKLFTSKELEKATDNFDLNRILGQG-----------GQ--AVK--- 305
++ L++ I K KE +K +++ + R L QG + A+K
Sbjct: 6 MKDILSNYSNLIYLNK--YVKEKDKYINDYRIIRTLNQGKFNKIILCEKDNKFYALKKYE 63
Query: 306 --------------KSKVIDESKVEEFINEVVILSQINHRNVVKLLGCCLETEVPL-LVY 350
K+ +SK ++F NE+ I++ I + + G + + ++Y
Sbjct: 64 KSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLTCEGI-ITNYDEVYIIY 122
Query: 351 EFIPNGTLFQYIH-----DQNEDFPITWEIRLRIAIEVSGALSYLHSAASIPIYHRDIKS 405
E++ N ++ ++ D+N I ++ I V + SY+H+ +I HRD+K
Sbjct: 123 EYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNEKNI--CHRDVKP 180
Query: 406 TNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHGTFGYLDPEYFRSSQFTD--KSDVYS 463
+NIL+D R K+SDFG S M + GT+ ++ PE+F + + K D++S
Sbjct: 181 SNILMDKNGRVKLSDFGESEYM--VDKKIKGSR-GTYEFMPPEFFSNESSYNGAKVDIWS 237
Query: 464 FGVVLTELLTGEKPIRFTILEEDKSLAAYFLCAMKEE-------RLFEILDARVMKQGGK 516
G+ L + P F SL F + F
Sbjct: 238 LGICLYVMFYNVVP--F---SLKISLVELFNNIRTKNIEYPLDRNHFLYPLTNKKSTCSN 292
Query: 517 DEIITVAK-LAKRCLNLNGKKRPTMREV 543
+ + K L N +R T +
Sbjct: 293 NFLSNEDIDFLKLFLRKNPAERITSEDA 320
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 118 bits (297), Expect = 2e-29
Identities = 69/310 (22%), Positives = 128/310 (41%), Gaps = 76/310 (24%)
Query: 289 DNFDLNRILGQG--GQ--------------------AVKKSKVI-DESKVEEFINEVVIL 325
D L + LG+G GQ AVK K E + + ++E+ ++
Sbjct: 35 DKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMM 94
Query: 326 SQI-NHRNVVKLLGCCLETEVPLLVYEFIPNGTLFQY-------------IHDQNEDFPI 371
I H+N++ LLG C + ++ E+ G L +Y ++ + +
Sbjct: 95 KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQM 154
Query: 372 TWEIRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQ 431
T++ + +++ + YL AS HRD+ + N+L+ + K++DFG +R +
Sbjct: 155 TFKDLVSCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNID 211
Query: 432 THMTTQVHGTFGYL-----DPEYFRSSQFTDKSDVYSFGVVLTELLT-GEKPIRFTILEE 485
+ T G L PE +T +SDV+SFGV++ E+ T G P
Sbjct: 212 YYKK----TTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSP-------- 259
Query: 486 DKSLAAYFLCAMKEERLFEILDARVMKQGGKDEI-----ITVAKLAKRCLNLNGKKRPTM 540
Y + E LF++L K+G + + + + + C + +RPT
Sbjct: 260 ------Y--PGIPVEELFKLL-----KEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTF 306
Query: 541 REVASELAGI 550
+++ +L I
Sbjct: 307 KQLVEDLDRI 316
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 118 bits (297), Expect = 2e-29
Identities = 59/292 (20%), Positives = 112/292 (38%), Gaps = 68/292 (23%)
Query: 290 NFDLNRILGQGG-----QAVKKS------KVI-----DESKVEEFINEVVILSQINH--R 331
+ + + +G GG Q + + K + D ++ + NE+ L+++
Sbjct: 10 IYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSD 69
Query: 332 NVVKLLGCCLETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEIRLRIAIEVSGALSYLH 391
+++L + + +V E N L ++ + + WE + + A+ +H
Sbjct: 70 KIIRLYDYEITDQYIYMVMEC-GNIDLNSWLK-KKKSIDP-WERK-SYWKNMLEAVHTIH 125
Query: 392 SAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQT--HMTTQVHGTFGYLDPE- 448
I H D+K N L+ D K+ DFG + M D T +QV GT Y+ PE
Sbjct: 126 QHG---IVHSDLKPANFLIVDG-MLKLIDFGIANQMQPDTTSVVKDSQV-GTVNYMPPEA 180
Query: 449 ----------YFRSSQFTDKSDVYSFGVVLTELLTGEKPIRFTILEEDKSLAAYFLCAMK 498
S+ + KSDV+S G +L + G+ P + +
Sbjct: 181 IKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTP--------------FQQIINQ 226
Query: 499 EERLFEILDARV-------MKQGGKDEIITVAKLAKRCLNLNGKKRPTMREV 543
+L I+D ++ +D + K CL + K+R ++ E+
Sbjct: 227 ISKLHAIIDPNHEIEFPDIPEKDLQDVL-------KCCLKRDPKQRISIPEL 271
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 118 bits (298), Expect = 2e-29
Identities = 57/224 (25%), Positives = 94/224 (41%), Gaps = 43/224 (19%)
Query: 289 DNFDLNRILGQG--GQ------------------AVK--KSKVIDESKVEEFINEVVILS 326
N L R LG G G+ AVK ++ + +F+ E +I+S
Sbjct: 71 KNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDE-LDFLMEALIIS 129
Query: 327 QINHRNVVKLLGCCLETEVPLLVYEFIPNGTLFQYI----HDQNEDFPITWEIRLRIAIE 382
+ NH+N+V+ +G L++ ++ E + G L ++ ++ + L +A +
Sbjct: 130 KFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARD 189
Query: 383 VSGALSYLHSAASIPIYHRDIKSTNILLD---DKYRAKVSDFGASRSMAVDQTHMTTQVH 439
++ YL HRDI + N LL AK+ DFG +R + +
Sbjct: 190 IACGCQYL---EENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAGYY----RK 242
Query: 440 GTFGYL-----DPEYFRSSQFTDKSDVYSFGVVLTELLT-GEKP 477
G L PE F FT K+D +SFGV+L E+ + G P
Sbjct: 243 GGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMP 286
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 117 bits (295), Expect = 3e-29
Identities = 66/331 (19%), Positives = 107/331 (32%), Gaps = 54/331 (16%)
Query: 241 VKRRREIKLKRKYFKRNGGLL--LQQELASTEGTIEKTKLF-TSKELEKATDNFDLNRIL 297
+ + K + L L E EG + KL E + +
Sbjct: 7 SGQAHSLASLAKTWSSGSAKLQRLGPETEDNEGVLLTEKLKPVDYEYREEVHWMTHQPRV 66
Query: 298 GQG-------------GQ--AVKKSKVIDESKVEEFINEVVILSQINHRNVVKLLGCCLE 342
G+G G AVKK ++ E+V + ++ +V L G E
Sbjct: 67 GRGSFGEVHRMKDKQTGFQCAVKKVRLEVFRV-----EELVACAGLSSPRIVPLYGAVRE 121
Query: 343 TEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEIRLR-IAIEVSGALSYLHSAASIPIYHR 401
+ E + G+L Q I Q P E R + L YLH+ + H
Sbjct: 122 GPWVNIFMELLEGGSLGQLI-KQMGCLP---EDRALYYLGQALEGLEYLHTRRIL---HG 174
Query: 402 DIKSTNILLDDK-YRAKVSDFGASRSMAVDQTHMTTQ----VHGTFGYLDPEYFRSSQFT 456
D+K+ N+LL RA + DFG + + D + + GT ++ PE
Sbjct: 175 DVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMGKPCD 234
Query: 457 DKSDVYSFGVVLTELLTGEKPIRFTILEEDKSLAAYFLCAMKEERLFEILDARVMKQGGK 516
K D++S ++ +L G P + A + + EI +
Sbjct: 235 AKVDIWSSCCMMLHMLNGCHP-----WTQYFRGPLCLKIASEPPPIREIPPS--CAPLTA 287
Query: 517 DEIITVAKLAKRCLNLNGKKRPTMREVASEL 547
I + L R + A EL
Sbjct: 288 QAI-------QEGLRKEPVHRAS----AMEL 307
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 119 bits (301), Expect = 6e-29
Identities = 72/291 (24%), Positives = 119/291 (40%), Gaps = 49/291 (16%)
Query: 277 KLFTSKELEKATDNFDLNRILGQG-------------GQ--AVK---KSKVIDESKVEEF 318
+F +D + R+LG+G GQ AVK K +V ++ E
Sbjct: 14 GMFVQHSTAIFSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESL 73
Query: 319 INEVVILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEIRLR 378
+ EV +L Q++H N++KL + LV E G LF I + + R
Sbjct: 74 LREVQLLKQLDHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRK---RFSEVDAAR 130
Query: 379 IAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDK---YRAKVSDFGASRSMAVDQTHMT 435
I +V ++Y+H I HRD+K N+LL+ K ++ DFG S + M
Sbjct: 131 IIRQVLSGITYMHKNK---IVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKK-MK 186
Query: 436 TQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLTELLTGEKPIRFTILEEDKSLAAYFLC 495
++ GT Y+ PE + + +K DV+S GV+L LL+G P F
Sbjct: 187 DKI-GTAYYIAPEVLHGT-YDEKCDVWSTGVILYILLSGCPP--FN-------------- 228
Query: 496 AMKEERLFE-ILDARV-MKQGGKDEIITVAK-LAKRCLNLNGKKRPTMREV 543
E + + + + + ++ AK L ++ L R + R+
Sbjct: 229 GANEYDILKKVEKGKYTFELPQWKKVSESAKDLIRKMLTYVPSMRISARDA 279
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 117 bits (296), Expect = 7e-29
Identities = 62/273 (22%), Positives = 106/273 (38%), Gaps = 51/273 (18%)
Query: 249 LKRKYFKRNGGLLLQ-QELASTEGTIEKTKLFTSKELEKATDNFDLNRILGQG--GQ--- 302
+ + + + +L E D L + LG+G GQ
Sbjct: 28 YHHHHHHDYDIPTTENLYFQGMLAGVSEYELPEDPRWELPRDRLVLGKPLGEGAFGQVVL 87
Query: 303 -----------------AVKKSKVI-DESKVEEFINEVVILSQI-NHRNVVKLLGCCLET 343
AVK K E + + I+E+ ++ I H+N++ LLG C +
Sbjct: 88 AEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQD 147
Query: 344 EVPLLVYEFIPNGTLFQY-------------IHDQNEDFPITWEIRLRIAIEVSGALSYL 390
++ E+ G L +Y N + ++ + + A +V+ + YL
Sbjct: 148 GPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYL 207
Query: 391 HSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHGTFGYL----- 445
AS HRD+ + N+L+ + K++DFG +R + + T G L
Sbjct: 208 ---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKK----TTNGRLPVKWM 260
Query: 446 DPEYFRSSQFTDKSDVYSFGVVLTELLT-GEKP 477
PE +T +SDV+SFGV+L E+ T G P
Sbjct: 261 APEALFDRIYTHQSDVWSFGVLLWEIFTLGGSP 293
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 119 bits (299), Expect = 9e-29
Identities = 66/304 (21%), Positives = 115/304 (37%), Gaps = 48/304 (15%)
Query: 263 QQELASTEGTIEKTKLFTSKELEKATDNFDLNRILGQGG-----QAVKKS-------KVI 310
++ L +F + + ++ + + LG G K K+I
Sbjct: 11 RENLYFQGDLQATPGMFITSKKGHLSEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKII 70
Query: 311 DESKV-----EEFINEVVILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGTLFQYIHDQ 365
++ V + + EV +L ++H N++KL + LV E G LF I +
Sbjct: 71 RKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLVMECYKGGELFDEIIHR 130
Query: 366 NEDFPITWEIRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDK---YRAKVSDFG 422
I +V ++YLH I HRD+K N+LL+ K K+ DFG
Sbjct: 131 M---KFNEVDAAVIIKQVLSGVTYLHKHN---IVHRDLKPENLLLESKEKDALIKIVDFG 184
Query: 423 ASRSMAVDQTHMTTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLTELLTGEKPIRFTI 482
S + M ++ GT Y+ PE R + +K DV+S GV+L LL G P
Sbjct: 185 LSAVFENQKK-MKERL-GTAYYIAPEVLRKK-YDEKCDVWSIGVILFILLAGYPPF---- 237
Query: 483 LEEDKSLAAYFLCAMKEERLFE-ILDARV-MKQGGKDEIITVAK-LAKRCLNLNGKKRPT 539
++ + + + + AK L K+ L + ++R +
Sbjct: 238 ------------GGQTDQEILRKVEKGKYTFDSPEWKNVSEGAKDLIKQMLQFDSQRRIS 285
Query: 540 MREV 543
++
Sbjct: 286 AQQA 289
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 115 bits (291), Expect = 1e-28
Identities = 62/282 (21%), Positives = 112/282 (39%), Gaps = 72/282 (25%)
Query: 247 IKLKRKYFKRNGGLLLQQELASTEGTIEKTKLFTSKELEKATDNFDLNRILGQG--GQ-- 302
K K KY R +++ ++ I+ T+L +++ E +N + LG G G+
Sbjct: 6 YKQKPKYQVRWK--IIESYEGNSYTFIDPTQLPYNEKWEFPRNNLQFGKTLGAGAFGKVV 63
Query: 303 ----------------AVKKSK-VIDESKVEEFINEVVILSQI-NHRNVVKLLGCCLETE 344
AVK K + E ++E+ I+S + H N+V LLG C
Sbjct: 64 EATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACTHGG 123
Query: 345 VPLLVYEFIPNGTLFQYIHDQNEDF-----------PITWEIRLRIAIEVSGALSYLHSA 393
L++ E+ G L ++ ++ + L + +V+ +++L
Sbjct: 124 PVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFL--- 180
Query: 394 ASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHGTFGYLDPEYFRSS 453
AS HRD+ + N+LL + + AK+ DFG +R + D Y
Sbjct: 181 ASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDI----------------MNDSNYIVKG 224
Query: 454 Q-----------------FTDKSDVYSFGVVLTELLT-GEKP 477
+T +SDV+S+G++L E+ + G P
Sbjct: 225 NARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNP 266
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 115 bits (290), Expect = 2e-28
Identities = 55/238 (23%), Positives = 95/238 (39%), Gaps = 70/238 (29%)
Query: 289 DNFDLNRILGQG--GQ---------------AVKKSKVI-DESKVEEFINEVVILSQI-N 329
++ ++G+G GQ A+K+ K + +F E+ +L ++ +
Sbjct: 25 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGH 84
Query: 330 HRNVVKLLGCCLETEVPLLVYEFIPNGTLFQY-------------IHDQNEDFPITWEIR 376
H N++ LLG C L E+ P+G L + + ++ +
Sbjct: 85 HPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQL 144
Query: 377 LRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRS---------- 426
L A +V+ + YL + HRD+ + NIL+ + Y AK++DFG SR
Sbjct: 145 LHFAADVARGMDYL---SQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKTMG 201
Query: 427 ------MAVDQTHMTTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLTELLT-GEKP 477
MA E S +T SDV+S+GV+L E+++ G P
Sbjct: 202 RLPVRWMA------------------IESLNYSVYTTNSDVWSYGVLLWEIVSLGGTP 241
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 115 bits (290), Expect = 2e-28
Identities = 63/310 (20%), Positives = 120/310 (38%), Gaps = 77/310 (24%)
Query: 289 DNFDLNRILGQG--GQ------------------AVKKSKVI-DESKVEEFINEVVILSQ 327
+N + R +G+G G+ AVK K +F E ++++
Sbjct: 47 NNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAE 106
Query: 328 INHRNVVKLLGCCLETEVPLLVYEFIPNGTLFQY---------------------IHDQN 366
++ N+VKLLG C + L++E++ G L ++
Sbjct: 107 FDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSP 166
Query: 367 EDFPITWEIRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRS 426
P++ +L IA +V+ ++YL + HRD+ + N L+ + K++DFG SR+
Sbjct: 167 GPPPLSCAEQLCIARQVAAGMAYL---SERKFVHRDLATRNCLVGENMVVKIADFGLSRN 223
Query: 427 MAVDQTHMTTQVHGTFGYL-----DPEYFRSSQFTDKSDVYSFGVVLTELLT-GEKPIRF 480
+ + + PE +++T +SDV+++GVVL E+ + G +P
Sbjct: 224 IYSADYYKA----DGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQP--- 276
Query: 481 TILEEDKSLAAYFLCAMKEERLFE-ILDARVMKQ--GGKDEIITVAKLAKRCLNLNGKKR 537
Y M E + + D ++ E+ L + C + R
Sbjct: 277 -----------Y--YGMAHEEVIYYVRDGNILACPENCPLEL---YNLMRLCWSKLPADR 320
Query: 538 PTMREVASEL 547
P+ + L
Sbjct: 321 PSFCSIHRIL 330
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 113 bits (285), Expect = 5e-28
Identities = 57/232 (24%), Positives = 97/232 (41%), Gaps = 50/232 (21%)
Query: 289 DNFDLNRILGQG--GQ------------------AVKKSK-VIDESKVEEFINEVVILSQ 327
+ + LG G G+ AVK K ++ E ++E+ +LS
Sbjct: 23 NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSY 82
Query: 328 I-NHRNVVKLLGCCLETEVPLLVYEFIPNGTLFQY---------------IHDQNEDFPI 371
+ NH N+V LLG C L++ E+ G L + ++++ +
Sbjct: 83 LGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELAL 142
Query: 372 TWEIRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQ 431
E L + +V+ +++L AS HRD+ + NILL K+ DFG +R + D
Sbjct: 143 DLEDLLSFSYQVAKGMAFL---ASKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDS 199
Query: 432 THMTTQVHGTFGYL-----DPEYFRSSQFTDKSDVYSFGVVLTELLT-GEKP 477
++ L PE + +T +SDV+S+G+ L EL + G P
Sbjct: 200 NYVVK----GNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSP 247
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 113 bits (284), Expect = 5e-28
Identities = 46/196 (23%), Positives = 89/196 (45%), Gaps = 29/196 (14%)
Query: 303 AVK--KSKVIDESKVEEFINEVVILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGTLFQ 360
A+K K K + EEF +E ++ +++ H NVV LLG + + +++ + +G L +
Sbjct: 43 AIKTLKDKAEGPLR-EEFRHEAMLRARLQHPNVVCLLGVVTKDQPLSMIFSYCSHGDLHE 101
Query: 361 Y-------------IHDQNEDFPITWEIRLRIAIEVSGALSYLHSAASIPIYHRDIKSTN 407
+ D+ + + + +++ + YL +S + H+D+ + N
Sbjct: 102 FLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYL---SSHHVVHKDLATRN 158
Query: 408 ILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHGTFGYL-----DPEYFRSSQFTDKSDVY 462
+L+ DK K+SD G R + + L PE +F+ SD++
Sbjct: 159 VLVYDKLNVKISDLGLFREVYAADYYKL----LGNSLLPIRWMAPEAIMYGKFSIDSDIW 214
Query: 463 SFGVVLTELLT-GEKP 477
S+GVVL E+ + G +P
Sbjct: 215 SYGVVLWEVFSYGLQP 230
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 113 bits (285), Expect = 9e-28
Identities = 60/278 (21%), Positives = 115/278 (41%), Gaps = 55/278 (19%)
Query: 248 KLKRKYFKRNGGLLLQQELASTEGTIEKTKLFTSKELEKATDNFDLNRILGQG--GQ--- 302
K + +Y + + + + ++ + + E +N + ++LG G G+
Sbjct: 4 KKQFRYESQLQMVQVTGSSDNEYFYVDFREYEYDLKWEFPRENLEFGKVLGSGAFGKVMN 63
Query: 303 ---------------AVKKSK-VIDESKVEEFINEVVILSQI-NHRNVVKLLGCCLETEV 345
AVK K D S+ E ++E+ +++Q+ +H N+V LLG C +
Sbjct: 64 ATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGP 123
Query: 346 PLLVYEFIPNGTLFQY--------------------IHDQNEDFPITWEIRLRIAIEVSG 385
L++E+ G L Y + ++ + +T+E L A +V+
Sbjct: 124 IYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAK 183
Query: 386 ALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHGTFGYL 445
+ +L HRD+ + N+L+ K+ DFG +R + D ++ L
Sbjct: 184 GMEFL---EFKSCVHRDLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVR----GNARL 236
Query: 446 -----DPEYFRSSQFTDKSDVYSFGVVLTELLT-GEKP 477
PE +T KSDV+S+G++L E+ + G P
Sbjct: 237 PVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNP 274
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 114 bits (288), Expect = 1e-27
Identities = 64/297 (21%), Positives = 113/297 (38%), Gaps = 60/297 (20%)
Query: 289 DNFDLNRILGQG--GQAVKKS---------KVIDESKVEEFINEVVILSQI-NHRNVVKL 336
+ +ILG G G V + K + + + E+ +L++ +H NV++
Sbjct: 15 NLVVSEKILGYGSSGTVVFQGSFQGRPVAVKRMLIDFCDIALMEIKLLTESDDHPNVIRY 74
Query: 337 LGCCLETEVPL-LVYEFIPNGTLFQYI---HDQNEDFPITWEIRLRIAI-EVSGALSYLH 391
C T+ L + E N L + + +E+ + E + +++ +++LH
Sbjct: 75 Y-CSETTDRFLYIALELC-NLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLH 132
Query: 392 SAASIPIYHRDIKSTNILLDDK-------------YRAKVSDFGASRSMAVDQTHMTTQV 438
S + I HRD+K NIL+ R +SDFG + + Q+ T +
Sbjct: 133 S---LKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSFRTNL 189
Query: 439 H---GTFGYLDPEYFRSSQF-------TDKSDVYSFGVVLTELLT-GEKPIRFTILEEDK 487
+ GT G+ PE S T D++S G V +L+ G+ P E
Sbjct: 190 NNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSRESN 249
Query: 488 SLAAYFLCAMKEERLFEILDARVMKQGGKDEIITVAK-LAKRCLNLNGKKRPTMREV 543
+ F MK +I A L + ++ + KRPT +V
Sbjct: 250 IIRGIF-------------SLDEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKV 293
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 112 bits (283), Expect = 1e-27
Identities = 64/328 (19%), Positives = 125/328 (38%), Gaps = 61/328 (18%)
Query: 279 FTSKELEKATDNFDLNRILGQGGQ---------------AVKKSKVIDESKVEEFINEVV 323
F + +E + R+L +GG A+K+ +E K I EV
Sbjct: 18 FVGQTVELGELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVC 77
Query: 324 ILSQI-NHRNVVKLLGCCLETEVP-------LLVYEFIPNGTLFQYIHDQNEDFPITWEI 375
+ ++ H N+V+ + L+ + G L +++ P++ +
Sbjct: 78 FMKKLSGHPNIVQFCSAASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCDT 137
Query: 376 RLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMT 435
L+I + A+ ++H PI HRD+K N+LL ++ K+ DFG++ +++ +
Sbjct: 138 VLKIFYQTCRAVQHMHRQ-KPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSW 196
Query: 436 T-----------QVHGTFGYLDPEYFRSSQ---FTDKSDVYSFGVVLTELLTGEKPIRFT 481
+ + T Y PE +K D+++ G +L L + P F
Sbjct: 197 SAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHP--F- 253
Query: 482 ILEEDKSLAAYFLCAMKEERLFEILDARVMKQGGKDEIITVAKLAKRCLNLNGKKRPTMR 541
ED + I++ + + L + L +N ++R ++
Sbjct: 254 ---EDGAKLR-------------IVNGKYSIPPHDTQYTVFHSLIRAMLQVNPEERLSIA 297
Query: 542 EV---ASELAGIKAWNGASNVIEEGLEE 566
EV E+A + N + I E LE+
Sbjct: 298 EVVHQLQEIAAARNVN-PKSPITELLEQ 324
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 113 bits (284), Expect = 2e-27
Identities = 39/364 (10%), Positives = 84/364 (23%), Gaps = 73/364 (20%)
Query: 233 GAWWLFKFVKRRREI--KLKRKYFKRNGGLLLQQELASTEGTIEKTKLFTSKELEKATDN 290
G ++ +KR E+ + + K ++ E + + + L +
Sbjct: 7 GDSFMRDLLKREEELIGYCREEALKEPAAMV---EAVTATVWPQNAETTVDSLLSQGERK 63
Query: 291 FDLNRILGQGGQ---------------AVK---KSKVIDESKVEEFINEVVILSQINHRN 332
L L G + A+K S++E +++ +
Sbjct: 64 LKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGES 123
Query: 333 VVKLLGCCLETEVP--------------------------LLVYEFIPNGTLFQYIHD-- 364
+ LL+ + L
Sbjct: 124 PEEARDRRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPA-ASVDLELLFSTLD 182
Query: 365 --QNEDFPITWEIRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFG 422
+ ++ + L S + H N+ + R + D
Sbjct: 183 FVYVFRGDEGILALHILTAQLIRLAANLQSKG---LVHGHFTPDNLFIMPDGRLMLGDVS 239
Query: 423 ASRSMAVDQTHMTTQVHGTFGYLDPEYFRSS--QFTDKSDVYSFGVVLTELLTGEKPIRF 480
Y E+ +S FT + + G+ + + P F
Sbjct: 240 ----ALWKVGTRGPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLP--F 293
Query: 481 TILEED-KSLAAYFLCAMKEERLFEILDARVMKQGGKDEIITVAKLAKRCLNLNGKKRPT 539
++ K + + K L R LN + ++R
Sbjct: 294 GLVTPGIKGSWKRPSLRVPGTDSLAFGSCTPLPDFVKT-------LIGRFLNFDRRRRLL 346
Query: 540 MREV 543
E
Sbjct: 347 PLEA 350
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 3e-26
Identities = 46/245 (18%), Positives = 89/245 (36%), Gaps = 34/245 (13%)
Query: 311 DESKVEEFINEVVILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGTLFQYIHDQNEDFP 370
S ++ ++ + + +N V L + + L +++ +
Sbjct: 101 SPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLED 160
Query: 371 ITWEIRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVD 430
+ L I I+++ A+ +LHS + HRD+K +NI KV DFG +M D
Sbjct: 161 REHGVCLHIFIQIAEAVEFLHSKG---LMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQD 217
Query: 431 Q------------THMTTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLTELLTGEKPI 478
+ T QV GT Y+ PE + ++ K D++S G++L ELL
Sbjct: 218 EEEQTVLTPMPAYATHTGQV-GTKLYMSPEQIHGNNYSHKVDIFSLGLILFELLYSFST- 275
Query: 479 RFTILEEDKSLAAYFLCAMKEERLFEILDARVMKQGGKDEIITVAKLAKRCLNLNGKKRP 538
M+ R+ + + + + L+ + +RP
Sbjct: 276 -----------------QMERVRIITDVRNLKFPLLFTQKYPQEHMMVQDMLSPSPTERP 318
Query: 539 TMREV 543
++
Sbjct: 319 EATDI 323
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 111 bits (279), Expect = 3e-26
Identities = 75/300 (25%), Positives = 121/300 (40%), Gaps = 59/300 (19%)
Query: 278 LFTSKELEKATDNFDLNRILGQGG-----QAVKKS-------KVIDESKV---------- 315
++ K+ K +++ R LG G +K+ KVI +S+
Sbjct: 25 MYVRKKEGKIGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNK 84
Query: 316 ------EEFINEVVILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGTLFQYIHDQNEDF 369
EE NE+ +L ++H N++KL + + LV EF G LF+ I +++
Sbjct: 85 NIEKFHEEIYNEISLLKSLDHPNIIKLFDVFEDKKYFYLVTEFYEGGELFEQIINRH--- 141
Query: 370 PITWEIRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDK---YRAKVSDFGASRS 426
I ++ + YLH I HRDIK NILL++K K+ DFG S
Sbjct: 142 KFDECDAANIMKQILSGICYLHKHN---IVHRDIKPENILLENKNSLLNIKIVDFGLSSF 198
Query: 427 MAVDQTHMTTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLTELLTGEKPIRFTILEED 486
+ D + ++ GT Y+ PE + + +K DV+S GV++ LL G P F
Sbjct: 199 FSKDYK-LRDRL-GTAYYIAPEVLKKK-YNEKCDVWSCGVIMYILLCGYPP--F------ 247
Query: 487 KSLAAYFLCAMKEERLFE-ILDARV-MKQGGKDEIITVAK-LAKRCLNLNGKKRPTMREV 543
++ + + + + I AK L K L + KR T E
Sbjct: 248 --------GGQNDQDIIKKVEKGKYYFDFNDWKNISDEAKELIKLMLTYDYNKRCTAEEA 299
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 110 bits (278), Expect = 4e-26
Identities = 68/283 (24%), Positives = 115/283 (40%), Gaps = 56/283 (19%)
Query: 288 TDNFDLNRILGQGG-----QAVKKS-------KVIDESKV-----EEFINEVVILSQINH 330
+ +++ +LG+G + + KVI+++ + EV +L +++H
Sbjct: 21 AERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDH 80
Query: 331 RNVVKLLGCCLETEVPL-LVYEFIPNGTLFQYIHDQ---NEDFPITWEIRLRIAIEVSGA 386
N++KL E +V E G LF I + +E + RI +V
Sbjct: 81 PNIMKLFEIL-EDSSSFYIVGELYTGGELFDEIIKRKRFSEH-----DAA-RIIKQVFSG 133
Query: 387 LSYLHSAASIPIYHRDIKSTNILLDDK---YRAKVSDFGASRSMAVDQTHMTTQVHGTFG 443
++Y+H I HRD+K NILL+ K K+ DFG S + M ++ GT
Sbjct: 134 ITYMHKHN---IVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTK-MKDRI-GTAY 188
Query: 444 YLDPEYFRSSQFTDKSDVYSFGVVLTELLTGEKPIRFTILEEDKSLAAYFLCAMKEERLF 503
Y+ PE R + + +K DV+S GV+L LL+G P F E +
Sbjct: 189 YIAPEVLRGT-YDEKCDVWSAGVILYILLSGTPP--FY--------------GKNEYDIL 231
Query: 504 E-ILDARV-MKQGGKDEIITVAK-LAKRCLNLNGKKRPTMREV 543
+ + + I AK L ++ L + R T +
Sbjct: 232 KRVETGKYAFDLPQWRTISDDAKDLIRKMLTFHPSLRITATQC 274
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 107 bits (270), Expect = 7e-26
Identities = 76/293 (25%), Positives = 128/293 (43%), Gaps = 65/293 (22%)
Query: 280 TSKELEKATDNFDLNRILGQG-------------GQ--AVK---KSKVIDESKVEEFINE 321
+ + + N+ L + +G+G G+ A+K K++ ++ + +++ E
Sbjct: 6 SCADEQPHIGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQ-LNPTSLQKLFRE 64
Query: 322 VVILSQINHRNVVKLLGCCLETEVPL-LVYEFIPNGTLFQYIHDQ---NEDFPITWEIRL 377
V I+ +NH N+VKL +ETE L L+ E+ G +F Y+ E E R
Sbjct: 65 VRIMKILNHPNIVKLFEV-IETEKTLYLIMEYASGGEVFDYLVAHGRMKEK-----EAR- 117
Query: 378 RIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQ 437
++ A+ Y H I HRD+K+ N+LLD K++DFG S V +
Sbjct: 118 SKFRQIVSAVQYCHQKR---IVHRDLKAENLLLDADMNIKIADFGFSNEFTVGG-KLDAF 173
Query: 438 VHGTFGYLDPEYFRSSQFT-DKSDVYSFGVVLTELLTGEKPIRFTILEEDKSLAAYFLCA 496
G Y PE F+ ++ + DV+S GV+L L++G P F + ++L
Sbjct: 174 C-GAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLP--F----DGQNLKE----- 221
Query: 497 MKEERLFE-ILDARV-----MKQGGKDEIITVAKLAKRCLNLNGKKRPTMREV 543
L E +L + M ++ L KR L LN KR T+ ++
Sbjct: 222 -----LRERVLRGKYRIPFYMSTDCEN-------LLKRFLVLNPIKRGTLEQI 262
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 107 bits (267), Expect = 4e-25
Identities = 28/277 (10%), Positives = 69/277 (24%), Gaps = 34/277 (12%)
Query: 277 KLFTSKELEKATDNFDLNRILGQGGQAVKKSKVIDESKVEEFINEVVILSQINHRNVVKL 336
+ E + + + + FI ++ + ++++
Sbjct: 109 HVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLVKDPQKKKMIRV 168
Query: 337 LGC----CLETEVPLLVYEFIPNGTLFQYIHDQN-EDFPITWEIRLRIAIEVSGALSYLH 391
+ + L T + + + + RL++ ++V L+ LH
Sbjct: 169 RLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLH 228
Query: 392 SAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHGTFGYLDPEYFR 451
+ H ++ +I+LD + ++ F +
Sbjct: 229 HYG---LVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGASAVSPIGRGFAPPETTAERMLP 285
Query: 452 SSQ-----FTDKSDVYSFGVVLTELLTGEKPIRFTILEEDKSLAAYFLCAMKEERLFEIL 506
Q T D ++ G+ + + + P T F I
Sbjct: 286 FGQHHPTLMTFAFDTWTLGLAIYWIWCADLP--NTDDAALGGSEWIF------RSCKNIP 337
Query: 507 DARVMKQGGKDEIITVAKLAKRCLNLNGKKRPTMREV 543
V L + L + R +
Sbjct: 338 QP-------------VRALLEGFLRYPKEDRLLPLQA 361
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 8e-25
Identities = 57/210 (27%), Positives = 89/210 (42%), Gaps = 29/210 (13%)
Query: 289 DNFDLNRILGQG--GQ-------------AVK---KSKVIDESKVEEFINEVVILSQINH 330
++F +ILG+G A+K K +I E+KV E ++S+++H
Sbjct: 30 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 89
Query: 331 RNVVKLLGCCLETEVPL-LVYEFIPNGTLFQYIHDQNEDFPITWEIRLRI-AIEVSGALS 388
VKL + + L + NG L +YI F E R E+ AL
Sbjct: 90 PFFVKLYFTF-QDDEKLYFGLSYAKNGELLKYIRKIGS-FD---ETCTRFYTAEIVSALE 144
Query: 389 YLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFG-ASRSMAVDQTHMTTQVHGTFGYLDP 447
YLH I HRD+K NILL++ +++DFG A + GT Y+ P
Sbjct: 145 YLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSP 201
Query: 448 EYFRSSQFTDKSDVYSFGVVLTELLTGEKP 477
E SD+++ G ++ +L+ G P
Sbjct: 202 ELLTEKSACKSSDLWALGCIIYQLVAGLPP 231
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 106 bits (266), Expect = 8e-25
Identities = 66/291 (22%), Positives = 108/291 (37%), Gaps = 62/291 (21%)
Query: 288 TDNFDLNRILGQGG-----QAVKKS-------KVIDESKV-----------EEFINEVVI 324
D + +++ LG G A ++ ++I + K E+ I
Sbjct: 134 RDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEI 193
Query: 325 LSQINHRNVVKLLGCCLETEVPLLVYEFIPNGTLFQYIHDQ---NEDFPITWEIRLRIAI 381
L ++NH ++K+ + E +V E + G LF + E +
Sbjct: 194 LKKLNHPCIIKIKNFF-DAEDYYIVLELMEGGELFDKVVGNKRLKEA-----TCK-LYFY 246
Query: 382 EVSGALSYLHSAASIPIYHRDIKSTNILLDDK---YRAKVSDFGASRSMAVDQTHMTTQV 438
++ A+ YLH I HRD+K N+LL + K++DFG S+ + + + M T
Sbjct: 247 QMLLAVQYLH---ENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILG-ETSLMRTLC 302
Query: 439 HGTFGYLDPEYFRSSQF---TDKSDVYSFGVVLTELLTGEKPIRFTILEEDKSLAAYFLC 495
GT YL PE S D +S GV+L L+G P F
Sbjct: 303 -GTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPP---------------FSE 346
Query: 496 AMKEERLFE-ILDARV-MKQGGKDEIITVAK-LAKRCLNLNGKKRPTMREV 543
+ L + I + E+ A L K+ L ++ K R T E
Sbjct: 347 HRTQVSLKDQITSGKYNFIPEVWAEVSEKALDLVKKLLVVDPKARFTTEEA 397
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 105 bits (263), Expect = 8e-25
Identities = 34/284 (11%), Positives = 82/284 (28%), Gaps = 47/284 (16%)
Query: 277 KLFTSKELEKATDNFDLNRILGQGGQAVKKSKVIDESKVEEFINEVVILSQINHRNVVKL 336
+ E + + + + FI ++ + ++++
Sbjct: 104 HVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLVKDPQKKKMIRV 163
Query: 337 LGCCLETEVP--LLVYEFI--PNGTLFQYIHD-QNEDFPITWEIRLRIAIEVSGALSYLH 391
+ V +Y + T + + + + RL++ ++V L+ LH
Sbjct: 164 RLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLH 223
Query: 392 SAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHGTFGYLDPEYF- 450
+ H ++ +I+LD + ++ F + G+ PE
Sbjct: 224 HYG---LVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGARVVSS-----VSRGFEPPELEA 275
Query: 451 ----------RSSQFTDKSDVYSFGVVLTELLTGEKPIRFTILEEDKSLAAYFLCAMKEE 500
R + T D ++ G+V+ + + P +D +L E
Sbjct: 276 RRATISYHRDRRTLMTFSFDAWALGLVIYWIWCADLP--I---TKDAALGGS-------E 323
Query: 501 RLFEILDARVMKQGGKDEIITVAK-LAKRCLNLNGKKRPTMREV 543
+F I + L + L + R +
Sbjct: 324 WIFR----------SCKNIPQPVRALLEGFLRYPKEDRLLPLQA 357
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 1e-24
Identities = 57/207 (27%), Positives = 97/207 (46%), Gaps = 27/207 (13%)
Query: 288 TDNFDLNRILGQG-------------GQ--AVKKSKVIDESKVEEFINEVVILSQINHRN 332
+ +GQG GQ A+++ + + K E INE++++ + + N
Sbjct: 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPN 78
Query: 333 VVKLLGCCLETEVPLLVYEFIPNGTLFQYIHDQ--NEDFPITWEIRLRIAIEVSGALSYL 390
+V L L + +V E++ G+L + + +E +I + E AL +L
Sbjct: 79 IVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEG-----QIAA-VCRECLQALEFL 132
Query: 391 HSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHGTFGYLDPEYF 450
HS I HRDIKS NILL K++DFG + +Q+ +T V GT ++ PE
Sbjct: 133 HSNQVI---HRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMV-GTPYWMAPEVV 188
Query: 451 RSSQFTDKSDVYSFGVVLTELLTGEKP 477
+ K D++S G++ E++ GE P
Sbjct: 189 TRKAYGPKVDIWSLGIMAIEMIEGEPP 215
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 104 bits (262), Expect = 1e-24
Identities = 70/300 (23%), Positives = 120/300 (40%), Gaps = 62/300 (20%)
Query: 278 LFTSKELEKATDNFDLNRILGQGG-----QAVKKS-------KVIDESK--------VEE 317
L + + D ++L ++G+G + + + K++D +K E+
Sbjct: 13 LDMADDDVLFEDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTED 72
Query: 318 FINEVVILSQINHRNVVKLLGCCLETEVPL-LVYEFIPNGTLFQYIHDQNEDFPITWEIR 376
E I + H ++V+LL ++ L +V+EF+ L I + + + E
Sbjct: 73 LKREASICHMLKHPHIVELLETY-SSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAV 131
Query: 377 LRIAI-EVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRA---KVSDFGASRSMAVDQT 432
+ ++ AL Y H I HRD+K +LL K + K+ FG + +
Sbjct: 132 ASHYMRQILEALRYCHDNN---IIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGL 188
Query: 433 HMTTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLTELLTGEKPIRFTILEEDKSLAAY 492
+V GT ++ PE + + DV+ GV+L LL+G P T
Sbjct: 189 VAGGRV-GTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGT----------- 236
Query: 493 FLCAMKEERLFEILDARVMKQGGK--------DEIITVAK-LAKRCLNLNGKKRPTMREV 543
+ERLFE ++K GK I AK L +R L L+ +R T+ E
Sbjct: 237 ------KERLFE----GIIK--GKYKMNPRQWSHISESAKDLVRRMLMLDPAERITVYEA 284
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 1e-24
Identities = 56/206 (27%), Positives = 91/206 (44%), Gaps = 25/206 (12%)
Query: 288 TDNFDLNRILGQG--GQAVKKS----------KVID-ESKVEEFINEVVILSQINHRNVV 334
+ FD+ LG+G G K K + ES ++E I E+ I+ Q + +VV
Sbjct: 28 EEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVESDLQEIIKEISIMQQCDSPHVV 87
Query: 335 KLLGCCLETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEIRLRIAI---EVSGALSYLH 391
K G + +V E+ G++ I +N+ IA L YLH
Sbjct: 88 KYYGSYFKNTDLWIVMEYCGAGSVSDIIRLRNKTLTEDE-----IATILQSTLKGLEYLH 142
Query: 392 SAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHGTFGYLDPEYFR 451
I HRDIK+ NILL+ + AK++DFG + + T + GT ++ PE +
Sbjct: 143 FMRKI---HRDIKAGNILLNTEGHAKLADFGVAGQLTDTMAKRNTVI-GTPFWMAPEVIQ 198
Query: 452 SSQFTDKSDVYSFGVVLTELLTGEKP 477
+ +D++S G+ E+ G+ P
Sbjct: 199 EIGYNCVADIWSLGITAIEMAEGKPP 224
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 2e-24
Identities = 62/207 (29%), Positives = 96/207 (46%), Gaps = 27/207 (13%)
Query: 288 TDNFDLNRILGQG-------------GQ--AVKKSKVIDESKVEEFINEVVILSQINHRN 332
D +G+G G+ AVK + + + E NEVVI+ H N
Sbjct: 44 RLLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFN 103
Query: 333 VVKLLGCCLETEVPLLVYEFIPNGTLFQYIHDQ--NEDFPITWEIRLRIAIEVSGALSYL 390
VV++ L E ++ EF+ G L + NE+ +I + V AL+YL
Sbjct: 104 VVEMYKSYLVGEELWVLMEFLQGGALTDIVSQVRLNEE-----QIAT-VCEAVLQALAYL 157
Query: 391 HSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHGTFGYLDPEYF 450
H+ I HRDIKS +ILL R K+SDFG ++ D + V GT ++ PE
Sbjct: 158 HAQGVI---HRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKSLV-GTPYWMAPEVI 213
Query: 451 RSSQFTDKSDVYSFGVVLTELLTGEKP 477
S + + D++S G+++ E++ GE P
Sbjct: 214 SRSLYATEVDIWSLGIMVIEMVDGEPP 240
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 104 bits (262), Expect = 2e-24
Identities = 55/223 (24%), Positives = 91/223 (40%), Gaps = 34/223 (15%)
Query: 282 KELEKATDNFDLNRILGQG--GQ-------------AVK---KSKVIDESKVEEFINEVV 323
KE+ D+F++ +++G+G + A+K K ++ +V F E
Sbjct: 54 KEVRLQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERD 113
Query: 324 ILSQINHRNVVKLLGCCLETEVPL-LVYEFIPNGTLFQYIHDQNEDFPITWEIRLRI-AI 381
+L + R + +L + E L LV E+ G L + E P R
Sbjct: 114 VLVNGDRRWITQLH-FAFQDENYLYLVMEYYVGGDLLTLLSKFGERIP---AEMARFYLA 169
Query: 382 EVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHGT 441
E+ A+ +H + HRDIK NILLD +++DFG+ + D T + GT
Sbjct: 170 EIVMAIDSVHR---LGYVHRDIKPDNILLDRCGHIRLADFGSCLKLRADGTVRSLVAVGT 226
Query: 442 FGYLDPEYFRSSQFTDKSDVY-------SFGVVLTELLTGEKP 477
YL PE ++ + Y + GV E+ G+ P
Sbjct: 227 PDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTP 269
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 2e-24
Identities = 68/278 (24%), Positives = 112/278 (40%), Gaps = 48/278 (17%)
Query: 289 DNFDLNRILGQGGQA-VKKS-----------KVIDESKVEEFIN----EVVILSQINHRN 332
+++DL + LG+G V+ + K++D + + E+ I +NH N
Sbjct: 7 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHEN 66
Query: 333 VVKLLGCCLETEVPL-LVYEFIPNGTLFQYIHDQ---NEDFPITWEIRLRIAIEVSGALS 388
VVK G L E+ G LF I E + + R ++ +
Sbjct: 67 VVKFYG-HRREGNIQYLFLEYCSGGELFDRIEPDIGMPEP-----DAQ-RFFHQLMAGVV 119
Query: 389 YLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQT--HMTTQVHGTFGYLD 446
YLH I HRDIK N+LLD++ K+SDFG + + + GT Y+
Sbjct: 120 YLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMC-GTLPYVA 175
Query: 447 PEYFRSSQFT-DKSDVYSFGVVLTELLTGEKPIRFTILEEDKSLAAYFLCAMKEERLFEI 505
PE + +F + DV+S G+VLT +L GE P + + S Y +E+ +
Sbjct: 176 PELLKRREFHAEPVDVWSCGIVLTAMLAGELP--WD--QPSDSCQEYSD---WKEKKTYL 228
Query: 506 LDARVMKQGGKDEIITVAKLAKRCLNLNGKKRPTMREV 543
+ + L + L N R T+ ++
Sbjct: 229 NPWKKIDSAPLA-------LLHKILVENPSARITIPDI 259
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 106 bits (265), Expect = 2e-24
Identities = 55/216 (25%), Positives = 94/216 (43%), Gaps = 26/216 (12%)
Query: 283 ELEKAT-DNFDLNRILGQGG------------------QAVKKSKVIDESKVEEFINEVV 323
E + D F R+LG+GG + + K ++ + + E
Sbjct: 178 EAQPMGEDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKK 237
Query: 324 ILSQINHRNVVKLLGCCLETEVPL-LVYEFIPNGTLFQYIHDQNEDFPITWEIRLRI-AI 381
IL++++ R +V L ET+ L LV + G + +I++ +ED P E R
Sbjct: 238 ILAKVHSRFIVSLA-YAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTA 296
Query: 382 EVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHGT 441
++ L +LH I +RD+K N+LLDD ++SD G + + QT GT
Sbjct: 297 QIVSGLEHLHQRN---IIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKTKGYA-GT 352
Query: 442 FGYLDPEYFRSSQFTDKSDVYSFGVVLTELLTGEKP 477
G++ PE ++ D ++ GV L E++ P
Sbjct: 353 PGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGP 388
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 106 bits (266), Expect = 3e-24
Identities = 63/217 (29%), Positives = 98/217 (45%), Gaps = 31/217 (14%)
Query: 283 ELEKAT-DNFDLNRILGQGG------------------QAVKKSKVIDESKVEEFINEVV 323
E + T + F R+LG+GG + ++K ++ +NE
Sbjct: 177 ERQPVTKNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQ 236
Query: 324 ILSQINHRNVVKLLGCCLETEVPL-LVYEFIPNGTLFQYIHDQNED-FPITWEIRLRI-A 380
IL ++N R VV L ET+ L LV + G L +I+ + FP E R A
Sbjct: 237 ILEKVNSRFVVSL-AYAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFP---EARAVFYA 292
Query: 381 IEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHG 440
E+ L LH I +RD+K NILLDD ++SD G + + QT G
Sbjct: 293 AEICCGLEDLHRER---IVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQT--IKGRVG 347
Query: 441 TFGYLDPEYFRSSQFTDKSDVYSFGVVLTELLTGEKP 477
T GY+ PE ++ ++T D ++ G +L E++ G+ P
Sbjct: 348 TVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSP 384
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 101 bits (254), Expect = 5e-24
Identities = 72/288 (25%), Positives = 121/288 (42%), Gaps = 66/288 (22%)
Query: 288 TDNFDLNRILGQGG-----QAVKKS-------KVIDESK-----VEEFINEVVILSQINH 330
+ +++ +LG+G + + KVI+++ + EV +L +++H
Sbjct: 21 AERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDH 80
Query: 331 RNVVKLLGCCLETEVPLLVYEFIPNGTLFQYIHDQ---NEDFPITWEIRLRIAIEVSGAL 387
N++KL ++ +V E G LF I + +E + RI +V +
Sbjct: 81 PNIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRKRFSEH-----DAA-RIIKQVFSGI 134
Query: 388 SYLHSAASIPIYHRDIKSTNILLDDKYRA---KVSDFGASRSMAVDQTHMTTQVHGTFGY 444
+Y+H I HRD+K NILL+ K + K+ DFG S + M ++ GT Y
Sbjct: 135 TYMHKHN---IVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTK-MKDRI-GTAYY 189
Query: 445 LDPEYFRSSQFTDKSDVYSFGVVLTELLTGEKPIRFTILEEDKSLAAYFLCAMKEERLFE 504
+ PE R + + +K DV+S GV+L LL+G P F K+ E + +
Sbjct: 190 IAPEVLRGT-YDEKCDVWSAGVILYILLSGTPP--FY----GKN----------EYDILK 232
Query: 505 ILDARVMKQGGK--------DEIITVAK-LAKRCLNLNGKKRPTMREV 543
RV GK I AK L ++ L + R T +
Sbjct: 233 ----RVET--GKYAFDLPQWRTISDDAKDLIRKMLTFHPSLRITATQC 274
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 101 bits (254), Expect = 5e-24
Identities = 68/279 (24%), Positives = 109/279 (39%), Gaps = 46/279 (16%)
Query: 288 TDNFDLNRILGQGG-----QAVKKS-------KVIDESK----VEEFINEVVILSQINHR 331
D F R LG G ++S K I++ + +E+ E+ +L ++H
Sbjct: 21 DDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHP 80
Query: 332 NVVKLLGCCLETEVPL-LVYEFIPNGTLFQYIHDQNEDFPITWEIR-LRIAIEVSGALSY 389
N++K+ E + +V E G L + I E + ++ AL+Y
Sbjct: 81 NIIKIFEVF-EDYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAY 139
Query: 390 LHSAASIPIYHRDIKSTNILLDDKYRA---KVSDFGASRSMAVDQTHMTTQVHGTFGYLD 446
HS + H+D+K NIL D K+ DFG + D+ T GT Y+
Sbjct: 140 FHSQH---VVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDEH-STNAA-GTALYMA 194
Query: 447 PEYFRSSQFTDKSDVYSFGVVLTELLTGEKPIRFTILEEDKSLAAYFLCAMKEERLFE-I 505
PE F+ T K D++S GVV+ LLTG P F S E + +
Sbjct: 195 PEVFKRD-VTFKCDIWSAGVVMYFLLTGCLP--F----TGTS----------LEEVQQKA 237
Query: 506 LDARVMKQGGKDEIITVAK-LAKRCLNLNGKKRPTMREV 543
+ A L K+ L + ++RP+ +V
Sbjct: 238 TYKEPNYAVECRPLTPQAVDLLKQMLTKDPERRPSAAQV 276
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 103 bits (258), Expect = 5e-24
Identities = 58/280 (20%), Positives = 102/280 (36%), Gaps = 45/280 (16%)
Query: 285 EKATDNFDLNRILGQGGQAV------KKS------KVIDESK---VEEFINEVVILSQIN 329
D +D+ LG G V K + K I+ NE+ I++Q++
Sbjct: 47 GSVYDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLH 106
Query: 330 HRNVVKLLGCCLETEVPL-LVYEFIPNGTLFQYIHDQNEDFPITWEIRLRIAI-EVSGAL 387
H ++ L E + + L+ EF+ G LF I ++ E + + + L
Sbjct: 107 HPKLINLHDAF-EDKYEMVLILEFLSGGELFDRIAAEDYKMS---EAEVINYMRQACEGL 162
Query: 388 SYLHSAASIPIYHRDIKSTNILLDDKYRA--KVSDFGASRSMAVDQTHMTTQVHGTFGYL 445
++H + I H DIK NI+ + K + K+ DFG + + + + T +
Sbjct: 163 KHMHEHS---IVHLDIKPENIMCETKKASSVKIIDFGLATKL--NPDEIVKVTTATAEFA 217
Query: 446 DPEYFRSSQFTDKSDVYSFGVVLTELLTGEKPIRFTILEEDKSLAAYFLCAMKEERLFEI 505
PE +D+++ GV+ LL+G P F E L +
Sbjct: 218 APEIVDREPVGFYTDMWAIGVLGYVLLSGLSP---------------FAGEDDLETLQNV 262
Query: 506 LDARV-MKQGGKDEIITVAK-LAKRCLNLNGKKRPTMREV 543
+ + AK K L +KR T+ +
Sbjct: 263 KRCDWEFDEDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDA 302
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 102 bits (255), Expect = 6e-24
Identities = 66/307 (21%), Positives = 120/307 (39%), Gaps = 66/307 (21%)
Query: 267 ASTEGTIEKTKLFTSKELEKATDNFDLNRILGQGGQA-VKKS-----------KVIDESK 314
+ + TKL KE E + + +LG GG V K +++ +
Sbjct: 21 MAPCNDLHATKLAPGKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDR 80
Query: 315 VEEFIN---------EVVILSQINHR--NVVKLLGCCLETEVPL-LVYEFI-PNGTLFQY 361
+ ++ EVV+L +++ V++LL E L+ E P LF +
Sbjct: 81 ISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDW-FERPDSFVLILERPEPVQDLFDF 139
Query: 362 IHDQ---NEDFPITWEIRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLD-DKYRAK 417
I ++ E+ R +V A+ + H+ + HRDIK NIL+D ++ K
Sbjct: 140 ITERGALQEE-----LAR-SFFWQVLEAVRHCHNCG---VLHRDIKDENILIDLNRGELK 190
Query: 418 VSDFGASRSMAVDQTHMTTQVHGTFGYLDPEYFRSSQFT-DKSDVYSFGVVLTELLTGEK 476
+ DFG+ + T T GT Y PE+ R ++ + V+S G++L +++ G+
Sbjct: 191 LIDFGSGALL--KDTVYTDFD-GTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDI 247
Query: 477 PIRFTILEEDKSLAAYFLCAMKEERLFEILDARVMKQGGKDEIITVAKLAKRCLNLNGKK 536
P +++ + + + + L + CL L
Sbjct: 248 PFE----HDEEIIRGQVFF------------RQRVSSECQH-------LIRWCLALRPSD 284
Query: 537 RPTMREV 543
RPT E+
Sbjct: 285 RPTFEEI 291
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 102 bits (255), Expect = 6e-24
Identities = 67/278 (24%), Positives = 110/278 (39%), Gaps = 48/278 (17%)
Query: 289 DNFDLNRILGQGGQAVKKS------------KVIDESKVEEFIN----EVVILSQINHRN 332
+++DL + LG+G + K++D + + E+ I +NH N
Sbjct: 7 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHEN 66
Query: 333 VVKLLGCCLETEVPL-LVYEFIPNGTLFQYIHDQ---NEDFPITWEIRLRIAIEVSGALS 388
VVK G L E+ G LF I E + + R ++ +
Sbjct: 67 VVKFYG-HRREGNIQYLFLEYCSGGELFDRIEPDIGMPEP-----DAQ-RFFHQLMAGVV 119
Query: 389 YLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQT--HMTTQVHGTFGYLD 446
YLH I HRDIK N+LLD++ K+SDFG + + + GT Y+
Sbjct: 120 YLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMC-GTLPYVA 175
Query: 447 PEYFRSSQFT-DKSDVYSFGVVLTELLTGEKPIRFTILEEDKSLAAYFLCAMKEERLFEI 505
PE + +F + DV+S G+VLT +L GE P + + S Y +E+ +
Sbjct: 176 PELLKRREFHAEPVDVWSCGIVLTAMLAGELP--WD--QPSDSCQEYSD---WKEKKTYL 228
Query: 506 LDARVMKQGGKDEIITVAKLAKRCLNLNGKKRPTMREV 543
+ + L + L N R T+ ++
Sbjct: 229 NPWKKIDSAPLA-------LLHKILVENPSARITIPDI 259
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 6e-24
Identities = 72/289 (24%), Positives = 122/289 (42%), Gaps = 67/289 (23%)
Query: 288 TDNFDLNRILGQGG-----QAVKKS-------KVIDESK-----VEEFINEVVILSQINH 330
+DN+D+ LG+G + V K+ K+I+ K ++ E I ++ H
Sbjct: 5 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQH 64
Query: 331 RNVVKLLGCCLETEVPL-LVYEFIPNGTLFQYIHDQ---NEDFPITWEIRLRIAIEVSGA 386
N+V+L + E LV++ + G LF+ I + +E + ++ +
Sbjct: 65 PNIVRLHDSI-QEESFHYLVFDLVTGGELFEDIVAREFYSEA-----DAS-HCIQQILES 117
Query: 387 LSYLHSAASIPIYHRDIKSTNILLDDKYRA---KVSDFGASRSMAVDQTHMTTQVHGTFG 443
++Y HS I HR++K N+LL K + K++DFG + + D GT G
Sbjct: 118 IAYCHSNG---IVHRNLKPENLLLASKAKGAAVKLADFGLAIEVN-DSEAWHGFA-GTPG 172
Query: 444 YLDPEYFRSSQFTDKSDVYSFGVVLTELLTGEKPIRFTILEEDKSLAAYFLCAMKEERLF 503
YL PE + ++ D+++ GV+L LL G P F +ED + RL+
Sbjct: 173 YLSPEVLKKDPYSKPVDIWACGVILYILLVGYPP--FW--DED------------QHRLY 216
Query: 504 EILDARVMKQGGK--------DEIITVAK-LAKRCLNLNGKKRPTMREV 543
++ G D + AK L L +N KKR T +
Sbjct: 217 A----QIKA--GAYDYPSPEWDTVTPEAKSLIDSMLTVNPKKRITADQA 259
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 102 bits (255), Expect = 8e-24
Identities = 70/291 (24%), Positives = 125/291 (42%), Gaps = 62/291 (21%)
Query: 282 KELEKATDNFDLNRILGQGG-----QAVKKS-------KVIDESKVEEFI-NEVVILSQI 328
+ +D F++ LG+G + +K KV+ ++ ++ + E+ +L ++
Sbjct: 46 SNRDALSDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTVDKKIVRTEIGVLLRL 105
Query: 329 NHRNVVKLLGCCLETEVPL-LVYEFIPNGTLFQYIHDQ---NEDFPITWEIRLRIAIEVS 384
+H N++KL ET + LV E + G LF I ++ +E + ++
Sbjct: 106 SHPNIIKLKEIF-ETPTEISLVLELVTGGELFDRIVEKGYYSER-----DAA-DAVKQIL 158
Query: 385 GALSYLHSAASIPIYHRDIKSTNILLDDKYRA---KVSDFGASRSMAVDQTHMTTQVHGT 441
A++YLH I HRD+K N+L K++DFG S+ + Q M T GT
Sbjct: 159 EAVAYLHENG---IVHRDLKPENLLYATPAPDAPLKIADFGLSK-IVEHQVLMKTVC-GT 213
Query: 442 FGYLDPEYFRSSQFTDKSDVYSFGVVLTELLTGEKPIRFTILEEDKSLAAYFLCAMKEER 501
GY PE R + + D++S G++ LL G +P F ++
Sbjct: 214 PGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEP---------------FYDERGDQF 258
Query: 502 LFEILDARVMKQGGK--------DEIITVAK-LAKRCLNLNGKKRPTMREV 543
+F R++ + DE+ AK L ++ + L+ KKR T +
Sbjct: 259 MFR----RILN--CEYYFISPWWDEVSLNAKDLVRKLIVLDPKKRLTTFQA 303
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 8e-24
Identities = 66/293 (22%), Positives = 110/293 (37%), Gaps = 74/293 (25%)
Query: 288 TDNFDLNRILGQGG-----QAVKKS-------KVIDESK-----VEEFINEVVILSQINH 330
T+ + L LG+G + VK +I+ K ++ E I + H
Sbjct: 10 TEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKH 69
Query: 331 RNVVKLLGCCLETEVPL-LVYEFIPNGTLFQYIHDQ---NEDFPITWEIRLRIAIE---- 382
N+V+L E L+++ + G LF+ I + +E A
Sbjct: 70 PNIVRLHDSI-SEEGHHYLIFDLVTGGELFEDIVAREYYSE----------ADASHCIQQ 118
Query: 383 VSGALSYLHSAASIPIYHRDIKSTNILLDDKYRA---KVSDFGASRSMAVDQTHMTTQVH 439
+ A+ + H + HR++K N+LL K + K++DFG + + +Q
Sbjct: 119 ILEAVLHCHQMG---VVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWFGFA- 174
Query: 440 GTFGYLDPEYFRSSQFTDKSDVYSFGVVLTELLTGEKPIRFTILEEDKSLAAYFLCAMKE 499
GT GYL PE R + D+++ GV+L LL G P +
Sbjct: 175 GTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFW----------------DEDQ 218
Query: 500 ERLFEILDARVMKQGGK--------DEIITVAK-LAKRCLNLNGKKRPTMREV 543
RL++ ++ G D + AK L + L +N KR T E
Sbjct: 219 HRLYQ----QIKA--GAYDFPSPEWDTVTPEAKDLINKMLTINPSKRITAAEA 265
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304 | Back alignment and structure |
|---|
Score = 100 bits (252), Expect = 1e-23
Identities = 70/294 (23%), Positives = 110/294 (37%), Gaps = 66/294 (22%)
Query: 281 SKELEKATDNFDLNRILGQGG-----QAVKKS-------KVIDESKV---EEFINEVVIL 325
S + F +LG G ++ K I +S NE+ +L
Sbjct: 1 SMQTTNIRKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVL 60
Query: 326 SQINHRNVVKLLGCCLETEVPL-LVYEFIPNGTLFQYIHDQ---NEDFPITWEIRLRIAI 381
+I H N+V L E+ LV + + G LF I ++ E + +
Sbjct: 61 KKIKHENIVTLEDIY-ESTTHYYLVMQLVSGGELFDRILERGVYTEK-----DAS-LVIQ 113
Query: 382 EVSGALSYLHSAASIPIYHRDIKSTNILL---DDKYRAKVSDFGASRSMAVDQTHMTTQV 438
+V A+ YLH I HRD+K N+L ++ + ++DFG S+ M+T
Sbjct: 114 QVLSAVKYLHENG---IVHRDLKPENLLYLTPEENSKIMITDFGLSKM--EQNGIMSTAC 168
Query: 439 HGTFGYLDPEYFRSSQFTDKSDVYSFGVVLTELLTGEKPIRFTILEEDKSLAAYFLCAMK 498
GT GY+ PE ++ D +S GV+ LL G P EE
Sbjct: 169 -GTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPFY----EET------------ 211
Query: 499 EERLFEILDARVMKQGGK--------DEIITVAK-LAKRCLNLNGKKRPTMREV 543
E +LFE ++ + G D+I AK L + +R T +
Sbjct: 212 ESKLFE----KIKE--GYYEFESPFWDDISESAKDFICHLLEKDPNERYTCEKA 259
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 1e-23
Identities = 63/287 (21%), Positives = 109/287 (37%), Gaps = 54/287 (18%)
Query: 282 KELEKATDNFDLNRILGQGG-----QAVKKS-------KVIDESKV---EEFINEVVILS 326
+ L +G+G AV+K K I + V + F E+ I+
Sbjct: 2 STKGDINQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMK 61
Query: 327 QINHRNVVKLLGCCLETEVPL-LVYEFIPNGTLFQYIHDQ---NEDFPITWEIRLRIAIE 382
++H N+++L E + LV E G LF+ + + E + RI +
Sbjct: 62 SLDHPNIIRLYETF-EDNTDIYLVMELCTGGELFERVVHKRVFRES-----DAA-RIMKD 114
Query: 383 VSGALSYLHSAASIPIYHRDIKSTNILLDDK---YRAKVSDFGASRSMAVDQTHMTTQVH 439
V A++Y H + HRD+K N L K+ DFG + + M T+V
Sbjct: 115 VLSAVAYCHKLN---VAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKM-MRTKV- 169
Query: 440 GTFGYLDPEYFRSSQFTDKSDVYSFGVVLTELLTGEKPIRFTILEEDKSLAAYFLCAMKE 499
GT Y+ P+ + + D +S GV++ LL G P F+ + +
Sbjct: 170 GTPYYVSPQVLEGL-YGPECDEWSAGVMMYVLLCGYPP--FS----APT----------D 212
Query: 500 ERLFE-ILDARV-MKQGGKDEIITVAK-LAKRCLNLNGKKRPTMREV 543
+ I + + + A+ L +R L + K+R T +
Sbjct: 213 SEVMLKIREGTFTFPEKDWLNVSPQAESLIRRLLTKSPKQRITSLQA 259
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 1e-23
Identities = 65/287 (22%), Positives = 113/287 (39%), Gaps = 56/287 (19%)
Query: 288 TDNFDL---NRILGQGG-----QAVKKS-------KVIDESKVEEFINEVVILSQI-NHR 331
++DL ++ LG+G + V K K+I + E+ L H
Sbjct: 7 YQHYDLDLKDKPLGEGSFSICRKCVHKKSNQAFAVKIISKRMEANTQKEITALKLCEGHP 66
Query: 332 NVVKLLGCCLETEVPLLVYEFIPNGTLFQYIHDQ---NEDFPITWEIRLRIAIEVSGALS 388
N+VKL + LV E + G LF+ I + +E E I ++ A+S
Sbjct: 67 NIVKLHEVFHDQLHTFLVMELLNGGELFERIKKKKHFSET-----EAS-YIMRKLVSAVS 120
Query: 389 YLHSAASIPIYHRDIKSTNILLDDKYRA---KVSDFGASRSMAVDQTHMTTQVHGTFGYL 445
++H + HRD+K N+L D+ K+ DFG +R D + T T Y
Sbjct: 121 HMHDVG---VVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLKTPC-FTLHYA 176
Query: 446 DPEYFRSSQFTDKSDVYSFGVVLTELLTGEKPIRFTILEEDKSLAAYFLCAMKEERLFEI 505
PE + + + D++S GV+L +L+G+ P F + + + + +
Sbjct: 177 APELLNQNGYDESCDLWSLGVILYTMLSGQVP--FQSHDRSLTCTS-------AVEIMK- 226
Query: 506 LDARVMKQGGK--------DEIITVAK-LAKRCLNLNGKKRPTMREV 543
++ K G + AK L + L ++ KR M +
Sbjct: 227 ---KIKK--GDFSFEGEAWKNVSQEAKDLIQGLLTVDPNKRLKMSGL 268
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 1e-23
Identities = 63/273 (23%), Positives = 109/273 (39%), Gaps = 37/273 (13%)
Query: 282 KELEKAT---DNFDLNRILGQGGQAVKKSKVIDESKVEEFINEVVILSQINHRNVVKL-- 336
K L K R +G + + +E+ E+ IL +++H NVVKL
Sbjct: 44 KVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAILKKLDHPNVVKLVE 103
Query: 337 -LGCCLETEVPLLVYEFIPNGTLFQYIHDQ--NEDFPITWEIRLRIAIEVSGALSYLHSA 393
L E + +V+E + G + + + +ED + R ++ + YLH
Sbjct: 104 VLDDPNEDHL-YMVFELVNQGPVMEVPTLKPLSED-----QAR-FYFQDLIKGIEYLHYQ 156
Query: 394 ASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHGTFGYLDPEYFRSS 453
I HRDIK +N+L+ + K++DFG S ++ V GT ++ PE +
Sbjct: 157 K---IIHRDIKPSNLLVGEDGHIKIADFGVSNEFKGSDALLSNTV-GTPAFMAPESLSET 212
Query: 454 QFT---DKSDVYSFGVVLTELLTGEKPIRFTILEEDKSLAAYFLCAMKEERLFEILDARV 510
+ DV++ GV L + G+ P F D+ + + E D
Sbjct: 213 RKIFSGKALDVWAMGVTLYCFVFGQCP--F----MDERIMCLHSKIKSQA--LEFPDQPD 264
Query: 511 MKQGGKDEIITVAKLAKRCLNLNGKKRPTMREV 543
+ + KD L R L+ N + R + E+
Sbjct: 265 IAEDLKD-------LITRMLDKNPESRIVVPEI 290
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 100 bits (252), Expect = 2e-23
Identities = 63/285 (22%), Positives = 114/285 (40%), Gaps = 59/285 (20%)
Query: 288 TDNFDLNRILGQGG-----QAVKKS-------KVIDESKVEEFINEVVILSQ-INHRNVV 334
TD +++ +G G + + K+ K+ID+SK + E+ IL + H N++
Sbjct: 21 TDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKRDPT-EEIEILLRYGQHPNII 79
Query: 335 KLLGCCLETEVPLLVYEFIPNGTLFQYIHDQ---NEDFPITWEIRLRIAIEVSGALSYLH 391
L + + +V E + G L I Q +E E + ++ + YLH
Sbjct: 80 TLKDVYDDGKYVYVVTELMKGGELLDKILRQKFFSER-----EAS-AVLFTITKTVEYLH 133
Query: 392 SAASIPIYHRDIKSTNILLDDKYRA----KVSDFGASRSMAVDQTHMTTQVHGTFGYLDP 447
+ + HRD+K +NIL D+ ++ DFG ++ + + + T T ++ P
Sbjct: 134 AQG---VVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGLLMTPC-YTANFVAP 189
Query: 448 EYFRSSQFTDKSDVYSFGVVLTELLTGEKPIRFTILEEDKSLAAYFLCAMKEERLFEILD 507
E + D++S GV+L +LTG P F E +
Sbjct: 190 EVLERQGYDAACDIWSLGVLLYTMLTGYTP--F-----------ANGPDDTPEEILA--- 233
Query: 508 ARVMKQGGK--------DEIITVAK-LAKRCLNLNGKKRPTMREV 543
R+ GK + + AK L + L+++ +R T V
Sbjct: 234 -RIGS--GKFSLSGGYWNSVSDTAKDLVSKMLHVDPHQRLTAALV 275
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 100 bits (250), Expect = 2e-23
Identities = 57/211 (27%), Positives = 93/211 (44%), Gaps = 34/211 (16%)
Query: 288 TDNFDLNRILGQGG-----QAVKKS-------KVID----ESKVEEFINEVVILSQINHR 331
+ F +G+G + + K+ID E ++E+ E+ +LSQ +
Sbjct: 21 EELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSP 80
Query: 332 NVVKLLGCCLETEVPLLVYEFIPNGTLFQYIHDQ--NEDFPITWEIRLRIAI---EVSGA 386
V K G L+ ++ E++ G+ + +E IA E+
Sbjct: 81 YVTKYYGSYLKDTKLWIIMEYLGGGSALDLLEPGPLDETQ---------IATILREILKG 131
Query: 387 LSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHGTFGYLD 446
L YLHS I HRDIK+ N+LL + K++DFG + + Q T V GT ++
Sbjct: 132 LDYLHSEKKI---HRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFV-GTPFWMA 187
Query: 447 PEYFRSSQFTDKSDVYSFGVVLTELLTGEKP 477
PE + S + K+D++S G+ EL GE P
Sbjct: 188 PEVIKQSAYDSKADIWSLGITAIELARGEPP 218
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 100 bits (250), Expect = 2e-23
Identities = 51/213 (23%), Positives = 95/213 (44%), Gaps = 32/213 (15%)
Query: 288 TDNFDLNRILGQG-------------GQ--AVKKSKVIDESKVEEFINEVVILSQINHRN 332
+ +++ LG G G A K + E ++E++I E+ IL+ +H
Sbjct: 18 NEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPY 77
Query: 333 VVKLLGCCLETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEIRLRIAI---EVSGALSY 389
+VKLLG ++ EF P G + + + + I + ++ AL++
Sbjct: 78 IVKLLGAYYHDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQ-----IQVVCRQMLEALNF 132
Query: 390 LHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHGTFGYLDPE- 448
LHS I HRD+K+ N+L+ + +++DFG S + + GT ++ PE
Sbjct: 133 LHSKRII---HRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRDSFI-GTPYWMAPEV 188
Query: 449 ----YFRSSQFTDKSDVYSFGVVLTELLTGEKP 477
+ + + K+D++S G+ L E+ E P
Sbjct: 189 VMCETMKDTPYDYKADIWSLGITLIEMAQIEPP 221
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 101 bits (254), Expect = 2e-23
Identities = 60/213 (28%), Positives = 95/213 (44%), Gaps = 33/213 (15%)
Query: 289 DNFDLNRILGQG--GQ-------------AVK---KSKVIDESKVEEFINEVVILSQINH 330
+++++ +++G+G G+ A+K K ++I S F E I++ N
Sbjct: 69 EDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANS 128
Query: 331 RNVVKLLGCCLETEVPL-LVYEFIPNGTLFQYIHDQNEDFPITWEIRLRI-AIEVSGALS 388
VV+L + + L +V E++P G L + N D P E R EV AL
Sbjct: 129 PWVVQLF-YAFQDDRYLYMVMEYMPGGDLVNLM--SNYDVP---EKWARFYTAEVVLALD 182
Query: 389 YLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHGTFGYLDPE 448
+HS + HRD+K N+LLD K++DFG M + GT Y+ PE
Sbjct: 183 AIHS---MGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISPE 239
Query: 449 YFRSSQFT---DKS-DVYSFGVVLTELLTGEKP 477
+S + D +S GV L E+L G+ P
Sbjct: 240 VLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTP 272
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 102 bits (255), Expect = 2e-23
Identities = 56/232 (24%), Positives = 103/232 (44%), Gaps = 34/232 (14%)
Query: 273 IEKTKLFTS--KELEKATDNFDLNRILGQG--GQ-------------AVK---KSKVIDE 312
+E K FTS K++ ++F++ +++G+G G+ A+K K +++
Sbjct: 56 LEWAKPFTSKVKQMRLHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKR 115
Query: 313 SKVEEFINEVVILSQINHRNVVKLLGCCLETEVPL-LVYEFIPNGTLFQYIHDQNEDFPI 371
++ F E +L + + + L + + L LV ++ G L + + P
Sbjct: 116 AETACFREERDVLVNGDSKWITTLH-YAFQDDNNLYLVMDYYVGGDLLTLLSKFEDRLP- 173
Query: 372 TWEIRLRI-AIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVD 430
E R E+ A+ +H + HRDIK NIL+D +++DFG+ + D
Sbjct: 174 --EEMARFYLAEMVIAIDSVHQ---LHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMED 228
Query: 431 QTHMTTQVHGTFGYLDPEYFRSSQFTDKS-----DVYSFGVVLTELLTGEKP 477
T ++ GT Y+ PE ++ + D +S GV + E+L GE P
Sbjct: 229 GTVQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETP 280
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 99.3 bits (248), Expect = 3e-23
Identities = 45/229 (19%), Positives = 82/229 (35%), Gaps = 47/229 (20%)
Query: 288 TDNFDLNRILGQG-------------GQ--AVKKSKVIDESKVEE--FINEVVILSQI-N 329
T F +G G G A+K+SK V+E + EV + +
Sbjct: 10 TTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQ 69
Query: 330 HRNVVKLLGCCLETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEIRLR-IAIEVSGALS 388
H +VV+ E + L+ E+ G+L I + E L+ + ++V L
Sbjct: 70 HSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLR 129
Query: 389 YLHSAASIPIYHRDIKSTNILLD-------------------DKYRAKVSDFGASRSMAV 429
Y+HS + + H DIK +NI + +K K+ D G +
Sbjct: 130 YIHSMS---LVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRI-- 184
Query: 430 DQTHMTTQVHGTFGYLDPEYFRSSQ-FTDKSDVYSFGVVLTELLTGEKP 477
+ + G +L E + + K+D+++ + + E
Sbjct: 185 --SSPQVEE-GDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPL 230
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 3e-23
Identities = 74/310 (23%), Positives = 127/310 (40%), Gaps = 67/310 (21%)
Query: 267 ASTEGTIEKTKLFTSKELEKATDNFDLNRILGQGG-----QAVKKS-------KVIDESK 314
+ + + F K +DN+D+ LG+G + V K+ K+I+ K
Sbjct: 7 MTGGQQMGRGSEFMMNASTKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKK 66
Query: 315 -----VEEFINEVVILSQINHRNVVKLLGCCLETEVPL-LVYEFIPNGTLFQYIHDQ--- 365
++ E I ++ H N+V+L + E LV++ + G LF+ I +
Sbjct: 67 LSARDFQKLEREARICRKLQHPNIVRLHDSI-QEESFHYLVFDLVTGGELFEDIVAREFY 125
Query: 366 NEDFPITWEIRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRA---KVSDFG 422
+E + ++ +++Y HS I HR++K N+LL K + K++DFG
Sbjct: 126 SEA-----DAS-HCIQQILESIAYCHSNG---IVHRNLKPENLLLASKAKGAAVKLADFG 176
Query: 423 ASRSMAVDQTHMTTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLTELLTGEKPIRFTI 482
+ + D GT GYL PE + ++ D+++ GV+L LL G P F
Sbjct: 177 LAIEVN-DSEAWHGFA-GTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPP--FW- 231
Query: 483 LEEDKSLAAYFLCAMKEERLFEILDARVMKQGGK--------DEIITVAK-LAKRCLNLN 533
+ED + RL+ ++ G D + AK L L +N
Sbjct: 232 -DED------------QHRLYA----QIKA--GAYDYPSPEWDTVTPEAKSLIDSMLTVN 272
Query: 534 GKKRPTMREV 543
KKR T +
Sbjct: 273 PKKRITADQA 282
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 100 bits (252), Expect = 3e-23
Identities = 58/212 (27%), Positives = 98/212 (46%), Gaps = 33/212 (15%)
Query: 289 DNFDLNRILGQG--GQ-------------AVK---KSKVIDESKVEEFINEVVILSQINH 330
D+F++ R +G+G G+ A+K K K ++ ++V E+ I+ + H
Sbjct: 15 DHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEH 74
Query: 331 RNVVKLLGCCLETEVPL-LVYEFIPNGTLFQYIHDQNEDFPITWEIRLRI-AIEVSGALS 388
+V L + E + +V + + G L ++ QN F E +++ E+ AL
Sbjct: 75 PFLVNLW-YSFQDEEDMFMVVDLLLGGDLRYHL-QQNVHFK---EETVKLFICELVMALD 129
Query: 389 YLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHGTFGYLDPE 448
YL + I HRD+K NILLD+ ++DF + + + T + GT Y+ PE
Sbjct: 130 YLQNQR---IIHRDMKPDNILLDEHGHVHITDFNIAAMLPRETQITT--MAGTKPYMAPE 184
Query: 449 YFRSSQFT--DKS-DVYSFGVVLTELLTGEKP 477
F S + + D +S GV ELL G +P
Sbjct: 185 MFSSRKGAGYSFAVDWWSLGVTAYELLRGRRP 216
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 102 bits (255), Expect = 5e-23
Identities = 59/322 (18%), Positives = 114/322 (35%), Gaps = 43/322 (13%)
Query: 242 KRRREIKLKRKYFKRNGGLLLQQELASTEGTIEKTKLFTSKELEKATDNFDLNRILGQGG 301
+R ++ + K + G + + + + + + D++D++ LG G
Sbjct: 110 RRGYDVDEQGKIVRGKGTVSSNYDNYVFDIWKQYYPQPVEIKHDHVLDHYDIHEELGTGA 169
Query: 302 QAV------KKS------KVIDESK---VEEFINEVVILSQINHRNVVKLLGCCLETEVP 346
V + + K + E E+ +S + H +V L E +
Sbjct: 170 FGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAF-EDDNE 228
Query: 347 L-LVYEFIPNGTLFQYIHDQNEDFPITWEIRLRIAIEVSGALSYLHSAASIPIYHRDIKS 405
+ ++YEF+ G LF+ + D++ + + + +V L ++H H D+K
Sbjct: 229 MVMIYEFMSGGELFEKVADEHNKM--SEDEAVEYMRQVCKGLCHMHENN---YVHLDLKP 283
Query: 406 TNILLDDK--YRAKVSDFGASRSMAVDQTHMTTQVHGTFGYLDPEYFRSSQFTDKSDVYS 463
NI+ K K+ DFG + + D GT + PE +D++S
Sbjct: 284 ENIMFTTKRSNELKLIDFGLTAHL--DPKQSVKVTTGTAEFAAPEVAEGKPVGYYTDMWS 341
Query: 464 FGVVLTELLTGEKPIRFTILEEDKSLAAYFLCAMKEERLFEILDARV-MKQGGKDEIITV 522
GV+ LL+G P F +E L + M I
Sbjct: 342 VGVLSYILLSGLSP---------------FGGENDDETLRNVKSCDWNMDDSAFSGISED 386
Query: 523 AK-LAKRCLNLNGKKRPTMREV 543
K ++ L + R T+ +
Sbjct: 387 GKDFIRKLLLADPNTRMTIHQA 408
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 98.9 bits (247), Expect = 7e-23
Identities = 67/294 (22%), Positives = 109/294 (37%), Gaps = 62/294 (21%)
Query: 285 EKATDNFDLNRILGQG-------------GQ--AVK---KSKVI-----DESKVEEFINE 321
+ D + +++ LG G + A+K K K + E
Sbjct: 6 KALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETE 65
Query: 322 VVILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGTLFQYIHDQ---NEDFPITWEIRLR 378
+ IL ++NH ++K+ + E +V E + G LF + E +
Sbjct: 66 IEILKKLNHPCIIKIKNFF-DAEDYYIVLELMEGGELFDKVVGNKRLKEA-----TCK-L 118
Query: 379 IAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDK---YRAKVSDFGASRSMAVDQTHMT 435
++ A+ YLH I HRD+K N+LL + K++DFG S+ + + + M
Sbjct: 119 YFYQMLLAVQYLHENG---IIHRDLKPENVLLSSQEEDCLIKITDFGHSKILG-ETSLMR 174
Query: 436 TQVHGTFGYLDPEYFRSSQ---FTDKSDVYSFGVVLTELLTGEKPIRFTILEEDKSLAAY 492
T GT YL PE S + D +S GV+L L+G P
Sbjct: 175 TLC-GTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPP--------------- 218
Query: 493 FLCAMKEERLFE-ILDARV-MKQGGKDEIITVAK-LAKRCLNLNGKKRPTMREV 543
F + L + I + E+ A L K+ L ++ K R T E
Sbjct: 219 FSEHRTQVSLKDQITSGKYNFIPEVWAEVSEKALDLVKKLLVVDPKARFTTEEA 272
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 98.2 bits (245), Expect = 9e-23
Identities = 58/216 (26%), Positives = 98/216 (45%), Gaps = 31/216 (14%)
Query: 289 DNFDLNRILGQGGQAV------KKS------KVID----ESKVEEFINEVVILSQINHRN 332
D+++L ++G G AV K I+ ++ ++E + E+ +SQ +H N
Sbjct: 15 DDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPN 74
Query: 333 VVKLLGCCLETEVPLLVYEFIPNG---TLFQYIHDQNEDFPITWEIRLRIAI---EVSGA 386
+V + + LV + + G + ++I + E + IA EV
Sbjct: 75 IVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLD-ESTIATILREVLEG 133
Query: 387 LSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHGTF-G-- 443
L YLH I HRD+K+ NILL + +++DFG S +A +V TF G
Sbjct: 134 LEYLHKNGQI---HRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGTP 190
Query: 444 -YLDPEYF-RSSQFTDKSDVYSFGVVLTELLTGEKP 477
++ PE + + K+D++SFG+ EL TG P
Sbjct: 191 CWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAP 226
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 98.7 bits (246), Expect = 1e-22
Identities = 67/340 (19%), Positives = 116/340 (34%), Gaps = 88/340 (25%)
Query: 272 TIEKTKLFTSKELEKATDNFDLNRILGQG-------------GQ--AVK-----KSKVID 311
+ + F L + + L +GQG A+K K + I+
Sbjct: 9 SGRENLYFQGGSLLELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQIN 68
Query: 312 ESKVEEFINEVVILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGTLFQYIHDQNEDFPI 371
VE EV ++ +++H N+ +L + + LV E G L ++ +D
Sbjct: 69 PKDVERIKTEVRLMKKLHHPNIARLYEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTG 128
Query: 372 TWEIRL-------------------------------------RIAIEVSGALSYLHSAA 394
+ + I ++ AL YLH+
Sbjct: 129 KCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLHNQG 188
Query: 395 SIPIYHRDIKSTNILLDDK--YRAKVSDFGASRSMAV----DQTHMTTQVHGTFGYLDPE 448
I HRDIK N L + K+ DFG S+ + MTT+ GT ++ PE
Sbjct: 189 ---ICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKA-GTPYFVAPE 244
Query: 449 YFRSSQ--FTDKSDVYSFGVVLTELLTGEKPIRFTILEEDKSLAAYFLCAMKEERLFE-I 505
++ + K D +S GV+L LL G P F + + +
Sbjct: 245 VLNTTNESYGPKCDAWSAGVLLHLLLMGAVP--F----PGVN----------DADTISQV 288
Query: 506 LDARV-MKQGGKDEIITVAK-LAKRCLNLNGKKRPTMREV 543
L+ ++ + + + +A+ L LN N +R
Sbjct: 289 LNKKLCFENPNYNVLSPLARDLLSNLLNRNVDERFDAMRA 328
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 99.0 bits (247), Expect = 1e-22
Identities = 63/288 (21%), Positives = 114/288 (39%), Gaps = 47/288 (16%)
Query: 279 FTSKELEKATDNFDLNR--ILGQGGQAV------KKS------KVIDESKV---EEFINE 321
+ + + +++ ILG G + K+I + EE NE
Sbjct: 77 IVTAKQGAVNSFYTVSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNE 136
Query: 322 VVILSQINHRNVVKLLGCCLETEVPL-LVYEFIPNGTLFQYIHDQNEDFPIT-WEIRLRI 379
+ +++Q++H N+++L E++ + LV E++ G LF I D++ + T +
Sbjct: 137 ISVMNQLDHANLIQLYD-AFESKNDIVLVMEYVDGGELFDRIIDESYNL--TELDTI-LF 192
Query: 380 AIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRA--KVSDFGASRSMAVDQTHMTTQ 437
++ + ++H I H D+K NIL ++ K+ DFG +R + +
Sbjct: 193 MKQICEGIRHMHQMY---ILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREK-LKVN 248
Query: 438 VHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLTELLTGEKPIRFTILEEDKSLAAYFLCAM 497
GT +L PE + +D++S GV+ LL+G P FL
Sbjct: 249 F-GTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSP---------------FLGDN 292
Query: 498 KEERLFEILDARV-MKQGGKDEIITVAK-LAKRCLNLNGKKRPTMREV 543
E L IL R ++ +I AK + L R + E
Sbjct: 293 DAETLNNILACRWDLEDEEFQDISEEAKEFISKLLIKEKSWRISASEA 340
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 97.4 bits (243), Expect = 2e-22
Identities = 71/295 (24%), Positives = 113/295 (38%), Gaps = 68/295 (23%)
Query: 281 SKELEKATDNFDLNRILGQGGQA-VKKS-----------KVIDESKVEEFIN-------- 320
K+ E + L +LG+GG V KVI ++V +
Sbjct: 23 GKDREAFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCP 82
Query: 321 -EVVILSQIN----HRNVVKLLGCCLETEVPL-LVYEF-IPNGTLFQYIHDQ---NEDFP 370
EV +L ++ H V++LL ET+ LV E +P LF YI ++ E
Sbjct: 83 LEVALLWKVGAGGGHPGVIRLLDW-FETQEGFMLVLERPLPAQDLFDYITEKGPLGEG-- 139
Query: 371 ITWEIRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKY-RAKVSDFGASRSMAV 429
R +V A+ + HS + HRDIK NIL+D + AK+ DFG+ +
Sbjct: 140 ---PSR-CFFGQVVAAIQHCHSRG---VVHRDIKDENILIDLRRGCAKLIDFGSGALL-- 190
Query: 430 DQTHMTTQVHGTFGYLDPEYFRSSQFT-DKSDVYSFGVVLTELLTGEKPIRFTILEEDKS 488
T GT Y PE+ Q+ + V+S G++L +++ G+ P + +
Sbjct: 191 HDEPYTDFD-GTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFE----RDQEI 245
Query: 489 LAAYFLCAMKEERLFEILDARVMKQGGKDEIITVAKLAKRCLNLNGKKRPTMREV 543
L A + L +RCL RP++ E+
Sbjct: 246 LEAELHF------------PAHVSPDCCA-------LIRRCLAPKPSSRPSLEEI 281
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 96.5 bits (241), Expect = 2e-22
Identities = 69/277 (24%), Positives = 111/277 (40%), Gaps = 52/277 (18%)
Query: 290 NFDLNRILGQG-------------GQ--AVK---KSKVIDESKVEEFINEVVILSQINHR 331
++ L LG G G AVK + K+ V + E+ L H
Sbjct: 12 HYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHP 71
Query: 332 NVVKLLGCCLETEVPL-LVYEFIPNGTLFQYIHDQ---NEDFPITWEIRLRIAIEVSGAL 387
+++KL + T +V E++ G LF YI E E R R+ ++ A+
Sbjct: 72 HIIKLYQV-ISTPTDFFMVMEYVSGGELFDYICKHGRVEEM-----EAR-RLFQQILSAV 124
Query: 388 SYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHGTFGYLDP 447
Y H + HRD+K N+LLD AK++DFG S M+ + T+ G+ Y P
Sbjct: 125 DYCHRHM---VVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRTSC--GSPNYAAP 179
Query: 448 EYFRSSQFT-DKSDVYSFGVVLTELLTGEKPIRFTILEEDKSLAAYFLCAMKEERLFEIL 506
E + + D++S GV+L LL G P F +D+ + F F I
Sbjct: 180 EVISGRLYAGPEVDIWSCGVILYALLCGTLP--F----DDEHVPTLFKKIRGGV--FYI- 230
Query: 507 DARVMKQGGKDEIITVAKLAKRCLNLNGKKRPTMREV 543
+ + L L ++ KR T++++
Sbjct: 231 -PEYLNRSVAT-------LLMHMLQVDPLKRATIKDI 259
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 101 bits (252), Expect = 2e-22
Identities = 53/213 (24%), Positives = 96/213 (45%), Gaps = 35/213 (16%)
Query: 289 DNFDLNRILGQGG------------------QAVKKSKVIDESKVEEFINEVVILSQIN- 329
++F ++RI+G+GG + + K ++ + +NE ++LS ++
Sbjct: 189 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVST 248
Query: 330 --HRNVVKLLGCCLETEVPL-LVYEFIPNGTLFQYIHDQNEDFPITWEIRLRI-AIEVSG 385
+V + T L + + + G L ++ Q+ F E +R A E+
Sbjct: 249 GDCPFIVCM-SYAFHTPDKLSFILDLMNGGDLHYHLS-QHGVFS---EADMRFYAAEIIL 303
Query: 386 ALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHGTFGYL 445
L ++H+ + +RD+K NILLD+ ++SD G + + + H V GT GY+
Sbjct: 304 GLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPH--ASV-GTHGYM 357
Query: 446 DPEYFRSSQFTDKS-DVYSFGVVLTELLTGEKP 477
PE + D S D +S G +L +LL G P
Sbjct: 358 APEVLQKGVAYDSSADWFSLGCMLFKLLRGHSP 390
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 98.8 bits (246), Expect = 2e-22
Identities = 43/221 (19%), Positives = 78/221 (35%), Gaps = 39/221 (17%)
Query: 288 TDNFDLNRILGQGGQAV--------KKS------KVID-----ESKVEEFINEVVILSQI 328
++L ++G+G + + K + + I+ V E+ +
Sbjct: 24 GGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLF 83
Query: 329 NHRNVVKLLGCCLETEVPLLVYEFIPNGTLFQYI-HDQNEDFPITWEIRLRIAI---EVS 384
NH N+V + +V F+ G+ I + IA V
Sbjct: 84 NHPNIVPYRATFIADNELWVVTSFMAYGSAKDLICTHFMDGMNELA-----IAYILQGVL 138
Query: 385 GALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVH----- 439
AL Y+H + HR +K+++IL+ + +S ++ SM
Sbjct: 139 KALDYIHHMGYV---HRSVKASHILISVDGKVYLSGLRSNLSMISHGQRQRVVHDFPKYS 195
Query: 440 -GTFGYLDPEYFRSSQ--FTDKSDVYSFGVVLTELLTGEKP 477
+L PE + + + KSD+YS G+ EL G P
Sbjct: 196 VKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVP 236
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 96.9 bits (242), Expect = 2e-22
Identities = 75/300 (25%), Positives = 117/300 (39%), Gaps = 78/300 (26%)
Query: 288 TDNFDLNRILGQGG-----QAVKKS-------KVIDESKV------------EEFINEVV 323
+N++ ILG+G + + K K+ID + E + EV
Sbjct: 16 YENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVD 75
Query: 324 ILSQIN-HRNVVKLLGCCLETEVPL-LVYEFIPNGTLFQYIHDQ---NEDFPITWEIRLR 378
IL +++ H N+++L ET LV++ + G LF Y+ ++ +E E R +
Sbjct: 76 ILRKVSGHPNIIQLKDTY-ETNTFFFLVFDLMKKGELFDYLTEKVTLSEK-----ETR-K 128
Query: 379 IAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQV 438
I + + LH I HRD+K NILLDD K++DFG S + + +
Sbjct: 129 IMRALLEVICALHKLN---IVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEK-LREVC 184
Query: 439 HGTFGYLDPEYFRSSQFTDKS------DVYSFGVVLTELLTGEKPIRFTILEEDKSLAAY 492
GT YL PE S + D++S GV++ LL G P
Sbjct: 185 -GTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPP--------------- 228
Query: 493 FLCAMKEERLFEILDARVMKQGGK--------DEIITVAK-LAKRCLNLNGKKRPTMREV 543
F K+ + +M G D+ K L R L + +KR T E
Sbjct: 229 FW-HRKQMLMLR----MIMS--GNYQFGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEA 281
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 97.3 bits (243), Expect = 2e-22
Identities = 62/289 (21%), Positives = 106/289 (36%), Gaps = 64/289 (22%)
Query: 285 EKATDNFDLNRILGQGG-----QAVKKS-------KVIDESK--VEEFINEVVILSQINH 330
++ + + + LG+G + V+ S K + E+ IL+ H
Sbjct: 1 KELYEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEISILNIARH 60
Query: 331 RNVVKLLGCCLETEVPL-LVYEFIPNGTLFQYIHDQNEDFPITWEIRLRIAIE----VSG 385
RN++ L E+ L +++EFI +F+ I+ + E R + V
Sbjct: 61 RNILHLHESF-ESMEELVMIFEFISGLDIFERINTSAFELN---E---REIVSYVHQVCE 113
Query: 386 ALSYLHSAASIPIYHRDIKSTNILLDDKYRA--KVSDFGASRSMAVDQTHMTTQVHGTFG 443
AL +LHS I H DI+ NI+ + + K+ +FG +R +
Sbjct: 114 ALQFLHSHN---IGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDN-FRLLF-TAPE 168
Query: 444 YLDPEYFRSSQFTDKSDVYSFGVVLTELLTGEKPIRFTILEEDKSLAAYFLCAMKEERLF 503
Y PE + + +D++S G ++ LL+G P F L E
Sbjct: 169 YYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINP--F--LAETNQ--------------- 209
Query: 504 EILDARVMKQGGK--------DEIITVAK-LAKRCLNLNGKKRPTMREV 543
+I++ +M + EI A R L K R T E
Sbjct: 210 QIIEN-IMN--AEYTFDEEAFKEISIEAMDFVDRLLVKERKSRMTASEA 255
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 97.5 bits (243), Expect = 4e-22
Identities = 69/299 (23%), Positives = 123/299 (41%), Gaps = 77/299 (25%)
Query: 288 TDNFDLNRILGQGG-----QAVKKS-------KVIDESKV-----------EEFINEVVI 324
+D ++G+G + V ++ K+++ + E E I
Sbjct: 93 YQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHI 152
Query: 325 LSQI-NHRNVVKLLGCCLETEVPL-LVYEFIPNGTLFQYIHDQ---NEDFPITWEIRLRI 379
L Q+ H +++ L+ E+ + LV++ + G LF Y+ ++ +E E R I
Sbjct: 153 LRQVAGHPHIITLIDSY-ESSSFMFLVFDLMRKGELFDYLTEKVALSEK-----ETR-SI 205
Query: 380 AIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVH 439
+ A+S+LH+ I HRD+K NILLDD + ++SDFG S + + +
Sbjct: 206 MRSLLEAVSFLHANN---IVHRDLKPENILLDDNMQIRLSDFGFSCHLEPGEK-LRELC- 260
Query: 440 GTFGYLDPEYFRSSQFTD------KSDVYSFGVVLTELLTGEKPIRFTILEEDKSLAAYF 493
GT GYL PE + S + D+++ GV+L LL G P F
Sbjct: 261 GTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPP--FW------------ 306
Query: 494 LCAMKEERLFEILDARVMKQGGK--------DEIITVAK-LAKRCLNLNGKKRPTMREV 543
++ + +M+ G+ D+ + K L R L ++ + R T +
Sbjct: 307 --HRRQILMLR----MIME--GQYQFSSPEWDDRSSTVKDLISRLLQVDPEARLTAEQA 357
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 95.2 bits (237), Expect = 6e-22
Identities = 37/279 (13%), Positives = 86/279 (30%), Gaps = 56/279 (20%)
Query: 286 KATDNFDLNRILGQGGQAVK---KSKVIDESKVEEFINEVVILSQINHRNVVKLLGCCLE 342
+A D L+R + A+ V+ + ++E ++ + LS+I+ V ++L
Sbjct: 49 QALDT-ALDRQV-----ALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHT 102
Query: 343 TEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEIRLRIAIEVSGALSYLHSAASIPIYHRD 402
L+V E+I G+L + + +R ++ A H A +
Sbjct: 103 RAGGLVVAEWIRGGSLQEVADT-----SPSPVGAIRAMQSLAAAADAAHRA---GVALSI 154
Query: 403 IKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHGTFGYLDPEYFRSSQFTDKSDVY 462
+ + + + + + D+
Sbjct: 155 DHPSRVRVSIDGDVVL---------------------AYPATMPDA-------NPQDDIR 186
Query: 463 SFGVVLTELLTGEKPIRFTILEEDKSLAAYFLCAMKEERLFEILDARVMKQGGKDEIITV 522
G L LL P LA A ++ + ++ + + + +
Sbjct: 187 GIGASLYALLVNRWP--LPEAGVRSGLAP----AERDTAG-QPIEPADIDRDIPFQ---I 236
Query: 523 AKLAKRCLNLNGKKRPTMREVASELAGIKAWNGASNVIE 561
+ +A R + +G R + + + A + V+
Sbjct: 237 SAVAARSVQGDGGIRSAS-TLLNLMQQATAVADRTEVLG 274
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 97.9 bits (244), Expect = 7e-22
Identities = 57/231 (24%), Positives = 98/231 (42%), Gaps = 29/231 (12%)
Query: 268 STEGTIEKTKLFTSKELEKAT-DNFDLNRILGQGG------------------QAVKKSK 308
S E+ ++ +K + T + F+ ++LG+G + +KK
Sbjct: 126 SDNSGAEEMEVSLAKPKHRVTMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEV 185
Query: 309 VIDESKVEEFINEVVILSQINHRNVVKLLGCCLETEVPL-LVYEFIPNGTLFQYIHDQNE 367
++ + +V + E +L H + L +T L V E+ G LF ++ +
Sbjct: 186 IVAKDEVAHTLTENRVLQNSRHPFLTALK-YSFQTHDRLCFVMEYANGGELFFHLS-RER 243
Query: 368 DFPITWEIRLRI-AIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRS 426
F E R R E+ AL YLHS ++ +Y RD+K N++LD K++DFG +
Sbjct: 244 VFS---EDRARFYGAEIVSALDYLHSEKNV-VY-RDLKLENLMLDKDGHIKITDFGLCK- 297
Query: 427 MAVDQTHMTTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLTELLTGEKP 477
+ GT YL PE + + D + GVV+ E++ G P
Sbjct: 298 EGIKDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 348
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 96.5 bits (240), Expect = 7e-22
Identities = 60/218 (27%), Positives = 95/218 (43%), Gaps = 32/218 (14%)
Query: 281 SKELEKATDNFDLNRILGQG-GQAVKKS-----------KVI----DESKVEEFINEVVI 324
K E D+F+ LG G G V K K+I + + I E+ +
Sbjct: 25 QKVGELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQV 84
Query: 325 LSQINHRNVVKLLGCCLETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEIRLRIAIEVS 384
L + N +V G + E + G+L Q + I +I +++I V
Sbjct: 85 LHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAG---RIPEQILGKVSIAVI 141
Query: 385 GALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGAS----RSMAVDQTHMTTQVHG 440
L+YL I HRD+K +NIL++ + K+ DFG S SMA + V G
Sbjct: 142 KGLTYLREKHKI--MHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMA------NSFV-G 192
Query: 441 TFGYLDPEYFRSSQFTDKSDVYSFGVVLTELLTGEKPI 478
T Y+ PE + + ++ +SD++S G+ L E+ G PI
Sbjct: 193 TRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPI 230
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 95.8 bits (239), Expect = 8e-22
Identities = 68/290 (23%), Positives = 112/290 (38%), Gaps = 58/290 (20%)
Query: 285 EKATDNFDLNRILGQGGQAV------KKS------KVIDESK---------VEEFINEVV 323
+K D +D+ LG G A+ K + K I + + EE EV
Sbjct: 8 QKVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVS 67
Query: 324 ILSQINHRNVVKLLGCCLETEVPL-LVYEFIPNGTLFQYIHDQN---EDFPITWEIRLRI 379
IL Q+ H NV+ L E + L+ E + G LF ++ + E+ E
Sbjct: 68 ILRQVLHHNVITLHDVY-ENRTDVVLILELVSGGELFDFLAQKESLSEE-----EAT-SF 120
Query: 380 AIEVSGALSYLHSAASIPIYHRDIKSTNILL----DDKYRAKVSDFGASRSMAVDQTHMT 435
++ ++YLH+ I H D+K NI+L K+ DFG + + +
Sbjct: 121 IKQILDGVNYLHTKK---IAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEI--EDGVEF 175
Query: 436 TQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLTELLTGEKPIRFTILEEDKSLAAYFLC 495
+ GT ++ PE ++D++S GV+ LL+G P FL
Sbjct: 176 KNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP---------------FLG 220
Query: 496 AMKEERLFEILDARV-MKQGGKDEIITVAK-LAKRCLNLNGKKRPTMREV 543
K+E L I + +AK ++ L +KR T++E
Sbjct: 221 DTKQETLANITSVSYDFDEEFFSHTSELAKDFIRKLLVKETRKRLTIQEA 270
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 95.0 bits (237), Expect = 9e-22
Identities = 67/288 (23%), Positives = 111/288 (38%), Gaps = 66/288 (22%)
Query: 290 NFDLNRILGQG-------------GQ--AVK---KSKVIDESKVEEFIN-EVVILSQINH 330
+ + +LG+G AVK K K+ E + E+ +L ++ H
Sbjct: 6 KYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRH 65
Query: 331 RNVVKLLG-CCLETEVPL-LVYEFIPNGT--LFQYIHDQNEDFPITWEIRLRIAIEVSGA 386
+NV++L+ E + + +V E+ G + + + FP+ + ++
Sbjct: 66 KNVIQLVDVLYNEEKQKMYMVMEYCVCGMQEMLDSV--PEKRFPV-CQAH-GYFCQLIDG 121
Query: 387 LSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSM---AVDQTHMTTQVHGTFG 443
L YLHS I H+DIK N+LL K+S G + ++ A D T T+Q G+
Sbjct: 122 LEYLHSQG---IVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCRTSQ--GSPA 176
Query: 444 YLDPEYFRSSQFTD--KSDVYSFGVVLTELLTGEKPIRFTILEEDKSLAAYFLCAMKEER 501
+ PE K D++S GV L + TG P F E ++ +
Sbjct: 177 FQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYP--F----EGDNIY----------K 220
Query: 502 LFE-ILDARV-----MKQGGKDEIITVAKLAKRCLNLNGKKRPTMREV 543
LFE I D L K L KR ++R++
Sbjct: 221 LFENIGKGSYAIPGDCGPPLSD-------LLKGMLEYEPAKRFSIRQI 261
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 95.6 bits (238), Expect = 1e-21
Identities = 63/290 (21%), Positives = 110/290 (37%), Gaps = 74/290 (25%)
Query: 290 NFDLNRILGQG-------------GQ--AVK---KSKVIDESKVEEFIN-----EVVILS 326
+ LG G + VK K KV+++ +E+ E+ ILS
Sbjct: 25 KYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILS 84
Query: 327 QINHRNVVKLLGCCLETEVPL-LVYEFIPNGT-LFQYIHDQ---NEDFPITWEIRLRIAI 381
++ H N++K+L E + LV E +G LF +I +E I
Sbjct: 85 RVEHANIIKVLDI-FENQGFFQLVMEKHGSGLDLFAFIDRHPRLDEP-----LAS-YIFR 137
Query: 382 EVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHGT 441
++ A+ YL I HRDIK NI++ + + K+ DFG++ + + T GT
Sbjct: 138 QLVSAVGYLRLKD---IIHRDIKDENIVIAEDFTIKLIDFGSAAYLERGK-LFYTFC-GT 192
Query: 442 FGYLDPEYFRSSQFT-DKSDVYSFGVVLTELLTGEKPIRFTILEEDKSLAAYFLCAMKEE 500
Y PE + + + +++S GV L L+ E P F
Sbjct: 193 IEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENP--F-------------------C 231
Query: 501 RLFEILDARV-----MKQGGKDEIITVAKLAKRCLNLNGKKRPTMREVAS 545
L E ++A + + + L L ++R T+ ++ +
Sbjct: 232 ELEETVEAAIHPPYLVSKELMS-------LVSGLLQPVPERRTTLEKLVT 274
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 95.0 bits (237), Expect = 2e-21
Identities = 73/308 (23%), Positives = 118/308 (38%), Gaps = 74/308 (24%)
Query: 271 GTIEKTKLFTSKELEKATDNFDLNRILGQGGQAV------KKS------KVIDESK---- 314
GT+ + + D +D LG G AV K + K I + +
Sbjct: 1 GTVFRQENVD--------DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSS 52
Query: 315 -----VEEFINEVVILSQINHRNVVKLLGCCLETEVPL-LVYEFIPNGTLFQYIHDQN-- 366
E+ EV IL +I H NV+ L E + + L+ E + G LF ++ ++
Sbjct: 53 RRGVSREDIEREVSILKEIQHPNVITLHEVY-ENKTDVILILELVAGGELFDFLAEKESL 111
Query: 367 -EDFPITWEIRLRIAIE----VSGALSYLHSAASIPIYHRDIKSTNILLDDKYRA----K 417
E A E + + YLHS I H D+K NI+L D+ K
Sbjct: 112 TE----------EEATEFLKQILNGVYYLHSLQ---IAHFDLKPENIMLLDRNVPKPRIK 158
Query: 418 VSDFGASRSMAVDQTHMTTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLTELLTGEKP 477
+ DFG + + D + + GT ++ PE ++D++S GV+ LL+G P
Sbjct: 159 IIDFGLAHKI--DFGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 216
Query: 478 IRFTILEEDKSLAAYFLCAMKEERLFEILDARV-MKQGGKDEIITVAK-LAKRCLNLNGK 535
FL K+E L + + +AK +R L + K
Sbjct: 217 ---------------FLGDTKQETLANVSAVNYEFEDEYFSNTSALAKDFIRRLLVKDPK 261
Query: 536 KRPTMREV 543
KR T+++
Sbjct: 262 KRMTIQDS 269
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 95.5 bits (238), Expect = 2e-21
Identities = 77/354 (21%), Positives = 129/354 (36%), Gaps = 70/354 (19%)
Query: 281 SKELEKATDNFDLNRILGQG-------------GQ--AVK---KSKVIDESKVEEFINEV 322
+ +D +D + +G G + AVK + IDE V+ E+
Sbjct: 12 DMPIMHDSDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAAIDE-NVQ---REI 67
Query: 323 VILSQINHRNVVKLLGCCLETEVPL-LVYEFIPNGTLFQYIHDQ---NEDFPITWEIRLR 378
+ + H N+V+ + T L ++ E+ G L++ I + +ED E R
Sbjct: 68 INHRSLRHPNIVRFKE-VILTPTHLAIIMEYASGGELYERICNAGRFSED-----EAR-F 120
Query: 379 IAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKY--RAKVSDFGASRSMAVDQTHMTT 436
++ +SY HS I HRD+K N LLD R K+ DFG S+S + +T
Sbjct: 121 FFQQLLSGVSYCHSMQ---ICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST 177
Query: 437 QVHGTFGYLDPEYFRSSQFT-DKSDVYSFGVVLTELLTGEKPIRFTILEEDKSLAAYF-- 493
GT Y+ PE ++ +DV+S GV L +L G P F ED +
Sbjct: 178 V--GTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYP--F----EDPEEPRDYRK 229
Query: 494 LCAMKEERLFEILDARVMKQGGKDEIITVAKLAKRCLNLNGKKRPTMREV---------- 543
+ I D + L R + R ++ E+
Sbjct: 230 TIQRILSVKYSIPDDIRISPECCH-------LISRIFVADPATRISIPEIKTHSWFLKNL 282
Query: 544 ASELAGIKAWNGASNVIEEGLEEIDCALGDIYIVANSETNGSINESFLDDVTVS 597
++L E+ ++ +D I + + T ++ LDD
Sbjct: 283 PADLMNESNTGSQFQEPEQPMQSLD----TIMQIISEATIPAVRNRCLDDFMTD 332
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 93.4 bits (233), Expect = 3e-21
Identities = 68/294 (23%), Positives = 111/294 (37%), Gaps = 72/294 (24%)
Query: 288 TDNFDLNRILGQGG-----QAVKKS-------KVIDESK---------VEEFINEVVILS 326
D++++ LG G + +K K I + + EE EV IL
Sbjct: 4 EDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILR 63
Query: 327 QINHRNVVKLLGCCLETEVPL-LVYEFIPNGTLFQYIHDQN---EDFPITWEIRLRIAIE 382
+I H N++ L E + + L+ E + G LF ++ ++ ED E + +
Sbjct: 64 EIRHPNIITLHDIF-ENKTDVVLILELVSGGELFDFLAEKESLTED-----EAT-QFLKQ 116
Query: 383 VSGALSYLHSAASIPIYHRDIKSTNILLDDKYRA----KVSDFGASRSMAVDQTHMTTQV 438
+ + YLHS I H D+K NI+L DK K+ DFG + +
Sbjct: 117 ILDGVHYLHSKR---IAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNE-FKNIF 172
Query: 439 HGTFGYLDPEYFRSSQFTDKSDVYSFGVVLTELLTGEKPIRFTILEEDKSLAAYFLCAMK 498
GT ++ PE ++D++S GV+ LL+G P F L E K
Sbjct: 173 -GTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP--F--LGETKQ---------- 217
Query: 499 EERLFEILDARVMKQGGK--------DEIITVAK-LAKRCLNLNGKKRPTMREV 543
E L + +AK +R L + K+R T+ +
Sbjct: 218 -----ETLTN-ISA--VNYDFDEEYFSNTSELAKDFIRRLLVKDPKRRMTIAQS 263
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 95.6 bits (238), Expect = 4e-21
Identities = 68/277 (24%), Positives = 113/277 (40%), Gaps = 52/277 (18%)
Query: 290 NFDLNRILGQG-------------GQ--AVK---KSKVIDESKVEEFINEVVILSQINHR 331
++ L LG G G AVK + K+ V + E+ L H
Sbjct: 17 HYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHP 76
Query: 332 NVVKLLGCCLETEVPL-LVYEFIPNGTLFQYI--HDQ-NEDFPITWEIRLRIAIEVSGAL 387
+++KL + T + +V E++ G LF YI + + +E E R R+ ++ +
Sbjct: 77 HIIKLYQV-ISTPSDIFMVMEYVSGGELFDYICKNGRLDEK-----ESR-RLFQQILSGV 129
Query: 388 SYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHGTFGYLDP 447
Y H + HRD+K N+LLD AK++DFG S M+ + T+ G+ Y P
Sbjct: 130 DYCHRHM---VVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRTSC--GSPNYAAP 184
Query: 448 EYFRSSQFT-DKSDVYSFGVVLTELLTGEKPIRFTILEEDKSLAAYFLCAMKEERLFEIL 506
E + + D++S GV+L LL G P F +D + F F
Sbjct: 185 EVISGRLYAGPEVDIWSSGVILYALLCGTLP--F----DDDHVPTLFKKICDGI--FYT- 235
Query: 507 DARVMKQGGKDEIITVAKLAKRCLNLNGKKRPTMREV 543
+ + L K L ++ KR T++++
Sbjct: 236 -PQYLNPSVIS-------LLKHMLQVDPMKRATIKDI 264
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 93.1 bits (232), Expect = 5e-21
Identities = 72/301 (23%), Positives = 117/301 (38%), Gaps = 63/301 (20%)
Query: 288 TDNFDLNR-ILGQGG-----QAVKKS-------KVIDESK---VEEFINEVVILSQI-NH 330
D + L +LG+G + K+I++ EV +L Q H
Sbjct: 11 EDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGH 70
Query: 331 RNVVKLLGCCLETEVPLLVYEFIPNGTLFQYIHDQ---NEDFPITWEIRLRIAIEVSGAL 387
RNV++L+ E + LV+E + G++ +IH + NE E + +V+ AL
Sbjct: 71 RNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNEL-----EAS-VVVQDVASAL 124
Query: 388 SYLHSAASIPIYHRDIKSTNILLDDKYRA---KVSDFGASRSM-------AVDQTHMTTQ 437
+LH+ I HRD+K NIL + + K+ DF + + + T
Sbjct: 125 DFLHNKG---IAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTP 181
Query: 438 VHGTFGYLDPEYFRSSQFTDKS-----DVYSFGVVLTELLTGEKPIRF-TILEEDKSLAA 491
G+ Y+ PE + D++S GV+L LL+G P F D
Sbjct: 182 C-GSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPP--FVGRCGSDCGWDR 238
Query: 492 YFLCAMKEERLFEILDARVMKQGGK--------DEIITVAK-LAKRCLNLNGKKRPTMRE 542
C + LFE + + GK I AK L + L + K+R + +
Sbjct: 239 GEACPACQNMLFE----SIQE--GKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQ 292
Query: 543 V 543
V
Sbjct: 293 V 293
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 94.0 bits (234), Expect = 5e-21
Identities = 69/290 (23%), Positives = 115/290 (39%), Gaps = 58/290 (20%)
Query: 285 EKATDNFDLNRILGQGG-----QAVKKS-------KVIDESK---------VEEFINEVV 323
+K D +D+ LG G + +KS K I + + EE EV
Sbjct: 8 QKVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVS 67
Query: 324 ILSQINHRNVVKLLGCCLETEVPL-LVYEFIPNGTLFQYIHDQN---EDFPITWEIRLRI 379
IL Q+ H N++ L E + L+ E + G LF ++ + E+ E
Sbjct: 68 ILRQVLHPNIITLHDVY-ENRTDVVLILELVSGGELFDFLAQKESLSEE-----EAT-SF 120
Query: 380 AIEVSGALSYLHSAASIPIYHRDIKSTNILLDDK----YRAKVSDFGASRSMAVDQTHMT 435
++ ++YLH+ I H D+K NI+L DK K+ DFG + ++
Sbjct: 121 IKQILDGVNYLHTKK---IAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHE--IEDGVEF 175
Query: 436 TQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLTELLTGEKPIRFTILEEDKSLAAYFLC 495
+ GT ++ PE ++D++S GV+ LL+G P FL
Sbjct: 176 KNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP---------------FLG 220
Query: 496 AMKEERLFEILDARV-MKQGGKDEIITVAK-LAKRCLNLNGKKRPTMREV 543
K+E L I + + +AK ++ L +KR T++E
Sbjct: 221 DTKQETLANITAVSYDFDEEFFSQTSELAKDFIRKLLVKETRKRLTIQEA 270
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 91.2 bits (227), Expect = 2e-20
Identities = 51/216 (23%), Positives = 92/216 (42%), Gaps = 27/216 (12%)
Query: 284 LEKATDNFDLNRILGQG-GQAVKKS-----------KVI----DESKVEEFINEV-VILS 326
+E D+ + LG+G V+K K I + + + + ++ + +
Sbjct: 2 MEVKADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMR 61
Query: 327 QINHRNVVKLLGCCL-ETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEIRLRIAIEVSG 385
++ V G E +V + E + Y ++ I +I +IA+ +
Sbjct: 62 TVDCPFTVTFYGALFREGDV-WICMELMDTSLDKFYKQVIDKGQTIPEDILGKIAVSIVK 120
Query: 386 ALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHGTFGYL 445
AL +LHS S+ I HRD+K +N+L++ + K+ DFG S + VD G Y+
Sbjct: 121 ALEHLHSKLSV-I-HRDVKPSNVLINALGQVKMCDFGISGYL-VDDVAKDIDA-GCKPYM 176
Query: 446 DPE----YFRSSQFTDKSDVYSFGVVLTELLTGEKP 477
PE ++ KSD++S G+ + EL P
Sbjct: 177 APERINPELNQKGYSVKSDIWSLGITMIELAILRFP 212
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 92.5 bits (230), Expect = 2e-20
Identities = 55/214 (25%), Positives = 83/214 (38%), Gaps = 38/214 (17%)
Query: 288 TDNFDLNRILGQG-------------GQ--AVKKSKVIDESK---VEEFINEVVILSQIN 329
F R +G G + A+KK + ++ I EV L ++
Sbjct: 53 EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLR 112
Query: 330 HRNVVKLLGCCLETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEIRLRIAI---EVSGA 386
H N ++ GC L LV E+ G+ + + IA
Sbjct: 113 HPNTIQYRGCYLREHTAWLVMEYCL-GSASDLLEVHKKPLQEVE-----IAAVTHGALQG 166
Query: 387 LSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHGTFGYLD 446
L+YLHS I HRD+K+ NILL + K+ DFG++ M + V GT ++
Sbjct: 167 LAYLHSHNMI---HRDVKAGNILLSEPGLVKLGDFGSASIM----APANSFV-GTPYWMA 218
Query: 447 PE---YFRSSQFTDKSDVYSFGVVLTELLTGEKP 477
PE Q+ K DV+S G+ EL + P
Sbjct: 219 PEVILAMDEGQYDGKVDVWSLGITCIELAERKPP 252
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 91.5 bits (228), Expect = 2e-20
Identities = 63/301 (20%), Positives = 109/301 (36%), Gaps = 61/301 (20%)
Query: 275 KTKLFTSKELEKATDNFDLN-RILGQGG-----QAVKKS-------KVIDESK-----VE 316
T+ + +E + + L + LG+G Q + KS K + + +
Sbjct: 14 GTENLYFQSMENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRA 73
Query: 317 EFINEVVILSQINHR-NVVKLLGCCLETEVPL-LVYEFIPNGTLFQYIHDQNEDFPITWE 374
E ++E+ +L V+ L E + L+ E+ G +F + + +
Sbjct: 74 EILHEIAVLELAKSCPRVINLHEVY-ENTSEIILILEYAAGGEIFSLCLPELAEMVSEND 132
Query: 375 IRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKY---RAKVSDFGASRSMAVDQ 431
+ R+ ++ + YLH I H D+K NILL Y K+ DFG SR +
Sbjct: 133 VI-RLIKQILEGVYYLHQNN---IVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIG-HA 187
Query: 432 THMTTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLTELLTGEKPIRFTILEEDKSLAA 491
+ + GT YL PE T +D+++ G++ LLT P F + ED
Sbjct: 188 CELREIM-GTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSP--F--VGEDNQ--- 239
Query: 492 YFLCAMKEERLFEILDARVMKQGGK--------DEIITVAK-LAKRCLNLNGKKRPTMRE 542
E + + + +A + L N +KRPT
Sbjct: 240 ------------ETYLN-ISQ--VNVDYSEETFSSVSQLATDFIQSLLVKNPEKRPTAEI 284
Query: 543 V 543
Sbjct: 285 C 285
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 91.6 bits (228), Expect = 3e-20
Identities = 59/229 (25%), Positives = 96/229 (41%), Gaps = 31/229 (13%)
Query: 269 TEGTIEKTKLFTSKELEKAT-DNFDLNRILGQG--GQ-------------AVK---KSKV 309
+ + K + + A D FD + LG G G+ A+K K KV
Sbjct: 20 AKAKEDFLKKWETPSQNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKV 79
Query: 310 IDESKVEEFINEVVILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGTLFQYIHDQNEDF 369
+ ++E +NE IL +N +VKL + +V E++ G +F ++ F
Sbjct: 80 VKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGR-F 138
Query: 370 PITWEIRLRI-AIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMA 428
E R A ++ YLHS + +RD+K N+L+D + +V+DFG A
Sbjct: 139 S---EPHARFYAAQIVLTFEYLHSLD---LIYRDLKPENLLIDQQGYIQVTDFG----FA 188
Query: 429 VDQTHMTTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLTELLTGEKP 477
T + GT L PE S + D ++ GV++ E+ G P
Sbjct: 189 KRVKGRTWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPP 237
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 91.2 bits (227), Expect = 3e-20
Identities = 66/277 (23%), Positives = 111/277 (40%), Gaps = 53/277 (19%)
Query: 290 NFDLNRILGQG-------------GQ--AVK---KSKVIDESKVEEFINEVVILSQINHR 331
+ + LG+G Q A+K + + E+ L + H
Sbjct: 10 PYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHP 69
Query: 332 NVVKLLGCCLETEVPL-LVYEFIPNGTLFQYIHDQ---NEDFPITWEIRLRIAIEVSGAL 387
+++KL + T + +V E+ G LF YI ++ ED E R R ++ A+
Sbjct: 70 HIIKLYDV-ITTPTDIVMVIEYA-GGELFDYIVEKKRMTED-----EGR-RFFQQIICAI 121
Query: 388 SYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHGTFGYLDP 447
Y H I HRD+K N+LLDD K++DFG S M T+ G+ Y P
Sbjct: 122 EYCHRHK---IVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGNFLKTSC--GSPNYAAP 176
Query: 448 EYFRSSQFT-DKSDVYSFGVVLTELLTGEKPIRFTILEEDKSLAAYFLCAMKEERLFEIL 506
E + + DV+S G+VL +L G P F +D+ + F + +
Sbjct: 177 EVINGKLYAGPEVDVWSCGIVLYVMLVGRLP--F----DDEFIPNLFKKVNSCV--YVM- 227
Query: 507 DARVMKQGGKDEIITVAKLAKRCLNLNGKKRPTMREV 543
+ G + L +R + + +R T++E+
Sbjct: 228 -PDFLSPGAQS-------LIRRMIVADPMQRITIQEI 256
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 89.3 bits (222), Expect = 1e-19
Identities = 60/286 (20%), Positives = 110/286 (38%), Gaps = 57/286 (19%)
Query: 288 TDNFDLNR-ILGQGG-----QAVKKS-------KVIDESKVEEFINEVVILSQI-NHRNV 333
TD++ L++ +LG G + + K++ + EV Q ++
Sbjct: 27 TDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLY--DSPKARQEVDHHWQASGGPHI 84
Query: 334 VKLLGCCLETEVP----LLVYEFIPNGTLFQYIHDQNEDFPITWEIRLRIAIEVSGALSY 389
V +L L++ E + G LF I ++ + E I ++ A+ +
Sbjct: 85 VCILDVYENMHHGKRCLLIIMECMEGGELFSRIQERGDQAFTEREAA-EIMRDIGTAIQF 143
Query: 390 LHSAASIPIYHRDIKSTNILLDDKYRA---KVSDFGASRSMAVDQTHMTTQVHGTFGYLD 446
LHS I HRD+K N+L K + K++DFG ++ Q + T T Y+
Sbjct: 144 LHS---HNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKE--TTQNALQTPC-YTPYYVA 197
Query: 447 PEYFRSSQFTDKSDVYSFGVVLTELLTGEKPIRFTILEEDKSLAAYFLCAMKEERLFEIL 506
PE ++ D++S GV++ LL G P F + + + +
Sbjct: 198 PEVLGPEKYDKSCDMWSLGVIMYILLCGFPP--FY--------------SNTGQAISPGM 241
Query: 507 DARVMKQGGK--------DEIITVAK-LAKRCLNLNGKKRPTMREV 543
R+ G+ E+ AK L + L + +R T+ +
Sbjct: 242 KRRIRL--GQYGFPNPEWSEVSEDAKQLIRLLLKTDPTERLTITQF 285
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 88.8 bits (221), Expect = 2e-19
Identities = 55/210 (26%), Positives = 90/210 (42%), Gaps = 31/210 (14%)
Query: 289 DNFDLNRILGQGG------------------QAVKKSKVIDESKVEEFINEVVILSQINH 330
++FD ++LG+G + ++K +I + +V + E +L H
Sbjct: 5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRH 64
Query: 331 RNVVKLLGCCLETEVPL-LVYEFIPNGTLFQYIHDQNEDFPITWEIRLRI-AIEVSGALS 388
+ L +T L V E+ G LF ++ + F E R R E+ AL
Sbjct: 65 PFLTALK-YAFQTHDRLCFVMEYANGGELFFHLS-RERVFT---EERARFYGAEIVSALE 119
Query: 389 YLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASR-SMAVDQTHMTTQVHGTFGYLDP 447
YLHS + +RDIK N++LD K++DFG + ++ T GT YL P
Sbjct: 120 YLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGAT--MKTFCGTPEYLAP 174
Query: 448 EYFRSSQFTDKSDVYSFGVVLTELLTGEKP 477
E + + D + GVV+ E++ G P
Sbjct: 175 EVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 204
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 88.4 bits (220), Expect = 3e-19
Identities = 59/210 (28%), Positives = 96/210 (45%), Gaps = 30/210 (14%)
Query: 289 DNFDLNRILGQGG------------------QAVKKSKVIDESKVEEFINEVVILSQI-N 329
+FDL R++G+G + VKK V D+ ++ E + Q N
Sbjct: 9 QDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASN 68
Query: 330 HRNVVKLLGCCLETEVPL-LVYEFIPNGTLFQYIHDQNEDFPITWEIRLRI-AIEVSGAL 387
H +V L C +TE L V E++ G L ++ + P E R + E+S AL
Sbjct: 69 HPFLVGLH-SCFQTESRLFFVIEYVNGGDLMFHMQ-RQRKLP---EEHARFYSAEISLAL 123
Query: 388 SYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHGTFGYLDP 447
+YLH I +RD+K N+LLD + K++D+G + + T+ GT Y+ P
Sbjct: 124 NYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCK-EGLRPGDTTSTFCGTPNYIAP 179
Query: 448 EYFRSSQFTDKSDVYSFGVVLTELLTGEKP 477
E R + D ++ GV++ E++ G P
Sbjct: 180 EILRGEDYGFSVDWWALGVLMFEMMAGRSP 209
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 87.8 bits (218), Expect = 3e-19
Identities = 51/219 (23%), Positives = 92/219 (42%), Gaps = 31/219 (14%)
Query: 282 KELEKATDNFDLNRILGQG-GQAVKK-----------SKVI----DESKVEEFINEV-VI 324
+ + ++ + +G G V K K + ++ + + + ++ V+
Sbjct: 18 QRYQAEINDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVV 77
Query: 325 LSQINHRNVVKLLGCCL-ETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEIRLRIAIEV 383
L + +V+ G + T+V + E + Q PI I ++ + +
Sbjct: 78 LKSHDCPYIVQCFGTFITNTDV-FIAMELMGTCAEKLKKRMQG---PIPERILGKMTVAI 133
Query: 384 SGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHGTFG 443
AL YL + I HRD+K +NILLD++ + K+ DFG S + VD G
Sbjct: 134 VKALYYLKEKHGV-I-HRDVKPSNILLDERGQIKLCDFGISGRL-VDDKAKDRSA-GCAA 189
Query: 444 YLDPE-----YFRSSQFTDKSDVYSFGVVLTELLTGEKP 477
Y+ PE + ++DV+S G+ L EL TG+ P
Sbjct: 190 YMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFP 228
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 87.6 bits (218), Expect = 5e-19
Identities = 71/233 (30%), Positives = 111/233 (47%), Gaps = 34/233 (14%)
Query: 270 EGTIEKTKL--FTSKELEKAT-DNFDLNRILGQG--GQ----------------AVK--K 306
EG+I++ + + EKA F+L ++LGQG G+ A+K K
Sbjct: 2 EGSIKEIAITHHVKEGHEKADPSQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLK 61
Query: 307 SKVIDESKVEEFINEVVILSQINHRNVVKLLGCCLETEVPL-LVYEFIPNGTLFQYIHDQ 365
+ E IL ++NH +VKL +TE L L+ +F+ G LF + +
Sbjct: 62 KATLKVRDRVRTKMERDILVEVNHPFIVKLH-YAFQTEGKLYLILDFLRGGDLFTRLS-K 119
Query: 366 NEDFPITWEIRLRI-AIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGAS 424
F E ++ E++ AL +LHS I +RD+K NILLD++ K++DFG S
Sbjct: 120 EVMFT---EEDVKFYLAELALALDHLHSLG---IIYRDLKPENILLDEEGHIKLTDFGLS 173
Query: 425 RSMAVDQTHMTTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLTELLTGEKP 477
+ ++D GT Y+ PE T +D +SFGV++ E+LTG P
Sbjct: 174 K-ESIDHEKKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLP 225
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 87.4 bits (217), Expect = 5e-19
Identities = 61/239 (25%), Positives = 94/239 (39%), Gaps = 37/239 (15%)
Query: 268 STEGTIEKTKLFTSKELEKATDNFDLNRILGQG--GQ---AVKKS-------KVID--ES 313
+++ L F+L ++G G GQ KV+D
Sbjct: 3 ASDSPARSLDEIDLSALRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGD 62
Query: 314 KVEEFINEVVILSQI-NHRNVVKLLGCCLETEVPL------LVYEFIPNGTLFQYIHDQN 366
+ EE E+ +L + +HRN+ G ++ P LV EF G++ I
Sbjct: 63 EEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIK-NT 121
Query: 367 EDFPITWEIRLRIAI---EVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGA 423
+ + E IA E+ LS+LH I HRDIK N+LL + K+ DFG
Sbjct: 122 KGNTLKEEW---IAYICREILRGLSHLHQHKVI---HRDIKGQNVLLTENAEVKLVDFGV 175
Query: 424 SRSMAVDQTHMTTQVHGTFGYLDPEYFRSSQFTD-----KSDVYSFGVVLTELLTGEKP 477
S + T + GT ++ PE + D KSD++S G+ E+ G P
Sbjct: 176 SAQLDRTVGRRNTFI-GTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPP 233
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 88.6 bits (220), Expect = 5e-19
Identities = 59/210 (28%), Positives = 96/210 (45%), Gaps = 30/210 (14%)
Query: 289 DNFDLNRILGQGG------------------QAVKKSKVIDESKVEEFINEVVILSQI-N 329
+FDL R++G+G + VKK V D+ ++ E + Q N
Sbjct: 52 QDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASN 111
Query: 330 HRNVVKLLGCCLETEVPL-LVYEFIPNGTLFQYIHDQNEDFPITWEIRLRI-AIEVSGAL 387
H +V L C +TE L V E++ G L ++ + P E R + E+S AL
Sbjct: 112 HPFLVGLH-SCFQTESRLFFVIEYVNGGDLMFHMQ-RQRKLP---EEHARFYSAEISLAL 166
Query: 388 SYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHGTFGYLDP 447
+YLH I +RD+K N+LLD + K++D+G + + T+ GT Y+ P
Sbjct: 167 NYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCK-EGLRPGDTTSTFCGTPNYIAP 222
Query: 448 EYFRSSQFTDKSDVYSFGVVLTELLTGEKP 477
E R + D ++ GV++ E++ G P
Sbjct: 223 EILRGEDYGFSVDWWALGVLMFEMMAGRSP 252
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 87.7 bits (218), Expect = 7e-19
Identities = 73/248 (29%), Positives = 110/248 (44%), Gaps = 40/248 (16%)
Query: 270 EGTIEKTKLFTSKELEKAT-DNFDLNRILGQG--GQ----------------AVK---KS 307
E + EK +NF+L ++LG G G+ A+K K+
Sbjct: 34 TVKHELRTANLTGHAEKVGIENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKA 93
Query: 308 KVIDESK-VEEFINEVVILSQINHRN-VVKLLGCCLETEVPL-LVYEFIPNGTLFQYIHD 364
++ ++K E E +L I +V L +TE L L+ ++I G LF ++
Sbjct: 94 TIVQKAKTTEHTRTERQVLEHIRQSPFLVTLH-YAFQTETKLHLILDYINGGELFTHL-- 150
Query: 365 QNED-FPITWEIRLRI-AIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFG 422
+ F E ++I E+ AL +LH I +RDIK NILLD ++DFG
Sbjct: 151 SQRERFT---EHEVQIYVGEIVLALEHLHKLG---IIYRDIKLENILLDSNGHVVLTDFG 204
Query: 423 ASRSMAVDQTHMTTQVHGTFGYLDPEYFRSSQF-TDKS-DVYSFGVVLTELLTGEKPIRF 480
S+ D+T GT Y+ P+ R DK+ D +S GV++ ELLTG P F
Sbjct: 205 LSKEFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASP--F 262
Query: 481 TILEEDKS 488
T+ E S
Sbjct: 263 TVDGEKNS 270
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 86.6 bits (215), Expect = 1e-18
Identities = 56/220 (25%), Positives = 92/220 (41%), Gaps = 30/220 (13%)
Query: 282 KELEKATDNFDLNRILGQG-GQAVKKS-----------KVI----DESKVEEFINEV-VI 324
+ + ++ +G+G +V K K I DE + ++ + ++ V+
Sbjct: 15 QHWDFTAEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVV 74
Query: 325 LSQINHRNVVKLLGCCL-ETEVPLLVYEFIPNGTLFQYIHD--QNEDFPITWEIRLRIAI 381
+ + +V+ G E + + E + + + ++ D I EI +I +
Sbjct: 75 MRSSDCPYIVQFYGALFREGDC-WICMELM-STSFDKFYKYVYSVLDDVIPEEILGKITL 132
Query: 382 EVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHGT 441
AL++L I HRDIK +NILLD K+ DFG S + VD T G
Sbjct: 133 ATVKALNHLKENLKI--IHRDIKPSNILLDRSGNIKLCDFGISGQL-VDSIAKTRDA-GC 188
Query: 442 FGYLDPEYFRSSQFTD----KSDVYSFGVVLTELLTGEKP 477
Y+ PE S +SDV+S G+ L EL TG P
Sbjct: 189 RPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFP 228
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 86.0 bits (214), Expect = 1e-18
Identities = 60/210 (28%), Positives = 97/210 (46%), Gaps = 34/210 (16%)
Query: 289 DNFDLNRILGQG--GQ-------------AVK---KSKVIDESKVEEFINEVVILSQINH 330
+F + R LG G G+ A+K K V+ +VE +E ++LS + H
Sbjct: 6 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTH 65
Query: 331 RNVVKLLGCCLETEVPL-LVYEFIPNGTLFQYIHDQNED-FPITWEIRLRI-AIEVSGAL 387
++++ G + + ++ ++I G LF + + FP + A EV AL
Sbjct: 66 PFIIRMWGTF-QDAQQIFMIMDYIEGGELFSLL--RKSQRFP---NPVAKFYAAEVCLAL 119
Query: 388 SYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHGTFGYLDP 447
YLHS I +RD+K NILLD K++DFG A +T + GT Y+ P
Sbjct: 120 EYLHSKD---IIYRDLKPENILLDKNGHIKITDFG----FAKYVPDVTYTLCGTPDYIAP 172
Query: 448 EYFRSSQFTDKSDVYSFGVVLTELLTGEKP 477
E + + D +SFG+++ E+L G P
Sbjct: 173 EVVSTKPYNKSIDWWSFGILIYEMLAGYTP 202
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 84.9 bits (211), Expect = 4e-18
Identities = 56/213 (26%), Positives = 95/213 (44%), Gaps = 33/213 (15%)
Query: 289 DNFDLNRILGQGG---------------------QAVKKSKVIDESK-VEEFINEVVILS 326
+ F+L R+LG+GG + +KK+ ++ +K E IL
Sbjct: 17 ECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILE 76
Query: 327 QINHRNVVKLLGCCLETEVPL-LVYEFIPNGTLFQYIHDQNEDFPITWEIRLRI-AIEVS 384
++ H +V L+ +T L L+ E++ G LF + + F E E+S
Sbjct: 77 EVKHPFIVDLI-YAFQTGGKLYLILEYLSGGELFMQLE-REGIFM---EDTACFYLAEIS 131
Query: 385 GALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHGTFGY 444
AL +LH I +RD+K NI+L+ + K++DFG + ++ +T GT Y
Sbjct: 132 MALGHLHQKG---IIYRDLKPENIMLNHQGHVKLTDFGLCK-ESIHDGTVTHTFCGTIEY 187
Query: 445 LDPEYFRSSQFTDKSDVYSFGVVLTELLTGEKP 477
+ PE S D +S G ++ ++LTG P
Sbjct: 188 MAPEILMRSGHNRAVDWWSLGALMYDMLTGAPP 220
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 85.4 bits (212), Expect = 4e-18
Identities = 61/233 (26%), Positives = 100/233 (42%), Gaps = 33/233 (14%)
Query: 268 STEGTIEKTKLFTSKELEKAT-DNFDLNRILGQG--GQ-------------AVK---KSK 308
+ + A +F +++G+G G+ AVK K
Sbjct: 16 APPPAPSQQINLGPSSNPHAKPSDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKA 75
Query: 309 VIDESKVEEFINEVVILSQ-INHRNVVKLLGCCLETEVPL-LVYEFIPNGTLFQYIHDQN 366
++ + + + ++E +L + + H +V L +T L V ++I G LF ++ +
Sbjct: 76 ILKKKEEKHIMSERNVLLKNVKHPFLVGLH-FSFQTADKLYFVLDYINGGELFYHLQ-RE 133
Query: 367 EDFPITWEIRLRI-AIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGAS- 424
F E R R A E++ AL YLHS I +RD+K NILLD + ++DFG
Sbjct: 134 RCFL---EPRARFYAAEIASALGYLHSLN---IVYRDLKPENILLDSQGHIVLTDFGLCK 187
Query: 425 RSMAVDQTHMTTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLTELLTGEKP 477
++ + T T+ GT YL PE + D + G VL E+L G P
Sbjct: 188 ENIEHNST--TSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPP 238
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 85.5 bits (212), Expect = 5e-18
Identities = 57/194 (29%), Positives = 97/194 (50%), Gaps = 38/194 (19%)
Query: 303 AVKKSKVIDESKVEEFIN-EVVILSQINHRNVVKLLGCCLET-----EVPL-LVYEFIPN 355
A+KK V+ + + F N E+ I+ +++H N+V+L + EV L LV +++P
Sbjct: 83 AIKK--VLQDKR---FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPE 137
Query: 356 GTLFQYIHD---QNEDFPITWEIR------LRIAIEVSGALSYLHSAASIPIYHRDIKST 406
T+++ + P+ ++ R +L+Y+HS I HRDIK
Sbjct: 138 -TVYRVARHYSRAKQTLPVI-YVKLYMYQLFR-------SLAYIHSFG---ICHRDIKPQ 185
Query: 407 NILLD-DKYRAKVSDFGASRSMAVDQTHMTTQVHGTFGYLDPEY-FRSSQFTDKSDVYSF 464
N+LLD D K+ DFG+++ + + + + + Y PE F ++ +T DV+S
Sbjct: 186 NLLLDPDTAVLKLCDFGSAKQLVRGEP-NVSYI-CSRYYRAPELIFGATDYTSSIDVWSA 243
Query: 465 GVVLTELLTGEKPI 478
G VL ELL G +PI
Sbjct: 244 GCVLAELLLG-QPI 256
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 84.6 bits (210), Expect = 6e-18
Identities = 65/211 (30%), Positives = 98/211 (46%), Gaps = 32/211 (15%)
Query: 289 DNFDLNRILGQGG------------------QAVKKSKVIDESKVEEFINEVVILSQI-N 329
DNF+ R+LG+G + +KK ++ + VE + E ILS N
Sbjct: 23 DNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARN 82
Query: 330 HRNVVKLLGCCLETEVPL-LVYEFIPNGTLFQYIHDQNEDFPITWEIRLRI-AIEVSGAL 387
H + +L CC +T L V EF+ G L +I ++ F E R R A E+ AL
Sbjct: 83 HPFLTQLF-CCFQTPDRLFFVMEFVNGGDLMFHIQ-KSRRFD---EARARFYAAEIISAL 137
Query: 388 SYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASR-SMAVDQTHMTTQVHGTFGYLD 446
+LH I +RD+K N+LLD + K++DFG + + T T GT Y+
Sbjct: 138 MFLHDKG---IIYRDLKLDNVLLDHEGHCKLADFGMCKEGICNGVT--TATFCGTPDYIA 192
Query: 447 PEYFRSSQFTDKSDVYSFGVVLTELLTGEKP 477
PE + + D ++ GV+L E+L G P
Sbjct: 193 PEILQEMLYGPAVDWWAMGVLLYEMLCGHAP 223
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 84.7 bits (210), Expect = 9e-18
Identities = 61/239 (25%), Positives = 107/239 (44%), Gaps = 44/239 (18%)
Query: 268 STEGTIEKTKLFTSKELEKATDNFDLNRILGQG--GQAVKKSKVIDESKV--------EE 317
+ K K E+ + +++G G G V ++K+++ +V +
Sbjct: 19 DDPNKVIKVLASDGKTGEQREIAYTNCKVIGNGSFG-VVFQAKLVESDEVAIKKVLQDKR 77
Query: 318 FIN-EVVILSQINHRNVVKLLGCCLET-----EVPL-LVYEFIPNGTLFQYIHD---QNE 367
F N E+ I+ + H NVV L EV L LV E++P T+++ +
Sbjct: 78 FKNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLNLVLEYVPE-TVYRASRHYAKLKQ 136
Query: 368 DFPITWEIR------LRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLD-DKYRAKVSD 420
P+ I+ LR +L+Y+HS I HRDIK N+LLD K+ D
Sbjct: 137 TMPML-LIKLYMYQLLR-------SLAYIHSIG---ICHRDIKPQNLLLDPPSGVLKLID 185
Query: 421 FGASRSMAVDQTHMTTQVHGTFGYLDPE-YFRSSQFTDKSDVYSFGVVLTELLTGEKPI 478
FG+++ + + + + + Y PE F ++ +T D++S G V+ EL+ G +P+
Sbjct: 186 FGSAKILIAGEP-NVSYI-CSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQG-QPL 241
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 84.8 bits (210), Expect = 1e-17
Identities = 63/281 (22%), Positives = 104/281 (37%), Gaps = 57/281 (20%)
Query: 293 LNRILGQGG-----QAVKKS-------KVIDESKVEEFINEVVILSQI-NHRNVVKLLGC 339
+++LG G Q K K++ + EV + + ++V+++
Sbjct: 66 TSQVLGLGINGKVLQIFNKRTQEKFALKMLQ--DCPKARREVELHWRASQCPHIVRIVDV 123
Query: 340 CLETEVP-----LLVYEFIPNGTLFQYIHDQNEDFPITWEIRLRIAIEVSGALSYLHSAA 394
E L+V E + G LF I D+ + E I + A+ YLHS
Sbjct: 124 Y-ENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREAS-EIMKSIGEAIQYLHS-- 179
Query: 395 SIPIYHRDIKSTNILLDDKYRA---KVSDFGASRSMAVDQTHMTTQVHGTFGYLDPEYFR 451
I I HRD+K N+L K K++DFG ++ + +TT T Y+ PE
Sbjct: 180 -INIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNS-LTTPC-YTPYYVAPEVLG 236
Query: 452 SSQFTDKSDVYSFGVVLTELLTGEKPIRFTILEEDKSLAAYFLCAMKEERLFEILDARVM 511
++ D++S GV++ LL G P F A + R+
Sbjct: 237 PEKYDKSCDMWSLGVIMYILLCGYPP--FY----SNHGLA------ISPGMKT----RIR 280
Query: 512 KQGGK--------DEIITVAK-LAKRCLNLNGKKRPTMREV 543
G+ E+ K L + L +R T+ E
Sbjct: 281 M--GQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEF 319
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 85.5 bits (211), Expect = 1e-17
Identities = 55/210 (26%), Positives = 90/210 (42%), Gaps = 30/210 (14%)
Query: 289 DNFDLNRILGQGG------------------QAVKKSKVIDESKVEEFINEVVILSQINH 330
+F+ +LG+G + +KK VI + VE + E +L+
Sbjct: 341 TDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGK 400
Query: 331 RNVVKLLGCCLETEVPL-LVYEFIPNGTLFQYIHDQNEDFPITWEIRLRI-AIEVSGALS 388
+ L C +T L V E++ G L +I F E A E++ L
Sbjct: 401 PPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGR-FK---EPHAVFYAAEIAIGLF 456
Query: 389 YLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASR-SMAVDQTHMTTQVHGTFGYLDP 447
+L S I +RD+K N++LD + K++DFG + ++ T T GT Y+ P
Sbjct: 457 FLQSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVT--TKTFCGTPDYIAP 511
Query: 448 EYFRSSQFTDKSDVYSFGVVLTELLTGEKP 477
E + D ++FGV+L E+L G+ P
Sbjct: 512 EIIAYQPYGKSVDWWAFGVLLYEMLAGQAP 541
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 83.4 bits (207), Expect = 2e-17
Identities = 58/229 (25%), Positives = 98/229 (42%), Gaps = 33/229 (14%)
Query: 272 TIEKTKLFTSKELEKAT-DNFDLNRILGQGG------------------QAVKKSKVIDE 312
T +K + ++ +F+ +LG+G + +KK VI +
Sbjct: 2 TNTVSKFDNNGNRDRMKLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQD 61
Query: 313 SKVEEFINEVVILSQI-NHRNVVKLLGCCLETEVPL-LVYEFIPNGTLFQYIHDQNEDFP 370
VE + E +L+ + +L C +T L V E++ G L +I Q F
Sbjct: 62 DDVECTMVEKRVLALPGKPPFLTQLH-SCFQTMDRLYFVMEYVNGGDLMYHIQ-QVGRFK 119
Query: 371 ITWEIRLRI-AIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASR-SMA 428
E A E++ L +L S I +RD+K N++LD + K++DFG + ++
Sbjct: 120 ---EPHAVFYAAEIAIGLFFLQSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKENIW 173
Query: 429 VDQTHMTTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLTELLTGEKP 477
T T GT Y+ PE + D ++FGV+L E+L G+ P
Sbjct: 174 DGVT--TKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAP 220
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 82.6 bits (205), Expect = 2e-17
Identities = 62/211 (29%), Positives = 96/211 (45%), Gaps = 32/211 (15%)
Query: 289 DNFDLNRILGQGG------------------QAVKKSKVIDESKVEEFINEVVILSQ-IN 329
++F L+++LG+G +A+KK V+ + VE + E +LS
Sbjct: 17 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWE 76
Query: 330 HRNVVKLLGCCLETEVPL-LVYEFIPNGTLFQYIHDQNEDFPITWEIRLRI-AIEVSGAL 387
H + + C +T+ L V E++ G L +I F R A E+ L
Sbjct: 77 HPFLTHMF-CTFQTKENLFFVMEYLNGGDLMYHIQ-SCHKFD---LSRATFYAAEIILGL 131
Query: 388 SYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASR-SMAVDQTHMTTQVHGTFGYLD 446
+LHS I +RD+K NILLD K++DFG + +M D T GT Y+
Sbjct: 132 QFLHSKG---IVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAK--TNTFCGTPDYIA 186
Query: 447 PEYFRSSQFTDKSDVYSFGVVLTELLTGEKP 477
PE ++ D +SFGV+L E+L G+ P
Sbjct: 187 PEILLGQKYNHSVDWWSFGVLLYEMLIGQSP 217
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 80.3 bits (199), Expect = 1e-16
Identities = 48/179 (26%), Positives = 80/179 (44%), Gaps = 11/179 (6%)
Query: 303 AVKKSKVIDESKVEEFIN--EVVILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGTLFQ 360
A+KK ++ V + I E+ +L Q+ H N+V LL LV+E+ + T+
Sbjct: 32 AIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVFRRKRRLHLVFEYCDH-TVLH 90
Query: 361 YIHDQNEDFPITWEIRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSD 420
+ P ++ I + A+++ H HRD+K NIL+ K+ D
Sbjct: 91 ELDRYQRGVPEH-LVK-SITWQTLQAVNFCHKHN---CIHRDVKPENILITKHSVIKLCD 145
Query: 421 FGASRSMAVDQTHMTTQVHGTFGYLDPEY-FRSSQFTDKSDVYSFGVVLTELLTGEKPI 478
FG +R + + +V T Y PE +Q+ DV++ G V ELL+G P+
Sbjct: 146 FGFARLLTGPSDYYDDEV-ATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSG-VPL 202
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 78.8 bits (195), Expect = 4e-16
Identities = 47/184 (25%), Positives = 80/184 (43%), Gaps = 25/184 (13%)
Query: 303 AVKKSKVIDESKVEEFINEVVILSQI-NHRNVVKLLGCCL--ETEVPLLVYEFIPNGTLF 359
VK K + + K+ E+ IL + N++ L + P LV+E + N
Sbjct: 65 VVKILKPVKKKKI---KREIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFK 121
Query: 360 QYIHDQNEDFPI---TWEIRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRA 416
Q D+ I +EI L+ AL Y HS I HRD+K N+++D ++R
Sbjct: 122 QLY-QTLTDYDIRFYMYEI-LK-------ALDYCHSMG---IMHRDVKPHNVMIDHEHRK 169
Query: 417 -KVSDFGASRSMAVDQTHMTTQVHGTFGYLDPEYFRSSQFTDKS-DVYSFGVVLTELLTG 474
++ D+G + Q +V + + PE Q D S D++S G +L ++
Sbjct: 170 LRLIDWGLAEFYHPGQE-YNVRV-ASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFR 227
Query: 475 EKPI 478
++P
Sbjct: 228 KEPF 231
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 78.0 bits (193), Expect = 8e-16
Identities = 49/179 (27%), Positives = 86/179 (48%), Gaps = 11/179 (6%)
Query: 303 AVKKSKVIDESKVEEFIN--EVVILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGTLFQ 360
A+KK D+ K+ + I E+ +L Q+ H N+V LL C + + LV+EF+ + T+
Sbjct: 54 AIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKKRWYLVFEFVDH-TILD 112
Query: 361 YIHDQNEDFPITWEIRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSD 420
+ ++ + ++ + + HS I HRDIK NIL+ K+ D
Sbjct: 113 DLELFPNGLDYQ-VVQ-KYLFQIINGIGFCHSHN---IIHRDIKPENILVSQSGVVKLCD 167
Query: 421 FGASRSMAVDQTHMTTQVHGTFGYLDPEY-FRSSQFTDKSDVYSFGVVLTELLTGEKPI 478
FG +R++A +V T Y PE ++ DV++ G ++TE+ G +P+
Sbjct: 168 FGFARTLAAPGEVYDDEV-ATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMG-EPL 224
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 77.2 bits (191), Expect = 9e-16
Identities = 43/187 (22%), Positives = 85/187 (45%), Gaps = 26/187 (13%)
Query: 303 AVKKSKVIDESKVEEF----INEVVILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGTL 358
A+K+ ++ D+ E + E+ +L ++ H+N+V+L + LV+EF L
Sbjct: 31 ALKRVRLDDDD--EGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEFCDQ-DL 87
Query: 359 FQYIHDQNEDFPITWEIR------LRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDD 412
+Y N D ++ L+ L + HS + HRD+K N+L++
Sbjct: 88 KKYFDSCNGDLDPE-IVKSFLFQLLK-------GLGFCHSRN---VLHRDLKPQNLLINR 136
Query: 413 KYRAKVSDFGASRSMAVDQTHMTTQVHGTFGYLDPEY-FRSSQFTDKSDVYSFGVVLTEL 471
K+++FG +R+ + + +V T Y P+ F + ++ D++S G + EL
Sbjct: 137 NGELKLANFGLARAFGIPVRCYSAEVV-TLWYRPPDVLFGAKLYSTSIDMWSAGCIFAEL 195
Query: 472 LTGEKPI 478
+P+
Sbjct: 196 ANAGRPL 202
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 76.7 bits (189), Expect = 3e-15
Identities = 42/167 (25%), Positives = 76/167 (45%), Gaps = 24/167 (14%)
Query: 321 EVVILSQINHRNVVKLLGCCLETEVPL------LVYEFIPNGTLFQYIHDQNEDF---PI 371
E+V++ +NH+N++ LL + +V E + L Q I + + +
Sbjct: 74 ELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDA-NLCQVIQMELDHERMSYL 132
Query: 372 TWEIRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQ 431
+++ L + +LHSA I HRD+K +NI++ K+ DFG +R+ A
Sbjct: 133 LYQM-LC-------GIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLART-AGTS 180
Query: 432 THMTTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLTELLTGEKPI 478
MT V T Y PE + + D++S G ++ E++ G +
Sbjct: 181 FMMTPYV-VTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKG-GVL 225
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 76.1 bits (188), Expect = 3e-15
Identities = 43/181 (23%), Positives = 91/181 (50%), Gaps = 15/181 (8%)
Query: 303 AVKKSKVIDESKVEEF----INEVVILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGTL 358
A+K+ ++ +++ E I E+ +L +++H N+V L+ LV+EF+ L
Sbjct: 49 ALKRIRL--DAEDEGIPSTAIREISLLKELHHPNIVSLIDVIHSERCLTLVFEFMEKD-L 105
Query: 359 FQYIHDQNEDFPITWEIRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKV 418
+ + + + +I++ ++ +++ H I HRD+K N+L++ K+
Sbjct: 106 KKVLDENKTGLQDS-QIKI-YLYQLLRGVAHCHQHR---ILHRDLKPQNLLINSDGALKL 160
Query: 419 SDFGASRSMAVDQTHMTTQVHGTFGYLDPEY-FRSSQFTDKSDVYSFGVVLTELLTGEKP 477
+DFG +R+ + T +V T Y P+ S +++ D++S G + E++TG KP
Sbjct: 161 ADFGLARAFGIPVRSYTHEVV-TLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITG-KP 218
Query: 478 I 478
+
Sbjct: 219 L 219
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 76.1 bits (188), Expect = 4e-15
Identities = 54/188 (28%), Positives = 86/188 (45%), Gaps = 26/188 (13%)
Query: 303 AVKKSKVIDESKVEEFIN-----EVVILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGT 357
A+KK K+ S+ ++ IN E+ +L +++H N++ LL LV++F+
Sbjct: 39 AIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDFMETD- 97
Query: 358 LFQYIHDQNEDFPITWEIR------LRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLD 411
L I D + + I+ L+ L YLH I HRD+K N+LLD
Sbjct: 98 LEVIIKDNSLVLTPS-HIKAYMLMTLQ-------GLEYLHQHW---ILHRDLKPNNLLLD 146
Query: 412 DKYRAKVSDFGASRSMAVDQTHMTTQVHGTFGYLDPEY-FRSSQFTDKSDVYSFGVVLTE 470
+ K++DFG ++S T QV T Y PE F + + D+++ G +L E
Sbjct: 147 ENGVLKLADFGLAKSFGSPNRAYTHQVV-TRWYRAPELLFGARMYGVGVDMWAVGCILAE 205
Query: 471 LLTGEKPI 478
LL P
Sbjct: 206 LLLR-VPF 212
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 75.7 bits (186), Expect = 5e-15
Identities = 47/199 (23%), Positives = 79/199 (39%), Gaps = 32/199 (16%)
Query: 360 QYIHDQNEDFPITWEIRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVS 419
+ + +T E + + +V+ + +L AS HRD+ + NILL +K K+
Sbjct: 179 EEAPEDLYKDFLTLEHLICYSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKIC 235
Query: 420 DFGASRSMAVDQTHMTTQVHGTFGYLD-----PEYFRSSQFTDKSDVYSFGVVLTELLT- 473
DFG +R + D + V L PE +T +SDV+SFGV+L E+ +
Sbjct: 236 DFGLARDIYKDPDY----VRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSL 291
Query: 474 GEKPIRFTILEEDKSLAAYFLCAMKEERLFEILDARVMKQ--GGKDEIITVAKLAKRCLN 531
G P Y + EE + + M+ E+ + C +
Sbjct: 292 GASP--------------YPGVKIDEEFCRRLKEGTRMRAPDYTTPEM---YQTMLDCWH 334
Query: 532 LNGKKRPTMREVASELAGI 550
+RPT E+ L +
Sbjct: 335 GEPSQRPTFSELVEHLGNL 353
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 53.8 bits (129), Expect = 7e-08
Identities = 33/108 (30%), Positives = 45/108 (41%), Gaps = 23/108 (21%)
Query: 289 DNFDLNRILGQG--GQ------------------AVKKSK-VIDESKVEEFINEVVILSQ 327
D L + LG+G GQ AVK K S+ ++E+ IL
Sbjct: 22 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIH 81
Query: 328 I-NHRNVVKLLGCCLETEVPLLV-YEFIPNGTLFQYIHDQNEDFPITW 373
I +H NVV LLG C + PL+V EF G L Y+ + +F
Sbjct: 82 IGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYK 129
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 74.5 bits (184), Expect = 7e-15
Identities = 42/181 (23%), Positives = 84/181 (46%), Gaps = 15/181 (8%)
Query: 303 AVKKSKVIDESKVEEF----INEVVILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGTL 358
A+KK ++ E E I E+ IL ++ H N+VKL + +LV+E + L
Sbjct: 30 ALKKIRLEKED--EGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEHLDQD-L 86
Query: 359 FQYIHDQNEDFPITWEIRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKV 418
+ + + +++ ++Y H + HRD+K N+L++ + K+
Sbjct: 87 KKLLDVCEGGLESV-TAKS-FLLQLLNGIAYCHDRR---VLHRDLKPQNLLINREGELKI 141
Query: 419 SDFGASRSMAVDQTHMTTQVHGTFGYLDPEY-FRSSQFTDKSDVYSFGVVLTELLTGEKP 477
+DFG +R+ + T ++ T Y P+ S +++ D++S G + E++ G P
Sbjct: 142 ADFGLARAFGIPVRKYTHEIV-TLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNG-TP 199
Query: 478 I 478
+
Sbjct: 200 L 200
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 74.6 bits (184), Expect = 1e-14
Identities = 46/181 (25%), Positives = 89/181 (49%), Gaps = 16/181 (8%)
Query: 303 AVKKSKVIDESKVEEF----INEVVILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGTL 358
A+K+ ++ E E I EV +L + H N+V L + LV+E++ L
Sbjct: 31 ALKEIRLEHE---EGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEYLDK-DL 86
Query: 359 FQYIHDQNEDFPITWEIRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKV 418
QY+ D + ++L + + G L+Y H + HRD+K N+L++++ K+
Sbjct: 87 KQYLDDCGNIINMH-NVKLFLFQLLRG-LAYCHRQK---VLHRDLKPQNLLINERGELKL 141
Query: 419 SDFGASRSMAVDQTHMTTQVHGTFGYLDPEY-FRSSQFTDKSDVYSFGVVLTELLTGEKP 477
+DFG +R+ ++ +V T Y P+ S+ ++ + D++ G + E+ TG +P
Sbjct: 142 ADFGLARAKSIPTKTYDNEVV-TLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATG-RP 199
Query: 478 I 478
+
Sbjct: 200 L 200
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 74.9 bits (184), Expect = 2e-14
Identities = 44/166 (26%), Positives = 77/166 (46%), Gaps = 22/166 (13%)
Query: 321 EVVILSQINHRNVVKLL-----GCCLETEVPL-LVYEFIPNGTLFQYIHDQNEDFPITWE 374
E+V++ +NH+N++ LL LE + LV E + L Q I + + +++
Sbjct: 111 ELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDA-NLCQVIQMELDHERMSYL 169
Query: 375 I--RLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQT 432
+ L + +LHSA I HRD+K +NI++ K+ DFG +R+
Sbjct: 170 LYQMLC-------GIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSF- 218
Query: 433 HMTTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLTELLTGEKPI 478
MT V T Y PE + + D++S G ++ E++ K +
Sbjct: 219 MMTPYV-VTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRH-KIL 262
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 73.5 bits (181), Expect = 4e-14
Identities = 54/228 (23%), Positives = 81/228 (35%), Gaps = 52/228 (22%)
Query: 288 TDNFDLNRILGQGGQ--------------AVKK--SKVIDESKVEEFIN---------EV 322
+ + R + G A+K+ + V D V + E+
Sbjct: 21 QSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREI 80
Query: 323 VILSQINHRNVVKLLGCCLETEVPL-----LVYEFIPNGTLFQYIHDQNEDFP------I 371
+L+ +H N++ L + E P LV E + L Q IHDQ
Sbjct: 81 RLLNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELMRT-DLAQVIHDQRIVISPQHIQYF 139
Query: 372 TWEIRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQ 431
+ I L L LH A + HRD+ NILL D + DF +R D
Sbjct: 140 MYHI-LL-------GLHVLHEAG---VVHRDLHPGNILLADNNDITICDFNLAREDTADA 188
Query: 432 THMTTQVHGTFGYLDPEY-FRSSQFTDKSDVYSFGVVLTELLTGEKPI 478
+ T V Y PE + FT D++S G V+ E+ K +
Sbjct: 189 -NKTHYV-THRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNR-KAL 233
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 73.1 bits (180), Expect = 4e-14
Identities = 54/228 (23%), Positives = 100/228 (43%), Gaps = 49/228 (21%)
Query: 285 EKATDNFDLNRILGQG-------------GQ--AVKKSKVIDES--KVEEFINEVVILSQ 327
K D F + R+ GQG G A+KK VI + + E + + L+
Sbjct: 19 RKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKK--VIQDPRFRNRE-LQIMQDLAV 75
Query: 328 INHRNVVKLL------GCCLETEVPL-LVYEFIPNGTLFQYI-HDQNEDFPITWE-IR-- 376
++H N+V+L G ++ L +V E++P+ TL + + I+
Sbjct: 76 LHHPNIVQLQSYFYTLGERDRRDIYLNVVMEYVPD-TLHRCCRNYYRRQVAPPPILIKVF 134
Query: 377 ----LRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLD-DKYRAKVSDFGASRSMAVDQ 431
+R ++ LH S+ + HRDIK N+L++ K+ DFG+++ ++ +
Sbjct: 135 LFQLIR-------SIGCLHLP-SVNVCHRDIKPHNVLVNEADGTLKLCDFGSAKKLSPSE 186
Query: 432 THMTTQVHGTFGYLDPEY-FRSSQFTDKSDVYSFGVVLTELLTGEKPI 478
+ + Y PE F + +T D++S G + E++ G +PI
Sbjct: 187 P-NVAYI-CSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLG-EPI 231
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 71.9 bits (177), Expect = 9e-14
Identities = 58/221 (26%), Positives = 96/221 (43%), Gaps = 40/221 (18%)
Query: 289 DNFD-LNRILGQG-------------GQAVKKSKVIDESKVEEF----INEVVILSQINH 330
++ L +I GQG GQ V KV+ E++ E F + E+ IL + H
Sbjct: 17 SKYEKLAKI-GQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKH 75
Query: 331 RNVVKLLGCCLETEVPL--------LVYEFIPNGTLFQYIHDQNEDFPITWEIRLRIAIE 382
NVV L+ C P LV++F + L + + F ++ EI+ R+
Sbjct: 76 ENVVNLIEICRTKASPYNRCKGSIYLVFDFCEH-DLAGLLSNVLVKFTLS-EIK-RVMQM 132
Query: 383 VSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAV----DQTHMTTQV 438
+ L Y+H I HRD+K+ N+L+ K++DFG +R+ ++ T +V
Sbjct: 133 LLNGLYYIHRNK---ILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRV 189
Query: 439 HGTFGYLDPEY-FRSSQFTDKSDVYSFGVVLTELLTGEKPI 478
T Y PE + D++ G ++ E+ T PI
Sbjct: 190 V-TLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTR-SPI 228
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 71.5 bits (176), Expect = 1e-13
Identities = 46/184 (25%), Positives = 89/184 (48%), Gaps = 17/184 (9%)
Query: 303 AVKKSKVIDESKVEEF----INEVVILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGTL 358
A+K+ K+ E E I E+ ++ ++ H N+V+L LV+EF+ N L
Sbjct: 34 ALKEVKLDSE---EGTPSTAIREISLMKELKHENIVRLYDVIHTENKLTLVFEFMDN-DL 89
Query: 359 FQYIHDQNEDF---PITWEIRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYR 415
+Y+ + + + ++ L++ H I HRD+K N+L++ + +
Sbjct: 90 KKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHENK---ILHRDLKPQNLLINKRGQ 146
Query: 416 AKVSDFGASRSMAVDQTHMTTQVHGTFGYLDPEY-FRSSQFTDKSDVYSFGVVLTELLTG 474
K+ DFG +R+ + +++V T Y P+ S ++ D++S G +L E++TG
Sbjct: 147 LKLGDFGLARAFGIPVNTFSSEVV-TLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITG 205
Query: 475 EKPI 478
KP+
Sbjct: 206 -KPL 208
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 72.0 bits (177), Expect = 1e-13
Identities = 42/165 (25%), Positives = 74/165 (44%), Gaps = 20/165 (12%)
Query: 321 EVVILSQINHRNVVKLLGCCLETEVPL------LVYEFIPNGTLFQYIHDQNEDFPITWE 374
E+ +L + H NV+ LL E LV F+ L + + + + +
Sbjct: 74 ELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFMGT-DLGKLMKHE----KLGED 128
Query: 375 IRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHM 434
+ ++ L Y+H+A I HRD+K N+ +++ K+ DFG +R + M
Sbjct: 129 RIQFLVYQMLKGLRYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGLARQA---DSEM 182
Query: 435 TTQVHGTFGYLDPEY-FRSSQFTDKSDVYSFGVVLTELLTGEKPI 478
T V T Y PE ++T D++S G ++ E++TG K +
Sbjct: 183 TGYV-VTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITG-KTL 225
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 70.8 bits (174), Expect = 2e-13
Identities = 47/169 (27%), Positives = 73/169 (43%), Gaps = 28/169 (16%)
Query: 321 EVVILSQINHRNVVKLLGCCLETEVPL------LVYEFIPNGTLFQYIHDQ--NEDF--P 370
E+ +L + H NV+ LL LV + L + Q +D
Sbjct: 78 ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGA-DLNNIVKCQKLTDDHVQF 136
Query: 371 ITWEIRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVD 430
+ ++I LR L Y+HSA I HRD+K +N+ +++ K+ DFG +R A
Sbjct: 137 LIYQI-LR-------GLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARHTA-- 183
Query: 431 QTHMTTQVHGTFGYLDPE-YFRSSQFTDKSDVYSFGVVLTELLTGEKPI 478
MT V T Y PE + D++S G ++ ELLTG + +
Sbjct: 184 -DEMTGYV-ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTG-RTL 229
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 70.9 bits (174), Expect = 3e-13
Identities = 54/260 (20%), Positives = 101/260 (38%), Gaps = 85/260 (32%)
Query: 284 LEKATDNFDLNRILGQG-------------GQ--AVKKSKVIDESKVEEFIN-EVVILSQ 327
LE ++ + L + LG G G+ A+KK V+ + + + N E+ I+
Sbjct: 2 LETSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKK--VLQDPR---YKNRELDIMKV 56
Query: 328 INHRNVVKLLGC-------------------------------------CLETEVPL-LV 349
++H N++KL+ L ++
Sbjct: 57 LDHVNIIKLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVI 116
Query: 350 YEFIPNGTLFQYIH---DQNEDFPITWEIR------LRIAIEVSGALSYLHSAASIPIYH 400
E++P+ TL + + P+ I R A+ ++HS I H
Sbjct: 117 MEYVPD-TLHKVLKSFIRSGRSIPMN-LISIYIYQLFR-------AVGFIHSLG---ICH 164
Query: 401 RDIKSTNILLD-DKYRAKVSDFGASRSMAVDQTHMTTQVHGTFGYLDPE-YFRSSQFTDK 458
RDIK N+L++ K+ DFG+++ + + + + Y PE ++++T
Sbjct: 165 RDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSEP-SVAYI-CSRFYRAPELMLGATEYTPS 222
Query: 459 SDVYSFGVVLTELLTGEKPI 478
D++S G V EL+ G KP+
Sbjct: 223 IDLWSIGCVFGELILG-KPL 241
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 70.0 bits (172), Expect = 3e-13
Identities = 46/186 (24%), Positives = 86/186 (46%), Gaps = 21/186 (11%)
Query: 303 AVKKSKVIDESKVEEF----INEVVILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGTL 358
A+K+ ++ E + E I EV +L ++ HRN+++L L++E+ N L
Sbjct: 63 AIKRIRL--EHEEEGVPGTAIREVSLLKELQHRNIIELKSVIHHNHRLHLIFEYAEN-DL 119
Query: 359 FQYIHDQNEDFPITWEIRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRA-- 416
+Y+ D+N D + I+ ++ +++ HS HRD+K N+LL +
Sbjct: 120 KKYM-DKNPDVSMR-VIK-SFLYQLINGVNFCHSRR---CLHRDLKPQNLLLSVSDASET 173
Query: 417 ---KVSDFGASRSMAVDQTHMTTQVHGTFGYLDPEY-FRSSQFTDKSDVYSFGVVLTELL 472
K+ DFG +R+ + T ++ T Y PE S ++ D++S + E+L
Sbjct: 174 PVLKIGDFGLARAFGIPIRQFTHEII-TLWYRPPEILLGSRHYSTSVDIWSIACIWAEML 232
Query: 473 TGEKPI 478
P+
Sbjct: 233 MK-TPL 237
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 69.8 bits (171), Expect = 6e-13
Identities = 43/192 (22%), Positives = 79/192 (41%), Gaps = 24/192 (12%)
Query: 303 AVKKSKVIDESKVEEFINEVVILSQINHRNVVKLLGCCLE-TEVPL-LVYEFIPNGTLFQ 360
A+K+ + E+ +L ++ H NV+ L L + + L++++ + L+
Sbjct: 52 ALKQIE--GTGISMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAEH-DLWH 108
Query: 361 YIHDQNEDFPITWEIRLRIAIEVS------GALSYLHSAASIPIYHRDIKSTNILLDDKY 414
I ++L + S + YLH+ + HRD+K NIL+ +
Sbjct: 109 IIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANW---VLHRDLKPANILVMGEG 165
Query: 415 RA----KVSDFGASRSMAV---DQTHMTTQVHGTFGYLDPEY-FRSSQFTDKSDVYSFGV 466
K++D G +R + V TF Y PE + +T D+++ G
Sbjct: 166 PERGRVKIADMGFARLFNSPLKPLADLDPVVV-TFWYRAPELLLGARHYTKAIDIWAIGC 224
Query: 467 VLTELLTGEKPI 478
+ ELLT +PI
Sbjct: 225 IFAELLTS-EPI 235
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 68.8 bits (169), Expect = 7e-13
Identities = 47/189 (24%), Positives = 78/189 (41%), Gaps = 21/189 (11%)
Query: 303 AVKKSKVIDESKVEEFIN-----EVVILSQIN---HRNVVKLLGCCLETEVPL-----LV 349
A+K +V + + EV +L ++ H NVV+L+ C + LV
Sbjct: 38 ALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCATSRTDREIKVTLV 97
Query: 350 YEFIPNGTLFQYIHDQNEDFPITWEIRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNIL 409
+E + L Y+ I+ + + L +LH+ I HRD+K NIL
Sbjct: 98 FEHVDQ-DLRTYLDKAPPPGLPAETIK-DLMRQFLRGLDFLHANC---IVHRDLKPENIL 152
Query: 410 LDDKYRAKVSDFGASRSMAVDQTHMTTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLT 469
+ K++DFG +R + +T V T Y PE S + D++S G +
Sbjct: 153 VTSGGTVKLADFGLARIYSYQMA-LTPVVV-TLWYRAPEVLLQSTYATPVDMWSVGCIFA 210
Query: 470 ELLTGEKPI 478
E+ KP+
Sbjct: 211 EMFRR-KPL 218
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 68.8 bits (169), Expect = 1e-12
Identities = 48/172 (27%), Positives = 79/172 (45%), Gaps = 29/172 (16%)
Query: 321 EVVILSQINHRNVVKLLGCCLETEVPL-----LVYEFIPNGT-LFQYIHDQN--EDFP-- 370
E+ IL + H N++ + + +V + + T L++ + Q+ D
Sbjct: 75 EIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLM--ETDLYKLLKTQHLSNDHICY 132
Query: 371 ITWEIRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVD 430
++I LR L Y+HSA + HRD+K +N+LL+ K+ DFG +R D
Sbjct: 133 FLYQI-LR-------GLKYIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARVADPD 181
Query: 431 QTH---MTTQVHGTFGYLDPEY-FRSSQFTDKSDVYSFGVVLTELLTGEKPI 478
H +T V T Y PE S +T D++S G +L E+L+ +PI
Sbjct: 182 HDHTGFLTEYV-ATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSN-RPI 231
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 68.9 bits (169), Expect = 1e-12
Identities = 42/168 (25%), Positives = 73/168 (43%), Gaps = 27/168 (16%)
Query: 321 EVVILSQINHRNVVKLLGCCLETEVPL------LVYEFIPNGTLFQYIHDQNEDF---PI 371
E+++L + H NV+ LL LV F+ L + + + + +
Sbjct: 73 ELLLLKHMQHENVIGLLDVFTPASSLRNFYDFYLVMPFMQT-DLQKIMGLKFSEEKIQYL 131
Query: 372 TWEIRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQ 431
+++ L+ L Y+HSA + HRD+K N+ +++ K+ DFG +R
Sbjct: 132 VYQM-LK-------GLKYIHSAG---VVHRDLKPGNLAVNEDCELKILDFGLARHA---D 177
Query: 432 THMTTQVHGTFGYLDPE-YFRSSQFTDKSDVYSFGVVLTELLTGEKPI 478
MT V T Y PE + D++S G ++ E+LTG K +
Sbjct: 178 AEMTGYV-VTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTG-KTL 223
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 68.4 bits (168), Expect = 1e-12
Identities = 55/205 (26%), Positives = 88/205 (42%), Gaps = 27/205 (13%)
Query: 286 KATDNFDLNRILGQGGQAVKKSKVIDESKVEEF----INEVVILSQIN---HRNVVKLLG 338
KA D + R + A+K+ +V E I EV +L + H NVV+L
Sbjct: 29 KARDLKNGGRFV-----ALKRVRVQTGE--EGMPLSTIREVAVLRHLETFEHPNVVRLFD 81
Query: 339 CCLETEVPL-----LVYEFIPNGTLFQYIHDQNEDFPITWEIRLRIAIEVSGALSYLHSA 393
C + LV+E + L Y+ E T I+ + ++ L +LHS
Sbjct: 82 VCTVSRTDRETKLTLVFEHVDQ-DLTTYLDKVPEPGVPTETIK-DMMFQLLRGLDFLHSH 139
Query: 394 ASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHGTFGYLDPEYFRSS 453
+ HRD+K NIL+ + K++DFG +R + +T+ V T Y PE S
Sbjct: 140 R---VVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMA-LTSVVV-TLWYRAPEVLLQS 194
Query: 454 QFTDKSDVYSFGVVLTELLTGEKPI 478
+ D++S G + E+ KP+
Sbjct: 195 SYATPVDLWSVGCIFAEMFRR-KPL 218
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 64.2 bits (157), Expect = 2e-11
Identities = 57/281 (20%), Positives = 93/281 (33%), Gaps = 78/281 (27%)
Query: 293 LNRILGQGG-----QAVKKS-------KVIDESKVEEFINEVVILSQI-NHRNVVKLLGC 339
+++LG G Q K K++ + EV + + ++V+++
Sbjct: 22 TSQVLGLGINGKVLQIFNKRTQEKFALKMLQ--DCPKARREVELHWRASQCPHIVRIVDV 79
Query: 340 CLETEVP-----LLVYEFIPNGTLFQYIHDQNEDFPITWEIRLRIAIEVSGALSYLHSAA 394
E L+V E + G LF I D+ + E I + A+ YLHS
Sbjct: 80 Y-ENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREAS-EIMKSIGEAIQYLHSIN 137
Query: 395 SIPIYHRDIKSTNILLDDKYRA---KVSDFGASRSMAVDQTHMTTQVHGTFGYLDPEYFR 451
I HRD+K N+L K K++DFG E
Sbjct: 138 ---IAHRDVKPENLLYTSKRPNAILKLTDFG----------------------FAKE-TT 171
Query: 452 SSQFTDKSDVYSFGVVLTELLTGEKPIRFTILEEDKSLAAYFLCAMKEERLFEILDARVM 511
++ D++S GV++ LL G P F A + R+
Sbjct: 172 GEKYDKSCDMWSLGVIMYILLCGYPP--FY----SNHGLA------ISPGMKT----RIR 215
Query: 512 KQGGK--------DEIITVAK-LAKRCLNLNGKKRPTMREV 543
G+ E+ K L + L +R T+ E
Sbjct: 216 M--GQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEF 254
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 63.4 bits (155), Expect = 5e-11
Identities = 44/182 (24%), Positives = 81/182 (44%), Gaps = 39/182 (21%)
Query: 321 EVVILSQINHRNVVKLL------GCCLETEVPL--------LVYEFIPNGT-LFQYIHDQ 365
E+ I+ +++H N+VK+ G L +V +V E++ T L +
Sbjct: 58 EIKIIRRLDHDNIVKVFEILGPSGSQLTDDVGSLTELNSVYIVQEYM--ETDLANVLEQG 115
Query: 366 N--EDFP--ITWEIRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDK-YRAKVSD 420
E+ +++ LR L Y+HSA + HRD+K N+ ++ + K+ D
Sbjct: 116 PLLEEHARLFMYQL-LR-------GLKYIHSAN---VLHRDLKPANLFINTEDLVLKIGD 164
Query: 421 FGASRSMAVDQTH---MTTQVHGTFGYLDPE-YFRSSQFTDKSDVYSFGVVLTELLTGEK 476
FG +R M +H ++ + T Y P + +T D+++ G + E+LTG K
Sbjct: 165 FGLARIMDPHYSHKGHLSEGL-VTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTG-K 222
Query: 477 PI 478
+
Sbjct: 223 TL 224
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 62.3 bits (152), Expect = 1e-10
Identities = 44/177 (24%), Positives = 71/177 (40%), Gaps = 32/177 (18%)
Query: 321 EVVILSQINHRNVVKLLGCCLETEVPL-----LVYEFIPNGT-LFQYIHDQN-EDFPITW 373
E+ IL H N++ + ++ E + T L + I Q D I +
Sbjct: 59 EIKILKHFKHENIITIFNIQRPDSFENFNEVYIIQELM--QTDLHRVISTQMLSDDHIQY 116
Query: 374 EIR--LRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQ 431
I LR A+ LH + + HRD+K +N+L++ KV DFG +R +
Sbjct: 117 FIYQTLR-------AVKVLHGSN---VIHRDLKPSNLLINSNCDLKVCDFGLARIIDESA 166
Query: 432 THMTTQVHGTFG---------YLDPEY-FRSSQFTDKSDVYSFGVVLTELLTGEKPI 478
+ G Y PE S++++ DV+S G +L EL +PI
Sbjct: 167 ADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLR-RPI 222
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429 | Back alignment and structure |
|---|
Score = 60.9 bits (148), Expect = 5e-10
Identities = 55/219 (25%), Positives = 91/219 (41%), Gaps = 63/219 (28%)
Query: 295 RILGQG--GQAVK----KS------KVI--DESKVEEFINEVVILSQINHR------NVV 334
+++G+G GQ VK K K++ ++ + E+ IL + + NV+
Sbjct: 103 KVIGKGSFGQVVKAYDHKVHQHVALKMVRNEKRFHRQAAEEIRILEHLRKQDKDNTMNVI 162
Query: 335 KLLGC-------CLETEVPLL---VYEFIPNGTLFQYIHDQNEDFPITWEIRLRIAIEVS 384
+L C+ E LL +YE I + + F + +R + A +
Sbjct: 163 HMLENFTFRNHICMTFE--LLSMNLYELIKKN--------KFQGFSLP-LVR-KFAHSIL 210
Query: 385 GALSYLHSAASIPIYHRDIKSTNILLDDKYRA--KVSDFGASRSMAVDQTHMTTQVHGTF 442
L LH I H D+K NILL + R+ KV DFG+S Q T
Sbjct: 211 QCLDALHKNR---IIHCDLKPENILLKQQGRSGIKVIDFGSS--CYEHQRVYT------- 258
Query: 443 GYLDPEYFRS------SQFTDKSDVYSFGVVLTELLTGE 475
Y+ ++R+ +++ D++S G +L ELLTG
Sbjct: 259 -YIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGY 296
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432 | Back alignment and structure |
|---|
Score = 60.1 bits (146), Expect = 9e-10
Identities = 32/192 (16%), Positives = 63/192 (32%), Gaps = 50/192 (26%)
Query: 321 EVVILSQINHRNVVKLLGCCLETEVPL-----LVYEF--------IPNGTLFQYIHDQNE 367
E+ IL+++ +++L + ++ +V E H +
Sbjct: 75 EITILNRLKSDYIIRLYDLIIPDDLLKFDELYIVLEIADSDLKKLFKTPIFLTEEHIKT- 133
Query: 368 DFPITWEIRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSM 427
I + + L +++H + I HRD+K N LL+ KV DFG +R++
Sbjct: 134 ---ILYNL-LL-------GENFIHESG---IIHRDLKPANCLLNQDCSVKVCDFGLARTI 179
Query: 428 AVDQTHMTTQVHGTFGYLDP----------EY------------FRSSQFTDKSDVYSFG 465
++ P + +T D++S G
Sbjct: 180 NSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTG 239
Query: 466 VVLTELLTGEKP 477
+ ELL +
Sbjct: 240 CIFAELLNMLQS 251
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373 | Back alignment and structure |
|---|
Score = 58.6 bits (142), Expect = 2e-09
Identities = 42/232 (18%), Positives = 82/232 (35%), Gaps = 75/232 (32%)
Query: 295 RILGQG--GQAVK----KS------KVI--DESKVEEFINEVVILSQIN----------- 329
R LG G + K++ D+ E +E+ +L ++N
Sbjct: 25 RKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKEDSMG 84
Query: 330 HRNVVKLLGC-----------CLETEVPLL---VYEFIPNGTLFQYIHDQNEDFPITWEI 375
+++KLL + E +L + I + E I
Sbjct: 85 ANHILKLLDHFNHKGPNGVHVVMVFE--VLGENLLALI----------KKYEHRGIPLIY 132
Query: 376 RLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRA------KVSDFGASRSMAV 429
+I+ ++ L Y+H I I H DIK N+L++ K++D G +
Sbjct: 133 VKQISKQLLLGLDYMHRRCGI-I-HTDIKPENVLMEIVDSPENLIQIKIADLGNACW--Y 188
Query: 430 DQTHMTTQVHGTFGYLDPEYFRS------SQFTDKSDVYSFGVVLTELLTGE 475
D+ + + +RS + + +D++S ++ EL+TG+
Sbjct: 189 DEHYTN--------SIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGD 232
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388 | Back alignment and structure |
|---|
Score = 56.6 bits (137), Expect = 9e-09
Identities = 48/192 (25%), Positives = 80/192 (41%), Gaps = 53/192 (27%)
Query: 321 EVVILSQIN-HRNVVKLLGCCLETEVPL--------LVYEFIPNGT-LFQYIHDQN-EDF 369
E++IL++++ H N+V LL V LV++++ T L I E
Sbjct: 58 EIMILTELSGHENIVNLL------NVLRADNDRDVYLVFDYM--ETDLHAVIRANILEPV 109
Query: 370 PITWEIR--LRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSM 427
+ + ++ + YLHS + HRD+K +NILL+ + KV+DFG SRS
Sbjct: 110 HKQYVVYQLIK-------VIKYLHSGG---LLHRDMKPSNILLNAECHVKVADFGLSRSF 159
Query: 428 AVDQTHMTTQVHGTFGYLDP---------EY------------FRSSQFTDKSDVYSFGV 466
+ + +Y S+++T D++S G
Sbjct: 160 VNIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGC 219
Query: 467 VLTELLTGEKPI 478
+L E+L G KPI
Sbjct: 220 ILGEILCG-KPI 230
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458 | Back alignment and structure |
|---|
Score = 56.8 bits (137), Expect = 1e-08
Identities = 51/275 (18%), Positives = 99/275 (36%), Gaps = 81/275 (29%)
Query: 263 QQELASTEGTIEKTKLFTSKELEKATDNFDLNRILGQG--GQ-------------AVKK- 306
+++ S++ T + + ++ D +++ ++G G G A+KK
Sbjct: 30 RKQHHSSKPTASMPRPHSDWQI---PDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKI 86
Query: 307 ----SKVIDESKVEEFINEVVILSQINHRNVVKLLGCCLETEVPL-----LVYEF----- 352
+ID ++ + E+ IL+++NH +VVK+L + +V +V E
Sbjct: 87 LRVFEDLIDCKRI---LREIAILNRLNHDHVVKVLDIVIPKDVEKFDELYVVLEIADSDF 143
Query: 353 ---IPNGTLFQYIHDQNEDFPITWEIRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNIL 409
+H + + + + L + Y+HSA I HRD+K N L
Sbjct: 144 KKLFRTPVYLTELHIKT----LLYNL-LV-------GVKYVHSAG---ILHRDLKPANCL 188
Query: 410 LDDKYRAKVSDFGASRSMAVDQTHMTTQVHGTFGYLDP---------------EY----- 449
++ KV DFG +R++ + + +
Sbjct: 189 VNQDCSVKVCDFGLARTVDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRW 248
Query: 450 -------FRSSQFTDKSDVYSFGVVLTELLTGEKP 477
+T+ DV+S G + ELL K
Sbjct: 249 YRAPELILLQENYTEAIDVWSIGCIFAELLNMIKE 283
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382 | Back alignment and structure |
|---|
Score = 55.5 bits (134), Expect = 2e-08
Identities = 43/179 (24%), Positives = 71/179 (39%), Gaps = 47/179 (26%)
Query: 321 EVVILSQINHR------NVVKLLGC-------CLETEVPLL---VYEFIPNGTLFQYIHD 364
EV +L +N +V L CL E +L +Y+ + N
Sbjct: 100 EVRLLELMNKHDTEMKYYIVHLKRHFMFRNHLCLVFE--MLSYNLYDLLRN--------T 149
Query: 365 QNEDFPITWEIRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRA--KVSDFG 422
+ R + A ++ AL +L + + I H D+K NILL + R+ K+ DFG
Sbjct: 150 NFRGVSLN-LTR-KFAQQMCTALLFLATP-ELSIIHCDLKPENILLCNPKRSAIKIVDFG 206
Query: 423 ASRSMAVDQTHMTTQVHGTFGYLDPEYFRS------SQFTDKSDVYSFGVVLTELLTGE 475
+S + Q Y+ ++RS + D++S G +L E+ TGE
Sbjct: 207 SS--CQLGQRIYQ--------YIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGE 255
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 55.6 bits (133), Expect = 3e-08
Identities = 89/615 (14%), Positives = 163/615 (26%), Gaps = 205/615 (33%)
Query: 88 SSGCCDMVCNIPQNSSTK-----VLDANTSNVYSRSIPEGCTSLSLVYADWIFSHYLETP 142
S D + S L + + + + E L + Y ++ S
Sbjct: 47 SKEEIDHIIMSKDAVSGTLRLFWTLLSKQEEMVQKFVEE---VLRINY-KFLMSPI---- 98
Query: 143 SGLKHEKMIPAVL--EWGKYKGVCYEDYNSQTK--VCNKDD-----RCLIQLSSGTIFPH 193
K E+ P+++ + + + Y D K V + L++L
Sbjct: 99 ---KTEQRQPSMMTRMYIEQRDRLYNDNQVFAKYNVSRLQPYLKLRQALLELRPAKNV-- 153
Query: 194 IVFGNISSFIIFRFVISILRLYLSGVG--------CTSGGLGMFLLIGAWWL-FKFVKRR 244
++ G + G G C S + + +WL K
Sbjct: 154 LIDG------------------VLGSGKTWVALDVCLSYKVQCKMDFKIFWLNLKNCNSP 195
Query: 245 REI--KLKRKYFKRNGGLLLQQELAST------EGTIEKTKLFTSKELEKA---TDN--- 290
+ L++ ++ + + + +S E +L SK E N
Sbjct: 196 ETVLEMLQKLLYQIDPNWTSRSDHSSNIKLRIHSIQAELRRLLKSKPYENCLLVLLNVQN 255
Query: 291 ------FDLN-RILGQGGQAV--KKSKVIDESKVEEFINEVVILSQ--INHRNVVKLLGC 339
F+L+ +IL + + +V D + + + V LL
Sbjct: 256 AKAWNAFNLSCKIL------LTTRFKQVTDFLSAATTTHISLDHHSMTLTPDEVKSLLLK 309
Query: 340 CLETEV-----------PLLVYEFIPNGTLFQYIHDQNEDFPITWE-------IRLRIAI 381
L+ P + + D TW+ +L I
Sbjct: 310 YLDCRPQDLPREVLTTNPRRLSII---AESIR-------DGLATWDNWKHVNCDKLTTII 359
Query: 382 EVSGALSYLHSAASIPIYHRDI--------KSTNI---LL-----DDKYR--AKVSDFGA 423
E S L+ L P +R + S +I LL D V +
Sbjct: 360 ESS--LNVLE-----PAEYRKMFDRLSVFPPSAHIPTILLSLIWFDVIKSDVMVVVNKLH 412
Query: 424 SRSMAV-DQTHMTTQVHGTFGYLD---------------------PEYFRSSQFT-DKSD 460
S+ T + YL+ P+ F S D
Sbjct: 413 KYSLVEKQPKESTISIPS--IYLELKVKLENEYALHRSIVDHYNIPKTFDSDDLIPPYLD 470
Query: 461 VYSFGVV---LTELLTGEKPIRFTILEEDKSLAAYFLCAMKEERLFEILDARVMKQGGKD 517
Y + + L + E+ F +F LD R ++Q
Sbjct: 471 QYFYSHIGHHLKNIEHPERMTLF-------------------RMVF--LDFRFLEQ---- 505
Query: 518 EIITVAKLAKRCLNLNGKKRPTMREVASELAGIKAWNGASNVIEEGLEEIDCALGDIYIV 577
K+ N + + L +K + + E + A+ D +
Sbjct: 506 ------KIRHDSTAWNASG-----SILNTLQQLKFYKPYICDNDPKYERLVNAILD--FL 552
Query: 578 ANSETNGSINESFLD 592
E N I + D
Sbjct: 553 PKIEEN-LICSKYTD 566
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397 | Back alignment and structure |
|---|
Score = 54.1 bits (130), Expect = 7e-08
Identities = 64/340 (18%), Positives = 105/340 (30%), Gaps = 122/340 (35%)
Query: 308 KVI--DESKVEEFINEVVILSQI--------NHRNVVKLLGC-----------CLETEVP 346
KV+ E E ++E+ +L + N VV+LL C+
Sbjct: 68 KVVKSAEHYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDFKISGVNGTHICM----- 122
Query: 347 LLVYEFIPNG-TLFQYIHDQNEDFPITWEIRLRIAIEVSGALSYLHSAASIPIYHRDIKS 405
V+E G L ++I ++ + +I +V L YLH+ I H DIK
Sbjct: 123 --VFE--VLGHHLLKWII-KSNYQGLPLPCVKKIIQQVLQGLDYLHTKCRII--HTDIKP 175
Query: 406 TNILL-------------------------------------------------DDKYRA 416
NILL +K +
Sbjct: 176 ENILLSVNEQYIRRLAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKV 235
Query: 417 KVSDFGASRSMAVDQTHMTTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLTELLTGE- 475
K++D G + V + T+ T Y E S + +D++S + EL TG+
Sbjct: 236 KIADLGNACW--VHKHF--TEDIQTRQYRSLEVLIGSGYNTPADIWSTACMAFELATGDY 291
Query: 476 --KPIRFTILEEDKSLAA----------------------YF--------LCAMKEERLF 503
+P D+ A +F + +K LF
Sbjct: 292 LFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFFTKKGDLKHITKLKPWGLF 351
Query: 504 EILDARVMKQGGKDEIITVAKLAKRCLNLNGKKRPTMREV 543
E+L + + ++E L L +KR T E
Sbjct: 352 EVLVEKY--EWSQEEAAGFTDFLLPMLELIPEKRATAAEC 389
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355 | Back alignment and structure |
|---|
Score = 52.3 bits (126), Expect = 2e-07
Identities = 43/240 (17%), Positives = 80/240 (33%), Gaps = 87/240 (36%)
Query: 295 RILGQG--GQAVKKSKVIDESKVEEFI----------------NEVVILSQINHR----- 331
LG+G G+ V+ +D ++ + + E+ +L +I +
Sbjct: 25 GNLGEGTFGKVVE---CLDHARGKSQVALKIIRNVGKYREAARLEINVLKKIKEKDKENK 81
Query: 332 -NVVKLLGC-------CLETEVPLL---VYEFIPNGTLFQYIHDQNEDFPITWEIRLRIA 380
V + C+ E LL +EF+ + +P+ +R +A
Sbjct: 82 FLCVLMSDWFNFHGHMCIAFE--LLGKNTFEFLKEN--------NFQPYPLP-HVR-HMA 129
Query: 381 IEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRA-------------------KVSDF 421
++ AL +LH H D+K NIL + +V+DF
Sbjct: 130 YQLCHALRFLHENQLT---HTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVADF 186
Query: 422 GASRSMAVDQTHMTTQVHGTFGYLDPEYFRS------SQFTDKSDVYSFGVVLTELLTGE 475
G++ + H T + ++R + DV+S G +L E G
Sbjct: 187 GSA--TFDHEHHTT--------IVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGF 236
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339 | Back alignment and structure |
|---|
Score = 48.4 bits (116), Expect = 4e-06
Identities = 52/243 (21%), Positives = 89/243 (36%), Gaps = 93/243 (38%)
Query: 295 RILGQG--GQAVK----KS-------KVI-------DESKVEEFINEVVILSQINHR--- 331
LG+G G+ V+ K+ K++ + ++ E + +L +N
Sbjct: 20 DTLGEGAFGKVVECIDHKAGGRHVAVKIVKNVDRYCEAARSE-----IQVLEHLNTTDPN 74
Query: 332 ---NVVKLLGC-------CLETEVPLL---VYEFI-PNGTLFQYIHDQNEDFPITWEIRL 377
V++L C+ E LL Y+FI NG F F + IR
Sbjct: 75 STFRCVQMLEWFEHHGHICIVFE--LLGLSTYDFIKENG--FLP-------FRLD-HIR- 121
Query: 378 RIAIEVSGALSYLHSAASIPIYHRDIKSTNILL-DDKYRA------------------KV 418
++A ++ ++++LHS H D+K NIL Y KV
Sbjct: 122 KMAYQICKSVNFLHSNKLT---HTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIKV 178
Query: 419 SDFGASRSMAVDQTHMTTQVHGTFGYLDPEYFRS------SQFTDKSDVYSFGVVLTELL 472
DFG++ D+ H T + ++R+ ++ DV+S G +L E
Sbjct: 179 VDFGSA--TYDDEHHST--------LVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYY 228
Query: 473 TGE 475
G
Sbjct: 229 LGF 231
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360 | Back alignment and structure |
|---|
Score = 46.9 bits (112), Expect = 1e-05
Identities = 59/238 (24%), Positives = 88/238 (36%), Gaps = 79/238 (33%)
Query: 295 RILGQG--GQAVK----KS------KVIDESKVEEFIN----EVVILSQINHR-----NV 333
R +G G G+ + + KV+ ++++ E IL +I + N+
Sbjct: 41 RKMGDGTFGRVLLCQHIDNKKYYAVKVV--RNIKKYTRSAKIEADILKKIQNDDINNNNI 98
Query: 334 VKLLGC-------CLETEVPLL---VYEFI-PNGTLFQYIHDQNEDFPITWEIRLRIAIE 382
VK G CL E L +YE I N + F I +I+ IE
Sbjct: 99 VKYHGKFMYYDHMCLIFE--PLGPSLYEIITRNN--YNG-------FHIE-DIK-LYCIE 145
Query: 383 VSGALSYLHSAASIPIYHRDIKSTNILLDDKYRA-------------------------K 417
+ AL+YL + H D+K NILLDD Y K
Sbjct: 146 ILKALNYLRKMSLT---HTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTKSTGIK 202
Query: 418 VSDFGASRSMAVDQTHMTTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLTELLTGE 475
+ DFG + + ++ Y PE + + SD++SFG VL EL TG
Sbjct: 203 LIDFG---CATFKSDYHGSIINTRQ-YRAPEVILNLGWDVSSDMWSFGCVLAELYTGS 256
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336 | Back alignment and structure |
|---|
Score = 45.6 bits (107), Expect = 3e-05
Identities = 24/137 (17%), Positives = 49/137 (35%), Gaps = 18/137 (13%)
Query: 348 LVYEFIPNGTLFQYIHDQNEDFPITWEIRLRIAIEVSGALSYLHSAASIPIYHRDIKSTN 407
+V EF G + + + + I +++ +L+ + S+ HRD+ N
Sbjct: 139 IVLEFEFGGIDLEQMRTK----LSSLATAKSILHQLTASLAVAEA--SLRFEHRDLHWGN 192
Query: 408 ILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHGTFGYL-DPEYFRSSQFT-DKSDVYSFG 465
+LL K+ +S + + G + S+ D V+
Sbjct: 193 VLLKKTSLKKLHYTLNGKSSTI----------PSCGLQVSIIDYTLSRLERDGIVVFCDV 242
Query: 466 VVLTELLTGEKPIRFTI 482
+ +L TG+ +F I
Sbjct: 243 SMDEDLFTGDGDYQFDI 259
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345 | Back alignment and structure |
|---|
Score = 42.8 bits (101), Expect = 2e-04
Identities = 18/59 (30%), Positives = 29/59 (49%), Gaps = 5/59 (8%)
Query: 377 LRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKV--SDFGASRSMAVDQTH 433
L++ I + L Y+H + H DIK+ N+LL K +V +D+G S + H
Sbjct: 154 LQLGIRMLDVLEYIHENEYV---HGDIKAANLLLGYKNPDQVYLADYGLSYRYCPNGNH 209
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352 | Back alignment and structure |
|---|
Score = 42.0 bits (99), Expect = 4e-04
Identities = 13/60 (21%), Positives = 30/60 (50%), Gaps = 5/60 (8%)
Query: 377 LRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKV--SDFGASRSMAVDQTHM 434
L++A + AL +LH + H ++ + NI +D + +++V + +G + H+
Sbjct: 162 LQVACRLLDALEFLHENEYV---HGNVTAENIFVDPEDQSQVTLAGYGFAFRYCPSGKHV 218
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364 | Back alignment and structure |
|---|
Score = 41.3 bits (97), Expect = 7e-04
Identities = 16/59 (27%), Positives = 31/59 (52%), Gaps = 5/59 (8%)
Query: 377 LRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKV--SDFGASRSMAVDQTH 433
L++++ + L Y+H + H DIK++N+LL+ K +V D+G + + H
Sbjct: 155 LQLSLRILDILEYIHEHEYV---HGDIKASNLLLNYKNPDQVYLVDYGLAYRYCPEGVH 210
|
Structure Templates Detected by HHsearch
Original result of HHsearch against PDB70 database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 608 | |||
| 4asz_A | 299 | BDNF/NT-3 growth factors receptor; transferase, TR | 100.0 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 100.0 | |
| 3omv_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 4gt4_A | 308 | Tyrosine-protein kinase transmembrane receptor RO; | 100.0 | |
| 4ase_A | 353 | Vascular endothelial growth factor receptor 2; tra | 100.0 | |
| 4b9d_A | 350 | Serine/threonine-protein kinase NEK1; transferase, | 100.0 | |
| 4fih_A | 346 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 3fpq_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 100.0 | |
| 4fie_A | 423 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 4aw0_A | 311 | HPDK1, 3-phosphoinositide-dependent protein kinase | 100.0 | |
| 3hmm_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 3hyh_A | 275 | Carbon catabolite-derepressing protein kinase; kin | 100.0 | |
| 3ubd_A | 304 | Ribosomal protein S6 kinase alpha-3; kinase-inhibi | 100.0 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 100.0 | |
| 4b99_A | 398 | Mitogen-activated protein kinase 7; transferase, i | 100.0 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 100.0 | |
| 4f9c_A | 361 | Cell division cycle 7-related protein kinase; Ser/ | 100.0 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 100.0 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 100.0 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 100.0 | |
| 3v5w_A | 689 | G-protein coupled receptor kinase 2; inhibitor com | 100.0 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 100.0 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 100.0 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 100.0 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 100.0 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 100.0 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 100.0 | |
| 4hcu_A | 269 | Tyrosine-protein kinase ITK/TSK; transferase-trans | 100.0 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 100.0 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 100.0 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 100.0 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 100.0 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 100.0 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 100.0 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 100.0 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 100.0 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 100.0 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 100.0 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 100.0 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 100.0 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 100.0 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 100.0 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 100.0 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 100.0 | |
| 3zgw_A | 347 | Maternal embryonic leucine zipper kinase; transfer | 100.0 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 100.0 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 100.0 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 100.0 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 100.0 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 100.0 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 100.0 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 100.0 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 100.0 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 100.0 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 100.0 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 100.0 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 100.0 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 100.0 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 100.0 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 100.0 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 100.0 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 100.0 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 100.0 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 100.0 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 100.0 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 100.0 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 100.0 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 100.0 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 100.0 | |
| 4hgt_A | 296 | Casein kinase I isoform delta; CK1D, inhibitor, tr | 100.0 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 100.0 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 100.0 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 100.0 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 100.0 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 100.0 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 100.0 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 100.0 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 100.0 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 100.0 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 100.0 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 100.0 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 100.0 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 100.0 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 100.0 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 100.0 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 100.0 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 100.0 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 100.0 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 100.0 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 100.0 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 100.0 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 100.0 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 100.0 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 100.0 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 100.0 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 100.0 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 100.0 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 100.0 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 100.0 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 100.0 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 100.0 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 100.0 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 100.0 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 100.0 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 100.0 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 100.0 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 100.0 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 100.0 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 100.0 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 100.0 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 100.0 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 100.0 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 100.0 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 100.0 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 100.0 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 100.0 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 100.0 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 100.0 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 100.0 | |
| 4fl3_A | 635 | Tyrosine-protein kinase SYK; transferase; HET: ANP | 100.0 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 100.0 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 100.0 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 100.0 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 100.0 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 100.0 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 100.0 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 100.0 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 100.0 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 100.0 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 100.0 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 100.0 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 100.0 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 100.0 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 100.0 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 100.0 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 100.0 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 100.0 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 100.0 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 100.0 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 100.0 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 100.0 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 100.0 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 100.0 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 100.0 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 100.0 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 100.0 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 100.0 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 100.0 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 100.0 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 100.0 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 100.0 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 100.0 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 100.0 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 100.0 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 100.0 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 100.0 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 100.0 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 100.0 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 100.0 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 100.0 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 100.0 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 100.0 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 100.0 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 100.0 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 100.0 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 100.0 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 100.0 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 100.0 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 100.0 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 100.0 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 100.0 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 100.0 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 100.0 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 100.0 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 100.0 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 100.0 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 100.0 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 100.0 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 100.0 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 100.0 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 100.0 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 100.0 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 100.0 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 100.0 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 100.0 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 100.0 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 100.0 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 100.0 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 100.0 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 100.0 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 100.0 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 100.0 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 100.0 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 100.0 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 100.0 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 100.0 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 100.0 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 100.0 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 100.0 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 100.0 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 100.0 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 100.0 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 100.0 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 100.0 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 100.0 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 100.0 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 100.0 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 100.0 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 100.0 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 100.0 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 100.0 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 100.0 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 100.0 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 100.0 | |
| 4exu_A | 371 | Mitogen-activated protein kinase 13; P38 kinase, t | 100.0 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 100.0 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 100.0 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 100.0 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 100.0 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 100.0 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 100.0 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 100.0 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 100.0 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 100.0 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 100.0 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 100.0 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 100.0 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 99.97 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 99.97 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 99.97 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 99.97 | |
| 4azs_A | 569 | Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15 | 99.94 | |
| 3en9_A | 540 | Glycoprotease, O-sialoglycoprotein endopeptidase/p | 99.87 | |
| 1zar_A | 282 | RIO2 kinase; serine kinase, winged-helix, RIO doma | 99.77 | |
| 1zth_A | 258 | RIO1 serine protein kinase; ribosome biogenesis, r | 99.51 | |
| 4gyi_A | 397 | RIO2 kinase; protein kinase, ADP complex, phosphoa | 99.29 | |
| 3tm0_A | 263 | Aminoglycoside 3'-phosphotransferase; protein kina | 98.9 | |
| 3sg8_A | 304 | APH(2'')-ID; antibiotic resistance enzyme, transfe | 98.6 | |
| 3dxp_A | 359 | Putative acyl-COA dehydrogenase; protein kinase-li | 98.57 | |
| 1nd4_A | 264 | Aminoglycoside 3'-phosphotransferase; protein kina | 98.57 | |
| 3r70_A | 320 | Aminoglycoside phosphotransferase; structural geno | 98.1 | |
| 3tdw_A | 306 | Gentamicin resistance protein; kinase, phosphoryl | 97.86 | |
| 4gkh_A | 272 | Aminoglycoside 3'-phosphotransferase APHA1-IAB; py | 97.74 | |
| 3ovc_A | 362 | Hygromycin-B 4-O-kinase; aminoglycoside phosphotra | 97.35 | |
| 3ats_A | 357 | Putative uncharacterized protein; hypothetical pro | 97.34 | |
| 2q83_A | 346 | YTAA protein; 2635576, structural genomics, joint | 96.97 | |
| 3d1u_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 96.81 | |
| 2yle_A | 229 | Protein spire homolog 1; actin-binding protein, ac | 96.79 | |
| 3jr1_A | 312 | Putative fructosamine-3-kinase; YP_719053.1, struc | 96.35 | |
| 2olc_A | 397 | MTR kinase, methylthioribose kinase; kinase ADP-2H | 95.65 | |
| 3feg_A | 379 | Choline/ethanolamine kinase; non-protein kinase, c | 95.43 | |
| 3csv_A | 333 | Aminoglycoside phosphotransferase; YP_614837.1, ph | 95.08 | |
| 3dxq_A | 301 | Choline/ethanolamine kinase family protein; NP_106 | 94.75 | |
| 2ppq_A | 322 | HSK, HK, homoserine kinase; structural genomics, M | 94.74 | |
| 1nw1_A | 429 | Choline kinase (49.2 KD); phospholipid synthesis, | 94.62 | |
| 3c5i_A | 369 | Choline kinase; choline, kinase, malaria, transfer | 94.22 | |
| 3f2s_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 93.67 | |
| 2qg7_A | 458 | Ethanolamine kinase PV091845; malaria, SGC, struct | 93.6 | |
| 2pyw_A | 420 | Uncharacterized protein; 5-methylthioribose kinase | 89.14 | |
| 3f7w_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 89.04 | |
| 4ann_A | 215 | ESSB; membrane protein, membrane secretion, ESS ty | 85.47 | |
| 4ano_A | 219 | ESSB; membrane protein, membrane secretion, ESS ty | 83.68 | |
| 3g15_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 83.6 | |
| 3mes_A | 424 | Choline kinase; malaria, structural genomics, stru | 82.35 | |
| 1zyl_A | 328 | Hypothetical protein YIHE; putative protein kinase | 81.92 |
| >4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-51 Score=420.79 Aligned_cols=247 Identities=26% Similarity=0.424 Sum_probs=205.5
Q ss_pred cCccccceeccCce--------------------EEEEEeecChhhHHHHHHHHHHHhhcCCCCccceecccccCccceE
Q 044312 289 DNFDLNRILGQGGQ--------------------AVKKSKVIDESKVEEFINEVVILSQINHRNVVKLLGCCLETEVPLL 348 (608)
Q Consensus 289 ~~f~~~~~lG~G~~--------------------avk~~~~~~~~~~~~~~~Ei~il~~l~H~niv~l~~~~~~~~~~~l 348 (608)
++|.+.++||+|+| |||+++..+....++|.+|+++|++|+|||||+++|+|.+.+..+|
T Consensus 13 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~l 92 (299)
T 4asz_A 13 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIM 92 (299)
T ss_dssp GGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEEE
T ss_pred HHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCCChHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEE
Confidence 46788899999974 6777776666778899999999999999999999999999999999
Q ss_pred EEeecCCCccchhccccC----------CCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEEcCCCcEEE
Q 044312 349 VYEFIPNGTLFQYIHDQN----------EDFPITWEIRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKV 418 (608)
Q Consensus 349 V~E~~~~gsL~~~l~~~~----------~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl 418 (608)
||||+++|+|.++|+... ....++|..+++|+.|||+||+|||+++ |+||||||+||||++++.+||
T Consensus 93 V~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~---iiHRDlKp~NILl~~~~~~Ki 169 (299)
T 4asz_A 93 VFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQH---FVHRDLATRNCLVGENLLVKI 169 (299)
T ss_dssp EEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEE
T ss_pred EEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCccCHhhEEECCCCcEEE
Confidence 999999999999997642 2236999999999999999999999998 999999999999999999999
Q ss_pred eeccCccccccCCcce-eeeeeccCCCCChhhhccCCCCCccchHhHHHHHHHHHh-CCCCCCccchhhcccHHHHHHHH
Q 044312 419 SDFGASRSMAVDQTHM-TTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLTELLT-GEKPIRFTILEEDKSLAAYFLCA 496 (608)
Q Consensus 419 ~DFGls~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~ellt-g~~p~~~~~~~~~~~l~~~~~~~ 496 (608)
+|||+|+......... .....||+.|||||++.+..++.|+|||||||+||||+| |+.||......
T Consensus 170 ~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~~~~------------ 237 (299)
T 4asz_A 170 GDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNN------------ 237 (299)
T ss_dssp CCCSCHHHHTGGGCEEETTTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHH------------
T ss_pred CCcccceecCCCCceeecCceecChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHH------------
Confidence 9999998765433322 234568999999999999999999999999999999999 89999743211
Q ss_pred hhhhhhHHHhhhhhhccCChhHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhhHHhc
Q 044312 497 MKEERLFEILDARVMKQGGKDEIITVAKLAKRCLNLNGKKRPTMREVASELAGIKAWN 554 (608)
Q Consensus 497 ~~~~~~~~~~d~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~evl~~L~~i~~~~ 554 (608)
.+...+......+.+..++.++.+|+.+||+.||++||||+||.+.|+.+....
T Consensus 238 ----~~~~~i~~~~~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~~i~~~L~~~~~~~ 291 (299)
T 4asz_A 238 ----EVIECITQGRVLQRPRTCPQEVYELMLGCWQREPHMRKNIKGIHTLLQNLAKAS 291 (299)
T ss_dssp ----HHHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHS
T ss_pred ----HHHHHHHcCCCCCCCccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhcC
Confidence 111111122223445567789999999999999999999999999999887643
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-50 Score=421.24 Aligned_cols=246 Identities=26% Similarity=0.429 Sum_probs=198.8
Q ss_pred cCccccceeccCce--------------------EEEEEeecChhhHHHHHHHHHHHhhcCCCCccceecccccCccceE
Q 044312 289 DNFDLNRILGQGGQ--------------------AVKKSKVIDESKVEEFINEVVILSQINHRNVVKLLGCCLETEVPLL 348 (608)
Q Consensus 289 ~~f~~~~~lG~G~~--------------------avk~~~~~~~~~~~~~~~Ei~il~~l~H~niv~l~~~~~~~~~~~l 348 (608)
++|.+.++||+|+| |||+++..+....++|.+|+++|++|+|||||+++|+|.+.+..+|
T Consensus 41 ~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~l 120 (329)
T 4aoj_A 41 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLLM 120 (329)
T ss_dssp GGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEEE
T ss_pred HHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEE
Confidence 46778899999985 6777776667778899999999999999999999999999999999
Q ss_pred EEeecCCCccchhccccCC------------CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEEcCCCcE
Q 044312 349 VYEFIPNGTLFQYIHDQNE------------DFPITWEIRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRA 416 (608)
Q Consensus 349 V~E~~~~gsL~~~l~~~~~------------~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ 416 (608)
||||+++|+|.++++.... ..+++|.++++|+.|||+||+|||+.+ |+||||||+||||++++.+
T Consensus 121 V~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~---iiHRDLKp~NILl~~~~~~ 197 (329)
T 4aoj_A 121 VFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLH---FVHRDLATRNCLVGQGLVV 197 (329)
T ss_dssp EEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEETTTEE
T ss_pred EEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcCC---eecccccHhhEEECCCCcE
Confidence 9999999999999976432 236999999999999999999999998 9999999999999999999
Q ss_pred EEeeccCccccccCCc-ceeeeeeccCCCCChhhhccCCCCCccchHhHHHHHHHHHh-CCCCCCccchhhcccHHHHHH
Q 044312 417 KVSDFGASRSMAVDQT-HMTTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLTELLT-GEKPIRFTILEEDKSLAAYFL 494 (608)
Q Consensus 417 kl~DFGls~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~ellt-g~~p~~~~~~~~~~~l~~~~~ 494 (608)
||+|||+|+....... ...+...||+.|||||++.+..++.++|||||||+||||+| |+.||......+
T Consensus 198 Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~~~~~--------- 268 (329)
T 4aoj_A 198 KIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTE--------- 268 (329)
T ss_dssp EECCCC----------------CCCCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSSCHHH---------
T ss_pred EEcccccceeccCCCcceecCcccccccccChhhhcCCCCCccccccchHHHHHHHHcCCCCCCCCCCHHH---------
Confidence 9999999987654332 23345679999999999999999999999999999999999 899997432211
Q ss_pred HHhhhhhhHHHhhhhhhccCChhHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhhHHh
Q 044312 495 CAMKEERLFEILDARVMKQGGKDEIITVAKLAKRCLNLNGKKRPTMREVASELAGIKAW 553 (608)
Q Consensus 495 ~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~evl~~L~~i~~~ 553 (608)
+...+......+.+..++.++.+|+.+||+.||++||||+||+++|+.+...
T Consensus 269 -------~~~~i~~g~~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~ei~~~L~~l~~~ 320 (329)
T 4aoj_A 269 -------AIDCITQGRELERPRACPPEVYAIMRGCWQREPQQRHSIKDVHARLQALAQA 320 (329)
T ss_dssp -------HHHHHHHTCCCCCCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHHHHHHHHHS
T ss_pred -------HHHHHHcCCCCCCcccccHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHhhC
Confidence 1111111222344556778899999999999999999999999999988764
|
| >3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-50 Score=410.34 Aligned_cols=250 Identities=26% Similarity=0.409 Sum_probs=196.4
Q ss_pred HhcCccccceeccCce------------EEEEEeec--ChhhHHHHHHHHHHHhhcCCCCccceecccccCccceEEEee
Q 044312 287 ATDNFDLNRILGQGGQ------------AVKKSKVI--DESKVEEFINEVVILSQINHRNVVKLLGCCLETEVPLLVYEF 352 (608)
Q Consensus 287 ~t~~f~~~~~lG~G~~------------avk~~~~~--~~~~~~~~~~Ei~il~~l~H~niv~l~~~~~~~~~~~lV~E~ 352 (608)
..+++.+.++||+|+| |||.++.. +....+.|.+|+.+|++++|||||+++|++.+ +..+|||||
T Consensus 34 ~~~~l~l~~~iG~G~fG~Vy~~~~~~~vAvK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~-~~~~iVmEy 112 (307)
T 3omv_A 34 EASEVMLSTRIGSGSFGTVYKGKWHGDVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTK-DNLAIVTQW 112 (307)
T ss_dssp CTTSCCEEEECCCCSSSEEEEEESSSEEEEEECCCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEEEEC
T ss_pred cHHHeEEeeEEeeCCCcEEEEEEECCcEEEEEEEecCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEC-CeEEEEEEc
Confidence 3456788999999985 88887653 34567889999999999999999999999865 568999999
Q ss_pred cCCCccchhccccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEEcCCCcEEEeeccCccccccCC-
Q 044312 353 IPNGTLFQYIHDQNEDFPITWEIRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQ- 431 (608)
Q Consensus 353 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGls~~~~~~~- 431 (608)
+++|+|.++|+.... +++|..+++|+.|||+||+|||+++ |+||||||+||||++++.+||+|||+|+......
T Consensus 113 ~~gGsL~~~l~~~~~--~l~~~~~~~i~~qia~gL~yLH~~~---IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~~~~ 187 (307)
T 3omv_A 113 CEGSSLYKHLHVQET--KFQMFQLIDIARQTAQGMDYLHAKN---IIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSG 187 (307)
T ss_dssp CSSCBHHHHHHTSCC--CCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCCSSSEEEETTEEEEECCCSSCBC------
T ss_pred CCCCCHHHHHhhcCC--CCCHHHHHHHHHHHHHHHHHHHHCC---ccCCccCHHHEEECCCCcEEEeeccCceecccCCc
Confidence 999999999976543 5999999999999999999999998 9999999999999999999999999998765322
Q ss_pred cceeeeeeccCCCCChhhhcc---CCCCCccchHhHHHHHHHHHhCCCCCCccchhhcccHHHHHHHHhhhhhhHHHhhh
Q 044312 432 THMTTQVHGTFGYLDPEYFRS---SQFTDKSDVYSFGVVLTELLTGEKPIRFTILEEDKSLAAYFLCAMKEERLFEILDA 508 (608)
Q Consensus 432 ~~~~~~~~gt~~y~aPE~~~~---~~~t~ksDV~S~Gvvl~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 508 (608)
........||+.|||||++.. ..++.|+|||||||+||||+||+.||....... .+...+..+. ..+
T Consensus 188 ~~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~~~------~~~~~~~~~~----~~p 257 (307)
T 3omv_A 188 SQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRD------QIIFMVGRGY----ASP 257 (307)
T ss_dssp ------CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHH------HHHHHHHTTC----CCC
T ss_pred ceeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCChHH------HHHHHHhcCC----CCC
Confidence 233455679999999999864 468999999999999999999999996322111 1111111110 001
Q ss_pred hhhccCChhHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhhHHh
Q 044312 509 RVMKQGGKDEIITVAKLAKRCLNLNGKKRPTMREVASELAGIKAW 553 (608)
Q Consensus 509 ~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~evl~~L~~i~~~ 553 (608)
.....+..++.++.+|+.+||+.||++||||.||+++|+.++..
T Consensus 258 -~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~Le~l~~~ 301 (307)
T 3omv_A 258 -DLSKLYKNCPKAMKRLVADCVKKVKEERPLFPQILSSIELLQHS 301 (307)
T ss_dssp -CSTTSCTTSCHHHHHHHHHHTCSSSTTSCCHHHHHHHHHHHHTT
T ss_pred -CcccccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhcc
Confidence 01123345677899999999999999999999999999888754
|
| >4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-50 Score=414.15 Aligned_cols=242 Identities=23% Similarity=0.366 Sum_probs=199.2
Q ss_pred CccccceeccCce--------------------EEEEEeec-ChhhHHHHHHHHHHHhhcCCCCccceecccccCccceE
Q 044312 290 NFDLNRILGQGGQ--------------------AVKKSKVI-DESKVEEFINEVVILSQINHRNVVKLLGCCLETEVPLL 348 (608)
Q Consensus 290 ~f~~~~~lG~G~~--------------------avk~~~~~-~~~~~~~~~~Ei~il~~l~H~niv~l~~~~~~~~~~~l 348 (608)
.+++.++||+|+| |||+++.. +....++|.+|+.+|++++|||||+++|+|.+.+..+|
T Consensus 27 ~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~~~~~~l 106 (308)
T 4gt4_A 27 AVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVCLLGVVTKDQPLSM 106 (308)
T ss_dssp GEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-CCC-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEE
T ss_pred HCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECcccChHHHHHHHHHHHHHHhCCCCCCCCcceEEEECCEEEE
Confidence 4566889999985 55655432 33446789999999999999999999999999999999
Q ss_pred EEeecCCCccchhccccCC-------------CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEEcCCCc
Q 044312 349 VYEFIPNGTLFQYIHDQNE-------------DFPITWEIRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYR 415 (608)
Q Consensus 349 V~E~~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~ 415 (608)
||||+++|+|.++|+.... +..++|..+++|+.|||+||+|||+++ |+||||||+||||++++.
T Consensus 107 V~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~---iiHRDLK~~NILl~~~~~ 183 (308)
T 4gt4_A 107 IFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSHH---VVHKDLATRNVLVYDKLN 183 (308)
T ss_dssp EEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGC
T ss_pred EEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCC---CCCCCccccceEECCCCC
Confidence 9999999999999965321 235899999999999999999999999 999999999999999999
Q ss_pred EEEeeccCccccccCC-cceeeeeeccCCCCChhhhccCCCCCccchHhHHHHHHHHHh-CCCCCCccchhhcccHHHHH
Q 044312 416 AKVSDFGASRSMAVDQ-THMTTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLTELLT-GEKPIRFTILEEDKSLAAYF 493 (608)
Q Consensus 416 ~kl~DFGls~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~ellt-g~~p~~~~~~~~~~~l~~~~ 493 (608)
+||+|||+++...... ....+...||+.|||||++.+..++.++|||||||+||||+| |+.||......
T Consensus 184 ~Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~~s~ksDVwSfGvvl~El~t~g~~Pf~~~~~~--------- 254 (308)
T 4gt4_A 184 VKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQ--------- 254 (308)
T ss_dssp EEECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTCCHH---------
T ss_pred EEECCcccceeccCCCceeEecccccCCcccCHHHHhCCCCCccchhhhHHHHHHHHHhCCCCCCCCCCHH---------
Confidence 9999999998765433 223345679999999999999999999999999999999999 89998743211
Q ss_pred HHHhhhhhhHHHhhhhhhccCChhHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhh
Q 044312 494 LCAMKEERLFEILDARVMKQGGKDEIITVAKLAKRCLNLNGKKRPTMREVASELAGI 550 (608)
Q Consensus 494 ~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~evl~~L~~i 550 (608)
.+.+.+......+.+..++.++.+|+.+||+.||++||||+||+++|+.+
T Consensus 255 -------~~~~~i~~~~~~~~p~~~~~~~~~li~~C~~~dP~~RPs~~ei~~~L~a~ 304 (308)
T 4gt4_A 255 -------DVVEMIRNRQVLPCPDDCPAWVYALMIECWNEFPSRRPRFKDIHSRLRAW 304 (308)
T ss_dssp -------HHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTS
T ss_pred -------HHHHHHHcCCCCCCcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHhc
Confidence 11122222223345567788999999999999999999999999999764
|
| >4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-48 Score=408.45 Aligned_cols=257 Identities=27% Similarity=0.407 Sum_probs=209.4
Q ss_pred CCHHHHHHHhcCccccceeccCce--------------------EEEEEeec-ChhhHHHHHHHHHHHhhcCC-CCccce
Q 044312 279 FTSKELEKATDNFDLNRILGQGGQ--------------------AVKKSKVI-DESKVEEFINEVVILSQINH-RNVVKL 336 (608)
Q Consensus 279 ~~~~~l~~~t~~f~~~~~lG~G~~--------------------avk~~~~~-~~~~~~~~~~Ei~il~~l~H-~niv~l 336 (608)
+...+++...++|++.+.||+|+| |||+++.. .....+.|.+|+++|++++| ||||++
T Consensus 54 ~~~~~wEi~~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~~~~~~~~~~~E~~il~~l~hhpnIV~l 133 (353)
T 4ase_A 54 YDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNL 133 (353)
T ss_dssp CCHHHHBCCGGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred CCCcccEecHHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEccccChHHHHHHHHHHHHHHHcCCCCcEEEE
Confidence 456677778889999999999986 44444332 23456789999999999955 999999
Q ss_pred ecccccC-ccceEEEeecCCCccchhccccCC-------------CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeccC
Q 044312 337 LGCCLET-EVPLLVYEFIPNGTLFQYIHDQNE-------------DFPITWEIRLRIAIEVSGALSYLHSAASIPIYHRD 402 (608)
Q Consensus 337 ~~~~~~~-~~~~lV~E~~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrD 402 (608)
+|+|.+. +..+||||||++|+|.++|+.... +..+++..++.|+.|||+||+|||+++ |+|||
T Consensus 134 ~g~~~~~~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~~---iiHRD 210 (353)
T 4ase_A 134 LGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRD 210 (353)
T ss_dssp EEEECCTTSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHTT---CCCSC
T ss_pred EEEEEecCCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhCC---eecCc
Confidence 9998764 568999999999999999976322 235899999999999999999999999 99999
Q ss_pred CCCCcEEEcCCCcEEEeeccCccccccCCcc-eeeeeeccCCCCChhhhccCCCCCccchHhHHHHHHHHHh-CCCCCCc
Q 044312 403 IKSTNILLDDKYRAKVSDFGASRSMAVDQTH-MTTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLTELLT-GEKPIRF 480 (608)
Q Consensus 403 lk~~NILl~~~~~~kl~DFGls~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~ellt-g~~p~~~ 480 (608)
|||+|||+++++.+||+|||+|+.+..+... ......||+.|||||++.+..++.++|||||||+||||+| |+.||..
T Consensus 211 LK~~NILl~~~~~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~y~~ksDVwS~Gv~l~El~t~G~~Pf~~ 290 (353)
T 4ase_A 211 LAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPG 290 (353)
T ss_dssp CSGGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTT
T ss_pred cCccceeeCCCCCEEECcchhhhhcccCCCceeeccccccccccCHHHHhcCCCCCcccEeehHHHHHHHHhCCCCCCCC
Confidence 9999999999999999999999977654433 3345679999999999999999999999999999999998 8999974
Q ss_pred cchhhcccHHHHHHHHhhhhhhHHHhhhhhhccCChhHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhhHHh
Q 044312 481 TILEEDKSLAAYFLCAMKEERLFEILDARVMKQGGKDEIITVAKLAKRCLNLNGKKRPTMREVASELAGIKAW 553 (608)
Q Consensus 481 ~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~evl~~L~~i~~~ 553 (608)
....+ .+...+....+...+...+.++.+|+.+||+.||++|||+.||+++|+.+...
T Consensus 291 ~~~~~---------------~~~~~i~~g~~~~~p~~~~~~~~~li~~c~~~dP~~RPt~~eil~~L~~llq~ 348 (353)
T 4ase_A 291 VKIDE---------------EFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQA 348 (353)
T ss_dssp CCCSH---------------HHHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred CCHHH---------------HHHHHHHcCCCCCCCccCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHHHH
Confidence 32111 11122222233344556678899999999999999999999999999887654
|
| >4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-48 Score=404.50 Aligned_cols=237 Identities=24% Similarity=0.387 Sum_probs=193.9
Q ss_pred cCccccceeccCce---------------EEEEEee--cChhhHHHHHHHHHHHhhcCCCCccceecccccCccceEEEe
Q 044312 289 DNFDLNRILGQGGQ---------------AVKKSKV--IDESKVEEFINEVVILSQINHRNVVKLLGCCLETEVPLLVYE 351 (608)
Q Consensus 289 ~~f~~~~~lG~G~~---------------avk~~~~--~~~~~~~~~~~Ei~il~~l~H~niv~l~~~~~~~~~~~lV~E 351 (608)
++|++.++||+|+| |||++.. .+....+.|.+|+.+|++|+|||||++++++.+.+..|||||
T Consensus 24 e~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~yiVmE 103 (350)
T 4b9d_A 24 EKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESFEENGSLYIVMD 103 (350)
T ss_dssp CCEEEEEEC------CEEEEEETTTCCEEEEEEEECTTSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred cceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCCHHHHHHHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEe
Confidence 57999999999985 8888764 344567889999999999999999999999999999999999
Q ss_pred ecCCCccchhccccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEEcCCCcEEEeeccCccccccCC
Q 044312 352 FIPNGTLFQYIHDQNEDFPITWEIRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQ 431 (608)
Q Consensus 352 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGls~~~~~~~ 431 (608)
|+++|+|.++|..... ..+++..++.|+.||+.||+|||+++ |+||||||+||||+.++.+||+|||+|+.+....
T Consensus 104 y~~gg~L~~~i~~~~~-~~~~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~ 179 (350)
T 4b9d_A 104 YCEGGDLFKRINAQKG-VLFQEDQILDWFVQICLALKHVHDRK---ILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTV 179 (350)
T ss_dssp CCTTCBHHHHHHHTTT-CCCCHHHHHHHHHHHHHHHHHHHHTT---CEETTCCGGGEEECTTCCEEECSTTEESCCCHHH
T ss_pred CCCCCcHHHHHHHcCC-CCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCCHHHEEECCCCCEEEcccccceeecCCc
Confidence 9999999999976433 25899999999999999999999999 9999999999999999999999999998765322
Q ss_pred cceeeeeeccCCCCChhhhccCCCCCccchHhHHHHHHHHHhCCCCCCccchhhcccHHHHHHHHhhhhhhHHHhhhhhh
Q 044312 432 THMTTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLTELLTGEKPIRFTILEEDKSLAAYFLCAMKEERLFEILDARVM 511 (608)
Q Consensus 432 ~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~ 511 (608)
...+...||+.|||||++.+..|+.++|||||||+||||+||+.||..... ...+. .++....
T Consensus 180 -~~~~~~~GT~~YmAPE~l~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~------~~~~~---------~i~~~~~- 242 (350)
T 4b9d_A 180 -ELARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEAGSM------KNLVL---------KIISGSF- 242 (350)
T ss_dssp -HHHHHHHSCCTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSH------HHHHH---------HHHHTCC-
T ss_pred -ccccccCCCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCH------HHHHH---------HHHcCCC-
Confidence 223446799999999999999999999999999999999999999974321 11111 1111111
Q ss_pred ccCChhHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 044312 512 KQGGKDEIITVAKLAKRCLNLNGKKRPTMREVASE 546 (608)
Q Consensus 512 ~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~evl~~ 546 (608)
...+...+.++.+|+.+||+.||++|||+.|++++
T Consensus 243 ~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~h 277 (350)
T 4b9d_A 243 PPVSLHYSYDLRSLVSQLFKRNPRDRPSVNSILEK 277 (350)
T ss_dssp CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred CCCCccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 12334566789999999999999999999999875
|
| >4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-47 Score=399.75 Aligned_cols=236 Identities=26% Similarity=0.371 Sum_probs=197.6
Q ss_pred cCccccceeccCce---------------EEEEEeecChhhHHHHHHHHHHHhhcCCCCccceecccccCccceEEEeec
Q 044312 289 DNFDLNRILGQGGQ---------------AVKKSKVIDESKVEEFINEVVILSQINHRNVVKLLGCCLETEVPLLVYEFI 353 (608)
Q Consensus 289 ~~f~~~~~lG~G~~---------------avk~~~~~~~~~~~~~~~Ei~il~~l~H~niv~l~~~~~~~~~~~lV~E~~ 353 (608)
..|++.++||+|+| |||++...+....+.+.+|+.+|++++|||||++++++.+.+..||||||+
T Consensus 74 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~ivmEy~ 153 (346)
T 4fih_A 74 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFL 153 (346)
T ss_dssp GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCSSGGGGHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEECCC
T ss_pred HhcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeCC
Confidence 46899999999984 899887766666778999999999999999999999999999999999999
Q ss_pred CCCccchhccccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEEcCCCcEEEeeccCccccccCCcc
Q 044312 354 PNGTLFQYIHDQNEDFPITWEIRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTH 433 (608)
Q Consensus 354 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGls~~~~~~~~~ 433 (608)
++|+|.+++.+. .+++..+..|+.||+.||+|||+++ |+||||||+||||+.++.+||+|||+|+.+.....
T Consensus 154 ~gg~L~~~l~~~----~l~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~~- 225 (346)
T 4fih_A 154 EGGALTDIVTHT----RMNEEQIAAVCLAVLQALSVLHAQG---VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVP- 225 (346)
T ss_dssp TTEEHHHHHHHS----CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECCSSSC-
T ss_pred CCCcHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHCC---cccccCCHHHEEECCCCCEEEecCcCceecCCCCC-
Confidence 999999998753 4899999999999999999999999 99999999999999999999999999987754332
Q ss_pred eeeeeeccCCCCChhhhccCCCCCccchHhHHHHHHHHHhCCCCCCccchhhcccHHHHHHHHhhhhhhHHHhhhhhhcc
Q 044312 434 MTTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLTELLTGEKPIRFTILEEDKSLAAYFLCAMKEERLFEILDARVMKQ 513 (608)
Q Consensus 434 ~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~ 513 (608)
..+...||+.|||||++.+..|+.++|||||||+||||++|+.||...... ..+ ..+... .. ....
T Consensus 226 ~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~------~~~-~~i~~~-----~~--~~~~ 291 (346)
T 4fih_A 226 RRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPL------KAM-KMIRDN-----LP--PRLK 291 (346)
T ss_dssp CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHH------HHH-HHHHHS-----SC--CCCS
T ss_pred cccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHH------HHH-HHHHcC-----CC--CCCC
Confidence 345567999999999999999999999999999999999999999632211 111 111110 00 0111
Q ss_pred CChhHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 044312 514 GGKDEIITVAKLAKRCLNLNGKKRPTMREVASE 546 (608)
Q Consensus 514 ~~~~~~~~l~~Li~~cl~~dp~~RPs~~evl~~ 546 (608)
.....+.++.+|+.+||+.||++|||+.|++++
T Consensus 292 ~~~~~s~~~~dli~~~L~~dP~~R~ta~e~l~H 324 (346)
T 4fih_A 292 NLHKVSPSLKGFLDRLLVRDPAQRATAAELLKH 324 (346)
T ss_dssp CGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred ccccCCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence 223456789999999999999999999999764
|
| >3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-47 Score=384.84 Aligned_cols=233 Identities=22% Similarity=0.376 Sum_probs=184.7
Q ss_pred cccceeccCce---------------EEEEEee--cChhhHHHHHHHHHHHhhcCCCCccceeccccc----CccceEEE
Q 044312 292 DLNRILGQGGQ---------------AVKKSKV--IDESKVEEFINEVVILSQINHRNVVKLLGCCLE----TEVPLLVY 350 (608)
Q Consensus 292 ~~~~~lG~G~~---------------avk~~~~--~~~~~~~~~~~Ei~il~~l~H~niv~l~~~~~~----~~~~~lV~ 350 (608)
++.++||+|+| |+|++.. ......+.|.+|+.+|++|+|||||++++++.+ ....+|||
T Consensus 29 ~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~lvm 108 (290)
T 3fpq_A 29 KFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVT 108 (290)
T ss_dssp EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEETTEEEEEEEE
T ss_pred EeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccCCCcEEEEEE
Confidence 56778999985 6676643 344556789999999999999999999999864 34679999
Q ss_pred eecCCCccchhccccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEEc-CCCcEEEeeccCcccccc
Q 044312 351 EFIPNGTLFQYIHDQNEDFPITWEIRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLD-DKYRAKVSDFGASRSMAV 429 (608)
Q Consensus 351 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~-~~~~~kl~DFGls~~~~~ 429 (608)
||+++|+|.+++.+.. ++++..+..|+.||+.||+|||+++ ++|+||||||+||||+ .++.+||+|||+|+....
T Consensus 109 Ey~~gg~L~~~l~~~~---~l~~~~~~~~~~qi~~aL~ylH~~~-~~IiHRDlKp~NILl~~~~g~vKl~DFGla~~~~~ 184 (290)
T 3fpq_A 109 ELMTSGTLKTYLKRFK---VMKIKVLRSWCRQILKGLQFLHTRT-PPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRA 184 (290)
T ss_dssp ECCCSCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHTSS-SCCCCCCCCGGGEEESSTTSCEEECCTTGGGGCCT
T ss_pred eCCCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC-CCEEecccChhheeEECCCCCEEEEeCcCCEeCCC
Confidence 9999999999998654 5999999999999999999999976 3599999999999998 478999999999986432
Q ss_pred CCcceeeeeeccCCCCChhhhccCCCCCccchHhHHHHHHHHHhCCCCCCccchhhcccHHHHHHHHhhhhhhHHHhhhh
Q 044312 430 DQTHMTTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLTELLTGEKPIRFTILEEDKSLAAYFLCAMKEERLFEILDAR 509 (608)
Q Consensus 430 ~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 509 (608)
.......||+.|||||++.+ .++.++|||||||+||||+||+.||..... .... ...+..+..
T Consensus 185 ---~~~~~~~GTp~YmAPE~~~~-~y~~~~DiwSlGvilyelltg~~Pf~~~~~-----~~~~-~~~i~~~~~------- 247 (290)
T 3fpq_A 185 ---SFAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQN-----AAQI-YRRVTSGVK------- 247 (290)
T ss_dssp ---TSBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSS-----HHHH-HHHHTTTCC-------
T ss_pred ---CccCCcccCccccCHHHcCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCCCc-----HHHH-HHHHHcCCC-------
Confidence 23345679999999998864 699999999999999999999999963211 1111 111111110
Q ss_pred hhccCChhHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 044312 510 VMKQGGKDEIITVAKLAKRCLNLNGKKRPTMREVASE 546 (608)
Q Consensus 510 ~~~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~evl~~ 546 (608)
....+...+.++.+|+.+||+.||++|||++|++++
T Consensus 248 -~~~~~~~~~~~~~~li~~~L~~dP~~R~s~~e~l~H 283 (290)
T 3fpq_A 248 -PASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNH 283 (290)
T ss_dssp -CGGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred -CCCCCccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 011122334578999999999999999999999853
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-47 Score=392.55 Aligned_cols=241 Identities=21% Similarity=0.237 Sum_probs=194.5
Q ss_pred hcCccccceeccCce---------------EEEEEeecChhhHHHHHHHHHHHhhcCCCCccceecccccCccceEEEee
Q 044312 288 TDNFDLNRILGQGGQ---------------AVKKSKVIDESKVEEFINEVVILSQINHRNVVKLLGCCLETEVPLLVYEF 352 (608)
Q Consensus 288 t~~f~~~~~lG~G~~---------------avk~~~~~~~~~~~~~~~Ei~il~~l~H~niv~l~~~~~~~~~~~lV~E~ 352 (608)
.+.|.+.++||+|+| |||+++... .+.+|+.+|++|+|||||++++++.+.+..||||||
T Consensus 57 ~~~~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~-----~~~~E~~il~~l~HpnIV~l~~~~~~~~~~~ivmEy 131 (336)
T 4g3f_A 57 VHWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEV-----FRVEELVACAGLSSPRIVPLYGAVREGPWVNIFMEL 131 (336)
T ss_dssp TTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTT-----CCTHHHHTTTTCCCTTBCCEEEEEEETTEEEEEECC
T ss_pred hhheEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHH-----hHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEec
Confidence 356888899999985 777776421 235799999999999999999999999999999999
Q ss_pred cCCCccchhccccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEEcCCC-cEEEeeccCccccccCC
Q 044312 353 IPNGTLFQYIHDQNEDFPITWEIRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKY-RAKVSDFGASRSMAVDQ 431 (608)
Q Consensus 353 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~-~~kl~DFGls~~~~~~~ 431 (608)
+++|+|.++|++.+ ++++..+..|+.||+.||+|||+++ |+||||||+||||+.++ .+||+|||+|+.+..+.
T Consensus 132 ~~gg~L~~~l~~~~---~l~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~~vKl~DFGla~~~~~~~ 205 (336)
T 4g3f_A 132 LEGGSLGQLIKQMG---CLPEDRALYYLGQALEGLEYLHTRR---ILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDG 205 (336)
T ss_dssp CTTCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHTTT---EECSCCCGGGEEECTTSCCEEECCCTTCEEC----
T ss_pred cCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---ceecccCHHHEEEeCCCCEEEEeeCCCCeEccCCC
Confidence 99999999998654 5999999999999999999999999 99999999999999887 69999999999775432
Q ss_pred cc----eeeeeeccCCCCChhhhccCCCCCccchHhHHHHHHHHHhCCCCCCccchhhcccHHHHHHHHhhhhhhHHHhh
Q 044312 432 TH----MTTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLTELLTGEKPIRFTILEEDKSLAAYFLCAMKEERLFEILD 507 (608)
Q Consensus 432 ~~----~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 507 (608)
.. ......||+.|||||++.+..++.++|||||||+||||+||+.||....... +.. .+..
T Consensus 206 ~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~---~~~------------~i~~ 270 (336)
T 4g3f_A 206 LGKSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGP---LCL------------KIAS 270 (336)
T ss_dssp --------CCCCCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSTTTCCSC---CHH------------HHHH
T ss_pred cccceecCCccccCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHH---HHH------------HHHc
Confidence 21 1233579999999999999999999999999999999999999997432211 111 1111
Q ss_pred hh-hhccCChhHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhhHHhc
Q 044312 508 AR-VMKQGGKDEIITVAKLAKRCLNLNGKKRPTMREVASELAGIKAWN 554 (608)
Q Consensus 508 ~~-~~~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~evl~~L~~i~~~~ 554 (608)
.. ...+.+...+..+.+|+.+||+.||++|||+.||+++|.......
T Consensus 271 ~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~sa~el~~~l~~~l~~~ 318 (336)
T 4g3f_A 271 EPPPIREIPPSCAPLTAQAIQEGLRKEPVHRASAMELRRKVGKALQEV 318 (336)
T ss_dssp SCCGGGGSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHT
T ss_pred CCCCchhcCccCCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHHhhh
Confidence 10 112234456778999999999999999999999999987766543
|
| >4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-46 Score=401.14 Aligned_cols=237 Identities=26% Similarity=0.373 Sum_probs=198.4
Q ss_pred hcCccccceeccCce---------------EEEEEeecChhhHHHHHHHHHHHhhcCCCCccceecccccCccceEEEee
Q 044312 288 TDNFDLNRILGQGGQ---------------AVKKSKVIDESKVEEFINEVVILSQINHRNVVKLLGCCLETEVPLLVYEF 352 (608)
Q Consensus 288 t~~f~~~~~lG~G~~---------------avk~~~~~~~~~~~~~~~Ei~il~~l~H~niv~l~~~~~~~~~~~lV~E~ 352 (608)
.+.|++.++||+|+| |||++........+.+.+|+.+|++++|||||++++++.+.+.+||||||
T Consensus 150 ~~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~iVmEy 229 (423)
T 4fie_A 150 RSYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEF 229 (423)
T ss_dssp GGTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTCSSGGGHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred hHhcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHhCCCCCCCceEEEEEECCEEEEEEeC
Confidence 356999999999984 89988876666778899999999999999999999999999999999999
Q ss_pred cCCCccchhccccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEEcCCCcEEEeeccCccccccCCc
Q 044312 353 IPNGTLFQYIHDQNEDFPITWEIRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQT 432 (608)
Q Consensus 353 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGls~~~~~~~~ 432 (608)
|++|+|.+++... .+++..+..|+.||+.||+|||+++ |+||||||+||||+.++.+||+|||+|+.+.....
T Consensus 230 ~~gG~L~~~i~~~----~l~e~~~~~~~~qil~aL~ylH~~~---IiHRDiKp~NILl~~~g~vKl~DFGla~~~~~~~~ 302 (423)
T 4fie_A 230 LEGGALTDIVTHT----RMNEEQIAAVCLAVLQALSVLHAQG---VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVP 302 (423)
T ss_dssp CTTEEHHHHHHHS----CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSTTTEEECTTCCEEECCCTTCEECCSSCC
T ss_pred CCCCcHHHHHhcc----CCCHHHHHHHHHHHHHHHHHHHHCC---eecccCCHHHEEEcCCCCEEEecCccceECCCCCc
Confidence 9999999998653 4899999999999999999999999 99999999999999999999999999987754332
Q ss_pred ceeeeeeccCCCCChhhhccCCCCCccchHhHHHHHHHHHhCCCCCCccchhhcccHHHHHHHHhhhhhhHHHhhhhhhc
Q 044312 433 HMTTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLTELLTGEKPIRFTILEEDKSLAAYFLCAMKEERLFEILDARVMK 512 (608)
Q Consensus 433 ~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~ 512 (608)
......||+.|||||++.+..|+.++|||||||+||||++|+.||...... ..+ ..+... ..+ ..
T Consensus 303 -~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~------~~~-~~i~~~-----~~~--~~ 367 (423)
T 4fie_A 303 -RRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPL------KAM-KMIRDN-----LPP--RL 367 (423)
T ss_dssp -CBCCCEECTTTCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHH------HHH-HHHHHS-----CCC--CC
T ss_pred -cccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHH------HHH-HHHHcC-----CCC--CC
Confidence 345567999999999999999999999999999999999999999632211 111 111110 000 11
Q ss_pred cCChhHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 044312 513 QGGKDEIITVAKLAKRCLNLNGKKRPTMREVASE 546 (608)
Q Consensus 513 ~~~~~~~~~l~~Li~~cl~~dp~~RPs~~evl~~ 546 (608)
......+.++.+|+.+||+.||++|||+.|++++
T Consensus 368 ~~~~~~s~~~~dli~~~L~~dP~~R~ta~ell~H 401 (423)
T 4fie_A 368 KNLHKVSPSLKGFLDRLLVRDPAQRATAAELLKH 401 (423)
T ss_dssp SCTTSSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred cccccCCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence 2223456789999999999999999999999764
|
| >4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-47 Score=388.62 Aligned_cols=234 Identities=26% Similarity=0.424 Sum_probs=196.8
Q ss_pred cCccccceeccCce---------------EEEEEee---cChhhHHHHHHHHHHHhhcCCCCccceecccccCccceEEE
Q 044312 289 DNFDLNRILGQGGQ---------------AVKKSKV---IDESKVEEFINEVVILSQINHRNVVKLLGCCLETEVPLLVY 350 (608)
Q Consensus 289 ~~f~~~~~lG~G~~---------------avk~~~~---~~~~~~~~~~~Ei~il~~l~H~niv~l~~~~~~~~~~~lV~ 350 (608)
++|++.+.||+|+| |||.+.. .+....+.+.+|+++|++|+|||||++++++.+.+..||||
T Consensus 32 ~dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~yivm 111 (311)
T 4aw0_A 32 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL 111 (311)
T ss_dssp GGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence 56999999999984 7777653 23455678999999999999999999999999999999999
Q ss_pred eecCCCccchhccccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEEcCCCcEEEeeccCccccccC
Q 044312 351 EFIPNGTLFQYIHDQNEDFPITWEIRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVD 430 (608)
Q Consensus 351 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGls~~~~~~ 430 (608)
||+++|+|.+++.+.+ .+++..+..++.||+.||+|||+++ |+||||||+||||+.++.+||+|||+|+.+...
T Consensus 112 Ey~~gG~L~~~i~~~~---~l~e~~~~~~~~qi~~al~ylH~~~---IiHRDlKPeNILl~~~g~vKl~DFGla~~~~~~ 185 (311)
T 4aw0_A 112 SYAKNGELLKYIRKIG---SFDETCTRFYTAEIVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPE 185 (311)
T ss_dssp CCCTTEEHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCEECCTT
T ss_pred ecCCCCCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCCHHHeEEcCCCCEEEEEcCCceecCCC
Confidence 9999999999998654 5999999999999999999999999 999999999999999999999999999987543
Q ss_pred C-cceeeeeeccCCCCChhhhccCCCCCccchHhHHHHHHHHHhCCCCCCccchhhcccHHHHHHHHhhhhhhHHHhhhh
Q 044312 431 Q-THMTTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLTELLTGEKPIRFTILEEDKSLAAYFLCAMKEERLFEILDAR 509 (608)
Q Consensus 431 ~-~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 509 (608)
. ........||+.|||||++.+..++.++||||+||+||||+||+.||..... ...+. .++...
T Consensus 186 ~~~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~------~~~~~---------~i~~~~ 250 (311)
T 4aw0_A 186 SKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNE------GLIFA---------KIIKLE 250 (311)
T ss_dssp TTCCCBCCCCSCGGGCCHHHHHHSCBCHHHHHHHHHHHHHHHHHSSCSSCCSSH------HHHHH---------HHHHTC
T ss_pred CCcccccCcccCcccCCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCH------HHHHH---------HHHcCC
Confidence 3 2334556899999999999999999999999999999999999999973221 11111 111111
Q ss_pred hhccCChhHHHHHHHHHHHHhccCCCCCCCHHHHHH
Q 044312 510 VMKQGGKDEIITVAKLAKRCLNLNGKKRPTMREVAS 545 (608)
Q Consensus 510 ~~~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~evl~ 545 (608)
...+...+.++.+|+.+||+.||++|||++|++.
T Consensus 251 --~~~p~~~s~~~~dli~~lL~~dp~~R~t~~e~~~ 284 (311)
T 4aw0_A 251 --YDFPEKFFPKARDLVEKLLVLDATKRLGCEEMEG 284 (311)
T ss_dssp --CCCCTTCCHHHHHHHHHHSCSSGGGSTTSGGGTC
T ss_pred --CCCCcccCHHHHHHHHHHccCCHhHCcChHHHcC
Confidence 1234455678999999999999999999998754
|
| >3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-47 Score=390.47 Aligned_cols=254 Identities=21% Similarity=0.295 Sum_probs=186.8
Q ss_pred cCccccceeccCce-------------EEEEEeecChhhHHHHH--HHHHHHhhcCCCCccceecccccCc----cceEE
Q 044312 289 DNFDLNRILGQGGQ-------------AVKKSKVIDESKVEEFI--NEVVILSQINHRNVVKLLGCCLETE----VPLLV 349 (608)
Q Consensus 289 ~~f~~~~~lG~G~~-------------avk~~~~~~~~~~~~~~--~Ei~il~~l~H~niv~l~~~~~~~~----~~~lV 349 (608)
+++.+.++||+|+| |||+++.. ..+.+. .|+..+.+++|||||++++++.+.+ ..+||
T Consensus 3 r~i~L~~~iG~G~fG~Vy~~~~~g~~VAvK~l~~~---~~~~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~~~~lV 79 (303)
T 3hmm_A 3 RTIVLQESIGKGRFGEVWRGKWRGEEVAVKIFSSR---EERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLV 79 (303)
T ss_dssp GGEEEEEEEEECSSSEEEEEEETTEEEEEEEECGG---GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEE
T ss_pred cEEEEEEEEeeCCCeEEEEEEECCEEEEEEEECcc---chhhHHHHHHHHHHhcCCCCCCCcEEEEEEecCCCceEEEEE
Confidence 35777899999985 78876532 333344 4566667889999999999997654 57999
Q ss_pred EeecCCCccchhccccCCCCCCCHHHHHHHHHHHHHHHHHHhhcC-----CCCeeccCCCCCcEEEcCCCcEEEeeccCc
Q 044312 350 YEFIPNGTLFQYIHDQNEDFPITWEIRLRIAIEVSGALSYLHSAA-----SIPIYHRDIKSTNILLDDKYRAKVSDFGAS 424 (608)
Q Consensus 350 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~-----~~~iiHrDlk~~NILl~~~~~~kl~DFGls 424 (608)
|||+++|+|.++++.. +++|..+++|+.|+|+||+|||++. .++|+||||||+||||++++.+||+|||+|
T Consensus 80 ~Ey~~~gsL~~~l~~~----~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki~DFGla 155 (303)
T 3hmm_A 80 SDYHEHGSLFDYLNRY----TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLA 155 (303)
T ss_dssp EECCTTCBHHHHHHHC----CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCTTC
T ss_pred ecCCCCCcHHHHHHhC----CCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCEEEEeCCCC
Confidence 9999999999999754 4899999999999999999999871 234999999999999999999999999999
Q ss_pred cccccCCcc---eeeeeeccCCCCChhhhccC------CCCCccchHhHHHHHHHHHhCCCCCCccchhhc--------c
Q 044312 425 RSMAVDQTH---MTTQVHGTFGYLDPEYFRSS------QFTDKSDVYSFGVVLTELLTGEKPIRFTILEED--------K 487 (608)
Q Consensus 425 ~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~------~~t~ksDV~S~Gvvl~elltg~~p~~~~~~~~~--------~ 487 (608)
+........ ......||+.|||||++.+. .++.|+|||||||+||||+||.+|+........ .
T Consensus 156 ~~~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~~~p~~~~~~~~ 235 (303)
T 3hmm_A 156 VRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSD 235 (303)
T ss_dssp EEEETTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSS
T ss_pred ccccCCCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCccccccccchhccccc
Confidence 876543322 12345799999999999764 367899999999999999999887643221110 0
Q ss_pred cHHHHHHHHhhhhhhHHHhhhhhhc-cCChhHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhhHHh
Q 044312 488 SLAAYFLCAMKEERLFEILDARVMK-QGGKDEIITVAKLAKRCLNLNGKKRPTMREVASELAGIKAW 553 (608)
Q Consensus 488 ~l~~~~~~~~~~~~~~~~~d~~~~~-~~~~~~~~~l~~Li~~cl~~dp~~RPs~~evl~~L~~i~~~ 553 (608)
............. .+++.+.. ....+.+..+.+|+.+||+.||++||||.||+++|+.+...
T Consensus 236 ~~~~~~~~~~~~~----~~rp~~p~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~~l~~~ 298 (303)
T 3hmm_A 236 PSVEEMRKVVCEQ----KLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQ 298 (303)
T ss_dssp CCHHHHHHHHTTS----CCCCCCCGGGGSSHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred chHHHHHHHHhcc----cCCCCCCccccchHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHHH
Confidence 0001111111111 11111111 11234667899999999999999999999999999988753
|
| >3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-46 Score=374.31 Aligned_cols=232 Identities=25% Similarity=0.388 Sum_probs=180.1
Q ss_pred cCccccceeccCce---------------EEEEEee---cChhhHHHHHHHHHHHhhcCCCCccceecccccCccceEEE
Q 044312 289 DNFDLNRILGQGGQ---------------AVKKSKV---IDESKVEEFINEVVILSQINHRNVVKLLGCCLETEVPLLVY 350 (608)
Q Consensus 289 ~~f~~~~~lG~G~~---------------avk~~~~---~~~~~~~~~~~Ei~il~~l~H~niv~l~~~~~~~~~~~lV~ 350 (608)
++|++.+.||+|+| |||.+.. .+....+.+.+|+.+|++++|||||++++++.+.+..+|||
T Consensus 13 g~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivm 92 (275)
T 3hyh_A 13 GNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSKDEIIMVI 92 (275)
T ss_dssp -CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred eCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEE
Confidence 57999999999984 8887753 23345678999999999999999999999999999999999
Q ss_pred eecCCCccchhccccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEEcCCCcEEEeeccCccccccC
Q 044312 351 EFIPNGTLFQYIHDQNEDFPITWEIRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVD 430 (608)
Q Consensus 351 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGls~~~~~~ 430 (608)
||+ +|+|.+++.+.. ++++..+..++.||+.||+|||+++ |+||||||+|||+++++.+||+|||+|+.....
T Consensus 93 Ey~-~g~L~~~l~~~~---~l~e~~~~~~~~qi~~al~ylH~~~---IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~ 165 (275)
T 3hyh_A 93 EYA-GNELFDYIVQRD---KMSEQEARRFFQQIISAVEYCHRHK---IVHRDLKPENLLLDEHLNVKIADFGLSNIMTDG 165 (275)
T ss_dssp ECC-CEEHHHHHHHSC---SCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCTTTEEECTTCCEEECCSSCC------
T ss_pred eCC-CCCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---cccccCChHHeEECCCCCEEEeecCCCeecCCC
Confidence 999 689999997653 5999999999999999999999999 999999999999999999999999999876432
Q ss_pred CcceeeeeeccCCCCChhhhccCCC-CCccchHhHHHHHHHHHhCCCCCCccchhhcccHHHHHHHHhhhhhhHHHhhhh
Q 044312 431 QTHMTTQVHGTFGYLDPEYFRSSQF-TDKSDVYSFGVVLTELLTGEKPIRFTILEEDKSLAAYFLCAMKEERLFEILDAR 509 (608)
Q Consensus 431 ~~~~~~~~~gt~~y~aPE~~~~~~~-t~ksDV~S~Gvvl~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 509 (608)
. ......||+.|||||++.+..+ +.++||||+||++|||+||+.||..... ...+. . +...
T Consensus 166 ~--~~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~~~------~~~~~-~--------i~~~- 227 (275)
T 3hyh_A 166 N--FLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDESI------PVLFK-N--------ISNG- 227 (275)
T ss_dssp -----------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSH------HHHHH-H--------HHHT-
T ss_pred C--ccCCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCCCH------HHHHH-H--------HHcC-
Confidence 2 2345679999999999998876 5799999999999999999999963221 11111 1 1111
Q ss_pred hhccCChhHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 044312 510 VMKQGGKDEIITVAKLAKRCLNLNGKKRPTMREVASE 546 (608)
Q Consensus 510 ~~~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~evl~~ 546 (608)
....+...+.++.+|+.+||+.||++|||++|++++
T Consensus 228 -~~~~p~~~s~~~~~li~~~L~~dP~~R~s~~eil~h 263 (275)
T 3hyh_A 228 -VYTLPKFLSPGAAGLIKRMLIVNPLNRISIHEIMQD 263 (275)
T ss_dssp -CCCCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHC
T ss_pred -CCCCCCCCCHHHHHHHHHHccCChhHCcCHHHHHcC
Confidence 112334556789999999999999999999999875
|
| >3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-46 Score=381.94 Aligned_cols=228 Identities=29% Similarity=0.326 Sum_probs=181.3
Q ss_pred cCccccceeccCce------------------EEEEEee--cChhhHHHHHHHHHHHhhcCCCCccceecccccCccceE
Q 044312 289 DNFDLNRILGQGGQ------------------AVKKSKV--IDESKVEEFINEVVILSQINHRNVVKLLGCCLETEVPLL 348 (608)
Q Consensus 289 ~~f~~~~~lG~G~~------------------avk~~~~--~~~~~~~~~~~Ei~il~~l~H~niv~l~~~~~~~~~~~l 348 (608)
++|++.+.||+|+| |||.++. ........+.+|+.+|++++|||||++++++.+.+..||
T Consensus 24 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~i 103 (304)
T 3ubd_A 24 SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQTEGKLYL 103 (304)
T ss_dssp GGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEECC------CCCCCCCCTTEECEEEEEEETTEEEE
T ss_pred cccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEE
Confidence 46999999999984 6666542 122334578899999999999999999999999999999
Q ss_pred EEeecCCCccchhccccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEEcCCCcEEEeeccCccccc
Q 044312 349 VYEFIPNGTLFQYIHDQNEDFPITWEIRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMA 428 (608)
Q Consensus 349 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGls~~~~ 428 (608)
||||+++|+|.+++.+.. .+++..+..++.||+.||+|||+++ |+||||||+|||+++++.+||+|||+|+...
T Consensus 104 vmEy~~gg~L~~~l~~~~---~l~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~vKl~DFGla~~~~ 177 (304)
T 3ubd_A 104 ILDFLRGGDLFTRLSKEV---MFTEEDVKFYLAELALALDHLHSLG---IIYRDLKPENILLDEEGHIKLTDFGLSKESI 177 (304)
T ss_dssp EECCCTTCEEHHHHHHHC---CCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCCGGGEEECTTSCEEEESSEEEEC--
T ss_pred EEEcCCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCCCHHHeEEcCCCCEEecccccceecc
Confidence 999999999999998754 5999999999999999999999999 9999999999999999999999999998654
Q ss_pred cCCcceeeeeeccCCCCChhhhccCCCCCccchHhHHHHHHHHHhCCCCCCccchhhcccHHHHHHHHhhhhhhHHHhhh
Q 044312 429 VDQTHMTTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLTELLTGEKPIRFTILEEDKSLAAYFLCAMKEERLFEILDA 508 (608)
Q Consensus 429 ~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 508 (608)
... .......||+.|||||++.+..++.++|||||||+||||+||+.||...... ..+. .+...
T Consensus 178 ~~~-~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~------~~~~---------~i~~~ 241 (304)
T 3ubd_A 178 DHE-KKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRK------ETMT---------MILKA 241 (304)
T ss_dssp ----CCCCSCCCCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH------HHHH---------HHHHC
T ss_pred CCC-ccccccccCcccCCHHHhccCCCCCCCcccchHHHHHHHHhCCCCCCCcCHH------HHHH---------HHHcC
Confidence 332 2234567999999999999999999999999999999999999999743221 1111 11111
Q ss_pred hhhccCChhHHHHHHHHHHHHhccCCCCCCCH
Q 044312 509 RVMKQGGKDEIITVAKLAKRCLNLNGKKRPTM 540 (608)
Q Consensus 509 ~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPs~ 540 (608)
....+...+.++.+|+.+||+.||++|||+
T Consensus 242 --~~~~p~~~s~~~~~li~~~L~~dP~~R~ta 271 (304)
T 3ubd_A 242 --KLGMPQFLSPEAQSLLRMLFKRNPANRLGA 271 (304)
T ss_dssp --CCCCCTTSCHHHHHHHHHHTCSSGGGSTTC
T ss_pred --CCCCCCcCCHHHHHHHHHHcccCHHHCCCC
Confidence 112344567789999999999999999995
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-45 Score=373.38 Aligned_cols=236 Identities=23% Similarity=0.391 Sum_probs=178.2
Q ss_pred cCccccceeccCce---------------EEEEEeecC-hhhHHHHHHHHHHHhhcCCCCccceecccccCc--------
Q 044312 289 DNFDLNRILGQGGQ---------------AVKKSKVID-ESKVEEFINEVVILSQINHRNVVKLLGCCLETE-------- 344 (608)
Q Consensus 289 ~~f~~~~~lG~G~~---------------avk~~~~~~-~~~~~~~~~Ei~il~~l~H~niv~l~~~~~~~~-------- 344 (608)
++|++.+.||+|+| |||+++... +...+.+.+|+.+|++|+|||||++++++.+.+
T Consensus 5 ~dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~~ 84 (299)
T 4g31_A 5 TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQPS 84 (299)
T ss_dssp HHEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECSSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC--------
T ss_pred hhCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCcccccccc
Confidence 35889999999985 888876543 344578999999999999999999999987544
Q ss_pred ----cceEEEeecCCCccchhccccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEEcCCCcEEEee
Q 044312 345 ----VPLLVYEFIPNGTLFQYIHDQNEDFPITWEIRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSD 420 (608)
Q Consensus 345 ----~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~D 420 (608)
..||||||+++|+|.+++..........+..++.|+.||+.||+|||+++ |+||||||+||||+.++.+||+|
T Consensus 85 ~~~~~l~ivmE~~~gg~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~ylH~~~---IiHRDlKp~NILl~~~~~vKl~D 161 (299)
T 4g31_A 85 SPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSKG---LMHRDLKPSNIFFTMDDVVKVGD 161 (299)
T ss_dssp --CEEEEEEEECCCSCCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECC
T ss_pred CCCcEEEEEEecCCCCcHHHHHHhcCCCChhHHHHHHHHHHHHHHHHHHHHHCc---CccccCcHHHeEECCCCcEEEcc
Confidence 36899999999999999987554334677888999999999999999999 99999999999999999999999
Q ss_pred ccCccccccCCcc-----------eeeeeeccCCCCChhhhccCCCCCccchHhHHHHHHHHHhCCCCCCccchhhcccH
Q 044312 421 FGASRSMAVDQTH-----------MTTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLTELLTGEKPIRFTILEEDKSL 489 (608)
Q Consensus 421 FGls~~~~~~~~~-----------~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~elltg~~p~~~~~~~~~~~l 489 (608)
||+|+.+..+... ..+...||+.|||||++.+..++.++|||||||+||||++ ||.... ..
T Consensus 162 FGla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyell~---Pf~~~~-----~~ 233 (299)
T 4g31_A 162 FGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---PFSTQM-----ER 233 (299)
T ss_dssp CCCC--------------------------CCCTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHS---CCSSHH-----HH
T ss_pred CccceecCCCccccccccccccccccCCcccCccccCHHHHcCCCCCCHHHHHHHHHHHHHHcc---CCCCcc-----HH
Confidence 9999877543221 1234579999999999999999999999999999999996 764211 00
Q ss_pred HHHHHHHhhhhhhHHHhhhhhhccCChhHHHHHHHHHHHHhccCCCCCCCHHHHHH
Q 044312 490 AAYFLCAMKEERLFEILDARVMKQGGKDEIITVAKLAKRCLNLNGKKRPTMREVAS 545 (608)
Q Consensus 490 ~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~evl~ 545 (608)
.. ............. .......+.+|+.+||+.||++|||+.|+++
T Consensus 234 ~~-~~~~~~~~~~p~~---------~~~~~~~~~~li~~~L~~dP~~Rps~~eil~ 279 (299)
T 4g31_A 234 VR-TLTDVRNLKFPPL---------FTQKYPCEYVMVQDMLSPSPMERPEAINIIE 279 (299)
T ss_dssp HH-HHHHHHTTCCCHH---------HHHHCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred HH-HHHHHhcCCCCCC---------CcccCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 00 0111111111100 1122345778999999999999999999975
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-42 Score=360.13 Aligned_cols=273 Identities=36% Similarity=0.589 Sum_probs=229.9
Q ss_pred cCCHHHHHHHhcCccccceeccCce--------------EEEEEeecChhhHHHHHHHHHHHhhcCCCCccceecccccC
Q 044312 278 LFTSKELEKATDNFDLNRILGQGGQ--------------AVKKSKVIDESKVEEFINEVVILSQINHRNVVKLLGCCLET 343 (608)
Q Consensus 278 ~~~~~~l~~~t~~f~~~~~lG~G~~--------------avk~~~~~~~~~~~~~~~Ei~il~~l~H~niv~l~~~~~~~ 343 (608)
.++..++..++++|++.+.||+|++ |||+.........+.+.+|+.++++++||||+++++++.+.
T Consensus 28 ~~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 107 (321)
T 2qkw_B 28 RVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDER 107 (321)
T ss_dssp --CCSCCCCCCCCCSCCCCSCBCSSSEEEEEECTTCCEEEEEECCSCCSSHHHHHHHHHHGGGSCCCTTBCCEEEECCCT
T ss_pred eecHHHHHHHHhccCccceeecCCCeeEEEEEECCCCEEEEEEecccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCC
Confidence 4555667778999999999999984 67766665666778999999999999999999999999999
Q ss_pred ccceEEEeecCCCccchhccccCC-CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEEcCCCcEEEeecc
Q 044312 344 EVPLLVYEFIPNGTLFQYIHDQNE-DFPITWEIRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFG 422 (608)
Q Consensus 344 ~~~~lV~E~~~~gsL~~~l~~~~~-~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFG 422 (608)
+..++||||+++|+|.+++..... ...+++..++.++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||
T Consensus 108 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg 184 (321)
T 2qkw_B 108 NEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTRA---IIHRDVKSINILLDENFVPKITDFG 184 (321)
T ss_dssp TCCEEEEECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCSTTEEECTTCCEEECCCT
T ss_pred CeEEEEEEcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcCCC---eecCCCCHHHEEECCCCCEEEeecc
Confidence 999999999999999999976432 235899999999999999999999999 9999999999999999999999999
Q ss_pred CccccccC-CcceeeeeeccCCCCChhhhccCCCCCccchHhHHHHHHHHHhCCCCCCccchhhcccHHHHHHHHhhhhh
Q 044312 423 ASRSMAVD-QTHMTTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLTELLTGEKPIRFTILEEDKSLAAYFLCAMKEER 501 (608)
Q Consensus 423 ls~~~~~~-~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~ 501 (608)
+++..... .........||+.|+|||.+.+..++.++||||||++++||++|+.||......+......+.........
T Consensus 185 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 264 (321)
T 2qkw_B 185 ISKKGTELDQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHNNGQ 264 (321)
T ss_dssp TCEECSSSSCCCCBCCCEEETTTCCHHHHHHCBCCTHHHHHHHHHHHHHHHHCCTTCSCSSSSSCCCHHHHTHHHHTTTC
T ss_pred cccccccccccccccccCCCccccCHHHhcCCCCCcccchHhHHHHHHHHHhCCCcccccCcHHHHHHHHHhhhcccccc
Confidence 99865432 22223445689999999999999999999999999999999999999986655555555555555555555
Q ss_pred hHHHhhhhhhccCChhHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhhHHh
Q 044312 502 LFEILDARVMKQGGKDEIITVAKLAKRCLNLNGKKRPTMREVASELAGIKAW 553 (608)
Q Consensus 502 ~~~~~d~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~evl~~L~~i~~~ 553 (608)
+.+++++........+.+..+.+++.+||+.||++|||+.||+++|+.+...
T Consensus 265 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~l~~ 316 (321)
T 2qkw_B 265 LEQIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLEYALRL 316 (321)
T ss_dssp CCSSSSSSCTTCSCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHS
T ss_pred HHHhcChhhccccCHHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHhhc
Confidence 5566666666666778889999999999999999999999999999988764
|
| >4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-42 Score=368.09 Aligned_cols=248 Identities=21% Similarity=0.337 Sum_probs=188.2
Q ss_pred hcCccccceeccCce---------------EEEEEeec--ChhhHHHHHHHHHHHhhcCCCCccceeccccc------Cc
Q 044312 288 TDNFDLNRILGQGGQ---------------AVKKSKVI--DESKVEEFINEVVILSQINHRNVVKLLGCCLE------TE 344 (608)
Q Consensus 288 t~~f~~~~~lG~G~~---------------avk~~~~~--~~~~~~~~~~Ei~il~~l~H~niv~l~~~~~~------~~ 344 (608)
.++|++.+.||+|+| |||+++.. .....+.+.+|+++|++|+|||||++++++.. ..
T Consensus 53 ~~~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~ 132 (398)
T 4b99_A 53 GDEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEFK 132 (398)
T ss_dssp CSSEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTTCC
T ss_pred CCCeEEEEEEecccCeEEEEEEECCCCCEEEEEEECccccchHHHHHHHHHHHHHHhcCCCCcceEeeeeecccccccCC
Confidence 357999999999984 88887542 33456789999999999999999999998753 35
Q ss_pred cceEEEeecCCCccchhccccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEEcCCCcEEEeeccCc
Q 044312 345 VPLLVYEFIPNGTLFQYIHDQNEDFPITWEIRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGAS 424 (608)
Q Consensus 345 ~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGls 424 (608)
..||||||++ |+|.+++.... ++++..+..|+.||+.||+|||+++ |+||||||+|||++.++.+||+|||+|
T Consensus 133 ~~~ivmE~~~-g~L~~~i~~~~---~l~~~~~~~~~~qil~al~ylH~~~---iiHRDlKP~NIl~~~~~~~Ki~DFGla 205 (398)
T 4b99_A 133 SVYVVLDLME-SDLHQIIHSSQ---PLTLEHVRYFLYQLLRGLKYMHSAQ---VIHRDLKPSNLLVNENCELKIGDFGMA 205 (398)
T ss_dssp CEEEEEECCS-EEHHHHHTSSS---CCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTCCEEECCCTTC
T ss_pred EEEEEEeCCC-CCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCc---CcCCCcCccccccCCCCCEEEeeccee
Confidence 7899999995 78999997643 5999999999999999999999999 999999999999999999999999999
Q ss_pred cccccCC---cceeeeeeccCCCCChhhhccC-CCCCccchHhHHHHHHHHHhCCCCCCccchhhcccHHHHHHHHhhh-
Q 044312 425 RSMAVDQ---THMTTQVHGTFGYLDPEYFRSS-QFTDKSDVYSFGVVLTELLTGEKPIRFTILEEDKSLAAYFLCAMKE- 499 (608)
Q Consensus 425 ~~~~~~~---~~~~~~~~gt~~y~aPE~~~~~-~~t~ksDV~S~Gvvl~elltg~~p~~~~~~~~~~~l~~~~~~~~~~- 499 (608)
+.+.... ........||+.|||||++.+. .++.++||||+||+++||++|+.||......+. ...+......
T Consensus 206 ~~~~~~~~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~~~~~~---l~~I~~~~g~p 282 (398)
T 4b99_A 206 RGLCTSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVHQ---LQLIMMVLGTP 282 (398)
T ss_dssp BCC-------CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHH---HHHHHHHHCCC
T ss_pred eecccCccccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCCCHHHH---HHHHHHhcCCC
Confidence 8764321 2233456899999999998875 569999999999999999999999974332211 1111111000
Q ss_pred --h--------hhHHHhhhhhhccC-------ChhHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 044312 500 --E--------RLFEILDARVMKQG-------GKDEIITVAKLAKRCLNLNGKKRPTMREVASE 546 (608)
Q Consensus 500 --~--------~~~~~~d~~~~~~~-------~~~~~~~l~~Li~~cl~~dp~~RPs~~evl~~ 546 (608)
. .....+.. ..... ....+.++.+|+.+||..||++|||+.|++++
T Consensus 283 ~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~H 345 (398)
T 4b99_A 283 SPAVIQAVGAERVRAYIQS-LPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAAAALRH 345 (398)
T ss_dssp CGGGTC-----CHHHHHHS-SCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSTTTSCCHHHHTTS
T ss_pred ChHHhhhhhhhhhhhhhhc-CCCcCCCCHHHhCCCCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence 0 00000000 00000 01235678999999999999999999999865
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-42 Score=357.25 Aligned_cols=278 Identities=35% Similarity=0.608 Sum_probs=229.7
Q ss_pred cccccCCHHHHHHHhcCccccceeccCce--------------EEEEEeecCh-hhHHHHHHHHHHHhhcCCCCccceec
Q 044312 274 EKTKLFTSKELEKATDNFDLNRILGQGGQ--------------AVKKSKVIDE-SKVEEFINEVVILSQINHRNVVKLLG 338 (608)
Q Consensus 274 ~~~~~~~~~~l~~~t~~f~~~~~lG~G~~--------------avk~~~~~~~-~~~~~~~~Ei~il~~l~H~niv~l~~ 338 (608)
...+.|+..++..++++|++.+.||+|++ |||+...... .....|.+|+.++++++||||+++++
T Consensus 15 ~~~~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~ 94 (326)
T 3uim_A 15 GQLKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRG 94 (326)
T ss_dssp CCCEECCTHHHHTTTTSSCSTTEEECCSSSEEEEECCSSSCCEEEEECCC-----CCCHHHHHHHGGGTCCCTTBCCCCE
T ss_pred CccceecHHHHHHHhhccccceeEecCCCcEEEEEEecCCCEEEEEEeccccCchHHHHHHHHHHHHHhccCCCccceEE
Confidence 34567899999999999999999999984 6676654221 22336899999999999999999999
Q ss_pred ccccCccceEEEeecCCCccchhccccCC-CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEEcCCCcEE
Q 044312 339 CCLETEVPLLVYEFIPNGTLFQYIHDQNE-DFPITWEIRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAK 417 (608)
Q Consensus 339 ~~~~~~~~~lV~E~~~~gsL~~~l~~~~~-~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~k 417 (608)
++.+....++||||+++|+|.+++..... ..++++..+..|+.|++.||+|||+.....|+||||||+|||++.++.+|
T Consensus 95 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~~~~~~~k 174 (326)
T 3uim_A 95 FCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAV 174 (326)
T ss_dssp EECCSSCCEEEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEECTTCCEE
T ss_pred EEecCCceEEEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEECCCCCEE
Confidence 99999999999999999999999986442 33599999999999999999999999212299999999999999999999
Q ss_pred EeeccCccccccCCcceeeeeeccCCCCChhhhccCCCCCccchHhHHHHHHHHHhCCCCCCccch--hhcccHHHHHHH
Q 044312 418 VSDFGASRSMAVDQTHMTTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLTELLTGEKPIRFTIL--EEDKSLAAYFLC 495 (608)
Q Consensus 418 l~DFGls~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~elltg~~p~~~~~~--~~~~~l~~~~~~ 495 (608)
|+|||+++..............||+.|+|||++.+..++.++||||||++++||++|+.||..... ........+...
T Consensus 175 l~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~ 254 (326)
T 3uim_A 175 VGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKG 254 (326)
T ss_dssp ECCCSSCEECCSSSSCEECCCCSCGGGCCHHHHHHSEECHHHHHHHHHHHHHHHHHCCCSBCHHHHTTTSCSBHHHHHTT
T ss_pred eccCccccccCcccccccccccCCcCccCHHHhccCCCCccccchhHHHHHHHHHhCCCcccccccccccchhHHHHHHH
Confidence 999999988765555555666799999999999999999999999999999999999999963221 122334444444
Q ss_pred HhhhhhhHHHhhhhhhccCChhHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhhH
Q 044312 496 AMKEERLFEILDARVMKQGGKDEIITVAKLAKRCLNLNGKKRPTMREVASELAGIK 551 (608)
Q Consensus 496 ~~~~~~~~~~~d~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~evl~~L~~i~ 551 (608)
......+..+.+...........+..+.+|+.+||+.||++|||+.||+++|++..
T Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~~~ 310 (326)
T 3uim_A 255 LLKEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEGDG 310 (326)
T ss_dssp TTSSCCSTTSSCTTCTTSCCHHHHHHHHHHHHHHTCSCGGGSCCHHHHHHHHHTSS
T ss_pred HhhchhhhhhcChhhccccCHHHHHHHHHHHHHHhCcCCccCCCHHHHHHHhcCcc
Confidence 44555556666666666777888899999999999999999999999999998743
|
| >4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-41 Score=357.28 Aligned_cols=248 Identities=20% Similarity=0.310 Sum_probs=185.3
Q ss_pred HHhcCccccceeccCce------------------EEEEEeecChhhHHHHHHHHHHHhhc-CCCCccceecccccCccc
Q 044312 286 KATDNFDLNRILGQGGQ------------------AVKKSKVIDESKVEEFINEVVILSQI-NHRNVVKLLGCCLETEVP 346 (608)
Q Consensus 286 ~~t~~f~~~~~lG~G~~------------------avk~~~~~~~~~~~~~~~Ei~il~~l-~H~niv~l~~~~~~~~~~ 346 (608)
...++|++.++||+|+| |||++ ........+.+|+++|+.+ +|||||++++++.+.+..
T Consensus 18 ~l~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i--~~~~~~~~~~~E~~~l~~~~~h~nIv~l~~~~~~~~~~ 95 (361)
T 4f9c_A 18 QLSNVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHL--IPTSHPIRIAAELQCLTVAGGQDNVMGVKYCFRKNDHV 95 (361)
T ss_dssp GGGGTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEE--CTTSCHHHHHHHHHHHHHTCSBTTBCCCSEEEEETTEE
T ss_pred CccCcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEE--ccccCHHHHHHHHHHHHHhcCCCCCceEEEEEEECCEE
Confidence 45678999999999986 33333 2334556789999999998 799999999999999999
Q ss_pred eEEEeecCCCccchhccccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEEcCC-CcEEEeeccCcc
Q 044312 347 LLVYEFIPNGTLFQYIHDQNEDFPITWEIRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDK-YRAKVSDFGASR 425 (608)
Q Consensus 347 ~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~-~~~kl~DFGls~ 425 (608)
+|||||+++|+|.+++. .+++..+..++.||+.||+|||+++ |+||||||+|||++.+ +.+||+|||+|+
T Consensus 96 ~lvmE~~~g~~L~~~~~------~l~~~~~~~~~~qll~al~ylH~~g---IiHRDiKPeNiLl~~~~~~~kl~DFGla~ 166 (361)
T 4f9c_A 96 VIAMPYLEHESFLDILN------SLSFQEVREYMLNLFKALKRIHQFG---IVHRDVKPSNFLYNRRLKKYALVDFGLAQ 166 (361)
T ss_dssp EEEEECCCCCCHHHHHT------TCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEETTTTEEEECCCTTCE
T ss_pred EEEEeCCCcccHHHHHc------CCCHHHHHHHHHHHHHHHHHHHHCC---eEeCcCCHHHeEEeCCCCeEEECcCCCCc
Confidence 99999999999999883 3899999999999999999999999 9999999999999876 799999999998
Q ss_pred ccccCCc---------------------------ceeeeeeccCCCCChhhhccC-CCCCccchHhHHHHHHHHHhCCCC
Q 044312 426 SMAVDQT---------------------------HMTTQVHGTFGYLDPEYFRSS-QFTDKSDVYSFGVVLTELLTGEKP 477 (608)
Q Consensus 426 ~~~~~~~---------------------------~~~~~~~gt~~y~aPE~~~~~-~~t~ksDV~S~Gvvl~elltg~~p 477 (608)
....... ...+...||+.|||||++.+. .++.++||||+||+++||++|+.|
T Consensus 167 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~ell~G~~P 246 (361)
T 4f9c_A 167 GTHDTKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLSGRYP 246 (361)
T ss_dssp ECTTCSCGGGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTCSS
T ss_pred ccCCccccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHHHHHHCCCC
Confidence 6542211 112345699999999999875 589999999999999999999999
Q ss_pred CCccchhhcccHHHHHHHHhhhh----------------------hhHHHhh---------h---------hhhccCChh
Q 044312 478 IRFTILEEDKSLAAYFLCAMKEE----------------------RLFEILD---------A---------RVMKQGGKD 517 (608)
Q Consensus 478 ~~~~~~~~~~~l~~~~~~~~~~~----------------------~~~~~~d---------~---------~~~~~~~~~ 517 (608)
|.....+. ..+...+ ...... ....... + ....+....
T Consensus 247 f~~~~~~~-~~l~~I~-~~~G~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~ 324 (361)
T 4f9c_A 247 FYKASDDL-TALAQIM-TIRGSRETIQAAKTFGKSILCSKEVPAQDLRKLCERLRGMDSSTPKLTSDIQGHATNLEGWNE 324 (361)
T ss_dssp SSCCSSHH-HHHHHHH-HHHCHHHHHHHHHHTTEEEEESSCCCCCCHHHHHHHHC----------------------CTT
T ss_pred CCCCCCHH-HHHHHHH-HhcCCccchhhhhhccccccccccCcchhhhHHHHhhcccccccccccccccccccccccccc
Confidence 96432211 1111111 000000 0000000 0 000011123
Q ss_pred HHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 044312 518 EIITVAKLAKRCLNLNGKKRPTMREVASE 546 (608)
Q Consensus 518 ~~~~l~~Li~~cl~~dp~~RPs~~evl~~ 546 (608)
.+.++.+|+.+||+.||++|||++|++++
T Consensus 325 is~~a~DLl~~lL~~dP~~R~ta~eaL~H 353 (361)
T 4f9c_A 325 VPDEAYDLLDKLLDLNPASRITAEEALLH 353 (361)
T ss_dssp CCHHHHHHHHHHTCSCTTTSCCHHHHHTS
T ss_pred CCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence 45678999999999999999999999854
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-41 Score=347.13 Aligned_cols=264 Identities=25% Similarity=0.410 Sum_probs=209.4
Q ss_pred cCccccceeccCce---------------EEEEEeecChhhHHHHHHHHHHHhhcCCCCccceecccccCccceEEEeec
Q 044312 289 DNFDLNRILGQGGQ---------------AVKKSKVIDESKVEEFINEVVILSQINHRNVVKLLGCCLETEVPLLVYEFI 353 (608)
Q Consensus 289 ~~f~~~~~lG~G~~---------------avk~~~~~~~~~~~~~~~Ei~il~~l~H~niv~l~~~~~~~~~~~lV~E~~ 353 (608)
++|.+.++||+|++ |+|+....+....+.|.+|+.++++++||||+++++++.+....++||||+
T Consensus 10 ~~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~ 89 (310)
T 3s95_A 10 SDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRLNFITEYI 89 (310)
T ss_dssp GGEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESCCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred hHeeccceecCCCCEEEEEEEECCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCcCcccEEEEEecCCeeEEEEEec
Confidence 46888999999984 677666666777889999999999999999999999999999999999999
Q ss_pred CCCccchhccccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEEcCCCcEEEeeccCccccccCCcc
Q 044312 354 PNGTLFQYIHDQNEDFPITWEIRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTH 433 (608)
Q Consensus 354 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGls~~~~~~~~~ 433 (608)
++++|.+++..... .+++..++.++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++........
T Consensus 90 ~~~~L~~~l~~~~~--~~~~~~~~~i~~qi~~al~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~ 164 (310)
T 3s95_A 90 KGGTLRGIIKSMDS--QYPWSQRVSFAKDIASGMAYLHSMN---IIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQ 164 (310)
T ss_dssp TTCBHHHHHHHCCT--TSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSTTSEEECTTSCEEECCCTTCEECC-----
T ss_pred CCCcHHHHHHhccC--CCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCCcCeEEECCCCCEEEeecccceeccccccc
Confidence 99999999987433 5899999999999999999999999 999999999999999999999999999876533221
Q ss_pred e-------------eeeeeccCCCCChhhhccCCCCCccchHhHHHHHHHHHhCCCCCCccchhhcccHHHHHHHHhhhh
Q 044312 434 M-------------TTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLTELLTGEKPIRFTILEEDKSLAAYFLCAMKEE 500 (608)
Q Consensus 434 ~-------------~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~ 500 (608)
. .....||+.|+|||++.+..++.++||||||++++||++|..|+.......... ..
T Consensus 165 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~~~~~~~~~~~~~----------~~ 234 (310)
T 3s95_A 165 PEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDF----------GL 234 (310)
T ss_dssp ---------------CCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHTCCSSTTTSCBCTTS----------SB
T ss_pred ccccccccccccccccccCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHhcCCCCCcchhhhHHHH----------hh
Confidence 1 114568999999999999999999999999999999999999986432221100 00
Q ss_pred hhHHHhhhhhhccCChhHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhhHHhcCCCchhhcchhhhhccc
Q 044312 501 RLFEILDARVMKQGGKDEIITVAKLAKRCLNLNGKKRPTMREVASELAGIKAWNGASNVIEEGLEEIDCAL 571 (608)
Q Consensus 501 ~~~~~~d~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~evl~~L~~i~~~~~~~~~~~~~l~e~~~~~ 571 (608)
.....++ ...+...+..+.+|+.+||+.||++|||+.|+++.|+.++............+++.+...
T Consensus 235 ~~~~~~~----~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~l~~~L~~l~~~~~~~~~~~~~~~~~~~~~ 301 (310)
T 3s95_A 235 NVRGFLD----RYCPPNCPPSFFPITVRCCDLDPEKRPSFVKLEHWLETLRMHLAGHLPLGPQLEQLDRGF 301 (310)
T ss_dssp CHHHHHH----HTCCTTCCTTHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHHHCCCCHHHHHHHHHHH
T ss_pred hhhcccc----ccCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhccCcccCCcchhhccchH
Confidence 0111111 122334556799999999999999999999999999999876543333334444444333
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-41 Score=376.11 Aligned_cols=239 Identities=22% Similarity=0.304 Sum_probs=197.4
Q ss_pred hcCccccceeccCce---------------EEEEEeecChhhHHHHHHHHHHHhhcCCCCccceecccccCccceEEEee
Q 044312 288 TDNFDLNRILGQGGQ---------------AVKKSKVIDESKVEEFINEVVILSQINHRNVVKLLGCCLETEVPLLVYEF 352 (608)
Q Consensus 288 t~~f~~~~~lG~G~~---------------avk~~~~~~~~~~~~~~~Ei~il~~l~H~niv~l~~~~~~~~~~~lV~E~ 352 (608)
.++|++.+.||+|+| |+|.+........+.+.+|+.+|++|+|||||++++++.+....+|||||
T Consensus 156 l~~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iv~E~ 235 (573)
T 3uto_A 156 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEF 235 (573)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred ccccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEeccchhhHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEee
Confidence 368999999999974 78887776667778899999999999999999999999999999999999
Q ss_pred cCCCccchhccccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEEcCC--CcEEEeeccCccccccC
Q 044312 353 IPNGTLFQYIHDQNEDFPITWEIRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDK--YRAKVSDFGASRSMAVD 430 (608)
Q Consensus 353 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~--~~~kl~DFGls~~~~~~ 430 (608)
+++|+|.++|..... .+++..+..++.||+.||+|||+++ |+||||||+|||++.+ +.+||+|||+++.+...
T Consensus 236 ~~gg~L~~~i~~~~~--~l~e~~~~~~~~qi~~al~ylH~~~---iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~~~~ 310 (573)
T 3uto_A 236 MSGGELFEKVADEHN--KMSEDEAVEYMRQVCKGLCHMHENN---YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPK 310 (573)
T ss_dssp CCCCBHHHHHTCTTS--CEEHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSCCCEEECCCSSCEECCTT
T ss_pred cCCCcHHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCChhhccccCCCCCCEEEeeccceeEccCC
Confidence 999999999875433 5999999999999999999999999 9999999999999854 79999999999987543
Q ss_pred CcceeeeeeccCCCCChhhhccCCCCCccchHhHHHHHHHHHhCCCCCCccchhhcccHHHHHHHHhhhhhhHHHhhhhh
Q 044312 431 QTHMTTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLTELLTGEKPIRFTILEEDKSLAAYFLCAMKEERLFEILDARV 510 (608)
Q Consensus 431 ~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~ 510 (608)
. ......||+.|||||++.+..|+.++|||||||+||||++|+.||......+ .+. .+.... ...
T Consensus 311 ~--~~~~~~GT~~y~APEv~~~~~y~~~~DiWSlGvilyeml~G~~Pf~~~~~~~------~~~-~i~~~~------~~~ 375 (573)
T 3uto_A 311 Q--SVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDE------TLR-NVKSCD------WNM 375 (573)
T ss_dssp S--EEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHH------HHH-HHHTTC------CCC
T ss_pred C--ceeeeEECccccCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHH------HHH-HHHhCC------CCC
Confidence 2 3445679999999999999999999999999999999999999997432211 111 111100 000
Q ss_pred hccCChhHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 044312 511 MKQGGKDEIITVAKLAKRCLNLNGKKRPTMREVASE 546 (608)
Q Consensus 511 ~~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~evl~~ 546 (608)
........+.++.+|+.+||+.||++|||+.|++++
T Consensus 376 ~~~~~~~~s~~~~dli~~~L~~dp~~R~t~~e~l~H 411 (573)
T 3uto_A 376 DDSAFSGISEDGKDFIRKLLLADPNTRMTIHQALEH 411 (573)
T ss_dssp CSGGGTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred CcccccCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 111112346688999999999999999999999875
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.9e-40 Score=335.97 Aligned_cols=271 Identities=33% Similarity=0.550 Sum_probs=216.6
Q ss_pred ccccCCHHHHHHHhcCcccc------ceeccCce-------------EEEEEeec----ChhhHHHHHHHHHHHhhcCCC
Q 044312 275 KTKLFTSKELEKATDNFDLN------RILGQGGQ-------------AVKKSKVI----DESKVEEFINEVVILSQINHR 331 (608)
Q Consensus 275 ~~~~~~~~~l~~~t~~f~~~------~~lG~G~~-------------avk~~~~~----~~~~~~~~~~Ei~il~~l~H~ 331 (608)
....|+.+++.+++++|+.. +.||+|++ |||+.... .....+.|.+|+.++++++||
T Consensus 11 ~~~~~~~~~l~~~~~~f~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~ 90 (307)
T 2nru_A 11 RFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVNNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHE 90 (307)
T ss_dssp CCEECCHHHHHHHTTTTCCSBTTTTCCEEEECSSEEEEEEESSSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCCCT
T ss_pred CCCcccHHHHHHHHcccccccccccCCccccCCCeEEEEEEECCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcCCC
Confidence 45679999999999999887 89999985 66666532 234567899999999999999
Q ss_pred CccceecccccCccceEEEeecCCCccchhccccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEEc
Q 044312 332 NVVKLLGCCLETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEIRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLD 411 (608)
Q Consensus 332 niv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~ 411 (608)
||+++++++.+.+..++||||+++++|.+++.......++++..++.++.||+.||+|||+.+ |+||||||+|||++
T Consensus 91 ~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dlkp~Nili~ 167 (307)
T 2nru_A 91 NLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENH---HIHRDIKSANILLD 167 (307)
T ss_dssp TBCCEEEEECSSSSCEEEEECCTTCBHHHHHHTGGGCCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEEC
T ss_pred CeEEEEEEEecCCceEEEEEecCCCcHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhcCC---eecCCCCHHHEEEc
Confidence 999999999999999999999999999999976544446999999999999999999999999 99999999999999
Q ss_pred CCCcEEEeeccCccccccCCc-ceeeeeeccCCCCChhhhccCCCCCccchHhHHHHHHHHHhCCCCCCccchhhcccHH
Q 044312 412 DKYRAKVSDFGASRSMAVDQT-HMTTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLTELLTGEKPIRFTILEEDKSLA 490 (608)
Q Consensus 412 ~~~~~kl~DFGls~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~elltg~~p~~~~~~~~~~~l~ 490 (608)
.++.+||+|||+++....... .......||+.|+|||.+.+ .++.++||||||++++||++|+.||........ +.
T Consensus 168 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~--~~ 244 (307)
T 2nru_A 168 EAFTAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPEALRG-EITPKSDIYSFGVVLLEIITGLPAVDEHREPQL--LL 244 (307)
T ss_dssp TTCCEEECCCTTCEECCSCSSCEECSSCCSCGGGCCHHHHTT-EECTHHHHHHHHHHHHHHHHCCCSBCTTBSSSB--TT
T ss_pred CCCcEEEeecccccccccccccccccccCCCcCcCChHHhcC-CCCccchhHHHHHHHHHHHHCCCCcccCcchHH--HH
Confidence 999999999999987653322 22334568999999998865 589999999999999999999999975432221 11
Q ss_pred HHHHHHh-hhhhhHHHhhhhhhccCChhHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhhHH
Q 044312 491 AYFLCAM-KEERLFEILDARVMKQGGKDEIITVAKLAKRCLNLNGKKRPTMREVASELAGIKA 552 (608)
Q Consensus 491 ~~~~~~~-~~~~~~~~~d~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~evl~~L~~i~~ 552 (608)
.+..... ....+.+.+++.. ...+...+..+.+++.+||+.||.+|||+.||+++|+.+.+
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~l~~~L~~l~~ 306 (307)
T 2nru_A 245 DIKEEIEDEEKTIEDYIDKKM-NDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQEMTA 306 (307)
T ss_dssp HHHHHHHTTSCCHHHHSCSSC-SCCCHHHHHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHC-
T ss_pred HHHHHhhhhhhhhhhhccccc-cccchHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHhc
Confidence 1111111 1112233333322 33456677889999999999999999999999999998764
|
| >3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-40 Score=369.44 Aligned_cols=236 Identities=20% Similarity=0.268 Sum_probs=187.9
Q ss_pred hcCccccceeccCce---------------EEEEEeec---ChhhHHHHH---HHHHHHhhcCCCCccceecccccCccc
Q 044312 288 TDNFDLNRILGQGGQ---------------AVKKSKVI---DESKVEEFI---NEVVILSQINHRNVVKLLGCCLETEVP 346 (608)
Q Consensus 288 t~~f~~~~~lG~G~~---------------avk~~~~~---~~~~~~~~~---~Ei~il~~l~H~niv~l~~~~~~~~~~ 346 (608)
-++|++.++||+|+| |||++... .......+. .++.+++.++|||||++++++.+.+.+
T Consensus 188 lddf~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~~~~l 267 (689)
T 3v5w_A 188 MNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKL 267 (689)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEE
T ss_pred hHHeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEECCEE
Confidence 357999999999985 77776431 122233333 446677788999999999999999999
Q ss_pred eEEEeecCCCccchhccccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEEcCCCcEEEeeccCccc
Q 044312 347 LLVYEFIPNGTLFQYIHDQNEDFPITWEIRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRS 426 (608)
Q Consensus 347 ~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGls~~ 426 (608)
||||||++||+|.++|.+.. .+++..+..++.||+.||+|||+++ |+||||||+||||+.++.+||+|||+|+.
T Consensus 268 ylVmEy~~GGdL~~~l~~~~---~l~E~~a~~y~~qIl~aL~yLH~~g---IiHRDLKPeNILld~~G~vKL~DFGlA~~ 341 (689)
T 3v5w_A 268 SFILDLMNGGDLHYHLSQHG---VFSEADMRFYAAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACD 341 (689)
T ss_dssp EEEECCCCSCBHHHHHHHHC---CCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCSGGGEEECTTSCEEECCCTTCEE
T ss_pred EEEEecCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCchHHeEEeCCCCEEecccceeee
Confidence 99999999999999998754 5999999999999999999999999 99999999999999999999999999987
Q ss_pred cccCCcceeeeeeccCCCCChhhhcc-CCCCCccchHhHHHHHHHHHhCCCCCCccchhhcccHHHHHHHHhhhhhhHHH
Q 044312 427 MAVDQTHMTTQVHGTFGYLDPEYFRS-SQFTDKSDVYSFGVVLTELLTGEKPIRFTILEEDKSLAAYFLCAMKEERLFEI 505 (608)
Q Consensus 427 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~t~ksDV~S~Gvvl~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 505 (608)
+.... .....||+.|||||++.. ..|+.++|||||||+||||++|+.||....... ...... .+
T Consensus 342 ~~~~~---~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~~---~~~i~~---------~i 406 (689)
T 3v5w_A 342 FSKKK---PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKD---KHEIDR---------MT 406 (689)
T ss_dssp CSSCC---CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCCC---HHHHHH---------HH
T ss_pred cCCCC---CCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHH---HHHHHH---------hh
Confidence 65432 234679999999999975 579999999999999999999999997322211 111110 11
Q ss_pred hhhhhhccCChhHHHHHHHHHHHHhccCCCCCCC-----HHHHHHH
Q 044312 506 LDARVMKQGGKDEIITVAKLAKRCLNLNGKKRPT-----MREVASE 546 (608)
Q Consensus 506 ~d~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPs-----~~evl~~ 546 (608)
+.. ....+...+.++.+|+.+||+.||.+|++ +.||+++
T Consensus 407 ~~~--~~~~p~~~S~~a~dLI~~lL~~dP~~Rl~~~~~ga~ei~~H 450 (689)
T 3v5w_A 407 LTM--AVELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKES 450 (689)
T ss_dssp HHC--CCCCCTTSCHHHHHHHHHHTCSCGGGCTTCSSSTHHHHTTS
T ss_pred cCC--CCCCCccCCHHHHHHHHHHccCCHhHCCCCCCCCHHHHhcC
Confidence 111 12234456778999999999999999998 6777654
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-40 Score=347.29 Aligned_cols=248 Identities=25% Similarity=0.452 Sum_probs=201.1
Q ss_pred hcCccccceeccCce----------------------EEEEEeec-ChhhHHHHHHHHHHHhhc-CCCCccceecccccC
Q 044312 288 TDNFDLNRILGQGGQ----------------------AVKKSKVI-DESKVEEFINEVVILSQI-NHRNVVKLLGCCLET 343 (608)
Q Consensus 288 t~~f~~~~~lG~G~~----------------------avk~~~~~-~~~~~~~~~~Ei~il~~l-~H~niv~l~~~~~~~ 343 (608)
.++|.+.+.||+|+| |||..+.. .....+.+.+|+.+|+++ +||||+++++++.+.
T Consensus 80 ~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~ 159 (370)
T 2psq_A 80 RDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD 159 (370)
T ss_dssp GGGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTCBHHHHHHHHHHHHHHHHSCCCTTBCCEEEEECSS
T ss_pred HHHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCcCHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEccC
Confidence 467889999999975 33443322 234567899999999999 899999999999999
Q ss_pred ccceEEEeecCCCccchhccccCC-------------CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEE
Q 044312 344 EVPLLVYEFIPNGTLFQYIHDQNE-------------DFPITWEIRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILL 410 (608)
Q Consensus 344 ~~~~lV~E~~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl 410 (608)
+..++||||+++|+|.+++..... ...+++..++.++.||+.||+|||+++ |+||||||+|||+
T Consensus 160 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll 236 (370)
T 2psq_A 160 GPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQK---CIHRDLAARNVLV 236 (370)
T ss_dssp SSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEE
T ss_pred CCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---eeccccchhhEEE
Confidence 999999999999999999986431 124899999999999999999999999 9999999999999
Q ss_pred cCCCcEEEeeccCccccccCCc-ceeeeeeccCCCCChhhhccCCCCCccchHhHHHHHHHHHh-CCCCCCccchhhccc
Q 044312 411 DDKYRAKVSDFGASRSMAVDQT-HMTTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLTELLT-GEKPIRFTILEEDKS 488 (608)
Q Consensus 411 ~~~~~~kl~DFGls~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~ellt-g~~p~~~~~~~~~~~ 488 (608)
+.++.+||+|||+++....... .......+|+.|+|||++.+..++.++||||||+++|||++ |+.||......+
T Consensus 237 ~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~p~~~~~~~~--- 313 (370)
T 2psq_A 237 TENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEE--- 313 (370)
T ss_dssp CTTCCEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGG---
T ss_pred CCCCCEEEccccCCcccCcccceecccCCCcccceECHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCCCCCCHHH---
Confidence 9999999999999986653322 12233456789999999999999999999999999999999 999986432211
Q ss_pred HHHHHHHHhhhhhhHHHhhhhhhccCChhHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhhHHhc
Q 044312 489 LAAYFLCAMKEERLFEILDARVMKQGGKDEIITVAKLAKRCLNLNGKKRPTMREVASELAGIKAWN 554 (608)
Q Consensus 489 l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~evl~~L~~i~~~~ 554 (608)
+...+........+...+.++.+|+.+||+.||++||++.|+++.|+.+....
T Consensus 314 -------------~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~L~~il~~~ 366 (370)
T 2psq_A 314 -------------LFKLLKEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILTLT 366 (370)
T ss_dssp -------------HHHHHHTTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred -------------HHHHHhcCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHh
Confidence 11122222223344566778999999999999999999999999999987643
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-40 Score=341.94 Aligned_cols=246 Identities=26% Similarity=0.428 Sum_probs=199.2
Q ss_pred hcCccccceeccCce------------------EEEEEeec-ChhhHHHHHHHHHHHhhcCCCCccceecccccCccceE
Q 044312 288 TDNFDLNRILGQGGQ------------------AVKKSKVI-DESKVEEFINEVVILSQINHRNVVKLLGCCLETEVPLL 348 (608)
Q Consensus 288 t~~f~~~~~lG~G~~------------------avk~~~~~-~~~~~~~~~~Ei~il~~l~H~niv~l~~~~~~~~~~~l 348 (608)
.++|++.+.||+|+| |||+.+.. .....+.|.+|+.++++++||||+++++++.+....++
T Consensus 48 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 127 (325)
T 3kul_A 48 ASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRLAMI 127 (325)
T ss_dssp GGGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECGGGCCEE
T ss_pred hhHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCccEE
Confidence 456888999999974 55555432 34456789999999999999999999999999999999
Q ss_pred EEeecCCCccchhccccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEEcCCCcEEEeeccCccccc
Q 044312 349 VYEFIPNGTLFQYIHDQNEDFPITWEIRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMA 428 (608)
Q Consensus 349 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGls~~~~ 428 (608)
||||+++++|.+++..... .+++..++.|+.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++...
T Consensus 128 v~e~~~~~~L~~~l~~~~~--~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~ 202 (325)
T 3kul_A 128 VTEYMENGSLDTFLRTHDG--QFTIMQLVGMLRGVGAGMRYLSDLG---YVHRDLAARNVLVDSNLVCKVSDFGLSRVLE 202 (325)
T ss_dssp EEECCTTCBHHHHHHTTTT--CSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCSSCEECC
T ss_pred EeeCCCCCcHHHHHHhccc--CCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCcceEEECCCCCEEECCCCcccccc
Confidence 9999999999999976433 5999999999999999999999999 9999999999999999999999999998765
Q ss_pred cCCcc--eeeeeeccCCCCChhhhccCCCCCccchHhHHHHHHHHHh-CCCCCCccchhhcccHHHHHHHHhhhhhhHHH
Q 044312 429 VDQTH--MTTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLTELLT-GEKPIRFTILEEDKSLAAYFLCAMKEERLFEI 505 (608)
Q Consensus 429 ~~~~~--~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~ellt-g~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 505 (608)
..... ......+|+.|+|||++.+..++.++||||||++++||++ |+.||....... +...
T Consensus 203 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~----------------~~~~ 266 (325)
T 3kul_A 203 DDPDAAYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTNRD----------------VISS 266 (325)
T ss_dssp ----CCEECC---CCGGGSCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTSCHHH----------------HHHH
T ss_pred cCccceeeccCCCCcccccCHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCcccCCHHH----------------HHHH
Confidence 43222 2233446778999999999999999999999999999999 999986332211 1111
Q ss_pred hhhhhhccCChhHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhhHHhc
Q 044312 506 LDARVMKQGGKDEIITVAKLAKRCLNLNGKKRPTMREVASELAGIKAWN 554 (608)
Q Consensus 506 ~d~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~evl~~L~~i~~~~ 554 (608)
+........+...+..+.+|+.+||+.||++|||+.||++.|+.+....
T Consensus 267 ~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~L~~l~~~~ 315 (325)
T 3kul_A 267 VEEGYRLPAPMGCPHALHQLMLDCWHKDRAQRPRFSQIVSVLDALIRSP 315 (325)
T ss_dssp HHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSC
T ss_pred HHcCCCCCCCCCcCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhCc
Confidence 1122223344566778999999999999999999999999999987643
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-40 Score=340.73 Aligned_cols=253 Identities=28% Similarity=0.451 Sum_probs=198.4
Q ss_pred hcCccccceeccCce-------------------EEEEEeecChhhHHHHHHHHHHHhhcCCCCccceecccccC--ccc
Q 044312 288 TDNFDLNRILGQGGQ-------------------AVKKSKVIDESKVEEFINEVVILSQINHRNVVKLLGCCLET--EVP 346 (608)
Q Consensus 288 t~~f~~~~~lG~G~~-------------------avk~~~~~~~~~~~~~~~Ei~il~~l~H~niv~l~~~~~~~--~~~ 346 (608)
.++|++.+.||+|++ |||+.........+.|.+|+.++++++||||+++++++... ...
T Consensus 9 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 88 (295)
T 3ugc_A 9 ERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNL 88 (295)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECHHHHTSC
T ss_pred HHHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCce
Confidence 356888999999874 56666655666678899999999999999999999998643 458
Q ss_pred eEEEeecCCCccchhccccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEEcCCCcEEEeeccCccc
Q 044312 347 LLVYEFIPNGTLFQYIHDQNEDFPITWEIRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRS 426 (608)
Q Consensus 347 ~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGls~~ 426 (608)
++||||+++++|.+++..... .+++..++.++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++.
T Consensus 89 ~lv~e~~~~~~L~~~l~~~~~--~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dikp~Nil~~~~~~~kl~Dfg~~~~ 163 (295)
T 3ugc_A 89 KLIMEYLPYGSLRDYLQKHKE--RIDHIKLLQYTSQICKGMEYLGTKR---YIHRDLATRNILVENENRVKIGDFGLTKV 163 (295)
T ss_dssp EEEEECCTTCBHHHHHHHCGG--GCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECCCCSCC-
T ss_pred EEEEEeCCCCCHHHHHHhccc--ccCHHHHHHHHHHHHHHHHHHhcCC---cccCCCCHhhEEEcCCCeEEEccCccccc
Confidence 999999999999999987543 4899999999999999999999999 99999999999999999999999999987
Q ss_pred cccCCcc--eeeeeeccCCCCChhhhccCCCCCccchHhHHHHHHHHHhCCCCCCccchhhcccHHHHHHHHhhh-----
Q 044312 427 MAVDQTH--MTTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLTELLTGEKPIRFTILEEDKSLAAYFLCAMKE----- 499 (608)
Q Consensus 427 ~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~elltg~~p~~~~~~~~~~~l~~~~~~~~~~----- 499 (608)
....... ......++..|+|||.+.+..++.++||||||++++||+||..|+...... +......
T Consensus 164 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~--------~~~~~~~~~~~~ 235 (295)
T 3ugc_A 164 LPQDKEFFKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAE--------FMRMIGNDKQGQ 235 (295)
T ss_dssp ------------CTTCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTTCTTCSHHHH--------HHHHHCTTCCTH
T ss_pred ccCCcceeeeccCCCCccceeCcHHhcCCCCChHHHHHHHHHHHHHHHhcccccCCChHH--------HHhhhcCccccc
Confidence 6543221 122344677899999999999999999999999999999999997632211 1111110
Q ss_pred ---hhhHHHhhhhhhccCChhHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhhHHh
Q 044312 500 ---ERLFEILDARVMKQGGKDEIITVAKLAKRCLNLNGKKRPTMREVASELAGIKAW 553 (608)
Q Consensus 500 ---~~~~~~~d~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~evl~~L~~i~~~ 553 (608)
..+.+.+........+...+.++.+|+.+||+.||++|||+.||++.|+.++..
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~el~~~L~~l~~~ 292 (295)
T 3ugc_A 236 MIVFHLIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDN 292 (295)
T ss_dssp HHHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred hhHHHHHHHHhccCcCCCCcCcCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHHh
Confidence 112222222233344556778899999999999999999999999999998764
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.6e-40 Score=337.46 Aligned_cols=253 Identities=28% Similarity=0.420 Sum_probs=195.7
Q ss_pred HHHHhcCccccceeccCce-------------EEEEEeec--ChhhHHHHHHHHHHHhhcCCCCccceecccccCccceE
Q 044312 284 LEKATDNFDLNRILGQGGQ-------------AVKKSKVI--DESKVEEFINEVVILSQINHRNVVKLLGCCLETEVPLL 348 (608)
Q Consensus 284 l~~~t~~f~~~~~lG~G~~-------------avk~~~~~--~~~~~~~~~~Ei~il~~l~H~niv~l~~~~~~~~~~~l 348 (608)
+....++|++.+.||+|++ |||..... .....+.|.+|+.++++++||||+++++++.+....++
T Consensus 32 ~~i~~~~y~i~~~lG~G~~g~V~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~l 111 (309)
T 3p86_A 32 MDIPWCDLNIKEKIGAGSFGTVHRAEWHGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNLSI 111 (309)
T ss_dssp CBCCGGGEEEEEEEEECSSEEEEEEEETTEEEEEEEECCCCCSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTCCEE
T ss_pred ccCChhHceeeeEeecCCCeEEEEEEECCCcEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCceEE
Confidence 3344668999999999985 66766542 34556789999999999999999999999999999999
Q ss_pred EEeecCCCccchhccccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEEcCCCcEEEeeccCccccc
Q 044312 349 VYEFIPNGTLFQYIHDQNEDFPITWEIRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMA 428 (608)
Q Consensus 349 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGls~~~~ 428 (608)
||||+++|+|.+++........+++..++.++.||+.||+|||+.+ .+|+||||||+|||++.++.+||+|||+++...
T Consensus 112 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~-~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~ 190 (309)
T 3p86_A 112 VTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRN-PPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKA 190 (309)
T ss_dssp EEECCTTCBHHHHHHSTTHHHHSCHHHHHHHHHHHHHHHHHHHTSS-SCCCCTTCCGGGEEECTTCCEEECCCC------
T ss_pred EEecCCCCcHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCC-CCEECCCCChhhEEEeCCCcEEECCCCCCcccc
Confidence 9999999999999986543334899999999999999999999986 349999999999999999999999999998654
Q ss_pred cCCcceeeeeeccCCCCChhhhccCCCCCccchHhHHHHHHHHHhCCCCCCccchhhcccHHHHHHHHhhhhhhHHHhhh
Q 044312 429 VDQTHMTTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLTELLTGEKPIRFTILEEDKSLAAYFLCAMKEERLFEILDA 508 (608)
Q Consensus 429 ~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 508 (608)
... .......||+.|+|||.+.+..++.++||||||+++|||++|+.||....... .. ..+...
T Consensus 191 ~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~------~~---------~~~~~~ 254 (309)
T 3p86_A 191 STF-LSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNPAQ------VV---------AAVGFK 254 (309)
T ss_dssp ------------CCTTSCHHHHTTCCCCTTHHHHHHHHHHHHHHHCCCTTTTSCHHH------HH---------HHHHHS
T ss_pred ccc-cccccCCCCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH------HH---------HHHHhc
Confidence 322 22344578999999999999999999999999999999999999997432211 00 000001
Q ss_pred hhhccCChhHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhhHHh
Q 044312 509 RVMKQGGKDEIITVAKLAKRCLNLNGKKRPTMREVASELAGIKAW 553 (608)
Q Consensus 509 ~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~evl~~L~~i~~~ 553 (608)
......+...+.++.+|+.+||+.||++|||+.||++.|+.+...
T Consensus 255 ~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~L~~~~~~ 299 (309)
T 3p86_A 255 CKRLEIPRNLNPQVAAIIEGCWTNEPWKRPSFATIMDLLRPLIKS 299 (309)
T ss_dssp CCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHC-
T ss_pred CCCCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHh
Confidence 112233445667899999999999999999999999999887653
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-40 Score=332.00 Aligned_cols=246 Identities=25% Similarity=0.395 Sum_probs=199.9
Q ss_pred hcCccccceeccCce--------------EEEEEeecChhhHHHHHHHHHHHhhcCCCCccceecccccCccceEEEeec
Q 044312 288 TDNFDLNRILGQGGQ--------------AVKKSKVIDESKVEEFINEVVILSQINHRNVVKLLGCCLETEVPLLVYEFI 353 (608)
Q Consensus 288 t~~f~~~~~lG~G~~--------------avk~~~~~~~~~~~~~~~Ei~il~~l~H~niv~l~~~~~~~~~~~lV~E~~ 353 (608)
.++|++.+.||+|++ |||+.+.. ....+++.+|+.++++++||||+++++++.+....++||||+
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 85 (268)
T 3sxs_A 7 REEITLLKELGSGQFGVVKLGKWKGQYDVAVKMIKEG-SMSEDEFFQEAQTMMKLSHPKLVKFYGVCSKEYPIYIVTEYI 85 (268)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECBT-TBCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEECC
T ss_pred hhheeeeeeeccCCCceEEEEEecCceeEEEEEeccC-CCcHHHHHHHHHHHHhCCCCCEeeEEEEEccCCceEEEEEcc
Confidence 457888999999974 66665542 234578999999999999999999999999999999999999
Q ss_pred CCCccchhccccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEEcCCCcEEEeeccCccccccCCcc
Q 044312 354 PNGTLFQYIHDQNEDFPITWEIRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTH 433 (608)
Q Consensus 354 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGls~~~~~~~~~ 433 (608)
++++|.+++..... .+++..++.++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++........
T Consensus 86 ~~~~L~~~l~~~~~--~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~ 160 (268)
T 3sxs_A 86 SNGCLLNYLRSHGK--GLEPSQLLEMCYDVCEGMAFLESHQ---FIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQYV 160 (268)
T ss_dssp TTCBHHHHHHHHGG--GCCHHHHHHHHHHHHHHHHHHHHTT---EEESSCSGGGEEECTTCCEEECCTTCEEECCTTCEE
T ss_pred CCCcHHHHHHHcCC--CCCHHHHHHHHHHHHHHHHHHHHCC---eecCCcCcceEEECCCCCEEEccCccceecchhhhh
Confidence 99999999987543 4899999999999999999999999 999999999999999999999999999876654444
Q ss_pred eeeeeeccCCCCChhhhccCCCCCccchHhHHHHHHHHHh-CCCCCCccchhhcccHHHHHHHHhhhhhhHHHhhhhhhc
Q 044312 434 MTTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLTELLT-GEKPIRFTILEEDKSLAAYFLCAMKEERLFEILDARVMK 512 (608)
Q Consensus 434 ~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~ellt-g~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~ 512 (608)
......+|+.|+|||.+.+..++.++||||||++++||++ |+.||....... .. ..+......
T Consensus 161 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~------~~----------~~~~~~~~~ 224 (268)
T 3sxs_A 161 SSVGTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNSE------VV----------LKVSQGHRL 224 (268)
T ss_dssp ECCSCCCCGGGCCHHHHHHSEEETTHHHHHHHHHHHHHHTTTCCTTTTSCHHH------HH----------HHHHTTCCC
T ss_pred cccCCCcCcccCCHHHHhccCCchhhhhHHHHHHHHHHHcCCCCCccccChHH------HH----------HHHHcCCCC
Confidence 4444556778999999999899999999999999999999 999986332211 00 001111112
Q ss_pred cCChhHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhhHHhcC
Q 044312 513 QGGKDEIITVAKLAKRCLNLNGKKRPTMREVASELAGIKAWNG 555 (608)
Q Consensus 513 ~~~~~~~~~l~~Li~~cl~~dp~~RPs~~evl~~L~~i~~~~~ 555 (608)
..+...+..+.+|+.+||+.||++|||+.|+++.|+.++...+
T Consensus 225 ~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~~~~k 267 (268)
T 3sxs_A 225 YRPHLASDTIYQIMYSCWHELPEKRPTFQQLLSSIEPLREKDK 267 (268)
T ss_dssp CCCTTSCHHHHHHHHHTTCSSGGGSCCHHHHHHHHGGGCC---
T ss_pred CCCCcChHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhhccC
Confidence 2233445689999999999999999999999999999876544
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-40 Score=347.00 Aligned_cols=246 Identities=25% Similarity=0.428 Sum_probs=191.1
Q ss_pred hcCccccceeccCce------------------EEEEEeec-ChhhHHHHHHHHHHHhhcCCCCccceecccccCccceE
Q 044312 288 TDNFDLNRILGQGGQ------------------AVKKSKVI-DESKVEEFINEVVILSQINHRNVVKLLGCCLETEVPLL 348 (608)
Q Consensus 288 t~~f~~~~~lG~G~~------------------avk~~~~~-~~~~~~~~~~Ei~il~~l~H~niv~l~~~~~~~~~~~l 348 (608)
.++|++.+.||+|+| |||..+.. .....+.|.+|+.+|++++||||+++++++.+....++
T Consensus 44 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 123 (373)
T 2qol_A 44 ATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMI 123 (373)
T ss_dssp GGGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEE
T ss_pred HhhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCceEE
Confidence 357899999999974 56665532 34456789999999999999999999999999999999
Q ss_pred EEeecCCCccchhccccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEEcCCCcEEEeeccCccccc
Q 044312 349 VYEFIPNGTLFQYIHDQNEDFPITWEIRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMA 428 (608)
Q Consensus 349 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGls~~~~ 428 (608)
||||+++|+|.++++.... .+++..++.++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++...
T Consensus 124 v~e~~~~~sL~~~l~~~~~--~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~ 198 (373)
T 2qol_A 124 VTEYMENGSLDSFLRKHDA--QFTVIQLVGMLRGIASGMKYLSDMG---YVHRDLAARNILINSNLVCKVSDFGLGRVLE 198 (373)
T ss_dssp EEECCTTCBHHHHHHTTTT--CSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCC-------
T ss_pred EEeCCCCCcHHHHHHhCCC--CCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCcceEEEcCCCCEEECcCccccccc
Confidence 9999999999999986533 5899999999999999999999999 9999999999999999999999999998765
Q ss_pred cCCcce--eeeeeccCCCCChhhhccCCCCCccchHhHHHHHHHHHh-CCCCCCccchhhcccHHHHHHHHhhhhhhHHH
Q 044312 429 VDQTHM--TTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLTELLT-GEKPIRFTILEEDKSLAAYFLCAMKEERLFEI 505 (608)
Q Consensus 429 ~~~~~~--~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~ellt-g~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 505 (608)
...... .....+++.|+|||++....++.++||||||+++|||++ |+.||...... .+.+.
T Consensus 199 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt~g~~P~~~~~~~----------------~~~~~ 262 (373)
T 2qol_A 199 DDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQ----------------DVIKA 262 (373)
T ss_dssp ---------------CTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTC-CTTTTCCHH----------------HHHHH
T ss_pred cCCccceeccCCCcCCCccChhhhccCCcCchhcHHHHHHHHHHHHhCCCCCCCCCCHH----------------HHHHH
Confidence 432221 122345778999999999999999999999999999998 99998633211 11122
Q ss_pred hhhhhhccCChhHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhhHHhc
Q 044312 506 LDARVMKQGGKDEIITVAKLAKRCLNLNGKKRPTMREVASELAGIKAWN 554 (608)
Q Consensus 506 ~d~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~evl~~L~~i~~~~ 554 (608)
+........+...+..+.+|+.+||+.||++||++.||++.|+.+....
T Consensus 263 i~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~~i~~~L~~~~~~~ 311 (373)
T 2qol_A 263 VDEGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLIRNP 311 (373)
T ss_dssp HHTTEECCCCTTCBHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHCG
T ss_pred HHcCCCCCCCccccHHHHHHHHHHhCcChhhCcCHHHHHHHHHHHHhCc
Confidence 2222233344566778999999999999999999999999999987643
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-40 Score=351.20 Aligned_cols=247 Identities=24% Similarity=0.400 Sum_probs=200.9
Q ss_pred HHhcCccccceeccCce---------------EEEEEeec-ChhhHHHHHHHHHHHhhcCCCCccceecccccCccceEE
Q 044312 286 KATDNFDLNRILGQGGQ---------------AVKKSKVI-DESKVEEFINEVVILSQINHRNVVKLLGCCLETEVPLLV 349 (608)
Q Consensus 286 ~~t~~f~~~~~lG~G~~---------------avk~~~~~-~~~~~~~~~~Ei~il~~l~H~niv~l~~~~~~~~~~~lV 349 (608)
...++|.+.+.||+|+| |||..+.. .....+.|.+|+++|++++||||+++++++.+.+..++|
T Consensus 111 ~~~~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv 190 (377)
T 3cbl_A 111 LNHEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIV 190 (377)
T ss_dssp CCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTTSCHHHHTTTTHHHHHHTTCCCTTBCCEEEEECSSSSCEEE
T ss_pred EchHHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEccccCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEecCCCcEEE
Confidence 34567889999999974 66665532 234456799999999999999999999999999999999
Q ss_pred EeecCCCccchhccccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEEcCCCcEEEeeccCcccccc
Q 044312 350 YEFIPNGTLFQYIHDQNEDFPITWEIRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAV 429 (608)
Q Consensus 350 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGls~~~~~ 429 (608)
|||+++|+|.+++..... .+++..++.++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++....
T Consensus 191 ~e~~~~g~L~~~l~~~~~--~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~Nil~~~~~~~kl~DfG~s~~~~~ 265 (377)
T 3cbl_A 191 MELVQGGDFLTFLRTEGA--RLRVKTLLQMVGDAAAGMEYLESKC---CIHRDLAARNCLVTEKNVLKISDFGMSREEAD 265 (377)
T ss_dssp EECCTTCBHHHHHHHHGG--GCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCGGGCEECTT
T ss_pred EEcCCCCCHHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHHCC---cCCcccCHHHEEEcCCCcEEECcCCCceecCC
Confidence 999999999999986543 4899999999999999999999999 99999999999999999999999999986543
Q ss_pred CCccee-eeeeccCCCCChhhhccCCCCCccchHhHHHHHHHHHh-CCCCCCccchhhcccHHHHHHHHhhhhhhHHHhh
Q 044312 430 DQTHMT-TQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLTELLT-GEKPIRFTILEEDKSLAAYFLCAMKEERLFEILD 507 (608)
Q Consensus 430 ~~~~~~-~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~ellt-g~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 507 (608)
...... ....+++.|+|||.+....++.++||||||+++|||+| |..||...... ...+.+.
T Consensus 266 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t~g~~p~~~~~~~----------------~~~~~~~ 329 (377)
T 3cbl_A 266 GVYAASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSNQ----------------QTREFVE 329 (377)
T ss_dssp SEEECCSSCCEEEGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCSSTTSCHH----------------HHHHHHH
T ss_pred CceeecCCCCCCCcCcCCHhHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHH----------------HHHHHHH
Confidence 211111 12235778999999999999999999999999999998 99998643221 1112222
Q ss_pred hhhhccCChhHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhhHHh
Q 044312 508 ARVMKQGGKDEIITVAKLAKRCLNLNGKKRPTMREVASELAGIKAW 553 (608)
Q Consensus 508 ~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~evl~~L~~i~~~ 553 (608)
.......+...+..+.+|+.+||+.||++|||+.||++.|+.++..
T Consensus 330 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i~~~ 375 (377)
T 3cbl_A 330 KGGRLPCPELCPDAVFRLMEQCWAYEPGQRPSFSTIYQELQSIRKR 375 (377)
T ss_dssp TTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred cCCCCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHhh
Confidence 2222334455677899999999999999999999999999998764
|
| >4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-40 Score=330.90 Aligned_cols=244 Identities=28% Similarity=0.452 Sum_probs=199.8
Q ss_pred hcCccccceeccCce--------------EEEEEeecChhhHHHHHHHHHHHhhcCCCCccceecccccCccceEEEeec
Q 044312 288 TDNFDLNRILGQGGQ--------------AVKKSKVIDESKVEEFINEVVILSQINHRNVVKLLGCCLETEVPLLVYEFI 353 (608)
Q Consensus 288 t~~f~~~~~lG~G~~--------------avk~~~~~~~~~~~~~~~Ei~il~~l~H~niv~l~~~~~~~~~~~lV~E~~ 353 (608)
.++|++.+.||+|++ |+|+.... ....+++.+|+.++++++||||+++++++.+....++||||+
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 87 (269)
T 4hcu_A 9 PSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREG-AMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFM 87 (269)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTEEEEEEEECTT-SBCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEECC
T ss_pred hhhceeeheecCCCccEEEEEEecCCCeEEEEEeccc-ccCHHHHHHHHHHHHhCCCCCEeeEEEEEecCCceEEEEEeC
Confidence 356888999999974 66665532 234578999999999999999999999999999999999999
Q ss_pred CCCccchhccccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEEcCCCcEEEeeccCccccccCCcc
Q 044312 354 PNGTLFQYIHDQNEDFPITWEIRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTH 433 (608)
Q Consensus 354 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGls~~~~~~~~~ 433 (608)
++++|.+++..... .+++..++.++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++........
T Consensus 88 ~~~~L~~~l~~~~~--~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~ 162 (269)
T 4hcu_A 88 EHGCLSDYLRTQRG--LFAAETLLGMCLDVCEGMAYLEEAC---VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYT 162 (269)
T ss_dssp TTCBHHHHHHTTTT--CCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECGGGCEEECCTTGGGGBCCHHHH
T ss_pred CCCcHHHHHHhcCc--ccCHHHHHHHHHHHHHHHHHHHhCC---eecCCcchheEEEcCCCCEEeccccccccccccccc
Confidence 99999999976443 5899999999999999999999999 999999999999999999999999999876543333
Q ss_pred eeeeeeccCCCCChhhhccCCCCCccchHhHHHHHHHHHh-CCCCCCccchhhcccHHHHHHHHhhhhhhHHHhhhhhhc
Q 044312 434 MTTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLTELLT-GEKPIRFTILEEDKSLAAYFLCAMKEERLFEILDARVMK 512 (608)
Q Consensus 434 ~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~ellt-g~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~ 512 (608)
......+|+.|+|||.+....++.++||||||++++||++ |+.||......+ +.+.+......
T Consensus 163 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~~g~~p~~~~~~~~----------------~~~~~~~~~~~ 226 (269)
T 4hcu_A 163 SSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSE----------------VVEDISTGFRL 226 (269)
T ss_dssp STTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH----------------HHHHHHTTCCC
T ss_pred cccCcccccccCCHHHhcCCCCCchhhhHHHHHHHHHHhcCCCCCCCCCCHHH----------------HHHHHhcCccC
Confidence 3344456788999999999999999999999999999999 999986332211 11111111122
Q ss_pred cCChhHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhhHHh
Q 044312 513 QGGKDEIITVAKLAKRCLNLNGKKRPTMREVASELAGIKAW 553 (608)
Q Consensus 513 ~~~~~~~~~l~~Li~~cl~~dp~~RPs~~evl~~L~~i~~~ 553 (608)
..+...+..+.+|+.+||+.||++|||+.|++++|+.+...
T Consensus 227 ~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~l~~~ 267 (269)
T 4hcu_A 227 YKPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIAES 267 (269)
T ss_dssp CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred CCCCcCCHHHHHHHHHHccCCcccCcCHHHHHHHHHHHHHc
Confidence 33344567899999999999999999999999999988753
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-40 Score=359.97 Aligned_cols=253 Identities=23% Similarity=0.376 Sum_probs=205.6
Q ss_pred CCHHHHHHHhcCccccceeccCce--------------EEEEEeecChhhHHHHHHHHHHHhhcCCCCccceecccccCc
Q 044312 279 FTSKELEKATDNFDLNRILGQGGQ--------------AVKKSKVIDESKVEEFINEVVILSQINHRNVVKLLGCCLETE 344 (608)
Q Consensus 279 ~~~~~l~~~t~~f~~~~~lG~G~~--------------avk~~~~~~~~~~~~~~~Ei~il~~l~H~niv~l~~~~~~~~ 344 (608)
+...+++...++|.+.+.||+|+| |||+++.. ....+.|.+|+.+|++++||||+++++++. .+
T Consensus 178 ~~~~~~~i~~~~~~~~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~-~~ 255 (454)
T 1qcf_A 178 WEKDAWEIPRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPG-SMSVEAFLAEANVMKTLQHDKLVKLHAVVT-KE 255 (454)
T ss_dssp CCTTCSBCCGGGEEEEEEEECCSSEEEEEEEETTTEEEEEEEECTT-SBCHHHHHHHHHHHTTCCCTTBCCEEEEEC-SS
T ss_pred ccccceeechHHeEEEEEcccCCceEEEEEEECCccEEEEEEecCC-CccHHHHHHHHHHHhhCCCCCEeeEEEEEe-CC
Confidence 344556667788999999999985 67776643 345789999999999999999999999986 56
Q ss_pred cceEEEeecCCCccchhccccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEEcCCCcEEEeeccCc
Q 044312 345 VPLLVYEFIPNGTLFQYIHDQNEDFPITWEIRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGAS 424 (608)
Q Consensus 345 ~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGls 424 (608)
..++||||+++|+|.++++.... ..+++..++.++.||+.||+|||+++ |+||||||+|||++.++.+||+|||++
T Consensus 256 ~~~lv~e~~~~g~L~~~l~~~~~-~~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DFG~a 331 (454)
T 1qcf_A 256 PIYIITEFMAKGSLLDFLKSDEG-SKQPLPKLIDFSAQIAEGMAFIEQRN---YIHRDLRAANILVSASLVCKIADFGLA 331 (454)
T ss_dssp SCEEEECCCTTCBHHHHHHSHHH-HTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCSGGGEEECTTCCEEECSTTGG
T ss_pred ccEEEEeecCCCcHHHHHHhccC-CCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCCHHHEEECCCCcEEEeeCCCc
Confidence 78999999999999999986432 14889999999999999999999999 999999999999999999999999999
Q ss_pred cccccCCcceeeeeeccCCCCChhhhccCCCCCccchHhHHHHHHHHHh-CCCCCCccchhhcccHHHHHHHHhhhhhhH
Q 044312 425 RSMAVDQTHMTTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLTELLT-GEKPIRFTILEEDKSLAAYFLCAMKEERLF 503 (608)
Q Consensus 425 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~ellt-g~~p~~~~~~~~~~~l~~~~~~~~~~~~~~ 503 (608)
+..............+++.|+|||.+....++.++||||||++||||+| |+.||...... .+.
T Consensus 332 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t~g~~P~~~~~~~----------------~~~ 395 (454)
T 1qcf_A 332 RVIEDNEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNP----------------EVI 395 (454)
T ss_dssp GGBCCHHHHTTCSSSSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHH----------------HHH
T ss_pred eEcCCCceeccCCCcccccccCHHHhccCCCCcHHHHHhHHHHHHHHHhCCCCCCCCCCHH----------------HHH
Confidence 8765332222233456788999999999999999999999999999999 99998632211 111
Q ss_pred HHhhhhhhccCChhHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhhHHh
Q 044312 504 EILDARVMKQGGKDEIITVAKLAKRCLNLNGKKRPTMREVASELAGIKAW 553 (608)
Q Consensus 504 ~~~d~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~evl~~L~~i~~~ 553 (608)
+.+........+...+.++.+|+.+||+.||++|||+++|++.|+.+...
T Consensus 396 ~~i~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~~i~~~L~~~~~~ 445 (454)
T 1qcf_A 396 RALERGYRMPRPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDDFYTA 445 (454)
T ss_dssp HHHHHTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSSS
T ss_pred HHHHcCCCCCCCCCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHhc
Confidence 11222223334456678899999999999999999999999999887653
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-39 Score=331.94 Aligned_cols=237 Identities=24% Similarity=0.385 Sum_probs=196.4
Q ss_pred hcCccccceeccCce---------------EEEEEeecChhhHHHHHHHHHHHhhcCCCCccceecccccCccceEEEee
Q 044312 288 TDNFDLNRILGQGGQ---------------AVKKSKVIDESKVEEFINEVVILSQINHRNVVKLLGCCLETEVPLLVYEF 352 (608)
Q Consensus 288 t~~f~~~~~lG~G~~---------------avk~~~~~~~~~~~~~~~Ei~il~~l~H~niv~l~~~~~~~~~~~lV~E~ 352 (608)
.++|++.+.||+|++ |||+.........+.+.+|+.++++++||||+++++++...+..++||||
T Consensus 19 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~ 98 (297)
T 3fxz_A 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEY 98 (297)
T ss_dssp GGTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred hhceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeecccccHHHHHHHHHHHHhcCCCCCCCeEeEEEEECCEEEEEEEC
Confidence 457899999999974 77777766666678899999999999999999999999999999999999
Q ss_pred cCCCccchhccccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEEcCCCcEEEeeccCccccccCCc
Q 044312 353 IPNGTLFQYIHDQNEDFPITWEIRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQT 432 (608)
Q Consensus 353 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGls~~~~~~~~ 432 (608)
+++|+|.+++... .+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++.......
T Consensus 99 ~~~~~L~~~~~~~----~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 171 (297)
T 3fxz_A 99 LAGGSLTDVVTET----CMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS 171 (297)
T ss_dssp CTTCBHHHHHHHS----CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECCSTTC
T ss_pred CCCCCHHHHHhhc----CCCHHHHHHHHHHHHHHHHHHHhCC---ceeCCCCHHHEEECCCCCEEEeeCCCceecCCccc
Confidence 9999999999754 4899999999999999999999999 99999999999999999999999999987654332
Q ss_pred ceeeeeeccCCCCChhhhccCCCCCccchHhHHHHHHHHHhCCCCCCccchhhcccHHHHHHHHhhhhhhHHHhhhhhhc
Q 044312 433 HMTTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLTELLTGEKPIRFTILEEDKSLAAYFLCAMKEERLFEILDARVMK 512 (608)
Q Consensus 433 ~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~ 512 (608)
......||+.|+|||.+.+..++.++||||||++++||++|+.||....... ........ .....
T Consensus 172 -~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~------~~~~~~~~--------~~~~~ 236 (297)
T 3fxz_A 172 -KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLR------ALYLIATN--------GTPEL 236 (297)
T ss_dssp -CBCCCCSCGGGCCHHHHHCSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHH------HHHHHHHH--------CSCCC
T ss_pred -ccCCccCCcCccChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH------HHHHHHhC--------CCCCC
Confidence 2344579999999999999999999999999999999999999996332211 00000000 00111
Q ss_pred cCChhHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 044312 513 QGGKDEIITVAKLAKRCLNLNGKKRPTMREVASE 546 (608)
Q Consensus 513 ~~~~~~~~~l~~Li~~cl~~dp~~RPs~~evl~~ 546 (608)
..+...+..+.+|+.+||+.||++|||+.|++++
T Consensus 237 ~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h 270 (297)
T 3fxz_A 237 QNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQH 270 (297)
T ss_dssp SCGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred CCccccCHHHHHHHHHHccCChhHCcCHHHHhhC
Confidence 2234556789999999999999999999999864
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-39 Score=340.89 Aligned_cols=260 Identities=27% Similarity=0.408 Sum_probs=207.7
Q ss_pred ccCCHHHHHHHhcCccccceeccCce--------------------EEEEEee-cChhhHHHHHHHHHHHhhc-CCCCcc
Q 044312 277 KLFTSKELEKATDNFDLNRILGQGGQ--------------------AVKKSKV-IDESKVEEFINEVVILSQI-NHRNVV 334 (608)
Q Consensus 277 ~~~~~~~l~~~t~~f~~~~~lG~G~~--------------------avk~~~~-~~~~~~~~~~~Ei~il~~l-~H~niv 334 (608)
..+...+++...++|.+.+.||+|+| |||+.+. ......+.+.+|+++++++ +||||+
T Consensus 10 ~~~~~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv 89 (359)
T 3vhe_A 10 LPYDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 89 (359)
T ss_dssp SCCCHHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBC
T ss_pred CCCCcccccccccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcCCHHHHHHHHHHHHHHHhhcCCccee
Confidence 44667777888899999999999985 4454443 2234457799999999999 899999
Q ss_pred ceecccccCc-cceEEEeecCCCccchhccccCC----------------------------------------------
Q 044312 335 KLLGCCLETE-VPLLVYEFIPNGTLFQYIHDQNE---------------------------------------------- 367 (608)
Q Consensus 335 ~l~~~~~~~~-~~~lV~E~~~~gsL~~~l~~~~~---------------------------------------------- 367 (608)
++++++.+.+ ..++||||+++|+|.++++....
T Consensus 90 ~~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 169 (359)
T 3vhe_A 90 NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVE 169 (359)
T ss_dssp CEEEEECSTTSCCEEEEECCTTEEHHHHHHTTTTSBCSCC----------------------------------------
T ss_pred eeeeeeecCCCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCcccccccccccc
Confidence 9999988755 48999999999999999976432
Q ss_pred -----------------CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEEcCCCcEEEeeccCccccccC
Q 044312 368 -----------------DFPITWEIRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVD 430 (608)
Q Consensus 368 -----------------~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGls~~~~~~ 430 (608)
+..+++..++.++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++.....
T Consensus 170 ~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~~---ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~ 246 (359)
T 3vhe_A 170 EKSLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRDLAARNILLSEKNVVKICDFGLARDIYKD 246 (359)
T ss_dssp --------------CTTTTCBCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCGGGSCTTSC
T ss_pred ccccchhhhcccccchhccccCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChhhEEEcCCCcEEEEeccceeeeccc
Confidence 112899999999999999999999999 999999999999999999999999999876443
Q ss_pred Cc-ceeeeeeccCCCCChhhhccCCCCCccchHhHHHHHHHHHh-CCCCCCccchhhcccHHHHHHHHhhhhhhHHHhhh
Q 044312 431 QT-HMTTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLTELLT-GEKPIRFTILEEDKSLAAYFLCAMKEERLFEILDA 508 (608)
Q Consensus 431 ~~-~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~ellt-g~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 508 (608)
.. .......||+.|+|||++.+..++.++||||||++++||+| |+.||....... .+...+..
T Consensus 247 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~---------------~~~~~~~~ 311 (359)
T 3vhe_A 247 PDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDE---------------EFCRRLKE 311 (359)
T ss_dssp TTCEEC--CEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSH---------------HHHHHHHH
T ss_pred ccchhccccCCCceeEChhhhcCCCCCchhhhhhHHHHHHHHHhcCCCCCCccchhH---------------HHHHHHHc
Confidence 22 23345678999999999999999999999999999999998 999986432211 11111122
Q ss_pred hhhccCChhHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhhHHhc
Q 044312 509 RVMKQGGKDEIITVAKLAKRCLNLNGKKRPTMREVASELAGIKAWN 554 (608)
Q Consensus 509 ~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~evl~~L~~i~~~~ 554 (608)
......+...+.++.+|+.+||+.||++|||+.||+++|+.+....
T Consensus 312 ~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~ 357 (359)
T 3vhe_A 312 GTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQAN 357 (359)
T ss_dssp TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred CCCCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHHHHh
Confidence 2222334455678999999999999999999999999999987643
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-40 Score=360.89 Aligned_cols=247 Identities=29% Similarity=0.463 Sum_probs=204.7
Q ss_pred HHHHhcCccccceeccCce---------------EEEEEeecChhhHHHHHHHHHHHhhcCCCCccceecccccCccceE
Q 044312 284 LEKATDNFDLNRILGQGGQ---------------AVKKSKVIDESKVEEFINEVVILSQINHRNVVKLLGCCLETEVPLL 348 (608)
Q Consensus 284 l~~~t~~f~~~~~lG~G~~---------------avk~~~~~~~~~~~~~~~Ei~il~~l~H~niv~l~~~~~~~~~~~l 348 (608)
++....+|.+.++||+|+| |||.++.. ....++|.+|+.+|++++||||+++++++.+....+|
T Consensus 215 ~~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~l 293 (495)
T 1opk_A 215 WEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYI 293 (495)
T ss_dssp CBCCGGGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSS-SSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEE
T ss_pred cccCHHHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCc-ccchHHHHHHHHHHHhcCCCCEeeEEEEEecCCcEEE
Confidence 3444567889999999974 67766542 3457889999999999999999999999999999999
Q ss_pred EEeecCCCccchhccccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEEcCCCcEEEeeccCccccc
Q 044312 349 VYEFIPNGTLFQYIHDQNEDFPITWEIRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMA 428 (608)
Q Consensus 349 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGls~~~~ 428 (608)
||||+++|+|.+++..... ..+++..++.|+.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++...
T Consensus 294 v~E~~~~g~L~~~l~~~~~-~~~~~~~~~~i~~qi~~~L~~LH~~~---ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~ 369 (495)
T 1opk_A 294 ITEFMTYGNLLDYLRECNR-QEVSAVVLLYMATQISSAMEYLEKKN---FIHRNLAARNCLVGENHLVKVADFGLSRLMT 369 (495)
T ss_dssp EEECCTTCBHHHHHHHSCT-TTSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECGGGCEEECCTTCEECCT
T ss_pred EEEccCCCCHHHHHHhcCc-CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChhhEEECCCCcEEEeecccceecc
Confidence 9999999999999986433 25899999999999999999999999 9999999999999999999999999998765
Q ss_pred cCCcceeeeeeccCCCCChhhhccCCCCCccchHhHHHHHHHHHh-CCCCCCccchhhcccHHHHHHHHhhhhhhHHHhh
Q 044312 429 VDQTHMTTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLTELLT-GEKPIRFTILEEDKSLAAYFLCAMKEERLFEILD 507 (608)
Q Consensus 429 ~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~ellt-g~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 507 (608)
...........++..|+|||.+....++.++||||||++||||+| |+.||...... .+.+.+.
T Consensus 370 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlG~~l~el~t~g~~p~~~~~~~----------------~~~~~~~ 433 (495)
T 1opk_A 370 GDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLS----------------QVYELLE 433 (495)
T ss_dssp TCCEECCTTCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCGG----------------GHHHHHH
T ss_pred CCceeecCCCcCCcceeCHhHHhcCCCCcHHhHHhHHHHHHHHHhCCCCCCCCCCHH----------------HHHHHHH
Confidence 433222333456788999999999999999999999999999999 99998643221 1222233
Q ss_pred hhhhccCChhHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhhH
Q 044312 508 ARVMKQGGKDEIITVAKLAKRCLNLNGKKRPTMREVASELAGIK 551 (608)
Q Consensus 508 ~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~evl~~L~~i~ 551 (608)
.......+...+..+.+|+.+||+.||++|||+.||++.|+.+.
T Consensus 434 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~el~~~L~~~~ 477 (495)
T 1opk_A 434 KDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMF 477 (495)
T ss_dssp TTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSC
T ss_pred cCCCCCCCCCCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHH
Confidence 33334445567788999999999999999999999999998774
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-40 Score=339.69 Aligned_cols=259 Identities=22% Similarity=0.302 Sum_probs=195.8
Q ss_pred hcCccccceeccCce-------------EEEEEeecChhhHHHHHHHHHHHhhcCCCCccceecccccCc----cceEEE
Q 044312 288 TDNFDLNRILGQGGQ-------------AVKKSKVIDESKVEEFINEVVILSQINHRNVVKLLGCCLETE----VPLLVY 350 (608)
Q Consensus 288 t~~f~~~~~lG~G~~-------------avk~~~~~~~~~~~~~~~Ei~il~~l~H~niv~l~~~~~~~~----~~~lV~ 350 (608)
.++|++.++||+|+| |||+.... ......+.+|+.++++++||||+++++++.+.. ..++||
T Consensus 23 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~lv~ 101 (322)
T 3soc_A 23 SMPLQLLEVKARGRFGCVWKAQLLNEYVAVKIFPIQ-DKQSWQNEYEVYSLPGMKHENILQFIGAEKRGTSVDVDLWLIT 101 (322)
T ss_dssp TEEEEEEEEEECSTTCEEEEEEETTEEEEEEEECGG-GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEE
T ss_pred hhhchhhheecccCceEEEEEEECCCEEEEEEeecC-chHHHHHHHHHHHHhcCCCCCchhhcceeccCCCCCceEEEEE
Confidence 457899999999984 77776543 334456677999999999999999999998754 369999
Q ss_pred eecCCCccchhccccCCCCCCCHHHHHHHHHHHHHHHHHHhhc----------CCCCeeccCCCCCcEEEcCCCcEEEee
Q 044312 351 EFIPNGTLFQYIHDQNEDFPITWEIRLRIAIEVSGALSYLHSA----------ASIPIYHRDIKSTNILLDDKYRAKVSD 420 (608)
Q Consensus 351 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~----------~~~~iiHrDlk~~NILl~~~~~~kl~D 420 (608)
||+++|+|.+++... .+++..++.++.|++.||+|||+. + |+||||||+|||++.++.+||+|
T Consensus 102 e~~~~g~L~~~l~~~----~~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~---ivH~Dlkp~Nill~~~~~~kL~D 174 (322)
T 3soc_A 102 AFHEKGSLSDFLKAN----VVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPA---ISHRDIKSKNVLLKNNLTACIAD 174 (322)
T ss_dssp ECCTTCBHHHHHHHC----CBCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECE---EECSCCSGGGEEECTTCCEEECC
T ss_pred ecCCCCCHHHHHHhc----CCCHHHHHHHHHHHHHHHHHHHhhccccccccCCC---EEeCCCChHhEEECCCCeEEEcc
Confidence 999999999999753 489999999999999999999998 7 99999999999999999999999
Q ss_pred ccCccccccCCcc-eeeeeeccCCCCChhhhccC-----CCCCccchHhHHHHHHHHHhCCCCCCccchhhcccHHHHHH
Q 044312 421 FGASRSMAVDQTH-MTTQVHGTFGYLDPEYFRSS-----QFTDKSDVYSFGVVLTELLTGEKPIRFTILEEDKSLAAYFL 494 (608)
Q Consensus 421 FGls~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~-----~~t~ksDV~S~Gvvl~elltg~~p~~~~~~~~~~~l~~~~~ 494 (608)
||+++........ ......||+.|+|||++.+. .++.++||||||+++|||+||+.||................
T Consensus 175 Fg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~ 254 (322)
T 3soc_A 175 FGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPFEEEIG 254 (322)
T ss_dssp CTTCEEECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCCCCCCCTTHHHHC
T ss_pred CCcccccccccCccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCcchhccchhhhhc
Confidence 9999876543322 22335689999999999863 45678999999999999999999987533222111111000
Q ss_pred HHhhhhhhHHHhhh-hhhcc-----CChhHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhhHHhc
Q 044312 495 CAMKEERLFEILDA-RVMKQ-----GGKDEIITVAKLAKRCLNLNGKKRPTMREVASELAGIKAWN 554 (608)
Q Consensus 495 ~~~~~~~~~~~~d~-~~~~~-----~~~~~~~~l~~Li~~cl~~dp~~RPs~~evl~~L~~i~~~~ 554 (608)
.......+.+.+.. ..... .....+.++.+|+.+||+.||++|||+.||++.|+.++...
T Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~l~~~~ 320 (322)
T 3soc_A 255 QHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAGCVGERITQMQRLT 320 (322)
T ss_dssp SSCCHHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHC
T ss_pred cCCchhhhhhhhhcccCCCCccccccccchHHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHh
Confidence 00000011111100 00000 11245667999999999999999999999999999998754
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-40 Score=333.25 Aligned_cols=247 Identities=29% Similarity=0.468 Sum_probs=206.8
Q ss_pred HHhcCccccceeccCce---------------EEEEEeecChhhHHHHHHHHHHHhhcCCCCccceecccccCccceEEE
Q 044312 286 KATDNFDLNRILGQGGQ---------------AVKKSKVIDESKVEEFINEVVILSQINHRNVVKLLGCCLETEVPLLVY 350 (608)
Q Consensus 286 ~~t~~f~~~~~lG~G~~---------------avk~~~~~~~~~~~~~~~Ei~il~~l~H~niv~l~~~~~~~~~~~lV~ 350 (608)
...++|++.+.||+|++ |+|.... +....+.+.+|+.++++++||||+++++++.+....++||
T Consensus 10 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 88 (288)
T 3kfa_A 10 MERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKE-DTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIIT 88 (288)
T ss_dssp CCGGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECS-CSTHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEE
T ss_pred ccccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCc-CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCEEEEE
Confidence 35667899999999974 6666653 3445788999999999999999999999999999999999
Q ss_pred eecCCCccchhccccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEEcCCCcEEEeeccCccccccC
Q 044312 351 EFIPNGTLFQYIHDQNEDFPITWEIRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVD 430 (608)
Q Consensus 351 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGls~~~~~~ 430 (608)
||+++++|.+++..... ..+++..++.++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++.....
T Consensus 89 e~~~~~~L~~~~~~~~~-~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~ 164 (288)
T 3kfa_A 89 EFMTYGNLLDYLRECNR-QEVSAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGD 164 (288)
T ss_dssp ECCTTEEHHHHHHHCCT-TTSCHHHHHHHHHHHHHHHHHHHHHT---CCCSCCSGGGEEECGGGCEEECCCCGGGTSCSS
T ss_pred EcCCCCcHHHHHHhccc-CCccHhHHHHHHHHHHHHHHHHHHCC---ccCCCCCcceEEEcCCCCEEEccCccceeccCC
Confidence 99999999999986443 25999999999999999999999999 999999999999999999999999999877655
Q ss_pred CcceeeeeeccCCCCChhhhccCCCCCccchHhHHHHHHHHHh-CCCCCCccchhhcccHHHHHHHHhhhhhhHHHhhhh
Q 044312 431 QTHMTTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLTELLT-GEKPIRFTILEEDKSLAAYFLCAMKEERLFEILDAR 509 (608)
Q Consensus 431 ~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~ellt-g~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 509 (608)
.........+|+.|+|||.+.+..++.++||||||+++++|++ |..||...... .+.+.+...
T Consensus 165 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~~g~~p~~~~~~~----------------~~~~~~~~~ 228 (288)
T 3kfa_A 165 TYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLS----------------QVYELLEKD 228 (288)
T ss_dssp SSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGG----------------GHHHHHHTT
T ss_pred ccccccCCccccCcCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHH----------------HHHHHHhcc
Confidence 4444455667889999999999999999999999999999999 99998643221 112222222
Q ss_pred hhccCChhHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhhHHh
Q 044312 510 VMKQGGKDEIITVAKLAKRCLNLNGKKRPTMREVASELAGIKAW 553 (608)
Q Consensus 510 ~~~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~evl~~L~~i~~~ 553 (608)
.....+...+..+.+|+.+||+.||++|||+.|+++.|+.+...
T Consensus 229 ~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~~~~l~~~~~~ 272 (288)
T 3kfa_A 229 YRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQE 272 (288)
T ss_dssp CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred CCCCCCCCCCHHHHHHHHHHhCCChhhCcCHHHHHHHHHHHHHh
Confidence 23344456677899999999999999999999999999888664
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-39 Score=329.74 Aligned_cols=245 Identities=26% Similarity=0.400 Sum_probs=185.1
Q ss_pred HhcCccccceeccCce------------------EEEEEee-cChhhHHHHHHHHHHHhhcCCCCccceecccccCccce
Q 044312 287 ATDNFDLNRILGQGGQ------------------AVKKSKV-IDESKVEEFINEVVILSQINHRNVVKLLGCCLETEVPL 347 (608)
Q Consensus 287 ~t~~f~~~~~lG~G~~------------------avk~~~~-~~~~~~~~~~~Ei~il~~l~H~niv~l~~~~~~~~~~~ 347 (608)
..++|++.+.||+|++ |+|..+. ......+.|.+|+.++++++||||+++++++. .+..+
T Consensus 13 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~ 91 (281)
T 1mp8_A 13 QRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVW 91 (281)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSCE
T ss_pred ehHHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCccceEEEEEc-cCccE
Confidence 3467889999999975 3333322 22344678999999999999999999999984 45789
Q ss_pred EEEeecCCCccchhccccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEEcCCCcEEEeeccCcccc
Q 044312 348 LVYEFIPNGTLFQYIHDQNEDFPITWEIRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSM 427 (608)
Q Consensus 348 lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGls~~~ 427 (608)
+||||+++++|.+++..... .+++..++.++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++..
T Consensus 92 lv~e~~~~~~L~~~l~~~~~--~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~ 166 (281)
T 1mp8_A 92 IIMELCTLGELRSFLQVRKY--SLDLASLILYAYQLSTALAYLESKR---FVHRDIAARNVLVSSNDCVKLGDFGLSRYM 166 (281)
T ss_dssp EEEECCTTEEHHHHHHHTTT--TSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECC-------
T ss_pred EEEecCCCCCHHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHhCC---eecccccHHHEEECCCCCEEECcccccccc
Confidence 99999999999999976432 5899999999999999999999999 999999999999999999999999999876
Q ss_pred ccCCcceeeeeeccCCCCChhhhccCCCCCccchHhHHHHHHHHHh-CCCCCCccchhhcccHHHHHHHHhhhhhhHHHh
Q 044312 428 AVDQTHMTTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLTELLT-GEKPIRFTILEEDKSLAAYFLCAMKEERLFEIL 506 (608)
Q Consensus 428 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~ellt-g~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 506 (608)
............+|+.|+|||.+....++.++||||||++++||++ |..||......+ .. ..+
T Consensus 167 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~pf~~~~~~~---~~-------------~~i 230 (281)
T 1mp8_A 167 EDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNND---VI-------------GRI 230 (281)
T ss_dssp ------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGG---HH-------------HHH
T ss_pred CcccccccccCCCcccccChhhcccCCCCCccCchHHHHHHHHHHhcCCCCCCcCCHHH---HH-------------HHH
Confidence 5443333344557789999999999999999999999999999997 999987432211 11 111
Q ss_pred hhhhhccCChhHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhhHHh
Q 044312 507 DARVMKQGGKDEIITVAKLAKRCLNLNGKKRPTMREVASELAGIKAW 553 (608)
Q Consensus 507 d~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~evl~~L~~i~~~ 553 (608)
........+...+..+.+|+.+||+.||++|||+.|+++.|+.+...
T Consensus 231 ~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~ 277 (281)
T 1mp8_A 231 ENGERLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEE 277 (281)
T ss_dssp HTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HcCCCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHH
Confidence 11111223445667899999999999999999999999999988653
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-39 Score=335.28 Aligned_cols=252 Identities=27% Similarity=0.441 Sum_probs=202.9
Q ss_pred HHHHHhcCccccceeccCce--------------------EEEEEee-cChhhHHHHHHHHHHHhhcCCCCccceecccc
Q 044312 283 ELEKATDNFDLNRILGQGGQ--------------------AVKKSKV-IDESKVEEFINEVVILSQINHRNVVKLLGCCL 341 (608)
Q Consensus 283 ~l~~~t~~f~~~~~lG~G~~--------------------avk~~~~-~~~~~~~~~~~Ei~il~~l~H~niv~l~~~~~ 341 (608)
++....++|.+.+.||+|++ |||..+. ......+.+.+|+.++++++||||+++++++.
T Consensus 17 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~ 96 (314)
T 2ivs_A 17 KWEFPRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIKLYGACS 96 (314)
T ss_dssp TTBCCGGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEC
T ss_pred ccccchhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCceeeEEEEEe
Confidence 33445678899999999974 3444432 23345678999999999999999999999999
Q ss_pred cCccceEEEeecCCCccchhccccCC---------------------CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeec
Q 044312 342 ETEVPLLVYEFIPNGTLFQYIHDQNE---------------------DFPITWEIRLRIAIEVSGALSYLHSAASIPIYH 400 (608)
Q Consensus 342 ~~~~~~lV~E~~~~gsL~~~l~~~~~---------------------~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH 400 (608)
+.+..++||||+++++|.+++..... ...+++..++.++.||+.||+|||+++ |+|
T Consensus 97 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH 173 (314)
T 2ivs_A 97 QDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMK---LVH 173 (314)
T ss_dssp SSSSCEEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHHTT---EEC
T ss_pred cCCceEEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHHCC---Ccc
Confidence 99999999999999999999986432 124899999999999999999999999 999
Q ss_pred cCCCCCcEEEcCCCcEEEeeccCccccccCCcc-eeeeeeccCCCCChhhhccCCCCCccchHhHHHHHHHHHh-CCCCC
Q 044312 401 RDIKSTNILLDDKYRAKVSDFGASRSMAVDQTH-MTTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLTELLT-GEKPI 478 (608)
Q Consensus 401 rDlk~~NILl~~~~~~kl~DFGls~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~ellt-g~~p~ 478 (608)
|||||+|||++.++.+||+|||+++........ ......+|+.|+|||.+.+..++.++||||||++++||++ |+.||
T Consensus 174 ~dikp~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~ 253 (314)
T 2ivs_A 174 RDLAARNILVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPY 253 (314)
T ss_dssp CCCSGGGEEEETTTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSS
T ss_pred cccchheEEEcCCCCEEEccccccccccccccceeccCCCCcccccChhhhcCCCcCchhhHHHHHHHHHHHHhCCCCCC
Confidence 999999999999999999999999876543322 2233456788999999999999999999999999999999 99998
Q ss_pred CccchhhcccHHHHHHHHhhhhhhHHHhhhhhhccCChhHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhhHHh
Q 044312 479 RFTILEEDKSLAAYFLCAMKEERLFEILDARVMKQGGKDEIITVAKLAKRCLNLNGKKRPTMREVASELAGIKAW 553 (608)
Q Consensus 479 ~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~evl~~L~~i~~~ 553 (608)
....... +.+.+........+...+..+.+|+.+||+.||++|||+.||+++|+.+...
T Consensus 254 ~~~~~~~----------------~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~ 312 (314)
T 2ivs_A 254 PGIPPER----------------LFNLLKTGHRMERPDNCSEEMYRLMLQCWKQEPDKRPVFADISKDLEKMMVK 312 (314)
T ss_dssp TTCCGGG----------------HHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred CCCCHHH----------------HHHHhhcCCcCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhh
Confidence 6432211 1112222222233445677899999999999999999999999999988654
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-40 Score=355.82 Aligned_cols=250 Identities=24% Similarity=0.382 Sum_probs=196.7
Q ss_pred HHHHHHhcCccccceeccCce--------------EEEEEeecChhhHHHHHHHHHHHhhcCCCCccceecccccCccce
Q 044312 282 KELEKATDNFDLNRILGQGGQ--------------AVKKSKVIDESKVEEFINEVVILSQINHRNVVKLLGCCLETEVPL 347 (608)
Q Consensus 282 ~~l~~~t~~f~~~~~lG~G~~--------------avk~~~~~~~~~~~~~~~Ei~il~~l~H~niv~l~~~~~~~~~~~ 347 (608)
..++...++|.+.++||+|+| |||..+... ...++|.+|+.+|++++||||+++++++.+ +..+
T Consensus 177 ~~~~i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~~~~ 254 (452)
T 1fmk_A 177 DAWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIY 254 (452)
T ss_dssp TCSBCCGGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCE
T ss_pred cccccChhHceeeeeecCCCCeEEEEEEECCCceEEEEEeccCC-CCHHHHHHHHHHHHhCCCCCEeeEEEEEcC-CceE
Confidence 344455678899999999984 666665422 346789999999999999999999999876 6789
Q ss_pred EEEeecCCCccchhccccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEEcCCCcEEEeeccCcccc
Q 044312 348 LVYEFIPNGTLFQYIHDQNEDFPITWEIRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSM 427 (608)
Q Consensus 348 lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGls~~~ 427 (608)
|||||+++|+|.+++...... .+++..++.++.||+.||+|||+++ |+||||||+|||+++++.+||+|||+++..
T Consensus 255 iv~e~~~~gsL~~~l~~~~~~-~~~~~~~~~i~~qi~~~l~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DfG~a~~~ 330 (452)
T 1fmk_A 255 IVTEYMSKGSLLDFLKGETGK-YLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLI 330 (452)
T ss_dssp EEECCCTTCBHHHHHSHHHHT-TCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCCTTC--
T ss_pred EEehhhcCCCHHHHHHhcCCC-CCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChhhEEECCCCCEEECCCccceec
Confidence 999999999999999764322 5899999999999999999999999 999999999999999999999999999876
Q ss_pred ccCCcceeeeeeccCCCCChhhhccCCCCCccchHhHHHHHHHHHh-CCCCCCccchhhcccHHHHHHHHhhhhhhHHHh
Q 044312 428 AVDQTHMTTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLTELLT-GEKPIRFTILEEDKSLAAYFLCAMKEERLFEIL 506 (608)
Q Consensus 428 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~ellt-g~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 506 (608)
............++..|+|||.+....++.++||||||++||||++ |+.||......+ +.+.+
T Consensus 331 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~----------------~~~~i 394 (452)
T 1fmk_A 331 EDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNRE----------------VLDQV 394 (452)
T ss_dssp ------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHH----------------HHHHH
T ss_pred CCCceecccCCcccccccCHhHHhcCCCCccccHHhHHHHHHHHHhCCCCCCCCCCHHH----------------HHHHH
Confidence 5433333334557889999999999999999999999999999999 999986332111 11111
Q ss_pred hhhhhccCChhHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhhHHh
Q 044312 507 DARVMKQGGKDEIITVAKLAKRCLNLNGKKRPTMREVASELAGIKAW 553 (608)
Q Consensus 507 d~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~evl~~L~~i~~~ 553 (608)
........+...+..+.+|+.+||+.||++|||+.+|++.|+.+...
T Consensus 395 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~l~~~L~~~~~~ 441 (452)
T 1fmk_A 395 ERGYRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTS 441 (452)
T ss_dssp HTTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSC
T ss_pred HcCCCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhcc
Confidence 12222334456678899999999999999999999999999887643
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-39 Score=330.18 Aligned_cols=248 Identities=27% Similarity=0.433 Sum_probs=195.0
Q ss_pred hcCccccceeccCce---------------EEEEEeec---ChhhHHHHHHHHHHHhhcCCCCccceecccccCccceEE
Q 044312 288 TDNFDLNRILGQGGQ---------------AVKKSKVI---DESKVEEFINEVVILSQINHRNVVKLLGCCLETEVPLLV 349 (608)
Q Consensus 288 t~~f~~~~~lG~G~~---------------avk~~~~~---~~~~~~~~~~Ei~il~~l~H~niv~l~~~~~~~~~~~lV 349 (608)
.++|++.+.||+|++ |+|..... .....+.|.+|+.++++++||||+++++++.+.+..++|
T Consensus 10 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv 89 (294)
T 4eqm_A 10 NERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEEDDCYYLV 89 (294)
T ss_dssp ETTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEECSSEEEEE
T ss_pred hccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEeeeeCCeEEEE
Confidence 457899999999974 67766432 334567899999999999999999999999999999999
Q ss_pred EeecCCCccchhccccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEEcCCCcEEEeeccCcccccc
Q 044312 350 YEFIPNGTLFQYIHDQNEDFPITWEIRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAV 429 (608)
Q Consensus 350 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGls~~~~~ 429 (608)
|||+++++|.+++.... ++++..++.++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++....
T Consensus 90 ~e~~~g~~L~~~l~~~~---~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 163 (294)
T 4eqm_A 90 MEYIEGPTLSEYIESHG---PLSVDTAINFTNQILDGIKHAHDMR---IVHRDIKPQNILIDSNKTLKIFDFGIAKALSE 163 (294)
T ss_dssp EECCCSCBHHHHHHHHC---SCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCSSSTTC--
T ss_pred EeCCCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEEeCCCcccccc
Confidence 99999999999997654 5899999999999999999999999 99999999999999999999999999987654
Q ss_pred CCcceeeeeeccCCCCChhhhccCCCCCccchHhHHHHHHHHHhCCCCCCccchhhcccHHHHHHHHhhhhhhHHHhhhh
Q 044312 430 DQTHMTTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLTELLTGEKPIRFTILEEDKSLAAYFLCAMKEERLFEILDAR 509 (608)
Q Consensus 430 ~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 509 (608)
..........||+.|+|||.+.+..++.++||||||+++|||++|+.||....... ......... . +.
T Consensus 164 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~------~~~~~~~~~-~-----~~ 231 (294)
T 4eqm_A 164 TSLTQTNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGETAVS------IAIKHIQDS-V-----PN 231 (294)
T ss_dssp -----------CCSSCCHHHHHTCCCCTTHHHHHHHHHHHHHHHSSCSSCSSCHHH------HHHHHHSSC-C-----CC
T ss_pred ccccccCccccCccccCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHH------HHHHHhhcc-C-----CC
Confidence 44334445679999999999999999999999999999999999999997432211 111111111 0 01
Q ss_pred hhccCChhHHHHHHHHHHHHhccCCCCCC-CHHHHHHHHHhhHHh
Q 044312 510 VMKQGGKDEIITVAKLAKRCLNLNGKKRP-TMREVASELAGIKAW 553 (608)
Q Consensus 510 ~~~~~~~~~~~~l~~Li~~cl~~dp~~RP-s~~evl~~L~~i~~~ 553 (608)
.........+..+.+++.+||+.||++|| +++++.+.|+.+...
T Consensus 232 ~~~~~~~~~~~~l~~li~~~l~~dp~~R~~~~~~l~~~l~~~~~~ 276 (294)
T 4eqm_A 232 VTTDVRKDIPQSLSNVILRATEKDKANRYKTIQEMKDDLSSVLHE 276 (294)
T ss_dssp HHHHSCTTSCHHHHHHHHHHSCSSGGGSCSSHHHHHHHHHTSSSS
T ss_pred cchhcccCCCHHHHHHHHHHhcCCHhHccccHHHHHHHHHHHHhh
Confidence 11122334567899999999999999998 899999988876543
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-39 Score=328.83 Aligned_cols=244 Identities=25% Similarity=0.414 Sum_probs=196.8
Q ss_pred HhcCccccceeccCce--------------EEEEEeecChhhHHHHHHHHHHHhhcCCCCccceecccccCccceEEEee
Q 044312 287 ATDNFDLNRILGQGGQ--------------AVKKSKVIDESKVEEFINEVVILSQINHRNVVKLLGCCLETEVPLLVYEF 352 (608)
Q Consensus 287 ~t~~f~~~~~lG~G~~--------------avk~~~~~~~~~~~~~~~Ei~il~~l~H~niv~l~~~~~~~~~~~lV~E~ 352 (608)
..++|++.+.||+|++ |||+.+.. ....+++.+|++++++++||||+++++++.+....++||||
T Consensus 22 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 100 (283)
T 3gen_A 22 DPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEG-SMSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEY 100 (283)
T ss_dssp CGGGEEEEEECC---CEEEEEEEETTTEEEEEEEECTT-SBCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEECC
T ss_pred CHHHHHhHhhcCCCCCceEEEEEEcCCCeEEEEEecCC-CCCHHHHHHHHHHHhcCCCCCEeeEEEEEecCCCeEEEEec
Confidence 4567889999999985 55555432 23457899999999999999999999999999999999999
Q ss_pred cCCCccchhccccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEEcCCCcEEEeeccCccccccCCc
Q 044312 353 IPNGTLFQYIHDQNEDFPITWEIRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQT 432 (608)
Q Consensus 353 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGls~~~~~~~~ 432 (608)
+++++|.+++..... .+++..++.++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++.......
T Consensus 101 ~~~~~L~~~l~~~~~--~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~ 175 (283)
T 3gen_A 101 MANGCLLNYLREMRH--RFQTQQLLEMCKDVCEAMEYLESKQ---FLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEY 175 (283)
T ss_dssp CTTCBHHHHHHCGGG--CCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCSGGGEEECTTSCEEECSTTGGGGBCCHHH
T ss_pred cCCCcHHHHHHHhcc--CCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCCccceEEEcCCCCEEEcccccccccccccc
Confidence 999999999976433 4899999999999999999999999 99999999999999999999999999987654332
Q ss_pred ceeeeeeccCCCCChhhhccCCCCCccchHhHHHHHHHHHh-CCCCCCccchhhcccHHHHHHHHhhhhhhHHHhhhhhh
Q 044312 433 HMTTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLTELLT-GEKPIRFTILEEDKSLAAYFLCAMKEERLFEILDARVM 511 (608)
Q Consensus 433 ~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~ellt-g~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~ 511 (608)
.......+|+.|+|||.+....++.++||||||++++||+| |+.||....... ..+.+.....
T Consensus 176 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~t~g~~p~~~~~~~~----------------~~~~~~~~~~ 239 (283)
T 3gen_A 176 TSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSE----------------TAEHIAQGLR 239 (283)
T ss_dssp HSTTSTTSCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTTCCTTTTSCHHH----------------HHHHHHTTCC
T ss_pred ccccCCccCcccCCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCccccChhH----------------HHHHHhcccC
Confidence 22334456788999999999999999999999999999998 999986432211 1111111122
Q ss_pred ccCChhHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhhHH
Q 044312 512 KQGGKDEIITVAKLAKRCLNLNGKKRPTMREVASELAGIKA 552 (608)
Q Consensus 512 ~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~evl~~L~~i~~ 552 (608)
...+...+..+.+|+.+||+.||++|||++|++++|+.+..
T Consensus 240 ~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~~~~ 280 (283)
T 3gen_A 240 LYRPHLASEKVYTIMYSCWHEKADERPTFKILLSNILDVMD 280 (283)
T ss_dssp CCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CCCCCcCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHhh
Confidence 22334456789999999999999999999999999988765
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-39 Score=341.05 Aligned_cols=253 Identities=26% Similarity=0.448 Sum_probs=204.9
Q ss_pred HHHhcCccccceeccCce----------------------EEEEEee-cChhhHHHHHHHHHHHhhc-CCCCccceeccc
Q 044312 285 EKATDNFDLNRILGQGGQ----------------------AVKKSKV-IDESKVEEFINEVVILSQI-NHRNVVKLLGCC 340 (608)
Q Consensus 285 ~~~t~~f~~~~~lG~G~~----------------------avk~~~~-~~~~~~~~~~~Ei~il~~l-~H~niv~l~~~~ 340 (608)
+...++|.+.+.||+|+| |||+.+. ......+.+.+|+++++++ +||||+++++++
T Consensus 65 ~i~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~ 144 (382)
T 3tt0_A 65 ELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGAC 144 (382)
T ss_dssp BCCGGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred ccchhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccccCHHHHHHHHHHHHHHHHhcCCchhhhheeee
Confidence 344578999999999985 3444332 2334567899999999999 999999999999
Q ss_pred ccCccceEEEeecCCCccchhccccCC-------------CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCc
Q 044312 341 LETEVPLLVYEFIPNGTLFQYIHDQNE-------------DFPITWEIRLRIAIEVSGALSYLHSAASIPIYHRDIKSTN 407 (608)
Q Consensus 341 ~~~~~~~lV~E~~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~N 407 (608)
.+.+..++||||+++|+|.+++..... ...+++..++.|+.||+.||+|||+.+ |+||||||+|
T Consensus 145 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~N 221 (382)
T 3tt0_A 145 TQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKK---CIHRDLAARN 221 (382)
T ss_dssp CSSSSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGG
T ss_pred ccCCceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCcce
Confidence 999999999999999999999976431 125899999999999999999999999 9999999999
Q ss_pred EEEcCCCcEEEeeccCccccccCCc-ceeeeeeccCCCCChhhhccCCCCCccchHhHHHHHHHHHh-CCCCCCccchhh
Q 044312 408 ILLDDKYRAKVSDFGASRSMAVDQT-HMTTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLTELLT-GEKPIRFTILEE 485 (608)
Q Consensus 408 ILl~~~~~~kl~DFGls~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~ellt-g~~p~~~~~~~~ 485 (608)
||++.++.+||+|||+++....... .......+|+.|+|||++.+..++.++||||||++++||++ |..||......
T Consensus 222 Ill~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~ellt~g~~p~~~~~~~- 300 (382)
T 3tt0_A 222 VLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVE- 300 (382)
T ss_dssp EEECTTCCEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHH-
T ss_pred EEEcCCCcEEEcccCcccccccccccccccCCCCCcceeCHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCHH-
Confidence 9999999999999999987653322 22334457889999999999999999999999999999999 99998633211
Q ss_pred cccHHHHHHHHhhhhhhHHHhhhhhhccCChhHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhhHHhcCC
Q 044312 486 DKSLAAYFLCAMKEERLFEILDARVMKQGGKDEIITVAKLAKRCLNLNGKKRPTMREVASELAGIKAWNGA 556 (608)
Q Consensus 486 ~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~evl~~L~~i~~~~~~ 556 (608)
.+.+.+........+...+.++.+|+.+||+.||++|||++||+++|+.+......
T Consensus 301 ---------------~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~~~ 356 (382)
T 3tt0_A 301 ---------------ELFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVALTSN 356 (382)
T ss_dssp ---------------HHHHHHHTTCCCCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHSCS
T ss_pred ---------------HHHHHHHcCCCCCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHHhc
Confidence 11122222222334445667899999999999999999999999999999876543
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-39 Score=348.75 Aligned_cols=241 Identities=27% Similarity=0.482 Sum_probs=198.5
Q ss_pred HhcCccccceeccCce-------------EEEEEeecChhhHHHHHHHHHHHhhcCCCCccceecccccCc-cceEEEee
Q 044312 287 ATDNFDLNRILGQGGQ-------------AVKKSKVIDESKVEEFINEVVILSQINHRNVVKLLGCCLETE-VPLLVYEF 352 (608)
Q Consensus 287 ~t~~f~~~~~lG~G~~-------------avk~~~~~~~~~~~~~~~Ei~il~~l~H~niv~l~~~~~~~~-~~~lV~E~ 352 (608)
..++|++.+.||+|+| |||..+. ....+.|.+|+.+|++++||||+++++++.+.. ..+|||||
T Consensus 191 ~~~~~~~~~~lG~G~fg~V~~~~~~~~~vavK~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~iv~e~ 268 (450)
T 1k9a_A 191 NMKELKLLQTIGKGEFGDVMLGDYRGNKVAVKCIKN--DATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEY 268 (450)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTEEEEEEEESS--CTTSHHHHHHHHHHHTCCCTTBCCEEEEEECTTSCEEEEEEC
T ss_pred ChHHeEEEeeecCcCCeeEEEEEecCCeEEEEEeCC--chHHHHHHHHHHHHHhccCCCEEEEEEEEEcCCCceEEEEEe
Confidence 4567889999999985 6776654 335678999999999999999999999987665 78999999
Q ss_pred cCCCccchhccccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEEcCCCcEEEeeccCccccccCCc
Q 044312 353 IPNGTLFQYIHDQNEDFPITWEIRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQT 432 (608)
Q Consensus 353 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGls~~~~~~~~ 432 (608)
+++|+|.+++...... .+++..++.++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++.....
T Consensus 269 ~~~g~L~~~l~~~~~~-~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~-- 342 (450)
T 1k9a_A 269 MAKGSLVDYLRSRGRS-VLGGDCLLKFSLDVCEAMEYLEGNN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASST-- 342 (450)
T ss_dssp CTTCBHHHHHHHHCTT-TCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTSCEEECCCTTCEECC----
T ss_pred cCCCcHHHHHHhcCCC-CCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCHhhEEECCCCCEEEeeCCCccccccc--
Confidence 9999999999875432 4799999999999999999999999 999999999999999999999999999854322
Q ss_pred ceeeeeeccCCCCChhhhccCCCCCccchHhHHHHHHHHHh-CCCCCCccchhhcccHHHHHHHHhhhhhhHHHhhhhhh
Q 044312 433 HMTTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLTELLT-GEKPIRFTILEEDKSLAAYFLCAMKEERLFEILDARVM 511 (608)
Q Consensus 433 ~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~ellt-g~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~ 511 (608)
.....+++.|+|||.+.+..++.++||||||++||||+| |+.||......+ +...+.....
T Consensus 343 --~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~----------------~~~~i~~~~~ 404 (450)
T 1k9a_A 343 --QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKD----------------VVPRVEKGYK 404 (450)
T ss_dssp ------CCCTTTSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTTCCSSTTSCTTT----------------HHHHHHTTCC
T ss_pred --ccCCCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHH----------------HHHHHHcCCC
Confidence 122357889999999999999999999999999999998 999987432211 1111222223
Q ss_pred ccCChhHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhhHHh
Q 044312 512 KQGGKDEIITVAKLAKRCLNLNGKKRPTMREVASELAGIKAW 553 (608)
Q Consensus 512 ~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~evl~~L~~i~~~ 553 (608)
...+..++..+.+|+.+||+.||++|||+.||++.|+.+...
T Consensus 405 ~~~p~~~~~~l~~li~~cl~~dp~~Rpt~~~l~~~L~~i~~~ 446 (450)
T 1k9a_A 405 MDAPDGCPPAVYDVMKNCWHLDAATRPTFLQLREQLEHIRTH 446 (450)
T ss_dssp CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred CCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHHh
Confidence 344556778899999999999999999999999999988764
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-39 Score=337.32 Aligned_cols=242 Identities=23% Similarity=0.452 Sum_probs=193.6
Q ss_pred cCccccceeccCce-------------------EEEEEee-cChhhHHHHHHHHHHHhhcCCCCccceecccccCccceE
Q 044312 289 DNFDLNRILGQGGQ-------------------AVKKSKV-IDESKVEEFINEVVILSQINHRNVVKLLGCCLETEVPLL 348 (608)
Q Consensus 289 ~~f~~~~~lG~G~~-------------------avk~~~~-~~~~~~~~~~~Ei~il~~l~H~niv~l~~~~~~~~~~~l 348 (608)
++|++.+.||+|+| |+|..+. ......+.|.+|+.++++++||||+++++++.+.. .++
T Consensus 15 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-~~~ 93 (327)
T 3poz_A 15 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQL 93 (327)
T ss_dssp GGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC-------CHHHHHHHHHHHHHCCBTTBCCEEEEEESSS-EEE
T ss_pred HHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCC-eEE
Confidence 46888999999985 3333321 22345678999999999999999999999998754 789
Q ss_pred EEeecCCCccchhccccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEEcCCCcEEEeeccCccccc
Q 044312 349 VYEFIPNGTLFQYIHDQNEDFPITWEIRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMA 428 (608)
Q Consensus 349 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGls~~~~ 428 (608)
|+||+++|+|.+++..... .+++..++.|+.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++...
T Consensus 94 v~e~~~~g~L~~~l~~~~~--~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~ 168 (327)
T 3poz_A 94 ITQLMPFGCLLDYVREHKD--NIGSQYLLNWCVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLG 168 (327)
T ss_dssp EEECCTTCBHHHHHHHSTT--SCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEETTEEEECCTTHHHHHT
T ss_pred EEEecCCCcHHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHhhCC---eeCCCCChheEEECCCCCEEEccCcceeEcc
Confidence 9999999999999987543 5899999999999999999999999 9999999999999999999999999998765
Q ss_pred cCCcc-eeeeeeccCCCCChhhhccCCCCCccchHhHHHHHHHHHh-CCCCCCccchhhcccHHHHHHHHhhhhhhHHHh
Q 044312 429 VDQTH-MTTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLTELLT-GEKPIRFTILEEDKSLAAYFLCAMKEERLFEIL 506 (608)
Q Consensus 429 ~~~~~-~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~ellt-g~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 506 (608)
..... ......+|+.|+|||++.+..++.++||||||++++||+| |+.||...... .+...+
T Consensus 169 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~----------------~~~~~~ 232 (327)
T 3poz_A 169 AEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPAS----------------EISSIL 232 (327)
T ss_dssp TTCC-------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGG----------------GHHHHH
T ss_pred CCcccccccCCCccccccChHHhccCCCCchhhhhhhHHHHHHHHhcCCCCccCCCHH----------------HHHHHH
Confidence 43322 2234456889999999999999999999999999999999 99998643221 122222
Q ss_pred hhhhhccCChhHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhhHH
Q 044312 507 DARVMKQGGKDEIITVAKLAKRCLNLNGKKRPTMREVASELAGIKA 552 (608)
Q Consensus 507 d~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~evl~~L~~i~~ 552 (608)
........+...+..+.+|+.+||+.||++||++.||+++|+.+..
T Consensus 233 ~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~l~~~~~ 278 (327)
T 3poz_A 233 EKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMAR 278 (327)
T ss_dssp HTTCCCCCCTTBCHHHHHHHHHHTCSCGGGSCCHHHHHHHHHHHHT
T ss_pred HcCCCCCCCccCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHh
Confidence 2222333445567789999999999999999999999999988754
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-38 Score=331.14 Aligned_cols=250 Identities=26% Similarity=0.372 Sum_probs=202.7
Q ss_pred cccCCHHHHHHHhcC----------ccccceeccCce---------------EEEEEeecChhhHHHHHHHHHHHhhcCC
Q 044312 276 TKLFTSKELEKATDN----------FDLNRILGQGGQ---------------AVKKSKVIDESKVEEFINEVVILSQINH 330 (608)
Q Consensus 276 ~~~~~~~~l~~~t~~----------f~~~~~lG~G~~---------------avk~~~~~~~~~~~~~~~Ei~il~~l~H 330 (608)
...++.++++.+++. |+..+.||+|++ |||+.........+.+.+|+.++++++|
T Consensus 22 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h 101 (321)
T 2c30_A 22 SGVVTHEQFKAALRMVVDQGDPRLLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQH 101 (321)
T ss_dssp ---CCHHHHHHHHHTTSCSSCHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCSHHHHHHHHHHHTTCCC
T ss_pred CCcCcHHHHHHHHhhccCCCCchhhhhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccchhHHHHHHHHHHHHHhCCC
Confidence 356888888888765 677789999974 7888776666677889999999999999
Q ss_pred CCccceecccccCccceEEEeecCCCccchhccccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEE
Q 044312 331 RNVVKLLGCCLETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEIRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILL 410 (608)
Q Consensus 331 ~niv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl 410 (608)
|||+++++++...+..++||||+++++|.+++... .+++..+..++.|++.||+|||+.+ |+||||||+|||+
T Consensus 102 ~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~----~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll 174 (321)
T 2c30_A 102 FNVVEMYKSYLVGEELWVLMEFLQGGALTDIVSQV----RLNEEQIATVCEAVLQALAYLHAQG---VIHRDIKSDSILL 174 (321)
T ss_dssp TTBCCEEEEEEETTEEEEEECCCCSCBHHHHHTTC----CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEE
T ss_pred CCcceEEEEEEECCEEEEEEecCCCCCHHHHHHhc----CCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEE
Confidence 99999999999999999999999999999988643 4899999999999999999999999 9999999999999
Q ss_pred cCCCcEEEeeccCccccccCCcceeeeeeccCCCCChhhhccCCCCCccchHhHHHHHHHHHhCCCCCCccchhhcccHH
Q 044312 411 DDKYRAKVSDFGASRSMAVDQTHMTTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLTELLTGEKPIRFTILEEDKSLA 490 (608)
Q Consensus 411 ~~~~~~kl~DFGls~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~elltg~~p~~~~~~~~~~~l~ 490 (608)
+.++.+||+|||+++....... ......||+.|+|||++.+..++.++||||||++++||++|+.||.......
T Consensus 175 ~~~~~~kl~Dfg~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~pf~~~~~~~----- 248 (321)
T 2c30_A 175 TLDGRVKLSDFGFCAQISKDVP-KRKSLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPYFSDSPVQ----- 248 (321)
T ss_dssp CTTCCEEECCCTTCEECCSSSC-CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHH-----
T ss_pred CCCCcEEEeeeeeeeecccCcc-ccccccCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH-----
Confidence 9999999999999987654322 2344579999999999999999999999999999999999999986332111
Q ss_pred HHHHHHhhhhhhHHHhhhhhhccCChhHHHHHHHHHHHHhccCCCCCCCHHHHHHHH
Q 044312 491 AYFLCAMKEERLFEILDARVMKQGGKDEIITVAKLAKRCLNLNGKKRPTMREVASEL 547 (608)
Q Consensus 491 ~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~evl~~L 547 (608)
.. ..+... ..+ ........+..+.+|+.+||+.||++|||+.|++++-
T Consensus 249 -~~-~~~~~~-----~~~--~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~hp 296 (321)
T 2c30_A 249 -AM-KRLRDS-----PPP--KLKNSHKVSPVLRDFLERMLVRDPQERATAQELLDHP 296 (321)
T ss_dssp -HH-HHHHHS-----SCC--CCTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHHTSG
T ss_pred -HH-HHHhcC-----CCC--CcCccccCCHHHHHHHHHHccCChhhCcCHHHHhcCh
Confidence 00 011100 000 0011223456799999999999999999999998753
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-38 Score=323.97 Aligned_cols=255 Identities=15% Similarity=0.142 Sum_probs=201.1
Q ss_pred hcCccccceeccCce---------------EEEEEeecChhhHHHHHHHHHHHhhc-CCCCccceecccccCccceEEEe
Q 044312 288 TDNFDLNRILGQGGQ---------------AVKKSKVIDESKVEEFINEVVILSQI-NHRNVVKLLGCCLETEVPLLVYE 351 (608)
Q Consensus 288 t~~f~~~~~lG~G~~---------------avk~~~~~~~~~~~~~~~Ei~il~~l-~H~niv~l~~~~~~~~~~~lV~E 351 (608)
.++|++.+.||+|++ |||.... ....+.+.+|+.+++++ +|+|++++++++.+....++|||
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~--~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv~e 86 (298)
T 1csn_A 9 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPR--RSDAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVID 86 (298)
T ss_dssp TTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEEC--CTTSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEE
T ss_pred ccceEEEEEEeecCCEEEEEEEECCCCcEEEEEEecc--CCccHHHHHHHHHHHHHhcCCCCCeEEeecCCCceeEEEEE
Confidence 457899999999974 6666543 23445788999999999 89999999999999999999999
Q ss_pred ecCCCccchhccccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEEcCCCc-----EEEeeccCccc
Q 044312 352 FIPNGTLFQYIHDQNEDFPITWEIRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYR-----AKVSDFGASRS 426 (608)
Q Consensus 352 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~-----~kl~DFGls~~ 426 (608)
|+ +++|.+++..... ++++..++.++.||+.||+|||+.+ |+||||||+|||++.++. +||+|||+++.
T Consensus 87 ~~-~~~L~~~l~~~~~--~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~~~~ 160 (298)
T 1csn_A 87 LL-GPSLEDLLDLCGR--KFSVKTVAMAAKQMLARVQSIHEKS---LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKF 160 (298)
T ss_dssp CC-CCBHHHHHHHTTT--CCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECCSSSTTTTCEEECCCTTCEE
T ss_pred ec-CCCHHHHHHHhcc--CCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEeccCCCCCCCeEEEEECccccc
Confidence 99 9999999986543 5899999999999999999999999 999999999999987765 99999999987
Q ss_pred cccCCcc------eeeeeeccCCCCChhhhccCCCCCccchHhHHHHHHHHHhCCCCCCccchhhcccHHHHHHHHhhhh
Q 044312 427 MAVDQTH------MTTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLTELLTGEKPIRFTILEEDKSLAAYFLCAMKEE 500 (608)
Q Consensus 427 ~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~ 500 (608)
....... ......||+.|+|||.+.+..++.++||||||++++||++|+.||......................
T Consensus 161 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 240 (298)
T 1csn_A 161 YRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQST 240 (298)
T ss_dssp SBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHHS
T ss_pred cccccccccccccCccCCCCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHcCCCCcchhhccccHHHHHHHHhhccCc
Confidence 6543221 2345579999999999999999999999999999999999999997533222111111111000000
Q ss_pred hhHHHhhhhhhccCChhHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhhHHhcCCCch
Q 044312 501 RLFEILDARVMKQGGKDEIITVAKLAKRCLNLNGKKRPTMREVASELAGIKAWNGASNV 559 (608)
Q Consensus 501 ~~~~~~d~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~evl~~L~~i~~~~~~~~~ 559 (608)
.. .......+.++.+|+.+||+.||++||++++|++.|+.+....+....
T Consensus 241 ~~---------~~~~~~~~~~l~~li~~~l~~dp~~RP~~~~l~~~l~~~~~~~~~~~~ 290 (298)
T 1csn_A 241 PL---------RELCAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLERLNTTED 290 (298)
T ss_dssp CH---------HHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHTTCCSC
T ss_pred cH---------HHHHhhCcHHHHHHHHHHhcCCcccCCCHHHHHHHHHHHHHhcCCCCC
Confidence 00 011123456899999999999999999999999999999876554443
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-39 Score=340.76 Aligned_cols=247 Identities=25% Similarity=0.366 Sum_probs=198.5
Q ss_pred hcCccccceeccCce--------------------EEEEEee-cChhhHHHHHHHHHHHhhcCCCCccceecccccCccc
Q 044312 288 TDNFDLNRILGQGGQ--------------------AVKKSKV-IDESKVEEFINEVVILSQINHRNVVKLLGCCLETEVP 346 (608)
Q Consensus 288 t~~f~~~~~lG~G~~--------------------avk~~~~-~~~~~~~~~~~Ei~il~~l~H~niv~l~~~~~~~~~~ 346 (608)
.++|.+.+.||+|+| |||+++. ........+.+|+.++++++||||+++++++.+....
T Consensus 70 ~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~ 149 (367)
T 3l9p_A 70 RKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPR 149 (367)
T ss_dssp GGGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred HhHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccccChhhHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCC
Confidence 457889999999974 4554432 2345566899999999999999999999999999999
Q ss_pred eEEEeecCCCccchhccccCC----CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEEcCCC---cEEEe
Q 044312 347 LLVYEFIPNGTLFQYIHDQNE----DFPITWEIRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKY---RAKVS 419 (608)
Q Consensus 347 ~lV~E~~~~gsL~~~l~~~~~----~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~---~~kl~ 419 (608)
++||||+++|+|.+++..... ...+++..++.++.||+.||+|||+.+ |+||||||+|||++.++ .+||+
T Consensus 150 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~~~~~kL~ 226 (367)
T 3l9p_A 150 FILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENH---FIHRDIAARNCLLTCPGPGRVAKIG 226 (367)
T ss_dssp EEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESCSSTTCCEEEC
T ss_pred EEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChhhEEEecCCCCceEEEC
Confidence 999999999999999986432 235899999999999999999999999 99999999999999544 59999
Q ss_pred eccCccccccCC-cceeeeeeccCCCCChhhhccCCCCCccchHhHHHHHHHHHh-CCCCCCccchhhcccHHHHHHHHh
Q 044312 420 DFGASRSMAVDQ-THMTTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLTELLT-GEKPIRFTILEEDKSLAAYFLCAM 497 (608)
Q Consensus 420 DFGls~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~ellt-g~~p~~~~~~~~~~~l~~~~~~~~ 497 (608)
|||+++...... ........+|+.|+|||++.+..++.++||||||++++||++ |..||......
T Consensus 227 DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~pf~~~~~~------------- 293 (367)
T 3l9p_A 227 DFGMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQ------------- 293 (367)
T ss_dssp CCHHHHHHHHHSSCTTCCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHH-------------
T ss_pred CCccccccccccccccCCCcCCcccEECHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHH-------------
Confidence 999998653222 122234557899999999999999999999999999999998 99998633211
Q ss_pred hhhhhHHHhhhhhhccCChhHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhhHHh
Q 044312 498 KEERLFEILDARVMKQGGKDEIITVAKLAKRCLNLNGKKRPTMREVASELAGIKAW 553 (608)
Q Consensus 498 ~~~~~~~~~d~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~evl~~L~~i~~~ 553 (608)
.+.+.+........+...+..+.+|+.+||+.||++|||+.||+++|+.+...
T Consensus 294 ---~~~~~i~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~l~~~~~~ 346 (367)
T 3l9p_A 294 ---EVLEFVTSGGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQD 346 (367)
T ss_dssp ---HHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred ---HHHHHHHcCCCCCCCccCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhhC
Confidence 11111122222233445667899999999999999999999999999988764
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-38 Score=331.57 Aligned_cols=234 Identities=27% Similarity=0.429 Sum_probs=193.4
Q ss_pred hcCccccceeccCce---------------EEEEEeec--ChhhHHHHHHHHHHHhhcCCCCccceecccccCccceEEE
Q 044312 288 TDNFDLNRILGQGGQ---------------AVKKSKVI--DESKVEEFINEVVILSQINHRNVVKLLGCCLETEVPLLVY 350 (608)
Q Consensus 288 t~~f~~~~~lG~G~~---------------avk~~~~~--~~~~~~~~~~Ei~il~~l~H~niv~l~~~~~~~~~~~lV~ 350 (608)
.++|++.+.||+|+| |||+.... +....+.+.+|+++|++++||||+++++++.+....++||
T Consensus 14 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~ 93 (328)
T 3fe3_A 14 IGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIETEKTLYLIM 93 (328)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cCCEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEE
Confidence 457999999999985 67766532 4456678999999999999999999999999999999999
Q ss_pred eecCCCccchhccccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEEcCCCcEEEeeccCccccccC
Q 044312 351 EFIPNGTLFQYIHDQNEDFPITWEIRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVD 430 (608)
Q Consensus 351 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGls~~~~~~ 430 (608)
||+++++|.+++.... .+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++.....
T Consensus 94 e~~~~~~L~~~l~~~~---~l~~~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~ 167 (328)
T 3fe3_A 94 EYASGGEVFDYLVAHG---RMKEKEARSKFRQIVSAVQYCHQKR---IVHRDLKAENLLLDADMNIKIADFGFSNEFTVG 167 (328)
T ss_dssp CCCTTCBHHHHHHHHC---CCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECSTTCCGGGSSS
T ss_pred ECCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---EeccCCCHHHEEEcCCCCEEEeeccCceecCCC
Confidence 9999999999997654 4899999999999999999999999 999999999999999999999999999876533
Q ss_pred CcceeeeeeccCCCCChhhhccCCCC-CccchHhHHHHHHHHHhCCCCCCccchhhcccHHHHHHHHhhhhhhHHHhhhh
Q 044312 431 QTHMTTQVHGTFGYLDPEYFRSSQFT-DKSDVYSFGVVLTELLTGEKPIRFTILEEDKSLAAYFLCAMKEERLFEILDAR 509 (608)
Q Consensus 431 ~~~~~~~~~gt~~y~aPE~~~~~~~t-~ksDV~S~Gvvl~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 509 (608)
. ......||+.|+|||++.+..++ .++||||||++++||++|+.||....... .. . .+...
T Consensus 168 ~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~------~~-~--------~i~~~- 229 (328)
T 3fe3_A 168 G--KLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKE------LR-E--------RVLRG- 229 (328)
T ss_dssp C--GGGTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCSSHHH------HH-H--------HHHHC-
T ss_pred C--ccccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCCCHHH------HH-H--------HHHhC-
Confidence 2 23445699999999999988875 79999999999999999999997432211 11 0 11111
Q ss_pred hhccCChhHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 044312 510 VMKQGGKDEIITVAKLAKRCLNLNGKKRPTMREVASE 546 (608)
Q Consensus 510 ~~~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~evl~~ 546 (608)
....+...+.++.+|+.+||+.||.+|||++|++++
T Consensus 230 -~~~~p~~~s~~~~~li~~~L~~dP~~R~t~~eil~h 265 (328)
T 3fe3_A 230 -KYRIPFYMSTDCENLLKRFLVLNPIKRGTLEQIMKD 265 (328)
T ss_dssp -CCCCCTTSCHHHHHHHHHHCCSSTTTSCCHHHHTTC
T ss_pred -CCCCCCCCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 112233456689999999999999999999999864
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-39 Score=335.08 Aligned_cols=249 Identities=24% Similarity=0.412 Sum_probs=199.0
Q ss_pred HHHhcCccccceeccCce--------------------EEEEEeec-ChhhHHHHHHHHHHHhhcCCCCccceecccccC
Q 044312 285 EKATDNFDLNRILGQGGQ--------------------AVKKSKVI-DESKVEEFINEVVILSQINHRNVVKLLGCCLET 343 (608)
Q Consensus 285 ~~~t~~f~~~~~lG~G~~--------------------avk~~~~~-~~~~~~~~~~Ei~il~~l~H~niv~l~~~~~~~ 343 (608)
....++|++.+.||+|+| |||..+.. .....+.|.+|+.++++++||||+++++++.+.
T Consensus 43 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~ 122 (343)
T 1luf_A 43 EYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAVG 122 (343)
T ss_dssp BCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSS
T ss_pred EecHHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEccC
Confidence 345678999999999974 34443322 233467899999999999999999999999999
Q ss_pred ccceEEEeecCCCccchhccccCC---------------------CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeccC
Q 044312 344 EVPLLVYEFIPNGTLFQYIHDQNE---------------------DFPITWEIRLRIAIEVSGALSYLHSAASIPIYHRD 402 (608)
Q Consensus 344 ~~~~lV~E~~~~gsL~~~l~~~~~---------------------~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrD 402 (608)
+..++||||+++|+|.+++..... ...+++..++.++.||+.||.|||+++ |+|||
T Consensus 123 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~---ivH~D 199 (343)
T 1luf_A 123 KPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERK---FVHRD 199 (343)
T ss_dssp SSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSC
T ss_pred CceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCC
Confidence 999999999999999999976421 136899999999999999999999999 99999
Q ss_pred CCCCcEEEcCCCcEEEeeccCccccccCCc-ceeeeeeccCCCCChhhhccCCCCCccchHhHHHHHHHHHh-CCCCCCc
Q 044312 403 IKSTNILLDDKYRAKVSDFGASRSMAVDQT-HMTTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLTELLT-GEKPIRF 480 (608)
Q Consensus 403 lk~~NILl~~~~~~kl~DFGls~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~ellt-g~~p~~~ 480 (608)
|||+|||++.++.+||+|||+++....... .......+|+.|+|||.+.+..++.++||||||+++|||++ |+.||..
T Consensus 200 lkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~ 279 (343)
T 1luf_A 200 LATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYG 279 (343)
T ss_dssp CSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTT
T ss_pred CCcceEEECCCCeEEEeecCCCcccccCccccccCCCcccceecChhhhccCCcCcccccHHHHHHHHHHHhcCCCcCCC
Confidence 999999999999999999999986643322 22334567899999999999999999999999999999999 9999863
Q ss_pred cchhhcccHHHHHHHHhhhhhhHHHhhhhhhccCChhHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhhHH
Q 044312 481 TILEEDKSLAAYFLCAMKEERLFEILDARVMKQGGKDEIITVAKLAKRCLNLNGKKRPTMREVASELAGIKA 552 (608)
Q Consensus 481 ~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~evl~~L~~i~~ 552 (608)
....+ ....+... .....+...+.++.+|+.+||+.||++|||+.||++.|+.+..
T Consensus 280 ~~~~~-------~~~~~~~~---------~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~L~~~~~ 335 (343)
T 1luf_A 280 MAHEE-------VIYYVRDG---------NILACPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMCE 335 (343)
T ss_dssp SCHHH-------HHHHHHTT---------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC
T ss_pred CChHH-------HHHHHhCC---------CcCCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHHHHHh
Confidence 32111 11111111 1122334566789999999999999999999999999988764
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-38 Score=323.78 Aligned_cols=245 Identities=27% Similarity=0.429 Sum_probs=193.7
Q ss_pred HhcCccccceeccCce------------------EEEEEeec-ChhhHHHHHHHHHHHhhcCCCCccceecccccCccce
Q 044312 287 ATDNFDLNRILGQGGQ------------------AVKKSKVI-DESKVEEFINEVVILSQINHRNVVKLLGCCLETEVPL 347 (608)
Q Consensus 287 ~t~~f~~~~~lG~G~~------------------avk~~~~~-~~~~~~~~~~Ei~il~~l~H~niv~l~~~~~~~~~~~ 347 (608)
..++|.+.+.||+|++ |||..... .....+.|.+|+.++++++||||+++++++.+ +..+
T Consensus 10 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~ 88 (281)
T 3cc6_A 10 AREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEE-EPTW 88 (281)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTSCHHHHHHHHHHHHHHHHHCCTTBCCEEEEECS-SSCE
T ss_pred cccceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEecccccCchHHHHHHHHHHHHHhCCCCCcceEEEEEcC-CCCE
Confidence 3467888999999974 34443322 23456789999999999999999999999865 4568
Q ss_pred EEEeecCCCccchhccccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEEcCCCcEEEeeccCcccc
Q 044312 348 LVYEFIPNGTLFQYIHDQNEDFPITWEIRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSM 427 (608)
Q Consensus 348 lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGls~~~ 427 (608)
+||||+++++|.+++..... .+++..++.++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++..
T Consensus 89 ~v~e~~~~~~L~~~l~~~~~--~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~ 163 (281)
T 3cc6_A 89 IIMELYPYGELGHYLERNKN--SLKVLTLVLYSLQICKAMAYLESIN---CVHRDIAVRNILVASPECVKLGDFGLSRYI 163 (281)
T ss_dssp EEEECCTTCBHHHHHHHHTT--TCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEEEETTEEEECCCCGGGCC
T ss_pred EEEecCCCCCHHHHHHhccc--cCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCccceEEECCCCcEEeCccCCCccc
Confidence 99999999999999976543 5899999999999999999999999 999999999999999999999999999876
Q ss_pred ccCCcceeeeeeccCCCCChhhhccCCCCCccchHhHHHHHHHHHh-CCCCCCccchhhcccHHHHHHHHhhhhhhHHHh
Q 044312 428 AVDQTHMTTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLTELLT-GEKPIRFTILEEDKSLAAYFLCAMKEERLFEIL 506 (608)
Q Consensus 428 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~ellt-g~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 506 (608)
............+++.|+|||.+....++.++||||||++++||++ |+.||....... . ...+
T Consensus 164 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~llt~g~~p~~~~~~~~---~-------------~~~~ 227 (281)
T 3cc6_A 164 EDEDYYKASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENKD---V-------------IGVL 227 (281)
T ss_dssp ---------CCCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCGGG---H-------------HHHH
T ss_pred ccccccccccCCCCcceeCchhhccCCCCchhccHHHHHHHHHHHhCCCCCcccCChHH---H-------------HHHH
Confidence 5443333344567889999999999999999999999999999998 999986332211 1 1111
Q ss_pred hhhhhccCChhHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhhHHh
Q 044312 507 DARVMKQGGKDEIITVAKLAKRCLNLNGKKRPTMREVASELAGIKAW 553 (608)
Q Consensus 507 d~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~evl~~L~~i~~~ 553 (608)
........+...+..+.+|+.+||+.||++|||+.|++++|+.+...
T Consensus 228 ~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~~ 274 (281)
T 3cc6_A 228 EKGDRLPKPDLCPPVLYTLMTRCWDYDPSDRPRFTELVCSLSDVYQM 274 (281)
T ss_dssp HHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred hcCCCCCCCCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHHHHHHh
Confidence 11111223344567899999999999999999999999999988764
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-39 Score=322.27 Aligned_cols=242 Identities=28% Similarity=0.447 Sum_probs=196.8
Q ss_pred cCccccceeccCce--------------EEEEEeecChhhHHHHHHHHHHHhhcCCCCccceecccccCccceEEEeecC
Q 044312 289 DNFDLNRILGQGGQ--------------AVKKSKVIDESKVEEFINEVVILSQINHRNVVKLLGCCLETEVPLLVYEFIP 354 (608)
Q Consensus 289 ~~f~~~~~lG~G~~--------------avk~~~~~~~~~~~~~~~Ei~il~~l~H~niv~l~~~~~~~~~~~lV~E~~~ 354 (608)
++|++.+.||+|++ |+|..... ....+.+.+|+.++++++||||+++++++.+.+..++||||++
T Consensus 8 ~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 86 (267)
T 3t9t_A 8 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREG-AMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVTEFME 86 (267)
T ss_dssp GGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTT-TBCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEEECCCT
T ss_pred hheeeeeEecCCCceeEEEEEecCCCeEEEEEcccc-CCCHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCeEEEEeCCC
Confidence 46788889999874 55655532 2245789999999999999999999999999999999999999
Q ss_pred CCccchhccccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEEcCCCcEEEeeccCccccccCCcce
Q 044312 355 NGTLFQYIHDQNEDFPITWEIRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHM 434 (608)
Q Consensus 355 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGls~~~~~~~~~~ 434 (608)
+++|.+++..... .+++..++.++.|++.||+|||+.+ ++||||||+|||++.++.+||+|||+++.........
T Consensus 87 ~~~L~~~~~~~~~--~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~~~ 161 (267)
T 3t9t_A 87 HGCLSDYLRTQRG--LFAAETLLGMCLDVCEGMAYLEEAC---VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTS 161 (267)
T ss_dssp TCBHHHHHHHTTT--CCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCCGGGEEECGGGCEEECCTTGGGGBCCHHHHS
T ss_pred CCcHHHHHhhCcc--cCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCchheEEECCCCCEEEcccccccccccccccc
Confidence 9999999976533 5899999999999999999999999 9999999999999999999999999998764332222
Q ss_pred eeeeeccCCCCChhhhccCCCCCccchHhHHHHHHHHHh-CCCCCCccchhhcccHHHHHHHHhhhhhhHHHhhhhhhcc
Q 044312 435 TTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLTELLT-GEKPIRFTILEEDKSLAAYFLCAMKEERLFEILDARVMKQ 513 (608)
Q Consensus 435 ~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~ellt-g~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~ 513 (608)
.....+++.|+|||.+....++.++||||||++++||++ |+.||......+ .. +.+.......
T Consensus 162 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~------~~----------~~i~~~~~~~ 225 (267)
T 3t9t_A 162 STGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSE------VV----------EDISTGFRLY 225 (267)
T ss_dssp TTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH------HH----------HHHHTTCCCC
T ss_pred cccccccccccChhhhcCCCccchhchhhhHHHHHHHhccCCCCCCCCCHHH------HH----------HHHhcCCcCC
Confidence 233456788999999999999999999999999999999 899986332111 01 1111111122
Q ss_pred CChhHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhhHH
Q 044312 514 GGKDEIITVAKLAKRCLNLNGKKRPTMREVASELAGIKA 552 (608)
Q Consensus 514 ~~~~~~~~l~~Li~~cl~~dp~~RPs~~evl~~L~~i~~ 552 (608)
.+...+..+.+|+.+||+.||++|||+.|++++|+.+..
T Consensus 226 ~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~~ 264 (267)
T 3t9t_A 226 KPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIAE 264 (267)
T ss_dssp CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CCccCcHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 333456789999999999999999999999999998875
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-38 Score=326.69 Aligned_cols=252 Identities=24% Similarity=0.430 Sum_probs=202.9
Q ss_pred HHHHhcCccccceeccCce--------------------EEEEEeec-ChhhHHHHHHHHHHHhhc-CCCCccceecccc
Q 044312 284 LEKATDNFDLNRILGQGGQ--------------------AVKKSKVI-DESKVEEFINEVVILSQI-NHRNVVKLLGCCL 341 (608)
Q Consensus 284 l~~~t~~f~~~~~lG~G~~--------------------avk~~~~~-~~~~~~~~~~Ei~il~~l-~H~niv~l~~~~~ 341 (608)
++...++|.+.+.||+|++ |||..+.. .....+.+.+|+.+++++ +||||+++++++.
T Consensus 18 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~ 97 (313)
T 1t46_A 18 WEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACT 97 (313)
T ss_dssp GBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred cccChhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcchhHHHHHHHHHHHHHHhhcccCCCeeeEEEEEe
Confidence 3344568999999999985 34444322 224467899999999999 9999999999999
Q ss_pred cCccceEEEeecCCCccchhccccCC---------------CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCC
Q 044312 342 ETEVPLLVYEFIPNGTLFQYIHDQNE---------------DFPITWEIRLRIAIEVSGALSYLHSAASIPIYHRDIKST 406 (608)
Q Consensus 342 ~~~~~~lV~E~~~~gsL~~~l~~~~~---------------~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~ 406 (608)
+.+..++||||+++|+|.+++..... ...+++..++.++.||+.||+|||+.+ |+||||||+
T Consensus 98 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~ 174 (313)
T 1t46_A 98 IGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKN---CIHRDLAAR 174 (313)
T ss_dssp SSSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGG
T ss_pred cCCCcEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCccc
Confidence 99999999999999999999976532 124899999999999999999999999 999999999
Q ss_pred cEEEcCCCcEEEeeccCccccccCCcc-eeeeeeccCCCCChhhhccCCCCCccchHhHHHHHHHHHh-CCCCCCccchh
Q 044312 407 NILLDDKYRAKVSDFGASRSMAVDQTH-MTTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLTELLT-GEKPIRFTILE 484 (608)
Q Consensus 407 NILl~~~~~~kl~DFGls~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~ellt-g~~p~~~~~~~ 484 (608)
|||++.++.+||+|||+++........ ......+|+.|+|||.+.+..++.++||||||++++||+| |+.||......
T Consensus 175 Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~ 254 (313)
T 1t46_A 175 NILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVD 254 (313)
T ss_dssp GEEEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSS
T ss_pred eEEEcCCCCEEEccccccccccccccceeccCCCCcceeeChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCCcccch
Confidence 999999999999999999877544332 2234457889999999999999999999999999999999 99998643221
Q ss_pred hcccHHHHHHHHhhhhhhHHHhhhhhhccCChhHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhhHHh
Q 044312 485 EDKSLAAYFLCAMKEERLFEILDARVMKQGGKDEIITVAKLAKRCLNLNGKKRPTMREVASELAGIKAW 553 (608)
Q Consensus 485 ~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~evl~~L~~i~~~ 553 (608)
. .+...+........+...+..+.+|+.+||+.||++|||+.|++++|+.+...
T Consensus 255 ~---------------~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~ 308 (313)
T 1t46_A 255 S---------------KFYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQISE 308 (313)
T ss_dssp H---------------HHHHHHHHTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred h---------------HHHHHhccCCCCCCcccCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHHH
Confidence 1 11112222222233445667899999999999999999999999999887664
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-38 Score=330.55 Aligned_cols=251 Identities=25% Similarity=0.434 Sum_probs=187.4
Q ss_pred HHhcCccccceeccCce------------------EEEEEeec--ChhhHHHHHHHHHHHhhcCCCCccceecccccCcc
Q 044312 286 KATDNFDLNRILGQGGQ------------------AVKKSKVI--DESKVEEFINEVVILSQINHRNVVKLLGCCLETEV 345 (608)
Q Consensus 286 ~~t~~f~~~~~lG~G~~------------------avk~~~~~--~~~~~~~~~~Ei~il~~l~H~niv~l~~~~~~~~~ 345 (608)
...++|++.+.||+|++ |||..+.. .....+.+.+|+.++++++||||+++++++.....
T Consensus 20 i~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 99 (323)
T 3qup_A 20 IPEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVSLRSRA 99 (323)
T ss_dssp CC---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC------CHHHHHHHHHHHHHTTCCCTTBCCCCEEEECC--
T ss_pred cChhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccCHHHHHHHHHHHHHHHHCCCCceehhhceeecccc
Confidence 34567999999999974 44544332 34557889999999999999999999999987765
Q ss_pred c------eEEEeecCCCccchhccccC---CCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEEcCCCcE
Q 044312 346 P------LLVYEFIPNGTLFQYIHDQN---EDFPITWEIRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRA 416 (608)
Q Consensus 346 ~------~lV~E~~~~gsL~~~l~~~~---~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ 416 (608)
. ++||||+++|+|.+++.... ....+++..++.++.||+.||+|||+.+ |+||||||+|||+++++.+
T Consensus 100 ~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~---ivH~Dikp~NIli~~~~~~ 176 (323)
T 3qup_A 100 KGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSRN---FIHRDLAARNCMLAEDMTV 176 (323)
T ss_dssp -----CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTSCE
T ss_pred ccCCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcCC---cccCCCCcceEEEcCCCCE
Confidence 5 99999999999999997532 1225899999999999999999999999 9999999999999999999
Q ss_pred EEeeccCccccccCCc-ceeeeeeccCCCCChhhhccCCCCCccchHhHHHHHHHHHh-CCCCCCccchhhcccHHHHHH
Q 044312 417 KVSDFGASRSMAVDQT-HMTTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLTELLT-GEKPIRFTILEEDKSLAAYFL 494 (608)
Q Consensus 417 kl~DFGls~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~ellt-g~~p~~~~~~~~~~~l~~~~~ 494 (608)
||+|||+++....... .......+++.|+|||.+.+..++.++||||||++++||++ |+.||......+
T Consensus 177 kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~--------- 247 (323)
T 3qup_A 177 CVADFGLSRKIYSGDYYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAE--------- 247 (323)
T ss_dssp EECCCCC-----------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGG---------
T ss_pred EEeeccccccccccccccccccccCcccccCchhhcCCCCCCccchhhHHHHHHHHHhCCCCCccccChHH---------
Confidence 9999999987643322 12234456789999999999999999999999999999999 899986432211
Q ss_pred HHhhhhhhHHHhhhhhhccCChhHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhhHHhcC
Q 044312 495 CAMKEERLFEILDARVMKQGGKDEIITVAKLAKRCLNLNGKKRPTMREVASELAGIKAWNG 555 (608)
Q Consensus 495 ~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~evl~~L~~i~~~~~ 555 (608)
+...+........+...+.++.+|+.+||+.||++|||+.|+++.|+.+.....
T Consensus 248 -------~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~l~~~~ 301 (323)
T 3qup_A 248 -------IYNYLIGGNRLKQPPECMEEVYDLMYQCWSADPKQRPSFTCLRMELENILGHLS 301 (323)
T ss_dssp -------HHHHHHTTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHC--
T ss_pred -------HHHHHhcCCCCCCCCccCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHhh
Confidence 111111111223344566789999999999999999999999999999876443
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-38 Score=326.37 Aligned_cols=253 Identities=16% Similarity=0.206 Sum_probs=198.7
Q ss_pred hcCccccceeccCce---------------EEEEEeecChhhHHHHHHHHHHHhhc-CCCCccceecccccCccceEEEe
Q 044312 288 TDNFDLNRILGQGGQ---------------AVKKSKVIDESKVEEFINEVVILSQI-NHRNVVKLLGCCLETEVPLLVYE 351 (608)
Q Consensus 288 t~~f~~~~~lG~G~~---------------avk~~~~~~~~~~~~~~~Ei~il~~l-~H~niv~l~~~~~~~~~~~lV~E 351 (608)
.++|++.+.||+|+| |||..... ...+.+.+|+.+++++ +||||+++++++.+....++|||
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e 85 (330)
T 2izr_A 8 GPNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMK--SRAPQLHLEYRFYKQLGSGDGIPQVYYFGPCGKYNAMVLE 85 (330)
T ss_dssp TTTEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETT--CSSCCHHHHHHHHHHHCSCTTSCCEEEEEEETTEEEEEEE
T ss_pred cCCeEEEEEeeccCCceEEEEEECCCCcEEEEEEeccc--cchHHHHHHHHHHHHhhCCCCCCEEEEEEecCCccEEEEE
Confidence 457899999999974 77766532 2345689999999999 99999999999999999999999
Q ss_pred ecCCCccchhccccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEEcCCCc-----EEEeeccCccc
Q 044312 352 FIPNGTLFQYIHDQNEDFPITWEIRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYR-----AKVSDFGASRS 426 (608)
Q Consensus 352 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~-----~kl~DFGls~~ 426 (608)
|+ +++|.+++..... .+++..++.|+.||+.||+|||+.+ |+||||||+|||++.++. +||+|||+++.
T Consensus 86 ~~-~~~L~~~~~~~~~--~~~~~~~~~i~~qi~~~l~~LH~~~---iiHrDlkp~Nill~~~~~~~~~~~kl~DFg~a~~ 159 (330)
T 2izr_A 86 LL-GPSLEDLFDLCDR--TFSLKTVLMIAIQLISRMEYVHSKN---LIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKE 159 (330)
T ss_dssp CC-CCBHHHHHHHTTT--CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECCGGGTCTTSEEECCCTTCEE
T ss_pred eC-CCCHHHHHHHcCC--CCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeeeccCCCCCCceEEEEEccccee
Confidence 99 9999999986432 5999999999999999999999999 999999999999998877 99999999987
Q ss_pred cccCCcc------eeeeeeccCCCCChhhhccCCCCCccchHhHHHHHHHHHhCCCCCCccchhhcccHHHHHHHHhhhh
Q 044312 427 MAVDQTH------MTTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLTELLTGEKPIRFTILEEDKSLAAYFLCAMKEE 500 (608)
Q Consensus 427 ~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~ 500 (608)
....... ......||+.|+|||++.+..++.++||||||++++||++|+.||....... ....+. .+...
T Consensus 160 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~Pf~~~~~~~---~~~~~~-~i~~~ 235 (330)
T 2izr_A 160 YIDPETKKHIPYREHKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGLKADT---LKERYQ-KIGDT 235 (330)
T ss_dssp SBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCSS---HHHHHH-HHHHH
T ss_pred eecCCCCccccccccCCcCCCccccChHHHcCCCCCchhHHHHHHHHHHHHhcCCCCcccccccc---HHHHHH-HHHhh
Confidence 6543221 1245679999999999999999999999999999999999999997543221 111111 11110
Q ss_pred hhHHHhhhhhhccCChhHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhhHHhcCCCc
Q 044312 501 RLFEILDARVMKQGGKDEIITVAKLAKRCLNLNGKKRPTMREVASELAGIKAWNGASN 558 (608)
Q Consensus 501 ~~~~~~d~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~evl~~L~~i~~~~~~~~ 558 (608)
.... .. .......+ ++.+|+.+||+.||.+||++.+|.+.|+.+....+...
T Consensus 236 ~~~~--~~---~~~~~~~p-~~~~li~~~l~~~p~~RP~~~~l~~~l~~~~~~~~~~~ 287 (330)
T 2izr_A 236 KRAT--PI---EVLCENFP-EMATYLRYVRRLDFFEKPDYDYLRKLFTDLFDRKGYMF 287 (330)
T ss_dssp HHHS--CH---HHHTTTCH-HHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHTTCCC
T ss_pred hccC--CH---HHHhccCh-HHHHHHHHHHhCCCCCCCCHHHHHHHHHHHHHHcCCCC
Confidence 0000 00 00011233 89999999999999999999999999998877665433
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-38 Score=320.57 Aligned_cols=241 Identities=31% Similarity=0.497 Sum_probs=185.4
Q ss_pred hcCccccceeccCce-------------EEEEEeecC----hhhHHHHHHHHHHHhhcCCCCccceecccccCccceEEE
Q 044312 288 TDNFDLNRILGQGGQ-------------AVKKSKVID----ESKVEEFINEVVILSQINHRNVVKLLGCCLETEVPLLVY 350 (608)
Q Consensus 288 t~~f~~~~~lG~G~~-------------avk~~~~~~----~~~~~~~~~Ei~il~~l~H~niv~l~~~~~~~~~~~lV~ 350 (608)
.++|++.+.||+|++ |||..+... ....+.+.+|+.++++++||||+++++++.+.+..++||
T Consensus 6 ~~~~~~~~~lg~G~~g~V~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 85 (271)
T 3dtc_A 6 FAELTLEEIIGIGGFGKVYRAFWIGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEPNLCLVM 85 (271)
T ss_dssp TTSEEEEEEEEEETTEEEEEEEETTEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEECCC--CEEEE
T ss_pred hhheeeeeeeccCCCeEEEEEEEcCCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCCceEEEE
Confidence 357888999999984 566654322 233578999999999999999999999999999999999
Q ss_pred eecCCCccchhccccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEEcC--------CCcEEEeecc
Q 044312 351 EFIPNGTLFQYIHDQNEDFPITWEIRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDD--------KYRAKVSDFG 422 (608)
Q Consensus 351 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~--------~~~~kl~DFG 422 (608)
||+++++|.+++... .+++..++.++.|++.||+|||+.+..+|+||||||+|||++. ++.+||+|||
T Consensus 86 e~~~~~~L~~~~~~~----~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~kl~Dfg 161 (271)
T 3dtc_A 86 EFARGGPLNRVLSGK----RIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFG 161 (271)
T ss_dssp ECCTTEEHHHHHTSS----CCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEESSCCSSSCCSSCCEEECCCC
T ss_pred EcCCCCCHHHHhhcC----CCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHEEEecccccccccCcceEEccCC
Confidence 999999999988642 5899999999999999999999988666899999999999986 6789999999
Q ss_pred CccccccCCcceeeeeeccCCCCChhhhccCCCCCccchHhHHHHHHHHHhCCCCCCccchhhcccHHHHHHHHhhhhhh
Q 044312 423 ASRSMAVDQTHMTTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLTELLTGEKPIRFTILEEDKSLAAYFLCAMKEERL 502 (608)
Q Consensus 423 ls~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~ 502 (608)
+++...... .....||+.|+|||.+.+..++.++||||||++++||++|+.||....... . .
T Consensus 162 ~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~------~---------~ 223 (271)
T 3dtc_A 162 LAREWHRTT---KMSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGLA------V---------A 223 (271)
T ss_dssp C----------------CCGGGSCHHHHHHCCCSHHHHHHHHHHHHHHHHHCCCTTTTSCHHH------H---------H
T ss_pred ccccccccc---ccCCCCccceeCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH------H---------H
Confidence 998654322 224568999999999999999999999999999999999999986322111 0 0
Q ss_pred HHHhhhhhhccCChhHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhh
Q 044312 503 FEILDARVMKQGGKDEIITVAKLAKRCLNLNGKKRPTMREVASELAGI 550 (608)
Q Consensus 503 ~~~~d~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~evl~~L~~i 550 (608)
............+...+..+.+|+.+||+.||++|||+.|++++|+.+
T Consensus 224 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~L~~l 271 (271)
T 3dtc_A 224 YGVAMNKLALPIPSTCPEPFAKLMEDCWNPDPHSRPSFTNILDQLTTI 271 (271)
T ss_dssp HHHHTSCCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHC-
T ss_pred HhhhcCCCCCCCCcccCHHHHHHHHHHhcCCcccCcCHHHHHHHHhcC
Confidence 111111122233445667899999999999999999999999999764
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-38 Score=334.27 Aligned_cols=260 Identities=17% Similarity=0.235 Sum_probs=197.3
Q ss_pred HhcCccccceeccCce--------------------EEEEEeecChh-----------hHHHHHHHHHHHhhcCCCCccc
Q 044312 287 ATDNFDLNRILGQGGQ--------------------AVKKSKVIDES-----------KVEEFINEVVILSQINHRNVVK 335 (608)
Q Consensus 287 ~t~~f~~~~~lG~G~~--------------------avk~~~~~~~~-----------~~~~~~~Ei~il~~l~H~niv~ 335 (608)
..++|.+.+.||+|+| |||........ ....+..|+..++.++||||++
T Consensus 33 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv~ 112 (364)
T 3op5_A 33 AAAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPK 112 (364)
T ss_dssp TCCEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSCC
T ss_pred CCCeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCCe
Confidence 4568999999999985 45554432211 1123455666778889999999
Q ss_pred eecccccC----ccceEEEeecCCCccchhccccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEEc
Q 044312 336 LLGCCLET----EVPLLVYEFIPNGTLFQYIHDQNEDFPITWEIRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLD 411 (608)
Q Consensus 336 l~~~~~~~----~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~ 411 (608)
+++++... ...+|||||+ +++|.+++..... .+++..++.|+.||+.||+|||+.+ |+||||||+|||++
T Consensus 113 ~~~~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~~~~--~l~~~~~~~i~~qi~~~l~~lH~~~---iiHrDlkp~Nill~ 186 (364)
T 3op5_A 113 YWGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEANAK--RFSRKTVLQLSLRILDILEYIHEHE---YVHGDIKASNLLLN 186 (364)
T ss_dssp EEEEEEEEETTEEEEEEEEECE-EEEHHHHHHHTTS--CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEE
T ss_pred EEeeeeeccCCcceEEEEEeCC-CCCHHHHHHhccC--CCCHHHHHHHHHHHHHHHHHHHHCC---eEEecCCHHHEEEe
Confidence 99998765 4589999999 9999999986433 5999999999999999999999999 99999999999999
Q ss_pred --CCCcEEEeeccCccccccCCcce------eeeeeccCCCCChhhhccCCCCCccchHhHHHHHHHHHhCCCCCCccch
Q 044312 412 --DKYRAKVSDFGASRSMAVDQTHM------TTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLTELLTGEKPIRFTIL 483 (608)
Q Consensus 412 --~~~~~kl~DFGls~~~~~~~~~~------~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~elltg~~p~~~~~~ 483 (608)
.++.+||+|||+++.+....... .....||+.|+|||++.+..++.++||||||+++|||+||+.||.....
T Consensus 187 ~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~Pf~~~~~ 266 (364)
T 3op5_A 187 YKNPDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLPWEDNLK 266 (364)
T ss_dssp SSCTTCEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGGTT
T ss_pred cCCCCeEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCCCCchhhHHHHHHHHHHHHhCCCCcccccc
Confidence 88999999999998765432211 1334599999999999999999999999999999999999999974221
Q ss_pred hhcccHHHHHHHHhhhhhhHHHhhhhhhccCChhHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhhHHhcCCCc
Q 044312 484 EEDKSLAAYFLCAMKEERLFEILDARVMKQGGKDEIITVAKLAKRCLNLNGKKRPTMREVASELAGIKAWNGASN 558 (608)
Q Consensus 484 ~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~evl~~L~~i~~~~~~~~ 558 (608)
. ........ ......+.+++++.+. ....+.++.+|+.+||+.+|++||++.+|++.|+.+....+...
T Consensus 267 ~--~~~~~~~~-~~~~~~~~~~~~~~~~---~~~~~~~~~~li~~cl~~~p~~RP~~~~l~~~l~~~~~~~~~~~ 335 (364)
T 3op5_A 267 D--PKYVRDSK-IRYRENIASLMDKCFP---AANAPGEIAKYMETVKLLDYTEKPLYENLRDILLQGLKAIGSKD 335 (364)
T ss_dssp C--HHHHHHHH-HHHHHCHHHHHHHHSC---TTCCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHTTCCC
T ss_pred C--HHHHHHHH-HHhhhhHHHHHHHhcc---cccCHHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHcCCCc
Confidence 1 11111111 1112233444443321 13445689999999999999999999999999999887655444
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-39 Score=336.25 Aligned_cols=252 Identities=24% Similarity=0.430 Sum_probs=202.0
Q ss_pred HHHHHhcCccccceeccCce--------------------EEEEEeec-ChhhHHHHHHHHHHHhhc-CCCCccceeccc
Q 044312 283 ELEKATDNFDLNRILGQGGQ--------------------AVKKSKVI-DESKVEEFINEVVILSQI-NHRNVVKLLGCC 340 (608)
Q Consensus 283 ~l~~~t~~f~~~~~lG~G~~--------------------avk~~~~~-~~~~~~~~~~Ei~il~~l-~H~niv~l~~~~ 340 (608)
+++...++|.+.+.||+|++ |+|..+.. .....+.+.+|+.+++++ +||||+++++++
T Consensus 40 ~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~ 119 (333)
T 2i1m_A 40 KWEFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGAC 119 (333)
T ss_dssp GGBCCTTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred cccCCHHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhcccccChHHHHHHHHHHHHHHhhcCCCCeeeEEEEE
Confidence 44555678999999999985 33443322 224567899999999999 899999999999
Q ss_pred ccCccceEEEeecCCCccchhccccCC-----------CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEE
Q 044312 341 LETEVPLLVYEFIPNGTLFQYIHDQNE-----------DFPITWEIRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNIL 409 (608)
Q Consensus 341 ~~~~~~~lV~E~~~~gsL~~~l~~~~~-----------~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NIL 409 (608)
.+.+..++||||+++|+|.+++..... ...+++..++.++.||+.||+|||+.+ |+||||||+|||
T Consensus 120 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~NIl 196 (333)
T 2i1m_A 120 THGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASKN---CIHRDVAARNVL 196 (333)
T ss_dssp CSSSSCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGCE
T ss_pred ecCCceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCC---cccCCcccceEE
Confidence 999999999999999999999975321 225899999999999999999999999 999999999999
Q ss_pred EcCCCcEEEeeccCccccccCCcc-eeeeeeccCCCCChhhhccCCCCCccchHhHHHHHHHHHh-CCCCCCccchhhcc
Q 044312 410 LDDKYRAKVSDFGASRSMAVDQTH-MTTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLTELLT-GEKPIRFTILEEDK 487 (608)
Q Consensus 410 l~~~~~~kl~DFGls~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~ellt-g~~p~~~~~~~~~~ 487 (608)
++.++.+||+|||+++........ ......+|+.|+|||.+.+..++.++||||||++++||+| |..||.......
T Consensus 197 ~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~-- 274 (333)
T 2i1m_A 197 LTNGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNS-- 274 (333)
T ss_dssp EEGGGEEEBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCSSH--
T ss_pred ECCCCeEEECccccccccccccceeecCCCCCCccccCHHHhccCCCChHHHHHHHHHHHHHHHcCCCCCCcccchhH--
Confidence 999999999999999876543322 2234557889999999999999999999999999999999 899986332111
Q ss_pred cHHHHHHHHhhhhhhHHHhhhhhhccCChhHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhhHH
Q 044312 488 SLAAYFLCAMKEERLFEILDARVMKQGGKDEIITVAKLAKRCLNLNGKKRPTMREVASELAGIKA 552 (608)
Q Consensus 488 ~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~evl~~L~~i~~ 552 (608)
.+..++........+...+..+.+|+.+||+.||++|||+.||++.|+.+..
T Consensus 275 -------------~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~~ 326 (333)
T 2i1m_A 275 -------------KFYKLVKDGYQMAQPAFAPKNIYSIMQACWALEPTHRPTFQQICSFLQEQAQ 326 (333)
T ss_dssp -------------HHHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred -------------HHHHHHhcCCCCCCCCCCCHHHHHHHHHHhccChhhCcCHHHHHHHHHHHHH
Confidence 1111222222223334456789999999999999999999999999988765
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9.6e-39 Score=324.02 Aligned_cols=249 Identities=24% Similarity=0.395 Sum_probs=199.5
Q ss_pred HHHHhcCccccceeccCce--------------EEEEEeecChhhHHHHHHHHHHHhhcCCCCccceecccccCccceEE
Q 044312 284 LEKATDNFDLNRILGQGGQ--------------AVKKSKVIDESKVEEFINEVVILSQINHRNVVKLLGCCLETEVPLLV 349 (608)
Q Consensus 284 l~~~t~~f~~~~~lG~G~~--------------avk~~~~~~~~~~~~~~~Ei~il~~l~H~niv~l~~~~~~~~~~~lV 349 (608)
++...++|++.+.||+|++ |||..+.. ....+.+.+|++++++++||||+++++++.+ +..++|
T Consensus 8 ~~v~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~~v 85 (279)
T 1qpc_A 8 WEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQG-SMSPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYII 85 (279)
T ss_dssp TBCCGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTT-SSCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEE
T ss_pred cccCHHhhhheeeecCCCCeEEEEEEEcCCcEEEEEEecCC-cccHHHHHHHHHHHHhCCCcCcceEEEEEcC-CCcEEE
Confidence 3444567889999999874 56655432 2356789999999999999999999999864 568999
Q ss_pred EeecCCCccchhccccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEEcCCCcEEEeeccCcccccc
Q 044312 350 YEFIPNGTLFQYIHDQNEDFPITWEIRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAV 429 (608)
Q Consensus 350 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGls~~~~~ 429 (608)
|||+++++|.+++..... ..+++..++.++.|++.||+|||+.+ |+||||||+|||+++++.+||+|||+++....
T Consensus 86 ~e~~~~~~L~~~l~~~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~ 161 (279)
T 1qpc_A 86 TEYMENGSLVDFLKTPSG-IKLTINKLLDMAAQIAEGMAFIEERN---YIHRDLRAANILVSDTLSCKIADFGLARLIED 161 (279)
T ss_dssp EECCTTCBHHHHTTSHHH-HTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCEECSS
T ss_pred EecCCCCCHHHHHhcCCC-CCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHhhEEEcCCCCEEECCCcccccccC
Confidence 999999999999976432 14899999999999999999999999 99999999999999999999999999987654
Q ss_pred CCcceeeeeeccCCCCChhhhccCCCCCccchHhHHHHHHHHHh-CCCCCCccchhhcccHHHHHHHHhhhhhhHHHhhh
Q 044312 430 DQTHMTTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLTELLT-GEKPIRFTILEEDKSLAAYFLCAMKEERLFEILDA 508 (608)
Q Consensus 430 ~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~ellt-g~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 508 (608)
..........++..|+|||.+....++.++||||||++++||++ |+.||......+ +.+.+..
T Consensus 162 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~----------------~~~~~~~ 225 (279)
T 1qpc_A 162 NEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPE----------------VIQNLER 225 (279)
T ss_dssp SCEECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHH----------------HHHHHHT
T ss_pred cccccccCCCCccCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCcccCHHH----------------HHHHHhc
Confidence 43333334456789999999998899999999999999999999 899986332211 0111111
Q ss_pred hhhccCChhHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhhHHhc
Q 044312 509 RVMKQGGKDEIITVAKLAKRCLNLNGKKRPTMREVASELAGIKAWN 554 (608)
Q Consensus 509 ~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~evl~~L~~i~~~~ 554 (608)
......+...+..+.+|+.+||+.||++|||+.++++.|+.+....
T Consensus 226 ~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~ 271 (279)
T 1qpc_A 226 GYRMVRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFTAT 271 (279)
T ss_dssp TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHC
T ss_pred ccCCCCcccccHHHHHHHHHHhccChhhCCCHHHHHHHHHHHHHhc
Confidence 1122233455678999999999999999999999999999887643
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-38 Score=327.85 Aligned_cols=238 Identities=23% Similarity=0.365 Sum_probs=186.6
Q ss_pred hcCccccceeccCce---------------EEEEEeecC-hhhHHHHHHHHHHHhhcCCCCccceecccccCc-------
Q 044312 288 TDNFDLNRILGQGGQ---------------AVKKSKVID-ESKVEEFINEVVILSQINHRNVVKLLGCCLETE------- 344 (608)
Q Consensus 288 t~~f~~~~~lG~G~~---------------avk~~~~~~-~~~~~~~~~Ei~il~~l~H~niv~l~~~~~~~~------- 344 (608)
.++|++.+.||+|++ |||+.+... ....+.+.+|+.+|++++||||+++++++.+..
T Consensus 5 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~ 84 (332)
T 3qd2_B 5 LTDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQEE 84 (332)
T ss_dssp HHHEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCSTTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHHHHH
T ss_pred hhcCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCCchhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchhhhh
Confidence 356889999999974 788876533 345688999999999999999999999986543
Q ss_pred --------------------------------------------------cceEEEeecCCCccchhccccCCCCCCCHH
Q 044312 345 --------------------------------------------------VPLLVYEFIPNGTLFQYIHDQNEDFPITWE 374 (608)
Q Consensus 345 --------------------------------------------------~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~ 374 (608)
..++||||+++++|.+++.........++.
T Consensus 85 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~ 164 (332)
T 3qd2_B 85 MDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHG 164 (332)
T ss_dssp HHC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCSGGGSCHH
T ss_pred hhhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccCccchhhH
Confidence 278999999999999999876554457888
Q ss_pred HHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEEcCCCcEEEeeccCccccccCCc-----------ceeeeeeccCC
Q 044312 375 IRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQT-----------HMTTQVHGTFG 443 (608)
Q Consensus 375 ~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGls~~~~~~~~-----------~~~~~~~gt~~ 443 (608)
.++.++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++....... .......||+.
T Consensus 165 ~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~ 241 (332)
T 3qd2_B 165 VCLHIFIQIAEAVEFLHSKG---LMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKL 241 (332)
T ss_dssp HHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEECSCC--------------CCCSCC-CGG
T ss_pred HHHHHHHHHHHHHHHHHhCC---eeecCCCcccEEEeCCCCEEEeecCcccccccchhhccccccccccccccccCCCcC
Confidence 89999999999999999999 99999999999999999999999999987654321 12233569999
Q ss_pred CCChhhhccCCCCCccchHhHHHHHHHHHhCCCCCCccchhhcccHHHHHHHHhhhhhhHHHhhhhhhccCChhHHHHHH
Q 044312 444 YLDPEYFRSSQFTDKSDVYSFGVVLTELLTGEKPIRFTILEEDKSLAAYFLCAMKEERLFEILDARVMKQGGKDEIITVA 523 (608)
Q Consensus 444 y~aPE~~~~~~~t~ksDV~S~Gvvl~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~ 523 (608)
|+|||.+.+..++.++||||||++++||++|..|+.. . .. ........... ......+..+.
T Consensus 242 y~aPE~~~~~~~~~~~Di~slG~il~el~~~~~~~~~-----~---~~-~~~~~~~~~~~---------~~~~~~~~~~~ 303 (332)
T 3qd2_B 242 YMSPEQIHGNNYSHKVDIFSLGLILFELLYSFSTQME-----R---VR-IITDVRNLKFP---------LLFTQKYPQEH 303 (332)
T ss_dssp GSCHHHHHCCCCCTHHHHHHHHHHHHHHHSCCCCHHH-----H---HH-HHHHHHTTCCC---------HHHHHHCHHHH
T ss_pred ccChHHhcCCCCcchhhHHHHHHHHHHHHHcCCChhH-----H---HH-HHHHhhccCCC---------cccccCChhHH
Confidence 9999999999999999999999999999998877420 0 00 00011111100 00123345678
Q ss_pred HHHHHHhccCCCCCCCHHHHHHH
Q 044312 524 KLAKRCLNLNGKKRPTMREVASE 546 (608)
Q Consensus 524 ~Li~~cl~~dp~~RPs~~evl~~ 546 (608)
+|+.+||+.||++|||+.|++++
T Consensus 304 ~li~~~l~~~p~~Rps~~~~l~~ 326 (332)
T 3qd2_B 304 MMVQDMLSPSPTERPEATDIIEN 326 (332)
T ss_dssp HHHHHHHCSSGGGSCCHHHHHHS
T ss_pred HHHHHHccCCCCcCCCHHHHhhc
Confidence 99999999999999999999864
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-39 Score=357.96 Aligned_cols=249 Identities=24% Similarity=0.388 Sum_probs=201.2
Q ss_pred HHHHHHhcCccccceeccCce--------------EEEEEeecChhhHHHHHHHHHHHhhcCCCCccceecccccCccce
Q 044312 282 KELEKATDNFDLNRILGQGGQ--------------AVKKSKVIDESKVEEFINEVVILSQINHRNVVKLLGCCLETEVPL 347 (608)
Q Consensus 282 ~~l~~~t~~f~~~~~lG~G~~--------------avk~~~~~~~~~~~~~~~Ei~il~~l~H~niv~l~~~~~~~~~~~ 347 (608)
..++...++|++.++||+|+| |||+++... ...++|.+|+.+|++++|+||+++++++.+ +..+
T Consensus 260 ~~~~i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~-~~~~ 337 (535)
T 2h8h_A 260 DAWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIY 337 (535)
T ss_dssp TCSBCCGGGEEEEEEEEECSSEEEEEEEETTTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCE
T ss_pred cceecchhhhhhheecccCCCeEEEEEEECCCceEEEEEeCCCC-CCHHHHHHHHHHHHhCCCCCEeeEEEEEee-ccce
Confidence 344455678899999999985 666665432 346789999999999999999999999876 6789
Q ss_pred EEEeecCCCccchhccccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEEcCCCcEEEeeccCcccc
Q 044312 348 LVYEFIPNGTLFQYIHDQNEDFPITWEIRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSM 427 (608)
Q Consensus 348 lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGls~~~ 427 (608)
|||||+++|+|.+++...... .+++..++.|+.||+.||+|||+++ |+||||||+|||+++++.+||+|||+++..
T Consensus 338 lv~e~~~~gsL~~~l~~~~~~-~l~~~~~~~i~~qi~~~L~~LH~~~---ivHrDlkp~NIll~~~~~~kl~DFG~a~~~ 413 (535)
T 2h8h_A 338 IVTEYMSKGSLLDFLKGETGK-YLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLI 413 (535)
T ss_dssp EEECCCTTEEHHHHHSHHHHT-TCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCTTSTTTC
T ss_pred EeeehhcCCcHHHHHhhcCCC-CCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCHhhEEEcCCCcEEEcccccceec
Confidence 999999999999999764322 4899999999999999999999999 999999999999999999999999999876
Q ss_pred ccCCcceeeeeeccCCCCChhhhccCCCCCccchHhHHHHHHHHHh-CCCCCCccchhhcccHHHHHHHHhhhhhhHHHh
Q 044312 428 AVDQTHMTTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLTELLT-GEKPIRFTILEEDKSLAAYFLCAMKEERLFEIL 506 (608)
Q Consensus 428 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~ellt-g~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 506 (608)
............++..|+|||.+....++.++||||||++||||++ |+.||......+ +.+.+
T Consensus 414 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t~g~~P~~~~~~~~----------------~~~~i 477 (535)
T 2h8h_A 414 EDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNRE----------------VLDQV 477 (535)
T ss_dssp CCHHHHTTCSTTSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTTCCSSTTCCHHH----------------HHHHH
T ss_pred CCCceecccCCcCcccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHH----------------HHHHH
Confidence 5332222233456788999999999999999999999999999999 899986332111 11111
Q ss_pred hhhhhccCChhHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhhHH
Q 044312 507 DARVMKQGGKDEIITVAKLAKRCLNLNGKKRPTMREVASELAGIKA 552 (608)
Q Consensus 507 d~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~evl~~L~~i~~ 552 (608)
........+..++..+.+|+.+||+.||++|||+.+|++.|+.+..
T Consensus 478 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~L~~~~~ 523 (535)
T 2h8h_A 478 ERGYRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFT 523 (535)
T ss_dssp HTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSC
T ss_pred HcCCCCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHhh
Confidence 1222233445667789999999999999999999999999987754
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-38 Score=328.05 Aligned_cols=244 Identities=25% Similarity=0.408 Sum_probs=190.9
Q ss_pred cCccccceeccCce-------------------EEEEEeec-ChhhHHHHHHHHHHHhhcCCCCccceecccccCccceE
Q 044312 289 DNFDLNRILGQGGQ-------------------AVKKSKVI-DESKVEEFINEVVILSQINHRNVVKLLGCCLETEVPLL 348 (608)
Q Consensus 289 ~~f~~~~~lG~G~~-------------------avk~~~~~-~~~~~~~~~~Ei~il~~l~H~niv~l~~~~~~~~~~~l 348 (608)
.+|.+.+.||+|++ |||..+.. .......|.+|+.++++++||||+++++++.+.+..+|
T Consensus 44 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 123 (333)
T 1mqb_A 44 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMI 123 (333)
T ss_dssp TTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEE
T ss_pred HHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCCcEE
Confidence 46777899999974 44444322 33456679999999999999999999999999999999
Q ss_pred EEeecCCCccchhccccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEEcCCCcEEEeeccCccccc
Q 044312 349 VYEFIPNGTLFQYIHDQNEDFPITWEIRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMA 428 (608)
Q Consensus 349 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGls~~~~ 428 (608)
||||+++++|.+++..... .+++..++.++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++...
T Consensus 124 v~e~~~~~~L~~~l~~~~~--~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~~ 198 (333)
T 1mqb_A 124 ITEYMENGALDKFLREKDG--EFSVLQLVGMLRGIAAGMKYLANMN---YVHRDLAARNILVNSNLVCKVSDFGLSRVLE 198 (333)
T ss_dssp EEECCTTEEHHHHHHHTTT--CSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCCCC-----
T ss_pred EEeCCCCCcHHHHHHhCCC--CCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChheEEECCCCcEEECCCCcchhhc
Confidence 9999999999999976433 5899999999999999999999999 9999999999999999999999999998765
Q ss_pred cCCcc--eeeeeeccCCCCChhhhccCCCCCccchHhHHHHHHHHHh-CCCCCCccchhhcccHHHHHHHHhhhhhhHHH
Q 044312 429 VDQTH--MTTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLTELLT-GEKPIRFTILEEDKSLAAYFLCAMKEERLFEI 505 (608)
Q Consensus 429 ~~~~~--~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~ellt-g~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 505 (608)
..... ......+|+.|+|||.+....++.++||||||++++||++ |+.||......+ +.+.
T Consensus 199 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~----------------~~~~ 262 (333)
T 1mqb_A 199 DDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHE----------------VMKA 262 (333)
T ss_dssp ------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH----------------HHHH
T ss_pred cccccccccCCCCccccccCchhcccCCCCchhhhHHHHHHHHHHHcCCCCCcccCCHHH----------------HHHH
Confidence 43221 1223346788999999999999999999999999999999 999986322111 1111
Q ss_pred hhhhhhccCChhHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhhHHh
Q 044312 506 LDARVMKQGGKDEIITVAKLAKRCLNLNGKKRPTMREVASELAGIKAW 553 (608)
Q Consensus 506 ~d~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~evl~~L~~i~~~ 553 (608)
+........+...+..+.+|+.+||+.||++||++.|+++.|+.+...
T Consensus 263 ~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~~~ 310 (333)
T 1mqb_A 263 INDGFRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRA 310 (333)
T ss_dssp HHTTCCCCCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHS
T ss_pred HHCCCcCCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhc
Confidence 111112223345667899999999999999999999999999988764
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-38 Score=323.10 Aligned_cols=245 Identities=28% Similarity=0.464 Sum_probs=188.0
Q ss_pred cCccccceeccCce-------------EEEEEeecChhhHHHHHHHHHHHhhcCCCCccceecccccCccceEEEeecCC
Q 044312 289 DNFDLNRILGQGGQ-------------AVKKSKVIDESKVEEFINEVVILSQINHRNVVKLLGCCLETEVPLLVYEFIPN 355 (608)
Q Consensus 289 ~~f~~~~~lG~G~~-------------avk~~~~~~~~~~~~~~~Ei~il~~l~H~niv~l~~~~~~~~~~~lV~E~~~~ 355 (608)
++|++.+.||+|++ |||+.. .....+.|.+|+.++++++||||+++++++.+ ..++||||+++
T Consensus 8 ~~~~~~~~lg~G~~g~V~~~~~~~~~vavK~~~--~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~--~~~lv~e~~~~ 83 (307)
T 2eva_A 8 KEIEVEEVVGRGAFGVVCKAKWRAKDVAIKQIE--SESERKAFIVELRQLSRVNHPNIVKLYGACLN--PVCLVMEYAEG 83 (307)
T ss_dssp GGEEEEEEEECCSSSEEEEEEETTEEEEEEECS--STTHHHHHHHHHHHHHHCCCTTBCCEEEBCTT--TTEEEEECCTT
T ss_pred hHeeeeeEeecCCCceEEEEEECCeeEEEEEec--ChhHHHHHHHHHHHHhcCCCCCcCeEEEEEcC--CcEEEEEcCCC
Confidence 46888899999985 555543 34556789999999999999999999999874 47999999999
Q ss_pred CccchhccccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEEcCCCc-EEEeeccCccccccCCcce
Q 044312 356 GTLFQYIHDQNEDFPITWEIRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYR-AKVSDFGASRSMAVDQTHM 434 (608)
Q Consensus 356 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~-~kl~DFGls~~~~~~~~~~ 434 (608)
++|.+++........+++..++.++.|+++||+|||+.+...|+||||||+|||++.++. +||+|||+++.....
T Consensus 84 ~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~Dfg~~~~~~~~---- 159 (307)
T 2eva_A 84 GSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTH---- 159 (307)
T ss_dssp CBHHHHHHCSSSEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEECCCCC-----------
T ss_pred CCHHHHHhccCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEEcccccccccccc----
Confidence 999999987544335789999999999999999999932222999999999999988876 799999999765422
Q ss_pred eeeeeccCCCCChhhhccCCCCCccchHhHHHHHHHHHhCCCCCCccchhhcccHHHHHHHHhhhhhhHHHhhhhhhccC
Q 044312 435 TTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLTELLTGEKPIRFTILEEDKSLAAYFLCAMKEERLFEILDARVMKQG 514 (608)
Q Consensus 435 ~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~ 514 (608)
.....||+.|+|||.+.+..++.++||||||++++||++|+.||....... ..... ... .......
T Consensus 160 ~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~----~~~~~-~~~---------~~~~~~~ 225 (307)
T 2eva_A 160 MTNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPA----FRIMW-AVH---------NGTRPPL 225 (307)
T ss_dssp -----CCTTSSCHHHHTCCCCCTHHHHHHHHHHHHHHHHTCCTTTTTCSSH----HHHHH-HHH---------TTCCCCC
T ss_pred cccCCCCCceEChhhhCCCCCCcHHHHHHHHHHHHHHHHCCCCchhhCccH----HHHHH-HHh---------cCCCCCc
Confidence 233468999999999999999999999999999999999999986322111 10000 000 1111122
Q ss_pred ChhHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhhHHhcC
Q 044312 515 GKDEIITVAKLAKRCLNLNGKKRPTMREVASELAGIKAWNG 555 (608)
Q Consensus 515 ~~~~~~~l~~Li~~cl~~dp~~RPs~~evl~~L~~i~~~~~ 555 (608)
....+..+.+|+.+||+.||++|||+.|+++.|+.+.....
T Consensus 226 ~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~~ 266 (307)
T 2eva_A 226 IKNLPKPIESLMTRCWSKDPSQRPSMEEIVKIMTHLMRYFP 266 (307)
T ss_dssp BTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHGGGCC
T ss_pred ccccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHhcc
Confidence 33456789999999999999999999999999999876543
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-38 Score=324.08 Aligned_cols=258 Identities=25% Similarity=0.369 Sum_probs=197.9
Q ss_pred hcCccccceeccCce---------------EEEEEeecC-hhhHHHHHHHHHHHhhcCCCCccceecccccCc--cceEE
Q 044312 288 TDNFDLNRILGQGGQ---------------AVKKSKVID-ESKVEEFINEVVILSQINHRNVVKLLGCCLETE--VPLLV 349 (608)
Q Consensus 288 t~~f~~~~~lG~G~~---------------avk~~~~~~-~~~~~~~~~Ei~il~~l~H~niv~l~~~~~~~~--~~~lV 349 (608)
.++|.+.++||+|++ |||+.+... ....+.+.+|++++++++||||+++++++.+.. ..+||
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv 87 (319)
T 4euu_A 8 NHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLI 87 (319)
T ss_dssp SEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEE
T ss_pred CCCEEEEEEecCCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCcceEEEEeecCCCceEEEE
Confidence 356889999999984 677665422 344678899999999999999999999987655 67999
Q ss_pred EeecCCCccchhccccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEE----cCCCcEEEeeccCcc
Q 044312 350 YEFIPNGTLFQYIHDQNEDFPITWEIRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILL----DDKYRAKVSDFGASR 425 (608)
Q Consensus 350 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl----~~~~~~kl~DFGls~ 425 (608)
|||+++++|.+++........+++..++.++.||+.||+|||+.+ |+||||||+|||+ +.++.+||+|||+++
T Consensus 88 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg~a~ 164 (319)
T 4euu_A 88 MEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENG---IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAAR 164 (319)
T ss_dssp EECCTTCBHHHHHHSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEECTTSCEEEEECCCTTCE
T ss_pred EeCCCCCCHHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEEeccCCCCceEEEccCCCce
Confidence 999999999999987655445999999999999999999999999 9999999999999 788889999999998
Q ss_pred ccccCCcceeeeeeccCCCCChhhhc--------cCCCCCccchHhHHHHHHHHHhCCCCCCccchhhc-ccHHHHHHHH
Q 044312 426 SMAVDQTHMTTQVHGTFGYLDPEYFR--------SSQFTDKSDVYSFGVVLTELLTGEKPIRFTILEED-KSLAAYFLCA 496 (608)
Q Consensus 426 ~~~~~~~~~~~~~~gt~~y~aPE~~~--------~~~~t~ksDV~S~Gvvl~elltg~~p~~~~~~~~~-~~l~~~~~~~ 496 (608)
....... .....||+.|+|||++. ...++.++||||||+++|||++|+.||........ ..........
T Consensus 165 ~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~ 242 (319)
T 4euu_A 165 ELEDDEQ--FVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITG 242 (319)
T ss_dssp ECCTTCC--BCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTTCGGGCHHHHHHHHHH
T ss_pred ecCCCCc--eeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHHhcC
Confidence 7654332 23456899999999986 57889999999999999999999999964322111 1111111111
Q ss_pred hhhhhhHHH---h--------hhhhhccCChhHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhh
Q 044312 497 MKEERLFEI---L--------DARVMKQGGKDEIITVAKLAKRCLNLNGKKRPTMREVASELAGI 550 (608)
Q Consensus 497 ~~~~~~~~~---~--------d~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~evl~~L~~i 550 (608)
.....+..+ . +..............+.+|+.+||+.||++|||++|++++....
T Consensus 243 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R~s~~ell~h~~d~ 307 (319)
T 4euu_A 243 KPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDI 307 (319)
T ss_dssp CCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHH
T ss_pred CCcccchhhhcccCCccccCccCCcccccchhHHHHhHHHHHHhccCChhhhccHHHhhhccHHH
Confidence 110000000 0 00011123456778899999999999999999999999988653
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-38 Score=331.64 Aligned_cols=242 Identities=22% Similarity=0.428 Sum_probs=191.3
Q ss_pred cCccccceeccCce-------------------EEEEEeec-ChhhHHHHHHHHHHHhhcCCCCccceecccccCccceE
Q 044312 289 DNFDLNRILGQGGQ-------------------AVKKSKVI-DESKVEEFINEVVILSQINHRNVVKLLGCCLETEVPLL 348 (608)
Q Consensus 289 ~~f~~~~~lG~G~~-------------------avk~~~~~-~~~~~~~~~~Ei~il~~l~H~niv~l~~~~~~~~~~~l 348 (608)
++|++.+.||+|+| |+|..... .....+.+.+|+.++++++||||+++++++. ....++
T Consensus 13 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~ 91 (325)
T 3kex_A 13 TELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRLLGLCP-GSSLQL 91 (325)
T ss_dssp TTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTTSCSCBCSCCHHHHHHHTCCCTTBCCEEEEEC-BSSEEE
T ss_pred hHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccccHHHHHHHHHHHHHHhcCCCCCcCeEEEEEc-CCccEE
Confidence 46888999999985 22332211 1233457889999999999999999999986 456889
Q ss_pred EEeecCCCccchhccccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEEcCCCcEEEeeccCccccc
Q 044312 349 VYEFIPNGTLFQYIHDQNEDFPITWEIRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMA 428 (608)
Q Consensus 349 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGls~~~~ 428 (608)
||||+++|+|.+++..... .+++..++.++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++...
T Consensus 92 v~e~~~~~~L~~~l~~~~~--~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~ 166 (325)
T 3kex_A 92 VTQYLPLGSLLDHVRQHRG--ALGPQLLLNWGVQIAKGMYYLEEHG---MVHRNLAARNVLLKSPSQVQVADFGVADLLP 166 (325)
T ss_dssp EEECCTTCBSHHHHHSSGG--GSCTTHHHHHHHHHHHHHHHHHHTT---CCCSCCSSTTEEESSSSCEEECSCSGGGGSC
T ss_pred EEEeCCCCCHHHHHHHccc--cCCHHHHHHHHHHHHHHHHHHHhCC---CCCCccchheEEECCCCeEEECCCCcccccC
Confidence 9999999999999976433 5899999999999999999999999 9999999999999999999999999998875
Q ss_pred cCCcc-eeeeeeccCCCCChhhhccCCCCCccchHhHHHHHHHHHh-CCCCCCccchhhcccHHHHHHHHhhhhhhHHHh
Q 044312 429 VDQTH-MTTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLTELLT-GEKPIRFTILEEDKSLAAYFLCAMKEERLFEIL 506 (608)
Q Consensus 429 ~~~~~-~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~ellt-g~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 506 (608)
..... ......+|..|+|||.+.+..++.++||||||+++|||+| |+.||......+ +.+.+
T Consensus 167 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~----------------~~~~~ 230 (325)
T 3kex_A 167 PDDKQLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAE----------------VPDLL 230 (325)
T ss_dssp CCTTCCC-----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCTTH----------------HHHHH
T ss_pred cccccccccCCCCcccccChHHhccCCCChhhHhHHhHHHHHHHHhCCCCCccccCHHH----------------HHHHH
Confidence 44322 2344567889999999999999999999999999999999 999987432211 11122
Q ss_pred hhhhhccCChhHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhhHH
Q 044312 507 DARVMKQGGKDEIITVAKLAKRCLNLNGKKRPTMREVASELAGIKA 552 (608)
Q Consensus 507 d~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~evl~~L~~i~~ 552 (608)
........+...+..+.+|+.+||+.||++|||+.|++++|+.+..
T Consensus 231 ~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~el~~~l~~~~~ 276 (325)
T 3kex_A 231 EKGERLAQPQICTIDVYMVMVKCWMIDENIRPTFKELANEFTRMAR 276 (325)
T ss_dssp HTTCBCCCCTTBCTTTTHHHHHHTCSCTTTSCCHHHHHHHHHHHTT
T ss_pred HcCCCCCCCCcCcHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHh
Confidence 2222223333455678999999999999999999999999988754
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-38 Score=329.37 Aligned_cols=252 Identities=25% Similarity=0.447 Sum_probs=199.9
Q ss_pred HHHHhcCccccceeccCce--------------------EEEEEeec-ChhhHHHHHHHHHHHhhc-CCCCccceecccc
Q 044312 284 LEKATDNFDLNRILGQGGQ--------------------AVKKSKVI-DESKVEEFINEVVILSQI-NHRNVVKLLGCCL 341 (608)
Q Consensus 284 l~~~t~~f~~~~~lG~G~~--------------------avk~~~~~-~~~~~~~~~~Ei~il~~l-~H~niv~l~~~~~ 341 (608)
++...++|.+.+.||+|++ |||..+.. .....+.+.+|+.+++++ +||||+++++++.
T Consensus 40 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~ 119 (344)
T 1rjb_A 40 WEFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACT 119 (344)
T ss_dssp GBCCGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred cccCHHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEecccccCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEe
Confidence 4445678999999999985 34444321 233457899999999999 9999999999999
Q ss_pred cCccceEEEeecCCCccchhccccCCC--------------------CCCCHHHHHHHHHHHHHHHHHHhhcCCCCeecc
Q 044312 342 ETEVPLLVYEFIPNGTLFQYIHDQNED--------------------FPITWEIRLRIAIEVSGALSYLHSAASIPIYHR 401 (608)
Q Consensus 342 ~~~~~~lV~E~~~~gsL~~~l~~~~~~--------------------~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHr 401 (608)
..+..++||||+++|+|.+++...... ..+++..++.++.||+.||+|||+.+ |+||
T Consensus 120 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~ 196 (344)
T 1rjb_A 120 LSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKS---CVHR 196 (344)
T ss_dssp SSSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTT---EEET
T ss_pred eCCccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---cccC
Confidence 999999999999999999999764321 23799999999999999999999999 9999
Q ss_pred CCCCCcEEEcCCCcEEEeeccCccccccCCcc-eeeeeeccCCCCChhhhccCCCCCccchHhHHHHHHHHHh-CCCCCC
Q 044312 402 DIKSTNILLDDKYRAKVSDFGASRSMAVDQTH-MTTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLTELLT-GEKPIR 479 (608)
Q Consensus 402 Dlk~~NILl~~~~~~kl~DFGls~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~ellt-g~~p~~ 479 (608)
||||+|||++.++.+||+|||+++........ ......+|+.|+|||.+.+..++.++||||||++++||+| |..||.
T Consensus 197 Dikp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~ 276 (344)
T 1rjb_A 197 DLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYP 276 (344)
T ss_dssp TCSGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSST
T ss_pred CCChhhEEEcCCCcEEeCCCccCcccccCccceeccCccCccCccCHHHhccCCCChhHhHHHHHHHHHHHHcCCCCCcc
Confidence 99999999999999999999999876544332 2334567889999999999999999999999999999998 999986
Q ss_pred ccchhhcccHHHHHHHHhhhhhhHHHhhhhhhccCChhHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhhHHh
Q 044312 480 FTILEEDKSLAAYFLCAMKEERLFEILDARVMKQGGKDEIITVAKLAKRCLNLNGKKRPTMREVASELAGIKAW 553 (608)
Q Consensus 480 ~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~evl~~L~~i~~~ 553 (608)
...... .+...+........+...+.++.+|+.+||+.||++|||+.||+++|+.+...
T Consensus 277 ~~~~~~---------------~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~ 335 (344)
T 1rjb_A 277 GIPVDA---------------NFYKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLGCQLAD 335 (344)
T ss_dssp TCCCSH---------------HHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC--
T ss_pred cCCcHH---------------HHHHHHhcCCCCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHHH
Confidence 432111 11112222222333445567899999999999999999999999999887553
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-38 Score=329.42 Aligned_cols=257 Identities=25% Similarity=0.415 Sum_probs=203.6
Q ss_pred cccCCHHHHHHHhcCccccceeccCce--------------------EEEEEeec-ChhhHHHHHHHHHHHhhcCCCCcc
Q 044312 276 TKLFTSKELEKATDNFDLNRILGQGGQ--------------------AVKKSKVI-DESKVEEFINEVVILSQINHRNVV 334 (608)
Q Consensus 276 ~~~~~~~~l~~~t~~f~~~~~lG~G~~--------------------avk~~~~~-~~~~~~~~~~Ei~il~~l~H~niv 334 (608)
...+..++++...++|++.+.||+|++ |||..... .......|.+|+.++++++||||+
T Consensus 12 ~~~~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~ 91 (322)
T 1p4o_A 12 ADVYVPDEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVV 91 (322)
T ss_dssp CSCCCCCTTBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBC
T ss_pred ccccChhhhcchhhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEecccccCHHHHHHHHHHHHHHHhcCCCCEe
Confidence 345666677778889999999999985 33333221 223456799999999999999999
Q ss_pred ceecccccCccceEEEeecCCCccchhccccCC-------CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCc
Q 044312 335 KLLGCCLETEVPLLVYEFIPNGTLFQYIHDQNE-------DFPITWEIRLRIAIEVSGALSYLHSAASIPIYHRDIKSTN 407 (608)
Q Consensus 335 ~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~-------~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~N 407 (608)
++++++.+.+..++||||+++|+|.+++..... ..++++..++.++.||+.||+|||+++ |+||||||+|
T Consensus 92 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~N 168 (322)
T 1p4o_A 92 RLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANK---FVHRDLAARN 168 (322)
T ss_dssp CEEEEECSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCSGGG
T ss_pred eeEEEEccCCccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHCC---CccCCCccce
Confidence 999999999999999999999999999976321 135799999999999999999999999 9999999999
Q ss_pred EEEcCCCcEEEeeccCccccccCCcc-eeeeeeccCCCCChhhhccCCCCCccchHhHHHHHHHHHh-CCCCCCccchhh
Q 044312 408 ILLDDKYRAKVSDFGASRSMAVDQTH-MTTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLTELLT-GEKPIRFTILEE 485 (608)
Q Consensus 408 ILl~~~~~~kl~DFGls~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~ellt-g~~p~~~~~~~~ 485 (608)
||++.++.+||+|||+++........ ......+|+.|+|||.+.+..++.++||||||++++||++ |+.||.......
T Consensus 169 Ili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~ 248 (322)
T 1p4o_A 169 CMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQ 248 (322)
T ss_dssp EEECTTCCEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHH
T ss_pred EEEcCCCeEEECcCccccccccccccccccCCCCCCCccChhhhccCCCCchhhHHHHHHHHHHHHhcCCCccccCCHHH
Confidence 99999999999999999866433221 1223456889999999999999999999999999999999 889986332111
Q ss_pred cccHHHHHHHHhhhhhhHHHhhhhhhccCChhHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhhH
Q 044312 486 DKSLAAYFLCAMKEERLFEILDARVMKQGGKDEIITVAKLAKRCLNLNGKKRPTMREVASELAGIK 551 (608)
Q Consensus 486 ~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~evl~~L~~i~ 551 (608)
. ...+........+...+..+.+|+.+||+.||++|||+.|++++|+.+.
T Consensus 249 -------~---------~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~e~l~~L~~~~ 298 (322)
T 1p4o_A 249 -------V---------LRFVMEGGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEM 298 (322)
T ss_dssp -------H---------HHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGS
T ss_pred -------H---------HHHHHcCCcCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHhh
Confidence 0 0111111112233456678999999999999999999999999997653
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-38 Score=328.72 Aligned_cols=243 Identities=23% Similarity=0.452 Sum_probs=191.3
Q ss_pred hcCccccceeccCce-------------------EEEEEee-cChhhHHHHHHHHHHHhhcCCCCccceecccccCccce
Q 044312 288 TDNFDLNRILGQGGQ-------------------AVKKSKV-IDESKVEEFINEVVILSQINHRNVVKLLGCCLETEVPL 347 (608)
Q Consensus 288 t~~f~~~~~lG~G~~-------------------avk~~~~-~~~~~~~~~~~Ei~il~~l~H~niv~l~~~~~~~~~~~ 347 (608)
.++|++.+.||+|+| |+|.... ......+.+.+|+.++++++||||+++++++.... .+
T Consensus 14 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~-~~ 92 (327)
T 3lzb_A 14 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQ 92 (327)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCSSCCCHHHHHHHHHHHTTCCBTTBCCCCEEEESSS-EE
T ss_pred HhHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEecCC-ce
Confidence 357899999999985 3333322 23345788999999999999999999999998754 78
Q ss_pred EEEeecCCCccchhccccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEEcCCCcEEEeeccCcccc
Q 044312 348 LVYEFIPNGTLFQYIHDQNEDFPITWEIRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSM 427 (608)
Q Consensus 348 lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGls~~~ 427 (608)
+|+|++++|+|.+++..... .+++..++.|+.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++..
T Consensus 93 ~v~~~~~~g~L~~~l~~~~~--~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kL~DfG~a~~~ 167 (327)
T 3lzb_A 93 LITQLMPFGCLLDYVREHKD--NIGSQYLLNWCVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLL 167 (327)
T ss_dssp EEECCCSSCBHHHHHHHTTT--CCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEETTEEEECCTTC----
T ss_pred EEEEecCCCcHHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHhhCC---CcCCCCCHHHEEEcCCCCEEEccCcceeEc
Confidence 99999999999999987543 5899999999999999999999999 999999999999999999999999999876
Q ss_pred ccCCc-ceeeeeeccCCCCChhhhccCCCCCccchHhHHHHHHHHHh-CCCCCCccchhhcccHHHHHHHHhhhhhhHHH
Q 044312 428 AVDQT-HMTTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLTELLT-GEKPIRFTILEEDKSLAAYFLCAMKEERLFEI 505 (608)
Q Consensus 428 ~~~~~-~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~ellt-g~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 505 (608)
..... .......+|+.|+|||.+.+..++.++||||||++++||++ |+.||...... .+...
T Consensus 168 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~----------------~~~~~ 231 (327)
T 3lzb_A 168 GAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPAS----------------EISSI 231 (327)
T ss_dssp ------------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGG----------------GHHHH
T ss_pred cCccccccccCCCccccccCHHHHcCCCCChHHHHHHHHHHHHHHHHCCCCCCCCCCHH----------------HHHHH
Confidence 53322 22233456788999999999999999999999999999999 99998743222 12222
Q ss_pred hhhhhhccCChhHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhhHH
Q 044312 506 LDARVMKQGGKDEIITVAKLAKRCLNLNGKKRPTMREVASELAGIKA 552 (608)
Q Consensus 506 ~d~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~evl~~L~~i~~ 552 (608)
+........+...+.++.+|+.+||+.||++||++.|+++.|+.+..
T Consensus 232 ~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~ 278 (327)
T 3lzb_A 232 LEKGERLPQPPICTIDVYMIMRKCWMIDADSRPKFRELIIEFSKMAR 278 (327)
T ss_dssp HHTTCCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHT
T ss_pred HHcCCCCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHh
Confidence 22222333445567789999999999999999999999999988865
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-38 Score=335.26 Aligned_cols=253 Identities=20% Similarity=0.284 Sum_probs=189.8
Q ss_pred hcCccccceeccC--ce---------------EEEEEeec--ChhhHHHHHHHHHHHhhcCCCCccceecccccCccceE
Q 044312 288 TDNFDLNRILGQG--GQ---------------AVKKSKVI--DESKVEEFINEVVILSQINHRNVVKLLGCCLETEVPLL 348 (608)
Q Consensus 288 t~~f~~~~~lG~G--~~---------------avk~~~~~--~~~~~~~~~~Ei~il~~l~H~niv~l~~~~~~~~~~~l 348 (608)
.++|++.++||+| ++ |||+++.. .....+.+.+|+.++++++|||||++++++.+.+..++
T Consensus 24 ~~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 103 (389)
T 3gni_B 24 GGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWV 103 (389)
T ss_dssp GGGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEE
T ss_pred CCcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCCCcEeEEEEECCEEEE
Confidence 4578999999999 63 77777643 34456788999999999999999999999999999999
Q ss_pred EEeecCCCccchhccccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEEcCCCcEEEeeccCccccc
Q 044312 349 VYEFIPNGTLFQYIHDQNEDFPITWEIRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMA 428 (608)
Q Consensus 349 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGls~~~~ 428 (608)
||||+++|+|.+++...... .+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||++....
T Consensus 104 v~e~~~~~~L~~~l~~~~~~-~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~NIll~~~~~~kl~dfg~~~~~~ 179 (389)
T 3gni_B 104 VTSFMAYGSAKDLICTHFMD-GMNELAIAYILQGVLKALDYIHHMG---YVHRSVKASHILISVDGKVYLSGLRSNLSMI 179 (389)
T ss_dssp EEECCTTCBHHHHHHHTCTT-CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCGGGCEECE
T ss_pred EEEccCCCCHHHHHhhhccc-CCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEcccccceeec
Confidence 99999999999999765322 5999999999999999999999999 9999999999999999999999999986553
Q ss_pred cCCcc------eeeeeeccCCCCChhhhcc--CCCCCccchHhHHHHHHHHHhCCCCCCccchhhcccHHHHHHHHhh--
Q 044312 429 VDQTH------MTTQVHGTFGYLDPEYFRS--SQFTDKSDVYSFGVVLTELLTGEKPIRFTILEEDKSLAAYFLCAMK-- 498 (608)
Q Consensus 429 ~~~~~------~~~~~~gt~~y~aPE~~~~--~~~t~ksDV~S~Gvvl~elltg~~p~~~~~~~~~~~l~~~~~~~~~-- 498 (608)
..... ......||+.|+|||++.+ ..++.++||||||++++||++|+.||........ +.........
T Consensus 180 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~--~~~~~~~~~~~~ 257 (389)
T 3gni_B 180 SHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQM--LLEKLNGTVPCL 257 (389)
T ss_dssp ETTEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTCCSTTH--HHHC--------
T ss_pred cccccccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCCCHHHH--HHHHhcCCCCcc
Confidence 22111 1122368899999999987 6799999999999999999999999964322111 0000000000
Q ss_pred -------hhh-------------hHHHhh---------hhhhccCChhHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 044312 499 -------EER-------------LFEILD---------ARVMKQGGKDEIITVAKLAKRCLNLNGKKRPTMREVASE 546 (608)
Q Consensus 499 -------~~~-------------~~~~~d---------~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~evl~~ 546 (608)
... +...+. .......+...+..+.+|+.+||+.||++|||+.|++++
T Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~ell~h 334 (389)
T 3gni_B 258 LDTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARPSASTLLNH 334 (389)
T ss_dssp ------------------------------------------------CCHHHHHHHHHHTCSCTTTSCCHHHHTTS
T ss_pred ccccccccccccccccccccccccccccccCccccccCCCCCCccccccCHHHHHHHHHHhhcCcccCCCHHHHhcC
Confidence 000 000000 000011223345679999999999999999999999865
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-38 Score=328.48 Aligned_cols=234 Identities=26% Similarity=0.335 Sum_probs=193.0
Q ss_pred cCccccceeccCce---------------EEEEEeec---ChhhHHHHHHHHHHHhhcCCCCccceecccccCccceEEE
Q 044312 289 DNFDLNRILGQGGQ---------------AVKKSKVI---DESKVEEFINEVVILSQINHRNVVKLLGCCLETEVPLLVY 350 (608)
Q Consensus 289 ~~f~~~~~lG~G~~---------------avk~~~~~---~~~~~~~~~~Ei~il~~l~H~niv~l~~~~~~~~~~~lV~ 350 (608)
++|++.+.||+|+| |+|.++.. .....+.+.+|+.+|++++||||+++++++.+.+..++||
T Consensus 5 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv~ 84 (337)
T 1o6l_A 5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVM 84 (337)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEEE
T ss_pred HHeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEeCCEEEEEE
Confidence 57889999999985 66666532 3345678999999999999999999999999999999999
Q ss_pred eecCCCccchhccccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEEcCCCcEEEeeccCccccccC
Q 044312 351 EFIPNGTLFQYIHDQNEDFPITWEIRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVD 430 (608)
Q Consensus 351 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGls~~~~~~ 430 (608)
||+++|+|.+++.... .+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++.....
T Consensus 85 E~~~gg~L~~~l~~~~---~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~ 158 (337)
T 1o6l_A 85 EYANGGELFFHLSRER---VFTEERARFYGAEIVSALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCKEGISD 158 (337)
T ss_dssp ECCTTCBHHHHHHHHS---CCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCSCCT
T ss_pred eCCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC---eecCcCCHHHEEECCCCCEEEeeccchhhcccC
Confidence 9999999999987643 5899999999999999999999999 999999999999999999999999999864332
Q ss_pred CcceeeeeeccCCCCChhhhccCCCCCccchHhHHHHHHHHHhCCCCCCccchhhcccHHHHHHHHhhhhhhHHHhhhhh
Q 044312 431 QTHMTTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLTELLTGEKPIRFTILEEDKSLAAYFLCAMKEERLFEILDARV 510 (608)
Q Consensus 431 ~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~ 510 (608)
. .......||+.|+|||++.+..++.++||||||++++||++|+.||...... ..+. .++..
T Consensus 159 ~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~------~~~~---------~i~~~-- 220 (337)
T 1o6l_A 159 G-ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE------RLFE---------LILME-- 220 (337)
T ss_dssp T-CCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHH------HHHH---------HHHHC--
T ss_pred C-CcccccccChhhCChhhhcCCCCCchhhcccchhHHHHHhcCCCCCCCCCHH------HHHH---------HHHcC--
Confidence 2 2234567999999999999999999999999999999999999999632211 1111 11111
Q ss_pred hccCChhHHHHHHHHHHHHhccCCCCCC-----CHHHHHHH
Q 044312 511 MKQGGKDEIITVAKLAKRCLNLNGKKRP-----TMREVASE 546 (608)
Q Consensus 511 ~~~~~~~~~~~l~~Li~~cl~~dp~~RP-----s~~evl~~ 546 (608)
....+...+.++.+|+.+||+.||++|| +++||+++
T Consensus 221 ~~~~p~~~s~~~~~li~~lL~~dP~~R~g~~~~~~~ei~~h 261 (337)
T 1o6l_A 221 EIRFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEH 261 (337)
T ss_dssp CCCCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTS
T ss_pred CCCCCCCCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHHcC
Confidence 1123345567899999999999999999 89998875
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-38 Score=353.96 Aligned_cols=246 Identities=26% Similarity=0.405 Sum_probs=194.3
Q ss_pred cCccccc-eeccCce-----------------EEEEEeec-ChhhHHHHHHHHHHHhhcCCCCccceecccccCccceEE
Q 044312 289 DNFDLNR-ILGQGGQ-----------------AVKKSKVI-DESKVEEFINEVVILSQINHRNVVKLLGCCLETEVPLLV 349 (608)
Q Consensus 289 ~~f~~~~-~lG~G~~-----------------avk~~~~~-~~~~~~~~~~Ei~il~~l~H~niv~l~~~~~~~~~~~lV 349 (608)
+++.+.+ .||+|+| |||.++.. .....++|.+|+.+|++++|||||++++++.. +..+||
T Consensus 335 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~-~~~~lv 413 (613)
T 2ozo_A 335 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLV 413 (613)
T ss_dssp TSEEEEEEEEEECSSSEEEEEEEECSSCEEEEEEEECCCCCSSTTHHHHHHHHHHHTTCCCTTBCCEEEEEES-SSEEEE
T ss_pred cceeEcCcEEecCCCcEEEEEEEecCCCcEEEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEecc-CCeEEE
Confidence 3444444 7999974 55655542 33467899999999999999999999999976 568999
Q ss_pred EeecCCCccchhccccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEEcCCCcEEEeeccCcccccc
Q 044312 350 YEFIPNGTLFQYIHDQNEDFPITWEIRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAV 429 (608)
Q Consensus 350 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGls~~~~~ 429 (608)
|||+++|+|.+++..... .+++..++.|+.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++....
T Consensus 414 ~E~~~~g~L~~~l~~~~~--~l~~~~~~~i~~qi~~~L~~LH~~~---iiHrDlkp~NILl~~~~~vkL~DFGla~~~~~ 488 (613)
T 2ozo_A 414 MEMAGGGPLHKFLVGKRE--EIPVSNVAELLHQVSMGMKYLEEKN---FVHRNLAARNVLLVNRHYAKISDFGLSKALGA 488 (613)
T ss_dssp EECCTTCBHHHHHTTCTT--TSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECCCSTTTTCC-
T ss_pred EEeCCCCcHHHHHhhccC--CCCHHHHHHHHHHHHHHHHHHHHCC---EEcCcCCHHHEEEcCCCcEEEeeccCcccccC
Confidence 999999999999976433 5999999999999999999999999 99999999999999999999999999987654
Q ss_pred CCccee--eeeeccCCCCChhhhccCCCCCccchHhHHHHHHHHHh-CCCCCCccchhhcccHHHHHHHHhhhhhhHHHh
Q 044312 430 DQTHMT--TQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLTELLT-GEKPIRFTILEEDKSLAAYFLCAMKEERLFEIL 506 (608)
Q Consensus 430 ~~~~~~--~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~ellt-g~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 506 (608)
...... ....+++.|+|||++....++.++||||||++||||++ |+.||......+ +.+.+
T Consensus 489 ~~~~~~~~~~~~~~~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~----------------~~~~i 552 (613)
T 2ozo_A 489 DDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPE----------------VMAFI 552 (613)
T ss_dssp -------------CCTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCSHH----------------HHHHH
T ss_pred CCceeeeccCCCCccceeCHhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCCHHH----------------HHHHH
Confidence 332221 22345689999999999999999999999999999998 999987432211 11222
Q ss_pred hhhhhccCChhHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhhHHhcCC
Q 044312 507 DARVMKQGGKDEIITVAKLAKRCLNLNGKKRPTMREVASELAGIKAWNGA 556 (608)
Q Consensus 507 d~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~evl~~L~~i~~~~~~ 556 (608)
........+..++.++.+|+.+||+.||++||++.+|++.|+.+......
T Consensus 553 ~~~~~~~~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~~~~~~~ 602 (613)
T 2ozo_A 553 EQGKRMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSLAS 602 (613)
T ss_dssp HTTCCCCCCTTCCHHHHHHHHHTTCSSTTTSCCHHHHHHHHHHHHHHHSC
T ss_pred HcCCCCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHHHhcc
Confidence 22223344556778999999999999999999999999999988665443
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-38 Score=325.03 Aligned_cols=240 Identities=23% Similarity=0.305 Sum_probs=193.3
Q ss_pred hcCccccceeccCce---------------EEEEEeecChhhHHHHHHHHHHHhhcCCCCccceecccccCccceEEEee
Q 044312 288 TDNFDLNRILGQGGQ---------------AVKKSKVIDESKVEEFINEVVILSQINHRNVVKLLGCCLETEVPLLVYEF 352 (608)
Q Consensus 288 t~~f~~~~~lG~G~~---------------avk~~~~~~~~~~~~~~~Ei~il~~l~H~niv~l~~~~~~~~~~~lV~E~ 352 (608)
.++|++.+.||+|+| |+|..+. .....+.+.+|+.+|++++||||+++++++.+.+..++||||
T Consensus 4 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~-~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~ 82 (321)
T 1tki_A 4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKV-KGTDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEF 82 (321)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC-CTHHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECC
T ss_pred hhceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEec-CcccHHHHHHHHHHHHhCCCCCCCeEeEEEecCCEEEEEEEe
Confidence 468999999999985 5555543 334567789999999999999999999999999999999999
Q ss_pred cCCCccchhccccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEEcC--CCcEEEeeccCccccccC
Q 044312 353 IPNGTLFQYIHDQNEDFPITWEIRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDD--KYRAKVSDFGASRSMAVD 430 (608)
Q Consensus 353 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~--~~~~kl~DFGls~~~~~~ 430 (608)
+++++|.+++..... .+++..+..++.||+.||+|||+.+ |+||||||+|||++. ++.+||+|||+++.....
T Consensus 83 ~~g~~L~~~l~~~~~--~~~~~~~~~i~~qi~~al~~lH~~g---ivH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~~~~ 157 (321)
T 1tki_A 83 ISGLDIFERINTSAF--ELNEREIVSYVHQVCEALQFLHSHN---IGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPG 157 (321)
T ss_dssp CCCCBHHHHHTSSSC--CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSCCCEEECCCTTCEECCTT
T ss_pred CCCCCHHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHHCC---CCcCCCCHHHEEEccCCCCCEEEEECCCCeECCCC
Confidence 999999999976432 5899999999999999999999999 999999999999987 789999999999876543
Q ss_pred CcceeeeeeccCCCCChhhhccCCCCCccchHhHHHHHHHHHhCCCCCCccchhhcccHHHHHHHHhhhhhhHHHhhhhh
Q 044312 431 QTHMTTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLTELLTGEKPIRFTILEEDKSLAAYFLCAMKEERLFEILDARV 510 (608)
Q Consensus 431 ~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~ 510 (608)
. ......||+.|+|||++.+..++.++||||||++++||++|..||....... .+. .+...... .+.
T Consensus 158 ~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~------~~~-~i~~~~~~--~~~-- 224 (321)
T 1tki_A 158 D--NFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQ------IIE-NIMNAEYT--FDE-- 224 (321)
T ss_dssp C--EEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHH------HHH-HHHHTCCC--CCH--
T ss_pred C--ccccccCChhhcCcHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCcCCCHHH------HHH-HHHcCCCC--CCh--
Confidence 2 3345679999999999998889999999999999999999999996432211 111 11100000 000
Q ss_pred hccCChhHHHHHHHHHHHHhccCCCCCCCHHHHHHHHH
Q 044312 511 MKQGGKDEIITVAKLAKRCLNLNGKKRPTMREVASELA 548 (608)
Q Consensus 511 ~~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~evl~~L~ 548 (608)
......+.++.+|+.+||..||++|||+.|++++-.
T Consensus 225 --~~~~~~s~~~~~li~~~L~~dp~~Rpt~~e~l~hp~ 260 (321)
T 1tki_A 225 --EAFKEISIEAMDFVDRLLVKERKSRMTASEALQHPW 260 (321)
T ss_dssp --HHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHH
T ss_pred --hhhccCCHHHHHHHHHHcCCChhHCcCHHHHhcChh
Confidence 001134567999999999999999999999998643
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-38 Score=343.39 Aligned_cols=247 Identities=21% Similarity=0.321 Sum_probs=198.9
Q ss_pred CHHHHHHHhcCccccceeccCce---------------EEEEEeec---ChhhHHHHHHHHHHHhhcCCCCccceecccc
Q 044312 280 TSKELEKATDNFDLNRILGQGGQ---------------AVKKSKVI---DESKVEEFINEVVILSQINHRNVVKLLGCCL 341 (608)
Q Consensus 280 ~~~~l~~~t~~f~~~~~lG~G~~---------------avk~~~~~---~~~~~~~~~~Ei~il~~l~H~niv~l~~~~~ 341 (608)
...++...+++|++.++||+|+| |+|+++.. .....+.+.+|+.++++++||||+++++++.
T Consensus 65 ~~~~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~ 144 (437)
T 4aw2_A 65 KVKQMRLHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAFQ 144 (437)
T ss_dssp HHHHHSCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEEE
T ss_pred hhhcccCChhheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEEe
Confidence 34556667889999999999985 56665431 1222344899999999999999999999999
Q ss_pred cCccceEEEeecCCCccchhccccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEEcCCCcEEEeec
Q 044312 342 ETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEIRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDF 421 (608)
Q Consensus 342 ~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DF 421 (608)
+.+..+|||||+++|+|.+++..... .+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+||
T Consensus 145 ~~~~~~lV~Ey~~gg~L~~~l~~~~~--~l~e~~~~~~~~qi~~aL~~LH~~g---iiHrDLKp~NILl~~~g~vkL~DF 219 (437)
T 4aw2_A 145 DDNNLYLVMDYYVGGDLLTLLSKFED--RLPEEMARFYLAEMVIAIDSVHQLH---YVHRDIKPDNILMDMNGHIRLADF 219 (437)
T ss_dssp CSSEEEEEECCCTTCBHHHHHHTTTT--CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCC
T ss_pred eCCEEEEEEecCCCCcHHHHHHHccC--CCCHHHHHHHHHHHHHHHHHHHhCC---eEecccCHHHeeEcCCCCEEEcch
Confidence 99999999999999999999986433 5999999999999999999999999 999999999999999999999999
Q ss_pred cCccccccCCcceeeeeeccCCCCChhhhc-----cCCCCCccchHhHHHHHHHHHhCCCCCCccchhhcccHHHHHHHH
Q 044312 422 GASRSMAVDQTHMTTQVHGTFGYLDPEYFR-----SSQFTDKSDVYSFGVVLTELLTGEKPIRFTILEEDKSLAAYFLCA 496 (608)
Q Consensus 422 Gls~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~t~ksDV~S~Gvvl~elltg~~p~~~~~~~~~~~l~~~~~~~ 496 (608)
|+++..............||+.|+|||++. ...++.++|||||||++|||++|+.||...... ..+
T Consensus 220 Gla~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~------~~~--- 290 (437)
T 4aw2_A 220 GSCLKLMEDGTVQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLV------ETY--- 290 (437)
T ss_dssp TTCEECCTTSCEECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCSSHH------HHH---
T ss_pred hhhhhcccCCCcccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCCChh------HHH---
Confidence 999877655544445567999999999987 567899999999999999999999999743221 111
Q ss_pred hhhhhhHHHhhhhhhccCC---hhHHHHHHHHHHHHhccCCCC--CCCHHHHHHH
Q 044312 497 MKEERLFEILDARVMKQGG---KDEIITVAKLAKRCLNLNGKK--RPTMREVASE 546 (608)
Q Consensus 497 ~~~~~~~~~~d~~~~~~~~---~~~~~~l~~Li~~cl~~dp~~--RPs~~evl~~ 546 (608)
..++........+ ...+.++.+|+.+||..+|++ ||+++|++++
T Consensus 291 ------~~i~~~~~~~~~p~~~~~~s~~~~dLi~~lL~~~~~r~~r~~~~eil~H 339 (437)
T 4aw2_A 291 ------GKIMNHKERFQFPTQVTDVSENAKDLIRRLICSREHRLGQNGIEDFKKH 339 (437)
T ss_dssp ------HHHHTHHHHCCCCSSCCCSCHHHHHHHHTTSSCGGGCTTTTTTHHHHTS
T ss_pred ------HhhhhccccccCCcccccCCHHHHHHHHHHhcccccccCCCCHHHHhCC
Confidence 1111111111112 235678999999999888888 9999999875
|
| >4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-37 Score=317.44 Aligned_cols=258 Identities=19% Similarity=0.222 Sum_probs=195.9
Q ss_pred HhcCccccceeccCce---------------EEEEEeecChhhHHHHHHHHHHHhhcCCCCccceeccc-ccCccceEEE
Q 044312 287 ATDNFDLNRILGQGGQ---------------AVKKSKVIDESKVEEFINEVVILSQINHRNVVKLLGCC-LETEVPLLVY 350 (608)
Q Consensus 287 ~t~~f~~~~~lG~G~~---------------avk~~~~~~~~~~~~~~~Ei~il~~l~H~niv~l~~~~-~~~~~~~lV~ 350 (608)
..++|++.+.||+|++ |||.... ....+.+.+|+.+++.++|++++..+..+ .+....++||
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~--~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~ 84 (296)
T 4hgt_A 7 VGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECV--KTKHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVM 84 (296)
T ss_dssp ----CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC-----CCCHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEE
T ss_pred cCCceEEeeeecCCCCeEEEEEEEcCCCceEEEEeecc--cccchHHHHHHHHHHHhcCCCCCCeeeeecCCCCceEEEE
Confidence 4578999999999974 5665433 22334688999999999888877776665 5667789999
Q ss_pred eecCCCccchhccccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEE---cCCCcEEEeeccCcccc
Q 044312 351 EFIPNGTLFQYIHDQNEDFPITWEIRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILL---DDKYRAKVSDFGASRSM 427 (608)
Q Consensus 351 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl---~~~~~~kl~DFGls~~~ 427 (608)
||+ +++|.+++..... .+++..++.++.||+.||+|||+.+ |+||||||+|||+ ++++.+||+|||+++..
T Consensus 85 e~~-~~~L~~~~~~~~~--~~~~~~~~~i~~qi~~~l~~LH~~~---ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a~~~ 158 (296)
T 4hgt_A 85 ELL-GPSLEDLFNFCSR--KFSLKTVLLLADQMISRIEYIHSKN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKY 158 (296)
T ss_dssp ECC-CCBHHHHHHHTTS--CCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECCGGGTTCEEECCCTTCEEC
T ss_pred Ecc-CCCHHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeeeeccCCCCeEEEecCccceec
Confidence 999 9999999975433 5999999999999999999999999 9999999999999 78899999999999876
Q ss_pred ccCCcc------eeeeeeccCCCCChhhhccCCCCCccchHhHHHHHHHHHhCCCCCCccchhhcccHHHHHHHHhhhhh
Q 044312 428 AVDQTH------MTTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLTELLTGEKPIRFTILEEDKSLAAYFLCAMKEER 501 (608)
Q Consensus 428 ~~~~~~------~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~ 501 (608)
...... ......||+.|+|||.+.+..++.++||||||++++||++|+.||.......................
T Consensus 159 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 238 (296)
T 4hgt_A 159 RDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTP 238 (296)
T ss_dssp BCTTTCCBCCCCCSCCCCSCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHSC
T ss_pred cCcccCccCCCCcccccCCCccccchHHhcCCCCCchhHHHHHHHHHHHHhcCCCCCcccchhhhhhhhhhhhcccccch
Confidence 543321 22345789999999999999999999999999999999999999975433222222111111000000
Q ss_pred hHHHhhhhhhccCChhHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhhHHhcCCCchhh
Q 044312 502 LFEILDARVMKQGGKDEIITVAKLAKRCLNLNGKKRPTMREVASELAGIKAWNGASNVIE 561 (608)
Q Consensus 502 ~~~~~d~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~evl~~L~~i~~~~~~~~~~~ 561 (608)
. .......+.++.+|+.+||+.||++|||+.||++.|+.+....+.+....
T Consensus 239 ~---------~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~~~~~~~~~~~~~ 289 (296)
T 4hgt_A 239 I---------EVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFSYDYV 289 (296)
T ss_dssp H---------HHHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHHHHTCCTTCC
T ss_pred h---------hhhhccCCHHHHHHHHHHHhcCCCCCCCHHHHHHHHHHHHHHhCCCccCc
Confidence 0 00112335689999999999999999999999999999988766555443
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-38 Score=326.96 Aligned_cols=257 Identities=27% Similarity=0.379 Sum_probs=200.7
Q ss_pred ccccceeccCce-------------------EEEEEeec-ChhhHHHHHHHHHHHhhcCCCCccceecccccC--ccceE
Q 044312 291 FDLNRILGQGGQ-------------------AVKKSKVI-DESKVEEFINEVVILSQINHRNVVKLLGCCLET--EVPLL 348 (608)
Q Consensus 291 f~~~~~lG~G~~-------------------avk~~~~~-~~~~~~~~~~Ei~il~~l~H~niv~l~~~~~~~--~~~~l 348 (608)
|++.+.||+|++ |||+.+.. .....+.+.+|+.+|++++||||+++++++.+. ...++
T Consensus 33 ~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~l 112 (318)
T 3lxp_A 33 LKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAASLQL 112 (318)
T ss_dssp EEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTTTEEEE
T ss_pred HhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccccChHHHHHHHHHHHHHHhCCCcchhhEEEEEecCCCceEEE
Confidence 488999999985 45554432 234467899999999999999999999999764 56799
Q ss_pred EEeecCCCccchhccccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEEcCCCcEEEeeccCccccc
Q 044312 349 VYEFIPNGTLFQYIHDQNEDFPITWEIRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMA 428 (608)
Q Consensus 349 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGls~~~~ 428 (608)
||||+++++|.+++... .+++..++.++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++...
T Consensus 113 v~e~~~~~~L~~~l~~~----~~~~~~~~~i~~~l~~~l~~LH~~~---ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~ 185 (318)
T 3lxp_A 113 VMEYVPLGSLRDYLPRH----SIGLAQLLLFAQQICEGMAYLHAQH---YIHRDLAARNVLLDNDRLVKIGDFGLAKAVP 185 (318)
T ss_dssp EECCCTTCBHHHHGGGS----CCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCGGGCEECC
T ss_pred EEecccCCcHHHHHhhC----CCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCchheEEEcCCCCEEECCcccccccc
Confidence 99999999999999754 3899999999999999999999999 9999999999999999999999999998775
Q ss_pred cCCcc--eeeeeeccCCCCChhhhccCCCCCccchHhHHHHHHHHHhCCCCCCccchhhcccHHHHHHHHhhhhhhHHHh
Q 044312 429 VDQTH--MTTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLTELLTGEKPIRFTILEEDKSLAAYFLCAMKEERLFEIL 506 (608)
Q Consensus 429 ~~~~~--~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 506 (608)
..... ......+|..|+|||.+.+..++.++||||||++++||++|+.||........ ..............+.+.+
T Consensus 186 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~-~~~~~~~~~~~~~~~~~~~ 264 (318)
T 3lxp_A 186 EGHEYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFL-ELIGIAQGQMTVLRLTELL 264 (318)
T ss_dssp TTCSEEEC---CCCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHH-HHHCSCCHHHHHHHHHHHH
T ss_pred ccccccccccCCCCCceeeChHHhcCCCCCcHHHHHHHHHHHHHHHhCCCcccccchhhh-hhhcccccchhHHHHHHHH
Confidence 43322 22344578889999999999999999999999999999999999863221100 0000000111112233334
Q ss_pred hhhhhccCChhHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhhHHhcC
Q 044312 507 DARVMKQGGKDEIITVAKLAKRCLNLNGKKRPTMREVASELAGIKAWNG 555 (608)
Q Consensus 507 d~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~evl~~L~~i~~~~~ 555 (608)
........+...+.++.+|+.+||+.||++|||+.|+++.|+.+....+
T Consensus 265 ~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~~~~ 313 (318)
T 3lxp_A 265 ERGERLPRPDKCPAEVYHLMKNCWETEASFRPTFENLIPILKTVHEKYQ 313 (318)
T ss_dssp HTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHH
T ss_pred hcccCCCCCccccHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHHhhc
Confidence 4444444556677899999999999999999999999999999876543
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-38 Score=326.56 Aligned_cols=250 Identities=25% Similarity=0.447 Sum_probs=200.7
Q ss_pred HhcCccccceeccCce----------------------EEEEEeec-ChhhHHHHHHHHHHHhhc-CCCCccceeccccc
Q 044312 287 ATDNFDLNRILGQGGQ----------------------AVKKSKVI-DESKVEEFINEVVILSQI-NHRNVVKLLGCCLE 342 (608)
Q Consensus 287 ~t~~f~~~~~lG~G~~----------------------avk~~~~~-~~~~~~~~~~Ei~il~~l-~H~niv~l~~~~~~ 342 (608)
..++|.+.+.||+|+| |||..+.. .....+.+.+|+.+++++ +||||+++++++.+
T Consensus 33 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~ 112 (334)
T 2pvf_A 33 PRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQ 112 (334)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred CHhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCCcHHHHHHHHHHHHHHHHhhcCCCEeeEEEEEcc
Confidence 4578999999999975 33333321 234567899999999999 99999999999999
Q ss_pred CccceEEEeecCCCccchhccccCC-------------CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEE
Q 044312 343 TEVPLLVYEFIPNGTLFQYIHDQNE-------------DFPITWEIRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNIL 409 (608)
Q Consensus 343 ~~~~~lV~E~~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NIL 409 (608)
.+..++||||+++|+|.+++..... ...+++..++.++.||+.||+|||+.+ |+||||||+|||
T Consensus 113 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIl 189 (334)
T 2pvf_A 113 DGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQK---CIHRDLAARNVL 189 (334)
T ss_dssp SSCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEE
T ss_pred CCceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCccceEE
Confidence 9999999999999999999986432 124899999999999999999999999 999999999999
Q ss_pred EcCCCcEEEeeccCccccccCCcc-eeeeeeccCCCCChhhhccCCCCCccchHhHHHHHHHHHh-CCCCCCccchhhcc
Q 044312 410 LDDKYRAKVSDFGASRSMAVDQTH-MTTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLTELLT-GEKPIRFTILEEDK 487 (608)
Q Consensus 410 l~~~~~~kl~DFGls~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~ellt-g~~p~~~~~~~~~~ 487 (608)
++.++.+||+|||+++........ ......+|+.|+|||++.+..++.++||||||++++||++ |+.||......+
T Consensus 190 l~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~-- 267 (334)
T 2pvf_A 190 VTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEE-- 267 (334)
T ss_dssp ECTTCCEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCHHH--
T ss_pred EcCCCCEEEccccccccccccccccccCCCCcccceeChHHhcCCCcChHHHHHHHHHHHHHHHhCCCCCcCcCCHHH--
Confidence 999999999999999876543221 2233457889999999998899999999999999999999 999986332111
Q ss_pred cHHHHHHHHhhhhhhHHHhhhhhhccCChhHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhhHHhcC
Q 044312 488 SLAAYFLCAMKEERLFEILDARVMKQGGKDEIITVAKLAKRCLNLNGKKRPTMREVASELAGIKAWNG 555 (608)
Q Consensus 488 ~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~evl~~L~~i~~~~~ 555 (608)
+...+........+...+..+.+|+.+||+.||++|||+.|+++.|+.+.....
T Consensus 268 --------------~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~l~~~~~ 321 (334)
T 2pvf_A 268 --------------LFKLLKEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILTLTT 321 (334)
T ss_dssp --------------HHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHC
T ss_pred --------------HHHHHhcCCCCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhccc
Confidence 111111112223344566789999999999999999999999999999876543
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-38 Score=320.05 Aligned_cols=248 Identities=25% Similarity=0.440 Sum_probs=185.9
Q ss_pred HhcCccccceeccCce------------EEEEEeec--ChhhHHHHHHHHHHHhhcCCCCccceecccccCccceEEEee
Q 044312 287 ATDNFDLNRILGQGGQ------------AVKKSKVI--DESKVEEFINEVVILSQINHRNVVKLLGCCLETEVPLLVYEF 352 (608)
Q Consensus 287 ~t~~f~~~~~lG~G~~------------avk~~~~~--~~~~~~~~~~Ei~il~~l~H~niv~l~~~~~~~~~~~lV~E~ 352 (608)
..++|++.++||+|+| |||+.+.. .....+.|.+|+.++++++||||++++++. .....++||||
T Consensus 22 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-~~~~~~lv~e~ 100 (289)
T 3og7_A 22 PDGQITVGQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS-TAPQLAIVTQW 100 (289)
T ss_dssp CTTSCEEEEEEEECSSEEEEEEESSSEEEEEEESCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEE-CSSSCEEEEEC
T ss_pred CccceeeeeEecCCCCeEEEEEEEcCceEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCcEEEEEeec-cCCccEEEEEe
Confidence 3567999999999985 66766543 345567899999999999999999999965 45568999999
Q ss_pred cCCCccchhccccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEEcCCCcEEEeeccCccccccC-C
Q 044312 353 IPNGTLFQYIHDQNEDFPITWEIRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVD-Q 431 (608)
Q Consensus 353 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGls~~~~~~-~ 431 (608)
+++++|.+++..... .+++..++.++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++..... .
T Consensus 101 ~~~~~L~~~l~~~~~--~~~~~~~~~i~~qi~~~L~~lH~~~---i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 175 (289)
T 3og7_A 101 CEGSSLYHHLHASET--KFEMKKLIDIARQTARGMDYLHAKS---IIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSG 175 (289)
T ss_dssp CCEEEHHHHHTTC-----CCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEETTTEEEECCCC----------
T ss_pred cCCCcHHHHHhhccC--CCCHHHHHHHHHHHHHHHHHHHhCC---cccccCccceEEECCCCCEEEccceeccccccccc
Confidence 999999999976443 5899999999999999999999999 999999999999999999999999999865432 1
Q ss_pred cceeeeeeccCCCCChhhhc---cCCCCCccchHhHHHHHHHHHhCCCCCCccchhhcccHHHHHHHHhhhhhhHHHhhh
Q 044312 432 THMTTQVHGTFGYLDPEYFR---SSQFTDKSDVYSFGVVLTELLTGEKPIRFTILEEDKSLAAYFLCAMKEERLFEILDA 508 (608)
Q Consensus 432 ~~~~~~~~gt~~y~aPE~~~---~~~~t~ksDV~S~Gvvl~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 508 (608)
........||+.|+|||.+. ...++.++||||||++++||++|+.||....... ............ +
T Consensus 176 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~------~~~~~~~~~~~~----~ 245 (289)
T 3og7_A 176 SHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRD------QIIEMVGRGSLS----P 245 (289)
T ss_dssp --------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCCCHH------HHHHHHHHTSCC----C
T ss_pred cccccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccccchHH------HHHHHhcccccC----c
Confidence 22234456899999999986 5678889999999999999999999996432211 011111111110 0
Q ss_pred hhhccCChhHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhhH
Q 044312 509 RVMKQGGKDEIITVAKLAKRCLNLNGKKRPTMREVASELAGIK 551 (608)
Q Consensus 509 ~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~evl~~L~~i~ 551 (608)
.........+..+.+|+.+||+.||++|||+.|+++.|+.+.
T Consensus 246 -~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~l~ 287 (289)
T 3og7_A 246 -DLSKVRSNCPKRMKRLMAECLKKKRDERPSFPRILAEIEELA 287 (289)
T ss_dssp -CTTSSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTT
T ss_pred -chhhccccCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHh
Confidence 011122355678999999999999999999999999998774
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-38 Score=330.02 Aligned_cols=260 Identities=23% Similarity=0.337 Sum_probs=201.3
Q ss_pred cCccccceeccCce-------------------EEEEEeecChhhHHHHHHHHHHHhhcCCCCccceecccc--cCccce
Q 044312 289 DNFDLNRILGQGGQ-------------------AVKKSKVIDESKVEEFINEVVILSQINHRNVVKLLGCCL--ETEVPL 347 (608)
Q Consensus 289 ~~f~~~~~lG~G~~-------------------avk~~~~~~~~~~~~~~~Ei~il~~l~H~niv~l~~~~~--~~~~~~ 347 (608)
++|++.+.||+|++ |||+.........+.+.+|++++++++||||+++++++. +....+
T Consensus 23 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 102 (327)
T 3lxl_A 23 RHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYRGVSYGPGRQSLR 102 (327)
T ss_dssp GGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSSCEEE
T ss_pred hhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccCCHHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCCceEE
Confidence 46888899999874 566666555666778999999999999999999999886 455688
Q ss_pred EEEeecCCCccchhccccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEEcCCCcEEEeeccCcccc
Q 044312 348 LVYEFIPNGTLFQYIHDQNEDFPITWEIRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSM 427 (608)
Q Consensus 348 lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGls~~~ 427 (608)
+||||+++++|.+++..... .+++..++.|+.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++..
T Consensus 103 lv~e~~~~~~L~~~l~~~~~--~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~ 177 (327)
T 3lxl_A 103 LVMEYLPSGCLRDFLQRHRA--RLDASRLLLYSSQICKGMEYLGSRR---CVHRDLAARNILVESEAHVKIADFGLAKLL 177 (327)
T ss_dssp EEEECCTTCBHHHHHHHHGG--GCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCGGGCEEC
T ss_pred EEEeecCCCCHHHHHHhccc--CCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCChhhEEECCCCCEEEcccccceec
Confidence 99999999999999986433 4899999999999999999999999 999999999999999999999999999876
Q ss_pred ccCCcc--eeeeeeccCCCCChhhhccCCCCCccchHhHHHHHHHHHhCCCCCCccchhhcccHHHHHHHHhhhhhhHHH
Q 044312 428 AVDQTH--MTTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLTELLTGEKPIRFTILEEDKSLAAYFLCAMKEERLFEI 505 (608)
Q Consensus 428 ~~~~~~--~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 505 (608)
...... ......+|+.|+|||.+.+..++.++||||||++++||++|+.||............ ..........+.+.
T Consensus 178 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~-~~~~~~~~~~~~~~ 256 (327)
T 3lxl_A 178 PLDKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMG-CERDVPALSRLLEL 256 (327)
T ss_dssp CTTCSEEECSSCCCSCGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHCC-----CCHHHHHHHH
T ss_pred ccCCccceeeccCCccccccCHHHhccCCCChHHhHHHHHHHHHHHHhCCCCCccccchhhhhcc-cccccccHHHHHHH
Confidence 543322 223345788899999999999999999999999999999999998632211000000 00000001122233
Q ss_pred hhhhhhccCChhHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhhHHhc
Q 044312 506 LDARVMKQGGKDEIITVAKLAKRCLNLNGKKRPTMREVASELAGIKAWN 554 (608)
Q Consensus 506 ~d~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~evl~~L~~i~~~~ 554 (608)
+........+...+..+.+|+.+||+.||++|||+.||+++|+.+....
T Consensus 257 ~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~ 305 (327)
T 3lxl_A 257 LEEGQRLPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQLDMLWSGS 305 (327)
T ss_dssp HHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHC----
T ss_pred hhcccCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhhh
Confidence 3333334455667788999999999999999999999999999886543
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-38 Score=329.14 Aligned_cols=253 Identities=28% Similarity=0.445 Sum_probs=200.2
Q ss_pred hcCccccceeccCce-------------------EEEEEeecChhhHHHHHHHHHHHhhcCCCCccceecccccCc--cc
Q 044312 288 TDNFDLNRILGQGGQ-------------------AVKKSKVIDESKVEEFINEVVILSQINHRNVVKLLGCCLETE--VP 346 (608)
Q Consensus 288 t~~f~~~~~lG~G~~-------------------avk~~~~~~~~~~~~~~~Ei~il~~l~H~niv~l~~~~~~~~--~~ 346 (608)
.++|++.+.||+|++ |||+.........+.|.+|+.++++++||||+++++++...+ ..
T Consensus 40 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 119 (326)
T 2w1i_A 40 ERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNL 119 (326)
T ss_dssp GGGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSCCSHHHHHHHHHHHHHHTCCCTTBCCEEEEECC----CC
T ss_pred HHHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEecCCCce
Confidence 346888899999974 556655555666788999999999999999999999987654 78
Q ss_pred eEEEeecCCCccchhccccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEEcCCCcEEEeeccCccc
Q 044312 347 LLVYEFIPNGTLFQYIHDQNEDFPITWEIRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRS 426 (608)
Q Consensus 347 ~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGls~~ 426 (608)
++||||+++++|.+++..... .+++..++.++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++.
T Consensus 120 ~lv~e~~~~~~L~~~l~~~~~--~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dikp~NIli~~~~~~kL~Dfg~~~~ 194 (326)
T 2w1i_A 120 KLIMEYLPYGSLRDYLQKHKE--RIDHIKLLQYTSQICKGMEYLGTKR---YIHRDLATRNILVENENRVKIGDFGLTKV 194 (326)
T ss_dssp EEEECCCTTCBHHHHHHHSTT--SSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEEEETTEEEECCCTTCEE
T ss_pred EEEEECCCCCCHHHHHHhccc--CCCHHHHHHHHHHHHHHHHHHHhCC---EeccCCCcceEEEcCCCcEEEecCcchhh
Confidence 999999999999999987543 5899999999999999999999999 99999999999999999999999999987
Q ss_pred cccCCcce--eeeeeccCCCCChhhhccCCCCCccchHhHHHHHHHHHhCCCCCCccchhhcccHHHHHHHHhhh-----
Q 044312 427 MAVDQTHM--TTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLTELLTGEKPIRFTILEEDKSLAAYFLCAMKE----- 499 (608)
Q Consensus 427 ~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~elltg~~p~~~~~~~~~~~l~~~~~~~~~~----- 499 (608)
........ .....++..|+|||.+.+..++.++||||||++++||+||..|+...... +......
T Consensus 195 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~--------~~~~~~~~~~~~ 266 (326)
T 2w1i_A 195 LPQDKEYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAE--------FMRMIGNDKQGQ 266 (326)
T ss_dssp CCSSCSEEECSSCCSCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHHTTCGGGSHHHH--------HHHHHCTTCCTH
T ss_pred ccccccccccccCCCCceeEECchhhcCCCCCchhhHHHHHHHHHHHHhcCCCCCCCHHH--------HHHhhccccchh
Confidence 75443221 22345677899999999988999999999999999999999987522110 1111100
Q ss_pred ---hhhHHHhhhhhhccCChhHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhhHHh
Q 044312 500 ---ERLFEILDARVMKQGGKDEIITVAKLAKRCLNLNGKKRPTMREVASELAGIKAW 553 (608)
Q Consensus 500 ---~~~~~~~d~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~evl~~L~~i~~~ 553 (608)
..+.+.+........+...+.++.+|+.+||+.||++|||+.||++.|+.++..
T Consensus 267 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~el~~~L~~l~~~ 323 (326)
T 2w1i_A 267 MIVFHLIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDQ 323 (326)
T ss_dssp HHHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred hhHHHHHHHhhcCCCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHH
Confidence 112222222222334456678899999999999999999999999999998764
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-38 Score=325.84 Aligned_cols=257 Identities=26% Similarity=0.388 Sum_probs=196.1
Q ss_pred cCccccceeccCce-------------------EEEEEee-cChhhHHHHHHHHHHHhhcCCCCccceecccccC--ccc
Q 044312 289 DNFDLNRILGQGGQ-------------------AVKKSKV-IDESKVEEFINEVVILSQINHRNVVKLLGCCLET--EVP 346 (608)
Q Consensus 289 ~~f~~~~~lG~G~~-------------------avk~~~~-~~~~~~~~~~~Ei~il~~l~H~niv~l~~~~~~~--~~~ 346 (608)
+.|++.+.||+|++ |||+.+. ......+.+.+|+.++++++||||+++++++.+. ...
T Consensus 21 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 100 (302)
T 4e5w_A 21 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGI 100 (302)
T ss_dssp GGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC-----CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC---CCE
T ss_pred hhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccccchhHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCceE
Confidence 45888999999975 4555442 2233467899999999999999999999999876 568
Q ss_pred eEEEeecCCCccchhccccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEEcCCCcEEEeeccCccc
Q 044312 347 LLVYEFIPNGTLFQYIHDQNEDFPITWEIRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRS 426 (608)
Q Consensus 347 ~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGls~~ 426 (608)
++||||+++++|.+++..... .+++..++.++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++.
T Consensus 101 ~lv~e~~~~~~L~~~l~~~~~--~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~~~~ 175 (302)
T 4e5w_A 101 KLIMEFLPSGSLKEYLPKNKN--KINLKQQLKYAVQICKGMDYLGSRQ---YVHRDLAARNVLVESEHQVKIGDFGLTKA 175 (302)
T ss_dssp EEEEECCTTCBHHHHHHHHTT--TCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCCTTCEE
T ss_pred EEEEEeCCCCcHHHHHHhccc--cCCHHHHHHHHHHHHHHHHHhhcCC---cccCCCchheEEEcCCCCEEECccccccc
Confidence 999999999999999976543 4899999999999999999999999 99999999999999999999999999987
Q ss_pred cccCCcc--eeeeeeccCCCCChhhhccCCCCCccchHhHHHHHHHHHhCCCCCCccchhhcccHHHHHHHHhhhhhhHH
Q 044312 427 MAVDQTH--MTTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLTELLTGEKPIRFTILEEDKSLAAYFLCAMKEERLFE 504 (608)
Q Consensus 427 ~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~ 504 (608)
....... ......+|..|+|||.+.+..++.++||||||++++||++|..|+.......... ............+..
T Consensus 176 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~-~~~~~~~~~~~~~~~ 254 (302)
T 4e5w_A 176 IETDKEYYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKM-IGPTHGQMTVTRLVN 254 (302)
T ss_dssp CCTTCCEEECCCCTTCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHH-HCSCCGGGHHHHHHH
T ss_pred ccCCCcceeccCCCCCCccccCCeeecCCCCCcchhHHHHHHHHHHHHHccCCCcchhhHHhhc-cCCcccccCHHHHHH
Confidence 7544322 2234557888999999999999999999999999999999999864211100000 000000001111222
Q ss_pred HhhhhhhccCChhHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhhH
Q 044312 505 ILDARVMKQGGKDEIITVAKLAKRCLNLNGKKRPTMREVASELAGIK 551 (608)
Q Consensus 505 ~~d~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~evl~~L~~i~ 551 (608)
.+........+...+..+.+|+.+||+.||++|||+.|+++.|+.+.
T Consensus 255 ~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~ll 301 (302)
T 4e5w_A 255 TLKEGKRLPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIEGFEALL 301 (302)
T ss_dssp HHHTTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHH
T ss_pred HHhccCCCCCCCCCCHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHh
Confidence 22222233344566788999999999999999999999999998764
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-38 Score=319.69 Aligned_cols=245 Identities=26% Similarity=0.411 Sum_probs=196.1
Q ss_pred cCccccc-eeccCce-----------------EEEEEeec-ChhhHHHHHHHHHHHhhcCCCCccceecccccCccceEE
Q 044312 289 DNFDLNR-ILGQGGQ-----------------AVKKSKVI-DESKVEEFINEVVILSQINHRNVVKLLGCCLETEVPLLV 349 (608)
Q Consensus 289 ~~f~~~~-~lG~G~~-----------------avk~~~~~-~~~~~~~~~~Ei~il~~l~H~niv~l~~~~~~~~~~~lV 349 (608)
++|.+.+ .||+|++ |||..+.. .....+.+.+|+.++++++||||+++++++ +.+..++|
T Consensus 9 ~~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-~~~~~~lv 87 (287)
T 1u59_A 9 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVC-QAEALMLV 87 (287)
T ss_dssp GGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-ESSSEEEE
T ss_pred HHhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCccchhHHHHHHHHHHHHHhCCCCCEeEEEEEe-cCCCcEEE
Confidence 3455555 7888874 55555442 345677899999999999999999999999 55678999
Q ss_pred EeecCCCccchhccccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEEcCCCcEEEeeccCcccccc
Q 044312 350 YEFIPNGTLFQYIHDQNEDFPITWEIRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAV 429 (608)
Q Consensus 350 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGls~~~~~ 429 (608)
|||+++++|.+++..... .+++..++.++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+++....
T Consensus 88 ~e~~~~~~L~~~l~~~~~--~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~ 162 (287)
T 1u59_A 88 MEMAGGGPLHKFLVGKRE--EIPVSNVAELLHQVSMGMKYLEEKN---FVHRDLAARNVLLVNRHYAKISDFGLSKALGA 162 (287)
T ss_dssp EECCTTEEHHHHHTTCTT--TSCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEEETTEEEECCCTTCEECTT
T ss_pred EEeCCCCCHHHHHHhCCc--cCCHHHHHHHHHHHHHHHHHHHHCC---EeeCCCchheEEEcCCCCEEECcccceeeecc
Confidence 999999999999975433 5899999999999999999999999 99999999999999999999999999987754
Q ss_pred CCcce--eeeeeccCCCCChhhhccCCCCCccchHhHHHHHHHHHh-CCCCCCccchhhcccHHHHHHHHhhhhhhHHHh
Q 044312 430 DQTHM--TTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLTELLT-GEKPIRFTILEEDKSLAAYFLCAMKEERLFEIL 506 (608)
Q Consensus 430 ~~~~~--~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~ellt-g~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 506 (608)
..... .....+|+.|+|||.+....++.++||||||++++||++ |+.||......+ +...+
T Consensus 163 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~----------------~~~~i 226 (287)
T 1u59_A 163 DDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPE----------------VMAFI 226 (287)
T ss_dssp CSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHH----------------HHHHH
T ss_pred CcceeeccccccccccccCHHHhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHHH----------------HHHHH
Confidence 33222 223346889999999998899999999999999999999 999986432211 11111
Q ss_pred hhhhhccCChhHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhhHHhcC
Q 044312 507 DARVMKQGGKDEIITVAKLAKRCLNLNGKKRPTMREVASELAGIKAWNG 555 (608)
Q Consensus 507 d~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~evl~~L~~i~~~~~ 555 (608)
........+...+..+.+|+.+||+.||++||++.|++++|+.+....+
T Consensus 227 ~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~~ 275 (287)
T 1u59_A 227 EQGKRMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSLA 275 (287)
T ss_dssp HTTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHHHH
T ss_pred hcCCcCCCCCCcCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhcC
Confidence 1111223445667789999999999999999999999999999876543
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-38 Score=322.97 Aligned_cols=259 Identities=27% Similarity=0.415 Sum_probs=204.8
Q ss_pred cCCHHHHHHHhcCccccceeccCce--------------------EEEEEee-cChhhHHHHHHHHHHHhhc-CCCCccc
Q 044312 278 LFTSKELEKATDNFDLNRILGQGGQ--------------------AVKKSKV-IDESKVEEFINEVVILSQI-NHRNVVK 335 (608)
Q Consensus 278 ~~~~~~l~~~t~~f~~~~~lG~G~~--------------------avk~~~~-~~~~~~~~~~~Ei~il~~l-~H~niv~ 335 (608)
.+...++....++|.+.+.||+|++ |||..+. ......+.+.+|+.+++++ +||||++
T Consensus 16 ~~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~ 95 (316)
T 2xir_A 16 PYDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVN 95 (316)
T ss_dssp CCCHHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCC
T ss_pred cccccceecchhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCCCcHHHHHHHHHHHHHHhcccCCCeee
Confidence 3455666667889999999999985 3444332 1233456899999999999 7999999
Q ss_pred eecccccCc-cceEEEeecCCCccchhccccCC-------------CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeecc
Q 044312 336 LLGCCLETE-VPLLVYEFIPNGTLFQYIHDQNE-------------DFPITWEIRLRIAIEVSGALSYLHSAASIPIYHR 401 (608)
Q Consensus 336 l~~~~~~~~-~~~lV~E~~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHr 401 (608)
+++++.+.+ ..++||||+++++|.+++..... +..+++..++.++.||+.||.|||+.+ |+||
T Consensus 96 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~ 172 (316)
T 2xir_A 96 LLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHR 172 (316)
T ss_dssp EEEEECCTTSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHTT---CCCS
T ss_pred EEEEEecCCCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhCC---cccc
Confidence 999987654 58999999999999999986542 123889999999999999999999999 9999
Q ss_pred CCCCCcEEEcCCCcEEEeeccCccccccCCc-ceeeeeeccCCCCChhhhccCCCCCccchHhHHHHHHHHHh-CCCCCC
Q 044312 402 DIKSTNILLDDKYRAKVSDFGASRSMAVDQT-HMTTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLTELLT-GEKPIR 479 (608)
Q Consensus 402 Dlk~~NILl~~~~~~kl~DFGls~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~ellt-g~~p~~ 479 (608)
||||+|||++.++.+||+|||+++....... .......+|+.|+|||.+.+..++.++||||||++++||+| |+.||.
T Consensus 173 dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~ 252 (316)
T 2xir_A 173 DLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYP 252 (316)
T ss_dssp CCSGGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSST
T ss_pred cCccceEEECCCCCEEECCCccccccccCccceeccCCCcceeecCchhhccccccchhHHHHHHHHHHHHHhCCCCCCc
Confidence 9999999999999999999999987654332 22334567899999999999999999999999999999998 999986
Q ss_pred ccchhhcccHHHHHHHHhhhhhhHHHhhhhhhccCChhHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhhHHhc
Q 044312 480 FTILEEDKSLAAYFLCAMKEERLFEILDARVMKQGGKDEIITVAKLAKRCLNLNGKKRPTMREVASELAGIKAWN 554 (608)
Q Consensus 480 ~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~evl~~L~~i~~~~ 554 (608)
...... .+ ...+........+...+..+.+++.+||+.||++|||+.||+++|+.+....
T Consensus 253 ~~~~~~------~~---------~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~ 312 (316)
T 2xir_A 253 GVKIDE------EF---------CRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQAN 312 (316)
T ss_dssp TCCCSH------HH---------HHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred ccchhH------HH---------HHHhccCccCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhhh
Confidence 432211 01 1111111112233445678999999999999999999999999999987654
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-37 Score=316.65 Aligned_cols=241 Identities=30% Similarity=0.556 Sum_probs=190.9
Q ss_pred hcCccccceeccCce---------------EEEEEeecChhh-------HHHHHHHHHHHhhcCCCCccceecccccCcc
Q 044312 288 TDNFDLNRILGQGGQ---------------AVKKSKVIDESK-------VEEFINEVVILSQINHRNVVKLLGCCLETEV 345 (608)
Q Consensus 288 t~~f~~~~~lG~G~~---------------avk~~~~~~~~~-------~~~~~~Ei~il~~l~H~niv~l~~~~~~~~~ 345 (608)
.++|++.+.||+|++ |||......... .+.+.+|+.++++++||||+++++++.+..
T Consensus 18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~- 96 (287)
T 4f0f_A 18 DNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNPP- 96 (287)
T ss_dssp STTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEETTTT-
T ss_pred hccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheeecCCC-
Confidence 467899999999974 677665422211 168999999999999999999999986654
Q ss_pred ceEEEeecCCCccchhccccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEEcCCCc-----EEEee
Q 044312 346 PLLVYEFIPNGTLFQYIHDQNEDFPITWEIRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYR-----AKVSD 420 (608)
Q Consensus 346 ~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~-----~kl~D 420 (608)
++||||+++++|.+++..... ++++..++.++.|++.||+|||+++ .+|+||||||+|||++.++. +||+|
T Consensus 97 -~lv~e~~~~~~L~~~l~~~~~--~~~~~~~~~~~~~l~~~l~~lH~~~-~~ivH~dikp~Nil~~~~~~~~~~~~kl~D 172 (287)
T 4f0f_A 97 -RMVMEFVPCGDLYHRLLDKAH--PIKWSVKLRLMLDIALGIEYMQNQN-PPIVHRDLRSPNIFLQSLDENAPVCAKVAD 172 (287)
T ss_dssp -EEEEECCTTCBHHHHHHCTTS--CCCHHHHHHHHHHHHHHHHHHHTSS-SCCBCSCCSGGGEEESCCCTTCSCCEEECC
T ss_pred -eEEEEecCCCCHHHHHhcccC--CccHHHHHHHHHHHHHHHHHHHhCC-CCeecCCCCcceEEEeccCCCCceeEEeCC
Confidence 799999999999998876443 5999999999999999999999986 35999999999999987776 99999
Q ss_pred ccCccccccCCcceeeeeeccCCCCChhhh--ccCCCCCccchHhHHHHHHHHHhCCCCCCccchhhcccHHHHHHHHhh
Q 044312 421 FGASRSMAVDQTHMTTQVHGTFGYLDPEYF--RSSQFTDKSDVYSFGVVLTELLTGEKPIRFTILEEDKSLAAYFLCAMK 498 (608)
Q Consensus 421 FGls~~~~~~~~~~~~~~~gt~~y~aPE~~--~~~~~t~ksDV~S~Gvvl~elltg~~p~~~~~~~~~~~l~~~~~~~~~ 498 (608)
||+++.... ......||+.|+|||.+ ....++.++||||||++++||++|+.||........ ..
T Consensus 173 fg~~~~~~~----~~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~----~~------ 238 (287)
T 4f0f_A 173 FGLSQQSVH----SVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKI----KF------ 238 (287)
T ss_dssp CTTCBCCSS----CEECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCCCHH----HH------
T ss_pred CCccccccc----cccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCccccccHH----HH------
Confidence 999975432 23446789999999998 445678999999999999999999999964322111 00
Q ss_pred hhhhHHHhhhhhhccCChhHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhh
Q 044312 499 EERLFEILDARVMKQGGKDEIITVAKLAKRCLNLNGKKRPTMREVASELAGI 550 (608)
Q Consensus 499 ~~~~~~~~d~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~evl~~L~~i 550 (608)
...+.........+...+.++.+|+.+||+.||++|||+.|+++.|+.+
T Consensus 239 ---~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~l 287 (287)
T 4f0f_A 239 ---INMIREEGLRPTIPEDCPPRLRNVIELCWSGDPKKRPHFSYIVKELSEL 287 (287)
T ss_dssp ---HHHHHHSCCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTC
T ss_pred ---HHHHhccCCCCCCCcccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhC
Confidence 0111111222334455677899999999999999999999999999764
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-38 Score=325.91 Aligned_cols=239 Identities=28% Similarity=0.427 Sum_probs=189.1
Q ss_pred hcCccccceeccCce---------------EEEEEeecCh-hhHHHHHHHHHHHhhcCCCCccceecccccCccceEEEe
Q 044312 288 TDNFDLNRILGQGGQ---------------AVKKSKVIDE-SKVEEFINEVVILSQINHRNVVKLLGCCLETEVPLLVYE 351 (608)
Q Consensus 288 t~~f~~~~~lG~G~~---------------avk~~~~~~~-~~~~~~~~Ei~il~~l~H~niv~l~~~~~~~~~~~lV~E 351 (608)
.++|++.+.||+|++ |||....... ...+.+.+|+.++++++||||+++++++.+.+..++|||
T Consensus 6 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e 85 (323)
T 3tki_A 6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLE 85 (323)
T ss_dssp TTCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred hhhceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEcccccchHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEEEE
Confidence 357899999999974 6676654322 234678999999999999999999999999999999999
Q ss_pred ecCCCccchhccccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEEcCCCcEEEeeccCccccccCC
Q 044312 352 FIPNGTLFQYIHDQNEDFPITWEIRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQ 431 (608)
Q Consensus 352 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGls~~~~~~~ 431 (608)
|+++++|.+++.... .+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++.+....
T Consensus 86 ~~~~~~L~~~l~~~~---~~~~~~~~~i~~qi~~aL~~LH~~g---ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~ 159 (323)
T 3tki_A 86 YCSGGELFDRIEPDI---GMPEPDAQRFFHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNN 159 (323)
T ss_dssp CCTTEEGGGGSBTTT---BCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTTCEECEETT
T ss_pred cCCCCcHHHHHhhcC---CCCHHHHHHHHHHHHHHHHHHHHCC---ccccccchHHEEEeCCCCEEEEEeeccceeccCC
Confidence 999999999997543 4899999999999999999999999 9999999999999999999999999998764332
Q ss_pred -cceeeeeeccCCCCChhhhccCCC-CCccchHhHHHHHHHHHhCCCCCCccchhhcccHHHHHHHHhhhhhhHHHhhhh
Q 044312 432 -THMTTQVHGTFGYLDPEYFRSSQF-TDKSDVYSFGVVLTELLTGEKPIRFTILEEDKSLAAYFLCAMKEERLFEILDAR 509 (608)
Q Consensus 432 -~~~~~~~~gt~~y~aPE~~~~~~~-t~ksDV~S~Gvvl~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 509 (608)
........||+.|+|||++.+..+ +.++||||||++++||++|+.||........ . + .......
T Consensus 160 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~-~----~---------~~~~~~~ 225 (323)
T 3tki_A 160 RERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQ-E----Y---------SDWKEKK 225 (323)
T ss_dssp EECCBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTTSH-H----H---------HHHHTTC
T ss_pred cccccCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCchHHH-H----H---------HHHhccc
Confidence 222345679999999999987775 7799999999999999999999974322111 0 0 0001111
Q ss_pred hhccCChhHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 044312 510 VMKQGGKDEIITVAKLAKRCLNLNGKKRPTMREVASE 546 (608)
Q Consensus 510 ~~~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~evl~~ 546 (608)
.........+..+.+|+.+||+.||++|||+.|++++
T Consensus 226 ~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eil~h 262 (323)
T 3tki_A 226 TYLNPWKKIDSAPLALLHKILVENPSARITIPDIKKD 262 (323)
T ss_dssp TTSTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred ccCCccccCCHHHHHHHHHHccCChhhCcCHHHHhhC
Confidence 1111123455678999999999999999999999864
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.8e-38 Score=329.39 Aligned_cols=239 Identities=25% Similarity=0.341 Sum_probs=192.0
Q ss_pred HhcCccccceeccCce---------------EEEEEeecCh------hhHHHHHHHHHHHhhcCCCCccceecccccCcc
Q 044312 287 ATDNFDLNRILGQGGQ---------------AVKKSKVIDE------SKVEEFINEVVILSQINHRNVVKLLGCCLETEV 345 (608)
Q Consensus 287 ~t~~f~~~~~lG~G~~---------------avk~~~~~~~------~~~~~~~~Ei~il~~l~H~niv~l~~~~~~~~~ 345 (608)
..+.|++.+.||+|+| |+|.++.... ...+.+.+|+.+|++++||||+++++++.+...
T Consensus 10 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~ 89 (361)
T 2yab_A 10 VEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYENRTD 89 (361)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSE
T ss_pred hhhceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEEeCCE
Confidence 3567999999999974 6776654322 135789999999999999999999999999999
Q ss_pred ceEEEeecCCCccchhccccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEEcCCC----cEEEeec
Q 044312 346 PLLVYEFIPNGTLFQYIHDQNEDFPITWEIRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKY----RAKVSDF 421 (608)
Q Consensus 346 ~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~----~~kl~DF 421 (608)
.++||||+++|+|.+++.... .+++..+..++.||+.||.|||+.+ |+||||||+|||+++++ .+||+||
T Consensus 90 ~~lv~e~~~gg~L~~~l~~~~---~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~~~~~~~vkl~DF 163 (361)
T 2yab_A 90 VVLILELVSGGELFDFLAQKE---SLSEEEATSFIKQILDGVNYLHTKK---IAHFDLKPENIMLLDKNIPIPHIKLIDF 163 (361)
T ss_dssp EEEEEECCCSCBHHHHHTTCS---CCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCTTSSSCCEEECCC
T ss_pred EEEEEEcCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEeCCCCCccCEEEEec
Confidence 999999999999999997543 5999999999999999999999999 99999999999998776 7999999
Q ss_pred cCccccccCCcceeeeeeccCCCCChhhhccCCCCCccchHhHHHHHHHHHhCCCCCCccchhhcccHHHHHHHHhhhhh
Q 044312 422 GASRSMAVDQTHMTTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLTELLTGEKPIRFTILEEDKSLAAYFLCAMKEER 501 (608)
Q Consensus 422 Gls~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~ 501 (608)
|+++...... ......||+.|+|||++....++.++||||||+++|||++|..||......+ .+. .+....
T Consensus 164 G~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~~ll~g~~Pf~~~~~~~------~~~-~i~~~~ 234 (361)
T 2yab_A 164 GLAHEIEDGV--EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQE------TLA-NITAVS 234 (361)
T ss_dssp SSCEECCTTC--CCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHH------HHH-HHHTTC
T ss_pred CCceEcCCCC--ccccCCCCccEECchHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHH------HHH-HHHhcC
Confidence 9998765432 2344569999999999999999999999999999999999999996432111 111 111100
Q ss_pred hHHHhhhhhhccCChhHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 044312 502 LFEILDARVMKQGGKDEIITVAKLAKRCLNLNGKKRPTMREVASE 546 (608)
Q Consensus 502 ~~~~~d~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~evl~~ 546 (608)
.. .++. .....+..+.+|+.+||..||++|||+.|++++
T Consensus 235 ~~--~~~~----~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~h 273 (361)
T 2yab_A 235 YD--FDEE----FFSQTSELAKDFIRKLLVKETRKRLTIQEALRH 273 (361)
T ss_dssp CC--CCHH----HHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred CC--CCch----hccCCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 00 0000 012335678999999999999999999999864
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-38 Score=339.57 Aligned_cols=243 Identities=24% Similarity=0.359 Sum_probs=196.3
Q ss_pred HHHHHHhcCccccceeccCce---------------EEEEEeec---ChhhHHHHHHHHHHHhhcCCCCccceecccccC
Q 044312 282 KELEKATDNFDLNRILGQGGQ---------------AVKKSKVI---DESKVEEFINEVVILSQINHRNVVKLLGCCLET 343 (608)
Q Consensus 282 ~~l~~~t~~f~~~~~lG~G~~---------------avk~~~~~---~~~~~~~~~~Ei~il~~l~H~niv~l~~~~~~~ 343 (608)
.+++...++|++.++||+|+| |+|+++.. .....+.+.+|+.+++.++|||||++++++.+.
T Consensus 62 ~~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~ 141 (410)
T 3v8s_A 62 RDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDD 141 (410)
T ss_dssp HHHSCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEEECS
T ss_pred HhcccCccccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEEC
Confidence 445556788999999999985 56655431 122334588999999999999999999999999
Q ss_pred ccceEEEeecCCCccchhccccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEEcCCCcEEEeeccC
Q 044312 344 EVPLLVYEFIPNGTLFQYIHDQNEDFPITWEIRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGA 423 (608)
Q Consensus 344 ~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGl 423 (608)
...+|||||+++|+|.+++... .+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+
T Consensus 142 ~~~~lV~E~~~gg~L~~~l~~~----~~~e~~~~~~~~qi~~aL~~LH~~g---ivHrDLKp~NILl~~~g~ikL~DFG~ 214 (410)
T 3v8s_A 142 RYLYMVMEYMPGGDLVNLMSNY----DVPEKWARFYTAEVVLALDAIHSMG---FIHRDVKPDNMLLDKSGHLKLADFGT 214 (410)
T ss_dssp SEEEEEECCCTTEEHHHHHHHC----CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTT
T ss_pred CEEEEEEeCCCCCcHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeeECCCCCEEEeccce
Confidence 9999999999999999998753 4899999999999999999999999 99999999999999999999999999
Q ss_pred ccccccCCcceeeeeeccCCCCChhhhccCC----CCCccchHhHHHHHHHHHhCCCCCCccchhhcccHHHHHHHHhhh
Q 044312 424 SRSMAVDQTHMTTQVHGTFGYLDPEYFRSSQ----FTDKSDVYSFGVVLTELLTGEKPIRFTILEEDKSLAAYFLCAMKE 499 (608)
Q Consensus 424 s~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~----~t~ksDV~S~Gvvl~elltg~~p~~~~~~~~~~~l~~~~~~~~~~ 499 (608)
++..............||+.|+|||++.... ++.++||||||+++|||++|+.||...... ..+
T Consensus 215 a~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~------~~~------ 282 (410)
T 3v8s_A 215 CMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLV------GTY------ 282 (410)
T ss_dssp CEECCTTSEEECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCSSHH------HHH------
T ss_pred eEeeccCCcccccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCCChh------hHH------
Confidence 9877654433444667999999999998765 789999999999999999999999733211 111
Q ss_pred hhhHHHhhhhhhccC--ChhHHHHHHHHHHHHhccCCCC--CCCHHHHHHH
Q 044312 500 ERLFEILDARVMKQG--GKDEIITVAKLAKRCLNLNGKK--RPTMREVASE 546 (608)
Q Consensus 500 ~~~~~~~d~~~~~~~--~~~~~~~l~~Li~~cl~~dp~~--RPs~~evl~~ 546 (608)
..++........ ....+.++.+|+.+||..+|.+ ||+++||+++
T Consensus 283 ---~~i~~~~~~~~~p~~~~~s~~~~~li~~lL~~~~~rlgR~~~~ei~~H 330 (410)
T 3v8s_A 283 ---SKIMNHKNSLTFPDDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRH 330 (410)
T ss_dssp ---HHHHTHHHHCCCCTTCCCCHHHHHHHHHHSSCGGGCTTSSCHHHHHTS
T ss_pred ---HHHHhccccccCCCcccccHHHHHHHHHHccChhhhCCCCCHHHHhcC
Confidence 112221111112 2245678999999999999988 9999999875
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-37 Score=319.35 Aligned_cols=236 Identities=23% Similarity=0.366 Sum_probs=184.0
Q ss_pred hcCccccceeccCce---------------EEEEEeecCh--------------------------hhHHHHHHHHHHHh
Q 044312 288 TDNFDLNRILGQGGQ---------------AVKKSKVIDE--------------------------SKVEEFINEVVILS 326 (608)
Q Consensus 288 t~~f~~~~~lG~G~~---------------avk~~~~~~~--------------------------~~~~~~~~Ei~il~ 326 (608)
.++|++.+.||+|++ |||....... ...+.+.+|+.+|+
T Consensus 12 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~ 91 (298)
T 2zv2_A 12 LNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAILK 91 (298)
T ss_dssp ETTEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHHHH
T ss_pred ecceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHHHH
Confidence 357899999999974 6776653221 12467899999999
Q ss_pred hcCCCCccceeccccc--CccceEEEeecCCCccchhccccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeccCCC
Q 044312 327 QINHRNVVKLLGCCLE--TEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEIRLRIAIEVSGALSYLHSAASIPIYHRDIK 404 (608)
Q Consensus 327 ~l~H~niv~l~~~~~~--~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk 404 (608)
+++||||+++++++.+ ....++||||+++++|.+++... ++++..++.++.||+.||+|||+.+ |+|||||
T Consensus 92 ~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~----~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlk 164 (298)
T 2zv2_A 92 KLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPTLK----PLSEDQARFYFQDLIKGIEYLHYQK---IIHRDIK 164 (298)
T ss_dssp TCCCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSSCSS----CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCC
T ss_pred hCCCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHhhcC----CCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCC
Confidence 9999999999999976 56789999999999998876432 5999999999999999999999999 9999999
Q ss_pred CCcEEEcCCCcEEEeeccCccccccCCcceeeeeeccCCCCChhhhccCC---CCCccchHhHHHHHHHHHhCCCCCCcc
Q 044312 405 STNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHGTFGYLDPEYFRSSQ---FTDKSDVYSFGVVLTELLTGEKPIRFT 481 (608)
Q Consensus 405 ~~NILl~~~~~~kl~DFGls~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~---~t~ksDV~S~Gvvl~elltg~~p~~~~ 481 (608)
|+|||++.++.+||+|||+++....... ......||+.|+|||.+.... .+.++||||||++++||++|+.||...
T Consensus 165 p~Nil~~~~~~~kl~Dfg~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~ 243 (298)
T 2zv2_A 165 PSNLLVGEDGHIKIADFGVSNEFKGSDA-LLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDE 243 (298)
T ss_dssp GGGEEECTTSCEEECCCTTCEECSSSSC-EECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred HHHEEECCCCCEEEecCCCccccccccc-cccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCc
Confidence 9999999999999999999987654322 234457999999999998765 378899999999999999999999632
Q ss_pred chhhcccHHHHHHHHhhhhhhHHHhhhhhhccCChhHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 044312 482 ILEEDKSLAAYFLCAMKEERLFEILDARVMKQGGKDEIITVAKLAKRCLNLNGKKRPTMREVASE 546 (608)
Q Consensus 482 ~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~evl~~ 546 (608)
... .. ...+. ............+..+.+|+.+||+.||++|||+.|++++
T Consensus 244 ~~~------~~-~~~~~--------~~~~~~~~~~~~~~~l~~li~~~l~~dp~~R~s~~e~l~h 293 (298)
T 2zv2_A 244 RIM------CL-HSKIK--------SQALEFPDQPDIAEDLKDLITRMLDKNPESRIVVPEIKLH 293 (298)
T ss_dssp SHH------HH-HHHHH--------HCCCCCCSSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTTC
T ss_pred cHH------HH-HHHHh--------cccCCCCCccccCHHHHHHHHHHhhcChhhCCCHHHHhcC
Confidence 211 10 01111 1111111223456789999999999999999999999764
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-38 Score=315.35 Aligned_cols=241 Identities=22% Similarity=0.347 Sum_probs=194.5
Q ss_pred cCccccceeccCce-------------EEEEEeec--ChhhHHHHHHHHHHHhhcCCCCccceecccccC--ccceEEEe
Q 044312 289 DNFDLNRILGQGGQ-------------AVKKSKVI--DESKVEEFINEVVILSQINHRNVVKLLGCCLET--EVPLLVYE 351 (608)
Q Consensus 289 ~~f~~~~~lG~G~~-------------avk~~~~~--~~~~~~~~~~Ei~il~~l~H~niv~l~~~~~~~--~~~~lV~E 351 (608)
++|.+.+.||+|++ |||..+.. .....+.|.+|+.++++++||||+++++++.+. ...++|||
T Consensus 10 ~~y~~~~~lg~G~~g~V~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e 89 (271)
T 3kmu_A 10 KQLNFLTKLNENHSGELWKGRWQGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPHPTLITH 89 (271)
T ss_dssp GGCEEEEEEEEETTEEEEEEEETTEEEEEEEECCTTCCHHHHHHHHHHGGGGCCCSCTTEECEEEEECTTTSSSCEEEEE
T ss_pred HHhHHHHHhcCCCcceEEEEEECCeeEEEEEecccccCHHHHHHHHHHHHHHHhcCCCchhheEEEEccCCCCCeEeeec
Confidence 46888999999974 67776653 345567899999999999999999999999876 78899999
Q ss_pred ecCCCccchhccccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEEcCCCcEEEeeccCccccccCC
Q 044312 352 FIPNGTLFQYIHDQNEDFPITWEIRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQ 431 (608)
Q Consensus 352 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGls~~~~~~~ 431 (608)
|+++|+|.+++..... ..+++..++.++.||+.||+|||+.+ .+|+||||||+|||++.++.+||.|||++.....
T Consensus 90 ~~~~~~L~~~l~~~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~-~~i~H~dikp~Nil~~~~~~~~l~~~~~~~~~~~-- 165 (271)
T 3kmu_A 90 WMPYGSLYNVLHEGTN-FVVDQSQAVKFALDMARGMAFLHTLE-PLIPRHALNSRSVMIDEDMTARISMADVKFSFQS-- 165 (271)
T ss_dssp CCTTCBHHHHHHSCSS-CCCCHHHHHHHHHHHHHHHHHHTTSS-SCCTTCCCSGGGEEECTTSCEEEEGGGSCCTTSC--
T ss_pred ccCCCcHHHHHhhccc-CCCCHHHHHHHHHHHHHHHHHHhcCC-CceecCCCccceEEEcCCcceeEEeccceeeecc--
Confidence 9999999999987543 25899999999999999999999976 3499999999999999999999999998765332
Q ss_pred cceeeeeeccCCCCChhhhccCCCCC---ccchHhHHHHHHHHHhCCCCCCccchhhcccHHHHHHHHhhhhhhHHHhhh
Q 044312 432 THMTTQVHGTFGYLDPEYFRSSQFTD---KSDVYSFGVVLTELLTGEKPIRFTILEEDKSLAAYFLCAMKEERLFEILDA 508 (608)
Q Consensus 432 ~~~~~~~~gt~~y~aPE~~~~~~~t~---ksDV~S~Gvvl~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 508 (608)
....||+.|+|||.+.+..++. ++||||||++++||++|+.||....... . ...+...
T Consensus 166 ----~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~------~---------~~~~~~~ 226 (271)
T 3kmu_A 166 ----PGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNME------I---------GMKVALE 226 (271)
T ss_dssp ----TTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSCHHH------H---------HHHHHHS
T ss_pred ----cCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccChHH------H---------HHHHHhc
Confidence 2235799999999998765544 8999999999999999999986322111 0 1111111
Q ss_pred hhhccCChhHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhhHH
Q 044312 509 RVMKQGGKDEIITVAKLAKRCLNLNGKKRPTMREVASELAGIKA 552 (608)
Q Consensus 509 ~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~evl~~L~~i~~ 552 (608)
......+...+..+.+++.+||+.||++|||+.|+++.|+.++.
T Consensus 227 ~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~L~~l~~ 270 (271)
T 3kmu_A 227 GLRPTIPPGISPHVSKLMKICMNEDPAKRPKFDMIVPILEKMQD 270 (271)
T ss_dssp CCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHCC
T ss_pred CCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhc
Confidence 22223344567789999999999999999999999999988753
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-37 Score=322.59 Aligned_cols=238 Identities=26% Similarity=0.379 Sum_probs=190.9
Q ss_pred hcCccccceeccCce---------------EEEEEeecCh------hhHHHHHHHHHHHhhcCCCCccceecccccCccc
Q 044312 288 TDNFDLNRILGQGGQ---------------AVKKSKVIDE------SKVEEFINEVVILSQINHRNVVKLLGCCLETEVP 346 (608)
Q Consensus 288 t~~f~~~~~lG~G~~---------------avk~~~~~~~------~~~~~~~~Ei~il~~l~H~niv~l~~~~~~~~~~ 346 (608)
.++|++.+.||+|+| |+|..+.... ...+.+.+|+.+|++++||||+++++++.+....
T Consensus 10 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~ 89 (326)
T 2y0a_A 10 DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDV 89 (326)
T ss_dssp HHHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred ccceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEE
Confidence 356889999999984 6676654322 2467899999999999999999999999999999
Q ss_pred eEEEeecCCCccchhccccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEEcCCC----cEEEeecc
Q 044312 347 LLVYEFIPNGTLFQYIHDQNEDFPITWEIRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKY----RAKVSDFG 422 (608)
Q Consensus 347 ~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~----~~kl~DFG 422 (608)
++||||+++++|.+++.... .+++..+..++.||+.||.|||+.+ |+||||||+|||++.++ .+||+|||
T Consensus 90 ~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg 163 (326)
T 2y0a_A 90 ILILELVAGGELFDFLAEKE---SLTEEEATEFLKQILNGVYYLHSLQ---IAHFDLKPENIMLLDRNVPKPRIKIIDFG 163 (326)
T ss_dssp EEEEECCCSCBHHHHHTTSS---CCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESCSSSSSCCEEECCCT
T ss_pred EEEEEcCCCCCHHHHHHhcC---CcCHHHHHHHHHHHHHHHHHHHHCC---eEcCCCCHHHEEEecCCCCCCCEEEEECC
Confidence 99999999999999997543 5899999999999999999999999 99999999999999877 79999999
Q ss_pred CccccccCCcceeeeeeccCCCCChhhhccCCCCCccchHhHHHHHHHHHhCCCCCCccchhhcccHHHHHHHHhhhhhh
Q 044312 423 ASRSMAVDQTHMTTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLTELLTGEKPIRFTILEEDKSLAAYFLCAMKEERL 502 (608)
Q Consensus 423 ls~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~ 502 (608)
+++...... ......||+.|+|||++....++.++||||||++++||++|+.||......+ ... .+.....
T Consensus 164 ~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~------~~~-~~~~~~~ 234 (326)
T 2y0a_A 164 LAHKIDFGN--EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQE------TLA-NVSAVNY 234 (326)
T ss_dssp TCEECCTTS--CCCCCCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHH------HHH-HHHHTCC
T ss_pred CCeECCCCC--ccccccCCcCcCCceeecCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHH------HHH-HHHhcCC
Confidence 998765332 2334569999999999999999999999999999999999999996432211 000 0000000
Q ss_pred HHHhhhhhhccCChhHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 044312 503 FEILDARVMKQGGKDEIITVAKLAKRCLNLNGKKRPTMREVASE 546 (608)
Q Consensus 503 ~~~~d~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~evl~~ 546 (608)
. ... ......+..+.+|+.+||+.||++|||+.|++++
T Consensus 235 -~-~~~----~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 272 (326)
T 2y0a_A 235 -E-FED----EYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQH 272 (326)
T ss_dssp -C-CCH----HHHTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHS
T ss_pred -C-cCc----cccccCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 0 000 0011334678999999999999999999999875
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-37 Score=321.35 Aligned_cols=250 Identities=18% Similarity=0.292 Sum_probs=188.4
Q ss_pred HhcCccccceeccCce--------------EEEEEeec--ChhhHHHHHHHHHHHhhcCCCCccceecccccCccceEEE
Q 044312 287 ATDNFDLNRILGQGGQ--------------AVKKSKVI--DESKVEEFINEVVILSQINHRNVVKLLGCCLETEVPLLVY 350 (608)
Q Consensus 287 ~t~~f~~~~~lG~G~~--------------avk~~~~~--~~~~~~~~~~Ei~il~~l~H~niv~l~~~~~~~~~~~lV~ 350 (608)
..++|++.++||+|++ |+|+.+.. +....+.+.+|+.++++++||||+++++++.+....++||
T Consensus 19 l~~~y~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 98 (311)
T 3niz_A 19 LMEKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVIHSERCLTLVF 98 (311)
T ss_dssp SSCEEEEEEEEEECSSCEEEEEEETTSCEEEEEEEC------CHHHHHHHHHHHHHHCCCTTBCCEEEEECCSSCEEEEE
T ss_pred hHhhhHhhhhccCCCCeEEEEEEECCCCEEEEEEEecccccchhhHHHHHHHHHHHHcCCCCEeeeeeEEccCCEEEEEE
Confidence 3467999999999984 67766542 2233578899999999999999999999999999999999
Q ss_pred eecCCCccchhccccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEEcCCCcEEEeeccCccccccC
Q 044312 351 EFIPNGTLFQYIHDQNEDFPITWEIRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVD 430 (608)
Q Consensus 351 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGls~~~~~~ 430 (608)
||++ ++|.+++..... .+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++.....
T Consensus 99 e~~~-~~l~~~~~~~~~--~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~ 172 (311)
T 3niz_A 99 EFME-KDLKKVLDENKT--GLQDSQIKIYLYQLLRGVAHCHQHR---ILHRDLKPQNLLINSDGALKLADFGLARAFGIP 172 (311)
T ss_dssp ECCS-EEHHHHHHTCTT--CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEETTSC
T ss_pred cCCC-CCHHHHHHhccC--CCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCchHhEEECCCCCEEEccCcCceecCCC
Confidence 9997 488888876433 5899999999999999999999999 999999999999999999999999999876433
Q ss_pred CcceeeeeeccCCCCChhhhcc-CCCCCccchHhHHHHHHHHHhCCCCCCccchhhcccHHHHHHHHhhhh---hhHHHh
Q 044312 431 QTHMTTQVHGTFGYLDPEYFRS-SQFTDKSDVYSFGVVLTELLTGEKPIRFTILEEDKSLAAYFLCAMKEE---RLFEIL 506 (608)
Q Consensus 431 ~~~~~~~~~gt~~y~aPE~~~~-~~~t~ksDV~S~Gvvl~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~---~~~~~~ 506 (608)
.. ......||+.|+|||++.+ ..++.++||||||++++||++|+.||......+. ........... ......
T Consensus 173 ~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~---~~~i~~~~~~~~~~~~~~~~ 248 (311)
T 3niz_A 173 VR-SYTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQ---LPKIFSILGTPNPREWPQVQ 248 (311)
T ss_dssp CC----CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTTTH---HHHHHHHHCCCCTTTSGGGT
T ss_pred cc-cccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCChHHH---HHHHHHHHCCCChHHhhhhh
Confidence 22 2334568999999999876 5689999999999999999999999974433221 11111111110 000000
Q ss_pred h-------------hhhhccCChhHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 044312 507 D-------------ARVMKQGGKDEIITVAKLAKRCLNLNGKKRPTMREVASE 546 (608)
Q Consensus 507 d-------------~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~evl~~ 546 (608)
+ ...........+.++.+|+.+||+.||++|||++|++++
T Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 301 (311)
T 3niz_A 249 ELPLWKQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMNH 301 (311)
T ss_dssp TSHHHHSCCCCCCCCCCHHHHSTTCCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred ccchhhhcccccccCCcHHHhCcccCHHHHHHHHHHcCCChhHCCCHHHHhcC
Confidence 0 000000112234678999999999999999999999863
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-38 Score=332.55 Aligned_cols=245 Identities=28% Similarity=0.437 Sum_probs=185.1
Q ss_pred CccccceeccCce------------------EEEEEee-cChhhHHHHHHHHHHHhhcCCCCccceeccccc-CccceEE
Q 044312 290 NFDLNRILGQGGQ------------------AVKKSKV-IDESKVEEFINEVVILSQINHRNVVKLLGCCLE-TEVPLLV 349 (608)
Q Consensus 290 ~f~~~~~lG~G~~------------------avk~~~~-~~~~~~~~~~~Ei~il~~l~H~niv~l~~~~~~-~~~~~lV 349 (608)
.|.+.+.||+|+| |||..+. .+....+.|.+|+.++++++||||+++++++.+ .+..++|
T Consensus 90 ~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~lv 169 (373)
T 3c1x_A 90 IVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVV 169 (373)
T ss_dssp EEEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSCSCSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCCSSCCEEE
T ss_pred eeecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCCCeEEE
Confidence 4677889999985 4444432 234567889999999999999999999998754 4578999
Q ss_pred EeecCCCccchhccccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEEcCCCcEEEeeccCcccccc
Q 044312 350 YEFIPNGTLFQYIHDQNEDFPITWEIRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAV 429 (608)
Q Consensus 350 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGls~~~~~ 429 (608)
|||+++|+|.+++..... .+++..++.++.||++||+|||+.+ |+||||||+|||+++++.+||+|||+++....
T Consensus 170 ~e~~~~g~L~~~l~~~~~--~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~ 244 (373)
T 3c1x_A 170 LPYMKHGDLRNFIRNETH--NPTVKDLIGFGLQVAKGMKFLASKK---FVHRDLAARNCMLDEKFTVKVADFGLARDMYD 244 (373)
T ss_dssp EECCTTCBHHHHHHCTTC--CCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCC--------
T ss_pred EECCCCCCHHHHHhhccc--CCCHHHHHHHHHHHHHHHHHHHHCC---EecCccchheEEECCCCCEEEeeccccccccc
Confidence 999999999999976443 4899999999999999999999999 99999999999999999999999999986643
Q ss_pred CCcc---eeeeeeccCCCCChhhhccCCCCCccchHhHHHHHHHHHh-CCCCCCccchhhcccHHHHHHHHhhhhhhHHH
Q 044312 430 DQTH---MTTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLTELLT-GEKPIRFTILEEDKSLAAYFLCAMKEERLFEI 505 (608)
Q Consensus 430 ~~~~---~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~ellt-g~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 505 (608)
.... ......+|+.|+|||.+.+..++.++||||||+++|||+| |.+||......+ ... .
T Consensus 245 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt~~~~p~~~~~~~~---~~~-------------~ 308 (373)
T 3c1x_A 245 KEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFD---ITV-------------Y 308 (373)
T ss_dssp -------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCSSC---HHH-------------H
T ss_pred cccccccccCCCCCcccccChHHhcCCCCCcHHHHHHHHHHHHHHHhCcCCCCCCCCHHH---HHH-------------H
Confidence 2211 2234457889999999999999999999999999999999 667775322111 111 0
Q ss_pred hhhhhhccCChhHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhhHHhcC
Q 044312 506 LDARVMKQGGKDEIITVAKLAKRCLNLNGKKRPTMREVASELAGIKAWNG 555 (608)
Q Consensus 506 ~d~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~evl~~L~~i~~~~~ 555 (608)
+........+...+..+.+++.+||+.||++|||+.|+++.|+.+.....
T Consensus 309 ~~~~~~~~~p~~~~~~l~~li~~cl~~dp~~RPs~~ell~~L~~i~~~~~ 358 (373)
T 3c1x_A 309 LLQGRRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFI 358 (373)
T ss_dssp HHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTCC
T ss_pred HHcCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhcc
Confidence 11111122334556789999999999999999999999999999876543
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-37 Score=317.78 Aligned_cols=247 Identities=26% Similarity=0.380 Sum_probs=194.6
Q ss_pred CccccceeccCce------------------EEEEEee-cChhhHHHHHHHHHHHhhcCCCCccceecccccCccc-eEE
Q 044312 290 NFDLNRILGQGGQ------------------AVKKSKV-IDESKVEEFINEVVILSQINHRNVVKLLGCCLETEVP-LLV 349 (608)
Q Consensus 290 ~f~~~~~lG~G~~------------------avk~~~~-~~~~~~~~~~~Ei~il~~l~H~niv~l~~~~~~~~~~-~lV 349 (608)
.|...++||+|++ |+|.... ......+.|.+|+.++++++||||+++++++.+.+.. ++|
T Consensus 22 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~v 101 (298)
T 3pls_A 22 VTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLPHVL 101 (298)
T ss_dssp EEEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEEE
T ss_pred EEccCceeccCCCceEEEEEEecCCCceeeeeeeeccccccHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecCCCCcEEE
Confidence 3566788999874 4444432 2334567899999999999999999999999876655 999
Q ss_pred EeecCCCccchhccccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEEcCCCcEEEeeccCcccccc
Q 044312 350 YEFIPNGTLFQYIHDQNEDFPITWEIRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAV 429 (608)
Q Consensus 350 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGls~~~~~ 429 (608)
|||+.+++|.+++..... .+++..++.++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++....
T Consensus 102 ~e~~~~~~L~~~~~~~~~--~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~ 176 (298)
T 3pls_A 102 LPYMCHGDLLQFIRSPQR--NPTVKDLISFGLQVARGMEYLAEQK---FVHRDLAARNCMLDESFTVKVADFGLARDILD 176 (298)
T ss_dssp ECCCTTCBHHHHHHCTTC--CCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTCCEEECCTTSSCTTTT
T ss_pred EecccCCCHHHHHhcccc--CCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCcceEEEcCCCcEEeCcCCCcccccC
Confidence 999999999999976433 5899999999999999999999999 99999999999999999999999999986643
Q ss_pred CCc---ceeeeeeccCCCCChhhhccCCCCCccchHhHHHHHHHHHhCCCCCCccchhhcccHHHHHHHHhhhhhhHHHh
Q 044312 430 DQT---HMTTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLTELLTGEKPIRFTILEEDKSLAAYFLCAMKEERLFEIL 506 (608)
Q Consensus 430 ~~~---~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 506 (608)
... .......+|+.|+|||.+.+..++.++||||||++++||++|..|+...... ..+...+
T Consensus 177 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~~~~~~~~~---------------~~~~~~~ 241 (298)
T 3pls_A 177 REYYSVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDP---------------FDLTHFL 241 (298)
T ss_dssp GGGGCSCCSSCTTCGGGGSCHHHHTTCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCG---------------GGHHHHH
T ss_pred CcccccccCcCCCCCccccChhhhccCCCChhhchhhHHHHHHHHhhCCCCCCccCCH---------------HHHHHHh
Confidence 221 1223446788999999999999999999999999999999966654321111 1111111
Q ss_pred hhhhhccCChhHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhhHHhcCC
Q 044312 507 DARVMKQGGKDEIITVAKLAKRCLNLNGKKRPTMREVASELAGIKAWNGA 556 (608)
Q Consensus 507 d~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~evl~~L~~i~~~~~~ 556 (608)
........+...+..+.+|+.+||+.||.+|||++|+++.|+.+......
T Consensus 242 ~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~l~~ 291 (298)
T 3pls_A 242 AQGRRLPQPEYCPDSLYQVMQQCWEADPAVRPTFRVLVGEVEQIVSALLG 291 (298)
T ss_dssp HTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHCCS
T ss_pred hcCCCCCCCccchHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHHhc
Confidence 11122233445567899999999999999999999999999998776543
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-37 Score=318.72 Aligned_cols=245 Identities=28% Similarity=0.436 Sum_probs=191.6
Q ss_pred cCccccceeccCce------------------EEEEEee-cChhhHHHHHHHHHHHhhcCCCCccceecccc-cCccceE
Q 044312 289 DNFDLNRILGQGGQ------------------AVKKSKV-IDESKVEEFINEVVILSQINHRNVVKLLGCCL-ETEVPLL 348 (608)
Q Consensus 289 ~~f~~~~~lG~G~~------------------avk~~~~-~~~~~~~~~~~Ei~il~~l~H~niv~l~~~~~-~~~~~~l 348 (608)
.+|++.++||+|++ |+|.... .+....+.+.+|+.++++++||||+++++++. .....++
T Consensus 25 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 104 (298)
T 3f66_A 25 LIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLV 104 (298)
T ss_dssp EEEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEE
T ss_pred eehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccCCCHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEcCCCceEE
Confidence 45788899999974 3343332 23345678999999999999999999999864 5567899
Q ss_pred EEeecCCCccchhccccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEEcCCCcEEEeeccCccccc
Q 044312 349 VYEFIPNGTLFQYIHDQNEDFPITWEIRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMA 428 (608)
Q Consensus 349 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGls~~~~ 428 (608)
||||+++|+|.+++..... .+++..++.++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++...
T Consensus 105 v~e~~~~~~L~~~l~~~~~--~~~~~~~~~i~~ql~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~a~~~~ 179 (298)
T 3f66_A 105 VLPYMKHGDLRNFIRNETH--NPTVKDLIGFGLQVAKGMKYLASKK---FVHRDLAARNCMLDEKFTVKVADFGLARDMY 179 (298)
T ss_dssp EEECCTTCBHHHHHHCTTC--CCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTCCEEECSCGGGCCCS
T ss_pred EEeCCCCCCHHHHHHhccc--CCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCchheEEECCCCCEEECccccccccc
Confidence 9999999999999976433 5899999999999999999999999 9999999999999999999999999998764
Q ss_pred cCCc---ceeeeeeccCCCCChhhhccCCCCCccchHhHHHHHHHHHhC-CCCCCccchhhcccHHHHHHHHhhhhhhHH
Q 044312 429 VDQT---HMTTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLTELLTG-EKPIRFTILEEDKSLAAYFLCAMKEERLFE 504 (608)
Q Consensus 429 ~~~~---~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~elltg-~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~ 504 (608)
.... .......+|+.|+|||.+.+..++.++||||||++++||++| .+||......+ .. .
T Consensus 180 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~~~---~~-------------~ 243 (298)
T 3f66_A 180 DKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFD---IT-------------V 243 (298)
T ss_dssp CGGGCBC-----CCBCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTSCTTT---HH-------------H
T ss_pred ccchhccccccCCCCCccccChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCccCCHHH---HH-------------H
Confidence 3321 123345678899999999999999999999999999999995 55554221111 00 1
Q ss_pred HhhhhhhccCChhHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhhHHhc
Q 044312 505 ILDARVMKQGGKDEIITVAKLAKRCLNLNGKKRPTMREVASELAGIKAWN 554 (608)
Q Consensus 505 ~~d~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~evl~~L~~i~~~~ 554 (608)
.+........+...+..+.+++.+||+.||++|||+.|+++.|+.+....
T Consensus 244 ~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~~~ 293 (298)
T 3f66_A 244 YLLQGRRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTF 293 (298)
T ss_dssp HHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTS
T ss_pred HHhcCCCCCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhh
Confidence 11111112223345668999999999999999999999999999987643
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-38 Score=320.61 Aligned_cols=239 Identities=22% Similarity=0.374 Sum_probs=190.0
Q ss_pred hcCccccceeccCce----------------------EEEEEeecChhhHHHHHHHHHHHhhcCCCCccceecccccCcc
Q 044312 288 TDNFDLNRILGQGGQ----------------------AVKKSKVIDESKVEEFINEVVILSQINHRNVVKLLGCCLETEV 345 (608)
Q Consensus 288 t~~f~~~~~lG~G~~----------------------avk~~~~~~~~~~~~~~~Ei~il~~l~H~niv~l~~~~~~~~~ 345 (608)
.++|.+.+.||+|++ |+|..........+.+.+|+.++++++||||+++++++.+.+.
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 86 (289)
T 4fvq_A 7 NEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLVLNYGVCVCGDE 86 (289)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGGGGGHHHHHHHHHHHHTSCCTTBCCEEEEECCTTC
T ss_pred hhHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhcccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEeCCC
Confidence 356888899999874 4444444445667889999999999999999999999999999
Q ss_pred ceEEEeecCCCccchhccccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEEcCCCc--------EE
Q 044312 346 PLLVYEFIPNGTLFQYIHDQNEDFPITWEIRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYR--------AK 417 (608)
Q Consensus 346 ~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~--------~k 417 (608)
.++||||+++++|.+++..... .+++..++.++.||+.||+|||+.+ |+||||||+|||++.++. +|
T Consensus 87 ~~lv~e~~~~~~L~~~l~~~~~--~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~~~~~k 161 (289)
T 4fvq_A 87 NILVQEFVKFGSLDTYLKKNKN--CINILWKLEVAKQLAAAMHFLEENT---LIHGNVCAKNILLIREEDRKTGNPPFIK 161 (289)
T ss_dssp CEEEEECCTTCBHHHHHHHTGG--GCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEEECCBGGGTBCCEEE
T ss_pred CEEEEECCCCCCHHHHHHhCCC--CCCHHHHHHHHHHHHHHHHHHhhCC---eECCCcCcceEEEecCCcccccccceee
Confidence 9999999999999999986543 4899999999999999999999999 999999999999998877 99
Q ss_pred EeeccCccccccCCcceeeeeeccCCCCChhhhcc-CCCCCccchHhHHHHHHHHHhCCCCCCccchhhcccHHHHHHHH
Q 044312 418 VSDFGASRSMAVDQTHMTTQVHGTFGYLDPEYFRS-SQFTDKSDVYSFGVVLTELLTGEKPIRFTILEEDKSLAAYFLCA 496 (608)
Q Consensus 418 l~DFGls~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~t~ksDV~S~Gvvl~elltg~~p~~~~~~~~~~~l~~~~~~~ 496 (608)
|+|||++...... ....+|+.|+|||.+.+ ..++.++||||||++++||++|..|+....... .
T Consensus 162 l~Dfg~~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~~~~-----~----- 226 (289)
T 4fvq_A 162 LSDPGISITVLPK-----DILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQ-----R----- 226 (289)
T ss_dssp ECCCCSCTTTSCH-----HHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHH-----H-----
T ss_pred eccCcccccccCc-----cccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCccccchH-----H-----
Confidence 9999999765322 23457899999999987 679999999999999999999655433211110 0
Q ss_pred hhhhhhHHHhhhhhhccCChhHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhhHHh
Q 044312 497 MKEERLFEILDARVMKQGGKDEIITVAKLAKRCLNLNGKKRPTMREVASELAGIKAW 553 (608)
Q Consensus 497 ~~~~~~~~~~d~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~evl~~L~~i~~~ 553 (608)
....... ....+...+.++.+|+.+||+.||++|||+.|++++|+.+...
T Consensus 227 -----~~~~~~~--~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~l~~p 276 (289)
T 4fvq_A 227 -----KLQFYED--RHQLPAPKAAELANLINNCMDYEPDHRPSFRAIIRDLNSLFTP 276 (289)
T ss_dssp -----HHHHHHT--TCCCCCCSSCTTHHHHHHHSCSSGGGSCCHHHHHHHHHTCC--
T ss_pred -----HHHHhhc--cCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcCC
Confidence 0000000 1112223345789999999999999999999999999988654
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-37 Score=336.76 Aligned_cols=240 Identities=23% Similarity=0.306 Sum_probs=192.1
Q ss_pred HhcCccccceeccCce---------------EEEEEeec--ChhhHHHHHHHHHHHhhcCCCCccceecccccCccceEE
Q 044312 287 ATDNFDLNRILGQGGQ---------------AVKKSKVI--DESKVEEFINEVVILSQINHRNVVKLLGCCLETEVPLLV 349 (608)
Q Consensus 287 ~t~~f~~~~~lG~G~~---------------avk~~~~~--~~~~~~~~~~Ei~il~~l~H~niv~l~~~~~~~~~~~lV 349 (608)
..++|++.+.||+|+| |+|++... .....+.+.+|+.++++++||||+++++++.+.+..++|
T Consensus 9 ~~~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv 88 (444)
T 3soa_A 9 FTEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISEEGHHYLI 88 (444)
T ss_dssp HHHHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSCHHHHHHHHHHHHHHHHHCCBTTBCCEEEEEECSSEEEEE
T ss_pred ccCCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCcCCCeEEEEEEECCEEEEE
Confidence 4567999999999985 56665432 234567799999999999999999999999999999999
Q ss_pred EeecCCCccchhccccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEEc---CCCcEEEeeccCccc
Q 044312 350 YEFIPNGTLFQYIHDQNEDFPITWEIRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLD---DKYRAKVSDFGASRS 426 (608)
Q Consensus 350 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~---~~~~~kl~DFGls~~ 426 (608)
|||+++|+|.+++.... .+++..+..++.||+.||+|||+.+ |+||||||+|||++ .++.+||+|||+++.
T Consensus 89 ~E~~~gg~L~~~i~~~~---~~~e~~~~~i~~qil~aL~~lH~~g---ivHrDlKp~NIll~~~~~~~~vkL~DFG~a~~ 162 (444)
T 3soa_A 89 FDLVTGGELFEDIVARE---YYSEADASHCIQQILEAVLHCHQMG---VVHRNLKPENLLLASKLKGAAVKLADFGLAIE 162 (444)
T ss_dssp ECCCBCCBHHHHHHHCS---CCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSSTTEEESBSSTTCCEEECCCSSCBC
T ss_pred EEeCCCCCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEeccCCCCcEEEccCceeEE
Confidence 99999999999988653 5899999999999999999999999 99999999999998 467899999999987
Q ss_pred cccCCcceeeeeeccCCCCChhhhccCCCCCccchHhHHHHHHHHHhCCCCCCccchhhcccHHHHHHHHhhhhhhHHHh
Q 044312 427 MAVDQTHMTTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLTELLTGEKPIRFTILEEDKSLAAYFLCAMKEERLFEIL 506 (608)
Q Consensus 427 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 506 (608)
...... ......||+.|+|||++....++.++||||||+++|+|++|..||....... ....+..+..
T Consensus 163 ~~~~~~-~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyell~G~~Pf~~~~~~~-------~~~~i~~~~~---- 230 (444)
T 3soa_A 163 VEGEQQ-AWFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWDEDQHR-------LYQQIKAGAY---- 230 (444)
T ss_dssp CCTTCC-BCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH-------HHHHHHHTCC----
T ss_pred ecCCCc-eeecccCCcccCCHHHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCccHHH-------HHHHHHhCCC----
Confidence 654332 2344679999999999999999999999999999999999999996322111 1111111100
Q ss_pred hhhhhccCChhHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 044312 507 DARVMKQGGKDEIITVAKLAKRCLNLNGKKRPTMREVASE 546 (608)
Q Consensus 507 d~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~evl~~ 546 (608)
..........+.++.+|+.+||+.||++|||+.|++++
T Consensus 231 --~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~L~h 268 (444)
T 3soa_A 231 --DFPSPEWDTVTPEAKDLINKMLTINPSKRITAAEALKH 268 (444)
T ss_dssp --CCCTTTTTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred --CCCccccccCCHHHHHHHHHHcCCChhHCCCHHHHhcC
Confidence 00011112456789999999999999999999999875
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-37 Score=318.65 Aligned_cols=247 Identities=22% Similarity=0.364 Sum_probs=187.7
Q ss_pred hcCccccceeccCce-------------EEEEEeecChhhHHHHHHHHHHHhh--cCCCCccceeccccc----CccceE
Q 044312 288 TDNFDLNRILGQGGQ-------------AVKKSKVIDESKVEEFINEVVILSQ--INHRNVVKLLGCCLE----TEVPLL 348 (608)
Q Consensus 288 t~~f~~~~~lG~G~~-------------avk~~~~~~~~~~~~~~~Ei~il~~--l~H~niv~l~~~~~~----~~~~~l 348 (608)
.++|++.+.||+|++ |||+.. ....+.+.+|.+++.. ++||||+++++++.+ ....++
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~vavK~~~---~~~~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~~~~~~~~l 83 (301)
T 3q4u_A 7 ARDITLLECVGKGRYGEVWRGSWQGENVAVKIFS---SRDEKSWFRETELYNTVMLRHENILGFIASDMTSRHSSTQLWL 83 (301)
T ss_dssp GGGCEEEEEEEECSSEEEEEEEETTEEEEEEEEC---GGGHHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEETTEEEEEE
T ss_pred cCcEEEEEeeccCCCcEEEEEEECCEEEEEEEec---cccchhhHHHHHHHHHhhccCcCeeeEEEeeccccCCCceeEE
Confidence 467899999999985 556553 3455677778877776 799999999998654 346799
Q ss_pred EEeecCCCccchhccccCCCCCCCHHHHHHHHHHHHHHHHHHh--------hcCCCCeeccCCCCCcEEEcCCCcEEEee
Q 044312 349 VYEFIPNGTLFQYIHDQNEDFPITWEIRLRIAIEVSGALSYLH--------SAASIPIYHRDIKSTNILLDDKYRAKVSD 420 (608)
Q Consensus 349 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH--------~~~~~~iiHrDlk~~NILl~~~~~~kl~D 420 (608)
||||+++|+|.++++.. .+++..++.++.||+.||+||| +.+ |+||||||+|||++.++.+||+|
T Consensus 84 v~e~~~~g~L~~~l~~~----~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~---ivH~Dlkp~Nill~~~~~~kl~D 156 (301)
T 3q4u_A 84 ITHYHEMGSLYDYLQLT----TLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPA---IAHRDLKSKNILVKKNGQCCIAD 156 (301)
T ss_dssp EECCCTTCBHHHHHTTC----CBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCE---EECSCCCGGGEEECTTSCEEECC
T ss_pred ehhhccCCCHHHHHhhc----ccCHHHHHHHHHHHHHHHHHHHHhhhhccCCCC---eecCCCChHhEEEcCCCCEEEee
Confidence 99999999999999643 4899999999999999999999 777 99999999999999999999999
Q ss_pred ccCccccccCCcce---eeeeeccCCCCChhhhccC------CCCCccchHhHHHHHHHHHhC----------CCCCCcc
Q 044312 421 FGASRSMAVDQTHM---TTQVHGTFGYLDPEYFRSS------QFTDKSDVYSFGVVLTELLTG----------EKPIRFT 481 (608)
Q Consensus 421 FGls~~~~~~~~~~---~~~~~gt~~y~aPE~~~~~------~~t~ksDV~S~Gvvl~elltg----------~~p~~~~ 481 (608)
||+++......... .....||+.|+|||.+... .++.++||||||+++|||+|| +.||...
T Consensus 157 fg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~pf~~~ 236 (301)
T 3q4u_A 157 LGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDV 236 (301)
T ss_dssp CTTCEEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTT
T ss_pred CCCeeecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCcccccccccccccc
Confidence 99998765433222 2234789999999999877 455799999999999999999 7787533
Q ss_pred chhhcccHHHHHHHHhhhhhhHHHhhhhh-hccCChhHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhh
Q 044312 482 ILEEDKSLAAYFLCAMKEERLFEILDARV-MKQGGKDEIITVAKLAKRCLNLNGKKRPTMREVASELAGI 550 (608)
Q Consensus 482 ~~~~~~~l~~~~~~~~~~~~~~~~~d~~~-~~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~evl~~L~~i 550 (608)
..... .... .......... .+.. ........+..+.+|+.+||+.||++|||+.||++.|+.+
T Consensus 237 ~~~~~-~~~~-~~~~~~~~~~----~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i 300 (301)
T 3q4u_A 237 VPNDP-SFED-MRKVVCVDQQ----RPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLTKI 300 (301)
T ss_dssp SCSSC-CHHH-HHHHHTTSCC----CCCCCGGGGGSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHHH
T ss_pred CCCCc-chhh-hhHHHhccCC----CCCCChhhccCccHHHHHHHHHHHhhcChhhCCCHHHHHHHHhcc
Confidence 22211 1111 1111100000 0000 0011234677899999999999999999999999999876
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-38 Score=329.92 Aligned_cols=241 Identities=24% Similarity=0.351 Sum_probs=190.1
Q ss_pred hcCccccceeccCce---------------EEEEEeecC-----hhhHHHHHHHHHHHhhcCCCCccceecccccCccce
Q 044312 288 TDNFDLNRILGQGGQ---------------AVKKSKVID-----ESKVEEFINEVVILSQINHRNVVKLLGCCLETEVPL 347 (608)
Q Consensus 288 t~~f~~~~~lG~G~~---------------avk~~~~~~-----~~~~~~~~~Ei~il~~l~H~niv~l~~~~~~~~~~~ 347 (608)
.+.|++.+.||+|+| |||...... ....+.+.+|+.++++++||||+++++++.+.+..+
T Consensus 23 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~ 102 (351)
T 3c0i_A 23 EDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGMLY 102 (351)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEE
T ss_pred ccceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEE
Confidence 356899999999985 666654321 124678999999999999999999999999999999
Q ss_pred EEEeecCCCccchhccccC-CCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEEcCCCc---EEEeeccC
Q 044312 348 LVYEFIPNGTLFQYIHDQN-EDFPITWEIRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYR---AKVSDFGA 423 (608)
Q Consensus 348 lV~E~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~---~kl~DFGl 423 (608)
|||||+++++|.+++.... ....+++..+..++.||+.||+|||+++ |+||||||+|||++.++. +||+|||+
T Consensus 103 lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~---ivHrDlkp~NIl~~~~~~~~~vkl~Dfg~ 179 (351)
T 3c0i_A 103 MVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDNN---IIHRDVKPHCVLLASKENSAPVKLGGFGV 179 (351)
T ss_dssp EEEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECSSSTTCCEEECCCTT
T ss_pred EEEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCChHHeEEecCCCCCcEEEecCcc
Confidence 9999999999988886532 2335899999999999999999999999 999999999999986554 99999999
Q ss_pred ccccccCCcceeeeeeccCCCCChhhhccCCCCCccchHhHHHHHHHHHhCCCCCCccchhhcccHHHHHHHHhhhhhhH
Q 044312 424 SRSMAVDQTHMTTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLTELLTGEKPIRFTILEEDKSLAAYFLCAMKEERLF 503 (608)
Q Consensus 424 s~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~ 503 (608)
++....... ......||+.|+|||++.+..++.++||||||++++||++|+.||..... ..+. .+......
T Consensus 180 a~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~-------~~~~-~i~~~~~~ 250 (351)
T 3c0i_A 180 AIQLGESGL-VAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGTKE-------RLFE-GIIKGKYK 250 (351)
T ss_dssp CEECCTTSC-BCCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCSSHH-------HHHH-HHHHTCCC
T ss_pred eeEecCCCe-eecCCcCCcCccCHHHHcCCCCCchHhhHHHHHHHHHHHHCCCCCCCcHH-------HHHH-HHHcCCCC
Confidence 987654322 23445699999999999999999999999999999999999999974211 0011 11110000
Q ss_pred HHhhhhhhccCChhHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 044312 504 EILDARVMKQGGKDEIITVAKLAKRCLNLNGKKRPTMREVASE 546 (608)
Q Consensus 504 ~~~d~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~evl~~ 546 (608)
..+.. ....+.++.+|+.+||+.||++|||+.|++++
T Consensus 251 --~~~~~----~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~h 287 (351)
T 3c0i_A 251 --MNPRQ----WSHISESAKDLVRRMLMLDPAERITVYEALNH 287 (351)
T ss_dssp --CCHHH----HTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred --CCccc----cccCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 00000 01335679999999999999999999999975
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-38 Score=324.91 Aligned_cols=246 Identities=26% Similarity=0.444 Sum_probs=194.6
Q ss_pred cCccccceeccCce-----------------EEEEEee-cChhhHHHHHHHHHHHhhc-CCCCccceecccccCccceEE
Q 044312 289 DNFDLNRILGQGGQ-----------------AVKKSKV-IDESKVEEFINEVVILSQI-NHRNVVKLLGCCLETEVPLLV 349 (608)
Q Consensus 289 ~~f~~~~~lG~G~~-----------------avk~~~~-~~~~~~~~~~~Ei~il~~l-~H~niv~l~~~~~~~~~~~lV 349 (608)
++|.+.+.||+|++ |||..+. ......+.+.+|+.+++++ +||||+++++++.+.+..++|
T Consensus 25 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv 104 (327)
T 1fvr_A 25 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA 104 (327)
T ss_dssp GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEE
T ss_pred HHccceeeeecCCCceEEEEEEccCCcccceeeeeeccccchHHHHHHHHHHHHHHhccCCCchhhhceeeeeCCceEEE
Confidence 46888999999974 4444443 2334556799999999999 999999999999999999999
Q ss_pred EeecCCCccchhccccC-------------CCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEEcCCCcE
Q 044312 350 YEFIPNGTLFQYIHDQN-------------EDFPITWEIRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRA 416 (608)
Q Consensus 350 ~E~~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ 416 (608)
|||+++++|.+++.... ....+++..++.++.||+.||+|||+.+ |+||||||+|||++.++.+
T Consensus 105 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIl~~~~~~~ 181 (327)
T 1fvr_A 105 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYVA 181 (327)
T ss_dssp ECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECGGGCE
T ss_pred EecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCccceEEEcCCCeE
Confidence 99999999999997643 1235899999999999999999999999 9999999999999999999
Q ss_pred EEeeccCccccccCCcceeeeeeccCCCCChhhhccCCCCCccchHhHHHHHHHHHh-CCCCCCccchhhcccHHHHHHH
Q 044312 417 KVSDFGASRSMAVDQTHMTTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLTELLT-GEKPIRFTILEEDKSLAAYFLC 495 (608)
Q Consensus 417 kl~DFGls~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~ellt-g~~p~~~~~~~~~~~l~~~~~~ 495 (608)
||+|||+++...... ......+++.|+|||.+....++.++||||||++++||++ |+.||......+
T Consensus 182 kL~Dfg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~---------- 249 (327)
T 1fvr_A 182 KIADFGLSRGQEVYV--KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAE---------- 249 (327)
T ss_dssp EECCTTCEESSCEEC--CC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH----------
T ss_pred EEcccCcCccccccc--cccCCCCCccccChhhhccccCCchhcchHHHHHHHHHHcCCCCCCCCCcHHH----------
Confidence 999999987543211 1233457889999999998889999999999999999998 999986332111
Q ss_pred HhhhhhhHHHhhhhhhccCChhHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhhHHhcC
Q 044312 496 AMKEERLFEILDARVMKQGGKDEIITVAKLAKRCLNLNGKKRPTMREVASELAGIKAWNG 555 (608)
Q Consensus 496 ~~~~~~~~~~~d~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~evl~~L~~i~~~~~ 555 (608)
+.+.+........+...+..+.+|+.+||+.||++|||+.|+++.|+.+....+
T Consensus 250 ------~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~~ 303 (327)
T 1fvr_A 250 ------LYEKLPQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEERK 303 (327)
T ss_dssp ------HHHHGGGTCCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSSS
T ss_pred ------HHHHhhcCCCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhhc
Confidence 111111112223344566789999999999999999999999999998876543
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-37 Score=329.46 Aligned_cols=240 Identities=25% Similarity=0.356 Sum_probs=192.5
Q ss_pred HHhcCccccceeccCce---------------EEEEEeec--ChhhHHHHHHHHHHHhhcCCCCccceecccccCccceE
Q 044312 286 KATDNFDLNRILGQGGQ---------------AVKKSKVI--DESKVEEFINEVVILSQINHRNVVKLLGCCLETEVPLL 348 (608)
Q Consensus 286 ~~t~~f~~~~~lG~G~~---------------avk~~~~~--~~~~~~~~~~Ei~il~~l~H~niv~l~~~~~~~~~~~l 348 (608)
...++|++.+.||+|+| |+|.+... .....+.+.+|+.++++++||||+++++++.+....++
T Consensus 26 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~l 105 (362)
T 2bdw_A 26 KFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYL 105 (362)
T ss_dssp HHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred CcccCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEE
Confidence 34567999999999974 66766532 34456789999999999999999999999999999999
Q ss_pred EEeecCCCccchhccccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEEcCC---CcEEEeeccCcc
Q 044312 349 VYEFIPNGTLFQYIHDQNEDFPITWEIRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDK---YRAKVSDFGASR 425 (608)
Q Consensus 349 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~---~~~kl~DFGls~ 425 (608)
||||+++|+|.+++.... .+++..+..++.||+.||+|||+.+ |+||||||+|||++.+ +.+||+|||+++
T Consensus 106 v~e~~~gg~L~~~l~~~~---~~~~~~~~~~~~qi~~al~~lH~~~---ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a~ 179 (362)
T 2bdw_A 106 VFDLVTGGELFEDIVARE---FYSEADASHCIQQILESIAYCHSNG---IVHRNLKPENLLLASKAKGAAVKLADFGLAI 179 (362)
T ss_dssp EECCCCSCBHHHHHTTCS---CCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEESCSSTTCCEEECCCTTCB
T ss_pred EEecCCCCCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCchHHEEEecCCCCCCEEEeecCcce
Confidence 999999999999887543 5899999999999999999999999 9999999999999864 459999999998
Q ss_pred ccccCCcceeeeeeccCCCCChhhhccCCCCCccchHhHHHHHHHHHhCCCCCCccchhhcccHHHHHHHHhhhhhhHHH
Q 044312 426 SMAVDQTHMTTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLTELLTGEKPIRFTILEEDKSLAAYFLCAMKEERLFEI 505 (608)
Q Consensus 426 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 505 (608)
...... ......||+.|+|||++.+..++.++||||||+++|||++|+.||...... .. ...+......
T Consensus 180 ~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~------~~-~~~i~~~~~~-- 248 (362)
T 2bdw_A 180 EVNDSE--AWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQH------RL-YAQIKAGAYD-- 248 (362)
T ss_dssp CCTTCC--SCCCSCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH------HH-HHHHHHTCCC--
T ss_pred EecCCc--ccccCCCCccccCHHHHccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHH------HH-HHHHHhCCCC--
Confidence 765332 233457999999999999999999999999999999999999998632211 11 1111111000
Q ss_pred hhhhhhccCChhHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 044312 506 LDARVMKQGGKDEIITVAKLAKRCLNLNGKKRPTMREVASE 546 (608)
Q Consensus 506 ~d~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~evl~~ 546 (608)
.........+.++.+|+.+||+.||++|||+.|++++
T Consensus 249 ----~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 285 (362)
T 2bdw_A 249 ----YPSPEWDTVTPEAKSLIDSMLTVNPKKRITADQALKV 285 (362)
T ss_dssp ----CCTTGGGGSCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred ----CCcccccCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 0000112345689999999999999999999999876
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-37 Score=322.20 Aligned_cols=249 Identities=22% Similarity=0.369 Sum_probs=195.7
Q ss_pred hcCccccceeccCce---------------EEEEEeecChhhHHHHHHHHHHHhhcCCCCccceecccc----cCccceE
Q 044312 288 TDNFDLNRILGQGGQ---------------AVKKSKVIDESKVEEFINEVVILSQINHRNVVKLLGCCL----ETEVPLL 348 (608)
Q Consensus 288 t~~f~~~~~lG~G~~---------------avk~~~~~~~~~~~~~~~Ei~il~~l~H~niv~l~~~~~----~~~~~~l 348 (608)
.++|++.+.||+|++ |||+....+....+.+.+|+.++++++||||+++++++. .....++
T Consensus 28 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~l 107 (317)
T 2buj_A 28 NKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYCLRERGAKHEAWL 107 (317)
T ss_dssp TEEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEETTEEEEEE
T ss_pred CeEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecCCHHHHHHHHHHHHHHhhcCCCCeeeEEEEEEeccCCCceeEE
Confidence 467999999999974 778777666777889999999999999999999999986 3457899
Q ss_pred EEeecCCCccchhccccC-CCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEEcCCCcEEEeeccCcccc
Q 044312 349 VYEFIPNGTLFQYIHDQN-EDFPITWEIRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSM 427 (608)
Q Consensus 349 V~E~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGls~~~ 427 (608)
||||+++++|.+++.... ....+++..++.++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++..
T Consensus 108 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~dlkp~NIl~~~~~~~kl~dfg~~~~~ 184 (317)
T 2buj_A 108 LLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAKG---YAHRDLKPTNILLGDEGQPVLMDLGSMNQA 184 (317)
T ss_dssp EEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEECCCSSCEES
T ss_pred EEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEcCCCCEEEEecCcchhc
Confidence 999999999999997631 2236999999999999999999999999 999999999999999999999999998765
Q ss_pred ccCCcc--------eeeeeeccCCCCChhhhccCC---CCCccchHhHHHHHHHHHhCCCCCCccchhhcccHHHHHHHH
Q 044312 428 AVDQTH--------MTTQVHGTFGYLDPEYFRSSQ---FTDKSDVYSFGVVLTELLTGEKPIRFTILEEDKSLAAYFLCA 496 (608)
Q Consensus 428 ~~~~~~--------~~~~~~gt~~y~aPE~~~~~~---~t~ksDV~S~Gvvl~elltg~~p~~~~~~~~~~~l~~~~~~~ 496 (608)
...... ......||+.|+|||.+.... ++.++||||||++++||++|+.||.......
T Consensus 185 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~----------- 253 (317)
T 2buj_A 185 CIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKG----------- 253 (317)
T ss_dssp CEEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHHHHHTT-----------
T ss_pred ccccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhhhhccc-----------
Confidence 321110 012345799999999987654 6899999999999999999999985211111
Q ss_pred hhhhhhHHHhhhhhhccCChhHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhhHHh
Q 044312 497 MKEERLFEILDARVMKQGGKDEIITVAKLAKRCLNLNGKKRPTMREVASELAGIKAW 553 (608)
Q Consensus 497 ~~~~~~~~~~d~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~evl~~L~~i~~~ 553 (608)
..+...+............+..+.+|+.+||+.||.+|||+.||+++|+.++..
T Consensus 254 ---~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~~~ 307 (317)
T 2buj_A 254 ---DSVALAVQNQLSIPQSPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQLEALQPP 307 (317)
T ss_dssp ---SCHHHHHHCC--CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTCCC
T ss_pred ---chhhHHhhccCCCCccccCCHHHHHHHHHHhhcChhhCCCHHHHHHHhhhcCCC
Confidence 011111111122222345567899999999999999999999999999887653
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-37 Score=312.80 Aligned_cols=255 Identities=19% Similarity=0.228 Sum_probs=197.3
Q ss_pred hcCccccceeccCce---------------EEEEEeecChhhHHHHHHHHHHHhhcCCCCccceeccc-ccCccceEEEe
Q 044312 288 TDNFDLNRILGQGGQ---------------AVKKSKVIDESKVEEFINEVVILSQINHRNVVKLLGCC-LETEVPLLVYE 351 (608)
Q Consensus 288 t~~f~~~~~lG~G~~---------------avk~~~~~~~~~~~~~~~Ei~il~~l~H~niv~l~~~~-~~~~~~~lV~E 351 (608)
.++|++.+.||+|++ |||..... ...+.+.+|+.+++.++|++++..+..+ .+....++|||
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e 85 (296)
T 3uzp_A 8 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVK--TKHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVME 85 (296)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESC--SSCCHHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEEE
T ss_pred ccEEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCC--cchhHHHHHHHHHHHhhcCCCCCccccccCCCCceEEEEE
Confidence 568999999999974 66665432 2345789999999999988877666655 56667899999
Q ss_pred ecCCCccchhccccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEE---cCCCcEEEeeccCccccc
Q 044312 352 FIPNGTLFQYIHDQNEDFPITWEIRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILL---DDKYRAKVSDFGASRSMA 428 (608)
Q Consensus 352 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl---~~~~~~kl~DFGls~~~~ 428 (608)
|+ +++|.+++..... .+++..++.++.||+.||+|||+++ |+||||||+|||+ ++++.+||+|||+++...
T Consensus 86 ~~-~~~L~~~~~~~~~--~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~~ 159 (296)
T 3uzp_A 86 LL-GPSLEDLFNFCSR--KFSLKTVLLLADQMISRIEYIHSKN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYR 159 (296)
T ss_dssp CC-CCBHHHHHHHTTT--CCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECCGGGTTCEEECCCTTCEECB
T ss_pred ec-CCCHHHHHHhhcc--CCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHeEEecCCCCCeEEEeeCCCccccc
Confidence 99 8999999975433 5999999999999999999999999 9999999999999 478899999999998765
Q ss_pred cCCcc------eeeeeeccCCCCChhhhccCCCCCccchHhHHHHHHHHHhCCCCCCccchhhcccHHHHHHHHhhhhhh
Q 044312 429 VDQTH------MTTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLTELLTGEKPIRFTILEEDKSLAAYFLCAMKEERL 502 (608)
Q Consensus 429 ~~~~~------~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~ 502 (608)
..... ......||+.|+|||.+.+..++.++||||||++++||++|+.||.................. ..
T Consensus 160 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~----~~ 235 (296)
T 3uzp_A 160 DARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEK----KM 235 (296)
T ss_dssp CTTTCCBCCCCCSCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHH----HH
T ss_pred ccccccccccccccccccccccCChhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcCchhhhhhhhhhccc----cc
Confidence 43321 124457999999999999999999999999999999999999999754332222221111110 00
Q ss_pred HHHhhhhhhccCChhHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhhHHhcCCCch
Q 044312 503 FEILDARVMKQGGKDEIITVAKLAKRCLNLNGKKRPTMREVASELAGIKAWNGASNV 559 (608)
Q Consensus 503 ~~~~d~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~evl~~L~~i~~~~~~~~~ 559 (608)
... ........+.++.+|+.+||+.||++|||+.||++.|+.+....+....
T Consensus 236 ~~~-----~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~~~~~~~ 287 (296)
T 3uzp_A 236 STP-----IEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFSYD 287 (296)
T ss_dssp HSC-----HHHHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHHHTTCCSS
T ss_pred CCc-----hHHHHhhCCHHHHHHHHHHHhcCcCcCCCHHHHHHHHHHHHHhcCCccc
Confidence 000 0001123456799999999999999999999999999999877655443
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-38 Score=320.06 Aligned_cols=241 Identities=27% Similarity=0.474 Sum_probs=189.3
Q ss_pred hcCccccceeccCce-------------EEEEEeecChhhHHHHHHHHHHHhhcCCCCccceecccccC-ccceEEEeec
Q 044312 288 TDNFDLNRILGQGGQ-------------AVKKSKVIDESKVEEFINEVVILSQINHRNVVKLLGCCLET-EVPLLVYEFI 353 (608)
Q Consensus 288 t~~f~~~~~lG~G~~-------------avk~~~~~~~~~~~~~~~Ei~il~~l~H~niv~l~~~~~~~-~~~~lV~E~~ 353 (608)
.++|++.+.||+|++ |||..+. ....+.|.+|+.++++++||||+++++++.+. +..++||||+
T Consensus 20 ~~~y~~~~~lg~G~~g~V~~~~~~~~~vavK~~~~--~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~ 97 (278)
T 1byg_A 20 MKELKLLQTIGKGEFGDVMLGDYRGNKVAVKCIKN--DATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYM 97 (278)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTEEEEEEECCC--CC--HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECCC
T ss_pred hhhceEEeEEecCCCceEEEEEEcCCEEEEEEecc--hhHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCCceEEEEecC
Confidence 467899999999984 5565543 33567899999999999999999999987554 4789999999
Q ss_pred CCCccchhccccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEEcCCCcEEEeeccCccccccCCcc
Q 044312 354 PNGTLFQYIHDQNEDFPITWEIRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTH 433 (608)
Q Consensus 354 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGls~~~~~~~~~ 433 (608)
++++|.+++..... ..+++..++.++.|++.||+|||+.+ ++||||||+|||++.++.+||+|||+++.....
T Consensus 98 ~~~~L~~~l~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~--- 170 (278)
T 1byg_A 98 AKGSLVDYLRSRGR-SVLGGDCLLKFSLDVCEAMEYLEGNN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASST--- 170 (278)
T ss_dssp TTEEHHHHHHHHHH-HHCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTSCEEECCCCC----------
T ss_pred CCCCHHHHHHhccc-ccCCHHHHHHHHHHHHHHHHHHHhCC---ccccCCCcceEEEeCCCcEEEeecccccccccc---
Confidence 99999999976432 13899999999999999999999999 999999999999999999999999998765432
Q ss_pred eeeeeeccCCCCChhhhccCCCCCccchHhHHHHHHHHHh-CCCCCCccchhhcccHHHHHHHHhhhhhhHHHhhhhhhc
Q 044312 434 MTTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLTELLT-GEKPIRFTILEEDKSLAAYFLCAMKEERLFEILDARVMK 512 (608)
Q Consensus 434 ~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~ellt-g~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~ 512 (608)
.....+++.|+|||.+.+..++.++||||||++++||++ |+.||......+ +...+......
T Consensus 171 -~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~----------------~~~~~~~~~~~ 233 (278)
T 1byg_A 171 -QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKD----------------VVPRVEKGYKM 233 (278)
T ss_dssp ------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGG----------------HHHHHTTTCCC
T ss_pred -ccCCCccccccCHHHhCCCCCCchhcHHHHHHHHHHHHhCCCCCCCCCCHHH----------------HHHHHhcCCCC
Confidence 123357889999999999999999999999999999998 999986432211 11111111222
Q ss_pred cCChhHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhhHHhc
Q 044312 513 QGGKDEIITVAKLAKRCLNLNGKKRPTMREVASELAGIKAWN 554 (608)
Q Consensus 513 ~~~~~~~~~l~~Li~~cl~~dp~~RPs~~evl~~L~~i~~~~ 554 (608)
..+...+..+.+++.+||+.||++|||+.|+++.|+.++...
T Consensus 234 ~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~i~~~~ 275 (278)
T 1byg_A 234 DAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIKTHE 275 (278)
T ss_dssp CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHC
T ss_pred CCcccCCHHHHHHHHHHhcCChhhCCCHHHHHHHHHHHHhhh
Confidence 334456778999999999999999999999999999988753
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-37 Score=320.07 Aligned_cols=249 Identities=25% Similarity=0.420 Sum_probs=188.6
Q ss_pred HHhcCccccceeccCce------------------EEEEEeec--ChhhHHHHHHHHHHHhhcCCCCccceecccccCc-
Q 044312 286 KATDNFDLNRILGQGGQ------------------AVKKSKVI--DESKVEEFINEVVILSQINHRNVVKLLGCCLETE- 344 (608)
Q Consensus 286 ~~t~~f~~~~~lG~G~~------------------avk~~~~~--~~~~~~~~~~Ei~il~~l~H~niv~l~~~~~~~~- 344 (608)
...++|.+.+.||+|++ |||..+.. .....+.+.+|+.++++++||||+++++++.+..
T Consensus 31 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~ 110 (313)
T 3brb_A 31 IDRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVCIEMSS 110 (313)
T ss_dssp CCGGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEC---
T ss_pred cCHHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccccchhHHHHHHHHHHHHhcCCCCCeeeeeEEEeeccc
Confidence 34567889999999974 45554432 3445678999999999999999999999997655
Q ss_pred ----cceEEEeecCCCccchhcccc---CCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEEcCCCcEE
Q 044312 345 ----VPLLVYEFIPNGTLFQYIHDQ---NEDFPITWEIRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAK 417 (608)
Q Consensus 345 ----~~~lV~E~~~~gsL~~~l~~~---~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~k 417 (608)
..++||||+++++|.+++... .....+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+|
T Consensus 111 ~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dikp~NIli~~~~~~k 187 (313)
T 3brb_A 111 QGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNRN---FLHRDLAARNCMLRDDMTVC 187 (313)
T ss_dssp ----CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTTT---CCCCCCSGGGEEECTTSCEE
T ss_pred cCCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCcceEEEcCCCcEE
Confidence 349999999999999998532 12235999999999999999999999999 99999999999999999999
Q ss_pred EeeccCccccccCCc-ceeeeeeccCCCCChhhhccCCCCCccchHhHHHHHHHHHh-CCCCCCccchhhcccHHHHHHH
Q 044312 418 VSDFGASRSMAVDQT-HMTTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLTELLT-GEKPIRFTILEEDKSLAAYFLC 495 (608)
Q Consensus 418 l~DFGls~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~ellt-g~~p~~~~~~~~~~~l~~~~~~ 495 (608)
|+|||+++....... .......+++.|+|||.+.+..++.++||||||++++||++ |..||.......
T Consensus 188 l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~---------- 257 (313)
T 3brb_A 188 VADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNHE---------- 257 (313)
T ss_dssp ECSCSCC----------------CCGGGSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGG----------
T ss_pred EeecCcceecccccccCcccccCCCccccCchhhcCCCccchhhhHHHHHHHHHHHhcCCCCCccCCHHH----------
Confidence 999999987653322 12233457889999999999999999999999999999999 888986432211
Q ss_pred HhhhhhhHHHhhhhhhccCChhHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhhHHh
Q 044312 496 AMKEERLFEILDARVMKQGGKDEIITVAKLAKRCLNLNGKKRPTMREVASELAGIKAW 553 (608)
Q Consensus 496 ~~~~~~~~~~~d~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~evl~~L~~i~~~ 553 (608)
+...+........+...+..+.+|+.+||+.||++|||+.|++++|+.+...
T Consensus 258 ------~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~l~~~ 309 (313)
T 3brb_A 258 ------MYDYLLHGHRLKQPEDCLDELYEIMYSCWRTDPLDRPTFSVLRLQLEKLLES 309 (313)
T ss_dssp ------HHHHHHTTCCCCCBTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred ------HHHHHHcCCCCCCCccccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHh
Confidence 1111111111223345567899999999999999999999999999988764
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-37 Score=317.61 Aligned_cols=243 Identities=27% Similarity=0.395 Sum_probs=193.5
Q ss_pred hcCccccc-eeccCce-----------------EEEEEeec--ChhhHHHHHHHHHHHhhcCCCCccceecccccCccce
Q 044312 288 TDNFDLNR-ILGQGGQ-----------------AVKKSKVI--DESKVEEFINEVVILSQINHRNVVKLLGCCLETEVPL 347 (608)
Q Consensus 288 t~~f~~~~-~lG~G~~-----------------avk~~~~~--~~~~~~~~~~Ei~il~~l~H~niv~l~~~~~~~~~~~ 347 (608)
.++|.+.+ .||+|++ |||..+.. +....+.+.+|+.++++++||||+++++++ +.+..+
T Consensus 15 ~~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-~~~~~~ 93 (291)
T 1xbb_A 15 RKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGIC-EAESWM 93 (291)
T ss_dssp GGGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEE-ESSSEE
T ss_pred chhhhhccCccccccCeeeEeeeecCCCceeeEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEE-CCCCcE
Confidence 35677777 8999975 45554432 233467899999999999999999999999 566789
Q ss_pred EEEeecCCCccchhccccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEEcCCCcEEEeeccCcccc
Q 044312 348 LVYEFIPNGTLFQYIHDQNEDFPITWEIRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSM 427 (608)
Q Consensus 348 lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGls~~~ 427 (608)
+||||+++++|.+++.... .+++..++.++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++..
T Consensus 94 lv~e~~~~~~L~~~l~~~~---~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~ 167 (291)
T 1xbb_A 94 LVMEMAELGPLNKYLQQNR---HVKDKNIIELVHQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLSKAL 167 (291)
T ss_dssp EEEECCTTEEHHHHHHHCT---TCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCCTTCEEC
T ss_pred EEEEeCCCCCHHHHHHhCc---CCCHHHHHHHHHHHHHHHHHHHhCC---eEcCCCCcceEEEeCCCcEEEccCCcceee
Confidence 9999999999999998643 4899999999999999999999999 999999999999999999999999999876
Q ss_pred ccCCcce--eeeeeccCCCCChhhhccCCCCCccchHhHHHHHHHHHh-CCCCCCccchhhcccHHHHHHHHhhhhhhHH
Q 044312 428 AVDQTHM--TTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLTELLT-GEKPIRFTILEEDKSLAAYFLCAMKEERLFE 504 (608)
Q Consensus 428 ~~~~~~~--~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~ellt-g~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~ 504 (608)
....... .....+++.|+|||.+.+..++.++||||||++++||++ |+.||....... +.+
T Consensus 168 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~----------------~~~ 231 (291)
T 1xbb_A 168 RADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSE----------------VTA 231 (291)
T ss_dssp CTTCSEEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHH----------------HHH
T ss_pred ccCCCcccccccCCCCceeeChHHhccCCCChhhhHHHHHHHHHHHHhcCCCCCCCCCHHH----------------HHH
Confidence 5443322 222346788999999998889999999999999999999 999987432211 111
Q ss_pred HhhhhhhccCChhHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhhHHh
Q 044312 505 ILDARVMKQGGKDEIITVAKLAKRCLNLNGKKRPTMREVASELAGIKAW 553 (608)
Q Consensus 505 ~~d~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~evl~~L~~i~~~ 553 (608)
.+........+...+..+.+++.+||+.||++||++.||++.|+.+-..
T Consensus 232 ~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~~ 280 (291)
T 1xbb_A 232 MLEKGERMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYD 280 (291)
T ss_dssp HHHTTCCCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHH
T ss_pred HHHcCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHH
Confidence 1111112233445677899999999999999999999999999887553
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-37 Score=325.27 Aligned_cols=246 Identities=25% Similarity=0.324 Sum_probs=189.1
Q ss_pred HHHHHhcCccccceeccCce---------------EEEEEeec-----ChhhHHHHHHHHHHHhhcCCCCccceeccccc
Q 044312 283 ELEKATDNFDLNRILGQGGQ---------------AVKKSKVI-----DESKVEEFINEVVILSQINHRNVVKLLGCCLE 342 (608)
Q Consensus 283 ~l~~~t~~f~~~~~lG~G~~---------------avk~~~~~-----~~~~~~~~~~Ei~il~~l~H~niv~l~~~~~~ 342 (608)
.+....++|++.+.||+|++ |+|..... +....+.+.+|+.++++++||||+++++++.+
T Consensus 20 ~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~ 99 (345)
T 3hko_A 20 SLLELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYED 99 (345)
T ss_dssp CHHHHHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEEEC
T ss_pred hhhhhhhheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhhcc
Confidence 34566778999999999984 56655432 34556789999999999999999999999999
Q ss_pred CccceEEEeecCCCccchhccccCC-------------------------------------CCCCCHHHHHHHHHHHHH
Q 044312 343 TEVPLLVYEFIPNGTLFQYIHDQNE-------------------------------------DFPITWEIRLRIAIEVSG 385 (608)
Q Consensus 343 ~~~~~lV~E~~~~gsL~~~l~~~~~-------------------------------------~~~l~~~~~~~i~~~ia~ 385 (608)
.+..++||||+++|+|.+++..... ...+++..+..|+.||+.
T Consensus 100 ~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~ 179 (345)
T 3hko_A 100 EQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFS 179 (345)
T ss_dssp SSEEEEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHH
T ss_pred CCeEEEEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHH
Confidence 9999999999999999999863110 112467788899999999
Q ss_pred HHHHHhhcCCCCeeccCCCCCcEEEcCCC--cEEEeeccCccccccCCc---ceeeeeeccCCCCChhhhcc--CCCCCc
Q 044312 386 ALSYLHSAASIPIYHRDIKSTNILLDDKY--RAKVSDFGASRSMAVDQT---HMTTQVHGTFGYLDPEYFRS--SQFTDK 458 (608)
Q Consensus 386 aL~yLH~~~~~~iiHrDlk~~NILl~~~~--~~kl~DFGls~~~~~~~~---~~~~~~~gt~~y~aPE~~~~--~~~t~k 458 (608)
||+|||+.+ |+||||||+|||++.++ .+||+|||+++.+..... .......||+.|+|||.+.. ..++.+
T Consensus 180 ~l~~LH~~~---ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~ 256 (345)
T 3hko_A 180 ALHYLHNQG---ICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPK 256 (345)
T ss_dssp HHHHHHHTT---EECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSSSCCCTH
T ss_pred HHHHHHHCC---ccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhccCCCCCCcH
Confidence 999999999 99999999999998766 899999999987643221 12345679999999999975 678999
Q ss_pred cchHhHHHHHHHHHhCCCCCCccchhhcccHHHHHHHHhhhhhhHHHhhhhhh--ccCChhHHHHHHHHHHHHhccCCCC
Q 044312 459 SDVYSFGVVLTELLTGEKPIRFTILEEDKSLAAYFLCAMKEERLFEILDARVM--KQGGKDEIITVAKLAKRCLNLNGKK 536 (608)
Q Consensus 459 sDV~S~Gvvl~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~--~~~~~~~~~~l~~Li~~cl~~dp~~ 536 (608)
+||||||++++||++|+.||......+ .. ..++..... .......+..+.+|+.+||+.||++
T Consensus 257 ~DiwslG~il~el~~g~~pf~~~~~~~------~~---------~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~ 321 (345)
T 3hko_A 257 CDAWSAGVLLHLLLMGAVPFPGVNDAD------TI---------SQVLNKKLCFENPNYNVLSPLARDLLSNLLNRNVDE 321 (345)
T ss_dssp HHHHHHHHHHHHHHHSSCSSCCSSHHH------HH---------HHHHHCCCCTTSGGGGGSCHHHHHHHHHHSCSCTTT
T ss_pred HHHHHHHHHHHHHHHCCCCCCCCChHH------HH---------HHHHhcccccCCcccccCCHHHHHHHHHHcCCChhH
Confidence 999999999999999999996432211 11 111111110 0111234568999999999999999
Q ss_pred CCCHHHHHHH
Q 044312 537 RPTMREVASE 546 (608)
Q Consensus 537 RPs~~evl~~ 546 (608)
||++.|++++
T Consensus 322 Rps~~~~l~h 331 (345)
T 3hko_A 322 RFDAMRALQH 331 (345)
T ss_dssp SCCHHHHHHS
T ss_pred CCCHHHHhcC
Confidence 9999999874
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-37 Score=331.36 Aligned_cols=236 Identities=26% Similarity=0.405 Sum_probs=187.1
Q ss_pred hcCccccceeccCce---------------EEEEEeec---ChhhHHHHHHHHHHHhhc-CCCCccceecccccCccceE
Q 044312 288 TDNFDLNRILGQGGQ---------------AVKKSKVI---DESKVEEFINEVVILSQI-NHRNVVKLLGCCLETEVPLL 348 (608)
Q Consensus 288 t~~f~~~~~lG~G~~---------------avk~~~~~---~~~~~~~~~~Ei~il~~l-~H~niv~l~~~~~~~~~~~l 348 (608)
.++|++.++||+|+| |+|+++.. .....+.+.+|..+|.++ +||||+++++++.+.+..+|
T Consensus 51 ~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~l 130 (396)
T 4dc2_A 51 LQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFF 130 (396)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEE
T ss_pred hhHcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEECCEEEE
Confidence 457999999999985 67766532 233445688999999887 89999999999999999999
Q ss_pred EEeecCCCccchhccccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEEcCCCcEEEeeccCccccc
Q 044312 349 VYEFIPNGTLFQYIHDQNEDFPITWEIRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMA 428 (608)
Q Consensus 349 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGls~~~~ 428 (608)
||||+++|+|.+++.... .+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++...
T Consensus 131 V~E~~~gg~L~~~l~~~~---~l~~~~~~~~~~qi~~aL~~LH~~g---ivHrDLKp~NILl~~~g~ikL~DFGla~~~~ 204 (396)
T 4dc2_A 131 VIEYVNGGDLMFHMQRQR---KLPEEHARFYSAEISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGL 204 (396)
T ss_dssp EEECCTTCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCCC
T ss_pred EEEcCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---EEeccCCHHHEEECCCCCEEEeecceeeecc
Confidence 999999999999998654 4999999999999999999999999 9999999999999999999999999998643
Q ss_pred cCCcceeeeeeccCCCCChhhhccCCCCCccchHhHHHHHHHHHhCCCCCCccchhhcc--cHHHHHHHHhhhhhhHHHh
Q 044312 429 VDQTHMTTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLTELLTGEKPIRFTILEEDK--SLAAYFLCAMKEERLFEIL 506 (608)
Q Consensus 429 ~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~elltg~~p~~~~~~~~~~--~l~~~~~~~~~~~~~~~~~ 506 (608)
.. ........||+.|+|||++.+..++.++||||||++++||++|+.||......... ....... ..+.
T Consensus 205 ~~-~~~~~~~~gt~~Y~aPE~l~~~~~~~~~DiwslGvllyell~G~~Pf~~~~~~~~~~~~~~~~~~--------~~i~ 275 (396)
T 4dc2_A 205 RP-GDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLF--------QVIL 275 (396)
T ss_dssp CT-TCCBCCCCBCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSTTTTC------CCHHHHH--------HHHH
T ss_pred cC-CCccccccCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCcccccccccchhhHHHHH--------HHHh
Confidence 22 22344567999999999999999999999999999999999999999643221110 0001111 1111
Q ss_pred hhhhhccCChhHHHHHHHHHHHHhccCCCCCCCH
Q 044312 507 DARVMKQGGKDEIITVAKLAKRCLNLNGKKRPTM 540 (608)
Q Consensus 507 d~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPs~ 540 (608)
.. ....+...+.++.+|+.+||+.||++||++
T Consensus 276 ~~--~~~~p~~~s~~~~~li~~lL~~dP~~R~~~ 307 (396)
T 4dc2_A 276 EK--QIRIPRSLSVKAASVLKSFLNKDPKERLGC 307 (396)
T ss_dssp HC--CCCCCTTSCHHHHHHHHHHTCSCTTTSTTC
T ss_pred cc--ccCCCCcCCHHHHHHHHHHhcCCHhHcCCC
Confidence 11 123344566789999999999999999996
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-37 Score=324.91 Aligned_cols=252 Identities=17% Similarity=0.235 Sum_probs=187.9
Q ss_pred hcCccccceeccCce------------------EEEEEeecChh-----------hHHHHHHHHHHHhhcCCCCccceec
Q 044312 288 TDNFDLNRILGQGGQ------------------AVKKSKVIDES-----------KVEEFINEVVILSQINHRNVVKLLG 338 (608)
Q Consensus 288 t~~f~~~~~lG~G~~------------------avk~~~~~~~~-----------~~~~~~~Ei~il~~l~H~niv~l~~ 338 (608)
.++|.+.+.||+|++ |||+....... ....+.+|+.+++.++||||+++++
T Consensus 36 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~~~ 115 (345)
T 2v62_A 36 GNQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLFYG 115 (345)
T ss_dssp SCEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCEEE
T ss_pred CceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCcceeec
Confidence 357889999999974 55555432211 1234778889999999999999999
Q ss_pred cccc----CccceEEEeecCCCccchhccccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEEcCCC
Q 044312 339 CCLE----TEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEIRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKY 414 (608)
Q Consensus 339 ~~~~----~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~ 414 (608)
++.. ....++||||+ +++|.+++.... .+++..++.|+.||+.||+|||+.+ |+||||||+|||++.++
T Consensus 116 ~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~---~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~ 188 (345)
T 2v62_A 116 SGLTEFKGRSYRFMVMERL-GIDLQKISGQNG---TFKKSTVLQLGIRMLDVLEYIHENE---YVHGDIKAANLLLGYKN 188 (345)
T ss_dssp EEEEESSSCEEEEEEEECE-EEEHHHHCBGGG---BCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEESSS
T ss_pred ccccccCCCcEEEEEEecc-CCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCcCHHHEEEccCC
Confidence 9987 67889999999 999999998654 5999999999999999999999999 99999999999999877
Q ss_pred --cEEEeeccCccccccCCcc------eeeeeeccCCCCChhhhccCCCCCccchHhHHHHHHHHHhCCCCCCccchhhc
Q 044312 415 --RAKVSDFGASRSMAVDQTH------MTTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLTELLTGEKPIRFTILEED 486 (608)
Q Consensus 415 --~~kl~DFGls~~~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~elltg~~p~~~~~~~~~ 486 (608)
.+||+|||+++.+...... ......||+.|+|||++.+..++.++||||||+++|||++|+.||........
T Consensus 189 ~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~ 268 (345)
T 2v62_A 189 PDQVYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCMLRWLCGKLPWEQNLKDPV 268 (345)
T ss_dssp TTSEEECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCTTGGGTTCHH
T ss_pred CCcEEEEeCCCceecccccccccchhccccccCCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCccccccccH
Confidence 9999999999876533211 11345689999999999999999999999999999999999999963211111
Q ss_pred ccHHHHHHHHhhhhhhHHHhhhhhhccCChhHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhhHH
Q 044312 487 KSLAAYFLCAMKEERLFEILDARVMKQGGKDEIITVAKLAKRCLNLNGKKRPTMREVASELAGIKA 552 (608)
Q Consensus 487 ~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~evl~~L~~i~~ 552 (608)
........... .+...+.. .......+.++.+|+.+||+.||++||++.+|++.|+.+..
T Consensus 269 --~~~~~~~~~~~-~~~~~~~~---~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~ 328 (345)
T 2v62_A 269 --AVQTAKTNLLD-ELPQSVLK---WAPSGSSCCEIAQFLVCAHSLAYDEKPNYQALKKILNPHGI 328 (345)
T ss_dssp --HHHHHHHHHHH-TTTHHHHH---HSCTTSCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHCTTCC
T ss_pred --HHHHHHHhhcc-cccHHHHh---hccccccHHHHHHHHHHHhhcCcccCCCHHHHHHHHhccCC
Confidence 00001101100 01111110 11112455689999999999999999999999999976543
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-38 Score=336.37 Aligned_cols=247 Identities=23% Similarity=0.316 Sum_probs=197.0
Q ss_pred CCHHHHHHHhcCccccceeccCce---------------EEEEEeec---ChhhHHHHHHHHHHHhhcCCCCccceeccc
Q 044312 279 FTSKELEKATDNFDLNRILGQGGQ---------------AVKKSKVI---DESKVEEFINEVVILSQINHRNVVKLLGCC 340 (608)
Q Consensus 279 ~~~~~l~~~t~~f~~~~~lG~G~~---------------avk~~~~~---~~~~~~~~~~Ei~il~~l~H~niv~l~~~~ 340 (608)
+..+++....++|++.+.||+|+| |||+++.. .....+.+.+|..++.+++||||+++++++
T Consensus 51 ~~~~~~~~~~~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~ 130 (412)
T 2vd5_A 51 VRLKEVRLQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAF 130 (412)
T ss_dssp HHHHHHSCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEEE
T ss_pred hhhhhccCChhhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEEE
Confidence 345566667889999999999984 67766531 223345688999999999999999999999
Q ss_pred ccCccceEEEeecCCCccchhccccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEEcCCCcEEEee
Q 044312 341 LETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEIRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSD 420 (608)
Q Consensus 341 ~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~D 420 (608)
.+.+..+|||||+++|+|.+++.+... .+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|
T Consensus 131 ~~~~~~~lVmE~~~gg~L~~~l~~~~~--~l~~~~~~~~~~qi~~aL~~LH~~g---iiHrDLKp~NILld~~g~vkL~D 205 (412)
T 2vd5_A 131 QDENYLYLVMEYYVGGDLLTLLSKFGE--RIPAEMARFYLAEIVMAIDSVHRLG---YVHRDIKPDNILLDRCGHIRLAD 205 (412)
T ss_dssp ECSSEEEEEECCCCSCBHHHHHHHHSS--CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECC
T ss_pred eeCCEEEEEEcCCCCCcHHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHHCC---eeecccCHHHeeecCCCCEEEee
Confidence 999999999999999999999986543 5899999999999999999999999 99999999999999999999999
Q ss_pred ccCccccccCCcceeeeeeccCCCCChhhhc-------cCCCCCccchHhHHHHHHHHHhCCCCCCccchhhcccHHHHH
Q 044312 421 FGASRSMAVDQTHMTTQVHGTFGYLDPEYFR-------SSQFTDKSDVYSFGVVLTELLTGEKPIRFTILEEDKSLAAYF 493 (608)
Q Consensus 421 FGls~~~~~~~~~~~~~~~gt~~y~aPE~~~-------~~~~t~ksDV~S~Gvvl~elltg~~p~~~~~~~~~~~l~~~~ 493 (608)
||+++..............||+.|+|||++. ...++.++|||||||++|||++|+.||......+ .+
T Consensus 206 FGla~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~------~~ 279 (412)
T 2vd5_A 206 FGSCLKLRADGTVRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAE------TY 279 (412)
T ss_dssp CTTCEECCTTSCEECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHH------HH
T ss_pred chhheeccCCCccccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCCCHHH------HH
Confidence 9999877654443344567999999999987 4578999999999999999999999997432211 11
Q ss_pred HHHhhhhhhHHHhhhhhhccC---ChhHHHHHHHHHHHHhccCCCCC---CCHHHHHHH
Q 044312 494 LCAMKEERLFEILDARVMKQG---GKDEIITVAKLAKRCLNLNGKKR---PTMREVASE 546 (608)
Q Consensus 494 ~~~~~~~~~~~~~d~~~~~~~---~~~~~~~l~~Li~~cl~~dp~~R---Ps~~evl~~ 546 (608)
. .++........ ....+.++.+|+.+||. +|++| |+++|++++
T Consensus 280 ~---------~i~~~~~~~~~p~~~~~~s~~~~dli~~lL~-~p~~Rlgr~~~~ei~~H 328 (412)
T 2vd5_A 280 G---------KIVHYKEHLSLPLVDEGVPEEARDFIQRLLC-PPETRLGRGGAGDFRTH 328 (412)
T ss_dssp H---------HHHTHHHHCCCC----CCCHHHHHHHHTTSS-CGGGCTTTTTHHHHHTS
T ss_pred H---------HHHhcccCcCCCccccCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhcC
Confidence 1 11111110111 13456789999999999 99998 588888764
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-37 Score=323.63 Aligned_cols=251 Identities=23% Similarity=0.360 Sum_probs=184.3
Q ss_pred HHhcCccccceeccCce---------------EEEEEeecChhhHHHHHHHHHHHhhcC-CCCccceeccc--------c
Q 044312 286 KATDNFDLNRILGQGGQ---------------AVKKSKVIDESKVEEFINEVVILSQIN-HRNVVKLLGCC--------L 341 (608)
Q Consensus 286 ~~t~~f~~~~~lG~G~~---------------avk~~~~~~~~~~~~~~~Ei~il~~l~-H~niv~l~~~~--------~ 341 (608)
....+|++.++||+|++ |||+.........+.+.+|+.+++++. ||||+++++++ .
T Consensus 25 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~~~ 104 (337)
T 3ll6_A 25 LGELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESDT 104 (337)
T ss_dssp ETTEEEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTTTSTT
T ss_pred ccCceEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCCchHHHHHHHHHHHHHHHhccCCChhhcccccccccccccc
Confidence 34457899999999974 778776666777788999999999995 99999999998 3
Q ss_pred cCccceEEEeecCCCccchhccccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEEcCCCcEEEeec
Q 044312 342 ETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEIRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDF 421 (608)
Q Consensus 342 ~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DF 421 (608)
.....++||||+. |+|.+++.......++++..++.++.||+.||+|||+.+ ++|+||||||+|||++.++.+||+||
T Consensus 105 ~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~-~~ivH~Dikp~NIl~~~~~~~kl~Df 182 (337)
T 3ll6_A 105 GQAEFLLLTELCK-GQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHRQK-PPIIHRDLKVENLLLSNQGTIKLCDF 182 (337)
T ss_dssp SSEEEEEEEECCS-EEHHHHHHHHHTTCSCCHHHHHHHHHHHHHHHHHHHTSS-SCCBCCCCCGGGCEECTTSCEEBCCC
T ss_pred CCceEEEEEEecC-CCHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCC-CCEEEccCCcccEEECCCCCEEEecC
Confidence 4456799999995 799998876434446999999999999999999999976 34999999999999999999999999
Q ss_pred cCccccccCCcce-----------eeeeeccCCCCChhhh---ccCCCCCccchHhHHHHHHHHHhCCCCCCccchhhcc
Q 044312 422 GASRSMAVDQTHM-----------TTQVHGTFGYLDPEYF---RSSQFTDKSDVYSFGVVLTELLTGEKPIRFTILEEDK 487 (608)
Q Consensus 422 Gls~~~~~~~~~~-----------~~~~~gt~~y~aPE~~---~~~~~t~ksDV~S~Gvvl~elltg~~p~~~~~~~~~~ 487 (608)
|+++......... .....||+.|+|||++ ....++.++||||||++++||++|+.||.....
T Consensus 183 g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~---- 258 (337)
T 3ll6_A 183 GSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGAK---- 258 (337)
T ss_dssp TTCBCCSSCC-------------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC---------
T ss_pred ccceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCCCcchhH----
Confidence 9998765432211 1134589999999998 566789999999999999999999999862211
Q ss_pred cHHHHHHHHhhhhhhHHHhhhhhhccCChhHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhhHHhcCCC
Q 044312 488 SLAAYFLCAMKEERLFEILDARVMKQGGKDEIITVAKLAKRCLNLNGKKRPTMREVASELAGIKAWNGAS 557 (608)
Q Consensus 488 ~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~evl~~L~~i~~~~~~~ 557 (608)
.+++............+..+.+|+.+||+.||++|||+.|++++|+.+.......
T Consensus 259 ---------------~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~~~~~~~~~ 313 (337)
T 3ll6_A 259 ---------------LRIVNGKYSIPPHDTQYTVFHSLIRAMLQVNPEERLSIAEVVHQLQEIAAARNVN 313 (337)
T ss_dssp ----------------------CCCCTTCCSSGGGHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHHTTCC
T ss_pred ---------------HHhhcCcccCCcccccchHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhccCCC
Confidence 0111111111222233456889999999999999999999999999998765433
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-37 Score=318.20 Aligned_cols=254 Identities=24% Similarity=0.368 Sum_probs=190.7
Q ss_pred hcCccccceeccCce---------------EEEEEee---cChhhHHHHHHHHHHHhhcCCCCccceecccccCccceEE
Q 044312 288 TDNFDLNRILGQGGQ---------------AVKKSKV---IDESKVEEFINEVVILSQINHRNVVKLLGCCLETEVPLLV 349 (608)
Q Consensus 288 t~~f~~~~~lG~G~~---------------avk~~~~---~~~~~~~~~~~Ei~il~~l~H~niv~l~~~~~~~~~~~lV 349 (608)
.++|++.+.||+|++ |||+.+. .+....+.+.+|+.++++++||||+++++++.+.+..++|
T Consensus 31 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv 110 (310)
T 2wqm_A 31 LANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIV 110 (310)
T ss_dssp GGGEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEE
T ss_pred ccceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCcEEEE
Confidence 357899999999974 6776654 2345567899999999999999999999999999999999
Q ss_pred EeecCCCccchhccccC-CCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEEcCCCcEEEeeccCccccc
Q 044312 350 YEFIPNGTLFQYIHDQN-EDFPITWEIRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMA 428 (608)
Q Consensus 350 ~E~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGls~~~~ 428 (608)
|||+++++|.+++.... ....+++..++.++.||+.||.|||+.+ ++||||||+|||++.++.+||+|||+++...
T Consensus 111 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dl~p~NIl~~~~~~~kl~Dfg~~~~~~ 187 (310)
T 2wqm_A 111 LELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSRR---VMHRDIKPANVFITATGVVKLGDLGLGRFFS 187 (310)
T ss_dssp EECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCC-------
T ss_pred EecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhhCC---eeCCCCcHHHEEEcCCCCEEEEeccceeeec
Confidence 99999999999987521 2235899999999999999999999999 9999999999999999999999999998764
Q ss_pred cCCcceeeeeeccCCCCChhhhccCCCCCccchHhHHHHHHHHHhCCCCCCccchhhcccHHHHHHHHhhhhhhHHHhhh
Q 044312 429 VDQTHMTTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLTELLTGEKPIRFTILEEDKSLAAYFLCAMKEERLFEILDA 508 (608)
Q Consensus 429 ~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 508 (608)
.... ......|++.|+|||.+....++.++||||||++++||++|+.||...... ..... ..+.. .
T Consensus 188 ~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~----~~~~~-~~~~~--------~ 253 (310)
T 2wqm_A 188 SKTT-AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMN----LYSLC-KKIEQ--------C 253 (310)
T ss_dssp ------------CCSSCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTC---CC----HHHHH-HHHHT--------T
T ss_pred CCCc-cccccCCCeeEeChHHhCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchh----HHHHH-HHhhc--------c
Confidence 3322 223456899999999999999999999999999999999999998632111 11110 01111 0
Q ss_pred hhhccCChhHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhhHHhcCCCc
Q 044312 509 RVMKQGGKDEIITVAKLAKRCLNLNGKKRPTMREVASELAGIKAWNGASN 558 (608)
Q Consensus 509 ~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~evl~~L~~i~~~~~~~~ 558 (608)
..........+.++.+|+.+||+.||++|||+.||++.|+.+++......
T Consensus 254 ~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~il~~l~~l~~~~~~~~ 303 (310)
T 2wqm_A 254 DYPPLPSDHYSEELRQLVNMCINPDPEKRPDVTYVYDVAKRMHACTASSL 303 (310)
T ss_dssp CSCCCCTTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHC---
T ss_pred cCCCCcccccCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHHhhhhhh
Confidence 11111123456789999999999999999999999999999998766543
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-37 Score=328.09 Aligned_cols=235 Identities=28% Similarity=0.379 Sum_probs=188.5
Q ss_pred hcCccccceeccCce---------------EEEEEee---cChhhHHHHHHHHHHHhhc-CCCCccceecccccCccceE
Q 044312 288 TDNFDLNRILGQGGQ---------------AVKKSKV---IDESKVEEFINEVVILSQI-NHRNVVKLLGCCLETEVPLL 348 (608)
Q Consensus 288 t~~f~~~~~lG~G~~---------------avk~~~~---~~~~~~~~~~~Ei~il~~l-~H~niv~l~~~~~~~~~~~l 348 (608)
.++|++.+.||+|+| |||+++. ......+.+.+|..+|+.+ +||||+++++++.+.+..+|
T Consensus 22 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~l 101 (353)
T 3txo_A 22 IDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPDRLFF 101 (353)
T ss_dssp -CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEE
T ss_pred hhheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEeCCEEEE
Confidence 468999999999984 6776653 2334567788999999998 79999999999999999999
Q ss_pred EEeecCCCccchhccccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEEcCCCcEEEeeccCccccc
Q 044312 349 VYEFIPNGTLFQYIHDQNEDFPITWEIRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMA 428 (608)
Q Consensus 349 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGls~~~~ 428 (608)
||||+++|+|.+++.... .+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++...
T Consensus 102 v~E~~~gg~L~~~l~~~~---~~~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NILl~~~g~ikL~DFG~a~~~~ 175 (353)
T 3txo_A 102 VMEFVNGGDLMFHIQKSR---RFDEARARFYAAEIISALMFLHDKG---IIYRDLKLDNVLLDHEGHCKLADFGMCKEGI 175 (353)
T ss_dssp EEECCCSCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCSC
T ss_pred EEeCCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---CcccCCCHHHEEECCCCCEEEccccceeecc
Confidence 999999999999997654 4899999999999999999999999 9999999999999999999999999998643
Q ss_pred cCCcceeeeeeccCCCCChhhhccCCCCCccchHhHHHHHHHHHhCCCCCCccchhhcccHHHHHHHHhhhhhhHHHhhh
Q 044312 429 VDQTHMTTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLTELLTGEKPIRFTILEEDKSLAAYFLCAMKEERLFEILDA 508 (608)
Q Consensus 429 ~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 508 (608)
... .......||+.|+|||++.+..++.++||||||+++|||++|+.||......+ .+ ..++..
T Consensus 176 ~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~------~~---------~~i~~~ 239 (353)
T 3txo_A 176 CNG-VTTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAENEDD------LF---------EAILND 239 (353)
T ss_dssp C----------CCGGGCCHHHHHHHHCTTHHHHHHHHHHHHHHHHSSCSSCCSSHHH------HH---------HHHHHC
T ss_pred cCC-ccccccCCCcCeEChhhcCCCCcCCccCCCcchHHHHHHHhCCCCCCCCCHHH------HH---------HHHHcC
Confidence 222 23345679999999999999999999999999999999999999997432211 11 111111
Q ss_pred hhhccCChhHHHHHHHHHHHHhccCCCCCCCH------HHHHHH
Q 044312 509 RVMKQGGKDEIITVAKLAKRCLNLNGKKRPTM------REVASE 546 (608)
Q Consensus 509 ~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPs~------~evl~~ 546 (608)
. ...+...+..+.+|+.+||+.||++||++ .|++++
T Consensus 240 ~--~~~p~~~~~~~~~li~~lL~~dP~~R~~~~~~~~~~~il~h 281 (353)
T 3txo_A 240 E--VVYPTWLHEDATGILKSFMTKNPTMRLGSLTQGGEHAILRH 281 (353)
T ss_dssp C--CCCCTTSCHHHHHHHHHHTCSSGGGSTTSGGGTCTHHHHTS
T ss_pred C--CCCCCCCCHHHHHHHHHHhhhCHHHccCCcccCCHHHHhhC
Confidence 1 12334456789999999999999999998 666653
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-37 Score=329.04 Aligned_cols=239 Identities=21% Similarity=0.266 Sum_probs=194.0
Q ss_pred hcCccccceeccCce---------------EEEEEeecChhhHHHHHHHHHHHhhcCCCCccceecccccCccceEEEee
Q 044312 288 TDNFDLNRILGQGGQ---------------AVKKSKVIDESKVEEFINEVVILSQINHRNVVKLLGCCLETEVPLLVYEF 352 (608)
Q Consensus 288 t~~f~~~~~lG~G~~---------------avk~~~~~~~~~~~~~~~Ei~il~~l~H~niv~l~~~~~~~~~~~lV~E~ 352 (608)
.++|++.+.||+|++ |+|............+.+|+.+|++++||||+++++++.+....++||||
T Consensus 50 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~E~ 129 (387)
T 1kob_A 50 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEF 129 (387)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEEC
T ss_pred ccceEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccchhhHHHHHHHHHHHHhCCCcCCCeEEEEEEeCCEEEEEEEc
Confidence 467999999999984 66666555555667899999999999999999999999999999999999
Q ss_pred cCCCccchhccccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEEcC--CCcEEEeeccCccccccC
Q 044312 353 IPNGTLFQYIHDQNEDFPITWEIRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDD--KYRAKVSDFGASRSMAVD 430 (608)
Q Consensus 353 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~--~~~~kl~DFGls~~~~~~ 430 (608)
+++|+|.+++..... .+++..++.++.||+.||+|||+.+ |+||||||+|||++. ++.+||+|||+++.....
T Consensus 130 ~~gg~L~~~l~~~~~--~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~~~~~vkL~DFG~a~~~~~~ 204 (387)
T 1kob_A 130 LSGGELFDRIAAEDY--KMSEAEVINYMRQACEGLKHMHEHS---IVHLDIKPENIMCETKKASSVKIIDFGLATKLNPD 204 (387)
T ss_dssp CCCCBHHHHTTCTTC--CBCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSTTCCCEEECCCTTCEECCTT
T ss_pred CCCCcHHHHHHhhcC--CCCHHHHHHHHHHHHHHHHHHHhCC---eeecccchHHeEEecCCCCceEEEecccceecCCC
Confidence 999999999976432 5899999999999999999999999 999999999999974 467999999999876543
Q ss_pred CcceeeeeeccCCCCChhhhccCCCCCccchHhHHHHHHHHHhCCCCCCccchhhcccHHHHHHHHhhhhhhHHHhhhhh
Q 044312 431 QTHMTTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLTELLTGEKPIRFTILEEDKSLAAYFLCAMKEERLFEILDARV 510 (608)
Q Consensus 431 ~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~ 510 (608)
. ......||+.|+|||++.+..++.++||||||++++||++|+.||......+ .. ..+..... ..
T Consensus 205 ~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~------~~-~~i~~~~~------~~ 269 (387)
T 1kob_A 205 E--IVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLE------TL-QNVKRCDW------EF 269 (387)
T ss_dssp S--CEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHH------HH-HHHHHCCC------CC
T ss_pred c--ceeeeccCCCccCchhccCCCCCCcccEeeHhHHHHHHHhCCCCCCCCCHHH------HH-HHHHhCCC------CC
Confidence 3 2344579999999999999999999999999999999999999997432111 00 01110000 00
Q ss_pred hccCChhHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 044312 511 MKQGGKDEIITVAKLAKRCLNLNGKKRPTMREVASE 546 (608)
Q Consensus 511 ~~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~evl~~ 546 (608)
........+.++.+|+.+||+.||++|||+.|++++
T Consensus 270 ~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~h 305 (387)
T 1kob_A 270 DEDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEH 305 (387)
T ss_dssp CSSTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred CccccccCCHHHHHHHHHHcCCChhHCcCHHHHhhC
Confidence 111223456789999999999999999999999875
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-37 Score=325.21 Aligned_cols=239 Identities=23% Similarity=0.362 Sum_probs=188.2
Q ss_pred hcCccccceeccCce--------------EEEEEeec--ChhhHHHHHHHHHHHhhcCC--CCccceecccccCccceEE
Q 044312 288 TDNFDLNRILGQGGQ--------------AVKKSKVI--DESKVEEFINEVVILSQINH--RNVVKLLGCCLETEVPLLV 349 (608)
Q Consensus 288 t~~f~~~~~lG~G~~--------------avk~~~~~--~~~~~~~~~~Ei~il~~l~H--~niv~l~~~~~~~~~~~lV 349 (608)
.++|++.+.||+|+| |||+.... +....+.+.+|+.+|++++| +||+++++++.+....+||
T Consensus 8 ~~~y~i~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~lv 87 (343)
T 3dbq_A 8 GRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMV 87 (343)
T ss_dssp SCEEEEEEEESCCSSEEEEEEECTTSCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred cCEEEEEEEEecCCCeEEEEEEeCCCCEEEEEEeeccccchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEeeCCEEEEE
Confidence 456899999999984 77776543 34456789999999999976 9999999999999999999
Q ss_pred EeecCCCccchhccccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEEcCCCcEEEeeccCcccccc
Q 044312 350 YEFIPNGTLFQYIHDQNEDFPITWEIRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAV 429 (608)
Q Consensus 350 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGls~~~~~ 429 (608)
||+ .+++|.+++.... .+++..+..++.||+.||+|||+.+ |+||||||+|||++ ++.+||+|||+++....
T Consensus 88 ~e~-~~~~L~~~l~~~~---~~~~~~~~~i~~qi~~al~~lH~~~---iiHrDikp~NIll~-~~~~kl~DFG~a~~~~~ 159 (343)
T 3dbq_A 88 MEC-GNIDLNSWLKKKK---SIDPWERKSYWKNMLEAVHTIHQHG---IVHSDLKPANFLIV-DGMLKLIDFGIANQMQP 159 (343)
T ss_dssp ECC-CSEEHHHHHHHSC---CCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEE-TTEEEECCCSSSCCC--
T ss_pred EeC-CCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCcceEEEE-CCcEEEeecccccccCc
Confidence 995 5889999998643 5899999999999999999999999 99999999999997 56899999999987654
Q ss_pred CCcc-eeeeeeccCCCCChhhhcc-----------CCCCCccchHhHHHHHHHHHhCCCCCCccchhhcccHHHHHHHHh
Q 044312 430 DQTH-MTTQVHGTFGYLDPEYFRS-----------SQFTDKSDVYSFGVVLTELLTGEKPIRFTILEEDKSLAAYFLCAM 497 (608)
Q Consensus 430 ~~~~-~~~~~~gt~~y~aPE~~~~-----------~~~t~ksDV~S~Gvvl~elltg~~p~~~~~~~~~~~l~~~~~~~~ 497 (608)
.... ......||+.|+|||++.. ..++.++||||||++++||++|+.||...... .
T Consensus 160 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~-----~------- 227 (343)
T 3dbq_A 160 DTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQ-----I------- 227 (343)
T ss_dssp ----------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCCSH-----H-------
T ss_pred ccccccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhhhH-----H-------
Confidence 3322 2345579999999999865 67899999999999999999999998632111 0
Q ss_pred hhhhhHHHhhhhhhccCChhHHHHHHHHHHHHhccCCCCCCCHHHHHHHHH
Q 044312 498 KEERLFEILDARVMKQGGKDEIITVAKLAKRCLNLNGKKRPTMREVASELA 548 (608)
Q Consensus 498 ~~~~~~~~~d~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~evl~~L~ 548 (608)
..+..++++......+...+.++.+|+.+||+.||++|||+.|++++..
T Consensus 228 --~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~hp~ 276 (343)
T 3dbq_A 228 --SKLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPY 276 (343)
T ss_dssp --HHHHHHHCTTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHH
T ss_pred --HHHHHHhcCCcccCCcccCCHHHHHHHHHHcCCChhHCCCHHHHHhCcc
Confidence 1122333333334444455668999999999999999999999998653
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-37 Score=313.45 Aligned_cols=238 Identities=24% Similarity=0.340 Sum_probs=191.4
Q ss_pred HhcCccccceeccCce---------------EEEEEeecChhhHHHHHHHHHHHhhcCCCCccceecccccCccceEEEe
Q 044312 287 ATDNFDLNRILGQGGQ---------------AVKKSKVIDESKVEEFINEVVILSQINHRNVVKLLGCCLETEVPLLVYE 351 (608)
Q Consensus 287 ~t~~f~~~~~lG~G~~---------------avk~~~~~~~~~~~~~~~Ei~il~~l~H~niv~l~~~~~~~~~~~lV~E 351 (608)
..++|++.+.||+|++ |+|+.........+.+.+|+.++++++||||+++++++.+....++|||
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 86 (277)
T 3f3z_A 7 INQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETFEDNTDIYLVME 86 (277)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred hhhhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCeEEEEEe
Confidence 3457899999999974 6676665555667899999999999999999999999999999999999
Q ss_pred ecCCCccchhccccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEE---cCCCcEEEeeccCccccc
Q 044312 352 FIPNGTLFQYIHDQNEDFPITWEIRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILL---DDKYRAKVSDFGASRSMA 428 (608)
Q Consensus 352 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl---~~~~~~kl~DFGls~~~~ 428 (608)
|+++++|.+++.... .+++..++.++.|++.||+|||+.+ |+||||||+|||+ +.++.+||+|||++....
T Consensus 87 ~~~~~~L~~~~~~~~---~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~~~~ 160 (277)
T 3f3z_A 87 LCTGGELFERVVHKR---VFRESDAARIMKDVLSAVAYCHKLN---VAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFK 160 (277)
T ss_dssp CCCSCBHHHHHHHHC---SCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESSSSTTCCEEECCCTTCEECC
T ss_pred ccCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCCCHHHEEEecCCCCCcEEEEecccceecc
Confidence 999999999887653 4899999999999999999999999 9999999999999 788999999999998765
Q ss_pred cCCcceeeeeeccCCCCChhhhccCCCCCccchHhHHHHHHHHHhCCCCCCccchhhcccHHHHHHHHhhhhhhHHHhhh
Q 044312 429 VDQTHMTTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLTELLTGEKPIRFTILEEDKSLAAYFLCAMKEERLFEILDA 508 (608)
Q Consensus 429 ~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 508 (608)
... ......||+.|+|||.+.+. ++.++||||||++++||++|+.||......+ ....+...... .
T Consensus 161 ~~~--~~~~~~~t~~y~aPE~~~~~-~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~-------~~~~~~~~~~~-~--- 226 (277)
T 3f3z_A 161 PGK--MMRTKVGTPYYVSPQVLEGL-YGPECDEWSAGVMMYVLLCGYPPFSAPTDSE-------VMLKIREGTFT-F--- 226 (277)
T ss_dssp TTS--CBCCCCSCTTTCCHHHHTTC-BCTTHHHHHHHHHHHHHHHSSCSSCCSSHHH-------HHHHHHHCCCC-C---
T ss_pred Ccc--chhccCCCCCccChHHhccc-CCchhhehhHHHHHHHHHHCCCCCCCCCHHH-------HHHHHHhCCCC-C---
Confidence 332 22345689999999998754 8999999999999999999999997432211 01111111000 0
Q ss_pred hhhccCChhHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 044312 509 RVMKQGGKDEIITVAKLAKRCLNLNGKKRPTMREVASE 546 (608)
Q Consensus 509 ~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~evl~~ 546 (608)
........+..+.+|+.+||+.||++|||+.|++++
T Consensus 227 --~~~~~~~~~~~~~~li~~~l~~dp~~R~s~~~~l~h 262 (277)
T 3f3z_A 227 --PEKDWLNVSPQAESLIRRLLTKSPKQRITSLQALEH 262 (277)
T ss_dssp --CHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHTTS
T ss_pred --CchhhhcCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 000001345679999999999999999999999864
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-37 Score=318.53 Aligned_cols=231 Identities=27% Similarity=0.391 Sum_probs=191.0
Q ss_pred cCccccceeccCce---------------EEEEEeec---ChhhHHHHHHHHHHHhhcCCCCccceecccccCccceEEE
Q 044312 289 DNFDLNRILGQGGQ---------------AVKKSKVI---DESKVEEFINEVVILSQINHRNVVKLLGCCLETEVPLLVY 350 (608)
Q Consensus 289 ~~f~~~~~lG~G~~---------------avk~~~~~---~~~~~~~~~~Ei~il~~l~H~niv~l~~~~~~~~~~~lV~ 350 (608)
++|++.+.||+|++ |+|..+.. .....+.+.+|+.+++.++||||+++++++.+....++||
T Consensus 6 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv~ 85 (318)
T 1fot_A 6 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIM 85 (318)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEE
T ss_pred HHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEEeCCEEEEEE
Confidence 56888999999974 66666532 2245678889999999999999999999999999999999
Q ss_pred eecCCCccchhccccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEEcCCCcEEEeeccCccccccC
Q 044312 351 EFIPNGTLFQYIHDQNEDFPITWEIRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVD 430 (608)
Q Consensus 351 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGls~~~~~~ 430 (608)
||+++|+|.+++.... .+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++.....
T Consensus 86 e~~~gg~L~~~l~~~~---~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~~kL~Dfg~a~~~~~~ 159 (318)
T 1fot_A 86 DYIEGGELFSLLRKSQ---RFPNPVAKFYAAEVCLALEYLHSKD---IIYRDLKPENILLDKNGHIKITDFGFAKYVPDV 159 (318)
T ss_dssp CCCCSCBHHHHHHHTS---SCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECTTSCEEECCCSSCEECSSC
T ss_pred eCCCCCCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChheEEEcCCCCEEEeecCcceecCCc
Confidence 9999999999998643 4899999999999999999999999 999999999999999999999999999865432
Q ss_pred CcceeeeeeccCCCCChhhhccCCCCCccchHhHHHHHHHHHhCCCCCCccchhhcccHHHHHHHHhhhhhhHHHhhhhh
Q 044312 431 QTHMTTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLTELLTGEKPIRFTILEEDKSLAAYFLCAMKEERLFEILDARV 510 (608)
Q Consensus 431 ~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~ 510 (608)
.....||+.|+|||++.+..++.++||||||++++||++|+.||...... ..+ ..++...
T Consensus 160 ----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~------~~~---------~~i~~~~- 219 (318)
T 1fot_A 160 ----TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTM------KTY---------EKILNAE- 219 (318)
T ss_dssp ----BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHH------HHH---------HHHHHCC-
T ss_pred ----cccccCCccccCHhHhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHH------HHH---------HHHHhCC-
Confidence 23457999999999999999999999999999999999999999632211 111 1111111
Q ss_pred hccCChhHHHHHHHHHHHHhccCCCCCC-----CHHHHHHH
Q 044312 511 MKQGGKDEIITVAKLAKRCLNLNGKKRP-----TMREVASE 546 (608)
Q Consensus 511 ~~~~~~~~~~~l~~Li~~cl~~dp~~RP-----s~~evl~~ 546 (608)
...+...+.++.+|+.+||+.||++|| +++|++++
T Consensus 220 -~~~p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~~i~~h 259 (318)
T 1fot_A 220 -LRFPPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNH 259 (318)
T ss_dssp -CCCCTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHTS
T ss_pred -CCCCCCCCHHHHHHHHHHhccCHHHcCCCcCCCHHHHhcC
Confidence 123344567899999999999999999 88888754
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-37 Score=326.19 Aligned_cols=241 Identities=24% Similarity=0.329 Sum_probs=183.3
Q ss_pred hcCccccceeccCce---------------EEEEEeecChhhHHHHHHHHHHHhhcCCCCccceecccccCccceEEEee
Q 044312 288 TDNFDLNRILGQGGQ---------------AVKKSKVIDESKVEEFINEVVILSQINHRNVVKLLGCCLETEVPLLVYEF 352 (608)
Q Consensus 288 t~~f~~~~~lG~G~~---------------avk~~~~~~~~~~~~~~~Ei~il~~l~H~niv~l~~~~~~~~~~~lV~E~ 352 (608)
.++|++.+.||+|+| |||+.... ....+.+.+|+.++++++||||+++++++.+....++||||
T Consensus 19 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~ 97 (361)
T 3uc3_A 19 SDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERG-AAIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIIMEY 97 (361)
T ss_dssp TTTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESS-TTSCHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred CCcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecC-ccccHHHHHHHHHHHhCCCCCCCcEEEEEeeCCEEEEEEEe
Confidence 467999999999974 77776542 23346789999999999999999999999999999999999
Q ss_pred cCCCccchhccccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEEcCCCc--EEEeeccCccccccC
Q 044312 353 IPNGTLFQYIHDQNEDFPITWEIRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYR--AKVSDFGASRSMAVD 430 (608)
Q Consensus 353 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~--~kl~DFGls~~~~~~ 430 (608)
+++|+|.+++.... .+++..+..++.||+.||+|||+++ |+||||||+|||++.++. +||+|||+++.....
T Consensus 98 ~~~~~L~~~l~~~~---~~~~~~~~~i~~ql~~~L~~LH~~~---ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~~~~~ 171 (361)
T 3uc3_A 98 ASGGELYERICNAG---RFSEDEARFFFQQLLSGVSYCHSMQ---ICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH 171 (361)
T ss_dssp CCSCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHTT---CCSCCCCGGGEEECSSSSCCEEECCCCCC------
T ss_pred CCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEcCCCCceEEEeecCcccccccc
Confidence 99999999997644 4899999999999999999999999 999999999999987765 999999999754322
Q ss_pred CcceeeeeeccCCCCChhhhccCCCCCc-cchHhHHHHHHHHHhCCCCCCccchhhcccHHHHHHHHhhhhhhHHHhhhh
Q 044312 431 QTHMTTQVHGTFGYLDPEYFRSSQFTDK-SDVYSFGVVLTELLTGEKPIRFTILEEDKSLAAYFLCAMKEERLFEILDAR 509 (608)
Q Consensus 431 ~~~~~~~~~gt~~y~aPE~~~~~~~t~k-sDV~S~Gvvl~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 509 (608)
. ......||+.|+|||++.+..++.+ +||||||++++||++|+.||....... ..... +..+....
T Consensus 172 ~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~--~~~~~---------~~~~~~~~ 238 (361)
T 3uc3_A 172 S--QPKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPR--DYRKT---------IQRILSVK 238 (361)
T ss_dssp -----------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC----CC--CHHHH---------HHHHHTTC
T ss_pred C--CCCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCccHH--HHHHH---------HHHHhcCC
Confidence 2 2234569999999999988888766 899999999999999999997432211 11111 11111111
Q ss_pred hhccCChhHHHHHHHHHHHHhccCCCCCCCHHHHHHHHH
Q 044312 510 VMKQGGKDEIITVAKLAKRCLNLNGKKRPTMREVASELA 548 (608)
Q Consensus 510 ~~~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~evl~~L~ 548 (608)
.........+..+.+|+.+||+.||++|||+.|++++-.
T Consensus 239 ~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~hp~ 277 (361)
T 3uc3_A 239 YSIPDDIRISPECCHLISRIFVADPATRISIPEIKTHSW 277 (361)
T ss_dssp CCCCTTSCCCHHHHHHHHHHSCSCTTTSCCHHHHHTSHH
T ss_pred CCCCCcCCCCHHHHHHHHHHccCChhHCcCHHHHHhCcc
Confidence 111222234678999999999999999999999998643
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-37 Score=328.03 Aligned_cols=235 Identities=25% Similarity=0.389 Sum_probs=190.8
Q ss_pred cCccccceeccCce---------------EEEEEee---cChhhHHHHHHHHHHHhhcCCCCccceecccccCccceEEE
Q 044312 289 DNFDLNRILGQGGQ---------------AVKKSKV---IDESKVEEFINEVVILSQINHRNVVKLLGCCLETEVPLLVY 350 (608)
Q Consensus 289 ~~f~~~~~lG~G~~---------------avk~~~~---~~~~~~~~~~~Ei~il~~l~H~niv~l~~~~~~~~~~~lV~ 350 (608)
++|++.+.||+|+| |+|.+.. ......+.+.+|+.+|++++|||||++++++.+.+..++||
T Consensus 15 ~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv~ 94 (384)
T 4fr4_A 15 DHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQDEEDMFMVV 94 (384)
T ss_dssp GGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred HHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEEE
Confidence 56899999999974 6776643 23345678999999999999999999999999999999999
Q ss_pred eecCCCccchhccccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEEcCCCcEEEeeccCccccccC
Q 044312 351 EFIPNGTLFQYIHDQNEDFPITWEIRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVD 430 (608)
Q Consensus 351 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGls~~~~~~ 430 (608)
||+++|+|.+++.... .+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++.....
T Consensus 95 e~~~gg~L~~~l~~~~---~l~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~ 168 (384)
T 4fr4_A 95 DLLLGGDLRYHLQQNV---HFKEETVKLFICELVMALDYLQNQR---IIHRDMKPDNILLDEHGHVHITDFNIAAMLPRE 168 (384)
T ss_dssp CCCTTEEHHHHHHTTC---CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECCTT
T ss_pred ecCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCcHHHeEECCCCCEEEeccceeeeccCC
Confidence 9999999999997643 5999999999999999999999999 999999999999999999999999999876533
Q ss_pred CcceeeeeeccCCCCChhhhcc---CCCCCccchHhHHHHHHHHHhCCCCCCccchhhcccHHHHHHHHhhhhhhHHHhh
Q 044312 431 QTHMTTQVHGTFGYLDPEYFRS---SQFTDKSDVYSFGVVLTELLTGEKPIRFTILEEDKSLAAYFLCAMKEERLFEILD 507 (608)
Q Consensus 431 ~~~~~~~~~gt~~y~aPE~~~~---~~~t~ksDV~S~Gvvl~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 507 (608)
. ......||+.|+|||++.. ..++.++||||||+++|||++|+.||............ ..+.
T Consensus 169 ~--~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~-------------~~~~ 233 (384)
T 4fr4_A 169 T--QITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIV-------------HTFE 233 (384)
T ss_dssp C--CBCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTTSCHHHHH-------------HHHH
T ss_pred C--ceeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCCCccHHHHH-------------HHHh
Confidence 2 3345679999999999874 45899999999999999999999999743222111110 0000
Q ss_pred hhhhccCChhHHHHHHHHHHHHhccCCCCCCC-HHHHHH
Q 044312 508 ARVMKQGGKDEIITVAKLAKRCLNLNGKKRPT-MREVAS 545 (608)
Q Consensus 508 ~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPs-~~evl~ 545 (608)
......+...+..+.+|+.+||+.||++||+ +.+|++
T Consensus 234 -~~~~~~p~~~s~~~~~li~~lL~~dP~~R~s~~~~l~~ 271 (384)
T 4fr4_A 234 -TTVVTYPSAWSQEMVSLLKKLLEPNPDQRFSQLSDVQN 271 (384)
T ss_dssp -HCCCCCCTTSCHHHHHHHHHHSCSSGGGSCCSHHHHHT
T ss_pred -hcccCCCCcCCHHHHHHHHHHhcCCHhHhcccHHHHHc
Confidence 0112234455678999999999999999998 666654
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-37 Score=313.66 Aligned_cols=236 Identities=27% Similarity=0.409 Sum_probs=191.1
Q ss_pred HhcCccccceeccCce---------------EEEEEeecChhhHHHHHHHHHHHhhcCCCCccceeccccc---------
Q 044312 287 ATDNFDLNRILGQGGQ---------------AVKKSKVIDESKVEEFINEVVILSQINHRNVVKLLGCCLE--------- 342 (608)
Q Consensus 287 ~t~~f~~~~~lG~G~~---------------avk~~~~~~~~~~~~~~~Ei~il~~l~H~niv~l~~~~~~--------- 342 (608)
...+|++.+.||+|++ |+|+.+... +.+.+|+.++++++||||+++++++..
T Consensus 9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~ 84 (284)
T 2a19_B 9 FGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN----EKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETSS 84 (284)
T ss_dssp HHHHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCS----GGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC-----
T ss_pred hccccceeeeeccCCceEEEEEEEcCCCeEEEEEEecccc----HHHHHHHHHHHhCCCCCEEEEeeeEeccccCccccc
Confidence 3456888999999974 667665432 457789999999999999999998854
Q ss_pred -------CccceEEEeecCCCccchhccccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEEcCCCc
Q 044312 343 -------TEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEIRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYR 415 (608)
Q Consensus 343 -------~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~ 415 (608)
....++||||+++++|.+++..... ..+++..++.++.||+.||.|||+.+ |+||||||+|||+++++.
T Consensus 85 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~ 160 (284)
T 2a19_B 85 KNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRG-EKLDKVLALELFEQITKGVDYIHSKK---LINRDLKPSNIFLVDTKQ 160 (284)
T ss_dssp ----CCEEEEEEEEECCCCSCBHHHHHHHGGG-SCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTE
T ss_pred ccccccCcceEEEEEeccCCCCHHHHHhhccC-CCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCCHHHEEEcCCCC
Confidence 4457999999999999999976432 25899999999999999999999999 999999999999999999
Q ss_pred EEEeeccCccccccCCcceeeeeeccCCCCChhhhccCCCCCccchHhHHHHHHHHHhCCCCCCccchhhcccHHHHHHH
Q 044312 416 AKVSDFGASRSMAVDQTHMTTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLTELLTGEKPIRFTILEEDKSLAAYFLC 495 (608)
Q Consensus 416 ~kl~DFGls~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~elltg~~p~~~~~~~~~~~l~~~~~~ 495 (608)
+||+|||+++...... ......||+.|+|||.+.+..++.++||||||++++||++|..|+... . ....
T Consensus 161 ~kl~Dfg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~--------~-~~~~ 229 (284)
T 2a19_B 161 VKIGDFGLVTSLKNDG--KRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFET--------S-KFFT 229 (284)
T ss_dssp EEECCCTTCEESSCCS--CCCCCCSCCTTSCHHHHHCSCCCTHHHHHHHHHHHHHHHSCCSSHHHH--------H-HHHH
T ss_pred EEECcchhheeccccc--cccccCCcccccChhhhccCCCcchhhhHHHHHHHHHHHhcCCcchhH--------H-HHHH
Confidence 9999999998765432 223456899999999999999999999999999999999999885310 0 0000
Q ss_pred HhhhhhhHHHhhhhhhccCChhHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhhHHh
Q 044312 496 AMKEERLFEILDARVMKQGGKDEIITVAKLAKRCLNLNGKKRPTMREVASELAGIKAW 553 (608)
Q Consensus 496 ~~~~~~~~~~~d~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~evl~~L~~i~~~ 553 (608)
.... ...+...+..+.+|+.+||+.||++|||+.|++++|+.++..
T Consensus 230 ~~~~------------~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~l~~~~~~ 275 (284)
T 2a19_B 230 DLRD------------GIISDIFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWKKS 275 (284)
T ss_dssp HHHT------------TCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHTC-
T ss_pred Hhhc------------ccccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhhC
Confidence 1111 112233456789999999999999999999999999888654
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-37 Score=322.61 Aligned_cols=235 Identities=27% Similarity=0.409 Sum_probs=188.1
Q ss_pred cCccccceeccCce---------------EEEEEeec---ChhhHHHHHHHHHHHhhc-CCCCccceecccccCccceEE
Q 044312 289 DNFDLNRILGQGGQ---------------AVKKSKVI---DESKVEEFINEVVILSQI-NHRNVVKLLGCCLETEVPLLV 349 (608)
Q Consensus 289 ~~f~~~~~lG~G~~---------------avk~~~~~---~~~~~~~~~~Ei~il~~l-~H~niv~l~~~~~~~~~~~lV 349 (608)
++|++.+.||+|+| |+|+++.. .....+.+.+|..+++++ +||||+++++++.+....++|
T Consensus 9 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~lv 88 (345)
T 3a8x_A 9 QDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFV 88 (345)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred hheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeCCEEEEE
Confidence 46888999999984 67776532 344567789999999988 899999999999999999999
Q ss_pred EeecCCCccchhccccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEEcCCCcEEEeeccCcccccc
Q 044312 350 YEFIPNGTLFQYIHDQNEDFPITWEIRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAV 429 (608)
Q Consensus 350 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGls~~~~~ 429 (608)
|||+++|+|.+++.... .+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++....
T Consensus 89 ~e~~~gg~L~~~l~~~~---~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~~kL~DFG~a~~~~~ 162 (345)
T 3a8x_A 89 IEYVNGGDLMFHMQRQR---KLPEEHARFYSAEISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLR 162 (345)
T ss_dssp ECCCCSCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCGGGCBCSCC
T ss_pred EeCCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCHHHEEECCCCCEEEEeccccccccC
Confidence 99999999999997653 4899999999999999999999999 99999999999999999999999999986432
Q ss_pred CCcceeeeeeccCCCCChhhhccCCCCCccchHhHHHHHHHHHhCCCCCCccchhhcc--cHHHHHHHHhhhhhhHHHhh
Q 044312 430 DQTHMTTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLTELLTGEKPIRFTILEEDK--SLAAYFLCAMKEERLFEILD 507 (608)
Q Consensus 430 ~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~elltg~~p~~~~~~~~~~--~l~~~~~~~~~~~~~~~~~d 507 (608)
.. .......||+.|+|||++.+..++.++||||||++++||++|+.||......... ....... ..+..
T Consensus 163 ~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~--------~~i~~ 233 (345)
T 3a8x_A 163 PG-DTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLF--------QVILE 233 (345)
T ss_dssp TT-CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTTTC-------CHHHHH--------HHHHH
T ss_pred CC-CcccccCCCccccCccccCCCCCChHHhHHHHHHHHHHHHhCCCCcCCcccccccccccHHHHH--------HHHHc
Confidence 22 2234567999999999999999999999999999999999999999642211110 0000011 11111
Q ss_pred hhhhccCChhHHHHHHHHHHHHhccCCCCCCCH
Q 044312 508 ARVMKQGGKDEIITVAKLAKRCLNLNGKKRPTM 540 (608)
Q Consensus 508 ~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPs~ 540 (608)
. ....+...+.++.+|+.+||+.||++||++
T Consensus 234 ~--~~~~p~~~s~~~~~li~~lL~~dP~~R~~~ 264 (345)
T 3a8x_A 234 K--QIRIPRSLSVKAASVLKSFLNKDPKERLGC 264 (345)
T ss_dssp C--CCCCCTTSCHHHHHHHHHHTCSSTTTSTTC
T ss_pred C--CCCCCCCCCHHHHHHHHHHhcCCHhHCCCC
Confidence 1 112344566789999999999999999996
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-37 Score=327.74 Aligned_cols=258 Identities=26% Similarity=0.286 Sum_probs=197.0
Q ss_pred cccCCHHHHHHHhcCccccceeccCce---------------EEEEEeecChhhHHHHHHHHHHHhhcC-----CCCccc
Q 044312 276 TKLFTSKELEKATDNFDLNRILGQGGQ---------------AVKKSKVIDESKVEEFINEVVILSQIN-----HRNVVK 335 (608)
Q Consensus 276 ~~~~~~~~l~~~t~~f~~~~~lG~G~~---------------avk~~~~~~~~~~~~~~~Ei~il~~l~-----H~niv~ 335 (608)
...++.++.....++|.+.++||+|++ |||..+. .....+.+..|+.+++.++ ||||++
T Consensus 22 ~~~~~~~~g~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~-~~~~~~~~~~e~~~l~~l~~~~~~h~~iv~ 100 (360)
T 3llt_A 22 IVHFSWKKGMLLNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRN-IKKYTRSAKIEADILKKIQNDDINNNNIVK 100 (360)
T ss_dssp GGSCCCCTTCEETTTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECS-CHHHHHHHHHHHHHHHHTCCCSTTGGGBCC
T ss_pred ceeeeeecceEecCEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEecc-chhhhhhhHHHHHHHHHhcccCCCCCCeec
Confidence 445666666677889999999999985 6666542 2445667888999999996 999999
Q ss_pred eecccccCccceEEEeecCCCccchhccccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEEcC---
Q 044312 336 LLGCCLETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEIRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDD--- 412 (608)
Q Consensus 336 l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~--- 412 (608)
+++++...+..+|||||+ +++|.+++...... .+++..+..++.||+.||+|||+.+ |+||||||+|||+++
T Consensus 101 ~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~-~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~ 175 (360)
T 3llt_A 101 YHGKFMYYDHMCLIFEPL-GPSLYEIITRNNYN-GFHIEDIKLYCIEILKALNYLRKMS---LTHTDLKPENILLDDPYF 175 (360)
T ss_dssp EEEEEEETTEEEEEECCC-CCBHHHHHHHTTTC-CCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESCTTC
T ss_pred ccceeeECCeeEEEEcCC-CCCHHHHHHhcCCC-CCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCcccEEEccccc
Confidence 999999999999999999 89999999875432 5899999999999999999999999 999999999999975
Q ss_pred ----------------------CCcEEEeeccCccccccCCcceeeeeeccCCCCChhhhccCCCCCccchHhHHHHHHH
Q 044312 413 ----------------------KYRAKVSDFGASRSMAVDQTHMTTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLTE 470 (608)
Q Consensus 413 ----------------------~~~~kl~DFGls~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~e 470 (608)
++.+||+|||+++..... .....||+.|+|||++.+..++.++||||||++++|
T Consensus 176 ~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~e 251 (360)
T 3llt_A 176 EKSLITVRRVTDGKKIQIYRTKSTGIKLIDFGCATFKSDY----HGSIINTRQYRAPEVILNLGWDVSSDMWSFGCVLAE 251 (360)
T ss_dssp CEEEEEEECTTTCCEEEEEEESCCCEEECCCTTCEETTSC----CCSCCSCGGGCCHHHHTTCCCCTTHHHHHHHHHHHH
T ss_pred cccccchhcccccccccccccCCCCEEEEeccCceecCCC----CcCccCcccccCcHHHcCCCCCCccchHHHHHHHHH
Confidence 788999999999865432 234568999999999999999999999999999999
Q ss_pred HHhCCCCCCccchhhcccHHHHHHHHhh---hhhhHHHh--------hh-hhhccC-----------------C---hhH
Q 044312 471 LLTGEKPIRFTILEEDKSLAAYFLCAMK---EERLFEIL--------DA-RVMKQG-----------------G---KDE 518 (608)
Q Consensus 471 lltg~~p~~~~~~~~~~~l~~~~~~~~~---~~~~~~~~--------d~-~~~~~~-----------------~---~~~ 518 (608)
|++|+.||......+. ...+..... ...+.... +. ...... + ...
T Consensus 252 ll~g~~pf~~~~~~~~---~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~ 328 (360)
T 3llt_A 252 LYTGSLLFRTHEHMEH---LAMMESIIQPIPKNMLYEATKTNGSKYVNKDELKLAWPENASSINSIKHVKKCLPLYKIIK 328 (360)
T ss_dssp HHHSSCSCCCSSHHHH---HHHHHHHTCCCCHHHHHHHTTSGGGGGEETTTTEECTTTTCSCHHHHHHHHTCCCHHHHCC
T ss_pred HHHCCCCCCCCcHHHH---HHHHHHhcCCCCHHHHhhhhhccCccccCcccceecCcccccchhhhhhhhhcccccccch
Confidence 9999999974332211 111111100 00000000 00 000000 0 011
Q ss_pred HHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 044312 519 IITVAKLAKRCLNLNGKKRPTMREVASE 546 (608)
Q Consensus 519 ~~~l~~Li~~cl~~dp~~RPs~~evl~~ 546 (608)
...+.+|+.+||+.||++|||+.|++++
T Consensus 329 ~~~l~~li~~~L~~dP~~Rpta~elL~h 356 (360)
T 3llt_A 329 HELFCDFLYSILQIDPTLRPSPAELLKH 356 (360)
T ss_dssp CHHHHHHHHHHCCSSGGGSCCHHHHTTS
T ss_pred HHHHHHHHHHHhcCChhhCCCHHHHhcC
Confidence 2568899999999999999999999753
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-37 Score=318.69 Aligned_cols=251 Identities=22% Similarity=0.357 Sum_probs=178.8
Q ss_pred hcCccccceeccCce---------------EEEEEeecC-hhhHHHHHHHHHHHhhcCCCCccceecccccCccceEEEe
Q 044312 288 TDNFDLNRILGQGGQ---------------AVKKSKVID-ESKVEEFINEVVILSQINHRNVVKLLGCCLETEVPLLVYE 351 (608)
Q Consensus 288 t~~f~~~~~lG~G~~---------------avk~~~~~~-~~~~~~~~~Ei~il~~l~H~niv~l~~~~~~~~~~~lV~E 351 (608)
.++|++.+.||+|++ |+|..+... ....+.+.+|+.++++++||||+++++++.+.+..++|||
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 83 (317)
T 2pmi_A 4 SSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKHENIVRLYDVIHTENKLTLVFE 83 (317)
T ss_dssp ---------------CEEEEEECSSSCCEEEEEEEECCSTTCSCHHHHHHHHHHTTCCBTTBCCEEEEECCTTEEEEEEE
T ss_pred ccceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeecccccccHHHHHHHHHHHHhcCCCCcceEEEEEEECCeEEEEEE
Confidence 356888899999874 777776433 3345788999999999999999999999999999999999
Q ss_pred ecCCCccchhccccC---CCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEEcCCCcEEEeeccCccccc
Q 044312 352 FIPNGTLFQYIHDQN---EDFPITWEIRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMA 428 (608)
Q Consensus 352 ~~~~gsL~~~l~~~~---~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGls~~~~ 428 (608)
|++ ++|.+++.... ....+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++...
T Consensus 84 ~~~-~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~ 159 (317)
T 2pmi_A 84 FMD-NDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHENK---ILHRDLKPQNLLINKRGQLKLGDFGLARAFG 159 (317)
T ss_dssp CCC-CBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCSSCEETT
T ss_pred ecC-CCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCChHHeEEcCCCCEEECcCccceecC
Confidence 997 59999887532 1225899999999999999999999999 9999999999999999999999999998764
Q ss_pred cCCcceeeeeeccCCCCChhhhccC-CCCCccchHhHHHHHHHHHhCCCCCCccchhhcccHHHHHHHHhhh--hhhH-H
Q 044312 429 VDQTHMTTQVHGTFGYLDPEYFRSS-QFTDKSDVYSFGVVLTELLTGEKPIRFTILEEDKSLAAYFLCAMKE--ERLF-E 504 (608)
Q Consensus 429 ~~~~~~~~~~~gt~~y~aPE~~~~~-~~t~ksDV~S~Gvvl~elltg~~p~~~~~~~~~~~l~~~~~~~~~~--~~~~-~ 504 (608)
.... ......||+.|+|||++.+. .++.++||||||++++||++|+.||......+. .......... .... .
T Consensus 160 ~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~---~~~i~~~~~~~~~~~~~~ 235 (317)
T 2pmi_A 160 IPVN-TFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQ---LKLIFDIMGTPNESLWPS 235 (317)
T ss_dssp SCCC-CCCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH---HHHHHHHHCSCCTTTCGG
T ss_pred CCcc-cCCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHH---HHHHHHHhCCCChhHhhh
Confidence 3222 22345689999999999764 689999999999999999999999974432211 1111111110 0000 0
Q ss_pred H-----------------hhhhhhccCChhHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 044312 505 I-----------------LDARVMKQGGKDEIITVAKLAKRCLNLNGKKRPTMREVASE 546 (608)
Q Consensus 505 ~-----------------~d~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~evl~~ 546 (608)
. +............+.++.+|+.+||+.||++|||+.|++++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~h 294 (317)
T 2pmi_A 236 VTKLPKYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALHH 294 (317)
T ss_dssp GGGCTTCCTTCCCCCCCCSHHHHGGGCSSCCCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred hhhhhhcccccccccchhHHHhhcccccccCCHHHHHHHHHHCCCCcccCCCHHHHhCC
Confidence 0 00000111122345689999999999999999999999753
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-38 Score=324.04 Aligned_cols=232 Identities=21% Similarity=0.209 Sum_probs=181.3
Q ss_pred hcCccccceeccCce---------------EEEEEee--cChhhHHHHHHHHHHHhhc-CCCCccceecccccCccceEE
Q 044312 288 TDNFDLNRILGQGGQ---------------AVKKSKV--IDESKVEEFINEVVILSQI-NHRNVVKLLGCCLETEVPLLV 349 (608)
Q Consensus 288 t~~f~~~~~lG~G~~---------------avk~~~~--~~~~~~~~~~~Ei~il~~l-~H~niv~l~~~~~~~~~~~lV 349 (608)
.++|++.++||+|++ |||+... ........+..|+..+.++ +||||+++++++.+....+||
T Consensus 56 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~~~~~~lv 135 (311)
T 3p1a_A 56 QQSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGGILYLQ 135 (311)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred hhheeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEEeCCEEEEE
Confidence 357999999999984 7776543 2234445666777766666 999999999999999999999
Q ss_pred EeecCCCccchhccccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEEcCCCcEEEeeccCcccccc
Q 044312 350 YEFIPNGTLFQYIHDQNEDFPITWEIRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAV 429 (608)
Q Consensus 350 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGls~~~~~ 429 (608)
|||+ +++|.+++..... .+++..++.|+.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++....
T Consensus 136 ~e~~-~~~L~~~~~~~~~--~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIll~~~~~~kl~DFG~a~~~~~ 209 (311)
T 3p1a_A 136 TELC-GPSLQQHCEAWGA--SLPEAQVWGYLRDTLLALAHLHSQG---LVHLDVKPANIFLGPRGRCKLGDFGLLVELGT 209 (311)
T ss_dssp EECC-CCBHHHHHHHHCS--CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECGGGCEEECCCTTCEECC-
T ss_pred Eecc-CCCHHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEECCCCCEEEccceeeeeccc
Confidence 9999 6799998876543 5999999999999999999999999 99999999999999999999999999987643
Q ss_pred CCcceeeeeeccCCCCChhhhccCCCCCccchHhHHHHHHHHHhCCCCCCccchhhcccHHHHHHHHhhhhhhHHHhhhh
Q 044312 430 DQTHMTTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLTELLTGEKPIRFTILEEDKSLAAYFLCAMKEERLFEILDAR 509 (608)
Q Consensus 430 ~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 509 (608)
.. ......||+.|+|||++.+ .++.++||||||++++||++|..|+..... ...+..... .+
T Consensus 210 ~~--~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~el~~g~~~~~~~~~----------~~~~~~~~~----~~- 271 (311)
T 3p1a_A 210 AG--AGEVQEGDPRYMAPELLQG-SYGTAADVFSLGLTILEVACNMELPHGGEG----------WQQLRQGYL----PP- 271 (311)
T ss_dssp -------CCCCCGGGCCGGGGGT-CCSTHHHHHHHHHHHHHHHHTCCCCSSHHH----------HHHHTTTCC----CH-
T ss_pred CC--CCcccCCCccccCHhHhcC-CCCchhhHHHHHHHHHHHHhCCCCCCCccH----------HHHHhccCC----Cc-
Confidence 22 2344568999999999875 799999999999999999999776542110 011111111 01
Q ss_pred hhccCChhHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 044312 510 VMKQGGKDEIITVAKLAKRCLNLNGKKRPTMREVASE 546 (608)
Q Consensus 510 ~~~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~evl~~ 546 (608)
+.....+.++.+|+.+||+.||++|||+.|++++
T Consensus 272 ---~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~h 305 (311)
T 3p1a_A 272 ---EFTAGLSSELRSVLVMMLEPDPKLRATAEALLAL 305 (311)
T ss_dssp ---HHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred ---ccccCCCHHHHHHHHHHcCCChhhCcCHHHHHhC
Confidence 1112345679999999999999999999999863
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-37 Score=326.90 Aligned_cols=231 Identities=26% Similarity=0.312 Sum_probs=186.2
Q ss_pred cceeccCce---------------EEEEEeecChhhHHHHHHHHHHHhhcCCCCccceecccccCccceEEEeecCCCcc
Q 044312 294 NRILGQGGQ---------------AVKKSKVIDESKVEEFINEVVILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGTL 358 (608)
Q Consensus 294 ~~~lG~G~~---------------avk~~~~~~~~~~~~~~~Ei~il~~l~H~niv~l~~~~~~~~~~~lV~E~~~~gsL 358 (608)
.+.||+|++ |+|..+.......+.|.+|+.+|++++||||+++++++.+.+..+|||||+++++|
T Consensus 94 ~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~~~~~~L 173 (373)
T 2x4f_A 94 TEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYVDGGEL 173 (373)
T ss_dssp EEECC-----CEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCTTCEE
T ss_pred ceEEecCcCEEEEEEEEcCCCcEEEEEEEcccccccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeCCCCCcH
Confidence 567999974 77777766666778899999999999999999999999999999999999999999
Q ss_pred chhccccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEE--cCCCcEEEeeccCccccccCCcceee
Q 044312 359 FQYIHDQNEDFPITWEIRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILL--DDKYRAKVSDFGASRSMAVDQTHMTT 436 (608)
Q Consensus 359 ~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl--~~~~~~kl~DFGls~~~~~~~~~~~~ 436 (608)
.+++..... .+++..++.++.||+.||+|||+.+ |+||||||+|||+ ++++.+||+|||+++....... ..
T Consensus 174 ~~~l~~~~~--~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~~~~--~~ 246 (373)
T 2x4f_A 174 FDRIIDESY--NLTELDTILFMKQICEGIRHMHQMY---ILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREK--LK 246 (373)
T ss_dssp HHHHHHTGG--GCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEEETTTTEEEECCCSSCEECCTTCB--CC
T ss_pred HHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHHCC---cccccCCHHHEEEecCCCCcEEEEeCCCceecCCccc--cc
Confidence 998875432 5899999999999999999999999 9999999999999 5678999999999987654322 23
Q ss_pred eeeccCCCCChhhhccCCCCCccchHhHHHHHHHHHhCCCCCCccchhhcccHHHHHHHHhhhhhhHHHhhhhhh--ccC
Q 044312 437 QVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLTELLTGEKPIRFTILEEDKSLAAYFLCAMKEERLFEILDARVM--KQG 514 (608)
Q Consensus 437 ~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~--~~~ 514 (608)
...||+.|+|||++....++.++||||||++++||++|+.||......+ . +..++..... ...
T Consensus 247 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~------~---------~~~i~~~~~~~~~~~ 311 (373)
T 2x4f_A 247 VNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDNDAE------T---------LNNILACRWDLEDEE 311 (373)
T ss_dssp CCCSSCTTCCHHHHTTCBCCHHHHHHHHHHHHHHHHHSSCTTCCSSHHH------H---------HHHHHHTCCCSCSGG
T ss_pred cccCCCcEeChhhccCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHH------H---------HHHHHhccCCCChhh
Confidence 4469999999999999999999999999999999999999997432211 0 1111111100 011
Q ss_pred ChhHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 044312 515 GKDEIITVAKLAKRCLNLNGKKRPTMREVASE 546 (608)
Q Consensus 515 ~~~~~~~l~~Li~~cl~~dp~~RPs~~evl~~ 546 (608)
....+.++.+|+.+||+.||++|||+.|++++
T Consensus 312 ~~~~~~~~~~li~~~L~~dp~~Rps~~e~l~h 343 (373)
T 2x4f_A 312 FQDISEEAKEFISKLLIKEKSWRISASEALKH 343 (373)
T ss_dssp GTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred hccCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 12345689999999999999999999999974
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-37 Score=316.19 Aligned_cols=249 Identities=20% Similarity=0.311 Sum_probs=187.7
Q ss_pred cCccccceeccCce---------------EEEEEeec--ChhhHHHHHHHHHHHhhcCCCCccceecccccCccceEEEe
Q 044312 289 DNFDLNRILGQGGQ---------------AVKKSKVI--DESKVEEFINEVVILSQINHRNVVKLLGCCLETEVPLLVYE 351 (608)
Q Consensus 289 ~~f~~~~~lG~G~~---------------avk~~~~~--~~~~~~~~~~Ei~il~~l~H~niv~l~~~~~~~~~~~lV~E 351 (608)
++|++.++||+|++ |||+.+.. .....+.+.+|+.++++++||||+++++++.+.+..++|||
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 81 (292)
T 3o0g_A 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE 81 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred CCceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCCcCCcchHHHHHHHHHhcCCCCCEeeEEeEEEeCCEEEEEEe
Confidence 46888999999974 77777643 33445789999999999999999999999999999999999
Q ss_pred ecCCCccchhccccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEEcCCCcEEEeeccCccccccCC
Q 044312 352 FIPNGTLFQYIHDQNEDFPITWEIRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQ 431 (608)
Q Consensus 352 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGls~~~~~~~ 431 (608)
|+++ +|.+.+..... .+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++......
T Consensus 82 ~~~~-~l~~~~~~~~~--~l~~~~~~~~~~ql~~~l~~lH~~~---ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 155 (292)
T 3o0g_A 82 FCDQ-DLKKYFDSCNG--DLDPEIVKSFLFQLLKGLGFCHSRN---VLHRDLKPQNLLINRNGELKLANFGLARAFGIPV 155 (292)
T ss_dssp CCSE-EHHHHHHHTTT--CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECCSCC
T ss_pred cCCC-CHHHHHHhCCC--CCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEeecccceecCCcc
Confidence 9975 66666654332 5999999999999999999999999 9999999999999999999999999998764332
Q ss_pred cceeeeeeccCCCCChhhhccCC-CCCccchHhHHHHHHHHHhCCCCCCccchhhcccHHHHHHHHhhh---hhhHHHhh
Q 044312 432 THMTTQVHGTFGYLDPEYFRSSQ-FTDKSDVYSFGVVLTELLTGEKPIRFTILEEDKSLAAYFLCAMKE---ERLFEILD 507 (608)
Q Consensus 432 ~~~~~~~~gt~~y~aPE~~~~~~-~t~ksDV~S~Gvvl~elltg~~p~~~~~~~~~~~l~~~~~~~~~~---~~~~~~~d 507 (608)
. ......||+.|+|||++.+.. ++.++||||||++++||++|..|+....... .. .......... ........
T Consensus 156 ~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~~~~~~-~~-~~~i~~~~~~~~~~~~~~~~~ 232 (292)
T 3o0g_A 156 R-CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVD-DQ-LKRIFRLLGTPTEEQWPSMTK 232 (292)
T ss_dssp S-CCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHH-HH-HHHHHHHHCCCCTTTCTTGGG
T ss_pred c-cccCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcCCCCHH-HH-HHHHHHHhCCCChhhhhhhcc
Confidence 2 234456899999999998766 8999999999999999999988864322111 11 1111111110 00000000
Q ss_pred ------------hhhhccCChhHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 044312 508 ------------ARVMKQGGKDEIITVAKLAKRCLNLNGKKRPTMREVASE 546 (608)
Q Consensus 508 ------------~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~evl~~ 546 (608)
...........+.++.+|+.+||+.||++|||++|++++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 283 (292)
T 3o0g_A 233 LPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQH 283 (292)
T ss_dssp STTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred cccccccccccCCcchhhcccccChHHHHHHHHHhccChhhCCCHHHHhcC
Confidence 000001112356788999999999999999999999864
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-37 Score=316.74 Aligned_cols=251 Identities=22% Similarity=0.261 Sum_probs=184.6
Q ss_pred cCccccceeccCce---------------EEEEEeec--ChhhHHHHHHHHHHHhhcCCCCccceecccccCccceEEEe
Q 044312 289 DNFDLNRILGQGGQ---------------AVKKSKVI--DESKVEEFINEVVILSQINHRNVVKLLGCCLETEVPLLVYE 351 (608)
Q Consensus 289 ~~f~~~~~lG~G~~---------------avk~~~~~--~~~~~~~~~~Ei~il~~l~H~niv~l~~~~~~~~~~~lV~E 351 (608)
++|++.+.||+|++ |||+.... +....+.+.+|+.++++++||||+++++++.+....++|||
T Consensus 3 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 82 (311)
T 4agu_A 3 EKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVFRRKRRLHLVFE 82 (311)
T ss_dssp CCEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred ccceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhCCCCCccchhheeecCCeEEEEEE
Confidence 57889999999984 66665432 22335778899999999999999999999999999999999
Q ss_pred ecCCCccchhccccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEEcCCCcEEEeeccCccccccCC
Q 044312 352 FIPNGTLFQYIHDQNEDFPITWEIRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQ 431 (608)
Q Consensus 352 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGls~~~~~~~ 431 (608)
|+++++|.+++.... .+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++......
T Consensus 83 ~~~~~~l~~~~~~~~---~~~~~~~~~i~~~l~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 156 (311)
T 4agu_A 83 YCDHTVLHELDRYQR---GVPEHLVKSITWQTLQAVNFCHKHN---CIHRDVKPENILITKHSVIKLCDFGFARLLTGPS 156 (311)
T ss_dssp CCSEEHHHHHHHTSS---CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECC---
T ss_pred eCCCchHHHHHhhhc---CCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCCChhhEEEcCCCCEEEeeCCCchhccCcc
Confidence 999999988876543 4899999999999999999999999 9999999999999999999999999998765332
Q ss_pred cceeeeeeccCCCCChhhhcc-CCCCCccchHhHHHHHHHHHhCCCCCCccchhhcccHHHHHHHHhhhhhhHHHhhhhh
Q 044312 432 THMTTQVHGTFGYLDPEYFRS-SQFTDKSDVYSFGVVLTELLTGEKPIRFTILEEDKSLAAYFLCAMKEERLFEILDARV 510 (608)
Q Consensus 432 ~~~~~~~~gt~~y~aPE~~~~-~~~t~ksDV~S~Gvvl~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~ 510 (608)
. ......||+.|+|||.+.+ ..++.++||||||++++||++|+.||......+.........................
T Consensus 157 ~-~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (311)
T 4agu_A 157 D-YYDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQQVFSTNQY 235 (311)
T ss_dssp ----------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHTCGG
T ss_pred c-ccCCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhcccccccccccccccc
Confidence 2 2334568999999999876 6789999999999999999999999975433221111100000000000000000000
Q ss_pred h----c----------cCChhHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 044312 511 M----K----------QGGKDEIITVAKLAKRCLNLNGKKRPTMREVASE 546 (608)
Q Consensus 511 ~----~----------~~~~~~~~~l~~Li~~cl~~dp~~RPs~~evl~~ 546 (608)
. . ......+..+.+|+.+||+.||++|||++|++++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 285 (311)
T 4agu_A 236 FSGVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLHH 285 (311)
T ss_dssp GTTCCCCCCSSCCCHHHHCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHTS
T ss_pred cccCcCCCccccchhhhhcccccHHHHHHHHHHccCChhhcCCHHHHhcC
Confidence 0 0 0002345678999999999999999999999864
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-37 Score=324.28 Aligned_cols=231 Identities=23% Similarity=0.313 Sum_probs=191.4
Q ss_pred cCccccceeccCce---------------EEEEEeec---ChhhHHHHHHHHHHHhhcCCCCccceecccccCccceEEE
Q 044312 289 DNFDLNRILGQGGQ---------------AVKKSKVI---DESKVEEFINEVVILSQINHRNVVKLLGCCLETEVPLLVY 350 (608)
Q Consensus 289 ~~f~~~~~lG~G~~---------------avk~~~~~---~~~~~~~~~~Ei~il~~l~H~niv~l~~~~~~~~~~~lV~ 350 (608)
++|++.+.||+|++ |+|.+... .....+.+.+|+.+|++++||||+++++++.+....+|||
T Consensus 41 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 120 (350)
T 1rdq_E 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVM 120 (350)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred HHCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEEEE
Confidence 57899999999974 66666432 2345678999999999999999999999999999999999
Q ss_pred eecCCCccchhccccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEEcCCCcEEEeeccCccccccC
Q 044312 351 EFIPNGTLFQYIHDQNEDFPITWEIRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVD 430 (608)
Q Consensus 351 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGls~~~~~~ 430 (608)
||+++|+|.+++.... .+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++.....
T Consensus 121 e~~~gg~L~~~l~~~~---~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~~kL~DFg~a~~~~~~ 194 (350)
T 1rdq_E 121 EYVAGGEMFSHLRRIG---RFSEPHARFYAAQIVLTFEYLHSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR 194 (350)
T ss_dssp ECCTTCBHHHHHHHHC---CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECSSC
T ss_pred cCCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---cccccCccceEEECCCCCEEEcccccceeccCC
Confidence 9999999999998654 4899999999999999999999999 999999999999999999999999999876432
Q ss_pred CcceeeeeeccCCCCChhhhccCCCCCccchHhHHHHHHHHHhCCCCCCccchhhcccHHHHHHHHhhhhhhHHHhhhhh
Q 044312 431 QTHMTTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLTELLTGEKPIRFTILEEDKSLAAYFLCAMKEERLFEILDARV 510 (608)
Q Consensus 431 ~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~ 510 (608)
.....||+.|+|||++.+..++.++||||||++++||++|+.||...... ..+ ..+....
T Consensus 195 ----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~------~~~---------~~i~~~~- 254 (350)
T 1rdq_E 195 ----TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPI------QIY---------EKIVSGK- 254 (350)
T ss_dssp ----BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH------HHH---------HHHHHCC-
T ss_pred ----cccccCCccccCHHHhcCCCCCCcCCEecccHhHhHHhhCCCCCCCCCHH------HHH---------HHHHcCC-
Confidence 23457899999999999999999999999999999999999999733211 111 1111111
Q ss_pred hccCChhHHHHHHHHHHHHhccCCCCCCC-----HHHHHHH
Q 044312 511 MKQGGKDEIITVAKLAKRCLNLNGKKRPT-----MREVASE 546 (608)
Q Consensus 511 ~~~~~~~~~~~l~~Li~~cl~~dp~~RPs-----~~evl~~ 546 (608)
...+...+.++.+|+.+||+.||++||+ ++||+++
T Consensus 255 -~~~p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~ei~~h 294 (350)
T 1rdq_E 255 -VRFPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNH 294 (350)
T ss_dssp -CCCCTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHTS
T ss_pred -CCCCCCCCHHHHHHHHHHhhcCHHhccCCccCCHHHHHhC
Confidence 1233455678999999999999999998 7777654
|
| >4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-37 Score=349.56 Aligned_cols=235 Identities=27% Similarity=0.399 Sum_probs=189.0
Q ss_pred ceeccCce-----------------EEEEEee--cChhhHHHHHHHHHHHhhcCCCCccceecccccCccceEEEeecCC
Q 044312 295 RILGQGGQ-----------------AVKKSKV--IDESKVEEFINEVVILSQINHRNVVKLLGCCLETEVPLLVYEFIPN 355 (608)
Q Consensus 295 ~~lG~G~~-----------------avk~~~~--~~~~~~~~~~~Ei~il~~l~H~niv~l~~~~~~~~~~~lV~E~~~~ 355 (608)
++||+|+| |||+++. .+....++|.+|+.+|++++|||||++++++.. +..+|||||+++
T Consensus 375 ~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~-~~~~lv~E~~~~ 453 (635)
T 4fl3_A 375 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAEL 453 (635)
T ss_dssp EEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGGCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEEEECCTT
T ss_pred CEeccCCCEEEEEEEEcCCCcceEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec-CCEEEEEEccCC
Confidence 47999985 5565543 223446889999999999999999999999964 567899999999
Q ss_pred CccchhccccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEEcCCCcEEEeeccCccccccCCcc--
Q 044312 356 GTLFQYIHDQNEDFPITWEIRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTH-- 433 (608)
Q Consensus 356 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGls~~~~~~~~~-- 433 (608)
|+|.+++.... .+++..++.|+.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++.+......
T Consensus 454 g~L~~~l~~~~---~l~~~~~~~i~~qi~~~L~yLH~~~---iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~ 527 (635)
T 4fl3_A 454 GPLNKYLQQNR---HVKDKNIIELVHQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYK 527 (635)
T ss_dssp EEHHHHHHHCT---TCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECCTTHHHHTTC------
T ss_pred CCHHHHHhhCC---CCCHHHHHHHHHHHHHHHHHHHHCC---EeCCCCChHhEEEeCCCCEEEEEcCCccccccCccccc
Confidence 99999997543 5899999999999999999999999 999999999999999999999999999876543321
Q ss_pred eeeeeeccCCCCChhhhccCCCCCccchHhHHHHHHHHHh-CCCCCCccchhhcccHHHHHHHHhhhhhhHHHhhhhhhc
Q 044312 434 MTTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLTELLT-GEKPIRFTILEEDKSLAAYFLCAMKEERLFEILDARVMK 512 (608)
Q Consensus 434 ~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~ellt-g~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~ 512 (608)
......+|+.|+|||++....++.++||||||++|+||++ |+.||...... .+.+.+......
T Consensus 528 ~~~~~~~t~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~----------------~~~~~i~~~~~~ 591 (635)
T 4fl3_A 528 AQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGS----------------EVTAMLEKGERM 591 (635)
T ss_dssp -------CGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHH----------------HHHHHHHTTCCC
T ss_pred cccCCCCceeeeChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHH----------------HHHHHHHcCCCC
Confidence 2233456789999999999999999999999999999998 99999643221 122222222333
Q ss_pred cCChhHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhhHH
Q 044312 513 QGGKDEIITVAKLAKRCLNLNGKKRPTMREVASELAGIKA 552 (608)
Q Consensus 513 ~~~~~~~~~l~~Li~~cl~~dp~~RPs~~evl~~L~~i~~ 552 (608)
..+...+.++.+|+.+||+.||++||++.+|++.|+.+..
T Consensus 592 ~~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~~~ 631 (635)
T 4fl3_A 592 GCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYY 631 (635)
T ss_dssp CCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHH
T ss_pred CCCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHH
Confidence 4455677889999999999999999999999999988754
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-37 Score=316.70 Aligned_cols=248 Identities=20% Similarity=0.316 Sum_probs=185.4
Q ss_pred cCccccceeccCce--------------EEEEEeecC--hhhHHHHHHHHHHHhhcCCCCccceecccccCccceEEEee
Q 044312 289 DNFDLNRILGQGGQ--------------AVKKSKVID--ESKVEEFINEVVILSQINHRNVVKLLGCCLETEVPLLVYEF 352 (608)
Q Consensus 289 ~~f~~~~~lG~G~~--------------avk~~~~~~--~~~~~~~~~Ei~il~~l~H~niv~l~~~~~~~~~~~lV~E~ 352 (608)
++|++.+.||+|++ |+|+..... ....+.+.+|+.++++++||||+++++++.+.+..++||||
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 81 (288)
T 1ob3_A 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEH 81 (288)
T ss_dssp CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred ccchhhhhcccCCCEEEEEEEcCCCCEEEEEEEeccccccccchhHHHHHHHHHhcCCCCEeeeeeEEccCCeEEEEEEe
Confidence 46888899999874 677765432 22347889999999999999999999999999999999999
Q ss_pred cCCCccchhccccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEEcCCCcEEEeeccCccccccCCc
Q 044312 353 IPNGTLFQYIHDQNEDFPITWEIRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQT 432 (608)
Q Consensus 353 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGls~~~~~~~~ 432 (608)
+++ +|.+++..... .+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++.......
T Consensus 82 ~~~-~l~~~~~~~~~--~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 155 (288)
T 1ob3_A 82 LDQ-DLKKLLDVCEG--GLESVTAKSFLLQLLNGIAYCHDRR---VLHRDLKPQNLLINREGELKIADFGLARAFGIPVR 155 (288)
T ss_dssp CSE-EHHHHHHTSTT--CCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECCTTHHHHHCC---
T ss_pred cCC-CHHHHHHhccc--CCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCCEEEeECccccccCcccc
Confidence 975 99988876433 5899999999999999999999999 99999999999999999999999999986543221
Q ss_pred ceeeeeeccCCCCChhhhccC-CCCCccchHhHHHHHHHHHhCCCCCCccchhhcccHHHHHHHHhhhh---hhHHH---
Q 044312 433 HMTTQVHGTFGYLDPEYFRSS-QFTDKSDVYSFGVVLTELLTGEKPIRFTILEEDKSLAAYFLCAMKEE---RLFEI--- 505 (608)
Q Consensus 433 ~~~~~~~gt~~y~aPE~~~~~-~~t~ksDV~S~Gvvl~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~---~~~~~--- 505 (608)
......||+.|+|||++.+. .++.++||||||++++||++|+.||......+ .+.. ........ .....
T Consensus 156 -~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~--~~~~-~~~~~~~~~~~~~~~~~~~ 231 (288)
T 1ob3_A 156 -KYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEAD--QLMR-IFRILGTPNSKNWPNVTEL 231 (288)
T ss_dssp -------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH--HHHH-HHHHHCCCCTTTSTTGGGS
T ss_pred -ccccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH--HHHH-HHHHHCCCChhhchhhhcc
Confidence 22345689999999999764 58999999999999999999999997432211 1111 11111000 00000
Q ss_pred --hhhhh-------hccCChhHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 044312 506 --LDARV-------MKQGGKDEIITVAKLAKRCLNLNGKKRPTMREVASE 546 (608)
Q Consensus 506 --~d~~~-------~~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~evl~~ 546 (608)
.++.. ........+.++.+|+.+||+.||++|||+.|++++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 281 (288)
T 1ob3_A 232 PKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEH 281 (288)
T ss_dssp TTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred cccccccccccCccHHHHhhhcCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence 00000 011122356788999999999999999999999864
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-37 Score=326.39 Aligned_cols=249 Identities=24% Similarity=0.366 Sum_probs=181.9
Q ss_pred HhcCccccceeccCce---------------EEEEEee--cChhhHHHHHHHHHHHhhcC-CCCccceecccccCc--cc
Q 044312 287 ATDNFDLNRILGQGGQ---------------AVKKSKV--IDESKVEEFINEVVILSQIN-HRNVVKLLGCCLETE--VP 346 (608)
Q Consensus 287 ~t~~f~~~~~lG~G~~---------------avk~~~~--~~~~~~~~~~~Ei~il~~l~-H~niv~l~~~~~~~~--~~ 346 (608)
..++|++.+.||+|+| |||++.. ......+.+.+|+.+|+++. ||||+++++++...+ ..
T Consensus 7 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~ 86 (388)
T 3oz6_A 7 VLRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRADNDRDV 86 (388)
T ss_dssp HHTTEEEEEC-------CEEEEEETTTCCEEEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTSSCE
T ss_pred ccCceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEecccccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCCCEE
Confidence 4568999999999974 7777643 34556778899999999997 999999999986543 68
Q ss_pred eEEEeecCCCccchhccccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEEcCCCcEEEeeccCccc
Q 044312 347 LLVYEFIPNGTLFQYIHDQNEDFPITWEIRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRS 426 (608)
Q Consensus 347 ~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGls~~ 426 (608)
++||||++ ++|.+++... .+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++.
T Consensus 87 ~lv~e~~~-~~L~~~~~~~----~~~~~~~~~i~~qi~~~L~~LH~~~---ivHrDlkp~NIll~~~~~~kl~DFG~a~~ 158 (388)
T 3oz6_A 87 YLVFDYME-TDLHAVIRAN----ILEPVHKQYVVYQLIKVIKYLHSGG---LLHRDMKPSNILLNAECHVKVADFGLSRS 158 (388)
T ss_dssp EEEEECCS-EEHHHHHHHT----CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEE
T ss_pred EEEecccC-cCHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCCCHHHeEEcCCCCEEecCCccccc
Confidence 99999996 6899888753 4899999999999999999999999 99999999999999999999999999986
Q ss_pred cccC--------------------CcceeeeeeccCCCCChhhhcc-CCCCCccchHhHHHHHHHHHhCCCCCCccchhh
Q 044312 427 MAVD--------------------QTHMTTQVHGTFGYLDPEYFRS-SQFTDKSDVYSFGVVLTELLTGEKPIRFTILEE 485 (608)
Q Consensus 427 ~~~~--------------------~~~~~~~~~gt~~y~aPE~~~~-~~~t~ksDV~S~Gvvl~elltg~~p~~~~~~~~ 485 (608)
+... .....+...||+.|+|||++.+ ..++.++|||||||+++||++|+.||.......
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~ 238 (388)
T 3oz6_A 159 FVNIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSSTMN 238 (388)
T ss_dssp SSSCCCCCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH
T ss_pred ccccccccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCHHH
Confidence 5321 1112344579999999999986 678999999999999999999999997433221
Q ss_pred cccHHHHHHHHhhhhh-----------hHHHhh---------------------h-hhhccCChhHHHHHHHHHHHHhcc
Q 044312 486 DKSLAAYFLCAMKEER-----------LFEILD---------------------A-RVMKQGGKDEIITVAKLAKRCLNL 532 (608)
Q Consensus 486 ~~~l~~~~~~~~~~~~-----------~~~~~d---------------------~-~~~~~~~~~~~~~l~~Li~~cl~~ 532 (608)
. +.. ......... ....+. . ..........+.++.+|+.+||+.
T Consensus 239 ~--~~~-i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~ 315 (388)
T 3oz6_A 239 Q--LER-IIGVIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCNEEALDLLDKLLQF 315 (388)
T ss_dssp H--HHH-HHHHHCCCCHHHHHTSCCSSHHHHHHHHHHHCC-----CCCCHHHHHHHHHHHCTTCCCCHHHHHHHHHHCCS
T ss_pred H--HHH-HHHhcCCCCHHHHHhccCHHHHHHHHhCcccccccCCCHHHhCcchhhhcccccccccCCHHHHHHHHHhhcc
Confidence 1 111 111100000 000000 0 000011123456799999999999
Q ss_pred CCCCCCCHHHHHHH
Q 044312 533 NGKKRPTMREVASE 546 (608)
Q Consensus 533 dp~~RPs~~evl~~ 546 (608)
||++|||+.|++++
T Consensus 316 dP~~R~t~~e~l~H 329 (388)
T 3oz6_A 316 NPNKRISANDALKH 329 (388)
T ss_dssp SGGGSCCHHHHTTS
T ss_pred CcccCCCHHHHhCC
Confidence 99999999999865
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-37 Score=319.63 Aligned_cols=251 Identities=25% Similarity=0.336 Sum_probs=185.1
Q ss_pred hcCcccc-ceeccCce---------------EEEEEeecChhhHHHHHHHHHHHhhc-CCCCccceecccccCccceEEE
Q 044312 288 TDNFDLN-RILGQGGQ---------------AVKKSKVIDESKVEEFINEVVILSQI-NHRNVVKLLGCCLETEVPLLVY 350 (608)
Q Consensus 288 t~~f~~~-~~lG~G~~---------------avk~~~~~~~~~~~~~~~Ei~il~~l-~H~niv~l~~~~~~~~~~~lV~ 350 (608)
.+.|.+. +.||+|++ |||+.........+.+.+|+.++.++ +||||+++++++.+.+..++||
T Consensus 11 ~~~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~ 90 (316)
T 2ac3_A 11 EDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVF 90 (316)
T ss_dssp TTSCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECCSSCCHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred ceeEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeCcchhHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEEEE
Confidence 3467774 77999974 78887766566678899999999985 7999999999999999999999
Q ss_pred eecCCCccchhccccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEEcCCCc---EEEeeccCcccc
Q 044312 351 EFIPNGTLFQYIHDQNEDFPITWEIRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYR---AKVSDFGASRSM 427 (608)
Q Consensus 351 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~---~kl~DFGls~~~ 427 (608)
||+++++|.+++.... .+++..+..++.||+.||+|||+.+ |+||||||+|||++.++. +||+|||+++..
T Consensus 91 e~~~~~~L~~~l~~~~---~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~~~ 164 (316)
T 2ac3_A 91 EKMRGGSILSHIHKRR---HFNELEASVVVQDVASALDFLHNKG---IAHRDLKPENILCEHPNQVSPVKICDFDLGSGI 164 (316)
T ss_dssp ECCTTCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEESCSSSSCSEEECCTTCCC--
T ss_pred EcCCCCcHHHHHhccC---CCCHHHHHHHHHHHHHHHHHHHhCC---ceeCCCCHHHEEEccCCCcCceEEEEccCcccc
Confidence 9999999999998653 5899999999999999999999999 999999999999988765 999999999865
Q ss_pred ccCCc------ceeeeeeccCCCCChhhhcc-----CCCCCccchHhHHHHHHHHHhCCCCCCccchhhcccHHHHHHHH
Q 044312 428 AVDQT------HMTTQVHGTFGYLDPEYFRS-----SQFTDKSDVYSFGVVLTELLTGEKPIRFTILEEDKSLAAYFLCA 496 (608)
Q Consensus 428 ~~~~~------~~~~~~~gt~~y~aPE~~~~-----~~~t~ksDV~S~Gvvl~elltg~~p~~~~~~~~~~~l~~~~~~~ 496 (608)
..... .......||+.|+|||++.. ..++.++||||||++++||++|+.||..................
T Consensus 165 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~ 244 (316)
T 2ac3_A 165 KLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPA 244 (316)
T ss_dssp -----------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCCCSCSCC----CCHH
T ss_pred ccCCccccccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCcccccccccccccccchh
Confidence 42211 11223458999999999875 56889999999999999999999999753322110000000000
Q ss_pred hhhhhhHHHhhhhhhccCC----hhHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 044312 497 MKEERLFEILDARVMKQGG----KDEIITVAKLAKRCLNLNGKKRPTMREVASE 546 (608)
Q Consensus 497 ~~~~~~~~~~d~~~~~~~~----~~~~~~l~~Li~~cl~~dp~~RPs~~evl~~ 546 (608)
. ...+.+.+.... ...+ ...+..+.+|+.+||+.||++|||+.|++++
T Consensus 245 ~-~~~~~~~i~~~~-~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~h 296 (316)
T 2ac3_A 245 C-QNMLFESIQEGK-YEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQH 296 (316)
T ss_dssp H-HHHHHHHHHHCC-CCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred H-HHHHHHHHhccC-cccCchhcccCCHHHHHHHHHHhhCChhhCCCHHHHhcC
Confidence 0 000001000000 0111 1245679999999999999999999999874
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-37 Score=319.75 Aligned_cols=244 Identities=28% Similarity=0.401 Sum_probs=183.6
Q ss_pred hcCccccceeccCce---------------EEEEEeec---ChhhHHHHHHHHHHHhhcCCCCccceecccccCccc---
Q 044312 288 TDNFDLNRILGQGGQ---------------AVKKSKVI---DESKVEEFINEVVILSQINHRNVVKLLGCCLETEVP--- 346 (608)
Q Consensus 288 t~~f~~~~~lG~G~~---------------avk~~~~~---~~~~~~~~~~Ei~il~~l~H~niv~l~~~~~~~~~~--- 346 (608)
.++|++.+.||+|++ |||..+.. +....+.|.+|+.++++++||||+++++++......
T Consensus 11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~ 90 (311)
T 3ork_A 11 SDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPL 90 (311)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEETTEEE
T ss_pred cCcEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccCCCCcc
Confidence 467999999999984 67776542 334456899999999999999999999998766544
Q ss_pred -eEEEeecCCCccchhccccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEEcCCCcEEEeeccCcc
Q 044312 347 -LLVYEFIPNGTLFQYIHDQNEDFPITWEIRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASR 425 (608)
Q Consensus 347 -~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGls~ 425 (608)
++||||+++++|.+++.... ++++..++.++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++
T Consensus 91 ~~lv~e~~~g~~L~~~l~~~~---~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~a~ 164 (311)
T 3ork_A 91 PYIVMEYVDGVTLRDIVHTEG---PMTPKRAIEVIADACQALNFSHQNG---IIHRDVKPANIMISATNAVKVMDFGIAR 164 (311)
T ss_dssp EEEEEECCCEEEHHHHHHHHC---SCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEETTSCEEECCCSCC-
T ss_pred cEEEEecCCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC---CCcCCCCHHHEEEcCCCCEEEeeccCcc
Confidence 99999999999999997654 5899999999999999999999999 9999999999999999999999999998
Q ss_pred ccccCCc--ceeeeeeccCCCCChhhhccCCCCCccchHhHHHHHHHHHhCCCCCCccchhhcccHHHHHHHHhhhhhhH
Q 044312 426 SMAVDQT--HMTTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLTELLTGEKPIRFTILEEDKSLAAYFLCAMKEERLF 503 (608)
Q Consensus 426 ~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~ 503 (608)
....... .......||+.|+|||++.+..++.++||||||+++|||++|+.||....... ............
T Consensus 165 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~------~~~~~~~~~~~~ 238 (311)
T 3ork_A 165 AIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVS------VAYQHVREDPIP 238 (311)
T ss_dssp -----------------CCTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHH------HHHHHHHCCCCC
T ss_pred cccccccccccccccCcCcccCCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHH------HHHHHhcCCCCC
Confidence 7654322 12234568999999999999999999999999999999999999996432211 111111111100
Q ss_pred HHhhhhhhccCChhHHHHHHHHHHHHhccCCCCCCCHHHHHH-HHHhh
Q 044312 504 EILDARVMKQGGKDEIITVAKLAKRCLNLNGKKRPTMREVAS-ELAGI 550 (608)
Q Consensus 504 ~~~d~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~evl~-~L~~i 550 (608)
+ .......+.++.+|+.+||+.||++||++.+++. .|..+
T Consensus 239 ----~---~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~ 279 (311)
T 3ork_A 239 ----P---SARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRV 279 (311)
T ss_dssp ----H---HHHSTTCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHH
T ss_pred ----c---ccccCCCCHHHHHHHHHHHhcCHhhChhhHHHHHHHHHHH
Confidence 0 0011234567999999999999999997766554 44333
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-37 Score=320.04 Aligned_cols=246 Identities=25% Similarity=0.386 Sum_probs=193.6
Q ss_pred hcCccccceeccCce--------------------EEEEEee-cChhhHHHHHHHHHHHhhcCCCCccceecccccCccc
Q 044312 288 TDNFDLNRILGQGGQ--------------------AVKKSKV-IDESKVEEFINEVVILSQINHRNVVKLLGCCLETEVP 346 (608)
Q Consensus 288 t~~f~~~~~lG~G~~--------------------avk~~~~-~~~~~~~~~~~Ei~il~~l~H~niv~l~~~~~~~~~~ 346 (608)
.++|.+.+.||+|++ |||.... ........+.+|+.++++++||||+++++++.+....
T Consensus 29 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 108 (327)
T 2yfx_A 29 RKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPR 108 (327)
T ss_dssp GGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred hhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEeccccchhhHHHHHHHHHHHhhCCCCCCCeEEEEEcCCCCc
Confidence 467899999999974 4444432 2345567899999999999999999999999999999
Q ss_pred eEEEeecCCCccchhccccCC----CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEEc---CCCcEEEe
Q 044312 347 LLVYEFIPNGTLFQYIHDQNE----DFPITWEIRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLD---DKYRAKVS 419 (608)
Q Consensus 347 ~lV~E~~~~gsL~~~l~~~~~----~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~---~~~~~kl~ 419 (608)
++||||+++++|.+++..... ...+++..++.++.||+.||.|||+.+ |+||||||+|||++ ++..+||+
T Consensus 109 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~---i~H~dlkp~NIli~~~~~~~~~kl~ 185 (327)
T 2yfx_A 109 FILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENH---FIHRDIAARNCLLTCPGPGRVAKIG 185 (327)
T ss_dssp EEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESCSSTTCCEEEC
T ss_pred EEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhCC---eecCcCCHhHEEEecCCCcceEEEC
Confidence 999999999999999986432 134899999999999999999999999 99999999999998 45569999
Q ss_pred eccCccccccCCc-ceeeeeeccCCCCChhhhccCCCCCccchHhHHHHHHHHHh-CCCCCCccchhhcccHHHHHHHHh
Q 044312 420 DFGASRSMAVDQT-HMTTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLTELLT-GEKPIRFTILEEDKSLAAYFLCAM 497 (608)
Q Consensus 420 DFGls~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~ellt-g~~p~~~~~~~~~~~l~~~~~~~~ 497 (608)
|||+++....... .......+|+.|+|||.+....++.++||||||++++||+| |+.||.......
T Consensus 186 Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~------------ 253 (327)
T 2yfx_A 186 DFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQE------------ 253 (327)
T ss_dssp CCHHHHHHHC------CCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHH------------
T ss_pred ccccccccccccccccCCCcCCCcceeCHhHhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCcCHHH------------
Confidence 9999976543221 12233457889999999999999999999999999999998 999986332111
Q ss_pred hhhhhHHHhhhhhhccCChhHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhhHH
Q 044312 498 KEERLFEILDARVMKQGGKDEIITVAKLAKRCLNLNGKKRPTMREVASELAGIKA 552 (608)
Q Consensus 498 ~~~~~~~~~d~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~evl~~L~~i~~ 552 (608)
+.+.+........+...+..+.+|+.+||+.||++||++.||+++|+.+..
T Consensus 254 ----~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~ 304 (327)
T 2yfx_A 254 ----VLEFVTSGGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQ 304 (327)
T ss_dssp ----HHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred ----HHHHHhcCCCCCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHhc
Confidence 111111111222334556789999999999999999999999999988865
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-37 Score=325.30 Aligned_cols=236 Identities=27% Similarity=0.343 Sum_probs=191.8
Q ss_pred HHhcCccccceeccCce---------------EEEEEeec---ChhhHHHHHHHHHHHhhc-CCCCccceecccccCccc
Q 044312 286 KATDNFDLNRILGQGGQ---------------AVKKSKVI---DESKVEEFINEVVILSQI-NHRNVVKLLGCCLETEVP 346 (608)
Q Consensus 286 ~~t~~f~~~~~lG~G~~---------------avk~~~~~---~~~~~~~~~~Ei~il~~l-~H~niv~l~~~~~~~~~~ 346 (608)
...++|.+.+.||+|+| |||.++.. .....+.+.+|..+++.+ +||||+++++++.+.+..
T Consensus 14 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~~~~ 93 (345)
T 1xjd_A 14 LKIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENL 93 (345)
T ss_dssp --CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEE
T ss_pred CChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEeCCEE
Confidence 44578999999999984 67766532 234567788999999887 999999999999999999
Q ss_pred eEEEeecCCCccchhccccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEEcCCCcEEEeeccCccc
Q 044312 347 LLVYEFIPNGTLFQYIHDQNEDFPITWEIRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRS 426 (608)
Q Consensus 347 ~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGls~~ 426 (608)
++||||+++|+|.+++.... .+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++.
T Consensus 94 ~lv~E~~~gg~L~~~l~~~~---~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~vkL~DFG~a~~ 167 (345)
T 1xjd_A 94 FFVMEYLNGGDLMYHIQSCH---KFDLSRATFYAAEIILGLQFLHSKG---IVYRDLKLDNILLDKDGHIKIADFGMCKE 167 (345)
T ss_dssp EEEEECCTTCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBC
T ss_pred EEEEeCCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCChhhEEECCCCCEEEeEChhhhh
Confidence 99999999999999998643 4899999999999999999999999 99999999999999999999999999986
Q ss_pred cccCCcceeeeeeccCCCCChhhhccCCCCCccchHhHHHHHHHHHhCCCCCCccchhhcccHHHHHHHHhhhhhhHHHh
Q 044312 427 MAVDQTHMTTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLTELLTGEKPIRFTILEEDKSLAAYFLCAMKEERLFEIL 506 (608)
Q Consensus 427 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 506 (608)
..... .......||+.|+|||++.+..++.++||||||++++||++|+.||......+ .+ .. +.
T Consensus 168 ~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~------~~-~~--------i~ 231 (345)
T 1xjd_A 168 NMLGD-AKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEE------LF-HS--------IR 231 (345)
T ss_dssp CCCTT-CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH------HH-HH--------HH
T ss_pred cccCC-CcccCCCCCcccCChhhhcCCCCCChhhhHHHHHHHHHHhcCCCCCCCCCHHH------HH-HH--------HH
Confidence 53322 22345679999999999999999999999999999999999999997432211 11 11 11
Q ss_pred hhhhhccCChhHHHHHHHHHHHHhccCCCCCCCHH-HHHH
Q 044312 507 DARVMKQGGKDEIITVAKLAKRCLNLNGKKRPTMR-EVAS 545 (608)
Q Consensus 507 d~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~-evl~ 545 (608)
.. ....+...+.++.+|+.+||+.||++||++. ||++
T Consensus 232 ~~--~~~~p~~~s~~~~~li~~lL~~dp~~R~~~~~~i~~ 269 (345)
T 1xjd_A 232 MD--NPFYPRWLEKEAKDLLVKLFVREPEKRLGVRGDIRQ 269 (345)
T ss_dssp HC--CCCCCTTSCHHHHHHHHHHSCSSGGGSBTTBSCGGG
T ss_pred hC--CCCCCcccCHHHHHHHHHHhcCCHhHcCCChHHHHc
Confidence 11 1122334567899999999999999999997 6654
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-37 Score=317.18 Aligned_cols=245 Identities=22% Similarity=0.267 Sum_probs=186.1
Q ss_pred hcCccccceeccCce---------------EEEEEeec---ChhhHHHHHHHHHHHhhcCCCCccceecccccCccceEE
Q 044312 288 TDNFDLNRILGQGGQ---------------AVKKSKVI---DESKVEEFINEVVILSQINHRNVVKLLGCCLETEVPLLV 349 (608)
Q Consensus 288 t~~f~~~~~lG~G~~---------------avk~~~~~---~~~~~~~~~~Ei~il~~l~H~niv~l~~~~~~~~~~~lV 349 (608)
-++|.+.+.||+|++ |+|..... +....+.+.+|+.++++++||||+++++++.+.+..++|
T Consensus 33 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv 112 (309)
T 2h34_A 33 FGPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEIDGQLYVD 112 (309)
T ss_dssp -CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEE
T ss_pred eccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEeeCCeEEEE
Confidence 467999999999974 66665432 233357899999999999999999999999999999999
Q ss_pred EeecCCCccchhccccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEEcCCCcEEEeeccCcccccc
Q 044312 350 YEFIPNGTLFQYIHDQNEDFPITWEIRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAV 429 (608)
Q Consensus 350 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGls~~~~~ 429 (608)
|||+++++|.+++.... ++++..++.++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||++.....
T Consensus 113 ~e~~~~~~L~~~l~~~~---~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~ 186 (309)
T 2h34_A 113 MRLINGVDLAAMLRRQG---PLAPPRAVAIVRQIGSALDAAHAAG---ATHRDVKPENILVSADDFAYLVDFGIASATTD 186 (309)
T ss_dssp EECCCCEEHHHHHHHHC---SCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECSCCC------
T ss_pred EEecCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCc---CCcCCCChHHEEEcCCCCEEEecCccCccccc
Confidence 99999999999998653 5899999999999999999999999 99999999999999999999999999987654
Q ss_pred CCcceeeeeeccCCCCChhhhccCCCCCccchHhHHHHHHHHHhCCCCCCccchhhcccHHHHHHHHhhhhhhHHHhhhh
Q 044312 430 DQTHMTTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLTELLTGEKPIRFTILEEDKSLAAYFLCAMKEERLFEILDAR 509 (608)
Q Consensus 430 ~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 509 (608)
..........|++.|+|||.+.+..++.++||||||++++||++|+.||...... .......... .
T Consensus 187 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~-------~~~~~~~~~~-------~ 252 (309)
T 2h34_A 187 EKLTQLGNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPPYQGDQLS-------VMGAHINQAI-------P 252 (309)
T ss_dssp ----------CCGGGCCGGGTCC----CCCHHHHHHHHHHHHHHSSCSSCSCHHH-------HHHHHHHSCC-------C
T ss_pred cccccccccCCCcCccCHHHHcCCCCCchHhHHHHHHHHHHHHHCCCCCCCchHH-------HHHHHhccCC-------C
Confidence 4333344567899999999999999999999999999999999999999742211 1111111000 0
Q ss_pred hhccCChhHHHHHHHHHHHHhccCCCCCC-CHHHHHHHHHhhHH
Q 044312 510 VMKQGGKDEIITVAKLAKRCLNLNGKKRP-TMREVASELAGIKA 552 (608)
Q Consensus 510 ~~~~~~~~~~~~l~~Li~~cl~~dp~~RP-s~~evl~~L~~i~~ 552 (608)
.........+.++.+|+.+||+.||++|| +++++++.|+.+..
T Consensus 253 ~~~~~~~~~~~~l~~li~~~l~~dP~~Rp~s~~~l~~~l~~~l~ 296 (309)
T 2h34_A 253 RPSTVRPGIPVAFDAVIARGMAKNPEDRYVTCGDLSAAAHAALA 296 (309)
T ss_dssp CGGGTSTTCCTHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHTCC
T ss_pred CccccCCCCCHHHHHHHHHhccCCHHHHHHhHHHHHHHHHHHHH
Confidence 01122334556799999999999999999 99999999887654
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-37 Score=313.99 Aligned_cols=243 Identities=26% Similarity=0.415 Sum_probs=187.4
Q ss_pred cCccccceeccCce------------------EEEEEeec---ChhhHHHHHHHHHHHhhcCCCCccceecccccCccce
Q 044312 289 DNFDLNRILGQGGQ------------------AVKKSKVI---DESKVEEFINEVVILSQINHRNVVKLLGCCLETEVPL 347 (608)
Q Consensus 289 ~~f~~~~~lG~G~~------------------avk~~~~~---~~~~~~~~~~Ei~il~~l~H~niv~l~~~~~~~~~~~ 347 (608)
++|++.+.||+|++ |||..+.. .....+.+.+|+.++++++||||+++++++.+.. .+
T Consensus 18 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~~ 96 (291)
T 1u46_A 18 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPP-MK 96 (291)
T ss_dssp GGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS-CE
T ss_pred hHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEccCC-ce
Confidence 46888899999874 34433321 3345678999999999999999999999998765 88
Q ss_pred EEEeecCCCccchhccccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEEcCCCcEEEeeccCcccc
Q 044312 348 LVYEFIPNGTLFQYIHDQNEDFPITWEIRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSM 427 (608)
Q Consensus 348 lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGls~~~ 427 (608)
+||||+++++|.+++..... .+++..+..++.|++.||.|||+++ ++||||||+|||++.++.+||+|||+++..
T Consensus 97 ~v~e~~~~~~L~~~l~~~~~--~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~Nili~~~~~~kl~Dfg~~~~~ 171 (291)
T 1u46_A 97 MVTELAPLGSLLDRLRKHQG--HFLLGTLSRYAVQVAEGMGYLESKR---FIHRDLAARNLLLATRDLVKIGDFGLMRAL 171 (291)
T ss_dssp EEEECCTTCBHHHHHHHHGG--GSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEEEETTEEEECCCTTCEEC
T ss_pred eeEecccCCCHHHHHHhccC--CcCHHHHHHHHHHHHHHHHHHHhCC---cccCCCchheEEEcCCCCEEEccccccccc
Confidence 99999999999999986533 5899999999999999999999999 999999999999999999999999999876
Q ss_pred ccCCcc--eeeeeeccCCCCChhhhccCCCCCccchHhHHHHHHHHHh-CCCCCCccchhhcccHHHHHHHHhhhhhhHH
Q 044312 428 AVDQTH--MTTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLTELLT-GEKPIRFTILEEDKSLAAYFLCAMKEERLFE 504 (608)
Q Consensus 428 ~~~~~~--~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~ellt-g~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~ 504 (608)
...... ......+|+.|+|||.+....++.++||||||++++||++ |+.||......+ .. ..
T Consensus 172 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~------~~---------~~ 236 (291)
T 1u46_A 172 PQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQ------IL---------HK 236 (291)
T ss_dssp CC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH------HH---------HH
T ss_pred cccccchhhhccCCCCceeeCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCcccCCHHH------HH---------HH
Confidence 543322 1233457888999999998889999999999999999999 999986432211 11 11
Q ss_pred HhhhhhhccCChhHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhhHH
Q 044312 505 ILDARVMKQGGKDEIITVAKLAKRCLNLNGKKRPTMREVASELAGIKA 552 (608)
Q Consensus 505 ~~d~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~evl~~L~~i~~ 552 (608)
+.........+...+.++.+++.+||+.||++|||+.++++.|+.+..
T Consensus 237 ~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~ 284 (291)
T 1u46_A 237 IDKEGERLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEAQP 284 (291)
T ss_dssp HHTSCCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC-
T ss_pred HHccCCCCCCCcCcCHHHHHHHHHHccCCcccCcCHHHHHHHHHHhCc
Confidence 111111122334566789999999999999999999999999987765
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-37 Score=310.16 Aligned_cols=239 Identities=25% Similarity=0.374 Sum_probs=191.9
Q ss_pred HhcCccccceeccCce---------------EEEEEee--cChhhHHHHHHHHHHHhhcCCCCccceecccccCccceEE
Q 044312 287 ATDNFDLNRILGQGGQ---------------AVKKSKV--IDESKVEEFINEVVILSQINHRNVVKLLGCCLETEVPLLV 349 (608)
Q Consensus 287 ~t~~f~~~~~lG~G~~---------------avk~~~~--~~~~~~~~~~~Ei~il~~l~H~niv~l~~~~~~~~~~~lV 349 (608)
..++|++.+.||+|++ |+|+... ......+.+.+|+.++++++||||+++++++.+....++|
T Consensus 4 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v 83 (284)
T 3kk8_A 4 FSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLV 83 (284)
T ss_dssp TTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred hhhhhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccCCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEcCCEEEEE
Confidence 3578999999999974 6666643 2344567899999999999999999999999999999999
Q ss_pred EeecCCCccchhccccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEEcCCCc---EEEeeccCccc
Q 044312 350 YEFIPNGTLFQYIHDQNEDFPITWEIRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYR---AKVSDFGASRS 426 (608)
Q Consensus 350 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~---~kl~DFGls~~ 426 (608)
|||+++++|.+.+.... .+++..+..++.|++.||+|||+.+ |+||||||+|||++.++. +||+|||++..
T Consensus 84 ~e~~~~~~l~~~~~~~~---~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~~ 157 (284)
T 3kk8_A 84 FDLVTGGELFEDIVARE---FYSEADASHCIQQILESIAYCHSNG---IVHRNLKPENLLLASKAKGAAVKLADFGLAIE 157 (284)
T ss_dssp ECCCCSCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEESSSSTTCCEEECCCTTCEE
T ss_pred EecCCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC---cCcCCCCHHHEEEecCCCCCcEEEeeceeeEE
Confidence 99999999999887653 5899999999999999999999999 999999999999976554 99999999976
Q ss_pred cccCCcceeeeeeccCCCCChhhhccCCCCCccchHhHHHHHHHHHhCCCCCCccchhhcccHHHHHHHHhhhhhhHHHh
Q 044312 427 MAVDQTHMTTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLTELLTGEKPIRFTILEEDKSLAAYFLCAMKEERLFEIL 506 (608)
Q Consensus 427 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 506 (608)
..... ......||+.|+|||.+.+..++.++||||||+++++|++|+.||....... ..........
T Consensus 158 ~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~-------~~~~~~~~~~---- 224 (284)
T 3kk8_A 158 VNDSE--AWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHR-------LYAQIKAGAY---- 224 (284)
T ss_dssp CCSSC--BCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH-------HHHHHHHTCC----
T ss_pred cccCc--cccCCCCCcCCcCchhhcCCCCCcccchHHHHHHHHHHHHCCCCCCCCchhH-------HHHHHHhccc----
Confidence 65332 2234568999999999999999999999999999999999999986432211 0011111100
Q ss_pred hhhhhccCChhHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 044312 507 DARVMKQGGKDEIITVAKLAKRCLNLNGKKRPTMREVASE 546 (608)
Q Consensus 507 d~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~evl~~ 546 (608)
..........+.++.+|+.+||+.||++|||+.|++++
T Consensus 225 --~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h 262 (284)
T 3kk8_A 225 --DYPSPEWDTVTPEAKSLIDSMLTVNPKKRITADQALKV 262 (284)
T ss_dssp --CCCTTTTTTSCHHHHHHHHHHSCSSTTTSCCHHHHTTS
T ss_pred --cCCchhhcccCHHHHHHHHHHcccChhhCCCHHHHhcC
Confidence 00111112445689999999999999999999999875
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-37 Score=323.19 Aligned_cols=235 Identities=26% Similarity=0.353 Sum_probs=188.9
Q ss_pred cCccccceeccCce---------------EEEEEeec---ChhhHHHHHHHHHHHhhcCCCCccceecccccCccceEEE
Q 044312 289 DNFDLNRILGQGGQ---------------AVKKSKVI---DESKVEEFINEVVILSQINHRNVVKLLGCCLETEVPLLVY 350 (608)
Q Consensus 289 ~~f~~~~~lG~G~~---------------avk~~~~~---~~~~~~~~~~Ei~il~~l~H~niv~l~~~~~~~~~~~lV~ 350 (608)
+.|...+.||+|++ |||+.... .....+.+.+|+.++++++||||+++++++.+.+..+|||
T Consensus 54 ~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 133 (348)
T 1u5q_A 54 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM 133 (348)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred hheeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCeEEEEE
Confidence 45888999999984 67776543 2334568999999999999999999999999999999999
Q ss_pred eecCCCccchhccccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEEcCCCcEEEeeccCccccccC
Q 044312 351 EFIPNGTLFQYIHDQNEDFPITWEIRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVD 430 (608)
Q Consensus 351 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGls~~~~~~ 430 (608)
||+. |+|.+++..... ++++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++.....
T Consensus 134 e~~~-g~l~~~l~~~~~--~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~ 207 (348)
T 1u5q_A 134 EYCL-GSASDLLEVHKK--PLQEVEIAAVTHGALQGLAYLHSHN---MIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA 207 (348)
T ss_dssp ECCS-EEHHHHHHHHTS--CCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEEETTTEEEECCCTTCBSSSSB
T ss_pred ecCC-CCHHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEECCCCCEEEeeccCceecCCC
Confidence 9996 688888865433 5899999999999999999999999 999999999999999999999999999875432
Q ss_pred CcceeeeeeccCCCCChhhhc---cCCCCCccchHhHHHHHHHHHhCCCCCCccchhhcccHHHHHHHHhhhhhhHHHhh
Q 044312 431 QTHMTTQVHGTFGYLDPEYFR---SSQFTDKSDVYSFGVVLTELLTGEKPIRFTILEEDKSLAAYFLCAMKEERLFEILD 507 (608)
Q Consensus 431 ~~~~~~~~~gt~~y~aPE~~~---~~~~t~ksDV~S~Gvvl~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 507 (608)
....||+.|+|||++. ...++.++||||||++++||++|+.||....... ... .+..
T Consensus 208 -----~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~------~~~---------~~~~ 267 (348)
T 1u5q_A 208 -----NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMS------ALY---------HIAQ 267 (348)
T ss_dssp -----CCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHH------HHH---------HHHH
T ss_pred -----CcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHH------HHH---------HHHh
Confidence 2346899999999984 5678999999999999999999999986322111 111 1111
Q ss_pred hhhhccCChhHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHh
Q 044312 508 ARVMKQGGKDEIITVAKLAKRCLNLNGKKRPTMREVASELAG 549 (608)
Q Consensus 508 ~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~evl~~L~~ 549 (608)
...........+..+.+|+.+||+.||++|||+.|++++..-
T Consensus 268 ~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~h~~~ 309 (348)
T 1u5q_A 268 NESPALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFV 309 (348)
T ss_dssp SCCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTCHHH
T ss_pred cCCCCCCCCCCCHHHHHHHHHHcccChhhCcCHHHHhhChhh
Confidence 111111223456679999999999999999999999986543
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-37 Score=323.01 Aligned_cols=238 Identities=25% Similarity=0.382 Sum_probs=177.3
Q ss_pred HHHhcCccccceeccCce---------------EEEEEeecChhhHHHHHHHHHHHhhcCCCCccceecccccCccceEE
Q 044312 285 EKATDNFDLNRILGQGGQ---------------AVKKSKVIDESKVEEFINEVVILSQINHRNVVKLLGCCLETEVPLLV 349 (608)
Q Consensus 285 ~~~t~~f~~~~~lG~G~~---------------avk~~~~~~~~~~~~~~~Ei~il~~l~H~niv~l~~~~~~~~~~~lV 349 (608)
....++|++.+.||+|++ |||..+. ....+.+.+|+.+|++++||||+++++++.+....++|
T Consensus 49 ~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv 126 (349)
T 2w4o_A 49 DALSDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKK--TVDKKIVRTEIGVLLRLSHPNIIKLKEIFETPTEISLV 126 (349)
T ss_dssp SCGGGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC------------CHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred ccccCcEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEecc--chhHHHHHHHHHHHHhCCCCCCcceeeeEecCCeEEEE
Confidence 345678999999999984 6666553 23456788999999999999999999999999999999
Q ss_pred EeecCCCccchhccccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEEcC---CCcEEEeeccCccc
Q 044312 350 YEFIPNGTLFQYIHDQNEDFPITWEIRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDD---KYRAKVSDFGASRS 426 (608)
Q Consensus 350 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~---~~~~kl~DFGls~~ 426 (608)
|||+++++|.+++.... .+++..++.++.||+.||.|||+.+ |+||||||+|||++. ++.+||+|||+++.
T Consensus 127 ~e~~~~~~L~~~l~~~~---~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~~ 200 (349)
T 2w4o_A 127 LELVTGGELFDRIVEKG---YYSERDAADAVKQILEAVAYLHENG---IVHRDLKPENLLYATPAPDAPLKIADFGLSKI 200 (349)
T ss_dssp ECCCCSCBHHHHHTTCS---SCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEESSSSTTCCEEECCCC----
T ss_pred EEeCCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCcccEEEecCCCCCCEEEccCccccc
Confidence 99999999999987643 4899999999999999999999999 999999999999975 88999999999986
Q ss_pred cccCCcceeeeeeccCCCCChhhhccCCCCCccchHhHHHHHHHHHhCCCCCCccchhhcccHHHHHHHHhhhhhhHHHh
Q 044312 427 MAVDQTHMTTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLTELLTGEKPIRFTILEEDKSLAAYFLCAMKEERLFEIL 506 (608)
Q Consensus 427 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 506 (608)
.... .......||+.|+|||++.+..++.++||||||+++|||++|+.||....... .... .+.
T Consensus 201 ~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~------~~~~--------~i~ 264 (349)
T 2w4o_A 201 VEHQ--VLMKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDERGDQ------FMFR--------RIL 264 (349)
T ss_dssp --------------CGGGSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCTTCHH------HHHH--------HHH
T ss_pred cCcc--cccccccCCCCccCHHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCcccH------HHHH--------HHH
Confidence 5432 22344568999999999999999999999999999999999999986322111 0011 111
Q ss_pred hhhh--hccCChhHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 044312 507 DARV--MKQGGKDEIITVAKLAKRCLNLNGKKRPTMREVASE 546 (608)
Q Consensus 507 d~~~--~~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~evl~~ 546 (608)
.... ........+.++.+|+.+||+.||++|||+.|++++
T Consensus 265 ~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 306 (349)
T 2w4o_A 265 NCEYYFISPWWDEVSLNAKDLVRKLIVLDPKKRLTTFQALQH 306 (349)
T ss_dssp TTCCCCCTTTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred hCCCccCCchhhhCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 1110 111123456789999999999999999999999875
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-36 Score=315.36 Aligned_cols=257 Identities=22% Similarity=0.337 Sum_probs=191.6
Q ss_pred HHHHHHhcCccccceeccCce-------------EEEEEeecChhhHHHHHHHHHHHhhc--CCCCccceecccccC---
Q 044312 282 KELEKATDNFDLNRILGQGGQ-------------AVKKSKVIDESKVEEFINEVVILSQI--NHRNVVKLLGCCLET--- 343 (608)
Q Consensus 282 ~~l~~~t~~f~~~~~lG~G~~-------------avk~~~~~~~~~~~~~~~Ei~il~~l--~H~niv~l~~~~~~~--- 343 (608)
..-....++|++.+.||+|++ |||+.. ......+.+|.+++..+ +||||+++++++.+.
T Consensus 30 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~vavK~~~---~~~~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~ 106 (337)
T 3mdy_A 30 LVQRTIAKQIQMVKQIGKGRYGEVWMGKWRGEKVAVKVFF---TTEEASWFRETEIYQTVLMRHENILGFIAADIKGTGS 106 (337)
T ss_dssp HHHTTHHHHCEEEEEEEEETTEEEEEEEETTEEEEEEEEE---GGGHHHHHHHHHHHTSTTCCCTTBCCEEEEEEESCGG
T ss_pred ccccccccceEEEeEeecCCCeEEEEEEECCceEEEEEEe---ccccchhhhHHHHHHHHhhcCCCeeeEEEEEccCCCC
Confidence 333445678999999999985 566554 23445566666666655 999999999999876
Q ss_pred -ccceEEEeecCCCccchhccccCCCCCCCHHHHHHHHHHHHHHHHHHhhc--------CCCCeeccCCCCCcEEEcCCC
Q 044312 344 -EVPLLVYEFIPNGTLFQYIHDQNEDFPITWEIRLRIAIEVSGALSYLHSA--------ASIPIYHRDIKSTNILLDDKY 414 (608)
Q Consensus 344 -~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~--------~~~~iiHrDlk~~NILl~~~~ 414 (608)
...++||||+++|+|.+++... .+++..++.++.|++.||+|||+. + |+||||||+|||++.++
T Consensus 107 ~~~~~lv~e~~~~g~L~~~l~~~----~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~---ivH~Dikp~Nill~~~~ 179 (337)
T 3mdy_A 107 WTQLYLITDYHENGSLYDYLKST----TLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPA---IAHRDLKSKNILVKKNG 179 (337)
T ss_dssp GCEEEEEECCCTTCBHHHHHHHC----CBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCC---EECSCCCGGGEEECTTS
T ss_pred CCceEEEEeccCCCcHHHHhhcc----CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCC---EEecccchHHEEECCCC
Confidence 6789999999999999999653 489999999999999999999998 6 99999999999999999
Q ss_pred cEEEeeccCccccccCCcce---eeeeeccCCCCChhhhccCCCCCc------cchHhHHHHHHHHHhC----------C
Q 044312 415 RAKVSDFGASRSMAVDQTHM---TTQVHGTFGYLDPEYFRSSQFTDK------SDVYSFGVVLTELLTG----------E 475 (608)
Q Consensus 415 ~~kl~DFGls~~~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~t~k------sDV~S~Gvvl~elltg----------~ 475 (608)
.+||+|||+++......... .....||+.|+|||++.....+.+ +||||||+++|||+|| +
T Consensus 180 ~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~~~~~~~~~~ 259 (337)
T 3mdy_A 180 TCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQ 259 (337)
T ss_dssp CEEECCCTTCEECC---------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCC
T ss_pred CEEEEeCCCceeeccccccccCCCCCCccCcceeChhhcccccCCccccCccccchHHHHHHHHHHHhccCccccccccc
Confidence 99999999997765433221 124568999999999988777665 9999999999999999 5
Q ss_pred CCCCccchhhcccHHHHHHHHhhhhhhHHHhhhhhhc-cCChhHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhhHHhc
Q 044312 476 KPIRFTILEEDKSLAAYFLCAMKEERLFEILDARVMK-QGGKDEIITVAKLAKRCLNLNGKKRPTMREVASELAGIKAWN 554 (608)
Q Consensus 476 ~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~-~~~~~~~~~l~~Li~~cl~~dp~~RPs~~evl~~L~~i~~~~ 554 (608)
.||......... ............. .+.... ......+.++.+|+.+||+.||++|||+.||+++|+.+....
T Consensus 260 ~p~~~~~~~~~~--~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~~~ 333 (337)
T 3mdy_A 260 LPYHDLVPSDPS--YEDMREIVCIKKL----RPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKTLAKMSESQ 333 (337)
T ss_dssp CTTTTTSCSSCC--HHHHHHHHTTSCC----CCCCCGGGGGSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHTT
T ss_pred ccHhhhcCCCCc--hhhhHHHHhhhcc----CccccccchhhHHHHHHHHHHHHhhhhChhhCCCHHHHHHHHHHHHhhc
Confidence 665432221111 0001111100000 000000 011266788999999999999999999999999999988754
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-37 Score=326.61 Aligned_cols=237 Identities=23% Similarity=0.365 Sum_probs=187.8
Q ss_pred cCccccceeccCce--------------EEEEEeec--ChhhHHHHHHHHHHHhhcC--CCCccceecccccCccceEEE
Q 044312 289 DNFDLNRILGQGGQ--------------AVKKSKVI--DESKVEEFINEVVILSQIN--HRNVVKLLGCCLETEVPLLVY 350 (608)
Q Consensus 289 ~~f~~~~~lG~G~~--------------avk~~~~~--~~~~~~~~~~Ei~il~~l~--H~niv~l~~~~~~~~~~~lV~ 350 (608)
++|++.+.||+|+| |||++... +....+.+.+|+.+|++++ ||||+++++++...+..+|||
T Consensus 56 ~~y~~~~~LG~G~fg~Vy~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~~~~~lv~ 135 (390)
T 2zmd_A 56 RIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVM 135 (390)
T ss_dssp EEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEE
T ss_pred CceEEEEEEccCCCeEEEEEEcCCCCEEEEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecCCEEEEEE
Confidence 45999999999984 67766542 3455688999999999996 599999999999999999999
Q ss_pred eecCCCccchhccccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEEcCCCcEEEeeccCccccccC
Q 044312 351 EFIPNGTLFQYIHDQNEDFPITWEIRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVD 430 (608)
Q Consensus 351 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGls~~~~~~ 430 (608)
| +.+++|.+++.... .+++..+..++.||+.||.|||+.+ |+||||||+|||++ ++.+||+|||+++.+...
T Consensus 136 E-~~~~~L~~~l~~~~---~~~~~~~~~i~~qi~~aL~~lH~~~---ivHrDlkp~NIll~-~~~~kl~DFG~a~~~~~~ 207 (390)
T 2zmd_A 136 E-CGNIDLNSWLKKKK---SIDPWERKSYWKNMLEAVHTIHQHG---IVHSDLKPANFLIV-DGMLKLIDFGIANQMQPD 207 (390)
T ss_dssp E-CCSEEHHHHHHHCS---SCCHHHHHHHHHHHHHHHHHHHTTT---CCCCCCCGGGEEES-SSCEEECCCSSSCCC---
T ss_pred e-cCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHEEEE-CCeEEEEecCccccccCC
Confidence 9 56889999998653 5899999999999999999999999 99999999999996 578999999999876543
Q ss_pred Ccc-eeeeeeccCCCCChhhhcc-----------CCCCCccchHhHHHHHHHHHhCCCCCCccchhhcccHHHHHHHHhh
Q 044312 431 QTH-MTTQVHGTFGYLDPEYFRS-----------SQFTDKSDVYSFGVVLTELLTGEKPIRFTILEEDKSLAAYFLCAMK 498 (608)
Q Consensus 431 ~~~-~~~~~~gt~~y~aPE~~~~-----------~~~t~ksDV~S~Gvvl~elltg~~p~~~~~~~~~~~l~~~~~~~~~ 498 (608)
... ......||+.|+|||++.. ..++.++|||||||+||||++|+.||...... .
T Consensus 208 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~-----~-------- 274 (390)
T 2zmd_A 208 TTSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQ-----I-------- 274 (390)
T ss_dssp ------CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCCCH-----H--------
T ss_pred CccccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhhHH-----H--------
Confidence 322 2344579999999999875 46899999999999999999999999632111 0
Q ss_pred hhhhHHHhhhhhhccCChhHHHHHHHHHHHHhccCCCCCCCHHHHHHHH
Q 044312 499 EERLFEILDARVMKQGGKDEIITVAKLAKRCLNLNGKKRPTMREVASEL 547 (608)
Q Consensus 499 ~~~~~~~~d~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~evl~~L 547 (608)
..+..++++......+...+.++.+|+.+||+.||++|||+.||+++.
T Consensus 275 -~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~hp 322 (390)
T 2zmd_A 275 -SKLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHP 322 (390)
T ss_dssp -HHHHHHHCTTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSH
T ss_pred -HHHHHHhCccccCCCCccchHHHHHHHHHHcccChhhCCCHHHHhhCc
Confidence 112233333333334444466899999999999999999999999764
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-37 Score=317.06 Aligned_cols=250 Identities=22% Similarity=0.299 Sum_probs=186.1
Q ss_pred HhcCccccceeccCce---------------EEEEEeecCh-----hhHHHHHHHHHHHhhc---CCCCccceecccccC
Q 044312 287 ATDNFDLNRILGQGGQ---------------AVKKSKVIDE-----SKVEEFINEVVILSQI---NHRNVVKLLGCCLET 343 (608)
Q Consensus 287 ~t~~f~~~~~lG~G~~---------------avk~~~~~~~-----~~~~~~~~Ei~il~~l---~H~niv~l~~~~~~~ 343 (608)
.+++|++.++||+|++ |||+...... .....+.+|+.+++++ +||||+++++++...
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~~ 86 (308)
T 3g33_A 7 ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCATS 86 (308)
T ss_dssp ---CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEEEC
T ss_pred cccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeeecc
Confidence 4678999999999984 7787764321 1235677788777776 499999999999765
Q ss_pred c-----cceEEEeecCCCccchhccccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEEcCCCcEEE
Q 044312 344 E-----VPLLVYEFIPNGTLFQYIHDQNEDFPITWEIRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKV 418 (608)
Q Consensus 344 ~-----~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl 418 (608)
. ..++||||+. ++|.+++...... .+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||
T Consensus 87 ~~~~~~~~~lv~e~~~-~~L~~~~~~~~~~-~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~Nil~~~~~~~kl 161 (308)
T 3g33_A 87 RTDREIKVTLVFEHVD-QDLRTYLDKAPPP-GLPAETIKDLMRQFLRGLDFLHANC---IVHRDLKPENILVTSGGTVKL 161 (308)
T ss_dssp CSSSEEEEEEEEECCC-CBHHHHHHTCCTT-CSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCTTTEEECTTSCEEE
T ss_pred CCCCceeEEEEehhhh-cCHHHHHhhccCC-CCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEcCCCCEEE
Confidence 4 4789999996 5999999875432 4999999999999999999999999 999999999999999999999
Q ss_pred eeccCccccccCCcceeeeeeccCCCCChhhhccCCCCCccchHhHHHHHHHHHhCCCCCCccchhhcccHHHHHHHHhh
Q 044312 419 SDFGASRSMAVDQTHMTTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLTELLTGEKPIRFTILEEDKSLAAYFLCAMK 498 (608)
Q Consensus 419 ~DFGls~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~elltg~~p~~~~~~~~~~~l~~~~~~~~~ 498 (608)
+|||+++...... ......||+.|+|||++.+..++.++||||||++++||++|+.||........ .........
T Consensus 162 ~Dfg~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~---~~~i~~~~~ 236 (308)
T 3g33_A 162 ADFGLARIYSYQM--ALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQ---LGKIFDLIG 236 (308)
T ss_dssp CSCSCTTTSTTCC--CSGGGGCCCSSCCHHHHHTSCCCSTHHHHHHHHHHHHTTTSSCSCCCSSHHHH---HHHHHHHHC
T ss_pred eeCccccccCCCc--ccCCccccccccCchHHcCCCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHH---HHHHHHHhC
Confidence 9999998764322 23445789999999999999999999999999999999999999974332211 111111110
Q ss_pred h---hhhHH---Hhhhhh-------hccCChhHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 044312 499 E---ERLFE---ILDARV-------MKQGGKDEIITVAKLAKRCLNLNGKKRPTMREVASE 546 (608)
Q Consensus 499 ~---~~~~~---~~d~~~-------~~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~evl~~ 546 (608)
. ..... ...... ......+.+..+.+|+.+||+.||++|||+.|++++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 297 (308)
T 3g33_A 237 LPPEDDWPRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQH 297 (308)
T ss_dssp CCCTTTSCSSCSSCGGGSCCCCCCCHHHHSCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred CCChhhccchhhccccccCCCCCCcHHHhCccccHHHHHHHHHHhcCCCccCCCHHHHhcC
Confidence 0 00000 000000 000112345678999999999999999999999864
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-37 Score=335.00 Aligned_cols=235 Identities=24% Similarity=0.327 Sum_probs=182.5
Q ss_pred hcCccccceeccCce---------------EEEEEee---cChhhHHHHHHHHHHHhhcCCCCccceecccccCccceEE
Q 044312 288 TDNFDLNRILGQGGQ---------------AVKKSKV---IDESKVEEFINEVVILSQINHRNVVKLLGCCLETEVPLLV 349 (608)
Q Consensus 288 t~~f~~~~~lG~G~~---------------avk~~~~---~~~~~~~~~~~Ei~il~~l~H~niv~l~~~~~~~~~~~lV 349 (608)
.++|++.+.||+|+| |||.++. ........+.+|+.++++++||||+++++++.+.+..+||
T Consensus 147 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv 226 (446)
T 4ejn_A 147 MNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFV 226 (446)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEEETTEEEEE
T ss_pred hHHcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEeeCCEEEEE
Confidence 467999999999984 6666653 2334456788999999999999999999999999999999
Q ss_pred EeecCCCccchhccccCCCCCCCHHHHHHHHHHHHHHHHHHhh-cCCCCeeccCCCCCcEEEcCCCcEEEeeccCccccc
Q 044312 350 YEFIPNGTLFQYIHDQNEDFPITWEIRLRIAIEVSGALSYLHS-AASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMA 428 (608)
Q Consensus 350 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~-~~~~~iiHrDlk~~NILl~~~~~~kl~DFGls~~~~ 428 (608)
|||+++|+|.+++.... .+++..+..++.||+.||+|||+ .+ |+||||||+|||++.++.+||+|||+++...
T Consensus 227 ~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~qi~~aL~~LH~~~g---iiHrDlkp~NIll~~~~~~kl~DFG~a~~~~ 300 (446)
T 4ejn_A 227 MEYANGGELFFHLSRER---VFSEDRARFYGAEIVSALDYLHSEKN---VVYRDLKLENLMLDKDGHIKITDFGLCKEGI 300 (446)
T ss_dssp ECCCSSCBHHHHHHHHS---CCCHHHHHHHHHHHHHHHHHHHHHTC---CCCCCCCGGGEEECSSSCEEECCCCCCCTTC
T ss_pred EeeCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHhhcCC---EEECCCCHHHEEECCCCCEEEccCCCceecc
Confidence 99999999999997653 58999999999999999999998 88 9999999999999999999999999998644
Q ss_pred cCCcceeeeeeccCCCCChhhhccCCCCCccchHhHHHHHHHHHhCCCCCCccchhhcccHHHHHHHHhhhhhhHHHhhh
Q 044312 429 VDQTHMTTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLTELLTGEKPIRFTILEEDKSLAAYFLCAMKEERLFEILDA 508 (608)
Q Consensus 429 ~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 508 (608)
... .......||+.|+|||++.+..++.++||||||++|+||++|+.||....... .+. .+...
T Consensus 301 ~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~------~~~---------~i~~~ 364 (446)
T 4ejn_A 301 KDG-ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEK------LFE---------LILME 364 (446)
T ss_dssp C------CCSSSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH------HHH---------HHHHC
T ss_pred CCC-cccccccCCccccCHhhcCCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHHH------HHH---------HHHhC
Confidence 322 22345679999999999999999999999999999999999999996432211 110 01111
Q ss_pred hhhccCChhHHHHHHHHHHHHhccCCCCCC-----CHHHHHHH
Q 044312 509 RVMKQGGKDEIITVAKLAKRCLNLNGKKRP-----TMREVASE 546 (608)
Q Consensus 509 ~~~~~~~~~~~~~l~~Li~~cl~~dp~~RP-----s~~evl~~ 546 (608)
....+...+.++.+|+.+||+.||++|| +++|++++
T Consensus 365 --~~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~t~~ell~h 405 (446)
T 4ejn_A 365 --EIRFPRTLGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQH 405 (446)
T ss_dssp --CCCCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTS
T ss_pred --CCCCCccCCHHHHHHHHHHcccCHHHhCCCCCCCHHHHHhC
Confidence 1123344567899999999999999999 99998864
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-37 Score=310.05 Aligned_cols=235 Identities=29% Similarity=0.431 Sum_probs=189.1
Q ss_pred HhcCccccceeccCce---------------EEEEEeec---ChhhHHHHHHHHHHHhhcCCCCccceecccccCccceE
Q 044312 287 ATDNFDLNRILGQGGQ---------------AVKKSKVI---DESKVEEFINEVVILSQINHRNVVKLLGCCLETEVPLL 348 (608)
Q Consensus 287 ~t~~f~~~~~lG~G~~---------------avk~~~~~---~~~~~~~~~~Ei~il~~l~H~niv~l~~~~~~~~~~~l 348 (608)
+.++|++.+.||+|++ |||..... .....+.+.+|+.++++++||||+++++++.+....++
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 86 (279)
T 3fdn_A 7 ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYL 86 (279)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEE
T ss_pred ecccEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEecCCEEEE
Confidence 3467899999999984 55555431 12235678999999999999999999999999999999
Q ss_pred EEeecCCCccchhccccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEEcCCCcEEEeeccCccccc
Q 044312 349 VYEFIPNGTLFQYIHDQNEDFPITWEIRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMA 428 (608)
Q Consensus 349 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGls~~~~ 428 (608)
||||+++++|.+++.... .+++..++.++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||++....
T Consensus 87 v~e~~~~~~l~~~l~~~~---~~~~~~~~~~~~qi~~~l~~LH~~~---i~H~dlkp~Nili~~~~~~~l~Dfg~~~~~~ 160 (279)
T 3fdn_A 87 ILEYAPLGTVYRELQKLS---KFDEQRTATYITELANALSYCHSKR---VIHRDIKPENLLLGSAGELKIADFGWSVHAP 160 (279)
T ss_dssp EECCCTTEEHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHTTT---CEECCCCGGGEEECTTSCEEECSCCEESCC-
T ss_pred EEecCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCC---EecccCChHhEEEcCCCCEEEEeccccccCC
Confidence 999999999999997653 4899999999999999999999999 9999999999999999999999999986544
Q ss_pred cCCcceeeeeeccCCCCChhhhccCCCCCccchHhHHHHHHHHHhCCCCCCccchhhcccHHHHHHHHhhhhhhHHHhhh
Q 044312 429 VDQTHMTTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLTELLTGEKPIRFTILEEDKSLAAYFLCAMKEERLFEILDA 508 (608)
Q Consensus 429 ~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 508 (608)
.. ......||+.|+|||.+.+..++.++||||||++++||++|+.||......+ .. ..+.
T Consensus 161 ~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~------~~-~~~~---------- 220 (279)
T 3fdn_A 161 SS---RRTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQE------TY-KRIS---------- 220 (279)
T ss_dssp ----------CCCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHH------HH-HHHH----------
T ss_pred cc---cccccCCCCCccCHhHhccCCCCccchhHhHHHHHHHHHHCCCCCCCCcHHH------HH-HHHH----------
Confidence 32 2234568999999999999999999999999999999999999987332211 00 0000
Q ss_pred hhhccCChhHHHHHHHHHHHHhccCCCCCCCHHHHHHHH
Q 044312 509 RVMKQGGKDEIITVAKLAKRCLNLNGKKRPTMREVASEL 547 (608)
Q Consensus 509 ~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~evl~~L 547 (608)
......+...+..+.+|+.+||+.||++|||+.|++++-
T Consensus 221 ~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~h~ 259 (279)
T 3fdn_A 221 RVEFTFPDFVTEGARDLISRLLKHNPSQRPMLREVLEHP 259 (279)
T ss_dssp HTCCCCCTTSCHHHHHHHHHHCCSSGGGSCCHHHHHHCH
T ss_pred hCCCCCCCcCCHHHHHHHHHHhccChhhCCCHHHHhhCc
Confidence 111223344567899999999999999999999999864
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-36 Score=312.71 Aligned_cols=241 Identities=24% Similarity=0.380 Sum_probs=196.4
Q ss_pred hcCccccceeccCce---------------EEEEEeecC-hhhHHHHHHHHHHHhhcCCCCccceecccccCccceEEEe
Q 044312 288 TDNFDLNRILGQGGQ---------------AVKKSKVID-ESKVEEFINEVVILSQINHRNVVKLLGCCLETEVPLLVYE 351 (608)
Q Consensus 288 t~~f~~~~~lG~G~~---------------avk~~~~~~-~~~~~~~~~Ei~il~~l~H~niv~l~~~~~~~~~~~lV~E 351 (608)
.+.|++.+.||+|++ |||...... ....+.+.+|+.++++++||||+++++++.+....++|||
T Consensus 21 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 100 (303)
T 3a7i_A 21 EELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIME 100 (303)
T ss_dssp GGTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTCSTTHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred HHHHHHhhhhcccCCeEEEEEEECCCCcEEEEEEecccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEE
Confidence 356888999999974 677665432 3457889999999999999999999999999999999999
Q ss_pred ecCCCccchhccccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEEcCCCcEEEeeccCccccccCC
Q 044312 352 FIPNGTLFQYIHDQNEDFPITWEIRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQ 431 (608)
Q Consensus 352 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGls~~~~~~~ 431 (608)
|+++++|.+++... ++++..++.++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||++.......
T Consensus 101 ~~~~~~L~~~~~~~----~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~~ 173 (303)
T 3a7i_A 101 YLGGGSALDLLEPG----PLDETQIATILREILKGLDYLHSEK---KIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQ 173 (303)
T ss_dssp CCTTEEHHHHHTTS----CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECBTTB
T ss_pred eCCCCcHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCChheEEECCCCCEEEeecccceecCccc
Confidence 99999999998642 5899999999999999999999999 9999999999999999999999999998765332
Q ss_pred cceeeeeeccCCCCChhhhccCCCCCccchHhHHHHHHHHHhCCCCCCccchhhcccHHHHHHHHhhhhhhHHHhhhhhh
Q 044312 432 THMTTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLTELLTGEKPIRFTILEEDKSLAAYFLCAMKEERLFEILDARVM 511 (608)
Q Consensus 432 ~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~ 511 (608)
. ......||+.|+|||.+.+..++.++||||||++++||++|+.||....... . ...+.....
T Consensus 174 ~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~------~----------~~~~~~~~~ 236 (303)
T 3a7i_A 174 I-KRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHPMK------V----------LFLIPKNNP 236 (303)
T ss_dssp C-CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHH------H----------HHHHHHSCC
T ss_pred c-ccCccCCCcCccCHHHHhcCCCCchhhhHHHHHHHHHHccCCCCCCCcCHHH------H----------HHHhhcCCC
Confidence 2 2234568999999999999999999999999999999999999986332111 0 001111111
Q ss_pred ccCChhHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhhHH
Q 044312 512 KQGGKDEIITVAKLAKRCLNLNGKKRPTMREVASELAGIKA 552 (608)
Q Consensus 512 ~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~evl~~L~~i~~ 552 (608)
.......+..+.+|+.+||+.||++|||+.|++++..-.+.
T Consensus 237 ~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~~~~~~~ 277 (303)
T 3a7i_A 237 PTLEGNYSKPLKEFVEACLNKEPSFRPTAKELLKHKFILRN 277 (303)
T ss_dssp CCCCSSCCHHHHHHHHHHCCSSGGGSCCHHHHTTCHHHHHH
T ss_pred CCCccccCHHHHHHHHHHcCCChhhCcCHHHHhhChhhhcC
Confidence 22233456679999999999999999999999987655444
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-37 Score=313.08 Aligned_cols=244 Identities=24% Similarity=0.385 Sum_probs=189.8
Q ss_pred hcCccccceeccCce---------------EEEEEeec--ChhhHHHHHHHHHHHhhcCCCCccceecccc--cCccceE
Q 044312 288 TDNFDLNRILGQGGQ---------------AVKKSKVI--DESKVEEFINEVVILSQINHRNVVKLLGCCL--ETEVPLL 348 (608)
Q Consensus 288 t~~f~~~~~lG~G~~---------------avk~~~~~--~~~~~~~~~~Ei~il~~l~H~niv~l~~~~~--~~~~~~l 348 (608)
.++|++.+.||+|++ |+|..... .....+.+.+|+.++++++||||+++++++. .....++
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 84 (279)
T 2w5a_A 5 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYI 84 (279)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGGGTEEEE
T ss_pred hhheeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCCCceEEE
Confidence 357888999999974 66666542 3455678999999999999999999999874 4567899
Q ss_pred EEeecCCCccchhccccC-CCCCCCHHHHHHHHHHHHHHHHHHhhcC--CCCeeccCCCCCcEEEcCCCcEEEeeccCcc
Q 044312 349 VYEFIPNGTLFQYIHDQN-EDFPITWEIRLRIAIEVSGALSYLHSAA--SIPIYHRDIKSTNILLDDKYRAKVSDFGASR 425 (608)
Q Consensus 349 V~E~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~aL~yLH~~~--~~~iiHrDlk~~NILl~~~~~~kl~DFGls~ 425 (608)
||||+++++|.+++.... ....+++..++.++.|++.||+|||+.+ ..+|+||||||+|||++.++.+||+|||+++
T Consensus 85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~ivH~dl~p~NIl~~~~~~~kl~dfg~~~ 164 (279)
T 2w5a_A 85 VMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLAR 164 (279)
T ss_dssp EEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHC------CCCCCSGGGEEECSSSCEEECCCCHHH
T ss_pred EEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcccCCCCeeEEeccchhhEEEcCCCCEEEecCchhe
Confidence 999999999999997632 2235899999999999999999999976 2349999999999999999999999999998
Q ss_pred ccccCCcceeeeeeccCCCCChhhhccCCCCCccchHhHHHHHHHHHhCCCCCCccchhhcccHHHHHHHHhhhhhhHHH
Q 044312 426 SMAVDQTHMTTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLTELLTGEKPIRFTILEEDKSLAAYFLCAMKEERLFEI 505 (608)
Q Consensus 426 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 505 (608)
....... ......|++.|+|||.+.+..++.++||||||++++||++|+.||....... ....+..
T Consensus 165 ~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~-------~~~~i~~------ 230 (279)
T 2w5a_A 165 ILNHDTS-FAKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKE-------LAGKIRE------ 230 (279)
T ss_dssp HC---CH-HHHHHHSCCTTCCHHHHHCC-CCHHHHHHHHHHHHHHHHHSSCSSCCSSHHH-------HHHHHHH------
T ss_pred eeccccc-cccccCCCccccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCcccCHHH-------HHHHHhh------
Confidence 7643321 1233468999999999999999999999999999999999999987432110 1111111
Q ss_pred hhhhhhccCChhHHHHHHHHHHHHhccCCCCCCCHHHHHHHHH
Q 044312 506 LDARVMKQGGKDEIITVAKLAKRCLNLNGKKRPTMREVASELA 548 (608)
Q Consensus 506 ~d~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~evl~~L~ 548 (608)
......+...+.++.+|+.+||+.||++|||+.||++++.
T Consensus 231 ---~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~~~ 270 (279)
T 2w5a_A 231 ---GKFRRIPYRYSDELNEIITRMLNLKDYHRPSVEEILENPL 270 (279)
T ss_dssp ---TCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSTT
T ss_pred ---cccccCCcccCHHHHHHHHHHcCCCcccCCCHHHHHhChh
Confidence 1111233455678999999999999999999999997653
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-37 Score=323.15 Aligned_cols=252 Identities=25% Similarity=0.382 Sum_probs=193.8
Q ss_pred hcCccccceeccCce---------------EEEEEeec-ChhhHHHHHHHHHHHhhcCCCCccceecccccCccceEEEe
Q 044312 288 TDNFDLNRILGQGGQ---------------AVKKSKVI-DESKVEEFINEVVILSQINHRNVVKLLGCCLETEVPLLVYE 351 (608)
Q Consensus 288 t~~f~~~~~lG~G~~---------------avk~~~~~-~~~~~~~~~~Ei~il~~l~H~niv~l~~~~~~~~~~~lV~E 351 (608)
.++|++.+.||+|++ |+|..... .....+.+.+|+.++++++||||+++++++.+.+..++|||
T Consensus 32 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 111 (360)
T 3eqc_A 32 DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME 111 (360)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEETTEEEEEEC
T ss_pred cccceeeeeecCCCCeEEEEEEECCCCcEEEEEEeccccCHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEECCEEEEEEE
Confidence 356889999999974 66666543 34556789999999999999999999999999999999999
Q ss_pred ecCCCccchhccccCCCCCCCHHHHHHHHHHHHHHHHHHhhc-CCCCeeccCCCCCcEEEcCCCcEEEeeccCccccccC
Q 044312 352 FIPNGTLFQYIHDQNEDFPITWEIRLRIAIEVSGALSYLHSA-ASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVD 430 (608)
Q Consensus 352 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~-~~~~iiHrDlk~~NILl~~~~~~kl~DFGls~~~~~~ 430 (608)
|+++++|.+++.... .+++..+..++.|++.||+|||+. + |+||||||+|||++.++.+||+|||+++.....
T Consensus 112 ~~~~~~L~~~l~~~~---~~~~~~~~~i~~~i~~~l~~lh~~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 185 (360)
T 3eqc_A 112 HMDGGSLDQVLKKAG---RIPEQILGKVSIAVIKGLTYLREKHK---IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS 185 (360)
T ss_dssp CCTTCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHHHC---CCCSCCSGGGEEECTTCCEEECCCCCCHHHHHH
T ss_pred CCCCCCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHhCC---EEcCCccHHHEEECCCCCEEEEECCCCcccccc
Confidence 999999999997654 489999999999999999999995 8 999999999999999999999999999765322
Q ss_pred CcceeeeeeccCCCCChhhhccCCCCCccchHhHHHHHHHHHhCCCCCCccchhhcccHHH-------------------
Q 044312 431 QTHMTTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLTELLTGEKPIRFTILEEDKSLAA------------------- 491 (608)
Q Consensus 431 ~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~elltg~~p~~~~~~~~~~~l~~------------------- 491 (608)
......||+.|+|||++.+..++.++||||||++++||++|+.||.............
T Consensus 186 ---~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 262 (360)
T 3eqc_A 186 ---MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGR 262 (360)
T ss_dssp ---C----CCCCTTCCHHHHTTCCCSHHHHHHHHHHHHHHHHHTSCCSSCCCHHHHHHHHC-------------------
T ss_pred ---cccCCCCCCCeECHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccCCCCCCCcccCCC
Confidence 2234568999999999999999999999999999999999999997543322110000
Q ss_pred ----HHHHHhhhhhhHHHhhhhhh----ccCChhHHHHHHHHHHHHhccCCCCCCCHHHHHHHHH
Q 044312 492 ----YFLCAMKEERLFEILDARVM----KQGGKDEIITVAKLAKRCLNLNGKKRPTMREVASELA 548 (608)
Q Consensus 492 ----~~~~~~~~~~~~~~~d~~~~----~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~evl~~L~ 548 (608)
+...........+.++.... .......+.++.+|+.+||+.||++|||++|++++-.
T Consensus 263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~ 327 (360)
T 3eqc_A 263 PLNKFGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAF 327 (360)
T ss_dssp -----------CCCHHHHHHHHHHSCCCCCCTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTSHH
T ss_pred cccccccCCCCcccchhhhhHHhccCCCCCCcccccHHHHHHHHHHhhcChhhCCCHHHHhhChH
Confidence 00000000111122221111 1112234668999999999999999999999997643
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-36 Score=320.03 Aligned_cols=235 Identities=25% Similarity=0.340 Sum_probs=191.6
Q ss_pred hcCccccceeccCce---------------EEEEEeec---ChhhHHHHHHHHHHHhhc-CCCCccceecccccCccceE
Q 044312 288 TDNFDLNRILGQGGQ---------------AVKKSKVI---DESKVEEFINEVVILSQI-NHRNVVKLLGCCLETEVPLL 348 (608)
Q Consensus 288 t~~f~~~~~lG~G~~---------------avk~~~~~---~~~~~~~~~~Ei~il~~l-~H~niv~l~~~~~~~~~~~l 348 (608)
.++|++.+.||+|+| |||.++.. .....+.+.+|..+|+.+ +||||+++++++.+.+..+|
T Consensus 19 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~l 98 (353)
T 2i0e_A 19 LTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYF 98 (353)
T ss_dssp CTTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEECSSEEEE
T ss_pred hHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcCCEEEE
Confidence 467999999999984 66666532 234567789999999988 89999999999999999999
Q ss_pred EEeecCCCccchhccccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEEcCCCcEEEeeccCccccc
Q 044312 349 VYEFIPNGTLFQYIHDQNEDFPITWEIRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMA 428 (608)
Q Consensus 349 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGls~~~~ 428 (608)
||||+++|+|.+++.... .+++..++.++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++...
T Consensus 99 v~E~~~gg~L~~~l~~~~---~~~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~ 172 (353)
T 2i0e_A 99 VMEYVNGGDLMYHIQQVG---RFKEPHAVFYAAEIAIGLFFLQSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKENI 172 (353)
T ss_dssp EEECCCSCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCCC
T ss_pred EEeCCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC---EEeccCCHHHEEEcCCCcEEEEeCCcccccc
Confidence 999999999999998654 4899999999999999999999999 9999999999999999999999999998643
Q ss_pred cCCcceeeeeeccCCCCChhhhccCCCCCccchHhHHHHHHHHHhCCCCCCccchhhcccHHHHHHHHhhhhhhHHHhhh
Q 044312 429 VDQTHMTTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLTELLTGEKPIRFTILEEDKSLAAYFLCAMKEERLFEILDA 508 (608)
Q Consensus 429 ~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 508 (608)
... .......||+.|+|||++.+..++.++||||||++++||++|+.||...... ..+ ..++..
T Consensus 173 ~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~------~~~---------~~i~~~ 236 (353)
T 2i0e_A 173 WDG-VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDED------ELF---------QSIMEH 236 (353)
T ss_dssp CTT-CCBCCCCSCGGGCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHH------HHH---------HHHHHC
T ss_pred cCC-cccccccCCccccChhhhcCCCcCCcccccchHHHHHHHHcCCCCCCCCCHH------HHH---------HHHHhC
Confidence 222 2234567999999999999999999999999999999999999999743211 111 111111
Q ss_pred hhhccCChhHHHHHHHHHHHHhccCCCCCCC-----HHHHHHH
Q 044312 509 RVMKQGGKDEIITVAKLAKRCLNLNGKKRPT-----MREVASE 546 (608)
Q Consensus 509 ~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPs-----~~evl~~ 546 (608)
. ...+...+.++.+|+.+||+.||++||+ ++|++++
T Consensus 237 ~--~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~i~~h 277 (353)
T 2i0e_A 237 N--VAYPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEH 277 (353)
T ss_dssp C--CCCCTTSCHHHHHHHHHHTCSCTTSCTTCSTTHHHHHHTS
T ss_pred C--CCCCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcC
Confidence 1 1233456678999999999999999996 4666553
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-36 Score=316.80 Aligned_cols=235 Identities=26% Similarity=0.355 Sum_probs=180.0
Q ss_pred hcCccccceeccCce------------------EEEEEeec----ChhhHHHHHHHHHHHhhcCCCCccceecccccCcc
Q 044312 288 TDNFDLNRILGQGGQ------------------AVKKSKVI----DESKVEEFINEVVILSQINHRNVVKLLGCCLETEV 345 (608)
Q Consensus 288 t~~f~~~~~lG~G~~------------------avk~~~~~----~~~~~~~~~~Ei~il~~l~H~niv~l~~~~~~~~~ 345 (608)
.++|++.+.||+|++ |+|..+.. .......+.+|+.+|++++||||+++++++.+.+.
T Consensus 16 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~ 95 (327)
T 3a62_A 16 PECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQTGGK 95 (327)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEEECSSC
T ss_pred HHHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEEEcCCE
Confidence 357889999999974 45554432 12345678899999999999999999999999999
Q ss_pred ceEEEeecCCCccchhccccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEEcCCCcEEEeeccCcc
Q 044312 346 PLLVYEFIPNGTLFQYIHDQNEDFPITWEIRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASR 425 (608)
Q Consensus 346 ~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGls~ 425 (608)
.++||||+++++|.+++.... .+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++
T Consensus 96 ~~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~qi~~al~~lH~~~---ivH~Dlkp~Nill~~~~~~kl~Dfg~~~ 169 (327)
T 3a62_A 96 LYLILEYLSGGELFMQLEREG---IFMEDTACFYLAEISMALGHLHQKG---IIYRDLKPENIMLNHQGHVKLTDFGLCK 169 (327)
T ss_dssp EEEEEECCTTEEHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCTTTEEECTTSCEEECCCSCC-
T ss_pred EEEEEeCCCCCcHHHHHHhCC---CCCHHHHHHHHHHHHHHHHHHHhCC---EEcccCCHHHeEECCCCcEEEEeCCccc
Confidence 999999999999999997643 4899999999999999999999999 9999999999999999999999999997
Q ss_pred ccccCCcceeeeeeccCCCCChhhhccCCCCCccchHhHHHHHHHHHhCCCCCCccchhhcccHHHHHHHHhhhhhhHHH
Q 044312 426 SMAVDQTHMTTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLTELLTGEKPIRFTILEEDKSLAAYFLCAMKEERLFEI 505 (608)
Q Consensus 426 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 505 (608)
...... .......||+.|+|||.+.+..++.++||||||+++|||++|+.||....... .+ ..+
T Consensus 170 ~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~------~~---------~~i 233 (327)
T 3a62_A 170 ESIHDG-TVTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGENRKK------TI---------DKI 233 (327)
T ss_dssp ----------CTTSSCCTTSCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH------HH---------HHH
T ss_pred ccccCC-ccccccCCCcCccCHhhCcCCCCCCcccchhHHHHHHHHHHCCCCCCCCCHHH------HH---------HHH
Confidence 644322 12334568999999999999999999999999999999999999997432211 01 111
Q ss_pred hhhhhhccCChhHHHHHHHHHHHHhccCCCCCC-----CHHHHHHH
Q 044312 506 LDARVMKQGGKDEIITVAKLAKRCLNLNGKKRP-----TMREVASE 546 (608)
Q Consensus 506 ~d~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RP-----s~~evl~~ 546 (608)
+.. ....+...+.++.+|+.+||+.||++|| ++.|++++
T Consensus 234 ~~~--~~~~p~~~~~~~~~li~~~L~~dp~~R~~~~~~~~~e~l~h 277 (327)
T 3a62_A 234 LKC--KLNLPPYLTQEARDLLKKLLKRNAASRLGAGPGDAGEVQAH 277 (327)
T ss_dssp HHT--CCCCCTTSCHHHHHHHHHHSCSCGGGSTTSSTTTHHHHHHS
T ss_pred HhC--CCCCCCCCCHHHHHHHHHHHhcCHhhccCCCCCCHHHHHcC
Confidence 111 1123344567899999999999999999 67777664
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-37 Score=346.43 Aligned_cols=249 Identities=26% Similarity=0.414 Sum_probs=195.6
Q ss_pred HHHHHHhcCccccceeccCce------------------EEEEEee-cChhhHHHHHHHHHHHhhcCCCCccceeccccc
Q 044312 282 KELEKATDNFDLNRILGQGGQ------------------AVKKSKV-IDESKVEEFINEVVILSQINHRNVVKLLGCCLE 342 (608)
Q Consensus 282 ~~l~~~t~~f~~~~~lG~G~~------------------avk~~~~-~~~~~~~~~~~Ei~il~~l~H~niv~l~~~~~~ 342 (608)
.+++...++|++.+.||+|+| |||+.+. ......+.|.+|+.++++++||||+++++++.+
T Consensus 383 ~~~~i~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~ 462 (656)
T 2j0j_A 383 RDYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVITE 462 (656)
T ss_dssp GGTBCCGGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTTCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred cccccccccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEec
Confidence 344445677899999999985 3444333 233445789999999999999999999999854
Q ss_pred CccceEEEeecCCCccchhccccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEEcCCCcEEEeecc
Q 044312 343 TEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEIRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFG 422 (608)
Q Consensus 343 ~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFG 422 (608)
+..++||||+++|+|.+++..... .+++..++.++.||+.||+|||+++ |+||||||+|||++.++.+||+|||
T Consensus 463 -~~~~lv~E~~~~g~L~~~l~~~~~--~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDikp~NILl~~~~~vkL~DFG 536 (656)
T 2j0j_A 463 -NPVWIIMELCTLGELRSFLQVRKF--SLDLASLILYAYQLSTALAYLESKR---FVHRDIAARNVLVSSNDCVKLGDFG 536 (656)
T ss_dssp -SSCEEEEECCTTCBHHHHHHHTTT--TCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECCCC
T ss_pred -CceEEEEEcCCCCcHHHHHHhccC--CCCHHHHHHHHHHHHHHHHHHHhCC---ccccccchHhEEEeCCCCEEEEecC
Confidence 568999999999999999976432 5899999999999999999999999 9999999999999999999999999
Q ss_pred CccccccCCcceeeeeeccCCCCChhhhccCCCCCccchHhHHHHHHHHHh-CCCCCCccchhhcccHHHHHHHHhhhhh
Q 044312 423 ASRSMAVDQTHMTTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLTELLT-GEKPIRFTILEEDKSLAAYFLCAMKEER 501 (608)
Q Consensus 423 ls~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~ellt-g~~p~~~~~~~~~~~l~~~~~~~~~~~~ 501 (608)
+++..............+|+.|+|||.+....++.++||||||+++|||++ |..||......+
T Consensus 537 ~a~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~---------------- 600 (656)
T 2j0j_A 537 LSRYMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNND---------------- 600 (656)
T ss_dssp CCCSCCC----------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH----------------
T ss_pred CCeecCCCcceeccCCCCCcceeCHHHhcCCCCCchhhHHHHHHHHHHHHHcCCCCCCCCCHHH----------------
Confidence 998775443333344567889999999999999999999999999999997 999986332211
Q ss_pred hHHHhhhhhhccCChhHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhhHH
Q 044312 502 LFEILDARVMKQGGKDEIITVAKLAKRCLNLNGKKRPTMREVASELAGIKA 552 (608)
Q Consensus 502 ~~~~~d~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~evl~~L~~i~~ 552 (608)
+...+........+...+..+.+|+.+||+.||++|||+.||++.|+.+..
T Consensus 601 ~~~~i~~~~~~~~~~~~~~~l~~li~~~l~~dP~~RPs~~el~~~L~~il~ 651 (656)
T 2j0j_A 601 VIGRIENGERLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILE 651 (656)
T ss_dssp HHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHHHHHcCCCCCCCccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHH
Confidence 011111111223344566789999999999999999999999999998864
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-37 Score=321.79 Aligned_cols=237 Identities=24% Similarity=0.337 Sum_probs=165.9
Q ss_pred cceeccCce---------------EEEEEeecChhhHHHHHHHHHHHhhcC-CCCccceecccccCccceEEEeecCCCc
Q 044312 294 NRILGQGGQ---------------AVKKSKVIDESKVEEFINEVVILSQIN-HRNVVKLLGCCLETEVPLLVYEFIPNGT 357 (608)
Q Consensus 294 ~~~lG~G~~---------------avk~~~~~~~~~~~~~~~Ei~il~~l~-H~niv~l~~~~~~~~~~~lV~E~~~~gs 357 (608)
.+.||+|+| |||.+. ......+.+|+.+++++. ||||+++++++.+....++||||+++|+
T Consensus 16 ~~~lG~G~~g~V~~~~~~~~~~~vavK~~~---~~~~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~~~~lv~e~~~~~~ 92 (325)
T 3kn6_A 16 DKPLGEGSFSICRKCVHKKSNQAFAVKIIS---KRMEANTQKEITALKLCEGHPNIVKLHEVFHDQLHTFLVMELLNGGE 92 (325)
T ss_dssp SCCSEEETTEEEEEEEETTTCCEEEEEEEE---GGGHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECCCCSCB
T ss_pred CCccccCCCeEEEEEEECCCCCEEEEEEEC---hhhhhhHHHHHHHHHHhcCCCCeeEEEEEEEcCCEEEEEEEccCCCc
Confidence 367888874 555553 345677889999999996 9999999999999999999999999999
Q ss_pred cchhccccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEEcCCC---cEEEeeccCccccccCCcce
Q 044312 358 LFQYIHDQNEDFPITWEIRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKY---RAKVSDFGASRSMAVDQTHM 434 (608)
Q Consensus 358 L~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~---~~kl~DFGls~~~~~~~~~~ 434 (608)
|.+++.... .+++..+..|+.||+.||+|||+.+ |+||||||+|||++.++ .+||+|||+++...... ..
T Consensus 93 L~~~l~~~~---~~~~~~~~~i~~qi~~~l~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~~~~~-~~ 165 (325)
T 3kn6_A 93 LFERIKKKK---HFSETEASYIMRKLVSAVSHMHDVG---VVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDN-QP 165 (325)
T ss_dssp HHHHHHHCS---CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEEC----CEEEECCCTTCEECCC-----
T ss_pred HHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC---CeecCCCHHHEEEecCCCcccEEEeccccceecCCCC-Cc
Confidence 999998653 5999999999999999999999999 99999999999997655 89999999998665332 22
Q ss_pred eeeeeccCCCCChhhhccCCCCCccchHhHHHHHHHHHhCCCCCCccchhhcccHHHHHHHHhhhhhhHHHhhhhhhccC
Q 044312 435 TTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLTELLTGEKPIRFTILEEDKSLAAYFLCAMKEERLFEILDARVMKQG 514 (608)
Q Consensus 435 ~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~ 514 (608)
.....||+.|+|||++.+..++.++||||||++++||++|+.||..................+...... ...+.
T Consensus 166 ~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~i~~~~~~------~~~~~ 239 (325)
T 3kn6_A 166 LKTPCFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKKGDFS------FEGEA 239 (325)
T ss_dssp ------------------CCCCHHHHHHHHHHHHHHHHHSSCTTC-------CCCHHHHHHHHTTTCCC------CCSHH
T ss_pred ccccCCCcCccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCccccccccHHHHHHHHHcCCCC------CCccc
Confidence 344568999999999999999999999999999999999999997432211111111111111111100 00000
Q ss_pred ChhHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 044312 515 GKDEIITVAKLAKRCLNLNGKKRPTMREVASE 546 (608)
Q Consensus 515 ~~~~~~~l~~Li~~cl~~dp~~RPs~~evl~~ 546 (608)
....+.++.+|+.+||+.||++|||+.|++++
T Consensus 240 ~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~h 271 (325)
T 3kn6_A 240 WKNVSQEAKDLIQGLLTVDPNKRLKMSGLRYN 271 (325)
T ss_dssp HHTSCHHHHHHHHHHHCCCTTTCCCTTTSTTC
T ss_pred ccCCCHHHHHHHHHHCCCChhHCCCHHHHhcC
Confidence 12345689999999999999999999998754
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-37 Score=327.48 Aligned_cols=259 Identities=25% Similarity=0.358 Sum_probs=199.3
Q ss_pred hcCccccceeccCce---------------EEEEEeecC-hhhHHHHHHHHHHHhhcCCCCccceecccccCc--cceEE
Q 044312 288 TDNFDLNRILGQGGQ---------------AVKKSKVID-ESKVEEFINEVVILSQINHRNVVKLLGCCLETE--VPLLV 349 (608)
Q Consensus 288 t~~f~~~~~lG~G~~---------------avk~~~~~~-~~~~~~~~~Ei~il~~l~H~niv~l~~~~~~~~--~~~lV 349 (608)
.++|.+.++||+|++ |||+.+... ....+.+.+|++++++++||||+++++++.+.. ..++|
T Consensus 8 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~lv 87 (396)
T 4eut_A 8 NHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLI 87 (396)
T ss_dssp SEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEE
T ss_pred CCceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCCCeEEEeeccCCCCeeEEE
Confidence 356889999999984 677665422 334678899999999999999999999987655 67999
Q ss_pred EeecCCCccchhccccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEE----cCCCcEEEeeccCcc
Q 044312 350 YEFIPNGTLFQYIHDQNEDFPITWEIRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILL----DDKYRAKVSDFGASR 425 (608)
Q Consensus 350 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl----~~~~~~kl~DFGls~ 425 (608)
|||+++|+|.+++........+++..++.++.||+.||+|||+.+ |+||||||+|||+ +.++.+||+|||+++
T Consensus 88 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~kL~DFG~a~ 164 (396)
T 4eut_A 88 MEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENG---IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAAR 164 (396)
T ss_dssp ECCCTTEEHHHHTTSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEEECTTSCEEEEECCGGGCE
T ss_pred EecCCCCCHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHHCC---EEECCcCHHHEEEeecCCCceeEEEecCCCce
Confidence 999999999999987655445999999999999999999999999 9999999999999 778889999999998
Q ss_pred ccccCCcceeeeeeccCCCCChhhhcc--------CCCCCccchHhHHHHHHHHHhCCCCCCccchhhcccHHHHHHHHh
Q 044312 426 SMAVDQTHMTTQVHGTFGYLDPEYFRS--------SQFTDKSDVYSFGVVLTELLTGEKPIRFTILEEDKSLAAYFLCAM 497 (608)
Q Consensus 426 ~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~t~ksDV~S~Gvvl~elltg~~p~~~~~~~~~~~l~~~~~~~~ 497 (608)
...... ......||+.|+|||++.. ..++.++||||||+++|||++|+.||......... ...+....
T Consensus 165 ~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~~~~~~--~~~~~~~~ 240 (396)
T 4eut_A 165 ELEDDE--QFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRN--KEVMYKII 240 (396)
T ss_dssp ECCCGG--GSSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTTCTTTC--HHHHHHHH
T ss_pred EccCCC--ccccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcccch--HHHHHHHh
Confidence 765432 2234568999999999865 56788999999999999999999999643221111 11111111
Q ss_pred hhhh---hHHH---h--------hhhhhccCChhHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhhHHh
Q 044312 498 KEER---LFEI---L--------DARVMKQGGKDEIITVAKLAKRCLNLNGKKRPTMREVASELAGIKAW 553 (608)
Q Consensus 498 ~~~~---~~~~---~--------d~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~evl~~L~~i~~~ 553 (608)
.... +... . +..............+.+++.+||+.||++||++.|+++.++.+...
T Consensus 241 ~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~ll~~~L~~dP~~R~s~~e~l~~l~~il~~ 310 (396)
T 4eut_A 241 TGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDILHR 310 (396)
T ss_dssp HSCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHHHTC
T ss_pred cCCCcccchhheeccCCCcccCccCCcccccchHHHhhchHHHHHhhccChhhhccHHHHHHHHHHHhhc
Confidence 1110 0000 0 00011122356778899999999999999999999999999887653
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-36 Score=330.81 Aligned_cols=245 Identities=21% Similarity=0.309 Sum_probs=182.0
Q ss_pred hcCccccceeccCce---------------EEEEEeec--ChhhHHHHHHHHHHHhhcCCCCccceecccccCc------
Q 044312 288 TDNFDLNRILGQGGQ---------------AVKKSKVI--DESKVEEFINEVVILSQINHRNVVKLLGCCLETE------ 344 (608)
Q Consensus 288 t~~f~~~~~lG~G~~---------------avk~~~~~--~~~~~~~~~~Ei~il~~l~H~niv~l~~~~~~~~------ 344 (608)
.++|++.+.||+|+| |||++... .....+.+.+|+.+|++++||||+++++++....
T Consensus 61 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~ 140 (464)
T 3ttj_A 61 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQ 140 (464)
T ss_dssp ETTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCC
T ss_pred cCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECccccChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCccccCC
Confidence 467999999999984 77776542 4456778999999999999999999999986553
Q ss_pred cceEEEeecCCCccchhccccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEEcCCCcEEEeeccCc
Q 044312 345 VPLLVYEFIPNGTLFQYIHDQNEDFPITWEIRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGAS 424 (608)
Q Consensus 345 ~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGls 424 (608)
..+|||||+++ +|.+.+.. .+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||++
T Consensus 141 ~~~lv~E~~~~-~l~~~~~~-----~l~~~~~~~~~~qil~aL~~lH~~~---iiHrDlkp~NIll~~~~~~kl~DFG~a 211 (464)
T 3ttj_A 141 DVYLVMELMDA-NLCQVIQM-----ELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLA 211 (464)
T ss_dssp EEEEEEECCSE-EHHHHHTS-----CCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCCCC
T ss_pred eEEEEEeCCCC-CHHHHHhh-----cCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChHhEEEeCCCCEEEEEEEee
Confidence 46999999965 56666542 3899999999999999999999999 999999999999999999999999999
Q ss_pred cccccCCcceeeeeeccCCCCChhhhccCCCCCccchHhHHHHHHHHHhCCCCCCccchhhcccHHHHHHHHhhh-----
Q 044312 425 RSMAVDQTHMTTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLTELLTGEKPIRFTILEEDKSLAAYFLCAMKE----- 499 (608)
Q Consensus 425 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~elltg~~p~~~~~~~~~~~l~~~~~~~~~~----- 499 (608)
+..... ...+...||+.|+|||++.+..++.++|||||||+|+||++|+.||......+. +. .....+..
T Consensus 212 ~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pF~g~~~~~~--~~-~i~~~lg~p~~~~ 286 (464)
T 3ttj_A 212 RTAGTS--FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQ--WN-KVIEQLGTPCPEF 286 (464)
T ss_dssp -----C--CCC----CCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHH--HH-HHHHHHCSCCHHH
T ss_pred eecCCC--cccCCCcccccccCHHHHcCCCCCHHHHHHHHHHHHHHHHhCCCCCCCCCHHHH--HH-HHHHhcCCCCHHH
Confidence 876432 233456799999999999999999999999999999999999999974332211 11 11110000
Q ss_pred -----hhhHHHhhh---------------hhhcc---CChhHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 044312 500 -----ERLFEILDA---------------RVMKQ---GGKDEIITVAKLAKRCLNLNGKKRPTMREVASE 546 (608)
Q Consensus 500 -----~~~~~~~d~---------------~~~~~---~~~~~~~~l~~Li~~cl~~dp~~RPs~~evl~~ 546 (608)
......+.. ..... .....+.++.+|+.+||+.||++|||++|++++
T Consensus 287 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~H 356 (464)
T 3ttj_A 287 MKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQH 356 (464)
T ss_dssp HTTSCHHHHHHHTTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred HHHcchhhhhHhhcccccCCCChHHhCcccccccccccccccCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 000001000 00000 001125679999999999999999999999985
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-36 Score=315.60 Aligned_cols=238 Identities=25% Similarity=0.360 Sum_probs=191.0
Q ss_pred hcCccccceeccCce---------------EEEEEeecCh------hhHHHHHHHHHHHhhcCCCCccceecccccCccc
Q 044312 288 TDNFDLNRILGQGGQ---------------AVKKSKVIDE------SKVEEFINEVVILSQINHRNVVKLLGCCLETEVP 346 (608)
Q Consensus 288 t~~f~~~~~lG~G~~---------------avk~~~~~~~------~~~~~~~~Ei~il~~l~H~niv~l~~~~~~~~~~ 346 (608)
.++|++.+.||+|++ |||..+.... ...+.+.+|+.++++++||||+++++++.+....
T Consensus 11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 90 (321)
T 2a2a_A 11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRTDV 90 (321)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred hccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEE
Confidence 456899999999974 6676654322 1367899999999999999999999999999999
Q ss_pred eEEEeecCCCccchhccccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEEcCCC----cEEEeecc
Q 044312 347 LLVYEFIPNGTLFQYIHDQNEDFPITWEIRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKY----RAKVSDFG 422 (608)
Q Consensus 347 ~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~----~~kl~DFG 422 (608)
++||||+++++|.+++.... .+++..++.++.|++.||+|||+.+ |+||||||+|||++.++ .+||+|||
T Consensus 91 ~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~i~~qi~~aL~~lH~~~---ivH~dikp~NIl~~~~~~~~~~~kl~Dfg 164 (321)
T 2a2a_A 91 VLILELVSGGELFDFLAQKE---SLSEEEATSFIKQILDGVNYLHTKK---IAHFDLKPENIMLLDKNIPIPHIKLIDFG 164 (321)
T ss_dssp EEEECCCCSCBHHHHHHTCS---CEEHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCTTSSSCCEEECCCT
T ss_pred EEEEEcCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCChHHEEEecCCCCcCCEEEccCc
Confidence 99999999999999997643 5899999999999999999999999 99999999999999887 79999999
Q ss_pred CccccccCCcceeeeeeccCCCCChhhhccCCCCCccchHhHHHHHHHHHhCCCCCCccchhhcccHHHHHHHHhhhhhh
Q 044312 423 ASRSMAVDQTHMTTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLTELLTGEKPIRFTILEEDKSLAAYFLCAMKEERL 502 (608)
Q Consensus 423 ls~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~ 502 (608)
+++...... ......||+.|+|||.+.+..++.++||||||++++||++|+.||......+ .. ..+.....
T Consensus 165 ~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~------~~-~~i~~~~~ 235 (321)
T 2a2a_A 165 LAHEIEDGV--EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQE------TL-ANITSVSY 235 (321)
T ss_dssp TCEECCTTC--CCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHH------HH-HHHHTTCC
T ss_pred cceecCccc--cccccCCCCCccCcccccCCCCCCccccHHHHHHHHHHHHCCCCCCCCCHHH------HH-HHHHhccc
Confidence 998765432 2234568999999999999999999999999999999999999996432211 01 01111000
Q ss_pred HHHhhhhhhccCChhHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 044312 503 FEILDARVMKQGGKDEIITVAKLAKRCLNLNGKKRPTMREVASE 546 (608)
Q Consensus 503 ~~~~d~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~evl~~ 546 (608)
..++.. ....+..+.+|+.+||+.||++|||+.|++++
T Consensus 236 --~~~~~~----~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~h 273 (321)
T 2a2a_A 236 --DFDEEF----FSHTSELAKDFIRKLLVKETRKRLTIQEALRH 273 (321)
T ss_dssp --CCCHHH----HTTCCHHHHHHHHTTSCSSTTTSCCHHHHHHS
T ss_pred --ccChhh----hcccCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 000000 11334578999999999999999999999874
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-36 Score=310.65 Aligned_cols=238 Identities=24% Similarity=0.359 Sum_probs=187.4
Q ss_pred ccccceeccCce---------------EEEEEeecChhhHHHHHHHHHHHhhcCCCCccceecccccCccceEEEeecCC
Q 044312 291 FDLNRILGQGGQ---------------AVKKSKVIDESKVEEFINEVVILSQINHRNVVKLLGCCLETEVPLLVYEFIPN 355 (608)
Q Consensus 291 f~~~~~lG~G~~---------------avk~~~~~~~~~~~~~~~Ei~il~~l~H~niv~l~~~~~~~~~~~lV~E~~~~ 355 (608)
|.....||+|++ |||.....+....+.+.+|+.++++++||||+++++++.+.+..++||||+++
T Consensus 24 ~~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~ 103 (295)
T 2clq_A 24 NGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIFMEQVPG 103 (295)
T ss_dssp TSSBCEEEECSSSEEEEEEETTTCCEEEEEEEECCCC---HHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCSE
T ss_pred CCCcEEEeecCcEEEEEEEECCCCeEEEEEEccCCchHHHHHHHHHHHHHHhCCCCCEeeEeeEEEeCCcEEEEEEeCCC
Confidence 444558999874 77777666666678899999999999999999999999999999999999999
Q ss_pred CccchhccccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEEcC-CCcEEEeeccCccccccCCcce
Q 044312 356 GTLFQYIHDQNEDFPITWEIRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDD-KYRAKVSDFGASRSMAVDQTHM 434 (608)
Q Consensus 356 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~-~~~~kl~DFGls~~~~~~~~~~ 434 (608)
++|.+++........+++..+..++.|++.||+|||+.+ |+||||||+|||++. ++.+||+|||+++...... ..
T Consensus 104 ~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~~~~~-~~ 179 (295)
T 2clq_A 104 GSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQ---IVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGIN-PC 179 (295)
T ss_dssp EEHHHHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTCCEEECCTTTCEESCC-----
T ss_pred CCHHHHHHhhccCCCccHHHHHHHHHHHHHHHHHHHhCC---EEccCCChhhEEEECCCCCEEEeecccccccCCCC-Cc
Confidence 999999987544445789999999999999999999999 999999999999987 8999999999998764322 12
Q ss_pred eeeeeccCCCCChhhhccCC--CCCccchHhHHHHHHHHHhCCCCCCccchhhcccHHHHHHHHhhhhhhHHHhhhhhhc
Q 044312 435 TTQVHGTFGYLDPEYFRSSQ--FTDKSDVYSFGVVLTELLTGEKPIRFTILEEDKSLAAYFLCAMKEERLFEILDARVMK 512 (608)
Q Consensus 435 ~~~~~gt~~y~aPE~~~~~~--~t~ksDV~S~Gvvl~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~ 512 (608)
.....||+.|+|||.+.... ++.++||||||++++||++|+.||....... .... .........
T Consensus 180 ~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~----~~~~----------~~~~~~~~~ 245 (295)
T 2clq_A 180 TETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQ----AAMF----------KVGMFKVHP 245 (295)
T ss_dssp -CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSSHH----HHHH----------HHHHHCCCC
T ss_pred ccccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCchh----HHHH----------hhccccccc
Confidence 23456899999999987653 8899999999999999999999986321111 0000 000011112
Q ss_pred cCChhHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 044312 513 QGGKDEIITVAKLAKRCLNLNGKKRPTMREVASE 546 (608)
Q Consensus 513 ~~~~~~~~~l~~Li~~cl~~dp~~RPs~~evl~~ 546 (608)
..+...+.++.+|+.+||+.||++||++.|++++
T Consensus 246 ~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~ 279 (295)
T 2clq_A 246 EIPESMSAEAKAFILKCFEPDPDKRACANDLLVD 279 (295)
T ss_dssp CCCTTSCHHHHHHHHHTTCSSTTTSCCHHHHHTS
T ss_pred cccccCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 3344566789999999999999999999999864
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-37 Score=322.33 Aligned_cols=234 Identities=24% Similarity=0.369 Sum_probs=189.2
Q ss_pred hcCccccceeccCce---------------EEEEEeec---ChhhHHHHHHHHHHHhhcCCCCccceecccccCccceEE
Q 044312 288 TDNFDLNRILGQGGQ---------------AVKKSKVI---DESKVEEFINEVVILSQINHRNVVKLLGCCLETEVPLLV 349 (608)
Q Consensus 288 t~~f~~~~~lG~G~~---------------avk~~~~~---~~~~~~~~~~Ei~il~~l~H~niv~l~~~~~~~~~~~lV 349 (608)
.++|.+.+.||+|+| |||..... .....+.+.+|+.+++.++||||+++++++.+....++|
T Consensus 8 i~~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv 87 (336)
T 3h4j_B 8 IGPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITTPTDIVMV 87 (336)
T ss_dssp ETTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred cCCEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEE
Confidence 357899999999985 56655421 122245789999999999999999999999999999999
Q ss_pred EeecCCCccchhccccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEEcCCCcEEEeeccCcccccc
Q 044312 350 YEFIPNGTLFQYIHDQNEDFPITWEIRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAV 429 (608)
Q Consensus 350 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGls~~~~~ 429 (608)
|||+ +|+|.+++.... .+++..+..++.||+.||.|||+.+ |+||||||+|||+++++.+||+|||+++....
T Consensus 88 ~E~~-~g~l~~~l~~~~---~l~~~~~~~i~~qi~~aL~~LH~~g---ivH~Dlkp~NIll~~~~~~kl~DFG~s~~~~~ 160 (336)
T 3h4j_B 88 IEYA-GGELFDYIVEKK---RMTEDEGRRFFQQIICAIEYCHRHK---IVHRDLKPENLLLDDNLNVKIADFGLSNIMTD 160 (336)
T ss_dssp ECCC-CEEHHHHHHHHC---SCCHHHHHHHHHHHHHHHHHHHHHT---CCCCCCSTTTEEECTTCCEEECCSSCTBTTTT
T ss_pred EECC-CCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCchhhEEEcCCCCEEEEEeccceeccC
Confidence 9999 789999887654 4899999999999999999999999 99999999999999999999999999987653
Q ss_pred CCcceeeeeeccCCCCChhhhccCCC-CCccchHhHHHHHHHHHhCCCCCCccchhhcccHHHHHHHHhhhhhhHHHhhh
Q 044312 430 DQTHMTTQVHGTFGYLDPEYFRSSQF-TDKSDVYSFGVVLTELLTGEKPIRFTILEEDKSLAAYFLCAMKEERLFEILDA 508 (608)
Q Consensus 430 ~~~~~~~~~~gt~~y~aPE~~~~~~~-t~ksDV~S~Gvvl~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 508 (608)
.. ......||+.|+|||.+.+..+ +.++||||||++++||++|+.||........ ...+..
T Consensus 161 ~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~----------------~~~i~~ 222 (336)
T 3h4j_B 161 GN--FLKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNL----------------FKKVNS 222 (336)
T ss_dssp SB--TTCCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSSTTC----------------BCCCCS
T ss_pred Cc--ccccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCccHHHH----------------HHHHHc
Confidence 32 2234569999999999988776 7899999999999999999999964322110 000000
Q ss_pred hhhccCChhHHHHHHHHHHHHhccCCCCCCCHHHHHHHH
Q 044312 509 RVMKQGGKDEIITVAKLAKRCLNLNGKKRPTMREVASEL 547 (608)
Q Consensus 509 ~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~evl~~L 547 (608)
.....+...+..+.+|+.+||+.||.+|||+.|++++-
T Consensus 223 -~~~~~p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp 260 (336)
T 3h4j_B 223 -CVYVMPDFLSPGAQSLIRRMIVADPMQRITIQEIRRDP 260 (336)
T ss_dssp -SCCCCCTTSCHHHHHHHHTTSCSSGGGSCCHHHHTTCH
T ss_pred -CCCCCcccCCHHHHHHHHHHcCCChhHCcCHHHHHhCh
Confidence 01122334566899999999999999999999998764
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-36 Score=314.94 Aligned_cols=261 Identities=22% Similarity=0.339 Sum_probs=198.8
Q ss_pred cCCHHHHHHHhcCccccceeccCce-------------EEEEEeecChhhHHHHHHHHHHHhh--cCCCCccceeccccc
Q 044312 278 LFTSKELEKATDNFDLNRILGQGGQ-------------AVKKSKVIDESKVEEFINEVVILSQ--INHRNVVKLLGCCLE 342 (608)
Q Consensus 278 ~~~~~~l~~~t~~f~~~~~lG~G~~-------------avk~~~~~~~~~~~~~~~Ei~il~~--l~H~niv~l~~~~~~ 342 (608)
..+...-....++|.+.+.||+|++ |||... ....+.+.+|++++.. ++||||+++++++..
T Consensus 31 ~~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~vavK~~~---~~~~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~ 107 (342)
T 1b6c_B 31 GLPLLVQRTIARTIVLQESIGKGRFGEVWRGKWRGEEVAVKIFS---SREERSWFREAEIYQTVMLRHENILGFIAADNK 107 (342)
T ss_dssp SSCHHHHHHHHHHCEEEEEEEEETTEEEEEEEETTEEEEEEEEC---GGGHHHHHHHHHHHHHSCCCCTTBCCEEEEEEC
T ss_pred CCceeecccccccEEEEeeecCCCCcEEEEEEEcCccEEEEEeC---chhHHHHHHHHHHHHHhhcCCCcEEEEEeeecc
Confidence 3344444556778999999999984 555543 4456778899999988 799999999999987
Q ss_pred Cc----cceEEEeecCCCccchhccccCCCCCCCHHHHHHHHHHHHHHHHHHh--------hcCCCCeeccCCCCCcEEE
Q 044312 343 TE----VPLLVYEFIPNGTLFQYIHDQNEDFPITWEIRLRIAIEVSGALSYLH--------SAASIPIYHRDIKSTNILL 410 (608)
Q Consensus 343 ~~----~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH--------~~~~~~iiHrDlk~~NILl 410 (608)
.. ..++||||+++|+|.+++... .+++..++.++.|++.||+||| +.+ |+||||||+|||+
T Consensus 108 ~~~~~~~~~lv~e~~~~g~L~~~l~~~----~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~---ivH~Dlkp~NIll 180 (342)
T 1b6c_B 108 DNGTWTQLWLVSDYHEHGSLFDYLNRY----TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPA---IAHRDLKSKNILV 180 (342)
T ss_dssp CCSSCCCEEEEECCCTTCBHHHHHHHC----CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCE---EECSCCSGGGEEE
T ss_pred cCCccceeEEEEeecCCCcHHHHHhcc----CccHHHHHHHHHHHHHHHHHHHHHHhhhcccCC---eeeCCCCHHHEEE
Confidence 75 789999999999999999753 4899999999999999999999 777 9999999999999
Q ss_pred cCCCcEEEeeccCccccccCCcc---eeeeeeccCCCCChhhhccCC------CCCccchHhHHHHHHHHHhC-------
Q 044312 411 DDKYRAKVSDFGASRSMAVDQTH---MTTQVHGTFGYLDPEYFRSSQ------FTDKSDVYSFGVVLTELLTG------- 474 (608)
Q Consensus 411 ~~~~~~kl~DFGls~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~------~t~ksDV~S~Gvvl~elltg------- 474 (608)
+.++.+||+|||+++........ ......||+.|+|||.+.... ++.++||||||++++||+||
T Consensus 181 ~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~ 260 (342)
T 1b6c_B 181 KKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIH 260 (342)
T ss_dssp CTTSCEEECCCTTCEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBC
T ss_pred CCCCCEEEEECCCceeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcCCcc
Confidence 99999999999999876543322 123456899999999998763 34689999999999999999
Q ss_pred ---CCCCCccchhhcccHHHHHHHHhhhhhhHHHhhhhhhc-cCChhHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhh
Q 044312 475 ---EKPIRFTILEEDKSLAAYFLCAMKEERLFEILDARVMK-QGGKDEIITVAKLAKRCLNLNGKKRPTMREVASELAGI 550 (608)
Q Consensus 475 ---~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~-~~~~~~~~~l~~Li~~cl~~dp~~RPs~~evl~~L~~i 550 (608)
+.||........ .... +........+ .+.... ....+.+..+.+|+.+||+.||++|||+.||+++|+.+
T Consensus 261 ~~~~~p~~~~~~~~~-~~~~-~~~~~~~~~~----~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~i~~~L~~i 334 (342)
T 1b6c_B 261 EDYQLPYYDLVPSDP-SVEE-MRKVVCEQKL----RPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQL 334 (342)
T ss_dssp CCCCCTTTTTSCSSC-CHHH-HHHHHTTSCC----CCCCCGGGGTSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHHH
T ss_pred cccccCccccCcCcc-cHHH-HHHHHHHHHh----CCCCcccccchhHHHHHHHHHHHHhccChhhCCCHHHHHHHHHHH
Confidence 677753322111 1111 1111111110 010000 01235677899999999999999999999999999998
Q ss_pred HHhc
Q 044312 551 KAWN 554 (608)
Q Consensus 551 ~~~~ 554 (608)
....
T Consensus 335 ~~~~ 338 (342)
T 1b6c_B 335 SQQE 338 (342)
T ss_dssp HHTT
T ss_pred HHHh
Confidence 7653
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-36 Score=329.10 Aligned_cols=180 Identities=27% Similarity=0.427 Sum_probs=144.4
Q ss_pred hcCccccceeccCce---------------EEEEEee--cChhhHHHHHHHHHHHhhcCCCCccceecccccC-----cc
Q 044312 288 TDNFDLNRILGQGGQ---------------AVKKSKV--IDESKVEEFINEVVILSQINHRNVVKLLGCCLET-----EV 345 (608)
Q Consensus 288 t~~f~~~~~lG~G~~---------------avk~~~~--~~~~~~~~~~~Ei~il~~l~H~niv~l~~~~~~~-----~~ 345 (608)
.++|++.+.||+|+| |||++.. .+....+.+.+|+.+|++++|||||++++++... ..
T Consensus 52 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~ 131 (458)
T 3rp9_A 52 PDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFDE 131 (458)
T ss_dssp CTTEEECCC-------CEEEEEECC--CEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCC
T ss_pred CCCeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhhcCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCcccCce
Confidence 468999999999984 7777653 2344567899999999999999999999998433 56
Q ss_pred ceEEEeecCCCccchhccccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEEcCCCcEEEeeccCcc
Q 044312 346 PLLVYEFIPNGTLFQYIHDQNEDFPITWEIRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASR 425 (608)
Q Consensus 346 ~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGls~ 425 (608)
.++||||+ +++|.+++.... .+++..+..++.||+.||+|||+.+ |+||||||+||||+.++.+||+|||+++
T Consensus 132 ~~lv~e~~-~~~L~~~~~~~~---~l~~~~~~~~~~qi~~aL~~LH~~~---iiHrDlKp~NILl~~~~~~kl~DFGla~ 204 (458)
T 3rp9_A 132 LYVVLEIA-DSDFKKLFRTPV---YLTELHIKTLLYNLLVGVKYVHSAG---ILHRDLKPANCLVNQDCSVKVCDFGLAR 204 (458)
T ss_dssp EEEEECCC-SEEHHHHHHSSC---CCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTCCEEECCCTTCB
T ss_pred EEEEEecc-ccchhhhcccCC---CCCHHHHHHHHHHHHHHHHHHHhCC---cCCCCCChhhEEECCCCCEeecccccch
Confidence 89999998 579999887543 5999999999999999999999999 9999999999999999999999999998
Q ss_pred ccccCCc--------------------------ceeeeeeccCCCCChhhh-ccCCCCCccchHhHHHHHHHHHhC
Q 044312 426 SMAVDQT--------------------------HMTTQVHGTFGYLDPEYF-RSSQFTDKSDVYSFGVVLTELLTG 474 (608)
Q Consensus 426 ~~~~~~~--------------------------~~~~~~~gt~~y~aPE~~-~~~~~t~ksDV~S~Gvvl~elltg 474 (608)
....... ...+...||+.|+|||++ ....++.++|||||||+|+||++|
T Consensus 205 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~elltg 280 (458)
T 3rp9_A 205 TVDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNM 280 (458)
T ss_dssp CTTSCTTCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHTT
T ss_pred hccCccccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHHHHh
Confidence 7643211 123445789999999986 566799999999999999999994
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-37 Score=310.36 Aligned_cols=233 Identities=20% Similarity=0.270 Sum_probs=187.2
Q ss_pred HhcCccccceeccCce---------------EEEEEee--cChhhHHHHHHHHHHHhhc-CCCCccceecccccCccceE
Q 044312 287 ATDNFDLNRILGQGGQ---------------AVKKSKV--IDESKVEEFINEVVILSQI-NHRNVVKLLGCCLETEVPLL 348 (608)
Q Consensus 287 ~t~~f~~~~~lG~G~~---------------avk~~~~--~~~~~~~~~~~Ei~il~~l-~H~niv~l~~~~~~~~~~~l 348 (608)
.+++|++.+.||+|++ |||..+. ........+.+|+.++.++ +||||+++++++.+.+..++
T Consensus 9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~~~~~l 88 (289)
T 1x8b_A 9 YTTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAEDDHMLI 88 (289)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEETTEEEE
T ss_pred ccchhhhhhhhcCCCceEEEEEEEcCCCceEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEE
Confidence 3457889999999974 7777664 2344567899999999999 99999999999999999999
Q ss_pred EEeecCCCccchhccccCC-CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEEcC---------------
Q 044312 349 VYEFIPNGTLFQYIHDQNE-DFPITWEIRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDD--------------- 412 (608)
Q Consensus 349 V~E~~~~gsL~~~l~~~~~-~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~--------------- 412 (608)
||||+++++|.+++..... ...+++..++.++.||+.||+|||+++ |+||||||+|||++.
T Consensus 89 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dikp~NIl~~~~~~~~~~~~~~~~~~ 165 (289)
T 1x8b_A 89 QNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSMS---LVHMDIKPSNIFISRTSIPNAASEEGDEDD 165 (289)
T ss_dssp EEECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEC----------------
T ss_pred EEEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHhCC---EeecCCCHHHEEEcCCCCCccccccccccc
Confidence 9999999999999976422 135899999999999999999999999 999999999999984
Q ss_pred ----CCcEEEeeccCccccccCCcceeeeeeccCCCCChhhhccC-CCCCccchHhHHHHHHHHHhCCCCCCccchhhcc
Q 044312 413 ----KYRAKVSDFGASRSMAVDQTHMTTQVHGTFGYLDPEYFRSS-QFTDKSDVYSFGVVLTELLTGEKPIRFTILEEDK 487 (608)
Q Consensus 413 ----~~~~kl~DFGls~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~t~ksDV~S~Gvvl~elltg~~p~~~~~~~~~~ 487 (608)
...+||+|||++....... ...||+.|+|||.+.+. .++.++||||||++++||++|.+|+.....
T Consensus 166 ~~~~~~~~kl~Dfg~~~~~~~~~-----~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~---- 236 (289)
T 1x8b_A 166 WASNKVMFKIGDLGHVTRISSPQ-----VEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNGDQ---- 236 (289)
T ss_dssp ----CCCEEECCCTTCEETTCSC-----CCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCCCSSSHH----
T ss_pred ccCCceEEEEcccccccccCCcc-----ccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCCCcchhH----
Confidence 4479999999998765332 23489999999999876 567899999999999999999887542110
Q ss_pred cHHHHHHHHhhhhhhHHHhhhhhhccCChhHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 044312 488 SLAAYFLCAMKEERLFEILDARVMKQGGKDEIITVAKLAKRCLNLNGKKRPTMREVASE 546 (608)
Q Consensus 488 ~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~evl~~ 546 (608)
...+.. ......+...+..+.+|+.+||+.||++|||+.|++++
T Consensus 237 ------~~~~~~---------~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h 280 (289)
T 1x8b_A 237 ------WHEIRQ---------GRLPRIPQVLSQEFTELLKVMIHPDPERRPSAMALVKH 280 (289)
T ss_dssp ------HHHHHT---------TCCCCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTC
T ss_pred ------HHHHHc---------CCCCCCCcccCHHHHHHHHHHhCCCcccCCCHHHHhhC
Confidence 001111 11122334456789999999999999999999999864
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-36 Score=305.17 Aligned_cols=239 Identities=29% Similarity=0.428 Sum_probs=190.2
Q ss_pred hcCccccceeccCce---------------EEEEEeecC-hhhHHHHHHHHHHHhhcCCCCccceecccccCccceEEEe
Q 044312 288 TDNFDLNRILGQGGQ---------------AVKKSKVID-ESKVEEFINEVVILSQINHRNVVKLLGCCLETEVPLLVYE 351 (608)
Q Consensus 288 t~~f~~~~~lG~G~~---------------avk~~~~~~-~~~~~~~~~Ei~il~~l~H~niv~l~~~~~~~~~~~lV~E 351 (608)
.++|++.+.||+|++ |||...... ....+.+.+|+.++++++||||+++++++.+.+..++|||
T Consensus 6 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 85 (276)
T 2yex_A 6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLE 85 (276)
T ss_dssp HHHEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGCTTHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred ecceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccchhhhHHHHHHHHHHHhcCCCCceeeeeEEEcCCEEEEEEE
Confidence 356888999999874 677665432 3446789999999999999999999999999999999999
Q ss_pred ecCCCccchhccccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEEcCCCcEEEeeccCccccccCC
Q 044312 352 FIPNGTLFQYIHDQNEDFPITWEIRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQ 431 (608)
Q Consensus 352 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGls~~~~~~~ 431 (608)
|+++++|.+++.... .+++..++.++.|++.||+|||+.+ ++||||||+|||++.++.+||+|||++.......
T Consensus 86 ~~~~~~L~~~l~~~~---~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~ 159 (276)
T 2yex_A 86 YCSGGELFDRIEPDI---GMPEPDAQRFFHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNN 159 (276)
T ss_dssp CCTTEEGGGGSBTTT---BCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTTCEECEETT
T ss_pred ecCCCcHHHHHhhcc---CCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCChHHEEEccCCCEEEeeCCCccccCCCc
Confidence 999999999987543 5899999999999999999999999 9999999999999999999999999998664322
Q ss_pred c-ceeeeeeccCCCCChhhhccCCC-CCccchHhHHHHHHHHHhCCCCCCccchhhcccHHHHHHHHhhhhhhHHHhhhh
Q 044312 432 T-HMTTQVHGTFGYLDPEYFRSSQF-TDKSDVYSFGVVLTELLTGEKPIRFTILEEDKSLAAYFLCAMKEERLFEILDAR 509 (608)
Q Consensus 432 ~-~~~~~~~gt~~y~aPE~~~~~~~-t~ksDV~S~Gvvl~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 509 (608)
. .......||+.|+|||.+.+..+ +.++||||||++++||++|+.||........ ... .... ..
T Consensus 160 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~-~~~-----~~~~--------~~ 225 (276)
T 2yex_A 160 RERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQ-EYS-----DWKE--------KK 225 (276)
T ss_dssp EECCBCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTTSH-HHH-----HHHT--------TC
T ss_pred chhcccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHHH-HHH-----Hhhh--------cc
Confidence 1 12334568999999999987765 7899999999999999999999974322110 000 0110 00
Q ss_pred hhccCChhHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 044312 510 VMKQGGKDEIITVAKLAKRCLNLNGKKRPTMREVASE 546 (608)
Q Consensus 510 ~~~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~evl~~ 546 (608)
.........+..+.+|+.+||+.||++|||+.|++++
T Consensus 226 ~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 262 (276)
T 2yex_A 226 TYLNPWKKIDSAPLALLHKILVENPSARITIPDIKKD 262 (276)
T ss_dssp TTSTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred cccCchhhcCHHHHHHHHHHCCCCchhCCCHHHHhcC
Confidence 0011122445678999999999999999999999753
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-37 Score=318.27 Aligned_cols=257 Identities=24% Similarity=0.384 Sum_probs=185.6
Q ss_pred hcCccccceeccCce-------------EEEEEeecChhhHHHHHHHHHHH--hhcCCCCccceeccc-----ccCccce
Q 044312 288 TDNFDLNRILGQGGQ-------------AVKKSKVIDESKVEEFINEVVIL--SQINHRNVVKLLGCC-----LETEVPL 347 (608)
Q Consensus 288 t~~f~~~~~lG~G~~-------------avk~~~~~~~~~~~~~~~Ei~il--~~l~H~niv~l~~~~-----~~~~~~~ 347 (608)
.++|++.+.||+|+| |||+... .....+..|.+++ +.++||||+++++.+ ......+
T Consensus 12 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~vavK~~~~---~~~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~~ 88 (336)
T 3g2f_A 12 LDNLKLLELIGRGRYGAVYKGSLDERPVAVKVFSF---ANRQNFINEKNIYRVPLMEHDNIARFIVGDERVTADGRMEYL 88 (336)
T ss_dssp TTSEEEEEEEEECSSEEEEEEEETTEEEEEEEEEG---GGHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECTTSCEEEE
T ss_pred hHHhheeeecccCCCeEEEEEEECCeEEEEEEeec---cchhhHHHHHHHHHHHhccCcchhhheecccccccCCCceEE
Confidence 357899999999985 5665543 3445555555554 458999999999743 3344678
Q ss_pred EEEeecCCCccchhccccCCCCCCCHHHHHHHHHHHHHHHHHHhhc---------CCCCeeccCCCCCcEEEcCCCcEEE
Q 044312 348 LVYEFIPNGTLFQYIHDQNEDFPITWEIRLRIAIEVSGALSYLHSA---------ASIPIYHRDIKSTNILLDDKYRAKV 418 (608)
Q Consensus 348 lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~---------~~~~iiHrDlk~~NILl~~~~~~kl 418 (608)
|||||+++|+|.+++... ..++..++.++.||+.||+|||+. + |+||||||+|||++.++.+||
T Consensus 89 lv~e~~~~g~L~~~l~~~----~~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~---ivH~Dikp~Nill~~~~~~kL 161 (336)
T 3g2f_A 89 LVMEYYPNGSLXKYLSLH----TSDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPA---ISHRDLNSRNVLVKNDGTCVI 161 (336)
T ss_dssp EEECCCTTCBHHHHHHHC----CBCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCC---EECSSCSGGGEEECTTSCEEE
T ss_pred EEEecCCCCcHHHHHhhc----ccchhHHHHHHHHHHHHHHHHHhhhccccccccc---eeecccccceEEEcCCCcEEE
Confidence 999999999999999754 358999999999999999999998 7 999999999999999999999
Q ss_pred eeccCccccccCCc-------ceeeeeeccCCCCChhhhcc-------CCCCCccchHhHHHHHHHHHhCCCCCCccchh
Q 044312 419 SDFGASRSMAVDQT-------HMTTQVHGTFGYLDPEYFRS-------SQFTDKSDVYSFGVVLTELLTGEKPIRFTILE 484 (608)
Q Consensus 419 ~DFGls~~~~~~~~-------~~~~~~~gt~~y~aPE~~~~-------~~~t~ksDV~S~Gvvl~elltg~~p~~~~~~~ 484 (608)
+|||+++.+..... .......||+.|+|||++.+ ..++.++||||||+++|||++|..|+......
T Consensus 162 ~DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~ 241 (336)
T 3g2f_A 162 SDFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGESV 241 (336)
T ss_dssp CCCTTCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGGSTTSCC
T ss_pred eeccceeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCcCCCccch
Confidence 99999987653221 11223468999999999986 45677999999999999999998776432211
Q ss_pred hcccHHHHHHHHhhh----hhhHHHhh-hhhhc------cCChhHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhhHHh
Q 044312 485 EDKSLAAYFLCAMKE----ERLFEILD-ARVMK------QGGKDEIITVAKLAKRCLNLNGKKRPTMREVASELAGIKAW 553 (608)
Q Consensus 485 ~~~~l~~~~~~~~~~----~~~~~~~d-~~~~~------~~~~~~~~~l~~Li~~cl~~dp~~RPs~~evl~~L~~i~~~ 553 (608)
...... +...... ......+. ..... ......+..+.+|+.+||+.||++|||+.||++.|+.+...
T Consensus 242 ~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~e~l~~L~~ll~~ 319 (336)
T 3g2f_A 242 PEYQMA--FQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIEDCWDQDAEARLTAQXAEERMAELMMI 319 (336)
T ss_dssp CCCCCT--THHHHCSSCCHHHHHHHHTTSCCCCCCCTTCCCCSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred hHHHHh--hhcccCCCchHHHHHhhhcccccCCCCCcccccccchHHHHHHHHHHHhcCChhhCcchHHHHHHHHHHHHH
Confidence 110000 0000000 00000000 00001 11234667899999999999999999999999999998865
Q ss_pred cCC
Q 044312 554 NGA 556 (608)
Q Consensus 554 ~~~ 556 (608)
...
T Consensus 320 ~~~ 322 (336)
T 3g2f_A 320 WER 322 (336)
T ss_dssp CCC
T ss_pred HHh
Confidence 443
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-37 Score=322.33 Aligned_cols=255 Identities=15% Similarity=0.198 Sum_probs=192.3
Q ss_pred hcCccccceeccCceE-----------------------EEEEeecChhhHHHHHHHHHHHhhcCCCCccc---------
Q 044312 288 TDNFDLNRILGQGGQA-----------------------VKKSKVIDESKVEEFINEVVILSQINHRNVVK--------- 335 (608)
Q Consensus 288 t~~f~~~~~lG~G~~a-----------------------vk~~~~~~~~~~~~~~~Ei~il~~l~H~niv~--------- 335 (608)
.++|.+.+.||+|+++ ||... ..+.+.+|+.++++++||||++
T Consensus 41 ~~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~-----~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~ 115 (352)
T 2jii_A 41 GRQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDA-----KDGRLFNEQNFFQRAAKPLQVNKWKKLYSTP 115 (352)
T ss_dssp SCEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEE-----TTSTHHHHHHHHHHHCCHHHHHHHHHHTTCT
T ss_pred CCeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEec-----ccchHHHHHHHHHHhcccchhhhhhhhccCC
Confidence 3578999999999852 22222 1146889999999999999998
Q ss_pred ------eeccccc-CccceEEEeecCCCccchhccccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcE
Q 044312 336 ------LLGCCLE-TEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEIRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNI 408 (608)
Q Consensus 336 ------l~~~~~~-~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NI 408 (608)
+++++.. ....+|||||+ +++|.+++..... ..+++..++.|+.||+.||+|||+.+ |+||||||+||
T Consensus 116 ~~~i~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~-~~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dikp~NI 190 (352)
T 2jii_A 116 LLAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVSPK-HVLSERSVLQVACRLLDALEFLHENE---YVHGNVTAENI 190 (352)
T ss_dssp TCSCCCCCEEEEETTTEEEEEEECC-CEEHHHHHHHSGG-GCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCCGGGE
T ss_pred ccCccchhhccccCCcEEEEEecCC-CcCHHHHHHhCCc-CCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCCHHHE
Confidence 4455544 67789999999 9999999986522 25999999999999999999999999 99999999999
Q ss_pred EEcCCC--cEEEeeccCccccccCCcc------eeeeeeccCCCCChhhhccCCCCCccchHhHHHHHHHHHhCCCCCCc
Q 044312 409 LLDDKY--RAKVSDFGASRSMAVDQTH------MTTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLTELLTGEKPIRF 480 (608)
Q Consensus 409 Ll~~~~--~~kl~DFGls~~~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~elltg~~p~~~ 480 (608)
|++.++ .+||+|||+++.+...... ......||+.|+|||++.+..++.++||||||++++||++|+.||..
T Consensus 191 l~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~ 270 (352)
T 2jii_A 191 FVDPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCGPSRRSDLQSLGYCMLKWLYGFLPWTN 270 (352)
T ss_dssp EEETTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGG
T ss_pred EEcCCCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCccc
Confidence 999998 8999999999876543221 11334789999999999999999999999999999999999999974
Q ss_pred cchhhcccHHHHHHHHhhhhhhHHHhhhhhhccCChhHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhhHHhcCCCc
Q 044312 481 TILEEDKSLAAYFLCAMKEERLFEILDARVMKQGGKDEIITVAKLAKRCLNLNGKKRPTMREVASELAGIKAWNGASN 558 (608)
Q Consensus 481 ~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~evl~~L~~i~~~~~~~~ 558 (608)
...... .... ....... ....+.+. .......+.++.+|+.+||+.||++|||+.||++.|+.+....+...
T Consensus 271 ~~~~~~-~~~~-~~~~~~~-~~~~~~~~---~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~~~~~~~ 342 (352)
T 2jii_A 271 CLPNTE-DIMK-QKQKFVD-KPGPFVGP---CGHWIRPSETLQKYLKVVMALTYEEKPPYAMLRNNLEALLQDLRVSP 342 (352)
T ss_dssp GTTCHH-HHHH-HHHHHHH-SCCCEECT---TSCEECCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHTTCCT
T ss_pred CCcCHH-HHHH-HHHhccC-Chhhhhhh---ccccCCCcHHHHHHHHHHHhCChhhCCCHHHHHHHHHHHHHhcCCCc
Confidence 321111 0000 0000000 00000000 00011335789999999999999999999999999999987765443
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-36 Score=309.41 Aligned_cols=239 Identities=26% Similarity=0.373 Sum_probs=183.4
Q ss_pred hcCccccceeccCce---------------EEEEEeec-ChhhHHHHHHHHHHHhhcCCCCccceecccccCccceEEEe
Q 044312 288 TDNFDLNRILGQGGQ---------------AVKKSKVI-DESKVEEFINEVVILSQINHRNVVKLLGCCLETEVPLLVYE 351 (608)
Q Consensus 288 t~~f~~~~~lG~G~~---------------avk~~~~~-~~~~~~~~~~Ei~il~~l~H~niv~l~~~~~~~~~~~lV~E 351 (608)
.++|.+.++||+|++ |+|+.... .....+.+.+|+++|++++||||+++++++.+....++|||
T Consensus 21 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 100 (285)
T 3is5_A 21 DDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNMYIVME 100 (285)
T ss_dssp HHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred hhheeecceeccCCCeEEEEEEEccCCceEEEEEeeccccchhHHHHHHHHHHHHhCCCchHHhHHHheecCCeEEEEEE
Confidence 356889999999985 56655442 23456889999999999999999999999999999999999
Q ss_pred ecCCCccchhccccC-CCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEE---cCCCcEEEeeccCcccc
Q 044312 352 FIPNGTLFQYIHDQN-EDFPITWEIRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILL---DDKYRAKVSDFGASRSM 427 (608)
Q Consensus 352 ~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl---~~~~~~kl~DFGls~~~ 427 (608)
|+++++|.+++.... ....+++..++.++.|++.||+|||+.+ |+||||||+|||+ +.++.+||+|||+++..
T Consensus 101 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a~~~ 177 (285)
T 3is5_A 101 TCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQH---VVHKDLKPENILFQDTSPHSPIKIIDFGLAELF 177 (285)
T ss_dssp CCSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEESSSSTTCCEEECCCCCCCC-
T ss_pred eCCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHhCC---EEECCCCHHHEEEecCCCCCCEEEEeeecceec
Confidence 999999999886532 1235999999999999999999999999 9999999999999 45678999999999876
Q ss_pred ccCCcceeeeeeccCCCCChhhhccCCCCCccchHhHHHHHHHHHhCCCCCCccchhhcccHHHHHHHHhhhhhhHHHhh
Q 044312 428 AVDQTHMTTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLTELLTGEKPIRFTILEEDKSLAAYFLCAMKEERLFEILD 507 (608)
Q Consensus 428 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 507 (608)
.... ......||+.|+|||.+. ..++.++||||||++++||++|+.||......+. .. ..... .
T Consensus 178 ~~~~--~~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~il~~ll~g~~pf~~~~~~~~------~~-~~~~~------~ 241 (285)
T 3is5_A 178 KSDE--HSTNAAGTALYMAPEVFK-RDVTFKCDIWSAGVVMYFLLTGCLPFTGTSLEEV------QQ-KATYK------E 241 (285)
T ss_dssp -----------CTTGGGCCHHHHT-TCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHH------HH-HHHHC------C
T ss_pred CCcc--cCcCcccccCcCChHHhc-cCCCcccCeehHHHHHHHHHhCCCCCCCCCHHHH------Hh-hhccC------C
Confidence 5332 234456899999999986 5789999999999999999999999974322110 00 00000 0
Q ss_pred hhhhccCChhHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 044312 508 ARVMKQGGKDEIITVAKLAKRCLNLNGKKRPTMREVASE 546 (608)
Q Consensus 508 ~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~evl~~ 546 (608)
... .......+.++.+|+.+||+.||++|||+.|++++
T Consensus 242 ~~~-~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~h 279 (285)
T 3is5_A 242 PNY-AVECRPLTPQAVDLLKQMLTKDPERRPSAAQVLHH 279 (285)
T ss_dssp CCC-CC--CCCCHHHHHHHHHHTCSCTTTSCCHHHHHTS
T ss_pred ccc-ccccCcCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 000 00111235678999999999999999999999853
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-37 Score=319.19 Aligned_cols=229 Identities=24% Similarity=0.348 Sum_probs=190.0
Q ss_pred HhcCccccceeccCce---------------EEEEEeecC--------hhhHHHHHHHHHHHhhcCCCCccceecccccC
Q 044312 287 ATDNFDLNRILGQGGQ---------------AVKKSKVID--------ESKVEEFINEVVILSQINHRNVVKLLGCCLET 343 (608)
Q Consensus 287 ~t~~f~~~~~lG~G~~---------------avk~~~~~~--------~~~~~~~~~Ei~il~~l~H~niv~l~~~~~~~ 343 (608)
..++|++.+.||+|++ |||..+... ....+.+.+|+.+|++++||||+++++++.+.
T Consensus 22 ~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~ 101 (335)
T 3dls_A 22 YSQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFENQ 101 (335)
T ss_dssp HHHHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEECS
T ss_pred cccceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEeeC
Confidence 4567999999999974 677765432 12345688899999999999999999999999
Q ss_pred ccceEEEeecCCC-ccchhccccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEEcCCCcEEEeecc
Q 044312 344 EVPLLVYEFIPNG-TLFQYIHDQNEDFPITWEIRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFG 422 (608)
Q Consensus 344 ~~~~lV~E~~~~g-sL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFG 422 (608)
+..++||||+.+| +|.+++.... .+++..+..|+.||+.||+|||+.+ |+||||||+|||++.++.+||+|||
T Consensus 102 ~~~~lv~e~~~~g~~l~~~~~~~~---~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~Dfg 175 (335)
T 3dls_A 102 GFFQLVMEKHGSGLDLFAFIDRHP---RLDEPLASYIFRQLVSAVGYLRLKD---IIHRDIKDENIVIAEDFTIKLIDFG 175 (335)
T ss_dssp SEEEEEEECCTTSCBHHHHHHTCC---CCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCT
T ss_pred CEEEEEEEeCCCCccHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCC---eEEeccCHHHEEEcCCCcEEEeecc
Confidence 9999999999777 9999887643 4899999999999999999999999 9999999999999999999999999
Q ss_pred CccccccCCcceeeeeeccCCCCChhhhccCCC-CCccchHhHHHHHHHHHhCCCCCCccchhhcccHHHHHHHHhhhhh
Q 044312 423 ASRSMAVDQTHMTTQVHGTFGYLDPEYFRSSQF-TDKSDVYSFGVVLTELLTGEKPIRFTILEEDKSLAAYFLCAMKEER 501 (608)
Q Consensus 423 ls~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-t~ksDV~S~Gvvl~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~ 501 (608)
+++...... ......||+.|+|||++.+..+ +.++||||||++++||++|+.||.....
T Consensus 176 ~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~------------------ 235 (335)
T 3dls_A 176 SAAYLERGK--LFYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEE------------------ 235 (335)
T ss_dssp TCEECCTTC--CBCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSGGG------------------
T ss_pred cceECCCCC--ceeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhHHH------------------
Confidence 998765433 2344569999999999988876 7899999999999999999999863111
Q ss_pred hHHHhhhhhhccCChhHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 044312 502 LFEILDARVMKQGGKDEIITVAKLAKRCLNLNGKKRPTMREVASE 546 (608)
Q Consensus 502 ~~~~~d~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~evl~~ 546 (608)
.... ....+...+.++.+|+.+||+.||++|||+.|++++
T Consensus 236 ---~~~~--~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~h 275 (335)
T 3dls_A 236 ---TVEA--AIHPPYLVSKELMSLVSGLLQPVPERRTTLEKLVTD 275 (335)
T ss_dssp ---GTTT--CCCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHHC
T ss_pred ---HHhh--ccCCCcccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 0000 011223345679999999999999999999999875
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-36 Score=329.68 Aligned_cols=233 Identities=26% Similarity=0.389 Sum_probs=191.0
Q ss_pred cCccccceeccCce---------------EEEEEeec---ChhhHHHHHHHHHHHhhcCCCCccceecccccCccceEEE
Q 044312 289 DNFDLNRILGQGGQ---------------AVKKSKVI---DESKVEEFINEVVILSQINHRNVVKLLGCCLETEVPLLVY 350 (608)
Q Consensus 289 ~~f~~~~~lG~G~~---------------avk~~~~~---~~~~~~~~~~Ei~il~~l~H~niv~l~~~~~~~~~~~lV~ 350 (608)
++|.+.+.||+|+| |||..... .....+.+.+|+.+|+.++||||+++++++.+.+..+|||
T Consensus 16 ~~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lv~ 95 (476)
T 2y94_A 16 GHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVISTPSDIFMVM 95 (476)
T ss_dssp TTEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cCEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEE
Confidence 56888999999974 67766532 1234568999999999999999999999999999999999
Q ss_pred eecCCCccchhccccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEEcCCCcEEEeeccCccccccC
Q 044312 351 EFIPNGTLFQYIHDQNEDFPITWEIRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVD 430 (608)
Q Consensus 351 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGls~~~~~~ 430 (608)
||+++|+|.+++.... .+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++.....
T Consensus 96 E~~~gg~L~~~l~~~~---~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDLkp~NIll~~~~~vkL~DFG~a~~~~~~ 169 (476)
T 2y94_A 96 EYVSGGELFDYICKNG---RLDEKESRRLFQQILSGVDYCHRHM---VVHRDLKPENVLLDAHMNAKIADFGLSNMMSDG 169 (476)
T ss_dssp ECCSSEEHHHHTTSSS---SCCHHHHHHHHHHHHHHHHHHHTTT---EECSCCSGGGEEECTTCCEEECCCSSCEECCTT
T ss_pred eCCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC---CCcccccHHHEEEecCCCeEEEeccchhhcccc
Confidence 9999999999997643 5999999999999999999999999 999999999999999999999999999876533
Q ss_pred CcceeeeeeccCCCCChhhhccCCC-CCccchHhHHHHHHHHHhCCCCCCccchhhcccHHHHHHHHhhhhhhHHHhhhh
Q 044312 431 QTHMTTQVHGTFGYLDPEYFRSSQF-TDKSDVYSFGVVLTELLTGEKPIRFTILEEDKSLAAYFLCAMKEERLFEILDAR 509 (608)
Q Consensus 431 ~~~~~~~~~gt~~y~aPE~~~~~~~-t~ksDV~S~Gvvl~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 509 (608)
. ......||+.|+|||++.+..+ +.++||||||++++||++|+.||...... ..+. .+.+..
T Consensus 170 ~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~------~~~~---------~i~~~~ 232 (476)
T 2y94_A 170 E--FLRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHVP------TLFK---------KICDGI 232 (476)
T ss_dssp C--CBCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCSSSH------HHHH---------HHHTTC
T ss_pred c--cccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCCCHH------HHHH---------HHhcCC
Confidence 2 2334569999999999988765 68999999999999999999999732211 1111 111111
Q ss_pred hhccCChhHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 044312 510 VMKQGGKDEIITVAKLAKRCLNLNGKKRPTMREVASE 546 (608)
Q Consensus 510 ~~~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~evl~~ 546 (608)
...+...+.++.+|+.+||+.||++|||+.|++++
T Consensus 233 --~~~p~~~s~~~~~Li~~~L~~dP~~Rpt~~eil~h 267 (476)
T 2y94_A 233 --FYTPQYLNPSVISLLKHMLQVDPMKRATIKDIREH 267 (476)
T ss_dssp --CCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTC
T ss_pred --cCCCccCCHHHHHHHHHHcCCCchhCcCHHHHHhC
Confidence 11233445679999999999999999999999975
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-36 Score=336.36 Aligned_cols=240 Identities=26% Similarity=0.333 Sum_probs=195.0
Q ss_pred hcCccccceeccCce---------------EEEEEeec---ChhhHHHHHHHHHHHhhcCCCCccceecccccCccceEE
Q 044312 288 TDNFDLNRILGQGGQ---------------AVKKSKVI---DESKVEEFINEVVILSQINHRNVVKLLGCCLETEVPLLV 349 (608)
Q Consensus 288 t~~f~~~~~lG~G~~---------------avk~~~~~---~~~~~~~~~~Ei~il~~l~H~niv~l~~~~~~~~~~~lV 349 (608)
.++|++.+.||+|+| |+|++... .....+.+.+|+.+|++++|||||++++++.+.+..+||
T Consensus 183 ~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lV 262 (576)
T 2acx_A 183 KNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLV 262 (576)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred ccceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEeeCCEEEEE
Confidence 467899999999984 66666431 233456789999999999999999999999999999999
Q ss_pred EeecCCCccchhccccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEEcCCCcEEEeeccCcccccc
Q 044312 350 YEFIPNGTLFQYIHDQNEDFPITWEIRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAV 429 (608)
Q Consensus 350 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGls~~~~~ 429 (608)
|||+++|+|.+++..... ..+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++....
T Consensus 263 mEy~~gg~L~~~l~~~~~-~~l~e~~~~~i~~qIl~aL~yLH~~g---IvHrDLKPeNILld~~g~vKL~DFGla~~~~~ 338 (576)
T 2acx_A 263 LTLMNGGDLKFHIYHMGQ-AGFPEARAVFYAAEICCGLEDLHRER---IVYRDLKPENILLDDHGHIRISDLGLAVHVPE 338 (576)
T ss_dssp ECCCCSCBHHHHHHSSSS-CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEECCCTTCEECCT
T ss_pred EEcCCCCcHHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHHCC---EeccCCchheEEEeCCCCeEEEecccceeccc
Confidence 999999999999976543 25899999999999999999999999 99999999999999999999999999987654
Q ss_pred CCcceeeeeeccCCCCChhhhccCCCCCccchHhHHHHHHHHHhCCCCCCccchhhcccHHHHHHHHhhhhhhHHHhhhh
Q 044312 430 DQTHMTTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLTELLTGEKPIRFTILEEDKSLAAYFLCAMKEERLFEILDAR 509 (608)
Q Consensus 430 ~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 509 (608)
.. ......||+.|+|||++.+..++.++|||||||++|||++|+.||........ .. .+...+. .
T Consensus 339 ~~--~~~~~~GT~~Y~APEvl~~~~~~~~~DiwSLGvilyeLltG~~PF~~~~~~~~--~~----------~i~~~i~-~ 403 (576)
T 2acx_A 339 GQ--TIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIK--RE----------EVERLVK-E 403 (576)
T ss_dssp TC--CEECCCSCGGGCCHHHHTTCEESSHHHHHHHHHHHHHHHHSSCSSSCSSSCCC--HH----------HHHHHHH-H
T ss_pred Cc--cccccCCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCcccccchh--HH----------HHHHHhh-c
Confidence 32 23445799999999999999999999999999999999999999974322111 00 0111111 1
Q ss_pred hhccCChhHHHHHHHHHHHHhccCCCCCC-----CHHHHHHH
Q 044312 510 VMKQGGKDEIITVAKLAKRCLNLNGKKRP-----TMREVASE 546 (608)
Q Consensus 510 ~~~~~~~~~~~~l~~Li~~cl~~dp~~RP-----s~~evl~~ 546 (608)
.....+...+.++.+|+.+||+.||++|| ++.||+++
T Consensus 404 ~~~~~p~~~s~~~~dLI~~lL~~dP~~R~g~~~~sa~eil~H 445 (576)
T 2acx_A 404 VPEEYSERFSPQARSLCSQLLCKDPAERLGCRGGSAREVKEH 445 (576)
T ss_dssp CCCCCCTTSCHHHHHHHHHHTCSSGGGSTTCSSSHHHHHHTS
T ss_pred ccccCCccCCHHHHHHHHHhccCCHHHcCCCCCCCHHHHHhC
Confidence 11223445667899999999999999999 77888764
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-37 Score=320.09 Aligned_cols=248 Identities=22% Similarity=0.350 Sum_probs=181.8
Q ss_pred cCccccceeccCce---------------EEEEEeecChh-hHHHHHHHHHHHhhcCCCCccceecccccCccceEEEee
Q 044312 289 DNFDLNRILGQGGQ---------------AVKKSKVIDES-KVEEFINEVVILSQINHRNVVKLLGCCLETEVPLLVYEF 352 (608)
Q Consensus 289 ~~f~~~~~lG~G~~---------------avk~~~~~~~~-~~~~~~~Ei~il~~l~H~niv~l~~~~~~~~~~~lV~E~ 352 (608)
++|.+.+.||+|++ |||+.+..... ....+.+|+.++++++||||+++++++.+.+..++||||
T Consensus 2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 81 (324)
T 3mtl_A 2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEY 81 (324)
T ss_dssp CSEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC------CCCCCCCHHHHSCCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred CceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEecccccccchhHHHHHHHHHhcCCCCCCeeeeEEeeCCEEEEEecc
Confidence 46888999999985 66665532221 122466899999999999999999999999999999999
Q ss_pred cCCCccchhccccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEEcCCCcEEEeeccCccccccCCc
Q 044312 353 IPNGTLFQYIHDQNEDFPITWEIRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQT 432 (608)
Q Consensus 353 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGls~~~~~~~~ 432 (608)
++ |+|.+++..... .+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++......
T Consensus 82 ~~-~~l~~~~~~~~~--~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~- 154 (324)
T 3mtl_A 82 LD-KDLKQYLDDCGN--IINMHNVKLFLFQLLRGLAYCHRQK---VLHRDLKPQNLLINERGELKLADFGLARAKSIPT- 154 (324)
T ss_dssp CS-EEHHHHHHHTTT--CCCHHHHHHHHHHHHHHHHHHHHTT---EEESSCCGGGEEECTTCCEEECSSSEEECC-----
T ss_pred cc-cCHHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCcCHHHEEECCCCCEEEccCcccccccCCc-
Confidence 96 599998876543 5899999999999999999999999 9999999999999999999999999998654322
Q ss_pred ceeeeeeccCCCCChhhhcc-CCCCCccchHhHHHHHHHHHhCCCCCCccchhhcccHHHHHHHHhh---hhhhHHHhhh
Q 044312 433 HMTTQVHGTFGYLDPEYFRS-SQFTDKSDVYSFGVVLTELLTGEKPIRFTILEEDKSLAAYFLCAMK---EERLFEILDA 508 (608)
Q Consensus 433 ~~~~~~~gt~~y~aPE~~~~-~~~t~ksDV~S~Gvvl~elltg~~p~~~~~~~~~~~l~~~~~~~~~---~~~~~~~~d~ 508 (608)
.......||+.|+|||.+.+ ..++.++||||||++++||++|+.||......+. ......... ..........
T Consensus 155 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~---~~~i~~~~~~~~~~~~~~~~~~ 231 (324)
T 3mtl_A 155 KTYDNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQ---LHFIFRILGTPTEETWPGILSN 231 (324)
T ss_dssp --------CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH---HHHHHHHHCCCCTTTSTTGGGC
T ss_pred cccccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHH---HHHHHHHhCCCChHhchhhhcc
Confidence 22334568999999999876 5689999999999999999999999975433221 111111111 1111111100
Q ss_pred hh-------------hccCChhHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 044312 509 RV-------------MKQGGKDEIITVAKLAKRCLNLNGKKRPTMREVASE 546 (608)
Q Consensus 509 ~~-------------~~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~evl~~ 546 (608)
.. ........+.++.+|+.+||+.||++|||++|++++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 282 (324)
T 3mtl_A 232 EEFKTYNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMKH 282 (324)
T ss_dssp HHHHHTCCCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred hhhcccccccccchhhhhhcCCCCHHHHHHHHHHcCcCcccCCCHHHHhcC
Confidence 00 000112345678999999999999999999999874
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-36 Score=322.82 Aligned_cols=236 Identities=25% Similarity=0.342 Sum_probs=181.8
Q ss_pred hcCccccceeccCce---------------EEEEEeec---ChhhHHHHHHHHHH-HhhcCCCCccceecccccCccceE
Q 044312 288 TDNFDLNRILGQGGQ---------------AVKKSKVI---DESKVEEFINEVVI-LSQINHRNVVKLLGCCLETEVPLL 348 (608)
Q Consensus 288 t~~f~~~~~lG~G~~---------------avk~~~~~---~~~~~~~~~~Ei~i-l~~l~H~niv~l~~~~~~~~~~~l 348 (608)
.++|++.+.||+|+| |||.++.. .....+.+.+|..+ ++.++||||+++++++.+.+..+|
T Consensus 37 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~~~~~~l 116 (373)
T 2r5t_A 37 PSDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYF 116 (373)
T ss_dssp GGGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEECSSEEEE
T ss_pred hhheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEeCCEEEE
Confidence 357999999999974 77776542 23345567778776 577899999999999999999999
Q ss_pred EEeecCCCccchhccccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEEcCCCcEEEeeccCccccc
Q 044312 349 VYEFIPNGTLFQYIHDQNEDFPITWEIRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMA 428 (608)
Q Consensus 349 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGls~~~~ 428 (608)
||||+++|+|.+++.... .+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++...
T Consensus 117 v~E~~~gg~L~~~l~~~~---~~~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~g~ikL~DFG~a~~~~ 190 (373)
T 2r5t_A 117 VLDYINGGELFYHLQRER---CFLEPRARFYAAEIASALGYLHSLN---IVYRDLKPENILLDSQGHIVLTDFGLCKENI 190 (373)
T ss_dssp EEECCCSCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCCBCGGGB
T ss_pred EEeCCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCHHHEEECCCCCEEEeeCccccccc
Confidence 999999999999997653 4899999999999999999999999 9999999999999999999999999998643
Q ss_pred cCCcceeeeeeccCCCCChhhhccCCCCCccchHhHHHHHHHHHhCCCCCCccchhhcccHHHHHHHHhhhhhhHHHhhh
Q 044312 429 VDQTHMTTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLTELLTGEKPIRFTILEEDKSLAAYFLCAMKEERLFEILDA 508 (608)
Q Consensus 429 ~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 508 (608)
... .......||+.|+|||++.+..++.++||||||+++|||++|+.||...... ..+ ..++..
T Consensus 191 ~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~------~~~---------~~i~~~ 254 (373)
T 2r5t_A 191 EHN-STTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTA------EMY---------DNILNK 254 (373)
T ss_dssp CCC-CCCCSBSCCCCCCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSBHH------HHH---------HHHHHS
T ss_pred cCC-CccccccCCccccCHHHhCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHH------HHH---------HHHHhc
Confidence 222 2334567999999999999999999999999999999999999999643221 111 111111
Q ss_pred hhhccCChhHHHHHHHHHHHHhccCCCCCCCHHHHHHHH
Q 044312 509 RVMKQGGKDEIITVAKLAKRCLNLNGKKRPTMREVASEL 547 (608)
Q Consensus 509 ~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~evl~~L 547 (608)
. ...+...+..+.+|+.+||+.||++||++.+.++.+
T Consensus 255 ~--~~~~~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~i 291 (373)
T 2r5t_A 255 P--LQLKPNITNSARHLLEGLLQKDRTKRLGAKDDFMEI 291 (373)
T ss_dssp C--CCCCSSSCHHHHHHHHHHTCSSGGGSTTTTTTHHHH
T ss_pred c--cCCCCCCCHHHHHHHHHHcccCHHhCCCCCCCHHHH
Confidence 1 122334567899999999999999999986544443
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-36 Score=326.28 Aligned_cols=253 Identities=19% Similarity=0.274 Sum_probs=196.3
Q ss_pred hcCccccceeccCce---------------EEEEEeecChhhHHHHHHHHHHHhhcCC-CCccceecccccCccceEEEe
Q 044312 288 TDNFDLNRILGQGGQ---------------AVKKSKVIDESKVEEFINEVVILSQINH-RNVVKLLGCCLETEVPLLVYE 351 (608)
Q Consensus 288 t~~f~~~~~lG~G~~---------------avk~~~~~~~~~~~~~~~Ei~il~~l~H-~niv~l~~~~~~~~~~~lV~E 351 (608)
.++|++.++||+|+| |||+.... ...+++.+|+++++.|+| +++..+..++.+.+..+||||
T Consensus 6 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~--~~~~~~~~E~~il~~L~~~~~i~~i~~~~~~~~~~~lvme 83 (483)
T 3sv0_A 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVK--TKHPQLLYESKIYRILQGGTGIPNVRWFGVEGDYNVLVMD 83 (483)
T ss_dssp TTTEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETT--CSSCCHHHHHHHHHHTTTSTTCCCEEEEEEETTEEEEEEE
T ss_pred CCcEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEeccc--cccHHHHHHHHHHHHhcCCCCCCeEEEEEeeCCEEEEEEE
Confidence 467999999999984 66655432 233468899999999976 566666666777888899999
Q ss_pred ecCCCccchhccccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEE---cCCCcEEEeeccCccccc
Q 044312 352 FIPNGTLFQYIHDQNEDFPITWEIRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILL---DDKYRAKVSDFGASRSMA 428 (608)
Q Consensus 352 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl---~~~~~~kl~DFGls~~~~ 428 (608)
|+ +++|.+++..... .+++..++.|+.||+.||+|||+++ |+||||||+|||| +.++.+||+|||+++.+.
T Consensus 84 ~~-g~sL~~ll~~~~~--~l~~~~~~~i~~qi~~aL~yLH~~g---IvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~ 157 (483)
T 3sv0_A 84 LL-GPSLEDLFNFCSR--KLSLKTVLMLADQMINRVEFVHSKS---FLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYR 157 (483)
T ss_dssp CC-CCBHHHHHHHTTT--CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECCGGGTTCEEECCCTTCEECB
T ss_pred CC-CCCHHHHHHhhcC--CCCHHHHHHHHHHHHHHHHHHHHCC---EeecccCcceEEEecCCCCCeEEEEeCCcceecc
Confidence 99 9999999975433 5999999999999999999999999 9999999999999 688999999999998765
Q ss_pred cCCcc------eeeeeeccCCCCChhhhccCCCCCccchHhHHHHHHHHHhCCCCCCccchhhcccHHHHHHHHhhhhhh
Q 044312 429 VDQTH------MTTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLTELLTGEKPIRFTILEEDKSLAAYFLCAMKEERL 502 (608)
Q Consensus 429 ~~~~~------~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~ 502 (608)
..... ......||+.|+|||++.+..++.++||||||++||||++|+.||............. .+....+
T Consensus 158 ~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~----~i~~~~~ 233 (483)
T 3sv0_A 158 DTSTHQHIPYRENKNLTGTARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYE----KISEKKV 233 (483)
T ss_dssp CTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSHHHHHH----HHHHHHH
T ss_pred CCccccccccccccccCCCccccCHHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccchhHHHHHH----HHhhccc
Confidence 43321 1235679999999999999999999999999999999999999997543322111111 1111111
Q ss_pred HHHhhhhhhccCChhHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhhHHhcCCC
Q 044312 503 FEILDARVMKQGGKDEIITVAKLAKRCLNLNGKKRPTMREVASELAGIKAWNGAS 557 (608)
Q Consensus 503 ~~~~d~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~evl~~L~~i~~~~~~~ 557 (608)
...+. ......+.++.+|+.+||+.+|++||++.+|++.|+.+....+..
T Consensus 234 ~~~~~-----~l~~~~p~~l~~li~~cl~~dP~~RPs~~el~~~L~~l~~~~~~~ 283 (483)
T 3sv0_A 234 ATSIE-----ALCRGYPTEFASYFHYCRSLRFDDKPDYSYLKRLFRDLFIREGFQ 283 (483)
T ss_dssp HSCHH-----HHHTTSCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHTTCC
T ss_pred cccHH-----HHhcCCcHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHHcCCC
Confidence 11111 011233568999999999999999999999999999987765543
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-36 Score=307.52 Aligned_cols=236 Identities=24% Similarity=0.365 Sum_probs=192.8
Q ss_pred hcCccccceeccCce---------------EEEEEeec---ChhhHHHHHHHHHHHhhcCCCCccceecccccCccceEE
Q 044312 288 TDNFDLNRILGQGGQ---------------AVKKSKVI---DESKVEEFINEVVILSQINHRNVVKLLGCCLETEVPLLV 349 (608)
Q Consensus 288 t~~f~~~~~lG~G~~---------------avk~~~~~---~~~~~~~~~~Ei~il~~l~H~niv~l~~~~~~~~~~~lV 349 (608)
.++|.+.+.||+|++ |+|..... +....+.+.+|+.++++++||||+++++++.+.+..++|
T Consensus 14 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 93 (294)
T 2rku_A 14 RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVV 93 (294)
T ss_dssp TEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred ccceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCEEEEE
Confidence 357888999999984 55554432 334567899999999999999999999999999999999
Q ss_pred EeecCCCccchhccccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEEcCCCcEEEeeccCcccccc
Q 044312 350 YEFIPNGTLFQYIHDQNEDFPITWEIRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAV 429 (608)
Q Consensus 350 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGls~~~~~ 429 (608)
|||+++++|.+++.... .+++..++.++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++....
T Consensus 94 ~e~~~~~~L~~~~~~~~---~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~ 167 (294)
T 2rku_A 94 LELCRRRSLLELHKRRK---ALTEPEARYYLRQIVLGCQYLHRNR---VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEY 167 (294)
T ss_dssp EECCTTCBHHHHHHHHC---SCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEECCS
T ss_pred EecCCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChHhEEEcCCCCEEEEeccCceeccc
Confidence 99999999999887643 5899999999999999999999999 99999999999999999999999999987643
Q ss_pred CCcceeeeeeccCCCCChhhhccCCCCCccchHhHHHHHHHHHhCCCCCCccchhhcccHHHHHHHHhhhhhhHHHhhhh
Q 044312 430 DQTHMTTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLTELLTGEKPIRFTILEEDKSLAAYFLCAMKEERLFEILDAR 509 (608)
Q Consensus 430 ~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 509 (608)
... ......||+.|+|||.+.+..++.++||||||++++||++|+.||......+ ... . +...
T Consensus 168 ~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~------~~~-~--------~~~~- 230 (294)
T 2rku_A 168 DGE-RKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKE------TYL-R--------IKKN- 230 (294)
T ss_dssp TTC-CBCCCCSCCSSCCHHHHTTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHH------HHH-H--------HHTT-
T ss_pred Ccc-ccccccCCCCcCCcchhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH------HHH-H--------Hhhc-
Confidence 322 2334568999999999999999999999999999999999999987432211 111 0 1110
Q ss_pred hhccCChhHHHHHHHHHHHHhccCCCCCCCHHHHHHHH
Q 044312 510 VMKQGGKDEIITVAKLAKRCLNLNGKKRPTMREVASEL 547 (608)
Q Consensus 510 ~~~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~evl~~L 547 (608)
....+...+..+.+|+.+||+.||++|||+.|++++-
T Consensus 231 -~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~~ 267 (294)
T 2rku_A 231 -EYSIPKHINPVAASLIQKMLQTDPTARPTINELLNDE 267 (294)
T ss_dssp -CCCCCTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGSH
T ss_pred -cCCCccccCHHHHHHHHHHcccChhhCcCHHHHhhCh
Confidence 1122334556899999999999999999999998753
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-36 Score=307.85 Aligned_cols=235 Identities=25% Similarity=0.395 Sum_probs=169.4
Q ss_pred cCccccceeccCce---------------EEEEEeecC---hhhHHHHHHHHHHHhhcCCCCccceecccccCccceEEE
Q 044312 289 DNFDLNRILGQGGQ---------------AVKKSKVID---ESKVEEFINEVVILSQINHRNVVKLLGCCLETEVPLLVY 350 (608)
Q Consensus 289 ~~f~~~~~lG~G~~---------------avk~~~~~~---~~~~~~~~~Ei~il~~l~H~niv~l~~~~~~~~~~~lV~ 350 (608)
++|.+.+.||+|++ |||...... ....+.+.+|+.++++++||||+++++++.+.+..++||
T Consensus 11 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 90 (278)
T 3cok_A 11 EDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDSNYVYLVL 90 (278)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEECSSEEEEEE
T ss_pred ccceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEccCCeEEEEE
Confidence 56888999999974 566554321 223477999999999999999999999999999999999
Q ss_pred eecCCCccchhccccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEEcCCCcEEEeeccCccccccC
Q 044312 351 EFIPNGTLFQYIHDQNEDFPITWEIRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVD 430 (608)
Q Consensus 351 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGls~~~~~~ 430 (608)
||+++++|.+++..... ++++..++.++.|++.||+|||+.+ ++||||||+|||++.++.+||+|||++......
T Consensus 91 e~~~~~~L~~~l~~~~~--~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~ 165 (278)
T 3cok_A 91 EMCHNGEMNRYLKNRVK--PFSENEARHFMHQIITGMLYLHSHG---ILHRDLTLSNLLLTRNMNIKIADFGLATQLKMP 165 (278)
T ss_dssp ECCTTEEHHHHHHTCSS--CCCHHHHHHHHHHHHHHHHHHHHTT---EECSSCCGGGEEECTTCCEEECCCTTCEECC--
T ss_pred ecCCCCcHHHHHhhccC--CCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCCEEEEeecceeeccCC
Confidence 99999999999986433 5899999999999999999999999 999999999999999999999999999876532
Q ss_pred CcceeeeeeccCCCCChhhhccCCCCCccchHhHHHHHHHHHhCCCCCCccchhhcccHHHHHHHHhhhhhhHHHhhhhh
Q 044312 431 QTHMTTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLTELLTGEKPIRFTILEEDKSLAAYFLCAMKEERLFEILDARV 510 (608)
Q Consensus 431 ~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~ 510 (608)
.. ......||+.|+|||.+.+..++.++||||||++++||++|+.||........ +..+....
T Consensus 166 ~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~---------------~~~~~~~~- 228 (278)
T 3cok_A 166 HE-KHYTLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNT---------------LNKVVLAD- 228 (278)
T ss_dssp ---------------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC--------------------CCSSC-
T ss_pred CC-cceeccCCCCcCCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCChhHHHH---------------HHHHhhcc-
Confidence 22 22345689999999999999999999999999999999999999874322110 00000000
Q ss_pred hccCChhHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 044312 511 MKQGGKDEIITVAKLAKRCLNLNGKKRPTMREVASE 546 (608)
Q Consensus 511 ~~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~evl~~ 546 (608)
...+...+.++.+|+.+||+.||++|||+.|++++
T Consensus 229 -~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h 263 (278)
T 3cok_A 229 -YEMPSFLSIEAKDLIHQLLRRNPADRLSLSSVLDH 263 (278)
T ss_dssp -CCCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred -cCCccccCHHHHHHHHHHcccCHhhCCCHHHHhcC
Confidence 11233455689999999999999999999999864
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-37 Score=318.60 Aligned_cols=250 Identities=20% Similarity=0.288 Sum_probs=179.3
Q ss_pred HHhcCccccceeccCce---------------EEEEEeecC--hhhHHHHHHHHHHHhhcCCCCccceecccccCccceE
Q 044312 286 KATDNFDLNRILGQGGQ---------------AVKKSKVID--ESKVEEFINEVVILSQINHRNVVKLLGCCLETEVPLL 348 (608)
Q Consensus 286 ~~t~~f~~~~~lG~G~~---------------avk~~~~~~--~~~~~~~~~Ei~il~~l~H~niv~l~~~~~~~~~~~l 348 (608)
...++|++.++||+|++ |||+.+... ....+.+.+|+.++++++||||+++++++.+....+|
T Consensus 31 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 110 (329)
T 3gbz_A 31 TSIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIHHNHRLHL 110 (329)
T ss_dssp -CGGGEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC--------CHHHHHHGGGCCCTTBCCEEEEEEETTEEEE
T ss_pred cchhhEEEEEEEEecCCeEEEEEEECCCCceEEEEEEcccccccccchhHHHHHHHHHHcCCCCcceEEEEEecCCEEEE
Confidence 34568999999999984 677665432 2335678899999999999999999999999999999
Q ss_pred EEeecCCCccchhccccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEE-----cCCCcEEEeeccC
Q 044312 349 VYEFIPNGTLFQYIHDQNEDFPITWEIRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILL-----DDKYRAKVSDFGA 423 (608)
Q Consensus 349 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl-----~~~~~~kl~DFGl 423 (608)
||||++ |+|.+++.... .+++..+..|+.||+.||+|||+.+ |+||||||+|||+ ++++.+||+|||+
T Consensus 111 v~e~~~-~~L~~~~~~~~---~~~~~~~~~i~~ql~~~l~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg~ 183 (329)
T 3gbz_A 111 IFEYAE-NDLKKYMDKNP---DVSMRVIKSFLYQLINGVNFCHSRR---CLHRDLKPQNLLLSVSDASETPVLKIGDFGL 183 (329)
T ss_dssp EEECCS-EEHHHHHHHCT---TCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEC-----CCEEEECCTTH
T ss_pred EEecCC-CCHHHHHhhcC---CCCHHHHHHHHHHHHHHHHHHHhCC---EECCCCCHHHEEEecCCCCccceEEECcCCC
Confidence 999997 59999987654 4899999999999999999999999 9999999999999 4556699999999
Q ss_pred ccccccCCcceeeeeeccCCCCChhhhccC-CCCCccchHhHHHHHHHHHhCCCCCCccchhhcccHHHHHHHHhhh---
Q 044312 424 SRSMAVDQTHMTTQVHGTFGYLDPEYFRSS-QFTDKSDVYSFGVVLTELLTGEKPIRFTILEEDKSLAAYFLCAMKE--- 499 (608)
Q Consensus 424 s~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~t~ksDV~S~Gvvl~elltg~~p~~~~~~~~~~~l~~~~~~~~~~--- 499 (608)
++....... ......||+.|+|||++.+. .++.++||||||++++||++|+.||......+ .+...+ .....
T Consensus 184 a~~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~--~~~~~~-~~~~~~~~ 259 (329)
T 3gbz_A 184 ARAFGIPIR-QFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEID--QLFKIF-EVLGLPDD 259 (329)
T ss_dssp HHHHC------------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH--HHHHHH-HHHCCCCT
T ss_pred ccccCCccc-ccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCCCHHH--HHHHHH-HHhCCCch
Confidence 987643322 23445689999999999875 48999999999999999999999997432211 111111 00000
Q ss_pred hhhHHHhh-------------hhhhccCChhHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 044312 500 ERLFEILD-------------ARVMKQGGKDEIITVAKLAKRCLNLNGKKRPTMREVASE 546 (608)
Q Consensus 500 ~~~~~~~d-------------~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~evl~~ 546 (608)
........ ..+........+.++.+|+.+||+.||++|||+.|++++
T Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 319 (329)
T 3gbz_A 260 TTWPGVTALPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALEH 319 (329)
T ss_dssp TTSTTGGGSTTCCTTCCCCCCCCHHHHHGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred hhhhhhhhhhhhhhhhhhhccccHhhhcccccCHHHHHHHHHHccCChhhCCCHHHHhCC
Confidence 00000000 000000011244678999999999999999999999853
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-36 Score=317.81 Aligned_cols=245 Identities=21% Similarity=0.301 Sum_probs=184.1
Q ss_pred hcCccccceeccCce---------------EEEEEee--cChhhHHHHHHHHHHHhhcCCCCccceecccccCc------
Q 044312 288 TDNFDLNRILGQGGQ---------------AVKKSKV--IDESKVEEFINEVVILSQINHRNVVKLLGCCLETE------ 344 (608)
Q Consensus 288 t~~f~~~~~lG~G~~---------------avk~~~~--~~~~~~~~~~~Ei~il~~l~H~niv~l~~~~~~~~------ 344 (608)
.++|++.+.||+|++ |||+... ......+.+.+|+.+|++++||||+++++++....
T Consensus 24 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~ 103 (367)
T 1cm8_A 24 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFT 103 (367)
T ss_dssp BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCC
T ss_pred cceEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCccccCc
Confidence 467999999999974 6776643 23344678999999999999999999999987653
Q ss_pred cceEEEeecCCCccchhccccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEEcCCCcEEEeeccCc
Q 044312 345 VPLLVYEFIPNGTLFQYIHDQNEDFPITWEIRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGAS 424 (608)
Q Consensus 345 ~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGls 424 (608)
..++||||+ +++|.+++... .+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||++
T Consensus 104 ~~~lv~e~~-~~~L~~~~~~~----~l~~~~~~~~~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~a 175 (367)
T 1cm8_A 104 DFYLVMPFM-GTDLGKLMKHE----KLGEDRIQFLVYQMLKGLRYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGLA 175 (367)
T ss_dssp CCEEEEECC-SEEHHHHHHHC----CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTC
T ss_pred eEEEEEecC-CCCHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHCC---ccccCcCHHHEEEcCCCCEEEEeeecc
Confidence 459999999 88999998752 4899999999999999999999999 999999999999999999999999999
Q ss_pred cccccCCcceeeeeeccCCCCChhhhcc-CCCCCccchHhHHHHHHHHHhCCCCCCccchhhcccHHHHH----------
Q 044312 425 RSMAVDQTHMTTQVHGTFGYLDPEYFRS-SQFTDKSDVYSFGVVLTELLTGEKPIRFTILEEDKSLAAYF---------- 493 (608)
Q Consensus 425 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~t~ksDV~S~Gvvl~elltg~~p~~~~~~~~~~~l~~~~---------- 493 (608)
+..... .+...+|+.|+|||++.+ ..++.++||||||++++||++|+.||........ +...+
T Consensus 176 ~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~--l~~i~~~~g~~~~~~ 249 (367)
T 1cm8_A 176 RQADSE----MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQ--LKEIMKVTGTPPAEF 249 (367)
T ss_dssp EECCSS----CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHH--HHHHHHHHCCCCHHH
T ss_pred cccccc----cCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCCCHHHH--HHHHHHhcCCCCHHH
Confidence 875432 234568999999999887 6899999999999999999999999974332211 11000
Q ss_pred HHHhhhhhhHHHhhh------hhhccCChhHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 044312 494 LCAMKEERLFEILDA------RVMKQGGKDEIITVAKLAKRCLNLNGKKRPTMREVASE 546 (608)
Q Consensus 494 ~~~~~~~~~~~~~d~------~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~evl~~ 546 (608)
...+........+.. ..........+..+.+|+.+||+.||++|||+.|++++
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~mL~~dP~~R~t~~e~l~h 308 (367)
T 1cm8_A 250 VQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAH 308 (367)
T ss_dssp HHTCSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred HHHhhhHHHHHHHHhCCCCCCCCHHHHCCCCCHHHHHHHHHHccCChhHCCCHHHHhcC
Confidence 000000111111100 00011112345689999999999999999999999875
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-36 Score=313.96 Aligned_cols=236 Identities=24% Similarity=0.376 Sum_probs=193.2
Q ss_pred hcCccccceeccCce---------------EEEEEee---cChhhHHHHHHHHHHHhhcCCCCccceecccccCccceEE
Q 044312 288 TDNFDLNRILGQGGQ---------------AVKKSKV---IDESKVEEFINEVVILSQINHRNVVKLLGCCLETEVPLLV 349 (608)
Q Consensus 288 t~~f~~~~~lG~G~~---------------avk~~~~---~~~~~~~~~~~Ei~il~~l~H~niv~l~~~~~~~~~~~lV 349 (608)
.++|.+.+.||+|+| |+|.... ......+.+.+|+.++++++||||+++++++.+.+..++|
T Consensus 40 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 119 (335)
T 2owb_A 40 RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVV 119 (335)
T ss_dssp TEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred CCceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEE
Confidence 467899999999984 5555543 2345567899999999999999999999999999999999
Q ss_pred EeecCCCccchhccccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEEcCCCcEEEeeccCcccccc
Q 044312 350 YEFIPNGTLFQYIHDQNEDFPITWEIRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAV 429 (608)
Q Consensus 350 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGls~~~~~ 429 (608)
|||+++++|.+++.... .+++..++.++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++....
T Consensus 120 ~e~~~~~~L~~~~~~~~---~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~ 193 (335)
T 2owb_A 120 LELCRRRSLLELHKRRK---ALTEPEARYYLRQIVLGCQYLHRNR---VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEY 193 (335)
T ss_dssp ECCCTTCBHHHHHHHHC---SCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTCCEEECCCTTCEECCS
T ss_pred EecCCCCCHHHHHhccC---CCCHHHHHHHHHHHHHHHHHHHHCC---CEecCCCchhEEEcCCCCEEEeeccCceeccc
Confidence 99999999999887643 5899999999999999999999999 99999999999999999999999999987653
Q ss_pred CCcceeeeeeccCCCCChhhhccCCCCCccchHhHHHHHHHHHhCCCCCCccchhhcccHHHHHHHHhhhhhhHHHhhhh
Q 044312 430 DQTHMTTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLTELLTGEKPIRFTILEEDKSLAAYFLCAMKEERLFEILDAR 509 (608)
Q Consensus 430 ~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 509 (608)
... ......||+.|+|||++.+..++.++||||||++++||++|+.||......+ ... .+. ..
T Consensus 194 ~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~------~~~-~~~--------~~- 256 (335)
T 2owb_A 194 DGE-RKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKE------TYL-RIK--------KN- 256 (335)
T ss_dssp TTC-CBCCCCSCCSSCCHHHHHTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHH------HHH-HHH--------HT-
T ss_pred Ccc-cccccCCCccccCHHHhccCCCCchhhHHHHHHHHHHHHHCcCCCCCCCHHH------HHH-HHh--------cC-
Confidence 322 2344568999999999999999999999999999999999999997432211 111 010 00
Q ss_pred hhccCChhHHHHHHHHHHHHhccCCCCCCCHHHHHHHH
Q 044312 510 VMKQGGKDEIITVAKLAKRCLNLNGKKRPTMREVASEL 547 (608)
Q Consensus 510 ~~~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~evl~~L 547 (608)
....+...+..+.+|+.+||+.||++|||+.|++++-
T Consensus 257 -~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~~~ 293 (335)
T 2owb_A 257 -EYSIPKHINPVAASLIQKMLQTDPTARPTINELLNDE 293 (335)
T ss_dssp -CCCCCTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGSH
T ss_pred -CCCCCccCCHHHHHHHHHHccCChhHCcCHHHHhcCc
Confidence 0112334556789999999999999999999998753
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-36 Score=310.81 Aligned_cols=238 Identities=25% Similarity=0.344 Sum_probs=189.3
Q ss_pred hcCccccceeccCce---------------EEEEEeecChhhHHHHHHHHHHHhhcCCCCccceecccccCccceEEEee
Q 044312 288 TDNFDLNRILGQGGQ---------------AVKKSKVIDESKVEEFINEVVILSQINHRNVVKLLGCCLETEVPLLVYEF 352 (608)
Q Consensus 288 t~~f~~~~~lG~G~~---------------avk~~~~~~~~~~~~~~~Ei~il~~l~H~niv~l~~~~~~~~~~~lV~E~ 352 (608)
.++|.+.+.||+|++ |+|..+.......+.+.+|+.++++++||||+++++++.+....++||||
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 87 (304)
T 2jam_A 8 RKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDIYESTTHYYLVMQL 87 (304)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC------HHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred hccceeeeeccCCCCceEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHhCCCCCeeehhhhcccCCEEEEEEEc
Confidence 457888999999974 77777655555567799999999999999999999999999999999999
Q ss_pred cCCCccchhccccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEE---cCCCcEEEeeccCcccccc
Q 044312 353 IPNGTLFQYIHDQNEDFPITWEIRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILL---DDKYRAKVSDFGASRSMAV 429 (608)
Q Consensus 353 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl---~~~~~~kl~DFGls~~~~~ 429 (608)
+++++|.+++.... .+++..+..++.|++.||.|||+.+ |+||||||+|||+ ++++.+||+|||+++....
T Consensus 88 ~~~~~L~~~l~~~~---~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~~~~~ 161 (304)
T 2jam_A 88 VSGGELFDRILERG---VYTEKDASLVIQQVLSAVKYLHENG---IVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQN 161 (304)
T ss_dssp CCSCBHHHHHHHHS---CCCHHHHHHHHHHHHHHHHHHHHTT---CCCCSCCGGGCEESSSSTTCCEEBCSCSTTCCCCC
T ss_pred CCCccHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEecCCCCCCEEEccCCcceecCC
Confidence 99999999987643 4899999999999999999999999 9999999999999 7889999999999976432
Q ss_pred CCcceeeeeeccCCCCChhhhccCCCCCccchHhHHHHHHHHHhCCCCCCccchhhcccHHHHHHHHhhhhhhHHHhhhh
Q 044312 430 DQTHMTTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLTELLTGEKPIRFTILEEDKSLAAYFLCAMKEERLFEILDAR 509 (608)
Q Consensus 430 ~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 509 (608)
. ......||+.|+|||.+.+..++.++||||||++++||++|+.||....... ....+..... .
T Consensus 162 ~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~-------~~~~i~~~~~------~ 225 (304)
T 2jam_A 162 G---IMSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPFYEETESK-------LFEKIKEGYY------E 225 (304)
T ss_dssp B---TTHHHHSCCCBCCTTTBSSCSCCHHHHHHHHHHHHHHHHHSSCTTTTSCHHH-------HHHHHHHCCC------C
T ss_pred C---ccccccCCCCccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHH-------HHHHHHcCCC------C
Confidence 2 1233458999999999999999999999999999999999999986332111 0111111100 0
Q ss_pred hhccCChhHHHHHHHHHHHHhccCCCCCCCHHHHHHHH
Q 044312 510 VMKQGGKDEIITVAKLAKRCLNLNGKKRPTMREVASEL 547 (608)
Q Consensus 510 ~~~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~evl~~L 547 (608)
.........+..+.+|+.+||+.||++|||+.|++++-
T Consensus 226 ~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~ 263 (304)
T 2jam_A 226 FESPFWDDISESAKDFICHLLEKDPNERYTCEKALSHP 263 (304)
T ss_dssp CCTTTTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTSH
T ss_pred CCccccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCc
Confidence 01112234567899999999999999999999998753
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-36 Score=305.63 Aligned_cols=233 Identities=25% Similarity=0.359 Sum_probs=190.6
Q ss_pred cCccccceeccCce---------------EEEEEeec---ChhhHHHHHHHHHHHhhcCCCCccceecccccCccceEEE
Q 044312 289 DNFDLNRILGQGGQ---------------AVKKSKVI---DESKVEEFINEVVILSQINHRNVVKLLGCCLETEVPLLVY 350 (608)
Q Consensus 289 ~~f~~~~~lG~G~~---------------avk~~~~~---~~~~~~~~~~Ei~il~~l~H~niv~l~~~~~~~~~~~lV~ 350 (608)
++|++.+.||+|++ |||..... .....+.+.+|+.++++++||||+++++++.+.+..++||
T Consensus 14 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 93 (284)
T 2vgo_A 14 DDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHDRKRIYLML 93 (284)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hhceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEEcCCEEEEEE
Confidence 56888999999974 55555432 1223567999999999999999999999999999999999
Q ss_pred eecCCCccchhccccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEEcCCCcEEEeeccCccccccC
Q 044312 351 EFIPNGTLFQYIHDQNEDFPITWEIRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVD 430 (608)
Q Consensus 351 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGls~~~~~~ 430 (608)
||+++++|.+++.... .+++..++.++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||++......
T Consensus 94 e~~~~~~L~~~l~~~~---~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~ 167 (284)
T 2vgo_A 94 EFAPRGELYKELQKHG---RFDEQRSATFMEELADALHYCHERK---VIHRDIKPENLLMGYKGELKIADFGWSVHAPSL 167 (284)
T ss_dssp CCCTTEEHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCSGGGEEECTTCCEEECCCTTCEECSSS
T ss_pred EeCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCHHHEEEcCCCCEEEecccccccCccc
Confidence 9999999999997654 4899999999999999999999999 999999999999999999999999998765432
Q ss_pred CcceeeeeeccCCCCChhhhccCCCCCccchHhHHHHHHHHHhCCCCCCccchhhcccHHHHHHHHhhhhhhHHHhhhhh
Q 044312 431 QTHMTTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLTELLTGEKPIRFTILEEDKSLAAYFLCAMKEERLFEILDARV 510 (608)
Q Consensus 431 ~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~ 510 (608)
. .....|++.|+|||.+.+..++.++||||||++++||++|+.||....... .. ..+...
T Consensus 168 ~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~------~~---------~~~~~~-- 227 (284)
T 2vgo_A 168 R---RRTMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHTE------TH---------RRIVNV-- 227 (284)
T ss_dssp C---BCCCCSCGGGCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHH------HH---------HHHHTT--
T ss_pred c---cccccCCCCcCCHHHhccCCCCcccchhhHHHHHHHHHHCCCCCCCCCHhH------HH---------HHHhcc--
Confidence 2 234568999999999999999999999999999999999999986432211 00 011111
Q ss_pred hccCChhHHHHHHHHHHHHhccCCCCCCCHHHHHHHH
Q 044312 511 MKQGGKDEIITVAKLAKRCLNLNGKKRPTMREVASEL 547 (608)
Q Consensus 511 ~~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~evl~~L 547 (608)
....+...+..+.+|+.+||+.||++|||+.|++++-
T Consensus 228 ~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~h~ 264 (284)
T 2vgo_A 228 DLKFPPFLSDGSKDLISKLLRYHPPQRLPLKGVMEHP 264 (284)
T ss_dssp CCCCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTCH
T ss_pred ccCCCCcCCHHHHHHHHHHhhcCHhhCCCHHHHhhCH
Confidence 1123344567899999999999999999999998753
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-36 Score=305.37 Aligned_cols=235 Identities=22% Similarity=0.382 Sum_probs=184.1
Q ss_pred CccccceeccCce---------------EEEEEee--cChhhHHHHHHHHHHHhhcCCCCccceeccccc----CccceE
Q 044312 290 NFDLNRILGQGGQ---------------AVKKSKV--IDESKVEEFINEVVILSQINHRNVVKLLGCCLE----TEVPLL 348 (608)
Q Consensus 290 ~f~~~~~lG~G~~---------------avk~~~~--~~~~~~~~~~~Ei~il~~l~H~niv~l~~~~~~----~~~~~l 348 (608)
.|.+.+.||+|++ |+|.... .+....+.+.+|+.++++++||||+++++++.. ....++
T Consensus 27 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~l 106 (290)
T 1t4h_A 27 FLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVL 106 (290)
T ss_dssp EEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEE
T ss_pred eEEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhhCHHHHHHHHHHHHHHHhCCCCCeeeeeeeeccccCCCceEEE
Confidence 4777889999985 4555543 234567789999999999999999999998764 456899
Q ss_pred EEeecCCCccchhccccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEEc-CCCcEEEeeccCcccc
Q 044312 349 VYEFIPNGTLFQYIHDQNEDFPITWEIRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLD-DKYRAKVSDFGASRSM 427 (608)
Q Consensus 349 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~-~~~~~kl~DFGls~~~ 427 (608)
||||+++++|.+++.... .+++..++.++.||+.||.|||+.+ .+|+||||||+|||++ +++.+||+|||++...
T Consensus 107 v~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~qi~~~l~~lH~~~-~~i~H~dikp~Nil~~~~~~~~kl~Dfg~~~~~ 182 (290)
T 1t4h_A 107 VTELMTSGTLKTYLKRFK---VMKIKVLRSWCRQILKGLQFLHTRT-PPIIHRDLKCDNIFITGPTGSVKIGDLGLATLK 182 (290)
T ss_dssp EEECCCSCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHTSS-SCCCCSCCCGGGEEESSTTSCEEECCTTGGGGC
T ss_pred EEEecCCCCHHHHHHHcc---CCCHHHHHHHHHHHHHHHHHHHcCC-CCEEECCCCHHHEEEECCCCCEEEeeCCCcccc
Confidence 999999999999997643 5899999999999999999999976 3499999999999998 7899999999999754
Q ss_pred ccCCcceeeeeeccCCCCChhhhccCCCCCccchHhHHHHHHHHHhCCCCCCccchhhcccHHHHHHHHhhhhhhHHHhh
Q 044312 428 AVDQTHMTTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLTELLTGEKPIRFTILEEDKSLAAYFLCAMKEERLFEILD 507 (608)
Q Consensus 428 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 507 (608)
... ......||+.|+|||.+. ..++.++||||||+++++|++|+.||...... .... .......
T Consensus 183 ~~~---~~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~-----~~~~-~~~~~~~------ 246 (290)
T 1t4h_A 183 RAS---FAKAVIGTPEFMAPEMYE-EKYDESVDVYAFGMCMLEMATSEYPYSECQNA-----AQIY-RRVTSGV------ 246 (290)
T ss_dssp CTT---SBEESCSSCCCCCGGGGG-TCCCTHHHHHHHHHHHHHHHHSSCTTTTCSSH-----HHHH-HHHTTTC------
T ss_pred ccc---ccccccCCcCcCCHHHHh-ccCCCcchHHHHHHHHHHHHhCCCCCCCcCcH-----HHHH-HHHhccC------
Confidence 432 234456899999999887 46999999999999999999999998632211 1111 1111110
Q ss_pred hhhhccCChhHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 044312 508 ARVMKQGGKDEIITVAKLAKRCLNLNGKKRPTMREVASE 546 (608)
Q Consensus 508 ~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~evl~~ 546 (608)
.....+...+.++.+|+.+||+.||++|||+.|++++
T Consensus 247 --~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h 283 (290)
T 1t4h_A 247 --KPASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNH 283 (290)
T ss_dssp --CCGGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred --CccccCCCCCHHHHHHHHHHccCChhhCCCHHHHhhC
Confidence 0011122234579999999999999999999999864
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-36 Score=323.73 Aligned_cols=240 Identities=23% Similarity=0.304 Sum_probs=179.3
Q ss_pred cCcccc-ceeccCce---------------EEEEEeecChhhHHHHHHHHHHHhh-cCCCCccceeccccc----Cccce
Q 044312 289 DNFDLN-RILGQGGQ---------------AVKKSKVIDESKVEEFINEVVILSQ-INHRNVVKLLGCCLE----TEVPL 347 (608)
Q Consensus 289 ~~f~~~-~~lG~G~~---------------avk~~~~~~~~~~~~~~~Ei~il~~-l~H~niv~l~~~~~~----~~~~~ 347 (608)
++|.+. +.||+|+| |||+++. ...+.+|+.++.+ .+||||+++++++.. ....+
T Consensus 61 ~~y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~-----~~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~~~~~~~ 135 (400)
T 1nxk_A 61 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD-----CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLL 135 (400)
T ss_dssp GTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEC-----SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEE
T ss_pred ccceeccceeeeccCeEEEEEEECCCCCEEEEEEeCc-----chhHHHHHHHHHHhcCCCCcceEeEEEeecccCCcEEE
Confidence 456665 68999974 6666542 3467889988754 489999999998865 56789
Q ss_pred EEEeecCCCccchhccccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEEcC---CCcEEEeeccCc
Q 044312 348 LVYEFIPNGTLFQYIHDQNEDFPITWEIRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDD---KYRAKVSDFGAS 424 (608)
Q Consensus 348 lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~---~~~~kl~DFGls 424 (608)
|||||+++|+|.+++..... ..+++..+..|+.||+.||.|||+.+ |+||||||+|||++. ++.+||+|||++
T Consensus 136 lv~E~~~gg~L~~~l~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~~~~kl~DFG~a 211 (400)
T 1nxk_A 136 IVMECLDGGELFSRIQDRGD-QAFTEREASEIMKSIGEAIQYLHSIN---IAHRDVKPENLLYTSKRPNAILKLTDFGFA 211 (400)
T ss_dssp EEEECCCSEEHHHHHHCC----CCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSTTCCEEECCCTTC
T ss_pred EEEEeCCCCcHHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCcCcceEEEecCCCCccEEEEecccc
Confidence 99999999999999986532 25999999999999999999999999 999999999999997 789999999999
Q ss_pred cccccCCcceeeeeeccCCCCChhhhccCCCCCccchHhHHHHHHHHHhCCCCCCccchhhcc-cHHHHHHHHhhhhhhH
Q 044312 425 RSMAVDQTHMTTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLTELLTGEKPIRFTILEEDK-SLAAYFLCAMKEERLF 503 (608)
Q Consensus 425 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~elltg~~p~~~~~~~~~~-~l~~~~~~~~~~~~~~ 503 (608)
+...... ......||+.|+|||++....++.++|||||||++|||++|+.||......... .... .+.....
T Consensus 212 ~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~----~i~~~~~- 284 (400)
T 1nxk_A 212 KETTSHN--SLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKT----RIRMGQY- 284 (400)
T ss_dssp EECC-------------CTTCCGGGSCCCCSSSHHHHHHHHHHHHHHHHSSCSCCCCTTCSSCCSHHH----HHHHTCC-
T ss_pred cccCCCC--ccccCCCCCCccCHhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCccccccHHHHH----HHHcCcc-
Confidence 8654322 234557899999999999999999999999999999999999999743322110 0100 0000000
Q ss_pred HHhhhhhhccCChhHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHh
Q 044312 504 EILDARVMKQGGKDEIITVAKLAKRCLNLNGKKRPTMREVASELAG 549 (608)
Q Consensus 504 ~~~d~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~evl~~L~~ 549 (608)
..........+.++.+|+.+||+.||++|||+.|++++-.-
T Consensus 285 -----~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~~ 325 (400)
T 1nxk_A 285 -----EFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWI 325 (400)
T ss_dssp -----CCCTTTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHH
T ss_pred -----cCCCcccccCCHHHHHHHHHHCCCChhHCcCHHHHhcCccc
Confidence 00011113456789999999999999999999999987543
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-37 Score=318.64 Aligned_cols=255 Identities=23% Similarity=0.374 Sum_probs=192.3
Q ss_pred HHHHHHHhcCccccceeccCce------------EEEEEeec--ChhhHHHHHHHHHHHhhcCCCCccceecccccCccc
Q 044312 281 SKELEKATDNFDLNRILGQGGQ------------AVKKSKVI--DESKVEEFINEVVILSQINHRNVVKLLGCCLETEVP 346 (608)
Q Consensus 281 ~~~l~~~t~~f~~~~~lG~G~~------------avk~~~~~--~~~~~~~~~~Ei~il~~l~H~niv~l~~~~~~~~~~ 346 (608)
.++++...++|++.+.||+|++ |+|+.+.. +....+.|.+|+.++++++||||+++++++.+....
T Consensus 25 ~~~~~i~~~~~~~~~~lg~G~~g~V~~~~~~~~~avk~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 104 (319)
T 2y4i_B 25 LQEWDIPFEQLEIGELIGKGRFGQVYHGRWHGEVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMSPPHL 104 (319)
T ss_dssp GGGSSSCCSCEECCCBCCCSSSSEEEEEEESSSEEEEECCCCSCCCCCCCCCCTTGGGGTTCCCTTBCCCCEEEECSSCE
T ss_pred cccccCCHHHeEEeeEeccCCceEEEEEEEcCeEEEEEeecCCCCHHHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCce
Confidence 3444455678999999999985 56665542 233456788999999999999999999999999999
Q ss_pred eEEEeecCCCccchhccccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEEcCCCcEEEeeccCccc
Q 044312 347 LLVYEFIPNGTLFQYIHDQNEDFPITWEIRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRS 426 (608)
Q Consensus 347 ~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGls~~ 426 (608)
++||||+++++|.+++..... .+++..++.++.||+.||+|||+.+ |+||||||+|||++ ++.+||+|||+++.
T Consensus 105 ~iv~e~~~~~~L~~~l~~~~~--~~~~~~~~~i~~qi~~al~~lH~~~---i~H~dlkp~NIl~~-~~~~~l~Dfg~~~~ 178 (319)
T 2y4i_B 105 AIITSLCKGRTLYSVVRDAKI--VLDVNKTRQIAQEIVKGMGYLHAKG---ILHKDLKSKNVFYD-NGKVVITDFGLFSI 178 (319)
T ss_dssp EEECBCCCSEEHHHHTTSSCC--CCCSHHHHHHHHHHHHHHHHHHHTT---CCCCCCCSTTEEEC---CCEECCCSCCC-
T ss_pred EEEeecccCCcHHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHhCC---ccccCCChhhEEEe-CCCEEEeecCCccc
Confidence 999999999999999976432 5899999999999999999999999 99999999999998 67999999999876
Q ss_pred cccCC----cceeeeeeccCCCCChhhhcc---------CCCCCccchHhHHHHHHHHHhCCCCCCccchhhcccHHHHH
Q 044312 427 MAVDQ----THMTTQVHGTFGYLDPEYFRS---------SQFTDKSDVYSFGVVLTELLTGEKPIRFTILEEDKSLAAYF 493 (608)
Q Consensus 427 ~~~~~----~~~~~~~~gt~~y~aPE~~~~---------~~~t~ksDV~S~Gvvl~elltg~~p~~~~~~~~~~~l~~~~ 493 (608)
..... ........|++.|+|||.+.. ..++.++||||||++++||++|+.||....... ..
T Consensus 179 ~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~------~~ 252 (319)
T 2y4i_B 179 SGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEA------II 252 (319)
T ss_dssp ---------CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCCHHH------HH
T ss_pred cccccccccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH------HH
Confidence 53211 112233458999999999874 457899999999999999999999997432211 01
Q ss_pred HHHhhhhhhHHHhhhhhhccCChhHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhhHHhcCC
Q 044312 494 LCAMKEERLFEILDARVMKQGGKDEIITVAKLAKRCLNLNGKKRPTMREVASELAGIKAWNGA 556 (608)
Q Consensus 494 ~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~evl~~L~~i~~~~~~ 556 (608)
..+... ..........+.++.+|+.+||+.||++|||+.||++.|+.+......
T Consensus 253 -~~~~~~--------~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~l~~~~~~ 306 (319)
T 2y4i_B 253 -WQMGTG--------MKPNLSQIGMGKEISDILLFCWAFEQEERPTFTKLMDMLEKLPKRNRR 306 (319)
T ss_dssp -HHHHTT--------CCCCCCCSSCCTTHHHHHHHHHCSSTTTSCCHHHHHHHHTTC------
T ss_pred -HHhccC--------CCCCCCcCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHhhcc
Confidence 111111 011111123455799999999999999999999999999998775443
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-36 Score=313.81 Aligned_cols=249 Identities=25% Similarity=0.389 Sum_probs=185.5
Q ss_pred hcCccccceeccCce---------------EEEEEeec--ChhhHHHHHHHHHHHhhcCCCCccceecccccCccceEEE
Q 044312 288 TDNFDLNRILGQGGQ---------------AVKKSKVI--DESKVEEFINEVVILSQINHRNVVKLLGCCLETEVPLLVY 350 (608)
Q Consensus 288 t~~f~~~~~lG~G~~---------------avk~~~~~--~~~~~~~~~~Ei~il~~l~H~niv~l~~~~~~~~~~~lV~ 350 (608)
.++|++.+.||+|++ |||+.... +....+.+.+|+.++++++||||+++++++.+....++||
T Consensus 24 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 103 (331)
T 4aaa_A 24 MEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKKRWYLVF 103 (331)
T ss_dssp GGGEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCSSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred hhhheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCCCchHHHHHHHHHHHHHhhCCCCCEeeEEEEeecCCEEEEEE
Confidence 356888999999973 77776543 2334567889999999999999999999999999999999
Q ss_pred eecCCCccchhccccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEEcCCCcEEEeeccCccccccC
Q 044312 351 EFIPNGTLFQYIHDQNEDFPITWEIRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVD 430 (608)
Q Consensus 351 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGls~~~~~~ 430 (608)
||+++++|.+++.... .+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++.....
T Consensus 104 e~~~~~~l~~~~~~~~---~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 177 (331)
T 4aaa_A 104 EFVDHTILDDLELFPN---GLDYQVVQKYLFQIINGIGFCHSHN---IIHRDIKPENILVSQSGVVKLCDFGFARTLAAP 177 (331)
T ss_dssp ECCSEEHHHHHHHSTT---CCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCTTC------
T ss_pred ecCCcchHHHHHhhcc---CCCHHHHHHHHHHHHHHHHHHHHCC---EEccCcChheEEEcCCCcEEEEeCCCceeecCC
Confidence 9999998888765433 4899999999999999999999999 999999999999999999999999999876433
Q ss_pred CcceeeeeeccCCCCChhhhccC-CCCCccchHhHHHHHHHHHhCCCCCCccchhhcccHHHHHHHHhhh--hhhHHHhh
Q 044312 431 QTHMTTQVHGTFGYLDPEYFRSS-QFTDKSDVYSFGVVLTELLTGEKPIRFTILEEDKSLAAYFLCAMKE--ERLFEILD 507 (608)
Q Consensus 431 ~~~~~~~~~gt~~y~aPE~~~~~-~~t~ksDV~S~Gvvl~elltg~~p~~~~~~~~~~~l~~~~~~~~~~--~~~~~~~d 507 (608)
.. ......||+.|+|||.+.+. .++.++||||||++++||++|+.||......+. +.... ..... ........
T Consensus 178 ~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~--~~~~~-~~~~~~~~~~~~~~~ 253 (331)
T 4aaa_A 178 GE-VYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQ--LYHIM-MCLGNLIPRHQELFN 253 (331)
T ss_dssp -------CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH--HHHHH-HHHCSCCHHHHHHHH
T ss_pred cc-ccCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCCcHHH--HHHHH-HHhCCCChhhhhHhh
Confidence 22 23345689999999999875 789999999999999999999999974432211 11111 00000 00000000
Q ss_pred h----------hhh-----ccCChhHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 044312 508 A----------RVM-----KQGGKDEIITVAKLAKRCLNLNGKKRPTMREVASE 546 (608)
Q Consensus 508 ~----------~~~-----~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~evl~~ 546 (608)
. ... .......+..+.+|+.+||+.||++|||+.|++++
T Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~h 307 (331)
T 4aaa_A 254 KNPVFAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLHH 307 (331)
T ss_dssp HCGGGTTCCCCCCSSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGS
T ss_pred hccccccccCccccccchhhhcccchhHHHHHHHHHHhccCcccCCCHHHHhcC
Confidence 0 000 00012346789999999999999999999999874
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-36 Score=303.68 Aligned_cols=237 Identities=26% Similarity=0.370 Sum_probs=186.9
Q ss_pred cCccccceeccCce---------------EEEEEeecCh------hhHHHHHHHHHHHhhcCCCCccceecccccCccce
Q 044312 289 DNFDLNRILGQGGQ---------------AVKKSKVIDE------SKVEEFINEVVILSQINHRNVVKLLGCCLETEVPL 347 (608)
Q Consensus 289 ~~f~~~~~lG~G~~---------------avk~~~~~~~------~~~~~~~~Ei~il~~l~H~niv~l~~~~~~~~~~~ 347 (608)
++|++.+.||+|++ |+|..+.... ...+.+.+|+.++++++||||+++++++.+....+
T Consensus 5 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 84 (283)
T 3bhy_A 5 DHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKTDVV 84 (283)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred hhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecCCCeEE
Confidence 46888999999974 6666654221 23678999999999999999999999999999999
Q ss_pred EEEeecCCCccchhccccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEEcCCC----cEEEeeccC
Q 044312 348 LVYEFIPNGTLFQYIHDQNEDFPITWEIRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKY----RAKVSDFGA 423 (608)
Q Consensus 348 lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~----~~kl~DFGl 423 (608)
+||||+++++|.+++.... .+++..++.++.||+.||+|||+.+ ++||||||+|||++.++ .+||+|||+
T Consensus 85 lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~~~~kl~dfg~ 158 (283)
T 3bhy_A 85 LILELVSGGELFDFLAEKE---SLTEDEATQFLKQILDGVHYLHSKR---IAHFDLKPENIMLLDKNVPNPRIKLIDFGI 158 (283)
T ss_dssp EEEECCCSCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESCSSSSSCCEEECCCTT
T ss_pred EEEeecCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCChHHEEEecCCCCCCceEEEeccc
Confidence 9999999999999997643 5899999999999999999999999 99999999999998876 899999999
Q ss_pred ccccccCCcceeeeeeccCCCCChhhhccCCCCCccchHhHHHHHHHHHhCCCCCCccchhhcccHHHHHHHHhhhhhhH
Q 044312 424 SRSMAVDQTHMTTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLTELLTGEKPIRFTILEEDKSLAAYFLCAMKEERLF 503 (608)
Q Consensus 424 s~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~ 503 (608)
++...... ......|++.|+|||.+....++.++||||||++++||++|+.||......+ . ...+.....
T Consensus 159 ~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~------~-~~~~~~~~~- 228 (283)
T 3bhy_A 159 AHKIEAGN--EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGETKQE------T-LTNISAVNY- 228 (283)
T ss_dssp CEECC----------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSSHHH------H-HHHHHTTCC-
T ss_pred ceeccCCC--cccccCCCcCccCcceecCCCCCcchhhhhHHHHHHHHHHCCCCCCCcchHH------H-HHHhHhccc-
Confidence 98764322 2234568999999999999999999999999999999999999986432211 0 001110000
Q ss_pred HHhhhhhhccCChhHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 044312 504 EILDARVMKQGGKDEIITVAKLAKRCLNLNGKKRPTMREVASE 546 (608)
Q Consensus 504 ~~~d~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~evl~~ 546 (608)
..... .....+..+.+|+.+||+.||++|||+.|++++
T Consensus 229 -~~~~~----~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h 266 (283)
T 3bhy_A 229 -DFDEE----YFSNTSELAKDFIRRLLVKDPKRRMTIAQSLEH 266 (283)
T ss_dssp -CCCHH----HHTTCCHHHHHHHHTTSCSSGGGSCCHHHHHHC
T ss_pred -CCcch----hcccCCHHHHHHHHHHccCCHhHCcCHHHHHhC
Confidence 00000 011334578999999999999999999999974
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-36 Score=310.73 Aligned_cols=240 Identities=24% Similarity=0.347 Sum_probs=186.7
Q ss_pred HhcCccccceeccCce---------------EEEEEeecChhhHHHHHHHHHHHhhcCCCCccceecccccCccceEEEe
Q 044312 287 ATDNFDLNRILGQGGQ---------------AVKKSKVIDESKVEEFINEVVILSQINHRNVVKLLGCCLETEVPLLVYE 351 (608)
Q Consensus 287 ~t~~f~~~~~lG~G~~---------------avk~~~~~~~~~~~~~~~Ei~il~~l~H~niv~l~~~~~~~~~~~lV~E 351 (608)
..++|++.+.||+|++ |+|..........+.+.+|+.++++++||||+++++++.+.+..++|||
T Consensus 17 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 96 (302)
T 2j7t_A 17 PNEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYYHDGKLWIMIE 96 (302)
T ss_dssp GGGTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC----CCHHHHHHHHHHHHHCCCTTBCCEEEEEECC-CEEEEEE
T ss_pred CccceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCCCHHHHHHHHHHHHHHhcCCCCCEeeeeeeeeeCCeEEEEEE
Confidence 3467899999999974 6777766666677899999999999999999999999999999999999
Q ss_pred ecCCCccchhccccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEEcCCCcEEEeeccCccccccCC
Q 044312 352 FIPNGTLFQYIHDQNEDFPITWEIRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQ 431 (608)
Q Consensus 352 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGls~~~~~~~ 431 (608)
|+++++|.+++..... .+++..++.++.||+.||.|||+.+ ++||||||+|||++.++.+||+|||++.......
T Consensus 97 ~~~~~~l~~~~~~~~~--~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 171 (302)
T 2j7t_A 97 FCPGGAVDAIMLELDR--GLTEPQIQVVCRQMLEALNFLHSKR---IIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTL 171 (302)
T ss_dssp CCTTEEHHHHHHHHTS--CCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEECTTSCEEECCCHHHHHHHHHH
T ss_pred eCCCCcHHHHHHhhcc--CCCHHHHHHHHHHHHHHHHHHhcCC---cccCCCCHHHEEECCCCCEEEEECCCCccccccc
Confidence 9999999998876433 5899999999999999999999999 9999999999999999999999999876432211
Q ss_pred cceeeeeeccCCCCChhhh-----ccCCCCCccchHhHHHHHHHHHhCCCCCCccchhhcccHHHHHHHHhhhhhhHHHh
Q 044312 432 THMTTQVHGTFGYLDPEYF-----RSSQFTDKSDVYSFGVVLTELLTGEKPIRFTILEEDKSLAAYFLCAMKEERLFEIL 506 (608)
Q Consensus 432 ~~~~~~~~gt~~y~aPE~~-----~~~~~t~ksDV~S~Gvvl~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 506 (608)
.......||+.|+|||.+ ....++.++||||||++++||++|+.||....... ..........
T Consensus 172 -~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~------~~~~~~~~~~----- 239 (302)
T 2j7t_A 172 -QKRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMR------VLLKIAKSDP----- 239 (302)
T ss_dssp -HC-----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSCHHH------HHHHHHHSCC-----
T ss_pred -cccccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCCHHH------HHHHHhccCC-----
Confidence 122345689999999998 46678999999999999999999999986432111 1111111000
Q ss_pred hhhhhccCChhHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 044312 507 DARVMKQGGKDEIITVAKLAKRCLNLNGKKRPTMREVASE 546 (608)
Q Consensus 507 d~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~evl~~ 546 (608)
.....+...+..+.+|+.+||+.||++|||+.|++++
T Consensus 240 ---~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h 276 (302)
T 2j7t_A 240 ---PTLLTPSKWSVEFRDFLKIALDKNPETRPSAAQLLEH 276 (302)
T ss_dssp ---CCCSSGGGSCHHHHHHHHHHSCSCTTTSCCHHHHTTS
T ss_pred ---cccCCccccCHHHHHHHHHHcccChhhCCCHHHHhcC
Confidence 0011223445689999999999999999999999864
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-36 Score=323.69 Aligned_cols=240 Identities=24% Similarity=0.336 Sum_probs=178.3
Q ss_pred HHhcCccccceeccCce---------------EEEEEeecC--------hhhHHHHHHHHHHHhhcCCCCccceeccccc
Q 044312 286 KATDNFDLNRILGQGGQ---------------AVKKSKVID--------ESKVEEFINEVVILSQINHRNVVKLLGCCLE 342 (608)
Q Consensus 286 ~~t~~f~~~~~lG~G~~---------------avk~~~~~~--------~~~~~~~~~Ei~il~~l~H~niv~l~~~~~~ 342 (608)
...++|.+.+.||+|+| |||.+.... ......+.+|+.+|++++||||+++++++..
T Consensus 132 ~~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~ 211 (419)
T 3i6u_A 132 ALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDA 211 (419)
T ss_dssp HHHTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEES
T ss_pred hhhccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEec
Confidence 45678999999999985 667665321 1223358899999999999999999999754
Q ss_pred CccceEEEeecCCCccchhccccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEEcCC---CcEEEe
Q 044312 343 TEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEIRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDK---YRAKVS 419 (608)
Q Consensus 343 ~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~---~~~kl~ 419 (608)
+..++||||+++|+|.+++.... .+++..+..++.|++.||+|||+.+ |+||||||+|||++.+ ..+||+
T Consensus 212 -~~~~lv~e~~~~g~L~~~l~~~~---~~~~~~~~~i~~qi~~~l~~LH~~~---ivHrDlkp~NIll~~~~~~~~~kl~ 284 (419)
T 3i6u_A 212 -EDYYIVLELMEGGELFDKVVGNK---RLKEATCKLYFYQMLLAVQYLHENG---IIHRDLKPENVLLSSQEEDCLIKIT 284 (419)
T ss_dssp -SEEEEEEECCTTCBGGGGTSSSC---CCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESSSSSSCCEEEC
T ss_pred -CceEEEEEcCCCCcHHHHHhccC---CCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChHhEEEecCCCcceEEEe
Confidence 45799999999999999887643 5899999999999999999999999 9999999999999754 459999
Q ss_pred eccCccccccCCcceeeeeeccCCCCChhhhcc---CCCCCccchHhHHHHHHHHHhCCCCCCccchhhcccHHHHHHHH
Q 044312 420 DFGASRSMAVDQTHMTTQVHGTFGYLDPEYFRS---SQFTDKSDVYSFGVVLTELLTGEKPIRFTILEEDKSLAAYFLCA 496 (608)
Q Consensus 420 DFGls~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~t~ksDV~S~Gvvl~elltg~~p~~~~~~~~~~~l~~~~~~~ 496 (608)
|||+++..... .......||+.|+|||++.. ..++.++||||||++++||++|+.||....... .+.. .
T Consensus 285 DFG~a~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~--~~~~----~ 356 (419)
T 3i6u_A 285 DFGHSKILGET--SLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQV--SLKD----Q 356 (419)
T ss_dssp CSSTTTSCC-------------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSSSC--CHHH----H
T ss_pred ecccceecCCC--ccccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcchH--HHHH----H
Confidence 99999876532 23345679999999999853 678899999999999999999999996432211 1111 1
Q ss_pred hhhhhhHHHhhhhhhccCChhHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 044312 497 MKEERLFEILDARVMKQGGKDEIITVAKLAKRCLNLNGKKRPTMREVASE 546 (608)
Q Consensus 497 ~~~~~~~~~~d~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~evl~~ 546 (608)
+...... . .+ +.....+..+.+|+.+||+.||++|||+.|++++
T Consensus 357 i~~~~~~-~-~~----~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~h 400 (419)
T 3i6u_A 357 ITSGKYN-F-IP----EVWAEVSEKALDLVKKLLVVDPKARFTTEEALRH 400 (419)
T ss_dssp HHTTCCC-C-CH----HHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred HhcCCCC-C-Cc----hhhcccCHHHHHHHHHHccCChhHCcCHHHHhCC
Confidence 1111000 0 00 0011245679999999999999999999999874
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-36 Score=316.38 Aligned_cols=256 Identities=21% Similarity=0.278 Sum_probs=186.4
Q ss_pred CHHHHHHHhcCccccceeccCce--------------EEEEEeec-----------ChhhHHHHHHHHHHHhhcCCCCcc
Q 044312 280 TSKELEKATDNFDLNRILGQGGQ--------------AVKKSKVI-----------DESKVEEFINEVVILSQINHRNVV 334 (608)
Q Consensus 280 ~~~~l~~~t~~f~~~~~lG~G~~--------------avk~~~~~-----------~~~~~~~~~~Ei~il~~l~H~niv 334 (608)
..+++....++|.+.+.||+|++ |||+.... +....+.+.+|+.++++++||||+
T Consensus 13 ~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv 92 (362)
T 3pg1_A 13 LIAELHAMQSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNIL 92 (362)
T ss_dssp HHHHHHHTTCSCEEEEEEEEETTEEEEEEECTTSCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTBC
T ss_pred HHHHHHHhccceEEeEEeccCCCEEEEEEECCCCCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCcc
Confidence 35678888999999999999984 67766432 122347899999999999999999
Q ss_pred ceeccccc-----CccceEEEeecCCCccchhccccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEE
Q 044312 335 KLLGCCLE-----TEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEIRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNIL 409 (608)
Q Consensus 335 ~l~~~~~~-----~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NIL 409 (608)
++++++.. ....++||||++ |+|.+++..... .+++..+..++.||+.||.|||+.+ |+||||||+|||
T Consensus 93 ~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~--~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~NIl 166 (362)
T 3pg1_A 93 GLRDIFVHFEEPAMHKLYLVTELMR-TDLAQVIHDQRI--VISPQHIQYFMYHILLGLHVLHEAG---VVHRDLHPGNIL 166 (362)
T ss_dssp CCSEEEEECCTTTCCEEEEEEECCS-EEHHHHHHCTTS--CCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEE
T ss_pred ceeeeEEeccCCCcceEEEEEccCC-CCHHHHHHhccc--CCCHHHHHHHHHHHHHHHHHHHHCc---CEecCCChHHEE
Confidence 99999843 346799999997 688888875432 5899999999999999999999999 999999999999
Q ss_pred EcCCCcEEEeeccCccccccCCcceeeeeeccCCCCChhhhcc-CCCCCccchHhHHHHHHHHHhCCCCCCccchhhccc
Q 044312 410 LDDKYRAKVSDFGASRSMAVDQTHMTTQVHGTFGYLDPEYFRS-SQFTDKSDVYSFGVVLTELLTGEKPIRFTILEEDKS 488 (608)
Q Consensus 410 l~~~~~~kl~DFGls~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~t~ksDV~S~Gvvl~elltg~~p~~~~~~~~~~~ 488 (608)
++.++.+||+|||+++...... ......+|+.|+|||.+.+ ..++.++||||||++++||++|+.||......+.
T Consensus 167 ~~~~~~~kl~Dfg~~~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~-- 242 (362)
T 3pg1_A 167 LADNNDITICDFNLAREDTADA--NKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQ-- 242 (362)
T ss_dssp ECTTCCEEECCTTC-----------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH--
T ss_pred EcCCCCEEEEecCccccccccc--ccceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCCCCHHHH--
Confidence 9999999999999997544322 2344568999999999877 6789999999999999999999999974332211
Q ss_pred HHHHHHHHhhhhhh-----------HHHhhhhhh-------ccCChhHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 044312 489 LAAYFLCAMKEERL-----------FEILDARVM-------KQGGKDEIITVAKLAKRCLNLNGKKRPTMREVASE 546 (608)
Q Consensus 489 l~~~~~~~~~~~~~-----------~~~~d~~~~-------~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~evl~~ 546 (608)
............. .+.+..... .......+..+.+|+.+||+.||++|||+.|++++
T Consensus 243 -~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 317 (362)
T 3pg1_A 243 -LNKIVEVVGTPKIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQALRH 317 (362)
T ss_dssp -HHHHHHHHCCCCHHHHHHTSCHHHHHHTTTCCCCCCCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred -HHHHHHHcCCCChHHhhhccchhhhHHHHhhcccCChhhHHhhCCCCCHHHHHHHHHHhcCChhhCCCHHHHHcC
Confidence 1111111111100 011100000 00112335678999999999999999999999864
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-36 Score=320.78 Aligned_cols=241 Identities=29% Similarity=0.353 Sum_probs=190.8
Q ss_pred hcCccccceeccCce------------------EEEEEeec----ChhhHHHHHHHHHHHhhc-CCCCccceecccccCc
Q 044312 288 TDNFDLNRILGQGGQ------------------AVKKSKVI----DESKVEEFINEVVILSQI-NHRNVVKLLGCCLETE 344 (608)
Q Consensus 288 t~~f~~~~~lG~G~~------------------avk~~~~~----~~~~~~~~~~Ei~il~~l-~H~niv~l~~~~~~~~ 344 (608)
.++|++.+.||+|+| |||+++.. .....+.+.+|+.+|+++ +||||+++++++.+..
T Consensus 53 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~ 132 (355)
T 1vzo_A 53 IENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTET 132 (355)
T ss_dssp GGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETT
T ss_pred ccceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEeeCc
Confidence 367999999999985 45554321 123456788899999999 7999999999999999
Q ss_pred cceEEEeecCCCccchhccccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEEcCCCcEEEeeccCc
Q 044312 345 VPLLVYEFIPNGTLFQYIHDQNEDFPITWEIRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGAS 424 (608)
Q Consensus 345 ~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGls 424 (608)
..+|||||+++++|.+++.... .+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++
T Consensus 133 ~~~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~DfG~a 206 (355)
T 1vzo_A 133 KLHLILDYINGGELFTHLSQRE---RFTEHEVQIYVGEIVLALEHLHKLG---IIYRDIKLENILLDSNGHVVLTDFGLS 206 (355)
T ss_dssp EEEEEECCCCSCBHHHHHHHHS---CCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEESCSSEE
T ss_pred eEEEEeecCCCCCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCcEEEeeCCCC
Confidence 9999999999999999997653 4899999999999999999999999 999999999999999999999999999
Q ss_pred cccccCCcceeeeeeccCCCCChhhhcc--CCCCCccchHhHHHHHHHHHhCCCCCCccchhhcccHHHHHHHHhhhhhh
Q 044312 425 RSMAVDQTHMTTQVHGTFGYLDPEYFRS--SQFTDKSDVYSFGVVLTELLTGEKPIRFTILEEDKSLAAYFLCAMKEERL 502 (608)
Q Consensus 425 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~t~ksDV~S~Gvvl~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~ 502 (608)
+..............||+.|+|||++.+ ..++.++||||||++|+||++|+.||....... ........
T Consensus 207 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~--~~~~~~~~------- 277 (355)
T 1vzo_A 207 KEFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKN--SQAEISRR------- 277 (355)
T ss_dssp EECCGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCC--CHHHHHHH-------
T ss_pred eecccCCCCcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCccc--hHHHHHHH-------
Confidence 8765444444445679999999999985 357899999999999999999999996432211 11111100
Q ss_pred HHHhhhhhhccCChhHHHHHHHHHHHHhccCCCCCC-----CHHHHHHHH
Q 044312 503 FEILDARVMKQGGKDEIITVAKLAKRCLNLNGKKRP-----TMREVASEL 547 (608)
Q Consensus 503 ~~~~d~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RP-----s~~evl~~L 547 (608)
+.. .....+...+..+.+|+.+||+.||++|| ++.|++++.
T Consensus 278 --~~~--~~~~~~~~~~~~~~~li~~~L~~dP~~R~~~~~~s~~ell~h~ 323 (355)
T 1vzo_A 278 --ILK--SEPPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHL 323 (355)
T ss_dssp --HHH--CCCCCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSG
T ss_pred --Hhc--cCCCCCcccCHHHHHHHHHHhhhCHHHhcCCCCCCHHHHHcCc
Confidence 000 11223445567899999999999999999 899988654
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-36 Score=312.76 Aligned_cols=244 Identities=24% Similarity=0.320 Sum_probs=189.8
Q ss_pred HHHHhcCcccc-ceeccCce---------------EEEEEee--cChhhHHHHHHHHHHHhhc-CCCCccceecccccCc
Q 044312 284 LEKATDNFDLN-RILGQGGQ---------------AVKKSKV--IDESKVEEFINEVVILSQI-NHRNVVKLLGCCLETE 344 (608)
Q Consensus 284 l~~~t~~f~~~-~~lG~G~~---------------avk~~~~--~~~~~~~~~~~Ei~il~~l-~H~niv~l~~~~~~~~ 344 (608)
.+...+.|.+. +.||+|++ |||..+. ........+.+|+.+++++ +||||+++++++.+..
T Consensus 23 ~~~~~~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~iv~~~~~~~~~~ 102 (327)
T 3lm5_A 23 MENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEVYENTS 102 (327)
T ss_dssp HHHHHHHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEETTEECHHHHHHHHHHHHHTTTCTTBCCEEEEEECSS
T ss_pred HHhhhhEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHhccCCCCEEEEEEEEEeCC
Confidence 34455567776 88999974 6776653 2234467899999999999 5699999999999999
Q ss_pred cceEEEeecCCCccchhccccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEEcC---CCcEEEeec
Q 044312 345 VPLLVYEFIPNGTLFQYIHDQNEDFPITWEIRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDD---KYRAKVSDF 421 (608)
Q Consensus 345 ~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~---~~~~kl~DF 421 (608)
..++||||+++|+|.+++..... ..+++..++.++.|++.||+|||+.+ |+||||||+|||++. ++.+||+||
T Consensus 103 ~~~lv~e~~~~~~L~~~~~~~~~-~~~~~~~~~~i~~ql~~~L~~LH~~g---ivH~Dikp~NIl~~~~~~~~~~kL~Df 178 (327)
T 3lm5_A 103 EIILILEYAAGGEIFSLCLPELA-EMVSENDVIRLIKQILEGVYYLHQNN---IVHLDLKPQNILLSSIYPLGDIKIVDF 178 (327)
T ss_dssp EEEEEEECCTTEEGGGGGSSCC--CCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEESCBTTBCCEEECCG
T ss_pred eEEEEEEecCCCcHHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHHCC---eecCcCChHHEEEecCCCCCcEEEeeC
Confidence 99999999999999999865432 25999999999999999999999999 999999999999997 789999999
Q ss_pred cCccccccCCcceeeeeeccCCCCChhhhccCCCCCccchHhHHHHHHHHHhCCCCCCccchhhcccHHHHHHHHhhhhh
Q 044312 422 GASRSMAVDQTHMTTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLTELLTGEKPIRFTILEEDKSLAAYFLCAMKEER 501 (608)
Q Consensus 422 Gls~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~ 501 (608)
|+++...... ......||+.|+|||++....++.++||||||++++||++|+.||......+. ... +..
T Consensus 179 g~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~------~~~-i~~-- 247 (327)
T 3lm5_A 179 GMSRKIGHAC--ELREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPFVGEDNQET------YLN-ISQ-- 247 (327)
T ss_dssp GGCEEC-----------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH------HHH-HHH--
T ss_pred ccccccCCcc--ccccccCCcCccCCeeecCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHH------HHH-HHh--
Confidence 9998764322 22345689999999999999999999999999999999999999964322110 000 000
Q ss_pred hHHHhhhhhhccCChhHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 044312 502 LFEILDARVMKQGGKDEIITVAKLAKRCLNLNGKKRPTMREVASE 546 (608)
Q Consensus 502 ~~~~~d~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~evl~~ 546 (608)
.............+..+.+|+.+||+.||++|||++|++++
T Consensus 248 ----~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~~ll~h 288 (327)
T 3lm5_A 248 ----VNVDYSEETFSSVSQLATDFIQSLLVKNPEKRPTAEICLSH 288 (327)
T ss_dssp ----TCCCCCTTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTC
T ss_pred ----cccccCchhhcccCHHHHHHHHHHcCCChhhCcCHHHHhCC
Confidence 00011112223456789999999999999999999999754
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-36 Score=317.72 Aligned_cols=241 Identities=22% Similarity=0.322 Sum_probs=187.9
Q ss_pred HhcCccccceeccCce---------------EEEEEeecChhhHHHHHHHHHHHhhc-CCCCccceecccccCccceEEE
Q 044312 287 ATDNFDLNRILGQGGQ---------------AVKKSKVIDESKVEEFINEVVILSQI-NHRNVVKLLGCCLETEVPLLVY 350 (608)
Q Consensus 287 ~t~~f~~~~~lG~G~~---------------avk~~~~~~~~~~~~~~~Ei~il~~l-~H~niv~l~~~~~~~~~~~lV~ 350 (608)
..++|++.+.||+|+| |||.+.... ..+.+|++++.++ +||||+++++++.+....++||
T Consensus 20 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~----~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ 95 (342)
T 2qr7_A 20 FTDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSK----RDPTEEIEILLRYGQHPNIITLKDVYDDGKYVYVVT 95 (342)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTT----CCCHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEE
T ss_pred ccccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEccc----CChHHHHHHHHHhcCCCCcCeEEEEEEcCCEEEEEE
Confidence 3567999999999985 566654322 2356788888888 7999999999999999999999
Q ss_pred eecCCCccchhccccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEEcCC----CcEEEeeccCccc
Q 044312 351 EFIPNGTLFQYIHDQNEDFPITWEIRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDK----YRAKVSDFGASRS 426 (608)
Q Consensus 351 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~----~~~kl~DFGls~~ 426 (608)
||+++|+|.+++.... .+++..+..++.||+.||+|||+++ |+||||||+|||+.++ +.+||+|||+++.
T Consensus 96 E~~~gg~L~~~i~~~~---~~~~~~~~~~~~qi~~al~~lH~~g---ivHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a~~ 169 (342)
T 2qr7_A 96 ELMKGGELLDKILRQK---FFSEREASAVLFTITKTVEYLHAQG---VVHRDLKPSNILYVDESGNPESIRICDFGFAKQ 169 (342)
T ss_dssp CCCCSCBHHHHHHTCT---TCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEESSSSCSGGGEEECCCTTCEE
T ss_pred eCCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---cEeccCCHHHEEEecCCCCcCeEEEEECCCccc
Confidence 9999999999987643 5899999999999999999999999 9999999999998543 3599999999987
Q ss_pred cccCCcceeeeeeccCCCCChhhhccCCCCCccchHhHHHHHHHHHhCCCCCCccchhhcccHHHHHHHHhhhhhhHHHh
Q 044312 427 MAVDQTHMTTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLTELLTGEKPIRFTILEEDKSLAAYFLCAMKEERLFEIL 506 (608)
Q Consensus 427 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 506 (608)
...... ......||+.|+|||++.+..++.++||||||+++|||++|+.||....... ... ....+.....
T Consensus 170 ~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~---~~~-~~~~i~~~~~---- 240 (342)
T 2qr7_A 170 LRAENG-LLMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPDDT---PEE-ILARIGSGKF---- 240 (342)
T ss_dssp CBCTTC-CBCCSSCCSSCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHSSCSSCSSTTSC---HHH-HHHHHHHCCC----
T ss_pred CcCCCC-ceeccCCCccccCHHHhcCCCCCCccCeeeHhHHHHHHhcCCCCCCCCCcCC---HHH-HHHHHccCCc----
Confidence 654322 2334568999999999988889999999999999999999999997422111 111 1111111110
Q ss_pred hhhhhccCChhHHHHHHHHHHHHhccCCCCCCCHHHHHHHHH
Q 044312 507 DARVMKQGGKDEIITVAKLAKRCLNLNGKKRPTMREVASELA 548 (608)
Q Consensus 507 d~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~evl~~L~ 548 (608)
..........+.++.+|+.+||+.||++|||+.|++++-.
T Consensus 241 --~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~il~hp~ 280 (342)
T 2qr7_A 241 --SLSGGYWNSVSDTAKDLVSKMLHVDPHQRLTAALVLRHPW 280 (342)
T ss_dssp --CCCSTTTTTSCHHHHHHHHHHTCSSTTTSCCHHHHTTSHH
T ss_pred --ccCccccccCCHHHHHHHHHHCCCChhHCcCHHHHhcCCe
Confidence 0011122345678999999999999999999999987643
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-36 Score=315.36 Aligned_cols=252 Identities=21% Similarity=0.288 Sum_probs=185.2
Q ss_pred cCccccceeccCce---------------EEEEEeecC--hhhHHHHHHHHHHHhhcCCCCccceecccccC--------
Q 044312 289 DNFDLNRILGQGGQ---------------AVKKSKVID--ESKVEEFINEVVILSQINHRNVVKLLGCCLET-------- 343 (608)
Q Consensus 289 ~~f~~~~~lG~G~~---------------avk~~~~~~--~~~~~~~~~Ei~il~~l~H~niv~l~~~~~~~-------- 343 (608)
++|++.+.||+|++ |||+..... ......+.+|+.++++++||||+++++++...
T Consensus 17 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 96 (351)
T 3mi9_A 17 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCK 96 (351)
T ss_dssp GGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSSSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC--------
T ss_pred cceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEecccccccchHHHHHHHHHHHhccCCCcccHhheeeccccccccCC
Confidence 57899999999974 677664322 23356788999999999999999999998763
Q ss_pred ccceEEEeecCCCccchhccccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEEcCCCcEEEeeccC
Q 044312 344 EVPLLVYEFIPNGTLFQYIHDQNEDFPITWEIRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGA 423 (608)
Q Consensus 344 ~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGl 423 (608)
+..++||||+++ +|.+.+..... .+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+
T Consensus 97 ~~~~lv~e~~~~-~l~~~l~~~~~--~~~~~~~~~i~~qi~~~l~~LH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg~ 170 (351)
T 3mi9_A 97 GSIYLVFDFCEH-DLAGLLSNVLV--KFTLSEIKRVMQMLLNGLYYIHRNK---ILHRDMKAANVLITRDGVLKLADFGL 170 (351)
T ss_dssp CEEEEEEECCSE-EHHHHHHCTTS--CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTT
T ss_pred ceEEEEEeccCC-CHHHHHhhccC--CCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCHHHEEEcCCCCEEEccchh
Confidence 467999999975 77777765433 4899999999999999999999999 99999999999999999999999999
Q ss_pred ccccccCC---cceeeeeeccCCCCChhhhcc-CCCCCccchHhHHHHHHHHHhCCCCCCccchhhcccHHHHHHHHhhh
Q 044312 424 SRSMAVDQ---THMTTQVHGTFGYLDPEYFRS-SQFTDKSDVYSFGVVLTELLTGEKPIRFTILEEDKSLAAYFLCAMKE 499 (608)
Q Consensus 424 s~~~~~~~---~~~~~~~~gt~~y~aPE~~~~-~~~t~ksDV~S~Gvvl~elltg~~p~~~~~~~~~~~l~~~~~~~~~~ 499 (608)
++.+.... ........||+.|+|||++.+ ..++.++||||||++++||++|+.||.....................
T Consensus 171 a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~ 250 (351)
T 3mi9_A 171 ARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITP 250 (351)
T ss_dssp CEECCCCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCT
T ss_pred cccccccccccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCh
Confidence 98765322 222344568999999999876 45899999999999999999999999753322211111100000000
Q ss_pred hhhHHHhhhhhhc------c--CC-h------hHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 044312 500 ERLFEILDARVMK------Q--GG-K------DEIITVAKLAKRCLNLNGKKRPTMREVASE 546 (608)
Q Consensus 500 ~~~~~~~d~~~~~------~--~~-~------~~~~~l~~Li~~cl~~dp~~RPs~~evl~~ 546 (608)
......-...... . .. . ..+..+.+|+.+||+.||++|||+.|++++
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 312 (351)
T 3mi9_A 251 EVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNH 312 (351)
T ss_dssp TTSTTGGGCGGGTSSCCCSSCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred hhccccccchhhcccccccccccCHHHHhhhccCChHHHHHHHHHhcCChhhCCCHHHHhCC
Confidence 0000000000000 0 00 0 013468899999999999999999999875
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-35 Score=308.82 Aligned_cols=243 Identities=22% Similarity=0.313 Sum_probs=187.5
Q ss_pred hcCccccceeccCce---------------EEEEEeecChhhHHHHHHHHHHHhhcC-CCCccceeccccc--CccceEE
Q 044312 288 TDNFDLNRILGQGGQ---------------AVKKSKVIDESKVEEFINEVVILSQIN-HRNVVKLLGCCLE--TEVPLLV 349 (608)
Q Consensus 288 t~~f~~~~~lG~G~~---------------avk~~~~~~~~~~~~~~~Ei~il~~l~-H~niv~l~~~~~~--~~~~~lV 349 (608)
.++|++.+.||+|++ |||..+ ....+.+.+|+.++++++ ||||+++++++.+ ....++|
T Consensus 35 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~---~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~lv 111 (330)
T 3nsz_A 35 QDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILK---PVKKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALV 111 (330)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEC---SCCHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCCEEEE
T ss_pred CCceEEEEEecccCCeEEEEEEECCCCcEEEEEEec---ccchHHHHHHHHHHHHcCCCCCEEEeeeeeccCCCCceEEE
Confidence 357899999999985 555544 345678999999999996 9999999999987 5678999
Q ss_pred EeecCCCccchhccccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEEcCCC-cEEEeeccCccccc
Q 044312 350 YEFIPNGTLFQYIHDQNEDFPITWEIRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKY-RAKVSDFGASRSMA 428 (608)
Q Consensus 350 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~-~~kl~DFGls~~~~ 428 (608)
|||+++++|.+++. .+++..+..++.||+.||+|||+.+ |+||||||+|||++.++ .+||+|||+++...
T Consensus 112 ~e~~~~~~l~~~~~------~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~ 182 (330)
T 3nsz_A 112 FEHVNNTDFKQLYQ------TLTDYDIRFYMYEILKALDYCHSMG---IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYH 182 (330)
T ss_dssp EECCCCCCHHHHGG------GCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTTEEEECCCTTCEECC
T ss_pred EeccCchhHHHHHH------hCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEEcCCCCEEEEEeCCCceEcC
Confidence 99999999998874 3789999999999999999999999 99999999999999766 89999999998765
Q ss_pred cCCcceeeeeeccCCCCChhhhcc-CCCCCccchHhHHHHHHHHHhCCCCCCccchhhcccHHHHHHHHhhhhhhHHHhh
Q 044312 429 VDQTHMTTQVHGTFGYLDPEYFRS-SQFTDKSDVYSFGVVLTELLTGEKPIRFTILEEDKSLAAYFLCAMKEERLFEILD 507 (608)
Q Consensus 429 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~t~ksDV~S~Gvvl~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 507 (608)
.... .....++..|+|||.+.. ..++.++||||||++++||++|+.||....... ..+. ..........+.+.++
T Consensus 183 ~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~-~~l~-~~~~~~~~~~~~~~~~ 258 (330)
T 3nsz_A 183 PGQE--YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNY-DQLV-RIAKVLGTEDLYDYID 258 (330)
T ss_dssp TTCC--CCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHH-HHHH-HHHHHHCHHHHHHHHH
T ss_pred CCCc--cccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcccCCchH-HHHH-HHHHhcCCchhhhHHH
Confidence 4332 234568999999999887 678999999999999999999999985432211 1111 1111112222222111
Q ss_pred hhh-----------------------hccCChhHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 044312 508 ARV-----------------------MKQGGKDEIITVAKLAKRCLNLNGKKRPTMREVASE 546 (608)
Q Consensus 508 ~~~-----------------------~~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~evl~~ 546 (608)
... ........+.++.+|+.+||+.||++|||++|++++
T Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~h 320 (330)
T 3nsz_A 259 KYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEH 320 (330)
T ss_dssp HTTCCCCTHHHHHHCCCCCCCGGGGCCTTTGGGCCHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred HhccccccchhhhhhhccccchhhhccccccccCCHHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence 100 011112246789999999999999999999999864
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-36 Score=339.17 Aligned_cols=235 Identities=25% Similarity=0.352 Sum_probs=193.8
Q ss_pred HhcCccccceeccCce---------------EEEEEee---cChhhHHHHHHHHHHHhhc-CCCCccceecccccCccce
Q 044312 287 ATDNFDLNRILGQGGQ---------------AVKKSKV---IDESKVEEFINEVVILSQI-NHRNVVKLLGCCLETEVPL 347 (608)
Q Consensus 287 ~t~~f~~~~~lG~G~~---------------avk~~~~---~~~~~~~~~~~Ei~il~~l-~H~niv~l~~~~~~~~~~~ 347 (608)
..++|++.++||+|+| |||+++. ......+.+..|..+|..+ +||||+++++++.+.+..+
T Consensus 339 ~~~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~~~~~ 418 (674)
T 3pfq_A 339 KLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLY 418 (674)
T ss_dssp -CTTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBCSSEEE
T ss_pred cccceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEeCCEEE
Confidence 3567999999999984 7777763 2344567889999999988 7999999999999999999
Q ss_pred EEEeecCCCccchhccccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEEcCCCcEEEeeccCcccc
Q 044312 348 LVYEFIPNGTLFQYIHDQNEDFPITWEIRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSM 427 (608)
Q Consensus 348 lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGls~~~ 427 (608)
|||||+++|+|.+++.... .+++..++.++.||+.||+|||+.+ |+||||||+||||+.++.+||+|||+++..
T Consensus 419 lV~E~~~gg~L~~~l~~~~---~~~~~~~~~~~~qi~~aL~~LH~~g---IiHrDLKp~NILl~~~g~ikL~DFGla~~~ 492 (674)
T 3pfq_A 419 FVMEYVNGGDLMYHIQQVG---RFKEPHAVFYAAEIAIGLFFLQSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKEN 492 (674)
T ss_dssp EEEECCCSCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHTS---EECCCCCSTTEEECSSSCEEECCCTTCEEC
T ss_pred EEEeCcCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCC---eEeccCChhhEEEcCCCcEEEeecceeecc
Confidence 9999999999999998754 4899999999999999999999999 999999999999999999999999999864
Q ss_pred ccCCcceeeeeeccCCCCChhhhccCCCCCccchHhHHHHHHHHHhCCCCCCccchhhcccHHHHHHHHhhhhhhHHHhh
Q 044312 428 AVDQTHMTTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLTELLTGEKPIRFTILEEDKSLAAYFLCAMKEERLFEILD 507 (608)
Q Consensus 428 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 507 (608)
.... .......||+.|+|||++.+..++.++||||||++||||++|+.||...... ..+ ..++.
T Consensus 493 ~~~~-~~~~~~~GT~~Y~APE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~~~------~~~---------~~i~~ 556 (674)
T 3pfq_A 493 IWDG-VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDED------ELF---------QSIME 556 (674)
T ss_dssp CCTT-CCBCCCCSCSSSCCHHHHTCCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHH------HHH---------HHHHS
T ss_pred ccCC-cccccccCCCcccCHhhhcCCCCCccceEechHHHHHHHHcCCCCCCCCCHH------HHH---------HHHHh
Confidence 4332 2344567999999999999999999999999999999999999999743211 111 11111
Q ss_pred hhhhccCChhHHHHHHHHHHHHhccCCCCCCCH-----HHHHH
Q 044312 508 ARVMKQGGKDEIITVAKLAKRCLNLNGKKRPTM-----REVAS 545 (608)
Q Consensus 508 ~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPs~-----~evl~ 545 (608)
.. ...+...+.++.+|+.+||+.||++||++ +||++
T Consensus 557 ~~--~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~ei~~ 597 (674)
T 3pfq_A 557 HN--VAYPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKE 597 (674)
T ss_dssp SC--CCCCTTSCHHHHHHHHHHSCSSSTTCTTCSTTHHHHHHS
T ss_pred CC--CCCCccCCHHHHHHHHHHccCCHHHCCCCCCCcHHHHhc
Confidence 11 12344567789999999999999999997 56554
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-37 Score=325.47 Aligned_cols=230 Identities=16% Similarity=0.175 Sum_probs=178.8
Q ss_pred HhcCccccceeccCce---------------EEEEEee---cChhhHHHHHHHH---HHHhhcCCCCccceeccc-----
Q 044312 287 ATDNFDLNRILGQGGQ---------------AVKKSKV---IDESKVEEFINEV---VILSQINHRNVVKLLGCC----- 340 (608)
Q Consensus 287 ~t~~f~~~~~lG~G~~---------------avk~~~~---~~~~~~~~~~~Ei---~il~~l~H~niv~l~~~~----- 340 (608)
..++|.+.+.||+|+| |||++.. ......+.|.+|+ ++|++++|||||++++.+
T Consensus 71 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~ 150 (377)
T 3byv_A 71 RPRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFD 150 (377)
T ss_dssp CCEEEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSE
T ss_pred CCceEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhh
Confidence 3567899999999974 7887763 3445678899999 555666899999999443
Q ss_pred --ccCc-----------------cceEEEeecCCCccchhccccCC----CCCCCHHHHHHHHHHHHHHHHHHhhcCCCC
Q 044312 341 --LETE-----------------VPLLVYEFIPNGTLFQYIHDQNE----DFPITWEIRLRIAIEVSGALSYLHSAASIP 397 (608)
Q Consensus 341 --~~~~-----------------~~~lV~E~~~~gsL~~~l~~~~~----~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ 397 (608)
.+.+ ..+|||||+ +|+|.+++..... ...+++..++.|+.||+.||+|||+++
T Consensus 151 ~~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~--- 226 (377)
T 3byv_A 151 LVKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYG--- 226 (377)
T ss_dssp EEECTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHHHTT---
T ss_pred hhhccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHHhCC---
Confidence 3332 378999999 6899999986421 113456889999999999999999999
Q ss_pred eeccCCCCCcEEEcCCCcEEEeeccCccccccCCcceeeeeeccCCCCChhhhccC-----------CCCCccchHhHHH
Q 044312 398 IYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHGTFGYLDPEYFRSS-----------QFTDKSDVYSFGV 466 (608)
Q Consensus 398 iiHrDlk~~NILl~~~~~~kl~DFGls~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----------~~t~ksDV~S~Gv 466 (608)
|+||||||+|||++.++.+||+|||+++.... ......| +.|+|||++... .++.++||||||+
T Consensus 227 ivHrDikp~NIll~~~~~~kL~DFG~a~~~~~----~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DvwSlG~ 301 (377)
T 3byv_A 227 LVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGA----RVVSSVS-RGFEPPELEARRATISYHRDRRTLMTFSFDAWALGL 301 (377)
T ss_dssp EECSCCCGGGEEECTTCCEEECCGGGCEETTC----EEECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHHHHHHHHH
T ss_pred eecCCCCHHHEEEcCCCCEEEEechhheecCC----cccCCCC-cCccChhhhcccccccccccccccCChhhhHHHHHH
Confidence 99999999999999999999999999985332 3344567 999999999887 8999999999999
Q ss_pred HHHHHHhCCCCCCccchhhcccHHHHHHHHhhhhhhHHHhhhhhhccCChhHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 044312 467 VLTELLTGEKPIRFTILEEDKSLAAYFLCAMKEERLFEILDARVMKQGGKDEIITVAKLAKRCLNLNGKKRPTMREVASE 546 (608)
Q Consensus 467 vl~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~evl~~ 546 (608)
++|||++|+.||....... ....+. ......+.++.+|+.+||+.||++|||+.|++++
T Consensus 302 il~elltg~~Pf~~~~~~~---------------~~~~~~------~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~h 360 (377)
T 3byv_A 302 VIYWIWCADLPITKDAALG---------------GSEWIF------RSCKNIPQPVRALLEGFLRYPKEDRLLPLQAMET 360 (377)
T ss_dssp HHHHHHHSSCCC------C---------------CSGGGG------SSCCCCCHHHHHHHHHHTCSSGGGCCCHHHHHTS
T ss_pred HHHHHHHCCCCCccccccc---------------chhhhh------hhccCCCHHHHHHHHHHcCCCchhCCCHHHHhhC
Confidence 9999999999986322111 011111 1113445689999999999999999999999874
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-36 Score=328.04 Aligned_cols=237 Identities=26% Similarity=0.381 Sum_probs=187.0
Q ss_pred hcCccccceeccCce---------------EEEEEeec--ChhhHHHHHHHHHHHhhcCCCCccceecccccCccceEEE
Q 044312 288 TDNFDLNRILGQGGQ---------------AVKKSKVI--DESKVEEFINEVVILSQINHRNVVKLLGCCLETEVPLLVY 350 (608)
Q Consensus 288 t~~f~~~~~lG~G~~---------------avk~~~~~--~~~~~~~~~~Ei~il~~l~H~niv~l~~~~~~~~~~~lV~ 350 (608)
.++|++.+.||+|++ |+|++... .....+.+.+|+.+|++++||||+++++++.+....++||
T Consensus 36 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 115 (494)
T 3lij_A 36 SEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLVM 115 (494)
T ss_dssp HHHEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC-----CTTHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hcCeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence 456999999999985 66666532 2334678999999999999999999999999999999999
Q ss_pred eecCCCccchhccccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEEcC---CCcEEEeeccCcccc
Q 044312 351 EFIPNGTLFQYIHDQNEDFPITWEIRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDD---KYRAKVSDFGASRSM 427 (608)
Q Consensus 351 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~---~~~~kl~DFGls~~~ 427 (608)
||+++|+|.+++.... .+++..+..++.||+.||+|||+.+ |+||||||+|||++. ++.+||+|||+++..
T Consensus 116 e~~~~g~L~~~~~~~~---~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~~~ 189 (494)
T 3lij_A 116 ECYKGGELFDEIIHRM---KFNEVDAAVIIKQVLSGVTYLHKHN---IVHRDLKPENLLLESKEKDALIKIVDFGLSAVF 189 (494)
T ss_dssp ECCCSCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESCSSTTCCEEECCCTTCEEC
T ss_pred ecCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCChhhEEEeCCCCCCcEEEEECCCCeEC
Confidence 9999999999887653 4899999999999999999999999 999999999999976 455999999999876
Q ss_pred ccCCcceeeeeeccCCCCChhhhccCCCCCccchHhHHHHHHHHHhCCCCCCccchhhcccHHHHHHHHhhhhhhHHHhh
Q 044312 428 AVDQTHMTTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLTELLTGEKPIRFTILEEDKSLAAYFLCAMKEERLFEILD 507 (608)
Q Consensus 428 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 507 (608)
.... ......||+.|+|||++. ..++.++||||||+++|+|++|+.||......+ ....+......
T Consensus 190 ~~~~--~~~~~~gt~~y~aPE~l~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~-------~~~~i~~~~~~---- 255 (494)
T 3lij_A 190 ENQK--KMKERLGTAYYIAPEVLR-KKYDEKCDVWSIGVILFILLAGYPPFGGQTDQE-------ILRKVEKGKYT---- 255 (494)
T ss_dssp BTTB--CBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH-------HHHHHHHTCCC----
T ss_pred CCCc--cccccCCCcCeeCHHHHc-ccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHH-------HHHHHHhCCCC----
Confidence 5432 234456999999999986 569999999999999999999999997432211 11111111000
Q ss_pred hhhhccCChhHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 044312 508 ARVMKQGGKDEIITVAKLAKRCLNLNGKKRPTMREVASE 546 (608)
Q Consensus 508 ~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~evl~~ 546 (608)
.........+..+.+|+.+||+.||.+|||+.|++++
T Consensus 256 --~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~h 292 (494)
T 3lij_A 256 --FDSPEWKNVSEGAKDLIKQMLQFDSQRRISAQQALEH 292 (494)
T ss_dssp --CCSGGGTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTC
T ss_pred --CCchhcccCCHHHHHHHHHHCCCChhhCccHHHHhcC
Confidence 0001112345679999999999999999999999875
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-36 Score=314.99 Aligned_cols=249 Identities=21% Similarity=0.319 Sum_probs=188.1
Q ss_pred HhcCccccceeccCce---------------EEEEEeec-ChhhHHHHHHHHHHHhhcCCCCccceecccccC-----cc
Q 044312 287 ATDNFDLNRILGQGGQ---------------AVKKSKVI-DESKVEEFINEVVILSQINHRNVVKLLGCCLET-----EV 345 (608)
Q Consensus 287 ~t~~f~~~~~lG~G~~---------------avk~~~~~-~~~~~~~~~~Ei~il~~l~H~niv~l~~~~~~~-----~~ 345 (608)
..++|++.+.||+|++ |||+.... .....+.+.+|+++|++++||||+++++++... ..
T Consensus 25 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 104 (364)
T 3qyz_A 25 VGPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKD 104 (364)
T ss_dssp CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCC
T ss_pred ccccEEEEEEeecCCCeEEEEEEECCCCeEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCccccce
Confidence 3568999999999984 66766542 234457899999999999999999999998654 36
Q ss_pred ceEEEeecCCCccchhccccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEEcCCCcEEEeeccCcc
Q 044312 346 PLLVYEFIPNGTLFQYIHDQNEDFPITWEIRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASR 425 (608)
Q Consensus 346 ~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGls~ 425 (608)
.++||||+. ++|.+++... .+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++
T Consensus 105 ~~iv~e~~~-~~L~~~l~~~----~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~a~ 176 (364)
T 3qyz_A 105 VYIVQDLME-TDLYKLLKTQ----HLSNDHICYFLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLAR 176 (364)
T ss_dssp EEEEEECCS-EEHHHHHHHC----CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCE
T ss_pred EEEEEcccC-cCHHHHHHhC----CCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCChHhEEECCCCCEEEEeCcceE
Confidence 799999996 5999988653 4899999999999999999999999 9999999999999999999999999998
Q ss_pred ccccCCcce--eeeeeccCCCCChhhhcc-CCCCCccchHhHHHHHHHHHhCCCCCCccchhhcccHHHHHHHHhhhh--
Q 044312 426 SMAVDQTHM--TTQVHGTFGYLDPEYFRS-SQFTDKSDVYSFGVVLTELLTGEKPIRFTILEEDKSLAAYFLCAMKEE-- 500 (608)
Q Consensus 426 ~~~~~~~~~--~~~~~gt~~y~aPE~~~~-~~~t~ksDV~S~Gvvl~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~-- 500 (608)
......... .....||+.|+|||++.+ ..++.++||||||++++||++|+.||......+. ...........
T Consensus 177 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~---~~~i~~~~~~~~~ 253 (364)
T 3qyz_A 177 VADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQ---LNHILGILGSPSQ 253 (364)
T ss_dssp ECCGGGCBCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSSGGGH---HHHHHHHHCSCCH
T ss_pred ecCCCCCccccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCChHHH---HHHHHHHhCCCCH
Confidence 765432221 244578999999998754 4589999999999999999999999974432221 11111111100
Q ss_pred -hhHHHhh---hhh----h-------ccCChhHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 044312 501 -RLFEILD---ARV----M-------KQGGKDEIITVAKLAKRCLNLNGKKRPTMREVASE 546 (608)
Q Consensus 501 -~~~~~~d---~~~----~-------~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~evl~~ 546 (608)
.+..+.+ ... . .......+.++.+|+.+||+.||++|||+.|++++
T Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 314 (364)
T 3qyz_A 254 EDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAH 314 (364)
T ss_dssp HHHHTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred HHHHHhhhhhHHHHHHhcCCccCCCHHHhCCCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 0000000 000 0 00012345678999999999999999999999864
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-36 Score=311.18 Aligned_cols=251 Identities=24% Similarity=0.389 Sum_probs=175.2
Q ss_pred HHhcCccccceeccCce---------------EEEEEeecC-hhhHHHHHHHHHHHhhcCCCCccceecccccCccceEE
Q 044312 286 KATDNFDLNRILGQGGQ---------------AVKKSKVID-ESKVEEFINEVVILSQINHRNVVKLLGCCLETEVPLLV 349 (608)
Q Consensus 286 ~~t~~f~~~~~lG~G~~---------------avk~~~~~~-~~~~~~~~~Ei~il~~l~H~niv~l~~~~~~~~~~~lV 349 (608)
...++|++.+.||+|++ |||...... ....+++.+|+.++++++||||+++++++...+..++|
T Consensus 12 i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 91 (303)
T 2vwi_A 12 INRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDELWLV 91 (303)
T ss_dssp -CCCCCEEEEECC---CCCEEEEEC----CEEEEECCC----------------CCCCCCCTTBCCEEEEEESSSCEEEE
T ss_pred cchhhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhhcchhHHHHHHHHHHHhhcCCCCEeeEEEEEeecCCcEEE
Confidence 34578999999999974 555544322 33457789999999999999999999999999999999
Q ss_pred EeecCCCccchhcccc-----CCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEEcCCCcEEEeeccCc
Q 044312 350 YEFIPNGTLFQYIHDQ-----NEDFPITWEIRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGAS 424 (608)
Q Consensus 350 ~E~~~~gsL~~~l~~~-----~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGls 424 (608)
|||+++++|.+++... .....+++..++.++.||+.||.|||+.+ ++||||||+|||++.++.+||+|||++
T Consensus 92 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~~ 168 (303)
T 2vwi_A 92 MKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNG---QIHRDVKAGNILLGEDGSVQIADFGVS 168 (303)
T ss_dssp EECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEECTTCCEEECCCHHH
T ss_pred ehhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCC---CCCCCCChhhEEEcCCCCEEEEeccch
Confidence 9999999999998741 11235899999999999999999999999 999999999999999999999999998
Q ss_pred cccccCCc----ceeeeeeccCCCCChhhhcc-CCCCCccchHhHHHHHHHHHhCCCCCCccchhhcccHHHHHHHHhhh
Q 044312 425 RSMAVDQT----HMTTQVHGTFGYLDPEYFRS-SQFTDKSDVYSFGVVLTELLTGEKPIRFTILEEDKSLAAYFLCAMKE 499 (608)
Q Consensus 425 ~~~~~~~~----~~~~~~~gt~~y~aPE~~~~-~~~t~ksDV~S~Gvvl~elltg~~p~~~~~~~~~~~l~~~~~~~~~~ 499 (608)
+....... .......||+.|+|||.+.. ..++.++||||||++++||++|+.||........ .......
T Consensus 169 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~------~~~~~~~ 242 (303)
T 2vwi_A 169 AFLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKV------LMLTLQN 242 (303)
T ss_dssp HHCC---------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTSCGGGH------HHHHHTS
T ss_pred heeccCCCccchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccCchhhH------HHHHhcc
Confidence 76643221 12234568999999999876 5689999999999999999999999874322110 0001111
Q ss_pred hhhHHHhhhhhhccCChhHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 044312 500 ERLFEILDARVMKQGGKDEIITVAKLAKRCLNLNGKKRPTMREVASE 546 (608)
Q Consensus 500 ~~~~~~~d~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~evl~~ 546 (608)
. ...........+.....+..+.+|+.+||+.||++|||+.|++++
T Consensus 243 ~-~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h 288 (303)
T 2vwi_A 243 D-PPSLETGVQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELLRH 288 (303)
T ss_dssp S-CCCTTC-----CCCCCCCHHHHHHHHHHCCSSGGGSCCHHHHHTS
T ss_pred C-CCccccccccchhhhhhhHHHHHHHHHHccCChhhCcCHHHHhhC
Confidence 0 000000000111223445679999999999999999999999864
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-36 Score=316.02 Aligned_cols=252 Identities=22% Similarity=0.255 Sum_probs=183.4
Q ss_pred HHhcCccccceeccCce---------------EEEEEeecChh-----hHHHHHHHHHHHhhcCCCCccceecccccCcc
Q 044312 286 KATDNFDLNRILGQGGQ---------------AVKKSKVIDES-----KVEEFINEVVILSQINHRNVVKLLGCCLETEV 345 (608)
Q Consensus 286 ~~t~~f~~~~~lG~G~~---------------avk~~~~~~~~-----~~~~~~~Ei~il~~l~H~niv~l~~~~~~~~~ 345 (608)
...++|++.+.||+|++ |||+....... ..+.+.+|+.++++++||||+++++++.+...
T Consensus 7 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 86 (346)
T 1ua2_A 7 SRAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSN 86 (346)
T ss_dssp ------CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTC
T ss_pred HHhcccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEeeCCc
Confidence 34567999999999974 66665532211 12468899999999999999999999999999
Q ss_pred ceEEEeecCCCccchhccccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEEcCCCcEEEeeccCcc
Q 044312 346 PLLVYEFIPNGTLFQYIHDQNEDFPITWEIRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASR 425 (608)
Q Consensus 346 ~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGls~ 425 (608)
.++||||+++ +|.+++..... .+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++
T Consensus 87 ~~lv~e~~~~-~l~~~~~~~~~--~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~ 160 (346)
T 1ua2_A 87 ISLVFDFMET-DLEVIIKDNSL--VLTPSHIKAYMLMTLQGLEYLHQHW---ILHRDLKPNNLLLDENGVLKLADFGLAK 160 (346)
T ss_dssp CEEEEECCSE-EHHHHHTTCCS--SCCSSHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECCCGGGS
T ss_pred eEEEEEcCCC-CHHHHHHhcCc--CCCHHHHHHHHHHHHHHHHHHHHCC---EECCCCCHHHEEEcCCCCEEEEecccce
Confidence 9999999975 88888876433 5889999999999999999999999 9999999999999999999999999998
Q ss_pred ccccCCcceeeeeeccCCCCChhhhccC-CCCCccchHhHHHHHHHHHhCCCCCCccchhhcccHHHHHHHHhhhh---h
Q 044312 426 SMAVDQTHMTTQVHGTFGYLDPEYFRSS-QFTDKSDVYSFGVVLTELLTGEKPIRFTILEEDKSLAAYFLCAMKEE---R 501 (608)
Q Consensus 426 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~t~ksDV~S~Gvvl~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~---~ 501 (608)
...... .......||+.|+|||.+.+. .++.++||||||++++||++|.+||......+ .+.. ........ .
T Consensus 161 ~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~~~~~--~~~~-i~~~~~~~~~~~ 236 (346)
T 1ua2_A 161 SFGSPN-RAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLD--QLTR-IFETLGTPTEEQ 236 (346)
T ss_dssp TTTSCC-CCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHH--HHHH-HHHHHCCCCTTT
T ss_pred eccCCc-ccCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCCHHH--HHHH-HHHHcCCCChhh
Confidence 764332 223445689999999999764 58999999999999999999999986432211 1111 11111000 0
Q ss_pred hHHHh---hh---hhh-----ccCChhHHHHHHHHHHHHhccCCCCCCCHHHHHHHH
Q 044312 502 LFEIL---DA---RVM-----KQGGKDEIITVAKLAKRCLNLNGKKRPTMREVASEL 547 (608)
Q Consensus 502 ~~~~~---d~---~~~-----~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~evl~~L 547 (608)
..... +. ... .......+.++.+|+.+||+.||++|||+.|++++-
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h~ 293 (346)
T 1ua2_A 237 WPDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMK 293 (346)
T ss_dssp SSSTTSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTSG
T ss_pred hhhhccCcccccccccCCCChHHhhccCCHHHHHHHHHHhccChhhCCCHHHHhcCh
Confidence 00000 00 000 000123456899999999999999999999998753
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-35 Score=313.42 Aligned_cols=245 Identities=17% Similarity=0.202 Sum_probs=196.2
Q ss_pred HHHHHhcCccccceeccCce--------------------EEEEEeecChhhHHHHHHHHHHHhhcC---CCCccceecc
Q 044312 283 ELEKATDNFDLNRILGQGGQ--------------------AVKKSKVIDESKVEEFINEVVILSQIN---HRNVVKLLGC 339 (608)
Q Consensus 283 ~l~~~t~~f~~~~~lG~G~~--------------------avk~~~~~~~~~~~~~~~Ei~il~~l~---H~niv~l~~~ 339 (608)
+++...++|.+.++||+|+| |||+. ......++.+|+++++.++ |+||++++++
T Consensus 59 ~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~---~~~~~~~~~~e~~~~~~l~~~~~~~iv~~~~~ 135 (365)
T 3e7e_A 59 EFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQ---KPANPWEFYIGTQLMERLKPSMQHMFMKFYSA 135 (365)
T ss_dssp EEECSSSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEE---SSCCHHHHHHHHHHHHHSCGGGGGGBCCEEEE
T ss_pred eEEECCEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEe---CCCChhHHHHHHHHHHHhhhhhhhhhhhhhee
Confidence 34455678999999999986 33333 3445678888999888886 9999999999
Q ss_pred cccCccceEEEeecCCCccchhccccC--CCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEEcC-----
Q 044312 340 CLETEVPLLVYEFIPNGTLFQYIHDQN--EDFPITWEIRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDD----- 412 (608)
Q Consensus 340 ~~~~~~~~lV~E~~~~gsL~~~l~~~~--~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~----- 412 (608)
+...+..+|||||+++|+|.+++.... ....+++..++.|+.||+.||+|||+.+ |+||||||+|||++.
T Consensus 136 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~---ivHrDiKp~NIll~~~~~~~ 212 (365)
T 3e7e_A 136 HLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCE---IIHGDIKPDNFILGNGFLEQ 212 (365)
T ss_dssp EECSSCEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCSGGGEEECGGGTCC
T ss_pred eecCCCcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhhCC---eecCCCCHHHEEecccccCc
Confidence 999999999999999999999997522 2235999999999999999999999999 999999999999998
Q ss_pred ------CCcEEEeeccCcccccc-CCcceeeeeeccCCCCChhhhccCCCCCccchHhHHHHHHHHHhCCCCCCccchhh
Q 044312 413 ------KYRAKVSDFGASRSMAV-DQTHMTTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLTELLTGEKPIRFTILEE 485 (608)
Q Consensus 413 ------~~~~kl~DFGls~~~~~-~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~elltg~~p~~~~~~~~ 485 (608)
++.+||+|||+++.+.. ..........||+.|+|||++.+..++.++||||||+++|||+||+.||.......
T Consensus 213 ~~~~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~ 292 (365)
T 3e7e_A 213 DDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGE 292 (365)
T ss_dssp ------CTTEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCCCEEEETTE
T ss_pred cccccccCCEEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcCCCCCccccHHHHHHHHHHHHhCCCccccCCCCc
Confidence 89999999999976542 22333455679999999999999999999999999999999999999986322211
Q ss_pred cccHHHHHHHHhhhhhhHHHhhhhhhccCChhHHHHHHHHHHHHhccCCCCC-CCHHHHHHHHHhhHHhc
Q 044312 486 DKSLAAYFLCAMKEERLFEILDARVMKQGGKDEIITVAKLAKRCLNLNGKKR-PTMREVASELAGIKAWN 554 (608)
Q Consensus 486 ~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~Li~~cl~~dp~~R-Ps~~evl~~L~~i~~~~ 554 (608)
. .+...+. .......+.+++..||+.+|.+| |+++++.+.|+.+....
T Consensus 293 ~--------------~~~~~~~-------~~~~~~~~~~~~~~~l~~~p~~r~~~~~~l~~~l~~~l~~~ 341 (365)
T 3e7e_A 293 C--------------KPEGLFR-------RLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQH 341 (365)
T ss_dssp E--------------EECSCCT-------TCSSHHHHHHHHHHHHCCCCTTCCCCHHHHHHHHHHHHHHH
T ss_pred e--------------eechhcc-------ccCcHHHHHHHHHHHcCCCCCCcchHHHHHHHHHHHHHHHh
Confidence 0 0000000 01224568889999999999999 78889999888876653
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-36 Score=322.98 Aligned_cols=185 Identities=24% Similarity=0.377 Sum_probs=153.4
Q ss_pred hcCccccceeccCce---------------EEEEEee--cChhhHHHHHHHHHHHhhcCCCCccceecccccC-----cc
Q 044312 288 TDNFDLNRILGQGGQ---------------AVKKSKV--IDESKVEEFINEVVILSQINHRNVVKLLGCCLET-----EV 345 (608)
Q Consensus 288 t~~f~~~~~lG~G~~---------------avk~~~~--~~~~~~~~~~~Ei~il~~l~H~niv~l~~~~~~~-----~~ 345 (608)
.++|.+.+.||+|++ |||+++. .+....+.+.+|+.+|++++||||+++++++... ..
T Consensus 25 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~ 104 (432)
T 3n9x_A 25 PDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFDE 104 (432)
T ss_dssp CTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTTTSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCC
T ss_pred cCCEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchhcChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCCCcCCe
Confidence 468999999999974 7777754 2344567899999999999999999999999766 56
Q ss_pred ceEEEeecCCCccchhccccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEEcCCCcEEEeeccCcc
Q 044312 346 PLLVYEFIPNGTLFQYIHDQNEDFPITWEIRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASR 425 (608)
Q Consensus 346 ~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGls~ 425 (608)
.++||||+. ++|.+++.... .+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++
T Consensus 105 ~~lv~e~~~-~~L~~~~~~~~---~l~~~~~~~i~~qil~aL~~LH~~g---ivHrDlkp~NILl~~~~~~kL~DFGla~ 177 (432)
T 3n9x_A 105 LYIVLEIAD-SDLKKLFKTPI---FLTEEHIKTILYNLLLGENFIHESG---IIHRDLKPANCLLNQDCSVKVCDFGLAR 177 (432)
T ss_dssp EEEEEECCS-EEHHHHHHSSC---CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCE
T ss_pred EEEEEecCC-cCHHHHHhccC---CCCHHHHHHHHHHHHHHHHHHHHCC---CCCCCCCHHHeEECCCCCEEEccCCCcc
Confidence 899999985 69999987543 5999999999999999999999999 9999999999999999999999999998
Q ss_pred ccccCCc---------------------ceeeeeeccCCCCChhhh-ccCCCCCccchHhHHHHHHHHHhCCCCCC
Q 044312 426 SMAVDQT---------------------HMTTQVHGTFGYLDPEYF-RSSQFTDKSDVYSFGVVLTELLTGEKPIR 479 (608)
Q Consensus 426 ~~~~~~~---------------------~~~~~~~gt~~y~aPE~~-~~~~~t~ksDV~S~Gvvl~elltg~~p~~ 479 (608)
....... ...+...||+.|+|||++ ....++.++|||||||+++||++|..||.
T Consensus 178 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~ 253 (432)
T 3n9x_A 178 TINSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHI 253 (432)
T ss_dssp EC-------------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTCTTTC
T ss_pred cccccccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhcccccc
Confidence 7653321 123456789999999986 56679999999999999999998655543
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-35 Score=316.45 Aligned_cols=247 Identities=25% Similarity=0.283 Sum_probs=188.6
Q ss_pred hcCccccceeccCce---------------EEEEEeecChhhHHHHHHHHHHHhhcC--------CCCccceecccc---
Q 044312 288 TDNFDLNRILGQGGQ---------------AVKKSKVIDESKVEEFINEVVILSQIN--------HRNVVKLLGCCL--- 341 (608)
Q Consensus 288 t~~f~~~~~lG~G~~---------------avk~~~~~~~~~~~~~~~Ei~il~~l~--------H~niv~l~~~~~--- 341 (608)
.++|++.++||+|++ |||+.+. .....+.+.+|+.+|++++ |+||+++++++.
T Consensus 36 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~-~~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~~~~~~ 114 (397)
T 1wak_A 36 NGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKS-AEHYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDFKISG 114 (397)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECS-CHHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEEEEEEE
T ss_pred CCeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEec-CCcchHHHHHHHHHHHHHhhcCCCCCCcceeeeeecceeecC
Confidence 468999999999984 6666653 3445678999999999995 788999999987
Q ss_pred -cCccceEEEeecCCCccchhccccCCCCCCCHHHHHHHHHHHHHHHHHHhhc-CCCCeeccCCCCCcEEEcCCC-----
Q 044312 342 -ETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEIRLRIAIEVSGALSYLHSA-ASIPIYHRDIKSTNILLDDKY----- 414 (608)
Q Consensus 342 -~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~-~~~~iiHrDlk~~NILl~~~~----- 414 (608)
+....+|||||+ +++|.+.+..... ..+++..++.|+.||+.||+|||++ + |+||||||+|||++.++
T Consensus 115 ~~~~~~~lv~e~~-~~~l~~~~~~~~~-~~~~~~~~~~i~~qi~~aL~~lH~~~g---ivHrDikp~NIll~~~~~~~~~ 189 (397)
T 1wak_A 115 VNGTHICMVFEVL-GHHLLKWIIKSNY-QGLPLPCVKKIIQQVLQGLDYLHTKCR---IIHTDIKPENILLSVNEQYIRR 189 (397)
T ss_dssp TTEEEEEEEECCC-CCBHHHHHHHTTT-SCCCHHHHHHHHHHHHHHHHHHHHTTC---EECCCCSGGGEEECCCHHHHHH
T ss_pred CCCceEEEEEecc-CccHHHHHHhccc-CCCCHHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHeeEeccchhhhh
Confidence 566889999999 5677666655432 2599999999999999999999998 8 99999999999999775
Q ss_pred --------------------------------------------cEEEeeccCccccccCCcceeeeeeccCCCCChhhh
Q 044312 415 --------------------------------------------RAKVSDFGASRSMAVDQTHMTTQVHGTFGYLDPEYF 450 (608)
Q Consensus 415 --------------------------------------------~~kl~DFGls~~~~~~~~~~~~~~~gt~~y~aPE~~ 450 (608)
.+||+|||+++..... .....||+.|+|||++
T Consensus 190 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~----~~~~~gt~~y~aPE~~ 265 (397)
T 1wak_A 190 LAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKH----FTEDIQTRQYRSLEVL 265 (397)
T ss_dssp HHHHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBC----SCSCCSCGGGCCHHHH
T ss_pred hhhhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEecccccccccccc----CccCCCCCcccCChhh
Confidence 7999999999876432 2344689999999999
Q ss_pred ccCCCCCccchHhHHHHHHHHHhCCCCCCccchhhcccHH---HHHHHHhhhhhh-------------------------
Q 044312 451 RSSQFTDKSDVYSFGVVLTELLTGEKPIRFTILEEDKSLA---AYFLCAMKEERL------------------------- 502 (608)
Q Consensus 451 ~~~~~t~ksDV~S~Gvvl~elltg~~p~~~~~~~~~~~l~---~~~~~~~~~~~~------------------------- 502 (608)
.+..++.++||||||++|+||++|+.||............ ............
T Consensus 266 ~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 345 (397)
T 1wak_A 266 IGSGYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFFTKKGDLKHITKL 345 (397)
T ss_dssp HTSCCCTHHHHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHHHHHHHHHHCSCCHHHHHHCTTGGGTBCTTSSBSSCCCC
T ss_pred cCCCCCcHHHHHHHHHHHHHHhhCCCCCCCCcccccCchHHHHHHHHHhcCCCChHHhhcccccccccCCcccccccccc
Confidence 9999999999999999999999999999754322211111 111111110000
Q ss_pred -----HHHhhhhhhccCChhHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 044312 503 -----FEILDARVMKQGGKDEIITVAKLAKRCLNLNGKKRPTMREVASE 546 (608)
Q Consensus 503 -----~~~~d~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~evl~~ 546 (608)
.+.+.. ....+...+..+.+|+.+||+.||++|||+.|++++
T Consensus 346 ~~~~~~~~~~~--~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 392 (397)
T 1wak_A 346 KPWGLFEVLVE--KYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLRH 392 (397)
T ss_dssp CCCCHHHHHHH--TSCCCHHHHHHHHHHHGGGGCSSGGGSCCHHHHHTS
T ss_pred CCcchhHhhhh--hcccchhhHHHHHHHHHHHhccChhhcCCHHHHhhC
Confidence 000000 112345667889999999999999999999999864
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-36 Score=305.77 Aligned_cols=239 Identities=22% Similarity=0.338 Sum_probs=174.6
Q ss_pred hcCccccceeccCce---------------EEEEEeec-Chh-hHHHHHHHHHHHhhcCCCCccceecccccCccceEEE
Q 044312 288 TDNFDLNRILGQGGQ---------------AVKKSKVI-DES-KVEEFINEVVILSQINHRNVVKLLGCCLETEVPLLVY 350 (608)
Q Consensus 288 t~~f~~~~~lG~G~~---------------avk~~~~~-~~~-~~~~~~~Ei~il~~l~H~niv~l~~~~~~~~~~~lV~ 350 (608)
.++|++.+.||+|++ |||+.+.. ... ..+.+.++...++.++||||+++++++.+.+..++||
T Consensus 6 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~~~~~lv~ 85 (290)
T 3fme_A 6 ADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALFREGDVWICM 85 (290)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSSEEEEE
T ss_pred HHhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccCcHHHHHHHHHHHHHHHhCCCCeEEEEeeeeeccCCEEEEE
Confidence 467899999999984 67766543 222 2334455555688889999999999999999999999
Q ss_pred eecCCCccchhcccc-CCCCCCCHHHHHHHHHHHHHHHHHHhhc-CCCCeeccCCCCCcEEEcCCCcEEEeeccCccccc
Q 044312 351 EFIPNGTLFQYIHDQ-NEDFPITWEIRLRIAIEVSGALSYLHSA-ASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMA 428 (608)
Q Consensus 351 E~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~ia~aL~yLH~~-~~~~iiHrDlk~~NILl~~~~~~kl~DFGls~~~~ 428 (608)
||++ |+|.+++... .....+++..++.++.|++.||+|||++ + |+||||||+|||++.++.+||+|||+++...
T Consensus 86 e~~~-~~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~ 161 (290)
T 3fme_A 86 ELMD-TSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLS---VIHRDVKPSNVLINALGQVKMCDFGISGYLV 161 (290)
T ss_dssp ECCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHSC---CCCCCCSGGGCEECTTCCEEBCCC-------
T ss_pred ehhc-cchHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhcCC---eecCCCCHHHEEECCCCCEEEeecCCccccc
Confidence 9996 5888877642 1223699999999999999999999998 8 9999999999999999999999999998765
Q ss_pred cCCcceeeeeeccCCCCChhhh----ccCCCCCccchHhHHHHHHHHHhCCCCCCccchhhcccHHHHHHHHhhhhhhHH
Q 044312 429 VDQTHMTTQVHGTFGYLDPEYF----RSSQFTDKSDVYSFGVVLTELLTGEKPIRFTILEEDKSLAAYFLCAMKEERLFE 504 (608)
Q Consensus 429 ~~~~~~~~~~~gt~~y~aPE~~----~~~~~t~ksDV~S~Gvvl~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~ 504 (608)
... ......||+.|+|||.+ ....++.++||||||++++||++|+.||....... . .+..
T Consensus 162 ~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~-----~---------~~~~ 225 (290)
T 3fme_A 162 DDV--AKDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPF-----Q---------QLKQ 225 (290)
T ss_dssp ----------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCSCHH-----H---------HHHH
T ss_pred ccc--cccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccccCchH-----H---------HHHH
Confidence 332 22334689999999996 56678999999999999999999999986322111 0 1111
Q ss_pred HhhhhhhccCChhHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 044312 505 ILDARVMKQGGKDEIITVAKLAKRCLNLNGKKRPTMREVASE 546 (608)
Q Consensus 505 ~~d~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~evl~~ 546 (608)
.+............+.++.+|+.+||+.||++|||+.|++++
T Consensus 226 ~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~e~l~h 267 (290)
T 3fme_A 226 VVEEPSPQLPADKFSAEFVDFTSQCLKKNSKERPTYPELMQH 267 (290)
T ss_dssp HHHSCCCCCCTTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTS
T ss_pred HhccCCCCcccccCCHHHHHHHHHHhhcChhhCcCHHHHHhC
Confidence 111111122223456789999999999999999999999874
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-35 Score=325.32 Aligned_cols=238 Identities=29% Similarity=0.403 Sum_probs=188.2
Q ss_pred HhcCccccceeccCce---------------EEEEEeecCh-------------hhHHHHHHHHHHHhhcCCCCccceec
Q 044312 287 ATDNFDLNRILGQGGQ---------------AVKKSKVIDE-------------SKVEEFINEVVILSQINHRNVVKLLG 338 (608)
Q Consensus 287 ~t~~f~~~~~lG~G~~---------------avk~~~~~~~-------------~~~~~~~~Ei~il~~l~H~niv~l~~ 338 (608)
..++|.+.++||+|+| |||.+..... ...+.+.+|+.+|++++||||+++++
T Consensus 34 i~~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~ 113 (504)
T 3q5i_A 34 IGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFD 113 (504)
T ss_dssp GGGTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCEEE
T ss_pred cccceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeEEE
Confidence 4678999999999985 6676653221 33578999999999999999999999
Q ss_pred ccccCccceEEEeecCCCccchhccccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEEcCCC---c
Q 044312 339 CCLETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEIRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKY---R 415 (608)
Q Consensus 339 ~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~---~ 415 (608)
++.+....++||||+++|+|.+++.... .+++..+..|+.||+.||+|||+.+ |+||||||+|||++.++ .
T Consensus 114 ~~~~~~~~~lv~e~~~gg~L~~~l~~~~---~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~ 187 (504)
T 3q5i_A 114 VFEDKKYFYLVTEFYEGGELFEQIINRH---KFDECDAANIMKQILSGICYLHKHN---IVHRDIKPENILLENKNSLLN 187 (504)
T ss_dssp EEECSSEEEEEEECCTTCBHHHHHHHHS---CCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESSTTCCSS
T ss_pred EEEcCCEEEEEEecCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCcHHHEEEecCCCCcc
Confidence 9999999999999999999999987653 4899999999999999999999999 99999999999998765 6
Q ss_pred EEEeeccCccccccCCcceeeeeeccCCCCChhhhccCCCCCccchHhHHHHHHHHHhCCCCCCccchhhcccHHHHHHH
Q 044312 416 AKVSDFGASRSMAVDQTHMTTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLTELLTGEKPIRFTILEEDKSLAAYFLC 495 (608)
Q Consensus 416 ~kl~DFGls~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~elltg~~p~~~~~~~~~~~l~~~~~~ 495 (608)
+||+|||+++...... ......||+.|+|||++. ..++.++||||||+++++|++|+.||......+ ...
T Consensus 188 ~kl~Dfg~a~~~~~~~--~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~-------~~~ 257 (504)
T 3q5i_A 188 IKIVDFGLSSFFSKDY--KLRDRLGTAYYIAPEVLK-KKYNEKCDVWSCGVIMYILLCGYPPFGGQNDQD-------IIK 257 (504)
T ss_dssp EEECCCTTCEECCTTS--CBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH-------HHH
T ss_pred EEEEECCCCEEcCCCC--ccccccCCcCCCCHHHhc-cCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHH-------HHH
Confidence 9999999998765432 234456999999999987 569999999999999999999999997432211 111
Q ss_pred HhhhhhhHHHhhhhhhccCChhHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 044312 496 AMKEERLFEILDARVMKQGGKDEIITVAKLAKRCLNLNGKKRPTMREVASE 546 (608)
Q Consensus 496 ~~~~~~~~~~~d~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~evl~~ 546 (608)
.+...... .+. ......+.++.+|+.+||+.||.+|||+.|++++
T Consensus 258 ~i~~~~~~--~~~----~~~~~~s~~~~~li~~~L~~dp~~R~t~~e~l~h 302 (504)
T 3q5i_A 258 KVEKGKYY--FDF----NDWKNISDEAKELIKLMLTYDYNKRCTAEEALNS 302 (504)
T ss_dssp HHHHCCCC--CCH----HHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred HHHcCCCC--CCc----cccCCCCHHHHHHHHHHcCCChhHCCCHHHHhcC
Confidence 11111100 000 0002345679999999999999999999999875
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-35 Score=328.18 Aligned_cols=237 Identities=24% Similarity=0.285 Sum_probs=191.0
Q ss_pred hcCccccceeccCce---------------EEEEEeec---ChhhHHHHHHHHHHHhhcCCCCccceecccccCccceEE
Q 044312 288 TDNFDLNRILGQGGQ---------------AVKKSKVI---DESKVEEFINEVVILSQINHRNVVKLLGCCLETEVPLLV 349 (608)
Q Consensus 288 t~~f~~~~~lG~G~~---------------avk~~~~~---~~~~~~~~~~Ei~il~~l~H~niv~l~~~~~~~~~~~lV 349 (608)
.++|.+.+.||+|+| |+|++... .....+.+.+|+.+|++++||||+++++++.+....+||
T Consensus 184 ~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lV 263 (543)
T 3c4z_A 184 EDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKTDLCLV 263 (543)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred hhheEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEeeCCEEEEE
Confidence 367888999999984 67766532 223457899999999999999999999999999999999
Q ss_pred EeecCCCccchhccccCC-CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEEcCCCcEEEeeccCccccc
Q 044312 350 YEFIPNGTLFQYIHDQNE-DFPITWEIRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMA 428 (608)
Q Consensus 350 ~E~~~~gsL~~~l~~~~~-~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGls~~~~ 428 (608)
|||+++|+|.+++..... ...+++..++.++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++...
T Consensus 264 mE~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~~g---IvHrDLKP~NILl~~~g~vkL~DFGla~~~~ 340 (543)
T 3c4z_A 264 MTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRN---IIYRDLKPENVLLDDDGNVRISDLGLAVELK 340 (543)
T ss_dssp ECCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEECCCTTCEECC
T ss_pred EEeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHHcC---CcccCCChHHEEEeCCCCEEEeecceeeecc
Confidence 999999999999876432 235999999999999999999999999 9999999999999999999999999998765
Q ss_pred cCCcceeeeeeccCCCCChhhhccCCCCCccchHhHHHHHHHHHhCCCCCCccchhhcccHHHHHHHHhhhhhhHHHhhh
Q 044312 429 VDQTHMTTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLTELLTGEKPIRFTILEEDKSLAAYFLCAMKEERLFEILDA 508 (608)
Q Consensus 429 ~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 508 (608)
.... ......||+.|+|||++.+..++.++|||||||++|||++|+.||....... ....... .++..
T Consensus 341 ~~~~-~~~~~~GT~~Y~APE~l~~~~~~~~~DiwSlGvilyelltG~~PF~~~~~~~--~~~~~~~---------~i~~~ 408 (543)
T 3c4z_A 341 AGQT-KTKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKV--ENKELKQ---------RVLEQ 408 (543)
T ss_dssp TTCC-CBCCCCSCTTTSCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCTTCCC--CHHHHHH---------HHHHC
T ss_pred CCCc-ccccccCCccccChhhhcCCCCChHHhcCcchHHHHHHHhCCCCCCCCccch--hHHHHHH---------HHhhc
Confidence 4332 2334579999999999999999999999999999999999999997432111 1111111 11111
Q ss_pred hhhccCChhHHHHHHHHHHHHhccCCCCCCCHH
Q 044312 509 RVMKQGGKDEIITVAKLAKRCLNLNGKKRPTMR 541 (608)
Q Consensus 509 ~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~ 541 (608)
....+...+..+.+|+.+||+.||++||++.
T Consensus 409 --~~~~p~~~s~~~~~li~~lL~~dP~~R~~~~ 439 (543)
T 3c4z_A 409 --AVTYPDKFSPASKDFCEALLQKDPEKRLGFR 439 (543)
T ss_dssp --CCCCCTTSCHHHHHHHHHHSCSSGGGSCCCB
T ss_pred --ccCCCcccCHHHHHHHHHhccCCHhHCCCCc
Confidence 1123445667899999999999999999763
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-36 Score=313.48 Aligned_cols=248 Identities=25% Similarity=0.365 Sum_probs=187.2
Q ss_pred cCCHHHHHHHhcCccccceeccCce---------------EEEEEeecChhhHHHHHHHHHHHhhc-CCCCccceecccc
Q 044312 278 LFTSKELEKATDNFDLNRILGQGGQ---------------AVKKSKVIDESKVEEFINEVVILSQI-NHRNVVKLLGCCL 341 (608)
Q Consensus 278 ~~~~~~l~~~t~~f~~~~~lG~G~~---------------avk~~~~~~~~~~~~~~~Ei~il~~l-~H~niv~l~~~~~ 341 (608)
.+...++....++|++.+.||+|++ |||..... ....+.+.+|+.+++++ +||||+++++++.
T Consensus 13 ~~~~~~l~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~-~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~ 91 (326)
T 2x7f_A 13 EIDLSALRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVT-GDEEEEIKQEINMLKKYSHHRNIATYYGAFI 91 (326)
T ss_dssp ---CCCCCCCTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-SSTTHHHHHHHHHHHHHCCSTTBCCEEEEEE
T ss_pred hccchhccCCCCcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecC-cccHHHHHHHHHHHHhccCCCCeeeeeeEEe
Confidence 3444455567889999999999974 66666543 33457899999999999 8999999999997
Q ss_pred c------CccceEEEeecCCCccchhccccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEEcCCCc
Q 044312 342 E------TEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEIRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYR 415 (608)
Q Consensus 342 ~------~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~ 415 (608)
. ....++||||+++++|.+++..... ..+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.
T Consensus 92 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~NIl~~~~~~ 167 (326)
T 2x7f_A 92 KKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKG-NTLKEEWIAYICREILRGLSHLHQHK---VIHRDIKGQNVLLTENAE 167 (326)
T ss_dssp ECC--CCCCEEEEEEECCTTEEHHHHHHHSGG-GCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEECTTCC
T ss_pred eccCccccceEEEEEEcCCCCcHHHHHHhccc-CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCcHHHEEEcCCCC
Confidence 6 4578999999999999999986432 25899999999999999999999999 999999999999999999
Q ss_pred EEEeeccCccccccCCcceeeeeeccCCCCChhhhc-----cCCCCCccchHhHHHHHHHHHhCCCCCCccchhhcccHH
Q 044312 416 AKVSDFGASRSMAVDQTHMTTQVHGTFGYLDPEYFR-----SSQFTDKSDVYSFGVVLTELLTGEKPIRFTILEEDKSLA 490 (608)
Q Consensus 416 ~kl~DFGls~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~t~ksDV~S~Gvvl~elltg~~p~~~~~~~~~~~l~ 490 (608)
+||+|||++....... .......||+.|+|||.+. ...++.++||||||++++||++|+.||.......
T Consensus 168 ~kl~Dfg~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~----- 241 (326)
T 2x7f_A 168 VKLVDFGVSAQLDRTV-GRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMR----- 241 (326)
T ss_dssp EEECCCTTTC--------------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTSCHHH-----
T ss_pred EEEeeCcCceecCcCc-cccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCCcHHH-----
Confidence 9999999998654322 1223456899999999987 5678999999999999999999999986322111
Q ss_pred HHHHHHhhhhhhHHHhhhhhhccCChhHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 044312 491 AYFLCAMKEERLFEILDARVMKQGGKDEIITVAKLAKRCLNLNGKKRPTMREVASE 546 (608)
Q Consensus 491 ~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~evl~~ 546 (608)
.. ..+.............+..+.+|+.+||..||++||++.|++++
T Consensus 242 -~~---------~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h 287 (326)
T 2x7f_A 242 -AL---------FLIPRNPAPRLKSKKWSKKFQSFIESCLVKNHSQRPATEQLMKH 287 (326)
T ss_dssp -HH---------HHHHHSCCCCCSCSCSCHHHHHHHHHHCCSSGGGSCCHHHHHTS
T ss_pred -HH---------HHhhcCccccCCccccCHHHHHHHHHHhccChhhCCCHHHHhhC
Confidence 00 00111111111223445689999999999999999999999874
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-36 Score=301.71 Aligned_cols=234 Identities=25% Similarity=0.371 Sum_probs=182.0
Q ss_pred hcCccccceeccCce---------------EEEEEeec---ChhhHHHHHHHHHHHhhcCCCCccceecccccCccceEE
Q 044312 288 TDNFDLNRILGQGGQ---------------AVKKSKVI---DESKVEEFINEVVILSQINHRNVVKLLGCCLETEVPLLV 349 (608)
Q Consensus 288 t~~f~~~~~lG~G~~---------------avk~~~~~---~~~~~~~~~~Ei~il~~l~H~niv~l~~~~~~~~~~~lV 349 (608)
.++|.+.+.||+|++ |||..... +....+.+.+|+.++++++||||+++++++.+.+..++|
T Consensus 10 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 89 (276)
T 2h6d_A 10 IGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPTDFFMV 89 (276)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred eccEEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCeEEEE
Confidence 357888999999974 56665432 123456889999999999999999999999999999999
Q ss_pred EeecCCCccchhccccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEEcCCCcEEEeeccCcccccc
Q 044312 350 YEFIPNGTLFQYIHDQNEDFPITWEIRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAV 429 (608)
Q Consensus 350 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGls~~~~~ 429 (608)
|||+++++|.+++.... .+++..+..++.||+.||+|||+.+ ++|+||||+|||++.++.+||+|||++.....
T Consensus 90 ~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~ 163 (276)
T 2h6d_A 90 MEYVSGGELFDYICKHG---RVEEMEARRLFQQILSAVDYCHRHM---VVHRDLKPENVLLDAHMNAKIADFGLSNMMSD 163 (276)
T ss_dssp EECCCSCBHHHHHHHHC---SCCHHHHHHHHHHHHHHHHHHHHHC---SSCCCCCGGGEEECTTSCEEECCCCGGGCCCC
T ss_pred EeccCCCcHHHHHhccC---CCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCChhhEEECCCCCEEEeecccccccCC
Confidence 99999999999997653 4899999999999999999999999 99999999999999999999999999987653
Q ss_pred CCcceeeeeeccCCCCChhhhccCCC-CCccchHhHHHHHHHHHhCCCCCCccchhhcccHHHHHHHHhhhhhhHHHhhh
Q 044312 430 DQTHMTTQVHGTFGYLDPEYFRSSQF-TDKSDVYSFGVVLTELLTGEKPIRFTILEEDKSLAAYFLCAMKEERLFEILDA 508 (608)
Q Consensus 430 ~~~~~~~~~~gt~~y~aPE~~~~~~~-t~ksDV~S~Gvvl~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 508 (608)
.. ......+++.|+|||.+.+..+ +.++||||||++++||++|+.||....... ....+...
T Consensus 164 ~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~-------~~~~~~~~-------- 226 (276)
T 2h6d_A 164 GE--FLRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHVPT-------LFKKIRGG-------- 226 (276)
T ss_dssp ---------------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCSSHHH-------HHHHHHHC--------
T ss_pred Cc--ceecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCCcHHH-------HHHHhhcC--------
Confidence 32 2234568999999999987765 689999999999999999999986322111 11111110
Q ss_pred hhhccCChhHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 044312 509 RVMKQGGKDEIITVAKLAKRCLNLNGKKRPTMREVASE 546 (608)
Q Consensus 509 ~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~evl~~ 546 (608)
....+...+..+.+++.+||+.||++|||+.|++++
T Consensus 227 --~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~l~h 262 (276)
T 2h6d_A 227 --VFYIPEYLNRSVATLLMHMLQVDPLKRATIKDIREH 262 (276)
T ss_dssp --CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHS
T ss_pred --cccCchhcCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence 011233445679999999999999999999999875
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-35 Score=303.55 Aligned_cols=239 Identities=23% Similarity=0.279 Sum_probs=184.8
Q ss_pred HhcCccccceeccCce---------------EEEEEeecC----hhhHHHHHHHHHHHhhcCCCCccceeccc--ccCcc
Q 044312 287 ATDNFDLNRILGQGGQ---------------AVKKSKVID----ESKVEEFINEVVILSQINHRNVVKLLGCC--LETEV 345 (608)
Q Consensus 287 ~t~~f~~~~~lG~G~~---------------avk~~~~~~----~~~~~~~~~Ei~il~~l~H~niv~l~~~~--~~~~~ 345 (608)
..++|.+.+.||+|++ |+|..+... ....+.+.+|+.++++++||||+++++++ .+...
T Consensus 3 l~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 82 (305)
T 2wtk_C 3 LIGKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQK 82 (305)
T ss_dssp --CCBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC---C
T ss_pred cccceeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCe
Confidence 3468999999999984 566554321 23457899999999999999999999998 45567
Q ss_pred ceEEEeecCCCccchhccccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEEcCCCcEEEeeccCcc
Q 044312 346 PLLVYEFIPNGTLFQYIHDQNEDFPITWEIRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASR 425 (608)
Q Consensus 346 ~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGls~ 425 (608)
.++||||++++ |.+++..... ..+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||++.
T Consensus 83 ~~lv~e~~~~~-l~~~~~~~~~-~~~~~~~~~~~~~qi~~al~~LH~~~---i~H~dlkp~NIl~~~~~~~kl~dfg~~~ 157 (305)
T 2wtk_C 83 MYMVMEYCVCG-MQEMLDSVPE-KRFPVCQAHGYFCQLIDGLEYLHSQG---IVHKDIKPGNLLLTTGGTLKISALGVAE 157 (305)
T ss_dssp EEEEEECCSEE-HHHHHHHSTT-CSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTTCE
T ss_pred EEEEehhccCC-HHHHHHhCcc-cccCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCcccEEEcCCCcEEeecccccc
Confidence 89999999875 7777765433 25999999999999999999999999 9999999999999999999999999998
Q ss_pred ccccC-CcceeeeeeccCCCCChhhhccCCC--CCccchHhHHHHHHHHHhCCCCCCccchhhcccHHHHHHHHhhhhhh
Q 044312 426 SMAVD-QTHMTTQVHGTFGYLDPEYFRSSQF--TDKSDVYSFGVVLTELLTGEKPIRFTILEEDKSLAAYFLCAMKEERL 502 (608)
Q Consensus 426 ~~~~~-~~~~~~~~~gt~~y~aPE~~~~~~~--t~ksDV~S~Gvvl~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~ 502 (608)
..... .........||+.|+|||++.+... +.++||||||++++||++|+.||...... ... ..+...
T Consensus 158 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~------~~~-~~i~~~-- 228 (305)
T 2wtk_C 158 ALHPFAADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIY------KLF-ENIGKG-- 228 (305)
T ss_dssp ECCTTCSSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSSHH------HHH-HHHHHC--
T ss_pred ccCccccccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCchHH------HHH-HHHhcC--
Confidence 76432 2222344568999999999986543 78999999999999999999998742211 111 111110
Q ss_pred HHHhhhhhhccCChhHHHHHHHHHHHHhccCCCCCCCHHHHHHHH
Q 044312 503 FEILDARVMKQGGKDEIITVAKLAKRCLNLNGKKRPTMREVASEL 547 (608)
Q Consensus 503 ~~~~d~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~evl~~L 547 (608)
....+...+..+.+|+.+||+.||++|||+.|++++-
T Consensus 229 --------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~~ 265 (305)
T 2wtk_C 229 --------SYAIPGDCGPPLSDLLKGMLEYEPAKRFSIRQIRQHS 265 (305)
T ss_dssp --------CCCCCSSSCHHHHHHHHHHTCSSTTTSCCHHHHHHSH
T ss_pred --------CCCCCCccCHHHHHHHHHHccCChhhCCCHHHHhcCc
Confidence 1122334567899999999999999999999998753
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-36 Score=316.10 Aligned_cols=243 Identities=23% Similarity=0.303 Sum_probs=170.9
Q ss_pred hcCccccceeccCce---------------EEEEEee--cChhhHHHHHHHHHHHhhcCCCCccceecccccC------c
Q 044312 288 TDNFDLNRILGQGGQ---------------AVKKSKV--IDESKVEEFINEVVILSQINHRNVVKLLGCCLET------E 344 (608)
Q Consensus 288 t~~f~~~~~lG~G~~---------------avk~~~~--~~~~~~~~~~~Ei~il~~l~H~niv~l~~~~~~~------~ 344 (608)
.++|++.+.||+|++ |||+... .+....+.+.+|+.+|++++||||+++++++... .
T Consensus 28 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~ 107 (367)
T 2fst_X 28 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN 107 (367)
T ss_dssp ETTEEEEEECC----CCEEEEEETTTTEEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCC
T ss_pred CCceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCccccCC
Confidence 468999999999974 6776643 2334567899999999999999999999998654 5
Q ss_pred cceEEEeecCCCccchhccccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEEcCCCcEEEeeccCc
Q 044312 345 VPLLVYEFIPNGTLFQYIHDQNEDFPITWEIRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGAS 424 (608)
Q Consensus 345 ~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGls 424 (608)
..++|+|++ +++|.+++... .+++..+..++.||++||+|||+.+ |+||||||+|||++.++.+||+|||++
T Consensus 108 ~~~lv~e~~-~~~L~~~~~~~----~l~~~~~~~i~~qi~~aL~~LH~~g---ivH~Dlkp~NIll~~~~~~kL~DFG~a 179 (367)
T 2fst_X 108 DVYLVTHLM-GADLNNIVKCQ----KLTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLA 179 (367)
T ss_dssp CCEEEEECC-CEECC-----C----CCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECC----
T ss_pred eEEEEeccc-CCCHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHhhEEECCCCCEEEeecccc
Confidence 679999999 78999988652 4899999999999999999999999 999999999999999999999999999
Q ss_pred cccccCCcceeeeeeccCCCCChhhhcc-CCCCCccchHhHHHHHHHHHhCCCCCCccchhhcccHHHHHHHHhh-----
Q 044312 425 RSMAVDQTHMTTQVHGTFGYLDPEYFRS-SQFTDKSDVYSFGVVLTELLTGEKPIRFTILEEDKSLAAYFLCAMK----- 498 (608)
Q Consensus 425 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~t~ksDV~S~Gvvl~elltg~~p~~~~~~~~~~~l~~~~~~~~~----- 498 (608)
+..... .+...||+.|+|||++.+ ..++.++||||||++++||++|+.||........ .........
T Consensus 180 ~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~---l~~i~~~~g~p~~~ 252 (367)
T 2fst_X 180 RHTADE----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQ---LKLILRLVGTPGAE 252 (367)
T ss_dssp ---------------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHH---HHHHHHHHCSCCHH
T ss_pred cccccc----CCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH---HHHHHHHhCCCCHH
Confidence 865422 344578999999999887 6789999999999999999999999974332211 111111110
Q ss_pred ------hhhhHHHhhhhhhcc-------CChhHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 044312 499 ------EERLFEILDARVMKQ-------GGKDEIITVAKLAKRCLNLNGKKRPTMREVASE 546 (608)
Q Consensus 499 ------~~~~~~~~d~~~~~~-------~~~~~~~~l~~Li~~cl~~dp~~RPs~~evl~~ 546 (608)
.......+.. +... .....+..+.+|+.+||+.||++|||+.|++++
T Consensus 253 ~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~t~~e~L~h 312 (367)
T 2fst_X 253 LLKKISSESARNYIQS-LTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH 312 (367)
T ss_dssp HHTTCCCHHHHHHHHT-SCCCCCCCHHHHTTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred HHHHhhhHHHHHHHhc-cCCCCCCCHHHHCCCCCHHHHHHHHHhCCCCcccCcCHHHHhcC
Confidence 0001111100 0000 001234678999999999999999999999865
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-36 Score=309.18 Aligned_cols=248 Identities=24% Similarity=0.333 Sum_probs=184.0
Q ss_pred hcCccccceeccCce---------------EEEEEeecChhhHHHHHHHHHHHhhcCCCCccceecccc-----------
Q 044312 288 TDNFDLNRILGQGGQ---------------AVKKSKVIDESKVEEFINEVVILSQINHRNVVKLLGCCL----------- 341 (608)
Q Consensus 288 t~~f~~~~~lG~G~~---------------avk~~~~~~~~~~~~~~~Ei~il~~l~H~niv~l~~~~~----------- 341 (608)
.++|.+.+.||+|++ |||+....+....+.+.+|+.++++++||||+++++++.
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 89 (320)
T 2i6l_A 10 GSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTDDVG 89 (320)
T ss_dssp TTTEEEEEECC-----CEEEEEETTTTEEEEEEEEECCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBCCC---
T ss_pred CCceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecCChHHHHHHHHHHHHHHhcCCCCeeEEEEeccccccccccccc
Confidence 457889999999974 788877777777889999999999999999999998863
Q ss_pred ---cCccceEEEeecCCCccchhccccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEEc-CCCcEE
Q 044312 342 ---ETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEIRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLD-DKYRAK 417 (608)
Q Consensus 342 ---~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~-~~~~~k 417 (608)
+....++||||++ |+|.+++... ++++..+..++.||+.||+|||+.+ |+||||||+|||++ +++.+|
T Consensus 90 ~~~~~~~~~lv~e~~~-~~L~~~~~~~----~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~k 161 (320)
T 2i6l_A 90 SLTELNSVYIVQEYME-TDLANVLEQG----PLLEEHARLFMYQLLRGLKYIHSAN---VLHRDLKPANLFINTEDLVLK 161 (320)
T ss_dssp -CCSCSEEEEEEECCS-EEHHHHHTTC----CCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEEETTTTEEE
T ss_pred cccccCceeEEeeccC-CCHHHHhhcC----CccHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCeEE
Confidence 4467899999997 6999988642 4899999999999999999999999 99999999999997 567999
Q ss_pred EeeccCccccccCCc--ceeeeeeccCCCCChhhhcc-CCCCCccchHhHHHHHHHHHhCCCCCCccchhhcccHHHHHH
Q 044312 418 VSDFGASRSMAVDQT--HMTTQVHGTFGYLDPEYFRS-SQFTDKSDVYSFGVVLTELLTGEKPIRFTILEEDKSLAAYFL 494 (608)
Q Consensus 418 l~DFGls~~~~~~~~--~~~~~~~gt~~y~aPE~~~~-~~~t~ksDV~S~Gvvl~elltg~~p~~~~~~~~~~~l~~~~~ 494 (608)
|+|||+++....... .......+|..|+|||.+.. ..++.++||||||++++||++|+.||......+. .....
T Consensus 162 l~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~---~~~~~ 238 (320)
T 2i6l_A 162 IGDFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQ---MQLIL 238 (320)
T ss_dssp ECCCTTCBCC--------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHH---HHHHH
T ss_pred EccCccccccCCCcccccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCCCHHHH---HHHHH
Confidence 999999987643211 11233457899999998865 6789999999999999999999999974332111 11111
Q ss_pred HHhh---hhhhHHH-------hhhhhh------ccCChhHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 044312 495 CAMK---EERLFEI-------LDARVM------KQGGKDEIITVAKLAKRCLNLNGKKRPTMREVASE 546 (608)
Q Consensus 495 ~~~~---~~~~~~~-------~d~~~~------~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~evl~~ 546 (608)
.... .....++ +..... .......+.++.+|+.+||+.||++|||+.|++++
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 306 (320)
T 2i6l_A 239 ESIPVVHEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEALSH 306 (320)
T ss_dssp HHSCCCCHHHHHHHHTTSCHHHHHHTTSCCCCHHHHSTTCCHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred HhcCCCchhhhhhhhhcCcccccccccCCCCChhHhcchhhHHHHHHHHHHcCCCccccCCHHHHhCC
Confidence 1100 0000000 000000 00112346789999999999999999999999864
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-35 Score=306.47 Aligned_cols=239 Identities=26% Similarity=0.364 Sum_probs=187.2
Q ss_pred HHhcCccccceeccCce---------------EEEEEeecChhhHHHHHHHHHHHhhcCCCCccceecccccCccceEEE
Q 044312 286 KATDNFDLNRILGQGGQ---------------AVKKSKVIDESKVEEFINEVVILSQINHRNVVKLLGCCLETEVPLLVY 350 (608)
Q Consensus 286 ~~t~~f~~~~~lG~G~~---------------avk~~~~~~~~~~~~~~~Ei~il~~l~H~niv~l~~~~~~~~~~~lV~ 350 (608)
...++|++.+.||+|++ |||.... ....+.+.+|+.++++++||||+++++++.+....++||
T Consensus 26 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 103 (314)
T 3com_A 26 QPEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPV--ESDLQEIIKEISIMQQCDSPHVVKYYGSYFKNTDLWIVM 103 (314)
T ss_dssp ----CEEEEEECC----CEEEEEEETTTCCEEEEEEEET--TSCCHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred cchhhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCc--hHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEe
Confidence 34567999999999974 5665543 334578999999999999999999999999999999999
Q ss_pred eecCCCccchhccccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEEcCCCcEEEeeccCccccccC
Q 044312 351 EFIPNGTLFQYIHDQNEDFPITWEIRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVD 430 (608)
Q Consensus 351 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGls~~~~~~ 430 (608)
||+++++|.+++..... .+++..++.++.||+.||.|||+.+ ++|+||||+|||++.++.+||+|||++......
T Consensus 104 e~~~~~~L~~~~~~~~~--~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~ 178 (314)
T 3com_A 104 EYCGAGSVSDIIRLRNK--TLTEDEIATILQSTLKGLEYLHFMR---KIHRDIKAGNILLNTEGHAKLADFGVAGQLTDT 178 (314)
T ss_dssp ECCTTEEHHHHHHHHTC--CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECBTT
T ss_pred ecCCCCCHHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHhCC---CcCCCcCHHHEEECCCCCEEEeecccchhhhhh
Confidence 99999999999875332 5899999999999999999999999 999999999999999999999999999876433
Q ss_pred CcceeeeeeccCCCCChhhhccCCCCCccchHhHHHHHHHHHhCCCCCCccchhhcccHHHHHHHHhhhhhhHHHhhhhh
Q 044312 431 QTHMTTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLTELLTGEKPIRFTILEEDKSLAAYFLCAMKEERLFEILDARV 510 (608)
Q Consensus 431 ~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~ 510 (608)
.. ......|++.|+|||.+.+..++.++||||||++++||++|+.||....... . .. ...... ..
T Consensus 179 ~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~-----~-~~-~~~~~~-------~~ 243 (314)
T 3com_A 179 MA-KRNTVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADIHPMR-----A-IF-MIPTNP-------PP 243 (314)
T ss_dssp BS-CBCCCCSCGGGCCHHHHSSSCBCTTHHHHHHHHHHHHHHHSSCTTTTSCHHH-----H-HH-HHHHSC-------CC
T ss_pred cc-ccCccCCCCCccChhhcCCCCCCccccHHHHHHHHHHHHhCCCCCCCCChHH-----H-HH-HHhcCC-------Cc
Confidence 22 2334568999999999999999999999999999999999999986322111 0 00 000000 00
Q ss_pred hccCChhHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 044312 511 MKQGGKDEIITVAKLAKRCLNLNGKKRPTMREVASE 546 (608)
Q Consensus 511 ~~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~evl~~ 546 (608)
....+...+..+.+|+.+||+.||.+|||+.|++++
T Consensus 244 ~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~~ 279 (314)
T 3com_A 244 TFRKPELWSDNFTDFVKQCLVKSPEQRATATQLLQH 279 (314)
T ss_dssp CCSSGGGSCHHHHHHHHHHTCSCTTTSCCHHHHTTS
T ss_pred ccCCcccCCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence 011123345689999999999999999999999874
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-35 Score=324.95 Aligned_cols=237 Identities=25% Similarity=0.377 Sum_probs=188.7
Q ss_pred hcCccccceeccCce---------------EEEEEee--cChhhHHHHHHHHHHHhhcCCCCccceecccccCccceEEE
Q 044312 288 TDNFDLNRILGQGGQ---------------AVKKSKV--IDESKVEEFINEVVILSQINHRNVVKLLGCCLETEVPLLVY 350 (608)
Q Consensus 288 t~~f~~~~~lG~G~~---------------avk~~~~--~~~~~~~~~~~Ei~il~~l~H~niv~l~~~~~~~~~~~lV~ 350 (608)
.++|++.++||+|++ |||++.. ......+.+.+|+.+|++++||||+++++++.+....++||
T Consensus 21 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 100 (486)
T 3mwu_A 21 AERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVG 100 (486)
T ss_dssp HHHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBCSCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hcceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHHHhCCCCCcCeEEEEEEcCCEEEEEE
Confidence 457999999999984 6776643 22345678999999999999999999999999999999999
Q ss_pred eecCCCccchhccccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEEc---CCCcEEEeeccCcccc
Q 044312 351 EFIPNGTLFQYIHDQNEDFPITWEIRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLD---DKYRAKVSDFGASRSM 427 (608)
Q Consensus 351 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~---~~~~~kl~DFGls~~~ 427 (608)
||+++++|.+++.... .+++..+..++.||+.||.|||+.+ |+||||||+|||++ .++.+||+|||+++..
T Consensus 101 e~~~~~~L~~~~~~~~---~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~ 174 (486)
T 3mwu_A 101 ELYTGGELFDEIIKRK---RFSEHDAARIIKQVFSGITYMHKHN---IVHRDLKPENILLESKEKDCDIKIIDFGLSTCF 174 (486)
T ss_dssp CCCCSCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEESSSSTTCCEEECSCSCTTTB
T ss_pred EcCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCchHHEEEecCCCCCCEEEEECCcCeEC
Confidence 9999999999887653 5899999999999999999999999 99999999999995 4567999999999876
Q ss_pred ccCCcceeeeeeccCCCCChhhhccCCCCCccchHhHHHHHHHHHhCCCCCCccchhhcccHHHHHHHHhhhhhhHHHhh
Q 044312 428 AVDQTHMTTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLTELLTGEKPIRFTILEEDKSLAAYFLCAMKEERLFEILD 507 (608)
Q Consensus 428 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 507 (608)
.... ......||+.|+|||++.+ .++.++||||||+++|+|++|+.||......+ ....+......
T Consensus 175 ~~~~--~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~-------~~~~i~~~~~~---- 240 (486)
T 3mwu_A 175 QQNT--KMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNEYD-------ILKRVETGKYA---- 240 (486)
T ss_dssp CCC------CCTTGGGGCCGGGGGS-CCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHH-------HHHHHHHTCCC----
T ss_pred CCCC--ccCCCcCCCCCCCHHHhCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH-------HHHHHHhCCCC----
Confidence 4332 2344569999999999875 59999999999999999999999996432211 11111111000
Q ss_pred hhhhccCChhHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 044312 508 ARVMKQGGKDEIITVAKLAKRCLNLNGKKRPTMREVASE 546 (608)
Q Consensus 508 ~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~evl~~ 546 (608)
...+.....+.++.+|+.+||+.||++|||+.|++++
T Consensus 241 --~~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~~~l~h 277 (486)
T 3mwu_A 241 --FDLPQWRTISDDAKDLIRKMLTFHPSLRITATQCLEH 277 (486)
T ss_dssp --SCSGGGGGSCHHHHHHHHHHTCSSTTTSCCHHHHHHC
T ss_pred --CCCcccCCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 0001112345689999999999999999999999985
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-35 Score=309.43 Aligned_cols=243 Identities=28% Similarity=0.441 Sum_probs=191.2
Q ss_pred HHHHHhcCccccceeccCce---------------EEEEEeecCh--------hhHHHHHHHHHHHhhc-CCCCccceec
Q 044312 283 ELEKATDNFDLNRILGQGGQ---------------AVKKSKVIDE--------SKVEEFINEVVILSQI-NHRNVVKLLG 338 (608)
Q Consensus 283 ~l~~~t~~f~~~~~lG~G~~---------------avk~~~~~~~--------~~~~~~~~Ei~il~~l-~H~niv~l~~ 338 (608)
......++|++.+.||+|++ |||....... ...+.+.+|+.+++++ +||||+++++
T Consensus 88 ~~~~~~~~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~ 167 (365)
T 2y7j_A 88 AAKEFYQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLID 167 (365)
T ss_dssp HHHHHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEE
T ss_pred hhhhhhhhcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEEE
Confidence 34555678999999999974 6776654321 1245788999999999 8999999999
Q ss_pred ccccCccceEEEeecCCCccchhccccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEEcCCCcEEE
Q 044312 339 CCLETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEIRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKV 418 (608)
Q Consensus 339 ~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl 418 (608)
++......+|||||+++++|.+++.... .+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||
T Consensus 168 ~~~~~~~~~lv~e~~~g~~L~~~l~~~~---~l~~~~~~~i~~qi~~~L~~LH~~g---i~H~Dlkp~NIl~~~~~~ikl 241 (365)
T 2y7j_A 168 SYESSSFMFLVFDLMRKGELFDYLTEKV---ALSEKETRSIMRSLLEAVSFLHANN---IVHRDLKPENILLDDNMQIRL 241 (365)
T ss_dssp EEEBSSEEEEEECCCTTCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEE
T ss_pred EEeeCCEEEEEEEeCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEE
Confidence 9999999999999999999999997643 5899999999999999999999999 999999999999999999999
Q ss_pred eeccCccccccCCcceeeeeeccCCCCChhhhcc------CCCCCccchHhHHHHHHHHHhCCCCCCccchhhcccHHHH
Q 044312 419 SDFGASRSMAVDQTHMTTQVHGTFGYLDPEYFRS------SQFTDKSDVYSFGVVLTELLTGEKPIRFTILEEDKSLAAY 492 (608)
Q Consensus 419 ~DFGls~~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~t~ksDV~S~Gvvl~elltg~~p~~~~~~~~~~~l~~~ 492 (608)
+|||++..+.... ......||+.|+|||++.+ ..++.++||||||+++|||++|+.||.......
T Consensus 242 ~DfG~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~------- 312 (365)
T 2y7j_A 242 SDFGFSCHLEPGE--KLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQIL------- 312 (365)
T ss_dssp CCCTTCEECCTTC--CBCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHH-------
T ss_pred EecCcccccCCCc--ccccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCCCHHH-------
Confidence 9999998765432 2344678999999999863 358899999999999999999999996422110
Q ss_pred HHHHhhhhhhHHHhhhhhhccCChhHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 044312 493 FLCAMKEERLFEILDARVMKQGGKDEIITVAKLAKRCLNLNGKKRPTMREVASE 546 (608)
Q Consensus 493 ~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~evl~~ 546 (608)
....+...... ...+. ....+..+.+|+.+||+.||++|||+.|++++
T Consensus 313 ~~~~i~~~~~~-~~~~~-----~~~~~~~~~~li~~~L~~dP~~Rps~~ell~h 360 (365)
T 2y7j_A 313 MLRMIMEGQYQ-FSSPE-----WDDRSSTVKDLISRLLQVDPEARLTAEQALQH 360 (365)
T ss_dssp HHHHHHHTCCC-CCHHH-----HSSSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred HHHHHHhCCCC-CCCcc-----cccCCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence 00111111000 00000 01234579999999999999999999999864
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-36 Score=317.53 Aligned_cols=250 Identities=21% Similarity=0.299 Sum_probs=183.3
Q ss_pred HHHHhcCccccceeccCce---------------EEEEEeecChhhHHHHHHHHHHHhhcCCCCccceeccccc------
Q 044312 284 LEKATDNFDLNRILGQGGQ---------------AVKKSKVIDESKVEEFINEVVILSQINHRNVVKLLGCCLE------ 342 (608)
Q Consensus 284 l~~~t~~f~~~~~lG~G~~---------------avk~~~~~~~~~~~~~~~Ei~il~~l~H~niv~l~~~~~~------ 342 (608)
++...++|.+.+.||+|+| |||+.... .....+|+.+|+.++||||+++++++..
T Consensus 2 l~~~~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~----~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~ 77 (383)
T 3eb0_A 2 LETSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQD----PRYKNRELDIMKVLDHVNIIKLVDYFYTTGDEEP 77 (383)
T ss_dssp ----CTTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECC----TTSCCHHHHHHTTCCCTTBCCEEEEEEEC-----
T ss_pred CccccceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecC----cchHHHHHHHHHHcCCCCccchhheeeecCcccc
Confidence 4556788999999999985 66665432 2233479999999999999999999843
Q ss_pred --------------------------------CccceEEEeecCCCccchhcccc-CCCCCCCHHHHHHHHHHHHHHHHH
Q 044312 343 --------------------------------TEVPLLVYEFIPNGTLFQYIHDQ-NEDFPITWEIRLRIAIEVSGALSY 389 (608)
Q Consensus 343 --------------------------------~~~~~lV~E~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~ia~aL~y 389 (608)
....++||||++ ++|.+.+... .....+++..+..++.||++||+|
T Consensus 78 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~ 156 (383)
T 3eb0_A 78 KPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVP-DTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGF 156 (383)
T ss_dssp --------------------------------CCEEEEEECCCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHH
T ss_pred cccccccccccccccccccccccccccccCCCceEEEEEEecCC-ccHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHH
Confidence 334789999997 5888777641 122369999999999999999999
Q ss_pred HhhcCCCCeeccCCCCCcEEEc-CCCcEEEeeccCccccccCCcceeeeeeccCCCCChhhhccC-CCCCccchHhHHHH
Q 044312 390 LHSAASIPIYHRDIKSTNILLD-DKYRAKVSDFGASRSMAVDQTHMTTQVHGTFGYLDPEYFRSS-QFTDKSDVYSFGVV 467 (608)
Q Consensus 390 LH~~~~~~iiHrDlk~~NILl~-~~~~~kl~DFGls~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~t~ksDV~S~Gvv 467 (608)
||+.+ |+||||||+|||++ .++.+||+|||+++...... ......+|+.|+|||.+.+. .++.++||||||++
T Consensus 157 LH~~g---i~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~i 231 (383)
T 3eb0_A 157 IHSLG---ICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSE--PSVAYICSRFYRAPELMLGATEYTPSIDLWSIGCV 231 (383)
T ss_dssp HHTTT---EECSCCCGGGEEEETTTTEEEECCCTTCEECCTTS--CCCCCCCCSSCCCHHHHTTCSSCCTHHHHHHHHHH
T ss_pred HHHCc---CccCccCHHHEEEcCCCCcEEEEECCCCcccCCCC--CCcCcccCCCccCHHHhcCCCCCCcchhhhhHHHH
Confidence 99999 99999999999998 68899999999998764332 23345689999999998765 48999999999999
Q ss_pred HHHHHhCCCCCCccchhhcccHHHHHHHHhhhhhhHHHhh---------------hhhhccCChhHHHHHHHHHHHHhcc
Q 044312 468 LTELLTGEKPIRFTILEEDKSLAAYFLCAMKEERLFEILD---------------ARVMKQGGKDEIITVAKLAKRCLNL 532 (608)
Q Consensus 468 l~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d---------------~~~~~~~~~~~~~~l~~Li~~cl~~ 532 (608)
++||++|+.||......+. +. .............+.. ..+....+...+.++.+|+.+||+.
T Consensus 232 l~ell~g~~pf~~~~~~~~--~~-~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~ 308 (383)
T 3eb0_A 232 FGELILGKPLFSGETSIDQ--LV-RIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPSLAIDLLEQILRY 308 (383)
T ss_dssp HHHHHHSSCSSCCSSHHHH--HH-HHHHHHCCCCHHHHHHHCTTC--CCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCS
T ss_pred HHHHHhCCCCCCCCChHHH--HH-HHHHHhCCCCHHHHHHhCcccccccCCccCcccHHhhCCCCCCHHHHHHHHHHccC
Confidence 9999999999974332211 11 1111111111111100 0111112334566799999999999
Q ss_pred CCCCCCCHHHHHHH
Q 044312 533 NGKKRPTMREVASE 546 (608)
Q Consensus 533 dp~~RPs~~evl~~ 546 (608)
||++|||+.|++++
T Consensus 309 dP~~R~t~~e~l~h 322 (383)
T 3eb0_A 309 EPDLRINPYEAMAH 322 (383)
T ss_dssp SGGGSCCHHHHHTS
T ss_pred ChhhCCCHHHHhcC
Confidence 99999999999864
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-35 Score=311.98 Aligned_cols=256 Identities=21% Similarity=0.296 Sum_probs=181.9
Q ss_pred HHHHHHHhcCccccceeccCce---------------EEEEEeecChhhHHHHHHHHHHHhhcCCCCccceecccccCcc
Q 044312 281 SKELEKATDNFDLNRILGQGGQ---------------AVKKSKVIDESKVEEFINEVVILSQINHRNVVKLLGCCLETEV 345 (608)
Q Consensus 281 ~~~l~~~t~~f~~~~~lG~G~~---------------avk~~~~~~~~~~~~~~~Ei~il~~l~H~niv~l~~~~~~~~~ 345 (608)
........++|.+.+.||+|+| |||+... +......+.+|++.++.++||||+++++++.....
T Consensus 15 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~-~~~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~ 93 (360)
T 3e3p_A 15 DERSRKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQ-DPRFRNRELQIMQDLAVLHHPNIVQLQSYFYTLGE 93 (360)
T ss_dssp SHHHHHHHTTEEEC----------CEEEEETTTCCEEEEEEEEC-CTTCCCHHHHHHHHHHHHCCTTBCCEEEEEEEECS
T ss_pred hhhchhhccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEec-CccccHHHHHHHHHHHhcCCCCcccHHHhhhcccc
Confidence 3456677889999999999984 6776643 23344567888999999999999999999865433
Q ss_pred -------ceEEEeecCCCccchhccc-cCCCCCCCHHHHHHHHHHHHHHHHHHh--hcCCCCeeccCCCCCcEEEcC-CC
Q 044312 346 -------PLLVYEFIPNGTLFQYIHD-QNEDFPITWEIRLRIAIEVSGALSYLH--SAASIPIYHRDIKSTNILLDD-KY 414 (608)
Q Consensus 346 -------~~lV~E~~~~gsL~~~l~~-~~~~~~l~~~~~~~i~~~ia~aL~yLH--~~~~~~iiHrDlk~~NILl~~-~~ 414 (608)
.++||||+++ +|.+.+.. ......+++..+..++.|++.||.||| +.+ |+||||||+|||++. ++
T Consensus 94 ~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~---ivH~Dlkp~NIll~~~~~ 169 (360)
T 3e3p_A 94 RDRRDIYLNVVMEYVPD-TLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSVN---VCHRDIKPHNVLVNEADG 169 (360)
T ss_dssp SCTTCEEEEEEEECCSC-BHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTTTC---CBCSCCCGGGEEEETTTT
T ss_pred ccccceeEEEEeecccc-cHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCCCC---eecCcCCHHHEEEeCCCC
Confidence 7899999976 55444432 222336899999999999999999999 888 999999999999996 89
Q ss_pred cEEEeeccCccccccCCcceeeeeeccCCCCChhhhccCC-CCCccchHhHHHHHHHHHhCCCCCCccchhhcccHHHHH
Q 044312 415 RAKVSDFGASRSMAVDQTHMTTQVHGTFGYLDPEYFRSSQ-FTDKSDVYSFGVVLTELLTGEKPIRFTILEEDKSLAAYF 493 (608)
Q Consensus 415 ~~kl~DFGls~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~t~ksDV~S~Gvvl~elltg~~p~~~~~~~~~~~l~~~~ 493 (608)
.+||+|||+++....... .....||+.|+|||++.+.. ++.++||||||++++||++|+.||........ ....
T Consensus 170 ~~kl~Dfg~a~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~---~~~~ 244 (360)
T 3e3p_A 170 TLKLCDFGSAKKLSPSEP--NVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQ---LHEI 244 (360)
T ss_dssp EEEECCCTTCBCCCTTSC--CCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH---HHHH
T ss_pred cEEEeeCCCceecCCCCC--cccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCCChHHH---HHHH
Confidence 999999999987654332 23456899999999986654 89999999999999999999999975332211 1111
Q ss_pred HHHhhh--hhhHHHhh----------------hhhhccCChhHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 044312 494 LCAMKE--ERLFEILD----------------ARVMKQGGKDEIITVAKLAKRCLNLNGKKRPTMREVASE 546 (608)
Q Consensus 494 ~~~~~~--~~~~~~~d----------------~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~evl~~ 546 (608)
...... ......++ ...........+.++.+|+.+||+.||++|||+.|++++
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 315 (360)
T 3e3p_A 245 VRVLGCPSREVLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEALCH 315 (360)
T ss_dssp HHHHCCCCHHHHHHHCTTCCCGGGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGGGSCCHHHHTTS
T ss_pred HHHcCCCCHHHHHhcccchhhccccccccCCcccccchhhccccHHHHHHHHHHhccCccccCCHHHHhcC
Confidence 111100 00101110 011112223356789999999999999999999999864
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-36 Score=312.13 Aligned_cols=246 Identities=24% Similarity=0.386 Sum_probs=189.4
Q ss_pred hcCccccceeccCce-------------EEEEEeecChh-----------------hHHHHHHHHHHHhhcCCCCcccee
Q 044312 288 TDNFDLNRILGQGGQ-------------AVKKSKVIDES-----------------KVEEFINEVVILSQINHRNVVKLL 337 (608)
Q Consensus 288 t~~f~~~~~lG~G~~-------------avk~~~~~~~~-----------------~~~~~~~Ei~il~~l~H~niv~l~ 337 (608)
.++|.+.+.||+|++ |||........ ..+.|.+|+.++++++||||++++
T Consensus 30 ~~~y~~~~~lg~G~~g~V~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~ 109 (348)
T 2pml_X 30 INDYRIIRTLNQGKFNKIILCEKDNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLTCE 109 (348)
T ss_dssp ETTEEEEEEEECCSSCCEEEEEETTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTTBCCCS
T ss_pred cCceEEEEEEcCCCCeEEEEEEcCCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCCcceEE
Confidence 468999999999984 66666532111 128899999999999999999999
Q ss_pred cccccCccceEEEeecCCCccchh------ccccCCCCCCCHHHHHHHHHHHHHHHHHHhh-cCCCCeeccCCCCCcEEE
Q 044312 338 GCCLETEVPLLVYEFIPNGTLFQY------IHDQNEDFPITWEIRLRIAIEVSGALSYLHS-AASIPIYHRDIKSTNILL 410 (608)
Q Consensus 338 ~~~~~~~~~~lV~E~~~~gsL~~~------l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~-~~~~~iiHrDlk~~NILl 410 (608)
+++.+.+..++||||+++++|.++ +.... ...+++..++.++.||+.||.|||+ .+ |+||||||+|||+
T Consensus 110 ~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~~---i~H~dl~p~Nil~ 185 (348)
T 2pml_X 110 GIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNY-TCFIPIQVIKCIIKSVLNSFSYIHNEKN---ICHRDVKPSNILM 185 (348)
T ss_dssp EEEESSSEEEEEEECCTTCBSSEESSSEESSCSSS-CCCCCHHHHHHHHHHHHHHHHHHHHTSC---EECCCCCGGGEEE
T ss_pred EEEeeCCeEEEEEeccCCCcHHHHHHHhhhhhhcc-ccCCCHHHHHHHHHHHHHHHHHHhccCC---EeecCCChHhEEE
Confidence 999999999999999999999998 55422 2369999999999999999999999 88 9999999999999
Q ss_pred cCCCcEEEeeccCccccccCCcceeeeeeccCCCCChhhhccC-CCCC-ccchHhHHHHHHHHHhCCCCCCccchhhccc
Q 044312 411 DDKYRAKVSDFGASRSMAVDQTHMTTQVHGTFGYLDPEYFRSS-QFTD-KSDVYSFGVVLTELLTGEKPIRFTILEEDKS 488 (608)
Q Consensus 411 ~~~~~~kl~DFGls~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~t~-ksDV~S~Gvvl~elltg~~p~~~~~~~~~~~ 488 (608)
+.++.+||+|||+++..... ......||+.|+|||.+.+. .++. ++||||||++++||++|+.||......
T Consensus 186 ~~~~~~kl~dfg~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~---- 258 (348)
T 2pml_X 186 DKNGRVKLSDFGESEYMVDK---KIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISL---- 258 (348)
T ss_dssp CTTSCEEECCCTTCEECBTT---EECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCSSCCSSCS----
T ss_pred cCCCcEEEeccccccccccc---cccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCCCCCCCcH----
Confidence 99999999999999876433 33455689999999999887 6666 999999999999999999999743221
Q ss_pred HHHHHHHHhhhhhhHHH---------hhhhhhccCChhHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 044312 489 LAAYFLCAMKEERLFEI---------LDARVMKQGGKDEIITVAKLAKRCLNLNGKKRPTMREVASE 546 (608)
Q Consensus 489 l~~~~~~~~~~~~~~~~---------~d~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~evl~~ 546 (608)
.. ....+........ .............+..+.+|+.+||+.||++|||+.|++++
T Consensus 259 -~~-~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~e~l~h 323 (348)
T 2pml_X 259 -VE-LFNNIRTKNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALKH 323 (348)
T ss_dssp -HH-HHHHHTSCCCCCCCSSSSSTTTTCC--------CCCHHHHHHHHHHCCSSGGGSCCHHHHHTS
T ss_pred -HH-HHHHHhccCcCCccchhhhhccccccccccchhhcCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 01 1111111100000 00000000113456789999999999999999999999864
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-35 Score=312.16 Aligned_cols=246 Identities=22% Similarity=0.322 Sum_probs=178.7
Q ss_pred hcCccccceeccCce---------------EEEEEee--cChhhHHHHHHHHHHHhhcCCCCccceecccccCc------
Q 044312 288 TDNFDLNRILGQGGQ---------------AVKKSKV--IDESKVEEFINEVVILSQINHRNVVKLLGCCLETE------ 344 (608)
Q Consensus 288 t~~f~~~~~lG~G~~---------------avk~~~~--~~~~~~~~~~~Ei~il~~l~H~niv~l~~~~~~~~------ 344 (608)
.++|++.+.||+|++ |||+... ......+.+.+|+.+++.++||||+++++++....
T Consensus 24 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~ 103 (371)
T 2xrw_A 24 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQ 103 (371)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTTCC
T ss_pred hhheeEeeeeEecCCEEEEEEEECCCCceEEEEEeccccCChHHHHHHHHHHHHHHhcCCCCccceEEeecccccccccc
Confidence 467999999999984 6776654 23455678999999999999999999999987654
Q ss_pred cceEEEeecCCCccchhccccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEEcCCCcEEEeeccCc
Q 044312 345 VPLLVYEFIPNGTLFQYIHDQNEDFPITWEIRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGAS 424 (608)
Q Consensus 345 ~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGls 424 (608)
..++||||++ ++|.+++.. .+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||++
T Consensus 104 ~~~lv~e~~~-~~l~~~~~~-----~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg~a 174 (371)
T 2xrw_A 104 DVYIVMELMD-ANLCQVIQM-----ELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLA 174 (371)
T ss_dssp EEEEEEECCS-EEHHHHHHS-----CCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECCCCC-
T ss_pred ceEEEEEcCC-CCHHHHHhh-----ccCHHHHHHHHHHHHHHHHHHHHCC---eecccCCHHHEEEcCCCCEEEEEeecc
Confidence 6799999996 578887752 4899999999999999999999999 999999999999999999999999999
Q ss_pred cccccCCcceeeeeeccCCCCChhhhccCCCCCccchHhHHHHHHHHHhCCCCCCccchhhcccHHHHHHHHhhh-----
Q 044312 425 RSMAVDQTHMTTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLTELLTGEKPIRFTILEEDKSLAAYFLCAMKE----- 499 (608)
Q Consensus 425 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~elltg~~p~~~~~~~~~~~l~~~~~~~~~~----- 499 (608)
+..... .......||+.|+|||++.+..++.++||||||++++||++|+.||........ + .........
T Consensus 175 ~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~--~-~~i~~~~~~~~~~~ 249 (371)
T 2xrw_A 175 RTAGTS--FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQ--W-NKVIEQLGTPCPEF 249 (371)
T ss_dssp -----------------CTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHH--H-HHHHC-CCCCCHHH
T ss_pred cccccc--cccCCceecCCccCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHH--H-HHHHHHhCCCCHHH
Confidence 865432 223445789999999999999999999999999999999999999974332110 0 000000000
Q ss_pred -----hhhHHHhh--------------hhhhccC----ChhHHHHHHHHHHHHhccCCCCCCCHHHHHHHH
Q 044312 500 -----ERLFEILD--------------ARVMKQG----GKDEIITVAKLAKRCLNLNGKKRPTMREVASEL 547 (608)
Q Consensus 500 -----~~~~~~~d--------------~~~~~~~----~~~~~~~l~~Li~~cl~~dp~~RPs~~evl~~L 547 (608)
..+...+. +...... ....+..+.+|+.+||+.||++|||++|++++-
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp 320 (371)
T 2xrw_A 250 MKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHP 320 (371)
T ss_dssp HTTSCHHHHHHHHSSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSGGGSCCHHHHHHSH
T ss_pred HHHhhhHHHHHHhhCccccccchhhhcccccCcccccccccccHHHHHHHHHHCcCChhhCCCHHHHhCCc
Confidence 00000000 0000000 112366899999999999999999999998753
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-36 Score=327.31 Aligned_cols=238 Identities=26% Similarity=0.376 Sum_probs=191.2
Q ss_pred hcCccccceeccCce---------------EEEEEeec---ChhhHHHHHHHHHHHhhcCCCCccceecccccCccceEE
Q 044312 288 TDNFDLNRILGQGGQ---------------AVKKSKVI---DESKVEEFINEVVILSQINHRNVVKLLGCCLETEVPLLV 349 (608)
Q Consensus 288 t~~f~~~~~lG~G~~---------------avk~~~~~---~~~~~~~~~~Ei~il~~l~H~niv~l~~~~~~~~~~~lV 349 (608)
.++|++.++||+|++ |||++... .....+.+.+|+.++++++||||+++++++.+....++|
T Consensus 25 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv 104 (484)
T 3nyv_A 25 SDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYLV 104 (484)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred cCceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEE
Confidence 457899999999974 67766432 244578899999999999999999999999999999999
Q ss_pred EeecCCCccchhccccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEE---cCCCcEEEeeccCccc
Q 044312 350 YEFIPNGTLFQYIHDQNEDFPITWEIRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILL---DDKYRAKVSDFGASRS 426 (608)
Q Consensus 350 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl---~~~~~~kl~DFGls~~ 426 (608)
|||+.+|+|.+++.... .+++..+..++.||+.||+|||+++ |+||||||+|||+ +.++.+||+|||+++.
T Consensus 105 ~e~~~~~~L~~~~~~~~---~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~ 178 (484)
T 3nyv_A 105 GEVYTGGELFDEIISRK---RFSEVDAARIIRQVLSGITYMHKNK---IVHRDLKPENLLLESKSKDANIRIIDFGLSTH 178 (484)
T ss_dssp ECCCCSCBHHHHHHTCS---CCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESSSSTTCCEEECCTTHHHH
T ss_pred EecCCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEEecCCCCCcEEEEeeeeeEE
Confidence 99999999999887643 5899999999999999999999999 9999999999999 5678999999999987
Q ss_pred cccCCcceeeeeeccCCCCChhhhccCCCCCccchHhHHHHHHHHHhCCCCCCccchhhcccHHHHHHHHhhhhhhHHHh
Q 044312 427 MAVDQTHMTTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLTELLTGEKPIRFTILEEDKSLAAYFLCAMKEERLFEIL 506 (608)
Q Consensus 427 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 506 (608)
..... ......||+.|+|||++.+ .++.++||||||+++|+|++|+.||......+ ....+......
T Consensus 179 ~~~~~--~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~-------~~~~i~~~~~~--- 245 (484)
T 3nyv_A 179 FEASK--KMKDKIGTAYYIAPEVLHG-TYDEKCDVWSTGVILYILLSGCPPFNGANEYD-------ILKKVEKGKYT--- 245 (484)
T ss_dssp BCCCC--SHHHHTTGGGTCCHHHHHT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH-------HHHHHHHCCCC---
T ss_pred ccccc--ccccCCCCccccCceeecC-CCCCcceeHHHHHHHHHHHHCCCCCCCCCHHH-------HHHHHHcCCCC---
Confidence 65332 2234569999999999876 69999999999999999999999997432211 11111111000
Q ss_pred hhhhhccCChhHHHHHHHHHHHHhccCCCCCCCHHHHHHHH
Q 044312 507 DARVMKQGGKDEIITVAKLAKRCLNLNGKKRPTMREVASEL 547 (608)
Q Consensus 507 d~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~evl~~L 547 (608)
...+.....+..+.+|+.+||+.||++|||+.|++++-
T Consensus 246 ---~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~h~ 283 (484)
T 3nyv_A 246 ---FELPQWKKVSESAKDLIRKMLTYVPSMRISARDALDHE 283 (484)
T ss_dssp ---CCSGGGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHTSH
T ss_pred ---CCCcccccCCHHHHHHHHHHCCCChhHCcCHHHHhhCh
Confidence 00011124567899999999999999999999999753
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-35 Score=301.89 Aligned_cols=238 Identities=29% Similarity=0.418 Sum_probs=189.8
Q ss_pred HhcCccccceeccCce---------------EEEEEeecC---------hhhHHHHHHHHHHHhhcC-CCCccceecccc
Q 044312 287 ATDNFDLNRILGQGGQ---------------AVKKSKVID---------ESKVEEFINEVVILSQIN-HRNVVKLLGCCL 341 (608)
Q Consensus 287 ~t~~f~~~~~lG~G~~---------------avk~~~~~~---------~~~~~~~~~Ei~il~~l~-H~niv~l~~~~~ 341 (608)
..++|++.+.||+|++ |||...... ....+.+.+|+.+++++. ||||+++++++.
T Consensus 15 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~ 94 (298)
T 1phk_A 15 FYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYE 94 (298)
T ss_dssp CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEE
T ss_pred hhhccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeeec
Confidence 4568999999999974 677665432 123567889999999995 999999999999
Q ss_pred cCccceEEEeecCCCccchhccccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEEcCCCcEEEeec
Q 044312 342 ETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEIRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDF 421 (608)
Q Consensus 342 ~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DF 421 (608)
+....++||||+++++|.+++.... .+++..++.++.||+.||+|||+.+ ++||||||+|||++.++.+||+||
T Consensus 95 ~~~~~~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~df 168 (298)
T 1phk_A 95 TNTFFFLVFDLMKKGELFDYLTEKV---TLSEKETRKIMRALLEVICALHKLN---IVHRDLKPENILLDDDMNIKLTDF 168 (298)
T ss_dssp CSSEEEEEEECCTTCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCC
T ss_pred cCCeEEEEEeccCCCcHHHHHhccC---CCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcceEEEcCCCcEEEecc
Confidence 9999999999999999999997643 5899999999999999999999999 999999999999999999999999
Q ss_pred cCccccccCCcceeeeeeccCCCCChhhhc------cCCCCCccchHhHHHHHHHHHhCCCCCCccchhhcccHHHHHHH
Q 044312 422 GASRSMAVDQTHMTTQVHGTFGYLDPEYFR------SSQFTDKSDVYSFGVVLTELLTGEKPIRFTILEEDKSLAAYFLC 495 (608)
Q Consensus 422 Gls~~~~~~~~~~~~~~~gt~~y~aPE~~~------~~~~t~ksDV~S~Gvvl~elltg~~p~~~~~~~~~~~l~~~~~~ 495 (608)
|++....... ......|++.|+|||.+. ...++.++||||||++++||++|+.||....... ...
T Consensus 169 g~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~-------~~~ 239 (298)
T 1phk_A 169 GFSCQLDPGE--KLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQML-------MLR 239 (298)
T ss_dssp TTCEECCTTC--CBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH-------HHH
T ss_pred cchhhcCCCc--ccccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCccHHH-------HHH
Confidence 9998765332 233456899999999985 4568899999999999999999999986432111 000
Q ss_pred HhhhhhhHHHhhhhhhccCChhHHHHHHHHHHHHhccCCCCCCCHHHHHH
Q 044312 496 AMKEERLFEILDARVMKQGGKDEIITVAKLAKRCLNLNGKKRPTMREVAS 545 (608)
Q Consensus 496 ~~~~~~~~~~~d~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~evl~ 545 (608)
.+..... ..........+..+.+|+.+||+.||++|||+.|+++
T Consensus 240 ~~~~~~~------~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 283 (298)
T 1phk_A 240 MIMSGNY------QFGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALA 283 (298)
T ss_dssp HHHHTCC------CCCTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred HHhcCCc------ccCcccccccCHHHHHHHHHHccCCcccCCCHHHHHh
Confidence 1111000 0001111345678999999999999999999999975
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-35 Score=301.63 Aligned_cols=238 Identities=27% Similarity=0.476 Sum_probs=179.8
Q ss_pred hcCccccceeccCce---------------EEEEEeecChhhHHHHHHHHHHHhhcCCCCccceeccccc----------
Q 044312 288 TDNFDLNRILGQGGQ---------------AVKKSKVIDESKVEEFINEVVILSQINHRNVVKLLGCCLE---------- 342 (608)
Q Consensus 288 t~~f~~~~~lG~G~~---------------avk~~~~~~~~~~~~~~~Ei~il~~l~H~niv~l~~~~~~---------- 342 (608)
.++|++.+.||+|++ |||.... .....+.+.+|+.++++++||||+++++++.+
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~ 83 (303)
T 1zy4_A 5 ASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRH-TEEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPMTA 83 (303)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEE-EHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC----
T ss_pred cccchhhheeccCCcEEEEEEEEcCCCeEEEEEEEec-cHHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhhhcc
Confidence 457889999999974 6666643 34456789999999999999999999998754
Q ss_pred ---CccceEEEeecCCCccchhccccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEEcCCCcEEEe
Q 044312 343 ---TEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEIRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVS 419 (608)
Q Consensus 343 ---~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~ 419 (608)
....++||||+++++|.+++..... .+++..++.++.|++.||+|||+++ |+||||||+|||++.++.+||+
T Consensus 84 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~--~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dlkp~Nil~~~~~~~kl~ 158 (303)
T 1zy4_A 84 VKKKSTLFIQMEYCENGTLYDLIHSENL--NQQRDEYWRLFRQILEALSYIHSQG---IIHRDLKPMNIFIDESRNVKIG 158 (303)
T ss_dssp --CEEEEEEEEECCCSCBHHHHHHHSCG--GGCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEEC
T ss_pred cccCCceEEEEecCCCCCHHHhhhcccc--ccchHHHHHHHHHHHHHHHHHHhCC---eecccCCHHhEEEcCCCCEEEe
Confidence 4567999999999999999986432 5889999999999999999999999 9999999999999999999999
Q ss_pred eccCccccccCC-------------cceeeeeeccCCCCChhhhccC-CCCCccchHhHHHHHHHHHhCCCCCCccchhh
Q 044312 420 DFGASRSMAVDQ-------------THMTTQVHGTFGYLDPEYFRSS-QFTDKSDVYSFGVVLTELLTGEKPIRFTILEE 485 (608)
Q Consensus 420 DFGls~~~~~~~-------------~~~~~~~~gt~~y~aPE~~~~~-~~t~ksDV~S~Gvvl~elltg~~p~~~~~~~~ 485 (608)
|||+++...... ........||+.|+|||.+.+. .++.++||||||++++||++ ||......
T Consensus 159 dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~---p~~~~~~~- 234 (303)
T 1zy4_A 159 DFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY---PFSTGMER- 234 (303)
T ss_dssp CCCCCSCTTC-------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS---CCSSHHHH-
T ss_pred eCcchhhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh---ccCCchhH-
Confidence 999998764221 1122345689999999999865 78999999999999999998 44311100
Q ss_pred cccHHHHHHHHhhhhhhHHHhhhhhhccCChhHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 044312 486 DKSLAAYFLCAMKEERLFEILDARVMKQGGKDEIITVAKLAKRCLNLNGKKRPTMREVASE 546 (608)
Q Consensus 486 ~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~evl~~ 546 (608)
.. ....+... ........+...+..+.+|+.+||+.||++|||+.|++++
T Consensus 235 ----~~-~~~~~~~~------~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h 284 (303)
T 1zy4_A 235 ----VN-ILKKLRSV------SIEFPPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLNS 284 (303)
T ss_dssp ----HH-HHHHHHST------TCCCCTTCCTTTSHHHHHHHHHHTCSSGGGSCCHHHHHHS
T ss_pred ----HH-HHHhcccc------ccccCccccccchHHHHHHHHHHHhcCcccCcCHHHHhCC
Confidence 00 01111110 1111122334556678999999999999999999999864
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-35 Score=306.48 Aligned_cols=249 Identities=21% Similarity=0.325 Sum_probs=188.7
Q ss_pred hcCccccceeccCce----------------EEEEEeecChhhHHHHHHHHHHHhhcCCCC------ccceecccccCcc
Q 044312 288 TDNFDLNRILGQGGQ----------------AVKKSKVIDESKVEEFINEVVILSQINHRN------VVKLLGCCLETEV 345 (608)
Q Consensus 288 t~~f~~~~~lG~G~~----------------avk~~~~~~~~~~~~~~~Ei~il~~l~H~n------iv~l~~~~~~~~~ 345 (608)
.++|++.+.||+|++ |||..+. .....+.+.+|+.++++++|+| ++++++++.+.+.
T Consensus 13 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~-~~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~~~~~~ 91 (339)
T 1z57_A 13 SARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKN-VDRYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFEHHGH 91 (339)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECS-SHHHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEEEETTE
T ss_pred cCceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEec-CCchhHHHHHHHHHHHHhhhcCCCCceeeEeeecccccCCc
Confidence 457899999999974 5555442 2344678899999999997665 9999999999999
Q ss_pred ceEEEeecCCCccchhccccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEEcC-------------
Q 044312 346 PLLVYEFIPNGTLFQYIHDQNEDFPITWEIRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDD------------- 412 (608)
Q Consensus 346 ~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~------------- 412 (608)
.++||||+ +++|.+++..... .++++..+..++.||+.||+|||+++ |+||||||+|||++.
T Consensus 92 ~~lv~e~~-~~~l~~~l~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~~~~~~~ 166 (339)
T 1z57_A 92 ICIVFELL-GLSTYDFIKENGF-LPFRLDHIRKMAYQICKSVNFLHSNK---LTHTDLKPENILFVQSDYTEAYNPKIKR 166 (339)
T ss_dssp EEEEEECC-CCBHHHHHHHTTT-CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESCCCEEEEEC----C
T ss_pred EEEEEcCC-CCCHHHHHHhcCC-CCCcHHHHHHHHHHHHHHHHHHHHCC---CcCCCCCHHHEEEeccccccccCCcccc
Confidence 99999999 8899999976543 25899999999999999999999999 999999999999987
Q ss_pred ------CCcEEEeeccCccccccCCcceeeeeeccCCCCChhhhccCCCCCccchHhHHHHHHHHHhCCCCCCccchhhc
Q 044312 413 ------KYRAKVSDFGASRSMAVDQTHMTTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLTELLTGEKPIRFTILEED 486 (608)
Q Consensus 413 ------~~~~kl~DFGls~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~elltg~~p~~~~~~~~~ 486 (608)
++.+||+|||+++..... .....||+.|+|||++.+..++.++||||||++++||++|+.||......+.
T Consensus 167 ~~~~~~~~~~kl~Dfg~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~ 242 (339)
T 1z57_A 167 DERTLINPDIKVVDFGSATYDDEH----HSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTVFPTHDSKEH 242 (339)
T ss_dssp EEEEESCCCEEECCCSSCEETTSC----CCSSCSCGGGCCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSCHHHH
T ss_pred ccccccCCCceEeeCcccccCccc----cccccCCccccChHHhhCCCCCcchhhHHHHHHHHHHHhCCCCCCCCChHHH
Confidence 668999999999865432 2345689999999999999999999999999999999999999975433221
Q ss_pred ccHHHHHHHHhhhhhhH----------------------HHhhh-----hhhccCChhHHHHHHHHHHHHhccCCCCCCC
Q 044312 487 KSLAAYFLCAMKEERLF----------------------EILDA-----RVMKQGGKDEIITVAKLAKRCLNLNGKKRPT 539 (608)
Q Consensus 487 ~~l~~~~~~~~~~~~~~----------------------~~~d~-----~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPs 539 (608)
...............+. ..+.. ..........+.++.+|+.+||+.||++|||
T Consensus 243 ~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt 322 (339)
T 1z57_A 243 LAMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFDLIQKMLEYDPAKRIT 322 (339)
T ss_dssp HHHHHHHHCSCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTSCC
T ss_pred HHHHHHHhCCCCHHHHhhccchhHHhhccccccccccccchhhhcCcchhhhcccchhhHHHHHHHHHHHhCcCcccccC
Confidence 11110000000000000 00000 0001123355778999999999999999999
Q ss_pred HHHHHHH
Q 044312 540 MREVASE 546 (608)
Q Consensus 540 ~~evl~~ 546 (608)
+.|++++
T Consensus 323 ~~ell~h 329 (339)
T 1z57_A 323 LREALKH 329 (339)
T ss_dssp HHHHTTS
T ss_pred HHHHhcC
Confidence 9999864
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-35 Score=318.76 Aligned_cols=185 Identities=24% Similarity=0.348 Sum_probs=158.5
Q ss_pred HhcCccccceeccCce---------------EEEEEeecChhhHHHHHHHHHHHhhc------CCCCccceecccccCcc
Q 044312 287 ATDNFDLNRILGQGGQ---------------AVKKSKVIDESKVEEFINEVVILSQI------NHRNVVKLLGCCLETEV 345 (608)
Q Consensus 287 ~t~~f~~~~~lG~G~~---------------avk~~~~~~~~~~~~~~~Ei~il~~l------~H~niv~l~~~~~~~~~ 345 (608)
...+|++.++||+|+| |||+++. +....+.+.+|+.+++.+ +|+||+++++++.....
T Consensus 95 ~~~ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~-~~~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~ 173 (429)
T 3kvw_A 95 VAYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRN-EKRFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTFRNH 173 (429)
T ss_dssp ETTTEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECS-CHHHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEETTE
T ss_pred ccCcEEEEEEcccCccEEEEEEEECCCCcEEEEEEECC-ccchHHHHHHHHHHHHHHhhccccCCcCEEEEEeecccCCe
Confidence 3567999999999985 6666553 334456788899988887 57799999999999999
Q ss_pred ceEEEeecCCCccchhccccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEEcCCCc--EEEeeccC
Q 044312 346 PLLVYEFIPNGTLFQYIHDQNEDFPITWEIRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYR--AKVSDFGA 423 (608)
Q Consensus 346 ~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~--~kl~DFGl 423 (608)
.++||||+. ++|.+++...... .+++..+..|+.||+.||+|||+.+ |+||||||+|||++.++. +||+|||+
T Consensus 174 ~~lv~e~~~-~~L~~~l~~~~~~-~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlKp~NILl~~~~~~~vkL~DFG~ 248 (429)
T 3kvw_A 174 ICMTFELLS-MNLYELIKKNKFQ-GFSLPLVRKFAHSILQCLDALHKNR---IIHCDLKPENILLKQQGRSGIKVIDFGS 248 (429)
T ss_dssp EEEEECCCC-CBHHHHHHHTTTC-CCCHHHHHHHHHHHHHHHHHHHHHT---EECSCCSGGGEEESSTTSCCEEECCCTT
T ss_pred EEEEEeccC-CCHHHHHHhccCC-CCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEEccCCCcceEEeeccc
Confidence 999999995 6999988765432 5899999999999999999999999 999999999999999887 99999999
Q ss_pred ccccccCCcceeeeeeccCCCCChhhhccCCCCCccchHhHHHHHHHHHhCCCCCCcc
Q 044312 424 SRSMAVDQTHMTTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLTELLTGEKPIRFT 481 (608)
Q Consensus 424 s~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~elltg~~p~~~~ 481 (608)
++..... .....||+.|+|||++.+..++.++|||||||+|+||++|+.||...
T Consensus 249 a~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~ 302 (429)
T 3kvw_A 249 SCYEHQR----VYTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLPGE 302 (429)
T ss_dssp CEETTCC----CCSSCSCGGGCCHHHHHTBCCCTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred ceecCCc----ccccCCCCCccChHHHhCCCCCchHHHHhHHHHHHHHHhCCCCCCCC
Confidence 9764322 23456899999999999999999999999999999999999999744
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-36 Score=307.89 Aligned_cols=244 Identities=23% Similarity=0.368 Sum_probs=188.3
Q ss_pred HHHHHHhcCccccceeccCce--------------EEEEEee--cChhhHHHHHHHHHHHhhcC--CCCccceecccccC
Q 044312 282 KELEKATDNFDLNRILGQGGQ--------------AVKKSKV--IDESKVEEFINEVVILSQIN--HRNVVKLLGCCLET 343 (608)
Q Consensus 282 ~~l~~~t~~f~~~~~lG~G~~--------------avk~~~~--~~~~~~~~~~~Ei~il~~l~--H~niv~l~~~~~~~ 343 (608)
+.+....++|++.+.||+|++ |||+... .+....+.+.+|+.++++++ |+||+++++++.+.
T Consensus 21 ~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~ 100 (313)
T 3cek_A 21 QSMSVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITD 100 (313)
T ss_dssp CEEEETTEEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGGCTTBCCEEEEEECS
T ss_pred eeeeeccceEEEEEEecCCCCEEEEEEEcCCCcEEEEEEeccccccccchHHHHHHHHHHHhccccCCceEEEEEEeecC
Confidence 334445667999999999984 6777654 23456788999999999997 59999999999999
Q ss_pred ccceEEEeecCCCccchhccccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEEcCCCcEEEeeccC
Q 044312 344 EVPLLVYEFIPNGTLFQYIHDQNEDFPITWEIRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGA 423 (608)
Q Consensus 344 ~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGl 423 (608)
...++||| +.+++|.+++.... .+++..++.++.|++.||.|||+.+ |+||||||+|||+++ +.+||+|||+
T Consensus 101 ~~~~lv~e-~~~~~L~~~l~~~~---~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIl~~~-~~~kL~Dfg~ 172 (313)
T 3cek_A 101 QYIYMVME-CGNIDLNSWLKKKK---SIDPWERKSYWKNMLEAVHTIHQHG---IVHSDLKPANFLIVD-GMLKLIDFGI 172 (313)
T ss_dssp SEEEEEEC-CCSEEHHHHHHHCS---SCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEET-TEEEECCCSS
T ss_pred CEEEEEEe-cCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCcccEEEEC-CeEEEeeccc
Confidence 99999999 55889999998643 5899999999999999999999999 999999999999975 7999999999
Q ss_pred ccccccCCcc-eeeeeeccCCCCChhhhcc-----------CCCCCccchHhHHHHHHHHHhCCCCCCccchhhcccHHH
Q 044312 424 SRSMAVDQTH-MTTQVHGTFGYLDPEYFRS-----------SQFTDKSDVYSFGVVLTELLTGEKPIRFTILEEDKSLAA 491 (608)
Q Consensus 424 s~~~~~~~~~-~~~~~~gt~~y~aPE~~~~-----------~~~t~ksDV~S~Gvvl~elltg~~p~~~~~~~~~~~l~~ 491 (608)
++........ ......||+.|+|||.+.. ..++.++||||||++++||++|+.||...... .
T Consensus 173 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~-----~- 246 (313)
T 3cek_A 173 ANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQ-----I- 246 (313)
T ss_dssp SCC--------------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTCCSH-----H-
T ss_pred cccccCccccccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhHHHH-----H-
Confidence 9876543221 2234568999999999875 47888999999999999999999998632211 0
Q ss_pred HHHHHhhhhhhHHHhhhhhhccCChhHHHHHHHHHHHHhccCCCCCCCHHHHHHHH
Q 044312 492 YFLCAMKEERLFEILDARVMKQGGKDEIITVAKLAKRCLNLNGKKRPTMREVASEL 547 (608)
Q Consensus 492 ~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~evl~~L 547 (608)
..+..++++......+...+..+.+|+.+||+.||++||++.|++++-
T Consensus 247 --------~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h~ 294 (313)
T 3cek_A 247 --------SKLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHP 294 (313)
T ss_dssp --------HHHHHHHCTTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSH
T ss_pred --------HHHHHHHhcccccCCcccchHHHHHHHHHHccCCcccCcCHHHHhcCc
Confidence 111222333333333444466899999999999999999999998754
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-36 Score=319.53 Aligned_cols=252 Identities=20% Similarity=0.317 Sum_probs=169.3
Q ss_pred Cccc-cceeccCce-----------------EEEEEeecChhhHHHHHHHHHHHhhcCCCCccceecccc--cCccceEE
Q 044312 290 NFDL-NRILGQGGQ-----------------AVKKSKVIDESKVEEFINEVVILSQINHRNVVKLLGCCL--ETEVPLLV 349 (608)
Q Consensus 290 ~f~~-~~~lG~G~~-----------------avk~~~~~~~~~~~~~~~Ei~il~~l~H~niv~l~~~~~--~~~~~~lV 349 (608)
.|++ .++||+|+| |||++.. ....+.+.+|+.+|++++||||+++++++. .....+||
T Consensus 21 ~y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~--~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~lv 98 (405)
T 3rgf_A 21 LFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEG--TGISMSACREIALLRELKHPNVISLQKVFLSHADRKVWLL 98 (405)
T ss_dssp HEECSSCCCC-----EEEEEEESSSSCCCCEEEEECSS--SSCCHHHHHHHHHHHHCCCTTBCCCCEEEEETTTTEEEEE
T ss_pred hhhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECC--CCCCHHHHHHHHHHHhcCCCCeeeEeeEEecCCCCeEEEE
Confidence 3554 457888875 4444432 223457889999999999999999999994 46788999
Q ss_pred EeecCCCccchhccccC------CCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEE----cCCCcEEEe
Q 044312 350 YEFIPNGTLFQYIHDQN------EDFPITWEIRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILL----DDKYRAKVS 419 (608)
Q Consensus 350 ~E~~~~gsL~~~l~~~~------~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl----~~~~~~kl~ 419 (608)
|||+. ++|.+++.... ....+++..++.|+.||+.||+|||+.+ |+||||||+|||+ +.++.+||+
T Consensus 99 ~e~~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~kl~ 174 (405)
T 3rgf_A 99 FDYAE-HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANW---VLHRDLKPANILVMGEGPERGRVKIA 174 (405)
T ss_dssp EECCS-EEHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECCSSTTTTCEEEC
T ss_pred EeCCC-CCHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhCC---EeCCCcCHHHeEEecCCCCCCcEEEE
Confidence 99996 58888776321 1224899999999999999999999999 9999999999999 678899999
Q ss_pred eccCccccccCCc--ceeeeeeccCCCCChhhhccC-CCCCccchHhHHHHHHHHHhCCCCCCccchhhc------ccHH
Q 044312 420 DFGASRSMAVDQT--HMTTQVHGTFGYLDPEYFRSS-QFTDKSDVYSFGVVLTELLTGEKPIRFTILEED------KSLA 490 (608)
Q Consensus 420 DFGls~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~-~~t~ksDV~S~Gvvl~elltg~~p~~~~~~~~~------~~l~ 490 (608)
|||+++....... .......||+.|+|||++.+. .++.++|||||||+++||++|+.||........ ....
T Consensus 175 Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~l 254 (405)
T 3rgf_A 175 DMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQL 254 (405)
T ss_dssp CTTCCC----------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCCCC------CCCCHHHH
T ss_pred ECCCceecCCCCcccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCCccccccccccchHHHH
Confidence 9999987653221 223446789999999999874 589999999999999999999999964322100 0001
Q ss_pred HHHHHHhhh---hhhHH---------Hhh---h---------hhhccCChhHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 044312 491 AYFLCAMKE---ERLFE---------ILD---A---------RVMKQGGKDEIITVAKLAKRCLNLNGKKRPTMREVASE 546 (608)
Q Consensus 491 ~~~~~~~~~---~~~~~---------~~d---~---------~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~evl~~ 546 (608)
......+.. ..... ... . ..........+..+.+|+.+||+.||.+|||++|++++
T Consensus 255 ~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ll~~~L~~dP~~R~ta~e~L~h 334 (405)
T 3rgf_A 255 DRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAMQD 334 (405)
T ss_dssp HHHHHHHCCCCTTTCGGGGGSTTHHHHHHHCCGGGGTTCCHHHHHHTTTCCTTSHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred HHHHHhhCCCChhhcchhhcCcchhhhhhhccccCCCcchhhhhHhhcCCCCCHHHHHHHHHHccCCcccCCCHHHHhcC
Confidence 111111100 00000 000 0 00001111124578899999999999999999999976
Q ss_pred H
Q 044312 547 L 547 (608)
Q Consensus 547 L 547 (608)
-
T Consensus 335 p 335 (405)
T 3rgf_A 335 P 335 (405)
T ss_dssp G
T ss_pred h
Confidence 4
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-36 Score=320.45 Aligned_cols=241 Identities=14% Similarity=0.097 Sum_probs=170.2
Q ss_pred hcCccccceeccCce---------------EEEEEeecC---hhhHHHHHHHHHHHhhc--CCCCccceecccc------
Q 044312 288 TDNFDLNRILGQGGQ---------------AVKKSKVID---ESKVEEFINEVVILSQI--NHRNVVKLLGCCL------ 341 (608)
Q Consensus 288 t~~f~~~~~lG~G~~---------------avk~~~~~~---~~~~~~~~~Ei~il~~l--~H~niv~l~~~~~------ 341 (608)
..+|.+.+.||+|+| |||+++... ....+.+.+|+.+++.| +||||++++..+.
T Consensus 61 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~hp~iv~~~~~~~~p~d~~ 140 (371)
T 3q60_A 61 ERKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAV 140 (371)
T ss_dssp EEEEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC----------CBCCCCEEE
T ss_pred ceeeeeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcccChhhhhhceeEEeeehhe
Confidence 456889999999984 778777643 24456788886555444 6999888653332
Q ss_pred -cC-----------------ccceEEEeecCCCccchhccccCCCCCCCHHHH------HHHHHHHHHHHHHHhhcCCCC
Q 044312 342 -ET-----------------EVPLLVYEFIPNGTLFQYIHDQNEDFPITWEIR------LRIAIEVSGALSYLHSAASIP 397 (608)
Q Consensus 342 -~~-----------------~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~------~~i~~~ia~aL~yLH~~~~~~ 397 (608)
.. ...+|||||++ |+|.+++..... .+.+..+ +.++.||+.||+|||+++
T Consensus 141 ~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~--~~~~~~~~~~~vk~~i~~qi~~aL~~LH~~~--- 214 (371)
T 3q60_A 141 AVQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLDF--VYVFRGDEGILALHILTAQLIRLAANLQSKG--- 214 (371)
T ss_dssp EETTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHHHH--SCCCCHHHHHHHHHHHHHHHHHHHHHHHHTT---
T ss_pred ecCCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHhcc--ccchhhhhhhhhHHHHHHHHHHHHHHHHHCC---
Confidence 11 34799999998 899999987533 3455666 788899999999999999
Q ss_pred eeccCCCCCcEEEcCCCcEEEeeccCccccccCCcceeeeeeccCCCCChhhhcc--CCCCCccchHhHHHHHHHHHhCC
Q 044312 398 IYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHGTFGYLDPEYFRS--SQFTDKSDVYSFGVVLTELLTGE 475 (608)
Q Consensus 398 iiHrDlk~~NILl~~~~~~kl~DFGls~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~t~ksDV~S~Gvvl~elltg~ 475 (608)
|+||||||+|||++.++.+||+|||+++..... .....+|+.|+|||++.+ ..++.++||||||++||||++|+
T Consensus 215 ivHrDikp~NIll~~~~~~kL~DFG~a~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~il~elltg~ 290 (371)
T 3q60_A 215 LVHGHFTPDNLFIMPDGRLMLGDVSALWKVGTR----GPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLF 290 (371)
T ss_dssp EEETTCSGGGEEECTTSCEEECCGGGEEETTCE----EEGGGSCGGGCCHHHHTCSEEECCHHHHHHHHHHHHHHHHHSS
T ss_pred CccCcCCHHHEEECCCCCEEEEecceeeecCCC----ccCccCCcCCcChhhccCCCCCcCccccHHHHHHHHHHHHhCC
Confidence 999999999999999999999999999865421 224457799999999987 67999999999999999999999
Q ss_pred CCCCccchhhcccHHHHHHHHhhhhhhHHHhhhhhhccCChhHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 044312 476 KPIRFTILEEDKSLAAYFLCAMKEERLFEILDARVMKQGGKDEIITVAKLAKRCLNLNGKKRPTMREVASE 546 (608)
Q Consensus 476 ~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~evl~~ 546 (608)
.||.......... ......................+..+.+|+.+||+.||++|||+.|++++
T Consensus 291 ~Pf~~~~~~~~~~--------~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 353 (371)
T 3q60_A 291 LPFGLVTPGIKGS--------WKRPSLRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAMET 353 (371)
T ss_dssp CSTTBCCTTCTTC--------CCBCCTTSCCCCSCCCTTSSCCCHHHHHHHHHHTCSSTTTCCCHHHHTTS
T ss_pred CCCCCcCcccccc--------hhhhhhhhccccccchhhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 9997543221100 00000000001111111223456789999999999999999999999863
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-35 Score=316.84 Aligned_cols=247 Identities=22% Similarity=0.254 Sum_probs=179.6
Q ss_pred hcCccccceeccCce--------------EEEEEeecChhhHHHHHHHHHHHhhcCCCCccceecccccCc------cce
Q 044312 288 TDNFDLNRILGQGGQ--------------AVKKSKVIDESKVEEFINEVVILSQINHRNVVKLLGCCLETE------VPL 347 (608)
Q Consensus 288 t~~f~~~~~lG~G~~--------------avk~~~~~~~~~~~~~~~Ei~il~~l~H~niv~l~~~~~~~~------~~~ 347 (608)
..+|++.++||+|+| |+|+..... ....+|+.+|++++||||+++++++.... ..+
T Consensus 39 ~~~Y~~~~~lG~G~~g~V~~a~~~~~~~~aikk~~~~~----~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~~ 114 (394)
T 4e7w_A 39 EIAYTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQDK----RFKNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLN 114 (394)
T ss_dssp EEEEEEEEEEEEETTEEEEEEEETTTEEEEEEEEECCT----TSCCHHHHHHHTCCCTTBCCEEEEEEEESSSSSCEEEE
T ss_pred cceEEEeEEEeeCCCeEEEEEEECCCCeEEEEEEecCc----chHHHHHHHHHhCCCCCcceEEEEEEecCCCCCceEEE
Confidence 346899999999985 445443211 22347999999999999999999985433 378
Q ss_pred EEEeecCCCccchhccccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEEc-CCCcEEEeeccCccc
Q 044312 348 LVYEFIPNGTLFQYIHDQNEDFPITWEIRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLD-DKYRAKVSDFGASRS 426 (608)
Q Consensus 348 lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~-~~~~~kl~DFGls~~ 426 (608)
+||||++++.+............+++..+..++.||++||+|||+.+ |+||||||+|||++ .++.+||+|||+++.
T Consensus 115 lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~~kL~DFG~a~~ 191 (394)
T 4e7w_A 115 LVLEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSIG---ICHRDIKPQNLLLDPPSGVLKLIDFGSAKI 191 (394)
T ss_dssp EEEECCSEEHHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEETTTTEEEECCCTTCEE
T ss_pred EEeeccCccHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCCCHHHEEEcCCCCcEEEeeCCCccc
Confidence 99999977544333322222336999999999999999999999999 99999999999999 789999999999987
Q ss_pred cccCCcceeeeeeccCCCCChhhhccC-CCCCccchHhHHHHHHHHHhCCCCCCccchhhcccHHHHHHHHhhhhhhH--
Q 044312 427 MAVDQTHMTTQVHGTFGYLDPEYFRSS-QFTDKSDVYSFGVVLTELLTGEKPIRFTILEEDKSLAAYFLCAMKEERLF-- 503 (608)
Q Consensus 427 ~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~t~ksDV~S~Gvvl~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~-- 503 (608)
...... .....+|+.|+|||++.+. .++.++||||||++++||++|+.||......+. +... ..........
T Consensus 192 ~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~--l~~i-~~~~g~p~~~~~ 266 (394)
T 4e7w_A 192 LIAGEP--NVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQ--LVEI-IKVLGTPSREQI 266 (394)
T ss_dssp CCTTCC--CCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH--HHHH-HHHHCCCCHHHH
T ss_pred ccCCCC--CcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHH--HHHH-HHHhCCCCHHHH
Confidence 643322 2345689999999998765 589999999999999999999999974332211 1111 1111100000
Q ss_pred HHhhhhh-------------hccCChhHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 044312 504 EILDARV-------------MKQGGKDEIITVAKLAKRCLNLNGKKRPTMREVASE 546 (608)
Q Consensus 504 ~~~d~~~-------------~~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~evl~~ 546 (608)
....+.. ........+.++.+|+.+||+.||++|||+.|++++
T Consensus 267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 322 (394)
T 4e7w_A 267 KTMNPNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALCH 322 (394)
T ss_dssp HHHCGGGSSSCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHTS
T ss_pred HhhChhhhhhccccccCCcHHHhccccCCHHHHHHHHHHhCCChhhCCCHHHHhcC
Confidence 0001110 111222355689999999999999999999999875
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-35 Score=305.24 Aligned_cols=239 Identities=24% Similarity=0.345 Sum_probs=181.8
Q ss_pred HhcCccccceeccCce---------------EEEEEeecC--------hhhHHHHHHHHHHHhhcCCCCccceecccccC
Q 044312 287 ATDNFDLNRILGQGGQ---------------AVKKSKVID--------ESKVEEFINEVVILSQINHRNVVKLLGCCLET 343 (608)
Q Consensus 287 ~t~~f~~~~~lG~G~~---------------avk~~~~~~--------~~~~~~~~~Ei~il~~l~H~niv~l~~~~~~~ 343 (608)
..++|.+.+.||+|++ |||...... ......+.+|+.+|++++||||+++++++...
T Consensus 8 l~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~ 87 (322)
T 2ycf_A 8 LRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAE 87 (322)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEESS
T ss_pred hhhceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEcCC
Confidence 3457999999999984 666654321 12234688999999999999999999998665
Q ss_pred ccceEEEeecCCCccchhccccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEEcCCCc---EEEee
Q 044312 344 EVPLLVYEFIPNGTLFQYIHDQNEDFPITWEIRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYR---AKVSD 420 (608)
Q Consensus 344 ~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~---~kl~D 420 (608)
. .++||||+++++|.+++.... .+++..+..++.||+.||+|||+++ |+||||||+|||++.++. +||+|
T Consensus 88 ~-~~lv~e~~~~~~L~~~~~~~~---~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~NIl~~~~~~~~~~kl~D 160 (322)
T 2ycf_A 88 D-YYIVLELMEGGELFDKVVGNK---RLKEATCKLYFYQMLLAVQYLHENG---IIHRDLKPENVLLSSQEEDCLIKITD 160 (322)
T ss_dssp S-EEEEEECCTTEETHHHHSTTC---CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESSSSSSCCEEECC
T ss_pred c-eEEEEecCCCCcHHHHHhccC---CCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEEecCCCCCeEEEcc
Confidence 4 899999999999999887543 5899999999999999999999999 999999999999987654 99999
Q ss_pred ccCccccccCCcceeeeeeccCCCCChhhhc---cCCCCCccchHhHHHHHHHHHhCCCCCCccchhhcccHHHHHHHHh
Q 044312 421 FGASRSMAVDQTHMTTQVHGTFGYLDPEYFR---SSQFTDKSDVYSFGVVLTELLTGEKPIRFTILEEDKSLAAYFLCAM 497 (608)
Q Consensus 421 FGls~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~t~ksDV~S~Gvvl~elltg~~p~~~~~~~~~~~l~~~~~~~~ 497 (608)
||+++...... ......||+.|+|||++. ...++.++||||||++++||++|+.||....... .+....
T Consensus 161 fg~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~--~~~~~~---- 232 (322)
T 2ycf_A 161 FGHSKILGETS--LMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQV--SLKDQI---- 232 (322)
T ss_dssp CTTCEECCCCH--HHHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTCSS--CHHHHH----
T ss_pred Cccceeccccc--ccccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchHH--HHHHHH----
Confidence 99998764321 223456899999999974 5678999999999999999999999996432211 111111
Q ss_pred hhhhhHHHhhhhhhccCChhHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 044312 498 KEERLFEILDARVMKQGGKDEIITVAKLAKRCLNLNGKKRPTMREVASE 546 (608)
Q Consensus 498 ~~~~~~~~~d~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~evl~~ 546 (608)
...... . .+.. ....+..+.+|+.+||+.||++|||+.|++++
T Consensus 233 ~~~~~~-~-~~~~----~~~~~~~~~~li~~~l~~dP~~Rps~~~~l~h 275 (322)
T 2ycf_A 233 TSGKYN-F-IPEV----WAEVSEKALDLVKKLLVVDPKARFTTEEALRH 275 (322)
T ss_dssp HHTCCC-C-CHHH----HTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred HhCccc-c-Cchh----hhhcCHHHHHHHHHHcccCHhhCCCHHHHhhC
Confidence 111000 0 0000 11335678999999999999999999999864
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-35 Score=304.88 Aligned_cols=250 Identities=25% Similarity=0.351 Sum_probs=187.9
Q ss_pred HHhcCccccceeccCce----------------EEEEEeecC--hhhHHHHHHHHHHHhhc---CCCCccceecccc---
Q 044312 286 KATDNFDLNRILGQGGQ----------------AVKKSKVID--ESKVEEFINEVVILSQI---NHRNVVKLLGCCL--- 341 (608)
Q Consensus 286 ~~t~~f~~~~~lG~G~~----------------avk~~~~~~--~~~~~~~~~Ei~il~~l---~H~niv~l~~~~~--- 341 (608)
.+.++|++.+.||+|++ |||+.+... ......+.+|+.+++++ +||||+++++++.
T Consensus 8 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~ 87 (326)
T 1blx_A 8 RADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSR 87 (326)
T ss_dssp CGGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEE
T ss_pred CchhceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCeEeeeeeeeecc
Confidence 35678999999999874 566554322 22234677788877766 8999999999987
Q ss_pred --cCccceEEEeecCCCccchhccccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEEcCCCcEEEe
Q 044312 342 --ETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEIRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVS 419 (608)
Q Consensus 342 --~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~ 419 (608)
.....++||||++ |+|.+++...... .+++..++.++.||+.||+|||+.+ |+||||||+|||++.++.+||+
T Consensus 88 ~~~~~~~~lv~e~~~-~~L~~~l~~~~~~-~~~~~~~~~~~~qi~~~l~~lH~~g---i~H~dlkp~Nili~~~~~~kl~ 162 (326)
T 1blx_A 88 TDRETKLTLVFEHVD-QDLTTYLDKVPEP-GVPTETIKDMMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLA 162 (326)
T ss_dssp CSSEEEEEEEEECCS-CBHHHHHHHSCTT-CSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEEC
T ss_pred cCCCceEEEEEecCC-CCHHHHHHhcccC-CCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCCHHHeEEcCCCCEEEe
Confidence 5667899999997 6999998765432 4899999999999999999999999 9999999999999999999999
Q ss_pred eccCccccccCCcceeeeeeccCCCCChhhhccCCCCCccchHhHHHHHHHHHhCCCCCCccchhhcccHHHHHHHHhhh
Q 044312 420 DFGASRSMAVDQTHMTTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLTELLTGEKPIRFTILEEDKSLAAYFLCAMKE 499 (608)
Q Consensus 420 DFGls~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~elltg~~p~~~~~~~~~~~l~~~~~~~~~~ 499 (608)
|||+++...... ......||+.|+|||.+.+..++.++||||||++++||++|+.||....... ...........
T Consensus 163 Dfg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~---~~~~i~~~~~~ 237 (326)
T 1blx_A 163 DFGLARIYSFQM--ALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVD---QLGKILDVIGL 237 (326)
T ss_dssp SCCSCCCCCGGG--GGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH---HHHHHHHHHCC
T ss_pred cCcccccccCCC--CccccccccceeCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCHHH---HHHHHHHHcCC
Confidence 999998765322 2344568999999999999999999999999999999999999997433211 11111111100
Q ss_pred ---hhhHHHh----------hhhhhccCChhHHHHHHHHHHHHhccCCCCCCCHHHHHH
Q 044312 500 ---ERLFEIL----------DARVMKQGGKDEIITVAKLAKRCLNLNGKKRPTMREVAS 545 (608)
Q Consensus 500 ---~~~~~~~----------d~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~evl~ 545 (608)
....... ............+..+.+|+.+||+.||++|||+.|+++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 296 (326)
T 1blx_A 238 PGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS 296 (326)
T ss_dssp CCGGGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred CCcccCccccccchhhhcccCcchhhhccccCCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence 0000000 000011122345678999999999999999999999985
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-35 Score=308.85 Aligned_cols=249 Identities=21% Similarity=0.299 Sum_probs=186.1
Q ss_pred HhcCccccceeccCce---------------EEEEEeec-ChhhHHHHHHHHHHHhhcCCCCccceecccccC-----cc
Q 044312 287 ATDNFDLNRILGQGGQ---------------AVKKSKVI-DESKVEEFINEVVILSQINHRNVVKLLGCCLET-----EV 345 (608)
Q Consensus 287 ~t~~f~~~~~lG~G~~---------------avk~~~~~-~~~~~~~~~~Ei~il~~l~H~niv~l~~~~~~~-----~~ 345 (608)
..++|.+.+.||+|++ |||+.... .......+.+|+.++++++||||+++++++... ..
T Consensus 9 i~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 88 (353)
T 2b9h_A 9 ISSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENIITIFNIQRPDSFENFNE 88 (353)
T ss_dssp SCTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTTCCC
T ss_pred cccceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeecccccchHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCccce
Confidence 3568999999999974 67766543 334466789999999999999999999987654 67
Q ss_pred ceEEEeecCCCccchhccccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEEcCCCcEEEeeccCcc
Q 044312 346 PLLVYEFIPNGTLFQYIHDQNEDFPITWEIRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASR 425 (608)
Q Consensus 346 ~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGls~ 425 (608)
.++||||+. ++|.+++... .+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++
T Consensus 89 ~~lv~e~~~-~~L~~~~~~~----~~~~~~~~~~~~qi~~~L~~LH~~~---ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~ 160 (353)
T 2b9h_A 89 VYIIQELMQ-TDLHRVISTQ----MLSDDHIQYFIYQTLRAVKVLHGSN---VIHRDLKPSNLLINSNCDLKVCDFGLAR 160 (353)
T ss_dssp EEEEECCCS-EEHHHHHHHC----CCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTCCEEECCCTTCE
T ss_pred EEEEEeccC-ccHHHHHhhc----CCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEEcCCCcEEEEeccccc
Confidence 899999996 6999988753 4899999999999999999999999 9999999999999999999999999998
Q ss_pred ccccCCcc---------eeeeeeccCCCCChhhhcc-CCCCCccchHhHHHHHHHHHhCCCCCCccchhhcccHHHHHHH
Q 044312 426 SMAVDQTH---------MTTQVHGTFGYLDPEYFRS-SQFTDKSDVYSFGVVLTELLTGEKPIRFTILEEDKSLAAYFLC 495 (608)
Q Consensus 426 ~~~~~~~~---------~~~~~~gt~~y~aPE~~~~-~~~t~ksDV~S~Gvvl~elltg~~p~~~~~~~~~~~l~~~~~~ 495 (608)
........ ......||+.|+|||++.. ..++.++||||||++++||++|+.||........ +. ....
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~--~~-~~~~ 237 (353)
T 2b9h_A 161 IIDESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQ--LL-LIFG 237 (353)
T ss_dssp ECC----------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHH--HH-HHHH
T ss_pred ccccccccccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCCCcHHH--HH-HHHH
Confidence 76532211 1123468999999998764 6789999999999999999999999974332211 11 1111
Q ss_pred Hhhh------------hhhHHHhhhhh------hccCChhHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 044312 496 AMKE------------ERLFEILDARV------MKQGGKDEIITVAKLAKRCLNLNGKKRPTMREVASE 546 (608)
Q Consensus 496 ~~~~------------~~~~~~~d~~~------~~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~evl~~ 546 (608)
.... ....+.+.... ........+.++.+|+.+||+.||++|||+.|++++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 306 (353)
T 2b9h_A 238 IIGTPHSDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALEH 306 (353)
T ss_dssp HHCCCCSTTTTTTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred HhCCCchhccccccccchhhHHhhcccCCCCcchhhhcccCCHHHHHHHHHhcCcCcccCCCHHHHhcC
Confidence 1000 00011110000 000112345678999999999999999999999864
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-35 Score=316.95 Aligned_cols=244 Identities=23% Similarity=0.299 Sum_probs=179.1
Q ss_pred cCccccceeccCce---------------EEEEEeecChhhHHHHHHHHHHHhhcCCCCccceecccccC------ccce
Q 044312 289 DNFDLNRILGQGGQ---------------AVKKSKVIDESKVEEFINEVVILSQINHRNVVKLLGCCLET------EVPL 347 (608)
Q Consensus 289 ~~f~~~~~lG~G~~---------------avk~~~~~~~~~~~~~~~Ei~il~~l~H~niv~l~~~~~~~------~~~~ 347 (608)
.+|++.+.||+|+| |||++... ...+.+|+++|++++|||||++++++... ...+
T Consensus 54 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~----~~~~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~~~~~ 129 (420)
T 1j1b_A 54 VSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQD----KRFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLN 129 (420)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC----TTSCCHHHHHHHTCCCTTBCCEEEEEEEEETTTTEEEEE
T ss_pred ceEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEeccc----chhHHHHHHHHHHcCCCCccceeeEEeccCCCCcceeEE
Confidence 46889999999985 66665432 12345799999999999999999988432 2367
Q ss_pred EEEeecCCCccchhcccc-CCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEEcCC-CcEEEeeccCcc
Q 044312 348 LVYEFIPNGTLFQYIHDQ-NEDFPITWEIRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDK-YRAKVSDFGASR 425 (608)
Q Consensus 348 lV~E~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~-~~~kl~DFGls~ 425 (608)
+||||+++ +|.+.+... .....+++..+..++.||++||+|||+.+ |+||||||+|||++.+ +.+||+|||+++
T Consensus 130 lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NILl~~~~~~~kl~DFG~a~ 205 (420)
T 1j1b_A 130 LVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAK 205 (420)
T ss_dssp EEEECCCE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTT---EECSCCSGGGEEEETTTTEEEECCCTTCE
T ss_pred eehhcccc-cHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChhhEEEeCCCCeEEeccchhhh
Confidence 99999975 666665431 12236999999999999999999999999 9999999999999954 678999999998
Q ss_pred ccccCCcceeeeeeccCCCCChhhhccC-CCCCccchHhHHHHHHHHHhCCCCCCccchhhcccHHHHHHHHhhh---hh
Q 044312 426 SMAVDQTHMTTQVHGTFGYLDPEYFRSS-QFTDKSDVYSFGVVLTELLTGEKPIRFTILEEDKSLAAYFLCAMKE---ER 501 (608)
Q Consensus 426 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~t~ksDV~S~Gvvl~elltg~~p~~~~~~~~~~~l~~~~~~~~~~---~~ 501 (608)
....... .....||+.|+|||++.+. .++.++|||||||+|+||++|+.||......+ .+... ...+.. +.
T Consensus 206 ~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~--~l~~i-~~~lg~p~~~~ 280 (420)
T 1j1b_A 206 QLVRGEP--NVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVD--QLVEI-IKVLGTPTREQ 280 (420)
T ss_dssp ECCTTCC--CCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH--HHHHH-HHHHCSCCHHH
T ss_pred hcccCCC--ceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHH--HHHHH-HHHhCCCCHHH
Confidence 7643322 2345689999999998765 79999999999999999999999997432211 11111 111111 11
Q ss_pred hHHHhhhh-------------hhccCChhHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 044312 502 LFEILDAR-------------VMKQGGKDEIITVAKLAKRCLNLNGKKRPTMREVASE 546 (608)
Q Consensus 502 ~~~~~d~~-------------~~~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~evl~~ 546 (608)
+..+ .+. +........+.++.+|+.+||+.||++|||+.|++++
T Consensus 281 ~~~~-~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t~~e~l~h 337 (420)
T 1j1b_A 281 IREM-NPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAH 337 (420)
T ss_dssp HHHH-CSCCCCCCCCCCCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred HHhh-ChhhhhhccCccCCCCHHHhcCCCCCHHHHHHHHHhccCChhHCCCHHHHhCC
Confidence 1110 000 0001122345789999999999999999999999875
|
| >4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-35 Score=308.58 Aligned_cols=243 Identities=23% Similarity=0.311 Sum_probs=182.9
Q ss_pred HhcCccccceeccCce---------------EEEEEeec--ChhhHHHHHHHHHHHhhcCCCCccceecccccCccc---
Q 044312 287 ATDNFDLNRILGQGGQ---------------AVKKSKVI--DESKVEEFINEVVILSQINHRNVVKLLGCCLETEVP--- 346 (608)
Q Consensus 287 ~t~~f~~~~~lG~G~~---------------avk~~~~~--~~~~~~~~~~Ei~il~~l~H~niv~l~~~~~~~~~~--- 346 (608)
..++|.+.+.||+|++ |||+.... .....+.+.+|+.++++++||||+++++++......
T Consensus 40 l~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 119 (371)
T 4exu_A 40 LPKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNF 119 (371)
T ss_dssp EETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSSTTC
T ss_pred ccccEEEEeEEecCCCeEEEEEEECCCCCEEEEEEecccccchhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCcccc
Confidence 3568999999999984 67766542 334467899999999999999999999999877655
Q ss_pred ---eEEEeecCCCccchhccccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEEcCCCcEEEeeccC
Q 044312 347 ---LLVYEFIPNGTLFQYIHDQNEDFPITWEIRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGA 423 (608)
Q Consensus 347 ---~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGl 423 (608)
++||||+. ++|.+++.. .+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+
T Consensus 120 ~~~~lv~e~~~-~~l~~~~~~-----~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIll~~~~~~kL~Dfg~ 190 (371)
T 4exu_A 120 YDFYLVMPFMQ-TDLQKIMGM-----EFSEEKIQYLVYQMLKGLKYIHSAG---VVHRDLKPGNLAVNEDCELKILDFGL 190 (371)
T ss_dssp CCCEEEEECCC-EEHHHHTTS-----CCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECSTTC
T ss_pred eeEEEEEcccc-ccHHHHhhc-----CCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCcCHHHeEECCCCCEEEEecCc
Confidence 99999996 688877732 3899999999999999999999999 99999999999999999999999999
Q ss_pred ccccccCCcceeeeeeccCCCCChhhhcc-CCCCCccchHhHHHHHHHHHhCCCCCCccchhhcccHHHHHHHHhh----
Q 044312 424 SRSMAVDQTHMTTQVHGTFGYLDPEYFRS-SQFTDKSDVYSFGVVLTELLTGEKPIRFTILEEDKSLAAYFLCAMK---- 498 (608)
Q Consensus 424 s~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~t~ksDV~S~Gvvl~elltg~~p~~~~~~~~~~~l~~~~~~~~~---- 498 (608)
++..... .....||+.|+|||++.+ ..++.++||||||++++||++|+.||......+. +. .......
T Consensus 191 a~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~--~~-~i~~~~~~~~~ 263 (371)
T 4exu_A 191 ARHADAE----MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQ--LT-QILKVTGVPGT 263 (371)
T ss_dssp C------------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHH--HH-HHHHHHCCCCH
T ss_pred ccccccC----cCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCChHHH--HH-HHHHHhCCCcH
Confidence 9865422 234568999999999987 6899999999999999999999999974332111 11 1110000
Q ss_pred -------hhhhHHHhhhhhhc-------cCChhHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 044312 499 -------EERLFEILDARVMK-------QGGKDEIITVAKLAKRCLNLNGKKRPTMREVASE 546 (608)
Q Consensus 499 -------~~~~~~~~d~~~~~-------~~~~~~~~~l~~Li~~cl~~dp~~RPs~~evl~~ 546 (608)
.......... ... ......+..+.+|+.+||+.||++|||+.|++++
T Consensus 264 ~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 324 (371)
T 4exu_A 264 EFVQKLNDKAAKSYIQS-LPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTH 324 (371)
T ss_dssp HHHTTCSCHHHHHHHHH-SCCCCCCCHHHHSTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred HHHHHhhhhhhhhhhhc-cCCCcchhHHHhccccChHHHHHHHHHCCCChhhcCCHHHHhcC
Confidence 0000000000 000 0012345689999999999999999999999864
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-34 Score=303.90 Aligned_cols=243 Identities=23% Similarity=0.299 Sum_probs=182.6
Q ss_pred hcCccccceeccCce---------------EEEEEee--cChhhHHHHHHHHHHHhhcCCCCccceecccccCcc-----
Q 044312 288 TDNFDLNRILGQGGQ---------------AVKKSKV--IDESKVEEFINEVVILSQINHRNVVKLLGCCLETEV----- 345 (608)
Q Consensus 288 t~~f~~~~~lG~G~~---------------avk~~~~--~~~~~~~~~~~Ei~il~~l~H~niv~l~~~~~~~~~----- 345 (608)
.++|.+.+.||+|++ |||+... ......+.+.+|+.++++++||||+++++++.....
T Consensus 23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 102 (353)
T 3coi_A 23 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFY 102 (353)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCC
T ss_pred CceEEEeeeEecCCCeEEEEEEECCCCCEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCcccHhheEecccccccce
Confidence 357889999999984 6666643 233446789999999999999999999999987654
Q ss_pred -ceEEEeecCCCccchhccccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEEcCCCcEEEeeccCc
Q 044312 346 -PLLVYEFIPNGTLFQYIHDQNEDFPITWEIRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGAS 424 (608)
Q Consensus 346 -~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGls 424 (608)
.++||||+. ++|.+++.. .+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||++
T Consensus 103 ~~~lv~e~~~-~~l~~~~~~-----~~~~~~~~~i~~qi~~al~~LH~~~---ivH~dlkp~NIl~~~~~~~kl~Dfg~~ 173 (353)
T 3coi_A 103 DFYLVMPFMQ-TDLQKIMGL-----KFSEEKIQYLVYQMLKGLKYIHSAG---VVHRDLKPGNLAVNEDCELKILDFGLA 173 (353)
T ss_dssp CCEEEEECCS-EEGGGTTTS-----CCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCCGGGEEECTTCCEEECSTTCT
T ss_pred eEEEEecccc-CCHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEeECCCCcEEEeecccc
Confidence 499999996 688887742 3899999999999999999999999 999999999999999999999999999
Q ss_pred cccccCCcceeeeeeccCCCCChhhhcc-CCCCCccchHhHHHHHHHHHhCCCCCCccchhhcccHHHHHHHHhh-----
Q 044312 425 RSMAVDQTHMTTQVHGTFGYLDPEYFRS-SQFTDKSDVYSFGVVLTELLTGEKPIRFTILEEDKSLAAYFLCAMK----- 498 (608)
Q Consensus 425 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~t~ksDV~S~Gvvl~elltg~~p~~~~~~~~~~~l~~~~~~~~~----- 498 (608)
+..... .....+|+.|+|||.+.+ ..++.++||||||++++||++|+.||......+. .........
T Consensus 174 ~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~---~~~i~~~~~~~~~~ 246 (353)
T 3coi_A 174 RHADAE----MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQ---LTQILKVTGVPGTE 246 (353)
T ss_dssp TC------------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSSCHHHH---HHHHHHHHCBCCHH
T ss_pred cCCCCC----ccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH---HHHHHHHhCCCCHH
Confidence 865422 234568999999999887 6789999999999999999999999974332211 111111100
Q ss_pred ------hhhhHHHhhhh---h---hccCChhHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 044312 499 ------EERLFEILDAR---V---MKQGGKDEIITVAKLAKRCLNLNGKKRPTMREVASE 546 (608)
Q Consensus 499 ------~~~~~~~~d~~---~---~~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~evl~~ 546 (608)
.......+... . ........+.++.+|+.+||+.||++|||+.|++++
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~h 306 (353)
T 3coi_A 247 FVQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTH 306 (353)
T ss_dssp HHTTCSCHHHHHHHHTSCBCSSCCTTTTCTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred HHHHHhhHHHHHHHHhCcCCCCccHHHhcCCcCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence 00000011000 0 001123456789999999999999999999999864
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-34 Score=303.34 Aligned_cols=246 Identities=20% Similarity=0.273 Sum_probs=186.0
Q ss_pred hcCccccceeccCce----------------EEEEEeecChhhHHHHHHHHHHHhhcCCCC------ccceecccccCcc
Q 044312 288 TDNFDLNRILGQGGQ----------------AVKKSKVIDESKVEEFINEVVILSQINHRN------VVKLLGCCLETEV 345 (608)
Q Consensus 288 t~~f~~~~~lG~G~~----------------avk~~~~~~~~~~~~~~~Ei~il~~l~H~n------iv~l~~~~~~~~~ 345 (608)
.++|++.+.||+|++ |||..+. .....+.+.+|+.++++++|++ ++.+++++.....
T Consensus 18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~-~~~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~ 96 (355)
T 2eu9_A 18 QERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRN-VGKYREAARLEINVLKKIKEKDKENKFLCVLMSDWFNFHGH 96 (355)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECS-CHHHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEEEETTE
T ss_pred cccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEcc-cccchhHHHHHHHHHHHHhhcCCCCceeEEEeeeeeeeCCe
Confidence 467999999999974 4555442 2345678889999999998766 8999999999999
Q ss_pred ceEEEeecCCCccchhccccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEE---------------
Q 044312 346 PLLVYEFIPNGTLFQYIHDQNEDFPITWEIRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILL--------------- 410 (608)
Q Consensus 346 ~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl--------------- 410 (608)
.+|||||+ +++|.+++..... .++++..++.++.||+.||+|||+.+ |+||||||+|||+
T Consensus 97 ~~lv~e~~-~~~l~~~l~~~~~-~~~~~~~~~~i~~qi~~~L~~lH~~~---ivH~Dlkp~NIll~~~~~~~~~~~~~~~ 171 (355)
T 2eu9_A 97 MCIAFELL-GKNTFEFLKENNF-QPYPLPHVRHMAYQLCHALRFLHENQ---LTHTDLKPENILFVNSEFETLYNEHKSC 171 (355)
T ss_dssp EEEEEECC-CCBHHHHHHHTTT-CCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEESCCCEEEEECCC-CC
T ss_pred EEEEEecc-CCChHHHHHhccC-CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEecccccccccccccc
Confidence 99999999 6677777765432 25899999999999999999999999 9999999999999
Q ss_pred ----cCCCcEEEeeccCccccccCCcceeeeeeccCCCCChhhhccCCCCCccchHhHHHHHHHHHhCCCCCCccchhhc
Q 044312 411 ----DDKYRAKVSDFGASRSMAVDQTHMTTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLTELLTGEKPIRFTILEED 486 (608)
Q Consensus 411 ----~~~~~~kl~DFGls~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~elltg~~p~~~~~~~~~ 486 (608)
+.++.+||+|||+++..... .....||+.|+|||++.+..++.++||||||++++||++|+.||......+.
T Consensus 172 ~~~~~~~~~~kl~Dfg~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~ 247 (355)
T 2eu9_A 172 EEKSVKNTSIRVADFGSATFDHEH----HTTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGFTLFQTHENREH 247 (355)
T ss_dssp CEEEESCCCEEECCCTTCEETTSC----CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH
T ss_pred cccccCCCcEEEeecCcccccccc----ccCCcCCCcccCCeeeecCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHH
Confidence 56789999999999864432 2345689999999999999999999999999999999999999974432221
Q ss_pred ccHHHHHHHHhhhh--hhH-----------------------HHhhh-----hhhccCChhHHHHHHHHHHHHhccCCCC
Q 044312 487 KSLAAYFLCAMKEE--RLF-----------------------EILDA-----RVMKQGGKDEIITVAKLAKRCLNLNGKK 536 (608)
Q Consensus 487 ~~l~~~~~~~~~~~--~~~-----------------------~~~d~-----~~~~~~~~~~~~~l~~Li~~cl~~dp~~ 536 (608)
. ..+....... .+. ..+.. ..........+.++.+|+.+||+.||++
T Consensus 248 ~---~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~ 324 (355)
T 2eu9_A 248 L---VMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDLMRRMLEFDPAQ 324 (355)
T ss_dssp H---HHHHHHHCCCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTT
T ss_pred H---HHHHHHcCCCcHHHhhhccchhhhcccccccccccchhccccccCCcccccccccchhHHHHHHHHHHHhcCChhh
Confidence 1 1111110000 000 00000 0001122345668999999999999999
Q ss_pred CCCHHHHHHH
Q 044312 537 RPTMREVASE 546 (608)
Q Consensus 537 RPs~~evl~~ 546 (608)
|||+.|++++
T Consensus 325 Rpt~~e~l~h 334 (355)
T 2eu9_A 325 RITLAEALLH 334 (355)
T ss_dssp SCCHHHHTTS
T ss_pred CcCHHHHhcC
Confidence 9999999753
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-34 Score=305.80 Aligned_cols=247 Identities=23% Similarity=0.291 Sum_probs=186.0
Q ss_pred hcCccccceeccCce---------------EEEEEeecChhhHHHHHHHHHHHhhcC-----------CCCccceecccc
Q 044312 288 TDNFDLNRILGQGGQ---------------AVKKSKVIDESKVEEFINEVVILSQIN-----------HRNVVKLLGCCL 341 (608)
Q Consensus 288 t~~f~~~~~lG~G~~---------------avk~~~~~~~~~~~~~~~Ei~il~~l~-----------H~niv~l~~~~~ 341 (608)
.++|.+.+.||+|++ |||.... +....+.+.+|+.++++++ |+||+++++++.
T Consensus 18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~-~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~~~~~ 96 (373)
T 1q8y_A 18 DARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRG-DKVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFN 96 (373)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECS-CHHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEE
T ss_pred CCeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecC-CccchhhhhHHHHHHHHhhcccccchhccccchHHHHHHHhh
Confidence 357999999999985 5665542 3345677899999999886 899999999987
Q ss_pred cCc----cceEEEeecCCCccchhccccCCCCCCCHHHHHHHHHHHHHHHHHHhhc-CCCCeeccCCCCCcEEEc-----
Q 044312 342 ETE----VPLLVYEFIPNGTLFQYIHDQNEDFPITWEIRLRIAIEVSGALSYLHSA-ASIPIYHRDIKSTNILLD----- 411 (608)
Q Consensus 342 ~~~----~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~-~~~~iiHrDlk~~NILl~----- 411 (608)
... ..++|||++ +++|.+++...... .+++..+..++.||+.||+|||++ + |+||||||+|||++
T Consensus 97 ~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~-~~~~~~~~~i~~qi~~aL~~lH~~~~---ivH~Dikp~NIll~~~~~~ 171 (373)
T 1q8y_A 97 HKGPNGVHVVMVFEVL-GENLLALIKKYEHR-GIPLIYVKQISKQLLLGLDYMHRRCG---IIHTDIKPENVLMEIVDSP 171 (373)
T ss_dssp EEETTEEEEEEEECCC-CEEHHHHHHHTTTS-CCCHHHHHHHHHHHHHHHHHHHHTTC---EECSCCSGGGEEEEEEETT
T ss_pred ccCCCCceEEEEEecC-CCCHHHHHHHhhcc-CCcHHHHHHHHHHHHHHHHHHHhcCC---EEecCCChHHeEEeccCCC
Confidence 654 789999999 88999999864332 589999999999999999999998 8 99999999999994
Q ss_pred -CCCcEEEeeccCccccccCCcceeeeeeccCCCCChhhhccCCCCCccchHhHHHHHHHHHhCCCCCCccchhhcccHH
Q 044312 412 -DKYRAKVSDFGASRSMAVDQTHMTTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLTELLTGEKPIRFTILEEDKSLA 490 (608)
Q Consensus 412 -~~~~~kl~DFGls~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~elltg~~p~~~~~~~~~~~l~ 490 (608)
..+.+||+|||+++..... .....||+.|+|||++.+..++.++||||||++++||++|+.||............
T Consensus 172 ~~~~~~kl~Dfg~a~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~ 247 (373)
T 1q8y_A 172 ENLIQIKIADLGNACWYDEH----YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDD 247 (373)
T ss_dssp TTEEEEEECCCTTCEETTBC----CCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHH
T ss_pred cCcceEEEcccccccccCCC----CCCCCCCccccCcHHHhCCCCCchHhHHHHHHHHHHHHhCCCCCCCCcccccCChH
Confidence 4458999999999876432 23346899999999999999999999999999999999999999743321111001
Q ss_pred ---HHHHHHhhhhh------------------------------hHHHhhhhhhccCChhHHHHHHHHHHHHhccCCCCC
Q 044312 491 ---AYFLCAMKEER------------------------------LFEILDARVMKQGGKDEIITVAKLAKRCLNLNGKKR 537 (608)
Q Consensus 491 ---~~~~~~~~~~~------------------------------~~~~~d~~~~~~~~~~~~~~l~~Li~~cl~~dp~~R 537 (608)
........... +..++. .....+...+.++.+|+.+||+.||++|
T Consensus 248 ~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~li~~~L~~dP~~R 325 (373)
T 1q8y_A 248 DHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLT--EKYKFSKDEAKEISDFLSPMLQLDPRKR 325 (373)
T ss_dssp HHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHH--HTTCCCHHHHHHHHHHHGGGGCSSTTTC
T ss_pred HHHHHHHHhcCCCCHHHHhccchhhhhcCCcchhcccccccccchhhhhh--hcccCCcchHHHHHHHHHHHhccCcccc
Confidence 11111110000 000010 1123445678899999999999999999
Q ss_pred CCHHHHHHH
Q 044312 538 PTMREVASE 546 (608)
Q Consensus 538 Ps~~evl~~ 546 (608)
||+.||+++
T Consensus 326 pt~~ell~h 334 (373)
T 1q8y_A 326 ADAGGLVNH 334 (373)
T ss_dssp BCHHHHHTC
T ss_pred CCHHHHhhC
Confidence 999999864
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-34 Score=295.42 Aligned_cols=238 Identities=26% Similarity=0.378 Sum_probs=188.0
Q ss_pred HhcCccccceeccCce---------------EEEEEeec--ChhhHHHHHHHHHHHhhcCCCCccceecccccCccceEE
Q 044312 287 ATDNFDLNRILGQGGQ---------------AVKKSKVI--DESKVEEFINEVVILSQINHRNVVKLLGCCLETEVPLLV 349 (608)
Q Consensus 287 ~t~~f~~~~~lG~G~~---------------avk~~~~~--~~~~~~~~~~Ei~il~~l~H~niv~l~~~~~~~~~~~lV 349 (608)
..++|++.+.||+|++ |||..... .....+.+.+|+.++++++||||+++++++.+....++|
T Consensus 20 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 99 (287)
T 2wei_A 20 FAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIV 99 (287)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBSSSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred HhhcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHHHHHhccCCCccEEEEEEeCCCeEEEE
Confidence 3457999999999974 66666432 234578899999999999999999999999999999999
Q ss_pred EeecCCCccchhccccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEEcCC---CcEEEeeccCccc
Q 044312 350 YEFIPNGTLFQYIHDQNEDFPITWEIRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDK---YRAKVSDFGASRS 426 (608)
Q Consensus 350 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~---~~~kl~DFGls~~ 426 (608)
|||+++++|.+++.... .+++..++.++.||+.||.|||+.+ ++||||||+|||++.+ +.+||+|||+++.
T Consensus 100 ~e~~~~~~L~~~l~~~~---~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~~~~ 173 (287)
T 2wei_A 100 GELYTGGELFDEIIKRK---RFSEHDAARIIKQVFSGITYMHKHN---IVHRDLKPENILLESKEKDCDIKIIDFGLSTC 173 (287)
T ss_dssp ECCCCSCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESCSSTTCCEEECSTTGGGT
T ss_pred EEccCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCChhhEEEecCCCcccEEEeccCccee
Confidence 99999999999887643 4899999999999999999999999 9999999999999754 4799999999987
Q ss_pred cccCCcceeeeeeccCCCCChhhhccCCCCCccchHhHHHHHHHHHhCCCCCCccchhhcccHHHHHHHHhhhhhhHHHh
Q 044312 427 MAVDQTHMTTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLTELLTGEKPIRFTILEEDKSLAAYFLCAMKEERLFEIL 506 (608)
Q Consensus 427 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 506 (608)
...... .....+|+.|+|||.+.+ .++.++||||||+++++|++|+.||....... ....+......
T Consensus 174 ~~~~~~--~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~-------~~~~~~~~~~~--- 240 (287)
T 2wei_A 174 FQQNTK--MKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNEYD-------ILKRVETGKYA--- 240 (287)
T ss_dssp BCCCSS--CSCHHHHHTTCCHHHHTT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH-------HHHHHHHCCCC---
T ss_pred ecCCCc--cccccCcccccChHHhcC-CCCCchhhHhHHHHHHHHHhCCCCCCCCCHHH-------HHHHHHcCCCC---
Confidence 643321 233458899999999875 48999999999999999999999987432111 11111111000
Q ss_pred hhhhhccCChhHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 044312 507 DARVMKQGGKDEIITVAKLAKRCLNLNGKKRPTMREVASE 546 (608)
Q Consensus 507 d~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~evl~~ 546 (608)
.........+.++.+|+.+||+.||++|||+.|++++
T Consensus 241 ---~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h 277 (287)
T 2wei_A 241 ---FDLPQWRTISDDAKDLIRKMLTFHPSLRITATQCLEH 277 (287)
T ss_dssp ---CCSGGGTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHS
T ss_pred ---CCchhhhhcCHHHHHHHHHHcccChhhCcCHHHHhcC
Confidence 0000112345679999999999999999999999874
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-34 Score=306.06 Aligned_cols=187 Identities=26% Similarity=0.388 Sum_probs=157.5
Q ss_pred HHHhcCccccceeccCce---------------EEEEEeecChhhHHHHHHHHHHHhhcC-CC-----CccceecccccC
Q 044312 285 EKATDNFDLNRILGQGGQ---------------AVKKSKVIDESKVEEFINEVVILSQIN-HR-----NVVKLLGCCLET 343 (608)
Q Consensus 285 ~~~t~~f~~~~~lG~G~~---------------avk~~~~~~~~~~~~~~~Ei~il~~l~-H~-----niv~l~~~~~~~ 343 (608)
+...++|++.+.||+|++ |||+++. .....+++.+|+.+++.++ |+ +|+++++++...
T Consensus 50 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~-~~~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~~~~ 128 (382)
T 2vx3_A 50 EKWMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKN-KKAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMFR 128 (382)
T ss_dssp CEETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECS-SHHHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEEEET
T ss_pred CEeeeeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEec-cHHHHHHHHHHHHHHHHHHhcccccceeEEEeeeeeccC
Confidence 445678999999999984 6666653 3344677888999998884 55 499999999999
Q ss_pred ccceEEEeecCCCccchhccccCCCCCCCHHHHHHHHHHHHHHHHHHhh--cCCCCeeccCCCCCcEEEc--CCCcEEEe
Q 044312 344 EVPLLVYEFIPNGTLFQYIHDQNEDFPITWEIRLRIAIEVSGALSYLHS--AASIPIYHRDIKSTNILLD--DKYRAKVS 419 (608)
Q Consensus 344 ~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~--~~~~~iiHrDlk~~NILl~--~~~~~kl~ 419 (608)
+..+|||||++ ++|.+++...... .+++..+..++.|++.||.|||+ .+ |+||||||+|||++ .++.+||+
T Consensus 129 ~~~~lv~e~~~-~~L~~~l~~~~~~-~~~~~~~~~i~~qi~~al~~lH~~~~~---ivHrDlkp~NIll~~~~~~~~kL~ 203 (382)
T 2vx3_A 129 NHLCLVFEMLS-YNLYDLLRNTNFR-GVSLNLTRKFAQQMCTALLFLATPELS---IIHCDLKPENILLCNPKRSAIKIV 203 (382)
T ss_dssp TEEEEEEECCC-CBHHHHHHHTTTS-CCCHHHHHHHHHHHHHHHHHHTSTTTC---EECCCCSGGGEEESSTTSCCEEEC
T ss_pred CceEEEEecCC-CCHHHHHhhcCcC-CCCHHHHHHHHHHHHHHHHHhccCCCC---EEcCCCCcccEEEecCCCCcEEEE
Confidence 99999999995 5999999875432 58999999999999999999995 45 99999999999995 47789999
Q ss_pred eccCccccccCCcceeeeeeccCCCCChhhhccCCCCCccchHhHHHHHHHHHhCCCCCCcc
Q 044312 420 DFGASRSMAVDQTHMTTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLTELLTGEKPIRFT 481 (608)
Q Consensus 420 DFGls~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~elltg~~p~~~~ 481 (608)
|||+++..... .....||+.|+|||++.+..++.++||||||++++||++|+.||...
T Consensus 204 DFG~a~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~ 261 (382)
T 2vx3_A 204 DFGSSCQLGQR----IYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGA 261 (382)
T ss_dssp CCTTCEETTCC----CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred eccCceecccc----cccccCCccccChHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence 99999876432 23456899999999999999999999999999999999999999743
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-34 Score=314.10 Aligned_cols=238 Identities=22% Similarity=0.327 Sum_probs=173.1
Q ss_pred CccccceeccCce--------------EEEEEeecChhhHHHHHHHHHHHhhc-CCCCccceecccccCccceEEEeecC
Q 044312 290 NFDLNRILGQGGQ--------------AVKKSKVIDESKVEEFINEVVILSQI-NHRNVVKLLGCCLETEVPLLVYEFIP 354 (608)
Q Consensus 290 ~f~~~~~lG~G~~--------------avk~~~~~~~~~~~~~~~Ei~il~~l-~H~niv~l~~~~~~~~~~~lV~E~~~ 354 (608)
.|...++||+|++ |||+... ...+.+.+|+.+|+++ +||||+++++++.+....+|||||+.
T Consensus 16 ~~~~~~~LG~G~~g~V~~~~~~~g~~vAvK~~~~---~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~lv~E~~~ 92 (434)
T 2rio_A 16 LVVSEKILGYGSSGTVVFQGSFQGRPVAVKRMLI---DFCDIALMEIKLLTESDDHPNVIRYYCSETTDRFLYIALELCN 92 (434)
T ss_dssp CEEEEEEEEECSTTCEEEEEESSSSEEEEEEEEG---GGHHHHHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEECCCS
T ss_pred eeeccCeEeeCCCeEEEEEEEECCeEEEEEEEcH---HHHHHHHHHHHHHHhccCCCCcCeEEEEEecCCeEEEEEecCC
Confidence 4455678999874 6666543 3356788999999987 89999999999999999999999995
Q ss_pred CCccchhccccCCCC----CCCHHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEEcCC-------------CcEE
Q 044312 355 NGTLFQYIHDQNEDF----PITWEIRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDK-------------YRAK 417 (608)
Q Consensus 355 ~gsL~~~l~~~~~~~----~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~-------------~~~k 417 (608)
|+|.+++....... ..++..++.++.||+.||+|||+.+ |+||||||+|||++.+ +.+|
T Consensus 93 -gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDLkp~NILl~~~~~~~~~~~~~~~~~~~k 168 (434)
T 2rio_A 93 -LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSLK---IIHRDLKPQNILVSTSSRFTADQQTGAENLRIL 168 (434)
T ss_dssp -EEHHHHHHTC------------CCHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEECCHHHHSCCTTCCCSCEEE
T ss_pred -CCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHCC---ccccCCChHhEEEecCcccccccccCCCceEEE
Confidence 69999997643211 1133356789999999999999999 9999999999999653 4899
Q ss_pred EeeccCccccccCCcc---eeeeeeccCCCCChhhhcc-------CCCCCccchHhHHHHHHHHHh-CCCCCCccchhhc
Q 044312 418 VSDFGASRSMAVDQTH---MTTQVHGTFGYLDPEYFRS-------SQFTDKSDVYSFGVVLTELLT-GEKPIRFTILEED 486 (608)
Q Consensus 418 l~DFGls~~~~~~~~~---~~~~~~gt~~y~aPE~~~~-------~~~t~ksDV~S~Gvvl~ellt-g~~p~~~~~~~~~ 486 (608)
|+|||+++........ ......||+.|+|||++.+ ..++.++|||||||+++||+| |+.||.......
T Consensus 169 L~DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~- 247 (434)
T 2rio_A 169 ISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSRE- 247 (434)
T ss_dssp ECCCTTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTTCSTTTHH-
T ss_pred EcccccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCCCCCchhhH-
Confidence 9999999877543322 1234579999999999975 678999999999999999999 999986322111
Q ss_pred ccHHHHHHHHhhhhhhHHHhhhhhhccCChhHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 044312 487 KSLAAYFLCAMKEERLFEILDARVMKQGGKDEIITVAKLAKRCLNLNGKKRPTMREVASE 546 (608)
Q Consensus 487 ~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~evl~~ 546 (608)
.. . .... . . .+..........+.++.+|+.+||+.||++|||+.||+++
T Consensus 248 ---~~-i---~~~~-~-~--~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~h 296 (434)
T 2rio_A 248 ---SN-I---IRGI-F-S--LDEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLRH 296 (434)
T ss_dssp ---HH-H---HHTC-C-C--CCCCTTCCCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred ---HH-H---hcCC-C-C--cccccccccccchHHHHHHHHHHhhCChhhCCCHHHHHhC
Confidence 00 0 0000 0 0 0001111234567789999999999999999999999863
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-35 Score=300.10 Aligned_cols=232 Identities=29% Similarity=0.424 Sum_probs=178.7
Q ss_pred HHHHHhcCccccceeccCce---------------EEEEEeecCh------hhHHHHHHHHHHHhhc----CCCCcccee
Q 044312 283 ELEKATDNFDLNRILGQGGQ---------------AVKKSKVIDE------SKVEEFINEVVILSQI----NHRNVVKLL 337 (608)
Q Consensus 283 ~l~~~t~~f~~~~~lG~G~~---------------avk~~~~~~~------~~~~~~~~Ei~il~~l----~H~niv~l~ 337 (608)
+.+...++|++.+.||+|++ |||....... .....+.+|+.+++++ +|+||++++
T Consensus 25 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~ 104 (312)
T 2iwi_A 25 DREAFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLL 104 (312)
T ss_dssp --------CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEE
T ss_pred chhhhhhceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEE
Confidence 44556778999999999974 6666543222 1234567899999999 899999999
Q ss_pred cccccCccceEEEee-cCCCccchhccccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEEc-CCCc
Q 044312 338 GCCLETEVPLLVYEF-IPNGTLFQYIHDQNEDFPITWEIRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLD-DKYR 415 (608)
Q Consensus 338 ~~~~~~~~~~lV~E~-~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~-~~~~ 415 (608)
+++.+.+..++|||+ +.+++|.+++.... .+++..++.++.||+.||+|||+.+ |+||||||+|||++ .++.
T Consensus 105 ~~~~~~~~~~~v~e~~~~~~~L~~~l~~~~---~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~ 178 (312)
T 2iwi_A 105 DWFETQEGFMLVLERPLPAQDLFDYITEKG---PLGEGPSRCFFGQVVAAIQHCHSRG---VVHRDIKDENILIDLRRGC 178 (312)
T ss_dssp EEC-----CEEEEECCSSEEEHHHHHHHHC---SCCHHHHHHHHHHHHHHHHHHHHHT---EECCCCSGGGEEEETTTTE
T ss_pred EEEecCCeEEEEEEecCCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCChhhEEEeCCCCe
Confidence 999999999999999 78999999998643 4899999999999999999999999 99999999999999 8899
Q ss_pred EEEeeccCccccccCCcceeeeeeccCCCCChhhhccCCCC-CccchHhHHHHHHHHHhCCCCCCccchhhcccHHHHHH
Q 044312 416 AKVSDFGASRSMAVDQTHMTTQVHGTFGYLDPEYFRSSQFT-DKSDVYSFGVVLTELLTGEKPIRFTILEEDKSLAAYFL 494 (608)
Q Consensus 416 ~kl~DFGls~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t-~ksDV~S~Gvvl~elltg~~p~~~~~~~~~~~l~~~~~ 494 (608)
+||+|||+++...... .....|+..|+|||++....+. .++||||||++++||++|+.||....
T Consensus 179 ~kl~dfg~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~------------ 243 (312)
T 2iwi_A 179 AKLIDFGSGALLHDEP---YTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERDQ------------ 243 (312)
T ss_dssp EEECCCSSCEECCSSC---BCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH------------
T ss_pred EEEEEcchhhhcccCc---ccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCChH------------
Confidence 9999999998765332 2345689999999999877764 58999999999999999999986211
Q ss_pred HHhhhhhhHHHhhhhhhccCChhHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 044312 495 CAMKEERLFEILDARVMKQGGKDEIITVAKLAKRCLNLNGKKRPTMREVASE 546 (608)
Q Consensus 495 ~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~evl~~ 546 (608)
++... ....+...+..+.+|+.+||+.||++|||+.|++++
T Consensus 244 ---------~~~~~--~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~ 284 (312)
T 2iwi_A 244 ---------EILEA--ELHFPAHVSPDCCALIRRCLAPKPSSRPSLEEILLD 284 (312)
T ss_dssp ---------HHHHT--CCCCCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHHS
T ss_pred ---------HHhhh--ccCCcccCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 00111 112233456689999999999999999999999864
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-35 Score=302.86 Aligned_cols=238 Identities=26% Similarity=0.415 Sum_probs=187.2
Q ss_pred ccCCHHHHHHHhcCccccceeccCce---------------EEEEEeecCh------hhHHHHHHHHHHHhhcC--CCCc
Q 044312 277 KLFTSKELEKATDNFDLNRILGQGGQ---------------AVKKSKVIDE------SKVEEFINEVVILSQIN--HRNV 333 (608)
Q Consensus 277 ~~~~~~~l~~~t~~f~~~~~lG~G~~---------------avk~~~~~~~------~~~~~~~~Ei~il~~l~--H~ni 333 (608)
+....++.+...++|++.+.||+|++ |||....... ...+.+.+|+.++++++ |+||
T Consensus 31 ~~~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i 110 (320)
T 3a99_A 31 KLAPGKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 110 (320)
T ss_dssp ---------CCTTTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSB
T ss_pred ccCcccccCCccCceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCc
Confidence 44455566667889999999999984 6666654221 12356778999999996 5999
Q ss_pred cceecccccCccceEEEeecCC-CccchhccccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEEc-
Q 044312 334 VKLLGCCLETEVPLLVYEFIPN-GTLFQYIHDQNEDFPITWEIRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLD- 411 (608)
Q Consensus 334 v~l~~~~~~~~~~~lV~E~~~~-gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~- 411 (608)
+++++++.+.+..++|||++.+ ++|.+++.... .+++..++.++.||+.||+|||+.+ |+||||||+|||++
T Consensus 111 ~~~~~~~~~~~~~~lv~e~~~~~~~L~~~l~~~~---~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~ 184 (320)
T 3a99_A 111 IRLLDWFERPDSFVLILERPEPVQDLFDFITERG---ALQEELARSFFWQVLEAVRHCHNCG---VLHRDIKDENILIDL 184 (320)
T ss_dssp CCEEEEEECSSEEEEEEECCSSEEEHHHHHHHHC---SCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEET
T ss_pred eEEEEEEecCCcEEEEEEcCCCCccHHHHHhccC---CCCHHHHHHHHHHHHHHHHHHHHCC---cEeCCCCHHHEEEeC
Confidence 9999999999999999999976 89999987643 5899999999999999999999999 99999999999999
Q ss_pred CCCcEEEeeccCccccccCCcceeeeeeccCCCCChhhhccCCC-CCccchHhHHHHHHHHHhCCCCCCccchhhcccHH
Q 044312 412 DKYRAKVSDFGASRSMAVDQTHMTTQVHGTFGYLDPEYFRSSQF-TDKSDVYSFGVVLTELLTGEKPIRFTILEEDKSLA 490 (608)
Q Consensus 412 ~~~~~kl~DFGls~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-t~ksDV~S~Gvvl~elltg~~p~~~~~~~~~~~l~ 490 (608)
+++.+||+|||+++..... ......||+.|+|||++....+ +.++||||||++++||++|+.||.....
T Consensus 185 ~~~~~kL~Dfg~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~------- 254 (320)
T 3a99_A 185 NRGELKLIDFGSGALLKDT---VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEE------- 254 (320)
T ss_dssp TTTEEEECCCTTCEECCSS---CBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHH-------
T ss_pred CCCCEEEeeCccccccccc---cccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCChhh-------
Confidence 7889999999999876532 2234568999999999987766 6889999999999999999999863110
Q ss_pred HHHHHHhhhhhhHHHhhhhhhccCChhHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 044312 491 AYFLCAMKEERLFEILDARVMKQGGKDEIITVAKLAKRCLNLNGKKRPTMREVASE 546 (608)
Q Consensus 491 ~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~evl~~ 546 (608)
+... ....+...+.++.+|+.+||+.||++|||+.||+++
T Consensus 255 --------------~~~~--~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h 294 (320)
T 3a99_A 255 --------------IIRG--QVFFRQRVSSECQHLIRWCLALRPSDRPTFEEIQNH 294 (320)
T ss_dssp --------------HHHC--CCCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred --------------hhcc--cccccccCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 0000 011223455689999999999999999999999863
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-34 Score=299.23 Aligned_cols=242 Identities=24% Similarity=0.337 Sum_probs=167.8
Q ss_pred hcCccccceeccCce---------------EEEEEeec-ChhhHHHHHHHHH-HHhhcCCCCccceecccccCccceEEE
Q 044312 288 TDNFDLNRILGQGGQ---------------AVKKSKVI-DESKVEEFINEVV-ILSQINHRNVVKLLGCCLETEVPLLVY 350 (608)
Q Consensus 288 t~~f~~~~~lG~G~~---------------avk~~~~~-~~~~~~~~~~Ei~-il~~l~H~niv~l~~~~~~~~~~~lV~ 350 (608)
.++|.+.+.||+|++ |||+.+.. ......++..|+. +++.++||||+++++++.+.+..++||
T Consensus 21 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~~~~~~lv~ 100 (327)
T 3aln_A 21 AEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFREGDCWICM 100 (327)
T ss_dssp SCSEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCCCHHHHHHHHHHHHHHHSSCCCTTBCCEEEEEECSSEEEEEE
T ss_pred HHHhhehheeccCCCEEEEEEEEcCCCCEEEEEEeecccCchHHHHHHHHHHHHHHcCCCCcEeeeeeEEEeCCceEEEE
Confidence 467889999999974 67776543 3344556667776 777789999999999999999999999
Q ss_pred eecCCCccchhcccc--CCCCCCCHHHHHHHHHHHHHHHHHHhhc-CCCCeeccCCCCCcEEEcCCCcEEEeeccCcccc
Q 044312 351 EFIPNGTLFQYIHDQ--NEDFPITWEIRLRIAIEVSGALSYLHSA-ASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSM 427 (608)
Q Consensus 351 E~~~~gsL~~~l~~~--~~~~~l~~~~~~~i~~~ia~aL~yLH~~-~~~~iiHrDlk~~NILl~~~~~~kl~DFGls~~~ 427 (608)
||+++ +|.+++... .....+++..+..++.|++.||.|||+. + |+||||||+|||++.++.+||+|||+++..
T Consensus 101 e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~---ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~ 176 (327)
T 3aln_A 101 ELMST-SFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENLK---IIHRDIKPSNILLDRSGNIKLCDFGISGQL 176 (327)
T ss_dssp CCCSE-EHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHHHS---CCCSCCCGGGEEEETTTEEEECCCSSSCC-
T ss_pred eecCC-ChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhccCC---EeECCCCHHHEEEcCCCCEEEccCCCceec
Confidence 99975 887777631 1123589999999999999999999998 8 999999999999999999999999999876
Q ss_pred ccCCcceeeeeeccCCCCChhhh----ccCCCCCccchHhHHHHHHHHHhCCCCCCccchhhcccHHHHHHHHhhhhhhH
Q 044312 428 AVDQTHMTTQVHGTFGYLDPEYF----RSSQFTDKSDVYSFGVVLTELLTGEKPIRFTILEEDKSLAAYFLCAMKEERLF 503 (608)
Q Consensus 428 ~~~~~~~~~~~~gt~~y~aPE~~----~~~~~t~ksDV~S~Gvvl~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~ 503 (608)
.... ......||+.|+|||.+ ....++.++||||||++++||++|+.||....... ..+.
T Consensus 177 ~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~--------------~~~~ 240 (327)
T 3aln_A 177 VDSI--AKTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVF--------------DQLT 240 (327)
T ss_dssp -------------------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC---------------------C
T ss_pred cccc--ccccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCcchHH--------------HHHH
Confidence 4332 22334689999999998 46678999999999999999999999986321110 0000
Q ss_pred HHhh---hhhhccCChhHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHh
Q 044312 504 EILD---ARVMKQGGKDEIITVAKLAKRCLNLNGKKRPTMREVASELAG 549 (608)
Q Consensus 504 ~~~d---~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~evl~~L~~ 549 (608)
.+.. +.+........+..+.+|+.+||+.||++|||+.||+++-.-
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~hp~~ 289 (327)
T 3aln_A 241 QVVKGDPPQLSNSEEREFSPSFINFVNLCLTKDESKRPKYKELLKHPFI 289 (327)
T ss_dssp CCCCSCCCCCCCCSSCCCCHHHHHHHHHHTCSSGGGSCCHHHHTTSHHH
T ss_pred HHhcCCCCCCCCcccccCCHHHHHHHHHHhhCChhhCcCHHHHHhChHH
Confidence 1111 011111123456789999999999999999999999876433
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-34 Score=300.68 Aligned_cols=240 Identities=21% Similarity=0.287 Sum_probs=160.7
Q ss_pred HhcCccccc-eeccCce---------------EEEEEeecChhhHHHHHHHH-HHHhhcCCCCccceeccccc----Ccc
Q 044312 287 ATDNFDLNR-ILGQGGQ---------------AVKKSKVIDESKVEEFINEV-VILSQINHRNVVKLLGCCLE----TEV 345 (608)
Q Consensus 287 ~t~~f~~~~-~lG~G~~---------------avk~~~~~~~~~~~~~~~Ei-~il~~l~H~niv~l~~~~~~----~~~ 345 (608)
..++|.+.+ .||+|++ |||+.... ....+|+ ..++.++||||+++++++.. ...
T Consensus 26 ~~~~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~-----~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~ 100 (336)
T 3fhr_A 26 VTDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDS-----PKARQEVDHHWQASGGPHIVCILDVYENMHHGKRC 100 (336)
T ss_dssp GGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESS-----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEE
T ss_pred ccceeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCc-----HHHHHHHHHHHHhcCCCChHHHHHHHhhccCCCce
Confidence 456788854 6999984 66665431 1223333 34566799999999999875 455
Q ss_pred ceEEEeecCCCccchhccccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEEcC---CCcEEEeecc
Q 044312 346 PLLVYEFIPNGTLFQYIHDQNEDFPITWEIRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDD---KYRAKVSDFG 422 (608)
Q Consensus 346 ~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~---~~~~kl~DFG 422 (608)
.++||||+++|+|.+++..... ..+++..++.++.||+.||+|||+.+ |+||||||+|||++. ++.+||+|||
T Consensus 101 ~~lv~e~~~gg~L~~~l~~~~~-~~l~~~~~~~i~~ql~~~l~~LH~~~---ivH~dlkp~NIll~~~~~~~~~kl~Dfg 176 (336)
T 3fhr_A 101 LLIIMECMEGGELFSRIQERGD-QAFTEREAAEIMRDIGTAIQFLHSHN---IAHRDVKPENLLYTSKEKDAVLKLTDFG 176 (336)
T ss_dssp EEEEEECCTTEEHHHHHHTC-C-CCCBHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESCSSTTCCEEECCCT
T ss_pred EEEEEeccCCCCHHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEEecCCCceEEEeccc
Confidence 8999999999999999987543 25999999999999999999999999 999999999999976 4559999999
Q ss_pred CccccccCCcceeeeeeccCCCCChhhhccCCCCCccchHhHHHHHHHHHhCCCCCCccchhhcccHHHHHHHHhhhhhh
Q 044312 423 ASRSMAVDQTHMTTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLTELLTGEKPIRFTILEEDKSLAAYFLCAMKEERL 502 (608)
Q Consensus 423 ls~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~ 502 (608)
+++..... ......+|+.|+|||++....++.++||||||++++||++|+.||........ ...........
T Consensus 177 ~~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~---~~~~~~~~~~~-- 248 (336)
T 3fhr_A 177 FAKETTQN---ALQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAI---SPGMKRRIRLG-- 248 (336)
T ss_dssp TCEEC-------------------------CHHHHHHHHHHHHHHHHHHHHSSCCC------------------------
T ss_pred cceecccc---ccccCCCCcCccChhhhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCccchhh---hhhHHHhhhcc--
Confidence 99865432 22345689999999999888899999999999999999999999863322110 00000000000
Q ss_pred HHHhhhhhhccCChhHHHHHHHHHHHHhccCCCCCCCHHHHHHHH
Q 044312 503 FEILDARVMKQGGKDEIITVAKLAKRCLNLNGKKRPTMREVASEL 547 (608)
Q Consensus 503 ~~~~d~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~evl~~L 547 (608)
............+.++.+|+.+||+.||++|||+.|++++-
T Consensus 249 ----~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp 289 (336)
T 3fhr_A 249 ----QYGFPNPEWSEVSEDAKQLIRLLLKTDPTERLTITQFMNHP 289 (336)
T ss_dssp ------CCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHSH
T ss_pred ----ccccCchhhccCCHHHHHHHHHHCCCChhHCcCHHHHhcCc
Confidence 00011111234567899999999999999999999999854
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-35 Score=314.89 Aligned_cols=236 Identities=25% Similarity=0.364 Sum_probs=175.0
Q ss_pred hcCccccceeccCce--------------EEEEEeecChhhHHHHHHHHHHHhhc-CCCCccceecccccCccceEEEee
Q 044312 288 TDNFDLNRILGQGGQ--------------AVKKSKVIDESKVEEFINEVVILSQI-NHRNVVKLLGCCLETEVPLLVYEF 352 (608)
Q Consensus 288 t~~f~~~~~lG~G~~--------------avk~~~~~~~~~~~~~~~Ei~il~~l-~H~niv~l~~~~~~~~~~~lV~E~ 352 (608)
..+|.+.++||+|++ |||++.. .....+.+|+.+|+++ +|||||++++++.+....+|||||
T Consensus 23 ~~~y~~~~~LG~G~~G~V~~~~~~~~~~vAvK~~~~---~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~lv~E~ 99 (432)
T 3p23_A 23 KISFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILP---ECFSFADREVQLLRESDEHPNVIRYFCTEKDRQFQYIAIEL 99 (432)
T ss_dssp TEEEEEEEEEEECGGGCEEEEEESSSSEEEEEEECT---TTEEECHHHHHHHHHSCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred cEEEecCCeeecCcCEEEEEEEEeCCeEEEEEEECH---HHHHHHHHHHHHHHhccCCCCcCeEEEEEecCCEEEEEEEC
Confidence 456888999999974 6666543 2223467899999999 899999999999999999999999
Q ss_pred cCCCccchhccccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEEcC-----CCcEEEeeccCcccc
Q 044312 353 IPNGTLFQYIHDQNEDFPITWEIRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDD-----KYRAKVSDFGASRSM 427 (608)
Q Consensus 353 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~-----~~~~kl~DFGls~~~ 427 (608)
+. |+|.+++..... .+.+..++.++.||+.||+|||+.+ |+||||||+|||++. ...+||+|||+++..
T Consensus 100 ~~-g~L~~~l~~~~~--~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a~~~ 173 (432)
T 3p23_A 100 CA-ATLQEYVEQKDF--AHLGLEPITLLQQTTSGLAHLHSLN---IVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKL 173 (432)
T ss_dssp CS-EEHHHHHHSSSC--CCCSSCHHHHHHHHHHHHHHHHHTT---CCCCCCSTTSEEECCCBTTTBCCEEECCTTEEECC
T ss_pred CC-CCHHHHHHhcCC--CccchhHHHHHHHHHHHHHHHHHCc---CEeCCCCHHHEEEecCCCCCceeEEEecccceeec
Confidence 95 699999986543 3455566789999999999999999 999999999999953 346889999999876
Q ss_pred ccCCc--ceeeeeeccCCCCChhhhc---cCCCCCccchHhHHHHHHHHHh-CCCCCCccchhhcccHHHHHHHHhhhhh
Q 044312 428 AVDQT--HMTTQVHGTFGYLDPEYFR---SSQFTDKSDVYSFGVVLTELLT-GEKPIRFTILEEDKSLAAYFLCAMKEER 501 (608)
Q Consensus 428 ~~~~~--~~~~~~~gt~~y~aPE~~~---~~~~t~ksDV~S~Gvvl~ellt-g~~p~~~~~~~~~~~l~~~~~~~~~~~~ 501 (608)
..... .......||+.|+|||++. ...++.++|||||||+++||++ |..||....... .........
T Consensus 174 ~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~~~~-------~~~~~~~~~ 246 (432)
T 3p23_A 174 AVGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQ-------ANILLGACS 246 (432)
T ss_dssp ------------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTTTHH-------HHHHTTCCC
T ss_pred cCCCcceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhhHHH-------HHHHhccCC
Confidence 54321 2234467999999999997 4577889999999999999999 889985321110 000000000
Q ss_pred hHHHhhhhhhccCChhHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 044312 502 LFEILDARVMKQGGKDEIITVAKLAKRCLNLNGKKRPTMREVASE 546 (608)
Q Consensus 502 ~~~~~d~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~evl~~ 546 (608)
. .........+..+.+|+.+||+.||++|||+.||+++
T Consensus 247 ~-------~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~evl~h 284 (432)
T 3p23_A 247 L-------DCLHPEKHEDVIARELIEKMIAMDPQKRPSAKHVLKH 284 (432)
T ss_dssp C-------TTSCTTCHHHHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred c-------cccCccccccHHHHHHHHHHHhCCHhhCCCHHHHHhC
Confidence 0 0011123445678899999999999999999999853
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-34 Score=292.71 Aligned_cols=239 Identities=23% Similarity=0.376 Sum_probs=167.2
Q ss_pred hcCccccceeccCce---------------EEEEEeecCh-hh-HHHHHHHHHHHhhcCCCCccceecccccCccceEEE
Q 044312 288 TDNFDLNRILGQGGQ---------------AVKKSKVIDE-SK-VEEFINEVVILSQINHRNVVKLLGCCLETEVPLLVY 350 (608)
Q Consensus 288 t~~f~~~~~lG~G~~---------------avk~~~~~~~-~~-~~~~~~Ei~il~~l~H~niv~l~~~~~~~~~~~lV~ 350 (608)
.++|++.+.||+|++ |||....... .. .+.+..+..+++.++||||+++++++.+.+..++||
T Consensus 24 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lv~ 103 (318)
T 2dyl_A 24 INDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVFIAM 103 (318)
T ss_dssp GGGEEEEEEC------CEEEEEETTTCCEEEEEEEETTSCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEE
T ss_pred hccccccceeeecCCeeEEEEEEecCCeEEEEEEecccccchHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEEEEE
Confidence 356888899999974 7777654322 22 233445556788889999999999999999999999
Q ss_pred eecCCCccchhccccCCCCCCCHHHHHHHHHHHHHHHHHHhhc-CCCCeeccCCCCCcEEEcCCCcEEEeeccCcccccc
Q 044312 351 EFIPNGTLFQYIHDQNEDFPITWEIRLRIAIEVSGALSYLHSA-ASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAV 429 (608)
Q Consensus 351 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~-~~~~iiHrDlk~~NILl~~~~~~kl~DFGls~~~~~ 429 (608)
||+ ++.+..+...... .+++..+..++.||+.||.|||+. + |+||||||+|||++.++.+||+|||+++....
T Consensus 104 e~~-~~~~~~l~~~~~~--~~~~~~~~~~~~~i~~~l~~lH~~~~---i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~ 177 (318)
T 2dyl_A 104 ELM-GTCAEKLKKRMQG--PIPERILGKMTVAIVKALYYLKEKHG---VIHRDVKPSNILLDERGQIKLCDFGISGRLVD 177 (318)
T ss_dssp CCC-SEEHHHHHHHHTS--CCCHHHHHHHHHHHHHHHHHHHHHHC---CCCCCCCGGGEEECTTSCEEECCCTTC-----
T ss_pred ecc-CCcHHHHHHHhcc--CCCHHHHHHHHHHHHHHHHHHHhhCC---EEeCCCCHHHEEECCCCCEEEEECCCchhccC
Confidence 999 4455544443222 589999999999999999999995 8 99999999999999999999999999976643
Q ss_pred CCcceeeeeeccCCCCChhhhc-----cCCCCCccchHhHHHHHHHHHhCCCCCCccchhhcccHHHHHHHHhhhhhhHH
Q 044312 430 DQTHMTTQVHGTFGYLDPEYFR-----SSQFTDKSDVYSFGVVLTELLTGEKPIRFTILEEDKSLAAYFLCAMKEERLFE 504 (608)
Q Consensus 430 ~~~~~~~~~~gt~~y~aPE~~~-----~~~~t~ksDV~S~Gvvl~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~ 504 (608)
.. ......+|+.|+|||.+. ...++.++||||||++++||++|+.||...... ...+.......
T Consensus 178 ~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~-----~~~~~~~~~~~---- 246 (318)
T 2dyl_A 178 DK--AKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTD-----FEVLTKVLQEE---- 246 (318)
T ss_dssp -----------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCCSH-----HHHHHHHHHSC----
T ss_pred Cc--cccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCCcc-----HHHHHHHhccC----
Confidence 32 223456899999999994 557889999999999999999999998632211 11111111100
Q ss_pred HhhhhhhccCChhHHHHHHHHHHHHhccCCCCCCCHHHHHHHH
Q 044312 505 ILDARVMKQGGKDEIITVAKLAKRCLNLNGKKRPTMREVASEL 547 (608)
Q Consensus 505 ~~d~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~evl~~L 547 (608)
..........+.++.+|+.+||+.||.+||++.|++++-
T Consensus 247 ----~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~ 285 (318)
T 2dyl_A 247 ----PPLLPGHMGFSGDFQSFVKDCLTKDHRKRPKYNKLLEHS 285 (318)
T ss_dssp ----CCCCCSSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTTSH
T ss_pred ----CCCCCccCCCCHHHHHHHHHHccCChhHCcCHHHHhhCH
Confidence 000111123456899999999999999999999998753
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-34 Score=318.49 Aligned_cols=253 Identities=24% Similarity=0.376 Sum_probs=190.5
Q ss_pred cCccccceeccCce---------------EEEEEee-cChhhHHHHHHHHHHHhhcCCCCccceeccccc------Cccc
Q 044312 289 DNFDLNRILGQGGQ---------------AVKKSKV-IDESKVEEFINEVVILSQINHRNVVKLLGCCLE------TEVP 346 (608)
Q Consensus 289 ~~f~~~~~lG~G~~---------------avk~~~~-~~~~~~~~~~~Ei~il~~l~H~niv~l~~~~~~------~~~~ 346 (608)
++|++.+.||+|++ |||+.+. ......+.+.+|+.++++++||||+++++++.. .+..
T Consensus 14 grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~~~~~ 93 (676)
T 3qa8_A 14 GPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPNDLP 93 (676)
T ss_dssp ---CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSCCCHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCCTTSSC
T ss_pred CCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCceeeeecccccccCCCeE
Confidence 57999999999974 7776654 345557789999999999999999999999765 6678
Q ss_pred eEEEeecCCCccchhccccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEEcCCCc---EEEeeccC
Q 044312 347 LLVYEFIPNGTLFQYIHDQNEDFPITWEIRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYR---AKVSDFGA 423 (608)
Q Consensus 347 ~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~---~kl~DFGl 423 (608)
++||||+++|+|.+++........+++..++.|+.|++.||+|||+.+ |+||||||+|||++.++. +||+|||+
T Consensus 94 ~LVmEy~~ggsL~~~L~~~~~~~~lse~~i~~I~~QLl~aL~yLHs~g---IVHrDLKP~NILl~~~g~~~~vKL~DFG~ 170 (676)
T 3qa8_A 94 LLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHENR---IIHRDLKPENIVLQPGPQRLIHKIIDLGY 170 (676)
T ss_dssp CCEEECCSSCBHHHHHHSSSCTTCCCSSHHHHHHHHHHHHHHHHHHTT---BCCCCCCSTTEEEECCSSSCEEEECSCCC
T ss_pred EEEEEeCCCCCHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCCHHHeEeecCCCceeEEEccccc
Confidence 999999999999999987554446899999999999999999999999 999999999999996654 99999999
Q ss_pred ccccccCCcceeeeeeccCCCCChhhhccCCCCCccchHhHHHHHHHHHhCCCCCCccchhhcccHHHHHHHHhhhh---
Q 044312 424 SRSMAVDQTHMTTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLTELLTGEKPIRFTILEEDKSLAAYFLCAMKEE--- 500 (608)
Q Consensus 424 s~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~--- 500 (608)
++...... ......||+.|+|||.+.+..++.++||||||++++||++|+.||....... .+. ......
T Consensus 171 a~~~~~~~--~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSLGviLyeLltG~~Pf~~~~~~~-----~~~-~~i~~~~~~ 242 (676)
T 3qa8_A 171 AKELDQGE--LCTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQPV-----QWH-GKVREKSNE 242 (676)
T ss_dssp CCBTTSCC--CCCCCCSCCTTCSSCSSCCSCCSTTHHHHHHHHHHHHHHSSCSSCCSSCHHH-----HSS-TTCC-----
T ss_pred cccccccc--ccccccCCcccCChHHhccCCCCchhHHHHHHHHHHHHHHCCCCCCcccchh-----hhh-hhhhcccch
Confidence 98765332 2344578999999999999999999999999999999999999986421110 000 000000
Q ss_pred --hhHHHhhh--------hhhccCChhHHHHHHHHHHHHhccCCCCCCCHHH-----HHHHHHhhHH
Q 044312 501 --RLFEILDA--------RVMKQGGKDEIITVAKLAKRCLNLNGKKRPTMRE-----VASELAGIKA 552 (608)
Q Consensus 501 --~~~~~~d~--------~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~e-----vl~~L~~i~~ 552 (608)
...+.... ..........+..+.+|+.+||..||++|||+.| .++.+..+..
T Consensus 243 ~~~~~~~l~g~~~~~~~lp~p~~l~~~ls~~L~dLI~~mL~~DP~kRPTa~elL~hp~F~~l~~iL~ 309 (676)
T 3qa8_A 243 HIVVYDDLTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQNPNVGCFQALDSILS 309 (676)
T ss_dssp -CCSCCCCSSSCCCCSSSCCSCCCCGGGHHHHHHHHHHHSCSSCC---CCTTCCCCTTHHHHHHHHC
T ss_pred hhhhhhhhccccccccccCCchhhchhhhHHHHHHHHHHccCCHhhCcCHHHHhcCHHHHHHHHHHh
Confidence 00000000 0011233457789999999999999999999988 4455555544
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-33 Score=318.55 Aligned_cols=226 Identities=22% Similarity=0.331 Sum_probs=177.8
Q ss_pred hcCccccceeccCce----------------EEEEEee-cChhhHHHHHHHHHHHhhcCCCCccceecccccCcc-----
Q 044312 288 TDNFDLNRILGQGGQ----------------AVKKSKV-IDESKVEEFINEVVILSQINHRNVVKLLGCCLETEV----- 345 (608)
Q Consensus 288 t~~f~~~~~lG~G~~----------------avk~~~~-~~~~~~~~~~~Ei~il~~l~H~niv~l~~~~~~~~~----- 345 (608)
.++|++.+.||+|+| |||.... .+....+.|.+|+.++++++||||+++++++.+.+.
T Consensus 79 ~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~~ 158 (681)
T 2pzi_A 79 AGQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHGDPV 158 (681)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSSCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTTSCEE
T ss_pred CCceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCccCCHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCCCCce
Confidence 367999999999974 5555432 233455688999999999999999999999987665
Q ss_pred ceEEEeecCCCccchhccccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEEcCCCcEEEeeccCcc
Q 044312 346 PLLVYEFIPNGTLFQYIHDQNEDFPITWEIRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASR 425 (608)
Q Consensus 346 ~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGls~ 425 (608)
.+|||||+++++|.+++.. .+++..++.|+.||+.||.|||+++ |+||||||+|||++.+ .+||+|||+++
T Consensus 159 ~~lv~E~~~g~~L~~~~~~-----~l~~~~~~~~~~qi~~aL~~lH~~g---iiHrDlkp~NIll~~~-~~kl~DFG~a~ 229 (681)
T 2pzi_A 159 GYIVMEYVGGQSLKRSKGQ-----KLPVAEAIAYLLEILPALSYLHSIG---LVYNDLKPENIMLTEE-QLKLIDLGAVS 229 (681)
T ss_dssp EEEEEECCCCEECC----C-----CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECSS-CEEECCCTTCE
T ss_pred eEEEEEeCCCCcHHHHHhC-----CCCHHHHHHHHHHHHHHHHHHHHCC---CeecccChHHeEEeCC-cEEEEecccch
Confidence 6999999999999987754 4899999999999999999999999 9999999999999986 99999999998
Q ss_pred ccccCCcceeeeeeccCCCCChhhhccCCCCCccchHhHHHHHHHHHhCCCCCCccchhhcccHHHHHHHHhhhhhhHHH
Q 044312 426 SMAVDQTHMTTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLTELLTGEKPIRFTILEEDKSLAAYFLCAMKEERLFEI 505 (608)
Q Consensus 426 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 505 (608)
..... ....||+.|+|||++.+.. +.++||||||++++||++|..|+........ ...
T Consensus 230 ~~~~~-----~~~~gt~~y~aPE~~~~~~-~~~sDi~slG~~l~~l~~g~~~~~~~~~~~~-----------~~~----- 287 (681)
T 2pzi_A 230 RINSF-----GYLYGTPGFQAPEIVRTGP-TVATDIYTVGRTLAALTLDLPTRNGRYVDGL-----------PED----- 287 (681)
T ss_dssp ETTCC-----SCCCCCTTTSCTTHHHHCS-CHHHHHHHHHHHHHHHHSCCCEETTEECSSC-----------CTT-----
T ss_pred hcccC-----CccCCCccccCHHHHcCCC-CCceehhhhHHHHHHHHhCCCCCcccccccc-----------ccc-----
Confidence 76432 3456899999999987654 8999999999999999999988753211100 000
Q ss_pred hhhhhhccCChhHHHHHHHHHHHHhccCCCCCCC-HHHHHHHHHhhH
Q 044312 506 LDARVMKQGGKDEIITVAKLAKRCLNLNGKKRPT-MREVASELAGIK 551 (608)
Q Consensus 506 ~d~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPs-~~evl~~L~~i~ 551 (608)
......+..+.+|+.+||+.||++||+ ++++.+.|..+.
T Consensus 288 -------~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~~ 327 (681)
T 2pzi_A 288 -------DPVLKTYDSYGRLLRRAIDPDPRQRFTTAEEMSAQLTGVL 327 (681)
T ss_dssp -------CHHHHHCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHH
T ss_pred -------ccccccCHHHHHHHhhhccCChhhCCCHHHHHHHHHHHHH
Confidence 000122356889999999999999995 666666666553
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A | Back alignment and structure |
|---|
Probab=99.97 E-value=1.4e-32 Score=280.62 Aligned_cols=220 Identities=15% Similarity=0.109 Sum_probs=170.4
Q ss_pred hcCccccceeccCce---------------EEEEEeec---ChhhHHHHHHHHHHHhhcCCCCccceecccccCccceEE
Q 044312 288 TDNFDLNRILGQGGQ---------------AVKKSKVI---DESKVEEFINEVVILSQINHRNVVKLLGCCLETEVPLLV 349 (608)
Q Consensus 288 t~~f~~~~~lG~G~~---------------avk~~~~~---~~~~~~~~~~Ei~il~~l~H~niv~l~~~~~~~~~~~lV 349 (608)
.++|++.+.||+|++ |||..... +....+.|.+|+.++++++||||+++++++.+.+..++|
T Consensus 30 ~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv 109 (286)
T 3uqc_A 30 NGRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHTRAGGLVV 109 (286)
T ss_dssp TTTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEE
T ss_pred cCcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEEECCcEEEE
Confidence 357999999999974 67776542 234457899999999999999999999999999999999
Q ss_pred EeecCCCccchhccccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEEcCCCcEEEeeccCcccccc
Q 044312 350 YEFIPNGTLFQYIHDQNEDFPITWEIRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAV 429 (608)
Q Consensus 350 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGls~~~~~ 429 (608)
|||+++++|.+++... .....+.+|+.|++.||+|||+++ |+||||||+|||++.++.+||++++
T Consensus 110 ~e~~~g~~L~~~l~~~-----~~~~~~~~i~~ql~~aL~~lH~~g---ivH~Dikp~NIll~~~g~~kl~~~~------- 174 (286)
T 3uqc_A 110 AEWIRGGSLQEVADTS-----PSPVGAIRAMQSLAAAADAAHRAG---VALSIDHPSRVRVSIDGDVVLAYPA------- 174 (286)
T ss_dssp EECCCEEEHHHHHTTC-----CCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEEETTSCEEECSCC-------
T ss_pred EEecCCCCHHHHHhcC-----CChHHHHHHHHHHHHHHHHHHHCC---CccCCCCcccEEEcCCCCEEEEecc-------
Confidence 9999999999998542 355678899999999999999999 9999999999999999999997443
Q ss_pred CCcceeeeeeccCCCCChhhhccCCCCCccchHhHHHHHHHHHhCCCCCCccchhhcccHHHHHHHHhhhhhhHHHhhhh
Q 044312 430 DQTHMTTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLTELLTGEKPIRFTILEEDKSLAAYFLCAMKEERLFEILDAR 509 (608)
Q Consensus 430 ~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 509 (608)
|++| ++.++||||||+++|||+||+.||............ . ..+... ..
T Consensus 175 --------------~~~~-------~~~~~Di~slG~il~elltg~~Pf~~~~~~~~~~~~------~--~~~~~~--~~ 223 (286)
T 3uqc_A 175 --------------TMPD-------ANPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAPA------E--RDTAGQ--PI 223 (286)
T ss_dssp --------------CCTT-------CCHHHHHHHHHHHHHHHHHSEECSCCCSBCCCSEEC------C--BCTTSC--BC
T ss_pred --------------ccCC-------CCchhHHHHHHHHHHHHHHCCCCCCcCCcchhhHHH------H--HHhccC--CC
Confidence 4443 688999999999999999999999743321100000 0 000000 00
Q ss_pred hhccCChhHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhhHHhc
Q 044312 510 VMKQGGKDEIITVAKLAKRCLNLNGKKRPTMREVASELAGIKAWN 554 (608)
Q Consensus 510 ~~~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~evl~~L~~i~~~~ 554 (608)
.........+.++.+|+.+||+.||++| |+.|+++.|+.+....
T Consensus 224 ~~~~~~~~~~~~l~~li~~~l~~dP~~R-s~~el~~~L~~~~~~~ 267 (286)
T 3uqc_A 224 EPADIDRDIPFQISAVAARSVQGDGGIR-SASTLLNLMQQATAVA 267 (286)
T ss_dssp CHHHHCTTSCHHHHHHHHHHHCTTSSCC-CHHHHHHHHHHHHC--
T ss_pred ChhhcccCCCHHHHHHHHHHcccCCccC-CHHHHHHHHHHHhccC
Confidence 0001122345679999999999999999 9999999999887643
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=99.97 E-value=8.8e-33 Score=296.94 Aligned_cols=232 Identities=16% Similarity=0.182 Sum_probs=172.4
Q ss_pred HHHhcCccccceeccCce---------------EEEEEeecCh---hhHHHHHHHHHHHhhcCC-CCccceecc------
Q 044312 285 EKATDNFDLNRILGQGGQ---------------AVKKSKVIDE---SKVEEFINEVVILSQINH-RNVVKLLGC------ 339 (608)
Q Consensus 285 ~~~t~~f~~~~~lG~G~~---------------avk~~~~~~~---~~~~~~~~Ei~il~~l~H-~niv~l~~~------ 339 (608)
...+.+|...+.||+|+| |||+.+.... ...+.|.+|+.+++.++| +|...+..+
T Consensus 74 ~~~~~~~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~ 153 (413)
T 3dzo_A 74 GERPRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFP 153 (413)
T ss_dssp SSCCEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCC
T ss_pred CCCceeEEEecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccc
Confidence 344556888899999984 7787763322 236789999999999987 433222221
Q ss_pred ---------------ccc-----CccceEEEeecCCCccchhcccc----CCCCCCCHHHHHHHHHHHHHHHHHHhhcCC
Q 044312 340 ---------------CLE-----TEVPLLVYEFIPNGTLFQYIHDQ----NEDFPITWEIRLRIAIEVSGALSYLHSAAS 395 (608)
Q Consensus 340 ---------------~~~-----~~~~~lV~E~~~~gsL~~~l~~~----~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~ 395 (608)
+.. ....+++|+++ +++|.+++... .....+++..++.|+.||++||+|||+++
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~- 231 (413)
T 3dzo_A 154 FDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYG- 231 (413)
T ss_dssp CEEEECCC---------------CCSEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTT-
T ss_pred hhhcccCCCCccccccCCCccccccceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCC-
Confidence 111 12346777766 68999988521 12235889999999999999999999999
Q ss_pred CCeeccCCCCCcEEEcCCCcEEEeeccCccccccCCcceeeeeeccCCCCChhhh----------ccCCCCCccchHhHH
Q 044312 396 IPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHGTFGYLDPEYF----------RSSQFTDKSDVYSFG 465 (608)
Q Consensus 396 ~~iiHrDlk~~NILl~~~~~~kl~DFGls~~~~~~~~~~~~~~~gt~~y~aPE~~----------~~~~~t~ksDV~S~G 465 (608)
|+||||||+|||++.++.+||+|||+++..... .....| +.|+|||++ ....++.++||||||
T Consensus 232 --iiHrDiKp~NILl~~~~~~kL~DFG~a~~~~~~----~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwSlG 304 (413)
T 3dzo_A 232 --LVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGAS----AVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLG 304 (413)
T ss_dssp --EECSCCCGGGEEECTTCCEEECCGGGCEETTEE----ECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHHHH
T ss_pred --cccCCcccceEEEecCCeEEEEeccceeecCCc----cccCCC-CceeCchhhhccccccccccCcCCCchhhHHHHH
Confidence 999999999999999999999999998865432 344567 999999999 555688999999999
Q ss_pred HHHHHHHhCCCCCCccchhhcccHHHHHHHHhhhhhhHHHhhhhhhccCChhHHHHHHHHHHHHhccCCCCCCCHHHHHH
Q 044312 466 VVLTELLTGEKPIRFTILEEDKSLAAYFLCAMKEERLFEILDARVMKQGGKDEIITVAKLAKRCLNLNGKKRPTMREVAS 545 (608)
Q Consensus 466 vvl~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~evl~ 545 (608)
|++|||++|+.||........ ...++ ......+..+.+|+.+||+.||++||++.|+++
T Consensus 305 vil~elltg~~Pf~~~~~~~~---------------~~~~~------~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~~l~ 363 (413)
T 3dzo_A 305 LAIYWIWCADLPNTDDAALGG---------------SEWIF------RSCKNIPQPVRALLEGFLRYPKEDRLLPLQAME 363 (413)
T ss_dssp HHHHHHHHSSCCCCTTGGGSC---------------SGGGG------SSCCCCCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred HHHHHHHHCCCCCCCcchhhh---------------HHHHH------hhcccCCHHHHHHHHHHccCChhhCcCHHHHHh
Confidence 999999999999974322111 01111 111234568999999999999999999999876
Q ss_pred H
Q 044312 546 E 546 (608)
Q Consensus 546 ~ 546 (608)
+
T Consensus 364 ~ 364 (413)
T 3dzo_A 364 T 364 (413)
T ss_dssp S
T ss_pred C
Confidence 4
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=4.2e-32 Score=278.43 Aligned_cols=215 Identities=23% Similarity=0.314 Sum_probs=164.5
Q ss_pred cCcccc-ceeccCce---------------EEEEEeecChhhHHHHHHHHHHH-hhcCCCCccceeccccc----Cccce
Q 044312 289 DNFDLN-RILGQGGQ---------------AVKKSKVIDESKVEEFINEVVIL-SQINHRNVVKLLGCCLE----TEVPL 347 (608)
Q Consensus 289 ~~f~~~-~~lG~G~~---------------avk~~~~~~~~~~~~~~~Ei~il-~~l~H~niv~l~~~~~~----~~~~~ 347 (608)
++|.+. +.||+|++ |+|..+. ...+.+|+.++ +.++||||+++++++.. ....+
T Consensus 17 ~~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~-----~~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~ 91 (299)
T 3m2w_A 17 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD-----CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLL 91 (299)
T ss_dssp GTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEC-----SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEE
T ss_pred cchhhcCcccccCCCeEEEEEEEcCCCcEEEEEEecc-----cHHHHHHHHHHHHhccCCCchhHHhhhhhhcCCCceEE
Confidence 456666 77999974 5665542 35678899888 55699999999999876 67789
Q ss_pred EEEeecCCCccchhccccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEEcC---CCcEEEeeccCc
Q 044312 348 LVYEFIPNGTLFQYIHDQNEDFPITWEIRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDD---KYRAKVSDFGAS 424 (608)
Q Consensus 348 lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~---~~~~kl~DFGls 424 (608)
+||||+++++|.+++..... ..+++..++.++.|++.||+|||+.+ |+||||||+|||++. ++.+||+|||++
T Consensus 92 lv~e~~~~~~L~~~l~~~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~~~kl~Dfg~a 167 (299)
T 3m2w_A 92 IVMECLDGGELFSRIQDRGD-QAFTEREASEIMKSIGEAIQYLHSIN---IAHRDVKPENLLYTSKRPNAILKLTDFGFA 167 (299)
T ss_dssp EEECCCCSCBHHHHHHHCTT-CCCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESSSSTTCCEEECCCTTC
T ss_pred EEEeecCCCcHHHHHHhccC-CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEecCCCCCcEEEeccccc
Confidence 99999999999999987543 25999999999999999999999999 999999999999998 788999999998
Q ss_pred cccccCCcceeeeeeccCCCCChhhhccCCCCCccchHhHHHHHHHHHhCCCCCCccchhhcccHHHHHHHHhhhhhhHH
Q 044312 425 RSMAVDQTHMTTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLTELLTGEKPIRFTILEEDKSLAAYFLCAMKEERLFE 504 (608)
Q Consensus 425 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~ 504 (608)
+... ...++.++||||||++++||++|+.||........ .......
T Consensus 168 ~~~~-----------------------~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~-----------~~~~~~~ 213 (299)
T 3m2w_A 168 KETT-----------------------GEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAI-----------SPGMKTR 213 (299)
T ss_dssp EECT-----------------------TCGGGGHHHHHHHHHHHHHHHHSSCSCCC------------------CCSCCS
T ss_pred cccc-----------------------cccCCchhhHHHHHHHHHHHHHCCCCCCCCcchhh-----------hHHHHHH
Confidence 6532 13467899999999999999999999863221100 0000000
Q ss_pred HhhhhhhccCC----hhHHHHHHHHHHHHhccCCCCCCCHHHHHHHHH
Q 044312 505 ILDARVMKQGG----KDEIITVAKLAKRCLNLNGKKRPTMREVASELA 548 (608)
Q Consensus 505 ~~d~~~~~~~~----~~~~~~l~~Li~~cl~~dp~~RPs~~evl~~L~ 548 (608)
+.... ...+ ...+.++.+|+.+||+.||++|||+.|++++-.
T Consensus 214 ~~~~~--~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~e~l~hp~ 259 (299)
T 3m2w_A 214 IRMGQ--YEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPW 259 (299)
T ss_dssp SCTTC--CSSCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHH
T ss_pred Hhhcc--ccCCchhcccCCHHHHHHHHHHcccChhhCCCHHHHhcChh
Confidence 00000 0001 234568999999999999999999999998643
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A | Back alignment and structure |
|---|
Probab=99.97 E-value=2.7e-32 Score=284.63 Aligned_cols=229 Identities=16% Similarity=0.189 Sum_probs=169.8
Q ss_pred hcCccccceeccCce-------------EEEEEeecC--------hhhHHHHHHHHHHHhhcC-----------------
Q 044312 288 TDNFDLNRILGQGGQ-------------AVKKSKVID--------ESKVEEFINEVVILSQIN----------------- 329 (608)
Q Consensus 288 t~~f~~~~~lG~G~~-------------avk~~~~~~--------~~~~~~~~~Ei~il~~l~----------------- 329 (608)
.++|++.+.||+|+| |||++.... ....+.+.+|+.+|+.++
T Consensus 19 ~~~y~~~~~lG~G~~g~V~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv~l~ 98 (336)
T 2vuw_A 19 TEKLQRCEKIGEGVFGEVFQTIADHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIGLN 98 (336)
T ss_dssp HHHHHTCEEEEEETTEEEEEEEETTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBCCEE
T ss_pred cccchheeeecccCceEEEEEEeCCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchhhhc
Confidence 356888999999974 788876532 234588999999999886
Q ss_pred ---------CCCccceeccccc-------------CccceEEEeecCCCccchhccccCCCCCCCHHHHHHHHHHHHHHH
Q 044312 330 ---------HRNVVKLLGCCLE-------------TEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEIRLRIAIEVSGAL 387 (608)
Q Consensus 330 ---------H~niv~l~~~~~~-------------~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL 387 (608)
||||+++++++.+ ....+|||||+++|+|.+.+.+ ..+++..+..|+.||+.||
T Consensus 99 ~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~----~~~~~~~~~~i~~qi~~aL 174 (336)
T 2vuw_A 99 SVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRT----KLSSLATAKSILHQLTASL 174 (336)
T ss_dssp EEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTT----TCCCHHHHHHHHHHHHHHH
T ss_pred ceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHh----cCCCHHHHHHHHHHHHHHH
Confidence 5666666666654 6789999999999987777744 2489999999999999999
Q ss_pred HHHh-hcCCCCeeccCCCCCcEEEcCCC--------------------cEEEeeccCccccccCCcceeeeeeccCCCCC
Q 044312 388 SYLH-SAASIPIYHRDIKSTNILLDDKY--------------------RAKVSDFGASRSMAVDQTHMTTQVHGTFGYLD 446 (608)
Q Consensus 388 ~yLH-~~~~~~iiHrDlk~~NILl~~~~--------------------~~kl~DFGls~~~~~~~~~~~~~~~gt~~y~a 446 (608)
+||| +.+ |+||||||+|||++.++ .+||+|||+++..... ...||+.|+|
T Consensus 175 ~~lH~~~~---ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~~------~~~gt~~y~a 245 (336)
T 2vuw_A 175 AVAEASLR---FEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDG------IVVFCDVSMD 245 (336)
T ss_dssp HHHHHHHC---CBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEETT------EEECCCCTTC
T ss_pred HHHHHhCC---EeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCCC------cEEEeecccC
Confidence 9999 899 99999999999999886 8999999999876432 3469999999
Q ss_pred hhhhccCCCCCccchHhHHHH-HHHHHhCCCCCCccchhhcccHHHHHHHHhhhhhhHHHhhhhhhccCChhHHHHHHHH
Q 044312 447 PEYFRSSQFTDKSDVYSFGVV-LTELLTGEKPIRFTILEEDKSLAAYFLCAMKEERLFEILDARVMKQGGKDEIITVAKL 525 (608)
Q Consensus 447 PE~~~~~~~t~ksDV~S~Gvv-l~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~L 525 (608)
||++.+.. +.++|||||+.+ .+++++|..||.... ........+..... .............+.++.+|
T Consensus 246 PE~~~g~~-~~~~Diwsl~~~~~~~~~~g~~p~~~~~------~~~~~~~~~~~~~~---~~~~~~~~~~~~~s~~~~dl 315 (336)
T 2vuw_A 246 EDLFTGDG-DYQFDIYRLMKKENNNRWGEYHPYSNVL------WLHYLTDKMLKQMT---FKTKCNTPAMKQIKRKIQEF 315 (336)
T ss_dssp SGGGCCCS-SHHHHHHHHHHHHHTTCTTSCCTHHHHH------HHHHHHHHHHHTCC---CSSCCCSHHHHHHHHHHHHH
T ss_pred hhhhcCCC-ccceehhhhhCCCCcccccccCCCcchh------hhhHHHHhhhhhhc---cCcccchhhhhhcCHHHHHH
Confidence 99998766 889999998777 777888999974100 00000000000000 00000001123567789999
Q ss_pred HHHHhccCCCCCCCHHHHH
Q 044312 526 AKRCLNLNGKKRPTMREVA 544 (608)
Q Consensus 526 i~~cl~~dp~~RPs~~evl 544 (608)
+.+||+.| |++|++
T Consensus 316 i~~~L~~d-----sa~e~l 329 (336)
T 2vuw_A 316 HRTMLNFS-----SATDLL 329 (336)
T ss_dssp HHHGGGSS-----SHHHHH
T ss_pred HHHHhccC-----CHHHHH
Confidence 99999976 898887
|
| >4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=2e-28 Score=272.85 Aligned_cols=165 Identities=20% Similarity=0.170 Sum_probs=123.6
Q ss_pred eEEEEEeec----------ChhhHHHHHHHHHHHhhc-CCCCccceecccccCccceEEEeecCCCccchhccccCCCCC
Q 044312 302 QAVKKSKVI----------DESKVEEFINEVVILSQI-NHRNVVKLLGCCLETEVPLLVYEFIPNGTLFQYIHDQNEDFP 370 (608)
Q Consensus 302 ~avk~~~~~----------~~~~~~~~~~Ei~il~~l-~H~niv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~ 370 (608)
++||.+... .+...++|.+|+++|+++ +|+||+++++++.++...||||||++|++|.++|.... +
T Consensus 262 ~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~~yLVMEyv~G~~L~d~i~~~~---~ 338 (569)
T 4azs_A 262 YVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQSGWLVMEKLPGRLLSDMLAAGE---E 338 (569)
T ss_dssp EEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSEEEEEEECCCSEEHHHHHHTTC---C
T ss_pred eEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCEEEEEEecCCCCcHHHHHHhCC---C
Confidence 488877542 123456799999999999 79999999999999999999999999999999998654 4
Q ss_pred CCHHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEEcCCCcEEEeeccCccccccCCcceeeeeeccCCCCChhhh
Q 044312 371 ITWEIRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHGTFGYLDPEYF 450 (608)
Q Consensus 371 l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGls~~~~~~~~~~~~~~~gt~~y~aPE~~ 450 (608)
++.. +|+.||+.||+|||+++ |+||||||+||||++++.+||+|||+|+....+.. ..+...||+.|||||++
T Consensus 339 l~~~---~I~~QIl~AL~ylH~~G---IIHRDIKPeNILL~~dg~vKL~DFGlAr~~~~~~~-~~~t~vGTp~YmAPE~l 411 (569)
T 4azs_A 339 IDRE---KILGSLLRSLAALEKQG---FWHDDVRPWNVMVDARQHARLIDFGSIVTTPQDCS-WPTNLVQSFFVFVNELF 411 (569)
T ss_dssp CCHH---HHHHHHHHHHHHHHHTT---CEESCCCGGGEEECTTSCEEECCCTTEESCC---C-CSHHHHHHHHHHHHHHC
T ss_pred CCHH---HHHHHHHHHHHHHHHCC---ceeccCchHhEEECCCCCEEEeecccCeeCCCCCc-cccCceechhhccHHHh
Confidence 6654 58899999999999999 99999999999999999999999999987654433 23446799999999998
Q ss_pred ccCCCCCccchHhHHHHHHHHHhCCCC
Q 044312 451 RSSQFTDKSDVYSFGVVLTELLTGEKP 477 (608)
Q Consensus 451 ~~~~~t~ksDV~S~Gvvl~elltg~~p 477 (608)
.+ .+..++|+||+|++++++.++..+
T Consensus 412 ~g-~~~~~~d~~s~g~~~~~l~~~~~~ 437 (569)
T 4azs_A 412 AE-NKSWNGFWRSAPVHPFNLPQPWSN 437 (569)
T ss_dssp ------------------CCCCTTHHH
T ss_pred CC-CCCCcccccccccchhhhccccch
Confidence 75 567789999999998887665443
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* | Back alignment and structure |
|---|
Probab=99.87 E-value=2.6e-23 Score=230.23 Aligned_cols=148 Identities=16% Similarity=0.207 Sum_probs=127.4
Q ss_pred HHHHHHHHHHHhhcCCCCccceecccccCccceEEEeecCCCccchhccccCCCCCCCHHHHHHHHHHHHHHHHHHhhcC
Q 044312 315 VEEFINEVVILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEIRLRIAIEVSGALSYLHSAA 394 (608)
Q Consensus 315 ~~~~~~Ei~il~~l~H~niv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~ 394 (608)
.+.|.+|+++|++++||||+++..++...+..+|||||+++++|.+++.. ++.++.|+++||+|||+++
T Consensus 383 ~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lVmE~~~ggsL~~~l~~-----------~~~i~~qi~~aL~~LH~~g 451 (540)
T 3en9_A 383 KSRTAREARYLALVKDFGIPAPYIFDVDLDNKRIMMSYINGKLAKDVIED-----------NLDIAYKIGEIVGKLHKND 451 (540)
T ss_dssp HHHHHHHHHHHHHGGGGTCCCCCEEEEETTTTEEEEECCCSEEHHHHSTT-----------CTHHHHHHHHHHHHHHHTT
T ss_pred HHHHHHHHHHHHhcCCCCcCceEEEEEeCCccEEEEECCCCCCHHHHHHH-----------HHHHHHHHHHHHHHHHHCc
Confidence 45689999999999999999766666677788999999999999999875 4589999999999999999
Q ss_pred CCCeeccCCCCCcEEEcCCCcEEEeeccCccccccCCcce------eeeeeccCCCCChhhhcc--CCCCCccchHhHHH
Q 044312 395 SIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHM------TTQVHGTFGYLDPEYFRS--SQFTDKSDVYSFGV 466 (608)
Q Consensus 395 ~~~iiHrDlk~~NILl~~~~~~kl~DFGls~~~~~~~~~~------~~~~~gt~~y~aPE~~~~--~~~t~ksDV~S~Gv 466 (608)
|+||||||+|||+++ .+||+|||+++......... .....||+.|||||++.. ..|+.++|+||..+
T Consensus 452 ---IiHrDiKp~NILl~~--~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl 526 (540)
T 3en9_A 452 ---VIHNDLTTSNFIFDK--DLYIIDFGLGKISNLDEDKAVDLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIIL 526 (540)
T ss_dssp ---EECTTCCTTSEEESS--SEEECCCTTCEECCCHHHHHHHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHH
T ss_pred ---CccCCCCHHHEEECC--eEEEEECccCEECCCccccccchhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHH
Confidence 999999999999998 99999999999875432221 235679999999999987 56888999999999
Q ss_pred HHHHHHhCCCCC
Q 044312 467 VLTELLTGEKPI 478 (608)
Q Consensus 467 vl~elltg~~p~ 478 (608)
-.++-+.++.+|
T Consensus 527 ~~l~~v~~r~rY 538 (540)
T 3en9_A 527 ELMKDVERRARY 538 (540)
T ss_dssp HHHHHHHTCSCC
T ss_pred HHHHHHHhcccc
Confidence 888888777665
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* | Back alignment and structure |
|---|
Probab=99.77 E-value=4.9e-19 Score=179.84 Aligned_cols=140 Identities=17% Similarity=0.162 Sum_probs=108.8
Q ss_pred HHHHHHHhcCccccceeccCce--------------EEEEEeecCh------------------hhHHHHHHHHHHHhhc
Q 044312 281 SKELEKATDNFDLNRILGQGGQ--------------AVKKSKVIDE------------------SKVEEFINEVVILSQI 328 (608)
Q Consensus 281 ~~~l~~~t~~f~~~~~lG~G~~--------------avk~~~~~~~------------------~~~~~~~~Ei~il~~l 328 (608)
...+......|.+.+.||+|++ |||..+.... .....+.+|+.+|+++
T Consensus 82 l~~~~~~~~~~~~~~~iG~G~~g~Vy~~~~~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l 161 (282)
T 1zar_A 82 LHRLVRSGKVDAIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKL 161 (282)
T ss_dssp HHHHHHTTSCSEEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHT
T ss_pred HHHHHhCCeEEEecCEeccCCCceEEEEEeCCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhc
Confidence 3344555666778899999974 6776643211 2356799999999999
Q ss_pred CCCCccceecccccCccceEEEeecCCCccchhccccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcE
Q 044312 329 NHRNVVKLLGCCLETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEIRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNI 408 (608)
Q Consensus 329 ~H~niv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NI 408 (608)
+ | +++.+++ +.+..++||||+++++|.+ +.. .....++.|++.||.|||+.+ |+||||||+||
T Consensus 162 ~--~-~~v~~~~-~~~~~~lvmE~~~g~~L~~-l~~---------~~~~~i~~qi~~~l~~lH~~g---iiHrDlkp~NI 224 (282)
T 1zar_A 162 Q--G-LAVPKVY-AWEGNAVLMELIDAKELYR-VRV---------ENPDEVLDMILEEVAKFYHRG---IVHGDLSQYNV 224 (282)
T ss_dssp T--T-SSSCCEE-EEETTEEEEECCCCEEGGG-CCC---------SCHHHHHHHHHHHHHHHHHTT---EECSCCSTTSE
T ss_pred c--C-CCcCeEE-eccceEEEEEecCCCcHHH-cch---------hhHHHHHHHHHHHHHHHHHCC---CEeCCCCHHHE
Confidence 9 5 6777755 3466799999999999988 422 123469999999999999999 99999999999
Q ss_pred EEcCCCcEEEeeccCccccccCCcceeeeeeccCCCCChhhhcc
Q 044312 409 LLDDKYRAKVSDFGASRSMAVDQTHMTTQVHGTFGYLDPEYFRS 452 (608)
Q Consensus 409 Ll~~~~~~kl~DFGls~~~~~~~~~~~~~~~gt~~y~aPE~~~~ 452 (608)
|++ ++.+||+|||+++. +..++|||++..
T Consensus 225 Ll~-~~~vkl~DFG~a~~--------------~~~~~a~e~l~r 253 (282)
T 1zar_A 225 LVS-EEGIWIIDFPQSVE--------------VGEEGWREILER 253 (282)
T ss_dssp EEE-TTEEEECCCTTCEE--------------TTSTTHHHHHHH
T ss_pred EEE-CCcEEEEECCCCeE--------------CCCCCHHHHHHH
Confidence 999 99999999999863 345789998753
|
| >1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A* | Back alignment and structure |
|---|
Probab=99.51 E-value=1.3e-14 Score=145.21 Aligned_cols=97 Identities=21% Similarity=0.171 Sum_probs=76.5
Q ss_pred HHHHHHHHHHhhcCCCCc--cceecccccCccceEEEeecCC-C----ccchhccccCCCCCCCHHHHHHHHHHHHHHHH
Q 044312 316 EEFINEVVILSQINHRNV--VKLLGCCLETEVPLLVYEFIPN-G----TLFQYIHDQNEDFPITWEIRLRIAIEVSGALS 388 (608)
Q Consensus 316 ~~~~~Ei~il~~l~H~ni--v~l~~~~~~~~~~~lV~E~~~~-g----sL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~ 388 (608)
..+.+|+.+|++++|+++ ++++.. ...+|||||+.+ | +|.++... .++..+..++.|++.||.
T Consensus 115 ~~~~~E~~~l~~l~~~~i~~p~~~~~----~~~~lVmE~~g~~g~~~~~L~~~~~~------~~~~~~~~i~~qi~~~l~ 184 (258)
T 1zth_A 115 IWTEKEFRNLERAKEAGVSVPQPYTY----MKNVLLMEFIGEDELPAPTLVELGRE------LKELDVEGIFNDVVENVK 184 (258)
T ss_dssp HHHHHHHHHHHHHHHTTCCCCCEEEE----ETTEEEEECCEETTEECCBHHHHGGG------GGGSCHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHHHhCCCCCCeEEEc----CCCEEEEEecCCCCCccccHHHHhhc------cChHHHHHHHHHHHHHHH
Confidence 368899999999988764 444432 467899999942 4 44444322 234456789999999999
Q ss_pred HHh-hcCCCCeeccCCCCCcEEEcCCCcEEEeeccCcccc
Q 044312 389 YLH-SAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSM 427 (608)
Q Consensus 389 yLH-~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGls~~~ 427 (608)
||| +.+ |+||||||+|||+++ .++|+|||++...
T Consensus 185 ~lH~~~g---ivHrDlkp~NILl~~--~~~liDFG~a~~~ 219 (258)
T 1zth_A 185 RLYQEAE---LVHADLSEYNIMYID--KVYFIDMGQAVTL 219 (258)
T ss_dssp HHHHTSC---EECSSCSTTSEEESS--SEEECCCTTCEET
T ss_pred HHHHHCC---EEeCCCCHHHEEEcC--cEEEEECcccccC
Confidence 999 888 999999999999998 9999999999754
|
| >4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A | Back alignment and structure |
|---|
Probab=99.29 E-value=4e-12 Score=133.19 Aligned_cols=131 Identities=11% Similarity=0.113 Sum_probs=86.7
Q ss_pred HHHHhcCccccceeccCce--------------EEEEEeec--------------ChhhHHHHHHHHHHHhhcCCCCccc
Q 044312 284 LEKATDNFDLNRILGQGGQ--------------AVKKSKVI--------------DESKVEEFINEVVILSQINHRNVVK 335 (608)
Q Consensus 284 l~~~t~~f~~~~~lG~G~~--------------avk~~~~~--------------~~~~~~~~~~Ei~il~~l~H~niv~ 335 (608)
+.+-..-|++.+.||+|++ |||..+.. ........+.+.++.....|+|+++
T Consensus 90 L~~rg~iY~I~~~IG~Gk~a~VY~a~d~~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~r 169 (397)
T 4gyi_A 90 HAARKDVYSVGSRIGVGKESDIMIVADEKGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKA 169 (397)
T ss_dssp HHHTTSCSEEEEEEEECSSEEEEEEECTTCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHH
T ss_pred HHHCCCEEEecCEeeeCCceEEEEEECCCCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHH
Confidence 3333344899999999984 78865421 0111222333333333334455544
Q ss_pred eecccccC------ccceEEEeecCCCccchhccccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEE
Q 044312 336 LLGCCLET------EVPLLVYEFIPNGTLFQYIHDQNEDFPITWEIRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNIL 409 (608)
Q Consensus 336 l~~~~~~~------~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NIL 409 (608)
++...... ...+|||||+++++|.++.... ....++.||+.+|.|||+.+ ||||||||.|||
T Consensus 170 L~~~gv~vp~p~~~~~~~LVME~i~G~~L~~l~~~~---------~~~~l~~qll~~l~~lH~~g---IVHrDLKp~NIL 237 (397)
T 4gyi_A 170 LYEEGFPVPEPIAQSRHTIVMSLVDALPMRQVSSVP---------DPASLYADLIALILRLAKHG---LIHGDFNEFNIL 237 (397)
T ss_dssp HHHTTCSCCCEEEEETTEEEEECCSCEEGGGCCCCS---------CHHHHHHHHHHHHHHHHHTT---EECSCCSTTSEE
T ss_pred HHhcCCCCCeeeeccCceEEEEecCCccHhhhcccH---------HHHHHHHHHHHHHHHHHHCC---CcCCCCCHHHEE
Confidence 44332211 2336999999998887654321 23467899999999999999 999999999999
Q ss_pred EcCCC----------cEEEeeccCccc
Q 044312 410 LDDKY----------RAKVSDFGASRS 426 (608)
Q Consensus 410 l~~~~----------~~kl~DFGls~~ 426 (608)
+++++ .+.|+||+-+..
T Consensus 238 l~~dgd~~d~~~~~~~~~iID~~Q~V~ 264 (397)
T 4gyi_A 238 IREEKDAEDPSSITLTPIIIXFPQMVS 264 (397)
T ss_dssp EEEEECSSCTTSEEEEEEECCCTTCEE
T ss_pred EeCCCCcccccccccceEEEEeCCccc
Confidence 98776 389999997754
|
| >3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A* | Back alignment and structure |
|---|
Probab=98.90 E-value=2.2e-09 Score=106.82 Aligned_cols=116 Identities=16% Similarity=0.088 Sum_probs=88.2
Q ss_pred eEEEEEeecChhhHHHHHHHHHHHhhcC-CCCccceecccccCccceEEEeecCCCccchhccccCCCCCCCHHHHHHHH
Q 044312 302 QAVKKSKVIDESKVEEFINEVVILSQIN-HRNVVKLLGCCLETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEIRLRIA 380 (608)
Q Consensus 302 ~avk~~~~~~~~~~~~~~~Ei~il~~l~-H~niv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~ 380 (608)
+++|............+.+|+.+|+.+. |..+.++++++.+.+..++||||++|.+|.+.+.. ......++
T Consensus 40 ~vlK~~~~~~~~~~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i~G~~l~~~~~~--------~~~~~~~~ 111 (263)
T 3tm0_A 40 LYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLLMSEADGVLCSEEYED--------EQSPEKII 111 (263)
T ss_dssp EEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCSSEEHHHHCCT--------TTCHHHHH
T ss_pred EEEEeCCcccCCCHHHHHHHHHHHHHHhcCCCCCeEEEEEecCCceEEEEEecCCeehhhccCC--------cccHHHHH
Confidence 4666655322233456899999999994 67888999999888889999999999998775421 11234678
Q ss_pred HHHHHHHHHHhhcC--------------------------------------------------------CCCeeccCCC
Q 044312 381 IEVSGALSYLHSAA--------------------------------------------------------SIPIYHRDIK 404 (608)
Q Consensus 381 ~~ia~aL~yLH~~~--------------------------------------------------------~~~iiHrDlk 404 (608)
.+++++|..||+.. ...++|+|++
T Consensus 112 ~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~~~~~~~~~l~HgDl~ 191 (263)
T 3tm0_A 112 ELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDTPFKDPRELYDFLKTEKPEEELVFSHGDLG 191 (263)
T ss_dssp HHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGGSTTCSSSSHHHHHHHHHHCCCCCCEEEECSSCC
T ss_pred HHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhccccccccccccccccCCCHHHHHHHHHhcCCCCCceEECCCCC
Confidence 89999999999811 1238999999
Q ss_pred CCcEEEcCCCcEEEeeccCcc
Q 044312 405 STNILLDDKYRAKVSDFGASR 425 (608)
Q Consensus 405 ~~NILl~~~~~~kl~DFGls~ 425 (608)
|.|||++++..+.|+||+.+.
T Consensus 192 ~~Nil~~~~~~~~lIDwe~a~ 212 (263)
T 3tm0_A 192 DSNIFVKDGKVSGFIDLGRSG 212 (263)
T ss_dssp TTSEEEETTEEEEECCCTTCE
T ss_pred cCcEEEECCcEEEEEEchhcc
Confidence 999999876667799998764
|
| >3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A | Back alignment and structure |
|---|
Probab=98.60 E-value=5.7e-08 Score=98.91 Aligned_cols=166 Identities=20% Similarity=0.204 Sum_probs=108.5
Q ss_pred ceEEEEEeecChhhHHHHHHHHHHHhhc-CCCC--ccceecccccCc---cceEEEeecCCCccchhccccCCCCCCCHH
Q 044312 301 GQAVKKSKVIDESKVEEFINEVVILSQI-NHRN--VVKLLGCCLETE---VPLLVYEFIPNGTLFQYIHDQNEDFPITWE 374 (608)
Q Consensus 301 ~~avk~~~~~~~~~~~~~~~Ei~il~~l-~H~n--iv~l~~~~~~~~---~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~ 374 (608)
.+.+|... .......+.+|.++|+.+ .+.. +.+++......+ ..++|||+++|.+|.+.... .++..
T Consensus 42 ~~vlR~~~--~~~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~vm~~i~G~~l~~~~~~-----~l~~~ 114 (304)
T 3sg8_A 42 DFIFKFPK--HSRGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAGFTKIKGVPLTPLLLN-----NLPKQ 114 (304)
T ss_dssp SEEEEEES--SHHHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEEEECCCCEECCHHHHH-----TSCHH
T ss_pred EEEEEecC--CcchHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEEEcccCCeECCccccc-----cCCHH
Confidence 35666543 234467899999999988 3333 445555544333 45899999999888754321 36788
Q ss_pred HHHHHHHHHHHHHHHHhhcC-------------------------------------------------------CCCee
Q 044312 375 IRLRIAIEVSGALSYLHSAA-------------------------------------------------------SIPIY 399 (608)
Q Consensus 375 ~~~~i~~~ia~aL~yLH~~~-------------------------------------------------------~~~ii 399 (608)
++..++.++++.|+.||+.. .+.++
T Consensus 115 ~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~~~~~~~~~~~~ 194 (304)
T 3sg8_A 115 SQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQMKKVDDFYRDILENEIYFKYYPCLI 194 (304)
T ss_dssp HHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHHHHHHHHHHHHHTCGGGTCCCCEEE
T ss_pred HHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccHHHHHHHHHHHHhccccccCCceeE
Confidence 88889999999999999621 13489
Q ss_pred ccCCCCCcEEEcC--CCcEEEeeccCccccccCCcceeeeeeccCCC---CChhhhcc-----CCC---------CCccc
Q 044312 400 HRDIKSTNILLDD--KYRAKVSDFGASRSMAVDQTHMTTQVHGTFGY---LDPEYFRS-----SQF---------TDKSD 460 (608)
Q Consensus 400 HrDlk~~NILl~~--~~~~kl~DFGls~~~~~~~~~~~~~~~gt~~y---~aPE~~~~-----~~~---------t~ksD 460 (608)
|+|++|.|||+++ ...+.|.||+.+....... ........ ..|+.... +.. .-..+
T Consensus 195 HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~~~-----Dl~~~~~~~~~~~~~~~~~~l~~Y~~~~~~~~~~r~~~~~~ 269 (304)
T 3sg8_A 195 HNDFSSDHILFDTEKNTICGIIDFGDAAISDPDN-----DFISLMEDDEEYGMEFVSKILNHYKHKDIPTVLEKYRMKEK 269 (304)
T ss_dssp CSCCCGGGEEEETTTTEEEEECCCTTCEEECTTH-----HHHTTCCTTTSCCHHHHHHHHHHHTCSCHHHHHHHHHHHHH
T ss_pred eCCCCcccEEEeCCCCCEEEEEeCCCCccCChHH-----HHHHHHhhccccCHHHHHHHHHHcCCCCcHHHHHHHHHHHH
Confidence 9999999999998 5568899999876432100 00001111 22332110 111 11258
Q ss_pred hHhHHHHHHHHHhCCCCC
Q 044312 461 VYSFGVVLTELLTGEKPI 478 (608)
Q Consensus 461 V~S~Gvvl~elltg~~p~ 478 (608)
.|+++.+++.+.+|..+|
T Consensus 270 ~~~l~~~~~~~~~g~~~~ 287 (304)
T 3sg8_A 270 YWSFEKIIYGKEYGYMDW 287 (304)
T ss_dssp HHHHHHHHHHHHTTCHHH
T ss_pred HHHHHHHHHHHHcCCHHH
Confidence 999999999999998775
|
| >3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134} | Back alignment and structure |
|---|
Probab=98.57 E-value=1.6e-07 Score=97.94 Aligned_cols=107 Identities=17% Similarity=0.242 Sum_probs=84.6
Q ss_pred HHHHHHHHHHHhhcC--CCCccceecccccC---ccceEEEeecCCCccchhccccCCCCCCCHHHHHHHHHHHHHHHHH
Q 044312 315 VEEFINEVVILSQIN--HRNVVKLLGCCLET---EVPLLVYEFIPNGTLFQYIHDQNEDFPITWEIRLRIAIEVSGALSY 389 (608)
Q Consensus 315 ~~~~~~Ei~il~~l~--H~niv~l~~~~~~~---~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~y 389 (608)
...+.+|..+++.|. +..+++++.++.+. +..++||||++|..|.+... ..++...+..++.++++.|+.
T Consensus 80 ~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~~~~vme~v~G~~l~~~~~-----~~l~~~~~~~~~~~l~~~La~ 154 (359)
T 3dxp_A 80 AHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGRAFYIMEFVSGRVLWDQSL-----PGMSPAERTAIYDEMNRVIAA 154 (359)
T ss_dssp --CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSSCEEEEECCCCBCCCCTTC-----TTCCHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCCeEEEEEecCCeecCCCcc-----ccCCHHHHHHHHHHHHHHHHH
Confidence 457889999999996 45688999988766 34799999999988754221 136788889999999999999
Q ss_pred HhhcC-------------------------------------------------------CCCeeccCCCCCcEEEcCCC
Q 044312 390 LHSAA-------------------------------------------------------SIPIYHRDIKSTNILLDDKY 414 (608)
Q Consensus 390 LH~~~-------------------------------------------------------~~~iiHrDlk~~NILl~~~~ 414 (608)
||+.. ...++|+|+++.|||++.++
T Consensus 155 LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~ 234 (359)
T 3dxp_A 155 MHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETESIPAMDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTE 234 (359)
T ss_dssp HHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCSCCHHHHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSS
T ss_pred HhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCcCChHHHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCC
Confidence 99831 23499999999999999765
Q ss_pred c--EEEeeccCccc
Q 044312 415 R--AKVSDFGASRS 426 (608)
Q Consensus 415 ~--~kl~DFGls~~ 426 (608)
. +.|.||+.+..
T Consensus 235 ~~v~~viDwe~a~~ 248 (359)
T 3dxp_A 235 PRVLAVLDWELSTL 248 (359)
T ss_dssp SCEEEECCCTTCEE
T ss_pred CcEEEEECcccccc
Confidence 3 68999998864
|
| >1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=98.57 E-value=7.2e-08 Score=95.11 Aligned_cols=111 Identities=18% Similarity=0.195 Sum_probs=82.0
Q ss_pred eEEEEEeecChhhHHHHHHHHHHHhhcCCCC--ccceecccccCccceEEEeecCCCccchhccccCCCCCCCHHHHHHH
Q 044312 302 QAVKKSKVIDESKVEEFINEVVILSQINHRN--VVKLLGCCLETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEIRLRI 379 (608)
Q Consensus 302 ~avk~~~~~~~~~~~~~~~Ei~il~~l~H~n--iv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i 379 (608)
+++|..... ....+.+|+.+++.+.+.+ +.+++++....+..++||||++|.+|. ... .. ...+
T Consensus 47 ~vlK~~~~~---~~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~~~~~~v~e~i~G~~l~--~~~------~~---~~~~ 112 (264)
T 1nd4_A 47 LFVKTDLSG---ALNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQDLL--SSH------LA---PAEK 112 (264)
T ss_dssp EEEEEECSC---TTSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEETT--TSC------CC---HHHH
T ss_pred EEEEeCCcc---cchhhhHHHHHHHHHHhCCCCCCeEEEeccCCCCCEEEEEecCCcccC--cCc------CC---HhHH
Confidence 566665432 3356789999999996544 566888887777889999999998884 211 11 1356
Q ss_pred HHHHHHHHHHHhhcC-------------------------------------------------------CCCeeccCCC
Q 044312 380 AIEVSGALSYLHSAA-------------------------------------------------------SIPIYHRDIK 404 (608)
Q Consensus 380 ~~~ia~aL~yLH~~~-------------------------------------------------------~~~iiHrDlk 404 (608)
+.++++.|..||+.. ...++|+|++
T Consensus 113 ~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~HgDl~ 192 (264)
T 1nd4_A 113 VSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAELFARLKARMPDGEDLVVTHGDAC 192 (264)
T ss_dssp HHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHHHHHHHHHTCCSSCCEEEECSSCC
T ss_pred HHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhhccCccHHHHHHHHHHhcCCCCCeEEECCCCC
Confidence 778888888888743 1129999999
Q ss_pred CCcEEEcCCCcEEEeeccCccc
Q 044312 405 STNILLDDKYRAKVSDFGASRS 426 (608)
Q Consensus 405 ~~NILl~~~~~~kl~DFGls~~ 426 (608)
|.|||++++..++|.||+.+..
T Consensus 193 ~~Nil~~~~~~~~liD~~~a~~ 214 (264)
T 1nd4_A 193 LPNIMVENGRFSGFIDCGRLGV 214 (264)
T ss_dssp GGGEEEETTEEEEECCCTTCEE
T ss_pred CCcEEEECCcEEEEEcchhccc
Confidence 9999998876677999998753
|
| >3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A* | Back alignment and structure |
|---|
Probab=97.86 E-value=7.4e-05 Score=75.89 Aligned_cols=120 Identities=15% Similarity=0.203 Sum_probs=82.0
Q ss_pred CceEEEEEeecChhhHHHHHHHHHHHhhcCCC---Cccceecccc-cCccceEEEeecCCCccchhccccCCCCCCCHHH
Q 044312 300 GGQAVKKSKVIDESKVEEFINEVVILSQINHR---NVVKLLGCCL-ETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEI 375 (608)
Q Consensus 300 G~~avk~~~~~~~~~~~~~~~Ei~il~~l~H~---niv~l~~~~~-~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~ 375 (608)
+.+.+|... .......+.+|.++|+.|.+. .|.+.+.+.. ..+..++|||+++|.+|.+.... .++...
T Consensus 40 ~~~VlR~~~--~~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~~~~v~e~i~G~~l~~~~~~-----~l~~~~ 112 (306)
T 3tdw_A 40 GDWVFRFPK--SQQGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGNPFVGYRKVQGQILGEDGMA-----VLPDDA 112 (306)
T ss_dssp TTEEEEEES--SHHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSCEEEEEECCCSEECHHHHHT-----TSCHHH
T ss_pred CEEEEEecC--CchHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCceEEEEeccCCeECchhhhh-----hCCHHH
Confidence 345666632 234467899999999999652 3566666663 44567899999999888663211 245555
Q ss_pred HHHHHHHHHHHHHHHhhcC---------------------------------------------------------CCCe
Q 044312 376 RLRIAIEVSGALSYLHSAA---------------------------------------------------------SIPI 398 (608)
Q Consensus 376 ~~~i~~~ia~aL~yLH~~~---------------------------------------------------------~~~i 398 (608)
+..++.++++.|+.||+.. ...+
T Consensus 113 ~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~~~~~l~~~~~~~l~~~~~~~~~~~~ 192 (306)
T 3tdw_A 113 KDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDESLRDYLTLRFQSYMTHPVYTRYTPRL 192 (306)
T ss_dssp HHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHHHHHHHHHHHHHHHHCHHHHCCCCEE
T ss_pred HHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccchhhHHHHHHHHHHHHhCcccccCCCee
Confidence 6666666666666666532 2236
Q ss_pred eccCCCCCcEEEcC---CCc-EEEeeccCccc
Q 044312 399 YHRDIKSTNILLDD---KYR-AKVSDFGASRS 426 (608)
Q Consensus 399 iHrDlk~~NILl~~---~~~-~kl~DFGls~~ 426 (608)
+|+|+++.|||+++ ++. ..|.||+.+..
T Consensus 193 ~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~ 224 (306)
T 3tdw_A 193 IHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAI 224 (306)
T ss_dssp ECSCCSGGGEEECTTCSSCCEEEECCCTTCEE
T ss_pred EeCCCCcccEEEecCCCCCceEEEEehhhcCC
Confidence 99999999999987 345 58999997753
|
| >4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A* | Back alignment and structure |
|---|
Probab=97.74 E-value=5.2e-05 Score=75.14 Aligned_cols=115 Identities=20% Similarity=0.198 Sum_probs=81.6
Q ss_pred eEEEEEeecChhhHHHHHHHHHHHhhcC-CCCccceecccccCccceEEEeecCCCccchhccccCCCCCCCHHHHHHHH
Q 044312 302 QAVKKSKVIDESKVEEFINEVVILSQIN-HRNVVKLLGCCLETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEIRLRIA 380 (608)
Q Consensus 302 ~avk~~~~~~~~~~~~~~~Ei~il~~l~-H~niv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~ 380 (608)
+.||... ......+.+|..+|+.|. +--|.++++++.+.+..++|||++++.++.+..... ......++
T Consensus 53 ~~lk~~~---~~~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~~~~lvme~l~G~~~~~~~~~~-------~~~~~~~~ 122 (272)
T 4gkh_A 53 LFLKHGK---GSVANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDAWLLTTAIPGKTAFQVLEEY-------PDSGENIV 122 (272)
T ss_dssp EEEEEEE---THHHHHHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCCSEEHHHHHHHC-------GGGHHHHH
T ss_pred EEEEECC---CCCHhHHHHHHHHHHHhccCCCcCeEEEEEEECCeEEEEEEeeCCccccccccCC-------HHHHHHHH
Confidence 4555543 334567889999999884 334778889888888999999999998776654321 11223455
Q ss_pred HHHHHHHHHHhhcC-------------------------------------------------------CCCeeccCCCC
Q 044312 381 IEVSGALSYLHSAA-------------------------------------------------------SIPIYHRDIKS 405 (608)
Q Consensus 381 ~~ia~aL~yLH~~~-------------------------------------------------------~~~iiHrDlk~ 405 (608)
.++++.|..||+.. .+.++|+|+.+
T Consensus 123 ~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~HGDl~~ 202 (272)
T 4gkh_A 123 DALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPVEQVWKEMHKLLPFSPDSVVTHGDFSL 202 (272)
T ss_dssp HHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTCCHHHHHHHHHTTCCCCCCEEEECSCCCT
T ss_pred HHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccchHHHHHHHHHHhcccccCCcEEEcCCCCC
Confidence 66666666666421 01278999999
Q ss_pred CcEEEcCCCcEEEeeccCccc
Q 044312 406 TNILLDDKYRAKVSDFGASRS 426 (608)
Q Consensus 406 ~NILl~~~~~~kl~DFGls~~ 426 (608)
.|||+++++.+-|.||+.+..
T Consensus 203 ~Nil~~~~~~~~viDwe~a~~ 223 (272)
T 4gkh_A 203 DNLIFDEGKLIGCIDVGRVGI 223 (272)
T ss_dssp TSEEEETTEEEEECCCTTCEE
T ss_pred CeEEEECCeEEEEEECccccc
Confidence 999999887778999998753
|
| >3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A* | Back alignment and structure |
|---|
Probab=97.34 E-value=0.0004 Score=71.76 Aligned_cols=45 Identities=4% Similarity=0.060 Sum_probs=34.0
Q ss_pred HHHHHHHHHHhhcC-C--CCccceecccccC---ccceEEEeecCCCccch
Q 044312 316 EEFINEVVILSQIN-H--RNVVKLLGCCLET---EVPLLVYEFIPNGTLFQ 360 (608)
Q Consensus 316 ~~~~~Ei~il~~l~-H--~niv~l~~~~~~~---~~~~lV~E~~~~gsL~~ 360 (608)
..+.+|+.+|+.|. + -.+.+++.++.+. ...++|||+++|..|.+
T Consensus 72 ~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~~~~~g~~~~v~e~l~G~~l~~ 122 (357)
T 3ats_A 72 YRLDHQFEVIRLVGELTDVPVPRVRWIETTGDVLGTPFFLMDYVEGVVPPD 122 (357)
T ss_dssp CCHHHHHHHHHHHHHHCCSCCCCEEEEECSSTTTSSCEEEEECCCCBCCCB
T ss_pred hHHHHHHHHHHHHhhcCCCCCCcEEEEccCCCccCCceEEEEecCCCChhh
Confidence 56788999988884 3 3577888877655 35689999999877764
|
| >2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis} | Back alignment and structure |
|---|
Probab=96.97 E-value=0.0032 Score=64.09 Aligned_cols=43 Identities=21% Similarity=0.157 Sum_probs=33.1
Q ss_pred HHHHHHHHhh--------c--CCCCeeccCCCCCcEEEcCCCcEEEeeccCcc
Q 044312 383 VSGALSYLHS--------A--ASIPIYHRDIKSTNILLDDKYRAKVSDFGASR 425 (608)
Q Consensus 383 ia~aL~yLH~--------~--~~~~iiHrDlk~~NILl~~~~~~kl~DFGls~ 425 (608)
+.+++.+|+. . ....++|+|+++.|||++.++.+.|.||+.+.
T Consensus 199 ~~~~~~~l~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~ 251 (346)
T 2q83_A 199 GLRIKDRLLQSTYVPWTEQLKKSPNLCHQDYGTGNTLLGENEQIWVIDLDTVS 251 (346)
T ss_dssp HHHHHHHHHHTTHHHHHHHHHHSCCEECSSCSTTSEEECGGGCEEECCCTTCE
T ss_pred HHHHHHHHHhchHHHHHHhccccCceecCCCCcccEEEeCCCcEEEEehhhcc
Confidence 3446667763 1 23459999999999999877889999999764
|
| >2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A | Back alignment and structure |
|---|
Probab=96.79 E-value=0.0046 Score=58.73 Aligned_cols=103 Identities=17% Similarity=0.107 Sum_probs=66.6
Q ss_pred CccchhccccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEEcCCCcEEEeeccCccccccCCccee
Q 044312 356 GTLFQYIHDQNEDFPITWEIRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMT 435 (608)
Q Consensus 356 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGls~~~~~~~~~~~ 435 (608)
-+|.+.|...+. |+++.+++.++.|.+++|.-+-..... ..+=+.|..|++..+|.+...+ ..+.
T Consensus 33 vSL~eIL~~~~~--PlsEEqaWALc~Qc~~~L~~~~~~~~~--~~~i~~~~~i~l~~dG~V~f~~-~~s~---------- 97 (229)
T 2yle_A 33 LSLEEILRLYNQ--PINEEQAWAVCYQCCGSLRAAARRRQP--RHRVRSAAQIRVWRDGAVTLAP-AADD---------- 97 (229)
T ss_dssp EEHHHHHHHHTS--CCCHHHHHHHHHHHHHHHHHHHHTTCC--CCCCCSGGGEEEETTSCEEECC-C-------------
T ss_pred ccHHHHHHHcCC--CcCHHHHHHHHHHHHHHHHhhhhcccC--CceecCCcceEEecCCceeccc-cccc----------
Confidence 378888887654 799999999999999998776221111 1223457899999998887653 1110
Q ss_pred eeeeccCCCCChhhhccCCCCCccchHhHHHHHHHHHhCCCC
Q 044312 436 TQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLTELLTGEKP 477 (608)
Q Consensus 436 ~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~elltg~~p 477 (608)
.....+.|||... ...+.+.-|||+|++||.-+--..|
T Consensus 98 ---~~~~~~~~pe~~~-~~~te~~~IysLG~tLY~ALDygL~ 135 (229)
T 2yle_A 98 ---AGEPPPVAGKLGY-SQCMETEVIESLGIIIYKALDYGLK 135 (229)
T ss_dssp ------------CCSS-SSSCHHHHHHHHHHHHHHHHTTTCC
T ss_pred ---ccccCCCChhhcc-ccchHHHHHHHHHHHHHHHhhcCCC
Confidence 1122456888764 3556788999999999998874443
|
| >3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT} | Back alignment and structure |
|---|
Probab=96.35 E-value=0.011 Score=59.84 Aligned_cols=118 Identities=19% Similarity=0.176 Sum_probs=73.4
Q ss_pred ceEEEEEeecChhhHHHHHHHHHHHhhcC---CCCccceecccccCccceEEEeecCCCccch-----------hccccC
Q 044312 301 GQAVKKSKVIDESKVEEFINEVVILSQIN---HRNVVKLLGCCLETEVPLLVYEFIPNGTLFQ-----------YIHDQN 366 (608)
Q Consensus 301 ~~avk~~~~~~~~~~~~~~~Ei~il~~l~---H~niv~l~~~~~~~~~~~lV~E~~~~gsL~~-----------~l~~~~ 366 (608)
.+.||.... .....|..|.+.|+.|. ...+++++.+....+..++||||+++..+.. .||...
T Consensus 61 ~~vlK~~~~---~~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g~~~lvme~l~G~~~~~~~~~~lG~~LA~LH~~~ 137 (312)
T 3jr1_A 61 TVFVKINER---SYRSMFRAEADQLALLAKTNSINVPLVYGIGNSQGHSFLLLEALNKSKNKQSSFTIFAEKIAQLHQIQ 137 (312)
T ss_dssp EEEEEEEEG---GGHHHHHHHHHHHHHHHHTTSSBCCCEEEEEECSSEEEEEEECCCCCCCCTTHHHHHHHHHHHHHHCC
T ss_pred eEEEEeCCc---ccHHHHHHHHHHHHHHHhhCCCCcceEEEEeecCCceEEEEEeccCCCCCchhHHHHHHHHHHHHcCC
Confidence 355555442 34677899999998883 3668889988877788999999999876531 233321
Q ss_pred C--CC-----------------CCCHHHHH---HHH--HH--------------HHHH-HHHHhhc-CCCCeeccCCCCC
Q 044312 367 E--DF-----------------PITWEIRL---RIA--IE--------------VSGA-LSYLHSA-ASIPIYHRDIKST 406 (608)
Q Consensus 367 ~--~~-----------------~l~~~~~~---~i~--~~--------------ia~a-L~yLH~~-~~~~iiHrDlk~~ 406 (608)
. .. .-+|.... ++. .+ +.+. ...|... ..+.++|+|+.+.
T Consensus 138 ~~~~fG~~~~~~~G~~~q~n~w~~~W~~f~~~~Rl~~~l~~a~~~g~~~~~~~~l~~~l~~~L~~~~~~~~l~HgD~~~~ 217 (312)
T 3jr1_A 138 GPDKYGLDFDTWLGPIYQPNDWQTSWAKFFSENRIGWQLQICKEKGLIFGNIDLIVQIVADTLSKHNPKPSILHGNLWIE 217 (312)
T ss_dssp CCSSBBCSSCEEETTEEECCCCBSCHHHHHHHHTHHHHHHHHHHHTCCCSCHHHHHHHHHHHHTTCCCCCEEECSSCSGG
T ss_pred CCCCCCCCCCCCCCCcCCCCCCcCCHHHHHHHHHHHHHHHHHHHcCCChHHHHHHHHHHHHHhccCCCCceeEeCCCCcC
Confidence 1 00 12454321 111 11 1111 2233221 2345999999999
Q ss_pred cEEEcCCCcEEEeecc
Q 044312 407 NILLDDKYRAKVSDFG 422 (608)
Q Consensus 407 NILl~~~~~~kl~DFG 422 (608)
|++++.++ +.|.|+.
T Consensus 218 N~l~~~~~-~~~iD~~ 232 (312)
T 3jr1_A 218 NCIQVDDK-IFVCNPA 232 (312)
T ss_dssp GEEEETTE-EEECSCC
T ss_pred cEeecCCC-eEEEcCc
Confidence 99999887 8888873
|
| >2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A* | Back alignment and structure |
|---|
Probab=95.65 E-value=0.019 Score=59.95 Aligned_cols=29 Identities=21% Similarity=0.287 Sum_probs=24.7
Q ss_pred CeeccCCCCCcEEEcCCCcEEEeeccCccc
Q 044312 397 PIYHRDIKSTNILLDDKYRAKVSDFGASRS 426 (608)
Q Consensus 397 ~iiHrDlk~~NILl~~~~~~kl~DFGls~~ 426 (608)
.++|+|+.+.|||++++ .++|.||..+..
T Consensus 228 ~L~HGDl~~~Nil~~~~-~~~lID~e~a~~ 256 (397)
T 2olc_A 228 TLIHGDLHTGSIFASEH-ETKVIDPEFAFY 256 (397)
T ss_dssp EEECSCCSGGGEEECSS-CEEECCCTTCEE
T ss_pred ceeeCCCCcCcEEEeCC-CeEEEeCccccc
Confidence 48999999999999876 489999987653
|
| >3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A* | Back alignment and structure |
|---|
Probab=95.43 E-value=0.034 Score=57.89 Aligned_cols=108 Identities=21% Similarity=0.267 Sum_probs=66.5
Q ss_pred hHHHHHHHHHHHhhcC-CCCccceecccccCccceEEEeecCCCccchh-----------------ccccCC--CCCC--
Q 044312 314 KVEEFINEVVILSQIN-HRNVVKLLGCCLETEVPLLVYEFIPNGTLFQY-----------------IHDQNE--DFPI-- 371 (608)
Q Consensus 314 ~~~~~~~Ei~il~~l~-H~niv~l~~~~~~~~~~~lV~E~~~~gsL~~~-----------------l~~~~~--~~~l-- 371 (608)
....+.+|.++++.|. +.-..++++.+.+. +||||++|.+|..- ||.... ..+.
T Consensus 96 ~~~~~~rE~~vl~~L~~~gv~P~ll~~~~~g----~v~e~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~ 171 (379)
T 3feg_A 96 GVDSLVLESVMFAILAERSLGPQLYGVFPEG----RLEQYIPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHW 171 (379)
T ss_dssp CHHHHHHHHHHHHHHHHTTSSCCEEEEETTE----EEEECCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCH
T ss_pred hHHHHHHHHHHHHHHHhcCCCCeEEEEcCCc----cEEEEecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCccc
Confidence 4567779999998884 33336777776542 89999998666421 111110 1112
Q ss_pred CHHHHHHHHHHHHH-------------------HHHHHh----hc-CCCCeeccCCCCCcEEEcCC----CcEEEeeccC
Q 044312 372 TWEIRLRIAIEVSG-------------------ALSYLH----SA-ASIPIYHRDIKSTNILLDDK----YRAKVSDFGA 423 (608)
Q Consensus 372 ~~~~~~~i~~~ia~-------------------aL~yLH----~~-~~~~iiHrDlk~~NILl~~~----~~~kl~DFGl 423 (608)
-|.++.++..++.. .+..|. .. ....++|+|+.+.|||++.+ +.+.|+||..
T Consensus 172 l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~~~~~L~~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~ 251 (379)
T 3feg_A 172 LFGTMERYLKQIQDLPPTGLPEMNLLEMYSLKDEMGNLRKLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEY 251 (379)
T ss_dssp HHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHHHHHHHHHHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTT
T ss_pred HHHHHHHHHHHHHhccCcccchhhhhhhHHHHHHHHHHHHHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEeccc
Confidence 24555555543322 233332 22 12348999999999999876 6899999987
Q ss_pred cc
Q 044312 424 SR 425 (608)
Q Consensus 424 s~ 425 (608)
+.
T Consensus 252 a~ 253 (379)
T 3feg_A 252 SS 253 (379)
T ss_dssp CE
T ss_pred CC
Confidence 75
|
| >3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP} | Back alignment and structure |
|---|
Probab=95.08 E-value=0.03 Score=56.94 Aligned_cols=31 Identities=29% Similarity=0.434 Sum_probs=26.6
Q ss_pred CCeeccCCCCCcEEEcCC----CcEEEeeccCccc
Q 044312 396 IPIYHRDIKSTNILLDDK----YRAKVSDFGASRS 426 (608)
Q Consensus 396 ~~iiHrDlk~~NILl~~~----~~~kl~DFGls~~ 426 (608)
..++|+|+.+.|||++.+ ..+.|.||+.+..
T Consensus 183 ~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~ 217 (333)
T 3csv_A 183 MVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKL 217 (333)
T ss_dssp CEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEE
T ss_pred CeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCc
Confidence 349999999999999874 6799999998764
|
| >3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti} | Back alignment and structure |
|---|
Probab=94.75 E-value=0.041 Score=55.10 Aligned_cols=29 Identities=28% Similarity=0.234 Sum_probs=24.2
Q ss_pred CeeccCCCCCcEEEcCCCcEEEeeccCccc
Q 044312 397 PIYHRDIKSTNILLDDKYRAKVSDFGASRS 426 (608)
Q Consensus 397 ~iiHrDlk~~NILl~~~~~~kl~DFGls~~ 426 (608)
.++|+|+.+.||+ ..++.+.|+||..+..
T Consensus 174 ~l~HgDl~~~Nil-~~~~~~~lID~e~a~~ 202 (301)
T 3dxq_A 174 AACHCDPLCENFL-DTGERMWIVDWEYSGM 202 (301)
T ss_dssp EEECSCCCGGGEE-ECSSCEEECCCTTCEE
T ss_pred eeeccCCCcCCEE-ECCCCEEEEecccccC
Confidence 3899999999999 5566789999987753
|
| >2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=94.74 E-value=0.059 Score=54.25 Aligned_cols=43 Identities=16% Similarity=0.248 Sum_probs=31.4
Q ss_pred HHHHHHHHhhc----CCCCeeccCCCCCcEEEcCCCcEEEeeccCcc
Q 044312 383 VSGALSYLHSA----ASIPIYHRDIKSTNILLDDKYRAKVSDFGASR 425 (608)
Q Consensus 383 ia~aL~yLH~~----~~~~iiHrDlk~~NILl~~~~~~kl~DFGls~ 425 (608)
+.+.++.++.. .+..++|+|+.+.|||++++..+.|.||+.+.
T Consensus 170 l~~~~~~l~~~~~~~~~~~liHgDl~~~Nil~~~~~~~~lIDf~~a~ 216 (322)
T 2ppq_A 170 IRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFAC 216 (322)
T ss_dssp HHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred HHHHHHHHHhhCcccCCcccCCCCCCccCEEEeCCceEEEecchhcc
Confidence 44455666532 12348999999999999987666899998764
|
| >1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8 | Back alignment and structure |
|---|
Probab=94.62 E-value=0.037 Score=58.69 Aligned_cols=40 Identities=28% Similarity=0.420 Sum_probs=28.1
Q ss_pred HHHHHHHHHHhhcCCCCc-cceecccccCccceEEEeecCCCccc
Q 044312 316 EEFINEVVILSQINHRNV-VKLLGCCLETEVPLLVYEFIPNGTLF 359 (608)
Q Consensus 316 ~~~~~Ei~il~~l~H~ni-v~l~~~~~~~~~~~lV~E~~~~gsL~ 359 (608)
+.+.+|..+++.|...++ .++++.+.+ .+|+||++|.+|.
T Consensus 120 ~~li~E~~~l~~L~~~g~~P~l~~~~~~----g~v~e~l~G~~l~ 160 (429)
T 1nw1_A 120 SHLVAESVIFTLLSERHLGPKLYGIFSG----GRLEEYIPSRPLS 160 (429)
T ss_dssp HHHHHHHHHHHHHHHTTSSSCEEEEETT----EEEECCCCEEECC
T ss_pred HHHHHHHHHHHHHHhCCCCCcEEEEeCC----CEEEEEeCCcccC
Confidence 566789999998853334 677776543 3899999875553
|
| >3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A* | Back alignment and structure |
|---|
Probab=94.22 E-value=0.1 Score=53.82 Aligned_cols=28 Identities=29% Similarity=0.461 Sum_probs=23.5
Q ss_pred CeeccCCCCCcEEEcCCCcEEEeeccCcc
Q 044312 397 PIYHRDIKSTNILLDDKYRAKVSDFGASR 425 (608)
Q Consensus 397 ~iiHrDlk~~NILl~~~~~~kl~DFGls~ 425 (608)
.++|+|+.+.|||++++. +.|+||..+.
T Consensus 213 ~l~HgDl~~~Nil~~~~~-~~lID~e~a~ 240 (369)
T 3c5i_A 213 VFCHNDLQENNIINTNKC-LRLIDFEYSG 240 (369)
T ss_dssp EEECSCCCGGGEEECC-C-EEECCCTTCE
T ss_pred EEEeCCCCcccEEecCCc-EEEEEecCCC
Confidence 389999999999998664 8999998764
|
| >2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax} | Back alignment and structure |
|---|
Probab=93.60 E-value=0.17 Score=53.91 Aligned_cols=37 Identities=19% Similarity=0.124 Sum_probs=26.4
Q ss_pred HHHHHHHhhcCCCCc-cceecccccCccceEEEeecCCCccc
Q 044312 319 INEVVILSQINHRNV-VKLLGCCLETEVPLLVYEFIPNGTLF 359 (608)
Q Consensus 319 ~~Ei~il~~l~H~ni-v~l~~~~~~~~~~~lV~E~~~~gsL~ 359 (608)
.+|..+++.|...++ .++++.+.. .+||||++|.+|.
T Consensus 152 ~~E~~vl~~L~~~gl~P~ll~~~~~----G~v~e~I~G~~l~ 189 (458)
T 2qg7_A 152 EREKKISCILYNKNIAKKIYVFFTN----GRIEEFMDGYALS 189 (458)
T ss_dssp HHHHHHHHHHTTSSSBCCEEEEETT----EEEEECCCSEECC
T ss_pred HHHHHHHHHHHhcCCCCCEEEEeCC----eEEEEeeCCccCC
Confidence 589999998865444 577777632 3599999876653
|
| >2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=89.14 E-value=0.31 Score=51.17 Aligned_cols=31 Identities=16% Similarity=0.187 Sum_probs=26.7
Q ss_pred CCeeccCCCCCcEEEcCCCcEEEeeccCcccc
Q 044312 396 IPIYHRDIKSTNILLDDKYRAKVSDFGASRSM 427 (608)
Q Consensus 396 ~~iiHrDlk~~NILl~~~~~~kl~DFGls~~~ 427 (608)
..++|+|+++.|||+++++ ++|.||+.+..-
T Consensus 232 ~~liHGDl~~~Nil~~~~~-~~lID~e~a~~G 262 (420)
T 2pyw_A 232 QALIHGDLHTGSVMVTQDS-TQVIDPEFSFYG 262 (420)
T ss_dssp CEEECSCCSGGGEEECSSC-EEECCCTTCEEE
T ss_pred CeEEecCCCCCcEEEeCCC-CEEEeCcccccC
Confidence 3499999999999998876 999999988653
|
| >3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX} | Back alignment and structure |
|---|
Probab=89.04 E-value=0.91 Score=44.70 Aligned_cols=57 Identities=18% Similarity=0.077 Sum_probs=33.9
Q ss_pred ccCc-eEEEEEeecChhhHHHHHHHHHHHhhcC-C--CCccceecccccCccceEEEeecCCCcc
Q 044312 298 GQGG-QAVKKSKVIDESKVEEFINEVVILSQIN-H--RNVVKLLGCCLETEVPLLVYEFIPNGTL 358 (608)
Q Consensus 298 G~G~-~avk~~~~~~~~~~~~~~~Ei~il~~l~-H--~niv~l~~~~~~~~~~~lV~E~~~~gsL 358 (608)
..|. +.||+...........|..|.+.|+.|. . --+.+++++. ..++||||++++..
T Consensus 37 ~DG~~~~vK~~~~~~~~~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~~----~~~lv~e~l~~~~~ 97 (288)
T 3f7w_A 37 ADGTPLFVKALPDDAPALDGLFRAEALGLDWLGRSFGSPVPQVAGWD----DRTLAMEWVDERPP 97 (288)
T ss_dssp TTSCEEEEEECCTTCCCCTTHHHHHHHHHHHHTCSTTCCSCCEEEEE----TTEEEEECCCCCCC
T ss_pred CCCCEEEEEEeCCCCcchhhHHHHHHHHHHHHHhhCCCCcceEEecc----CceEEEEeecccCC
Confidence 3443 3445433222333456889999999884 2 2345556542 35789999987654
|
| >4ann_A ESSB; membrane protein, membrane secretion, ESS type VII secretion virulence; 1.05A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=85.47 E-value=1.3 Score=41.90 Aligned_cols=116 Identities=7% Similarity=0.072 Sum_probs=76.6
Q ss_pred CCCCccceecccccCccceEEEeecCCCccchhccccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcE
Q 044312 329 NHRNVVKLLGCCLETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEIRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNI 408 (608)
Q Consensus 329 ~H~niv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NI 408 (608)
.||+++.. ..-.+.+...+.|+.-++ ...+-.-. .++...+++++..|+....+++. -+|--|.|+||
T Consensus 43 ~~~~Fl~~-~I~e~eD~v~~~y~~~~~--~~~f~~ik----~~~~~eKlr~l~ni~~l~~~~~~-----r~tf~L~P~NL 110 (215)
T 4ann_A 43 HSPYFIDA-ELTELRDSFQIHYDINDN--HTPFDNIK----SFTKNEKLRYLLNIKNLEEVNRT-----RYTFVLAPDEL 110 (215)
T ss_dssp CCTTBCCE-EEEECSSEEEEEECCCTT--SEEGGGGG----GSCHHHHHHHHHHGGGGGGGGGS-----SEECCCSGGGE
T ss_pred cCCcccce-EEEEcccEEEEEEEcCcc--cCCHHHHH----hcCHHHHHHHHHHHHHHHHHhcC-----ceEEEEecceE
Confidence 67888866 444555555555555433 33322211 37889999999999988866654 45778999999
Q ss_pred EEcCCCcEEEeeccCccccccCCcceeeeeeccCCCCChhhhccCCCCCccchHhHHHHHHHHHhCCCCCC
Q 044312 409 LLDDKYRAKVSDFGASRSMAVDQTHMTTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLTELLTGEKPIR 479 (608)
Q Consensus 409 Ll~~~~~~kl~DFGls~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~elltg~~p~~ 479 (608)
+++.++.+++.-.|+...++ |. ..++..=.-.+=+++..+++++..|.
T Consensus 111 ~f~~~~~p~i~~RGik~~l~------------------P~-----~~~ee~fL~qyKAliiall~~K~~Fe 158 (215)
T 4ann_A 111 FFTRDGLPIAKTRGLQNVVD------------------PL-----PVSEAEFLTRYKALVICAFNEKQSFD 158 (215)
T ss_dssp EECTTSCEEESCCEETTTBS------------------CC-----CCCHHHHHHHHHHHHHHHHCTTCCHH
T ss_pred EEcCCCCEEEEEccCccCCC------------------CC-----CCCHHHHHHHHHHHHHHHHcCCCCHH
Confidence 99999999998777644332 11 11111223356678888999988865
|
| >4ano_A ESSB; membrane protein, membrane secretion, ESS type V secretion S; HET: MSE; 1.70A {Geobacillus thermodenitrificans ng80-2organism_taxid} | Back alignment and structure |
|---|
Probab=83.68 E-value=2 Score=40.67 Aligned_cols=115 Identities=15% Similarity=0.097 Sum_probs=74.5
Q ss_pred CCCCccceecccccCccceEEEeecCCCccchhccccCCCCCCCHHHHHHHHHHHHHHHH-HHhhcCCCCeeccCCCCCc
Q 044312 329 NHRNVVKLLGCCLETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEIRLRIAIEVSGALS-YLHSAASIPIYHRDIKSTN 407 (608)
Q Consensus 329 ~H~niv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~-yLH~~~~~~iiHrDlk~~N 407 (608)
.||++ -...-.+.+...+.|+.-+++.=...++ .++...+++++..|+.... +++. -+|--|.|+|
T Consensus 48 ~~~~f--~~~I~~~eD~~~i~y~~~~~~~~f~~i~------~~~~~eKlrll~nl~~L~~~~~~~-----r~tf~l~P~N 114 (219)
T 4ano_A 48 VDPCI--VRDIDVSEDEVKVVIKPPSSFLTFAAIR------KTTLLSRIRAAIHLVSKVKHHSAR-----RLIFIVCPEN 114 (219)
T ss_dssp SCSSS--EEEEEECSSEEEEEEECCTTCEEHHHHH------TSCHHHHHHHHHHHHHHHSSCCSS-----SEECCCCGGG
T ss_pred cCCCC--CeEEEEeCCEEEEEEEcCcccCcHHHHH------hcCHHHHHHHHHHHHHHHHHhhhC-----ceeEEEeCce
Confidence 67777 3333355666666666554433333332 3788999999999988777 5554 5577899999
Q ss_pred EEEcCCCcEEEeeccCccccccCCcceeeeeeccCCCCChhhhccCCCCCccchHhHHHHHHHHHhCCCCCC
Q 044312 408 ILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLTELLTGEKPIR 479 (608)
Q Consensus 408 ILl~~~~~~kl~DFGls~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~elltg~~p~~ 479 (608)
|+++.++.+++.-.|+-..+++.. +.+|- =.-.+=+++..++.++..|.
T Consensus 115 L~f~~~~~p~i~hRGi~~~lpP~e-------------~~ee~----------fl~qyKali~all~~K~~Fe 163 (219)
T 4ano_A 115 LMFNRALEPFFLHVGVKESLPPDE-------------WDDER----------LLREVKATVLALTEGEYRFD 163 (219)
T ss_dssp EEECTTCCEEESCCEETTTBSSCS-------------CCHHH----------HHHHHHHHHHHHTTCSSCHH
T ss_pred EEEeCCCcEEEEEcCCcccCCCCC-------------CCHHH----------HHHHHHHHHHHHHcCCCCHH
Confidence 999999999998877654332111 11221 12356677778888877654
|
| >3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A* | Back alignment and structure |
|---|
Probab=83.60 E-value=0.98 Score=47.04 Aligned_cols=29 Identities=34% Similarity=0.465 Sum_probs=24.4
Q ss_pred eeccCCCCCcEEE------cCCCcEEEeeccCccc
Q 044312 398 IYHRDIKSTNILL------DDKYRAKVSDFGASRS 426 (608)
Q Consensus 398 iiHrDlk~~NILl------~~~~~~kl~DFGls~~ 426 (608)
++|+|+.+.|||+ +++..++++||..|..
T Consensus 246 fcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~~ 280 (401)
T 3g15_A 246 FCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSSY 280 (401)
T ss_dssp EECSCCCGGGEEEETTGGGCSSCCEEECCCTTCEE
T ss_pred eEEecCCCCeEEEecCcccCcCCeEEEechHhccC
Confidence 5799999999999 4567799999987753
|
| >3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum} | Back alignment and structure |
|---|
Probab=82.35 E-value=3.3 Score=43.49 Aligned_cols=28 Identities=21% Similarity=0.418 Sum_probs=25.0
Q ss_pred CeeccCCCCCcEEEcCCCcEEEeeccCcc
Q 044312 397 PIYHRDIKSTNILLDDKYRAKVSDFGASR 425 (608)
Q Consensus 397 ~iiHrDlk~~NILl~~~~~~kl~DFGls~ 425 (608)
.++|+|+.+.||+ ++++.+.|+||..+.
T Consensus 263 ~~~H~D~~~~N~l-~~~~~~~~IDwe~a~ 290 (424)
T 3mes_A 263 VFAHNDLQENNLL-QTQNNIRMIDYEYSA 290 (424)
T ss_dssp EEECSCCCGGGEE-ECSSCEEECCCTTCE
T ss_pred eEECCCCCcccee-cCCCcEEEEecccCC
Confidence 4899999999999 778899999998775
|
| >1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=81.92 E-value=1.3 Score=44.26 Aligned_cols=28 Identities=25% Similarity=0.311 Sum_probs=24.3
Q ss_pred CeeccCCCCCcEEEcCCCcEEEeeccCccc
Q 044312 397 PIYHRDIKSTNILLDDKYRAKVSDFGASRS 426 (608)
Q Consensus 397 ~iiHrDlk~~NILl~~~~~~kl~DFGls~~ 426 (608)
.++|+|+++.|||++ + .+.|.||+.+..
T Consensus 196 ~l~HgD~~~~Nil~~-~-~~~lIDfe~a~~ 223 (328)
T 1zyl_A 196 LRLHGDCHAGNILWR-D-GPMFVDLDDARN 223 (328)
T ss_dssp EECCSSCSGGGEEES-S-SEEECCCTTCCE
T ss_pred eeeeCCCCcccEeEc-C-CCEEEECCCCCc
Confidence 389999999999999 4 899999987653
|
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST
Original result of RPS-BLAST against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
E-value |
| 608 | ||||
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 2e-63 | |
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 1e-60 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 2e-58 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 2e-57 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 5e-57 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 7e-57 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 5e-56 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 9e-56 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 3e-55 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 2e-54 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 3e-54 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 3e-54 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 5e-54 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 9e-54 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 1e-53 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 1e-53 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 3e-53 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 4e-53 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 5e-53 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 2e-52 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 5e-52 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 9e-52 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 1e-51 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 5e-51 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 8e-51 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 3e-50 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 4e-50 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 4e-50 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 8e-50 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 1e-49 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 2e-48 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 1e-47 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 4e-46 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 7e-46 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 1e-45 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 1e-45 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 3e-45 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 6e-45 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 2e-41 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 5e-40 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 9e-40 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 1e-39 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 2e-39 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 4e-39 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 3e-38 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 5e-38 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 9e-38 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 1e-37 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 1e-37 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 3e-37 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 8e-36 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 2e-35 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 9e-35 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 2e-34 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 4e-34 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 5e-34 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 3e-32 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 5e-32 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 2e-31 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 3e-29 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 3e-28 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 2e-22 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 3e-10 |
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 208 bits (530), Expect = 2e-63
Identities = 62/288 (21%), Positives = 118/288 (40%), Gaps = 35/288 (12%)
Query: 283 ELEKATDNFDLNRILGQGG------------QAVK--KSKVIDESKVEEFINEVVILSQI 328
+ E + + +G G AVK +++ F NEV +L +
Sbjct: 2 DWEIPDGQITVGQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKT 61
Query: 329 NHRNVVKLLGCCLETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEIRLRIAIEVSGALS 388
H N++ +G ++ +V ++ +L+ ++H F + IA + + +
Sbjct: 62 RHVNILLFMGYSTAPQL-AIVTQWCEGSSLYHHLHIIETKFE--MIKLIDIARQTAQGMD 118
Query: 389 YLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQ-THMTTQVHGTFGYLDP 447
YLH+ I HRD+KS NI L + K+ DFG + + +H Q+ G+ ++ P
Sbjct: 119 YLHAK---SIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAP 175
Query: 448 EYFRSSQ---FTDKSDVYSFGVVLTELLTGEKPIRFTILEEDKSLAAYFLCAMKEERLFE 504
E R ++ +SDVY+FG+VL EL+TG+ P + + + + L
Sbjct: 176 EVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPY------SNINNRDQIIFMVGRGYLSP 229
Query: 505 ILDARVMKQGGKDEIITVAKLAKRCLNLNGKKRPTMREVASELAGIKA 552
L + + +L CL +RP ++ + + +
Sbjct: 230 DLSKVR-----SNCPKAMKRLMAECLKKKRDERPLFPQILASIELLAR 272
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 202 bits (515), Expect = 1e-60
Identities = 67/303 (22%), Positives = 119/303 (39%), Gaps = 51/303 (16%)
Query: 284 LEKATDNFDLNRILGQGGQ---------------AVKK-SKVIDESKVEEFINEVVILSQ 327
+E D+F+ LG G A K I + + I E+ +L +
Sbjct: 1 MELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHE 60
Query: 328 INHRNVVKLLGCCLETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEIRLRIAIEVSGAL 387
N +V G + E + G+L Q + I +I +++I V L
Sbjct: 61 CNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAG---RIPEQILGKVSIAVIKGL 117
Query: 388 SYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHGTFGYLDP 447
+YL I HRD+K +NIL++ + K+ DFG S + M GT Y+ P
Sbjct: 118 TYLREKHK--IMHRDVKPSNILVNSRGEIKLCDFGVSGQL---IDSMANSFVGTRSYMSP 172
Query: 448 EYFRSSQFTDKSDVYSFGVVLTELLTGEKPIRFTILEED--------------------- 486
E + + ++ +SD++S G+ L E+ G PI +E
Sbjct: 173 ERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRT 232
Query: 487 --KSLAAYFLCAMKEERLFEILDARVMKQGGKDEIITVAKLAK----RCLNLNGKKRPTM 540
+ L++Y + + +FE+LD V + K + + +CL N +R +
Sbjct: 233 PGRPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADL 292
Query: 541 REV 543
+++
Sbjct: 293 KQL 295
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 195 bits (496), Expect = 2e-58
Identities = 73/297 (24%), Positives = 126/297 (42%), Gaps = 35/297 (11%)
Query: 283 ELEKATDNFDLNRILGQGGQ---------------AVKKSKVIDESKVEEFINEVVILSQ 327
+ E + + LG G AVK K D +VEEF+ E ++ +
Sbjct: 11 KWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLK-EDTMEVEEFLKEAAVMKE 69
Query: 328 INHRNVVKLLGCCLETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEIRLRIAIEVSGAL 387
I H N+V+LLG C ++ EF+ G L Y+ + N ++ + L +A ++S A+
Sbjct: 70 IKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQ-EVSAVVLLYMATQISSAM 128
Query: 388 SYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHGTFGYLDP 447
YL HRD+ + N L+ + + KV+DFG SR M D + P
Sbjct: 129 EYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAP 185
Query: 448 EYFRSSQFTDKSDVYSFGVVLTELLTGEKPIRFTILEEDKSLAAYFLCAMKEERLFEILD 507
E ++F+ KSDV++FGV+L E+ T + +++E+L+
Sbjct: 186 ESLAYNKFSIKSDVWAFGVLLWEIATYGMS---------------PYPGIDLSQVYELLE 230
Query: 508 ARVMKQGGKDEIITVAKLAKRCLNLNGKKRPTMREVASELAGIKAWNGASNVIEEGL 564
+ + V +L + C N RP+ E+ + + S+ +E+ L
Sbjct: 231 KDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQESSISDEVEKEL 287
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 192 bits (488), Expect = 2e-57
Identities = 65/277 (23%), Positives = 125/277 (45%), Gaps = 39/277 (14%)
Query: 289 DNFDLNRILGQGGQ-------------AVKKSKVIDESKVEEFINEVVILSQINHRNVVK 335
L + +G+G AVK K +++ + F+ E +++Q+ H N+V+
Sbjct: 7 KELKLLQTIGKGEFGDVMLGDYRGNKVAVKCIK--NDATAQAFLAEASVMTQLRHSNLVQ 64
Query: 336 LLGCCLETEVPL-LVYEFIPNGTLFQYIHDQNEDFPITWEIRLRIAIEVSGALSYLHSAA 394
LLG +E + L +V E++ G+L Y+ + + + L+ +++V A+ YL
Sbjct: 65 LLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRS-VLGGDCLLKFSLDVCEAMEYLEGN- 122
Query: 395 SIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHGTFGYLDPEYFRSSQ 454
HRD+ + N+L+ + AKVSDFG ++ + + PE R +
Sbjct: 123 --NFVHRDLAARNVLVSEDNVAKVSDFGLTKEA----SSTQDTGKLPVKWTAPEALREKK 176
Query: 455 FTDKSDVYSFGVVLTELLTGEKPIRFTILEEDKSLAAYFLCAMKEERLFEILDARVMKQG 514
F+ KSDV+SFG++L E+ + + I +D + +++ + D
Sbjct: 177 FSTKSDVWSFGILLWEIYSFGRVPYPRIPLKD------VVPRVEKGYKMDAPDGCPPA-- 228
Query: 515 GKDEIITVAKLAKRCLNLNGKKRPTMREVASELAGIK 551
V ++ K C +L+ RP+ ++ +L IK
Sbjct: 229 -------VYEVMKNCWHLDAAMRPSFLQLREQLEHIK 258
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 191 bits (485), Expect = 5e-57
Identities = 67/275 (24%), Positives = 113/275 (41%), Gaps = 33/275 (12%)
Query: 289 DNFDLNRILGQGG-----QAVKKS------KVIDESKV--EEFINEVVILSQINHRNVVK 335
+ +G G + K I E + E+FI E ++ +++H +V+
Sbjct: 5 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQ 64
Query: 336 LLGCCLETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEIRLRIAIEVSGALSYLHSAAS 395
L G CLE LV+EF+ +G L Y+ Q E L + ++V ++YL A
Sbjct: 65 LYGVCLEQAPICLVFEFMEHGCLSDYLRTQR--GLFAAETLLGMCLDVCEGMAYLEEA-- 120
Query: 396 IPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHGTFGYLDPEYFRSSQF 455
+ HRD+ + N L+ + KVSDFG +R + DQ +T + PE F S++
Sbjct: 121 -CVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRY 179
Query: 456 TDKSDVYSFGVVLTELLTGEKPIRFTILEEDKSLAAYFLCAMKEERLFEILDARVMKQGG 515
+ KSDV+SFGV++ E+ + K + E +
Sbjct: 180 SSKSDVWSFGVLMWEVFSEGKI---------------PYENRSNSEVVEDISTGFRLYKP 224
Query: 516 KDEIITVAKLAKRCLNLNGKKRPTMREVASELAGI 550
+ V ++ C + RP + +LA I
Sbjct: 225 RLASTHVYQIMNHCWKERPEDRPAFSRLLRQLAEI 259
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 190 bits (484), Expect = 7e-57
Identities = 57/273 (20%), Positives = 111/273 (40%), Gaps = 35/273 (12%)
Query: 289 DNFDLNRILGQGGQ--------------AVKKSKVIDESKVEEFINEVVILSQINHRNVV 334
+ L LG G AVK K + F+ E ++ Q+ H+ +V
Sbjct: 13 ETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQ-GSMSPDAFLAEANLMKQLQHQRLV 71
Query: 335 KLLGCCLETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEIRLRIAIEVSGALSYLHSAA 394
+L + + ++ E++ NG+L ++ + +T L +A +++ ++++
Sbjct: 72 RLYAVVTQEPI-YIITEYMENGSLVDFLKTPS-GIKLTINKLLDMAAQIAEGMAFIEER- 128
Query: 395 SIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHGTFGYLDPEYFRSSQ 454
HRD+++ NIL+ D K++DFG +R + ++ + PE
Sbjct: 129 --NYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGT 186
Query: 455 FTDKSDVYSFGVVLTELLTGEKPIRFTILEEDKSLAAYFLCAMKEERLFEILDARVMKQG 514
FT KSDV+SFG++LTE++T + M + + L+
Sbjct: 187 FTIKSDVWSFGILLTEIVTHGRI---------------PYPGMTNPEVIQNLERGYRMVR 231
Query: 515 GKDEIITVAKLAKRCLNLNGKKRPTMREVASEL 547
+ + +L + C + RPT + S L
Sbjct: 232 PDNCPEELYQLMRLCWKERPEDRPTFDYLRSVL 264
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 189 bits (481), Expect = 5e-56
Identities = 60/304 (19%), Positives = 118/304 (38%), Gaps = 52/304 (17%)
Query: 279 FTSKELEKATDNFD---------LNRILGQGGQ------------------AVKK-SKVI 310
FT ++ +A F + +++G G A+K
Sbjct: 7 FTFEDPNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGY 66
Query: 311 DESKVEEFINEVVILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGTLFQYIHDQNEDFP 370
E + +F++E I+ Q +H NV+ L G ++ +++ EF+ NG+L ++ +
Sbjct: 67 TEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDG--Q 124
Query: 371 ITWEIRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVD 430
T + + ++ + YL HRD+ + NIL++ KVSDFG SR + D
Sbjct: 125 FTVIQLVGMLRGIAAGMKYLADM---NYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDD 181
Query: 431 QTHMTT----QVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLTELLTGEKPIRFTILEED 486
+ T + PE + +FT SDV+S+G+V+ E+++ +
Sbjct: 182 TSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGER--------- 232
Query: 487 KSLAAYFLCAMKEERLFEILDARVMKQGGKDEIITVAKLAKRCLNLNGKKRPTMREVASE 546
M + + ++ D + +L C + RP ++ +
Sbjct: 233 ------PYWDMTNQDVINAIEQDYRLPPPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNT 286
Query: 547 LAGI 550
L +
Sbjct: 287 LDKM 290
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 187 bits (477), Expect = 9e-56
Identities = 63/279 (22%), Positives = 115/279 (41%), Gaps = 43/279 (15%)
Query: 289 DNFDLNRILGQGGQ---------------AVK--KSKVIDESKVEEFINEVVILSQINHR 331
+++++ +G G K + E++ + ++EV +L ++ H
Sbjct: 4 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHP 63
Query: 332 NVVKLLGCCLETE--VPLLVYEFIPNGTLFQYIHD-QNEDFPITWEIRLRIAIEVSGALS 388
N+V+ ++ +V E+ G L I E + E LR+ +++ AL
Sbjct: 64 NIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALK 123
Query: 389 YLH--SAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHGTFGYLD 446
H S + HRD+K N+ LD K K+ DFG +R + D + GT Y+
Sbjct: 124 ECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKA-FVGTPYYMS 182
Query: 447 PEYFRSSQFTDKSDVYSFGVVLTELLTGEKPIRFTILEEDKSLAAYFLCAMKEERLFEIL 506
PE + +KSD++S G +L EL P F ++E +I
Sbjct: 183 PEQMNRMSYNEKSDIWSLGCLLYELCALMPP---------------FTAFSQKELAGKIR 227
Query: 507 DARVMKQGGK--DEIITVAKLAKRCLNLNGKKRPTMREV 543
+ + + + DE+ ++ R LNL RP++ E+
Sbjct: 228 EGKFRRIPYRYSDELN---EIITRMLNLKDYHRPSVEEI 263
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 187 bits (475), Expect = 3e-55
Identities = 60/312 (19%), Positives = 123/312 (39%), Gaps = 61/312 (19%)
Query: 282 KELEKATDNFDLNRILGQGGQ--------------------AVKK-SKVIDESKVEEFIN 320
LE +N + R +G+G AVK + +F
Sbjct: 6 LSLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQR 65
Query: 321 EVVILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGTLFQYIHDQNEDF----------- 369
E ++++ ++ N+VKLLG C + L++E++ G L +++ +
Sbjct: 66 EAALMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLST 125
Query: 370 ----------PITWEIRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVS 419
P++ +L IA +V+ ++YL HRD+ + N L+ + K++
Sbjct: 126 RARVSSPGPPPLSCAEQLCIARQVAAGMAYLS---ERKFVHRDLATRNCLVGENMVVKIA 182
Query: 420 DFGASRSMA-VDQTHMTTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLTELLTGEKPI 478
DFG SR++ D ++ PE +++T +SDV+++GVVL E+ +
Sbjct: 183 DFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQ- 241
Query: 479 RFTILEEDKSLAAYFLCAMKEERLFEILDARVMKQGGKDEIITVAKLAKRCLNLNGKKRP 538
+ EE ++ + D ++ ++ + + L + C + RP
Sbjct: 242 -------------PYYGMAHEEVIYYVRDGNILAC-PENCPLELYNLMRLCWSKLPADRP 287
Query: 539 TMREVASELAGI 550
+ + L +
Sbjct: 288 SFCSIHRILQRM 299
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 184 bits (467), Expect = 2e-54
Identities = 69/273 (25%), Positives = 108/273 (39%), Gaps = 44/273 (16%)
Query: 289 DNFDLNRILGQGGQ---------------AVK---KSKVIDESKVEEFINEVVILSQINH 330
++F++ R LG+G A+K K+++ + EV I S + H
Sbjct: 6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRH 65
Query: 331 RNVVKLLGCCLETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEIRLRIAIEVSGALSYL 390
N+++L G + L+ E+ P GT+++ + + + E++ ALSY
Sbjct: 66 PNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLS---KFDEQRTATYITELANALSYC 122
Query: 391 HSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHGTFGYLDPEYF 450
HS + HRDIK N+LL K++DFG S + + GT YL PE
Sbjct: 123 HSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTT---LCGTLDYLPPEMI 176
Query: 451 RSSQFTDKSDVYSFGVVLTELLTGEKPIRFTILEEDKSLAAYFLCAMKEERLFEILDARV 510
+K D++S GV+ E L G+ P F +E I
Sbjct: 177 EGRMHDEKVDLWSLGVLCYEFLVGKPP---------------FEANTYQETYKRISRVEF 221
Query: 511 MKQGGKDEIITVAKLAKRCLNLNGKKRPTMREV 543
E L R L N +RP +REV
Sbjct: 222 TFPDFVTE--GARDLISRLLKHNPSQRPMLREV 252
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 185 bits (470), Expect = 3e-54
Identities = 61/319 (19%), Positives = 123/319 (38%), Gaps = 60/319 (18%)
Query: 273 IEKTKLFTSKELEKATDNFDLNRILGQGGQ--------------------AVKK-SKVID 311
++ + + E +N + ++LG G AVK + D
Sbjct: 21 VDFREYEYDLKWEFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKAD 80
Query: 312 ESKVEEFINEVVILSQI-NHRNVVKLLGCCLETEVPLLVYEFIPNGTLFQYIHDQNEDF- 369
S+ E ++E+ +++Q+ +H N+V LLG C + L++E+ G L Y+ + E F
Sbjct: 81 SSEREALMSELKMMTQLGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFS 140
Query: 370 -------------------PITWEIRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILL 410
+T+E L A +V+ + +L HRD+ + N+L+
Sbjct: 141 EDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFK---SCVHRDLAARNVLV 197
Query: 411 DDKYRAKVSDFGASRSMAVDQTHMT-TQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLT 469
K+ DFG +R + D ++ ++ PE +T KSDV+S+G++L
Sbjct: 198 THGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLW 257
Query: 470 ELLTGEKPIRFTILEEDKSLAAYFLCAMKEERLFEILDARVMKQGGKDEIITVAKLAKRC 529
E+ + + + ++++ + + + C
Sbjct: 258 EIFSLGVNP--------------YPGIPVDANFYKLIQNGFKMDQPFYATEEIYIIMQSC 303
Query: 530 LNLNGKKRPTMREVASELA 548
+ +KRP+ + S L
Sbjct: 304 WAFDSRKRPSFPNLTSFLG 322
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 184 bits (467), Expect = 3e-54
Identities = 66/288 (22%), Positives = 123/288 (42%), Gaps = 44/288 (15%)
Query: 282 KELEKATDNFDL-NRILGQGGQ-----------------AVKK-SKVIDESKVEEFINEV 322
K+L DN + + LG G A+K + +++ EE + E
Sbjct: 1 KKLFLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREA 60
Query: 323 VILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEIRLRIAIE 382
I+ Q+++ +V+L+G C + E +LV E G L +++ + E+ P + +
Sbjct: 61 QIMHQLDNPYIVRLIGVC-QAEALMLVMEMAGGGPLHKFLVGKREEIP--VSNVAELLHQ 117
Query: 383 VSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMT--TQVHG 440
VS + YL HRD+ + N+LL +++ AK+SDFG S+++ D ++ T +
Sbjct: 118 VSMGMKYLEEK---NFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKW 174
Query: 441 TFGYLDPEYFRSSQFTDKSDVYSFGVVLTELLT-GEKPIRFTILEEDKSLAAYFLCAMKE 499
+ PE +F+ +SDV+S+GV + E L+ G+KP + MK
Sbjct: 175 PLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYK----------------KMKG 218
Query: 500 ERLFEILDARVMKQGGKDEIITVAKLAKRCLNLNGKKRPTMREVASEL 547
+ ++ + + + L C + RP V +
Sbjct: 219 PEVMAFIEQGKRMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRM 266
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 183 bits (466), Expect = 5e-54
Identities = 56/273 (20%), Positives = 111/273 (40%), Gaps = 35/273 (12%)
Query: 289 DNFDLNRILGQGGQ--------------AVKKSKVIDESKVEEFINEVVILSQINHRNVV 334
++ L LGQG A+K K E F+ E ++ ++ H +V
Sbjct: 17 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKP-GTMSPEAFLQEAQVMKKLRHEKLV 75
Query: 335 KLLGCCLETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEIRLRIAIEVSGALSYLHSAA 394
+L E + +V E++ G+L ++ + + + +A +++ ++Y+
Sbjct: 76 QLYAVVSEEPI-YIVTEYMSKGSLLDFLKGETGKYLR-LPQLVDMAAQIASGMAYVERM- 132
Query: 395 SIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHGTFGYLDPEYFRSSQ 454
HRD+++ NIL+ + KV+DFG +R + ++ + PE +
Sbjct: 133 --NYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGR 190
Query: 455 FTDKSDVYSFGVVLTELLTGEKPIRFTILEEDKSLAAYFLCAMKEERLFEILDARVMKQG 514
FT KSDV+SFG++LTEL T + M + + ++
Sbjct: 191 FTIKSDVWSFGILLTELTTKGRV---------------PYPGMVNREVLDQVERGYRMPC 235
Query: 515 GKDEIITVAKLAKRCLNLNGKKRPTMREVASEL 547
+ ++ L +C ++RPT + + L
Sbjct: 236 PPECPESLHDLMCQCWRKEPEERPTFEYLQAFL 268
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 183 bits (466), Expect = 9e-54
Identities = 61/316 (19%), Positives = 122/316 (38%), Gaps = 55/316 (17%)
Query: 273 IEKTKLFTSKELEKATDNFDLNRILGQGGQ--------------------AVKK-SKVID 311
I+ T+L + E + + LG G AVK
Sbjct: 7 IDPTQLPYDHKWEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAH 66
Query: 312 ESKVEEFINEVVILSQI-NHRNVVKLLGCCLETEVPLLVYEFIPNGTLFQYIHD------ 364
++ E ++E+ +LS + NH N+V LLG C L++ E+ G L ++
Sbjct: 67 LTEREALMSELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFI 126
Query: 365 ---------QNEDFPITWEIRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYR 415
++++ + E L + +V+ +++L S HRD+ + NILL
Sbjct: 127 CSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASK---NCIHRDLAARNILLTHGRI 183
Query: 416 AKVSDFGASRSMAVDQTHM-TTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLTELLTG 474
K+ DFG +R + D ++ ++ PE + +T +SDV+S+G+ L EL +
Sbjct: 184 TKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSL 243
Query: 475 EKPIRFTILEEDKSLAAYFLCAMKEERLFEILDARVMKQGGKDEIITVAKLAKRCLNLNG 534
+ + + ++++ + + + K C + +
Sbjct: 244 GSS--------------PYPGMPVDSKFYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADP 289
Query: 535 KKRPTMREVASELAGI 550
KRPT +++ +
Sbjct: 290 LKRPTFKQIVQLIEKQ 305
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 182 bits (464), Expect = 1e-53
Identities = 66/292 (22%), Positives = 124/292 (42%), Gaps = 41/292 (14%)
Query: 268 STEGTIEKTKLFTSKELEKATDNFDLNRILGQGGQ---------------AVKKSKVIDE 312
S E +EK + S + + +GQG A+++ + +
Sbjct: 1 SDEEILEKLRSIVS--VGDPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQ 58
Query: 313 SKVEEFINEVVILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGTLFQYIHDQNEDFPIT 372
K E INE++++ + + N+V L L + +V E++ G+L + + +
Sbjct: 59 PKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTET----CMD 114
Query: 373 WEIRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQT 432
+ E AL +LHS + HRDIKS NILL K++DFG + +Q+
Sbjct: 115 EGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS 171
Query: 433 HMTTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLTELLTGEKPIRFTILEEDKSLAAY 492
+T V GT ++ PE + K D++S G++ E++ GE P
Sbjct: 172 KRSTMV-GTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPP--------------- 215
Query: 493 FLCAMKEERLFEILDARVMKQGGKDEIITVAK-LAKRCLNLNGKKRPTMREV 543
+L L+ I + +++ + + RCL+++ +KR + +E+
Sbjct: 216 YLNENPLRALYLIATNGTPELQNPEKLSAIFRDFLNRCLDMDVEKRGSAKEL 267
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 181 bits (461), Expect = 1e-53
Identities = 61/272 (22%), Positives = 110/272 (40%), Gaps = 33/272 (12%)
Query: 289 DNFDLNRILGQGG-----QAVKKS------KVIDESKV--EEFINEVVILSQINHRNVVK 335
+ + LG G + K+I E + +EFI E ++ ++H +V+
Sbjct: 4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQ 63
Query: 336 LLGCCLETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEIRLRIAIEVSGALSYLHSAAS 395
L G C + ++ E++ NG L Y+ + F + L + +V A+ YL S
Sbjct: 64 LYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQ--TQQLLEMCKDVCEAMEYLESK-- 119
Query: 396 IPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHGTFGYLDPEYFRSSQF 455
HRD+ + N L++D+ KVSDFG SR + D+ + + PE S+F
Sbjct: 120 -QFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYSKF 178
Query: 456 TDKSDVYSFGVVLTELLTGEKPIRFTILEEDKSLAAYFLCAMKEERLFEILDARVMKQGG 515
+ KSD+++FGV++ E+ + K E + +
Sbjct: 179 SSKSDIWAFGVLMWEIYSLGKM---------------PYERFTNSETAEHIAQGLRLYRP 223
Query: 516 KDEIITVAKLAKRCLNLNGKKRPTMREVASEL 547
V + C + +RPT + + S +
Sbjct: 224 HLASEKVYTIMYSCWHEKADERPTFKILLSNI 255
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 182 bits (462), Expect = 3e-53
Identities = 72/291 (24%), Positives = 134/291 (46%), Gaps = 45/291 (15%)
Query: 285 EKATDNFDLNRILGQGGQ------------------AVKK-SKVIDESKVEEFINEVVIL 325
+F N ++G+G AVK +++ D +V +F+ E +I+
Sbjct: 25 SSLIVHF--NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIM 82
Query: 326 SQINHRNVVKLLGCCLETE-VPLLVYEFIPNGTLFQYIHDQNEDFPITWEIRLRIAIEVS 384
+H NV+ LLG CL +E PL+V ++ +G L +I ++ + + + ++V+
Sbjct: 83 KDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKD--LIGFGLQVA 140
Query: 385 GALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMA---VDQTHMTTQVHGT 441
+ +L S HRD+ + N +LD+K+ KV+DFG +R M D H T
Sbjct: 141 KGMKFLASK---KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLP 197
Query: 442 FGYLDPEYFRSSQFTDKSDVYSFGVVLTELLTGEKPIRFTILEEDKSLAAYFLCAMKEER 501
++ E ++ +FT KSDV+SFGV+L EL+T P D + + ++ R
Sbjct: 198 VKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPP-----YPDVNTFDITVYLLQGRR 252
Query: 502 LFEILDARVMKQGGKDEIITVAKLAKRCLNLNGKKRPTMREVASELAGIKA 552
L + + + ++ +C + + RP+ E+ S ++ I +
Sbjct: 253 LLQ----------PEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFS 293
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 181 bits (460), Expect = 4e-53
Identities = 56/295 (18%), Positives = 108/295 (36%), Gaps = 41/295 (13%)
Query: 293 LNRILGQGGQ-------------AVKKSKVIDESKVEEFINEVVILSQINHRNVVKLLGC 339
L +G+G AVK E + E+ + H N++ +
Sbjct: 7 LQESIGKGRFGEVWRGKWRGEEVAVKIFS-SREERSWFREAEIYQTVMLRHENILGFIAA 65
Query: 340 CLETE----VPLLVYEFIPNGTLFQYIHDQNEDFPITWEIRLRIAIEVSGALSYLHSAA- 394
+ LV ++ +G+LF Y++ +T E +++A+ + L++LH
Sbjct: 66 DNKDNGTWTQLWLVSDYHEHGSLFDYLNRY----TVTVEGMIKLALSTASGLAHLHMEIV 121
Query: 395 ----SIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHM---TTQVHGTFGYLDP 447
I HRD+KS NIL+ ++D G + + GT Y+ P
Sbjct: 122 GTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAP 181
Query: 448 EYFRSS------QFTDKSDVYSFGVVLTELLTGEKPIRFTILEE----DKSLAAYFLCAM 497
E S + ++D+Y+ G+V E+ + D + + M
Sbjct: 182 EVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEM 241
Query: 498 KEERLFEILDARVMKQGGKDEII-TVAKLAKRCLNLNGKKRPTMREVASELAGIK 551
++ + L + + E + +AK+ + C NG R T + L+ +
Sbjct: 242 RKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLS 296
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 180 bits (458), Expect = 5e-53
Identities = 58/288 (20%), Positives = 117/288 (40%), Gaps = 42/288 (14%)
Query: 285 EKATDNFDLNRILGQGGQ-------------------AVKK-SKVIDESKVEEFINEVVI 324
E +++G G A+K E + +F+ E I
Sbjct: 3 EIHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGI 62
Query: 325 LSQINHRNVVKLLGCCLETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEIRLRIAIEVS 384
+ Q +H N+++L G + + +++ E++ NG L +++ +++ +F + + ++
Sbjct: 63 MGQFSHHNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDGEFS--VLQLVGMLRGIA 120
Query: 385 GALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQ--THMTTQVHGTF 442
+ YL + HRD+ + NIL++ KVSDFG SR + D T+ T+
Sbjct: 121 AGMKYLANM---NYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPI 177
Query: 443 GYLDPEYFRSSQFTDKSDVYSFGVVLTELLTGEKPIRFTILEEDKSLAAYFLCAMKEERL 502
+ PE +FT SDV+SFG+V+ E++T + + +
Sbjct: 178 RWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGER---------------PYWELSNHEV 222
Query: 503 FEILDARVMKQGGKDEIITVAKLAKRCLNLNGKKRPTMREVASELAGI 550
+ ++ D + +L +C +RP ++ S L +
Sbjct: 223 MKAINDGFRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKL 270
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 178 bits (453), Expect = 2e-52
Identities = 54/275 (19%), Positives = 108/275 (39%), Gaps = 44/275 (16%)
Query: 291 FDLNRILGQGGQ---------------AVKK--SKVIDESKVEEFINEVVILSQINHRNV 333
+ +G+G A + + + +S+ + F E +L + H N+
Sbjct: 11 LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNI 70
Query: 334 VKLLGCCLET----EVPLLVYEFIPNGTLFQYIHDQNEDFPITWEIRLRIAIEVSGALSY 389
V+ T + +LV E + +GTL Y+ + ++ ++ L +
Sbjct: 71 VRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFK---VMKIKVLRSWCRQILKGLQF 127
Query: 390 LHSAASIPIYHRDIKSTNILLDDK-YRAKVSDFGASRSMAVDQTHMTTQVHGTFGYLDPE 448
LH+ + PI HRD+K NI + K+ D G + + + V GT ++ PE
Sbjct: 128 LHT-RTPPIIHRDLKCDNIFITGPTGSVKIGDLGLAT---LKRASFAKAVIGTPEFMAPE 183
Query: 449 YFRSSQFTDKSDVYSFGVVLTELLTGEKPIRFTILEEDKSLAAYFLCAMKEERLFEILDA 508
+ ++ + DVY+FG+ + E+ T E P Y C + +
Sbjct: 184 MYE-EKYDESVDVYAFGMCMLEMATSEYP--------------YSECQNAAQIYRRVTSG 228
Query: 509 RVMKQGGKDEIITVAKLAKRCLNLNGKKRPTMREV 543
K I V ++ + C+ N +R +++++
Sbjct: 229 VKPASFDKVAIPEVKEIIEGCIRQNKDERYSIKDL 263
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 177 bits (451), Expect = 5e-52
Identities = 67/276 (24%), Positives = 118/276 (42%), Gaps = 45/276 (16%)
Query: 294 NRILGQGGQ-----------------AVK--KSKVIDESKVEEFINEVVILSQINHRNVV 334
++ LG G AVK K++ D + +E + E ++ Q+++ +V
Sbjct: 12 DKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIV 71
Query: 335 KLLGCCLETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEIRLRIAIEVSGALSYLHSAA 394
+++G C E E +LV E G L +Y+ + + + + +VS + YL +
Sbjct: 72 RMIGIC-EAESWMLVMEMAELGPLNKYLQQNR---HVKDKNIIELVHQVSMGMKYLEES- 126
Query: 395 SIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVH--GTFGYLDPEYFRS 452
HRD+ + N+LL ++ AK+SDFG S+++ D+ + Q H + PE
Sbjct: 127 --NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINY 184
Query: 453 SQFTDKSDVYSFGVVLTELLT-GEKPIRFTILEEDKSLAAYFLCAMKEERLFEILDARVM 511
+F+ KSDV+SFGV++ E + G+KP R MK + +L+
Sbjct: 185 YKFSSKSDVWSFGVLMWEAFSYGQKPYR----------------GMKGSEVTAMLEKGER 228
Query: 512 KQGGKDEIITVAKLAKRCLNLNGKKRPTMREVASEL 547
+ L C + + RP V L
Sbjct: 229 MGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRL 264
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 178 bits (452), Expect = 9e-52
Identities = 63/291 (21%), Positives = 96/291 (32%), Gaps = 50/291 (17%)
Query: 274 EKTKLFTSKELEKATDNFDLNRILGQGGQ---------------AVK---KSKVIDESKV 315
+ +LF + EK F R +G G A+K S K
Sbjct: 3 DVAELFFKDDPEK---LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKW 59
Query: 316 EEFINEVVILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEI 375
++ I EV L ++ H N ++ GC L LV E+ + P+
Sbjct: 60 QDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKK---PLQEVE 116
Query: 376 RLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMT 435
+ L+YLHS + HRD+K+ NILL + K+ DFG++ M
Sbjct: 117 IAAVTHGALQGLAYLHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSASIM-----APA 168
Query: 436 TQVHGTFGYLDPEYFRSS---QFTDKSDVYSFGVVLTELLTGEKPIRFTILEEDKSLAAY 492
GT ++ PE + Q+ K DV+S G+ EL + P
Sbjct: 169 NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPP--------------- 213
Query: 493 FLCAMKEERLFEILDARVMKQGGKDEIITVAKLAKRCLNLNGKKRPTMREV 543
L+ I CL + RPT +
Sbjct: 214 LFNMNAMSALYHIAQNESPALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVL 264
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 177 bits (450), Expect = 1e-51
Identities = 63/276 (22%), Positives = 103/276 (37%), Gaps = 40/276 (14%)
Query: 288 TDNFDLNRILGQGGQ---------------AVKKSKVIDESKVEEFINEVVILSQINHRN 332
D +++ LG G A K E ++E+++ E+ IL+ +H N
Sbjct: 11 EDFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPN 70
Query: 333 VVKLLGCCLETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEIRLRIAIEVSGALSYLHS 392
+VKLL ++ EF G + + + P+T + + AL+YLH
Sbjct: 71 IVKLLDAFYYENNLWILIEFCAGGAVDAVMLELER--PLTESQIQVVCKQTLDALNYLHD 128
Query: 393 AASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHGTFGYLDPEYFRS 452
I HRD+K+ NIL K++DFG S + + GT ++ PE
Sbjct: 129 N---KIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFI-GTPYWMAPEVVMC 184
Query: 453 SQ-----FTDKSDVYSFGVVLTELLTGEKPIRFTILEEDKSLAAYFLCAMKEERLFEILD 507
+ K+DV+S G+ L E+ E P + + L K E
Sbjct: 185 ETSKDRPYDYKADVWSLGITLIEMAEIEPPH------HELNPMRVLLKIAKSEPPTLAQP 238
Query: 508 ARVMKQGGKDEIITVAKLAKRCLNLNGKKRPTMREV 543
+R K+CL N R T ++
Sbjct: 239 SRWSSN--------FKDFLKKCLEKNVDARWTTSQL 266
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 176 bits (446), Expect = 5e-51
Identities = 60/294 (20%), Positives = 113/294 (38%), Gaps = 52/294 (17%)
Query: 289 DNFDLNRILGQGG-----------------QAVKK-SKVIDESKVEEFINEVVILSQI-N 329
++ ++G+G A+K+ + + +F E+ +L ++ +
Sbjct: 10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGH 69
Query: 330 HRNVVKLLGCCLETEVPLLVYEFIPNGTLFQYIHDQNEDF-------------PITWEIR 376
H N++ LLG C L E+ P+G L ++ ++ +
Sbjct: 70 HPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQL 129
Query: 377 LRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTT 436
L A +V+ + YL HRD+ + NIL+ + Y AK++DFG SR + T
Sbjct: 130 LHFAADVARGMDYLSQK---QFIHRDLAARNILVGENYVAKIADFGLSRGQ--EVYVKKT 184
Query: 437 QVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLTELLTGEKPIRFTILEEDKSLAAYFLCA 496
++ E S +T SDV+S+GV+L E+++ C
Sbjct: 185 MGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGT---------------PYCG 229
Query: 497 MKEERLFEILDARVMKQGGKDEIITVAKLAKRCLNLNGKKRPTMREVASELAGI 550
M L+E L + + V L ++C +RP+ ++ L +
Sbjct: 230 MTCAELYEKLPQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRM 283
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 174 bits (442), Expect = 8e-51
Identities = 70/273 (25%), Positives = 115/273 (42%), Gaps = 38/273 (13%)
Query: 289 DNFDLNRILGQGG-----QAVKKS-------KVIDESK----VEEFINEVVILSQINHRN 332
+++DL + LG+G AV + K++D + E E+ I +NH N
Sbjct: 5 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHEN 64
Query: 333 VVKLLGCCLETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEIRLRIAIEVSGALSYLHS 392
VVK G E + L E+ G LF I + R ++ + YLH
Sbjct: 65 VVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDI---GMPEPDAQRFFHQLMAGVVYLHG 121
Query: 393 AASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVD-QTHMTTQVHGTFGYLDPEYFR 451
I HRDIK N+LLD++ K+SDFG + + + + ++ GT Y+ PE +
Sbjct: 122 I---GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLK 178
Query: 452 SSQF-TDKSDVYSFGVVLTELLTGEKPIRFTILEEDKSLAAYFLCAMKEERLFEILDARV 510
+F + DV+S G+VLT +L GE P + S + KE++ + ++
Sbjct: 179 RREFHAEPVDVWSCGIVLTAMLAGELPW------DQPSDSCQEYSDWKEKKTYLNPWKKI 232
Query: 511 MKQGGKDEIITVAKLAKRCLNLNGKKRPTMREV 543
L + L N R T+ ++
Sbjct: 233 DSA--------PLALLHKILVENPSARITIPDI 257
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 173 bits (438), Expect = 3e-50
Identities = 62/287 (21%), Positives = 113/287 (39%), Gaps = 40/287 (13%)
Query: 283 ELEKATDNFDLNRILGQGGQ------------------AVKK-SKVIDESKVEEFINEVV 323
+ E + +L R +G+G A+K +S E+F+ E +
Sbjct: 1 DYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEAL 60
Query: 324 ILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEIRLRIAIEV 383
+ Q +H ++VKL+G E V ++ E G L ++ + + + + A ++
Sbjct: 61 TMRQFDHPHIVKLIGVITENPV-WIIMELCTLGELRSFLQVRK--YSLDLASLILYAYQL 117
Query: 384 SGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHGTFG 443
S AL+YL S HRDI + N+L+ K+ DFG SR M + ++
Sbjct: 118 STALAYLESK---RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIK 174
Query: 444 YLDPEYFRSSQFTDKSDVYSFGVVLTELLTGEKPIRFTILEEDKSLAAYFLCAMKEERLF 503
++ PE +FT SDV+ FGV + E+L + D + + +
Sbjct: 175 WMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNND---VIGRIENGERLPMP 231
Query: 504 EILDARVMKQGGKDEIITVAKLAKRCLNLNGKKRPTMREVASELAGI 550
+ L +C + +RP E+ ++L+ I
Sbjct: 232 PNCPPT------------LYSLMTKCWAYDPSRRPRFTELKAQLSTI 266
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 175 bits (444), Expect = 4e-50
Identities = 55/272 (20%), Positives = 102/272 (37%), Gaps = 37/272 (13%)
Query: 289 DNFDLNRILGQGGQ---------------AVKKSKVIDESKVEEFINEVVILSQINHRNV 333
D++D++ LG G A K ES E E+ +S + H +
Sbjct: 26 DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTL 85
Query: 334 VKLLGCCLETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEIRLRIAIEVSGALSYLHSA 393
V L + +++YEF+ G LF+ + D++ ++ + + +V L ++H
Sbjct: 86 VNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHN--KMSEDEAVEYMRQVCKGLCHMHEN 143
Query: 394 ASIPIYHRDIKSTNILLDDKY--RAKVSDFGASRSMAVDQTHMTTQVHGTFGYLDPEYFR 451
H D+K NI+ K K+ DFG + + Q+ T GT + PE
Sbjct: 144 ---NYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVT--TGTAEFAAPEVAE 198
Query: 452 SSQFTDKSDVYSFGVVLTELLTGEKPIRFTILEEDKSLAAYFLCAMKEERLFEILDARVM 511
+D++S GV+ LL+G P ++ + + +
Sbjct: 199 GKPVGYYTDMWSVGVLSYILLSGLSPF------GGENDDETLRNVKSCDWNMDDSAFSGI 252
Query: 512 KQGGKDEIITVAKLAKRCLNLNGKKRPTMREV 543
+ GKD ++ L + R T+ +
Sbjct: 253 SEDGKD-------FIRKLLLADPNTRMTIHQA 277
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 174 bits (441), Expect = 4e-50
Identities = 55/287 (19%), Positives = 117/287 (40%), Gaps = 43/287 (14%)
Query: 286 KATDNFDLNRILGQGG-------------------QAVKK-SKVIDESKVEEFINEVVIL 325
K T+ F ++LG G A+K+ + +E ++E ++
Sbjct: 7 KETE-FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVM 65
Query: 326 SQINHRNVVKLLGCCLETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEIRLRIAIEVSG 385
+ +++ +V +LLG CL + V L+ + +P G L Y+ + ++ + L ++++
Sbjct: 66 ASVDNPHVCRLLGICLTSTV-QLITQLMPFGCLLDYVREHKDNIG--SQYLLNWCVQIAK 122
Query: 386 ALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHM-TTQVHGTFGY 444
++YL + HRD+ + N+L+ K++DFG ++ + ++ +
Sbjct: 123 GMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKW 179
Query: 445 LDPEYFRSSQFTDKSDVYSFGVVLTELLTGEKPIRFTILEEDKSLAAYFLCAMKEERLFE 504
+ E +T +SDV+S+GV + EL+T + +
Sbjct: 180 MALESILHRIYTHQSDVWSYGVTVWELMTFGSK---------------PYDGIPASEISS 224
Query: 505 ILDARVMKQGGKDEIITVAKLAKRCLNLNGKKRPTMREVASELAGIK 551
IL+ I V + +C ++ RP RE+ E + +
Sbjct: 225 ILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMA 271
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 171 bits (435), Expect = 8e-50
Identities = 62/282 (21%), Positives = 106/282 (37%), Gaps = 43/282 (15%)
Query: 289 DNFDLNRILGQGGQ------------------AVK---KSKVIDESKVEEFINEVVILSQ 327
+ L LG G AVK + +++FI EV +
Sbjct: 8 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHS 67
Query: 328 INHRNVVKLLGCCLETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEIRLRIAIEVSGAL 387
++HRN+++L G L + +V E P G+L + F R A++V+ +
Sbjct: 68 LDHRNLIRLYGVVLTPPM-KMVTELAPLGSLLDRLRKHQGHFL--LGTLSRYAVQVAEGM 124
Query: 388 SYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTH--MTTQVHGTFGYL 445
YL S HRD+ + N+LL + K+ DFG R++ + H M F +
Sbjct: 125 GYLESK---RFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWC 181
Query: 446 DPEYFRSSQFTDKSDVYSFGVVLTELLTGEKPIRFTILEEDKSLAAYFLCAMKEERLFEI 505
PE ++ F+ SD + FGV L E+ T + ++ + L +I
Sbjct: 182 APESLKTRTFSHASDTWMFGVTLWEMFTYGQE--------------PWIGLNGSQILHKI 227
Query: 506 LDARVMKQGGKDEIITVAKLAKRCLNLNGKKRPTMREVASEL 547
+D + + +C + RPT + L
Sbjct: 228 DKEGERLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFL 269
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 171 bits (435), Expect = 1e-49
Identities = 63/279 (22%), Positives = 110/279 (39%), Gaps = 44/279 (15%)
Query: 285 EKATDNFDLNRILGQGGQ---------------AVK---KSKVIDESKVEEFINEVVILS 326
+K ++F +ILG+G A+K K +I E+KV E ++S
Sbjct: 4 KKRPEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMS 63
Query: 327 QINHRNVVKLLGCCLETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEIRLRIAIEVSGA 386
+++H VKL + E + NG L +YI E+ A
Sbjct: 64 RLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIG---SFDETCTRFYTAEIVSA 120
Query: 387 LSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVD-QTHMTTQVHGTFGYL 445
L YLH I HRD+K NILL++ +++DFG ++ ++ + + GT Y+
Sbjct: 121 LEYLHGK---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYV 177
Query: 446 DPEYFRSSQFTDKSDVYSFGVVLTELLTGEKPIRFTILEEDKSLAAYFLCAMKEERLFEI 505
PE SD+++ G ++ +L+ G P F + +I
Sbjct: 178 SPELLTEKSACKSSDLWALGCIIYQLVAGLPP---------------FRAGNEYLIFQKI 222
Query: 506 LDARVMKQGGKDEIITVAK-LAKRCLNLNGKKRPTMREV 543
+ ++ A+ L ++ L L+ KR E+
Sbjct: 223 IKLEYDF---PEKFFPKARDLVEKLLVLDATKRLGCEEM 258
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 168 bits (426), Expect = 2e-48
Identities = 75/293 (25%), Positives = 118/293 (40%), Gaps = 46/293 (15%)
Query: 288 TDNFDLNRILGQGGQ---------------AVK---KSKVIDESKVEEFINEVVILSQIN 329
+D ++L ILG GG AVK D S F E + +N
Sbjct: 6 SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALN 65
Query: 330 HRNVVKLLGCCLETE----VPLLVYEFIPNGTLFQYIHDQNEDFPITWEIRLRIAIEVSG 385
H +V + +P +V E++ TL +H + P+T + + + +
Sbjct: 66 HPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEG---PMTPKRAIEVIADACQ 122
Query: 386 ALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHM--TTQVHGTFG 443
AL++ H I HRD+K NI++ KV DFG +R++A + T V GT
Sbjct: 123 ALNFSHQN---GIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQ 179
Query: 444 YLDPEYFRSSQFTDKSDVYSFGVVLTELLTGEKPIRFTILEEDKSLAAYFLCAMKEERLF 503
YL PE R +SDVYS G VL E+LTGE P S + ++E+ +
Sbjct: 180 YLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPF------TGDSPVSVAYQHVREDPIP 233
Query: 504 EILDARVMKQGGKDEIITVAKLAKRCLNLNGKKRP-TMREVASELAGIKAWNG 555
+ + + L N + R T E+ ++L ++ NG
Sbjct: 234 PSARHEGLSADLDA-------VVLKALAKNPENRYQTAAEMRADL--VRVHNG 277
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 167 bits (423), Expect = 1e-47
Identities = 65/278 (23%), Positives = 105/278 (37%), Gaps = 34/278 (12%)
Query: 282 KELEKATDNFDLNRILGQGGQ---------------AVKK-SKVIDESKVEEFINEVVIL 325
K+ E D +D +LG G A+K +K E K NE+ +L
Sbjct: 2 KQAEDIRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVL 61
Query: 326 SQINHRNVVKLLGCCLETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEIRLRIAIEVSG 385
+I H N+V L L+ + + G LF I ++ T R+ +V
Sbjct: 62 HKIKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKG---FYTERDASRLIFQVLD 118
Query: 386 ALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHGTFGYL 445
A+ YLH + + LD+ + +SDFG S+ D + + GT GY+
Sbjct: 119 AVKYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKME--DPGSVLSTACGTPGYV 176
Query: 446 DPEYFRSSQFTDKSDVYSFGVVLTELLTGEKPIRFTILEEDKSLAAYFLCAMKEERLFEI 505
PE ++ D +S GV+ LL G P D++ A F +K E F+
Sbjct: 177 APEVLAQKPYSKAVDCWSIGVIAYILLCGYPPF------YDENDAKLFEQILKAEYEFDS 230
Query: 506 LDARVMKQGGKDEIITVAKLAKRCLNLNGKKRPTMREV 543
+ KD + + + +KR T +
Sbjct: 231 PYWDDISDSAKD-------FIRHLMEKDPEKRFTCEQA 261
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 163 bits (412), Expect = 4e-46
Identities = 65/308 (21%), Positives = 127/308 (41%), Gaps = 47/308 (15%)
Query: 273 IEKTKLFTSKELEKATDNFDLNRILGQGGQ--------------------AVKK-SKVID 311
++ E E A + ++R LGQG A+K ++
Sbjct: 4 FSAADVYVPDEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAAS 63
Query: 312 ESKVEEFINEVVILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGTLFQYIHDQNEDF-- 369
+ EF+NE ++ + N +VV+LLG + + L++ E + G L Y+
Sbjct: 64 MRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMAN 123
Query: 370 -----PITWEIRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGAS 424
P + +++A E++ ++YL++ HRD+ + N ++ + + K+ DFG +
Sbjct: 124 NPVLAPPSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMT 180
Query: 425 RSM-AVDQTHMTTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLTELLTGEKPIRFTIL 483
R + D + ++ PE + FT SDV+SFGVVL E+ T +
Sbjct: 181 RDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQ------ 234
Query: 484 EEDKSLAAYFLCAMKEERLFEILDARVMKQGGKDEIITVAKLAKRCLNLNGKKRPTMREV 543
+ E+ L +++ ++ + + + +L + C N K RP+ E+
Sbjct: 235 --------PYQGLSNEQVLRFVMEGGLLDK-PDNCPDMLFELMRMCWQYNPKMRPSFLEI 285
Query: 544 ASELAGIK 551
S +
Sbjct: 286 ISSIKEEM 293
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 163 bits (414), Expect = 7e-46
Identities = 52/272 (19%), Positives = 95/272 (34%), Gaps = 37/272 (13%)
Query: 289 DNFDLNRILGQGGQ---------------AVKKSKVIDESKVEEFINEVVILSQINHRNV 333
D +D+ LG G K NE+ I++Q++H +
Sbjct: 29 DYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKL 88
Query: 334 VKLLGCCLETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEIRLRIAIEVSGALSYLHSA 393
+ L + +L+ EF+ G LF I ++ + ++ + + L ++H
Sbjct: 89 INLHDAFEDKYEMVLILEFLSGGELFDRIAAED--YKMSEAEVINYMRQACEGLKHMHEH 146
Query: 394 ASIPIYHRDIKSTNILLD--DKYRAKVSDFGASRSMAVDQTHMTTQVHGTFGYLDPEYFR 451
I H DIK NI+ + K+ DFG + + D+ T T + PE
Sbjct: 147 ---SIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVT--TATAEFAAPEIVD 201
Query: 452 SSQFTDKSDVYSFGVVLTELLTGEKPIRFTILEEDKSLAAYFLCAMKEERLFEILDARVM 511
+D+++ GV+ LL+G P + + + F+ +
Sbjct: 202 REPVGFYTDMWAIGVLGYVLLSGLSPF------AGEDDLETLQNVKRCDWEFDEDAFSSV 255
Query: 512 KQGGKDEIITVAKLAKRCLNLNGKKRPTMREV 543
KD K L +KR T+ +
Sbjct: 256 SPEAKD-------FIKNLLQKEPRKRLTVHDA 280
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 162 bits (411), Expect = 1e-45
Identities = 59/281 (20%), Positives = 102/281 (36%), Gaps = 45/281 (16%)
Query: 282 KELEKATDNFDLNRILGQGG---------------QAVKKSKVIDESKVEEFINEVVILS 326
KEL + + + LG+G K K + + E+ IL+
Sbjct: 1 KEL---YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVK-VKGTDQVLVKKEISILN 56
Query: 327 QINHRNVVKLLGCCLETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEIRLRIAIEVSGA 386
HRN++ L E ++++EFI +F+ I+ F + + +V A
Sbjct: 57 IARHRNILHLHESFESMEELVMIFEFISGLDIFERINTSA--FELNEREIVSYVHQVCEA 114
Query: 387 LSYLHSAASIPIYHRDIKSTNILLDDK--YRAKVSDFGASRSMAVDQTHMTTQVHGTFGY 444
L +LHS I H DI+ NI+ + K+ +FG +R + Y
Sbjct: 115 LQFLHSH---NIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLL--FTAPEY 169
Query: 445 LDPEYFRSSQFTDKSDVYSFGVVLTELLTGEKPIRFTILEEDKSLAAYFLCAMKEERLFE 504
PE + + +D++S G ++ LL+G P FL ++ +
Sbjct: 170 YAPEVHQHDVVSTATDMWSLGTLVYVLLSGINP---------------FLAETNQQIIEN 214
Query: 505 ILDARVMKQGGKDEIIT--VAKLAKRCLNLNGKKRPTMREV 543
I++A + I+ R L K R T E
Sbjct: 215 IMNAEYTFDEEAFKEISIEAMDFVDRLLVKERKSRMTASEA 255
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 161 bits (408), Expect = 1e-45
Identities = 64/309 (20%), Positives = 120/309 (38%), Gaps = 56/309 (18%)
Query: 282 KELEKATDNFDLNRILGQGGQ----------------------AVKK-SKVIDESKVEEF 318
E D L + LG+G AVK E + +
Sbjct: 6 PRWELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDL 65
Query: 319 INEVVILSQI-NHRNVVKLLGCCLETEVPLLVYEFIPNGTLFQYIHDQ------------ 365
I+E+ ++ I H+N++ LLG C + ++ E+ G L +Y+ +
Sbjct: 66 ISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPS 125
Query: 366 -NEDFPITWEIRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGAS 424
N + ++ + + A +V+ + YL S HRD+ + N+L+ + K++DFG +
Sbjct: 126 HNPEEQLSSKDLVSCAYQVARGMEYLASK---KCIHRDLAARNVLVTEDNVMKIADFGLA 182
Query: 425 RSMAVDQTHMTTQVH-GTFGYLDPEYFRSSQFTDKSDVYSFGVVLTELLTGEKPIRFTIL 483
R + + T ++ PE +T +SDV+SFGV+L E+ T
Sbjct: 183 RDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGS------ 236
Query: 484 EEDKSLAAYFLCAMKEERLFEILDARVMKQGGKDEIITVAKLAKRCLNLNGKKRPTMREV 543
+ E LF++L + + + + C + +RPT +++
Sbjct: 237 ---------PYPGVPVEELFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQL 287
Query: 544 ASELAGIKA 552
+L I A
Sbjct: 288 VEDLDRIVA 296
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 160 bits (405), Expect = 3e-45
Identities = 71/309 (22%), Positives = 117/309 (37%), Gaps = 54/309 (17%)
Query: 279 FTSKELEKATDNFDLNRILGQGGQ--------------------AVKK-SKVIDESKVEE 317
+ + + E D L + LG+G AVK + S+
Sbjct: 3 YDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRA 62
Query: 318 FINEVVILSQINHR-NVVKLLGCCLETEVPL-LVYEFIPNGTLFQYIHDQNEDF------ 369
++E+ IL I H NVV LLG C + PL ++ EF G L Y+ + +F
Sbjct: 63 LMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVA 122
Query: 370 -------PITWEIRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFG 422
+T E + + +V+ + +L S HRD+ + NILL +K K+ DFG
Sbjct: 123 PEDLYKDFLTLEHLICYSFQVAKGMEFLAS---RKCIHRDLAARNILLSEKNVVKICDFG 179
Query: 423 ASRSMAVDQTH-MTTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLTELLTGEKPIRFT 481
+R + D + ++ PE +T +SDV+SFGV+L E+ +
Sbjct: 180 LARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPY-- 237
Query: 482 ILEEDKSLAAYFLCAMKEERLFEILDARVMKQGGKDEIITVAKLAKRCLNLNGKKRPTMR 541
+ F +KE D + + C + +RPT
Sbjct: 238 ---PGVKIDEEFCRRLKEGTRMRAPD---------YTTPEMYQTMLDCWHGEPSQRPTFS 285
Query: 542 EVASELAGI 550
E+ L +
Sbjct: 286 ELVEHLGNL 294
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 159 bits (402), Expect = 6e-45
Identities = 70/286 (24%), Positives = 109/286 (38%), Gaps = 52/286 (18%)
Query: 289 DNFDLNRILGQGGQ---------------AVKK---------SKVIDESKVEEFINEVVI 324
+N++ ILG+G AVK S + E + EV I
Sbjct: 3 ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDI 62
Query: 325 LSQIN-HRNVVKLLGCCLETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEIRLRIAIEV 383
L +++ H N+++L LV++ + G LF Y+ ++ ++ + +I +
Sbjct: 63 LRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKV---TLSEKETRKIMRAL 119
Query: 384 SGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHGTFG 443
+ LH I HRD+K NILLDD K++DFG S + D +V GT
Sbjct: 120 LEVICALHKL---NIVHRDLKPENILLDDDMNIKLTDFGFSCQL--DPGEKLREVCGTPS 174
Query: 444 YLDPEYFRSSQ------FTDKSDVYSFGVVLTELLTGEKPIRFTILEEDKSLAAYFLCAM 497
YL PE S + + D++S GV++ LL G P + M
Sbjct: 175 YLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFW------HRKQMLMLRMIM 228
Query: 498 KEERLFEILDARVMKQGGKDEIITVAKLAKRCLNLNGKKRPTMREV 543
F + KD L R L + +KR T E
Sbjct: 229 SGNYQFGSPEWDDYSDTVKD-------LVSRFLVVQPQKRYTAEEA 267
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 150 bits (380), Expect = 2e-41
Identities = 64/273 (23%), Positives = 105/273 (38%), Gaps = 43/273 (15%)
Query: 289 DNFDLNRILGQGGQ---------------AVK---KSKVIDESKVEEFINEVVILS-QIN 329
++F L+++LG+G A+K K V+ + VE + E +LS
Sbjct: 2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWE 61
Query: 330 HRNVVKLLGCCLETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEIRLRIAIEVSGALSY 389
H + + E V E++ G L +I + A E+ L +
Sbjct: 62 HPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCH---KFDLSRATFYAAEIILGLQF 118
Query: 390 LHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHGTFGYLDPEY 449
LHS I +RD+K NILLD K++DFG + + T GT Y+ PE
Sbjct: 119 LHSK---GIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNTFC-GTPDYIAPEI 174
Query: 450 FRSSQFTDKSDVYSFGVVLTELLTGEKPIRFTILEEDKSLAAYFLCAMKEERLFEILDAR 509
++ D +SFGV+L E+L G+ P + F + + R
Sbjct: 175 LLGQKYNHSVDWWSFGVLLYEMLIGQSPF------HGQDEEELFHSIRMDNPFYP----R 224
Query: 510 VMKQGGKDEIITVAKLAKRCLNLNGKKRPTMRE 542
+++ KD L + +KR +R
Sbjct: 225 WLEKEAKD-------LLVKLFVREPEKRLGVRG 250
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 146 bits (368), Expect = 5e-40
Identities = 51/284 (17%), Positives = 103/284 (36%), Gaps = 34/284 (11%)
Query: 289 DNFDLNRILGQGGQ---------------AVK--KSKVIDESKVEEFINEVVILSQINHR 331
+NF +G+G A+K + E I E+ +L ++NH
Sbjct: 2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 61
Query: 332 NVVKLLGCCLETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEIRLRIAIEVSGALSYLH 391
N+VKLL LV+EF+ D + I + ++ L++ H
Sbjct: 62 NIVKLLDVIHTENKLYLVFEFLHQDLK--KFMDASALTGIPLPLIKSYLFQLLQGLAFCH 119
Query: 392 SAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHGTFGYLDPEYFR 451
S + HRD+K N+L++ + K++DFG +R+ V T +V +
Sbjct: 120 SH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLG 176
Query: 452 SSQFTDKSDVYSFGVVLTELLTGEKP--------IRFTILEEDKSLAAYFLCAMKEERLF 503
++ D++S G + E++T F I + + +
Sbjct: 177 CKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDY 236
Query: 504 EILDARVMKQGGKDEIITVAKLAK----RCLNLNGKKRPTMREV 543
+ + +Q + + + + + L+ + KR + +
Sbjct: 237 KPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAA 280
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 145 bits (367), Expect = 9e-40
Identities = 65/278 (23%), Positives = 116/278 (41%), Gaps = 46/278 (16%)
Query: 289 DNFDLNRILGQGGQ---------------AVK---KSKVIDESKVEEFINEVVILSQINH 330
+F + R LG G A+K K V+ +VE +E ++LS + H
Sbjct: 4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTH 63
Query: 331 RNVVKLLGCCLETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEIRLRIAIEVSGALSYL 390
++++ G + + ++ ++I G LF + + A EV AL YL
Sbjct: 64 PFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKS---QRFPNPVAKFYAAEVCLALEYL 120
Query: 391 HSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHGTFGYLDPEYF 450
HS I +RD+K NILLD K++DFG ++ + +T + GT Y+ PE
Sbjct: 121 HSK---DIIYRDLKPENILLDKNGHIKITDFGFAKYV----PDVTYTLCGTPDYIAPEVV 173
Query: 451 RSSQFTDKSDVYSFGVVLTELLTGEKPIRFTILEEDKSLAAYFLCAMKEERLFEILDARV 510
+ + D +SFG+++ E+L G P F + + +IL+A +
Sbjct: 174 STKPYNKSIDWWSFGILIYEMLAGYTP---------------FYDSNTMKTYEKILNAEL 218
Query: 511 MKQGGKDEIITVAKLAKRCLNLNGKKRPT-MREVASEL 547
+E V L R + + +R ++ ++
Sbjct: 219 RFPPFFNE--DVKDLLSRLITRDLSQRLGNLQNGTEDV 254
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 144 bits (364), Expect = 1e-39
Identities = 48/283 (16%), Positives = 104/283 (36%), Gaps = 34/283 (12%)
Query: 289 DNFDLNRILGQGGQ--------------AVKKSKV--IDESKVEEFINEVVILSQINHRN 332
+ + +G+G A+KK ++ DE I E+ IL ++ H N
Sbjct: 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSN 61
Query: 333 VVKLLGCCLETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEIRLRIAIEVSGALSYLHS 392
+VKL + +LV+E + + + +++ ++Y H
Sbjct: 62 IVKLYDVIHTKKRLVLVFEHLDQDLKKLLDVCEG---GLESVTAKSFLLQLLNGIAYCHD 118
Query: 393 AASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHGTFGYLDPEYFRS 452
+ HRD+K N+L++ + K++DFG +R+ + T ++ + S
Sbjct: 119 R---RVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIVTLWYRAPDVLMGS 175
Query: 453 SQFTDKSDVYSFGVVLTELLTGEKP------------IRFTILEEDKSLAAYFLCAMKEE 500
+++ D++S G + E++ G I + + K +
Sbjct: 176 KKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYD 235
Query: 501 RLFEILDARVMKQGGKDEIITVAKLAKRCLNLNGKKRPTMREV 543
F + + + K + L + L L+ +R T ++
Sbjct: 236 PNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQA 278
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 145 bits (366), Expect = 2e-39
Identities = 58/276 (21%), Positives = 101/276 (36%), Gaps = 38/276 (13%)
Query: 289 DNFD-LNRILGQGG-----QAVKKS-------KVIDESKVEEFINEVVILSQI-NHRNVV 334
D++ +++LG G Q K K++ + EV + + ++V
Sbjct: 11 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQ--DCPKARREVELHWRASQCPHIV 68
Query: 335 KLLGCC----LETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEIRLRIAIEVSGALSYL 390
+++ + L+V E + G LF I D+ + T I + A+ YL
Sbjct: 69 RIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQ-AFTEREASEIMKSIGEAIQYL 127
Query: 391 HSAASIPIYHRDIKSTNILLDDKY---RAKVSDFGASRSMAVDQTHMTTQVHGTFGYLDP 447
HS I HRD+K N+L K K++DFG ++ + T T Y+ P
Sbjct: 128 HSIN---IAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTT--PCYTPYYVAP 182
Query: 448 EYFRSSQFTDKSDVYSFGVVLTELLTGEKPIRFTILEEDKSLAAYFLCAMKEERLFEILD 507
E ++ D++S GV++ LL G P F + F +
Sbjct: 183 EVLGPEKYDKSCDMWSLGVIMYILLCGYPP--FYSNHGLAISPGMKTRIRMGQYEFPNPE 240
Query: 508 ARVMKQGGKDEIITVAKLAKRCLNLNGKKRPTMREV 543
+ + K L + L +R T+ E
Sbjct: 241 WSEVSEEVKM-------LIRNLLKTEPTQRMTITEF 269
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 145 bits (366), Expect = 4e-39
Identities = 54/284 (19%), Positives = 109/284 (38%), Gaps = 50/284 (17%)
Query: 289 DNFDLNRILGQGGQ---------------AVK---KSKVIDESKVEEFINEVV---ILSQ 327
++F ++RI+G+GG A+K K ++ + +NE + ++S
Sbjct: 4 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVST 63
Query: 328 INHRNVVKLLGCCLETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEIRLRIAIEVSGAL 387
+ +V + + + + + G L ++ + A E+ L
Sbjct: 64 GDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHG---VFSEADMRFYAAEIILGL 120
Query: 388 SYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHGTFGYLDP 447
++H+ + +RD+K NILLD+ ++SD G + + + H + GT GY+ P
Sbjct: 121 EHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHAS---VGTHGYMAP 174
Query: 448 EYFRSSQ-FTDKSDVYSFGVVLTELLTGEKPIRFTILEEDKSLAAYFLCAMKEERLFEIL 506
E + + +D +S G +L +LL G P R K + EI
Sbjct: 175 EVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFR----------------QHKTKDKHEID 218
Query: 507 DARVMKQGGKDEIIT--VAKLAKRCLNLNGKKRPT-MREVASEL 547
+ + + + L + L + +R + A E+
Sbjct: 219 RMTLTMAVELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEV 262
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 142 bits (358), Expect = 3e-38
Identities = 53/289 (18%), Positives = 105/289 (36%), Gaps = 36/289 (12%)
Query: 288 TDNFDLNRILGQGGQ---------------AVKK-SKVIDESKVEEFINEVVILSQINHR 331
+ +G+G A+KK S ++ + + E+ IL + H
Sbjct: 7 GPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHE 66
Query: 332 NVVKLLGCCLETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEIRLRIAIEVSGALSYLH 391
N++ + + + ++ + ++ + ++ + ++ L Y+H
Sbjct: 67 NIIGINDIIRAPTIEQMKDVYLVTHLMGADLYKLLKTQHLSNDHICYFLYQILRGLKYIH 126
Query: 392 SAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMT--TQVHGTFGYLDPEY 449
SA + HRD+K +N+LL+ K+ DFG +R D H T+ T Y PE
Sbjct: 127 SA---NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEI 183
Query: 450 FRSSQFTDKS-DVYSFGVVLTELLTGEKPIRFTILEEDKSLAAYFLCAMKEERLFEILDA 508
+S+ KS D++S G +L E+L+ + + L + +E L I++
Sbjct: 184 MLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINL 243
Query: 509 RVMKQGGKDEIIT--------------VAKLAKRCLNLNGKKRPTMREV 543
+ L + L N KR + +
Sbjct: 244 KARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQA 292
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 140 bits (354), Expect = 5e-38
Identities = 57/292 (19%), Positives = 102/292 (34%), Gaps = 39/292 (13%)
Query: 286 KATDNFDLNRILGQGGQ----------------AVK--KSKVIDESKVEEFINEVVILSQ 327
+A ++ +G+G A+K + + +E I EV +L
Sbjct: 4 RADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRH 63
Query: 328 I---NHRNVVKLLGCCLETEVPLLVYEFIPNGTLFQ---YIHDQNEDFPITWEIRLRIAI 381
+ H NVV+L C + + + Q D+ + + E +
Sbjct: 64 LETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMF 123
Query: 382 EVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHGT 441
++ L +LHS + HRD+K NIL+ + K++DFG +R + + V T
Sbjct: 124 QLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTS--VVVT 178
Query: 442 FGYLDPEYFRSSQFTDKSDVYSFGVVLTELLTGEKPIRFTILEEDKSLAAYFLCAMKEER 501
Y PE S + D++S G + E+ + R + + + EE
Sbjct: 179 LWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEED 238
Query: 502 LFEILDARVMKQGGK---------DEIITVAK-LAKRCLNLNGKKRPTMREV 543
+ K +I + K L +CL N KR +
Sbjct: 239 WPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSA 290
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 139 bits (351), Expect = 9e-38
Identities = 68/282 (24%), Positives = 111/282 (39%), Gaps = 50/282 (17%)
Query: 289 DNFDLNRILGQGG-----QAVKKS-------KVIDESK---------VEEFINEVVILSQ 327
D +D LG G + +KS K I + + E+ EV IL +
Sbjct: 10 DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKE 69
Query: 328 INHRNVVKLLGCCLETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEIRLRIAIEVSGAL 387
I H NV+ L +L+ E + G LF ++ ++ +T E ++ +
Sbjct: 70 IQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKE---SLTEEEATEFLKQILNGV 126
Query: 388 SYLHSAASIPIYHRDIKSTNILLDD----KYRAKVSDFGASRSMAVDQTHMTTQVHGTFG 443
YLHS I H D+K NI+L D K R K+ DFG + + D + + GT
Sbjct: 127 YYLHSL---QIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKI--DFGNEFKNIFGTPE 181
Query: 444 YLDPEYFRSSQFTDKSDVYSFGVVLTELLTGEKPIRFTILEEDKSLAAYFLCAMKEERLF 503
++ PE ++D++S GV+ LL+G P FL K+E L
Sbjct: 182 FVAPEIVNYEPLGLEADMWSIGVITYILLSGASP---------------FLGDTKQETLA 226
Query: 504 EILDARVMKQGGKDEIIT--VAKLAKRCLNLNGKKRPTMREV 543
+ + + +R L + KKR T+++
Sbjct: 227 NVSAVNYEFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDS 268
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 140 bits (354), Expect = 1e-37
Identities = 58/286 (20%), Positives = 104/286 (36%), Gaps = 36/286 (12%)
Query: 289 DNFDLNRILGQGG-----QAVKKS-------KVIDESKVEEFINEVVILSQINHRNVVKL 336
++ +++G G QA K + + K E+ I+ +++H N+V+L
Sbjct: 20 VSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDK-RFKNRELQIMRKLDHCNIVRL 78
Query: 337 LGCCLETEVP------LLVYEFIPNGTLFQYIHDQNEDFPITWEIRLRIAIEVSGALSYL 390
+ LV +++P H + ++ +L+Y+
Sbjct: 79 RYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYI 138
Query: 391 HSAASIPIYHRDIKSTNILLD-DKYRAKVSDFGASRSMAVDQTHMTTQVHGTFGYLDPEY 449
HS I HRDIK N+LLD D K+ DFG+++ + + +++ + +
Sbjct: 139 HSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSY-ICSRYYRAPELI 194
Query: 450 FRSSQFTDKSDVYSFGVVLTELLTGEKPIR-----------FTILEEDKSLAAYFLCAMK 498
F ++ +T DV+S G VL ELL G+ +L +
Sbjct: 195 FGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNY 254
Query: 499 EERLFEILDARVMKQGGKDEIITVAK-LAKRCLNLNGKKRPTMREV 543
E F + A + + A L R L R T E
Sbjct: 255 TEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEA 300
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 138 bits (349), Expect = 1e-37
Identities = 49/286 (17%), Positives = 107/286 (37%), Gaps = 38/286 (13%)
Query: 289 DNFDLNRILGQGGQ---------------AVKKSKV--IDESKVEEFINEVVILSQINHR 331
++ +G+G A+K+ ++ DE + E+ +L ++ H+
Sbjct: 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHK 61
Query: 332 NVVKLLGCCLETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEIRLRIAIEVSGALSYLH 391
N+V+L + LV+EF + + EI ++ L + H
Sbjct: 62 NIVRLHDVLHSDKKLTLVFEFCDQDLKKYFDSCNGDLD---PEIVKSFLFQLLKGLGFCH 118
Query: 392 SAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHGTFGYLDPEYFR 451
S + HRD+K N+L++ K+++FG +R+ + + +V + F
Sbjct: 119 SR---NVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEVVTLWYRPPDVLFG 175
Query: 452 SSQFTDKSDVYSFGVVLTELLTGEKPIRFTILEEDKSLAAYF-------------LCAMK 498
+ ++ D++S G + EL +P+ F + D L F + +
Sbjct: 176 AKLYSTSIDMWSAGCIFAELANAGRPL-FPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLP 234
Query: 499 EERLFEILDARVMKQGGKDEIITVAK-LAKRCLNLNGKKRPTMREV 543
+ + + + A ++ + L + L N +R + E
Sbjct: 235 DYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEA 280
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 138 bits (347), Expect = 3e-37
Identities = 56/281 (19%), Positives = 97/281 (34%), Gaps = 39/281 (13%)
Query: 295 RILGQGGQ---------------AVKKSKV-----IDESKVEEFINEVVILSQINHRNVV 334
LG+G A+KK K+ + + E+ +L +++H N++
Sbjct: 4 DFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNII 63
Query: 335 KLLGCCLETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEIRLRIAIEVSGALSYLHSAA 394
LL LV++F+ + +T + L YLH
Sbjct: 64 GLLDAFGHKSNISLVFDFMETDLEVIIKDNS---LVLTPSHIKAYMLMTLQGLEYLHQH- 119
Query: 395 SIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHGTFGYLDPEYFRSSQ 454
I HRD+K N+LLD+ K++DFG ++S T QV T Y PE ++
Sbjct: 120 --WILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYTHQV-VTRWYRAPELLFGAR 176
Query: 455 FTD-KSDVYSFGVVLTELLTGEKPIR-----------FTILEEDKSLAAYFLCAMKEERL 502
D+++ G +L ELL + F L +C++ +
Sbjct: 177 MYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVT 236
Query: 503 FEILDARVMKQGGKDEIITVAKLAKRCLNLNGKKRPTMREV 543
F+ + + L + N R T +
Sbjct: 237 FKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQA 277
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 134 bits (337), Expect = 8e-36
Identities = 49/284 (17%), Positives = 90/284 (31%), Gaps = 42/284 (14%)
Query: 289 DNFDLNRILGQGGQ---------------AVKKSKVIDESKVEEFINEVVILSQINHRNV 333
+ + L R +G G A+K V ++K + E I +
Sbjct: 7 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECV--KTKHPQLHIESKIYKMMQGGVG 64
Query: 334 VKLLG-CCLETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEIRLRIAIEVSGALSYLHS 392
+ + C E + ++V E + + + + L +A ++ + Y+HS
Sbjct: 65 IPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCSR---KFSLKTVLLLADQMISRIEYIHS 121
Query: 393 AASIPIYHRDIKSTNIL---LDDKYRAKVSDFGASRSMAVDQTH------MTTQVHGTFG 443
HRD+K N L + DFG ++ +TH + GT
Sbjct: 122 KN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTAR 178
Query: 444 YLDPEYFRSSQFTDKSDVYSFGVVLTELLTGEKPIRFTILEEDKSLAAYFLCAMKEERLF 503
Y + + + D+ S G VL G P + + K ER+
Sbjct: 179 YASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKR---------QKYERIS 229
Query: 504 EILDARVMKQGGKDEIITVAKLAKRCLNLNGKKRPTMREVASEL 547
E + ++ K A C +L +P +
Sbjct: 230 EKKMSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLF 273
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 132 bits (332), Expect = 2e-35
Identities = 61/280 (21%), Positives = 109/280 (38%), Gaps = 56/280 (20%)
Query: 289 DNFDLNRILGQGGQ---------------AVK---KSKVIDESKVE---EFINEVVILSQ 327
+ + +LG GG A+K K ++ D ++ EVV+L +
Sbjct: 4 SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKK 63
Query: 328 IN--HRNVVKLLGCCLETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEIRLRIAIEVSG 385
++ V++LL + +L+ E + + E+ +V
Sbjct: 64 VSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERG--ALQEELARSFFWQVLE 121
Query: 386 ALSYLHSAASIPIYHRDIKSTNILLD-DKYRAKVSDFGASRSMAVDQTHMTTQVHGTFGY 444
A+ + H+ + HRDIK NIL+D ++ K+ DFG+ + + + T GT Y
Sbjct: 122 AVRHCHNC---GVLHRDIKDENILIDLNRGELKLIDFGSGA---LLKDTVYTDFDGTRVY 175
Query: 445 LDPEYFRSSQFTDKS-DVYSFGVVLTELLTGEKPIRFTILEEDKSLAAYFLCAMKEERLF 503
PE+ R ++ +S V+S G++L +++ G+ P F EE +F + E
Sbjct: 176 SPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIP--FEHDEEIIRGQVFFRQRVSSE--- 230
Query: 504 EILDARVMKQGGKDEIITVAKLAKRCLNLNGKKRPTMREV 543
L + CL L RPT E+
Sbjct: 231 ------------------CQHLIRWCLALRPSDRPTFEEI 252
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 132 bits (332), Expect = 9e-35
Identities = 67/278 (24%), Positives = 105/278 (37%), Gaps = 43/278 (15%)
Query: 289 DNFDLNRILGQGGQ---------------AVK---KSKVIDESKVEEFINEVVILSQINH 330
++FD ++LG+G A+K K +I + +V + E +L H
Sbjct: 5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRH 64
Query: 331 RNVVKLLGCCLETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEIRLRIAIEVSGALSYL 390
+ L + V E+ G LF ++ + T E E+ AL YL
Sbjct: 65 PFLTALKYAFQTHDRLCFVMEYANGGELFFHLS---RERVFTEERARFYGAEIVSALEYL 121
Query: 391 HSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHGTFGYLDPEYF 450
HS + +RDIK N++LD K++DFG + D M T GT YL PE
Sbjct: 122 HSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFC-GTPEYLAPEVL 177
Query: 451 RSSQFTDKSDVYSFGVVLTELLTGEKPIRFTILEEDKSLAAYFLCAMKEERLFEILDARV 510
+ + D + GVV+ E++ G P ++ F + EE F R
Sbjct: 178 EDNDYGRAVDWWGLGVVMYEMMCGRLPF------YNQDHERLFELILMEEIRFP----RT 227
Query: 511 MKQGGKDEIITVAKLAKRCLNLNGKKRPTMREV-ASEL 547
+ K L L + K+R A E+
Sbjct: 228 LSPEAKS-------LLAGLLKKDPKQRLGGGPSDAKEV 258
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 131 bits (331), Expect = 2e-34
Identities = 60/278 (21%), Positives = 106/278 (38%), Gaps = 46/278 (16%)
Query: 289 DNFDLNRILGQGGQ---------------AVK---KSKVIDESKVEEFINEVVILSQINH 330
D FD + LG G A+K K KV+ ++E +NE IL +N
Sbjct: 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 331 RNVVKLLGCCLETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEIRLRIAIEVSGALSYL 390
+VKL + +V E++ G +F ++ + A ++ YL
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIG---RFSEPHARFYAAQIVLTFEYL 157
Query: 391 HSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHGTFGYLDPEYF 450
HS + +RD+K N+L+D + +V+DFG A T + GT L PE
Sbjct: 158 HSL---DLIYRDLKPENLLIDQQGYIQVTDFG----FAKRVKGRTWTLCGTPEALAPEII 210
Query: 451 RSSQFTDKSDVYSFGVVLTELLTGEKPIRFTILEEDKSLAAYFLCAMKEERLFEILDARV 510
S + D ++ GV++ E+ G P D+ + Y + R + +
Sbjct: 211 LSKGYNKAVDWWALGVLIYEMAAGYPP-----FFADQPIQIYEKIVSGKVRFPSHFSSDL 265
Query: 511 MKQGGKDEIITVAKLAKRCLNLNGKKR-PTMREVASEL 547
L + L ++ KR ++ +++
Sbjct: 266 K------------DLLRNLLQVDLTKRFGNLKNGVNDI 291
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 130 bits (328), Expect = 4e-34
Identities = 55/304 (18%), Positives = 109/304 (35%), Gaps = 48/304 (15%)
Query: 279 FTSKELEKAT----DNFDLNRILGQGGQ---------------AVK--KSKVIDESKVEE 317
F +E+ K + + +G G A+K E +
Sbjct: 4 FYRQEVTKTAWEVRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKR 63
Query: 318 FINEVVILSQINHRNVVKLLGCCLETEVPLLVYEFIPN----GTLFQYIHDQNEDFPITW 373
E+ +L + H NV+ LL E +F GT + +
Sbjct: 64 AYRELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMKHE---KLGE 120
Query: 374 EIRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTH 433
+ + ++ L Y+H+A I HRD+K N+ +++ K+ DFG +R +
Sbjct: 121 DRIQFLVYQMLKGLRYIHAA---GIIHRDLKPGNLAVNEDCELKILDFGLARQA---DSE 174
Query: 434 MTTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLTELLTGEKP--------IRFTILEE 485
MT V + ++T D++S G ++ E++TG+ I++
Sbjct: 175 MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKV 234
Query: 486 DKSLAAYFLCAMKEERLFEILDA--RVMKQGGKDEIITVAKLAK----RCLNLNGKKRPT 539
+ A F+ ++ + + + K+ + + LA + L L+ ++R T
Sbjct: 235 TGTPPAEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVT 294
Query: 540 MREV 543
E
Sbjct: 295 AGEA 298
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 129 bits (325), Expect = 5e-34
Identities = 54/299 (18%), Positives = 103/299 (34%), Gaps = 50/299 (16%)
Query: 289 DNFDLNRILGQGGQ---------------AVKK--SKVIDESKVEEFINEVVILSQINHR 331
++ +GQG A+KK + E + E+ IL + H
Sbjct: 10 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHE 69
Query: 332 NVVKLLGCCLETEVP--------LLVYEFIPNGTLFQYIHDQNEDFPITWEIRLRIAIEV 383
NVV L+ C P LV++F + + T R+ +
Sbjct: 70 NVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLV---KFTLSEIKRVMQML 126
Query: 384 SGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQT---HMTTQVHG 440
L+ L+ I HRD+K+ N+L+ K++DFG +R+ ++ + + T
Sbjct: 127 ---LNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVV 183
Query: 441 TFGYLDPEYFRSSQ-FTDKSDVYSFGVVLTELLTGEKP--------IRFTILEEDKSLAA 491
T Y PE + + D++ G ++ E+ T I + S+
Sbjct: 184 TLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITP 243
Query: 492 YFLCAMKEERLFEILDARVMKQGGKDEIITVAK-------LAKRCLNLNGKKRPTMREV 543
+ L+E L+ ++ + + L + L L+ +R +
Sbjct: 244 EVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDA 302
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 124 bits (311), Expect = 3e-32
Identities = 38/283 (13%), Positives = 80/283 (28%), Gaps = 38/283 (13%)
Query: 289 DNFDLNRILGQGG-----QAVKKS-------KVID-ESKVEEFINEVVILSQINHRNVVK 335
++ + R +G+G + K S + +E + +
Sbjct: 5 VHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAPQLRDEYRTYKLLAGCTGIP 64
Query: 336 LLGCCLETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEIRLRIAIEVSGALSYLHSAAS 395
+ + + ++ + +L + F + A ++ + +H
Sbjct: 65 NVYYFGQEGLHNVLVIDLLGPSLEDLLDLCGRKFS--VKTVAMAAKQMLARVQSIHEK-- 120
Query: 396 IPIYHRDIKSTNILLDDKYR-----AKVSDFGASRSMAVDQT------HMTTQVHGTFGY 444
+ +RDIK N L+ V DFG + T + GT Y
Sbjct: 121 -SLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARY 179
Query: 445 LDPEYFRSSQFTDKSDVYSFGVVLTELLTGEKPIRFTILEEDKSLAAYFLCAMKEERLFE 504
+ + + + D+ + G V L G P + + K ER+ E
Sbjct: 180 MSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATN---------KQKYERIGE 230
Query: 505 ILDARVMKQGGKDEIITVAKLAKRCLNLNGKKRPTMREVASEL 547
+ +++ K NL P +
Sbjct: 231 KKQSTPLRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQGLF 273
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 124 bits (311), Expect = 5e-32
Identities = 54/293 (18%), Positives = 109/293 (37%), Gaps = 49/293 (16%)
Query: 289 DNFDLNRILGQGG-----QAVKKS-------KVIDESKVEEFINEVVILSQIN-HRNVVK 335
D++ L R LG+G +A+ + K++ K ++ E+ IL + N++
Sbjct: 35 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKKKIKREIKILENLRGGPNIIT 94
Query: 336 LLGCCLE--TEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEIRLRIAIEVSGALSYLHSA 393
L + + P LV+E + N Q +T E+ AL Y HS
Sbjct: 95 LADIVKDPVSRTPALVFEHVNNTDFKQLYQ------TLTDYDIRFYMYEILKALDYCHSM 148
Query: 394 ASIPIYHRDIKSTNILLD-DKYRAKVSDFGASRSMAVDQTHMTTQVHGTFGYLDPEYFRS 452
I HRD+K N+++D + + ++ D+G + Q + + + PE
Sbjct: 149 ---GIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEY--NVRVASRYFKGPELLVD 203
Query: 453 SQFTD-KSDVYSFGVVLTELLTGEKPIR------------FTILEEDKSLAAYFLCAMKE 499
Q D D++S G +L ++ ++P +L + ++
Sbjct: 204 YQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIEL 263
Query: 500 ERLFEILDARVMKQGGKDEIITVAK---------LAKRCLNLNGKKRPTMREV 543
+ F + R ++ + + + + + L + + R T RE
Sbjct: 264 DPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREA 316
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 122 bits (307), Expect = 2e-31
Identities = 76/285 (26%), Positives = 113/285 (39%), Gaps = 45/285 (15%)
Query: 289 DNFDLNRILGQGGQ------------------AVK---KSKVIDESK-VEEFINEVVILS 326
+NF+L ++LG G A+K K+ ++ ++K E E +L
Sbjct: 24 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLE 83
Query: 327 QINHR-NVVKLLGCCLETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEIRLRIAIEVSG 385
I +V L L+ ++I G LF ++ + T E+
Sbjct: 84 HIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQR---ERFTEHEVQIYVGEIVL 140
Query: 386 ALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHGTFGYL 445
AL +LH I +RDIK NILLD ++DFG S+ D+T GT Y+
Sbjct: 141 ALEHLHKL---GIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFCGTIEYM 197
Query: 446 DPEYFRSSQ--FTDKSDVYSFGVVLTELLTGEKPIRFTILEEDKSLAAYFLCAMKEERLF 503
P+ R D +S GV++ ELLTG P FT+ E S A +K E +
Sbjct: 198 APDIVRGGDSGHDKAVDWWSLGVLMYELLTGASP--FTVDGEKNSQAEISRRILKSEPPY 255
Query: 504 EILDARVMKQGGKDEIITVAKLAKRCLNLNGKKRPTM-REVASEL 547
+ M KD L +R L + KKR A E+
Sbjct: 256 P----QEMSALAKD-------LIQRLLMKDPKKRLGCGPRDADEI 289
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 116 bits (292), Expect = 3e-29
Identities = 63/305 (20%), Positives = 106/305 (34%), Gaps = 50/305 (16%)
Query: 279 FTSKELEKA----TDNFDLNRILGQGGQ---------------AVK--KSKVIDESKVEE 317
F +EL K + + +G G AVK +
Sbjct: 4 FYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKR 63
Query: 318 FINEVVILSQINHRNVVKLLGCC-----LETEVPLLVYEFIPNGTLFQYIHDQNEDFPIT 372
E+ +L + H NV+ LL LE + + + L + Q +T
Sbjct: 64 TYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQ----KLT 119
Query: 373 WEIRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQT 432
+ + ++ L Y+HSA I HRD+K +N+ +++ K+ DFG +R
Sbjct: 120 DDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARHT---DD 173
Query: 433 HMTTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLTELLTGEKPIRFT--------ILE 484
MT V + + D++S G ++ ELLTG T IL
Sbjct: 174 EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILR 233
Query: 485 EDKSLAAYFLCAMKEERLFEILDA--RVMKQGGKDEIITVAKLAK----RCLNLNGKKRP 538
+ A L + E + + ++ K + I LA + L L+ KR
Sbjct: 234 LVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRI 293
Query: 539 TMREV 543
T +
Sbjct: 294 TAAQA 298
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 114 bits (285), Expect = 3e-28
Identities = 52/303 (17%), Positives = 107/303 (35%), Gaps = 59/303 (19%)
Query: 289 DNFDLNRILGQGGQ---------------AVKK--SKVIDESKVEEFINEVVILSQINHR 331
+ + +G G Q A+KK +++ + E+V++ +NH+
Sbjct: 17 KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHK 76
Query: 332 NVVKLLGCCL------ETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEIRLRIAIEVSG 385
N++ LL E + LV E + + E + ++
Sbjct: 77 NIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQM------ELDHERMSYLLYQMLC 130
Query: 386 ALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHGTFGYL 445
+ +LH S I HRD+K +NI++ K+ DFG +R+ + M T T Y
Sbjct: 131 GIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTA--GTSFMMTPYVVTRYYR 185
Query: 446 DPEYFRSSQFTDKSDVYSFGVVLTELLTGEKP--------IRFTILEEDKSLAAYFL--- 494
PE + + D++S G ++ E++ + ++E+ + F+
Sbjct: 186 APEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKL 245
Query: 495 --------------CAMKEERLFEILDARVMKQGGKDEIITVAKLAKRCLNLNGKKRPTM 540
+ +LF + K + L + L ++ KR ++
Sbjct: 246 QPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISV 305
Query: 541 REV 543
+
Sbjct: 306 DDA 308
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 97.0 bits (240), Expect = 2e-22
Identities = 55/313 (17%), Positives = 98/313 (31%), Gaps = 62/313 (19%)
Query: 291 FDLNRILGQGG-----QAVKKS-------KVIDESKV--EEFINEVVILSQINHRNVVKL 336
+ L R LG G A K++ KV E +E+ +L ++N + K
Sbjct: 15 YILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKE 74
Query: 337 LGCCLETEVPLLVY--EFIPNGTLFQYIH-----------DQNEDFPITWEIRLRIAIEV 383
+ LL + PNG + + E I +I+ ++
Sbjct: 75 DSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQL 134
Query: 384 SGALSYLHSAASIPIYHRDIKSTNILLD-DKYRAKVSDFG-ASRSMAVDQTHMTTQVHGT 441
L Y+H I H DIK N+L++ + A A T T
Sbjct: 135 LLGLDYMHRRCGII--HTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNSIQT 192
Query: 442 FGYLDPEYFRSSQFTDKSDVYSFGVVLTELLTGEKP------------------------ 477
Y PE + + +D++S ++ EL+TG+
Sbjct: 193 REYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQIIELLG 252
Query: 478 -IRFTILEEDKSLAAYF-----LCAMKEERLFEILDARVMKQGGKDEIITVAK-LAKRCL 530
+ +L K +F L + + + + + D K + L
Sbjct: 253 ELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPML 312
Query: 531 NLNGKKRPTMREV 543
L+ +KR +
Sbjct: 313 QLDPRKRADAGGL 325
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 57.9 bits (139), Expect = 3e-10
Identities = 21/132 (15%), Positives = 42/132 (31%), Gaps = 10/132 (7%)
Query: 296 ILGQGGQAVKKSKVIDESKVEEFINEVVILSQINHRNVVKLLGCCLETEVPLLVYEFIPN 355
G + KK K + F + ++ R + KL G + Y + N
Sbjct: 31 FHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKV-----YAWEGN 85
Query: 356 GTLFQYIHDQNEDFPITWEIRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYR 415
L + I + + + ++ + I H D+ N+L+ +
Sbjct: 86 AVLMELIDAKELYRVRVENPD-EVLDMILEEVAKFYHR---GIVHGDLSQYNVLVSE-EG 140
Query: 416 AKVSDFGASRSM 427
+ DF S +
Sbjct: 141 IWIIDFPQSVEV 152
|
Homologous Domains Detected by HHsearch
Original result of HHsearch against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 608 | |||
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 100.0 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 100.0 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 100.0 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 100.0 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 100.0 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 100.0 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 100.0 | |
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 100.0 | |
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 100.0 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 100.0 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 100.0 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 100.0 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 100.0 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 100.0 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 100.0 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 100.0 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 100.0 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 100.0 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 100.0 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 100.0 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 100.0 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 100.0 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 100.0 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 100.0 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 100.0 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 100.0 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 100.0 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 100.0 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 100.0 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 100.0 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 100.0 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 100.0 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 100.0 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 100.0 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 100.0 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 100.0 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 100.0 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 100.0 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 100.0 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 100.0 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 100.0 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 100.0 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 100.0 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 100.0 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 100.0 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 100.0 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 100.0 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 99.98 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.7 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 97.8 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 97.04 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 94.53 | |
| d1nw1a_ | 395 | Choline kinase {Caenorhabditis elegans [TaxId: 623 | 93.62 | |
| d1zyla1 | 325 | RdoA {Escherichia coli [TaxId: 562]} | 89.91 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 84.74 | |
| d1gl4a2 | 40 | EGF-like domain of nidogen-1 {Mouse (Mus musculus) | 82.41 |
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.9e-48 Score=390.99 Aligned_cols=244 Identities=27% Similarity=0.427 Sum_probs=190.3
Q ss_pred cCccccceeccCce--------------EEEEEeecChhhHHHHHHHHHHHhhcCCCCccceecccccCccceEEEeecC
Q 044312 289 DNFDLNRILGQGGQ--------------AVKKSKVIDESKVEEFINEVVILSQINHRNVVKLLGCCLETEVPLLVYEFIP 354 (608)
Q Consensus 289 ~~f~~~~~lG~G~~--------------avk~~~~~~~~~~~~~~~Ei~il~~l~H~niv~l~~~~~~~~~~~lV~E~~~ 354 (608)
++|++.+.||+|+| |||+++. +....++|.+|++++++++|||||+++|++.+.+..+|||||++
T Consensus 5 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~-~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~lv~E~~~ 83 (263)
T d1sm2a_ 5 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIRE-GAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFME 83 (263)
T ss_dssp SCEEEEEEEECCSSCCEEEEEETTTEEEEEEECCS-SSSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCT
T ss_pred HHcEEEEEEeeCCCeEEEEEEECCCCEEEEEEECC-CcCcHHHHHHHHHHHHhcCCCCcccccceeccCCceEEEEEecC
Confidence 46888999999984 7787664 34456789999999999999999999999999999999999999
Q ss_pred CCccchhccccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEEcCCCcEEEeeccCccccccCCcce
Q 044312 355 NGTLFQYIHDQNEDFPITWEIRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHM 434 (608)
Q Consensus 355 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGls~~~~~~~~~~ 434 (608)
+|+|.+++..... .+++..++.|+.|||.||+|||+++ |+||||||+|||+++++.+||+|||+++.........
T Consensus 84 ~g~L~~~l~~~~~--~~~~~~~~~i~~qia~gl~~lH~~~---iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~~ 158 (263)
T d1sm2a_ 84 HGCLSDYLRTQRG--LFAAETLLGMCLDVCEGMAYLEEAC---VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTS 158 (263)
T ss_dssp TCBHHHHHHTTTT--CCCHHHHHHHHHHHHHHHHHHHHTT---CCCTTCSGGGEEECGGGCEEECSCC------------
T ss_pred CCcHHHHhhcccc--CCCHHHHHHHHHHHHHHHHhhhccc---eeecccchhheeecCCCCeEecccchheeccCCCcee
Confidence 9999999876543 5899999999999999999999999 9999999999999999999999999998876554444
Q ss_pred eeeeeccCCCCChhhhccCCCCCccchHhHHHHHHHHHhCCCCCCccchhhcccHHHHHHHHhhhhhhHHHhhhhhhccC
Q 044312 435 TTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLTELLTGEKPIRFTILEEDKSLAAYFLCAMKEERLFEILDARVMKQG 514 (608)
Q Consensus 435 ~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~ 514 (608)
.....||+.|+|||++.+..++.|+|||||||++|||+|+..|+..... ... +.+.+........
T Consensus 159 ~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~t~~~~~~~~~~-----~~~----------~~~~i~~~~~~~~ 223 (263)
T d1sm2a_ 159 STGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRS-----NSE----------VVEDISTGFRLYK 223 (263)
T ss_dssp ------CTTSCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSCC-----HHH----------HHHHHHHTCCCCC
T ss_pred ecceecCcccCChHHhcCCCCCchhhhcchHHHHHHHHHCCCCCCCCCC-----HHH----------HHHHHHhcCCCCC
Confidence 4556789999999999999999999999999999999996544332111 111 1111222222334
Q ss_pred ChhHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhhHHh
Q 044312 515 GKDEIITVAKLAKRCLNLNGKKRPTMREVASELAGIKAW 553 (608)
Q Consensus 515 ~~~~~~~l~~Li~~cl~~dp~~RPs~~evl~~L~~i~~~ 553 (608)
+...+.++.+|+.+||+.||++||||+||+++|+++...
T Consensus 224 p~~~~~~l~~li~~cl~~~p~~Rps~~~il~~L~~i~es 262 (263)
T d1sm2a_ 224 PRLASTHVYQIMNHCWKERPEDRPAFSRLLRQLAEIAES 262 (263)
T ss_dssp CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred ccccCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHHhC
Confidence 455667899999999999999999999999999998753
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=2.5e-48 Score=397.25 Aligned_cols=243 Identities=24% Similarity=0.419 Sum_probs=189.4
Q ss_pred cCccccceeccCce------------------EEEEEee-cChhhHHHHHHHHHHHhhcCCCCccceecccccCccceEE
Q 044312 289 DNFDLNRILGQGGQ------------------AVKKSKV-IDESKVEEFINEVVILSQINHRNVVKLLGCCLETEVPLLV 349 (608)
Q Consensus 289 ~~f~~~~~lG~G~~------------------avk~~~~-~~~~~~~~~~~Ei~il~~l~H~niv~l~~~~~~~~~~~lV 349 (608)
++|++.++||+|+| |||+... ......+.|.+|+++|++++|||||+++|++.+.+..++|
T Consensus 26 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~iv 105 (299)
T d1jpaa_ 26 SCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMII 105 (299)
T ss_dssp GGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEEE
T ss_pred hhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEEE
Confidence 35667789999985 3344332 3445567899999999999999999999999999999999
Q ss_pred EeecCCCccchhccccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEEcCCCcEEEeeccCcccccc
Q 044312 350 YEFIPNGTLFQYIHDQNEDFPITWEIRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAV 429 (608)
Q Consensus 350 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGls~~~~~ 429 (608)
|||+++|+|.+++..... .+++..++.|+.|||+||+|||+++ |+||||||+||||+.++.+||+|||+++.+..
T Consensus 106 ~Ey~~~g~L~~~~~~~~~--~l~~~~~~~i~~qia~gl~yLH~~~---iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~~ 180 (299)
T d1jpaa_ 106 TEFMENGSLDSFLRQNDG--QFTVIQLVGMLRGIAAGMKYLADMN---YVHRDLAARNILVNSNLVCKVSDFGLSRFLED 180 (299)
T ss_dssp EECCTTEEHHHHHHTTTT--CSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCC--------
T ss_pred EEecCCCcceeeeccccC--CCCHHHHHHHHHHHHHHHHHHhhCC---CccCccccceEEECCCCcEEECCcccceEccC
Confidence 999999999998876433 5999999999999999999999999 99999999999999999999999999987754
Q ss_pred CCcce----eeeeeccCCCCChhhhccCCCCCccchHhHHHHHHHHHh-CCCCCCccchhhcccHHHHHHHHhhhhhhHH
Q 044312 430 DQTHM----TTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLTELLT-GEKPIRFTILEEDKSLAAYFLCAMKEERLFE 504 (608)
Q Consensus 430 ~~~~~----~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~ellt-g~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~ 504 (608)
..... .....||+.|||||.+.+..++.++|||||||+||||+| |+.||...... .+..
T Consensus 181 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~~~----------------~~~~ 244 (299)
T d1jpaa_ 181 DTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQ----------------DVIN 244 (299)
T ss_dssp ---------------CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHH----------------HHHH
T ss_pred CCCcceeeecccccCCccccCHHHHhcCCCCcccccccchHHHHHHHhCCCCCCCCCCHH----------------HHHH
Confidence 33221 223457899999999999999999999999999999998 89998632211 1111
Q ss_pred HhhhhhhccCChhHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhhHH
Q 044312 505 ILDARVMKQGGKDEIITVAKLAKRCLNLNGKKRPTMREVASELAGIKA 552 (608)
Q Consensus 505 ~~d~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~evl~~L~~i~~ 552 (608)
.+........+...+.++.+|+.+||+.||++||||.||++.|+.+..
T Consensus 245 ~i~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ei~~~L~~~l~ 292 (299)
T d1jpaa_ 245 AIEQDYRLPPPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNTLDKMIR 292 (299)
T ss_dssp HHHTTCCCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHH
T ss_pred HHHcCCCCCCCccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhc
Confidence 222222334455677889999999999999999999999999988755
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=8.1e-49 Score=398.51 Aligned_cols=250 Identities=28% Similarity=0.443 Sum_probs=208.8
Q ss_pred HHHHHhcCccccceeccCce---------------EEEEEeecChhhHHHHHHHHHHHhhcCCCCccceecccccCccce
Q 044312 283 ELEKATDNFDLNRILGQGGQ---------------AVKKSKVIDESKVEEFINEVVILSQINHRNVVKLLGCCLETEVPL 347 (608)
Q Consensus 283 ~l~~~t~~f~~~~~lG~G~~---------------avk~~~~~~~~~~~~~~~Ei~il~~l~H~niv~l~~~~~~~~~~~ 347 (608)
+++...++|++.++||+|+| |||+++. +....++|.+|+.+|++++|||||++++++.+.+..+
T Consensus 11 ~wei~~~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~-~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ 89 (287)
T d1opja_ 11 KWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKE-DTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFY 89 (287)
T ss_dssp TTBCCGGGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCT-TCSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCE
T ss_pred ccEecHHHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECC-ccchHHHHHHHHHHHHhCCCCCEecCCccEeeCCeeE
Confidence 34444567899999999984 7887654 3445788999999999999999999999999999999
Q ss_pred EEEeecCCCccchhccccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEEcCCCcEEEeeccCcccc
Q 044312 348 LVYEFIPNGTLFQYIHDQNEDFPITWEIRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSM 427 (608)
Q Consensus 348 lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGls~~~ 427 (608)
|||||+++|+|.+++..... ..+++..++.|+.|||.||+|||+++ |+||||||+||||++++.+||+|||+|+..
T Consensus 90 iv~E~~~~g~l~~~l~~~~~-~~~~~~~~~~i~~qi~~gL~yLH~~~---iiHrDlKp~NILl~~~~~~Kl~DFG~a~~~ 165 (287)
T d1opja_ 90 IITEFMTYGNLLDYLRECNR-QEVSAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRLM 165 (287)
T ss_dssp EEEECCTTCBHHHHHHHSCT-TTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCCCTTTC
T ss_pred EEeecccCcchHHHhhhccc-cchHHHHHHHHHHHHHHHHHHHHHCC---cccCccccCeEEECCCCcEEEccccceeec
Confidence 99999999999999976433 36999999999999999999999999 999999999999999999999999999987
Q ss_pred ccCCcceeeeeeccCCCCChhhhccCCCCCccchHhHHHHHHHHHhCCCCCCccchhhcccHHHHHHHHhhhhhhHHHhh
Q 044312 428 AVDQTHMTTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLTELLTGEKPIRFTILEEDKSLAAYFLCAMKEERLFEILD 507 (608)
Q Consensus 428 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 507 (608)
..+.........|++.|+|||++.+..++.|+|||||||++|||++|..|+..... ...+.+++.
T Consensus 166 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell~~~~p~~~~~~---------------~~~~~~~i~ 230 (287)
T d1opja_ 166 TGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGID---------------LSQVYELLE 230 (287)
T ss_dssp CSSSSEEETTEEECGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCSSTTCC---------------HHHHHHHHH
T ss_pred CCCCceeeccccccccccChHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCcch---------------HHHHHHHHh
Confidence 66555555566789999999999999999999999999999999998777542211 111223333
Q ss_pred hhhhccCChhHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhhHH
Q 044312 508 ARVMKQGGKDEIITVAKLAKRCLNLNGKKRPTMREVASELAGIKA 552 (608)
Q Consensus 508 ~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~evl~~L~~i~~ 552 (608)
.....+.+...+.++.+|+.+||+.||++|||+.||++.|+.+..
T Consensus 231 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ei~~~L~~~~~ 275 (287)
T d1opja_ 231 KDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQ 275 (287)
T ss_dssp TTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTS
T ss_pred cCCCCCCCccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHH
Confidence 334445555677889999999999999999999999998877643
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.3e-48 Score=391.66 Aligned_cols=249 Identities=24% Similarity=0.407 Sum_probs=196.1
Q ss_pred hcCccccceeccCce------------EEEEEee--cChhhHHHHHHHHHHHhhcCCCCccceecccccCccceEEEeec
Q 044312 288 TDNFDLNRILGQGGQ------------AVKKSKV--IDESKVEEFINEVVILSQINHRNVVKLLGCCLETEVPLLVYEFI 353 (608)
Q Consensus 288 t~~f~~~~~lG~G~~------------avk~~~~--~~~~~~~~~~~Ei~il~~l~H~niv~l~~~~~~~~~~~lV~E~~ 353 (608)
.++|.+.+.||+|+| |||+++. .+....+.|.+|+.+|++++|||||++++++.+ ...+|||||+
T Consensus 7 ~~~~~~~~~lG~G~fg~Vy~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~-~~~~lv~Ey~ 85 (276)
T d1uwha_ 7 DGQITVGQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTA-PQLAIVTQWC 85 (276)
T ss_dssp TTCCCCCSEEEECSSCEEEEEESSSEEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEEEECC
T ss_pred cccEEEEEEEeeCCCcEEEEEEECCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeeeEEEec-cEEEEEEecC
Confidence 467889999999985 8888764 345667899999999999999999999998865 5679999999
Q ss_pred CCCccchhccccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEEcCCCcEEEeeccCccccccCC-c
Q 044312 354 PNGTLFQYIHDQNEDFPITWEIRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQ-T 432 (608)
Q Consensus 354 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGls~~~~~~~-~ 432 (608)
++|+|.++++.... .+++..++.|+.|||+||+|||+++ |+||||||+||||+.++.+||+|||+|+...... .
T Consensus 86 ~~g~L~~~l~~~~~--~~~~~~~~~i~~qi~~gl~yLH~~~---ivHrDlKp~NiLl~~~~~~Kl~DFGla~~~~~~~~~ 160 (276)
T d1uwha_ 86 EGSSLYHHLHIIET--KFEMIKLIDIARQTAQGMDYLHAKS---IIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGS 160 (276)
T ss_dssp CEEEHHHHHHTSCC--CCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEETTSSEEECCCCCSCC-------
T ss_pred CCCCHHHHHhhccC--CCCHHHHHHHHHHHHHHHHHHhcCC---EeccccCHHHEEEcCCCCEEEccccceeeccccCCc
Confidence 99999999976443 5999999999999999999999998 9999999999999999999999999998765432 2
Q ss_pred ceeeeeeccCCCCChhhhcc---CCCCCccchHhHHHHHHHHHhCCCCCCccchhhcccHHHHHHHHhhhhhhHHHhhhh
Q 044312 433 HMTTQVHGTFGYLDPEYFRS---SQFTDKSDVYSFGVVLTELLTGEKPIRFTILEEDKSLAAYFLCAMKEERLFEILDAR 509 (608)
Q Consensus 433 ~~~~~~~gt~~y~aPE~~~~---~~~t~ksDV~S~Gvvl~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 509 (608)
.......||+.|||||++.. ..++.++|||||||+||||+||+.||....... .+......+.. .+
T Consensus 161 ~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~~------~~~~~~~~~~~----~p- 229 (276)
T d1uwha_ 161 HQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRD------QIIFMVGRGYL----SP- 229 (276)
T ss_dssp -----CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHH------HHHHHHHHTSC----CC-
T ss_pred ccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCChHH------HHHHHHhcCCC----CC-
Confidence 33455679999999999864 358999999999999999999999996322111 01111111100 00
Q ss_pred hhccCChhHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhhHHh
Q 044312 510 VMKQGGKDEIITVAKLAKRCLNLNGKKRPTMREVASELAGIKAW 553 (608)
Q Consensus 510 ~~~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~evl~~L~~i~~~ 553 (608)
.....+...+.++.+|+.+||+.||++||||+||+++|+.++..
T Consensus 230 ~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~~il~~Le~l~~~ 273 (276)
T d1uwha_ 230 DLSKVRSNCPKAMKRLMAECLKKKRDERPLFPQILASIELLARS 273 (276)
T ss_dssp CGGGSCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred cchhccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHc
Confidence 11223345667899999999999999999999999999988764
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-47 Score=386.99 Aligned_cols=248 Identities=23% Similarity=0.382 Sum_probs=201.1
Q ss_pred HHHHhcCccccceeccCce--------------EEEEEeecChhhHHHHHHHHHHHhhcCCCCccceecccccCccceEE
Q 044312 284 LEKATDNFDLNRILGQGGQ--------------AVKKSKVIDESKVEEFINEVVILSQINHRNVVKLLGCCLETEVPLLV 349 (608)
Q Consensus 284 l~~~t~~f~~~~~lG~G~~--------------avk~~~~~~~~~~~~~~~Ei~il~~l~H~niv~l~~~~~~~~~~~lV 349 (608)
++...++|++.+.||+|+| |||+++. +....+.|.+|+.+|++++|||||++++++.+ +..+||
T Consensus 8 wei~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~~~~-~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~-~~~~iv 85 (272)
T d1qpca_ 8 WEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQ-GSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYII 85 (272)
T ss_dssp TBCCGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECT-TSSCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEE
T ss_pred eecCHHHeEEeEEEecCCCcEEEEEEECCCCEEEEEEEcc-CcCCHHHHHHHHHHHHhCCCCCEeEEEeeecc-CCeEEE
Confidence 3334567888999999985 7887764 33456789999999999999999999998865 567999
Q ss_pred EeecCCCccchhccccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEEcCCCcEEEeeccCcccccc
Q 044312 350 YEFIPNGTLFQYIHDQNEDFPITWEIRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAV 429 (608)
Q Consensus 350 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGls~~~~~ 429 (608)
|||+++|+|.+++...... ++++..+++|+.|||+||+|||+++ |+||||||+||||++++.+||+|||+|+....
T Consensus 86 ~Ey~~~g~L~~~~~~~~~~-~l~~~~~~~i~~qi~~gl~~lH~~~---ivHrDiKp~NIll~~~~~~Kl~DFGla~~~~~ 161 (272)
T d1qpca_ 86 TEYMENGSLVDFLKTPSGI-KLTINKLLDMAAQIAEGMAFIEERN---YIHRDLRAANILVSDTLSCKIADFGLARLIED 161 (272)
T ss_dssp EECCTTCBHHHHTTSHHHH-TCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCEECSS
T ss_pred EEeCCCCcHHHHHhhcCCC-CCCHHHHHHHHHHHHHHHHHHHhCC---cccCccchhheeeecccceeeccccceEEccC
Confidence 9999999999988764332 5999999999999999999999999 99999999999999999999999999998765
Q ss_pred CCcceeeeeeccCCCCChhhhccCCCCCccchHhHHHHHHHHHhCCCCCCccchhhcccHHHHHHHHhhhhhhHHHhhhh
Q 044312 430 DQTHMTTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLTELLTGEKPIRFTILEEDKSLAAYFLCAMKEERLFEILDAR 509 (608)
Q Consensus 430 ~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 509 (608)
..........||+.|||||++.+..++.++|||||||++|||+||..|+...... .. +...+...
T Consensus 162 ~~~~~~~~~~gt~~y~APE~~~~~~~~~~sDvwS~Gvvl~ellt~~~~~~~~~~~-----~~----------~~~~i~~~ 226 (272)
T d1qpca_ 162 NEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTN-----PE----------VIQNLERG 226 (272)
T ss_dssp SCEECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCH-----HH----------HHHHHHTT
T ss_pred CccccccccCCcccccChHHHhCCCCCchhhhhhhHHHHHHHHhCCCCCCCCCCH-----HH----------HHHHHHhc
Confidence 5444445567899999999999999999999999999999999976654321111 11 11111222
Q ss_pred hhccCChhHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhhHH
Q 044312 510 VMKQGGKDEIITVAKLAKRCLNLNGKKRPTMREVASELAGIKA 552 (608)
Q Consensus 510 ~~~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~evl~~L~~i~~ 552 (608)
.....+...+.++.+|+.+||+.||++||||+||++.|+.+-.
T Consensus 227 ~~~~~p~~~~~~l~~li~~cl~~~P~~Rpt~~ei~~~L~~~ft 269 (272)
T d1qpca_ 227 YRMVRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFT 269 (272)
T ss_dssp CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CCCCCcccChHHHHHHHHHHcCCCHhHCcCHHHHHHHhhhhhh
Confidence 2233445567789999999999999999999999999987644
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-46 Score=376.36 Aligned_cols=240 Identities=26% Similarity=0.423 Sum_probs=202.2
Q ss_pred cCccccceeccCce--------------EEEEEeecChhhHHHHHHHHHHHhhcCCCCccceecccccCccceEEEeecC
Q 044312 289 DNFDLNRILGQGGQ--------------AVKKSKVIDESKVEEFINEVVILSQINHRNVVKLLGCCLETEVPLLVYEFIP 354 (608)
Q Consensus 289 ~~f~~~~~lG~G~~--------------avk~~~~~~~~~~~~~~~Ei~il~~l~H~niv~l~~~~~~~~~~~lV~E~~~ 354 (608)
++|++.++||+|+| |||+++.. ....++|.+|+.++++++|||||+++|++.+.+..++||||++
T Consensus 4 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~l~~~-~~~~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~~~iv~Ey~~ 82 (258)
T d1k2pa_ 4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEG-SMSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMA 82 (258)
T ss_dssp CCCCCCCCCCEETTEEEEEEEETTTEEEEEEEEESS-SSCHHHHHHHHHHHHTCCCTTBCCEEEEECCSSSEEEEEECCT
T ss_pred HHCEEeEEEecCCCeEEEEEEECCCCEEEEEEECcC-cCCHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEEEccC
Confidence 57889999999985 77877653 3356789999999999999999999999999999999999999
Q ss_pred CCccchhccccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEEcCCCcEEEeeccCccccccCCcce
Q 044312 355 NGTLFQYIHDQNEDFPITWEIRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHM 434 (608)
Q Consensus 355 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGls~~~~~~~~~~ 434 (608)
+|+|.+++..... .+++..+++|+.|||+||+|||+.+ |+||||||+|||+++++.+||+|||+++.........
T Consensus 83 ~g~l~~~~~~~~~--~~~~~~~~~i~~qi~~gl~~LH~~~---iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~~~ 157 (258)
T d1k2pa_ 83 NGCLLNYLREMRH--RFQTQQLLEMCKDVCEAMEYLESKQ---FLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTS 157 (258)
T ss_dssp TEEHHHHHHSGGG--CCCHHHHHHHHHHHHHHHHHHHHTT---BCCSCCSGGGEEECTTCCEEECCCSSCCBCSSSSCCC
T ss_pred CCcHHHhhhcccc--CCcHHHHHHHHHHHHHHHHHHhhcC---cccccccceeEEEcCCCcEEECcchhheeccCCCcee
Confidence 9999999776543 5899999999999999999999999 9999999999999999999999999998776555444
Q ss_pred eeeeeccCCCCChhhhccCCCCCccchHhHHHHHHHHHh-CCCCCCccchhhcccHHHHHHHHhhhhhhHHHhhhhhhcc
Q 044312 435 TTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLTELLT-GEKPIRFTILEEDKSLAAYFLCAMKEERLFEILDARVMKQ 513 (608)
Q Consensus 435 ~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~ellt-g~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~ 513 (608)
.....||+.|+|||.+....++.|+||||||+++|||+| |+.||......+ +...+....+..
T Consensus 158 ~~~~~~t~~y~aPE~~~~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~~~----------------~~~~i~~~~~~~ 221 (258)
T d1k2pa_ 158 SVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSE----------------TAEHIAQGLRLY 221 (258)
T ss_dssp CCCSCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCHHH----------------HHHHHHTTCCCC
T ss_pred ecccCCCCCcCCcHHhcCCCCCcceeecccchhhHhHHhcCCCCCCCCCHHH----------------HHHHHHhCCCCC
Confidence 555678999999999999999999999999999999998 788987432221 111111222334
Q ss_pred CChhHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhh
Q 044312 514 GGKDEIITVAKLAKRCLNLNGKKRPTMREVASELAGI 550 (608)
Q Consensus 514 ~~~~~~~~l~~Li~~cl~~dp~~RPs~~evl~~L~~i 550 (608)
.+...+.++.+|+.+||+.||++|||++||+++|..|
T Consensus 222 ~p~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~di 258 (258)
T d1k2pa_ 222 RPHLASEKVYTIMYSCWHEKADERPTFKILLSNILDV 258 (258)
T ss_dssp CCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHCC
T ss_pred CcccccHHHHHHHHHHccCCHhHCcCHHHHHHHhhCC
Confidence 4455667899999999999999999999999998643
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-46 Score=381.06 Aligned_cols=244 Identities=23% Similarity=0.396 Sum_probs=193.6
Q ss_pred cCccccceeccCce-------------------EEEEEee-cChhhHHHHHHHHHHHhhcCCCCccceecccccCccceE
Q 044312 289 DNFDLNRILGQGGQ-------------------AVKKSKV-IDESKVEEFINEVVILSQINHRNVVKLLGCCLETEVPLL 348 (608)
Q Consensus 289 ~~f~~~~~lG~G~~-------------------avk~~~~-~~~~~~~~~~~Ei~il~~l~H~niv~l~~~~~~~~~~~l 348 (608)
..|++.++||+|+| |||+++. ......++|.+|+.+|++++|||||+++|++.+.+..++
T Consensus 7 ~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~~~~~~ 86 (283)
T d1mqba_ 7 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMI 86 (283)
T ss_dssp TTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEE
T ss_pred HHeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECcccChHHHHHHHHHHHHHHhcCCCCEeeeeEEEecCCceEE
Confidence 45788899999984 5565543 234456689999999999999999999999999999999
Q ss_pred EEeecCCCccchhccccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEEcCCCcEEEeeccCccccc
Q 044312 349 VYEFIPNGTLFQYIHDQNEDFPITWEIRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMA 428 (608)
Q Consensus 349 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGls~~~~ 428 (608)
||||+.+++|.+++..... .+++..++.++.||+.||+|||+.+ |+||||||+||||+.++.+||+|||+++.+.
T Consensus 87 v~e~~~~~~l~~~~~~~~~--~~~~~~~~~i~~~i~~gl~~lH~~~---iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~ 161 (283)
T d1mqba_ 87 ITEYMENGALDKFLREKDG--EFSVLQLVGMLRGIAAGMKYLANMN---YVHRDLAARNILVNSNLVCKVSDFGLSRVLE 161 (283)
T ss_dssp EEECCTTEEHHHHHHHTTT--CSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCCCC-----
T ss_pred EEEecccCcchhhhhcccc--cccHHHHHHHHHHHHHhhhhccccc---cccCccccceEEECCCCeEEEcccchhhccc
Confidence 9999999999988876543 5999999999999999999999999 9999999999999999999999999998765
Q ss_pred cCCc--ceeeeeeccCCCCChhhhccCCCCCccchHhHHHHHHHHHhCCCCCCccchhhcccHHHHHHHHhhhhhhHHHh
Q 044312 429 VDQT--HMTTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLTELLTGEKPIRFTILEEDKSLAAYFLCAMKEERLFEIL 506 (608)
Q Consensus 429 ~~~~--~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 506 (608)
.... .......||+.|||||++.+..++.++|||||||++|||+++..|+...... ..+.+.+
T Consensus 162 ~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~el~t~~~~~~~~~~~---------------~~~~~~i 226 (283)
T d1mqba_ 162 DDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSN---------------HEVMKAI 226 (283)
T ss_dssp ------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCH---------------HHHHHHH
T ss_pred CCCccceEeccCCCCccccCHHHHccCCCCCcccccccHHHHHHHHhCCCCccccCCH---------------HHHHHHH
Confidence 4332 2233456899999999999999999999999999999999976665422111 1122223
Q ss_pred hhhhhccCChhHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhhHH
Q 044312 507 DARVMKQGGKDEIITVAKLAKRCLNLNGKKRPTMREVASELAGIKA 552 (608)
Q Consensus 507 d~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~evl~~L~~i~~ 552 (608)
....+.+.+...+.++.+|+.+||+.||++||||.||++.|+.+..
T Consensus 227 ~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~L~~l~~ 272 (283)
T d1mqba_ 227 NDGFRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIR 272 (283)
T ss_dssp HTTCCCCCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHH
T ss_pred hccCCCCCchhhHHHHHHHHHHHCcCCHhHCcCHHHHHHHHHHHhh
Confidence 3333445556677889999999999999999999999999988765
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1e-46 Score=382.29 Aligned_cols=242 Identities=26% Similarity=0.424 Sum_probs=196.8
Q ss_pred cCccccc-eeccCce-----------------EEEEEee-cChhhHHHHHHHHHHHhhcCCCCccceecccccCccceEE
Q 044312 289 DNFDLNR-ILGQGGQ-----------------AVKKSKV-IDESKVEEFINEVVILSQINHRNVVKLLGCCLETEVPLLV 349 (608)
Q Consensus 289 ~~f~~~~-~lG~G~~-----------------avk~~~~-~~~~~~~~~~~Ei~il~~l~H~niv~l~~~~~~~~~~~lV 349 (608)
++|.+.+ +||+|+| |||.++. .+....++|.+|+++|++++|||||++++++.+ +..+||
T Consensus 8 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~-~~~~lv 86 (285)
T d1u59a_ 8 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLV 86 (285)
T ss_dssp GGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEE
T ss_pred cCeEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChhcCHHHHHHHHHHHHHHHhCCCCCEeeEeeeecc-CeEEEE
Confidence 3455666 4888874 6676654 344567889999999999999999999999864 567999
Q ss_pred EeecCCCccchhccccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEEcCCCcEEEeeccCcccccc
Q 044312 350 YEFIPNGTLFQYIHDQNEDFPITWEIRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAV 429 (608)
Q Consensus 350 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGls~~~~~ 429 (608)
|||+++|+|.+++..... .+++..+++|+.|||+||+|||+++ |+||||||+|||++.++.+||+|||+++.+..
T Consensus 87 mE~~~~g~L~~~l~~~~~--~l~~~~~~~i~~qi~~gL~ylH~~~---iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~ 161 (285)
T d1u59a_ 87 MEMAGGGPLHKFLVGKRE--EIPVSNVAELLHQVSMGMKYLEEKN---FVHRDLAARNVLLVNRHYAKISDFGLSKALGA 161 (285)
T ss_dssp EECCTTEEHHHHHTTCTT--TSCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEEETTEEEECCCTTCEECTT
T ss_pred EEeCCCCcHHHHhhcccc--CCCHHHHHHHHHHHHHHHHHHHhCC---eecCcCchhheeeccCCceeeccchhhhcccc
Confidence 999999999999865433 5999999999999999999999999 99999999999999999999999999998764
Q ss_pred CCcce--eeeeeccCCCCChhhhccCCCCCccchHhHHHHHHHHHh-CCCCCCccchhhcccHHHHHHHHhhhhhhHHHh
Q 044312 430 DQTHM--TTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLTELLT-GEKPIRFTILEEDKSLAAYFLCAMKEERLFEIL 506 (608)
Q Consensus 430 ~~~~~--~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~ellt-g~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 506 (608)
..... .....||+.|||||++....++.++|||||||++|||+| |+.||......+ +...+
T Consensus 162 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~~~----------------~~~~i 225 (285)
T d1u59a_ 162 DDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPE----------------VMAFI 225 (285)
T ss_dssp CSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHH----------------HHHHH
T ss_pred cccccccccccccCccccChHHHhCCCCCccchhhcchHHHHHHHhCCCCCCCCCCHHH----------------HHHHH
Confidence 43222 234468999999999999999999999999999999998 899997332111 11112
Q ss_pred hhhhhccCChhHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhhHH
Q 044312 507 DARVMKQGGKDEIITVAKLAKRCLNLNGKKRPTMREVASELAGIKA 552 (608)
Q Consensus 507 d~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~evl~~L~~i~~ 552 (608)
....+.+.+...+.++.+|+.+||+.||++||||.+|++.|+.+..
T Consensus 226 ~~~~~~~~p~~~~~~l~~li~~cl~~~p~~RPs~~~i~~~L~~~~~ 271 (285)
T d1u59a_ 226 EQGKRMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYY 271 (285)
T ss_dssp HTTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HcCCCCCCCCcCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHH
Confidence 2222334455677889999999999999999999999999987654
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.8e-46 Score=379.16 Aligned_cols=233 Identities=27% Similarity=0.409 Sum_probs=189.2
Q ss_pred ceeccCce-----------------EEEEEee--cChhhHHHHHHHHHHHhhcCCCCccceecccccCccceEEEeecCC
Q 044312 295 RILGQGGQ-----------------AVKKSKV--IDESKVEEFINEVVILSQINHRNVVKLLGCCLETEVPLLVYEFIPN 355 (608)
Q Consensus 295 ~~lG~G~~-----------------avk~~~~--~~~~~~~~~~~Ei~il~~l~H~niv~l~~~~~~~~~~~lV~E~~~~ 355 (608)
++||+|+| |||+++. .+....++|.+|+.+|++++|||||+++++|.+ +..+|||||+++
T Consensus 13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~-~~~~lvmE~~~~ 91 (277)
T d1xbba_ 13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAEL 91 (277)
T ss_dssp EEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEES-SSEEEEEECCTT
T ss_pred CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhCCHHHHHHHHHHHHHHHhCCCCCCceEEEEecc-CCEEEEEEcCCC
Confidence 56888874 6676643 334456789999999999999999999999854 567899999999
Q ss_pred CccchhccccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEEcCCCcEEEeeccCccccccCCcce-
Q 044312 356 GTLFQYIHDQNEDFPITWEIRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHM- 434 (608)
Q Consensus 356 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGls~~~~~~~~~~- 434 (608)
|+|.++++... ++++..++.|+.|||.||+|||+++ |+||||||+|||++.++.+||+|||+++.+.......
T Consensus 92 g~L~~~l~~~~---~l~~~~~~~i~~qi~~gl~ylH~~~---iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~~~~~ 165 (277)
T d1xbba_ 92 GPLNKYLQQNR---HVKDKNIIELVHQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYK 165 (277)
T ss_dssp EEHHHHHHHCT---TCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSEEE
T ss_pred CcHHHHHhhcc---CCCHHHHHHHHHHHHHHHhhHHhCC---cccCCCcchhhcccccCcccccchhhhhhccccccccc
Confidence 99999987643 5999999999999999999999999 9999999999999999999999999998775443322
Q ss_pred -eeeeeccCCCCChhhhccCCCCCccchHhHHHHHHHHHh-CCCCCCccchhhcccHHHHHHHHhhhhhhHHHhhhhhhc
Q 044312 435 -TTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLTELLT-GEKPIRFTILEEDKSLAAYFLCAMKEERLFEILDARVMK 512 (608)
Q Consensus 435 -~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~ellt-g~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~ 512 (608)
.....||+.|||||.+.+..++.++|||||||++|||+| |+.||...... .+...+....+.
T Consensus 166 ~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~~----------------~~~~~i~~~~~~ 229 (277)
T d1xbba_ 166 AQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGS----------------EVTAMLEKGERM 229 (277)
T ss_dssp C----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHH----------------HHHHHHHTTCCC
T ss_pred cccccCCCceecCchhhcCCCCCchhhhccchhhhhHHhhCCCCCCCCCCHH----------------HHHHHHHcCCCC
Confidence 234568999999999999999999999999999999998 89998732211 111222222233
Q ss_pred cCChhHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhh
Q 044312 513 QGGKDEIITVAKLAKRCLNLNGKKRPTMREVASELAGI 550 (608)
Q Consensus 513 ~~~~~~~~~l~~Li~~cl~~dp~~RPs~~evl~~L~~i 550 (608)
+.+...+.++.+|+.+||+.||++|||++||++.|+..
T Consensus 230 ~~p~~~~~~~~~li~~cl~~dp~~RPs~~~i~~~L~~~ 267 (277)
T d1xbba_ 230 GCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNY 267 (277)
T ss_dssp CCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHH
T ss_pred CCCcccCHHHHHHHHHHcCCCHhHCcCHHHHHHHhhCH
Confidence 44556778899999999999999999999999888765
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-46 Score=378.69 Aligned_cols=237 Identities=28% Similarity=0.425 Sum_probs=190.3
Q ss_pred cCccccceeccCce---------------EEEEEeecC-hhhHHHHHHHHHHHhhcCCCCccceecccccCccceEEEee
Q 044312 289 DNFDLNRILGQGGQ---------------AVKKSKVID-ESKVEEFINEVVILSQINHRNVVKLLGCCLETEVPLLVYEF 352 (608)
Q Consensus 289 ~~f~~~~~lG~G~~---------------avk~~~~~~-~~~~~~~~~Ei~il~~l~H~niv~l~~~~~~~~~~~lV~E~ 352 (608)
++|++.+.||+|+| |||++.... ....+.|.+|+.+|++++|||||++++++.+.+..+|||||
T Consensus 5 ~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~~~ivmEy 84 (271)
T d1nvra_ 5 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEY 84 (271)
T ss_dssp TEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred cceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHhCCCCCEeeEeeeeccCceeEEEEec
Confidence 56899999999984 788776432 23456799999999999999999999999999999999999
Q ss_pred cCCCccchhccccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEEcCCCcEEEeeccCccccccCC-
Q 044312 353 IPNGTLFQYIHDQNEDFPITWEIRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQ- 431 (608)
Q Consensus 353 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGls~~~~~~~- 431 (608)
+++|+|.+++.... .+++..+..++.||+.||+|||+++ |+||||||+|||+++++.+||+|||+|+......
T Consensus 85 ~~gg~L~~~l~~~~---~l~e~~~~~i~~qi~~al~ylH~~~---IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~~~~~ 158 (271)
T d1nvra_ 85 CSGGELFDRIEPDI---GMPEPDAQRFFHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNR 158 (271)
T ss_dssp CTTEEGGGGSBTTT---BCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTCCEEECCCTTCEECEETTE
T ss_pred cCCCcHHHHHhcCC---CCCHHHHHHHHHHHHHHHHHHHHcC---CccCcccHHHEEECCCCCEEEccchhheeeccCCc
Confidence 99999999997543 5999999999999999999999999 9999999999999999999999999998775433
Q ss_pred cceeeeeeccCCCCChhhhccCCC-CCccchHhHHHHHHHHHhCCCCCCccchhhcccHHHHHHHHhhhhhhHHHhhhhh
Q 044312 432 THMTTQVHGTFGYLDPEYFRSSQF-TDKSDVYSFGVVLTELLTGEKPIRFTILEEDKSLAAYFLCAMKEERLFEILDARV 510 (608)
Q Consensus 432 ~~~~~~~~gt~~y~aPE~~~~~~~-t~ksDV~S~Gvvl~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~ 510 (608)
....+...||+.|||||++.+..+ +.++|||||||+||||+||+.||........ . +. .+.....
T Consensus 159 ~~~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~~----~-~~---------~~~~~~~ 224 (271)
T d1nvra_ 159 ERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQ----E-YS---------DWKEKKT 224 (271)
T ss_dssp ECCBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTSH----H-HH---------HHHTTCT
T ss_pred cccccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCChHHH----H-HH---------HHhcCCC
Confidence 223445679999999999988876 5789999999999999999999964322110 0 00 0111111
Q ss_pred hccCChhHHHHHHHHHHHHhccCCCCCCCHHHHHH
Q 044312 511 MKQGGKDEIITVAKLAKRCLNLNGKKRPTMREVAS 545 (608)
Q Consensus 511 ~~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~evl~ 545 (608)
........+.++.+|+.+||+.||++|||++|+++
T Consensus 225 ~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~ 259 (271)
T d1nvra_ 225 YLNPWKKIDSAPLALLHKILVENPSARITIPDIKK 259 (271)
T ss_dssp TSTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred CCCccccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 11122344568899999999999999999999875
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.4e-46 Score=377.14 Aligned_cols=236 Identities=24% Similarity=0.387 Sum_probs=197.2
Q ss_pred cCccccceeccCce---------------EEEEEeecChhhHHHHHHHHHHHhhcCCCCccceecccccCccceEEEeec
Q 044312 289 DNFDLNRILGQGGQ---------------AVKKSKVIDESKVEEFINEVVILSQINHRNVVKLLGCCLETEVPLLVYEFI 353 (608)
Q Consensus 289 ~~f~~~~~lG~G~~---------------avk~~~~~~~~~~~~~~~Ei~il~~l~H~niv~l~~~~~~~~~~~lV~E~~ 353 (608)
++|++.++||+|+| |||+++..+....+.+.+|+.+|++++|||||++++++.+.+..+|||||+
T Consensus 20 ~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmEy~ 99 (293)
T d1yhwa1 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYL 99 (293)
T ss_dssp TTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred cccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccChHHHHHHHHHHHHHhCCCCCEeeEeEEEEECCEEEEEEEec
Confidence 46999999999984 889887766667788999999999999999999999999999999999999
Q ss_pred CCCccchhccccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEEcCCCcEEEeeccCccccccCCcc
Q 044312 354 PNGTLFQYIHDQNEDFPITWEIRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTH 433 (608)
Q Consensus 354 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGls~~~~~~~~~ 433 (608)
++|+|.+++.+. .+++..+..|+.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++.+.....
T Consensus 100 ~gg~L~~~~~~~----~l~~~~~~~i~~qi~~aL~yLH~~~---iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~~~~- 171 (293)
T d1yhwa1 100 AGGSLTDVVTET----CMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS- 171 (293)
T ss_dssp TTCBHHHHHHHS----CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECCSTTC-
T ss_pred CCCcHHHHhhcc----CCCHHHHHHHHHHHHHHHHHHHHCC---CcccCCcHHHeEECCCCcEeeccchhheeeccccc-
Confidence 999999987653 4899999999999999999999999 99999999999999999999999999987654332
Q ss_pred eeeeeeccCCCCChhhhccCCCCCccchHhHHHHHHHHHhCCCCCCccchhhcccHHHHHHHHhhhhhhHHHhhhhhhcc
Q 044312 434 MTTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLTELLTGEKPIRFTILEEDKSLAAYFLCAMKEERLFEILDARVMKQ 513 (608)
Q Consensus 434 ~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~ 513 (608)
......||+.|+|||++.+..++.++|||||||++|||+||+.||....... ......... .....
T Consensus 172 ~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~------~~~~~~~~~--------~~~~~ 237 (293)
T d1yhwa1 172 KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLR------ALYLIATNG--------TPELQ 237 (293)
T ss_dssp CBCCCCSCGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHH------HHHHHHHHC--------SCCCS
T ss_pred cccccccCCCccChhhhcCCCCCchhceehHhHHHHHHhhCCCCCCCCCHHH------HHHHHHhCC--------CCCCC
Confidence 3345579999999999999999999999999999999999999996322111 111111110 01112
Q ss_pred CChhHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 044312 514 GGKDEIITVAKLAKRCLNLNGKKRPTMREVASE 546 (608)
Q Consensus 514 ~~~~~~~~l~~Li~~cl~~dp~~RPs~~evl~~ 546 (608)
.+...+.++.+|+.+||+.||++|||+.|++++
T Consensus 238 ~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~H 270 (293)
T d1yhwa1 238 NPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQH 270 (293)
T ss_dssp SGGGSCHHHHHHHHHHTCSSTTTSCCHHHHTTC
T ss_pred CcccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 234456789999999999999999999999754
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.3e-47 Score=379.90 Aligned_cols=240 Identities=24% Similarity=0.390 Sum_probs=183.0
Q ss_pred cCccccceeccCce---------------EEEEEeec--ChhhHHHHHHHHHHHhhcCCCCccceeccccc--CccceEE
Q 044312 289 DNFDLNRILGQGGQ---------------AVKKSKVI--DESKVEEFINEVVILSQINHRNVVKLLGCCLE--TEVPLLV 349 (608)
Q Consensus 289 ~~f~~~~~lG~G~~---------------avk~~~~~--~~~~~~~~~~Ei~il~~l~H~niv~l~~~~~~--~~~~~lV 349 (608)
++|++.+.||+|+| |||.+... ++...+.|.+|+++|++++|||||++++++.+ ....+||
T Consensus 4 edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~iv 83 (269)
T d2java1 4 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIV 83 (269)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CEEEE
T ss_pred hhCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhCCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCCCEEEEE
Confidence 57999999999985 78877543 44556789999999999999999999999865 4567999
Q ss_pred EeecCCCccchhccccC-CCCCCCHHHHHHHHHHHHHHHHHHhhcC--CCCeeccCCCCCcEEEcCCCcEEEeeccCccc
Q 044312 350 YEFIPNGTLFQYIHDQN-EDFPITWEIRLRIAIEVSGALSYLHSAA--SIPIYHRDIKSTNILLDDKYRAKVSDFGASRS 426 (608)
Q Consensus 350 ~E~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~aL~yLH~~~--~~~iiHrDlk~~NILl~~~~~~kl~DFGls~~ 426 (608)
|||+++|+|.+++.+.. .+..+++..++.++.||+.||+|||+.+ ..+|+||||||+||||+.++.+||+|||+++.
T Consensus 84 mEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG~a~~ 163 (269)
T d2java1 84 MEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARI 163 (269)
T ss_dssp EECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCHHHHHH
T ss_pred EecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEEeeccceee
Confidence 99999999999987532 2236999999999999999999999865 23499999999999999999999999999988
Q ss_pred cccCCcceeeeeeccCCCCChhhhccCCCCCccchHhHHHHHHHHHhCCCCCCccchhhcccHHHHHHHHhhhhhhHHHh
Q 044312 427 MAVDQTHMTTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLTELLTGEKPIRFTILEEDKSLAAYFLCAMKEERLFEIL 506 (608)
Q Consensus 427 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 506 (608)
+..+. .......||+.|||||++.+..++.++|||||||++|||+||+.||......+ ....+ .
T Consensus 164 ~~~~~-~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyel~tg~~Pf~~~~~~~-------~~~~i--------~ 227 (269)
T d2java1 164 LNHDT-SFAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKE-------LAGKI--------R 227 (269)
T ss_dssp C------------CCCSCCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHH-------HHHHH--------H
T ss_pred cccCC-CccccCCCCcccCCHHHHcCCCCChHHHHHhhCHHHHHHhhCCCCCCCCCHHH-------HHHHH--------H
Confidence 75433 23345679999999999999999999999999999999999999996322111 11111 1
Q ss_pred hhhhhccCChhHHHHHHHHHHHHhccCCCCCCCHHHHHH
Q 044312 507 DARVMKQGGKDEIITVAKLAKRCLNLNGKKRPTMREVAS 545 (608)
Q Consensus 507 d~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~evl~ 545 (608)
.. .....+...+.++.+|+.+||+.||++|||+.|+++
T Consensus 228 ~~-~~~~~~~~~s~~l~~li~~~L~~dp~~Rps~~ell~ 265 (269)
T d2java1 228 EG-KFRRIPYRYSDELNEIITRMLNLKDYHRPSVEEILE 265 (269)
T ss_dssp HT-CCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred cC-CCCCCCcccCHHHHHHHHHHcCCChhHCcCHHHHHh
Confidence 11 112234456778999999999999999999999975
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5e-46 Score=372.79 Aligned_cols=232 Identities=28% Similarity=0.422 Sum_probs=194.0
Q ss_pred cCccccceeccCce---------------EEEEEee---cChhhHHHHHHHHHHHhhcCCCCccceecccccCccceEEE
Q 044312 289 DNFDLNRILGQGGQ---------------AVKKSKV---IDESKVEEFINEVVILSQINHRNVVKLLGCCLETEVPLLVY 350 (608)
Q Consensus 289 ~~f~~~~~lG~G~~---------------avk~~~~---~~~~~~~~~~~Ei~il~~l~H~niv~l~~~~~~~~~~~lV~ 350 (608)
++|++.+.||+|+| |+|++.. .+....+.+.+|+.+|++++|||||++++++.+.+..+|||
T Consensus 6 ~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~ivm 85 (263)
T d2j4za1 6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLIL 85 (263)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hHeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEECCEEEEEE
Confidence 46899999999985 6776643 22344678999999999999999999999999999999999
Q ss_pred eecCCCccchhccccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEEcCCCcEEEeeccCccccccC
Q 044312 351 EFIPNGTLFQYIHDQNEDFPITWEIRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVD 430 (608)
Q Consensus 351 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGls~~~~~~ 430 (608)
||+++|+|.+++.... .+++..+..|+.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++.....
T Consensus 86 Ey~~~g~L~~~l~~~~---~l~e~~~~~i~~qi~~al~~lH~~~---ivHrDiKp~Nill~~~~~~kl~DFG~a~~~~~~ 159 (263)
T d2j4za1 86 EYAPLGTVYRELQKLS---KFDEQRTATYITELANALSYCHSKR---VIHRDIKPENLLLGSAGELKIADFGWSVHAPSS 159 (263)
T ss_dssp ECCTTCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCCSCSCCCCC
T ss_pred eecCCCcHHHHHhhcC---CCCHHHHHHHHHHHHHHHHHHHHCC---eeeeeeccccceecCCCCEeecccceeeecCCC
Confidence 9999999999998654 5999999999999999999999999 999999999999999999999999999876533
Q ss_pred CcceeeeeeccCCCCChhhhccCCCCCccchHhHHHHHHHHHhCCCCCCccchhhcccHHHHHHHHhhhhhhHHHhhhhh
Q 044312 431 QTHMTTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLTELLTGEKPIRFTILEEDKSLAAYFLCAMKEERLFEILDARV 510 (608)
Q Consensus 431 ~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~ 510 (608)
. .....||+.|||||++.+..++.++|||||||+||||++|+.||...... ..+. . +...
T Consensus 160 ~---~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~------~~~~-~--------i~~~-- 219 (263)
T d2j4za1 160 R---RTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQ------ETYK-R--------ISRV-- 219 (263)
T ss_dssp C---CEETTEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHH------HHHH-H--------HHTT--
T ss_pred c---ccccCCCCcccCHHHHcCCCCCchhhhhhHhHHHHHHhcCCCCCCCCCHH------HHHH-H--------HHcC--
Confidence 2 34567999999999999999999999999999999999999999633211 1111 1 1111
Q ss_pred hccCChhHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 044312 511 MKQGGKDEIITVAKLAKRCLNLNGKKRPTMREVASE 546 (608)
Q Consensus 511 ~~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~evl~~ 546 (608)
....+...++++.+|+.+||+.||++|||++|++++
T Consensus 220 ~~~~p~~~s~~~~~li~~~L~~dp~~R~t~~eil~h 255 (263)
T d2j4za1 220 EFTFPDFVTEGARDLISRLLKHNPSQRPMLREVLEH 255 (263)
T ss_dssp CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTC
T ss_pred CCCCCccCCHHHHHHHHHHccCCHhHCcCHHHHHcC
Confidence 112334566789999999999999999999999864
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.9e-46 Score=384.79 Aligned_cols=245 Identities=25% Similarity=0.463 Sum_probs=197.7
Q ss_pred HHhcCccccceeccCce--------------------EEEEEee-cChhhHHHHHHHHHHHhhc-CCCCccceecccccC
Q 044312 286 KATDNFDLNRILGQGGQ--------------------AVKKSKV-IDESKVEEFINEVVILSQI-NHRNVVKLLGCCLET 343 (608)
Q Consensus 286 ~~t~~f~~~~~lG~G~~--------------------avk~~~~-~~~~~~~~~~~Ei~il~~l-~H~niv~l~~~~~~~ 343 (608)
...++|++.++||+|+| |||.... .+......|.+|+.+|+++ +|||||++++++.+.
T Consensus 34 i~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~ 113 (325)
T d1rjba_ 34 FPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLS 113 (325)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred CCHHHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEeccccCHHHHHHHHHHHHHHHHhcCCCcEeEEEEEEeeC
Confidence 34467999999999986 3333322 2334456799999999998 899999999999999
Q ss_pred ccceEEEeecCCCccchhccccCC--------------------CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeccCC
Q 044312 344 EVPLLVYEFIPNGTLFQYIHDQNE--------------------DFPITWEIRLRIAIEVSGALSYLHSAASIPIYHRDI 403 (608)
Q Consensus 344 ~~~~lV~E~~~~gsL~~~l~~~~~--------------------~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDl 403 (608)
+..+|||||+++|+|.++|+.... ...+++..++.|+.||+.||+|||+++ |+||||
T Consensus 114 ~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~~---IiHRDl 190 (325)
T d1rjba_ 114 GPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKS---CVHRDL 190 (325)
T ss_dssp SSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTT---EEETTC
T ss_pred CeEEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccC
Confidence 999999999999999999976432 124899999999999999999999999 999999
Q ss_pred CCCcEEEcCCCcEEEeeccCccccccCCcc-eeeeeeccCCCCChhhhccCCCCCccchHhHHHHHHHHHh-CCCCCCcc
Q 044312 404 KSTNILLDDKYRAKVSDFGASRSMAVDQTH-MTTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLTELLT-GEKPIRFT 481 (608)
Q Consensus 404 k~~NILl~~~~~~kl~DFGls~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~ellt-g~~p~~~~ 481 (608)
||+|||++.++.+||+|||+|+........ ......||+.|||||++.+..++.++|||||||+||||+| |+.||...
T Consensus 191 Kp~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwS~Gvil~emlt~g~~Pf~~~ 270 (325)
T d1rjba_ 191 AARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGI 270 (325)
T ss_dssp SGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTC
T ss_pred chhccccccCCeEEEeeccccccccCCCceeeeccccCCCccCChHHHcCCCCCcceeccchhHHHHHHHhCCCCCCCCC
Confidence 999999999999999999999876644332 2335668999999999999999999999999999999998 89998632
Q ss_pred chhhcccHHHHHHHHhhhhhhHHHhhhhhhccCChhHHHHHHHHHHHHhccCCCCCCCHHHHHHHHH
Q 044312 482 ILEEDKSLAAYFLCAMKEERLFEILDARVMKQGGKDEIITVAKLAKRCLNLNGKKRPTMREVASELA 548 (608)
Q Consensus 482 ~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~evl~~L~ 548 (608)
.... .+.+++......+.+...+.++.+|+.+||+.||++|||++||+++|.
T Consensus 271 ~~~~---------------~~~~~~~~~~~~~~p~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~ 322 (325)
T d1rjba_ 271 PVDA---------------NFYKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLG 322 (325)
T ss_dssp CCSH---------------HHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred CHHH---------------HHHHHHhcCCCCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHh
Confidence 2211 112223333334455567788999999999999999999999999984
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.9e-46 Score=376.14 Aligned_cols=244 Identities=26% Similarity=0.404 Sum_probs=186.9
Q ss_pred hcCccccceeccCce------------------EEEEEee-cChhhHHHHHHHHHHHhhcCCCCccceecccccCccceE
Q 044312 288 TDNFDLNRILGQGGQ------------------AVKKSKV-IDESKVEEFINEVVILSQINHRNVVKLLGCCLETEVPLL 348 (608)
Q Consensus 288 t~~f~~~~~lG~G~~------------------avk~~~~-~~~~~~~~~~~Ei~il~~l~H~niv~l~~~~~~~~~~~l 348 (608)
.++|++.+.||+|+| |||.++. ......+.|.+|+.+|++++|||||++++++. .+..++
T Consensus 6 ~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~~~i 84 (273)
T d1mp8a_ 6 RERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVWI 84 (273)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSCEE
T ss_pred HHHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEe-cCeEEE
Confidence 457899999999985 3333332 23444678999999999999999999999996 467899
Q ss_pred EEeecCCCccchhccccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEEcCCCcEEEeeccCccccc
Q 044312 349 VYEFIPNGTLFQYIHDQNEDFPITWEIRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMA 428 (608)
Q Consensus 349 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGls~~~~ 428 (608)
||||+++|+|.+++..... ++++..++.++.||++||+|||+.+ |+||||||+|||+++++.+||+|||+++...
T Consensus 85 v~E~~~~g~l~~~~~~~~~--~l~~~~~~~~~~qi~~gl~ylH~~~---iiHrDlKp~NIll~~~~~~Kl~DfG~a~~~~ 159 (273)
T d1mp8a_ 85 IMELCTLGELRSFLQVRKY--SLDLASLILYAYQLSTALAYLESKR---FVHRDIAARNVLVSSNDCVKLGDFGLSRYME 159 (273)
T ss_dssp EEECCTTEEHHHHHHHTTT--TSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECC--------
T ss_pred EEEeccCCcHHhhhhccCC--CCCHHHHHHHHHHHHHHhhhhcccC---eeccccchhheeecCCCcEEEccchhheecc
Confidence 9999999999998776443 5899999999999999999999999 9999999999999999999999999998876
Q ss_pred cCCcceeeeeeccCCCCChhhhccCCCCCccchHhHHHHHHHHHh-CCCCCCccchhhcccHHHHHHHHhhhhhhHHHhh
Q 044312 429 VDQTHMTTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLTELLT-GEKPIRFTILEEDKSLAAYFLCAMKEERLFEILD 507 (608)
Q Consensus 429 ~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~ellt-g~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 507 (608)
...........||+.|+|||++....++.++|||||||++|||+| |.+||......+ +...+.
T Consensus 160 ~~~~~~~~~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~~~----------------~~~~i~ 223 (273)
T d1mp8a_ 160 DSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNND----------------VIGRIE 223 (273)
T ss_dssp -----------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGG----------------HHHHHH
T ss_pred CCcceeccceecCcccchhhHhccCCCCCccccccchHHHHHHHhcCCCCCCCCCHHH----------------HHHHHH
Confidence 554445556678999999999999999999999999999999998 888886432211 111111
Q ss_pred hhhhccCChhHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhhHHh
Q 044312 508 ARVMKQGGKDEIITVAKLAKRCLNLNGKKRPTMREVASELAGIKAW 553 (608)
Q Consensus 508 ~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~evl~~L~~i~~~ 553 (608)
.....+.+...+.++.+|+.+||+.||++|||+.||+++|+.+...
T Consensus 224 ~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ei~~~L~~i~~~ 269 (273)
T d1mp8a_ 224 NGERLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEE 269 (273)
T ss_dssp TTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred cCCCCCCCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHH
Confidence 1122234556678899999999999999999999999999887643
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5e-46 Score=377.78 Aligned_cols=237 Identities=25% Similarity=0.342 Sum_probs=195.3
Q ss_pred cCccccceeccCce---------------EEEEEeecChhhHHHHHHHHHHHhhcCCCCccceecccccCccceEEEeec
Q 044312 289 DNFDLNRILGQGGQ---------------AVKKSKVIDESKVEEFINEVVILSQINHRNVVKLLGCCLETEVPLLVYEFI 353 (608)
Q Consensus 289 ~~f~~~~~lG~G~~---------------avk~~~~~~~~~~~~~~~Ei~il~~l~H~niv~l~~~~~~~~~~~lV~E~~ 353 (608)
+.|++.+.||+|+| |||++........+.|.+|+++|++++|||||++++++.+.+..+|||||+
T Consensus 12 d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lvmEy~ 91 (288)
T d2jfla1 12 DFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFC 91 (288)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSSSGGGGGTHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred cCeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCeEEEEEecC
Confidence 46889999999984 888887766777889999999999999999999999999999999999999
Q ss_pred CCCccchhccccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEEcCCCcEEEeeccCccccccCCcc
Q 044312 354 PNGTLFQYIHDQNEDFPITWEIRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTH 433 (608)
Q Consensus 354 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGls~~~~~~~~~ 433 (608)
++|+|.+++.+... ++++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+|+...... .
T Consensus 92 ~~g~L~~~~~~~~~--~l~e~~~~~i~~qi~~gL~ylH~~~---ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~~~~-~ 165 (288)
T d2jfla1 92 AGGAVDAVMLELER--PLTESQIQVVCKQTLDALNYLHDNK---IIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTI-Q 165 (288)
T ss_dssp TTEEHHHHHHHHTS--CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECHHHH-H
T ss_pred CCCcHHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHHCC---EEEeecChhheeECCCCCEEEEechhhhccCCCc-c
Confidence 99999999876433 5999999999999999999999999 9999999999999999999999999997654321 1
Q ss_pred eeeeeeccCCCCChhhhc-----cCCCCCccchHhHHHHHHHHHhCCCCCCccchhhcccHHHHHHHHhhhhhhHHHhhh
Q 044312 434 MTTQVHGTFGYLDPEYFR-----SSQFTDKSDVYSFGVVLTELLTGEKPIRFTILEEDKSLAAYFLCAMKEERLFEILDA 508 (608)
Q Consensus 434 ~~~~~~gt~~y~aPE~~~-----~~~~t~ksDV~S~Gvvl~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 508 (608)
......||+.|||||++. ...++.++|||||||++|||+||+.||......+ . + ..+...
T Consensus 166 ~~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~~~---~---~---------~~i~~~ 230 (288)
T d2jfla1 166 RRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMR---V---L---------LKIAKS 230 (288)
T ss_dssp HHTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCGGG---H---H---------HHHHHS
T ss_pred cccccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCCHHH---H---H---------HHHHcC
Confidence 223457999999999984 4568999999999999999999999997432211 0 1 111111
Q ss_pred h-hhccCChhHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 044312 509 R-VMKQGGKDEIITVAKLAKRCLNLNGKKRPTMREVASE 546 (608)
Q Consensus 509 ~-~~~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~evl~~ 546 (608)
. .....+...+.++.+|+.+||+.||++|||+.|++++
T Consensus 231 ~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~ell~h 269 (288)
T d2jfla1 231 EPPTLAQPSRWSSNFKDFLKKCLEKNVDARWTTSQLLQH 269 (288)
T ss_dssp CCCCCSSGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTS
T ss_pred CCCCCCccccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 0 0112234556789999999999999999999999764
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.5e-46 Score=378.24 Aligned_cols=244 Identities=23% Similarity=0.379 Sum_probs=192.7
Q ss_pred hcCccccceeccCce--------------EEEEEeecChhhHHHHHHHHHHHhhcCCCCccceecccccCccceEEEeec
Q 044312 288 TDNFDLNRILGQGGQ--------------AVKKSKVIDESKVEEFINEVVILSQINHRNVVKLLGCCLETEVPLLVYEFI 353 (608)
Q Consensus 288 t~~f~~~~~lG~G~~--------------avk~~~~~~~~~~~~~~~Ei~il~~l~H~niv~l~~~~~~~~~~~lV~E~~ 353 (608)
.++|++.+.||+|+| |||+++. +....+.|.+|+.+|++++|||||++++++.+ +..++||||+
T Consensus 16 ~~~~~i~~~iG~G~fg~Vy~~~~~~~~~vAiK~l~~-~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~-~~~~lv~Ey~ 93 (285)
T d1fmka3 16 RESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKP-GTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYM 93 (285)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCT-TSSCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECCC
T ss_pred HHHEEEeeEEeeCCCeEEEEEEECCCCEEEEEEECc-ccCCHHHHHHHHHHHHhcccCCEeEEEEEEec-CCeEEEEEec
Confidence 457999999999985 7777654 33456789999999999999999999999865 5678999999
Q ss_pred CCCccchhccccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEEcCCCcEEEeeccCccccccCCcc
Q 044312 354 PNGTLFQYIHDQNEDFPITWEIRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTH 433 (608)
Q Consensus 354 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGls~~~~~~~~~ 433 (608)
++|+|.+++...... .++|..++.|+.|||.||+|||+.+ |+||||||+||||++++++||+|||+++........
T Consensus 94 ~~g~l~~~~~~~~~~-~l~~~~~~~i~~~i~~gl~~LH~~~---ivH~DlKp~NIll~~~~~~kl~DfGla~~~~~~~~~ 169 (285)
T d1fmka3 94 SKGSLLDFLKGETGK-YLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYT 169 (285)
T ss_dssp TTCBHHHHHSHHHHT-TCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCCTTC--------
T ss_pred CCCchhhhhhhcccc-cchHHHHHHHHHHHHHHHHHHhhhh---eecccccceEEEECCCCcEEEcccchhhhccCCCce
Confidence 999999988764332 5999999999999999999999999 999999999999999999999999999887655444
Q ss_pred eeeeeeccCCCCChhhhccCCCCCccchHhHHHHHHHHHhCCCCCCccchhhcccHHHHHHHHhhhhhhHHHhhhhhhcc
Q 044312 434 MTTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLTELLTGEKPIRFTILEEDKSLAAYFLCAMKEERLFEILDARVMKQ 513 (608)
Q Consensus 434 ~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~ 513 (608)
......||+.|+|||++....++.++||||||++||||+||..|+...... .. +...+......+
T Consensus 170 ~~~~~~gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el~t~~~p~~~~~~~-----~~----------~~~~i~~~~~~~ 234 (285)
T d1fmka3 170 ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVN-----RE----------VLDQVERGYRMP 234 (285)
T ss_dssp ------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCH-----HH----------HHHHHHTTCCCC
T ss_pred eeccccccccccChHHHhCCCCCcHHhhhcchHHHHHHHhCCCCCCCCCCH-----HH----------HHHHHHhcCCCC
Confidence 455567999999999999999999999999999999999977665432211 11 111112222334
Q ss_pred CChhHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhhHH
Q 044312 514 GGKDEIITVAKLAKRCLNLNGKKRPTMREVASELAGIKA 552 (608)
Q Consensus 514 ~~~~~~~~l~~Li~~cl~~dp~~RPs~~evl~~L~~i~~ 552 (608)
.+...+.++.+|+.+||+.||++||||++|++.|+....
T Consensus 235 ~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~~~~ 273 (285)
T d1fmka3 235 CPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFT 273 (285)
T ss_dssp CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTS
T ss_pred CCcccCHHHHHHHHHHcccCHhHCcCHHHHHHHHhhhhc
Confidence 455667889999999999999999999999998877554
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.2e-46 Score=384.09 Aligned_cols=251 Identities=25% Similarity=0.382 Sum_probs=195.0
Q ss_pred HhcCccccceeccCce---------------EEEEEeec-ChhhHHHHHHHHHHHhhcCCCCccceecccccCccceEEE
Q 044312 287 ATDNFDLNRILGQGGQ---------------AVKKSKVI-DESKVEEFINEVVILSQINHRNVVKLLGCCLETEVPLLVY 350 (608)
Q Consensus 287 ~t~~f~~~~~lG~G~~---------------avk~~~~~-~~~~~~~~~~Ei~il~~l~H~niv~l~~~~~~~~~~~lV~ 350 (608)
..++|++.++||+|+| |+|+++.. +....+.+.+|+.+|++++|||||+++++|.+.+..+|||
T Consensus 4 ~~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~iVm 83 (322)
T d1s9ja_ 4 KDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICM 83 (322)
T ss_dssp CGGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCCCTTHHHHHHHHGGGGGGCCCTTBCCEEEEEECSSEEEEEE
T ss_pred CccCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhhCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEE
Confidence 3568999999999984 78887643 3445678999999999999999999999999999999999
Q ss_pred eecCCCccchhccccCCCCCCCHHHHHHHHHHHHHHHHHHhh-cCCCCeeccCCCCCcEEEcCCCcEEEeeccCcccccc
Q 044312 351 EFIPNGTLFQYIHDQNEDFPITWEIRLRIAIEVSGALSYLHS-AASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAV 429 (608)
Q Consensus 351 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~-~~~~~iiHrDlk~~NILl~~~~~~kl~DFGls~~~~~ 429 (608)
||+++|+|.+++.+.. .+++..+..++.||+.||.|||+ ++ |+||||||+|||+++++.+||+|||+|+....
T Consensus 84 Ey~~gg~L~~~l~~~~---~l~~~~~~~~~~qil~aL~yLH~~~~---IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~ 157 (322)
T d1s9ja_ 84 EHMDGGSLDQVLKKAG---RIPEQILGKVSIAVIKGLTYLREKHK---IMHRDVKPSNILVNSRGEIKLCDFGVSGQLID 157 (322)
T ss_dssp ECCTTEEHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHHHC---CCCSCCSGGGEEECTTCCEEECCCCCCHHHHH
T ss_pred EcCCCCcHHHHHhhcC---CCCHHHHHHHHHHHHHHHHHHHHhCC---EEccccCHHHeeECCCCCEEEeeCCCccccCC
Confidence 9999999999998654 48999999999999999999997 48 99999999999999999999999999987643
Q ss_pred CCcceeeeeeccCCCCChhhhccCCCCCccchHhHHHHHHHHHhCCCCCCccchhhcccHHHHH----------------
Q 044312 430 DQTHMTTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLTELLTGEKPIRFTILEEDKSLAAYF---------------- 493 (608)
Q Consensus 430 ~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~elltg~~p~~~~~~~~~~~l~~~~---------------- 493 (608)
. ..+...||+.|||||++.+..++.++|||||||+++||++|+.||......+........
T Consensus 158 ~---~~~~~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (322)
T d1s9ja_ 158 S---MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPG 234 (322)
T ss_dssp H---TC---CCSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHHHSSCCSSCCCTTHHHHHC-------------------
T ss_pred C---ccccccCCccccCchHHcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhcCCcccCCccccccc
Confidence 2 224467999999999999999999999999999999999999999753322110000000
Q ss_pred -------HHHhhhhhhHHHhhhhhhcc----CChhHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 044312 494 -------LCAMKEERLFEILDARVMKQ----GGKDEIITVAKLAKRCLNLNGKKRPTMREVASE 546 (608)
Q Consensus 494 -------~~~~~~~~~~~~~d~~~~~~----~~~~~~~~l~~Li~~cl~~dp~~RPs~~evl~~ 546 (608)
..........+.++...... .....+.++.+|+.+||+.||++|||++|++++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~L~H 298 (322)
T d1s9ja_ 235 RPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVH 298 (322)
T ss_dssp -----------CCCCHHHHHHHHHTSCCCCCCBTTBCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred ccccccccccccchhHHHHHhhhhccCCccCccccCCHHHHHHHHHHcCCChhHCcCHHHHhhC
Confidence 00000001111111111111 111235679999999999999999999999985
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=2.1e-45 Score=376.08 Aligned_cols=250 Identities=24% Similarity=0.404 Sum_probs=200.7
Q ss_pred HHHHHhcCccccceeccCce--------------------EEEEEeec-ChhhHHHHHHHHHHHhhcCCCCccceecccc
Q 044312 283 ELEKATDNFDLNRILGQGGQ--------------------AVKKSKVI-DESKVEEFINEVVILSQINHRNVVKLLGCCL 341 (608)
Q Consensus 283 ~l~~~t~~f~~~~~lG~G~~--------------------avk~~~~~-~~~~~~~~~~Ei~il~~l~H~niv~l~~~~~ 341 (608)
+|+...++|++.+.||+|+| |||+++.. .....++|.+|+.+|++++||||+++++++.
T Consensus 7 ~~e~p~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~ 86 (301)
T d1lufa_ 7 SLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCA 86 (301)
T ss_dssp HTBCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC
T ss_pred hccCCHHHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhcChHHHHHHHHHHHHHHhcCCCCcccceeeec
Confidence 34556678999999999984 56665432 2334678999999999999999999999999
Q ss_pred cCccceEEEeecCCCccchhccccCC---------------------CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeec
Q 044312 342 ETEVPLLVYEFIPNGTLFQYIHDQNE---------------------DFPITWEIRLRIAIEVSGALSYLHSAASIPIYH 400 (608)
Q Consensus 342 ~~~~~~lV~E~~~~gsL~~~l~~~~~---------------------~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH 400 (608)
+.+..++||||+++|+|.+++..... ...+++..++.|+.|||.||+|||+.+ |+|
T Consensus 87 ~~~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~~---ivH 163 (301)
T d1lufa_ 87 VGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERK---FVH 163 (301)
T ss_dssp SSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCC
T ss_pred cCCceEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccCC---eEe
Confidence 99999999999999999999864321 224899999999999999999999999 999
Q ss_pred cCCCCCcEEEcCCCcEEEeeccCccccccCC-cceeeeeeccCCCCChhhhccCCCCCccchHhHHHHHHHHHhCC-CCC
Q 044312 401 RDIKSTNILLDDKYRAKVSDFGASRSMAVDQ-THMTTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLTELLTGE-KPI 478 (608)
Q Consensus 401 rDlk~~NILl~~~~~~kl~DFGls~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~elltg~-~p~ 478 (608)
|||||+|||++.++.+||+|||+++...... ....+...||+.|+|||.+.+..++.|+|||||||++|||++|. +||
T Consensus 164 rDlKp~NILld~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~t~ksDVwS~Gvvl~ell~~~~~p~ 243 (301)
T d1lufa_ 164 RDLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPY 243 (301)
T ss_dssp SCCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTT
T ss_pred eEEcccceEECCCCcEEEccchhheeccCCccccccCCCCcCcCcCCHHHHccCCCChhhhhccchhhHHHHHccCCCCC
Confidence 9999999999999999999999998764332 22334567899999999999999999999999999999999986 566
Q ss_pred CccchhhcccHHHHHHHHhhhhhhHHHhhhhhhccCChhHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhhH
Q 044312 479 RFTILEEDKSLAAYFLCAMKEERLFEILDARVMKQGGKDEIITVAKLAKRCLNLNGKKRPTMREVASELAGIK 551 (608)
Q Consensus 479 ~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~evl~~L~~i~ 551 (608)
......+ ....+.. ....+.+...+.++.+|+.+||+.||++||||.||+++|+++.
T Consensus 244 ~~~~~~e-------~~~~v~~---------~~~~~~p~~~~~~~~~li~~cl~~~P~~RPt~~ev~~~L~~i~ 300 (301)
T d1lufa_ 244 YGMAHEE-------VIYYVRD---------GNILACPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMC 300 (301)
T ss_dssp TTSCHHH-------HHHHHHT---------TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTT
T ss_pred CCCCHHH-------HHHHHHc---------CCCCCCCccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhc
Confidence 5322211 1111111 1122344566778999999999999999999999999998874
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7e-45 Score=365.85 Aligned_cols=233 Identities=22% Similarity=0.377 Sum_probs=184.0
Q ss_pred cccceeccCce---------------EEEEEeec--ChhhHHHHHHHHHHHhhcCCCCccceeccccc----CccceEEE
Q 044312 292 DLNRILGQGGQ---------------AVKKSKVI--DESKVEEFINEVVILSQINHRNVVKLLGCCLE----TEVPLLVY 350 (608)
Q Consensus 292 ~~~~~lG~G~~---------------avk~~~~~--~~~~~~~~~~Ei~il~~l~H~niv~l~~~~~~----~~~~~lV~ 350 (608)
++.++||+|+| |+|++... .....+.|.+|+++|++++|||||++++++.+ ....+|||
T Consensus 12 ~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~~~ivm 91 (270)
T d1t4ha_ 12 KFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVT 91 (270)
T ss_dssp EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEEEE
T ss_pred EeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeccccCCEEEEEE
Confidence 56678999985 67766542 44556789999999999999999999999864 34679999
Q ss_pred eecCCCccchhccccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEEc-CCCcEEEeeccCcccccc
Q 044312 351 EFIPNGTLFQYIHDQNEDFPITWEIRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLD-DKYRAKVSDFGASRSMAV 429 (608)
Q Consensus 351 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~-~~~~~kl~DFGls~~~~~ 429 (608)
||+++|+|.+++.+.. .+++..+..|+.||++||+|||+++ .+|+||||||+|||++ +++.+||+|||+++....
T Consensus 92 E~~~~g~L~~~l~~~~---~~~~~~~~~~~~qi~~gl~yLH~~~-~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~~~~~ 167 (270)
T d1t4ha_ 92 ELMTSGTLKTYLKRFK---VMKIKVLRSWCRQILKGLQFLHTRT-PPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRA 167 (270)
T ss_dssp ECCCSCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHTSS-SCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCCT
T ss_pred eCCCCCcHHHHHhccc---cccHHHHHHHHHHHHHHHHHHHHCC-CCEEeCCcChhhceeeCCCCCEEEeecCcceeccC
Confidence 9999999999997654 5899999999999999999999976 3499999999999996 578999999999986443
Q ss_pred CCcceeeeeeccCCCCChhhhccCCCCCccchHhHHHHHHHHHhCCCCCCccchhhcccHHHHHHHHhhhhhhHHHhhhh
Q 044312 430 DQTHMTTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLTELLTGEKPIRFTILEEDKSLAAYFLCAMKEERLFEILDAR 509 (608)
Q Consensus 430 ~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 509 (608)
. ......||+.|||||++.+ .++.++|||||||++|||++|+.||..... ..... ..+..+.
T Consensus 168 ~---~~~~~~GT~~Y~aPE~~~~-~~~~~~DIwSlGvilyel~~g~~Pf~~~~~-----~~~~~-~~i~~~~-------- 229 (270)
T d1t4ha_ 168 S---FAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQN-----AAQIY-RRVTSGV-------- 229 (270)
T ss_dssp T---SBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSS-----HHHHH-HHHTTTC--------
T ss_pred C---ccCCcccCccccCHHHhCC-CCCCcCchhhHHHHHHHHHHCCCCCCCccc-----HHHHH-HHHHcCC--------
Confidence 2 2345679999999999865 699999999999999999999999963211 11111 1111110
Q ss_pred hhccCChhHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 044312 510 VMKQGGKDEIITVAKLAKRCLNLNGKKRPTMREVASE 546 (608)
Q Consensus 510 ~~~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~evl~~ 546 (608)
.....+...+.++.+|+.+||+.||++|||+.|++++
T Consensus 230 ~~~~~~~~~~~~~~~li~~~l~~dp~~R~s~~ell~H 266 (270)
T d1t4ha_ 230 KPASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNH 266 (270)
T ss_dssp CCGGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred CCcccCccCCHHHHHHHHHHccCCHhHCcCHHHHhCC
Confidence 0111122344578999999999999999999999763
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.7e-45 Score=367.20 Aligned_cols=238 Identities=27% Similarity=0.481 Sum_probs=189.4
Q ss_pred cCccccceeccCce-------------EEEEEeecChhhHHHHHHHHHHHhhcCCCCccceeccccc-CccceEEEeecC
Q 044312 289 DNFDLNRILGQGGQ-------------AVKKSKVIDESKVEEFINEVVILSQINHRNVVKLLGCCLE-TEVPLLVYEFIP 354 (608)
Q Consensus 289 ~~f~~~~~lG~G~~-------------avk~~~~~~~~~~~~~~~Ei~il~~l~H~niv~l~~~~~~-~~~~~lV~E~~~ 354 (608)
++|++.+.||+|+| |||+++. ....+.|.+|+++|++++|||||+++|++.+ .+..+|||||++
T Consensus 7 ~~~~~~~~lG~G~fg~Vy~~~~~~~~vAvK~i~~--~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~ey~~ 84 (262)
T d1byga_ 7 KELKLLQTIGKGEFGDVMLGDYRGNKVAVKCIKN--DATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMA 84 (262)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTEEEEEEECCC--CC--HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECCCT
T ss_pred HHeEEeEEEecCCCeEEEEEEECCeEEEEEEECc--HHHHHHHHHHHHHHHhCCCCCEeeEEEEEEecCCcEEEEEeccC
Confidence 46788899999984 7777653 4456789999999999999999999999865 456899999999
Q ss_pred CCccchhccccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEEcCCCcEEEeeccCccccccCCcce
Q 044312 355 NGTLFQYIHDQNEDFPITWEIRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHM 434 (608)
Q Consensus 355 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGls~~~~~~~~~~ 434 (608)
+|+|.+++..... ..+++..+++|+.|||.||.|||+.+ |+||||||+|||++.++.+||+|||+++.....
T Consensus 85 ~g~L~~~l~~~~~-~~l~~~~~~~i~~~i~~al~ylH~~~---ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~~~~---- 156 (262)
T d1byga_ 85 KGSLVDYLRSRGR-SVLGGDCLLKFSLDVCEAMEYLEGNN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASST---- 156 (262)
T ss_dssp TEEHHHHHHHHHH-HHCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTSCEEECCCCC-----------
T ss_pred CCCHHHHHHhcCC-CCCCHHHHHHHHHHHHhhccccccCc---eeccccchHhheecCCCCEeecccccceecCCC----
Confidence 9999999976432 25899999999999999999999998 999999999999999999999999999865432
Q ss_pred eeeeeccCCCCChhhhccCCCCCccchHhHHHHHHHHHh-CCCCCCccchhhcccHHHHHHHHhhhhhhHHHhhhhhhcc
Q 044312 435 TTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLTELLT-GEKPIRFTILEEDKSLAAYFLCAMKEERLFEILDARVMKQ 513 (608)
Q Consensus 435 ~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~ellt-g~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~ 513 (608)
.....+|..|+|||++.+..++.++||||||+++|||+| |+.||......+ +...+....+.+
T Consensus 157 ~~~~~~~~~y~aPE~l~~~~~t~~sDIwSfG~il~el~t~~~~p~~~~~~~~----------------~~~~i~~~~~~~ 220 (262)
T d1byga_ 157 QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKD----------------VVPRVEKGYKMD 220 (262)
T ss_dssp -----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGG----------------HHHHHTTTCCCC
T ss_pred CccccccccCCChHHHhCCCCChHHHHHhHHHHHHHHHHCCCCCCCCCCHHH----------------HHHHHHcCCCCC
Confidence 233457899999999999999999999999999999998 677765322211 111122223344
Q ss_pred CChhHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhhHH
Q 044312 514 GGKDEIITVAKLAKRCLNLNGKKRPTMREVASELAGIKA 552 (608)
Q Consensus 514 ~~~~~~~~l~~Li~~cl~~dp~~RPs~~evl~~L~~i~~ 552 (608)
.+...+.++.+|+.+||+.||++||||.||+++|+.++.
T Consensus 221 ~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~L~~i~~ 259 (262)
T d1byga_ 221 APDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIKT 259 (262)
T ss_dssp CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CCccCCHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHh
Confidence 555667889999999999999999999999999999875
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1e-44 Score=373.53 Aligned_cols=241 Identities=23% Similarity=0.454 Sum_probs=194.4
Q ss_pred CccccceeccCce-------------------EEEEEee-cChhhHHHHHHHHHHHhhcCCCCccceecccccCccceEE
Q 044312 290 NFDLNRILGQGGQ-------------------AVKKSKV-IDESKVEEFINEVVILSQINHRNVVKLLGCCLETEVPLLV 349 (608)
Q Consensus 290 ~f~~~~~lG~G~~-------------------avk~~~~-~~~~~~~~~~~Ei~il~~l~H~niv~l~~~~~~~~~~~lV 349 (608)
+|++.++||+|+| |||+++. .+....++|.+|+.+|++++|||||+++|+|.+. ..+++
T Consensus 10 dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~-~~~~v 88 (317)
T d1xkka_ 10 EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQLI 88 (317)
T ss_dssp TEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC----CTHHHHHHHHHHHHHCCCTTBCCEEEEEESS-SEEEE
T ss_pred HCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC-CeeEE
Confidence 5899999999985 4444432 2334567899999999999999999999999765 56788
Q ss_pred EeecCCCccchhccccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEEcCCCcEEEeeccCcccccc
Q 044312 350 YEFIPNGTLFQYIHDQNEDFPITWEIRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAV 429 (608)
Q Consensus 350 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGls~~~~~ 429 (608)
+|++.+|+|.+++..... .+++..+++|+.|||.||+|||+++ |+||||||+|||++.++.+||+|||+++....
T Consensus 89 ~e~~~~~~l~~~~~~~~~--~~~~~~~~~i~~qi~~gl~yLH~~~---iiHrDlKp~NIll~~~~~~kl~DFGla~~~~~ 163 (317)
T d1xkka_ 89 TQLMPFGCLLDYVREHKD--NIGSQYLLNWCVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLGA 163 (317)
T ss_dssp EECCTTCBHHHHHHHTSS--SCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEETTEEEECCCSHHHHTTT
T ss_pred EEeccCCccccccccccc--CCCHHHHHHHHHHHHHHHHHHHHcC---cccCcchhhcceeCCCCCeEeeccccceeccc
Confidence 999999999998876543 5999999999999999999999999 99999999999999999999999999988754
Q ss_pred CCcc-eeeeeeccCCCCChhhhccCCCCCccchHhHHHHHHHHHh-CCCCCCccchhhcccHHHHHHHHhhhhhhHHHhh
Q 044312 430 DQTH-MTTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLTELLT-GEKPIRFTILEEDKSLAAYFLCAMKEERLFEILD 507 (608)
Q Consensus 430 ~~~~-~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~ellt-g~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 507 (608)
.... ......||+.|||||++.+..++.++|||||||+||||+| |+.||...... .+...+.
T Consensus 164 ~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~el~t~g~~p~~~~~~~----------------~~~~~i~ 227 (317)
T d1xkka_ 164 EEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPAS----------------EISSILE 227 (317)
T ss_dssp TCC--------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCGG----------------GHHHHHH
T ss_pred ccccccccccccCccccChHHHhcCCCChhhhhhhHHHHHHHHHHCCCCCCCCCCHH----------------HHHHHHH
Confidence 4332 2344568999999999999999999999999999999999 78887633221 1222333
Q ss_pred hhhhccCChhHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhhHH
Q 044312 508 ARVMKQGGKDEIITVAKLAKRCLNLNGKKRPTMREVASELAGIKA 552 (608)
Q Consensus 508 ~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~evl~~L~~i~~ 552 (608)
...+...+...+.++.+|+.+||+.||++|||+.||+++|+.+..
T Consensus 228 ~~~~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~eil~~l~~~~~ 272 (317)
T d1xkka_ 228 KGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMAR 272 (317)
T ss_dssp HTCCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred cCCCCCCCcccCHHHHHHHHHhCCCChhhCcCHHHHHHHHHHHHh
Confidence 333334455677889999999999999999999999999987754
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.7e-45 Score=368.85 Aligned_cols=235 Identities=26% Similarity=0.410 Sum_probs=192.8
Q ss_pred cCccccceeccCce---------------EEEEEee---cChhhHHHHHHHHHHHhhcCCCCccceecccccCccceEEE
Q 044312 289 DNFDLNRILGQGGQ---------------AVKKSKV---IDESKVEEFINEVVILSQINHRNVVKLLGCCLETEVPLLVY 350 (608)
Q Consensus 289 ~~f~~~~~lG~G~~---------------avk~~~~---~~~~~~~~~~~Ei~il~~l~H~niv~l~~~~~~~~~~~lV~ 350 (608)
++|++.+.||+|+| |||.+.. .+....+.+.+|+++|++++|||||++++++.+.+..+|||
T Consensus 8 ~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ivm 87 (288)
T d1uu3a_ 8 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL 87 (288)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSSEEEEEE
T ss_pred CCCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEECCEEEEEE
Confidence 46999999999984 7887653 23445678999999999999999999999999999999999
Q ss_pred eecCCCccchhccccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEEcCCCcEEEeeccCccccccC
Q 044312 351 EFIPNGTLFQYIHDQNEDFPITWEIRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVD 430 (608)
Q Consensus 351 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGls~~~~~~ 430 (608)
||+++|+|.+++...+ .+++..+..++.|++.||+|||+.+ |+||||||+|||+++++.+||+|||+++.+...
T Consensus 88 Ey~~gg~L~~~~~~~~---~l~e~~~~~~~~qi~~al~ylH~~~---iiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~~ 161 (288)
T d1uu3a_ 88 SYAKNGELLKYIRKIG---SFDETCTRFYTAEIVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPE 161 (288)
T ss_dssp CCCTTEEHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCEECC--
T ss_pred EccCCCCHHHhhhccC---CCCHHHHHHHHHHHHHHHHhhcccc---EEcCcCCccccccCCCceEEecccccceecccC
Confidence 9999999999987654 5999999999999999999999999 999999999999999999999999999887543
Q ss_pred C-cceeeeeeccCCCCChhhhccCCCCCccchHhHHHHHHHHHhCCCCCCccchhhcccHHHHHHHHhhhhhhHHHhhhh
Q 044312 431 Q-THMTTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLTELLTGEKPIRFTILEEDKSLAAYFLCAMKEERLFEILDAR 509 (608)
Q Consensus 431 ~-~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 509 (608)
. ........||+.|||||++.+..++.++|||||||+||||++|+.||...... ..+. .+...
T Consensus 162 ~~~~~~~~~~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~------~~~~---------~i~~~- 225 (288)
T d1uu3a_ 162 SKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEY------LIFQ---------KIIKL- 225 (288)
T ss_dssp --------CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHH------HHHH---------HHHTT-
T ss_pred CcccccccccCCccccCceeeccCCCCcccceehhhHHHHHHhhCCCCCCCcCHH------HHHH---------HHHcC-
Confidence 2 22334567999999999999999999999999999999999999999732211 1111 11111
Q ss_pred hhccCChhHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 044312 510 VMKQGGKDEIITVAKLAKRCLNLNGKKRPTMREVASE 546 (608)
Q Consensus 510 ~~~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~evl~~ 546 (608)
....+...+.++.+|+.+||+.||++|||++|+++.
T Consensus 226 -~~~~p~~~s~~~~~li~~~L~~dP~~R~t~~e~~~~ 261 (288)
T d1uu3a_ 226 -EYDFPEKFFPKARDLVEKLLVLDATKRLGCEEMEGY 261 (288)
T ss_dssp -CCCCCTTCCHHHHHHHHTTSCSSGGGSTTSGGGTCH
T ss_pred -CCCCCccCCHHHHHHHHHHccCCHhHCcCHHHHcCC
Confidence 112334566789999999999999999999998654
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.7e-44 Score=369.91 Aligned_cols=231 Identities=26% Similarity=0.354 Sum_probs=189.1
Q ss_pred CccccceeccCce---------------EEEEEeecC---hhhHHHHHHHHHHHhhcCCCCccceecccccCccceEEEe
Q 044312 290 NFDLNRILGQGGQ---------------AVKKSKVID---ESKVEEFINEVVILSQINHRNVVKLLGCCLETEVPLLVYE 351 (608)
Q Consensus 290 ~f~~~~~lG~G~~---------------avk~~~~~~---~~~~~~~~~Ei~il~~l~H~niv~l~~~~~~~~~~~lV~E 351 (608)
.|+..+.||+|+| |||++.... ....+.|.+|+.+|++++|||||++++++.+.+..+||||
T Consensus 16 ~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv~E 95 (309)
T d1u5ra_ 16 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVME 95 (309)
T ss_dssp HEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred hcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEECCEEEEEEE
Confidence 4888999999984 888876432 3445779999999999999999999999999999999999
Q ss_pred ecCCCccchhccccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEEcCCCcEEEeeccCccccccCC
Q 044312 352 FIPNGTLFQYIHDQNEDFPITWEIRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQ 431 (608)
Q Consensus 352 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGls~~~~~~~ 431 (608)
|+++|+|..++.... ++++..+..|+.||+.||.|||+++ |+||||||+|||+++++.+||+|||+++.....
T Consensus 96 ~~~~g~l~~~~~~~~---~l~e~~~~~i~~qi~~aL~yLH~~~---iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~~~~- 168 (309)
T d1u5ra_ 96 YCLGSASDLLEVHKK---PLQEVEIAAVTHGALQGLAYLHSHN---MIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA- 168 (309)
T ss_dssp CCSEEHHHHHHHHTS---CCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEEETTTEEEECCCTTCBSSSSB-
T ss_pred ecCCCchHHHHHhCC---CCCHHHHHHHHHHHHHHHHHHHhCC---EeccCCCcceEEECCCCCEEEeecccccccCCC-
Confidence 999999876665432 5999999999999999999999999 999999999999999999999999999865432
Q ss_pred cceeeeeeccCCCCChhhhcc---CCCCCccchHhHHHHHHHHHhCCCCCCccchhhcccHHHHHHHHhhhhhhHHHhhh
Q 044312 432 THMTTQVHGTFGYLDPEYFRS---SQFTDKSDVYSFGVVLTELLTGEKPIRFTILEEDKSLAAYFLCAMKEERLFEILDA 508 (608)
Q Consensus 432 ~~~~~~~~gt~~y~aPE~~~~---~~~t~ksDV~S~Gvvl~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 508 (608)
....||+.|||||++.+ ..++.++|||||||++|||++|+.||...... ..+ ..+...
T Consensus 169 ----~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~~------~~~---------~~i~~~ 229 (309)
T d1u5ra_ 169 ----NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAM------SAL---------YHIAQN 229 (309)
T ss_dssp ----CCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHH------HHH---------HHHHHS
T ss_pred ----CccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCCHH------HHH---------HHHHhC
Confidence 33569999999999864 46899999999999999999999998632211 111 111111
Q ss_pred hhhccCChhHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 044312 509 RVMKQGGKDEIITVAKLAKRCLNLNGKKRPTMREVASE 546 (608)
Q Consensus 509 ~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~evl~~ 546 (608)
......+...+.++.+|+.+||+.||++|||+.|++++
T Consensus 230 ~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~H 267 (309)
T d1u5ra_ 230 ESPALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKH 267 (309)
T ss_dssp CCCCCSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTC
T ss_pred CCCCCCCCCCCHHHHHHHHHHCcCChhHCcCHHHHHhC
Confidence 11112233456789999999999999999999999874
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.6e-44 Score=367.61 Aligned_cols=255 Identities=27% Similarity=0.394 Sum_probs=194.0
Q ss_pred HHHHHHHhcCccccceeccCce--------------------EEEEEee-cChhhHHHHHHHHHHHhhc-CCCCccceec
Q 044312 281 SKELEKATDNFDLNRILGQGGQ--------------------AVKKSKV-IDESKVEEFINEVVILSQI-NHRNVVKLLG 338 (608)
Q Consensus 281 ~~~l~~~t~~f~~~~~lG~G~~--------------------avk~~~~-~~~~~~~~~~~Ei~il~~l-~H~niv~l~~ 338 (608)
..+++...++|++.++||+|+| |||+++. ......+.+.+|..++.++ +|+|||++++
T Consensus 5 ~~~wei~~~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~ 84 (299)
T d1ywna1 5 ASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLG 84 (299)
T ss_dssp HHHHBCCGGGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----CHHHHHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred CccccccHHHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEccccCcHHHHHHHHHHHHHHhhcCCCeEEEeee
Confidence 3445555578999999999985 4555443 2334567788999988887 7899999999
Q ss_pred ccccC-ccceEEEeecCCCccchhccccCC-------------CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeccCCC
Q 044312 339 CCLET-EVPLLVYEFIPNGTLFQYIHDQNE-------------DFPITWEIRLRIAIEVSGALSYLHSAASIPIYHRDIK 404 (608)
Q Consensus 339 ~~~~~-~~~~lV~E~~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk 404 (608)
++.+. ...++||||+++|+|.++++.... ...+++..++.++.|||+||+|||+++ |+|||||
T Consensus 85 ~~~~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~---ivHrDlK 161 (299)
T d1ywna1 85 ACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRDLA 161 (299)
T ss_dssp EECSTTSCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCC
T ss_pred eeccCCCeEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhCC---CcCCcCC
Confidence 98654 468999999999999999975421 224899999999999999999999999 9999999
Q ss_pred CCcEEEcCCCcEEEeeccCccccccCCcc-eeeeeeccCCCCChhhhccCCCCCccchHhHHHHHHHHHhCC-CCCCccc
Q 044312 405 STNILLDDKYRAKVSDFGASRSMAVDQTH-MTTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLTELLTGE-KPIRFTI 482 (608)
Q Consensus 405 ~~NILl~~~~~~kl~DFGls~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~elltg~-~p~~~~~ 482 (608)
|+||||++++.+||+|||+|+........ ......||+.|||||++.+..++.++|||||||++|||+||. .||....
T Consensus 162 p~NILl~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gvil~ellt~~~~p~~~~~ 241 (299)
T d1ywna1 162 ARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVK 241 (299)
T ss_dssp GGGEEECGGGCEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCC
T ss_pred ccceeECCCCcEEEccCcchhhccccccccccCceeeCccccchhHhhcCCCCcccceeehHHHHHHHHhCCCCCCCCCC
Confidence 99999999999999999999876543322 234567999999999999999999999999999999999975 5665322
Q ss_pred hhhcccHHHHHHHHhhhhhhHHHhhhhhhccCChhHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhhHHh
Q 044312 483 LEEDKSLAAYFLCAMKEERLFEILDARVMKQGGKDEIITVAKLAKRCLNLNGKKRPTMREVASELAGIKAW 553 (608)
Q Consensus 483 ~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~evl~~L~~i~~~ 553 (608)
... .+...+........+...+.++.+|+.+||+.||++|||+.||+++|+.+.+.
T Consensus 242 ~~~---------------~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~eil~~L~~ilq~ 297 (299)
T d1ywna1 242 IDE---------------EFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQA 297 (299)
T ss_dssp CSH---------------HHHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HHH---------------HHHHHHhcCCCCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhC
Confidence 111 11112222222334455667899999999999999999999999999987643
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=100.00 E-value=4.5e-44 Score=373.02 Aligned_cols=236 Identities=21% Similarity=0.300 Sum_probs=196.5
Q ss_pred cCccccceeccCce---------------EEEEEeecChhhHHHHHHHHHHHhhcCCCCccceecccccCccceEEEeec
Q 044312 289 DNFDLNRILGQGGQ---------------AVKKSKVIDESKVEEFINEVVILSQINHRNVVKLLGCCLETEVPLLVYEFI 353 (608)
Q Consensus 289 ~~f~~~~~lG~G~~---------------avk~~~~~~~~~~~~~~~Ei~il~~l~H~niv~l~~~~~~~~~~~lV~E~~ 353 (608)
++|++.+.||+|+| |||++........+.+.+|+.+|++++|||||++++++.+.+..+|||||+
T Consensus 26 ~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE~~ 105 (350)
T d1koaa2 26 DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFM 105 (350)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEEETTEEEEEECCC
T ss_pred cCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEcccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcC
Confidence 57999999999984 888887766677788999999999999999999999999999999999999
Q ss_pred CCCccchhccccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEEc--CCCcEEEeeccCccccccCC
Q 044312 354 PNGTLFQYIHDQNEDFPITWEIRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLD--DKYRAKVSDFGASRSMAVDQ 431 (608)
Q Consensus 354 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~--~~~~~kl~DFGls~~~~~~~ 431 (608)
++|+|.+++..... .+++..+..|+.||+.||+|||+++ |+||||||+|||++ .++.+||+|||+++.+....
T Consensus 106 ~gg~L~~~l~~~~~--~l~e~~~~~i~~qi~~aL~ylH~~~---iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~~~~~ 180 (350)
T d1koaa2 106 SGGELFEKVADEHN--KMSEDEAVEYMRQVCKGLCHMHENN---YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQ 180 (350)
T ss_dssp CSCBHHHHHTCTTS--CBCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSTTSCCEEECCCTTCEECCTTS
T ss_pred CCCCHHHHHHhhcC--CCCHHHHHHHHHHHHHHHHHHHhcC---CeeeeechhHeeeccCCCCeEEEeecchheeccccc
Confidence 99999999865433 5999999999999999999999999 99999999999996 46789999999998765433
Q ss_pred cceeeeeeccCCCCChhhhccCCCCCccchHhHHHHHHHHHhCCCCCCccchhhcccHHHHHHHHhhhhhhHHHhhhhh-
Q 044312 432 THMTTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLTELLTGEKPIRFTILEEDKSLAAYFLCAMKEERLFEILDARV- 510 (608)
Q Consensus 432 ~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~- 510 (608)
......||+.|||||++.+..++.++|||||||++|||++|+.||...... ..+. .+.....
T Consensus 181 --~~~~~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~------~~~~---------~i~~~~~~ 243 (350)
T d1koaa2 181 --SVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDD------ETLR---------NVKSCDWN 243 (350)
T ss_dssp --CEEEECSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHH------HHHH---------HHHHTCCC
T ss_pred --ccceecCcccccCHHHHcCCCCChhHhhhhhhHHHHHHHhCCCCCCCCCHH------HHHH---------HHHhCCCC
Confidence 335567999999999999999999999999999999999999999633211 1111 1111100
Q ss_pred -hccCChhHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 044312 511 -MKQGGKDEIITVAKLAKRCLNLNGKKRPTMREVASE 546 (608)
Q Consensus 511 -~~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~evl~~ 546 (608)
........+.++.+|+.+||+.||++|||++|++++
T Consensus 244 ~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~h 280 (350)
T d1koaa2 244 MDDSAFSGISEDGKDFIRKLLLADPNTRMTIHQALEH 280 (350)
T ss_dssp SCCGGGGGCCHHHHHHHHHHCCSSGGGSCCHHHHHHS
T ss_pred CCcccccCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 011112345689999999999999999999999875
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=3.7e-44 Score=367.24 Aligned_cols=239 Identities=26% Similarity=0.354 Sum_probs=178.6
Q ss_pred HhcCccccceeccCce---------------EEEEEeecC-hhhHHHHHHHHHHHhhcCCCCccceecccccCccceEEE
Q 044312 287 ATDNFDLNRILGQGGQ---------------AVKKSKVID-ESKVEEFINEVVILSQINHRNVVKLLGCCLETEVPLLVY 350 (608)
Q Consensus 287 ~t~~f~~~~~lG~G~~---------------avk~~~~~~-~~~~~~~~~Ei~il~~l~H~niv~l~~~~~~~~~~~lV~ 350 (608)
..+.|++.+.||+|+| |||.+.... ....+.+.+|+.+|++++|||||++++++.+.+..+|||
T Consensus 7 i~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lvm 86 (307)
T d1a06a_ 7 IRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIM 86 (307)
T ss_dssp GGGTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC----------CHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred CccceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhhhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEE
Confidence 3467999999999984 888875422 233467889999999999999999999999999999999
Q ss_pred eecCCCccchhccccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEEc---CCCcEEEeeccCcccc
Q 044312 351 EFIPNGTLFQYIHDQNEDFPITWEIRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLD---DKYRAKVSDFGASRSM 427 (608)
Q Consensus 351 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~---~~~~~kl~DFGls~~~ 427 (608)
||+++|+|.+++.... .+++..+..++.||+.||+|||+++ |+||||||+|||+. +++.+||+|||+++..
T Consensus 87 E~~~gg~L~~~l~~~~---~l~e~~~~~~~~qi~~al~ylH~~~---iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~~ 160 (307)
T d1a06a_ 87 QLVSGGELFDRIVEKG---FYTERDASRLIFQVLDAVKYLHDLG---IVHRDLKPENLLYYSLDEDSKIMISDFGLSKME 160 (307)
T ss_dssp CCCCSCBHHHHHHTCS---CCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESSSSTTCCEEECCC------
T ss_pred eccCCCcHHHhhhccc---CCCHHHHHHHHHHHHHHHHhhhhce---eeeEEecccceeecccCCCceEEEeccceeEEc
Confidence 9999999999997643 5999999999999999999999999 99999999999994 5789999999999866
Q ss_pred ccCCcceeeeeeccCCCCChhhhccCCCCCccchHhHHHHHHHHHhCCCCCCccchhhcccHHHHHHHHhhhhhhHHHhh
Q 044312 428 AVDQTHMTTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLTELLTGEKPIRFTILEEDKSLAAYFLCAMKEERLFEILD 507 (608)
Q Consensus 428 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 507 (608)
.... ......||+.|||||++.+..++.++|||||||+||||++|+.||......+ .........
T Consensus 161 ~~~~--~~~~~~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~------~~~~i~~~~------- 225 (307)
T d1a06a_ 161 DPGS--VLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAK------LFEQILKAE------- 225 (307)
T ss_dssp --------------CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH------HHHHHHTTC-------
T ss_pred cCCC--eeeeeeeCccccCcHHHcCCCCCcHHHhhhhhHHHHHHHhCCCCCCCCCHHH------HHHHHhccC-------
Confidence 4332 2344679999999999999999999999999999999999999997322111 111111100
Q ss_pred hhhhccCChhHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 044312 508 ARVMKQGGKDEIITVAKLAKRCLNLNGKKRPTMREVASE 546 (608)
Q Consensus 508 ~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~evl~~ 546 (608)
...........+.++.+|+.+||+.||++|||++|++++
T Consensus 226 ~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~h 264 (307)
T d1a06a_ 226 YEFDSPYWDDISDSAKDFIRHLMEKDPEKRFTCEQALQH 264 (307)
T ss_dssp CCCCTTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHS
T ss_pred CCCCCccccCCCHHHHHHHHHHccCCHhHCcCHHHHhcC
Confidence 001112223556789999999999999999999999875
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.2e-44 Score=368.50 Aligned_cols=244 Identities=25% Similarity=0.433 Sum_probs=194.4
Q ss_pred cCccccceeccCce-----------------EEEEEee-cChhhHHHHHHHHHHHhhc-CCCCccceecccccCccceEE
Q 044312 289 DNFDLNRILGQGGQ-----------------AVKKSKV-IDESKVEEFINEVVILSQI-NHRNVVKLLGCCLETEVPLLV 349 (608)
Q Consensus 289 ~~f~~~~~lG~G~~-----------------avk~~~~-~~~~~~~~~~~Ei~il~~l-~H~niv~l~~~~~~~~~~~lV 349 (608)
++|++.++||+|+| |||+++. ......+.|.+|+++|+++ +|||||++++++.+.+..++|
T Consensus 10 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~iV 89 (309)
T d1fvra_ 10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA 89 (309)
T ss_dssp GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEE
T ss_pred HHcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECcccChHHHHHHHHHHHHHHhccCCCCEeeEEEEEecCCeeEEE
Confidence 56888999999974 4555432 3344567899999999999 799999999999999999999
Q ss_pred EeecCCCccchhccccC-------------CCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEEcCCCcE
Q 044312 350 YEFIPNGTLFQYIHDQN-------------EDFPITWEIRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRA 416 (608)
Q Consensus 350 ~E~~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~ 416 (608)
|||+++|+|.++|+... ....+++..+++++.|||+||.|||+.+ |+||||||+|||++.++.+
T Consensus 90 ~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~~---iiHrDlkp~NIL~~~~~~~ 166 (309)
T d1fvra_ 90 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYVA 166 (309)
T ss_dssp ECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECGGGCE
T ss_pred EEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcCC---ccccccccceEEEcCCCce
Confidence 99999999999997531 2236999999999999999999999999 9999999999999999999
Q ss_pred EEeeccCccccccCCcceeeeeeccCCCCChhhhccCCCCCccchHhHHHHHHHHHhCCC-CCCccchhhcccHHHHHHH
Q 044312 417 KVSDFGASRSMAVDQTHMTTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLTELLTGEK-PIRFTILEEDKSLAAYFLC 495 (608)
Q Consensus 417 kl~DFGls~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~elltg~~-p~~~~~~~~~~~l~~~~~~ 495 (608)
||+|||+++....... .....||..|+|||.+....++.++||||||+++|||++|.. ||..... .
T Consensus 167 kl~DfG~a~~~~~~~~--~~~~~gt~~y~aPE~l~~~~~~~~sDvwSfGvil~ell~~~~~p~~~~~~------~----- 233 (309)
T d1fvra_ 167 KIADFGLSRGQEVYVK--KTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTC------A----- 233 (309)
T ss_dssp EECCTTCEESSCEECC--C----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCH------H-----
T ss_pred EEcccccccccccccc--ccceecCCcccchHHhccCCCCccceeehhHHHHHHHHhcCCCCCCCCCH------H-----
Confidence 9999999986543222 234468999999999999999999999999999999999765 5542211 1
Q ss_pred HhhhhhhHHHhhhhhhccCChhHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhhHHh
Q 044312 496 AMKEERLFEILDARVMKQGGKDEIITVAKLAKRCLNLNGKKRPTMREVASELAGIKAW 553 (608)
Q Consensus 496 ~~~~~~~~~~~d~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~evl~~L~~i~~~ 553 (608)
.+.+.+....+.+.+...+.++.+|+.+||+.||++||||+||+++|+.+...
T Consensus 234 -----~~~~~i~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L~~i~~~ 286 (309)
T d1fvra_ 234 -----ELYEKLPQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEE 286 (309)
T ss_dssp -----HHHHHGGGTCCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHS
T ss_pred -----HHHHHHHhcCCCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhc
Confidence 11112222223344556678999999999999999999999999999988653
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.4e-44 Score=362.67 Aligned_cols=241 Identities=26% Similarity=0.416 Sum_probs=188.4
Q ss_pred cCccccceeccCce------------------EEEEEee---cChhhHHHHHHHHHHHhhcCCCCccceecccccCccce
Q 044312 289 DNFDLNRILGQGGQ------------------AVKKSKV---IDESKVEEFINEVVILSQINHRNVVKLLGCCLETEVPL 347 (608)
Q Consensus 289 ~~f~~~~~lG~G~~------------------avk~~~~---~~~~~~~~~~~Ei~il~~l~H~niv~l~~~~~~~~~~~ 347 (608)
++|++.+.||+|+| |||+++. .+....++|.+|+.+|++++|||||+++|++.+ ...+
T Consensus 8 ~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~-~~~~ 86 (273)
T d1u46a_ 8 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLT-PPMK 86 (273)
T ss_dssp GGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCE
T ss_pred HHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEee-cchh
Confidence 45888999999985 5565542 234456789999999999999999999999965 4678
Q ss_pred EEEeecCCCccchhccccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEEcCCCcEEEeeccCcccc
Q 044312 348 LVYEFIPNGTLFQYIHDQNEDFPITWEIRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSM 427 (608)
Q Consensus 348 lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGls~~~ 427 (608)
+||||+++|+|.+++..... ++++..++.++.|||+||.|||+++ |+||||||+|||++.++.+||+|||+++..
T Consensus 87 lv~e~~~~~~l~~~~~~~~~--~l~~~~~~~~~~qi~~gl~ylH~~~---iiHrDikp~NIll~~~~~vkl~DfGl~~~~ 161 (273)
T d1u46a_ 87 MVTELAPLGSLLDRLRKHQG--HFLLGTLSRYAVQVAEGMGYLESKR---FIHRDLAARNLLLATRDLVKIGDFGLMRAL 161 (273)
T ss_dssp EEEECCTTCBHHHHHHHHGG--GSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEEEETTEEEECCCTTCEEC
T ss_pred eeeeeecCcchhhhhhcccC--CCCHHHHHHHHHHHHHHHHHhhhCC---EeeeeecHHHhccccccceeeccchhhhhc
Confidence 99999999999998876543 5999999999999999999999999 999999999999999999999999999987
Q ss_pred ccCCcc--eeeeeeccCCCCChhhhccCCCCCccchHhHHHHHHHHHh-CCCCCCccchhhcccHHHHHHHHhhhhhhHH
Q 044312 428 AVDQTH--MTTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLTELLT-GEKPIRFTILEEDKSLAAYFLCAMKEERLFE 504 (608)
Q Consensus 428 ~~~~~~--~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~ellt-g~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~ 504 (608)
...... ......|+..|+|||.+.+..++.++||||||+++|||+| |+.||......+ .. ..
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~~~~~------~~---------~~ 226 (273)
T d1u46a_ 162 PQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQ------IL---------HK 226 (273)
T ss_dssp CC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH------HH---------HH
T ss_pred ccCCCcceecCccccCcccCCHHHHhCCCCCcchhhhhhHHHHHHHHhCCCCCCCCcCHHH------HH---------HH
Confidence 544332 2234567889999999999999999999999999999998 899986322211 11 11
Q ss_pred HhhhhhhccCChhHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhh
Q 044312 505 ILDARVMKQGGKDEIITVAKLAKRCLNLNGKKRPTMREVASELAGI 550 (608)
Q Consensus 505 ~~d~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~evl~~L~~i 550 (608)
+.......+.+...+..+.+|+.+||+.||++||||.||++.|++.
T Consensus 227 i~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~ei~~~L~~~ 272 (273)
T d1u46a_ 227 IDKEGERLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEA 272 (273)
T ss_dssp HHTSCCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred HHhCCCCCCCcccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHhc
Confidence 1112222334455667899999999999999999999999988764
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.3e-44 Score=365.46 Aligned_cols=242 Identities=28% Similarity=0.438 Sum_probs=194.8
Q ss_pred cceeccCce------------------EEEEEee-cChhhHHHHHHHHHHHhhcCCCCccceeccccc-CccceEEEeec
Q 044312 294 NRILGQGGQ------------------AVKKSKV-IDESKVEEFINEVVILSQINHRNVVKLLGCCLE-TEVPLLVYEFI 353 (608)
Q Consensus 294 ~~~lG~G~~------------------avk~~~~-~~~~~~~~~~~Ei~il~~l~H~niv~l~~~~~~-~~~~~lV~E~~ 353 (608)
.++||+|+| |||+++. .+....++|.+|+++|++++|||||+++|++.+ ....++||||+
T Consensus 32 ~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~E~~ 111 (311)
T d1r0pa_ 32 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYM 111 (311)
T ss_dssp EEEEEEETTEEEEEEEECC----CEEEEEEEECCCCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEEEEEECC
T ss_pred ceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecCCceEEEEEEe
Confidence 578999974 5666653 455667889999999999999999999999875 45789999999
Q ss_pred CCCccchhccccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEEcCCCcEEEeeccCccccccCCcc
Q 044312 354 PNGTLFQYIHDQNEDFPITWEIRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTH 433 (608)
Q Consensus 354 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGls~~~~~~~~~ 433 (608)
++|+|.++++.... .+++..+++++.|+|.||.|||+.+ |+||||||+||||++++.+||+|||+++........
T Consensus 112 ~~g~l~~~~~~~~~--~~~~~~~~~i~~qia~gL~~lH~~~---iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~~~~~ 186 (311)
T d1r0pa_ 112 KHGDLRNFIRNETH--NPTVKDLIGFGLQVAKGMKFLASKK---FVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFD 186 (311)
T ss_dssp TTCBHHHHHHCTTC--CCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTCCEEECSSGGGCCTTTTTCC
T ss_pred ecCchhhhhccccc--cchHHHHHHHHHHHHHhhhhhcccC---cccCCccHHhEeECCCCCEEEecccchhhccccccc
Confidence 99999999886543 4789999999999999999999999 999999999999999999999999999876543322
Q ss_pred ---eeeeeeccCCCCChhhhccCCCCCccchHhHHHHHHHHHhCCCCCCccchhhcccHHHHHHHHhhhhhhHHHhhhhh
Q 044312 434 ---MTTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLTELLTGEKPIRFTILEEDKSLAAYFLCAMKEERLFEILDARV 510 (608)
Q Consensus 434 ---~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~ 510 (608)
......||+.|+|||.+....++.++||||||+++|||+||..||....... .... .+. ...
T Consensus 187 ~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl~El~t~~~p~~~~~~~~--~~~~------------~i~-~g~ 251 (311)
T d1r0pa_ 187 SVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTF--DITV------------YLL-QGR 251 (311)
T ss_dssp CTTCTTCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCC--------CHH------------HHH-TTC
T ss_pred cceecccccccccccChHHHhcCCCCChhHhhhhHHHHHHHHHCCCCCCCCCCHH--HHHH------------HHH-cCC
Confidence 2234568999999999999999999999999999999999888875322111 1111 111 111
Q ss_pred hccCChhHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhhHHhcC
Q 044312 511 MKQGGKDEIITVAKLAKRCLNLNGKKRPTMREVASELAGIKAWNG 555 (608)
Q Consensus 511 ~~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~evl~~L~~i~~~~~ 555 (608)
+...+...+.++.+|+.+||+.||++||+|.||+++|+.+.....
T Consensus 252 ~~~~p~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~L~~i~~~~~ 296 (311)
T d1r0pa_ 252 RLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFI 296 (311)
T ss_dssp CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTCC
T ss_pred CCCCcccCcHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHhhh
Confidence 223344556789999999999999999999999999999976533
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=100.00 E-value=1.1e-43 Score=370.37 Aligned_cols=238 Identities=21% Similarity=0.267 Sum_probs=197.1
Q ss_pred cCccccceeccCce---------------EEEEEeecChhhHHHHHHHHHHHhhcCCCCccceecccccCccceEEEeec
Q 044312 289 DNFDLNRILGQGGQ---------------AVKKSKVIDESKVEEFINEVVILSQINHRNVVKLLGCCLETEVPLLVYEFI 353 (608)
Q Consensus 289 ~~f~~~~~lG~G~~---------------avk~~~~~~~~~~~~~~~Ei~il~~l~H~niv~l~~~~~~~~~~~lV~E~~ 353 (608)
++|++.+.||+|+| |||+++.......+.+.+|+.+|++++|||||++++++.+.+..+|||||+
T Consensus 29 d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivmE~~ 108 (352)
T d1koba_ 29 DYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFL 108 (352)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEECC
T ss_pred cceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcC
Confidence 57999999999984 888877666666778999999999999999999999999999999999999
Q ss_pred CCCccchhccccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEEc--CCCcEEEeeccCccccccCC
Q 044312 354 PNGTLFQYIHDQNEDFPITWEIRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLD--DKYRAKVSDFGASRSMAVDQ 431 (608)
Q Consensus 354 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~--~~~~~kl~DFGls~~~~~~~ 431 (608)
++|+|.+++..... ++++..+..|+.||+.||+|||+++ |+||||||+||||+ .++.+||+|||+|+.+....
T Consensus 109 ~gg~L~~~~~~~~~--~l~e~~~~~i~~qi~~aL~ylH~~~---iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~~~~~ 183 (352)
T d1koba_ 109 SGGELFDRIAAEDY--KMSEAEVINYMRQACEGLKHMHEHS---IVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDE 183 (352)
T ss_dssp CCCBHHHHTTCTTC--CBCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSTTCCCEEECCCTTCEECCTTS
T ss_pred CCChHHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHHCC---eeecccccccccccccCCCeEEEeecccceecCCCC
Confidence 99999988875433 5999999999999999999999999 99999999999998 57899999999998876433
Q ss_pred cceeeeeeccCCCCChhhhccCCCCCccchHhHHHHHHHHHhCCCCCCccchhhcccHHHHHHHHhhhhhhHHHhhhhhh
Q 044312 432 THMTTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLTELLTGEKPIRFTILEEDKSLAAYFLCAMKEERLFEILDARVM 511 (608)
Q Consensus 432 ~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~ 511 (608)
......||+.|+|||++.+..++.++|||||||+||||+||+.||......+ .+. .+.... ....
T Consensus 184 --~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~------~~~-~i~~~~------~~~~ 248 (352)
T d1koba_ 184 --IVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLE------TLQ-NVKRCD------WEFD 248 (352)
T ss_dssp --CEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHH------HHH-HHHHCC------CCCC
T ss_pred --ceeeccCcccccCHHHHcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHH------HHH-HHHhCC------CCCC
Confidence 3455679999999999999999999999999999999999999996322111 110 111100 0111
Q ss_pred ccCChhHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 044312 512 KQGGKDEIITVAKLAKRCLNLNGKKRPTMREVASE 546 (608)
Q Consensus 512 ~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~evl~~ 546 (608)
.......+.++.+|+.+||+.||++|||+.|++++
T Consensus 249 ~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~H 283 (352)
T d1koba_ 249 EDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEH 283 (352)
T ss_dssp SSTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred cccccCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 12223456789999999999999999999999875
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-43 Score=362.62 Aligned_cols=247 Identities=27% Similarity=0.452 Sum_probs=198.9
Q ss_pred hcCccccceeccCce----------------------EEEEEee-cChhhHHHHHHHHHHHhhc-CCCCccceecccccC
Q 044312 288 TDNFDLNRILGQGGQ----------------------AVKKSKV-IDESKVEEFINEVVILSQI-NHRNVVKLLGCCLET 343 (608)
Q Consensus 288 t~~f~~~~~lG~G~~----------------------avk~~~~-~~~~~~~~~~~Ei~il~~l-~H~niv~l~~~~~~~ 343 (608)
.++|++.+.||+|+| |||+++. .......++.+|...+.++ +|||||+++++|.+.
T Consensus 12 ~~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~~~~ 91 (299)
T d1fgka_ 12 RDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQD 91 (299)
T ss_dssp GGGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred HHHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECcccChHHHHHHHHHHHHHHHhcCCCeEEecccccccC
Confidence 457888999999986 4444433 2334567899999999998 899999999999999
Q ss_pred ccceEEEeecCCCccchhccccCC-------------CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEE
Q 044312 344 EVPLLVYEFIPNGTLFQYIHDQNE-------------DFPITWEIRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILL 410 (608)
Q Consensus 344 ~~~~lV~E~~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl 410 (608)
...++||||+++|+|.++|..... ...+++..++.++.|||.||+|||+.+ |+||||||+|||+
T Consensus 92 ~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~~---ivHrDiKp~NiLl 168 (299)
T d1fgka_ 92 GPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKK---CIHRDLAARNVLV 168 (299)
T ss_dssp SSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEE
T ss_pred CeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhCC---EEeeeecccceee
Confidence 999999999999999999975431 235899999999999999999999999 9999999999999
Q ss_pred cCCCcEEEeeccCccccccCCcc-eeeeeeccCCCCChhhhccCCCCCccchHhHHHHHHHHHh-CCCCCCccchhhccc
Q 044312 411 DDKYRAKVSDFGASRSMAVDQTH-MTTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLTELLT-GEKPIRFTILEEDKS 488 (608)
Q Consensus 411 ~~~~~~kl~DFGls~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~ellt-g~~p~~~~~~~~~~~ 488 (608)
+.++.+||+|||+++........ ......+|+.|+|||.+.+..++.|+||||||+++|||++ |..||......
T Consensus 169 ~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~y~~k~DiwS~Gvvl~ell~~g~~p~~~~~~~---- 244 (299)
T d1fgka_ 169 TEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVE---- 244 (299)
T ss_dssp CTTCCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHH----
T ss_pred cCCCCeEeccchhhccccccccccccccCCCChhhhhhhHhcCCCCCchhhhHHhHHHHHHhccCCCCCCCCCCHH----
Confidence 99999999999999877643322 2344568999999999999999999999999999999998 67887632211
Q ss_pred HHHHHHHHhhhhhhHHHhhhhhhccCChhHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhhHHh
Q 044312 489 LAAYFLCAMKEERLFEILDARVMKQGGKDEIITVAKLAKRCLNLNGKKRPTMREVASELAGIKAW 553 (608)
Q Consensus 489 l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~evl~~L~~i~~~ 553 (608)
.+.+.+......+.+...+.++.+|+.+||+.||++|||+.||++.|+++.+.
T Consensus 245 ------------~~~~~i~~~~~~~~p~~~~~~l~~li~~cl~~dP~~Rps~~eil~~L~~i~a~ 297 (299)
T d1fgka_ 245 ------------ELFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVAL 297 (299)
T ss_dssp ------------HHHHHHHTTCCCCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred ------------HHHHHHHcCCCCCCCccchHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHhhc
Confidence 11222223333344556677899999999999999999999999999988653
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.3e-43 Score=357.42 Aligned_cols=238 Identities=26% Similarity=0.365 Sum_probs=192.2
Q ss_pred hcCccccceeccCce---------------EEEEEeec------ChhhHHHHHHHHHHHhhcCCCCccceecccccCccc
Q 044312 288 TDNFDLNRILGQGGQ---------------AVKKSKVI------DESKVEEFINEVVILSQINHRNVVKLLGCCLETEVP 346 (608)
Q Consensus 288 t~~f~~~~~lG~G~~---------------avk~~~~~------~~~~~~~~~~Ei~il~~l~H~niv~l~~~~~~~~~~ 346 (608)
.++|++.+.||+|+| |||.++.. .....+.|.+|+.+|++++|||||++++++.+.+..
T Consensus 9 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~ 88 (293)
T d1jksa_ 9 DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDV 88 (293)
T ss_dssp GGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred ccCEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEE
Confidence 467999999999985 77876532 122468899999999999999999999999999999
Q ss_pred eEEEeecCCCccchhccccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEEcCCC----cEEEeecc
Q 044312 347 LLVYEFIPNGTLFQYIHDQNEDFPITWEIRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKY----RAKVSDFG 422 (608)
Q Consensus 347 ~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~----~~kl~DFG 422 (608)
+|||||+++|+|.+++.... .+++..+..++.||+.||+|||+.+ |+||||||+|||++.++ .+||+|||
T Consensus 89 ~iv~E~~~gg~L~~~i~~~~---~l~~~~~~~~~~qi~~al~yLH~~~---ivHrDiKp~Nill~~~~~~~~~vkl~DfG 162 (293)
T d1jksa_ 89 ILILELVAGGELFDFLAEKE---SLTEEEATEFLKQILNGVYYLHSLQ---IAHFDLKPENIMLLDRNVPKPRIKIIDFG 162 (293)
T ss_dssp EEEEECCCSCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCSSSSSCCEEECCCT
T ss_pred EEEEEcCCCccccchhcccc---ccchhHHHHHHHHHHHHHHhhhhcc---eeecccccceEEEecCCCcccceEecchh
Confidence 99999999999999997654 5999999999999999999999999 99999999999998776 49999999
Q ss_pred CccccccCCcceeeeeeccCCCCChhhhccCCCCCccchHhHHHHHHHHHhCCCCCCccchhhcccHHHHHHHHhhhhhh
Q 044312 423 ASRSMAVDQTHMTTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLTELLTGEKPIRFTILEEDKSLAAYFLCAMKEERL 502 (608)
Q Consensus 423 ls~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~ 502 (608)
+++...... ......||+.|+|||++.+..++.++|||||||++|||++|+.||......+ .+. .+.....
T Consensus 163 ~a~~~~~~~--~~~~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~------~~~-~i~~~~~ 233 (293)
T d1jksa_ 163 LAHKIDFGN--EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQE------TLA-NVSAVNY 233 (293)
T ss_dssp TCEECTTSC--BCSCCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH------HHH-HHHTTCC
T ss_pred hhhhcCCCc--cccccCCCCcccCHHHHcCCCCCCcccchhhhHHHHHHHcCCCCCCCCCHHH------HHH-HHHhcCC
Confidence 998765332 2344568999999999999999999999999999999999999997432211 111 1111000
Q ss_pred HHHhhhhhhccCChhHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 044312 503 FEILDARVMKQGGKDEIITVAKLAKRCLNLNGKKRPTMREVASE 546 (608)
Q Consensus 503 ~~~~d~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~evl~~ 546 (608)
..........+.++.+|+.+||+.||++|||++|++++
T Consensus 234 ------~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~h 271 (293)
T d1jksa_ 234 ------EFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQH 271 (293)
T ss_dssp ------CCCHHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred ------CCCchhcCCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 00000112345678999999999999999999999753
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.8e-43 Score=361.80 Aligned_cols=251 Identities=24% Similarity=0.423 Sum_probs=204.4
Q ss_pred HHHHhcCccccceeccCce--------------------EEEEEee-cChhhHHHHHHHHHHHhhc-CCCCccceecccc
Q 044312 284 LEKATDNFDLNRILGQGGQ--------------------AVKKSKV-IDESKVEEFINEVVILSQI-NHRNVVKLLGCCL 341 (608)
Q Consensus 284 l~~~t~~f~~~~~lG~G~~--------------------avk~~~~-~~~~~~~~~~~Ei~il~~l-~H~niv~l~~~~~ 341 (608)
++...++|++.++||+|+| |||+++. .......+|.+|+.+++++ +|||||++++++.
T Consensus 18 ~~~~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~ 97 (311)
T d1t46a_ 18 WEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACT 97 (311)
T ss_dssp GBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred ccCCHHHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECcccCHHHHHHHHHHHHHHHhccCCCCEEEEEEEEe
Confidence 4444578899999999984 6666654 3344567899999999999 7999999999999
Q ss_pred cCccceEEEeecCCCccchhccccCC---------------CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCC
Q 044312 342 ETEVPLLVYEFIPNGTLFQYIHDQNE---------------DFPITWEIRLRIAIEVSGALSYLHSAASIPIYHRDIKST 406 (608)
Q Consensus 342 ~~~~~~lV~E~~~~gsL~~~l~~~~~---------------~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~ 406 (608)
+....+|||||+++|+|.++++.... ...+++..+++++.|||+||+|||+++ ++||||||+
T Consensus 98 ~~~~~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~~---ivHrDLKp~ 174 (311)
T d1t46a_ 98 IGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKN---CIHRDLAAR 174 (311)
T ss_dssp SSSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGG
T ss_pred eCCEEEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccccc
Confidence 99999999999999999999976431 225899999999999999999999999 999999999
Q ss_pred cEEEcCCCcEEEeeccCccccccCCc-ceeeeeeccCCCCChhhhccCCCCCccchHhHHHHHHHHHhCC-CCCCccchh
Q 044312 407 NILLDDKYRAKVSDFGASRSMAVDQT-HMTTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLTELLTGE-KPIRFTILE 484 (608)
Q Consensus 407 NILl~~~~~~kl~DFGls~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~elltg~-~p~~~~~~~ 484 (608)
|||++.++.+||+|||+++....... .......||+.|+|||++....++.++||||||+++|||+|+. +|+......
T Consensus 175 NIl~~~~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwS~G~~l~ellt~g~p~~~~~~~~ 254 (311)
T d1t46a_ 175 NILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVD 254 (311)
T ss_dssp GEEEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSS
T ss_pred cccccccCcccccccchheeccCCCcceEeeecccChHHcCHHHhcCCCCCCcccccchHHHHHHHHhCCCCCCCCCCHH
Confidence 99999999999999999998764433 3334567899999999999999999999999999999999954 444321111
Q ss_pred hcccHHHHHHHHhhhhhhHHHhhhhhhccCChhHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhhHH
Q 044312 485 EDKSLAAYFLCAMKEERLFEILDARVMKQGGKDEIITVAKLAKRCLNLNGKKRPTMREVASELAGIKA 552 (608)
Q Consensus 485 ~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~evl~~L~~i~~ 552 (608)
..+.+++....+...+...+.++.+|+.+||+.||++||||.||+++|+++..
T Consensus 255 ---------------~~~~~~i~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~~il~~L~~~i~ 307 (311)
T d1t46a_ 255 ---------------SKFYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQIS 307 (311)
T ss_dssp ---------------HHHHHHHHHTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred ---------------HHHHHHHhcCCCCCCcccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhhc
Confidence 11223333444444555667889999999999999999999999999987644
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.8e-43 Score=363.90 Aligned_cols=234 Identities=26% Similarity=0.345 Sum_probs=195.3
Q ss_pred cCccccceeccCce---------------EEEEEee---cChhhHHHHHHHHHHHhhcCCCCccceecccccCccceEEE
Q 044312 289 DNFDLNRILGQGGQ---------------AVKKSKV---IDESKVEEFINEVVILSQINHRNVVKLLGCCLETEVPLLVY 350 (608)
Q Consensus 289 ~~f~~~~~lG~G~~---------------avk~~~~---~~~~~~~~~~~Ei~il~~l~H~niv~l~~~~~~~~~~~lV~ 350 (608)
++|++.+.||+|+| |||+++. .+....+.+.+|+.+|++++|||||++++++.+.+..++||
T Consensus 5 ~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~iv~ 84 (337)
T d1o6la_ 5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVM 84 (337)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEEE
T ss_pred HhcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeeccccccccce
Confidence 56999999999985 7777653 23445688999999999999999999999999999999999
Q ss_pred eecCCCccchhccccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEEcCCCcEEEeeccCccccccC
Q 044312 351 EFIPNGTLFQYIHDQNEDFPITWEIRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVD 430 (608)
Q Consensus 351 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGls~~~~~~ 430 (608)
||+++|+|.+++.... .+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+|+.....
T Consensus 85 ey~~gg~L~~~~~~~~---~~~e~~~~~~~~qil~al~ylH~~~---iiHRDlKP~NILl~~~g~vkl~DFG~a~~~~~~ 158 (337)
T d1o6la_ 85 EYANGGELFFHLSRER---VFTEERARFYGAEIVSALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCKEGISD 158 (337)
T ss_dssp ECCTTCBHHHHHHHHS---CCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCSCCT
T ss_pred eccCCCchhhhhhccc---CCcHHHHHHHHHHHhhhhhhhhhcC---ccccccCHHHeEecCCCCEEEeecccccccccC
Confidence 9999999999988754 4899999999999999999999999 999999999999999999999999999876533
Q ss_pred CcceeeeeeccCCCCChhhhccCCCCCccchHhHHHHHHHHHhCCCCCCccchhhcccHHHHHHHHhhhhhhHHHhhhhh
Q 044312 431 QTHMTTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLTELLTGEKPIRFTILEEDKSLAAYFLCAMKEERLFEILDARV 510 (608)
Q Consensus 431 ~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~ 510 (608)
. .......||+.|+|||++.+..++.++|||||||++|||++|+.||...... ..+. . +...
T Consensus 159 ~-~~~~~~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~G~~pf~~~~~~------~~~~-~--------i~~~-- 220 (337)
T d1o6la_ 159 G-ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE------RLFE-L--------ILME-- 220 (337)
T ss_dssp T-CCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHH------HHHH-H--------HHHC--
T ss_pred C-cccccceeCHHHhhhhhccCCCCChhhcccchhhHHHHHHHCCCCCCCcCHH------HHHH-H--------HhcC--
Confidence 2 2344567999999999999999999999999999999999999999743221 1111 1 1111
Q ss_pred hccCChhHHHHHHHHHHHHhccCCCCCCC-----HHHHHHH
Q 044312 511 MKQGGKDEIITVAKLAKRCLNLNGKKRPT-----MREVASE 546 (608)
Q Consensus 511 ~~~~~~~~~~~l~~Li~~cl~~dp~~RPs-----~~evl~~ 546 (608)
....+...+.++.+|+.+||+.||++||+ +.|++++
T Consensus 221 ~~~~p~~~s~~~~dli~~~L~~dP~~R~~~~~~~~~eil~H 261 (337)
T d1o6la_ 221 EIRFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEH 261 (337)
T ss_dssp CCCCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTS
T ss_pred CCCCCccCCHHHHHHHHhhccCCchhhcccccccHHHHHcC
Confidence 12334456678999999999999999995 7777764
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=100.00 E-value=5.5e-43 Score=353.70 Aligned_cols=245 Identities=29% Similarity=0.431 Sum_probs=191.2
Q ss_pred hcCccccceeccCce---------------EEEEEee---cChhhHHHHHHHHHHHhhcCCCCccceecccccCc----c
Q 044312 288 TDNFDLNRILGQGGQ---------------AVKKSKV---IDESKVEEFINEVVILSQINHRNVVKLLGCCLETE----V 345 (608)
Q Consensus 288 t~~f~~~~~lG~G~~---------------avk~~~~---~~~~~~~~~~~Ei~il~~l~H~niv~l~~~~~~~~----~ 345 (608)
.++|++.+.||+|+| |||.++. .+....+.|.+|+++|++++|||||++++++...+ .
T Consensus 6 ~drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~~~ 85 (277)
T d1o6ya_ 6 SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPL 85 (277)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSSEE
T ss_pred cceeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeeccCCCce
Confidence 467999999999984 7888754 23445678999999999999999999999987654 3
Q ss_pred ceEEEeecCCCccchhccccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEEcCCCcEEEeeccCcc
Q 044312 346 PLLVYEFIPNGTLFQYIHDQNEDFPITWEIRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASR 425 (608)
Q Consensus 346 ~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGls~ 425 (608)
.+|||||+++++|.+++.... ++++..++.|+.||+.||+|||+++ |+||||||+|||++.++..+|+|||.++
T Consensus 86 ~~lvmE~~~g~~L~~~~~~~~---~l~~~~~~~i~~qi~~al~~lH~~~---iiHrDiKP~NIll~~~~~~~l~d~~~~~ 159 (277)
T d1o6ya_ 86 PYIVMEYVDGVTLRDIVHTEG---PMTPKRAIEVIADACQALNFSHQNG---IIHRDVKPANIMISATNAVKVMDFGIAR 159 (277)
T ss_dssp EEEEEECCCEEEHHHHHHHHC---SCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTSCEEECCCTTCE
T ss_pred EEEEEECCCCCEehhhhcccC---CCCHHHHHHHHHHHHHHHHHHHhCC---ccCccccCcccccCccccceeehhhhhh
Confidence 789999999999999887654 5999999999999999999999999 9999999999999999999999999987
Q ss_pred ccccCC--cceeeeeeccCCCCChhhhccCCCCCccchHhHHHHHHHHHhCCCCCCccchhhcccHHHHHHHHhhhhhhH
Q 044312 426 SMAVDQ--THMTTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLTELLTGEKPIRFTILEEDKSLAAYFLCAMKEERLF 503 (608)
Q Consensus 426 ~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~ 503 (608)
...... ........||+.|||||++.+..++.++|||||||++|||+||+.||...... ..+...+.....
T Consensus 160 ~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~------~~~~~~~~~~~~- 232 (277)
T d1o6ya_ 160 AIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPV------SVAYQHVREDPI- 232 (277)
T ss_dssp ECC----------------TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHH------HHHHHHHHCCCC-
T ss_pred hhccccccccccccccCcccccCHHHHcCCCCCcceecccchHHHHHHHhCCCCCCCcCHH------HHHHHHHhcCCC-
Confidence 654322 22334567999999999999999999999999999999999999999733211 111111111111
Q ss_pred HHhhhhhhccCChhHHHHHHHHHHHHhccCCCCCC-CHHHHHHHHHhhH
Q 044312 504 EILDARVMKQGGKDEIITVAKLAKRCLNLNGKKRP-TMREVASELAGIK 551 (608)
Q Consensus 504 ~~~d~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RP-s~~evl~~L~~i~ 551 (608)
.........+.++.+|+.+||+.||++|| |++|+++.|.+++
T Consensus 233 ------~~~~~~~~~s~~l~~li~~~L~~dp~~R~~sa~~l~~~l~r~~ 275 (277)
T d1o6ya_ 233 ------PPSARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRVH 275 (277)
T ss_dssp ------CGGGTSSSCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHH
T ss_pred ------CCchhccCCCHHHHHHHHHHccCCHhHCHhHHHHHHHHHHHHh
Confidence 11122234567899999999999999999 8999999988765
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2e-43 Score=362.32 Aligned_cols=250 Identities=26% Similarity=0.399 Sum_probs=200.8
Q ss_pred HHHHHHhcCccccceeccCce--------------------EEEEEee-cChhhHHHHHHHHHHHhhcCCCCccceeccc
Q 044312 282 KELEKATDNFDLNRILGQGGQ--------------------AVKKSKV-IDESKVEEFINEVVILSQINHRNVVKLLGCC 340 (608)
Q Consensus 282 ~~l~~~t~~f~~~~~lG~G~~--------------------avk~~~~-~~~~~~~~~~~Ei~il~~l~H~niv~l~~~~ 340 (608)
++++...++|.+.++||+|+| |||+++. ........|.+|+.++++++|||||++++++
T Consensus 13 ~~~ei~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~ 92 (308)
T d1p4oa_ 13 DEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVV 92 (308)
T ss_dssp CTTBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEE
T ss_pred cceeecHHHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECcccChHHHHHHHHHHHHHHHcCCCCEeeeeeEE
Confidence 345555678899999999984 5666543 2334456799999999999999999999999
Q ss_pred ccCccceEEEeecCCCccchhccccC-------CCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEEcCC
Q 044312 341 LETEVPLLVYEFIPNGTLFQYIHDQN-------EDFPITWEIRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDK 413 (608)
Q Consensus 341 ~~~~~~~lV~E~~~~gsL~~~l~~~~-------~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~ 413 (608)
...+..++||||+++|+|.+++.... ....+++..+++++.|+|+||.|||+++ |+||||||+|||++++
T Consensus 93 ~~~~~~~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~~---ivHrDlk~~NiLld~~ 169 (308)
T d1p4oa_ 93 SQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANK---FVHRDLAARNCMVAED 169 (308)
T ss_dssp CSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCSGGGEEECTT
T ss_pred ecCCceeEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhCC---eeeceEcCCceeecCC
Confidence 99999999999999999999987532 1234799999999999999999999998 9999999999999999
Q ss_pred CcEEEeeccCccccccCCcce-eeeeeccCCCCChhhhccCCCCCccchHhHHHHHHHHHhCC-CCCCccchhhcccHHH
Q 044312 414 YRAKVSDFGASRSMAVDQTHM-TTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLTELLTGE-KPIRFTILEEDKSLAA 491 (608)
Q Consensus 414 ~~~kl~DFGls~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~elltg~-~p~~~~~~~~~~~l~~ 491 (608)
+++||+|||+++......... .....||+.|+|||.+.+..++.++||||||+++|||+||. .||...... .
T Consensus 170 ~~~Kl~DFGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~G~il~El~t~~~~p~~~~~~~------~ 243 (308)
T d1p4oa_ 170 FTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNE------Q 243 (308)
T ss_dssp CCEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHH------H
T ss_pred ceEEEeecccceeccCCcceeeccceecccccCCHHHHccCCCCcccccccHHHHHHHHHhCCCCCCCCCCHH------H
Confidence 999999999998775433322 23446899999999999999999999999999999999985 666422111 1
Q ss_pred HHHHHhhhhhhHHHhhhhhhccCChhHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhh
Q 044312 492 YFLCAMKEERLFEILDARVMKQGGKDEIITVAKLAKRCLNLNGKKRPTMREVASELAGI 550 (608)
Q Consensus 492 ~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~evl~~L~~i 550 (608)
. .+.+........+...+..+.+|+.+||+.+|++||||.||+++|+..
T Consensus 244 ~----------~~~i~~~~~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~~il~~L~~~ 292 (308)
T d1p4oa_ 244 V----------LRFVMEGGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEE 292 (308)
T ss_dssp H----------HHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGG
T ss_pred H----------HHHHHhCCCCCCcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHh
Confidence 1 111111122333455667899999999999999999999999988665
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=2e-42 Score=355.84 Aligned_cols=231 Identities=27% Similarity=0.399 Sum_probs=192.8
Q ss_pred cCccccceeccCce---------------EEEEEee---cChhhHHHHHHHHHHHhhcCCCCccceecccccCccceEEE
Q 044312 289 DNFDLNRILGQGGQ---------------AVKKSKV---IDESKVEEFINEVVILSQINHRNVVKLLGCCLETEVPLLVY 350 (608)
Q Consensus 289 ~~f~~~~~lG~G~~---------------avk~~~~---~~~~~~~~~~~Ei~il~~l~H~niv~l~~~~~~~~~~~lV~ 350 (608)
++|++.+.||+|+| |||+++. .+....+.+.+|+.+|++++|||||++++++.+.+..++||
T Consensus 4 ~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivm 83 (316)
T d1fota_ 4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIM 83 (316)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEE
T ss_pred hHeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEeeCCeeeeEe
Confidence 46899999999984 7887753 23345678999999999999999999999999999999999
Q ss_pred eecCCCccchhccccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEEcCCCcEEEeeccCccccccC
Q 044312 351 EFIPNGTLFQYIHDQNEDFPITWEIRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVD 430 (608)
Q Consensus 351 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGls~~~~~~ 430 (608)
||+++|+|..++.... .+++..+..++.||+.||+|||+++ |+||||||+||||+.++.+||+|||+|+.....
T Consensus 84 E~~~gg~l~~~~~~~~---~~~~~~~~~~~~qi~~al~~lH~~~---iiHrDiKp~NILl~~~g~vkL~DFG~a~~~~~~ 157 (316)
T d1fota_ 84 DYIEGGELFSLLRKSQ---RFPNPVAKFYAAEVCLALEYLHSKD---IIYRDLKPENILLDKNGHIKITDFGFAKYVPDV 157 (316)
T ss_dssp CCCCSCBHHHHHHHTS---SCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECTTSCEEECCCSSCEECSSC
T ss_pred eecCCccccccccccc---cccccHHHHHHHHHHHhhhhhccCc---EEccccCchheeEcCCCCEEEecCccceEeccc
Confidence 9999999999887654 4889999999999999999999999 999999999999999999999999999876532
Q ss_pred CcceeeeeeccCCCCChhhhccCCCCCccchHhHHHHHHHHHhCCCCCCccchhhcccHHHHHHHHhhhhhhHHHhhhhh
Q 044312 431 QTHMTTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLTELLTGEKPIRFTILEEDKSLAAYFLCAMKEERLFEILDARV 510 (608)
Q Consensus 431 ~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~ 510 (608)
.....||+.|||||++.+..++.++|||||||+||||+||+.||...... ... ..++...
T Consensus 158 ----~~~~~Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~------~~~---------~~i~~~~- 217 (316)
T d1fota_ 158 ----TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTM------KTY---------EKILNAE- 217 (316)
T ss_dssp ----BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHH------HHH---------HHHHHCC-
T ss_pred ----cccccCcccccCHHHHcCCCCCchhhccccchhHHHHHhCCCCCCCcCHH------HHH---------HHHHcCC-
Confidence 23467999999999999999999999999999999999999999742211 111 1111111
Q ss_pred hccCChhHHHHHHHHHHHHhccCCCCCC-----CHHHHHHH
Q 044312 511 MKQGGKDEIITVAKLAKRCLNLNGKKRP-----TMREVASE 546 (608)
Q Consensus 511 ~~~~~~~~~~~l~~Li~~cl~~dp~~RP-----s~~evl~~ 546 (608)
...+...+.++.+++.+||..||.+|| |++|++++
T Consensus 218 -~~~p~~~s~~~~~li~~~L~~dp~~R~~~~r~t~~~il~H 257 (316)
T d1fota_ 218 -LRFPPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNH 257 (316)
T ss_dssp -CCCCTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHTS
T ss_pred -CCCCCCCCHHHHHHHHHHhhhCHHhccccchhhHHHHHcC
Confidence 123345567899999999999999996 88888764
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=100.00 E-value=2.6e-42 Score=348.29 Aligned_cols=235 Identities=29% Similarity=0.427 Sum_probs=191.8
Q ss_pred cCccccceeccCce---------------EEEEEeecCh---------hhHHHHHHHHHHHhhcC-CCCccceecccccC
Q 044312 289 DNFDLNRILGQGGQ---------------AVKKSKVIDE---------SKVEEFINEVVILSQIN-HRNVVKLLGCCLET 343 (608)
Q Consensus 289 ~~f~~~~~lG~G~~---------------avk~~~~~~~---------~~~~~~~~Ei~il~~l~-H~niv~l~~~~~~~ 343 (608)
++|++.+.||+|+| |||++..... ...+.+.+|+.+|++++ |||||++++++.+.
T Consensus 3 ~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~ 82 (277)
T d1phka_ 3 ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETN 82 (277)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEECS
T ss_pred ccCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeecccC
Confidence 57999999999984 7887754321 22356889999999996 99999999999999
Q ss_pred ccceEEEeecCCCccchhccccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEEcCCCcEEEeeccC
Q 044312 344 EVPLLVYEFIPNGTLFQYIHDQNEDFPITWEIRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGA 423 (608)
Q Consensus 344 ~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGl 423 (608)
+..+|||||+++|+|.++++... ++++..++.++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+
T Consensus 83 ~~~~ivmE~~~~g~L~~~l~~~~---~l~e~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~Nill~~~~~~kl~DFG~ 156 (277)
T d1phka_ 83 TFFFLVFDLMKKGELFDYLTEKV---TLSEKETRKIMRALLEVICALHKLN---IVHRDLKPENILLDDDMNIKLTDFGF 156 (277)
T ss_dssp SEEEEEEECCTTCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTT
T ss_pred cceEEEEEcCCCchHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHcC---CcccccccceEEEcCCCCeEEccchh
Confidence 99999999999999999997654 5999999999999999999999999 99999999999999999999999999
Q ss_pred ccccccCCcceeeeeeccCCCCChhhhcc------CCCCCccchHhHHHHHHHHHhCCCCCCccchhhcccHHHHHHHHh
Q 044312 424 SRSMAVDQTHMTTQVHGTFGYLDPEYFRS------SQFTDKSDVYSFGVVLTELLTGEKPIRFTILEEDKSLAAYFLCAM 497 (608)
Q Consensus 424 s~~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~t~ksDV~S~Gvvl~elltg~~p~~~~~~~~~~~l~~~~~~~~ 497 (608)
++...... ..+...||+.|+|||.+.. ..++.++||||+||+++||++|+.||....... ..
T Consensus 157 a~~~~~~~--~~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~~~------~~---- 224 (277)
T d1phka_ 157 SCQLDPGE--KLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQML------ML---- 224 (277)
T ss_dssp CEECCTTC--CBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH------HH----
T ss_pred eeEccCCC--ceeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCCHHH------HH----
Confidence 98765432 2345679999999999853 357889999999999999999999997432211 01
Q ss_pred hhhhhHHHhhhh--hhccCChhHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 044312 498 KEERLFEILDAR--VMKQGGKDEIITVAKLAKRCLNLNGKKRPTMREVASE 546 (608)
Q Consensus 498 ~~~~~~~~~d~~--~~~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~evl~~ 546 (608)
..++... .........++++.+|+.+||+.||++|||++||+++
T Consensus 225 -----~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~~p~~R~s~~eil~h 270 (277)
T d1phka_ 225 -----RMIMSGNYQFGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAH 270 (277)
T ss_dssp -----HHHHHTCCCCCTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTS
T ss_pred -----HHHHhCCCCCCCcccccCCHHHHHHHHHHccCChhHCcCHHHHHcC
Confidence 1111111 1111223566789999999999999999999998753
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.5e-43 Score=358.15 Aligned_cols=254 Identities=21% Similarity=0.294 Sum_probs=186.2
Q ss_pred cCccccceeccCce-------------EEEEEeecChhhHHHHHHHH--HHHhhcCCCCccceecccccCc----cceEE
Q 044312 289 DNFDLNRILGQGGQ-------------AVKKSKVIDESKVEEFINEV--VILSQINHRNVVKLLGCCLETE----VPLLV 349 (608)
Q Consensus 289 ~~f~~~~~lG~G~~-------------avk~~~~~~~~~~~~~~~Ei--~il~~l~H~niv~l~~~~~~~~----~~~lV 349 (608)
+.|.+.++||+|+| |||+++. ...+.+.+|. ..+.+++|||||++++++.+.+ ..+||
T Consensus 3 ~~~~l~~~iG~G~fg~Vy~~~~~g~~vAvK~~~~---~~~~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~~~lv 79 (303)
T d1vjya_ 3 RTIVLQESIGKGRFGEVWRGKWRGEEVAVKIFSS---REERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLV 79 (303)
T ss_dssp GGEEEEEEEECCSSSEEEEEEETTEEEEEEEECG---GGHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEE
T ss_pred cEEEEEEEEeeCCCeEEEEEEECCEEEEEEEECc---cchhHHHHHHHHHHHhhCCCCcCcceEEEEEeCCCcceEEEEE
Confidence 45677889999985 7776643 2334444444 4556789999999999997654 57899
Q ss_pred EeecCCCccchhccccCCCCCCCHHHHHHHHHHHHHHHHHHhhcC-----CCCeeccCCCCCcEEEcCCCcEEEeeccCc
Q 044312 350 YEFIPNGTLFQYIHDQNEDFPITWEIRLRIAIEVSGALSYLHSAA-----SIPIYHRDIKSTNILLDDKYRAKVSDFGAS 424 (608)
Q Consensus 350 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~-----~~~iiHrDlk~~NILl~~~~~~kl~DFGls 424 (608)
|||+++|+|.+++++. .++|..+++++.|+|.||+|||+.. ..+|+||||||+||||++++.+||+|||++
T Consensus 80 ~Ey~~~g~L~~~l~~~----~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~DFGl~ 155 (303)
T d1vjya_ 80 SDYHEHGSLFDYLNRY----TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLA 155 (303)
T ss_dssp EECCTTCBHHHHHHHC----CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCTTC
T ss_pred EecccCCCHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCeEEEecCcc
Confidence 9999999999999764 4899999999999999999999741 233999999999999999999999999999
Q ss_pred cccccCCcc---eeeeeeccCCCCChhhhccCC------CCCccchHhHHHHHHHHHhCCCCCCccchhhcc--------
Q 044312 425 RSMAVDQTH---MTTQVHGTFGYLDPEYFRSSQ------FTDKSDVYSFGVVLTELLTGEKPIRFTILEEDK-------- 487 (608)
Q Consensus 425 ~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~------~t~ksDV~S~Gvvl~elltg~~p~~~~~~~~~~-------- 487 (608)
+........ ......||+.|+|||++.... ++.|+|||||||+||||+||..|+.........
T Consensus 156 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~~~~~~~~~ 235 (303)
T d1vjya_ 156 VRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSD 235 (303)
T ss_dssp EEEETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSS
T ss_pred ccccCCCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCcccccccchhhccccc
Confidence 877543322 234567999999999987653 577999999999999999999887532211110
Q ss_pred cHHHHHHHHhhhhhhHHHhhhhhhcc-CChhHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhhHHh
Q 044312 488 SLAAYFLCAMKEERLFEILDARVMKQ-GGKDEIITVAKLAKRCLNLNGKKRPTMREVASELAGIKAW 553 (608)
Q Consensus 488 ~l~~~~~~~~~~~~~~~~~d~~~~~~-~~~~~~~~l~~Li~~cl~~dp~~RPs~~evl~~L~~i~~~ 553 (608)
............+ .+++..... ...+.+..+.+|+.+||+.||++|||+.||+++|+++...
T Consensus 236 ~~~~~~~~~~~~~----~~~p~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~~L~~i~~~ 298 (303)
T d1vjya_ 236 PSVEEMRKVVCEQ----KLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQ 298 (303)
T ss_dssp CCHHHHHHHHTTS----CCCCCCCGGGGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred chHHHHHHHHhcc----ccCCCCCcccCChHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHHh
Confidence 0001111111111 111111111 1234556799999999999999999999999999988764
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=9.9e-42 Score=355.39 Aligned_cols=231 Identities=23% Similarity=0.319 Sum_probs=192.9
Q ss_pred cCccccceeccCce---------------EEEEEee---cChhhHHHHHHHHHHHhhcCCCCccceecccccCccceEEE
Q 044312 289 DNFDLNRILGQGGQ---------------AVKKSKV---IDESKVEEFINEVVILSQINHRNVVKLLGCCLETEVPLLVY 350 (608)
Q Consensus 289 ~~f~~~~~lG~G~~---------------avk~~~~---~~~~~~~~~~~Ei~il~~l~H~niv~l~~~~~~~~~~~lV~ 350 (608)
++|++.+.||+|+| |||++.. .+....+.+.+|+.+|++++|||||++++++.+....++||
T Consensus 41 d~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~v~ 120 (350)
T d1rdqe_ 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVM 120 (350)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cCeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeeccccccccccccccc
Confidence 47999999999984 7787653 23345678999999999999999999999999999999999
Q ss_pred eecCCCccchhccccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEEcCCCcEEEeeccCccccccC
Q 044312 351 EFIPNGTLFQYIHDQNEDFPITWEIRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVD 430 (608)
Q Consensus 351 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGls~~~~~~ 430 (608)
||+.+|+|.+++.... .+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++.+...
T Consensus 121 e~~~~g~l~~~l~~~~---~l~e~~~~~i~~qi~~aL~yLH~~~---iiHRDIKP~NILl~~~g~ikL~DFG~a~~~~~~ 194 (350)
T d1rdqe_ 121 EYVAGGEMFSHLRRIG---RFSEPHARFYAAQIVLTFEYLHSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR 194 (350)
T ss_dssp ECCTTCBHHHHHHHHC---CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECSSC
T ss_pred ccccccchhhhHhhcC---CCCHHHHHHHHHHHHHHHHHHHhCC---EecCcCCHHHcccCCCCCEEeeeceeeeecccc
Confidence 9999999999997654 4999999999999999999999999 999999999999999999999999999876432
Q ss_pred CcceeeeeeccCCCCChhhhccCCCCCccchHhHHHHHHHHHhCCCCCCccchhhcccHHHHHHHHhhhhhhHHHhhhhh
Q 044312 431 QTHMTTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLTELLTGEKPIRFTILEEDKSLAAYFLCAMKEERLFEILDARV 510 (608)
Q Consensus 431 ~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~ 510 (608)
.....||+.|||||++.+..++.++|||||||+||||+||+.||..... ...+. .+...
T Consensus 195 ----~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~------~~~~~---------~i~~~-- 253 (350)
T d1rdqe_ 195 ----TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQP------IQIYE---------KIVSG-- 253 (350)
T ss_dssp ----BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH------HHHHH---------HHHHC--
T ss_pred ----cccccCccccCCHHHHcCCCCCccccccchhHHHHHHHhCCCCCCCcCH------HHHHH---------HHhcC--
Confidence 2346799999999999999999999999999999999999999963221 11111 11111
Q ss_pred hccCChhHHHHHHHHHHHHhccCCCCCC-----CHHHHHHH
Q 044312 511 MKQGGKDEIITVAKLAKRCLNLNGKKRP-----TMREVASE 546 (608)
Q Consensus 511 ~~~~~~~~~~~l~~Li~~cl~~dp~~RP-----s~~evl~~ 546 (608)
....+...+.++.+|+.+||+.||.+|+ |++|++++
T Consensus 254 ~~~~p~~~s~~~~~li~~~L~~dP~kR~~~~r~t~~ell~H 294 (350)
T d1rdqe_ 254 KVRFPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNH 294 (350)
T ss_dssp CCCCCTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHTS
T ss_pred CCCCCccCCHHHHHHHHHHhhhCHHhccccccccHHHHHcC
Confidence 1123345667899999999999999994 88888753
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.9e-42 Score=353.44 Aligned_cols=233 Identities=26% Similarity=0.368 Sum_probs=191.6
Q ss_pred cCccccceeccCce---------------EEEEEee---cChhhHHHHHHHHHHHh-hcCCCCccceecccccCccceEE
Q 044312 289 DNFDLNRILGQGGQ---------------AVKKSKV---IDESKVEEFINEVVILS-QINHRNVVKLLGCCLETEVPLLV 349 (608)
Q Consensus 289 ~~f~~~~~lG~G~~---------------avk~~~~---~~~~~~~~~~~Ei~il~-~l~H~niv~l~~~~~~~~~~~lV 349 (608)
++|++.+.||+|+| |||+++. ......+.+.+|..++. .++|||||++++++.+.+..|||
T Consensus 2 ddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~yiv 81 (320)
T d1xjda_ 2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFV 81 (320)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEE
T ss_pred CCeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccCCceeEE
Confidence 57999999999984 7887753 23345667788888765 68999999999999999999999
Q ss_pred EeecCCCccchhccccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEEcCCCcEEEeeccCcccccc
Q 044312 350 YEFIPNGTLFQYIHDQNEDFPITWEIRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAV 429 (608)
Q Consensus 350 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGls~~~~~ 429 (608)
|||+++|+|.+++.... .+++..+..++.||+.||+|||+++ |+||||||+|||+++++.+||+|||+++....
T Consensus 82 mEy~~~g~L~~~i~~~~---~~~e~~~~~~~~qi~~al~ylH~~~---iiHrDikp~NiL~~~~~~~kl~DFG~a~~~~~ 155 (320)
T d1xjda_ 82 MEYLNGGDLMYHIQSCH---KFDLSRATFYAAEIILGLQFLHSKG---IVYRDLKLDNILLDKDGHIKIADFGMCKENML 155 (320)
T ss_dssp EECCTTCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCCCC
T ss_pred EeecCCCcHHHHhhccC---CCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCcccceeecCCCceeccccchhhhccc
Confidence 99999999999998654 4899999999999999999999999 99999999999999999999999999987654
Q ss_pred CCcceeeeeeccCCCCChhhhccCCCCCccchHhHHHHHHHHHhCCCCCCccchhhcccHHHHHHHHhhhhhhHHHhhhh
Q 044312 430 DQTHMTTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLTELLTGEKPIRFTILEEDKSLAAYFLCAMKEERLFEILDAR 509 (608)
Q Consensus 430 ~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 509 (608)
.. ...+...||+.|+|||++.+..++.++|||||||++|||+||+.||....... ....+...
T Consensus 156 ~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~PF~~~~~~~-------~~~~i~~~--------- 218 (320)
T d1xjda_ 156 GD-AKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEE-------LFHSIRMD--------- 218 (320)
T ss_dssp TT-CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH-------HHHHHHHC---------
T ss_pred cc-ccccccCCCCCcCCHHHHcCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCHHH-------HHHHHHcC---------
Confidence 33 23345679999999999999999999999999999999999999997432211 11111111
Q ss_pred hhccCChhHHHHHHHHHHHHhccCCCCCCCHH-HHHH
Q 044312 510 VMKQGGKDEIITVAKLAKRCLNLNGKKRPTMR-EVAS 545 (608)
Q Consensus 510 ~~~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~-evl~ 545 (608)
....+...+.++.+|+.+||+.||++||++. |+++
T Consensus 219 -~~~~p~~~s~~~~dli~~~L~~dP~~R~s~~~~l~~ 254 (320)
T d1xjda_ 219 -NPFYPRWLEKEAKDLLVKLFVREPEKRLGVRGDIRQ 254 (320)
T ss_dssp -CCCCCTTSCHHHHHHHHHHSCSSGGGSBTTBSCGGG
T ss_pred -CCCCCccCCHHHHHHHHHhcccCCCCCcCHHHHHHh
Confidence 1123345567899999999999999999995 6754
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=9.8e-42 Score=357.30 Aligned_cols=235 Identities=21% Similarity=0.291 Sum_probs=186.3
Q ss_pred cCccccceeccCce---------------EEEEEee---cChhhHHHHHH---HHHHHhhcCCCCccceecccccCccce
Q 044312 289 DNFDLNRILGQGGQ---------------AVKKSKV---IDESKVEEFIN---EVVILSQINHRNVVKLLGCCLETEVPL 347 (608)
Q Consensus 289 ~~f~~~~~lG~G~~---------------avk~~~~---~~~~~~~~~~~---Ei~il~~l~H~niv~l~~~~~~~~~~~ 347 (608)
++|++.+.||+|+| |||++.. ........+.+ |+.+++.++|||||++++++.+.+..+
T Consensus 4 ddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~~~~ 83 (364)
T d1omwa3 4 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLS 83 (364)
T ss_dssp TTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEEE
T ss_pred HhCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEECCEEE
Confidence 57999999999985 7777642 11222233444 467778889999999999999999999
Q ss_pred EEEeecCCCccchhccccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEEcCCCcEEEeeccCcccc
Q 044312 348 LVYEFIPNGTLFQYIHDQNEDFPITWEIRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSM 427 (608)
Q Consensus 348 lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGls~~~ 427 (608)
|||||+++|+|.+++.... .+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+|+.+
T Consensus 84 ivmE~~~gg~L~~~l~~~~---~~~e~~~~~~~~qi~~aL~ylH~~~---iiHrDlKP~NILl~~~g~iKl~DFGla~~~ 157 (364)
T d1omwa3 84 FILDLMNGGDLHYHLSQHG---VFSEADMRFYAAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDF 157 (364)
T ss_dssp EEECCCCSCBHHHHHHHHC---SCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECSSSCEEECCCTTCEEC
T ss_pred EEEEecCCCcHHHHHHhcc---cccHHHHHHHHHHHHHHHHHHHHCC---ccceeeccceeEEcCCCcEEEeeeceeeec
Confidence 9999999999999998654 4899999999999999999999999 999999999999999999999999999876
Q ss_pred ccCCcceeeeeeccCCCCChhhhcc-CCCCCccchHhHHHHHHHHHhCCCCCCccchhhcccHHHHHHHHhhhhhhHHHh
Q 044312 428 AVDQTHMTTQVHGTFGYLDPEYFRS-SQFTDKSDVYSFGVVLTELLTGEKPIRFTILEEDKSLAAYFLCAMKEERLFEIL 506 (608)
Q Consensus 428 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~t~ksDV~S~Gvvl~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 506 (608)
.... .....||+.|+|||++.. ..++.++|||||||+||||+||+.||........ .. ..... .
T Consensus 158 ~~~~---~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~---~~-~~~~~--------~ 222 (364)
T d1omwa3 158 SKKK---PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDK---HE-IDRMT--------L 222 (364)
T ss_dssp SSSC---CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSCH---HH-HHHHS--------S
T ss_pred CCCc---ccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCHHHH---HH-HHHhc--------c
Confidence 5432 234579999999999975 5689999999999999999999999974322211 10 00000 0
Q ss_pred hhhhhccCChhHHHHHHHHHHHHhccCCCCCCC-----HHHHHHH
Q 044312 507 DARVMKQGGKDEIITVAKLAKRCLNLNGKKRPT-----MREVASE 546 (608)
Q Consensus 507 d~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPs-----~~evl~~ 546 (608)
......+...+.++.+|+.+||+.||++||| ++|++++
T Consensus 223 --~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~~~a~eil~H 265 (364)
T d1omwa3 223 --TMAVELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKES 265 (364)
T ss_dssp --SCCCCCCSSSCHHHHHHHHHHTCSSTTTSTTTSSSTHHHHHTS
T ss_pred --cCCCCCCCCCCHHHHHHHHHHcccCHHHhCCCcccCHHHHHcC
Confidence 0111223455678999999999999999999 5777754
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-41 Score=349.91 Aligned_cols=238 Identities=24% Similarity=0.315 Sum_probs=192.2
Q ss_pred hcCccccceeccCce---------------EEEEEeecChhhHHHHHHHHHHHhhcCCCCccceecccccCccceEEEee
Q 044312 288 TDNFDLNRILGQGGQ---------------AVKKSKVIDESKVEEFINEVVILSQINHRNVVKLLGCCLETEVPLLVYEF 352 (608)
Q Consensus 288 t~~f~~~~~lG~G~~---------------avk~~~~~~~~~~~~~~~Ei~il~~l~H~niv~l~~~~~~~~~~~lV~E~ 352 (608)
.++|++.+.||+|+| |||.++.. ......+.+|+++|++++|||||++++++.+.+..||||||
T Consensus 4 ~~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~-~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~lvmE~ 82 (321)
T d1tkia_ 4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVK-GTDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEF 82 (321)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCC-THHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECC
T ss_pred ccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCC-cccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEec
Confidence 467999999999985 77776643 33446788999999999999999999999999999999999
Q ss_pred cCCCccchhccccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEEcC--CCcEEEeeccCccccccC
Q 044312 353 IPNGTLFQYIHDQNEDFPITWEIRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDD--KYRAKVSDFGASRSMAVD 430 (608)
Q Consensus 353 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~--~~~~kl~DFGls~~~~~~ 430 (608)
+++|+|.+++..... ++++..+..|+.||+.||+|||+++ |+||||||+|||++. ...+||+|||+++.....
T Consensus 83 ~~gg~L~~~i~~~~~--~l~e~~~~~i~~qi~~al~yLH~~~---iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~~~~ 157 (321)
T d1tkia_ 83 ISGLDIFERINTSAF--ELNEREIVSYVHQVCEALQFLHSHN---IGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPG 157 (321)
T ss_dssp CCCCBHHHHHTSSSC--CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSCCCEEECCCTTCEECCTT
T ss_pred CCCCcHHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHHcC---CCcccccccceeecCCCceEEEEcccchhhccccC
Confidence 999999999976532 5899999999999999999999999 999999999999984 458999999999876433
Q ss_pred CcceeeeeeccCCCCChhhhccCCCCCccchHhHHHHHHHHHhCCCCCCccchhhcccHHHHHHHHhhhhhhHHHhhhhh
Q 044312 431 QTHMTTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLTELLTGEKPIRFTILEEDKSLAAYFLCAMKEERLFEILDARV 510 (608)
Q Consensus 431 ~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~ 510 (608)
. ......+|+.|+|||.+.+..++.++|||||||++|||++|+.||...... ..+......... ++
T Consensus 158 ~--~~~~~~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll~G~~Pf~~~~~~------~~~~~i~~~~~~---~~--- 223 (321)
T d1tkia_ 158 D--NFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQ------QIIENIMNAEYT---FD--- 223 (321)
T ss_dssp C--EEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHH------HHHHHHHHTCCC---CC---
T ss_pred C--cccccccccccccchhccCCCCCchhhcccHHHHHHHHHhCCCCCCCCCHH------HHHHHHHhCCCC---CC---
Confidence 2 334567899999999999999999999999999999999999999743221 111111111000 00
Q ss_pred hccCChhHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 044312 511 MKQGGKDEIITVAKLAKRCLNLNGKKRPTMREVASE 546 (608)
Q Consensus 511 ~~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~evl~~ 546 (608)
.......+.++.+|+.+||..||++|||+.|++++
T Consensus 224 -~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~h 258 (321)
T d1tkia_ 224 -EEAFKEISIEAMDFVDRLLVKERKSRMTASEALQH 258 (321)
T ss_dssp -HHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred -hhhccCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 00011345678999999999999999999999875
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-41 Score=347.45 Aligned_cols=243 Identities=22% Similarity=0.237 Sum_probs=179.1
Q ss_pred cceeccCce---------------EEEEEeecChhh-----HHHHHHHHHHHhhcCCCCccceecccccCccceEEEeec
Q 044312 294 NRILGQGGQ---------------AVKKSKVIDESK-----VEEFINEVVILSQINHRNVVKLLGCCLETEVPLLVYEFI 353 (608)
Q Consensus 294 ~~~lG~G~~---------------avk~~~~~~~~~-----~~~~~~Ei~il~~l~H~niv~l~~~~~~~~~~~lV~E~~ 353 (608)
.++||+|+| |||+++...... .+.+.+|+.+|++++|||||++++++.+.+..+|||||+
T Consensus 3 l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~~ivmE~~ 82 (299)
T d1ua2a_ 3 LDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDFM 82 (299)
T ss_dssp EEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEECC
T ss_pred ceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccCCceeehhhhh
Confidence 467888874 788765432221 346899999999999999999999999999999999999
Q ss_pred CCCccchhccccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEEcCCCcEEEeeccCccccccCCcc
Q 044312 354 PNGTLFQYIHDQNEDFPITWEIRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTH 433 (608)
Q Consensus 354 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGls~~~~~~~~~ 433 (608)
.++++..++.... .+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++.......
T Consensus 83 ~~~~~~~~~~~~~---~l~~~~~~~~~~qil~aL~~lH~~~---iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~~~~- 155 (299)
T d1ua2a_ 83 ETDLEVIIKDNSL---VLTPSHIKAYMLMTLQGLEYLHQHW---ILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNR- 155 (299)
T ss_dssp SEEHHHHHTTCCS---SCCSSHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCCC-
T ss_pred cchHHhhhhhccc---CCCHHHHHHHHHHHHHHHHHhhccc---eecccCCcceEEecCCCccccccCccccccCCCcc-
Confidence 8887766654332 5889999999999999999999999 99999999999999999999999999987654332
Q ss_pred eeeeeeccCCCCChhhhccC-CCCCccchHhHHHHHHHHHhCCCCCCccchhhcccHHHHHHHHhhh---hhhHHHhhh-
Q 044312 434 MTTQVHGTFGYLDPEYFRSS-QFTDKSDVYSFGVVLTELLTGEKPIRFTILEEDKSLAAYFLCAMKE---ERLFEILDA- 508 (608)
Q Consensus 434 ~~~~~~gt~~y~aPE~~~~~-~~t~ksDV~S~Gvvl~elltg~~p~~~~~~~~~~~l~~~~~~~~~~---~~~~~~~d~- 508 (608)
......||+.|+|||++... .++.++|||||||+++||+||+.||......+. + ......... .........
T Consensus 156 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~--l-~~i~~~~~~~~~~~~~~~~~~~ 232 (299)
T d1ua2a_ 156 AYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQ--L-TRIFETLGTPTEEQWPDMCSLP 232 (299)
T ss_dssp CCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHH--H-HHHHHHHCCCCTTTSSSTTSST
T ss_pred cccceecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCCCHHHH--H-HHHHHhcCCCChhhccchhccc
Confidence 22345689999999998755 579999999999999999999999874332211 1 111111100 000000000
Q ss_pred --hhh--------ccCChhHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 044312 509 --RVM--------KQGGKDEIITVAKLAKRCLNLNGKKRPTMREVASE 546 (608)
Q Consensus 509 --~~~--------~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~evl~~ 546 (608)
... .......+.++.+|+.+||+.||++|||++|++++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~H 280 (299)
T d1ua2a_ 233 DYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKM 280 (299)
T ss_dssp TCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTS
T ss_pred hhhhhccCCCCChHHhcccCCHHHHHHHHHHccCChhhCcCHHHHhCC
Confidence 000 00011235679999999999999999999999753
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-41 Score=351.71 Aligned_cols=239 Identities=23% Similarity=0.308 Sum_probs=184.4
Q ss_pred hcCccccc-eeccCce---------------EEEEEeecChhhHHHHHHHHHHHhhc-CCCCccceeccccc----Cccc
Q 044312 288 TDNFDLNR-ILGQGGQ---------------AVKKSKVIDESKVEEFINEVVILSQI-NHRNVVKLLGCCLE----TEVP 346 (608)
Q Consensus 288 t~~f~~~~-~lG~G~~---------------avk~~~~~~~~~~~~~~~Ei~il~~l-~H~niv~l~~~~~~----~~~~ 346 (608)
.++|.+.. .||+|+| |||+++. .+.+.+|+.++.++ +|||||++++++.+ ....
T Consensus 10 ~~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~-----~~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~~~~~ 84 (335)
T d2ozaa1 10 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD-----CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCL 84 (335)
T ss_dssp GGTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEC-----SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEE
T ss_pred ccCEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECC-----cHHHHHHHHHHHHhcCCCCCCeEEEEEeecccCCCEE
Confidence 35788765 5999985 7777642 35678899987655 89999999999864 4678
Q ss_pred eEEEeecCCCccchhccccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEEcC---CCcEEEeeccC
Q 044312 347 LLVYEFIPNGTLFQYIHDQNEDFPITWEIRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDD---KYRAKVSDFGA 423 (608)
Q Consensus 347 ~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~---~~~~kl~DFGl 423 (608)
+|||||+++|+|.++|..... ..+++..+..|+.||+.||+|||+.+ |+||||||+|||+++ .+.+||+|||+
T Consensus 85 ~ivmEy~~gg~L~~~i~~~~~-~~l~e~~~~~i~~qi~~al~ylH~~~---iiHRDiKp~NIll~~~~~~~~~Kl~DFG~ 160 (335)
T d2ozaa1 85 LIVMECLDGGELFSRIQDRGD-QAFTEREASEIMKSIGEAIQYLHSIN---IAHRDVKPENLLYTSKRPNAILKLTDFGF 160 (335)
T ss_dssp EEEEECCCSEEHHHHHHSCSC-CCEEHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCSSTTCCEEECCCTT
T ss_pred EEEEECCCCCcHHHHHHhcCC-CCcCHHHHHHHHHHHHHHHHHHHHcC---Cccccccccccccccccccccccccccce
Confidence 999999999999999986433 25999999999999999999999999 999999999999985 56799999999
Q ss_pred ccccccCCcceeeeeeccCCCCChhhhccCCCCCccchHhHHHHHHHHHhCCCCCCccchhhcccHHHHHHHHhhhhhhH
Q 044312 424 SRSMAVDQTHMTTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLTELLTGEKPIRFTILEEDKSLAAYFLCAMKEERLF 503 (608)
Q Consensus 424 s~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~ 503 (608)
++...... ......||+.|||||++.+..++.++|||||||+||||+||+.||........ .............
T Consensus 161 a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~y~~~~DiwSlGvily~lltg~~Pf~~~~~~~~---~~~~~~~i~~~~~- 234 (335)
T d2ozaa1 161 AKETTSHN--SLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAI---SPGMKTRIRMGQY- 234 (335)
T ss_dssp CEECCCCC--CCCCCSCCCSSCCCCCCCGGGGSHHHHHHHHHHHHHHHTTSSCSCEETTCC-----------CCCSCSS-
T ss_pred eeeccCCC--ccccccCCcccCCcHHHcCCCCCHHHHHHhhchhHHHHhhCCCCCCCCCHHHH---HHHHHHHHhcCCC-
Confidence 98765433 23456799999999999999999999999999999999999999963221110 0000000000000
Q ss_pred HHhhhhhhccCChhHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 044312 504 EILDARVMKQGGKDEIITVAKLAKRCLNLNGKKRPTMREVASE 546 (608)
Q Consensus 504 ~~~d~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~evl~~ 546 (608)
..........+.++.+|+.+||+.||++|||+.|++++
T Consensus 235 -----~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~h 272 (335)
T d2ozaa1 235 -----EFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNH 272 (335)
T ss_dssp -----SCCTTHHHHSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred -----CCCCcccccCCHHHHHHHHHHccCChhHCcCHHHHHcC
Confidence 00000012345689999999999999999999999875
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.4e-41 Score=344.17 Aligned_cols=250 Identities=22% Similarity=0.314 Sum_probs=186.0
Q ss_pred cCccccceeccCce---------------EEEEEeecC--hhhHHHHHHHHHHHhhcCCCCccceecccccCccceEEEe
Q 044312 289 DNFDLNRILGQGGQ---------------AVKKSKVID--ESKVEEFINEVVILSQINHRNVVKLLGCCLETEVPLLVYE 351 (608)
Q Consensus 289 ~~f~~~~~lG~G~~---------------avk~~~~~~--~~~~~~~~~Ei~il~~l~H~niv~l~~~~~~~~~~~lV~E 351 (608)
++|++.++||+|+| |||+++... +...+.+.+|+++|++++|||||++++++.+....++|||
T Consensus 2 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~~~iv~e 81 (298)
T d1gz8a_ 2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFE 81 (298)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred CCCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEEeccccccccceeEEEe
Confidence 57999999999984 888875432 2346789999999999999999999999999999999999
Q ss_pred ecCCCccchhccccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEEcCCCcEEEeeccCccccccCC
Q 044312 352 FIPNGTLFQYIHDQNEDFPITWEIRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQ 431 (608)
Q Consensus 352 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGls~~~~~~~ 431 (608)
|+.+ ++.+++..... ..+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+|+......
T Consensus 82 ~~~~-~~~~~~~~~~~-~~l~e~~~~~~~~qil~~L~yLH~~~---IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~~~~ 156 (298)
T d1gz8a_ 82 FLHQ-DLKKFMDASAL-TGIPLPLIKSYLFQLLQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV 156 (298)
T ss_dssp CCSE-EHHHHHHHTTT-TCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECSTTHHHHHCCCS
T ss_pred ecCC-chhhhhhhhcc-cCCCHHHHHHHHHHHHHHHHHhhcCC---EEccccCchheeecccCcceeccCCcceeccCCc
Confidence 9965 45555543322 25999999999999999999999999 9999999999999999999999999998765432
Q ss_pred cceeeeeeccCCCCChhhhccCC-CCCccchHhHHHHHHHHHhCCCCCCccchhhcccHHHHHHHHhh-hhhh-HHHhh-
Q 044312 432 THMTTQVHGTFGYLDPEYFRSSQ-FTDKSDVYSFGVVLTELLTGEKPIRFTILEEDKSLAAYFLCAMK-EERL-FEILD- 507 (608)
Q Consensus 432 ~~~~~~~~gt~~y~aPE~~~~~~-~t~ksDV~S~Gvvl~elltg~~p~~~~~~~~~~~l~~~~~~~~~-~~~~-~~~~d- 507 (608)
. ......||+.|+|||.+.... ++.++|||||||++|||++|+.||......+ .+...+..... .+.. .....
T Consensus 157 ~-~~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~~--~~~~i~~~~~~~~~~~~~~~~~~ 233 (298)
T d1gz8a_ 157 R-TYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEID--QLFRIFRTLGTPDEVVWPGVTSM 233 (298)
T ss_dssp B-CTTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH--HHHHHHHHHCCCCTTTSTTGGGS
T ss_pred c-cceeecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCCCHHH--HHHHHHHhcCCCchhhccccccc
Confidence 2 234457999999999977665 5789999999999999999999997432211 11111110000 0000 00000
Q ss_pred hhhhcc-----------CChhHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 044312 508 ARVMKQ-----------GGKDEIITVAKLAKRCLNLNGKKRPTMREVASE 546 (608)
Q Consensus 508 ~~~~~~-----------~~~~~~~~l~~Li~~cl~~dp~~RPs~~evl~~ 546 (608)
+..... .....+.++.+|+.+||+.||++|||+.|++++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~H 283 (298)
T d1gz8a_ 234 PDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAH 283 (298)
T ss_dssp TTCCTTSCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred cccccccccccccchhhhccCCCHHHHHHHHHHccCChhHCcCHHHHhCC
Confidence 000000 001234678999999999999999999999864
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.1e-41 Score=341.98 Aligned_cols=249 Identities=24% Similarity=0.319 Sum_probs=185.8
Q ss_pred hcCccccceeccCce----------------EEEEEeec--ChhhHHHHHHHHHHHhhc---CCCCccceeccccc----
Q 044312 288 TDNFDLNRILGQGGQ----------------AVKKSKVI--DESKVEEFINEVVILSQI---NHRNVVKLLGCCLE---- 342 (608)
Q Consensus 288 t~~f~~~~~lG~G~~----------------avk~~~~~--~~~~~~~~~~Ei~il~~l---~H~niv~l~~~~~~---- 342 (608)
.++|++.++||+|+| |||+++.. ++.....+.+|+.+|+.| +||||+++++++..
T Consensus 6 ~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~~ 85 (305)
T d1blxa_ 6 DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTD 85 (305)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECS
T ss_pred cCCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceeeeeecccccc
Confidence 468999999999974 77876542 223344567788877766 79999999999853
Q ss_pred -CccceEEEeecCCCccchhccccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEEcCCCcEEEeec
Q 044312 343 -TEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEIRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDF 421 (608)
Q Consensus 343 -~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DF 421 (608)
....+++|||+.++++......... .+++..+..++.||+.||+|||+++ |+||||||+|||+++++.+||+||
T Consensus 86 ~~~~~~~~~e~~~~~~~~~~~~~~~~--~~~~~~~~~~~~qi~~aL~yLH~~~---ivHrDiKp~NILi~~~~~~kl~df 160 (305)
T d1blxa_ 86 RETKLTLVFEHVDQDLTTYLDKVPEP--GVPTETIKDMMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLADF 160 (305)
T ss_dssp SEEEEEEEEECCSCBHHHHHHHSCTT--CSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECSC
T ss_pred cCceEEEEEEeccCCchhhhhhccCC--CCCHHHHHHHHHHHHHHHHHHHhCC---EEecCCCccEEEEcCCCCeeecch
Confidence 3467999999988776554443322 5899999999999999999999999 999999999999999999999999
Q ss_pred cCccccccCCcceeeeeeccCCCCChhhhccCCCCCccchHhHHHHHHHHHhCCCCCCccchhhcccHHHHHHHHhhh--
Q 044312 422 GASRSMAVDQTHMTTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLTELLTGEKPIRFTILEEDKSLAAYFLCAMKE-- 499 (608)
Q Consensus 422 Gls~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~elltg~~p~~~~~~~~~~~l~~~~~~~~~~-- 499 (608)
|+++...... ......||+.|+|||++.+..++.++||||+||++|||++|+.||......+. +. ........
T Consensus 161 g~~~~~~~~~--~~~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~ell~g~~pf~~~~~~~~--~~-~i~~~~~~~~ 235 (305)
T d1blxa_ 161 GLARIYSFQM--ALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQ--LG-KILDVIGLPG 235 (305)
T ss_dssp CSCCCCCGGG--GGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH--HH-HHHHHHCCCC
T ss_pred hhhhhhcccc--cCCCcccChhhcCcchhcCCCCChhehhhchHHHHHHHHHCCCCCCCCCHHHH--HH-HHHHhhCCCc
Confidence 9998654332 33456799999999999999999999999999999999999999974332211 11 11111100
Q ss_pred -hhhHHH----------hhhhhhccCChhHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 044312 500 -ERLFEI----------LDARVMKQGGKDEIITVAKLAKRCLNLNGKKRPTMREVASE 546 (608)
Q Consensus 500 -~~~~~~----------~d~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~evl~~ 546 (608)
...... .............++.+.+|+.+||+.||++|||+.|++++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L~H 293 (305)
T d1blxa_ 236 EEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSH 293 (305)
T ss_dssp GGGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred hhcccccccchhhhhccccccchhhccccCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence 000000 00000111223445678999999999999999999999864
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.8e-41 Score=340.34 Aligned_cols=227 Identities=26% Similarity=0.415 Sum_probs=183.3
Q ss_pred hcCccccceeccCce---------------EEEEEeecC---h---hhHHHHHHHHHHHhhcC--CCCccceecccccCc
Q 044312 288 TDNFDLNRILGQGGQ---------------AVKKSKVID---E---SKVEEFINEVVILSQIN--HRNVVKLLGCCLETE 344 (608)
Q Consensus 288 t~~f~~~~~lG~G~~---------------avk~~~~~~---~---~~~~~~~~Ei~il~~l~--H~niv~l~~~~~~~~ 344 (608)
.++|++.+.||+|+| |||+++... . .....+.+|+.+|++++ |||||++++++.+.+
T Consensus 3 ~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~~ 82 (273)
T d1xwsa_ 3 ESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPD 82 (273)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSS
T ss_pred CCeEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEeeCC
Confidence 357999999999985 777765311 1 12244778999999996 899999999999999
Q ss_pred cceEEEeecCC-CccchhccccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEEcC-CCcEEEeecc
Q 044312 345 VPLLVYEFIPN-GTLFQYIHDQNEDFPITWEIRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDD-KYRAKVSDFG 422 (608)
Q Consensus 345 ~~~lV~E~~~~-gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~-~~~~kl~DFG 422 (608)
..++||||+.+ ++|.+++.... .+++..+..++.||+.||+|||+.+ |+||||||+|||++. ++.+||+|||
T Consensus 83 ~~~lv~e~~~~~~~l~~~~~~~~---~l~e~~~~~~~~qi~~al~~lH~~~---iiHrDiKp~NIll~~~~~~vkl~DFG 156 (273)
T d1xwsa_ 83 SFVLILERPEPVQDLFDFITERG---ALQEELARSFFWQVLEAVRHCHNCG---VLHRDIKDENILIDLNRGELKLIDFG 156 (273)
T ss_dssp EEEEEEECCSSEEEHHHHHHHHC---SCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEETTTTEEEECCCT
T ss_pred eEEEEEEeccCcchHHHHHhccC---CCCHHHHHHHHHHHHHHHHHHHHCC---CccccCcccceEEecCCCeEEECccc
Confidence 99999999976 57777776543 5999999999999999999999999 999999999999985 5799999999
Q ss_pred CccccccCCcceeeeeeccCCCCChhhhccCCC-CCccchHhHHHHHHHHHhCCCCCCccchhhcccHHHHHHHHhhhhh
Q 044312 423 ASRSMAVDQTHMTTQVHGTFGYLDPEYFRSSQF-TDKSDVYSFGVVLTELLTGEKPIRFTILEEDKSLAAYFLCAMKEER 501 (608)
Q Consensus 423 ls~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-t~ksDV~S~Gvvl~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~ 501 (608)
+++..... ..+...||+.|+|||++.+..+ +.++|||||||++|||+||+.||....
T Consensus 157 ~a~~~~~~---~~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~------------------- 214 (273)
T d1xwsa_ 157 SGALLKDT---VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE------------------- 214 (273)
T ss_dssp TCEECCSS---CBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH-------------------
T ss_pred cceecccc---cccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCch-------------------
Confidence 99865432 2345679999999999987765 567899999999999999999986311
Q ss_pred hHHHhhhhhhccCChhHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 044312 502 LFEILDARVMKQGGKDEIITVAKLAKRCLNLNGKKRPTMREVASE 546 (608)
Q Consensus 502 ~~~~~d~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~evl~~ 546 (608)
++... ....+...+.++.+|+.+||+.||++|||++|++++
T Consensus 215 --~i~~~--~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~h 255 (273)
T d1xwsa_ 215 --EIIRG--QVFFRQRVSSECQHLIRWCLALRPSDRPTFEEIQNH 255 (273)
T ss_dssp --HHHHC--CCCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred --HHhhc--ccCCCCCCCHHHHHHHHHHccCCHhHCcCHHHHhcC
Confidence 00111 112233456789999999999999999999999764
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=100.00 E-value=2.4e-40 Score=335.71 Aligned_cols=248 Identities=20% Similarity=0.297 Sum_probs=186.4
Q ss_pred cCccccceeccCce--------------EEEEEeec--ChhhHHHHHHHHHHHhhcCCCCccceecccccCccceEEEee
Q 044312 289 DNFDLNRILGQGGQ--------------AVKKSKVI--DESKVEEFINEVVILSQINHRNVVKLLGCCLETEVPLLVYEF 352 (608)
Q Consensus 289 ~~f~~~~~lG~G~~--------------avk~~~~~--~~~~~~~~~~Ei~il~~l~H~niv~l~~~~~~~~~~~lV~E~ 352 (608)
++|++.++||+|+| |||+++.. ++...+.|.+|+.+|++++|||||++++++.+.+..+++||+
T Consensus 2 ~~Y~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i~~e~ 81 (286)
T d1ob3a_ 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEH 81 (286)
T ss_dssp CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred CCceeccEEecCCCcEEEEEEeCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEeeeeecccCCceeEEEEe
Confidence 57899999999984 88887653 233467899999999999999999999999999999999999
Q ss_pred cCCCccchhccccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEEcCCCcEEEeeccCccccccCCc
Q 044312 353 IPNGTLFQYIHDQNEDFPITWEIRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQT 432 (608)
Q Consensus 353 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGls~~~~~~~~ 432 (608)
+.++.+..+..... .+++..+..|+.||+.||+|||+.+ |+||||||+|||++.++.+||+|||++.......
T Consensus 82 ~~~~~~~~~~~~~~---~l~~~~~~~i~~qi~~~L~~LH~~~---IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~~~~- 154 (286)
T d1ob3a_ 82 LDQDLKKLLDVCEG---GLESVTAKSFLLQLLNGIAYCHDRR---VLHRDLKPQNLLINREGELKIADFGLARAFGIPV- 154 (286)
T ss_dssp CSEEHHHHHHTSTT---CCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECCTTHHHHHCC---
T ss_pred ehhhhHHHHHhhcC---CcchhhhHHHHHHHHHHHHHhccCc---EEecCCCCceeeEcCCCCEEecccccceecccCc-
Confidence 98766666554332 5999999999999999999999999 9999999999999999999999999998765332
Q ss_pred ceeeeeeccCCCCChhhhccC-CCCCccchHhHHHHHHHHHhCCCCCCccchhhcccHHHHHHHHhhhh---hhHHHhh-
Q 044312 433 HMTTQVHGTFGYLDPEYFRSS-QFTDKSDVYSFGVVLTELLTGEKPIRFTILEEDKSLAAYFLCAMKEE---RLFEILD- 507 (608)
Q Consensus 433 ~~~~~~~gt~~y~aPE~~~~~-~~t~ksDV~S~Gvvl~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~---~~~~~~d- 507 (608)
.......+++.|+|||.+... .++.++|||||||+++||++|+.||......+ .+...+ ...... .......
T Consensus 155 ~~~~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~~--~~~~i~-~~~~~~~~~~~~~~~~~ 231 (286)
T d1ob3a_ 155 RKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEAD--QLMRIF-RILGTPNSKNWPNVTEL 231 (286)
T ss_dssp -------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH--HHHHHH-HHHCCCCTTTSTTGGGS
T ss_pred cccceecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCCCHHH--HHHHHH-HhhCCCChhhccchhhh
Confidence 223344689999999998754 56899999999999999999999997432211 111111 111100 0000000
Q ss_pred -----------hhhhccCChhHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 044312 508 -----------ARVMKQGGKDEIITVAKLAKRCLNLNGKKRPTMREVASE 546 (608)
Q Consensus 508 -----------~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~evl~~ 546 (608)
+..........+..+.+|+.+||+.||++|||++|++++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~H 281 (286)
T d1ob3a_ 232 PKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEH 281 (286)
T ss_dssp TTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred hhcccccccccCcchhhhcccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 000111223345688999999999999999999999753
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=4.6e-39 Score=328.37 Aligned_cols=250 Identities=19% Similarity=0.251 Sum_probs=187.5
Q ss_pred cCccccceeccCce---------------EEEEEeecChhhHHHHHHHHHHHhhcCCCCccc-eecccccCccceEEEee
Q 044312 289 DNFDLNRILGQGGQ---------------AVKKSKVIDESKVEEFINEVVILSQINHRNVVK-LLGCCLETEVPLLVYEF 352 (608)
Q Consensus 289 ~~f~~~~~lG~G~~---------------avk~~~~~~~~~~~~~~~Ei~il~~l~H~niv~-l~~~~~~~~~~~lV~E~ 352 (608)
++|++.+.||+|+| |||..... ...+++.+|++++++++|+|++. +..+..+.+..++||||
T Consensus 7 ~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~--~~~~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~ivme~ 84 (299)
T d1ckia_ 7 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVK--TKHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMEL 84 (299)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESC--TTSCCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEEEEEEC
T ss_pred CEEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchh--ccCHHHHHHHHHHHHccCCCcccEEEEEEecCCEEEEEEEE
Confidence 57999999999985 77776543 23456889999999998766554 45555777888999999
Q ss_pred cCCCccchhccccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEEc---CCCcEEEeeccCcccccc
Q 044312 353 IPNGTLFQYIHDQNEDFPITWEIRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLD---DKYRAKVSDFGASRSMAV 429 (608)
Q Consensus 353 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~---~~~~~kl~DFGls~~~~~ 429 (608)
+ +++|.+.+..... .+++..++.++.|++.||+|||+++ |+||||||+|||++ .+..+||+|||+|+.+..
T Consensus 85 ~-~~~l~~~~~~~~~--~~~~~~~~~~~~qi~~~l~~lH~~~---iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~~~ 158 (299)
T d1ckia_ 85 L-GPSLEDLFNFCSR--KFSLKTVLLLADQMISRIEYIHSKN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRD 158 (299)
T ss_dssp C-CCBHHHHHHHTTT--CCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECCGGGTTCEEECCCSSCEECBC
T ss_pred c-CCchhhhhhhccC--CCcHHHHHHHHHHHHHHHHHHHHCC---eeeccCCHhhccccccCCCceeeeeccCcceeccc
Confidence 9 5577666655433 5999999999999999999999999 99999999999986 456799999999998754
Q ss_pred CCcc------eeeeeeccCCCCChhhhccCCCCCccchHhHHHHHHHHHhCCCCCCccchhhcccHHHHHHHHhhhhhhH
Q 044312 430 DQTH------MTTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLTELLTGEKPIRFTILEEDKSLAAYFLCAMKEERLF 503 (608)
Q Consensus 430 ~~~~------~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~ 503 (608)
.... ......||+.|||||.+.+..++.++|||||||+++||+||+.||.............. .......
T Consensus 159 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~~~~----~~~~~~~ 234 (299)
T d1ckia_ 159 ARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYER----ISEKKMS 234 (299)
T ss_dssp TTTCCBCCCCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHHHHHHHHHHHSSCTTCCCC-------HHH----HHHHHHH
T ss_pred cccccceeccccCCcCCCccccCHHHHhCCCCCChhhEEecCHHHHHHHhCCCcccccchHHHHHHHHH----hhcccCC
Confidence 3321 22345799999999999999999999999999999999999999975433222111100 0000000
Q ss_pred HHhhhhhhccCChhHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhhHHhcC
Q 044312 504 EILDARVMKQGGKDEIITVAKLAKRCLNLNGKKRPTMREVASELAGIKAWNG 555 (608)
Q Consensus 504 ~~~d~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~evl~~L~~i~~~~~ 555 (608)
. .........+.++.+|+.+||+.+|++||++.++.+.|+.+....+
T Consensus 235 ----~-~~~~~~~~~p~~~~~li~~cl~~~p~~RP~~~~i~~~l~~~~~~~~ 281 (299)
T d1ckia_ 235 ----T-PIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQG 281 (299)
T ss_dssp ----S-CHHHHTTTSCHHHHHHHHHHHHSCTTCCCCHHHHHHHHHHHHHHHT
T ss_pred ----C-ChhHhccCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHHHcC
Confidence 0 0011122345679999999999999999999999999988755433
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=100.00 E-value=8.5e-39 Score=325.42 Aligned_cols=252 Identities=15% Similarity=0.151 Sum_probs=195.7
Q ss_pred hcCccccceeccCce---------------EEEEEeecChhhHHHHHHHHHHHhhcCC-CCccceecccccCccceEEEe
Q 044312 288 TDNFDLNRILGQGGQ---------------AVKKSKVIDESKVEEFINEVVILSQINH-RNVVKLLGCCLETEVPLLVYE 351 (608)
Q Consensus 288 t~~f~~~~~lG~G~~---------------avk~~~~~~~~~~~~~~~Ei~il~~l~H-~niv~l~~~~~~~~~~~lV~E 351 (608)
.++|++.++||+|+| |||..... ...+.+.+|+++++.|+| +|++++++++.+....++|||
T Consensus 4 g~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~--~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~~vme 81 (293)
T d1csna_ 4 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRR--SDAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVID 81 (293)
T ss_dssp TTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECC--TTSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEE
T ss_pred CCceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEccc--cCcHHHHHHHHHHHHhcCCCCCCEEEEEeecCCccEEEEE
Confidence 468999999999985 77765432 234567889999999965 999999999999999999999
Q ss_pred ecCCCccchhccccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEEcC-----CCcEEEeeccCccc
Q 044312 352 FIPNGTLFQYIHDQNEDFPITWEIRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDD-----KYRAKVSDFGASRS 426 (608)
Q Consensus 352 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~-----~~~~kl~DFGls~~ 426 (608)
|+ +++|.+++..... .+++.++..++.|++.||+|||+.+ |+||||||+|||++. ++.+||+|||+|+.
T Consensus 82 ~~-~~~l~~~~~~~~~--~~~~~~~~~i~~q~~~~l~~lH~~g---iiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~~ 155 (293)
T d1csna_ 82 LL-GPSLEDLLDLCGR--KFSVKTVAMAAKQMLARVQSIHEKS---LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKF 155 (293)
T ss_dssp CC-CCBHHHHHHHTTT--CCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECCSSSTTTTCEEECCCTTCEE
T ss_pred ec-CCCHHHHHHhhcc--chhhHHHHHHHHHHHHHHHHHHHCC---ceeccCCccceeecCcccccCCceEEcccceeEE
Confidence 99 7899998876543 5899999999999999999999999 999999999999974 56899999999987
Q ss_pred cccCCcc------eeeeeeccCCCCChhhhccCCCCCccchHhHHHHHHHHHhCCCCCCccchhhcccHHHHHHHHhhhh
Q 044312 427 MAVDQTH------MTTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLTELLTGEKPIRFTILEEDKSLAAYFLCAMKEE 500 (608)
Q Consensus 427 ~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~ 500 (608)
....... ......||+.|||||.+.+..++.++||||||++++||+||+.||............. .+...
T Consensus 156 ~~~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~----~i~~~ 231 (293)
T d1csna_ 156 YRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYE----RIGEK 231 (293)
T ss_dssp SBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHH----HHHHH
T ss_pred cccCccccceeecccCceEEchhhcCHHHhcCCCCChHHHHHHhhHHHHHHHhCCCcCCCccchhHHHHHH----HHHhc
Confidence 6533221 2334679999999999999999999999999999999999999997433222111110 11111
Q ss_pred hhHHHhhhhhhccCChhHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhhHHhcCC
Q 044312 501 RLFEILDARVMKQGGKDEIITVAKLAKRCLNLNGKKRPTMREVASELAGIKAWNGA 556 (608)
Q Consensus 501 ~~~~~~d~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~evl~~L~~i~~~~~~ 556 (608)
... ....+.....+.++.+++..|+..+|++||+++.+.+.|+.+....+.
T Consensus 232 ~~~-----~~~~~l~~~~p~~l~~ii~~~~~~~~~~rP~y~~l~~~l~~~~~~~~~ 282 (293)
T d1csna_ 232 KQS-----TPLRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLERLNT 282 (293)
T ss_dssp HHH-----SCHHHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHTTC
T ss_pred cCC-----CChHHhcCCCCHHHHHHHHHHhcCCcccCcCHHHHHHHHHHHHHHcCC
Confidence 000 000111123456799999999999999999999999988887654443
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.5e-39 Score=336.01 Aligned_cols=252 Identities=20% Similarity=0.305 Sum_probs=183.8
Q ss_pred hcCccccceeccCce---------------EEEEEeecC-hhhHHHHHHHHHHHhhcCCCCccceecccccCc----cce
Q 044312 288 TDNFDLNRILGQGGQ---------------AVKKSKVID-ESKVEEFINEVVILSQINHRNVVKLLGCCLETE----VPL 347 (608)
Q Consensus 288 t~~f~~~~~lG~G~~---------------avk~~~~~~-~~~~~~~~~Ei~il~~l~H~niv~l~~~~~~~~----~~~ 347 (608)
+.+|++.++||+|+| |||++.... ....+.+.+|+.+|++++||||+++++++.... ..+
T Consensus 7 ~~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~~~ 86 (345)
T d1pmea_ 7 GPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDV 86 (345)
T ss_dssp CTTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCE
T ss_pred CCCeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhcChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccccccceE
Confidence 457999999999984 888876533 445678999999999999999999999986553 234
Q ss_pred EEEeecCCCccchhccccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEEcCCCcEEEeeccCcccc
Q 044312 348 LVYEFIPNGTLFQYIHDQNEDFPITWEIRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSM 427 (608)
Q Consensus 348 lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGls~~~ 427 (608)
++++++.+|+|.+++... .+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++..
T Consensus 87 ~l~~~~~~g~L~~~l~~~----~l~~~~i~~i~~qil~al~yLH~~~---iiHRDIKp~NILl~~~~~~kl~DfG~a~~~ 159 (345)
T d1pmea_ 87 YLVTHLMGADLYKLLKTQ----HLSNDHICYFLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARVA 159 (345)
T ss_dssp EEEEECCCEEHHHHHHHC----CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEEC
T ss_pred EEEEeecCCchhhhhhcC----CCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCCCcceEEECCCCCEEEcccCceeec
Confidence 555667799999999653 4899999999999999999999999 999999999999999999999999999876
Q ss_pred ccCCcc--eeeeeeccCCCCChhhhcc-CCCCCccchHhHHHHHHHHHhCCCCCCccchhhcccHHHHHHHHhhhhhhH-
Q 044312 428 AVDQTH--MTTQVHGTFGYLDPEYFRS-SQFTDKSDVYSFGVVLTELLTGEKPIRFTILEEDKSLAAYFLCAMKEERLF- 503 (608)
Q Consensus 428 ~~~~~~--~~~~~~gt~~y~aPE~~~~-~~~t~ksDV~S~Gvvl~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~- 503 (608)
...... ......||+.|+|||++.. ..++.++||||+||+++||++|+.||......+..................
T Consensus 160 ~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (345)
T d1pmea_ 160 DPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNC 239 (345)
T ss_dssp CGGGCBCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHT
T ss_pred cCCCccceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCCCHHHHHHHHhhhccCCChhhhhh
Confidence 543222 2344568999999999854 567899999999999999999999997433221111110000000000000
Q ss_pred ----HHhhh--hhhcc-------CChhHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 044312 504 ----EILDA--RVMKQ-------GGKDEIITVAKLAKRCLNLNGKKRPTMREVASE 546 (608)
Q Consensus 504 ----~~~d~--~~~~~-------~~~~~~~~l~~Li~~cl~~dp~~RPs~~evl~~ 546 (608)
..... ..... .....+.++.+|+.+||+.||++|||+.|++++
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ta~e~L~h 295 (345)
T d1pmea_ 240 IINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAH 295 (345)
T ss_dssp CCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred hhhhhhhcccccCCccCCCCHHHhCCCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 00000 00000 011234578999999999999999999999864
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.3e-39 Score=332.30 Aligned_cols=252 Identities=21% Similarity=0.270 Sum_probs=180.7
Q ss_pred cCccccceeccCce---------------EEEEEeec--ChhhHHHHHHHHHHHhhcCCCCccceeccccc--------C
Q 044312 289 DNFDLNRILGQGGQ---------------AVKKSKVI--DESKVEEFINEVVILSQINHRNVVKLLGCCLE--------T 343 (608)
Q Consensus 289 ~~f~~~~~lG~G~~---------------avk~~~~~--~~~~~~~~~~Ei~il~~l~H~niv~l~~~~~~--------~ 343 (608)
++|++.++||+|+| |||++... .+...+.+.+|+.+|++++||||+++++.+.. .
T Consensus 10 ~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~~~ 89 (318)
T d3blha1 10 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCK 89 (318)
T ss_dssp GGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC---------
T ss_pred CCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHHhcCCCccceEeeeecccccccccC
Confidence 67999999999974 88876542 33445789999999999999999999998854 3
Q ss_pred ccceEEEeecCCCccchhccccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEEcCCCcEEEeeccC
Q 044312 344 EVPLLVYEFIPNGTLFQYIHDQNEDFPITWEIRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGA 423 (608)
Q Consensus 344 ~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGl 423 (608)
...++||||+.++.+........ .++...+..|+.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+
T Consensus 90 ~~~~iv~e~~~~~~~~~~~~~~~---~~~~~~~~~i~~qil~~l~~lH~~~---ivHrDlKp~NILl~~~~~~kl~dfg~ 163 (318)
T d3blha1 90 GSIYLVFDFCEHDLAGLLSNVLV---KFTLSEIKRVMQMLLNGLYYIHRNK---ILHRDMKAANVLITRDGVLKLADFGL 163 (318)
T ss_dssp -CEEEEEECCCEEHHHHHTCTTC---CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEECCCTT
T ss_pred ceEEEEEeccCCCccchhhhccc---ccccHHHHHHHHHHHHHHHHhccCC---EEecCcCchheeecCCCcEEeeecce
Confidence 45789999998776655444322 4899999999999999999999999 99999999999999999999999999
Q ss_pred ccccccCCcc---eeeeeeccCCCCChhhhccC-CCCCccchHhHHHHHHHHHhCCCCCCccchhhcccHHHHHHHHhhh
Q 044312 424 SRSMAVDQTH---MTTQVHGTFGYLDPEYFRSS-QFTDKSDVYSFGVVLTELLTGEKPIRFTILEEDKSLAAYFLCAMKE 499 (608)
Q Consensus 424 s~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~-~~t~ksDV~S~Gvvl~elltg~~p~~~~~~~~~~~l~~~~~~~~~~ 499 (608)
++........ ......||+.|+|||.+.+. .++.++|||||||+++||++|+.||.....................
T Consensus 164 ~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~ 243 (318)
T d3blha1 164 ARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITP 243 (318)
T ss_dssp CEECCC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCT
T ss_pred eeecccccccccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCCCCHHHHHHHHHHhcCCCCh
Confidence 9876533221 22334689999999998765 6899999999999999999999999743222111111111000000
Q ss_pred hhh--------HHHhhhhhhccCC-------hhHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 044312 500 ERL--------FEILDARVMKQGG-------KDEIITVAKLAKRCLNLNGKKRPTMREVASE 546 (608)
Q Consensus 500 ~~~--------~~~~d~~~~~~~~-------~~~~~~l~~Li~~cl~~dp~~RPs~~evl~~ 546 (608)
... ...+......... ......+.+|+.+||+.||++|||++|++++
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL~H 305 (318)
T d3blha1 244 EVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNH 305 (318)
T ss_dssp TTSTTCCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred hhccccchhhhhhhhcccccccccchhhhccccCCHHHHHHHHHHCcCChhHCcCHHHHHcC
Confidence 000 0000000000000 0113467789999999999999999999864
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.1e-39 Score=332.97 Aligned_cols=247 Identities=21% Similarity=0.289 Sum_probs=182.3
Q ss_pred hcCccccceeccCce---------------EEEEEee--cChhhHHHHHHHHHHHhhcCCCCccceecccccCc------
Q 044312 288 TDNFDLNRILGQGGQ---------------AVKKSKV--IDESKVEEFINEVVILSQINHRNVVKLLGCCLETE------ 344 (608)
Q Consensus 288 t~~f~~~~~lG~G~~---------------avk~~~~--~~~~~~~~~~~Ei~il~~l~H~niv~l~~~~~~~~------ 344 (608)
.++|++.++||+|+| |||+++. .+....+.+.+|+.+|++++|||||+++++|...+
T Consensus 17 ~~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~~ 96 (346)
T d1cm8a_ 17 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFT 96 (346)
T ss_dssp BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCC
T ss_pred CCcEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhhcChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCccccccc
Confidence 468999999999985 8888764 34455678999999999999999999999997654
Q ss_pred cceEEEeecCCCccchhccccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEEcCCCcEEEeeccCc
Q 044312 345 VPLLVYEFIPNGTLFQYIHDQNEDFPITWEIRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGAS 424 (608)
Q Consensus 345 ~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGls 424 (608)
..+|||||+ +.+|..+++.. .+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+|++|||++
T Consensus 97 ~~~lv~e~~-~~~l~~~~~~~----~l~~~~~~~~~~qi~~aL~~LH~~~---IiHrDiKp~NIL~~~~~~~kl~Dfg~a 168 (346)
T d1cm8a_ 97 DFYLVMPFM-GTDLGKLMKHE----KLGEDRIQFLVYQMLKGLRYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGLA 168 (346)
T ss_dssp CCEEEEECC-SEEHHHHHHHC----CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTC
T ss_pred eEEEEEecc-cccHHHHHHhc----cccHHHHHHHHHHHHHHHHHHHhCC---CcccccCcchhhcccccccccccccce
Confidence 469999999 55777766542 4999999999999999999999999 999999999999999999999999999
Q ss_pred cccccCCcceeeeeeccCCCCChhhhccC-CCCCccchHhHHHHHHHHHhCCCCCCccchhhcccHHHH--------HHH
Q 044312 425 RSMAVDQTHMTTQVHGTFGYLDPEYFRSS-QFTDKSDVYSFGVVLTELLTGEKPIRFTILEEDKSLAAY--------FLC 495 (608)
Q Consensus 425 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~t~ksDV~S~Gvvl~elltg~~p~~~~~~~~~~~l~~~--------~~~ 495 (608)
+..... .+...||+.|+|||.+.+. .++.++||||+||+++||++|+.||.............. +..
T Consensus 169 ~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (346)
T d1cm8a_ 169 RQADSE----MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQ 244 (346)
T ss_dssp EECCSS----CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHH
T ss_pred eccCCc----cccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCCChHHHHHHHHhccCCCcHHHHh
Confidence 876432 2445789999999998764 568999999999999999999999974322111000000 000
Q ss_pred HhhhhhhHHHhhh------hhhccCChhHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 044312 496 AMKEERLFEILDA------RVMKQGGKDEIITVAKLAKRCLNLNGKKRPTMREVASE 546 (608)
Q Consensus 496 ~~~~~~~~~~~d~------~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~evl~~ 546 (608)
............. ..........+..+.+|+.+||..||++|||++|++++
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~eiL~H 301 (346)
T d1cm8a_ 245 RLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAH 301 (346)
T ss_dssp TCSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred hhcchhhhhhhccCCcccccchHHhccCCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence 0000000000000 00011112345678899999999999999999999875
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.8e-39 Score=335.61 Aligned_cols=245 Identities=23% Similarity=0.272 Sum_probs=179.6
Q ss_pred CccccceeccCce---------------EEEEEeecChhhHHHHHHHHHHHhhcCCCCccceecccccC------ccceE
Q 044312 290 NFDLNRILGQGGQ---------------AVKKSKVIDESKVEEFINEVVILSQINHRNVVKLLGCCLET------EVPLL 348 (608)
Q Consensus 290 ~f~~~~~lG~G~~---------------avk~~~~~~~~~~~~~~~Ei~il~~l~H~niv~l~~~~~~~------~~~~l 348 (608)
.|+..++||+|+| |||+++... ..+.+|+.+|++++||||+++++++... ...+|
T Consensus 21 ~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~----~~~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~~~l 96 (350)
T d1q5ka_ 21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDK----RFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNL 96 (350)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS----SSCCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCEEEE
T ss_pred CcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccc----hHHHHHHHHHHhcCCCCCCcEEEEEEecCccCCceEEEE
Confidence 5788899999984 777775432 2235799999999999999999998532 34689
Q ss_pred EEeecCCCccchhccccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEEcCCC-cEEEeeccCcccc
Q 044312 349 VYEFIPNGTLFQYIHDQNEDFPITWEIRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKY-RAKVSDFGASRSM 427 (608)
Q Consensus 349 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~-~~kl~DFGls~~~ 427 (608)
||||++++.+..+.+.......+++..+..|+.||+.||+|||+++ |+||||||+|||++.++ .+||+|||+++..
T Consensus 97 v~Ey~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~~~---IiHrDiKp~NILl~~~~~~~kl~DFG~a~~~ 173 (350)
T d1q5ka_ 97 VLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL 173 (350)
T ss_dssp EEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECTTTCCEEECCCTTCEEC
T ss_pred EEeccCCccHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHHhcC---CcccCCCcceEEEecCCCceeEecccchhhc
Confidence 9999987644444333233346999999999999999999999999 99999999999999764 8999999999876
Q ss_pred ccCCcceeeeeeccCCCCChhhhcc-CCCCCccchHhHHHHHHHHHhCCCCCCccchhhcccHHHHHHHHhhh---hhhH
Q 044312 428 AVDQTHMTTQVHGTFGYLDPEYFRS-SQFTDKSDVYSFGVVLTELLTGEKPIRFTILEEDKSLAAYFLCAMKE---ERLF 503 (608)
Q Consensus 428 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~t~ksDV~S~Gvvl~elltg~~p~~~~~~~~~~~l~~~~~~~~~~---~~~~ 503 (608)
..... .....||+.|+|||.+.. ..++.++||||+||+++||++|+.||......+ .+...+ ..... ..+.
T Consensus 174 ~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~~--~l~~i~-~~~g~~~~~~~~ 248 (350)
T d1q5ka_ 174 VRGEP--NVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVD--QLVEII-KVLGTPTREQIR 248 (350)
T ss_dssp CTTSC--CCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHH--HHHHHH-HHHCCCCHHHHH
T ss_pred cCCcc--cccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCCCHHH--HHHHHH-HHhCCChHHhhh
Confidence 54332 234568999999998765 578999999999999999999999997433221 111111 11000 0010
Q ss_pred HHhhh------------hhhccCChhHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 044312 504 EILDA------------RVMKQGGKDEIITVAKLAKRCLNLNGKKRPTMREVASE 546 (608)
Q Consensus 504 ~~~d~------------~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~evl~~ 546 (608)
..... ..........+.++.+|+.+||+.||++|||+.|++++
T Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~H 303 (350)
T d1q5ka_ 249 EMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAH 303 (350)
T ss_dssp HHCC---CCCCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred hhccchhhccccccccCchhhhcccCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 00000 00011122346679999999999999999999999864
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.1e-38 Score=321.95 Aligned_cols=249 Identities=19% Similarity=0.288 Sum_probs=191.3
Q ss_pred cCccccceeccCce---------------EEEEEeec--ChhhHHHHHHHHHHHhhcCCCCccceecccccCccceEEEe
Q 044312 289 DNFDLNRILGQGGQ---------------AVKKSKVI--DESKVEEFINEVVILSQINHRNVVKLLGCCLETEVPLLVYE 351 (608)
Q Consensus 289 ~~f~~~~~lG~G~~---------------avk~~~~~--~~~~~~~~~~Ei~il~~l~H~niv~l~~~~~~~~~~~lV~E 351 (608)
++|++.++||+|+| |||+++.. .....+.+.+|+.+|++++||||+++++++.+....++|+|
T Consensus 2 ~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~iv~~ 81 (292)
T d1unla_ 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE 81 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred CCCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhCChHHHHHHHHHHHHHHhcCcCCEEeeccccccccceeEEee
Confidence 47999999999984 89987643 33457889999999999999999999999999999999999
Q ss_pred ecCCCccchhccccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEEcCCCcEEEeeccCccccccCC
Q 044312 352 FIPNGTLFQYIHDQNEDFPITWEIRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQ 431 (608)
Q Consensus 352 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGls~~~~~~~ 431 (608)
++.+++|..++.... .+++..+..++.|++.||+|||+++ |+||||||+|||++.++.+||+|||.++......
T Consensus 82 ~~~~~~l~~~~~~~~---~~~~~~~~~~~~q~~~aL~~lH~~~---IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~~~~ 155 (292)
T d1unla_ 82 FCDQDLKKYFDSCNG---DLDPEIVKSFLFQLLKGLGFCHSRN---VLHRDLKPQNLLINRNGELKLANFGLARAFGIPV 155 (292)
T ss_dssp CCSEEHHHHHHHTTT---CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECCSCC
T ss_pred ecccccccccccccc---ccchhHHHHHHHHHHHHHHHhhcCC---EeeecccCcccccccCCceeeeecchhhcccCCC
Confidence 999998888776543 5899999999999999999999999 9999999999999999999999999998765433
Q ss_pred cceeeeeeccCCCCChhhhccCC-CCCccchHhHHHHHHHHHhCCCCCCccchhhcccHHHHHHHHhhhh---hh---HH
Q 044312 432 THMTTQVHGTFGYLDPEYFRSSQ-FTDKSDVYSFGVVLTELLTGEKPIRFTILEEDKSLAAYFLCAMKEE---RL---FE 504 (608)
Q Consensus 432 ~~~~~~~~gt~~y~aPE~~~~~~-~t~ksDV~S~Gvvl~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~---~~---~~ 504 (608)
. ......+++.|+|||.+.... ++.++|||||||+++||++|+.||........ ....+....... .. ..
T Consensus 156 ~-~~~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~ 232 (292)
T d1unla_ 156 R-CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDD--QLKRIFRLLGTPTEEQWPSMTK 232 (292)
T ss_dssp S-CCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHH--HHHHHHHHHCCCCTTTCTTGGG
T ss_pred c-cceeeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCCCCCHHH--HHHHHHhhcCCCChhhhhhhhh
Confidence 2 233445788999999987665 68999999999999999999999753222111 111111111100 00 00
Q ss_pred Hhh---------hhhhccCChhHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 044312 505 ILD---------ARVMKQGGKDEIITVAKLAKRCLNLNGKKRPTMREVASE 546 (608)
Q Consensus 505 ~~d---------~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~evl~~ 546 (608)
..+ ...........+..+.+|+.+||+.||.+|||++||+++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~H 283 (292)
T d1unla_ 233 LPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQH 283 (292)
T ss_dssp STTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred cccccccccccccchhhhccccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 000 000111122345678999999999999999999999754
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6e-39 Score=330.66 Aligned_cols=238 Identities=27% Similarity=0.343 Sum_probs=190.2
Q ss_pred cCccccceeccCce------------------EEEEEee----cChhhHHHHHHHHHHHhhcCC-CCccceecccccCcc
Q 044312 289 DNFDLNRILGQGGQ------------------AVKKSKV----IDESKVEEFINEVVILSQINH-RNVVKLLGCCLETEV 345 (608)
Q Consensus 289 ~~f~~~~~lG~G~~------------------avk~~~~----~~~~~~~~~~~Ei~il~~l~H-~niv~l~~~~~~~~~ 345 (608)
++|++.++||+|+| |||.++. .+....+.+.+|+++|++++| |||+++++++.+...
T Consensus 24 ~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~~~ 103 (322)
T d1vzoa_ 24 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETK 103 (322)
T ss_dssp GGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTE
T ss_pred hceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeeccCCc
Confidence 56999999999984 6665532 122345678999999999966 899999999999999
Q ss_pred ceEEEeecCCCccchhccccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEEcCCCcEEEeeccCcc
Q 044312 346 PLLVYEFIPNGTLFQYIHDQNEDFPITWEIRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASR 425 (608)
Q Consensus 346 ~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGls~ 425 (608)
.++||||+.+|+|.+++.... .++...+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++
T Consensus 104 ~~~v~e~~~~~~L~~~i~~~~---~~~e~~~~~~~~Qi~~al~~lH~~~---ivHrDiKp~Nill~~~~~vkL~DFG~a~ 177 (322)
T d1vzoa_ 104 LHLILDYINGGELFTHLSQRE---RFTEHEVQIYVGEIVLALEHLHKLG---IIYRDIKLENILLDSNGHVVLTDFGLSK 177 (322)
T ss_dssp EEEEECCCCSCBHHHHHHHHS---CCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEESCSSEEE
T ss_pred eeeeeecccccHHHHHHHhcc---cccHHHHHHHHHHHHHHHHHhhcCC---EEeccCCccceeecCCCCEEEeeccchh
Confidence 999999999999999998765 4788999999999999999999999 9999999999999999999999999998
Q ss_pred ccccCCcceeeeeeccCCCCChhhhccC--CCCCccchHhHHHHHHHHHhCCCCCCccchhhcccHHHHHHHHhhhhhhH
Q 044312 426 SMAVDQTHMTTQVHGTFGYLDPEYFRSS--QFTDKSDVYSFGVVLTELLTGEKPIRFTILEEDKSLAAYFLCAMKEERLF 503 (608)
Q Consensus 426 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~t~ksDV~S~Gvvl~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~ 503 (608)
.+............|++.|+|||.+... .++.++|||||||+||||++|+.||........ ........
T Consensus 178 ~~~~~~~~~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~---~~~i~~~~------ 248 (322)
T d1vzoa_ 178 EFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNS---QAEISRRI------ 248 (322)
T ss_dssp ECCGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCC---HHHHHHHH------
T ss_pred hhcccccccccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHH---HHHHHHhc------
Confidence 7765544445556799999999999765 468899999999999999999999974432211 11110000
Q ss_pred HHhhhhhhccCChhHHHHHHHHHHHHhccCCCCCCC-----HHHHHH
Q 044312 504 EILDARVMKQGGKDEIITVAKLAKRCLNLNGKKRPT-----MREVAS 545 (608)
Q Consensus 504 ~~~d~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPs-----~~evl~ 545 (608)
.......+...+.++.+|+.+||+.||++||| ++|+++
T Consensus 249 ----~~~~~~~~~~~s~~~~~li~~~l~~dP~~R~s~~~~t~~eil~ 291 (322)
T d1vzoa_ 249 ----LKSEPPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKE 291 (322)
T ss_dssp ----HHCCCCCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHT
T ss_pred ----ccCCCCCcccCCHHHHHHHHHHcccCHHHcCCCCcccHHHHHc
Confidence 01112234466788999999999999999995 677764
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=100.00 E-value=1.4e-37 Score=321.63 Aligned_cols=242 Identities=23% Similarity=0.314 Sum_probs=183.3
Q ss_pred cCccccceeccCce---------------EEEEEeecChhhHHHHHHHHHHHhhcC-CCCccceeccccc--CccceEEE
Q 044312 289 DNFDLNRILGQGGQ---------------AVKKSKVIDESKVEEFINEVVILSQIN-HRNVVKLLGCCLE--TEVPLLVY 350 (608)
Q Consensus 289 ~~f~~~~~lG~G~~---------------avk~~~~~~~~~~~~~~~Ei~il~~l~-H~niv~l~~~~~~--~~~~~lV~ 350 (608)
++|++.++||+|+| |||+++. ...+.+.+|+.+|++++ ||||+++++++.. ....++||
T Consensus 35 d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~---~~~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~~~v~ 111 (328)
T d3bqca1 35 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKP---VKKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVF 111 (328)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECS---SCHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSEEEEE
T ss_pred cCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECH---HHHHHHHHHHHHHHhccCCCCCcEEEEEEEecCCCceeEEE
Confidence 57999999999985 6776653 44678899999999995 9999999999864 45689999
Q ss_pred eecCCCccchhccccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEEcCC-CcEEEeeccCcccccc
Q 044312 351 EFIPNGTLFQYIHDQNEDFPITWEIRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDK-YRAKVSDFGASRSMAV 429 (608)
Q Consensus 351 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~-~~~kl~DFGls~~~~~ 429 (608)
||+++++|..+.+ .+++..+..++.||+.||+|||+++ |+||||||+|||++.+ ..+||+|||+|+....
T Consensus 112 e~~~~~~L~~~~~------~l~e~~i~~i~~qil~aL~~LH~~g---IvHrDiKp~NILi~~~~~~vkl~DFG~a~~~~~ 182 (328)
T d3bqca1 112 EHVNNTDFKQLYQ------TLTDYDIRFYMYEILKALDYCHSMG---IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHP 182 (328)
T ss_dssp ECCCSCBGGGTTT------SCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTTEEEECCGGGCEECCT
T ss_pred eecCCCcHHHHhc------CCCHHHHHHHHHHHHHHHHHHhhcc---cccccccccceEEcCCCCeeeecccccceeccC
Confidence 9999999877642 4899999999999999999999999 9999999999999865 4699999999987654
Q ss_pred CCcceeeeeeccCCCCChhhhccC-CCCCccchHhHHHHHHHHHhCCCCCCccchhhcccHHHHHHHHhhhhhhHHHhhh
Q 044312 430 DQTHMTTQVHGTFGYLDPEYFRSS-QFTDKSDVYSFGVVLTELLTGEKPIRFTILEEDKSLAAYFLCAMKEERLFEILDA 508 (608)
Q Consensus 430 ~~~~~~~~~~gt~~y~aPE~~~~~-~~t~ksDV~S~Gvvl~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 508 (608)
.. ......+|+.|+|||.+.+. .++.++||||+|++++||++|+.||......... ...................
T Consensus 183 ~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~--~~~i~~~~g~~~~~~~~~~ 258 (328)
T d3bqca1 183 GQ--EYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQ--LVRIAKVLGTEDLYDYIDK 258 (328)
T ss_dssp TC--CCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHH--HHHHHHHHCHHHHHHHHHH
T ss_pred CC--cccccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCchhHHH--HHHHHHHHCCchhhhhhhh
Confidence 33 23445689999999998765 4799999999999999999999998744322111 0111111111000000000
Q ss_pred -----------------------hhhccCChhHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 044312 509 -----------------------RVMKQGGKDEIITVAKLAKRCLNLNGKKRPTMREVASE 546 (608)
Q Consensus 509 -----------------------~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~evl~~ 546 (608)
..........+.++.+|+.+||+.||++|||++|++++
T Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L~H 319 (328)
T d3bqca1 259 YNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEH 319 (328)
T ss_dssp TTCCCCGGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred cccccCcccchhcccccccchhhcccccccccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 00011112345678999999999999999999999863
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.8e-37 Score=324.21 Aligned_cols=244 Identities=20% Similarity=0.304 Sum_probs=176.7
Q ss_pred cCccccceeccCce---------------EEEEEee--cChhhHHHHHHHHHHHhhcCCCCccceeccccc------Ccc
Q 044312 289 DNFDLNRILGQGGQ---------------AVKKSKV--IDESKVEEFINEVVILSQINHRNVVKLLGCCLE------TEV 345 (608)
Q Consensus 289 ~~f~~~~~lG~G~~---------------avk~~~~--~~~~~~~~~~~Ei~il~~l~H~niv~l~~~~~~------~~~ 345 (608)
++|++.++||+|+| |||++.. .+....+.+.+|+.+|++++|||||++++++.. ...
T Consensus 17 ~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~~~ 96 (355)
T d2b1pa1 17 KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQD 96 (355)
T ss_dssp TTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCCE
T ss_pred CCeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhcCHHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccccccCce
Confidence 57999999999984 8888764 344556789999999999999999999999863 357
Q ss_pred ceEEEeecCCCccchhccccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEEcCCCcEEEeeccCcc
Q 044312 346 PLLVYEFIPNGTLFQYIHDQNEDFPITWEIRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASR 425 (608)
Q Consensus 346 ~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGls~ 425 (608)
.++||||+.++.+ +.+.. .+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+|++|||+++
T Consensus 97 ~~iv~Ey~~~~l~-~~~~~-----~~~~~~i~~~~~qil~gl~~LH~~g---iiHrDlKP~Nil~~~~~~~kl~df~~~~ 167 (355)
T d2b1pa1 97 VYLVMELMDANLC-QVIQM-----ELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLAR 167 (355)
T ss_dssp EEEEEECCSEEHH-HHHTS-----CCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCCCC--
T ss_pred eEEEEeccchHHH-Hhhhc-----CCCHHHHHHHHHHHHHHHHHhhhcc---cccccCCccccccccccceeeechhhhh
Confidence 8999999966544 44432 4899999999999999999999999 9999999999999999999999999988
Q ss_pred ccccCCcceeeeeeccCCCCChhhhccCCCCCccchHhHHHHHHHHHhCCCCCCccchhhcccHHHHHHHHhh-------
Q 044312 426 SMAVDQTHMTTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLTELLTGEKPIRFTILEEDKSLAAYFLCAMK------- 498 (608)
Q Consensus 426 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~elltg~~p~~~~~~~~~~~l~~~~~~~~~------- 498 (608)
...... ..+...+|+.|+|||++.+..++.++||||+||+++||++|+.||........ +.. ......
T Consensus 168 ~~~~~~--~~~~~~~t~~y~aPE~l~~~~~~~~~DiwSlG~~l~ell~g~~pF~~~~~~~~--~~~-i~~~~~~~~~~~~ 242 (355)
T d2b1pa1 168 TAGTSF--MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQ--WNK-VIEQLGTPCPEFM 242 (355)
T ss_dssp ---------------CCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHH--HHH-HHHHHCCCCHHHH
T ss_pred cccccc--ccccccccccccChhhhcCCCCCCCcccccccchHHHHhhCCCCCCCCCHHHH--HHH-HHHhccCCCHHHH
Confidence 665332 33455789999999999999999999999999999999999999964321111 000 000000
Q ss_pred ---hhhhHHHhhh---------------hhhcc---CChhHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 044312 499 ---EERLFEILDA---------------RVMKQ---GGKDEIITVAKLAKRCLNLNGKKRPTMREVASE 546 (608)
Q Consensus 499 ---~~~~~~~~d~---------------~~~~~---~~~~~~~~l~~Li~~cl~~dp~~RPs~~evl~~ 546 (608)
.......... ..... .....+.++.+|+.+||..||++|||++||+++
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL~H 311 (355)
T d2b1pa1 243 KKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQH 311 (355)
T ss_dssp TTSCHHHHHHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred HHhhhhHHHHhhcCccccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence 0000001110 00000 112346678999999999999999999999865
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.1e-37 Score=322.77 Aligned_cols=245 Identities=22% Similarity=0.268 Sum_probs=181.3
Q ss_pred hcCccccceeccCce---------------EEEEEeec--ChhhHHHHHHHHHHHhhcCCCCccceecccccC-----cc
Q 044312 288 TDNFDLNRILGQGGQ---------------AVKKSKVI--DESKVEEFINEVVILSQINHRNVVKLLGCCLET-----EV 345 (608)
Q Consensus 288 t~~f~~~~~lG~G~~---------------avk~~~~~--~~~~~~~~~~Ei~il~~l~H~niv~l~~~~~~~-----~~ 345 (608)
.++|++.++||+|+| |||+++.. +....+.+.+|+.+|++++|||||++++++... ..
T Consensus 17 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~~ 96 (348)
T d2gfsa1 17 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN 96 (348)
T ss_dssp ETTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTCC
T ss_pred CCCeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchhcChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeccccccCc
Confidence 567999999999984 88887642 334567899999999999999999999998533 34
Q ss_pred ceEEEeecCCCccchhccccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEEcCCCcEEEeeccCcc
Q 044312 346 PLLVYEFIPNGTLFQYIHDQNEDFPITWEIRLRIAIEVSGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVSDFGASR 425 (608)
Q Consensus 346 ~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGls~ 425 (608)
.+++++++.+|+|.+++... .+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+|++|||++.
T Consensus 97 ~~~i~~~~~gg~L~~~~~~~----~l~e~~~~~i~~qil~aL~~LH~~g---iiHrDiKp~NILi~~~~~~kl~dfg~a~ 169 (348)
T d2gfsa1 97 DVYLVTHLMGADLNNIVKCQ----KLTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR 169 (348)
T ss_dssp CCEEEEECCSEEHHHHHTTC----CCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECCC----
T ss_pred eEEEEEeecCCchhhhcccc----cccHHHHHHHHHHHHHHHHHHHhCC---CcccccCCccccccccccccccccchhc
Confidence 46777888899999998643 4999999999999999999999999 9999999999999999999999999997
Q ss_pred ccccCCcceeeeeeccCCCCChhhhccC-CCCCccchHhHHHHHHHHHhCCCCCCccchhhcccHHHHHHHHhhhh--h-
Q 044312 426 SMAVDQTHMTTQVHGTFGYLDPEYFRSS-QFTDKSDVYSFGVVLTELLTGEKPIRFTILEEDKSLAAYFLCAMKEE--R- 501 (608)
Q Consensus 426 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~t~ksDV~S~Gvvl~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~--~- 501 (608)
..... .....||+.|+|||.+.+. .++.++|||||||+++||++|+.||........ ........... .
T Consensus 170 ~~~~~----~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~~~---~~~i~~~~~~~~~~~ 242 (348)
T d2gfsa1 170 HTDDE----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQ---LKLILRLVGTPGAEL 242 (348)
T ss_dssp CCTGG----GSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHH---HHHHHHHHCCCCHHH
T ss_pred ccCcc----cccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCCCHHHH---HHHHHHhcCCCChHH
Confidence 65422 2345689999999987765 468999999999999999999999974322111 11111110000 0
Q ss_pred --------hHHHhhhhhh-cc-----CChhHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 044312 502 --------LFEILDARVM-KQ-----GGKDEIITVAKLAKRCLNLNGKKRPTMREVASE 546 (608)
Q Consensus 502 --------~~~~~d~~~~-~~-----~~~~~~~~l~~Li~~cl~~dp~~RPs~~evl~~ 546 (608)
.......... .. .....+.++.+|+.+||+.||++|||++|++++
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~elL~H 301 (348)
T d2gfsa1 243 LKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH 301 (348)
T ss_dssp HTTCCCHHHHHHHTTSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred hhhccchhhhhhhhhcccCCCcchhhhcCCCCHHHHHHHHHHCcCChhhCcCHHHHhcC
Confidence 0000000000 00 011235678999999999999999999999864
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=99.98 E-value=8.5e-33 Score=289.03 Aligned_cols=249 Identities=22% Similarity=0.228 Sum_probs=176.5
Q ss_pred CccccceeccCce---------------EEEEEeecChhhHHHHHHHHHHHhhcC-----------CCCccceecccccC
Q 044312 290 NFDLNRILGQGGQ---------------AVKKSKVIDESKVEEFINEVVILSQIN-----------HRNVVKLLGCCLET 343 (608)
Q Consensus 290 ~f~~~~~lG~G~~---------------avk~~~~~~~~~~~~~~~Ei~il~~l~-----------H~niv~l~~~~~~~ 343 (608)
+|++.++||+|+| |||+++. +....+.+.+|+.++++++ |+||+++++++...
T Consensus 14 rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~-~~~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~~~~ 92 (362)
T d1q8ya_ 14 RYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRG-DKVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNHK 92 (362)
T ss_dssp TEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECS-CHHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEEE
T ss_pred cEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEec-cccchHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEEeeec
Confidence 5999999999985 7777653 3334577889999998885 57899999888643
Q ss_pred --ccceEEEeecCCCccchhccccCCCCCCCHHHHHHHHHHHHHHHHHHhh-cCCCCeeccCCCCCcEEEcCCC------
Q 044312 344 --EVPLLVYEFIPNGTLFQYIHDQNEDFPITWEIRLRIAIEVSGALSYLHS-AASIPIYHRDIKSTNILLDDKY------ 414 (608)
Q Consensus 344 --~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~-~~~~~iiHrDlk~~NILl~~~~------ 414 (608)
...+++|+++..+..............+++..+..++.||+.||+|||+ .+ |+||||||+||||+.++
T Consensus 93 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh~~~~---IvHrDlKp~NIll~~~~~~~~~~ 169 (362)
T d1q8ya_ 93 GPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCG---IIHTDIKPENVLMEIVDSPENLI 169 (362)
T ss_dssp ETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTC---EECSCCSGGGEEEEEEETTTTEE
T ss_pred cccceeeeeeecccccccccccccccccCCcHHHHHHHHHHHHHHHHHHhhhcC---cccccCChhHeeeeccCcccccc
Confidence 3456677776655544443333334468999999999999999999998 77 99999999999998654
Q ss_pred cEEEeeccCccccccCCcceeeeeeccCCCCChhhhccCCCCCccchHhHHHHHHHHHhCCCCCCccchhhcccHHHHHH
Q 044312 415 RAKVSDFGASRSMAVDQTHMTTQVHGTFGYLDPEYFRSSQFTDKSDVYSFGVVLTELLTGEKPIRFTILEEDKSLAAYFL 494 (608)
Q Consensus 415 ~~kl~DFGls~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~elltg~~p~~~~~~~~~~~l~~~~~ 494 (608)
.+|++|||.+...... .....||+.|+|||++....++.++||||+||+++||++|+.||................
T Consensus 170 ~~kl~dfg~s~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pF~~~~~~~~~~~~~~~~ 245 (362)
T d1q8ya_ 170 QIKIADLGNACWYDEH----YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIA 245 (362)
T ss_dssp EEEECCCTTCEETTBC----CCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHHHHHH
T ss_pred eeeEeecccccccccc----cccccccccccChhhccccCCCccccccchHHHHHHHHHCCCCCCCCccccccchhHHHH
Confidence 3999999999765422 234568999999999999999999999999999999999999986432211111111110
Q ss_pred ---HHhhh---hhh------HHHhh-------------------hhhhccCChhHHHHHHHHHHHHhccCCCCCCCHHHH
Q 044312 495 ---CAMKE---ERL------FEILD-------------------ARVMKQGGKDEIITVAKLAKRCLNLNGKKRPTMREV 543 (608)
Q Consensus 495 ---~~~~~---~~~------~~~~d-------------------~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~ev 543 (608)
..+.. ... ....+ ...........+.++.+|+.+||..||++|||++|+
T Consensus 246 ~~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~Rpta~e~ 325 (362)
T d1q8ya_ 246 QIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAGGL 325 (362)
T ss_dssp HHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCHHHH
T ss_pred HHHHHhCCCCHHHhhcccccccccccchhhhccccccCCchhhhcccccccCcccCHHHHHHHHHHCCCChhHCcCHHHH
Confidence 00000 000 00000 001122345667889999999999999999999999
Q ss_pred HHH
Q 044312 544 ASE 546 (608)
Q Consensus 544 l~~ 546 (608)
+++
T Consensus 326 L~H 328 (362)
T d1q8ya_ 326 VNH 328 (362)
T ss_dssp HTC
T ss_pred hcC
Confidence 743
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.70 E-value=6.6e-18 Score=159.01 Aligned_cols=125 Identities=18% Similarity=0.188 Sum_probs=92.2
Q ss_pred HHHHHHHHHHhhcCCCCccceecccccCccceEEEeecCCCccchhccccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCC
Q 044312 316 EEFINEVVILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEIRLRIAIEVSGALSYLHSAAS 395 (608)
Q Consensus 316 ~~~~~Ei~il~~l~H~niv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~ 395 (608)
..+.+|...+.++.|.++++.+++. ..+|+|||+++..+.+ ++......++.|++++|+|||+++
T Consensus 59 ~~~~~e~~~l~~l~~~~v~~~~~~~----~~~lvme~~~~~~~~~----------l~~~~~~~i~~ql~~~l~~lH~~g- 123 (191)
T d1zara2 59 RSARNEFRALQKLQGLAVPKVYAWE----GNAVLMELIDAKELYR----------VRVENPDEVLDMILEEVAKFYHRG- 123 (191)
T ss_dssp HHHHHHHHHHHHTTTSSSCCEEEEE----TTEEEEECCCCEEGGG----------CCCSCHHHHHHHHHHHHHHHHHTT-
T ss_pred HHHHHHHHHHHHccCCCcceEEEec----CCEEEEEeeccccccc----------hhhHHHHHHHHHHHHHHHHHhhCC-
Confidence 3456788999999999999888653 3479999998765433 233345678999999999999999
Q ss_pred CCeeccCCCCCcEEEcCCCcEEEeeccCccccccCCcceeeeeeccCCCCCh------hhhccCCCCCccchHhHHHHH
Q 044312 396 IPIYHRDIKSTNILLDDKYRAKVSDFGASRSMAVDQTHMTTQVHGTFGYLDP------EYFRSSQFTDKSDVYSFGVVL 468 (608)
Q Consensus 396 ~~iiHrDlk~~NILl~~~~~~kl~DFGls~~~~~~~~~~~~~~~gt~~y~aP------E~~~~~~~t~ksDV~S~Gvvl 468 (608)
|+||||||+|||++++ .++|+|||+|+......... |+.. +. ....|+.++|+||..--+
T Consensus 124 --iiHrDiKP~NILv~~~-~~~liDFG~a~~~~~~~~~~---------~l~rd~~~~~~~-f~r~y~~~~d~~s~~~~~ 189 (191)
T d1zara2 124 --IVHGDLSQYNVLVSEE-GIWIIDFPQSVEVGEEGWRE---------ILERDVRNIITY-FSRTYRTEKDINSAIDRI 189 (191)
T ss_dssp --EECSCCSTTSEEEETT-EEEECCCTTCEETTSTTHHH---------HHHHHHHHHHHH-HHHHHCCCCCHHHHHHHH
T ss_pred --EEEccCChhheeeeCC-CEEEEECCCcccCCCCCcHH---------HHHHHHHHHHHH-HcCCCCCcccHHHHHHHH
Confidence 9999999999999965 58999999997654322110 1110 11 135678899999976443
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=97.80 E-value=3.5e-05 Score=73.58 Aligned_cols=116 Identities=16% Similarity=0.104 Sum_probs=80.5
Q ss_pred eEEEEEeecChhhHHHHHHHHHHHhhcC-CCCccceecccccCccceEEEeecCCCccchhccccCCCCCCCHHHHHHHH
Q 044312 302 QAVKKSKVIDESKVEEFINEVVILSQIN-HRNVVKLLGCCLETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEIRLRIA 380 (608)
Q Consensus 302 ~avk~~~~~~~~~~~~~~~Ei~il~~l~-H~niv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~ 380 (608)
+.||+...........+.+|...+..+. +--+.+++.+..+.+..++||+++++.++.+..... .. ...++
T Consensus 40 ~vlk~~~~~~~~~~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~~~~~lv~~~l~G~~~~~~~~~~-----~~---~~~~~ 111 (263)
T d1j7la_ 40 LYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLLMSEADGVLCSEEYEDE-----QS---PEKII 111 (263)
T ss_dssp EEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCSSEEHHHHTTTC-----SC---HHHHH
T ss_pred EEEEEcCCCcccchhhHHHHHHHHHHHhccCCCCcEEEEEecCCceEEEEEeccccccccccccc-----cc---HHHHH
Confidence 5666665544445566788998888774 434678888887788899999999998776543221 11 22345
Q ss_pred HHHHHHHHHHhhcC--------------------------------------------------------CCCeeccCCC
Q 044312 381 IEVSGALSYLHSAA--------------------------------------------------------SIPIYHRDIK 404 (608)
Q Consensus 381 ~~ia~aL~yLH~~~--------------------------------------------------------~~~iiHrDlk 404 (608)
.++++.|+.||+.. ...++|+|+.
T Consensus 112 ~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~HgD~~ 191 (263)
T d1j7la_ 112 ELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDTPFKDPRELYDFLKTEKPEEELVFSHGDLG 191 (263)
T ss_dssp HHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCCGGGGSTTCSCSSHHHHHHHHHHSCCCCCEEEECSCCC
T ss_pred HHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHHHhhhhhhhcccccccchHHHHHHHHHHhcCCcCCcEEEEeecc
Confidence 55666666666421 0127899999
Q ss_pred CCcEEEcCCCcEEEeeccCcc
Q 044312 405 STNILLDDKYRAKVSDFGASR 425 (608)
Q Consensus 405 ~~NILl~~~~~~kl~DFGls~ 425 (608)
|.|||++++...-|.||+.+.
T Consensus 192 ~~Nil~~~~~~~~lIDwe~a~ 212 (263)
T d1j7la_ 192 DSNIFVKDGKVSGFIDLGRSG 212 (263)
T ss_dssp TTSEEEETTEEEEECCCTTCE
T ss_pred CcceeecCCceEEEeechhcc
Confidence 999999987667799998775
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=97.04 E-value=0.00037 Score=65.81 Aligned_cols=110 Identities=18% Similarity=0.172 Sum_probs=69.5
Q ss_pred eEEEEEeecChhhHHHHHHHHHHHhhcCC--CCccceecccccCccceEEEeecCCCccchhccccCCCCCCCHHHHHHH
Q 044312 302 QAVKKSKVIDESKVEEFINEVVILSQINH--RNVVKLLGCCLETEVPLLVYEFIPNGTLFQYIHDQNEDFPITWEIRLRI 379 (608)
Q Consensus 302 ~avk~~~~~~~~~~~~~~~Ei~il~~l~H--~niv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i 379 (608)
+.+|..... ....+..|...|+.|.. -.+.+++.+..+.+..++||++++|.++.+.. ... ..+
T Consensus 38 ~vlK~~~~~---~~~~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v~~~i~G~~~~~~~--------~~~---~~~ 103 (255)
T d1nd4a_ 38 LFVKTDLSG---ALNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQDLLSSH--------LAP---AEK 103 (255)
T ss_dssp EEEEEECSC---TTSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEETTTSC--------CCH---HHH
T ss_pred EEEEeCCcc---CHhHHHHHHHHHHHHHhcCCCCCceeeecccccceEEEEEeeecccccccc--------ccH---HHH
Confidence 345544332 33456778888877743 34677888888888899999999887664421 110 111
Q ss_pred HHHHHHHHHHHhh---------------------------------------------------cC----CCCeeccCCC
Q 044312 380 AIEVSGALSYLHS---------------------------------------------------AA----SIPIYHRDIK 404 (608)
Q Consensus 380 ~~~ia~aL~yLH~---------------------------------------------------~~----~~~iiHrDlk 404 (608)
+.++++.|.-||+ .. .+.++|+|+.
T Consensus 104 ~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~liHgD~~ 183 (255)
T d1nd4a_ 104 VSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAELFARLKARMPDGEDLVVTHGDAC 183 (255)
T ss_dssp HHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHHHHHHHHHTCCSSCCEEEECSSCC
T ss_pred HHHHHHHHHHHccCChhhCCCcccchhhHHHHHHHHHHhhhccccccchhhhhHHHHHHHHHHHhCCccCCceEEeCCCC
Confidence 2233333333332 11 1127999999
Q ss_pred CCcEEEcCCCcEEEeeccCcc
Q 044312 405 STNILLDDKYRAKVSDFGASR 425 (608)
Q Consensus 405 ~~NILl~~~~~~kl~DFGls~ 425 (608)
|.|||++++..+-|.||+.+.
T Consensus 184 ~~Nvl~~~~~~~~iID~~~~~ 204 (255)
T d1nd4a_ 184 LPNIMVENGRFSGFIDCGRLG 204 (255)
T ss_dssp GGGEEEETTEEEEECCCTTCE
T ss_pred CcceEEeCCceEEEEEchhcc
Confidence 999999987667899998764
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=94.53 E-value=0.028 Score=56.32 Aligned_cols=29 Identities=21% Similarity=0.287 Sum_probs=24.9
Q ss_pred CeeccCCCCCcEEEcCCCcEEEeeccCccc
Q 044312 397 PIYHRDIKSTNILLDDKYRAKVSDFGASRS 426 (608)
Q Consensus 397 ~iiHrDlk~~NILl~~~~~~kl~DFGls~~ 426 (608)
.++|+|+.|.|||++++ .++|.||..+..
T Consensus 224 ~LiHGDl~~gNIlv~~~-~~~vID~E~a~~ 252 (392)
T d2pula1 224 TLIHGDLHTGSIFASEH-ETKVIDPEFAFY 252 (392)
T ss_dssp EEECSCCCGGGEEECSS-CEEECCCTTCEE
T ss_pred ceeccCCcCCceeEcCC-ceEEechhhccc
Confidence 48999999999999976 489999987653
|
| >d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Choline kinase domain: Choline kinase species: Caenorhabditis elegans [TaxId: 6239]
Probab=93.62 E-value=0.049 Score=54.40 Aligned_cols=41 Identities=27% Similarity=0.395 Sum_probs=28.7
Q ss_pred HHHHHHHHHHHhhcCCCCc-cceecccccCccceEEEeecCCCccc
Q 044312 315 VEEFINEVVILSQINHRNV-VKLLGCCLETEVPLLVYEFIPNGTLF 359 (608)
Q Consensus 315 ~~~~~~Ei~il~~l~H~ni-v~l~~~~~~~~~~~lV~E~~~~gsL~ 359 (608)
.....+|..+++.+.-.++ .++++++.+ .+|+||+++.+|.
T Consensus 88 ~idr~~E~~i~~~ls~~gl~Pkll~~~~~----g~I~efi~g~~l~ 129 (395)
T d1nw1a_ 88 ESHLVAESVIFTLLSERHLGPKLYGIFSG----GRLEEYIPSRPLS 129 (395)
T ss_dssp HHHHHHHHHHHHHHHHTTSSSCEEEEETT----EEEECCCCEEECC
T ss_pred hhHHHHHHHHHHHHHhCCCCCeEEEEcCC----ceEEEEeccccCC
Confidence 3456689999988843344 577887753 6899999875553
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Probab=89.91 E-value=0.41 Score=45.93 Aligned_cols=29 Identities=28% Similarity=0.383 Sum_probs=23.3
Q ss_pred CCeeccCCCCCcEEEcCCCcEEEeeccCccc
Q 044312 396 IPIYHRDIKSTNILLDDKYRAKVSDFGASRS 426 (608)
Q Consensus 396 ~~iiHrDlk~~NILl~~~~~~kl~DFGls~~ 426 (608)
..++|+|+.+.|||++++ ..+.||+-+..
T Consensus 192 ~~liHgDlh~~NvL~~~~--~~~IDFdd~~~ 220 (325)
T d1zyla1 192 VLRLHGDCHAGNILWRDG--PMFVDLDDARN 220 (325)
T ss_dssp CEECCSSCSGGGEEESSS--EEECCCTTCCE
T ss_pred ceeecCCCCcccEEEeCC--ceEEechhccc
Confidence 348999999999999754 45889997753
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=84.74 E-value=0.28 Score=46.73 Aligned_cols=29 Identities=17% Similarity=0.203 Sum_probs=25.9
Q ss_pred CeeccCCCCCcEEEcCCCcEEEeeccCcc
Q 044312 397 PIYHRDIKSTNILLDDKYRAKVSDFGASR 425 (608)
Q Consensus 397 ~iiHrDlk~~NILl~~~~~~kl~DFGls~ 425 (608)
.+||+|+.+.||+++.+...-|.||+.+.
T Consensus 184 giIHgDl~~dNvl~~~~~v~gvIDF~~~~ 212 (316)
T d2ppqa1 184 GVIHADLFQDNVFFLGDELSGLIDFYFAC 212 (316)
T ss_dssp EEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred ccccCCcchhhhhcccccceeEecccccc
Confidence 39999999999999988777899999874
|
| >d1gl4a2 g.3.11.5 (A:359-398) EGF-like domain of nidogen-1 {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Knottins (small inhibitors, toxins, lectins) superfamily: EGF/Laminin family: EGF-like domain of nidogen-1 domain: EGF-like domain of nidogen-1 species: Mouse (Mus musculus) [TaxId: 10090]
Probab=82.41 E-value=0.13 Score=33.06 Aligned_cols=24 Identities=13% Similarity=0.163 Sum_probs=19.2
Q ss_pred ccCCCcccccccCcccCccccccc
Q 044312 162 GVCYEDYNSQTKVCNKDDRCLIQL 185 (608)
Q Consensus 162 ~~C~~~s~c~~~~~gy~c~C~~gy 185 (608)
..|.....|.+...+|.|.|..||
T Consensus 7 ~~C~~~A~C~Nt~Gsy~C~C~~Gy 30 (40)
T d1gl4a2 7 HQCSVHAECRDYATGFCCRCVANY 30 (40)
T ss_dssp GGSCTTEEEEECSSCEEEEECTTE
T ss_pred CCCCCCCEeecCCCCeEeECCCCC
Confidence 356666778766678999999999
|